Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
A4GALT	"A14GALT, Gb3S, P(k), P1"	ENSG00000128274	"Alpha 1,4-galactosyltransferase (P blood group)"	Q9NPC4	22	42692112-42721298	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 21.5;ASC TERT1: 17.6;TIME: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"NK-cell: 1.4;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	13	"dendritic cells: 3.4;NK-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001141			Uncertain	Mitochondria				Mitochondria		"HPA001141: AB_1078139"	"unprognostic (2.59e-2)"	"prognostic favourable (2.48e-4)"	"unprognostic (2.24e-2)"	"unprognostic (4.54e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.82e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.74e-1)"	22.7	5.9	3.5	8.2	3.7	3.8	15.3	1.4	3.8	21.2	12.0	2.3	32.6	4.8	13.0	16.9	15.0	11.7	11.0	26.8	2.3	1.3	30.0	4.4	14.0	6.4	2.9	3.0	11.8	3.4	1.4	7.7	12.6	2.9	15.4	2.1	9.9	15.4	39.8	12.5	8.7	7.0	18.6	5.3	11.4	11.3	6.7	2.4	1.3	10.7	13.0	10.1	16.1	25.6	0.1	3.4	0.0	0.0	1.4	0.0	0.0	0.6	7.3	0.0	0.0	21.5	17.6	11.0	2.9	3.1	0.6	1.1	2.3	1.2	7.1	5.1	5.1	0.7	7.0	3.4	0.1	0.0	1.4	0.1	11.5	0.2	6.5	0.0	0.5	10.3	1.0	3.0	0.5	2.5	0.0	0.0	2.7	10.0	0.0	0.0	0.9	1.8	0.0	1.6	0.7	14.5	12.5	0.1	0.0	8.9	0.2	0.0	5.7	0.8	15.4	0.0	1.4	13.1	3.8	1.5	6.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	3.4	0.0	0.0	3.5	3.7	1.4	3.8	2.3	1.3	2.9	3.0	2.9	2.4
AAED1	C9orf21	ENSG00000158122	"AhpC/TSA antioxidant enzyme domain containing 1"	Q7RTV5	9	96639577-96655303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021294	Approved									"HPA021294: AB_1845818"	"unprognostic (4.17e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.35e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (3.13e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.70e-2)"	27.7	7.4	4.9	7.4	6.3	12.5	20.5	2.6	4.8	11.5	10.5	6.2	3.0	4.6	11.2	11.2	11.6	11.3	11.2	41.9	5.1	4.8	13.7	11.1	13.1	15.8	7.3	3.3	13.9	10.5	4.5	6.0	8.0	5.6	9.9	5.6	9.4	6.0	5.1	26.6	7.0	7.4	14.0	10.0	15.3	8.2	10.7	5.2	2.9	19.1	11.1	7.5	16.3	10.0	6.7	5.4	25.7	7.1	3.6	6.9	1.9	7.0	3.7	1.8	6.4	15.3	26.2	7.2	7.7	11.9	6.7	6.5	8.1	8.0	0.2	6.5	12.7	6.7	6.2	3.8	4.0	7.0	3.8	4.0	3.3	6.7	11.7	3.2	11.6	12.5	6.6	4.7	5.9	5.7	7.8	3.1	6.8	4.9	0.1	5.7	2.4	6.9	0.1	5.3	0.1	9.4	1.7	2.9	3.7	5.7	4.9	4.1	1.9	5.9	10.5	11.3	4.7	10.9	5.1	8.1	3.6	2.7	4.9	3.0	10.3	25.7	6.5	13.9	6.8	7.1	6.9	6.7	6.4	6.7	5.4	5.3	3.4	5.7	1.3	3.6	6.3	3.5	6.4	1.9	4.9	6.3	2.6	4.3	5.1	4.8	7.3	3.3	5.6	5.2
AARD	"C8orf85, LOC441376"	ENSG00000205002	"Alanine and arginine rich domain containing protein"	Q4LEZ3	8	116938199-116944487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 18.4;testis: 43.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 19.7;SK-BR-3: 11.2;U-2 OS: 5.4;U-266/84: 4.0"	"Cancer enriched"	"Detected in many"	8	"breast cancer: 27.0"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	4	"midbrain: 7.3"	HPA068290			Approved	"Lipid droplets"				"Lipid droplets"		"HPA068290: "	"unprognostic (5.81e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.28e-8)"	"unprognostic (3.42e-2)"	"unprognostic (4.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.29e-2)"	"unprognostic (8.57e-3)"	"unprognostic (4.20e-1)"	"unprognostic (2.23e-6)"	"unprognostic (1.67e-1)"	"unprognostic (9.78e-3)"	"unprognostic (3.77e-2)"	"unprognostic (5.27e-4)"	0.4	0.8	0.7	1.8	1.2	0.3	4.9	0.0	0.9	0.3	4.5	0.0	0.0	0.2	1.1	0.8	8.1	0.2	0.4	0.1	0.5	0.6	1.3	0.1	2.9	1.0	0.4	0.5	0.1	0.1	0.1	0.0	0.6	0.5	8.4	0.7	4.0	2.1	0.2	0.2	1.1	0.8	18.4	0.1	0.3	7.2	43.6	0.1	0.0	0.2	0.2	0.5	10.2	5.6	1.1	1.0	3.3	0.9	1.5	2.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.2	1.6	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.5	0.0	0.2	0.1	2.3	0.0	0.2	0.4	0.0	0.1	0.1	0.0	0.0	2.3	0.1	0.4	0.8	0.1	1.1	2.0	0.0	0.0	0.1	0.0	0.0	1.9	0.3	0.0	11.2	0.0	0.5	0.0	0.0	0.1	5.4	0.2	0.0	1.6	4.0	0.0	2.9	0.1	0.3	3.3	0.9	0.6	0.6	0.4	0.3	0.6	0.5	0.4	0.2	1.1	0.5	0.6	3.1	1.5	0.6	1.0	2.0	0.1	0.7	1.2	0.0	0.4	0.5	0.6	0.4	0.5	0.5	0.1
ABCA10	EST698739	ENSG00000154263	"ATP binding cassette subfamily A member 10"	Q8WWZ4	17	69147214-69244846	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ovary: 11.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.7;HSkMC: 3.7;HUVEC TERT2: 3.6;RT4: 3.5;U-2197: 5.4"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.8"									HPA014535	Uncertain									"HPA014535: AB_1844426"	"unprognostic (1.45e-4)"	"unprognostic (3.17e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"unprognostic (4.91e-1)"	"unprognostic (2.70e-4)"	"unprognostic (5.23e-3)"	"unprognostic (6.98e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.86e-3)"	4.6	0.5	0.0	0.0	0.2	0.0	10.4	5.0	0.4	1.6	1.7			0.6	2.7	2.4	1.1	6.3	3.1	2.7	0.1	0.2	0.5	2.7	2.5	0.1	0.1		11.6	1.3	0.1	1.3	0.0		0.8	3.8		2.6	0.2	3.5	4.1	1.4	1.7	0.2	0.3	1.0	1.6			3.1		0.3	1.3	1.9	0.0	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.2	0.0	1.7	0.3	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.8	0.0	0.0	0.0	1.4	0.0	1.0	0.0	0.0	3.7	0.5	0.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ABCA5	EST90625	ENSG00000154265	"ATP binding cassette subfamily A member 5"	Q8WWZ7	17	69244311-69327244	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 52.8"	"Cell line enhanced"	"Detected in many"		"SiHa: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022032, HPA062904"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA022032: AB_1844427, HPA062904: "	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.17e-2)"	"unprognostic (8.05e-4)"	"unprognostic (3.05e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"prognostic favourable (9.97e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.52e-2)"	10.5	8.6	6.7	3.8	9.8	6.0	12.7	35.6	12.4	8.8	9.6	4.3	13.5	9.7	6.0	7.7	8.6	6.6	4.6	5.2	5.3	6.2	7.9	21.7	4.9	3.3	4.1	7.9	6.9	20.3	13.0	35.9	5.3	13.6	7.4	10.6	15.5	8.2	11.4	52.8	24.0	15.5	3.4	7.6	4.3	8.9	9.0	3.9	1.7	7.9	10.3	5.9	5.5	8.1	4.2	3.9	4.5	0.7	3.0	4.2	1.2	4.2	2.0	1.6	2.4	7.7	5.6	0.5	4.4	4.8	4.6	6.9	0.6	1.6	0.0	2.4	3.8	6.3	1.0	3.7	5.2	0.1	2.9	0.0	4.7	2.9	10.3	0.0	2.7	5.5	4.5	1.9	5.3	10.0	0.0	1.7	0.4	3.6	2.6	0.0	1.6	2.9	0.3	0.1	0.4	0.9	7.0	8.8	1.4	15.8	7.3	4.5	7.5	2.7	7.3	5.3	1.5	4.8	0.9	9.0	0.2	0.3	2.1	0.0	4.7	0.7	0.7	4.5	3.1	0.2	4.2	2.4	4.0	3.4	0.5	4.2	2.1	3.4	1.9	3.0	0.1	3.9	2.4	1.2	6.7	9.8	35.6	12.4	5.3	6.2	4.1	7.9	13.6	3.9
ABHD12B	"BEM46L3, C14orf29"	ENSG00000131969	"Abhydrolase domain containing 12B"	Q7Z5M8	14	50872160-50904970	"Predicted intracellular proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 10.0;retina: 10.0;skin 1: 21.6"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.4;Hep G2: 1.5;NB-4: 2.5;NTERA-2: 1.7;RH-30: 2.1;SH-SY5Y: 1.4;T-47d: 1.4;THP-1: 2.0"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 7.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.3;neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.4"	"Region enriched"	"Detected in single"	5	"thalamus: 2.3"	"Low region specificity"	"Detected in many"			HPA002873	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm		"HPA002873: AB_2220573"	"unprognostic (6.61e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.99e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.31e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.70e-3)"	"unprognostic (3.16e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.68e-1)"	1.1	0.2	2.4	0.4	10.0	2.4	2.8	0.3	5.2	0.2	1.5	5.4	0.3	0.2	0.8	0.4	0.7	2.0	0.4	0.5	1.4	1.2	0.6	0.2	0.8	0.4	2.2	2.7	0.3	1.1	1.3	0.3	0.4	2.2	0.3	2.4	10.0	0.2	0.2	0.2	21.6	0.3	0.2	0.7	0.2	0.2	1.2	3.9	0.0	0.4	0.0	0.3	0.2	0.2	0.0	0.1	5.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.5	0.5	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.7	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.9	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	2.4	10.0	0.3	5.2	1.4	1.2	2.2	2.7	2.2	3.9
ABHD13	"bA153I24.2, BEM46L1, C13orf6, FLJ14906"	ENSG00000139826	"Abhydrolase domain containing 13"	Q7L211	13	108218379-108234255	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032143, HPA032144"	Approved		Approved	Cytosol				Cytosol		"HPA032143: AB_2674178, HPA032144: AB_10602304"	"unprognostic (2.69e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.62e-2)"	13.6	12.5	13.8	14.3	14.2	26.7	14.9	17.0	15.5	13.6	17.0	6.8	14.5	13.8	16.3	21.0	15.2	13.5	13.8	12.9	11.7	10.4	12.5	20.1	15.4	14.8	10.1	10.4	13.2	12.4	9.6	14.1	16.5	11.1	13.0	15.0	10.5	14.7	18.1	12.9	12.7	16.7	13.7	10.1	20.0	13.9	8.9	8.2	26.4	15.4	11.3	14.5	13.3	18.6	8.5	8.9	19.2	10.4	11.8	11.8	10.1	9.0	3.8	10.1	5.6	7.9	9.4	4.9	8.9	9.0	7.9	9.4	5.7	8.6	7.6	9.4	6.9	8.3	7.5	10.4	12.6	10.2	6.6	9.3	5.4	5.7	7.9	19.2	11.5	9.7	9.9	6.2	8.0	9.3	5.0	4.3	8.1	3.7	9.3	8.1	4.7	4.5	8.0	7.2	4.4	11.1	8.1	7.7	9.6	4.7	7.9	9.6	7.4	17.9	9.6	5.6	5.8	6.6	6.0	8.5	6.7	8.4	13.3	12.1	10.2	8.7	10.4	19.2	8.0	9.5	11.8	8.5	10.9	9.5	8.9	8.1	10.5	8.7	11.3	11.8	8.4	6.7	10.2	10.1	13.8	14.2	17.0	15.5	11.7	10.4	10.1	10.4	11.1	8.2
ABHD14A	"DKFZP564O243, DORZ1"	ENSG00000248487	"Abhydrolase domain containing 14A"	Q9BUJ0	3	51971426-51981199	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 34.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038153, HPA056913"	Approved		Enhanced	Vesicles			260000	Vesicles		"HPA038153: , HPA056913: "	"unprognostic (4.15e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.92e-2)"	"prognostic favourable (4.72e-4)"	"unprognostic (3.96e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.30e-2)"	11.8	28.0	23.3	6.0	25.8	9.0	9.2	39.6	45.0	18.3	7.3	12.2	8.5	8.0	6.9	23.2	5.4	19.6	9.3	16.4	22.3	27.8	26.2	13.0	9.7	8.9	16.6	23.4	14.8	20.6	15.6	21.3	7.0	18.7	11.6	5.6	26.1	17.7	12.5	23.8	3.9	6.6	8.8	14.5	7.7	11.0	6.2	7.0	6.6	24.1	8.4	8.8	9.2	7.4	15.4	13.9	4.5	6.0	12.0	30.9	15.3	2.8	5.4	3.4	10.4	34.7	17.5	1.9	3.7	6.2	4.5	6.1	6.1	11.3	3.1	2.6	9.2	2.4	3.8	4.1	1.4	10.2	4.2	9.2	15.9	20.2	9.7	12.6	12.4	16.5	2.9	3.8	1.9	5.8	3.7	10.7	7.0	3.2	5.8	12.9	1.9	12.8	4.2	1.8	29.8	8.6	4.4	7.1	11.1	9.4	2.0	5.5	2.9	13.9	3.4	4.1	4.5	9.9	4.3	15.7	14.6	2.6	7.7	20.2	5.9	2.1	6.0	4.5	30.2	3.5	30.9	15.4	26.7	26.8	10.4	12.4	24.6	26.2	0.6	12.0	2.2	13.9	25.7	15.3	23.3	25.8	39.6	45.0	22.3	27.8	16.6	23.4	18.7	7.0
ABHD18	"C4orf29, FLJ21106"	ENSG00000164074	"Abhydrolase domain containing 18"	Q0P651	4	127965306-128039927	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050168, HPA051676"	Approved		Approved	"Nuclear membrane"	"Intracellular and membrane"			"Nuclear membrane"		"HPA050168: , HPA051676: "	"unprognostic (1.91e-1)"	"unprognostic (8.66e-2)"	"prognostic favourable (5.35e-4)"	"unprognostic (1.74e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.32e-2)"	"prognostic favourable (9.13e-4)"	7.6	8.2	7.4	13.2	10.5	9.9	8.4	14.1	7.9	7.1	13.6	8.6	8.3	13.7	9.2	9.8	7.2	7.8	9.6	25.1	7.0	7.5	9.1	15.7	9.2	12.0	7.2	5.2	10.8	24.5	8.0	16.3	7.0	8.4	6.8	10.2	7.5	8.9	11.1	18.7	10.6	19.0	9.8	9.7	10.0	8.2	4.0	8.1	18.2	9.2	10.9	10.5	8.4	7.5	10.2	8.8	14.2	7.1	5.2	8.8	3.5	3.5	2.8	3.6	4.5	2.9	4.0	5.4	3.5	2.8	3.1	4.2	6.6	6.2	9.5	5.8	1.4	3.4	7.6	4.1	3.4	7.9	2.5	6.9	4.6	5.3	4.0	11.8	8.9	3.3	2.9	3.3	2.1	5.5	11.5	7.0	2.9	6.3	15.5	5.6	3.7	2.8	8.7	1.2	6.1	4.6	3.6	8.4	3.1	3.3	6.0	3.6	5.1	4.9	4.7	2.0	2.7	5.1	3.3	12.5	12.4	11.3	3.4	12.7	3.2	11.1	7.1	9.5	6.3	5.9	4.6	6.8	8.0	7.3	5.7	10.2	8.7	8.8	14.2	5.2	4.2	8.8	8.2	3.5	7.4	10.5	14.1	7.9	7.0	7.5	7.2	5.2	8.4	8.1
ABHD8	"FLJ11743, MGC14280, MGC2512"	ENSG00000127220	"Abhydrolase domain containing 8"	Q96I13	19	17292131-17310236	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.0"	"Cell line enhanced"	"Detected in many"		"PC-3: 27.9;U-266/70: 21.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037658, HPA058209"	Approved		Approved	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA037658: AB_10672602, HPA058209: "	"unprognostic (4.71e-3)"	"unprognostic (5.06e-2)"	"prognostic unfavourable (5.25e-4)"	"unprognostic (7.45e-3)"	"unprognostic (7.09e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.61e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (3.04e-5)"	"unprognostic (3.77e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.24e-2)"	5.4	14.7	24.7	6.0	23.6	6.4	3.7	20.3	34.0	4.6	5.4	4.1	6.1	4.6	5.9	3.7	3.9	6.2	5.4	6.8	22.0	17.5	6.1	12.4	7.3	6.5	12.3	17.1	9.3	11.0	11.4	9.1	8.9	9.0	7.9	1.6	8.5	12.6	11.6	11.4	6.8	3.6	4.6	4.6	7.7	6.5	19.6	6.9	4.8	6.6	3.2	3.8	4.8	4.6	1.3	6.0	5.6	4.8	3.2	3.6	1.7	11.2	3.2	1.7	6.5	2.2	0.7	17.7	2.3	3.1	2.5	3.2	2.8	7.7	0.8	3.2	1.8	1.5	1.6	4.0	0.5	13.2	10.9	3.7	4.9	4.8	7.2	0.2	5.2	2.0	2.4	4.2	0.5	1.8	3.2	6.5	1.0	0.5	4.4	0.6	3.1	27.9	6.7	5.2	3.2	2.2	1.1	2.0	11.1	5.1	1.7	7.0	7.1	6.4	1.1	2.3	5.1	11.8	4.0	21.3	16.0	4.0	7.9	4.4	2.1	0.1	4.8	5.6	2.5	3.7	1.7	0.7	3.6	2.1	6.0	1.3	2.9	2.6	3.0	3.2	4.0	2.9	2.5	1.7	24.7	23.6	20.3	34.0	22.0	17.5	12.3	17.1	9.0	6.9
ABR	MDB	ENSG00000159842	"Active BCR-related"	Q12979	17	1003518-1229021	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 43.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 19.2;HEK 293: 10.4;LHCN-M2: 12.9;RPMI-8226: 11.0;TIME: 21.3;U-251 MG: 21.5;U-698: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"basophil: 8.9"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053618, HPA054824"	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA053618: , HPA054824: "	"unprognostic (1.69e-1)"	"prognostic favourable (4.03e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.20e-3)"	"unprognostic (4.43e-3)"	"prognostic favourable (2.21e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.74e-2)"	12.9	5.8	31.8	18.0	28.7	6.0	5.8	7.0	43.6	6.6	19.9	12.0	2.3	9.4	7.9	4.0	11.0	6.1	6.7	26.6	24.0	16.9	6.8	4.0	9.3	6.9	14.1	27.0	3.9	5.0	8.3	6.0	7.2	11.3	4.6	21.6	19.4	23.7	3.4	2.9	5.9	11.9	25.1	8.1	8.1	13.6	3.8	11.3	2.9	7.0	2.3	18.0	7.2	7.4	0.3	0.7	8.9	0.8	0.0	0.8	0.0	0.5	0.6	0.2	0.0	0.9	0.1	0.5	0.1	0.1	0.0	0.0	0.4	0.0	19.2	0.3	0.1	0.1	2.1	0.0	0.4	5.9	10.4	0.0	0.2	0.0	0.4	2.3	6.8	0.2	0.0	0.1	6.8	0.0	0.0	0.0	12.9	0.8	0.0	2.6	0.1	0.1	0.1	0.0	11.0	0.1	0.2	0.2	0.3	0.1	0.0	1.0	6.0	3.0	21.3	0.1	0.2	2.1	21.5	0.0	0.2	15.7	1.0	4.2	0.4	8.9	0.3	1.0	0.2	0.8	0.4	0.1	0.3	0.0	0.7	0.3	0.0	0.3	0.9	0.0	0.4	0.0	0.8	0.0	31.8	28.7	7.0	43.6	24.0	16.9	14.1	27.0	11.3	11.3
ABTB2	"ABTB2A, BTBD22, DKFZP586C1619"	ENSG00000166016	"Ankyrin repeat and BTB domain containing 2"	Q8N961	11	34150988-34358008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 31.6"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"eosinophil: 8.1;plasmacytoid DC: 2.8"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.8;granulocytes: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020065, HPA030699"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA020065: AB_1844459, HPA030699: "	"unprognostic (3.00e-1)"	"prognostic unfavourable (5.70e-5)"	"unprognostic (2.61e-1)"	"unprognostic (9.09e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.86e-1)"	"prognostic favourable (3.51e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.58e-2)"	3.1	13.7	4.8	2.7	6.7	3.2	2.2	5.0	5.8	8.0	8.5	10.6	18.2	11.7	7.4	6.3	4.4	4.1	3.2	13.0	4.7	3.9	8.4	8.0	2.9	2.7	9.0	1.5	2.8	2.2	0.3	2.8	8.1	15.8	4.5	3.6	7.5	8.7	31.6	19.4	5.6	20.2	3.6	20.2	1.2	3.0	3.1	7.7	6.4	2.1	3.5	2.8	3.4	5.0	0.0	2.8	8.1	0.4	0.0	0.1	0.1	4.0	12.1	4.9	1.3	1.3	0.1	4.9	2.4	1.9	2.1	4.1	2.9	3.0	0.1	4.1	3.0	7.9	2.7	2.8	1.8	0.1	6.7	0.0	7.1	12.8	0.7	6.5	0.9	0.7	1.5	4.3	1.9	0.0	1.3	0.3	1.3	10.1	0.2	7.8	6.1	6.6	1.2	2.9	4.6	7.7	9.7	6.2	5.1	6.0	18.8	4.8	4.0	2.8	0.6	2.4	0.4	7.5	4.3	0.7	0.3	0.1	5.5	1.8	7.3	0.0	0.1	8.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	2.8	0.1	0.1	4.8	6.7	5.0	5.6	4.7	3.9	9.0	1.5	15.8	7.7
AC008560.1		ENSG00000253251	"Uncharacterized protein FLJ26957 "	Q6ZNX1	5	65624765-65630891	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA066071, HPA068764"	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA066071: , HPA068764: "	"unprognostic (7.87e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.09e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-1)"	"prognostic favourable (1.17e-4)"	5.8	7.1	7.3	6.5	13.1	31.5	10.0	8.7	13.3	5.4	6.6	7.1	5.5	7.0	5.9	7.4	6.3	5.3	6.1	4.9	8.2	7.9	11.6	9.7	6.2	9.9	9.9	8.0	5.9	8.7	3.8	13.1	6.5	11.3	10.7	7.6	5.7	6.4	6.6	6.6	7.0	7.6	7.8	9.1	8.9	6.0	7.5	8.6	10.4	6.9	6.4	8.3	5.3	5.0	5.0	4.4	13.4	4.1	6.3	8.8	2.9	2.8	3.7	5.7	12.0	3.3	3.8	6.8	4.3	3.8	6.1	7.8	6.4	8.7	5.1	4.9	5.0	3.6	5.5	5.2	9.2	6.7	6.9	4.6	9.7	8.5	2.6	5.0	8.0	2.3	7.3	6.4	6.8	4.1	6.5	12.0	5.0	7.1	7.2	7.3	4.5	2.2	5.0	5.4	7.9	5.1	6.1	7.8	5.9	3.8	3.5	10.8	4.2	4.5	3.2	5.7	7.5	4.4	6.8	7.6	13.9	11.3	4.2	6.2	5.3	13.4	4.1	7.5	5.4	3.7	5.7	5.0	6.5	5.6	3.7	4.9	8.8	8.1	4.3	6.3	4.1	4.4	7.9	2.9	7.3	13.1	8.7	13.3	8.2	7.9	9.9	8.0	11.3	8.6
AC091057.5		ENSG00000284906	"Rho GTPase-activating protein 11B "	Q3KRB8	15	30624548-30685606	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 7.1;lymphoid tissue: 14.4;testis: 5.8"	"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA064479	Uncertain		Uncertain	Vesicles				Vesicles		"HPA064479: "																		0.2	0.1	0.8	10.3	1.8	7.1	0.5	0.7	0.9	0.1	5.1	0.6	0.0	1.1	0.8	0.2	1.8	0.2	0.3	0.2	1.0		0.0	0.1	0.9	2.8	0.1	0.0	0.1	0.0	0.0	0.4	0.7	0.6	0.0	1.2	0.3	0.1	0.1	0.4	0.9	1.5	0.8	1.9	1.4	1.0	5.8	2.1	14.4	0.0	1.4	5.7	0.5	0.0	1.0	1.0	1.6	0.3	0.0	0.8	0.0	4.3	2.9	5.0	2.5	0.1	0.6	2.8	4.6	1.8	3.2	3.7	3.0	3.7	2.8	1.8	1.9	4.0	2.5	1.6	2.8	6.1	3.0	7.4	9.9	1.3	0.0	4.7	5.3	0.2	0.2	2.1	1.6	2.2	4.4	8.6	2.2	2.1	3.6	4.0	1.5	1.5	5.1	5.1	1.3	0.9	2.8	2.4	2.2	5.4	2.0	1.0	2.5	2.4	2.5	5.0	4.2	2.4	3.9	3.0	3.2	6.1	1.7	5.3	4.0	1.6	0.3	0.2	0.4	0.0	0.0	0.6	0.8	0.6	0.1	1.0	0.1	0.1	0.1	0.0	0.1	1.0	0.6	0.0										
ACOXL	FLJ11042	ENSG00000153093	"Acyl-CoA oxidase like"	Q9NUZ1	2	110732573-111118222	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 29.7;lung: 20.8;placenta: 23.8"	"Group enriched"	"Detected in some"	4	"A-431: 8.9;RPMI-8226: 16.2;RT4: 20.8;U-266/70: 14.1"	"Group enriched"	"Detected in some"	6	"lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035392, HPA035393"			Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA035392: , HPA035393: "	"unprognostic (1.62e-1)"	"unprognostic (7.30e-2)"	"unprognostic (6.77e-4)"	"unprognostic (2.93e-7)"	"unprognostic (1.32e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-1)"	"prognostic favourable (6.48e-4)"	0.3	0.3	0.2	0.5	0.4	1.6	0.3	0.2	0.4	0.4	0.4	0.2	2.3	0.0	0.3	29.7	0.2	0.5	0.4	0.3	0.2	0.2	0.6	0.2	20.8	0.6	0.2	0.2	0.2	0.4	4.9	0.7	23.8	0.4	4.1	0.1	0.2	0.5	0.2	0.3	0.4	0.3	2.6	0.2	1.3	0.4	4.6	0.2	0.6	1.5	0.2	0.9	8.5	5.2	1.0	0.6	4.1	1.1	0.7	0.6	0.3	8.9	0.0	0.2	0.3	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.6	0.6	0.2	0.1	0.1	1.0	0.0	0.0	0.0	0.2	3.1	0.2	0.4	0.2	0.0	0.1	0.2	0.1	0.9	0.0	0.1	0.0	1.4	1.4	0.1	3.2	0.7	0.4	3.1	0.4	0.1	0.1	16.2	0.0	20.8	2.0	0.4	0.1	0.4	0.1	0.2	0.9	0.3	0.2	0.4	0.2	0.1	14.1	3.6	0.5	0.1	0.2	0.2	2.2	1.1	0.5	0.4	0.7	0.2	1.0	0.4	0.6	0.2	0.8	0.5	0.4	4.1	0.7	0.4	0.6	0.4	0.3	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2
ACP7	"FLJ16165, PAPL, PAPL1"	ENSG00000183760	"Acid phosphatase 7, tartrate resistant (putative)"	Q6ZNF0	19	39083913-39111493	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 15.2;lymphoid tissue: 6.1;skin 1: 14.1;tongue: 5.5"	"Cell line enriched"	"Detected in some"	5	"U-87 MG: 31.2"	"Group enriched"	"Detected in some"	5	"cervical cancer: 0.8;head and neck cancer: 2.6;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA042613	Uncertain				"Secreted - unknown location"					"HPA042613: AB_10963214"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.51e-5)"	"unprognostic (4.36e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.42e-1)"	0.3	0.3	1.6	0.3	5.5	0.3	1.0	15.2	5.4	0.9	0.3	4.2	0.3	0.4	0.4	1.4	1.1	0.3	0.9	0.3	2.5	1.2	0.3	0.3	0.4	0.3	6.5	0.7	0.3	0.3	0.3	0.0	0.3	5.2	1.2	0.3	0.0	0.6	0.3	0.3	14.1	0.3	0.3	4.1	0.3	0.6	0.4	5.3	0.0	0.3	5.5	6.1	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.4	0.5	0.3	3.5	0.0	0.0	0.0	0.2	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.4	0.2	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.2	0.8	0.0	0.0	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.5	15.2	5.4	2.5	1.2	6.5	0.7	5.2	5.3
ACR		ENSG00000100312	Acrosin	P10323	22	50738196-50745334	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	87	"testis: 106.3"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.7;HUVEC TERT2: 1.1;NTERA-2: 1.7;TIME: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA048687	Enhanced				"Secreted in male reproductive system"					"HPA048687: "	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.27e-3)"	"unprognostic (3.58e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.30e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.25e-1)"	0.9	0.0	0.2	0.2	0.3	0.0	0.6	0.2	0.3	0.2	0.2	0.2	0.2	0.1	0.3	0.7	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.3	0.6	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	1.2	0.0	106.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.6	0.2	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	1.4	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2
ACRBP	"CT23, OY-TES-1, SP32"	ENSG00000111644	"Acrosin binding protein"	Q8NEB7	12	6638075-6647460	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 170.4"	"Cell line enhanced"	"Detected in some"		"HEL: 5.4;HMC-1: 7.2;U-266/70: 16.0;U-266/84: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.7;intermediate monocyte: 9.8;myeloid DC: 11.0;non-classical monocyte: 17.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 11.0;monocytes: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039081, HPA039082"	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"			"Nucleoplasm, Vesicles"		"HPA039081: AB_10670920, HPA039082: AB_10671036"	"unprognostic (7.76e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.31e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.40e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.41e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.80e-4)"	0.8	0.4	0.3	0.9	0.8	2.5	0.5	1.3	0.6	0.4	1.6	0.6	0.5	2.2	0.4	4.2	0.5	0.6	1.7	1.0	0.6	0.3	0.9	0.7	0.8	3.6	0.4	0.3	0.4	1.5	0.0	0.5	0.4	0.8	0.7	0.4	0.8	0.5	0.1	0.3	0.4	3.3	0.6	0.6	2.3	0.6	170.4	0.3	0.5	3.9	0.3	0.8	0.7	0.5	1.2	11.0	1.6	17.6	0.3	0.1	6.5	0.2	0.1	0.8	2.7	0.9	1.3	1.4	0.0	0.0	0.1	0.1	0.0	1.9	0.3	0.9	0.2	0.0	0.5	0.0	0.2	0.6	0.0	5.4	0.6	0.0	2.0	0.1	7.2	0.1	3.6	1.0	0.1	0.6	3.6	0.0	0.1	0.4	0.2	1.9	1.6	0.0	0.3	0.1	0.3	0.6	0.1	1.1	0.1	0.0	0.7	1.2	0.0	2.0	0.8	0.1	0.8	0.6	0.0	16.0	10.5	0.5	0.6	2.0	0.0	0.9	7.7	0.7	0.1	9.8	0.0	0.8	0.0	0.0	11.0	1.2	0.1	0.1	1.6	0.3	17.6	2.8	0.0	6.5	0.3	0.8	1.3	0.6	0.6	0.3	0.4	0.3	0.8	0.3
ACSBG1	"BG1, BGM, FLJ30320, hBG1, hsBG, KIAA0631, MGC14352"	ENSG00000103740	"Acyl-CoA synthetase bubblegum family member 1"	Q96GR2	15	78167468-78245688	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 11.4;brain: 40.5;skin 1: 19.9"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 7.9;SK-MEL-30: 3.7"	"Cancer enhanced"	"Detected in some"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041642, CAB045955, HPA058869"	Approved		Approved	Vesicles				Vesicles		"CAB045955: AB_11124196, HPA041642: AB_2677593, HPA058869: AB_2683840"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.42e-2)"	1.1	11.4	16.9	1.5	26.9	4.5	3.8	6.6	27.0	1.1	1.2	10.5	0.0	1.6	1.2	2.3	1.3	5.9	1.3	1.1	16.4	8.5	1.0	1.0	1.7	1.6	21.1	13.9	1.2	1.0	0.9	0.3	1.1	32.9	2.0	1.1	0.0	1.5	1.4	1.2	19.9	1.5	1.2	40.5	1.3	1.2	5.4	19.0	0.0	1.2	0.0	1.1	1.5	0.2	0.4	3.9	1.2	0.2	0.6	0.2	1.5	0.7	0.1	1.6	2.3	0.0	0.0	0.6	0.5	0.0	0.5	0.1	0.5	0.6	0.7	0.2	0.1	0.9	0.1	0.3	0.2	0.4	1.3	0.7	1.4	0.6	0.0	0.7	1.6	0.6	0.0	0.4	0.2	0.2	0.5	1.1	0.1	0.4	0.6	1.4	7.9	0.3	0.3	1.0	0.5	0.0	0.9	0.5	0.9	0.4	1.0	3.7	0.5	0.5	0.9	0.6	0.6	0.5	0.3	0.9	0.3	0.8	0.3	0.5	1.5	0.4	0.2	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.4	0.2	0.1	1.2	0.6	0.2	3.9	0.0	1.5	16.9	26.9	6.6	17.9	16.4	8.5	21.1	13.9	32.9	19.0
ACSL6	"ACS2, FACL6, KIAA0837, LACS2, LACS5"	ENSG00000164398	"Acyl-CoA synthetase long chain family member 6"	Q9UKU0	5	131949973-132012243	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.0;ductus deferens: 30.1;seminal vesicle: 35.8;testis: 23.0"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 14.6;U-937: 8.5"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA040470	Enhanced									"HPA040470: AB_10794033"	"unprognostic (1.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.89e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.38e-3)"	"unprognostic (5.84e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.57e-2)"	"unprognostic (9.28e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.70e-1)"	0.6	4.8	16.5	1.5	15.7	21.3	0.7	22.8	34.0	0.5	0.7	5.3	30.1	5.4	0.5	1.0	0.9	0.7	0.9	2.0	12.4	9.7	2.3	2.6	0.8	2.5	9.6	12.1	0.5	1.9	13.0	2.7	1.1	12.1	0.8	0.8	3.3	0.8	35.8	3.6	0.6	3.3	0.5	4.2	1.2	1.2	23.0	4.7	0.0	0.9	0.0	1.5	0.7	0.3	0.1	0.0	0.6	0.1	1.2	4.2	1.1	0.0	0.0	0.2	0.1	0.5	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.1	1.6	0.2	0.0	0.0	0.9	0.1	0.0	2.2	0.0	0.2	2.1	0.0	0.1	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	1.4	0.9	0.1	0.1	0.0	0.0	0.0	0.0	14.6	0.7	0.2	0.2	1.1	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.5	0.0	0.3	8.5	0.5	0.6	0.1	0.1	1.5	0.0	3.5	0.1	2.1	4.2	0.0	0.1	3.9	1.8	0.2	1.2	0.0	0.0	0.1	1.1	16.5	15.7	22.8	18.8	12.4	9.7	9.6	12.1	12.1	4.7
ACSM4		ENSG00000215009	"Acyl-CoA synthetase medium chain family member 4"	P0C7M7	12	7304284-7328724	"Enzymes, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.0;testis: 3.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.8;Karpas-707: 2.5;NB-4: 3.9;SH-SY5Y: 4.6;U-87 MG: 6.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 0.6"	"Low region specificity"	"Detected in all"			HPA049895	Uncertain									"HPA049895: "	"unprognostic (9.50e-5)"	"unprognostic (5.45e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.06e-4)"	"unprognostic (1.77e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.24e-3)"	"unprognostic (3.31e-3)"	"unprognostic (3.85e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.45e-9)"	"unprognostic (1.82e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.73e-1)"	0.2	0.5	0.1	0.7	0.1	0.0	0.1	0.1	0.6	0.1	0.1			0.9	0.1	0.0	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1		0.1	0.1	0.0	0.1	0.0		0.1	0.0		0.1	0.0	0.1	0.1	1.3	0.0	0.1	2.0	0.1	3.6			0.1		0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.3	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	3.9	0.0	0.0	0.5	0.4	0.3	0.0	0.0	0.7	4.6	0.7	1.1	0.0	0.0	1.4	1.0	0.5	0.4	0.1	0.0	0.1	0.1	0.0	6.6	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ACSM6	"bA310E22.3, C10orf129"	ENSG00000173124	"Acyl-CoA synthetase medium chain family member 6"	Q6P461	10	95194200-95228928	"Enzymes, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 16.3;pancreas: 7.3;stomach 1: 6.2"	"Cell line enriched"	"Detected in single"	30	"RT4: 9.0"	"Cancer enriched"	"Detected in single"	7	"urothelial cancer: 1.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.0"	"Low lineage specificity"	"Detected in single"											HPA044593	Uncertain									"HPA044593: AB_10960261"	"unprognostic (2.91e-2)"				"unprognostic (2.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.48e-2)"		"unprognostic (6.34e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.75e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (7.71e-4)"	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.8	0.4	0.0	6.2	0.3	0.0	16.3	0.8	0.0	0.0	2.5	1.9	0.1	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACTL7B	Tact1	ENSG00000148156	"Actin like 7B"	Q9Y614	9	108854589-108856967	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	437	"testis: 43.6"	"Cell line enhanced"	"Detected in single"		"BEWO: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021803, HPA024664"	Enhanced									"HPA021803: AB_1844551, HPA024664: AB_1844552"					"unprognostic (7.64e-2)"	"unprognostic (1.62e-1)"								"unprognostic (3.09e-1)"	"unprognostic (3.83e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.5	0.0	1.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ACTR3B	"ARP11, ARP3beta"	ENSG00000133627	"ARP3 actin related protein 3 homolog B"	Q9P1U1	7	152759749-152855378	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 38.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047016, HPA051683"	Uncertain									"HPA047016: , HPA051683: "	"unprognostic (1.20e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.34e-3)"	"unprognostic (5.89e-2)"	"unprognostic (5.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.11e-3)"	"unprognostic (5.62e-2)"	"prognostic favourable (1.66e-4)"	"prognostic favourable (4.53e-4)"	"unprognostic (4.14e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.48e-2)"	3.3	8.2	16.4	3.8	38.1	3.9	7.5	12.7	37.3	4.6	4.0	6.2	7.8	4.4	5.2	8.8	3.3	8.6	3.2	5.1	21.9	11.2	7.1	7.0	3.5	4.5	8.1	14.1	6.8	8.7	11.7	10.9	3.9	7.9	4.4	4.5	5.3	13.6	5.4	6.6	4.4	3.6	3.7	5.1	3.3	5.0	14.8	5.8	2.6	5.7	1.8	4.8	4.2	2.7	2.7	1.9	0.4	0.8	2.5	4.7	2.7	11.7	5.7	10.8	13.4	3.2	4.1	9.0	6.2	4.0	2.6	2.6	6.9	7.0	10.0	4.8	4.0	4.3	9.9	2.9	3.2	3.7	5.2	4.1	4.0	6.4	3.5	5.5	1.6	2.0	3.7	1.5	3.9	3.3	21.0	0.2	5.5	12.3	8.1	10.9	23.3	6.4	6.6	4.1	7.9	4.2	6.7	21.3	17.9	7.9	6.2	5.2	6.4	4.4	1.9	2.6	0.6	3.3	5.4	9.0	9.7	6.9	5.2	8.0	5.4	0.0	0.8	0.0	2.1	0.5	2.7	1.7	2.2	4.3	1.9	2.7	4.7	2.7	0.4	2.5	0.3	1.0	3.0	2.7	16.4	38.1	12.7	23.9	21.9	11.2	8.1	14.1	7.9	5.8
ACTRT1	"AIP1, ARIP1, Arp-T1, KIAA0705"	ENSG00000123165	"Actin related protein T1"	Q8TDG2	X	128050962-128052398	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	83	"testis: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003119	Supported									"HPA003119: AB_1078219"															"unprognostic (3.68e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ACTRT2	"Arp-T2, ARPM2, FLJ25424"	ENSG00000169717	"Actin related protein T2"	Q8TDY3	1	3021483-3022903	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	139	"testis: 60.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;NTERA-2: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006480, HPA025079"	Enhanced									"HPA006480: AB_1845047, HPA025079: AB_1845048"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACTRT3	ARPM1	ENSG00000184378	"Actin related protein T3"	Q9BYD9	3	169766921-169769895	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"testis: 57.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.6;HSkMC: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.4"	"Group enriched"	"Detected in many"	4	"B-cells: 1.2;T-cells: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035817, HPA035818"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA035817: AB_10671938, HPA035818: "	"unprognostic (2.35e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.10e-2)"	"prognostic unfavourable (4.11e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.31e-4)"	"unprognostic (2.64e-1)"	"unprognostic (9.16e-2)"	"unprognostic (4.41e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.22e-1)"	1.0	0.7	0.9	0.4	1.1	0.5	1.5	2.4	1.3	1.0	0.5	0.5	1.3	0.7	0.7	1.4	0.6	1.4	0.5	0.7	0.7	0.9	1.8	1.7	0.7	0.6	1.0	0.4	1.1	0.3	0.8	1.0	0.7	1.1	1.0	0.4	0.6	0.5	1.3	0.7	0.3	0.5	1.0	0.6	0.1	0.8	57.4	0.7	0.2	1.0	0.1	0.5	1.5	3.1	1.2	0.5	0.0	0.0	0.0	3.4	0.4	3.5	2.1	0.1	1.1	15.6	5.0	0.0	4.3	2.5	2.7	2.3	0.0	4.5	0.0	6.0	4.8	2.3	1.2	2.0	2.8	2.6	1.5	8.2	1.8	0.4	2.6	0.9	0.7	10.1	0.5	3.3	0.6	4.8	0.0	0.0	4.7	1.8	0.3	0.1	3.8	4.5	0.6	0.0	0.1	2.8	0.9	2.8	2.0	5.1	1.3	0.1	2.2	3.6	2.1	0.0	0.0	2.2	0.0	0.5	0.2	0.2	1.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	3.4	1.2	0.0	1.1	0.5	1.1	0.4	0.4	0.0	0.0	0.0	0.5	0.0	0.4	0.9	1.1	2.4	1.3	0.7	0.9	1.0	0.4	1.1	0.7
ADAL		ENSG00000168803	"Adenosine deaminase like"	Q6DHV7	15	43330657-43354555	"Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046215, HPA048175"	Approved		Approved	Microtubules				Microtubules		"HPA046215: , HPA048175: "	"unprognostic (1.65e-2)"	"unprognostic (1.53e-3)"	"unprognostic (9.80e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.69e-1)"	"prognostic favourable (7.64e-9)"	"unprognostic (2.37e-3)"	"unprognostic (8.77e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.44e-2)"	6.9	7.9	10.0	4.6	12.4	4.7	7.1	9.0	11.3	4.0	6.2	9.9	4.2	6.9	6.8	11.0	5.1	4.3	4.7	23.8	9.3	10.3	14.1	10.6	4.2	5.2	10.5	9.0	4.6	5.2	15.6	10.6	3.4	10.7	7.7	5.9	11.8	4.9	8.0	20.9	3.5	8.6	8.8	14.0	4.7	4.7	12.5	9.2	4.4	13.0	9.7	5.6	6.1	3.6	5.0	7.3	8.8	4.6	5.0	8.7	3.0	4.7	2.4	9.7	10.4	4.1	5.5	4.5	5.4	5.7	8.9	13.7	9.7	2.3	5.8	9.4	6.1	5.2	0.0	4.0	7.9	5.5	6.4	13.4	16.0	7.9	5.7	0.0	10.2	7.0	7.8	6.5	6.7	1.9	14.2	11.2	9.6	3.2	8.2	6.6	3.9	3.6	10.8	14.2	8.4	8.2	2.9	12.4	8.3	9.3	8.2	8.3	8.7	9.3	2.3	15.6	7.4	11.8	11.5	11.8	19.5	2.3	8.8	14.4	12.8	8.8	3.3	7.7	5.9	4.6	4.7	5.0	5.5	5.0	4.5	5.0	5.8	7.0	2.3	5.0	3.9	7.3	8.7	3.0	10.0	12.4	9.0	11.3	9.3	10.3	10.5	9.0	10.7	9.2
ADAM11	MDC	ENSG00000073670	"ADAM metallopeptidase domain 11"	O75078	17	44759031-44781846	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 42.3;heart muscle: 11.2"	"Cell line enriched"	"Detected in some"	4	"HEK 293: 20.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 1.7"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074550	Enhanced									"HPA074550: "	"unprognostic (1.79e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.37e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.46e-3)"	"unprognostic (7.16e-2)"	"unprognostic (9.99e-16)"	"unprognostic (1.39e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.00e-1)"	1.2	0.5	8.5	0.6	7.5	1.0	0.6	42.3	23.1	0.9	0.8	0.7	0.0	0.8	4.0	1.1	1.1	1.2	1.5	11.2	11.4	4.2	0.7	0.6	0.7	0.7	2.7	9.8	0.9	0.6	0.7	0.6	0.7	5.5	1.6	0.6	0.2	0.5	2.2	0.8	2.5	0.7	2.6	1.5	0.7	0.7	2.3	1.1	0.0	0.6	0.0	0.6	0.7	0.3	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.6	4.8	0.2	0.0	0.3	0.1	0.0	1.3	0.4	0.7	0.2	0.1	0.3	0.0	0.0	3.6	0.0	0.4	1.4	20.5	0.2	0.4	0.3	0.1	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.4	0.4	0.1	4.1	0.0	2.4	0.8	1.3	2.8	0.0	0.3	0.0	0.1	3.7	1.9	0.0	0.1	1.0	1.4	0.7	0.0	0.6	1.7	1.8	0.4	0.7	0.2	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.7	0.0	0.0	8.5	7.5	42.3	21.0	11.4	4.2	2.7	9.8	5.5	1.1
ADAM2	"CT15, FTNB, PH-30b, PH30"	ENSG00000104755	"ADAM metallopeptidase domain 2"	Q99965	8	39743735-39838289	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	416	"testis: 50.6"	"Cell line enriched"	"Detected in single"	21	"U-266/70: 2.0"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB022390, HPA024621, HPA026581"	Enhanced									"CAB022390: , HPA024621: AB_1844576, HPA026581: AB_1844577"				"unprognostic (4.74e-2)"								"unprognostic (1.67e-3)"					"unprognostic (3.82e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADAM20		ENSG00000134007	"ADAM metallopeptidase domain 20"	O43506	14	70522358-70535015	"Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	18	"testis: 18.7"	"Low cell line specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in many"			HPA059377	Enhanced									"HPA059377: "	"unprognostic (4.13e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.57e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.06e-2)"	"unprognostic (9.52e-3)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.7	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.0	18.7	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.6	0.0	1.0	0.0	0.3	0.3	0.4	0.2	0.0	0.0	0.3	0.2	0.1	0.3	0.3	0.0	0.0	0.2	0.3	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.5	0.4	0.2	0.0	0.0	0.3	0.6	0.6	0.2	0.5	0.0	0.0	0.1	1.1	0.6	0.4	0.6	0.3	0.9	0.4	0.2	0.0	0.3	0.5	0.6	0.1	0.2	0.0	0.3	0.1	0.0	0.0	0.7	0.4	0.0	0.1	0.2	0.0	0.5	0.2	0.4	0.1	0.1	0.0	0.0	0.2	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	0.7	0.4	0.1	0.1	0.1	0.1	0.1	0.1
ADAM21	ADAM31	ENSG00000139985	"ADAM metallopeptidase domain 21"	Q9UKJ8	14	70452157-70459899	"Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 19.7"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 4.5;U-251 MG: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA059016	Uncertain									"HPA059016: "	"unprognostic (7.85e-2)"	"unprognostic (7.67e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.72e-1)"	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.3	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	19.7	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.8	0.0	0.0	0.0	0.0	1.6	0.3	0.9	0.2	0.3	0.8	1.6	1.6	0.5	0.9	0.6	0.1	0.4	0.1	1.0	0.0	0.6	0.7	0.1	0.5	1.6	1.0	0.6	0.8	0.6	0.1	0.4	0.3	0.0	0.3	1.0	0.1	0.4	0.9	0.3	0.1	0.8	2.1	0.0	2.0	0.2	0.1	0.2	1.2	1.2	0.0	0.3	0.0	0.7	0.7	0.0	0.7	1.7	0.5	1.7	0.5	4.5	0.2	0.3	4.3	0.3	2.3	0.0	2.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.2	0.2	0.0	0.8	0.8	1.6	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.1	0.3	0.4	0.1	0.3	0.2	0.1	0.1	0.1
ADAM28	"ADAM23, eMDCII, MDC-Lm, MDC-Ls"	ENSG00000042980	"ADAM metallopeptidase domain 28"	Q9UKQ2	8	24294040-24359018	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.1"	"Cell line enriched"	"Detected in some"	8	"CAPAN-2: 24.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 24.9;naive B-cell: 32.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074034	Enhanced		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"			"Plasma membrane"	Mitochondria	"HPA074034: "	"unprognostic (4.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-2)"	"prognostic favourable (3.17e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.62e-1)"	2.0	1.7	7.7	17.4	8.8	3.5	2.1	0.9	5.8	6.7	5.8	12.7	2.0	3.7	3.1	133.1	2.7	5.1	16.7	1.1	8.9	5.0	3.1	1.1	3.1	10.1	12.4	3.7	1.8	2.7	1.0	22.5	1.9	10.8	3.3	5.0	1.9	12.6	5.1	0.7	1.8	17.9	1.7	26.0	15.5	38.7	0.9	12.1	0.8	1.8	0.4	19.9	7.4	1.6	32.2	7.5	12.5	0.9	0.9	0.0	0.9	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	1.0	24.7	0.2	0.7	0.0	0.1	0.0	0.8	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.2	3.2	0.6	0.1	0.1	0.0	0.3	0.6	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.1	1.1	2.1	0.1	1.9	0.9	0.2	12.5	0.9	6.4	0.0	0.2	0.0	24.9	0.0	0.0	7.5	32.2	0.0	0.0	1.6	0.9	0.0	0.4	0.0	0.9	7.7	8.8	0.9	5.8	8.9	5.0	12.4	3.7	10.8	12.1
ADAMTS15		ENSG00000166106	"ADAM metallopeptidase with thrombospondin type 1 motif 15"	Q8TE58	11	130448974-130476641	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 36.0;ASC TERT1: 21.7;EFO-21: 18.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA042867	Uncertain		Approved	Cytosol	"Secreted to extracellular matrix"			Cytosol		"HPA042867: AB_10794535"	"unprognostic (7.64e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.07e-3)"	"unprognostic (7.07e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (9.72e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.95e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (5.63e-5)"	47.4	1.1	0.2	1.7	0.3	0.1	14.5	0.1	0.8	3.4	3.8	0.8	3.0	0.6	3.7	9.8	3.8	9.3	9.1	12.6	0.4	0.3	9.1	0.4	6.6	5.6	0.8	0.2	7.0	1.6	0.9	1.0	16.4	1.3	3.7	2.1	10.9	1.0	1.3	1.6	4.1	3.1	6.9	1.4	1.9	4.9	2.4	0.6	0.7	9.8	2.5	0.8	8.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.4	36.0	21.7	0.0	1.3	2.5	0.5	0.1	0.2	0.6	0.0	18.1	0.1	3.3	0.3	0.3	0.1	0.0	0.8	0.0	1.6	0.0	0.3	0.0	0.0	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.6	2.7	0.0	2.0	0.0	0.0	0.0	0.3	0.0	5.8	0.0	0.0	1.9	0.0	0.0	0.3	4.3	3.4	1.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.4	0.3	0.8	0.2	1.3	0.6
ADAMTS16	ADAMTS16s	ENSG00000145536	"ADAM metallopeptidase with thrombospondin type 1 motif 16"	Q8TE57	5	5140330-5320304	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.4;ovary: 16.3"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 6.2;U-2 OS: 4.9;U-2197: 9.1;U-87 MG: 4.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 20.4;cerebral cortex: 5.2"	"Cell type enriched"	"Detected in single"	10	"NK-cell: 3.6"	"Lineage enriched"	"Detected in single"	10	"NK-cells: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA067668			Approved	"Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria"	"Secreted to extracellular matrix"			"Nuclear membrane, Mitochondria"	"Nucleoplasm, Midbody ring"	"HPA067668: "	"unprognostic (8.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.98e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.18e-1)"	"prognostic favourable (3.29e-5)"	"unprognostic (1.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.86e-3)"	7.4	0.4	1.8	0.5	2.8	0.6	1.0	20.4	5.2	2.6	0.9	0.1	3.7	0.6	2.3	11.0	1.9	1.1	8.8	0.9	1.7	0.5	5.4	0.6	0.9	0.2	0.5	1.9	16.3	6.3	0.0	0.5	0.2	2.2	0.7	0.4	0.0	0.4	0.8	0.5	0.5	0.6	10.4	0.6	0.4	0.6	0.8	0.0	0.0	0.8	0.0	0.1	3.4	1.5	0.2	0.1	0.3	0.0	3.6	0.2	0.0	2.6	2.7	2.7	0.1	0.2	0.6	0.2	0.1	0.1	0.6	0.9	0.1	2.4	0.2	3.3	0.0	0.2	0.0	0.0	0.8	0.1	1.6	0.1	3.9	0.1	0.0	0.3	0.1	0.0	0.0	6.2	0.2	0.0	0.8	0.4	1.2	0.1	0.1	0.3	1.7	2.5	0.5	3.3	0.2	0.1	0.0	1.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	3.3	4.9	9.1	2.1	0.5	0.2	0.1	4.7	0.1	0.4	0.3	0.0	0.1	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.3	3.6	0.0	0.0	0.0	0.0	1.8	2.8	20.4	5.2	1.7	0.5	0.5	1.9	2.2	0.0
ADAMTS17	"FLJ16363, FLJ32769"	ENSG00000140470	"ADAM metallopeptidase with thrombospondin type 1 motif 17"	Q8TE56	15	99971589-100342005	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Deafness, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 12.0;RPMI-8226: 4.5;SK-BR-3: 4.6;SK-MEL-30: 5.9;WM-115: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA062487			Approved	Nucleoplasm	"Secreted to extracellular matrix"			Nucleoplasm		"HPA062487: "	"unprognostic (7.73e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.56e-1)"	"unprognostic (9.90e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.03e-3)"	"unprognostic (4.70e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.43e-2)"	1.2	2.0	3.6	2.7	3.1	1.5	1.9	0.7	4.5	1.9	2.1	2.9	6.4	2.5	4.9	1.9	5.1	2.9	1.9	2.2	3.4	1.6	2.2	15.7	10.5	2.0	1.6	1.0	3.0	12.2	0.3	3.5	1.6	1.7	1.9	2.1	2.7	8.3	4.7	13.5	5.0	2.8	6.6	2.1	2.5	3.6	4.0	2.0	20.1	1.9	2.7	2.1	2.7	2.1	0.1	0.0	1.4	0.1	0.2	0.8	0.1	0.0	0.0	0.0	0.8	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.1	0.2	2.2	0.4	0.0	0.0	12.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.2	1.0	3.6	0.7	0.4	1.8	0.0	1.1	4.5	0.0	0.4	3.8	0.8	0.5	4.6	5.9	0.0	0.6	0.7	0.0	1.6	1.1	0.1	0.7	0.0	0.0	0.0	0.9	5.5	1.4	0.0	0.0	0.1	0.0	0.5	0.0	0.8	0.2	0.0	0.1	0.5	0.5	0.4	0.2	0.1	0.0	0.0	0.1	3.6	3.1	0.7	4.5	3.4	1.6	1.6	1.0	1.7	2.0
ADAMTS19		ENSG00000145808	"ADAM metallopeptidase with thrombospondin type 1 motif 19"	Q8TE59	5	129460265-129738683	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 16.6;endometrium 1: 14.6;smooth muscle: 9.0"	"Group enriched"	"Detected in some"	8	"MCF7: 11.7;SH-SY5Y: 27.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"olfactory region: 4.8"	"Low region specificity"	"Detected in all"			"HPA056171, HPA058438"	Uncertain		Approved	Vesicles,Midbody	"Secreted to extracellular matrix"			"Vesicles, Midbody"		"HPA056171: , HPA058438: "	"unprognostic (1.14e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.49e-2)"		"unprognostic (3.93e-2)"		"unprognostic (4.17e-2)"	"unprognostic (5.99e-3)"	"unprognostic (5.17e-1)"		"unprognostic (1.14e-1)"	"unprognostic (5.88e-2)"		"unprognostic (3.06e-2)"	0.2	1.2	0.7	0.6	3.6	0.1	0.2	0.0	4.9	16.6	0.5	1.2	0.0	0.4	14.6	0.3	1.5	2.6	0.8	0.5	1.0	0.8	0.7	0.1	0.2	0.2	0.5	4.3	2.8	0.2	0.2	0.1	5.3	1.8	0.4	0.6	0.9	1.1	0.2	0.8	0.2	0.3	9.0	1.0	0.2	0.2	0.4	0.8	0.0	0.1	1.8	0.1	0.9	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	27.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.6	0.0	4.9	1.0	0.8	0.5	4.3	1.8	0.8
ADAMTS2	"ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP"	ENSG00000087116	"ADAM metallopeptidase with thrombospondin type 1 motif 2"	O95450	5	179110851-179345430	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.7;ASC TERT1: 13.7;BJ: 12.1;fHDF/TERT166: 14.2;HHSteC: 44.5;HSkMC: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA028363, HPA028444"	Uncertain		Approved	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"			"Plasma membrane"	Vesicles	"HPA028363: , HPA028444: AB_10601964"	"unprognostic (6.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.85e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (1.71e-8)"	"unprognostic (1.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.48e-2)"	24.2	4.3	0.9	5.8	0.7	0.7	29.1	0.9	2.3	16.3	10.1	0.4	3.9	2.7	12.0	9.5	6.0	7.2	9.5	10.1	0.7	1.2	4.2	7.4	13.1	25.9	1.0	1.3	6.3	2.7	1.0	8.7	15.1	2.4	6.0	2.6	3.8	2.5	3.8	3.8	4.6	4.6	13.8	0.7	16.5	4.2	4.3	0.5	0.8	3.2	5.9	1.2	8.8	14.7	1.4	1.3	2.1	0.3	0.8	0.6	0.1	0.0	0.0	0.0	0.3	13.7	13.7	0.0	12.1	2.0	4.6	4.9	0.0	0.0	0.0	0.1	14.2	0.0	0.7	0.0	2.0	0.0	0.6	0.0	0.0	0.9	44.5	0.0	0.0	35.5	0.0	1.2	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.5	0.0	0.0	0.1	0.0	3.9	0.0	7.7	1.2	10.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	1.5	0.3	0.4	0.6	0.2	0.3	0.6	0.5	0.4	1.3	1.4	0.5	0.5	2.1	0.8	0.1	0.8	0.5	0.1	0.9	0.7	0.9	2.3	0.7	1.2	1.0	1.3	2.4	0.5
ADAMTS20	GON-1	ENSG00000173157	"ADAM metallopeptidase with thrombospondin type 1 motif 20"	P59510	12	43353866-43551921	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	8	"brain: 5.1;placenta: 3.6;retina: 1.5;testis: 2.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;Karpas-707: 6.6;NB-4: 2.9;NTERA-2: 5.2;U-266/70: 7.5;U-266/84: 3.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027608, HPA027609"	Uncertain				"Secreted to extracellular matrix"					"HPA027608: AB_10600098, HPA027609: AB_10599024"	"unprognostic (3.18e-2)"			"unprognostic (1.19e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.04e-1)"		"unprognostic (9.61e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.26e-1)"		"unprognostic (1.05e-4)"	"unprognostic (7.42e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.81e-3)"	"unprognostic (2.57e-1)"	0.2	0.0	0.7	0.1	1.4	0.1	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.2	0.0	3.6	5.1	0.0	0.0	1.5	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	2.3	1.1	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.6	0.2	0.0	0.0	2.9	5.2	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.7	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.7	0.0	0.0	7.5	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.0	1.2	0.3	0.7	0.6	0.0	5.1	1.1
ADAMTS3	"ADAMTS-4, KIAA0366"	ENSG00000156140	"ADAM metallopeptidase with thrombospondin type 1 motif 3"	O15072	4	72280969-72569386	"Cancer-related genes, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 12.3;AN3-CA: 7.1;HEL: 12.7;K-562: 10.8;SH-SY5Y: 6.5;U-2 OS: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021368, HPA021369"	Uncertain		Approved	"Intermediate filaments"	"Secreted to extracellular matrix"			"Intermediate filaments"		"HPA021368: , HPA021369: "	"unprognostic (1.93e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.60e-3)"	"unprognostic (5.92e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.50e-4)"	5.3	2.6	3.3	4.4	5.6	2.1	7.8	0.3	4.6	4.4	2.3	1.1	1.9	0.5	9.6	14.4	1.0	7.5	1.9	2.8	1.3	0.9	4.7	2.7	3.1	2.0	0.7	2.2	7.5	1.0	12.4	1.1	8.2	2.2	2.6	1.1	3.9	1.4	3.4	0.8	1.5	0.9	4.6	1.8	1.9	1.6	5.6	1.3	0.6	4.4	0.8	1.0	2.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	7.1	0.1	0.3	0.1	0.6	2.0	1.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	1.7	0.0	1.6	12.7	0.9	0.0	0.2	0.0	0.0	1.6	0.1	0.6	0.1	0.0	10.8	0.0	0.0	0.0	1.1	0.0	2.0	3.7	0.0	2.5	0.0	4.2	0.0	0.5	6.5	0.0	0.5	0.1	0.1	0.1	0.1	5.3	7.9	0.0	0.6	0.0	0.0	0.0	1.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.6	0.3	4.6	1.3	0.9	0.7	2.2	2.2	1.3
ADAMTS6	ADAM-TS6	ENSG00000049192	"ADAM metallopeptidase with thrombospondin type 1 motif 6"	Q9UKP5	5	65148736-65481920	"Cancer-related genes, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 32.4"	"Cell line enhanced"	"Detected in many"		"BJ: 9.8;HBF TERT88: 10.8;hTEC/SVTERT24-B: 10.0;hTERT-HME1: 11.9;TIME: 11.2;U-2197: 12.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 4.8;naive B-cell: 3.6"	"Group enriched"	"Detected in many"	13	"B-cells: 4.8;T-cells: 1.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043441	Enhanced				"Secreted to extracellular matrix"					"HPA043441: "	"unprognostic (1.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.70e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.39e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-6)"	"unprognostic (3.23e-5)"	"unprognostic (2.09e-1)"	"unprognostic (3.02e-4)"	"unprognostic (4.18e-3)"	2.2	0.7	0.9	2.0	0.8	0.3	1.8	0.2	1.8	2.9	1.4	0.8	1.6	0.6	5.1	3.0	1.0	2.7	6.3	2.3	0.8	0.9	1.5	0.5	2.3	1.7	0.8	1.4	1.8	0.5	0.4	2.0	32.4	2.9	2.3	0.9	1.4	0.6	0.9	0.4	0.8	2.4	5.4	3.2	3.4	1.8	1.9	0.7	3.3	0.9	1.2	1.9	3.6	1.7	4.8	0.2	0.0	0.0	0.0	1.4	0.1	2.0	0.0	0.5	0.5	0.0	1.6	0.0	9.8	5.8	6.1	7.2	0.0	0.2	0.0	0.0	3.7	0.4	0.1	1.9	10.8	1.5	0.0	0.1	3.6	0.2	0.3	0.0	0.5	0.7	0.0	10.0	11.9	5.4	0.0	0.0	3.7	0.0	0.5	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	11.2	2.4	3.6	12.8	7.8	0.0	0.0	0.0	2.7	0.5	0.0	0.0	0.0	0.0	1.3	0.0	1.0	4.8	0.3	0.5	0.0	3.6	1.3	1.4	0.0	0.0	0.0	0.2	0.0	0.1	0.9	0.8	0.2	1.4	0.8	0.9	0.8	1.4	2.9	0.7
ADAMTS8	"ADAM-TS8, FLJ41712, METH2"	ENSG00000134917	"ADAM metallopeptidase with thrombospondin type 1 motif 8"	Q9UP79	11	130404925-130428993	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 13.0;lung: 21.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.9;HMC-1: 5.7;NTERA-2: 2.8;U-2 OS: 12.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 6.4;cerebral cortex: 7.6;hippocampal formation: 7.3;olfactory region: 5.2"	HPA066349	Approved				"Secreted to extracellular matrix"		2200000			"HPA066349: "	"unprognostic (4.76e-6)"	"unprognostic (3.92e-2)"	"unprognostic (6.13e-2)"	"prognostic favourable (1.38e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.09e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.03e-3)"	"unprognostic (5.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-1)"	2.1	0.1	1.5	10.2	2.5	0.0	0.5	0.6	4.4	1.3	5.3	0.5	0.2	1.1	2.6	1.5	3.1	1.7	13.0	3.9	1.6	0.6	2.1	0.2	21.0	0.2	0.7	0.2	1.0	0.7	0.0	0.8	2.7	0.9	2.9	0.5	0.7	0.3	5.7	0.4	0.1	1.6	7.4	0.8	0.9	5.6	0.2	0.4	0.2	0.4	0.2	0.4	3.8	3.4	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	1.8	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	2.5	0.6	3.2	1.6	0.6	0.7	0.2	0.9	0.4
ADCK1	FLJ39600	ENSG00000063761	"AarF domain containing kinase 1"	Q86TW2	14	77800083-77935012	"Enzymes, Predicted secreted proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051012, HPA055014"	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"			Nucleoplasm		"HPA051012: , HPA055014: "	"unprognostic (6.36e-2)"	"unprognostic (7.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (1.70e-4)"	"prognostic favourable (4.11e-5)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.38e-1)"	"prognostic favourable (5.82e-6)"	"unprognostic (6.30e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.57e-2)"	"unprognostic (4.06e-1)"	7.2	11.0	11.0	7.0	15.2	7.4	6.9	6.8	20.5	5.6	10.3	19.0	7.7	11.2	7.7	10.3	7.7	7.1	9.1	11.1	12.4	10.4	8.8	10.5	6.2	6.0	13.5	9.4	6.6	9.8	11.3	11.3	7.8	15.0	8.2	10.3	13.8	10.6	8.9	13.7	8.5	8.5	10.5	10.6	9.7	7.5	5.5	11.5	10.8	9.1	7.8	7.5	6.9	5.0	4.0	8.9	1.4	7.2	3.4	5.3	3.1	3.3	5.4	3.2	10.8	8.1	4.6	4.3	3.4	5.7	3.1	3.7	2.9	8.0	7.3	5.5	6.0	6.4	17.8	5.4	2.0	4.2	5.6	1.9	3.4	4.8	8.3	2.8	4.1	5.7	10.1	1.2	3.9	4.4	6.9	4.5	4.0	16.8	3.4	5.6	6.4	6.4	5.6	0.5	5.8	4.4	8.5	7.2	4.0	6.6	9.2	4.0	13.3	6.2	3.9	2.9	2.3	5.9	3.0	4.6	5.0	4.1	4.4	4.9	3.7	1.4	4.7	1.3	5.3	7.2	3.5	1.7	2.2	3.1	8.9	4.0	2.5	4.6	0.4	3.4	2.8	7.0	3.7	3.1	11.0	15.2	6.8	20.5	12.4	10.4	13.5	9.4	15.0	11.5
ADCK2	MGC20727	ENSG00000133597	"AarF domain containing kinase 2"	Q7Z695	7	140673153-140696261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036036	Approved		Uncertain	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA036036: AB_10672078"	"unprognostic (2.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.10e-3)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-3)"	"prognostic favourable (9.75e-5)"	"unprognostic (1.89e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.13e-1)"	12.3	10.6	15.3	11.3	16.6	8.8	13.4	15.4	27.0	12.3	15.1	26.3	13.2	8.8	10.3	11.4	18.0	20.0	10.3	10.2	16.6	18.2	12.3	12.5	12.8	15.6	19.5	13.1	14.5	22.8	21.4	12.7	19.9	18.2	14.4	13.2	10.7	16.8	14.0	12.5	25.8	13.0	10.9	24.0	13.6	13.0	7.6	13.3	20.6	25.1	9.9	16.2	13.4	18.9	8.2	12.0	3.2	5.0	5.1	7.3	2.2	15.9	11.5	2.7	12.7	10.0	11.4	16.4	8.3	10.1	8.7	5.8	10.5	11.3	21.4	12.6	5.8	13.2	13.8	9.4	2.6	15.8	14.2	4.5	4.5	5.1	13.9	3.0	11.3	9.5	28.9	4.9	6.9	7.4	7.9	10.5	3.1	19.9	22.4	7.4	4.0	12.5	17.7	0.1	10.4	4.7	16.0	10.8	7.5	11.4	16.6	11.4	14.7	6.1	7.8	10.9	3.8	18.0	16.0	7.3	11.2	15.8	16.0	12.1	12.9	0.0	3.7	3.2	5.4	5.0	4.9	8.2	4.8	5.3	5.7	4.2	7.3	4.7	0.1	5.1	3.0	12.0	6.0	2.2	15.3	16.6	15.4	27.0	16.6	18.2	19.5	13.1	18.2	13.3
ADCY7	"AC7, KIAA0037"	ENSG00000121281	"Adenylate cyclase 7"	P51828	16	50246137-50318135	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 22.9;HMC-1: 63.9;RPMI-8226: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041218, HPA048241"	Uncertain		Approved	Cytosol				Cytosol		"HPA041218: , HPA048241: "	"unprognostic (1.98e-1)"	"prognostic unfavourable (5.31e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.59e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.18e-1)"	"unprognostic (9.52e-4)"	6.3	4.3	7.0	17.4	9.7	14.9	3.9	1.2	5.2	3.7	5.0	9.8	0.8	2.8	3.7	4.8	13.2	5.3	6.9	7.3	5.3	4.2	3.3	3.6	16.4	16.5	8.8	4.4	17.1	3.7	1.0	3.4	9.7	8.6	3.5	5.9	6.2	6.5	1.6	1.8	7.9	10.4	5.0	12.3	26.9	4.9	2.1	9.2	21.8	3.7	3.1	26.0	6.6	6.1	3.6	12.5	6.5	16.7	8.4	7.0	5.0	3.9	5.4	0.2	0.7	0.5	7.0	0.5	2.8	1.3	2.1	2.0	5.1	8.2	1.6	7.4	11.1	14.3	5.6	2.4	2.7	15.1	2.0	22.9	4.1	1.4	6.4	4.3	63.9	3.7	2.3	1.6	2.5	0.6	8.3	3.2	3.0	2.3	1.6	10.2	0.9	7.7	1.6	2.1	31.7	1.5	0.3	0.9	2.6	1.5	0.6	1.3	0.1	12.8	5.0	0.3	7.5	0.8	0.7	0.3	0.1	3.5	2.4	9.3	1.0	6.5	7.8	2.9	7.0	11.7	5.1	3.2	2.8	5.0	12.5	3.6	2.6	3.7	4.4	8.4	16.7	6.5	3.9	5.0	7.0	9.7	1.2	5.2	5.3	4.2	8.8	4.4	8.6	9.2
ADGB	"C6orf103, CAPN16, dJ408K24.1, FLJ23121"	ENSG00000118492	Androglobin	Q8N7X0	6	146598965-146815462	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.9;epididymis: 13.1;testis: 30.6"	"Cell line enriched"	"Detected in single"	25	"HDLM-2: 17.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 6.6;pons and medulla: 20.9"	"Cell type enriched"	"Detected in single"	10	"myeloid DC: 2.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 2.6"					"Low region specificity"	"Detected in all"			"HPA036340, HPA036341"	Enhanced		Uncertain	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA036340: , HPA036341: AB_10672241"	"unprognostic (4.15e-3)"		"unprognostic (1.23e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-2)"		"unprognostic (3.11e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.68e-1)"		0.1	0.1	1.6	0.1	6.6	0.1	0.2	0.0	0.2	1.0	0.5	5.1	0.0	0.1	0.4	13.1	0.2	9.8	0.1	0.1	2.2	2.7	0.2	0.2	4.8	0.2	0.0	0.0	4.3	0.1	0.3	0.8	0.2	20.9	0.2	0.4	0.0	0.1	0.3	0.1	0.3	0.1	0.1	0.4	0.1	0.2	30.6	1.2	0.0	0.2	0.1	0.2	0.1	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	6.6	0.0	0.1	2.2	2.7	0.0	0.0	20.9	1.2
ADGRA1	"GPR123, KIAA1828"	ENSG00000197177	"Adhesion G protein-coupled receptor A1"	Q86SQ6	10	133070929-133131675	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 7.8;brain: 26.6"	"Cell line enriched"	"Detected in single"	18	"RH-30: 11.9"	"Cancer enriched"	"Detected in single"	13	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042773	Approved									"HPA042773: AB_10794764"		"unprognostic (8.31e-2)"			"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"		"unprognostic (2.29e-1)"		"unprognostic (1.54e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.51e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.66e-1)"			0.8	7.8	9.9	0.7	9.3	0.7	0.7	3.5	26.6	0.7	0.7	3.2	0.0	0.7	0.7	0.7	0.7	4.3	0.7	0.7	11.6	14.6	1.0	1.1	0.9	0.7	7.5	6.6	0.7	0.8	0.7	1.9	0.7	5.3	0.7	0.7	0.3	4.1	0.7	0.7	0.7	0.7	0.7	4.6	1.0	0.8	1.0	1.4	0.0	0.7	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	9.3	3.5	19.0	11.6	14.6	7.5	6.6	5.3	1.4
ADGRE1	"EMR1, TM7LN3"	ENSG00000174837	"Adhesion G protein-coupled receptor E1"	Q14246	19	6887566-6940459	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"blood: 64.1;lymphoid tissue: 50.0"	"Cell line enhanced"	"Detected in some"		"A549: 5.8;BJ hTERT+: 7.8;HDLM-2: 19.0;HMC-1: 13.6;Karpas-707: 16.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 64.1"	"Group enriched"	"Detected in many"	17	"granulocytes: 64.1;monocytes: 20.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA052809	Uncertain						9100			"HPA052809: "	"unprognostic (2.06e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.93e-5)"	"unprognostic (6.77e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-7)"	"unprognostic (6.69e-2)"	"unprognostic (3.33e-4)"	"unprognostic (1.11e-2)"	"unprognostic (1.35e-1)"	1.8	0.5	0.7	7.2	2.4	5.9	0.5	0.3	1.7	0.5	0.6	0.3	0.0	2.8	0.4	0.9	0.4	0.6	0.7	1.3	1.5	0.7	0.7	4.1	4.6	6.6	1.7	0.0	0.3	0.4	0.0	1.0	1.8	0.9	0.5	0.5	0.5	0.5	0.0	0.4	0.3	2.8	1.7	1.9	50.0	0.7	1.2	1.0	6.9	0.5	0.0	1.7	2.8	0.4	0.0	2.4	64.1	20.2	0.1	2.0	1.9	2.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.1	0.0	0.0	0.0	0.4	13.6	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.1	0.5	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.2	0.3	0.1	0.8	3.0	0.1	3.9	3.6	0.0	27.2	4.3	64.1	0.0	12.0	0.0	0.0	1.5	0.2	2.4	0.0	2.0	0.1	1.6	0.1	20.2	0.1	0.4	1.9	0.7	2.4	0.3	1.7	1.5	0.7	1.7	0.0	0.9	1.0
ADGRE3	EMR3	ENSG00000131355	"Adhesion G protein-coupled receptor E3"	Q9BY15	19	14619117-14690027	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 70.7;lung: 26.3"	"Cell line enriched"	"Detected in single"	38	"HMC-1: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basophil: 36.3;eosinophil: 69.6;neutrophil: 70.7"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 70.7"					"Not detected"	"Not detected"			HPA015638	Uncertain				"Secreted to blood"					"HPA015638: AB_1848039"	"unprognostic (2.11e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.69e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.07e-2)"	"unprognostic (9.61e-2)"	"unprognostic (9.11e-4)"	"unprognostic (4.68e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	1.7	0.2	0.3	8.5	0.8	4.0	0.3	0.2	0.7	0.2	0.4	0.3	0.1	2.1	0.2	0.7	0.4	0.6	1.2	0.6	0.3	0.3	0.4	1.1	26.3	5.9	0.4	0.1	0.5	0.3	0.0	0.3	1.7	0.7	0.6	0.5	0.7	6.2	0.1	0.9	0.2	3.2	0.7	0.6	8.1	0.4	0.8	0.3	0.8	0.5	0.9	3.4	2.6	0.4	0.0	0.7	70.7	8.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.3	3.2	69.6	0.0	7.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	70.7	0.0	8.0	0.0	0.0	0.9	0.3	0.8	0.2	0.7	0.3	0.3	0.4	0.1	0.7	0.3
ADGRF2	"GPR111, hGPCR35, PGR20"	ENSG00000164393	"Adhesion G protein-coupled receptor F2"	Q8IZF7	6	47656436-47697797	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 6.0;lymphoid tissue: 5.0;skeletal muscle: 4.7;skin 1: 6.0;tongue: 7.7"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.4;U-87 MG: 3.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA035507	Uncertain									"HPA035507: AB_10601809"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.95e-1)"	"unprognostic (1.59e-1)"		"unprognostic (1.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.51e-4)"		"unprognostic (3.05e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.99e-2)"	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.4	1.2	0.3	0.1	0.0	0.0	0.0	0.2	0.0	6.0	4.2	0.0	0.5	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.8	0.6	0.3	0.2	0.0	0.0	0.4	0.0	4.7	6.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	7.7	5.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.2	0.0	0.0	0.0	0.0	0.3	0.0
ADGRF3	"GPR113, hGPCR37, PGR23"	ENSG00000173567	"Adhesion G protein-coupled receptor F3"	Q8IZF5	2	26308173-26346817	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"vagina: 7.6"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 3.9;U-937: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044500	Uncertain									"HPA044500: AB_10794290"	"unprognostic (9.58e-3)"	"unprognostic (2.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.68e-4)"	"unprognostic (8.98e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.66e-4)"	"unprognostic (2.29e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.70e-5)"	0.4	0.5	0.4	1.1	0.9	1.4	0.5	2.1	1.2	1.0	1.2	0.1	0.1	2.0	0.8	0.1	0.8	0.5	0.5	1.3	3.3	0.3	3.4	0.7	2.6	1.8	0.3	0.1	0.8	3.2	0.0	0.8	0.7	1.5	0.6	0.4	0.1	2.7	2.6	0.4	0.8	0.7	0.1	1.5	1.4	0.8	2.8	0.7	2.0	0.9	0.1	0.5	0.7	7.6	1.3	0.0	2.0	0.8	0.5	1.5	0.0	0.5	0.2	0.4	1.4	0.1	0.3	2.1	0.2	0.2	0.0	0.3	0.7	0.0	2.4	1.6	0.2	0.9	0.0	0.0	0.0	0.5	0.5	1.0	1.6	0.2	0.0	0.8	1.0	0.3	0.0	0.1	0.0	0.6	0.1	1.0	0.1	0.1	3.9	1.1	2.7	0.0	2.3	2.2	1.0	0.2	3.1	1.9	0.9	0.0	1.0	0.0	0.1	0.2	0.4	0.1	0.5	0.9	0.3	1.8	1.4	2.7	0.1	3.5	0.4	0.0	0.0	2.0	1.1	0.8	0.8	1.3	0.5	0.6	0.0	0.3	0.7	1.5	0.1	0.5	0.3	0.0	1.5	0.0	0.4	0.9	2.1	1.2	3.3	0.3	0.3	0.1	1.5	0.7
ADGRF4	"FLJ38076, GPR115, PGR18"	ENSG00000153294	"Adhesion G protein-coupled receptor F4"	Q8IZF3	6	47685864-47722021	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 15.8;placenta: 23.9;skin 1: 30.7;tongue: 17.8"	"Cell line enhanced"	"Detected in some"		"A-431: 5.7;HaCaT: 8.7;HBEC3-KT: 13.9;hTCEpi: 21.6;RT4: 5.4;U-87 MG: 18.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007131, HPA007158"	Enhanced		Uncertain	Mitochondria				Mitochondria		"HPA007131: AB_2667756, HPA007158: AB_1849254"	"unprognostic (1.40e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.77e-2)"		"unprognostic (2.04e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavourable (5.52e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.66e-8)"	"unprognostic (1.62e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	0.0	0.5	0.0	0.1	0.1	0.0	1.9	0.3	0.0	7.0	1.0	0.1	0.0	0.0	1.0	0.0	15.8	0.9	0.5	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	23.9	0.2	1.9	1.2	0.0	1.8	0.0	0.4	30.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	17.8	14.0	2.3	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.8	0.0	0.0	0.0	0.0	0.6	0.0	3.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	8.7	0.0	13.9	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	21.6	0.2	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0
ADGRG4	"GPR112, PGR17, RP1-299I16"	ENSG00000156920	"Adhesion G protein-coupled receptor G4"	Q8IZF6	X	136300963-136416888	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	21	"intestine: 23.6"	"Cell line enhanced"	"Detected in single"		"TIME: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA035324	Uncertain									"HPA035324: AB_10671512"											"unprognostic (3.40e-3)"		"unprognostic (7.68e-5)"	"unprognostic (7.61e-2)"				0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	12.9	0.0	0.0	7.1	0.7	1.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.0	23.6	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADGRG5	"GPR114, PGR27"	ENSG00000159618	"Adhesion G protein-coupled receptor G5"	Q8IZF4	16	57542421-57591681	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 37.7;lymphoid tissue: 25.6"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 28.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 37.7"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"thalamus: 0.4"	"Low region specificity"	"Detected in single"			HPA007133	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"	Nucleoplasm	"HPA007133: AB_1849253"	"unprognostic (6.11e-3)"	"prognostic favourable (4.25e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.09e-4)"	"unprognostic (3.80e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.37e-3)"	"unprognostic (7.69e-3)"	"unprognostic (4.52e-1)"	"unprognostic (1.62e-3)"	"unprognostic (6.32e-3)"	0.7	0.6	2.4	20.2	2.7	1.4	0.8	0.6	2.1	0.6	2.1	2.5	0.0	4.3	0.5	0.2	1.7	0.8	0.8	0.5	1.6	1.1	0.5	0.6	2.9	12.1	2.6	0.9	0.5	0.4	0.2	0.8	0.0	2.9	1.2	1.7	0.5	4.6	0.8	0.4	0.7	7.5	0.3	3.5	12.8	0.5	1.2	3.5	3.4	1.1	0.2	25.6	2.8	0.9	4.0	21.9	37.7	0.0	8.8	11.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.4	2.6	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	37.7	11.1	0.0	5.6	4.0	1.6	6.4	0.7	2.8	0.4	4.0	0.1	8.8	0.0	21.9	0.0	2.3	2.4	2.7	0.6	2.1	1.6	1.1	2.6	0.9	2.9	3.5
ADORA2B		ENSG00000170425	"Adenosine A2b receptor"	P29275	17	15944917-15975746	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 56.7;hTERT-HME1: 21.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 12.8;myeloid DC: 8.4"	"Group enriched"	"Detected in many"	86	"dendritic cells: 8.4;granulocytes: 12.8;monocytes: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073747			Uncertain	Cytosol				Cytosol		"HPA073747: "	"unprognostic (6.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.68e-1)"	"unprognostic (7.88e-3)"	"unprognostic (2.64e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.66e-9)"	"unprognostic (2.07e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.84e-1)"	1.5	1.5	7.6	4.5	9.1	1.6	1.8	7.3	8.7	2.9	15.3	2.4	0.0	0.8	1.7	1.5	11.1	2.2	3.8	1.2	6.6	3.0	0.6	0.7	4.1	1.0	1.9	5.4	0.6	2.8	0.4	1.9	9.0	5.2	1.7	12.8	10.5	1.9	0.7	0.7	10.4	1.6	2.8	3.9	0.7	2.6	0.7	2.6	0.1	0.6	4.4	4.5	6.8	5.6	0.0	8.4	12.8	4.5	0.0	0.0	1.5	11.2	6.2	0.2	0.2	2.0	3.9	0.2	2.1	9.7	6.3	7.9	2.9	11.8	1.5	2.7	1.9	17.7	2.7	16.2	8.5	3.2	6.2	10.9	2.0	4.3	7.9	0.0	56.7	2.3	6.9	9.0	21.2	3.2	0.5	0.0	6.2	2.9	0.7	2.2	0.6	8.8	0.0	0.1	0.0	6.5	3.0	0.3	0.4	4.8	1.2	2.9	0.0	1.7	2.6	2.3	6.0	6.3	10.1	0.9	0.0	0.0	9.0	0.0	3.1	12.8	4.0	2.6	0.0	4.5	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.4	0.0	2.3	0.1	0.0	1.5	7.6	9.1	7.3	8.7	6.6	3.0	1.9	5.4	5.2	2.6
ADPRHL1	ARH2	ENSG00000153531	"ADP-ribosylhydrolase like 1"	Q8NDY3	13	113399610-113453524	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 89.6;skeletal muscle: 68.1"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 14.6;T-47d: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebellum: 2.6"	"Low region specificity"	"Detected in some"			HPA066478	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA066478: "	"unprognostic (3.03e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.31e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (4.88e-4)"	"prognostic unfavourable (2.55e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.02e-1)"	1.8	1.0	0.6	0.2	1.1	0.0	0.8	0.5	3.0	0.4	1.4	0.3	0.0	0.9	0.4	4.0	2.2	1.9	0.7	89.6	0.5	0.8	0.2	0.4	0.5	0.1	0.7	1.1	0.5	1.5	0.0	1.8	1.4	0.3	0.9	0.5	0.0	1.9	0.1	68.1	0.9	3.0	0.2	0.5	0.3	1.0	1.3	0.0	0.1	0.7	21.8	0.6	0.3	0.5	1.9	2.8	1.7	1.6	1.1	2.5	1.0	3.9	9.5	0.9	3.0	3.1	5.0	2.7	1.5	0.7	0.5	0.4	2.6	9.8	1.4	5.7	1.7	2.2	3.7	0.2	0.4	1.4	1.6	4.1	2.3	0.7	1.0	0.3	1.7	1.7	2.3	3.1	0.4	0.1	1.1	0.4	3.9	8.6	0.6	2.4	2.1	5.0	6.3	2.5	3.6	1.0	0.4	14.6	3.3	1.0	4.7	1.2	26.2	0.5	0.3	0.1	1.8	4.4	0.5	1.4	1.1	4.6	2.9	0.8	2.1	0.4	1.2	0.1	0.1	1.6	1.8	1.9	0.8	2.5	2.8	0.8	1.4	1.5	1.7	1.1	1.3	0.5	1.3	1.0	0.6	1.1	0.5	3.0	0.5	0.8	0.7	1.1	0.3	0.0
ADRA2C	"ADRA2L2, ADRA2RL2, ADRARL2"	ENSG00000184160	"Adrenoceptor alpha 2C"	P18825	4	3766348-3768526	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 35.1"	"Cell line enhanced"	"Detected in some"		"Hep G2: 11.0;MCF7: 18.2;NTERA-2: 6.4;SCLC-21H: 7.0;SH-SY5Y: 8.5;T-47d: 6.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"basal ganglia: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"basal ganglia: 41.4"	HPA057688	Uncertain									"HPA057688: "	"unprognostic (1.44e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.12e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.01e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.48e-2)"	6.5	2.4	2.1	1.0	9.8	0.4	9.2	0.5	2.6	35.1	1.5	0.6	12.8	1.0	20.3	18.0	2.1	6.4	5.5	3.0	1.2	1.0	9.2	1.3	2.0	1.2	0.7	1.6	7.6	4.1	0.5	4.2	27.6	1.1	7.3	0.6	3.6	0.8	24.6	2.6	2.1	0.9	3.0	0.7	7.5	0.7	6.2	2.0	0.2	0.8	1.9	0.5	2.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.1	0.5	0.0	0.2	0.4	0.0	0.0	0.0	2.0	1.2	0.0	2.1	0.3	0.0	0.2	0.0	0.0	0.0	5.6	0.0	0.0	11.0	0.6	0.0	0.8	0.9	0.4	0.0	0.0	0.0	0.4	0.0	2.7	18.2	0.0	0.0	6.4	0.0	0.0	5.9	0.0	0.0	0.3	7.0	8.5	2.5	0.0	0.1	6.0	0.1	0.0	0.0	4.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	9.8	0.5	1.4	1.2	1.0	0.7	1.6	1.1	2.0
ADTRP	"AIG1L, C6orf105, dJ413H6.1"	ENSG00000111863	"Androgen dependent TFPI regulating protein"	Q96IZ2	6	11712054-11807046	"Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 48.3;intestine: 61.2;retina: 38.0;seminal vesicle: 48.0"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 10.3;HUVEC TERT2: 35.2;RPMI-8226: 13.3;TIME: 19.0;U-138 MG: 12.7;U-266/84: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 12.4"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 10.5;T-reg: 9.8"	"Lineage enriched"	"Detected in many"	7	"T-cells: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048113	Uncertain		Uncertain	Nucleoli				Nucleoli		"HPA048113: "	"unprognostic (6.82e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.14e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.41e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.90e-1)"	"prognostic unfavourable (1.13e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.26e-1)"	0.8	0.4	0.6	10.6	0.8	0.0	0.9	0.3	2.1	0.4	21.8	1.5	48.3	22.4	0.4	4.0	0.9	0.5	0.3	0.5	1.2	0.4	3.8	1.0	3.9	2.0	0.4	1.1	0.4	0.6	0.8	0.3	0.3	12.4	1.7	16.2	38.0	0.7	48.0	0.4	12.7	61.2	0.5	0.4	1.0	11.4	14.1	0.1	0.8	0.7	0.6	3.2	2.7	0.5	0.2	0.2	1.4	0.3	0.1	10.5	1.5	1.6	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.3	0.4	0.3	1.5	0.8	0.0	0.7	0.3	0.7	0.0	4.7	0.6	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	8.7	3.5	10.3	35.2	8.5	0.0	1.2	0.0	0.0	0.2	0.1	2.4	0.0	0.1	13.3	0.7	0.1	0.0	0.1	0.6	0.0	0.3	0.0	0.3	19.0	12.7	0.9	0.3	1.0	0.5	14.9	0.0	2.6	0.5	0.1	1.4	0.1	0.0	0.0	0.3	2.3	0.2	2.8	0.2	0.1	0.1	10.5	0.8	0.2	0.1	0.2	0.2	9.8	1.5	0.6	0.8	0.3	2.1	1.2	0.4	0.4	1.1	12.4	0.1
AFMID	"DKFZp686F03259, KF"	ENSG00000183077	Arylformamidase	Q63HM1	17	78187317-78207701	"Enzymes, Predicted intracellular proteins"	"Tryptophan catabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.7"	"Cell line enhanced"	"Detected in all"		"Hep G2: 61.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 14.5"	"Group enriched"	"Detected in all"	5	"B-cells: 5.1;dendritic cells: 6.7;monocytes: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023861, HPA026536"	Uncertain		Approved	Mitochondria				Mitochondria		"HPA023861: AB_1844636, HPA026536: AB_1844637"	"unprognostic (3.55e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.65e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.53e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.59e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.79e-2)"	5.9	3.5	12.1	5.4	17.1	4.6	33.0	27.1	18.3	6.1	7.5	44.8	11.7	8.5	7.5	7.0	7.7	11.3	11.4	9.4	17.3	12.0	39.4	78.7	10.6	5.2	29.7	13.3	15.9	27.7	6.9	4.1	12.4	18.1	10.7	9.2	5.8	24.7	11.8	7.9	15.5	7.1	6.6	27.0	6.2	10.2	6.2	23.9	3.9	6.5	5.6	6.2	6.7	7.4	5.1	6.7	1.7	14.5	1.6	1.1	1.5	6.9	9.9	8.7	7.9	9.8	11.5	4.7	10.0	5.7	7.0	8.5	10.5	5.8	21.8	6.6	7.6	6.0	14.7	8.7	9.9	13.8	11.7	17.5	11.6	61.2	8.6	14.4	9.0	15.4	9.3	8.2	10.7	13.1	17.7	7.6	5.4	6.9	11.0	22.0	7.1	17.0	12.6	8.9	26.0	9.5	6.4	19.3	14.4	8.6	25.9	8.1	7.8	14.0	6.4	10.8	7.1	6.8	7.0	11.7	7.7	22.3	8.9	7.1	2.7	1.1	6.1	0.7	0.7	14.5	1.1	5.1	1.0	1.1	6.7	2.0	0.6	0.6	1.7	1.6	9.3	4.4	0.9	1.5	12.1	17.1	27.1	18.3	17.3	12.0	29.7	13.3	18.1	23.9
AGAP4	"AGAP8, CTGLF1, CTGLF5, Em:AC012044.1, MRIP2"	ENSG00000188234	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 4"	Q96P64	10	45825594-45853875	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA042490	Uncertain									"HPA042490: "	"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.50e-2)"	"unprognostic (4.10e-4)"	"unprognostic (4.13e-3)"	"unprognostic (5.72e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.76e-5)"	"unprognostic (7.49e-2)"	"unprognostic (3.19e-1)"	"unprognostic (8.58e-2)"	"unprognostic (5.28e-4)"	2.6	5.6	3.4	4.8	5.2	4.3	5.9	13.6	5.2	3.2	4.1			8.4	4.5	6.2	2.6	4.3	3.9	3.3	3.9	4.1	4.0	3.9	3.8	5.8	3.2		5.6	4.2	1.7	7.5	2.5		5.4	4.3		4.1	5.1	4.6	12.7	4.8	2.8	3.2	8.0	4.4	5.6			4.8		3.7	3.2	3.3	1.5	1.3	4.8	1.4	2.3	2.2	0.3	4.9	3.0	14.0	8.3	5.1	6.9	7.2	6.0	4.2	5.0	7.9	7.5	12.3	4.9	5.5	3.7	11.7	8.6	6.9	6.9	5.2	8.7	0.5	11.9	13.3	7.6	6.3	6.2	5.2	9.8	7.3	9.2	4.9	8.7	6.7	3.5	5.6	9.7	21.3	9.0	1.4	9.6	4.2	7.2	6.3	6.5	10.3	11.2	3.2	8.7	7.3	9.8	4.8	4.8	3.4	7.4	6.5	8.8	10.0	8.9	9.0	5.8	11.6	1.8	4.8	1.1	2.5	1.6	1.4	1.2	0.6	0.8	2.2	1.3	1.5	0.8	1.1	3.8	2.3	0.6	1.0	0.8	0.3										
AGAP5	"CTGLF2, Em:AC073389.1"	ENSG00000172650	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 5"	A6NIR3	10	73674285-73698159	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA042490	Uncertain									"HPA042490: "	"unprognostic (1.84e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.52e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.04e-3)"	"unprognostic (4.33e-3)"	"unprognostic (5.83e-5)"	"unprognostic (3.33e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.17e-2)"	2.8	4.3	1.7	3.4	2.5	2.7	4.6	4.7	1.7	3.3	2.4			3.4	3.3	4.4	2.6	3.1	2.3	4.1	2.0	1.9	3.3	5.4	2.9	4.0	1.8		5.3	9.2	3.0	5.0	2.4		4.3	3.1		6.4	2.5	8.5	6.9	3.7	2.0	2.3	4.4	3.5	7.5			4.1		2.6	2.4	3.0	1.4	1.8	2.9	0.8	0.0	2.0	0.2	3.0	3.9	5.0	5.6	4.1	3.1	7.5	3.8	2.8	2.7	2.2	5.0	4.3	3.7	3.1	2.9	7.6	3.7	3.1	1.8	4.4	4.3	2.9	7.5	5.6	3.4	7.3	4.9	3.4	3.4	2.9	8.1	2.2	3.8	7.5	2.3	2.8	2.8	9.5	1.4	10.5	3.8	2.1	2.7	2.7	2.9	2.3	2.0	2.2	8.1	4.5	4.5	6.1	3.6	3.4	4.5	3.4	4.8	8.9	4.5	2.1	3.4	8.5	1.4	2.9	0.7	0.4	2.0	0.8	0.5	0.8	0.8	0.3	0.5	1.4	0.4	0.5	0.3	0.0	0.3	1.8	0.1	0.2										
AGAP6	"bA324H6.1, CTGLF3"	ENSG00000204149	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 6"	Q5VW22	10	49982190-50010499	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA042490	Uncertain									"HPA042490: "	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.07e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.34e-2)"	"unprognostic (7.48e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.91e-2)"	"prognostic favourable (2.66e-4)"	"unprognostic (9.93e-3)"	"prognostic unfavourable (9.70e-10)"	"unprognostic (8.04e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.85e-2)"	"prognostic favourable (1.83e-7)"	5.1	4.5	2.9	5.5	4.6	6.1	6.0	11.2	4.0	4.3	5.1			10.0	5.2	5.2	3.4	4.5	3.9	3.5	3.3	3.4	5.2	8.8	5.3	7.5	2.9		5.7	7.4	2.9	10.2	3.8		7.0	5.0		7.8	4.6	14.1	12.4	6.2	4.5	2.7	8.9	4.8	7.2			7.5		4.8	3.3	4.4	2.0	2.0	4.0	1.6	3.4	2.4	0.6	5.6	5.3	8.9	10.0	8.3	6.8	6.9	7.0	4.1	5.3	5.4	10.7	6.4	6.8	4.2	4.1	10.2	5.8	5.2	4.9	5.0	11.2	8.0	14.0	9.7	3.5	11.9	15.2	7.0	9.6	5.8	12.4	4.4	11.8	10.5	4.0	8.1	10.8	30.6	5.0	11.2	9.7	5.1	4.1	6.0	6.7	7.2	8.9	2.8	10.7	4.9	8.1	9.6	7.7	7.2	9.3	4.9	9.5	11.8	7.7	8.7	5.7	17.0	3.4	4.0	1.6	2.0	2.4	0.7	1.5	0.8	0.9	0.9	0.8	2.0	1.4	1.9	2.2	3.4	0.1	2.0	1.3	0.6										
AGBL3	"CCP3, MGC32955"	ENSG00000146856	"ATP/GTP binding protein like 3"	Q8NEM8	7	134986508-135147963	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 8.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020397, HPA024150"	Uncertain		Uncertain	"Nuclear speckles,Mitochondria,Cytosol"				"Nuclear speckles, Mitochondria, Cytosol"		"HPA020397: AB_2242453, HPA024150: AB_1844639"	"unprognostic (8.84e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.32e-3)"	"unprognostic (4.18e-2)"	"unprognostic (7.15e-4)"	"unprognostic (5.00e-3)"	"unprognostic (6.10e-4)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (4.02e-4)"	"unprognostic (2.18e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.11e-3)"	3.2	2.7	4.2	4.1	8.4	3.8	4.6	8.7	4.5	4.3	2.4	4.4	4.5	1.6	5.5	15.4	2.2	3.6	3.1	2.4	5.0	3.4	5.3	2.6	3.6	4.0	2.7	4.5	6.8	4.5	0.6	9.2	1.9	3.3	3.8	3.0	3.1	4.9	4.3	4.2	4.7	3.7	3.3	2.9	6.5	4.4	18.7	3.7	2.7	5.4	0.8	2.8	3.3	2.5	2.2	1.7	0.5	0.2	2.2	5.0	1.7	2.6	1.4	3.6	0.8	1.0	1.4	2.2	0.7	0.0	0.5	0.8	4.7	3.0	4.3	1.3	0.0	2.8	1.3	0.5	0.0	3.4	8.8	3.6	5.3	4.6	0.0	1.6	0.0	0.2	0.0	2.1	0.0	1.5	2.6	2.5	0.6	2.5	0.9	1.5	3.1	0.3	2.5	0.2	1.2	2.6	0.5	2.1	2.4	0.5	0.0	0.3	1.9	3.5	0.0	0.4	0.9	0.5	1.6	5.3	1.6	1.9	1.8	4.3	4.4	0.0	0.2	0.4	2.4	0.0	1.8	2.1	1.2	2.5	0.5	2.2	2.0	5.0	0.5	2.2	0.1	1.7	1.7	1.7	4.2	8.4	8.7	4.5	5.0	3.4	2.7	4.5	3.3	3.7
AGBL4	"CCP6, FLJ14442"	ENSG00000186094	"ATP/GTP binding protein like 4"	Q5VU57	1	48532855-50023913	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 20.4;pituitary gland: 31.5"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.6;SCLC-21H: 5.2;SH-SY5Y: 2.0;U-937: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA037994	Approved									"HPA037994: AB_10673036"	"unprognostic (3.06e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.31e-4)"	"unprognostic (3.42e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.85e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.51e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.85e-1)"	1.4	4.5	7.8	0.8	13.6	1.1	1.5	1.3	20.4	1.0	0.8	3.0	0.1	0.7	1.0	4.5	0.9	7.8	1.0	3.7	7.1	7.2	10.2	4.6	1.6	0.8	3.2	11.6	1.3	2.7	3.6	31.5	2.7	6.7	1.0	0.7	4.6	0.8	1.5	0.9	1.5	0.8	0.7	1.5	1.3	1.1	10.7	1.9	0.0	3.4	0.0	0.8	0.7	0.7	0.8	0.5	2.2	0.3	0.6	1.8	0.2	0.0	0.5	0.8	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.1	0.4	3.6	0.4	0.1	0.1	0.1	0.1	0.3	5.2	2.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.4	0.2	0.0	0.2	0.0	0.1	0.1	2.2	0.5	2.2	0.3	0.4	0.3	0.3	1.8	0.5	0.2	0.1	0.2	0.8	0.4	0.2	1.0	0.6	0.2	0.5	0.3	0.2	7.8	13.6	1.3	20.4	7.1	7.2	3.2	11.6	6.7	1.9
AKNAD1	"C1orf62, MGC26989"	ENSG00000162641	"AKNA domain containing 1"	Q5T1N1	1	108815898-108858228	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	57	"testis: 12.1"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.5;HBEC3-KT: 1.2;hTCEpi: 3.9;hTERT-HME1: 2.1;LHCN-M2: 1.2"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA030270, HPA030271, HPA030272"	Uncertain									"HPA030270: AB_10610980, HPA030271: AB_10600873, HPA030272: AB_10601342"	"unprognostic (4.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.00e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-5)"	"unprognostic (8.15e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.00e-8)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.22e-2)"	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.9	0.6	0.0	0.9	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.5	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.2	2.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALDH3B2	ALDH8	ENSG00000132746	"Aldehyde dehydrogenase 3 family member B2"	P48448	11	67662162-67681200	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 28.1;esophagus: 48.2;lymphoid tissue: 34.2;skin 1: 38.7"	"Group enriched"	"Detected in some"	5	"MCF7: 30.9;SK-BR-3: 32.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			HPA045132	Approved									"HPA045132: AB_10795993"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.65e-2)"		"unprognostic (2.13e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.12e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.92e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	28.1	0.1	0.1	6.7	0.1	0.1	5.0	0.0	1.5	2.4	48.2	1.5	0.1	0.1	0.1	0.0	0.6	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.6	0.3	11.2	0.1	1.8	0.0	0.1	17.1	4.6	0.1	38.7	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.8	0.1	25.7	34.2	4.6	11.6	1.0	0.1	0.6	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	1.8	1.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	30.9	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.0	32.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ALG10	"ALG10A, DIE2, FLJ14751"	ENSG00000139133	"ALG10, alpha-1,2-glucosyltransferase"	Q5BKT4	12	34022281-34029694	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA043329, HPA063387"	Approved		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA043329: , HPA063387: "	"unprognostic (1.71e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.80e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.88e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.29e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (6.45e-2)"	6.2	7.0	2.7	5.4	5.9	6.9	6.9	4.0	5.5	5.3	4.6	3.8	3.6	3.4	10.3	5.5	6.0	6.2	3.7	4.6	2.6	2.9	4.6	5.7	5.4	6.7	4.1	1.7	7.1	7.8	7.5	6.1	7.2	3.5	5.8	4.1	8.7	9.0	4.4	4.6	5.1	5.0	4.0	3.5	6.1	5.1	8.0	3.6	17.2	6.2	3.0	9.8	5.8	4.8	2.7	1.8	4.5	2.7	2.1	3.8	1.6	4.5	5.3	3.5	5.8	4.2	3.3	12.4	4.4	4.1	4.7	8.6	7.8	11.0	6.9	6.4	2.2	6.9	6.6	5.6	6.5	11.0	6.3	6.3	5.7	3.1	1.7	9.2	6.7	3.6	3.3	10.1	7.7	3.1	9.6	11.6	3.9	6.2	5.9	5.1	13.0	6.8	5.3	12.6	7.0	2.6	6.8	3.1	2.5	7.6	3.2	5.5	7.8	2.5	6.8	6.6	9.8	8.8	5.5	6.3	11.4	13.3	4.6	3.7	5.2	0.0	2.7	4.5	1.9	1.2	3.0	2.5	2.6	1.1	1.8	2.7	3.1	3.8	0.4	2.1	1.2	1.8	3.0	1.6	2.7	5.9	4.0	5.5	2.6	2.9	4.1	1.7	3.5	3.6
ALG1L	ALG1L1	ENSG00000189366	"ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like"	Q6GMV1	3	125929275-125937039	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 11.4;urinary bladder: 12.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 11.1;CAPAN-2: 10.1;HaCaT: 10.8;MCF7: 20.9;T-47d: 14.1;U-266/70: 7.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA036108	Uncertain									"HPA036108: AB_10673344"	"unprognostic (7.06e-3)"	"unprognostic (1.50e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"prognostic favourable (3.00e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.37e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.50e-6)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.57e-2)"	"prognostic favourable (6.24e-4)"	0.0	0.5	2.3	0.8	1.6	0.0	1.1	0.3	1.8	0.8	0.9			0.0	0.9	11.4	1.3	2.0	0.4	0.1	1.6	2.0	1.0	1.0	0.7	0.0	2.2		1.7	0.7	0.0	1.2	1.2		1.2	0.6		1.6	0.6	5.9	5.5	0.1	0.2	1.0	0.0	1.1	0.5			1.0		2.3	12.5	0.9	3.1	2.4	4.8	0.2	5.3	5.0	2.1	0.7	0.6	0.3	0.0	0.0	0.2	1.3	0.0	0.0	0.1	0.3	11.1	10.1	3.0	4.9	0.0	10.8	0.3	0.0	0.6	0.4	2.6	0.5	1.7	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.8	1.0	0.0	20.9	0.6	0.2	4.5	2.7	0.1	0.0	5.0	0.0	0.6	1.7	0.7	0.4	0.1	0.5	14.1	0.2	0.2	0.1	1.7	0.1	0.0	7.9	1.1	4.1	0.1	0.0	0.7	4.8	0.1	0.2	3.9	0.2	2.1	3.1	2.1	4.2	0.0	1.9	2.3	1.6	0.8	5.3	0.0	2.4	5.0	2.1										
ALPK1	"FLJ22670, KIAA1527, Lak"	ENSG00000073331	"Alpha kinase 1"	Q96QP1	4	112285509-112442620	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA027435, HPA027443"	Approved		Approved	Centrosome				Centrosome		"HPA027435: AB_10599614, HPA027443: AB_10599421"	"unprognostic (6.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (5.82e-7)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.81e-1)"	"prognostic favourable (1.17e-4)"	15.1	10.6	5.3	8.3	7.7	17.3	9.3	1.3	5.9	10.8	9.5	5.8	3.0	4.5	9.8	9.2	8.8	9.2	7.5	6.1	6.1	2.3	10.8	13.4	13.2	11.4	9.7	1.0	17.4	9.7	11.0	14.0	11.5	6.6	14.0	7.8	9.6	10.4	6.8	5.0	11.8	12.1	11.3	16.6	16.2	7.4	4.2	8.5	13.7	12.4	4.7	13.7	13.6	11.6	0.9	3.2	16.3	4.3	0.4	0.8	1.2	1.6	5.0	1.5	0.3	6.5	10.4	2.0	1.9	3.4	2.6	3.2	0.5	7.6	5.0	3.3	3.2	1.1	1.7	3.0	3.8	6.4	1.7	3.6	2.0	0.4	10.5	2.2	2.2	12.9	8.5	3.7	7.8	1.0	0.9	8.8	4.9	3.0	1.2	2.0	0.4	1.2	0.6	1.1	1.6	3.8	1.8	0.5	0.8	1.8	6.5	2.8	2.9	4.0	1.9	2.3	2.1	3.7	1.2	2.2	0.7	4.3	5.7	4.5	2.1	1.3	3.2	1.4	0.2	4.3	0.6	0.8	0.6	0.1	3.2	0.9	0.8	0.6	16.3	0.4	1.9	0.5	0.0	1.2	5.3	7.7	1.3	5.9	6.1	2.3	9.7	1.0	6.6	8.5
ALPK2	HAK	ENSG00000198796	"Alpha kinase 2"	Q86TB3	18	58481247-58628957	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 35.3;skeletal muscle: 35.3;tongue: 12.4"	"Cell line enhanced"	"Detected in many"		"BJ: 26.0;BJ hTERT+: 15.8;fHDF/TERT166: 23.5;U-138 MG: 13.3"	"Cancer enriched"	"Detected in some"	6	"renal cancer: 7.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.8"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Low region specificity"	"Detected in many"			"HPA027377, HPA027976, HPA028084, HPA029801"	Uncertain		Approved	Cytosol				Cytosol		"HPA027377: AB_10600635, HPA027976: AB_10611246, HPA028084: AB_10601996, HPA029801: AB_10602006"	"unprognostic (7.35e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.60e-3)"	"unprognostic (2.64e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavourable (8.20e-5)"	"unprognostic (5.27e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.20e-2)"	0.8	0.0	0.1	2.8	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.8	0.0	0.4	35.3	0.1	0.0	5.2	2.8	0.1	3.3	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.2	0.4	0.1	35.3	0.3	0.6	0.1	0.1	0.2	1.2	0.6	0.1	5.5	0.3	12.4	7.9	0.5	0.1	0.0	0.5	0.0	1.8	0.0	0.3	0.0	0.0	6.9	0.5	0.0	0.2	1.8	0.1	26.0	15.8	11.0	9.5	1.6	0.0	0.0	2.7	23.5	0.0	0.0	0.0	11.3	5.6	0.0	0.0	2.1	0.9	1.4	0.0	0.0	1.6	0.0	3.3	0.1	0.0	0.0	0.2	7.0	0.0	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.3	5.8	1.8	4.4	10.7	9.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.5	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
ALPPL2		ENSG00000163286	"Alkaline phosphatase, placental like 2"	P10696	2	232406843-232410714	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 4.2;lung: 9.4"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 24.5;HaCaT: 18.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 49.1;testis cancer: 64.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB020698, HPA038764, HPA038765, HPA051699"	Supported		Approved	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"CAB020698: , HPA038764: , HPA038765: , HPA051699: "		"unprognostic (1.39e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.27e-2)"		"unprognostic (2.89e-1)"		"unprognostic (1.46e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.69e-3)"			"unprognostic (1.65e-1)"	"unprognostic (2.67e-1)"		"unprognostic (6.72e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	0.2	1.5	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.5	24.5	0.0	0.0	0.0	18.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMN1		ENSG00000151743	"Antagonist of mitotic exit network 1 homolog"	Q8IY45	12	31671137-31729174	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 27.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046157, HPA062290"	Approved		Approved	Centrosome				Centrosome		"HPA046157: AB_10965846, HPA062290: "	"unprognostic (2.11e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.93e-2)"	"unprognostic (8.60e-3)"	"unprognostic (4.08e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.30e-1)"	5.3	9.9	24.8	6.1	20.9	3.1	9.0	13.8	28.3	9.6	4.3	11.1	2.9	3.8	10.8	7.9	6.0	17.0	6.9	10.1	22.4	20.9	11.3	5.8	6.5	10.3	19.6	15.2	16.0	8.2	8.5	16.1	5.4	14.8	8.9	4.3	8.9	5.9	7.8	12.8	5.4	4.1	7.3	19.4	8.4	8.4	46.5	16.2	11.7	7.9	4.2	9.0	7.7	5.5	12.3	6.6	27.4	2.7	4.7	9.8	3.4	4.0	8.8	7.2	0.8	7.0	9.0	4.2	4.2	6.6	3.0	5.8	4.6	16.1	2.0	9.7	3.7	2.3	3.3	5.1	6.1	3.4	4.3	7.0	3.2	6.5	12.6	3.7	3.7	6.0	8.3	5.1	7.3	17.0	6.1	6.7	11.4	2.5	2.1	3.0	9.9	4.3	3.1	11.6	3.3	6.9	9.1	11.6	9.6	5.6	1.5	8.8	13.5	4.2	9.5	5.1	4.2	4.2	7.7	7.3	6.9	7.2	6.4	3.5	9.5	4.3	2.7	3.3	4.3	1.9	4.3	12.3	4.5	4.6	2.1	11.5	9.8	5.9	27.4	4.7	1.6	6.6	6.7	3.4	24.8	20.9	13.8	28.3	22.4	20.9	19.6	15.2	14.8	16.2
ANGEL2	"Ccr4d, FLJ12793, KIAA0759L"	ENSG00000174606	"Angel homolog 2"	Q5VTE6	1	212992182-213015826	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030795, HPA030796"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Mitochondria"				Nucleoplasm	"Nuclear bodies, Mitochondria"	"HPA030795: , HPA030796: AB_10600979"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.70e-3)"	"unprognostic (6.46e-2)"	"prognostic unfavourable (8.39e-6)"	"unprognostic (9.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-1)"	"prognostic favourable (1.20e-4)"	11.4	11.7	18.0	10.8	32.6	9.5	17.8	21.6	22.7	14.5	9.3	16.9	8.6	8.6	14.8	14.2	10.2	12.2	10.4	9.2	17.4	13.8	13.3	13.0	11.0	15.8	17.0	13.9	19.1	10.5	15.5	14.8	10.8	13.8	14.5	11.0	12.3	9.8	11.2	11.0	15.1	10.7	12.2	14.9	15.5	10.5	9.0	15.9	19.5	14.0	7.9	14.9	10.8	9.7	7.8	7.2	7.6	5.9	14.1	11.3	6.7	8.6	6.9	11.3	9.6	8.6	12.7	10.1	7.1	11.9	11.4	11.4	4.6	6.4	8.4	6.5	7.0	6.8	12.9	6.8	11.5	15.7	7.8	8.4	5.5	4.5	9.5	8.3	10.1	7.8	8.8	8.9	9.1	9.6	9.7	8.7	13.0	2.8	9.5	5.6	26.5	5.0	4.8	20.2	8.7	8.9	5.8	5.5	16.1	8.5	11.6	13.1	8.9	6.1	7.1	9.4	5.0	11.5	10.7	6.4	6.1	5.6	10.5	6.2	8.6	7.4	5.9	7.6	7.4	5.5	9.1	7.8	9.2	7.6	7.2	5.3	9.8	8.1	4.0	14.1	4.4	4.4	11.3	6.7	18.0	32.6	21.6	22.7	17.4	13.8	17.0	13.9	13.8	15.9
ANGPTL1	"ANG3, ANGPT3, AngY, ARP1"	ENSG00000116194	"Angiopoietin like 1"	O95841	1	178849705-178871052	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	18	"ASC diff: 47.6;ASC TERT1: 19.2;HHSteC: 20.6;HSkMC: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.3;naive B-cell: 2.9"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009976	Approved				"Secreted to blood"		100000			"HPA009976: AB_1844822"	"unprognostic (2.59e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.63e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-2)"	"prognostic favourable (8.73e-4)"	"unprognostic (3.81e-2)"	"unprognostic (5.78e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.31e-2)"	"prognostic favourable (5.11e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.61e-3)"	17.7	16.3	1.2	8.5	1.1	0.0	14.4	0.7	1.4	26.3	36.2	0.9	9.6	2.6	34.6	46.5	33.6	29.7	16.6	12.9	1.0	0.6	15.9	7.1	12.4	15.8	0.6	2.5	35.7	6.4	0.0	2.2	42.0	1.6	16.7	8.7	0.9	14.2	4.2	20.0	4.5	28.2	22.7	1.8	7.0	13.1	24.7	0.4	0.9	19.3	57.5	2.8	25.5	13.7	2.9	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	47.6	19.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	20.6	0.0	0.0	46.9	0.0	0.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	2.9	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.7	1.4	1.0	0.6	0.6	2.5	1.6	0.4
ANKAR	FLJ25415	ENSG00000151687	"Ankyrin and armadillo repeat containing"	Q7Z5J8	2	189674290-189761193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 2.3;testis: 9.0"	"Cell line enhanced"	"Detected in some"		"TIME: 2.7"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036168	Uncertain		Approved	"Nucleoplasm,Centriolar satellite"				"Centriolar satellite"	Nucleoplasm	"HPA036168: AB_10673345"	"unprognostic (2.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.34e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-2)"	0.2	0.4	0.2	0.0	0.2	0.0	0.4	0.2	0.2	0.2	0.2			0.0	0.3	0.7	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.4	0.2	0.5	0.2		0.2	0.2	1.2	0.3	0.1		0.5	0.3		0.4	0.0	0.2	0.2	0.3	0.0	0.2	0.2	0.6	9.0			0.6		0.1	0.2	0.2	2.3	0.3	0.5	0.4	0.0	0.6	0.1	0.6	0.5	0.4	0.5	0.4	1.0	0.0	0.0	0.7	0.2	0.5	0.9	1.1	0.3	0.3	1.0	0.8	0.7	0.0	0.3	0.9	0.6	0.6	0.4	1.3	0.0	1.8	0.2	1.3	0.2	0.3	1.4	0.0	0.1	0.9	0.3	0.4	0.0	0.5	0.0	0.7	0.3	0.4	0.0	0.6	2.2	0.0	0.0	0.5	0.3	0.8	2.4	1.8	2.7	0.8	1.1	0.0	0.0	1.0	0.4	0.1	0.4	0.1	0.2	0.0	0.0	0.5	0.6	0.4	0.1	0.6	0.3	0.1	0.1	2.3	0.2	0.5	0.0	0.0	0.3	0.3	0.0	0.1										
ANKDD1A	FLJ25870	ENSG00000166839	"Ankyrin repeat and death domain containing 1A"	Q495B1	15	64911902-64958700	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 18.7;RT4: 14.1;U-266/84: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebellum: 29.1"	HPA040757	Approved		Approved	Nucleoplasm	"Secreted - unknown location"			Nucleoplasm		"HPA040757: AB_10960566"	"unprognostic (3.72e-4)"	"unprognostic (1.86e-1)"	"unprognostic (6.07e-3)"	"unprognostic (3.25e-2)"	"unprognostic (4.78e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.11e-3)"	"unprognostic (5.57e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.15e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.64e-2)"	3.9	12.4	7.9	3.7	9.5	3.2	2.3	7.9	9.4	4.3	2.2	0.6	3.5	1.9	4.7	7.6	5.1	5.9	3.9	3.6	8.3	3.9	2.0	1.3	4.4	6.3	4.2	9.8	5.8	7.6	3.5	4.4	5.4	3.5	3.3	0.5	2.4	3.3	4.2	1.5	4.9	2.4	6.5	3.0	14.2	2.6	8.6	1.1	0.0	3.8	0.9	1.6	5.1	4.0	1.0	1.5	1.4	1.9	6.8	4.0	0.8	1.0	2.8	1.4	1.3	2.2	1.6	5.5	1.3	3.4	1.3	1.9	1.6	1.4	1.2	1.5	2.8	1.4	2.8	0.2	1.0	0.7	0.8	1.4	3.0	1.1	1.6	1.1	2.3	1.3	0.4	0.8	0.5	0.9	0.2	18.7	0.4	2.7	0.4	2.0	1.7	1.3	0.8	0.8	8.9	0.1	14.1	2.8	3.5	0.7	0.9	1.3	1.1	1.1	1.4	2.6	2.7	2.3	1.3	5.2	18.2	1.0	2.8	2.5	0.8	1.0	0.9	0.1	2.1	1.9	0.8	1.0	1.1	3.2	1.5	0.7	0.8	0.8	1.4	6.8	1.8	0.0	4.0	0.8	7.9	9.5	7.9	9.4	8.3	3.9	4.2	9.8	3.5	1.1
ANKEF1	"ANKRD5, dJ839B4.6, FLJ21669"	ENSG00000132623	"Ankyrin repeat and EF-hand domain containing 1"	Q9NU02	20	9986126-10058303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 25.0;testis: 22.7"	"Cell line enhanced"	"Detected in many"		"U-266/84: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA041151	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"				"Nucleoli fibrillar center, Plasma membrane, Cytosol"		"HPA041151: AB_10796569"	"unprognostic (4.72e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.38e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavourable (1.81e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.73e-2)"	"prognostic favourable (4.44e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (3.11e-1)"	5.6	2.9	1.4	2.3	2.4	0.5	3.7	5.7	2.0	2.7	3.1	0.8	11.3	2.9	1.9	4.2	4.7	4.9	4.0	3.2	2.3	2.5	5.7	6.7	2.3	1.3	1.5	1.1	3.6	25.0	5.3	13.6	1.7	4.1	3.4	3.0	3.0	4.2	13.0	1.7	2.9	3.6	1.0	1.2	1.8	5.1	22.7	1.0	3.2	8.6	2.5	3.9	2.1	2.6	2.5	1.6	0.7	0.1	1.5	5.4	1.3	10.1	10.3	1.4	2.5	2.1	1.2	5.9	1.9	0.1	1.8	0.9	6.0	9.2	0.0	3.2	0.4	8.8	1.8	12.1	2.2	0.0	1.6	1.3	2.0	5.5	1.4	1.1	0.2	3.7	8.6	1.6	1.7	1.5	3.8	9.0	0.4	3.2	1.6	0.0	4.3	2.4	0.0	0.0	6.9	4.4	6.5	7.8	3.9	4.7	10.3	0.0	9.0	0.9	1.1	1.3	1.5	0.1	2.0	9.3	17.9	1.6	2.6	0.3	1.7	0.0	0.0	0.0	2.8	0.1	5.4	2.5	3.3	2.6	0.2	2.3	4.1	3.0	0.7	1.5	0.0	1.6	3.8	1.3	1.4	2.4	5.7	2.0	2.3	2.5	1.5	1.1	4.1	1.0
ANKFN1	FLJ38335	ENSG00000153930	"Ankyrin repeat and fibronectin type III domain containing 1"	Q8N957	17	55882301-56511659	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.8;cervix, uterine: 19.9;fallopian tube: 10.9"	"Cell line enhanced"	"Detected in some"		"HeLa: 7.9;MOLT-4: 16.4;T-47d: 5.7;U-2197: 5.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA021566, HPA022538, HPA048953"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA021566: AB_1844828, HPA022538: AB_1844829, HPA048953: "	"unprognostic (6.64e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.38e-5)"	"unprognostic (2.39e-1)"	"unprognostic (2.31e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.44e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.93e-2)"	"unprognostic (9.51e-2)"	3.9	1.0	5.5	0.5	10.2	0.5	1.2	2.6	4.7	19.9	0.7	11.4	0.5	0.7	0.8	3.4	0.7	10.9	0.9	0.5	6.8	4.6	0.7	0.6	2.0	0.6	6.3	3.7	0.5	0.5	0.5	1.0	2.1	11.8	0.9	0.8	0.0	0.7	0.8	0.6	5.2	0.8	0.5	7.5	0.6	1.1	3.6	10.0	0.0	0.6	0.0	0.5	3.2	5.3	0.2	0.5	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.1	0.0	1.3	0.2	0.3	0.0	2.8	0.2	0.3	0.0	0.1	0.3	0.2	0.7	0.1	0.0	0.0	0.2	0.0	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.1	0.1	0.4	16.4	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	1.5	0.0	1.7	0.0	0.3	5.7	0.0	0.0	0.0	0.4	5.5	0.1	1.5	0.3	0.0	0.8	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.1	0.3	0.1	0.5	0.0	0.0	5.5	10.2	2.6	4.7	6.8	4.6	6.3	3.7	11.8	10.0
ANKK1	X-kinase	ENSG00000170209	"Ankyrin repeat and kinase domain containing 1"	Q8NFD2	11	113387791-113400418	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skin 1: 9.7;tongue: 6.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.0;hTCEpi: 6.5;RT4: 3.1;U-266/70: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"basophil: 1.4;naive B-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA012813	Uncertain									"HPA012813: AB_1844832"	"unprognostic (5.63e-3)"	"unprognostic (6.67e-3)"	"unprognostic (5.09e-3)"	"unprognostic (6.27e-3)"	"unprognostic (5.56e-4)"	"unprognostic (7.02e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.50e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.39e-6)"	"unprognostic (3.17e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.65e-2)"	0.6	0.5	0.6	0.6	2.0	0.4	1.2	0.6	1.4	1.5	0.6	0.6	0.6	0.4	0.7	0.9	0.6	3.3	0.6	0.6	0.6	1.2	0.6	0.6	0.6	1.1	0.6	0.6	1.0	0.6	0.4	4.7	0.6	0.6	1.9	0.1	0.6	1.8	1.0	0.7	9.7	0.6	0.6	2.3	0.9	0.2	1.0	0.6	0.6	1.2	6.3	1.5	0.6	1.2	1.3	0.2	1.4	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.5	0.0	0.4	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.1	0.1	0.3	3.1	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.0	1.3	0.6	0.0	0.0	0.1	0.0	1.4	0.1	0.2	0.4	0.1	0.1	0.0	0.1	0.0	0.0	1.3	0.2	0.1	0.7	0.1	0.0	0.2	0.0	0.1	0.6	2.0	0.6	1.4	0.6	1.2	0.6	0.6	0.6	0.6
ANKMY1	"FLJ20499, ZMYND13"	ENSG00000144504	"Ankyrin repeat and MYND domain containing 1"	Q9P2S6	2	240479422-240569209	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 45.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA026620, HPA048869"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA026620: AB_1844834, HPA048869: "	"unprognostic (2.89e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.46e-1)"	"unprognostic (3.97e-5)"	"unprognostic (8.32e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.59e-5)"	"unprognostic (2.01e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.42e-2)"	"prognostic favourable (3.20e-4)"	4.5	4.3	5.2	9.0	7.9	9.8	5.8	6.4	7.3	7.2	5.7	10.3	10.8	5.8	6.6	9.0	5.3	21.8	9.2	3.6	6.1	4.3	5.1	5.1	6.3	7.2	8.7	4.8	7.3	8.0	6.6	5.4	6.4	6.4	5.8	5.1	5.1	6.9	13.6	5.0	7.2	6.2	5.8	6.3	7.3	8.4	45.0	6.7	6.0	6.0	3.4	10.7	5.8	6.0	7.4	4.2	6.9	3.4	2.0	7.5	3.4	5.2	11.5	2.5	4.6	2.3	3.3	10.4	2.5	3.8	2.1	2.8	3.7	10.8	5.2	0.4	2.8	5.8	4.8	5.9	2.5	9.6	3.9	10.3	5.6	9.6	1.9	5.7	10.0	5.2	14.5	1.9	13.8	2.1	9.6	6.7	3.5	5.0	5.3	9.4	2.1	6.9	14.9	7.6	8.2	3.2	11.3	5.9	4.4	2.0	5.5	7.6	4.8	8.9	2.7	7.8	2.7	3.1	4.4	15.6	3.9	5.0	4.4	8.8	6.0	0.1	3.3	6.9	7.5	2.6	4.3	4.7	4.8	4.7	4.2	7.4	7.1	5.1	1.3	2.0	3.4	2.8	1.5	3.4	5.2	7.9	6.4	7.3	6.1	4.3	8.7	4.8	6.4	6.7
ANKRD18A	"FLJ35740, KIAA2015"	ENSG00000180071	"Ankyrin repeat domain 18A"	Q8IVF6	9	38571358-38620660	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"bone marrow: 24.4;brain: 11.1;testis: 19.1"	"Cell line enhanced"	"Detected in many"		"HL-60: 16.9;THP-1: 8.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA046346, HPA046695, HPA049923, HPA051288"	Uncertain		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA046346: , HPA046695: , HPA049923: , HPA051288: "	"unprognostic (4.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.94e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.14e-1)"	0.5	0.7	1.4	0.8	9.1	24.4	1.1	0.4	4.1	1.0	2.1	8.5	2.4	0.9	0.7	1.1	1.4	1.2	2.7	1.1	3.0	2.2	1.5	1.2	1.5	0.8	4.8	2.3	0.4	4.1	2.5	3.2	0.7	8.7	1.6	1.5	0.4	0.9	3.9	0.4	2.4	1.5	0.7	11.1	0.5	2.0	19.1	6.9	0.0	3.8	0.0	0.5	0.7	0.8	0.4	0.0	1.1	0.0	0.1	1.7	0.1	4.6	3.6	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	2.0	0.0	0.9	3.5	3.3	0.0	0.0	4.8	0.0	4.8	2.8	0.0	16.9	0.4	0.0	2.3	0.0	3.1	0.0	1.6	0.4	0.3	4.3	0.1	0.8	3.7	2.1	0.0	6.4	6.4	2.1	1.9	1.5	3.0	2.3	0.5	0.1	2.5	8.0	4.4	0.0	1.3	0.1	0.0	0.3	0.5	0.0	0.0	0.0	2.0	0.0	0.0	1.1	0.5	0.0	0.7	0.0	1.3	0.8	0.0	0.4	0.7	1.7	0.5	0.1	0.0	0.0	1.0	0.1	1.4	9.1	0.4	4.1	3.0	2.2	4.8	2.3	8.7	6.9
ANKRD20A1	"ANKRD20A, DKFZp434A171"	ENSG00000260691	"Ankyrin repeat domain 20 family member A1"	Q5TYW2	9	67859147-67902094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.3;testis: 6.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 7.0;U-266/70: 11.4;U-266/84: 3.9"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	6	"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.3"									"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753"	Uncertain									"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: "	"unprognostic (4.92e-1)"	"unprognostic (4.31e-3)"			"unprognostic (3.97e-1)"			"unprognostic (2.30e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.32e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-2)"		0.1	0.0		0.0		0.3	0.1		0.8	0.3	0.2			0.0	0.0	0.1	0.3	0.3	0.0	0.0			0.2	0.1	0.0	0.0			0.0	1.1	0.0		0.0		0.1	0.9		0.2	0.1	0.0	0.4	0.1	0.3		0.8	0.0	6.5			0.5		0.0	0.0		0.0	0.0	2.3	0.1	0.1	0.3	0.0	0.2	0.4	1.4	0.6	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.8	0.9	0.4	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.2	0.4	7.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.3	0.6	1.0	11.4	3.9	0.0	0.5	0.0	1.8	0.0	0.0	2.3	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0										
ANKRD20A8P	ANKRD20B	ENSG00000229089	"Ankyrin repeat domain 20 family member A8, pseudogene"	Q5CZ79	2	94811046-94857282	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 3.2;thyroid gland: 5.0"	"Group enriched"	"Detected in some"	8	"RT4: 2.7;U-2 OS: 9.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753"	Uncertain									"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: "								"unprognostic (3.08e-1)"		"unprognostic (3.86e-1)"		"unprognostic (3.79e-2)"	"unprognostic (1.30e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.38e-2)"		1.1	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.4	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.9	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	3.2			5.0		0.0	0.0		0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	0.5	0.0	0.3	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ANKRD22	MGC22805	ENSG00000152766	"Ankyrin repeat domain 22"	Q5VYY1	10	88822132-88851818	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 40.2;stomach 1: 27.6;tongue: 29.0"	"Cell line enhanced"	"Detected in some"		"A-431: 8.8;CAPAN-2: 28.2;HaCaT: 6.9;HL-60: 8.3;RT4: 19.0;T-47d: 12.9;U-937: 7.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 15.4"	"Group enriched"	"Detected in many"	13	"granulocytes: 15.4;monocytes: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA012922	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA012922: AB_1844838"	"unprognostic (1.86e-1)"	"unprognostic (1.48e-3)"	"unprognostic (9.73e-3)"	"prognostic favourable (8.73e-6)"	"unprognostic (1.18e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.21e-3)"	"prognostic unfavourable (6.15e-4)"	"unprognostic (1.09e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.01e-3)"	0.4	0.5	2.3	8.4	3.6	5.3	2.3	0.3	3.2	6.7	6.7	0.5	0.0	2.0	0.3	0.2	21.9	0.3	4.3	1.1	4.0	0.6	6.0	1.6	1.3	6.1	3.6	0.2	0.3	40.2	0.1	1.6	0.2	2.7	2.0	7.2	0.1	3.7	0.0	0.3	18.5	2.1	1.3	7.4	8.8	27.6	0.3	1.4	7.9	0.3	29.0	14.6	4.4	8.6	0.1	0.4	15.4	6.8	0.5	0.8	1.2	8.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.1	0.1	0.0	6.9	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	8.3	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	6.6	0.1	0.1	0.0	0.0	0.0	0.1	19.0	0.0	0.0	0.0	1.4	0.0	12.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.6	0.1	0.1	4.8	2.5	0.1	6.8	0.0	0.0	0.4	0.1	0.4	0.1	0.8	0.2	15.4	0.5	1.2	0.4	0.0	1.2	2.3	3.6	0.3	3.2	4.0	0.6	3.6	0.2	2.7	1.4
ANKRD24	KIAA1981	ENSG00000089847	"Ankyrin repeat domain 24"	Q8TF21	19	4183354-4224814	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.5;U-266/70: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	9	"B-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041534, HPA048498"	Uncertain		Uncertain	Microtubules,Cytosol				"Microtubules, Cytosol"		"HPA041534: , HPA048498: "	"unprognostic (3.70e-2)"	"unprognostic (3.96e-3)"	"unprognostic (5.23e-9)"	"unprognostic (7.03e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.31e-1)"	"prognostic favourable (9.13e-5)"	"unprognostic (1.53e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.73e-4)"	1.4	2.1	6.0	0.8	8.5	1.1	1.2	1.4	22.1	1.0	1.1	0.8	0.1	1.9	1.0	2.1	0.5	1.4	1.3	0.6	5.1	4.4	1.8	5.5	1.1	1.0	4.1	9.4	1.4	3.3	2.4	3.8	1.9	2.3	4.3	0.9	1.0	1.7	1.7	2.5	1.1	1.5	0.7	2.3	1.5	1.6	7.3	1.8	0.1	1.9	0.1	0.6	0.6	0.1	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	3.2	0.3	3.3	0.2	0.0	0.0	0.0	0.1	0.1	0.1	2.0	0.4	0.1	0.1	0.5	0.0	2.4	0.3	0.1	0.1	0.1	1.8	0.1	0.3	1.7	0.1	0.3	0.8	0.1	0.1	5.5	0.0	0.7	0.0	0.1	2.4	0.7	0.4	0.0	0.4	0.0	0.2	0.9	0.2	0.1	0.1	0.3	0.7	0.4	0.0	0.1	1.2	0.9	0.0	18.5	1.6	0.1	0.8	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	8.5	1.4	22.1	5.1	4.4	4.1	9.4	2.3	1.8
ANKRD29	FLJ25053	ENSG00000154065	"Ankyrin repeat domain 29"	Q8N6D5	18	23598926-23662885	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 12.6;BJ hTERT+: 12.0;hTCEpi: 11.9;PC-3: 11.4;U-2197: 14.9;U-87 MG: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 1.1;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	14	"dendritic cells: 1.6;T-cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041272, HPA049419"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA041272: AB_2677387, HPA049419: AB_2680757"	"unprognostic (4.52e-3)"	"unprognostic (8.37e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.01e-3)"	"prognostic favourable (1.92e-5)"	"unprognostic (3.29e-2)"	"prognostic favourable (5.98e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.54e-1)"	"prognostic favourable (7.20e-5)"	"unprognostic (1.10e-2)"	"unprognostic (9.46e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.64e-5)"	11.8	6.1	8.9	6.6	6.6	0.2	9.9	1.9	15.1	8.4	3.0	3.7	3.0	1.2	13.1	6.4	6.5	9.6	4.4	4.9	9.8	5.3	2.5	1.6	25.2	14.6	8.7	6.2	12.4	0.8	18.4	6.0	0.3	17.9	7.0	1.8	4.3	5.1	7.5	3.2	3.2	4.5	9.8	3.2	2.0	11.7	2.9	3.1	1.6	2.3	5.5	11.1	4.8	9.1	0.0	1.6	0.0	0.0	0.0	1.1	0.0	1.6	4.8	0.0	0.0	1.2	12.6	0.1	4.7	12.0	1.9	2.4	2.1	0.4	0.0	0.7	2.2	2.4	0.0	6.2	0.4	0.1	4.3	0.0	3.1	0.1	0.2	0.0	0.3	3.3	11.9	1.9	3.2	1.2	0.0	0.2	3.2	0.5	0.0	0.0	0.8	11.4	0.0	0.3	1.1	3.0	1.7	0.7	5.9	1.2	0.2	0.1	1.4	0.0	2.8	0.3	1.7	14.9	4.2	0.0	0.0	0.0	15.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	8.9	6.6	1.9	15.1	9.8	5.3	8.7	6.2	17.9	3.1
ANKRD30A	NY-BR-1	ENSG00000148513	"Ankyrin repeat domain 30A"	Q9BXX3	10	37125788-37384111	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"breast: 31.7;testis: 17.8"	"Group enriched"	"Detected in some"	33	"A549: 3.8;U-266/70: 15.2"	"Cancer enriched"	"Detected in single"	37	"breast cancer: 11.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA071849			Uncertain	Nucleoli				Nucleoli		"HPA071849: "	"unprognostic (2.79e-1)"											"unprognostic (2.81e-1)"	"unprognostic (1.01e-7)"	"unprognostic (1.41e-1)"		"unprognostic (5.93e-1)"		0.6	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD30B	NY-BR-1.1	ENSG00000180777	"Ankyrin repeat domain 30B"	Q9BXX2	18	14728272-14852738	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	17	"testis: 42.2"	"Cell line enriched"	"Detected in some"	7	"U-2197: 31.3"	"Cancer enhanced"	"Detected in single"		"breast cancer: 2.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA060455, HPA071849"	Uncertain		Uncertain	Nucleoli				Nucleoli		"HPA060455: , HPA071849: "	"unprognostic (1.53e-1)"		"unprognostic (1.50e-1)"		"unprognostic (1.01e-2)"				"unprognostic (1.65e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-9)"	"unprognostic (1.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.98e-2)"		0.3	0.2	1.2	0.1	2.5	0.1	2.3	0.0	1.8	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.9	0.9	0.1	0.1	0.1	0.1	0.4	1.2	0.1	0.6	0.1	0.0	0.1	1.0	0.1	0.2	2.5	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	42.2	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.7	2.5	0.1	31.3	0.0	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.5	0.0	1.8	0.9	0.9	0.4	1.2	1.0	0.0
ANKRD33	"C12orf7, DKFZp686O1689, PANKY"	ENSG00000167612	"Ankyrin repeat domain 33"	Q7Z3H0	12	51887960-51891664	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	14	"placenta: 21.9;retina: 19.5"	"Cell line enhanced"	"Detected in single"		"BEWO: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058753	Enhanced									"HPA058753: "			"unprognostic (4.42e-2)"	"unprognostic (2.13e-5)"	"unprognostic (8.25e-4)"	"unprognostic (2.37e-1)"	"unprognostic (3.25e-5)"	"unprognostic (2.42e-1)"		"unprognostic (4.07e-1)"	"unprognostic (6.21e-2)"		"unprognostic (5.51e-10)"	"unprognostic (4.41e-3)"	"unprognostic (5.56e-2)"		"unprognostic (2.18e-1)"	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	1.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.8	21.9	0.0	0.0	0.0	19.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0
ANKRD34A	ANKRD34	ENSG00000272031	"Ankyrin repeat domain 34A"	Q69YU3	1	145959442-145964582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 18.1"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 12.4"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.5;T-cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029642, HPA029643"	Uncertain		Enhanced	Cytosol				Cytosol		"HPA029642: AB_10599277, HPA029643: AB_10601878"	"unprognostic (1.98e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.68e-3)"	"unprognostic (9.66e-8)"	"unprognostic (6.36e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.23e-2)"	0.8	1.3	6.4	2.0	10.5	0.3	0.6	7.8	18.1	0.9	0.7	1.2	0.0	1.6	1.5	1.2	0.9	0.7	1.1	1.7	4.2		0.5	0.2	0.7	1.4	0.4	6.7	1.6	0.5	2.0	1.2	0.5	5.7	1.7	0.4	1.3	0.8	2.2	2.3	0.8	1.6	1.6	0.0	1.4	1.1	0.5	1.0	0.0	0.6	0.0	1.5	0.9	0.0	1.5	0.4	0.6	0.3	0.3	3.5	1.0	1.4	0.7	0.7	2.4	3.5	2.7	0.3	2.7	5.1	0.6	1.7	0.2	0.8	2.7	0.3	3.4	0.6	1.1	0.8	0.4	5.8	1.7	0.2	2.1	0.0	0.5	0.3	2.3	2.4	0.3	2.2	2.5	0.9	1.3	6.3	4.0	2.5	1.1	0.8	0.3	3.0	0.3	0.6	12.4	1.1	0.1	3.4	2.5	0.5	0.1	1.6	3.6	0.4	0.8	6.2	4.2	5.3	1.3	4.4	8.4	0.4	6.1	2.2	0.4	0.0	0.1	0.6	3.5	0.3	2.6	1.5	1.7	1.9	0.4	1.4	2.3	3.4	0.3	0.3	0.0	0.1	1.7	1.0										
ANKRD34B	DP58	ENSG00000189127	"Ankyrin repeat domain 34B"	A5PLL1	5	80556755-80570488	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 31.0"	"Cell line enriched"	"Detected in some"	29	"RPTEC TERT1: 45.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.3"	"Region enriched"	"Detected in many"	6	"basal ganglia: 31.0"	"Cell type enriched"	"Detected in some"	5	"neutrophil: 7.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043327	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria"	Cytosol	"HPA043327: AB_10794180"	"unprognostic (1.05e-1)"	"unprognostic (4.16e-6)"		"unprognostic (2.07e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.03e-1)"		"unprognostic (8.25e-4)"	"unprognostic (6.44e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.41e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.93e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.94e-2)"	0.1	0.3	0.9	1.5	31.0	5.7	0.3	0.0	0.9	0.5	0.1	0.4	0.3	0.1	0.2	0.2	0.1	0.1	0.2	0.1	1.0	4.1	2.8	0.1	0.2	3.0	1.2	0.2	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.2	0.0	0.3	0.2	0.0	0.1	0.1	0.2	0.4	1.0	0.1	1.0	5.1	0.0	0.1	0.0	4.6	0.1	0.0	0.0	0.0	7.2	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	45.8	0.0	0.1	0.2	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.3	0.9	31.0	0.0	0.9	1.0	4.1	1.2	0.2	0.7	5.1
ANKRD35	FLJ25124	ENSG00000198483	"Ankyrin repeat domain 35"	Q8N283	1	145866560-145885866	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 42.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.8;THP-1: 7.2;TIME: 9.2;U-87 MG: 9.2;U-937: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 5.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035453	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA035453: AB_10672864"	"prognostic favourable (9.35e-4)"	"prognostic favourable (2.90e-4)"	"unprognostic (2.07e-1)"	"unprognostic (7.39e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.29e-10)"	"unprognostic (8.80e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.92e-2)"	"unprognostic (8.69e-3)"	2.1	1.2	3.3	1.0	3.7	0.4	3.6	12.1	7.4	16.1	1.7	0.8	0.3	0.5	2.1	1.3	11.4	2.5	1.1	0.8	3.4	3.6	0.4	1.4	0.8	0.5	3.7	3.4	2.8	0.5	0.2	0.3	0.3	8.0	2.5	0.8	0.3	4.2	2.3	5.2	42.4	0.7	1.8	2.0	0.4	1.2	0.8	0.3	0.7	0.3	14.9	13.6	2.3	7.7	0.0	1.3	0.3	5.5	1.5	2.9	1.9	0.1	0.0	0.0	0.0	2.5	10.8	0.3	1.5	3.9	0.5	1.3	0.4	0.0	0.0	0.3	1.2	0.2	0.0	0.0	0.2	0.0	0.0	3.1	0.0	0.0	1.2	3.0	0.1	3.7	0.5	0.3	0.1	0.4	0.0	0.0	2.3	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	7.2	9.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	9.2	8.1	0.0	0.0	5.5	0.0	2.0	2.0	0.3	0.0	0.8	2.9	0.7	0.0	0.6	1.9	0.3	1.5	0.4	1.3	1.5	1.9	3.3	3.7	12.1	7.4	3.4	3.6	3.7	3.4	8.0	0.3
ANKRD36	UNQ2430	ENSG00000135976	"Ankyrin repeat domain 36"	A6QL64	2	97113496-97264521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 14.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA051757: , HPA057661: "	"unprognostic (4.24e-3)"	"unprognostic (7.59e-2)"	"unprognostic (6.15e-3)"	"unprognostic (9.86e-2)"	"unprognostic (9.83e-3)"	"unprognostic (5.25e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.14e-7)"	"unprognostic (1.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.75e-1)"	5.1	3.3	8.8	6.0	14.5	22.0	6.8	20.5	10.2	5.6	4.6	4.8	2.2	3.0	8.5	7.7	2.4	6.0	3.8	3.9	7.6	3.3	3.2	1.8	5.0	5.0	4.0	11.3	8.9	5.1	5.3	9.2	2.3	6.8	4.8	5.2	4.7	4.3	3.1	2.2	5.9	4.3	4.7	3.7	5.9	5.1	13.3	8.2	5.6	5.4	2.1	3.7	4.0	4.9	9.9	11.7	9.3	3.3	4.9	9.2	1.7	6.3	1.6	5.3	3.3	1.2	2.7	2.4	2.5	1.7	1.9	2.0	1.6	3.3	8.2	1.7	2.3	3.2	1.9	2.2	1.6	3.9	2.9	6.2	7.0	3.0	0.5	4.5	2.7	1.8	1.4	1.4	2.5	3.5	4.2	14.3	0.9	1.1	5.7	5.9	1.2	2.9	5.5	2.2	2.3	1.5	3.1	3.7	2.7	2.6	1.5	0.8	1.6	2.6	5.3	5.5	5.4	6.3	2.9	8.4	3.6	6.7	3.2	6.5	1.8	9.3	2.6	3.5	9.2	1.2	9.1	9.9	8.4	7.3	1.2	9.9	8.6	9.2	3.9	4.9	3.3	11.7	7.0	1.7	8.8	14.5	20.5	10.2	7.6	3.3	4.0	11.3	6.8	8.2
ANKRD37	Lrp2bp	ENSG00000186352	"Ankyrin repeat domain 37"	Q7Z713	4	185396021-185400628	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036626, HPA058127"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Cytosol"	Mitochondria	"HPA036626: AB_10671963, HPA058127: "	"unprognostic (9.08e-2)"	"unprognostic (2.85e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.08e-1)"	7.7	8.9	11.0	3.9	15.2	3.3	10.9	9.9	20.9	17.2	7.5	6.0	5.4	4.8	4.9	4.1	35.8	8.0	4.8	13.6	12.0	9.6	6.4	14.2	12.4	3.0	12.3	5.8	14.8	13.5	1.7	11.7	10.7	16.8	24.1	7.0	8.4	35.4	21.9	22.1	7.3	4.9	5.0	16.1	4.6	5.2	8.7	14.2	1.5	14.2	18.6	12.2	14.3	22.8	7.7	4.2	10.2	3.9	3.2	8.1	3.0	6.6	1.0	0.7	3.8	5.2	3.3	3.6	3.1	2.3	2.3	5.0	1.6	1.9	3.2	1.3	5.6	2.5	3.6	4.0	2.9	9.0	1.0	2.2	3.4	4.8	2.2	2.0	4.9	0.6	4.3	2.1	3.0	2.8	3.3	5.4	6.2	1.7	1.7	8.0	1.1	5.3	0.5	1.0	8.7	2.8	0.5	5.3	9.5	2.1	2.1	9.2	1.9	1.3	3.7	4.9	3.9	2.8	3.5	10.2	2.9	1.4	14.0	1.5	5.7	0.4	3.8	10.2	5.5	3.5	4.7	7.6	4.3	8.1	2.6	7.7	3.3	4.7	2.0	3.2	3.9	4.2	5.1	3.0	11.0	15.2	9.9	20.9	12.0	9.6	12.3	5.8	16.8	14.2
ANKRD42	"FLJ37874, PPP1R79, SARP"	ENSG00000137494	"Ankyrin repeat domain 42"	Q8N9B4	11	83193739-83260694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 41.8"	"Cell line enhanced"	"Detected in all"		"U-2197: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039917	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039917: AB_10672894"	"unprognostic (6.59e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.31e-3)"	"unprognostic (9.12e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.90e-1)"	5.6	14.5	13.9	5.4	22.1	8.3	7.1	4.8	15.1	8.2	5.4	3.0	11.6	5.8	6.9	22.2	5.6	17.2	8.7	5.4	18.1	13.4	12.3	5.2	7.4	4.5	8.2	12.4	9.9	8.6	16.8	17.9	4.5	13.1	8.4	4.8	6.5	6.7	10.3	6.1	6.2	5.3	6.7	8.7	4.8	6.4	41.8	5.3	1.0	13.0	1.5	4.5	6.8	16.1	7.1	4.8	7.9	11.1	5.8	4.3	2.1	3.9	6.8	3.2	6.7	10.6	11.1	3.0	8.0	6.2	4.7	2.9	4.1	4.7	1.6	10.3	7.1	8.4	3.4	5.4	3.9	2.1	2.7	2.7	9.2	2.7	7.2	7.7	6.5	6.5	6.5	11.9	6.4	4.9	8.0	1.5	6.8	5.7	1.1	8.5	2.8	4.3	1.8	4.9	2.0	15.8	4.7	2.6	3.5	10.3	6.5	2.0	9.8	4.3	7.0	7.4	5.1	26.8	3.7	2.0	4.6	3.3	5.8	4.8	3.1	7.9	3.6	4.3	4.1	4.1	2.8	7.1	3.7	4.3	4.8	5.2	1.9	3.0	3.0	5.8	11.1	2.0	1.4	2.1	13.9	22.1	4.8	15.1	18.1	13.4	8.2	12.4	13.1	5.3
ANKRD6	KIAA0957	ENSG00000135299	"Ankyrin repeat domain 6"	Q9Y2G4	6	89433170-89633834	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.8"	"Cell line enhanced"	"Detected in many"		"AF22: 10.0;BEWO: 30.6;HAP1: 9.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.0;intermediate monocyte: 2.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB020693, HPA035694, HPA064642"	Approved		Enhanced	Vesicles				Vesicles		"CAB020693: , HPA035694: , HPA064642: "	"unprognostic (3.80e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.10e-1)"	3.9	2.2	11.7	3.0	7.8	1.6	3.9	47.8	17.8	5.7	2.9	2.8	1.1	1.0	6.1	4.4	4.9	11.7	5.7	8.9	7.8	9.1	5.4	4.5	5.7	2.5	4.2	12.0	15.6	4.3	9.3	4.2	4.3	7.3	3.6	1.1	6.6	7.7	2.3	4.0	1.9	1.8	5.4	5.0	2.0	2.6	6.1	3.7	2.0	5.6	3.3	2.5	4.4	4.0	0.3	0.1	3.0	2.9	0.6	1.0	0.3	0.0	1.2	10.0	4.2	0.1	0.4	30.6	0.1	0.1	0.0	0.6	0.3	0.8	0.0	1.0	0.0	0.0	9.1	5.1	0.4	0.0	6.8	3.6	0.0	0.3	0.1	0.0	1.4	0.6	1.4	0.0	0.0	1.0	0.3	2.3	0.0	1.1	0.1	0.3	2.8	1.0	3.6	0.0	0.0	1.5	5.1	6.6	2.3	0.8	6.7	3.3	1.9	2.2	0.0	1.6	0.6	0.1	0.8	0.3	0.0	0.0	0.1	0.0	1.2	0.0	0.4	3.0	1.0	2.9	0.0	0.0	0.7	0.0	0.1	0.3	0.3	0.4	0.7	0.6	0.0	0.0	0.2	0.3	11.7	7.8	47.8	11.6	7.8	9.1	4.2	12.0	7.3	3.7
ANKRD62	DKFZp779B1634	ENSG00000181626	"Ankyrin repeat domain 62"	A6NC57	18	12093853-12129749	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	9	"testis: 47.1"	"Cell line enriched"	"Detected in single"	6	"U-2 OS: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059835	Enhanced									"HPA059835: "	"unprognostic (2.45e-2)"	"unprognostic (1.18e-1)"		"unprognostic (2.37e-3)"	"unprognostic (9.46e-2)"	"unprognostic (3.01e-1)"		"unprognostic (1.98e-1)"		"unprognostic (6.61e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.55e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.52e-3)"	"unprognostic (8.70e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	5.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0
ANKRD65		ENSG00000235098	"Ankyrin repeat domain 65"	E5RJM6	1	1418420-1421769	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.8;fallopian tube: 33.6"	"Group enriched"	"Detected in some"	7	"Hep G2: 19.9;RT4: 19.5;SCLC-21H: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"myeloid DC: 4.8;plasmacytoid DC: 10.4"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 10.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065720	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA065720: "	"unprognostic (2.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.59e-1)"	"prognostic favourable (1.08e-5)"	"unprognostic (1.64e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.81e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.76e-2)"	4.6	1.1	12.4	2.8	20.8	0.4	4.2	8.0	13.3	6.7	4.8	21.0	3.7	2.2	4.0	5.6	6.7	33.6	2.7	2.2	12.0	8.6	1.9	0.9	9.9	7.1	37.8	8.2	6.9	13.3	1.1	0.6	6.3	13.7	8.9	1.8	2.1	14.0	21.2	2.8	4.8	2.1	3.8	16.7	1.4	4.3	3.1	28.0	4.2	1.8	1.0	6.3	13.2	3.3	0.5	10.4	0.3	0.3	0.0	0.4	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.5	2.6	0.2	2.5	0.0	0.3	0.2	0.0	0.0	19.9	0.5	0.0	0.0	0.2	3.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	2.6	0.0	0.0	19.5	27.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	4.8	0.5	0.1	0.4	0.0	0.0	0.0	10.4	0.0	0.2	12.4	20.8	8.0	13.3	12.0	8.6	37.8	8.2	13.7	28.0
ANKRD7	TSA806	ENSG00000106013	"Ankyrin repeat domain 7"	Q92527	7	118214669-118496171	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	58	"testis: 184.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.2;SCLC-21H: 9.9;U-266/70: 12.7;WM-115: 4.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043489, HPA052941"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA043489: AB_10959304, HPA052941: "	"unprognostic (1.29e-1)"	"unprognostic (7.22e-4)"		"unprognostic (3.13e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.49e-2)"		"unprognostic (1.69e-1)"	"unprognostic (5.51e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.57e-4)"	"unprognostic (3.32e-2)"	0.1	0.1	0.5	0.0	0.8	0.0	0.1	0.1	1.0	0.1	0.1	0.0	0.0	0.1	0.1	1.3	0.1	0.1	0.0	0.1	0.4	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.9	0.0	1.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	184.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	3.1	0.4	1.0	0.0	0.0	0.8	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	5.2	1.6	0.0	0.0	0.1	0.3	0.1	1.4	1.0	0.0	0.0	0.0	1.9	0.0	0.0	2.3	0.4	0.7	0.0	0.0	0.0	2.2	1.4	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	2.4	0.0	0.0	1.9	0.0	1.2	0.4	0.0	1.1	0.3	0.0	12.7	0.6	0.5	1.8	0.0	4.0	0.0	0.0	1.0	0.4	0.0	0.3	3.1	0.2	0.6	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.4	0.0	0.1	0.5	0.8	0.1	1.0	0.4	0.1	0.1	0.3	1.0	0.0
ANKRD9		ENSG00000156381	"Ankyrin repeat domain 9"	Q96BM1	14	102501760-102509799	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055985	Uncertain									"HPA055985: "	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.76e-2)"	"unprognostic (7.31e-3)"	"unprognostic (6.78e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.17e-1)"	"prognostic favourable (1.17e-7)"	"unprognostic (3.89e-1)"	"unprognostic (4.74e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.15e-1)"	5.5	5.1	7.1	2.6	4.5	10.0	4.6	5.6	11.8	2.5	12.6	3.6	2.3	31.6	2.0	4.9	5.8	1.5	6.7	27.0	6.0	4.2	6.3	3.8	3.8	0.9	5.5	4.3	2.8	5.2	8.0	1.8	8.3	9.0	5.4	6.8	4.6	7.1	3.9	67.4	6.2	20.5	3.0	6.1	2.6	10.2	10.1	4.6	0.4	2.6	13.3	2.7	4.7	4.1	0.5	0.4	1.2	2.3	0.9	1.1	0.4	8.9	4.3	7.8	7.3	8.2	3.4	12.3	10.8	4.0	4.9	4.8	1.1	6.1	0.0	12.2	3.0	14.8	3.8	2.2	2.5	6.3	15.5	2.3	7.2	2.0	4.2	0.8	7.9	1.6	13.3	2.7	2.7	2.1	4.5	0.8	2.3	7.9	1.2	2.5	3.7	19.5	12.1	7.4	0.5	5.0	9.3	6.4	6.8	7.7	5.0	13.2	7.6	3.4	4.8	5.0	6.5	24.3	8.3	7.0	3.8	0.2	5.9	1.7	4.8	0.7	0.4	0.2	0.3	0.5	0.6	0.2	0.3	0.2	0.4	0.5	0.5	0.3	1.2	0.9	2.3	0.4	1.1	0.4	7.1	4.5	5.6	11.8	6.0	4.2	5.5	4.3	9.0	4.6
ANKUB1	C3orf16	ENSG00000206199	"Ankyrin repeat and ubiquitin domain containing 1"	A6NFN9	3	149761100-149968385	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 12.2;lung: 11.9;ovary: 10.4"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 5.2"	"Cell type enriched"	"Detected in single"	8	"neutrophil: 4.8"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.8"					"Low region specificity"	"Detected in many"			HPA053749	Uncertain									"HPA053749: "	"unprognostic (1.71e-2)"	"unprognostic (1.89e-4)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.18e-9)"	"unprognostic (3.06e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.07e-4)"	0.0	0.0	0.8	0.2	1.2	0.6	0.0	0.0	0.3	2.1	0.0	1.8	0.0	0.2	0.9	0.1	0.0	12.2	0.1	0.0	1.5	1.7	0.0	0.0	11.9	0.1	0.0	0.0	10.4	0.1	0.0	1.1	0.1	5.2	0.1	0.0	0.0	0.5	0.0	0.1	0.6	0.1	0.0	0.3	0.2	0.3	2.2	0.8	0.0	0.0	0.6	0.1	0.1	0.0	0.4	0.3	4.8	0.4	0.2	0.3	0.0	0.6	0.8	0.8	0.3	0.0	0.1	0.6	0.3	0.0	0.1	0.0	1.2	1.2	1.1	0.2	0.0	1.8	0.5	0.6	0.2	0.6	0.4	1.1	2.5	0.5	0.0	0.5	0.9	0.2	0.0	0.0	0.1	0.0	0.6	1.0	0.0	0.4	0.7	1.1	0.5	0.6	1.1	0.8	0.7	0.0	1.1	0.7	0.1	0.5	0.6	0.0	1.0	0.3	0.0	0.7	0.6	0.3	0.4	0.7	0.5	1.0	0.5	1.0	0.2	0.5	0.4	0.5	0.2	0.1	0.1	0.3	0.1	0.2	0.0	0.4	0.1	0.3	4.8	0.2	0.1	0.3	0.1	0.0	0.8	1.2	0.0	0.3	1.5	1.7	0.0	0.0	5.2	0.8
ANO4	"FLJ34221, FLJ34272, FLJ35277, TMEM16D"	ENSG00000151572	"Anoctamin 4"	Q32M45	12	100717526-101128641	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 20.3;brain: 19.2;seminal vesicle: 14.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 14.1;LHCN-M2: 6.8;SK-MEL-30: 10.9;TIME: 22.4;WM-115: 7.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053412	Uncertain									"HPA053412: "	"unprognostic (1.11e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.54e-2)"	"prognostic favourable (5.48e-5)"	"unprognostic (1.16e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.41e-1)"	0.9	20.3	10.3	0.6	16.7	0.6	0.7	2.8	13.0	13.3	0.8	17.2	1.4	1.1	7.9	1.2	0.7	1.0	0.8	0.8	9.5	5.8	0.8	0.6	0.7	0.6	10.9	8.6	13.8	1.6	0.8	2.2	0.7	12.1	8.7	0.9	0.0	3.6	14.0	0.6	0.7	0.9	1.5	4.4	0.6	0.6	2.1	19.2	0.0	0.8	0.0	1.3	1.4	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.8	1.1	0.0	4.9	4.4	4.2	2.0	0.0	0.0	0.0	0.0	14.1	0.2	5.1	4.2	3.9	0.0	0.0	0.0	2.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	6.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	10.9	0.0	0.0	22.4	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	16.7	2.8	13.0	9.5	5.8	10.9	8.6	12.1	19.2
ANP32D	PP32R2	ENSG00000139223	"Acidic nuclear phosphoprotein 32 family member D"	O95626	12	48472665-48473624	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.3;REH: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA063133, HPA067561"	Uncertain		Enhanced	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome"	Cytosol	"HPA063133: , HPA067561: "		"unprognostic (2.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.11e-2)"		"unprognostic (1.72e-3)"		"unprognostic (2.30e-2)"		"unprognostic (3.62e-3)"		"unprognostic (2.76e-2)"		"unprognostic (3.48e-1)"		0.1	0.9	0.3	0.0	0.2	0.1	0.2	0.2	0.6	0.0	0.5			0.0	0.6	0.8	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.7	0.0	0.2		1.1	0.1	0.0	0.2	0.5		0.3	0.2		0.4	0.3	0.2	0.0	0.1	0.2	0.2	0.5	0.2	0.9			0.8		0.0	0.4	0.1	0.1	0.1	0.6	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.4	0.4	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.6	0.2	0.0	0.0	0.3	0.0										
ANXA8L1	"ANXA8L2, bA145E20.2, bA301J7.3"	ENSG00000264230	"Annexin A8 like 1"	Q5VT79	10	46375627-46391784	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 35.9;skin 1: 75.4;tongue: 34.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 71.2;HBEC3-KT: 108.3;hTCEpi: 28.7;SiHa: 25.6"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	5	"classical monocyte: 3.2;myeloid DC: 5.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.0;monocytes: 3.2"									"HPA045246, HPA047451"			Approved	Nucleoplasm				Nucleoplasm		"HPA045246: , HPA047451: "	"unprognostic (3.67e-3)"	"unprognostic (4.56e-3)"	"unprognostic (9.14e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.05e-2)"	"unprognostic (6.94e-3)"	"unprognostic (8.33e-5)"	"unprognostic (3.43e-1)"	"unprognostic (8.26e-10)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	4.8	0.0	0.0	5.6	0.3	0.0	0.0	0.0	0.7	1.2	35.9	1.2	0.0	0.9	0.0		0.0	0.1	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.4	0.0	0.9	0.0	0.0	1.1	0.7	0.0	75.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	34.2	13.3	6.9	0.6	0.0	5.0	0.8	3.2	0.5	0.0	0.5	14.2	3.7	0.0	0.0	0.0	0.0	5.2	0.2	0.0	0.0	0.0	0.3	2.5	0.0	0.1	0.0	71.2	0.0	108.3	0.0	6.1	0.0	0.0	6.9	0.0	2.5	0.0	0.1	0.0	28.7	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.1	0.0	0.0	16.6	0.0	0.0	25.6	2.2	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5										
AP3M2	"AP47B, CLA20"	ENSG00000070718	"Adaptor related protein complex 3 mu 2 subunit"	P53677	8	42152946-42171673	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014876, HPA045591, HPA048380"	Approved									"CAB014876: , HPA045591: , HPA048380: "	"unprognostic (5.53e-2)"	"unprognostic (2.26e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavourable (3.46e-4)"	"unprognostic (3.33e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.02e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.80e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.32e-1)"	"unprognostic (8.04e-2)"	"prognostic favourable (2.38e-4)"	6.6	10.1	17.1	6.4	25.8	8.0	7.6	20.0	30.0	7.7	5.9	10.6	7.8	6.2	11.4	11.7	6.2	14.6	9.1	11.6	15.7	22.2	11.0	3.6	9.3	9.5	16.9	28.1	8.7	5.5	21.1	11.5	17.4	29.2	9.3	7.8	10.1	4.9	10.6	6.8	10.6	5.7	8.8	16.2	8.4	5.3	19.4	8.2	3.8	11.8	4.1	8.7	8.2	6.1	3.9	5.9	2.5	2.4	6.4	14.5	4.4	12.1	12.6	11.2	13.0	10.2	10.1	2.5	14.3	14.2	13.7	16.2	7.0	14.8	7.2	9.2	8.1	14.4	17.5	9.0	17.7	10.0	16.5	13.8	10.1	4.8	9.4	5.9	8.3	9.2	15.5	14.9	8.5	9.2	16.5	6.9	12.3	5.8	17.4	6.9	12.5	8.9	16.9	21.3	7.8	10.4	14.5	15.9	11.5	8.6	4.4	15.3	13.0	3.8	5.8	8.4	12.1	12.3	6.4	5.9	11.3	6.5	11.7	0.8	23.0	2.5	1.6	1.3	6.8	2.4	8.9	3.9	14.5	7.4	3.7	2.9	13.7	5.5	2.0	6.4	2.3	5.9	4.9	4.4	17.1	25.8	20.0	30.0	15.7	22.2	16.9	28.1	29.2	8.2
AP3S2	sigma3b	ENSG00000157823	"Adaptor related protein complex 3 sigma 2 subunit"	P59780	15	89830599-89894638	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049270	Uncertain		Approved	Vesicles				Vesicles		"HPA049270: "	"unprognostic (1.46e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.78e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.31e-2)"	"prognostic favourable (5.55e-16)"	"unprognostic (7.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.67e-3)"	18.0	20.9	18.4	7.9	20.2	6.7	14.3	16.8	24.7	13.5	13.2	20.4	13.4	7.9	9.9	12.6	15.3	13.2	12.8	22.2	16.6	19.4	27.3	29.3	11.6	8.6	19.8	14.6	15.2	20.0	36.4	17.3	15.3	19.2	11.5	14.4	21.6	10.8	16.6	43.3	9.5	12.8	13.2	20.1	11.5	10.8	10.9	12.8	12.2	19.4	9.2	12.8	11.7	8.9	6.0	10.1	13.9	16.4	7.2	7.4	7.8	5.1	24.9	13.4	14.0	27.1	18.7	11.3	23.1	29.7	29.8	24.2	10.5	13.7	4.7	20.9	15.2	12.1	22.6	12.9	23.5	19.7	11.4	14.3	11.2	13.7	11.3	6.1	8.9	12.5	16.2	8.3	16.7	15.3	11.2	13.0	19.1	11.2	10.3	3.2	14.8	4.7	6.0	13.5	9.5	16.8	14.6	10.2	8.9	27.2	16.8	15.8	10.6	5.4	6.3	16.1	7.8	24.6	7.6	11.3	35.1	11.3	14.2	7.3	9.4	3.9	14.6	6.9	5.0	13.0	7.3	3.9	7.0	7.1	10.1	6.0	5.6	3.9	13.9	7.2	16.4	6.8	7.4	7.8	18.4	20.2	16.8	24.7	16.6	19.4	19.8	14.6	19.2	12.8
APCDD1L	FLJ90166	ENSG00000198768	"APC down-regulated 1 like"	Q8NCL9	20	58459101-58515131	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"salivary gland: 39.2;smooth muscle: 10.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 42.4;hTEC/SVTERT24-B: 15.0;HUVEC TERT2: 15.2;TIME: 29.8;U-87 MG: 18.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA067015	Uncertain		Uncertain	Mitochondria				Mitochondria		"HPA067015: "	"unprognostic (2.61e-1)"	"unprognostic (8.26e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.35e-5)"	"unprognostic (4.09e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.06e-4)"	"unprognostic (7.63e-4)"	"unprognostic (2.14e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.55e-13)"	"unprognostic (5.01e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.81e-3)"	0.5	0.6	0.2	0.6	0.2	0.0	5.2	0.6	0.1	3.3	1.2	0.1	0.0	0.1	2.4	0.2	0.8	0.0	2.1	5.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.5	0.0	0.1	3.6	0.7	3.2	39.2	1.7	0.6	0.9	0.8	10.9	0.3	0.0	0.6	0.1	0.0	0.0	0.1	1.0	0.6	6.1	5.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	9.0	0.0	0.9	0.6	0.0	2.7	0.0	0.0	42.4	0.4	0.0	1.4	1.4	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	1.2	0.0	15.0	0.2	15.2	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.8	6.4	0.4	0.0	8.3	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0
APOBEC4	"C1orf169, FLJ25691, MGC26594, RP1-127C7.4"	ENSG00000173627	"Apolipoprotein B mRNA editing enzyme catalytic polypeptide like 4"	Q8WW27	1	183646404-183653316	"Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 15.9;testis: 23.6"	"Cell line enriched"	"Detected in single"	12	"SCLC-21H: 3.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA015636, HPA015637"	Approved									"HPA015636: AB_1844942, HPA015637: AB_1844941"			"unprognostic (2.27e-1)"	"prognostic favourable (2.65e-4)"				"unprognostic (2.61e-1)"		"unprognostic (3.84e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.73e-1)"		"unprognostic (7.10e-2)"	"unprognostic (4.00e-2)"			0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.0	0.3	0.6	0.1	0.0	0.1	0.2	5.4	0.0	15.9	0.0	0.0	0.1	0.1	0.0	0.0	4.1	0.0	0.0	0.0	5.6	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	23.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.1
APOL4	APOLIV	ENSG00000100336	"Apolipoprotein L4"	Q9BPW4	22	36189124-36204840	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.1;HDLM-2: 45.5;HSkMC: 7.4;K-562: 9.7;SCLC-21H: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 4.3;intermediate monocyte: 2.3;myeloid DC: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;monocytes: 4.3"									"HPA049797, HPA055435"	Uncertain		Supported	Vesicles	"Secreted to blood"			Vesicles		"HPA049797: , HPA055435: "	"unprognostic (2.73e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.31e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"prognostic favourable (3.45e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (2.00e-5)"	"unprognostic (4.26e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.18e-2)"	"prognostic favourable (2.40e-6)"	2.3	0.8	1.1	2.7	1.3	0.0	2.3	0.9	1.0	2.4	1.2	0.7	0.7	2.2	2.0	0.7	2.4	3.1	3.2	2.8	0.8	1.0	10.3	1.1	7.3	1.7	1.0	0.7	4.2	0.9	0.0	1.9	3.0	1.2	9.0	1.5	1.8	2.9	1.6	1.0	1.6	5.4	2.1	2.3	1.1	2.3	0.7	1.2	7.1	1.1	0.7	2.3	7.4	1.4	0.4	3.8	0.6	4.3	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.9	8.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	45.5	0.0	2.4	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.3	9.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	20.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	4.3	0.0	0.0	2.3	0.0	0.4	0.0	0.0	3.8	0.3	0.0	0.0	0.2	0.8	0.2	0.0	0.0	1.2	1.1	1.3	0.9	1.0	0.8	1.0	1.0	0.7	1.2	1.2
APOL5	APOLV	ENSG00000128313	"Apolipoprotein L5"	Q9BWW9	22	35717872-35729483	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"liver: 1.8;skeletal muscle: 5.4;testis: 2.6"	"Cell line enriched"	"Detected in single"	13	"U-698: 6.1"	"Cancer enriched"	"Detected in single"	7	"liver cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA040968	Uncertain									"HPA040968: AB_10963933"	"unprognostic (2.23e-1)"				"unprognostic (7.61e-4)"	"unprognostic (9.34e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.23e-1)"			"unprognostic (4.18e-2)"		"unprognostic (4.37e-5)"	"unprognostic (3.23e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.59e-1)"	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.5	1.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
APOL6	"APOL-VI, APOLVI"	ENSG00000221963	"Apolipoprotein L6"	Q9BWW8	22	35648395-35668409	"Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB028574, HPA029165, HPA029167"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB028574: , HPA029165: AB_10670037, HPA029167: AB_10670832"	"unprognostic (7.25e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.76e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.71e-2)"	"prognostic favourable (6.61e-4)"	40.6	9.2	4.8	18.8	5.5	10.1	32.3	1.9	4.2	7.4	17.9	4.1	5.0	14.0	8.8	9.5	9.8	5.9	12.5	9.3	4.0	4.3	15.4	36.9	15.8	17.0	4.6	2.2	17.0	4.7	3.7	5.1	8.9	5.9	11.7	8.9	6.4	10.1	5.6	7.4	3.6	36.6	6.4	7.6	19.5	10.1	2.5	4.5	12.7	24.8	7.7	13.4	8.5	14.1	1.2	2.8	9.2	9.0	5.9	9.1	4.2	7.0	2.3	0.2	0.8	17.9	9.0	10.0	3.0	8.1	10.1	12.7	1.1	8.1	9.9	1.5	7.9	9.3	0.0	4.9	2.6	18.6	0.1	4.2	1.5	2.2	14.1	5.7	7.3	11.4	3.3	3.4	1.9	2.0	0.4	18.0	1.8	0.7	8.0	1.8	0.3	3.0	3.4	3.9	4.8	4.4	16.3	0.2	0.1	4.8	4.2	5.6	0.7	6.7	2.2	2.5	1.5	1.7	1.6	9.6	7.6	0.9	4.8	9.1	3.5	6.4	5.6	2.9	9.1	8.9	7.7	1.2	6.1	7.2	2.8	1.0	6.0	6.7	9.2	5.9	9.0	0.3	6.3	4.2	4.8	5.5	1.9	4.2	4.0	4.3	4.6	2.2	5.9	4.5
APOLD1	"DKFZP434F0318, FLJ25138"	ENSG00000178878	"Apolipoprotein L domain containing 1"	Q96LR9	12	12725917-12829975	"Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 109.5"	"Cell line enhanced"	"Detected in many"		"AF22: 26.1;HDLM-2: 13.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 5.8;olfactory region: 24.7"	"Low region specificity"	"Detected in all"			"HPA052462, HPA058882"	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA052462: , HPA058882: "	"unprognostic (1.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.58e-3)"	"unprognostic (8.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.15e-2)"	109.5	8.8	11.2	9.2	17.7	0.6	34.4	9.8	17.5	25.5	9.0	7.7	2.9	2.5	7.1	7.0	18.8	14.0	18.7	22.3	13.0	11.8	7.4	9.3	7.1	3.4	16.6	3.3	10.0	12.8	17.2	4.7	44.8	16.7	7.2	7.1	8.1	4.4	3.7	16.6	7.4	6.0	28.0	13.9	4.7	5.3	5.4	12.4	5.7	34.4	9.9	3.3	10.9	7.1	2.3	1.7	4.8	0.9	0.8	2.7	0.3	4.3	0.1	26.1	0.8	0.8	1.5	0.2	4.2	6.9	4.3	6.3	1.7	4.6	1.3	0.4	1.6	1.4	1.0	0.2	7.3	13.2	1.0	0.4	1.3	0.0	1.6	0.6	0.4	1.0	1.2	1.5	3.3	3.2	0.4	1.8	2.2	0.8	0.7	0.7	0.1	0.8	2.0	0.5	0.6	0.5	0.4	2.3	2.4	4.0	0.4	9.5	0.1	2.1	3.9	1.0	1.4	5.8	3.8	1.3	0.6	1.0	1.4	2.8	4.8	4.8	0.9	0.7	0.9	0.4	1.1	2.2	2.0	1.3	0.6	2.3	1.6	1.0	4.4	0.8	0.6	1.7	2.7	0.3	11.2	17.7	9.8	17.5	13.0	11.8	16.6	3.3	16.7	12.4
AQP11		ENSG00000178301	"Aquaporin 11"	Q8NBQ7	11	77589391-77610355	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 60.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 8.7;Hep G2: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 2.0;NK-cells: 2.0;T-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042879			Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA042879: AB_10794919"	"unprognostic (4.95e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.62e-5)"	"unprognostic (2.42e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.65e-1)"	"prognostic favourable (9.89e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.66e-3)"	1.0	14.5	4.2	0.8	3.5	0.6	1.1	5.0	4.8	0.6	22.4	2.1	0.7	24.7	0.8	1.2	0.5	0.9	2.4	0.7	2.5	4.5	5.2	13.9	0.6	0.9	3.4	3.4	9.3	3.6	0.9	1.8	3.5	3.4	3.9	2.1	3.8	0.8	0.7	1.0	1.0	60.1	0.6	1.5	1.0	2.3	7.4	1.7	0.0	1.6	0.2	0.4	0.8	0.6	2.0	0.1	0.3	0.1	2.0	2.3	0.8	1.1	3.6	1.5	2.4	3.5	0.9	1.6	1.9	0.8	1.8	0.8	8.7	1.7	1.8	0.9	0.8	1.1	0.6	0.1	0.9	5.3	1.5	1.4	1.2	14.4	1.1	3.0	1.7	0.9	0.3	1.0	0.2	0.3	0.9	1.1	2.0	1.8	1.1	2.0	1.6	3.4	1.6	3.9	0.6	1.0	1.4	1.5	1.1	2.4	0.5	0.9	1.8	0.4	1.0	1.4	4.6	2.8	1.2	1.2	0.8	1.4	0.5	0.2	2.0	0.0	0.0	0.3	1.9	0.0	1.3	0.3	0.8	1.5	0.1	2.0	2.3	0.7	0.0	2.0	0.1	0.1	0.1	0.8	4.2	3.5	5.0	4.8	2.5	4.5	3.4	3.4	3.4	1.7
AQP12A	AQP12	ENSG00000184945	"Aquaporin 12A"	Q8IXF9	2	240691845-240698483	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	182	"pancreas: 65.3"	"Cell line enhanced"	"Detected in single"		"HMC-1: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042216	Supported									"HPA042216: "			"unprognostic (9.82e-2)"							"unprognostic (1.63e-2)"	"unprognostic (9.48e-2)"			"unprognostic (2.14e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AQP12B	INSSA3	ENSG00000185176	"Aquaporin 12B"	A6NM10	2	240676418-240682906	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	386	"pancreas: 82.5"	"Cell line enhanced"	"Detected in single"		"U-138 MG: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042216	Supported									"HPA042216: "			"unprognostic (1.30e-1)"							"unprognostic (2.87e-2)"	"unprognostic (1.68e-1)"			"unprognostic (3.41e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AQP3	GIL	ENSG00000165272	"Aquaporin 3 (Gill blood group)"	Q92482	9	33441154-33447633	"Blood group antigen proteins, Plasma proteins, Predicted membrane proteins"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 28.0;HeLa: 50.9;RT4: 47.4;SK-BR-3: 32.8;U-266/70: 34.0;U-266/84: 44.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 2.1;pons and medulla: 6.7"	"Group enriched"	"Detected in many"	6	"MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1"	"Lineage enriched"	"Detected in many"	16	"T-cells: 42.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014924	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA014924: "	"unprognostic (4.29e-2)"	"prognostic favourable (5.31e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.51e-2)"	1.3	0.4	0.4	2.7	0.2	1.9	5.2	0.9	0.3	29.7	26.7	0.1	1.7	9.9	5.5	3.2	179.6	3.3	2.0	6.0	2.1	0.4	23.9	44.0	16.5	5.7	0.5	0.3	3.6	5.7	0.0	0.7	5.3	6.7	15.5	1.2	0.4	194.2	5.5	0.9	65.2	33.2	5.1	0.3	17.2	3.9	1.2	0.0	70.6	0.6	132.4	156.1	37.6	60.2	2.6	2.4	0.5	0.1	0.5	42.1	10.3	0.1	8.4	0.4	0.0	15.5	2.8	0.2	0.0	0.2	0.2	0.2	4.4	2.6	0.1	2.0	0.0	28.0	1.3	0.1	0.0	13.3	1.3	0.9	50.9	0.4	0.0	0.2	0.3	0.4	1.4	0.1	0.0	0.1	14.3	13.0	1.5	6.2	12.7	4.9	1.1	0.1	0.2	21.2	2.3	0.2	47.4	0.4	1.0	7.1	32.8	0.0	0.2	2.2	0.2	0.0	0.2	0.0	0.0	34.0	44.0	3.1	0.1	0.0	0.0	0.3	0.1	0.0	4.5	0.0	41.1	2.6	39.2	12.0	0.0	0.5	22.7	10.8	0.5	0.5	0.1	2.4	42.1	10.3	0.4	0.2	0.9	0.3	2.1	0.4	0.5	0.3	6.7	0.0
AQP6	AQP2L	ENSG00000086159	"Aquaporin 6"	Q13520	12	49967194-49977139	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	25	"kidney: 40.1"	"Cell line enhanced"	"Detected in some"		"A549: 2.5;SH-SY5Y: 2.6"	"Cancer enriched"	"Detected in many"	9	"renal cancer: 9.1"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in some"	7	"cerebellum: 23.5"	"Low region specificity"	"Detected in all"			HPA015278	Enhanced									"HPA015278: AB_10600982"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.77e-1)"	0.1	0.2	0.6	0.1	1.1	0.0	0.1	0.3	1.6	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.7	0.5	40.1	0.2	0.1	0.1	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.0	0.1	1.0	0.3	0.1	0.0	0.1	0.1	0.4	0.1	0.2	0.7	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.8	0.5	1.2	0.2	0.2	0.4	0.2	0.4	2.5	0.1	0.3	0.1	0.0	0.0	0.5	0.3	0.0	0.0	1.4	1.6	0.0	1.1	0.0	0.3	0.4	0.0	0.1	0.2	1.7	0.0	0.1	0.9	0.4	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.7	0.0	1.2	0.0	0.7	0.5	1.3	1.2	0.2	0.7	1.2	0.0	0.6	2.6	0.8	0.0	0.8	0.0	0.1	0.0	0.7	1.1	0.0	0.7	0.2	0.2	0.0	0.3	0.3	0.5	1.2	0.2	0.1	0.4	0.1	0.1	0.3	0.1	0.2	0.5	0.8	0.2	0.3	1.1	0.2	0.2	0.2	0.3	0.2	0.6	1.1	0.3	0.3	0.7	0.5	1.2	0.1	0.3	0.1
AQP8		ENSG00000103375	"Aquaporin 8"	O94778	16	25215731-25228940	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	29	"intestine: 40.9;pancreas: 163.4"	"Cell line enriched"	"Detected in single"	6	"Hep G2: 4.9"	"Group enriched"	"Detected in some"	42	"colorectal cancer: 6.4;liver cancer: 3.2;pancreatic cancer: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046259	Enhanced									"HPA046259: AB_10960494"	"unprognostic (8.75e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.34e-3)"	"unprognostic (8.47e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.71e-2)"	0.2	0.0	0.2	3.4	0.2	0.0	0.2	0.2	0.2	0.2	40.9	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	163.4	0.0	0.2	0.2	0.2	0.2	19.9	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.0	4.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.6	0.0	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
AQP9	"HsT17287, SSC1"	ENSG00000103569	"Aquaporin 9"	O43315	15	58138169-58185911	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"blood: 127.8;liver: 147.0"	"Cell line enriched"	"Detected in single"	27	"U-87 MG: 25.3"	"Cancer enriched"	"Detected in many"	30	"liver cancer: 132.4"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	20	"neutrophil: 127.8"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 127.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074762, CAB075684"	Enhanced									"CAB075684: , HPA074762: "	"unprognostic (1.91e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.28e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.80e-3)"	"unprognostic (6.98e-2)"	"prognostic unfavourable (5.72e-11)"	"unprognostic (8.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.39e-2)"	7.8	0.3	0.6	12.9	0.7	9.8	0.6	0.7	1.4	0.2	0.3	0.1	1.0	0.0	0.2	7.8	0.7	3.0	0.8	2.0	0.4	0.2	0.8	147.0	8.6	12.0	2.4	0.4	1.2	0.3	2.8	0.4	1.4	0.6	0.4	0.0	0.5	0.4	0.8	0.4	6.9	0.3	1.0	0.5	15.8	0.7	2.5	0.4	0.4	0.5	0.1	0.4	1.3	0.6	0.0	0.2	127.8	6.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	25.3	0.1	0.0	0.0	6.2	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	127.8	0.0	2.3	0.0	0.0	1.7	0.6	0.7	0.7	1.4	0.4	0.2	2.4	0.4	0.6	0.4
ARGFX		ENSG00000186103	"Arginine-fifty homeobox"	A6NJG6	3	121570704-121586634	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.6;testis: 2.2"	"Cell line enhanced"	"Detected in some"		"K-562: 1.7;Karpas-707: 1.5;U-698: 1.9"	"Cancer enriched"	"Detected in single"	119	"testis cancer: 6.4"					"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.6"									HPA043049	Uncertain									"HPA043049: "															"unprognostic (6.00e-2)"			0.3	0.1	0.2	0.5	0.2	0.9	0.2	0.1	0.2	0.1	0.1			0.0	0.2	0.1	0.0	0.1	0.3	0.3	0.2	0.2	0.0	0.4	0.1	0.1	0.1		0.1	0.5	0.0	0.1	0.0		0.1	0.0		0.2	0.1	1.1	0.8	0.4	0.0	0.1	0.5	0.1	2.2			0.1		0.0	0.2	0.1	0.4	0.2	3.6	0.8	0.7	0.3	0.2	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.2	0.0	0.2	0.3	0.0	0.0	0.2	1.0	0.5	0.7	0.0	0.4	0.0	1.1	0.0	0.3	0.4	0.0	0.0	1.7	1.5	0.4	0.0	0.0	0.1	0.4	1.0	0.3	0.0	0.3	0.0	0.0	0.0	0.5	0.4	0.6	0.0	0.4	0.5	0.0	0.2	0.5	0.0	0.5	1.2	0.5	1.9	0.0	0.2	0.2	0.8	0.3	0.4	0.2	0.4	0.2	0.4	0.1	0.1	0.2	0.4	0.2	0.3	3.6	0.7	0.8	0.2	0.1	0.2										
ARHGAP11B		ENSG00000285077	"Rho GTPase activating protein 11B"	Q3KRB8	15	30624494-30638805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 2.6;intestine: 2.7;stomach 1: 1.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 17.6"									"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA064479	Uncertain		Uncertain	Vesicles				Vesicles		"HPA064479: "																		0.2	0.0		0.0		0.3	0.0		0.0	0.0	1.1			1.1	0.0	0.0	2.6	0.1	0.0	0.0			0.0	0.1	0.1	1.6			0.0	0.0	0.0		1.0		0.0	2.7		0.0	0.0	0.0	0.3	0.1	0.0		0.3	1.9	0.4			0.0		0.9	0.3		1.0	0.8	0.0	0.0	0.0	1.3	0.0	2.8	0.4	0.0	1.7	0.6	0.6	1.6	0.2	1.0	1.3	0.5	4.6	3.0	0.0	1.4	1.0	5.2	4.1	0.1	2.4	4.0	0.4	0.0	17.6	1.4	0.4	0.8	0.2	0.4	0.1	0.5	1.1	1.5	1.3	7.6	3.8	0.2	2.4	0.6	0.9	0.2	0.8	1.8	1.1	1.3	4.5	2.7	1.0	1.1	1.3	0.6	1.5	3.3	1.3	4.7	2.6	0.1	3.0	2.9	2.1	1.4	1.1	3.6	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.3	0.9	0.8	1.0	0.3	0.6	0.0	0.0	0.0	0.3	0.2	0.0										
ARHGAP36	FLJ30058	ENSG00000147256	"Rho GTPase activating protein 36"	Q6ZRI8	X	131058242-131089883	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 58.4;brain: 25.5;pituitary gland: 50.3"	"Cell line enriched"	"Detected in single"	164	"SH-SY5Y: 62.9"	"Cancer enriched"	"Detected in some"	21	"thyroid cancer: 62.5"	"Region enriched"	"Detected in many"	5	"hypothalamus: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 104.3"	"Group enriched"	"Detected in many"	5	"basal ganglia: 19.8;hypothalamus: 57.8;midbrain: 27.1;pons and medulla: 20.1"	"HPA002064, HPA076209"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"				Nucleoplasm	"Vesicles, Plasma membrane"	"HPA002064: AB_1078891, HPA076209: "	"unprognostic (2.92e-2)"			"unprognostic (7.71e-9)"	"unprognostic (2.19e-1)"	"unprognostic (8.15e-2)"				"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.73e-1)"		"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.31e-1)"		6.9	58.4	1.4	0.2	3.6	0.1	1.0	0.0	2.7	0.5	0.2	0.0	0.0	0.1	0.1	2.0	0.3	0.2	0.2	0.1	1.0	25.5	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	50.3	0.3	5.4	0.3	0.2	0.6	0.2	0.2	13.7	0.1	0.1	0.1	0.8	0.1	0.2	0.6	0.0	0.5	0.5	4.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	62.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.6	0.0	0.4	1.0	25.5	0.5	0.0	5.4	0.0
ARHGAP42	"AD031, FLJ32810, GRAF3, TMEM133"	ENSG00000165895	"Rho GTPase activating protein 42"	"A6NI28, Q9H2Q1"	11	100687653-100993941	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 38.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 22.8;RH-30: 15.8;RT4: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039924, HPA060528"	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA039924: AB_10674428, HPA060528: "	"unprognostic (1.04e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavourable (9.29e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.03e-1)"	11.1	4.9	6.8	8.9	5.8	0.9	10.4	3.0	7.0	9.8	8.3	4.1	2.3	9.9	11.4	7.7	4.3	5.6	9.5	6.5	8.8	3.8	11.9	12.7	13.7	5.1	6.3	5.3	4.8	2.6	9.1	6.0	38.0	5.9	4.8	8.4	25.5	5.1	3.8	9.0	7.2	12.1	5.8	8.7	8.2	11.7	4.1	6.7	12.7	10.9	7.4	3.8	5.5	7.9	1.5	2.5	0.0	0.0	0.7	0.4	0.3	0.5	3.5	4.6	0.1	2.5	3.4	3.1	0.5	0.9	1.1	2.1	4.4	22.8	0.7	6.4	1.7	7.7	2.3	1.7	1.1	0.0	1.9	11.0	8.9	1.4	4.5	0.1	0.0	3.3	2.1	4.2	0.7	1.7	0.4	0.0	3.4	0.6	1.2	0.0	5.5	5.6	3.4	15.8	0.4	5.3	14.8	2.5	1.6	7.6	0.2	6.0	0.8	1.4	3.0	3.0	3.7	3.5	1.7	3.3	0.0	4.4	3.5	2.7	12.9	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.7	0.0	2.5	0.0	0.3	6.8	5.8	3.0	7.0	8.8	3.8	6.3	5.3	5.9	6.7
ARHGEF33		ENSG00000214694	"Rho guanine nucleotide exchange factor 33"	A8MVX0	2	38889841-38975449	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 42.5"	"Group enriched"	"Detected in some"	4	"BEWO: 8.8;HeLa: 3.9;SiHa: 11.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	5	"cerebellum: 42.5"	"Cell type enriched"	"Detected in single"	8	"eosinophil: 6.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.7"	"Region enriched"	"Detected in single"	32	"cerebellum: 314.4"	"Region enriched"	"Detected in many"	11	"cerebellum: 47.0"	"HPA034661, HPA041051"	Enhanced		Supported	Vesicles				Vesicles		"HPA034661: AB_10669679, HPA041051: "	"unprognostic (8.38e-2)"	"unprognostic (7.05e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.99e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.99e-1)"	0.3	4.0	3.7	1.0	8.6	0.0	1.7	42.5	3.4	2.3	0.7	0.6	0.7	0.1	2.8	5.1	0.7	2.2	1.4	0.8	3.3	3.6	1.4	0.2	1.2	0.5	2.0	2.9	6.8	0.2	2.2	3.5	0.8	3.2	1.7	0.6	0.8	0.4	1.2	0.4	1.3	0.6	1.0	1.5	0.5	0.9	10.1	2.4	0.2	1.4	0.2	0.4	1.2	0.6	0.2	0.1	6.7	0.8	0.0	0.2	0.1	0.3	0.0	0.4	0.2	0.2	0.2	8.8	0.8	0.0	0.0	0.0	0.1	0.2	0.4	0.1	0.8	0.0	0.0	0.0	0.0	1.8	0.9	0.2	3.9	0.3	0.7	0.3	0.3	0.8	0.9	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.9	0.4	0.4	0.3	11.0	0.4	0.0	0.0	0.3	0.6	0.2	1.4	0.0	0.1	0.5	0.2	0.0	0.2	0.2	0.1	0.0	0.6	6.7	0.0	0.8	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	3.7	8.6	42.5	3.4	3.3	3.6	2.0	2.9	3.2	2.4
ARHGEF37	FLJ41603	ENSG00000183111	"Rho guanine nucleotide exchange factor 37"	A1IGU5	5	149551947-149634968	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 66.1;seminal vesicle: 73.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 9.9;HaCaT: 18.2;hTCEpi: 24.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 9.0;neutrophil: 4.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 9.0"	"Region enhanced"	"Detected in some"		"cerebellum: 9.5"	"Low region specificity"	"Detected in all"			"HPA043885, HPA053487"	Uncertain		Approved	Cytosol				Cytosol		"HPA043885: , HPA053487: "	"unprognostic (3.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.16e-2)"	"prognostic favourable (6.85e-4)"	"unprognostic (4.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.10e-1)"	2.5	2.7	10.8	1.9	13.2	3.0	16.8	6.7	7.1	4.0	10.2	17.5	66.1	4.5	4.4	9.5	7.6	7.4	4.6	6.4	12.8	9.5	4.6	1.4	4.3	1.0	19.1	5.8	2.2	7.0	29.6	5.3	3.6	12.3	16.0	5.2	12.0	23.2	73.8	11.9	29.3	4.8	7.0	31.7	1.0	11.7	4.8	15.1	0.7	2.1	4.8	3.4	6.4	5.4	0.7	1.1	9.0	1.2	0.2	0.8	0.0	2.9	1.1	0.8	3.6	0.2	0.4	2.1	0.4	0.6	0.6	0.6	0.0	3.9	0.4	9.9	0.4	18.2	0.3	1.8	1.2	0.8	0.9	0.3	1.8	0.2	0.7	0.0	0.5	0.5	24.2	1.8	2.4	2.9	0.4	0.7	0.0	0.4	0.5	0.5	0.2	2.2	0.3	0.4	0.0	4.0	1.5	1.5	3.5	2.2	0.2	0.3	5.4	0.1	2.3	0.2	0.7	0.0	0.5	0.5	1.0	0.3	0.7	0.1	2.5	9.0	0.9	0.5	0.4	1.2	0.5	0.2	0.3	0.3	0.3	0.7	0.8	0.6	4.9	0.2	0.5	1.1	0.2	0.0	10.8	13.2	6.7	7.1	12.8	9.5	19.1	5.8	12.3	15.1
ARHGEF38	FLJ20184	ENSG00000236699	"Rho guanine nucleotide exchange factor 38"	Q9NXL2	4	105552620-105708093	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 35.5"	"Group enriched"	"Detected in some"	8	"RPTEC TERT1: 16.0;SK-BR-3: 8.9;T-47d: 9.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA036510, HPA045484"	Uncertain		Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA036510: AB_10672357, HPA045484: "	"unprognostic (1.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.47e-3)"	"unprognostic (2.79e-1)"	"unprognostic (6.14e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.16e-8)"	"unprognostic (2.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (3.19e-3)"	"unprognostic (6.45e-3)"	0.2	0.2	0.2	3.2	0.2	0.0	10.8	0.2	0.2	3.5	7.6	0.0	1.6	2.3	1.4	15.7	0.4	1.1	11.7	0.2	0.2	0.2	13.8	0.4	16.1	0.0	0.2	0.0	1.3	12.9	0.0	35.5	0.4	0.0	14.6	5.6	0.2	13.9	0.5	0.2	1.0	9.6	0.0	0.2	0.2	4.1	0.6	0.0	0.0	8.0	0.7	2.0	0.5	0.4	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	16.0	0.0	0.0	0.0	0.0	8.9	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
ARL10	ARL10A	ENSG00000175414	"ADP ribosylation factor like GTPase 10"	Q8N8L6	5	176365468-176401865	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047044	Approved									"HPA047044: AB_2679915"	"unprognostic (2.50e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.31e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.78e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.96e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.33e-2)"	5.0	3.4	11.1	4.4	11.7	7.0	5.5	11.0	15.6	7.6	7.6	10.1	3.3	2.6	8.0	5.9	8.5	4.6	7.0	6.4	8.7	7.7	3.6	1.9	3.5	5.5	9.2	10.9	11.8	3.9	5.7	9.0	5.9	6.7	5.9	2.9	4.3	3.3	6.2	9.8	25.7	4.8	8.2	10.8	5.1	3.8	3.3	7.9	4.3	4.0	3.1	4.5	6.1	7.6	2.5	0.9	1.4	0.4	1.2	2.0	0.3	0.4	0.1	11.9	5.6	6.4	7.9	0.6	3.1	1.5	4.8	5.1	0.3	0.4	1.1	0.6	6.1	7.8	0.1	0.9	7.2	0.1	4.8	1.0	9.6	1.2	3.9	0.2	1.5	4.6	0.5	6.2	0.0	7.9	0.4	1.2	6.3	7.2	1.3	0.3	2.2	1.3	3.4	2.9	0.0	3.0	4.1	11.0	11.4	2.8	1.7	2.3	0.4	0.9	5.9	4.5	3.7	3.3	0.6	0.4	0.8	0.4	3.7	0.2	1.5	0.7	0.3	0.4	1.4	0.3	1.3	2.5	1.1	2.0	0.3	2.3	0.8	1.5	1.4	1.2	0.4	0.9	1.3	0.3	11.1	11.7	11.0	15.6	8.7	7.7	9.2	10.9	6.7	7.9
ARL13A	ARL13	ENSG00000174225	"ADP ribosylation factor like GTPase 13A"	Q5H913	X	100969708-100990829	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 16.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA037377, HPA037378"	Uncertain									"HPA037377: , HPA037378: AB_10670932"	"unprognostic (4.40e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.37e-4)"	"unprognostic (2.14e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.6	0.0	0.5	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	1.2	0.4	0.1	0.1	0.2	0.3	16.6	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.8	0.2	0.0	0.4	0.1	0.5	0.0	1.0	1.9	0.1	0.6	0.0	0.0	0.5	0.3	0.1	0.0	0.0	6.5	0.7	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.4	1.1	1.1	0.7	0.0	1.6	0.1	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.1	0.7	0.0	0.2	0.0	1.5	0.0	0.1	0.7	0.0	0.4	0.0	0.1	1.2	0.3	0.0	0.3	1.9	0.6	0.3	0.0	0.0	0.3	0.2	0.2	1.2	0.3	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.5	0.1	0.0	0.1	0.4	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ARL17A	"ARF1P2, ARL17P1"	ENSG00000185829	"ADP ribosylation factor like GTPase 17A"	Q8IVW1	17	46516702-46579682	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA046814	Uncertain									"HPA046814: "	"unprognostic (8.57e-4)"	"unprognostic (7.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.57e-5)"	"unprognostic (2.07e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.48e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.61e-2)"	3.5	3.3	2.8	6.4	3.2	6.1	5.3	7.6	6.0	4.3	4.5			1.7	6.6	6.1	5.8	5.0	1.4	3.7	3.3	2.9	3.4	2.2	4.3	7.6	2.4		7.3	4.7	2.9	7.1	2.4		6.2	6.3		5.6	3.3	9.2	7.4	4.6	5.2	3.5	4.9	4.5	2.9			6.1		6.0	4.3	6.1	6.8	6.9	5.4	4.6	6.6	6.6	1.4	2.4	3.1	7.9	4.5	1.5	2.4	2.2	3.6	0.7	1.2	2.2	12.3	3.2	15.3	2.3	1.2	3.4	2.7	2.2	2.8	8.1	14.6	2.3	18.7	9.5	2.7	3.7	3.2	1.9	8.1	1.8	2.0	5.1	3.8	5.6	5.2	1.0	5.9	4.6	3.9	1.5	11.2	12.3	5.3	1.6	6.0	3.2	2.5	2.6	0.9	1.0	6.8	7.5	8.5	14.1	9.9	2.8	2.4	10.4	12.6	3.5	2.8	8.5	5.1	5.4	4.6	2.6	6.1	3.7	3.9	5.7	5.3	6.2	4.6	6.8	4.6	6.6	2.3	6.6	4.1	6.9	3.2	1.4										
ARL17B	ARL17	ENSG00000228696	"ADP ribosylation factor like GTPase 17B"	Q8IVW1	17	46274784-46361797	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 14.0;HEK 293: 17.4;U-266/84: 15.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA046814	Uncertain									"HPA046814: "	"unprognostic (2.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.56e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.78e-2)"	"unprognostic (8.83e-2)"	3.1	4.9	2.6	3.3	2.4	4.6	5.1	6.2	4.9	3.9	4.3			0.2	5.0	2.4	4.2	3.5	0.4	4.9	3.0	3.0	4.1	3.2	2.3	3.2	2.6		7.3	3.6	2.3	3.4	1.3		3.5	3.6		2.7	3.9	5.4	2.3	2.3	5.8	3.1	2.4	2.6	2.6			4.4		3.5	3.6	3.3	10.0	16.2	4.1	10.9	6.0	10.9	4.4	2.2	0.5	4.3	1.8	1.8	0.8	0.6	1.6	1.1	3.2	2.7	14.0	2.0	6.7	1.2	3.2	0.6	4.1	1.9	3.8	5.6	17.4	1.3	5.8	5.3	1.4	1.2	1.5	0.4	2.7	1.1	0.8	5.2	0.8	2.7	6.6	0.7	1.8	2.0	1.4	0.7	4.0	10.4	3.5	7.1	1.8	1.6	1.0	1.8	1.3	0.2	1.3	5.3	2.2	5.8	10.8	1.4	1.2	4.5	15.2	0.9	1.1	4.9	1.1	4.1	10.9	2.4	6.3	6.5	5.5	8.8	8.8	9.4	9.2	10.0	10.9	9.6	1.9	6.0	7.4	16.2	6.9	4.4										
ARL9		ENSG00000196503	"ADP ribosylation factor like GTPase 9"	Q6T311	4	56505209-56525481	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.7;testis: 12.6"	"Cell line enhanced"	"Detected in some"		"HSkMC: 4.3;REH: 8.5;SCLC-21H: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA072942	Enhanced		Approved	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA072942: "	"unprognostic (9.91e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.24e-3)"	"unprognostic (6.86e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.79e-6)"	"unprognostic (1.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-2)"	1.3	1.1	4.4	0.8	4.9	3.4	2.0	1.5	7.1	1.3	1.3	0.6	2.4	1.0	2.0	1.1	1.1	1.2	2.4	0.8	3.9	3.2	0.5	0.5	0.6	1.0	1.3	2.9	3.0	0.4	0.4	1.6	0.3	8.7	2.2	1.0	1.9	0.9	3.8	0.4	4.1	1.0	3.7	2.5	0.8	1.0	12.6	0.6	0.1	1.1	1.2	0.7	1.5	2.5	2.1	2.2	1.6	0.4	1.4	1.4	0.1	0.0	0.5	0.5	0.5	1.1	2.8	0.1	0.9	0.5	2.1	2.1	0.4	0.7	0.7	0.0	1.4	0.2	0.4	0.2	1.1	0.1	0.1	0.3	0.0	0.1	2.7	0.2	0.7	4.3	0.6	1.8	0.4	2.0	0.2	0.9	2.0	0.0	0.3	0.1	2.2	1.3	8.5	0.0	0.1	0.1	0.3	9.0	0.1	0.3	0.4	0.2	0.2	0.1	0.4	0.3	0.4	0.0	0.1	0.3	0.4	0.4	0.1	0.0	0.3	0.8	0.4	0.4	0.7	0.4	0.4	1.0	1.2	1.0	0.3	2.1	1.4	0.6	1.6	1.4	0.4	2.2	1.0	0.1	4.4	4.9	1.5	7.1	3.9	3.2	1.3	2.9	8.7	0.6
ARMC12	"C6orf81, FLJ25390"	ENSG00000157343	"Armadillo repeat containing 12"	Q5T9G4	6	35737032-35749079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 60.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.2;HSkMC: 9.5;MOLT-4: 6.5;U-698: 7.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 3.2;plasmacytoid DC: 2.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.9;monocytes: 1.0;T-cells: 3.2"	"Not detected"	"Not detected"							"HPA030895, HPA075457, HPA075777"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA030895: AB_10602114, HPA075457: , HPA075777: "	"unprognostic (1.94e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.48e-1)"	"unprognostic (3.52e-2)"	"unprognostic (6.36e-4)"	"unprognostic (8.99e-2)"	"unprognostic (1.17e-12)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.09e-1)"	0.5	0.4	0.9	0.5	1.2	0.7	0.7	0.5	0.9	0.6	0.5	0.5	0.5	0.0	0.5	5.8	0.5	0.6	0.8	0.5	0.7	0.9	0.5	1.4	0.5	1.1	0.7	0.5	1.0	0.5	0.1	4.8	0.5	0.5	1.1	0.3	0.6	0.5	1.0	0.5	0.5	0.5	0.6	0.5	0.8	0.1	60.2	0.5	0.5	0.7	0.5	0.6	0.5	0.5	0.1	2.9	0.0	1.0	0.2	3.2	0.4	0.0	0.5	3.1	3.8	7.2	3.4	0.0	0.1	0.2	0.3	0.4	0.1	0.2	0.7	0.1	0.1	0.1	1.1	0.2	0.2	1.6	0.9	0.4	0.1	0.1	3.7	0.0	0.0	9.5	2.3	0.1	1.3	0.7	0.1	4.4	1.1	0.4	6.5	0.8	0.5	0.2	3.0	0.0	0.0	0.8	0.0	0.9	3.1	0.0	0.0	0.5	2.0	0.3	0.0	0.6	0.3	0.1	0.0	1.0	0.3	7.1	0.3	3.9	0.3	0.0	1.0	0.0	0.1	0.0	1.2	0.0	1.2	0.5	0.7	0.1	0.7	3.2	0.0	0.2	0.1	2.9	0.0	0.4	0.9	1.2	0.5	0.6	0.7	0.9	0.7	0.5	0.5	0.5
ARMC2	"bA787I22.1, DKFZp434P0714"	ENSG00000118690	"Armadillo repeat containing 2"	Q8NEN0	6	108848416-108974472	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 31.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA025809, HPA053696"	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA025809: AB_1845032, HPA053696: "	"unprognostic (4.42e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.00e-4)"	"unprognostic (1.13e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.19e-5)"	"unprognostic (7.55e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.38e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.28e-1)"	6.0	5.2	13.3	5.6	19.6	7.8	7.3	9.6	14.7	7.4	4.2	7.9	2.1	2.0	8.2	11.9	3.7	21.5	5.4	9.4	12.2	7.0	4.6	2.8	8.8	4.0	4.0	11.8	6.1	3.3	9.9	20.0	7.0	16.7	4.4	4.9	5.7	3.8	5.2	3.7	5.3	3.5	4.4	6.3	5.8	4.9	31.8	7.1	2.4	11.0	2.8	4.3	4.0	5.0	2.7	4.6	9.5	4.7	4.8	7.0	1.6	3.7	2.2	11.0	7.0	5.4	6.8	2.5	2.2	3.2	5.7	7.7	3.4	3.3	5.7	2.9	3.6	3.2	6.0	4.5	10.0	1.6	5.1	5.4	5.0	3.5	3.0	8.3	2.4	7.8	6.3	6.6	1.9	5.4	2.2	8.9	5.9	2.8	7.2	7.6	3.4	2.8	8.2	9.0	4.7	5.2	4.4	15.3	5.7	7.8	2.0	5.4	4.0	4.3	2.7	4.9	2.5	4.1	3.0	4.2	5.6	5.0	8.3	5.8	6.0	4.3	3.5	0.9	3.4	4.7	3.2	1.4	2.7	3.7	2.8	2.7	1.6	3.9	9.5	4.8	3.7	4.6	7.0	1.6	13.3	19.6	9.6	14.7	12.2	7.0	4.0	11.8	16.7	7.1
ARMC3	"CT81, FLJ32827"	ENSG00000165309	"Armadillo repeat containing 3"	Q5W041	10	22928024-23038523	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 40.2;fallopian tube: 38.6;testis: 25.7"	"Cell line enriched"	"Detected in some"	9	"CAPAN-2: 11.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 4.0"	"Region enhanced"	"Detected in many"		"pons and medulla: 40.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037823, HPA037824"	Enhanced									"HPA037823: AB_2675689, HPA037824: AB_10671634"	"unprognostic (8.11e-3)"	"unprognostic (5.78e-2)"	"unprognostic (6.63e-2)"	"unprognostic (7.81e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-1)"		"unprognostic (5.23e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (7.37e-3)"	"unprognostic (4.02e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.97e-1)"	"unprognostic (6.21e-3)"	"unprognostic (9.53e-4)"	"unprognostic (1.40e-2)"	0.3	0.4	3.5	0.3	10.1	0.3	0.4	0.0	1.0	1.9	0.3	11.3	0.0	0.3	1.7	9.0	0.5	38.6	0.3	0.4	4.7	4.1	0.7	0.3	4.1	0.3	1.9	2.2	4.5	0.6	0.3	4.1	0.3	40.2	0.3	0.3	0.0	0.3	0.5	0.3	0.3	0.3	0.4	1.0	0.3	0.3	25.7	6.3	0.0	0.6	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.9	2.3	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.8	0.2	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	3.5	10.1	0.0	1.0	4.7	4.1	1.9	2.2	40.2	6.3
ARMCX2	"ALEX2, GASP9, KIAA0512"	ENSG00000184867	"Armadillo repeat containing, X-linked 2"	Q7L311	X	101655281-101659891	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 92.7"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 48.4;NTERA-2: 34.8;RH-30: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005761	Enhanced		Approved	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA005761: AB_10600782"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.59e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.41e-2)"	"prognostic favourable (3.45e-5)"	"unprognostic (9.06e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.69e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.25e-1)"	7.7	21.5	12.5	6.7	19.9	1.0	14.2	17.6	17.5	17.1	11.4	8.2	38.8	3.7	18.4	92.7	6.2	16.7	12.5	18.8	13.2	17.1	13.3	2.6	8.3	4.9	11.8	13.3	28.8	9.8	34.1	38.9	15.4	12.4	17.6	5.3	9.7	23.6	41.8	3.8	3.2	6.2	19.3	9.0	10.9	8.3	6.3	10.7	1.4	35.1	3.6	4.3	13.9	18.9	7.6	1.6	0.0	1.4	4.3	4.4	1.9	0.0	0.0	15.0	0.1	13.4	12.2	0.1	16.4	20.6	0.4	0.4	0.0	6.3	0.0	0.0	21.5	0.4	0.0	0.3	0.1	0.0	0.5	0.0	17.6	0.0	14.1	0.1	0.0	19.2	5.2	12.8	0.1	17.4	0.0	0.1	48.4	0.0	0.0	0.2	34.8	0.1	4.1	26.7	0.0	0.8	0.0	6.0	11.1	0.0	0.0	0.4	7.6	0.0	3.8	18.5	19.7	11.5	0.1	0.0	0.0	0.0	16.9	0.0	0.3	0.0	0.7	0.0	1.6	1.4	0.7	5.1	1.5	1.5	1.1	7.6	4.2	4.4	0.0	4.3	0.9	1.6	0.9	1.9	12.5	19.9	17.6	17.5	13.2	17.1	11.8	13.3	12.4	10.7
ARMCX6	"FLJ20811, GASP10"	ENSG00000198960	"Armadillo repeat containing, X-linked 6"	Q7L4S7	X	101615118-101618001	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043030, HPA048125"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Cytosol	"Nucleoplasm, Nuclear membrane"	"HPA043030: , HPA048125: "	"unprognostic (1.20e-1)"	"unprognostic (2.80e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.92e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.82e-3)"	"unprognostic (2.38e-2)"	15.1	17.2	11.7	12.1	12.1	7.6	12.7	10.9	12.1	18.7	12.0	15.4	22.6	6.7	17.3	25.9	17.3	14.1	12.4	15.6	11.3	12.6	14.1	12.2	11.2	12.1	13.1	10.3	21.3	27.2	23.4	21.0	16.3	13.1	17.7	9.0	11.8	39.2	23.5	6.5	11.3	10.4	17.1	16.7	22.6	10.6	9.0	11.4	17.9	17.3	9.7	19.3	18.8	13.7	12.8	14.1	10.0	7.0	8.1	8.7	6.4	6.6	7.8	12.3	7.0	25.2	15.0	2.4	13.9	13.6	12.5	24.5	4.7	6.4	7.1	14.3	13.0	6.9	11.9	5.6	9.8	6.1	7.3	6.6	10.9	6.2	11.6	6.4	8.4	9.3	5.8	7.7	4.0	12.7	5.4	9.1	18.7	16.3	9.4	0.0	8.8	1.6	9.7	16.5	2.6	9.0	0.9	6.8	6.4	8.2	0.0	10.4	5.7	3.1	9.8	15.3	6.9	21.2	3.2	11.3	6.0	0.0	4.5	1.7	5.0	10.0	3.8	6.3	6.5	7.0	8.7	12.8	7.0	7.3	8.1	9.1	8.4	7.8	0.5	8.1	5.0	14.1	3.9	6.4	11.7	12.1	10.9	12.1	11.3	12.6	13.1	10.3	13.1	11.4
ARMS2	"ARMD8, LOC387715"	ENSG00000254636	"Age-related maculopathy susceptibility 2"	P0C7Q2	10	122454653-122457352	"Disease related genes, Predicted intracellular proteins"			"Age-related macular degeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"placenta: 21.2;testis: 6.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;HeLa: 1.4;HSkMC: 1.5;SiHa: 1.1;TIME: 1.4;WM-115: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA067225	Enhanced									"HPA067225: "	"unprognostic (3.05e-1)"	"unprognostic (1.50e-1)"		"unprognostic (5.69e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.49e-2)"		"unprognostic (1.98e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.60e-2)"	"unprognostic (5.29e-5)"	"unprognostic (2.53e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.68e-2)"	"unprognostic (5.25e-2)"	0.5	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.0	0.7	0.2	0.2	0.2	0.4	1.7	0.3	0.2	0.2	0.4	0.2	0.2	0.2	0.2	2.3	0.2	0.0	1.0	21.2	0.2	0.2	0.0	0.2	2.7	0.2	0.2	1.9	0.2	0.2	0.2	0.2	0.2	6.6	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.5	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	1.4	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2
ARPC1A	"Arc40, SOP2Hs, SOP2L"	ENSG00000241685	"Actin related protein 2/3 complex subunit 1A"	Q92747	7	99325910-99366262	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA004334	Approved		Approved	"Cell Junctions,Cytosol"			2400000	"Cell Junctions"	Cytosol	"HPA004334: AB_1078215"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.95e-2)"	"prognostic unfavourable (4.70e-4)"	"unprognostic (2.52e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.88e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.83e-1)"	36.6	39.8	40.2	25.2	41.0	18.7	49.1	32.3	55.9	40.0	43.6	32.3	37.9	50.1	30.4	45.9	58.3	43.3	32.1	65.3	45.9	43.5	30.6	41.2	29.6	32.2	38.6	39.7	47.2	41.9	30.9	31.4	31.8	40.6	28.2	44.2	33.9	31.7	36.7	20.9	46.1	55.0	31.9	27.9	26.8	53.1	28.6	25.1	23.7	44.4	41.8	31.6	31.5	33.9	11.1	16.1	33.2	29.1	10.9	12.6	9.9	45.4	24.8	28.2	12.9	26.3	44.8	24.0	32.7	38.4	33.4	33.3	27.8	52.5	15.9	48.4	39.7	19.3	36.9	47.5	40.4	7.9	31.1	8.5	18.5	22.4	29.0	10.0	11.2	41.6	26.6	43.0	46.0	54.6	21.3	18.5	51.2	66.5	16.7	13.4	26.4	56.1	9.9	19.5	19.5	24.8	27.6	29.1	24.9	32.0	46.0	43.6	23.0	14.8	42.3	42.8	38.4	75.4	52.1	7.2	13.2	22.6	37.0	22.5	56.1	33.2	18.9	31.9	9.8	28.6	7.6	11.0	9.3	12.6	16.1	11.1	12.1	9.1	23.8	10.9	29.1	11.7	12.1	9.9	40.2	41.0	32.3	55.9	45.9	43.5	38.6	39.7	40.6	25.1
ARSJ	FLJ23548	ENSG00000180801	"Arylsulfatase family member J"	Q5FYB0	4	113900284-113979727	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 20.0;HUVEC TERT2: 18.0;LHCN-M2: 18.3;TIME: 23.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 15.4"	"HPA036481, HPA036482"	Uncertain		Supported	"Actin filaments"	"Secreted in other tissues"			"Actin filaments"		"HPA036481: , HPA036482: AB_10672356"	"unprognostic (1.98e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavourable (6.08e-4)"	"unprognostic (2.54e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.20e-1)"	"prognostic favourable (2.97e-6)"	"unprognostic (2.26e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-2)"	3.5	2.2	2.6	2.0	2.7	0.0	2.6	10.3	3.4	7.9	4.7	0.9	4.1	1.0	4.8	2.2	9.1	4.6	6.0	5.2	1.5	1.2	9.4	3.4	6.9	3.5	1.8	3.6	4.7	2.6	13.3	1.8	6.7	4.2	7.2	5.4	1.8	9.1	3.9	0.8	1.7	1.7	10.5	2.9	0.5	5.8	0.9	2.0	0.6	1.9	3.6	1.7	7.5	18.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.1	2.4	0.2	0.0	4.4	9.1	0.0	20.0	15.2	12.6	4.9	0.5	1.4	0.0	2.5	9.5	2.1	0.1	4.9	15.8	0.0	0.9	0.0	1.9	0.0	13.6	0.0	0.0	5.6	5.0	8.5	17.5	18.0	0.0	0.0	18.3	0.1	0.0	0.0	0.6	3.6	0.0	2.2	0.0	16.5	0.0	0.0	0.7	1.3	0.2	0.9	0.1	0.0	23.0	14.5	4.0	2.1	9.4	0.0	0.0	0.0	7.1	0.0	4.4	0.0	0.0	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.7	10.3	3.4	1.5	1.2	1.8	3.6	4.2	2.0
ART1	"ART2, CD296"	ENSG00000129744	"ADP-ribosyltransferase 1"	P52961	11	3645128-3664416	"CD markers, Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	20	"skeletal muscle: 50.9;tongue: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051148	Uncertain									"HPA051148: "	"unprognostic (3.73e-1)"							"unprognostic (4.58e-2)"		"unprognostic (3.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.06e-1)"		"unprognostic (1.73e-1)"		1.5	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.2	0.1	50.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	13.7	0.5	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.4	0.0
ART4	"CD297, DO, DOK1"	ENSG00000111339	"ADP-ribosyltransferase 4 (Dombrock blood group)"	Q93070	12	14825569-14843533	"Blood group antigen proteins, CD markers, Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 33.7;lymphoid tissue: 17.8;placenta: 17.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.1;HEL: 10.0;Hep G2: 6.0;HUVEC TERT2: 22.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"olfactory region: 2.2"	"Low region specificity"	"Detected in many"			HPA075664			Approved	"Rods & Rings"	"Secreted to blood"		11000000	"Rods & Rings"		"HPA075664: "	"unprognostic (2.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.62e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.71e-1)"	2.7	2.0	0.2	1.7	0.2	2.4	2.1	0.2	0.2	1.4	1.3	0.1	1.9	0.0	1.1	3.7	3.1	1.9	6.1	10.1	0.2	0.2	6.6	33.7	2.1	17.0	0.2	0.0	1.3	1.9	0.0	0.4	17.8	0.3	0.8	0.2	0.0	0.7	0.4	1.9	0.5	0.8	1.5	0.2	17.8	0.5	1.4	0.0	0.1	4.6	1.3	1.3	1.3	1.2	0.6	0.6	1.4	0.4	0.6	1.3	0.3	0.0	0.0	0.2	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	6.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.4	0.5	0.3	0.4	0.5	0.3	0.3	0.2	0.6	0.5	1.3	1.4	0.6	0.2	0.6	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.3	0.0
ART5		ENSG00000167311	"ADP-ribosyltransferase 5"	Q96L15	11	3638503-3642316	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 12.1;testis: 33.3"	"Cell line enhanced"	"Detected in some"		"AF22: 3.3;AN3-CA: 3.5;BEWO: 6.1;BJ hTERT+ SV40 Large T+ RasG12V: 3.5;HEK 293: 4.2;U-2 OS: 4.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 4.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"memory CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Region enriched"	"Detected in single"	5	"olfactory region: 0.5"	"Not detected"	"Not detected"			"HPA041637, HPA044099"	Uncertain				"Secreted in other tissues"					"HPA041637: , HPA044099: "	"unprognostic (6.32e-2)"	"unprognostic (3.26e-5)"	"unprognostic (4.09e-3)"	"unprognostic (2.06e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.67e-1)"	"prognostic favourable (1.85e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.18e-1)"	0.8	0.1	0.3	0.3	0.5	0.0	0.8	0.3	0.6	3.3	0.3	0.3	1.0	0.0	3.3	0.9	0.4	1.5	1.2	2.9	0.3	0.2	0.7	0.6	0.9	0.3	0.3	0.3	9.3	0.3	1.7	0.6	1.7	0.5	1.1	0.0	5.3	1.2	0.8	12.1	0.3	0.4	1.0	0.3	0.5	0.3	33.3	0.5	0.3	3.5	5.2	0.5	0.5	1.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	3.3	3.5	0.0	0.0	6.1	0.4	3.0	1.5	3.5	0.1	0.0	0.0	1.6	0.4	0.0	2.9	0.0	0.8	0.0	4.2	0.0	0.6	0.3	0.1	0.0	2.7	1.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.6	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	2.9	0.1	1.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.6	0.3	0.2	0.3	0.3	0.5	0.5
ASAH2B	"ASAH2C, ASAH2L, bA449O16.3, bA98I6.3"	ENSG00000204147	"N-acylsphingosine amidohydrolase 2B"	P0C7U1	10	50739318-50816495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"intestine: 27.5"	"Cell line enhanced"	"Detected in many"		"PC-3: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA061171	Supported		Approved	"Focal adhesion sites"				"Focal adhesion sites"		"HPA061171: "	"unprognostic (6.86e-3)"	"unprognostic (1.91e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.42e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	2.8	8.3	6.5	3.3	10.7	2.3	4.6	4.4	14.5	4.0	4.5	1.5	3.8	27.5	5.1	6.2	4.4	4.8	4.3	7.8	7.2	9.0	7.3	12.2	3.7	2.9	5.7	8.3	5.6	7.6	8.8	12.8	2.1	7.4	6.3	5.3	7.0	6.6	4.4	5.7	3.0	16.0	4.4	3.9	3.0	6.4	5.2	2.0	2.7	5.6	6.8	4.8	3.8	3.4	1.4	3.2	0.5	0.1	0.7	6.0	1.5	1.9	2.0	3.1	5.1	1.0	2.6	2.5	9.5	5.2	5.8	4.8	6.7	4.9	0.1	3.6	2.0	2.0	3.5	4.1	4.8	3.6	4.0	1.3	5.8	4.4	3.8	1.7	1.9	3.2	4.8	5.6	8.5	1.2	6.1	2.5	4.7	4.2	2.7	0.2	4.0	19.0	0.1	7.2	2.4	3.4	7.1	5.9	11.9	3.2	4.0	3.3	6.8	1.2	6.3	2.5	11.4	5.2	11.2	2.9	0.4	0.0	12.6	0.0	4.2	0.5	0.1	0.0	2.2	0.0	6.0	0.7	3.5	2.5	0.0	1.4	4.9	4.5	0.4	0.7	0.1	3.2	3.9	1.5	6.5	10.7	4.4	14.5	7.2	9.0	5.7	8.3	7.4	2.0
ASB4	ASB-4	ENSG00000005981	"Ankyrin repeat and SOCS box containing 4"	Q9Y574	7	95478444-95540232	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"adrenal gland: 28.6;pituitary gland: 40.1;skeletal muscle: 20.7"	"Cell line enhanced"	"Detected in some"		"A549: 6.8;Hep G2: 11.1;SCLC-21H: 7.0"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.2"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basal ganglia: 10.0;hypothalamus: 37.1"	"Region enriched"	"Detected in single"	7	"midbrain: 3.7"	HPA055240	Uncertain									"HPA055240: "	"unprognostic (1.41e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.24e-1)"	"unprognostic (9.13e-7)"	"unprognostic (1.71e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.23e-2)"	0.3	28.6	0.7	0.1	1.1	0.3	0.2	0.1	1.3	0.1	0.1	1.3	0.1	0.2	0.1	0.3	0.1	0.2	0.4	2.6	0.7	0.6	0.1	1.0	0.4	0.1	1.7	0.5	0.1	0.4	0.0	40.1	1.3	0.2	0.2	0.0	0.1	0.3	0.1	20.7	0.2	0.2	0.1	1.6	0.1	0.4	0.2	0.1	0.2	0.2	2.5	0.4	0.1	0.1	1.0	0.6	1.3	0.3	0.9	0.7	0.0	0.3	6.8	0.3	2.5	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.8	1.3	0.2	0.1	0.2	0.3	0.0	0.0	0.0	0.2	0.2	0.1	0.5	11.1	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.1	0.1	0.6	0.0	0.2	0.2	0.3	0.2	1.5	0.1	0.2	0.0	0.2	0.2	7.0	0.0	0.1	0.3	0.7	0.1	0.3	0.3	0.4	0.4	0.1	0.1	0.8	0.2	0.4	0.2	0.4	0.2	0.3	0.3	0.5	0.6	0.1	0.7	1.0	0.6	0.5	0.2	1.0	0.7	0.7	1.3	0.9	0.3	0.6	0.3	0.0	0.7	1.1	0.1	1.3	0.7	0.6	1.7	0.5	0.2	0.1
ASB5		ENSG00000164122	"Ankyrin repeat and SOCS box containing 5"	Q8WWX0	4	176213673-176277571	"Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 133.4"	"Cell line enriched"	"Detected in some"	16	"LHCN-M2: 161.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028870			Approved	"Plasma membrane"				"Plasma membrane"		"HPA028870: AB_10611679"					"unprognostic (1.76e-1)"	"prognostic unfavourable (5.67e-4)"		"unprognostic (1.90e-1)"			"unprognostic (7.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.65e-1)"		"unprognostic (6.80e-3)"	2.3	0.0	0.3	0.3	0.2	0.0	0.0	0.2	0.2	0.3	3.5	0.0	0.0	0.1	0.2	6.3	7.9	0.0	0.4	1.3	0.2	0.2	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	9.6	1.3	0.0	8.0	0.1	133.4	0.0	0.5	23.5	1.0	0.0	2.0	2.2	0.0	0.0	2.3	31.4	2.2	15.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.9	0.0	3.5	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	161.1	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.5	0.0	0.0	0.0
ASB8	"FLJ21255, MGC5540"	ENSG00000177981	"Ankyrin repeat and SOCS box containing 8"	Q9H765	12	48147788-48181213	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003299	Approved									"HPA003299: AB_1845072"	"unprognostic (1.35e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.40e-3)"	"unprognostic (3.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.29e-3)"	"unprognostic (3.82e-3)"	"unprognostic (1.14e-1)"	"prognostic favourable (6.57e-6)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.26e-2)"	12.6	12.8	11.1	8.2	13.8	22.7	9.1	18.2	17.2	9.8	9.7	12.2	7.4	9.0	11.5	9.9	10.7	8.3	8.6	19.0	10.2	10.4	13.3	13.4	7.5	9.2	10.9	10.2	9.8	10.3	14.5	14.7	7.7	16.8	9.3	11.5	15.4	10.2	10.0	106.4	9.3	11.3	10.6	9.6	10.1	9.0	8.5	8.8	15.7	10.2	22.3	11.1	10.5	7.2	11.1	9.3	42.7	12.3	13.1	14.2	8.2	9.2	7.6	9.4	13.8	13.9	12.3	6.6	17.8	11.6	11.6	11.0	12.3	11.7	15.7	13.6	14.8	8.4	14.8	10.2	13.1	18.9	12.1	19.0	10.8	6.4	10.6	18.2	17.7	12.0	9.7	15.1	9.9	11.6	14.4	19.7	10.4	8.7	16.6	13.0	3.4	14.2	11.0	14.3	16.4	9.1	9.9	14.1	9.4	10.6	12.5	10.3	22.9	12.4	8.9	10.1	7.4	10.2	7.5	17.5	20.4	13.7	12.8	40.5	5.6	25.6	8.7	42.7	12.3	9.7	11.5	11.1	13.3	12.3	8.5	8.9	13.6	14.2	20.7	13.1	12.3	9.3	12.6	8.2	11.1	13.8	18.2	17.2	10.2	10.4	10.9	10.2	16.8	8.8
ASCL3	"bHLHa42, HASH3, Sgn1"	ENSG00000176009	"Achaete-scute family bHLH transcription factor 3"	Q9NQ33	11	8937579-8938211	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	37	"salivary gland: 13.7"	"Cell line enhanced"	"Detected in some"		"A549: 2.5;CACO-2: 1.1;U-2 OS: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA027032	Uncertain									"HPA027032: AB_10602434"											"unprognostic (8.91e-2)"	"unprognostic (1.32e-1)"		"unprognostic (3.53e-1)"				0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.0		13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1			0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	2.5	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.3	0.8	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	2.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ASNSD1	"FLJ20752, NBLA00058, NS3TP1"	ENSG00000138381	"Asparagine synthetase domain containing 1"	"L0R819, Q9NWL6"	2	189661385-189670831	"Predicted intracellular proteins"	"Amino-acid biosynthesis, Asparagine biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA036132, HPA036133, HPA075042"	Uncertain		Approved	Cytosol				Cytosol		"HPA036132: , HPA036133: AB_10696650, HPA075042: "	"unprognostic (1.32e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.15e-3)"	"prognostic favourable (4.54e-4)"	"unprognostic (8.42e-2)"	"prognostic unfavourable (8.66e-4)"	"unprognostic (5.68e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (8.98e-3)"	"unprognostic (8.11e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	23.1	22.4	25.5	15.9	24.7	25.5	29.1	41.0	29.4	22.7	19.5	14.1	18.1	18.0	23.6	17.3	18.2	20.6	18.2	23.9	22.9	26.0	25.0	31.9	16.9	22.3	24.2	22.6	33.2	22.4	20.8	36.8	26.8	29.1	19.6	16.5	13.2	18.2	18.6	52.4	14.0	15.4	23.9	27.8	22.0	18.1	14.0	21.8	20.1	25.0	19.8	20.8	22.4	23.6	15.9	11.0	41.9	11.2	21.5	24.5	15.2	13.2	10.4	21.9	18.4	23.9	23.3	19.3	29.0	27.3	31.4	31.2	25.9	9.5	26.5	17.6	24.8	11.0	23.6	20.1	36.8	27.8	26.4	24.6	19.8	26.0	26.6	24.2	13.8	23.8	14.9	27.4	24.2	28.0	22.8	20.0	29.1	17.5	28.7	25.9	32.8	40.8	16.3	19.7	25.2	17.6	18.8	25.1	15.9	20.9	15.5	24.6	22.3	22.5	21.8	25.4	19.7	21.5	28.5	29.3	39.5	46.5	21.6	14.5	22.5	24.6	11.2	41.9	17.7	9.4	21.5	15.8	19.5	19.0	11.0	15.9	23.3	20.8	20.4	21.5	10.3	10.1	24.5	15.2	25.5	24.7	41.0	29.4	22.9	26.0	24.2	22.6	29.1	21.8
ASPG	C14orf76	ENSG00000166183	Asparaginase	Q86U10	14	104085679-104115581	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 29.7;liver: 88.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.6;HDLM-2: 3.0;HeLa: 2.4;HMC-1: 3.1;RPTEC TERT1: 1.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA069761	Enhanced									"HPA069761: "	"unprognostic (1.45e-2)"	"unprognostic (7.43e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.75e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.32e-2)"	0.7	0.5	0.4	0.4	0.5	0.0	2.1	0.4	0.5	1.5	2.3	0.5	0.4	0.5	1.6	1.0	10.2	2.0	0.8	29.7	0.4	0.0	9.8	88.7	1.3	0.9	0.4	0.4	4.9	0.4	0.7	0.4	0.8	0.7	0.4	0.8	1.2	0.8	0.4	0.4	5.2	0.8	1.1	0.4	0.4	1.6	0.9	0.4	0.4	1.3	0.6	1.7	0.5	2.8	0.2	0.0	1.0	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.2	1.8	0.8	2.6	0.0	0.2	0.0	0.0	0.0	3.0	0.0	0.0	2.4	0.0	0.0	0.0	3.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.7	0.0	0.7	0.6	1.8	1.9	1.4	1.2	0.0	0.1	0.8	0.2	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.5	0.4	0.0	0.4	0.4	0.7	0.4
ASPHD2	FLJ39838	ENSG00000128203	"Aspartate beta-hydroxylase domain containing 2"	Q6ICH7	22	26429273-26445015	"Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 18.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000820	Uncertain									"HPA000820: AB_1078231"	"unprognostic (1.12e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (4.06e-5)"	"unprognostic (6.55e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.11e-2)"	0.9	1.1	7.6	3.8	23.9	2.1	1.1	17.6	13.1	1.8	3.3	1.2	0.3	2.0	2.1	10.5	2.0	0.7	2.7	0.5	5.8	5.0	3.6	0.6	1.5	6.4	3.3	4.4	1.0	1.1	0.4	5.6	2.0	3.9	1.4	3.5	1.1	1.3	1.3	0.6	8.5	2.2	1.4	1.7	4.1	13.0	2.7	4.2	2.4	3.4	0.6	5.3	3.5	1.0	1.7	4.0	0.9	7.7	0.0	1.5	0.7	1.3	0.7	3.5	5.6	0.5	0.3	1.9	1.7	3.9	3.7	5.4	0.0	0.3	1.1	0.4	1.7	1.6	3.9	6.0	2.0	7.9	5.2	0.3	0.0	0.2	3.6	1.9	0.9	0.6	2.9	1.9	2.6	3.9	1.4	18.8	1.1	0.4	1.5	0.8	3.4	0.8	10.1	2.0	3.0	5.2	0.5	9.5	4.1	1.8	0.2	1.9	0.2	2.9	3.6	2.4	11.8	0.5	3.6	5.4	1.3	2.3	3.6	7.1	1.5	0.0	2.1	0.9	0.7	5.4	1.5	1.6	1.2	1.2	3.5	1.7	0.8	0.7	0.6	0.0	7.7	4.0	0.7	0.7	7.6	23.9	17.6	11.4	5.8	5.0	3.3	4.4	3.9	4.2
ASTN1	ASTN	ENSG00000152092	"Astrotactin 1"	O14525	1	176857302-177164973	"Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 19.9;brain: 52.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.9;NTERA-2: 4.5;SCLC-21H: 2.8;U-2 OS: 3.6;U-266/84: 20.1"	"Cancer enriched"	"Detected in some"	14	"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074112			Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA074112: "	"unprognostic (4.41e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.03e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.36e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.74e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.16e-1)"	1.4	19.9	21.5	1.6	23.8	1.1	1.7	15.0	52.5	1.3	1.5	7.4	1.9	1.5	2.3	5.4	1.2	3.2	1.9	1.7	17.4	13.7	1.3	1.4	1.4	1.2	8.5	18.8	8.9	1.7	1.2	8.2	1.6	9.8	2.4	1.6	2.2	2.0	3.3	1.3	1.1	1.5	2.2	5.8	3.6	1.2	1.9	7.2	0.0	1.2	0.0	1.5	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.9	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	23.8	15.0	27.2	17.4	13.7	8.5	18.8	9.8	7.2
ASXL3	KIAA1713	ENSG00000141431	"Additional sex combs like 3, transcriptional regulator"	Q9C0F0	18	33578233-33751192	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.3"	"Cell line enhanced"	"Detected in some"		"AF22: 4.0;RPMI-8226: 11.9;SCLC-21H: 4.6;SH-SY5Y: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039539, HPA040034"	Uncertain									"HPA039539: , HPA040034: "	"unprognostic (2.05e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.73e-4)"	"unprognostic (1.30e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.16e-2)"	"unprognostic (5.35e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.47e-12)"	"unprognostic (4.69e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.67e-2)"	1.0	0.7	6.6	0.7	5.4	0.4	0.8	0.4	10.3	3.4	1.7	1.7	1.7	1.5	1.4	1.8	0.6	2.6	2.0	2.1	4.0	3.3	2.8	1.3	0.9	0.6	5.4	8.8	9.2	1.7	3.7	2.5	1.0	4.3	2.3	1.1	0.9	1.0	2.8	0.4	0.5	1.8	7.4	5.5	0.8	2.3	6.1	5.4	0.0	3.2	0.0	0.5	1.7	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	11.9	0.0	0.0	4.6	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.6	5.4	0.4	10.3	4.0	3.3	5.4	8.8	4.3	5.4
ATAD3C	FLJ34599	ENSG00000215915	"ATPase family, AAA domain containing 3C"	Q5T2N8	1	1449689-1470158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"RPMI-8226: 16.1"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA065305			Approved	Mitochondria				Mitochondria		"HPA065305: "	"unprognostic (9.23e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.79e-2)"	"prognostic favourable (5.15e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.12e-3)"	0.7	0.0	2.1	1.7	2.3	0.7	2.7	0.3	1.5	1.3	1.8			0.9	1.4	2.6	0.7	2.5	1.3	0.4	2.8	1.5	3.1	4.9	2.2	0.7	2.6		1.1	5.0	0.1	1.5	0.3		4.0	0.6		5.4	4.5	0.2	1.2	0.5	1.3	4.3	0.5	0.5	0.7			4.1		0.9	2.2	0.9	2.1	0.6	2.9	0.6	1.6	4.3	0.7	0.3	0.0	0.3	0.5	0.5	0.1	0.3	0.1	0.1	0.2	0.1	1.6	3.2	0.3	0.4	0.1	0.4	1.3	0.5	0.1	0.1	1.3	0.2	0.9	2.0	0.2	0.3	0.3	0.0	0.2	0.2	1.0	0.0	0.3	3.8	0.1	0.9	0.5	1.0	0.5	0.2	0.4	0.1	16.1	1.1	0.3	2.7	1.0	0.0	0.6	0.2	3.5	0.3	0.3	0.2	0.3	0.5	0.2	1.9	2.6	0.6	0.2	0.4	0.1	2.9	0.6	1.1	1.1	0.4	4.3	2.1	1.5	1.3	0.1	1.3	1.9	1.4	2.5	1.6	0.3	0.6	2.0	0.7										
ATOH8	"bHLHa21, FLJ14708, HATH6"	ENSG00000168874	"Atonal bHLH transcription factor 8"	Q96SQ7	2	85751344-85788066	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"thyroid gland: 41.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.2;RH-30: 18.8;RT4: 12.1;TIME: 17.7;U-2197: 12.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 15.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 2.9;MAIT T-cell: 1.7"	"Group enriched"	"Detected in many"	12	"monocytes: 2.9;T-cells: 1.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA028406			Supported	Nucleoplasm				Nucleoplasm		"HPA028406: "	"unprognostic (7.70e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.56e-1)"	"prognostic favourable (8.98e-6)"	"unprognostic (3.32e-2)"	"prognostic favourable (3.80e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-2)"	36.4	2.4	3.7	2.4	4.3	0.8	19.9	2.9	4.9	10.5	4.0	4.3	4.5	2.7	11.5	2.2	5.0	7.6	5.7	12.9	5.0	2.0	3.6	30.8	21.1	4.5	6.3	2.1	9.7	4.3	1.0	2.3	3.2	5.4	9.0	1.3	6.4	3.5	12.1	25.2	8.4	3.2	5.8	4.1	8.1	4.4	2.0	4.6	0.3	41.8	4.2	1.1	10.4	24.5	0.0	0.2	0.0	2.9	0.0	1.7	0.4	0.0	3.6	5.0	11.2	4.9	0.3	0.1	9.4	1.0	2.8	1.2	0.0	0.0	0.0	3.5	6.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	8.4	0.5	3.2	0.0	0.0	3.7	0.0	0.0	0.0	1.9	0.0	0.0	7.7	0.1	0.0	0.0	0.1	0.1	0.0	18.8	0.1	0.0	12.1	8.3	1.8	1.8	0.0	0.6	0.0	0.0	17.7	4.4	0.1	12.3	0.0	0.0	0.0	0.0	1.5	0.0	8.7	0.0	2.9	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	3.7	4.3	2.9	4.9	5.0	2.0	6.3	2.1	5.4	4.6
ATP10A	"ATP10C, ATPVA, ATPVC, KIAA0566"	ENSG00000206190	"ATPase phospholipid transporting 10A (putative)"	O60312	15	25677273-25865172	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 12.8;fHDF/TERT166: 18.7;HMC-1: 12.5;RPTEC TERT1: 10.0;SK-MEL-30: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"dendritic cells: 3.0;NK-cells: 4.7;T-cells: 4.0"	"Low region specificity"	"Detected in all"							"HPA041496, HPA042509"	Uncertain									"HPA041496: , HPA042509: "	"unprognostic (3.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.18e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (6.60e-5)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.42e-2)"	7.4	14.1	5.3	5.4	9.8	4.7	5.7	3.4	11.0	5.3	3.3	6.2	1.4	1.5	1.9	2.1	3.7	3.1	7.1	2.9	8.0	5.8	6.0	1.0	12.2	14.8	9.3	9.0	1.6	1.9	1.9	2.5	3.6	11.3	3.6	2.3	4.0	14.4	1.5	0.7	3.3	3.6	5.3	6.4	3.5	4.0	6.0	6.2	1.5	3.0	1.6	3.3	4.2	3.3	0.0	3.0	0.0	0.3	4.7	4.0	1.7	0.0	3.3	0.6	0.0	2.7	2.5	0.0	12.8	6.2	3.9	6.9	0.0	0.0	0.0	0.7	18.7	0.0	6.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.6	0.0	0.5	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.9	0.7	2.3	2.3	0.8	10.0	0.0	0.0	0.0	0.0	0.0	16.9	5.1	0.5	0.0	5.2	0.2	7.5	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.3	0.0	1.9	0.2	1.9	0.0	2.2	2.1	0.4	0.0	4.0	3.7	0.0	4.7	0.1	3.0	0.7	1.7	5.3	9.8	3.4	11.0	8.0	5.8	9.3	9.0	11.3	6.2
ATP10B	"ATPVB, FLJ21477, KIAA0715"	ENSG00000118322	"ATPase phospholipid transporting 10B (putative)"	O94823	5	160563120-160852214	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.8;intestine: 35.4"	"Cell line enriched"	"Detected in single"	23	"WM-115: 17.4"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 19.0;pancreatic cancer: 4.2;stomach cancer: 8.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034574	Uncertain									"HPA034574: AB_10669992"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.47e-4)"	"unprognostic (3.99e-2)"	"unprognostic (6.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.38e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.14e-1)"	0.5	0.4	4.3	4.1	9.4	0.4	0.7	5.1	10.0	1.7	33.8	27.8	1.5	18.9	0.4	11.4	8.2	0.7	12.8	0.5	5.5	2.8	0.5	0.4	0.5	0.4	13.8	6.8	0.4	4.2	0.4	0.4	0.4	13.1	0.5	35.4	0.0	2.8	1.0	0.4	8.4	21.1	1.6	20.2	0.4	4.1	0.7	14.0	0.0	0.5	0.0	2.5	1.8	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.2	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	9.4	5.1	10.0	5.5	2.8	13.8	6.8	13.1	14.0
ATP10D	"ATPVD, KIAA1487"	ENSG00000145246	"ATPase phospholipid transporting 10D (putative)"	Q9P241	4	47485288-47593486	"Enzymes, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 55.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"basophil: 31.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 31.5"									HPA050808	Approved		Supported	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA050808: "	"unprognostic (1.62e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.43e-1)"	"prognostic favourable (5.00e-8)"	"unprognostic (3.97e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.37e-2)"	8.1	9.7	7.6	6.8	8.0	1.4	6.9	3.9	7.5	10.2	7.4	5.2	10.4	4.5	12.9	10.1	15.2	6.7	8.6	7.4	7.3	4.0	14.5	5.8	9.4	6.7	7.0	4.8	10.0	6.2	16.9	18.6	55.7	8.1	8.1	4.5	7.7	7.5	11.5	2.8	14.8	6.0	11.4	8.9	12.7	7.6	3.9	7.3	3.6	10.7	5.4	9.2	9.9	13.1	3.6	1.8	31.5	2.9	1.0	0.9	0.6	1.5	1.0	2.4	1.6	6.8	7.4	0.4	10.5	12.7	5.0	9.1	5.4	9.0	4.7	3.9	16.9	2.7	24.5	8.8	7.8	1.8	1.9	3.7	1.7	0.3	6.0	1.1	2.3	6.3	6.7	9.8	6.6	8.5	0.0	2.5	13.7	0.5	2.5	0.7	0.8	1.3	2.8	5.3	0.0	9.1	1.8	1.6	2.9	4.9	1.2	3.1	2.2	1.2	12.8	12.5	2.5	1.1	4.5	1.1	0.8	0.0	6.1	6.9	4.0	31.5	1.4	0.1	0.6	2.3	0.9	1.3	0.2	0.3	1.8	3.6	0.0	0.4	0.7	1.0	2.9	1.1	0.3	0.6	7.6	8.0	3.9	7.5	7.3	4.0	7.0	4.8	8.1	7.3
ATP13A4	"DKFZp761I1011, FLJ37958"	ENSG00000127249	"ATPase 13A4"	Q4VNC1	3	193402077-193593111	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 46.4;parathyroid gland: 52.5;thyroid gland: 51.2"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 9.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 23.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051932			Approved	Nucleoplasm				Nucleoplasm		"HPA051932: "	"unprognostic (4.97e-2)"	"unprognostic (1.50e-3)"	"unprognostic (4.86e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.72e-2)"	"prognostic favourable (3.91e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.00e-1)"	0.6	0.7	11.2	0.6	11.1	0.6	17.8	2.6	10.1	1.8	2.2	8.4	9.0	0.9	0.6	46.4	11.8	2.7	4.3	0.6	11.1	5.1	0.8	0.7	22.0	0.8	7.5	7.7	0.8	3.9	52.5	3.5	0.6	9.0	0.6	3.2	0.5	4.5	16.7	0.6	11.2	0.6	0.7	6.1	0.7	7.6	0.8	7.5	0.0	51.2	7.8	9.5	0.6	3.7	0.4	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.2	0.2	0.1	1.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	1.9	0.9	1.4	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	11.2	11.1	2.6	10.1	11.1	5.1	7.5	7.7	9.0	7.5
ATP13A5	FLJ16025	ENSG00000187527	"ATPase 13A5"	Q4VNC0	3	193274790-193378843	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"brain: 15.2;breast: 17.5;salivary gland: 28.9"	"Cell line enhanced"	"Detected in some"		"PC-3: 1.7;SK-BR-3: 5.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.3"	"Region enriched"	"Detected in many"	10	"pons and medulla: 15.2"	"Cell type enriched"	"Detected in single"	9	"neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA031771, HPA031774"	Uncertain									"HPA031771: , HPA031774: "	"unprognostic (7.98e-2)"	"unprognostic (3.01e-4)"		"unprognostic (2.06e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.93e-1)"		"unprognostic (1.67e-4)"	"unprognostic (3.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.14e-2)"		"unprognostic (1.73e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.10e-2)"		0.1	0.0	1.4	0.1	1.5	0.1	17.5	0.3	0.9	0.1	0.1	2.8	0.1	0.0	0.3	0.9	0.9	0.0	0.1	0.1	1.0	0.7	0.1	0.1	0.4	0.1	0.9	0.1	0.2	0.1	0.1	0.2	0.1	15.2	0.3	0.0	0.4	28.9	0.1	1.3	5.1	0.1	0.1	0.3	0.1	1.4	0.3	0.1	0.4	1.4	1.3	0.7	0.1	0.1	0.4	0.4	4.1	0.3	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.7	1.0	1.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.2	0.7	1.7	0.3	1.0	0.0	0.0	0.4	0.6	0.0	0.0	5.7	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.9	0.3	0.9	0.0	0.3	0.4	0.3	0.4	0.3	0.3	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.2	0.2	4.1	0.3	0.0	0.4	0.1	0.1	1.4	1.5	0.3	0.9	1.0	0.7	0.9	0.1	15.2	0.1
ATP4A	ATP6A	ENSG00000105675	"ATPase H+/K+ transporting alpha subunit"	P20648	19	35550043-35563658	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"stomach 1: 120.1"	"Cell line enhanced"	"Detected in some"		"THP-1: 1.1;U-138 MG: 1.5"	"Cancer enriched"	"Detected in single"	21	"stomach cancer: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA039154	Enhanced						790000			"HPA039154: AB_10672772"	"unprognostic (3.54e-2)"	"unprognostic (6.98e-3)"		"unprognostic (2.77e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-3)"		"unprognostic (4.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	0.1	0.2	0.1	0.1	0.6	0.0	0.1	0.1	0.6	0.1	0.1	3.4	0.1	0.0	0.1	0.1	4.9	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	2.1	0.1	0.1	120.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.1	0.0	1.5	0.3	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1
ATP5MC2	ATP5G2	ENSG00000135390	"ATP synthase membrane subunit c locus 2"	Q06055	12	53632726-53677408	"Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051469	Approved									"HPA051469: "	"unprognostic (1.48e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.65e-1)"	"unprognostic (8.42e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.45e-3)"	"unprognostic (3.78e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.41e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.09e-2)"	39.1	60.1	52.8	34.8	48.0	49.7	64.3	47.4	72.1	46.4	57.0	49.5	38.2	50.3	57.0	63.3	52.3	71.2	48.2	107.6	45.9	43.7	60.3	60.1	46.8	105.6	49.3	57.9	67.3	99.2	47.9	50.8	34.0	42.2	46.4	73.3	49.7	69.1	43.1	165.8	50.3	45.4	53.3	51.3	51.6	57.4	38.1	32.9	82.1	46.2	92.9	67.0	47.4	41.7	112.1	133.4	30.2	96.4	71.7	99.0	126.2	27.4	58.9	62.2	56.3	42.9	105.0	29.2	24.2	54.6	72.5	49.8	20.1	65.1	33.4	59.6	47.4	26.6	79.4	56.3	64.5	55.8	95.2	91.1	47.6	41.4	93.5	69.2	45.5	116.5	83.8	70.2	117.0	93.0	64.5	98.7	73.5	72.1	70.6	168.9	53.0	65.8	71.4	59.0	82.9	88.4	34.6	32.4	59.5	32.7	38.1	81.7	123.7	126.4	44.4	35.6	49.1	27.2	37.5	51.8	43.2	24.2	52.9	73.1	54.3	30.2	96.4	27.1	68.9	89.6	75.8	112.1	89.2	73.6	133.4	99.5	99.0	81.4	22.0	71.7	79.5	103.0	92.7	126.2	52.8	48.0	47.4	72.1	45.9	43.7	49.3	57.9	42.2	32.9
ATP6AP1L		ENSG00000205464	"ATPase H+ transporting accessory protein 1 like"	Q52LC2	5	82279462-82386977	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"MOLT-4: 15.3"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	8	"dendritic cells: 1.3;NK-cells: 1.5;T-cells: 1.2"									HPA053771	Approved		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA053771: "	"unprognostic (1.64e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.43e-2)"	1.6	1.0	2.6	0.2	2.4	0.6	0.7	2.5	2.1	1.8	1.2			0.1	1.5	0.1	1.4	2.4	1.7	2.0	2.7	1.8	0.8	1.4	1.5	0.7	2.5		4.4	2.4	0.1	2.0	0.7		1.4	0.6		2.6	2.5	3.3	5.1	0.2	0.6	2.7	0.8	1.8	3.8			1.5		0.4	0.9	0.5	0.1	1.3	0.0	0.1	1.5	1.2	0.0	0.1	0.0	0.1	1.0	0.6	0.3	0.0	0.1	0.3	0.4	0.9	0.1	0.0	0.0	0.0	0.8	0.0	0.3	2.8	0.0	1.2	0.6	0.5	0.2	0.3	2.2	0.2	0.0	2.0	1.1	0.0	2.6	0.5	0.7	1.2	0.0	0.2	15.3	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.4	0.2	0.4	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.2	0.1	0.7	1.2	0.0	1.5	0.0	1.3	0.0	0.0										
ATP6V0B	"ATP6F, HATPL, VMA16"	ENSG00000117410	"ATPase H+ transporting V0 subunit b"	Q99437	1	43974487-43978295	"Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 173.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 173.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 58.0;granulocytes: 173.6;monocytes: 78.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044281			Approved	Cytosol				Cytosol		"HPA044281: "	"unprognostic (1.38e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.69e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavourable (4.79e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.23e-2)"	"prognostic favourable (3.24e-4)"	"unprognostic (6.13e-2)"	"prognostic favourable (3.62e-6)"	"unprognostic (5.55e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (8.87e-4)"	20.4	35.7	35.4	21.8	35.3	84.2	28.5	29.1	56.4	23.3	28.3	32.2	26.7	19.2	13.9	35.6	21.9	20.0	22.0	24.8	41.2	44.7	47.6	56.3	25.8	28.5	43.6	31.5	12.9	87.0	32.5	36.3	35.0	33.9	27.0	32.0	32.4	34.8	22.2	27.9	20.1	20.2	19.1	34.8	33.2	25.2	15.3	24.8	16.3	38.7	19.5	24.7	23.2	16.5	23.7	58.0	173.6	78.0	8.8	14.2	87.6	23.3	22.8	18.9	23.8	29.2	15.4	23.2	21.0	31.3	40.9	35.4	24.5	25.6	21.7	19.5	22.2	19.4	44.3	31.7	19.3	20.3	46.1	27.2	39.4	35.2	46.3	42.2	52.8	19.0	41.8	45.0	40.0	19.7	27.0	47.7	33.5	24.7	17.4	70.3	31.3	48.8	24.7	18.2	59.2	42.5	28.9	44.7	22.1	14.2	56.1	52.7	23.0	76.0	9.9	21.1	18.0	38.0	50.6	38.6	56.8	24.0	28.7	60.2	33.0	31.9	78.0	64.2	13.2	48.1	13.0	23.7	14.2	12.7	48.1	19.1	10.8	10.9	173.6	8.8	44.0	58.0	13.7	87.6	35.4	35.3	29.1	56.4	41.2	44.7	43.6	31.5	33.9	24.8
ATP6V0D2	"ATP6D2, FLJ38708, VMA6"	ENSG00000147614	"ATPase H+ transporting V0 subunit d2"	Q8N8Y2	8	85987323-86154228	"Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 56.8"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 6.2;U-87 MG: 9.5"	"Cancer enriched"	"Detected in many"	9	"renal cancer: 36.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055327, HPA058496"	Enhanced		Approved	Vesicles				Vesicles		"HPA055327: , HPA058496: "	"unprognostic (3.79e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.36e-5)"	"unprognostic (4.02e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-1)"	"prognostic favourable (2.20e-6)"	"unprognostic (8.58e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	6.6	0.3	0.2	1.3	0.3	0.8	0.3	0.2	0.2	0.2	1.5	0.0	11.9	0.7	0.2	1.0	0.2	0.2	0.1	0.2	0.3	0.3	56.8	0.3	12.2	1.2	0.5	0.0	0.8	0.2	0.3	0.2	0.2	0.0	0.8	2.0	5.7	1.1	1.2	0.2	0.9	1.0	0.0	0.3	0.4	0.3	0.2	0.0	1.0	0.4	0.3	0.6	0.3	0.2	2.2	1.7	4.6	1.0	2.0	1.5	0.3	0.6	1.3	0.7	0.8	0.0	0.6	2.5	0.0	0.0	1.1	0.3	0.3	0.4	0.4	0.3	0.1	2.8	0.8	1.8	0.5	0.4	0.1	0.9	1.8	0.2	0.0	0.8	1.5	0.6	0.1	1.0	0.8	0.5	0.5	0.8	0.5	1.0	0.0	0.8	0.3	0.2	0.2	0.3	0.3	0.0	1.2	3.8	0.3	0.1	0.9	6.2	2.0	0.1	0.3	0.7	0.9	0.8	0.5	0.5	0.2	0.7	9.5	0.7	0.8	2.6	1.0	0.8	1.1	0.5	0.8	1.2	1.0	0.9	0.5	2.2	1.5	1.3	4.6	2.0	1.0	1.7	0.9	0.3	0.2	0.3	0.2	0.2	0.3	0.3	0.5	0.0	0.0	0.0
ATP6V1G3	"ATP6G3, Vma10"	ENSG00000151418	"ATPase H+ transporting V1 subunit G3"	Q96LB4	1	198523222-198540945	"Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"ductus deferens: 16.9;kidney: 33.4"	"Cell line enhanced"	"Detected in some"		"BJ: 2.8;BJ hTERT+: 1.7;fHDF/TERT166: 6.8;TIME: 1.5;U-2197: 2.1"	"Cancer enriched"	"Detected in single"	140	"renal cancer: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028701	Enhanced									"HPA028701: AB_10611681"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.8	1.7	1.2	0.4	0.0	0.0	0.0	0.6	6.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.3	0.0	0.0	0.1	0.0	1.5	0.1	1.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP9B	ATPIIB	ENSG00000166377	"ATPase phospholipid transporting 9B (putative)"	O43861	18	79069285-79378287	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029364	Approved									"HPA029364: AB_10602595"	"unprognostic (2.84e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.51e-3)"	"unprognostic (7.32e-2)"	"unprognostic (7.66e-4)"	"unprognostic (2.45e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.09e-2)"	14.5	11.0	11.7	16.8	11.6	30.1	11.7	16.8	15.2	14.3	10.7	17.5	15.2	7.1	21.8	17.6	11.3	11.9	14.5	10.7	11.4	8.2	13.1	16.7	13.9	13.2	10.8	9.7	18.2	14.3	25.8	15.5	10.9	11.3	12.8	11.4	12.3	14.2	17.3	18.8	13.3	9.1	14.8	17.1	9.7	11.5	22.1	12.4	19.3	14.6	9.6	16.4	14.6	13.3	9.8	8.4	14.2	16.3	8.6	12.2	6.9	15.4	8.1	11.3	12.5	5.9	9.9	8.8	8.3	5.6	5.0	4.2	8.7	11.0	8.6	13.9	6.0	7.0	9.3	4.6	8.1	13.2	3.9	10.1	9.3	6.1	7.8	18.4	10.9	7.9	5.9	8.1	5.0	6.9	9.7	21.8	7.0	13.5	12.0	7.2	16.1	10.1	11.5	9.4	11.5	7.1	13.4	8.4	8.8	9.3	9.8	5.7	11.5	11.0	12.1	10.5	17.1	4.7	5.5	10.9	17.8	19.4	6.1	12.2	10.8	14.2	12.0	9.1	8.4	10.1	9.8	9.0	9.6	8.1	8.4	9.8	12.2	9.5	13.0	8.6	16.3	8.0	7.4	6.9	11.7	11.6	16.8	15.2	11.4	8.2	10.8	9.7	11.3	12.4
ATRNL1	"ALP, FLJ45344, KIAA0534"	ENSG00000107518	"Attractin like 1"	Q5VV63	10	115093365-115948992	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.4;LHCN-M2: 9.3;RH-30: 13.7;SH-SY5Y: 9.8;U-266/70: 11.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"memory B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038070	Uncertain		Approved	Nucleoplasm,Mitochondria			33000000	"Nucleoplasm, Mitochondria"		"HPA038070: AB_10697237"	"unprognostic (3.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.08e-3)"	0.9	11.7	8.6	0.7	15.9	0.3	2.1	2.2	26.0	0.9	2.3	2.1	1.1	0.8	12.0	1.1	1.5	1.0	0.8	2.9	9.3	5.8	4.8	2.9	0.6	1.0	4.0	15.7	17.5	2.3	0.3	11.1	3.3	8.4	6.9	0.9	2.0	1.8	8.3	3.8	0.6	1.0	13.4	2.0	0.8	0.9	13.0	2.5	0.0	2.0	0.0	0.9	1.1	1.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.2	20.4	0.0	0.0	0.0	0.1	0.4	3.0	4.4	0.1	0.1	0.0	1.4	0.5	0.0	1.1	0.0	3.5	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	6.9	9.3	0.2	8.0	0.0	6.6	0.1	5.9	13.7	8.8	3.1	0.0	3.4	9.8	0.0	0.0	0.2	1.2	0.0	0.0	0.0	2.5	0.0	2.9	11.3	0.0	3.3	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	15.9	2.2	26.0	9.3	5.8	4.0	15.7	8.4	2.5
AVPR1B	AVPR3	ENSG00000198049	"Arginine vasopressin receptor 1B"	P47901	1	206109692-206117699	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	23	"pituitary gland: 52.8"	"Cell line enhanced"	"Detected in single"		"PC-3: 3.5"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075404	Enhanced									"HPA075404: "		"unprognostic (4.87e-2)"		"unprognostic (1.44e-1)"	"unprognostic (4.82e-1)"			"unprognostic (2.82e-1)"		"unprognostic (2.87e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.66e-3)"	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.6	0.5	0.1	1.3	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	52.8	0.1	0.1	0.2	0.8	0.0	0.0	0.4	0.0	0.0	1.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.9	3.5	0.0	0.0	0.2	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0
AXDND1	"C1orf125, FLJ32940"	ENSG00000162779	"Axonemal dynein light chain domain containing 1"	Q5T1B0	1	179365720-179554735	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 18.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;HBF TERT88: 1.8;SH-SY5Y: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071114	Enhanced									"HPA071114: "	"unprognostic (1.67e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.78e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.99e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.48e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.25e-1)"	0.0	0.5	0.1	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.3	0.2	0.0	0.0	0.0	2.1	0.0	0.3	0.2	0.0	0.1	0.1	0.7	0.0	0.3	0.0	0.0	0.6	0.0	0.1	0.1	0.3	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.1	1.7	1.2	0.3	18.0	0.0	0.0	0.6	0.0	0.3	0.3	0.0	0.2	0.0	2.1	0.4	0.0	0.6	0.0	0.4	0.0	0.0	0.9	0.0	0.0	2.8	0.9	0.3	0.9	0.2	0.0	0.9	0.3	0.1	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	1.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.1	1.2	0.6	0.0	0.0	0.3	1.7	0.0	0.0	0.2	0.7	0.0	0.2	0.7	0.5	0.0	0.1	1.0	1.4	0.0	0.8	0.0	0.3	0.0	0.3	0.0	0.2	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.0	0.8	0.1	0.1	0.0	0.6	0.5	0.0
B3GALT5	"B3GalT-V, B3T5, beta3Gal-T5, GLCT5"	ENSG00000183778	"Beta-1,3-galactosyltransferase 5"	Q9Y2C3	21	39556442-39673137	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.8;intestine: 27.1;lymphoid tissue: 14.8"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 18.1;RPTEC TERT1: 21.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"basal ganglia: 15.8"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054092, HPA054684"	Approved				"Intracellular and membrane"					"HPA054092: , HPA054684: "	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"prognostic favourable (6.36e-4)"	"unprognostic (9.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (7.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	0.1	0.3	0.5	3.1	15.8	0.1	1.8	0.3	1.5	3.0	16.2	0.6	0.0	19.4	1.4	1.6	2.3	1.0	12.9	0.2	1.3	1.5	0.6	0.3	0.2	0.1	0.7	0.1	0.7	6.2	0.1	7.9	0.7	2.2	1.0	27.1	2.2	5.5	0.1	0.2	1.1	23.4	0.7	2.0	0.2	3.8	0.6	3.6	1.8	1.1	0.8	14.8	1.1	5.9	0.2	0.2	1.0	0.2	0.3	0.2	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	18.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	4.9	0.5	0.0	2.1	0.1	21.5	1.3	3.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.1	0.8	0.0	0.0	0.0	0.9	0.0	0.2	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.0	0.3	0.0	0.2	0.0	0.0	0.5	15.8	0.3	1.5	1.3	1.5	0.7	0.1	2.2	3.6
B3GNT7	beta3GnT7	ENSG00000156966	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7"	Q8NFL0	2	231395543-231401164	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 93.7;intestine: 41.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 14.9;HEL: 11.7;THP-1: 10.4;WM-115: 18.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA035625, HPA035626"	Enhanced				"Intracellular and membrane"		2100000			"HPA035625: AB_10601118, HPA035626: "	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.77e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.18e-1)"	"prognostic favourable (6.00e-4)"	"unprognostic (3.57e-1)"	3.0	10.3	5.3	2.3	4.9	5.5	1.9	0.9	3.2	1.2	28.0	3.8	0.8	12.2	1.6	3.5	1.9	3.6	93.7	26.8	4.2	4.4	1.4	1.3	17.7	1.8	4.0	2.0	13.0	18.9	6.7	8.9	10.7	3.2	1.6	35.5	2.0	4.0	2.3	0.4	2.4	41.2	1.1	1.9	6.7	17.1	1.6	2.2	1.2	4.2	1.7	3.9	1.2	0.6	7.1	4.2	0.4	0.3	19.9	2.0	0.5	0.5	2.1	0.2	0.4	0.1	0.2	0.7	0.2	0.8	0.0	0.1	1.0	14.9	1.6	4.5	0.2	3.8	0.2	0.0	0.1	0.2	0.4	11.7	0.3	0.7	0.1	0.1	0.6	0.1	1.1	0.1	0.2	0.2	0.3	0.3	0.1	0.6	0.1	0.5	4.8	2.5	0.2	0.0	0.2	0.5	1.3	0.4	0.6	0.2	1.3	0.5	0.5	10.4	0.2	0.3	0.3	0.2	0.1	1.8	0.6	0.5	0.3	0.1	18.0	0.3	0.0	0.4	2.0	0.3	0.4	7.1	0.0	0.2	4.2	5.1	0.1	0.5	0.1	19.9	0.3	2.1	0.1	0.5	5.3	4.9	0.9	3.2	4.2	4.4	4.0	2.0	3.2	2.2
B3GNT9	MGC4655	ENSG00000237172	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9"	Q6UX72	16	67148105-67151214	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 24.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.5;T-cells: 1.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA052743, HPA062734"	Approved		Approved	"Nucleoli fibrillar center,Golgi apparatus"	"Intracellular and membrane"			"Golgi apparatus"	"Nucleoli fibrillar center"	"HPA052743: , HPA062734: "	"unprognostic (2.56e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.56e-3)"	5.6	7.3	5.0	5.2	7.1	0.6	7.2	0.9	8.8	12.6	5.7	12.4	12.6	3.5	11.7	11.3	6.6	11.4	11.4	11.4	6.0	3.9	7.0	5.0	7.3	4.6	12.2	5.3	20.6	3.1	34.7	17.9	7.9	5.5	12.0	3.6	16.6	8.9	15.9	2.1	4.7	4.4	8.0	5.3	5.0	6.1	9.7	7.1	0.8	25.2	4.6	3.9	8.6	7.9	0.1	1.5	0.2	0.1	0.0	1.9	0.1	2.2	4.1	0.3	0.4	13.5	14.0	0.5	10.6	17.2	6.9	9.0	1.9	0.4	0.3	0.7	16.3	5.2	0.1	0.5	3.8	3.5	1.5	0.3	4.6	1.7	11.0	0.2	0.2	11.6	4.0	6.7	0.2	0.9	0.4	1.3	10.7	1.3	1.2	0.6	2.5	3.7	3.4	6.2	2.0	1.0	2.8	2.4	5.3	24.0	0.1	0.3	0.6	1.8	2.1	12.4	0.5	12.4	4.7	1.6	1.1	0.4	15.5	0.6	6.0	0.0	0.1	0.2	0.9	0.0	1.1	0.1	1.9	1.6	0.2	0.0	0.4	0.2	0.0	0.0	0.0	1.5	0.6	0.1	5.0	7.1	0.9	8.8	6.0	3.9	12.2	5.3	5.5	7.1
B3GNTL1	B3GNT8	ENSG00000175711	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1"	Q67FW5	17	82942155-83051810	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.6;HL-60: 18.3;THP-1: 17.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023585, HPA024547"	Supported		Approved	Nucleoli				Nucleoli		"HPA023585: AB_2061075, HPA024547: AB_1845240"	"unprognostic (1.51e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.61e-7)"	"unprognostic (9.95e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.80e-2)"	"unprognostic (4.17e-9)"	"unprognostic (2.02e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.39e-3)"	3.7	4.3	6.5	7.2	13.9	17.7	4.0	6.4	10.7	4.7	3.6	4.2	1.7	4.7	6.3	6.1	3.7	8.3	3.9	6.2	6.9	4.7	2.9	3.4	4.4	5.6	3.8	7.1	6.6	7.6	1.7	6.1	3.9	7.1	4.6	2.8	3.7	5.6	4.5	5.0	4.4	3.3	5.1	4.4	6.6	4.9	4.0	3.7	6.9	4.4	4.8	3.3	4.3	3.8	3.7	8.8	16.9	5.7	2.4	11.2	3.3	8.1	5.4	0.1	2.6	1.5	4.9	3.4	3.0	2.6	3.4	2.7	3.2	17.6	4.0	5.8	3.6	1.5	1.3	0.0	3.0	6.1	3.6	8.4	8.0	10.9	5.5	18.3	0.3	1.7	1.5	2.1	3.4	4.1	3.6	3.8	2.7	1.8	5.1	7.0	1.3	4.0	6.7	0.6	0.3	1.9	1.7	1.7	0.6	2.5	1.9	2.5	0.0	17.6	6.8	6.7	4.5	0.9	5.2	0.8	1.9	3.0	7.4	2.4	0.9	2.6	5.7	0.9	2.7	5.0	4.1	2.8	4.3	3.0	8.8	3.7	3.8	4.6	16.9	2.4	2.5	3.5	11.2	3.3	6.5	13.9	6.4	10.7	6.9	4.7	3.8	7.1	7.1	3.7
BAALC		ENSG00000164929	"BAALC, MAP3K1 and KLF4 binding"	Q8WXS3	8	103140710-103230305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 121.3"	"Cell line enhanced"	"Detected in some"		"AF22: 24.4;BJ hTERT+: 8.5;SCLC-21H: 13.3;SH-SY5Y: 9.8;U-87 MG: 36.2"	"Cancer enriched"	"Detected in many"	8	"glioma: 139.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"NK-cell: 6.9"	"Lineage enriched"	"Detected in single"	25	"NK-cells: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027132, HPA068307"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA027132: AB_10600985, HPA068307: "	"unprognostic (1.68e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.62e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.27e-3)"	7.8	11.1	42.3	3.2	51.9	3.9	3.0	12.5	121.3	2.8	2.9	18.9	0.0	2.3	3.0	2.0	2.2	4.6	2.9	3.2	38.1	34.5	2.8	3.4	4.9	2.6	48.3	25.1	2.7	2.6	1.9	5.2	5.7	41.4	2.0	2.9	0.0	2.1	2.4	3.0	2.7	2.8	3.1	51.2	8.8	2.4	2.6	24.6	0.0	2.8	0.0	2.2	2.8	0.3	0.2	0.1	0.0	0.0	6.9	0.1	0.4	0.2	1.4	24.4	0.2	0.2	7.3	0.0	1.2	8.5	0.0	0.1	0.2	0.0	0.1	0.2	4.6	0.4	0.4	0.0	0.0	0.0	1.4	0.2	0.3	0.0	0.5	0.0	0.5	1.4	1.4	0.3	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.6	0.4	0.1	0.1	0.5	0.0	0.0	13.3	9.8	0.2	0.0	0.0	0.1	0.1	1.4	7.7	0.5	0.2	0.5	0.0	0.1	0.1	36.2	0.1	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.9	0.0	0.1	0.0	0.4	42.3	51.9	12.5	43.6	38.1	34.5	48.3	25.1	41.4	24.6
BARHL1		ENSG00000125492	"BarH like homeobox 1"	Q9BZE3	9	132582185-132590266	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	44	"brain: 40.1"	"Cell line enriched"	"Detected in single"	105	"SCLC-21H: 19.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"cerebellum: 23.8;pons and medulla: 40.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebellum: 3.6;midbrain: 2.9;pons and medulla: 1.1"	"Region enhanced"	"Detected in many"		"cerebellum: 16.3"	HPA004809	Enhanced									"HPA004809: AB_1078266"					"unprognostic (2.29e-1)"					"unprognostic (6.42e-2)"	"unprognostic (8.07e-2)"			"unprognostic (9.31e-2)"				0.3	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.5	0.3	0.0	0.0	0.0	2.2	0.0	0.2	0.9	0.0	0.0	0.0	40.1	0.1	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.9	0.0	0.5	2.2	0.0	40.1	0.0
BBC3	"JFY1, PUMA"	ENSG00000105327	"BCL2 binding component 3"	"Q96PG8, Q9BXH1"	19	47220822-47232766	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 18.6;NB-4: 21.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 6.1;neutrophil: 6.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.4"									"CAB007752, HPA070403"	Approved		Approved	Cytosol				Cytosol		"CAB007752: AB_562336, HPA070403: "	"unprognostic (4.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (1.31e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.38e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.66e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.57e-1)"	"prognostic favourable (2.62e-5)"	6.8	5.4	4.0	4.7	2.9	9.4	6.5	14.0	7.2	6.3	8.9	1.4	2.3	5.9	5.4	3.7	8.2	5.0	8.0	5.8	4.9	3.9	4.6	5.9	19.0	11.8	3.6	4.3	5.2	11.8	1.6	2.5	5.6	3.4	9.8	4.9	4.5	9.2	4.2	28.6	9.4	6.6	5.7	2.8	7.4	7.9	3.2	3.0	13.3	6.2	1.7	3.2	8.2	3.0	0.2	0.4	6.4	1.0	1.0	1.1	0.3	2.3	5.2	5.7	1.2	1.4	2.7	14.1	3.7	5.1	0.9	2.3	1.5	3.9	9.1	1.6	0.9	0.7	0.8	3.3	0.1	5.8	10.1	2.6	1.8	10.0	18.6	0.4	8.6	6.4	5.4	1.9	1.8	6.5	6.6	5.7	0.6	5.2	0.9	21.3	3.6	0.7	2.5	0.8	10.5	0.2	0.8	0.9	8.7	1.7	3.6	11.2	1.2	7.2	4.3	1.1	7.2	0.1	1.2	9.4	2.0	5.7	1.7	1.3	3.9	6.1	0.9	0.5	0.9	1.0	0.8	0.2	0.2	0.6	0.4	0.0	1.1	0.7	6.4	1.0	0.8	0.1	0.5	0.3	4.0	2.9	14.0	5.7	4.9	3.9	3.6	4.3	3.4	3.0
BBOF1	"C14orf45, CCDC176"	ENSG00000119636	"Basal body orientation factor 1"	Q8ND07	14	74019353-74082863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.7"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003090, HPA003136, HPA075108"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"				"Nucleoplasm, Plasma membrane"	"Centriolar satellite"	"HPA003090: AB_1845571, HPA003136: AB_1078330, HPA075108: "	"unprognostic (1.84e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.71e-2)"	"prognostic favourable (6.34e-4)"	"unprognostic (1.11e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.40e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.93e-2)"	"unprognostic (6.04e-3)"	5.3	3.5	9.4	4.1	12.5	6.0	8.4	4.3	12.5	7.7	6.5	4.4	8.5	2.5	8.2	16.4	6.1	24.1	6.6	4.8	11.5	8.2	10.6	2.8	7.6	2.2	7.3	9.2	5.8	3.2	6.1	17.4	3.0	22.3	6.4	4.2	5.8	4.4	8.9	5.3	3.7	2.7	7.7	13.8	1.8	3.9	37.7	6.7	2.5	14.5	2.6	2.6	7.0	3.4	1.5	5.0	2.4	0.1	2.1	4.2	3.0	4.8	2.8	1.2	8.0	5.4	12.0	1.0	4.2	6.0	4.3	4.1	1.0	3.3	4.7	1.2	5.1	1.2	1.6	0.7	4.9	0.7	0.9	0.5	2.7	1.0	4.6	2.3	0.3	5.7	4.0	9.6	1.2	1.5	2.5	0.9	3.1	3.8	7.4	1.2	0.4	2.0	2.7	3.1	0.8	7.4	1.2	4.9	3.1	8.2	3.3	2.2	8.5	0.2	3.5	5.3	3.8	7.1	1.2	1.8	4.2	2.9	15.7	0.3	1.5	2.4	0.1	0.2	3.4	0.0	4.0	1.3	3.2	2.2	0.2	1.5	4.2	3.4	2.4	2.1	0.0	5.0	0.6	3.0	9.4	12.5	4.3	12.5	11.5	8.2	7.3	9.2	22.3	6.7
BCL6B	"BAZF, ZBTB28, ZNF62"	ENSG00000161940	"B cell CLL/lymphoma 6B"	Q8N143	17	7023020-7030290	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 7.7;HMC-1: 23.5;HUVEC TERT2: 41.7;TIME: 16.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059147, HPA075112"	Uncertain		Approved	Vesicles				Vesicles		"HPA059147: , HPA075112: "	"unprognostic (5.61e-2)"	"unprognostic (9.43e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.40e-1)"	"prognostic favourable (8.56e-5)"	"unprognostic (2.81e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (4.04e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.26e-2)"	23.9	4.0	2.5	4.4	3.4	0.0	11.5	2.0	4.1	5.2	3.9	2.3	1.2	2.5	9.7	3.9	4.0	4.2	10.8	12.7	2.4	2.4	6.0	6.1	26.2	5.2	3.4	0.8	7.4	3.0	2.4	4.7	15.9	4.9	6.8	1.8	4.5	4.6	2.9	8.6	3.5	4.0	6.3	2.9	17.9	3.4	2.3	2.4	0.5	10.0	8.2	2.5	6.6	28.6	1.1	0.6	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.2	0.0	23.5	0.0	0.0	0.0	0.0	41.7	1.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	16.4	0.3	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	3.4	2.0	4.1	2.4	2.4	3.4	0.8	4.9	2.4
BEAN1	SCA31	ENSG00000166546	"Brain expressed associated with NEDD4 1"	Q3B7T3	16	66427297-66493529	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 9.5;BEWO: 4.8;RPTEC TERT1: 8.4;U-87 MG: 5.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"eosinophil: 1.9;neutrophil: 5.2;plasmacytoid DC: 2.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.4;granulocytes: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053851	Uncertain		Uncertain	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA053851: "	"unprognostic (1.92e-1)"	"unprognostic (5.79e-4)"	"unprognostic (3.83e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.01e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.18e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-2)"	1.2	1.2	2.9	1.1	2.5	2.9	1.2	6.9	9.6	1.2	0.7	0.1	0.0	0.6	1.2	1.9	1.8	1.9	1.4	3.0	4.6	4.1	0.9	1.1	1.4	0.9	2.3	3.2	1.4	1.9	0.1	0.4	4.5	11.6	1.0	0.9	5.0	1.9	0.4	3.6	3.2	0.8	0.8	1.7	1.2	1.2	3.1	0.2	0.0	1.9	3.1	0.9	1.0	1.0	0.3	2.4	5.2	0.5	0.4	0.2	0.1	0.8	0.9	1.0	9.5	0.3	0.1	4.8	0.3	0.0	0.1	0.1	0.0	1.0	0.1	0.5	0.3	0.2	0.1	0.1	0.3	0.0	0.6	0.0	0.2	0.7	0.7	0.1	0.0	0.7	1.9	0.6	0.3	0.0	0.1	0.3	0.2	0.5	0.0	0.4	0.3	0.5	0.1	0.2	0.5	8.4	0.6	0.1	0.2	0.2	0.2	1.4	0.2	0.1	0.3	0.4	2.6	0.1	0.4	0.5	0.1	0.1	5.5	0.2	1.3	0.4	0.5	1.9	0.2	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.2	0.1	5.2	0.4	0.2	2.4	0.1	0.1	2.9	2.5	6.9	9.6	4.6	4.1	2.3	3.2	11.6	0.2
BEND2	"CXorf20, MGC33653"	ENSG00000177324	"BEN domain containing 2"	Q8NDZ0	X	18162931-18220883	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 23.2"	"Cell line enhanced"	"Detected in single"		"HeLa: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 4.1;neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.1"									"HPA009420, HPA013142"	Enhanced									"HPA009420: AB_2064489, HPA013142: AB_2668784"														"unprognostic (2.23e-2)"	"unprognostic (1.17e-1)"			0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	4.1	0.4	0.4	0.4	5.1	0.4	0.2	0.4	0.8	0.0	0.1	0.4	0.5	0.0	0.0	0.2	0.5	0.2	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.4	1.5	0.2	0.1	0.5	0.5	0.0	0.0	0.1	0.2	0.0	0.5	0.8	0.3	0.5	0.1	0.5	0.4	0.3	0.2	0.3	0.7	0.0	0.4	0.4	0.0	0.2	0.3	0.4	0.2	0.1	0.8	0.4	0.2	0.4	0.1	0.8	0.2	0.8	0.2	0.7	0.4	4.1	0.4	0.1	0.3	0.1	0.1	0.2	0.2	0.2	0.1	0.4	0.3	0.4	1.8	0.4	0.1	0.3	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BEND4	"CCDC4, FLJ35632, FLJ43965"	ENSG00000188848	"BEN domain containing 4"	Q6ZU67	4	42110938-42152878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 26.7"	"Cell line enhanced"	"Detected in some"		"HAP1: 24.1;HEK 293: 5.8;HEL: 14.7;MOLT-4: 9.0;U-698: 9.6"	"Group enriched"	"Detected in some"	43	"prostate cancer: 6.3;testis cancer: 5.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"memory B-cell: 1.1;naive B-cell: 3.3"	"Lineage enriched"	"Detected in single"	12	"B-cells: 3.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA036850	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA036850: AB_10600787"	"unprognostic (3.62e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.82e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.24e-1)"	0.4	0.3	3.9	5.0	1.0	1.6	0.3	0.2	2.6	0.2	0.6	0.0	0.0	0.5	0.4	0.2	0.3	0.2	0.4	0.3	2.8	1.9	0.3	0.5	1.0	3.7	2.8	1.1	0.6	0.3	0.1	3.8	0.8	1.8	6.4	0.7	0.2	0.8	0.2	0.2	0.2	2.8	0.4	0.4	4.8	0.5	26.7	0.3	4.8	0.3	0.0	3.0	0.7	2.3	3.3	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	24.1	0.0	0.0	0.0	5.8	14.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	4.4	1.3	0.0	0.0	0.0	0.0	0.0	3.4	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	3.9	1.0	0.2	2.6	2.8	1.9	2.8	1.1	1.8	0.3
BEST2	"FLJ20132, VMD2L1"	ENSG00000039987	"Bestrophin 2"	Q8NFU1	19	12751702-12758458	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 25.2;retina: 28.7;skin 1: 11.7"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 3.5"	HPA046229	Approved									"HPA046229: AB_10966140"	"unprognostic (3.19e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.02e-3)"		"unprognostic (2.77e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.46e-3)"	"unprognostic (9.18e-6)"	"unprognostic (3.45e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-5)"	0.2	0.1	0.2	4.1	0.2	1.8	0.3	0.2	1.3	0.4	25.2	0.2	0.2	0.0	0.2	0.7	0.2	0.2	0.3	0.2	0.2	0.1	0.2	0.2	0.2	2.2	0.2	0.2	0.4	0.2	0.4	0.2	0.2	0.2	0.2	12.8	28.7	0.6	0.2	0.2	11.7	11.5	0.5	0.2	0.2	0.1	0.3	0.2	0.2	0.4	1.5	5.2	0.2	1.0	3.1	2.7	2.2	0.8	1.7	2.1	1.2	0.9	0.7	2.3	3.5	0.0	0.4	1.6	1.0	0.0	0.5	0.7	2.6	3.6	2.9	0.9	1.2	1.8	0.0	0.5	0.6	3.3	1.5	2.4	3.2	0.9	0.4	1.1	5.1	0.5	0.3	0.4	0.3	0.3	0.6	1.5	0.5	3.0	0.8	1.9	3.0	2.6	0.4	1.3	0.5	1.0	1.2	1.9	1.9	1.5	0.7	0.6	1.8	0.9	2.6	0.9	1.0	1.6	2.1	0.9	1.3	1.1	1.3	2.7	1.8	1.7	0.5	0.4	1.4	0.8	1.1	2.2	1.0	0.8	0.2	3.1	2.1	2.1	2.2	1.7	0.5	2.7	0.7	1.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
BEST3	"MGC13168, MGC40411, VMD2L3"	ENSG00000127325	"Bestrophin 3"	Q8N1M1	12	69643360-69699476	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 125.0"	"Group enriched"	"Detected in some"	16	"REH: 18.3;RPMI-8226: 19.6;U-698: 32.7"	"Cancer enriched"	"Detected in single"	9	"glioma: 2.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054582	Approved									"HPA054582: "	"unprognostic (1.53e-1)"	"unprognostic (7.00e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.26e-3)"		"unprognostic (7.30e-7)"	"unprognostic (1.81e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.47e-2)"		"unprognostic (3.03e-1)"	1.6	0.5	1.7	0.1	1.9	2.4	0.6	6.3	9.3	0.2	0.2	0.9	0.0	0.2	0.2	2.4	1.7	0.1	0.2	0.4	1.8	0.7	0.4	0.3	0.1	0.2	1.8	0.6	0.2	1.0	0.1	0.7	0.3	1.2	1.7	0.2	0.1	1.9	0.1	125.0	0.9	0.1	0.1	1.9	0.1	0.1	2.5	1.0	0.5	0.2	21.9	0.7	0.1	0.0	1.2	0.9	1.7	0.5	0.6	1.0	0.7	0.1	0.2	0.7	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.4	0.1	0.2	1.3	0.3	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.5	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.6	0.1	0.2	0.2	0.0	0.8	0.1	0.0	0.0	0.7	0.3	18.3	0.6	19.6	0.9	0.1	0.4	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.5	0.1	0.7	0.1	0.2	32.7	1.4	0.0	0.1	0.3	0.5	0.3	0.5	0.4	0.8	1.2	1.0	0.7	0.3	0.8	1.0	1.0	1.7	0.6	0.4	0.9	0.4	0.7	1.7	1.9	6.3	1.5	1.8	0.7	1.8	0.6	1.2	1.0
BEST4	VMD2L2	ENSG00000142959	"Bestrophin 4"	Q8NFU0	1	44783585-44787705	"Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 34.3"	"Cell line enhanced"	"Detected in some"		"Hep G2: 7.3;U-698: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA058564	Uncertain									"HPA058564: "	"unprognostic (5.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-2)"	"unprognostic (6.51e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.97e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.13e-3)"	0.5	1.1	0.6	1.4	2.5	0.4	0.5	2.1	0.7	1.2	32.7	0.5	0.5	8.8	0.7	2.6	0.5	7.2	0.5	0.5	1.0	3.2	0.5	0.5	1.1	0.5	0.5	0.5	0.5	0.5	0.4	1.8	0.5	0.5	0.5	15.9	0.5	0.5	0.5	0.5	1.8	34.3	0.5	0.5	0.5	0.2	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	3.0	0.9	0.7	0.1	0.9	2.8	0.4	0.2	0.6	1.1	1.2	0.4	0.4	3.4	0.8	0.4	0.3	0.1	0.4	1.5	0.3	1.5	0.4	1.6	0.2	0.2	0.4	0.7	0.7	0.2	1.8	7.3	0.4	0.0	0.9	0.7	0.9	0.4	0.7	1.0	0.2	0.6	0.2	0.2	0.0	0.5	2.4	0.2	0.4	0.3	0.6	0.5	0.1	2.5	0.9	0.3	0.2	0.3	1.2	0.1	1.7	0.5	0.5	0.5	0.5	1.2	0.3	5.2	1.2	0.3	0.2	0.1	0.1	0.5	1.1	0.1	2.7	3.0	1.9	2.8	0.0	2.0	1.0	1.8	0.7	0.9	0.0	0.9	2.2	0.4	0.6	2.5	2.1	0.7	1.0	3.2	0.5	0.5	0.5	0.5
BHLHE22	"Beta3, BHLHB5, bHLHe22, CAGL85, TNRC20"	ENSG00000180828	"Basic helix-loop-helix family member e22"	Q8NFJ8	8	64580367-64583628	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 30.7"	"Cell line enriched"	"Detected in some"	23	"THP-1: 40.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 31.9;cerebellum: 34.4;cerebral cortex: 22.4;hippocampal formation: 50.8"	"Group enriched"	"Detected in many"	8	"amygdala: 37.8;cerebellum: 21.5;cerebral cortex: 22.5;hippocampal formation: 63.6"	"HPA064128, HPA064872, HPA067500"	Enhanced									"HPA064128: AB_2685195, HPA064872: AB_2685377, HPA067500: AB_2685855"	"unprognostic (9.17e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.28e-5)"	"unprognostic (7.22e-3)"	"unprognostic (6.47e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.86e-7)"	"unprognostic (3.20e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.86e-1)"	2.9	1.3	30.7	2.9	1.4	0.3	1.7	21.1	15.8	1.7	1.7	1.2	0.3	1.1	0.5	0.4	2.2	0.6	1.1	0.8	27.2	2.1	0.5	1.3	1.4	2.4	1.7	6.5	0.4	1.3	0.5	1.2	0.2	3.4	0.5	1.4	2.5	1.2	5.4	0.5	0.8	1.7	1.1	2.6	2.9	1.1	0.7	0.2	0.0	0.6	0.0	1.3	2.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	1.4	21.1	10.6	27.2	2.1	1.7	6.5	3.4	0.2
BHLHE23	"bA305P22.3, Beta4, BHLHB4, bHLHe23"	ENSG00000125533	"Basic helix-loop-helix family member e23"	Q8NDY6	20	63005927-63007035	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 1.0;lymphoid tissue: 4.1;retina: 1.3;testis: 1.8"	"Cell line enriched"	"Detected in single"	23	"MOLT-4: 16.5"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 3.0"	HPA030575	Uncertain									"HPA030575: AB_10601459"															"unprognostic (1.74e-1)"			0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.8	0.0	4.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.7	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BICDL1	"BICDR-1, CCDC64, FLJ26450"	ENSG00000135127	"BICD family like cargo adaptor 1"	Q6ZP65	12	119989869-120094494	"Predicted intracellular proteins"	"Neurogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 29.9;skin 1: 20.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 27.3;MCF7: 14.7;SCLC-21H: 17.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061116	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	Vesicles	"HPA061116: "	"unprognostic (2.17e-1)"	"prognostic favourable (6.50e-4)"	"unprognostic (1.68e-3)"	"unprognostic (3.05e-2)"	"unprognostic (6.81e-4)"	"prognostic favourable (3.15e-4)"	"prognostic unfavourable (6.84e-4)"	"unprognostic (5.11e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.26e-2)"	"prognostic favourable (3.93e-5)"	"prognostic favourable (1.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.15e-1)"	4.0	0.8	2.7	3.8	2.3	0.7	0.9	11.9	6.5	0.8	0.9			1.3	0.0	16.5	7.5	0.7	1.4	0.0	3.1	5.1	29.9	0.5	0.7	8.7	1.5		0.0	1.1	1.2	18.4	0.1		0.9	1.0		1.4	0.1	0.0	20.5	1.1	0.0	0.7	2.3	8.6	8.0			6.3		6.0	1.2	3.5	0.5	0.1	0.9	0.8	0.2	3.4	0.7	1.8	5.7	0.3	0.0	0.5	0.0	7.0	0.0	0.0	0.0	0.0	5.1	3.2	9.0	2.4	0.0	4.3	0.7	0.9	0.0	0.6	0.9	0.0	2.5	9.7	0.0	1.1	9.5	0.0	27.3	0.0	0.3	0.0	0.3	1.1	0.0	14.7	6.4	0.1	11.7	2.7	0.7	0.5	2.4	3.5	4.5	17.2	1.2	2.0	5.4	1.4	12.3	4.4	0.0	0.1	1.6	0.0	0.1	2.3	8.7	3.5	0.3	1.3	0.9	0.9	0.0	0.0	3.4	0.0	1.3	0.5	3.4	2.9	0.0	0.5	2.6	2.0	0.0	0.2	0.8	0.1	0.6	0.7										
BIVM	FLJ20159	ENSG00000134897	"Basic, immunoglobulin-like variable motif containing"	Q86UB2	13	102799049-102841535	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 3.6;NK-cells: 6.3;T-cells: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050126	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA050126: "	"unprognostic (8.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.89e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.29e-2)"	"unprognostic (3.33e-2)"	6.8	7.6	10.8	3.3	15.6	3.4	9.6	32.3	16.9	9.2	6.9	6.9	10.5	6.8	10.1	14.3	5.6	7.7	6.9	18.7	10.9	8.4	17.7	17.6	6.4	4.5	9.3	10.8	10.1	10.3	6.4	10.7	7.4	10.4	8.7	8.2	6.3	6.7	9.8	16.9	8.3	6.7	8.8	7.1	7.0	8.9	2.2	9.8	4.3	8.4	7.4	3.6	6.7	6.3	0.6	1.2	3.6	0.4	6.3	4.9	0.9	7.5	2.4	8.9	10.3	11.6	17.7	2.1	9.0	9.1	5.7	6.3	2.7	3.4	0.0	4.0	8.7	5.2	7.3	7.1	8.0	6.9	9.0	6.4	6.7	4.5	10.3	7.2	11.1	14.3	9.1	3.1	10.1	8.5	6.9	0.0	11.6	1.6	8.1	9.4	2.1	6.3	0.0	4.3	3.2	26.1	3.1	13.9	12.0	3.7	4.3	5.9	6.8	9.9	6.1	7.3	1.8	5.3	5.5	6.0	2.6	0.0	9.2	0.0	12.6	3.6	0.4	0.8	2.4	0.2	4.9	0.5	1.4	3.1	1.2	0.6	0.9	2.1	0.4	6.3	0.1	0.5	1.2	0.9	10.8	15.6	32.3	16.9	10.9	8.4	9.3	10.8	10.4	9.8
BPIFA3	"bA49G10.4, C20orf71, SPLUNC3"	ENSG00000131059	"BPI fold containing family A member 3"	Q9BQP9	20	33217310-33227758	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"testis: 86.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062708	Enhanced				"Secreted in male reproductive system"					"HPA062708: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	86.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BPIFB3	"C20orf185, dJ726C3.4, LPLUNC3, RYA3"	ENSG00000186190	"BPI fold containing family B member 3"	P59826	20	33055424-33073628	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"blood: 1.2;pituitary gland: 2.8;salivary gland: 3.1;testis: 3.0"	"Group enriched"	"Detected in some"	27	"HEL: 8.1;HMC-1: 5.8"	"Cancer enriched"	"Detected in single"	7	"ovarian cancer: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045741	Uncertain				"Intracellular and membrane"					"HPA045741: "										"unprognostic (4.33e-2)"					"unprognostic (1.06e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	2.8	0.0		0.0	0.0		3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0			0.2		0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2										
BRINP2	"DBCCR1L2, FAM5B"	ENSG00000198797	"BMP/retinoic acid inducible neural specific 2"	Q9C0B6	1	177171497-177282422	"Predicted secreted proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"adrenal gland: 11.5;brain: 27.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.5;PC-3: 2.6;REH: 3.0;SCLC-21H: 9.5;SH-SY5Y: 2.1"	"Cancer enriched"	"Detected in some"	5	"glioma: 11.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050681	Uncertain				"Secreted in other tissues"					"HPA050681: "	"unprognostic (7.78e-2)"	"unprognostic (4.49e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.20e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.82e-3)"	0.4	11.5	12.2	0.3	8.2	0.3	1.9	0.4	27.9	0.3	0.4	0.6	0.0	0.3	0.5	0.9	0.3	0.6	0.4	0.4	7.0	6.0	0.3	0.4	0.3	0.3	4.5	3.6	0.3	0.3	0.3	2.0	1.0	0.8	0.4	0.3	0.0	0.3	0.4	0.3	0.3	0.3	0.4	1.5	0.5	0.3	1.8	0.3	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	2.6	3.0	0.0	0.0	0.0	0.0	9.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	8.2	0.4	15.9	7.0	6.0	4.5	3.6	0.8	0.3
BSPH1	"BSP1, ELSPBP2"	ENSG00000188334	"Binder of sperm protein homolog 1"	Q075Z2	19	47968046-47992170	"Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"epididymis: 97.1"	"Group enriched"	"Detected in some"	5	"BEWO: 1.2;HMC-1: 1.3;NB-4: 4.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA048335	Enhanced				"Secreted in male reproductive system"					"HPA048335: "																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0			0.0	0.0	97.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
BSPRY	FLJ20150	ENSG00000119411	"B-box and SPRY domain containing"	Q5W0U4	9	113349541-113371233	"Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 67.7;salivary gland: 68.2"	"Cell line enhanced"	"Detected in some"		"A-431: 19.7;CAPAN-2: 12.7;MCF7: 29.4;RPMI-8226: 15.4;SK-BR-3: 14.8;T-47d: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"basal ganglia: 20.8"	"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 8.0"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042889, HPA077485"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA042889: AB_10795515, HPA077485: "	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.95e-2)"	"prognostic favourable (4.56e-14)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.70e-1)"	0.2	1.6	1.0	4.6	20.8	2.1	6.1	4.1	1.4	2.9	5.4	0.4	7.9	3.6	1.0	6.4	14.2	1.9	8.5	1.4	0.6	0.7	9.3	0.4	4.1	0.6	0.7	1.3	0.3	37.8	67.7	10.1	1.7	0.6	2.4	4.5	2.7	68.2	4.8	0.1	12.4	6.8	0.4	0.3	0.3	10.4	2.1	1.8	1.2	28.2	10.7	5.4	1.5	3.2	0.0	8.0	0.0	0.0	0.0	0.4	0.1	19.7	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	4.1	12.7	0.0	0.2	0.0	1.8	0.2	0.0	0.0	2.1	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	29.4	0.3	0.0	0.5	0.0	0.4	0.0	15.4	1.9	4.3	6.8	0.0	0.0	14.8	0.0	14.9	2.1	0.0	0.0	0.0	0.0	0.0	4.8	6.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.0	0.0	0.1	1.0	20.8	4.1	1.4	0.6	0.7	0.7	1.3	0.6	1.8
BSX	BSX1	ENSG00000188909	"Brain specific homeobox"	Q3C1V8	11	122977570-122981720	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 4.9;pituitary gland: 1.7;testis: 1.7"	"Group enriched"	"Detected in some"	21	"HDLM-2: 1.5;SCLC-21H: 2.6;SH-SY5Y: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"hypothalamus: 5.3"	"Region enriched"	"Detected in single"	8	"hypothalamus: 4.5"	HPA015654	Uncertain									"HPA015654: AB_1845470"																		0.0	0.0	0.9	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	1.7	0.0	4.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.8	0.0	4.9	0.0	1.2	4.5	0.0
BTBD11	"ABTB2B, FLJ33957"	ENSG00000151136	"BTB domain containing 11"	A6QL63	12	107318413-107659642	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 61.8"	"Cell line enhanced"	"Detected in many"		"A549: 19.0;Hep G2: 10.0;MOLT-4: 12.7;PC-3: 9.0;RT4: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 7.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055898, HPA061334"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA055898: , HPA061334: "	"unprognostic (3.40e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.85e-2)"	"unprognostic (8.78e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.92e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.07e-3)"	0.9	1.1	3.7	2.4	6.6	3.3	2.7	4.6	10.2	6.8	1.0	2.2	3.2	1.1	1.3	1.5	24.1	0.8	1.2	1.0	2.9	9.4	3.7	1.4	1.0	4.0	8.3	3.0	0.6	1.2	61.8	3.2	2.0	19.0	3.1	1.0	1.7	6.2	1.6	0.9	8.4	1.6	1.0	4.9	1.5	1.0	1.1	1.2	24.8	14.4	9.5	9.0	2.3	7.9	0.3	1.3	2.8	0.8	0.3	7.2	1.2	0.1	19.0	3.9	0.0	1.4	0.4	0.0	0.4	0.0	0.2	0.0	0.2	3.1	0.0	4.7	0.1	6.9	3.9	7.2	0.2	0.0	1.2	0.0	0.1	10.0	0.0	0.1	0.0	1.5	3.0	0.0	2.3	0.5	0.0	0.0	0.1	0.6	12.7	1.5	4.0	9.0	0.0	6.1	0.0	0.0	8.6	5.0	1.9	0.0	0.2	0.0	0.4	0.5	0.8	0.0	0.2	0.0	1.5	0.0	0.0	0.0	5.0	1.9	0.0	1.3	0.8	1.1	2.1	0.3	7.2	0.1	2.4	1.4	1.3	0.3	3.0	2.7	2.8	0.3	0.6	0.2	1.1	1.2	3.7	6.6	4.6	10.2	2.9	9.4	8.3	3.0	19.0	1.2
BTBD18		ENSG00000233436	"BTB domain containing 18"	B2RXH4	11	57743514-57751781	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.5;testis: 7.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.0;Hep G2: 2.4;PC-3: 1.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049325	Uncertain									"HPA049325: "	"unprognostic (6.68e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.47e-2)"	"unprognostic (8.69e-3)"	"unprognostic (4.84e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-1)"	"unprognostic (7.17e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.42e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.88e-1)"	0.0	0.0	0.1	0.1	0.3	1.2	0.0	0.7	0.4	0.0	0.0			0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0		0.3	0.0	0.0	0.1	0.1		0.0	0.0		0.0	0.0	0.7	1.4	0.1	0.0	0.0	0.1	0.0	7.0			0.0		0.0	0.0	0.0	2.5	0.8	0.3	1.0	0.3	2.1	0.2	0.3	0.4	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.5	2.4	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.6	0.4	0.0	1.5	0.5	0.3	0.1	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.3	0.5	0.6	0.1	0.1	0.5	0.0	0.6	0.6	0.5	0.6	0.4	0.2	0.0	0.6	0.0	0.2	1.0	0.1	0.9	1.1	0.7	0.2	2.5	2.1	0.9	0.3	0.3	0.6	0.8	1.4	0.2										
BTBD19		ENSG00000222009	"BTB domain containing 19"	C9JJ37	1	44808482-44815585	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 6.4;TIME: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042633, HPA076404"	Uncertain		Uncertain	Cytosol				Cytosol		"HPA042633: , HPA076404: "	"unprognostic (4.69e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-4)"	"unprognostic (5.32e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (4.18e-8)"	"unprognostic (2.20e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.70e-1)"	6.7	8.7	3.5	3.6	1.9	2.7	4.9	0.6	2.8	13.5	2.0	2.4	6.2	1.6	13.9	21.4	2.1	6.4	4.2	3.8	1.3	1.4	4.2	2.2	4.1	1.8	1.4	4.0	8.4	1.5	3.2	11.9	7.9	6.3	5.6	1.8	7.6	1.7	8.3	1.8	1.2	2.2	5.6	1.9	2.3	2.2	3.5	0.6	0.1	6.0	2.0	1.4	2.1	4.3	0.0	0.2	2.3	0.1	0.0	0.2	0.0	0.1	1.1	1.0	1.1	2.3	2.6	0.7	2.2	1.3	1.0	2.1	0.0	0.9	0.1	1.0	3.7	0.3	0.0	1.1	0.4	0.9	0.2	2.0	0.3	1.1	2.4	0.0	1.6	3.9	0.1	3.7	0.7	6.4	0.2	0.0	2.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.7	0.0	0.0	0.0	0.3	0.1	1.2	0.0	0.0	14.9	3.8	3.0	1.8	1.6	0.5	0.1	0.0	2.3	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	3.5	1.9	0.6	2.8	1.3	1.4	1.4	4.0	6.3	0.6
BTBD8		ENSG00000189195	"BTB domain containing 8"	Q5XKL5	1	92080305-92184725	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 42.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA024216, HPA035311"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA024216: AB_1852385, HPA035311: AB_10671933"	"unprognostic (2.94e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.04e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.15e-1)"	3.4	4.6	11.7	1.2	27.3	0.7	3.3	20.3	42.3	2.3	2.4	4.0	0.6	1.7	3.4	4.7	2.0	3.3	2.3	2.8	7.8	2.1	2.4	1.9	2.5	1.4	4.5	23.3	5.0	2.7	5.1	6.0	2.5	16.4	3.3	2.5	1.2	2.8	2.7	2.3	1.8	2.1	2.0	6.6	1.8	2.4	8.3	9.9	0.2	3.7	0.0	1.1	4.7	2.7	0.5	0.8	0.6	0.7	0.9	2.3	0.4	2.8	2.3	1.7	0.0	5.2	10.5	5.7	1.8	2.5	1.5	1.9	0.5	3.3	1.2	6.7	1.6	0.8	1.3	3.3	2.4	2.9	1.9	2.1	0.6	0.9	1.1	1.1	1.3	6.1	2.8	0.9	1.8	1.6	2.5	0.8	2.8	1.7	0.8	2.2	1.7	1.8	1.8	1.7	0.2	3.3	2.1	0.9	1.5	3.0	1.5	1.5	2.3	1.6	1.1	2.0	1.2	1.1	0.7	2.2	0.9	0.0	1.6	0.2	0.4	0.0	0.6	0.0	2.3	0.1	0.5	0.5	1.0	0.9	0.0	0.5	1.8	1.4	0.6	0.9	0.7	0.8	0.9	0.4	11.7	27.3	20.3	42.3	7.8	2.1	4.5	23.3	16.4	9.9
BTG4	"APRO3, PC3B"	ENSG00000137707	"BTG anti-proliferation factor 4"	Q9NY30	11	111467526-111512354	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 24.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.2;Karpas-707: 8.4;U-266/70: 5.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	18	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA057157			Approved	"Endoplasmic reticulum,Golgi apparatus"				"Endoplasmic reticulum, Golgi apparatus"		"HPA057157: "		"unprognostic (1.58e-1)"		"unprognostic (2.68e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.80e-4)"		"unprognostic (1.42e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.39e-2)"					"unprognostic (1.31e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.2	0.0	0.2	0.4	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.7	1.6	0.1	0.0	0.0	8.4	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.4	5.8	2.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.8	0.2
BTNL9	"BTN8, FLJ32535"	ENSG00000165810	"Butyrophilin like 9"	Q6UXG8	5	181040225-181061523	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 128.2;breast: 76.8"	"Cell line enriched"	"Detected in some"	6	"U-698: 28.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.8"	"Group enriched"	"Detected in many"	6	"B-cells: 3.8;granulocytes: 1.3"	"Not detected"	"Not detected"							HPA043429			Approved	"Nuclear membrane,Vesicles"				"Nuclear membrane"	Vesicles	"HPA043429: AB_10961264"	"unprognostic (2.69e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavourable (7.51e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.43e-1)"	"prognostic favourable (1.55e-9)"	"unprognostic (2.15e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.56e-2)"	128.2	2.5	1.5	5.3	1.7	0.3	76.8	1.0	1.8	3.2	11.3	0.8	3.5	0.7	3.9	3.7	2.9	6.0	3.7	11.0	3.4	1.3	3.4	3.0	25.4	2.7	2.5	1.2	1.0	2.0	3.0	1.6	4.3	1.5	3.4	1.5	3.8	3.0	3.5	34.4	2.0	1.9	3.2	2.1	12.7	2.0	3.0	0.9	1.1	6.1	4.0	5.5	3.1	18.3	3.8	0.4	1.3	0.3	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.6	0.0	0.2	1.1	0.0	0.2	0.5	0.0	0.0	0.2	2.8	1.1	0.2	0.1	0.0	0.5	3.3	0.0	0.1	0.0	0.0	0.0	0.7	0.3	0.0	0.1	0.1	0.1	0.1	1.8	0.0	0.2	0.1	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	4.3	0.1	0.0	0.2	0.1	28.0	0.1	0.0	0.0	1.0	0.3	0.5	0.2	0.1	0.1	3.8	0.2	0.2	0.1	1.9	0.2	0.2	1.3	0.3	0.1	0.4	0.0	0.1	1.5	1.7	1.0	1.8	3.4	1.3	2.5	1.2	1.5	0.9
C10orf113	bA165O3.1	ENSG00000204683	"Chromosome 10 open reading frame 113"	Q5VZT2	10	21125763-21146559	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"salivary gland: 1.2;testis: 4.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.6;hTCEpi: 1.2;RT4: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA037013	Uncertain									"HPA037013: AB_10672106"	"unprognostic (2.55e-2)"	"unprognostic (6.57e-2)"												"unprognostic (4.18e-1)"		"unprognostic (5.00e-1)"	"unprognostic (3.11e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.7	0.0			0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0		0.0	0.0	0.0	0.4	0.0		0.0	0.0		1.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	4.8			0.2		0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C10orf67	"bA215C7.4, C10orf115, LINC01552, MGC46732"	ENSG00000179133	"Chromosome 10 open reading frame 67"	Q8IYJ2	10	23201916-23344845	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 7.3;pituitary gland: 9.0;testis: 13.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 5.2;SiHa: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.2"	"Low lineage specificity"	"Detected in many"											"HPA038130, HPA038131"	Approved		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles"				Nucleoplasm	"Nucleoli, Nuclear speckles"	"HPA038130: , HPA038131: AB_10670658"	"unprognostic (4.76e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.92e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.91e-1)"		"unprognostic (1.54e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.98e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.84e-3)"	"unprognostic (9.58e-2)"	0.1	0.1	1.3	1.7	2.6	0.2	0.0	0.1	1.9	0.3	0.5	0.4	1.3	0.5	0.2	4.6	0.1	7.3	0.2	3.2	1.6	1.4	5.0	0.5	4.0	0.3	0.9	0.5	1.8	0.3	0.4	9.0	0.1	1.2	0.1	0.0	0.2	0.1	0.1	0.6	1.9	0.4	0.0	0.7	0.2	0.1	13.8	0.6	0.0	0.6	0.7	0.1	0.1	0.1	1.1	1.1	1.0	0.5	1.1	4.2	0.0	1.5	0.1	1.9	0.2	0.0	0.5	0.4	0.2	0.1	2.0	1.6	0.1	2.4	0.2	0.2	1.5	5.2	0.2	0.7	1.6	0.5	0.4	0.1	0.7	0.3	1.0	0.1	0.0	0.6	1.7	0.6	1.0	0.0	0.2	0.7	0.0	0.3	0.1	0.5	0.9	0.1	0.1	0.2	0.4	1.7	0.3	0.9	0.4	8.4	0.3	0.1	0.3	0.3	0.2	0.4	1.5	0.4	0.1	1.0	0.2	0.1	2.5	0.2	0.1	1.0	0.5	0.6	0.7	0.3	0.6	1.1	1.5	0.8	0.1	1.0	1.1	1.0	0.8	1.1	0.3	1.1	4.2	0.0	1.3	2.6	0.1	1.9	1.6	1.4	0.9	0.5	1.2	0.6
C10orf82	"Em:AC016825.4, MGC33547"	ENSG00000165863	"Chromosome 10 open reading frame 82"	Q8WW14	10	116663696-116670264	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 12.7;testis: 44.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;HEK 293: 1.3;Hep G2: 5.1;NTERA-2: 2.8;T-47d: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	127	"basophil: 12.7"	"Lineage enriched"	"Detected in single"	127	"granulocytes: 12.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043022			Approved	Mitochondria				Mitochondria		"HPA043022: "	"unprognostic (9.98e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.52e-2)"		"unprognostic (3.46e-3)"	"unprognostic (3.48e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.07e-1)"	0.4	1.1	0.4	0.9	1.2	0.2	1.0	0.8	3.3	0.4	0.7	0.0	1.0	0.3	0.3	1.5	1.2	0.3	0.3	0.5	0.4	1.3	0.5	0.3	0.2	0.2	0.4	0.9	3.2	0.9	0.2	1.2	0.3	4.1	1.1	0.4	0.6	1.8	1.1	0.2	0.4	0.6	0.7	2.0	0.3	0.4	44.7	0.0	0.0	3.3	0.0	0.2	0.4	1.9	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.8	3.3	0.4	1.3	0.4	0.9	4.1	0.0
C10orf90	"bA422P15.2, FATS, FLJ32938"	ENSG00000154493	"Chromosome 10 open reading frame 90"	Q96M02	10	126424997-126670446	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 30.9;breast: 9.2;salivary gland: 18.6;testis: 12.3"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 48.4;U-2197: 14.8;U-266/84: 10.4;U-87 MG: 15.4;WM-115: 12.1"	"Cancer enriched"	"Detected in some"	5	"melanoma: 4.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA038648, HPA075229"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA038648: AB_10672721, HPA075229: "	"unprognostic (1.21e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.06e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.73e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-11)"	"unprognostic (2.69e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.88e-1)"	1.9	0.8	7.5	1.0	21.5	0.8	9.2	1.4	18.7	0.9	0.9	30.9	0.0	0.7	0.8	0.8	0.9	0.7	1.1	0.8	10.8	5.9	0.9	0.8	0.8	0.7	26.0	5.9	0.9	1.1	0.7	0.5	1.3	14.4	0.9	1.0	1.7	18.6	0.7	0.9	1.9	0.8	0.8	17.2	0.8	0.7	12.3	28.0	0.0	1.3	0.0	2.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	48.4	0.0	0.1	0.0	1.9	0.0	14.8	0.2	0.0	10.4	0.0	15.4	0.0	12.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	21.5	1.4	11.3	10.8	5.9	26.0	5.9	14.4	28.0
C11orf21		ENSG00000110665	"Chromosome 11 open reading frame 21"	Q9P2W6	11	2295645-2303049	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 29.5;bone marrow: 30.4;lymphoid tissue: 16.0"	"Cell line enhanced"	"Detected in some"		"HEL: 30.1;HL-60: 11.4;NB-4: 10.4;THP-1: 7.3;U-937: 12.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA037607	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA037607: AB_10672909"	"unprognostic (5.25e-3)"	"unprognostic (2.65e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.58e-4)"	"unprognostic (8.98e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.84e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.07e-2)"	1.5	0.4	0.7	8.7	0.5	30.4	0.7	0.2	0.7	1.5	0.8	1.7	0.8	0.2	1.6	1.3	0.7	1.0	5.4	15.6	0.4	0.4	1.0	1.3	5.2	8.5	2.2	0.9	0.7	0.6	0.0	0.8	0.8	1.0	0.8	0.8	1.4	9.3	0.1	0.4	0.8	3.3	0.6	1.4	16.0	2.0	0.9	1.0	6.4	1.1	2.7	11.5	1.0	0.9	2.6	7.3	29.5	23.2	9.5	10.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	30.1	0.0	0.1	0.3	11.4	0.5	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	12.8	0.0	29.5	6.3	18.7	10.6	13.1	7.3	2.0	3.6	8.4	7.3	2.6	5.4	7.5	5.5	9.5	23.2	0.7	2.6	6.4	0.7	0.5	0.2	0.7	0.4	0.4	2.2	0.9	1.0	1.0
C11orf42	MGC34805	ENSG00000180878	"Chromosome 11 open reading frame 42"	Q8N5U0	11	6205566-6211132	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 27.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 4.1;HeLa: 4.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063404	Enhanced									"HPA063404: "	"unprognostic (4.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.49e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.50e-2)"	"unprognostic (9.30e-2)"	"unprognostic (6.47e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.74e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	0.1	1.0	1.2	0.1	0.2	0.1	0.1	1.1	0.3	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	2.0	0.9	0.1	0.1	0.1	0.3	27.9	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.5	0.4	0.0	0.1	0.0	0.4	2.5	0.4	1.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	2.1	0.8	0.6	0.1	0.0	1.9	0.0	0.0	0.0	0.6	4.1	0.0	4.7	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.8	0.9	0.4	1.4	1.3	0.8	1.2	0.2	0.0	0.4	1.1	0.3	0.2	1.1	0.5	0.4	0.9	0.4	1.0	0.4	1.9	0.3	0.5	1.1	0.4	0.7	1.7	0.4	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1
C11orf45	"FLJ43646, MGC35558"	ENSG00000174370	"Chromosome 11 open reading frame 45"	Q8TAV5	11	128899565-128906035	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 12.3;U-937: 9.5"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.5;monocytes: 1.8;T-cells: 1.1"									HPA039716	Approved		Approved	Cytosol	"Secreted - unknown location"			Cytosol		"HPA039716: AB_10672892"	"unprognostic (8.32e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.50e-5)"	"unprognostic (1.97e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.80e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.55e-9)"	"unprognostic (2.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.87e-2)"	"unprognostic (7.22e-2)"	0.7	4.9	1.1	0.3	5.3	0.4	0.7	0.0	1.0	0.9	0.4			1.2	0.3	0.4	3.3	0.9	2.1	5.0	0.7	0.9	1.6	0.2	2.8	0.3	1.1		0.7	4.1	4.7	3.7	2.1		1.2	0.6		1.7	3.6	0.0	8.0	0.6	0.1	1.5	1.6	2.0	1.0			1.8		0.6	1.7	1.8	0.4	3.5	0.0	1.8	0.0	1.1	0.6	2.4	4.7	0.0	0.0	0.1	0.4	1.8	0.8	5.1	1.9	4.8	6.8	6.1	0.0	3.4	0.4	2.5	2.5	12.3	0.9	0.0	1.2	0.3	3.0	0.0	0.2	0.0	0.0	0.3	1.7	1.3	0.8	1.1	0.0	0.3	2.1	1.3	2.7	2.5	1.9	3.4	1.2	4.9	0.5	4.3	1.2	0.0	0.2	2.0	5.6	0.4	0.7	4.1	0.6	0.0	7.0	0.0	0.8	0.1	0.0	0.0	0.9	9.5	0.2	0.0	1.8	0.0	0.3	0.8	0.7	0.4	0.5	0.5	3.5	0.4	1.1	0.7	0.0	0.0	0.0	0.7	0.0	0.6										
C11orf53	MGC50104	ENSG00000150750	"Chromosome 11 open reading frame 53"	Q8IXP5	11	111245805-111286401	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 7.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.7;SH-SY5Y: 1.1;SiHa: 2.7;SK-BR-3: 2.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA056128	Uncertain									"HPA056128: "	"unprognostic (3.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.84e-2)"		"unprognostic (1.94e-1)"		"unprognostic (8.07e-3)"		"unprognostic (5.60e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.50e-1)"		"unprognostic (9.95e-2)"	"unprognostic (8.66e-2)"		"unprognostic (3.52e-2)"	1.4	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	2.6			1.2	1.6	0.0	0.0	1.8	2.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0		0.9	0.8	0.0	0.6	1.2		0.4	2.4		4.1	0.0	3.2	0.0	3.0	0.0	0.0	0.0	4.5	7.6			0.0		0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	2.7	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C11orf70	MGC13040	ENSG00000137691	"Chromosome 11 open reading frame 70"	Q9BRQ4	11	102047443-102084560	"Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 25.5;testis: 54.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 14.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 16.0"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038585	Enhanced		Approved	Centrosome				Centrosome		"HPA038585: AB_10795357"	"unprognostic (9.70e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.77e-6)"	"unprognostic (1.76e-2)"	"unprognostic (8.68e-3)"	"unprognostic (2.94e-2)"	"unprognostic (6.73e-3)"	2.5	3.7	2.9	1.1	4.2	0.1	3.1	0.7	1.4	5.9	1.6	5.4	11.6	0.8	5.3	11.9	2.3	25.5	4.9	1.7	3.9	4.5	3.0	0.3	7.2	1.2	1.7	1.3	7.5	0.8	3.7	13.7	4.0	16.0	5.6	0.8	4.2	1.1	7.0	0.5	1.6	0.8	5.5	1.9	0.2	1.6	54.7	2.2	0.0	3.3	1.1	0.8	3.8	2.5	0.6	0.3	2.3	0.6	0.3	0.4	0.2	0.0	6.6	6.7	0.0	6.1	14.7	0.2	2.6	6.7	3.6	5.2	0.5	8.6	0.0	1.6	5.1	1.6	1.6	0.8	2.6	0.0	1.0	0.0	1.1	0.0	4.3	0.0	0.0	6.2	8.4	9.4	6.3	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	9.9	1.8	7.4	0.0	8.5	0.1	0.0	7.5	0.0	1.0	0.9	2.8	8.8	2.1	0.1	0.0	0.0	3.0	0.0	0.4	1.6	0.6	0.4	0.3	0.2	0.2	0.5	0.3	0.3	0.1	0.6	0.4	0.3	2.3	0.3	0.2	0.3	0.2	0.2	2.9	4.2	0.7	1.4	3.9	4.5	1.7	1.3	16.0	2.2
C11orf71	FLJ20010	ENSG00000180425	"Chromosome 11 open reading frame 71"	Q6IPW1	11	114391443-114400511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in all"	5	"testis: 83.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA063943, HPA074787"			Supported	Nucleoplasm				Nucleoplasm		"HPA063943: , HPA074787: "	"unprognostic (1.24e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-2)"	"prognostic favourable (6.94e-4)"	"unprognostic (7.35e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-2)"	"prognostic favourable (7.01e-9)"	"unprognostic (5.68e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.17e-2)"	3.9	7.3	5.7	3.4	12.1	2.2	5.7	4.1	8.1	4.2	4.9	10.2	5.6	5.5	3.7	18.0	3.2	5.4	3.9	5.4	6.9	6.1	10.6	15.0	3.9	4.3	10.3	4.7	5.0	6.9	8.7	6.9	2.5	6.7	5.6	4.6	5.7	7.2	5.0	9.9	5.6	5.1	2.1	5.7	5.4	5.2	83.2	12.2	6.4	9.5	4.7	3.2	3.1	3.1	10.5	13.6	14.5	17.7	13.2	11.9	11.3	1.1	3.2	3.4	11.0	5.2	3.0	2.4	0.5	1.4	1.3	1.2	2.7	19.6	5.2	7.0	0.8	5.1	2.2	2.3	1.7	6.0	1.3	3.9	2.3	5.3	5.0	2.3	4.5	4.9	2.6	1.8	5.6	1.7	4.1	4.9	2.6	4.5	4.1	3.5	1.8	2.1	3.1	2.8	13.4	3.0	2.4	9.5	3.7	12.3	1.4	1.9	9.3	1.2	1.7	0.3	5.2	3.9	0.9	4.8	7.9	4.1	0.7	5.4	1.4	11.7	17.7	11.1	10.3	11.1	6.3	7.0	7.0	7.1	10.6	10.5	11.4	11.9	14.5	13.2	12.2	13.6	7.7	11.3	5.7	12.1	4.1	8.1	6.9	6.1	10.3	4.7	6.7	12.2
C11orf80	"FLJ22531, TOPOVIBL"	ENSG00000173715	"Chromosome 11 open reading frame 80"	Q8N6T0	11	66744451-66843328	"Predicted intracellular proteins"	Meiosis		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA038932, HPA038933"	Approved		Approved	Centrosome				Centrosome		"HPA038932: , HPA038933: AB_10671867"	"unprognostic (2.81e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.54e-3)"	"unprognostic (4.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.98e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.26e-1)"	2.8	7.6	15.0	12.9	15.0	4.8	10.3	26.2	11.9	7.1	10.1	1.7	4.7	7.7	5.9	13.3	16.4	5.4	4.6	4.2	8.3	7.2	13.4	2.2	4.4	5.8	5.0	11.9	3.3	4.7	10.9	12.4	3.9	8.0	10.0	9.0	5.5	10.7	9.5	1.3	35.6	17.3	4.2	2.7	6.8	5.1	15.2	2.5	15.1	3.6	7.6	15.3	4.8	8.8	10.6	9.7	3.1	1.0	1.7	4.2	0.7	9.0	4.8	9.9	6.7	0.5	3.2	1.8	3.8	4.6	4.5	5.7	16.7	11.1	14.8	2.2	3.1	16.6	4.6	5.8	4.6	3.7	2.6	2.4	6.0	4.2	1.1	1.6	2.8	0.8	20.1	3.5	6.7	14.4	4.3	5.7	2.7	10.0	5.9	5.3	15.7	6.7	3.5	4.6	11.4	19.7	3.1	7.4	7.4	6.3	17.4	13.4	12.0	1.1	6.3	3.2	5.9	3.4	5.5	4.0	8.8	10.7	3.6	2.9	4.1	1.9	0.9	3.1	2.1	0.5	3.7	10.6	3.8	3.0	0.5	8.9	4.2	3.5	2.3	1.7	1.0	9.7	4.0	0.7	15.0	15.0	26.2	11.9	8.3	7.2	5.0	11.9	8.0	2.5
C11orf91		ENSG00000205177	"Chromosome 11 open reading frame 91"	Q3C1V1	11	33698261-33700801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 7.2;gallbladder: 7.2;testis: 16.6"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 14.9;hTERT-HME1: 9.6;HUVEC TERT2: 7.6;TIME: 11.6;U-2197: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA047064, HPA050487"	Uncertain		Supported	Vesicles				Vesicles		"HPA047064: , HPA050487: "	"unprognostic (9.22e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.68e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	7.2	0.2	1.2	2.1	3.0	0.9	2.1	0.3	1.3	0.3	0.3	0.3	0.3	0.0	0.4	0.9	4.3	0.3	7.2	0.7	0.4	0.6	0.9	0.9	1.4	0.3	0.7	0.3	0.6	1.9	0.0	0.3	1.0	1.3	0.3	0.0	0.3	0.9	0.3	0.4	1.3	0.3	0.8	0.8	0.3	2.7	16.6	0.3	0.6	0.3	0.3	0.3	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	1.4	0.0	0.0	0.0	1.7	0.0	0.8	0.4	0.2	0.6	0.0	0.1	1.7	0.6	0.4	14.9	1.2	0.4	0.0	0.0	2.8	0.7	0.3	0.0	0.0	0.0	0.1	1.2	9.6	7.6	0.0	2.3	3.6	0.0	0.0	0.3	0.0	4.7	0.0	0.0	0.0	1.0	1.9	0.0	0.3	0.0	1.5	0.1	0.0	0.0	11.6	1.1	0.3	9.6	0.3	0.7	0.5	0.0	2.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.0	0.3	1.3	0.4	0.6	0.7	0.3	1.3	0.3
C12orf4		ENSG00000047621	"Chromosome 12 open reading frame 4"	Q9NQ89	12	4487728-4538508	"Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037871	Uncertain		Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA037871: AB_10670531"	"unprognostic (5.88e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.07e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.96e-3)"	"unprognostic (8.59e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.92e-1)"	12.4	9.6	15.6	13.6	20.8	12.9	12.1	22.1	28.3	11.8	12.0	9.9	7.2	6.9	11.1	9.1	12.4	10.3	10.7	11.6	17.7	11.4	10.5	9.4	10.7	14.7	11.7	19.0	12.4	10.0	11.2	22.7	15.4	22.0	12.7	13.6	6.8	9.5	11.5	17.9	9.4	10.4	15.3	14.5	14.4	10.2	14.1	13.6	13.4	13.0	9.5	15.8	12.8	10.2	5.0	7.0	2.7	13.8	4.2	6.7	4.4	8.4	6.5	8.1	9.6	8.1	12.2	17.2	16.4	6.8	15.2	18.6	11.5	7.0	7.2	3.4	10.6	6.3	11.4	9.4	20.6	21.5	7.8	12.5	6.4	5.6	11.9	10.7	11.8	10.8	5.5	18.1	20.5	8.6	7.3	12.6	14.1	4.1	8.5	4.5	11.9	6.2	9.3	12.8	4.6	9.4	8.9	3.2	6.4	11.2	8.2	6.9	3.4	9.3	8.9	13.2	12.2	14.4	17.1	2.9	3.8	17.8	9.8	8.8	12.2	0.0	7.8	2.7	4.6	12.8	5.0	5.0	4.5	4.6	6.7	5.0	5.0	4.5	2.5	4.2	13.8	7.0	6.7	4.4	15.6	20.8	22.1	28.3	17.7	11.4	11.7	19.0	22.0	13.6
C12orf54	MGC35033	ENSG00000177627	"Chromosome 12 open reading frame 54"	Q6X4T0	12	48482503-48496512	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	38	"testis: 34.8"	"Group enriched"	"Detected in some"	4	"HaCaT: 2.8;HBEC3-KT: 9.2;hTCEpi: 2.6;hTERT-HME1: 5.5"	"Group enriched"	"Detected in some"	9	"cervical cancer: 2.9;head and neck cancer: 2.1;lung cancer: 1.6;urothelial cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA073090			Approved	"Intermediate filaments"				"Intermediate filaments"		"HPA073090: "	"unprognostic (2.59e-3)"	"unprognostic (5.49e-2)"	"unprognostic (7.94e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.99e-2)"		"unprognostic (5.96e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.37e-1)"	"unprognostic (5.06e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.92e-1)"	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.3	0.1	0.6	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.0	34.8	0.1	0.1	0.1	0.1	0.9	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	9.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	5.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.2	0.1	0.3	0.1	0.1	0.1
C12orf56		ENSG00000185306	"Chromosome 12 open reading frame 56"	Q8IXR9	12	64264762-64391192	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 8.9;testis: 15.0"	"Group enriched"	"Detected in some"	10	"hTEC/SVTERT24-B: 9.8;SCLC-21H: 8.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA056986	Enhanced									"HPA056986: "	"unprognostic (5.85e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.35e-4)"	"unprognostic (1.79e-4)"	"unprognostic (9.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.38e-4)"	"unprognostic (8.86e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.69e-2)"	0.3	0.1	0.1	0.0	0.5	0.2	0.1	1.3	0.2	1.8	0.4	0.9	1.0	0.0	0.1	0.0	1.8	0.2	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.6	0.3	0.4	0.2	0.1	2.7	0.5	0.0	0.0	1.6	0.1	0.0	0.1	0.2	0.1	15.0	0.0	8.9	0.0	0.6	0.9	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.2	0.1	0.5	0.0	0.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.1	8.3	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.3	0.1	0.1	0.1	0.1	0.0	0.4	0.0
C12orf60	MGC47869	ENSG00000182993	"Chromosome 12 open reading frame 60"	Q5U649	12	14803572-14906586	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA043911			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA043911: AB_10963941"	"unprognostic (3.71e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.09e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.25e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.75e-2)"	1.7	8.9	2.6	2.3	9.9	1.7	1.8	1.9	4.7	1.5	1.3	4.8	1.6	0.7	1.1	2.9	1.3	2.9	1.8	5.4	3.7	2.0	4.8	8.7	2.0	3.2	6.3	4.7	1.5	2.1	1.7	3.8	1.6	7.2	2.1	1.2	5.1	1.9	1.4	2.5	1.3	1.4	0.8	9.2	5.5	1.9	22.5	4.9	1.7	3.3	1.0	2.0	1.5	1.7	3.9	1.1	3.6	1.4	3.3	4.5	1.2	2.6	2.8	2.8	8.2	3.1	2.2	2.6	1.9	1.0	2.0	2.4	1.2	2.9	2.3	2.3	0.7	3.0	3.2	6.3	2.7	5.1	3.2	1.8	0.8	1.9	2.6	2.6	1.0	1.2	3.9	2.1	4.3	3.9	2.9	0.5	2.7	0.8	1.0	1.6	9.8	1.6	3.1	4.9	3.3	3.7	0.8	2.1	2.5	4.2	1.0	3.7	3.2	1.2	3.0	1.8	2.0	1.4	2.1	1.4	1.0	7.5	2.3	2.4	2.6	0.3	1.3	3.6	2.3	1.4	3.7	3.9	1.9	3.3	1.1	2.6	4.5	3.8	0.3	3.3	0.8	1.0	3.6	1.2	2.6	9.9	1.9	4.7	3.7	2.0	6.3	4.7	7.2	4.9
C12orf65	"FLJ38663, SPG55"	ENSG00000130921	"Chromosome 12 open reading frame 65"	Q9H3J6	12	123232916-123257959	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"		"Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 80.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057595	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Cytosol"	Mitochondria	"HPA057595: "	"unprognostic (9.07e-3)"	"unprognostic (1.51e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavourable (4.29e-9)"	"unprognostic (9.33e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.83e-3)"	"prognostic favourable (7.82e-5)"	7.8	15.7	13.2	11.3	15.1	9.6	9.0	21.6	18.2	14.1	10.8	12.3	11.6	13.8	14.9	16.5	10.7	11.7	11.1	17.4	13.2	15.2	12.1	15.6	10.6	18.8	11.5	13.2	21.3	12.4	8.8	24.6	9.2	15.0	15.1	9.7	13.1	21.2	10.8	14.3	17.7	12.6	10.5	14.2	14.7	11.7	17.3	12.2	80.9	15.3	7.9	15.5	14.3	13.7	23.6	10.0	22.6	4.6	17.1	28.9	10.0	14.5	10.0	11.4	22.3	5.7	6.1	6.9	12.1	7.7	12.3	9.1	10.8	8.6	18.1	10.5	3.9	10.7	12.3	6.6	11.8	13.6	11.0	21.3	9.9	9.4	12.8	9.9	10.8	6.4	16.1	8.9	18.5	8.0	22.5	7.5	8.2	6.3	23.7	18.3	8.7	15.5	17.7	13.6	16.8	11.5	8.3	24.3	10.5	13.5	6.9	12.6	11.0	11.6	9.0	13.4	16.1	12.1	12.2	12.4	14.3	16.6	8.7	13.1	17.5	22.6	3.5	14.0	15.9	3.8	19.8	23.6	22.0	21.1	6.0	20.2	28.9	24.7	3.7	17.1	4.6	10.0	18.5	10.0	13.2	15.1	21.6	18.2	13.2	15.2	11.5	13.2	15.0	12.2
C12orf76	FLJ40142	ENSG00000174456	"Chromosome 12 open reading frame 76"	Q8N812	12	110027028-110073686	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 47.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA039713, HPA042013"	Uncertain		Approved	"Plasma membrane,Actin filaments"				"Actin filaments"	"Plasma membrane"	"HPA039713: AB_2676640, HPA042013: "	"unprognostic (9.20e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-2)"	"prognostic favourable (6.44e-5)"	"unprognostic (1.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (5.74e-5)"	"unprognostic (2.09e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.26e-1)"	5.7	8.8	34.6	8.4	26.1	11.6	9.4	19.7	47.6	6.6	6.1	32.6	2.5	7.6	8.1	14.0	5.9	12.0	6.7	5.3	36.1	33.5	8.5	7.9	9.7	11.4	36.2	21.2	11.9	8.4	5.1	7.5	9.4	26.1	7.5	6.4	5.9	7.7	7.9	8.3	14.6	7.4	5.3	38.7	11.1	9.2	9.8	27.4	4.8	11.1	1.8	7.9	6.3	5.0	14.0	12.8	31.3	9.4	14.3	16.3	11.1	6.4	9.5	11.6	10.4	8.3	17.1	12.7	5.7	3.2	5.5	4.1	7.8	6.3	7.9	6.8	2.5	12.8	4.7	4.7	4.1	11.7	10.1	7.9	14.5	15.7	7.8	12.8	15.4	13.7	15.6	4.8	8.8	8.5	11.7	20.7	5.6	6.9	6.5	21.1	9.0	8.7	12.4	7.1	12.8	9.9	6.2	23.2	12.6	7.1	5.3	12.7	11.5	6.7	10.9	8.4	6.1	6.3	3.3	9.5	10.9	6.5	9.3	7.4	4.8	31.3	9.4	11.2	8.3	6.2	9.2	14.0	13.1	9.3	8.8	11.8	16.3	10.6	12.8	14.3	6.1	12.8	12.6	11.1	34.6	26.1	19.7	35.1	36.1	33.5	36.2	21.2	26.1	27.4
C14orf177	FLJ25773	ENSG00000176605	"Chromosome 14 open reading frame 177"	Q52M58	14	98711613-98717761	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	19	"blood: 1.6;testis: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	17	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 1.6"									HPA018091	Uncertain									"HPA018091: AB_1848845"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.4			0.0		0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0										
C14orf178	FLJ25976	ENSG00000197734	"Chromosome 14 open reading frame 178"	Q8N769	14	77760830-77769742	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 8.5;testis: 13.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 4.6;TIME: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA062581	Uncertain									"HPA062581: "	"unprognostic (2.50e-2)"	"unprognostic (1.65e-3)"		"unprognostic (1.84e-2)"	"unprognostic (2.06e-1)"			"unprognostic (7.93e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.96e-2)"	"unprognostic (7.33e-4)"	"unprognostic (2.10e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.20e-2)"	0.8	0.7	4.6	1.4	2.6	3.9	1.0	1.7	3.2	0.8	0.9	1.7	0.0	0.8	1.4	4.5	1.5	0.8	1.5	1.0	1.5	1.4	0.8	0.8	0.7	2.0	1.5	0.4	1.6	0.5	1.5	1.9	2.5	2.5	1.0	0.8	1.5	1.1	0.6	1.7	4.9	0.9	0.3	1.4	1.1	0.6	13.7	0.8	0.4	2.1	0.6	1.3	1.1	0.7	6.5	8.5	1.5	3.1	5.1	4.2	1.5	0.2	1.1	2.7	1.9	2.2	0.0	1.1	0.4	0.3	0.5	0.5	4.6	2.4	0.9	0.6	1.0	0.9	0.3	0.0	1.1	0.6	1.6	0.5	1.0	2.2	0.7	0.8	1.8	0.5	0.0	0.0	1.5	0.0	0.4	1.3	0.5	1.7	1.7	1.6	1.9	0.0	1.2	0.3	0.7	0.0	2.2	1.9	0.3	1.5	2.1	0.1	1.3	0.3	4.9	1.1	1.1	1.3	0.2	1.3	0.9	1.6	0.7	2.2	0.4	0.2	1.1	0.4	4.2	3.1	2.9	3.5	1.4	1.9	0.5	6.5	3.0	2.3	1.5	5.1	2.4	8.5	0.4	1.5	4.6	2.6	1.7	3.2	1.5	1.4	1.5	0.4	2.5	0.8
C14orf28	DRIP-1	ENSG00000179476	"Chromosome 14 open reading frame 28"	Q4W4Y0	14	44897295-44907257	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059635			Approved	Cytosol				Cytosol		"HPA059635: "	"unprognostic (5.41e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.06e-6)"	"unprognostic (1.18e-1)"	"unprognostic (6.64e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.13e-3)"	"unprognostic (7.33e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.01e-1)"	8.8	5.3	5.0	4.1	5.6	1.6	11.8	4.0	6.2	13.3	10.3	7.2	10.7	7.3	14.4	8.4	6.5	9.2	8.9	8.5	4.8	4.1	5.1	14.4	5.1	4.4	10.6	4.3	12.4	12.4	4.4	5.0	5.7	5.6	12.8	5.8	5.9	11.4	8.7	7.4	5.9	9.0	20.4	5.4	5.9	8.5	16.1	5.4	1.7	6.6	3.2	5.0	19.0	9.2	6.8	3.4	6.9	3.5	3.9	9.7	2.1	2.3	1.7	3.2	5.5	6.5	3.5	7.3	4.8	5.3	2.4	3.7	0.1	3.1	3.1	2.9	3.3	1.3	0.8	2.3	4.1	11.5	0.6	1.5	0.8	3.2	1.9	1.3	3.6	2.7	3.9	0.7	3.8	1.2	0.8	4.5	1.8	4.6	1.3	2.7	0.6	1.9	2.3	4.0	1.3	3.3	3.1	0.7	1.0	2.0	3.9	2.1	7.0	1.4	1.9	8.9	4.4	1.5	0.9	6.2	5.0	2.0	2.6	0.7	2.8	1.8	1.7	6.9	4.3	2.6	4.9	6.8	4.4	5.6	2.0	5.1	9.7	5.5	3.8	3.9	3.5	3.4	4.8	2.1	5.0	5.6	4.0	6.2	4.8	4.1	10.6	4.3	5.6	5.4
C14orf39	SIX6OS1	ENSG00000179008	"Chromosome 14 open reading frame 39"	Q8N1H7	14	60396469-60515543	"Plasma proteins, Predicted intracellular proteins"	"DNA recombination, Meiosis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 16.9;salivary gland: 6.7;testis: 14.9"	"Cell line enhanced"	"Detected in some"		"HEL: 5.4;HSkMC: 4.2;MOLT-4: 20.4;RH-30: 5.6;U-2 OS: 11.5"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA059518	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA059518: "	"unprognostic (6.17e-2)"	"unprognostic (1.73e-3)"		"unprognostic (3.00e-6)"	"unprognostic (2.78e-1)"	"unprognostic (6.97e-2)"		"unprognostic (7.55e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"		"unprognostic (7.46e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	1.0	2.7	0.0	0.6	0.2	0.0	0.1	0.0	0.5	0.5	0.8	0.0	0.0	0.3	0.6	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.4	1.7	0.0	0.6	16.9	0.0	0.2	1.6	0.0	1.6	6.7	0.1	3.8	0.0	0.3	0.1	0.5	0.0	0.6	14.9	0.0	0.0	0.4	1.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	5.4	0.0	0.0	0.0	0.0	0.3	4.2	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.0	20.4	0.2	2.7	1.3	0.0	5.6	0.0	0.3	1.5	0.1	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	1.4	0.1	0.4	0.2	0.0
C15orf48	"MIR147BHG, NMES1"	ENSG00000166920	"Chromosome 15 open reading frame 48"	Q9C002	15	45430529-45448761	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 95.5;lymphoid tissue: 56.1;testis: 47.2"	"Cell line enhanced"	"Detected in some"		"A-431: 24.2;CAPAN-2: 45.6;HMC-1: 10.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"classical monocyte: 3.2;intermediate monocyte: 3.7;myeloid DC: 3.0;neutrophil: 2.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 3.0;granulocytes: 2.1;monocytes: 3.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA012943	Enhanced									"HPA012943: "	"unprognostic (5.29e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.74e-3)"	"unprognostic (1.48e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.95e-2)"	"unprognostic (8.86e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.66e-1)"	0.6	0.1	0.4	56.1	0.4	7.2	2.9	0.4	0.4	9.0	87.2	0.5	26.0	6.0	0.9	0.9	33.5	0.6	6.0	2.8	0.4	0.1	1.4	1.6	11.2	0.4	0.4	0.4	0.6	3.3	0.0	0.4	10.6	0.5	2.5	95.5	0.8	6.1	21.5	0.5	14.9	54.6	3.1	0.8	0.6	10.8	47.2	0.4	1.6	0.9	33.1	19.6	1.4	10.9	0.0	3.0	2.1	3.7	0.0	0.2	1.6	24.2	6.0	0.0	0.1	0.3	0.0	1.0	1.2	8.7	1.6	4.5	0.9	45.6	0.0	1.1	0.1	0.6	0.7	0.3	3.9	2.7	0.6	0.0	0.1	0.1	4.1	0.0	10.6	0.4	0.4	8.1	0.0	0.0	0.0	0.2	0.2	1.1	0.0	0.6	0.0	0.1	0.0	0.1	0.1	1.0	1.9	0.0	0.2	1.4	2.8	0.1	0.5	0.5	0.2	0.2	0.5	0.3	0.3	0.7	0.4	0.1	0.8	0.2	0.1	0.0	3.2	0.3	0.2	3.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	2.1	0.0	0.4	0.5	0.0	1.6	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.5	0.4
C15orf53	FLJ35695	ENSG00000175779	"Chromosome 15 open reading frame 53"	Q8NAA6	15	38628005-39180499	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 8.0;gallbladder: 6.3"	"Group enriched"	"Detected in some"	9	"HEL: 4.6;HMC-1: 3.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.2"	"Cell type enriched"	"Detected in single"	10	"T-reg: 8.0"	"Lineage enriched"	"Detected in single"	81	"T-cells: 8.0"									HPA041914	Uncertain									"HPA041914: AB_10794640"	"unprognostic (9.94e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.30e-1)"			"unprognostic (5.38e-5)"	"unprognostic (1.02e-1)"	"unprognostic (8.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.30e-1)"	"unprognostic (3.58e-1)"		"unprognostic (4.30e-5)"	"unprognostic (2.59e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.49e-3)"	0.2	0.1	0.1	2.8	0.1	0.2	0.2	0.4	0.1	0.3	1.9	0.0	0.0	0.3	0.3	1.8	0.7	0.3	6.3	0.2	0.1	0.1	0.3	0.2	2.3	0.5	0.3	0.0	1.3	0.1	0.0	0.1	0.0	1.2	0.2	0.3	0.0	1.3	0.1	0.2	0.6	1.0	0.8	0.7	1.7	0.5	0.2	0.0	0.1	0.2	2.4	3.9	0.7	0.3	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.3	0.0	1.2	0.0
C15orf61	LOC145853	ENSG00000189227	"Chromosome 15 open reading frame 61"	A6NNL5	15	67521068-67530143	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 45.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062820			Approved	Nucleoli,Vesicles,Cytosol	"Secreted - unknown location"			"Nucleoli, Vesicles"	Cytosol	"HPA062820: "	"unprognostic (1.35e-1)"	"unprognostic (9.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.87e-3)"	"unprognostic (8.95e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.45e-2)"	"prognostic favourable (5.31e-5)"	"unprognostic (2.42e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	9.9	10.0	10.8	4.7	18.1	11.0	17.9	14.5	17.2	5.5	6.0	2.4	5.6	7.5	6.3	5.9	5.5	5.2	5.1	21.0	8.7	7.2	8.4	6.4	7.2	7.5	6.9	10.9	7.9	20.7	8.8	10.9	5.8	7.3	7.2	6.4	5.9	7.0	6.4	45.8	8.4	5.0	7.0	5.8	5.0	6.6	25.2	5.5	3.6	7.7	16.9	3.7	4.6	8.0	7.2	7.2	10.7	6.6	5.1	9.8	5.0	4.3	4.6	1.2	5.1	5.4	7.9	3.3	1.9	3.4	3.6	2.8	3.5	3.1	3.6	4.1	2.1	5.1	4.6	1.3	2.9	2.1	10.9	3.9	3.5	4.6	3.5	4.7	3.2	8.1	3.6	1.2	4.3	1.6	4.3	8.1	1.1	2.4	3.8	7.7	2.0	5.9	5.2	2.6	13.2	2.5	3.0	6.9	5.2	3.3	3.2	5.8	2.8	7.3	1.7	4.8	7.3	5.9	4.9	7.7	11.1	8.8	2.0	9.3	2.4	8.6	6.6	10.7	7.0	5.2	8.0	7.2	9.2	6.9	6.9	5.6	9.8	7.9	0.8	5.1	4.4	7.2	5.6	5.0	10.8	18.1	14.5	17.2	8.7	7.2	6.9	10.9	7.3	5.5
C15orf62	LOC643338	ENSG00000188277	"Chromosome 15 open reading frame 62"	A8K5M9	15	40770080-40772449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 22.8;lymphoid tissue: 21.9;tongue: 18.8"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 19.5;SK-BR-3: 6.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"olfactory region: 1.5"	"Low region specificity"	"Detected in all"			HPA044636	Approved									"HPA044636: AB_10794052"	"unprognostic (9.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.40e-1)"	1.5	0.9	0.8	1.5	1.1	1.5	1.1	4.0	1.7	1.7	1.0	0.8	0.8	2.0	1.1	0.8	22.8	0.9	1.4	0.8	0.8	0.6	0.9	1.9	1.6	2.1	1.1	0.8	1.3	0.9	0.0	1.3	0.8	0.9	1.1	0.0	0.8	5.4	1.8	1.9	11.9	1.8	0.8	0.8	1.5	1.2	0.9	0.8	1.8	1.0	18.8	21.9	0.9	3.8	0.4	0.7	0.0	0.1	0.4	1.0	0.1	0.6	0.5	1.8	2.2	0.7	0.2	0.4	0.8	0.2	0.0	0.2	2.0	2.4	1.1	2.0	0.0	4.4	0.8	0.0	0.0	1.6	1.8	1.1	4.0	0.6	0.0	0.9	1.4	0.2	1.0	0.0	0.1	0.6	0.9	1.3	0.0	0.5	1.4	1.7	0.7	0.8	1.5	0.3	0.5	19.5	1.6	3.9	0.9	0.6	6.2	0.2	2.2	1.4	0.9	2.2	1.0	2.0	0.7	1.5	1.0	1.0	0.7	3.3	0.7	0.0	0.0	0.0	0.7	0.1	0.2	0.0	0.9	0.6	0.0	0.4	1.0	1.0	0.0	0.4	0.0	0.7	0.8	0.1	0.8	1.1	4.0	0.9	0.8	0.6	1.1	0.8	0.9	0.8
C15orf65	FLJ27352	ENSG00000261652	"Chromosome 15 open reading frame 65"	H3BRN8	15	55408548-55418764	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 27.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.5"	"Group enriched"	"Detected in many"	5	"B-cells: 2.3;granulocytes: 6.5;monocytes: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA067189	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA067189: "	"unprognostic (2.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.50e-2)"	"prognostic favourable (3.18e-7)"	"unprognostic (1.59e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.16e-3)"	"unprognostic (6.69e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.80e-1)"	3.4	3.1	6.5	0.9	7.4	0.8	5.4	2.4	6.7	7.7	5.2	3.7	5.4	2.9	3.7	11.2	3.4	13.7	5.3	7.0	6.0	7.6	11.2	1.9	3.8	2.2	5.2	6.8	4.6	11.0	6.2	17.2	1.2	12.0	5.8	6.2	2.8	27.6	5.3	8.7	2.4	2.5	3.7	3.4	1.9	7.8	11.3	4.6	1.7	7.1	0.6	1.8	3.6	1.5	2.3	0.6	6.5	1.6	0.0	0.7	0.4	0.8	1.7	2.9	1.8	4.5	6.6	0.5	1.6	2.2	1.4	2.8	0.0	1.5	1.3	4.4	5.1	1.3	0.0	2.7	0.5	2.4	2.0	1.2	10.0	0.4	8.7	2.8	1.6	2.8	14.7	4.1	1.2	2.6	2.3	4.3	6.1	2.2	0.1	9.2	0.9	3.3	0.5	0.0	11.1	7.6	0.0	7.8	4.7	2.0	3.3	12.7	6.8	2.7	1.9	2.4	0.9	2.5	0.9	1.9	4.9	1.2	6.1	7.2	1.1	6.5	1.1	3.9	0.5	1.6	0.0	1.9	0.1	0.7	0.6	2.3	0.1	0.0	2.1	0.0	0.8	0.2	0.0	0.4	6.5	7.4	2.4	6.7	6.0	7.6	5.2	6.8	12.0	4.6
C16orf46	FLJ32702	ENSG00000166455	"Chromosome 16 open reading frame 46"	Q6P387	16	81053497-81077267	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 25.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041136, HPA041379"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041136: AB_10795535, HPA041379: AB_10794666"	"unprognostic (7.73e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.53e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.72e-2)"	2.0	2.5	5.2	1.8	6.8	2.2	3.1	3.3	8.6	2.8	1.4	3.5	1.3	1.3	2.8	4.4	1.7	8.6	2.0	1.4	5.8	5.8	2.4	3.0	2.2	1.1	5.9	6.0	1.7	2.6	2.9	14.4	3.2	8.6	3.0	1.4	3.5	2.0	2.4	2.5	1.0	1.0	1.9	4.2	1.1	1.1	25.2	2.5	1.5	8.9	0.5	1.3	1.9	1.3	0.2	0.4	1.1	0.4	0.0	2.0	0.0	2.8	0.4	1.1	0.5	5.1	1.0	2.6	0.5	3.5	1.9	1.1	0.6	4.0	0.7	1.8	0.7	1.0	1.1	1.9	3.5	0.6	0.7	0.8	2.3	2.7	3.0	1.0	2.1	2.1	1.5	4.6	2.8	1.7	1.7	1.4	1.5	1.9	0.3	5.4	1.2	0.6	2.1	0.3	0.4	3.4	1.6	1.5	1.3	3.9	1.3	0.7	1.2	1.4	1.3	0.9	0.4	0.8	0.7	1.5	2.1	1.6	1.8	1.4	0.9	0.0	0.4	1.1	0.2	0.0	2.0	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.0	0.0	0.2	0.4	0.0	0.0	5.2	6.8	3.3	8.6	5.8	5.8	5.9	6.0	8.6	2.5
C16orf71	"DKFZp686H2240, FLJ43261"	ENSG00000166246	"Chromosome 16 open reading frame 71"	Q8IYS4	16	4734272-4749396	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"fallopian tube: 14.1;testis: 48.9"	"Cell line enhanced"	"Detected in many"		"MCF7: 7.5;U-2197: 8.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.1"	"Low lineage specificity"	"Detected in many"											HPA049468	Enhanced		Uncertain	"Nuclear speckles"				"Nuclear speckles"		"HPA049468: AB_2680779"	"unprognostic (1.24e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.39e-1)"	"prognostic favourable (7.49e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.79e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.54e-5)"	"unprognostic (1.65e-1)"	0.3	0.5	0.7	0.3	1.9	0.0	0.3	1.0	1.0	0.9	0.3	2.4	0.6	0.2	0.6	2.5	0.4	14.1	0.8	0.3	1.1	1.0	1.0	1.1	1.7	0.1	0.7	0.5	1.2	0.4	0.8	1.7	0.1	3.6	0.5	0.1	0.4	1.3	1.1	0.4	0.2	0.3	0.4	0.5	0.2	0.3	48.9	0.7	0.2	1.1	0.0	0.4	0.3	0.5	1.4	4.1	0.0	1.1	0.0	0.7	0.4	0.6	3.2	0.7	1.9	4.3	1.9	1.4	1.8	1.5	1.4	1.9	1.5	1.3	0.1	1.8	2.6	1.5	1.7	1.7	0.3	0.7	1.1	0.4	2.4	0.1	1.3	1.4	0.6	0.5	0.4	5.7	1.5	0.8	1.1	0.9	1.5	7.5	0.4	1.2	1.0	1.6	0.5	0.8	2.2	4.0	0.7	4.9	1.8	1.8	1.5	0.6	6.6	0.4	0.6	1.2	1.3	8.2	0.9	3.2	2.5	0.8	0.7	0.4	1.3	0.0	0.7	0.0	0.2	0.2	0.0	0.0	0.7	0.1	0.9	1.4	0.4	0.5	0.0	0.0	1.1	4.1	0.0	0.4	0.7	1.9	1.0	1.0	1.1	1.0	0.7	0.5	3.6	0.7
C16orf86	FLJ41802	ENSG00000159761	"Chromosome 16 open reading frame 86"	Q6ZW13	16	67666816-67668758	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.9"	"Cell line enhanced"	"Detected in many"		"HSkMC: 6.9;T-47d: 4.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA073475	Enhanced									"HPA073475: "	"unprognostic (1.01e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.33e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.68e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.05e-1)"	"unprognostic (8.35e-3)"	"prognostic favourable (1.47e-4)"	"unprognostic (1.59e-1)"	"prognostic favourable (2.12e-7)"	"unprognostic (1.34e-1)"	"unprognostic (4.22e-1)"	"unprognostic (5.92e-2)"	"unprognostic (3.05e-1)"	4.6	3.4	2.0	2.9	5.9	1.6	2.6	8.6	4.0	2.5	2.9	2.6	5.8	0.9	3.0	4.2	2.8	2.8	4.7	4.1	1.9	2.3	3.7	3.6	2.4	3.6	2.6	2.1	2.3	1.9	4.6	2.2	2.4	3.9	3.5	1.3	2.6	2.9	3.1	6.7	1.3	1.9	2.6	3.0	3.1	1.6	26.9	3.0	4.5	2.6	1.3	2.2	2.9	1.8	5.9	10.2	4.1	3.3	1.2	2.6	2.5	0.3	0.9	1.4	0.5	2.0	1.8	1.3	1.7	3.6	0.8	1.2	0.1	0.0	0.1	0.9	1.8	0.1	0.2	0.4	0.3	0.0	0.2	0.2	0.2	0.0	3.6	0.1	1.9	6.9	0.2	1.5	0.2	1.5	0.3	4.3	1.8	0.0	0.2	0.9	0.6	0.0	2.5	0.0	3.0	4.3	0.2	1.0	0.5	0.0	0.0	0.2	4.4	0.6	0.1	0.2	0.1	0.9	0.1	0.5	1.2	1.2	1.5	0.2	0.3	1.7	3.3	4.1	1.1	1.0	1.8	2.9	2.6	1.5	5.3	5.9	0.9	1.7	1.1	1.2	1.1	10.2	1.8	2.5	2.0	5.9	8.6	4.0	1.9	2.3	2.6	2.1	3.9	3.0
C16orf95		ENSG00000260456	"Chromosome 16 open reading frame 95"	Q9H693	16	87083562-87317420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 47.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA040850, HPA067924"	Supported		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA040850: AB_10794882, HPA067924: "	"unprognostic (3.51e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.92e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.23e-1)"	1.5	1.7	1.7	1.0	2.6	2.2	0.8	1.5	2.0	0.5	1.0	1.5	1.2	1.2	0.7	1.2	0.5	0.8	1.2	1.0	1.7	1.4	1.1	2.6	0.7	0.9	1.9	0.9	0.7	2.1	1.0	0.9	0.5	1.8	0.6	0.6	0.9	1.1	1.2	3.0	0.5	1.2	1.2	1.3	0.7	1.1	47.2	1.1	1.2	0.7	0.6	0.9	0.7	0.4	3.4	6.0	1.1	6.0	1.5	5.7	3.2	3.2	9.0	3.1	3.8	3.6	2.1	5.4	2.9	1.2	3.0	2.3	4.3	5.1	8.0	8.5	0.6	2.6	2.9	2.0	1.4	3.9	5.2	7.5	3.1	5.9	3.2	0.8	1.5	3.7	0.7	3.4	1.1	2.8	6.7	4.1	3.5	8.3	2.7	6.8	2.9	5.4	6.3	1.4	4.5	1.7	1.3	3.9	3.2	7.3	0.4	2.4	4.4	3.6	3.2	5.5	2.3	3.2	2.8	12.4	10.0	15.2	7.3	7.5	3.7	0.0	4.9	1.1	4.9	4.8	3.6	3.4	4.3	4.5	4.5	2.9	3.5	5.7	0.8	1.5	6.0	6.0	5.1	3.2	1.7	2.6	1.5	2.0	1.7	1.4	1.9	0.9	1.8	1.1
C17orf107		ENSG00000205710	"Chromosome 17 open reading frame 107"	Q6ZR85	17	4899418-4902932	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 25.7;salivary gland: 26.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 5.4;HMC-1: 7.2;hTCEpi: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 6.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.7"	"Not detected"	"Not detected"							HPA069713	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA069713: "	"prognostic favourable (5.06e-5)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.61e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.05e-1)"	"prognostic favourable (8.61e-4)"	"unprognostic (1.17e-1)"	"prognostic favourable (2.68e-4)"	"unprognostic (9.29e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.12e-1)"	2.4	3.7	5.0	2.3	5.1	4.2	3.0	7.7	8.7	3.9	1.4	0.2	5.9	2.1	1.9	5.9	1.3	1.8	3.3	15.3	3.8	4.3	2.2	8.8	2.9	1.0	1.6	4.2	6.4	7.7	6.2	25.7	1.5	1.7	4.5	0.9	2.1	26.0	6.4	0.6	3.3	1.6	1.2	2.2	2.1	4.6	4.7	0.6	0.1	1.9	0.6	2.7	3.3	1.9	0.0	0.0	6.7	0.2	0.0	0.9	0.1	0.6	0.8	1.0	0.3	2.1	1.7	1.5	3.8	0.5	0.2	0.5	0.7	0.7	0.4	0.6	5.4	1.4	0.1	0.5	0.3	0.1	0.8	2.0	0.6	0.7	3.0	0.0	7.2	1.7	6.5	0.1	0.4	0.2	0.0	0.1	0.1	0.7	0.1	0.6	0.3	0.7	0.3	0.2	2.8	0.3	0.3	0.1	0.5	0.6	2.3	0.3	0.6	1.0	0.5	0.3	0.7	0.6	0.5	0.6	0.6	0.1	0.4	0.1	0.3	0.0	0.2	0.8	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.8	6.7	0.0	0.1	0.0	0.0	0.1	5.0	5.1	7.7	8.7	3.8	4.3	1.6	4.2	1.7	0.6
C17orf47	FLJ40121	ENSG00000181013	"Chromosome 17 open reading frame 47"	Q8NEP4	17	58541587-58544368	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	36	"testis: 26.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.0;Karpas-707: 1.5;MCF7: 2.6;SCLC-21H: 1.5;T-47d: 1.6;U-138 MG: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA028424	Uncertain									"HPA028424: AB_10601690"	"unprognostic (4.97e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.62e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.62e-8)"	"unprognostic (9.29e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.01e-3)"	"unprognostic (3.37e-3)"	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.2	0.4	0.3	0.1	0.1	0.1	0.1	0.5	0.0	0.3	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.4	0.3	26.7	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	2.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	2.6	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.1	1.5	0.3	0.1	0.2	0.0	1.6	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.6	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
C17orf50		ENSG00000270806	"Chromosome 17 open reading frame 50"	Q8WW18	17	35760897-35765079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 63.6"	"Cell line enriched"	"Detected in some"	5	"HaCaT: 10.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 2.3;dendritic cells: 3.5;T-cells: 3.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA043184, HPA063464"			Supported	Nucleoplasm				Nucleoplasm		"HPA043184: , HPA063464: "	"unprognostic (2.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.84e-2)"	"unprognostic (5.12e-3)"		"unprognostic (2.04e-2)"		"unprognostic (1.97e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.68e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.54e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	63.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.5	0.0	0.6	0.2	3.7	0.6	0.0	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1.2	0.1	0.0	10.6	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.1	0.1	0.0	0.0	0.3	0.0	0.5	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.6	1.9	2.3	2.0	1.2	0.0	1.9	3.5	3.7	0.0	0.2	0.0	3.5	0.0	0.6										
C17orf51	"FLJ12977, FLJ31874, FLJ33618"	ENSG00000212719	"Chromosome 17 open reading frame 51"	A8MQB3	17	21524790-21574458	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 41.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA052106	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"				"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA052106: "	"unprognostic (1.99e-1)"	"unprognostic (5.29e-2)"	"unprognostic (6.35e-3)"	"unprognostic (2.78e-3)"	"unprognostic (3.72e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.36e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.51e-3)"	"unprognostic (7.42e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.17e-1)"	"unprognostic (6.42e-5)"	"unprognostic (9.05e-3)"	6.1	7.2	8.0	4.2	8.4	0.8	3.0	41.2	20.5	5.3	4.5	5.2	3.1	3.2	8.3	10.1	3.2	6.7	3.6	6.5	8.6	7.3	4.0	3.8	3.0	3.0	5.9	8.1	5.9	6.6	7.8	8.9	2.1	5.5	6.3	3.2	3.8	5.0	7.0	7.3	3.0	2.4	6.6	5.0	3.3	4.1	9.2	5.9	1.2	2.9	2.2	3.0	4.0	4.7	4.2	4.1	1.2	3.9	2.6	6.0	1.8	2.6	6.1	2.3	7.9	7.3	6.9	2.1	7.1	3.5	5.2	5.9	12.1	0.4	3.5	4.0	3.9	0.3	9.8	3.7	8.6	11.0	15.2	0.7	5.6	5.0	13.6	0.9	3.9	6.5	3.4	10.5	11.4	3.7	1.9	0.8	4.4	0.0	7.6	0.3	4.3	5.2	7.4	4.8	0.5	1.9	0.5	5.1	0.9	6.6	0.2	5.2	0.1	0.3	6.6	6.1	6.3	14.5	8.5	2.3	2.8	13.5	7.3	1.3	7.1	0.0	3.9	0.0	4.0	1.8	3.1	2.2	1.9	1.8	1.9	4.2	6.0	5.1	1.2	2.6	1.0	4.1	1.7	1.8	8.0	8.4	41.2	14.5	8.6	7.3	5.9	8.1	5.5	5.9
C17orf64		ENSG00000141371	"Chromosome 17 open reading frame 64"	Q86WR6	17	60392429-60431421	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 74.5"	"Cell line enhanced"	"Detected in some"		"MCF7: 10.8;THP-1: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 5.8;granulocytes: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044415	Enhanced		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA044415: AB_10797148"	"unprognostic (3.00e-1)"	"unprognostic (2.60e-2)"		"unprognostic (2.36e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.68e-6)"	"unprognostic (3.30e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.80e-2)"	"unprognostic (5.46e-2)"	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	74.5	0.1	0.2	0.0	0.1	0.1	0.0	0.0	1.0	5.8	2.5	0.6	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.1	1.2	0.0	0.0	0.0	0.6	0.7	1.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	1.7	0.2	0.5	1.7	0.0	0.1	0.0	0.0	0.0	0.6	0.0	10.8	0.3	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.0	2.7	0.3	0.0	0.1	0.0	0.0	1.7	1.3	0.2	0.0	1.4	0.0	0.0	0.6	0.0	0.1	0.5	0.0	1.0	0.3	0.0	1.8	0.2	0.0	0.6	2.5	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.1
C17orf80	"FLJ20721, HLC-8, MIG3, SPEP1"	ENSG00000141219	"Chromosome 17 open reading frame 80"	Q9BSJ5	17	73232233-73248947	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA012896	Uncertain		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA012896: AB_1850766"	"unprognostic (9.22e-2)"	"unprognostic (1.62e-1)"	"prognostic favourable (1.43e-4)"	"unprognostic (5.55e-3)"	"unprognostic (8.58e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (9.02e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.37e-1)"	8.0	10.5	12.8	8.5	13.2	2.4	10.6	27.8	15.4	11.3	11.7	8.4	5.3	9.1	13.1	9.0	10.8	11.2	7.8	13.5	13.8	10.0	11.5	8.6	10.2	11.0	11.8	12.7	16.0	10.1	17.2	24.9	10.9	11.8	11.6	9.0	9.4	9.0	11.2	22.2	7.5	10.4	12.4	14.4	9.9	9.7	32.5	11.3	16.1	14.6	8.3	10.3	10.3	13.3	6.5	7.1	14.6	5.0	5.2	8.7	3.9	9.8	10.4	14.5	8.8	10.7	9.2	14.1	13.0	11.3	18.5	17.6	9.9	8.2	18.8	9.3	6.6	9.9	20.1	7.5	21.7	6.8	13.7	17.3	11.0	11.5	9.3	18.1	10.2	7.1	9.4	12.3	10.2	15.8	18.6	11.3	12.3	5.6	21.0	8.6	11.5	11.3	12.7	39.9	9.6	9.6	7.5	17.8	16.0	6.9	12.7	15.1	13.9	11.5	8.6	19.4	17.9	6.2	12.3	12.8	15.2	18.1	7.8	8.3	12.3	14.6	4.0	5.7	8.5	5.0	8.7	6.5	6.3	7.5	4.6	5.8	6.0	8.6	1.9	5.2	4.7	7.1	8.6	3.9	12.8	13.2	27.8	15.4	13.8	10.0	11.8	12.7	11.8	11.3
C17orf97	"LIAT1, LOC400566"	ENSG00000187624	"Chromosome 17 open reading frame 97"	Q6ZQX7	17	410327-431062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 9.0;U-2197: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.7"	"Low lineage specificity"	"Detected in many"											HPA023583	Approved		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA023583: AB_1853122"	"unprognostic (6.62e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.07e-3)"	"unprognostic (7.73e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.12e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.98e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.19e-2)"	2.1	4.9	6.0	2.4	10.6	1.9	2.7	5.2	8.7	3.9	3.6	4.2	4.4	2.2	3.5	4.5	2.4	13.6	6.6	3.8	5.2	6.1	7.6	1.9	3.8	2.8	4.0	7.6	3.8	3.8	3.4	8.2	1.4	6.2	3.3	2.9	4.2	3.5	5.8	4.3	2.5	4.7	1.9	2.8	2.1	2.4	53.2	2.9	5.0	6.9	1.8	1.9	3.1	1.8	0.4	0.9	2.7	0.4	0.8	1.4	0.2	2.6	3.9	1.8	2.2	1.0	0.8	0.9	2.0	1.4	1.5	1.0	0.1	4.0	0.7	1.5	4.3	9.0	4.9	1.0	1.5	0.3	0.6	1.9	3.4	0.3	3.4	0.4	0.8	1.0	2.5	3.4	0.4	1.5	0.3	0.1	1.0	2.3	6.5	3.5	2.8	1.2	0.7	0.4	2.4	6.3	2.3	0.6	2.1	2.4	3.4	0.5	2.0	2.9	1.5	1.9	0.9	12.0	0.8	0.2	0.2	0.0	2.3	0.9	1.1	0.4	0.4	2.7	0.3	0.2	0.0	0.2	0.2	0.8	0.5	0.4	1.4	1.3	0.2	0.8	0.4	0.9	0.0	0.2	6.0	10.6	5.2	8.7	5.2	6.1	4.0	7.6	6.2	2.9
C18orf63	DKFZP781G0119	ENSG00000206043	"Chromosome 18 open reading frame 63"	Q68DL7	18	74315813-74359187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	48	"testis: 17.4"	"Cell line enhanced"	"Detected in single"		"CACO-2: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA042233			Approved	Mitochondria				Mitochondria		"HPA042233: AB_10960843"								"unprognostic (1.40e-1)"					"unprognostic (1.43e-4)"					0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C19orf18	MGC41906	ENSG00000177025	"Chromosome 19 open reading frame 18"	Q8NEA5	19	57958437-57974534	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 22.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 4.5;HEK 293: 6.5;RT4: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA014527	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA014527: AB_1845612"	"unprognostic (5.38e-2)"	"unprognostic (6.36e-3)"	"unprognostic (3.70e-2)"	"prognostic favourable (5.07e-4)"	"unprognostic (4.85e-2)"	"unprognostic (9.50e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.40e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.08e-5)"	"unprognostic (1.11e-2)"	"unprognostic (8.75e-5)"	"unprognostic (1.53e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.05e-3)"	1.1	1.7	1.4	1.1	1.8	0.4	3.6	1.1	1.1	1.1	1.3	1.1	1.1	0.8	1.4	5.6	1.1	1.8	1.4	4.2	1.9	1.8	1.1	1.1	1.1	1.1	2.1	1.1	1.3	1.1	1.0	3.6	1.1	3.1	2.7	0.8	1.1	1.2	1.6	4.2	1.2	1.1	1.1	2.3	1.1	0.8	22.6	1.1	1.1	1.3	1.1	1.1	1.1	1.1	2.8	1.6	0.7	0.9	0.8	1.2	0.4	0.2	0.0	1.8	4.5	1.1	1.5	1.4	2.2	0.5	0.6	1.4	0.0	0.4	0.4	1.0	0.6	0.1	0.1	0.0	1.5	0.0	6.5	0.4	0.0	1.5	1.6	0.0	1.1	1.8	2.6	0.1	0.4	0.3	0.2	0.0	3.2	0.0	0.9	0.0	0.1	0.4	1.3	0.0	1.2	1.1	4.3	1.9	0.4	0.9	0.0	0.6	1.5	1.4	0.9	0.3	0.4	0.5	0.5	0.9	3.8	0.1	0.0	0.0	0.5	0.0	0.6	0.7	0.1	0.2	0.0	2.8	1.0	0.6	1.6	1.3	0.6	1.2	0.5	0.8	0.9	1.0	0.0	0.4	1.4	1.8	1.1	1.1	1.9	1.8	2.1	1.1	3.1	1.1
C19orf38	HIDE1	ENSG00000214212	"Chromosome 19 open reading frame 38"	A8MVS5	19	10836575-10869790	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 58.7;bone marrow: 54.4"	"Cell line enriched"	"Detected in some"	4	"U-937: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"classical monocyte: 44.3;eosinophil: 26.1;intermediate monocyte: 48.7;myeloid DC: 26.2;neutrophil: 37.3;non-classical monocyte: 58.7"	"Group enriched"	"Detected in many"	19	"dendritic cells: 26.2;granulocytes: 37.3;monocytes: 58.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA012150, HPA055027"			Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"				Cytosol	"Golgi apparatus, Plasma membrane"	"HPA012150: AB_10603448, HPA055027: "	"unprognostic (6.65e-3)"	"prognostic favourable (2.43e-4)"	"unprognostic (6.44e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.56e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavourable (1.75e-7)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.11e-2)"	2.7	1.2	2.1	6.9	4.0	54.4	1.8	0.7	3.1	2.0	1.3	4.8	0.0	1.3	0.9	4.0	0.9	2.6	2.1	5.6	2.4	2.1	1.4	2.3	12.8	19.6	4.2	0.6	1.6	1.3	0.3	1.0	1.9	3.8	1.6	1.0	1.5	1.0	0.8	2.3	0.6	1.7	2.3	6.3	22.3	1.2	15.0	3.7	4.1	0.7	0.5	2.0	2.8	3.5	2.1	26.2	37.3	58.7	1.2	0.8	20.7	1.5	0.0	0.1	0.3	1.4	0.8	0.1	0.2	0.0	0.2	0.6	0.1	0.2	3.7	0.3	0.0	0.1	0.2	0.2	0.2	1.7	0.4	0.2	0.0	0.0	1.1	2.4	0.4	4.0	0.4	0.7	0.2	0.1	0.2	7.9	0.1	1.3	0.1	5.7	0.3	0.2	2.8	0.0	1.9	0.0	0.1	0.2	0.1	0.7	0.0	0.5	0.1	5.5	0.0	0.0	0.0	0.7	0.0	4.8	2.2	1.1	0.0	32.0	0.0	1.2	44.3	26.1	0.1	48.7	0.2	2.1	0.1	0.1	26.2	1.2	0.8	0.2	37.3	1.2	58.7	0.5	0.3	20.7	2.1	4.0	0.7	3.1	2.4	2.1	4.2	0.6	3.8	3.7
C1orf100		ENSG00000173728	"Chromosome 1 open reading frame 100"	Q5SVJ3	1	244352635-244389663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	66	"testis: 65.3"	"Cell line enriched"	"Detected in single"	51	"K-562: 10.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA031179, HPA031180"			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA031179: AB_10599995, HPA031180: AB_10599026"	"unprognostic (9.84e-2)"	"unprognostic (2.14e-3)"	"unprognostic (3.37e-2)"	"unprognostic (9.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.45e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.67e-5)"	"unprognostic (1.85e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
C1orf141		ENSG00000203963	"Chromosome 1 open reading frame 141"	Q5JVX7	1	67092165-67231853	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 14.9;fallopian tube: 12.8;testis: 18.7"	"Cell line enriched"	"Detected in single"	37	"HEL: 17.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"pons and medulla: 14.9"	"Group enriched"	"Detected in some"	5	"basophil: 2.5;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.5"					"Low region specificity"	"Detected in all"			HPA035316			Uncertain	"Intermediate filaments"				"Intermediate filaments"		"HPA035316: AB_10600886"					"unprognostic (1.48e-1)"			"unprognostic (8.09e-2)"		"unprognostic (2.71e-1)"	"unprognostic (2.79e-3)"			"unprognostic (1.01e-1)"	"unprognostic (2.20e-2)"			0.0	0.0	1.1	0.0	2.6	0.0	0.0	0.1	1.3	0.3	0.1	1.9	0.0	0.0	0.1	1.1	0.0	12.8	0.2	0.0	2.6	1.8	0.1	0.1	2.0	0.1	0.3	0.7	1.8	0.0	0.0	1.0	0.0	14.9	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.5	0.0	0.2	18.7	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	2.5	0.1	0.4	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	17.7	0.4	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.4	0.0	0.1	0.0	0.5	1.1	2.6	0.1	1.3	2.6	1.8	0.3	0.7	14.9	0.9
C1orf158	MGC35194	ENSG00000157330	"Chromosome 1 open reading frame 158"	Q8N1D5	1	12746215-12763699	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 23.5;testis: 74.6"	"Low cell line specificity"	"Detected in some"			"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.6;glioma: 1.0;ovarian cancer: 0.5"	"Region enhanced"	"Detected in many"		"pons and medulla: 9.3"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 0.5"	HPA028396			Uncertain	Cytosol				Cytosol		"HPA028396: AB_10603451"	"unprognostic (1.11e-2)"			"unprognostic (4.94e-3)"	"unprognostic (4.62e-1)"			"unprognostic (8.00e-2)"		"unprognostic (4.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.45e-1)"		"unprognostic (3.51e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-2)"		0.0	0.0	0.7	0.0	2.4	0.3	0.0	0.0	0.2	0.9	0.0	6.2	0.0	0.0	0.4	4.2	0.1	23.5	0.1	0.0	1.0	1.4	0.0	0.0	2.8	0.1	0.2	0.1	4.8	0.1	0.0	0.4	0.1	9.3	0.0	0.0	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.2	0.1	0.1	74.6	0.9	0.0	0.5	0.0	0.1	0.0	0.0	0.9	0.6	2.3	0.6	1.1	0.8	0.1	0.5	1.3	1.1	0.7	0.6	0.0	1.0	0.1	0.3	0.2	0.2	1.3	0.7	1.1	0.3	0.3	0.4	0.1	0.1	0.2	0.2	0.7	1.1	1.9	0.5	0.0	0.9	1.0	0.1	0.7	0.2	0.1	0.0	0.9	1.4	0.3	0.5	0.2	0.7	1.5	0.5	0.6	0.3	0.9	0.1	0.5	1.8	0.8	0.5	0.6	0.3	0.7	0.2	0.5	0.5	0.8	0.4	0.8	0.6	0.5	1.2	1.0	1.1	0.5	1.6	0.6	0.5	0.7	0.5	0.6	0.5	0.5	0.5	0.1	0.9	0.8	0.7	2.3	1.1	0.6	0.6	0.4	0.1	0.7	2.4	0.0	0.2	1.0	1.4	0.2	0.1	9.3	0.9
C1orf159	FLJ20584	ENSG00000131591	"Chromosome 1 open reading frame 159"	Q96HA4	1	1081818-1116361	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA010019	Approved									"HPA010019: AB_1078885"	"unprognostic (2.79e-1)"	"unprognostic (9.46e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.60e-3)"	"prognostic unfavourable (9.58e-6)"	"unprognostic (1.34e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.26e-3)"	"prognostic unfavourable (1.77e-6)"	"unprognostic (4.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (7.56e-2)"	"prognostic favourable (1.62e-4)"	3.7	6.6	8.3	4.9	9.0	5.6	3.1	7.6	10.0	5.5	6.0	11.3	5.4	6.1	6.0	6.9	6.6	4.0	5.9	3.8	8.8	5.8	5.0	5.0	5.6	4.2	6.6	4.9	5.8	5.3	2.2	4.4	5.6	5.0	6.6	1.8	5.8	10.2	6.5	3.6	23.7	5.5	7.5	5.2	7.0	9.0	17.5	5.6	5.2	4.0	5.2	6.4	5.4	4.4	5.0	4.3	9.9	4.9	4.7	5.7	3.9	11.8	9.6	4.5	7.8	1.4	1.4	10.1	6.7	1.6	6.1	4.1	5.1	12.5	3.4	8.3	2.1	9.8	1.9	6.3	1.7	6.4	13.9	2.3	16.4	5.3	2.9	3.9	5.6	3.1	2.9	3.2	1.2	2.9	13.7	2.7	2.2	9.1	7.3	10.1	4.1	15.4	9.1	5.2	6.1	3.5	4.3	9.3	12.4	5.2	9.4	5.3	6.6	5.1	4.9	6.6	7.0	9.7	6.9	4.5	6.0	5.9	5.7	10.8	5.3	9.9	4.9	2.6	5.3	4.4	5.4	5.0	4.9	5.7	3.2	4.7	5.3	5.0	1.1	4.7	3.1	4.3	1.7	3.9	8.3	9.0	7.6	10.0	8.8	5.8	6.6	4.9	5.0	5.6
C1orf162	MGC24133	ENSG00000143110	"Chromosome 1 open reading frame 162"	Q8NEQ5	1	111473792-111478512	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 119.1;lymphoid tissue: 86.6"	"Group enriched"	"Detected in some"	7	"HDLM-2: 44.4;HL-60: 21.6;NB-4: 12.0;THP-1: 17.1;U-937: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA026988	Approved									"HPA026988: AB_10600887"	"unprognostic (8.79e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (3.14e-6)"	"unprognostic (1.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-1)"	39.8	9.3	9.2	25.1	17.9	37.5	20.1	4.6	9.3	5.2	6.3	4.9	0.8	2.7	5.4	7.4	4.9	10.2	11.7	14.8	13.4	4.7	17.3	14.8	40.1	86.6	17.5	1.9	5.8	4.5	1.3	9.7	5.6	15.3	5.0	6.9	5.0	5.9	2.5	7.2	3.6	8.3	13.5	31.0	78.1	5.8	6.1	13.9	10.6	6.2	1.1	20.0	7.2	6.7	24.7	83.3	98.7	119.1	40.1	27.8	74.8	0.1	0.0	0.1	0.3	0.1	0.2	0.2	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.2	44.4	0.1	0.1	0.1	0.0	0.2	21.6	3.6	0.0	0.8	0.3	0.3	0.6	0.1	0.1	0.1	0.1	0.1	12.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	17.1	0.0	0.2	0.3	0.2	0.2	0.2	0.0	0.2	0.1	35.9	0.4	68.4	82.5	98.7	14.2	119.1	4.1	17.5	17.7	8.2	83.3	24.7	27.8	16.8	11.4	40.1	86.3	24.9	5.0	74.8	9.2	17.9	4.6	9.3	13.4	4.7	17.5	1.9	15.3	13.9
C1orf167	"DKFZp434E1410, RP11-56N19.2"	ENSG00000215910	"Chromosome 1 open reading frame 167"	Q5SNV9	1	11761787-11789585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	22	"testis: 34.0"	"Cell line enriched"	"Detected in single"	52	"U-698: 25.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"											HPA039114	Enhanced									"HPA039114: AB_10673606"	"unprognostic (2.93e-3)"	"unprognostic (1.34e-2)"		"unprognostic (7.48e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.38e-4)"	"unprognostic (2.71e-1)"	"unprognostic (5.55e-3)"	"unprognostic (3.92e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.90e-3)"	"unprognostic (3.96e-2)"	"unprognostic (8.38e-5)"	"unprognostic (5.46e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.38e-2)"	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.1	34.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.2	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.3	0.0	0.9	1.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
C1orf194		ENSG00000179902	"Chromosome 1 open reading frame 194"	Q5T5A4	1	109105951-109113857	"Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 36.5;fallopian tube: 60.2;testis: 77.6"	"Cell line enhanced"	"Detected in some"		"AF22: 4.4;RPTEC TERT1: 1.0;SCLC-21H: 6.1;U-87 MG: 1.7"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8"	"Region enriched"	"Detected in many"	5	"pons and medulla: 36.5"	"Cell type enriched"	"Detected in some"	5	"eosinophil: 5.3"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031144, HPA049684"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA031144: AB_10602109, HPA049684: "	"unprognostic (9.91e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.28e-2)"	"prognostic favourable (1.36e-4)"	"unprognostic (3.03e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.91e-3)"	"unprognostic (5.27e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.98e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.08e-6)"	"unprognostic (4.18e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.27e-3)"	0.3	0.4	1.5	0.3	6.8	0.3	0.4	0.3	2.6	1.8	0.3	12.3	0.0	0.4	1.0	11.1	0.4	60.2	0.3	0.3	3.0	1.6	0.3	0.3	7.5	0.4	0.5	1.8	10.3	0.7	0.4	2.7	0.3	36.5	0.4	0.4	0.0	0.3	0.3	0.3	0.3	0.4	0.4	0.7	0.3	0.5	77.6	2.3	0.0	0.5	0.0	0.3	0.5	0.2	0.2	0.0	5.3	0.0	0.0	0.3	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	6.1	0.3	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.4	0.0	0.0	5.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	6.8	0.3	2.6	3.0	1.6	0.5	1.8	36.5	2.3
C1orf228	"MGC33556, NCRNA00082, p40"	ENSG00000198520	"Chromosome 1 open reading frame 228"	Q6PIY5	1	44674692-44725591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 14.0;testis: 17.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 8.4;MOLT-4: 6.9;NB-4: 9.8;U-937: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034769	Uncertain		Uncertain	Cytosol				Cytosol		"HPA034769: AB_10670979"	"unprognostic (2.01e-5)"	"unprognostic (4.28e-3)"	"unprognostic (7.27e-2)"	"prognostic favourable (8.64e-4)"	"unprognostic (9.23e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.22e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.25e-10)"	"unprognostic (1.99e-4)"	"unprognostic (1.50e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.09e-3)"	0.9	2.2	6.3	0.7	11.2	4.3	1.5	3.2	6.8	1.7	1.0	5.6	3.9	0.7	3.1	6.8	1.3	14.0	1.5	0.6	6.5	2.4	1.4	7.0	2.0	1.5	1.4	7.5	4.5	1.4	3.0	5.4	0.8	7.7	1.8	0.9	3.3	1.6	1.4	0.5	1.7	0.8	0.9	2.4	0.8	1.4	17.9	5.4	0.2	1.3	0.0	1.0	0.8	0.8	1.4	6.2	10.4	2.7	0.5	2.3	1.8	0.2	0.3	2.0	0.1	0.7	2.5	0.5	0.0	0.3	0.5	0.3	0.4	4.2	0.3	0.3	0.9	0.5	0.0	0.0	0.0	1.1	0.2	1.0	2.5	0.6	0.2	8.4	5.0	2.0	0.3	0.8	0.0	0.2	0.1	0.7	0.2	0.1	6.9	9.8	0.1	0.1	3.6	0.1	2.4	0.8	0.0	1.4	0.9	0.0	1.4	1.1	0.4	4.4	0.0	0.3	0.3	0.3	0.0	0.3	0.3	0.2	0.3	13.4	0.4	10.4	2.7	7.5	0.3	0.8	0.1	0.7	1.5	1.0	1.3	1.4	2.2	2.3	1.2	0.5	0.1	6.2	0.1	1.8	6.3	11.2	3.2	6.8	6.5	2.4	1.4	7.5	7.7	5.4
C1orf43	"DKFZp586G1722, NICE-3"	ENSG00000143612	"Chromosome 1 open reading frame 43"	Q9BWL3	1	154206706-154220637	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010725	Approved									"HPA010725: AB_1078341"	"unprognostic (3.90e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.87e-2)"	"unprognostic (6.15e-3)"	"prognostic unfavourable (6.57e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.23e-1)"	36.4	36.5	45.5	20.4	47.7	20.7	43.4	36.0	43.5	29.0	33.7	36.2	28.0	34.9	23.1	36.7	30.9	30.9	31.8	53.5	39.9	35.2	55.5	80.2	30.5	27.6	48.4	29.4	23.4	68.9	28.8	24.2	25.1	31.1	29.8	37.2	25.2	31.0	29.0	124.2	27.0	36.6	27.4	46.1	27.0	30.1	19.5	33.8	22.0	38.4	49.0	28.4	32.7	29.0	29.2	59.0	39.0	56.1	21.2	41.6	56.4	28.9	30.9	26.0	30.7	39.0	39.3	16.1	29.1	50.6	34.0	31.8	21.2	41.2	38.3	44.4	26.2	29.7	35.7	26.4	24.5	30.1	39.4	29.5	34.4	27.4	60.7	37.0	35.1	31.9	62.8	36.1	75.4	39.2	30.9	36.5	44.1	46.3	27.8	33.9	50.1	47.4	25.5	23.9	69.2	42.4	30.6	42.4	55.8	26.3	70.2	98.5	69.3	82.1	26.7	26.6	22.4	31.8	36.6	67.3	65.4	36.5	44.5	37.3	70.6	39.0	56.1	35.7	25.4	50.4	30.5	29.2	29.6	27.7	59.0	25.6	31.3	26.1	32.2	21.2	45.3	43.6	41.6	56.4	45.5	47.7	36.0	43.5	39.9	35.2	48.4	29.4	31.1	33.8
C1orf54	FLJ23221	ENSG00000118292	"Chromosome 1 open reading frame 54"	Q8WWF1	1	150268200-150280916	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 20.5;AN3-CA: 30.9;ASC diff: 22.0;ASC TERT1: 36.7;HSkMC: 29.7;HUVEC TERT2: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"myeloid DC: 36.2"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 36.2"	"Low region specificity"	"Detected in all"							"HPA026518, HPA043874"	Approved		Approved	"Plasma membrane"	"Secreted to blood"			"Plasma membrane"		"HPA026518: AB_1845647, HPA043874: "	"unprognostic (4.64e-3)"	"unprognostic (6.81e-3)"	"unprognostic (4.01e-3)"	"unprognostic (5.69e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.21e-1)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.48e-2)"	16.0	8.8	16.4	19.0	19.3	4.5	13.8	5.8	10.5	11.9	14.0	4.5	19.1	5.8	19.8	21.1	11.0	17.1	21.6	13.8	13.7	13.7	12.7	12.0	11.8	21.5	21.8	8.3	8.3	6.8	2.0	6.7	24.4	14.0	15.3	11.1	10.9	9.8	30.4	13.4	4.5	8.1	24.1	20.4	27.3	8.3	5.7	14.8	4.9	8.3	17.1	11.2	22.0	14.3	0.3	36.2	0.4	7.7	0.2	1.5	2.2	0.5	0.1	20.5	30.9	22.0	36.7	0.6	3.3	4.9	0.9	3.0	0.2	0.6	0.1	1.1	2.9	0.8	0.0	0.1	1.1	0.3	3.6	0.5	0.5	0.3	4.5	1.1	0.8	29.7	1.5	6.1	0.4	28.5	0.4	4.0	3.1	1.1	0.2	7.1	1.7	1.1	5.1	0.5	0.4	0.3	1.6	0.4	0.4	0.4	0.2	2.2	0.4	15.5	0.2	7.3	0.6	0.2	0.3	1.7	1.4	0.3	16.2	0.9	0.2	0.0	7.7	0.3	0.2	6.8	0.9	0.3	1.5	0.6	36.2	0.3	1.5	0.8	0.4	0.2	1.9	0.7	0.6	2.2	16.4	19.3	5.8	10.5	13.7	13.7	21.8	8.3	14.0	14.8
C1orf56	"FLJ20519, MENT"	ENSG00000143443	"Chromosome 1 open reading frame 56"	Q9BUN1	1	151047740-151051986	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"blood: 54.8;testis: 67.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 15.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037429, HPA037430"	Enhanced				"Secreted to blood"		90000000			"HPA037429: AB_10671755, HPA037430: AB_2675473"	"unprognostic (7.60e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.70e-3)"	"unprognostic (3.28e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.79e-2)"	3.3	6.4	2.9	2.0	3.6	0.9	3.1	3.8	3.5	3.7	2.7	5.2	5.1	2.9	3.4	5.6	3.1	4.3	4.6	5.6	3.1	2.1	4.0	6.4	2.6	2.8	3.3	2.0	4.8	7.0	3.9	6.3	3.0	3.4	4.7	1.2	4.3	6.5	6.4	4.0	3.3	2.0	3.8	2.3	2.7	3.1	67.7	3.8	0.7	7.1	1.2	1.7	3.3	3.0	16.3	7.8	54.8	15.4	15.5	28.4	1.0	3.9	8.0	2.8	1.2	4.7	4.6	2.5	2.2	3.3	1.5	1.1	3.5	5.7	0.9	3.7	2.4	5.4	1.5	0.3	0.8	5.1	1.7	1.0	6.3	4.2	3.2	1.1	0.8	3.3	1.7	2.2	0.8	2.2	2.1	2.0	1.3	15.5	1.5	2.7	4.6	4.5	1.3	2.7	2.8	1.2	2.2	3.7	7.3	7.2	3.7	5.2	7.4	2.9	2.2	1.9	3.5	5.1	2.0	4.9	3.8	12.5	3.7	0.6	2.4	54.8	7.3	13.7	27.8	15.4	20.8	14.2	24.2	24.2	5.5	16.3	20.6	28.4	20.2	15.5	12.7	7.8	13.7	1.0	2.9	3.6	3.8	3.5	3.1	2.1	3.3	2.0	3.4	3.8
C1orf74	"FLJ25078, URLC4"	ENSG00000162757	"Chromosome 1 open reading frame 74"	Q96LT6	1	209779208-209784559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028496	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA028496: AB_10602698"	"unprognostic (3.25e-1)"	"prognostic unfavourable (8.52e-6)"	"unprognostic (8.41e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.40e-2)"	2.5	3.9	5.7	5.5	8.5	2.3	5.8	10.4	8.9	2.7	3.8	5.8	4.0	3.3	2.3	5.2	10.4	2.8	2.3	4.1	3.7	2.9	4.9	4.1	2.2	9.8	5.1	4.6	2.5	4.5	4.5	6.5	3.4	4.8	4.6	5.2	3.9	5.1	2.7	2.3	15.0	4.1	2.4	4.9	4.9	3.9	3.9	5.0	4.9	3.2	0.0	5.7	3.9	4.7	6.3	5.5	5.9	1.9	2.8	2.9	1.9	5.6	3.0	1.9	1.1	2.6	2.9	4.4	3.2	4.2	3.9	4.1	5.9	4.4	5.9	1.9	2.1	11.4	1.2	9.3	4.6	5.9	3.8	3.9	2.2	0.5	3.6	5.5	1.8	1.7	8.3	4.8	8.0	2.3	7.7	4.3	3.4	2.8	4.6	5.7	7.9	5.1	4.9	9.0	8.3	3.3	4.9	7.6	8.2	4.4	3.4	4.8	5.3	2.9	2.1	3.4	3.9	3.4	5.1	4.0	4.0	6.6	3.0	4.6	4.7	5.9	1.6	1.4	2.9	1.9	2.1	3.8	1.4	2.3	3.2	6.3	2.4	2.8	1.1	2.8	1.0	5.5	1.2	1.9	5.7	8.5	10.4	8.9	3.7	2.9	5.1	4.6	4.8	5.0
C1orf87	"CREF, MGC34837"	ENSG00000162598	"Chromosome 1 open reading frame 87"	Q8N0U7	1	59987269-60073770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.1;fallopian tube: 33.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.2;HSkMC: 3.2;SCLC-21H: 1.4"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 19.1;pons and medulla: 17.7"	"Cell type enriched"	"Detected in single"	19	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA031366, HPA031368"	Enhanced									"HPA031366: AB_2673847, HPA031368: AB_10600795"				"unprognostic (1.16e-2)"	"unprognostic (9.87e-2)"			"unprognostic (3.83e-2)"		"unprognostic (1.92e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.11e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"			0.3	0.3	3.2	0.3	19.1	0.3	0.3	0.0	0.9	1.7	0.3	3.4	0.0	0.3	0.9	4.8	0.3	33.4	0.3	0.3	3.8	4.5	0.5	0.3	6.8	0.3	1.3	0.7	5.1	0.4	0.7	0.8	0.3	17.7	0.4	0.3	2.5	3.4	0.6	0.3	0.3	0.3	0.3	0.9	0.3	0.3	1.2	3.6	0.0	0.3	0.0	0.3	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	3.2	19.1	0.0	0.9	3.8	4.5	1.3	0.7	17.7	3.6
C1QL2	"C1QTNF10, CTRP10"	ENSG00000144119	"Complement C1q like 2"	Q7Z5L3	2	119156243-119158889	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 15.4"	"Group enriched"	"Detected in some"	14	"NTERA-2: 2.2;SCLC-21H: 7.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hippocampal formation: 25.0"	"Low region specificity"	"Detected in many"			HPA057934	Uncertain				"Secreted in brain"					"HPA057934: "	"unprognostic (6.95e-2)"				"unprognostic (9.74e-2)"			"unprognostic (4.48e-3)"		"unprognostic (1.08e-1)"	"unprognostic (9.91e-4)"			"unprognostic (2.60e-5)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"		0.7	0.7	15.3	0.7	6.8	0.7	1.1	0.9	15.1	0.7	0.7	3.1	0.0	0.7	0.7	0.7	0.7	0.7	0.7	0.8	15.4	9.0	0.7	0.8	0.7	1.3	4.5	5.4	0.7	0.7	0.7	0.3	0.7	1.3	0.7	0.7	2.4	1.0	0.7	0.7	0.9	0.7	0.7	1.5	0.8	0.7	1.1	3.1	0.0	0.7	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	6.8	0.9	15.1	15.4	9.0	4.5	5.4	1.3	3.1
C1QTNF7	CTRP7	ENSG00000163145	"C1q and TNF related 7"	Q9BXJ2	4	15339818-15446166	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 39.6"	"Group enriched"	"Detected in some"	5	"ASC diff: 9.0;ASC TERT1: 6.2;HSkMC: 3.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB007055, HPA051797, HPA055392"	Uncertain		Approved	Vesicles	"Secreted to blood"	238000000		Vesicles		"CAB007055: , HPA051797: , HPA055392: "	"unprognostic (6.61e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.16e-2)"	"unprognostic (6.50e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.98e-3)"	"unprognostic (2.31e-2)"	"unprognostic (7.69e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.97e-4)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (7.56e-3)"	"unprognostic (7.28e-3)"	16.0	0.9	0.6	24.7	0.8	0.0	7.4	0.3	0.7	39.6	12.0	0.5	3.3	0.6	24.6	10.1	17.3	6.2	20.3	5.4	0.6	0.6	4.0	1.0	7.9	0.5	0.8	0.5	15.9	1.3	0.0	1.4	5.4	0.8	22.0	3.2	5.4	2.7	2.4	2.2	3.5	4.1	22.1	0.7	10.2	10.4	4.4	0.1	0.3	4.2	13.0	2.0	16.3	15.8	0.1	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	3.3	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.3	0.7	0.6	0.6	0.8	0.5	0.8	0.1
C20orf144	"bclt, dJ63M2.6"	ENSG00000149609	"Chromosome 20 open reading frame 144"	Q9BQM9	20	33662284-33665619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	165	"testis: 53.4"	"Cell line enhanced"	"Detected in some"		"BJ: 1.4;PC-3: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA019029	Enhanced									"HPA019029: "	"unprognostic (2.16e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.64e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.72e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C20orf196	FLJ25067	ENSG00000171984	"Chromosome 20 open reading frame 196"	Q8IYI0	20	5750393-5863912	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 30.4;U-698: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040749	Approved		Approved	"Endoplasmic reticulum,Golgi apparatus,Vesicles"				"Endoplasmic reticulum, Golgi apparatus, Vesicles"		"HPA040749: AB_10673093"	"unprognostic (2.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.20e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.72e-3)"	"unprognostic (6.66e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.59e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.76e-1)"	"prognostic favourable (4.05e-5)"	5.4	13.9	7.1	15.5	7.3	17.8	8.1	10.6	8.7	6.8	7.9	9.2	12.6	11.9	7.7	8.7	7.4	6.7	8.0	12.3	7.0	7.0	6.9	4.1	9.3	17.6	8.9	6.7	7.7	11.1	2.8	10.6	5.1	6.9	8.7	7.4	10.9	19.1	12.9	15.1	5.6	13.7	6.7	7.1	14.2	6.2	4.2	7.8	20.4	9.6	9.4	16.8	6.4	6.6	21.7	10.9	15.6	10.8	16.2	22.7	10.2	4.7	6.0	3.0	1.3	1.9	1.5	1.3	1.4	2.4	1.9	2.8	2.7	5.4	18.7	3.6	1.4	2.2	1.9	3.5	2.2	5.6	2.3	6.8	0.9	10.1	4.2	8.2	3.2	2.4	5.1	2.9	1.9	3.8	9.5	7.5	3.4	2.1	11.4	30.4	3.6	3.2	9.4	4.0	8.4	2.8	2.4	4.8	4.5	2.8	2.7	5.5	2.1	8.7	2.2	2.1	3.0	1.9	3.0	5.2	8.7	24.8	1.0	8.6	3.6	11.2	8.7	15.6	17.0	10.4	13.2	19.7	19.5	16.7	9.2	21.7	18.8	13.4	3.9	16.2	10.8	10.9	22.7	10.2	7.1	7.3	10.6	8.7	7.0	7.0	8.9	6.7	6.9	7.8
C20orf202		ENSG00000215595	"Chromosome 20 open reading frame 202"	A1L168	20	1203454-1208274	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"placenta: 8.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.0;U-266/70: 3.0"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in single"		"T-reg: 2.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 2.0"					"Low region specificity"	"Detected in all"			HPA042786	Uncertain									"HPA042786: AB_10795760"	"unprognostic (8.20e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.15e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.55e-2)"	"unprognostic (5.82e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.24e-3)"	1.3	0.1	1.3	0.2	1.0	0.0	0.7	2.6	0.8	0.3	0.7			0.6	0.2	0.0	0.6	1.0	1.5	1.1	1.2	1.1	0.9	0.2	3.2	0.3	1.4		0.0	0.7	1.0	0.4	8.2		0.1	0.5		0.8	1.4	1.0	1.1	2.5	0.3	1.7	0.4	0.6	1.4			0.3		0.2	0.8	0.2	0.0	0.0	0.0	0.1	0.0	2.0	0.2	0.2	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.1	4.0	0.1	0.0	0.2	0.1	0.2	0.1	1.0	0.3	0.3	0.0	0.9	0.1	0.4	0.0	0.2	0.1	0.0	0.4	0.0	1.1	1.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.5	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.1	0.2	0.3	3.0	1.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.2										
C20orf24	"PNAS-11, RIP5"	ENSG00000101084	"Chromosome 20 open reading frame 24"	Q9BUV8	20	36605734-36612557	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA057387	Uncertain		Approved	Cytosol				Cytosol		"HPA057387: "	"unprognostic (2.14e-1)"	"unprognostic (4.75e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (4.56e-6)"	"unprognostic (4.47e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.37e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavourable (2.46e-4)"	"unprognostic (2.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.98e-2)"	17.0	19.7	15.1	18.5	16.3	25.1	29.1	11.9	21.1	15.8	31.1	10.9	15.2	21.9	11.8	18.1	55.5	10.8	25.1	24.2	14.3	14.0	35.6	71.1	21.4	24.4	15.0	11.7	9.5	27.6	15.4	8.5	19.3	12.6	13.3	26.5	9.8	21.5	17.9	70.0	13.6	26.1	14.6	12.7	26.2	20.0	19.0	11.3	20.4	21.6	42.3	28.3	14.3	20.4	10.0	15.8	41.3	24.2	6.1	11.9	7.7	35.7	26.9	8.9	11.8	21.3	12.3	23.9	22.4	12.3	21.4	19.5	73.6	45.1	15.6	55.6	19.2	26.6	19.1	35.0	20.5	11.7	19.8	37.0	38.2	80.5	25.0	38.9	18.2	15.3	37.1	31.0	17.6	19.6	25.2	36.6	20.2	24.2	22.7	50.2	16.3	57.5	18.2	22.9	38.9	18.5	26.7	16.5	12.5	32.3	83.9	28.1	17.7	32.0	22.1	32.1	22.1	33.1	33.9	23.4	37.8	26.2	34.6	45.4	17.0	7.2	24.2	29.9	6.2	12.4	6.2	10.0	7.4	9.6	15.8	8.1	9.0	6.7	41.3	6.1	14.7	10.8	11.9	7.7	15.1	16.3	11.9	21.1	14.3	14.0	15.0	11.7	12.6	11.3
C20orf85	"bA196N14.1, LLC1"	ENSG00000124237	"Chromosome 20 open reading frame 85"	Q9H1P6	20	58150904-58161150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 113.6;testis: 62.8"	"Cell line enriched"	"Detected in single"	9	"SCLC-21H: 3.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 57.9"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"basal ganglia: 1.5"	"Low region specificity"	"Detected in many"			"HPA058271, HPA065540"	Enhanced									"HPA058271: , HPA065540: "				"unprognostic (4.50e-3)"				"unprognostic (1.87e-1)"		"unprognostic (1.03e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.46e-2)"		"unprognostic (3.62e-1)"	"unprognostic (2.79e-2)"			0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.1	7.4	0.0	0.5	0.2	0.0	1.4	26.9	0.0	113.6	0.0	0.0	0.1	0.8	0.0	0.0	29.4	0.3	0.0	0.0	29.0	0.0	0.0	0.9	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	62.8	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.1	0.1	0.8	0.0	0.0	1.5	0.1
C20orf96	dJ1103G7.2	ENSG00000196476	"Chromosome 20 open reading frame 96"	Q9NUD7	20	270863-290778	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA048649	Uncertain		Approved	"Centriolar satellite"				"Centriolar satellite"		"HPA048649: "	"unprognostic (1.59e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.21e-2)"	"prognostic unfavourable (6.12e-5)"	"unprognostic (4.62e-2)"	"unprognostic (5.12e-1)"	"unprognostic (3.24e-1)"	"prognostic favourable (4.12e-5)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"prognostic favourable (1.05e-4)"	5.6	8.6	10.4	5.5	18.4	7.1	8.2	11.2	13.6	10.5	7.8	13.5	7.7	9.7	16.9	21.8	4.4	33.9	9.1	6.5	11.7	9.9	13.2	4.7	10.3	5.2	12.5	9.1	17.7	7.3	8.3	25.1	4.0	22.0	11.2	8.8	11.8	10.2	8.6	3.4	3.8	8.1	10.8	13.8	8.0	8.2	23.4	13.4	5.9	15.1	2.0	5.2	7.4	6.7	3.5	6.4	0.0	2.8	2.5	2.9	1.6	4.2	13.3	14.0	12.3	3.7	3.6	6.2	3.0	3.9	4.5	6.1	2.5	8.2	10.5	2.0	3.6	3.7	5.2	2.3	5.3	2.6	8.0	7.0	0.1	14.4	10.3	5.7	3.0	5.0	2.1	7.7	0.9	9.0	14.3	5.3	3.9	2.1	6.7	22.4	4.6	5.8	20.7	2.5	8.6	7.1	6.5	1.5	12.5	3.6	5.3	8.9	9.0	12.8	6.0	4.5	7.9	4.0	2.5	12.2	12.3	7.3	2.5	18.0	4.2	0.0	2.8	0.0	1.6	2.2	1.0	3.5	1.0	1.3	6.4	3.4	2.2	2.9	0.0	2.5	1.6	3.0	1.4	1.6	10.4	18.4	11.2	13.6	11.7	9.9	12.5	9.1	22.0	13.4
C21orf140		ENSG00000222018	"Chromosome 21 open reading frame 140"	B9A014	21	34400317-34401072	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.9;T-47d: 3.0;U-937: 3.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045123	Uncertain									"HPA045123: AB_10961912"																		0.9	2.2	1.0	1.0	1.9	0.4	1.1	2.8	6.1	1.3	1.6			0.9	2.2	0.2	3.9	1.1	1.9	1.4	1.3	0.9	0.9	0.4	2.0	2.4	1.0		2.4	2.4	0.2	1.5	0.8		1.4	0.2		1.3	0.2	3.2	1.5	0.7	0.2	0.8	0.8	5.0	7.4			2.2		0.2	2.6	1.3	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.2	0.1	1.7	0.8	0.0	0.0	0.6	1.7	0.0	0.0	0.0	2.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.1	1.0	0.3	2.4	2.5	0.0	1.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.6	0.4	0.9	0.0	0.1	0.2	1.3	0.0	0.0	0.1	1.4	1.3	0.2	0.3	3.0	2.3	0.0	1.3	0.7	0.7	0.9	1.3	0.7	0.1	1.1	3.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0										
C21orf58		ENSG00000160298	"Chromosome 21 open reading frame 58"	P58505	21	46300181-46323875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"fallopian tube: 27.2;lymphoid tissue: 22.7;pituitary gland: 25.1"	"Cell line enhanced"	"Detected in many"		"REH: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.2"	"Low lineage specificity"	"Detected in many"											"HPA035110, HPA035111"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA035110: AB_10603683, HPA035111: "	"unprognostic (2.19e-1)"	"unprognostic (6.74e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.08e-2)"	"prognostic favourable (7.00e-4)"	"unprognostic (4.74e-3)"	"unprognostic (6.14e-2)"	"prognostic unfavourable (7.48e-4)"	"unprognostic (1.38e-1)"	"prognostic favourable (4.20e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-10)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.07e-2)"	1.3	1.8	2.2	4.3	5.0	11.1	5.2	3.6	3.1	3.2	3.5	4.6	3.3	4.7	2.2	9.7	3.1	27.2	3.2	2.6	2.9	2.9	1.3	1.3	9.1	5.9	2.9	1.8	8.0	3.2	1.4	25.1	2.1	5.8	2.3	2.7	1.9	2.5	1.7	1.6	5.3	4.3	1.5	1.8	2.8	3.7	5.7	2.2	22.7	1.8	2.1	4.6	1.7	2.1	2.1	1.8	8.2	0.5	0.7	1.8	0.9	12.2	5.6	14.9	9.3	1.5	2.0	8.3	7.6	2.8	5.3	5.2	2.6	9.0	8.9	1.9	2.1	9.9	4.0	3.2	1.6	9.2	8.7	14.3	14.7	1.4	0.3	4.0	8.2	0.9	0.7	3.8	0.9	3.3	8.1	23.7	4.3	5.0	19.9	5.5	6.4	2.8	29.6	6.7	7.9	1.6	2.3	12.3	7.7	5.7	4.1	1.8	10.0	8.1	2.3	3.3	9.4	3.2	4.5	9.6	4.2	4.2	5.8	17.7	8.5	8.2	0.5	1.1	0.9	0.3	0.5	0.2	1.1	1.2	0.1	2.1	1.8	1.4	0.7	0.7	0.2	1.8	1.3	0.9	2.2	5.0	3.6	3.1	2.9	2.9	2.9	1.8	5.8	2.2
C21orf62	"B37, C21orf120, PRED81"	ENSG00000205929	"Chromosome 21 open reading frame 62"	Q9NYP8	21	32793564-32813743	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 13.4;kidney: 18.2;ovary: 16.2;pituitary gland: 38.6"	"Group enriched"	"Detected in some"	11	"AF22: 7.0;RPTEC TERT1: 4.0"	"Cancer enriched"	"Detected in some"	6	"glioma: 11.0"	"Region enriched"	"Detected in many"	4	"pons and medulla: 13.4"	"Cell type enhanced"	"Detected in some"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA016899	Enhanced				"Secreted - unknown location"					"HPA016899: AB_1845704"	"unprognostic (1.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.37e-3)"	"unprognostic (9.56e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.78e-1)"	"prognostic favourable (1.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.07e-2)"	2.2	0.4	1.6	1.1	2.1	0.3	0.3	0.3	2.4	0.1	0.3	3.9	0.0	0.1	0.2	8.4	0.3	1.2	0.4	0.4	3.0	2.4	18.2	0.3	0.2	0.2	1.5	1.0	16.2	5.6	0.1	38.6	0.1	13.4	4.1	0.1	0.0	0.3	0.3	0.3	0.3	0.6	0.3	1.8	0.2	0.3	0.4	3.1	0.0	0.2	0.0	1.1	0.2	0.3	0.0	0.4	1.1	0.0	0.0	1.7	0.1	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.6	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.4	1.7	0.1	1.6	2.1	0.3	2.4	3.0	2.4	1.5	1.0	13.4	3.1
C22orf31	"bK747E2.1, HS747E2A"	ENSG00000100249	"Chromosome 22 open reading frame 31"	O95567	22	29058672-29061844	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 3.4;testis: 12.7"	"Cell line enhanced"	"Detected in single"		"RT4: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA000604	Uncertain									"HPA000604: AB_1079086"																		0.0	0.4	0.9	0.0	3.4	0.0	0.4	0.4	0.9	0.5	0.3			0.2	0.4	1.6	0.5	0.5	0.0	0.0	1.0	0.2	0.2	0.0	0.2	0.0	0.8		1.1	0.0	0.2	0.4	0.0		0.2	0.3		0.5	0.0	0.1	0.6	0.4	0.1	0.0	0.0	0.6	12.7			0.1		0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.8	0.0	1.0	0.9	0.0	0.0	0.5	0.7	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C22orf42		ENSG00000205856	"Chromosome 22 open reading frame 42"	Q6IC83	22	32149006-32159322	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 12.9;testis: 28.6"	"Cell line enhanced"	"Detected in single"		"THP-1: 1.4"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 0.8;prostate cancer: 1.0"	"Group enriched"	"Detected in some"	14	"hypothalamus: 12.9;pons and medulla: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA019531	Enhanced									"HPA019531: AB_1853016"					"unprognostic (5.67e-2)"						"unprognostic (6.13e-3)"	"unprognostic (8.21e-3)"		"unprognostic (7.06e-2)"	"unprognostic (4.54e-2)"			0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.4	0.0	0.1	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	12.9	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.4	0.0	3.8	0.0	5.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.5	1.0	28.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.4	0.1	12.9	0.6	0.0	5.9	0.1
C22orf46	"CTA-216E10.6, FLJ23584"	ENSG00000184208	"Chromosome 22 open reading frame 46"	C9J442	22	41688939-41698136	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 19.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA052741	Uncertain		Approved	Nucleoplasm,Nucleoli	"Secreted - unknown location"			Nucleoplasm	Nucleoli	"HPA052741: "	"unprognostic (3.76e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.45e-2)"	"prognostic favourable (4.70e-4)"	"unprognostic (1.56e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	3.9	2.0	8.1	3.1	6.8	1.0	3.9	2.2	5.7	2.7	2.4			2.3	3.1	4.5	1.7	2.4	2.7	4.8	8.7	7.5	2.7	2.3	2.2	3.1	12.8		5.2	1.4	8.3	3.5	2.1		3.3	2.8		2.8	3.0	3.3	3.3	2.6	2.9	19.8	2.8	2.4	6.2			3.5		3.1	2.2	1.5	1.1	0.4	0.1	2.6	3.5	1.2	0.7	8.7	4.5	11.0	6.7	8.1	8.6	9.9	7.4	8.0	6.3	8.5	4.5	5.7	5.5	5.4	6.1	4.1	5.6	5.7	7.6	19.5	5.3	6.0	9.3	3.7	4.7	4.4	11.9	6.8	7.7	10.5	7.5	1.6	9.8	8.1	5.5	14.4	3.5	5.4	4.5	3.5	5.1	9.1	6.0	5.4	6.0	2.7	4.2	8.6	7.8	11.1	9.0	5.5	4.3	8.3	14.2	4.4	3.9	17.3	17.6	5.1	5.0	5.4	11.2	0.1	0.5	0.0	0.7	0.4	0.9	1.1	1.1	1.1	0.2	0.5	0.9	1.2	0.1	3.5	2.6	0.4	0.7	0.7										
C2CD4B	"FAM148B, NLF2"	ENSG00000205502	"C2 calcium dependent domain containing 4B"	A6NLJ0	15	62163535-62165283	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"pancreas: 192.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.8;HUVEC TERT2: 6.1;NTERA-2: 2.5;SCLC-21H: 1.8;TIME: 1.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046880	Uncertain									"HPA046880: AB_10959458"	"unprognostic (6.60e-2)"	"prognostic favourable (4.22e-4)"	"unprognostic (2.24e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.15e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.16e-3)"	"unprognostic (7.89e-2)"	"unprognostic (5.24e-1)"	"unprognostic (8.64e-3)"	"unprognostic (1.48e-1)"	12.1	1.0	0.2	4.3	0.5	3.0	7.9	0.1	0.7	1.7	2.0	0.3	0.4	2.2	3.7	3.2	3.2	1.2	5.0	2.0	0.3	0.3	0.7	1.7	9.2	0.7	0.5	0.0	1.6	192.0	0.7	2.5	1.4	0.6	2.2	0.6	0.5	0.9	1.0	2.8	1.6	1.8	1.5	0.9	0.4	7.8	1.0	0.2	4.6	0.9	4.1	0.6	3.9	4.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.3	0.3	0.3	0.5	0.0	0.6	0.2
C2orf16	DKFZp434G118	ENSG00000221843	"Chromosome 2 open reading frame 16"	Q68DN1	2	27537386-27582721	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"testis: 22.3"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 6.2;SiHa: 4.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			"HPA052136, HPA056962"	Uncertain		Uncertain	"Nuclear bodies"				"Nuclear bodies"		"HPA052136: , HPA056962: "	"unprognostic (4.32e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.36e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.79e-3)"	"unprognostic (4.59e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.53e-3)"	0.2	0.5	0.2	0.2	0.2	0.0	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0.2	1.0	0.5	0.1	0.4	0.5	0.2	0.2	0.2	0.9	0.2	0.2	0.2	0.2	0.4	0.4	0.0	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.6	22.3	0.2	0.2	0.7	0.2	0.2	0.4	0.2	0.0	0.3	0.3	1.0	0.0	0.6	0.1	1.5	1.6	2.3	1.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.2	2.1	0.8	2.0	0.0	0.5	0.0	0.0	0.0	1.4	0.4	3.0	1.2	1.5	0.0	1.7	1.3	0.0	0.0	0.2	0.0	0.2	1.2	2.1	0.1	0.3	0.0	0.8	0.4	0.0	1.2	1.3	0.5	0.0	1.5	6.2	1.1	4.4	1.1	0.6	1.0	1.1	2.7	1.4	2.0	0.9	1.0	0.4	0.0	1.9	0.5	0.3	2.0	0.0	1.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.3	0.0	0.8	0.2	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
C2orf40	"augurin, ECRG4"	ENSG00000119147	"Chromosome 2 open reading frame 40"	Q9H1Z8	2	106063246-106078159	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;HSkMC: 1.0;NB-4: 1.3"	"Cancer enriched"	"Detected in many"	11	"thyroid cancer: 72.8"	"Region enriched"	"Detected in all"	7	"pons and medulla: 44.8"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 10.0;naive CD8 T-cell: 8.2"	"Lineage enriched"	"Detected in single"	77	"T-cells: 10.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 44.8;cerebellum: 37.1;hippocampal formation: 85.7;pons and medulla: 114.2;thalamus: 69.1"	"Low region specificity"	"Detected in many"			HPA008546	Uncertain				"Secreted to blood"					"HPA008546: AB_2066524"	"prognostic favourable (4.58e-4)"	"unprognostic (3.91e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.61e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.30e-4)"	27.5	14.0	1.6	7.6	3.2	0.4	12.7	4.1	4.1	21.8	11.0	18.7	19.9	2.9	19.5	25.8	16.5	15.9	10.3	6.5	3.2	5.1	14.7	1.4	8.4	1.0	6.2	3.7	7.9	3.4	1.0	27.6	4.2	44.8	37.1	3.0	33.9	10.2	50.7	4.1	3.2	6.4	66.8	9.6	12.0	50.6	11.0	1.9	0.1	44.2	8.2	2.5	46.6	26.8	0.1	0.0	0.0	0.0	0.1	10.0	1.7	0.0	0.0	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	2.4	1.6	0.0	0.0	10.0	8.2	0.0	0.1	0.0	0.0	0.7	1.7	1.6	3.2	4.1	4.1	3.2	5.1	6.2	3.7	44.8	1.9
C2orf54	FLJ22671	ENSG00000172478	"Chromosome 2 open reading frame 54"	Q08AI8	2	240886048-240896889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 63.8;lymphoid tissue: 28.6;tongue: 35.5"	"Group enriched"	"Detected in some"	6	"CACO-2: 21.1;HaCaT: 15.8;SK-BR-3: 56.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 3.4"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 3.4"	"Not detected"	"Not detected"							HPA052722			Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA052722: "	"unprognostic (5.86e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (2.77e-4)"		"unprognostic (1.43e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.05e-1)"	0.3	0.0	0.3	1.5	0.3	0.0	0.9	0.3	0.3	8.9	3.9	0.3	0.3	6.3	0.7	0.4	63.8	0.3	0.3	0.3	0.3	0.0	2.8	2.8	5.5	0.3	0.3	0.3	0.3	0.4	0.0	0.3	0.7	0.3	0.5	1.1	0.3	7.6	0.3	0.3	18.6	3.6	0.3	0.3	0.3	1.0	0.3	0.3	1.0	0.3	35.5	28.6	0.8	19.1	0.8	0.1	0.7	0.2	3.4	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	21.1	1.3	0.1	0.1	0.0	15.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	5.1	0.1	3.1	1.0	0.0	0.0	56.0	0.0	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.0	0.3	0.5	0.0	0.1	0.8	0.1	0.2	0.1	3.4	0.2	0.0	0.2	0.1	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
C2orf68		ENSG00000168887	"Chromosome 2 open reading frame 68"	Q2NKX9	2	85606654-85612066	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051143	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria"				"Nucleoplasm, Nuclear membrane, Mitochondria"	Nucleoli	"HPA051143: "	"unprognostic (1.71e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.07e-2)"	"prognostic unfavourable (1.12e-6)"	"unprognostic (9.34e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (6.76e-6)"	"unprognostic (4.24e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (1.11e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.81e-3)"	10.7	9.8	7.0	17.4	12.3	11.5	16.5	16.6	9.9	16.5	15.2	17.2	17.7	13.1	17.1	15.0	13.6	14.3	16.2	13.7	7.7	6.6	13.5	16.8	17.5	15.6	16.1	7.2	22.2	25.4	13.3	14.6	21.8	11.4	16.5	14.1	10.8	20.6	20.6	23.3	18.6	18.5	14.8	10.9	17.5	13.4	15.1	12.3	37.1	17.2	20.4	17.6	15.2	17.0	15.4	16.5	36.1	22.7	19.2	20.1	9.5	8.5	8.0	13.1	9.9	13.5	6.7	8.9	3.9	5.2	6.5	8.8	7.1	10.4	11.6	6.0	7.2	9.5	7.2	7.9	7.1	6.1	15.0	19.9	11.7	7.4	11.1	10.7	10.5	10.2	9.1	4.9	13.1	10.7	10.0	13.1	6.3	9.7	12.1	10.4	6.2	6.9	13.6	25.0	11.4	8.4	9.1	16.8	12.1	6.1	8.1	7.9	9.2	5.4	6.3	4.7	13.1	5.3	3.7	16.9	11.8	10.8	7.0	10.8	5.7	18.0	22.7	36.1	15.4	15.0	14.5	10.9	14.7	14.5	16.5	15.4	20.1	18.7	36.1	19.2	16.9	10.6	11.9	9.5	7.0	12.3	16.6	9.9	7.7	6.6	16.1	7.2	11.4	12.3
C2orf73	FLJ40298	ENSG00000177994	"Chromosome 2 open reading frame 73"	Q8N5S3	2	54330034-54383742	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.8;pituitary gland: 11.9;testis: 39.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.5;BJ hTERT+: 1.6;CAPAN-2: 1.6;HSkMC: 1.7;RPTEC TERT1: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055221, HPA059596"	Uncertain									"HPA055221: , HPA059596: "	"unprognostic (1.56e-2)"	"unprognostic (7.00e-3)"		"unprognostic (1.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.46e-2)"		"unprognostic (2.74e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.69e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.99e-2)"	"unprognostic (3.80e-2)"	0.4	0.9	2.0	0.3	6.4	0.3	0.4	0.9	1.6	0.7	0.4	4.1	1.6	0.3	0.6	3.5	0.4	7.3	0.3	0.4	2.7	1.2	0.8	0.4	1.6	0.3	0.9	4.4	0.9	0.9	1.0	11.9	0.3	11.8	0.6	0.3	0.3	0.4	0.6	0.4	0.4	0.4	0.3	1.5	0.4	0.4	39.2	1.7	0.0	1.7	0.0	0.3	0.4	0.4	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.4	0.7	0.0	2.5	0.0	0.0	1.6	0.0	0.8	0.0	1.6	0.0	0.6	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.7	0.4	1.0	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	2.6	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.4	0.9	1.6	2.7	1.2	0.9	4.4	11.8	1.7
C2orf80	"GONDA1, LOC389073"	ENSG00000188674	"Chromosome 2 open reading frame 80"	Q0P641	2	208165343-208190073	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 35.3"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 5.8"	"Cancer enriched"	"Detected in single"	41	"glioma: 11.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.4"					"Low region specificity"	"Detected in all"			HPA042639			Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA042639: AB_10794915"					"unprognostic (6.36e-2)"					"unprognostic (2.12e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.05e-1)"		"unprognostic (1.83e-1)"	"unprognostic (2.98e-2)"			0.9	1.0	20.8	1.3	20.8	2.4	0.9	0.4	35.3	0.7	1.1	1.1	0.0	1.0	1.0	0.9	2.2	1.0	1.4	0.9	16.3	14.2	0.9	1.1	1.0	1.1	8.0	13.1	1.0	0.7	0.8	0.4	0.9	9.6	1.1	1.1	0.5	1.4	1.4	1.2	2.0	1.3	0.9	2.1	1.0	1.2	1.7	2.4	0.0	1.1	0.0	0.8	0.9	0.0	1.5	1.7	8.4	1.2	1.0	0.7	0.2	0.4	0.5	2.7	0.9	0.0	0.0	0.2	0.6	0.6	0.0	0.0	0.9	1.1	1.5	0.9	0.3	0.4	0.0	0.0	0.0	0.4	0.3	0.9	1.3	0.4	0.0	1.1	1.8	0.4	0.5	0.3	0.3	0.0	0.5	1.4	0.0	0.8	0.0	1.5	5.8	1.8	0.4	0.3	0.4	0.0	1.2	0.8	1.3	0.3	0.9	0.2	0.5	0.0	0.7	0.5	0.3	0.3	0.5	0.8	0.3	1.1	0.0	0.6	0.9	4.3	1.2	0.9	0.7	0.7	0.5	0.9	0.7	0.7	0.3	1.5	0.6	0.7	8.4	1.0	0.5	1.7	0.3	0.2	20.8	20.8	0.4	23.1	16.3	14.2	8.0	13.1	9.6	2.4
C2orf83	DKFZp547H025	ENSG00000042304	"Chromosome 2 open reading frame 83"	Q53S99	2	227610090-227648606	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"placenta: 16.3"	"Cell line enriched"	"Detected in single"	14	"U-2197: 12.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA030319	Approved									"HPA030319: AB_10602112"					"unprognostic (1.12e-2)"									"unprognostic (1.03e-1)"				0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.0	0.0	16.3		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.4			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C2orf91		ENSG00000205086	"Chromosome 2 open reading frame 91"	Q6ZV80	2	41935368-41954266	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 5.1;lung: 4.7"	"Group enriched"	"Detected in some"	6	"AN3-CA: 5.1;HDLM-2: 17.5"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 0.8"	"Region enhanced"	"Detected in some"		"midbrain: 5.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA042517	Uncertain									"HPA042517: AB_10795508"	"unprognostic (9.49e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.47e-1)"	0.3	2.1	0.3	0.3	1.3	1.5	0.3	0.3	0.8	0.4	0.3	0.8	0.2	0.0	0.4	1.0	0.3	0.3	0.3	0.5	0.3	0.4	0.9	0.3	4.7	0.9	5.1	0.2	0.4	0.4	0.4	0.5	0.2	1.9	0.8	0.2	0.8	3.5	0.2	0.2	1.3	0.3	0.2	2.2	0.6	1.3	1.1	0.2	0.2	0.2	0.2	0.6	0.2	0.3	1.2	1.4	2.8	1.2	1.2	0.9	0.3	0.2	0.4	0.7	5.1	0.2	0.1	0.3	0.1	0.1	0.0	0.3	0.4	0.3	0.3	0.3	0.2	0.2	0.0	0.1	0.1	17.5	0.3	0.2	0.3	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.1	0.1	1.8	0.1	0.3	0.1	0.1	0.3	0.1	0.0	0.6	0.1	0.1	0.3	0.2	1.8	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.4	0.1	0.2	0.2	0.0	0.2	1.3	1.2	1.4	0.6	0.9	0.5	0.6	0.7	0.5	1.4	1.2	0.7	0.9	2.8	1.2	1.0	1.3	0.4	0.3	0.3	1.3	0.3	0.8	0.3	0.4	5.1	0.2	1.9	0.2
C3orf14	HT021	ENSG00000114405	"Chromosome 3 open reading frame 14"	Q9HBI5	3	62318973-62336213	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 105.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 21.0"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA048286	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA048286: "	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.69e-3)"	"unprognostic (6.91e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.76e-5)"	"unprognostic (1.57e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"prognostic favourable (4.33e-5)"	"unprognostic (8.19e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-1)"	3.8	14.7	28.2	5.6	23.6	1.0	35.0	16.4	31.2	5.0	3.9	7.7	2.5	3.3	5.5	6.8	11.0	4.1	6.8	4.6	20.9	22.0	9.6	2.9	6.4	5.0	19.9	20.5	8.2	6.3	2.3	19.0	4.8	25.9	17.8	4.1	4.1	5.0	5.6	1.0	12.0	2.7	6.8	15.2	3.0	6.1	20.9	8.1	1.2	9.2	3.8	8.2	13.5	3.4	3.7	6.7	5.2	21.0	0.7	6.1	2.1	0.0	5.7	6.9	0.0	5.0	7.3	5.3	9.3	5.6	11.8	11.7	0.0	8.4	0.0	0.0	6.3	1.5	0.0	5.9	9.1	0.0	3.9	5.1	0.0	0.0	3.4	0.0	11.0	3.3	8.0	13.3	10.9	5.7	0.6	0.0	11.6	105.2	0.0	0.0	8.7	11.8	0.0	0.0	2.8	9.6	16.0	12.1	10.2	6.2	22.3	8.6	9.0	5.7	0.1	5.8	0.0	26.9	9.3	5.7	0.0	0.0	5.6	0.0	20.2	5.2	4.3	0.4	0.2	14.3	0.1	3.7	3.6	2.8	4.6	1.1	1.0	0.7	0.3	0.7	21.0	6.7	6.1	2.1	28.2	23.6	16.4	31.2	20.9	22.0	19.9	20.5	25.9	8.1
C3orf18	G20	ENSG00000088543	"Chromosome 3 open reading frame 18"	Q9UK00	3	50558025-50571027	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.9;NK-cells: 2.1;T-cells: 7.7"	"Group enriched"	"Detected in many"	4	"cerebellum: 31.6;olfactory region: 33.8"	"Low region specificity"	"Detected in all"			HPA012105	Approved		Approved	Cytosol				Cytosol		"HPA012105: AB_1845717"	"unprognostic (9.29e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.29e-2)"	"prognostic favourable (2.80e-9)"	"unprognostic (7.65e-2)"	"unprognostic (4.49e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.59e-1)"	5.1	6.7	10.0	3.4	12.3	1.2	6.2	34.5	20.1	6.0	6.1	8.0	2.2	2.2	8.0	5.1	5.0	8.4	6.0	25.3	8.1	9.7	6.0	3.0	4.1	3.9	11.4	9.3	14.0	6.1	19.2	7.4	2.6	10.3	8.5	3.2	11.9	7.3	11.0	32.4	2.8	2.9	10.4	6.9	4.1	5.2	9.8	6.1	1.8	6.9	7.2	4.0	6.8	4.9	2.9	0.9	0.8	0.5	2.1	7.7	3.0	1.1	1.6	1.9	0.4	6.4	5.8	0.6	6.8	10.6	6.2	4.5	0.1	1.7	1.3	1.6	9.2	0.1	0.0	2.6	3.3	29.2	0.2	2.8	3.8	0.5	3.2	0.0	3.7	5.7	0.3	6.0	0.3	1.2	0.6	1.3	3.6	0.2	0.2	0.8	2.4	7.6	0.6	0.2	1.6	0.3	0.2	2.1	10.1	1.8	0.4	0.1	2.0	0.8	0.3	6.2	4.9	11.3	0.8	1.8	1.4	0.2	8.9	3.1	0.1	0.0	0.5	0.8	6.3	0.2	7.7	2.9	5.5	6.0	0.5	1.8	6.4	7.7	0.0	2.1	0.1	0.9	2.5	3.0	10.0	12.3	34.5	20.1	8.1	9.7	11.4	9.3	10.3	6.1
C3orf20	DKFZP434N1817	ENSG00000131379	"Chromosome 3 open reading frame 20"	Q8ND61	3	14675099-14773034	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"testis: 30.9"	"Group enriched"	"Detected in some"	4	"Daudi: 5.6;HEL: 11.9;U-698: 8.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA039584	Uncertain		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039584: AB_10795152"	"unprognostic (1.23e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.76e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-4)"	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	30.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.2	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	11.9	0.1	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.9	0.0	0.5	0.8	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	1.2	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0
C3orf22	MGC34728	ENSG00000180697	"Chromosome 3 open reading frame 22"	Q8N5N4	3	126526999-126558965	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	25	"testis: 28.3"	"Cell line enhanced"	"Detected in single"		"MCF7: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA059199	Enhanced									"HPA059199: "	"unprognostic (2.10e-1)"			"unprognostic (5.14e-5)"	"unprognostic (2.55e-1)"		"unprognostic (9.21e-2)"			"unprognostic (2.01e-1)"		"unprognostic (2.75e-1)"	"unprognostic (1.08e-3)"		"unprognostic (1.34e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C3orf30	"FLJ32859, TSCPA"	ENSG00000163424	"Chromosome 3 open reading frame 30"	Q96M34	3	119146150-119160042	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	156	"testis: 46.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.9;HEL: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062468	Enhanced									"HPA062468: "				"unprognostic (4.06e-3)"				"unprognostic (3.67e-2)"									"unprognostic (2.66e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C3orf36	FLJ22173	ENSG00000221972	"Chromosome 3 open reading frame 36"	Q3SXR2	3	133928145-133929812	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"lung: 8.2;seminal vesicle: 14.7"	"Group enriched"	"Detected in some"	5	"EFO-21: 6.4;HeLa: 1.6;TIME: 5.1"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046432	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA046432: "	"unprognostic (3.56e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.29e-3)"	"unprognostic (4.64e-4)"	"unprognostic (5.05e-3)"	"unprognostic (8.18e-5)"	"unprognostic (1.22e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.08e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	1.1	1.9	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.2	0.7			0.2	1.3	0.0	0.6	1.1	0.8	0.7	0.0	0.0	1.9	0.0	8.2	0.1	0.0		0.0	0.7	1.6	0.2	0.1		2.3	0.3		0.4	14.7	0.0	0.1	1.4	1.0	0.0	1.5	0.8	0.0			2.7		0.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	6.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C3orf49		ENSG00000163632	"Chromosome 3 open reading frame 49"	Q96BT1	3	63819362-63848636	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 4.0"	"Cell line enhanced"	"Detected in many"		"HeLa: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA053582	Uncertain									"HPA053582: "	"unprognostic (2.90e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.14e-2)"	"unprognostic (9.47e-3)"	"unprognostic (7.61e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.07e-1)"	0.4	0.1	0.5	0.4	1.0	0.9	0.4	1.8	4.0	0.4	0.4	0.4	0.4	1.3	0.5	0.4	1.7	0.4	0.4	0.8	0.5	0.5	0.4	0.6	0.6	0.4	0.4	0.4	1.2	1.3	0.0	0.4	0.4	0.4	0.4	0.0	0.4	0.5	0.4	2.6	2.0	0.4	0.4	0.4	0.4	0.3	3.6	0.4	0.4	0.7	0.4	0.4	0.5	0.4	1.1	0.5	1.7	0.9	2.2	1.1	0.1	0.7	1.9	1.0	1.3	0.0	0.3	1.1	1.6	0.0	0.1	0.0	1.1	1.0	2.6	0.4	0.0	1.1	0.0	0.1	0.3	1.5	1.7	2.2	4.6	0.5	0.0	0.8	0.8	0.2	0.1	0.0	0.1	0.0	1.3	1.2	0.0	4.3	1.2	1.1	1.3	0.4	1.7	1.1	2.5	0.1	1.1	1.2	0.8	0.3	2.6	0.3	0.7	1.0	1.4	0.8	1.0	1.7	1.9	0.8	2.3	0.5	2.7	3.7	1.0	1.7	0.6	0.2	1.1	0.4	0.4	0.6	0.6	0.8	0.4	1.1	1.1	1.0	1.2	2.2	0.9	0.5	0.8	0.1	0.5	1.0	1.8	1.3	0.5	0.5	0.4	0.4	0.4	0.4
C3orf67	"FLJ42117, FLJ42930"	ENSG00000163689	"Chromosome 3 open reading frame 67"	Q6ZVT6	3	58717365-59050084	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 10.4;testis: 28.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.2;T-reg: 2.2"	"Group enriched"	"Detected in many"	13	"B-cells: 2.2;T-cells: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069696			Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA069696: "	"unprognostic (4.59e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-5)"	"unprognostic (1.91e-1)"	"unprognostic (9.33e-3)"	"unprognostic (1.67e-3)"	"unprognostic (3.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (6.68e-3)"	"unprognostic (8.95e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.06e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.81e-2)"	0.5	1.8	1.2	1.0	4.3	0.3	0.6	0.5	2.0	1.5	0.7	0.5	0.0	0.1	0.6	1.6	10.4	3.4	0.7	0.4	0.9	0.9	0.7	1.9	0.6	1.8	0.5	0.9	0.7	0.8	1.3	8.4	1.3	1.3	1.0	0.9	1.6	2.6	0.4	0.2	0.4	0.3	0.5	0.6	0.4	0.5	28.4	0.5	0.4	0.4	2.0	3.6	0.3	2.9	2.2	0.0	0.0	0.1	0.1	2.2	0.3	10.4	1.7	2.9	0.0	1.8	5.7	0.0	5.0	1.6	2.2	1.8	0.9	3.4	10.9	1.7	1.2	1.1	4.7	2.4	4.0	1.7	0.3	0.0	1.8	0.0	0.9	0.0	0.0	1.1	2.4	4.7	3.8	4.5	8.3	0.1	3.0	1.4	0.5	0.0	3.7	7.4	10.5	0.0	4.4	2.3	0.1	7.6	3.6	1.4	1.0	3.1	3.4	0.0	0.1	0.2	3.4	5.4	2.2	4.5	9.3	2.1	2.6	0.0	6.9	0.0	0.1	0.0	0.2	0.0	0.0	1.7	0.7	0.0	0.0	2.2	0.1	0.7	0.0	0.1	0.0	0.0	2.2	0.3	1.2	4.3	0.5	2.0	0.9	0.9	0.5	0.9	1.3	0.5
C3orf70		ENSG00000187068	"Chromosome 3 open reading frame 70"	A6NLC5	3	185078050-185153014	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 26.6"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 19.0;SK-BR-3: 8.3;WM-115: 10.2"	"Cancer enhanced"	"Detected in many"		"glioma: 10.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041861	Uncertain		Approved	Cytosol				Cytosol		"HPA041861: AB_10804119"	"unprognostic (1.45e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.92e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.62e-4)"	"unprognostic (5.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.91e-2)"	"prognostic unfavourable (6.40e-6)"	"unprognostic (1.06e-1)"	"unprognostic (8.48e-2)"	"unprognostic (6.57e-2)"	"unprognostic (7.84e-2)"	4.6	2.3	14.4	4.7	13.8	0.9	2.0	7.9	18.2	7.2	12.1	11.1	7.9	5.3	12.1	6.1	10.1	6.8	6.1	3.3	11.1	10.2	1.6	1.3	2.4	1.3	11.4	7.1	5.9	1.1	4.0	1.4	2.9	10.5	10.2	8.2	5.2	5.5	16.4	1.5	2.9	6.5	26.6	11.1	4.2	4.4	7.5	7.0	0.0	2.4	1.0	1.7	13.2	3.3	1.2	1.2	3.4	1.6	1.7	1.1	0.5	0.0	0.1	2.2	0.0	0.0	0.1	0.1	2.9	0.1	0.5	0.0	1.3	0.0	0.0	0.0	0.3	0.1	1.0	0.0	0.2	0.0	0.7	2.5	0.1	0.7	0.0	0.4	4.2	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	1.0	0.2	0.1	4.6	0.1	0.0	0.4	19.0	0.2	0.9	8.3	0.5	0.6	2.1	0.8	0.0	2.2	0.1	1.4	0.0	0.0	0.0	0.0	0.0	10.2	3.4	1.2	1.7	0.8	1.0	1.0	1.0	0.8	0.8	0.6	1.2	1.0	1.1	3.3	1.7	1.6	1.2	0.7	0.5	14.4	13.8	7.9	9.6	11.1	10.2	11.4	7.1	10.5	7.0
C3orf80		ENSG00000180044	"Chromosome 3 open reading frame 80"	F5H4A9	3	160225496-160228213	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.0;intestine: 8.6"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 55.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA047439	Uncertain									"HPA047439: AB_10965171"	"unprognostic (5.34e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.92e-3)"	"unprognostic (6.70e-3)"	"unprognostic (4.28e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.09e-10)"	"unprognostic (1.32e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.11e-3)"	"unprognostic (5.00e-2)"	1.3	0.4	5.2	1.6	9.3	1.4	0.7	5.4	25.0	0.5	8.6	0.1	0.0	1.8	1.2	0.5	5.7	0.3	1.4	0.6	4.3	2.0	0.6	0.8	2.0	0.3	1.7	9.3	0.3	0.4	1.4	0.7	0.3	1.2	1.8	3.3	0.0	0.6	0.8	0.2	0.2	1.3	1.8	0.5	2.7	2.5	1.3	0.0	0.0	0.5	0.0	0.4	2.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	1.1	0.7	4.6	1.3	0.0	0.0	0.9	55.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.5	0.0	0.0	0.1	11.4	0.0	0.0	0.2	0.0	1.4	0.1	0.0	0.0	0.4	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.2	9.3	5.4	25.0	4.3	2.0	1.7	9.3	1.2	0.0
C4orf22		ENSG00000197826	"Chromosome 4 open reading frame 22"	Q6V702	4	80335720-80963756	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.0;fallopian tube: 19.8;testis: 34.8"	"Cell line enhanced"	"Detected in some"		"A-431: 3.5;ASC TERT1: 2.1;BJ: 4.5;LHCN-M2: 2.7;SCLC-21H: 3.0;U-251 MG: 2.9;U-87 MG: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 8.4;pons and medulla: 22.0"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.2;naive B-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.1"	"Low region specificity"	"Detected in many"							HPA043383	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA043383: AB_10797140"	"unprognostic (4.77e-4)"	"unprognostic (1.52e-1)"		"unprognostic (4.06e-2)"	"unprognostic (1.45e-2)"			"unprognostic (7.24e-2)"		"unprognostic (3.27e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.61e-2)"	0.1	0.1	1.4	0.1	8.4	0.1	0.3	0.6	0.2	0.9	0.1	5.1	0.1	0.3	0.4	7.8	0.2	19.8	0.3	0.1	2.8	2.5	0.4	0.1	5.9	0.3	0.1	0.1	3.5	0.1	0.1	1.2	0.1	22.0	0.2	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.2	0.4	0.1	0.1	34.8	2.4	2.9	0.7	0.0	0.2	0.1	0.0	2.1	0.5	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.3	2.1	0.0	4.5	0.8	0.1	0.2	0.0	0.0	1.3	0.0	1.5	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	2.9	0.0	0.0	1.2	2.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.4	8.4	0.6	0.2	2.8	2.5	0.1	0.1	22.0	2.4
C4orf47	LOC441054	ENSG00000205129	"Chromosome 4 open reading frame 47"	A7E2U8	4	185426249-185449826	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.8;fallopian tube: 20.3;testis: 20.6"	"Cell line enhanced"	"Detected in some"		"A-431: 4.1;ASC TERT1: 4.3;U-87 MG: 10.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 4.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043662, HPA063485"	Enhanced		Approved	Vesicles				Vesicles		"HPA043662: AB_10964715, HPA063485: "	"unprognostic (3.38e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.84e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (5.82e-5)"	"unprognostic (3.72e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.71e-3)"	"prognostic unfavourable (4.75e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.64e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.50e-1)"	0.9	0.5	4.4	0.7	13.3	0.8	3.7	1.7	4.0	1.8	0.7	3.6	0.8	0.6	2.2	12.3	0.7	20.3	1.8	1.2	3.8	3.8	2.4	1.0	3.3	0.5	2.4	2.9	3.0	1.3	1.0	7.1	0.7	20.8	1.2	0.7	2.1	1.0	1.4	0.6	1.9	0.7	1.0	4.7	0.8	0.5	20.6	5.5	0.0	7.3	0.0	0.6	1.0	0.6	0.1	0.7	4.1	0.6	0.9	0.6	0.2	4.1	0.0	0.4	2.2	0.8	4.3	1.3	0.1	0.3	0.4	0.5	0.6	2.5	0.1	0.8	0.2	0.3	0.5	0.6	1.0	0.8	0.7	0.0	0.1	0.6	1.0	0.0	0.3	0.9	1.0	1.0	0.5	0.0	0.6	0.3	3.2	0.5	0.0	0.0	0.5	1.6	0.1	0.1	0.3	1.2	0.1	2.3	1.0	0.7	0.1	2.6	0.2	0.7	1.3	0.7	0.3	0.0	0.1	1.8	0.0	0.0	10.7	0.0	0.3	0.0	0.6	0.6	0.2	0.1	0.4	0.0	0.6	0.6	0.2	0.1	0.1	0.2	4.1	0.9	0.2	0.7	0.0	0.2	4.4	13.3	1.7	4.0	3.8	3.8	2.4	2.9	20.8	5.5
C5orf34	FLJ32363	ENSG00000172244	"Chromosome 5 open reading frame 34"	Q96MH7	5	43486701-43515145	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA045386	Approved									"HPA045386: AB_10965552"	"unprognostic (2.67e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (2.65e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.66e-4)"	"unprognostic (7.79e-3)"	"unprognostic (6.51e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.97e-6)"	"unprognostic (9.87e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.39e-3)"	"unprognostic (5.99e-2)"	3.1	1.7	2.9	6.1	6.6	3.0	4.5	2.7	6.1	4.5	2.9	0.9	1.9	2.0	3.0	1.5	3.5	3.0	2.0	2.0	4.8	2.5	2.5	1.4	2.4	7.3	1.9	3.2	2.7	1.3	1.6	1.5	3.2	4.9	7.1	3.9	2.0	3.6	3.9	1.6	3.9	2.6	9.2	3.0	3.2	2.4	12.8	1.0	15.0	3.6	2.0	7.9	8.5	3.6	1.9	5.9	0.8	0.5	2.0	3.5	0.9	4.2	5.1	7.4	8.8	1.1	2.6	8.4	6.5	6.0	10.7	8.5	3.1	4.5	11.3	6.9	2.1	4.3	8.9	3.1	11.9	5.2	10.6	2.3	18.4	2.7	0.5	6.1	1.3	2.0	1.0	10.8	5.9	5.0	7.2	3.1	8.4	3.2	3.3	8.6	5.3	5.8	6.3	14.8	7.0	2.8	2.0	5.2	6.4	11.0	5.4	4.4	9.1	6.5	3.2	8.5	10.4	8.8	6.8	3.3	4.6	7.0	4.9	7.9	9.0	0.0	0.2	0.1	1.2	0.5	2.1	1.9	1.3	1.3	0.7	1.1	1.9	3.5	0.8	2.0	0.3	5.9	0.5	0.9	2.9	6.6	2.7	6.1	4.8	2.5	1.9	3.2	4.9	1.0
C5orf38	"CEI, IRX2NB"	ENSG00000186493	"Chromosome 5 open reading frame 38"	Q86SI9	5	2752131-2755397	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"salivary gland: 34.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 37.4;HaCaT: 12.8;hTCEpi: 20.5;MCF7: 10.9;SiHa: 15.7;SK-BR-3: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA073667			Approved	"Golgi apparatus,Vesicles"	"Secreted - unknown location"			"Golgi apparatus, Vesicles"		"HPA073667: "	"unprognostic (5.00e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.72e-5)"	"unprognostic (4.08e-2)"	"unprognostic (2.24e-2)"		"unprognostic (2.67e-2)"	"unprognostic (8.38e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.84e-7)"	"unprognostic (2.60e-2)"	"unprognostic (8.01e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.60e-2)"	8.3	0.5	4.5	0.6	7.6	0.5	16.3	10.4	3.0	0.6	1.1	1.5	9.8	0.7	0.7	6.8	4.1	0.6	0.6	2.4	6.0	7.0	6.6	0.5	19.4	1.1	10.5	2.0	0.5	3.8	5.0	2.6	4.3	14.8	5.9	0.7	3.4	34.9	3.9	0.9	10.6	0.5	0.5	12.2	0.7	11.2	1.5	4.7	0.0	5.0	1.6	2.4	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	6.7	0.0	2.9	2.1	37.4	4.8	3.8	3.2	2.8	1.9	0.0	0.0	0.0	0.9	12.8	0.7	3.7	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	20.5	0.8	2.6	0.0	0.0	0.0	0.8	10.9	0.0	0.1	1.0	0.0	0.0	1.3	0.0	4.2	0.0	1.0	0.0	15.7	14.7	0.0	6.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	7.6	10.4	0.3	6.0	7.0	10.5	2.0	14.8	4.7
C5orf49	LOC134121	ENSG00000215217	"Chromosome 5 open reading frame 49"	A4QMS7	5	7830378-7851490	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 35.9;fallopian tube: 65.6;testis: 28.9"	"Cell line enhanced"	"Detected in some"		"AF22: 3.1;CAPAN-2: 2.0;RPTEC TERT1: 2.2;SCLC-21H: 1.4;T-47d: 2.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 9.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043759	Enhanced									"HPA043759: "	"unprognostic (1.55e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.93e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.20e-2)"	1.0	1.3	9.7	1.0	16.9	0.8	1.6	0.5	7.4	3.0	0.9	12.2	1.2	1.0	2.1	9.9	0.9	65.6	1.3	0.9	10.4	12.4	3.5	1.3	10.1	0.9	5.7	6.3	6.9	2.4	2.7	5.9	0.9	35.9	2.3	0.9	0.7	0.9	2.0	0.9	1.1	0.9	1.1	2.7	0.9	1.4	28.9	4.0	0.0	1.6	0.0	0.9	0.9	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	3.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	2.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.2	1.1	0.0	0.0	0.2	0.0	2.2	0.1	1.4	0.8	0.9	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	16.9	0.5	7.4	10.4	12.4	5.7	6.3	35.9	4.0
C5orf63	"FLJ44606, YDR286C"	ENSG00000164241	"Chromosome 5 open reading frame 63"	A6NC05	5	127042558-127073492	"Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 32.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA043240	Approved	Approved	Approved	Mitochondria				Mitochondria		"HPA043240: AB_10962511"	"unprognostic (2.71e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.94e-4)"	"unprognostic (1.34e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.07e-2)"	4.4	4.4	3.3	10.1	4.6	2.8	5.9	6.8	21.4	2.9	10.9	5.5	3.3	5.6	7.5	4.8	7.6	4.2	3.8	7.3	4.4	4.9	8.0	7.0	4.6	6.8	4.6	4.8	4.4	7.5	9.2	27.7	2.7	6.8	5.5	11.0	11.3	13.7	3.9	6.6	3.3	9.2	3.2	6.2	5.6	6.8	13.8	3.0	8.5	9.0	5.1	9.1	4.9	5.1	11.9	9.8	3.9	1.5	12.3	10.1	2.9	0.5	2.4	0.7	1.4	1.9	2.9	0.3	2.6	0.3	3.3	1.9	6.0	7.6	0.0	10.9	2.1	1.0	4.6	2.9	4.7	1.0	3.7	6.1	9.2	7.1	4.6	3.5	0.3	3.0	7.3	4.2	2.2	2.8	0.4	1.1	3.2	4.9	0.1	3.3	0.4	1.9	2.7	1.6	4.2	3.6	3.7	6.1	5.0	3.4	1.5	0.2	6.3	5.3	2.1	6.9	6.4	7.9	1.6	3.7	9.5	0.2	32.0	0.4	3.6	3.4	0.3	3.9	6.7	1.5	5.3	11.9	6.1	7.1	3.0	10.8	9.2	6.8	1.4	12.3	0.4	9.8	10.1	2.9	3.3	4.6	6.8	3.2	4.4	4.9	4.6	4.8	6.8	3.0
C6orf118	"bA85G2.1, MGC23884"	ENSG00000112539	"Chromosome 6 open reading frame 118"	Q5T5N4	6	165279664-165309607	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 14.5;fallopian tube: 23.9;pituitary gland: 10.4;testis: 9.6"	"Group enriched"	"Detected in some"	5	"AF22: 7.2;SCLC-21H: 4.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA029787, HPA029789"	Approved		Uncertain	Mitochondria				Mitochondria		"HPA029787: AB_10599999, HPA029789: AB_10601002"	"unprognostic (2.84e-1)"	"unprognostic (3.09e-4)"		"unprognostic (2.70e-2)"	"unprognostic (7.99e-2)"	"unprognostic (5.34e-2)"		"unprognostic (1.41e-1)"		"unprognostic (2.50e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.18e-9)"	"unprognostic (3.22e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.55e-3)"	"unprognostic (4.50e-1)"	0.3	0.3	4.4	0.3	11.4	0.3	0.3	0.1	0.8	1.5	0.3	7.5	0.1	0.3	1.0	7.2	0.3	23.9	0.3	0.3	4.3	2.7	0.3	0.3	4.7	0.3	0.3	1.0	3.4	0.3	0.3	10.4	0.3	14.5	0.3	0.3	0.0	0.3	0.4	0.3	0.3	0.3	0.3	0.8	0.3	0.3	9.6	3.9	0.0	0.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.2	0.0	0.2	0.0	4.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	11.4	0.1	0.8	4.3	2.7	0.3	1.0	14.5	3.9
C6orf136	Em:AB023049.8	ENSG00000204564	"Chromosome 6 open reading frame 136"	Q5SQH8	6	30647039-30653210	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046804	Uncertain									"HPA046804: "	"unprognostic (1.94e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.43e-1)"	"prognostic favourable (9.16e-8)"	"unprognostic (2.33e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.03e-2)"	"prognostic favourable (7.51e-4)"	7.4	13.4	13.5	7.1	19.0	7.5	6.9	22.6	30.0	8.1	22.5	11.9	8.4	24.2	6.2	16.4	9.6	8.4	6.8	16.9	13.5	15.1	14.4	11.7	9.2	8.1	15.8	18.1	5.2	13.3	20.4	12.3	7.0	24.9	7.3	21.3	8.4	8.9	12.1	21.3	14.3	21.5	7.7	11.7	8.2	9.1	7.6	9.5	3.6	10.7	13.0	6.8	10.0	5.8	3.5	2.5	2.2	1.2	1.1	3.9	1.2	3.7	6.1	3.3	2.9	5.1	6.2	5.8	1.4	1.7	3.8	5.3	4.0	2.6	3.2	2.3	1.1	5.0	0.5	0.2	4.1	2.8	4.6	1.7	4.2	2.4	1.3	5.2	5.4	2.8	5.7	2.8	3.4	1.5	4.2	2.4	0.8	6.2	2.3	5.8	3.6	3.4	4.5	3.0	6.4	8.2	5.4	7.9	1.5	1.9	6.5	4.3	3.2	1.2	0.7	1.1	5.5	2.2	4.7	6.3	7.3	2.2	2.0	4.6	2.5	0.1	1.2	0.2	2.0	1.0	2.6	3.5	2.4	1.4	1.2	2.3	3.9	2.3	2.2	1.1	1.1	2.5	1.7	1.2	13.5	19.0	22.6	30.0	13.5	15.1	15.8	18.1	24.9	9.5
C6orf141	MGC46457	ENSG00000197261	"Chromosome 6 open reading frame 141"	Q5SZD1	6	49550646-49561907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.6;gallbladder: 18.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 8.9;HeLa: 7.0;hTCEpi: 7.0;PC-3: 12.0;T-47d: 7.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"basal ganglia: 30.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA036199	Uncertain		Approved	"Nuclear membrane"				"Nuclear membrane"		"HPA036199: "	"prognostic favourable (3.92e-6)"	"unprognostic (1.58e-1)"	"unprognostic (9.87e-2)"	"prognostic favourable (1.15e-4)"	"unprognostic (4.95e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.89e-8)"	"unprognostic (2.33e-2)"	"unprognostic (5.81e-1)"	"unprognostic (3.77e-1)"	"unprognostic (4.43e-1)"	4.7	0.2	1.0	3.0	30.6	0.0	4.9	3.1	1.8	3.7	2.1	0.3	4.4	10.5	4.4	3.6	2.9	1.9	18.9	0.4	0.3	0.4	0.3	1.1	0.6	0.6	0.5	0.1	0.5	3.3	0.0	2.0	0.2	2.8	1.1	1.4	0.0	2.2	0.9	1.2	4.6	1.4	1.4	0.3	0.1	9.1	3.1	2.9	0.0	1.1	0.4	0.8	1.7	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	3.1	0.0	0.0	0.0	0.0	1.6	0.8	0.9	0.0	0.0	0.2	3.3	0.0	0.5	1.5	8.9	1.0	2.3	0.0	0.0	5.6	0.0	7.0	0.0	0.3	0.0	0.0	0.3	7.0	0.0	5.0	1.7	0.1	0.0	0.0	0.1	0.0	0.0	3.3	12.0	0.0	0.0	0.0	1.6	5.2	0.2	0.0	2.2	0.0	0.0	7.5	0.0	2.7	0.4	0.0	0.0	5.7	0.0	0.0	0.0	5.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	30.6	3.1	1.3	0.3	0.4	0.5	0.1	2.8	2.9
C6orf15	STG	ENSG00000204542	"Chromosome 6 open reading frame 15"	Q6UXA7	6	31111223-31112559	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix, uterine: 5.6;lymphoid tissue: 7.3;skin 1: 10.8;tongue: 11.5"	"Group enriched"	"Detected in some"	11	"RH-30: 8.1;U-2 OS: 3.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA001436	Uncertain				"Secreted - unknown location"					"HPA001436: AB_2243752"	"unprognostic (2.73e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-1)"		"unprognostic (1.77e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.71e-2)"			"unprognostic (1.72e-1)"		"unprognostic (1.90e-1)"	"unprognostic (1.34e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.3	10.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	7.3	0.0	11.5	3.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0
C6orf223	MGC45491	ENSG00000181577	"Chromosome 6 open reading frame 223"	Q8N319	6	44000580-44005958	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 23.6;lung: 9.4"	"Cell line enhanced"	"Detected in some"		"A-431: 16.8;RPTEC TERT1: 23.8;THP-1: 9.9;U-937: 5.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA035765, HPA046117"	Uncertain		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA035765: , HPA046117: AB_10964082"	"unprognostic (2.94e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (7.06e-3)"	"unprognostic (2.34e-4)"	"unprognostic (1.39e-3)"	"unprognostic (2.70e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavourable (9.38e-5)"	"unprognostic (2.95e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.31e-1)"	0.1	0.4	1.1	1.3	0.9	0.5	23.6	0.2	3.0	0.7	1.4	0.0	0.0	1.8	0.8	4.7	0.1	0.2	6.9	2.9	1.1	0.8	4.9	1.4	9.4	2.8	0.1	1.2	0.1	2.4	0.1	0.8	0.2	0.9	0.2	0.7	3.4	3.1	0.1	0.3	0.5	3.1	0.2	0.0	0.7	0.2	0.3	0.0	1.0	2.1	1.1	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.6	0.0	0.1	0.0	9.9	0.0	0.0	0.2	0.3	0.0	0.1	2.0	3.5	1.2	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.2	3.0	1.1	0.8	0.1	1.2	0.9	0.0
C6orf52		ENSG00000137434	"Chromosome 6 open reading frame 52"	Q5T4I8	6	10671418-10694797	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 17.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 8.5;NB-4: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.2"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA051142	Uncertain		Approved	"Nuclear speckles,Intermediate filaments"				"Nuclear speckles"	"Intermediate filaments"	"HPA051142: "	"unprognostic (1.14e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.63e-1)"	"prognostic favourable (6.50e-5)"	"unprognostic (9.12e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.31e-3)"	"unprognostic (7.65e-2)"	1.6	2.4	5.6	1.4	4.8	0.9	3.0	2.7	4.3	1.2	1.5	4.4	5.5	7.7	1.4	9.0	0.9	8.0	1.2	0.7	4.9	5.3	3.8	1.4	1.7	1.1	4.5	3.2	1.9	7.7	1.5	2.9	1.5	4.4	3.1	1.0	0.7	1.8	1.7	1.2	2.5	2.1	0.9	4.0	1.0	1.6	17.7	2.6	1.6	2.1	1.0	1.6	1.0	2.0	0.7	1.0	4.7	1.0	1.4	6.2	0.6	1.1	2.7	2.5	2.1	0.9	0.0	4.3	0.2	0.1	0.3	0.6	2.9	2.3	0.1	3.9	0.0	0.2	2.4	0.0	1.0	1.3	4.1	0.6	0.5	0.4	0.0	0.8	0.4	0.5	3.8	1.0	1.5	0.0	4.6	0.3	1.0	8.5	1.8	7.5	2.3	3.0	1.5	0.2	1.0	1.2	0.6	4.9	3.0	0.9	0.6	4.8	0.2	1.5	0.4	2.0	0.6	1.5	1.7	3.5	7.4	1.5	3.4	1.0	1.9	0.0	0.5	4.7	1.2	1.0	0.4	0.5	1.5	1.3	1.0	0.7	0.7	0.6	0.6	1.4	0.7	0.8	6.2	0.6	5.6	4.8	2.7	4.3	4.9	5.3	4.5	3.2	4.4	2.6
C6orf62	"DKFZP564G182, FLJ12619, XTP12"	ENSG00000112308	"Chromosome 6 open reading frame 62"	Q9GZU0	6	24704861-24720836	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030564, HPA030566"	Supported		Approved	Cytosol				Cytosol		"HPA030564: AB_10600000, HPA030566: AB_10599425"	"unprognostic (2.07e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.10e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavourable (5.77e-5)"	"unprognostic (1.18e-1)"	"unprognostic (3.67e-1)"	"prognostic favourable (4.04e-4)"	"unprognostic (4.16e-3)"	"unprognostic (3.94e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.01e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.93e-2)"	"prognostic favourable (3.62e-6)"	38.9	38.3	46.0	42.8	49.9	37.8	52.0	34.3	50.1	30.7	35.4	31.4	49.9	30.8	31.0	42.6	33.1	32.0	41.9	27.8	38.2	40.5	35.1	49.0	54.6	67.6	50.0	36.7	37.8	52.9	35.6	33.6	37.9	33.9	33.6	31.3	33.8	47.4	52.6	31.1	33.7	38.6	28.8	36.4	58.3	38.9	46.0	38.1	75.2	41.5	28.1	56.5	35.6	34.2	48.4	48.7	64.0	62.3	52.7	65.3	103.5	22.9	14.2	17.4	29.5	22.0	28.5	19.2	27.2	35.6	41.0	43.9	17.8	20.7	26.4	42.9	31.8	19.2	20.0	26.6	45.5	44.5	9.6	27.7	23.1	23.9	37.7	33.7	33.2	22.1	53.7	27.7	37.0	31.7	24.4	19.7	38.4	18.9	25.8	50.7	19.3	14.4	20.8	18.9	26.5	24.4	34.7	29.6	16.7	32.5	37.2	49.3	32.6	27.0	28.1	37.1	17.9	14.0	37.0	46.5	73.1	32.8	13.3	46.6	35.8	47.7	62.1	64.0	55.7	62.0	58.6	48.4	57.4	60.6	47.7	41.8	57.6	65.3	44.2	52.7	62.3	48.7	53.4	103.5	46.0	49.9	34.3	50.1	38.2	40.5	50.0	36.7	33.9	38.1
C7orf26	MGC2718	ENSG00000146576	"Chromosome 7 open reading frame 26"	Q96N11	7	6590017-6608726	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042899, HPA052175"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"				Nucleoplasm	"Nucleoli, Intermediate filaments, Cytosol"	"HPA042899: , HPA052175: "	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (6.95e-5)"	"unprognostic (4.72e-2)"	"unprognostic (2.26e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.55e-1)"	19.8	17.1	13.4	21.7	17.7	29.2	20.0	20.6	26.9	19.0	17.9	21.1	21.5	19.4	23.0	15.4	14.7	19.9	15.6	12.8	14.4	14.1	15.4	18.4	19.3	24.1	18.8	20.2	20.6	23.9	17.2	16.6	14.0	15.4	21.1	11.5	16.4	21.2	16.6	18.7	21.9	16.4	19.6	13.1	27.3	18.6	16.8	16.1	31.7	18.3	18.5	20.6	17.6	19.6	4.2	6.4	4.6	3.4	3.3	6.1	1.9	11.1	9.3	6.5	15.4	10.7	6.0	8.6	6.7	5.9	9.7	6.0	8.7	4.7	13.2	8.8	4.9	12.4	8.7	6.1	4.4	5.1	12.5	4.9	5.8	9.1	12.6	11.7	15.9	6.9	9.3	5.8	6.1	10.5	12.9	10.1	5.7	18.7	10.2	24.3	13.0	12.5	20.9	5.2	11.2	6.3	9.8	8.6	15.9	6.5	21.6	9.0	9.8	17.7	7.5	8.1	26.5	8.8	14.6	12.3	12.0	12.2	5.4	13.1	23.8	1.1	3.4	4.6	4.7	3.3	6.1	4.1	5.7	6.0	2.6	4.2	5.9	4.9	3.4	3.3	3.3	6.4	5.4	1.9	13.4	17.7	20.6	26.9	14.4	14.1	18.8	20.2	15.4	16.1
C7orf57		ENSG00000164746	"Chromosome 7 open reading frame 57"	Q8NEG2	7	48035511-48061304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.0;fallopian tube: 20.9;testis: 11.4"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 10.1;U-266/70: 5.9;U-698: 3.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 20.0"	"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021286	Enhanced									"HPA021286: AB_1845760"	"unprognostic (1.74e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.77e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-5)"	"unprognostic (5.17e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.20e-1)"	0.2	0.2	2.3	0.2	5.0	0.5	0.3	0.1	1.0	0.8	0.2	3.5	0.0	0.3	0.9	7.1	1.4	20.9	0.2	0.3	3.7	4.0	0.3	0.2	4.3	0.3	0.1	0.4	1.6	0.1	0.7	0.4	0.2	20.0	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.7	0.2	0.2	11.4	2.1	0.0	0.5	1.8	0.4	0.2	0.5	0.0	0.1	0.0	0.0	0.6	2.3	0.1	0.8	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.5	0.3	0.4	0.0	2.4	0.0	0.2	0.2	0.3	0.0	1.0	0.7	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.1	0.0	0.0	0.1	0.4	0.1	0.2	0.0	0.2	1.0	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.6	0.9	0.5	0.6	5.9	0.8	3.4	1.4	0.0	1.0	0.0	0.0	0.0	0.6	0.0	2.3	0.0	0.6	0.6	0.1	0.0	0.4	0.2	0.0	0.6	0.0	0.0	0.0	0.1	2.3	5.0	0.1	1.0	3.7	4.0	0.1	0.4	20.0	2.1
C7orf61	IMAGE:4839025	ENSG00000185955	"Chromosome 7 open reading frame 61"	Q8IZ16	7	100456615-100464271	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 80.4"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 21.7;NB-4: 8.0;TIME: 12.7"	"Cancer enhanced"	"Detected in some"		"glioma: 3.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA060395	Enhanced		Approved	Vesicles				Vesicles		"HPA060395: "	"unprognostic (1.88e-1)"	"unprognostic (5.02e-1)"	"unprognostic (1.26e-2)"	"unprognostic (7.70e-5)"	"unprognostic (1.65e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.39e-13)"	"unprognostic (9.54e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.24e-2)"	0.5	0.3	2.8	0.6	3.1	1.2	0.5	1.4	3.4	0.5	0.5	0.5	0.5	0.1	0.8	0.8	0.5	0.7	0.6	0.5	3.0	2.3	0.5	0.5	0.5	0.8	3.2	0.5	1.0	0.5	0.4	0.9	0.6	0.6	0.5	0.2	0.5	0.5	0.7	0.5	0.7	0.5	0.5	3.1	1.0	0.1	80.4	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.1	0.6	1.3	1.2	0.8	2.9	0.2	0.8	0.2	0.7	0.8	0.8	1.9	0.3	0.3	1.3	0.2	0.7	0.9	0.4	0.6	1.4	0.7	0.5	0.3	0.0	0.5	0.8	1.4	1.2	1.6	0.0	1.0	0.4	0.3	0.3	0.3	0.8	1.2	21.7	0.6	1.1	1.2	2.0	0.4	8.0	0.5	0.9	2.1	0.0	0.4	0.3	0.3	0.0	0.0	0.5	0.7	1.3	0.3	2.2	12.7	1.1	1.9	2.4	0.3	0.3	0.2	0.8	0.2	1.9	0.1	0.0	1.2	0.0	0.8	0.7	0.3	0.0	1.1	0.6	0.6	0.1	0.1	1.6	1.3	0.8	0.4	0.0	2.9	0.2	2.8	3.1	1.4	1.5	3.0	2.3	3.2	0.5	0.6	0.5
C8orf34	"vest-1, VEST1"	ENSG00000165084	"Chromosome 8 open reading frame 34"	Q49A92	8	68330722-68819022	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.3;parathyroid gland: 19.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.4;HEK 293: 5.7;LHCN-M2: 4.9;RH-30: 5.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044420, HPA053065"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA044420: AB_10963791, HPA053065: "	"unprognostic (1.75e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.59e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.55e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.80e-4)"	"unprognostic (5.21e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.84e-4)"	"unprognostic (1.33e-1)"	4.2	0.9	7.4	0.8	10.6	1.1	1.5	9.6	8.4	4.0	0.7	9.6	0.2	0.7	1.5	2.5	2.1	15.3	3.2	1.6	8.9	7.0	1.0	0.7	8.3	0.8	3.7	5.0	1.4	2.1	19.9	2.7	0.9	10.4	3.9	0.9	3.5	1.4	2.2	0.9	1.8	0.8	1.7	3.2	0.8	1.7	1.4	6.7	0.0	1.0	1.1	0.7	1.2	1.1	1.8	2.0	2.9	0.7	1.3	1.8	0.5	0.3	0.0	0.8	0.4	1.2	2.2	0.2	1.4	4.4	0.7	0.6	0.3	0.4	0.2	0.9	1.2	0.3	0.3	0.8	0.2	0.1	5.7	0.7	1.0	0.4	0.2	0.1	0.5	0.1	0.6	0.8	1.5	0.1	0.3	1.0	4.9	0.6	0.1	0.5	2.5	0.1	0.2	5.3	0.1	0.6	0.4	1.1	0.1	0.3	0.3	0.0	2.5	0.2	0.1	1.0	0.6	3.3	0.2	0.8	0.0	0.1	0.4	0.3	0.8	2.1	0.7	1.2	1.4	0.3	1.1	1.0	1.2	1.1	0.3	1.8	1.5	1.8	2.9	1.3	0.5	2.0	0.8	0.5	7.4	10.6	9.6	8.4	8.9	7.0	3.7	5.0	10.4	6.7
C8orf44	FLJ11267	ENSG00000213865	"Chromosome 8 open reading frame 44"	Q96CB5	8	66667615-66685564	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA043660, HPA054753"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA043660: AB_10794889, HPA054753: "	"unprognostic (6.19e-2)"	"unprognostic (7.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.61e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.73e-2)"	"prognostic favourable (4.21e-4)"	"unprognostic (7.35e-2)"	"prognostic unfavourable (1.08e-7)"	"unprognostic (4.01e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.49e-1)"	"prognostic favourable (2.68e-6)"	5.8	4.5	15.8	6.1	18.1	8.6	9.6	16.6	14.9	6.6	5.3	10.4	7.2	4.3	8.4	27.7	4.2	7.7	5.6	5.8	10.6	7.7	5.9	4.0	4.7	10.1	11.4	9.0	10.2	4.6	6.8	14.6	5.8	8.6	6.8	8.3	8.9	7.7	7.0	11.6	12.4	5.3	5.9	9.2	7.5	6.4	15.3	11.5	9.4	10.8	3.0	8.0	6.8	6.0	5.8	4.4	5.7	3.1	0.6	3.8	1.5	8.8	3.5	5.9	4.1	3.6	7.0	3.2	2.5	2.4	3.3	3.9	3.5	10.0	9.9	1.6	4.2	6.1	5.6	2.1	4.7	7.4	5.4	8.3	10.6	7.3	2.9	3.7	5.9	5.9	4.9	4.5	4.8	4.2	9.5	6.6	3.3	3.2	4.2	5.2	5.1	4.4	4.1	1.9	2.0	4.9	1.9	4.8	3.8	2.6	1.7	3.2	5.9	2.4	6.0	3.6	4.7	3.4	1.5	7.8	2.6	4.1	5.8	4.0	1.8	5.7	3.1	4.0	1.9	2.5	1.4	5.8	2.4	2.2	2.6	4.8	3.8	2.8	3.6	0.6	1.3	4.4	3.4	1.5	15.8	18.1	16.6	14.9	10.6	7.7	11.4	9.0	8.6	11.5
C8orf46	MGC33510	ENSG00000169085	"Chromosome 8 open reading frame 46"	Q8TAG6	8	66460003-66518524	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 51.7"	"Cell line enhanced"	"Detected in some"		"A-431: 3.2;CAPAN-2: 3.2;fHDF/TERT166: 3.2;LHCN-M2: 4.2;SK-MEL-30: 4.6;T-47d: 5.9;WM-115: 5.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 16.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"amygdala: 164.2;basal ganglia: 80.3;cerebral cortex: 305.1;hippocampal formation: 240.3"	"Low region specificity"	"Detected in all"			HPA075134			Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA075134: "	"unprognostic (6.87e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.36e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.53e-4)"	"unprognostic (7.87e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.36e-3)"	"unprognostic (3.53e-4)"	"unprognostic (1.86e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.91e-2)"	1.2	1.4	14.9	1.2	16.6	1.2	1.2	1.8	51.7	1.6	1.2	16.3	0.0	1.0	1.6	1.3	1.5	1.2	1.7	2.2	39.1	8.3	1.3	1.2	1.4	1.4	13.8	19.4	1.1	1.8	1.1	0.2	1.1	10.9	2.2	1.3	0.0	1.7	5.3	3.1	1.4	1.4	2.0	17.9	1.2	1.1	1.4	10.0	0.0	1.3	0.0	1.1	1.5	0.2	0.0	0.7	0.0	0.0	0.0	0.7	0.1	3.2	0.2	0.5	2.1	0.0	0.1	0.0	0.3	0.4	0.5	0.1	0.0	3.2	0.0	0.3	3.2	0.1	0.0	0.0	2.3	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.2	4.2	0.5	0.0	0.0	0.2	0.2	0.0	0.5	0.0	1.3	0.1	0.5	0.0	0.0	0.0	4.6	5.9	0.0	0.0	0.4	0.7	0.2	2.8	0.1	1.2	0.0	1.2	0.1	5.8	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.9	16.6	1.8	26.7	39.1	8.3	13.8	19.4	10.9	10.0
C8orf58	FLJ34715	ENSG00000241852	"Chromosome 8 open reading frame 58"	Q8NAV2	8	22599601-22604150	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA024667, HPA028286"	Uncertain		Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA024667: AB_1845783, HPA028286: AB_1845784"	"unprognostic (8.88e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.72e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (3.58e-6)"	"unprognostic (1.67e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	12.3	5.4	6.0	6.3	6.2	4.4	14.5	12.9	7.1	10.3	5.9	6.5	5.8	4.0	10.9	7.6	8.6	7.3	8.9	6.7	6.3	3.6	9.4	5.7	9.2	7.4	4.2	5.9	10.5	5.5	5.8	4.4	28.5	5.3	12.3	3.9	10.2	7.1	7.1	8.2	13.0	6.2	7.3	3.3	19.7	4.9	11.6	4.2	4.0	7.9	6.5	5.7	6.3	7.6	1.8	0.5	3.7	1.6	0.1	2.3	0.6	4.8	7.2	20.2	11.6	5.5	6.4	5.5	10.9	9.1	13.6	9.8	1.3	4.2	1.0	5.3	11.9	4.8	3.6	10.2	8.8	1.4	1.7	2.8	7.0	0.7	9.8	1.0	4.4	9.2	8.8	8.1	5.2	7.9	1.7	1.4	10.8	3.4	2.1	5.2	12.3	4.9	3.5	5.1	1.1	8.2	4.5	2.1	6.6	5.3	3.9	12.2	3.7	2.3	10.9	14.9	12.1	10.3	9.9	1.8	1.1	0.9	7.7	2.0	12.1	0.0	0.9	3.7	0.7	1.6	0.4	1.7	0.4	1.0	0.5	1.8	2.3	1.8	0.0	0.1	0.0	0.5	0.0	0.6	6.0	6.2	12.9	7.1	6.3	3.6	4.2	5.9	5.3	4.2
C8orf76	FLJ14825	ENSG00000189376	"Chromosome 8 open reading frame 76"	Q96K31	8	123219957-123241398	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA023708	Uncertain		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA023708: AB_1845785"	"prognostic unfavourable (9.95e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.71e-2)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavourable (5.95e-11)"	"unprognostic (1.54e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.71e-2)"	11.9	15.4	13.5	11.4	21.8	13.8	14.5	18.5	15.2	12.0	13.5	11.5	27.0	11.8	9.2	16.1	16.4	9.5	11.2	11.1	11.5	11.8	10.1	19.3	10.2	15.9	11.8	10.6	9.8	12.3	8.5	24.0	15.5	10.9	11.5	15.8	12.5	13.9	23.7	16.9	10.0	12.5	10.8	9.4	15.9	10.4	7.4	14.4	18.8	13.9	9.9	18.3	10.3	10.7	12.7	17.2	24.4	18.9	13.4	18.6	11.0	8.4	7.8	7.3	5.1	7.2	6.6	5.0	8.0	7.8	9.4	9.5	7.1	6.2	5.8	8.8	7.6	6.5	8.3	4.3	10.7	9.2	11.8	6.8	3.6	10.0	12.9	3.5	5.6	4.8	8.5	8.4	7.1	8.3	9.7	4.5	7.8	24.7	10.3	8.1	5.9	13.6	5.5	3.7	6.6	8.0	7.0	9.6	9.0	8.0	59.1	8.4	7.2	8.7	4.5	5.4	10.2	5.8	6.5	6.0	6.6	6.3	5.8	8.1	5.7	15.9	16.7	24.4	13.3	18.9	13.9	11.2	14.5	16.8	17.2	12.7	13.9	13.7	9.8	13.4	15.3	14.9	18.6	11.0	13.5	21.8	18.5	15.2	11.5	11.8	11.8	10.6	10.9	14.4
C8orf86	FLJ43582	ENSG00000196166	"Chromosome 8 open reading frame 86"	Q6ZUL3	8	38510834-38528662	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.3;intestine: 3.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA025066	Uncertain									"HPA025066: AB_1848937"	"unprognostic (9.54e-2)"			"unprognostic (9.14e-3)"	"unprognostic (2.38e-2)"					"unprognostic (2.47e-1)"		"unprognostic (5.63e-2)"		"unprognostic (2.69e-2)"	"unprognostic (2.21e-1)"			0.5	0.2	0.6	0.1	0.4	0.6	0.2	1.5	0.9	0.2	0.2			3.9	0.2	0.2	0.3	0.4	0.6	0.1	0.7	0.7	0.5	0.8	0.0	0.0	0.5		0.2	0.3	0.0	1.1	0.0		0.2	0.1		0.3	0.0	1.0	0.6	1.8	0.0	0.3	0.2	0.7	0.5			0.0		0.0	0.3	0.1	1.3	0.7	2.3	0.6	1.4	0.7	0.2	0.1	0.0	0.2	0.6	0.7	2.1	0.3	1.7	0.4	0.1	0.1	0.5	0.3	0.5	0.3	0.0	1.0	0.1	0.0	0.2	0.9	0.3	0.0	1.0	0.0	0.5	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.7	0.0	1.4	0.1	1.5	0.0	0.4	0.0	0.0	0.0	1.3	0.5	0.3	0.5	0.3	0.3	1.2	0.0	0.7	0.6	0.5	1.2	0.1	0.6	1.0	0.6	0.4	0.3	0.1	2.0	0.6	0.4	0.5	0.3	0.5	0.9	0.5	0.5	0.3	1.3	0.7	0.7	2.3	1.4	0.4	0.7	0.4	0.2										
C9orf131	MGC41945	ENSG00000174038	"Chromosome 9 open reading frame 131"	Q5VYM1	9	35041095-35045991	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 46.6"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.9;RT4: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.7"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA022029			Approved	Mitochondria				Mitochondria		"HPA022029: AB_10960628"	"unprognostic (1.10e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.47e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.90e-4)"	"unprognostic (4.19e-3)"	0.2	0.1	0.2	0.2	0.3	1.3	0.3	0.6	0.3	1.0	0.2	0.2	0.2	0.0	2.2	0.8	0.2	0.2	1.4	0.2	0.2	0.2	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.3	0.7	0.2	0.4	0.2	0.2	0.4	0.2	0.2	0.2	0.8	0.5	0.2	0.2	0.2	0.2	0.2	46.6	0.2	0.2	0.3	0.2	0.2	0.3	0.2	1.0	0.1	2.7	0.5	0.9	1.4	0.0	3.3	0.1	0.3	0.8	0.7	0.0	1.0	1.0	0.0	0.0	0.0	0.9	1.8	0.7	0.3	0.0	2.1	0.0	0.0	0.4	0.3	0.5	1.2	3.9	0.9	0.0	0.4	1.2	0.0	0.5	0.0	0.0	0.4	3.3	2.4	0.0	0.5	0.7	1.8	0.6	0.0	0.0	0.3	0.0	0.3	13.7	0.3	0.0	1.2	0.0	0.5	0.7	0.0	0.0	0.0	0.3	0.0	0.3	0.2	0.9	1.3	0.3	0.5	1.5	2.7	0.5	0.0	0.5	0.0	0.0	0.5	0.4	1.4	0.0	1.0	0.5	0.8	1.3	0.9	0.0	0.1	0.1	0.0	0.2	0.3	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.2
C9orf152	bA470J20.2	ENSG00000188959	"Chromosome 9 open reading frame 152"	Q5JTZ5	9	110190048-110208189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.9;salivary gland: 34.3;stomach 1: 20.7"	"Group enriched"	"Detected in some"	6	"SK-BR-3: 9.7;T-47d: 18.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050769	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA050769: "	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (7.22e-5)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.06e-2)"	0.4	0.0	0.4	1.7	0.4	0.0	6.1	0.4	0.4	5.3	16.1	0.5	10.5	9.1	1.0	0.4	2.4	1.5	7.1	0.4	0.4	0.0	0.4	0.5	3.6	0.4	0.4	0.4	0.4	3.9	0.0	0.8	0.4	0.4	11.6	20.9	0.4	34.3	17.0	0.4	3.8	7.0	0.4	0.4	0.4	20.7	0.4	0.4	0.4	0.4	1.6	5.2	1.3	0.4	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	1.4	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.6	0.1	0.1	0.0	9.7	0.0	18.7	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
C9orf47	"bA791O21.3, C9orf108, FLJ37523"	ENSG00000186354	"Chromosome 9 open reading frame 47"	Q6ZRZ4	9	88990863-88996140	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 6.6;ASC diff: 3.2;HeLa: 5.6"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"classical monocyte: 2.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.2"									CAB009902	Approved				"Secreted - unknown location"					"CAB009902: AB_2184764"	"unprognostic (6.51e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.94e-4)"	"unprognostic (2.24e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.47e-2)"	"unprognostic (9.39e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.19e-6)"	"unprognostic (5.61e-2)"	"unprognostic (3.72e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.77e-2)"	1.7	5.3	0.6	1.0	0.7	0.8	2.3	0.0	0.7	1.8	1.0			0.3	1.1	0.6	2.1	2.1	0.9	1.8	0.8	0.5	3.9	0.8	1.0	1.7	0.4		0.4	1.7	0.0	3.3	1.2		1.9	0.2		0.3	0.8	0.0	0.0	0.8	1.4	0.5	1.7	1.0	0.0			0.7		0.5	0.9	1.9	0.0	0.2	0.3	2.2	0.0	0.0	0.4	0.0	0.4	6.6	0.2	3.2	1.9	0.1	1.1	0.3	0.4	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.5	0.0	0.1	0.0	5.6	0.0	0.0	0.4	0.0	0.2	0.1	0.7	0.0	0.7	0.3	0.0	0.0	0.5	1.6	1.4	0.4	0.3	0.7	0.0	0.0	0.0	0.6	0.2	0.5	0.3	0.1	0.0	0.1	1.8	1.8	0.6	1.4	1.1	0.0	0.0	0.0	0.0	0.7	0.5	0.1	0.0	2.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4										
C9orf50	FLJ35803	ENSG00000179058	"Chromosome 9 open reading frame 50"	Q5SZB4	9	129612225-129620776	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 9.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 4.5"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA026743	Enhanced									"HPA026743: AB_1845829"	"unprognostic (2.23e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.79e-3)"	"unprognostic (5.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.14e-2)"	"unprognostic (4.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.44e-3)"	"unprognostic (5.28e-2)"	0.0	0.4	1.5	0.1	1.2	0.2	0.0	0.9	2.5	0.2	0.2			0.0	0.2	0.0	0.0	1.5	1.5	0.0	1.0	1.4	0.4	0.0	0.1	0.1	1.1		0.0	0.0	0.1	0.5	0.2		0.1	0.0		0.8	1.5	0.0	0.0	0.0	0.4	0.8	0.3	0.1	9.4			0.5		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.8	0.3	2.0	0.2	0.8	0.0	0.5	1.8	1.2	0.5	0.0	0.6	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	1.1	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.7	4.5	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.1	1.6	0.4	0.2	0.0	0.4	0.0	0.0	1.2	0.3	0.2	0.1	0.0	0.0	0.0	0.6	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C9orf66	FLJ31158	ENSG00000183784	"Chromosome 9 open reading frame 66"	Q5T8R8	9	212824-215741	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 20.9;kidney: 17.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.5;MCF7: 3.7;RT4: 3.5;THP-1: 7.6"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 20.9"	"Group enriched"	"Detected in many"	4	"granulocytes: 20.9;monocytes: 6.0"									HPA035652	Uncertain									"HPA035652: AB_10601151"	"unprognostic (1.24e-1)"	"unprognostic (7.20e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.65e-3)"	"unprognostic (9.92e-2)"	"unprognostic (5.66e-2)"	"prognostic favourable (1.32e-5)"	"unprognostic (2.04e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.10e-3)"	0.5	3.1	0.3	0.3	0.9	1.7	0.7	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.5	0.1	0.3	0.3	0.3	0.1	17.8	0.5	0.3	0.3	0.3	0.3	0.5	1.3	1.9	0.3	0.3	0.3	0.7	0.0	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	1.4	0.2	0.7	0.8	0.3	1.3	0.3	0.3	0.4	0.3	2.0	3.0	20.9	6.0	1.6	0.6	0.6	0.1	0.4	0.3	0.4	0.1	0.1	3.5	0.1	0.0	0.2	0.1	0.7	2.1	0.4	1.0	0.3	0.6	0.1	0.0	0.0	0.2	1.1	0.3	0.5	0.3	0.1	0.8	1.1	0.2	0.1	0.1	0.0	0.0	1.9	0.8	0.0	3.7	0.2	2.4	0.4	0.8	0.4	0.3	2.1	0.1	3.5	0.6	0.4	0.0	0.2	0.5	1.6	7.6	1.1	0.3	0.8	0.5	0.2	0.9	0.4	0.1	0.2	1.3	0.6	7.0	4.9	8.0	0.3	3.3	0.1	1.8	0.6	0.4	3.0	2.0	0.1	0.2	20.9	1.6	6.0	0.7	0.1	0.6	0.3	0.9	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.8
C9orf84	FLJ32779	ENSG00000165181	"Chromosome 9 open reading frame 84"	Q5VXU9	9	111686173-111795008	"Predicted intracellular proteins, Predicted membrane proteins"	Meiosis	"DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 33.0"	"Cell line enriched"	"Detected in some"	5	"U-2 OS: 21.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA032108			Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA032108: AB_10669884"	"unprognostic (2.63e-1)"	"unprognostic (1.83e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.33e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.31e-2)"	0.1	2.9	0.1	0.5	0.2	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.7	0.0	0.3	0.6	0.2	0.0	0.1	0.1	0.1	0.0	2.4	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.1	1.1	33.0	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.2	0.2	4.1	0.0	0.1	0.2	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	4.7	1.1	0.4	0.0	0.2	0.0	0.0	21.9	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	4.1	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CA10	"CA-RPX, CARPX, HUCEP-15"	ENSG00000154975	"Carbonic anhydrase 10"	Q9NS85	17	51630313-52160017	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 59.5;cervix, uterine: 23.4"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 2.1;RT4: 3.7;SCLC-21H: 11.4"	"Cancer enhanced"	"Detected in some"		"glioma: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054825, HPA057837"	Supported		Approved	Vesicles	"Secreted in brain"			Vesicles		"HPA054825: , HPA057837: "		"unprognostic (2.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.43e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.21e-3)"	"unprognostic (9.18e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.51e-1)"		0.5	3.8	14.4	0.5	6.3	0.5	0.5	59.5	36.7	23.4	0.8	1.7	0.0	0.8	0.7	0.5	0.6	0.7	0.6	0.5	8.0	12.4	7.8	0.5	0.5	0.5	7.0	5.0	2.5	0.8	0.5	1.8	14.2	18.3	0.5	0.7	2.9	1.5	0.5	0.5	0.5	1.1	0.6	4.2	0.5	0.6	6.0	1.3	0.0	0.5	0.0	0.5	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	2.1	3.7	11.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	6.3	59.5	17.9	8.0	12.4	7.0	5.0	18.3	1.3
CABCOCO1	"bA63A2.1, C10orf107, Em:AC022398.2, MGC44593"	ENSG00000183346	"Ciliary associated calcium binding coiled-coil 1"	Q8IVU9	10	61662961-61766766	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 33.1;testis: 18.6"	"Cell line enriched"	"Detected in some"	4	"MOLT-4: 23.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041398	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				Centrosome	"Nucleoplasm, Cytosol"	"HPA041398: AB_10794374"	"unprognostic (1.89e-3)"	"unprognostic (7.37e-2)"	"unprognostic (2.23e-1)"	"prognostic favourable (1.79e-4)"	"prognostic unfavourable (4.88e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.52e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.33e-2)"	1.5	1.2	6.3	0.7	5.7	0.5	2.1	0.4	6.8	6.1	1.6	9.5	3.0	1.0	5.2	7.6	0.9	33.1	3.8	0.7	8.1	7.3	2.6	0.9	10.3	0.9	8.1	5.8	4.1	1.6	10.0	5.2	1.4	13.7	5.9	1.3	1.5	1.7	3.7	0.6	0.8	0.9	3.0	14.8	1.9	0.9	18.6	5.6	0.0	1.9	0.0	0.6	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	2.4	0.0	0.4	1.6	0.3	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	0.1	0.8	0.1	0.0	0.1	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	5.2	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	5.7	0.4	6.8	8.1	7.3	8.1	5.8	13.7	5.6
CABS1	"C4orf35, CLPH, FLJ32897, NYD-SP26"	ENSG00000145309	"Calcium binding protein, spermatid associated 1"	Q96KC9	4	70334966-70337116	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"testis: 75.3"	"Cell line enriched"	"Detected in single"	5	"NTERA-2: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044016, HPA055352"	Enhanced									"HPA044016: AB_10964494, HPA055352: AB_2682790"															"unprognostic (1.36e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACNG3		ENSG00000006116	"Calcium voltage-gated channel auxiliary subunit gamma 3"	O60359	16	24255553-24362801	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"brain: 32.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.3;Karpas-707: 1.0;U-266/70: 1.0"	"Cancer enriched"	"Detected in single"	15	"glioma: 0.7"	"Group enriched"	"Detected in many"	6	"amygdala: 12.8;basal ganglia: 13.1;cerebral cortex: 20.0;hippocampal formation: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077238	Enhanced									"HPA077238: "					"unprognostic (5.61e-2)"						"unprognostic (3.09e-1)"			"unprognostic (2.12e-1)"	"unprognostic (1.17e-1)"			0.4	1.8	12.8	0.4	13.1	0.5	0.3	0.2	32.2	0.3	0.4	0.1	0.0	0.3	0.3	0.4	0.3	0.4	0.3	0.3	12.7	2.2	0.3	0.4	0.3	0.4	1.8	2.3	0.4	0.3	0.3	0.0	0.4	0.3	0.4	0.4	0.1	0.3	0.4	0.3	0.4	0.3	0.4	0.3	0.4	0.4	0.6	0.0	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.0	0.0	0.2	0.9	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	12.8	13.1	0.2	20.0	12.7	2.2	1.8	2.3	0.3	0.0
CACNG4	"MGC11138, MGC24983"	ENSG00000075461	"Calcium voltage-gated channel auxiliary subunit gamma 4"	Q9UBN1	17	66964910-67033398	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.8;prostate: 16.5"	"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 95.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 159.8"	"HPA005803, HPA065370"	Enhanced		Approved	Cytosol				Cytosol		"HPA005803: , HPA065370: "	"unprognostic (1.27e-1)"	"unprognostic (3.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.91e-1)"	"unprognostic (7.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.85e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.38e-10)"	"unprognostic (8.57e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.71e-2)"	"unprognostic (4.28e-1)"	0.7	1.8	16.0	0.8	32.3	0.7	8.1	3.5	37.8	1.2	0.9	11.4	0.2	1.0	1.2	0.8	0.8	6.2	1.2	0.7	9.6	12.9	0.8	0.7	8.0	0.7	7.5	7.1	0.7	1.2	4.9	0.1	1.6	6.8	16.5	0.8	0.1	0.9	2.4	0.8	0.9	0.9	2.0	4.2	0.7	1.7	0.9	10.3	0.0	0.7	0.0	0.7	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	3.8	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	3.8	0.0	0.0	0.1	2.0	0.0	2.6	3.8	95.2	0.8	2.5	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	32.3	3.5	13.0	9.6	12.9	7.5	7.1	6.8	10.3
CACNG5		ENSG00000075429	"Calcium voltage-gated channel auxiliary subunit gamma 5"	Q9UF02	17	66835117-66885486	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 6.5;lymphoid tissue: 3.3;retina: 8.8"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.7;RPMI-8226: 1.5;SH-SY5Y: 3.5;THP-1: 1.5"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"olfactory region: 152.3"	"Low region specificity"	"Detected in all"			HPA050115	Uncertain									"HPA050115: "					"unprognostic (1.85e-3)"					"unprognostic (3.84e-2)"	"unprognostic (1.44e-1)"		"unprognostic (2.46e-6)"	"unprognostic (4.52e-2)"	"unprognostic (1.29e-1)"			0.3	0.3	2.7	0.7	2.6	0.3	0.3	1.7	6.5	0.4	0.7	6.3	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.4	2.1	2.0	1.0	0.3	0.3	3.3	1.1	2.3	0.3	0.7	0.3	0.8	0.3	0.7	0.5	0.5	8.8	0.3	0.3	0.3	0.4	0.7	0.3	1.7	1.3	0.3	0.7	3.8	0.0	0.3	0.0	3.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.5	0.0	0.0	0.4	3.5	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.6	1.7	6.5	2.1	2.0	1.1	2.3	0.7	3.8
CACNG6		ENSG00000130433	"Calcium voltage-gated channel auxiliary subunit gamma 6"	Q9BXT2	19	53992288-54012669	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"blood: 11.4;skeletal muscle: 45.4"	"Cell line enhanced"	"Detected in some"		"A549: 12.4;EFO-21: 21.8;HHSteC: 5.7"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	96	"basophil: 11.4;eosinophil: 7.8"	"Lineage enriched"	"Detected in single"	114	"granulocytes: 11.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056615			Approved	"Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	Cytosol	"HPA056615: "	"unprognostic (1.83e-1)"	"unprognostic (9.51e-2)"		"unprognostic (7.07e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.89e-2)"		"unprognostic (2.27e-1)"		"unprognostic (7.69e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.07e-8)"	"unprognostic (9.79e-2)"	"unprognostic (1.28e-1)"			0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0			0.0	0.0	0.0	0.1	5.9	0.0	0.0	0.2	0.2	0.0	0.0	1.1	0.0	0.0		0.0	0.0	0.0	0.9	0.0		0.1	0.0		0.4	0.0	45.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	12.4	0.3	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	1.0	0.0	21.8	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	5.7	0.0	0.1	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.5	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	2.5	0.0	0.0	0.0	3.0	0.1	0.2	0.0	0.0	11.4	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CACNG8		ENSG00000142408	"Calcium voltage-gated channel auxiliary subunit gamma 8"	Q8WXS5	19	53963040-53990215	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"blood: 7.9;brain: 22.8"	"Group enriched"	"Detected in some"	5	"AF22: 6.4;HMC-1: 21.2;TIME: 12.9"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.6"	"Group enriched"	"Detected in many"	5	"amygdala: 9.4;basal ganglia: 9.1;cerebral cortex: 13.6;hippocampal formation: 20.3;hypothalamus: 5.4"	"Cell type enriched"	"Detected in some"	7	"basophil: 7.9"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 7.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041351	Enhanced									"HPA041351: AB_10796666"	"unprognostic (7.01e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.29e-4)"	"unprognostic (9.66e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.40e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.82e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	0.4	0.4	9.4	0.4	9.1	0.6	0.4	0.7	22.8	0.3	0.3	2.1	0.0	0.4	0.5	0.4	0.3	0.4	0.4	0.3	20.3	5.4	0.3	0.3	0.4	0.4	2.3	2.0	0.4	0.3	0.5	0.0	0.3	1.5	0.4	0.4	0.0	0.4	0.3	0.9	0.7	0.4	0.4	0.9	0.4	0.6	1.5	0.0	0.0	0.4	0.0	0.3	0.3	0.0	0.4	0.3	7.9	0.2	0.3	0.3	0.1	0.0	2.1	6.4	0.2	0.0	0.1	0.1	0.1	0.3	0.0	0.2	0.4	0.3	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.9	2.3	0.5	0.0	1.0	0.0	21.2	0.3	0.0	0.0	0.2	2.1	0.1	0.2	0.0	0.1	0.0	0.0	1.3	2.6	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.1	0.1	0.0	0.2	0.0	12.9	0.1	1.2	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.1	7.9	0.2	1.1	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.4	0.3	0.2	0.5	0.3	0.1	0.3	0.1	0.1	9.4	9.1	0.7	13.6	20.3	5.4	2.3	2.0	1.5	0.0
CADM2	"IGSF4D, Necl-3, NECL3, SynCAM2"	ENSG00000175161	"Cell adhesion molecule 2"	Q8N3J6	3	84958981-86074429	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 52.7"	"Cell line enhanced"	"Detected in some"		"AF22: 6.3;AN3-CA: 17.9;U-266/70: 3.1"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 5.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010024	Enhanced						350000			"HPA010024: AB_2068039"	"unprognostic (2.23e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.90e-4)"	"unprognostic (8.64e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.07e-5)"	"unprognostic (9.82e-3)"	"unprognostic (1.26e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.16e-2)"	5.8	6.3	33.5	2.1	22.7	1.7	3.6	44.8	52.7	2.3	3.0	7.0	0.0	2.0	2.0	2.2	2.7	4.6	2.6	4.2	28.6	11.7	1.9	2.5	2.2	1.8	16.3	31.0	2.3	2.4	3.0	5.5	1.9	24.2	3.4	2.7	8.8	2.3	6.2	4.9	2.0	2.6	2.1	14.0	2.0	3.2	2.2	20.5	0.0	2.1	0.0	1.8	2.0	1.1	1.0	0.0	5.0	0.0	0.0	0.2	0.0	0.0	0.0	6.3	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	2.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	22.7	44.8	49.5	28.6	11.7	16.3	31.0	24.2	20.5
CALB2	CAL2	ENSG00000172137	"Calbindin 2"	P22676	16	71358713-71390438	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 50.6;brain: 118.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.1;HEL: 23.4;HMC-1: 51.0;U-2 OS: 14.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"cerebellum: 31.2;hypothalamus: 74.2;pons and medulla: 118.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000106, HPA007305, HPA007306"	Enhanced	Supported	Enhanced	Cytosol			6400	Cytosol		"CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (5.78e-5)"	"unprognostic (1.75e-3)"	"unprognostic (5.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.55e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.54e-4)"	"unprognostic (1.97e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.04e-2)"	50.6	11.6	10.1	5.1	7.5	0.9	18.2	31.2	9.9	1.7	8.9	1.7	0.0	1.7	1.4	3.0	3.0	2.4	2.0	2.2	5.9	74.2	0.9	0.9	2.1	0.9	17.7	7.5	5.6	1.4	0.9	3.0	0.9	118.9	1.1	6.0	4.9	2.1	1.3	1.0	1.0	2.7	2.7	7.5	0.9	1.2	14.6	1.5	0.0	0.8	0.2	1.8	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.7	6.5	0.0	0.2	0.0	1.2	0.2	0.1	0.2	0.0	0.0	8.1	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.2	0.0	0.0	51.0	0.0	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	14.6	0.1	1.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	7.5	31.2	9.9	5.9	74.2	17.7	7.5	118.9	1.5
CALHM2	FAM26B	ENSG00000138172	"Calcium homeostasis modulator family member 2"	Q9HA72	10	103446786-103452402	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 23.4;BJ: 18.5;BJ hTERT+: 18.8;fHDF/TERT166: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014706	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria"	Cytosol	"HPA014706: AB_2243916"	"unprognostic (2.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.85e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (3.03e-6)"	"unprognostic (8.59e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.74e-1)"	24.2	10.5	3.7	10.2	3.8	1.8	28.7	1.9	7.1	34.1	9.2	3.9	8.0	5.6	36.0	18.4	13.4	19.7	18.2	17.0	3.9	2.2	5.7	3.7	11.1	15.9	4.8	5.4	32.5	4.5	1.9	4.0	23.6	4.8	18.2	4.0	10.7	7.6	10.0	8.9	8.9	9.0	19.8	5.5	24.4	7.2	14.1	3.1	3.0	11.0	9.2	10.8	19.9	24.1	7.1	36.6	11.2	47.9	14.0	21.5	17.1	5.2	3.7	0.9	1.2	14.1	23.4	4.5	18.5	18.8	5.7	8.1	1.6	2.6	1.6	2.1	21.2	2.5	1.9	0.0	1.1	0.2	10.7	3.8	1.1	0.3	6.4	0.6	0.3	8.0	0.0	1.7	0.0	6.7	0.8	9.9	3.7	12.1	1.4	1.7	2.3	3.4	4.4	1.5	3.5	0.5	0.4	2.6	1.1	0.7	3.1	1.0	0.6	1.2	11.9	1.8	2.2	6.3	1.3	1.5	3.5	1.9	15.7	11.6	0.3	11.2	22.7	0.4	21.5	42.2	17.5	7.1	14.8	17.6	36.6	1.5	2.9	11.2	0.9	14.0	47.9	4.2	18.9	17.1	3.7	3.8	1.9	7.1	3.9	2.2	4.8	5.4	4.8	3.1
CALHM3	"bA225H22.7, FAM26A"	ENSG00000183128	"Calcium homeostasis modulator 3"	Q86XJ0	10	103472804-103479240	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 1.8;pancreas: 2.8;testis: 2.0"	"Cell line enriched"	"Detected in some"	5	"U-266/84: 17.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.5"					"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.8;myeloid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018205	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA018205: AB_2069267"	"unprognostic (2.88e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.26e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.06e-1)"		"unprognostic (1.25e-2)"		"unprognostic (1.88e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.44e-1)"		"unprognostic (4.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.53e-1)"	0.2	0.1	0.5	0.0	0.6	0.0	0.0	0.2	0.7	0.3	0.1			0.8	0.3	0.9	0.0	0.3	0.0	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.0		0.4	2.8	0.0	0.2	0.7		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	2.0			0.0		0.0	0.2	0.4	0.0	1.5	0.0	1.8	0.0	0.7	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.3	3.2	0.4	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	17.0	0.2	0.2	0.0	0.0	0.0	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.7	1.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4										
CALHM5	"C6orf188, dJ493F7.3, FAM26E, MGC45451"	ENSG00000178033	"Calcium homeostasis modulator family member 5"	Q8N5C1	6	116511646-116524792	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.2;fHDF/TERT166: 6.5;HUVEC TERT2: 6.6;LHCN-M2: 7.0;TIME: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034969, HPA034970"	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA034969: AB_10670299, HPA034970: "	"unprognostic (2.71e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.37e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.24e-7)"	"unprognostic (1.16e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.65e-3)"	11.5	1.7	1.0	2.5	1.6	0.2	8.1	0.6	1.7	5.9	4.3	1.9	0.4	1.4	7.9	6.2	7.6	2.9	3.6	10.1	1.2	1.1	6.0	1.4	4.0	5.8	1.5	2.1	4.6	0.8	1.6	1.4	18.5	1.8	5.3	2.6	14.4	2.1	2.6	4.0	3.2	2.9	11.0	1.3	4.0	2.1	5.2	0.6	0.0	4.4	6.8	1.5	8.2	4.0	0.1	0.0	0.1	0.6	0.3	0.0	0.6	0.0	0.0	5.4	0.0	3.3	5.3	0.0	4.3	6.2	1.6	4.7	0.2	0.0	0.0	0.4	6.5	0.0	0.0	0.0	1.8	0.0	0.2	0.9	0.0	0.0	0.8	0.0	0.0	3.2	0.0	4.1	0.0	6.6	0.0	1.2	7.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	3.0	1.0	0.3	0.2	0.0	0.0	0.0	2.6	0.0	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.6	1.0	1.6	0.6	1.7	1.2	1.1	1.5	2.1	1.8	0.6
CALML4	"MGC4809, NY-BR-20"	ENSG00000129007	"Calmodulin like 4"	Q96GE6	15	68190705-68206110	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 44.0;gallbladder: 28.4;intestine: 91.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 39.2;non-classical monocyte: 44.0"	"Lineage enriched"	"Detected in many"	10	"monocytes: 44.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA051109	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA051109: "	"unprognostic (1.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.97e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.05e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.19e-3)"	"unprognostic (6.24e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.32e-1)"	2.4	2.5	1.8	12.0	1.1	0.8	2.2	2.6	1.0	3.2	40.3	2.2	7.7	34.0	1.5	7.8	5.1	7.3	28.4	1.4	2.6	0.7	12.6	12.3	3.1	2.6	0.9	1.3	2.3	5.3	0.0	3.1	2.1	8.4	4.3	21.8	3.1	1.9	6.7	1.4	1.7	91.6	2.7	1.0	5.3	5.4	2.4	0.6	1.1	1.5	1.3	1.3	1.9	2.0	0.0	4.5	1.8	44.0	0.0	0.0	2.8	2.5	7.7	5.7	3.4	0.6	1.0	4.0	1.6	1.5	2.6	2.6	14.9	16.0	2.5	2.0	1.1	10.8	12.8	2.3	1.0	2.1	12.4	4.1	13.2	5.2	2.3	3.5	5.5	1.1	3.4	1.5	2.2	2.9	3.8	2.9	0.6	7.2	5.6	7.7	4.9	2.3	8.4	5.6	5.1	0.9	4.3	2.9	3.3	2.5	2.3	6.7	1.7	3.4	2.4	3.8	3.5	6.6	6.3	10.6	6.2	7.0	2.4	6.9	1.3	0.0	6.5	0.0	0.0	39.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.8	0.0	44.0	0.2	0.0	2.8	1.8	1.1	2.6	1.0	2.6	0.7	0.9	1.3	8.4	0.6
CAMK2N2	CaM-KIIN	ENSG00000163888	"Calcium/calmodulin dependent protein kinase II inhibitor 2"	Q96S95	3	184259213-184261463	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adrenal gland: 14.2;brain: 38.3;pancreas: 37.0;pituitary gland: 12.5"	"Cell line enhanced"	"Detected in many"		"REH: 18.7;SCLC-21H: 19.6;U-138 MG: 20.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050835, HPA075200"	Approved		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA050835: , HPA075200: "	"unprognostic (7.28e-2)"	"prognostic favourable (9.77e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.72e-3)"	"unprognostic (5.17e-9)"	"unprognostic (3.47e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-3)"	1.3	14.2	22.2	1.3	9.6	1.1	1.3	29.7	38.3	1.3	1.3	3.2	0.0	1.4	1.2	1.2	1.2	1.3	1.3	1.2	12.3	32.7	1.3	1.7	1.2	1.2	18.0	8.2	1.1	37.0	2.0	12.5	1.3	25.1	1.4	1.3	1.1	1.2	1.4	1.1	1.2	1.4	1.4	9.3	1.2	1.7	1.3	4.5	0.0	1.3	0.0	1.2	1.2	0.0	0.0	0.5	0.0	0.2	0.0	0.3	0.0	11.1	0.2	1.4	0.6	0.4	0.4	1.0	0.3	4.1	2.6	2.7	0.4	0.5	0.4	2.7	0.2	1.4	0.7	0.4	1.5	9.1	0.4	0.3	0.2	0.4	0.1	0.2	1.4	0.3	0.6	0.4	1.9	0.0	0.0	3.3	0.4	5.9	0.1	0.1	7.9	3.6	18.7	5.4	1.5	0.6	2.1	19.6	4.2	1.8	0.5	0.1	6.0	0.1	0.0	20.4	8.9	1.9	3.3	2.2	3.3	2.7	4.7	1.1	1.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	22.2	9.6	29.7	38.3	12.3	32.7	18.0	8.2	25.1	4.5
CAMKV	"MGC8407, VACAMKL"	ENSG00000164076	"CaM kinase like vesicle associated"	Q8NCB2	3	49857988-49870222	"Enzymes, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	36	"brain: 77.2"	"Cell line enhanced"	"Detected in some"		"AF22: 5.2;HAP1: 6.9;NTERA-2: 24.6;RPMI-8226: 4.7;SCLC-21H: 8.4;SH-SY5Y: 5.4"	"Group enriched"	"Detected in some"	11	"glioma: 4.0;testis cancer: 5.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007656, CAB034931"	Enhanced	Supported	Approved	"Nucleoplasm,Cytokinetic bridge"				Nucleoplasm	"Cytokinetic bridge"	"CAB034931: AB_2068550, HPA007656: AB_1078391"	"unprognostic (9.47e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.70e-7)"	"unprognostic (2.76e-1)"	"unprognostic (7.95e-4)"		"unprognostic (3.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.61e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.67e-3)"	1.2	2.1	20.7	1.2	77.2	1.2	1.2	0.5	62.8	1.2	1.2	1.7	0.0	1.2	1.2	1.2	1.2	1.2	1.2	1.2	33.4	11.7	1.2	1.2	1.2	1.2	3.3	23.5	1.2	1.2	1.2	1.8	1.2	2.1	1.2	1.2	0.0	1.2	1.2	1.2	1.3	1.2	1.2	1.9	1.2	1.3	2.1	6.0	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	5.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.7	0.1	24.6	0.1	0.7	0.0	4.7	0.0	0.0	8.4	5.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	20.7	77.2	0.5	34.0	33.4	11.7	3.3	23.5	2.1	6.0
CAPN11		ENSG00000137225	"Calpain 11"	Q9UMQ6	6	44158811-44184402	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"testis: 63.7"	"Group enriched"	"Detected in some"	5	"NTERA-2: 4.3;TIME: 10.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB018070, HPA030955"	Enhanced									"CAB018070: AB_2069481, HPA030955: "	"unprognostic (2.20e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.62e-6)"	"unprognostic (2.38e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.89e-2)"	1.1	0.3	0.1	0.2	0.1	0.2	1.9	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.6	0.3	0.2	0.1	0.1	0.0	63.7	0.1	0.1	0.1	0.1	0.2	0.2	0.3	0.4	1.2	1.3	0.1	0.1	0.8	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.4	0.4	0.0	0.0	0.0	0.3	4.3	0.0	0.7	0.2	0.4	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	10.8	0.5	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.3	0.4	0.1	0.2	1.3	0.1	0.0	1.2	0.0	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CAPN12		ENSG00000182472	"Calpain 12"	Q6ZSI9	19	38730187-38769904	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 24.5;gallbladder: 21.0;liver: 21.8;salivary gland: 34.3"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 17.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 2.4"	"Group enriched"	"Detected in many"	7	"basophil: 24.5;NK-cell: 12.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 24.5;NK-cells: 12.7"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"hippocampal formation: 3.6"	HPA053322			Approved	"Nucleoplasm,Focal adhesion sites"				"Focal adhesion sites"	Nucleoplasm	"HPA053322: "	"unprognostic (1.81e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavourable (5.90e-6)"	"unprognostic (7.04e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.59e-2)"	0.6	0.4	0.2	4.7	0.2	0.2	0.7	0.2	0.3	4.2	4.1	0.1	5.6	1.2	1.1	1.0	1.2	3.6	21.0	0.7	1.0	0.4	7.1	21.8	2.0	1.8	0.2	0.1	0.4	5.0	0.2	0.7	0.5	2.4	2.2	0.7	0.4	34.3	3.0	0.3	4.5	1.9	0.5	0.4	4.9	1.6	0.6	0.1	0.4	0.4	1.6	5.2	1.5	1.0	1.7	0.0	24.5	0.0	12.7	2.6	0.7	0.2	1.8	0.1	0.0	0.3	0.1	2.2	0.1	0.0	0.0	0.1	3.2	0.1	0.7	0.1	0.0	1.3	0.0	0.7	0.0	0.1	0.0	0.3	0.7	0.9	0.0	0.0	17.2	0.8	2.5	0.3	0.0	0.0	0.4	0.5	0.3	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.2	1.8	0.0	0.1	0.0	0.1	0.4	0.1	0.1	1.4	0.0	0.0	0.1	0.0	0.4	0.9	0.7	0.0	0.1	0.0	0.6	24.5	0.0	1.8	2.6	0.0	2.5	1.5	0.7	1.3	0.0	1.7	0.0	0.6	0.4	12.7	0.0	0.0	0.5	0.7	0.2	0.2	0.2	0.3	1.0	0.4	0.2	0.1	2.4	0.1
CAPN8	nCL-2	ENSG00000203697	"Calpain 8"	A6NHC0	1	223538007-223665734	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 32.0;stomach 1: 85.8"	"Cell line enriched"	"Detected in some"	9	"RT4: 41.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 28.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073939			Approved	"Nucleoplasm,Nuclear membrane,Vesicles"				"Nucleoplasm, Nuclear membrane, Vesicles"		"HPA073939: "	"unprognostic (4.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.72e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.12e-6)"	"unprognostic (6.95e-2)"	"unprognostic (5.59e-2)"	"unprognostic (3.83e-2)"	"unprognostic (5.44e-3)"	0.2	0.0	0.5	10.3	0.3	0.0	7.5	0.2	0.3	1.0	7.9	0.6	0.2	2.2	0.3	3.3	0.6	0.4	32.0	0.2	0.2	0.1	2.5	0.2	13.0	0.2	0.2	0.2	0.2	8.0	0.0	0.2	0.8	0.2	4.6	9.9	0.2	4.6	0.3	0.3	1.5	4.0	3.2	0.2	0.2	85.8	0.4	0.2	0.3	0.2	1.5	1.2	15.1	3.9	0.4	0.0	1.1	0.0	0.0	1.4	1.5	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	2.4	0.0	0.0	0.0	4.4	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.2	2.1	0.0	0.0	0.0	0.9	41.1	0.6	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.9	0.7	0.0	0.0	0.1	1.4	1.1	0.0	0.0	0.0	0.0	1.5	0.5	0.3	0.2	0.3	0.2	0.1	0.2	0.2	0.2	0.2
CAPNS2	"MGC12536, MGC14804"	ENSG00000256812	"Calpain small subunit 2"	Q96L46	16	55566672-55567687	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 56.0;skin 1: 44.1;tongue: 45.6"	"Cell line enriched"	"Detected in some"	10	"hTCEpi: 69.8"	"Group enriched"	"Detected in many"	15	"cervical cancer: 19.6;head and neck cancer: 26.3;lung cancer: 10.2;melanoma: 5.8;urothelial cancer: 21.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"eosinophil: 6.9;intermediate monocyte: 2.1"	"Group enriched"	"Detected in many"	9	"granulocytes: 6.9;monocytes: 2.1"	"Not detected"	"Not detected"							"HPA059749, HPA076768"	Enhanced		Approved	Cytosol				Cytosol		"HPA059749: , HPA076768: "	"unprognostic (3.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.77e-3)"	"unprognostic (4.14e-1)"	"unprognostic (3.32e-2)"		"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.48e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.69e-1)"	0.1	0.0	0.1	0.1	0.4	0.2	3.4	0.1	0.1	5.8	0.1	0.1	0.1	0.0	0.4	0.1	56.0	0.3	0.1	0.1	0.1	0.0	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.3	0.0	0.2	6.7	0.1	0.6	44.1	0.1	1.3	0.1	0.1	0.0	0.1	0.1	0.3	0.1	45.6	14.6	12.3	10.8	0.0	0.5	6.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	69.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	6.9	0.0	2.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CAPS2		ENSG00000180881	"Calcyphosine 2"	Q9BXY5	12	75275979-75390928	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.7"	"Cell line enhanced"	"Detected in many"		"A549: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040004	Uncertain		Approved	Nucleoplasm,Nucleoli,Centrosome				Centrosome	"Nucleoplasm, Nucleoli"	"HPA040004: AB_10794758"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.69e-1)"	2.6	4.2	8.0	1.2	5.8	1.6	3.7	15.5	11.2	3.7	2.5	5.5	2.1	1.8	5.0	8.8	3.6	21.7	3.4	5.4	6.3	6.6	6.6	4.2	5.8	1.3	5.4	5.6	4.5	2.6	7.3	15.8	0.9	7.8	5.1	2.0	4.4	5.5	3.6	3.8	2.6	1.9	2.0	8.7	2.6	3.2	8.0	9.5	1.4	9.3	2.2	1.4	2.6	2.0	0.1	0.6	0.0	0.7	1.1	1.8	0.1	1.8	5.0	1.4	0.4	2.5	1.9	0.2	1.0	0.2	2.7	2.9	0.0	2.3	0.5	4.4	0.7	1.1	0.0	2.2	1.9	1.7	0.8	2.1	0.8	0.0	0.0	0.3	0.0	0.8	1.3	2.3	0.5	0.3	0.4	0.8	3.5	0.1	2.4	2.0	0.7	0.7	0.0	0.0	0.2	3.5	0.0	2.9	1.4	0.2	0.1	1.6	1.7	0.7	1.1	2.5	1.1	0.6	0.4	0.2	0.0	0.0	2.2	0.0	2.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.7	0.0	0.0	0.1	0.6	0.9	0.0	1.1	0.7	0.6	1.8	0.1	8.0	5.8	15.5	11.2	6.3	6.6	5.4	5.6	7.8	9.5
CAPSL	MGC26610	ENSG00000152611	"Calcyphosine like"	Q8WWF8	5	35904295-35938779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 34.9;epididymis: 18.3;fallopian tube: 59.4"	"Group enriched"	"Detected in some"	4	"BJ hTERT+ SV40 Large T+: 7.3;BJ hTERT+ SV40 Large T+ RasG12V: 6.2;HBF TERT88: 4.8;REH: 7.6;U-698: 18.6"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 14.1;ovarian cancer: 3.4"	"Region enriched"	"Detected in many"	7	"pons and medulla: 34.9"	"Cell type enriched"	"Detected in single"	13	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA046811, HPA058495"	Enhanced		Approved	Nucleoplasm,Microtubules				"Nucleoplasm, Microtubules"		"HPA046811: AB_2679819, HPA058495: AB_2683735"	"unprognostic (1.16e-1)"	"unprognostic (3.40e-2)"		"unprognostic (2.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.20e-2)"		"unprognostic (7.35e-2)"		"unprognostic (1.29e-1)"	"unprognostic (1.92e-3)"	"unprognostic (4.42e-1)"	"unprognostic (3.62e-4)"		"unprognostic (1.46e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.52e-1)"	0.1	0.2	3.6	0.1	4.4	0.2	0.2	0.0	0.5	2.4	0.1	4.3	0.4	0.1	1.3	18.3	0.2	59.4	0.2	0.2	5.2	5.3	0.7	0.1	11.8	0.1	0.3	0.0	6.7	0.4	0.1	17.0	0.2	34.9	0.2	0.1	0.0	0.4	0.4	0.2	0.2	0.1	0.2	0.8	0.1	0.2	5.4	0.5	0.5	3.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.8	7.3	6.2	0.0	0.0	2.1	0.0	0.9	0.0	0.1	0.0	4.8	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	1.3	0.0	0.0	1.2	2.2	0.0	0.5	0.0	0.0	18.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.6	4.4	0.0	0.3	5.2	5.3	0.3	0.0	34.9	0.5
CARMIL3	"BC008134, C14orf121, crml-1, LRRC16B"	ENSG00000186648	"Capping protein regulator and myosin 1 linker 3"	Q8ND23	14	24052000-24069728	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 30.6;pituitary gland: 7.8;skin 1: 9.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.2;HMC-1: 5.8;Karpas-707: 5.2;SCLC-21H: 8.5;SH-SY5Y: 4.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030596	Uncertain									"HPA030596: AB_10603012"	"unprognostic (2.67e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.09e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.29e-4)"	"unprognostic (6.13e-2)"	"unprognostic (8.92e-4)"	"unprognostic (4.02e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.39e-4)"	"unprognostic (4.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.16e-1)"	0.6	1.6	6.5	1.4	5.2	1.0	0.8	30.6	7.9	0.6	0.9	3.3	0.0	2.3	0.6	0.5	1.0	0.6	1.6	0.4	7.4	5.2	1.0	0.8	0.9	1.4	2.8	2.4	0.6	1.3	0.5	7.8	0.5	7.2	0.8	1.0	1.7	1.6	0.7	0.5	9.4	1.6	0.7	2.9	1.0	1.2	3.1	2.8	0.0	1.0	0.0	2.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.1	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.3	0.0	0.0	1.3	0.0	0.1	0.1	0.1	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.3	1.2	0.0	0.5	0.1	0.6	0.0	0.0	0.0	0.0	8.5	4.2	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	5.2	30.6	7.7	7.4	5.2	2.8	2.4	7.2	2.8
CASC1	"FLJ10921, LAS1, PPP1R54"	ENSG00000118307	"Cancer susceptibility 1"	Q6TDU7	12	25108420-25195162	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 17.1;pituitary gland: 21.5;testis: 25.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.2"	"Group enriched"	"Detected in many"	5	"B-cells: 2.6;granulocytes: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039662	Enhanced									"HPA039662: AB_10795468"	"unprognostic (6.42e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.62e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.21e-4)"	"unprognostic (2.54e-2)"	"prognostic favourable (3.13e-4)"	"unprognostic (2.01e-1)"	"unprognostic (8.74e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.19e-1)"	0.6	1.0	3.1	0.5	7.6	0.8	2.0	0.7	4.6	2.7	0.6	3.7	1.9	0.2	2.2	12.4	0.9	17.1	1.0	0.9	3.5	4.0	3.6	0.3	4.8	0.7	1.5	4.1	5.4	1.3	5.5	21.5	0.4	12.2	1.4	0.3	1.1	1.0	3.4	0.4	1.4	0.4	0.7	2.4	0.5	1.0	25.3	2.5	0.0	5.2	0.0	0.4	0.6	0.6	2.6	0.7	4.2	0.4	0.2	0.6	0.3	0.6	1.1	1.2	0.9	0.0	0.7	0.7	0.0	0.9	0.8	0.8	0.1	3.3	3.4	1.1	0.0	0.6	0.1	0.6	0.7	1.0	0.2	0.0	0.1	0.0	0.0	0.5	1.4	0.0	0.5	0.6	0.0	0.0	1.7	1.2	0.0	0.0	0.5	1.3	0.4	0.0	1.1	0.5	0.0	3.2	0.3	2.1	0.8	0.5	0.0	0.6	3.2	0.2	0.0	0.2	2.6	1.6	0.3	1.4	0.6	2.7	0.9	0.6	0.6	0.4	0.3	0.8	0.3	0.3	0.3	1.6	0.1	0.6	0.1	2.6	0.4	0.5	4.2	0.2	0.4	0.7	0.0	0.3	3.1	7.6	0.7	4.6	3.5	4.0	1.5	4.1	12.2	2.5
CASC10	"bA418C1.3, C10orf114"	ENSG00000204682	"Cancer susceptibility 10"	Q5T4H9	10	21492658-21497262	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.8;liver: 13.6"	"Cell line enhanced"	"Detected in many"		"A549: 10.1;AF22: 10.2;AN3-CA: 14.1;BEWO: 13.6;SK-BR-3: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in many"											HPA064131	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA064131: "	"unprognostic (2.69e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.87e-3)"	"prognostic unfavourable (8.87e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavourable (5.86e-4)"	1.8	2.6	8.9	0.9	6.2	0.9	0.9	2.0	8.0	2.5	0.8	6.1	0.1	1.0	1.3	1.1	1.2	2.4	1.7	3.8	11.8	3.8	6.3	13.6	1.5	1.3	3.3	4.2	2.6	1.3	3.7	3.3	7.2	2.7	1.9	0.7	2.0	1.0	1.8	5.0	3.3	0.9	1.5	2.2	0.8	0.9	2.6	5.3	0.1	5.6	0.0	0.8	2.3	1.6	0.6	0.4	2.2	0.3	1.0	0.4	0.2	1.7	10.1	10.2	14.1	1.9	1.0	13.6	0.9	0.4	0.1	0.2	1.5	3.5	0.5	1.5	0.8	2.2	1.8	0.5	0.1	0.3	1.9	0.1	1.4	2.3	0.5	0.0	0.1	1.3	1.8	0.1	0.1	0.9	0.6	0.1	0.1	1.6	0.6	0.6	1.4	0.9	0.7	0.1	0.0	2.0	1.4	1.3	5.0	4.7	8.9	0.6	1.6	7.7	2.4	0.8	8.0	0.2	1.0	0.1	0.2	0.1	4.4	0.0	4.4	1.5	0.3	0.3	0.3	0.2	0.2	0.3	0.2	0.1	0.0	0.6	0.2	0.4	2.2	1.0	0.3	0.4	0.2	0.2	8.9	6.2	2.0	8.0	11.8	3.8	3.3	4.2	2.7	5.3
CATSPER4		ENSG00000188782	"Cation channel sperm associated 4"	Q7RTX7	1	26190561-26202968	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	34	"testis: 13.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.1;hTCEpi: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045257	Enhanced									"HPA045257: AB_10968995"	"unprognostic (7.20e-2)"	"unprognostic (2.06e-2)"		"unprognostic (4.56e-2)"		"unprognostic (2.69e-2)"		"unprognostic (3.49e-1)"		"unprognostic (3.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.16e-1)"		"unprognostic (3.06e-1)"	"unprognostic (6.78e-2)"	"unprognostic (6.98e-2)"	"unprognostic (6.67e-5)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	13.5			0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CATSPERB	"C14orf161, FLJ14298"	ENSG00000133962	"Cation channel sperm associated auxiliary subunit beta"	Q9H7T0	14	91580696-91780707	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 15.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.9;U-937: 3.8"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA035134	Uncertain		Uncertain	Vesicles				Vesicles		"HPA035134: AB_10671510"	"unprognostic (2.69e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.93e-1)"	"unprognostic (7.04e-3)"	"unprognostic (2.72e-5)"	"unprognostic (1.81e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.81e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.34e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.85e-2)"	"unprognostic (8.31e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.71e-3)"	0.6	0.1	0.0	0.6	0.0	0.0	1.4	0.0	0.2	0.4	0.9			0.3	0.4	0.4	0.6	0.7	1.2	0.6	0.0	0.0	0.3	0.2	0.9	1.1	0.0		0.2	15.1	1.0	0.3	0.0		0.9	0.7		3.7	0.0	1.7	4.2	1.2	0.1	0.0	0.8	2.0	2.0			0.9		0.6	0.5	0.3	0.4	0.2	1.1	0.2	0.7	1.6	0.4	0.6	0.0	0.7	1.7	0.0	0.0	1.9	0.3	0.3	0.0	0.0	2.4	3.9	1.2	0.9	0.0	0.7	0.0	0.5	0.7	1.4	2.1	0.4	1.3	2.3	0.0	1.7	0.8	0.6	0.7	0.4	0.5	0.0	0.5	0.2	0.5	2.3	0.6	0.7	0.2	0.5	0.3	0.0	0.0	0.4	0.9	1.7	0.1	0.0	0.8	1.6	0.4	2.2	0.9	0.2	0.2	0.0	0.3	0.9	0.9	0.3	0.2	3.8	1.0	1.1	0.2	0.6	1.1	0.0	1.5	0.4	1.6	1.0	0.0	0.2	1.1	1.4	0.4	0.7	0.2	0.2	0.0	0.4										
CATSPERG	"C19orf15, DKFZp434A1022, FLJ46353"	ENSG00000099338	"Cation channel sperm associated auxiliary subunit gamma"	Q6ZRH7	19	38335775-38370943	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 35.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;HMC-1: 5.2;MCF7: 4.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.8;monocytes: 1.8"					"Low region specificity"	"Detected in all"			HPA052777			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in male reproductive system"			Nucleoli	"Nucleoplasm, Cytosol"	"HPA052777: "	"unprognostic (8.50e-5)"	"unprognostic (5.12e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.37e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.07e-3)"	0.9	0.8	2.9	0.8	7.7	1.1	1.3	4.3	5.8	1.2	1.1	6.5	1.9	1.2	1.2	1.8	0.9	1.4	0.9	0.8	3.9	1.0	1.0	1.0	1.1	1.0	7.4	2.2	1.3	1.0	1.0	1.2	0.8	5.2	1.3	1.0	0.4	2.0	1.1	1.0	2.0	1.1	0.9	3.2	0.9	1.0	35.7	6.5	2.2	1.3	0.0	1.0	0.9	3.3	0.1	0.6	4.8	1.8	0.2	0.5	0.2	0.2	0.4	0.2	1.8	0.8	0.0	4.1	0.2	0.0	0.0	0.0	1.3	0.8	0.3	0.0	0.0	0.6	0.5	0.1	0.0	0.9	0.2	0.1	0.2	0.0	0.1	0.3	5.2	0.0	0.8	0.0	0.5	0.1	0.0	1.3	0.0	4.2	0.0	0.0	0.0	0.8	0.1	0.0	0.8	1.9	0.1	0.4	0.5	0.4	0.9	0.2	0.4	0.0	0.3	0.0	1.0	0.6	0.0	0.7	0.9	0.0	0.2	0.2	0.0	0.3	0.8	1.8	0.4	0.9	0.2	0.0	0.1	0.2	0.6	0.1	0.5	0.2	4.8	0.2	1.8	0.4	0.3	0.2	2.9	7.7	4.3	5.8	3.9	1.0	7.4	2.2	5.2	6.5
CATSPERZ	"C11orf20, DKFZP566E164, TEX40"	ENSG00000219435	"Catsper channel auxiliary subunit zeta"	Q9NTU4	11	64300391-64304770	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	105	"testis: 139.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.6;CACO-2: 15.3;PC-3: 9.1;T-47d: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052822			Approved	Nucleoplasm				Nucleoplasm		"HPA052822: "	"unprognostic (1.89e-1)"	"unprognostic (7.81e-2)"			"unprognostic (1.88e-1)"				"unprognostic (8.23e-2)"	"unprognostic (2.18e-1)"		"unprognostic (1.11e-1)"	"unprognostic (5.66e-4)"	"unprognostic (5.96e-2)"	"unprognostic (3.07e-2)"		"unprognostic (1.43e-1)"	0.1	0.0	0.5	0.0	0.4	0.0	0.8	0.1	0.9	0.2	0.1	0.1	0.2	0.0	0.1	0.7	0.1	0.0	0.2	0.0	0.5	0.2	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.3	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	139.5	0.1	0.0	0.4	0.0	0.1	0.1	0.2	0.5	0.4	0.6	0.6	0.0	0.3	0.0	0.0	4.1	0.3	0.0	0.5	1.0	5.6	0.0	0.3	0.0	0.0	15.3	3.2	0.1	0.2	0.1	3.4	3.1	0.5	0.1	0.0	0.0	1.5	0.1	1.0	0.1	0.0	0.0	0.1	0.3	0.9	0.0	0.2	1.6	0.7	0.2	0.7	0.0	0.7	1.1	9.1	1.7	0.0	2.0	4.5	1.4	0.1	0.9	1.7	0.5	0.2	7.5	0.4	0.2	0.2	0.1	2.1	0.0	0.4	0.1	0.5	0.2	0.0	0.1	0.0	0.3	0.0	0.3	0.2	0.1	0.5	0.0	0.2	0.0	0.1	0.1	0.0	0.6	0.0	0.6	0.4	0.0	0.0	0.5	0.4	0.1	0.3	0.5	0.2	0.1	0.2	0.1	0.1
CBWD1		ENSG00000172785	"COBW domain containing 1"	Q9BRT8	9	121038-179147	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 53.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA042759: , HPA042813: "	"unprognostic (3.75e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.23e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.80e-7)"	"unprognostic (7.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.94e-2)"	"unprognostic (4.98e-3)"	6.3	14.1	5.5	5.3	6.7	3.8	7.2	5.5	4.5	4.9	5.5			4.6	4.5	8.3	10.4	5.0	3.5	7.0	4.9	6.9	16.3	10.1	5.7	4.1	5.9		5.5	10.5	7.5	7.6	8.3		7.2	5.7		8.6	4.5	7.5	7.1	4.1	4.2	4.8	5.6	6.1	6.3			10.0		7.3	6.9	5.1	8.2	28.0	7.0	28.2	4.5	7.6	15.6	12.5	4.7	6.9	3.6	9.0	8.2	15.3	6.6	4.4	9.2	7.0	6.9	4.8	11.5	8.6	2.4	2.2	3.3	6.3	10.0	19.7	11.6	0.1	11.2	21.1	9.8	33.1	5.2	7.3	3.0	2.2	18.1	9.8	3.8	25.4	7.5	15.1	7.1	53.7	6.9	10.3	13.8	10.5	21.9	11.9	35.7	12.4	7.5	13.6	5.1	5.1	10.7	31.8	10.2	4.9	6.9	6.3	5.7	3.0	4.1	13.2	12.1	17.8	5.7	1.2	25.3	7.0	4.2	28.2	6.8	8.2	7.6	6.7	28.0	5.6	6.7	7.3	3.8	4.5	21.3	7.4	6.6	15.6										
CBWD2		ENSG00000136682	"COBW domain containing 2"	Q8IUF1	2	113437691-113496189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA042759: , HPA042813: "	"unprognostic (4.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.14e-1)"	"prognostic unfavourable (3.22e-5)"	"unprognostic (7.69e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.21e-1)"	"unprognostic (7.57e-3)"	2.0	5.7	3.2	2.6	6.0	0.3	4.3	7.0	4.1	5.6	3.6			0.9	4.1	4.9	5.9	2.1	2.5	9.1	3.1	4.5	8.9	6.6	1.8	1.3	3.2		3.0	3.6	7.7	5.3	3.4		4.1	3.6		4.3	5.0	15.0	1.7	2.2	5.0	1.6	2.3	3.3	1.2			6.2		2.5	4.2	2.5	7.8	26.5	13.8	27.4	7.5	10.4	17.5	8.2	5.0	5.5	6.2	14.4	6.7	10.3	6.4	4.1	5.1	6.7	8.4	5.2	10.9	19.8	6.8	6.9	5.8	7.1	6.9	3.7	15.3	9.0	8.9	15.7	4.8	3.8	4.3	6.2	4.4	7.4	4.4	9.2	5.1	11.9	7.4	8.8	12.0	12.8	6.6	11.0	5.7	14.4	28.5	13.5	13.4	15.2	4.5	16.7	2.4	2.7	7.9	11.1	10.9	4.3	6.1	2.6	6.2	4.6	19.2	5.8	7.1	23.6	10.2	4.2	27.4	13.8	5.2	27.1	5.6	7.3	7.9	6.1	26.5	7.8	6.8	6.2	7.5	7.5	21.2	6.5	10.4	17.5										
CBWD3	bA561O23.1	ENSG00000196873	"COBW domain containing 3"	Q5JTY5	9	68232003-68300015	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"blood: 34.4"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042759, HPA042813"	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA042759: , HPA042813: "	"unprognostic (1.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.71e-3)"	"unprognostic (9.99e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.43e-3)"	"unprognostic (5.16e-4)"	3.8	6.0	4.4	6.6	4.9	4.0	6.5	5.7	5.1	2.7	4.7			4.2	2.9	2.1	5.4	3.0	1.8	2.9	4.8	4.4	7.7	11.1	2.9	5.7	4.5		3.6	10.7	4.2	5.0	5.5		4.1	3.2		3.7	3.6	5.2	4.9	7.6	2.8	3.9	5.0	6.3	3.2			5.1		4.3	4.5	3.5	20.3	24.4	34.4	33.9	5.7	14.0	19.9	21.1	15.7	7.7	12.0	5.8	1.9	10.2	10.6	4.2	4.5	5.3	4.4	20.8	24.6	10.3	7.7	26.0	14.1	20.9	12.3	37.7	9.1	9.4	35.9	20.9	7.3	17.7	11.8	4.8	6.5	8.2	10.7	10.4	17.2	20.0	6.6	13.6	20.7	23.7	11.4	26.5	9.5	24.1	26.6	5.1	9.2	12.0	7.7	17.4	10.5	13.0	7.6	20.7	4.9	7.0	17.7	11.4	20.4	11.9	47.0	30.0	20.8	26.3	12.5	9.1	33.9	24.8	11.6	27.2	10.0	20.3	10.8	11.9	24.4	18.4	11.7	10.9	34.4	5.7	19.0	18.3	14.0	19.9										
CBWD5		ENSG00000147996	"COBW domain containing 5"	Q5RIA9	9	65668805-65734041	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA042759: , HPA042813: "	"unprognostic (1.34e-1)"	"unprognostic (3.62e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.23e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.02e-3)"	"unprognostic (5.32e-3)"	"unprognostic (9.24e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.87e-1)"	4.1	6.0	5.2	3.7	6.8	2.5	9.2	8.2	3.7	2.8	3.3			5.4	1.7	4.8	3.3	1.7	2.2	2.4	6.2	6.0	7.6	17.9	1.9	2.6	4.8		2.1	6.6	2.9	4.0	2.9		4.3	5.5		2.2	3.8	2.1	2.8	4.4	2.5	2.6	5.7	2.2	2.1			5.1		4.4	5.4	1.5	5.5	11.7	7.7	14.0	2.5	5.5	9.3	14.9	16.2	5.7	7.3	8.9	4.1	7.0	10.6	7.2	8.4	8.7	2.1	13.9	20.4	6.8	6.1	11.1	26.2	8.5	16.0	3.3	6.3	5.7	26.1	36.3	6.7	12.8	3.7	7.2	9.9	7.7	6.3	15.2	8.0	15.3	8.6	18.1	6.4	13.6	7.1	17.4	11.2	8.0	20.4	13.4	9.8	7.7	7.8	8.6	6.8	3.1	31.7	8.6	4.3	3.8	14.1	11.7	12.2	5.0	13.4	4.8	16.0	14.8	14.4	1.6	11.6	7.7	3.4	14.0	3.7	5.5	5.5	4.7	11.7	2.9	5.1	4.1	7.1	2.5	8.5	4.9	4.1	9.3										
CC2D2B	"bA248J23.4, bA690P14.3, C10orf130, C10orf131"	ENSG00000188649	"Coiled-coil and C2 domain containing 2B"	Q6DHV5	10	95907603-96032684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.6"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA044091, HPA072122"	Enhanced		Approved	Nucleoli				Nucleoli		"HPA044091: , HPA072122: "	"unprognostic (6.38e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.63e-1)"	"unprognostic (8.18e-3)"	"unprognostic (2.11e-3)"	"unprognostic (9.11e-4)"	"unprognostic (1.93e-2)"	"unprognostic (4.34e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.41e-1)"	0.5	1.7	1.0	1.7	1.0	1.7	0.6	0.3	3.1	0.8	0.8			0.6	2.3	0.2	0.8	1.3	2.0	0.8	0.6	0.6	0.6	0.3	0.9	1.1	0.9		0.8	0.2	0.0	0.4	0.7		0.9	0.0		0.5	0.1	1.6	2.6	0.9	1.2	0.7	1.4	0.6	10.6			4.0		0.0	1.0	1.1	4.1	1.0	1.8	1.0	0.8	2.9	0.5	1.1	3.9	3.8	7.1	0.2	0.4	4.1	3.8	0.4	0.6	0.1	4.1	0.8	5.0	3.0	0.0	2.7	0.3	0.2	0.0	4.9	8.6	9.1	3.3	3.1	0.0	9.6	0.6	0.6	0.0	0.4	0.1	0.3	7.8	2.9	0.9	2.4	4.4	3.2	8.3	6.5	11.4	3.4	4.2	0.7	1.3	7.0	3.7	4.2	1.1	2.7	6.9	4.3	3.3	4.4	4.4	3.0	5.5	2.6	10.8	0.1	3.3	9.8	2.8	0.0	1.0	0.2	1.9	0.3	2.9	3.4	1.4	1.1	0.9	4.1	1.3	0.4	1.8	0.8	0.8	1.0	0.8	0.5										
CCDC105	FLJ40365	ENSG00000160994	"Coiled-coil domain containing 105"	Q8IYK2	19	15010744-15023269	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	94	"testis: 38.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA058585	Approved									"HPA058585: "																		0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	38.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0
CCDC107	MGC31967	ENSG00000159884	"Coiled-coil domain containing 107"	Q8WV48	9	35658290-35661511	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016857, HPA050442"			Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA016857: AB_10669751, HPA050442: "	"unprognostic (3.70e-3)"	"unprognostic (7.07e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.15e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.75e-2)"	42.1	23.4	11.1	15.4	10.3	5.4	50.3	17.2	12.9	17.5	35.2	8.5	18.1	15.0	24.9	28.6	22.4	18.2	31.5	31.3	10.2	11.0	13.0	15.0	14.0	14.1	9.7	7.9	15.3	80.2	7.6	10.5	10.8	8.4	22.8	13.7	11.5	14.6	24.5	29.3	9.6	16.0	44.8	9.7	13.5	24.2	9.2	8.8	19.3	14.0	8.8	10.9	38.9	24.1	20.7	32.5	7.6	11.0	16.4	46.9	18.3	7.9	7.2	6.0	7.5	30.3	19.5	3.5	13.5	12.2	8.7	8.1	3.3	2.4	5.2	6.0	17.7	2.7	4.4	6.5	6.4	15.3	7.1	2.4	11.0	8.1	7.2	3.8	9.5	11.5	7.8	9.2	7.2	6.0	3.2	10.1	10.8	5.1	4.2	5.6	4.4	22.3	6.1	1.4	4.1	28.7	4.3	3.9	6.6	7.0	9.8	6.6	5.1	4.7	7.5	13.9	7.7	10.0	12.3	4.5	6.7	10.4	25.7	6.1	12.1	7.6	10.6	5.1	36.1	11.0	46.9	20.7	31.7	31.4	11.8	20.1	15.5	21.3	2.1	16.4	6.4	32.5	35.2	18.3	11.1	10.3	17.2	12.9	10.2	11.0	9.7	7.9	8.4	8.8
CCDC122	FLJ31846	ENSG00000151773	"Coiled-coil domain containing 122"	Q5T0U0	13	43823909-43879727	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 11.2;hTERT-HME1: 11.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034233, HPA054995, HPA061456"	Approved		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"CAB034233: AB_2228702, HPA054995: , HPA061456: "	"unprognostic (1.74e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.75e-2)"	4.3	6.7	5.0	8.5	9.5	1.8	7.5	2.4	5.6	5.5	5.5	7.2	8.8	3.3	8.0	10.7	4.5	8.6	5.9	8.3	6.1	5.0	10.4	5.7	5.5	4.6	9.8	5.8	12.2	6.9	8.4	15.6	8.2	6.0	9.8	6.9	3.6	5.7	4.8	3.3	7.8	7.3	9.8	6.4	7.7	5.8	9.7	11.0	5.2	10.9	4.5	4.7	6.2	11.8	3.6	3.0	6.4	2.6	3.6	1.9	1.0	2.1	1.8	0.8	0.0	0.7	4.5	2.3	5.8	6.4	3.0	3.4	3.1	7.9	3.6	3.3	3.5	3.5	0.8	0.9	4.3	5.7	2.7	1.5	1.0	1.7	8.4	0.8	0.4	11.2	7.1	4.4	11.6	1.5	0.0	1.1	4.1	2.6	0.5	0.5	1.0	1.8	0.8	0.0	1.9	4.7	1.2	2.1	3.1	3.9	0.1	3.5	0.7	0.6	6.8	0.2	0.8	5.2	0.0	0.0	0.0	1.6	2.9	0.1	3.0	6.4	1.6	2.4	1.3	1.4	1.6	2.4	1.9	1.4	1.2	3.6	1.3	1.4	3.9	3.6	2.6	3.0	1.7	1.0	5.0	9.5	2.4	5.6	6.1	5.0	9.8	5.8	6.0	11.0
CCDC126	FLJ23031	ENSG00000169193	"Coiled-coil domain containing 126"	Q96EE4	7	23597379-23644708	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"basophil: 75.4"	"Lineage enriched"	"Detected in all"	18	"granulocytes: 75.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026883	Uncertain		Approved	Nucleoplasm	"Secreted to blood"		31000000	Nucleoplasm		"HPA026883: AB_1846131"	"unprognostic (2.02e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.28e-1)"	6.7	8.1	8.7	4.4	9.2	6.9	19.5	11.6	13.2	7.4	6.5	5.6	5.8	8.7	8.0	5.3	6.6	6.7	6.2	5.7	13.8	8.9	7.6	11.7	6.5	9.3	10.5	3.9	7.4	9.8	12.2	12.6	4.6	11.1	6.0	6.5	5.8	7.5	6.5	10.0	6.6	9.4	6.7	12.9	6.1	6.8	41.3	8.1	5.4	9.9	5.0	8.6	7.0	7.7	3.8	3.0	75.4	3.6	2.9	4.1	2.9	4.8	3.4	7.5	9.5	12.6	7.0	17.2	6.1	6.0	5.2	7.7	3.5	1.6	10.4	9.6	5.1	2.8	3.2	2.9	6.9	2.1	4.3	1.8	1.4	4.5	5.1	4.7	9.2	7.5	8.5	1.7	1.6	7.0	4.1	2.9	6.3	2.2	3.2	5.7	3.5	4.2	2.2	11.8	3.1	5.5	2.2	4.6	8.6	6.3	6.1	4.5	5.1	4.4	8.4	3.1	5.6	7.1	4.8	8.4	8.3	7.4	3.4	6.9	16.8	75.4	3.6	16.4	3.0	3.3	3.7	3.8	3.3	3.5	3.0	3.2	4.1	3.2	6.9	2.9	3.1	0.6	3.6	2.9	8.7	9.2	11.6	13.2	13.8	8.9	10.5	3.9	11.1	8.1
CCDC129	FLJ38344	ENSG00000180347	"Coiled-coil domain containing 129"	Q6ZRS4	7	31514071-31658720	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 17.2;salivary gland: 10.9"	"Cell line enhanced"	"Detected in some"		"AF22: 1.5;CACO-2: 1.3;RH-30: 2.1;T-47d: 2.6;U-2 OS: 5.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"cerebellum: 7.9;midbrain: 5.0;pons and medulla: 17.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA024103	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm		"HPA024103: AB_1846132"	"unprognostic (1.11e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.78e-5)"	"unprognostic (9.72e-3)"	"unprognostic (1.78e-1)"		"unprognostic (3.89e-2)"	"unprognostic (6.42e-3)"		"unprognostic (1.01e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.53e-1)"		0.1	0.0	0.1	0.6	2.0	0.1	3.3	7.9	0.3	3.7	0.9	1.2	0.0	2.1	1.1	0.2	0.1	0.1	0.1	0.0	0.4	1.4	0.1	0.0	0.4	0.0	5.0	0.0	0.0	0.2	0.0	0.4	0.9	17.2	0.1	0.2	0.0	10.9	0.0	0.0	4.5	0.9	1.1	0.2	0.0	0.8	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.8	0.8	1.1	0.0	0.1	1.0	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.5	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.2	0.1	2.1	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	2.6	0.0	0.0	0.0	5.4	0.2	0.3	0.2	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.2	0.0	0.1	0.7	0.2	0.1	0.1	0.8	1.0	0.4	1.1	0.1	0.0	0.8	0.0	0.1	0.1	2.0	7.9	0.3	0.4	1.4	5.0	0.0	17.2	0.0
CCDC140	FLJ32447	ENSG00000163081	"Coiled-coil domain containing 140"	Q96MF4	2	222298147-222305217	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.6;salivary gland: 1.2;skeletal muscle: 3.1;skin 1: 1.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.2;BJ hTERT+ SV40 Large T+ RasG12V: 2.1;NB-4: 3.7;RH-30: 2.1;SK-MEL-30: 3.9;WM-115: 2.3"	"Cancer enriched"	"Detected in single"	9	"melanoma: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA042500, HPA048166"	Uncertain									"HPA042500: , HPA048166: AB_2680295"					"unprognostic (2.50e-2)"	"unprognostic (3.54e-1)"			"unprognostic (5.25e-2)"									0.3	0.0	0.0	0.0	0.0	0.4	0.2	1.5	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4		0.0	0.0	0.0	0.0	0.0		0.0	0.0		1.2	0.0	3.1	1.8	0.0	0.0	1.6	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	2.2	1.5	2.1	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	0.0	2.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCDC142	FLJ14397	ENSG00000135637	"Coiled-coil domain containing 142"	Q17RM4	2	74471986-74483408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA056946	Approved									"HPA056946: "	"unprognostic (2.00e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavourable (1.87e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.69e-3)"	"prognostic unfavourable (4.46e-4)"	"unprognostic (9.05e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.44e-2)"	"unprognostic (5.65e-3)"	"unprognostic (8.94e-3)"	"prognostic unfavourable (3.71e-7)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.31e-3)"	5.5	6.5	5.7	6.3	5.3	3.8	4.5	11.7	6.1	9.6	5.1	9.8	9.2	12.5	10.6	4.0	5.8	5.5	3.7	4.0	5.6	3.6	5.2	10.0	4.2	7.9	7.6	3.5	8.3	5.1	12.1	6.9	3.6	5.3	6.7	5.0	6.3	9.3	7.4	3.4	6.8	9.1	7.8	3.3	7.8	5.4	6.5	6.4	18.1	5.8	2.6	7.1	5.8	4.6	9.4	5.1	8.0	5.0	6.9	8.1	1.7	3.1	2.4	4.3	3.8	2.5	2.7	9.9	4.7	2.4	3.4	2.6	7.4	4.5	3.7	3.3	1.9	6.0	2.6	3.3	1.7	5.4	10.6	6.8	7.5	4.6	1.0	4.0	5.1	1.8	2.1	5.3	1.8	2.4	3.1	2.3	3.2	2.4	4.8	3.7	4.6	6.6	6.6	7.9	3.4	1.8	3.8	6.8	4.3	3.4	7.8	3.4	5.1	2.7	2.2	7.5	4.9	5.1	6.1	8.1	3.7	3.2	3.0	2.1	4.1	8.0	5.0	7.4	8.1	2.8	6.7	5.2	5.0	5.6	2.5	9.4	7.8	6.0	4.4	6.9	5.0	5.1	2.3	1.7	5.7	5.3	11.7	6.1	5.6	3.6	7.6	3.5	5.3	6.4
CCDC144A	"FLJ43983, KIAA0565"	ENSG00000170160	"Coiled-coil domain containing 144A"	A2RUR9	17	16689537-16777881	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 44.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.9;TIME: 9.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA022996, HPA047220, HPA047851"	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA022996: AB_1846136, HPA047220: , HPA047851: "	"unprognostic (8.54e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.74e-1)"	3.7	1.9	2.5	2.7	3.5	5.5	2.7	12.0	3.6	2.1	3.1	2.8	0.4	0.9	5.4	3.9	1.3	2.6	1.7	2.5	4.7	0.8	1.0	1.5	2.8	2.3	4.3	1.8	7.3	5.4	0.2	16.7	3.7	10.3	3.0	1.4	1.7	2.2	1.5	2.4	3.7	2.0	2.5	4.2	2.4	2.2	44.4	2.8	2.4	1.8	0.4	1.5	2.8	4.9	1.0	0.8	0.8	1.3	1.0	3.8	0.0	0.5	3.8	0.9	2.4	3.4	10.9	0.4	0.2	0.0	0.2	0.2	4.8	0.1	0.5	3.3	6.7	5.9	4.9	0.3	0.3	3.4	0.3	0.5	0.5	0.3	0.2	0.7	3.1	2.0	0.1	2.3	0.2	0.1	0.5	0.3	2.2	0.2	0.1	1.2	0.8	0.4	1.5	0.2	0.1	0.1	4.6	1.2	1.3	0.7	0.2	1.4	4.0	0.2	9.3	0.8	0.5	5.2	1.5	6.6	6.8	0.2	0.4	6.8	1.8	0.7	0.6	0.3	2.2	0.5	1.4	1.0	2.1	1.4	0.4	0.5	3.8	1.9	0.8	1.0	1.3	0.8	2.1	0.0	2.5	3.5	12.0	3.6	4.7	0.8	4.3	1.8	10.3	2.8
CCDC149	DKFZp761B107	ENSG00000181982	"Coiled-coil domain containing 149"	Q6ZUS6	4	24806117-24980204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 4.5"	"Lineage enriched"	"Detected in single"	6	"monocytes: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044158, HPA047913"	Uncertain		Approved	Nucleoli				Nucleoli		"HPA044158: , HPA047913: "	"unprognostic (1.68e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.09e-2)"	"prognostic favourable (6.63e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.11e-4)"	"unprognostic (9.71e-5)"	"unprognostic (2.68e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.82e-2)"	"unprognostic (8.59e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.80e-3)"	"unprognostic (8.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.80e-2)"	11.7	8.3	20.1	8.2	14.7	2.8	16.7	14.8	20.6	13.2	10.8	6.9	11.1	5.3	12.9	9.2	7.9	13.9	9.9	10.9	15.9	11.5	7.5	10.3	10.0	4.4	11.5	12.7	15.9	31.7	12.8	11.2	11.6	11.3	14.3	8.6	7.5	29.8	10.1	8.6	6.9	6.4	14.5	9.9	5.8	13.8	5.4	9.4	0.9	11.9	4.6	4.3	9.6	18.3	0.0	0.8	0.8	4.5	0.2	0.0	1.2	4.1	1.6	3.3	0.5	5.2	9.7	1.0	6.0	9.2	4.8	5.6	0.1	4.6	0.0	2.9	11.4	0.7	1.0	0.7	3.2	0.0	0.0	0.0	0.3	0.3	4.4	0.0	0.0	6.6	4.3	2.7	0.0	3.9	0.0	0.8	2.9	4.4	0.0	0.1	3.8	4.6	0.0	0.0	0.2	8.7	3.0	4.6	0.0	2.6	3.8	12.3	6.5	9.3	9.3	7.0	0.8	5.2	5.2	0.1	0.0	0.0	21.6	0.9	4.8	0.0	4.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.2	1.5	0.7	0.0	1.2	20.1	14.7	14.8	20.0	15.9	11.5	11.5	12.7	11.3	9.4
CCDC15	FLJ13215	ENSG00000149548	"Coiled-coil domain containing 15"	Q0P6D6	11	124954121-125041489	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.2;testis: 19.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA040450, HPA041738"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA040450: AB_10794031, HPA041738: AB_10794675"	"unprognostic (2.38e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.59e-4)"	"unprognostic (2.12e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.04e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.66e-1)"	1.9	1.3	2.2	2.5	3.9	3.2	5.2	1.2	2.4	1.6	2.2	2.2	0.3	1.3	2.2	2.9	2.4	2.1	1.5	0.9	1.9	1.2	1.2	2.4	2.6	2.0	1.6	0.8	1.7	2.3	1.7	3.8	1.6	1.6	3.0	1.6	1.5	7.7	2.2	0.8	3.7	1.8	1.2	3.3	2.5	1.5	19.4	2.3	16.2	1.3	2.6	2.9	2.6	2.2	1.5	1.1	6.7	1.7	2.3	3.9	1.3	4.7	0.9	6.4	0.0	0.5	1.8	0.0	5.2	6.4	4.9	6.1	0.1	4.0	5.6	4.6	1.8	3.8	2.7	3.5	8.9	4.7	1.1	6.9	0.8	1.5	0.2	2.0	4.0	0.4	2.5	10.2	5.1	3.7	4.6	5.8	10.3	1.0	4.2	2.3	1.5	5.9	5.3	11.7	1.8	0.7	2.0	3.6	3.2	3.0	0.3	1.3	7.3	1.8	2.6	10.1	2.3	4.4	6.4	1.4	1.5	4.9	1.4	11.3	6.7	6.7	1.3	1.7	2.4	1.7	2.5	0.8	2.2	3.9	0.4	1.5	3.1	3.4	0.8	2.3	1.7	1.1	3.7	1.3	2.2	3.9	1.2	2.4	1.9	1.2	1.6	0.8	1.6	2.3
CCDC152	LOC100129792	ENSG00000198865	"Coiled-coil domain containing 152"	Q4G0S7	5	42756801-42802360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 52.8;pituitary gland: 24.3"	"Cell line enhanced"	"Detected in some"		"HeLa: 10.8;U-2 OS: 19.5;U-266/84: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036240	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036240: AB_10671242"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.24e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (6.25e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.40e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.14e-3)"	4.0	6.0	7.5	2.5	10.2	1.6	3.0	1.0	8.4	2.1	2.3	4.1	0.5	5.0	2.7	1.9	2.0	1.6	6.1	4.6	7.1	3.2	3.6	52.8	3.2	8.6	4.9	5.5	8.2	2.1	0.0	24.3	2.8	20.9	2.1	0.3	1.9	2.1	0.3	1.5	3.1	12.4	0.6	8.8	6.9	1.9	5.7	8.5	8.5	1.7	0.5	3.0	2.9	3.1	3.6	10.0	0.3	0.7	6.2	6.1	1.3	0.3	0.1	0.9	0.1	2.8	3.5	0.0	4.7	0.1	0.0	0.3	0.0	0.2	0.0	0.3	2.1	3.7	0.0	0.0	0.4	0.0	0.3	0.2	10.8	4.5	2.8	0.1	0.0	4.5	0.0	1.9	0.0	1.4	0.5	1.1	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.3	5.4	0.0	0.1	0.0	0.4	0.1	0.1	0.2	19.5	4.5	0.1	0.1	13.0	0.1	5.7	0.1	0.1	0.1	0.1	0.1	4.0	0.7	4.9	2.2	3.0	5.0	0.7	3.6	4.0	6.1	0.3	6.2	0.3	10.0	1.9	1.3	7.5	10.2	1.0	8.4	7.1	3.2	4.9	5.5	20.9	8.5
CCDC154	"C16orf29, LOC645811"	ENSG00000197599	"Coiled-coil domain containing 154"	A6NI56	16	1434383-1444556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"testis: 10.8"	"Cell line enhanced"	"Detected in some"		"A-431: 7.3;SCLC-21H: 26.0;U-266/70: 4.7"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebellum: 5.4"	"HPA041158, HPA043535, HPA048237"	Uncertain		Approved	"Golgi apparatus,Plasma membrane"				"Plasma membrane"	"Golgi apparatus"	"HPA041158: , HPA043535: , HPA048237: "	"unprognostic (2.40e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-4)"	"unprognostic (3.28e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.76e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.34e-2)"	"unprognostic (4.19e-5)"	"unprognostic (2.35e-2)"	"unprognostic (8.02e-6)"	"unprognostic (9.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.35e-5)"	0.6	1.5	0.6	1.5	1.1	1.6	0.5	4.5	1.4	1.0	0.7			2.6	1.3	0.4	0.0	1.5	0.7	0.2	0.7	0.9	1.2	0.4	0.4	2.5	0.5		1.3	1.1	0.0	3.9	0.6		2.9	0.0		1.2	0.8	1.2	2.9	1.2	0.2	0.7	3.4	3.7	10.8			2.8		0.6	0.2	0.6	0.7	0.0	0.8	0.1	0.0	1.1	0.0	7.3	0.3	0.2	0.5	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.3	0.3	0.1	0.4	0.0	0.2	0.1	0.0	0.0	0.9	0.4	0.0	0.5	0.0	3.7	0.2	0.1	2.1	0.1	0.1	0.0	0.1	26.0	0.4	0.1	0.1	1.1	0.8	1.9	0.0	0.4	0.1	0.3	0.0	4.7	1.2	0.0	0.0	3.7	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	1.1	0.0	0.7	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0										
CCDC157		ENSG00000187860	"Coiled-coil domain containing 157"	Q569K6	22	30356635-30378658	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"fallopian tube: 11.5;testis: 43.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042943	Uncertain									"HPA042943: AB_10794767"	"unprognostic (3.69e-3)"	"unprognostic (1.72e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.61e-1)"	"unprognostic (7.74e-3)"	"unprognostic (8.72e-4)"	"unprognostic (1.35e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.89e-4)"	"unprognostic (2.33e-2)"	"unprognostic (2.60e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.45e-2)"	0.9	1.8	4.3	1.5	5.9	2.5	2.0	3.3	4.0	1.6	1.4	2.5	2.2	1.5	1.6	3.0	1.4	11.5	2.0	1.1	4.4	5.8	3.3	1.0	3.5	2.0	2.3	1.9	2.1	3.0	1.7	4.5	0.9	5.9	1.6	0.9	2.1	2.4	1.7	0.9	1.8	1.1	0.9	1.2	1.8	1.4	43.7	1.8	1.3	4.4	1.2	1.2	1.1	0.8	1.6	2.3	6.7	1.6	1.9	2.3	1.2	2.8	3.2	3.0	5.6	1.7	1.1	3.7	1.4	1.8	2.9	2.8	4.1	2.1	2.5	1.8	1.5	2.8	1.6	1.9	1.5	1.7	6.9	1.4	3.0	2.4	2.0	2.6	2.4	1.0	1.4	5.2	0.9	1.7	2.2	2.3	2.3	2.7	3.3	2.8	3.8	1.7	2.9	1.7	2.2	6.9	2.9	10.1	6.6	4.5	1.7	1.8	5.4	1.1	3.0	2.7	3.6	1.8	1.1	1.9	0.9	2.0	4.4	1.6	2.2	2.0	1.6	2.0	2.1	1.1	2.3	0.9	1.8	2.1	0.9	1.6	1.1	1.8	6.7	1.9	1.4	2.3	1.4	1.2	4.3	5.9	3.3	4.0	4.4	5.8	2.3	1.9	5.9	1.8
CCDC159		ENSG00000183401	"Coiled-coil domain containing 159"	P0C7I6	19	11344684-11354944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047126, HPA054655"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA047126: AB_10961722, HPA054655: "	"unprognostic (1.46e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.35e-3)"	"prognostic favourable (1.87e-7)"	"unprognostic (5.02e-2)"	"unprognostic (1.06e-3)"	"unprognostic (9.23e-3)"	"unprognostic (2.40e-2)"	"unprognostic (6.68e-2)"	"prognostic favourable (9.46e-4)"	"prognostic favourable (1.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-2)"	"prognostic favourable (8.62e-4)"	7.9	24.6	21.0	13.4	35.1	22.2	10.9	15.5	28.6	14.8	12.9	30.6	28.3	17.8	13.9	21.1	11.8	14.2	19.0	13.6	22.8	11.9	13.4	18.9	12.8	14.7	38.5	22.9	19.2	15.1	34.3	20.8	7.3	28.0	24.7	9.5	17.7	14.5	17.4	6.3	14.6	14.3	12.5	24.2	24.1	16.1	28.2	43.5	7.5	17.8	8.5	11.2	13.7	12.6	9.9	16.5	21.2	28.0	15.7	15.2	11.8	2.2	1.9	1.6	5.1	6.7	9.7	1.7	3.6	3.8	4.3	5.8	0.6	2.4	1.8	9.4	6.8	1.8	1.0	5.8	2.7	9.0	1.4	4.4	1.6	2.3	11.7	1.7	6.6	11.6	15.4	3.1	4.2	12.1	3.9	21.4	2.1	2.7	2.6	3.5	0.9	7.3	3.0	0.0	12.0	3.9	3.2	0.7	2.7	3.7	4.2	6.7	6.2	7.4	8.0	3.4	1.0	5.9	3.3	19.7	4.7	3.8	4.6	9.0	4.9	21.2	28.0	19.1	12.1	23.6	11.7	8.1	8.2	11.0	16.5	9.9	7.5	5.9	13.2	15.7	16.4	4.3	15.2	11.8	21.0	35.1	15.5	28.6	22.8	11.9	38.5	22.9	28.0	43.5
CCDC168	"C13orf40, FLJ40176"	ENSG00000175820	"Coiled-coil domain containing 168"	Q8NDH2	13	102729369-102759070	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 23.7"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.5;MOLT-4: 1.3;NB-4: 1.0;THP-1: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048184, HPA058793"	Uncertain									"HPA048184: , HPA058793: "	"unprognostic (2.06e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.39e-4)"	"unprognostic (2.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.85e-1)"	"unprognostic (6.94e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.9	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.7	0.1	0.0	0.0	0.3	0.0	0.2	0.3	0.2	0.7	0.1	0.0	0.0	1.5	0.3	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.3	1.0	0.0	0.3	0.4	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.3	0.3	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC171	"bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740"	ENSG00000164989	"Coiled-coil domain containing 171"	Q6TFL3	9	15553086-16061663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 9.4;HEL: 14.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA019803, HPA019806, HPA024133"	Uncertain		Uncertain	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA019803: AB_1845846, HPA019806: AB_1845847, HPA024133: AB_1845848"	"unprognostic (1.35e-2)"	"unprognostic (2.03e-4)"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.76e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.91e-3)"	2.5	2.5	5.8	5.5	7.5	4.0	3.6	8.2	7.8	4.1	2.4	1.1	6.9	1.9	11.6	5.8	2.4	4.6	3.4	2.6	4.9	4.1	2.8	1.3	2.5	2.4	3.4	7.6	6.3	3.4	4.2	7.8	7.3	6.6	3.4	2.5	2.0	1.9	7.4	2.4	4.9	2.2	7.1	6.1	1.5	3.1	20.4	3.3	20.2	4.3	1.4	2.2	2.5	2.8	1.6	0.7	5.1	0.6	0.4	1.8	0.2	1.7	0.9	2.1	2.1	1.2	2.6	1.4	1.4	1.1	1.4	1.5	0.6	0.8	9.4	0.7	0.8	0.4	0.9	1.3	1.5	2.0	0.9	14.6	1.5	1.3	1.8	2.1	1.9	1.5	2.6	1.1	2.1	0.6	0.4	2.6	1.6	0.7	4.0	1.9	1.7	2.1	4.8	1.6	0.3	1.0	1.4	3.1	1.5	2.8	1.0	3.5	1.1	1.5	1.1	2.8	1.6	0.8	0.9	1.4	1.7	6.2	1.2	1.2	2.0	5.1	0.6	0.0	0.8	0.6	1.8	0.7	0.7	0.7	0.7	1.6	0.5	0.9	0.5	0.4	0.4	0.7	0.6	0.2	5.8	7.5	8.2	7.8	4.9	4.1	3.4	7.6	6.6	3.3
CCDC173	"C2orf77, LOC129881"	ENSG00000154479	"Coiled-coil domain containing 173"	Q0VFZ6	2	169645425-169694433	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 19.5;testis: 53.4"	"Cell line enhanced"	"Detected in some"		"HEL: 14.9;HMC-1: 3.6;SCLC-21H: 3.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042995, HPA048454"	Uncertain									"HPA042995: , HPA048454: "	"unprognostic (1.66e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.20e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.26e-6)"	"unprognostic (8.73e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.41e-1)"	0.6	0.6	2.8	0.9	5.1	2.5	1.4	0.7	3.5	1.3	0.6	5.6	1.8	0.8	1.8	7.8	0.6	11.0	1.0	0.5	4.8	3.2	2.1	0.8	4.0	0.5	1.3	2.6	4.1	1.4	1.3	19.5	0.5	14.3	0.7	0.7	0.7	0.5	1.0	0.4	0.5	0.7	0.8	1.4	0.5	0.7	53.4	4.0	0.0	3.1	0.0	0.4	0.5	0.5	0.3	0.4	2.2	0.9	0.2	1.0	0.1	0.7	1.2	1.2	0.3	0.0	0.1	1.3	0.6	0.0	0.6	0.1	0.4	0.2	0.2	0.2	0.0	0.9	1.0	1.3	1.0	0.1	0.7	14.9	1.1	0.4	0.0	1.4	3.6	0.0	0.2	1.9	0.0	0.0	3.3	0.1	0.0	1.8	0.3	0.4	0.3	0.8	0.0	0.0	0.0	0.4	0.7	3.8	1.0	0.1	0.0	0.1	0.9	0.1	0.1	0.4	0.2	1.0	0.5	0.5	0.4	0.4	0.9	0.0	0.3	2.2	0.2	0.0	0.3	0.9	1.0	0.3	0.2	0.5	0.3	0.2	0.3	0.3	0.8	0.2	0.0	0.4	0.0	0.1	2.8	5.1	0.7	2.9	4.8	3.2	1.3	2.6	14.3	4.0
CCDC181	"C1orf114, FLJ25846"	ENSG00000117477	"Coiled-coil domain containing 181"	Q5TID7	1	169394870-169460669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 22.3;testis: 29.2"	"Cell line enhanced"	"Detected in some"		"AF22: 7.2;NTERA-2: 13.9;SCLC-21H: 8.5;SH-SY5Y: 10.1;U-251 MG: 6.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"basophil: 3.2"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027189, HPA027275, HPA027281, HPA027312"	Enhanced		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA027189: AB_10599252, HPA027275: AB_10602172, HPA027281: AB_10601452, HPA027312: AB_10601349"	"unprognostic (2.45e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.97e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.89e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.41e-2)"	0.8	3.3	6.3	1.0	8.3	0.9	0.9	5.9	8.4	2.6	0.7	1.6	0.4	0.7	4.6	2.7	0.9	14.5	4.6	2.3	6.6	9.9	7.5	0.6	2.4	0.6	5.2	5.0	8.0	3.0	17.3	22.3	0.5	8.7	2.9	0.7	5.3	0.8	2.9	0.7	1.1	0.9	2.7	4.9	0.5	1.2	29.2	4.1	0.0	1.1	0.0	0.5	1.4	0.8	0.1	0.0	3.2	0.1	0.0	0.2	0.0	0.2	0.3	7.2	0.1	0.2	0.2	0.2	0.1	0.0	1.8	3.8	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.0	0.3	0.2	1.6	1.7	0.1	0.0	0.0	1.9	0.1	0.7	0.0	0.4	0.0	0.1	0.1	0.1	1.3	0.1	4.3	0.0	13.9	0.0	0.0	6.0	0.1	1.1	0.0	8.5	10.1	0.0	0.3	0.5	0.0	0.0	0.5	1.5	4.5	0.2	6.2	2.1	1.9	0.0	2.9	0.1	5.5	3.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	6.3	8.3	5.9	8.4	6.6	9.9	5.2	5.0	8.7	4.1
CCDC182		ENSG00000166329	"Coiled-coil domain containing 182"	A6NF36	17	57744481-57745312	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 21.5"	"Cell line enhanced"	"Detected in some"		"REH: 3.0;THP-1: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 0.5"	HPA023446	Uncertain									"HPA023446: AB_1859510"					"unprognostic (1.22e-1)"										"unprognostic (3.14e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
CCDC183	"bA216L13.7, KIAA1984, MGC15438"	ENSG00000213213	"Coiled-coil domain containing 183"	Q5T5S1	9	136796350-136807741	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 26.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 2.0;HL-60: 1.4;HSkMC: 1.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 4.5"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA043812	Uncertain									"HPA043812: AB_10961860"	"unprognostic (2.91e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.89e-5)"	"unprognostic (3.45e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.16e-3)"	"unprognostic (4.32e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.20e-2)"	"unprognostic (5.15e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.6	0.2	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	1.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC189	"C16orf93, MGC104706"	ENSG00000196118	"Coiled-coil domain containing 189"	A1A4V9	16	30757423-30762710	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041806, HPA046289"	Approved		Approved	Cytosol				Cytosol		"HPA041806: AB_2677684, HPA046289: "	"unprognostic (5.84e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.45e-4)"	"unprognostic (3.60e-2)"	"unprognostic (5.41e-3)"	"unprognostic (7.76e-5)"	"unprognostic (1.66e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.15e-4)"	"unprognostic (1.22e-3)"	"unprognostic (1.06e-7)"	"unprognostic (1.75e-3)"	"unprognostic (2.14e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.41e-2)"	1.0	4.2	4.7	3.1	5.3	11.0	4.8	0.9	6.4	3.2	2.8	2.9	5.5	2.0	2.2	15.0	1.2	15.6	4.2	0.8	5.5	6.8	4.5	0.9	5.5	1.9	7.5	3.3	3.1	3.0	4.4	10.3	1.2	7.6	3.0	3.1	2.3	3.4	5.1	0.4	1.8	1.4	1.3	1.3	1.9	2.0	23.7	2.2	2.3	6.3	1.6	3.4	1.7	0.8	1.2	13.0	6.2	3.1	1.8	1.1	0.8	7.1	4.9	1.4	5.8	1.6	1.8	0.4	2.7	1.0	2.9	2.2	0.4	5.3	0.2	4.8	2.0	8.9	0.8	4.4	1.2	0.8	11.6	1.9	10.1	3.1	0.3	2.9	2.1	0.4	0.4	5.4	4.4	2.2	2.7	1.3	2.1	3.7	3.1	5.8	2.3	2.7	3.0	1.9	5.5	6.5	0.1	5.0	1.8	2.9	8.2	1.8	8.0	3.7	1.9	1.5	1.2	2.5	2.7	3.9	2.2	2.6	8.7	7.5	0.7	1.2	1.3	6.2	0.2	1.4	1.1	1.2	0.0	0.2	1.8	0.1	0.0	0.4	0.6	1.8	3.1	13.0	0.1	0.8	4.7	5.3	0.9	6.4	5.5	6.8	7.5	3.3	7.6	2.2
CCDC190	"C1orf110, MGC48998"	ENSG00000185860	"Coiled-coil domain containing 190"	Q86UF4	1	162824458-162868815	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 8.3;lung: 7.2;tongue: 7.5"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 4.1;HUVEC TERT2: 4.9;LHCN-M2: 7.5;TIME: 17.0;U-2197: 9.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028579, HPA028584, HPA028592"	Uncertain		Approved	Vesicles				Vesicles		"HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001"	"unprognostic (4.29e-1)"	"unprognostic (8.37e-2)"		"unprognostic (1.75e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-2)"		"unprognostic (8.33e-3)"		"unprognostic (3.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.41e-5)"	"unprognostic (2.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.26e-1)"	"unprognostic (1.70e-1)"	0.2	0.1	1.1	0.2	1.7	0.0	0.2	0.2	0.9	0.3	0.2	0.2	0.2	0.0	0.2	0.8	8.3	1.1	1.3	1.0	1.2	0.7	0.2	0.2	7.2	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.5	0.0	0.2	0.2	0.3	0.2	0.1	0.7	0.2	0.6	0.2	7.5	2.4	0.3	0.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.0	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	4.1	2.6	4.9	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.4	0.0	9.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.1	1.7	0.2	0.6	1.2	0.7	0.4	0.2	0.2	0.2
CCDC191	KIAA1407	ENSG00000163617	"Coiled-coil domain containing 191"	Q8NCU4	3	113964137-114056613	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047833	Approved		Approved	Mitochondria				Mitochondria		"HPA047833: AB_10961639"	"unprognostic (2.59e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.57e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.90e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.54e-1)"	"prognostic favourable (3.45e-4)"	3.8	4.5	6.3	4.5	13.3	4.2	7.6	3.0	9.7	7.6	4.0	11.7	11.5	2.9	8.2	12.4	3.4	18.5	5.7	2.4	8.2	7.8	7.7	2.4	7.2	6.1	6.2	9.8	7.7	6.6	16.7	31.1	3.4	12.5	6.5	5.2	7.1	5.0	7.9	1.6	11.4	5.1	7.0	8.9	7.5	4.8	12.7	7.9	3.6	11.3	2.4	6.1	5.2	4.5	10.0	4.4	5.3	0.9	0.8	2.2	1.0	4.8	2.7	4.3	3.6	1.2	6.5	1.4	1.2	2.1	1.7	2.6	0.5	5.7	1.3	2.0	2.2	6.1	1.3	2.4	3.9	0.9	1.0	0.9	0.9	0.5	1.8	1.5	0.7	2.8	6.2	2.2	3.3	3.2	0.4	3.0	1.0	2.3	3.0	0.6	0.7	2.1	2.0	0.9	2.8	6.0	2.5	2.5	4.2	1.9	0.5	2.0	10.4	0.6	3.3	2.6	0.8	1.4	0.8	4.4	3.5	4.9	3.7	0.8	1.4	0.1	0.9	1.8	1.1	0.9	1.2	10.0	2.2	1.8	1.0	9.4	1.1	1.8	5.3	0.8	0.6	4.4	1.6	1.0	6.3	13.3	3.0	9.7	8.2	7.8	6.2	9.8	12.5	7.9
CCDC3	DKFZp761F241	ENSG00000151468	"Coiled-coil domain containing 3"	Q9BQI4	10	12896625-13099652	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 89.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.7;HAP1: 13.7;HDLM-2: 22.5;U-2 OS: 14.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA062425			Approved	Nucleoplasm,Cytosol	"Secreted to blood"			Nucleoplasm	Cytosol	"HPA062425: "	"unprognostic (2.26e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.56e-3)"	"unprognostic (5.41e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (1.38e-5)"	"unprognostic (1.54e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.88e-2)"	37.1	5.0	14.0	2.5	9.0	0.2	33.6	4.9	15.0	23.0	4.2	2.9	3.4	2.9	16.2	18.6	26.9	21.8	89.3	11.0	8.0	3.0	4.2	8.5	8.0	12.3	4.3	8.7	39.1	2.9	3.8	4.2	9.6	3.2	14.3	3.4	8.8	2.8	10.3	12.0	55.7	5.5	11.8	3.4	9.8	5.8	11.0	3.1	10.4	8.3	9.6	2.0	12.4	14.2	0.1	0.0	0.0	0.0	0.0	0.9	1.0	0.0	0.2	1.2	6.7	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.5	0.0	1.3	13.7	2.5	0.4	22.5	5.8	0.0	0.2	0.0	0.5	0.0	0.0	1.7	1.7	0.3	0.0	0.7	0.0	0.1	0.7	0.1	0.0	3.8	1.1	0.0	0.0	3.0	0.2	0.0	0.0	2.6	1.1	4.9	0.7	0.0	0.0	0.0	0.0	0.0	14.9	0.8	0.2	0.0	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	14.0	9.0	4.9	15.0	8.0	3.0	4.3	8.7	3.2	3.1
CCDC30	"FLJ20972, LOC728621, PFD6L"	ENSG00000186409	"Coiled-coil domain containing 30"	Q5VVM6	1	42463330-42654664	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 27.1"	"Cell line enriched"	"Detected in single"	18	"HMC-1: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"											"HPA036344, HPA036345"	Approved									"HPA036344: AB_10795572, HPA036345: AB_10796213"	"unprognostic (3.21e-2)"	"unprognostic (8.48e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.72e-3)"	"unprognostic (6.77e-3)"	"unprognostic (7.68e-3)"	"unprognostic (4.61e-3)"	"unprognostic (1.41e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.70e-3)"	"unprognostic (6.95e-3)"	1.4	1.7	5.5	1.2	11.1	1.1	2.5	4.1	7.9	3.2	1.4	1.9	9.2	1.1	2.1	14.3	1.1	8.0	1.9	1.2	4.9	3.7	5.5	1.2	6.5	1.1	2.2	6.0	3.2	2.1	6.8	27.1	1.4	13.7	2.3	1.1	1.7	1.5	9.5	1.1	1.3	1.3	1.3	2.0	1.8	1.2	12.4	2.2	0.0	5.3	0.0	1.2	1.4	1.4	0.6	0.5	2.9	0.3	0.4	0.8	0.2	0.2	0.1	0.4	0.4	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	16.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.8	0.0	0.4	0.2	0.0	0.1	0.1	0.2	0.8	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.2	0.2	0.3	2.9	0.3	0.9	0.4	0.1	0.4	0.4	0.3	0.1	0.4	0.6	0.8	0.4	1.6	0.4	0.2	0.5	0.6	0.2	5.5	11.1	4.1	7.9	4.9	3.7	2.2	6.0	13.7	2.2
CCDC39		ENSG00000284862	"Coiled-coil domain containing 39"	Q9UFE4	3	180602858-180679500	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.3"	"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA035363, HPA035364"	Enhanced									"HPA035363: AB_2674588, HPA035364: AB_10601095"																		0.0	1.7	1.1	3.6	7.5	1.8	0.0	0.3	2.9	0.6	0.1	3.3	0.0	3.1	2.0	10.4	1.2	5.8	3.4	1.4	1.7		0.1	0.0	5.7	10.3	0.0	1.3	4.6	0.3	0.0	6.4	0.0	23.3	0.7	0.0	1.4	1.6	0.0	0.2	10.7	2.7	0.0	0.2	4.2	1.6	12.4	1.1	0.0	3.5	0.0	0.0	1.9	0.0	1.2	0.6	0.0	0.2	0.7	1.5	0.3	3.9	2.6	8.4	2.2	0.0	0.0	2.7	1.9	0.0	0.0	0.0	3.1	3.7	10.5	3.5	0.0	3.5	0.1	0.0	0.0	5.8	5.1	5.0	6.8	6.7	0.0	8.0	5.0	0.0	0.0	0.0	0.0	0.0	3.5	0.7	0.3	1.0	4.1	0.1	5.1	5.2	5.5	2.7	13.3	0.0	5.6	4.0	4.5	2.3	2.3	1.5	5.8	5.3	6.3	6.9	3.0	2.2	6.5	6.7	4.6	11.0	4.4	7.6	1.4	0.0	0.2	0.0	0.8	0.1	1.5	1.2	0.4	0.0	0.2	0.3	1.1	0.3	0.0	0.7	0.2	0.6	1.1	0.3										
CCDC40	"CILD15, FAP172, FLJ20753, FLJ32021, KIAA1640"	ENSG00000141519	"Coiled-coil domain containing 40"	Q4G0X9	17	80036632-80100613	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 24.3;testis: 29.5"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 13.8;SH-SY5Y: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022974	Enhanced		Approved	Microtubules				Microtubules		"HPA022974: AB_1848791"	"unprognostic (5.89e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.76e-3)"	"prognostic favourable (2.95e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.04e-5)"	"unprognostic (7.38e-2)"	"prognostic unfavourable (2.45e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.91e-3)"	"unprognostic (4.26e-2)"	3.4	3.6	3.0	3.0	10.4	1.0	3.6	2.5	5.1	3.2	2.4	10.2	2.3	1.3	4.5	10.1	1.5	24.3	3.8	3.8	6.2	4.8	5.5	2.3	5.5	1.5	3.3	3.1	4.5	3.2	3.6	10.2	1.4	19.4	4.4	1.3	4.8	2.5	4.1	2.6	2.2	2.6	2.8	3.5	2.3	3.2	29.5	5.0	0.0	6.0	1.2	1.2	2.0	1.4	0.9	0.5	2.5	0.4	0.7	1.1	0.1	2.3	7.8	7.0	7.8	0.9	1.1	1.9	2.2	1.6	2.0	2.1	0.8	3.3	0.3	1.1	1.6	0.7	1.8	1.7	0.5	0.1	1.4	0.1	3.8	3.8	1.7	0.2	2.5	1.8	2.4	2.4	0.2	1.1	0.9	0.0	1.6	2.7	0.1	0.5	3.3	2.6	2.0	3.9	0.0	4.0	1.6	13.8	10.0	3.4	1.7	1.6	3.2	0.2	1.3	4.4	2.7	2.8	0.5	2.3	0.7	0.3	1.0	0.2	2.1	1.7	0.4	0.4	0.5	0.2	1.1	0.5	0.3	0.2	0.0	0.9	0.5	0.4	2.5	0.7	0.2	0.5	0.1	0.1	3.0	10.4	2.5	5.1	6.2	4.8	3.3	3.1	19.4	5.0
CCDC63	"FLJ35843, ODA5"	ENSG00000173093	"Coiled-coil domain containing 63"	Q8NA47	12	110846769-110907535	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 26.2"	"Cell line enriched"	"Detected in single"	18	"MCF7: 9.7"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"cerebellum: 10.3"	"Not detected"	"Not detected"			HPA061568			Approved	"Nucleoplasm,Nuclear bodies,Vesicles"				"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA061568: "					"unprognostic (1.98e-2)"	"unprognostic (1.05e-1)"		"unprognostic (1.17e-1)"	"unprognostic (2.65e-1)"					"unprognostic (5.59e-2)"	"unprognostic (1.09e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC7	"BIOT2, C10orf68, FLJ13031, FLJ32762"	ENSG00000216937	"Coiled-coil domain containing 7"	Q96M83	10	32446140-32882874	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 65.5"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA075536			Approved	"Nucleoli,Mitotic spindle,Cytosol"				Nucleoli	"Mitotic spindle, Cytosol"	"HPA075536: "	"unprognostic (3.43e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.65e-5)"	"unprognostic (6.95e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.95e-5)"	"unprognostic (7.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	2.1	2.1	3.2	3.8	3.6	2.8	2.2	4.8	3.6	2.3	2.1	4.2	4.3	2.0	3.4	5.1	2.0	1.7	1.9	2.3	2.6	1.9	1.9	1.7	2.0	2.8	4.2	1.5	2.7	2.3	2.1	8.5	1.8	3.0	2.1	2.3	1.8	2.0	3.2	2.0	2.0	1.8	2.1	5.4	2.0	2.0	65.5	3.2	3.4	2.7	0.3	2.2	2.3	2.3	2.4	1.7	0.1	0.6	2.9	5.9	0.5	2.5	2.8	0.8	3.5	2.4	1.9	1.3	2.3	0.8	0.8	2.5	0.6	3.8	1.9	1.2	1.6	1.3	1.3	1.4	3.1	6.6	0.3	1.0	2.0	0.7	4.3	1.0	1.9	1.7	0.7	1.7	0.6	1.0	1.5	6.5	3.2	0.4	0.8	0.6	0.7	2.8	1.6	3.6	0.3	2.3	0.5	1.9	1.9	0.4	0.4	1.5	1.9	1.5	3.8	2.0	2.3	2.6	1.3	2.1	1.4	1.9	2.5	7.3	1.1	0.0	0.6	0.1	3.4	0.3	3.3	2.4	5.3	2.9	0.3	1.2	5.9	3.9	0.1	2.9	0.3	1.7	3.5	0.5	3.2	3.6	4.8	3.6	2.6	1.9	4.2	1.5	3.0	3.2
CCDC73	NY-SAR-79	ENSG00000186714	"Coiled-coil domain containing 73"	Q6ZRK6	11	32602246-32794658	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 13.7"	"Cell line enhanced"	"Detected in some"		"BJ: 2.7;MOLT-4: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.3;naive B-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA038668, HPA038669"	Uncertain									"HPA038668: AB_10673292, HPA038669: "	"unprognostic (9.41e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.36e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.73e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.62e-5)"	"unprognostic (3.87e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.20e-3)"	0.2	0.6	0.2	0.2	0.2	0.7	0.2	0.8	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.5	0.4	1.0	0.2	0.4	0.2	0.2	1.7	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	1.1	0.0	13.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2	0.5	1.3	0.0	0.0	0.2	0.1	0.0	0.5	0.5	0.0	0.0	0.4	2.7	0.0	0.0	0.1	0.1	0.4	0.5	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.3	0.9	0.1	0.0	0.9	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.3	5.7	1.2	0.4	0.5	0.2	0.4	0.2	0.0	0.7	0.3	0.4	0.2	0.3	0.0	0.2	0.2	0.0	0.4	0.3	0.4	1.3	1.6	0.4	0.4	0.2	0.8	0.1	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.2	0.2	0.2	0.8	0.4	0.2	0.5	0.2	0.2	0.2	0.2
CCDC74A	FLJ40345	ENSG00000163040	"Coiled-coil domain containing 74A"	Q96AQ1	2	131527675-131533666	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.1;testis: 41.2"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 19.0;SCLC-21H: 15.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 3.3"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 3.3"									HPA060727			Uncertain	Vesicles				Vesicles		"HPA060727: "	"prognostic favourable (5.11e-4)"	"unprognostic (2.89e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (2.33e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (1.70e-7)"	"unprognostic (7.28e-3)"	"prognostic favourable (4.92e-4)"	"unprognostic (5.96e-2)"	"unprognostic (3.53e-2)"	1.3	12.8	5.8	2.7	6.5	0.2	6.8	1.1	4.4	5.6	1.9	3.2	4.7	0.9	7.1	7.1	1.9	26.1	5.1	2.2	5.1	6.8	3.0	0.5	3.0	0.9	2.2	4.1	7.1	1.5	13.3	14.1	0.9	13.6	5.2	1.3	2.4	1.8	5.1	0.9	3.5	0.8	5.9	3.0	1.0	1.0	41.2	1.9	2.2	2.6	0.9	1.2	4.5	2.7	0.0	3.3	0.0	0.1	0.0	0.8	0.2	0.0	3.9	4.0	0.2	5.7	13.9	0.3	3.3	5.6	3.1	2.3	0.1	5.9	1.5	2.1	5.1	3.0	1.7	1.0	1.2	3.9	7.4	0.0	3.7	0.1	0.7	0.1	0.3	4.5	0.4	3.0	0.0	1.2	2.1	4.3	2.7	2.4	8.4	2.3	19.0	2.5	4.0	0.0	1.7	7.8	0.0	15.6	11.4	0.4	0.5	0.5	5.4	0.8	1.2	0.9	2.9	12.0	2.5	0.9	0.7	0.5	12.9	0.3	5.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.4	3.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	5.8	6.5	1.1	4.4	5.1	6.8	2.2	4.1	13.6	1.9
CCDC74B	DKFZp434E2321	ENSG00000152076	"Coiled-coil domain containing 74B"	Q96LY2	2	130139287-130145134	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 12.4;testis: 22.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 10.4;SH-SY5Y: 14.8"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060727			Uncertain	Vesicles				Vesicles		"HPA060727: "	"prognostic favourable (4.46e-4)"	"unprognostic (4.75e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.76e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.69e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.43e-3)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.48e-4)"	"unprognostic (8.31e-3)"	"unprognostic (9.94e-3)"	0.0	1.4	2.8	0.1	2.4	0.0	0.4	0.0	2.2	8.3	0.1			0.0	3.5	0.6	0.1	12.4	1.1	0.1	3.0	4.0	1.0	0.0	1.0	0.1	0.9		2.1	0.2	7.5	7.7	0.0		2.7	0.0		0.2	2.5	0.0	0.1	0.0	1.0	1.4	0.0	0.0	22.7			3.7		0.0	0.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	1.8	2.8	0.1	2.6	5.7	0.6	2.2	1.1	0.3	0.5	0.8	0.7	0.0	3.6	2.0	1.0	0.2	0.3	0.4	1.9	5.4	0.0	6.7	0.1	0.3	0.1	0.2	1.2	0.0	0.9	0.0	0.1	0.1	1.7	0.8	2.0	0.0	0.0	5.8	5.8	4.4	0.0	3.1	1.7	0.0	10.4	14.8	1.6	0.1	0.2	5.9	0.6	0.4	1.1	4.9	5.9	0.5	0.1	0.2	0.0	6.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5										
CCDC83	"CT148, FLJ42119, MGC34732"	ENSG00000150676	"Coiled-coil domain containing 83"	Q8IWF9	11	85855101-85920021	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 27.7"	"Cell line enriched"	"Detected in single"	10	"MCF7: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039707, HPA039882"			Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA039707: AB_10795259, HPA039882: AB_10795410"	"unprognostic (1.14e-1)"				"unprognostic (4.09e-1)"					"unprognostic (1.49e-2)"		"unprognostic (4.43e-2)"	"unprognostic (7.05e-6)"	"unprognostic (3.52e-1)"			"unprognostic (2.17e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.0	1.8	0.8	0.3	0.6	0.0	0.1	0.0	0.5	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.1	0.7	0.3	0.3	0.2	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.1	0.3	7.7	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.6	0.3	0.1	0.1	0.1	0.5	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.2	0.1	0.3	0.8	0.6	0.3	0.6	0.4	0.4	0.3	0.3	0.3	0.3	0.4	0.3	0.5	1.8	0.3	0.8	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC85A	KIAA1912	ENSG00000055813	"Coiled-coil domain containing 85A"	Q96PX6	2	56184123-56386173	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 22.2;fHDF/TERT166: 36.4;U-266/70: 16.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"B-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043106, HPA057020"	Uncertain				"Intracellular and membrane"					"HPA043106: AB_10794770, HPA057020: "	"unprognostic (2.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.87e-2)"	"unprognostic (3.66e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.62e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.55e-5)"	"unprognostic (3.28e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.83e-2)"	16.0	1.4	10.5	1.3	7.5	0.4	7.8	3.4	18.8	4.2	1.6	4.9	3.0	0.9	9.3	1.6	1.4	3.5	2.1	6.5	7.9	8.5	1.9	0.7	8.1	1.1	6.6	10.2	1.2	1.4	3.0	1.0	14.4	8.8	3.4	1.4	1.0	1.9	4.5	7.2	2.7	1.3	7.3	10.6	1.4	1.3	1.0	5.2	0.0	13.5	2.2	1.3	1.8	3.9	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.2	0.4	0.0	5.6	0.5	4.9	0.5	0.0	0.0	22.2	0.8	36.4	0.9	0.0	0.0	2.8	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	1.7	0.1	0.0	0.6	4.8	0.0	3.0	0.6	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.1	0.0	0.0	2.6	0.0	7.4	4.0	1.1	0.0	0.4	16.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	7.5	3.4	18.8	7.9	8.5	6.6	10.2	8.8	5.2
CCDC89	FLJ38159	ENSG00000179071	"Coiled-coil domain containing 89"	Q8N998	11	85684866-85686277	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 40.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 5.4;LHCN-M2: 6.2;SCLC-21H: 7.3;U-2197: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040628	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA040628: AB_2677053"	"unprognostic (5.81e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.16e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.41e-3)"	"unprognostic (7.75e-3)"	"unprognostic (5.10e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.52e-1)"	0.7	0.9	0.9	0.1	1.8	0.0	1.3	6.4	1.3	1.5	0.6	2.0	0.9	0.1	2.8	0.9	0.3	10.5	1.1	1.0	1.2	1.2	1.4	0.3	1.2	0.6	0.9	1.2	5.9	0.2	2.7	5.2	0.7	3.7	1.7	0.7	0.9	0.4	1.9	0.7	0.5	0.5	2.6	1.2	0.4	1.1	40.6	0.9	0.1	0.4	0.2	0.0	0.7	0.7	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.1	0.0	0.1	3.7	5.0	0.2	1.4	0.0	0.0	0.1	0.2	0.0	0.1	5.4	4.2	1.9	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.3	2.5	0.0	0.0	2.8	0.1	4.0	0.0	0.0	0.0	0.0	6.2	0.3	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.3	2.8	7.3	1.8	0.0	0.9	0.0	0.6	0.0	0.0	3.7	0.0	8.3	3.4	0.0	3.7	0.0	3.2	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	6.4	1.3	1.2	1.2	0.9	1.2	3.7	0.9
CCDC96	FLJ90575	ENSG00000173013	"Coiled-coil domain containing 96"	Q2M329	4	7040849-7042939	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 52.9"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA047546	Enhanced									"HPA047546: "	"unprognostic (6.20e-3)"	"unprognostic (4.03e-2)"	"unprognostic (7.95e-2)"	"prognostic favourable (4.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.77e-1)"	"unprognostic (9.24e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.92e-1)"	"prognostic favourable (4.87e-4)"	"unprognostic (1.43e-1)"	"prognostic favourable (3.80e-5)"	"unprognostic (4.37e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-2)"	0.8	1.4	1.7	0.5	3.9	1.1	1.2	1.1	2.6	0.8	0.6	2.4	0.6	0.9	0.9	3.3	0.8	10.5	1.0	0.5	2.4	2.7	1.2	0.5	1.7	0.7	1.5	2.4	3.0	1.3	1.1	3.0	0.5	4.0	0.9	0.6	0.8	0.9	1.2	0.6	1.6	0.6	0.7	1.2	0.8	1.0	52.9	1.5	0.0	1.5	0.5	0.6	0.6	1.0	0.6	1.6	0.5	3.8	0.4	1.6	0.6	1.6	4.6	2.5	2.0	3.3	2.3	0.5	4.7	2.8	5.2	3.2	1.6	4.1	1.0	1.3	2.6	2.1	0.9	2.1	1.6	0.1	0.7	1.0	2.1	1.1	1.6	1.3	2.6	2.0	2.2	3.2	0.4	2.1	0.7	0.4	3.3	4.0	2.7	1.7	1.0	2.8	1.1	1.7	0.3	9.2	1.7	6.8	1.5	3.7	1.7	0.8	1.8	2.4	2.3	4.4	1.2	2.7	3.5	0.0	0.1	0.9	3.5	0.1	1.4	0.0	1.6	0.0	0.3	3.8	0.7	0.6	0.4	0.0	1.6	0.0	0.3	1.6	0.5	0.4	2.9	0.0	0.0	0.6	1.7	3.9	1.1	2.6	2.4	2.7	1.5	2.4	4.0	1.5
CCER2		ENSG00000262484	"Coiled-coil glutamate rich protein 2"	I3L3R5	19	38908980-38912158	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.5;skin 1: 9.9"	"Cell line enhanced"	"Detected in some"		"A549: 4.0;THP-1: 4.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA069716	Uncertain				"Secreted - unknown location"					"HPA069716: "	"unprognostic (6.58e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.01e-9)"	"unprognostic (1.75e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.61e-1)"	"prognostic favourable (2.32e-4)"	0.9	1.0	2.7	1.1	5.1	2.4	1.6	4.7	4.6	1.2	0.9	2.7	0.4	1.3	1.5	1.6	3.9	1.0	0.6	0.6	3.1	2.4	0.9	2.1	0.9	1.5	2.5	0.4	1.0	0.6	1.4	2.6	0.7	9.5	1.1	0.9	1.4	1.1	1.2	4.4	9.9	1.4	0.8	3.5	1.2	1.1	4.0	1.4	0.4	0.8	0.4	0.8	0.4	0.4	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.3	4.0	1.0	0.4	0.7	0.2	0.8	0.0	0.0	0.1	0.2	0.3	1.5	2.8	0.3	0.2	0.4	0.6	0.1	0.0	1.1	1.3	0.2	0.8	0.0	0.0	1.6	1.6	0.4	0.7	0.3	0.0	0.0	0.7	2.7	0.0	2.6	0.6	1.2	0.9	0.5	2.0	0.4	0.7	0.3	1.9	1.2	0.8	0.5	0.5	0.0	3.0	4.0	0.0	0.2	2.0	0.1	0.1	1.8	1.3	0.7	0.3	2.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	2.7	5.1	4.7	4.6	3.1	2.4	2.5	0.4	9.5	1.4
CCM2L	"C20orf160, dJ310O13.5"	ENSG00000101331	"CCM2 like scaffolding protein"	Q9NUG4	20	32010450-32032180	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 53.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 10.4;HUVEC TERT2: 12.2;NTERA-2: 6.6;RH-30: 4.6;SCLC-21H: 11.3;TIME: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA008434, HPA071063"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA008434: AB_1845671, HPA071063: "	"unprognostic (1.71e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	7.2	1.8	2.1	1.8	2.0	0.2	15.0	2.1	2.2	4.4	1.4	1.7	2.1	1.2	7.1	2.3	1.9	2.6	2.4	5.4	2.0	1.7	3.1	1.0	15.1	1.3	2.3	1.5	1.8	1.0	1.4	1.4	6.7	2.5	1.9	1.2	4.9	1.4	2.0	3.5	1.5	1.6	3.2	1.4	53.0	1.4	1.6	1.6	0.2	3.0	5.2	1.0	2.0	4.6	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	3.5	0.0	0.0	6.6	0.0	0.8	4.6	0.2	0.0	0.0	11.3	1.3	0.3	0.0	0.0	3.6	0.0	6.2	0.1	2.0	0.0	0.0	0.2	0.0	0.2	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.1	2.0	2.1	2.2	2.0	1.7	2.3	1.5	2.5	1.6
CCNG2		ENSG00000138764	"Cyclin G2"	Q16589	4	77157151-77433388	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 16.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 99.1"	HPA034684	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA034684: AB_10669894"	"unprognostic (2.58e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.73e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavourable (8.57e-4)"	"unprognostic (2.04e-1)"	"prognostic favourable (2.47e-5)"	"unprognostic (7.98e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.05e-3)"	18.4	8.1	11.3	13.5	15.1	25.9	26.7	53.0	17.2	15.1	12.3	8.9	9.6	8.6	16.4	10.7	45.2	8.0	10.4	6.3	9.6	5.4	23.0	3.4	12.8	21.4	7.3	10.6	12.5	7.2	8.8	7.7	20.0	7.3	26.1	11.0	12.2	18.4	10.5	7.5	12.8	9.8	13.5	7.4	14.2	7.7	8.0	7.8	25.3	17.3	7.2	22.6	20.3	18.6	4.8	2.2	16.0	2.3	1.6	4.6	0.6	10.2	1.3	23.1	12.2	15.3	19.7	15.7	8.6	24.9	6.7	12.6	1.5	14.9	20.7	14.0	8.0	7.4	6.0	28.5	13.1	14.3	4.0	1.7	6.0	3.0	8.0	3.0	21.6	16.6	14.2	3.1	7.0	10.1	0.9	12.7	12.4	4.0	14.0	6.5	2.3	1.4	8.1	22.5	1.3	42.5	28.5	6.1	19.6	10.2	16.2	6.0	12.0	4.6	9.3	9.2	9.4	6.6	1.4	9.3	7.1	14.6	6.4	4.8	4.6	11.4	1.5	16.0	0.8	2.0	1.9	2.7	1.2	0.8	1.5	4.8	0.9	0.5	6.5	1.6	2.3	2.2	4.6	0.6	11.3	15.1	53.0	17.2	9.6	5.4	7.3	10.6	7.3	7.8
CCNI2	FLJ16793	ENSG00000205089	"Cyclin I family member 2"	Q6ZMN8	5	132747445-132754403	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 17.4;seminal vesicle: 15.7"	"Cell line enriched"	"Detected in some"	6	"MOLT-4: 23.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA056288	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA056288: "	"unprognostic (3.84e-2)"	"unprognostic (2.44e-3)"	"prognostic favourable (8.21e-4)"	"unprognostic (5.97e-2)"	"unprognostic (3.39e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.71e-7)"	"unprognostic (1.58e-1)"	0.3	0.7	3.4	5.6	3.5	0.3	0.3	8.4	4.7	1.2	5.8	3.5	17.4	7.8	0.2	0.7	0.5	0.8	5.2	0.6	3.9	2.6	3.8	0.3	0.7	1.7	3.9	0.5	0.3	7.4	0.4	0.9	0.5	4.1	1.7	6.5	1.5	8.4	15.7	0.7	0.7	8.9	0.4	7.2	0.8	5.5	1.4	3.9	7.0	0.8	0.7	2.1	2.4	0.3	0.3	0.1	0.7	0.1	0.2	2.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	23.7	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	1.0	0.2	0.3	0.0	0.0	0.0	0.0	1.7	3.6	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.3	0.1	2.7	0.3	2.1	2.1	0.0	0.3	1.8	0.9	0.3	0.2	0.1	0.1	2.7	0.3	3.4	3.5	8.4	2.8	3.9	2.6	3.9	0.5	4.1	3.9
CCNJ	"bA690P14.1, FLJ10895"	ENSG00000107443	"Cyclin J"	Q5T5M9	10	96043394-96060870	"Predicted intracellular proteins"		Cyclin		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036531, HPA058151"	Approved		Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA036531: AB_10696656, HPA058151: "	"unprognostic (1.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.65e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.77e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.08e-2)"	7.1	10.5	5.0	8.9	9.2	18.1	7.7	11.4	8.2	6.9	8.6	6.4	9.3	8.1	10.8	8.3	6.7	8.7	8.0	5.3	4.9	5.5	11.4	6.4	8.2	8.2	5.0	3.7	8.7	9.3	11.3	11.0	7.4	6.6	7.1	7.1	9.2	7.6	7.3	7.3	5.3	11.7	7.7	5.0	13.4	7.4	9.9	5.7	16.3	7.2	5.8	8.3	6.8	5.0	1.9	6.9	1.1	4.0	1.2	3.1	2.1	5.0	4.1	25.1	24.9	2.5	2.0	3.6	3.2	3.8	4.9	4.4	10.4	2.2	7.0	3.7	3.1	3.1	16.6	3.5	6.3	3.4	6.7	6.8	3.0	14.7	6.0	6.8	3.3	3.8	4.7	4.5	10.8	11.2	9.9	0.1	2.9	4.9	11.5	7.7	13.9	3.4	13.8	1.1	0.5	5.5	4.8	3.8	13.3	3.7	0.9	6.9	5.8	7.5	5.6	3.1	6.7	3.4	7.5	1.4	0.5	6.5	3.5	12.0	2.0	0.3	4.0	1.1	2.3	3.3	3.1	1.8	2.0	1.2	6.9	1.9	2.9	2.6	0.5	1.2	3.2	1.4	1.5	2.1	5.0	9.2	11.4	8.2	4.9	5.5	5.0	3.7	6.6	5.7
CCNJL	FLJ14166	ENSG00000135083	"Cyclin J like"	Q8IV13	5	160249106-160345396	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 48.9"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 26.3;WM-115: 19.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	19	"cerebellum: 48.9"	"Group enriched"	"Detected in some"	19	"neutrophil: 13.5;NK-cell: 4.1"	"Group enriched"	"Detected in many"	35	"granulocytes: 13.5;NK-cells: 4.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049970	Approved		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA049970: "	"unprognostic (1.09e-2)"	"unprognostic (2.36e-2)"	"prognostic favourable (7.31e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.60e-4)"	"unprognostic (1.26e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-3)"	"unprognostic (6.63e-3)"	"unprognostic (2.62e-1)"	"prognostic favourable (7.10e-4)"	"prognostic favourable (8.02e-4)"	1.0	3.0	0.9	3.4	1.2	1.3	2.1	48.9	1.5	2.1	9.0	0.9	1.5	1.8	1.1	1.5	0.8	1.0	1.0	4.4	2.5	0.8	2.7	1.2	9.0	2.5	1.5	1.1	5.3	0.2	0.0	17.0	1.7	2.1	2.0	7.9	3.9	7.6	2.0	0.6	0.4	2.7	1.0	0.9	5.8	4.4	10.7	1.2	4.8	8.4	1.7	2.6	4.0	5.4	0.1	0.2	13.5	0.0	4.1	0.0	0.2	3.0	11.0	9.0	0.1	0.0	0.0	0.0	0.0	0.1	1.0	0.4	4.8	8.7	0.0	8.6	0.1	3.7	1.2	26.3	0.7	0.0	0.2	4.7	3.9	3.5	0.1	0.0	1.0	0.0	2.3	1.5	6.6	6.7	0.0	0.0	2.9	1.5	0.0	7.7	8.4	6.2	1.7	3.0	1.0	7.0	14.0	3.0	8.2	1.4	2.2	10.0	5.0	0.5	8.1	1.6	10.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	19.9	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	13.5	4.1	0.0	0.2	0.0	0.2	0.9	1.2	48.9	1.5	2.5	0.8	1.5	1.1	2.1	1.2
CCR7	"BLR2, CD197, CDw197, CMKBR7, EBI1"	ENSG00000126353	"C-C motif chemokine receptor 7"	P32248	17	40553769-40565472	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"blood: 252.3;lymphoid tissue: 110.6"	"Cell line enriched"	"Detected in some"	79	"HDLM-2: 171.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 252.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 252.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003796, HPA031383, HPA074467"	Enhanced		Approved	Mitochondria				Mitochondria		"CAB003796: AB_562261, HPA031383: , HPA074467: "	"prognostic favourable (3.84e-4)"	"prognostic favourable (8.03e-6)"	"unprognostic (2.26e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.35e-3)"	"prognostic favourable (7.61e-7)"	"unprognostic (2.71e-4)"	"unprognostic (2.58e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.68e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.12e-1)"	"prognostic unfavourable (7.72e-4)"	"unprognostic (1.02e-1)"	"unprognostic (7.95e-2)"	2.8	0.4	0.2	26.0	0.2	5.2	1.7	0.2	0.3	2.2	1.2	0.3	0.8	0.3	1.2	0.5	1.4	2.3	2.0	1.9	0.2	0.2	1.5	1.7	3.4	110.6	0.3	0.2	1.5	0.3	0.0	1.0	1.0	0.4	1.3	2.1	0.7	8.4	0.2	0.2	1.1	16.2	0.2	0.4	20.3	1.8	1.2	0.3	57.1	2.0	1.2	53.8	4.2	1.3	58.8	2.9	2.3	0.3	44.1	252.3	109.3	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	171.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.9	0.1	1.1	0.2	0.0	0.0	1.1	0.3	0.2	3.1	0.1	3.6	37.2	53.3	15.3	0.2	58.8	252.3	133.9	2.3	44.1	0.2	2.9	30.3	109.3	0.2	0.2	0.2	0.3	0.2	0.2	0.3	0.2	0.4	0.3
CCSER1	"FAM190A, KIAA1680"	ENSG00000184305	"Coiled-coil serine rich protein 1"	Q9C0I3	4	90127535-91601913	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.5;RT4: 3.7;SCLC-21H: 3.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.0;myeloid DC: 1.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041880, HPA054709"	Uncertain									"HPA041880: AB_10796461, HPA054709: AB_2682581"	"unprognostic (4.03e-4)"	"unprognostic (4.21e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.32e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.61e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.42e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.64e-4)"	"unprognostic (6.94e-2)"	2.9	6.4	2.4	1.9	5.2	3.4	4.5	17.0	7.6	2.2	3.4	0.0	6.3	2.0	2.1	2.1	2.1	4.1	1.9	4.7	7.4	1.9	5.6	1.7	2.1	2.3	1.8	7.6	1.9	3.3	1.7	10.4	1.4	2.1	3.0	1.8	2.9	5.0	7.1	1.7	3.0	6.4	1.7	2.5	2.7	2.6	11.4	0.5	0.0	4.6	0.0	2.6	4.9	5.9	1.0	1.0	0.0	0.1	0.3	0.1	0.0	0.2	0.2	0.2	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.1	0.0	0.2	0.3	0.0	0.0	4.5	0.3	1.2	0.9	0.1	0.0	1.6	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.1	0.2	0.4	0.8	0.1	0.0	0.3	0.3	3.7	3.9	1.5	0.0	1.2	0.0	0.8	0.0	0.4	0.0	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	1.0	0.9	0.1	0.1	0.0	0.3	0.0	0.3	0.0	0.0	2.4	5.2	17.0	7.6	7.4	1.9	1.8	7.6	2.1	0.5
CD300C	"CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR"	ENSG00000167850	"CD300c molecule"	Q08708	17	74541108-74546143	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 46.8"	"Cell line enhanced"	"Detected in some"		"HEL: 5.2;HMC-1: 25.6;THP-1: 4.8;U-937: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 28.6;intermediate monocyte: 46.8;myeloid DC: 32.5;non-classical monocyte: 46.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 32.5;monocytes: 46.8"									"HPA014523, HPA060349"	Approved		Uncertain	"Golgi apparatus,Vesicles,Mitochondria"				"Golgi apparatus"	"Vesicles, Mitochondria"	"HPA014523: AB_1846293, HPA060349: "	"unprognostic (1.55e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.99e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.37e-3)"	"unprognostic (6.27e-2)"	"prognostic unfavourable (8.53e-5)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	9.8	2.8	3.6	9.0	4.6	10.9	1.8	0.4	2.9	1.2	1.7	2.9	0.0	1.5	1.4	1.9	1.0	1.9	2.8	3.4	2.0	1.7	1.9	2.1	11.2	12.3	5.3	1.3	1.1	1.3	0.5	1.2	3.8	3.9	1.9	1.8	1.8	1.8	0.7	1.1	0.9	2.3	4.1	7.1	14.2	1.6	0.9	2.7	0.1	1.6	0.1	1.4	3.5	1.1	0.4	32.5	8.4	46.8	8.6	0.1	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	2.4	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.7	12.1	0.0	8.4	28.6	1.4	0.1	46.8	0.1	0.4	0.0	0.0	32.5	0.3	0.0	0.0	1.0	8.6	46.4	2.1	0.0	10.7	3.6	4.6	0.4	2.9	2.0	1.7	5.3	1.3	3.9	2.7
CDADC1	NYD-SP15	ENSG00000102543	"Cytidine and dCMP deaminase domain containing 1"	Q9BWV3	13	49247925-49293485	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047615, HPA058314"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA047615: , HPA058314: "	"unprognostic (2.81e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.58e-3)"	"prognostic favourable (6.03e-4)"	"unprognostic (7.68e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.89e-1)"	"prognostic favourable (1.19e-5)"	"unprognostic (3.35e-2)"	"unprognostic (5.92e-3)"	"unprognostic (5.40e-2)"	"unprognostic (8.27e-3)"	9.3	13.8	11.6	6.5	10.4	11.0	8.6	14.1	12.9	8.4	8.6	7.1	8.4	6.3	9.7	12.5	6.7	7.6	6.7	8.5	9.5	9.7	18.6	15.4	7.0	5.7	9.8	11.2	9.5	5.6	8.8	12.5	4.3	10.7	8.2	6.7	7.6	6.8	9.5	7.9	4.7	6.0	8.4	14.2	8.7	8.0	23.5	8.8	5.5	18.5	7.2	5.2	6.5	7.4	1.0	1.3	10.3	2.7	1.8	3.3	1.4	2.5	3.2	2.8	3.4	13.8	7.6	1.4	6.1	3.8	3.1	3.3	3.2	2.1	3.5	1.3	2.7	4.4	5.6	2.7	4.0	7.5	4.5	4.0	3.0	3.2	6.1	7.4	2.1	5.2	6.8	2.9	3.7	4.5	2.5	2.6	3.9	0.9	7.0	6.1	1.0	2.7	4.7	3.0	3.4	4.5	0.8	1.6	1.4	4.1	2.7	3.5	1.9	6.5	3.4	1.7	3.1	4.3	2.8	0.8	2.8	2.2	1.4	8.6	4.6	10.3	1.9	1.5	2.4	1.5	2.6	0.7	1.8	3.3	1.3	1.0	1.6	2.3	2.0	1.8	2.7	1.3	2.5	1.4	11.6	10.4	14.1	12.9	9.5	9.7	9.8	11.2	10.7	8.8
CDC42EP5	"Borg3, CEP5"	ENSG00000167617	"CDC42 effector protein 5"	Q6NZY7	19	54465026-54473264	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.7"	"Cell line enhanced"	"Detected in some"		"AF22: 1.5;ASC TERT1: 1.8;BEWO: 1.4;CACO-2: 2.6;HBEC3-KT: 1.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA043449	Approved									"HPA043449: AB_10961041"	"unprognostic (7.67e-2)"	"unprognostic (1.24e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.36e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.52e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.13e-2)"	"prognostic unfavourable (2.79e-5)"	"unprognostic (1.73e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.37e-3)"	"prognostic favourable (1.36e-4)"	11.0	1.8	0.0	9.6	0.1	1.8	8.1	0.0	1.8	12.9	32.7	0.4	2.7	1.8	6.1	4.5	7.3	4.1	7.2	7.2	0.0	0.0	4.2	1.8	9.4	10.4	0.7	0.0	5.9	3.8	1.8	1.1	5.8	0.4	17.0	1.8	4.4	9.8	2.9	4.7	2.7	29.4	6.3	0.9	4.8	6.1	7.9	0.0	4.4	2.8	5.3	6.5	17.7	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.8	1.4	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.7	0.0	0.4	0.0
CDCP2		ENSG00000157211	"CUB domain containing protein 2"	Q5VXM1	1	54132968-54153770	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.2"	"Cell line enhanced"	"Detected in single"		"CACO-2: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 0.4"	HPA031143	Uncertain				"Secreted - unknown location"					"HPA031143: AB_10611819"	"unprognostic (1.08e-1)"	"unprognostic (5.16e-2)"		"unprognostic (1.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.67e-2)"	"unprognostic (7.67e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.12e-1)"	"unprognostic (2.21e-2)"	0.5	0.3	0.1	0.1	0.5	0.3	0.9	0.1	0.6	1.1	0.2			0.0	0.1	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.1	0.4	0.3	0.0	0.0		0.1	0.0	0.0	0.0	0.0		0.1	0.0		0.2	0.5	0.0	0.6	0.3	0.2	0.0	2.2	0.2	0.1			0.6		0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.1	0.3	0.0	0.7	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CDH11	"CAD11, OB"	ENSG00000140937	"Cadherin 11"	P55287	16	64943753-65126112	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 71.0"	"Cell line enhanced"	"Detected in many"		"BJ: 47.1;fHDF/TERT166: 64.3;HSkMC: 44.3;PC-3: 55.3;U-2197: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013072	Enhanced						70000			"CAB013072: AB_2533068"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.93e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.30e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.75e-2)"	"prognostic unfavourable (2.48e-9)"	"unprognostic (1.43e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.07e-3)"	8.1	3.6	5.5	9.2	12.1	0.3	6.1	5.5	8.8	24.1	4.3	7.5	2.4	2.7	25.9	5.9	3.0	6.8	22.4	4.6	7.3	5.1	4.8	1.0	20.8	5.9	7.8	8.5	71.0	1.7	1.2	6.0	44.2	8.3	8.0	4.9	22.2	7.3	9.7	2.5	5.7	3.4	20.5	10.6	35.1	5.1	4.0	5.4	0.1	4.8	1.9	4.9	18.4	11.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.2	0.0	7.3	15.9	0.0	47.1	27.3	12.1	6.9	0.8	0.0	0.0	0.0	64.3	0.0	0.0	0.3	8.7	0.0	0.4	0.0	0.2	0.0	6.0	0.0	2.8	44.3	0.0	14.8	3.0	3.4	0.0	0.0	6.4	0.0	0.0	0.0	3.7	55.3	0.1	7.3	0.0	0.0	0.0	0.1	7.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	3.4	37.8	13.3	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	12.1	5.5	8.8	7.3	5.1	7.8	8.5	8.3	5.4
CDH12	"Br-cadherin, CDHB"	ENSG00000154162	"Cadherin 12"	P55289	5	21750673-22853622	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.7;cervix, uterine: 9.3;pituitary gland: 8.6"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.5;PC-3: 5.1;SCLC-21H: 7.4;U-2 OS: 3.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029325	Uncertain		Uncertain	Vesicles				Vesicles		"HPA029325: "	"unprognostic (2.38e-1)"	"unprognostic (3.21e-1)"		"unprognostic (4.95e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.31e-2)"		"unprognostic (3.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.25e-4)"	"unprognostic (7.35e-2)"	"unprognostic (3.48e-2)"		"unprognostic (5.19e-2)"	0.5	5.2	5.8	0.3	17.7	0.4	1.7	2.0	13.8	9.3	0.5	0.0	0.0	0.5	1.3	1.0	0.4	6.7	0.3	0.5	6.3	3.4	0.7	0.5	0.8	0.3	1.4	4.8	0.5	0.5	0.6	8.6	0.7	4.2	0.5	0.6	1.4	3.1	0.9	0.5	2.5	0.4	0.9	2.5	0.3	0.4	2.9	0.5	0.0	0.4	0.0	0.5	1.5	0.2	0.1	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.0	1.0	0.4	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.7	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.1	0.2	0.0	0.1	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.0	5.8	17.7	2.0	13.8	6.3	3.4	1.4	4.8	4.2	0.5
CDH16		ENSG00000166589	"Cadherin 16"	O75309	16	66908122-66918984	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 139.7"	"Cell line enriched"	"Detected in single"	96	"RPTEC TERT1: 69.3"	"Cancer enriched"	"Detected in many"	15	"renal cancer: 96.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB013526, HPA036260"	Enhanced									"CAB013526: , HPA036260: "		"unprognostic (1.07e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.96e-1)"		"unprognostic (9.81e-2)"	"unprognostic (4.24e-3)"	"unprognostic (5.81e-2)"	"unprognostic (5.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-2)"		"prognostic favourable (1.02e-7)"	"unprognostic (2.19e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.36e-3)"	"unprognostic (2.34e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.6	0.0	0.0	0.3	0.0	3.5	0.1	3.4	0.2	0.0	0.0	0.0	139.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.3	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDH17	"cadherin, HPT-1"	ENSG00000079112	"Cadherin 17"	Q12864	8	94127171-94217303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 184.4"	"Group enriched"	"Detected in some"	7	"CACO-2: 33.3;U-266/70: 55.3"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 156.4;stomach cancer: 54.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 12.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 12.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023614, HPA023616, CAB025143, HPA026556"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"			3400000	"Cell Junctions"	Nucleoplasm	"CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897"	"unprognostic (2.08e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.46e-2)"	0.3	0.2	0.2	17.6	0.3	0.3	0.3	0.2	0.2	0.3	88.9	0.2	0.2	54.5	0.4	0.3	0.4	0.4	7.0	0.6	0.2	0.3	0.3	0.3	0.3	0.5	0.2	0.2	0.3	0.4	0.0	0.3	0.2	0.2	0.4	44.0	0.2	0.3	0.2	0.3	0.2	184.4	1.4	0.2	0.6	0.3	0.3	0.2	0.3	0.2	0.2	0.5	0.4	0.3	1.5	0.8	12.1	1.0	1.4	0.6	0.1	0.1	6.1	0.3	0.4	0.0	0.1	0.5	0.1	0.1	0.0	0.1	33.3	1.5	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.5	0.1	0.6	0.2	0.1	0.1	1.7	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.4	0.2	0.5	0.2	0.2	0.4	0.1	1.0	0.1	0.1	0.6	0.4	0.2	0.2	0.2	0.3	0.3	0.2	0.3	0.3	0.5	0.2	55.3	0.1	0.1	0.1	0.2	0.3	2.5	1.0	1.2	0.5	0.8	0.3	0.6	0.5	0.4	0.8	1.5	0.5	0.6	12.1	1.4	0.5	0.7	0.5	0.1	0.2	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2
CDH18	"CDH14, EY-CADHERIN"	ENSG00000145526	"Cadherin 18"	Q13634	5	19472951-20575873	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 105.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.1;BEWO: 3.7;EFO-21: 6.3;U-2 OS: 9.9;U-2197: 8.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	7	"cerebellum: 105.4"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014416	Uncertain				"Intracellular and membrane"					"HPA014416: "	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"		"unprognostic (5.26e-7)"	"unprognostic (6.36e-2)"	"unprognostic (1.10e-1)"		"unprognostic (1.44e-2)"		"unprognostic (1.20e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.30e-2)"		"unprognostic (1.51e-2)"	"unprognostic (8.69e-2)"		"unprognostic (1.76e-2)"	0.7	9.3	6.9	0.7	7.1	0.7	0.6	105.4	23.2	1.0	0.6	0.0	0.0	0.7	0.6	0.6	0.7	0.7	0.7	0.6	4.6	8.1	0.9	0.6	0.7	0.8	1.8	8.3	0.7	1.2	2.1	11.3	0.6	7.1	0.8	0.7	2.2	0.6	0.8	0.9	0.8	0.7	0.6	2.2	0.7	0.6	3.7	1.3	0.0	0.6	0.0	0.6	0.6	0.3	0.7	0.3	1.2	0.5	0.6	0.4	0.5	1.6	0.0	0.3	0.0	1.0	4.1	3.7	0.2	2.3	0.1	0.7	0.0	0.0	0.0	6.3	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.1	2.5	0.0	0.2	0.7	0.4	0.2	0.0	0.2	0.3	0.2	0.0	0.1	1.2	0.0	0.0	0.8	0.2	0.1	0.1	0.0	0.1	0.0	0.0	1.9	9.9	8.7	0.0	2.4	0.0	0.0	2.8	0.0	0.0	1.1	0.5	0.3	0.4	0.1	0.2	0.3	0.2	0.2	0.2	0.7	0.4	0.4	1.2	0.6	0.4	0.3	0.2	0.5	6.9	7.1	105.4	14.1	4.6	8.1	1.8	8.3	7.1	1.3
CDH19	CDH7	ENSG00000071991	"Cadherin 19"	Q9H159	18	66501083-66604138	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 37.1"	"Group enriched"	"Detected in some"	12	"SK-MEL-30: 19.7;WM-115: 35.1"	"Cancer enriched"	"Detected in some"	21	"melanoma: 16.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA056332	Uncertain						160000			"HPA056332: "	"unprognostic (1.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.26e-2)"		"unprognostic (4.10e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.58e-3)"	"unprognostic (8.16e-3)"	"unprognostic (8.21e-2)"	"unprognostic (1.56e-5)"	4.5	7.5	4.1	5.4	17.4	0.5	2.3	0.9	10.2	6.4	17.9	5.7	4.6	3.8	1.6	3.2	11.7	2.4	4.7	37.1	5.2	2.3	1.1	7.0	2.1	0.5	22.0	5.5	2.0	2.2	0.6	1.1	5.2	13.1	4.7	5.2	6.9	4.5	7.6	6.0	2.6	5.9	7.2	12.5	4.0	5.8	1.9	20.0	0.0	1.7	2.7	0.4	5.7	12.6	0.2	0.0	1.3	0.1	0.2	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	19.7	0.8	0.0	0.0	0.0	0.2	0.1	0.0	2.2	0.1	0.0	0.1	0.0	35.1	0.0	0.1	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	4.1	17.4	0.9	10.2	5.2	2.3	22.0	5.5	13.1	20.0
CDH20	"Cdh7, CDH7L3"	ENSG00000101542	"Cadherin 20"	Q9HBT6	18	61333582-61555773	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 8.8;brain: 32.8"	"Cell line enhanced"	"Detected in some"		"AF22: 3.1;ASC diff: 9.9;HHSteC: 4.6;SH-SY5Y: 6.7"	"Cancer enriched"	"Detected in single"	15	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"basophil: 4.5"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015490	Uncertain									"HPA015490: AB_1845900"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.11e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.93e-1)"	8.8	1.2	13.4	1.1	13.7	1.0	1.2	6.9	32.8	1.5	1.1	16.8	0.0	1.0	1.1	2.3	2.5	1.3	1.1	1.1	16.0	7.3	1.2	1.0	1.0	1.1	20.4	9.8	1.0	1.3	1.0	1.1	1.1	12.6	1.5	1.0	0.5	1.0	1.1	3.4	2.0	1.0	1.1	12.8	1.2	1.1	1.4	18.9	0.0	1.2	0.5	1.0	1.1	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.4	0.0	0.0	3.1	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.4	13.4	13.7	6.9	14.0	16.0	7.3	20.4	9.8	12.6	18.9
CDH22	"C20orf25, dJ998H6.1"	ENSG00000149654	"Cadherin 22"	Q9UJ99	20	46173733-46308498	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 55.8"	"Cell line enriched"	"Detected in single"	18	"SCLC-21H: 8.3"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in all"		"cerebellum: 55.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012164, HPA012715"	Uncertain	Supported								"HPA012164: AB_1845902, HPA012715: "	"unprognostic (2.41e-4)"	"unprognostic (1.72e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.32e-3)"	"unprognostic (3.39e-2)"	"unprognostic (4.73e-1)"	"unprognostic (4.32e-1)"	"unprognostic (2.54e-2)"	"unprognostic (5.54e-2)"	"unprognostic (4.50e-4)"	"unprognostic (2.62e-1)"	"unprognostic (3.09e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.83e-2)"	0.7	4.2	10.2	0.5	5.7	0.5	0.8	55.8	15.5	0.7	0.6	1.0	0.0	0.6	0.7	0.7	1.2	4.0	0.5	1.0	3.5	3.7	0.7	0.5	0.6	0.5	1.2	8.7	0.9	4.2	0.5	1.1	0.5	3.0	1.5	0.7	1.8	1.0	1.8	1.2	10.4	0.9	0.5	1.9	0.5	0.9	1.4	1.3	0.0	0.7	0.0	0.5	0.5	0.6	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	10.2	5.7	55.8	14.8	3.5	3.7	1.2	8.7	3.0	1.3
CDH26	VR20	ENSG00000124215	"Cadherin 26"	Q8IXH8	20	59958427-60034011	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.1;prostate: 15.3"	"Cell line enriched"	"Detected in some"	6	"RT4: 33.9"	"Group enriched"	"Detected in some"	6	"cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.4;eosinophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"HPA015722, HPA047578"	Uncertain		Supported	"Plasma membrane,Microtubules"				"Plasma membrane"	Microtubules	"HPA015722: AB_2077659, HPA047578: "	"unprognostic (2.42e-1)"	"prognostic favourable (7.62e-4)"	"unprognostic (4.71e-4)"	"unprognostic (8.17e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"prognostic favourable (3.75e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.26e-4)"	"unprognostic (8.24e-3)"	"unprognostic (9.96e-7)"	"unprognostic (1.85e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	0.8	0.5	0.8	0.7	1.2	1.3	0.8	2.0	1.1	3.8	0.7	0.7	0.7	0.5	1.3	0.7	3.8	2.5	0.7	0.7	1.2	1.0	0.7	0.7	2.9	0.7	1.3	0.7	2.0	0.7	0.7	1.9	0.7	1.4	15.3	0.4	1.4	2.8	0.7	1.0	0.4	0.7	0.7	1.6	0.7	1.9	0.7	0.7	4.2	0.7	0.7	16.1	6.2	1.3	0.0	0.9	1.6	1.4	0.0	0.2	0.4	0.0	0.5	0.1	0.0	0.4	0.2	0.3	0.1	0.0	0.1	0.0	0.6	0.6	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.1	0.0	5.2	0.0	0.1	0.0	0.2	0.2	0.1	1.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.4	0.4	0.1	0.0	0.0	0.6	0.0	33.9	0.7	0.1	0.3	0.2	0.1	0.1	0.4	0.1	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.0	0.8	0.0	0.0	1.4	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.8	1.2	2.0	1.1	1.2	1.0	1.3	0.7	1.4	0.7
CDH4		ENSG00000179242	"Cadherin 4"	P55283	20	61252426-61940617	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.4;lymphoid tissue: 10.2;skeletal muscle: 9.8"	"Cell line enhanced"	"Detected in some"		"AF22: 7.9;hTERT-HME1: 10.4;U-2 OS: 14.2;U-251 MG: 24.7"	"Group enriched"	"Detected in many"	6	"glioma: 6.9;renal cancer: 3.4;thyroid cancer: 2.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015613			Supported	"Plasma membrane"				"Plasma membrane"		"HPA015613: AB_1845905"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.39e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.72e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.78e-2)"	1.0	1.2	17.4	0.7	15.8	0.9	0.9	1.3	13.6	0.9	0.7	4.0	0.0	0.8	0.9	0.7	1.4	2.6	0.9	1.0	10.2	6.9	0.8	0.9	1.0	0.9	2.8	11.8	6.2	2.0	0.7	0.5	0.9	3.3	0.8	0.7	0.6	1.5	3.6	9.8	2.7	0.8	0.7	1.6	10.2	0.8	1.9	3.1	0.0	1.7	0.0	0.7	0.8	0.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.9	7.9	0.0	0.1	0.5	0.1	2.2	0.0	4.0	0.4	0.2	0.0	0.0	0.2	2.6	2.9	0.0	4.3	1.6	0.2	0.0	0.0	0.1	0.1	5.5	0.0	0.1	0.8	1.0	0.8	10.4	0.8	0.0	0.0	1.6	0.3	0.1	0.0	0.9	0.0	0.0	0.0	1.1	2.5	0.0	0.7	1.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	14.2	0.1	24.7	4.6	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.4	0.0	17.4	15.8	1.3	13.6	10.2	6.9	2.8	11.8	3.3	3.1
CDH7		ENSG00000081138	"Cadherin 7"	Q9ULB5	18	65750252-65890341	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 16.7"	"Cell line enhanced"	"Detected in some"		"AF22: 16.9;HEK 293: 3.2;Karpas-707: 6.2;RH-30: 8.1;U-87 MG: 3.8"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061419	Approved									"HPA061419: "	"unprognostic (2.81e-3)"		"unprognostic (6.95e-2)"		"unprognostic (2.26e-1)"			"unprognostic (2.24e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.28e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.49e-1)"		"unprognostic (1.72e-1)"	0.4	0.6	2.6	0.3	4.3	0.6	0.4	15.3	7.5	0.3	0.3	0.0	0.0	0.4	0.3	0.6	0.3	0.3	0.4	0.4	0.5	2.5	0.3	0.6	0.4	0.3	1.5	2.1	1.6	0.3	0.3	1.2	0.3	16.7	3.6	0.5	1.3	0.4	1.9	1.0	0.5	0.3	0.2	1.3	0.4	0.3	1.8	0.1	0.7	0.5	0.0	0.4	0.3	0.2	0.8	0.5	1.9	0.4	0.6	0.4	0.1	0.0	0.2	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.1	0.7	0.3	0.1	8.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.8	1.3	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	3.8	0.0	0.0	1.2	0.4	0.4	0.3	0.2	0.3	0.3	0.3	0.3	0.0	0.8	0.4	0.4	1.9	0.6	0.3	0.5	0.2	0.1	2.6	4.3	15.3	5.2	0.5	2.5	1.5	2.1	16.7	0.1
CDH8		ENSG00000150394	"Cadherin 8"	P55286	16	61647242-62037035	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 29.6;seminal vesicle: 9.5"	"Group enriched"	"Detected in some"	4	"AF22: 6.8;fHDF/TERT166: 6.0;HaCaT: 13.6;LHCN-M2: 16.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014908, HPA076441"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA014908: AB_1845908, HPA076441: "	"unprognostic (1.91e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.91e-4)"	"unprognostic (6.02e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.06e-1)"	0.9	0.9	13.0	0.7	20.4	0.7	1.2	0.5	29.6	1.4	0.8	5.5	0.0	1.2	0.9	1.1	1.0	0.7	1.1	1.1	10.4	7.7	0.8	0.7	0.9	0.7	9.3	12.2	3.7	0.7	0.8	0.9	1.3	12.8	1.4	0.9	0.0	1.4	9.5	1.4	0.9	1.0	1.4	7.7	0.8	0.8	1.2	5.6	0.0	1.0	0.0	0.8	1.7	0.3	0.0	0.0	1.0	0.2	0.1	0.1	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	6.0	13.6	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.3	0.0	16.4	0.0	0.0	0.0	1.2	1.2	0.0	0.0	1.0	0.0	1.8	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.1	0.0	13.0	20.4	0.5	17.8	10.4	7.7	9.3	12.2	12.8	5.6
CDH9		ENSG00000113100	"Cadherin 9"	Q9ULB4	5	26880600-27121150	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 46.8"	"Cell line enhanced"	"Detected in some"		"K-562: 9.2;NTERA-2: 13.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"amygdala: 46.8;basal ganglia: 24.6;cerebral cortex: 23.7;hippocampal formation: 15.9;olfactory region: 15.6"	"Cell type enhanced"	"Detected in some"		"neutrophil: 8.3"	"Group enriched"	"Detected in many"	5	"B-cells: 4.1;granulocytes: 8.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA007167	Approved									"HPA007167: AB_1078489"					"unprognostic (1.49e-1)"								"unprognostic (2.27e-4)"					0.7	0.5	46.8	1.0	24.6	2.8	0.7	0.5	23.7	0.5	0.8	0.0	0.0	0.6	0.9	1.2	0.7	0.5	0.7	0.5	15.9	3.5	10.5	0.5	0.6	1.6	1.2	15.6	0.6	1.1	1.0	0.5	0.8	1.5	1.0	1.2	0.0	0.5	0.1	0.5	1.9	1.5	0.8	0.6	0.8	0.9	3.7	2.6	0.0	1.9	0.0	1.7	0.5	0.5	4.1	0.9	8.3	1.1	0.1	0.8	1.1	2.4	0.9	0.5	0.8	0.4	0.0	1.6	0.0	0.9	0.3	0.6	0.0	0.9	1.3	0.3	0.3	0.3	0.1	0.5	0.0	0.1	0.2	0.5	0.7	2.5	0.0	0.0	1.5	0.6	0.7	0.0	0.0	0.2	9.2	2.3	0.0	1.5	0.8	0.5	13.6	0.5	0.3	0.3	0.4	0.5	0.5	3.1	0.3	0.0	0.4	0.4	0.5	0.9	1.7	0.1	0.8	0.8	0.3	2.7	1.0	4.3	1.0	1.0	0.8	1.3	0.2	0.4	0.2	0.7	0.6	4.1	0.4	0.2	0.1	2.5	0.3	0.5	8.3	0.1	1.1	0.9	0.8	1.1	46.8	24.6	0.5	23.7	15.9	3.5	1.2	15.6	1.5	2.6
CDHR4	"CDH29, VLLR9392"	ENSG00000187492	"Cadherin related family member 4"	A6H8M9	3	49790732-49799835	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 37.8;fallopian tube: 42.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.6;HeLa: 4.4"	"Cancer enriched"	"Detected in some"	6	"endometrial cancer: 6.8"	"Region enhanced"	"Detected in some"		"pons and medulla: 5.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 17.7"	"Low region specificity"	"Detected in many"			HPA076277	Enhanced				"Intracellular and membrane"					"HPA076277: "	"unprognostic (1.50e-4)"	"unprognostic (4.87e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-3)"	"unprognostic (6.35e-7)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.07e-11)"	"unprognostic (2.65e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.37e-1)"	0.2	0.1	0.4	0.1	1.6	0.3	0.1	0.0	0.0	4.9	0.2	1.9	0.0	0.1	1.3	37.8	0.1	42.7	0.1	0.1	0.7	0.9	0.1	0.1	11.4	0.1	0.0	0.0	8.0	0.0	0.0	0.8	0.6	5.7	0.1	0.1	0.0	0.1	0.2	0.1	0.9	0.1	0.3	0.2	0.0	0.1	3.9	0.0	0.0	0.0	0.5	0.2	0.2	0.1	1.1	1.5	3.0	4.1	1.3	0.4	5.8	0.5	1.7	0.5	0.3	0.5	4.6	0.3	0.4	0.1	0.9	1.0	0.0	2.6	0.0	0.2	1.1	0.5	0.1	0.0	0.3	0.3	0.3	0.8	4.4	1.0	0.0	0.3	0.5	0.7	1.5	0.8	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.8	0.3	0.2	0.8	0.2	0.0	0.0	0.3	0.1	0.1	1.5	1.1	0.0	0.2	0.1	0.0	0.6	0.2	0.7	0.1	0.6	2.3	0.1	2.1	1.2	0.0	3.0	4.1	0.4	0.4	1.6	0.3	0.4	0.3	0.3	1.5	1.1	0.3	0.4	2.5	1.3	0.2	0.5	0.2	5.8	0.4	1.6	0.0	0.0	0.7	0.9	0.0	0.0	5.7	0.0
CDRT1	"FBXW10B, FBXW10P1, HREP, SM25H2"	ENSG00000241322	"CMT1A duplicated region transcript 1"	O95170	17	15565483-15619512	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 9.8;testis: 12.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 15.3;HaCaT: 28.1;HeLa: 9.5"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"T-reg: 2.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.1"									"HPA013332, HPA047457"			Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA013332: AB_1848471, HPA047457: "	"unprognostic (2.25e-1)"	"unprognostic (2.78e-1)"	"unprognostic (7.03e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.93e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.31e-8)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.86e-1)"	1.1	1.8	0.0	0.9	0.0	0.0	0.7	0.2	0.0	2.4	0.3			2.9	0.0	0.8	9.8	0.3	0.7	0.7	0.0	0.0	0.1	0.5	0.9	0.7	0.0		0.0	0.0	0.0	0.1	1.8		0.3	0.6		2.6	0.1	2.1	4.4	1.3	0.0	0.0	0.2	2.6	12.8			1.6		3.0	2.0	4.1	0.4	0.1	0.0	0.3	0.1	2.1	0.0	2.3	6.7	0.2	1.9	0.2	0.7	0.1	0.5	1.5	0.2	0.7	5.0	15.3	0.1	0.4	1.3	28.1	0.4	0.3	0.4	2.3	0.3	0.1	9.5	0.2	0.2	0.0	0.1	0.3	0.9	0.6	0.4	0.1	0.0	1.2	0.8	0.1	0.4	0.2	0.2	0.8	0.0	0.4	0.0	1.8	3.7	0.1	0.2	2.2	2.0	0.1	0.1	0.1	1.2	0.5	1.4	0.0	0.4	0.6	2.9	0.0	1.7	0.1	0.8	0.0	0.2	0.0	0.2	0.3	0.1	0.1	0.2	0.0	0.1	0.4	0.1	0.2	0.0	0.1	0.1	0.0	2.1	0.0										
CDRT15		ENSG00000223510	"CMT1A duplicated region transcript 15"	Q96T59	17	14235673-14236862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 5.1;testis: 19.0"	"Cell line enhanced"	"Detected in many"		"HEK 293: 6.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"T-reg: 2.0"	"Low lineage specificity"	"Detected in single"											HPA055952	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA055952: "	"unprognostic (3.27e-2)"	"unprognostic (1.77e-2)"	"unprognostic (8.61e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.30e-7)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.38e-2)"	0.1	0.3	0.0	1.5	0.0	0.5	0.1	0.3	0.1	0.2	0.2			0.9	0.1	0.0	0.4	0.2	0.4	0.2	0.1	0.1	0.1	0.5	0.2	3.8	0.1		0.4	0.2	0.0	0.1	0.0		0.2	0.0		0.9	0.0	0.1	5.1	1.0	0.0	0.3	1.1	0.4	19.0			0.5		0.0	0.2	0.2	0.2	0.3	0.5	0.1	0.0	2.0	0.0	1.3	2.3	1.6	3.7	0.0	0.0	0.9	1.4	0.0	0.0	0.1	4.4	0.6	3.7	0.9	0.0	1.7	0.0	0.0	0.0	3.7	6.9	2.1	3.8	3.1	0.0	1.7	2.7	0.0	0.0	0.0	0.0	0.0	1.7	0.8	0.0	0.9	1.8	2.7	1.5	2.3	1.4	0.7	1.5	0.0	1.9	1.8	3.3	0.4	1.0	0.6	0.8	0.9	2.0	6.0	0.9	1.4	1.6	1.2	1.4	1.7	0.9	2.8	4.3	0.0	0.1	0.5	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0										
CDS1		ENSG00000163624	"CDP-diacylglycerol synthase 1"	Q92903	4	84582979-84651338	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 48.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 20.6;hTCEpi: 25.8;SK-BR-3: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"myeloid DC: 2.1"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036187, HPA064546"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	"Nuclear membrane"	"HPA036187: AB_10601797, HPA064546: "	"unprognostic (8.74e-2)"	"unprognostic (7.11e-2)"	"prognostic favourable (5.22e-4)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.67e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.06e-1)"	0.9	4.6	7.4	2.5	10.4	0.4	6.7	13.3	12.9	4.3	16.7	3.3	9.3	24.8	2.0	19.1	17.4	20.5	8.8	0.5	7.4	8.4	11.9	0.6	10.6	0.8	6.4	4.7	5.5	4.5	19.3	7.1	19.7	14.1	6.1	13.6	4.2	11.2	4.3	0.2	12.9	48.0	0.8	2.4	1.0	11.5	5.1	2.3	0.9	19.3	7.9	6.1	3.5	7.4	0.0	2.1	0.0	0.0	0.0	0.4	0.0	11.5	0.2	0.6	0.1	0.0	0.0	12.1	0.0	0.1	0.3	0.2	4.9	20.6	0.0	0.9	0.0	12.1	3.8	10.2	0.1	0.8	5.7	0.0	1.8	1.1	0.0	0.3	0.8	0.1	25.8	0.0	3.7	0.0	0.0	0.0	0.0	8.1	0.1	0.0	1.7	0.8	0.0	0.0	2.4	5.8	8.8	4.8	0.1	1.3	28.0	0.0	8.5	0.2	0.0	0.0	0.7	1.3	1.5	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.4	10.4	13.3	12.9	7.4	8.4	6.4	4.7	14.1	2.3
CEACAM19	CEAL1	ENSG00000186567	"Carcinoembryonic antigen related cell adhesion molecule 19"	Q7Z692	19	44662278-44684359	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 13.8;TIME: 17.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014462, HPA052865"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoli, Mitochondria"	Nucleoplasm	"HPA014462: , HPA052865: "	"unprognostic (2.91e-1)"	"unprognostic (5.29e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.26e-9)"	"unprognostic (8.01e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.70e-1)"	1.6	2.9	1.1	0.8	1.9	1.0	2.4	4.3	1.7	3.1	2.4			2.7	2.7	1.4	2.4	4.3	2.1	4.1	1.2	1.8	3.3	4.3	3.8	0.6	0.6		4.0	4.7	1.2	3.9	1.8		4.1	3.3		2.9	3.0	12.5	10.8	2.9	3.0	0.9	1.8	2.0	3.0			3.4		1.7	1.0	4.4	1.7	0.5	1.7	1.0	1.0	0.7	0.6	4.3	8.8	1.3	0.9	3.1	3.6	3.3	2.4	3.6	0.8	1.6	0.3	1.0	0.1	0.8	3.3	5.3	2.2	0.9	0.7	1.2	5.0	0.1	4.7	1.4	3.2	0.2	0.8	1.1	8.8	2.2	5.4	2.1	0.3	0.2	1.2	1.0	0.0	0.5	0.8	1.0	0.0	1.6	0.2	13.8	1.0	1.7	0.4	0.9	0.9	0.8	1.2	0.3	17.8	0.3	6.1	1.3	0.7	0.1	0.3	0.0	0.4	1.7	1.4	1.7	1.0	0.6	0.6	0.4	0.3	0.5	0.3	0.6	0.2	1.7	0.4	0.7	1.6	1.0	0.5	0.5	0.3	0.6										
CEACAM21	"FLJ13540, R29124_1"	ENSG00000007129	"Carcinoembryonic antigen related cell adhesion molecule 21"	Q3KPI0	19	41549518-41586844	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 19.1;bone marrow: 21.1;lymphoid tissue: 22.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 9.5;Karpas-707: 7.6;U-266/70: 8.4;U-937: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA043411	Uncertain									"HPA043411: AB_10794886"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.73e-2)"	"prognostic favourable (1.89e-5)"	"unprognostic (2.57e-1)"	"unprognostic (8.02e-4)"	"unprognostic (3.04e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.37e-6)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.37e-1)"	1.8	1.2	1.6	18.5	1.7	21.1	1.3	1.0	1.4	3.5	3.8	2.4	0.0	1.2	3.9	1.4	1.5	1.4	1.1	2.1	2.0	7.2	1.4	1.8	7.2	19.2	8.4	0.5	1.1	0.7	0.3	1.0	2.4	1.9	1.2	1.2	2.0	4.3	6.2	0.5	0.6	5.0	0.9	3.3	22.7	1.4	1.5	1.6	11.1	1.2	0.7	22.4	2.9	0.8	6.9	7.0	13.0	4.6	10.3	19.1	10.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.1	0.1	0.1	0.1	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	8.4	1.5	1.6	0.0	6.4	0.0	0.0	2.6	10.8	19.1	4.6	12.8	6.7	16.5	13.1	2.8	6.9	14.2	13.8	13.0	10.3	2.8	7.0	14.6	10.1	1.6	1.7	1.0	1.4	2.0	7.2	8.4	0.5	1.9	1.6
CENPBD1	MGC16385	ENSG00000177946	"CENPB DNA-binding domain containing 1"	B2RD01	16	89969773-89972832	"Predicted intracellular proteins"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEK 293: 7.6;K-562: 4.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA052759, HPA060522"	Uncertain		Approved	Nucleoli,Vesicles				"Nucleoli, Vesicles"		"HPA052759: , HPA060522: "	"unprognostic (2.63e-2)"	"unprognostic (2.22e-3)"	"unprognostic (4.43e-2)"	"unprognostic (3.48e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.86e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.44e-2)"	"prognostic favourable (5.27e-11)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-2)"	7.2	5.9	6.6	2.6	7.3	4.5	6.3	6.1	9.5	3.3	4.0	4.9	10.5	5.9	3.6	5.0	4.0	3.6	4.6	4.2	6.6	6.1	7.6	5.6	6.7	7.1	7.9	7.0	7.6	8.9	3.9	7.1	4.4	6.2	4.9	6.0	3.8	6.0	4.8	4.2	5.1	2.9	3.8	5.6	6.6	4.7	8.2	6.3	2.5	3.5	1.8	2.5	4.8	2.7	3.7	3.6	1.4	1.6	1.4	2.7	1.3	1.2	0.0	0.2	0.4	0.5	0.9	2.1	0.8	0.3	0.0	0.0	0.6	0.0	1.3	1.2	0.9	2.0	0.0	0.0	0.3	0.0	7.6	0.0	0.3	0.5	0.4	0.4	1.2	0.0	1.3	0.0	0.0	0.0	4.6	0.9	0.0	1.1	1.4	0.5	0.6	0.5	3.1	1.6	0.0	0.0	0.0	2.7	1.9	2.8	0.3	0.1	0.7	0.0	0.0	0.2	1.8	0.2	1.2	0.8	1.3	1.0	0.5	1.2	0.5	0.6	1.6	1.4	2.4	0.7	2.1	1.2	1.9	0.8	3.6	3.7	2.7	2.3	0.5	1.4	1.4	3.1	1.1	1.3	6.6	7.3	6.1	9.5	6.6	6.1	7.9	7.0	6.2	6.3
CEP295NL	"DDC8, KIAA1731NL"	ENSG00000178404	"CEP295 N-terminal like"	Q96MC4	17	78870910-78903217	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 37.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.0;Karpas-707: 3.2;TIME: 3.2;U-2 OS: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.5"									"HPA023609, HPA024619, HPA025717"	Uncertain		Approved	Vesicles				Vesicles		"HPA023609: AB_10610974, HPA024619: AB_10602076, HPA025717: AB_10601900"	"unprognostic (1.68e-3)"	"unprognostic (4.56e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.03e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.89e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.75e-3)"	0.1	0.0	0.1	0.1	0.1	1.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	37.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.2	3.5	0.4	0.1	0.1	0.0	0.7	0.1	0.0	0.9	0.2	0.6	4.0	1.7	0.1	0.6	1.1	0.2	0.6	0.0	1.1	0.6	0.1	0.0	0.2	0.6	0.0	0.0	0.0	1.3	0.3	0.4	0.2	0.1	0.3	0.0	1.2	0.0	0.4	0.0	3.2	0.1	0.0	0.3	0.0	0.3	0.6	0.8	0.5	0.1	0.2	0.0	0.1	0.9	0.5	0.4	0.7	0.1	1.0	3.2	1.4	5.4	1.7	0.7	1.2	1.6	0.0	0.0	0.1	1.7	0.0	0.4	0.7	0.0	0.4	0.0	0.1	0.1	0.0	0.2	0.4	0.0	0.0	3.5	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CERS5	"FLJ25304, LASS5, MGC45411, Trh4"	ENSG00000139624	"Ceramide synthase 5"	Q8N5B7	12	50129306-50167533	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026589	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA026589: AB_1852727"	"unprognostic (1.59e-2)"	"unprognostic (9.83e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.49e-3)"	"prognostic unfavourable (4.63e-5)"	"unprognostic (5.56e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.88e-3)"	"unprognostic (5.67e-2)"	"prognostic unfavourable (9.33e-11)"	"unprognostic (8.37e-2)"	"unprognostic (1.03e-1)"	"prognostic favourable (5.76e-5)"	"unprognostic (3.26e-1)"	18.0	13.2	18.3	13.3	21.6	10.9	18.0	38.3	19.6	21.1	15.0	17.5	8.9	6.3	22.6	20.9	14.1	17.7	14.9	9.9	16.7	11.6	16.0	7.8	14.7	15.1	13.9	19.1	22.5	13.8	23.9	22.4	19.7	14.3	15.6	11.5	14.9	14.6	16.2	5.0	21.5	12.2	21.8	10.3	15.7	13.3	11.6	14.4	12.7	15.5	7.0	14.9	18.4	18.3	21.0	26.1	33.5	35.1	29.0	26.3	22.3	9.3	10.4	23.0	6.5	12.9	10.8	19.5	20.6	17.8	19.8	18.8	24.5	14.7	14.1	17.2	29.1	8.7	10.1	7.9	19.6	22.1	10.3	11.8	8.8	14.8	25.6	11.9	16.0	18.6	12.0	16.3	15.2	18.0	8.8	13.1	24.8	16.2	10.4	32.5	14.8	10.1	13.6	15.1	10.0	25.6	12.0	7.0	11.4	17.4	8.2	27.5	11.2	13.8	17.1	17.0	11.4	12.8	8.9	12.8	12.1	11.3	13.5	8.3	7.8	24.8	19.0	28.1	26.0	25.5	22.9	17.9	22.9	22.4	18.2	21.0	17.9	24.3	33.5	29.0	35.1	26.1	26.3	22.3	18.3	21.6	38.3	19.6	16.7	11.6	13.9	19.1	14.3	14.4
CES4A	"CES8, FLJ37464"	ENSG00000172824	"Carboxylesterase 4A"	Q5XG92	16	66988589-67009758	"Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 32.3"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.0"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA035701	Approved		Approved	Cytosol	"Secreted - unknown location"			Cytosol		"HPA035701: AB_10696357"	"unprognostic (6.34e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (2.35e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.33e-3)"	3.2	3.6	12.9	2.4	11.8	2.2	3.6	8.7	13.8	2.6	1.7	8.5	3.5	2.3	1.6	13.0	2.2	32.3	2.0	3.2	9.1	2.6	3.9	11.7	3.1	1.4	5.8	13.7	2.1	3.0	3.3	10.0	2.2	7.2	2.1	1.7	2.1	4.2	3.5	5.8	13.9	2.3	1.4	2.4	1.5	2.3	2.0	9.9	0.0	5.0	1.0	2.0	2.4	1.6	0.9	1.6	0.0	5.0	0.0	1.6	1.3	0.3	1.2	0.1	0.0	0.9	0.9	0.0	0.1	0.4	0.1	0.0	0.0	1.5	0.0	0.1	1.5	0.7	0.0	0.2	0.0	19.4	0.0	0.0	0.9	0.0	0.1	0.0	4.6	1.6	3.3	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.2	0.0	1.2	0.0	0.2	0.9	0.9	4.2	2.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	4.5	1.3	0.0	1.7	0.0	0.0	0.0	2.1	0.0	0.7	3.3	0.9	0.9	1.6	1.1	1.6	0.0	1.2	0.2	0.0	0.0	5.0	1.5	0.4	1.3	12.9	11.8	8.7	13.8	9.1	2.6	5.8	13.7	7.2	9.9
CFAP100	"CCDC37, FLJ40083, MIA1"	ENSG00000163885	"Cilia and flagella associated protein 100"	Q494V2	3	126394939-126436556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 38.7;fallopian tube: 29.2;testis: 21.9"	"Cell line enhanced"	"Detected in some"		"AF22: 1.2;BEWO: 1.4;HaCaT: 1.2;Hep G2: 1.1;NTERA-2: 1.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.0"	"Group enriched"	"Detected in many"	6	"basal ganglia: 14.7;pons and medulla: 38.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA046354	Enhanced									"HPA046354: "	"unprognostic (1.79e-2)"	"unprognostic (3.75e-3)"	"unprognostic (7.17e-5)"	"unprognostic (1.61e-3)"	"unprognostic (6.75e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.70e-5)"	"unprognostic (3.57e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.58e-4)"	0.3	0.3	1.6	0.3	14.7	0.3	0.3	0.0	0.8	3.2	0.3	10.9	0.0	0.3	1.5	12.0	0.3	29.2	0.3	0.3	4.5	3.0	0.4	0.3	8.2	0.4	0.1	1.1	3.4	0.3	0.3	1.9	0.3	38.7	0.3	0.3	0.0	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	21.9	4.5	0.0	0.3	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	14.7	0.0	0.8	4.5	3.0	0.1	1.1	38.7	4.5
CFAP126	"C1orf192, Flattop, Fltp"	ENSG00000188931	"Cilia and flagella associated protein 126"	Q5VTH2	1	161364731-161367874	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 53.4;fallopian tube: 85.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.2;RPTEC TERT1: 2.5;SCLC-21H: 2.4;T-47d: 1.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	7	"pons and medulla: 53.4"	"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045904	Enhanced									"HPA045904: AB_10960411"																		0.7	0.7	5.8	0.7	7.5	0.7	1.1	1.2	2.7	3.0	0.7	23.3	0.0	0.7	2.7	14.8	0.7	85.7	0.8	0.7	7.0	8.0	1.8	0.8	8.1	0.7	4.1	3.9	11.2	0.8	0.7	3.3	0.7	53.4	0.8	0.7	0.0	0.7	1.2	2.8	0.7	0.7	0.7	3.3	0.7	0.7	15.3	4.3	0.0	2.7	0.1	0.8	0.7	0.0	0.0	0.1	0.6	0.5	0.0	1.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	2.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	5.8	7.5	1.2	2.7	7.0	8.0	4.1	3.9	53.4	4.3
CFAP157	C9orf117	ENSG00000160401	"Cilia and flagella associated protein 157"	Q5JU67	9	127706989-127716002	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 30.2;epididymis: 24.0;fallopian tube: 44.8;testis: 11.5"	"Cell line enhanced"	"Detected in many"		"A549: 9.1;HeLa: 7.4;MCF7: 6.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 19.8;pons and medulla: 30.2"	"Cell type enriched"	"Detected in single"	11	"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA021474, HPA021786"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA021474: AB_1845801, HPA021786: AB_1845802"	"unprognostic (1.69e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.41e-2)"	"prognostic favourable (1.45e-4)"	"unprognostic (3.02e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.14e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.93e-4)"	"unprognostic (9.32e-3)"	"unprognostic (4.95e-3)"	"unprognostic (5.71e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	0.4	0.4	3.1	0.3	19.8	0.3	0.3	0.1	0.4	5.3	0.3	7.0	1.6	0.2	1.0	24.0	0.8	44.8	0.6	0.4	4.6	5.8	0.4	0.3	6.1	0.4	0.0	0.0	4.4	0.9	0.2	4.4	0.3	30.2	0.4	0.2	0.0	0.5	1.3	0.4	0.6	0.3	0.2	0.5	0.4	0.4	11.5	3.5	0.0	0.4	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.5	9.1	0.9	1.2	0.0	0.0	1.2	1.1	0.0	0.0	0.0	0.9	1.3	1.4	1.4	0.0	4.5	0.0	0.0	0.0	3.4	1.0	0.9	7.4	2.2	0.0	0.7	2.0	0.0	0.0	0.0	0.0	0.0	3.0	0.7	0.0	6.5	1.3	0.5	0.8	4.9	2.0	0.9	1.5	0.0	0.4	6.3	1.1	1.9	3.6	0.7	3.2	0.3	1.7	1.9	1.5	4.9	0.8	1.0	2.5	1.1	0.7	0.7	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	19.8	0.1	0.3	4.6	5.8	0.0	0.0	30.2	3.5
CFAP161	"C15orf26, FLJ38615"	ENSG00000156206	"Cilia and flagella associated protein 161"	Q6P656	15	81007033-81149175	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.0;fallopian tube: 22.4;retina: 14.9;testis: 18.2"	"Group enriched"	"Detected in some"	5	"HEL: 41.4;K-562: 13.9"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Region enhanced"	"Detected in many"		"pons and medulla: 18.0"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA076975	Supported									"HPA076975: "	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.07e-2)"	"prognostic favourable (3.05e-4)"	"unprognostic (1.57e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.24e-2)"	"unprognostic (6.22e-2)"	0.8	0.4	2.3	0.4	5.2	0.9	0.6	0.4	1.1	1.5	0.4	6.8	0.2	0.2	1.1	5.4	0.4	22.4	0.5	1.1	3.3	3.3	0.5	0.5	4.0	0.3	0.6	1.1	4.2	2.7	0.2	9.9	2.1	18.0	0.4	0.3	14.9	0.5	0.5	0.5	0.9	0.4	0.6	0.8	0.9	0.5	18.2	1.5	0.0	1.0	0.0	0.6	0.5	0.2	0.0	0.3	2.3	0.4	0.0	0.7	7.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	41.4	0.0	0.1	0.0	0.0	5.6	0.0	0.0	0.1	0.5	0.8	13.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.0	0.5	0.4	0.0	0.2	0.4	0.0	0.0	0.2	0.7	0.3	0.0	0.0	0.1	2.3	0.0	0.1	0.1	0.0	7.3	2.3	5.2	0.4	1.1	3.3	3.3	0.6	1.1	18.0	1.5
CFAP46	"bA288G11.4, bA288G11.5, bB137A17.2, bB137A17.3, C10orf123, C10orf124, C10orf92, C10orf93, DKFZp434A1721, FLJ25954, TTC40"	ENSG00000171811	"Cilia and flagella associated protein 46"	Q8IYW2	10	132808392-132942823	"Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 32.8;testis: 35.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.0;CAPAN-2: 2.5;HAP1: 3.3;RPTEC TERT1: 3.0;SH-SY5Y: 3.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 2.7"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.7"					"Low region specificity"	"Detected in all"			"HPA037786, HPA038034, HPA038867, HPA038868"	Uncertain									"HPA037786: AB_10672392, HPA038034: , HPA038867: , HPA038868: "	"unprognostic (2.83e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.11e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.64e-4)"	"unprognostic (1.21e-2)"	"unprognostic (8.08e-2)"	"unprognostic (4.56e-3)"	"unprognostic (2.08e-2)"	0.4	0.7	3.4	0.4	6.7	0.4	0.6	0.7	4.6	1.1	0.4	6.8	2.7	0.6	0.6	9.9	0.7	8.7	0.6	0.8	5.3	3.9	2.4	0.6	2.1	0.4	2.7	3.8	2.3	0.9	1.5	4.2	0.4	9.0	0.5	0.4	1.5	0.6	1.0	32.8	0.5	0.6	0.4	0.9	0.5	3.1	35.5	2.0	0.0	3.5	0.0	0.4	0.4	0.2	0.0	0.0	0.0	2.7	0.7	0.0	0.0	0.0	0.1	0.6	2.0	0.0	0.0	0.0	0.9	0.0	0.6	0.1	0.0	2.5	0.0	0.2	0.1	0.8	3.3	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	1.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.7	0.0	0.0	0.0	3.4	6.7	0.7	4.6	5.3	3.9	2.7	3.8	9.0	2.0
CFAP47	"CHDC2, CXorf22, CXorf30, CXorf59, FLJ36601, MGC34831, RP13-11B7.1"	ENSG00000165164	"Cilia and flagella associated protein 47"	Q6ZTR5	X	35919734-36385319	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.4;fallopian tube: 12.8;pituitary gland: 24.5"	"Group enriched"	"Detected in some"	7	"Karpas-707: 4.1;U-266/70: 7.7"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044633, HPA054859"	Uncertain									"HPA044633: AB_10960684, HPA054859: "	"unprognostic (1.88e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.50e-5)"	"unprognostic (2.69e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.19e-3)"	0.3	0.3	2.0	0.2	5.9	0.2	0.3	0.3	1.2	0.9	0.3	6.2	1.2	0.2	0.7	7.0	0.3	12.8	0.2	0.3	3.7	1.3	0.4	0.5	3.7	0.2	1.2	1.5	5.3	0.3	2.3	24.5	0.3	12.4	0.3	0.2	2.0	0.3	0.3	0.3	0.3	0.3	0.2	1.1	0.3	0.3	2.1	2.7	0.0	1.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.1	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	5.9	0.3	1.2	3.7	1.3	1.2	1.5	12.4	2.7
CFAP54	"C12orf55, C12orf63, FLJ31514, FLJ44112"	ENSG00000188596	"Cilia and flagella associated protein 54"	Q96N23	12	96489571-96875555	"Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.7;testis: 15.1"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 10.5;TIME: 12.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"basal ganglia: 16.5;pons and medulla: 30.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039897	Enhanced		Approved	Microtubules,Cytosol				Microtubules	Cytosol	"HPA039897: AB_10674427"	"unprognostic (1.87e-4)"	"unprognostic (3.63e-2)"	"unprognostic (8.07e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.91e-2)"	"unprognostic (6.16e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.55e-5)"	"unprognostic (2.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.26e-2)"	"unprognostic (8.00e-2)"	1.0	0.9	3.4	1.9	16.5	4.5	1.4	1.0	3.4	2.0	1.4	9.5	1.8	2.3	3.3	8.6	1.2	8.9	1.5	0.9	5.3	3.6	1.4	1.5	8.1	1.9	1.3	3.1	3.8	0.7	1.3	11.7	0.9	30.7	1.7	1.5	0.3	1.8	1.9	1.8	2.9	1.5	1.9	1.7	1.9	1.6	15.1	5.2	0.0	2.4	0.5	1.6	1.0	1.1	2.7	1.6	3.7	1.4	1.5	1.7	0.1	1.6	0.8	1.3	1.8	0.8	1.1	1.1	1.4	0.3	0.4	0.6	0.8	2.4	1.4	2.1	0.5	1.3	0.7	0.4	0.5	2.2	1.0	1.4	3.0	0.8	0.2	2.6	1.7	0.4	0.5	1.9	0.7	10.5	0.7	4.9	1.3	0.7	1.2	2.4	2.4	1.4	1.5	1.5	1.7	3.0	1.8	2.3	1.7	1.3	0.7	1.5	2.3	0.7	12.7	2.4	2.9	2.2	2.4	5.4	2.3	1.1	1.7	1.2	1.7	3.7	1.4	1.4	1.7	0.9	1.4	1.4	1.3	1.3	0.4	2.7	1.6	1.5	3.7	1.5	1.1	1.6	1.0	0.1	3.4	16.5	1.0	3.4	5.3	3.6	1.3	3.1	30.7	5.2
CFAP57	"FLJ32000, WDR65"	ENSG00000243710	"Cilia and flagella associated protein 57"	Q96MR6	1	43172149-43254358	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 25.6;testis: 29.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 6.8;HDLM-2: 4.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 12.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002736, HPA028623"	Enhanced		Approved	Cytosol				Cytosol		"HPA002736: AB_2272982, HPA028623: AB_10603234"	"unprognostic (1.15e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.16e-1)"	"prognostic favourable (6.02e-4)"	"unprognostic (2.50e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.78e-2)"	0.4	0.4	1.6	0.3	6.7	0.2	0.6	0.1	1.8	1.6	0.3	4.2	0.0	0.3	1.0	9.1	0.4	25.6	0.5	0.4	3.6	2.7	1.5	2.7	4.7	0.2	0.3	1.4	7.1	0.9	0.4	5.9	0.5	12.7	0.7	0.3	0.3	0.5	0.5	0.4	0.9	0.3	0.3	0.4	0.2	0.4	29.2	0.4	0.0	1.9	0.0	0.3	0.5	0.2	3.2	2.4	0.7	4.8	1.2	1.5	1.4	2.9	1.0	0.7	0.6	0.2	0.1	0.9	1.1	1.8	1.4	1.4	0.8	1.2	0.3	1.3	2.4	6.8	0.4	0.9	2.6	4.4	0.2	0.3	0.6	0.6	0.5	0.0	0.3	0.2	1.1	1.1	0.4	2.0	0.2	0.1	0.2	0.1	0.3	0.3	1.4	0.1	0.4	1.0	0.2	2.9	0.5	1.1	0.5	1.3	0.2	1.1	1.6	0.5	3.8	0.2	1.4	0.7	0.8	0.4	0.6	0.3	0.3	0.8	0.8	0.5	1.1	0.7	1.4	2.0	1.4	2.2	1.4	1.2	2.4	3.2	1.3	1.3	0.0	1.2	4.8	1.9	1.5	1.4	1.6	6.7	0.1	1.8	3.6	2.7	0.3	1.4	12.7	0.4
CFAP61	"C20orf26, CaM-IP3, dJ1002M8.3, DKFZP434K156"	ENSG00000089101	"Cilia and flagella associated protein 61"	Q8NHU2	20	20052514-20360702	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.1;heart muscle: 14.8;pituitary gland: 15.0;skeletal muscle: 23.9;testis: 25.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.2;HMC-1: 4.1;SCLC-21H: 9.5;SK-MEL-30: 3.7;U-87 MG: 7.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.3;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA009079	Approved									"HPA009079: AB_1078344"	"unprognostic (5.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (3.67e-3)"	"unprognostic (8.58e-4)"	"unprognostic (8.24e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.76e-4)"	"unprognostic (2.77e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.06e-1)"	0.2	1.2	1.0	0.2	9.5	0.1	0.5	0.6	2.6	0.9	0.2	5.3	0.8	0.1	1.1	4.5	0.2	15.1	0.3	14.8	4.0	1.9	1.1	0.2	3.5	0.2	0.9	2.0	3.3	0.5	1.0	15.0	0.2	11.4	0.5	0.2	0.1	0.3	0.4	23.9	0.5	0.3	0.3	0.7	0.2	0.3	25.5	1.1	0.0	1.1	0.0	0.2	0.2	0.2	0.0	1.5	0.0	0.0	0.6	2.3	0.0	0.4	1.3	0.2	0.5	0.0	0.0	0.5	0.1	0.4	0.0	0.4	0.0	0.7	4.2	0.1	0.0	0.1	0.2	0.0	0.1	1.1	1.5	0.0	0.4	0.0	0.0	0.0	4.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.3	0.3	0.0	0.3	2.1	0.7	0.0	9.5	0.2	0.2	0.4	3.7	0.7	0.0	0.7	0.0	0.4	0.6	0.3	1.4	0.4	0.0	7.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.6	0.0	1.5	0.0	0.0	1.0	9.5	0.6	2.6	4.0	1.9	0.9	2.0	11.4	1.1
CFAP69	"C7orf63, FAP69, FLJ21062"	ENSG00000105792	"Cilia and flagella associated protein 69"	A5D8W1	7	90245174-90311063	"Predicted intracellular proteins"	"Differentiation, Olfaction, Sensory transduction, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 8.2;RPTEC TERT1: 8.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062883	Uncertain									"HPA062883: "	"unprognostic (7.69e-4)"	"unprognostic (9.93e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.13e-3)"	"unprognostic (3.12e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.80e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.46e-3)"	"unprognostic (2.44e-3)"	6.7	2.5	3.4	4.1	9.4	0.5	10.5	2.8	6.3	7.4	5.2	3.5	6.7	3.0	11.1	18.6	3.3	16.3	7.2	4.3	4.0	4.9	7.6	5.1	6.4	1.0	1.7	6.3	7.5	4.0	11.0	17.5	1.4	10.3	23.1	3.5	7.4	4.6	8.1	2.8	4.5	3.2	7.3	3.3	3.4	3.9	11.1	2.8	0.0	9.2	4.1	1.5	5.7	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	2.3	0.3	4.4	5.0	5.2	0.9	0.2	3.5	1.4	2.1	8.2	3.3	0.4	0.2	4.0	1.3	1.6	1.9	2.5	0.0	1.5	0.0	1.1	2.3	2.9	0.5	0.1	5.9	2.4	5.9	2.1	1.5	1.8	0.0	2.5	2.1	0.0	3.4	2.1	1.1	0.0	0.5	0.0	8.1	1.0	0.9	1.9	3.6	0.5	0.9	1.4	0.1	0.2	4.5	1.0	4.4	1.4	0.9	0.2	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	9.4	2.8	6.3	4.0	4.9	1.7	6.3	10.3	2.8
CFAP70	"FLJ25765, TTC18"	ENSG00000156042	"Cilia and flagella associated protein 70"	Q5T0N1	10	73253759-73358859	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 27.2;testis: 22.3"	"Cell line enhanced"	"Detected in many"		"PC-3: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037582, HPA070304"	Enhanced									"HPA037582: , HPA070304: "	"unprognostic (2.29e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.94e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-1)"	1.6	3.8	3.8	1.1	7.1	0.6	3.9	3.3	4.3	2.6	0.8	8.2	8.7	1.6	2.1	13.8	0.9	17.3	1.8	1.4	4.2	5.3	4.0	2.2	3.3	1.0	3.7	3.8	4.0	2.4	10.1	27.2	0.8	14.7	4.2	0.9	4.0	2.9	8.5	1.2	3.5	0.8	1.3	4.4	1.4	1.7	22.3	6.5	0.5	6.1	0.5	1.1	0.8	1.0	2.7	1.2	1.1	0.5	1.5	4.1	1.0	1.7	2.1	2.4	2.0	4.1	3.6	0.7	0.9	0.3	0.6	0.6	1.7	7.7	0.9	1.2	0.3	1.2	1.3	1.7	0.9	1.6	3.7	1.5	1.9	1.7	0.4	0.8	0.9	2.2	4.1	1.3	1.1	0.0	0.7	5.0	0.7	3.0	2.0	1.6	0.8	9.0	1.3	2.0	3.9	3.8	0.6	3.3	0.3	0.8	1.6	1.3	3.0	1.3	1.4	0.6	2.1	0.9	2.2	5.1	2.8	2.2	2.9	1.7	0.6	0.2	0.1	1.1	1.0	0.5	2.2	1.8	2.0	1.6	0.6	2.7	4.1	3.6	0.3	1.5	0.4	1.2	1.8	1.0	3.8	7.1	3.3	4.3	4.2	5.3	3.7	3.8	14.7	6.5
CFAP73	"CCDC42B, MIA2"	ENSG00000186710	"Cilia and flagella associated protein 73"	A6NFT4	12	113149858-113159276	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2;epididymis: 17.8;fallopian tube: 35.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.3;REH: 3.2;T-47d: 3.8;U-698: 12.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Region enhanced"	"Detected in many"		"pons and medulla: 27.2"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.0;naive CD4 T-cell: 1.3"	"Group enriched"	"Detected in many"	9	"B-cells: 1.0;T-cells: 1.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA048539	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"				"Nucleoli fibrillar center"	"Nucleoplasm, Vesicles"	"HPA048539: "	"unprognostic (2.42e-2)"	"prognostic favourable (1.29e-4)"	"unprognostic (1.90e-3)"	"prognostic favourable (5.52e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.14e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.62e-4)"	"unprognostic (2.03e-4)"	"unprognostic (1.60e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.55e-2)"	0.2	0.3	4.3	0.5	16.9	2.0	0.3	0.5	0.9	3.1	0.3	15.3	1.0	0.5	1.0	17.8	0.6	35.5	0.4	0.2	5.8	6.1	0.6	0.2	5.7	0.9	0.2	0.9	6.8	0.3	0.7	0.9	0.2	27.2	0.3	0.3	0.0	2.2	0.9	0.5	4.5	0.6	0.2	1.1	0.5	3.9	1.5	4.7	0.0	0.5	0.5	1.3	0.4	0.0	1.0	0.1	0.0	0.0	0.0	1.3	0.2	0.3	0.1	0.4	0.4	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.5	3.0	6.3	0.2	0.0	1.0	0.0	0.0	0.0	0.2	0.5	0.3	2.1	0.2	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.3	1.1	0.4	0.2	3.2	0.0	0.5	0.8	0.7	0.6	0.1	0.0	0.9	0.0	3.8	0.0	0.1	0.1	1.0	0.3	0.2	0.6	0.2	12.7	0.9	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	4.3	16.9	0.5	0.9	5.8	6.1	0.2	0.9	27.2	4.7
CFAP74	"C1orf222, FLJ45476, KIAA1751"	ENSG00000142609	"Cilia and flagella associated protein 74"	Q9C0B2	1	1921951-2003837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.8;fallopian tube: 12.1;testis: 26.4"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA028521, HPA029274, HPA030240"	Enhanced									"HPA028521: AB_10601881, HPA029274: AB_10601997, HPA030240: AB_10601961"	"unprognostic (5.41e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.12e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.26e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-1)"	0.4	2.3	1.3	0.5	4.8	1.6	0.3	11.8	3.8	1.7	0.4	3.9	0.4	0.4	1.0	6.6	1.6	12.1	1.2	0.3	1.9	1.8	0.2	1.7	3.1	1.0	0.8	1.5	2.5	0.1	0.3	2.4	0.5	5.4	0.2	0.4	0.0	0.5	0.7	1.2	5.5	0.3	0.2	0.4	0.4	0.3	26.4	1.0	0.0	1.9	0.0	0.2	0.9	0.1	1.4	1.2	1.5	1.4	1.9	1.1	0.1	1.5	0.0	2.4	1.5	0.0	3.5	2.1	0.3	0.0	0.0	1.2	3.4	0.3	2.0	3.1	0.6	0.5	0.0	0.6	0.5	1.8	2.8	4.2	5.1	2.3	0.6	3.2	1.4	2.3	2.1	0.0	0.0	0.0	5.8	1.6	1.2	0.6	1.6	1.1	1.9	2.6	1.7	0.7	1.0	0.0	3.3	3.1	1.1	0.6	0.3	0.1	0.7	0.9	3.6	2.0	2.0	0.8	2.3	2.2	0.8	2.2	0.2	3.2	1.0	0.3	1.4	1.1	0.8	0.6	0.3	1.0	0.6	0.5	0.5	1.4	0.8	1.1	1.5	1.9	0.9	1.2	0.6	0.1	1.3	4.8	11.8	3.8	1.9	1.8	0.8	1.5	5.4	1.0
CFAP97D1	C17orf105	ENSG00000231256	"CFAP97 domain containing 1"	B2RV13	17	43780435-43787612	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 45.9"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053028	Approved									"HPA053028: "	"unprognostic (7.80e-2)"	"unprognostic (5.46e-2)"		"unprognostic (3.37e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.80e-2)"	"unprognostic (3.09e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.41e-1)"	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.1	45.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.9	3.0	1.0	1.3	0.7	0.3	1.0	0.1	0.2	1.0	0.2	0.2	0.5	0.4	0.0	0.0	0.2	0.4	0.6	0.8	0.2	0.1	0.6	0.3	0.4	0.3	0.4	0.7	1.8	1.2	0.6	0.1	0.4	0.9	0.5	0.0	0.7	0.6	0.5	0.5	1.0	0.1	0.1	1.1	2.0	0.6	0.5	0.9	0.7	0.2	0.3	0.6	1.1	1.0	0.6	0.6	0.6	1.5	1.8	0.6	1.0	1.7	0.9	0.4	0.4	0.5	0.2	0.7	1.6	0.6	2.1	1.0	0.9	0.7	0.6	0.5	0.8	0.5	0.3	0.4	1.5	0.7	0.7	3.0	1.3	0.7	0.9	0.4	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0
CGB1		ENSG00000267631	"Chorionic gonadotropin beta subunit 1"	A6NKQ9	19	49035610-49036895	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"pancreas: 8.4"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 20.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038925, HPA038934"	Uncertain		Approved	Cytosol	"Secreted to blood"			Cytosol		"HPA038925: , HPA038934: "																		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	8.4	0.0	1.4	0.1		0.0	0.0		0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.9	0.1	0.1	0.0	0.0	0.5	0.3	4.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CGB7	CG-beta-a	ENSG00000196337	"Chorionic gonadotropin beta subunit 7"	P0DN87	19	49054275-49058860	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skin 1: 8.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.9;HaCaT: 5.6;HBEC3-KT: 4.7;hTCEpi: 6.8;U-251 MG: 10.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted in other tissues"			Cytosol		"HPA038925: , HPA038934: "	"unprognostic (9.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.60e-5)"	"unprognostic (2.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.83e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.89e-8)"	"unprognostic (1.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.28e-2)"	0.3	0.2	0.3	0.3	0.3	0.0	0.8	0.3	1.5	1.7	0.3	0.3	3.7	0.3	1.2	0.5	4.0	1.0	2.0	2.0	0.4	0.2	1.0	0.3	0.8	0.3	0.3	0.3	0.9	2.5	0.0	2.7	3.7	1.3	4.6	0.0	0.8	1.3	3.9	6.4	8.1	0.3	0.3	0.3	0.3	0.0	1.5	0.3	0.3	0.9	2.2	0.3	2.4	2.7	0.2	0.0	0.0	0.0	0.0	0.3	0.0	3.1	0.8	0.2	1.5	0.0	0.2	6.9	0.6	0.0	1.4	1.2	1.2	2.6	0.0	0.1	1.3	5.6	0.1	4.7	0.5	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.4	6.8	0.4	0.7	0.0	0.0	0.2	1.3	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.9	0.1	0.1	1.4	0.1	0.1	1.0	0.1	0.2	2.2	2.3	0.0	10.2	0.3	0.4	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.3	1.5	0.4	0.2	0.3	0.3	1.3	0.3
CGREF1	CGR11	ENSG00000138028	"Cell growth regulator with EF-hand domain 1"	Q99674	2	27098889-27119115	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.6"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 38.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008241, HPA071103"	Uncertain		Approved	"Golgi apparatus"	"Secreted in brain"		22000	"Golgi apparatus"		"HPA008241: AB_1846605, HPA071103: "	"unprognostic (1.39e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (3.18e-4)"	"unprognostic (8.45e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (5.22e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.30e-2)"	"unprognostic (7.24e-4)"	"unprognostic (1.20e-2)"	5.0	3.0	15.7	1.4	28.8	2.2	7.1	14.8	31.6	2.1	3.2	2.8	0.2	4.6	5.6	2.0	3.4	5.9	4.6	2.8	16.1	13.8	3.4	10.3	0.9	0.8	8.5	15.9	11.0	3.8	0.4	1.4	0.7	10.3	5.1	4.6	0.8	13.7	1.4	3.1	2.1	6.3	6.4	2.6	1.0	13.4	4.0	3.6	0.0	0.7	1.6	2.8	4.0	0.5	1.0	0.9	0.9	1.0	0.9	1.1	0.6	3.5	3.0	0.1	3.9	9.1	3.4	0.2	4.3	0.0	0.4	0.2	0.8	3.0	0.0	1.2	8.5	0.2	0.6	0.9	0.2	0.0	1.8	0.1	5.2	7.6	8.4	2.3	0.3	2.3	8.7	1.2	1.0	0.3	0.1	0.1	0.5	11.2	1.7	3.1	1.0	8.3	0.1	0.0	0.2	0.0	0.1	8.7	13.1	8.5	38.3	4.3	12.3	6.4	0.0	0.0	3.5	0.0	0.3	1.1	0.3	0.3	0.0	0.1	4.9	0.9	1.0	0.0	0.7	0.8	0.5	1.0	1.0	0.7	0.5	0.7	0.6	1.1	0.6	0.9	0.4	0.9	0.7	0.6	15.7	28.8	14.8	20.5	16.1	13.8	8.5	15.9	10.3	3.6
CHIC1	BRX	ENSG00000204116	"Cysteine rich hydrophobic domain 1"	Q5VXU3	X	73563200-73687102	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 18.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026782, HPA052062"	Uncertain		Approved	"Nuclear speckles,Vesicles,Cytosol"				"Nuclear speckles, Vesicles"	Cytosol	"HPA026782: AB_1846654, HPA052062: "	"unprognostic (9.85e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.10e-2)"	"unprognostic (9.95e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.65e-1)"	"prognostic favourable (2.75e-4)"	"unprognostic (1.37e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.76e-2)"	5.6	13.9	11.0	7.1	16.3	1.5	7.5	14.7	17.6	14.6	8.2	8.5	7.7	4.7	11.1	7.9	5.1	8.7	9.2	10.3	11.7	13.2	12.4	3.4	5.6	7.2	11.2	13.8	11.8	4.1	13.3	18.2	4.4	16.8	9.9	8.6	6.8	5.1	13.0	4.6	6.0	5.9	10.7	15.4	7.7	4.9	3.3	12.5	3.7	12.8	2.6	6.8	7.4	10.1	1.1	0.2	1.0	0.3	1.2	3.0	0.6	4.0	4.1	2.1	2.7	6.0	8.2	0.0	4.5	6.1	3.7	4.5	2.7	5.1	1.9	6.3	4.0	1.2	3.0	2.2	8.3	4.6	3.7	2.7	3.4	0.0	3.9	0.0	5.5	5.6	2.7	7.0	3.8	5.3	0.7	18.3	7.2	0.6	1.6	0.0	6.6	4.1	1.6	5.3	1.2	4.7	2.0	1.2	1.7	5.1	2.4	5.4	2.0	1.1	6.1	4.3	4.2	8.5	2.7	5.2	12.9	0.0	6.3	3.0	3.3	1.0	0.1	0.0	1.9	0.1	3.0	1.1	1.5	1.9	0.0	1.1	1.5	2.0	0.0	1.2	0.3	0.2	1.2	0.6	11.0	16.3	14.7	17.6	11.7	13.2	11.2	13.8	16.8	12.5
CHODL	"C21orf68, FLJ12627, MT75, PRED12"	ENSG00000154645	Chondrolectin	Q9H9P2	21	17901263-18267373	"Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 59.6"	"Cell line enhanced"	"Detected in some"		"U-266/70: 4.0;U-266/84: 9.8;U-87 MG: 11.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 6.8;hypothalamus: 8.2;pons and medulla: 8.6"	"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 4.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 4.9"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.1;hypothalamus: 14.3;pons and medulla: 11.4"	"Region enriched"	"Detected in all"	6	"olfactory region: 208.8"	HPA017282	Enhanced									"HPA017282: AB_1846687"	"unprognostic (3.91e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.37e-2)"	"prognostic unfavourable (1.18e-6)"	"unprognostic (6.74e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.79e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.02e-1)"	2.3	1.9	0.8	2.1	6.8	0.0	1.1	0.5	0.8	0.3	2.3	0.5	4.0	1.5	0.7	1.1	1.4	0.5	0.8	3.4	1.3	8.2	4.7	0.0	0.3	0.3	1.4	0.8	0.5	0.0	0.5	2.1	1.7	8.6	8.2	3.4	1.4	0.6	1.8	1.3	2.1	0.9	0.4	2.2	12.3	0.7	59.6	1.1	0.1	0.9	4.3	1.1	1.1	1.1	0.4	0.6	0.0	0.1	0.4	4.9	0.3	0.0	0.0	0.9	0.0	0.0	0.2	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	2.4	0.2	0.4	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.6	0.1	2.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.3	0.0	1.0	0.9	0.0	0.1	0.1	0.1	0.1	0.0	0.0	4.0	9.8	0.3	11.3	0.0	0.1	0.0	0.0	0.0	0.7	0.0	4.9	0.4	0.3	0.8	0.1	0.2	0.0	1.1	0.0	0.4	0.1	0.6	1.0	0.3	0.8	6.8	0.5	0.8	1.3	8.2	1.4	0.8	8.6	1.1
CHPF2	"ChSy-3, CSGlcA-T, KIAA1402"	ENSG00000033100	"Chondroitin polymerizing factor 2"	Q9P2E5	7	151232489-151238827	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020992	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			"Nucleoplasm, Cytosol"		"HPA020992: AB_1847267"	"unprognostic (8.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"prognostic unfavourable (9.47e-4)"	"unprognostic (4.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.54e-2)"	"prognostic favourable (2.51e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.59e-3)"	13.5	29.3	13.4	19.0	12.9	22.6	19.1	13.1	20.2	15.3	14.4	11.4	20.7	14.9	19.5	16.9	13.3	14.9	17.6	18.8	13.7	12.5	14.9	20.7	17.4	23.4	11.4	17.4	14.4	23.7	16.7	41.5	18.6	11.8	18.5	10.8	12.2	25.4	19.8	7.9	14.2	17.1	17.3	9.4	28.1	20.1	12.9	11.1	16.2	17.5	7.4	13.7	18.9	12.8	2.7	9.5	9.9	5.6	2.6	5.7	3.7	8.9	7.3	4.9	14.4	17.2	17.1	7.5	18.9	29.6	10.3	12.6	4.8	15.3	2.7	33.5	30.0	11.3	2.2	13.5	4.5	10.3	6.7	2.8	8.0	6.7	16.2	5.8	24.0	26.2	7.6	9.7	3.5	16.2	2.7	7.9	16.3	14.7	5.4	22.7	6.6	8.5	5.1	2.9	9.0	10.0	7.1	5.4	9.5	10.1	10.0	4.8	3.8	9.6	22.0	11.5	1.9	15.2	16.0	14.6	2.1	3.9	41.7	7.8	15.5	1.2	5.6	7.9	5.7	5.1	5.4	2.7	3.1	5.1	6.3	2.7	2.2	2.3	9.9	2.6	5.0	9.5	3.4	3.7	13.4	12.9	13.1	20.2	13.7	12.5	11.4	17.4	11.8	11.1
CHRM5		ENSG00000184984	"Cholinergic receptor muscarinic 5"	P08912	15	33968720-34067457	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 22.8"	"Group enriched"	"Detected in some"	5	"BEWO: 5.4;HMC-1: 18.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.8"	"Region enhanced"	"Detected in many"		"hypothalamus: 15.4"	"Low region specificity"	"Detected in many"			HPA013172	Uncertain									"HPA013172: AB_1854212"	"unprognostic (8.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.67e-2)"	"unprognostic (4.32e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.61e-4)"	"unprognostic (7.95e-2)"	"unprognostic (1.33e-6)"	"unprognostic (1.42e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.07e-2)"	0.3	0.5	1.2	0.9	15.7	1.3	2.1	0.8	6.9	0.3	0.4	5.1	0.0	1.1	0.5	0.8	0.5	0.3	0.6	0.3	6.8	4.4	0.6	0.9	0.4	1.0	5.8	4.5	0.5	1.0	0.1	0.5	4.8	17.8	0.6	0.3	0.0	0.5	0.1	0.7	1.8	1.8	0.2	22.8	0.7	0.6	5.2	0.0	0.0	2.3	0.0	0.3	0.4	0.3	0.3	0.9	4.8	0.3	0.2	0.3	0.0	0.1	0.2	0.8	0.3	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.5	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.2	0.7	0.3	0.2	0.0	0.5	18.8	0.4	0.0	0.2	0.1	0.0	0.6	1.2	0.1	0.2	0.2	2.2	0.2	0.3	0.1	0.3	0.2	0.0	0.4	0.3	0.3	0.3	0.7	0.2	0.2	1.1	0.2	0.2	0.2	0.2	0.1	0.9	0.3	0.4	0.1	0.2	0.3	1.5	0.3	0.2	0.3	0.1	0.3	0.2	0.2	0.2	0.1	0.3	0.1	0.2	4.8	0.2	0.1	0.9	0.2	0.0	1.2	15.7	0.8	6.9	6.8	4.4	5.8	4.5	17.8	0.0
CHRNB3		ENSG00000147432	"Cholinergic receptor nicotinic beta 3 subunit"	Q05901	8	42697376-42737407	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 19.6;pancreas: 6.8;testis: 5.0"	"Group enriched"	"Detected in some"	6	"NTERA-2: 3.3;U-266/84: 7.1"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 19.6;midbrain: 8.2"	"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 1.5;T-reg: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	32	"cerebellum: 21.0;midbrain: 30.4"	HPA045555	Enhanced									"HPA045555: AB_10960891"					"unprognostic (8.63e-2)"						"unprognostic (4.12e-1)"			"unprognostic (7.29e-2)"	"unprognostic (1.62e-1)"			0.1	0.1	0.3	0.1	0.8	0.1	0.1	19.6	2.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.4	0.1	0.1	0.1	0.8	8.2	2.3	0.1	6.8	0.1	0.9	0.1	1.1	0.1	0.1	3.4	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	5.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	3.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.8	19.6	2.7	0.4	0.4	8.2	2.3	1.1	0.0
CHST12	"C4S-2, C4ST2"	ENSG00000136213	"Carbohydrate sulfotransferase 12"	Q9NRB3	7	2403560-2448483	"Enzymes, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 25.6;NB-4: 26.5;U-266/70: 37.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041680	Approved		Approved	"Golgi apparatus"			430000	"Golgi apparatus"		"HPA041680: AB_10959789"	"unprognostic (4.12e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.88e-2)"	"prognostic favourable (1.32e-5)"	"unprognostic (9.61e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	24.2	12.0	9.4	12.1	10.5	14.5	11.2	17.8	16.5	11.9	10.1	13.2	9.0	13.5	14.4	10.6	5.9	11.7	10.9	12.0	8.8	7.7	9.3	6.8	13.6	10.3	10.4	9.2	9.6	17.5	4.9	14.4	9.6	12.7	11.8	4.2	12.3	14.1	11.6	11.9	11.5	10.1	8.1	9.5	25.0	12.4	10.2	8.6	9.0	11.2	4.4	11.8	10.6	10.3	5.7	21.0	16.4	3.5	37.4	30.2	6.7	3.8	4.0	2.4	4.4	3.7	2.7	12.5	7.0	3.3	3.1	4.2	4.4	1.5	3.4	13.4	3.1	3.2	1.5	1.9	0.8	4.5	8.3	2.3	3.4	4.9	1.7	7.8	25.6	3.6	1.1	2.7	0.3	3.2	6.1	12.4	1.4	3.6	8.2	26.5	8.4	7.2	3.1	3.2	17.9	1.5	2.1	3.0	12.2	3.4	2.6	1.7	3.2	10.0	5.3	4.5	11.8	8.8	6.2	37.9	14.6	1.5	3.6	4.0	7.8	15.5	3.5	16.4	30.2	2.8	18.9	5.2	10.7	24.5	6.6	5.7	4.5	13.5	1.0	37.4	1.2	21.0	10.2	6.7	9.4	10.5	17.8	16.5	8.8	7.7	10.4	9.2	12.7	8.6
CHST5	"FLJ22167, I-GLCNAC-6-ST"	ENSG00000135702	"Carbohydrate sulfotransferase 5"	Q9GZS9	16	75528535-75535247	"Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 32.9"	"Cell line enhanced"	"Detected in many"		"PC-3: 4.6"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.4;stomach cancer: 1.5"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA043804	Enhanced				"Intracellular and membrane"					"HPA043804: AB_10960563"	"unprognostic (6.82e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.46e-2)"		"unprognostic (6.76e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.09e-2)"	"unprognostic (9.03e-3)"	"unprognostic (4.27e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.42e-2)"	0.4	0.0	0.7	0.4	1.7	0.0	0.4	2.4	1.1	0.4	17.5	0.4	0.4	32.9	0.4	0.4	0.4	1.1	0.4	0.4	0.8	0.8	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.5	0.4	0.4	0.4	21.6	0.4	0.4	0.4	2.1	0.0	28.5	0.4	0.4	0.4	1.7	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	1.3	1.1	3.0	1.3	1.1	1.1	0.4	0.4	1.0	1.4	1.6	0.4	0.9	0.7	0.0	0.3	0.6	0.5	0.6	1.9	1.2	0.6	0.3	1.1	0.1	0.7	0.0	0.4	1.4	0.2	0.5	1.8	0.3	0.7	0.8	1.1	0.1	0.0	0.4	0.2	0.4	1.3	0.0	2.7	0.7	3.7	0.9	4.6	0.5	0.4	2.6	1.6	0.4	2.1	3.6	1.9	1.4	0.2	1.0	0.3	0.3	1.5	1.0	2.6	0.3	0.7	1.8	0.2	1.0	0.3	0.9	3.0	1.0	1.0	0.9	1.0	0.8	1.0	0.8	0.7	0.5	1.3	1.1	1.1	2.6	1.1	1.3	1.1	0.7	0.4	0.7	1.7	2.4	1.1	0.8	0.8	0.4	0.4	0.4	0.4
CHST9	"GALNAC-4-ST2, GALNAC4ST-2"	ENSG00000154080	"Carbohydrate sulfotransferase 9"	Q7L1S5	18	26906481-27185317	"Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 23.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.3;Hep G2: 9.3;RPTEC TERT1: 29.3;SCLC-21H: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA011393	Uncertain				"Intracellular and membrane"					"HPA011393: AB_1846733"	"unprognostic (9.24e-3)"	"unprognostic (1.13e-2)"		"unprognostic (4.81e-3)"	"unprognostic (6.63e-3)"	"unprognostic (4.53e-3)"	"unprognostic (9.98e-3)"	"unprognostic (9.21e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.38e-1)"		"unprognostic (3.93e-3)"	0.3	0.4	1.7	0.3	2.4	0.2	3.7	1.0	2.6	4.0	2.1	4.5	0.7	0.4	0.3	0.9	2.2	13.6	4.5	3.4	3.7	2.7	2.4	12.1	8.6	0.1	2.6	0.8	1.2	11.9	0.1	4.3	0.1	4.9	4.8	0.4	5.3	23.4	2.7	0.4	0.4	0.7	0.3	5.3	7.1	1.0	8.5	4.2	0.0	0.3	3.9	7.0	2.6	10.5	0.5	0.1	0.8	0.1	0.3	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	29.3	0.0	6.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.5	0.2	0.3	0.5	0.3	0.0	0.1	0.1	0.0	1.7	2.4	1.0	2.6	3.7	2.7	2.6	0.8	4.9	4.2
CHSY3	"CHSY-2, CSS3"	ENSG00000198108	"Chondroitin sulfate synthase 3"	Q70JA7	5	129904472-130186634	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 12.5;ASC TERT1: 11.1;HSkMC: 7.2;TIME: 6.7;U-138 MG: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044612	Uncertain				"Intracellular and membrane"					"HPA044612: AB_10795883"	"unprognostic (3.43e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.83e-2)"	"unprognostic (5.88e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.08e-6)"	"unprognostic (5.22e-3)"	"unprognostic (9.93e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.74e-2)"	11.7	1.6	7.0	2.7	8.9	0.3	5.7	0.4	10.4	12.5	1.7	2.1	0.0	1.5	4.2	1.6	1.8	2.6	7.2	3.0	4.8	2.2	1.0	4.8	4.6	1.4	2.1	8.9	1.1	1.1	2.1	0.9	5.6	1.0	1.4	1.6	6.3	1.3	1.8	2.2	2.8	1.3	5.2	1.5	1.9	1.5	1.9	2.1	0.0	2.9	1.3	1.3	3.9	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.1	0.0	12.5	11.1	1.0	2.7	0.1	0.4	0.4	0.0	0.1	0.0	0.2	4.1	0.0	0.0	0.1	0.0	0.0	1.5	1.7	5.5	0.4	1.2	0.0	0.0	7.2	0.0	0.1	1.1	2.9	0.0	1.8	4.8	0.0	0.0	0.0	0.6	1.1	0.4	5.3	0.0	0.2	0.0	4.3	0.0	0.0	0.0	0.2	0.2	0.4	6.7	13.4	2.8	0.1	1.8	0.0	0.0	0.0	0.3	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.0	8.9	0.4	10.4	4.8	2.2	2.1	8.9	1.0	2.1
CILP2	MGC45771	ENSG00000160161	"Cartilage intermediate layer protein 2"	Q8IUL8	19	19538248-19546659	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 9.4;testis: 10.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.7;HEK 293: 5.1;NB-4: 3.8;THP-1: 4.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA041847	Uncertain				"Secreted to extracellular matrix"		11000000			"HPA041847: AB_10795599"	"unprognostic (6.51e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.42e-4)"	"prognostic unfavourable (3.22e-6)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.13e-3)"	"unprognostic (4.48e-2)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.41e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.59e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.36e-2)"	2.8	0.1	0.9	1.1	1.0	3.1	3.6	0.3	1.1	3.1	0.7	0.0	0.8	0.1	0.7	1.1	0.8	0.9	5.6	1.0	0.8	1.4	0.2	0.7	0.9	2.5	0.3	0.0	9.4	0.2	1.4	0.9	2.4	0.4	1.2	0.2	3.0	2.8	0.9	4.0	0.7	0.3	0.5	0.1	0.7	0.2	10.1	0.0	0.0	7.8	0.4	1.8	1.1	0.6	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.2	0.3	0.2	8.7	0.3	1.2	1.1	0.0	0.5	0.1	2.3	0.9	0.1	2.2	0.4	1.0	0.2	0.0	0.1	0.6	5.1	0.0	0.2	0.3	0.3	0.0	0.6	1.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.7	0.0	3.8	3.2	1.6	0.6	0.0	0.0	0.1	0.0	0.1	2.2	0.5	2.7	0.3	0.5	4.9	0.0	0.1	1.1	0.4	0.2	0.7	1.9	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.3	1.1	0.8	1.4	0.3	0.0	0.4	0.0
CKLF	"C32, CKLF1, CKLF3, CKLF4, HSPC224, UCK-1"	ENSG00000217555	"Chemokine like factor"	Q9UBR5	16	66552563-66566251	"Predicted membrane proteins, Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 142.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 142.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA062779			Approved	Vesicles	"Secreted to blood"			Vesicles		"HPA062779: "	"unprognostic (1.64e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (5.67e-5)"	"unprognostic (2.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.79e-2)"	"unprognostic (8.05e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (1.06e-9)"	"unprognostic (2.36e-1)"	"unprognostic (2.65e-1)"	"prognostic favourable (2.22e-4)"	"unprognostic (1.07e-1)"	18.8	21.1	16.1	27.7	16.9	29.9	18.8	19.0	14.9	14.8	20.6	11.0	9.1	15.7	14.8	15.2	12.5	16.4	22.8	11.0	14.9	13.4	15.0	14.6	28.9	41.2	23.1	11.0	14.5	12.0	11.4	13.5	14.6	15.0	14.6	22.0	10.9	13.0	9.7	6.8	9.0	26.5	16.9	20.8	44.4	12.2	42.5	18.6	40.2	12.3	11.7	24.6	17.6	13.0	9.4	32.2	142.0	39.6	17.7	25.6	34.2	35.3	31.6	6.6	19.1	17.9	14.7	4.8	17.7	13.5	19.4	29.0	29.4	43.5	13.9	22.4	15.2	19.1	13.2	10.6	27.4	17.2	6.7	10.1	28.1	35.9	10.8	31.7	27.5	10.0	8.6	24.1	8.6	23.0	16.2	40.3	24.2	11.8	30.6	31.5	2.1	51.3	52.5	35.1	38.8	64.7	19.7	9.3	11.3	54.3	3.6	16.4	10.5	21.5	14.1	28.1	25.4	9.7	20.8	19.2	39.3	71.1	23.7	27.9	22.7	64.6	39.6	74.8	20.6	19.8	25.6	9.4	19.2	20.0	32.2	8.8	10.2	14.1	142.0	17.7	18.6	16.3	22.9	34.2	16.1	16.9	19.0	14.9	14.9	13.4	23.1	11.0	15.0	18.6
CLBA1	C14orf79	ENSG00000140104	"Clathrin binding box of aftiphilin containing 1"	Q96F83	14	104985775-105010482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042052, HPA061117"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA042052: , HPA061117: "	"unprognostic (1.49e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.77e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.95e-1)"	2.1	5.3	5.4	2.6	12.5	2.0	6.6	3.5	13.5	7.6	3.4	5.2	11.8	2.3	6.8	15.1	5.1	18.9	6.5	2.4	6.2	6.5	8.9	6.1	7.4	1.8	3.3	5.9	6.8	11.3	13.2	15.3	2.4	5.3	7.6	3.5	7.6	6.3	8.3	1.3	9.2	2.2	4.4	2.1	2.4	5.9	23.9	1.8	1.8	17.6	1.0	2.3	4.2	3.3	1.8	2.3	2.4	1.1	1.0	1.4	0.5	4.0	7.2	2.2	6.7	2.2	3.3	3.4	3.3	3.0	3.9	1.7	0.7	7.1	0.4	6.9	3.2	8.6	0.8	4.8	2.5	3.3	2.5	0.2	6.1	0.3	7.7	1.7	1.8	2.0	11.2	4.2	8.3	2.2	2.3	1.1	2.3	13.6	0.7	5.2	2.8	6.9	2.5	1.2	2.2	8.4	2.3	14.1	7.4	4.6	2.1	3.8	14.7	2.5	2.4	4.9	2.3	9.9	2.5	1.4	0.9	0.3	6.3	0.5	3.4	1.8	1.1	0.4	1.4	1.1	0.3	1.2	1.4	0.3	0.5	1.8	0.6	1.3	2.4	1.0	1.0	2.3	0.6	0.5	5.4	12.5	3.5	13.5	6.2	6.5	3.3	5.9	5.3	1.8
CLDN18	SFTPJ	ENSG00000066405	"Claudin 18"	P56856	3	137998735-138033655	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"gallbladder: 37.4;lung: 91.9;stomach 1: 126.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.1"	"Group enriched"	"Detected in some"	11	"pancreatic cancer: 113.7;stomach cancer: 186.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013010, CAB013243, HPA018446"	Enhanced									"CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: "	"unprognostic (1.03e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.14e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.42e-5)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.95e-1)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.7	0.8	0.1	0.1	0.1	0.1	0.3	0.1	37.4	2.0	0.1	0.0	0.1	0.1	91.9	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.1	0.1	126.9	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.4	0.1	0.0	0.5	0.4	0.9	0.4	1.4	0.7	0.5	0.2	0.2	0.0	0.1	0.7	0.5	0.0	0.2	0.5	1.8	0.0	1.0	0.4	0.1	0.6	0.1	2.5	0.1	0.2	0.1	3.1	1.1	0.6	0.6	0.7	0.0	0.0	0.3	0.2	0.4	1.9	0.6	2.0	0.4	1.5	0.2	0.0	0.3	1.0	0.3	0.4	0.6	0.0	0.3	0.7	0.4	0.3	1.0	1.7	1.3	0.4	2.0	0.1	0.0	0.9	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.1
CLDN23	CLDNL	ENSG00000253958	"Claudin 23"	Q96B33	8	8701938-8704106	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 9.6;Daudi: 7.6;RT4: 8.1;SK-BR-3: 8.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.4;plasmacytoid DC: 3.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070578			Uncertain	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA070578: "	"unprognostic (1.86e-1)"	"unprognostic (1.53e-1)"	"prognostic favourable (3.46e-4)"	"unprognostic (2.97e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.97e-2)"	"unprognostic (8.25e-3)"	"prognostic favourable (9.65e-8)"	"unprognostic (7.76e-2)"	"unprognostic (3.17e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.33e-3)"	9.1	1.0	0.3	7.1	1.4	0.3	6.1	0.4	0.6	2.6	14.8	0.5	3.8	5.5	1.0	6.3	2.8	1.4	10.6	1.4	0.9	0.2	6.5	13.3	8.7	3.1	1.1	0.3	2.6	3.2	1.5	0.7	15.7	1.7	3.3	8.8	2.8	6.0	2.5	0.9	10.0	20.0	0.5	0.3	2.4	18.0	1.5	0.5	0.4	8.8	4.3	3.0	6.0	5.3	0.5	3.9	0.8	2.4	0.0	0.0	0.6	0.2	3.1	0.0	0.2	0.9	0.1	9.6	2.4	1.9	2.5	3.9	1.8	5.1	7.6	0.0	0.1	3.0	0.0	0.1	0.2	1.5	0.0	0.0	1.0	0.1	4.5	0.0	0.1	1.3	1.0	0.0	0.0	0.0	0.1	0.0	0.3	3.9	0.1	0.2	2.4	1.6	0.0	0.0	0.0	1.2	8.1	0.4	1.1	3.1	8.3	0.1	1.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.8	0.0	2.4	0.0	0.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.6	0.3	1.4	0.4	0.6	0.9	0.2	1.1	0.3	1.7	0.5
CLDN5	"AWAL, BEC1, CPETRL1, TMVCF"	ENSG00000184113	"Claudin 5"	O00501	22	19523024-19527545	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 101.1"	"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 40.1;SCLC-21H: 25.2"	"Cancer enhanced"	"Detected in all"		"glioma: 32.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"basophil: 7.4;naive CD4 T-cell: 3.4;neutrophil: 4.1"	"Group enriched"	"Detected in many"	20	"granulocytes: 7.4;T-cells: 3.4"	"Low region specificity"	"Detected in all"							CAB002607	Approved						730000			"CAB002607: "	"unprognostic (1.26e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.96e-2)"	101.1	4.9	13.9	6.8	17.9	1.9	45.5	7.1	20.0	10.6	19.4	10.2	3.0	9.9	10.2	5.1	7.8	9.5	11.7	14.1	16.9	15.0	7.6	6.0	43.6	9.2	19.8	4.5	8.6	5.5	2.4	1.5	13.1	20.0	8.2	5.0	5.4	4.1	5.1	26.2	10.2	10.3	7.6	18.9	13.5	8.8	6.5	11.9	0.3	20.1	7.3	3.7	7.6	34.7	0.1	0.2	7.4	0.2	0.0	3.4	20.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	40.1	0.3	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.4	0.3	0.0	0.0	0.0	25.2	0.1	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	3.4	0.1	4.1	0.0	0.0	0.1	0.0	20.9	13.9	17.9	7.1	15.8	16.9	15.0	19.8	4.5	20.0	11.9
CLDND2	MGC33839	ENSG00000160318	"Claudin domain containing 2"	Q8NHS1	19	51367098-51369003	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"testis: 31.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA056971	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA056971: "	"unprognostic (2.86e-1)"	"unprognostic (4.29e-5)"	"unprognostic (2.29e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.42e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.94e-9)"	"unprognostic (4.00e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.70e-2)"	7.7	7.8	6.8	3.2	11.1	13.3	3.3	10.9	16.5	2.6	3.6	1.4	8.4	7.7	3.0	2.5	2.9	2.8	4.5	2.5	9.9	4.7	2.8	3.5	4.0	3.2	19.6	5.2	6.7	9.1	1.5	2.9	1.8	7.4	3.8	2.4	1.7	7.5	6.0	11.9	1.5	7.1	3.8	10.2	7.3	3.3	31.4	10.6	0.0	2.9	2.2	1.2	3.2	3.0	1.7	3.0	5.8	2.0	5.3	4.5	0.7	2.0	5.9	2.2	3.0	3.2	2.9	1.2	1.0	0.5	1.0	1.3	0.7	7.0	5.5	1.2	0.6	2.7	0.7	0.3	0.2	3.9	9.5	4.8	9.2	11.5	1.2	1.4	1.4	2.2	0.9	0.2	0.6	0.6	3.1	4.1	0.9	1.3	1.1	8.0	0.9	7.5	1.1	5.0	2.2	1.6	1.6	1.3	1.5	2.5	0.5	2.1	1.5	0.4	1.4	2.2	4.4	2.3	0.9	3.8	4.0	2.0	5.3	5.5	1.3	5.8	0.9	4.1	3.5	2.0	2.0	1.7	0.8	4.5	1.4	1.1	0.6	1.5	0.5	5.3	0.7	3.0	1.2	0.7	6.8	11.1	10.9	16.5	9.9	4.7	19.6	5.2	7.4	10.6
CLEC18B	MRCL2	ENSG00000140839	"C-type lectin domain family 18 member B"	Q6UXF7	16	74408270-74421953	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"kidney: 28.1"	"Cell line enhanced"	"Detected in some"		"AF22: 3.0;K-562: 7.4;U-266/70: 2.8"	"Group enriched"	"Detected in some"	12	"glioma: 2.7;ovarian cancer: 1.2;renal cancer: 5.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048976	Uncertain				"Secreted to blood"					"HPA048976: "	"unprognostic (5.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.30e-3)"	"unprognostic (9.37e-2)"	"prognostic unfavourable (2.07e-4)"	"unprognostic (7.15e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.43e-2)"	"unprognostic (4.27e-2)"	0.1	1.1	1.1	0.3	1.4	0.1	0.1	2.5	1.2	0.1	0.1			0.4	0.1	0.6	1.2	0.1	0.3	0.0	1.0	1.0	28.1	0.1	0.0	0.1	1.0		0.1	0.3	0.1	0.1	0.1		0.2	0.1		0.2	0.0	0.2	0.0	0.2	0.1	2.0	0.1	0.1	6.1			0.1		0.1	0.0	0.6	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	1.6	3.0	1.8	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.2	1.1	0.5	1.1	1.0	0.0	0.1	0.3	0.3	0.4	0.3	0.1	0.7	0.0	0.3	1.8	0.4	0.1	0.1	0.0	7.4	0.0	0.3	0.0	0.0	0.0	1.2	0.8	0.4	0.0	1.6	0.0	0.3	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.4	0.2	0.9	2.8	1.6	0.3	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0										
CLEC18C	"MGC34761, MRCL3"	ENSG00000157335	"C-type lectin domain family 18 member C"	Q8NCF0	16	70173322-70187361	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	13	"kidney: 16.5;testis: 4.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.0;RT4: 1.2;TIME: 2.9"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048976	Uncertain				"Secreted to blood"					"HPA048976: "		"unprognostic (3.90e-1)"		"unprognostic (3.03e-1)"	"unprognostic (1.20e-4)"					"unprognostic (5.55e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.92e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-3)"		"unprognostic (6.98e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	16.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	4.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.3	1.2	0.5	0.2	0.0	0.0	0.0	0.0	0.6	2.9	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CLECL1	DCAL1	ENSG00000184293	"C-type lectin like 1"	Q8IZS7	12	9715860-9733299	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	9	"blood: 42.4;intestine: 11.5;lymphoid tissue: 20.6"	"Group enriched"	"Detected in some"	5	"HEL: 15.7;Karpas-707: 21.7;U-698: 55.5;U-937: 30.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 42.4"	"Lineage enriched"	"Detected in many"	5	"B-cells: 42.4"									HPA063928			Supported	"Plasma membrane,Centriolar satellite"				"Plasma membrane, Centriolar satellite"		"HPA063928: "	"unprognostic (2.18e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.55e-4)"	"unprognostic (5.10e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-5)"	"unprognostic (3.31e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.10e-2)"	"unprognostic (7.39e-2)"	2.7	1.0	0.8	9.8	1.1	0.9	1.1	0.3	0.9	0.6	1.7	1.3	0.1	1.6	0.7	1.3	2.6	0.9	1.5	2.7	1.0	0.9	1.6	1.4	1.9	15.5	1.3	0.7	0.5	1.7	0.0	0.9	0.5	0.9	0.8	2.8	0.8	1.5	0.1	0.5	0.5	11.5	0.9	2.5	20.5	2.6	0.6	0.3	2.2	0.9	0.5	20.6	2.8	2.4	42.4	8.6	0.7	4.6	0.0	3.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	55.5	0.0	30.5	0.0	0.7	2.6	0.1	1.7	4.6	0.0	42.4	1.4	3.5	6.1	14.5	0.0	0.5	0.1	0.0	4.6	8.6	0.1	2.1	0.8	1.1	0.3	0.9	1.0	0.9	1.3	0.7	0.9	0.3
CLIC6	"CLIC1L, CLIC5"	ENSG00000159212	"Chloride intracellular channel 6"	Q96NY7	21	34669389-34718227	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 63.3;retina: 85.1;stomach 1: 45.1"	"Group enriched"	"Detected in some"	4	"HMC-1: 4.3;NTERA-2: 5.8;T-47d: 11.7;THP-1: 5.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	12	"pons and medulla: 63.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA055123, HPA065285"	Enhanced									"HPA055123: , HPA065285: "	"prognostic favourable (6.11e-5)"	"unprognostic (2.17e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-2)"	"prognostic favourable (3.15e-5)"	"unprognostic (4.90e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.43e-3)"	7.7	0.0	0.8	3.0	1.7	0.0	5.7	0.6	2.3	8.7	1.8	12.4	0.6	0.9	1.0	5.2	1.2	6.1	4.5	6.3	5.4	1.0	0.9	0.6	6.4	0.4	0.4	0.5	2.3	1.2	0.0	1.3	0.6	63.3	4.0	1.3	85.1	10.9	3.8	1.9	2.3	1.1	1.9	0.6	0.7	45.1	1.1	0.6	2.4	8.2	0.9	1.8	7.5	2.0	0.3	0.1	0.4	0.0	0.2	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	1.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.1	0.0	4.3	0.2	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.4	11.7	5.2	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.1	0.8	1.7	0.6	2.3	5.4	1.0	0.4	0.5	63.3	0.6
CLPSL1	"C6orf127, dJ510O8.6"	ENSG00000204140	"Colipase like 1"	A2RUU4	6	35781017-35793675	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	12	"epididymis: 123.5;pancreas: 103.6"	"Cell line enriched"	"Detected in single"	17	"T-47d: 13.6"	"Group enriched"	"Detected in some"	6	"breast cancer: 3.6;cervical cancer: 1.0;endometrial cancer: 2.8;ovarian cancer: 1.8;pancreatic cancer: 3.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA073155	Enhanced				"Secreted in male reproductive system"					"HPA073155: "	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"		"unprognostic (4.75e-1)"				"unprognostic (2.54e-1)"		"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"			"unprognostic (1.97e-1)"	"unprognostic (6.60e-2)"		"unprognostic (7.06e-3)"	0.1	0.1	1.6	0.0	0.2	0.0	0.8	0.1	0.9	0.1	0.1	0.0	9.6	0.0	0.1	123.5	0.1	0.1	0.0	0.1	1.8	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.1	103.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	13.6	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.1	0.9	1.8	0.1	0.2	0.0	0.0	0.0
CLRN2		ENSG00000249581	"Clarin 2"	A0PK11	4	17515165-17527104	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"kidney: 1.2;salivary gland: 1.1;testis: 1.7"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA042407	Uncertain									"HPA042407: AB_10806237"																		0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.6	0.3	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.5	1.2	0.1	0.4	0.0	0.4		0.0	0.0	0.0	0.2	0.0		0.1	0.0		1.1	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CLRN3	"MGC32871, TMEM12, USH3AL1"	ENSG00000180745	"Clarin 3"	Q8NCR9	10	127877841-127892947	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 69.3;kidney: 14.7;liver: 25.6"	"Cell line enriched"	"Detected in some"	6	"CACO-2: 7.0"	"Group enriched"	"Detected in many"	10	"colorectal cancer: 45.3;liver cancer: 9.4;pancreatic cancer: 10.7;renal cancer: 30.0;stomach cancer: 16.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014482	Approved									"HPA014482: AB_2082885"	"unprognostic (7.34e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.22e-2)"		"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"		"unprognostic (2.62e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.67e-1)"	"unprognostic (8.86e-2)"	"prognostic favourable (8.98e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.89e-3)"	"unprognostic (3.00e-2)"	0.4	0.2	0.3	3.1	0.2	0.0	0.2	0.2	0.3	0.2	27.5	0.3	0.2	23.7	0.2	1.3	0.2	0.1	9.5	0.2	0.3	0.2	14.7	25.6	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	23.5	0.2	0.2	0.2	0.2	0.1	69.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	1.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.2	7.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	1.4	0.0	0.1	0.3	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.2	0.2
CLUL1		ENSG00000079101	"Clusterin like 1"	Q15846	18	596988-650334	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 45.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 24.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			"CAB025264, HPA075240"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted in other tissues"			"Endoplasmic reticulum"	"Plasma membrane"	"CAB025264: , HPA075240: "	"unprognostic (1.75e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.81e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.97e-3)"	"unprognostic (8.38e-3)"	"unprognostic (3.76e-2)"	"unprognostic (4.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.36e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.37e-2)"	0.5	1.4	5.0	0.5	3.8	4.3	3.1	4.5	6.6	2.1	1.0	1.4	1.0	0.6	1.9	0.7	1.6	2.4	2.5	0.4	5.9	6.4	7.5	0.7	1.8	0.8	4.9	2.0	7.4	1.6	2.5	6.1	0.7	5.1	12.0	0.0	45.2	3.1	1.6	0.1	0.8	1.7	0.4	5.3	0.1	3.9	3.4	2.8	0.3	9.4	0.1	0.4	2.1	0.3	1.0	1.3	2.1	0.3	0.1	2.0	0.5	2.5	3.9	7.4	5.0	0.0	0.0	4.4	2.8	0.2	0.0	0.0	3.0	1.5	3.1	0.7	0.0	1.1	0.0	0.4	0.0	2.5	6.8	5.2	2.1	24.3	0.0	1.7	1.0	0.2	0.0	0.0	0.0	0.3	7.2	9.0	0.0	0.8	3.0	5.5	0.5	1.7	6.2	3.5	10.8	0.8	0.7	6.5	4.5	2.9	1.8	2.2	2.4	0.7	0.6	3.0	4.3	2.1	1.4	5.1	8.9	6.4	2.4	3.3	2.5	0.9	0.3	0.2	0.2	0.0	0.1	1.0	0.4	0.2	0.5	0.1	0.1	0.8	2.1	0.1	0.0	1.3	2.0	0.5	5.0	3.8	4.5	5.7	5.9	6.4	4.9	2.0	5.1	2.8
CLVS2	"bA160A10.4, C6orf212, C6orf213, RLBP1L2"	ENSG00000146352	"Clavesin 2"	Q5SYC1	6	122995971-123072927	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 39.9"	"Group enriched"	"Detected in some"	8	"HEL: 14.3;SCLC-21H: 11.2"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043764	Uncertain									"HPA043764: AB_10960281"	"unprognostic (1.35e-1)"		"unprognostic (3.28e-2)"		"unprognostic (4.68e-2)"				"unprognostic (3.60e-1)"		"unprognostic (2.38e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.72e-3)"	"unprognostic (9.60e-2)"		"unprognostic (8.71e-2)"	0.7	2.8	5.0	0.9	9.6	0.7	0.8	39.9	22.6	2.1	1.1	0.6	0.0	0.9	3.1	0.7	0.8	0.7	0.8	0.7	5.8	3.9	0.7	0.8	0.7	0.8	3.0	10.2	0.7	0.7	0.7	6.3	0.7	8.5	7.9	1.1	0.1	0.8	1.1	0.7	0.8	0.9	2.8	1.3	0.7	0.8	1.0	1.8	0.0	0.7	0.0	0.7	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	9.6	39.9	22.6	5.8	3.9	3.0	10.2	8.5	1.8
CMTM1	"CKLFH, CKLFH1a, CKLFSF1"	ENSG00000089505	"CKLF like MARVEL transmembrane domain containing 1"	Q8IZ96	16	66566393-66579137	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 80.7"	"Cell line enhanced"	"Detected in many"		"REH: 16.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"granulocytes: 8.7"									"HPA013801, HPA017136"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA013801: AB_1846990, HPA017136: AB_1846992"	"unprognostic (2.37e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.97e-3)"	"unprognostic (5.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (5.68e-5)"	"unprognostic (2.47e-2)"	"unprognostic (1.56e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.49e-1)"	0.9	0.8	0.8	1.9	1.2	0.0	0.5	2.2	1.3	0.7	0.9	0.5	0.5	1.7	1.3	1.1	0.6	0.8	1.5	0.7	0.8	1.1	0.8	0.5	0.9	1.2	0.8	0.6	1.7	0.5	0.3	1.1	0.9	0.7	0.7	0.2	0.5	0.6	0.5	0.6	0.6	1.2	0.5	0.9	2.8	0.9	80.7	0.7	0.8	0.7	0.5	0.6	0.9	0.6	0.3	1.9	8.7	2.1	1.3	1.9	1.1	4.2	6.7	1.2	5.6	2.4	2.3	1.2	5.6	2.6	4.5	4.6	1.3	2.8	1.9	2.9	1.6	3.3	1.9	0.3	2.4	7.3	1.3	0.7	2.9	1.4	1.1	3.9	4.9	1.9	0.5	4.0	0.5	2.3	3.4	2.7	1.9	1.6	7.3	3.7	1.0	2.4	16.6	14.3	4.6	4.0	1.9	3.2	4.2	7.7	0.6	2.0	2.0	2.8	5.6	7.9	12.6	4.7	2.4	2.7	6.6	7.2	3.8	5.3	9.3	8.7	2.1	7.1	1.9	0.6	1.6	0.2	0.6	0.9	1.9	0.3	0.5	0.6	8.4	1.3	1.2	0.5	0.6	1.1	0.8	1.2	2.2	1.0	0.8	1.1	0.8	0.6	0.7	0.7
CNBD1	FLJ35802	ENSG00000176571	"Cyclic nucleotide binding domain containing 1"	Q8NA66	8	86866442-87615219	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 16.9"	"Group enriched"	"Detected in some"	11	"Karpas-707: 9.1;U-266/70: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA025037, HPA027469, HPA027786"	Uncertain				"Secreted in male reproductive system"					"HPA025037: AB_10794318, HPA027469: AB_10599492, HPA027786: AB_10600231"															"unprognostic (1.89e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CNBD2	"C20orf152, CNMPD1, dJ954P9.1"	ENSG00000149646	"Cyclic nucleotide binding domain containing 2"	Q96M20	20	35954564-36030700	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 31.1"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043182	Uncertain									"HPA043182: AB_10794389"	"unprognostic (1.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.59e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.82e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.85e-2)"	1.7	1.7	1.8	2.4	3.2	4.9	2.5	3.3	4.6	1.7	3.3	0.5	1.8	2.4	1.7	9.6	1.7	1.6	3.3	2.2	2.0	1.8	5.2	3.2	1.7	2.2	1.8	1.1	1.7	2.5	2.4	1.8	0.7	2.6	1.7	1.6	2.6	3.8	1.9	10.0	1.9	2.7	1.3	1.7	2.0	1.7	31.1	2.5	2.0	2.7	6.5	1.9	1.6	1.6	0.8	0.2	2.5	2.2	3.3	2.6	0.2	1.8	2.8	4.4	4.0	3.3	1.6	2.7	0.4	1.6	3.1	2.8	6.9	4.0	3.2	1.4	2.3	1.6	2.9	5.0	3.1	1.2	4.5	4.8	8.2	13.9	2.6	2.6	0.7	3.1	4.7	2.3	2.6	4.6	1.4	16.0	1.9	4.6	3.0	7.4	0.6	4.5	1.8	2.7	11.1	4.2	1.9	8.2	3.6	1.7	4.6	2.1	2.6	4.4	1.9	2.1	2.2	0.7	0.5	13.7	7.8	7.8	2.1	4.5	0.8	2.5	0.5	0.3	2.6	2.2	0.3	0.5	0.5	1.2	0.2	0.8	0.4	0.6	2.1	3.3	0.7	0.2	2.1	0.2	1.8	3.2	3.3	4.6	2.0	1.8	1.8	1.1	2.6	2.5
CNGA2	"CNCA, CNCA1, CNG2, FLJ46312, OCNC1, OCNCa, OCNCALPHA"	ENSG00000183862	"Cyclic nucleotide gated channel alpha 2"	Q16280	X	151738451-151745304	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Olfaction, Sensory transduction, Transport"	"Calmodulin-binding, Ion channel, Ligand-gated ion channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	26	"testis: 2.5"	"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"olfactory region: 0.6"	"Not detected"	"Not detected"			HPA015065	Uncertain									"HPA015065: AB_1847034"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CNPPD1	"C2orf24, CGI-57"	ENSG00000115649	"Cyclin Pas1/PHO80 domain containing 1"	Q9BV87	2	219171897-219178106	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049303	Uncertain									"HPA049303: "	"unprognostic (9.24e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.43e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.74e-3)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (1.77e-1)"	"unprognostic (4.15e-3)"	"unprognostic (5.54e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.35e-1)"	"prognostic favourable (1.62e-10)"	"unprognostic (1.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.54e-2)"	25.9	41.2	17.2	21.2	21.5	34.6	25.7	21.5	22.5	17.9	30.8	36.1	16.8	30.3	21.2	22.7	40.2	17.0	26.4	24.1	15.4	13.3	61.3	27.3	24.9	27.3	26.1	20.4	22.7	29.1	30.7	11.5	26.2	20.4	22.1	23.1	28.0	24.6	26.7	39.2	29.5	32.6	25.5	24.6	32.9	23.0	22.6	23.4	21.5	32.1	20.6	32.2	28.7	21.4	37.3	38.7	31.1	45.6	21.1	28.3	26.5	15.6	11.8	11.9	21.9	24.6	12.4	17.1	20.3	12.0	17.0	13.6	25.4	19.6	9.0	12.0	19.8	22.1	15.7	16.4	9.9	22.9	9.2	36.5	12.3	25.1	30.2	21.4	25.4	13.2	21.2	16.7	15.0	14.1	29.0	33.8	9.8	28.6	23.3	16.3	7.6	15.2	34.9	8.8	30.4	26.1	22.1	15.5	18.6	11.7	29.4	21.5	23.4	24.6	13.3	13.9	13.0	27.1	19.2	26.9	10.5	19.2	18.8	25.7	8.9	28.3	25.1	24.5	22.7	37.3	19.7	34.0	22.2	22.7	38.7	37.3	15.6	17.3	31.1	21.1	45.6	21.4	28.3	26.5	17.2	21.5	21.5	22.5	15.4	13.3	26.1	20.4	20.4	23.4
CNPY4	"MGC40499, PRAT4B"	ENSG00000166997	"Canopy FGF signaling regulator 4"	Q8N129	7	100119613-100125511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014166, HPA025240"	Uncertain		Approved	Vesicles	"Intracellular and membrane"			Vesicles		"HPA014166: AB_1853895, HPA025240: AB_2082630"	"unprognostic (9.64e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.09e-3)"	"unprognostic (8.44e-2)"	"prognostic unfavourable (9.76e-4)"	"unprognostic (2.71e-1)"	"prognostic unfavourable (3.99e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (3.59e-5)"	"unprognostic (6.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.35e-2)"	12.9	18.3	10.9	13.4	9.9	5.5	11.6	16.5	13.1	22.8	13.0	14.8	8.8	6.1	23.5	15.8	6.3	16.2	20.3	13.6	9.9	9.1	11.0	6.7	9.2	15.5	9.5	9.9	26.1	7.2	17.6	17.8	20.8	10.4	14.0	10.3	18.0	6.5	17.0	4.7	8.3	9.5	21.7	11.4	14.0	8.4	9.1	13.7	16.4	11.1	9.6	9.5	13.0	16.2	2.8	5.2	8.8	9.3	8.3	15.2	4.7	3.3	5.8	14.4	25.8	34.0	16.4	7.2	12.4	13.4	6.5	12.3	3.1	3.0	7.2	14.4	22.2	3.3	5.6	6.0	6.8	6.7	5.7	3.0	9.5	4.3	9.6	5.0	5.6	14.9	1.7	5.9	2.7	22.6	2.4	4.8	9.3	9.5	10.6	6.6	7.4	8.3	3.1	10.8	3.8	6.7	0.8	3.6	7.4	11.9	9.6	6.3	4.9	2.8	18.2	20.9	12.7	8.7	5.5	4.1	6.6	6.5	12.2	7.8	8.5	8.8	3.7	5.7	11.8	8.0	15.2	2.8	12.1	14.7	5.2	2.4	9.9	14.9	1.7	8.3	9.3	3.3	9.6	4.7	10.9	9.9	16.5	13.1	9.9	9.1	9.5	9.9	10.4	13.7
CNTD1	"CNTD, FLJ40137"	ENSG00000176563	"Cyclin N-terminal domain containing 1"	Q8N815	17	42798792-42811587	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	11	"testis: 31.0"	"Cell line enhanced"	"Detected in some"		"A-431: 6.1;ASC diff: 4.2;SiHa: 3.3;T-47d: 2.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA023324			Uncertain	"Nucleoplasm,Plasma membrane,Focal adhesion sites"				Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"HPA023324: AB_1848931"	"unprognostic (5.92e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.29e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.89e-7)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.81e-4)"	0.2	0.1	0.7	0.0	1.4	0.0	1.6	0.2	1.7	0.2	0.6	0.4	0.0	0.0	0.1	0.9	0.1	0.5	0.0	0.1	1.5	0.3	1.2	0.1	0.3	0.0	0.5	0.8	0.3	0.8	0.0	0.1	0.0	0.9	1.1	1.5	0.1	0.5	0.0	0.2	0.1	0.2	0.7	0.8	0.1	2.3	31.0	1.6	0.0	0.1	0.0	0.0	0.2	0.1	0.9	0.1	2.7	0.3	0.1	0.3	0.3	6.1	0.7	0.4	1.3	4.2	1.5	0.0	0.0	0.3	0.4	1.4	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.6	1.3	0.0	0.0	0.2	0.5	0.0	0.0	0.2	0.0	0.3	0.7	0.0	0.0	0.0	3.3	0.3	0.8	2.4	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.3	0.1	0.1	0.5	0.4	0.0	0.3	0.0	0.3	0.2	0.3	0.4	0.1	0.0	0.1	0.9	0.0	0.0	2.7	0.1	0.1	0.0	0.0	0.3	0.7	1.4	0.2	1.7	1.5	0.3	0.5	0.8	0.9	1.6
CNTD2	"CCNP, FLJ13265"	ENSG00000105219	"Cyclin N-terminal domain containing 2"	Q9H8S5	19	40222208-40226697	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 8.0;brain: 12.0;liver: 7.9"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.8;Karpas-707: 1.4;SCLC-21H: 6.6;T-47d: 1.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 12.0"	"Cell type enriched"	"Detected in single"	81	"basophil: 8.0"	"Lineage enriched"	"Detected in single"	81	"granulocytes: 8.0"					"Low region specificity"	"Detected in single"			HPA045615	Uncertain									"HPA045615: "	"unprognostic (1.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.79e-4)"	"unprognostic (5.27e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.43e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.10e-2)"	3.9	1.0	0.7	0.1	1.2	0.3	1.4	12.0	1.8	1.0	0.2	0.4	0.0	0.4	0.3	2.1	0.1	1.9	0.7	1.5	1.1	0.8	5.6	7.9	0.3	0.2	0.5	0.0	0.4	0.1	0.1	3.5	2.8	1.3	1.5	0.5	0.4	0.4	0.3	0.7	0.6	0.6	0.4	0.8	0.6	0.7	1.0	0.0	0.0	1.4	0.7	0.1	0.2	0.1	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.1	0.0	0.0	0.7	0.3	0.2	0.0	0.0	0.9	0.7	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	1.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.2	0.1	0.0	6.6	0.3	0.5	0.0	0.6	1.5	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.4	0.0	0.3	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	12.0	1.8	1.1	0.8	0.5	0.0	1.3	0.0
CNTNAP3	"CASPR3, CNTNAP3A, FLJ14195, KIAA1714"	ENSG00000106714	"Contactin associated protein like 3"	Q9BZ76	9	39072767-39288315	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 10.6;esophagus: 9.5"	"Cell line enhanced"	"Detected in some"		"A549: 12.4;AF22: 15.1;TIME: 9.5;WM-115: 25.2"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	22	"neutrophil: 10.6"	"Lineage enriched"	"Detected in single"	107	"granulocytes: 10.6"									HPA047731	Uncertain				"Intracellular and membrane"					"HPA047731: "	"unprognostic (9.06e-3)"	"unprognostic (3.07e-2)"	"unprognostic (5.74e-2)"	"unprognostic (7.89e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.33e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.93e-3)"	2.9	0.1	1.2	0.3	4.8	1.0	2.6	0.4	2.5	0.8	2.4			0.6	0.2	0.2	9.5	1.6	1.1	4.1	1.2	1.3	1.1	0.0	0.8	0.0	0.8		0.0	0.0	0.0	0.3	1.7		1.6	1.4		2.8	1.7	0.0	8.3	1.0	2.5	1.1	2.4	0.1	1.9			1.3		0.3	0.5	1.9	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.7	12.4	15.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	3.1	1.2	2.9	0.0	0.0	1.1	0.0	3.3	0.3	0.1	0.1	0.0	0.4	2.8	0.0	1.1	5.9	0.0	0.0	0.2	0.0	0.0	0.0	2.6	3.8	0.0	0.4	3.4	0.3	0.5	1.4	0.5	4.4	0.0	2.4	0.0	2.1	9.5	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	25.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0										
CNTNAP3B		ENSG00000154529	"Contactin associated protein like 3B"	Q96NU0	9	41890314-42129510	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 18.1;AF22: 25.9;WM-115: 17.4"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	9	"neutrophil: 7.5"	"Lineage enriched"	"Detected in single"	76	"granulocytes: 7.5"									HPA047731	Uncertain									"HPA047731: "	"unprognostic (2.68e-2)"	"unprognostic (9.63e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.99e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.20e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.74e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.78e-3)"	"unprognostic (7.93e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.05e-4)"	4.1	0.6	1.1	0.3	2.2	0.0	4.7	0.5	2.2	1.5	1.1			0.4	1.3	0.0	7.3	1.9	1.3	2.5	1.3	1.4	4.9	1.0	2.1	0.0	0.9		0.4	0.3	0.0	1.2	2.4		1.0	1.7		1.9	1.1	0.7	6.5	0.6	1.9	0.9	1.6	0.5	1.1			0.8		0.1	2.0	1.4	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	18.1	25.9	0.0	0.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.1	2.2	1.5	1.4	0.0	0.0	0.9	0.0	3.2	1.6	0.5	0.9	0.0	2.0	2.1	0.2	0.3	4.2	0.4	0.1	0.0	0.1	0.0	0.0	2.5	5.5	0.0	0.4	7.0	0.8	0.5	1.9	0.2	0.7	0.0	3.5	0.0	2.5	4.5	0.1	1.7	0.1	0.5	0.0	0.0	0.0	0.0	0.8	17.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0										
CNTNAP5	"caspr5, FLJ31966"	ENSG00000155052	"Contactin associated protein like 5"	Q8WYK1	2	124025287-124915287	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 22.4"	"Cell line enhanced"	"Detected in some"		"AF22: 3.2;HMC-1: 2.1;NTERA-2: 1.7;SCLC-21H: 1.3;SH-SY5Y: 7.2"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA069095, HPA069356"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"				"Nucleoli fibrillar center"	"Nucleoplasm, Vesicles"	"HPA069095: , HPA069356: "				"unprognostic (6.32e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.23e-1)"		"unprognostic (2.25e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.62e-6)"	"unprognostic (3.65e-3)"	"unprognostic (5.32e-2)"		"unprognostic (9.58e-2)"	0.7	2.8	12.9	0.7	7.9	1.0	0.7	3.3	22.4	0.6	0.8	1.5	0.0	1.0	0.7	0.7	0.7	0.6	4.2	0.7	14.0	4.0	1.2	0.7	0.7	0.7	2.2	8.4	0.6	1.1	0.7	0.8	0.7	15.2	0.8	0.8	0.4	0.6	1.0	0.7	0.8	0.9	0.8	1.9	0.7	0.7	0.9	2.8	0.0	0.7	0.0	0.6	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.1	0.0	1.3	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.9	7.9	3.3	22.4	14.0	4.0	2.2	8.4	15.2	2.8
COL21A1		ENSG00000124749	"Collagen type XXI alpha 1 chain"	Q96P44	6	56056590-56394094	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"ASC TERT1: 18.9;BEWO: 6.1;HSkMC: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA031212			Supported	Cytosol	"Secreted to extracellular matrix"		180000	Cytosol		"HPA031212: AB_10599941"	"unprognostic (1.69e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.32e-3)"	"unprognostic (6.84e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-3)"	3.9	1.6	6.6	2.1	2.3	0.3	3.0	5.1	3.6	25.8	11.3	5.2	7.9	0.8	20.0	7.0	3.3	7.6	3.9	4.5	8.5	2.5	1.4	1.5	7.4	0.7	3.6	4.6	3.9	2.1	0.8	3.6	26.4	6.9	5.4	2.2	5.9	4.4	10.9	2.3	6.3	2.6	24.2	5.3	0.7	5.7	3.8	5.8	0.0	2.1	4.1	0.8	10.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.6	0.1	0.0	1.0	18.9	6.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.6	0.1	0.0	19.2	0.7	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.6	2.3	5.1	3.6	8.5	2.5	3.6	4.6	6.9	5.8
COL22A1		ENSG00000169436	"Collagen type XXII alpha 1 chain"	Q8NFW1	8	138588235-138914006	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 46.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.4;RT4: 9.9;SCLC-21H: 6.7;U-2 OS: 5.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024830	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"			Vesicles	"Endoplasmic reticulum"	"HPA024830: AB_1847102"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.19e-6)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (1.05e-2)"	"unprognostic (5.57e-3)"	"prognostic unfavourable (2.13e-6)"	"unprognostic (2.01e-1)"	"unprognostic (9.24e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.66e-15)"	"unprognostic (2.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.09e-1)"	0.1	12.0	0.2	1.3	1.1	0.0	0.1	6.8	1.1	1.3	0.7	1.4	10.8	0.3	2.4	1.9	0.2	0.5	0.4	0.2	0.3	0.8	2.8	0.1	0.1	0.5	0.3	0.0	0.3	0.2	1.7	46.5	0.0	1.9	4.7	0.1	1.6	0.8	5.1	0.5	0.1	0.4	2.2	1.8	0.3	3.7	0.8	0.1	1.4	0.3	0.7	1.7	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	9.9	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	6.8	0.3	0.3	0.8	0.3	0.0	1.9	0.1
COL28A1		ENSG00000215018	"Collagen type XXVIII alpha 1 chain"	Q2UY09	7	7356203-7535853	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 3.2;U-266/70: 13.9;U-266/84: 3.7;WM-115: 6.7"	"Cancer enhanced"	"Detected in many"		"glioma: 4.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"olfactory region: 4.5"	"Not detected"	"Not detected"			"HPA043844, HPA060468"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"			"Nucleoplasm, Cytosol"		"HPA043844: , HPA060468: "	"unprognostic (6.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.71e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.09e-2)"	2.7	3.7	1.0	7.0	1.1	0.3	3.1	2.4	1.6	10.2	11.8	0.6	11.5	1.3	2.9	16.2	14.7	5.5	5.7	7.0	1.3	2.2	2.8	1.9	1.3	1.0	9.8	0.2	2.9	5.8	0.1	12.2	0.5	6.1	5.8	4.7	12.8	19.3	6.2	5.6	2.1	6.6	16.0	7.9	0.3	5.7	3.2	0.2	0.2	1.4	10.2	0.9	8.4	14.2	0.6	0.3	1.6	0.2	2.1	1.0	0.0	2.0	0.0	0.0	0.0	0.2	1.1	0.3	0.1	0.6	0.0	0.0	1.6	0.6	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.1	0.0	0.3	2.0	0.2	0.3	0.0	0.9	0.5	0.0	0.1	0.0	3.2	0.1	0.2	0.0	0.1	1.0	0.0	0.1	0.8	1.0	0.0	0.7	1.8	0.0	13.9	3.7	0.0	0.2	0.8	6.7	0.5	0.1	0.3	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.6	0.4	1.0	1.6	2.1	0.1	0.3	0.0	0.0	1.0	1.1	2.4	1.3	1.3	2.2	9.8	0.2	6.1	0.2
COPZ2	MGC23008	ENSG00000005243	"Coatomer protein complex subunit zeta 2"	Q9P299	17	48026167-48038030	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 38.9;ASC TERT1: 44.2;BJ: 28.9;BJ hTERT+: 30.1;fHDF/TERT166: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055999	Uncertain									"HPA055999: "	"unprognostic (2.66e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (3.45e-9)"	"unprognostic (7.42e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (2.89e-6)"	"prognostic unfavourable (4.66e-4)"	27.1	10.9	5.1	6.0	4.2	0.0	25.6	2.0	4.2	17.4	10.8	4.8	13.7	2.3	11.0	21.2	13.9	7.3	17.7	29.3	6.5	3.4	7.6	15.9	7.1	10.2	7.4	4.1	6.4	11.7	6.8	8.8	9.9	9.3	13.9	6.4	13.9	9.5	16.9	38.3	14.7	4.5	31.4	12.6	4.6	6.6	6.1	4.8	0.7	14.0	17.0	5.3	19.3	9.3	0.3	0.7	0.0	2.1	0.5	2.4	0.3	8.5	1.7	0.9	0.0	38.9	44.2	0.0	28.9	30.1	8.0	8.9	0.0	0.9	0.0	6.6	60.9	8.9	0.0	0.1	8.0	0.3	0.0	3.0	4.6	0.0	16.1	0.0	0.2	26.2	3.4	6.0	0.8	1.2	0.0	0.1	19.7	3.8	0.1	0.0	0.0	0.5	0.0	0.0	1.3	0.5	0.0	0.0	1.3	5.6	0.0	6.1	1.3	0.9	7.8	21.5	3.4	16.8	0.1	21.4	2.3	0.2	23.3	0.0	2.9	0.0	2.1	0.0	1.7	1.7	0.0	0.0	0.7	2.4	0.7	0.3	0.3	1.8	0.0	0.5	0.7	0.0	0.0	0.3	5.1	4.2	2.0	4.2	6.5	3.4	7.4	4.1	9.3	4.8
COQ10A	FLJ32452	ENSG00000135469	"Coenzyme Q10A"	Q96MF6	12	56266858-56270966	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 43.5;skeletal muscle: 103.7;tongue: 46.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068931			Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"				Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"HPA068931: "	"unprognostic (4.55e-2)"	"unprognostic (4.88e-3)"	"prognostic unfavourable (5.46e-4)"	"unprognostic (8.99e-3)"	"unprognostic (2.77e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.86e-3)"	"unprognostic (6.09e-2)"	"unprognostic (8.57e-2)"	"prognostic favourable (2.06e-4)"	"unprognostic (5.03e-2)"	"prognostic favourable (3.44e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.07e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.15e-1)"	2.9	12.4	5.0	2.3	6.8	2.2	3.1	7.6	7.3	3.7	2.9	4.8	5.9	1.9	3.6	7.7	4.3	5.2	3.2	43.5	4.5	5.4	7.2	12.8	3.5	3.4	5.6	3.9	4.5	5.5	6.0	9.9	1.7	4.8	4.1	2.7	14.0	6.5	5.6	103.7	2.2	2.9	3.7	3.6	3.8	2.6	2.4	3.0	4.9	5.4	46.1	6.2	2.7	3.3	11.7	6.8	8.0	1.1	5.0	8.6	3.6	2.4	10.2	9.9	6.4	5.7	5.7	4.2	3.5	8.5	12.6	12.6	7.9	3.8	14.6	8.1	8.9	2.3	11.4	2.0	7.5	2.2	12.7	6.8	9.3	8.2	7.8	5.3	4.1	5.9	3.3	9.3	3.7	6.6	4.5	6.0	11.6	3.3	7.6	19.1	8.4	5.9	16.4	10.8	9.6	6.9	1.5	14.3	15.5	12.2	2.5	3.8	3.9	5.9	4.6	2.4	7.0	6.7	3.6	12.6	13.5	7.1	7.0	5.0	1.8	8.0	1.0	0.9	7.7	1.1	7.9	11.7	7.1	8.2	1.7	6.7	8.6	8.4	0.4	5.0	0.8	6.8	4.6	3.6	5.0	6.8	7.6	7.3	4.5	5.4	5.6	3.9	4.8	3.0
COQ10B	FLJ13448	ENSG00000115520	"Coenzyme Q10B"	Q9H8M1	2	197453423-197475308	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046057	Approved		Approved	Cytosol				Cytosol		"HPA046057: "	"unprognostic (9.17e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.82e-3)"	"unprognostic (8.28e-3)"	"unprognostic (5.76e-3)"	"unprognostic (4.55e-1)"	"unprognostic (2.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (6.00e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.13e-3)"	24.5	34.0	19.3	14.5	18.2	34.0	21.8	13.3	23.2	15.1	16.8	16.6	13.0	13.9	19.2	14.6	16.7	14.9	23.2	28.7	18.7	18.8	30.1	34.3	17.3	15.3	18.3	14.1	15.2	25.0	20.4	23.0	33.1	20.6	16.1	18.2	17.6	17.4	16.3	16.0	13.3	22.3	25.5	17.3	17.7	17.8	9.1	12.6	11.5	18.7	16.2	16.4	21.1	14.1	14.8	11.7	40.6	17.8	13.9	24.1	16.0	6.9	6.6	4.8	8.6	23.4	16.8	11.4	18.1	26.2	19.5	21.8	13.4	8.4	6.5	15.6	14.6	6.3	6.9	9.6	22.4	12.7	6.0	9.3	9.6	15.6	19.6	7.5	21.6	18.6	15.1	18.6	13.3	10.5	7.8	17.4	18.6	9.1	8.1	11.6	7.4	13.7	6.1	7.2	8.5	21.0	18.8	3.1	6.1	8.3	10.9	22.5	7.8	10.6	11.1	19.3	6.7	21.5	13.0	16.6	23.5	7.3	24.1	7.3	14.8	27.3	13.6	24.4	20.7	15.6	23.3	14.8	20.0	20.5	11.7	11.5	21.1	21.4	40.6	13.9	17.8	7.4	24.1	16.0	19.3	18.2	13.3	23.2	18.7	18.8	18.3	14.1	20.6	12.6
COX8C	COX8-3	ENSG00000187581	"Cytochrome c oxidase subunit 8C"	Q7Z4L0	14	93347191-93348356	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	72	"testis: 72.8"	"Cell line enriched"	"Detected in some"	9	"U-937: 17.6"	"Group enriched"	"Detected in some"	8	"ovarian cancer: 2.9;testis cancer: 6.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.0"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			HPA003127	Approved									"HPA003127: AB_1078560"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"		"unprognostic (1.47e-1)"	"unprognostic (3.76e-3)"			"unprognostic (2.11e-1)"		"unprognostic (2.77e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.15e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	72.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CPA5		ENSG00000158525	"Carboxypeptidase A5"	Q8WXQ8	7	130344816-130368730	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"blood: 25.2;testis: 30.4"	"Cell line enhanced"	"Detected in some"		"RH-30: 10.9;RT4: 4.9;U-266/84: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 8.0;naive CD8 T-cell: 20.3;T-reg: 25.2"	"Lineage enriched"	"Detected in single"	114	"T-cells: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020322			Approved	Nucleoplasm	"Secreted in male reproductive system"			Nucleoplasm		"HPA020322: AB_10960562"	"unprognostic (2.44e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.10e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (5.83e-4)"	"unprognostic (1.43e-1)"	"unprognostic (8.88e-13)"	"unprognostic (5.16e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.08e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	1.6	0.1	0.1	0.1	0.4	0.0	1.0	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.4	0.1	0.1	1.6	0.0	30.4	0.1	0.1	0.1	0.1	0.7	0.8	0.1	0.0	0.0	0.2	0.0	0.0	25.2	3.1	0.8	0.0	0.1	0.6	0.0	0.0	0.0	0.4	3.2	0.2	0.4	2.4	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.0	0.0	1.8	0.7	0.7	1.2	0.5	0.0	0.0	0.0	1.1	0.0	1.2	0.0	0.0	1.6	0.1	0.0	0.4	0.0	0.8	0.0	0.0	10.9	0.3	1.4	4.9	1.4	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	8.2	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	8.0	4.1	0.0	0.0	2.1	20.3	0.0	0.0	0.0	0.0	25.2	3.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1
CPEB2		ENSG00000137449	"Cytoplasmic polyadenylation element binding protein 2"	Q7Z5Q1	4	15002674-15070153	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 24.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072513			Approved	Cytosol				Cytosol		"HPA072513: "	"unprognostic (6.59e-2)"	"unprognostic (4.21e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.34e-2)"	10.0	7.5	18.5	6.0	21.5	23.0	13.6	11.5	21.0	8.8	11.5	28.7	13.2	9.6	8.2	9.4	13.6	7.1	10.7	7.8	17.4	16.2	13.5	18.9	9.5	6.4	27.2	17.4	7.9	5.4	23.8	6.4	7.4	16.4	10.2	10.7	20.7	8.9	21.9	7.1	23.0	9.5	10.8	21.7	6.6	10.8	37.4	27.6	3.6	6.1	7.8	7.2	8.3	12.6	0.4	0.7	2.4	0.4	1.3	1.6	0.3	1.3	8.1	0.8	0.3	6.0	11.1	1.4	4.6	3.1	2.8	2.1	0.2	1.6	0.8	0.9	4.2	1.4	1.7	1.0	1.8	2.2	0.6	0.2	6.2	1.4	2.8	0.3	1.0	5.5	5.4	6.9	6.6	2.6	0.1	5.9	11.6	0.6	0.1	1.8	0.8	1.2	0.1	0.6	0.3	24.7	1.0	0.7	4.5	1.5	1.0	4.6	0.5	5.2	5.0	10.2	0.8	6.4	2.4	3.9	0.5	0.4	8.4	4.6	3.8	0.0	0.4	1.7	0.5	0.4	1.6	0.1	0.8	0.5	0.7	0.4	0.9	0.3	2.4	1.3	0.2	0.3	0.2	0.3	18.5	21.5	11.5	21.0	17.4	16.2	27.2	17.4	16.4	27.6
CPED1	"C7orf58, FLJ21986"	ENSG00000106034	"Cadherin like and PC-esterase domain containing 1"	A4D0V7	7	120988677-121297444	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 28.0;K-562: 54.5;LHCN-M2: 19.3;U-138 MG: 16.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 7.6;intermediate monocyte: 7.8;myeloid DC: 17.2;non-classical monocyte: 4.8;plasmacytoid DC: 10.3"	"Group enriched"	"Detected in many"	9	"dendritic cells: 17.2;monocytes: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA012058	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA012058: AB_1845761"	"unprognostic (7.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.52e-3)"	"prognostic favourable (3.00e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.69e-2)"	"prognostic unfavourable (4.87e-4)"	"unprognostic (6.28e-3)"	"unprognostic (5.05e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.54e-4)"	21.6	8.3	3.2	8.0	3.7	0.1	7.8	1.1	2.7	19.4	16.3	4.1	15.0	3.7	21.8	15.7	10.5	12.2	14.4	10.3	2.9	1.7	3.9	19.4	9.0	1.5	5.1	1.9	36.8	2.0	0.4	4.5	10.6	3.1	20.7	6.7	18.5	2.8	17.1	24.4	2.9	10.6	48.9	8.7	9.9	8.6	7.1	3.8	0.2	4.9	15.9	1.4	34.3	14.6	1.0	17.2	1.4	7.8	0.0	0.1	2.1	1.9	0.0	0.1	0.0	4.6	13.5	0.1	7.9	28.0	2.7	7.6	0.2	0.1	0.2	0.1	4.3	0.1	0.1	0.0	7.3	0.1	0.2	2.2	0.1	16.1	8.1	0.0	0.0	5.5	0.0	6.4	0.1	1.3	54.5	4.1	19.3	0.0	0.0	0.0	0.0	0.3	0.0	11.0	5.4	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.0	0.2	0.8	16.4	0.4	13.7	7.6	1.7	0.0	0.2	1.9	0.0	0.8	1.4	7.6	0.0	0.0	7.8	0.1	1.0	0.0	0.0	17.2	0.3	0.0	0.0	0.3	0.0	4.8	10.3	0.0	2.1	3.2	3.7	1.1	2.7	2.9	1.7	5.1	1.9	3.1	3.8
CPLX2	"CPX-2, DKFZp547D155"	ENSG00000145920	"Complexin 2"	Q6PUV4	5	175796310-175884020	"Predicted intracellular proteins"	"Differentiation, Exocytosis, Mast cell degranulation, Neurogenesis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 95.3;epididymis: 80.1"	"Group enriched"	"Detected in some"	22	"A549: 103.7;Hep G2: 62.5;SCLC-21H: 44.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071191, HPA074390"	Supported		Uncertain	Vesicles				Vesicles		"HPA071191: , HPA074390: "	"unprognostic (1.36e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.49e-3)"		"unprognostic (6.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.90e-5)"	"unprognostic (6.88e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.87e-2)"	1.7	23.3	72.6	2.0	32.7	1.4	1.3	79.0	95.3	1.3	2.6	2.6	0.3	2.7	1.3	80.1	1.4	1.4	1.4	1.3	68.3	16.3	1.4	1.3	2.1	1.3	37.2	26.3	1.3	7.9	1.3	11.3	1.3	17.9	1.4	2.2	0.2	1.3	1.4	1.3	1.4	2.5	1.6	4.0	1.3	5.1	3.1	3.7	0.0	1.4	0.0	1.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	103.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	44.1	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	72.6	32.7	79.0	66.6	68.3	16.3	37.2	26.3	17.9	3.7
CPLX3	CPX-III	ENSG00000213578	"Complexin 3"	Q8WVH0	15	74826547-74831802	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.8;lymphoid tissue: 31.8;prostate: 56.4;retina: 32.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.5;Karpas-707: 4.8;SK-BR-3: 2.7;U-266/84: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			CAB079003		Supported								"CAB079003: "																		0.4	2.5	6.4	0.5	7.4	0.4	0.4	20.8	19.6	0.5	0.5	3.3	0.0	0.4	0.4	0.5	0.5	0.4	0.4	13.4	6.4	0.8	0.4	0.4	0.4	0.5	0.6	7.9	0.4	0.4	0.4	1.7	0.4	8.2	56.4	0.4	32.8	9.8	0.4	0.4	0.5	0.6	0.4	1.0	31.8	4.6	2.2	1.2	0.0	0.4	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.5	0.0	0.0	0.1	0.2	0.1	0.0	5.5	0.1	0.0	0.2	0.1	0.0	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.2	0.2	0.0	0.0	0.0	4.8	0.0	0.1	0.0	0.9	0.1	0.3	0.2	0.0	0.4	0.0	0.1	2.1	0.1	0.0	2.7	1.1	1.6	0.0	0.0	0.1	0.1	0.5	0.0	1.3	3.1	2.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	7.4	20.8	19.6	6.4	0.8	0.6	7.9	8.2	1.2
CPLX4	CPX-IV	ENSG00000166569	"Complexin 4"	Q7Z7G2	18	59275156-59318649	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"retina: 61.9"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"cerebellum: 6.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047627	Enhanced									"HPA047627: "					"unprognostic (1.85e-1)"		"unprognostic (4.46e-1)"			"unprognostic (4.20e-2)"		"unprognostic (4.05e-2)"		"unprognostic (9.90e-3)"				0.1	0.3	0.2	0.0	0.1	2.8	0.1	6.3	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.8	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.3	0.2	0.3	0.0	0.1	0.2	0.0	0.2	0.0	0.4	0.1	0.0	61.9	0.3	0.0	0.3	1.9	0.1	0.0	0.2	0.3	0.1	1.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.6	0.7	1.7	0.3	0.8	0.7	0.1	0.1	0.8	0.4	0.8	0.7	0.2	0.8	0.8	0.0	0.1	0.0	0.3	0.6	0.5	0.1	0.2	1.1	0.2	0.0	1.2	0.3	0.0	0.2	1.5	0.8	0.0	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.1	0.7	0.6	0.4	0.3	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.4	0.2	0.0	0.9	0.0	0.1	0.3	0.6	0.6	0.2	0.9	0.0	0.8	0.4	0.4	0.1	0.2	0.6	0.4	0.3	0.1	0.3	0.0	0.3	0.1	0.4	0.3	0.0	0.6	0.2	0.7	1.7	0.8	0.1	0.7	0.2	0.1	0.2	0.1	6.3	0.1	0.1	0.1	0.3	0.0	0.4	0.0
CPSF4L		ENSG00000187959	"Cleavage and polyadenylation specific factor 4 like"	A6NMK7	17	73248449-73262352	"Predicted intracellular proteins"		RNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Cell line enriched"	"Detected in single"	9	"Hep G2: 7.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"eosinophil: 1.9;neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA044047	Uncertain									"HPA044047: AB_10961638"	"unprognostic (7.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (6.57e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.66e-2)"	"unprognostic (9.03e-8)"	"unprognostic (6.71e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.90e-2)"	"unprognostic (7.44e-3)"	0.6	0.6	0.3	0.0	0.5	0.0	1.9	0.3	0.3	0.5	0.4			0.6	0.7	1.2	0.4	1.2	0.2	0.5	0.3	0.2	0.1	0.5	0.4	0.0	0.5		0.9	1.9	0.0	0.5	0.0		0.4	0.6		2.3	0.3	0.1	0.6	0.3	0.0	0.2	0.2	0.6	2.1			0.7		0.0	0.1	0.1	0.0	0.0	1.9	0.8	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.5	0.0	0.0	0.1	0.3	0.8	0.3	0.0	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.7	0.8	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.7	0.0	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.8	0.0	0.2	0.0										
CPXM2	"CPX2, UNQ676"	ENSG00000121898	"Carboxypeptidase X, M14 family member 2"	Q8N436	10	123706207-123940267	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	19	"BJ: 9.9;fHDF/TERT166: 38.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 16.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048375	Uncertain				"Secreted - unknown location"					"HPA048375: "	"unprognostic (1.50e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.14e-1)"	"prognostic favourable (9.02e-4)"	"unprognostic (3.48e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-3)"	17.0	4.1	0.8	5.0	2.1	0.1	12.3	1.3	1.6	6.4	40.9	6.7	5.7	3.8	12.2	37.8	20.0	9.1	9.4	14.3	1.7	4.0	6.6	1.5	4.6	3.7	6.1	0.7	12.8	3.2	1.9	7.1	11.6	16.9	14.7	4.5	26.5	5.6	8.3	5.0	4.5	9.1	45.5	21.6	13.8	14.4	7.7	3.4	2.6	9.5	11.9	4.0	32.5	20.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.4	0.6	0.0	0.0	0.0	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	2.1	1.3	1.6	1.7	4.0	6.1	0.7	16.9	3.4
CRIP3	"bA480N24.2, TLP, TLP-A"	ENSG00000146215	"Cysteine rich protein 3"	Q6Q6R5	6	43299710-43308797	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 25.5;heart muscle: 24.8;liver: 29.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.0;HEK 293: 4.8;HeLa: 5.0;Hep G2: 9.0;NTERA-2: 8.2;RPMI-8226: 6.7;THP-1: 3.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	14	"myeloid DC: 25.5"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 25.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA036198	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA036198: AB_10670791"	"unprognostic (8.35e-3)"	"unprognostic (4.14e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.49e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.30e-3)"	"unprognostic (5.02e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.80e-4)"	0.4	0.5	4.2	5.6	5.8	2.5	2.1	9.4	3.0	0.8	0.8	0.6	3.1	2.2	0.8	2.7	0.9	1.0	4.6	24.8	3.5	3.5	10.4	29.0	0.6	5.3	2.3	2.2	1.0	2.4	0.8	1.1	0.7	2.1	4.1	0.5	1.0	0.7	9.5	0.5	1.8	4.5	1.0	1.7	4.4	0.3	13.5	0.4	0.6	1.1	0.4	6.1	1.8	0.5	1.7	25.5	0.5	1.5	0.2	0.0	0.9	0.0	1.1	0.3	0.1	0.4	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.4	0.0	0.9	4.0	0.1	0.0	0.0	4.8	0.0	5.0	9.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.2	0.0	0.0	0.0	6.7	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.9	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	1.5	0.5	0.0	1.0	0.0	1.4	0.0	0.0	25.5	1.7	0.0	0.0	0.4	0.2	1.3	0.2	0.0	0.9	4.2	5.8	9.4	3.0	3.5	3.5	2.3	2.2	2.1	0.4
CRISPLD1	"Cocoacrisp, DKFZp762F133, LCRISP1"	ENSG00000121005	"Cysteine rich secretory protein LCCL domain containing 1"	Q9H336	8	74984515-75034558	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.4"	"Group enriched"	"Detected in some"	5	"AF22: 51.1;SH-SY5Y: 27.6"	"Cancer enhanced"	"Detected in many"		"glioma: 30.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	32	"plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	32	"dendritic cells: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024725	Uncertain				"Secreted - unknown location"					"HPA024725: AB_1847238"	"unprognostic (2.16e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.39e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	3.2	1.0	5.3	1.7	24.7	1.0	22.4	0.7	8.2	5.4	3.8	15.9	0.0	0.5	7.1	4.0	4.0	5.9	7.8	8.4	10.2	6.4	1.6	1.6	2.2	1.8	7.8	4.7	4.7	1.8	12.1	1.9	5.7	34.4	20.0	1.2	3.1	15.1	2.2	0.7	3.2	1.7	5.4	29.6	1.4	1.7	3.2	9.3	6.0	12.9	1.6	1.1	2.4	1.9	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	51.1	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.7	0.3	0.0	0.0	7.3	0.0	0.0	4.2	0.0	0.0	0.0	1.9	0.0	1.9	0.0	1.1	0.0	0.4	2.8	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	5.2	1.8	0.0	7.0	0.0	0.0	0.0	0.3	27.6	0.0	0.0	2.9	3.9	2.3	0.0	1.4	7.7	0.0	0.2	0.9	0.3	0.0	1.7	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	5.3	24.7	0.7	8.2	10.2	6.4	7.8	4.7	34.4	9.3
CRISPLD2	"DKFZP434B044, LCRISP2, LGL1"	ENSG00000103196	"Cysteine rich secretory protein LCCL domain containing 2"	Q9H0B8	16	84819984-84920768	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.9;BEWO: 23.2;HHSteC: 55.4;HSkMC: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 36.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 36.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA030054, HPA030055"	Approved		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	219300000000		"Nucleoplasm, Nucleoli"		"HPA030054: , HPA030055: AB_10611821"	"unprognostic (8.91e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavourable (1.97e-6)"	"unprognostic (7.35e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.15e-3)"	29.2	11.6	2.2	41.1	5.0	3.0	57.2	2.1	3.6	44.1	26.0	2.5	10.6	4.2	38.5	58.7	21.1	43.6	107.4	19.1	2.1	2.0	10.1	6.7	31.0	21.4	5.5	1.6	37.1	9.1	1.0	6.4	50.2	7.1	31.6	7.3	21.9	6.8	23.6	15.9	12.0	17.5	48.0	8.6	10.0	22.5	16.8	3.1	0.4	15.9	11.4	3.3	40.3	32.7	0.0	0.5	36.0	7.9	0.0	0.1	1.3	0.3	0.7	0.2	2.0	14.9	5.6	23.2	11.3	10.0	9.1	6.4	1.5	0.9	0.0	1.0	9.9	0.3	0.0	0.0	9.2	0.0	0.0	0.1	0.2	0.0	55.4	0.0	0.1	23.3	0.0	2.6	0.0	0.0	0.1	0.1	1.0	0.4	0.1	0.5	0.6	0.6	0.0	0.1	0.1	0.1	1.7	2.2	0.1	2.6	1.2	0.2	4.5	0.3	1.3	0.1	0.6	9.5	0.3	0.1	0.0	1.9	0.0	0.2	1.3	4.4	7.9	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	1.3	2.2	5.0	2.1	3.6	2.1	2.0	5.5	1.6	7.1	3.1
CRYBG2	"AIM1L, FLJ38020"	ENSG00000176092	"Crystallin beta-gamma domain containing 2"	Q8N1P7	1	26321698-26360080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.9;placenta: 55.0"	"Cell line enhanced"	"Detected in some"		"A-431: 7.0;BEWO: 15.1;CACO-2: 24.6;CAPAN-2: 16.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029629			Approved	Nucleoplasm				Nucleoplasm		"HPA029629: AB_10601331"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (5.11e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.39e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (3.53e-4)"	"unprognostic (2.94e-2)"	"unprognostic (4.83e-9)"	"unprognostic (9.12e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.63e-2)"	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	8.0	4.4	0.0	0.0	4.9	0.9	0.6	43.9	0.2	2.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	55.0	0.0	0.8	1.4	0.1	5.1	0.0	0.0	13.8	10.4	0.0	0.0	0.0	0.9	1.2	0.0	0.1	0.0	22.0	19.8	4.9	16.1	0.7	0.0	2.4	0.1	0.2	1.7	0.3	7.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	24.6	16.5	0.1	5.0	0.0	6.1	0.0	4.4	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.3	1.6	0.3	0.0	0.0	2.9	0.0	4.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.1	0.5	0.7	1.7	0.7	0.0	0.6	0.5	0.5	2.4	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYGA	"CRY-g-A, CRYG1, CRYG5"	ENSG00000168582	"Crystallin gamma A"	P11844	2	208160740-208163576	"Predicted intracellular proteins"		"Eye lens protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.8"	"Cell line enriched"	"Detected in single"	5	"U-138 MG: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA043386	Supported									"HPA043386: "					"unprognostic (1.49e-1)"													0.1	0.0	1.0	0.1	1.8	0.0	0.1	0.1	1.5	0.1	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.0	0.1	0.1	0.9	1.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.8	0.1	1.5	0.9	1.1	0.3	0.1	0.1	0.1
CRYGN		ENSG00000127377	"Crystallin gamma N"	Q8WXF5	7	151428835-151440813	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"seminal vesicle: 4.3;thyroid gland: 16.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.6;CAPAN-2: 2.6;MOLT-4: 2.0;SCLC-21H: 3.6"	"Cancer enriched"	"Detected in some"	25	"thyroid cancer: 15.7"					"Group enriched"	"Detected in some"	31	"memory CD4 T-cell: 3.4;naive CD4 T-cell: 3.4;naive CD8 T-cell: 2.2"	"Lineage enriched"	"Detected in single"	35	"T-cells: 3.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 9.3"	"Not detected"	"Not detected"			HPA050788	Uncertain									"HPA050788: AB_2681239"	"unprognostic (1.69e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.55e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.94e-5)"	"unprognostic (2.49e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.48e-2)"	"unprognostic (8.93e-10)"	"unprognostic (2.55e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.36e-1)"	0.3	0.0	0.3	0.0	0.5	0.0	0.2	0.0	0.4	1.1	0.3			0.0	0.9	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0		0.4	0.0	2.6	0.8	0.3		0.3	0.0		0.1	4.3	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0			16.3		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.4	0.0	0.0	0.0	0.6	0.0	0.0	1.6	0.0	0.3	0.0	0.7	1.0	2.6	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	2.0	0.5	1.1	0.6	0.3	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	3.4	2.2	0.0	0.0	0.0	0.0	0.0	0.4										
CSHL1	"CS-5, CSHP1, CSL, hCS-L, MGC149868"	ENSG00000204414	"Chorionic somatomammotropin hormone like 1"	Q14406	17	63909597-63918838	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	864	"pituitary gland: 334.1;placenta: 293.7"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.3;SCLC-21H: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB025646, HPA043715"	Enhanced				"Secreted to blood"					"CAB025646: , HPA043715: "																		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	334.1	293.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
CSMD3		ENSG00000164796	"CUB and Sushi multiple domains 3"	Q7Z407	8	112222928-113437099	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 26.6"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 2.3;hTCEpi: 2.3;hTERT-HME1: 1.6;LHCN-M2: 3.3;RH-30: 2.1;SCLC-21H: 1.4;U-2 OS: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029007	Uncertain									"HPA029007: AB_10601802"	"unprognostic (2.26e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.26e-2)"		"unprognostic (3.54e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.33e-2)"	"unprognostic (5.03e-10)"	"unprognostic (1.95e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.74e-3)"	1.0	1.0	26.6	1.0	21.9	1.0	1.0	6.0	18.3	1.6	1.1	2.2	0.0	1.1	1.1	1.1	1.0	2.3	1.0	1.0	14.2	6.7	1.1	1.0	1.1	1.0	3.0	15.8	1.0	1.0	1.0	5.7	1.0	10.9	2.1	1.2	0.0	1.0	2.1	1.0	1.0	1.2	1.1	3.6	2.4	1.3	5.0	7.0	0.0	1.0	0.0	1.0	1.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	2.3	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.3	0.0	1.6	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	21.9	6.0	18.3	14.2	6.7	3.0	15.8	10.9	7.0
CSNK1A1L	MGC33182	ENSG00000180138	"Casein kinase 1 alpha 1 like"	Q8N752	13	37103259-37105664	"Enzymes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 10.5;testis: 9.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	40	"neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	42	"granulocytes: 10.5"									HPA051334			Uncertain	Cytosol				Cytosol		"HPA051334: "	"unprognostic (1.23e-2)"		"unprognostic (1.59e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.40e-2)"		"unprognostic (5.40e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.28e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.38e-1)"		0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.0			0.0		0.0	0.0	0.0	0.1	0.2	10.5	0.2	0.1	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.6	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	10.5	0.1	0.2	0.1	0.2	0.2										
CSRNP3	"FAM130A2, FLJ32093, PPP1R73, TAIP-2"	ENSG00000178662	"Cysteine and serine rich nuclear protein 3"	Q8WYN3	2	165469647-165689407	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 31.7;pituitary gland: 21.1"	"Cell line enhanced"	"Detected in some"		"AF22: 12.7;PC-3: 3.1;SCLC-21H: 9.3;SH-SY5Y: 7.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017905	Supported		Uncertain	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA017905: AB_1857757"	"unprognostic (2.85e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.41e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.08e-2)"	2.1	5.5	9.3	1.4	24.9	0.7	6.7	8.8	31.7	5.7	2.0	3.2	0.4	2.1	6.3	2.3	2.0	2.5	2.5	3.4	9.3	10.2	3.7	1.8	1.4	1.1	5.3	13.2	7.8	8.0	6.0	21.1	1.1	7.8	3.9	2.5	4.0	4.9	5.1	0.9	2.1	1.7	5.7	2.9	2.1	2.0	1.9	4.8	0.0	5.3	0.0	1.0	1.9	2.5	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.6	0.0	0.4	0.2	0.6	0.0	0.0	0.9	0.6	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	3.1	0.0	0.0	0.7	0.7	0.0	9.3	7.6	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.3	0.0	0.3	0.6	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.3	24.9	8.8	31.7	9.3	10.2	5.3	13.2	7.8	4.8
CST9	"CLM, CTES7A"	ENSG00000173335	"Cystatin 9"	Q5W186	20	23602410-23605876	"Predicted secreted proteins"		"Antimicrobial, Protease inhibitor, Thiol protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	11	"breast: 6.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	37	"breast cancer: 9.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA029190	Uncertain				"Secreted - unknown location"					"HPA029190: AB_10602804"	"unprognostic (2.06e-2)"									"unprognostic (2.21e-4)"								0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT45A2	"CT45-2, CT45.2"	ENSG00000271449	"Cancer/testis antigen family 45 member A2"	Q5DJT8	X	135811668-135820012	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	42	"testis: 4.2"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 32.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.0	0.0	0.0	0.0	0.0	0.0	3.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT45A5	"CT45-5, CT45.5"	ENSG00000228836	"Cancer/testis antigen family 45 member A5"	P0DMU8	X	135777130-135785298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	14	"testis: 10.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 17.9;Karpas-707: 12.5;U-266/84: 64.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "																		0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.5			0.0		0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	1.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	2.4	0.0	0.0	0.9	64.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT45A6	"CT45-6, CT45.6"	ENSG00000278289	"Cancer/testis antigen family 45 member A6"	P0DMU7	X	135794706-135802656	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	5	"testis: 2.9"	"Cell line enriched"	"Detected in some"	9	"U-266/84: 46.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0	0.0	0.6	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	2.9			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A1	CT47.1	ENSG00000236371	"Cancer/testis antigen family 47, member A1"	Q5JQC4	X	120982476-120985788	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	43	"testis: 4.2"	"Cell line enriched"	"Detected in single"	8	"U-266/70: 7.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A10	CT47.10	ENSG00000224089	"Cancer/testis antigen family 47, member A10"	Q5JQC4	X	120938701-120942023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 5.0"	"Cell line enriched"	"Detected in single"	14	"U-266/70: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A11	CT47.11	ENSG00000226929	"Cancer/testis antigen family 47, member A11"	Q5JQC4	X	120933840-120937158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	68	"testis: 6.7"	"Group enriched"	"Detected in some"	7	"EFO-21: 1.6;U-87 MG: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A12	CT47.12	ENSG00000226685	"Cancer/testis antigen family 47, member A12"	Q5JQC4	X	120930250-120932301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"testis: 5.4"	"Cell line enhanced"	"Detected in some"		"U-2197: 1.1;U-266/70: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.0	3.1	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A2	CT47.2	ENSG00000242362	"Cancer/testis antigen family 47, member A2"	Q5JQC4	X	120977606-120980928	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 5.0"	"Cell line enriched"	"Detected in single"	14	"U-266/70: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A3	CT47.3	ENSG00000236126	"Cancer/testis antigen family 47, member A3"	Q5JQC4	X	120972746-120976068	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 5.0"	"Cell line enriched"	"Detected in single"	14	"U-266/70: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A4	CT47.4	ENSG00000230594	"Cancer/testis antigen family 47, member A4"	Q5JQC4	X	120967886-120971208	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 5.0"	"Cell line enriched"	"Detected in single"	14	"U-266/70: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A5	CT47.5	ENSG00000237957	"Cancer/testis antigen family 47, member A5"	Q5JQC4	X	120963026-120966348	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 5.0"	"Cell line enriched"	"Detected in single"	14	"U-266/70: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A6	CT47.6	ENSG00000226023	"Cancer/testis antigen family 47, member A6"	Q5JQC4	X	120958165-120961487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	31	"testis: 3.1"	"Group enriched"	"Detected in some"	12	"U-266/70: 4.1;U-266/84: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A7	CT47.7	ENSG00000228517	"Cancer/testis antigen family 47, member A7"	Q5JQC4	X	120953288-120956600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"testis: 1.2"	"Cell line enhanced"	"Detected in single"		"U-138 MG: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A8	CT47.8	ENSG00000230347	"Cancer/testis antigen family 47, member A8"	Q5JQC4	X	120948422-120951744	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 5.0"	"Cell line enriched"	"Detected in single"	14	"U-266/70: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT47A9	CT47.9	ENSG00000226600	"Cancer/testis antigen family 47, member A9"	Q5JQC4	X	120943561-120946883	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 5.0"	"Cell line enriched"	"Detected in single"	14	"U-266/70: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported									"HPA042483: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT62		ENSG00000225362	"Cancer/testis antigen 62"	P0C5K7	15	71110244-71115494	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	50	"testis: 31.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.4;T-47d: 7.4;U-2197: 5.9"	"Group enriched"	"Detected in some"	8	"breast cancer: 2.3;prostate cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045306	Uncertain									"HPA045306: AB_10960632"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-3)"	"unprognostic (9.17e-2)"	"unprognostic (3.55e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.16e-2)"		"unprognostic (9.27e-3)"		"unprognostic (1.02e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.95e-5)"	"unprognostic (2.89e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.52e-1)"	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	31.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	1.4	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	3.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	1.5	0.0	7.4	0.0	0.9	0.0	0.0	5.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
CTAGE1	"CT21.1, CT21.2, CTAGE, cTAGE-1, cTAGE-2"	ENSG00000212710	"Cutaneous T cell lymphoma-associated antigen 1"	"Q96RT6, Q9HC47"	18	22413601-22417915	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	49	"testis: 12.9"	"Cell line enhanced"	"Detected in some"		"HBF TERT88: 2.2;U-2 OS: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000387, HPA000922, CAB016204"	Uncertain									"CAB016204: AB_673617, HPA000387: AB_1078582, HPA000922: AB_1078581"					"unprognostic (1.41e-1)"		"unprognostic (5.65e-2)"	"unprognostic (2.34e-1)"		"unprognostic (1.81e-2)"	"unprognostic (1.52e-1)"		"unprognostic (1.70e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.62e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTAGE15	CTAGE15P	ENSG00000271079	"CTAGE family member 15"	A4D2H0	7	143571801-143574387	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	15	"testis: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000387, HPA000922"	Uncertain									"HPA000387: AB_1078582, HPA000922: AB_1078581"	"unprognostic (2.82e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.32e-1)"		"unprognostic (2.44e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.52e-2)"		"unprognostic (9.94e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.39e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0		0.1	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1			0.1		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.6	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CTAGE4	"cTAGE-4, FLJ43692"	ENSG00000225932	"CTAGE family member 4"	Q8IX94	7	144183466-144186053	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skin 1: 9.1"	"Cell line enhanced"	"Detected in some"		"A-431: 13.5;hTCEpi: 12.0;RPTEC TERT1: 10.7;T-47d: 7.6;WM-115: 7.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.3;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.0"									"HPA000387, HPA000922"	Uncertain									"HPA000387: AB_1078582, HPA000922: AB_1078581"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (5.17e-2)"		"unprognostic (2.80e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.15e-1)"		"unprognostic (1.26e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.91e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.68e-1)"	1.3	0.9	0.2	0.0	0.7	0.0	3.8	0.1	0.2	0.7	1.2			3.7	1.4	2.5	1.3	1.1	1.9	1.4	0.2	0.4	1.3	1.6	2.0	0.0	0.7		1.9	4.1	0.0	2.1	0.8		1.3	3.5		2.0	0.3	0.3	9.1	1.0	0.0	0.4	1.3	2.4	4.9			7.5		0.0	0.8	1.3	0.4	0.0	0.0	0.0	0.0	2.0	0.0	13.5	0.1	0.0	0.0	0.0	0.0	5.7	0.4	0.2	0.0	0.2	1.3	4.3	0.0	0.0	0.5	0.4	0.0	2.4	0.1	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.3	12.0	0.4	3.7	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	10.7	3.5	0.0	0.0	4.9	5.0	0.4	7.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0										
CTAGE6	"CTAGE6P, MGC41943"	ENSG00000271321	"CTAGE family member 6"	Q86UF2	7	143755089-143757696	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	40	"testis: 15.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.1;HeLa: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000387, HPA000922"	Uncertain									"HPA000387: AB_1078582, HPA000922: AB_1078581"		"unprognostic (1.51e-2)"											"unprognostic (8.90e-12)"	"unprognostic (1.73e-2)"			"unprognostic (2.86e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	15.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.7	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CTAGE9		ENSG00000236761	"CTAGE family member 9"	A4FU28	6	131708684-131711017	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	29	"testis: 11.6"	"Cell line enhanced"	"Detected in single"		"A-431: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000387, HPA000922"	Uncertain									"HPA000387: AB_1078582, HPA000922: AB_1078581"	"unprognostic (3.92e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.48e-2)"			"unprognostic (1.92e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.36e-1)"		"unprognostic (5.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.74e-4)"	"unprognostic (3.15e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.41e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.3	0.0		0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	11.6			0.2		0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.2	0.2	1.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.2	0.2										
CTRL		ENSG00000141086	"Chymotrypsin like"	P40313	16	67927640-67932414	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	281	"pancreas: 639.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA034504, HPA034505"	Enhanced				"Secreted to digestive system"					"HPA034504: AB_2674196, HPA034505: AB_10602212"	"unprognostic (3.03e-5)"	"unprognostic (3.53e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.66e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.83e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.20e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.29e-3)"	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	639.8	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	1.1	1.1	0.7	0.0	2.2	0.5	0.5	3.7	1.1	0.3	0.2	0.1	1.8	0.3	0.7	1.1	1.3	2.3	1.4	0.7	0.4	0.7	1.0	5.6	0.7	3.1	1.4	6.3	0.7	1.1	1.4	0.3	0.9	2.5	1.2	0.2	3.9	1.0	0.0	1.5	1.0	0.6	1.0	0.7	2.7	6.2	2.2	2.8	0.5	4.5	0.0	0.9	2.6	1.4	1.3	0.7	0.6	1.2	4.3	1.6	0.1	2.0	0.5	1.6	6.5	2.7	3.6	0.2	0.8	0.8	0.6	0.7	0.3	1.5	0.7	0.2	0.3	1.1	0.5	0.9	0.6	0.5	2.2	1.1	0.0	0.7	1.1	0.0	0.5	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CTSO	CTSO1	ENSG00000256043	"Cathepsin O"	P43234	4	155924118-155953917	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 12.3;HSkMC: 14.6;Karpas-707: 27.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002041	Approved				"Intracellular and membrane"		24000			"HPA002041: AB_1078408"	"unprognostic (3.96e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.10e-3)"	"unprognostic (2.55e-1)"	"unprognostic (3.80e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.79e-1)"	13.7	16.4	11.9	12.6	12.0	1.8	14.9	3.7	12.4	16.0	18.5	11.6	10.2	13.3	19.3	27.3	10.8	15.6	16.9	19.7	9.7	8.6	21.2	41.6	26.4	19.4	10.2	6.7	16.3	10.7	13.6	9.4	18.7	9.7	16.1	9.8	24.0	13.8	16.8	5.9	6.2	27.5	14.4	11.4	19.3	10.8	9.0	7.7	5.5	17.1	10.2	10.3	12.4	12.5	7.0	8.9	5.3	14.8	12.0	10.9	8.9	0.3	0.2	1.5	1.6	5.6	12.3	0.0	3.5	7.1	1.3	1.8	0.0	4.6	0.0	0.7	2.3	0.0	0.0	0.3	0.9	5.2	0.1	0.4	0.0	0.0	5.9	0.7	0.1	14.6	1.3	0.8	0.6	1.2	0.0	27.5	4.1	0.3	0.3	0.1	0.3	0.2	1.6	0.3	1.7	5.3	2.3	0.2	1.7	0.8	2.9	1.0	1.5	1.0	2.0	4.3	0.2	0.4	1.1	3.1	0.0	0.0	7.8	0.0	5.8	5.3	12.0	0.8	7.9	14.8	10.9	5.8	6.1	7.3	8.9	7.0	6.7	6.8	0.5	12.0	10.7	8.3	6.8	8.9	11.9	12.0	3.7	12.4	9.7	8.6	10.2	6.7	9.7	7.7
CUZD1	"ERG-1, UO-44"	ENSG00000138161	"CUB and zona pellucida like domains 1"	Q86UP6	10	122832149-122850793	"Predicted membrane proteins"	"Cell adhesion, Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	200	"pancreas: 650.6"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 7.1;LHCN-M2: 7.9"	"Cancer enriched"	"Detected in some"	54	"pancreatic cancer: 32.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Group enriched"	"Detected in many"	6	"B-cells: 1.1;T-cells: 3.2"	"Low region specificity"	"Detected in single"							"HPA068479, HPA068660, HPA074117"	Enhanced		Approved	Nucleoli,Vesicles				Nucleoli	Vesicles	"HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: "	"unprognostic (4.68e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.52e-5)"	"unprognostic (8.08e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.16e-4)"	"unprognostic (4.19e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.15e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.64e-3)"	"unprognostic (2.75e-3)"	"unprognostic (4.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.83e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	650.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.2	0.0	3.2	0.2	1.6	1.6	1.7	0.0	0.4	0.8	1.0	2.5	0.7	0.3	1.7	1.8	3.6	0.9	0.7	1.0	1.7	0.0	1.5	2.6	2.2	2.2	3.5	4.6	0.8	0.3	0.0	3.7	1.1	0.3	1.5	7.1	1.7	1.3	1.5	7.9	0.4	1.9	2.7	1.7	1.3	0.0	4.0	0.6	1.3	1.3	1.8	0.7	0.8	0.4	1.1	1.3	1.9	3.5	0.0	2.4	0.9	0.0	1.9	1.4	3.1	1.2	5.8	0.0	0.0	0.1	0.3	0.8	0.1	1.3	0.6	0.9	1.1	0.1	1.1	1.4	0.7	0.0	0.0	0.2	0.2	3.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
CWH43	"CWH43-C, FLJ21511"	ENSG00000109182	"Cell wall biogenesis 43 C-terminal homolog"	Q9H720	4	48986247-49062081	"Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 26.1;seminal vesicle: 22.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.6;NB-4: 1.4;SH-SY5Y: 1.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 20.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042814, HPA048140"	Uncertain									"HPA042814: , HPA048140: "	"unprognostic (9.38e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.14e-2)"	"prognostic favourable (1.32e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-4)"	"unprognostic (1.24e-1)"	"prognostic favourable (2.29e-11)"	"unprognostic (5.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.51e-2)"	0.1	0.0	0.1	9.3	0.1	0.0	1.0	0.1	0.2	5.1	9.7	0.2	11.1	0.0	2.0	2.2	19.8	8.6	0.4	0.1	0.1	0.1	7.6	1.1	0.8	0.1	0.1	0.1	0.2	0.1	0.0	0.4	0.1	0.1	26.1	9.1	0.4	2.7	22.9	0.1	16.9	0.1	1.9	0.1	0.1	5.2	0.7	0.1	0.3	10.6	12.6	3.6	3.7	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
CXCL16	"CXCLG16, SR-PSOX, SRPSOX"	ENSG00000161921	"C-X-C motif chemokine ligand 16"	Q9H2A7	17	4733526-4739922	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 34.3;CACO-2: 23.6;CAPAN-2: 18.7;HaCaT: 38.5;T-47d: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 18.3;intermediate monocyte: 29.3;myeloid DC: 10.7;neutrophil: 25.9;non-classical monocyte: 37.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 10.7;granulocytes: 25.9;monocytes: 37.7"									"HPA053253, HPA066315"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	1103333	4000000	"Golgi apparatus"	Vesicles	"HPA053253: , HPA066315: "	"unprognostic (4.64e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.05e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.60e-1)"	32.5	9.5	8.2	18.7	9.7	16.3	9.7	2.0	6.6	8.0	17.2	15.8	3.4	19.1	4.8	10.5	13.1	9.5	23.0	5.2	9.9	6.9	12.5	34.8	41.9	28.8	13.3	5.1	10.6	11.0	34.6	8.6	9.7	10.0	9.8	8.3	12.7	26.6	5.9	3.3	11.3	29.5	5.2	16.5	34.1	18.7	51.9	10.0	4.5	8.1	8.5	10.1	9.7	7.4	3.4	10.7	25.9	37.7	0.0	0.3	6.9	34.3	4.7	0.0	11.1	0.1	0.9	4.4	0.4	3.3	3.3	4.5	23.6	18.7	0.0	4.2	0.2	38.5	5.5	4.0	1.1	3.5	6.3	0.0	0.5	10.4	2.3	0.0	5.1	0.2	6.6	1.7	0.2	0.9	0.0	0.2	0.2	7.2	0.1	0.6	0.0	2.9	0.4	0.0	5.1	7.0	5.7	0.0	0.3	7.0	2.8	1.8	18.5	0.4	0.1	0.5	2.5	0.8	2.0	1.2	1.5	0.0	0.1	0.1	0.8	0.0	18.3	4.0	0.1	29.3	0.1	2.9	0.3	0.2	10.7	3.4	0.1	0.3	25.9	0.0	37.7	4.6	0.0	6.9	8.2	9.7	2.0	6.6	9.9	6.9	13.3	5.1	10.0	10.0
CXorf21	FLJ11577	ENSG00000120280	"Chromosome X open reading frame 21"	Q9HAI6	X	30558824-30577844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.9;bone marrow: 16.0;lymphoid tissue: 16.7"	"Cell line enriched"	"Detected in some"	7	"THP-1: 57.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001185	Uncertain		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA001185: AB_1078591"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.25e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.66e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.23e-2)"	6.5	2.1	4.6	9.8	4.0	16.0	2.0	0.8	4.4	1.4	3.0	2.3	0.2	4.3	1.2	2.4	1.4	1.5	3.6	1.5	5.0	2.1	1.9	2.8	6.1	12.9	6.3	0.0	1.0	2.0	0.7	1.5	2.7	5.1	1.5	3.1	1.1	3.3	0.5	0.8	1.1	5.3	1.8	9.9	16.7	3.1	0.8	5.2	9.1	1.4	1.2	9.3	4.8	1.4	11.1	21.9	14.9	18.9	3.2	1.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	4.7	2.6	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	7.4	0.0	0.0	7.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.8	0.0	0.0	0.0	0.0	0.0	5.4	0.5	2.6	0.0	8.3	0.0	3.4	10.3	11.4	0.8	9.6	0.1	11.1	1.0	0.5	12.0	10.8	1.0	0.7	14.9	3.2	18.9	21.9	1.6	3.5	4.6	4.0	0.8	4.4	5.0	2.1	6.3	0.0	5.1	5.2
CXorf36	"DIA1R, FLJ14103"	ENSG00000147113	"Chromosome X open reading frame 36"	Q9H7Y0	X	45148374-45200901	"Disease related genes, Predicted secreted proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	143	"HUVEC TERT2: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA002806	Uncertain				"Secreted - unknown location"		370000			"HPA002806: AB_1078595"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.07e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.98e-1)"	"unprognostic (8.47e-2)"	"unprognostic (3.11e-2)"	42.1	3.2	3.8	6.2	4.4	0.8	47.7	1.4	3.2	17.9	7.3	2.9	6.7	2.4	28.5	10.2	8.0	9.9	7.5	23.6	4.7	3.7	4.5	2.1	9.3	12.1	6.8	1.2	7.9	4.2	4.3	3.7	39.6	4.2	12.0	3.5	4.3	4.4	7.7	14.4	4.9	4.7	17.7	6.4	5.0	4.2	5.6	2.0	0.3	12.3	12.0	3.7	10.6	26.5	0.5	0.2	2.4	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.3	0.1	0.3	0.4	0.4	0.4	0.0	0.5	0.4	0.3	2.4	0.1	0.0	0.2	0.1	0.1	3.8	4.4	1.4	3.2	4.7	3.7	6.8	1.2	4.2	2.0
CXorf40B		ENSG00000197021	"Chromosome X open reading frame 40B"	Q96DE9	X	149929527-149938811	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA060897	Approved									"HPA060897: "	"unprognostic (5.44e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.03e-2)"	"unprognostic (7.57e-2)"	"unprognostic (6.38e-2)"	"unprognostic (5.94e-2)"	"unprognostic (4.66e-2)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (7.14e-3)"	16.1	48.4	15.1	16.7	21.5	40.1	21.4	15.2	27.7	16.8	17.0	17.4	23.0	14.9	18.4	27.8	16.4	14.9	20.7	19.9	15.2	13.6	19.2	23.4	16.0	18.3	19.5	20.7	25.4	28.4	16.0	25.5	33.1	17.3	18.4	15.4	16.7	24.6	25.6	13.8	28.2	15.7	15.0	14.4	22.2	17.1	15.7	18.1	15.8	18.6	13.9	20.0	15.9	15.0	17.2	22.3	20.9	15.7	32.2	23.3	16.9	13.1	19.0	10.9	9.4	10.2	15.0	11.7	13.4	14.0	16.5	20.5	14.7	10.9	17.5	36.6	14.0	7.2	15.3	14.4	12.0	11.0	16.1	7.9	22.8	14.3	19.5	15.6	14.9	15.6	20.0	20.0	19.6	16.3	9.4	22.4	14.7	35.3	12.2	16.5	8.0	22.7	11.6	11.1	21.3	10.0	18.2	8.4	7.4	5.9	14.4	15.1	9.6	10.8	12.5	13.2	8.1	22.2	27.0	16.9	8.8	42.4	14.5	20.8	11.9	17.0	15.7	20.9	23.3	12.2	20.9	17.2	17.3	22.1	17.1	15.6	17.4	20.9	6.6	32.2	10.3	22.3	20.8	16.9	15.1	21.5	15.2	27.7	15.2	13.6	19.5	20.7	17.3	18.1
CXorf58	FLJ25444	ENSG00000165182	"Chromosome X open reading frame 58"	Q96LI9	X	23907801-23939507	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"testis: 8.4"	"Cell line enhanced"	"Detected in some"		"PC-3: 2.4;U-266/70: 2.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"monocytes: 1.0;T-cells: 1.8"									"HPA031542, HPA031543, HPA031544"	Uncertain									"HPA031542: , HPA031543: AB_10603789, HPA031544: "	"unprognostic (9.74e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.19e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.06e-3)"	0.1	0.4	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0			0.0	0.1	0.2	0.0	0.9	0.0	0.2	0.2	0.3	0.6	0.2	0.1	0.0	0.2		0.0	0.4	0.2	0.3	0.0		0.0	0.0		0.3	0.0	0.7	0.0	0.1	0.0	0.3	0.0	0.0	8.4			0.6		0.0	0.2	0.0	0.1	0.2	0.1	1.0	0.0	1.8	0.1	0.8	0.3	0.0	0.0	0.2	0.0	0.4	0.1	0.4	0.1	0.1	0.0	1.0	1.2	0.3	0.0	0.7	0.1	0.9	0.0	0.5	0.7	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.8	0.7	0.6	0.0	0.4	0.2	0.1	0.2	0.1	1.0	0.0	2.4	0.5	0.0	0.1	1.3	0.0	1.2	0.2	0.6	0.1	0.5	1.4	0.1	0.4	0.1	0.0	0.2	0.4	2.3	1.1	0.3	0.2	0.1	0.4	0.0	0.0	0.1	0.3	1.0	1.4	0.1	1.3	1.0	0.0	0.1	1.0	0.7	0.0	0.0	0.2	0.2	1.8	0.1										
CYB561D1	"FLJ39035, FLJ44753"	ENSG00000174151	"Cytochrome b561 family member D1"	Q8N8Q1	1	109494052-109502932	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027028	Uncertain									"HPA027028: AB_1847365"	"unprognostic (2.15e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.27e-1)"	"prognostic favourable (4.68e-4)"	"unprognostic (4.53e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.29e-2)"	"prognostic favourable (5.16e-6)"	"unprognostic (4.30e-1)"	"prognostic favourable (2.22e-4)"	"unprognostic (1.20e-3)"	"unprognostic (2.75e-1)"	"unprognostic (4.95e-3)"	"unprognostic (5.82e-2)"	6.1	10.5	8.7	10.7	12.0	9.1	7.0	21.7	13.4	4.2	8.4	7.9	13.4	7.1	6.9	14.8	9.3	7.0	6.7	4.6	9.6	5.6	8.2	4.2	7.4	12.8	9.7	10.2	9.4	19.4	11.1	11.2	7.0	8.8	6.8	7.7	4.6	10.8	8.4	7.8	22.5	12.2	6.8	7.8	12.1	9.0	3.9	11.1	10.6	10.3	6.6	12.8	7.0	12.2	4.5	3.0	10.8	4.5	8.7	8.3	3.5	8.2	4.8	3.6	4.2	12.3	9.1	9.1	7.2	5.6	8.2	5.9	4.8	3.7	7.4	7.7	9.2	9.5	4.7	5.9	5.4	6.1	4.3	5.0	6.7	3.7	5.8	10.1	15.6	9.7	14.7	8.1	4.3	5.9	3.1	3.4	5.3	10.4	3.6	5.4	1.7	7.5	6.0	14.5	2.9	7.6	14.0	5.3	4.6	8.1	8.0	7.5	5.5	5.5	7.6	8.2	9.7	11.1	5.8	4.0	2.8	3.7	8.3	8.4	9.0	3.8	3.8	5.6	6.3	4.2	5.5	3.5	6.6	5.6	2.7	4.5	8.3	5.8	10.8	8.7	4.5	3.0	4.7	3.5	8.7	12.0	21.7	13.4	9.6	5.6	9.7	10.2	8.8	11.1
CYB5D1	FLJ32499	ENSG00000182224	"Cytochrome b5 domain containing 1"	Q6P9G0	17	7857746-7862282	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA021632	Uncertain		Approved	"Nucleoli,Golgi apparatus"				"Nucleoli, Golgi apparatus"		"HPA021632: AB_1847368"	"unprognostic (1.99e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.27e-3)"	"unprognostic (1.79e-2)"	14.0	13.0	13.2	5.5	22.5	7.2	13.1	14.1	16.8	10.5	7.9	14.0	12.8	6.5	10.9	17.0	7.9	28.2	9.4	13.9	14.4	12.0	19.2	13.0	8.8	4.7	9.4	13.5	14.6	13.1	9.7	18.1	7.0	16.5	11.0	7.8	11.7	10.5	13.2	9.9	10.1	6.0	9.4	6.5	5.9	8.4	14.5	11.7	6.9	22.8	8.6	5.6	7.4	7.5	3.4	3.1	2.7	2.3	1.6	5.9	1.8	16.1	12.0	5.8	15.4	10.4	9.3	3.5	8.3	8.3	9.0	8.6	7.6	3.1	7.0	5.9	6.7	14.5	12.8	10.9	13.5	4.6	14.7	4.6	15.7	10.8	4.7	8.1	3.3	7.8	13.8	15.6	14.2	9.5	3.3	4.8	4.9	7.0	12.6	3.3	7.3	12.5	8.7	2.7	7.0	14.1	3.1	7.9	5.3	13.2	7.4	7.6	8.7	3.3	6.6	7.0	6.1	12.2	10.5	2.5	6.1	3.9	14.6	4.5	4.4	0.5	2.3	0.1	2.7	1.9	3.3	3.4	2.4	1.4	3.1	1.5	5.9	3.1	2.7	1.6	1.1	1.4	2.2	1.8	13.2	22.5	14.1	16.8	14.4	12.0	9.4	13.5	16.5	11.7
CYB5D2	MGC32124	ENSG00000167740	"Cytochrome b5 domain containing 2"	Q8WUJ1	17	4143168-4187310	"Predicted intracellular proteins, Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042299	Approved		Approved	"Nuclear membrane,Nucleoli,Centrosome"	"Secreted - unknown location"			"Nuclear membrane"	"Nucleoli, Centrosome"	"HPA042299: AB_10793879"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.16e-2)"	"prognostic favourable (6.19e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.75e-2)"	"prognostic favourable (4.98e-6)"	"unprognostic (1.57e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.71e-3)"	"prognostic favourable (7.76e-5)"	"unprognostic (2.04e-1)"	"prognostic favourable (2.03e-10)"	"unprognostic (2.01e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.97e-1)"	13.1	17.3	18.7	5.1	26.4	3.6	15.0	20.6	27.5	15.0	8.1	21.8	14.6	13.3	13.9	27.1	9.8	17.4	14.5	10.3	17.8	21.6	22.9	25.3	8.6	7.4	19.7	26.1	19.5	17.0	28.5	18.5	9.9	19.1	12.0	6.8	17.3	17.5	16.8	12.2	11.7	10.3	7.8	21.7	7.9	12.3	54.1	17.1	4.8	20.6	7.1	6.8	12.0	8.6	9.4	13.0	14.7	12.7	5.9	12.5	9.0	7.8	10.5	6.1	6.4	39.3	11.6	2.5	7.6	16.4	5.5	5.7	3.1	5.2	2.5	6.9	8.8	11.1	2.5	3.5	2.2	8.3	12.6	2.4	6.6	5.2	7.1	1.0	4.8	15.1	8.4	3.0	6.0	10.0	2.5	15.5	4.2	9.6	3.6	1.6	2.2	5.7	4.4	5.4	6.2	12.8	4.1	4.9	4.1	8.5	5.0	11.2	13.2	1.5	13.5	8.1	2.1	7.5	3.9	3.0	2.2	1.9	10.0	2.2	3.1	0.6	12.7	14.7	7.2	10.4	8.1	9.4	11.4	8.8	12.0	9.4	10.8	9.7	11.7	5.9	9.4	13.0	12.5	9.0	18.7	26.4	20.6	27.5	17.8	21.6	19.7	26.1	19.1	17.1
CYB5RL	LOC606495	ENSG00000215883	"Cytochrome b5 reductase like"	Q6IPT4	1	54169651-54200036	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042671, HPA060463"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA042671: , HPA060463: "	"unprognostic (2.03e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.90e-4)"	"unprognostic (6.45e-3)"	"unprognostic (9.75e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.86e-1)"	1.7	4.9	1.9	0.8	1.9	1.6	2.4	1.3	1.7	2.5	2.2			2.6	2.5	2.3	2.1	2.9	2.0	3.5	2.1	1.7	2.7	2.6	1.5	2.1	2.3		5.0	4.1	1.8	4.2	1.1		2.1	2.7		3.2	1.4	3.7	3.9	1.5	2.4	1.8	2.5	2.8	1.2			3.1		2.2	2.8	1.8	1.4	1.8	2.6	3.5	3.1	1.5	1.2	4.0	5.4	7.4	7.7	6.1	5.8	2.5	3.2	4.6	6.3	6.8	5.1	4.4	6.7	3.8	2.2	3.7	11.5	3.3	7.1	7.6	4.7	7.6	8.7	5.2	4.6	6.5	3.9	3.1	4.5	7.4	3.4	5.4	8.2	3.2	4.5	5.0	6.5	3.6	7.4	4.3	10.5	9.1	6.2	2.8	4.6	11.0	5.4	2.1	7.3	6.5	5.1	5.0	2.4	4.8	3.9	7.0	5.7	4.8	7.7	9.9	5.4	13.9	7.2	2.2	1.8	1.6	1.0	3.5	0.8	1.1	1.5	0.6	1.6	1.4	1.2	1.2	2.6	3.1	0.8	1.8	0.5	1.2										
CYLC1		ENSG00000183035	"Cylicin 1"	P35663	X	83861126-83886699	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"testis: 24.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA070355	Enhanced									"HPA070355: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP2A7	CYP2A	ENSG00000198077	"Cytochrome P450 family 2 subfamily A member 7"	P20853	19	40875439-40882752	"Enzymes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	134	"liver: 53.7"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.9"	"Group enriched"	"Detected in some"	238	"breast cancer: 9.2;liver cancer: 25.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB033510, HPA046713, HPA047262"	Enhanced				"Intracellular and membrane"					"CAB033510: AB_782366, HPA046713: , HPA047262: "	"unprognostic (2.18e-1)"				"unprognostic (3.60e-2)"		"unprognostic (2.65e-3)"	"unprognostic (8.89e-2)"		"unprognostic (1.39e-2)"	"unprognostic (3.95e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.99e-2)"		"unprognostic (1.06e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
CYP4F22	FLJ39501	ENSG00000171954	"Cytochrome P450 family 4 subfamily F member 22"	Q6NT55	19	15508493-15552317	"Disease related genes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	Ichthyosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 44.6;skin 1: 29.0"	"Cell line enhanced"	"Detected in some"		"HEL: 1.3;MCF7: 5.2;RT4: 2.5;T-47d: 3.1;U-2 OS: 2.5"	"Group enriched"	"Detected in many"	7	"breast cancer: 4.5;head and neck cancer: 5.7;liver cancer: 8.5;melanoma: 4.5;urothelial cancer: 13.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 6.1;MAIT T-cell: 4.6;non-classical monocyte: 13.2"	"Group enriched"	"Detected in many"	9	"monocytes: 13.2;T-cells: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058960	Uncertain									"HPA058960: "	"unprognostic (2.32e-3)"	"unprognostic (1.17e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.21e-5)"	"unprognostic (8.10e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.03e-2)"	0.5	0.0	0.0	0.1	0.0	0.1	3.6	0.0	0.0	5.4	0.1	0.0	10.3	0.2	0.6	0.2	12.1	0.1	0.6	0.0	0.0	0.0	0.0	19.3	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	5.2	0.0	0.0	1.6	44.6	1.2	29.0	0.1	1.0	0.0	0.3	0.5	0.7	0.0	0.4	0.0	14.7	6.7	5.5	10.3	0.0	0.2	0.0	13.2	1.0	4.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	1.8	6.1	4.6	0.0	0.6	1.5	0.2	0.0	0.0	0.4	0.0	1.0	13.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
CYP4X1	MGC40051	ENSG00000186377	"Cytochrome P450 family 4 subfamily X member 1"	Q8N118	1	47023568-47050751	"Enzymes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 38.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.6;CACO-2: 6.1;HEK 293: 2.5;NTERA-2: 2.8;SCLC-21H: 3.7;T-47d: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA017661	Approved									"HPA017661: AB_2669633"	"unprognostic (1.19e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.56e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.03e-2)"	7.9	3.6	9.0	1.1	14.9	0.5	16.0	7.1	16.9	38.1	2.0	1.6	2.5	2.1	3.6	3.2	12.0	9.7	2.0	6.7	4.8	10.6	6.3	10.0	8.9	2.0	3.3	13.5	1.7	2.0	2.0	4.1	1.5	7.8	8.0	2.3	17.6	23.7	3.4	4.5	5.0	1.8	2.4	2.0	1.0	14.3	4.2	0.9	0.0	4.0	6.9	8.8	3.9	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.2	0.1	0.0	0.1	0.0	0.0	6.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.5	0.0	0.6	0.2	3.7	0.0	0.0	0.3	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	14.9	7.1	16.9	4.8	10.6	3.3	13.5	7.8	0.9
CYYR1	C21orf95	ENSG00000166265	"Cysteine and tyrosine rich 1"	Q96J86	21	26466209-26573284	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"breast: 59.8"	"Cell line enhanced"	"Detected in some"		"AF22: 8.8;NTERA-2: 24.7;PC-3: 6.8;RH-30: 10.4;SCLC-21H: 21.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	38	"plasmacytoid DC: 21.1"	"Lineage enriched"	"Detected in single"	73	"dendritic cells: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034921, HPA067685"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"CAB034921: AB_2089315, HPA067685: "	"unprognostic (5.64e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.88e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.44e-3)"	"unprognostic (9.29e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	30.9	28.9	3.8	7.7	4.4	4.0	59.8	2.1	4.3	19.0	8.4	2.7	13.4	3.5	15.1	14.7	13.1	8.6	10.8	29.1	4.7	3.9	10.6	7.1	23.8	13.4	5.6	2.5	9.8	4.5	5.1	3.5	21.7	3.9	11.7	4.0	11.6	5.4	10.5	14.5	4.8	6.8	14.6	5.0	34.1	5.9	9.2	2.5	3.6	11.2	9.1	2.7	11.2	23.9	0.0	21.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.1	0.0	0.2	3.4	0.0	0.0	1.6	0.0	0.0	0.0	24.7	6.8	0.0	10.4	0.0	1.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	21.1	0.0	0.0	3.8	4.4	2.1	4.3	4.7	3.9	5.6	2.5	3.9	2.5
DACH2		ENSG00000126733	"Dachshund family transcription factor 2"	Q96NX9	X	86148458-86832604	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 29.5;epididymis: 9.3;fallopian tube: 8.0"	"Cell line enriched"	"Detected in some"	7	"HAP1: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							"HPA000258, HPA001367"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA000258: AB_1078618, HPA001367: "	"unprognostic (5.73e-3)"		"unprognostic (3.22e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.71e-2)"	"unprognostic (6.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.01e-3)"	"unprognostic (2.63e-2)"	0.9	0.9	7.9	0.6	29.5	0.6	0.6	0.2	17.8	1.0	0.8	0.3	0.0	1.2	1.2	9.3	0.7	8.0	0.6	0.6	13.5	10.8	2.4	0.6	0.9	0.6	3.4	10.4	1.4	1.1	0.7	1.3	0.6	11.8	1.5	0.7	1.6	0.7	0.8	0.6	0.7	1.3	0.8	0.7	0.6	1.4	0.7	1.7	0.0	0.7	0.0	0.6	1.4	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	29.5	0.2	16.8	13.5	10.8	3.4	10.4	11.8	1.7
DACT2	"bA503C24.7, C6orf116, DAPPER2"	ENSG00000164488	"Dishevelled binding antagonist of beta catenin 2"	Q5SW24	6	168292830-168319754	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 14.2;placenta: 54.8"	"Cell line enhanced"	"Detected in some"		"A549: 6.4;CACO-2: 5.1;EFO-21: 2.9;Hep G2: 2.9;hTCEpi: 3.5;NTERA-2: 4.6;SCLC-21H: 5.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 14.1"	"Region enriched"	"Detected in many"	8	"basal ganglia: 14.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA030251, HPA030252"	Approved	Supported								"HPA030251: AB_10611108, HPA030252: AB_10601993"	"unprognostic (5.22e-6)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-2)"	"prognostic favourable (1.07e-5)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.05e-3)"	"unprognostic (2.48e-1)"	"prognostic favourable (5.76e-5)"	"unprognostic (1.51e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.03e-4)"	"unprognostic (4.23e-2)"	1.0	1.3	0.5	0.4	14.2	0.0	0.4	1.5	1.4	2.3	1.1	1.2	1.0	0.9	3.7	2.2	0.7	2.2	2.9	2.7	0.9	0.5	2.2	2.4	2.0	0.4	1.1	0.9	0.9	1.6	0.0	0.4	54.8	1.7	6.1	0.4	1.6	5.3	0.5	0.4	5.6	0.8	0.8	0.7	0.4	0.5	1.0	0.7	0.9	0.4	0.4	0.8	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.8	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	14.2	1.5	1.4	0.9	0.5	1.1	0.9	1.7	0.7
DAND5	"CER2, CKTSF1B3, Coco, DANTE, DTE, FLJ38607, GREM3"	ENSG00000179284	"DAN domain BMP antagonist family member 5"	Q8N907	19	12965159-12974762	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 5.3;heart muscle: 13.7"	"Cell line enriched"	"Detected in some"	15	"SH-SY5Y: 20.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA043493, HPA049472"	Uncertain		Approved	Mitochondria	"Secreted in other tissues"			Mitochondria		"HPA043493: , HPA049472: "	"unprognostic (1.18e-2)"	"unprognostic (4.63e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.82e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.95e-3)"	"unprognostic (7.27e-3)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.48e-10)"	"unprognostic (4.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.37e-1)"	0.2	2.0	0.9	0.9	2.5	3.0	0.4	1.4	1.4	0.2	3.6	2.1	0.0	0.4	0.4	0.4	0.3	0.1	0.7	13.7	0.4	0.3	0.1	0.1	0.2	0.3	0.5	0.0	0.4	0.4	0.4	0.2	0.0	3.8	0.2	0.5	3.6	2.6	0.0	0.2	0.7	2.5	0.4	1.6	0.1	0.7	0.8	0.3	0.0	0.5	0.0	0.0	0.3	0.2	1.6	1.4	5.3	0.6	1.4	1.2	0.3	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.4	0.0	0.7	0.3	0.0	0.0	0.2	0.2	0.0	0.3	0.0	0.1	0.4	1.3	0.0	0.5	0.3	0.1	0.2	0.2	0.2	0.0	0.3	0.2	0.1	1.1	20.5	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.3	0.1	0.2	0.5	0.1	0.1	0.0	0.3	0.1	2.7	0.6	1.3	0.7	0.4	0.6	0.9	0.4	0.4	0.2	1.6	0.7	1.2	5.3	1.4	0.3	1.4	0.2	0.3	0.9	2.5	1.4	0.8	0.4	0.3	0.5	0.0	3.8	0.3
DBX2	FLJ16139	ENSG00000185610	"Developing brain homeobox 2"	Q6ZNG2	12	45014672-45051099	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 10.7"	"Group enriched"	"Detected in some"	4	"HEK 293: 1.2;HeLa: 1.6;SCLC-21H: 1.7"	"Cancer enriched"	"Detected in single"	32	"glioma: 4.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066053	Uncertain									"HPA066053: "	"unprognostic (1.13e-4)"			"unprognostic (9.99e-2)"	"unprognostic (7.82e-3)"	"unprognostic (5.24e-2)"				"unprognostic (5.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.22e-2)"		"unprognostic (4.76e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.19e-1)"		2.0	0.5	4.4	0.5	3.6	0.5	1.8	1.2	10.7	0.9	0.5	5.1	0.2	0.4	0.5	0.4	0.6	0.6	0.7	0.9	4.4	4.6	1.1	0.4	0.5	0.5	5.9	3.1	0.4	0.4	0.5	0.0	0.4	10.3	0.7	0.5	0.0	0.8	0.7	0.7	2.1	0.4	0.5	10.3	0.4	0.5	2.9	1.8	0.0	0.7	1.3	0.6	0.6	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.4	3.6	1.2	4.6	4.4	4.6	5.9	3.1	10.3	1.8
DCAF12L2	WDR40C	ENSG00000198354	"DDB1 and CUL4 associated factor 12 like 2"	Q5VW00	X	126163499-126166097	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 15.7;epididymis: 53.6;testis: 15.8"	"Group enriched"	"Detected in some"	6	"HAP1: 5.7;NTERA-2: 4.8;U-2 OS: 7.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044737, HPA048981, HPA053138"	Approved		Uncertain	Cytosol				Cytosol		"HPA044737: , HPA048981: , HPA053138: "	"unprognostic (1.16e-4)"			"unprognostic (8.83e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.52e-2)"		"unprognostic (2.72e-1)"		"unprognostic (3.02e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.47e-4)"	"unprognostic (1.56e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.51e-1)"	1.1	1.2	1.1	0.1	1.9	0.1	2.3	0.5	2.1	1.9	0.9	0.0	15.7	0.1	2.4	53.6	0.5	3.0	0.2	0.4	1.0	3.9	0.4	0.1	0.2	0.2	1.0	1.7	1.9	0.2	2.4	1.3	0.1	1.3	2.0	0.2	0.2	0.6	5.6	0.4	0.5	0.5	2.0	0.8	0.2	0.7	15.8	0.1	0.0	0.4	0.0	0.3	2.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	0.5	2.1	1.0	3.9	1.0	1.7	1.3	0.1
DCAF4L1	WDR21B	ENSG00000182308	"DDB1 and CUL4 associated factor 4 like 1"	Q3SXM0	4	41981696-41986467	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"testis: 37.5"	"Cell line enhanced"	"Detected in some"		"REH: 3.6"	"Cancer enriched"	"Detected in single"	49	"testis cancer: 8.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											CAB073535	Enhanced									"CAB073535: "	"unprognostic (6.24e-2)"	"unprognostic (7.52e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.63e-3)"	"unprognostic (4.64e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.83e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.76e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.36e-4)"	0.1	0.1	0.1	0.2	0.2	0.1	1.1	0.5	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.3	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.9	0.3	0.1	0.1	0.1	0.5	0.0	37.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.3	1.4	0.3	0.0	0.4	0.0	0.1	0.2	0.3	2.3	0.1	0.1	1.4	0.4	0.1	0.2	0.2	0.3	0.8	0.6	0.3	0.1	0.8	1.9	0.2	0.6	0.2	0.8	2.1	2.0	0.3	0.2	2.3	1.2	0.1	2.2	0.6	0.2	0.0	1.0	0.0	0.2	0.1	0.8	2.9	0.3	0.6	3.6	0.4	0.6	0.2	0.4	0.6	0.7	0.2	0.1	0.3	0.2	0.2	0.4	0.3	2.0	0.6	2.1	0.9	2.8	0.3	0.3	2.0	1.0	0.9	0.3	0.1	0.3	0.2	0.0	0.3	0.4	0.2	0.1	0.6	0.0	0.4	1.4	0.0	0.3	0.3	0.0	0.0	0.1	0.2	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1
DCAF8L1	WDR42B	ENSG00000226372	"DDB1 and CUL4 associated factor 8 like 1"	A6NGE4	X	27977993-27981449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"testis: 8.4"	"Cell line enriched"	"Detected in single"	23	"Karpas-707: 20.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043787	Enhanced									"HPA043787: AB_10961430"															"unprognostic (1.40e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DCLK3	"DCAMKL3, DCDC3C, KIAA1765"	ENSG00000163673	"Doublecortin like kinase 3"	Q9C098	3	36712422-36764349	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 10.0;testis: 8.0"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.3;SCLC-21H: 3.2;SH-SY5Y: 2.6;U-2 OS: 1.8;U-2197: 2.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040685	Approved									"HPA040685: "	"unprognostic (9.09e-3)"	"unprognostic (1.41e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.07e-2)"	"unprognostic (6.11e-5)"	"unprognostic (7.94e-3)"	"unprognostic (5.80e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.36e-2)"	1.1	0.4	2.6	1.4	10.0	0.3	0.1	0.1	2.3	0.5	0.2	0.3	0.0	0.5	0.3	0.1	0.1	0.2	0.6	0.9	1.4	0.9	0.0	0.1	0.3	0.2	0.6	0.0	0.0	0.2	0.4	1.8	1.1	0.4	0.3	0.3	1.3	1.7	0.2	2.7	0.4	0.4	0.9	0.7	0.1	0.0	8.0	3.2	0.0	0.9	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	3.2	2.6	0.1	0.3	0.0	0.0	0.4	0.3	0.0	1.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	10.0	0.1	2.3	1.4	0.9	0.6	0.0	0.4	3.2
DDIAS	"C11orf82, FLJ25416, FLJ38838, noxin"	ENSG00000165490	"DNA damage induced apoptosis suppressor"	Q8IXT1	11	82899975-82958277	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.6;testis: 16.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA038540, HPA038541"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"		"HPA038540: AB_10672648, HPA038541: "	"unprognostic (2.53e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.86e-6)"	"unprognostic (4.65e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.24e-3)"	"unprognostic (2.04e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.11e-16)"	"unprognostic (7.17e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.13e-2)"	1.3	1.0	0.8	6.1	0.8	7.0	1.7	0.8	1.2	1.9	2.3	1.2	0.2	1.3	1.5	2.6	5.5	1.0	0.4	2.6	0.9	0.7	1.0	2.3	3.1	5.0	0.8	0.6	1.3	0.9	0.0	0.5	2.5	1.0	0.9	2.0	0.2	2.1	0.2	10.1	2.3	1.9	1.5	0.9	5.5	1.1	16.3	0.9	17.6	0.8	9.5	5.9	1.8	1.8	2.0	4.5	5.8	10.7	1.9	0.7	3.2	6.0	9.5	9.8	7.1	1.0	1.5	7.2	11.4	4.8	12.6	14.7	9.3	7.5	7.3	17.1	2.6	11.5	16.6	7.2	17.5	13.2	8.9	10.4	4.9	4.1	0.1	12.7	9.2	0.3	0.7	15.9	7.3	5.9	10.4	12.7	11.1	8.7	12.0	10.4	11.7	10.9	8.9	19.0	9.4	2.7	10.0	7.4	9.9	7.0	7.1	2.7	7.7	5.3	2.8	12.7	17.2	33.3	13.8	7.2	18.9	25.5	4.0	9.2	12.0	0.6	10.7	3.9	0.5	8.3	0.3	1.1	0.3	0.7	4.5	2.0	0.7	0.4	5.8	1.9	7.8	1.4	0.5	3.2	0.8	0.8	0.8	1.2	0.9	0.7	0.8	0.6	1.0	0.9
DDO		ENSG00000203797	"D-aspartate oxidase"	Q99489	6	110391771-110415562	"Enzymes, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 14.5;U-937: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.9;myeloid DC: 7.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037525, HPA037526"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA037525: AB_2675523, HPA037526: AB_10672352"	"unprognostic (1.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.43e-1)"	"prognostic favourable (8.69e-5)"	"unprognostic (3.51e-4)"	"unprognostic (3.36e-3)"	"unprognostic (1.27e-3)"	"unprognostic (9.06e-2)"	3.7	11.0	5.2	1.1	12.1	1.6	3.3	1.9	5.5	2.7	3.6	10.8	4.9	8.6	2.7	5.4	1.2	6.1	3.9	21.0	6.9	3.4	12.3	12.8	3.9	1.3	8.0	6.1	1.2	5.5	18.6	1.9	2.1	8.0	2.9	3.9	2.3	4.9	3.2	11.3	0.8	7.9	5.6	7.7	2.6	1.9	0.4	8.2	0.0	3.3	5.7	0.5	3.6	1.6	0.0	7.3	0.1	4.9	1.7	0.0	1.5	0.2	0.0	0.0	0.1	0.0	0.2	1.0	0.2	5.1	1.2	0.9	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	2.3	4.6	0.0	4.7	0.0	4.0	1.6	0.0	0.0	0.1	0.0	2.6	0.1	0.0	0.0	1.8	4.2	0.0	0.0	0.2	0.0	0.1	0.1	2.9	14.5	0.0	4.6	0.1	0.1	0.0	0.4	0.6	0.7	1.0	0.9	1.0	0.1	0.0	2.4	0.1	0.3	0.0	1.9	16.1	0.0	0.1	4.6	0.0	0.0	4.9	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.1	1.7	1.6	0.0	0.0	1.5	5.2	12.1	1.9	5.5	6.9	3.4	8.0	6.1	8.0	8.2
DDX43	"CT13, DKFZp434H2114, HAGE"	ENSG00000080007	"DEAD-box helicase 43"	Q9NXZ2	6	73394748-73417569	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 35.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.8;CAPAN-2: 14.8;HHSteC: 4.1;U-2 OS: 9.5"	"Cancer enriched"	"Detected in many"	15	"testis cancer: 13.0"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA031381	Enhanced									"HPA031381: AB_10601885"	"unprognostic (4.03e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.59e-4)"	"unprognostic (1.64e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.78e-2)"	1.3	0.7	0.6	1.0	0.7	0.7	1.9	0.4	0.8	0.8	2.6	1.2	2.1	1.4	1.0	0.4	1.1	0.7	6.1	1.2	0.7	0.6	0.8	1.0	1.6	0.9	1.0	0.0	2.9	1.9	0.1	0.7	5.7	3.3	1.8	0.7	1.5	4.3	2.2	0.4	1.4	1.7	3.0	1.9	1.2	2.4	35.2	0.7	0.4	1.8	1.3	1.9	1.7	0.7	2.3	0.8	2.9	0.9	1.6	3.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.5	0.0	0.0	0.0	0.1	14.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	2.9	3.3	0.9	2.6	2.3	2.5	2.8	0.8	2.3	1.3	0.4	0.6	1.6	0.8	0.2	1.4	0.7	0.6	0.7	0.4	0.8	0.7	0.6	1.0	0.0	3.3	0.7
DDX60L	FLJ31033	ENSG00000181381	"DExD/H-box 60 like"	Q5H9U9	4	168356735-168537786	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.5"	"Group enriched"	"Detected in all"	4	"granulocytes: 22.5;monocytes: 7.8"									"HPA043211, HPA055501"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA043211: AB_10794390, HPA055501: "	"unprognostic (8.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavourable (3.04e-5)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (1.13e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.69e-1)"	12.7	5.0	2.8	13.1	3.1	33.0	9.9	1.4	3.2	7.2	8.4	3.2	2.7	6.0	9.2	7.9	3.8	6.9	6.7	6.0	2.4	2.4	4.5	6.0	25.8	17.7	3.8	1.4	7.3	5.1	4.4	5.2	32.6	3.4	5.0	6.5	6.8	7.0	5.7	3.3	4.3	14.0	5.3	4.2	11.9	9.5	2.7	3.1	25.3	5.8	3.5	8.1	4.9	6.8	1.6	2.4	22.5	7.8	1.7	3.7	1.6	6.0	3.6	1.4	0.6	3.7	10.7	7.0	6.1	13.0	23.1	16.1	0.0	14.4	0.1	0.3	6.2	2.4	0.6	3.7	6.7	3.5	0.5	13.4	4.0	0.3	4.5	5.5	3.4	3.0	1.1	8.3	0.7	16.2	0.2	0.1	14.8	0.1	4.9	3.5	0.3	3.0	2.7	3.1	0.0	2.2	3.6	0.2	1.9	10.9	1.3	6.1	1.0	7.7	17.3	1.2	8.2	2.9	2.1	5.9	0.9	0.0	4.1	16.3	1.7	1.6	4.0	3.5	2.7	6.3	3.7	0.9	2.7	2.7	2.4	1.6	2.2	2.3	22.5	1.7	7.8	0.0	3.6	1.6	2.8	3.1	1.4	3.2	2.4	2.4	3.8	1.4	3.4	3.1
DEFB107A	"DEFB-7, DEFB107"	ENSG00000186572	"Defensin beta 107A"	Q8IZN7	8	7811720-7815716	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	100	"epididymis: 77.2"	"Cell line enhanced"	"Detected in single"		"NB-4: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045626	Approved				"Secreted in male reproductive system"					"HPA045626: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.1			0.0	0.3	77.2	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB107B	HsT21816	ENSG00000198129	"Defensin beta 107B"	Q8IZN7	8	7495846-7509311	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	95	"epididymis: 78.7"	"Cell line enhanced"	"Detected in single"		"NB-4: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045626	Approved				"Secreted in male reproductive system"					"HPA045626: "																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.3	78.7	0.1	0.8	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0
DEFB108B		ENSG00000184276	"Defensin beta 108B"	Q8NET1	11	71833200-71837710	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	28	"HaCaT: 2.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042588	Uncertain				"Secreted - unknown location"					"HPA042588: AB_10959523"																		0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0		0.0	0.3	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB118	"C20orf63, DEFB-18, dJ1018D12.3, ESC42"	ENSG00000131068	"Defensin beta 118"	Q96PH6	20	31368618-31373923	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	147	"epididymis: 167.4"	"Group enriched"	"Detected in some"	5	"BEWO: 2.8;NB-4: 4.4;RPMI-8226: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042634	Enhanced				"Secreted in male reproductive system"					"HPA042634: AB_10797505"														"unprognostic (3.24e-1)"				0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	167.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DEFB119	"DEFB-19, DEFB-20, DEFB120"	ENSG00000180483	"Defensin beta 119"	Q8N690	20	31377164-31390603	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	61	"epididymis: 218.6;testis: 126.7"	"Cell line enhanced"	"Detected in some"		"NB-4: 5.0;RPMI-8226: 3.1;SCLC-21H: 1.2;SH-SY5Y: 2.4"	"Cancer enriched"	"Detected in single"	67	"testis cancer: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043059	Supported				"Secreted in male reproductive system"					"HPA043059: AB_10797025"															"unprognostic (2.03e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	218.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	126.7	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	1.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB129	"bA530N10.3, C20orf87, DEFB-29"	ENSG00000125903	"Defensin beta 129"	Q9H1M3	20	227258-229886	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"epididymis: 223.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;NB-4: 7.0;RPMI-8226: 1.6;SH-SY5Y: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA014581	Supported				"Secreted in male reproductive system"					"HPA014581: "																		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	14.0	0.0	0.2	223.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.1	0.6	0.1	0.0	0.1	0.1	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DENND6B	"AFI1B, FAM116B, MGC33692"	ENSG00000205593	"DENN domain containing 6B"	Q8NEG7	22	50309030-50327060	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 24.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 8.2;RPMI-8226: 11.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018934, HPA021653, HPA029570"	Uncertain		Uncertain	"Plasma membrane"				"Plasma membrane"		"HPA018934: AB_1848365, HPA021653: AB_1848366, HPA029570: AB_10602131"	"unprognostic (2.50e-2)"	"unprognostic (2.55e-2)"	"prognostic unfavourable (1.41e-4)"	"prognostic favourable (5.93e-5)"	"unprognostic (9.39e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-2)"	2.7	5.5	11.6	4.3	17.0	2.0	3.2	21.1	22.8	5.7	2.8	7.5	5.5	2.5	5.2	5.3	3.4	24.7	6.2	2.3	8.4	10.2	5.7	1.3	7.3	5.2	4.9	14.4	4.3	6.4	6.8	15.1	2.3	10.4	4.7	2.3	4.1	5.9	7.4	1.1	5.0	3.0	3.6	3.2	4.4	4.2	9.0	4.5	0.0	6.0	1.0	3.5	4.4	2.7	0.7	1.8	0.5	3.9	1.0	0.7	0.9	0.6	2.3	4.9	5.4	1.2	4.8	0.0	1.0	2.4	0.6	0.4	0.1	3.5	8.2	2.1	2.3	4.2	0.1	0.1	0.2	2.0	1.2	1.4	3.9	0.2	1.1	0.2	3.7	4.1	5.2	0.1	0.7	1.0	1.7	1.5	1.2	3.6	0.0	0.8	0.3	0.2	1.1	0.0	11.9	6.2	2.0	2.1	4.0	2.6	3.4	0.4	5.4	1.2	1.1	0.9	0.8	0.8	0.1	1.3	0.3	1.1	2.2	0.9	1.0	0.5	2.6	0.1	0.4	3.2	0.6	0.6	0.6	0.7	1.8	0.7	0.6	0.7	0.5	1.0	3.9	1.4	0.6	0.9	11.6	17.0	21.1	22.8	8.4	10.2	4.9	14.4	10.4	4.5
DEPDC4	"DEP.4, FLJ33505"	ENSG00000166153	"DEP domain containing 4"	Q8N2C3	12	100203669-100267079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 7.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"							"Group enriched"	"Detected in some"	7	"naive B-cell: 2.8;naive CD4 T-cell: 2.1;naive CD8 T-cell: 1.8"	"Group enriched"	"Detected in many"	8	"B-cells: 2.8;T-cells: 2.1"					"Low region specificity"	"Detected in all"			HPA039323	Uncertain		Approved	Microtubules				Microtubules		"HPA039323: AB_10674283"	"unprognostic (8.89e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.62e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.09e-4)"	"unprognostic (5.02e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-2)"	0.2	0.6	1.3	0.2	1.0	0.7	1.4	0.2	1.3	0.4	1.0			2.1	0.5	0.7	1.1	0.6	0.6	0.6	1.0	1.2	3.3	2.2	0.3	0.3	1.1		1.3	1.8	1.0	1.2	1.1		1.3	1.4		0.9	1.9	0.3	0.6	0.6	0.2	1.6	0.1	0.9	7.5			0.8		0.2	1.0	0.5	2.8	0.0	0.0	0.3	0.0	2.1	0.0	2.0	3.0	5.6	1.6	0.3	0.7	3.5	2.9	2.1	6.2	3.7	4.7	1.2	2.2	1.9	1.5	3.2	4.8	2.4	6.8	2.5	5.3	7.8	1.5	5.3	0.7	2.5	3.1	0.6	1.5	2.2	0.5	1.6	4.6	1.0	2.8	2.1	1.6	4.6	2.6	3.1	3.3	5.7	5.2	2.9	1.3	1.6	3.4	1.7	2.3	1.8	4.6	2.7	0.3	4.2	1.7	1.7	2.2	2.5	2.6	4.9	1.2	2.0	3.4	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	2.8	2.1	1.8	0.0	0.0	0.1	0.0	0.0	0.0										
DEPDC7		ENSG00000121690	"DEP domain containing 7"	Q96QD5	11	33015864-33033582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 51.8;liver: 42.2"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 26.7;RH-30: 20.2;SiHa: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA015800			Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA015800: AB_1847610"	"unprognostic (2.34e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.26e-2)"	"prognostic favourable (7.26e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.94e-2)"	0.6	0.5	2.0	1.4	4.1	0.9	2.0	0.5	2.6	1.7	15.3	4.3	1.2	14.1	1.2	1.4	3.1	0.8	3.1	0.9	2.6	1.4	10.9	42.2	0.7	0.4	4.0	1.5	1.3	2.7	3.5	0.8	1.2	2.8	1.4	3.1	1.2	1.7	1.0	3.3	3.4	51.8	1.0	3.2	0.5	2.2	15.6	3.3	1.8	0.6	2.0	0.9	0.9	2.4	0.0	4.4	9.0	0.7	3.0	3.1	0.6	4.5	2.5	3.7	1.6	1.9	1.9	2.4	8.0	2.7	4.9	6.6	6.5	0.4	0.0	1.8	7.9	4.6	5.3	1.9	5.8	0.0	7.4	1.2	7.8	9.2	1.6	4.3	5.5	2.3	2.9	2.8	2.1	0.0	2.9	0.0	26.7	0.5	0.0	7.0	2.4	0.0	0.0	20.2	0.0	1.6	0.6	0.8	2.1	18.4	3.3	15.9	0.8	2.3	0.0	3.2	5.3	17.1	5.1	0.0	0.0	0.0	1.1	0.0	15.6	4.0	0.7	9.0	0.3	0.2	0.0	0.0	0.6	0.3	4.4	0.0	2.9	3.1	0.0	3.0	0.0	1.8	0.0	0.6	2.0	4.1	0.5	2.6	2.6	1.4	4.0	1.5	2.8	3.3
DEXI	MYLE	ENSG00000182108	"Dexi homolog"	O95424	16	10928891-10942460	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041511	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA041511: AB_10796675"	"unprognostic (4.14e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.47e-2)"	"prognostic favourable (4.23e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.33e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.83e-2)"	15.0	25.2	15.7	8.0	20.8	4.1	10.7	14.0	27.5	12.2	13.9	9.8	12.7	11.1	11.7	18.5	12.9	14.5	11.6	32.2	13.1	13.6	13.3	26.3	9.5	9.9	18.8	12.3	15.9	18.0	22.1	12.9	13.3	21.3	13.6	6.6	13.7	15.4	16.6	81.6	10.3	11.1	12.1	9.4	12.7	10.6	8.9	11.9	13.7	18.4	10.6	8.1	10.9	10.5	4.0	2.4	8.2	0.7	3.9	7.0	1.2	9.3	13.7	7.4	13.0	30.2	16.6	6.8	14.5	15.1	9.5	9.1	6.4	9.9	11.2	21.9	16.4	12.2	8.7	15.6	8.2	26.2	19.5	5.5	9.0	27.1	17.3	9.5	10.5	16.9	18.0	9.3	10.8	13.7	12.6	11.2	10.5	16.5	11.8	10.3	10.3	14.3	11.0	9.8	17.1	11.8	7.0	15.3	13.5	13.8	15.3	11.5	12.1	16.5	14.9	9.6	10.4	22.7	9.4	14.9	11.4	3.2	8.4	20.4	10.8	1.7	0.6	8.2	6.0	0.7	5.6	0.6	5.2	7.0	0.4	4.0	6.4	6.0	0.7	3.9	0.3	2.4	3.9	1.2	15.7	20.8	14.0	27.5	13.1	13.6	18.8	12.3	21.3	11.9
DGKB	"DAGK2, DGK, DGK-BETA, KIAA0718"	ENSG00000136267	"Diacylglycerol kinase beta"	Q9Y6T7	7	14145049-14974777	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 37.7"	"Cell line enhanced"	"Detected in some"		"AF22: 2.7;fHDF/TERT166: 5.5;hTEC/SVTERT24-B: 2.1;SCLC-21H: 2.8;SH-SY5Y: 2.1;U-266/70: 7.4"	"Cancer enriched"	"Detected in single"	11	"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020321		Supported								"HPA020321: "	"unprognostic (9.89e-2)"	"unprognostic (9.72e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.34e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-4)"	1.1	5.2	11.5	1.1	37.7	0.8	0.8	1.3	34.0	4.9	1.6	1.4	0.0	0.9	6.1	0.9	1.6	2.7	1.3	1.4	10.5	4.3	2.6	1.1	0.8	0.8	2.2	11.3	0.8	0.9	0.8	1.8	0.7	4.8	1.1	1.7	0.0	0.9	0.9	1.2	0.9	1.2	3.1	3.5	0.8	0.8	0.9	7.9	0.0	0.9	0.0	0.8	1.5	0.6	0.7	0.6	1.3	0.3	0.6	0.5	0.1	0.1	0.0	2.7	0.1	0.0	0.2	0.1	0.0	1.2	0.0	0.3	0.2	0.0	0.1	0.0	5.5	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.0	2.8	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	7.4	0.0	0.0	0.1	0.1	0.1	0.7	0.3	0.3	0.5	0.2	0.4	0.3	0.5	0.2	0.1	0.7	0.5	0.4	1.3	0.6	0.2	0.6	0.2	0.1	11.5	37.7	1.3	19.1	10.5	4.3	2.2	11.3	4.8	7.9
DGKG	DAGK3	ENSG00000058866	"Diacylglycerol kinase gamma"	P49619	3	186105668-186362237	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 19.8;HL-60: 6.3;U-266/84: 7.5;U-87 MG: 12.5;U-937: 5.9"	"Cancer enhanced"	"Detected in some"		"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 4.2;eosinophil: 2.4;intermediate monocyte: 2.4;myeloid DC: 2.9;neutrophil: 5.3;non-classical monocyte: 2.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;granulocytes: 5.3;monocytes: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036577	Approved		Approved	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA036577: AB_10672358"	"unprognostic (2.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.24e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.21e-3)"	"unprognostic (3.80e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.09e-2)"	"unprognostic (8.05e-7)"	"unprognostic (3.47e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-3)"	3.1	6.9	13.4	3.1	7.1	14.5	1.9	53.4	23.1	2.7	3.5	6.2	1.1	3.0	1.9	14.6	8.5	7.7	2.2	15.0	15.3	7.4	3.1	2.1	4.3	2.1	7.4	11.3	2.0	1.6	4.7	7.5	13.5	25.2	3.1	2.1	7.8	1.9	4.0	2.4	1.4	2.7	5.3	5.6	2.0	3.3	1.2	7.1	0.0	2.5	0.0	2.1	4.8	2.4	0.6	2.9	5.3	4.2	0.0	0.0	1.3	2.6	4.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	2.3	0.0	0.2	0.0	0.0	0.0	19.8	0.0	2.6	0.0	2.9	0.0	6.3	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.3	0.1	0.1	2.2	0.4	1.2	1.4	0.0	2.2	0.0	0.0	0.5	0.0	0.8	0.0	1.6	0.1	4.1	0.0	0.0	0.7	2.0	2.4	0.0	7.5	0.0	12.5	5.9	2.3	0.0	4.2	2.4	0.0	2.4	0.0	0.6	0.0	0.0	2.9	0.3	0.0	0.0	5.3	0.0	2.8	0.5	0.0	1.3	13.4	7.1	53.4	14.7	15.3	7.4	7.4	11.3	25.2	7.1
DHRS12	"FLJ13639, SDR40C1"	ENSG00000102796	"Dehydrogenase/reductase 12"	A0PJE2	13	51767993-51804157	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 36.3"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB034238, HPA057028, HPA058315"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB034238: AB_2091845, HPA057028: , HPA058315: "	"prognostic favourable (1.41e-4)"	"unprognostic (1.98e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.98e-1)"	"prognostic favourable (2.22e-16)"	"unprognostic (2.85e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.44e-1)"	15.6	6.4	6.9	4.1	7.1	3.9	11.1	5.2	10.9	9.5	7.6	13.8	7.1	5.5	8.4	16.0	7.7	7.5	7.4	8.3	6.0	6.0	14.2	15.8	8.7	4.8	5.8	6.2	10.4	37.6	11.1	10.0	7.3	8.0	7.7	4.7	14.0	11.5	13.0	10.4	10.1	12.2	8.3	7.2	8.3	7.3	3.9	6.5	4.4	10.2	6.9	9.2	6.4	5.7	6.0	4.5	36.3	7.3	1.6	11.6	5.7	0.9	3.1	5.6	7.6	2.5	5.3	5.2	1.7	3.9	2.2	1.2	3.5	15.6	3.9	1.2	3.2	1.9	0.1	0.8	0.3	3.6	2.7	1.2	1.0	3.2	6.7	0.7	1.1	3.4	6.0	0.7	3.2	5.2	1.6	4.4	2.5	4.5	1.5	3.2	6.7	0.5	0.5	0.7	6.4	8.8	2.6	3.4	7.1	2.6	5.7	6.8	5.9	3.9	9.1	1.3	1.9	0.3	1.8	2.1	1.5	1.9	4.0	2.1	4.9	2.9	7.3	0.2	6.4	6.2	11.6	6.0	9.9	8.0	4.0	5.6	8.8	6.2	36.3	1.6	7.0	4.5	8.6	5.7	6.9	7.1	5.2	10.9	6.0	6.0	5.8	6.2	8.0	6.5
DHRS13	"MGC23280, SDR7C5"	ENSG00000167536	"Dehydrogenase/reductase 13"	Q6UX07	17	28897781-28903071	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 29.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022991	Uncertain		Approved	Vesicles	"Secreted - unknown location"			Vesicles		"HPA022991: AB_1853865"	"unprognostic (8.87e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.37e-2)"	"prognostic unfavourable (3.39e-6)"	"unprognostic (2.38e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.55e-1)"	2.3	6.0	5.9	5.1	7.9	31.7	5.9	24.9	5.7	6.4	4.5	6.4	9.0	4.1	2.6	6.5	6.7	4.0	3.0	2.7	5.3	10.9	6.9	27.0	4.1	8.6	6.7	5.4	3.6	9.5	8.5	5.3	9.5	9.9	14.9	3.5	5.0	11.8	10.9	1.1	6.8	3.0	3.2	5.6	8.0	5.5	2.8	3.6	4.4	5.5	1.2	8.1	9.2	5.1	4.0	3.1	29.7	3.5	4.6	6.3	3.1	5.6	3.6	8.4	10.6	1.3	1.9	8.2	3.0	3.9	5.6	8.7	11.0	3.3	15.3	5.2	0.6	5.0	11.8	3.3	2.4	15.5	11.4	8.6	6.6	6.0	3.2	4.4	1.0	1.4	3.0	3.5	3.8	1.7	19.4	5.3	1.1	10.1	9.5	7.3	5.1	0.5	15.2	8.0	11.8	10.3	9.5	12.1	10.1	4.8	33.5	6.5	22.3	7.1	0.5	1.8	5.5	4.3	4.1	12.4	11.6	9.6	5.4	5.6	4.5	0.4	2.3	1.6	4.8	3.5	5.9	3.6	6.1	6.0	3.1	4.0	6.3	4.6	29.7	4.6	3.3	1.7	5.7	3.1	5.9	7.9	24.9	5.7	5.3	10.9	6.7	5.4	9.9	3.6
DHRS4L2	SDR25C3	ENSG00000187630	"Dehydrogenase/reductase 4 like 2"	Q6PKH6	14	23969874-24006408	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA023972	Uncertain		Uncertain	"Nuclear membrane,Vesicles"	"Secreted - unknown location"			Vesicles	"Nuclear membrane"	"HPA023972: AB_1854890"	"unprognostic (1.41e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.97e-3)"	"unprognostic (7.34e-2)"	"prognostic favourable (3.21e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.65e-2)"	6.3	11.2	6.9	12.8	7.9	3.0	11.4	14.6	9.6	7.2	9.9	3.4	2.6	12.1	5.6	10.4	25.5	5.4	4.3	8.9	5.0	4.1	42.0	33.0	16.7	7.2	4.6	2.4	7.1	28.4	6.0	5.2	3.1	7.6	8.3	9.5	5.4	14.2	10.9	18.7	9.8	14.9	6.4	5.6	8.1	7.1	28.2	4.5	13.8	5.9	32.8	14.5	5.3	7.1	10.4	22.3	3.2	27.2	7.9	11.5	14.7	8.5	12.8	2.2	10.9	21.3	22.3	0.2	7.7	15.2	11.2	8.4	3.7	10.1	5.5	5.3	15.4	9.3	9.9	12.8	9.4	18.1	5.9	1.3	11.1	22.9	15.7	7.1	22.1	23.0	16.3	7.3	10.8	13.1	4.3	19.8	12.0	26.7	17.6	7.3	4.4	14.2	27.8	9.0	17.3	16.1	11.3	11.9	7.2	10.5	9.7	6.4	11.8	10.6	9.2	5.9	6.2	7.0	3.8	11.6	9.1	1.6	5.1	10.3	8.4	2.3	27.2	3.2	10.1	22.5	10.4	10.4	10.8	11.5	22.3	8.2	11.1	10.1	1.3	7.9	13.2	18.3	10.3	14.7	6.9	7.9	14.6	9.6	5.0	4.1	4.6	2.4	7.6	4.5
DIRC1		ENSG00000174325	"Disrupted in renal carcinoma 1"	Q969H9	2	188734155-188790104	"Disease related genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 5.9;gallbladder: 2.1"	"Group enriched"	"Detected in some"	5	"ASC TERT1: 24.1;HSkMC: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA068508			Approved	Nucleoplasm				Nucleoplasm		"HPA068508: "	"unprognostic (3.11e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.80e-2)"			"unprognostic (2.77e-1)"		"unprognostic (2.28e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.00e-1)"			"unprognostic (7.39e-4)"			"unprognostic (6.95e-2)"	1.4	0.0	0.0	0.4	0.0	0.0	5.9	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.7	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	24.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DISP2	"C15orf36, DISPB, HsT16908, KIAA1742, LINC00594"	ENSG00000140323	"Dispatched RND transporter family member 2"	A7MBM2	15	40358235-40378639	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 37.2"	"Group enriched"	"Detected in some"	5	"HaCaT: 8.0;SCLC-21H: 16.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059903	Uncertain		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA059903: "	"unprognostic (3.43e-4)"	"unprognostic (7.65e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.47e-8)"	"unprognostic (1.96e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-1)"	0.8	2.5	9.0	1.5	7.6	1.3	0.6	37.2	14.5	0.7	4.0	1.0	0.0	3.4	0.9	0.9	0.7	1.1	1.1	0.8	9.0	7.0	0.5	0.7	0.9	1.5	2.9	14.0	1.3	1.4	0.6	2.8	1.0	11.4	0.8	3.9	0.3	1.2	1.8	0.8	1.3	3.0	1.4	2.0	1.1	3.9	2.4	1.8	0.0	3.4	0.0	0.6	1.2	0.4	0.9	1.1	2.9	0.4	1.1	0.6	0.2	1.5	0.6	0.4	2.5	0.1	0.1	0.9	0.2	0.1	1.0	1.5	2.3	0.7	0.2	1.7	0.9	8.0	0.3	1.3	0.6	0.2	0.5	0.4	0.5	0.1	0.0	0.5	1.5	1.8	0.0	0.3	0.2	0.5	0.6	1.0	1.3	0.3	0.2	0.4	0.4	1.1	0.2	0.4	0.5	0.3	2.1	16.6	2.4	0.3	0.2	0.2	0.4	0.2	0.5	1.1	0.9	0.2	0.2	0.3	0.2	0.3	0.4	0.7	2.3	2.1	0.4	0.5	0.6	0.3	0.4	0.5	0.4	0.4	0.2	0.9	0.5	0.6	2.9	1.1	0.4	1.1	0.4	0.2	9.0	7.6	37.2	14.5	9.0	7.0	2.9	14.0	11.4	1.8
DISP3	"KIAA1337, PTCHD2"	ENSG00000204624	"Dispatched RND transporter family member 3"	Q9P2K9	1	11479166-11537584	"Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Differentiation, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.4;testis: 7.5"	"Cell line enhanced"	"Detected in some"		"AF22: 7.8;NTERA-2: 3.3;SCLC-21H: 3.2;SH-SY5Y: 10.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054579	Uncertain		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA054579: "	"unprognostic (4.93e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.34e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.80e-2)"	"unprognostic (3.88e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.79e-4)"	"unprognostic (1.34e-1)"	0.9	1.9	7.3	1.1	10.0	0.9	0.9	4.1	17.4	0.9	1.0	9.0	0.0	1.3	1.1	0.9	0.8	1.0	0.8	0.8	7.3	5.7	0.9	0.8	0.9	1.2	4.0	6.5	0.9	1.6	0.8	4.2	0.8	5.1	1.6	0.9	5.4	0.9	0.8	0.8	0.8	1.3	1.0	2.1	1.1	1.2	7.5	6.8	0.0	0.9	0.0	1.0	0.9	0.1	0.6	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	7.8	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.3	0.0	0.8	0.0	2.0	0.0	0.2	3.2	10.8	2.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.3	10.0	4.1	12.9	7.3	5.7	4.0	6.5	5.1	6.8
DKK2		ENSG00000155011	"Dickkopf WNT signaling pathway inhibitor 2"	Q9UBU2	4	106921802-107283806	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 21.7"	"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 3.0"	"Lineage enriched"	"Detected in single"	13	"T-cells: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB009727, HPA052611"	Uncertain		Supported	"Golgi apparatus"	"Secreted in other tissues"			"Golgi apparatus"		"CAB009727: AB_2091492, HPA052611: "	"unprognostic (3.14e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.04e-3)"	"unprognostic (2.47e-2)"	"unprognostic (5.11e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.58e-2)"	6.6	1.2	3.0	1.5	2.5	0.0	4.8	1.8	3.6	21.7	3.6	0.2	0.0	0.1	1.4	2.4	2.0	0.9	1.6	3.1	2.9	2.2	0.4	0.3	7.9	0.9	2.0	1.5	6.3	0.3	0.9	3.4	3.4	2.5	2.9	0.7	6.8	2.7	2.4	2.4	6.1	0.5	0.9	2.3	1.7	0.4	0.5	0.2	0.1	1.3	4.4	3.7	1.1	2.6	0.0	0.2	0.0	0.1	0.0	3.0	0.0	0.0	0.0	3.6	0.0	0.7	0.3	0.0	0.1	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.1	0.0	2.7	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.1	0.1	3.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.0	2.5	1.8	3.6	2.9	2.2	2.0	1.5	2.5	0.2
DLEC1	"CFAP81, DLC1"	ENSG00000008226	"Deleted in lung and esophageal cancer 1"	Q9Y238	3	38039205-38124025	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 21.1;fallopian tube: 23.2;testis: 28.9"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.4;RT4: 2.8;SK-BR-3: 1.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA019077	Enhanced		Supported	Cytosol				Cytosol		"HPA019077: AB_1847724"	"unprognostic (1.24e-4)"	"unprognostic (3.60e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.50e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.62e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.94e-4)"	0.8	0.3	1.3	0.7	8.3	1.1	0.5	0.0	0.6	3.3	0.6	6.1	3.5	0.7	1.1	21.1	0.3	23.2	1.3	0.3	1.7	2.5	0.3	0.3	10.0	1.7	0.5	0.2	6.3	0.2	0.6	14.2	0.3	9.8	0.8	0.6	0.8	0.6	1.8	0.2	0.7	0.7	0.3	0.6	0.7	0.6	28.9	1.7	0.0	0.8	0.0	0.6	0.4	0.1	0.2	0.1	0.9	0.4	0.1	1.1	0.1	0.1	0.0	1.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.7	0.0	0.0	0.2	0.2	0.5	0.0	0.2	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.2	0.1	3.4	0.0	0.0	0.0	0.2	0.1	2.8	0.5	0.2	0.3	1.7	0.5	0.1	0.3	0.0	0.0	0.4	0.3	0.0	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.4	0.4	0.8	0.2	0.4	0.2	1.1	0.0	0.1	0.1	0.2	0.0	0.9	0.1	0.1	0.1	0.2	0.1	1.3	8.3	0.0	0.6	1.7	2.5	0.5	0.2	9.8	1.7
DLEU7	FLJ44882	ENSG00000186047	"Deleted in lymphocytic leukemia, 7"	Q6UYE1	13	50711008-50843939	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 13.2"	"Group enriched"	"Detected in some"	8	"NTERA-2: 15.1;U-698: 6.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 1.5;naive B-cell: 1.3;neutrophil: 1.2;T-reg: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA053750	Uncertain									"HPA053750: "	"unprognostic (3.97e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.03e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.75e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-1)"	0.7	1.0	4.8	0.8	7.8	0.5	0.5	5.8	13.2	0.6	0.7	0.5	0.0	0.6	0.8	3.0	0.5	0.5	0.4	0.5	4.6	5.7	1.4	0.5	0.5	0.4	3.7	4.2	0.6	0.7	0.4	0.1	0.5	4.1	0.7	0.8	0.0	0.4	0.5	0.5	1.0	0.8	0.5	1.2	0.8	0.5	0.9	0.8	1.3	1.9	0.0	0.5	0.4	0.1	1.3	0.0	1.2	1.5	0.0	1.4	0.7	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	15.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.3	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	1.3	0.1	0.0	1.2	0.0	0.0	0.0	1.4	0.7	4.8	7.8	5.8	9.9	4.6	5.7	3.7	4.2	4.1	0.8
DLK2	"EGFL9, MGC2487"	ENSG00000171462	"Delta like non-canonical Notch ligand 2"	Q6UY11	6	43450352-43456632	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 19.3"	"Cell line enhanced"	"Detected in many"		"HaCaT: 16.2;HBEC3-KT: 8.8;hTCEpi: 26.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA061223, HPA068672, HPA070955"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles				Nucleoplasm	"Nucleoli, Vesicles"	"HPA061223: , HPA068672: , HPA070955: "	"unprognostic (4.65e-5)"	"unprognostic (1.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.68e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.80e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.65e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.27e-12)"	"unprognostic (7.71e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.43e-2)"	1.0	1.1	4.5	1.4	7.9	1.7	4.3	12.2	8.2	2.2	0.7	0.9	6.4	1.1	1.4	3.8	10.5	1.1	0.9	1.8	4.1	4.6	0.7	0.7	1.1	1.7	1.5	4.8	1.7	1.5	0.4	0.5	1.3	0.9	10.4	0.5	0.3	12.4	13.0	0.7	19.3	1.0	0.6	1.5	1.5	1.1	1.1	1.2	1.3	0.8	4.7	3.9	2.2	5.3	0.8	1.8	1.0	0.5	2.5	3.2	0.3	5.1	1.8	0.5	7.7	0.0	0.4	1.7	1.9	2.1	2.1	1.0	1.8	0.2	0.9	1.2	0.3	16.2	5.4	8.8	0.4	1.0	2.0	0.4	0.9	2.7	0.5	0.3	1.1	0.9	26.6	0.6	5.0	0.0	0.4	0.7	0.8	1.9	0.4	0.4	0.7	1.9	1.0	0.9	0.5	0.3	1.8	5.7	0.5	0.6	0.2	0.3	0.5	1.6	0.5	0.8	2.5	0.6	3.7	1.2	0.3	1.7	0.1	0.7	0.5	0.9	0.4	0.4	0.7	0.3	3.2	0.6	2.2	2.2	0.1	0.8	0.9	0.4	1.0	2.5	0.5	1.8	0.3	0.3	4.5	7.9	12.2	8.2	4.1	4.6	1.5	4.8	0.9	1.2
DLX6		ENSG00000006377	"Distal-less homeobox 6"	P56179	7	97005548-97011039	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.2;placenta: 11.3;testis: 10.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.5;BEWO: 24.9;HAP1: 11.2;SCLC-21H: 5.5;SH-SY5Y: 8.2"	"Cancer enriched"	"Detected in many"	8	"endometrial cancer: 12.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 23.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"olfactory region: 44.2"	"HPA030608, HPA061460"	Uncertain		Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA030608: AB_10600867, HPA061460: "	"unprognostic (7.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.06e-2)"	"unprognostic (8.16e-2)"	"unprognostic (3.05e-1)"		"unprognostic (4.32e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.86e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.12e-7)"	"unprognostic (5.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.58e-2)"	"unprognostic (8.12e-2)"	0.9	0.4	1.8	0.3	23.2	0.9	0.4	0.3	6.1	5.7	0.6	0.5	0.0	0.4	7.0	2.4	0.3	1.5	0.3	0.5	3.9	2.6	0.4	0.3	0.3	1.0	0.5	2.8	0.9	0.3	0.4	0.4	11.3	0.0	0.7	0.3	0.0	1.7	2.5	0.5	1.6	0.3	0.9	0.3	0.5	0.4	10.4	4.2	0.1	0.7	0.0	0.8	0.9	0.6	0.4	0.6	1.5	0.7	0.5	0.7	0.3	0.0	0.0	0.0	7.5	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.5	0.0	1.4	11.2	0.0	0.0	0.0	2.9	0.0	4.2	5.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	1.6	5.5	8.2	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.8	0.6	1.1	0.5	0.6	0.2	0.3	0.5	0.4	0.4	0.3	0.3	0.4	0.7	0.6	1.5	0.5	0.7	0.6	0.5	0.3	1.8	23.2	0.3	6.1	3.9	2.6	0.5	2.8	0.0	4.2
DMRT2		ENSG00000173253	"Doublesex and mab-3 related transcription factor 2"	Q9Y5R5	9	1049858-1057552	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 27.3;lymphoid tissue: 18.4;parathyroid gland: 52.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.8;RH-30: 5.2;RPMI-8226: 19.3;SK-MEL-30: 5.3;THP-1: 3.7;WM-115: 3.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.8"	"Group enriched"	"Detected in some"	9	"cerebral cortex: 2.3;hippocampal formation: 0.9"	HPA029297	Uncertain									"HPA029297: AB_10600905"	"unprognostic (5.67e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.24e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.10e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.43e-3)"	"unprognostic (8.93e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.27e-3)"	3.8	0.5	1.9	0.5	6.5	0.4	4.5	0.5	4.5	0.5	1.6	11.0	2.6	0.4	0.5	1.3	0.6	0.6	0.4	0.5	3.2	1.3	27.3	0.4	2.4	0.6	7.0	2.5	0.4	0.4	52.9	0.7	0.6	3.6	0.6	1.1	0.0	1.4	1.5	9.0	0.6	0.4	0.5	3.0	0.4	0.4	0.9	6.2	18.4	0.4	6.6	0.5	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	5.2	19.3	0.0	0.8	3.0	0.0	0.0	0.0	5.3	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	3.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	6.5	0.5	4.5	3.2	1.3	7.0	2.5	3.6	6.2
DMRTA1		ENSG00000176399	"DMRT like family A1"	Q5VZB9	9	22446841-22455740	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 12.2;salivary gland: 16.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.1;LHCN-M2: 4.7;RPTEC TERT1: 4.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 2.5"	"HPA044764, HPA062253"	Uncertain		Approved	Vesicles				Vesicles		"HPA044764: AB_10959788, HPA062253: "	"unprognostic (1.47e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.74e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.67e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.64e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.92e-1)"	"prognostic favourable (1.14e-6)"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.53e-3)"	2.1	0.2	0.7	1.4	0.7	0.0	5.6	0.8	0.7	2.4	1.0	0.7	1.1	0.7	1.2	1.8	5.5	0.3	1.2	0.6	0.6	0.5	5.5	12.2	1.1	1.4	0.8	0.4	0.6	2.7	6.1	2.9	0.0	0.9	2.4	0.4	1.9	16.3	0.5	0.9	0.5	0.8	0.7	0.7	0.4	2.8	0.6	0.0	1.1	5.0	0.6	2.0	0.9	1.7	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.6	0.1	0.0	0.4	0.1	0.2	0.0	10.1	0.3	0.4	0.1	0.1	0.0	2.2	0.0	0.3	2.0	2.7	0.3	0.0	0.7	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	1.9	0.7	0.0	3.7	4.7	1.0	0.0	0.0	2.0	3.4	0.0	0.2	1.4	4.8	0.0	0.2	0.0	1.3	0.8	2.2	0.0	0.0	3.4	0.0	3.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.8	0.7	0.6	0.5	0.8	0.4	0.9	0.0
DMRTA2		ENSG00000142700	"DMRT like family A2"	Q96SC8	1	50417550-50423500	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 8.5;esophagus: 3.8;pituitary gland: 5.4;testis: 4.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;HBEC3-KT: 4.2;RH-30: 15.3;SH-SY5Y: 3.2;SiHa: 3.1"	"Cancer enhanced"	"Detected in many"		"glioma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA043098, HPA062958"	Uncertain		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"			Mitochondria	Nucleoplasm	"HPA043098: AB_10796684, HPA062958: "	"unprognostic (1.60e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.75e-2)"		"unprognostic (1.15e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.79e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.21e-3)"	"unprognostic (7.08e-3)"	"unprognostic (4.16e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.68e-3)"	0.2	0.1	0.4	0.1	1.5	0.2	0.2	0.4	2.1	0.3	0.3	8.5	0.0	0.4	0.2	0.1	3.8	0.2	0.1	0.1	1.2	0.7	0.2	0.2	0.2	0.2	1.2	0.0	0.2	0.1	0.4	5.4	0.2	2.1	0.2	0.3	0.0	0.5	0.2	0.3	0.1	0.2	0.1	2.0	0.3	0.2	4.0	3.7	0.3	0.2	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	1.2	4.2	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	3.2	3.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.4	1.8	1.2	0.7	1.2	0.0	2.1	3.7
DMRTB1		ENSG00000143006	"DMRT like family B with proline rich C-terminal 1"	Q96MA1	1	53459399-53467488	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	104	"testis: 78.1"	"Cell line enhanced"	"Detected in single"		"NB-4: 1.2"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA036490, HPA058553"	Enhanced									"HPA036490: AB_10671844, HPA058553: "										"unprognostic (2.20e-3)"					"unprognostic (1.36e-1)"	"unprognostic (1.67e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0
DMRTC1		ENSG00000269502	"DMRT like family C1"	Q5HYR2	X	72872025-72943814	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 4.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.7;Daudi: 3.7;NTERA-2: 1.2;U-266/70: 1.2;U-266/84: 1.4;U-698: 2.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.2"	"Group enriched"	"Detected in many"	17	"B-cells: 2.2;T-cells: 1.2"									"HPA046874, HPA046992"	Uncertain									"HPA046874: , HPA046992: "					"unprognostic (1.83e-1)"													0.0	1.3		0.0		0.0	0.0		4.0	0.6	0.1			0.0	1.1	0.0	0.1	2.1	0.2	0.0			0.0	0.0	0.0	0.6			1.3	0.0	0.0		0.0		0.0	0.3		0.0	0.2	0.0	0.0	0.1	0.6		0.7	0.0	1.1			2.0		0.8	0.0		2.2	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	1.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.5	0.0	2.2	0.7	1.2	0.0	0.0	0.0	0.0	0.4	0.1										
DMRTC1B		ENSG00000184911	"DMRT like family C1B"	Q5HYR2	X	72777009-72848802	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 15.1;ovary: 12.1;pituitary gland: 12.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.1;SK-BR-3: 1.1;U-138 MG: 1.0;U-266/70: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.8"	"Group enriched"	"Detected in many"	12	"B-cells: 2.1;T-cells: 2.8"									"HPA046874, HPA046992"	Uncertain									"HPA046874: , HPA046992: "					"unprognostic (2.00e-1)"						"unprognostic (1.91e-2)"	"unprognostic (1.54e-1)"				"unprognostic (6.52e-2)"		0.3	4.6	11.0	1.7	15.1	0.1	0.7	4.5	14.3	1.7	0.6	2.2	1.4	0.5	2.2	9.6	0.3	3.3	0.6	0.2	8.6	14.2	1.6	0.2	1.1	1.4	4.9	9.1	12.1	5.2	1.5	12.1	0.2	2.2	3.8	0.8	2.4	1.0	1.9	0.2	0.5	0.5	0.6	2.2	1.3	1.2	7.1	2.9	0.7	3.9	0.2	2.1	0.3	0.2	2.1	0.0	0.0	0.0	0.2	2.8	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.8	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.4	0.0	2.1	2.1	2.8	0.0	0.2	0.0	0.0	0.0	0.2	11.0	15.1	4.5	11.4	8.6	14.2	4.9	9.1	2.2	2.9
DMRTC2		ENSG00000142025	"DMRT like family C2"	Q8IXT2	19	41844743-41852333	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"testis: 53.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.3;monocytes: 1.1"	"Not detected"	"Not detected"							HPA045016	Uncertain									"HPA045016: AB_10960404"	"unprognostic (6.80e-3)"			"unprognostic (4.38e-2)"								"unprognostic (5.36e-2)"		"unprognostic (2.69e-1)"	"unprognostic (1.02e-1)"			0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.3	1.1	0.2	0.2	0.0	0.2	0.0	0.5	1.0	0.0	0.0	0.3	0.4	0.0	0.5	0.0	0.7	1.1	0.1	0.1	0.2	0.6	0.0	0.0	0.0	1.1	0.6	0.0	0.8	0.2	0.0	0.6	1.6	0.3	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	1.1	0.0	1.1	0.7	1.3	0.9	0.1	0.3	0.3	0.4	0.2	0.2	0.9	0.1	1.0	1.2	0.1	0.3	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.2	1.3	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DNAH10OS	FLJ45278	ENSG00000250091	"Dynein axonemal heavy chain 10 opposite strand"	P0CZ25	12	123926424-123934984	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 7.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"											HPA039786	Enhanced									"HPA039786: AB_10795115"	"unprognostic (1.62e-2)"	"unprognostic (1.97e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.69e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.45e-1)"	"unprognostic (8.63e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.15e-2)"	0.9	0.3	3.6	0.4	5.2	0.8	1.2	7.6	6.3	0.4	0.7			0.3	0.8	0.8	0.5	0.5	0.6	1.0	3.7	1.5	3.7	0.5	1.5	0.4	1.4		1.6	2.7	2.1	1.1	0.6		1.1	0.4		0.9	1.8	1.7	0.6	0.4	1.3	1.0	0.8	1.4	0.9			1.8		0.4	0.4	0.3	0.6	0.3	3.3	0.7	0.3	1.0	0.3	0.6	4.4	3.6	4.8	2.4	2.1	1.3	0.7	3.7	0.6	0.6	0.4	0.4	0.5	1.5	1.8	0.4	1.0	0.2	0.3	2.1	0.5	0.9	0.3	0.2	0.8	0.4	3.2	0.4	1.3	0.9	0.2	0.8	0.2	0.8	0.8	2.9	0.3	0.7	0.4	0.5	0.3	0.2	0.1	3.7	1.4	0.8	3.5	0.4	0.4	0.8	0.8	0.3	1.4	5.1	0.2	1.2	0.5	2.3	0.9	0.2	3.2	0.5	1.8	1.1	0.7	0.3	1.0	0.4	0.8	0.6	0.3	0.8	0.1	0.6	0.4	0.5	3.3	0.3	0.3	0.3	0.3	0.3										
DNAH12	"DHC3, DLP12, DNAH12L, DNAH7L, Dnahc3, DNHD2, FLJ40427, FLJ44290, hdhc3, HL-19"	ENSG00000174844	"Dynein axonemal heavy chain 12"	Q6ZR08	3	57293699-57544344	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.0;fallopian tube: 16.7;lung: 17.5;testis: 17.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.1;LHCN-M2: 2.1"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Region enriched"	"Detected in many"	8	"pons and medulla: 23.0"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.2"	"Low lineage specificity"	"Detected in single"											"HPA037493, HPA058203, HPA061365"	Enhanced									"HPA037493: AB_10671758, HPA058203: AB_2683637, HPA061365: "	"unprognostic (4.85e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.43e-5)"	"unprognostic (2.82e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.47e-2)"	0.2	0.3	0.6	0.1	3.0	0.1	0.4	0.2	0.5	1.3	0.2	5.3	0.0	0.1	1.4	11.6	0.2	16.7	0.5	0.1	2.9	0.8	0.2	0.3	17.5	0.2	0.4	0.0	7.6	3.1	0.1	8.9	0.1	23.0	0.2	0.2	0.0	0.3	0.2	0.2	0.3	0.2	0.2	0.4	0.2	0.2	17.6	1.0	0.0	0.3	0.0	0.1	0.2	0.2	0.5	0.5	0.0	0.0	1.2	0.9	0.1	0.3	0.7	0.0	0.0	0.9	0.3	0.1	0.0	0.2	0.3	0.0	3.1	0.3	0.1	0.0	0.4	0.4	0.0	0.3	0.2	0.7	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.6	0.1	0.4	0.2	0.2	0.1	2.1	0.0	0.0	0.4	0.0	0.5	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.9	0.1	0.0	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	0.0	0.5	0.2	0.0	0.0	1.2	0.0	0.5	0.0	0.1	0.6	3.0	0.2	0.3	2.9	0.8	0.4	0.0	23.0	1.0
DNAH14	"C1orf67, DKFZp781B1548, Dnahc14, HL-18, HL18, MGC27277"	ENSG00000185842	"Dynein axonemal heavy chain 14"	Q0VDD8	1	224896262-225399292	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 32.4;testis: 29.9"	"Cell line enhanced"	"Detected in many"		"K-562: 25.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 3.5"	"Low lineage specificity"	"Detected in single"											"HPA027718, HPA028545, HPA031379"	Uncertain		Supported	Centrosome				Centrosome		"HPA027718: AB_10601210, HPA028545: , HPA031379: "	"unprognostic (1.16e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.09e-3)"	"unprognostic (9.94e-4)"	"unprognostic (4.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.33e-9)"	"unprognostic (6.76e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	1.6	5.2	6.3	2.7	2.5	2.5	5.2	0.9	3.4	3.1	2.9	0.2	3.8	1.7	3.3	6.5	2.0	2.6	5.3	3.7	7.0	5.5	4.2	6.8	5.4	0.6	2.9	4.6	5.5	11.2	3.4	32.4	2.6	7.2	4.3	3.7	3.6	3.4	7.8	0.6	1.0	1.1	4.6	8.5	1.0	3.8	29.9	0.8	3.2	7.1	0.9	0.4	2.5	1.9	0.6	0.2	0.4	0.2	3.5	0.9	0.0	10.2	5.3	4.9	5.3	1.9	4.0	11.7	2.1	2.0	4.0	3.5	8.3	11.4	0.0	5.4	2.1	0.1	7.5	2.0	6.7	0.0	12.5	4.9	3.6	1.8	2.4	10.2	1.7	3.9	4.6	5.4	3.8	1.3	25.2	0.0	6.7	2.7	1.8	10.6	13.7	6.5	0.0	18.5	9.4	3.6	4.8	8.2	9.3	8.3	6.3	16.7	11.5	8.9	0.2	0.0	7.9	0.2	0.0	11.5	7.1	0.1	0.0	0.0	7.4	0.0	0.1	0.3	0.1	0.2	0.0	0.6	0.3	0.7	0.2	0.3	0.4	0.5	0.4	3.5	0.1	0.0	0.9	0.0	6.3	2.5	0.9	3.4	7.0	5.5	2.9	4.6	7.2	0.8
DNAH2	"DNHD3, FLJ46675, KIAA1503"	ENSG00000183914	"Dynein axonemal heavy chain 2"	Q9P225	17	7717354-7833744	"Predicted intracellular proteins, Predicted membrane proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 14.3;parathyroid gland: 20.0;testis: 21.0"	"Cell line enhanced"	"Detected in some"		"A-431: 4.8;CACO-2: 7.5;CAPAN-2: 4.7;SCLC-21H: 4.5;SiHa: 4.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA067103	Enhanced		Approved	Microtubules				Microtubules		"HPA067103: "	"unprognostic (2.03e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.50e-3)"	"unprognostic (1.29e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (8.74e-3)"	"unprognostic (4.60e-2)"	0.2	0.1	1.5	0.2	4.8	0.5	0.5	1.8	0.9	1.3	0.2	7.9	1.1	0.2	0.7	5.7	0.2	14.3	0.4	0.2	2.1	1.9	0.2	0.3	5.5	0.2	0.2	0.6	3.0	0.5	20.0	1.2	1.8	7.0	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	21.0	0.7	0.2	0.3	0.2	0.2	0.2	0.2	1.2	0.6	3.2	0.7	0.6	0.7	0.1	4.8	0.2	0.2	0.3	0.1	0.0	0.8	0.2	0.1	0.0	0.1	7.5	4.7	0.2	2.3	0.1	0.4	0.0	1.1	0.1	0.1	0.2	0.1	0.5	0.1	1.2	0.3	0.2	0.4	0.0	0.7	0.1	0.0	0.2	0.3	0.0	0.9	0.1	0.4	0.4	1.6	0.2	0.5	0.1	0.0	1.4	4.5	0.3	4.5	0.1	2.3	0.4	0.3	0.2	0.4	0.8	0.1	0.0	0.4	0.1	0.2	0.1	0.1	0.8	0.7	0.7	0.4	0.7	0.3	0.5	0.5	0.4	0.6	0.2	1.2	0.5	0.7	3.2	0.6	0.3	0.6	0.3	0.1	1.5	4.8	1.8	0.9	2.1	1.9	0.2	0.6	7.0	0.7
DNAH3	"DKFZp434N074, DLP3, Dnahc3b, Hsadhc3"	ENSG00000158486	"Dynein axonemal heavy chain 3"	Q8TD57	16	20933111-21159441	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 10.4;testis: 6.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 1.1;CACO-2: 1.0;CAPAN-2: 1.1;hTEC/SVTERT24-B: 1.3;U-698: 1.2"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062493			Approved	"Nuclear membrane,Intermediate filaments"				"Nuclear membrane"	"Intermediate filaments"	"HPA062493: "	"unprognostic (1.68e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.57e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.2			0.0	0.2	0.0	0.0	10.4	0.0	0.0	0.5	0.7	0.0	0.0	1.8	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.3		0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	6.2			0.0		0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	1.0	1.1	0.1	0.4	0.0	0.4	0.1	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.2	0.8	0.0	0.3	1.3	0.0	0.0	0.4	0.3	0.1	0.0	0.1	0.0	0.6	0.1	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.3	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.7	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DNAH6	"Dnahc6, DNHL1, FLJ37357, HL-2"	ENSG00000115423	"Dynein axonemal heavy chain 6"	Q9C0G6	2	84516455-84819589	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;fallopian tube: 15.3;pituitary gland: 17.4"	"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CACO-2: 1.5;SK-MEL-30: 2.9;U-266/70: 1.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"naive CD4 T-cell: 3.8;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	16	"T-cells: 3.8"	"Low region specificity"	"Detected in many"							HPA036391	Enhanced									"HPA036391: AB_10672220"	"unprognostic (4.87e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-8)"	"unprognostic (2.04e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.97e-2)"	1.4	1.2	7.7	0.8	17.7	0.7	1.7	0.6	10.0	1.8	1.0	3.2	0.7	0.7	2.0	11.0	0.6	15.3	0.8	0.6	7.9	3.5	1.9	3.6	4.8	1.0	0.9	7.2	5.1	1.2	6.2	17.4	0.7	23.7	1.1	1.1	0.5	0.6	1.3	0.5	0.7	0.8	0.8	1.6	0.8	2.0	7.2	3.0	0.0	3.9	0.0	0.8	0.7	0.6	0.0	0.2	0.1	0.0	0.0	3.8	0.4	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.0	0.9	0.0	2.9	0.0	0.5	0.0	0.5	0.5	0.4	0.2	1.6	0.1	0.0	0.8	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	3.8	1.2	0.0	0.0	0.0	0.2	0.0	0.4	7.7	17.7	0.6	10.0	7.9	3.5	0.9	7.2	23.7	3.0
DNAJB7	HSC3	ENSG00000172404	"DnaJ heat shock protein family (Hsp40) member B7"	Q7Z6W7	22	40859549-40862126	"Predicted intracellular proteins"		Chaperone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"testis: 24.9"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA000534	Approved									"HPA000534: AB_1078693"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.46e-4)"	"unprognostic (3.32e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.45e-2)"	0.1	0.1	0.1	0.2	0.2	0.9	0.1	1.1	0.3	0.2	0.1	0.1	0.1	0.9	0.2	1.3	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.1	0.0	0.3	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.6	0.3	0.9	0.1	0.1	0.2	0.3	24.9	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.9	0.5	2.4	0.6	0.5	1.6	0.1	0.4	0.1	1.0	1.5	0.0	0.0	1.7	1.0	0.0	0.0	0.0	0.3	0.3	1.6	0.2	0.1	0.6	0.0	0.0	0.0	0.1	0.7	0.6	2.2	0.6	0.0	1.5	0.5	0.0	0.0	0.2	0.0	0.0	1.1	1.7	0.1	0.6	1.9	1.9	1.3	0.3	1.1	1.1	0.7	0.0	0.6	1.6	0.4	0.5	0.7	0.3	0.3	1.0	0.0	1.0	1.6	1.3	0.5	1.7	0.9	1.0	0.1	0.5	1.3	1.9	0.5	0.3	0.7	0.4	0.7	0.3	0.6	0.6	0.3	0.9	1.6	0.9	2.4	0.5	0.6	0.5	0.2	0.1	0.1	0.2	1.1	0.2	0.1	0.1	0.1	0.1	0.3	0.1
DNAJC14	"DNAJ, DRIP78, FLJ32792, HDJ3, LIP6"	ENSG00000135392	"DnaJ heat shock protein family (Hsp40) member C14"	Q6Y2X3	12	55820960-55830824	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA017653	Approved									"HPA017653: AB_1847799"	"unprognostic (2.54e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.14e-2)"	"unprognostic (6.91e-3)"	"unprognostic (6.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.63e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.89e-3)"	"unprognostic (4.73e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.92e-2)"	18.0	20.6	17.0	15.8	17.8	16.5	17.6	19.5	24.7	19.4	16.8	20.0	15.7	15.2	23.5	18.7	18.4	21.0	18.3	19.1	17.6	14.5	21.7	26.2	17.8	19.0	17.7	13.8	17.9	29.7	31.4	22.0	26.6	15.1	17.7	16.9	18.6	18.2	20.2	14.9	17.7	20.9	18.4	17.7	23.3	17.1	32.5	19.3	37.8	24.9	14.3	20.8	18.7	14.4	16.0	16.5	22.6	14.1	14.8	19.7	12.8	14.5	18.1	20.4	19.2	19.7	18.9	21.8	17.0	22.6	21.2	15.4	15.0	26.6	18.1	32.5	17.9	18.3	15.9	19.5	18.6	32.6	12.5	27.3	20.1	14.2	18.7	15.1	23.9	15.7	15.8	21.2	19.1	22.6	20.8	23.5	23.8	22.0	28.0	15.0	14.7	15.3	22.0	17.8	16.5	18.2	15.7	26.8	24.7	14.6	20.1	12.8	40.1	22.8	22.0	20.4	20.1	19.1	13.9	27.0	25.5	18.4	21.0	14.8	26.2	22.6	12.3	18.7	19.7	10.9	15.2	16.0	13.8	16.4	11.3	12.3	12.8	15.0	13.3	14.8	14.1	16.5	11.6	12.8	17.0	17.8	19.5	24.7	17.6	14.5	17.7	13.8	15.1	19.3
DNAJC16	KIAA0962	ENSG00000116138	"DnaJ heat shock protein family (Hsp40) member C16"	Q9Y2G8	1	15526813-15592379	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043643	Approved		Approved	Vesicles				Vesicles		"HPA043643: AB_10796794"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-2)"	"prognostic favourable (6.77e-4)"	"unprognostic (4.52e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.74e-2)"	"prognostic favourable (7.24e-4)"	"unprognostic (3.67e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.70e-2)"	9.6	11.5	9.8	9.5	18.7	3.9	12.3	13.2	24.3	10.2	10.9	18.4	14.2	12.0	12.9	14.7	11.5	13.0	11.2	9.1	11.0	10.8	22.1	20.0	8.9	10.5	11.1	10.8	13.1	13.4	20.1	20.3	13.9	17.2	10.8	11.2	12.0	12.1	10.8	19.2	10.2	11.2	11.9	10.7	11.3	9.9	11.1	11.0	11.4	13.9	8.9	12.5	10.3	9.4	6.9	4.1	3.8	4.1	3.2	8.0	3.6	7.4	7.1	5.9	10.8	16.2	13.1	5.5	8.9	9.1	9.0	9.7	6.1	11.0	6.5	6.0	8.9	9.3	7.2	7.9	12.7	7.6	3.4	6.6	8.2	10.6	16.1	10.2	7.7	9.5	9.4	14.5	8.1	10.0	14.0	5.9	10.2	3.0	5.2	5.2	5.7	5.0	6.1	7.6	7.2	11.1	5.2	6.6	6.3	9.2	8.8	7.6	5.6	4.1	13.5	15.9	5.7	14.6	4.8	8.1	11.4	5.8	9.9	5.9	7.5	3.8	4.1	3.0	5.6	4.0	8.0	6.8	5.8	5.0	4.1	6.9	7.4	6.3	2.3	3.2	2.9	3.7	5.3	3.6	9.8	18.7	13.2	24.3	11.0	10.8	11.1	10.8	17.2	11.0
DNAJC18	MGC29463	ENSG00000170464	"DnaJ heat shock protein family (Hsp40) member C18"	Q9H819	5	139408588-139444491	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 51.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036538, HPA060154"	Approved		Supported	"Cell Junctions"				"Cell Junctions"		"HPA036538: AB_10670802, HPA060154: "	"unprognostic (2.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.73e-3)"	"unprognostic (8.76e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"prognostic favourable (5.89e-4)"	"unprognostic (8.09e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.97e-2)"	4.1	4.0	8.2	2.9	15.7	1.9	4.3	10.7	19.5	4.7	3.3	12.4	0.7	1.8	7.6	4.9	3.9	4.9	4.2	6.3	8.7	8.7	4.5	1.2	4.5	3.3	8.8	11.7	10.7	2.3	6.5	7.1	4.1	16.2	4.9	3.0	3.4	2.1	5.9	8.4	2.2	2.4	6.8	9.0	2.9	2.4	51.4	7.5	1.2	5.1	1.7	2.6	3.4	3.3	3.5	2.0	2.1	2.0	6.0	6.7	1.4	1.7	1.8	11.6	10.7	6.5	6.9	1.3	3.5	7.7	6.2	11.3	4.1	1.4	7.7	9.6	5.4	3.0	6.5	10.5	6.5	17.5	8.6	5.2	4.0	1.9	5.1	0.6	2.6	9.2	1.3	10.3	6.3	8.4	2.3	7.5	9.1	1.0	2.3	2.4	8.0	2.6	6.3	12.7	1.2	3.7	1.9	10.8	11.3	3.6	1.4	7.9	1.6	3.9	10.8	8.3	0.0	2.5	7.4	8.9	11.7	4.1	4.4	3.9	3.5	1.9	2.0	2.1	2.2	1.3	3.2	3.5	3.2	4.1	1.5	3.5	3.2	2.0	0.6	6.0	0.7	2.0	6.7	1.4	8.2	15.7	10.7	19.5	8.7	8.7	8.8	11.7	16.2	7.5
DNAJC22	"FLJ13236, wus"	ENSG00000178401	"DnaJ heat shock protein family (Hsp40) member C22"	Q8N4W6	12	49346917-49357546	"Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 10.0;intestine: 10.0;liver: 18.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.2;CACO-2: 17.5;CAPAN-2: 11.0;EFO-21: 18.9;MCF7: 15.4;T-47d: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"midbrain: 1.4"	"Low region specificity"	"Detected in many"			HPA039953			Approved	Vesicles				Vesicles		"HPA039953: "	"unprognostic (5.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.01e-2)"	"prognostic favourable (4.56e-5)"	"unprognostic (4.77e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-2)"	"prognostic unfavourable (7.54e-4)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.83e-2)"	1.1	0.3	0.5	0.4	1.0	0.0	0.4	0.4	2.2	1.5	5.4	0.8	0.4	10.0	2.2	1.3	0.4	0.8	10.0	0.4	0.7	0.5	5.2	18.9	0.4	0.4	1.0	1.2	0.4	5.2	2.7	0.4	0.9	4.6	0.4	5.2	0.8	1.2	0.4	0.4	0.2	8.3	0.4	0.8	0.4	4.4	0.6	0.4	0.4	6.6	0.4	0.4	0.4	0.7	0.7	0.8	2.7	0.5	0.5	0.5	0.4	1.6	10.4	0.0	11.2	0.0	0.0	3.7	0.4	3.3	1.1	2.4	17.5	11.0	0.0	18.9	0.4	0.1	1.6	0.0	1.9	0.1	2.5	0.3	0.2	8.7	2.7	0.0	1.9	0.1	0.0	1.7	0.3	1.6	0.1	0.3	0.8	15.4	0.0	0.0	0.0	5.4	0.0	5.4	0.1	0.3	0.0	1.8	0.9	0.3	0.5	3.5	13.9	0.2	0.2	1.2	3.5	0.1	1.5	0.0	0.0	0.0	2.6	0.0	2.3	2.3	0.5	0.5	0.5	0.3	0.3	0.4	0.4	0.3	0.1	0.7	0.3	0.3	2.7	0.5	0.4	0.8	0.2	0.4	0.5	1.0	0.4	2.2	0.7	0.5	1.0	1.2	4.6	0.4
DNAJC5G	"CSP-gamma, FLJ40417"	ENSG00000163793	"DnaJ heat shock protein family (Hsp40) member C5 gamma"	Q8N7S2	2	27275421-27281499	"Predicted membrane proteins"		Chaperone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	19	"epididymis: 35.8;testis: 58.0"	"Cell line enhanced"	"Detected in some"		"A-431: 2.9;HAP1: 3.9;HMC-1: 1.7;SH-SY5Y: 2.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"							HPA041445	Approved									"HPA041445: AB_2677485"	"unprognostic (1.43e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.75e-4)"	"unprognostic (2.08e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.97e-2)"	0.1	0.7	0.5	0.1	0.1	0.0	0.1	0.1	2.1	0.4	0.1	0.1	0.1	0.0	0.3	35.8	0.1	0.2	0.1	1.3	0.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	58.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.5	0.9	2.4	0.9	0.4	0.7	0.8	2.9	1.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.1	0.3	0.0	1.5	0.1	0.9	1.7	0.0	0.0	0.0	0.7	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.0	1.6	1.6	0.4	0.0	0.4	0.3	2.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.4	0.3	0.0	0.0	1.6	0.9	0.6	0.3	0.5	0.2	0.2	0.3	0.3	0.1	0.5	0.7	0.3	2.4	0.4	0.6	0.9	0.2	0.8	0.5	0.1	0.1	2.1	0.4	0.0	0.1	0.1	0.1	0.1
DNHD1	"C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184"	ENSG00000179532	"Dynein heavy chain domain 1"	Q96M86	11	6497260-6593758	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 58.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA039698, HPA040267, HPA057639"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"				"Nucleoplasm, Cytokinetic bridge"		"HPA039698: AB_10795111, HPA040267: , HPA057639: "	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.25e-3)"	"unprognostic (5.45e-9)"	"unprognostic (2.33e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.56e-4)"	"unprognostic (8.15e-2)"	1.9	2.1	3.6	1.9	5.9	6.8	2.1	6.8	3.4	2.6	2.9	1.6	2.2	2.2	2.8	3.5	1.3	2.0	3.1	1.8	2.3	1.9	1.5	3.1	3.1	3.4	1.5	1.6	3.3	1.6	1.3	2.0	1.3	2.0	2.3	2.0	2.0	2.3	3.2	1.9	3.4	3.6	6.4	2.2	3.5	1.8	58.7	1.3	1.3	2.5	1.3	2.8	2.2	11.0	1.8	1.5	3.0	0.4	0.1	2.2	0.5	4.3	4.6	4.2	4.0	3.5	5.0	4.2	2.0	1.9	2.3	1.5	3.5	3.8	3.7	0.9	1.6	7.3	2.1	1.7	2.6	2.3	3.8	3.0	5.9	2.7	2.2	4.2	1.9	3.4	2.9	4.2	6.2	1.0	3.7	4.4	1.6	0.9	1.4	4.7	4.2	3.4	2.2	1.8	2.7	2.3	2.5	2.3	4.4	1.3	4.1	3.1	2.2	4.5	1.8	2.3	2.4	5.0	2.9	10.6	8.3	5.6	2.2	4.8	2.7	0.0	0.4	3.0	1.3	0.0	1.4	0.3	1.3	0.5	0.6	1.8	1.9	2.2	1.3	0.1	0.3	1.5	1.3	0.5	3.6	5.9	6.8	3.4	2.3	1.9	1.5	1.6	2.0	1.3
DOLPP1	LSFR2	ENSG00000167130	"Dolichyldiphosphatase 1"	Q86YN1	9	129081100-129090438	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019179	Approved		Approved	"Vesicles,Intermediate filaments"				Vesicles	"Intermediate filaments"	"HPA019179: AB_1847827"	"unprognostic (1.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.12e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.10e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.37e-3)"	"unprognostic (7.59e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.34e-2)"	6.4	12.8	10.0	6.8	10.6	7.7	6.8	11.7	19.3	8.3	17.1	17.7	8.6	28.6	6.0	7.4	18.8	6.6	9.2	4.1	10.1	10.7	9.4	21.8	6.7	6.6	13.2	10.6	7.7	10.5	10.4	6.9	11.6	12.5	10.0	14.2	6.1	10.3	5.8	5.2	10.3	27.7	6.3	15.2	8.5	11.8	12.2	11.0	9.4	6.3	8.5	9.1	7.8	8.0	8.8	12.5	9.8	8.3	7.9	21.7	7.2	4.3	16.6	16.3	14.9	5.5	4.7	18.9	10.7	6.2	20.3	11.3	21.3	14.4	8.3	9.4	6.6	31.3	16.7	8.9	8.6	9.8	10.3	11.0	11.2	16.3	9.7	11.3	13.7	5.0	12.5	13.3	10.6	9.0	18.1	8.4	5.7	21.8	13.0	11.8	14.0	13.5	15.3	13.2	15.0	7.4	7.0	18.6	12.2	13.4	12.3	4.5	22.5	7.5	7.4	17.5	8.4	16.4	14.4	10.5	20.0	12.7	7.7	2.3	11.5	4.4	6.8	9.8	8.9	8.1	21.7	8.8	10.9	10.8	8.5	6.0	11.1	10.5	1.4	7.9	8.3	12.5	10.1	7.2	10.0	10.6	11.7	19.3	10.1	10.7	13.2	10.6	12.5	11.0
DOPEY1	"dJ202D23.2, KIAA1117"	ENSG00000083097	"Dopey family member 1"	Q5JWR5	6	83067666-83171350	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027902, HPA027904"	Approved		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA027902: AB_10600003, HPA027904: AB_10600877"	"unprognostic (7.18e-2)"	"unprognostic (3.91e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.05e-3)"	"unprognostic (8.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.47e-1)"	"prognostic favourable (7.36e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	9.7	8.7	15.7	11.3	19.5	5.5	13.3	25.2	21.2	11.9	9.5	10.1	10.1	9.5	13.9	9.5	9.5	12.0	8.9	10.6	15.2	7.0	8.9	7.5	9.1	8.3	10.9	12.9	17.7	12.1	20.3	21.7	7.3	17.3	12.4	11.0	9.0	13.8	14.9	12.7	16.6	11.7	9.5	13.1	9.5	9.5	14.9	12.8	10.7	16.9	8.5	8.9	12.2	10.7	2.3	2.8	1.4	1.4	1.2	4.1	1.3	3.7	2.7	9.0	8.1	8.2	8.6	4.3	6.3	5.3	4.3	6.3	5.7	0.9	7.2	4.5	6.8	5.0	9.1	6.9	5.5	6.3	10.2	6.0	3.7	2.1	4.4	8.8	6.3	6.8	9.7	6.0	15.8	6.4	12.5	5.4	4.7	3.5	2.6	4.0	1.8	5.5	7.2	6.8	2.6	5.8	10.4	16.2	3.0	4.7	3.0	1.2	4.8	5.0	10.6	5.5	2.0	5.5	4.9	6.7	4.7	4.2	2.9	4.1	4.3	0.1	1.3	1.4	1.9	1.4	1.6	2.3	1.6	4.1	2.8	1.9	3.0	1.4	0.2	1.2	1.2	1.2	1.5	1.3	15.7	19.5	25.2	21.2	15.2	7.0	10.9	12.9	17.3	12.8
DPCR1	"bCX105N19.6, C6orf37, PBLT"	ENSG00000168631	"Diffuse panbronchiolitis critical region 1"	Q3MIW9	6	30934523-30954221	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"gallbladder: 53.4;stomach 1: 70.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.0;HMC-1: 1.0;NTERA-2: 2.3;RPTEC TERT1: 1.8"	"Group enriched"	"Detected in some"	9	"pancreatic cancer: 56.8;stomach cancer: 55.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA014036	Enhanced									"HPA014036: AB_1847841"	"unprognostic (2.81e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.13e-4)"	"unprognostic (6.74e-2)"	"unprognostic (4.29e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (6.58e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.58e-2)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	1.9	0.0	0.0	0.0	0.0	4.8	0.0	53.4	0.0	0.0	0.0	0.0	2.5	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
DPEP3		ENSG00000141096	"Dipeptidase 3"	Q9H4B8	16	67975663-67980829	"Enzymes, Predicted intracellular proteins"	Meiosis	"Dipeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 56.7"	"Cell line enriched"	"Detected in single"	11	"U-266/70: 4.8"	"Group enriched"	"Detected in many"	10	"melanoma: 3.7;ovarian cancer: 16.9;testis cancer: 5.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"neutrophil: 9.2;NK-cell: 2.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 9.2;NK-cells: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031870, HPA058607"	Enhanced				"Intracellular and membrane"		16000000			"HPA031870: AB_2674079, HPA058607: AB_2683775"	"unprognostic (9.93e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.49e-3)"	"unprognostic (9.97e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.51e-1)"	0.2	0.0	0.1	0.4	0.4	1.0	0.6	0.1	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.6	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	0.2	0.3	0.1	0.1	0.0	0.5	0.0	0.4	1.4	0.2	56.7	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.8	0.1	9.2	0.5	2.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.2	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.5	0.3	0.4	0.0	0.0	0.1	0.8	0.8	0.3	9.2	2.3	0.1	0.0	0.0	0.3	0.1	0.4	0.1	0.3	0.3	0.1	0.1	0.0	0.9	0.1
DPPA5	Esg1	ENSG00000203909	"Developmental pluripotency associated 5"	A6NC42	6	73353062-73354295	"Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lung: 2.0;testis: 6.8"	"Cell line enhanced"	"Detected in single"		"MCF7: 1.6"	"Cancer enriched"	"Detected in single"	2209	"testis cancer: 347.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA064505	Uncertain									"HPA064505: "															"unprognostic (1.85e-1)"			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.1	6.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DPY19L1	KIAA0877	ENSG00000173852	"Dpy-19 like C-mannosyltransferase 1"	Q2PZI1	7	34928876-35038271	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059139	Uncertain		Approved	Vesicles				Vesicles		"HPA059139: "	"unprognostic (4.66e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.53e-3)"	"unprognostic (2.47e-3)"	"unprognostic (2.50e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.02e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavourable (2.99e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.12e-2)"	9.7	12.2	11.0	10.2	13.0	9.0	13.7	16.9	27.0	15.6	9.3	13.5	4.5	4.8	17.7	4.3	7.1	10.3	13.8	18.1	11.8	13.4	7.2	25.2	13.0	9.9	16.3	12.0	8.6	6.7	5.0	11.2	19.0	23.6	8.6	11.3	10.3	6.4	8.4	4.0	4.5	6.8	17.5	38.1	14.1	9.0	31.7	5.8	2.3	10.4	3.6	8.4	11.5	11.3	1.6	1.6	2.8	2.3	1.6	4.1	1.0	5.3	21.1	12.0	15.3	23.7	19.0	2.5	11.9	10.8	7.5	10.6	5.0	14.1	7.7	17.5	12.3	9.5	9.1	6.5	16.9	4.1	7.3	11.3	13.4	8.2	8.6	10.6	10.6	9.7	5.4	10.1	6.7	30.7	8.4	31.7	26.1	3.0	0.1	10.5	7.7	9.5	7.8	15.9	11.0	28.3	18.6	5.5	14.5	10.7	1.5	6.1	10.7	12.7	35.5	14.9	18.1	10.3	16.1	14.4	30.9	8.8	18.4	9.8	41.4	2.8	1.7	0.1	3.9	2.3	4.1	1.3	1.7	3.1	1.5	1.6	0.6	1.8	0.3	1.6	0.8	1.6	1.0	1.0	11.0	13.0	16.9	27.0	11.8	13.4	16.3	12.0	23.6	5.8
DPY19L3		ENSG00000178904	"Dpy-19 like C-mannosyltransferase 3"	Q6ZPD9	19	32405543-32485895	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008325	Approved		Approved	Microtubules				Microtubules		"HPA008325: AB_1847853"	"unprognostic (9.58e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.60e-1)"	"unprognostic (5.21e-2)"	"prognostic favourable (5.55e-4)"	"unprognostic (2.00e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.27e-1)"	"prognostic favourable (1.70e-4)"	"unprognostic (3.26e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.72e-3)"	8.4	10.9	20.7	8.1	23.0	11.5	10.1	11.2	18.5	12.8	6.2	15.2	9.9	4.2	10.7	9.3	6.1	8.9	9.7	6.4	17.9	14.1	8.6	7.4	7.6	7.1	15.3	11.0	19.3	11.3	15.0	13.3	11.7	14.5	16.1	6.7	9.8	10.2	8.7	3.6	4.9	5.9	7.6	15.7	10.8	9.8	12.3	10.2	6.8	15.3	4.5	6.9	8.3	7.5	2.9	2.2	9.0	2.7	1.3	2.2	0.8	3.0	5.8	21.8	9.6	22.4	11.5	10.9	9.3	6.6	3.9	6.9	6.7	3.4	11.8	5.9	6.6	1.6	8.8	4.1	7.3	6.0	5.7	15.7	5.8	6.1	14.7	8.1	9.1	12.0	2.2	4.7	4.5	9.1	11.3	3.8	10.0	5.0	2.1	4.1	9.1	2.3	5.7	8.7	3.5	7.3	7.4	4.8	13.1	4.5	4.4	4.9	3.3	9.5	9.9	7.9	5.6	4.7	9.7	5.8	11.8	8.0	11.1	9.8	12.7	6.0	2.5	7.4	1.8	1.9	1.0	2.0	1.7	1.7	2.2	2.9	1.4	1.6	9.0	1.3	2.7	1.6	2.2	0.8	20.7	23.0	11.2	15.0	17.9	14.1	15.3	11.0	14.5	10.2
DQX1	FLJ23757	ENSG00000144045	"DEAQ-box RNA dependent ATPase 1"	Q8TE96	2	74518131-74526336	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 41.0"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 6.4;Hep G2: 18.0;hTCEpi: 6.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039158	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039158: AB_10960125"	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.13e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.16e-3)"	0.1	0.0	0.1	2.1	0.2	0.0	0.1	0.1	0.1	0.8	13.3	0.2	0.1	14.7	0.1	0.1	3.7	0.2	3.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.0	0.1	0.2	5.1	0.1	0.6	0.1	0.1	1.5	41.0	0.3	0.1	0.2	2.9	0.1	0.1	0.2	0.1	0.7	1.5	1.1	1.4	0.7	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.5	0.1	0.3	0.0	0.0	0.7	0.1	6.4	0.1	0.0	0.3	0.4	0.1	18.0	0.0	0.2	0.3	0.0	6.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.1	0.1	0.1	0.0	1.2	0.0	0.1	0.0	2.5	0.0	0.6	0.0	0.0	0.8	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
DRC3	"CFAP134, DKFZP586M1120, LRRC48"	ENSG00000171962	"Dynein regulatory complex subunit 3"	Q9H069	17	17972813-18016889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 46.9"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 7.1;U-87 MG: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036040, HPA036041"	Approved									"HPA036040: AB_10602349, HPA036041: "	"prognostic favourable (1.51e-4)"	"unprognostic (5.86e-3)"	"unprognostic (9.48e-2)"	"prognostic favourable (4.05e-5)"	"unprognostic (1.06e-1)"	"unprognostic (7.64e-5)"	"unprognostic (6.11e-2)"	"unprognostic (5.47e-3)"	"unprognostic (8.59e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.33e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-2)"	0.7	1.1	3.3	0.4	5.9	0.3	2.2	1.2	3.1	5.0	0.7	8.2	7.2	0.9	5.3	15.9	0.7	46.9	2.3	1.1	5.1	5.1	3.7	1.1	6.5	0.7	0.8	2.3	8.2	3.3	6.8	18.5	0.6	13.4	2.2	0.7	6.1	1.6	2.1	1.3	1.2	0.5	1.9	1.2	0.9	0.8	15.4	2.6	0.0	7.0	0.3	0.5	0.6	1.0	0.4	0.4	3.1	0.7	0.0	1.0	0.2	1.0	3.9	0.6	2.3	0.4	1.5	0.3	1.0	0.5	1.9	2.0	0.6	4.2	0.0	3.3	0.6	3.3	1.2	0.5	1.1	0.2	2.7	0.1	0.3	0.0	1.4	0.6	0.2	1.3	1.1	3.0	0.4	0.5	0.0	0.3	2.2	1.2	0.2	0.1	0.7	0.8	0.2	1.1	0.0	7.1	1.4	1.2	3.4	1.4	0.1	3.6	3.8	0.0	1.0	1.1	0.9	0.2	0.5	0.5	0.2	0.1	5.7	0.0	3.3	0.0	0.7	2.0	0.3	0.2	0.2	0.4	0.1	1.0	0.4	0.3	0.3	0.6	3.1	0.0	0.2	0.2	0.0	0.2	3.3	5.9	1.2	3.1	5.1	5.1	0.8	2.3	13.4	2.6
DRP2		ENSG00000102385	"Dystrophin related protein 2"	Q13474	X	101219769-101264497	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 20.3"	"Cell line enhanced"	"Detected in some"		"RH-30: 11.0;TIME: 18.5;U-87 MG: 4.5"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002949			Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles, Plasma membrane"		"HPA002949: AB_1078706"	"unprognostic (8.47e-4)"	"unprognostic (3.56e-3)"	"unprognostic (1.01e-2)"	"unprognostic (5.58e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.27e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.44e-16)"	"unprognostic (3.71e-4)"	"unprognostic (4.22e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.25e-1)"	1.1	1.5	9.3	1.2	17.2	1.1	0.8	0.4	20.3	1.7	2.8	1.2	0.0	1.1	2.5	2.7	1.3	1.0	1.3	0.9	5.8	4.2	0.7	0.6	0.8	0.8	4.6	10.1	4.4	0.6	0.6	2.4	0.7	2.6	4.1	1.8	0.5	0.7	3.1	0.7	0.8	1.2	2.2	3.1	0.7	0.7	1.6	2.2	0.9	0.6	0.0	0.8	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	2.3	0.1	0.1	0.2	0.1	0.4	0.1	0.3	1.0	0.0	0.4	0.3	0.3	0.1	0.0	0.3	0.0	0.7	0.1	0.2	0.2	0.5	0.0	0.2	0.1	0.4	1.5	0.0	0.7	0.0	1.4	0.0	0.9	1.6	0.0	1.3	0.5	0.1	0.1	0.3	11.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.1	18.5	0.2	0.7	0.2	0.4	0.0	0.1	0.0	4.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	9.3	17.2	0.4	20.3	5.8	4.2	4.6	10.1	2.6	2.2
DSEL	"C18orf4, DE-epi2, FLJ11477, NCAG1"	ENSG00000171451	"Dermatan sulfate epimerase-like"	Q8IZU8	18	67506582-67516980	"Predicted membrane proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 19.5;BJ hTERT+: 11.3;LHCN-M2: 24.3;U-138 MG: 25.3"	"Cancer enhanced"	"Detected in many"		"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA060942			Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA060942: "	"unprognostic (2.49e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.40e-3)"	"unprognostic (7.11e-2)"	"unprognostic (4.91e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.16e-4)"	10.2	3.4	8.8	3.2	15.5	1.6	9.4	7.9	12.8	10.9	4.5	15.7	2.5	2.2	5.7	4.0	3.1	7.1	8.3	5.1	8.6	8.4	9.0	7.1	6.0	1.9	13.2	4.5	7.6	3.6	3.6	1.3	11.5	9.7	4.8	3.5	2.4	2.3	4.9	1.9	3.2	2.7	7.4	11.1	4.5	3.1	3.4	10.9	0.0	2.8	1.1	1.6	3.6	8.4	0.2	0.1	0.6	0.1	0.3	3.2	0.3	0.0	0.0	2.3	0.0	4.6	6.8	0.3	19.5	11.3	5.0	2.1	0.0	0.0	0.0	0.0	9.8	0.1	0.4	0.8	4.8	0.0	0.0	0.0	2.2	0.0	3.9	0.0	0.0	6.9	1.3	3.0	7.2	0.9	0.0	0.2	24.3	0.0	0.0	0.0	0.3	2.0	0.2	5.1	0.0	2.2	0.0	0.9	1.1	1.8	0.0	0.0	0.0	0.0	1.7	25.3	0.7	1.8	2.2	0.1	0.0	0.0	5.3	0.0	2.1	0.6	0.1	0.2	0.2	0.0	1.7	0.1	0.8	1.2	0.0	0.2	0.5	3.2	0.5	0.3	0.1	0.1	0.2	0.3	8.8	15.5	7.9	9.9	8.6	8.4	13.2	4.5	9.7	10.9
DUS4L	"DUS4, PP35"	ENSG00000105865	"Dihydrouridine synthase 4 like"	O95620	7	107563484-107578464	"Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044301	Approved		Approved	Cytosol				Cytosol		"HPA044301: AB_10967460"	"unprognostic (7.95e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.29e-2)"	"unprognostic (9.21e-3)"	"unprognostic (7.74e-3)"	"unprognostic (6.72e-3)"	4.5	6.2	9.4	7.0	10.4	2.9	7.8	5.0	8.2	5.5	5.7	7.5	6.2	4.8	5.7	10.4	5.5	6.0	4.7	10.1	8.0	7.7	9.9	9.0	3.9	5.0	10.3	6.2	7.8	5.4	8.0	5.1	4.8	7.6	7.8	5.7	5.7	5.1	4.8	7.1	7.1	5.2	5.3	11.0	4.3	5.4	7.7	6.6	6.6	8.5	5.9	5.7	6.2	4.5	1.5	1.3	0.5	1.3	1.2	2.4	0.7	6.5	3.0	3.0	1.8	1.2	2.0	3.9	1.9	2.6	2.8	2.7	3.4	5.4	7.0	3.5	1.5	1.9	3.1	4.0	4.3	2.1	2.6	2.4	1.6	3.7	3.0	4.8	0.4	2.0	5.4	2.7	9.1	4.0	8.6	2.6	4.2	4.8	6.6	8.3	4.2	5.4	3.5	2.7	7.8	5.3	3.3	2.7	6.8	3.0	6.4	5.4	3.0	3.8	2.9	4.0	3.2	3.0	4.4	4.9	6.0	7.8	4.3	6.8	4.8	0.0	1.2	0.1	1.4	1.3	1.6	1.5	2.3	1.2	1.3	0.7	1.9	2.4	0.5	1.2	0.7	1.1	1.7	0.7	9.4	10.4	5.0	8.2	8.0	7.7	10.3	6.2	7.6	6.6
DUSP27		ENSG00000198842	"Dual specificity phosphatase 27, atypical"	Q5VZP5	1	167094045-167129165	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"heart muscle: 46.8;skeletal muscle: 64.8;tongue: 18.2"	"Cell line enriched"	"Detected in some"	10	"RH-30: 17.7"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 12.8;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA012912			Approved	Nucleoplasm				Nucleoplasm		"HPA012912: "	"unprognostic (1.26e-2)"		"unprognostic (1.74e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	2.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.1	46.8	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.0	0.0	0.9	0.0	64.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.5	18.2	0.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.0	0.1	0.1
DXO	DOM3Z	ENSG00000204348	"Decapping exoribonuclease"	O77932	6	31969810-31972292	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 32.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046708	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA046708: "	"unprognostic (4.56e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.43e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.64e-3)"	"prognostic favourable (5.87e-4)"	"unprognostic (4.29e-2)"	"prognostic unfavourable (4.77e-6)"	"unprognostic (9.17e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.23e-3)"	4.3	18.4	8.3	8.0	11.0	4.2	7.0	15.5	12.4	7.1	5.0	6.5	8.6	7.8	6.4	6.4	4.0	7.9	6.0	8.4	7.7	6.5	8.5	8.7	5.1	4.3	9.0	6.5	10.5	12.3	9.4	12.4	4.7	7.4	7.6	4.2	5.8	5.5	6.8	5.6	3.4	4.1	6.3	4.9	7.2	7.6	32.8	7.3	3.4	8.8	4.7	4.3	6.4	5.5	2.2	3.2	1.5	1.9	3.0	3.3	1.5	3.0	1.3	0.4	14.1	1.7	1.0	1.5	1.6	2.6	4.4	3.6	2.2	2.9	1.0	3.1	5.8	4.1	1.5	3.2	1.6	1.9	4.4	1.9	2.9	2.8	3.9	0.0	2.7	2.2	2.9	1.8	3.0	6.6	2.4	3.2	1.8	4.4	0.1	2.3	0.7	0.1	0.1	2.0	1.8	5.2	0.7	7.3	5.5	3.3	1.4	3.7	0.0	4.4	0.9	0.8	4.8	2.8	3.6	1.9	3.4	2.4	2.6	4.6	2.1	0.0	1.0	1.5	1.1	1.9	3.3	1.4	1.4	1.8	3.2	2.2	1.3	1.6	0.6	3.0	1.2	1.2	0.6	1.5	8.3	11.0	15.5	9.4	7.7	6.5	9.0	6.5	7.4	7.3
DYDC2	"bA36D19.6, MGC16186"	ENSG00000133665	"DPY30 domain containing 2"	Q96IM9	10	80344745-80368073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 16.3;fallopian tube: 56.4"	"Cell line enhanced"	"Detected in some"		"AF22: 4.3;NTERA-2: 6.8;SCLC-21H: 5.9;SH-SY5Y: 4.0;U-2197: 4.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 3.2"	"Group enriched"	"Detected in many"	5	"amygdala: 6.3;basal ganglia: 9.1;hippocampal formation: 7.7;hypothalamus: 6.8;pons and medulla: 16.3"	"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA038006, HPA038007"	Enhanced									"HPA038006: AB_10672734, HPA038007: AB_2675783"	"unprognostic (1.60e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.85e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.55e-1)"	"prognostic favourable (3.54e-4)"	"unprognostic (1.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.34e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.41e-4)"	"unprognostic (9.86e-2)"	"unprognostic (5.40e-2)"	0.2	0.2	6.3	0.2	9.1	0.6	0.4	0.1	1.7	1.6	0.3	3.0	0.1	0.3	1.3	10.0	0.5	56.4	0.4	0.2	7.7	6.8	0.3	0.3	3.6	0.2	0.2	0.4	4.3	0.6	0.2	0.1	0.4	16.3	0.3	0.2	0.1	0.3	0.3	0.3	0.3	0.2	0.2	0.6	0.2	0.4	5.2	0.7	0.1	0.3	0.1	0.2	0.2	0.1	0.6	0.6	2.4	0.3	1.2	0.4	0.0	0.2	0.1	4.3	0.1	0.5	0.0	0.1	0.0	0.6	0.4	0.1	0.4	0.7	0.1	0.9	0.1	0.2	0.3	0.1	0.1	0.2	0.6	0.3	0.2	1.5	0.0	0.0	0.4	0.2	1.0	0.0	0.1	0.0	0.2	0.3	0.2	0.3	0.7	0.0	6.8	0.0	1.8	0.5	1.5	0.0	0.1	5.9	4.0	0.2	0.0	0.6	0.0	2.7	0.1	0.1	0.3	4.3	0.0	0.1	0.1	0.3	0.3	0.0	0.0	2.4	0.3	0.1	0.3	0.1	0.4	0.3	0.3	0.2	0.0	0.6	0.3	0.4	0.5	1.2	0.2	0.6	0.0	0.0	6.3	9.1	0.1	1.6	7.7	6.8	0.2	0.4	16.3	0.7
EBLN2		ENSG00000255423	"Endogenous Bornavirus like nucleoprotein 2"	Q6P2I7	3	73061659-73063337	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 15.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA062510, HPA068795"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA062510: , HPA068795: "	"unprognostic (1.23e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.29e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.19e-3)"	"unprognostic (8.38e-6)"	"unprognostic (1.54e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.12e-1)"	2.2	1.2	0.0	2.1	0.0	15.3	2.6	0.5	0.3	2.4	1.5			1.0	2.6	2.5	1.8	3.1	1.1	2.1	0.1	0.0	0.8	1.8	3.1	1.7	0.1		5.1	2.6	1.2	1.2	1.9		1.6	2.4		3.1	0.5	1.3	2.2	2.1	1.4	1.0	2.1	1.8	0.9			2.4		1.5	2.4	2.9	2.6	2.2	6.3	1.5	1.1	3.8	0.2	1.3	0.9	5.2	4.6	1.4	2.9	3.9	2.1	0.4	1.3	1.0	2.6	4.3	3.2	0.8	2.7	1.8	2.0	2.2	2.6	1.3	1.2	2.2	5.0	2.2	0.8	4.1	4.8	2.9	1.6	2.6	2.6	1.8	1.6	5.0	1.4	2.8	2.0	5.8	3.3	1.4	5.2	1.3	2.0	1.4	5.4	1.2	2.5	1.3	2.3	0.7	3.5	1.6	3.4	1.5	2.9	4.0	3.1	5.0	2.4	2.6	1.5	4.6	2.5	0.3	1.5	6.3	3.6	0.5	3.0	1.5	3.2	3.1	0.5	2.6	2.7	3.8	3.3	1.1	0.6	2.2	3.7	0.2										
ECM2		ENSG00000106823	"Extracellular matrix protein 2"	O94769	9	92493554-92536655	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"ASC diff: 11.1;ASC TERT1: 20.3;HSkMC: 21.4;hTCEpi: 24.4;hTERT-HME1: 6.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035347	Approved				"Secreted to extracellular matrix"		5500000			"HPA035347: AB_10669856"	"unprognostic (2.48e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.30e-1)"	"prognostic favourable (4.50e-5)"	"unprognostic (6.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (4.09e-6)"	"unprognostic (1.12e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.63e-3)"	43.3	5.0	5.4	7.2	4.3	0.0	18.6	9.5	1.9	20.9	6.5	5.4	11.6	2.9	14.7	27.5	8.4	11.6	11.2	13.8	9.3	3.6	10.1	28.2	8.8	2.3	11.0	4.2	34.6	1.9	4.9	4.7	1.4	17.8	16.4	2.4	5.8	3.4	8.1	6.0	5.8	5.4	10.1	15.8	0.5	2.8	15.4	7.4	1.1	8.3	15.5	2.4	13.7	8.8	0.3	0.6	0.0	0.5	0.1	0.5	0.0	0.4	0.0	0.2	0.0	11.1	20.3	0.7	0.4	0.6	0.0	0.3	0.3	0.0	0.0	0.0	1.0	0.3	0.5	0.4	0.0	2.4	0.0	0.0	0.0	0.0	1.9	0.1	0.0	21.4	24.4	0.5	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.5	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.5	0.2	0.5	0.0	0.0	0.1	0.1	0.6	0.0	0.0	5.4	4.3	9.5	1.9	9.3	3.6	11.0	4.2	17.8	7.4
ECT2L	"ARHGEF32, C6orf91, FBXO49, LFDH"	ENSG00000203734	"Epithelial cell transforming 2 like"	Q008S8	6	138795926-138904070	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 8.1;epididymis: 7.7;fallopian tube: 18.5;lung: 12.2;ovary: 9.4"	"Cell line enhanced"	"Detected in some"		"HEL: 2.7;SCLC-21H: 2.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"pons and medulla: 8.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA035488	Uncertain									"HPA035488: AB_10672865"	"unprognostic (2.88e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.53e-3)"	"unprognostic (3.48e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.03e-2)"	"unprognostic (5.90e-4)"	"unprognostic (2.32e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.65e-3)"	0.5	0.3	0.7	0.2	1.1	0.5	0.4	0.8	0.7	1.1	0.3	4.2	0.0	0.2	0.6	7.7	1.0	18.5	1.7	2.7	1.1	1.1	0.1	0.2	12.2	0.2	0.3	0.0	9.4	0.1	0.3	1.8	0.2	8.1	0.3	0.1	0.8	0.6	0.2	0.5	0.7	0.6	1.6	0.3	0.3	0.3	1.2	0.8	0.0	0.4	0.0	0.1	0.8	0.3	0.6	0.3	1.7	0.6	0.7	0.8	0.0	0.2	0.1	0.2	0.8	0.0	0.4	1.2	0.0	0.0	0.1	0.1	0.8	0.8	0.8	0.3	0.0	0.3	0.0	0.0	0.8	0.2	0.5	2.7	0.2	0.0	0.1	0.9	0.4	1.3	0.9	0.0	0.0	0.0	0.2	0.9	0.0	0.3	0.6	1.0	0.6	0.6	0.5	0.3	0.2	0.0	0.6	2.8	0.6	0.2	0.7	0.4	0.3	1.1	0.0	0.6	0.3	0.8	0.3	0.4	0.2	0.3	0.4	0.7	0.2	1.7	0.3	0.6	0.3	0.3	0.4	0.3	0.2	0.7	0.1	0.6	0.7	0.8	0.6	0.7	0.6	0.3	0.2	0.0	0.7	1.1	0.8	0.7	1.1	1.1	0.3	0.0	8.1	0.8
EDDM3A	"FAM12A, HE3-ALPHA"	ENSG00000181562	"Epididymal protein 3A"	Q14507	14	20745892-20748380	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"ductus deferens: 61.8;epididymis: 129.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;NB-4: 3.3;SH-SY5Y: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.2"									HPA049952	Approved				"Secreted in male reproductive system"					"HPA049952: "	"unprognostic (1.42e-1)"				"unprognostic (9.88e-2)"								"unprognostic (8.56e-3)"		"unprognostic (2.10e-1)"			0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	61.8	0.0	0.1	129.9	0.1	0.2	0.0	0.1	0.1	0.1	1.5	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.2	14.7	0.1	0.1	0.1	0.0	0.1	0.4	0.4	4.7	0.0	0.0	0.1	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
EFCAB1	FLJ11767	ENSG00000034239	"EF-hand calcium binding domain 1"	Q9HAE3	8	48710789-48735311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 61.9"	"Cell line enhanced"	"Detected in some"		"A-431: 8.9;ASC diff: 3.9;ASC TERT1: 9.1;CAPAN-2: 4.4;hTEC/SVTERT24-B: 3.7;SCLC-21H: 7.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.9"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023527, HPA069955"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA023527: AB_2231065, HPA069955: "	"unprognostic (5.29e-3)"	"unprognostic (7.39e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.67e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.77e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.94e-3)"	"unprognostic (7.81e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.47e-3)"	0.6	1.5	5.4	0.5	9.5	0.9	2.5	0.2	4.1	8.1	0.8	14.0	10.3	0.9	8.6	19.0	0.9	61.9	0.9	0.6	9.1	8.4	0.6	0.9	16.5	0.5	2.7	3.9	13.7	1.8	0.4	2.0	0.8	23.9	4.2	0.7	1.9	1.8	4.6	0.5	3.5	1.1	2.7	1.4	0.6	0.8	19.7	3.0	0.0	0.5	0.3	0.6	1.4	2.1	1.0	0.0	4.1	0.0	1.1	1.1	0.3	8.9	0.0	1.1	0.0	3.9	9.1	0.0	0.1	0.9	0.0	0.3	0.0	4.4	0.0	0.0	0.2	2.4	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.1	3.2	0.3	3.7	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.5	0.3	0.1	0.0	0.0	0.0	2.1	7.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.5	0.0	1.1	1.0	0.7	0.8	0.0	0.8	0.5	0.3	4.1	1.1	0.0	0.0	0.7	0.3	5.4	9.5	0.2	4.1	9.1	8.4	2.7	3.9	23.9	3.0
EFCAB10		ENSG00000185055	"EF-hand calcium binding domain 10"	A6NFE3	7	105565120-105600875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 29.0;testis: 34.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA019751	Uncertain									"HPA019751: AB_1848011"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-3)"	"unprognostic (8.96e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.11e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.58e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-3)"	"unprognostic (6.87e-2)"	"unprognostic (3.07e-9)"	"unprognostic (2.13e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.67e-2)"	0.4	0.8	2.0	0.9	9.6	2.2	0.3	0.7	3.7	1.5	0.7	4.2	0.0	0.7	1.3	6.2	0.9	29.0	0.5	0.5	2.9	3.5	0.7	0.7	6.4	1.0	0.7	3.5	6.9	1.6	0.2	2.0	0.4	11.8	0.7	0.5	0.0	1.0	0.2	1.3	1.4	0.8	0.2	1.1	0.9	0.8	34.9	2.3	0.0	0.7	0.0	0.3	0.8	0.4	2.9	1.7	3.7	1.2	1.4	3.0	0.6	2.0	5.9	3.2	2.1	0.6	0.2	1.3	2.9	0.0	0.0	0.1	1.1	1.3	2.9	2.6	0.1	0.8	0.1	0.0	0.0	1.1	5.3	1.5	4.0	3.2	0.4	1.8	1.9	0.2	0.0	0.2	0.0	0.0	4.3	2.4	0.1	4.4	2.1	4.0	5.3	2.2	1.4	3.3	6.2	0.3	1.3	3.1	4.1	1.7	6.1	1.0	1.2	2.2	1.5	3.0	2.1	6.4	1.9	3.4	4.0	2.6	1.8	2.9	1.5	3.7	1.2	1.0	1.9	0.9	1.7	1.6	1.9	1.6	0.7	2.9	3.0	2.2	1.4	1.4	0.9	1.7	1.2	0.6	2.0	9.6	0.7	3.7	2.9	3.5	0.7	3.5	11.8	2.3
EFCAB11	C14orf143	ENSG00000140025	"EF-hand calcium binding domain 11"	Q9BUY7	14	89794669-89954777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 36.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 12.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA051209			Approved	"Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"		"HPA051209: "	"unprognostic (1.03e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.84e-7)"	"unprognostic (4.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.45e-2)"	4.7	5.8	10.2	6.2	8.1	5.3	9.3	5.7	7.6	5.6	5.2	10.4	6.7	5.1	4.9	6.9	6.2	11.0	4.9	3.7	7.8	6.6	7.6	5.8	3.2	3.3	8.6	5.7	5.2	4.8	8.3	8.2	8.4	7.7	5.4	5.6	6.1	5.6	5.4	2.4	3.7	3.6	6.3	8.4	6.7	4.4	36.9	6.2	2.5	7.9	3.3	6.3	5.2	4.1	2.6	2.1	12.8	5.3	3.3	1.6	0.8	4.9	7.6	6.6	8.2	4.1	4.4	18.7	7.2	6.6	9.9	6.9	8.9	17.5	7.7	13.8	4.8	10.8	5.7	14.4	14.3	8.6	3.6	5.5	6.5	14.5	0.9	7.0	13.4	3.0	3.6	6.4	7.4	8.2	5.8	7.6	11.7	25.5	5.2	9.5	2.8	13.7	6.0	10.5	5.5	9.1	13.7	2.8	4.7	9.1	17.0	8.5	13.8	5.1	6.9	5.4	7.4	5.6	7.0	4.6	13.1	13.3	7.8	3.3	9.7	12.8	1.3	3.4	0.6	3.0	0.3	2.6	1.0	1.0	2.1	2.6	1.6	1.4	4.0	3.3	5.3	1.8	1.3	0.8	10.2	8.1	5.7	7.6	7.8	6.6	8.6	5.7	7.7	6.2
EFCAB13	"C17orf57, FLJ40342"	ENSG00000178852	"EF-hand calcium binding domain 13"	Q8IY85	17	47323290-47441312	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"vagina: 29.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			"CAB002501, HPA021633, HPA023249, HPA026561"	Uncertain		Enhanced	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear speckles"	"CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596"	"unprognostic (1.66e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.79e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.46e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.90e-3)"	4.1	2.8	2.9	12.2	3.4	3.4	6.5	2.8	3.8	6.5	4.7	2.3	3.5	4.8	8.9	4.4	2.4	4.2	4.1	3.5	2.3	1.5	7.5	4.0	3.1	4.3	3.6	0.4	5.5	2.8	8.4	7.6	5.4	3.2	9.3	3.4	2.6	5.4	2.0	1.3	2.2	6.3	9.9	3.5	4.6	3.5	20.0	2.7	2.4	14.9	0.7	4.3	5.5	29.9	5.6	1.0	5.3	2.1	0.8	2.6	0.8	0.9	3.9	1.7	0.2	2.1	7.2	3.0	2.2	0.5	0.6	1.1	1.7	5.6	0.3	6.5	0.8	1.0	0.0	0.4	3.9	0.2	0.6	5.1	3.2	0.5	2.0	3.9	0.6	1.3	1.9	2.7	0.0	4.4	1.5	9.7	2.4	0.1	1.7	2.2	0.9	3.1	4.6	1.2	1.8	9.1	3.2	1.2	0.6	1.2	0.1	2.6	6.5	4.7	1.6	0.2	1.3	0.4	1.0	10.0	6.9	0.9	6.2	7.7	4.2	5.3	2.1	0.6	1.1	1.2	0.9	4.3	0.9	0.6	1.0	5.6	2.6	1.2	0.0	0.8	0.7	0.4	0.1	0.8	2.9	3.4	2.8	3.8	2.3	1.5	3.6	0.4	3.2	2.7
EFCAB2	"CFAP200, DRC8, MGC12458"	ENSG00000203666	"EF-hand calcium binding domain 2"	Q5VUJ9	1	244969705-245127164	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 34.2;THP-1: 30.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 10.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031206, HPA031207"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA031206: AB_10599710, HPA031207: AB_10599946"	"unprognostic (1.36e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.02e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (6.51e-4)"	"unprognostic (4.88e-2)"	11.0	12.5	16.7	5.6	18.6	10.8	14.7	20.1	15.5	11.6	7.3	23.6	13.9	3.0	18.7	19.5	9.6	32.1	13.1	13.7	18.0	14.3	12.5	6.5	11.2	7.8	22.3	12.3	10.6	12.1	14.6	20.6	14.7	16.3	9.2	11.3	11.8	7.4	16.0	15.5	6.1	6.5	13.2	20.9	6.4	10.5	24.4	21.9	5.4	23.7	13.5	9.1	11.5	16.0	3.6	10.8	4.9	1.8	2.9	0.8	1.2	3.1	3.9	8.9	2.3	3.2	7.6	10.9	3.9	4.2	5.1	4.7	10.0	8.5	10.8	8.5	4.9	2.5	3.6	2.3	3.2	1.1	2.1	5.2	15.6	4.4	6.9	5.3	34.2	6.6	4.8	6.8	6.4	7.8	19.9	8.8	4.4	3.2	1.1	14.6	11.4	3.0	20.5	1.3	2.8	13.0	5.3	7.0	9.5	6.9	2.6	5.7	2.6	30.1	1.2	6.3	2.3	3.4	14.2	3.0	5.0	7.2	5.0	15.3	5.1	1.2	1.7	2.8	0.5	1.8	0.8	3.6	0.7	0.4	5.5	3.3	0.6	0.6	4.9	2.9	1.3	10.8	0.8	1.2	16.7	18.6	20.1	15.5	18.0	14.3	22.3	12.3	16.3	21.9
EFCAB3	FLJ25818	ENSG00000172421	"EF-hand calcium binding domain 3"	Q8N7B9	17	62343941-62416479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"testis: 11.3"	"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 2.0;T-47d: 2.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA046862	Uncertain									"HPA046862: AB_2679844"													"unprognostic (2.99e-6)"					0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3			0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	1.2	1.9	0.3	0.5	1.3	0.3	0.0	0.1	0.3	0.0	0.3	0.7	0.1	0.0	0.5	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.8	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.2	0.9	0.6	1.4	1.4	0.0	1.5	0.0	1.1	0.4	0.6	0.7	2.0	0.0	1.9	0.3	2.1	0.0	0.5	0.2	0.4	0.5	0.1	0.0	0.5	0.2	0.5	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
EFCC1	"C3orf73, CCDC48, FLJ12057"	ENSG00000114654	"EF-hand and coiled-coil domain containing 1"	Q9HA90	3	129001629-129040742	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 34.1"	"Group enriched"	"Detected in some"	7	"AF22: 3.2;HL-60: 8.5;U-266/84: 2.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042798, HPA050888"	Uncertain									"HPA042798: , HPA050888: "	"unprognostic (1.74e-1)"	"unprognostic (5.16e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.66e-3)"	"unprognostic (7.23e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.04e-1)"	"prognostic favourable (9.70e-4)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.20e-1)"	3.7	0.5	0.9	4.7	0.5	0.3	1.9	1.7	1.0	2.3	4.6	0.5	2.2	4.8	5.1	2.3	1.6	0.8	34.1	1.9	1.5	0.8	1.8	0.7	12.9	0.4	0.4	0.2	6.1	0.5	0.3	1.5	1.0	2.3	2.7	1.2	1.4	1.8	1.6	2.3	1.1	3.8	5.0	0.4	6.2	4.5	0.6	0.0	0.3	2.6	3.6	0.7	2.0	2.5	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.6	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.5	1.7	1.0	1.5	0.8	0.4	0.2	2.3	0.0
EFHB	"CFAP21, FLJ25200"	ENSG00000163576	"EF-hand domain family member B"	Q8N7U6	3	19879472-19947025	"Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 23.3;testis: 19.2"	"Cell line enriched"	"Detected in single"	33	"RPTEC TERT1: 21.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA078067			Approved	Nucleoli				Nucleoli		"HPA078067: "	"unprognostic (9.70e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.51e-5)"	"unprognostic (4.43e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.92e-2)"	"unprognostic (5.47e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.13e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	1.1	1.5	3.9	0.7	6.0	0.7	1.8	0.7	4.3	2.0	0.7	6.5	0.0	0.6	2.0	7.8	1.0	23.3	1.3	0.8	6.3	4.7	1.8	0.7	3.9	0.7	4.4	2.2	5.5	0.5	0.5	1.6	1.0	9.5	1.0	1.0	2.3	0.6	1.3	0.7	1.1	0.6	1.6	3.1	1.2	0.6	19.2	6.0	0.0	1.2	0.0	0.8	0.7	0.6	1.3	0.6	1.1	0.8	0.4	2.2	0.4	0.0	0.5	0.2	0.2	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	21.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.1	2.2	0.1	0.1	0.8	0.3	0.4	0.0	1.3	0.5	0.3	1.1	0.4	0.3	0.6	0.0	0.4	3.9	6.0	0.7	3.8	6.3	4.7	4.4	2.2	9.5	6.0
EGFL6	MAEG	ENSG00000198759	"EGF like domain multiple 6"	Q8IUX8	X	13569605-13633575	"Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"placenta: 137.5"	"Group enriched"	"Detected in some"	5	"BJ hTERT+: 9.4;NTERA-2: 3.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001838	Enhanced				"Secreted to extracellular matrix"					"HPA001838: "	"unprognostic (1.66e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.15e-3)"	"unprognostic (3.76e-3)"	"unprognostic (1.77e-2)"	"prognostic favourable (9.73e-4)"	"unprognostic (4.13e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-3)"	"prognostic favourable (4.95e-4)"	"unprognostic (2.39e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.14e-9)"	"unprognostic (7.10e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.82e-3)"	16.1	0.1	0.3	0.2	0.2	0.1	2.3	0.0	0.2	0.4	4.1	0.0	0.1	0.2	0.5	0.4	3.3	0.6	1.5	0.6	0.1	0.7	0.2	0.1	18.6	0.2	0.1	0.1	0.2	0.3	0.1	1.7	137.5	0.9	0.6	0.2	27.1	0.2	0.1	0.1	0.4	0.2	2.0	0.6	0.2	0.4	0.2	0.0	0.0	0.2	0.2	0.4	4.1	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.1	0.7	0.1	0.1	0.9	0.0
EGR3	PILOT	ENSG00000179388	"Early growth response 3"	Q06889	8	22687659-22693302	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.5;HMC-1: 7.3;MCF7: 23.9;SK-MEL-30: 16.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"amygdala: 11.5;basal ganglia: 33.6;cerebral cortex: 35.0;hippocampal formation: 13.7;olfactory region: 12.8"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	10	"amygdala: 26.1;basal ganglia: 40.1;cerebral cortex: 47.9;hippocampal formation: 32.4;olfactory region: 18.2"	"Group enriched"	"Detected in many"	9	"amygdala: 29.0;basal ganglia: 68.2;cerebral cortex: 57.2;hippocampal formation: 56.6;olfactory region: 75.0"	"HPA006206, CAB009373"	Uncertain		Uncertain	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB009373: AB_2097202, HPA006206: AB_10602491"	"prognostic favourable (1.83e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.44e-2)"	"prognostic favourable (4.78e-4)"	"unprognostic (3.48e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.07e-2)"	20.7	17.7	11.5	12.3	33.6	5.6	7.1	0.8	35.0	7.4	3.3	11.1	0.2	0.9	3.8	1.0	4.0	14.6	20.6	8.5	13.7	2.0	3.0	2.0	4.1	7.3	1.9	12.8	10.6	2.9	12.8	5.0	1.2	3.6	10.3	2.2	2.6	2.3	4.0	1.6	28.4	3.6	8.3	1.6	2.8	5.3	4.1	2.1	5.5	5.8	1.3	5.8	12.3	2.5	0.8	0.0	2.1	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	1.4	4.5	0.1	0.4	0.5	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.3	0.2	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.3	0.4	0.2	0.2	0.0	0.1	0.2	0.1	0.0	23.9	0.0	0.2	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.1	0.4	0.0	16.0	1.1	0.0	0.0	0.2	0.1	0.2	0.3	0.3	0.0	0.0	0.7	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	11.5	33.6	0.8	35.0	13.7	2.0	1.9	12.8	3.6	2.1
EGR4	"NGFI-C, PAT133"	ENSG00000135625	"Early growth response 4"	Q05215	2	73290929-73293705	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 20.0"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 5.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA028983	Enhanced									"HPA028983: AB_10603665"	"unprognostic (7.75e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.39e-4)"	"unprognostic (2.43e-3)"	"unprognostic (2.68e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.07e-3)"	1.1	0.8	4.9	1.0	15.9	0.9	0.6	17.2	20.0	0.6	0.6	1.2	0.0	0.5	0.6	0.5	0.6	0.6	0.6	0.6	8.8	1.9	0.6	0.6	0.6	0.6	0.3	4.4	0.6	0.5	0.6	2.3	0.6	0.0	0.7	0.6	0.0	0.5	0.5	0.6	0.6	0.6	0.6	0.3	0.6	0.7	4.9	2.6	0.0	0.5	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	15.9	17.2	20.0	8.8	1.9	0.3	4.4	0.0	2.6
EHF	"ESE3, ESEJ"	ENSG00000135373	"ETS homologous factor"	Q9NZC4	11	34621093-34661057	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 152.4;salivary gland: 118.0;seminal vesicle: 161.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 34.7;HaCaT: 23.9;HBEC3-KT: 26.3;RT4: 53.1;T-47d: 53.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	10	"myeloid DC: 4.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA050923, HPA060734"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"			Nucleoplasm	"Golgi apparatus"	"HPA050923: , HPA060734: "	"unprognostic (1.06e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (5.81e-4)"	"unprognostic (2.82e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.79e-2)"	"prognostic unfavourable (6.94e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.08e-2)"	0.8	1.0	0.8	9.3	0.9	0.0	32.1	0.7	0.7	19.3	16.0	0.5	152.4	6.9	4.5	21.4	69.0	23.0	22.1	0.7	0.9	0.9	11.6	1.6	9.9	0.1	1.5	0.3	4.7	10.5	0.2	0.9	0.5	1.4	20.7	22.3	0.2	118.0	161.8	0.7	12.8	10.1	1.7	3.3	0.7	10.1	1.4	0.5	0.4	1.2	50.3	59.7	13.7	30.3	0.0	4.9	0.0	0.4	0.0	0.0	0.2	11.4	6.6	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.1	34.7	0.0	4.4	0.0	23.9	0.0	26.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.2	4.7	53.1	0.0	0.0	0.1	3.6	0.0	53.8	0.1	0.0	0.0	0.3	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.9	0.7	0.7	0.9	0.9	1.5	0.3	1.4	0.5
EIF4E3	MGC39820	ENSG00000163412	"Eukaryotic translation initiation factor 4E family member 3"	Q8N5X7	3	71675416-71754773	"Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 19.7;U-937: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.8"	"Group enriched"	"Detected in many"	8	"granulocytes: 14.8;monocytes: 4.2;T-cells: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058649, HPA076465"	Approved		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA058649: , HPA076465: "	"unprognostic (3.16e-3)"	"unprognostic (7.60e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.31e-2)"	"prognostic favourable (6.63e-4)"	"unprognostic (3.10e-2)"	"prognostic favourable (4.64e-5)"	"unprognostic (3.16e-2)"	"unprognostic (4.58e-2)"	"prognostic favourable (6.99e-5)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.83e-2)"	18.8	9.4	17.2	11.8	22.6	17.7	25.6	13.9	19.4	9.6	16.3	11.5	3.7	10.4	11.0	8.5	16.0	12.2	11.9	30.3	18.6	14.6	10.5	8.8	13.7	11.7	15.2	12.4	17.9	19.4	26.7	14.6	4.7	12.8	14.8	13.0	10.8	12.9	14.5	40.4	7.2	17.6	25.6	19.4	15.3	9.9	5.9	6.7	7.8	19.7	14.5	7.8	17.6	21.8	0.2	0.9	14.8	4.2	1.0	5.4	1.6	0.3	1.3	1.3	4.2	1.3	3.3	1.7	1.1	1.2	1.1	0.6	0.6	0.6	0.0	2.8	1.1	1.5	4.6	6.4	0.9	14.6	1.4	0.0	0.1	0.1	4.6	2.3	2.5	2.9	4.1	0.3	3.5	3.5	0.5	19.7	0.2	4.9	2.0	0.5	10.3	2.3	1.1	5.1	0.6	14.1	7.0	2.6	7.1	7.6	1.7	0.2	7.3	0.1	0.9	0.6	3.3	9.0	1.0	13.8	12.8	0.0	0.4	26.6	2.5	1.2	4.2	5.9	2.2	1.8	3.4	0.2	3.1	3.6	0.9	0.1	2.3	2.7	14.8	1.0	2.3	0.0	5.4	1.6	17.2	22.6	13.9	19.4	18.6	14.6	15.2	12.4	12.8	6.7
ELAVL3	"DKFZp547J036, HUC, HUCL, MGC20653, PLE21"	ENSG00000196361	"ELAV like RNA binding protein 3"	Q14576	19	11451326-11481046	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 53.8"	"Group enriched"	"Detected in some"	8	"SCLC-21H: 39.6;SH-SY5Y: 22.8"	"Cancer enriched"	"Detected in some"	10	"glioma: 11.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.9;naive B-cell: 1.9"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013066	Enhanced									"CAB013066: AB_221448"	"unprognostic (1.47e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.78e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.60e-3)"	1.0	2.4	14.0	1.5	13.2	1.0	1.0	45.2	53.8	1.0	1.3	12.2	0.0	1.2	1.1	1.6	1.2	1.0	1.0	1.1	17.3	13.0	1.1	1.1	1.1	1.0	14.3	18.3	1.0	1.0	1.0	1.3	1.0	9.5	1.6	1.2	0.1	1.0	1.2	4.0	1.0	1.2	1.2	21.9	1.1	1.2	1.5	5.1	0.0	1.0	0.0	1.0	1.0	0.0	1.9	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	39.6	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	1.9	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	14.0	13.2	45.2	35.2	17.3	13.0	14.3	18.3	9.5	5.1
ELMOD1	DKFZp547C176	ENSG00000110675	"ELMO domain containing 1"	Q8N336	11	107591091-107666779	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 51.1;pituitary gland: 20.8;skin 1: 34.7"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 11.6;RH-30: 26.5"	"Cancer enriched"	"Detected in single"	15	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038435, HPA066479"			Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038435: AB_10795575, HPA066479: "	"unprognostic (2.74e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.13e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.39e-1)"	1.5	4.2	10.7	1.5	41.1	1.3	4.1	12.8	51.1	1.5	1.4	1.7	0.0	1.4	1.6	1.3	1.2	3.6	1.2	4.8	13.8	14.3	4.7	1.3	1.6	1.3	8.7	15.2	1.2	1.2	1.2	20.8	1.2	14.8	2.1	1.3	1.4	1.3	1.2	2.8	34.7	1.3	1.4	6.6	1.2	1.2	2.9	3.9	0.0	1.3	0.0	1.2	1.1	0.1	0.9	0.7	2.4	0.9	1.8	0.5	0.2	0.0	0.0	4.4	0.1	0.0	0.0	0.1	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.2	0.4	2.1	0.3	0.4	0.0	1.8	0.1	0.0	0.0	1.2	0.1	0.0	0.4	0.1	0.0	0.0	11.6	0.0	0.1	0.8	0.0	0.0	0.1	0.5	1.7	0.0	26.5	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.6	0.1	0.0	0.0	3.5	0.0	2.0	1.6	0.9	0.6	0.4	0.6	0.4	0.5	0.5	0.2	0.2	0.9	0.4	0.5	2.4	1.8	0.6	0.7	0.4	0.2	10.7	41.1	12.8	26.9	13.8	14.3	8.7	15.2	14.8	3.9
ELOA3B	"HsT828, TCEB3CL"	ENSG00000278674	"Elongin A3 family member B"	Q3SY89	18	47022287-47023927	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEK 293: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048971, HPA049178, HPA050086"	Uncertain									"HPA048971: , HPA049178: , HPA050086: "																		0.0	0.0		0.0		0.6	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.3	0.4	0.0	0.0		0.0	0.0	0.2			0.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3										
EMID1	"EMI5, EMU1, hEmu1"	ENSG00000186998	"EMI domain containing 1"	Q96A84	22	29205851-29259597	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.0"	"Group enriched"	"Detected in some"	4	"HEL: 12.9;NB-4: 44.9"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 23.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"NK-cell: 2.3"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000592	Uncertain				"Secreted in other tissues"					"HPA000592: AB_1078737"	"unprognostic (2.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.08e-1)"	2.6	19.3	17.8	3.6	12.7	11.7	2.4	3.5	17.9	2.9	5.4	14.2	2.2	4.8	10.5	2.5	0.9	10.4	4.8	1.3	12.6	6.1	7.7	2.1	7.0	13.3	5.6	14.7	4.8	12.7	4.5	1.2	4.7	3.8	5.2	3.4	2.9	4.7	4.2	0.7	3.6	7.4	2.3	2.6	31.0	7.0	2.1	6.9	4.6	8.4	0.5	2.2	5.0	1.4	0.1	0.0	0.0	0.0	2.3	0.3	0.1	0.0	0.1	2.2	4.8	0.0	0.0	0.3	0.0	0.0	0.2	0.1	2.6	0.3	0.0	2.2	0.0	0.0	1.1	0.0	0.0	5.1	4.0	12.9	0.0	0.5	0.3	1.8	1.0	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.0	3.5	0.0	44.9	0.5	0.2	0.0	0.1	4.9	0.0	0.0	6.1	3.0	0.2	0.0	0.0	1.9	2.4	0.0	0.0	3.8	0.0	0.0	0.2	0.0	0.0	0.0	6.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	17.8	12.7	3.5	17.9	12.6	6.1	5.6	14.7	3.8	6.9
EML5	"EMAP-2, HuEMAP-2"	ENSG00000165521	"Echinoderm microtubule associated protein like 5"	Q05BV3	14	88612431-88792752	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.0;ovary: 26.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 10.4;SH-SY5Y: 22.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054019, HPA055379"	Uncertain									"HPA054019: , HPA055379: "	"unprognostic (2.28e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.67e-4)"	"unprognostic (3.42e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.11e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.53e-3)"	0.8	9.1	5.1	1.5	9.0	0.8	1.4	23.0	5.0	0.8	1.6	1.9	0.1	1.2	1.7	0.7	1.6	1.7	1.1	0.9	5.8	2.6	1.9	1.1	1.2	1.5	1.6	4.7	26.8	2.2	6.0	13.7	0.7	3.8	7.6	0.7	4.5	1.6	0.7	0.6	1.3	1.4	1.8	1.6	1.5	1.6	4.9	2.1	0.9	3.9	0.8	1.1	1.2	0.9	0.9	0.3	0.0	0.2	0.0	2.4	0.4	2.0	1.3	1.9	1.8	0.0	0.0	3.9	1.9	0.3	0.2	0.1	0.6	1.7	1.0	0.8	0.0	4.6	3.6	0.1	0.1	3.1	2.8	1.4	1.3	1.1	0.0	2.8	0.4	0.0	0.1	0.0	0.0	0.0	1.4	10.4	0.0	2.5	3.5	1.1	1.6	2.1	2.3	2.0	1.0	0.1	4.0	5.3	22.3	2.5	4.5	1.5	2.0	1.4	0.8	2.1	0.4	0.3	2.7	4.8	1.3	4.3	0.9	1.2	0.8	0.0	0.0	0.0	0.2	0.2	2.4	0.9	0.5	0.2	0.3	0.5	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.4	5.1	9.0	23.0	5.0	5.8	2.6	1.6	4.7	3.8	2.1
EML6	FLJ42562	ENSG00000214595	"Echinoderm microtubule associated protein like 6"	Q6ZMW3	2	54723499-54972025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.2;lymphoid tissue: 11.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.2;SCLC-21H: 20.1;U-698: 22.8"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.5"	"Lineage enriched"	"Detected in single"	26	"B-cells: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062808, HPA068759"	Uncertain		Approved	Vesicles,Mitochondria				Mitochondria	Vesicles	"HPA062808: , HPA068759: "	"unprognostic (1.06e-1)"	"unprognostic (6.89e-4)"	"unprognostic (7.83e-2)"	"unprognostic (9.96e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.26e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.85e-6)"	"unprognostic (5.00e-1)"	"unprognostic (5.81e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.13e-3)"	0.1	3.3	1.8	4.0	2.8	0.0	0.2	7.2	4.2	0.0	0.6			0.6	0.0	1.3	0.3	0.4	0.1	0.0	1.9	2.1	1.3	0.2	0.1	7.9	1.5		0.0	0.5	3.0	3.4	1.4		0.4	0.8		0.1	0.4	0.6	0.8	1.8	0.3	0.5	2.7	0.4	1.5			3.1		11.9	0.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	1.1	0.7	0.2	1.5	0.1	0.2	0.2	0.2	0.6	0.2	7.2	0.1	0.4	0.2	1.0	0.3	0.3	0.7	0.3	0.4	0.5	2.7	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.0	1.1	0.0	0.7	1.4	0.2	0.3	1.1	0.6	0.5	0.6	0.0	0.7	20.1	2.7	0.3	0.0	0.0	0.0	0.0	0.2	0.3	1.6	0.4	0.4	4.9	1.2	22.8	1.2	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
EN2		ENSG00000164778	"Engrailed homeobox 2"	P19622	7	155458129-155464831	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 26.5"	"Cell line enhanced"	"Detected in some"		"AF22: 26.9;AN3-CA: 9.9;HAP1: 5.8;HEK 293: 16.3;SK-MEL-30: 7.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 6.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	8	"cerebellum: 31.1"	"Region enriched"	"Detected in some"	6	"cerebellum: 71.6"	"HPA045646, HPA069809"			Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA045646: , HPA069809: "	"unprognostic (2.44e-3)"	"unprognostic (1.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.99e-3)"	"prognostic unfavourable (1.74e-6)"	"unprognostic (2.54e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.03e-13)"	"unprognostic (4.91e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.64e-3)"	0.3	0.2	0.1	0.0	0.1	0.0	0.1	26.5	0.1	0.0	0.0			0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.3		1.3	1.2	5.0	0.0	0.0		0.0	0.0		0.0	0.0	0.8	1.1	0.0	0.0	0.4	0.0	0.0	2.1			0.0		0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.4	26.9	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	5.8	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.2	3.4	0.0	0.0	0.0	1.3	0.0	2.1	0.0	0.1	0.2	0.0	0.0	1.9	0.0	7.9	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ENHO	"C9orf165, UNQ470"	ENSG00000168913	"Energy homeostasis associated"	Q6UWT2	9	34521040-34523041	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 79.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 13.2;NTERA-2: 18.2;SCLC-21H: 9.3;SH-SY5Y: 8.8"	"Cancer enhanced"	"Detected in many"		"glioma: 44.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"myeloid DC: 19.4"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042575	Approved				"Secreted to blood"	4236667				"HPA042575: AB_10794914"	"unprognostic (2.63e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (3.71e-4)"	"unprognostic (1.30e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.78e-4)"	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.76e-2)"	1.5	1.9	58.0	1.9	59.3	1.7	3.7	15.5	79.6	2.9	3.9	13.9	0.0	3.0	1.4	1.4	1.5	3.6	1.8	1.8	36.3	37.5	1.5	12.0	2.0	1.4	52.0	27.1	1.5	2.6	1.2	1.0	1.3	13.7	5.2	3.2	0.1	1.8	1.7	1.6	3.8	3.6	1.3	17.1	1.6	5.3	6.4	13.4	0.0	1.4	0.0	1.4	1.5	0.0	0.0	19.4	0.0	2.5	2.7	0.0	0.4	0.1	0.9	5.2	13.2	0.1	0.0	0.3	0.0	0.0	2.1	2.1	0.5	0.2	2.2	3.6	0.0	0.2	6.0	0.4	0.4	0.3	5.8	0.0	0.1	1.2	0.1	0.0	2.9	0.0	0.1	0.0	0.2	0.0	0.0	1.9	0.4	0.3	0.0	0.0	18.2	3.7	0.1	0.0	0.3	0.5	0.0	9.3	8.8	0.7	4.1	0.4	0.3	1.7	0.0	0.4	2.0	0.1	0.1	1.1	1.2	0.1	0.4	0.0	3.0	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	2.7	0.7	1.0	0.0	0.4	58.0	59.3	15.5	37.0	36.3	37.5	52.0	27.1	13.7	13.4
ENO4	"AC023283.3, C10orf134"	ENSG00000188316	"Enolase family member 4"	A6NNW6	10	116849512-116911788	"Enzymes, Predicted intracellular proteins"	Glycolysis	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.1;epididymis: 12.6;fallopian tube: 13.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.6;MCF7: 8.2;T-47d: 5.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037937, HPA037938"	Enhanced		Approved	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA037937: AB_10697089, HPA037938: "	"unprognostic (2.92e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.55e-4)"	"unprognostic (8.38e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.87e-5)"	"unprognostic (1.08e-2)"	0.7	2.1	4.3	0.6	4.3	0.2	2.2	2.6	3.6	1.7	1.0	8.0	0.9	0.3	4.3	12.6	1.4	13.6	1.3	0.5	6.4	4.7	2.3	2.7	3.9	1.2	4.1	4.8	4.2	3.2	3.7	3.4	0.5	12.1	2.1	0.8	3.0	1.6	1.2	0.2	1.1	0.5	0.9	4.4	0.5	0.8	8.8	1.9	0.2	4.2	0.0	0.6	1.8	0.5	1.8	1.0	0.0	0.6	0.0	1.2	0.1	1.4	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.3	1.1	0.0	0.9	2.0	2.6	0.0	0.7	0.8	0.0	1.5	0.0	1.0	0.3	0.0	0.0	0.0	0.1	0.6	0.6	0.0	0.1	0.1	0.0	0.7	8.2	0.0	0.0	1.4	0.2	0.0	0.0	0.0	1.1	0.6	0.9	0.0	2.1	0.1	0.0	5.1	0.0	0.5	0.0	0.7	0.4	1.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.0	1.6	0.2	0.0	0.3	1.8	0.2	0.0	0.0	0.0	0.2	1.0	1.2	0.1	4.3	4.3	2.6	3.6	6.4	4.7	4.1	4.8	12.1	1.9
ENTHD1	FLJ25421	ENSG00000176177	"ENTH domain containing 1"	Q8IYW4	22	39743044-39893864	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 15.8"	"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 6.8"	"Cancer enriched"	"Detected in single"	30	"melanoma: 7.0"	"Region enriched"	"Detected in single"	20	"basal ganglia: 2.0"	"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.5"	"Not detected"	"Not detected"							HPA019800	Uncertain									"HPA019800: AB_1848842"	"unprognostic (5.28e-3)"	"unprognostic (1.27e-1)"	"unprognostic (8.04e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.97e-4)"	"unprognostic (6.02e-2)"		"unprognostic (1.16e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.47e-4)"	"unprognostic (3.60e-2)"	"unprognostic (7.75e-10)"	"unprognostic (3.68e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.06e-1)"	0.0	0.0	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	15.8	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.9	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ENTPD7	"FLJ30978, LALP1"	ENSG00000198018	"Ectonucleoside triphosphate diphosphohydrolase 7"	Q9NQZ7	10	99659506-99706240	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 46.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014351	Uncertain		Approved	Nucleoplasm			24000	Nucleoplasm		"HPA014351: AB_1848183"	"unprognostic (1.82e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.01e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.32e-3)"	"unprognostic (9.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.39e-1)"	3.1	5.6	2.2	5.1	2.1	6.4	2.7	2.4	3.3	4.4	15.7	1.3	11.3	18.6	3.9	5.7	9.1	3.1	9.1	3.2	2.0	1.7	6.0	14.5	4.2	7.1	1.4	1.9	3.2	23.9	3.6	8.6	8.5	1.5	5.6	4.9	3.4	9.0	13.2	1.6	4.4	46.1	5.6	1.4	5.4	5.1	3.5	0.5	2.5	3.5	6.0	6.3	11.4	5.0	0.9	7.7	3.7	2.2	2.7	2.2	1.3	5.1	6.0	8.0	14.7	4.0	4.0	9.6	9.8	20.5	12.8	10.8	10.9	5.9	4.5	5.7	13.2	13.8	6.7	4.0	10.5	1.9	5.3	3.3	4.7	10.0	5.9	11.9	7.8	3.7	6.8	16.1	15.3	12.9	6.4	4.4	5.1	4.6	2.4	2.5	4.7	2.6	0.0	6.1	2.4	14.0	16.9	3.3	6.3	6.8	2.6	8.6	7.1	6.1	8.1	11.1	7.1	7.1	8.2	4.5	7.4	4.1	10.8	3.6	3.0	0.3	2.2	3.7	2.2	2.2	2.0	0.9	0.8	1.8	5.0	0.3	1.4	0.9	2.0	2.7	1.2	7.7	0.6	1.3	2.2	2.1	2.4	3.3	2.0	1.7	1.4	1.9	1.5	0.5
EPB41L4B	EHM2	ENSG00000095203	"Erythrocyte membrane protein band 4.1 like 4B"	Q9H329	9	109171975-109320964	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 28.1;pancreas: 59.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 17.4;hTCEpi: 27.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042862	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA042862: AB_10794534"	"prognostic unfavourable (1.02e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.60e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.82e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.29e-1)"	6.5	4.2	7.3	1.2	14.6	0.0	4.8	4.9	11.4	1.1	18.4	1.5	7.1	15.1	0.7	5.9	0.7	3.2	1.8	3.5	2.9	3.5	1.9	28.1	1.7	0.2	1.6	6.8	4.7	59.8	3.3	0.9	1.1	2.7	2.2	18.7	2.4	8.0	3.5	2.2	5.6	16.1	0.3	2.2	0.2	9.4	2.7	1.3	0.4	14.6	1.3	1.2	1.2	1.3	0.8	0.0	0.1	0.0	0.0	0.0	0.0	4.5	5.7	0.4	0.4	0.4	0.0	17.4	0.6	0.2	2.0	1.0	9.8	4.5	0.0	1.2	0.5	7.5	11.6	6.1	2.1	4.8	2.7	0.0	1.8	13.9	1.2	0.2	0.0	0.1	27.3	0.8	9.4	0.1	0.1	0.0	2.8	11.6	0.2	0.1	7.5	8.5	0.0	0.0	0.3	7.0	6.9	7.2	0.7	1.8	12.1	0.0	2.8	0.0	0.2	4.1	4.2	1.3	1.6	0.0	0.0	0.0	3.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	14.6	4.9	11.4	2.9	3.5	1.6	6.8	2.7	1.3
EPHA6	FLJ35246	ENSG00000080224	"EPH receptor A6"	Q9UF33	3	96814581-97752460	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.9;ovary: 13.2;testis: 15.5"	"Group enriched"	"Detected in some"	6	"HEK 293: 8.0;U-266/70: 24.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA007397, HPA058047"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA007397: AB_2667821, HPA058047: "	"unprognostic (9.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-4)"	"unprognostic (7.21e-5)"	"unprognostic (8.51e-2)"	"unprognostic (1.32e-1)"		"unprognostic (1.82e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.14e-3)"	0.8	0.5	8.7	0.5	9.8	0.3	0.8	27.9	9.9	2.2	5.8	1.1	0.3	0.6	2.2	1.0	2.1	4.2	2.1	1.1	15.4	1.3	1.3	0.5	0.5	0.4	1.1	6.8	13.2	1.4	0.7	0.6	0.5	5.7	2.5	1.8	0.2	0.6	1.7	0.4	0.5	1.1	3.2	0.8	0.4	1.7	15.5	2.8	0.0	4.3	0.0	0.5	2.1	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	8.0	0.0	2.0	0.0	0.0	1.9	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.5	0.0	0.1	0.0	2.1	0.0	0.8	24.3	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	9.8	27.9	9.9	15.4	1.3	1.1	6.8	5.7	2.8
EPHX4	"ABHD7, EPHXRP, FLJ90341"	ENSG00000172031	"Epoxide hydrolase 4"	Q8IUS5	1	92029982-92063536	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 13.3;brain: 20.7"	"Cell line enhanced"	"Detected in some"		"A-431: 9.9;CAPAN-2: 8.6;EFO-21: 17.6;RPTEC TERT1: 24.4;U-251 MG: 7.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 13.3"	"Lineage enriched"	"Detected in single"	24	"T-cells: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035067	Uncertain		Approved	Vesicles				Vesicles		"HPA035067: AB_10601465"	"unprognostic (1.27e-1)"	"unprognostic (4.17e-2)"	"unprognostic (6.76e-3)"	"unprognostic (6.10e-8)"	"prognostic unfavourable (9.43e-4)"	"unprognostic (5.36e-3)"	"unprognostic (2.72e-4)"	"unprognostic (4.85e-2)"	"unprognostic (9.44e-3)"	"unprognostic (7.93e-2)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.36e-6)"	"unprognostic (6.93e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.25e-1)"	1.0	1.3	5.8	1.3	14.1	0.3	3.2	1.7	20.7	2.4	1.0	0.3	0.1	1.6	1.7	1.3	2.1	1.3	1.2	1.2	3.3	2.4	0.9	0.4	1.5	0.7	3.1	9.8	0.6	0.3	0.5	1.3	1.9	4.4	2.2	1.4	1.5	0.4	4.1	0.4	0.6	0.9	2.5	1.1	0.4	0.5	2.6	2.1	0.0	3.9	0.0	0.7	1.9	0.4	0.1	0.0	0.0	0.0	0.5	13.3	1.4	9.9	0.3	1.9	0.0	0.0	0.0	0.5	0.2	3.7	0.3	0.2	0.0	8.6	0.0	17.6	0.0	0.1	0.3	0.8	0.3	0.0	5.3	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.4	0.0	0.0	3.0	0.0	0.0	0.3	0.6	1.4	0.3	1.9	3.5	0.3	0.2	0.0	24.4	1.9	1.2	1.5	6.0	0.0	1.8	0.0	1.4	0.1	0.0	0.0	0.0	7.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.3	0.0	2.3	0.1	1.7	3.3	0.0	0.0	0.4	3.4	0.0	0.5	0.0	0.0	0.0	1.4	5.8	14.1	1.7	20.7	3.3	2.4	3.1	9.8	4.4	2.1
EPN3	"FLJ20778, MGC129899"	ENSG00000049283	"Epsin 3"	Q9H201	17	50532543-50543750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 12.4;HBEC3-KT: 17.2;hTCEpi: 9.7;MCF7: 27.5;RT4: 21.6;SK-BR-3: 11.2;T-47d: 24.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebral cortex: 6.8;pons and medulla: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebellum: 4.7;midbrain: 7.9;pons and medulla: 7.5;thalamus: 10.2"	"HPA055546, HPA063224"	Approved		Supported	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA055546: , HPA063224: "	"unprognostic (1.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.00e-2)"	"prognostic favourable (1.53e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (3.52e-3)"	0.4	7.7	0.5	1.9	0.7	0.4	1.9	1.1	6.8	5.3	7.8	1.5	24.0	5.1	0.7	3.8	26.2	6.0	12.6	6.6	0.5	0.7	10.9	0.4	0.7	0.0	2.0	1.4	10.3	18.3	9.6	0.9	8.4	17.8	9.3	3.4	0.3	16.7	18.7	0.4	19.7	5.1	0.5	0.6	0.3	23.8	2.2	0.0	3.4	1.2	15.9	21.9	8.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.1	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	6.3	5.4	0.0	0.1	0.0	12.4	0.0	17.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	9.7	0.0	1.3	0.0	0.0	0.0	0.0	27.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	21.6	0.2	0.0	0.0	11.2	0.0	24.9	0.1	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	1.1	6.8	0.5	0.7	2.0	1.4	17.8	0.0
EPSTI1	"BRESI1, MGC29634"	ENSG00000133106	"Epithelial stromal interaction 1"	Q96J88	13	42886388-42992271	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 42.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 36.1;BJ hTERT+ SV40 Large T+ RasG12V: 37.8;HDLM-2: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017362	Approved									"HPA017362: AB_1848226"	"unprognostic (2.06e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.55e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (1.02e-5)"	"unprognostic (7.90e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-3)"	"unprognostic (8.13e-2)"	22.4	11.9	3.9	42.2	5.5	18.2	7.1	1.4	3.7	6.5	14.1	5.1	5.9	20.3	7.0	9.7	6.8	5.4	11.2	7.5	3.8	3.9	14.8	7.9	14.6	18.7	5.4	3.9	5.4	2.9	5.1	4.7	18.1	6.4	6.5	6.8	6.6	10.5	16.8	3.0	2.7	22.2	5.8	7.4	28.3	9.2	5.8	4.0	28.5	7.6	4.3	18.0	10.1	5.4	12.7	14.4	19.3	26.8	10.2	26.4	9.7	1.0	0.0	0.0	0.0	0.0	2.0	1.1	0.8	9.6	36.1	37.8	8.4	2.1	1.3	0.3	1.2	4.2	0.0	1.4	4.6	26.6	0.0	4.2	0.0	0.0	8.8	0.0	0.7	6.7	1.9	2.9	0.2	0.5	0.0	6.7	0.9	0.0	6.7	1.0	0.2	0.0	0.0	0.0	12.7	6.0	0.2	0.7	0.0	0.1	0.0	0.6	0.2	0.7	1.4	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.7	0.0	0.3	19.3	16.2	13.0	5.5	26.8	5.7	12.7	11.1	6.0	14.4	10.9	5.3	4.0	7.8	10.2	16.6	1.7	26.4	9.7	3.9	5.5	1.4	3.7	3.8	3.9	5.4	3.9	6.4	4.0
EPYC	"DSPG3, Pg-Lb, SLRR3B"	ENSG00000083782	Epiphycan	Q99645	12	90963679-91005026	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"placenta: 67.1"	"Group enriched"	"Detected in some"	5	"HaCaT: 1.4;U-266/70: 3.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.6"	"Group enriched"	"Detected in many"	5	"amygdala: 3.8;basal ganglia: 3.8;cerebral cortex: 6.2;hippocampal formation: 4.4"	"HPA038212, HPA045455"	Approved				"Secreted to extracellular matrix"					"HPA038212: AB_10672739, HPA045455: "	"unprognostic (2.25e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.28e-2)"		"unprognostic (1.81e-2)"		"unprognostic (4.07e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.23e-1)"	"prognostic unfavourable (1.85e-4)"	"unprognostic (2.77e-2)"	"unprognostic (6.44e-9)"	"unprognostic (2.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.20e-1)"	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.4	0.1	0.2	0.4	0.5	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	2.5	0.0	0.0	0.0	67.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	3.9	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EQTN	"AFAF, C9orf11, equatorin, SPACA8"	ENSG00000120160	Equatorin	Q9NQ60	9	27284659-27297139	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	54	"testis: 39.9"	"Cell line enhanced"	"Detected in some"		"AF22: 1.0;BEWO: 2.2;HaCaT: 1.2;HAP1: 1.3;HSkMC: 1.8;K-562: 1.3;RT4: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015089, HPA015504"	Enhanced				"Intracellular and membrane"					"HPA015089: AB_1845795, HPA015504: AB_2067598"	"unprognostic (7.83e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.12e-3)"	"unprognostic (1.34e-3)"	"unprognostic (4.41e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.67e-2)"		"unprognostic (1.14e-1)"	"unprognostic (4.59e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.42e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.4	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.4	0.1	0.1	39.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.2	1.3	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	1.1	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.2	0.1	0.2	0.2
ERI2	"EXOD1, KIAA1504, MGC16943, ZGRF5"	ENSG00000196678	"ERI1 exoribonuclease family member 2"	A8K979	16	20780193-20900349	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"basophil: 11.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.8"	"Low region specificity"	"Detected in all"							"HPA035384, HPA035385"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA035384: AB_10602316, HPA035385: "	"unprognostic (1.25e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.01e-3)"	"unprognostic (4.36e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.28e-3)"	18.5	14.3	9.2	7.5	10.4	8.5	15.0	7.8	11.9	8.3	11.2	12.0	9.3	12.2	8.2	12.1	12.4	9.1	8.9	8.4	9.0	7.9	12.7	19.4	8.2	5.3	11.7	7.4	9.9	14.4	19.2	14.9	10.1	11.1	12.0	15.7	8.1	10.3	11.0	7.0	10.7	12.1	11.8	12.2	6.4	12.7	21.3	9.7	10.8	9.7	12.1	6.6	9.6	15.1	0.6	2.4	11.8	2.9	0.7	0.9	0.6	10.8	5.2	14.3	6.2	4.4	5.6	8.6	8.5	5.1	7.8	9.9	6.5	11.3	3.0	9.9	4.7	8.2	14.2	8.9	14.6	9.6	7.5	7.4	6.1	11.2	4.0	14.1	6.2	5.1	11.1	10.5	8.8	4.7	23.3	9.0	13.1	9.6	2.0	12.6	8.8	2.9	16.2	11.7	6.7	7.2	8.5	7.3	8.9	5.5	10.6	6.5	22.2	15.7	3.5	8.4	4.7	8.1	11.4	5.5	8.4	1.8	7.9	11.5	11.5	11.8	2.3	2.0	0.6	1.7	0.4	0.6	0.5	0.6	2.4	0.1	0.4	0.3	0.1	0.7	2.9	0.8	0.9	0.6	9.2	10.4	7.8	11.9	9.0	7.9	11.7	7.4	11.1	9.7
ERICH3	"C1orf173, DKFZp547I048, RP11-653A5.1"	ENSG00000178965	"Glutamate rich 3"	Q5RHP9	1	74568111-74673738	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.5;fallopian tube: 21.1;testis: 26.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.2;SCLC-21H: 3.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA028655, HPA072916"	Approved									"HPA028655: AB_10961002, HPA072916: "	"unprognostic (4.49e-4)"	"unprognostic (1.02e-2)"		"prognostic favourable (1.56e-5)"	"unprognostic (1.71e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.83e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-4)"	"unprognostic (9.21e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.90e-2)"	0.4	3.5	12.7	0.5	10.7	0.4	1.4	7.0	14.5	7.6	0.5	0.5	0.0	0.5	1.7	3.0	0.4	21.1	0.5	0.5	12.0	4.2	0.5	0.6	3.7	0.7	1.0	10.3	1.2	0.4	0.4	6.3	0.5	2.4	0.5	0.6	0.0	0.7	0.5	0.4	0.5	0.5	0.5	0.7	0.6	0.6	26.4	1.6	0.0	0.5	0.0	0.7	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.0	3.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	10.7	7.0	12.0	12.0	4.2	1.0	10.3	2.4	1.6
ERICH5	"C8orf47, FLJ39553"	ENSG00000177459	"Glutamate rich 5"	Q6P6B1	8	98064311-98093610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 27.9;retina: 26.7"	"Cell line enhanced"	"Detected in some"		"A549: 6.8;EFO-21: 5.2;HAP1: 6.3;HEK 293: 9.1;RPTEC TERT1: 6.1;RT4: 15.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 23.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	9	"myeloid DC: 5.3"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA025070, HPA025293, HPA027233"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780"	"unprognostic (2.88e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.73e-1)"	"prognostic favourable (3.76e-4)"	"unprognostic (4.36e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.17e-2)"	"prognostic favourable (9.38e-4)"	0.5	0.2	2.3	0.2	6.7	0.0	0.8	0.4	2.2	2.0	3.3	0.1	3.6	4.3	1.1	0.6	0.7	8.8	13.1	5.4	0.7	2.6	8.7	8.1	1.7	0.7	1.0	2.2	1.6	27.9	0.6	1.7	4.1	1.9	2.2	3.0	26.7	1.3	1.9	0.1	0.6	1.3	0.4	1.0	0.2	9.5	3.4	0.5	0.3	0.6	0.0	0.5	3.1	0.5	0.0	5.3	0.0	0.0	0.0	0.5	0.0	0.0	6.8	0.0	0.0	0.1	0.0	4.0	3.6	1.3	1.9	1.4	0.1	2.0	0.0	5.2	0.9	0.3	6.3	0.1	2.3	0.0	9.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.8	1.4	2.7	0.0	0.0	0.1	6.1	15.9	3.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.3	6.7	0.4	2.2	0.7	2.6	1.0	2.2	1.9	0.5
ERICH6	"C3orf44, ERICH6A, FAM194A, MGC39662"	ENSG00000163645	"Glutamate rich 6"	Q7L0X2	3	150659885-150703971	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 35.4"	"Cell line enhanced"	"Detected in some"		"A549: 3.6;SH-SY5Y: 3.9;U-266/70: 4.0;U-266/84: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA048373	Enhanced									"HPA048373: "	"unprognostic (7.38e-2)"	"unprognostic (3.89e-3)"	"unprognostic (7.02e-3)"	"unprognostic (2.52e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.44e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.16e-2)"	0.4	0.4	0.4	0.2	1.8	0.3	0.3	0.4	1.5	0.3	0.3	0.4	0.1	0.6	0.5	1.9	0.3	0.4	0.8	0.4	0.7	0.4	0.8	0.3	0.3	0.6	0.3	0.6	0.5	0.5	0.0	3.9	0.4	0.5	0.5	0.1	0.3	0.3	0.5	0.2	0.3	0.4	0.4	0.3	0.4	0.4	35.4	0.6	0.0	1.3	0.0	0.2	0.4	0.3	2.6	3.5	0.1	0.1	5.9	8.0	2.0	0.1	3.6	0.2	1.5	0.0	0.0	0.0	0.3	0.0	0.3	0.5	1.6	1.5	0.0	2.2	0.0	0.2	0.0	0.0	0.2	1.6	1.2	1.0	0.6	0.1	0.0	0.0	0.1	0.2	0.0	0.9	0.0	0.0	0.0	2.5	0.0	0.6	0.9	0.0	0.9	0.0	1.0	0.9	0.0	0.1	0.8	1.8	3.9	0.0	0.3	0.0	0.9	1.2	0.1	0.6	1.4	1.5	0.2	4.0	6.2	0.7	0.7	0.1	0.0	0.0	0.1	0.1	4.1	0.0	8.0	2.6	2.6	3.1	0.1	2.3	3.5	3.6	0.1	5.9	0.1	3.5	2.5	2.0	0.4	1.8	0.4	1.5	0.7	0.4	0.3	0.6	0.5	0.6
ERICH6B	"FAM194B, FLJ32682"	ENSG00000165837	"Glutamate rich 6B"	Q5W0A0	13	45534522-45615739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	55	"testis: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043559	Uncertain									"HPA043559: "	"unprognostic (6.77e-3)"	"unprognostic (3.52e-3)"	"unprognostic (3.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.98e-3)"	"unprognostic (7.27e-3)"	"unprognostic (9.81e-2)"	"unprognostic (3.05e-3)"	"unprognostic (3.37e-3)"	"unprognostic (5.70e-8)"	"unprognostic (4.42e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.74e-2)"	"unprognostic (7.89e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ERMN	"ERMIN, JN, KIAA1189"	ENSG00000136541	Ermin	Q8TAM6	2	157318625-157327713	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 106.7"	"Cell line enriched"	"Detected in some"	6	"HAP1: 20.8"	"Group enriched"	"Detected in some"	12	"endometrial cancer: 2.2;glioma: 9.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038295, HPA038296"	Enhanced		Approved	"Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"		"HPA038295: AB_10805353, HPA038296: AB_10796217"	"unprognostic (7.89e-2)"	"unprognostic (9.06e-3)"	"unprognostic (2.71e-2)"	"prognostic favourable (6.93e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.02e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.84e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.97e-3)"	"unprognostic (5.76e-2)"	1.6	1.4	29.1	2.9	50.5	9.7	1.6	2.7	106.7	1.4	1.8	52.4	0.0	1.8	1.6	1.5	1.7	1.4	1.9	1.6	40.9	21.4	1.5	1.5	2.0	3.1	75.1	18.4	1.5	1.6	1.4	0.1	1.4	54.5	1.5	1.9	4.3	2.4	1.5	1.7	1.9	1.9	1.6	100.9	2.5	2.2	1.7	69.5	0.0	1.6	0.0	2.7	1.7	0.1	1.7	1.3	3.9	1.6	2.4	2.1	0.7	0.1	0.3	0.3	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.2	1.2	0.0	1.9	0.3	20.8	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.0	0.2	2.8	0.4	0.2	0.7	2.3	0.3	0.5	0.0	0.4	0.5	0.0	1.0	0.4	0.6	0.0	0.1	0.0	0.7	1.2	0.0	0.2	0.1	0.2	0.6	3.4	1.9	0.5	1.8	0.9	1.0	2.6	1.6	1.1	2.1	1.2	1.0	0.7	0.8	0.6	0.6	1.7	1.5	1.6	3.9	2.4	1.0	1.3	0.9	0.7	29.1	50.5	2.7	27.9	40.9	21.4	75.1	18.4	54.5	69.5
ERV3-1	"envR, ERV-R, ERV3, H-PLK, HERV-R"	ENSG00000213462	"Endogenous retrovirus group 3 member 1, envelope"	Q14264	7	64990809-65006743	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 10.1;monocytes: 2.5"									"HPA017209, HPA046508"	Enhanced		Approved	Vesicles				Vesicles		"HPA017209: , HPA046508: "	"unprognostic (2.74e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.03e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.88e-2)"	27.2	41.3	9.9	9.0	11.7	8.6	18.3	13.8	11.6	9.4	7.1	8.7	5.6	3.9	11.2	31.9	18.9	9.0	17.9	8.4	10.1	7.2	7.3	4.0	10.7	5.6	11.2	9.2	10.6	7.6	9.6	19.3	21.2	11.7	8.1	6.5	9.3	14.9	13.1	5.1	14.2	5.8	8.5	13.2	7.0	6.9	9.4	12.7	12.6	10.2	6.2	10.2	10.5	13.8	0.9	1.2	10.1	2.5	1.4	1.5	1.1	2.1	0.7	12.8	19.5	8.0	3.3	8.6	4.0	4.5	1.4	3.3	0.7	14.2	3.5	3.8	1.5	2.5	1.7	0.9	2.2	2.6	0.9	1.9	0.6	6.8	0.6	5.2	2.6	3.9	1.1	1.3	0.3	8.2	8.4	7.0	5.3	5.4	3.3	3.2	3.6	0.8	7.7	0.5	2.5	2.2	4.4	2.4	12.3	4.4	1.3	0.4	3.2	11.6	6.6	4.9	0.6	3.6	2.0	2.2	5.1	1.1	3.9	15.2	2.9	0.1	1.5	3.4	0.9	2.5	0.8	0.7	0.2	0.7	1.2	0.9	0.6	0.6	10.1	1.4	0.8	0.7	1.5	1.1	9.9	11.7	13.8	11.6	10.1	7.2	11.2	9.2	11.7	12.7
ESPNL	FLJ42568	ENSG00000144488	"Espin like"	Q6ZVH7	2	238100157-238133287	"Predicted intracellular proteins"	Hearing	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.9;pituitary gland: 8.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.6;Daudi: 5.0;fHDF/TERT166: 4.6;HHSteC: 5.3;THP-1: 3.6;U-87 MG: 4.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	5	"cerebellum: 9.9"	"Cell type enriched"	"Detected in single"	5	"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"B-cells: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055103	Uncertain									"HPA055103: "	"unprognostic (8.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.94e-6)"	"unprognostic (3.49e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.67e-2)"	0.6	0.5	0.3	6.0	0.3	0.0	0.6	9.9	0.6	1.2	1.1	0.6	0.3	1.4	1.5	0.3	0.8	2.8	0.3	1.3	0.3	0.0	1.1	3.5	0.7	2.6	0.3	0.3	4.0	1.3	0.0	8.2	0.3	2.0	1.5	0.2	0.6	2.0	3.5	0.3	0.1	4.9	1.6	0.3	3.8	0.8	0.4	0.8	0.3	2.0	0.3	2.8	0.4	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.7	1.4	0.6	1.9	1.0	1.6	1.8	0.0	0.0	5.0	2.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.9	1.8	5.3	0.0	1.1	1.9	0.0	0.2	0.0	0.0	1.7	0.0	2.0	0.0	0.0	2.2	0.3	0.0	1.6	0.2	0.7	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.2	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	9.9	0.6	0.3	0.0	0.3	0.3	2.0	0.8
EVA1C	"B18, B19, C21orf63, C21orf64, FAM176C, PRED34"	ENSG00000166979	"Eva-1 homolog C"	P58658	21	32412006-32515397	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 13.1;CAPAN-2: 13.2;HBEC3-KT: 9.4;hTCEpi: 10.5;HUVEC TERT2: 10.2;SK-MEL-30: 11.4;U-87 MG: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"granulocytes: 1.8;NK-cells: 3.8;T-cells: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015720, HPA029944, CAB034174"	Enhanced									"CAB034174: AB_1564317, HPA015720: AB_1845705, HPA029944: AB_10601092"	"unprognostic (7.55e-3)"	"unprognostic (8.91e-3)"	"unprognostic (5.51e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.16e-2)"	"prognostic favourable (5.06e-4)"	"unprognostic (1.40e-3)"	"unprognostic (4.24e-3)"	"unprognostic (3.39e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.25e-3)"	17.1	3.9	5.0	4.5	11.9	1.7	28.1	5.0	7.9	11.9	9.3	12.2	19.5	2.6	18.8	12.8	13.1	23.9	14.3	12.6	4.8	4.2	5.1	2.6	14.3	8.0	9.4	4.1	12.0	5.9	7.5	6.7	8.3	9.8	16.4	3.5	7.4	11.8	25.8	5.8	14.2	5.3	17.2	7.2	5.3	8.2	10.5	8.5	0.5	9.1	10.5	10.7	14.2	14.9	0.0	0.1	1.8	0.5	3.8	5.2	1.8	0.0	13.1	0.1	0.5	2.9	1.9	0.3	2.8	0.5	0.9	0.2	0.0	13.2	0.1	0.2	0.1	0.0	0.5	9.4	0.2	1.4	0.0	0.0	6.2	0.4	3.5	0.0	0.0	0.9	10.5	1.9	7.3	10.2	0.0	0.0	0.5	0.0	0.0	0.0	0.5	2.9	0.0	0.3	0.0	0.3	0.2	3.9	0.6	8.3	0.7	11.4	0.4	0.0	9.2	1.2	0.3	1.6	0.6	0.2	0.0	0.1	11.3	0.1	2.9	1.8	0.0	0.0	4.6	0.2	5.2	0.0	4.9	4.5	0.1	0.0	1.0	2.5	0.0	3.8	0.5	0.0	0.6	1.8	5.0	11.9	5.0	7.9	4.8	4.2	9.4	4.1	9.8	8.5
EVI2A	"EVDA, EVI2"	ENSG00000126860	"Ecotropic viral integration site 2A"	P22794	17	31317560-31321884	"Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.7;brain: 74.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 19.8;Karpas-707: 32.7;RPMI-8226: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA045033, HPA057051"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA045033: , HPA057051: "	"unprognostic (7.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.39e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (7.55e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (2.63e-6)"	"unprognostic (7.64e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.90e-2)"	6.4	4.7	26.8	25.8	36.0	15.1	4.7	3.8	30.0	5.2	6.2	16.5	0.0	6.3	2.2	1.6	3.5	2.1	10.6	2.6	42.5	21.8	2.2	5.3	12.5	27.4	64.7	13.9	1.6	1.6	1.0	1.6	11.6	33.7	2.4	8.2	0.0	3.0	2.0	1.2	1.5	6.8	4.1	74.0	20.4	6.9	1.2	59.7	32.1	2.0	0.6	22.6	14.2	2.2	8.6	17.9	51.7	26.5	8.9	19.2	23.9	0.0	0.0	0.0	0.0	1.6	10.4	0.0	1.3	2.2	1.7	6.0	0.0	0.4	8.8	0.0	1.7	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	19.8	10.2	11.1	12.8	0.0	2.4	6.8	0.6	0.3	32.7	12.9	0.1	7.3	11.2	0.0	0.0	7.6	1.3	50.6	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	11.1	4.2	7.2	0.2	0.3	4.7	14.8	0.0	9.9	5.8	7.4	5.9	1.3	26.5	1.0	11.3	12.7	13.7	8.6	16.1	13.1	17.9	4.2	19.2	16.8	51.7	8.9	9.6	5.9	17.1	23.9	26.8	36.0	3.8	24.0	42.5	21.8	64.7	13.9	33.7	59.7
EVPLL		ENSG00000214860	"Envoplakin like"	A8MZ36	17	18377662-18389647	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 22.2;lymphoid tissue: 10.4"	"Cell line enhanced"	"Detected in some"		"A-431: 1.9;HeLa: 3.2;hTCEpi: 11.3;RT4: 3.9;SiHa: 2.1;T-47d: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045728	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA045728: AB_10960394"	"unprognostic (1.34e-1)"	"unprognostic (4.88e-2)"				"unprognostic (2.06e-5)"	"unprognostic (1.58e-1)"	"unprognostic (2.08e-2)"		"unprognostic (1.64e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.62e-1)"	"unprognostic (4.60e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.06e-2)"	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	3.3	0.5	0.0	0.7	0.4	0.8	0.9	22.2	0.4	0.8	0.0	0.0	0.0	0.9	2.0	1.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	1.7	0.2	0.0	2.1	3.1	0.1	7.8	0.4	1.4	0.0	0.1	1.7	2.5	0.0	0.1	2.2	9.5	10.4	3.5	7.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.5	0.0	2.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EVX1		ENSG00000106038	"Even-skipped homeobox 1"	P49640	7	27242700-27250493	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 6.5;prostate: 6.4;seminal vesicle: 6.7;urinary bladder: 8.9"	"Cell line enriched"	"Detected in some"	12	"RT4: 17.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	26	"pons and medulla: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"midbrain: 1.0;pons and medulla: 1.0"	"Region enriched"	"Detected in single"	9	"pons and medulla: 1.1"	HPA055132			Approved	Nucleoplasm				Nucleoplasm		"HPA055132: "	"unprognostic (2.73e-2)"	"unprognostic (3.59e-1)"	"unprognostic (4.31e-1)"		"unprognostic (5.16e-2)"		"unprognostic (1.76e-3)"	"unprognostic (2.08e-2)"			"unprognostic (8.48e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.26e-8)"	"unprognostic (2.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.83e-2)"	0.1	6.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	4.2	0.6	0.1	0.1	0.0	0.9	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.5	3.0	6.4	0.7	0.1	0.1	6.7	0.1	0.0	0.1	1.9	0.1	0.1	0.0	1.7	0.1	0.1	0.1	0.1	0.1	8.9	5.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	3.0	0.1
EVX2		ENSG00000174279	"Even-skipped homeobox 2"	Q03828	2	176077472-176083913	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 3.4;prostate: 3.8;seminal vesicle: 5.0;testis: 6.1;vagina: 2.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.4;SCLC-21H: 1.5;SH-SY5Y: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"midbrain: 1.6;pons and medulla: 1.2"	"Region enriched"	"Detected in single"	7	"pons and medulla: 0.8"	HPA041576	Uncertain									"HPA041576: AB_10796347"		"unprognostic (2.27e-1)"	"unprognostic (1.68e-3)"		"unprognostic (1.83e-1)"				"unprognostic (3.41e-1)"	"unprognostic (5.75e-1)"		"unprognostic (3.13e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.32e-1)"		"unprognostic (4.93e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.9			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		3.8	1.8		0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1			0.0		0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.8	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
EXD3	"FLJ20433, LOC54932, mut-7"	ENSG00000187609	"Exonuclease 3'-5' domain containing 3"	Q8N9H8	9	137306896-137423262	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA047395	Approved		Approved	"Actin filaments,Focal adhesion sites"				"Focal adhesion sites"	"Actin filaments"	"HPA047395: AB_10962864"	"unprognostic (2.91e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.75e-3)"	"prognostic favourable (4.30e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.72e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.99e-3)"	"unprognostic (2.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (5.05e-2)"	9.7	10.9	8.0	10.1	11.1	8.4	10.4	11.9	12.4	11.2	15.5	16.5	14.9	22.8	10.2	17.5	11.1	11.5	14.1	10.5	8.7	7.9	11.8	7.3	12.3	8.0	9.5	11.2	11.1	13.3	8.3	13.8	8.3	11.0	14.0	8.9	13.9	17.5	11.4	15.9	17.4	20.6	15.8	7.4	16.3	14.3	5.1	9.1	1.7	11.4	6.8	7.8	10.0	10.8	4.0	5.3	10.8	6.0	5.3	8.5	3.6	5.7	4.9	2.4	6.8	2.0	3.0	5.7	2.8	3.3	2.5	3.9	3.3	12.3	2.5	7.9	2.1	10.7	0.7	3.1	0.8	5.8	5.9	2.0	8.7	5.1	6.2	1.4	21.5	3.4	4.3	2.2	1.9	8.6	4.7	4.6	2.1	15.4	0.1	4.9	2.8	3.4	4.4	2.0	17.2	5.1	3.3	3.3	5.9	2.8	6.0	2.7	9.7	6.4	10.7	3.5	3.4	5.5	4.3	6.1	2.7	2.1	6.7	4.5	6.6	10.8	5.0	10.6	3.5	6.0	4.0	3.9	6.0	3.3	5.3	4.0	4.8	3.7	1.2	5.3	5.8	3.4	8.5	3.6	8.0	11.1	11.9	12.4	8.7	7.9	9.5	11.2	11.0	9.1
EXOC3L1	"EXOC3L, FLJ35539, FLJ35587"	ENSG00000179044	"Exocyst complex component 3 like 1"	Q86VI1	16	67184366-67190204	"Predicted intracellular proteins"	Exocytosis			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;HUVEC TERT2: 5.8;SCLC-21H: 11.0;TIME: 3.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.8;non-classical monocyte: 2.0"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA029574	Uncertain		Approved	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA029574: AB_10602495"	"unprognostic (1.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.48e-3)"	"unprognostic (2.88e-1)"	"unprognostic (6.64e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.35e-1)"	4.5	2.4	0.3	1.8	0.9	0.0	2.4	0.4	1.2	1.4	0.6	0.3	0.3	0.8	3.6	0.8	1.2	0.9	1.5	4.5	1.3	0.2	3.3	1.4	8.7	1.8	0.3	0.8	2.0	1.0	0.4	1.1	6.0	1.0	1.6	0.3	2.4	1.1	0.5	1.8	0.7	1.0	0.8	1.0	26.6	0.7	1.0	0.3	0.3	4.1	1.0	0.5	1.0	0.5	0.0	0.7	1.8	2.0	0.0	0.0	0.3	0.2	0.1	1.2	0.4	0.0	0.1	3.1	0.4	0.0	0.0	0.0	1.4	0.3	0.1	1.7	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.7	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.8	0.5	0.0	0.1	0.2	0.3	0.1	0.5	0.6	1.3	1.2	0.2	0.0	0.2	11.0	1.3	1.4	0.3	0.1	1.0	0.1	3.9	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.8	0.0	0.3	0.0	1.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.8	0.0	2.0	0.0	0.0	0.3	0.3	0.9	0.4	1.2	1.3	0.2	0.3	0.8	1.0	0.3
EXOC3L2	"FLJ36147, XTP7"	ENSG00000283632	"Exocyst complex component 3 like 2"	Q2M3D2	19	45212621-45245431	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HEL: 17.8;K-562: 16.4"									"Group enriched"	"Detected in some"	4	"basophil: 1.6;neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.5"									"HPA041595, HPA061110"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"				Vesicles	"Nucleoplasm, Golgi apparatus, Cytosol"	"HPA041595: AB_10794521, HPA061110: "																		3.2	4.3	0.0	2.0	0.0	0.9	3.0	0.0	0.3	3.6	2.1	0.1	2.4	2.3	14.5	1.2	2.3	0.6	6.9	1.9	0.0		12.7	9.4	3.4	6.3	0.0	0.0	3.4	2.8	2.4	3.5	0.4	0.0	3.7	0.2	13.7	3.3	3.6	1.0	2.4	3.9	1.6	0.0	12.6	2.4	2.1	0.0	0.0	4.6	1.5	3.2	1.6	3.3	0.5	0.3	2.5	0.4	0.2	0.4	0.2	0.1	0.3	2.3	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.1	2.1	0.0	1.1	0.0	0.1	0.0	0.1	0.0	17.8	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	16.4	0.3	0.0	0.2	0.0	0.0	0.2	0.5	1.2	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.3	0.4	0.8	1.6	0.3	0.1	0.2	0.1	0.0	0.1	0.2	0.1	1.6	0.4	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.3	2.5	0.2	0.3	0.3	0.1	0.2										
EXTL1	"EXTL, MGC70794"	ENSG00000158008	"Exostosin like glycosyltransferase 1"	Q92935	1	26019884-26036464	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.1;heart muscle: 6.0;skeletal muscle: 20.5"	"Cell line enriched"	"Detected in some"	10	"WM-115: 57.4"	"Cancer enriched"	"Detected in some"	13	"melanoma: 21.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA037749	Approved				"Intracellular and membrane"		68000			"HPA037749: AB_10805350"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-2)"	0.6	2.1	15.3	0.6	9.5	0.5	2.0	1.1	21.1	1.3	0.6	1.4	0.0	0.7	2.5	0.7	1.5	1.7	1.2	6.0	12.7	3.7	0.7	0.5	0.7	0.8	3.7	7.9	2.3	1.0	0.5	0.5	1.0	2.9	1.2	0.6	2.7	0.8	0.9	20.5	1.6	0.7	2.9	2.7	2.2	0.6	1.0	0.8	0.0	0.9	3.2	0.6	0.9	0.2	0.1	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	57.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.1	15.3	9.5	1.1	21.1	12.7	3.7	3.7	7.9	2.9	0.8
FABP12		ENSG00000197416	"Fatty acid binding protein 12"	A6NFH5	8	81524981-81531378	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 6.7;testis: 13.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.2;RT4: 1.1"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA044041	Enhanced									"HPA044041: AB_10962213"		"unprognostic (1.18e-1)"			"unprognostic (7.31e-3)"	"unprognostic (3.07e-1)"									"unprognostic (2.63e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0			0.8	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0		0.0	0.0	0.0	0.5	0.0		0.0	0.0		0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2			0.0		0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FADS3	"CYB5RP, LLCDL3"	ENSG00000221968	"Fatty acid desaturase 3"	Q9Y5Q0	11	61873519-61892051	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 63.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 62.2;HHSteC: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.9;naive B-cell: 10.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045224	Approved		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA045224: AB_10967570"	"unprognostic (4.69e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.91e-2)"	"prognostic unfavourable (9.54e-5)"	"unprognostic (1.76e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (1.50e-9)"	"unprognostic (1.14e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.37e-1)"	63.1	25.9	15.7	17.5	17.9	4.1	23.5	8.7	16.5	9.3	8.3	13.8	5.9	4.3	9.8	25.4	7.4	9.0	9.9	22.7	14.4	11.6	16.6	8.5	16.3	15.4	16.9	10.0	12.7	12.1	12.4	5.0	48.2	15.1	7.1	4.4	16.8	5.5	11.3	15.7	4.2	9.0	14.9	13.3	9.7	8.3	6.0	15.6	1.1	6.1	7.3	15.7	10.4	9.9	10.6	0.7	5.7	1.2	0.6	2.4	0.7	7.6	2.4	0.7	4.8	62.2	12.6	15.5	15.5	37.8	16.6	16.1	3.4	2.8	5.7	10.1	30.8	4.2	2.9	42.1	8.8	1.6	1.6	4.7	10.1	6.7	53.9	0.4	0.9	13.8	18.3	19.9	38.1	19.1	4.5	10.8	28.2	8.8	1.7	2.3	2.2	6.3	9.6	30.7	15.8	18.5	2.7	1.2	1.5	17.7	2.4	15.7	3.4	1.0	12.9	16.2	11.2	4.7	6.7	3.3	1.6	6.8	13.5	2.3	11.7	0.0	0.7	5.7	1.8	1.2	1.6	8.9	1.6	2.4	0.7	10.6	0.1	0.6	0.3	0.6	0.8	0.0	0.4	0.7	15.7	17.9	8.7	15.4	14.4	11.6	16.9	10.0	15.1	15.6
FAM105A	"FLJ11127, NET20"	ENSG00000145569	"Family with sequence similarity 105 member A"	Q9NUU6	5	14581775-14615007	"Enzymes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 13.8;HMC-1: 43.3;THP-1: 12.0;U-937: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046638	Uncertain		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA046638: "	"unprognostic (1.47e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.42e-1)"	"prognostic favourable (1.02e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.38e-2)"	"prognostic unfavourable (7.62e-4)"	"unprognostic (3.14e-1)"	"unprognostic (8.79e-3)"	5.1	3.5	4.0	7.9	4.9	35.4	5.2	3.1	5.1	6.3	15.4	9.0	4.5	8.3	3.0	5.6	2.9	3.1	4.1	3.0	3.9	4.3	5.2	1.9	28.8	16.7	6.1	3.8	4.0	13.3	1.9	8.7	6.7	7.9	12.6	17.3	10.3	3.1	13.5	1.3	2.6	13.7	3.3	10.8	13.2	5.4	4.4	4.1	3.5	27.2	3.0	6.2	7.1	5.8	0.1	26.7	6.9	26.2	14.1	9.6	16.2	0.0	0.6	1.2	0.0	0.2	0.0	5.2	1.5	1.4	0.4	0.7	1.9	1.3	0.0	0.8	0.7	0.1	2.6	1.2	0.6	0.8	3.6	3.4	13.8	0.3	1.3	0.0	43.3	0.1	0.3	0.2	0.0	0.0	0.0	5.4	0.1	1.0	0.0	1.2	1.9	9.2	0.3	0.5	1.5	0.0	10.4	4.5	5.0	0.7	0.4	0.0	0.4	12.0	0.0	0.6	3.4	0.2	1.1	0.0	0.0	0.0	0.7	20.5	0.2	0.0	26.2	0.1	4.5	12.4	6.0	0.1	5.7	6.1	26.7	0.1	7.8	7.5	6.9	14.1	9.4	19.7	9.6	16.2	4.0	4.9	3.1	5.1	3.9	4.3	6.1	3.8	7.9	4.1
FAM110D	"FLJ14050, GRRP1"	ENSG00000197245	"Family with sequence similarity 110 member D"	Q8TAY7	1	26159020-26163962	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"TIME: 4.0;U-2 OS: 4.9;U-937: 3.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA013664	Approved									"HPA013664: AB_1848712"	"unprognostic (7.53e-2)"	"unprognostic (4.45e-3)"	"unprognostic (4.80e-4)"	"unprognostic (1.84e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.16e-3)"	"unprognostic (7.67e-5)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.29e-3)"	"unprognostic (6.63e-2)"	"unprognostic (9.87e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.96e-1)"	17.2	2.2	2.8	2.5	5.4	2.4	14.2	1.2	3.3	10.4	3.8	1.1	3.7	3.3	12.5	5.0	8.6	10.9	6.5	11.6	3.5	2.3	6.3	1.3	8.8	2.9	4.5	0.0	4.8	6.6	3.6	3.7	2.2	5.6	6.9	2.2	4.6	7.9	3.5	9.4	5.3	4.2	8.7	3.4	1.6	4.9	3.3	2.4	0.1	6.9	10.4	2.5	4.2	14.5	1.2	0.9	4.4	0.9	1.6	0.8	0.2	0.4	0.5	1.5	1.0	0.0	0.0	0.7	0.2	0.1	0.3	0.5	0.3	1.0	1.9	1.9	0.0	0.3	0.6	0.6	0.1	0.6	0.4	0.4	0.9	1.1	0.3	0.5	0.1	0.6	0.4	0.2	0.3	2.1	0.3	0.8	0.3	0.5	0.7	0.4	1.7	0.1	0.3	0.1	0.4	0.1	0.4	1.6	1.5	0.3	0.1	0.2	0.6	0.7	4.0	0.2	4.9	0.4	0.1	0.1	0.5	0.4	0.0	3.0	0.3	3.8	0.9	0.9	0.8	0.5	0.5	0.7	0.6	0.5	0.3	1.2	0.7	0.7	4.4	1.6	0.7	0.9	0.3	0.2	2.8	5.4	1.2	3.3	3.5	2.3	4.5	0.0	5.6	2.4
FAM120AOS	C9orf10OS	ENSG00000188938	"Family with sequence similarity 120A opposite strand"	Q5T036	9	93446494-93453592	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA021475	Approved									"HPA021475: "	"unprognostic (1.20e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.10e-2)"	"unprognostic (8.07e-2)"	"prognostic unfavourable (2.95e-5)"	"unprognostic (3.10e-1)"	"unprognostic (3.42e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.93e-1)"	"prognostic favourable (6.04e-4)"	"unprognostic (2.33e-1)"	"unprognostic (7.91e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.42e-1)"	18.2	18.4	20.5	18.4	19.7	9.5	22.4	12.5	23.1	17.0	22.5	20.0	19.4	13.1	17.3	34.8	17.4	15.6	17.9	21.8	16.9	17.8	20.4	16.9	16.1	13.9	18.0	15.5	19.3	23.8	29.3	32.1	48.4	18.4	23.7	23.6	28.1	17.5	20.1	18.2	18.0	20.6	19.2	17.8	14.9	21.7	9.1	13.2	21.9	27.6	11.1	18.5	19.4	22.8	15.0	11.1	12.6	14.2	10.6	11.7	6.1	16.3	15.1	10.9	11.8	15.9	7.0	17.5	10.4	11.0	11.5	8.9	11.3	13.2	14.3	13.2	11.5	21.0	11.2	10.8	10.7	22.9	8.9	14.5	14.3	12.7	16.0	11.9	9.3	8.8	15.2	10.9	18.5	12.4	15.0	20.4	10.8	38.4	15.3	5.7	15.0	16.8	12.9	14.9	14.2	15.6	14.8	23.3	11.2	15.3	16.6	15.0	17.8	9.1	8.1	7.2	11.4	24.8	14.3	14.8	19.3	6.1	11.7	7.5	14.7	10.8	12.3	7.8	6.5	11.9	8.5	15.0	9.8	8.6	10.1	11.0	11.7	9.0	12.6	10.6	14.2	11.1	9.2	6.1	20.5	19.7	12.5	23.1	16.9	17.8	18.0	15.5	18.4	13.2
FAM122C	RP3-473B4.1	ENSG00000156500	"Family with sequence similarity 122C"	Q6P4D5	X	134796395-134854835	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 15.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA059961	Approved		Uncertain	Nucleoplasm				Nucleoplasm		"HPA059961: "	"unprognostic (1.32e-2)"	"unprognostic (3.50e-2)"	"unprognostic (7.63e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.50e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.16e-3)"	4.2	3.8	4.1	4.7	6.0	8.7	4.1	2.9	5.0	4.6	3.8	7.9	3.8	1.8	11.5	4.2	3.5	4.7	3.4	3.9	4.0	4.2	3.6	3.2	5.6	7.1	6.3	4.6	22.0	2.1	2.9	5.5	2.9	5.3	4.4	3.2	11.5	6.6	3.2	2.9	3.3	4.0	7.9	6.2	6.4	4.7	12.0	5.2	9.1	3.8	2.1	6.5	5.9	3.5	4.8	7.0	7.3	5.8	4.5	3.8	2.1	1.1	1.5	4.6	4.6	1.2	1.8	2.7	3.9	3.4	3.5	4.9	3.3	4.6	1.6	5.9	1.7	1.7	3.8	1.4	2.5	3.9	1.5	2.7	15.4	1.4	1.4	4.0	2.4	1.9	0.7	3.4	2.2	2.9	11.3	9.0	2.5	7.0	4.1	3.3	2.5	3.4	7.1	3.1	3.3	1.1	1.0	1.8	3.1	2.4	0.7	3.9	1.1	1.1	0.9	2.1	1.4	3.2	2.4	3.4	3.0	6.7	3.0	4.5	2.3	2.7	2.8	7.3	2.6	3.1	2.7	4.8	3.0	3.8	1.9	4.1	3.7	3.3	5.3	4.5	5.8	7.0	2.7	2.1	4.1	6.0	2.9	5.0	4.0	4.2	6.3	4.6	5.3	5.2
FAM131A	"C3orf40, MGC21688"	ENSG00000175182	"Family with sequence similarity 131 member A"	Q6UXB0	3	184335926-184348421	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 54.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 31.7;basal ganglia: 23.9;cerebral cortex: 59.8;hippocampal formation: 86.5"	HPA042800	Uncertain		Approved	Nucleoli	"Secreted - unknown location"			Nucleoli		"HPA042800: AB_10797023"	"unprognostic (1.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavourable (2.22e-4)"	"unprognostic (2.88e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.02e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.28e-2)"	8.1	14.9	18.8	4.6	26.4	2.5	5.0	21.9	54.7	5.4	6.4	8.0	4.8	6.3	7.5	4.9	7.5	7.7	8.4	11.9	28.1	13.0	4.1	3.0	6.0	3.4	9.1	25.9	8.8	11.3	9.2	16.4	5.0	7.8	6.7	3.5	3.3	7.1	11.7	9.3	10.5	5.8	8.7	5.9	5.3	5.5	7.0	7.0	0.8	3.5	3.9	2.7	5.5	4.1	2.1	5.5	11.1	6.5	1.6	2.2	2.5	8.1	3.4	5.4	9.5	7.4	6.1	5.1	3.6	8.3	5.8	4.5	2.6	2.9	1.2	15.2	3.5	7.6	0.0	6.6	3.7	8.7	9.1	0.0	5.1	5.5	7.5	0.1	6.4	4.5	1.1	4.9	11.4	11.6	1.8	1.2	2.1	6.2	3.1	0.2	9.3	6.8	5.7	2.2	7.8	5.8	0.2	16.6	17.3	2.3	6.4	8.5	18.8	2.1	11.7	7.1	5.6	5.7	11.4	13.7	8.3	0.8	22.9	1.2	5.0	2.0	4.8	6.0	1.5	6.5	1.6	2.0	1.2	1.6	5.5	2.1	1.2	1.5	11.1	1.6	3.4	2.3	2.2	2.5	18.8	26.4	21.9	54.7	28.1	13.0	9.1	25.9	7.8	7.0
FAM135B	C8ORFK32	ENSG00000147724	"Family with sequence similarity 135 member B"	Q49AJ0	8	138130023-138496822	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 8.1;brain: 14.3;testis: 10.3"	"Cell line enriched"	"Detected in some"	11	"RH-30: 13.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023911, HPA023950, HPA024815"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"				"Nuclear membrane"	Nucleoplasm	"HPA023911: AB_1845791, HPA023950: AB_1845792, HPA024815: AB_10601376"	"unprognostic (3.78e-1)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.36e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.85e-4)"	"unprognostic (9.92e-3)"	"unprognostic (9.82e-3)"	"unprognostic (4.47e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.30e-1)"	0.6	8.1	12.1	0.9	6.8	0.6	0.7	13.9	14.3	0.7	2.7	1.3	0.0	1.4	0.6	0.9	0.7	0.7	0.7	0.8	9.3	4.5	1.4	0.8	0.7	0.6	4.6	5.6	0.6	1.9	0.6	3.6	0.6	5.2	1.3	2.3	0.7	0.7	1.4	0.6	0.6	1.4	0.8	2.5	0.6	2.5	10.3	3.5	0.0	0.6	0.0	0.6	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	13.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	6.8	13.9	12.3	9.3	4.5	4.6	5.6	5.2	3.5
FAM149A	"DKFZP564J102, MST119, MSTP119"	ENSG00000109794	"Family with sequence similarity 149 member A"	A5PLN7	4	186104419-186172667	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 11.2;MOLT-4: 8.0;RT4: 9.3;SCLC-21H: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA044019, HPA055004"	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA044019: , HPA055004: "	"unprognostic (1.80e-2)"	"unprognostic (8.44e-2)"	"unprognostic (4.64e-2)"	"prognostic favourable (2.67e-6)"	"unprognostic (7.08e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.36e-1)"	8.7	4.3	17.6	3.7	22.7	0.3	8.6	5.1	12.4	6.1	7.3	8.2	4.7	4.6	6.0	9.8	9.1	11.1	12.8	7.3	15.4	10.0	27.3	37.7	4.3	1.1	8.9	5.8	6.2	19.6	8.8	3.7	1.9	7.4	7.5	6.2	12.2	12.2	13.3	7.0	1.7	3.9	13.8	12.4	1.9	8.4	3.6	5.7	1.0	2.7	3.2	1.5	8.4	4.9	1.0	0.7	0.2	0.0	0.0	4.0	0.0	0.0	3.2	2.9	0.1	11.2	4.6	0.1	0.0	0.0	0.3	0.3	0.0	1.9	0.0	1.6	1.5	0.0	5.1	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.7	0.1	0.2	2.1	0.3	0.2	0.0	0.0	0.0	2.5	1.3	1.6	8.0	0.3	5.1	0.0	0.3	0.0	2.0	1.7	9.3	14.2	3.9	0.1	0.0	4.4	1.0	0.0	0.8	0.2	1.7	0.0	1.6	0.0	0.0	0.0	0.8	0.0	1.3	0.2	0.0	0.0	0.1	0.0	0.1	1.0	0.1	1.1	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.7	4.0	0.0	17.6	22.7	5.1	12.4	15.4	10.0	8.9	5.8	7.4	5.7
FAM149B1	KIAA0974	ENSG00000138286	"Family with sequence similarity 149 member B1"	Q96BN6	10	73168166-73244504	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039189, HPA039859"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA039189: AB_10805355, HPA039859: "	"unprognostic (2.23e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavourable (7.81e-4)"	"unprognostic (5.13e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.24e-2)"	9.3	8.9	21.3	7.3	17.0	5.4	10.1	7.7	15.1	12.2	13.4	14.9	10.3	5.4	9.1	10.6	10.5	11.4	12.8	15.7	19.2	14.2	17.5	15.2	7.9	6.3	20.8	9.8	12.6	9.3	12.9	10.8	10.3	13.6	10.5	8.0	8.1	9.0	9.1	9.4	5.8	9.5	9.3	22.8	5.9	7.2	16.6	13.2	6.2	9.8	13.4	7.3	8.3	7.3	2.7	2.7	5.0	1.8	4.6	3.4	1.3	7.1	5.4	12.1	11.2	26.6	16.6	7.9	8.1	16.0	5.5	9.8	3.4	12.5	5.3	3.2	14.2	6.8	7.0	10.2	6.7	6.5	3.6	6.8	4.2	5.7	13.9	9.3	4.5	14.2	7.5	7.1	27.9	13.9	6.1	9.9	10.0	6.4	6.1	8.8	5.2	14.2	4.0	7.6	5.4	14.9	7.1	2.7	11.5	6.4	17.0	9.8	9.8	5.9	7.3	5.4	5.5	5.4	10.2	10.9	4.9	4.7	9.3	9.2	4.3	5.0	0.7	2.5	2.2	1.8	2.8	2.7	2.2	2.1	1.5	2.2	3.4	3.1	1.5	4.6	1.0	2.7	2.5	1.3	21.3	17.0	7.7	15.1	19.2	14.2	20.8	9.8	13.6	13.2
FAM151A	"C1orf179, MGC27169"	ENSG00000162391	"Family with sequence similarity 151 member A"	Q8WW52	1	54609182-54623556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"intestine: 45.8;kidney: 59.3"	"Cell line enriched"	"Detected in single"	45	"CACO-2: 40.7"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.3;renal cancer: 3.2;testis cancer: 5.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"eosinophil: 2.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016840	Approved									"HPA016840: AB_2669461"	"unprognostic (1.89e-1)"	"unprognostic (6.90e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.97e-6)"	"unprognostic (1.71e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.91e-3)"	"unprognostic (9.99e-2)"	"prognostic favourable (4.09e-5)"	"unprognostic (5.85e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-3)"	0.1	0.0	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.6	0.1	0.1	0.2	0.0	0.1	0.8	0.1	0.0	59.3	5.6	0.1	1.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.0	45.8	0.1	0.1	0.5	0.0	0.3	0.1	0.3	0.1	0.1	0.9	0.1	0.1	0.0	0.4	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	40.7	0.4	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.9	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
FAM153A	NY-REN-7	ENSG00000170074	"Family with sequence similarity 153 member A"	Q9UHL3	5	177707981-177783398	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 10.6;lymphoid tissue: 8.9;testis: 15.2"	"Cell line enhanced"	"Detected in some"		"A549: 2.5;Daudi: 1.0;K-562: 1.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 5.1;naive CD8 T-cell: 2.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 5.1"									"HPA042585, HPA044022, HPA046691, HPA052337, HPA055498"	Uncertain									"HPA042585: , HPA044022: , HPA046691: , HPA052337: , HPA055498: "	"unprognostic (5.92e-5)"	"unprognostic (1.41e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.58e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.77e-2)"	"unprognostic (4.75e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.11e-1)"	0.5	0.3	1.3	0.5	3.5	1.1	0.2	10.6	4.3	1.3	0.2			0.6	0.4	0.4	0.4	1.2	0.5	0.3	2.0	1.5	0.3	0.3	0.5	1.2	0.0		5.3	0.5	0.3	5.2	0.2		3.9	0.3		0.3	0.5	0.5	1.5	0.5	0.2	0.0	8.9	0.3	15.2			1.3		1.4	0.2	0.6	0.3	0.1	0.0	0.0	0.0	5.1	0.2	0.0	2.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.7	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.3	5.1	2.2	0.0	0.0	0.0	0.1	0.0	0.2										
FAM153B		ENSG00000182230	"Family with sequence similarity 153 member B"	P0C7A2	5	176060689-176116015	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 16.2;ovary: 15.3;testis: 14.7"	"Cell line enriched"	"Detected in some"	4	"U-2 OS: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.1"	"Low lineage specificity"	"Detected in many"											"HPA042585, HPA044022, HPA046691, HPA052337, HPA055498"	Uncertain									"HPA042585: , HPA044022: , HPA046691: , HPA052337: , HPA055498: "	"unprognostic (1.08e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.66e-2)"	"unprognostic (3.62e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.47e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.06e-1)"	2.1	2.1	8.1	1.7	5.6	1.4	0.4	16.2	11.1	1.5	0.4	0.4	0.4	0.3	0.7	2.8	0.4	4.5	2.6	1.5	7.9	2.6	0.6	0.4	1.3	3.5	0.4	2.6	15.3	1.2	0.3	7.1	0.4	1.4	2.7	0.6	0.6	0.6	0.9	0.5	0.7	0.6	0.4	1.0	8.5	0.5	14.7	1.8	0.4	1.2	0.4	1.9	0.4	0.4	0.5	2.6	0.7	0.3	0.3	3.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.3	0.1	0.3	0.0	0.5	0.5	0.4	0.4	0.0	0.4	3.1	3.0	0.5	0.3	0.1	2.6	0.0	0.3	8.1	5.6	16.2	11.1	7.9	2.6	0.4	2.6	1.4	1.8
FAM155A		ENSG00000204442	"Family with sequence similarity 155 member A"	B1AL88	13	107163510-107866735	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.0;pituitary gland: 10.3"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 11.6;SCLC-21H: 7.1;SH-SY5Y: 16.1;U-138 MG: 5.0;U-87 MG: 10.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA039453, HPA058768"	Enhanced		Approved	Nucleoplasm,Vesicles,Centrosome				"Nucleoplasm, Vesicles"	Centrosome	"HPA039453: AB_10795290, HPA058768: "	"unprognostic (8.40e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-3)"	"unprognostic (2.69e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.26e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.02e-5)"	"unprognostic (5.56e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.69e-3)"	0.9	2.7	10.7	0.6	4.3	0.4	0.6	6.9	19.0	1.5	0.7	0.6	0.0	0.5	1.7	4.0	0.7	0.7	1.3	0.7	8.8	10.8	0.7	0.4	1.2	0.5	6.4	4.9	0.7	0.5	0.4	10.3	1.2	2.0	2.7	0.7	0.7	0.3	3.8	0.4	0.5	0.7	1.2	2.7	0.6	0.7	2.3	0.5	0.0	1.3	0.0	0.9	1.4	0.2	0.2	0.0	0.4	0.1	0.8	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	0.0	2.4	0.1	2.3	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.2	0.0	11.6	1.9	7.1	16.1	0.0	0.0	0.0	4.1	0.0	0.2	5.0	2.0	1.7	0.2	0.0	0.0	0.0	10.2	0.0	3.4	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.4	0.8	0.0	0.0	0.0	0.0	10.7	4.3	6.9	12.3	8.8	10.8	6.4	4.9	2.0	0.5
FAM155B	"CXorf63, TED, TMEM28"	ENSG00000130054	"Family with sequence similarity 155 member B"	O75949	X	69505241-69532508	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 25.0;seminal vesicle: 6.7;thyroid gland: 10.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.8;HAP1: 15.2;Hep G2: 5.5;NTERA-2: 21.0;SCLC-21H: 10.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036093	Uncertain									"HPA036093: AB_10673613"	"prognostic unfavourable (4.61e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.09e-4)"	"unprognostic (7.07e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.94e-3)"	"prognostic unfavourable (1.83e-4)"	"prognostic favourable (6.63e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.21e-2)"	0.0	0.5	1.4	0.0	1.1	0.0	0.1	3.5	1.4	0.1	0.0			0.0	0.2	0.3	0.0	0.7	0.1	25.0	1.1	2.1	0.5	0.0	0.0	0.0	1.3		0.0	1.8	0.9	1.1	0.0		0.9	0.0		1.1	6.7	0.0	0.0	0.0	0.0	0.4	0.6	0.5	0.8			10.4		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.6	0.0	4.2	0.0	0.0	15.2	0.6	0.0	0.0	4.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.7	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.1	0.0	10.0	0.7	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FAM160A1	FLJ43373	ENSG00000164142	"Family with sequence similarity 160 member A1"	Q05DH4	4	151409216-151663632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 33.6"	"Cell line enhanced"	"Detected in many"		"A-431: 8.1;HaCaT: 7.4;HeLa: 9.9;hTERT-HME1: 9.3;SiHa: 8.8;SK-BR-3: 7.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"amygdala: 3.0;cerebellum: 7.5;pons and medulla: 4.8"	"Cell type enriched"	"Detected in single"	13	"plasmacytoid DC: 5.8"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046348	Enhanced		Approved	Cytosol				Cytosol		"HPA046348: AB_10966145"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-12)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.28e-1)"	1.4	1.2	3.0	3.4	0.8	1.5	3.8	7.5	0.9	6.3	5.2	0.6	10.4	1.7	6.1	5.9	13.1	2.8	4.9	6.5	0.7	0.7	7.0	1.6	5.4	0.1	0.6	0.0	3.7	23.7	11.1	9.4	1.8	4.8	4.5	3.3	10.0	11.1	12.5	33.6	12.6	9.0	1.8	0.7	0.7	2.3	3.5	0.0	0.9	11.4	22.0	10.0	6.2	5.0	0.0	5.8	0.4	0.0	0.1	0.1	0.0	8.1	0.7	0.0	0.2	0.0	0.0	3.0	0.4	1.9	0.8	0.2	3.5	3.0	0.0	0.9	0.1	7.4	2.1	6.2	1.2	0.0	3.6	0.0	9.9	0.8	0.0	0.0	0.1	0.1	6.2	0.0	9.3	0.1	0.0	0.0	0.5	1.2	0.0	0.0	2.9	0.8	0.0	2.0	0.3	4.3	5.6	1.4	0.4	8.8	7.8	0.0	3.3	0.0	0.0	0.5	3.6	0.2	1.4	0.0	0.0	0.0	2.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	5.8	0.0	0.0	3.0	0.8	7.5	0.9	0.7	0.7	0.6	0.0	4.8	0.0
FAM160B2	"FLJ21801, RAI16"	ENSG00000158863	"Family with sequence similarity 160 member B2"	Q86V87	8	22089159-22104898	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025040	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA025040: AB_1856049"	"unprognostic (3.45e-1)"	"unprognostic (2.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.28e-2)"	"prognostic favourable (4.56e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.67e-3)"	"unprognostic (3.38e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.75e-3)"	15.8	11.8	9.6	13.1	10.0	6.6	14.3	14.3	14.8	12.9	13.2	12.9	20.8	12.0	13.2	16.9	13.7	14.1	14.5	26.0	8.5	6.9	12.3	9.8	11.0	11.2	12.5	10.5	11.4	22.1	15.3	14.1	22.4	10.9	14.4	6.0	13.4	18.8	25.1	15.1	24.4	13.4	25.3	10.4	12.3	16.1	6.4	10.3	6.5	16.0	11.6	13.2	19.9	11.2	2.7	0.9	0.5	1.4	1.7	3.2	2.1	3.7	9.2	4.4	6.8	8.9	8.3	6.8	5.7	12.5	8.5	5.9	3.8	4.5	3.8	6.3	17.9	5.2	3.2	10.3	1.8	3.3	3.5	5.7	2.4	2.6	12.1	1.5	5.3	13.9	7.0	6.2	4.2	8.7	3.8	3.3	8.0	7.7	4.1	2.2	1.8	3.2	4.3	3.2	2.2	7.1	9.1	1.5	4.8	3.5	7.4	4.8	4.4	3.4	8.3	8.6	6.6	7.7	3.9	2.6	0.8	0.7	9.1	2.8	9.2	0.0	1.2	0.5	3.2	0.7	1.9	2.7	2.1	2.6	0.8	2.3	1.9	2.7	0.3	1.7	1.4	0.9	0.3	2.1	9.6	10.0	14.3	14.8	8.5	6.9	12.5	10.5	10.9	10.3
FAM162B	"bA86F4.2, C6orf189"	ENSG00000183807	"Family with sequence similarity 162 member B"	Q5T6X4	6	116752197-116765723	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 51.6"	"Cell line enhanced"	"Detected in some"		"BJ: 6.8;BJ hTERT+: 18.6;BJ hTERT+ SV40 Large T+ RasG12V: 18.0;HHSteC: 5.2;HSkMC: 6.3"	"Cancer enriched"	"Detected in many"	18	"testis cancer: 32.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"olfactory region: 6.9"	"HPA036112, HPA060342"	Enhanced									"HPA036112: AB_10696649, HPA060342: AB_2684258"	"unprognostic (1.81e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.86e-5)"	"unprognostic (8.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.32e-2)"	"unprognostic (6.27e-3)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-3)"	"unprognostic (4.34e-2)"	11.4	12.5	2.2	1.0	4.0	0.5	11.2	0.5	8.6	13.0	3.8	1.1	4.8	1.1	7.8	7.0	6.5	6.7	4.9	7.7	2.0	1.8	4.3	1.0	14.6	2.4	2.7	5.8	7.7	1.5	2.5	6.1	51.6	1.9	9.7	2.2	6.0	6.5	11.8	7.3	2.5	1.9	3.7	1.3	0.5	3.0	2.9	0.5	0.0	8.7	5.2	1.4	5.7	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	6.8	18.6	3.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	6.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	4.0	0.5	8.6	2.0	1.8	2.7	5.8	1.9	0.5
FAM163B	C9orf166	ENSG00000196990	"Family with sequence similarity 163 member B"	P0C2L3	9	133578415-133586197	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 41.7"	"Cell line enriched"	"Detected in some"	21	"SH-SY5Y: 39.0"	"Cancer enriched"	"Detected in some"	6	"glioma: 3.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067336	Supported		Approved	"Nuclear bodies,Plasma membrane,Cytosol"				"Nuclear bodies, Plasma membrane, Cytosol"		"HPA067336: "	"unprognostic (2.94e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.31e-3)"	"unprognostic (7.61e-2)"	"unprognostic (5.75e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.73e-4)"	0.1	8.2	10.0	0.0	2.7	0.0	0.0	3.2	41.7	0.0	0.4			0.0	0.0	0.3	0.0	0.0	0.4	1.2	6.1	3.9	0.1	2.7	0.0	1.3	3.3		0.0	0.1	0.0	0.0	0.6		0.0	0.4		0.4	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.8			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.5	0.1	0.0	0.0	0.0	1.8	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FAM166A		ENSG00000188163	"Family with sequence similarity 166 member A"	Q6J272	9	137243584-137247770	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	53	"testis: 54.2"	"Cell line enhanced"	"Detected in some"		"T-47d: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023307	Enhanced									"HPA023307: AB_1848930"	"unprognostic (2.22e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.67e-4)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.18e-3)"	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.3	0.1	1.0	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.7	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	54.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	1.4	0.5	1.2	0.8	0.0	0.7	0.0	0.5	0.0	0.0	0.5	2.0	0.6	0.1	0.0	1.0	0.0	0.0	0.0	1.1	0.7	0.5	1.2	1.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.9	0.0	0.3	0.3	0.3	0.3	0.1	0.6	0.1	0.8	0.8	0.8	0.3	1.0	0.8	3.2	0.9	0.7	0.8	1.0	0.3	0.1	0.8	1.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1
FAM166B		ENSG00000215187	"Family with sequence similarity 166 member B"	A8MTA8	9	35561831-35563899	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 77.3;fallopian tube: 26.1;skeletal muscle: 102.9"	"Cell line enhanced"	"Detected in some"		"AF22: 2.5;Hep G2: 5.6"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 11.7;ovarian cancer: 4.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA045540	Enhanced									"HPA045540: AB_10962627"	"unprognostic (4.18e-5)"	"unprognostic (7.56e-3)"	"unprognostic (1.65e-1)"	"prognostic favourable (2.61e-5)"	"unprognostic (5.66e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.21e-1)"	"prognostic favourable (6.20e-6)"	"unprognostic (3.69e-3)"	"unprognostic (9.09e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.52e-5)"	2.8	77.3	0.9	0.7	1.2	0.0	0.7	0.1	0.5	1.3	0.6	3.1	0.3	0.0	0.5	9.4	0.8	26.1	0.9	0.1	1.3	1.5	0.4	0.1	2.7	0.1	0.1	0.2	2.5	0.1	0.0	0.2	0.1	3.8	0.1	0.0	0.7	0.6	0.6	102.9	0.2	0.3	0.3	0.4	0.2	0.0	0.5	0.6	0.1	0.3	1.3	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	2.5	0.7	0.6	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.0	0.3	1.3	0.0	0.2	1.4	0.5	0.9	0.0	0.3	0.0	0.0	5.6	0.0	0.4	0.4	0.0	0.5	0.0	0.5	0.4	0.0	0.6	0.0	0.1	0.0	0.4	0.5	0.6	0.0	0.2	0.0	2.0	0.3	0.8	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.7	0.4	0.8	0.0	1.3	0.8	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	1.2	0.1	0.5	1.3	1.5	0.1	0.2	3.8	0.6
FAM167B	"C1orf90, MGC10820"	ENSG00000183615	"Family with sequence similarity 167 member B"	Q9BTA0	1	32247233-32248856	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"vagina: 91.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.9;EFO-21: 8.7;SK-MEL-30: 21.0;U-2197: 21.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 46.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.5"	"Lineage enriched"	"Detected in many"	4	"T-cells: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029398, HPA062074"	Uncertain		Approved	"Actin filaments"				"Actin filaments"		"HPA029398: AB_10602807, HPA062074: "	"unprognostic (2.16e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (1.11e-4)"	"unprognostic (6.03e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.36e-3)"	"unprognostic (7.44e-3)"	"unprognostic (3.64e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.04e-2)"	"unprognostic (5.08e-2)"	17.2	10.5	1.4	5.0	1.7	0.1	20.1	1.7	1.9	6.1	3.1	1.1	7.4	3.6	7.8	2.2	4.5	3.4	5.5	11.3	1.8	1.7	20.3	18.4	22.4	6.2	3.2	0.6	3.8	6.6	5.2	8.5	5.8	3.3	9.2	2.7	5.2	2.6	8.2	3.3	1.1	4.1	7.5	2.6	1.4	4.0	1.8	2.7	1.2	11.8	1.5	1.9	7.2	91.1	1.0	0.0	0.8	0.0	0.3	4.5	0.7	0.6	1.2	0.4	0.0	0.9	0.8	0.0	3.0	6.9	1.3	1.9	0.0	0.6	0.1	8.7	5.1	1.0	0.2	0.0	0.4	0.1	0.0	0.0	2.7	0.4	0.3	0.0	0.1	0.8	0.5	1.0	0.3	2.5	0.0	0.0	0.1	0.4	0.1	0.0	0.2	2.9	0.6	0.0	0.8	0.8	0.3	1.3	0.3	1.9	0.1	21.0	0.3	0.0	2.2	0.6	0.7	21.5	0.0	0.1	0.2	0.4	0.2	0.1	0.2	0.0	0.0	0.8	2.6	0.0	0.7	0.5	0.8	0.8	0.0	1.0	0.5	1.6	0.0	0.3	0.0	0.0	4.5	0.7	1.4	1.7	1.7	1.9	1.8	1.7	3.2	0.6	3.3	2.7
FAM170A	ZNFD	ENSG00000164334	"Family with sequence similarity 170 member A"	A1A519	5	119629559-119635822	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 37.0"	"Cell line enhanced"	"Detected in single"		"THP-1: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037900, HPA037902"	Enhanced									"HPA037900: AB_2675728, HPA037902: AB_2675730"	"unprognostic (2.26e-1)"	"unprognostic (1.13e-1)"		"unprognostic (9.70e-3)"			"unprognostic (1.89e-1)"					"unprognostic (1.06e-1)"	"unprognostic (1.02e-4)"	"unprognostic (2.12e-1)"		"unprognostic (2.25e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.9	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0
FAM171B	"FLJ34104, KIAA1946"	ENSG00000144369	"Family with sequence similarity 171 member B"	Q6P995	2	186693971-186765965	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 24.9;U-138 MG: 17.3"	"Cancer enriched"	"Detected in many"	5	"glioma: 15.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010639, HPA013434"	Approved		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA010639: AB_1852447, HPA013434: AB_2262499"	"unprognostic (2.52e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.03e-2)"	"unprognostic (9.43e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (9.51e-7)"	"unprognostic (4.63e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.24e-3)"	"prognostic unfavourable (5.03e-4)"	3.1	13.1	32.0	2.0	32.6	1.1	3.7	12.7	62.0	6.7	2.1	5.8	0.1	1.6	7.1	2.6	2.4	3.2	4.9	1.9	25.5	13.1	1.8	1.1	2.0	1.6	9.1	23.0	9.7	1.6	11.4	13.4	3.5	9.7	3.2	2.5	1.4	17.8	2.8	1.3	3.8	1.9	4.5	8.4	2.0	2.4	1.6	10.4	0.0	2.7	0.0	1.7	2.9	1.8	0.3	1.3	1.1	1.7	2.4	1.1	0.5	2.3	2.7	4.1	12.8	12.3	9.3	0.1	2.5	4.5	3.1	4.5	7.5	12.3	0.0	0.9	7.2	0.3	5.6	2.4	4.5	0.0	3.2	2.8	1.3	0.0	1.0	0.8	1.0	11.8	1.0	2.4	1.9	6.8	0.0	24.9	5.9	1.6	1.6	0.0	5.4	2.8	0.0	8.0	0.5	4.9	8.8	12.9	7.0	1.3	0.8	3.4	1.0	0.6	4.0	17.3	2.3	0.3	1.6	6.6	6.4	0.0	5.3	0.0	2.4	1.1	0.7	0.3	0.8	1.7	0.7	0.3	1.0	0.9	0.6	0.2	0.6	1.1	0.4	2.4	1.6	1.3	0.1	0.5	32.0	32.6	12.7	30.4	25.5	13.1	9.1	23.0	9.7	10.4
FAM172A	"C5orf21, DKFZP564D172"	ENSG00000113391	"Family with sequence similarity 172 member A"	Q8WUF8	5	93618069-94111699	"Predicted intracellular proteins, Predicted secreted proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012299, HPA045505"	Approved		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"			Nucleoplasm	Cytosol	"HPA012299: AB_1845724, HPA045505: "	"unprognostic (1.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.03e-2)"	18.4	15.4	24.2	17.8	21.8	9.8	19.3	28.8	20.8	19.9	14.4	15.5	13.9	11.2	19.1	16.1	17.7	18.8	14.3	14.0	21.0	19.9	18.5	8.0	14.9	22.4	18.9	13.0	23.0	18.2	20.7	28.4	15.1	15.6	19.4	12.3	12.6	14.3	22.6	6.2	11.8	12.9	26.2	20.8	13.6	13.7	8.3	16.6	16.1	22.8	9.5	16.1	19.0	15.7	9.8	7.1	13.1	7.3	12.3	11.9	6.4	4.5	5.3	13.1	14.7	15.8	19.1	6.8	9.8	7.6	4.2	4.2	3.6	6.4	6.6	7.4	11.5	4.0	3.9	13.8	10.0	4.5	4.7	8.7	11.2	2.4	6.7	6.7	10.2	16.7	7.9	3.9	7.5	9.7	1.7	2.0	17.4	5.0	5.6	5.1	2.0	4.4	6.3	13.8	6.2	6.7	8.9	11.7	20.9	7.9	3.3	7.2	8.1	8.2	9.5	10.2	9.2	6.6	11.5	8.5	12.3	7.5	16.0	7.5	18.6	13.1	5.4	7.0	11.9	7.3	11.9	9.4	8.9	8.7	7.1	9.8	10.1	10.2	13.0	12.3	5.1	6.8	9.2	6.4	24.2	21.8	28.8	20.8	21.0	19.9	18.9	13.0	15.6	16.6
FAM173A	"C16orf24, MGC2494"	ENSG00000103254	"Family with sequence similarity 173 member A"	Q9BQD7	16	720581-722601	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046262	Approved		Approved	Cytosol				Cytosol		"HPA046262: AB_10963070"	"unprognostic (3.94e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.54e-2)"	"prognostic favourable (8.88e-4)"	"unprognostic (2.11e-1)"	"unprognostic (4.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.70e-2)"	"prognostic favourable (4.24e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.28e-2)"	"unprognostic (3.60e-3)"	16.0	10.4	15.6	10.3	9.1	7.3	9.6	8.9	21.5	4.8	15.5	8.2	9.3	19.1	6.5	8.3	6.1	5.2	10.6	11.1	13.6	11.5	18.6	15.8	7.5	7.5	11.3	12.2	4.3	10.2	8.5	13.4	5.8	9.2	8.4	3.5	6.5	15.1	8.6	37.3	6.2	14.5	5.6	9.5	15.0	19.3	21.8	7.9	8.6	7.8	11.1	7.1	5.9	8.9	9.0	6.0	5.3	6.8	6.3	18.0	4.2	6.3	4.2	0.8	2.3	0.1	0.3	10.1	5.5	1.4	1.3	1.5	4.2	5.3	8.1	9.9	0.6	9.9	0.8	2.7	0.3	18.0	11.2	3.4	4.4	4.4	1.9	5.7	4.7	0.7	2.0	0.6	1.6	0.5	7.2	3.7	1.1	10.3	0.9	13.7	3.2	13.8	3.4	2.0	15.3	3.5	2.3	3.6	9.5	2.9	4.7	9.1	5.2	5.1	4.6	1.2	9.9	3.5	3.8	32.9	14.7	8.8	2.5	4.2	3.1	0.0	6.8	5.3	7.3	3.9	16.5	9.0	5.8	12.9	4.4	9.0	5.9	18.0	0.8	6.3	4.8	6.0	12.5	4.2	15.6	9.1	8.9	21.5	13.6	11.5	11.3	12.2	9.2	7.9
FAM174A	"NS5ATP6, TMEM157, UNQ1912"	ENSG00000174132	"Family with sequence similarity 174 member A"	Q8TBP5	5	100535305-100586741	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 28.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	8	"neutrophil: 28.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019539	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA019539: AB_2293743"	"unprognostic (2.34e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.02e-3)"	"prognostic unfavourable (2.57e-6)"	"unprognostic (5.55e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.69e-2)"	"prognostic favourable (5.48e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.45e-1)"	15.6	24.6	18.8	8.3	21.0	3.0	15.3	14.2	26.8	11.1	12.0	16.5	14.0	11.8	11.3	15.2	18.0	35.9	9.5	17.3	22.0	25.0	18.3	15.2	17.6	5.5	19.3	18.2	9.1	26.8	23.6	21.9	15.6	24.1	19.5	9.1	16.6	16.5	13.7	38.8	20.4	10.7	9.6	19.4	10.1	15.5	37.3	12.2	4.4	14.3	17.0	9.6	9.9	11.7	1.5	2.2	28.0	2.7	2.5	2.7	1.6	4.9	5.3	2.1	6.8	5.3	4.2	7.6	11.5	6.4	4.7	6.4	1.0	6.5	0.9	23.4	4.9	4.3	1.8	7.4	3.4	6.0	5.4	0.6	9.1	3.0	7.2	2.5	6.3	5.5	17.7	3.6	2.7	7.0	1.8	6.9	7.8	10.0	0.7	5.4	1.1	14.3	1.7	8.2	8.6	8.2	6.0	4.3	11.6	8.0	7.2	6.3	7.0	5.6	8.0	6.0	3.7	9.5	9.0	21.7	28.4	1.1	7.4	3.4	5.2	3.6	2.5	3.4	1.8	2.7	2.7	1.4	1.8	2.2	2.2	1.5	1.6	2.1	28.0	2.5	2.7	2.2	2.2	1.6	18.8	21.0	14.2	26.8	22.0	25.0	19.3	18.2	24.1	12.2
FAM174B	"LOC400451, MGC102891"	ENSG00000185442	"Family with sequence similarity 174 member B"	Q3ZCQ3	15	92617443-92809884	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 57.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.0;MCF7: 25.3;RPMI-8226: 29.7;RT4: 62.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 4.5;granulocytes: 3.7;T-cells: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015306	Approved		Approved	"Intermediate filaments"				"Intermediate filaments"		"HPA015306: "	"unprognostic (3.00e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.50e-1)"	"prognostic favourable (9.03e-5)"	"unprognostic (4.68e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.35e-2)"	"unprognostic (8.23e-3)"	"unprognostic (7.67e-3)"	"unprognostic (5.05e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.35e-2)"	6.1	3.5	5.9	3.3	6.3	0.7	17.9	3.9	8.6	10.9	6.2	2.9	21.5	3.6	5.1	4.9	5.2	14.6	6.4	4.2	7.4	8.3	3.3	4.0	16.3	5.5	6.5	6.2	10.2	57.6	2.5	15.9	4.6	6.7	19.4	9.2	7.7	47.7	10.8	16.3	4.9	5.0	4.6	4.9	3.2	17.3	9.7	3.6	4.2	28.9	3.9	4.8	24.4	15.3	0.4	4.5	3.7	0.9	0.7	10.9	0.7	0.0	3.5	2.3	0.7	0.0	0.0	0.2	1.3	6.2	0.0	0.0	21.0	2.4	0.3	6.0	0.1	0.1	3.9	0.1	0.0	0.1	1.8	0.2	0.3	0.2	0.4	0.3	0.9	0.3	0.1	0.0	0.0	3.0	0.3	15.6	3.5	25.3	0.7	0.0	11.3	0.0	2.4	6.5	29.7	1.5	62.7	1.4	1.1	1.8	12.1	3.8	9.7	2.1	0.0	0.0	0.4	0.1	2.9	0.4	4.6	0.7	0.0	0.2	1.5	1.1	0.8	0.9	0.2	0.9	0.4	0.4	2.5	0.0	0.6	0.3	2.8	3.3	3.7	0.7	0.0	4.5	10.9	0.7	5.9	6.3	3.9	8.6	7.4	8.3	6.5	6.2	6.7	3.6
FAM177B	"FLJ43505, RP11-452F19.2"	ENSG00000197520	"Family with sequence similarity 177 member B"	A6PVY3	1	222737207-222750805	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 26.5;stomach 1: 34.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.5;fHDF/TERT166: 1.1;HUVEC TERT2: 2.3;RPMI-8226: 2.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	21	"memory B-cell: 17.9;naive B-cell: 26.5"	"Lineage enriched"	"Detected in many"	25	"B-cells: 26.5"					"Low region specificity"	"Detected in all"			HPA063059	Uncertain									"HPA063059: "	"unprognostic (8.19e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.57e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.56e-6)"	"unprognostic (5.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.29e-2)"	0.6	1.1	1.1	6.4	5.5	0.0	0.5	0.4	2.3	0.4	4.6	0.2	2.0	3.3	0.5	0.1	0.8	0.4	12.6	0.4	1.8	0.7	0.6	0.5	1.6	10.3	1.8	0.0	0.4	0.6	0.2	1.3	2.0	2.0	0.8	6.5	0.6	8.3	0.3	0.4	0.4	14.2	0.6	4.9	5.6	34.2	1.2	1.5	0.3	0.5	1.4	14.6	1.0	0.6	26.5	1.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	1.5	0.2	1.1	0.7	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.3	0.7	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	2.4	0.5	0.9	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	17.9	0.0	0.0	0.0	26.5	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.6	1.1	5.5	0.4	2.3	1.8	0.7	1.8	0.0	2.0	1.5
FAM178B	LOC51252	ENSG00000168754	"Family with sequence similarity 178 member B"	Q8IXR5	2	96875882-96986592	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.2;lymphoid tissue: 13.3;testis: 29.5"	"Cell line enhanced"	"Detected in some"		"K-562: 17.1;RH-30: 4.7;RPMI-8226: 18.7;WM-115: 18.8"	"Cancer enriched"	"Detected in many"	5	"melanoma: 8.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2;naive CD4 T-cell: 2.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042516, HPA062110"	Uncertain		Uncertain	"Nuclear speckles,Golgi apparatus"				"Nuclear speckles"	"Golgi apparatus"	"HPA042516: AB_10806241, HPA062110: "	"unprognostic (2.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.04e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.02e-4)"	"unprognostic (4.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.82e-11)"	"unprognostic (6.93e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.63e-3)"	"unprognostic (1.08e-1)"	0.8	0.0	2.4	0.6	3.8	18.2	0.6	1.0	1.5	0.6	1.0	0.6	0.6	0.1	0.7	6.8	0.6	1.5	0.6	0.6	3.4	1.9	0.6	0.6	0.6	0.6	5.3	0.6	0.6	0.6	0.0	0.6	1.1	0.6	0.6	0.2	1.0	0.6	1.0	0.6	1.2	0.6	0.6	8.5	13.3	0.0	29.5	0.6	0.6	0.6	0.6	0.6	1.0	0.6	0.0	0.8	0.0	0.0	0.1	2.6	0.6	4.1	0.0	0.0	1.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.4	1.7	0.0	0.0	0.1	0.0	0.0	4.7	18.7	0.0	0.0	0.6	0.0	0.0	3.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	18.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.6	1.7	0.0	0.1	0.0	0.8	0.0	0.6	2.4	3.8	1.0	1.5	3.4	1.9	5.3	0.6	0.6	0.6
FAM180A	"HWKM1940, UNQ1940"	ENSG00000189320	"Family with sequence similarity 180 member A"	Q6UWF9	7	135728348-135748846	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.0"	"Cell line enriched"	"Detected in some"	4	"U-2197: 73.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"basophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA021224	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"			Nucleoplasm		"HPA021224: AB_1851352"	"unprognostic (3.85e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.97e-3)"	"unprognostic (5.62e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.88e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.35e-4)"	"unprognostic (6.62e-4)"	9.3	2.6	0.1	1.7	0.5	0.0	5.6	0.1	1.0	7.8	5.7	0.3	0.5	0.7	9.4	2.0	5.1	3.0	21.2	14.7	0.1	0.1	8.7	23.0	4.6	0.0	0.1	0.0	8.1	1.1	0.0	0.3	1.4	0.5	6.1	1.8	1.9	2.2	0.1	3.5	5.5	3.2	8.1	0.4	0.9	1.6	3.9	0.1	0.0	4.6	4.8	0.9	6.6	8.3	0.6	0.2	2.0	0.3	0.4	0.5	0.1	0.0	0.0	0.0	0.0	7.9	8.2	0.0	4.1	15.7	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	10.0	1.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	16.3	0.0	73.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.0	0.1	0.1	0.3	0.1	0.2	0.2	0.3	0.2	0.0	0.6	0.4	0.5	0.8	0.4	0.3	0.2	0.2	0.1	0.1	0.5	0.1	1.0	0.1	0.1	0.1	0.0	0.5	0.1
FAM181A	C14orf152	ENSG00000140067	"Family with sequence similarity 181 member A"	Q8N9Y4	14	93918894-93929608	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.3;testis: 19.2"	"Cell line enriched"	"Detected in some"	9	"AF22: 9.8"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 3.1;glioma: 9.7;ovarian cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 31.1"	HPA001603	Enhanced									"HPA001603: AB_1078326"		"unprognostic (8.19e-2)"		"unprognostic (6.78e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.31e-1)"		"unprognostic (2.05e-2)"		"unprognostic (1.84e-2)"					"unprognostic (6.27e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.37e-2)"	0.6	0.6	9.3	0.6	8.3	0.6	0.6	2.1	6.0	0.8	0.6	7.6	0.0	0.6	0.8	0.6	0.7	5.2	0.7	0.7	6.4	6.6	0.6	0.6	1.4	0.6	5.3	6.0	0.6	0.6	0.6	1.5	0.6	6.8	0.6	0.6	0.0	0.7	0.7	3.7	0.6	0.6	0.6	6.4	0.6	0.7	19.2	3.8	0.0	2.6	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	8.3	2.1	5.7	6.4	6.6	5.3	6.0	6.8	3.8
FAM181B	"LOC220382, MGC33846"	ENSG00000182103	"Family with sequence similarity 181 member B"	A6NEQ2	11	82729941-82733864	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 29.6"	"Cell line enhanced"	"Detected in some"		"RT4: 6.6;SH-SY5Y: 3.5;U-2 OS: 3.4"	"Cancer enriched"	"Detected in many"	19	"glioma: 29.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066861	Approved		Approved	"Nuclear membrane,Mitochondria"				Mitochondria	"Nuclear membrane"	"HPA066861: "	"unprognostic (2.84e-4)"	"unprognostic (3.47e-2)"	"unprognostic (1.80e-1)"	"prognostic favourable (8.07e-4)"	"unprognostic (6.71e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.27e-4)"	"unprognostic (2.52e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.20e-3)"	"unprognostic (7.20e-2)"	1.9	2.9	18.3	1.8	13.3	1.5	1.6	16.9	29.6	2.0	1.7	18.6	0.0	1.9	2.2	1.8	1.5	2.6	1.4	2.0	19.6	11.3	2.0	1.3	1.3	1.4	17.1	13.0	2.7	1.5	1.5	1.1	1.4	17.2	1.9	1.5	0.7	3.2	2.7	1.7	1.7	2.3	1.6	16.9	1.3	1.8	1.7	16.7	0.0	2.1	0.0	1.7	2.2	0.5	0.2	0.0	0.6	0.3	0.3	0.4	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.3	0.1	0.4	0.0	0.1	0.1	0.5	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.1	0.1	0.1	1.2	0.1	0.0	0.0	0.0	0.2	6.6	1.0	3.5	0.0	0.0	0.1	0.1	0.4	0.0	0.1	3.4	0.1	0.1	0.3	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.4	0.0	0.6	0.3	0.3	0.0	0.1	0.0	18.3	13.3	16.9	11.4	19.6	11.3	17.1	13.0	17.2	16.7
FAM182B		ENSG00000175170	"Family with sequence similarity 182 member B"	Q5T319	20	25763466-25868225	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 7.6;testis: 9.9"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 17.0"	"Cancer enhanced"	"Detected in some"		"glioma: 1.4"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA050100	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA050100: "	"unprognostic (8.05e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.88e-4)"	"unprognostic (1.61e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.47e-9)"	"unprognostic (2.36e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.54e-2)"	"unprognostic (3.18e-1)"	0.4	0.9	2.9	0.2	3.8	0.0	0.8	7.6	5.9	0.6	0.2			0.1	1.2	0.3	0.6	6.4	0.2	0.3	3.0	3.7	0.4	0.0	1.2	0.2	2.0		1.7	0.8	0.5	2.7	4.4		1.7	0.1		0.8	0.5	1.2	5.2	0.7	0.4	1.2	0.8	0.6	9.9			1.4		0.0	0.0	0.4	0.2	0.2	2.1	0.1	0.7	1.2	0.4	2.1	0.9	1.2	1.2	0.6	0.1	0.5	0.3	0.0	0.0	0.4	0.0	3.0	0.2	1.3	1.4	4.0	0.0	0.4	0.0	0.0	0.3	0.0	0.6	0.0	0.3	0.2	1.1	0.8	0.1	0.0	1.1	0.1	0.9	2.7	0.0	0.1	1.4	0.7	0.1	1.6	0.1	0.1	0.6	0.4	0.0	17.0	1.1	0.7	0.2	1.2	0.5	0.6	0.3	0.2	3.6	0.8	0.5	1.7	0.3	0.8	0.1	0.5	1.4	0.0	0.1	1.7	0.6	0.0	0.6	0.1	1.0	0.3	0.2	0.2	0.9	1.2	2.1	0.7	0.0	0.1	0.0	0.4										
FAM184A	"C6orf60, FLJ13942"	ENSG00000111879	"Family with sequence similarity 184 member A"	Q8NB25	6	118959763-119149387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 31.4"	"Cell line enhanced"	"Detected in many"		"AF22: 16.4;HEK 293: 9.6;K-562: 13.4;SCLC-21H: 10.7;SH-SY5Y: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034571, HPA034572, HPA041955"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA034571: AB_10602498, HPA034572: , HPA041955: AB_2677768"	"unprognostic (1.21e-1)"	"unprognostic (4.11e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.16e-4)"	"unprognostic (8.38e-3)"	"unprognostic (4.02e-2)"	"unprognostic (9.11e-3)"	"unprognostic (8.16e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.32e-1)"	4.0	2.8	14.2	3.7	13.7	0.6	6.1	13.9	16.0	2.8	3.0	4.6	0.4	3.8	3.9	3.6	2.6	3.9	2.3	2.4	11.3	10.5	6.7	6.4	15.3	4.9	9.1	10.0	7.1	5.1	14.2	15.4	31.4	11.9	4.0	1.9	2.7	2.9	4.1	1.2	2.3	2.6	3.1	4.6	1.0	1.7	23.2	7.1	0.1	8.5	1.1	5.8	2.1	2.0	0.5	0.0	0.0	0.2	0.3	1.9	0.0	0.1	0.3	16.4	1.6	0.2	0.2	0.0	0.5	0.3	0.5	0.8	2.1	1.3	1.1	0.0	0.2	0.0	5.0	0.0	0.2	1.3	9.6	0.5	1.5	7.2	0.1	0.0	1.5	0.3	0.2	0.1	0.0	0.0	13.4	0.6	0.2	0.3	0.3	0.0	5.5	1.2	0.0	0.0	0.0	0.1	0.1	10.7	7.9	0.5	0.5	1.6	2.2	1.9	0.2	0.8	0.5	0.2	4.1	4.1	4.4	0.3	1.3	0.0	2.1	0.0	0.0	0.0	0.2	0.2	0.6	0.5	0.2	0.0	0.0	0.1	1.5	1.2	0.0	0.3	0.0	0.0	1.9	0.0	14.2	13.7	13.9	12.9	11.3	10.5	9.1	10.0	11.9	7.1
FAM184B	KIAA1276	ENSG00000047662	"Family with sequence similarity 184 member B"	Q9ULE4	4	17629306-17781512	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 5.1;skeletal muscle: 11.1"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 6.8;T-47d: 1.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044119, HPA048458"	Enhanced									"HPA044119: , HPA048458: "	"unprognostic (1.20e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.13e-4)"	"unprognostic (2.04e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.54e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-4)"	1.5	0.6	3.2	0.5	5.0	0.8	0.6	2.0	5.1	0.3	1.1	2.5	0.0	0.3	0.4	0.8	0.4	0.3	0.4	0.3	3.6	2.7	1.2	0.3	0.4	0.5	3.3	1.2	0.5	0.3	0.8	0.4	0.3	3.7	0.5	0.8	0.1	0.9	0.3	11.1	1.1	0.4	0.3	2.0	0.5	0.5	0.6	2.9	0.0	0.4	0.4	0.4	0.3	0.0	0.2	0.0	0.2	0.1	0.0	0.9	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.2	0.7	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.3	0.5	0.1	0.2	0.9	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.8	1.3	0.0	0.1	0.2	0.0	0.0	0.1	6.8	0.2	0.0	0.0	0.9	1.7	0.2	0.3	0.0	0.0	0.1	0.3	0.2	0.2	0.1	0.1	0.3	0.6	0.0	0.1	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.2	0.3	0.9	0.2	0.0	0.1	0.0	0.0	0.0	3.2	5.0	2.0	3.1	3.6	2.7	3.3	1.2	3.7	2.9
FAM185A	MGC35361	ENSG00000222011	"Family with sequence similarity 185 member A"	Q8N0U4	7	102748971-102809225	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 10.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020470, HPA029883"	Uncertain		Enhanced	Cytosol				Cytosol		"HPA020470: AB_1853890, HPA029883: AB_10601903"	"unprognostic (8.28e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.97e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.03e-1)"	"prognostic favourable (9.36e-5)"	"unprognostic (3.64e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.13e-3)"	"unprognostic (5.25e-2)"	3.7	4.6	6.6	3.0	4.9	3.6	3.8	9.3	6.3	5.6	4.3	4.4	4.1	2.3	3.8	3.1	4.4	3.1	3.4	4.2	4.2	2.3	4.0	9.4	4.8	2.3	5.1	6.0	4.7	3.7	8.7	4.8	2.8	4.0	5.2	4.3	6.1	5.1	8.4	9.5	4.6	3.1	3.7	4.5	3.0	5.9	2.2	5.1	3.0	3.8	2.4	2.7	4.4	4.0	3.3	2.6	7.5	3.0	1.2	2.2	0.9	1.3	3.5	1.6	4.1	0.6	1.7	4.2	0.9	1.7	1.6	0.5	3.4	2.9	0.0	2.2	1.2	3.6	2.3	2.4	1.6	1.7	2.0	0.2	0.4	4.1	1.0	2.9	0.4	0.0	2.7	0.9	1.2	2.0	2.1	1.5	1.6	2.7	1.4	0.3	1.7	0.0	0.3	0.1	10.1	0.8	2.5	1.4	2.9	3.4	5.3	0.4	3.2	0.0	3.5	0.4	1.7	2.5	0.5	4.8	1.5	0.6	0.7	0.9	0.0	0.0	3.0	3.3	2.1	2.2	0.9	3.3	1.4	2.2	2.6	1.9	1.3	1.5	7.5	1.2	1.0	2.4	1.6	0.9	6.6	4.9	9.3	6.3	4.2	2.3	5.1	6.0	4.0	5.1
FAM186A	LOC121006	ENSG00000185958	"Family with sequence similarity 186 member A"	A6NE01	12	50326230-50396622	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 19.3"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA047128	Uncertain									"HPA047128: AB_10967726"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.96e-2)"	"unprognostic (4.65e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.22e-3)"	0.2	0.2	0.4	0.3	0.8	0.9	0.2	0.9	0.8	0.2	0.2	0.2	0.2	0.1	0.2	1.2	0.2	0.1	0.2	0.3	0.4	0.4	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	1.0	0.2	0.2	0.2	0.2	0.2	0.4	0.2	2.0	0.8	0.3	0.2	0.2	0.3	0.0	19.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.9	3.1	1.5	1.8	1.4	0.3	0.6	0.2	0.2	2.1	0.0	0.0	1.0	0.3	0.0	0.1	0.0	0.2	1.0	0.8	0.7	0.6	0.3	0.1	0.2	0.0	1.2	0.8	0.4	0.9	1.0	0.4	0.5	0.9	0.9	0.3	0.0	0.2	0.0	0.9	1.6	1.0	1.7	0.2	0.8	0.9	0.2	0.7	0.5	0.2	0.1	1.3	0.4	0.2	0.4	0.4	0.2	1.1	0.3	0.0	0.6	0.9	0.5	0.5	1.2	0.4	0.8	0.9	0.1	0.2	2.4	1.5	1.2	1.4	0.7	0.8	0.5	0.8	0.5	0.2	0.8	0.9	1.2	3.1	1.8	0.6	0.9	0.4	0.3	0.4	0.8	0.9	0.8	0.4	0.4	0.2	0.2	0.2	0.2
FAM186B	"C12orf25, DKFZP434J0113"	ENSG00000135436	"Family with sequence similarity 186 member B"	Q8IYM0	12	49582885-49605639	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"testis: 58.0"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.3"	"Group enriched"	"Detected in many"	7	"B-cells: 2.3;T-cells: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039736, HPA040028"	Uncertain									"HPA039736: AB_10795295, HPA040028: AB_10795684"	"unprognostic (2.96e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.00e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.11e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.42e-5)"	"unprognostic (1.56e-1)"	"unprognostic (6.18e-2)"	"unprognostic (2.10e-5)"	"unprognostic (7.23e-2)"	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.0	0.3	0.4	0.2	0.2	0.2	0.2	0.5	1.0	0.9	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.1	58.0	0.2	0.2	0.6	0.2	0.2	0.2	0.2	2.3	0.2	0.0	0.2	0.2	1.4	0.0	0.8	3.7	0.4	1.3	0.4	0.2	1.9	0.0	0.5	0.2	0.4	4.7	1.5	2.7	0.9	0.3	1.3	0.7	0.7	0.4	0.9	1.1	1.6	2.1	0.7	0.4	3.0	0.8	0.2	1.0	0.7	2.1	0.3	2.5	2.1	0.7	2.6	0.3	0.3	0.6	1.4	1.0	0.3	1.2	1.4	1.2	3.2	0.8	1.5	0.7	2.3	1.6	1.3	1.5	0.3	1.5	1.3	0.8	1.5	1.1	4.8	0.6	1.3	0.7	0.0	0.2	0.0	0.1	0.1	1.4	0.1	0.4	0.1	0.2	2.3	1.0	0.4	0.0	0.2	0.1	0.2	1.3	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
FAM189A1	"KIAA0574, TMEM228"	ENSG00000104059	"Family with sequence similarity 189 member A1"	O60320	15	29120254-29570723	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 15.3;parathyroid gland: 6.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.2;HDLM-2: 15.2;REH: 3.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA009410, HPA010637"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA009410: AB_1852332, HPA010637: AB_1852333"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.97e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.39e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.12e-1)"	0.8	1.5	12.8	0.6	7.9	0.4	0.6	4.2	9.5	0.4	4.0	1.5	0.0	1.0	1.1	0.8	0.6	1.5	0.5	0.7	15.3	4.7	1.7	0.5	1.5	0.5	3.5	3.4	0.4	3.3	6.5	0.0	0.7	4.0	0.8	3.0	0.0	1.1	0.5	0.4	0.8	3.2	1.0	0.7	1.3	0.6	2.3	0.3	0.0	1.9	0.0	1.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.2	15.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.5	0.0	0.0	0.5	0.0	3.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	12.8	7.9	4.2	9.5	15.3	4.7	3.5	3.4	4.0	0.3
FAM196A	"C10orf141, FLJ45557, INSYN2"	ENSG00000188916	"Family with sequence similarity 196 member A"	Q6ZSG2	10	127135426-127196158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.7"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 5.3;U-87 MG: 10.4"	"Group enriched"	"Detected in some"	13	"breast cancer: 3.4;glioma: 3.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	30	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	30	"dendritic cells: 3.0"	"Low region specificity"	"Detected in many"							"HPA035898, HPA035899"	Uncertain									"HPA035898: AB_10964352, HPA035899: AB_10961723"	"unprognostic (4.00e-2)"	"unprognostic (9.28e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.18e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.18e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.47e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.45e-1)"	0.6	0.4	3.7	1.0	11.7	0.4	3.0	2.3	8.3	0.3	1.7	0.9	0.0	0.8	0.4	1.7	0.6	0.4	1.0	1.0	2.8	5.0	1.2	0.3	0.5	0.5	4.4	3.0	3.4	0.9	0.3	0.8	0.4	4.7	3.6	0.7	0.3	3.4	0.7	0.4	0.8	1.4	0.8	1.9	1.5	0.9	3.0	2.9	2.2	0.5	0.0	0.7	1.6	0.3	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.2	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.2	0.8	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.2	0.0	5.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.5	0.0	0.1	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	3.7	11.7	2.3	3.6	2.8	5.0	4.4	3.0	4.7	2.9
FAM196B	C5orf57	ENSG00000204767	"Family with sequence similarity 196 member B"	A6NMK8	5	169864264-169980740	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.5;breast: 14.4;salivary gland: 10.6"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 19.8;HUVEC TERT2: 12.6;U-138 MG: 32.9;U-251 MG: 11.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047227	Uncertain									"HPA047227: "	"unprognostic (5.30e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.92e-1)"		"unprognostic (1.26e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.31e-5)"	"unprognostic (5.16e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.73e-3)"	1.4	1.5	3.8	1.3	8.8	1.1	14.4	2.3	10.4	0.6	0.6	13.5	0.0	0.5	0.8	0.5	0.6	0.6	1.1	0.8	4.9	3.6	1.4	0.7	0.7	0.6	6.7	3.5	4.6	0.6	0.5	3.3	0.6	5.2	2.1	0.6	6.7	10.6	0.6	0.5	1.0	0.5	1.1	7.9	3.0	0.5	0.7	5.9	0.0	2.3	0.0	0.5	0.8	0.4	0.3	0.1	0.9	0.4	0.0	0.4	0.0	0.1	0.2	0.7	0.0	5.2	1.9	0.0	3.5	1.8	3.0	2.3	0.0	0.0	0.0	7.9	19.8	0.0	0.1	6.1	5.8	0.0	0.0	0.0	1.3	0.0	1.0	0.0	0.0	0.7	0.0	4.1	3.7	12.6	0.0	0.0	7.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	32.9	0.3	0.9	11.1	0.0	0.0	0.0	5.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.4	0.9	0.0	0.2	0.0	0.0	0.0	3.8	8.8	2.3	8.3	4.9	3.6	6.7	3.5	5.2	5.9
FAM198B	"C4orf18, DKFZp434L142, ENED, FLJ38155"	ENSG00000164125	"Family with sequence similarity 198 member B"	Q6UWH4	4	158124474-158173318	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 83.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.1;ASC TERT1: 39.8;HSkMC: 45.6;HUVEC TERT2: 50.9;WM-115: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"classical monocyte: 23.8;intermediate monocyte: 14.8;myeloid DC: 7.6;non-classical monocyte: 6.8"	"Group enriched"	"Detected in many"	37	"dendritic cells: 7.6;monocytes: 23.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007227	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoli fibrillar center"	"HPA007227: AB_1847689"	"unprognostic (4.87e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.60e-3)"	"unprognostic (9.42e-3)"	"unprognostic (2.37e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.74e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.89e-2)"	24.1	83.8	13.9	12.9	12.6	0.9	15.9	22.9	16.0	16.7	8.9	12.1	6.2	4.5	27.5	13.2	6.0	10.6	12.6	25.8	24.2	9.0	4.2	2.9	6.9	7.1	18.6	20.2	50.1	4.8	4.4	2.7	9.5	12.4	8.3	8.1	4.2	7.9	10.8	3.8	3.5	6.3	23.9	25.9	15.7	7.5	7.0	17.5	0.0	8.2	3.1	2.3	14.2	7.3	0.0	7.6	0.4	23.8	0.0	0.0	7.3	3.2	2.6	1.6	0.3	21.1	39.8	3.0	0.8	0.6	0.1	1.0	3.4	1.2	0.0	0.1	1.3	0.0	18.6	4.9	0.5	0.0	0.0	0.2	0.0	9.5	14.1	0.1	0.0	45.6	1.2	6.5	0.7	50.9	3.3	0.0	9.4	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	7.1	0.1	0.0	0.0	7.4	2.1	1.4	0.0	2.4	4.3	4.7	2.5	1.6	0.0	0.0	11.6	0.6	0.0	19.6	0.0	23.8	0.0	0.0	14.8	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.4	0.0	6.8	0.3	0.0	7.3	13.9	12.6	22.9	16.0	24.2	9.0	18.6	20.2	12.4	17.5
FAM19A3	"TAFA-3, TAFA3"	ENSG00000184599	"Family with sequence similarity 19 member A3, C-C motif chemokine like"	Q7Z5A8	1	112720419-112727235	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	12	"adrenal gland: 19.6;brain: 5.2;testis: 8.8"	"Cell line enhanced"	"Detected in some"		"A-431: 2.7;BJ hTERT+: 9.3;HEL: 3.6;U-87 MG: 3.7"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA055927	Approved				"Secreted in other tissues"					"HPA055927: AB_2682972"	"unprognostic (9.96e-2)"	"unprognostic (4.30e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.63e-4)"	"prognostic unfavourable (9.60e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.14e-6)"	"unprognostic (2.10e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-1)"	0.1	19.6	0.4	0.1	0.0	0.0	0.3	5.2	0.4	0.1	0.0			0.0	0.1	0.9	0.2	0.4	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.4	3.9		0.6	0.0	0.0	0.2	0.1		0.3	0.0		0.1	0.2	0.0	0.2	0.0	0.0	1.2	0.0	0.0	8.8			0.2		0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.2	0.0	0.0	0.6	0.7	0.2	9.3	0.7	0.6	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.5	0.4	1.5	0.3	3.6	0.0	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.2	0.0	0.0	0.4	0.4	0.4	0.1	0.0	0.2	2.3	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.3	0.6	0.0	1.1	0.0	1.3	1.3	0.2	0.5	0.1	0.0	0.0	3.7	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FAM19A5	TAFA-5	ENSG00000219438	"Family with sequence similarity 19 member A5, C-C motif chemokine like"	Q7Z5A7	22	48489460-48850912	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.2"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 13.5;HEK 293: 9.1;Hep G2: 20.8;NTERA-2: 11.7;U-2 OS: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025629	Approved				"Secreted in brain"					"CAB025629: "	"unprognostic (2.86e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.82e-3)"	"unprognostic (2.41e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.31e-3)"	"unprognostic (2.64e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.94e-2)"	1.9	2.5	22.7	1.7	18.7	0.7	2.7	19.1	40.2	12.2	1.8	8.5	0.1	2.0	8.1	6.9	1.1	3.4	3.4	1.4	23.6	22.8	1.9	3.0	2.2	1.2	18.1	12.9	8.3	2.4	0.8	1.9	0.8	8.7	4.0	1.0	0.7	7.3	5.7	1.5	1.9	2.6	1.8	9.9	1.1	3.7	2.5	7.3	1.3	1.1	0.0	1.0	2.9	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.8	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.5	0.0	0.9	0.0	0.0	0.0	9.1	0.0	0.1	20.8	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.2	11.7	0.0	0.5	0.0	5.0	0.0	0.0	5.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	16.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	18.7	19.1	21.9	23.6	22.8	18.1	12.9	8.7	7.3
FAM204A	"bA319I23.1, C10orf84, FLJ13188"	ENSG00000165669	"Family with sequence similarity 204 member A"	Q9H8W3	10	118297930-118342328	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038182, HPA062025"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA038182: AB_10669519, HPA062025: "	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (8.52e-3)"	"unprognostic (4.47e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.13e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (8.59e-4)"	"unprognostic (5.55e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.76e-3)"	31.2	17.5	30.0	18.5	31.6	40.3	28.1	18.9	37.8	24.9	26.8	20.0	19.6	17.9	27.4	29.5	26.1	19.2	19.2	29.5	25.4	21.7	25.0	24.8	21.4	22.4	23.4	25.9	26.2	21.4	19.1	31.3	19.1	30.4	21.1	21.6	19.4	21.9	20.7	36.3	17.1	18.5	34.0	31.2	24.1	20.8	39.9	20.9	19.8	26.0	21.9	23.0	32.8	18.4	27.4	32.4	36.6	35.1	17.5	27.2	28.7	21.4	9.7	16.0	22.3	16.0	17.5	9.1	17.0	32.1	24.7	22.4	11.4	20.1	15.3	10.6	18.3	18.6	13.4	17.8	22.5	24.0	16.6	12.7	10.0	10.0	23.9	32.8	18.1	12.0	21.8	18.1	38.1	21.0	13.2	18.1	20.4	12.0	20.1	30.6	11.3	8.7	17.3	31.0	11.2	22.3	11.0	10.3	16.3	11.7	10.9	25.0	17.4	23.8	14.6	13.0	12.2	11.5	25.8	13.0	11.5	22.0	25.4	35.6	13.1	29.8	31.7	36.6	21.7	34.4	22.7	27.4	24.6	19.8	32.4	20.2	21.3	24.7	17.6	17.5	35.1	23.5	27.2	28.7	30.0	31.6	18.9	37.8	25.4	21.7	23.4	25.9	30.4	20.9
FAM205A	C9orf144B	ENSG00000205108	"Family with sequence similarity 205 member A"	Q6ZU69	9	34723055-34729467	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	243	"testis: 24.3"	"Cell line enhanced"	"Detected in single"		"THP-1: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA071267	Enhanced									"HPA071267: "	"unprognostic (2.25e-1)"					"unprognostic (3.66e-3)"		"unprognostic (6.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.73e-3)"	"unprognostic (7.82e-2)"	"unprognostic (9.61e-2)"	"unprognostic (6.41e-2)"	"unprognostic (4.78e-1)"		"unprognostic (7.34e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM209B	"C20orf107, dJ1153D9.4"	ENSG00000213714	"Family with sequence similarity 209 member B"	Q5JX69	20	56533246-56536520	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 40.8"	"Cell line enhanced"	"Detected in many"		"U-266/70: 4.9"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in many"		"eosinophil: 3.4"	"Low lineage specificity"	"Detected in many"											HPA042144	Enhanced									"HPA042144: AB_10794414"	"unprognostic (2.93e-1)"	"unprognostic (6.90e-2)"	"unprognostic (9.49e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.59e-4)"	"unprognostic (3.47e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.48e-4)"	0.2	0.0	0.0	0.2	0.1	4.1	0.3	0.1	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0		0.0	0.3	0.0	0.2	0.0		0.1	0.1		0.2	0.0	0.3	0.3	0.2	0.0	0.0	0.9	0.1	40.8			0.0		0.3	0.0	0.0	1.0	0.8	3.4	1.1	0.0	2.1	0.4	0.0	2.7	0.7	0.0	0.0	0.3	0.4	1.0	1.8	2.3	0.9	1.7	0.1	0.3	1.8	1.1	1.4	1.2	0.7	2.1	0.4	1.1	1.1	0.0	1.1	0.0	2.2	4.1	1.3	2.0	0.2	1.4	0.0	0.2	1.9	0.0	2.6	0.8	2.0	0.5	1.4	0.7	0.8	0.2	1.4	0.9	1.7	0.4	0.9	3.3	0.6	1.4	0.6	0.0	0.3	0.6	1.7	0.1	4.9	4.4	0.9	0.3	0.9	0.3	0.0	1.1	3.4	2.1	0.4	0.3	0.0	0.1	1.3	0.8	1.0	0.7	0.0	1.8	0.0	0.7	0.0	0.0	0.4										
FAM216A	"C12orf24, HSU79274"	ENSG00000204856	"Family with sequence similarity 216 member A"	Q8WUB2	12	110468364-110490385	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 43.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038286	Enhanced		Approved	"Actin filaments"				"Actin filaments"		"HPA038286: "	"unprognostic (7.91e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.02e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.76e-1)"	"prognostic unfavourable (4.49e-5)"	"unprognostic (8.49e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavourable (4.18e-10)"	"unprognostic (7.60e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.05e-1)"	3.3	6.6	8.6	6.1	11.7	3.7	3.9	15.8	19.7	4.6	2.5	3.8	0.7	1.8	4.9	1.5	2.6	3.9	4.2	7.0	11.6	13.0	3.0	3.2	2.1	6.3	8.3	11.9	6.5	2.3	4.4	4.0	3.7	12.5	4.1	2.5	1.2	2.2	5.1	6.0	1.9	2.3	5.6	6.6	4.3	2.2	43.9	6.2	5.0	3.0	1.4	4.4	3.8	2.5	9.9	5.5	3.2	4.9	2.5	12.3	5.4	7.9	7.0	5.0	6.6	3.7	6.9	1.3	14.2	3.8	16.4	7.5	6.9	2.3	28.9	3.8	6.5	5.8	9.4	8.5	18.6	9.2	22.8	14.8	4.4	5.0	5.5	17.7	11.6	6.3	2.1	8.3	18.3	5.4	15.8	7.5	10.8	2.7	14.1	22.7	17.4	12.8	7.2	7.7	20.3	5.7	0.1	25.1	8.2	6.9	4.3	3.5	11.5	10.3	4.8	5.5	2.3	4.8	13.6	13.9	10.1	22.5	8.9	16.4	10.0	1.4	4.9	1.9	3.1	3.3	4.4	9.2	4.8	5.0	5.5	9.9	12.3	7.3	3.2	2.5	3.1	2.9	3.3	5.4	8.6	11.7	15.8	19.7	11.6	13.0	8.3	11.9	12.5	6.2
FAM216B	"C13orf30, FLJ40919"	ENSG00000179813	"Family with sequence similarity 216 member B"	Q8N7L0	13	42781550-42791549	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 21.0;epididymis: 18.2;fallopian tube: 51.3;lung: 28.5;ovary: 18.3"	"Cell line enriched"	"Detected in single"	12	"U-87 MG: 6.3"	"Group enriched"	"Detected in some"	10	"endometrial cancer: 4.4;lung cancer: 1.4;ovarian cancer: 0.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.5;pons and medulla: 21.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040118	Uncertain									"HPA040118: AB_10674429"	"unprognostic (1.03e-2)"		"unprognostic (2.24e-1)"	"prognostic favourable (9.77e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.32e-1)"		"unprognostic (1.19e-1)"	"unprognostic (2.54e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.27e-1)"		"unprognostic (8.14e-3)"	"unprognostic (1.37e-1)"		"unprognostic (1.30e-2)"	0.3	0.2	1.7	0.9	9.5	0.2	0.2	0.1	0.6	3.0	0.3	8.0	0.0	0.3	1.3	18.2	0.2	51.3	0.4	10.0	3.1	3.2	0.2	0.2	28.5	2.2	0.1	0.0	18.3	0.3	0.2	2.0	0.2	21.0	0.2	0.5	0.0	0.7	0.2	0.2	0.2	1.5	0.2	0.5	0.3	0.3	1.0	1.7	0.0	0.2	0.0	3.9	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	9.5	0.1	0.6	3.1	3.2	0.1	0.0	21.0	1.7
FAM217A	"C6orf146, MGC43581"	ENSG00000145975	"Family with sequence similarity 217 member A"	Q8IXS0	6	4049434-4087344	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"testis: 16.9"	"Cell line enhanced"	"Detected in single"		"HeLa: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							HPA035455	Uncertain									"HPA035455: AB_10669905"	"unprognostic (5.93e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.54e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.51e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.4	1.3	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.5	0.3	0.1	0.3	0.4	0.5	1.3	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM217B	"C20orf177, dJ551D2.5"	ENSG00000196227	"Family with sequence similarity 217 member B"	Q9NTX9	20	59933764-59948680	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041021, HPA056698"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA041021: AB_10959734, HPA056698: "	"unprognostic (1.78e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.04e-8)"	"unprognostic (2.78e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.63e-2)"	5.5	5.2	17.7	7.2	18.2	14.7	6.2	18.7	29.6	6.4	5.4	10.7	5.0	6.2	8.6	7.3	5.9	7.2	5.1	11.7	15.5	14.3	6.8	2.8	6.5	10.3	14.4	19.1	13.7	4.0	5.9	14.3	7.7	14.1	9.6	4.6	4.7	5.8	11.8	16.5	4.3	7.1	5.8	10.7	7.4	5.6	10.8	11.6	8.5	8.5	4.9	10.4	7.0	6.8	7.2	8.0	13.8	7.0	9.3	13.5	6.9	5.2	3.6	8.5	5.8	4.1	6.2	6.8	7.6	6.5	8.4	6.1	18.9	11.6	11.8	12.9	3.1	13.2	9.2	6.3	8.3	6.5	5.8	11.0	9.1	10.8	2.6	17.4	14.9	3.6	7.9	6.2	2.0	2.4	7.8	5.0	5.4	9.7	30.4	9.6	8.3	7.5	7.4	8.4	11.4	3.2	8.4	8.7	10.4	10.2	13.2	11.1	12.8	12.5	3.4	7.1	8.3	7.2	4.0	8.5	14.4	14.0	9.8	11.5	4.6	9.6	7.0	9.5	11.0	4.6	13.5	6.6	10.6	10.0	8.0	7.2	11.0	11.6	13.8	9.3	4.3	6.4	9.1	6.9	17.7	18.2	18.7	29.6	15.5	14.3	14.4	19.1	14.1	11.6
FAM220A	"ACPIN1, C7orf70, MGC12966, SIPAR"	ENSG00000178397	"Family with sequence similarity 220 member A"	Q7Z4H9	7	6329409-6348981	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.7;testis: 40.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA055050			Approved	Vesicles				Vesicles		"HPA055050: "	"unprognostic (3.49e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.69e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.26e-2)"	"unprognostic (4.02e-2)"	"prognostic unfavourable (5.17e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.14e-2)"	"prognostic unfavourable (3.47e-4)"	"unprognostic (3.71e-2)"	5.8	6.9	10.5	5.1	9.3	2.3	7.7	14.0	16.6	7.5	6.1	6.8	3.8	4.3	8.1	6.1	8.9	6.2	5.9	12.6	10.3	9.7	6.5	5.1	4.9	6.8	8.3	11.6	8.7	10.5	15.3	7.2	6.0	7.9	6.6	4.4	5.6	7.2	6.9	56.7	7.7	4.6	7.3	7.9	5.8	5.3	40.9	5.4	9.7	9.1	11.8	7.7	7.5	6.3	11.1	9.6	9.5	5.5	16.2	10.2	3.8	15.8	10.0	7.4	17.2	17.1	14.5	8.1	8.1	10.2	9.9	11.6	6.6	8.9	13.2	9.4	9.6	11.7	11.1	6.9	12.9	9.2	7.1	4.4	8.0	7.4	18.5	7.9	6.7	8.1	23.3	7.4	17.9	9.2	8.5	12.7	8.5	12.4	4.9	14.6	17.2	13.1	12.7	11.1	11.1	9.0	5.8	7.5	13.1	11.4	14.1	17.0	13.6	20.9	6.9	7.8	18.0	15.2	10.4	13.7	21.2	14.4	9.1	14.4	24.0	6.7	5.5	9.5	5.5	4.5	5.7	11.1	6.6	8.5	9.6	10.6	10.2	8.4	2.4	16.2	4.7	7.7	8.3	3.8	10.5	9.3	14.0	16.6	10.3	9.7	8.3	11.6	7.9	5.4
FAM222A	"C12orf34, FLJ14721"	ENSG00000139438	"Family with sequence similarity 222 member A"	Q5U5X8	12	109714228-109770507	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.9"	"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 50.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040181, HPA058774"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites,Mitochondria"				"Nucleoplasm, Plasma membrane"	"Focal adhesion sites, Mitochondria"	"HPA040181: AB_10796448, HPA058774: "	"unprognostic (8.59e-3)"	"prognostic favourable (1.82e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.66e-2)"	"unprognostic (8.17e-2)"	"prognostic favourable (4.81e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.16e-2)"	"prognostic favourable (8.59e-4)"	"unprognostic (3.93e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	1.8	16.0	7.3	2.3	17.4	2.0	3.0	15.1	25.5	1.6	3.3	37.9	0.0	10.0	1.5	2.7	2.1	1.4	2.6	4.4	11.7	9.6	7.7	2.7	1.8	1.7	23.2	7.9	7.8	6.9	1.5	13.1	1.3	15.1	2.3	3.0	10.3	7.3	2.1	2.8	4.7	5.1	1.8	27.8	6.3	8.0	17.4	23.0	0.0	1.4	0.0	2.1	1.4	2.4	0.2	0.6	0.9	0.2	0.0	0.2	0.0	0.8	1.3	0.7	1.6	0.4	0.0	0.5	0.2	0.1	0.7	0.1	11.7	0.2	0.1	1.0	0.3	0.5	0.8	0.0	0.2	7.5	1.7	1.4	0.3	2.6	0.1	1.1	1.5	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.1	4.7	0.3	1.5	1.3	2.3	0.9	3.4	0.5	1.5	0.6	8.3	50.2	1.0	1.6	3.3	1.9	1.2	0.1	0.2	1.4	0.6	1.0	1.3	1.6	1.0	0.1	0.8	1.6	0.0	0.2	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	7.3	17.4	15.1	13.7	11.7	9.6	23.2	7.9	15.1	23.0
FAM227B	"C15orf33, FLJ32800"	ENSG00000166262	"Family with sequence similarity 227 member B"	Q96M60	15	49326962-49620931	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA049774, HPA061695"	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA049774: , HPA061695: "	"unprognostic (1.19e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.28e-4)"	"unprognostic (3.32e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.57e-3)"	"unprognostic (6.32e-3)"	"unprognostic (6.41e-2)"	"unprognostic (7.48e-5)"	"unprognostic (2.70e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.76e-1)"	1.9	7.6	8.0	6.4	8.4	1.8	9.1	2.4	6.7	10.5	6.5	11.6	10.6	3.8	9.0	10.5	4.8	11.0	5.3	11.5	7.8	7.2	10.9	9.7	4.9	7.6	9.8	7.1	13.9	8.6	9.0	28.4	1.8	6.6	8.1	3.9	6.7	7.2	8.7	10.8	5.2	4.0	11.3	9.5	3.7	4.5	19.0	8.1	12.1	10.1	5.2	5.6	8.6	4.0	5.5	4.7	7.8	0.9	3.3	8.2	2.6	0.9	0.9	5.9	3.2	1.9	3.5	0.7	2.5	3.4	3.7	6.1	0.8	2.8	1.7	5.8	3.9	0.9	2.1	3.5	4.4	3.9	1.7	3.7	1.5	1.8	5.0	1.6	1.6	3.7	4.7	2.2	2.3	3.4	5.8	2.8	8.1	3.8	3.4	1.4	2.6	1.5	3.0	5.0	8.8	5.5	1.1	4.5	6.2	2.3	2.9	6.8	3.5	1.3	2.4	2.6	2.1	3.4	1.4	14.1	11.4	5.3	2.9	4.4	2.7	7.8	0.3	2.4	4.9	0.7	6.4	4.0	4.9	6.4	0.5	5.5	8.2	7.8	0.6	3.3	0.9	4.7	4.2	2.6	8.0	8.4	2.4	6.7	7.8	7.2	9.8	7.1	6.6	8.1
FAM241A	"C4orf32, FLJ39370"	ENSG00000174749	"Family with sequence similarity 241 member A"	Q8N8J7	4	112145397-112195256	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 49.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA062443, HPA069294"	Approved		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"HPA062443: , HPA069294: "	"unprognostic (3.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.20e-3)"	"prognostic unfavourable (8.87e-4)"	"unprognostic (4.08e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.39e-2)"	43.2	4.8	3.3	11.9	3.0	7.0	49.5	3.6	3.1	6.9	9.5	4.6	10.7	3.1	8.9	6.0	7.6	5.2	6.2	18.5	4.3	3.0	6.4	6.9	10.2	7.2	5.6	1.8	5.2	3.8	7.1	6.3	12.6	3.4	9.7	3.2	2.8	22.3	17.2	11.6	7.2	4.7	9.0	4.3	9.7	8.3	7.7	3.6	6.3	8.5	7.3	6.0	9.3	24.7	2.7	2.8	5.7	1.7	1.7	1.7	0.7	3.9	1.6	1.6	1.3	8.4	4.8	2.5	3.4	0.8	0.6	1.1	1.1	5.0	25.9	3.2	1.8	1.9	2.5	3.5	1.2	12.2	4.2	2.8	3.8	2.1	5.0	6.4	1.7	5.2	5.7	0.9	6.0	17.9	5.2	12.6	2.0	4.1	2.3	4.6	2.0	3.7	5.3	2.7	5.3	2.7	3.8	3.0	2.4	3.1	5.8	1.6	4.1	2.7	11.3	2.0	6.2	1.3	1.2	5.2	6.8	12.0	4.8	3.2	2.6	5.7	1.7	1.6	1.5	1.3	1.3	1.5	1.6	1.1	0.9	2.7	1.5	1.7	4.2	1.7	1.6	2.8	1.7	0.7	3.3	3.0	3.6	2.4	4.3	3.0	5.6	1.8	3.4	3.6
FAM35A	"bA163M19.1, FAM35A1, MGC5560"	ENSG00000122376	"Family with sequence similarity 35 member A"	Q86V20	10	87094161-87191468	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036582	Uncertain		Approved	"Nucleoplasm,Actin filaments"				Nucleoplasm	"Actin filaments"	"HPA036582: AB_10670233"	"unprognostic (1.08e-1)"	"unprognostic (2.72e-1)"	"prognostic favourable (6.06e-4)"	"unprognostic (1.77e-1)"	"prognostic favourable (3.09e-4)"	"unprognostic (5.34e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.44e-3)"	"unprognostic (3.61e-2)"	17.3	16.9	5.4	14.4	7.2	5.4	15.4	6.4	4.9	12.6	20.2	4.7	9.1	15.0	10.8	10.6	12.6	9.3	7.4	11.5	6.0	6.1	31.2	35.3	12.5	16.4	9.0	3.5	12.7	10.2	3.6	19.4	7.4	6.8	14.0	11.6	7.4	11.4	14.0	9.3	9.1	33.1	14.8	6.9	15.6	8.7	7.1	7.9	12.0	30.7	12.6	9.4	12.3	13.6	9.0	10.7	4.9	11.1	11.2	13.7	8.5	15.9	12.9	7.4	17.0	8.3	8.1	10.8	10.8	15.2	14.5	16.0	14.8	12.3	11.7	6.0	14.6	10.7	18.2	8.2	15.0	16.6	12.0	16.2	12.3	13.9	12.9	25.2	14.2	7.4	15.2	13.2	22.9	9.6	20.5	21.2	13.4	9.1	20.5	18.0	8.5	9.0	12.7	14.7	12.9	13.3	13.4	3.7	15.3	8.3	9.8	14.3	21.7	14.2	9.4	8.3	7.5	12.3	21.4	11.9	26.0	28.4	14.0	31.6	4.4	4.9	7.0	2.3	6.8	11.1	13.7	9.0	10.3	10.0	10.7	7.2	10.5	10.5	0.1	11.2	8.4	3.7	9.7	8.5	5.4	7.2	6.4	4.9	6.0	6.1	9.0	3.5	6.8	7.9
FAM43A	FLJ90022	ENSG00000185112	"Family with sequence similarity 43 member A"	Q8N2R8	3	194686544-194689037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 46.9;NB-4: 27.9;PC-3: 22.1;TIME: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048345	Uncertain		Approved	Vesicles				Vesicles		"HPA048345: "	"unprognostic (1.61e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.71e-3)"	"unprognostic (5.13e-3)"	"unprognostic (9.80e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.91e-3)"	"prognostic unfavourable (9.96e-4)"	10.7	1.8	1.6	3.5	1.6	2.4	10.4	2.7	4.2	5.2	4.2	2.1	1.6	0.8	4.8	2.7	5.3	6.0	4.2	7.0	2.7	1.6	4.6	23.5	5.6	8.0	2.5	3.6	3.5	7.0	0.5	2.7	9.3	4.1	7.9	1.7	3.3	6.7	2.1	5.5	8.6	3.8	2.9	1.6	20.6	2.7	6.1	2.3	2.6	2.6	5.8	5.2	5.7	8.9	5.0	8.7	3.6	1.3	2.8	1.4	0.4	0.1	0.7	0.5	0.4	9.5	4.6	3.8	1.2	3.2	0.0	0.0	0.2	0.1	0.4	13.4	4.4	1.4	0.8	0.3	0.0	0.3	2.4	1.7	3.7	0.5	0.7	0.4	4.9	1.2	2.0	0.2	0.0	46.9	0.9	0.9	0.1	0.7	0.0	27.9	2.2	22.1	2.0	0.1	0.2	0.0	0.0	13.0	1.1	0.8	0.8	2.7	0.5	5.7	23.4	0.5	0.7	0.6	0.2	0.0	0.4	1.2	0.2	12.7	8.8	3.6	1.3	1.5	1.0	1.1	1.4	2.3	0.6	0.9	1.3	5.0	0.1	0.3	1.6	2.8	0.7	8.7	0.4	0.4	1.6	1.6	2.7	4.2	2.7	1.6	2.5	3.6	4.1	2.3
FAM43B	FLJ44952	ENSG00000183114	"Family with sequence similarity 43 member B"	Q6ZT52	1	20552439-20555010	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"adrenal gland: 21.9;brain: 14.9;epididymis: 8.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.5;BJ hTERT+: 3.3;fHDF/TERT166: 6.5;Hep G2: 4.8;SCLC-21H: 5.9;SiHa: 11.0"	"Cancer enhanced"	"Detected in some"		"glioma: 4.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA050813	Approved		Approved	Cytosol				Cytosol		"HPA050813: "	"unprognostic (1.51e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.74e-1)"	"unprognostic (8.33e-2)"	"unprognostic (5.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.46e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.78e-4)"	"unprognostic (1.06e-2)"	"unprognostic (6.05e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.12e-2)"	3.2	21.9	5.6	1.5	14.9	0.9	1.5	8.8	14.4	1.6	1.3	2.4	0.0	1.1	1.4	8.7	1.3	1.6	1.5	3.3	5.3	12.1	2.6	1.4	1.2	1.0	10.1	6.0	1.0	1.2	0.9	0.7	2.5	11.2	1.4	1.1	0.5	1.2	1.3	2.8	1.0	1.2	2.9	4.0	1.4	0.9	1.3	2.8	0.0	1.3	1.7	0.9	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	4.5	0.2	0.1	0.0	0.5	3.3	0.6	0.0	0.1	0.0	0.0	0.2	6.5	0.0	0.7	0.0	0.1	0.0	0.9	0.1	0.3	4.8	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.4	0.0	0.0	0.0	0.0	0.0	5.9	0.7	11.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	14.9	8.8	14.4	5.3	12.1	10.1	6.0	11.2	2.8
FAM45A		ENSG00000119979	"Family with sequence similarity 45 member A"	Q8TCE6	10	119104086-119137984	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041159			Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"		"HPA041159: AB_10793871"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.20e-2)"	12.2	13.2	16.2	8.5	20.0	17.0	9.5	10.2	17.6	11.6	12.5	10.2	6.5	7.6	9.4	10.7	16.0	9.0	8.5	10.8	13.5	10.4	16.6	18.9	8.6	6.8	10.6	17.6	17.3	8.8	11.6	5.4	10.8	18.4	8.9	11.0	7.7	10.7	8.3	14.0	12.0	9.7	9.8	13.5	8.4	9.7	7.1	11.5	10.1	14.8	10.8	9.9	13.1	14.7	2.3	9.9	30.2	19.2	3.8	10.0	6.0	8.3	9.8	12.5	14.4	21.4	21.4	5.5	11.9	29.8	10.7	10.3	9.5	11.2	5.9	4.5	14.6	12.6	10.6	10.4	9.3	10.0	6.0	1.3	3.4	8.3	24.4	3.5	2.8	22.2	8.9	7.8	11.0	14.4	2.8	6.7	13.4	6.7	4.4	6.0	7.5	4.0	4.8	15.7	4.3	10.3	8.9	2.1	8.3	8.5	8.9	17.4	8.6	12.3	14.6	7.6	3.9	7.8	6.0	7.3	2.7	6.5	12.3	15.3	3.4	23.0	15.1	30.2	4.2	18.3	3.4	2.3	6.3	5.5	9.9	1.9	3.1	4.1	20.1	3.8	19.2	2.5	10.0	6.0	16.2	20.0	10.2	17.6	13.5	10.4	10.6	17.6	18.4	11.5
FAM47A	MGC27003	ENSG00000185448	"Family with sequence similarity 47 member A"	Q5JRC9	X	34129756-34132314	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	127	"testis: 12.7"	"Group enriched"	"Detected in some"	7	"REH: 1.4;U-266/84: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA000610	Uncertain									"HPA000610: AB_1078805"															"unprognostic (1.68e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM47B	FLJ35782	ENSG00000189132	"Family with sequence similarity 47 member B"	Q8NA70	X	34942796-34944915	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	44	"testis: 18.8"	"Cell line enhanced"	"Detected in single"		"U-138 MG: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046829, HPA050996"	Uncertain									"HPA046829: , HPA050996: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM47E	"FLJ42946, LOC100129583"	ENSG00000189157	"Family with sequence similarity 47 member E"	Q6ZV65	4	76214040-76283780	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 8.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"naive B-cell: 3.1;plasmacytoid DC: 2.3"	"Group enriched"	"Detected in many"	5	"B-cells: 3.1;dendritic cells: 2.3"									HPA053331	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA053331: "	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.90e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-8)"	"unprognostic (1.01e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.01e-2)"	5.5	6.8	12.5	0.8	8.5	1.2	8.9	2.4	14.8	3.7	3.2	9.2	4.4	4.3	2.4	15.5	1.6	23.5	5.1	3.2	10.1	13.7	9.1	11.2	4.8	0.9	10.7	15.5	1.2	9.7	9.9	10.3	10.0	12.1	5.2	3.8	2.7	5.4	4.0	9.5	2.0	4.2	3.0	13.3	1.8	6.0	9.2	6.2	0.0	13.2	1.5	0.9	2.6	1.1	3.1	2.3	0.1	0.4	0.1	0.5	0.1	0.8	3.6	3.3	0.9	2.5	0.4	0.7	0.4	2.3	0.7	0.8	4.2	3.2	0.2	1.0	1.2	1.1	1.5	0.8	1.3	3.4	0.2	0.2	2.0	5.9	1.5	0.8	0.6	1.5	0.9	1.0	0.9	0.5	0.3	2.1	1.1	5.2	0.3	0.4	0.7	1.8	0.5	0.9	0.5	4.5	3.0	5.6	4.1	1.5	1.9	0.6	1.9	0.4	0.9	0.7	0.7	2.1	0.6	8.0	1.9	0.3	2.4	0.3	1.1	0.0	0.4	0.1	0.2	0.0	0.5	0.2	0.2	0.1	0.2	3.1	0.4	0.1	0.1	0.1	0.4	2.3	0.0	0.1	12.5	8.5	2.4	14.8	10.1	13.7	10.7	15.5	12.1	6.2
FAM49A	"DKFZP566A1524, FLJ11080"	ENSG00000197872	"Family with sequence similarity 49 member A"	Q9H0Q0	2	16549459-16666331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 45.8;brain: 39.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 22.7;HUVEC TERT2: 18.1;RH-30: 40.8;SK-BR-3: 12.0;TIME: 14.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017847, HPA060398"	Approved		Approved	Nucleoplasm				Nucleoplasm		"CAB017847: , HPA060398: "	"unprognostic (3.45e-1)"	"unprognostic (1.83e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.78e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.74e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavourable (1.83e-6)"	"unprognostic (1.32e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.82e-2)"	"prognostic unfavourable (4.46e-4)"	10.8	9.1	22.7	15.6	28.0	15.3	7.0	6.6	39.5	13.7	5.3	7.0	1.2	2.9	8.2	2.1	4.3	6.2	8.7	3.3	17.2	14.1	1.9	6.1	9.6	13.4	10.2	25.2	10.0	2.4	1.1	4.8	15.3	9.9	6.9	5.3	2.9	3.2	7.3	6.0	2.9	4.6	8.6	6.0	20.1	3.4	1.8	6.3	1.9	31.8	1.1	13.6	7.7	7.4	8.9	15.5	45.8	34.4	13.4	5.3	8.5	0.2	0.0	2.6	0.1	2.7	0.8	7.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.0	1.6	0.6	1.0	0.0	2.7	0.1	1.5	0.0	0.0	1.4	0.0	22.7	1.3	1.0	0.2	0.0	18.1	0.1	2.0	1.6	0.1	0.0	5.2	1.1	0.0	0.8	40.8	0.1	2.2	10.1	0.4	1.5	0.0	12.0	0.0	0.4	0.7	14.2	0.2	2.3	0.0	0.0	1.2	0.0	1.3	6.0	1.1	0.8	0.0	23.6	31.4	5.3	29.8	0.6	8.9	0.2	2.7	15.5	6.1	0.2	2.1	45.8	13.4	34.4	7.7	0.1	8.5	22.7	28.0	6.6	33.3	17.2	14.1	10.2	25.2	9.9	6.3
FAM69A	FLJ23493	ENSG00000154511	"Family with sequence similarity 69 member A"	Q5T7M9	1	92832737-92961522	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015718, HPA017281"	Approved		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA015718: AB_1848405, HPA017281: AB_1848406"	"prognostic favourable (8.96e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavourable (1.45e-7)"	"unprognostic (1.26e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.66e-2)"	13.3	3.4	20.7	10.4	22.5	7.0	7.8	19.4	22.2	7.3	13.2	15.9	4.2	8.8	15.7	3.8	9.3	8.3	11.1	5.3	22.6	18.0	6.1	24.7	4.5	10.1	25.0	12.2	6.0	3.5	20.5	4.1	12.8	17.7	9.5	12.4	5.4	5.5	11.3	7.5	5.6	8.2	19.4	24.7	7.6	8.8	6.4	24.4	9.6	6.2	3.6	8.8	12.2	6.0	22.5	7.1	0.2	0.9	11.8	14.2	6.7	4.2	4.7	1.9	4.7	7.4	13.9	2.4	13.4	27.7	7.6	15.5	2.7	0.9	14.5	2.4	24.7	5.5	0.3	10.1	12.7	5.8	4.8	0.5	3.7	6.8	2.6	1.3	0.9	8.2	8.1	16.7	3.8	0.1	5.1	15.5	9.6	1.6	4.8	1.2	3.5	1.9	4.3	14.3	4.5	1.1	4.5	4.9	3.8	3.7	3.7	4.9	1.8	0.4	0.5	9.0	6.9	17.5	4.7	23.4	22.3	17.0	4.3	0.9	0.8	0.0	0.9	0.0	10.5	0.4	8.1	22.5	12.1	8.2	4.3	13.6	14.2	12.1	0.2	11.8	0.2	7.1	10.7	6.7	20.7	22.5	19.4	22.0	22.6	18.0	25.0	12.2	17.7	24.4
FAM69C	C18orf51	ENSG00000187773	"Family with sequence similarity 69 member C"	Q0P6D2	18	74434099-74457944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.1;heart muscle: 10.8"	"Cell line enriched"	"Detected in some"	9	"SK-MEL-30: 10.7"	"Group enriched"	"Detected in some"	18	"glioma: 11.1;melanoma: 6.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048928	Enhanced									"HPA048928: "	"unprognostic (6.35e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.09e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.31e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.91e-4)"	"unprognostic (2.16e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.40e-3)"	1.1	0.9	13.8	0.7	20.5	0.6	1.1	3.5	29.1	3.4	1.0	9.5	0.0	0.7	0.9	0.8	0.8	1.0	1.3	10.8	11.0	9.0	0.8	1.1	0.6	0.7	15.5	5.2	0.7	0.9	0.8	0.1	0.9	9.9	1.1	0.9	3.7	0.9	1.7	2.3	7.0	0.9	0.9	5.3	0.8	3.0	7.3	18.8	0.0	0.8	0.0	0.7	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	20.5	3.5	10.3	11.0	9.0	15.5	5.2	9.9	18.8
FAM71A	FLJ32796	ENSG00000162771	"Family with sequence similarity 71 member A"	Q8IYT1	1	212624474-212626778	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	149	"testis: 57.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.1;SK-BR-3: 1.5;U-266/70: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA028462	Enhanced									"HPA028462: AB_10601904"																		0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	57.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM71E1		ENSG00000142530	"Family with sequence similarity 71 member E1"	Q6IPT2	19	50466785-50476753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 36.0"	"Cell line enriched"	"Detected in many"	4	"HEK 293: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA048111			Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA048111: "	"unprognostic (2.16e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.66e-2)"	"unprognostic (8.65e-2)"	"unprognostic (8.19e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.45e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (5.35e-7)"	"unprognostic (7.26e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.37e-2)"	0.5	1.3	4.3	0.9	5.4	0.5	1.3	3.6	4.3	2.0	1.3	0.0	7.1	2.2	0.9	3.6	1.2	2.7	2.1	1.6	3.1	5.0	2.3	3.6	3.5	0.5	5.5	2.8	2.6	5.6	1.4	10.9	1.1	1.5	1.9	0.8	0.6	7.4	4.7	4.6	1.3	1.8	0.5	2.1	0.7	1.9	36.0	0.5	1.5	3.6	4.6	0.7	0.8	0.3	2.4	2.3	1.6	0.9	3.6	3.5	0.8	2.3	1.6	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	2.2	0.4	0.0	0.1	3.6	0.0	0.9	0.0	0.2	17.0	0.0	0.9	0.0	2.8	0.1	2.2	0.7	1.9	0.2	0.4	0.0	0.6	1.2	0.0	3.3	0.6	0.0	0.0	2.5	1.7	0.3	1.0	1.1	3.1	4.0	1.0	1.2	4.1	0.5	3.1	1.2	0.0	0.0	1.1	0.2	0.3	0.9	1.8	0.1	0.0	0.0	0.2	0.8	0.9	1.6	2.3	0.1	3.5	1.4	2.2	1.3	0.2	2.4	2.3	3.0	0.7	3.6	0.5	2.3	0.2	0.8	4.3	5.4	3.6	4.3	3.1	5.0	5.5	2.8	1.5	0.5
FAM71F1	"FAM137A, NYD-SP18"	ENSG00000135248	"Family with sequence similarity 71 member F1"	Q96KD3	7	128709061-128731743	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	146	"testis: 64.8"	"Cell line enriched"	"Detected in some"	12	"NTERA-2: 19.0"	"Cancer enriched"	"Detected in single"	23	"testis cancer: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA020636			Uncertain	Cytosol				Cytosol		"HPA020636: AB_1854739"	"unprognostic (3.09e-2)"	"unprognostic (3.39e-3)"		"unprognostic (6.03e-2)"	"unprognostic (5.25e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-5)"	"unprognostic (1.48e-1)"	"unprognostic (2.18e-6)"	"unprognostic (6.97e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.99e-1)"	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	64.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.2	1.5	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.0
FAM71F2	FAM137B	ENSG00000205085	"Family with sequence similarity 71 member F2"	Q6NXP2	7	128672288-128687872	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	7	"testis: 28.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA020513, HPA024248"	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA020513: AB_1853077, HPA024248: "	"unprognostic (1.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.83e-2)"	"unprognostic (8.29e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.65e-4)"	"unprognostic (3.17e-2)"	"unprognostic (3.85e-4)"	"unprognostic (3.00e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.40e-4)"	"unprognostic (2.47e-2)"	1.4	1.1	0.7	0.7	1.2	1.3	0.7	1.8	1.1	0.7	0.7	0.7	0.7	0.4	0.7	1.6	0.7	0.5	0.8	0.9	0.7	0.7	0.9	0.7	0.7	0.7	0.7	0.7	0.9	0.7	0.2	2.5	0.7	0.7	0.9	0.5	0.7	1.6	0.7	1.6	1.3	0.7	1.0	0.7	1.2	1.0	28.1	0.7	0.7	0.9	0.7	0.7	0.7	0.7	1.4	1.3	4.2	0.8	1.2	0.9	0.2	0.8	1.3	1.5	2.9	2.6	2.0	0.7	1.7	0.4	0.4	1.0	0.3	1.4	0.9	0.8	2.8	1.9	0.2	0.7	0.7	0.8	1.3	0.5	2.6	0.2	0.7	0.7	1.8	1.6	0.7	2.9	0.5	0.4	0.4	1.4	1.2	1.3	0.4	1.4	0.9	1.9	1.0	0.3	0.4	1.0	3.5	1.2	0.7	0.7	0.8	2.2	1.0	0.4	4.2	1.8	0.7	3.8	1.5	2.9	2.4	0.9	1.0	1.2	1.2	3.9	0.8	0.6	0.5	0.4	0.5	0.8	0.6	0.5	0.3	1.4	0.6	0.6	4.2	1.2	0.5	1.3	0.9	0.2	0.7	1.2	1.8	1.1	0.7	0.7	0.7	0.7	0.7	0.7
FAM72B	RP11-439A17.6	ENSG00000188610	"Family with sequence similarity 72 member B"	Q86X60	1	121167646-121185539	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 6.5;lymphoid tissue: 9.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.3"	"Low lineage specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA043271: , HPA067321: "	"unprognostic (8.53e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.25e-3)"	"unprognostic (4.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-4)"	"unprognostic (8.22e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.46e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.30e-2)"	1.0	0.8	1.3	4.1	1.0	6.5	0.6	5.1	1.0	0.5	1.0			1.3	0.4	0.2	3.0	0.5	1.0	0.2	1.6	0.9	0.3	0.4	0.8	9.3	1.4		0.4	0.1	1.5	0.1	1.4		0.2	1.3		0.5	0.0	0.0	2.1	1.3	0.7	1.4	3.2	0.9	3.6			0.2		7.9	0.9	0.9	0.8	3.3	0.1	2.4	0.8	1.4	1.1	11.9	4.4	7.4	3.6	0.7	1.1	5.8	6.4	2.7	7.5	6.3	0.1	6.3	26.6	8.9	1.2	7.5	10.1	3.6	11.6	17.6	7.5	11.5	4.9	5.3	0.4	19.9	10.3	0.6	0.4	5.9	12.0	4.5	15.0	16.4	5.4	5.0	10.0	16.4	13.9	9.1	15.0	15.8	12.1	2.9	1.4	8.0	4.6	4.8	3.7	3.7	5.0	15.6	1.5	6.2	10.5	12.0	11.2	14.6	18.1	26.3	5.5	21.7	14.3	0.0	2.4	0.0	0.0	0.9	0.0	0.8	0.4	0.5	3.3	0.3	0.0	0.1	0.1	0.8	1.1	0.4	1.4	1.1										
FAM72D		ENSG00000215784	"Family with sequence similarity 72 member D"	Q6L9T8	1	145096000-145112696	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.7"	"Low lineage specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA043271: , HPA067321: "	"unprognostic (2.70e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.10e-3)"	"unprognostic (5.88e-5)"	"unprognostic (7.65e-4)"	"unprognostic (6.72e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.46e-1)"	"unprognostic (0.00e+0)"	"unprognostic (6.63e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.74e-2)"	"unprognostic (6.50e-2)"	1.1	0.7	0.8	7.2	0.8	5.5	0.7	4.0	0.9	0.6	1.1	0.6	0.4	1.4	0.8	0.4	4.4	0.2	0.5	0.4	1.0	0.7	0.5	0.4	1.3	7.6	1.0	0.4	0.4	0.4	0.3	0.4	1.5	0.8	0.4	1.6	0.4	0.6	0.4	0.4	2.9	2.0	0.5	1.1	3.3	0.8	6.7	0.4	17.7	0.4	2.7	7.4	1.1	2.5	0.1	0.7	0.1	1.7	0.0	1.0	0.5	8.3	5.1	6.0	2.4	0.2	0.5	6.6	4.8	1.4	6.1	3.8	3.4	7.6	13.7	4.9	0.7	8.9	7.3	1.4	7.2	11.0	7.3	6.8	2.5	5.0	0.1	12.2	7.7	0.3	0.5	4.8	9.3	2.7	13.6	19.2	4.0	6.3	8.2	11.9	11.4	7.1	7.3	7.6	16.2	2.1	1.1	5.9	5.0	3.6	3.3	2.2	9.3	7.9	1.2	4.5	5.0	3.8	8.6	14.5	22.8	21.3	0.0	9.7	5.1	0.0	1.2	0.0	0.0	1.7	0.0	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.0	0.5	0.8	0.8	4.0	0.9	1.0	0.7	1.0	0.4	0.8	0.4
FAM76A	MGC34648	ENSG00000009780	"Family with sequence similarity 76 member A"	Q8TAV0	1	27725979-27763122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044762, HPA077897"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA044762: AB_10795886, HPA077897: "	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.44e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.22e-2)"	"prognostic favourable (2.26e-4)"	"unprognostic (6.32e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-2)"	22.1	8.6	10.6	12.2	17.2	14.3	14.1	17.9	18.3	14.7	12.8	17.4	8.4	10.2	15.9	16.6	13.9	13.8	15.3	13.8	11.3	11.4	13.7	13.8	13.1	11.3	9.5	16.1	14.6	14.4	11.7	19.5	12.8	14.3	12.9	16.2	15.7	12.4	16.8	39.7	15.4	12.1	17.8	11.9	12.1	13.8	28.5	10.9	13.6	18.7	17.8	13.8	14.0	14.1	13.6	14.6	13.7	12.2	12.0	16.0	6.4	8.6	7.0	8.0	8.2	10.1	8.8	14.4	8.1	8.6	12.1	11.9	8.0	11.7	15.9	5.3	9.0	11.5	10.0	9.0	9.4	8.2	7.6	4.9	9.9	9.4	8.1	7.8	7.7	9.0	9.8	13.2	13.3	6.0	9.3	15.0	8.6	8.4	18.4	7.2	12.6	7.0	11.2	9.5	9.0	9.6	12.5	11.6	5.2	9.3	10.1	9.7	7.3	3.1	6.4	14.3	6.2	16.5	5.6	13.7	14.9	13.0	8.9	10.2	6.1	10.0	12.2	13.7	14.7	12.1	15.6	12.2	15.3	14.0	10.4	13.6	14.5	16.0	8.3	12.0	12.1	14.6	11.3	6.4	10.6	17.2	17.9	18.3	11.3	11.4	9.5	16.1	14.3	10.9
FAM78A	"C9orf59, FLJ00024"	ENSG00000126882	"Family with sequence similarity 78 member A"	Q5JUQ0	9	131258076-131276547	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.7;skeletal muscle: 32.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 18.1;HEL: 17.1;HL-60: 16.9;NB-4: 26.6;THP-1: 23.8;U-937: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021472, HPA023914"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"			"Nucleoplasm, Vesicles"		"HPA021472: AB_1848411, HPA023914: AB_1848412"	"unprognostic (5.16e-2)"	"prognostic favourable (3.67e-4)"	"unprognostic (3.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.71e-1)"	"prognostic favourable (2.00e-4)"	"unprognostic (3.24e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.83e-1)"	"unprognostic (5.84e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.61e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.39e-1)"	4.9	1.5	2.9	9.3	4.6	12.4	2.5	1.1	4.3	1.0	1.6	3.4	0.8	1.8	1.2	1.1	1.1	1.1	2.0	19.2	3.8	2.0	2.1	2.5	8.0	18.4	4.3	1.0	1.8	0.8	0.8	1.0	5.8	3.2	1.3	1.1	5.4	2.7	0.7	32.3	0.8	6.1	1.2	3.6	15.9	2.3	20.1	2.4	23.7	1.5	1.8	15.0	3.1	0.8	14.4	5.2	14.5	10.9	2.5	10.5	6.9	0.3	0.1	1.1	2.5	0.8	0.2	18.1	0.2	0.1	0.2	0.1	0.1	0.1	7.5	0.1	0.1	0.0	7.3	0.1	0.0	1.9	0.6	17.1	0.2	0.1	0.3	16.9	0.7	0.2	0.3	0.0	0.0	10.0	6.0	2.1	0.2	2.6	0.7	26.6	1.2	0.2	1.8	1.0	10.5	0.1	0.0	0.7	0.9	1.0	0.3	1.0	0.6	23.8	0.2	1.0	1.1	0.6	0.0	1.6	0.8	4.4	0.1	15.9	0.2	0.4	8.6	14.5	8.6	10.9	6.8	12.5	8.3	9.3	5.2	14.4	10.5	8.7	8.8	2.5	8.1	2.4	8.2	6.9	2.9	4.6	1.1	4.3	3.8	2.0	4.3	1.0	3.2	2.4
FAM78B		ENSG00000188859	"Family with sequence similarity 78 member B"	Q5VT40	1	166057426-166166969	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.2;SK-MEL-30: 10.9;U-2 OS: 3.0;WM-115: 3.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052789, HPA073246"	Uncertain		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA052789: , HPA073246: "	"unprognostic (7.38e-3)"	"unprognostic (1.14e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.16e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.69e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.87e-11)"	"unprognostic (7.41e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.69e-2)"	3.3	1.5	5.1	2.7	6.4	1.4	3.1	8.6	10.5	3.6	2.8	1.0	0.3	3.5	3.6	1.1	1.6	1.1	2.3	3.2	2.4	1.1	2.7	2.8	1.6	1.8	1.1	3.1	2.1	5.2	1.1	3.5	1.4	2.1	1.8	1.1	5.7	2.2	1.3	3.1	2.0	1.6	1.1	1.2	2.2	3.6	3.7	1.5	0.0	1.7	1.7	1.3	2.7	2.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	12.2	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.3	0.1	0.6	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.3	0.8	0.5	0.0	0.2	10.9	0.3	0.4	0.2	0.7	3.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	6.4	8.6	10.5	2.4	1.1	1.1	3.1	2.1	1.5
FAM81A	MGC26690	ENSG00000157470	"Family with sequence similarity 81 member A"	Q8TBF8	15	59372693-59523549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.2"	"Cell line enriched"	"Detected in many"	4	"Daudi: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.5;plasmacytoid DC: 12.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001847, HPA065797"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA001847: , HPA065797: "	"unprognostic (3.43e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.90e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.13e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.08e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.76e-1)"	"unprognostic (7.80e-2)"	1.0	0.8	13.7	3.1	14.0	0.4	1.8	1.2	32.2	8.4	5.2	3.2	0.7	3.0	3.3	5.7	1.0	7.8	2.1	1.9	16.1	8.7	8.7	0.8	1.1	5.7	5.6	17.7	1.1	2.5	0.6	3.3	1.1	3.7	3.1	6.6	1.2	3.3	2.2	0.9	1.5	1.8	1.7	4.3	1.8	3.1	2.2	1.9	0.0	2.7	0.0	6.6	0.9	1.1	2.6	12.5	0.4	0.6	0.1	0.0	0.3	5.7	8.4	0.6	0.1	0.2	0.1	3.4	0.3	0.0	0.5	1.6	1.0	1.0	36.7	0.2	0.1	4.4	4.7	1.4	1.1	0.4	2.4	0.0	5.6	0.3	0.0	3.1	0.7	0.0	0.9	0.2	0.4	0.0	0.0	0.0	0.5	1.9	0.0	0.1	0.5	3.0	0.8	8.5	0.9	1.9	2.1	1.7	0.5	3.3	0.1	5.4	1.4	1.9	0.2	1.4	4.3	1.6	6.2	0.0	0.0	0.4	1.4	1.2	3.8	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.5	2.6	0.0	0.0	0.4	0.1	0.0	12.5	0.0	0.3	13.7	14.0	1.2	32.2	16.1	8.7	5.6	17.7	3.7	1.9
FAM84A	"FLJ35392, NSE1"	ENSG00000162981	"Family with sequence similarity 84 member A"	Q96KN4	2	14632686-14650814	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.0;hTCEpi: 11.8;RT4: 31.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047703	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA047703: "	"unprognostic (1.05e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.36e-1)"	0.9	1.8	22.0	9.1	14.8	0.6	2.7	3.1	31.8	9.9	34.0	1.7	0.9	22.4	3.0	29.0	22.6	2.8	5.6	2.1	7.7	7.7	3.3	1.8	5.6	0.8	3.6	11.2	7.9	3.3	2.0	3.0	5.9	2.4	11.1	31.9	1.6	15.9	2.5	1.3	14.4	21.3	3.0	2.5	0.8	3.0	20.0	3.9	0.6	2.2	10.4	3.8	9.5	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	1.6	0.4	0.3	0.0	0.2	0.0	0.0	0.2	6.0	0.6	2.6	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.4	11.8	0.0	3.9	0.0	0.0	0.0	0.8	4.8	0.0	0.1	0.5	2.5	0.0	0.0	0.1	4.5	31.2	2.8	1.3	0.0	1.2	0.0	0.0	0.0	1.8	5.4	0.4	0.0	2.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	14.8	3.1	31.8	7.7	7.7	3.6	11.2	2.4	3.9
FAM86B1	MGC16279	ENSG00000186523	"Family with sequence similarity 86 member B1"	Q8N7N1	8	12182096-12194133	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 7.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 5.7"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA041610, HPA055718"	Uncertain		Uncertain	Vesicles				Vesicles		"HPA041610: , HPA055718: "	"unprognostic (1.90e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.69e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.58e-2)"	0.9	2.0	3.2	1.0	6.9	1.2	0.7	4.8	7.5	0.8	0.5			2.2	4.0	1.3	1.2	2.8	1.3	1.1	3.3	4.1	1.3	0.1	1.2	0.7	2.8		5.0	0.9	2.0	5.4	0.3		2.6	0.0		2.4	1.0	2.0	3.0	0.7	0.1	2.3	1.4	0.3	0.6			2.6		0.0	0.8	1.1	0.2	0.6	0.9	0.1	0.0	0.8	0.2	0.5	2.8	0.0	5.7	0.0	0.7	2.4	4.6	0.3	1.0	0.7	1.6	1.3	1.0	0.2	0.2	4.8	0.9	0.8	0.8	0.5	0.7	0.2	0.7	0.8	3.0	1.9	2.1	0.3	0.4	0.5	1.3	0.2	1.6	1.6	0.2	2.6	0.0	1.3	1.8	0.4	1.5	0.9	0.7	0.3	1.3	4.7	0.9	0.9	0.5	0.6	2.1	0.0	0.0	1.0	0.9	3.9	1.6	0.6	1.3	0.6	0.8	0.1	0.7	0.8	0.1	0.7	0.1	0.0	0.7	0.2	0.8	0.5	0.3	0.0	0.6	0.7	0.9	0.0	0.0	0.6	0.4	0.2										
FAM98C	FLJ44669	ENSG00000130244	"Family with sequence similarity 98 member C"	Q17RN3	19	38403135-38409088	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040930, HPA041730"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA040930: AB_10795484, HPA041730: AB_10804114"	"unprognostic (3.01e-2)"	"unprognostic (6.44e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavourable (8.51e-5)"	"unprognostic (2.82e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.96e-1)"	"prognostic favourable (5.53e-4)"	10.8	8.9	18.3	9.3	16.9	11.0	9.8	17.0	19.9	8.7	14.2	12.8	9.0	19.6	9.9	7.2	14.3	13.8	9.1	11.6	16.0	13.1	9.1	13.4	8.7	9.5	12.3	16.9	10.2	22.4	10.6	8.1	7.6	13.0	12.5	7.0	8.2	17.7	9.5	2.5	17.0	22.2	6.8	12.7	10.1	19.2	5.4	9.7	5.3	11.8	7.7	11.2	9.4	9.5	6.0	3.2	12.6	3.4	3.3	5.6	1.6	11.7	12.8	1.5	7.4	1.6	5.6	6.5	6.8	5.8	6.8	7.2	2.1	8.6	10.7	7.7	4.0	5.7	2.9	4.9	1.1	17.2	6.0	3.5	2.1	4.9	7.3	3.0	6.4	5.3	10.3	3.4	6.3	4.0	9.6	11.8	4.0	13.0	4.3	2.3	1.1	13.8	8.9	3.1	6.3	8.2	6.2	2.6	7.6	6.9	12.2	4.0	9.3	9.4	5.1	3.1	8.3	9.4	8.2	12.7	6.4	4.5	7.9	7.0	4.9	0.0	2.3	12.6	3.1	3.3	4.2	2.6	5.6	4.6	3.2	6.0	4.3	3.4	2.0	3.3	3.4	1.2	4.4	1.6	18.3	16.9	17.0	19.9	16.0	13.1	12.3	16.9	13.0	9.7
FAT3	"CDHF15, CDHR10, KIAA1989"	ENSG00000165323	"FAT atypical cadherin 3"	Q8TDW7	11	92352096-92896470	"Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.5;seminal vesicle: 6.0"	"Cell line enhanced"	"Detected in some"		"AF22: 8.0;fHDF/TERT166: 2.4;NTERA-2: 2.7;U-2 OS: 2.3;U-251 MG: 4.6"	"Cancer enriched"	"Detected in single"	6	"glioma: 1.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026878	Uncertain									"HPA026878: AB_1848430"	"unprognostic (5.00e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.76e-6)"	"unprognostic (1.27e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.56e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.66e-4)"	"unprognostic (8.83e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.25e-1)"	0.5	0.1	2.6	0.1	10.5	0.1	0.3	1.4	7.3	0.4	0.2			0.1	0.4	1.0	0.1	0.4	0.2	0.2	1.8	2.2	0.4	0.1	1.4	0.0	2.2		0.8	0.0	0.0	1.8	0.2		3.2	0.2		0.1	6.0	0.2	0.1	0.1	0.2	0.2	0.2	1.2	0.8			0.0		0.4	1.3	0.3	0.2	0.2	0.7	0.0	0.2	0.3	0.0	0.0	0.3	8.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.4	0.0	0.0	0.0	1.6	2.4	1.3	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.7	0.2	0.0	0.2	0.3	0.0										
FAXC	"C6orf168, dJ273F20, MGC2817"	ENSG00000146267	"Failed axon connections homolog"	Q5TGI0	6	99271169-99350062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 14.7;SCLC-21H: 21.5;SH-SY5Y: 15.0;SK-MEL-30: 13.2;WM-115: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039106	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA039106: AB_10697546"	"unprognostic (8.03e-2)"	"unprognostic (4.91e-2)"	"unprognostic (5.04e-3)"	"unprognostic (6.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (5.00e-3)"	"unprognostic (7.56e-2)"	"unprognostic (7.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.79e-3)"	"unprognostic (2.47e-3)"	"unprognostic (6.70e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.49e-3)"	0.7	3.3	9.4	2.1	12.2	0.4	4.6	11.0	19.7	1.8	13.3	1.8	5.1	2.3	4.5	15.3	8.6	2.4	3.5	1.3	7.7	10.3	2.5	0.3	2.3	0.4	9.1	9.9	3.4	2.2	9.3	10.4	1.4	7.5	10.1	4.3	1.4	5.8	15.1	0.9	0.4	2.1	19.1	4.8	0.8	5.2	2.8	1.6	0.0	2.0	0.2	0.5	13.6	1.7	1.2	0.6	1.4	0.6	0.8	0.4	0.0	2.3	1.9	6.5	8.9	0.0	0.0	2.4	3.1	1.9	5.1	4.4	1.2	0.8	0.0	0.3	0.6	0.1	14.7	2.9	4.4	0.0	7.3	0.0	1.2	0.4	0.4	0.0	0.0	0.3	4.6	0.1	2.4	0.0	0.3	0.0	1.6	4.2	0.0	0.0	7.6	3.0	0.0	0.6	0.0	2.7	0.1	21.5	15.0	2.7	2.0	13.2	6.2	0.0	0.6	1.6	2.9	0.0	9.3	0.0	0.0	0.0	0.1	0.0	12.1	0.8	0.6	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.2	1.2	0.3	0.4	1.4	0.8	0.3	0.6	0.2	0.0	9.4	12.2	11.0	17.4	7.7	10.3	9.1	9.9	7.5	1.6
FBLN7	"FLJ37440, TM14"	ENSG00000144152	"Fibulin 7"	Q53RD9	2	112138385-112188216	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 17.4;BJ hTERT+: 12.4;SCLC-21H: 11.2;SH-SY5Y: 9.0;U-2197: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"memory CD4 T-cell: 18.5;naive CD4 T-cell: 16.2;T-reg: 17.4"	"Lineage enriched"	"Detected in single"	36	"T-cells: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034992			Approved	"Plasma membrane,Cell Junctions"	"Secreted to extracellular matrix"		27000	"Plasma membrane"	"Cell Junctions"	"HPA034992: AB_10601469"	"unprognostic (1.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.70e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.80e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.33e-2)"	7.5	5.8	2.9	9.0	3.4	1.1	10.4	10.3	16.4	12.4	2.3	1.6	4.1	1.7	6.5	8.2	2.9	10.5	7.1	3.3	4.0	3.8	2.5	6.6	3.7	11.8	6.9	4.2	2.8	3.4	16.7	27.4	13.6	10.5	4.7	2.0	14.7	3.9	9.0	1.9	7.1	3.8	3.2	2.2	7.3	4.1	2.0	1.1	8.7	14.9	5.5	9.5	3.6	10.4	0.0	0.5	0.0	0.0	0.0	18.5	3.5	0.0	0.1	17.4	0.0	1.9	1.4	0.0	3.8	12.4	4.2	6.6	0.0	0.1	0.0	0.1	5.7	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.3	0.8	0.9	0.0	0.0	1.3	0.1	7.0	0.0	1.0	0.0	0.0	1.4	0.0	0.4	0.0	0.4	0.3	0.0	0.0	4.4	0.2	0.0	11.2	9.0	0.0	0.0	0.5	0.4	0.1	3.6	0.6	0.5	18.0	0.5	0.0	0.0	0.0	0.5	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.7	0.0	18.5	0.2	0.0	0.0	16.2	0.5	0.0	0.0	0.0	0.5	17.4	3.5	2.9	3.4	10.3	16.4	4.0	3.8	6.9	4.2	10.5	1.1
FBN3		ENSG00000142449	"Fibrillin 3"	Q75N90	19	8065402-8149846	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 5.2;salivary gland: 7.5"	"Group enriched"	"Detected in some"	4	"NTERA-2: 12.4;REH: 17.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA049482	Uncertain				"Secreted to extracellular matrix"					"HPA049482: "	"unprognostic (9.66e-3)"	"unprognostic (5.15e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (5.15e-4)"	"unprognostic (4.14e-2)"	"unprognostic (5.14e-3)"	"unprognostic (6.26e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.17e-1)"	0.2	0.0	1.0	0.2	1.2	0.0	0.5	0.2	2.4	0.2	0.2	2.8	0.2	0.0	0.7	0.2	0.5	1.8	0.2	0.2	1.0	1.1	3.6	0.5	5.2	0.2	2.4	0.2	0.8	0.2	0.0	1.9	0.2	2.1	1.7	0.3	0.2	7.5	0.2	0.9	0.6	0.3	0.3	2.0	0.2	0.1	1.1	1.7	0.8	3.7	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	3.7	0.4	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	12.4	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	0.2	2.4	1.0	1.1	2.4	0.2	2.1	1.7
FBXL13	"DRC6, Fbl13, MGC21636"	ENSG00000161040	"F-box and leucine rich repeat protein 13"	Q8NEE6	7	102813230-103074843	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 23.2;testis: 24.8"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 12.4;U-266/84: 15.1;U-87 MG: 8.7;U-937: 10.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	46	"eosinophil: 6.2;neutrophil: 23.2"	"Lineage enriched"	"Detected in single"	73	"granulocytes: 23.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA057232	Uncertain									"HPA057232: "	"unprognostic (1.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.73e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.69e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.64e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.47e-1)"	0.7	1.7	1.9	0.6	2.6	0.6	0.6	0.5	2.1	1.0	0.5	3.4	2.8	0.4	2.2	5.2	0.5	6.7	0.6	0.6	1.6	1.1	1.3	0.4	1.3	0.5	1.5	0.8	4.6	0.9	0.5	6.0	0.4	7.3	0.8	0.6	4.0	0.5	0.7	0.4	0.7	0.5	0.7	1.8	0.7	6.2	24.8	1.5	0.0	1.5	0.0	0.3	0.6	0.6	0.3	0.0	23.2	0.0	0.0	0.1	0.0	0.5	0.1	0.2	1.1	0.0	0.2	0.1	0.4	0.4	0.2	0.2	0.4	0.4	0.8	0.4	0.3	0.3	0.0	0.0	0.4	0.4	0.2	6.5	1.0	0.2	2.3	6.0	0.3	0.0	0.1	3.5	0.1	12.4	2.0	0.3	0.9	0.4	0.4	5.5	0.9	0.3	0.2	0.0	0.4	1.5	0.3	0.5	0.5	0.2	0.0	0.1	0.0	0.2	0.3	1.8	3.5	1.4	0.1	0.8	15.1	1.6	8.7	10.7	5.2	0.0	0.0	6.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	23.2	0.0	0.0	0.0	0.0	0.0	1.9	2.6	0.5	2.1	1.6	1.1	1.5	0.8	7.3	1.5
FBXL16	"C16orf22, Fbl16, MGC33974"	ENSG00000127585	"F-box and leucine rich repeat protein 16"	Q8N461	16	692498-705829	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"brain: 102.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 12.8;MCF7: 10.4;SCLC-21H: 21.5;SH-SY5Y: 16.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.3"	"Lineage enriched"	"Detected in single"	9	"T-cells: 3.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 279.3;basal ganglia: 710.3;cerebral cortex: 403.7;hippocampal formation: 376.0"	"HPA039504, HPA056354"	Enhanced									"HPA039504: AB_10794197, HPA056354: AB_2683105"	"unprognostic (5.51e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (6.24e-5)"	"unprognostic (2.58e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.75e-1)"	"prognostic favourable (7.34e-5)"	"unprognostic (1.62e-3)"	"prognostic favourable (1.87e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.36e-2)"	1.7	5.7	53.5	2.0	75.8	1.6	1.8	17.7	102.2	1.6	1.8	2.5	0.1	2.2	1.6	1.6	1.7	1.8	1.6	1.6	44.9	10.2	2.1	1.6	1.7	1.8	10.2	25.8	1.6	3.6	2.6	3.8	1.6	5.1	1.9	1.6	0.0	5.5	2.4	1.6	2.2	1.9	1.5	2.5	2.0	2.8	5.0	11.9	0.0	2.0	0.0	1.7	1.6	0.0	0.3	0.0	0.0	0.0	0.0	3.3	0.3	0.4	0.6	0.2	12.8	0.1	0.1	0.4	0.4	0.1	2.3	0.1	1.2	0.1	0.2	3.5	0.0	2.3	1.0	1.3	0.1	6.4	0.3	0.0	3.0	0.5	0.0	1.3	0.2	0.0	2.0	0.0	1.2	0.0	0.6	3.2	0.0	10.4	0.3	0.0	0.6	4.1	0.0	0.0	7.2	0.1	0.0	21.5	16.0	2.2	0.4	0.2	1.1	0.0	0.0	0.1	4.4	0.0	1.6	0.6	3.7	1.6	1.8	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.3	1.5	0.2	0.0	0.0	3.3	0.7	0.0	0.0	0.0	0.0	1.2	0.3	53.5	75.8	17.7	56.5	44.9	10.2	10.2	25.8	5.1	11.9
FBXL17	"DKFZP434C1715, Fbl17, Fbx13, FBXO13"	ENSG00000145743	"F-box and leucine rich repeat protein 17"	Q9UF56	5	107859035-108382098	"Predicted intracellular proteins, Predicted membrane proteins"	"Neurogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036410, HPA036411"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA036410: , HPA036411: AB_10669603"	"unprognostic (8.15e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.30e-2)"	"prognostic favourable (4.60e-8)"	"unprognostic (1.86e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (3.35e-2)"	13.7	13.8	22.2	7.8	27.4	5.4	13.3	18.0	27.4	11.5	9.8	7.9	12.0	10.3	10.1	9.3	12.0	9.3	10.4	25.1	18.5	19.0	16.8	13.6	9.8	12.0	16.8	17.1	9.7	9.8	27.5	12.5	6.1	11.7	12.0	10.5	12.4	9.6	14.4	46.1	9.6	10.5	11.6	12.3	10.4	9.6	8.2	8.9	16.8	23.8	9.7	10.0	10.8	9.0	2.0	1.9	3.3	1.3	1.0	2.3	0.5	6.5	6.5	7.5	13.7	12.6	13.3	5.0	8.0	18.0	6.6	8.9	1.3	13.8	7.3	12.7	12.9	2.9	5.9	9.1	10.3	7.3	5.4	6.9	7.6	3.2	6.6	4.6	8.0	9.4	13.8	6.1	4.5	7.8	0.9	9.5	14.3	4.9	4.0	5.9	1.0	6.1	5.6	10.0	9.4	9.2	9.1	6.4	11.0	10.4	9.3	9.8	7.3	11.0	8.4	15.0	4.7	4.6	10.3	7.5	10.4	5.4	13.2	7.1	9.7	0.4	0.9	3.3	2.1	1.3	2.2	1.1	1.9	2.3	1.1	2.0	2.0	1.6	1.7	1.0	0.7	1.9	1.3	0.5	22.2	27.4	18.0	27.4	18.5	19.0	16.8	17.1	11.7	8.9
FBXL6	FBL6	ENSG00000182325	"F-box and leucine rich repeat protein 6"	Q8N531	8	144355431-144359376	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 4.3"	"Low lineage specificity"	"Detected in many"											HPA008867			Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA008867: AB_2668161"	"unprognostic (2.97e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.13e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.29e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.04e-2)"	"unprognostic (9.73e-2)"	"prognostic unfavourable (4.49e-10)"	"unprognostic (3.93e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.00e-1)"	6.1	5.8	3.1	7.7	3.6	6.0	8.2	8.1	5.6	6.9	13.4	3.7	9.9	14.3	4.4	7.5	8.3	4.4	12.0	2.7	2.9	3.1	5.7	15.5	11.6	9.9	3.8	2.6	2.7	13.8	5.1	4.6	6.1	3.2	4.9	6.3	3.6	9.6	9.4	4.6	7.5	19.1	3.1	2.9	8.3	6.2	5.6	3.5	6.0	3.9	6.8	6.5	5.1	4.7	0.7	2.4	1.9	4.3	0.8	1.2	0.2	8.1	2.5	1.8	11.9	2.5	0.6	3.7	4.2	4.6	4.1	2.8	2.7	3.5	3.9	5.2	1.9	5.4	2.2	5.4	0.9	7.0	3.2	7.9	1.4	6.8	3.8	1.9	7.9	1.1	4.9	2.3	6.1	3.4	3.7	5.9	1.5	14.1	5.2	1.9	2.6	7.9	6.3	2.2	12.4	5.3	2.6	2.9	2.9	4.7	7.2	6.9	11.9	3.3	2.9	1.9	7.8	9.8	4.9	2.4	1.8	2.7	3.1	4.7	2.6	0.0	0.6	1.9	1.2	1.3	1.1	0.7	0.9	0.8	0.5	0.5	0.1	0.4	0.2	0.8	4.3	2.4	0.1	0.2	3.1	3.6	8.1	5.6	2.9	3.1	3.8	2.6	3.2	3.5
FBXL7	"FBL6, FBL7, KIAA0840"	ENSG00000183580	"F-box and leucine rich repeat protein 7"	Q9UJT9	5	15500196-15939795	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA055464	Uncertain									"HPA055464: "	"unprognostic (3.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.93e-2)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (6.69e-4)"	"unprognostic (1.94e-3)"	13.8	23.3	11.5	6.2	13.6	0.8	10.6	4.0	11.9	16.5	12.1	24.2	9.4	3.0	28.1	12.9	11.9	11.8	10.2	18.4	13.2	4.7	4.5	3.1	7.3	3.3	14.1	9.3	26.8	2.0	1.8	4.1	8.1	11.1	11.9	6.8	12.3	4.4	24.0	3.1	3.9	5.0	28.9	10.1	5.5	8.8	5.7	16.8	0.0	6.6	5.7	3.1	12.2	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	10.1	14.6	8.4	6.4	0.0	8.6	10.5	6.2	6.5	0.0	0.0	0.0	0.0	13.2	0.0	5.0	3.2	6.2	0.0	0.7	0.0	0.0	0.0	3.3	0.0	0.0	7.6	0.0	5.0	0.4	14.3	0.0	3.8	4.6	0.0	0.0	0.0	3.4	1.6	0.0	7.1	0.0	0.0	0.0	2.9	10.0	0.0	3.0	9.1	0.0	0.0	14.0	13.0	2.6	7.3	3.8	0.0	0.0	0.0	7.2	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	13.6	4.0	11.9	13.2	4.7	14.1	9.3	11.1	16.8
FBXO16	FBX16	ENSG00000214050	"F-box protein 16"	Q8IX29	8	28348287-28490318	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 22.9;pituitary gland: 42.3"	"Cell line enhanced"	"Detected in many"		"AF22: 15.4;Karpas-707: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 11.5"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058676, HPA076472"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Vesicles, Plasma membrane, Cytosol"		"HPA058676: , HPA076472: "	"unprognostic (3.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.56e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.95e-3)"	"unprognostic (6.49e-2)"	"prognostic favourable (6.70e-5)"	"unprognostic (3.41e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.07e-1)"	0.9	2.3	7.3	1.3	17.6	2.6	3.4	15.8	9.9	5.4	2.0	1.1	7.6	2.6	1.8	22.9	1.1	5.7	2.1	2.0	4.2	6.8	4.0	7.2	1.9	1.5	4.4	7.5	1.2	6.3	7.2	42.3	1.0	6.3	4.3	2.6	4.6	5.9	7.3	1.1	0.8	3.8	1.2	2.1	1.7	2.7	4.8	1.4	0.0	8.7	0.2	3.3	1.9	1.1	0.6	11.5	1.4	0.3	0.1	0.5	0.2	12.0	2.5	15.4	6.0	0.4	0.0	0.4	0.1	0.6	2.4	4.5	2.4	3.6	4.6	5.6	0.1	4.1	1.7	2.5	2.3	1.8	2.9	2.2	0.2	1.3	0.3	2.6	1.6	0.2	8.3	0.6	2.5	0.0	0.8	17.8	1.0	4.1	0.3	3.6	3.3	3.5	0.1	3.6	7.1	3.2	2.1	10.0	4.2	0.3	2.5	6.7	10.7	4.5	0.5	1.3	4.7	2.7	2.2	3.9	3.4	3.9	5.2	0.6	2.7	0.5	0.3	0.1	0.2	0.2	0.5	0.4	0.4	0.3	0.9	0.6	0.2	0.3	1.4	0.1	0.2	11.5	0.3	0.2	7.3	17.6	15.8	9.9	4.2	6.8	4.4	7.5	6.3	1.4
FBXO21	"FBX21, KIAA0875"	ENSG00000135108	"F-box protein 21"	O94952	12	117141988-117190531	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 78.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062411, HPA071452"	Approved		Approved	Mitochondria				Mitochondria		"HPA062411: , HPA071452: "	"unprognostic (6.38e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.58e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.01e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.44e-2)"	"prognostic favourable (2.05e-8)"	"unprognostic (1.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.29e-2)"	8.1	29.4	17.8	8.8	21.6	5.2	11.4	27.0	28.0	12.6	10.5	18.8	25.5	10.6	16.1	70.1	10.2	78.4	14.2	18.9	17.9	18.4	33.3	17.0	11.2	8.2	13.5	21.4	38.8	19.0	17.3	18.8	12.3	17.5	17.4	9.8	14.0	10.7	19.8	16.3	11.8	9.5	12.8	17.0	11.6	11.8	27.8	14.2	9.9	19.1	6.9	9.3	12.7	10.2	12.8	8.5	3.7	10.5	9.2	13.0	7.1	9.4	22.4	14.2	7.8	11.7	12.2	16.2	12.6	13.7	11.9	9.7	14.4	6.7	12.4	12.5	12.9	12.9	16.6	12.6	14.3	6.9	14.9	0.6	12.4	11.6	10.6	4.0	4.4	12.0	12.2	9.5	15.2	16.5	4.9	4.1	10.1	15.4	11.4	2.9	21.1	14.7	13.6	20.6	13.0	11.9	22.6	28.1	17.0	31.6	8.4	6.8	19.5	1.6	12.7	7.9	10.3	9.2	8.1	7.3	7.5	16.3	11.5	6.3	11.0	1.1	5.8	3.7	10.7	10.5	11.2	9.8	11.3	11.1	8.5	12.8	13.0	11.7	0.5	9.2	10.1	5.8	11.4	7.1	17.8	21.6	27.0	28.0	17.9	18.4	13.5	21.4	17.5	14.2
FBXO36	"Fbx36, FLJ37592"	ENSG00000153832	"F-box protein 36"	Q8NEA4	2	229922302-230013109	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053865			Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA053865: "	"unprognostic (4.39e-3)"	"unprognostic (6.51e-2)"	"unprognostic (2.38e-2)"	"prognostic favourable (2.28e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.68e-1)"	4.0	7.8	8.9	1.9	12.6	1.9	7.3	4.1	12.2	6.7	2.8	11.9	4.7	3.2	5.4	8.9	3.8	21.7	3.9	2.9	8.3	9.1	10.3	3.7	4.9	2.1	8.1	6.9	6.8	3.7	11.7	11.7	3.6	10.1	6.4	3.0	9.3	5.0	5.8	2.0	6.1	3.2	3.9	8.9	2.1	3.7	14.0	5.2	2.7	14.8	2.8	2.7	2.9	3.3	2.8	3.6	0.8	1.7	2.7	4.5	1.2	1.2	2.5	3.0	1.2	1.5	9.2	6.0	1.6	4.2	2.2	3.9	0.8	4.0	0.1	0.8	2.8	1.0	1.4	0.8	3.9	0.3	0.9	0.5	0.9	1.5	5.9	1.0	0.4	9.7	6.8	4.3	3.3	2.3	1.7	0.7	2.6	5.1	2.1	2.4	7.9	2.9	2.6	0.8	0.6	4.0	1.0	2.9	3.7	2.6	2.1	1.0	4.4	1.8	1.7	3.7	1.4	6.0	0.6	2.7	2.2	0.9	4.6	0.5	2.7	0.1	1.7	0.1	2.5	1.3	2.1	2.8	1.9	1.7	3.6	2.0	4.5	2.5	0.8	2.7	0.9	1.7	3.5	1.2	8.9	12.6	4.1	12.2	8.3	9.1	8.1	6.9	10.1	5.2
FBXO41	"Fbx41, KIAA1940"	ENSG00000163013	"F-box protein 41"	Q8TF61	2	73254682-73284431	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055246, HPA058386"			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA055246: , HPA058386: "	"unprognostic (1.15e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.17e-2)"	"prognostic unfavourable (5.76e-4)"	"unprognostic (1.74e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (7.97e-3)"	"unprognostic (7.55e-2)"	"unprognostic (9.13e-3)"	"unprognostic (4.35e-2)"	"prognostic unfavourable (1.08e-5)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-2)"	1.5	3.6	21.9	5.9	19.3	4.2	2.1	21.7	33.3	1.2	2.1	1.7	0.9	2.2	1.9	3.6	1.6	2.0	2.7	1.1	18.8	10.6	0.8	1.1	2.2	9.4	5.9	17.8	2.5	4.1	9.8	7.3	1.1	6.8	3.0	2.4	0.8	3.7	3.3	0.6	3.4	2.7	2.1	2.1	7.5	2.5	2.4	3.5	2.1	1.5	0.0	9.0	2.8	0.8	0.5	0.9	0.0	2.6	1.1	0.7	0.4	3.5	1.7	0.6	0.0	0.1	0.1	0.8	0.7	0.6	1.2	1.5	4.0	2.1	26.5	0.1	0.1	2.9	3.7	2.3	1.2	11.0	0.3	8.1	4.0	1.6	0.9	12.2	6.2	1.5	0.9	0.0	0.9	0.2	1.6	4.4	1.2	0.9	4.2	11.4	2.7	1.6	14.9	6.8	12.9	0.7	1.2	9.2	3.4	4.5	1.9	2.8	2.6	5.1	0.2	4.1	3.6	3.7	0.7	5.2	2.2	12.6	1.0	13.4	1.7	0.0	0.5	0.0	0.6	2.6	0.7	0.5	0.4	0.0	0.9	0.2	0.4	0.4	0.0	1.1	0.1	0.7	0.2	0.4	21.9	19.3	21.7	33.3	18.8	10.6	5.9	17.8	6.8	3.5
FBXO47		ENSG00000204952	"F-box protein 47"	Q5MNV8	17	38936432-38967402	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"testis: 12.2;vagina: 3.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.2;Daudi: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA057438	Uncertain									"HPA057438: "		"unprognostic (1.53e-1)"			"unprognostic (2.98e-1)"			"unprognostic (2.82e-1)"	"unprognostic (3.92e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.59e-2)"		"unprognostic (2.29e-2)"	"unprognostic (6.85e-2)"	"unprognostic (4.15e-1)"			0.1	0.1	0.1	0.0	0.5	0.0	1.9	0.7	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.3	0.1	0.1	0.0	0.4	0.1	1.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	1.2	0.1	0.1	12.2	0.7	0.0	0.1	0.0	0.0	0.1	3.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.1	0.4	0.0	0.1	0.1	0.0	1.2	1.6	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.7	0.4	0.1	0.1	1.0	0.3	1.2	0.7
FBXO8	"FBS, FBX8"	ENSG00000164117	"F-box protein 8"	Q9NRD0	4	174236658-174284264	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002885	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA002885: AB_1078835"	"unprognostic (8.17e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.25e-1)"	"prognostic favourable (1.29e-7)"	"unprognostic (1.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.72e-1)"	16.8	18.5	13.5	9.2	14.1	7.3	16.4	19.4	14.0	15.6	17.3	14.0	10.7	13.4	13.1	19.5	16.4	15.1	13.1	19.1	13.3	12.0	20.2	43.5	11.8	9.5	14.6	10.1	15.7	22.6	16.5	26.9	27.1	14.3	16.8	15.3	14.7	13.3	13.1	7.4	16.0	18.9	18.8	14.7	13.9	14.7	10.0	14.0	18.2	19.9	6.5	12.4	20.6	18.2	12.6	8.6	19.2	8.9	9.8	15.5	7.8	4.7	3.2	6.5	2.2	14.6	16.0	5.1	9.7	8.9	6.4	6.5	2.5	8.4	3.6	9.2	6.3	3.0	4.3	5.6	6.8	10.8	9.8	3.2	5.3	3.9	11.1	4.3	3.5	9.2	13.9	5.9	7.8	6.4	6.7	18.8	8.4	4.7	4.5	4.5	1.8	3.4	2.6	4.3	5.7	10.0	2.0	6.0	39.3	4.3	7.6	10.7	4.3	4.7	7.3	3.8	3.6	10.7	5.4	9.7	4.6	3.1	12.7	3.1	5.2	19.2	6.2	12.7	12.3	7.8	15.5	12.6	14.2	12.1	8.5	10.7	13.5	11.8	6.2	9.8	8.9	8.6	15.0	7.8	13.5	14.1	19.4	14.0	13.3	12.0	14.6	10.1	14.3	14.0
FBXW10	"C17orf1, C17orf1A, Fbw10, HREP, SM2SH2"	ENSG00000171931	"F-box and WD repeat domain containing 10"	Q5XX13	17	18744024-18779349	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 15.9"	"Cell line enhanced"	"Detected in some"		"A549: 5.7;ASC diff: 2.1;CAPAN-2: 3.0;HaCaT: 4.3;HeLa: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047457			Approved	Nucleoplasm				Nucleoplasm		"HPA047457: "	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.59e-2)"	"unprognostic (7.47e-2)"	"unprognostic (4.54e-1)"	"unprognostic (5.08e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.20e-7)"	"unprognostic (3.16e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.05e-1)"	0.1	0.7	0.1	0.1	0.7	0.0	0.1	1.9	0.6	0.6	0.1	0.1	0.1	0.4	0.1	2.1	0.2	0.8	0.4	0.1	0.6	0.3	0.2	1.1	0.3	0.1	0.1	0.8	0.1	0.1	0.1	0.4	0.1	1.6	0.1	0.0	0.4	0.3	0.2	0.8	0.1	0.4	0.1	0.1	0.1	0.3	15.9	0.1	0.1	1.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	5.7	0.0	0.1	2.1	1.3	0.1	0.0	0.2	0.0	0.3	0.0	3.0	0.1	0.1	0.4	4.3	0.0	0.0	0.2	0.1	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.6	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.4	1.5	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	1.9	0.6	0.6	0.3	0.1	0.8	1.6	0.1
FBXW12	"Fbw12, FBXO35"	ENSG00000164049	"F-box and WD repeat domain containing 12"	Q6X9E4	3	48372219-48401259	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"pancreas: 12.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;HEK 293: 1.7;SH-SY5Y: 1.0;THP-1: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA037491, HPA037492"	Uncertain									"HPA037491: , HPA037492: "	"unprognostic (5.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-3)"	"unprognostic (6.96e-3)"	"unprognostic (2.36e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.81e-3)"	0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.9	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.1		0.1	12.4	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.9	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.2	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.8	1.0	0.0	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.3	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FCF1	"Bka, C14orf111, CGI-35, UTP24"	ENSG00000119616	"FCF1, rRNA-processing protein"	Q9Y324	14	74713144-74738620	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046681	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA046681: AB_10960541"	"unprognostic (1.39e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.94e-3)"	"prognostic unfavourable (5.54e-6)"	"unprognostic (3.17e-1)"	"unprognostic (3.43e-2)"	"unprognostic (7.36e-2)"	"prognostic unfavourable (3.54e-4)"	"unprognostic (7.79e-2)"	"prognostic favourable (2.26e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.47e-1)"	23.9	26.0	19.5	18.4	23.0	18.3	27.1	15.7	21.6	25.6	21.6	24.6	25.9	14.4	29.5	18.5	30.4	30.6	17.8	21.9	17.7	18.2	24.6	25.1	21.1	24.2	25.2	17.5	32.7	18.3	23.1	34.5	24.4	23.8	22.8	23.2	20.8	22.7	25.4	26.3	20.3	19.3	23.8	34.9	21.4	19.8	19.4	21.6	28.3	37.8	23.3	30.5	26.6	24.0	19.0	25.2	15.8	14.5	12.1	18.1	6.8	35.6	26.3	19.1	21.5	30.4	26.9	25.2	31.4	24.2	31.4	28.1	29.2	29.4	32.0	20.5	27.3	26.4	31.7	29.6	55.6	29.6	13.8	22.1	16.6	19.0	22.0	27.0	20.4	21.1	26.3	33.3	35.1	29.2	26.4	19.3	28.2	25.5	31.2	9.7	25.5	30.7	23.8	37.5	15.2	16.0	29.3	13.4	19.6	40.3	21.4	17.9	27.4	18.8	26.6	25.1	27.0	23.7	35.8	17.1	44.6	49.8	23.9	25.7	27.8	10.0	14.5	15.8	16.6	12.3	18.1	19.0	16.0	14.2	11.2	18.7	17.4	17.8	12.1	12.1	14.2	25.2	15.4	6.8	19.5	23.0	15.7	21.6	17.7	18.2	25.2	17.5	23.8	21.6
FER1L6	C8ORFK23	ENSG00000214814	"Fer-1 like family member 6"	Q2WGJ9	8	123851987-124120061	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"stomach 1: 29.3"	"Cell line enhanced"	"Detected in some"		"AF22: 2.7;ASC TERT1: 4.9;BJ hTERT+: 3.2;PC-3: 4.4;U-87 MG: 4.3"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 4.2;stomach cancer: 5.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054117	Enhanced									"HPA054117: "	"unprognostic (1.90e-1)"	"unprognostic (3.08e-3)"	"unprognostic (2.06e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.36e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.23e-6)"	"unprognostic (7.09e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.39e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	3.1			1.7	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	7.3		0.0	0.0	0.4	0.0	3.8	0.0	0.0	0.0	29.3	3.8			1.3		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.7	0.0	0.2	4.9	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.1	0.9	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.3	4.4	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.1	0.0	4.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FGF11	"FHF3, FLJ16061, MGC102953, MGC45269"	ENSG00000161958	"Fibroblast growth factor 11"	Q92914	17	7438273-7444937	"Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.5"	"Cell line enhanced"	"Detected in many"		"A-431: 9.3;HaCaT: 16.9;LHCN-M2: 11.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066605, HPA075188"	Enhanced		Approved	Centrosome				Centrosome		"HPA066605: , HPA075188: "	"unprognostic (7.35e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.79e-4)"	"unprognostic (9.15e-2)"	"unprognostic (3.28e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.00e-6)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.90e-3)"	"unprognostic (4.97e-3)"	3.3	23.5	10.5	3.0	13.8	2.1	2.9	4.5	11.6	6.4	1.6	4.6	0.1	1.8	3.1	1.9	13.0	1.7	3.2	11.6	11.7	4.6	3.4	1.1	1.3	6.2	8.1	5.2	1.6	1.3	1.5	1.0	2.0	10.6	1.4	1.4	6.8	3.7	1.7	8.8	19.7	1.3	2.9	4.1	2.4	1.6	2.8	9.9	2.5	7.2	7.1	9.0	2.9	8.7	0.0	0.0	1.6	0.6	0.0	0.3	0.0	9.3	0.6	5.2	0.0	3.0	0.1	2.6	0.2	3.2	0.3	0.6	0.2	1.0	2.8	0.7	0.1	16.9	1.9	5.3	1.2	5.8	4.1	5.1	0.5	1.3	0.5	0.2	5.7	0.6	1.5	0.4	0.2	0.2	2.0	0.2	11.2	2.1	1.6	2.2	1.9	0.2	4.4	4.7	1.1	0.7	0.8	1.1	5.3	0.6	0.6	0.4	0.3	0.4	0.1	0.3	5.6	0.0	0.2	0.4	1.3	0.9	1.3	3.1	0.6	0.0	0.0	1.6	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.3	0.0	10.5	13.8	4.5	11.6	11.7	4.6	8.1	5.2	10.6	9.9
FHAD1	KIAA1937	ENSG00000142621	"Forkhead associated phosphopeptide binding domain 1"	B1AJZ9	1	15247272-15400283	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.8;epididymis: 16.0;fallopian tube: 17.9;testis: 28.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 13.5;HMC-1: 38.9;K-562: 8.3;U-87 MG: 20.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	4	"pons and medulla: 13.8"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 3.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054284	Enhanced									"HPA054284: "	"unprognostic (3.18e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.36e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.04e-3)"	0.4	0.4	1.4	0.8	2.0	0.0	1.1	0.2	0.9	2.6	0.4	6.7	0.8	1.0	1.0	16.0	0.2	17.9	0.6	0.2	3.0	2.6	0.6	0.3	7.6	0.2	0.5	0.2	8.2	0.9	1.8	1.1	0.5	13.8	1.0	0.3	0.5	0.6	1.3	0.1	0.3	1.1	0.3	0.6	0.2	2.5	28.5	2.8	0.0	1.4	0.1	0.3	0.9	0.3	0.8	0.4	0.0	1.6	1.2	3.6	0.8	0.9	0.2	0.8	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.5	2.6	0.3	0.1	0.2	0.1	0.0	0.1	13.5	0.1	0.0	0.0	0.0	0.2	1.1	38.9	0.4	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.2	0.0	3.4	0.1	4.0	0.0	0.0	4.4	0.0	20.9	0.0	0.1	0.0	1.6	0.0	3.6	0.6	0.1	0.8	0.4	1.2	0.4	0.0	0.0	1.5	0.0	1.2	1.2	0.0	0.0	0.8	1.4	2.0	0.2	0.9	3.0	2.6	0.5	0.2	13.8	2.8
FITM1	FIT1	ENSG00000139914	"Fat storage inducing transmembrane protein 1"	A5D6W6	14	24131275-24132849	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 56.1;skeletal muscle: 94.7;tongue: 79.9"	"Cell line enriched"	"Detected in some"	17	"RH-30: 26.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019842	Uncertain									"HPA019842: AB_1853025"	"unprognostic (1.81e-2)"	"unprognostic (4.29e-7)"	"unprognostic (2.77e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.24e-2)"	"unprognostic (6.68e-2)"	"prognostic favourable (1.00e-3)"	"unprognostic (1.20e-4)"	"unprognostic (4.57e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.62e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-3)"	0.8	1.7	0.0	0.2	0.0	0.6	0.3	0.4	0.2	0.2	0.3	0.0	0.0	0.5	0.2	2.2	1.2	0.2	0.2	56.1	0.0	0.0	0.2	13.1	0.2	0.3	0.0	0.0	0.2	11.9	0.2	0.2	0.2	0.0	0.7	0.2	0.1	2.9	0.3	94.7	0.5	0.4	0.2	0.0	2.5	0.3	0.3	0.0	0.0	0.5	79.9	3.6	0.3	0.0	0.8	0.3	0.0	1.1	0.4	1.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.5	0.1	0.0	0.7	0.7	0.2	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.2	0.3	0.0	0.3	0.2	26.4	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.5	1.1	0.3	0.2	1.1	1.5	0.3	0.8	0.6	0.6	0.0	0.4	0.4	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FJX1	"FLJ22416, FLJ25593"	ENSG00000179431	"Four jointed box 1"	Q86VR8	11	35618419-35620868	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.4"	"Cell line enhanced"	"Detected in many"		"U-251 MG: 26.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059220	Uncertain		Approved	Vesicles	"Intracellular and membrane"			Vesicles		"HPA059220: "	"unprognostic (8.99e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-3)"	"unprognostic (5.20e-2)"	"unprognostic (5.72e-2)"	"unprognostic (9.56e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.39e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (9.24e-9)"	"unprognostic (1.64e-2)"	"unprognostic (9.64e-2)"	"unprognostic (8.35e-2)"	"prognostic unfavourable (6.56e-4)"	6.0	3.5	7.8	3.5	10.3	0.7	3.6	6.6	25.4	8.8	1.4	7.9	0.0	1.1	10.1	3.4	3.1	6.1	4.5	2.4	8.0	4.9	3.8	4.9	2.2	2.3	5.7	5.7	12.2	17.0	1.7	1.8	6.6	7.7	4.1	1.1	2.7	2.6	4.7	1.1	10.3	1.1	3.4	5.1	7.8	1.7	1.2	3.3	1.7	2.2	3.0	3.4	3.7	2.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	9.9	5.0	5.3	1.7	1.8	5.8	1.6	11.2	7.6	10.8	7.8	6.3	3.1	0.0	2.6	4.4	10.6	1.8	18.5	9.2	0.1	14.6	0.9	1.9	0.2	4.4	1.1	0.0	2.2	14.1	5.6	17.1	4.9	5.3	0.0	10.3	2.3	0.3	0.0	7.3	14.8	0.6	11.8	2.3	8.2	12.3	5.0	2.8	1.2	0.9	3.1	21.3	0.2	9.5	8.6	15.8	1.6	26.4	0.0	0.0	0.0	15.3	0.5	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	10.3	6.6	12.3	8.0	4.9	5.7	5.7	7.7	3.3
FMR1NB	"CT37, FLJ25736, NY-SAR-35"	ENSG00000176988	"FMR1 neighbor"	Q8N0W7	X	147981329-148026667	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	87	"testis: 38.0"	"Group enriched"	"Detected in some"	23	"U-266/70: 34.3;U-266/84: 26.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA011284, CAB026403"	Enhanced									"CAB026403: , HPA011284: AB_1078898"				"unprognostic (2.22e-3)"			"unprognostic (1.05e-1)"			"unprognostic (1.83e-1)"					"unprognostic (4.38e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.85e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FNDC1	"bA243O10.1, dJ322A24.1, FNDC2, KIAA1866"	ENSG00000164694	"Fibronectin type III domain containing 1"	Q4ZHG4	6	159169397-159272109	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 36.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.8;fHDF/TERT166: 7.6;HEK 293: 1.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.5"	"Region enriched"	"Detected in single"	6	"hippocampal formation: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA030962, HPA030963"	Approved		Approved	"Nuclear speckles"	"Secreted to extracellular matrix"			"Nuclear speckles"		"HPA030962: AB_10696212, HPA030963: "	"unprognostic (4.59e-2)"	"unprognostic (9.17e-3)"	"unprognostic (7.62e-2)"	"prognostic favourable (6.10e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (1.93e-6)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.76e-3)"	5.2	0.6	0.5	7.6	0.7	0.0	2.5	0.3	0.7	9.7	12.9	3.2	0.0	2.1	4.8	2.2	2.2	0.9	13.1	3.5	4.8	0.5	1.0	1.5	1.2	2.1	0.7	0.0	4.8	1.2	0.0	0.4	0.7	0.5	0.7	1.6	1.0	2.5	0.6	6.2	1.2	7.0	10.2	1.5	0.7	0.7	2.1	0.1	1.0	36.6	11.8	3.6	1.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.1	2.8	7.6	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.2	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.3	0.7	4.8	0.5	0.7	0.0	0.5	0.1
FNDC4	"FLJ22362, FRCP1"	ENSG00000115226	"Fibronectin type III domain containing 4"	Q9H6D8	2	27491883-27495245	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 45.9;liver: 57.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 16.9;ASC diff: 17.3;HUVEC TERT2: 20.7;SH-SY5Y: 16.2;TIME: 18.9;U-87 MG: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051804, HPA063581"	Uncertain		Approved	Nucleoplasm,Aggresome,Cytosol	"Intracellular and membrane"			Nucleoplasm	"Aggresome, Cytosol"	"HPA051804: , HPA063581: "	"unprognostic (2.57e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.87e-2)"	"prognostic unfavourable (5.07e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.28e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.40e-3)"	"prognostic unfavourable (6.11e-4)"	18.5	45.9	13.4	2.7	13.7	0.7	9.1	10.8	29.5	3.8	2.0	4.0	0.5	1.5	2.8	2.8	11.8	1.5	10.0	3.1	15.6	8.5	2.3	57.6	2.0	1.4	12.0	8.6	16.5	4.6	18.6	2.8	2.5	22.2	6.3	2.1	1.9	2.1	3.3	1.3	2.4	1.4	4.7	5.4	3.5	3.2	10.2	3.8	0.0	1.8	0.7	2.7	4.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.6	16.9	17.3	10.6	0.1	3.8	7.7	2.8	2.4	0.7	0.2	0.0	0.4	12.2	0.0	6.4	2.3	2.4	0.0	1.0	0.8	0.0	8.7	6.4	0.0	0.1	9.0	1.1	4.8	0.9	20.7	0.9	0.0	10.2	0.0	0.0	0.0	5.9	0.3	0.0	0.0	0.0	1.6	0.0	0.1	16.2	0.1	0.0	0.1	0.0	0.0	18.9	2.6	1.2	1.0	2.9	0.0	0.0	0.0	14.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	13.7	10.8	29.5	15.6	8.5	12.0	8.6	22.2	3.8
FNDC7	FLJ35838	ENSG00000143107	"Fibronectin type III domain containing 7"	Q5VTL7	1	108712657-108742740	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.0;testis: 5.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.2;PC-3: 1.1;U-87 MG: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA028079, HPA054297"	Enhanced		Approved	"Nucleoplasm,Actin filaments"	"Secreted in male reproductive system"			"Actin filaments"	Nucleoplasm	"HPA028079: AB_10602501, HPA054297: "	"unprognostic (2.35e-2)"	"unprognostic (2.65e-2)"			"unprognostic (3.74e-1)"			"unprognostic (8.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-4)"		"unprognostic (1.90e-10)"	"unprognostic (1.59e-2)"	"unprognostic (1.33e-1)"		"unprognostic (1.31e-1)"	0.1	0.1	0.6	0.1	0.8	0.6	0.1	0.4	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.7	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.8	0.1	3.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	5.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.5	0.6	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.9	0.5	0.0	0.9	0.0	0.0	0.1	0.2	0.1	0.6	0.2	0.3	0.0	0.0	1.2	0.5	0.0	0.1	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.2	0.9	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.5	0.3	0.3	0.1	0.4	0.2	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.4	1.1	1.7	0.7	0.1	0.1	3.0	0.1
FNDC8	DKFZp434H2215	ENSG00000073598	"Fibronectin type III domain containing 8"	Q8TC99	17	35121579-35130732	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"testis: 85.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.0"	"Group enriched"	"Detected in many"	15	"B-cells: 1.3;T-cells: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026521	Supported									"HPA026521: AB_2106163"	"unprognostic (1.45e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.10e-1)"		"unprognostic (5.88e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.70e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.48e-3)"	"unprognostic (9.02e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.47e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	2.0	0.2	0.7	2.2	0.8	0.6	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	2.5	0.4	0.0	0.3	0.2	0.0	0.0	0.6	4.3	0.1	0.7	0.2	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.1	0.4	1.8	1.1	0.6	0.4	2.6	1.2	2.5	0.0	0.7	0.5	0.7	0.9	0.6	0.4	0.5	0.7	0.0	0.0	0.2	0.7	0.9	1.7	2.1	2.4	0.2	0.7	0.6	0.0	0.1	0.0	0.2	0.1	1.3	0.6	0.6	0.0	0.0	1.3	2.0	0.7	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
FNDC9	"C5orf40, MGC27121"	ENSG00000172568	"Fibronectin type III domain containing 9"	Q8TBE3	5	157341600-157345721	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"adrenal gland: 9.4;brain: 24.0;pituitary gland: 10.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.7;HeLa: 1.8;Karpas-707: 3.0;U-266/70: 1.6"	"Cancer enriched"	"Detected in single"	16	"glioma: 0.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basal ganglia: 21.9;hypothalamus: 28.4"	"Low region specificity"	"Detected in all"			HPA011115	Uncertain									"HPA011115: AB_1079374"	"unprognostic (2.35e-3)"	"unprognostic (3.80e-2)"	"unprognostic (2.93e-1)"		"unprognostic (3.53e-3)"	"unprognostic (4.90e-3)"		"unprognostic (3.40e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.35e-6)"	"unprognostic (3.63e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-3)"	0.6	9.4	3.9	1.5	21.1	2.0	0.6	9.1	24.0	0.5	1.1	0.0	0.0	0.6	0.6	0.9	0.5	0.6	0.6	0.7	1.9	22.0	0.7	0.6	0.5	0.9	1.3	3.8	0.5	0.5	0.5	10.0	0.6	5.8	0.6	1.2	0.0	0.5	0.6	0.6	0.6	0.8	0.8	1.3	0.6	0.6	0.5	0.4	0.0	0.6	0.0	0.5	0.6	0.0	0.5	0.3	0.8	0.8	0.0	1.9	0.1	0.0	0.2	0.4	0.4	0.0	0.0	0.4	1.0	0.0	0.2	0.0	0.2	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.8	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.5	1.0	0.3	0.3	1.6	0.0	1.0	0.3	0.0	0.1	0.0	0.0	0.8	1.9	0.2	0.1	0.0	0.6	1.3	0.0	0.5	0.8	1.5	0.2	0.0	0.8	0.3	0.0	0.1	3.9	21.1	9.1	13.3	1.9	22.0	1.3	3.8	5.8	0.4
FOXD4	"FKHL9, FOXD4a, FREAC5"	ENSG00000170122	"Forkhead box D4"	Q12950	9	116231-118204	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 5.7;testis: 3.1"	"Cell line enhanced"	"Detected in many"		"THP-1: 8.7"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	8	"eosinophil: 1.8"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.8"									HPA012836	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA012836: AB_2105429"	"unprognostic (8.27e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.20e-2)"	"unprognostic (9.46e-2)"	"unprognostic (2.52e-4)"	"unprognostic (3.66e-4)"	"unprognostic (7.06e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.02e-3)"	0.6	0.6	1.2	0.5	1.4	0.1	0.1	5.7	1.5	0.4	0.2			0.4	0.7	0.1	0.1	0.3	0.1	0.2	1.3	1.5	1.6	0.2	0.6	0.7	0.8		0.3	0.5	0.2	0.7	0.6		0.7	0.3		0.3	0.5	1.4	0.3	0.6	0.4	0.4	1.0	0.6	3.1			0.2		0.2	0.2	0.1	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.6	0.5	0.0	0.4	0.8	0.4	3.6	0.2	0.4	0.0	0.3	1.0	0.2	3.7	0.6	0.0	0.0	0.9	0.2	0.3	3.5	3.0	0.0	0.5	0.3	0.2	2.5	1.9	0.5	0.0	0.0	0.1	0.0	1.2	1.6	0.1	1.3	0.3	2.1	0.1	1.8	0.3	0.8	0.5	0.9	1.8	1.7	1.4	1.0	0.5	0.0	0.9	8.7	0.5	1.1	1.1	0.7	1.3	0.1	0.4	0.8	0.8	2.0	1.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FOXD4L4	"bA460E7.2, FOXD4L2"	ENSG00000184659	"Forkhead box D4 like 4"	Q8WXT5	9	65736555-65738784	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA012836	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA012836: AB_2105429"	"unprognostic (6.92e-2)"	"unprognostic (5.48e-2)"			"unprognostic (5.19e-2)"						"unprognostic (7.78e-2)"		"unprognostic (7.93e-3)"	"unprognostic (7.14e-2)"				0.4	0.6	0.3	1.0	1.2	0.0	0.2	1.5	1.3	0.7	0.2			0.0	0.2	0.0	0.2	0.2	0.1	0.4	1.0	0.7	0.2	0.1	0.0	0.1	0.6		0.2	0.0	0.0	0.2	0.2		0.2	0.1		0.4	0.1	0.4	0.0	0.4	0.1	0.2	0.5	0.1	0.5			0.0		0.2	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.7	0.5	1.4	0.0	0.2	0.3	0.7	0.0	0.0	0.2	1.0	0.0	0.5	0.2	0.2	0.0	0.2	0.0	0.0	0.2	1.1	0.2	0.5	0.0	0.2	0.2	0.7	0.3	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.7	0.0	0.5	0.2	0.0	0.1	0.3	0.2	0.0	0.0	0.3	0.7	1.0	0.4	0.0	0.2	0.7	0.0	0.1	0.5	0.0	0.4	1.0	0.5	0.7	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FOXL2NB	"C3orf72, FLJ43329"	ENSG00000206262	"FOXL2 neighbor"	Q6ZUU3	3	138947234-138953451	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ovary: 51.6;parathyroid gland: 25.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.4;fHDF/TERT166: 10.5;HEL: 10.4;hTCEpi: 4.9;SiHa: 8.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"											"HPA061017, HPA071790"			Enhanced	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA061017: , HPA071790: "	"unprognostic (3.32e-1)"	"unprognostic (1.13e-1)"		"unprognostic (3.86e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.40e-5)"		"unprognostic (3.30e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.16e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-10)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-2)"	0.1	1.0	0.6	0.1	1.4	0.2	0.1	0.2	0.9	15.3	0.1	0.5	0.1	0.0	12.6	0.9	0.2	7.3	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.5	0.4	51.6	0.4	25.0	9.4	3.2	1.0	0.1	0.0	1.3	0.1	0.5	0.1	0.3	0.1	2.5	0.3	0.1	0.0	0.4	0.3	0.1	0.4	0.3	0.1	0.4	2.3	0.6	0.5	2.8	0.4	0.7	0.4	0.0	2.1	1.4	0.7	5.4	0.3	0.1	2.3	0.1	0.0	0.2	0.0	0.2	0.4	0.2	1.1	10.5	0.5	0.2	0.1	0.2	0.1	0.3	10.4	3.2	0.1	0.0	0.1	0.4	0.2	4.9	0.2	0.1	0.0	4.0	0.2	2.6	0.2	0.1	0.3	0.3	0.1	0.1	0.0	0.0	0.5	1.5	0.2	0.2	8.1	0.2	0.0	0.2	3.0	0.2	0.3	0.2	0.3	0.1	0.4	0.1	0.1	0.3	0.3	0.1	1.3	0.4	0.3	0.4	0.3	0.2	0.4	0.3	0.3	0.2	0.6	0.4	0.3	2.8	0.7	0.2	0.5	0.4	0.0	0.6	1.4	0.2	0.9	0.3	0.2	0.5	0.4	1.0	0.3
FOXQ1	HFH1	ENSG00000164379	"Forkhead box Q1"	Q9C009	6	1312440-1314748	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 65.5;vagina: 39.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 16.4;CAPAN-2: 9.9;HaCaT: 19.2;Hep G2: 40.4;RT4: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA059700			Supported	Nucleoplasm				Nucleoplasm		"HPA059700: "	"unprognostic (2.04e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.65e-3)"	"prognostic favourable (6.68e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.96e-2)"	0.6	0.5	2.3	0.6	4.0	0.5	1.4	1.6	5.9	7.1	1.9	3.2	0.0	6.9	1.1	0.7	7.2	3.2	31.8	0.5	2.2	1.9	7.1	3.6	5.8	0.5	2.7	1.5	0.5	10.1	0.5	1.8	1.2	3.8	18.2	0.8	7.5	35.8	1.3	0.6	16.8	0.8	6.6	1.9	0.5	65.5	0.6	0.8	0.8	3.1	7.8	11.7	26.3	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.5	0.0	0.0	0.0	0.0	0.0	0.3	6.6	0.0	0.0	16.4	9.9	0.0	0.2	0.0	19.2	0.0	0.8	0.0	0.0	0.5	0.0	3.5	40.4	0.0	0.0	1.0	0.0	7.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	17.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	4.0	1.6	5.9	2.2	1.9	2.7	1.5	3.8	0.8
FOXS1	"FKHL18, FREAC10"	ENSG00000179772	"Forkhead box S1"	O43638	20	31844301-31845619	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.5;RH-30: 11.9;U-2 OS: 15.9;U-251 MG: 4.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042475	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA042475: AB_10964265"	"unprognostic (2.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavourable (1.10e-8)"	"unprognostic (1.09e-3)"	"unprognostic (2.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.00e-2)"	5.9	3.1	2.7	3.0	4.7	0.3	11.7	2.7	4.9	9.7	2.6	4.8	1.8	0.9	15.5	6.2	2.8	3.6	11.7	14.0	3.2	2.6	5.5	0.9	6.5	4.6	4.1	4.8	4.0	1.1	0.8	3.2	14.4	5.2	5.0	1.6	7.0	2.0	7.0	4.5	1.8	1.8	3.7	2.6	5.5	1.6	9.7	0.6	3.0	4.9	7.0	3.1	4.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.9	0.1	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.1	0.1	0.0	15.9	0.0	4.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	4.7	2.7	4.9	3.2	2.6	4.1	4.8	5.2	0.6
FPR2	"ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R"	ENSG00000171049	"Formyl peptide receptor 2"	P25090	19	51752026-51770526	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 128.2;lymphoid tissue: 32.2"	"Cell line enriched"	"Detected in some"	18	"U-937: 25.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"neutrophil: 128.2"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 128.2"									HPA029154	Approved									"HPA029154: AB_10602133"	"unprognostic (3.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.41e-5)"	"unprognostic (1.08e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.90e-1)"	7.9	1.1	0.6	30.7	2.1	8.7	0.8	0.4	1.9	0.6	0.8	0.8	0.0	0.4	0.6	0.2	1.0	2.6	3.3	5.0	1.9	0.6	1.3	2.4	17.3	32.2	2.8	0.0	1.6	1.1	0.0	1.1	4.4	2.3	0.6	0.1	1.1	1.0	0.0	1.1	0.4	1.1	3.3	3.0	29.1	1.2	2.5	1.6	0.8	1.0	0.9	0.3	4.4	2.2	0.0	1.7	128.2	12.7	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.2	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.8	25.4	0.0	0.4	12.7	0.6	0.0	11.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	128.2	0.0	7.5	0.3	0.0	3.9	0.6	2.1	0.4	1.9	1.9	0.6	2.8	0.0	2.3	1.6
FRAT2		ENSG00000181274	"FRAT2, WNT signaling pathway regulator"	O75474	10	97332497-97334709	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 70.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 29.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 29.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049763	Uncertain		Approved	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA049763: "	"unprognostic (4.93e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.87e-2)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (3.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.25e-2)"	"prognostic favourable (2.55e-4)"	"unprognostic (7.87e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.08e-2)"	5.0	3.8	5.7	8.7	7.5	23.8	9.7	8.6	9.4	5.7	18.8	4.8	10.2	21.9	6.0	5.9	13.2	6.4	7.2	7.7	6.1	4.9	5.8	15.6	12.0	22.4	5.6	2.0	3.0	16.5	4.8	3.2	9.6	7.7	8.8	14.0	5.4	22.4	4.9	8.7	17.8	20.3	3.7	5.9	28.0	11.5	14.9	7.3	9.0	8.1	8.3	11.1	7.9	13.2	1.2	1.9	29.3	3.7	0.6	1.1	1.1	5.3	2.1	3.5	15.7	2.5	2.1	13.1	1.2	4.4	1.9	1.9	3.3	6.3	6.5	4.3	1.2	10.1	9.2	4.7	1.5	9.7	14.0	8.7	4.6	7.2	1.5	13.9	10.5	1.6	10.2	1.8	5.9	4.7	7.6	2.1	0.9	8.7	6.0	17.7	21.8	8.8	6.2	1.4	9.2	4.5	4.8	6.4	5.2	1.5	9.6	6.0	14.5	22.1	2.1	1.1	1.4	0.8	3.1	5.8	5.9	3.2	1.3	24.2	0.4	3.3	3.7	7.1	0.6	2.3	0.3	0.5	0.7	0.9	1.9	1.2	1.1	0.7	29.3	0.6	3.5	0.4	0.3	1.1	5.7	7.5	8.6	9.4	6.1	4.9	5.6	2.0	7.7	7.3
FRG2	FRG2A	ENSG00000205097	"FSHD region gene 2"	Q64ET8	4	190024351-190027257	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 2.0;brain: 2.8;skin 1: 3.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.1;HMC-1: 2.1;Karpas-707: 1.1"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"basophil: 2.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.0"									"HPA039264, HPA047769"	Uncertain									"HPA039264: , HPA047769: "																		0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.8	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.4			0.2		0.0	0.1	0.0	0.2	0.1	2.0	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.6	0.0	0.2	0.0	0.3	0.1	0.0	0.0	1.1	0.4	0.8	0.4	0.3	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.3	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.7	0.2	0.3	0.2	0.2	0.0	0.2	0.3	0.2	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.0	0.1	0.1	0.0										
FRG2B		ENSG00000225899	"FSHD region gene 2 family member B"	Q96QU4	10	133623895-133626795	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 2.0;kidney: 1.9;pancreas: 1.2"	"Cell line enriched"	"Detected in single"	22	"HDLM-2: 13.0"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.1"									"HPA039264, HPA047769"	Uncertain									"HPA039264: , HPA047769: "																		0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.0	0.8	0.0	0.0			0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.1	1.9	0.1	0.0	0.0	0.0		0.4	1.2	0.0	0.0	0.5		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8			0.0		0.0	0.0	0.0	0.2	0.0	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0										
FRMD1	"bA164L23.1, DKFZp434O0117, FLJ00181, FLJ22615, FLJ40260"	ENSG00000153303	"FERM domain containing 1"	Q8N878	6	168053166-168101511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 10.8;lymphoid tissue: 29.4"	"Group enriched"	"Detected in some"	8	"K-562: 4.6;RPMI-8226: 7.3"	"Cancer enriched"	"Detected in single"	6	"colorectal cancer: 1.9"	"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA030347	Enhanced		Approved	"Actin filaments"				"Actin filaments"		"HPA030347: AB_10600207"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.25e-1)"	"unprognostic (2.58e-4)"	"unprognostic (8.63e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.11e-3)"			6.4	0.1	0.0	6.0	0.2	0.0	10.8	0.2	0.1	0.2	9.8	0.0	0.0	2.3	0.2	0.2	0.3	0.2	0.5	0.1	0.0	0.0	5.6	0.2	0.1	0.0	1.5	0.2	0.2	0.2	0.0	0.1	0.3	0.6	0.1	6.8	1.1	1.7	0.0	2.6	0.2	4.5	0.1	1.0	2.9	7.5	8.1	0.0	29.4	0.1	1.2	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	1.5	0.2	0.6	0.0
FRMD3	"EPB41L4O, MGC20553"	ENSG00000172159	"FERM domain containing 3"	A2A2Y4	9	83242990-83538546	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 48.5;skeletal muscle: 42.1"	"Cell line enhanced"	"Detected in some"		"HEL: 11.6;RPMI-8226: 39.2;SCLC-21H: 14.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 27.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.8;intermediate monocyte: 4.7;neutrophil: 3.8;non-classical monocyte: 2.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.8;monocytes: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017285	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"				"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA017285: "	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.87e-2)"	"prognostic favourable (7.24e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-1)"	"prognostic favourable (1.79e-4)"	"unprognostic (1.68e-3)"	12.7	4.6	3.5	2.8	2.3	3.0	16.8	2.0	3.0	4.6	7.1	1.7	14.3	1.9	5.5	9.8	4.1	1.9	2.9	48.5	3.2	4.5	11.7	0.7	2.9	0.9	3.6	1.7	1.4	1.4	8.9	6.1	8.7	2.9	5.1	4.1	5.3	2.1	35.3	42.1	1.6	10.9	3.5	2.8	4.3	2.2	6.1	0.8	0.0	8.8	11.1	0.7	3.8	5.0	0.6	0.6	3.8	4.7	0.4	0.6	9.2	0.0	2.2	1.9	0.1	0.4	0.1	0.1	2.0	0.1	0.0	0.0	0.2	2.6	0.4	2.4	0.9	0.1	0.1	0.0	0.0	0.1	0.1	11.6	2.5	1.4	0.1	0.0	0.1	0.5	0.0	0.0	0.1	1.3	0.0	0.0	2.5	0.3	0.0	0.0	0.2	3.6	0.0	1.5	39.2	3.2	5.1	14.5	7.0	0.7	0.1	0.4	0.8	0.4	2.2	0.1	0.3	0.0	1.4	0.2	0.1	0.0	0.5	3.8	1.4	0.0	2.8	0.0	0.4	4.7	0.6	0.5	0.2	0.1	0.4	0.6	0.1	0.0	3.8	0.4	2.1	0.6	0.0	9.2	3.5	2.3	2.0	3.0	3.2	4.5	3.6	1.7	2.9	0.8
FRMPD3	"KIAA1817, RP5-1070B1.1"	ENSG00000147234	"FERM and PDZ domain containing 3"	Q5JV73	X	107522450-107605251	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.6;ovary: 10.3;thyroid gland: 6.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.6;SCLC-21H: 3.3;U-698: 2.9;WM-115: 3.9"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6"					"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.7;naive B-cell: 1.2"	"Group enriched"	"Detected in many"	15	"B-cells: 1.2;T-cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003164	Uncertain									"HPA003164: AB_1078260"	"unprognostic (1.27e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.48e-4)"	"unprognostic (1.69e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.43e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.83e-9)"	"unprognostic (4.59e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.26e-1)"	0.0	0.5	2.5	0.7	1.8	0.1	0.5	8.6	6.7	0.2	0.1			0.0	0.9	0.0	0.1	0.4	0.4	0.0	3.1	5.0	0.0	0.0	0.2	1.3	2.6		10.3	0.1	0.0	0.4	0.0		0.6	0.2		0.4	2.6	0.0	0.0	0.0	1.1	2.2	0.2	0.0	0.5			6.0		0.9	0.1	0.0	1.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	2.1	0.7	0.0	0.0	0.0	0.8	0.0	0.4	0.2	0.0	0.5	10.6	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.3	3.3	0.2	0.6	0.2	0.0	0.4	0.0	0.0	1.0	1.2	0.1	0.0	0.0	0.0	2.9	0.1	0.0	3.9	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.2	1.0	0.0	1.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0										
FRRS1	"SDFR2, SDR2"	ENSG00000156869	"Ferric chelate reductase 1"	Q6ZNA5	1	99708632-99766631	"Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 27.1"	"Cell line enhanced"	"Detected in many"		"HEL: 27.6;K-562: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"eosinophil: 5.5"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 5.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA017883	Approved									"HPA017883: AB_2294223"	"unprognostic (3.97e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.54e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (6.53e-4)"	"unprognostic (2.65e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.54e-2)"	10.3	6.2	0.6	2.7	1.2	1.5	5.1	0.5	1.2	6.4	6.1	1.2	14.5	2.6	10.7	6.5	11.2	2.0	3.4	2.9	0.6	0.6	1.9	27.1	3.8	1.7	2.1	0.0	5.3	2.0	1.5	2.3	9.8	0.9	4.4	4.0	1.6	8.4	13.4	2.0	7.2	8.0	3.3	3.1	1.5	4.2	2.9	1.3	1.4	5.6	5.4	6.0	5.1	7.0	0.3	0.5	5.5	0.8	0.0	0.1	0.1	5.5	1.0	2.4	2.1	7.6	4.1	12.2	1.4	2.7	1.7	6.5	6.7	7.3	3.2	5.7	1.6	12.7	3.8	5.9	2.1	6.5	2.4	27.6	2.7	7.2	1.1	3.1	7.4	6.1	7.5	3.4	1.3	0.3	18.5	0.1	1.4	1.7	1.0	1.2	1.7	5.1	0.0	9.0	1.3	1.1	13.8	0.5	0.1	2.3	10.4	5.4	3.8	3.9	0.6	3.0	4.1	2.6	1.5	2.3	0.0	5.4	6.6	1.3	1.4	0.5	0.4	5.5	0.0	0.8	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.6	1.2	0.5	1.2	0.6	0.6	2.1	0.0	0.9	1.3
FSCB	"C14orf155, DKFZP434F1017"	ENSG00000189139	"Fibrous sheath CABYR binding protein"	Q5H9T9	14	44504342-44507279	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 27.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA003546	Supported									"HPA003546: AB_1845561"															"unprognostic (8.13e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FSCN3		ENSG00000106328	"Fascin actin-bundling protein 3"	Q9NQT6	7	127591409-127602144	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"testis: 62.1"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA075174	Enhanced									"HPA075174: "	"unprognostic (7.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.87e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.91e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.68e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.14e-5)"	"unprognostic (1.27e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.34e-2)"	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	62.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.3	0.0	0.0	0.3	0.0	0.0	1.0	0.3	0.8	0.0	0.0	1.4	0.1	0.4	0.3	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	2.4	0.6	0.0	0.0	0.3	0.6	0.0	0.7	0.7	0.7	1.3	0.0	0.5	0.7	0.2	0.0	0.5	0.2	0.3	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.1	0.5	0.0	0.8	0.3	0.7	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FSIP1	FLJ35989	ENSG00000150667	"Fibrous sheath interacting protein 1"	Q8NA03	15	39588357-39782830	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 17.8;pituitary gland: 11.8;testis: 13.9"	"Cell line enhanced"	"Detected in many"		"BJ: 7.2"	"Cancer enriched"	"Detected in some"	8	"breast cancer: 6.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA041002	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm		"HPA041002: AB_10796565"	"unprognostic (1.55e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.17e-3)"	"unprognostic (5.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.81e-1)"	0.8	0.7	2.9	0.7	9.3	1.1	1.9	1.0	5.7	0.8	11.7	1.5	0.8	0.5	1.4	2.5	0.6	2.3	0.7	0.8	3.1	3.0	1.6	0.7	0.9	0.5	1.2	4.1	0.7	0.6	1.7	11.8	0.8	4.5	0.8	17.8	0.6	0.5	0.7	0.9	1.7	0.6	0.9	1.1	0.6	1.1	13.9	1.4	0.5	1.0	0.0	0.5	1.0	0.9	1.0	1.0	1.8	1.3	1.5	3.4	1.4	0.6	2.3	6.1	0.8	1.1	2.1	0.1	7.2	1.5	1.2	2.2	1.7	0.6	0.5	0.5	2.1	1.5	1.0	1.2	1.9	2.5	0.6	4.4	1.7	0.1	0.6	0.9	4.9	1.4	5.1	2.8	1.2	1.3	0.2	0.6	1.8	0.3	0.6	0.4	0.7	1.2	0.6	1.2	0.1	2.4	2.7	1.5	4.6	1.5	0.2	0.3	2.1	0.5	1.0	3.0	1.7	1.6	0.8	1.2	2.6	0.3	6.1	1.6	1.4	1.8	1.3	1.5	3.4	0.8	2.7	0.8	1.8	2.1	1.0	1.0	1.1	0.9	1.1	1.5	1.0	0.0	0.4	1.4	2.9	9.3	1.0	5.7	3.1	3.0	1.2	4.1	4.5	1.4
FSIP2	FLJ34780	ENSG00000188738	"Fibrous sheath interacting protein 2"	Q5CZC0	2	185738895-185833290	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 27.6"	"Cell line enhanced"	"Detected in some"		"AF22: 2.7;HeLa: 2.2;Karpas-707: 2.8;RT4: 4.7;U-266/70: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA036139			Approved	Microtubules,Mitochondria				Microtubules	Mitochondria	"HPA036139: AB_10602134"	"unprognostic (5.28e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.17e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.55e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.79e-3)"	"unprognostic (4.89e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.64e-5)"	0.4	0.2	0.1	0.1	0.1	0.0	0.3	0.1	0.3	0.3	2.7	0.1	0.1	0.0	0.6	0.5	0.1	0.2	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.4	0.6	0.5	0.5	0.3	1.4	0.3	0.2	0.1	0.1	0.3	0.6	0.6	0.1	0.5	3.6	27.6	0.1	0.1	0.4	0.1	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	2.8	0.1	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.5	0.1
FSTL4	KIAA1061	ENSG00000053108	"Follistatin like 4"	Q6MZW2	5	133196455-133612564	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.5"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 32.7;U-266/70: 11.7;U-266/84: 11.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045920	Uncertain		Approved	"Nuclear membrane,Mitochondria"	"Secreted to blood"			Mitochondria	"Nuclear membrane"	"HPA045920: AB_10965844"	"unprognostic (5.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.74e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.74e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.02e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.25e-2)"	0.7	2.2	8.4	1.0	14.6	3.0	1.1	18.5	18.0	1.0	1.6	1.7	0.0	1.1	0.5	2.8	3.1	1.6	0.7	0.6	1.5	3.2	4.8	0.5	2.0	0.4	1.9	10.1	0.8	2.9	7.1	4.0	6.4	2.6	2.9	1.9	1.4	1.4	0.1	1.5	5.3	1.2	0.3	1.0	0.5	2.3	2.8	4.7	0.0	1.3	0.0	1.7	10.2	1.6	2.8	1.2	3.4	1.1	0.8	2.3	1.2	4.3	7.5	0.8	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	6.7	0.9	0.3	6.1	0.0	0.1	0.9	0.2	0.0	0.4	0.3	0.3	7.3	0.6	0.0	0.0	0.4	0.1	1.1	0.0	0.0	0.0	3.4	4.0	0.0	7.1	0.8	0.3	8.0	0.8	0.3	0.7	7.6	0.0	8.3	32.7	0.7	1.6	1.4	0.1	2.8	0.3	0.2	0.3	1.3	0.4	0.2	11.7	11.7	0.3	0.1	0.0	0.2	3.4	1.1	0.6	1.2	0.4	2.3	2.8	1.7	1.2	0.6	2.6	2.1	1.3	2.4	0.8	0.7	1.2	1.6	1.2	8.4	14.6	18.5	18.0	1.5	3.2	1.9	10.1	2.6	4.7
FTCDNL1	FONG	ENSG00000226124	"Formiminotransferase cyclodeaminase N-terminal like"	E5RQL4	2	199760544-199851173	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA065748			Uncertain	Vesicles	"Secreted in other tissues"			Vesicles		"HPA065748: "	"unprognostic (1.78e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.82e-2)"	"unprognostic (5.37e-2)"	"unprognostic (9.86e-2)"	"prognostic favourable (3.31e-4)"	"unprognostic (3.92e-2)"	"unprognostic (4.63e-2)"	"prognostic unfavourable (5.74e-4)"	"unprognostic (1.21e-2)"	4.5	9.4	5.5	1.8	19.0	4.0	4.2	1.6	12.0	1.7	2.3	9.7	2.6	2.1	1.2	3.9	2.9	3.9	2.0	5.3	5.8	4.8	8.0	17.9	2.8	3.5	7.6	7.5	2.4	4.3	1.9	2.0	1.5	7.9	2.8	2.5	2.7	4.8	1.7	13.1	2.4	1.8	3.4	9.1	8.0	2.1	2.8	4.0	0.1	11.0	2.4	1.8	1.6	1.9	3.8	10.6	2.0	6.2	1.2	2.4	1.9	0.7	2.4	0.1	0.1	2.5	1.5	1.8	0.9	0.9	1.3	0.5	0.0	4.4	2.5	0.3	1.0	0.0	1.1	6.5	1.5	3.0	0.8	1.9	1.0	2.1	0.9	6.4	8.2	1.1	0.3	0.5	0.1	0.0	3.4	0.1	0.9	7.5	2.4	2.6	2.1	5.1	0.4	0.2	0.1	0.5	0.0	3.0	0.0	4.2	4.0	4.1	6.0	8.6	0.7	3.5	0.0	2.2	1.5	6.5	3.5	1.4	6.5	3.3	1.7	0.0	5.3	2.0	0.6	6.2	2.3	3.8	2.2	0.8	6.9	2.1	1.5	2.4	0.0	1.2	5.6	10.6	0.0	1.9	5.5	19.0	1.6	12.0	5.8	4.8	7.6	7.5	7.9	4.0
FUK	FLJ39408	ENSG00000157353	Fucokinase	Q8N0W3	16	70454421-70480274	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041971	Approved		Approved	Vesicles				Vesicles		"HPA041971: AB_10795648"	"unprognostic (4.55e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.82e-3)"	"unprognostic (4.85e-2)"	"prognostic favourable (8.91e-4)"	"unprognostic (2.49e-2)"	"unprognostic (9.68e-2)"	"unprognostic (8.89e-2)"	"prognostic favourable (8.38e-4)"	6.7	11.3	11.5	9.8	13.2	8.5	7.3	13.9	13.5	7.5	12.1	15.5	15.1	18.5	8.3	11.5	8.2	10.8	9.4	7.2	9.4	7.4	13.1	11.9	8.1	9.1	12.5	12.4	10.5	12.2	17.1	16.4	11.0	9.8	9.1	7.7	12.9	10.8	9.4	9.0	13.0	13.1	6.3	9.3	9.7	12.2	6.1	12.5	7.2	12.0	4.2	11.1	7.6	6.8	4.3	3.2	3.9	4.4	2.9	6.7	2.5	3.0	4.3	2.6	5.6	1.5	1.8	9.7	1.8	2.9	2.4	3.1	3.8	10.1	2.2	8.6	1.7	4.5	1.7	4.4	1.5	4.1	6.2	2.8	7.9	4.4	3.7	3.6	2.1	3.0	5.3	1.8	4.5	4.4	5.4	2.7	1.8	9.7	4.3	8.4	1.6	2.4	6.4	0.6	9.6	6.1	5.4	4.2	5.0	10.1	3.5	5.1	14.8	7.1	4.6	1.9	2.5	4.1	2.0	9.5	4.5	4.5	3.4	3.5	4.2	0.6	4.4	1.8	4.8	2.5	4.1	1.9	4.8	4.8	2.7	4.3	6.7	3.1	3.9	2.9	2.8	3.2	3.2	2.5	11.5	13.2	13.9	13.5	9.4	7.4	12.5	12.4	9.8	12.5
FUT10		ENSG00000172728	"Fucosyltransferase 10"	Q6P4F1	8	33370824-33473422	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053970, HPA058655"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"			"Nucleoplasm, Endoplasmic reticulum, Golgi apparatus"		"HPA053970: , HPA058655: "	"unprognostic (6.02e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.40e-3)"	"unprognostic (6.07e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.76e-4)"	"unprognostic (3.06e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-3)"	"unprognostic (6.01e-3)"	5.6	7.2	7.9	3.9	10.9	2.0	8.9	18.8	8.6	10.9	6.3	6.9	5.0	6.4	10.5	5.3	5.8	8.4	4.8	5.4	7.4	4.5	8.3	5.2	6.0	4.1	5.8	7.2	13.6	10.9	14.5	11.7	8.2	6.8	6.0	6.9	12.4	6.7	5.9	2.4	9.7	6.1	7.3	5.1	3.8	5.7	4.1	4.6	5.8	6.9	2.2	6.0	6.6	7.2	2.4	3.5	1.9	1.5	3.8	4.1	2.1	2.1	4.4	7.0	8.4	11.1	11.3	3.7	4.5	7.2	4.3	5.9	6.6	3.9	2.5	5.4	5.6	6.1	10.2	4.1	4.4	5.7	3.9	8.3	3.7	7.3	5.1	1.8	3.0	7.8	7.4	1.1	5.4	8.7	7.6	3.4	4.1	1.3	6.5	2.7	9.9	2.9	4.8	5.4	1.4	6.2	5.5	2.4	2.3	2.5	3.8	4.9	3.7	1.9	7.1	3.3	1.5	8.5	3.5	1.4	2.2	1.7	2.0	5.4	3.4	1.1	1.5	1.9	3.7	0.7	4.0	2.4	2.2	3.5	3.5	1.0	2.5	2.4	1.1	3.8	0.5	2.0	4.1	2.1	7.9	10.9	18.8	8.6	7.4	4.5	5.8	7.2	6.8	4.6
FUT3	"CD174, LE"	ENSG00000171124	"Fucosyltransferase 3 (Lewis blood group)"	P21217	19	5842888-5851474	"Blood group antigen proteins, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.6;intestine: 49.3;lymphoid tissue: 38.4"	"Group enriched"	"Detected in some"	4	"A-431: 30.2;RH-30: 10.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"											HPA046966	Supported									"HPA046966: "	"prognostic unfavourable (6.86e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.63e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"prognostic favourable (8.22e-7)"	"unprognostic (5.66e-3)"	"unprognostic (9.56e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.07e-1)"	0.2	0.1	0.2	14.5	0.2	0.0	0.4	0.2	0.2	10.9	40.4	0.2	32.5	18.8	0.4	0.5	53.6	0.7	21.5	0.1	0.2	0.2	3.8	0.9	5.1	0.1	0.2	0.1	0.5	4.7	0.0	0.3	0.6	0.1	1.0	18.1	0.2	27.5	31.6	0.1	1.0	49.3	1.0	0.2	0.1	8.1	1.3	0.1	0.3	0.1	14.9	38.4	2.9	16.1	0.2	1.6	0.8	0.6	0.0	0.5	0.0	30.2	0.0	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.4	0.0	1.3	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	10.2	1.0	0.0	0.5	0.0	0.1	0.0	4.8	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.8	0.0	0.0	1.6	0.5	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1
FUT4	"CD15, ELFT, FCT3A, FUC-TIV"	ENSG00000196371	"Fucosyltransferase 4"	P22083	11	94543840-94549898	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"bone marrow: 71.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 20.4;NB-4: 13.2;THP-1: 25.8;U-937: 18.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB000014, CAB016129"	Enhanced		Supported	Vesicles				Vesicles		"CAB000014: , CAB016129: AB_626918"	"unprognostic (6.36e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavourable (3.64e-4)"	"unprognostic (7.26e-2)"	"unprognostic (4.14e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.10e-3)"	5.5	2.4	5.5	6.1	6.2	71.3	6.3	3.0	6.0	4.4	8.3	6.7	4.7	10.9	5.9	2.5	3.0	4.6	7.5	3.7	6.2	2.2	4.1	3.0	6.0	5.4	8.1	2.5	4.9	11.4	1.4	2.9	3.4	4.8	3.4	8.3	3.8	6.3	2.9	1.7	1.9	10.1	5.8	5.7	6.5	9.7	2.9	4.5	10.4	2.9	1.9	3.1	4.4	3.0	0.7	1.9	2.5	3.9	0.8	1.9	0.8	1.6	0.8	1.0	0.0	3.1	2.8	5.1	1.4	0.7	1.3	1.5	6.9	2.2	0.0	3.5	2.4	0.8	1.6	0.1	1.2	10.5	1.6	5.2	1.1	0.1	1.6	20.4	4.6	2.4	0.0	1.7	0.0	2.0	5.2	0.0	1.5	0.7	4.2	13.2	1.9	1.9	3.8	0.0	0.0	1.4	1.1	1.4	0.5	0.8	2.1	0.8	1.2	25.8	1.9	1.0	2.9	0.0	0.5	0.6	0.3	0.0	0.9	18.3	0.6	2.0	3.1	2.5	1.1	1.5	0.7	0.6	1.0	1.3	1.8	0.7	1.1	0.7	1.7	0.8	3.9	1.9	1.9	0.8	5.5	6.2	3.0	6.0	6.2	2.2	8.1	2.5	4.8	4.5
FUT5	FUC-TV	ENSG00000130383	"Fucosyltransferase 5"	Q11128	19	5865826-5870540	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.6"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.8;SH-SY5Y: 2.9;U-266/70: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046966	Uncertain									"HPA046966: "				"unprognostic (7.72e-2)"	"unprognostic (3.59e-1)"		"unprognostic (5.03e-2)"			"unprognostic (1.20e-1)"								0.2	0.1	1.0	0.1	0.5	3.6	0.1	0.0	0.4	0.1	0.1			0.1	0.1	0.1	0.5	0.3	0.3	1.1	0.4	0.3	0.2	1.1	0.1	0.2	0.9		0.2	0.5	0.1	0.3	0.1		0.1	0.1		0.4	0.1	1.2	0.5	0.1	0.1	0.8	0.2	0.1	1.6			0.1		0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.0	0.7	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FUT9	Fuc-TIX	ENSG00000172461	"Fucosyltransferase 9"	Q9Y231	6	96015984-96215612	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 37.7;stomach 1: 35.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 4.1;RT4: 9.4;SCLC-21H: 9.6;SK-BR-3: 5.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070923			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"				Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA070923: "	"unprognostic (1.60e-1)"	"unprognostic (2.48e-1)"		"unprognostic (5.99e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.40e-1)"		"unprognostic (2.97e-1)"		"unprognostic (1.35e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	1.1	1.7	18.5	1.1	22.5	1.1	1.9	37.7	28.6	1.1	1.1	10.7	0.0	4.1	1.4	1.2	1.1	1.4	1.1	1.1	20.0	6.2	1.2	1.1	1.1	1.1	10.2	24.0	1.1	8.0	1.1	0.9	1.7	13.8	1.5	1.2	0.0	1.1	1.5	1.2	1.1	1.1	1.1	10.2	1.1	35.4	1.1	16.5	0.0	1.2	0.0	1.1	2.2	0.4	0.3	0.2	1.5	0.1	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	9.4	9.6	0.2	0.0	5.4	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.8	0.2	0.0	0.2	0.0	0.0	18.5	22.5	37.7	28.6	20.0	6.2	10.2	24.0	13.8	16.5
GAB4		ENSG00000215568	"GRB2 associated binding protein family member 4"	Q2WGN9	22	16961936-17008222	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	17	"testis: 19.6"	"Cell line enhanced"	"Detected in single"		"HAP1: 1.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044621	Uncertain									"HPA044621: AB_10967265"																		0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.1	0.8	0.0	0.1	0.0	0.4	0.6	0.1	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	1.1	0.0	0.5	0.0
GABRA2		ENSG00000151834	"Gamma-aminobutyric acid type A receptor alpha2 subunit"	P47869	4	46248427-46475230	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 52.6"	"Cell line enhanced"	"Detected in some"		"U-2 OS: 9.4;U-87 MG: 4.4;WM-115: 5.0"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB079061		Supported			"Intracellular and membrane"					"CAB079061: "	"unprognostic (2.03e-2)"		"unprognostic (2.77e-1)"	"unprognostic (2.45e-4)"	"unprognostic (6.87e-3)"	"unprognostic (2.65e-1)"		"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.90e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.22e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.04e-2)"	2.2	1.3	38.5	1.4	34.4	1.2	1.9	10.4	52.6	1.7	4.5	4.9	0.0	2.0	1.4	11.7	1.7	1.0	1.6	1.0	38.9	7.7	8.8	1.4	1.0	1.4	3.7	31.0	1.9	1.0	0.9	0.6	1.5	10.5	1.0	3.5	0.0	1.2	1.9	1.0	1.3	7.7	1.3	6.9	2.3	1.6	1.5	7.1	0.0	1.1	0.0	1.4	1.2	0.8	0.2	0.3	1.0	0.1	0.1	0.1	0.0	0.5	0.5	0.1	0.6	0.0	0.0	0.5	0.3	0.0	0.0	0.0	2.1	0.6	0.2	0.5	0.0	0.8	0.0	0.0	0.1	0.5	0.5	0.1	0.7	0.2	0.8	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.8	0.2	0.0	0.4	0.0	0.3	0.9	0.1	0.0	0.6	0.4	0.1	0.6	0.2	0.0	0.1	0.3	0.0	0.3	0.4	0.1	0.5	9.4	0.5	0.1	0.7	1.2	0.2	4.4	0.4	5.0	1.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.1	0.1	0.3	0.0	0.0	38.5	34.4	10.4	31.4	38.9	7.7	3.7	31.0	10.5	7.1
GABRA6		ENSG00000145863	"Gamma-aminobutyric acid type A receptor alpha6 subunit"	Q16445	5	161547063-161702593	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	23	"brain: 96.4"	"Group enriched"	"Detected in some"	9	"AF22: 1.0;PC-3: 1.4;TIME: 1.0;U-266/70: 2.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	36	"cerebellum: 96.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	40	"cerebellum: 1204.9"	"Region enriched"	"Detected in single"	44	"cerebellum: 189.6"	CAB022462	Approved									"CAB022462: "																"unprognostic (3.79e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.4	0.1	0.0	0.0	0.0	0.0	2.6	0.0
GABRE		ENSG00000102287	"Gamma-aminobutyric acid type A receptor epsilon subunit"	P78334	X	151953124-151974680	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"placenta: 36.4;vagina: 27.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.3;EFO-21: 14.6;HeLa: 6.5;SiHa: 6.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"hypothalamus: 21.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA045918	Uncertain									"HPA045918: AB_10961281"	"unprognostic (1.33e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.39e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.44e-2)"	"unprognostic (6.73e-2)"	"prognostic unfavourable (4.05e-11)"	"unprognostic (1.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.28e-2)"	14.8	1.0	1.5	2.2	2.8	0.3	16.5	1.0	1.6	8.9	5.8	0.0	2.2	1.4	6.0	4.1	5.0	1.5	4.2	16.3	1.0	21.8	1.1	0.9	2.3	0.7	1.1	0.6	1.6	2.5	0.4	4.1	36.4	4.5	5.9	0.8	3.8	2.0	6.3	0.9	5.6	10.1	2.5	1.1	0.9	1.0	0.9	0.4	0.0	2.5	5.9	3.5	2.9	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	4.3	0.0	0.0	0.6	0.0	1.1	0.5	2.2	0.8	0.0	14.6	3.0	2.3	0.0	0.8	0.7	0.0	0.5	1.6	6.5	0.8	0.2	0.0	0.2	1.0	0.6	1.2	0.3	0.6	0.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.9	1.0	0.0	0.0	0.0	1.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.8	1.0	1.3	1.0	21.8	1.1	0.6	4.5	0.4
GABRG1		ENSG00000163285	"Gamma-aminobutyric acid type A receptor gamma1 subunit"	Q8N1C3	4	46035769-46124081	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 35.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.3;THP-1: 2.6;U-2 OS: 1.8;U-266/70: 5.3"	"Cancer enriched"	"Detected in single"	8	"glioma: 0.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035622	Approved									"HPA035622: AB_10603669"	"unprognostic (2.50e-1)"				"unprognostic (2.20e-1)"		"unprognostic (6.06e-2)"			"unprognostic (1.46e-2)"	"unprognostic (7.39e-4)"		"unprognostic (1.23e-1)"		"unprognostic (1.28e-1)"	"unprognostic (1.99e-1)"		1.5	1.5	20.3	1.2	25.9	1.2	1.3	26.4	35.7	1.3	1.3	12.2	0.0	1.4	1.4	1.3	1.3	1.7	1.3	1.2	26.0	14.6	1.4	1.4	1.2	1.3	10.2	14.0	3.9	1.2	1.3	1.6	1.2	17.9	1.2	1.3	0.0	1.2	1.3	1.2	1.2	1.4	1.4	17.8	1.4	1.3	1.8	17.8	0.0	1.5	0.0	1.2	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.6	0.0	0.3	1.8	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	25.9	26.4	18.5	26.0	14.6	10.2	14.0	17.9	17.8
GABRG3		ENSG00000182256	"Gamma-aminobutyric acid type A receptor gamma3 subunit"	Q99928	15	26971282-27541991	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 15.3;prostate: 13.5;testis: 16.6"	"Cell line enhanced"	"Detected in some"		"K-562: 4.9;PC-3: 6.3;SK-MEL-30: 4.1;U-2 OS: 2.9;U-266/70: 3.8;U-87 MG: 16.8"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054010	Supported									"HPA054010: "	"unprognostic (1.23e-1)"	"unprognostic (1.67e-1)"		"unprognostic (1.02e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.41e-1)"	"unprognostic (1.43e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.83e-1)"	0.5	1.3	2.2	0.8	10.4	0.5	1.2	3.1	15.3	2.2	0.5	0.8	0.0	0.4	0.7	4.4	0.5	1.3	0.5	0.4	3.0	5.8	1.0	0.6	0.5	1.5	1.0	7.8	0.5	0.4	0.4	6.4	0.5	2.7	13.5	0.5	4.0	1.5	3.4	0.5	0.9	0.4	0.6	0.8	2.3	0.4	16.6	0.5	0.3	3.3	0.0	1.9	0.4	0.7	0.8	0.3	0.9	0.4	0.3	0.3	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.4	0.4	6.3	0.0	0.0	1.1	0.0	0.0	0.1	1.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	3.8	0.0	0.0	16.8	0.1	0.0	0.4	0.4	0.1	0.1	0.1	0.2	0.3	0.1	0.1	0.0	0.8	0.3	0.1	0.9	0.3	0.1	0.3	0.1	0.0	2.2	10.4	3.1	15.3	3.0	5.8	1.0	7.8	2.7	0.5
GABRP		ENSG00000094755	"Gamma-aminobutyric acid type A receptor pi subunit"	O00591	5	170763350-170814047	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.0;lymphoid tissue: 57.7"	"Cell line enhanced"	"Detected in many"		"A-431: 44.6;EFO-21: 52.2;HeLa: 31.3;PC-3: 71.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 10.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 10.1;monocytes: 6.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB014883	Uncertain									"CAB014883: "	"unprognostic (3.98e-3)"	"prognostic favourable (3.37e-4)"	"unprognostic (8.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.89e-2)"	"unprognostic (4.97e-3)"	"unprognostic (3.72e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.92e-3)"	"unprognostic (6.52e-3)"	1.5	0.5	0.5	1.3	0.5	1.1	31.6	0.5	1.1	18.5	1.7	0.6	2.6	2.6	30.4	9.9	37.0	2.2	8.6	1.0	0.5	0.4	6.9	3.8	2.5	0.5	0.5	0.5	1.1	4.3	0.0	2.4	5.5	0.6	6.8	0.4	0.8	25.5	3.2	2.0	10.0	3.9	0.5	0.5	0.8	5.0	1.0	0.5	2.5	0.6	3.1	57.7	1.2	20.0	0.9	1.1	10.1	6.1	0.2	1.3	3.1	44.6	2.0	2.2	1.5	0.1	0.9	5.2	0.8	0.3	0.1	0.1	8.0	5.1	0.7	52.2	0.2	16.2	1.3	0.1	0.1	0.7	1.6	2.9	31.3	1.1	0.1	1.0	2.5	0.3	0.6	0.6	0.4	0.3	12.0	5.7	0.1	1.4	1.9	1.0	18.4	71.4	2.8	1.4	1.7	3.0	2.4	1.8	0.8	16.5	0.8	0.5	0.9	0.5	1.9	4.1	15.2	3.4	3.3	2.2	1.3	1.3	0.5	2.9	0.6	10.1	2.3	6.8	0.5	1.7	1.3	0.3	0.5	0.4	0.7	0.9	0.7	0.6	5.4	0.2	6.1	1.1	0.7	3.1	0.5	0.5	0.5	0.6	0.5	0.4	0.5	0.5	0.6	0.5
GAGE12F		ENSG00000236362	"G antigen 12F"	"P0CL80, P0CL82, O76087"	X	49551278-49568218	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"blood: 16.2;testis: 58.6"	"Group enriched"	"Detected in some"	4	"AN3-CA: 133.5;K-562: 130.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.2	0.0	0.0	0.1	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	58.6			0.0		0.0	0.0	0.0	7.0	8.5	3.1	9.1	9.6	14.7	16.2	1.1	0.0	0.0	133.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	130.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.0	0.0	0.5	6.7	0.8	0.0	0.1	0.0	7.7	0.0	0.0	0.0	16.7	0.9	9.1	3.1	3.9	7.5	2.5	7.0	10.3	7.2	0.0	6.2	8.5	7.5	0.9	9.6	6.3	8.5	14.7	16.2										
GAGE12G		ENSG00000215269	"G antigen 12G"	"P0CL81, O76087, P0CL82"	X	49570434-49577754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	33	"blood: 7.4;stomach 1: 14.0"	"Cell line enriched"	"Detected in some"	7	"AN3-CA: 145.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"T-reg: 7.4"	"Low lineage specificity"	"Detected in many"											HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: "																		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.1	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0			0.0		0.0	0.0	0.0	2.6	1.4	1.3	2.5	0.4	7.4	6.2	0.0	0.0	0.0	145.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.4	2.5	1.3	0.8	2.2	1.3	1.5	3.6	0.5	0.0	2.6	0.6	3.2	0.0	0.4	1.8	1.4	7.4	6.2										
GALNT13	"GalNAc-T13, KIAA1918"	ENSG00000144278	"Polypeptide N-acetylgalactosaminyltransferase 13"	Q8IUC8	2	153871913-154453849	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.0"	"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 27.7;U-251 MG: 7.2;WM-115: 20.7"	"Cancer enriched"	"Detected in some"	5	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060775	Approved									"HPA060775: "	"unprognostic (1.97e-1)"	"unprognostic (3.43e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.00e-3)"	"unprognostic (4.21e-3)"	"unprognostic (7.73e-3)"	"unprognostic (6.50e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.57e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.05e-5)"	"unprognostic (8.61e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.05e-1)"	3.0	7.7	8.5	0.7	6.2	0.6	1.4	39.0	29.1	3.1	0.9	7.9	0.6	0.7	3.1	2.3	0.7	1.0	1.1	0.6	7.8	8.9	0.6	0.4	3.4	0.4	8.3	3.1	1.1	1.0	0.5	3.1	1.0	10.5	3.6	1.0	1.1	10.9	2.6	1.7	0.8	0.8	2.0	10.4	0.5	1.1	1.3	4.3	0.0	0.4	0.0	0.5	1.5	0.2	0.2	0.6	2.2	0.9	0.2	0.8	0.0	0.0	3.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	1.7	0.0	3.2	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.1	4.6	4.3	0.0	0.2	0.6	0.0	0.0	4.7	27.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	7.2	0.3	0.0	0.0	4.5	0.0	20.7	0.0	0.9	2.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.8	0.1	0.2	0.0	0.6	0.4	0.0	8.5	6.2	39.0	7.4	7.8	8.9	8.3	3.1	10.5	4.3
GALNT15	"GALNT7, GALNTL2, pp-GalNAc-T15"	ENSG00000131386	"Polypeptide N-acetylgalactosaminyltransferase 15"	Q8N3T1	3	16174649-16231992	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 66.7;brain: 52.3"	"Group enriched"	"Detected in some"	5	"ASC diff: 43.8;ASC TERT1: 43.2;HSkMC: 32.9"	"Cancer enriched"	"Detected in many"	5	"glioma: 21.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"cerebellum: 10.7;pons and medulla: 6.7"	"Low region specificity"	"Detected in all"			HPA017076	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"		25000	"Golgi apparatus"	Cytosol	"HPA017076: AB_1849458"	"unprognostic (3.87e-1)"	"unprognostic (4.84e-4)"	"unprognostic (6.39e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.40e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-6)"	"unprognostic (5.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.78e-3)"	66.7	5.3	7.6	2.6	17.4	1.1	22.8	2.3	31.5	3.9	8.6	28.1	1.1	2.8	3.5	3.3	11.4	5.3	5.2	7.3	14.8	6.6	8.3	2.8	3.1	3.4	38.9	8.4	8.4	3.2	1.6	1.0	35.5	24.8	4.9	3.8	1.3	8.0	4.1	17.3	11.6	5.3	10.5	52.3	12.8	4.6	8.1	19.9	0.0	6.3	1.6	1.5	16.6	23.5	0.6	0.9	0.9	0.3	0.3	0.4	0.3	0.0	0.0	0.0	0.0	43.8	43.2	0.0	0.9	0.7	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	32.9	0.0	0.4	0.5	0.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	7.7	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.2	0.3	0.2	0.2	0.1	0.4	0.2	0.3	0.0	0.6	0.4	0.2	0.9	0.3	0.3	0.9	0.3	0.3	7.6	17.4	2.3	13.6	14.8	6.6	38.9	8.4	24.8	19.9
GALNT17	"GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17"	ENSG00000185274	"Polypeptide N-acetylgalactosaminyltransferase 17"	Q6IS24	7	71132169-71713600	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.9"	"Cell line enhanced"	"Detected in some"		"AF22: 9.5;NTERA-2: 7.2;RPMI-8226: 7.9;SK-BR-3: 30.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA013624, HPA047986"	Approved		Uncertain	"Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoli, Nuclear bodies"	"HPA013624: AB_1858787, HPA047986: "	"unprognostic (2.79e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (4.60e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.63e-3)"	"prognostic favourable (3.91e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.94e-3)"	1.8	7.8	8.2	2.1	13.9	0.5	1.2	25.7	42.9	2.3	4.9	1.7	1.9	0.8	7.9	4.6	8.9	4.4	2.7	19.4	13.2	4.6	2.3	0.6	3.5	0.5	2.1	12.0	22.3	9.4	0.6	4.1	0.7	4.5	9.1	1.4	1.2	1.7	8.3	1.9	0.8	1.5	12.3	1.2	3.3	1.1	3.8	0.8	0.3	9.4	0.0	1.8	10.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	7.9	0.0	0.0	0.5	0.0	0.0	30.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	13.9	25.7	22.5	13.2	4.6	2.1	12.0	4.5	0.8
GALNT18	"GalNAc-T18, GALNT15, GALNTL4, MGC71806"	ENSG00000110328	"Polypeptide N-acetylgalactosaminyltransferase 18"	Q6P9A2	11	11270876-11622005	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 18.5;HaCaT: 23.8;HBEC3-KT: 16.6;PC-3: 16.7;RPMI-8226: 17.4;SK-BR-3: 21.7;U-87 MG: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	17	"gdT-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012955	Approved		Approved	Mitochondria			200000	Mitochondria		"HPA012955: AB_1849460"	"unprognostic (1.26e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.69e-2)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.42e-3)"	"unprognostic (6.68e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.81e-2)"	18.6	6.0	15.5	4.9	13.5	0.8	9.1	21.3	16.2	7.0	13.3	5.8	8.3	3.9	15.0	6.4	7.8	7.6	12.6	21.9	13.1	7.0	19.7	6.6	31.2	5.8	10.0	12.1	3.8	9.5	9.1	4.3	26.6	12.8	8.2	4.3	7.1	10.4	11.5	6.1	7.6	4.9	15.0	6.5	4.0	4.1	13.3	8.4	0.7	39.2	5.6	4.2	10.3	9.1	0.0	0.0	0.0	0.0	0.0	1.7	0.3	18.5	6.8	0.9	4.2	0.0	0.0	0.1	2.0	5.1	0.2	0.0	0.7	2.4	0.0	1.4	0.0	23.8	4.5	16.6	0.0	0.0	6.7	0.0	0.0	0.0	0.2	0.0	0.0	0.1	6.9	0.0	6.3	0.0	0.0	0.0	0.9	4.5	0.2	0.0	0.7	16.7	0.0	0.0	17.4	12.8	2.3	0.3	1.9	3.4	21.7	0.1	4.5	0.0	0.0	0.3	3.8	0.1	0.1	0.0	0.0	0.0	15.8	0.0	4.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	15.5	13.5	21.3	16.2	13.1	7.0	10.0	12.1	12.8	8.4
GALNT6	GalNAc-T6	ENSG00000139629	"Polypeptide N-acetylgalactosaminyltransferase 6"	Q8NCL4	12	51351247-51392867	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 35.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 33.6;CACO-2: 33.2;SK-BR-3: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 23.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011762, HPA017086"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"		2900000	"Nucleoplasm, Golgi apparatus"		"HPA011762: AB_1849450, HPA017086: AB_1849452"	"unprognostic (2.03e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.26e-2)"	"prognostic favourable (9.85e-4)"	"unprognostic (1.35e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.27e-2)"	"prognostic favourable (5.40e-4)"	"unprognostic (1.88e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.13e-4)"	"unprognostic (5.65e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.18e-2)"	3.1	1.8	4.0	4.1	9.5	4.4	10.6	1.0	5.1	19.5	13.4	15.4	0.5	11.8	0.9	14.4	2.8	3.7	6.8	0.8	7.1	3.6	2.5	0.8	4.1	4.0	14.4	3.6	1.4	6.3	0.4	1.6	9.9	5.8	1.3	3.9	0.9	23.8	6.3	0.6	5.5	16.9	0.8	8.3	5.5	35.4	0.8	9.7	6.6	1.8	2.3	6.6	2.2	2.2	2.9	3.7	23.8	6.5	10.8	3.4	2.8	11.5	1.2	0.2	0.0	0.0	0.1	18.5	19.4	33.6	8.3	5.6	33.2	6.1	0.1	1.8	10.9	11.1	0.6	8.4	5.3	2.6	1.2	7.4	0.2	0.2	0.3	3.9	26.1	0.7	7.8	7.4	7.1	20.4	1.6	0.3	0.0	22.6	12.5	2.9	1.6	21.0	0.0	0.0	3.3	6.5	0.8	0.1	7.5	0.1	33.9	0.0	18.8	1.7	23.9	0.0	4.2	0.0	0.0	0.6	0.1	1.0	2.3	8.7	0.1	4.5	4.4	23.8	3.4	3.7	1.4	0.8	1.7	2.6	3.7	2.9	2.7	2.3	0.8	10.8	6.5	3.1	1.1	2.8	4.0	9.5	1.0	5.1	7.1	3.6	14.4	3.6	5.8	9.7
GALNT8	GALNAC-T8	ENSG00000130035	"Polypeptide N-acetylgalactosaminyltransferase 8"	"Q9NY28, P17658"	12	4720341-4851927	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Glycosyltransferase, Ion channel, Potassium channel, Transferase, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 12.7;intestine: 33.2;testis: 18.5"	"Group enriched"	"Detected in some"	4	"Karpas-707: 26.3;NTERA-2: 9.3;U-266/84: 7.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.0"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in single"			"HPA012638, HPA073461"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"			"Golgi apparatus, Vesicles"		"HPA012638: AB_2294503, HPA073461: "	"unprognostic (2.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.06e-5)"	"unprognostic (1.16e-2)"	"unprognostic (6.67e-5)"	"unprognostic (5.18e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.33e-2)"	1.1	2.2	5.3	2.2	6.5	0.5	3.1	1.4	12.7	1.0	15.5	9.4	0.0	7.2	0.9	0.4	0.7	1.2	1.1	3.7	8.0	1.7	1.2	0.8	0.9	1.0	5.7	9.6	1.6	0.9	0.2	3.7	0.5	6.0	1.1	33.2	0.1	1.0	0.9	0.7	0.9	14.7	2.1	3.5	1.2	1.3	18.5	11.5	0.0	0.8	0.5	0.9	1.2	0.9	1.0	0.7	0.1	0.1	0.9	3.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	26.3	0.0	0.0	0.2	0.1	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.3	7.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.4	0.3	0.7	1.2	0.0	1.0	0.0	0.1	0.1	0.9	0.0	0.7	3.0	0.0	5.3	6.5	1.4	12.7	8.0	1.7	5.7	9.6	6.0	11.5
GALNTL5	"GalNAc-T5L, GALNT15"	ENSG00000106648	"Polypeptide N-acetylgalactosaminyltransferase like 5"	Q7Z4T8	7	151956379-152019934	"Disease related genes, Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 45.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011140	Enhanced									"HPA011140: AB_1078944"					"unprognostic (2.33e-2)"									"unprognostic (2.09e-1)"	"unprognostic (1.55e-1)"			0.0	0.0	1.2	0.0	0.7	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	0.0	1.9	1.1	0.0	0.0	0.0	0.0	0.0
GALNTL6	"GalNAc-T6L, GALNT17"	ENSG00000174473	"Polypeptide N-acetylgalactosaminyltransferase like 6"	Q49A17	4	171812254-173041559	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.5;lymphoid tissue: 7.3;testis: 6.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.3;SCLC-21H: 2.4;SK-MEL-30: 1.9;U-266/70: 2.8;WM-115: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 4.5;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	8	"B-cells: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031019	Uncertain				"Intracellular and membrane"					"HPA031019: AB_10601653"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.50e-2)"	"unprognostic (8.32e-2)"	"unprognostic (3.25e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.73e-2)"	0.2	0.7	3.9	1.2	8.3	1.1	0.7	1.0	9.5	3.3	1.0	0.6	0.0	0.7	0.3	0.3	0.2	0.3	0.5	0.5	3.6	4.1	0.3	0.5	0.5	1.3	7.6	2.4	0.1	0.5	0.1	0.0	0.1	1.8	2.2	0.7	1.3	0.3	0.2	0.5	0.6	1.2	0.3	0.5	7.3	2.9	6.4	1.2	0.0	0.5	1.1	0.4	0.5	0.6	4.5	0.5	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.5	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.7	1.2	0.0	1.3	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.7	2.3	0.2	1.1	0.3	0.6	1.4	0.0	0.0	0.1	0.0	0.0	0.0	2.4	1.0	0.0	0.5	1.9	0.0	0.3	0.0	0.0	0.1	0.0	0.1	2.8	0.0	0.0	0.3	0.1	1.7	0.0	0.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	8.3	1.0	5.9	3.6	4.1	7.6	2.4	1.8	1.2
GALP		ENSG00000197487	"Galanin like peptide"	Q9UBC7	19	56176020-56185775	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Hormone, Neuropeptide"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"brain: 4.4;liver: 4.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;EFO-21: 1.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Region enhanced"	"Detected in many"		"pons and medulla: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hippocampal formation: 29.0"	HPA053938	Uncertain				"Secreted in brain"					"HPA053938: "				"unprognostic (8.51e-3)"			"unprognostic (1.22e-2)"			"unprognostic (2.65e-1)"					"unprognostic (7.02e-2)"			0.0	0.2	1.2	0.0	1.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	4.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.0	0.1	1.1	0.7	0.4	0.0	4.4	0.0
GANC		ENSG00000214013	"Glucosidase alpha, neutral C"	Q8TET4	15	42273233-42356935	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016949	Approved		Approved	"Nucleoplasm,Actin filaments"				"Nucleoplasm, Actin filaments"		"HPA016949: AB_1849465"	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.51e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.49e-2)"	"prognostic favourable (9.76e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.74e-2)"	13.3	14.0	12.5	17.3	20.7	17.6	14.4	16.6	14.2	15.8	14.3	25.6	15.4	11.7	17.9	26.0	20.7	12.9	13.0	12.4	13.4	10.4	13.5	18.0	30.5	13.8	25.0	13.7	18.8	13.1	17.4	20.5	10.8	19.8	13.1	17.8	18.3	20.4	13.7	23.9	13.9	15.4	15.9	25.1	15.5	13.1	24.5	22.6	17.4	16.8	12.3	18.3	16.2	16.3	17.6	12.2	9.3	10.1	4.0	7.4	4.7	6.1	3.2	7.9	8.5	9.6	13.5	5.0	13.6	14.7	15.0	12.6	4.7	4.4	3.4	7.4	13.7	12.9	9.4	14.5	10.4	8.4	4.3	8.4	8.5	9.1	8.1	8.1	7.3	9.1	8.7	6.1	10.4	10.1	8.7	9.5	11.8	1.3	5.4	9.0	4.8	4.1	10.5	9.2	11.7	11.3	5.8	5.9	8.4	7.6	6.7	4.8	2.5	19.3	9.2	15.8	4.2	13.0	8.1	10.3	13.6	6.9	7.4	15.0	8.7	9.3	9.3	7.4	3.7	10.1	5.0	16.2	5.7	6.9	12.2	17.6	7.4	4.4	5.0	4.0	8.1	9.6	5.5	4.7	12.5	20.7	16.6	14.2	13.4	10.4	25.0	13.7	19.8	22.6
GARNL3	"bA356B19.1, DKFZp761J1523"	ENSG00000136895	"GTPase activating Rap/RanGAP domain like 3"	Q5VVW2	9	127224265-127393660	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.3"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 5.9;SH-SY5Y: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.8;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028757, HPA074886"	Enhanced		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA028757: AB_2294383, HPA074886: "	"unprognostic (3.15e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (6.88e-4)"	"unprognostic (2.22e-1)"	"unprognostic (3.23e-7)"	"unprognostic (6.39e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.78e-5)"	4.2	8.4	11.4	2.5	13.5	0.4	6.4	33.3	19.6	9.1	3.6	12.9	3.8	3.0	10.6	6.6	7.0	8.5	5.8	16.3	7.5	9.6	3.4	3.0	3.8	2.0	7.8	10.7	6.6	3.5	15.7	3.1	2.3	12.9	9.0	3.1	4.3	7.0	6.4	2.2	4.3	2.7	10.1	7.2	2.4	2.9	4.0	9.4	0.0	8.6	1.5	2.1	7.9	4.8	0.5	3.8	0.0	0.5	0.0	1.3	0.2	0.8	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.6	0.3	1.8	1.9	0.6	0.0	1.7	0.1	0.9	3.3	0.0	0.3	0.0	1.4	0.0	2.9	1.9	0.8	0.7	0.3	0.2	2.6	0.0	0.0	1.3	1.4	1.1	0.1	1.0	0.0	0.6	0.7	2.7	0.2	2.0	5.9	3.2	4.1	2.1	6.5	1.3	4.7	0.5	1.6	0.1	0.0	0.4	1.9	0.0	0.6	4.1	3.9	2.0	0.9	1.0	0.8	0.0	0.5	0.0	1.2	0.1	0.3	0.2	0.1	1.3	0.5	0.5	0.8	0.0	0.0	0.0	0.0	3.8	0.6	0.2	11.4	13.5	33.3	19.6	7.5	9.6	7.8	10.7	12.9	9.4
GAS1		ENSG00000180447	"Growth arrest specific 1"	P54826	9	86944363-86947189	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Growth arrest"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 61.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.3;ASC diff: 13.3;BJ hTERT+: 26.2;HSkMC: 18.7;RH-30: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB024164, HPA036085, HPA066902"	Approved		Approved	"Nuclear speckles"				"Nuclear speckles"		"CAB024164: AB_2107950, HPA036085: , HPA066902: "	"unprognostic (2.78e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (1.97e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.46e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.25e-3)"	"unprognostic (4.30e-2)"	"prognostic unfavourable (1.96e-5)"	"prognostic unfavourable (8.26e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavourable (1.13e-5)"	"unprognostic (3.59e-2)"	26.5	2.9	0.9	8.3	1.1	0.0	14.0	1.3	1.3	26.4	9.1	2.1	15.0	0.9	61.8	37.1	10.0	20.9	11.8	9.9	1.0	0.5	4.5	0.8	4.1	5.7	1.8	0.8	31.5	4.3	0.8	3.2	50.1	2.0	18.1	1.0	8.7	4.8	8.9	8.1	10.1	3.4	24.5	0.9	1.2	6.3	18.9	0.5	3.6	6.0	3.8	1.6	11.3	15.6	0.0	0.8	0.0	0.0	0.1	0.6	0.0	0.0	0.0	3.3	19.3	13.3	5.0	0.3	3.6	26.2	1.3	1.1	0.0	0.0	0.0	0.2	6.7	0.2	0.0	0.1	0.5	2.1	7.4	0.0	10.8	0.0	6.7	0.0	0.3	18.7	2.8	0.4	2.3	0.0	0.0	0.0	5.5	0.0	0.0	0.1	4.0	0.0	3.8	39.9	0.0	0.2	0.0	0.4	1.7	5.4	0.0	5.7	0.0	0.1	0.0	5.6	1.6	0.4	1.2	0.0	0.0	0.0	0.2	0.2	1.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.9	1.1	1.3	1.2	1.0	0.5	1.8	0.8	2.0	0.5
GBGT1	"A3GALNT, FS, MGC44848, UDP-GalNAc"	ENSG00000148288	"Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group)"	Q8N5D6	9	133152948-133163945	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 30.0;HMC-1: 28.1;HUVEC TERT2: 11.6;NB-4: 13.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051298	Approved				"Intracellular and membrane"					"HPA051298: "	"unprognostic (4.63e-3)"	"unprognostic (8.03e-2)"	"prognostic unfavourable (6.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.38e-1)"	"unprognostic (2.97e-2)"	"unprognostic (7.43e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.27e-3)"	"unprognostic (2.35e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavourable (3.46e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.35e-2)"	10.2	12.9	6.7	13.7	5.7	10.3	15.5	8.1	7.8	5.8	5.6	6.3	4.7	4.1	8.5	5.7	6.7	7.8	9.0	7.2	7.0	4.6	7.7	2.0	11.2	20.4	6.7	4.3	15.8	4.4	5.6	5.6	19.7	8.8	8.4	3.9	16.7	6.3	8.2	2.9	4.2	7.3	8.2	7.2	11.2	21.7	4.3	5.7	1.7	8.1	3.2	11.5	8.3	9.0	3.4	3.2	5.2	11.2	0.9	0.5	2.5	0.0	0.7	0.7	0.0	0.5	0.6	0.2	2.3	1.8	1.3	0.0	0.0	0.4	0.5	7.7	2.2	8.4	5.0	0.4	0.0	0.0	0.2	30.0	0.5	0.0	6.2	1.1	28.1	2.6	0.8	0.3	0.0	11.6	8.7	0.1	0.4	0.1	0.1	13.5	2.4	0.2	2.2	0.2	0.8	0.7	0.1	0.2	0.8	0.0	1.2	0.0	0.0	6.6	7.2	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.1	4.8	0.4	4.7	11.2	5.2	0.2	7.7	0.5	1.7	0.4	0.0	3.2	3.4	0.1	0.1	2.0	0.9	6.4	2.3	0.2	2.5	6.7	5.7	8.1	7.8	7.0	4.6	6.7	4.3	8.8	5.7
GBP4	Mpa2	ENSG00000162654	"Guanylate binding protein 4"	Q96PP9	1	89181148-89198932	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.8;HDLM-2: 7.9;HEL: 10.4;REH: 8.8;RT4: 14.8;U-266/70: 13.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA030101, HPA062039"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"				"Golgi apparatus"	"Plasma membrane"	"HPA030101: AB_10601654, HPA062039: "	"unprognostic (1.32e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.22e-1)"	"unprognostic (9.93e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"prognostic favourable (9.29e-5)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavourable (1.30e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.02e-3)"	25.4	4.4	3.9	18.4	5.9	3.6	9.4	2.1	5.0	7.8	5.8	4.4	2.9	8.0	10.5	7.4	7.9	6.3	5.7	9.2	4.6	4.4	8.5	9.8	34.7	20.5	5.8	4.4	12.8	2.4	9.3	4.8	9.1	6.9	12.7	4.8	17.4	4.8	4.8	12.0	3.2	11.0	5.1	7.4	23.4	7.4	2.6	2.7	8.1	23.3	5.7	15.2	9.3	7.7	3.3	2.0	5.1	12.6	12.2	7.6	4.4	0.6	0.0	0.1	0.2	0.1	0.1	0.5	1.5	6.2	6.7	6.1	0.1	9.8	0.5	0.8	1.8	0.7	0.0	0.3	0.3	7.9	0.1	10.4	0.3	0.3	0.9	0.2	0.3	0.3	0.0	0.1	0.0	1.5	0.3	1.9	0.0	0.1	5.1	0.3	0.4	0.1	8.8	0.2	0.3	0.1	14.8	0.2	0.5	0.2	0.5	0.2	0.5	1.1	0.4	0.2	1.4	0.2	0.1	13.3	0.2	0.3	0.3	0.1	1.8	0.4	3.8	0.4	6.6	12.6	5.8	2.3	7.3	7.3	2.0	3.3	5.5	5.1	5.1	12.2	11.5	0.7	7.6	4.4	3.9	5.9	2.1	5.0	4.6	4.4	5.8	4.4	6.9	2.7
GBP6	DKFZp686G0786	ENSG00000183347	"Guanylate binding protein family member 6"	Q6ZN66	1	89364058-89386461	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 106.5;lymphoid tissue: 60.5;tongue: 61.3"	"Group enriched"	"Detected in some"	9	"A-431: 7.8;HaCaT: 17.3"	"Group enriched"	"Detected in many"	7	"cervical cancer: 21.7;head and neck cancer: 38.1;lung cancer: 14.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"granulocytes: 3.4;T-cells: 2.7"									HPA027744	Enhanced									"HPA027744: AB_10602809"	"unprognostic (7.60e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.05e-3)"	"unprognostic (5.85e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.34e-1)"	"unprognostic (7.99e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.04e-6)"	"unprognostic (1.43e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.91e-3)"	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	6.9	0.0	0.0	0.0	0.0	0.1	0.0	106.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	15.6	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	61.3	60.5	0.1	6.8	0.6	0.6	3.4	0.6	0.3	2.7	0.4	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.3	0.0	17.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.9	0.6	0.4	0.7	0.2	1.2	0.6	0.9	1.2	0.4	0.4	0.7	0.7	3.4	0.3	0.4	0.6	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GBP7	"FLJ38822, GBP4L"	ENSG00000213512	"Guanylate binding protein 7"	Q8N8V2	1	89131751-89176040	"Predicted intracellular proteins"		Antimicrobial		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"liver: 48.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	58	"liver cancer: 10.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA051245	Uncertain									"HPA051245: "	"unprognostic (4.22e-5)"	"unprognostic (7.32e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.66e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.15e-2)"	"unprognostic (2.80e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.35e-2)"	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.3	1.3	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.5	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.5	0.0	0.2	0.0	0.2	0.9	0.2	0.1	0.3	0.2	0.1	0.1	0.3	0.2	0.2	1.3	1.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GBX2		ENSG00000168505	"Gastrulation brain homeobox 2"	P52951	2	236165236-236168369	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 11.9"	"Cell line enhanced"	"Detected in some"		"AF22: 31.8;BEWO: 5.5;PC-3: 9.3;TIME: 5.0"	"Group enriched"	"Detected in some"	6	"glioma: 1.7;testis cancer: 6.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 0.7;thalamus: 1.4"	"Region enhanced"	"Detected in many"		"thalamus: 6.3"	HPA067809			Approved	Nucleoplasm				Nucleoplasm		"HPA067809: "	"unprognostic (5.30e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.55e-4)"	"unprognostic (8.69e-7)"	"unprognostic (2.08e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.39e-4)"	0.1	0.1	0.3	0.4	5.8	0.1	0.1	11.9	3.6	0.1	0.2	4.2	0.0	0.3	0.1	0.1	0.2	0.1	0.1	0.4	0.6	3.8	0.2	0.3	0.1	0.1	1.2	0.3	0.1	0.1	0.1	0.2	1.4	6.3	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.2	0.3	4.6	0.1	0.1	1.3	2.8	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	31.8	1.2	0.0	0.0	5.5	0.4	0.0	0.8	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.2	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.1	0.0	0.4	0.7	0.0	0.2	0.8	9.3	0.0	3.4	0.0	0.3	0.0	0.4	0.2	1.0	0.0	0.3	0.0	0.0	5.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.8	11.9	0.0	0.6	3.8	1.2	0.3	6.3	2.8
GCM1	"GCMA, hGCMa"	ENSG00000137270	"Glial cells missing homolog 1"	Q9NP62	6	53126964-53148829	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"placenta: 102.4"	"Cell line enriched"	"Detected in some"	22	"BEWO: 29.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.5"	"Group enriched"	"Detected in many"	8	"B-cells: 1.8;granulocytes: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011343, HPA073469"	Enhanced		Approved	Vesicles				Vesicles		"HPA011343: , HPA073469: "	"unprognostic (2.81e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.42e-2)"		"unprognostic (2.96e-2)"	0.3	0.3	0.1	0.1	0.1	0.3	0.5	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	1.5	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.2	102.4	0.1	0.2	0.0	0.1	0.1	0.1	3.1	0.0	0.4	0.1	0.1	2.2	0.0	2.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.8	0.2	4.5	0.3	0.4	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.0	29.6	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.1	0.6	0.3	2.2	0.2	0.1	0.2	0.7	0.1	0.1	0.2	1.8	0.2	0.2	4.5	0.4	0.3	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
GCNT3	"C2/4GnT, C2GnT-M, C2GnT2"	ENSG00000140297	"Glucosaminyl (N-acetyl) transferase 3, mucin type"	O95395	15	59594875-59640239	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 29.6;intestine: 103.3;salivary gland: 27.4"	"Cell line enriched"	"Detected in some"	5	"A549: 55.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 29.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011154	Enhanced		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA011154: AB_1078961"	"unprognostic (5.09e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.92e-2)"	"prognostic favourable (1.78e-4)"	"unprognostic (3.99e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavourable (6.49e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.43e-1)"	0.3	0.5	0.3	8.8	0.4	0.0	0.3	0.3	0.3	5.3	37.6	0.3	0.3	25.4	1.3	0.4	8.7	0.7	29.6	0.3	0.3	0.2	9.9	0.4	0.7	0.3	0.3	0.3	1.1	1.7	0.0	0.4	1.0	0.5	1.0	33.4	0.3	27.4	0.3	0.3	0.2	103.3	0.9	0.3	0.3	6.5	1.7	0.3	0.5	0.7	5.2	15.5	0.7	14.0	1.2	1.4	3.4	0.8	1.1	0.7	0.1	0.0	55.8	0.0	0.0	0.0	0.4	0.0	0.0	2.9	0.0	0.0	2.3	2.3	0.2	9.6	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	11.2	0.0	0.1	0.1	0.1	1.3	0.2	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.2	3.9	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.1	0.1	0.2	3.5	0.1	0.0	2.6	0.8	0.6	0.7	0.4	0.4	0.6	0.5	0.3	0.2	1.2	0.4	0.6	3.4	1.1	0.4	1.4	0.5	0.1	0.3	0.4	0.3	0.3	0.3	0.2	0.3	0.3	0.5	0.3
GCNT4	C2GNT3	ENSG00000176928	"Glucosaminyl (N-acetyl) transferase 4, core 2"	Q9P109	5	75025346-75030899	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.6;intestine: 13.1;stomach 1: 10.4"	"Cell line enriched"	"Detected in some"	5	"RT4: 26.3"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"basophil: 13.6"	"Group enriched"	"Detected in many"	54	"granulocytes: 13.6;T-cells: 11.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037431	Approved		Supported	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA037431: AB_10670382"	"unprognostic (1.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.49e-3)"	"unprognostic (6.04e-2)"	"prognostic favourable (1.93e-7)"	"unprognostic (8.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.06e-2)"	"unprognostic (5.82e-2)"	0.6	0.6	0.3	1.0	0.7	0.0	0.9	0.0	2.3	1.1	1.1			13.1	1.4	0.6	1.3	1.1	2.5	0.3	0.3	0.1	1.8	0.4	1.0	1.7	0.1		0.9	3.0	8.4	0.1	3.0		1.0	0.2		0.5	2.4	1.0	1.5	10.8	0.7	0.0	0.6	10.4	1.0			0.5		1.1	6.4	2.0	0.0	0.0	13.6	0.1	0.2	11.6	1.6	0.2	0.1	1.0	1.6	1.8	0.6	0.1	2.0	5.2	1.0	0.9	2.5	0.1	0.0	0.2	1.5	0.7	1.0	1.8	0.2	0.0	0.0	0.8	0.2	0.2	0.8	0.0	0.0	0.3	2.9	0.1	0.3	0.0	0.0	0.3	0.1	0.0	1.4	0.0	0.4	0.0	0.0	0.0	2.6	0.2	26.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.7	0.1	0.0	0.0	0.0	0.3	0.0	0.1	13.6	0.0	0.0	0.9	0.0	3.5	0.0	8.1	2.6	0.0	0.0	8.1	5.9	0.1	0.2	0.1	0.0	11.6	1.6										
GCNT7	"C20orf105, dJ1153D9.2"	ENSG00000124091	"Glucosaminyl (N-acetyl) transferase family member 7"	Q6ZNI0	20	56491492-56525925	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"blood: 3.9;bone marrow: 9.6"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052617	Uncertain									"HPA052617: "	"unprognostic (3.57e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.96e-2)"	"unprognostic (9.08e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.69e-2)"	0.2	0.2	0.0	0.7	0.0	9.6	0.3	0.6	0.3	0.0	0.2			0.3	0.2	0.0	0.3	0.1	0.5	0.1	0.0	0.0	0.1	0.3	0.4	0.4	0.0		0.5	0.5	0.0	0.6	0.1		0.3	0.0		0.4	0.0	0.3	1.0	0.4	0.0	0.1	0.5	0.3	1.6			0.3		0.0	0.6	0.3	1.0	0.9	3.9	0.7	0.3	1.1	0.1	0.6	0.9	0.8	0.5	0.0	0.0	1.1	1.0	0.0	0.0	0.0	2.1	0.5	0.1	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.1	1.1	1.7	0.5	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.0	1.3	0.7	1.3	0.5	0.7	0.1	0.4	0.5	0.0	1.8	1.0	0.5	1.2	0.9	0.2	0.8	0.2	0.0	2.2	0.4	0.5	0.5	1.6	0.1	0.5	0.3	0.6	0.5	1.1	0.7	0.9	0.8	0.5	0.8	0.7	0.7	0.5	0.4	1.0	1.1	0.4	3.9	0.3	0.7	0.9	0.9	0.1										
GCSAML	"C1orf150, FLJ44728"	ENSG00000169224	"Germinal center associated signaling and motility like"	Q5JQS6	1	247507058-247577690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 48.3;brain: 17.6"	"Group enriched"	"Detected in some"	73	"HEL: 27.8;HMC-1: 110.6"	"Cancer enriched"	"Detected in single"	13	"prostate cancer: 1.9"	"Region enriched"	"Detected in some"	10	"cerebellum: 17.6"	"Cell type enriched"	"Detected in single"	439	"basophil: 48.3"	"Lineage enriched"	"Detected in single"	439	"granulocytes: 48.3"					"Not detected"	"Not detected"			"HPA027507, HPA027510"	Uncertain		Approved	Cytosol				Cytosol		"HPA027507: AB_10600756, HPA027510: "	"unprognostic (5.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.76e-4)"	"unprognostic (3.21e-1)"	"unprognostic (6.14e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-2)"	3.7	0.3	0.4	1.1	0.4	2.4	1.6	17.6	0.4	3.8	2.1	0.2	0.0	2.2	2.4	2.2	1.9	0.6	2.7	1.3	0.4	0.5	0.5	0.4	5.6	1.1	0.5	0.0	0.3	0.5	0.1	0.4	0.3	1.7	9.5	2.4	0.4	1.0	0.9	0.5	1.2	2.5	6.6	0.9	0.5	1.4	5.3	0.0	1.4	0.4	2.4	1.5	3.4	9.4	0.1	0.0	48.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	27.8	0.0	0.0	0.0	0.0	110.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	48.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	17.6	0.4	0.4	0.5	0.5	0.0	1.7	0.0
GCSAML-AS1		ENSG00000284824	"GCSAML antisense RNA 1"	Q8N628	1	247524679-247532613	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	6	"testis: 4.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 2.0;SK-MEL-30: 1.2"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058578			Uncertain	"Plasma membrane"				"Plasma membrane"		"HPA058578: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.5	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.5			0.0		0.0	0.0		0.0	0.8	0.6	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.8	0.0	0.0										
GDAP1L1		ENSG00000124194	"Ganglioside induced differentiation associated protein 1 like 1"	Q96MZ0	20	44247099-44280917	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 47.4"	"Group enriched"	"Detected in some"	5	"NTERA-2: 9.6;SCLC-21H: 23.6;SH-SY5Y: 11.6"	"Cancer enriched"	"Detected in single"	14	"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054182, HPA063265"	Approved		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA054182: , HPA063265: "	"unprognostic (6.58e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.23e-4)"	"unprognostic (3.69e-1)"	"unprognostic (5.15e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.07e-1)"	"unprognostic (4.74e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.81e-5)"	"unprognostic (8.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.13e-1)"	1.1	3.9	18.9	1.3	14.9	1.2	1.1	17.8	47.4	1.2	1.2	1.4	0.0	1.0	1.5	1.1	1.1	1.2	1.1	1.3	13.1	14.3	1.1	1.0	1.0	1.0	9.1	12.2	3.0	1.8	2.4	7.1	1.0	10.6	1.1	1.1	0.9	1.0	1.1	1.1	1.5	1.3	1.2	2.6	1.0	1.9	2.8	1.6	0.0	1.1	0.0	1.0	1.1	0.0	0.1	0.0	0.7	0.1	0.5	0.8	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	23.6	11.6	0.0	0.1	1.0	0.0	3.0	0.0	0.9	0.5	0.2	0.0	0.0	0.1	0.6	0.8	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.7	0.5	0.1	0.0	0.0	0.0	18.9	14.9	17.8	25.7	13.1	14.3	9.1	12.2	10.6	1.6
GDF10	BMP-3b	ENSG00000266524	"Growth differentiation factor 10"	P55107	10	47300386-47313547	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 15.8;tongue: 14.8"	"Cell line enhanced"	"Detected in some"		"AF22: 17.3;MOLT-4: 3.7;SH-SY5Y: 7.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.3;naive CD4 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Region enriched"	"Detected in many"	8	"cerebellum: 47.7"	"Low region specificity"	"Detected in all"			HPA015498	Uncertain		Approved	Vesicles	"Secreted in other tissues"			Vesicles		"HPA015498: AB_1849584"	"unprognostic (4.34e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.09e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-7)"	"unprognostic (3.49e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.63e-1)"	6.8	4.4	1.4	0.3	2.8	0.0	10.8	7.6	5.2	1.9	0.4	1.7	0.0	0.0	2.3	2.4	5.4	0.5	2.9	2.1	3.0		0.0	0.0	15.8	0.9	0.0	5.0	0.1	11.6	0.2	0.0	0.0	0.9	2.8	0.3	6.8	3.0	0.3	2.5	0.3	0.1	0.6	0.8	0.1	0.1	10.5	0.8	0.0	3.7	14.8	2.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1										
GDF5OS		ENSG00000204183	"Growth differentiation factor 5 opposite strand"	Q5U4N7	20	35433029-35435450	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.3"	"Cell line enhanced"	"Detected in some"		"U-2197: 2.8;U-87 MG: 1.8"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062720	Uncertain									"HPA062720: "		"unprognostic (2.87e-2)"		"unprognostic (9.00e-3)"	"unprognostic (7.43e-2)"					"unprognostic (1.46e-1)"			"unprognostic (4.13e-4)"	"unprognostic (1.13e-1)"				1.4	0.2	0.0	0.0	0.1	1.6	0.3	0.0	0.1	0.0	0.2			0.0	0.2	0.0	0.4	0.4	0.3	0.4	0.0	0.0	0.1	0.0	0.7	0.6	0.1		0.1	0.0	0.0	0.4	0.1		0.2	0.0		1.8	0.0	0.1	0.9	0.1	0.0	0.0	0.4	0.0	1.6			0.1		0.0	0.4	0.0	1.0	0.6	2.3	0.5	0.5	1.3	0.0	0.2	0.7	0.1	0.5	0.0	1.0	0.7	1.0	0.3	0.1	0.0	0.3	0.8	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.4	0.3	0.2	0.9	0.2	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.1	1.4	0.0	0.3	0.0	0.0	0.6	0.0	0.1	0.2	0.3	0.0	0.9	0.4	0.0	0.2	0.5	0.0	0.6	0.0	0.0	1.0	0.4	2.8	0.3	0.4	0.0	0.5	1.8	0.4	0.1	1.0	0.5	0.9	0.2	0.2	0.3	0.3	0.5	0.2	0.1	1.0	0.2	0.3	2.3	0.5	0.3	0.6	1.3	0.0										
GDPD3	MGC4171	ENSG00000102886	"Glycerophosphodiester phosphodiesterase domain containing 3"	Q7L5L3	16	30104810-30113856	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 30.8;lymphoid tissue: 40.8;tongue: 36.6"	"Group enriched"	"Detected in many"	6	"MCF7: 13.7;SK-BR-3: 48.5"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 21.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"eosinophil: 1.6;neutrophil: 5.1"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 5.1"	"Region enhanced"	"Detected in single"		"cerebellum: 0.9"	"Not detected"	"Not detected"			"HPA041148, HPA041470"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"				Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041148: AB_10794545, HPA041470: AB_10795121"	"unprognostic (4.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.86e-3)"	"unprognostic (6.59e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (5.89e-9)"	"unprognostic (3.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.79e-3)"	3.0	0.9	1.2	10.5	1.2	0.5	2.5	5.7	1.3	9.4	11.3	1.2	1.2	4.0	2.8	3.4	30.8	2.1	3.6	1.7	1.2	0.7	5.9	1.2	3.7	2.3	1.2	1.2	3.3	1.2	0.4	2.3	12.9	2.5	2.4	7.4	1.2	4.9	1.2	1.3	5.3	8.6	2.4	1.2	4.1	8.3	1.2	1.2	1.9	2.3	36.6	40.8	2.7	9.2	0.1	0.0	5.1	0.2	0.0	0.2	0.0	5.3	0.0	1.8	0.5	0.5	2.8	1.6	0.5	0.4	0.5	0.6	0.6	3.7	0.6	0.7	0.3	0.5	0.5	0.2	0.5	1.0	1.5	0.1	0.8	2.5	0.5	0.2	0.4	0.1	0.7	1.5	0.1	2.1	0.4	0.9	0.7	13.7	0.4	0.9	1.1	0.2	2.5	0.6	2.9	1.1	2.4	0.5	0.9	0.0	48.5	0.3	0.9	1.0	1.5	0.5	0.5	1.1	0.5	1.6	0.3	0.6	1.4	0.8	0.3	0.1	0.0	1.6	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	5.1	0.0	0.1	0.0	0.1	0.0	1.2	1.2	5.7	1.3	1.2	0.7	1.2	1.2	2.5	1.2
GFOD2	"FLJ23802, MGC11335"	ENSG00000141098	"Glucose-fructose oxidoreductase domain containing 2"	Q3B7J2	16	67674531-67719421	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040939, HPA041112"	Uncertain		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"			Nucleoplasm	Cytosol	"HPA040939: AB_10796564, HPA041112: AB_10794541"	"unprognostic (9.80e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.16e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-2)"	"prognostic favourable (5.95e-4)"	"unprognostic (1.17e-1)"	"prognostic favourable (8.66e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.87e-2)"	"unprognostic (9.64e-2)"	9.0	9.4	9.6	7.7	13.8	13.4	8.6	42.9	18.9	10.7	10.6	5.0	9.4	10.7	8.1	5.9	21.8	12.2	8.4	6.8	10.1	12.4	9.8	24.4	7.9	6.9	8.2	11.1	5.6	9.0	14.1	11.7	19.4	10.8	7.4	8.7	6.4	8.7	7.2	6.5	14.1	8.1	8.6	5.7	12.8	7.5	8.3	5.1	6.1	9.7	13.2	12.8	9.0	16.4	9.1	6.5	10.6	5.5	6.4	10.2	4.1	9.3	15.1	9.3	19.1	9.4	7.1	10.9	7.8	10.0	14.6	14.9	12.8	8.5	15.7	7.3	9.0	11.8	9.5	8.9	12.4	9.4	11.7	4.0	8.0	18.3	7.2	6.5	7.8	5.9	10.4	19.2	5.8	20.9	8.2	3.1	8.1	19.8	10.5	7.7	12.6	8.2	17.0	5.4	12.2	8.9	13.2	19.0	11.1	19.2	6.5	5.9	9.8	4.3	16.1	11.3	11.3	10.0	7.6	8.0	11.2	17.1	7.0	9.5	8.1	0.7	5.5	5.7	5.6	3.5	9.0	8.0	9.5	9.6	5.6	9.1	8.4	6.6	10.6	6.4	3.4	6.5	10.2	4.1	9.6	13.8	42.9	18.9	10.1	12.4	8.2	11.1	10.8	5.1
GFRA1	"GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1"	ENSG00000151892	"GDNF family receptor alpha 1"	P56159	10	116056925-116273467	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 16.7;BJ hTERT+ SV40 Large T+ RasG12V: 29.2;EFO-21: 17.8;fHDF/TERT166: 32.3;HBF TERT88: 24.4;MCF7: 21.3;U-251 MG: 19.9"	"Cancer enriched"	"Detected in many"	11	"breast cancer: 40.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043829	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"			89000	"Golgi apparatus"	Nucleoplasm	"HPA043829: "	"unprognostic (2.07e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.10e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.64e-2)"	24.0	4.3	6.3	9.5	13.8	0.3	26.8	0.8	8.4	12.5	14.9	1.8	5.9	2.2	6.7	23.4	11.1	12.7	11.5	6.4	4.8	6.7	7.0	21.9	3.2	7.4	9.5	2.7	10.0	7.3	2.2	3.9	0.3	2.9	12.1	4.8	3.4	5.4	6.6	7.5	6.8	7.2	9.8	3.4	5.8	7.8	5.3	1.9	2.6	2.6	10.7	8.1	10.5	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.7	0.0	0.0	0.0	0.0	2.9	0.1	16.7	29.2	0.0	0.0	0.0	17.8	32.3	0.0	0.0	0.0	24.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	4.2	0.0	0.0	0.0	0.0	2.2	21.3	2.6	0.0	1.8	0.0	0.0	0.7	0.0	1.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	19.9	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	13.8	0.8	4.6	4.8	6.7	9.5	2.7	2.9	1.9
GGT6	FLJ90165	ENSG00000167741	"Gamma-glutamyltransferase 6"	Q6P531	17	4556927-4560818	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.4;salivary gland: 52.7"	"Group enriched"	"Detected in some"	8	"RT4: 29.8;SK-BR-3: 10.2;T-47d: 31.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023362, HPA027213"	Approved						33000			"HPA023362: AB_1848955, HPA027213: AB_10601326"	"unprognostic (2.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"prognostic favourable (4.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.06e-2)"	"prognostic favourable (9.42e-7)"	"unprognostic (1.56e-1)"	"unprognostic (5.71e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.07e-3)"	0.3	0.4	0.3	12.7	0.3	0.0	3.2	0.3	0.4	4.1	24.9	0.4	1.0	17.0	0.9	15.9	25.2	3.0	7.7	0.3	0.3	0.1	18.8	0.6	4.2	0.3	0.3	0.3	1.5	28.6	0.0	1.0	0.4	0.4	5.7	12.7	0.4	52.7	3.7	0.3	25.2	40.4	2.8	0.3	0.3	8.7	0.8	0.3	1.0	0.7	19.6	18.8	16.5	8.2	0.6	0.7	3.5	0.5	0.6	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	29.8	0.1	0.1	0.0	10.2	0.0	31.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.5	0.2	0.4	0.3	0.2	0.3	0.5	0.3	0.1	0.6	0.5	0.4	1.9	0.6	0.5	0.7	0.4	0.0	0.3	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.4	0.3
GGTLC1	"dJ831C21.1, dJ831C21.2, GGTLA3, GGTLA4"	ENSG00000149435	"Gamma-glutamyltransferase light chain 1"	Q9BX51	20	23985050-23988779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	13	"lung: 24.2;testis: 11.1"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.2;SK-BR-3: 1.7;T-47d: 1.1;U-2197: 4.4"	"Cancer enriched"	"Detected in some"	8	"lung cancer: 7.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045635, HPA047534"	Uncertain									"HPA045635: , HPA047534: "				"unprognostic (3.14e-1)"			"unprognostic (1.62e-1)"	"unprognostic (1.94e-2)"			"unprognostic (5.32e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1			1.4		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.8	0.1	0.0	0.0	1.7	0.0	1.1	0.0	0.0	0.0	0.1	4.4	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2										
GGTLC2	GGTL4	ENSG00000100121	"Gamma-glutamyltransferase light chain 2"	Q14390	22	22644475-22647903	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"testis: 11.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;RPMI-8226: 4.5;THP-1: 2.8;U-2 OS: 2.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA045635, HPA047534"	Uncertain									"HPA045635: , HPA047534: "				"unprognostic (2.58e-2)"			"unprognostic (2.35e-2)"	"unprognostic (7.17e-2)"		"unprognostic (2.96e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.48e-2)"		"unprognostic (1.55e-1)"		0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0			0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	11.1			0.2		0.0	0.0	0.0	0.3	0.9	1.4	1.3	0.8	0.7	0.6	0.0	0.5	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.5	1.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	2.8	0.0	0.0	2.3	0.0	0.0	0.7	0.5	0.1	0.0	0.2	0.0	0.5	1.3	0.0	0.0	0.5	0.2	0.3	0.7	0.4	0.9	0.0	0.0	0.3	1.4	0.8	0.7	0.0	0.7	0.6										
GIMAP6	"FLJ22690, IAN6"	ENSG00000133561	"GTPase, IMAP family member 6"	Q6P9H5	7	150625375-150632648	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 7.5;HUVEC TERT2: 50.1;MOLT-4: 16.5;TIME: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"monocytes: 17.2;NK-cells: 46.4;T-cells: 31.1"									HPA026715	Uncertain									"HPA026715: AB_1849675"	"unprognostic (8.58e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.56e-3)"	"prognostic favourable (3.12e-4)"	"unprognostic (1.22e-1)"	"prognostic favourable (2.91e-4)"	"prognostic favourable (1.56e-4)"	"unprognostic (2.88e-2)"	"unprognostic (8.75e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.68e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavourable (5.27e-4)"	"unprognostic (2.75e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.27e-1)"	32.5	6.7	4.8	15.5	5.5	0.8	21.2	2.0	4.5	12.1	8.6	5.2	3.3	6.4	11.9	7.6	6.3	10.4	9.4	17.6	5.2	4.7	10.7	7.1	19.6	41.9	6.8	3.8	5.6	4.7	3.3	3.4	15.9	5.6	10.0	6.0	8.1	6.1	5.6	10.7	5.3	14.0	12.8	7.0	42.0	6.8	4.7	5.5	19.9	12.2	8.1	16.1	9.3	10.6	0.1	5.1	2.6	17.2	46.4	31.1	32.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	2.4	0.0	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	50.1	0.0	1.8	0.0	0.0	16.5	2.1	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	14.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	2.6	13.1	0.4	27.5	17.2	31.1	0.1	25.9	29.2	5.1	0.0	27.3	25.7	1.8	46.4	12.6	0.1	23.3	32.0	4.8	5.5	2.0	4.5	5.2	4.7	6.8	3.8	5.6	5.5
GIMAP8	"DKFZp667I133, hIAN6, IAN9"	ENSG00000171115	"GTPase, IMAP family member 8"	Q8ND71	7	150450630-150479392	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"HUVEC TERT2: 35.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA014474, HPA017765"	Supported									"HPA014474: AB_1849685, HPA017765: AB_1849683"	"unprognostic (7.86e-2)"	"unprognostic (7.87e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.07e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.07e-2)"	"unprognostic (6.26e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.04e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (8.47e-4)"	"unprognostic (3.85e-1)"	"unprognostic (1.31e-1)"	17.9	4.5	2.6	13.4	4.8	0.2	23.4	1.3	3.8	8.3	5.4	3.1	3.0	4.3	11.3	9.8	5.3	7.1	8.9	16.6	3.8	2.8	6.7	7.5	31.9	34.6	4.0	1.5	4.3	4.3	3.6	2.9	10.3	3.1	7.9	4.8	5.3	4.9	3.6	8.4	4.3	8.4	8.6	4.7	32.8	4.4	3.9	3.1	3.5	10.9	6.2	8.7	7.3	10.2	0.2	5.6	2.1	25.9	6.4	8.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.4	0.0	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.2	18.7	0.0	7.0	25.9	8.0	0.2	6.9	6.3	5.6	0.0	7.9	6.3	2.1	6.4	22.6	0.3	3.2	10.1	2.6	4.8	1.3	3.8	3.8	2.8	4.0	1.5	3.1	3.1
GINM1	"C6orf72, dJ12G14.2"	ENSG00000055211	"Glycoprotein integral membrane 1"	Q9NU53	6	149566294-149591748	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017210, HPA041679"	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane"			8700	"Nucleoli fibrillar center, Plasma membrane"		"HPA017210: AB_1845743, HPA041679: "	"unprognostic (6.09e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.79e-3)"	32.1	26.3	21.3	17.8	34.7	20.0	51.5	26.1	27.6	28.8	25.7	22.4	29.0	14.2	29.3	36.9	21.5	24.1	24.3	48.2	20.3	18.3	51.3	29.6	28.4	32.9	43.6	21.4	31.7	28.3	27.1	17.5	34.0	23.0	23.6	19.8	21.7	20.7	40.1	29.2	20.9	17.3	36.7	31.3	18.6	22.8	31.0	30.2	11.5	41.5	21.6	13.1	28.6	22.6	16.8	12.6	23.7	16.0	8.0	8.1	7.7	7.7	5.6	9.1	12.3	49.3	29.6	14.9	26.8	31.4	20.3	25.5	7.3	10.5	5.8	14.8	25.2	16.1	5.9	13.3	26.7	9.6	13.1	5.5	5.4	8.7	18.8	10.8	5.3	32.8	11.6	17.2	11.9	21.8	7.1	9.6	19.1	10.0	6.8	8.1	3.2	6.0	7.2	16.4	4.3	28.9	6.9	5.8	5.6	26.6	15.8	5.5	9.9	11.0	15.2	11.0	11.6	28.0	17.6	9.5	11.0	7.2	20.4	9.8	10.1	11.9	13.7	17.1	6.8	13.2	7.9	16.8	8.1	7.4	10.0	11.7	7.9	6.4	23.7	8.0	16.0	12.6	7.5	7.7	21.3	34.7	26.1	27.6	20.3	18.3	43.6	21.4	23.0	30.2
GJA10	CX62	ENSG00000135355	"Gap junction protein alpha 10"	Q969M2	6	89894469-89921760	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	12	"testis: 2.3"	"Group enriched"	"Detected in some"	9	"HAP1: 2.8;NTERA-2: 1.6"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021145	Uncertain									"HPA021145: "															"unprognostic (1.09e-1)"			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GJA9	"CX58, CX59, GJA10"	ENSG00000131233	"Gap junction protein alpha 9"	P57773	1	38874451-38881587	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"testis: 15.8"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA067850	Uncertain									"HPA067850: "	"unprognostic (2.00e-1)"	"unprognostic (8.78e-2)"			"unprognostic (4.55e-2)"	"unprognostic (2.66e-1)"		"unprognostic (4.79e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.63e-1)"		"unprognostic (4.11e-3)"	"unprognostic (2.32e-2)"	1.1	0.1	0.7	0.4	0.9	0.2	0.4	0.9	1.0	0.4	0.7	0.7	0.4	0.9	0.4	0.4	1.4	0.6	0.8	2.3	1.2	0.6	0.4	0.4	0.4	0.4	1.2	0.4	0.4	0.4	0.0	0.9	0.4	0.7	0.5	1.3	1.8	0.8	0.4	0.6	1.9	0.5	0.4	1.8	0.4	1.2	15.8	0.4	0.4	1.1	0.4	0.4	1.2	0.7	1.5	1.0	1.8	1.2	0.4	1.5	0.4	0.6	0.9	0.8	0.6	0.0	0.0	0.7	0.7	0.0	0.1	0.0	0.2	2.0	0.4	0.1	0.0	0.2	0.0	0.4	0.3	0.8	0.8	0.4	0.7	1.3	0.0	1.0	0.7	0.0	0.4	0.4	0.0	0.0	0.4	1.5	0.1	0.2	0.5	0.1	0.3	0.4	0.7	0.2	0.2	0.0	1.5	0.8	0.8	0.0	0.6	1.7	0.3	0.4	2.2	1.9	0.5	0.4	0.1	0.4	0.7	0.5	1.9	0.6	0.8	0.0	1.1	0.0	0.6	1.2	0.4	0.9	0.5	0.3	1.0	1.5	1.1	0.6	1.8	0.4	0.3	0.3	1.5	0.4	0.7	0.9	0.9	1.0	1.2	0.6	1.2	0.4	0.7	0.4
GJB5	CX31.1	ENSG00000189280	"Gap junction protein beta 5"	O95377	1	34755047-34758512	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 39.0;lymphoid tissue: 26.1;skin 1: 37.7;tongue: 28.0"	"Cell line enhanced"	"Detected in some"		"A-431: 9.7;HaCaT: 31.1;HBEC3-KT: 13.9;hTCEpi: 51.5;RT4: 17.3"	"Group enriched"	"Detected in many"	5	"cervical cancer: 36.7;head and neck cancer: 57.5;lung cancer: 13.7;urothelial cancer: 21.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038146	Uncertain									"HPA038146: AB_10697242"	"unprognostic (2.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.71e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.67e-3)"	0.0	0.1	0.7	0.0	0.5	0.1	2.6	0.6	2.3	7.5	0.1	0.0	0.5	0.0	0.1	2.1	39.0	0.4	3.3	0.1	0.8	0.1	0.1	0.1	0.3	0.0	0.2	0.5	0.1	0.6	0.0	0.4	7.0	0.2	3.0	0.1	0.0	5.6	2.1	0.2	37.7	0.1	0.3	0.1	0.0	0.1	0.8	0.0	0.6	0.6	28.0	26.1	3.4	11.7	0.0	0.0	0.0	0.8	0.0	0.1	0.8	9.7	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	31.1	0.0	13.9	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	51.5	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	17.3	0.0	0.0	1.2	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.8	0.7	0.5	0.6	2.3	0.8	0.1	0.2	0.5	0.2	0.0
GJC3	"CX30.2, GJE1"	ENSG00000176402	"Gap junction protein gamma 3"	Q8NFK1	7	99923269-99929620	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 9.1;pancreas: 12.1;salivary gland: 9.0"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 5.7;U-2197: 4.9"	"Group enriched"	"Detected in many"	5	"breast cancer: 3.8;melanoma: 3.0;prostate cancer: 3.6"					"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.5;T-reg: 2.1"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015024	Uncertain									"HPA015024: AB_1847132"	"unprognostic (9.31e-2)"	"unprognostic (6.43e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.81e-3)"	1.0	0.5	0.1	0.0	0.3	0.0	9.1	0.0	0.5	0.0	0.1			0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	1.1	2.8	0.1	0.1	0.6		0.3	12.1	0.0	0.1	1.2		4.3	0.0		9.0	0.0	0.0	2.0	0.0	0.1	0.7	0.0	0.8	1.6			0.2		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.4	0.6	0.8	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.4	1.2	2.6	0.0	0.0	0.5	0.5	0.0	0.0	0.2	0.3	0.9	0.2	2.3	0.0	0.4	0.3	0.4	0.0	0.1	0.6	1.1	1.4	1.7	0.3	1.3	0.5	1.2	3.0	0.2	0.0	1.2	0.8	0.0	1.1	0.5	0.6	0.3	1.0	5.7	1.8	0.2	0.8	0.2	1.0	4.9	0.3	0.4	1.4	0.1	0.6	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	2.1	0.4										
GJD4	"CX40.1, FLJ90023"	ENSG00000177291	"Gap junction protein delta 4"	Q96KN9	10	35605410-35608935	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 5.4;brain: 3.5"	"Cell line enhanced"	"Detected in many"		"RH-30: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 5.4"	"Not detected"	"Not detected"							HPA038266	Uncertain									"HPA038266: AB_10672741"	"unprognostic (2.05e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.74e-6)"	"unprognostic (2.00e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.92e-2)"		"unprognostic (8.49e-2)"		"unprognostic (7.70e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.19e-10)"	"unprognostic (3.06e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.31e-1)"	0.2	0.2	0.7	0.2	1.0	2.5	0.2	0.2	3.5	0.5	0.2	0.2	0.2	1.0	0.7	0.2	0.3	0.2	1.3	0.3	0.6	1.3	0.2	0.3	0.2	0.4	0.8	0.2	0.2	0.4	0.3	0.5	0.4	0.2	0.3	0.3	0.2	0.8	0.2	1.5	2.6	0.8	0.2	0.3	0.4	0.8	0.9	0.2	0.2	0.9	0.2	0.2	0.4	0.2	0.7	0.9	5.4	0.6	0.6	0.8	0.2	0.9	0.9	0.5	1.5	0.2	0.0	1.4	0.2	0.0	0.0	0.3	0.7	1.4	1.0	0.5	0.1	1.5	0.1	0.3	0.3	1.1	0.8	0.9	0.4	0.6	0.0	0.2	0.8	0.3	0.3	0.3	0.1	0.2	1.8	1.9	0.2	1.3	1.3	1.0	0.9	2.4	0.8	5.8	0.4	0.1	1.6	1.2	0.8	0.8	0.6	1.3	1.0	1.3	1.4	1.0	2.0	0.8	0.6	1.0	0.6	0.3	0.9	0.8	1.0	1.8	0.6	0.7	0.5	0.2	0.4	0.6	0.5	0.4	0.4	0.7	0.8	0.7	5.4	0.6	0.2	0.9	0.2	0.2	0.7	1.0	0.2	3.3	0.6	1.3	0.8	0.2	0.2	0.2
GK2	"GKP2, GKTA"	ENSG00000196475	"Glycerol kinase 2"	Q14410	4	79406352-79408293	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	90	"testis: 61.0"	"Cell line enriched"	"Detected in single"	52	"SCLC-21H: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 2.0"	HPA060687	Uncertain									"HPA060687: "															"unprognostic (1.31e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GK3P	"GKP3, GKTB"	ENSG00000229894	"Glycerol kinase 3 pseudogene"	Q14409	4	165277812-165279679	"Enzymes, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 17.0"	"Cell line enhanced"	"Detected in single"		"TIME: 1.0"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 2.9"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 2.9"									HPA060687	Uncertain									"HPA060687: "	"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.01e-2)"		"unprognostic (1.17e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.19e-2)"			"unprognostic (6.99e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.56e-1)"	"unprognostic (3.34e-4)"	0.0	0.0		0.0		0.4	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	17.0			0.0		0.0	0.0		0.0	0.1	2.9	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.2	1.0	0.0	0.1	0.0	0.1	0.0	0.4	0.8	0.0	0.0	0.7	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.9	0.0	0.1	0.0	0.1	0.0										
GK5	MGC40579	ENSG00000175066	"Glycerol kinase 5 (putative)"	Q6ZS86	3	142157527-142225607	"Enzymes, Predicted intracellular proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042606, HPA057998"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA042606: AB_10795509, HPA057998: "	"unprognostic (7.79e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.89e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.59e-3)"	6.1	12.2	5.6	5.7	7.2	10.8	10.9	9.0	9.4	11.5	10.9	8.4	11.5	14.4	10.9	14.8	7.9	7.2	8.3	5.4	5.5	4.1	5.7	3.1	6.2	3.5	9.3	6.0	11.5	4.8	5.4	20.3	3.7	12.6	13.5	11.8	6.7	14.8	14.7	5.0	8.8	14.0	9.4	11.6	3.5	8.1	6.2	5.3	4.6	7.4	4.2	6.1	8.5	6.7	1.3	1.1	3.6	5.3	3.8	3.8	0.5	10.9	2.7	4.0	2.7	8.3	15.8	6.9	3.6	2.5	4.0	2.5	4.2	6.1	7.9	3.3	3.5	4.7	4.5	3.5	5.3	2.8	4.4	5.1	6.6	3.1	4.5	5.8	6.9	6.5	3.1	2.6	3.5	2.3	4.5	4.8	7.3	7.0	5.1	4.9	2.6	3.2	4.9	4.2	2.9	4.2	6.9	3.9	2.9	10.1	10.7	3.2	14.9	3.9	2.5	3.2	2.7	7.0	4.0	5.1	4.8	8.1	5.8	3.7	5.4	3.6	1.1	0.7	3.8	0.9	1.9	0.5	1.3	1.4	0.8	1.3	1.0	1.7	3.2	3.8	5.3	1.1	0.6	0.5	5.6	7.2	9.0	9.4	5.5	4.1	9.3	6.0	12.6	5.3
GKN1	"AMP18, BRICD1, CA11"	ENSG00000169605	"Gastrokine 1"	Q9NS71	2	68974573-68980974	"Plasma proteins, Predicted secreted proteins"		Mitogen		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"stomach 1: 918.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 5.1;HMC-1: 13.9;MOLT-4: 9.7;NTERA-2: 13.2;REH: 5.6;U-2 OS: 8.6;U-266/70: 8.6"	"Cancer enriched"	"Detected in some"	116	"stomach cancer: 255.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA047684	Enhanced				"Secreted to digestive system"		26000000			"HPA047684: "						"unprognostic (5.40e-2)"					"prognostic unfavourable (1.54e-4)"			"unprognostic (4.54e-1)"			"prognostic favourable (4.53e-4)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.4	0.0	2.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	918.9	0.0	0.0	1.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	5.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.7	0.0	13.2	0.0	5.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	8.6	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0
GLB1L	MGC10771	ENSG00000163521	"Galactosidase beta 1 like"	Q6UWU2	2	219236606-219245478	"Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 57.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 18.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043058	Enhanced				"Secreted - unknown location"					"HPA043058: AB_10806375"	"unprognostic (4.30e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.48e-3)"	"unprognostic (3.27e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.50e-2)"	6.9	5.4	2.7	2.0	3.7	2.3	5.6	1.6	3.3	4.0	5.8	4.6	4.5	1.6	5.3	7.9	2.5	14.3	8.6	3.4	3.1	3.5	18.5	3.5	4.1	2.5	2.1	2.1	6.1	3.1	11.7	6.7	7.4	5.6	4.5	2.0	13.2	5.8	3.0	1.4	2.5	4.4	3.4	2.3	3.9	2.1	57.0	1.4	3.1	5.0	1.4	2.4	4.0	2.0	1.7	2.8	3.2	8.9	1.4	1.8	2.2	2.4	4.3	6.7	5.5	7.4	9.2	3.4	4.1	8.8	5.2	4.9	1.6	6.9	0.8	3.8	3.6	1.3	1.9	4.1	4.1	2.2	3.3	2.5	6.3	3.9	18.4	0.9	4.0	10.9	2.5	4.9	3.0	4.7	1.5	4.8	4.8	3.5	2.1	2.5	1.1	1.2	2.2	3.7	3.4	10.6	1.4	4.3	3.9	3.5	4.8	4.0	7.6	2.2	3.6	4.4	5.4	2.6	2.3	4.7	1.3	1.3	8.1	1.1	11.1	2.0	7.0	0.5	1.1	8.9	0.6	0.6	0.9	1.1	2.8	1.7	1.8	1.3	3.2	1.4	6.7	1.2	0.3	2.2	2.7	3.7	1.6	3.3	3.1	3.5	2.1	2.1	5.6	1.4
GLB1L2		ENSG00000149328	"Galactosidase beta 1 like 2"	Q8IW92	11	134331874-134378341	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 36.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 24.1;HaCaT: 25.3;HMC-1: 14.0;SCLC-21H: 17.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 11.2"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 5.8;NK-cell: 5.8"	"Group enriched"	"Detected in many"	23	"NK-cells: 5.8;T-cells: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA054808, HPA059955"	Uncertain		Supported	Nucleoplasm	"Secreted - unknown location"			Nucleoplasm		"HPA054808: , HPA059955: "	"unprognostic (2.63e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.01e-1)"	0.8	1.2	1.6	4.4	4.2	0.1	4.5	0.3	2.5	6.0	13.5	4.5	8.7	3.6	20.5	6.6	3.0	17.1	15.7	0.8	2.2	2.7	13.8	0.3	4.1	1.3	0.9	1.4	9.5	6.5	22.7	8.6	5.4	11.2	23.5	7.8	36.2	5.2	17.4	0.8	5.9	2.7	5.6	0.7	0.2	5.7	7.0	0.3	1.4	15.0	5.2	2.6	5.1	2.9	0.2	0.0	0.0	0.0	5.8	5.8	0.8	7.4	0.7	4.0	2.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	6.3	24.1	0.0	8.0	0.0	25.3	12.2	0.2	0.0	0.0	11.5	0.0	3.2	0.3	1.1	0.0	14.0	0.1	0.3	0.0	0.0	0.0	12.1	0.0	0.0	7.2	2.0	1.4	2.3	8.8	0.0	0.0	0.7	6.8	5.2	17.2	6.4	5.5	6.9	0.0	8.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.5	0.0	0.0	0.0	5.8	0.0	2.3	0.0	1.3	2.3	0.0	0.2	1.6	2.6	0.0	5.8	0.0	0.0	0.0	0.8	1.6	4.2	0.3	2.5	2.2	2.7	0.9	1.4	11.2	0.3
GLB1L3	FLJ90231	ENSG00000166105	"Galactosidase beta 1 like 3"	Q8NCI6	11	134274245-134319564	"Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.1;prostate: 18.5;seminal vesicle: 10.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.8;HEK 293: 8.0;MOLT-4: 2.9;NTERA-2: 4.9;PC-3: 6.6;SCLC-21H: 10.5"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 5.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"gdT-cell: 2.3;memory CD4 T-cell: 5.7;memory CD8 T-cell: 3.5;naive CD4 T-cell: 4.8;naive CD8 T-cell: 3.6;T-reg: 2.4"	"Lineage enriched"	"Detected in single"	57	"T-cells: 5.7"	"Not detected"	"Not detected"							HPA039916	Uncertain									"HPA039916: "	"unprognostic (1.64e-3)"	"unprognostic (7.80e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.55e-2)"	"unprognostic (8.69e-3)"	"prognostic favourable (1.97e-4)"	"unprognostic (6.58e-3)"	"unprognostic (3.81e-1)"	"unprognostic (6.95e-3)"	"unprognostic (9.73e-2)"	"unprognostic (1.52e-5)"	"unprognostic (1.39e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.07e-1)"	0.5	2.7	4.0	1.2	19.1	0.6	1.2	10.3	14.4	0.8	1.2	0.0	0.0	0.5	3.8	0.4	0.5	0.4	0.5	0.4	2.7	2.6	1.3	0.4	0.5	2.1	1.4	6.1	0.4	0.6	0.4	1.1	0.5	5.8	18.5	0.5	1.0	3.4	10.8	0.5	5.4	0.5	0.5	0.6	0.6	0.6	2.4	1.4	0.0	3.4	0.0	0.8	0.9	1.2	0.0	0.0	0.0	0.0	0.0	5.7	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.3	0.0	2.8	8.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	4.9	6.6	0.0	0.0	0.0	0.0	0.0	10.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.3	0.0	5.7	3.5	0.0	0.0	4.8	3.6	0.0	0.0	0.0	0.0	2.4	1.0	4.0	19.1	10.3	14.4	2.7	2.6	1.4	6.1	5.8	1.4
GLIPR1L2	MGC39497	ENSG00000180481	"GLIPR1 like 2"	Q4G1C9	12	75391070-75432688	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 44.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 5.7;SK-BR-3: 8.4;U-2 OS: 11.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039795, HPA039866"	Enhanced		Approved	"Golgi apparatus,Vesicles,Cytosol"				Vesicles	"Golgi apparatus, Cytosol"	"HPA039795: AB_10805595, HPA039866: AB_10795235"	"unprognostic (1.23e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.78e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.82e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.57e-2)"	1.3	3.1	5.5	1.2	10.4	0.8	3.0	2.9	5.8	2.2	1.2	4.2	2.9	1.0	2.7	4.2	1.4	3.5	1.5	2.5	5.5	4.6	2.5	1.9	2.7	1.1	6.6	3.9	7.7	3.0	7.3	5.2	1.3	6.2	2.3	0.8	2.0	1.4	3.6	2.4	2.2	1.2	1.5	8.1	1.9	1.0	44.0	5.0	1.4	2.8	0.5	0.8	1.7	1.4	1.4	2.6	2.0	0.7	1.0	3.4	0.6	0.3	0.5	0.3	0.5	4.3	2.5	0.7	0.6	0.5	0.2	0.3	0.1	0.4	0.3	1.5	0.4	0.2	0.1	0.1	0.4	0.8	0.3	0.1	0.6	5.7	3.2	0.5	0.1	0.8	1.3	0.6	2.3	0.2	0.3	0.7	1.1	0.1	0.6	0.4	0.3	0.2	0.1	0.1	0.3	0.1	0.4	1.1	0.6	0.7	8.4	2.4	2.5	0.2	1.2	1.0	11.1	1.2	0.4	1.0	1.0	0.3	0.4	0.3	0.8	1.8	0.3	0.5	1.1	0.2	0.7	1.1	1.2	2.0	0.4	1.4	2.2	3.3	2.0	1.0	0.7	2.6	3.4	0.6	5.5	10.4	2.9	5.8	5.5	4.6	6.6	3.9	6.2	5.0
GLIS1	FLJ36155	ENSG00000174332	"GLIS family zinc finger 1"	Q8NBF1	1	53506237-53738106	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 8.9;seminal vesicle: 14.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.2;BJ hTERT+: 6.2;PC-3: 9.9;U-138 MG: 7.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001409	Uncertain									"HPA001409: AB_1078974"	"unprognostic (1.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.37e-4)"	"unprognostic (1.98e-4)"	1.1	0.1	0.5	0.6	1.2	0.0	0.9	3.9	1.6	4.2	0.5	0.5	0.5	0.6	1.4	1.0	0.6	0.8	1.0	1.0	2.3	0.7	3.3	0.5	0.5	0.5	0.5	0.5	1.0	0.5	0.0	0.5	1.2	0.8	8.9	0.1	5.5	0.5	14.7	0.5	1.7	0.6	0.5	0.5	0.5	0.9	4.1	0.5	0.5	0.5	0.5	1.0	2.7	4.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	4.0	5.2	0.0	2.7	6.2	2.4	1.8	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.8	0.0	1.7	0.0	1.8	0.1	1.4	0.0	0.0	3.6	0.2	3.0	2.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	9.9	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	1.3	0.1	1.8	0.0	0.0	4.4	0.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	3.9	1.6	2.3	0.7	0.5	0.5	0.8	0.5
GLIS3	"MGC33662, ZNF515"	ENSG00000107249	"GLIS family zinc finger 3"	Q8NEA6	9	3824127-4348392	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Congenital hypothyroidism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 57.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 15.2;HSkMC: 23.0;RPTEC TERT1: 14.3;U-251 MG: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056426	Approved		Supported	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA056426: "	"unprognostic (6.24e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.63e-3)"	"unprognostic (4.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.91e-3)"	"unprognostic (6.88e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.35e-2)"	5.6	2.8	5.6	4.4	7.4	1.0	2.9	3.5	9.5	13.4	2.9	10.7	33.5	1.6	6.1	6.5	1.5	15.0	14.7	4.7	8.9	4.5	11.4	5.1	5.7	2.6	7.7	3.8	10.4	17.3	6.4	8.8	2.8	16.3	5.3	4.0	4.6	5.2	57.8	2.1	1.4	2.2	5.1	26.7	3.8	3.2	4.6	10.2	0.0	29.3	1.4	1.7	5.6	8.8	0.0	0.0	1.8	0.9	0.3	0.7	0.0	0.6	6.6	2.0	0.0	2.6	7.3	0.2	5.0	15.2	2.2	3.3	1.1	2.4	0.0	4.0	3.7	0.0	1.3	0.0	4.7	1.5	1.0	0.0	0.3	0.0	8.0	0.7	0.0	23.0	0.0	7.0	0.7	0.4	0.0	0.1	1.9	0.2	0.0	0.9	0.1	0.9	0.0	4.6	0.0	14.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.0	2.6	0.6	2.6	11.9	0.0	0.0	0.0	7.0	0.0	2.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.7	1.1	0.3	0.9	0.0	0.1	0.0	5.6	7.4	3.5	9.5	8.9	4.5	7.7	3.8	16.3	10.2
GLP2R		ENSG00000065325	"Glucagon like peptide 2 receptor"	O95838	17	9822206-9892102	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 32.7"	"Cell line enriched"	"Detected in some"	5	"HeLa: 41.8"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 1.1"	"Group enriched"	"Detected in some"	4	"basal ganglia: 2.9;cerebral cortex: 4.1;olfactory region: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cerebral cortex: 2.1;hippocampal formation: 2.6"	"Low region specificity"	"Detected in many"			"CAB022690, HPA049244"	Supported		Supported	"Plasma membrane"				"Plasma membrane"		"CAB022690: , HPA049244: "	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.66e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.63e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.16e-3)"	"unprognostic (3.40e-8)"	"unprognostic (9.53e-5)"	"unprognostic (5.51e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.48e-3)"	7.9	0.7	0.6	2.0	2.9	0.0	2.6	0.3	4.3	6.6	14.5	0.0	1.7	12.4	1.9	0.4	5.3	1.4	32.7	0.9	0.6	0.5	0.4	3.2	1.4	0.7	0.6	1.6	0.8	2.1	0.0	0.3	1.5	0.5	8.4	7.5	0.8	0.4	0.2	0.3	0.3	15.4	15.6	0.6	0.3	4.9	1.1	0.2	0.0	0.5	0.1	0.4	13.5	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	41.8	0.3	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.3	4.1	0.6	0.5	0.6	1.6	0.5	0.2
GLRA4		ENSG00000188828	"Glycine receptor alpha 4"	Q5JXX5	X	103707224-103728655	"Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 3.5;endometrium 1: 5.1;smooth muscle: 6.7"	"Cell line enriched"	"Detected in single"	13	"SCLC-21H: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA044759	Uncertain									"HPA044759: AB_10795885"	"unprognostic (4.96e-2)"		"unprognostic (2.09e-2)"		"unprognostic (3.95e-1)"	"unprognostic (2.24e-1)"			"unprognostic (1.28e-1)"		"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.94e-7)"	"unprognostic (4.49e-1)"	"unprognostic (1.94e-1)"		"unprognostic (1.87e-1)"	0.0	0.0	0.9	0.1	1.5	0.0	0.3	2.8	3.5	1.9	1.4	0.9	0.0	2.2	5.1	0.1	0.2	0.6	0.1	0.1	1.5	1.8	0.0	0.0	0.0	0.0	0.5	1.0	1.2	0.0	2.4	0.2	0.0	1.2	0.5	1.8	0.0	0.0	0.4	0.1	0.3	2.3	6.7	1.5	0.0	0.1	1.4	0.0	2.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	1.5	2.8	3.5	1.5	1.8	0.5	1.0	1.2	0.0
GLT1D1	FLJ31978	ENSG00000151948	"Glycosyltransferase 1 domain containing 1"	Q96MS3	12	128853427-128984968	"Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.1;bone marrow: 25.4;liver: 24.7"	"Group enriched"	"Detected in some"	7	"MOLT-4: 12.2;NTERA-2: 17.6;SCLC-21H: 8.3"	"Group enriched"	"Detected in some"	6	"liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 23.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039051, HPA039052"			Enhanced	Cytosol	"Secreted - unknown location"			Cytosol		"HPA039051: AB_10673299, HPA039052: AB_10672839"	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.93e-5)"	"unprognostic (2.39e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.41e-1)"	3.0	0.6	7.0	7.0	12.4	25.4	0.6	7.1	15.5	1.8	0.6	1.2	0.2	0.5	4.1	1.4	0.9	2.1	2.1	1.2	6.3	10.5	1.2	24.7	2.2	4.5	5.8	6.4	0.6	1.2	0.4	1.0	1.0	7.6	1.3	0.7	2.6	0.4	1.9	8.2	1.3	0.6	3.6	1.6	9.2	0.6	14.7	1.3	0.1	2.0	0.0	0.8	1.7	0.6	0.0	1.4	23.1	3.8	0.0	0.3	0.8	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	23.1	0.0	1.1	1.4	0.0	0.8	7.0	12.4	7.1	15.5	6.3	10.5	5.8	6.4	7.6	1.3
GLT6D1	GLTDC1	ENSG00000204007	"Glycosyltransferase 6 domain containing 1"	Q7Z4J2	9	135623656-135639540	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	28	"testis: 10.3"	"Cell line enhanced"	"Detected in single"		"CACO-2: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023424	Uncertain				"Intracellular and membrane"					"HPA023424: AB_1849729"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GLT8D2	FLJ31494	ENSG00000120820	"Glycosyltransferase 8 domain containing 2"	Q9H1C3	12	103988984-104064183	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 27.9;BJ hTERT+: 34.4;HSkMC: 25.8;RPTEC TERT1: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"amygdala: 8.0;cerebral cortex: 20.1;hippocampal formation: 16.6"	"Low region specificity"	"Detected in many"			"HPA012740, HPA026904, HPA070791"	Approved		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA012740: , HPA026904: AB_1849731, HPA070791: "	"unprognostic (4.02e-1)"	"prognostic unfavourable (7.37e-4)"	"unprognostic (9.53e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavourable (1.58e-6)"	"prognostic unfavourable (7.92e-4)"	"unprognostic (7.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.03e-3)"	10.2	5.2	2.2	9.9	3.3	0.2	12.0	0.7	2.4	32.8	10.3	1.4	8.8	2.5	24.5	23.1	13.5	13.3	19.1	18.8	2.2	1.8	3.4	2.8	6.9	2.2	2.1	2.1	25.5	2.5	5.9	12.5	6.9	3.5	19.6	5.3	21.8	6.7	8.3	4.0	2.7	6.7	17.3	2.2	1.0	5.5	7.8	0.8	1.0	26.0	10.9	5.7	11.2	13.1	0.8	0.9	0.2	0.6	0.0	2.1	0.0	0.1	0.2	0.2	8.7	11.4	27.9	0.2	12.5	34.4	3.2	4.2	0.1	0.0	0.3	0.7	14.3	0.0	0.1	4.6	2.8	0.6	3.9	0.2	4.6	0.0	5.1	0.3	0.2	25.8	0.2	3.9	5.5	1.7	0.1	0.5	14.1	0.1	0.2	0.1	1.0	2.6	0.3	13.4	0.1	17.6	0.1	0.5	0.7	13.1	0.3	0.1	2.3	0.2	0.2	5.3	2.5	0.5	0.7	1.5	0.3	0.1	0.4	0.2	0.4	0.0	0.0	0.0	2.1	0.6	0.7	0.8	0.3	1.3	0.2	0.0	0.0	0.3	0.2	0.0	0.1	0.9	0.0	0.0	2.2	3.3	0.7	2.4	2.2	1.8	2.1	2.1	3.5	0.8
GLYATL3	"bA28H17.2, C6orf140"	ENSG00000203972	"Glycine-N-acyltransferase like 3"	Q5SZD4	6	49499958-49527047	"Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"intestine: 2.0;liver: 5.6"	"Cell line enriched"	"Detected in single"	73	"T-47d: 18.0"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044044	Uncertain									"HPA044044: AB_10960855"				"unprognostic (3.57e-1)"			"unprognostic (6.85e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GNAS	"GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI"	ENSG00000087460	"GNAS complex locus"	"O95467, P63092, P84996, Q5JWF2"	20	58839718-58911192	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		Transducer	"Cancer-related genes, Cushing syndrome, Disease mutation, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 303.3;thyroid gland: 304.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010337, HPA018122, HPA027478, HPA028386"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"			Nucleoplasm	"Plasma membrane, Cytosol"	"CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.90e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (8.01e-2)"	"unprognostic (4.29e-2)"	"prognostic favourable (8.76e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (3.49e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.36e-1)"	56.2	79.0	84.2	34.4	44.5	42.1	87.4	86.0	107.4	43.2	42.3	25.4	27.0	33.2	37.2	44.7	41.0	43.6	34.4	106.0	71.0	144.0	39.6	35.3	46.6	44.6	75.8	64.7	43.6	118.1	120.9	303.3	49.8	85.6	36.3	31.5	42.7	171.6	31.1	172.9	26.3	34.9	40.5	61.4	36.9	42.4	18.2	27.4	56.0	304.5	80.6	41.0	37.3	44.6	27.3	41.5	29.9	36.2	25.3	24.2	24.6	9.6	32.5	54.8	25.5	93.1	42.6	49.2	55.8	51.0	63.9	45.8	94.7	50.1	31.7	86.9	72.5	41.8	50.2	74.3	43.3	20.9	30.2	35.2	49.4	62.0	43.1	20.4	22.2	50.7	37.8	31.0	41.7	48.3	30.9	43.3	42.0	132.2	104.3	50.1	17.4	34.4	64.2	48.0	55.9	51.2	38.2	68.0	155.7	77.6	77.0	62.2	58.9	56.1	53.1	84.8	76.2	30.5	52.5	75.9	49.0	66.9	37.2	10.0	43.2	29.9	24.8	29.5	20.7	35.7	22.1	26.7	22.0	22.2	37.8	27.3	21.3	24.2	29.1	25.3	36.2	41.5	23.3	24.6	84.2	44.5	86.0	107.4	71.0	144.0	75.8	64.7	85.6	27.4
GNGT2	GNG9	ENSG00000167083	"G protein subunit gamma transducin 2"	O14610	17	49202791-49210574	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"blood: 29.1;lymphoid tissue: 21.1;retina: 46.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 35.6;HDLM-2: 30.6;HUVEC TERT2: 9.2;RH-30: 11.3;TIME: 8.9;U-698: 10.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 29.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"							HPA043381	Enhanced									"HPA043381: "	"unprognostic (9.11e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.99e-2)"	"unprognostic (4.62e-5)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (3.11e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.23e-1)"	2.7	2.1	2.7	9.4	3.7	1.3	1.8	0.7	2.2	2.1	2.3	2.0	0.4	2.6	1.6	1.2	1.8	1.7	3.3	2.4	2.5	1.9	3.0	2.6	6.2	12.2	3.2	0.4	1.7	1.2	0.1	1.4	1.9	2.2	2.2	3.3	46.7	1.6	1.1	0.6	0.6	4.9	2.9	4.5	21.1	1.7	0.8	2.5	6.0	2.5	1.4	16.6	3.6	5.1	2.0	9.7	0.9	29.1	10.6	14.4	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.6	0.5	0.0	0.0	35.6	0.3	0.1	0.0	0.0	0.0	2.0	30.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	9.2	0.0	0.2	0.8	0.0	2.7	2.1	0.3	0.0	6.9	11.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.9	0.0	5.7	0.0	0.0	0.1	1.6	10.9	0.1	0.1	0.0	0.0	4.3	0.4	14.4	21.5	12.6	1.9	2.4	10.2	9.7	2.0	1.5	5.9	0.9	10.6	29.1	0.8	1.8	5.4	2.7	3.7	0.7	2.2	2.5	1.9	3.2	0.4	2.2	2.5
GNRH2		ENSG00000125787	"Gonadotropin releasing hormone 2"	O43555	20	3043622-3045747	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 10.2"	"Cell line enhanced"	"Detected in many"		"U-266/84: 7.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA004338	Uncertain				"Secreted to blood"					"HPA004338: AB_1079012"	"unprognostic (1.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.04e-3)"	"unprognostic (7.00e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.47e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	0.8	0.9	0.6	1.2	0.9	0.4	0.5	5.1	1.7	1.6	0.5	0.5	0.5	0.3	1.3	10.2	0.5	2.4	2.0	1.1	0.7	1.2	1.7	3.3	0.5	0.6	1.5	0.5	5.6	0.5	0.5	1.8	0.5	1.2	4.2	0.1	1.0	1.6	2.0	0.5	0.1	0.5	0.5	0.5	0.5	2.2	3.9	0.5	0.5	2.8	0.5	0.5	0.5	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	3.2	3.9	1.9	0.5	0.6	0.8	0.0	0.5	0.8	1.9	0.8	1.5	0.1	0.2	3.2	1.2	1.0	0.9	1.2	3.6	1.3	1.1	2.5	0.0	0.2	2.1	2.5	2.5	2.4	0.0	0.8	1.4	0.5	1.3	1.0	0.7	2.5	1.4	0.0	0.9	0.4	0.8	0.5	2.7	4.5	2.1	0.2	2.7	1.5	2.9	1.4	0.0	1.9	0.8	1.6	1.8	1.1	7.4	1.0	1.7	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	5.1	1.7	0.7	1.2	1.5	0.5	1.2	0.5
GOLGA7B	"bA451M19.3, bA459F3.4, C10orf132, C10orf133"	ENSG00000155265	"Golgin A7 family member B"	Q2TAP0	10	97850239-97871580	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 39.6;epididymis: 35.9;skin 1: 21.4"	"Cell line enhanced"	"Detected in some"		"A-431: 5.0;HDLM-2: 5.4;SK-MEL-30: 21.4;U-87 MG: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.3"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046878	Uncertain									"HPA046878: "	"unprognostic (7.90e-2)"	"unprognostic (1.70e-3)"	"unprognostic (7.10e-3)"	"unprognostic (1.06e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.20e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.89e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.15e-7)"	"unprognostic (2.12e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.90e-3)"	2.5	4.5	16.4	2.1	12.0	1.3	2.5	39.6	24.1	1.3	1.5	4.4	1.3	3.2	1.3	35.9	2.3	1.1	1.5	3.4	19.8	12.8	1.0	1.1	1.7	2.8	11.1	20.4	1.0	6.6	1.0	6.7	1.3	10.7	1.3	1.8	0.6	1.4	1.7	4.9	21.4	3.8	1.2	5.4	1.5	2.3	1.7	6.2	0.0	1.4	0.5	2.5	1.2	1.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	5.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	2.0	0.0	0.1	0.0	1.9	0.0	0.4	0.0	5.4	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.3	0.0	1.8	0.1	0.1	0.3	0.8	1.5	0.0	1.0	21.4	2.1	0.1	0.1	0.1	0.0	0.0	0.2	1.7	0.7	0.0	3.9	2.2	2.4	0.0	0.0	0.0	0.7	0.0	0.3	0.0	2.3	1.9	0.0	0.0	1.5	1.4	0.0	0.0	0.0	0.0	1.2	0.3	16.4	12.0	39.6	24.1	19.8	12.8	11.1	20.4	10.7	6.2
GOLGA8A	"GM88, GOLGIN-67"	ENSG00000175265	"Golgin A8 family member A"	A7E2F4	15	34379068-34437466	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 30.0"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"NK-cell: 2.7"	"Low lineage specificity"	"Detected in single"											HPA051808	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA051808: "	"unprognostic (4.80e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.10e-2)"	"unprognostic (8.11e-3)"	"prognostic favourable (7.58e-4)"	"unprognostic (2.74e-2)"	"unprognostic (4.37e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.25e-2)"	"prognostic unfavourable (2.16e-6)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-1)"	"prognostic favourable (5.68e-6)"	2.6	4.7	3.6	5.1	4.4	3.1	5.8	20.1	3.5	6.3	3.5			5.8	5.3	18.0	4.1	3.7	3.6	2.9	3.9	3.7	2.6	0.4	2.3	6.5	3.3		7.4	3.3	8.0	2.4	0.7		4.6	0.8		6.7	5.3	2.6	18.4	4.0	1.2	3.8	8.3	3.3	8.3			5.7		0.6	2.6	5.3	0.7	0.0	0.8	0.0	2.7	0.2	0.0	1.0	5.9	1.7	5.9	0.0	0.0	1.2	9.2	0.0	1.5	0.7	10.3	0.0	0.0	1.7	1.1	9.7	4.3	3.1	2.4	8.9	3.6	21.7	30.0	6.5	0.6	8.3	5.8	0.0	8.9	1.0	0.2	0.1	19.7	18.4	4.1	1.8	2.2	15.1	3.1	3.2	8.8	5.2	7.3	3.4	6.1	8.0	3.7	6.1	4.2	1.0	1.6	5.0	4.8	7.4	1.7	0.0	1.6	17.7	5.8	2.5	2.3	17.7	1.6	0.0	0.0	0.8	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0										
GOLGA8B		ENSG00000215252	"Golgin A8 family member B"	A8MQT2	15	34525207-34588503	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 25.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 14.3;Hep G2: 12.7;NB-4: 19.7"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	16	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 2.2"									HPA051808	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA051808: "	"unprognostic (2.12e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.06e-2)"	"unprognostic (7.90e-3)"	"unprognostic (9.67e-3)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (9.38e-6)"	"unprognostic (2.14e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.31e-1)"	"prognostic favourable (5.79e-4)"	2.6	3.4	0.0	2.8	0.6	6.8	4.3	2.5	2.7	2.5	2.0			0.0	4.1	6.1	0.8	3.8	2.8	1.6	0.0	0.7	3.0	2.3	4.5	8.0	0.0		9.0	25.2	0.1	4.9	0.9		5.4	0.1		4.6	5.2	1.8	3.3	5.4	0.5	0.0	5.2	4.0	5.3			16.4		3.1	3.0	1.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	2.0	2.2	0.2	4.2	2.3	4.6	6.0	1.8	0.5	2.1	3.5	2.2	2.8	0.0	4.0	1.9	1.7	0.8	1.9	1.7	2.9	7.0	0.3	14.3	12.7	3.4	1.7	2.3	6.6	2.6	1.2	3.8	2.1	0.7	0.2	1.9	1.0	0.8	19.7	2.6	3.8	0.1	0.0	0.3	1.7	4.0	3.2	4.8	1.0	0.3	2.2	1.9	3.9	0.0	3.1	7.3	0.9	3.2	1.4	1.3	2.9	1.0	0.9	0.8	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GOT1L1	MGC33309	ENSG00000169154	"Glutamic-oxaloacetic transaminase 1 like 1"	Q8NHS2	8	37934281-37940129	"Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"testis: 16.4"	"Cell line enriched"	"Detected in single"	5	"MOLT-4: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA028778	Uncertain									"HPA028778: AB_10602138"														"unprognostic (6.93e-3)"	"unprognostic (5.46e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GP2	ZAP75	ENSG00000169347	"Glycoprotein 2"	P55259	16	20309572-20327808	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	354	"pancreas: 1812.8"	"Low cell line specificity"	"Detected in some"			"Cancer enriched"	"Detected in many"	14	"pancreatic cancer: 320.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015739, HPA016668"	Enhanced				"Intracellular and membrane"		27000			"HPA015739: AB_1849905, HPA016668: AB_1849907"	"unprognostic (2.14e-2)"		"unprognostic (1.97e-2)"	"unprognostic (5.68e-2)"			"unprognostic (4.29e-2)"	"unprognostic (1.63e-1)"			"unprognostic (2.84e-1)"	"unprognostic (6.35e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.8	0.1	0.1	0.1	0.0	5.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.4	1812.8	0.0	0.1	0.1	0.1	0.8	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.4	1.4	2.3	0.9	0.6	0.8	0.3	0.5	0.3	0.6	1.0	0.0	0.2	1.3	0.3	0.0	0.5	0.2	1.3	0.7	1.3	1.4	0.4	0.6	0.1	0.4	0.7	0.3	0.2	0.4	1.3	0.2	0.0	0.4	0.9	0.0	0.3	0.1	0.0	0.0	0.7	0.8	0.5	0.0	0.4	0.6	0.1	1.2	0.7	0.7	1.8	0.1	0.2	0.7	0.5	0.6	1.4	0.2	0.5	0.5	0.0	1.1	2.2	0.8	1.0	0.7	0.8	0.3	0.3	0.6	0.3	2.0	0.9	0.7	0.8	0.3	0.5	0.6	0.7	0.7	0.1	1.4	0.7	0.7	2.3	0.6	0.2	1.4	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
GPAT2	CT123	ENSG00000186281	"Glycerol-3-phosphate acyltransferase 2, mitochondrial"	Q6NUI2	2	96021946-96039451	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 7.3;BJ hTERT+ SV40 Large T+: 18.0;BJ hTERT+ SV40 Large T+ RasG12V: 10.7;HBF TERT88: 4.1;U-2 OS: 10.3"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							HPA036841	Uncertain		Approved	Mitochondria				Mitochondria		"HPA036841: AB_10601479"	"unprognostic (1.42e-2)"	"unprognostic (2.39e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.99e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.43e-6)"	"unprognostic (2.11e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.65e-1)"	4.3	1.1	1.5	1.9	3.1	1.5	3.6	0.2	1.6	0.8	1.0			0.0	1.1	5.1	0.9	1.0	2.2	3.9	1.1	0.7	0.5	0.5	1.3	3.2	1.2		0.9	1.1	0.0	0.2	2.0		0.6	1.5		1.8	4.9	1.4	0.5	1.3	2.4	2.3	4.4	3.0	7.3			1.2		2.6	2.6	0.8	4.3	1.1	0.5	2.5	0.2	3.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.3	0.0	18.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.4	0.0	2.6	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	2.6	1.9	2.8	4.3	1.3	2.0	1.1	4.1	0.8	3.0	0.0	0.2	2.5	0.0	1.3	1.5										
GPBAR1	"BG37, GPCR, GPCR19, GPR131, M-BAR, MGC40597, TGR5"	ENSG00000179921	"G protein-coupled bile acid receptor 1"	Q8TDU6	2	218259496-218263859	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 85.6;gallbladder: 73.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.0;HHSteC: 5.0;U-937: 5.0"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 3.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 85.6;non-classical monocyte: 78.5"	"Lineage enriched"	"Detected in many"	5	"monocytes: 85.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA062890	Enhanced									"HPA062890: "	"unprognostic (8.47e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.88e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.76e-3)"	"unprognostic (4.32e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.40e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.29e-1)"	19.9	1.1	0.3	2.6	0.4	1.8	11.4	0.2	0.4	0.7	2.7	0.5	0.8	1.0	1.1	1.4	1.3	0.9	73.8	3.8	0.2	0.0	3.2	1.7	2.2	3.8	0.4	0.2	1.4	1.5	0.0	0.7	8.9	0.4	2.0	0.5	0.9	0.5	0.9	0.8	0.8	3.2	10.3	0.2	6.5	5.5	1.5	0.2	1.0	1.5	1.8	0.6	3.2	0.7	0.0	17.4	0.8	85.6	0.0	0.1	15.8	0.2	0.1	0.4	0.0	3.0	0.1	0.9	0.0	0.4	0.0	0.1	0.8	0.4	0.2	0.3	0.3	0.1	0.1	0.3	0.0	0.0	0.7	0.3	0.5	0.4	5.0	0.3	1.4	0.0	2.5	0.0	0.0	0.2	0.3	0.4	0.6	0.3	0.2	0.7	0.2	0.0	0.2	0.0	0.1	1.6	1.1	2.6	2.3	0.2	0.7	0.4	0.0	0.8	0.0	0.1	0.3	0.2	0.2	0.3	0.7	0.1	0.3	5.0	0.2	0.0	36.4	0.0	0.1	85.6	0.1	0.0	0.0	0.1	17.4	0.0	0.0	0.0	0.8	0.0	78.5	0.7	0.1	15.8	0.3	0.4	0.2	0.4	0.2	0.0	0.4	0.2	0.4	0.2
GPC2	"cerebroglycan, DKFZp547M109, FLJ38962"	ENSG00000213420	"Glypican 2"	Q8N158	7	100169606-100177372	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 34.3;skin 1: 9.4;testis: 16.7"	"Cell line enhanced"	"Detected in some"		"AF22: 23.7;AN3-CA: 9.5;BEWO: 8.4;SH-SY5Y: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			CAB025423	Uncertain				"Intracellular and membrane"					"CAB025423: "	"unprognostic (4.33e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.59e-4)"	"unprognostic (3.42e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-4)"	"unprognostic (7.25e-4)"	"unprognostic (1.67e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (9.94e-4)"	0.5	0.5	3.2	3.5	1.9	1.9	0.6	2.2	4.3	0.8	0.9	2.1	0.0	0.5	2.6	0.3	0.2	0.4	0.4	0.3	2.9	1.6	0.2	0.1	0.5	2.2	2.0	0.9	0.8	0.3	0.5	0.7	0.3	1.5	0.5	0.8	0.5	1.7	0.4	0.8	9.4	0.7	0.8	3.3	1.4	0.3	16.7	2.0	34.3	0.3	0.7	2.0	0.6	1.1	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.0	0.1	23.7	9.5	0.0	0.0	8.4	0.7	0.0	0.1	0.2	0.0	0.3	2.0	0.5	0.2	0.8	0.8	0.3	0.0	0.0	0.7	0.2	0.3	0.0	0.4	0.5	3.6	0.8	0.4	0.5	0.0	1.1	0.9	0.0	0.6	0.3	5.4	0.6	4.1	1.3	6.2	1.6	0.0	0.1	0.4	6.3	26.2	0.5	0.6	0.8	0.4	0.4	0.9	0.2	3.8	0.5	0.1	0.8	0.2	2.8	0.2	1.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.3	3.2	1.9	2.2	1.7	2.9	1.6	2.0	0.9	1.5	2.0
GPC5		ENSG00000179399	"Glypican 5"	P78333	13	91398607-92873682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;kidney: 14.8;testis: 11.3"	"Group enriched"	"Detected in some"	11	"CACO-2: 30.6;HeLa: 17.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040152, HPA044081"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA040152: , HPA044081: "	"unprognostic (4.99e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.93e-5)"	"prognostic unfavourable (4.37e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.49e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.82e-6)"	"unprognostic (3.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.69e-3)"	0.8	3.8	11.8	1.1	18.3	0.8	0.7	3.1	18.9	0.6	1.5	2.9	0.1	0.7	0.6	0.9	0.6	0.8	1.6	2.3	11.8	6.0	14.8	2.9	6.5	1.0	7.3	5.6	1.5	0.8	0.6	7.7	1.4	19.4	0.9	1.5	0.0	0.8	1.5	0.6	0.7	0.8	0.8	4.4	0.7	0.9	11.3	6.6	0.0	2.7	0.0	0.7	0.6	0.3	0.5	0.4	0.3	1.8	2.0	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	17.5	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.3	0.0	0.0	0.0	0.7	0.4	0.0	0.5	0.1	1.2	0.4	0.2	0.0	0.5	0.3	2.0	1.8	0.0	0.0	0.2	11.8	18.3	3.1	8.6	11.8	6.0	7.3	5.6	19.4	6.6
GPR108	LUSTR2	ENSG00000125734	"G protein-coupled receptor 108"	Q9NPR9	19	6729914-6737603	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041924, HPA041951, HPA063863"	Uncertain		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus"	Vesicles	"HPA041924: AB_10804122, HPA041951: AB_10795385, HPA063863: "	"unprognostic (2.00e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (1.04e-7)"	"unprognostic (1.58e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.57e-2)"	"prognostic favourable (1.29e-9)"	"unprognostic (8.68e-3)"	"unprognostic (2.95e-2)"	"unprognostic (4.96e-3)"	"unprognostic (4.13e-3)"	17.6	29.7	15.4	13.8	17.9	14.2	20.1	15.2	23.1	22.2	24.3	24.3	27.0	20.4	20.6	20.8	25.1	26.1	23.5	14.0	14.6	12.3	35.4	33.9	19.6	17.1	20.5	12.9	22.6	41.5	30.9	15.1	27.1	17.2	24.0	17.7	31.3	35.4	27.4	10.6	19.1	29.2	16.9	15.7	20.9	20.6	26.3	19.4	17.2	38.8	14.7	23.1	21.4	19.8	14.8	25.8	54.3	36.3	23.1	26.7	35.5	11.5	12.6	7.8	15.2	30.6	16.6	8.8	9.0	27.4	12.5	13.4	7.7	13.3	5.5	16.8	18.4	9.9	8.8	18.8	6.5	22.1	10.1	8.9	13.3	10.2	30.1	5.7	12.2	18.0	36.0	12.1	24.5	14.7	8.9	36.9	12.6	8.0	10.0	8.3	5.6	11.2	8.2	8.9	20.8	26.1	11.4	0.0	8.5	9.1	14.9	13.8	14.3	13.9	12.1	7.2	4.6	22.8	9.5	23.9	12.9	3.8	24.7	18.4	7.7	20.4	35.8	35.7	26.7	32.7	24.3	14.8	21.4	22.5	25.8	14.1	15.5	17.7	54.3	23.1	36.3	9.2	23.4	35.5	15.4	17.9	15.2	23.1	14.6	12.3	20.5	12.9	17.2	19.4
GPR137	"C11orf4, GPR137A, TM7SF1L1"	ENSG00000173264	"G protein-coupled receptor 137"	Q96N19	11	64270062-64289500	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 64.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 15.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062871	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments"				"Nucleoplasm, Nucleoli"	"Actin filaments"	"HPA062871: "	"unprognostic (2.25e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavourable (5.34e-4)"	"unprognostic (5.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.61e-3)"	"prognostic favourable (6.18e-4)"	"unprognostic (4.95e-2)"	"unprognostic (8.66e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.41e-1)"	10.3	12.2	18.6	12.8	21.8	10.4	12.0	20.0	23.1	8.9	10.5	13.2	13.8	11.2	9.0	10.4	10.5	13.3	10.3	9.7	18.5	14.3	14.0	14.1	9.3	10.8	15.4	9.1	7.3	9.4	16.4	10.1	28.9	16.5	10.5	5.8	12.4	13.9	12.8	9.9	15.9	11.4	7.1	12.7	11.3	13.6	64.8	14.4	9.9	14.3	5.5	9.3	9.5	16.2	3.9	3.4	15.7	3.0	1.9	3.4	1.4	8.9	20.0	6.9	20.0	13.5	7.2	29.3	10.7	9.0	10.7	6.9	14.7	12.6	9.2	18.6	6.7	18.0	9.6	5.9	3.1	29.1	12.1	8.7	20.5	9.4	7.7	5.8	17.0	9.0	9.4	9.3	7.1	5.7	7.8	22.5	6.4	22.7	6.5	15.6	9.4	20.0	13.0	7.4	14.9	7.4	12.2	11.0	13.4	13.0	17.7	11.5	19.4	2.4	9.2	29.6	20.5	22.3	7.7	18.0	33.1	7.7	21.2	4.9	18.0	1.7	3.0	5.3	2.7	2.8	3.4	2.8	2.3	2.0	3.1	3.9	2.6	2.2	15.7	1.9	2.3	3.4	1.6	1.4	18.6	21.8	20.0	23.1	18.5	14.3	15.4	9.1	16.5	14.4
GPR137B	TM7SF1	ENSG00000077585	"G protein-coupled receptor 137B"	O60478	1	236142505-236221865	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.7;SK-MEL-30: 65.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 11.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026422	Approved									"HPA026422: AB_1849338"	"unprognostic (1.59e-3)"	"unprognostic (6.89e-2)"	"prognostic unfavourable (1.63e-4)"	"unprognostic (6.49e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.02e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.44e-1)"	12.6	6.0	26.3	11.6	32.0	4.5	11.3	12.1	23.2	16.3	7.8	18.4	5.6	7.6	14.9	31.8	7.5	5.1	15.8	19.7	24.1	16.3	51.2	16.7	12.7	18.8	23.4	16.7	10.2	3.3	2.0	3.1	22.4	18.9	8.7	8.8	31.1	5.5	12.2	1.7	13.2	6.8	12.7	26.5	16.2	8.4	3.1	20.0	3.8	11.9	1.7	12.7	19.0	10.4	0.5	1.2	11.7	6.8	0.1	2.7	0.4	1.7	2.4	2.0	1.8	26.7	15.2	0.6	3.8	8.5	2.3	3.3	0.5	2.0	0.2	6.2	4.0	1.3	2.6	2.3	2.3	1.6	4.9	0.9	0.3	0.4	3.7	1.3	9.5	9.8	8.0	1.8	0.9	3.7	0.1	0.0	3.9	2.0	1.1	0.5	0.9	0.9	1.8	3.2	0.7	3.4	6.2	1.4	2.9	1.3	5.3	65.5	6.9	2.3	3.3	3.6	2.5	8.3	3.7	0.3	2.1	0.2	2.1	0.9	5.4	11.7	0.9	9.2	0.9	4.0	0.5	0.5	0.7	2.7	1.2	0.3	0.4	0.9	0.2	0.1	6.8	0.3	1.8	0.4	26.3	32.0	12.1	17.6	24.1	16.3	23.4	16.7	18.9	20.0
GPR137C	"DKFZp762F0713, TM7SF1L2"	ENSG00000180998	"G protein-coupled receptor 137C"	Q8N3F9	14	52553148-52637713	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 31.1;epididymis: 16.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 2.4;NK-cells: 3.9;T-cells: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003640, HPA030763"	Uncertain		Approved	Vesicles				Vesicles		"HPA003640: , HPA030763: AB_10602352"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.84e-2)"	"unprognostic (8.50e-3)"	"unprognostic (7.34e-3)"	"unprognostic (5.95e-3)"	"unprognostic (2.32e-2)"	"unprognostic (4.41e-2)"	"unprognostic (8.42e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.88e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.60e-1)"	1.4	2.2	7.1	1.0	11.0	3.3	1.9	31.1	20.2	1.4	1.2	7.5	0.2	2.0	2.5	16.6	1.7	1.2	2.8	2.4	5.9	10.6	1.2	1.3	1.7	2.1	6.3	7.5	1.6	0.7	2.3	1.8	1.8	13.3	1.6	1.5	3.2	1.7	1.5	1.3	1.8	1.2	1.5	7.0	2.5	1.4	6.5	8.3	0.0	2.1	0.0	1.2	2.1	0.7	0.7	0.5	2.4	0.5	3.9	4.1	0.8	0.8	0.3	8.1	7.4	2.3	0.7	3.2	3.4	2.3	3.5	8.6	1.5	1.6	0.8	2.5	2.8	1.9	2.7	0.5	5.3	1.2	1.8	0.9	2.3	0.9	0.3	0.5	1.9	0.4	0.0	3.3	0.2	1.8	1.2	3.5	5.1	3.9	0.3	1.1	2.0	4.7	1.8	5.1	0.3	1.0	5.7	8.3	10.4	1.7	0.5	0.2	5.1	0.0	0.3	8.1	8.7	5.9	2.8	0.8	2.0	1.8	2.0	0.4	2.4	1.2	0.5	0.5	3.1	0.1	4.1	0.3	2.0	3.9	0.2	0.7	1.5	1.8	2.4	3.9	0.4	0.5	1.4	0.8	7.1	11.0	31.1	14.1	5.9	10.6	6.3	7.5	13.3	8.3
GPR139	PGR3	ENSG00000180269	"G protein-coupled receptor 139"	Q6DWJ6	16	20031485-20073917	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 2.8;endometrium 1: 2.1;smooth muscle: 1.0"	"Cell line enriched"	"Detected in single"	10	"NTERA-2: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA046596	Uncertain									"HPA046596: "					"unprognostic (2.94e-1)"													0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0			0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.2	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GPR142	PGR2	ENSG00000257008	"G protein-coupled receptor 142"	Q7Z601	17	74367407-74372622	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.3;lymphoid tissue: 1.3"	"Cell line enhanced"	"Detected in single"		"U-937: 1.1"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031392	Uncertain		Uncertain	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA031392: AB_10601935"	"unprognostic (6.81e-2)"		"unprognostic (1.75e-1)"			"unprognostic (1.98e-1)"		"unprognostic (1.34e-1)"		"unprognostic (1.36e-1)"	"unprognostic (6.54e-5)"	"unprognostic (4.16e-2)"	"unprognostic (4.85e-7)"	"unprognostic (3.95e-2)"	"unprognostic (7.72e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.68e-3)"	0.2	0.0	0.0	1.3	0.1	0.0	0.1	1.3	0.2	0.3	0.1			0.8	0.6	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.2	0.0		0.1	0.8	0.0	0.0	0.1		0.2	0.1		0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.1			0.2		0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GPR148	PGR6	ENSG00000173302	"G protein-coupled receptor 148"	Q8TDV2	2	130729070-130730336	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 2.6;pancreas: 1.1;pituitary gland: 2.2;stomach 1: 3.5"	"Group enriched"	"Detected in some"	11	"CACO-2: 2.5;SCLC-21H: 2.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA060527	Uncertain									"HPA060527: "											"unprognostic (7.16e-4)"				"unprognostic (3.38e-1)"			0.0	0.2	0.1	0.0	0.4	0.0	0.0	2.6	0.4	0.0	0.2			0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.1		0.0	1.1	0.0	2.2	0.0		0.0	0.3		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.5	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GPR149	"IEDA, PGR10, R35"	ENSG00000174948	"G protein-coupled receptor 149"	Q86SP6	3	154337672-154429715	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"brain: 23.5;pituitary gland: 6.5;seminal vesicle: 8.7"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basal ganglia: 23.5;pons and medulla: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 15.0"	"Low region specificity"	"Detected in all"			HPA018020	Uncertain									"HPA018020: AB_1849334"																		0.2	0.3	0.2	0.2	23.5	0.2	0.2	0.0	0.8	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	1.9	0.2	0.2	0.2	0.2	0.8	0.0	0.2	0.2	0.2	6.5	0.2	6.5	0.3	0.3	0.4	0.2	8.7	0.2	0.3	0.3	0.2	0.6	0.2	0.5	1.1	2.1	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	23.5	0.0	0.8	0.2	1.9	0.8	0.0	6.5	2.1
GPR15		ENSG00000154165	"G protein-coupled receptor 15"	P49685	3	98531899-98533150	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 12.9;intestine: 27.1;lymphoid tissue: 26.3;urinary bladder: 9.4"	"Group enriched"	"Detected in some"	22	"HDLM-2: 10.9;U-266/70: 4.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 4.4;memory CD4 T-cell: 12.9;memory CD8 T-cell: 6.1;T-reg: 12.9"	"Group enriched"	"Detected in many"	30	"B-cells: 4.4;T-cells: 12.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA013775	Approved									"HPA013775: AB_1849264"	"unprognostic (8.03e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.66e-2)"	"unprognostic (9.48e-3)"	"unprognostic (5.60e-5)"	"unprognostic (5.17e-1)"	"unprognostic (6.77e-3)"	"unprognostic (3.96e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.04e-3)"	"unprognostic (4.23e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.54e-1)"	0.9	0.1	0.1	13.4	0.1	0.0	2.5	0.1	0.2	1.1	15.3	0.1	0.1	1.8	0.1	0.1	2.6	0.2	2.1	0.2	0.1	0.1	0.3	0.4	1.9	24.9	0.1	0.4	0.4	0.1	0.0	0.2	0.1	0.3	1.4	27.1	0.3	4.6	0.7	0.1	0.4	11.8	1.5	0.2	4.3	1.1	0.2	0.1	3.6	0.7	2.0	26.3	9.4	2.4	4.4	0.2	0.2	0.0	0.0	12.9	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.8	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.4	4.4	12.9	6.1	0.0	0.7	0.6	1.0	0.2	0.0	0.0	0.2	12.9	2.8	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.3	0.1
GPR151	"GALR4, PGR7"	ENSG00000173250	"G protein-coupled receptor 151"	Q8TDV0	5	146513103-146516190	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"blood: 1.5;brain: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	19	"thalamus: 36.8"	"Region enriched"	"Detected in single"	7	"thalamus: 4.6"	HPA065728		Supported								"HPA065728: "					"unprognostic (2.09e-1)"					"unprognostic (2.30e-1)"				"unprognostic (1.14e-1)"	"unprognostic (1.32e-2)"			0.0	0.1	0.4	0.0	0.5	0.1	0.0	0.0	2.2	0.0	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.8		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.3			0.0		0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.4	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
GPR152	PGR5	ENSG00000175514	"G protein-coupled receptor 152"	Q8TDT2	11	67451301-67452729	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 1.7;lymphoid tissue: 1.6"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 3.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035078	Uncertain									"HPA035078: AB_10670286"								"unprognostic (3.81e-2)"		"unprognostic (1.69e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"		"unprognostic (3.76e-3)"				0.1	0.0	0.0	0.6	0.0	0.6	0.0	0.1	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.6	0.0		0.0	0.0	0.3	0.0	0.0		0.1	0.0		0.2	0.0	0.3	0.1	1.7	0.0	0.1	1.6	0.7	0.0			0.0		0.0	0.1	0.0	0.2	0.1	1.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.5	0.0	1.0	0.0	0.3	0.0	0.0	0.0										
GPR153	PGR1	ENSG00000158292	"G protein-coupled receptor 153"	Q6NV75	1	6247346-6260975	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.9;PC-3: 35.5;RH-30: 16.8;SCLC-21H: 17.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"granulocytes: 1.3;monocytes: 1.0;T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007159	Approved									"HPA007159: AB_1849268"	"unprognostic (1.02e-2)"	"unprognostic (2.40e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (5.74e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (3.75e-4)"	"unprognostic (8.54e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	11.0	2.9	11.9	3.8	5.2	0.5	16.1	1.3	10.6	16.1	19.9	3.7	4.6	5.4	8.3	15.9	7.0	7.1	5.8	7.7	5.8	5.1	2.7	6.3	12.6	2.3	2.0	2.7	14.8	2.1	5.9	10.2	9.2	4.2	6.8	7.1	7.2	2.6	4.9	1.4	8.7	18.3	6.6	1.2	8.8	3.0	2.9	2.5	1.8	1.6	5.5	3.5	6.1	9.6	0.0	0.3	1.3	1.0	0.3	1.7	0.1	3.0	0.5	7.5	9.0	13.9	5.5	0.6	2.0	1.9	0.8	0.9	1.3	1.2	0.0	3.1	2.1	3.9	0.4	8.8	0.3	2.0	1.8	0.0	1.2	0.2	2.7	0.3	1.2	3.4	2.3	0.6	0.4	0.6	0.4	0.0	2.6	3.3	1.0	2.3	0.6	35.5	3.7	16.8	0.2	0.3	1.7	17.1	6.1	1.3	5.2	4.2	2.0	1.6	1.7	1.8	1.7	0.2	0.9	0.1	0.1	0.6	0.8	4.1	0.7	1.3	0.0	0.9	1.4	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.3	1.0	0.3	0.0	0.1	11.9	5.2	1.3	10.6	5.8	5.1	2.0	2.7	4.2	2.5
GPR155	"DEP.7, DEPDC3, FLJ31819, PGR22"	ENSG00000163328	"G protein-coupled receptor 155"	Q7Z3F1	2	174431571-174487094	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.5;stomach 1: 43.2"	"Cell line enhanced"	"Detected in many"		"U-266/70: 16.0;WM-115: 10.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036159, HPA057384"	Approved		Approved	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"		"HPA036159: AB_10671835, HPA057384: "	"unprognostic (3.91e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.11e-4)"	"unprognostic (5.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.82e-2)"	"unprognostic (4.54e-2)"	4.5	10.1	9.3	6.6	34.5	2.6	3.0	15.1	17.3	3.2	11.4	6.1	2.2	4.0	2.6	13.1	6.7	2.5	5.9	6.8	15.5	9.4	19.8	7.3	3.3	5.9	7.7	11.5	3.0	16.9	8.0	3.2	4.7	27.4	8.0	4.2	4.9	3.7	8.8	5.1	13.4	5.1	7.8	6.9	5.3	43.2	2.6	9.9	1.6	8.3	0.8	3.8	6.6	3.6	1.5	0.8	9.6	6.8	4.7	7.0	1.9	0.7	0.4	1.0	2.4	5.6	3.1	0.6	4.2	1.4	0.7	2.4	0.3	0.3	2.4	1.3	2.9	0.4	1.4	1.3	2.3	0.9	1.6	2.5	1.4	0.2	1.0	0.9	1.3	4.5	3.6	2.1	0.7	1.1	0.4	6.0	4.7	0.7	1.7	1.1	0.5	1.7	2.0	6.1	1.1	2.4	1.5	6.5	5.5	1.3	1.0	2.1	0.4	0.4	3.0	3.1	1.2	4.4	0.6	16.0	2.3	0.4	3.5	0.8	10.5	1.5	2.9	0.1	2.4	5.4	2.2	1.3	4.4	4.0	0.8	1.5	3.5	5.4	9.6	4.7	6.8	0.5	7.0	1.9	9.3	34.5	15.1	16.2	15.5	9.4	7.7	11.5	27.4	9.9
GPR156	"GABABL, PGR28"	ENSG00000175697	"G protein-coupled receptor 156"	Q8NFN8	3	120164645-120285094	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 7.7"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 3.0;PC-3: 3.0;SiHa: 7.9;U-2 OS: 4.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028642, HPA028644"	Uncertain		Supported	"Plasma membrane"				"Plasma membrane"		"HPA028642: AB_10599711, HPA028644: AB_10600441"	"unprognostic (2.85e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.62e-4)"	"unprognostic (2.03e-1)"	"unprognostic (4.54e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.03e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.91e-3)"	"unprognostic (6.71e-2)"	0.9	0.5	0.8	1.6	2.2	0.0	1.0	0.1	1.0	1.4	0.7	0.0	0.0	0.0	1.2	0.0	1.9	3.4	1.3	0.2	0.4	0.3	0.3	0.0	0.2	0.0	0.3	0.0	1.4	0.0	0.0	1.4	1.2	0.7	1.9	0.2	0.4	2.4	1.5	0.1	0.3	0.2	1.6	1.5	0.1	0.3	7.7	1.2	0.0	0.1	0.0	0.4	2.5	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.2	0.8	0.1	0.9	1.3	0.1	0.6	0.0	0.8	3.0	0.1	0.1	0.1	0.5	0.0	0.0	0.0	2.0	0.0	0.8	0.2	0.0	1.9	0.2	0.4	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.9	3.0	0.0	0.0	0.0	0.0	0.0	1.0	1.5	7.9	0.0	0.9	1.0	0.1	0.2	0.2	4.4	0.0	0.3	1.0	0.4	0.1	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	2.2	0.1	1.0	0.4	0.3	0.3	0.0	0.7	1.2
GPR157	FLJ12132	ENSG00000180758	"G protein-coupled receptor 157"	Q5UAW9	1	9100305-9129170	"G-protein coupled receptors, Predicted membrane proteins"	Differentiation	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 32.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.9;SK-BR-3: 33.2;U-266/70: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028697	Uncertain		Uncertain	"Nucleoli,Plasma membrane,Cell Junctions"				Nucleoli	"Plasma membrane, Cell Junctions"	"HPA028697: AB_10601810"	"unprognostic (2.83e-3)"	"unprognostic (1.13e-2)"	"unprognostic (5.91e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.13e-4)"	"unprognostic (7.11e-2)"	"unprognostic (7.52e-3)"	"unprognostic (3.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-3)"	3.5	3.1	0.3	3.7	0.6	0.5	3.5	0.5	0.4	6.2	2.8	0.9	3.9	2.2	2.1	2.1	23.4	2.1	6.9	10.7	0.8	0.4	2.9	6.9	5.5	3.1	0.3	0.1	4.5	4.3	9.8	1.2	19.0	1.4	2.9	1.2	5.2	14.7	7.1	32.2	14.2	3.3	4.0	0.4	2.4	2.2	2.1	0.8	3.6	4.8	25.2	16.2	4.4	8.3	2.4	1.1	4.6	1.5	1.2	2.6	0.7	4.6	2.6	0.8	2.1	0.7	0.7	4.3	1.4	0.9	1.2	1.6	2.1	1.8	0.6	1.8	1.5	9.9	2.4	0.9	1.8	12.8	3.9	0.0	7.7	3.1	2.6	0.0	1.0	0.7	2.0	2.1	1.3	0.9	0.7	16.9	0.5	3.4	1.9	0.9	0.9	3.3	0.3	0.7	2.2	0.8	3.1	1.2	3.2	5.7	33.2	2.8	4.7	0.5	7.0	4.2	1.1	10.9	0.6	16.3	2.6	0.0	3.1	6.6	1.7	1.9	1.5	0.4	2.6	1.2	2.0	1.5	1.9	2.3	0.8	2.4	1.9	2.2	4.6	1.2	0.6	1.1	0.8	0.7	0.3	0.6	0.5	0.4	0.8	0.4	0.3	0.1	1.4	0.8
GPR160	"GPCR1, GPCR150"	ENSG00000173890	"G protein-coupled receptor 160"	Q9UJ42	3	170037929-170085403	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 71.0"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 30.4;SK-BR-3: 24.2;THP-1: 47.8;U-266/70: 52.8;U-266/84: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA006970	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA006970: AB_1849275"	"unprognostic (1.70e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.21e-2)"	"prognostic favourable (1.21e-4)"	"unprognostic (5.71e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.77e-1)"	"prognostic favourable (4.93e-7)"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.43e-1)"	"prognostic favourable (3.61e-4)"	7.0	1.4	3.1	21.7	2.5	23.6	8.2	0.9	1.8	2.6	31.2	1.5	7.9	18.0	1.9	21.5	2.6	1.8	16.2	3.0	1.9	1.7	27.4	2.1	23.2	25.6	2.7	0.4	1.6	14.7	71.0	3.5	2.9	1.8	10.7	18.1	11.8	14.2	4.7	2.0	1.8	43.2	0.9	4.7	17.9	18.0	2.9	2.4	6.6	3.8	1.0	10.7	9.1	6.9	11.2	2.9	10.1	1.1	0.3	3.0	1.2	15.6	0.3	0.0	0.1	0.0	0.1	3.9	0.1	0.1	0.1	0.5	2.8	2.0	7.2	3.3	0.1	0.1	2.1	0.1	0.2	11.0	4.3	4.7	0.2	5.8	0.0	9.2	6.4	0.0	0.2	0.5	0.5	0.3	1.5	18.8	0.1	10.0	0.6	1.9	2.5	0.6	1.3	0.3	30.4	8.2	21.6	1.5	0.4	0.1	24.2	1.1	14.2	47.8	0.4	0.0	0.1	1.8	1.1	52.8	30.3	12.7	0.2	10.0	0.7	1.5	1.1	8.1	0.5	0.4	0.9	6.8	0.9	0.4	2.2	11.2	3.0	1.1	10.1	0.3	0.1	2.9	0.3	1.2	3.1	2.5	0.9	1.8	1.9	1.7	2.7	0.4	1.8	2.4
GPR161	RE2	ENSG00000143147	"G protein-coupled receptor 161"	Q8N6U8	1	168079543-168137667	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 27.1;smooth muscle: 21.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 23.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015576, HPA072047"	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA015576: AB_1849283, HPA072047: "	"unprognostic (1.45e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.57e-6)"	"unprognostic (3.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	2.4	0.9	2.1	3.6	1.7	0.0	1.9	1.2	4.0	7.3	4.9	3.1	8.5	0.8	27.1	8.2	7.4	7.7	5.6	2.4	2.8	1.5	1.1	0.4	2.8	0.4	3.0	1.2	7.6	11.0	4.9	1.3	1.3	3.0	8.2	2.3	3.4	2.3	9.4	0.8	1.5	2.1	21.0	3.0	1.2	2.2	3.0	0.8	1.4	1.2	1.7	0.7	2.8	6.8	0.3	1.2	1.5	0.5	0.2	0.3	0.2	6.1	3.8	15.3	9.8	3.7	6.6	0.0	5.9	6.4	5.0	5.4	23.8	1.0	0.0	3.3	8.8	18.2	3.7	5.8	2.9	2.3	4.7	2.2	3.0	0.1	1.5	0.6	1.5	2.3	3.7	4.3	7.0	10.1	2.0	0.1	7.6	0.5	0.7	0.1	6.3	6.0	1.8	6.6	0.0	2.6	1.6	3.1	13.5	6.4	0.2	17.6	3.4	0.7	13.5	10.5	5.4	14.0	6.6	0.0	0.0	0.0	2.8	0.0	2.6	1.5	0.3	0.2	0.1	0.3	0.1	0.1	0.1	0.0	1.2	0.3	0.1	0.3	1.3	0.2	0.5	0.3	0.0	0.2	2.1	1.7	1.2	4.0	2.8	1.5	3.0	1.2	3.0	0.8
GPR162	"A-2, GRCA"	ENSG00000250510	"G protein-coupled receptor 162"	Q16538	12	6821545-6829972	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.6"	"Cell line enhanced"	"Detected in many"		"AF22: 13.3;AN3-CA: 15.8;NTERA-2: 14.9;SH-SY5Y: 10.2;U-2 OS: 12.6"	"Cancer enriched"	"Detected in many"	6	"glioma: 16.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.3;intermediate monocyte: 3.7;neutrophil: 14.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 14.7;monocytes: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055135	Enhanced		Approved	"Centriolar satellite"	"Intracellular and membrane"			"Centriolar satellite"		"HPA055135: "	"unprognostic (4.76e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.83e-3)"	"unprognostic (1.18e-1)"	"prognostic favourable (4.29e-5)"	"unprognostic (3.82e-3)"	"prognostic unfavourable (1.37e-6)"	"unprognostic (3.10e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.64e-2)"	2.7	6.7	19.6	4.2	13.2	1.5	2.4	41.3	47.6	2.1	3.4	4.7	0.8	3.1	3.8	2.8	1.9	16.9	5.7	4.2	25.9	18.4	1.4	3.7	6.0	1.7	9.9	17.7	2.0	1.7	5.3	8.4	4.3	10.2	2.1	3.0	3.6	1.3	2.1	1.6	1.7	4.2	5.7	5.3	2.8	2.0	1.2	3.6	0.1	1.1	0.0	1.1	2.4	0.5	0.0	1.8	14.7	6.3	0.0	0.0	1.7	0.0	3.0	13.3	15.8	1.5	1.0	0.0	1.0	3.5	3.0	1.8	0.3	0.0	0.0	0.1	1.9	0.1	2.1	0.0	1.5	0.0	0.9	1.5	0.1	0.0	2.3	0.3	0.0	2.4	0.0	4.6	0.2	8.1	0.7	0.1	1.1	0.0	0.4	1.1	14.9	0.1	0.0	1.7	2.7	1.0	0.0	1.1	10.2	0.0	0.0	0.4	0.1	3.9	5.4	2.1	12.6	1.1	1.8	0.0	0.9	0.0	2.2	2.7	0.2	0.0	6.3	0.0	0.0	3.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	14.7	0.0	1.3	1.6	0.0	1.7	19.6	13.2	41.3	32.4	25.9	18.4	9.9	17.7	10.2	3.6
GPR17		ENSG00000144230	"G protein-coupled receptor 17"	Q13304	2	127645864-127652639	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 43.8"	"Cell line enhanced"	"Detected in some"		"HeLa: 4.5;REH: 7.5;TIME: 7.4;U-2 OS: 3.1;U-2197: 3.5;U-251 MG: 4.4"	"Cancer enriched"	"Detected in some"	32	"glioma: 16.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"naive B-cell: 4.0"	"Lineage enriched"	"Detected in single"	11	"B-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029766	Enhanced	Supported	Approved	Vesicles				Vesicles		"HPA029766: AB_10612114"	"unprognostic (8.10e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.77e-5)"	"unprognostic (8.40e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.31e-1)"	7.0	2.2	23.7	6.8	21.3	0.8	5.4	4.1	25.6	2.4	16.4	43.8	0.0	3.3	11.2	3.3	5.0	4.0	4.3	12.5	20.6	1.2	2.3	1.6	9.3	2.4	9.1	9.9	1.4	4.6	0.5	0.4	2.7	18.8	3.9	0.8	0.1	1.7	0.5	13.1	6.7	3.8	0.5	6.3	12.6	5.0	1.8	22.6	0.0	2.8	0.0	0.5	6.1	3.9	4.0	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.3	0.6	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	4.5	0.8	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	0.0	0.0	0.6	0.2	0.1	0.2	7.5	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.3	0.0	7.4	0.0	3.1	3.5	4.4	0.2	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.7	21.3	4.1	25.6	20.6	1.2	9.1	9.9	18.8	22.6
GPR171	H963	ENSG00000174946	"G protein-coupled receptor 171"	O14626	3	151197832-151203201	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.2;intestine: 19.5;lymphoid tissue: 33.0"	"Cell line enriched"	"Detected in single"	26	"U-266/70: 24.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 45.2"	"Lineage enriched"	"Detected in many"	18	"T-cells: 45.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA062429	Approved									"HPA062429: "	"unprognostic (6.82e-6)"	"unprognostic (4.90e-3)"	"unprognostic (7.10e-2)"	"unprognostic (6.85e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.04e-3)"	"unprognostic (4.19e-4)"	"unprognostic (6.09e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.72e-6)"	"unprognostic (1.31e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.02e-2)"	4.1	0.9	0.4	15.1	0.4	0.4	1.6	0.3	0.3	4.0	6.8	0.3	0.6	3.5	1.4	1.6	2.7	3.9	4.6	1.3	0.4	0.4	4.3	2.7	10.7	33.0	0.7	0.5	1.9	1.0	0.0	0.7	0.8	1.5	2.2	3.8	1.7	2.4	1.2	1.0	1.1	19.5	1.1	2.7	20.7	4.0	1.0	0.5	19.9	2.2	1.8	8.5	7.0	2.4	0.1	0.8	1.0	0.1	2.5	45.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.0	11.6	0.0	45.2	0.0	16.2	21.5	0.8	0.1	9.9	8.4	0.3	2.5	0.1	0.7	8.0	3.4	0.4	0.4	0.3	0.3	0.4	0.4	0.7	0.5	1.5	0.5
GPR173	SREB3	ENSG00000184194	"G protein-coupled receptor 173"	Q9NS66	X	53049091-53080615	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 23.2"	"Cell line enhanced"	"Detected in many"		"HAP1: 10.3"	"Cancer enhanced"	"Detected in many"		"glioma: 8.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 5.7;NK-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003905			Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA003905: AB_1078922"	"unprognostic (2.68e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.95e-3)"	"prognostic unfavourable (2.88e-6)"	"unprognostic (3.87e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.70e-2)"	"prognostic favourable (2.33e-5)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (2.47e-4)"	"unprognostic (1.08e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.95e-2)"	2.5	5.2	8.2	3.0	9.4	2.2	3.1	15.4	23.2	4.2	2.8	11.6	0.8	1.8	6.4	5.0	2.4	7.7	3.3	4.2	7.9	10.0	2.4	1.1	2.8	2.1	7.3	11.2	15.0	1.3	1.3	14.6	4.5	9.7	3.2	2.6	6.4	2.0	5.4	4.6	3.9	2.1	4.5	6.5	4.0	2.1	2.4	9.6	0.7	3.1	0.1	1.5	3.3	2.8	0.9	0.7	5.7	0.4	1.8	0.7	0.0	0.0	0.0	8.2	0.5	4.7	2.8	0.0	1.3	3.0	2.2	2.6	0.8	0.1	0.2	2.0	2.8	0.7	10.3	0.0	1.9	0.6	1.0	0.5	8.4	0.3	6.8	0.5	0.1	6.6	0.0	3.3	4.7	3.5	0.0	5.7	3.2	4.2	0.0	0.0	6.3	3.6	0.1	2.5	0.3	0.5	0.4	5.9	8.3	0.0	0.4	0.0	1.1	0.1	6.5	3.6	5.2	2.3	1.1	0.2	0.3	0.7	2.5	0.0	2.0	5.7	0.2	0.3	0.7	0.1	0.5	0.3	0.2	0.1	0.1	0.9	0.5	0.4	1.2	1.8	0.4	0.7	0.0	0.0	8.2	9.4	15.4	15.1	7.9	10.0	7.3	11.2	9.7	9.6
GPR174	FKSG79	ENSG00000147138	"G protein-coupled receptor 174"	Q9BXC1	X	79144663-79175315	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 73.8"	"Cell line enriched"	"Detected in some"	7	"MOLT-4: 41.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA041025	Enhanced		Uncertain	Vesicles				Vesicles		"HPA041025: AB_10794260"	"unprognostic (6.38e-3)"	"unprognostic (9.87e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.48e-4)"	"unprognostic (7.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.53e-5)"	"unprognostic (2.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-2)"	2.2	0.5	0.4	20.3	0.4	2.6	1.3	0.3	0.4	2.4	5.1	0.0	0.5	2.1	1.6	0.9	2.6	0.9	1.9	1.0	0.4	0.4	1.9	1.7	8.2	16.6	0.5	0.0	1.0	0.7	0.0	1.1	0.3	0.2	1.7	2.0	1.6	3.8	0.1	0.5	0.7	9.1	0.2	1.0	21.0	2.2	0.5	0.0	73.8	2.5	1.6	28.1	5.1	1.8	4.0	1.8	6.0	9.1	6.5	8.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	41.8	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	0.0	0.0	6.0	0.0	4.7	5.7	3.4	1.7	4.0	7.5	8.6	0.1	3.9	6.1	6.8	0.4	6.5	9.1	1.8	7.6	2.7	0.4	0.4	0.3	0.4	0.4	0.4	0.5	0.0	0.2	0.0
GPR176	Gm1012	ENSG00000166073	"G protein-coupled receptor 176"	Q14439	15	39799032-39920892	"G-protein coupled receptors, Predicted membrane proteins"	"Biological rhythms"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 68.5;fHDF/TERT166: 46.2;U-138 MG: 30.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"eosinophil: 2.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039943, HPA039979"	Approved									"HPA039943: AB_10697711, HPA039979: "	"unprognostic (4.02e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.38e-3)"	"unprognostic (9.32e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (9.38e-7)"	"prognostic unfavourable (6.84e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.26e-2)"	9.8	9.6	9.7	5.9	18.4	0.5	8.9	22.6	16.0	8.0	2.9	2.5	1.3	2.8	5.6	3.1	2.9	3.8	10.5	5.4	8.4	12.7	4.7	2.8	5.4	8.0	7.2	7.4	2.5	2.3	3.3	4.1	3.6	11.3	10.9	3.5	3.2	2.5	5.7	3.1	3.0	2.5	6.9	3.0	5.6	2.5	9.9	2.0	1.2	5.1	3.1	8.0	9.5	4.5	0.0	0.5	2.8	0.0	0.0	0.0	0.0	12.4	0.6	0.8	0.1	9.0	16.4	0.0	26.5	68.5	16.3	25.3	0.9	2.0	0.1	2.4	46.2	0.3	2.0	2.1	24.5	0.4	3.1	1.9	2.0	0.0	10.1	0.0	0.1	12.4	0.2	14.6	12.1	6.1	0.3	0.2	22.4	0.5	0.0	0.0	0.8	2.5	0.7	8.2	0.1	0.4	0.1	3.3	13.0	6.8	0.0	1.0	2.5	0.1	7.7	30.1	8.7	1.8	9.7	0.3	1.0	0.0	6.2	0.0	11.7	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	9.7	18.4	22.6	14.3	8.4	12.7	7.2	7.4	11.3	2.0
GPR180	ITR	ENSG00000152749	"G protein-coupled receptor 180"	Q86V85	13	94601903-94634645	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047250	Approved		Approved	Vesicles				Vesicles		"HPA047250: "	"unprognostic (3.91e-3)"	"unprognostic (3.28e-1)"	"unprognostic (4.16e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-3)"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.86e-2)"	"prognostic unfavourable (3.18e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.80e-2)"	14.6	6.8	7.6	6.6	11.4	2.7	15.9	14.7	13.1	8.3	6.1	7.6	5.2	5.7	7.1	5.8	5.3	7.3	5.3	7.6	7.9	8.8	7.5	18.7	6.8	6.3	8.8	7.8	7.3	10.6	7.5	18.8	9.9	10.8	7.6	7.4	12.3	7.5	7.2	5.6	5.7	5.1	8.1	12.1	6.0	7.7	3.5	8.8	8.6	10.2	3.9	7.3	6.4	6.9	1.5	2.5	0.3	1.5	1.5	4.3	1.3	13.0	3.3	4.7	5.0	10.1	11.0	2.0	8.9	7.1	8.7	11.7	4.0	9.0	4.3	3.9	7.6	8.3	6.7	6.3	12.0	11.3	4.3	8.4	4.6	0.0	8.0	12.0	6.9	6.3	5.4	5.3	7.3	8.8	2.3	2.1	8.6	1.9	6.0	2.7	3.1	3.7	7.0	6.4	1.8	9.8	3.9	7.0	5.0	4.1	9.3	10.9	6.5	5.0	7.9	5.4	4.3	6.4	7.4	3.6	3.6	2.0	9.0	9.9	7.3	0.3	1.5	0.3	2.4	1.0	4.3	1.5	2.9	1.7	2.5	1.5	3.5	2.9	0.0	1.5	1.1	1.8	3.4	1.3	7.6	11.4	14.7	13.1	7.9	8.8	8.8	7.8	10.8	8.8
GPR182	"ADMR, AM-R, G10D, hrhAMR"	ENSG00000166856	"G protein-coupled receptor 182"	O15218	12	56994446-56998441	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"liver: 9.5;lymphoid tissue: 29.1;testis: 12.9"	"Cell line enhanced"	"Detected in some"		"A549: 2.2;RH-30: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027037	Enhanced									"HPA027037: AB_1844622"	"unprognostic (6.13e-2)"	"unprognostic (6.23e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.10e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.94e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.34e-3)"	0.4	3.2	0.0	0.8	0.0	0.0	0.6	0.1	0.3	0.7	0.4	0.0	0.6	0.0	1.2	0.7	1.3	0.7	0.1	0.3	0.0	0.0	1.3	9.5	1.9	7.5	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.6	0.1	0.1	0.3	0.3	0.7	0.0	29.1	0.2	12.9	0.0	0.2	1.4	0.3	0.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.5	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	1.3	1.0	0.7	0.0	0.0	0.3	6.2	0.0	0.0	0.6	0.1	0.5	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.4	0.3	0.0	0.4	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0
GPR19		ENSG00000183150	"G protein-coupled receptor 19"	Q15760	12	12660891-12696207	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 9.2;brain: 13.3;pituitary gland: 9.8;testis: 9.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.2;NTERA-2: 24.1;WM-115: 12.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 9.2"	"Group enriched"	"Detected in many"	16	"granulocytes: 4.2;T-cells: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013955	Uncertain									"HPA013955: AB_1849287"	"unprognostic (1.92e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.62e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.21e-1)"	"unprognostic (8.25e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.67e-12)"	"unprognostic (5.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.60e-1)"	1.0	2.4	7.5	4.8	13.3	2.3	1.2	11.5	13.0	0.8	1.5	2.8	0.0	1.1	0.7	0.7	1.5	1.0	1.1	0.7	8.5	8.4	0.7	0.8	0.8	4.3	5.6	6.3	0.5	1.1	1.0	9.8	1.1	3.7	0.5	1.9	0.4	0.6	0.6	0.4	2.2	1.1	1.1	6.7	1.7	1.3	9.8	3.6	0.3	0.7	0.0	5.8	1.3	0.2	0.3	0.0	4.2	0.0	0.4	9.2	0.5	0.9	0.3	10.0	0.2	0.0	0.0	4.3	0.9	1.0	1.8	1.5	3.9	6.0	4.0	1.5	0.7	0.8	1.6	0.2	2.9	23.2	0.2	0.9	0.4	0.6	0.0	1.0	0.4	0.0	0.0	1.9	1.1	0.3	0.1	8.3	0.3	1.4	0.3	0.5	24.1	1.8	2.6	1.5	0.1	0.1	0.8	3.3	3.0	0.4	0.9	7.7	0.5	1.0	0.0	0.5	4.5	0.8	2.3	4.6	4.0	7.7	1.9	2.8	12.3	0.0	0.0	0.0	1.8	0.0	1.4	0.3	3.8	2.1	0.0	0.1	0.7	1.4	4.2	0.4	0.0	0.0	9.2	0.5	7.5	13.3	11.5	10.6	8.5	8.4	5.6	6.3	3.7	3.6
GPR21		ENSG00000188394	"G protein-coupled receptor 21"	Q99679	9	123034527-123035696	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 4.6"	"Cell line enriched"	"Detected in some"	8	"HBEC3-KT: 8.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA041651	Uncertain									"HPA041651: AB_10794673"													"unprognostic (9.22e-3)"			"unprognostic (1.46e-1)"		3.6	0.0	1.1	1.7	2.2	0.2	1.1	0.1	4.6	2.1	0.4			0.0	2.7	1.0	1.9	0.9	0.8	0.5	0.7	0.4	0.3	0.0	0.5	1.9	0.3		1.4	0.0	0.2	0.0	1.5		0.1	0.6		0.1	0.7	0.4	0.6	0.3	1.7	0.4	0.9	0.5	0.0			1.0		0.9	1.3	2.0	0.9	0.0	0.1	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.0	8.2	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2										
GPR27	SREB1	ENSG00000170837	"G protein-coupled receptor 27"	Q9NS67	3	71754050-71756496	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 23.2;parathyroid gland: 29.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 12.8;HL-60: 12.2;MCF7: 10.5;NTERA-2: 21.1;RPTEC TERT1: 10.1;SH-SY5Y: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"eosinophil: 3.7;neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029395	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"				Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA029395: AB_10602907"	"prognostic favourable (5.63e-4)"	"unprognostic (2.99e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-1)"	"prognostic favourable (1.21e-6)"	"unprognostic (2.97e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.79e-2)"	1.7	4.5	14.9	1.7	23.2	14.5	4.3	4.4	15.4	3.4	1.0	5.8	1.7	0.6	5.5	3.3	2.7	7.7	1.2	3.5	12.8	12.4	3.2	0.9	2.4	5.5	10.6	8.8	5.0	2.6	29.6	5.1	2.0	5.9	5.7	0.7	3.3	1.7	5.1	1.8	1.9	0.7	3.3	16.8	3.7	2.4	4.2	3.6	0.0	6.8	1.2	0.5	2.1	2.8	0.0	0.2	10.5	0.8	0.0	0.4	0.1	0.0	0.8	1.4	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	12.8	0.0	0.0	3.2	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	12.2	0.7	0.0	2.2	0.0	0.9	0.0	0.0	0.0	0.0	10.5	0.8	0.2	21.1	0.0	0.0	0.0	0.0	10.1	5.7	2.2	8.0	2.8	0.0	0.0	7.4	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	3.7	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.1	10.5	0.0	0.1	0.0	0.0	0.1	14.9	23.2	4.4	9.9	12.8	12.4	10.6	8.8	5.9	3.6
GPR31	"12-HETER, HETER1"	ENSG00000120436	"G protein-coupled receptor 31"	O00270	6	167156271-167158329	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.7;epididymis: 2.5;lymphoid tissue: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	28	"myeloid DC: 2.7"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 2.7"	"Not detected"	"Not detected"							"HPA014014, HPA027108"	Uncertain									"HPA014014: AB_1849292, HPA027108: AB_10601474"	"unprognostic (9.92e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-3)"		"unprognostic (2.20e-3)"	"unprognostic (5.95e-3)"	"unprognostic (4.03e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.86e-1)"	"unprognostic (8.10e-4)"	"unprognostic (2.45e-1)"	"unprognostic (6.01e-2)"	0.0	0.0	0.1	0.9	0.1	0.2	0.1	0.0	0.1	0.1	0.1			0.5	0.0	2.5	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	4.5	0.2		0.0	0.0	0.0	0.1	0.0		0.0	0.1		0.1	0.0	0.0	0.0	0.9	0.0	0.2	2.1	0.3	1.1			0.1		1.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GPR34		ENSG00000171659	"G protein-coupled receptor 34"	Q9UPC5	X	41688973-41697277	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 60.8"	"Cell line enhanced"	"Detected in some"		"HMC-1: 5.1;U-937: 1.4"	"Cancer enhanced"	"Detected in all"		"glioma: 26.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"basophil: 60.8;eosinophil: 25.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010668, CAB025490"	Uncertain		Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB025490: , HPA010668: AB_1849294"	"unprognostic (1.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.81e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-3)"	"unprognostic (3.18e-2)"	25.1	12.4	15.1	9.7	16.6	0.4	15.0	2.1	11.7	10.5	9.1	13.5	1.0	4.4	4.9	6.6	5.8	5.5	12.2	5.9	16.0	9.5	11.7	5.3	11.4	26.8	22.4	7.5	5.4	4.4	2.8	3.3	29.3	15.4	5.7	9.3	4.9	7.1	6.4	2.1	2.4	11.4	11.5	34.0	22.3	5.1	5.0	21.4	1.9	3.4	1.5	11.1	12.5	3.7	0.3	0.4	60.8	2.8	3.0	0.1	0.5	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	1.0	0.4	0.0	0.2	0.0	0.1	5.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.8	0.3	0.5	0.1	1.1	0.0	0.3	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.1	0.8	0.1	0.0	0.0	0.1	0.6	1.4	0.0	60.8	2.2	25.3	0.0	2.8	0.0	0.3	0.1	0.0	0.4	0.1	0.0	0.0	0.2	3.0	1.5	0.0	0.1	0.5	15.1	16.6	2.1	11.7	16.0	9.5	22.4	7.5	15.4	21.4
GPR4		ENSG00000177464	"G protein-coupled receptor 4"	P46093	19	45589764-45602208	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"vagina: 32.0"	"Group enriched"	"Detected in some"	12	"HUVEC TERT2: 14.6;TIME: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014278	Uncertain									"HPA014278: AB_1849300"	"unprognostic (2.49e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavourable (9.19e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.66e-2)"	"prognostic unfavourable (2.07e-5)"	"unprognostic (6.46e-3)"	"unprognostic (1.93e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.49e-3)"	22.6	5.4	6.7	8.4	14.8	1.9	19.7	6.1	12.0	3.3	3.3	3.0	0.3	3.0	5.4	2.7	2.9	4.0	8.6	23.1	8.1	4.5	7.5	4.9	18.6	4.1	8.4	1.3	3.8	6.6	4.5	4.4	10.3	18.6	4.1	2.5	4.5	2.1	3.2	7.7	2.2	3.1	6.8	13.0	4.5	4.4	1.8	8.9	0.0	12.7	2.4	2.2	5.4	32.0	1.1	0.7	1.4	0.3	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.9	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.7	0.0	0.0	0.2	0.2	14.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.5	0.3	0.4	0.5	0.4	0.4	0.1	1.1	0.4	0.8	1.4	0.7	0.2	0.7	0.3	0.0	6.7	14.8	6.1	12.0	8.1	4.5	8.4	1.3	18.6	8.9
GPR45	"PSP24, PSP24A"	ENSG00000135973	"G protein-coupled receptor 45"	Q9Y5Y3	2	105241743-105243049	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 5.7"	"Group enriched"	"Detected in some"	11	"BEWO: 3.1;U-2 OS: 9.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA055940	Uncertain									"HPA055940: "	"unprognostic (3.80e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.71e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.13e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.99e-2)"	0.1	0.1	1.4	0.1	2.3	0.0	0.1	0.0	5.7	0.0	0.1			0.2	0.0	0.0	0.2	0.0	0.1	0.1	1.4	3.1	0.1	0.0	0.0	0.3	1.2		0.1	0.0	0.0	0.0	0.2		0.2	0.0		0.4	0.1	0.2	0.4	0.4	0.0	0.4	0.2	0.2	1.2			0.3		0.0	0.1	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	9.6	0.0	0.1	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GPR63	"PSP24(beta), PSP24B"	ENSG00000112218	"G protein-coupled receptor 63"	Q9BZJ6	6	96794126-96837463	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 7.8;HHSteC: 12.7;Karpas-707: 19.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039103	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA039103: AB_10672841"	"unprognostic (8.22e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.53e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-2)"	1.8	3.4	3.8	3.1	11.0	0.8	1.6	7.5	10.7	3.3	3.9	1.6	1.0	5.1	1.9	1.5	2.0	2.8	2.7	1.9	3.2	2.2	1.4	0.5	1.4	0.9	2.2	6.4	4.0	5.0	3.9	4.3	2.5	10.1	3.3	6.2	2.5	1.7	2.2	1.0	1.7	3.6	3.6	1.4	1.3	4.1	8.0	5.2	2.5	2.3	0.0	0.9	2.2	4.8	0.8	0.9	2.6	0.6	1.4	1.1	0.1	0.0	0.1	1.5	0.3	2.1	0.8	0.4	0.9	0.0	0.0	0.2	0.2	1.1	0.0	0.0	0.1	1.1	4.9	2.2	0.0	7.8	3.7	4.6	0.4	0.0	12.7	2.9	0.5	2.4	0.4	0.0	3.4	0.0	3.3	19.0	0.4	0.4	2.2	0.0	4.9	0.7	0.0	1.7	3.8	0.3	0.2	2.2	1.4	0.3	3.0	0.5	1.2	0.6	0.0	1.3	1.9	0.2	1.7	1.5	0.8	0.1	0.8	1.8	1.0	0.8	0.6	0.2	0.6	0.2	0.3	0.7	1.1	0.6	0.1	0.8	1.0	0.9	2.6	1.4	0.2	0.9	0.3	0.1	3.8	11.0	7.5	10.7	3.2	2.2	2.2	6.4	10.1	5.2
GPR82		ENSG00000171657	"G protein-coupled receptor 82"	Q96P67	X	41724155-41730135	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 23.2;lymphoid tissue: 12.0"	"Cell line enriched"	"Detected in single"	16	"HMC-1: 9.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"eosinophil: 23.2;NK-cell: 6.6"	"Group enriched"	"Detected in many"	9	"granulocytes: 23.2;NK-cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035914	Approved									"HPA035914: AB_10670671"	"unprognostic (5.62e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.62e-4)"	"unprognostic (1.41e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.00e-3)"	"unprognostic (1.18e-1)"	1.2	2.2	1.6	3.9	5.9	0.2	1.1	0.6	1.5	0.9	2.7	0.3	0.0	3.0	0.8	1.1	1.1	1.1	1.1	0.7	2.5	1.1	4.7	5.0	10.0	9.0	2.5	0.1	0.7	1.5	0.1	1.1	0.3	3.2	1.1	2.1	0.8	0.8	0.7	0.4	0.7	5.2	0.6	7.3	3.6	1.6	0.4	2.3	1.6	0.8	0.6	12.0	2.4	0.9	0.1	0.2	23.2	1.6	6.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.3	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.2	23.2	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	6.6	1.4	0.0	0.0	0.1	1.6	5.9	0.6	1.5	2.5	1.1	2.5	0.1	3.2	2.3
GPR84	EX33	ENSG00000139572	"G protein-coupled receptor 84"	Q9NQS5	12	54362445-54364487	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.2"	"Group enriched"	"Detected in some"	5	"HL-60: 9.1;NB-4: 28.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	23	"basophil: 6.0;classical monocyte: 8.7;myeloid DC: 12.9;neutrophil: 5.3"	"Group enriched"	"Detected in many"	53	"dendritic cells: 12.9;granulocytes: 6.0;monocytes: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA027603	Enhanced									"HPA027603: AB_10612115"	"unprognostic (5.40e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.36e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.16e-3)"	"unprognostic (7.43e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.36e-9)"	"unprognostic (1.27e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.44e-2)"	7.2	2.3	2.7	11.2	6.8	27.2	0.7	0.4	3.3	1.0	0.9	5.0	0.0	0.8	0.6	0.9	1.1	1.7	1.8	3.2	1.6	2.1	2.4	0.8	5.3	2.7	4.4	0.0	2.7	1.0	0.7	2.3	6.7	5.0	1.2	1.3	0.7	1.2	0.7	1.1	1.4	0.8	2.8	6.7	8.0	1.2	2.1	7.5	0.9	2.1	0.0	2.8	3.0	2.1	0.0	12.9	6.0	8.7	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.1	1.6	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.7	0.0	6.0	8.7	0.0	0.0	0.3	0.0	0.0	0.0	0.1	12.9	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	1.8	2.7	6.8	0.4	3.3	1.6	2.1	4.4	0.0	5.0	7.5
GPR87	GPR95	ENSG00000138271	"G protein-coupled receptor 87"	Q9BY21	3	151294086-151316952	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 24.8;skin 1: 19.7;tongue: 21.9"	"Cell line enhanced"	"Detected in some"		"A-431: 30.8;HaCaT: 24.6;HBEC3-KT: 32.8;hTCEpi: 43.8;hTERT-HME1: 18.4;RT4: 12.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3"	"Region enriched"	"Detected in single"	12	"pons and medulla: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066313			Approved	"Nucleoplasm,Lipid droplets,Mitochondria"				"Lipid droplets, Mitochondria"	Nucleoplasm	"HPA066313: "	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"		"unprognostic (4.07e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.28e-2)"		"unprognostic (4.61e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (4.62e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.66e-4)"	"unprognostic (8.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.17e-1)"	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.4	6.5	0.0	0.0	2.8	0.0	0.4	2.1	24.8	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.6	11.1	5.1	4.5	0.0	0.0	9.5	4.0	0.0	19.7	0.0	0.4	0.0	0.0	0.2	0.7	0.0	2.0	0.0	21.9	13.5	6.2	13.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.2	0.0	0.0	11.3	0.0	0.0	0.0	24.6	0.0	32.8	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	43.8	0.0	18.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	1.7	0.0	0.0	0.0	1.1	12.9	0.0	0.0	5.4	0.1	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.1	0.0
GPR88		ENSG00000181656	"G protein-coupled receptor 88"	Q9GZN0	1	100538137-100542018	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Mental retardation"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"brain: 62.7"	"Group enriched"	"Detected in some"	8	"HSkMC: 4.8;SCLC-21H: 5.9"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 12.0"	"Group enriched"	"Detected in many"	7	"basal ganglia: 62.7;thalamus: 32.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	11	"basal ganglia: 643.5"	"Region enriched"	"Detected in some"	35	"basal ganglia: 223.4"	HPA007488		Approved								"HPA007488: "	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.37e-3)"	"unprognostic (5.41e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.03e-2)"	"unprognostic (7.76e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.93e-4)"	"unprognostic (1.85e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.35e-2)"	0.7	0.6	1.2	0.5	62.7	0.2	10.9	0.0	6.8	0.1	0.3	0.8	0.0	0.6	0.2	0.2	0.2	0.1	0.2	0.4	0.9	0.8	0.3	13.1	0.2	0.3	0.7	1.1	3.8	0.1	4.6	0.5	0.2	7.0	0.6	0.5	0.3	0.7	0.1	0.3	0.1	0.5	0.3	0.5	13.7	0.4	0.2	32.8	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	62.7	0.0	6.8	0.9	0.8	0.7	1.1	7.0	32.8
GPRC5B	RAIG-2	ENSG00000167191	"G protein-coupled receptor class C group 5 member B"	Q9NZH0	16	19856691-19886167	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 108.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 38.4;HHSteC: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"naive CD4 T-cell: 6.5"	"Lineage enriched"	"Detected in many"	4	"T-cells: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015247	Enhanced		Supported	Nucleoplasm,Nucleoli,Vesicles				Vesicles	"Nucleoplasm, Nucleoli"	"HPA015247: AB_1849323"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (9.27e-5)"	"unprognostic (2.60e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (6.30e-4)"	"unprognostic (4.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.42e-3)"	"unprognostic (6.78e-3)"	12.6	4.4	45.2	3.2	55.9	1.0	7.3	22.8	108.0	5.4	2.9	95.1	4.9	4.0	7.1	9.3	5.5	12.7	9.2	22.3	47.8	28.7	12.1	2.7	3.9	4.6	63.1	34.9	13.7	12.7	9.5	3.8	9.3	38.6	6.3	2.3	3.8	20.8	11.5	35.1	2.5	3.3	5.1	61.6	2.2	22.7	19.6	63.1	0.0	7.2	2.6	2.7	6.2	3.0	0.0	0.0	0.0	1.5	0.0	6.5	1.3	0.4	12.3	12.3	2.2	12.7	0.8	2.2	0.1	3.1	1.2	0.8	11.3	0.4	0.0	38.4	0.4	0.6	9.0	0.0	0.7	0.0	3.3	0.0	0.0	0.0	26.2	0.0	0.0	1.1	0.0	2.1	0.0	6.0	2.5	0.2	2.8	0.6	0.0	0.0	13.4	5.8	3.5	0.0	0.0	0.4	5.7	9.5	0.8	1.4	0.8	11.0	0.0	0.2	1.1	0.0	1.4	6.0	0.3	0.1	0.0	0.0	0.6	0.1	0.7	0.0	0.1	0.0	0.0	1.5	0.0	0.0	1.6	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.3	0.0	0.0	1.3	45.2	55.9	22.8	40.5	47.8	28.7	63.1	34.9	38.6	63.1
GPRC5D		ENSG00000111291	"G protein-coupled receptor class C group 5 member D"	Q9NZD1	12	12940775-12952147	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 18.4;skin 1: 33.9"	"Group enriched"	"Detected in some"	10	"Karpas-707: 36.6;RPMI-8226: 35.5;U-266/84: 10.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 2.1"	"Cell type enriched"	"Detected in some"	4	"memory B-cell: 18.4"	"Lineage enriched"	"Detected in many"	17	"B-cells: 18.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA071909	Approved									"HPA071909: "	"unprognostic (4.27e-2)"	"unprognostic (8.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.34e-2)"	"prognostic favourable (5.09e-4)"	"unprognostic (3.00e-5)"	"unprognostic (4.06e-2)"	"unprognostic (3.06e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.63e-2)"	1.0	0.5	0.4	3.1	0.4	0.3	4.2	0.4	0.4	0.8	3.8	0.4	0.4	2.4	1.0	0.4	3.7	0.3	1.5	0.7	0.4	0.2	0.8	0.7	4.4	5.9	0.4	0.4	0.4	2.9	0.0	1.0	0.9	2.1	0.9	3.4	0.7	8.6	0.4	0.4	33.9	3.8	0.4	0.4	5.1	3.3	3.7	0.4	0.4	1.3	5.2	4.1	1.3	0.7	18.4	0.1	1.0	0.0	0.0	0.2	1.9	0.5	0.6	0.0	0.6	0.0	0.0	1.4	0.1	0.0	0.0	0.1	0.5	1.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	36.6	0.1	1.2	0.0	0.0	0.3	0.0	0.0	0.0	35.5	0.0	1.4	1.1	0.2	0.8	0.6	0.0	0.0	0.0	1.0	0.0	1.7	0.0	0.0	1.9	10.0	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	18.4	0.1	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.4	0.4	0.4	0.4	0.4	0.2	0.4	0.4	2.1	0.4
GPRIN3	"FLJ42625, GRIN3"	ENSG00000185477	"GPRIN family member 3"	Q6ZVF9	4	89236386-89308010	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 46.0;RPMI-8226: 11.8;SCLC-21H: 12.3;U-266/70: 7.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 41.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"basal ganglia: 53.1"	"HPA043148, HPA057666, HPA059092"	Enhanced		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA043148: , HPA057666: , HPA059092: "	"unprognostic (9.05e-2)"	"unprognostic (4.92e-2)"	"prognostic favourable (7.22e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.13e-1)"	"prognostic favourable (8.33e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.93e-1)"	"unprognostic (7.82e-4)"	7.0	1.8	4.0	11.5	9.1	8.9	3.2	41.0	5.0	3.5	7.2	2.8	0.0	8.4	2.3	1.7	1.8	2.1	5.6	5.4	3.6	4.1	5.5	2.8	11.2	12.7	4.1	3.1	4.8	7.0	1.1	12.4	1.4	6.5	2.1	9.8	6.4	2.9	1.0	2.1	1.6	7.0	2.0	6.0	12.9	4.7	1.1	6.2	5.3	2.9	1.4	10.5	4.5	2.4	0.3	1.5	0.1	2.2	2.9	6.6	1.4	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	46.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	11.8	0.1	0.0	12.3	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.1	5.5	0.0	0.2	0.0	0.0	0.1	0.5	0.0	4.8	1.7	6.6	0.3	4.7	3.7	1.5	0.1	1.9	1.9	0.1	2.9	2.2	0.0	5.3	1.4	4.0	9.1	41.0	5.0	3.6	4.1	4.1	3.1	6.5	6.2
GREB1	KIAA0575	ENSG00000196208	"Growth regulation by estrogen in breast cancer 1"	Q4ZG55	2	11482341-11642788	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 74.9"	"Cell line enhanced"	"Detected in some"		"AF22: 14.8;Hep G2: 14.0;MCF7: 21.9;SH-SY5Y: 14.9;T-47d: 50.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 17.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA024616, HPA027843, HPA028416"	Uncertain		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA024616: AB_10599728, HPA027843: AB_10601103, HPA028416: AB_10601344"	"unprognostic (1.52e-2)"	"unprognostic (4.63e-1)"	"unprognostic (1.46e-1)"	"prognostic favourable (1.05e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.80e-2)"	1.2	2.0	3.0	0.6	5.0	0.5	11.1	1.3	5.4	13.7	0.5	2.8	3.0	0.7	21.3	15.6	0.6	11.2	1.8	2.3	3.9	3.0	1.3	1.5	0.6	0.6	3.9	3.5	74.9	2.9	0.6	5.0	9.4	3.8	19.2	0.5	2.8	0.7	2.4	2.1	1.2	0.6	7.3	3.2	0.4	0.8	10.9	3.2	0.0	0.5	0.5	0.5	0.8	5.7	0.8	1.0	2.8	0.6	1.0	1.3	0.4	0.0	0.3	14.8	0.1	0.1	0.1	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.1	0.0	0.1	1.1	0.0	0.0	1.7	1.3	0.0	0.1	14.0	0.1	0.1	0.7	0.2	0.8	0.2	0.1	0.0	0.1	0.3	0.1	21.9	0.4	0.7	4.8	0.0	10.2	0.0	0.6	0.0	0.0	4.3	14.9	0.3	0.4	10.9	50.6	0.2	0.0	1.5	0.7	0.1	0.0	2.2	1.5	8.6	2.5	4.2	0.4	2.6	0.6	0.8	0.7	0.3	0.3	0.5	0.5	0.4	0.4	0.8	0.5	1.3	2.8	1.0	0.5	1.0	0.5	0.4	3.0	5.0	1.3	5.4	3.9	3.0	3.9	3.5	3.8	3.2
GRIK4	"GluK4, GRIK, KA1"	ENSG00000149403	"Glutamate ionotropic receptor kainate type subunit 4"	Q16099	11	120511700-120988904	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 19.3;ovary: 8.5"	"Group enriched"	"Detected in some"	4	"HDLM-2: 6.2;HEL: 19.2;T-47d: 5.0"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA074453	Enhanced									"HPA074453: "	"unprognostic (9.63e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.64e-4)"	"unprognostic (1.48e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.84e-11)"	"unprognostic (1.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.58e-2)"	1.0	5.4	11.3	1.0	9.0	0.8	1.3	3.9	19.3	1.2	1.1	9.4	0.0	1.2	1.1	0.9	1.2	1.7	1.1	1.6	13.9	7.2	1.0	0.8	3.1	1.0	8.7	11.0	8.5	0.8	0.8	2.6	1.5	12.3	1.5	1.1	0.0	1.1	1.0	1.0	1.3	1.2	1.0	6.3	1.4	0.9	2.0	8.2	0.0	6.3	0.0	1.0	1.2	0.4	0.0	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	6.2	0.6	19.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	5.0	0.0	0.2	0.0	0.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	11.3	9.0	3.9	14.0	13.9	7.2	8.7	11.0	12.3	8.2
GRIK5	"GluK5, GRIK2, KA2"	ENSG00000105737	"Glutamate ionotropic receptor kainate type subunit 5"	Q16478	19	41998321-42069498	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.9"	"Cell line enhanced"	"Detected in some"		"HEL: 9.1;NTERA-2: 9.0;REH: 24.8;SCLC-21H: 7.1;SH-SY5Y: 15.8"	"Cancer enhanced"	"Detected in many"		"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"eosinophil: 1.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074001			Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA074001: "	"unprognostic (4.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.30e-3)"	"unprognostic (6.68e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.86e-1)"	"unprognostic (5.82e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.73e-2)"	"prognostic favourable (7.23e-4)"	"unprognostic (8.43e-2)"	"prognostic unfavourable (9.32e-4)"	"unprognostic (6.47e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.12e-2)"	1.7	5.4	9.6	2.3	12.2	3.4	2.4	17.2	23.9	2.7	6.9	4.9	1.3	1.2	3.8	2.7	2.4	4.5	2.6	5.6	21.7	8.9	3.8	0.3	0.6	2.6	5.0	5.3	5.3	3.5	17.8	9.1	0.3	5.5	4.5	1.6	5.8	0.7	8.9	1.0	1.1	1.4	6.7	7.6	1.8	2.7	13.6	3.5	1.0	10.3	0.3	1.0	2.2	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.2	9.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	9.0	0.0	24.8	0.0	0.1	4.1	0.0	7.1	15.8	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	1.0	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	12.2	17.2	12.7	21.7	8.9	5.0	5.3	5.5	3.5
GRINA	"HNRGW, LFG1, NMDARA1, TMBIM3"	ENSG00000178719	"Glutamate ionotropic receptor NMDA type subunit associated protein 1"	Q7Z429	8	143990058-143993415	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036980, HPA036981"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	Cytosol	"HPA036980: AB_10696791, HPA036981: AB_10962980"	"unprognostic (2.73e-3)"	"unprognostic (2.18e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.01e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.70e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.72e-2)"	76.4	48.8	46.6	52.3	61.0	89.0	70.2	73.8	85.8	37.1	28.4	34.5	37.1	35.6	33.1	42.1	30.5	41.4	37.5	35.2	54.2	45.1	61.7	143.7	49.7	67.4	47.4	51.5	46.1	32.0	66.8	29.3	42.4	46.5	42.6	17.7	49.3	44.4	99.4	32.8	37.4	33.5	38.0	43.3	82.0	23.2	52.2	24.3	24.3	54.7	19.2	26.8	43.2	31.3	4.5	12.4	10.2	19.3	1.6	2.6	6.4	12.6	24.8	12.7	21.5	67.7	34.2	18.8	18.1	42.9	30.9	28.6	15.0	10.6	9.1	20.0	40.8	11.4	22.6	26.8	12.7	12.9	15.5	9.4	14.4	17.8	71.7	1.9	15.2	44.0	74.2	22.4	32.7	14.9	8.8	12.8	26.5	76.4	5.3	5.1	8.9	37.5	7.2	6.4	17.5	15.8	35.9	8.6	14.0	26.4	29.7	35.2	57.1	12.5	15.0	19.6	21.5	26.1	13.1	20.8	11.9	6.8	24.8	12.5	11.1	0.9	16.6	4.6	1.4	19.3	2.0	4.5	1.4	1.6	7.1	4.3	2.6	2.3	10.2	1.6	18.0	12.4	1.2	6.4	46.6	61.0	73.8	85.8	54.2	45.1	47.4	51.5	46.5	24.3
GRM4	"GPRC1D, mGlu4, MGLUR4"	ENSG00000124493	"Glutamate metabotropic receptor 4"	Q14833	6	34018645-34155622	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"brain: 101.6"	"Group enriched"	"Detected in some"	8	"BEWO: 6.4;SCLC-21H: 25.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Region enriched"	"Detected in many"	21	"cerebellum: 101.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"cerebellum: 83.5"	"Region enriched"	"Detected in many"	4	"cerebellum: 252.6"	CAB022096	Enhanced									"CAB022096: "	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.56e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.15e-11)"	"unprognostic (5.32e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.07e-1)"	0.2	0.1	0.4	0.3	4.9	0.2	0.2	101.6	7.2	0.6	0.1	0.3	0.1	0.5	0.5	0.1	0.1	0.3	0.1	0.1	0.5	0.9	0.2	0.3	0.3	0.2	0.3	0.4	0.2	3.5	0.1	0.0	0.3	4.3	0.3	0.2	0.1	0.1	0.2	0.3	0.6	0.8	0.7	1.1	0.1	0.2	1.6	0.5	0.0	0.3	0.0	0.7	0.4	0.0	0.2	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	25.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	4.9	101.6	1.0	0.5	0.9	0.3	0.4	4.3	0.5
GRPR	"BB2, BB2R"	ENSG00000126010	"Gastrin releasing peptide receptor"	P30550	X	16123556-16153021	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 24.5"	"Group enriched"	"Detected in some"	10	"PC-3: 17.6;T-47d: 22.0;U-138 MG: 30.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 6.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.9;non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA069604			Supported	"Plasma membrane"				"Plasma membrane"		"HPA069604: "	"unprognostic (3.32e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.86e-2)"	0.5	0.4	3.4	4.7	2.3	0.2	3.5	0.3	3.5	3.7	1.4	0.0	2.5	0.2	1.0	2.8	7.5	0.3	0.2	0.5	3.5	0.4	0.3	0.3	0.4	0.2	0.3	1.9	0.3	24.5	0.4	0.3	0.2	1.1	0.7	0.6	2.0	0.4	0.4	0.4	0.3	0.5	1.2	0.4	0.3	2.1	0.4	0.0	0.0	0.4	0.0	0.2	0.4	0.4	0.6	0.2	0.4	1.9	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.5	0.0	2.3	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.2	17.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	22.0	0.0	0.1	30.1	0.3	0.0	0.9	0.1	0.1	0.1	0.0	0.0	0.4	0.0	1.1	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.4	0.0	1.6	0.1	0.0	0.4	3.4	2.3	0.3	3.5	3.5	0.4	0.3	1.9	1.1	0.0
GSC2	GSCL	ENSG00000063515	"Goosecoid homeobox 2"	O15499	22	19148576-19150283	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	12	"testis: 6.3"	"Cell line enriched"	"Detected in single"	8	"THP-1: 4.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043011	Uncertain									"HPA043011: AB_10959883"						"unprognostic (3.29e-1)"									"unprognostic (1.56e-1)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5										
GTDC1	"FLJ11753, Hmat-Xa"	ENSG00000121964	"Glycosyltransferase like domain containing 1"	Q4AE62	2	143938068-144332568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036694	Uncertain		Approved	Cytosol				Cytosol		"HPA036694: AB_10671709"	"unprognostic (1.44e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-7)"	"unprognostic (8.01e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-3)"	"unprognostic (6.96e-2)"	"prognostic unfavourable (6.60e-4)"	"unprognostic (2.44e-1)"	"unprognostic (8.23e-2)"	"unprognostic (6.31e-3)"	"unprognostic (1.89e-1)"	14.5	12.9	22.1	7.1	17.3	12.3	8.9	7.3	26.7	12.9	6.9	15.3	1.6	4.0	6.8	9.8	7.5	6.0	10.1	15.2	21.4	14.1	9.4	6.4	8.0	9.8	18.2	14.9	12.6	7.0	10.9	10.7	9.3	14.1	6.4	6.7	7.0	5.9	6.0	8.8	5.3	4.8	7.1	24.0	12.6	4.8	11.7	11.6	6.1	10.6	3.1	11.2	8.9	6.3	4.3	2.0	10.8	2.5	8.0	12.3	3.4	4.6	1.9	14.0	2.6	14.4	13.3	4.2	3.2	8.2	7.2	9.9	2.1	4.3	10.0	2.3	5.8	1.3	2.8	4.8	15.5	12.8	3.2	15.5	1.7	2.2	5.9	6.2	8.4	9.2	12.0	7.8	11.4	10.3	2.8	11.7	16.4	2.1	1.6	6.8	3.9	3.1	4.7	7.2	2.6	8.0	9.5	7.0	5.6	6.3	5.4	6.3	3.5	7.1	6.3	8.0	5.9	3.5	4.0	7.4	0.0	5.6	4.7	4.2	10.7	2.1	2.5	7.3	5.7	2.2	12.3	4.3	3.8	9.5	2.0	3.4	0.8	6.3	10.8	8.0	2.4	0.7	4.7	3.4	22.1	17.3	7.3	26.7	21.4	14.1	18.2	14.9	14.1	11.6
GTPBP8	HSPC135	ENSG00000163607	"GTP binding protein 8 (putative)"	Q8N3Z3	3	112990918-113015060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034831, HPA058631"	Approved		Enhanced	Mitochondria				Mitochondria		"HPA034831: AB_10671506, HPA058631: "	"unprognostic (1.98e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.21e-2)"	"prognostic favourable (3.07e-5)"	"unprognostic (7.10e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.69e-1)"	7.5	9.3	7.4	7.3	7.8	9.5	7.3	8.5	10.1	7.1	11.9	9.2	8.3	8.0	8.3	5.2	12.2	6.4	7.4	20.0	7.6	7.6	12.2	8.2	6.2	13.2	7.6	8.3	10.4	12.1	13.0	12.1	9.3	9.5	8.2	9.3	6.6	9.6	5.2	25.3	6.5	11.8	7.4	11.7	9.3	9.1	22.7	8.9	25.4	13.4	14.3	10.2	9.6	8.0	6.7	12.2	6.7	7.0	11.9	15.8	7.8	19.2	8.8	11.7	13.1	7.1	12.4	9.3	13.3	11.6	13.7	17.1	15.4	8.3	12.6	7.9	7.3	13.2	15.5	12.9	15.8	5.6	10.8	34.5	8.9	8.0	6.8	22.0	8.5	9.8	9.3	7.5	5.4	12.6	12.2	15.0	13.2	7.6	14.0	10.8	24.0	16.7	12.0	10.7	8.0	9.6	12.2	13.5	13.7	10.8	8.5	17.7	9.6	15.0	7.5	10.0	14.8	3.6	12.4	9.8	12.8	17.7	10.0	18.3	11.0	6.7	7.0	4.5	10.4	4.6	9.1	6.7	11.9	10.0	12.2	5.9	15.8	10.3	1.0	11.9	3.9	5.8	8.2	7.8	7.4	7.8	8.5	10.1	7.6	7.6	7.6	8.3	9.5	8.9
GTSF1L	"C20orf65, dJ1028D15.4, FAM112A"	ENSG00000124196	"Gametocyte specific factor 1 like"	Q9H1H1	20	43726164-43726998	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 104.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.3;EFO-21: 1.2;REH: 3.9;U-698: 4.3"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 7.5"	"Lineage enriched"	"Detected in many"	5	"T-cells: 7.5"	"Low region specificity"	"Detected in some"							HPA054694	Enhanced		Uncertain	Nucleoli				Nucleoli		"HPA054694: "	"unprognostic (2.61e-2)"	"unprognostic (4.24e-6)"		"unprognostic (9.96e-3)"		"unprognostic (1.30e-4)"		"unprognostic (3.50e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.06e-2)"		"unprognostic (2.45e-7)"	"unprognostic (1.19e-1)"	"unprognostic (9.54e-2)"		"unprognostic (6.07e-3)"	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	104.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	7.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.9	4.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.7	1.0	0.0	1.4	0.6	0.8	0.0	0.0	0.0	0.0	7.5	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0
GXYLT2	GLT8D4	ENSG00000172986	"Glucoside xylosyltransferase 2"	A0PJZ3	3	72888073-72998138	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 13.5;HSkMC: 12.9;MOLT-4: 23.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA068429	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Midbody ring"				Nucleoplasm	"Cytokinetic bridge, Midbody ring"	"HPA068429: "	"unprognostic (9.43e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (4.79e-3)"	"unprognostic (5.29e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.33e-2)"	"prognostic unfavourable (1.46e-7)"	"unprognostic (3.22e-3)"	"unprognostic (4.70e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavourable (2.42e-5)"	8.7	7.2	3.1	6.2	4.0	2.1	5.2	1.1	4.0	10.2	4.5	8.1	3.4	0.9	8.4	9.3	4.2	6.7	12.4	20.6	3.4	2.4	2.2	1.0	5.2	2.4	5.6	4.7	24.8	11.9	2.8	3.8	4.9	4.2	11.3	2.7	10.7	8.0	5.2	2.2	2.6	2.5	12.0	5.4	1.0	2.6	8.4	4.7	14.9	12.1	3.7	2.3	12.2	6.9	0.4	3.0	1.7	0.1	0.8	1.4	0.1	0.1	1.2	0.0	7.5	6.9	13.5	1.1	1.2	2.8	2.7	6.6	0.3	0.8	0.0	2.1	3.2	0.1	0.7	1.5	2.6	0.0	0.9	0.0	5.0	7.9	8.7	3.1	0.0	12.9	0.7	6.5	1.0	0.0	3.7	0.1	1.6	1.7	23.1	0.1	4.4	1.5	0.1	6.4	0.0	0.8	1.1	0.7	3.4	6.4	0.3	0.8	2.5	1.0	0.0	2.9	9.3	9.0	4.2	0.7	0.1	0.1	7.6	1.5	5.1	0.4	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.4	0.2	0.2	1.7	0.8	0.1	3.0	1.4	0.1	3.1	4.0	1.1	4.0	3.4	2.4	5.6	4.7	4.2	4.7
H1FNT	"H1T2, HANP1"	ENSG00000187166	"H1 histone family member N, testis specific"	Q75WM6	12	48328980-48330279	"Predicted intracellular proteins"	"Differentiation, DNA condensation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	57	"testis: 71.7"	"Group enriched"	"Detected in some"	7	"U-266/70: 4.9;U-266/84: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.2"					"Not detected"	"Not detected"			HPA046204	Approved									"HPA046204: "	"unprognostic (2.94e-1)"	"unprognostic (2.50e-1)"			"unprognostic (1.95e-1)"	"unprognostic (1.50e-3)"		"unprognostic (1.30e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-5)"	"unprognostic (1.91e-1)"	"unprognostic (7.68e-4)"	"unprognostic (3.41e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.79e-3)"	"unprognostic (9.84e-2)"	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	71.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	1.2	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H1FOO		ENSG00000178804	"H1 histone family member O oocyte specific"	Q8IZA3	3	129543214-129551467	"Predicted intracellular proteins"	Meiosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	80	"testis: 10.8"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.0;SCLC-21H: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA037992	Enhanced									"HPA037992: AB_10671517"															"unprognostic (5.43e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HAGHL	MGC2605	ENSG00000103253	"Hydroxyacylglutathione hydrolase like"	Q6PII5	16	726936-735525	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.7"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 29.4;U-266/70: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074402	Approved									"HPA074402: "	"unprognostic (6.74e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.56e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.52e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.83e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.77e-1)"	"prognostic favourable (1.18e-5)"	"unprognostic (1.92e-2)"	"unprognostic (5.36e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.41e-1)"	2.7	8.7	10.0	6.2	19.7	4.5	1.2	13.0	15.5	1.7	2.1	9.4	2.5	2.9	3.7	2.7	1.1	7.9	2.6	5.3	10.6	10.9	4.9	1.4	4.0	8.3	15.9	6.7	1.4	2.4	5.8	8.1	2.3	10.7	2.6	0.9	4.5	9.6	4.0	1.3	2.7	4.5	1.1	13.9	8.4	5.8	3.5	9.1	2.9	0.9	1.6	3.8	1.8	1.0	13.1	3.7	1.3	1.5	8.5	7.2	3.1	2.1	2.3	0.5	3.0	0.5	1.1	2.3	1.9	1.3	0.4	0.5	1.0	3.0	4.8	2.9	0.1	2.9	0.5	0.7	0.0	14.0	2.0	1.5	5.3	1.8	3.6	6.0	4.5	2.1	0.7	0.0	1.0	0.3	2.8	4.3	0.6	14.4	0.1	8.4	3.3	5.0	3.1	1.4	29.4	1.2	0.7	11.1	6.6	1.0	8.6	9.1	5.4	10.5	1.9	2.3	3.6	0.8	1.2	31.5	4.0	6.6	3.7	6.0	4.2	0.0	1.5	1.3	6.2	0.5	7.2	13.1	4.1	6.8	1.9	3.5	1.2	4.6	0.0	8.5	0.2	3.7	4.7	3.1	10.0	19.7	13.0	14.1	10.6	10.9	15.9	6.7	10.7	9.1
HAND1	"bHLHa27, eHand, Hxt, Thing1"	ENSG00000113196	"Heart and neural crest derivatives expressed 1"	O96004	5	154474972-154478264	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 25.9;intestine: 35.1;smooth muscle: 14.2"	"Cell line enriched"	"Detected in some"	7	"SH-SY5Y: 50.8"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 0.6;testis cancer: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040925	Approved		Uncertain	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	"Nuclear membrane"	"HPA040925: AB_10796563"			"unprognostic (2.37e-2)"					"unprognostic (8.29e-2)"		"unprognostic (2.46e-3)"	"unprognostic (7.23e-2)"				"unprognostic (5.21e-2)"		"unprognostic (6.38e-3)"	0.2	6.0	0.1	9.7	0.1	0.0	0.1	0.1	0.1	0.1	35.1	0.0	0.0	4.4	0.1	0.0	0.1	0.1	5.3	25.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	3.6	0.0	5.4	2.6	0.1	0.1	0.0	0.1	0.1	20.8	14.2	0.1	0.1	0.1	0.2	0.0	0.7	0.1	0.0	0.0	9.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	50.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
HAPLN1	CRTL1	ENSG00000145681	"Hyaluronan and proteoglycan link protein 1"	P10915	5	83637805-83721613	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 41.8"	"Group enriched"	"Detected in some"	37	"PC-3: 44.7;TIME: 28.2;U-2 OS: 46.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019105, HPA019482, HPA025238"	Enhanced	Approved	Supported	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA019105: AB_1850496, HPA019482: AB_1850498, HPA025238: "	"unprognostic (5.74e-4)"	"unprognostic (2.94e-2)"	"unprognostic (6.58e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.76e-3)"	"unprognostic (6.01e-4)"	"unprognostic (2.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-2)"	"prognostic unfavourable (4.81e-9)"	"unprognostic (6.87e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.91e-2)"	0.1	0.0	5.4	1.5	3.9	0.0	0.1	0.6	4.7	0.1	4.7	0.1	0.1	3.8	0.5	0.1	1.2	0.0	0.5	1.8	3.4	1.3	0.4	0.1	0.9	0.1	1.7	0.7	0.2	0.2	0.0	0.1	41.8	1.5	4.9	5.8	1.5	0.9	0.1	0.1	0.5	9.3	0.3	0.6	0.1	2.4	0.1	0.1	0.1	0.3	0.5	0.3	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	44.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.2	0.0	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.4	3.9	0.6	4.4	3.4	1.3	1.7	0.7	1.5	0.1
HAPLN2	BRAL1	ENSG00000132702	"Hyaluronan and proteoglycan link protein 2"	Q9GZV7	1	156619294-156625725	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	39	"brain: 108.1"	"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 1.1;U-266/70: 4.5;U-87 MG: 1.3"	"Cancer enriched"	"Detected in some"	10	"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045765	Enhanced				"Secreted in brain"					"HPA045765: AB_10964781"	"unprognostic (3.19e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.31e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-3)"	1.5	1.5	11.0	1.3	21.1	1.3	1.3	4.4	45.3	1.3	1.3	43.6	0.0	2.7	1.6	1.3	1.3	1.4	1.3	1.3	21.2	13.9	1.4	1.3	1.4	1.3	49.3	9.3	1.3	1.3	1.6	0.0	1.3	43.1	1.9	1.3	0.0	1.4	1.5	1.9	1.6	1.7	1.3	108.1	1.3	1.3	1.7	31.5	0.0	1.3	0.0	1.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	4.5	0.1	0.2	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	21.1	4.4	15.1	21.2	13.9	49.3	9.3	43.1	31.5
HAPLN3	"EXLD1, HsT19883"	ENSG00000140511	"Hyaluronan and proteoglycan link protein 3"	Q96S86	15	88877288-88895626	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.4;lymphoid tissue: 23.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.6;U-2 OS: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 25.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 25.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039237	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"			"Plasma membrane, Cytosol"		"HPA039237: AB_10805357"	"unprognostic (1.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.21e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.13e-3)"	"unprognostic (4.30e-1)"	"prognostic unfavourable (4.18e-13)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.12e-1)"	9.9	1.3	1.1	20.6	2.7	4.4	8.7	1.0	2.3	5.3	2.6	1.1	0.3	1.4	4.4	4.9	5.7	6.0	4.7	9.8	3.2	1.0	3.0	0.8	8.7	23.6	3.1	0.9	5.2	2.3	0.9	2.2	2.7	3.6	5.2	1.1	3.2	6.4	1.6	4.2	6.0	4.1	4.7	6.2	6.9	3.6	1.9	1.8	5.7	7.2	7.6	10.9	6.0	5.6	0.8	1.1	0.7	0.6	4.8	25.4	3.2	1.2	4.3	0.9	9.6	2.7	3.0	3.0	2.6	0.6	1.0	1.3	2.7	4.0	0.0	7.6	3.3	1.0	9.1	1.2	0.0	20.6	8.0	3.0	0.2	0.0	0.4	0.0	0.1	1.1	0.5	1.9	0.1	4.5	0.0	5.9	0.4	0.1	0.0	0.0	7.1	0.1	0.0	0.4	7.2	1.8	0.1	0.1	2.6	0.5	0.5	3.6	0.0	0.3	0.8	6.9	20.6	5.2	0.4	0.9	0.0	0.0	2.5	0.0	5.9	0.7	0.6	0.0	0.6	0.3	3.0	0.1	10.0	4.1	1.1	0.8	10.2	4.5	0.1	4.8	0.1	0.4	25.4	3.2	1.1	2.7	1.0	2.3	3.2	1.0	3.1	0.9	3.6	1.8
HAPLN4	"BRAL2, KIAA1926"	ENSG00000187664	"Hyaluronan and proteoglycan link protein 4"	Q86UW8	19	19255641-19262796	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 38.5;intestine: 24.3"	"Cell line enhanced"	"Detected in some"		"NB-4: 5.6;NTERA-2: 14.6;SCLC-21H: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055856	Enhanced				"Secreted in brain"					"HPA055856: "					"unprognostic (3.36e-4)"													0.5	1.9	3.0	0.4	7.5	0.4	0.7	8.9	38.5	2.4	0.6	1.6	0.0	19.6	1.6	0.5	0.4	0.7	0.6	0.5	8.9	9.4	0.5	7.5	0.6	0.4	7.8	2.7	1.4	1.3	0.4	0.2	0.7	26.4	1.1	0.6	0.4	0.5	0.8	0.4	0.4	24.3	0.6	3.8	0.4	0.8	0.5	0.0	0.0	0.4	0.0	0.4	0.5	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	5.6	14.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	7.5	8.9	38.5	8.9	9.4	7.8	2.7	26.4	0.0
HAS1	HAS	ENSG00000105509	"Hyaluronan synthase 1"	Q92839	19	51713112-51723994	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.7;lymphoid tissue: 13.7;ovary: 23.6"	"Cell line enriched"	"Detected in some"	4	"U-87 MG: 49.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"eosinophil: 5.9;neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067602	Approved		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA067602: "	"unprognostic (3.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.26e-4)"	"unprognostic (7.17e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.49e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.30e-11)"	"unprognostic (9.12e-4)"	"unprognostic (8.99e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.43e-2)"	23.7	0.5	0.6	13.7	1.3	2.8	1.0	1.5	1.9	0.6	1.2	0.4	1.1	0.1	0.8	2.5	1.3	5.8	5.5	5.9	1.4	2.0	0.3	0.6	4.5	0.3	0.6	0.3	23.6	2.2	0.0	0.3	0.3	0.6	0.4	0.5	1.0	0.3	1.2	2.1	2.7	4.0	3.6	0.9	0.7	0.7	0.9	0.3	0.3	0.3	0.8	0.3	1.8	0.3	0.1	0.1	5.9	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	11.7	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	49.8	0.0	0.1	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.6	1.3	1.5	1.7	1.4	2.0	0.6	0.3	0.6	0.3
HAS2		ENSG00000170961	"Hyaluronan synthase 2"	Q92819	8	121612116-121641390	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 22.8"	"Group enriched"	"Detected in some"	4	"HBF TERT88: 33.9;hTEC/SVTERT24-B: 32.6;LHCN-M2: 43.3;U-138 MG: 85.2;U-251 MG: 25.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052060			Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA052060: "	"unprognostic (7.01e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.57e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-7)"	"unprognostic (1.47e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.54e-3)"	22.8	0.9	1.6	9.1	2.4	0.0	5.5	0.8	1.7	4.0	8.5	2.0	0.0	2.6	1.5	2.5	4.8	3.9	7.7	8.3	1.7	1.7	1.2	2.7	6.5	4.5	1.8	0.6	1.2	1.8	0.3	0.7	2.1	5.7	4.3	5.6	2.7	1.9	0.1	2.7	3.8	9.5	3.7	4.2	0.3	2.3	3.2	2.6	0.4	1.7	5.5	2.1	5.7	1.4	0.0	0.2	0.7	0.2	0.3	0.1	0.0	0.0	0.5	0.0	0.0	1.0	2.5	0.0	4.8	3.6	6.3	11.0	0.0	0.0	0.0	0.0	4.3	0.8	0.0	0.0	33.9	0.0	0.1	0.0	0.1	0.0	4.3	0.0	0.0	6.7	0.0	32.6	3.0	0.0	0.0	0.0	43.3	0.0	0.0	0.0	0.0	0.7	0.0	5.6	0.0	0.0	0.4	0.0	0.1	2.0	0.0	1.1	0.0	0.0	0.0	85.2	0.3	7.9	25.2	0.0	0.0	0.0	1.8	0.0	1.7	0.5	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.7	0.3	0.2	0.2	0.1	0.0	1.6	2.4	0.8	1.7	1.7	1.7	1.8	0.6	5.7	2.6
HAS3		ENSG00000103044	"Hyaluronan synthase 3"	O00219	16	69105564-69118719	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 22.6;urinary bladder: 22.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 14.1;PC-3: 75.1;RT4: 29.7"	"Group enriched"	"Detected in many"	8	"cervical cancer: 17.1;head and neck cancer: 44.9;lung cancer: 23.3;urothelial cancer: 31.1"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031554, CAB033850"	Supported		Approved	Microtubules				Microtubules		"CAB033850: AB_2116418, HPA031554: AB_10670703"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.59e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (5.36e-4)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.40e-3)"	0.4	0.2	0.4	0.4	1.0	0.3	5.5	1.1	1.3	3.3	3.7	0.4	0.4	1.9	0.8	1.1	22.6	0.7	3.5	2.4	0.6	0.6	1.2	0.7	18.0	0.4	0.4	0.4	0.9	2.2	0.1	1.0	3.3	1.1	3.5	2.3	0.6	7.6	2.1	0.6	5.7	2.1	1.4	0.4	0.4	9.0	2.0	0.4	0.5	4.0	11.7	11.1	22.9	13.6	1.5	1.2	2.2	1.4	0.4	2.0	1.1	0.9	4.7	0.2	0.2	0.1	0.1	1.8	0.3	0.1	0.2	0.1	1.0	2.4	0.2	0.5	0.1	14.1	0.7	8.4	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	2.3	0.3	0.8	0.1	0.0	0.1	0.0	0.5	0.3	0.1	4.2	75.1	0.5	0.0	0.0	7.7	29.7	5.3	0.2	0.5	0.0	0.0	0.2	0.2	0.1	0.2	0.2	8.2	0.4	0.3	0.2	0.0	0.3	0.0	0.1	0.8	1.4	2.2	1.4	0.7	1.3	0.7	1.1	0.5	1.2	1.5	2.0	0.7	0.5	0.4	1.1	1.0	1.5	1.1	0.4	1.0	1.1	1.3	0.6	0.6	0.4	0.4	1.1	0.4
HDGFL1	"dJ309H15.1, Hdgfrp1, HRP-1, PWWP1"	ENSG00000112273	"HDGF like 1"	Q5TGJ6	6	22569493-22571666	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	296	"testis: 97.1"	"Cell line enriched"	"Detected in single"	8	"K-562: 4.9"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 21.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045679, HPA063707"	Enhanced									"HPA045679: AB_2679415, HPA063707: AB_2685099"						"unprognostic (1.55e-1)"									"unprognostic (6.18e-2)"		"unprognostic (4.03e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HEATR4	MGC48595	ENSG00000187105	"HEAT repeat containing 4"	Q86WZ0	14	73478484-73558947	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 14.0"	"Cell line enhanced"	"Detected in many"		"MCF7: 5.7;SCLC-21H: 5.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA003642	Enhanced									"HPA003642: AB_1079376"	"unprognostic (5.25e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.50e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.82e-3)"	0.3	0.3	0.7	0.7	1.1	0.8	0.4	3.4	1.1	0.7	0.3			2.0	1.0	0.1	0.5	0.7	0.7	0.7	0.9	0.8	0.3	0.9	0.4	1.6	0.5		1.0	0.8	0.5	0.5	0.1		0.5	0.0		0.8	0.0	2.0	4.4	0.7	0.0	0.8	0.9	0.7	14.0			1.0		0.0	0.2	0.7	3.0	1.0	1.7	0.7	1.4	2.3	0.4	1.6	1.8	0.8	1.3	0.1	0.0	0.6	0.7	0.0	0.1	0.3	0.5	0.4	1.8	0.1	0.0	3.5	0.0	0.0	0.2	0.4	0.4	1.3	0.3	0.1	0.3	1.1	2.3	0.0	0.0	0.2	0.0	0.0	0.6	0.7	0.0	5.7	0.4	2.0	0.8	1.7	1.0	0.9	0.7	0.0	2.5	5.7	0.7	1.9	2.5	2.9	3.0	0.2	1.0	0.2	2.2	1.8	0.2	1.4	0.4	0.4	1.2	0.4	0.2	1.0	0.7	0.3	1.8	0.5	1.0	2.1	2.2	1.2	0.3	3.0	2.3	2.3	1.7	1.4	0.1	1.0	1.1	0.4										
HECTD2	FLJ37306	ENSG00000165338	"HECT domain E3 ubiquitin protein ligase 2"	Q5U5R9	10	91409280-91514829	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 21.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"NK-cell: 6.7"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037767	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA037767: AB_10671378"	"unprognostic (6.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.37e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.44e-2)"	"prognostic unfavourable (1.67e-5)"	"unprognostic (6.98e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.84e-2)"	8.7	8.8	16.5	6.9	17.9	2.4	10.8	20.3	19.5	14.3	10.1	5.1	9.1	4.6	17.2	16.6	8.3	12.1	11.4	8.1	11.9	8.7	7.3	4.7	8.7	4.7	5.8	11.3	16.8	7.4	14.4	18.6	10.2	6.5	24.8	7.6	7.5	7.7	24.3	7.7	6.8	6.0	18.4	6.8	5.3	7.5	9.7	6.4	2.9	9.8	5.1	3.6	13.7	10.5	0.6	0.4	0.1	0.8	6.7	1.0	0.5	4.0	2.1	21.2	8.7	4.7	5.1	3.8	3.3	4.5	6.8	6.3	0.2	3.9	0.0	2.9	3.4	0.3	5.7	2.4	8.4	4.4	7.1	2.3	14.9	1.3	2.3	0.4	1.5	5.2	2.2	4.9	4.2	5.1	3.1	10.6	10.5	1.9	2.5	1.3	8.8	2.1	6.3	14.0	2.4	4.7	1.1	5.0	5.3	6.5	1.5	6.6	9.6	1.4	5.3	6.9	4.7	0.4	6.3	0.7	1.4	5.9	6.0	0.0	3.9	0.0	0.1	0.0	1.0	0.8	0.6	0.2	0.5	0.7	0.4	0.6	0.5	0.6	0.1	6.7	0.2	0.0	0.1	0.5	16.5	17.9	20.3	19.5	11.9	8.7	5.8	11.3	6.5	6.4
HELT	"bHLHb44, HCM1228, HESL, MEGANE, Mgn"	ENSG00000187821	"Helt bHLH transcription factor"	A6NFD8	4	185018841-185020804	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"kidney: 2.9;lung: 2.2;skin 1: 2.0"	"Group enriched"	"Detected in some"	8	"HAP1: 5.1;HEK 293: 3.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036188, HPA036189"	Uncertain									"HPA036188: AB_10672237, HPA036189: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	2.2	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.0	0.5	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HEPHL1	DKFZp686F22190	ENSG00000181333	"Hephaestin like 1"	Q6MZM0	11	94021361-94113751	"Predicted membrane proteins"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"tongue: 68.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;HaCaT: 4.1;HBEC3-KT: 7.3"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 20.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	21	"olfactory region: 1.4"	"Not detected"	"Not detected"			HPA031517	Uncertain						51000000			"HPA031517: AB_10603769"	"unprognostic (9.16e-2)"	"prognostic unfavourable (4.94e-4)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-6)"	"unprognostic (3.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.71e-2)"	"unprognostic (5.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.25e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	6.5	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	68.0	16.2	0.0	4.8	1.1	0.3	0.1	0.0	0.9	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	1.4	0.2	0.1	0.0	0.0	0.1	0.5	0.0	0.3	0.0	4.1	0.0	7.3	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.3	1.1	0.0	0.1	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HERC6	FLJ20637	ENSG00000138642	"HECT and RLD domain containing E3 ubiquitin protein ligase family member 6"	Q8IVU3	4	88378739-88443111	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 46.0;BJ hTERT+ SV40 Large T+ RasG12V: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035846	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA035846: AB_10673487"	"unprognostic (1.95e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.22e-2)"	"prognostic favourable (7.14e-5)"	"unprognostic (1.80e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.77e-2)"	8.0	7.5	7.8	7.2	10.2	7.3	6.3	2.1	14.6	13.6	6.3	5.9	3.4	5.4	13.2	9.6	23.9	10.4	11.2	9.8	7.7	8.4	10.4	5.0	8.3	4.6	7.3	15.8	9.8	6.3	5.2	8.4	7.1	8.5	9.1	6.5	7.2	28.4	5.7	2.9	4.3	7.1	8.5	5.6	8.0	7.3	3.9	5.3	9.0	5.9	7.6	7.8	7.2	13.8	3.6	2.7	4.5	6.4	5.6	13.4	4.2	2.5	1.7	0.1	0.3	0.1	1.5	0.5	0.3	8.6	46.0	34.3	0.1	3.2	0.0	0.6	0.8	0.9	4.2	2.2	3.0	5.2	0.8	2.4	1.4	0.2	1.5	4.2	1.6	2.1	0.5	3.5	0.1	1.3	0.0	0.5	1.0	1.5	1.9	1.3	0.6	0.8	1.3	0.0	0.1	3.1	3.1	0.1	1.1	3.2	1.0	5.1	1.9	0.7	0.4	0.6	0.8	0.1	0.8	0.1	0.0	0.0	2.1	0.9	2.1	4.4	3.1	4.5	6.7	3.1	13.4	3.6	9.4	6.5	2.7	2.7	7.5	5.1	1.9	5.6	6.4	0.3	11.8	4.2	7.8	10.2	2.1	14.6	7.7	8.4	7.3	15.8	8.5	5.3
HES2	bHLHb40	ENSG00000069812	"Hes family bHLH transcription factor 2"	Q9Y543	1	6412418-6424670	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 22.6;placenta: 60.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 10.7;HaCaT: 19.9;HBEC3-KT: 17.1;hTCEpi: 9.9;TIME: 29.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 4.9;neutrophil: 3.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039462	Uncertain									"HPA039462: AB_10673533"	"unprognostic (1.96e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.56e-4)"	"unprognostic (4.74e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.38e-1)"	"unprognostic (7.67e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.00e-2)"	0.8	0.0	0.2	0.7	0.2	0.2	0.7	0.2	0.3	6.7	6.0	0.2	0.2	0.1	0.4	0.4	22.6	2.5	0.2	0.2	0.2	0.0	1.0	0.4	3.8	0.2	0.2	0.2	0.5	0.2	0.2	0.4	60.9	0.3	1.2	4.6	0.5	2.9	0.6	0.2	14.5	0.9	0.2	0.2	0.2	0.0	1.8	0.2	0.7	0.2	8.6	6.0	0.3	11.9	0.6	0.6	4.9	0.4	0.5	0.6	0.2	0.9	0.3	0.0	0.1	0.2	0.0	10.7	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.9	0.1	19.9	0.5	17.1	0.0	0.0	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.0	9.9	0.0	0.4	5.2	0.1	0.2	0.0	1.5	0.0	0.8	0.0	7.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	1.0	5.6	0.2	0.7	0.3	29.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.9	0.4	0.6	0.5	0.3	0.3	0.4	0.5	0.4	0.1	0.6	0.4	0.6	3.9	0.5	0.3	0.6	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.3	0.2
HES4	bHLHb42	ENSG00000188290	"Hes family bHLH transcription factor 4"	Q9HCC6	1	998962-1000172	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	8	"HEK 293: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"eosinophil: 12.4"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 12.4"					"Low region specificity"	"Detected in all"			HPA062465			Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA062465: "	"unprognostic (6.23e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.07e-2)"	"prognostic favourable (3.85e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (2.99e-4)"	"unprognostic (6.25e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.77e-1)"	"unprognostic (7.76e-2)"	"prognostic unfavourable (6.27e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.08e-3)"	14.8	4.0	8.3	3.9	15.6	2.8	8.7	2.5	16.9	7.6	10.8	2.9	4.8	5.4	7.8	9.0	7.5	6.8	9.6	13.6	5.9	9.4	5.3	3.2	9.1	2.2	7.3	4.0	4.2	14.8	3.1	5.7	6.1	7.2	10.4	2.6	12.8	5.6	9.4	8.0	7.8	4.2	12.1	3.4	8.6	6.1	3.4	3.1	9.0	3.6	8.4	3.3	10.6	5.6	0.0	0.3	12.4	1.4	0.0	0.0	0.0	4.5	0.5	0.5	0.0	0.0	0.0	5.8	2.7	0.3	1.7	1.8	0.7	1.4	0.0	6.6	0.2	8.0	0.7	0.1	0.0	0.0	65.3	0.0	0.7	0.9	0.5	0.0	0.5	0.0	0.6	0.1	0.1	0.2	1.2	0.1	0.0	2.4	3.6	0.2	0.0	6.3	0.0	0.6	1.3	0.6	0.0	0.3	1.5	1.9	4.6	8.2	3.4	0.0	0.3	0.5	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	12.4	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	8.3	15.6	2.5	7.0	5.9	9.4	7.3	4.0	7.2	3.1
HES5	bHLHb38	ENSG00000197921	"Hes family bHLH transcription factor 5"	Q5TA89	1	2528745-2530245	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 16.7"	"Cell line enhanced"	"Detected in some"		"AF22: 2.6;HaCaT: 5.0;HAP1: 1.1;SCLC-21H: 1.0"	"Cancer enhanced"	"Detected in some"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA065458, HPA076164"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA065458: , HPA076164: "	"unprognostic (2.04e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.60e-4)"	"unprognostic (1.76e-4)"	"unprognostic (1.60e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.67e-1)"	"unprognostic (9.95e-4)"	"unprognostic (1.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.72e-1)"	1.1	0.9	11.1	1.1	12.7	1.4	2.8	3.5	16.7	1.0	1.9	1.2	0.4	1.2	1.9	2.7	1.6	1.1	1.2	2.3	9.7	11.2	1.0	1.0	1.4	1.1	4.1	15.8	1.0	0.9	1.0	2.4	2.2	1.6	1.3	1.4	6.3	1.2	1.1	1.6	6.2	1.2	0.9	0.9	1.0	1.2	2.0	1.9	0.0	1.1	1.9	1.4	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	5.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	12.7	3.5	16.7	9.7	11.2	4.1	15.8	1.6	1.9
HES6	bHLHb41	ENSG00000144485	"Hes family bHLH transcription factor 6"	Q96HZ4	2	238238267-238240662	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 47.4"	"Cell line enhanced"	"Detected in many"		"NB-4: 50.4;SCLC-21H: 33.4;SK-MEL-30: 48.2;U-937: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"eosinophil: 8.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061763			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"				"Nucleoli, Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA061763: "	"unprognostic (1.35e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.40e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (2.79e-4)"	"prognostic favourable (9.18e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.35e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.13e-2)"	"unprognostic (8.50e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.49e-2)"	2.1	5.2	15.4	3.4	10.6	10.5	3.0	7.3	47.4	3.7	12.2	17.1	0.8	18.1	6.3	1.5	1.6	14.3	5.7	1.7	17.5	9.1	1.9	2.5	2.2	3.3	11.4	12.3	1.3	13.9	5.3	23.6	1.7	14.3	2.0	9.6	1.5	3.8	1.7	8.2	1.7	12.9	3.3	18.8	4.6	5.2	9.4	11.7	0.4	5.5	1.7	2.8	1.3	1.0	0.3	1.4	8.0	0.3	0.1	1.0	0.2	1.2	1.4	6.4	7.2	0.4	0.2	4.1	0.4	0.4	0.6	0.9	1.1	0.8	0.0	1.0	0.1	0.8	6.5	0.4	0.2	2.8	7.8	1.4	1.0	13.1	1.0	10.5	8.8	0.6	4.0	0.9	1.3	0.4	13.3	0.1	0.4	3.2	1.6	50.4	10.2	1.1	7.1	16.2	3.0	0.8	0.6	33.4	14.6	1.9	2.9	48.2	2.5	22.4	0.6	0.6	1.3	3.5	3.7	3.0	0.5	2.2	2.2	25.7	1.1	0.1	0.3	8.0	1.0	0.2	0.0	0.2	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.1	0.3	1.4	0.7	0.2	15.4	10.6	7.3	39.3	17.5	9.1	11.4	12.3	14.3	11.7
HEXDC	FLJ23825	ENSG00000169660	"Hexosaminidase D"	Q8WVB3	17	82418318-82442645	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 72.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 30.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022834, HPA023379, HPA027844"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"				"Nucleoli fibrillar center, Mitochondria"		"HPA022834: AB_1850641, HPA023379: AB_1850643, HPA027844: AB_10600711"	"unprognostic (8.69e-3)"	"prognostic favourable (7.70e-4)"	"unprognostic (7.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.51e-2)"	"prognostic favourable (2.71e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.14e-2)"	"prognostic favourable (5.57e-4)"	"unprognostic (9.04e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (2.52e-5)"	12.7	8.5	7.1	16.6	9.3	14.3	8.7	13.2	7.3	10.1	7.6	8.8	12.8	8.0	10.0	11.1	7.9	10.3	9.4	5.7	7.2	4.6	9.9	11.6	12.4	11.6	12.8	5.5	13.6	72.9	10.2	14.6	5.7	7.4	14.1	4.2	7.0	13.3	9.2	20.4	11.3	12.3	6.0	6.1	15.6	8.8	4.7	11.4	8.6	11.7	8.6	10.7	8.3	8.8	5.9	30.3	3.3	11.5	11.9	9.8	4.4	3.0	7.6	3.4	5.2	10.2	8.9	10.4	3.8	4.7	4.1	4.6	2.6	10.3	7.9	4.2	1.6	4.2	2.0	2.3	1.9	5.5	12.9	3.6	6.7	4.5	9.2	2.4	9.2	6.3	2.3	1.1	4.1	5.2	4.5	2.7	1.1	6.9	8.3	8.9	3.1	4.6	9.8	2.8	15.5	3.1	4.5	4.7	10.1	8.0	5.2	7.2	8.4	9.1	5.2	2.6	5.0	2.0	2.6	12.5	2.3	5.9	2.1	6.8	2.7	3.3	1.7	2.7	9.8	11.5	6.5	4.6	2.2	3.4	2.0	5.9	3.5	5.1	3.0	11.9	4.9	30.3	1.4	4.4	7.1	9.3	13.2	7.3	7.2	4.6	12.8	5.5	7.4	11.4
HHATL	"C3orf3, GUP1, KIAA1173, MBOAT3, MSTP002, OACT3"	ENSG00000010282	"Hedgehog acyltransferase like"	Q9HCP6	3	42692663-42702827	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"brain: 57.1;heart muscle: 184.7;skeletal muscle: 93.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.1;HSkMC: 1.3;Karpas-707: 1.1;NTERA-2: 1.4;RPMI-8226: 4.1;THP-1: 1.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 25.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018174	Enhanced									"HPA018174: AB_2116671"	"unprognostic (1.72e-2)"	"unprognostic (1.56e-1)"		"unprognostic (5.20e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.94e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.14e-1)"	1.5	1.6	12.9	1.3	29.0	1.3	1.9	2.3	15.2	1.5	1.4	36.5	0.0	1.3	1.7	1.5	2.7	2.0	1.5	184.7	14.5	8.9	1.4	1.3	1.5	1.4	51.6	10.5	1.4	1.8	1.4	0.9	1.4	25.9	1.9	1.4	5.4	4.7	1.4	93.6	1.6	1.4	1.4	57.1	1.4	1.3	1.7	39.9	0.0	9.3	7.2	1.4	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.3	0.0	1.4	0.0	0.5	0.0	4.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.5	0.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	29.0	2.3	15.2	14.5	8.9	51.6	10.5	25.9	39.9
HIST1H1T	"H1FT, H1t"	ENSG00000187475	"Histone cluster 1 H1 family member t"	P22492	6	26107419-26108136	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	59	"testis: 257.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.8;SiHa: 3.9;U-266/84: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	44	"neutrophil: 4.3"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 4.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"olfactory region: 5.1"	"HPA065718, HPA068266"	Enhanced									"HPA065718: AB_2685543, HPA068266: AB_2685967"	"unprognostic (1.06e-2)"	"unprognostic (1.80e-2)"		"unprognostic (9.52e-2)"		"unprognostic (9.94e-2)"		"unprognostic (5.12e-1)"		"unprognostic (1.57e-1)"	"unprognostic (7.48e-3)"	"unprognostic (6.51e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-1)"		"unprognostic (6.28e-3)"	0.0	0.0	0.2	0.8	0.3	0.4	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.0	0.0	0.3	0.1	0.1	0.6	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.2	0.2	0.0	257.2	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.3	0.0	1.8	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	3.9	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	1.7	0.2	0.3	0.0	0.2	0.3	0.1	0.2	0.0	0.0	0.0
HIVEP3	"FLJ16752, KBP-1, KBP1, KIAA1555, KRC, Schnurri-3, SHN3, ZAS3, ZNF40C"	ENSG00000127124	"Human immunodeficiency virus type I enhancer binding protein 3"	Q5T1R4	1	41506365-42035925	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.3;lymphoid tissue: 16.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.5;hTEC/SVTERT24-B: 9.1;Karpas-707: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005728	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA005728: AB_10612117"	"unprognostic (2.87e-3)"	"unprognostic (2.38e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.70e-3)"	"unprognostic (3.73e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.07e-8)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.21e-1)"	4.2	1.5	7.5	5.4	5.7	3.8	3.6	20.3	11.7	1.2	1.4	5.1	0.0	1.2	1.1	1.1	3.2	1.3	2.0	2.1	6.1	3.0	1.4	1.2	4.6	4.1	4.8	4.7	1.6	2.4	2.3	8.3	1.8	6.5	2.2	1.5	0.5	3.7	1.1	1.6	11.7	1.3	2.2	5.0	2.9	1.9	1.4	5.1	16.6	2.9	1.8	5.4	1.9	1.6	1.0	1.5	0.1	3.7	0.2	2.1	1.1	1.8	0.6	0.2	1.7	2.2	1.0	0.0	0.9	0.2	2.3	4.0	0.1	0.3	3.8	0.6	0.9	2.5	0.4	0.4	3.0	17.5	0.5	0.2	0.8	0.0	0.4	0.3	0.3	5.5	0.4	9.1	1.0	0.5	0.0	10.6	1.7	1.1	2.8	0.7	0.5	2.2	1.8	2.7	2.0	1.4	0.3	2.0	0.6	2.5	0.6	0.5	0.8	3.2	3.2	2.0	2.1	0.6	4.3	3.2	1.3	2.5	7.9	0.2	7.1	0.1	1.7	0.0	2.1	3.7	0.5	0.6	0.9	1.0	1.5	1.0	0.2	0.8	0.1	0.2	3.1	0.3	0.3	1.1	7.5	5.7	20.3	11.7	6.1	3.0	4.8	4.7	6.5	5.1
HKR1	ZNF875	ENSG00000181666	"HKR1, GLI-Kruppel zinc finger family member"	P10072	19	37312837-37369365	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA036126, HPA044855"	Approved		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA036126: AB_10670708, HPA044855: "	"unprognostic (1.04e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.92e-3)"	"unprognostic (9.82e-2)"	"prognostic favourable (4.41e-4)"	"prognostic unfavourable (5.18e-5)"	"unprognostic (1.34e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-3)"	13.0	25.8	14.6	13.2	22.4	12.6	24.9	29.8	27.2	20.5	14.5	22.9	21.5	7.7	24.8	24.1	12.4	22.9	17.9	26.9	14.6	15.6	19.3	12.3	12.9	14.3	14.9	17.4	22.6	14.2	31.0	35.5	17.2	21.2	27.5	13.8	49.4	18.7	19.3	18.1	27.1	13.4	17.0	13.3	20.2	14.2	22.6	15.5	16.4	30.9	13.7	20.1	15.0	15.6	12.4	7.9	10.0	5.1	9.9	14.8	5.7	4.1	10.4	13.4	17.8	9.8	8.6	9.4	7.0	10.6	13.0	14.1	5.2	4.9	14.5	17.0	7.3	3.4	8.8	9.3	13.5	7.6	15.0	5.1	12.6	5.5	12.9	4.7	12.4	12.7	11.6	8.8	19.3	7.9	0.9	0.9	9.4	8.4	10.4	9.3	27.0	5.9	7.1	5.9	5.6	11.4	16.7	16.7	22.8	7.0	8.9	8.8	12.8	9.0	7.1	10.3	7.5	7.8	10.8	18.7	19.7	15.0	1.1	5.8	11.6	10.0	4.2	6.6	8.0	5.1	14.8	10.7	10.6	11.4	6.3	12.4	14.4	12.0	4.0	9.9	3.6	7.9	12.2	5.7	14.6	22.4	29.8	27.2	14.6	15.6	14.9	17.4	21.2	15.5
HLF	MGC33822	ENSG00000108924	"HLF, PAR bZIP transcription factor"	Q16534	17	55265012-55325065	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"liver: 78.8"	"Cell line enriched"	"Detected in some"	6	"Hep G2: 58.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory CD4 T-cell: 2.4;T-reg: 2.1"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068156, HPA071210"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA068156: , HPA071210: "	"unprognostic (1.24e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"prognostic favourable (1.88e-4)"	"unprognostic (5.30e-3)"	"prognostic favourable (2.71e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.19e-1)"	"prognostic favourable (3.55e-6)"	"unprognostic (8.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.60e-2)"	9.5	15.2	13.3	2.0	26.2	1.0	10.8	15.2	38.0	10.5	10.6	6.4	2.4	1.7	10.3	8.5	18.1	9.3	6.1	15.9	12.6	6.9	9.2	78.8	9.5	2.1	6.6	24.5	34.6	2.7	2.8	8.0	1.5	12.3	9.9	3.1	23.7	15.9	9.5	5.3	11.6	3.0	14.3	5.5	5.7	4.7	3.4	6.3	0.0	23.4	7.1	5.6	9.2	5.2	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	9.7	0.2	0.0	0.0	58.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.9	0.0	0.1	0.1	4.8	0.0	4.1	0.2	0.0	2.6	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	1.9	1.7	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.1	13.3	26.2	15.2	38.0	12.6	6.9	6.6	24.5	12.3	6.3
HMCN2	"DKFZp434P0216, FLJ23816"	ENSG00000148357	"Hemicentin 2"	Q8NDA2	9	130265882-130434123	"Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.1;RH-30: 18.7;SH-SY5Y: 4.4;U-138 MG: 3.1;U-87 MG: 4.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053903, HPA070647"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"		7700000	Vesicles		"HPA053903: , HPA070647: "	"unprognostic (1.61e-1)"	"unprognostic (8.05e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.53e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.78e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.97e-4)"	"unprognostic (3.36e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.96e-3)"	"unprognostic (8.63e-2)"	7.4	1.7	0.2	10.2	0.2	0.1	3.8	0.1	0.4	18.3	25.0	0.0	1.0	5.9	21.9	25.1	4.9	5.1	5.0	8.7	0.4	0.4	1.4	0.4	2.7	2.3	0.0	0.0	8.9	0.8	0.2	0.1	0.3	0.8	5.1	2.3	0.1	1.7	3.4	24.3	2.8	11.2	20.8	0.5	0.3	2.3	6.3	0.0	1.8	2.6	10.9	1.5	12.1	7.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.5	0.0	18.7	0.1	0.0	0.1	2.8	4.4	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.4	0.4	0.4	0.0	0.0	0.8	0.0
HMGXB3	"HMGX3, KIAA0194, SMF"	ENSG00000113716	"HMG-box containing 3"	Q12766	5	150000046-150053142	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"parathyroid gland: 151.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005967			Approved	Nucleoli				Nucleoli		"HPA005967: AB_1080044"	"unprognostic (3.66e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavourable (3.37e-5)"	"unprognostic (9.72e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.89e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-2)"	12.0	14.2	8.2	14.5	14.4	15.3	16.1	14.5	17.4	11.3	10.3	15.0	15.4	8.3	13.9	20.0	9.3	13.5	12.1	9.4	8.6	8.3	11.6	11.7	14.7	10.3	10.1	11.0	15.0	13.8	151.8	15.3	11.8	12.9	17.6	10.8	16.8	12.4	18.4	12.5	13.1	9.9	12.8	8.9	14.4	12.0	17.7	7.3	15.3	14.7	10.1	12.0	11.2	10.1	5.8	6.2	5.1	5.9	2.2	8.1	3.7	12.2	14.4	10.2	16.1	14.7	12.5	17.8	11.9	22.0	17.9	22.6	20.2	15.0	11.7	14.0	16.2	9.1	19.4	20.4	15.5	10.9	13.9	10.3	15.2	9.8	20.4	19.6	23.4	16.3	15.3	26.2	20.7	12.7	13.4	12.3	18.8	9.7	12.2	10.2	7.7	21.7	10.6	14.2	11.3	10.7	15.4	13.2	13.3	10.4	25.5	26.4	11.9	12.8	10.9	26.8	11.4	12.9	21.9	14.6	13.7	16.7	31.3	15.1	13.8	5.1	4.7	4.0	7.0	5.9	5.5	5.8	5.7	4.9	6.2	5.0	4.4	4.6	0.5	2.2	3.9	4.6	8.1	3.7	8.2	14.4	14.5	17.4	8.6	8.3	10.1	11.0	12.9	7.3
HMX2	NKX5-2	ENSG00000188816	"H6 family homeobox 2"	A2RU54	10	123148122-123150672	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 2.0;brain: 5.1;kidney: 5.5"	"Cell line enriched"	"Detected in some"	13	"REH: 28.3"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 0.9"	"Group enriched"	"Detected in some"	41	"hypothalamus: 5.1;pons and medulla: 3.0"	"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.0"	"Region enhanced"	"Detected in single"		"hypothalamus: 0.6"	"Group enriched"	"Detected in some"	4	"basal ganglia: 1.1;hypothalamus: 4.0"	"CAB013268, CAB022752"	Approved									"CAB013268: , CAB022752: "	"unprognostic (3.98e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.18e-2)"		"unprognostic (2.73e-2)"		"unprognostic (7.64e-2)"	"unprognostic (3.29e-1)"		"unprognostic (2.10e-3)"	"unprognostic (5.29e-1)"		"unprognostic (5.01e-2)"			"unprognostic (2.25e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.1	1.2	0.0	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.3	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	3.0	0.0
HORMAD1	"CT46, DKFZP434A1315"	ENSG00000143452	"HORMA domain containing 1"	Q86X24	1	150698060-150720888	"Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"testis: 78.1"	"Cell line enhanced"	"Detected in some"		"A549: 5.6;HeLa: 4.4;hTCEpi: 19.3;SiHa: 5.9;THP-1: 11.1;U-2 OS: 3.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 1.2;neutrophil: 4.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.4;monocytes: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028346, HPA037850"	Enhanced		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA028346: , HPA037850: AB_10696358"	"unprognostic (7.21e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.79e-9)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-2)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	1.8	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	3.2	0.1	0.1	0.1	0.4	0.0	78.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.6	4.4	1.2	0.0	0.2	0.1	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.1	4.4	0.0	0.0	0.0	0.1	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.0	0.1	0.0	11.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	1.2	0.3	0.2	0.4	0.0	0.2	0.1	0.0	0.6	0.1	0.0	0.0	4.4	0.0	0.5	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
HOXA11	"HOX1, HOX1I"	ENSG00000005073	"Homeobox A11"	P31270	7	27181510-27185223	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 35.7;endometrium 1: 60.9;smooth muscle: 27.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.5;HEK 293: 24.6;THP-1: 17.6;U-937: 22.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006770, HPA035623"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA006770: , HPA035623: AB_10601576"	"unprognostic (5.95e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.29e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.82e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavourable (2.57e-5)"	"unprognostic (2.17e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.56e-1)"	1.5	0.4	0.0	1.7	0.0	0.0	2.0	0.0	0.0	35.7	9.3	0.0	5.7	0.0	60.9	8.8	0.0	0.7	0.0	0.2	0.0	0.0	3.6	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	9.0	0.0	16.5	2.4	0.0	0.1	6.3	4.9	0.7	0.2	27.3	0.0	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	20.1	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.1	0.0	6.7	8.2	5.8	0.0	14.5	17.5	10.3	7.4	0.1	0.8	0.0	3.3	12.2	1.6	8.6	0.0	7.5	0.8	24.6	3.0	6.0	0.3	0.5	6.1	0.8	3.7	0.3	0.0	0.0	7.4	0.1	0.0	1.1	0.1	0.0	4.7	0.0	7.2	0.3	0.0	0.1	4.9	4.2	3.2	0.0	3.5	0.0	1.0	0.6	17.6	0.0	0.1	7.1	1.6	0.7	0.0	0.0	0.0	0.1	22.9	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HOXA4	"HOX1, HOX1D"	ENSG00000197576	"Homeobox A4"	Q00056	7	27128507-27130799	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 18.7;HEK 293: 14.3;REH: 13.1;WM-115: 18.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	18	"pons and medulla: 26.7"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	47	"pons and medulla: 11.9"	"Region enriched"	"Detected in single"	60	"pons and medulla: 24.6"	HPA060088	Approved		Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA060088: "	"unprognostic (3.37e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (6.37e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.59e-4)"	"unprognostic (3.93e-2)"	8.9	6.2	0.4	2.2	0.3	0.2	11.6	0.3	1.2	2.7	7.5	0.4	8.2	3.5	3.9	10.3	27.5	18.1	5.7	4.8	0.3	0.0	9.6	2.0	10.5	3.0	1.4	0.3	8.8	1.1	17.6	0.3	0.5	26.7	4.1	1.7	0.3	0.7	5.6	29.8	3.5	5.2	4.9	25.8	5.5	9.3	1.6	0.4	0.3	2.3	3.4	1.2	5.5	10.9	0.9	1.4	0.1	0.5	0.1	0.3	0.2	5.8	2.0	0.0	18.7	0.0	0.0	1.2	0.5	0.6	1.9	2.0	3.7	1.2	1.5	0.1	1.8	2.5	0.7	0.3	1.5	0.0	14.3	0.0	0.6	8.5	2.2	2.0	3.5	2.1	1.6	6.6	0.5	6.6	0.0	0.0	6.4	1.6	0.0	7.0	0.0	4.6	13.1	2.9	0.1	9.4	1.4	0.9	0.0	1.8	0.0	6.9	0.4	1.0	8.6	0.0	3.0	4.9	0.1	0.0	0.0	0.7	4.0	3.2	18.7	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.2	0.2	0.2	0.0	0.3	0.0	0.0	0.1	0.5	1.4	0.0	0.2	0.4	0.3	0.3	1.2	0.3	0.0	1.4	0.3	26.7	0.4
HOXA6	"HOX1, HOX1B"	ENSG00000106006	"Homeobox A6"	P31267	7	27145396-27150603	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 10.4"	"Group enriched"	"Detected in some"	9	"AN3-CA: 28.6;HEK 293: 39.0"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	8	"basophil: 5.9;NK-cell: 2.0"	"Group enriched"	"Detected in many"	8	"granulocytes: 5.9;NK-cells: 2.0"	"Region enriched"	"Detected in single"	34	"pons and medulla: 3.5"					"HPA004203, HPA077900"	Approved		Supported	"Nucleoplasm,Nuclear speckles"				Nucleoplasm	"Nuclear speckles"	"HPA004203: AB_1079079, HPA077900: "	"unprognostic (1.70e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.06e-2)"		"unprognostic (9.73e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.17e-1)"	"prognostic favourable (2.03e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.81e-2)"		"unprognostic (3.93e-1)"	3.2	2.9	0.0	1.2	0.0	0.0	2.3	0.0	0.0	1.6	5.4			0.0	6.7	4.6	0.1	10.4	0.0	0.0	0.0	0.0	5.9	0.0	2.3	0.8	0.0		0.0	0.0	0.5	0.0	0.0		2.5	1.5		0.0	2.2	1.0	3.2	4.2	1.4	1.0	0.0	1.2	0.0			0.0		0.0	4.3	1.3	0.1	0.5	5.9	0.1	2.0	0.2	0.0	0.5	0.9	0.0	28.6	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.6	3.3	0.6	1.0	0.2	1.3	0.7	0.0	0.0	0.8	39.0	0.4	0.5	0.3	0.0	0.6	1.0	2.3	0.0	0.0	0.3	1.3	0.2	0.0	0.3	0.3	0.0	0.1	0.0	1.0	3.7	0.0	0.0	2.8	1.8	3.0	0.0	1.3	0.1	0.6	0.3	0.3	0.0	0.0	0.4	1.5	1.0	0.0	0.0	0.6	0.0	2.8	2.8	5.9	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.0	0.0	0.5	0.2	0.0										
HOXB3	"HOX2, HOX2G"	ENSG00000120093	"Homeobox B3"	P14651	17	48548870-48604912	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 56.7;epididymis: 44.9;seminal vesicle: 68.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 20.2;EFO-21: 17.7;HEK 293: 21.4;RPTEC TERT1: 16.6;U-251 MG: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	40	"pons and medulla: 9.3"	"Region enriched"	"Detected in single"	29	"pons and medulla: 12.9"	"CAB009860, HPA064990"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB009860: AB_2119262, HPA064990: "	"unprognostic (5.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.14e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.60e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.32e-1)"	"prognostic favourable (8.45e-6)"	8.3	4.5	1.0	7.3	1.1	0.2	8.0	1.0	1.0	11.3	16.4	1.0	56.7	2.3	10.1	44.9	5.5	17.7	3.6	1.7	1.0	0.0	16.3	1.6	4.8	1.6	1.0	1.0	2.8	1.7	6.7	1.0	3.8	2.6	4.1	4.9	1.0	1.0	68.4	4.0	2.9	11.3	3.5	4.8	6.5	7.8	3.7	1.0	1.0	1.8	1.0	1.1	6.4	5.2	0.1	2.8	1.7	0.9	1.4	1.1	0.4	3.2	6.8	4.6	2.1	3.8	5.4	1.2	0.1	0.0	0.1	0.1	3.2	20.2	1.6	17.7	14.5	0.1	0.9	0.3	0.0	5.2	21.4	5.0	3.0	0.0	6.3	0.0	13.3	6.2	0.0	6.0	0.4	6.3	6.8	0.1	3.7	0.1	0.3	0.1	0.1	0.7	0.0	3.3	0.6	16.6	3.0	0.0	0.0	0.7	0.0	3.3	6.5	1.4	7.0	2.2	7.0	1.2	19.1	1.7	2.0	0.1	4.5	0.0	3.7	1.7	0.1	0.0	0.9	0.1	0.4	0.0	0.5	1.1	0.3	0.1	0.8	1.0	0.0	1.4	0.9	2.8	1.1	0.4	1.0	1.1	1.0	1.0	1.0	0.0	1.0	1.0	2.6	1.0
HOXB8	"HOX2, HOX2D"	ENSG00000120068	"Homeobox B8"	P17481	17	48611377-48614939	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 49.3;ductus deferens: 45.4;epididymis: 39.2;kidney: 16.1;seminal vesicle: 34.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 20.6;HDLM-2: 9.2;HEK 293: 21.2;LHCN-M2: 10.8;RPTEC TERT1: 22.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 33.3"	"Region enriched"	"Detected in single"	82	"pons and medulla: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	48	"pons and medulla: 6.8"	"Low region specificity"	"Detected in many"			HPA075905			Supported	Nucleoplasm				Nucleoplasm		"HPA075905: "	"unprognostic (4.44e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.07e-5)"	"unprognostic (6.63e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.00e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.14e-2)"	"prognostic favourable (1.30e-7)"	"unprognostic (1.77e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.88e-3)"	3.5	4.3	0.0	1.6	0.0	0.0	2.5	0.0	0.0	7.7	2.1	0.0	45.4	0.0	2.1	39.2	0.0	0.9	0.0	0.0	0.0	0.0	16.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.4	0.2	0.2	8.2	1.9	0.8	0.0	0.1	34.6	0.2	0.4	4.0	1.1	49.3	0.0	4.3	2.8	0.0	0.1	0.1	0.0	0.0	5.0	6.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.1	3.2	0.0	0.4	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.0	20.6	3.2	0.0	0.0	0.0	0.0	9.2	21.2	0.5	0.0	0.0	0.2	0.0	3.1	0.6	0.0	0.0	0.0	1.3	6.1	0.0	10.8	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	22.5	0.5	0.0	0.0	0.3	0.0	3.0	0.2	0.0	5.1	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0
HOXC6	"HOX3, HOX3C"	ENSG00000197757	"Homeobox C6"	P09630	12	53990624-54030823	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 31.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 37.3;fHDF/TERT166: 18.6;HDLM-2: 31.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	17	"pons and medulla: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	23	"pons and medulla: 1.5"	"Not detected"	"Not detected"			HPA054981			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA054981: "	"unprognostic (3.54e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.68e-6)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-3)"	"unprognostic (5.01e-4)"	"unprognostic (5.52e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.81e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavourable (3.55e-6)"	"unprognostic (8.63e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.71e-2)"	10.9	11.2	0.4	1.2	0.4	0.0	16.3	0.4	0.4	0.7	1.9	0.6	0.4	0.0	3.9	14.8	3.1	13.5	0.4	2.0	0.4	0.0	11.3	0.4	0.9	3.0	0.4	0.4	31.2	0.4	0.0	0.4	4.0	7.0	0.8	0.0	0.4	0.4	0.4	11.0	7.6	8.8	6.1	8.1	1.0	0.3	3.3	0.4	0.4	0.6	0.8	0.4	0.7	2.5	0.0	0.0	0.1	0.0	0.0	0.5	0.0	2.4	1.7	0.0	37.3	13.7	13.0	0.3	1.9	1.9	3.1	2.8	1.5	2.8	1.1	2.5	18.6	4.2	1.4	0.2	2.8	31.2	10.8	1.9	4.8	0.0	1.5	0.2	4.7	12.3	2.0	6.1	2.2	0.1	1.3	0.0	10.8	0.5	0.0	1.2	0.0	1.6	0.0	1.4	0.0	9.4	0.1	0.0	4.6	2.8	2.7	7.6	6.6	0.5	0.0	3.9	8.4	4.2	2.6	0.3	0.3	0.0	1.4	0.3	7.9	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	7.0	0.4
HOXD1	"HOX4, HOX4G"	ENSG00000128645	"Homeobox D1"	Q9GZZ0	2	176188579-176190907	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.9;epididymis: 14.1;seminal vesicle: 20.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 5.7;Hep G2: 5.9;RPTEC TERT1: 18.3;RT4: 14.1;SCLC-21H: 4.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"pons and medulla: 1.2"	"Low region specificity"	"Detected in many"			"HPA040062, HPA056900"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA040062: , HPA056900: "	"unprognostic (8.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.64e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.54e-5)"	"unprognostic (4.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.32e-1)"	2.4	0.6	1.5	1.1	3.5	0.3	2.0	0.6	3.9	0.5	5.2	18.8	11.8	0.7	0.8	14.1	0.9	8.8	1.4	0.3	4.1	2.2	6.8	0.2	5.7	0.9	9.8	1.3	1.2	0.5	0.2	0.2	0.3	15.5	1.7	3.7	0.3	1.0	20.4	0.3	1.2	4.4	0.9	18.9	1.5	0.7	2.2	6.3	0.0	0.4	0.0	0.5	4.6	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	5.7	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	5.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	18.3	14.1	4.9	0.8	0.0	0.0	0.9	0.0	0.0	3.3	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.5	0.6	3.2	4.1	2.2	9.8	1.3	15.5	6.3
HOXD4	"HOX4, HOX4B"	ENSG00000170166	"Homeobox D4"	P09016	2	176151222-176153226	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 21.0;seminal vesicle: 26.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.1;HEK 293: 21.6;RPTEC TERT1: 16.0;SK-MEL-30: 6.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.3"	"Region enriched"	"Detected in some"	7	"pons and medulla: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Region enriched"	"Detected in single"	31	"pons and medulla: 8.2"	"HPA054383, HPA070349"	Approved		Supported	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA054383: , HPA070349: "	"unprognostic (9.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.10e-3)"	"unprognostic (9.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.19e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.61e-1)"	3.4	4.9	0.5	0.5	0.5	0.0	4.0	0.5	0.7	2.8	3.4	0.5	13.8	0.2	15.6	21.0	0.5	7.9	0.5	0.5	0.5	0.0	10.2	0.5	0.5	0.6	1.1	0.5	9.7	0.5	0.0	0.5	0.5	7.6	1.5	0.8	0.5	0.5	26.2	1.3	1.0	3.5	5.3	3.7	4.4	0.4	1.5	0.5	0.5	0.8	0.5	0.5	2.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.1	1.7	0.0	0.1	0.4	0.0	0.6	0.5	0.0	0.0	9.1	1.6	0.1	1.5	0.0	0.2	0.0	21.6	0.2	0.0	0.0	0.3	0.0	0.0	4.9	1.4	0.0	0.2	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	16.0	2.5	1.3	2.1	0.3	0.0	6.0	0.0	0.0	2.7	0.2	0.1	1.4	1.1	0.0	0.0	0.0	1.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.7	0.5	0.0	1.1	0.5	7.6	0.5
HPR		ENSG00000261701	"Haptoglobin-related protein"	P00739	16	72063224-72077246	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"liver: 151.4"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 32.8"	"Cancer enriched"	"Detected in some"	53	"liver cancer: 185.1"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA047750	Supported		Approved	Vesicles	"Secreted to blood"	49000000000	77000000000	Vesicles		"HPA047750: "	"unprognostic (2.43e-1)"		"unprognostic (4.69e-2)"	"unprognostic (5.97e-3)"	"unprognostic (2.42e-1)"		"unprognostic (2.32e-3)"	"unprognostic (2.36e-1)"		"unprognostic (1.66e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.44e-6)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-1)"		0.2	0.0	1.3	0.0	1.6	0.0	0.0	0.0	0.6	0.1	0.0			0.1	0.0	0.1	0.0	0.0	0.1	15.2	0.7	0.8	0.1	151.4	0.0	0.1	2.1		0.4	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2			0.0		0.0	0.0	0.0	1.1	2.9	1.1	1.0	0.4	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	1.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	1.1	1.3	1.0	0.1	0.5	0.4	0.4	0.3	1.1	2.0	1.1	0.3	0.4	0.3	2.9	2.3	0.3										
HRH2		ENSG00000113749	"Histamine receptor H2"	P25021	5	175658030-175710756	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 45.7;bone marrow: 30.1"	"Group enriched"	"Detected in some"	4	"RPMI-8226: 35.4;SK-MEL-30: 10.6;THP-1: 9.8;U-937: 11.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 4.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 45.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 45.7;monocytes: 13.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA013770	Approved									"HPA013770: AB_1851086"	"unprognostic (8.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.66e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.77e-2)"	7.9	1.5	5.9	11.1	11.6	30.1	2.8	1.0	12.1	3.9	2.8	0.9	0.5	5.9	2.3	1.3	1.6	2.7	2.6	18.6	3.4	1.7	2.4	1.2	5.4	12.3	2.3	4.9	1.6	1.6	0.3	1.3	9.5	2.4	3.0	1.3	0.6	1.7	4.8	1.2	2.1	7.2	3.5	4.4	9.9	10.3	1.2	5.6	9.9	1.8	0.2	3.0	2.8	2.0	0.0	6.4	45.7	13.1	0.6	2.3	3.7	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.7	1.6	0.0	3.8	0.0	35.4	0.0	0.2	0.2	0.0	0.0	0.0	10.6	0.0	9.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.8	2.4	28.9	12.9	13.6	0.0	12.0	0.1	0.0	1.1	0.2	6.4	0.0	2.3	1.4	45.7	0.6	13.1	5.0	0.8	3.7	5.9	11.6	1.0	12.1	3.4	1.7	2.3	4.9	2.4	5.6
HS6ST2		ENSG00000171004	"Heparan sulfate 6-O-sulfotransferase 2"	Q96MM7	X	132626016-132961395	"Predicted intracellular proteins, Predicted membrane proteins"		Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.5;kidney: 17.3;ovary: 18.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 19.3;HeLa: 13.1;RH-30: 28.0;RT4: 13.9;SH-SY5Y: 34.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 29.5"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.8"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.8"	"Low region specificity"	"Detected in all"							"HPA034625, HPA034626"	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm		"HPA034625: AB_10612119, HPA034626: "	"unprognostic (7.62e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.39e-5)"	"unprognostic (1.36e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.54e-1)"	"prognostic favourable (6.03e-4)"	0.4	3.2	6.5	0.9	29.5	0.1	2.6	3.0	6.7	1.0	0.8	0.8	0.6	0.3	4.5	3.2	5.0	2.5	0.5	0.4	4.1	9.1	17.3	0.2	1.0	0.3	3.5	0.9	18.2	6.5	0.1	1.3	9.9	3.3	5.4	1.2	0.0	1.1	1.6	6.7	0.3	0.2	2.0	3.3	0.2	1.1	7.9	0.7	0.7	0.6	1.7	2.7	2.3	0.6	0.0	0.0	0.0	0.0	1.8	0.6	0.0	4.3	0.0	6.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.0	0.0	0.0	6.4	0.0	0.2	9.1	0.0	0.0	0.0	19.3	0.0	13.1	0.0	0.0	0.0	0.0	0.3	8.5	0.0	0.0	0.4	0.0	0.0	0.0	3.1	0.1	0.0	4.9	0.2	0.0	28.0	0.0	5.6	13.9	0.7	34.9	6.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.0	9.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	6.5	29.5	3.0	5.8	4.1	9.1	3.5	0.9	3.3	0.7
HS6ST3		ENSG00000185352	"Heparan sulfate 6-O-sulfotransferase 3"	Q8IZP7	13	96090839-96839562	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.7"	"Cell line enriched"	"Detected in some"	6	"RT4: 19.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA078257			Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments"	"Intracellular and membrane"		9800	"Nucleoplasm, Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA078257: "	"unprognostic (2.34e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.78e-2)"		"unprognostic (1.55e-1)"		"unprognostic (3.67e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.19e-1)"	"prognostic favourable (6.12e-5)"	"unprognostic (1.54e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.89e-2)"	0.9	4.5	1.5	0.0	1.9	0.0	0.0	0.4	18.7	1.9	0.0			0.2	2.1	2.2	0.2	0.1	0.0	0.2	3.2	2.7	0.7	0.0	0.0	0.0	0.9		0.0	2.1	0.0	0.7	0.0		0.1	0.0		0.0	0.1	0.6	0.1	0.0	1.6	0.4	0.0	0.7	0.1			2.4		0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	1.2	0.0	1.3	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	19.2	1.0	0.8	0.1	0.1	0.0	0.5	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HSD11B1L	"SCDR10, SDR26C2"	ENSG00000167733	"Hydroxysteroid 11-beta dehydrogenase 1 like"	Q7Z5J1	19	5680604-5688523	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 34.4"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049078			Supported	Vesicles	"Secreted in brain"			Vesicles		"HPA049078: "	"unprognostic (2.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.73e-3)"	"unprognostic (5.26e-2)"	"unprognostic (9.37e-2)"	"prognostic favourable (4.38e-4)"	"unprognostic (4.81e-3)"	"unprognostic (6.63e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.52e-1)"	"unprognostic (1.73e-2)"	3.9	8.8	34.4	2.1	19.2	4.7	5.0	10.3	29.7	3.9	2.9	5.4	3.7	2.6	3.6	8.5	2.2	7.6	4.8	3.8	25.4	16.1	6.7	3.5	4.4	2.3	11.7	20.4	6.1	6.2	5.8	8.5	2.5	10.7	4.0	1.9	3.2	9.1	6.9	15.0	6.9	2.9	2.7	6.0	2.6	3.3	4.3	7.5	0.0	6.6	1.3	1.8	2.5	2.2	2.5	4.8	2.5	5.8	1.4	4.5	1.7	3.0	2.9	10.7	2.0	5.1	5.5	2.2	2.3	4.6	1.1	4.7	1.3	3.0	0.7	5.1	2.0	1.5	1.3	1.7	1.0	2.5	3.3	2.0	2.6	1.9	3.5	0.8	7.3	5.4	3.7	1.7	1.5	1.7	1.9	2.9	4.3	0.4	1.8	2.1	2.9	3.4	3.4	0.4	2.6	8.9	0.7	2.9	17.8	0.5	1.5	11.4	2.5	0.7	2.9	2.7	4.8	4.5	1.8	7.2	2.3	0.8	7.4	1.1	2.1	1.7	2.5	0.2	1.2	5.8	1.6	1.2	3.2	3.6	2.3	2.5	4.5	3.9	2.5	1.4	2.9	4.8	0.9	1.7	34.4	19.2	10.3	29.7	25.4	16.1	11.7	20.4	10.7	7.5
HSF5	FLJ40311	ENSG00000176160	"Heat shock transcription factor 5"	Q4G112	17	58420167-58488384	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 65.6"	"Cell line enhanced"	"Detected in single"		"CACO-2: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 3.7;T-cells: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA063613	Enhanced									"HPA063613: "	"unprognostic (2.13e-1)"	"unprognostic (1.21e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.17e-2)"	"unprognostic (7.48e-3)"	"unprognostic (7.40e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.58e-2)"	"unprognostic (6.65e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.64e-2)"	0.1	0.0	0.0	2.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.8	0.0	65.6	0.0	3.3	0.0	0.1	2.4	0.0	0.0	3.7	0.1	0.0	0.0	0.5	3.2	0.8	0.0	0.0	0.1	0.4	0.0	0.6	0.2	0.1	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.1	3.1	1.7	1.5	0.1	3.7	3.2	2.2	0.0	0.5	0.0	0.1	2.3	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR1F	"5-HT1F, HTR1EL"	ENSG00000179097	"5-hydroxytryptamine receptor 1F"	P30939	3	87990696-87993835	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"placenta: 5.7"	"Group enriched"	"Detected in some"	6	"A549: 1.2;K-562: 4.4;LHCN-M2: 4.3"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	16	"basophil: 3.2"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 3.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005555	Uncertain									"HPA005555: AB_1856708"	"unprognostic (1.66e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.78e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.80e-2)"	"unprognostic (2.67e-6)"	"unprognostic (1.25e-4)"	"unprognostic (1.55e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.31e-2)"	2.8	0.5	0.7	0.0	0.6	1.5	1.6	0.0	1.8	1.4	0.0			0.0	1.2	0.3	0.1	0.4	0.1	0.3	0.6	0.4	0.6	0.0	0.9	0.1	0.8		0.4	0.7	0.3	1.4	5.7		0.4	0.0		0.1	1.0	0.6	0.4	0.0	1.3	0.3	1.7	0.0	0.3			1.5		0.5	0.6	0.7	0.1	0.2	3.2	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0										
HTR5A	5-HT5A	ENSG00000157219	"5-hydroxytryptamine receptor 5A"	P47898	7	155070324-155085749	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"brain: 15.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB017467	Approved									"CAB017467: AB_2122566"					"unprognostic (1.62e-2)"										"unprognostic (1.15e-1)"			0.4	0.4	2.6	0.4	3.9	0.4	0.4	15.4	15.0	0.4	0.4	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	2.6	5.9	0.4	0.4	0.4	0.4	2.3	2.5	0.4	0.4	0.4	0.1	0.4	2.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.8	0.4	0.4	1.4	0.3	3.3	0.4	0.0	0.4	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	3.9	15.4	9.8	2.6	5.9	2.3	2.5	2.4	0.3
HTRA4	FLJ90724	ENSG00000169495	"HtrA serine peptidase 4"	P83105	8	38974164-38988662	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"placenta: 55.2"	"Cell line enriched"	"Detected in single"	134	"BEWO: 71.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"hippocampal formation: 2.3"	"Low region specificity"	"Detected in all"			HPA045402	Enhanced				"Secreted in female reproductive system"					"HPA045402: "	"unprognostic (1.20e-1)"	"unprognostic (5.83e-4)"	"unprognostic (8.02e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.58e-1)"	"unprognostic (5.19e-3)"	"unprognostic (2.39e-3)"	"unprognostic (1.19e-3)"	2.6	1.1	0.2	0.3	0.2	3.4	0.9	0.2	0.4	1.2	0.5	0.2	1.9	0.0	2.3	0.5	0.5	0.1	0.2	0.2	0.2	0.0	0.2	0.2	4.3	1.0	0.2	0.2	0.4	0.3	0.4	0.5	55.2	0.4	0.5	0.3	1.8	0.8	0.5	0.6	0.4	0.6	0.3	1.8	2.5	0.1	0.4	0.2	0.2	0.6	0.2	0.8	0.5	0.9	3.1	2.2	2.5	1.0	1.0	1.7	0.0	0.1	0.1	0.1	0.1	0.3	0.2	71.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.1	0.1	0.5	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.2	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.3	0.1	1.5	0.8	2.3	1.4	0.7	1.7	1.5	1.3	1.2	0.6	3.1	1.3	1.4	2.5	1.0	1.0	2.2	1.4	0.0	0.2	0.2	0.2	0.4	0.2	0.0	0.2	0.2	0.4	0.2
IER5L	bA247A12.2	ENSG00000188483	"Immediate early response 5 like"	Q5T953	9	129175552-129178262	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 15.2;SiHa: 21.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA021327			Approved	Nucleoplasm				Nucleoplasm		"HPA021327: AB_2121674"	"unprognostic (2.46e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.90e-3)"	"unprognostic (8.49e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.37e-3)"	"prognostic unfavourable (1.48e-6)"	"unprognostic (6.91e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.29e-1)"	12.6	11.3	6.0	6.4	9.0	3.3	31.3	2.1	15.3	29.6	8.2	3.5	14.9	5.0	17.4	10.8	13.0	11.0	14.3	14.9	6.4	5.0	14.8	15.0	9.4	8.1	5.5	3.9	35.0	5.4	3.2	8.0	9.8	7.9	15.2	3.7	6.1	8.1	30.1	8.4	8.0	5.3	10.5	11.8	5.7	11.1	6.2	4.1	1.2	9.4	4.9	3.8	20.7	25.5	0.0	0.3	2.1	1.1	0.4	0.8	0.2	5.1	15.2	4.3	8.3	3.2	5.1	13.1	7.7	0.7	1.2	1.2	0.8	8.5	0.1	3.1	1.8	11.3	0.2	0.9	0.2	0.7	1.1	0.0	3.2	1.4	2.4	0.1	0.1	5.6	1.2	0.9	0.1	0.5	0.4	2.7	0.2	13.2	0.1	0.6	0.4	8.0	0.7	0.3	2.2	4.6	0.7	1.9	2.6	21.4	7.0	8.7	2.1	1.3	3.1	7.4	4.4	5.0	11.0	1.5	1.0	0.1	9.5	1.5	3.2	0.0	1.1	0.0	0.3	0.6	0.0	0.0	0.1	0.8	0.3	0.0	0.0	0.0	2.1	0.4	0.2	0.1	0.0	0.2	6.0	9.0	2.1	9.0	6.4	5.0	5.5	3.9	7.9	4.1
IFFO1	"HOM-TES-103, IFFO"	ENSG00000010295	"Intermediate filament family orphan 1"	Q0D2I5	12	6538375-6556083	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069344	Approved									"HPA069344: "	"unprognostic (1.05e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.43e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.25e-2)"	"prognostic favourable (6.53e-5)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (7.47e-7)"	"unprognostic (5.71e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.58e-2)"	11.7	12.6	13.2	12.2	11.2	14.6	9.1	22.8	20.0	10.6	10.4	10.3	2.6	6.9	13.9	8.0	6.2	9.8	10.0	13.1	11.5	8.8	6.1	7.5	11.9	14.4	9.2	13.3	11.8	5.1	2.1	9.9	11.2	12.7	7.9	6.2	13.5	5.0	12.1	19.9	4.6	7.5	12.3	12.9	17.8	5.4	10.3	10.6	6.5	5.3	6.8	10.6	9.7	9.4	1.7	4.8	3.9	9.2	3.9	2.8	3.0	0.0	0.0	4.5	0.0	7.0	11.5	0.1	6.7	6.1	5.5	4.8	1.0	0.0	1.3	0.0	6.4	0.0	3.4	0.9	1.8	10.2	11.2	5.2	0.1	7.3	4.8	5.5	8.6	7.0	0.0	4.1	0.0	5.3	0.0	1.6	13.4	0.0	4.7	4.2	10.5	0.0	7.8	7.9	2.3	1.7	0.0	0.0	4.1	0.0	0.0	3.3	0.0	5.8	8.0	5.3	0.0	4.5	3.9	2.2	0.7	4.0	3.9	2.2	13.8	0.2	6.6	3.9	2.7	5.0	2.6	1.3	2.4	2.8	4.8	1.7	1.0	1.5	2.3	3.9	9.2	2.5	1.7	3.0	13.2	11.2	22.8	20.0	11.5	8.8	9.2	13.3	12.7	10.6
IFFO2		ENSG00000169991	"Intermediate filament family orphan 2"	Q5TF58	1	18904281-18956686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 76.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"basophil: 10.6"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 10.6"									"HPA015987, HPA064603"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA015987: AB_2121678, HPA064603: "	"unprognostic (1.43e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.27e-3)"	"unprognostic (3.24e-3)"	"unprognostic (7.42e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.24e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.36e-1)"	3.5	5.1	3.8	5.0	7.8	5.7	8.9	22.3	6.4	6.7	4.6	6.2	4.9	1.4	4.7	2.2	28.7	3.6	4.8	2.7	4.4	4.0	4.9	8.9	5.0	5.3	6.8	3.6	2.4	14.5	13.0	4.0	4.7	9.3	6.6	2.0	3.4	7.9	6.5	4.3	76.8	2.5	13.5	8.9	3.9	2.9	1.4	4.6	3.2	4.3	33.2	11.3	6.3	8.8	0.8	0.6	10.6	0.3	0.3	1.0	0.1	8.2	13.5	3.6	10.0	2.3	1.9	5.9	6.2	4.1	3.4	2.4	18.5	9.7	0.1	8.1	4.7	20.8	2.7	13.3	2.8	49.4	2.4	0.1	2.5	7.2	1.7	1.4	15.9	1.2	13.5	4.6	5.9	7.3	0.6	1.6	2.2	1.7	1.3	1.3	1.5	3.2	4.6	2.2	3.5	2.0	5.3	11.7	0.6	4.7	6.7	4.6	1.8	0.7	19.8	4.6	6.4	2.7	18.0	3.6	3.9	0.2	3.1	2.0	5.4	10.6	0.3	0.0	0.6	0.3	0.8	0.8	0.5	0.7	0.1	0.3	0.5	1.0	0.1	0.3	0.0	0.6	0.5	0.1	3.8	7.8	22.3	6.4	4.4	4.0	6.8	3.6	9.3	4.6
IFI27L2	"FAM14A, TLH29"	ENSG00000119632	"Interferon alpha inducible protein 27 like 2"	Q9H2X8	14	94127779-94130253	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049588			Approved	Nucleoli,Cytosol	"Intracellular and membrane"			Cytosol	Nucleoli	"HPA049588: "	"unprognostic (9.70e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.76e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.79e-3)"	"unprognostic (3.96e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.88e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.52e-2)"	11.4	39.9	38.6	18.3	23.8	17.0	18.8	15.2	24.7	19.9	16.0	23.5	8.7	11.6	15.8	9.6	24.5	21.9	20.8	38.9	29.7	32.4	13.2	3.7	16.5	21.5	37.1	22.8	25.9	13.2	11.7	20.6	5.4	27.4	10.6	9.7	20.4	7.2	12.5	4.0	16.0	13.5	15.5	35.7	17.0	15.7	9.1	22.9	13.8	8.5	16.0	22.5	12.0	17.2	31.5	29.6	19.8	38.7	6.0	30.5	31.9	8.3	5.9	1.7	11.9	8.6	22.1	1.0	15.6	16.1	11.8	13.9	1.6	3.8	3.7	17.1	16.8	10.3	1.2	20.8	4.8	24.9	0.9	5.7	5.8	0.5	14.5	6.7	15.7	20.0	7.7	7.0	4.3	7.8	0.5	56.9	12.2	15.7	3.9	4.1	2.1	6.7	0.1	5.5	4.9	18.0	3.2	3.1	4.7	0.4	0.1	10.0	19.3	11.2	7.6	7.9	4.8	10.6	4.3	23.2	19.2	1.2	25.2	14.9	5.1	19.8	38.7	7.1	25.6	25.9	16.4	31.5	24.4	28.1	29.6	27.4	17.6	23.0	5.7	6.0	18.8	24.6	30.5	31.9	38.6	23.8	15.2	22.8	29.7	32.4	37.1	22.8	27.4	22.9
IFI44	"MTAP44, p44, TLDC5"	ENSG00000137965	"Interferon induced protein 44"	Q8TCB0	1	78649796-78664078	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 47.9;BJ hTERT+ SV40 Large T+ RasG12V: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA027148, HPA043858"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA027148: AB_1851411, HPA043858: "	"unprognostic (1.20e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.81e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (1.37e-8)"	"unprognostic (1.71e-1)"	"unprognostic (2.07e-3)"	"unprognostic (8.89e-2)"	"unprognostic (4.90e-2)"	35.2	12.6	10.2	16.2	11.7	47.8	13.0	4.3	8.2	10.0	8.1	6.6	10.5	10.5	13.6	29.9	15.2	8.3	24.9	10.7	10.8	9.8	26.9	11.2	18.6	16.5	11.9	10.5	10.9	5.2	3.0	19.6	11.4	10.5	11.0	5.3	11.3	35.4	13.2	7.5	5.5	8.8	10.2	15.1	32.3	11.2	4.8	11.0	22.3	13.8	11.3	8.1	13.6	8.0	2.2	5.9	3.7	13.0	6.1	12.4	5.5	2.0	0.0	0.3	0.0	1.4	10.0	0.0	1.3	17.4	47.9	59.2	0.0	5.8	2.7	13.6	1.2	1.1	0.0	0.7	7.8	5.8	0.0	6.9	5.1	0.0	2.0	0.0	0.0	6.3	0.0	20.8	0.2	8.9	0.0	9.4	11.3	0.0	5.7	0.5	0.0	3.8	4.5	14.5	0.3	1.4	1.3	0.1	0.3	0.4	0.1	20.5	0.0	0.2	11.0	8.8	3.7	0.9	8.8	0.8	0.9	0.0	13.7	7.9	2.4	0.3	13.0	0.1	6.2	12.3	12.4	2.2	9.1	5.9	5.9	1.6	3.9	5.0	3.7	6.1	6.3	1.7	4.3	5.5	10.2	11.7	4.3	8.2	10.8	9.8	11.9	10.5	10.5	11.0
IFI44L	"C1orf29, GS3686"	ENSG00000137959	"Interferon induced protein 44 like"	Q53G44	1	78619922-78646145	"Predicted intracellular proteins"	"Antiviral defense"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 25.3;BJ hTERT+ SV40 Large T+ RasG12V: 27.4;HSkMC: 14.7;SK-MEL-30: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA053247, HPA060372"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA053247: , HPA060372: "	"unprognostic (2.41e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.99e-3)"	"prognostic unfavourable (2.95e-4)"	"prognostic favourable (3.82e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.52e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (7.58e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.03e-2)"	33.6	5.3	9.4	6.2	10.6	36.2	7.6	3.3	10.4	3.8	4.0	12.3	2.7	3.5	10.6	19.7	3.8	4.9	15.0	7.4	9.2	11.0	15.7	4.9	9.5	5.1	10.6	9.4	6.6	2.2	1.9	5.6	8.6	21.6	5.4	3.1	14.4	26.3	5.2	3.5	2.7	3.8	7.0	17.2	23.1	3.7	5.0	12.2	21.6	10.0	4.9	5.2	10.4	3.2	3.6	2.2	2.3	5.6	4.4	2.2	1.5	0.0	0.0	1.0	0.0	0.5	6.8	0.0	0.2	5.3	25.3	27.4	0.0	0.3	5.6	3.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.4	0.0	0.6	0.1	0.1	14.7	0.1	1.8	0.3	0.2	0.0	0.8	0.5	0.0	0.3	0.1	0.0	2.5	0.0	0.0	0.0	1.3	0.1	0.0	0.0	6.8	0.0	11.5	0.0	0.1	0.2	0.2	0.3	0.5	0.7	1.1	0.2	0.0	4.2	0.0	0.0	0.1	5.0	0.3	0.5	5.6	1.6	3.6	2.2	1.7	1.6	1.6	0.8	0.8	2.3	4.4	2.1	2.2	0.5	1.5	9.4	10.6	3.3	10.4	9.2	11.0	10.6	9.4	21.6	12.2
IFI6	"6-16, FAM14C, G1P3, IFI-6-16, IFI616"	ENSG00000126709	"Interferon alpha inducible protein 6"	P09912	1	27666061-27672218	"Predicted membrane proteins"	"Antiviral defense, Apoptosis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 225.6"	"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 131.9;BJ hTERT+ SV40 Large T+ RasG12V: 154.2;EFO-21: 53.0;SK-MEL-30: 93.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA005543	Approved		Approved	Mitochondria				Mitochondria		"HPA005543: AB_1849342"	"unprognostic (4.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.96e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.77e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.81e-1)"	"unprognostic (8.40e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.72e-2)"	32.3	27.5	24.9	13.5	28.2	37.3	10.9	14.2	36.1	11.4	13.8	22.9	6.5	16.5	26.8	68.0	8.6	11.9	113.9	19.3	23.0	42.3	44.8	23.5	31.6	5.8	20.0	17.0	14.1	21.3	5.9	60.1	225.6	34.3	13.9	10.1	31.6	111.4	10.1	7.4	5.4	12.5	17.0	26.0	27.3	35.4	15.4	6.8	24.8	35.2	7.9	9.7	7.8	7.6	9.7	19.4	84.9	58.6	15.8	27.5	16.8	1.4	0.4	2.2	1.3	7.1	3.9	8.8	4.6	21.3	131.9	154.2	0.7	5.6	0.5	53.0	2.1	0.5	0.5	1.0	4.3	10.8	1.7	3.4	1.1	0.4	1.9	1.1	4.4	4.2	0.1	7.9	0.1	1.2	0.2	9.3	1.4	0.4	4.0	14.2	0.4	4.5	2.7	1.2	1.3	1.1	0.0	3.1	2.8	5.7	1.3	93.6	0.6	4.4	2.0	1.2	1.9	0.9	0.8	11.1	6.3	0.3	2.4	9.9	3.4	29.3	44.4	39.4	22.7	58.6	22.4	9.7	23.0	20.7	19.4	8.0	24.3	23.6	84.9	15.8	38.8	2.0	27.5	16.8	24.9	28.2	14.2	36.1	23.0	42.3	20.0	17.0	34.3	6.8
IFNA16	IFN-alphaO	ENSG00000147885	"Interferon alpha 16"	P05015	9	21216373-21217311	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"					"HPA047557: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IFNL2	"IL-28A, IL28A"	ENSG00000183709	"Interferon lambda 2"	Q8IZJ0	19	39268514-39270092	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"pancreas: 4.1;testis: 1.7"	"Cell line enriched"	"Detected in single"	24	"HDLM-2: 16.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB025489	Uncertain				"Secreted to blood"					"CAB025489: "	"unprognostic (1.37e-1)"	"unprognostic (2.84e-1)"				"unprognostic (1.05e-1)"				"unprognostic (2.11e-2)"	"unprognostic (1.08e-1)"			"unprognostic (6.96e-2)"				0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGDCC3	"HsT18880, PUNC"	ENSG00000174498	"Immunoglobulin superfamily DCC subclass member 3"	Q8IVU1	15	65327127-65378040	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.8;parathyroid gland: 16.6;placenta: 12.2"	"Group enriched"	"Detected in some"	5	"AF22: 42.5;CACO-2: 10.7;Hep G2: 33.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015713			Uncertain	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA015713: "	"unprognostic (7.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.24e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.67e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.77e-5)"	"unprognostic (4.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-2)"	0.2	0.6	3.5	0.4	2.1	0.2	1.7	10.8	4.6	1.0	0.5	3.3	0.0	0.3	1.6	0.4	0.2	1.4	0.4	0.4	3.2	2.6	0.6	0.2	0.3	0.2	2.5	1.7	1.7	0.3	16.6	2.9	12.2	2.6	0.5	0.3	0.6	0.2	0.5	0.5	0.4	0.3	0.6	2.2	0.3	0.4	4.7	2.7	3.7	1.7	0.0	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.5	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	10.7	0.1	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.4	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	2.1	10.8	4.6	3.2	2.6	2.5	1.7	2.6	2.7
IGFBPL1	bA113O24.1	ENSG00000137142	"Insulin like growth factor binding protein like 1"	Q8WX77	9	38408994-38424447	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 11.0;pituitary gland: 7.4;thyroid gland: 27.2"	"Group enriched"	"Detected in some"	6	"AF22: 68.0;NTERA-2: 18.7;RH-30: 19.5;SCLC-21H: 70.0;SH-SY5Y: 67.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basal ganglia: 12.5;olfactory region: 16.2"	"Low region specificity"	"Detected in many"			HPA051354	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted to blood"			"Nucleoplasm, Vesicles"		"HPA051354: "	"unprognostic (5.63e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.67e-2)"	1.6	2.6	3.8	1.1	11.0	0.3	0.4	4.7	4.7	0.7	1.0	1.0	0.0	1.9	2.1	0.5	0.7	1.0	1.9	3.7	3.3	2.3	0.7	0.6	1.2	0.4	1.4	1.5	0.5	1.6	0.4	7.4	1.1	1.8	1.6	0.7	0.2	0.5	2.9	0.3	0.3	1.2	2.1	0.6	0.4	2.5	3.3	1.5	2.6	27.2	0.0	0.4	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	68.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.1	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	18.7	0.1	0.0	19.5	0.1	0.0	0.0	70.0	67.9	1.1	0.0	0.0	0.3	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	11.0	4.7	4.7	3.3	2.3	1.4	1.5	1.8	1.5
IGFL2	UNQ645	ENSG00000204866	"IGF like family member 2"	Q6UWQ7	19	46143106-46161299	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"skin 1: 26.8;tongue: 24.8"	"Cell line enriched"	"Detected in single"	42	"CACO-2: 42.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	24	"memory CD4 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.4"									HPA059137	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in other tissues"			Nucleoplasm	"Plasma membrane"	"HPA059137: "	"unprognostic (1.53e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.26e-3)"	"unprognostic (9.63e-3)"	"unprognostic (4.14e-9)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.91e-3)"	1.5	0.0	0.4	0.1	0.1	0.0	1.8	0.1	0.4	0.3	0.3	0.1	0.1	0.0	0.1	0.5	1.0	0.0	0.1	1.1	0.1	0.1	0.1	0.1	0.8	1.2	0.4	0.1	0.1	0.1	3.4	0.1	1.6	0.9	0.1	0.7	0.1	0.5	0.1	0.1	26.8	0.1	0.1	0.3	0.1	0.0	2.4	0.1	0.4	0.1	24.8	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.4	0.1	0.1	0.4	0.1	0.9	0.1
IGFL4		ENSG00000204869	"IGF like family member 4"	Q6B9Z1	19	46039748-46077118	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 8.5;skin 1: 13.9"	"Cell line enhanced"	"Detected in some"		"A549: 7.7;HaCaT: 6.9;RH-30: 3.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA047655	Approved		Approved	Cytosol	"Secreted - unknown location"			Cytosol		"HPA047655: "	"unprognostic (1.22e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.96e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.59e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.85e-1)"	0.1	0.8	4.4	0.3	4.4	0.2	0.3	3.9	8.5	0.2	0.3	0.0	0.0	0.9	1.0	2.9	1.9	0.4	1.1	1.9	2.8	2.8	0.3	0.4	0.7	0.9	1.2	6.0	2.0	0.2	3.3	4.5	0.2	2.1	0.9	0.5	4.6	1.1	0.0	0.5	13.9	0.7	0.1	1.6	0.5	0.7	0.8	0.5	0.0	1.5	0.6	0.2	1.2	0.2	0.3	1.6	1.3	0.7	0.2	0.5	0.1	0.1	7.7	0.2	0.6	0.0	1.3	0.5	0.0	0.0	0.0	0.0	1.7	0.3	1.1	0.1	0.1	6.9	0.0	0.0	0.0	0.8	1.2	0.0	0.9	1.9	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.9	0.1	0.6	0.3	0.4	0.1	3.3	1.6	0.0	0.4	0.5	0.5	0.0	0.2	2.0	0.5	1.4	0.7	0.9	1.6	0.5	0.5	1.0	0.5	0.2	0.2	1.0	2.1	1.3	0.7	0.7	0.5	0.3	0.3	0.3	0.2	0.1	0.1	0.3	0.1	0.4	0.9	0.2	0.1	1.6	0.4	0.1	4.4	4.4	3.9	8.5	2.8	2.8	1.2	6.0	2.1	0.5
IGLON5	LOC402665	ENSG00000142549	"IgLON family member 5"	A6NGN9	19	51311848-51330354	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 33.6;testis: 11.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 24.9;NTERA-2: 11.2;SH-SY5Y: 16.2;U-2 OS: 4.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 12.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							HPA041994	Approved				"Secreted in brain"					"HPA041994: AB_10794641"	"unprognostic (2.09e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.47e-4)"	"unprognostic (6.38e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (5.62e-7)"	"unprognostic (1.77e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.86e-3)"	2.0	4.6	9.6	1.1	6.0	1.9	0.7	33.6	16.5	0.6	0.8	0.8	0.0	0.9	0.8	2.2	2.8	0.7	1.0	1.2	9.5	13.7	0.6	2.3	0.6	0.6	11.1	8.4	1.5	1.1	0.5	0.5	1.3	29.3	1.1	0.7	3.0	1.1	2.4	0.6	1.5	1.1	0.8	10.9	0.7	0.7	11.5	2.6	0.0	0.6	0.0	0.6	1.1	0.4	0.0	0.9	1.4	0.3	0.2	0.3	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	11.2	0.0	0.0	0.0	2.4	0.0	0.1	0.1	16.2	0.0	0.0	0.0	0.1	1.5	0.0	0.0	4.7	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.4	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.3	0.9	0.0	0.0	9.6	6.0	33.6	10.7	9.5	13.7	11.1	8.4	29.3	2.6
IGSF11	"BT-IgSF, CT119, Igsf13, MGC35227, VSIG3"	ENSG00000144847	"Immunoglobulin superfamily member 11"	Q5DX21	3	118900557-119146068	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Growth regulation"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.8;ovary: 21.1;testis: 39.9"	"Cell line enhanced"	"Detected in some"		"A549: 5.9;HEL: 4.3;SK-MEL-30: 25.6;U-266/70: 8.9;U-266/84: 10.4"	"Group enriched"	"Detected in many"	9	"glioma: 9.2;melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046377	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"				"Cell Junctions"	"Nucleoplasm, Cytosol"	"HPA046377: AB_10966195"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-4)"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (7.57e-2)"	1.1	10.5	12.5	1.4	14.6	0.9	1.2	3.4	23.9	1.3	2.6	27.8	0.0	1.1	1.6	2.3	2.0	1.6	1.9	2.2	12.3	6.0	10.6	0.9	1.0	1.0	25.2	8.9	21.1	5.1	3.8	1.4	1.1	15.3	1.3	1.8	7.0	1.4	2.0	2.9	2.6	1.6	1.5	20.5	1.0	1.4	39.9	20.7	0.0	5.0	0.0	1.1	1.1	0.7	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	5.9	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	2.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	25.6	0.5	0.1	0.0	0.0	1.0	0.0	0.0	8.9	10.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.5	14.6	3.4	13.6	12.3	6.0	25.2	8.9	15.3	20.7
IGSF22	"FLJ37794, IGFN2"	ENSG00000179057	"Immunoglobulin superfamily member 22"	Q8N9C0	11	18704305-18726230	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"salivary gland: 22.7"	"Cell line enhanced"	"Detected in single"		"RH-30: 2.9"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"basal ganglia: 3.9"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"											CAB026459	Uncertain									"CAB026459: "	"unprognostic (4.05e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.38e-2)"	"unprognostic (8.70e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.99e-4)"	"unprognostic (9.35e-2)"	"unprognostic (3.72e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.94e-3)"	0.3	0.1	0.7	0.2	3.9	0.0	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.6	0.3	0.2	0.2	0.1	0.7	0.3	0.4	1.5	0.2	0.2	0.2	0.3	0.3	0.2	1.2	0.5	0.0	0.5	0.2	0.2	0.2	0.0	0.2	22.7	0.2	0.5	4.6	0.4	0.2	0.2	0.2	0.0	2.2	0.2	0.2	0.2	1.3	0.3	0.5	0.2	0.2	0.0	0.0	0.0	1.0	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.1	0.2	0.7	3.9	0.2	1.1	0.4	1.5	0.3	0.2	0.2	0.2
IGSF23		ENSG00000216588	"Immunoglobulin superfamily member 23"	A1L1A6	19	44613630-44636781	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 6.0;intestine: 19.9;liver: 20.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 13.7;Hep G2: 8.1;SiHa: 6.3"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 12.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.0"									"HPA051811, HPA054591"	Uncertain		Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA051811: , HPA054591: "	"unprognostic (1.54e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.53e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.11e-1)"	"prognostic favourable (7.20e-6)"	"unprognostic (7.35e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-8)"	"unprognostic (1.26e-1)"	"unprognostic (6.38e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.85e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	10.8	0.1	0.1	12.2	0.1	0.5	0.1	0.1	0.1	0.6	0.1	0.1	0.4	20.6	0.1	0.1	0.1	0.1	0.1	3.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.1	0.1	0.0	19.9	0.1	0.6	0.1	0.0	1.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	6.0	1.2	0.0	0.0	0.2	0.4	0.8	0.0	0.5	0.0	0.0	0.7	0.5	0.6	0.0	0.6	13.7	0.4	0.0	1.0	0.4	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.3	8.1	0.0	0.0	0.1	0.4	0.0	0.8	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	6.3	2.2	0.0	0.3	0.0	2.5	0.4	0.5	0.6	0.0	1.2	0.0	0.0	0.1	0.3	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
IGSF3	"EWI-3, MGC117164, V8"	ENSG00000143061	"Immunoglobulin superfamily member 3"	O75054	1	116574399-116667755	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 61.2;WM-115: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036305, HPA036306"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036305: , HPA036306: AB_10671245"	"unprognostic (9.87e-2)"	"unprognostic (3.64e-1)"	"unprognostic (9.51e-2)"	"prognostic unfavourable (1.98e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (4.03e-6)"	"unprognostic (9.40e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (2.03e-4)"	"unprognostic (4.18e-1)"	"prognostic favourable (2.87e-6)"	"unprognostic (5.29e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	1.4	1.5	1.9	1.2	5.1	0.1	7.7	2.5	8.3	5.8	5.7	1.5	3.0	6.7	2.5	6.5	22.0	1.7	3.5	7.9	1.8	2.8	10.7	0.8	7.4	0.3	1.8	2.8	0.7	4.5	1.4	2.7	42.9	4.1	5.1	5.1	7.8	9.3	5.5	1.1	16.1	12.9	2.4	1.7	0.5	7.3	3.6	0.9	6.2	8.1	9.0	9.3	8.2	9.8	0.0	0.2	0.3	0.6	0.0	0.7	0.2	5.3	9.1	7.0	1.7	1.6	3.4	18.9	0.0	0.2	0.7	0.2	5.2	3.0	0.0	2.8	0.0	14.9	3.1	7.3	0.3	61.2	2.3	2.9	3.5	0.1	0.0	0.2	5.5	0.4	5.8	0.0	1.3	0.0	0.8	0.0	0.1	18.7	0.2	0.1	4.4	0.2	2.1	8.6	0.0	5.4	6.7	4.1	12.5	2.2	21.0	13.5	7.0	0.3	0.0	1.2	4.2	0.0	5.5	0.0	0.3	0.0	0.5	0.1	59.0	0.0	0.6	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.2	1.9	5.1	2.5	8.3	1.8	2.8	1.8	2.8	4.1	0.9
IGSF5	JAM4	ENSG00000183067	"Immunoglobulin superfamily member 5"	Q9NSI5	21	39745407-39802096	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 5.8"	"Cell line enhanced"	"Detected in many"		"T-47d: 10.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"					"Cell type enriched"	"Detected in single"	5	"neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.2"					"Low region specificity"	"Detected in all"			HPA057282	Uncertain		Approved	"Focal adhesion sites"				"Focal adhesion sites"		"HPA057282: "	"unprognostic (1.06e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.06e-2)"	"unprognostic (9.73e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.15e-1)"		"unprognostic (1.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.35e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.01e-1)"	"unprognostic (4.18e-1)"	"unprognostic (3.75e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.07e-2)"	0.0	2.0	0.9	0.0	3.4	0.1	1.3	0.1	0.7	1.1	0.3			0.2	0.9	3.4	0.0	0.9	0.3	5.8	1.2	2.3	0.3	0.3	0.1	0.2	1.3		1.5	2.5	0.3	1.5	4.3		2.4	0.9		0.9	0.4	0.0	0.6	0.1	0.4	0.7	0.3	0.6	1.5			0.8		0.2	0.5	0.2	0.4	0.3	2.2	0.4	0.0	0.4	0.0	1.3	0.7	4.4	1.1	4.4	3.5	1.1	0.8	1.2	1.2	1.9	0.7	1.3	1.4	1.2	1.6	1.2	1.5	2.9	2.5	2.2	2.1	1.3	3.2	0.5	2.7	1.8	0.6	3.2	5.3	2.8	3.2	0.6	2.5	0.9	1.7	1.5	0.3	0.6	2.4	0.8	0.7	2.0	0.8	1.8	1.9	2.0	0.5	1.2	2.9	1.7	10.6	1.1	0.4	1.9	2.2	0.9	1.8	0.9	0.8	0.9	1.1	1.4	1.9	0.1	0.4	0.4	0.4	0.0	0.2	0.1	0.3	0.1	0.1	0.4	0.1	0.2	2.2	0.0	0.1	0.3	0.0	0.0										
IGSF6	DORA	ENSG00000140749	"Immunoglobulin superfamily member 6"	O95976	16	21639537-21652660	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 96.8;lymphoid tissue: 49.7"	"Cell line enhanced"	"Detected in some"		"THP-1: 2.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 96.8"	"Lineage enhanced"	"Detected in many"		"granulocytes: 96.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041023, HPA041072"	Uncertain									"HPA041023: AB_10794434, HPA041072: AB_10794262"	"unprognostic (7.94e-2)"	"prognostic favourable (4.92e-4)"	"unprognostic (1.18e-2)"	"prognostic favourable (1.54e-5)"	"unprognostic (3.27e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.28e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.02e-1)"	17.8	3.9	5.0	16.7	7.7	2.0	2.0	0.9	5.1	2.3	5.8	3.8	0.0	4.1	1.1	2.7	1.2	2.1	1.3	3.6	4.7	2.7	1.7	8.5	16.2	30.2	6.5	0.2	3.5	1.4	0.8	1.1	6.5	5.9	2.1	1.6	0.8	3.6	2.1	0.7	0.9	3.5	1.3	10.6	49.7	2.4	0.6	6.2	3.4	1.2	0.9	2.1	1.5	1.0	0.2	18.7	96.8	28.5	0.2	0.1	12.7	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.6	1.6	0.1	0.1	0.4	0.1	0.1	0.1	1.0	0.0	0.4	0.0	0.7	0.0	1.5	1.1	0.1	0.0	0.1	0.0	0.2	0.5	0.4	0.1	0.5	0.7	0.8	0.6	0.0	1.7	0.0	0.6	0.3	0.8	0.5	0.3	0.3	0.1	0.2	0.3	2.0	0.4	1.7	0.1	0.1	0.9	0.8	0.4	1.3	0.6	0.8	0.3	0.0	23.7	3.4	0.0	28.5	0.0	0.2	0.0	0.0	18.7	0.0	0.0	0.1	96.8	0.2	18.6	4.0	0.0	12.7	5.0	7.7	0.9	5.1	4.7	2.7	6.5	0.2	5.9	6.2
IGSF9B	KIAA1030	ENSG00000080854	"Immunoglobulin superfamily member 9B"	Q9UPX0	11	133908564-133956985	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.7"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 17.9;SH-SY5Y: 9.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 39.7"	"Cell type enriched"	"Detected in single"	9	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010744, HPA010802"	Uncertain		Approved	Cytosol				Cytosol		"HPA010744: , HPA010802: AB_1079194"	"unprognostic (9.04e-4)"	"unprognostic (1.74e-2)"	"unprognostic (7.52e-3)"	"unprognostic (4.38e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.99e-4)"	"unprognostic (3.17e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.14e-4)"	"unprognostic (3.12e-3)"	2.2	2.1	4.9	3.7	6.8	0.7	1.2	39.7	12.4	7.4	6.8	2.4	4.6	1.1	7.7	4.3	5.9	7.6	4.9	13.4	2.9	3.1	1.1	0.5	1.8	1.6	2.1	4.0	2.4	2.1	1.5	6.2	1.3	3.8	4.2	2.4	6.1	2.1	6.4	5.0	2.4	2.4	12.8	1.6	1.8	3.7	5.0	2.3	0.0	4.9	2.6	1.2	5.2	3.1	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.0	0.3	1.2	0.0	0.0	0.0	3.9	0.1	0.0	0.1	0.0	0.0	2.6	1.6	0.8	0.5	3.2	2.6	0.0	0.1	2.9	2.5	0.0	0.0	0.0	0.2	0.7	3.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.8	0.4	0.3	2.0	0.1	0.0	0.0	0.0	0.3	0.0	17.9	9.1	0.1	0.2	0.0	1.8	0.0	0.0	1.3	1.4	1.1	0.8	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.2	4.9	6.8	39.7	9.7	2.9	3.1	2.1	4.0	3.8	2.3
IL17B	"IL-17B, IL-20, MGC138900, MGC138901, NIRF, ZCYTO7"	ENSG00000127743	"Interleukin 17B"	Q9UHF5	5	149371324-149404202	"Cancer-related genes, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 4.4;Hep G2: 2.0;K-562: 1.6;Karpas-707: 3.6;NB-4: 2.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	6	"midbrain: 8.9"	"Cell type enriched"	"Detected in single"	14	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 4.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042441	Uncertain				"Secreted to blood"	75000				"HPA042441: AB_10797014"	"unprognostic (2.83e-4)"	"unprognostic (2.71e-2)"	"unprognostic (4.90e-3)"	"unprognostic (9.22e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (9.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.54e-2)"	"unprognostic (9.30e-3)"	"unprognostic (3.22e-1)"	"unprognostic (6.98e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.10e-1)"	2.1	3.3	0.1	2.2	0.1	0.6	7.5	0.1	0.8	4.7	4.2	0.1	2.8	0.7	6.8	3.6	4.1	1.6	1.1	5.1	0.1	0.0	0.8	0.1	0.9	0.1	8.9	1.2	0.7	0.1	0.0	0.1	0.4	1.4	3.6	0.4	2.4	7.1	5.6	1.5	1.3	1.7	5.3	5.4	1.1	1.3	5.9	0.4	0.4	0.6	1.6	0.3	1.8	1.3	0.0	0.2	4.3	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.9	0.3	0.8	0.0	0.0	0.0	0.0	0.5	0.0	4.4	0.0	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.1	0.4	0.0	0.5	0.2	0.1	0.0	0.0	0.9	4.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.8	0.1	0.0	8.9	1.2	1.4	0.4
IL17REL	FLJ41993	ENSG00000188263	"Interleukin 17 receptor E like"	Q6ZVW7	22	49994513-50012659	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 11.7;stomach 1: 4.6"	"Cell line enhanced"	"Detected in some"		"HEL: 1.1;SK-BR-3: 3.8"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 1.9;hypothalamus: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045546	Supported									"HPA045546: AB_10963836"	"unprognostic (3.33e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.65e-4)"	"unprognostic (2.72e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-2)"	0.1	0.1	0.3	11.7	0.3	0.0	0.1	0.2	1.9	0.3	0.4	0.0	0.0	1.7	0.2	0.9	0.2	0.3	0.0	0.1	0.2	1.4	0.1	0.1	0.8	3.9	0.4	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.3	0.5	0.0	2.0	0.0	0.1	0.3	3.3	0.0	0.1	1.9	4.6	0.6	0.0	8.1	0.2	0.6	8.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.1	3.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	1.9	0.2	1.4	0.4	0.0	0.0	0.0
IL1RAPL2	"IL-1R9, IL1R9, IL1RAPL-2, TIGIRR-1"	ENSG00000189108	"Interleukin 1 receptor accessory protein like 2"	Q9NP60	X	104566315-105767829	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 8.0;parathyroid gland: 8.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.7;hTERT-HME1: 10.8;NTERA-2: 2.0;RT4: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036128, HPA036129"	Uncertain									"HPA036128: AB_10669983, HPA036129: AB_2674957"	"unprognostic (1.62e-1)"	"unprognostic (1.50e-1)"		"unprognostic (1.66e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.48e-4)"	"unprognostic (9.32e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.80e-5)"	"unprognostic (1.78e-2)"	"unprognostic (2.79e-3)"	"unprognostic (5.91e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.84e-2)"	0.2	4.2	1.5	0.0	5.0	0.0	1.2	1.1	8.0	0.4	0.6	0.0	0.8	0.4	0.1	0.2	0.2	0.4	1.9	0.5	0.4	0.8	0.4	2.8	0.1	0.0	1.1	2.2	0.9	0.2	8.9	0.1	1.1	2.2	0.4	0.1	0.0	0.8	1.1	0.1	0.3	0.2	0.4	0.3	0.1	0.4	1.9	0.5	0.0	0.2	0.0	0.1	2.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.8	0.0	0.0	0.0	0.4	0.4	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	3.7	0.7	0.2	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	5.0	1.1	8.0	0.4	0.8	1.1	2.2	2.2	0.5
IL27RA	"CRL1, IL-27R, TCCR, WSX-1, WSX1, zcytor1"	ENSG00000104998	"Interleukin 27 receptor subunit alpha"	Q6UWB1	19	14031748-14053216	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 25.2;lymphoid tissue: 32.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA073441			Approved	Vesicles			4100000	Vesicles		"HPA073441: "	"prognostic favourable (1.74e-6)"	"unprognostic (1.99e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.35e-2)"	"prognostic unfavourable (2.58e-10)"	"unprognostic (5.45e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.87e-3)"	8.4	2.1	2.8	26.0	2.7	3.5	20.6	3.0	3.5	3.5	3.9	1.1	2.7	3.6	3.6	2.0	3.4	4.2	4.1	5.8	3.8	3.6	4.8	2.1	11.8	25.3	2.6	2.3	2.3	3.5	8.1	1.1	2.0	2.5	5.0	3.4	1.2	7.4	2.1	2.8	2.6	9.0	3.0	2.5	18.0	4.1	2.4	1.6	32.3	4.9	2.2	28.3	6.0	6.8	14.6	18.2	5.3	19.7	19.1	25.2	16.9	8.1	3.5	3.6	4.8	0.3	1.9	1.5	3.8	8.0	7.0	10.1	1.7	6.7	0.1	4.1	3.4	1.6	5.6	2.2	5.5	15.7	3.9	19.9	0.8	2.9	0.6	9.5	0.3	1.8	0.9	3.3	0.7	2.8	13.7	14.9	0.3	11.4	7.1	20.7	4.7	2.5	6.2	2.1	7.6	4.3	1.9	3.2	1.7	4.9	0.3	5.5	6.2	5.8	4.4	0.7	8.8	7.1	4.1	15.5	7.4	7.2	0.6	19.4	4.6	5.3	19.7	0.5	22.9	16.3	20.2	14.6	22.7	18.9	18.2	12.8	25.2	19.4	1.5	19.1	7.5	6.8	19.9	16.9	2.8	2.7	3.0	3.5	3.8	3.6	2.6	2.3	2.5	1.6
IL31	IL-31	ENSG00000204671	"Interleukin 31"	Q6EBC2	12	122172030-122174199	"Predicted secreted proteins"	Immunity	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 1.9"	"Group enriched"	"Detected in some"	11	"HDLM-2: 1.3;Karpas-707: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB025657	Uncertain				"Secreted to blood"	37797				"CAB025657: "														"unprognostic (1.70e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL36B	"FIL1, FILI-(ETA), IL-1F8, IL-1H2, IL1-ETA, IL1F8, IL1H2, MGC126880, MGC126882"	ENSG00000136696	"Interleukin 36 beta"	Q9NZH7	2	113022091-113052867	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"esophagus: 3.6;lymphoid tissue: 6.3;skin 1: 11.7"	"Cell line enriched"	"Detected in some"	21	"U-87 MG: 40.6"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA035664	Uncertain				"Secreted to blood"	15280				"HPA035664: AB_10669672"		"unprognostic (8.45e-2)"			"unprognostic (1.62e-1)"	"unprognostic (3.56e-2)"		"unprognostic (1.06e-1)"	"unprognostic (3.77e-2)"		"unprognostic (2.40e-3)"			"unprognostic (2.05e-1)"			"unprognostic (7.10e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0			0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.9	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0			0.0		6.3	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.7	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IL9R	CD129	ENSG00000124334	"Interleukin 9 receptor"	Q01113	X	155997581-156010817	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 6.3;urinary bladder: 10.9"	"Cell line enriched"	"Detected in some"	11	"HMC-1: 74.2"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 1.4"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.7;pons and medulla: 4.7;thalamus: 1.5"	"Cell type enhanced"	"Detected in many"		"eosinophil: 6.3"	"Group enriched"	"Detected in many"	25	"B-cells: 4.1;granulocytes: 6.3;T-cells: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA063240, HPA064557"	Approved				"Intracellular and membrane"					"HPA063240: , HPA064557: "	"unprognostic (1.07e-2)"	"unprognostic (3.27e-3)"	"unprognostic (9.52e-3)"	"unprognostic (4.13e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.26e-4)"	"unprognostic (8.94e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.98e-8)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.07e-1)"	"prognostic favourable (1.90e-7)"	0.3	0.1	0.3	1.1	1.7	0.4	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.7	3.0	0.3	0.5	0.4	0.9	0.3	0.3	0.2	0.3	0.5	1.3	3.2	0.3	0.3	0.3	0.3	0.0	0.3	0.3	4.7	0.4	1.2	0.3	0.4	0.3	0.3	0.4	2.4	0.3	0.3	3.5	0.8	0.3	1.5	0.3	0.4	0.3	2.9	10.9	0.3	4.1	0.0	6.3	0.0	0.1	2.4	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	6.8	0.0	0.0	0.0	0.1	74.2	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.3	2.6	1.3	0.0	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	0.0	1.8	0.8	1.3	0.0	4.1	0.0	0.0	1.8	0.1	0.0	0.0	2.4	0.3	0.3	1.7	0.4	0.3	0.3	0.2	0.3	0.3	4.7	1.5
ILDR2	C1orf32	ENSG00000143195	"Immunoglobulin like domain containing receptor 2"	Q71H61	1	166895711-166975482	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.6;testis: 18.0"	"Cell line enhanced"	"Detected in some"		"AF22: 9.8;MOLT-4: 5.1;U-2 OS: 12.6;U-251 MG: 6.6"	"Cancer enhanced"	"Detected in some"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA012545, HPA012815"	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA012545: AB_2126894, HPA012815: "	"unprognostic (9.14e-2)"	"unprognostic (5.05e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.89e-5)"	"unprognostic (2.09e-1)"	"unprognostic (8.55e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.87e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	0.8	1.1	9.8	0.9	6.4	1.4	0.5	2.1	14.6	0.7	2.9	3.6	0.1	0.7	0.9	1.4	0.9	0.8	1.3	3.1	7.2	7.7	6.3	1.3	1.4	1.0	2.7	8.0	0.8	0.7	0.5	3.3	0.8	3.1	2.3	1.2	2.8	0.8	2.8	0.8	0.7	0.8	2.0	2.3	0.7	0.7	18.0	3.1	1.9	0.9	0.0	1.1	0.9	0.3	0.0	0.4	0.3	0.0	0.0	0.3	0.5	0.0	0.0	9.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	1.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	2.3	1.9	0.0	0.0	0.2	0.0	3.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	5.1	0.0	3.4	0.0	0.0	0.3	0.7	0.7	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	12.6	0.0	6.6	2.3	0.0	0.5	1.4	1.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.5	9.8	6.4	2.1	11.4	7.2	7.7	2.7	8.0	3.1	3.1
IMMP1L	"FLJ25059, IMMP1"	ENSG00000148950	"Inner mitochondrial membrane peptidase subunit 1"	Q96LU5	11	31432401-31509645	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA058308	Approved									"HPA058308: "	"unprognostic (2.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (7.97e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.66e-3)"	"unprognostic (5.15e-3)"	"prognostic favourable (6.72e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.04e-3)"	9.1	16.6	25.4	11.6	27.8	8.8	15.4	28.4	18.5	10.0	11.3	11.7	12.8	12.1	9.6	25.6	8.4	7.7	5.1	20.4	21.7	17.4	16.2	11.9	10.7	11.2	16.1	12.1	14.0	23.8	7.2	18.2	8.7	11.4	11.2	8.3	17.4	13.6	12.0	39.8	10.1	10.3	9.3	13.2	7.6	10.8	13.8	12.6	17.6	10.0	13.3	10.8	6.8	7.5	16.4	20.0	14.8	1.7	16.9	21.7	7.8	10.7	15.7	41.7	12.4	5.6	3.8	7.8	14.3	3.2	6.0	4.6	12.0	8.3	11.2	10.0	6.1	12.5	14.3	10.8	9.1	15.1	30.3	13.3	23.5	15.3	6.0	17.3	12.8	3.2	9.7	3.5	7.7	6.4	21.2	13.6	5.7	13.4	21.8	24.9	8.5	13.8	17.2	36.0	10.9	20.4	13.3	11.5	13.2	16.6	8.3	14.2	18.9	17.8	3.0	14.1	14.0	10.9	22.8	12.4	25.7	19.6	18.5	11.8	13.8	9.0	1.7	14.8	15.6	1.6	14.5	16.4	14.0	15.5	4.0	15.0	17.7	21.7	0.3	16.9	1.6	20.0	16.6	7.8	25.4	27.8	28.4	18.5	21.7	17.4	16.1	12.1	11.4	12.6
IMMP2L	"IMMP2L-IT1, IMP2"	ENSG00000184903	"Inner mitochondrial membrane peptidase subunit 2"	Q96T52	7	110663051-111562517	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA026711	Approved		Approved	Mitochondria				Mitochondria		"HPA026711: AB_1851760"	"unprognostic (2.55e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavourable (1.89e-5)"	"unprognostic (5.64e-3)"	"unprognostic (1.00e-1)"	"unprognostic (4.17e-1)"	"unprognostic (5.68e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.71e-1)"	12.4	12.4	7.9	7.3	10.8	2.9	11.8	5.4	9.1	12.4	11.1	5.7	10.6	5.2	23.8	10.4	8.0	11.5	5.8	8.6	7.1	6.0	23.8	17.7	7.4	4.4	5.7	6.1	14.4	10.0	13.4	15.7	8.0	6.3	13.8	5.8	31.6	11.6	15.8	18.6	7.5	10.9	14.4	5.6	5.3	9.8	9.0	5.6	8.2	16.7	8.3	9.5	11.0	9.2	18.1	11.7	5.8	8.4	24.3	15.1	5.1	7.8	4.7	2.8	11.7	7.6	7.7	5.0	5.4	5.5	3.6	3.8	2.3	9.2	12.9	14.9	4.7	4.4	3.0	10.9	6.0	8.0	3.1	4.4	18.7	6.4	11.6	8.1	0.5	13.4	14.5	1.5	10.1	4.7	14.1	10.0	2.7	5.4	10.8	9.1	2.8	7.4	2.3	23.5	6.7	13.2	3.3	3.3	10.4	2.3	11.1	30.0	4.5	4.7	3.0	5.6	5.8	5.6	6.5	5.7	1.5	7.9	6.1	3.8	29.3	5.8	5.1	1.6	6.4	6.4	11.4	16.3	10.8	7.2	9.4	18.1	15.1	10.5	0.2	24.3	8.4	11.7	6.4	5.1	7.9	10.8	5.4	9.1	7.1	6.0	5.7	6.1	6.3	5.6
INPP4B		ENSG00000109452	"Inositol polyphosphate-4-phosphatase type II B"	O15327	4	142023160-142847432	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 51.5;SK-MEL-30: 22.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 19.2"	"Group enriched"	"Detected in many"	6	"NK-cells: 9.1;T-cells: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037681, HPA037682"	Approved		Approved	Centrosome				Centrosome		"HPA037681: AB_10670389, HPA037682: AB_10671377"	"unprognostic (9.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.03e-3)"	"unprognostic (5.76e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.39e-2)"	15.4	4.7	8.4	8.5	12.5	2.2	21.2	5.1	10.3	28.1	7.1	1.8	5.6	5.0	19.7	18.4	9.1	9.2	8.7	18.4	5.9	6.1	6.1	2.0	9.9	10.8	5.5	8.9	15.4	4.0	2.3	3.8	6.2	4.6	8.3	5.8	1.7	4.9	6.8	10.8	4.7	7.3	10.2	3.1	7.0	7.0	19.6	2.4	8.2	6.5	4.9	7.4	15.8	14.6	0.0	0.0	2.2	0.1	9.1	19.2	3.7	9.1	3.8	2.5	1.2	1.9	1.2	0.5	11.1	13.0	2.8	5.4	1.0	51.5	0.2	3.1	9.9	14.0	0.0	12.9	6.7	0.0	0.3	2.2	1.4	0.0	0.6	0.4	1.7	2.1	1.8	2.0	6.8	1.6	0.0	0.5	6.1	16.3	0.3	0.0	0.1	2.8	0.1	8.6	0.4	3.9	17.0	0.2	0.2	1.2	3.9	22.9	11.8	1.6	1.0	6.6	8.1	9.7	0.1	0.1	0.0	0.0	1.5	10.0	17.0	2.2	0.1	0.0	3.3	0.0	6.5	0.0	19.2	8.5	0.0	0.0	13.2	5.7	0.2	9.1	0.0	0.0	9.8	3.7	8.4	12.5	5.1	10.3	5.9	6.1	5.5	8.9	4.6	2.4
INS-IGF2		ENSG00000129965	"INS-IGF2 readthrough"	F8WCM5	11	2132538-2161209	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	148	"pancreas: 467.6"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 2.1;SH-SY5Y: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB019430	Enhanced				"Secreted to digestive system"					"CAB019430: AB_10691857"					"unprognostic (1.33e-1)"						"unprognostic (2.34e-1)"							0.1	0.4	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.3	0.1	0.0	0.3	0.0	0.4	467.6	0.0	0.1	3.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.1	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.3	0.1	0.3	0.0	0.0	0.0
INSL6	RIF1	ENSG00000120210	"Insulin like 6"	Q9Y581	9	5131979-5185668	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 22.3"	"Cell line enhanced"	"Detected in some"		"HEL: 1.1;HL-60: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA021364	Enhanced				"Secreted to blood"					"HPA021364: AB_1851807"	"unprognostic (3.85e-4)"	"unprognostic (7.41e-4)"						"unprognostic (1.28e-1)"		"unprognostic (1.94e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.30e-1)"		"unprognostic (2.52e-3)"	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.2	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	22.3	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0
IPP	KLHL27	ENSG00000197429	"Intracisternal A particle-promoted polypeptide"	Q9Y573	1	45694324-45750650	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075545	Approved									"HPA075545: "	"unprognostic (8.45e-3)"	"unprognostic (1.35e-1)"	"prognostic favourable (9.11e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.84e-3)"	"prognostic unfavourable (2.27e-4)"	"unprognostic (2.99e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.03e-2)"	"prognostic favourable (1.11e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-1)"	6.6	8.7	7.2	5.1	10.1	3.5	7.9	5.8	11.3	6.8	7.1	13.8	7.6	6.1	15.0	7.2	8.2	8.7	7.6	8.6	7.7	7.4	9.4	8.7	5.3	7.8	7.8	8.3	10.2	8.5	16.5	12.7	5.5	10.7	10.1	7.4	10.5	10.7	8.8	17.7	7.2	8.4	11.4	9.2	4.5	7.2	14.8	6.7	16.0	12.7	5.8	9.3	8.9	6.6	4.7	1.0	5.1	1.2	5.0	7.5	3.5	8.1	7.8	7.1	10.3	9.0	16.6	5.7	8.8	6.2	6.1	6.3	4.8	6.0	4.5	9.3	10.7	6.1	7.7	6.5	8.8	10.3	4.9	6.3	7.0	5.9	9.1	1.7	5.7	14.0	7.4	13.2	7.2	5.9	7.7	9.1	10.7	5.4	6.1	0.5	4.4	4.5	2.6	13.0	3.7	5.0	8.9	10.4	6.7	16.7	9.0	8.2	8.8	1.6	7.0	6.7	8.4	4.6	6.7	7.6	8.6	8.2	10.8	2.7	10.4	4.5	0.9	5.1	7.5	0.6	5.6	4.7	4.6	6.0	1.0	4.4	5.8	6.7	4.2	5.0	1.2	1.0	6.8	3.5	7.2	10.1	5.8	11.3	7.7	7.4	7.8	8.3	10.7	6.7
IQCA1	"DRC11, FLJ22527, IQCA"	ENSG00000132321	"IQ motif containing with AAA domain 1"	Q86XH1	2	236324147-236507542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 27.8;thyroid gland: 30.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.2;HBEC3-KT: 3.9;HeLa: 4.7;U-2 OS: 16.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 4.4"	"Group enriched"	"Detected in many"	4	"NK-cells: 1.2;T-cells: 4.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA057320			Uncertain	Nucleoplasm				Nucleoplasm		"HPA057320: "	"unprognostic (1.73e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.62e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.23e-5)"	"unprognostic (1.55e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.62e-1)"	"prognostic favourable (2.54e-4)"	"unprognostic (1.19e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.91e-3)"	"unprognostic (5.30e-2)"	1.8	2.7	13.4	1.4	19.2	0.8	3.5	3.8	11.6	2.2	1.0	6.7	0.4	0.9	3.4	9.1	1.6	17.8	3.5	1.1	12.9	10.0	6.6	0.8	5.1	1.3	8.8	9.3	4.7	2.4	0.9	27.8	1.1	13.0	3.1	1.0	2.7	2.6	2.8	0.8	0.9	1.2	1.5	3.2	5.5	1.1	7.4	8.0	1.4	30.0	0.0	1.6	3.0	1.0	0.7	0.0	0.0	0.0	1.2	4.4	0.1	0.1	0.0	0.3	0.3	0.0	0.0	0.4	0.2	0.0	0.1	0.4	0.1	0.0	0.0	4.2	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.0	4.7	0.0	0.1	0.0	0.0	0.3	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	16.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.2	0.8	0.0	0.7	1.1	4.4	0.0	1.2	0.0	0.0	0.3	0.1	13.4	19.2	3.8	10.0	12.9	10.0	8.8	9.3	13.0	8.0
IQCD	"CFAP84, DRC10"	ENSG00000166578	"IQ motif containing D"	Q96DY2	12	113195441-113221094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 22.4;testis: 33.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 22.3;CAPAN-2: 8.6;RPTEC TERT1: 11.0;U-698: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.6;classical monocyte: 2.8;myeloid DC: 2.1;plasmacytoid DC: 3.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.7;granulocytes: 3.6;monocytes: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA046810, HPA048782"	Supported		Approved	Nucleoplasm				Nucleoplasm		"HPA046810: , HPA048782: "	"unprognostic (3.90e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.26e-5)"	"unprognostic (2.23e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.04e-1)"	"prognostic favourable (3.90e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.20e-2)"	1.2	1.2	2.8	1.3	6.4	0.6	1.8	2.0	3.8	2.6	1.1	6.8	1.7	0.6	2.3	6.3	1.8	22.4	1.4	1.6	3.8	3.2	3.4	0.6	3.0	1.3	4.8	1.5	2.5	1.4	5.4	8.7	1.2	11.4	1.1	1.2	1.6	1.2	1.7	0.7	0.9	0.7	1.4	2.5	0.6	1.0	33.8	6.4	0.0	4.0	1.1	3.3	1.6	1.0	0.6	3.7	3.6	2.8	0.0	0.1	0.5	2.7	3.2	1.1	0.8	1.2	1.3	0.7	0.4	22.3	1.1	1.5	0.5	8.6	3.0	2.4	0.6	0.5	0.5	0.9	1.8	0.2	0.9	1.0	1.1	0.5	0.7	0.3	0.7	0.5	0.6	3.5	1.1	0.7	0.2	0.2	0.2	3.1	0.2	5.8	0.2	0.8	0.2	0.5	0.8	11.0	3.4	2.5	1.0	0.7	1.1	3.5	4.0	1.7	0.3	0.5	1.7	1.1	0.6	0.9	0.7	12.0	1.6	0.1	1.9	3.6	2.8	0.0	0.1	0.2	0.0	0.6	0.0	0.0	2.1	0.2	0.0	0.1	0.1	0.0	0.0	3.7	0.0	0.5	2.8	6.4	2.0	3.8	3.8	3.2	4.8	1.5	11.4	6.4
IQCH	FLJ12476	ENSG00000103599	"IQ motif containing H"	Q86VS3	15	67254800-67502260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 14.5;testis: 20.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.0;dendritic cells: 1.2;T-cells: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040845	Uncertain		Approved	Cytosol				Cytosol		"HPA040845: AB_10672898"	"unprognostic (2.69e-1)"	"unprognostic (2.94e-3)"	"unprognostic (3.11e-2)"	"unprognostic (5.89e-5)"	"unprognostic (2.48e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.16e-3)"	"unprognostic (6.42e-2)"	0.9	1.8	1.3	0.4	2.9	0.2	2.5	0.9	2.8	1.4	0.8	2.9	4.1	0.3	1.3	6.4	0.9	10.0	2.1	1.3	1.6	2.1	3.3	1.5	2.4	0.5	1.2	1.8	2.7	1.4	6.5	14.5	0.5	2.6	1.2	1.1	3.5	1.0	1.4	0.9	1.0	0.8	0.6	1.4	0.8	1.6	20.9	1.4	0.6	6.1	0.7	0.4	1.3	1.0	1.0	1.2	0.1	0.3	0.2	2.1	0.3	2.8	3.0	1.3	2.2	2.0	4.6	1.0	1.5	1.2	2.4	1.6	0.3	3.1	1.8	1.4	2.5	4.7	4.3	1.7	3.9	0.3	2.0	0.6	3.0	0.4	3.4	0.9	0.6	3.1	1.8	5.0	4.8	0.9	4.2	1.9	1.6	3.0	0.7	0.7	1.6	1.9	0.6	2.1	2.1	2.7	1.2	4.5	1.2	2.0	2.8	7.8	7.2	0.4	2.0	2.6	1.3	4.1	1.7	4.0	5.3	0.5	5.3	2.1	2.6	0.0	0.3	0.1	1.2	0.0	2.1	0.4	1.0	1.1	1.1	1.0	0.9	0.8	0.0	0.2	0.1	1.2	0.8	0.3	1.3	2.9	0.9	2.8	1.6	2.1	1.2	1.8	2.6	1.4
IQCJ		ENSG00000214216	"IQ motif containing J"	Q1A5X6	3	158962928-159266307	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 19.5"	"Cell line enriched"	"Detected in single"	21	"Daudi: 10.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052835	Uncertain									"HPA052835: "	"unprognostic (1.99e-2)"																	0.5	0.5	19.5	0.5	10.0	0.5	1.6	0.4	14.5	0.5	0.5	0.1	0.0	0.5	0.5	0.5	0.8	0.5	0.7	1.0	9.4	0.6	0.6	0.5	0.5	0.9	0.9	7.4	0.6	0.5	0.5	3.6	0.5	6.8	0.5	0.5	0.0	0.5	0.9	0.5	0.5	0.5	0.5	0.5	0.5	0.5	4.8	1.5	0.0	0.5	0.0	0.6	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	10.0	0.4	14.5	9.4	0.6	0.9	7.4	6.8	1.5
IQCK	"FLJ36575, MGC35048"	ENSG00000174628	"IQ motif containing K"	Q8N0W5	16	19716456-19858467	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026792, HPA048786"	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA026792: AB_1853889, HPA048786: "	"unprognostic (4.21e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.29e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.68e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.13e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.98e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	5.5	4.8	9.3	2.8	11.4	1.1	7.8	3.7	7.1	10.1	3.7	13.9	19.4	5.1	6.3	19.9	2.5	25.2	7.5	4.8	10.4	11.2	11.2	3.0	5.3	2.3	8.3	8.9	8.9	5.7	20.7	14.6	4.4	12.1	5.4	4.2	9.3	8.2	22.4	4.0	3.3	2.7	5.3	8.5	2.6	5.1	27.2	7.9	1.1	21.0	3.2	1.9	5.7	3.5	1.5	1.0	0.0	3.8	0.1	3.0	1.0	2.5	7.1	9.0	6.0	2.7	8.9	0.5	0.0	4.5	4.3	3.3	0.4	4.9	0.3	5.0	2.5	3.0	2.0	3.4	2.9	1.1	1.9	0.1	1.8	3.4	8.9	1.6	0.1	5.0	3.0	5.4	1.3	4.5	2.7	0.8	2.6	8.6	1.6	1.0	2.7	6.6	5.3	0.7	0.4	10.6	1.8	8.3	3.6	3.6	1.2	5.5	3.6	0.9	3.1	0.9	0.9	4.8	0.9	0.2	0.5	0.0	5.5	0.2	1.8	0.0	0.7	0.0	1.4	3.8	2.5	1.5	1.6	2.3	0.4	0.6	3.0	1.5	0.0	0.1	3.5	1.0	1.2	1.0	9.3	11.4	3.7	7.1	10.4	11.2	8.3	8.9	12.1	7.9
IQSEC3	"KIAA1110, MGC30156"	ENSG00000120645	"IQ motif and Sec7 domain 3"	Q9UPP2	12	66765-178460	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8"	"Cell line enhanced"	"Detected in some"		"HEL: 9.4;U-266/70: 12.7;U-266/84: 3.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.2;plasmacytoid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039025			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA039025: AB_10672768"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.82e-3)"	"unprognostic (2.83e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.36e-2)"	5.6	1.3	5.6	0.7	4.2	0.8	0.4	19.8	15.5	1.6	0.4	0.5	0.0	0.5	2.0	0.5	0.4	5.2	2.2	1.9	6.5	5.1	2.4	0.2	2.9	0.5	3.7	4.7	2.1	1.2	0.0	2.2	1.3	5.0	1.5	0.2	0.4	0.2	4.5	1.3	0.2	0.7	1.9	1.4	0.3	0.6	1.2	0.8	0.0	0.3	0.0	0.2	1.3	0.6	0.0	2.1	0.0	0.0	0.5	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	12.7	3.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	1.2	0.0	0.5	0.0	2.1	0.0	0.4	5.6	4.2	19.8	12.4	6.5	5.1	3.7	4.7	5.0	0.8
IRGC	"CINEMA, Iigp5, IRGC1"	ENSG00000124449	"Immunity related GTPase cinema"	Q6NXR0	19	43716010-43720021	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"testis: 49.4"	"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA046769, HPA060064"	Enhanced									"HPA046769: , HPA060064: "		"unprognostic (3.38e-2)"		"unprognostic (3.83e-2)"	"unprognostic (8.52e-2)"					"unprognostic (1.26e-1)"				"unprognostic (2.55e-1)"	"unprognostic (2.81e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IRX1	IRX-5	ENSG00000170549	"Iroquois homeobox 1"	P78414	5	3596054-3601403	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.1;breast: 36.0;salivary gland: 20.9"	"Group enriched"	"Detected in some"	4	"AF22: 7.0;REH: 28.3;U-251 MG: 11.5"	"Group enriched"	"Detected in many"	6	"breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043160	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA043160: AB_10794771"	"unprognostic (1.52e-2)"				"unprognostic (1.26e-2)"	"unprognostic (2.27e-1)"		"unprognostic (3.73e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.78e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.58e-2)"		5.3	0.4	2.6	0.4	2.1	1.4	36.0	6.6	1.5	0.4	0.4	2.0	6.0	0.4	0.4	1.7	0.8	0.4	0.4	1.0	3.1	3.2	13.9	0.4	8.0	0.6	4.2	1.0	0.4	0.7	0.4	0.7	0.4	16.1	0.5	0.4	2.8	20.9	1.5	0.4	6.8	0.4	0.4	5.1	0.4	0.4	0.5	1.6	3.0	0.5	0.5	0.9	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.4	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	28.3	0.0	0.0	2.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.1	6.6	0.2	3.1	3.2	4.2	1.0	16.1	1.6
IRX3	IRX-1	ENSG00000177508	"Iroquois homeobox 3"	P78415	16	54283304-54286763	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 87.8"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 28.5;NB-4: 47.2;RPTEC TERT1: 56.9;T-47d: 29.4;THP-1: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062522			Approved	Vesicles				Vesicles		"HPA062522: "	"unprognostic (4.21e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.25e-1)"	4.4	2.5	1.8	0.1	2.1	0.0	38.3	3.8	0.7	15.3	0.5	1.5	46.8	0.1	4.0	18.1	14.1	5.3	0.2	46.9	3.2	3.6	9.8	1.0	46.8	1.9	4.6	0.3	1.6	2.1	15.4	3.4	1.0	7.8	10.0	0.0	5.9	20.5	87.8	9.1	33.8	0.2	0.6	8.2	0.2	7.7	1.4	3.2	0.4	8.9	9.1	6.5	2.6	6.6	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.2	0.2	3.7	3.6	2.0	0.8	0.4	1.5	3.4	3.3	0.8	1.0	1.6	0.0	0.5	2.3	6.9	3.0	0.8	4.5	3.3	2.3	0.0	5.0	3.4	0.1	3.8	1.0	0.6	14.4	6.4	2.9	0.0	0.0	0.0	28.5	1.7	7.0	47.2	0.2	0.0	5.3	4.6	0.0	56.9	1.4	2.5	0.4	4.8	12.3	0.5	29.4	47.1	0.8	14.1	1.5	2.5	1.2	0.0	0.0	0.0	9.2	12.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	1.8	2.1	3.8	0.3	3.2	3.6	4.6	0.3	7.8	3.2
IRX6	"IRX-3, IRX7"	ENSG00000159387	"Iroquois homeobox 6"	P78412	16	55323760-55330760	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 11.1;breast: 18.9;heart muscle: 11.1;skin 1: 9.3"	"Cell line enhanced"	"Detected in some"		"AF22: 2.4;HEK 293: 2.8;RPTEC TERT1: 10.4;SK-MEL-30: 6.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"B-cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA018332	Uncertain		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA018332: AB_1851920"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"		"unprognostic (4.93e-4)"	"unprognostic (2.48e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.46e-1)"	"prognostic favourable (3.34e-4)"	"unprognostic (3.63e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.63e-3)"	"unprognostic (7.12e-3)"	"unprognostic (5.48e-2)"	"unprognostic (5.23e-3)"	11.1	0.0	0.2	0.2	1.4	0.0	18.9	0.2	0.5	3.3	0.2	0.2	0.2	0.0	0.6	0.2	0.5	0.0	0.2	11.1	0.2	0.4	1.5	0.2	2.3	0.2	0.2	0.2	0.5	0.2	0.1	0.2	0.2	0.2	0.2	0.0	2.0	2.5	0.2	2.7	9.3	0.2	0.2	0.2	1.6	0.0	0.6	0.2	3.5	0.7	0.2	2.3	0.2	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	10.4	0.0	0.2	0.1	0.1	1.7	6.6	0.6	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.2	0.5	0.2	0.4	0.2	0.2	0.2	0.2
ISLR	HsT17563	ENSG00000129009	"Immunoglobulin superfamily containing leucine rich repeat"	O14498	15	74173671-74176872	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 33.1;ASC TERT1: 17.8;fHDF/TERT166: 74.3;HSkMC: 13.5;RPMI-8226: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"olfactory region: 145.0"	"Low region specificity"	"Detected in many"			"HPA040326, HPA050811"	Approved		Approved	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"		110000000	"Plasma membrane"	"Golgi apparatus"	"HPA040326: , HPA050811: "	"unprognostic (2.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.16e-2)"	"unprognostic (6.81e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavourable (4.89e-8)"	"unprognostic (1.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.86e-3)"	24.6	6.8	3.3	10.4	4.6	0.1	21.4	2.0	12.1	72.8	19.7	2.9	13.2	4.1	67.3	36.3	23.0	22.1	29.6	17.7	1.7	1.7	8.0	2.5	10.2	5.8	3.3	7.2	80.2	3.4	1.2	13.8	31.5	3.9	32.2	4.0	36.4	10.0	17.9	12.5	13.6	8.8	27.5	9.0	9.8	10.3	16.3	0.6	1.3	18.9	17.0	9.9	27.9	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	33.1	17.8	0.1	5.1	0.0	0.0	0.0	0.0	2.0	0.0	0.3	74.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	22.8	0.0	0.0	0.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.9	0.0	0.1	0.5	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.6	2.0	12.1	1.7	1.7	3.3	7.2	3.9	0.6
ISLR2	KIAA1465	ENSG00000167178	"Immunoglobulin superfamily containing leucine rich repeat 2"	Q6UXK2	15	74100311-74138540	"Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.9;testis: 11.6"	"Group enriched"	"Detected in some"	12	"SCLC-21H: 26.9;SH-SY5Y: 40.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA012930, HPA067333"	Uncertain						66000			"HPA012930: , HPA067333: "	"unprognostic (1.31e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.44e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.53e-3)"	"unprognostic (7.73e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.46e-2)"	"unprognostic (9.19e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.44e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.64e-2)"	1.6	2.1	7.5	1.0	16.8	0.4	1.5	2.0	25.9	2.4	1.2	0.1	0.0	1.1	3.9	0.6	1.2	2.0	1.6	6.3	3.5	4.8	0.5	0.5	1.2	2.6	0.7	7.2	0.6	1.3	1.3	0.6	0.6	1.7	0.7	0.9	3.0	0.9	1.1	3.0	1.0	2.0	1.8	0.3	1.5	1.0	11.6	3.4	0.0	0.7	2.1	0.6	0.9	0.4	1.1	0.9	2.5	0.7	0.5	0.4	0.2	0.0	0.1	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	26.9	40.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	1.5	0.7	0.2	0.4	0.3	0.2	0.5	0.3	0.2	0.2	1.1	0.4	0.4	2.5	0.5	0.4	0.9	0.2	0.2	7.5	16.8	2.0	20.3	3.5	4.8	0.7	7.2	1.7	3.4
ISM2	"FLJ32147, TAIL1, THSD3"	ENSG00000100593	"Isthmin 2"	Q6H9L7	14	77474394-77498850	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"placenta: 193.8"	"Cell line enriched"	"Detected in some"	15	"BEWO: 89.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"basal ganglia: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA039314, HPA039742"	Supported		Supported	Nucleoplasm	"Secreted in female reproductive system"			Nucleoplasm		"HPA039314: AB_10673239, HPA039742: AB_10673427"	"unprognostic (5.69e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.34e-1)"		"unprognostic (2.16e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.13e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.95e-1)"	0.7	0.0	0.2	0.2	4.2	0.0	0.1	0.1	0.3	1.1	0.2	0.1	0.3	0.1	2.7	0.9	0.2	0.5	0.1	0.1	0.1	0.8	0.6	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.1	0.5	193.8	0.2	3.2	0.0	0.2	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.4	0.2	0.1	0.2	0.1	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.1	0.3	0.1	0.8	0.1	0.1	0.2	0.2
ITGB8		ENSG00000105855	"Integrin subunit beta 8"	P26012	7	20330702-20415754	"Cancer-related genes, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 16.3;EFO-21: 21.0;RPTEC TERT1: 32.6;WM-115: 46.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	105	"basophil: 13.8"	"Lineage enriched"	"Detected in single"	105	"granulocytes: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027796, HPA027797"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA027796: AB_10600299, HPA027797: AB_10600879"	"unprognostic (8.32e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.47e-2)"	"prognostic favourable (1.77e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.92e-3)"	4.7	4.1	18.0	5.8	20.0	1.2	12.7	7.8	24.3	22.1	4.6	19.4	9.0	4.6	10.5	19.0	8.8	10.4	11.7	3.9	19.4	12.5	28.1	1.7	3.7	1.3	29.3	14.5	7.1	17.5	8.1	7.7	10.7	22.8	9.6	4.4	37.5	16.6	13.1	0.9	8.5	6.0	7.0	23.1	0.8	6.2	8.7	24.0	0.0	3.4	1.3	9.0	6.8	9.9	0.0	0.0	13.8	0.1	0.0	0.1	0.0	10.0	0.4	16.3	2.0	1.4	5.7	0.0	0.0	0.1	0.1	0.5	0.1	2.5	0.0	21.0	0.7	11.2	0.7	1.6	0.2	0.0	0.2	0.0	7.8	0.0	0.7	0.0	0.0	0.6	4.6	0.2	0.8	0.8	0.0	3.0	0.3	0.0	0.0	0.0	1.2	1.8	0.0	1.4	0.0	32.6	0.8	0.2	0.7	3.1	0.0	8.1	0.2	0.0	1.1	4.3	2.8	1.2	2.1	3.8	0.0	0.0	1.0	0.0	46.6	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	18.0	20.0	7.8	14.2	19.4	12.5	29.3	14.5	22.8	24.0
ITLN2	HL-2	ENSG00000158764	"Intelectin 2"	Q8WWU7	1	160945025-160954799	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"intestine: 88.4"	"Cell line enhanced"	"Detected in some"		"HEL: 15.3;HHSteC: 2.6;HMC-1: 4.6;SK-MEL-30: 4.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA006683, HPA067326"	Enhanced				"Secreted to digestive system"					"HPA006683: AB_2129681, HPA067326: "		"unprognostic (1.42e-1)"	"unprognostic (9.62e-3)"	"unprognostic (4.61e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.84e-4)"	"unprognostic (2.47e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.01e-1)"		"unprognostic (1.84e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.91e-2)"	3.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	27.4	0.1	0.1	53.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	2.5	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	88.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	2.6	0.0	4.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
IZUMO2	"C19orf41, MGC33947, SCRL"	ENSG00000161652	"IZUMO family member 2"	Q6UXV1	19	50152548-50163195	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"testis: 33.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.6;RH-30: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042143	Uncertain									"HPA042143: AB_10794078"			"unprognostic (1.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.31e-2)"			"unprognostic (1.81e-1)"		"unprognostic (1.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"		"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.75e-2)"		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.4	1.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	1.0	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.1	0.8	0.1	0.0	0.1	0.0	0.1	0.0
IZUMO4	C19orf36	ENSG00000099840	"IZUMO family member 4"	Q1ZYL8	19	2096429-2099593	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 108.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 10.8;RPMI-8226: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048496	Enhanced				"Secreted in male reproductive system"					"HPA048496: "	"unprognostic (2.75e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.65e-2)"	"prognostic favourable (7.08e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.18e-5)"	"unprognostic (2.67e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.48e-1)"	"prognostic favourable (1.69e-4)"	"unprognostic (2.12e-1)"	"unprognostic (6.58e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.68e-1)"	"unprognostic (7.51e-3)"	1.6	1.1	4.4	0.9	5.6	0.6	0.9	1.3	4.4	1.0	0.8	2.9	1.2	0.6	0.9	1.6	1.0	1.4	1.3	1.6	4.4	2.1	1.1	2.0	0.9	1.1	10.5	3.3	3.0	8.3	0.8	2.7	0.6	4.2	1.9	0.8	0.6	1.4	1.6	0.9	1.4	0.7	0.7	3.6	0.8	1.0	108.2	6.6	0.4	1.3	0.8	1.4	0.9	0.6	5.3	2.8	3.4	3.1	1.0	5.1	2.6	0.7	0.7	0.4	3.3	1.5	1.6	0.4	0.5	0.8	0.6	0.1	0.3	0.7	0.6	0.8	0.8	0.7	0.1	3.7	0.2	1.5	0.2	0.0	1.3	1.0	4.2	0.0	0.6	0.6	1.4	1.0	1.1	0.0	0.0	10.8	1.4	0.2	1.0	0.3	0.3	0.9	0.8	0.0	13.1	1.7	0.4	0.6	0.9	0.5	1.2	0.5	0.6	1.2	0.5	0.5	0.2	0.1	0.3	1.2	1.4	1.0	1.8	1.1	0.3	0.0	1.6	1.4	1.6	2.2	3.5	5.3	5.1	3.7	2.2	1.8	4.1	1.7	3.4	1.0	3.1	2.8	4.7	2.6	4.4	5.6	1.3	4.4	4.4	2.1	10.5	3.3	4.2	6.6
JAKMIP3	"bA140A10.5, C10orf14, C10orf39, FLJ37857, KIAA4091, NECC2"	ENSG00000188385	"Janus kinase and microtubule interacting protein 3"	Q5VZ66	10	132104671-132184809	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.8"	"Cell line enhanced"	"Detected in some"		"A549: 4.5;RPMI-8226: 2.5;U-266/84: 10.5"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022872	Uncertain									"HPA022872: AB_2249331"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.55e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.28e-5)"	"unprognostic (1.55e-2)"	"unprognostic (5.71e-6)"	"unprognostic (1.43e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.19e-4)"	"unprognostic (1.59e-2)"	0.2	1.8	2.7	0.0	2.8	0.1	0.6	5.2	8.8	0.3	0.1			0.0	1.2	0.6	0.5	0.9	0.6	1.0	4.2	4.1	0.0	0.0	0.2	0.0	5.2		3.5	0.6	0.0	2.8	0.0		3.3	0.2		0.4	1.6	1.5	0.2	0.1	1.0	7.0	0.1	0.5	1.1			0.4		0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.2	2.1	0.1	0.0	0.1	0.2	0.3	0.1	0.0	0.1	1.7	0.2	1.8	0.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.8	1.6	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.1	1.3	0.1	0.0	0.0	2.5	0.0	0.1	0.9	0.3	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.9	0.1	0.0	0.3	10.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
JHY	"C11orf63, FLJ23554, Jhy"	ENSG00000109944	"Junctional cadherin complex regulator"	Q6NUN7	11	122882528-122959798	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 51.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039612, HPA040344, HPA077658, HPA077748"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA039612: AB_10674424, HPA040344: , HPA077658: , HPA077748: "	"unprognostic (5.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"prognostic favourable (7.94e-5)"	"unprognostic (9.97e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.97e-1)"	"prognostic favourable (8.77e-4)"	"unprognostic (6.46e-3)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (2.58e-4)"	"unprognostic (7.79e-2)"	3.6	0.9	1.9	1.6	2.1	0.2	2.3	1.6	2.2	2.1	2.4	1.2	1.0	0.7	1.5	2.5	1.0	5.1	1.5	1.6	1.5	2.6	5.3	1.0	2.8	1.0	1.7	1.4	2.1	1.5	6.3	4.2	2.3	1.7	2.3	0.8	1.9	1.0	1.5	2.4	1.0	1.2	1.0	2.2	1.3	1.0	51.0	1.3	1.4	3.4	1.5	1.2	1.7	1.2	2.4	4.9	0.3	0.6	4.3	4.1	1.1	2.8	3.9	2.3	0.1	0.6	0.4	0.7	6.0	7.0	2.5	1.1	0.2	10.5	0.0	1.5	9.2	2.4	2.7	1.4	1.2	9.3	2.8	0.1	1.9	0.1	0.9	1.6	4.9	2.9	7.7	0.4	0.6	3.8	0.0	0.0	1.9	1.7	0.0	0.6	0.3	3.6	0.9	0.0	1.2	7.2	3.2	6.0	4.3	7.2	3.9	2.6	4.8	0.6	1.2	8.3	1.0	0.2	4.8	0.1	0.0	0.0	2.2	2.1	5.5	0.3	0.6	0.1	2.9	0.1	4.1	2.4	3.0	3.9	4.9	1.4	2.1	2.1	0.3	4.3	0.0	1.1	0.6	1.1	1.9	2.1	1.6	2.2	1.5	2.6	1.7	1.4	1.7	1.3
JKAMP	"C14orf100, CDA06, HSPC213, HSPC327, JAMP"	ENSG00000050130	"JNK1/MAPK8 associated membrane protein"	Q9P055	14	59484443-59505410	"Cancer-related genes, Predicted membrane proteins"	"Unfolded protein response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA031172, HPA071650"	Supported		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA031172: AB_10670563, HPA071650: "	"unprognostic (1.48e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.49e-3)"	"prognostic unfavourable (3.09e-6)"	"unprognostic (2.68e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.14e-1)"	"prognostic favourable (1.36e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.73e-1)"	19.0	29.5	19.3	13.0	25.5	15.7	24.2	16.7	28.4	17.5	21.3	25.0	18.1	13.8	22.8	19.6	18.6	23.2	21.7	18.3	18.8	29.4	38.9	26.1	22.2	16.2	29.5	19.5	19.7	18.7	42.3	44.5	24.1	36.9	22.9	22.5	22.8	24.9	20.3	15.9	17.5	25.0	20.7	30.3	22.1	18.7	24.6	27.0	18.6	24.6	18.0	14.7	21.0	16.7	14.9	29.0	37.0	31.7	18.0	18.3	21.5	19.7	23.3	20.1	16.4	15.0	19.9	15.3	31.0	26.5	18.3	21.8	7.3	36.2	9.8	27.8	28.6	14.4	14.7	19.1	24.7	29.3	8.4	9.8	15.0	14.5	20.0	16.5	19.4	21.7	21.7	17.1	11.8	18.6	8.9	19.7	34.4	17.8	9.0	12.7	11.0	20.6	10.6	24.4	9.0	31.5	19.6	8.6	15.0	28.1	22.5	16.4	22.7	12.7	24.4	19.3	25.3	17.6	20.3	9.2	16.3	11.4	27.3	11.2	24.2	28.2	25.2	32.5	15.1	29.8	14.6	14.9	16.5	15.9	21.2	13.6	17.7	16.6	37.0	18.0	31.7	29.0	18.3	21.5	19.3	25.5	16.7	28.4	18.8	29.4	29.5	19.5	36.9	27.0
JPH3	"CAGL237, HDL2, JP-3, JP3, TNRC22"	ENSG00000154118	"Junctophilin 3"	Q8WXH2	16	87601835-87698156	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 44.2"	"Cell line enhanced"	"Detected in some"		"MCF7: 6.4;NTERA-2: 5.7;SH-SY5Y: 7.3;SiHa: 4.7;U-2 OS: 23.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076304			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA076304: "	"unprognostic (8.97e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.82e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.28e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.36e-2)"	1.3	3.6	27.2	1.6	24.1	1.1	1.2	18.9	44.2	1.5	1.4	1.2	0.0	1.4	1.3	1.2	2.4	1.4	1.2	1.2	30.9	14.6	1.2	1.2	1.2	1.2	8.3	12.2	1.1	1.5	1.2	4.4	1.2	6.4	1.3	1.3	0.8	1.2	1.7	1.1	1.2	1.7	1.3	3.3	1.2	1.5	1.8	3.5	0.0	1.2	0.0	1.2	1.1	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.8	0.0	0.0	1.5	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.4	0.0	0.0	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.5	7.3	4.7	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	27.2	24.1	18.9	30.3	30.9	14.6	8.3	12.2	6.4	3.5
JPH4	"JPHL1, KIAA1831"	ENSG00000092051	"Junctophilin 4"	Q96JJ6	14	23568035-23578800	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.7;seminal vesicle: 37.8"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 9.9;SH-SY5Y: 24.6;U-2 OS: 18.6"	"Cancer enhanced"	"Detected in some"		"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 5.4;myeloid DC: 5.9"	"Group enriched"	"Detected in many"	14	"dendritic cells: 5.9;monocytes: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013492			Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB013492: "	"unprognostic (3.30e-2)"	"unprognostic (1.91e-3)"	"unprognostic (5.05e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.77e-3)"	"unprognostic (5.98e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.96e-3)"	1.9	12.3	33.6	2.0	43.8	1.3	1.6	45.3	63.7	3.4	1.9	2.1	8.0	1.8	17.1	6.2	1.5	5.1	1.6	1.3	32.3	16.8	2.7	1.3	3.4	2.0	8.3	27.6	6.2	1.5	3.1	23.2	1.6	9.8	11.6	1.7	0.8	1.2	37.8	1.2	1.6	2.2	13.9	4.2	2.9	1.7	2.2	10.9	0.0	1.3	0.0	1.7	1.7	1.8	0.0	5.9	0.4	5.4	0.0	0.0	1.0	0.0	0.0	0.5	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	9.9	24.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	5.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	33.6	43.8	45.3	42.6	32.3	16.8	8.3	27.6	9.8	10.9
JRKL	HHMJG	ENSG00000183340	"JRK like"	Q9Y4A0	11	96389989-96507574	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046184, HPA060341"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"				Nucleoplasm	"Cytokinetic bridge"	"HPA046184: AB_10963576, HPA060341: "	"unprognostic (4.59e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	"unprognostic (4.94e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.12e-2)"	"unprognostic (3.99e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.20e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.57e-3)"	11.5	7.8	10.4	10.2	12.3	1.4	10.3	11.1	9.8	12.5	10.1	6.2	7.9	8.2	13.0	9.1	9.7	12.3	8.7	8.4	9.2	6.8	9.1	5.9	8.0	9.7	10.0	7.8	16.4	7.0	13.4	15.6	12.0	10.0	13.5	10.7	6.0	9.7	11.7	9.9	8.9	12.4	12.8	17.9	10.4	9.9	17.9	13.1	11.6	14.0	6.3	10.3	12.4	14.8	5.3	9.0	6.0	5.7	3.9	7.6	3.4	6.7	4.3	9.0	6.6	18.0	20.1	6.5	11.5	7.9	8.4	10.9	7.2	16.5	9.3	16.9	10.6	10.7	4.4	7.8	9.7	10.0	4.1	8.6	11.1	5.4	14.5	4.8	5.5	9.5	12.5	12.0	15.1	7.5	4.5	4.1	13.4	1.4	6.2	14.0	1.3	5.9	6.4	8.6	7.5	10.2	7.1	3.6	6.5	6.7	4.7	5.0	5.6	6.6	9.1	16.0	7.1	13.9	4.6	3.5	7.7	5.5	7.4	7.9	6.9	6.0	5.7	5.5	3.8	4.5	5.3	5.3	6.0	4.7	5.7	4.1	7.6	6.8	2.1	3.9	5.2	9.0	2.8	3.4	10.4	12.3	11.1	9.8	9.2	6.8	10.0	7.8	10.0	13.1
KAAG1	"RU2, RU2AS"	ENSG00000146049	"Kidney associated antigen 1"	Q9UBP8	6	24356903-24358284	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"kidney: 9.1;pancreas: 4.3"	"Group enriched"	"Detected in some"	4	"CACO-2: 8.5;EFO-21: 6.8;Hep G2: 8.3"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA036021	Approved									"HPA036021: AB_10601918"	"unprognostic (7.57e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.77e-2)"		"unprognostic (1.87e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.23e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.3	0.9	0.0	0.1	0.4	0.0	0.0	0.0	9.1	1.3	0.0	0.0	0.0		0.1	4.3	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			1.7		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1										
KANK4	"ANKRD38, KIAA0172"	ENSG00000132854	"KN motif and ankyrin repeat domains 4"	Q5T7N3	1	62236979-62319414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.2;pancreas: 18.4;parathyroid gland: 20.4;placenta: 14.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 26.0;CACO-2: 3.7;Hep G2: 10.9;SCLC-21H: 5.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 23.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014030	Uncertain		Uncertain	Microtubules,Cytosol				Cytosol	Microtubules	"HPA014030: AB_2128155"	"unprognostic (1.66e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.74e-6)"	10.6	0.7	0.9	1.0	3.1	0.1	3.1	0.5	2.2	0.6	1.2	8.9	1.0	0.4	0.3	1.0	0.4	0.7	0.6	0.6	1.9	2.7	1.7	3.6	2.9	0.1	11.1	0.1	0.4	18.4	20.4	0.4	14.4	23.2	1.8	1.2	2.6	10.4	0.8	0.5	0.8	0.6	0.2	13.4	0.8	2.4	1.0	4.9	0.1	0.7	0.8	0.2	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	26.0	0.1	0.0	0.1	0.0	3.7	0.0	0.0	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	10.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.8	0.5	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	3.1	0.5	2.2	1.9	2.7	11.1	0.1	23.2	4.9
KBTBD3	BKLHD3	ENSG00000182359	"Kelch repeat and BTB domain containing 3"	Q8NAB2	11	106051098-106077765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047385	Uncertain									"HPA047385: "	"unprognostic (9.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.43e-2)"	"unprognostic (4.09e-2)"	"unprognostic (8.73e-3)"	"unprognostic (6.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.43e-1)"	"prognostic favourable (3.42e-7)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.55e-2)"	4.6	6.7	9.3	3.7	11.4	2.4	7.8	29.8	13.6	7.2	4.7	11.9	4.1	5.0	6.2	11.2	5.0	6.4	2.8	7.6	10.6	7.1	10.9	6.9	5.9	4.0	15.7	9.4	9.2	7.3	8.3	17.1	2.6	18.1	6.4	4.5	4.6	9.8	7.7	7.1	5.1	4.4	5.0	12.9	4.7	5.0	8.1	14.5	2.7	9.8	2.9	4.7	5.1	4.8	10.4	6.1	18.5	4.6	10.8	11.9	6.3	3.0	2.4	4.5	5.2	6.4	6.3	1.3	2.8	4.0	2.5	2.1	2.0	6.1	2.0	7.7	1.1	2.3	2.5	2.6	2.1	4.1	1.0	4.9	1.2	2.2	2.8	1.6	3.8	2.5	6.7	2.2	2.1	3.7	1.9	4.1	2.6	0.7	4.3	4.3	2.0	3.3	2.1	3.0	7.6	8.9	0.8	3.9	4.4	3.6	4.2	2.9	5.7	2.6	3.1	1.3	2.2	1.3	1.2	1.8	1.0	3.8	2.5	4.1	2.2	18.5	4.6	13.8	10.4	2.6	9.2	10.4	11.8	10.6	6.1	9.1	11.3	9.6	2.9	10.8	2.5	3.4	11.9	6.3	9.3	11.4	29.8	13.6	10.6	7.1	15.7	9.4	18.1	14.5
KCNAB3	"AKR6A9, KCNA3B"	ENSG00000170049	"Potassium voltage-gated channel subfamily A regulatory beta subunit 3"	O43448	17	7921859-7929803	"Predicted intracellular proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 36.1;endometrium 1: 17.2"	"Cell line enhanced"	"Detected in many"		"REH: 14.9;SH-SY5Y: 8.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"cerebellum: 36.1;cerebral cortex: 31.6"	"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.5;plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077993			Approved	Mitochondria				Mitochondria		"HPA077993: "	"unprognostic (3.02e-2)"	"unprognostic (5.59e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (5.84e-4)"	"unprognostic (2.19e-1)"	"unprognostic (5.72e-2)"	"unprognostic (8.50e-2)"	"unprognostic (8.55e-2)"	"unprognostic (3.27e-4)"	"unprognostic (7.47e-3)"	"unprognostic (3.03e-6)"	"unprognostic (2.12e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.97e-2)"	"unprognostic (9.54e-3)"	1.4	0.7	4.2	2.7	5.2	5.5	1.2	36.1	31.6	1.8	1.4	0.8	0.0	1.3	17.2	2.2	0.8	3.5	2.1	0.7	4.7	2.9	1.7	1.1	1.5	3.8	2.4	6.3	2.1	1.0	0.8	4.9	1.6	5.9	2.3	2.0	3.8	1.3	1.4	1.0	3.3	1.9	11.4	5.2	2.6	2.2	1.7	1.9	0.8	1.6	0.0	3.3	1.0	1.0	0.1	1.7	0.5	0.2	0.0	0.7	0.1	1.3	1.1	5.5	1.4	0.6	1.4	1.9	4.9	3.1	4.2	4.8	0.7	0.3	2.2	0.3	0.8	0.4	1.5	0.7	6.0	1.8	2.3	0.7	0.9	0.0	5.1	0.2	3.0	2.1	1.6	4.5	0.2	0.3	0.5	0.3	0.7	1.0	0.8	2.6	0.8	0.7	14.9	1.5	0.6	0.5	1.7	0.3	8.0	0.4	0.0	0.9	1.4	0.1	0.3	0.7	2.8	1.1	0.4	1.1	1.2	1.2	2.1	2.9	1.0	0.0	0.2	0.0	0.5	0.0	0.7	0.0	0.0	0.0	1.5	0.1	0.2	0.2	0.5	0.0	0.0	1.7	0.0	0.1	4.2	5.2	36.1	31.6	4.7	2.9	2.4	6.3	5.9	1.9
KCNB2	Kv2.2	ENSG00000182674	"Potassium voltage-gated channel subfamily B member 2"	Q92953	8	72537391-72938349	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2"	"Group enriched"	"Detected in some"	5	"HaCaT: 3.2;HDLM-2: 3.0;HEK 293: 7.4;SCLC-21H: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA065970			Approved	"Nucleoli,Plasma membrane,Midbody"				"Plasma membrane"	"Nucleoli, Midbody"	"HPA065970: "	"unprognostic (9.87e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"		"unprognostic (1.44e-2)"		"unprognostic (2.72e-1)"	"unprognostic (6.93e-5)"	"unprognostic (5.53e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.26e-1)"		0.8	1.9	3.8	0.6	5.3	0.4	0.7	0.3	9.7	0.5	0.7	0.0	0.0	1.2	0.4	0.4	1.1	2.1	0.5	0.4	7.1	3.1	0.5	0.4	0.6	0.5	0.9	7.8	0.4	2.4	0.4	9.2	0.5	3.2	0.7	0.7	4.2	0.5	0.5	0.4	0.4	1.6	0.5	1.6	8.6	2.4	1.7	0.4	0.9	0.4	0.0	0.9	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	5.3	0.3	9.7	7.1	3.1	0.9	7.8	3.2	0.4
KCNH7	"erg3, HERG3, Kv11.3"	ENSG00000184611	"Potassium voltage-gated channel subfamily H member 7"	Q9NS40	2	162371407-162838730	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.0;pituitary gland: 5.4"	"Group enriched"	"Detected in some"	13	"SCLC-21H: 10.5;SK-BR-3: 9.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.5;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018039	Uncertain									"HPA018039: AB_1852125"	"unprognostic (1.80e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.66e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.12e-3)"	"unprognostic (7.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.52e-2)"	"unprognostic (7.55e-3)"	"unprognostic (2.76e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.68e-2)"	0.4	1.0	4.4	0.9	6.8	0.8	0.4	6.0	11.0	0.4	0.4	0.0	0.7	0.7	0.4	0.6	0.4	0.5	0.4	1.0	2.6	1.8	0.6	2.7	0.5	0.5	0.7	4.6	0.4	1.0	0.3	5.4	0.6	3.1	0.4	0.3	0.4	0.4	1.5	0.3	0.4	0.5	0.4	0.7	1.1	2.5	1.6	0.3	0.0	0.4	0.0	0.3	0.4	0.4	0.1	0.1	3.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	10.5	0.7	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.0	4.4	6.8	6.0	11.0	2.6	1.8	0.7	4.6	3.1	0.3
KCNH8	"elk3, Kv12.1"	ENSG00000183960	"Potassium voltage-gated channel subfamily H member 8"	Q96L42	3	19148454-19535646	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 31.3;pituitary gland: 16.1"	"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.1;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	5	"B-cells: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA016586, HPA077537, HPA077773"	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA016586: AB_1852127, HPA077537: , HPA077773: "	"unprognostic (6.68e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.56e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.04e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.89e-2)"	"unprognostic (8.71e-5)"	"unprognostic (1.72e-1)"	0.6	7.0	8.4	1.6	22.0	1.4	2.4	1.3	11.4	1.3	1.9	31.3	0.0	2.2	1.2	1.2	0.7	1.4	2.2	1.0	11.8	5.7	0.7	0.7	0.8	3.2	16.4	10.2	0.7	2.7	0.8	16.1	0.6	15.0	2.2	2.5	0.1	3.3	1.4	0.6	1.9	1.8	1.1	9.9	2.6	5.9	4.0	18.1	0.0	1.1	0.0	3.2	0.9	0.5	4.5	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	9.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	8.4	22.0	1.3	11.4	11.8	5.7	16.4	10.2	15.0	18.1
KCNJ9	"GIRK3, Kir3.3"	ENSG00000162728	"Potassium voltage-gated channel subfamily J member 9"	Q92806	1	160081570-160090563	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	27	"brain: 52.0"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 2.3;SH-SY5Y: 2.7;U-266/70: 2.8"	"Cancer enriched"	"Detected in single"	35	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070478	Enhanced									"HPA070478: "	"unprognostic (2.35e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.24e-2)"	1.4	1.9	15.6	1.4	15.3	1.4	1.4	32.1	52.0	1.4	1.4	11.9	0.0	1.4	1.4	1.4	1.4	1.4	1.4	1.4	18.4	11.1	1.5	1.4	1.4	1.4	18.3	20.6	1.4	1.4	1.4	0.7	1.4	7.4	1.4	1.4	0.0	1.4	1.4	1.4	1.4	1.5	1.4	11.4	1.4	1.5	1.7	11.6	0.0	1.4	0.0	1.4	1.4	0.0	0.8	0.0	0.0	0.3	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	2.3	2.7	0.0	0.1	0.3	0.0	0.1	0.3	0.0	0.0	0.5	0.0	2.8	0.2	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.5	0.3	1.1	0.4	0.2	1.1	0.0	0.8	0.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	15.6	15.3	32.1	27.2	18.4	11.1	18.3	20.6	7.4	11.6
KCNK13	"K2p13.1, THIK-1, THIK1"	ENSG00000152315	"Potassium two pore domain channel subfamily K member 13"	Q9HB14	14	90061765-90185857	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.3;parathyroid gland: 14.3;testis: 13.2"	"Cell line enhanced"	"Detected in some"		"MCF7: 2.3;RT4: 5.1;SCLC-21H: 2.2;SK-BR-3: 2.2;U-2 OS: 2.5;U-266/84: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"classical monocyte: 1.5;intermediate monocyte: 1.3;myeloid DC: 3.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.8;monocytes: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003514	Approved		Approved	"Nuclear speckles,Cell Junctions"				"Nuclear speckles, Cell Junctions"		"HPA003514: "	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.65e-2)"	0.8	1.1	2.9	2.2	3.5	0.1	0.4	0.2	4.2	0.4	0.6	4.0	0.0	0.6	0.3	1.5	0.3	0.4	0.5	2.7	2.9	2.4	4.8	0.7	0.7	1.6	6.3	1.4	0.4	2.7	14.3	0.6	1.2	3.6	0.4	0.7	0.1	1.1	0.7	0.1	0.1	0.7	0.4	8.3	1.1	0.5	13.2	5.4	0.7	2.7	0.0	0.6	0.8	0.1	0.0	3.8	0.0	1.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.9	1.2	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.5	5.1	2.2	0.7	0.0	2.2	1.4	0.0	1.9	0.0	0.0	2.5	0.0	0.8	0.7	2.2	0.0	0.2	0.0	0.1	0.0	1.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.3	2.9	3.5	0.2	4.2	2.9	2.4	6.3	1.4	3.6	5.4
KCNK17	"K2p17.1, TALK-2, TALK2, TASK-4, TASK4"	ENSG00000124780	"Potassium two pore domain channel subfamily K member 17"	Q96T54	6	39299001-39314553	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 29.1;retina: 20.0"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 41.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	34	"plasmacytoid DC: 29.1"	"Lineage enriched"	"Detected in single"	34	"dendritic cells: 29.1"					"Not detected"	"Not detected"			HPA043892	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA043892: AB_10962838"	"unprognostic (5.33e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.77e-11)"	"unprognostic (5.89e-2)"	"unprognostic (5.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.86e-3)"	0.7	0.4	0.3	0.6	1.1	1.4	3.3	0.3	0.8	0.7	1.3	0.8	1.9	3.0	1.9	0.5	1.0	1.3	6.5	7.9	0.6	0.6	0.3	4.6	10.4	0.9	2.6	0.8	0.4	6.1	0.4	2.7	6.3	1.9	1.1	0.6	20.0	2.9	1.0	0.2	0.1	1.7	1.5	0.6	1.1	5.4	0.6	0.1	3.4	9.3	2.6	2.4	0.9	0.5	0.0	29.1	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	41.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	29.1	0.0	0.1	0.3	1.1	0.3	0.8	0.6	0.6	2.6	0.8	1.9	0.1
KCNK7	K2p7.1	ENSG00000173338	"Potassium two pore domain channel subfamily K member 7"	Q9Y2U2	11	65592855-65595996	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skin 1: 35.0;tongue: 20.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 12.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	12	"basophil: 4.8;naive B-cell: 2.9;neutrophil: 3.6"	"Group enriched"	"Detected in many"	12	"B-cells: 2.9;granulocytes: 4.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA077577			Approved	"Plasma membrane"				"Plasma membrane"		"HPA077577: "	"unprognostic (1.12e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.08e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.11e-2)"	0.6	0.6	0.8	0.3	0.7	3.9	2.6	1.6	2.1	1.4	0.5	0.8	0.3	0.4	0.4	0.3	10.8	0.6	0.3	0.5	0.8	0.4	0.3	0.3	0.3	0.3	0.6	1.1	0.6	0.3	0.1	0.3	0.5	0.4	0.3	0.1	0.3	0.8	0.4	1.8	35.0	0.5	0.3	0.7	0.5	0.3	0.3	0.5	0.7	0.3	20.7	5.7	0.3	3.4	2.9	0.0	4.8	0.2	0.2	0.3	0.1	0.5	2.3	0.1	0.7	0.0	0.0	0.2	0.2	0.0	0.5	0.1	0.2	1.6	0.7	0.7	0.2	3.7	0.0	0.0	0.0	0.8	2.6	0.8	1.1	1.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	1.4	2.2	0.7	1.7	0.9	0.7	1.0	2.1	1.5	0.0	0.3	1.0	0.2	12.1	2.7	0.5	0.7	1.2	0.6	2.1	0.0	0.6	1.8	1.9	0.1	2.0	1.3	0.4	1.3	1.0	1.0	4.8	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	2.9	0.1	0.0	3.6	0.2	0.2	0.0	0.0	0.1	0.8	0.7	1.6	2.1	0.8	0.4	0.6	1.1	0.4	0.5
KCNN1	"hSK1, KCa2.1"	ENSG00000105642	"Potassium calcium-activated channel subfamily N member 1"	Q92952	19	17951293-18000080	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	12	"brain: 32.5"	"Cell line enriched"	"Detected in some"	12	"REH: 57.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"basophil: 2.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065938			Approved	"Actin filaments,Cytosol"				"Actin filaments, Cytosol"		"HPA065938: "	"unprognostic (7.55e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.94e-5)"	"unprognostic (3.92e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.71e-3)"	"unprognostic (3.38e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.24e-3)"	"unprognostic (3.24e-1)"	0.8	0.9	25.8	1.5	11.3	0.9	0.8	3.3	27.0	1.6	1.0	0.5	0.1	1.0	1.7	1.0	1.0	0.9	1.0	1.3	32.5	3.3	0.9	0.8	0.8	1.0	5.0	8.7	2.6	0.9	0.7	0.2	0.8	4.1	1.2	0.8	0.0	1.5	1.3	1.0	0.9	1.2	0.9	1.2	0.9	0.9	2.8	1.6	0.0	0.9	0.0	1.0	0.9	0.0	0.2	0.2	2.3	0.1	0.1	0.2	0.0	0.0	0.2	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.0	0.0	0.1	0.1	0.9	1.8	0.1	0.0	0.0	0.0	4.9	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.7	0.0	57.4	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.5	0.1	0.0	0.2	0.0	0.0	25.8	11.3	3.3	22.4	32.5	3.3	5.0	8.7	4.1	1.6
KCNN3	"hSK3, KCa2.3, SKCA3"	ENSG00000143603	"Potassium calcium-activated channel subfamily N member 3"	Q9UGI6	1	154697455-154870280	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 17.7;HMC-1: 12.3;Karpas-707: 30.3;RPMI-8226: 8.2;U-266/70: 29.2;U-698: 9.8"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.8;memory B-cell: 4.8"	"Group enriched"	"Detected in many"	9	"B-cells: 4.8;granulocytes: 5.8;monocytes: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057127	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA057127: "	"unprognostic (2.09e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.22e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (9.51e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.89e-2)"	"prognostic unfavourable (1.97e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.80e-2)"	1.7	2.5	20.6	6.5	21.7	1.0	1.8	5.7	26.7	9.3	9.1	12.4	1.1	5.4	12.6	1.7	3.5	10.3	3.1	4.0	21.6	8.0	3.5	1.0	3.1	5.8	12.0	10.9	2.1	1.0	1.5	2.6	0.7	13.3	3.4	4.6	0.1	2.7	2.7	8.5	1.1	3.9	10.6	8.1	5.0	4.4	1.3	15.5	0.2	3.7	3.5	9.2	8.3	4.9	4.8	0.4	5.8	2.7	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.2	0.0	0.1	0.0	0.4	0.0	30.3	0.3	0.0	0.1	0.0	0.3	1.1	0.0	7.5	8.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	29.2	3.8	9.8	0.3	0.0	2.8	5.8	0.0	0.0	0.0	0.2	0.0	4.8	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.4	20.6	21.7	5.7	10.3	21.6	8.0	12.0	10.9	13.3	15.5
KCTD18	"6530404F10Rik, FLJ31322, FLJ37818"	ENSG00000155729	"Potassium channel tetramerization domain containing 18"	Q6PI47	2	200488952-200519784	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045498, HPA058028"	Approved		Approved	Mitochondria				Mitochondria		"HPA045498: AB_10959387, HPA058028: "	"unprognostic (2.90e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.01e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.21e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	14.3	14.6	13.7	13.1	15.4	11.5	14.3	9.2	14.8	12.3	13.8	17.4	15.5	11.6	13.5	19.4	16.1	12.5	16.5	14.8	13.6	11.2	13.8	13.3	11.4	14.9	16.3	11.4	15.0	16.5	17.1	13.2	10.0	14.9	15.9	11.7	13.7	14.1	14.0	14.7	12.3	11.3	24.0	17.6	13.0	12.9	9.3	14.6	18.0	19.4	19.9	14.6	17.4	11.7	7.2	7.2	11.4	7.9	7.1	9.6	5.6	7.2	6.7	3.3	12.4	16.1	20.1	8.6	8.9	11.3	5.7	7.5	5.4	8.3	5.1	6.8	8.9	7.0	3.3	10.7	7.4	12.3	3.6	7.3	4.8	3.7	11.0	5.9	8.7	13.4	20.4	6.6	12.7	4.9	5.0	6.9	10.2	7.4	12.7	5.8	1.9	6.1	8.9	7.5	5.9	7.5	7.2	3.8	5.3	7.0	6.1	10.5	8.0	9.6	8.1	11.8	2.7	5.9	4.2	13.4	9.7	5.8	13.5	6.3	8.3	11.4	5.5	10.4	5.9	7.9	9.0	7.2	7.7	8.5	5.9	7.1	9.6	9.6	4.4	7.1	5.2	7.2	8.5	5.6	13.7	15.4	9.2	14.8	13.6	11.2	16.3	11.4	14.9	14.6
KCTD19	FLJ40162	ENSG00000168676	"Potassium channel tetramerization domain containing 19"	Q17RG1	16	67289428-67326763	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 57.3"	"Cell line enhanced"	"Detected in some"		"HBF TERT88: 3.9;U-2197: 3.6;U-266/70: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 1.6;neutrophil: 6.6;plasmacytoid DC: 5.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.3;granulocytes: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA049310, HPA053321"	Uncertain									"HPA049310: , HPA053321: "	"unprognostic (2.44e-1)"	"unprognostic (2.14e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.88e-4)"	"unprognostic (4.44e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.71e-2)"	"unprognostic (8.44e-2)"	0.2	0.1	0.2	0.7	0.8	3.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.3	0.7	0.4	0.3	0.6	0.1	0.1	0.4	0.3	0.1	0.1	0.1	0.1	0.4	0.2	0.1	0.0	0.3	0.2	0.3	0.1	0.1	0.4	0.1	0.1	0.4	1.4	0.1	0.1	0.1	0.3	0.3	57.3	0.3	1.4	0.2	0.1	0.1	0.4	0.1	1.1	5.3	6.6	0.9	1.0	0.6	0.6	0.0	0.6	0.3	0.0	0.0	0.0	0.6	0.7	0.8	1.2	0.6	1.0	0.6	0.9	0.6	0.0	0.3	1.2	0.0	3.9	0.7	2.7	1.0	0.0	0.0	0.6	0.4	0.4	0.8	1.0	1.1	0.6	0.2	1.1	0.3	0.0	0.0	1.1	1.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.7	1.5	0.2	0.7	0.2	0.2	0.6	1.1	0.0	0.8	3.6	0.1	10.9	1.9	0.6	1.2	0.1	1.0	1.6	0.9	0.8	0.6	0.5	0.4	0.6	0.4	0.5	0.3	1.1	0.5	0.5	6.6	1.0	0.5	5.3	0.4	0.6	0.2	0.8	0.1	0.2	0.1	0.4	0.1	0.4	0.3	0.3
KCTD8		ENSG00000183783	"Potassium channel tetramerization domain containing 8"	Q6ZWB6	4	44173909-44448807	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.0;NTERA-2: 2.8;PC-3: 1.7;SCLC-21H: 10.6;U-2 OS: 3.2"	"Cancer enhanced"	"Detected in some"		"glioma: 0.9;thyroid cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA031562	Enhanced		Approved	Vesicles				Vesicles		"HPA031562: AB_10602609"	"unprognostic (1.49e-2)"	"unprognostic (7.70e-3)"		"unprognostic (1.53e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.77e-2)"		"unprognostic (1.48e-1)"		"unprognostic (7.85e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.57e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.44e-1)"	2.0	1.4	5.4	0.9	12.2	0.7	0.9	19.5	18.9	2.2	1.0	8.5	3.5	0.8	4.2	1.3	0.8	1.1	1.5	1.1	4.8	5.2	2.8	0.7	1.0	0.7	8.9	4.0	4.3	2.4	0.7	0.2	0.7	6.8	1.5	1.1	2.3	1.7	3.1	2.6	0.8	0.9	2.3	8.0	0.7	2.6	3.8	8.3	0.0	8.6	0.4	0.7	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.7	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	12.2	19.5	8.5	4.8	5.2	8.9	4.0	6.8	8.3
KDELR3		ENSG00000100196	"KDEL endoplasmic reticulum protein retention receptor 3"	O43731	22	38468062-38483447	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 48.5;salivary gland: 57.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 57.8;BJ: 36.3;BJ hTERT+: 37.4;fHDF/TERT166: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043477, HPA076405"	Uncertain		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA043477: AB_10962952, HPA076405: "	"unprognostic (1.76e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavourable (1.19e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (6.05e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.07e-2)"	10.5	4.0	1.3	3.4	1.4	0.2	11.6	0.9	1.3	15.7	7.7	1.8	5.3	6.6	6.2	14.8	5.5	5.7	20.9	14.2	1.5	1.1	10.9	44.5	8.6	5.8	1.0	1.2	7.2	48.5	9.3	12.4	11.6	1.8	9.2	10.3	5.5	57.2	7.1	2.1	3.6	15.1	6.6	2.2	3.0	15.5	4.1	0.9	1.1	6.7	6.5	16.9	6.8	6.5	1.2	4.3	0.9	0.1	0.3	2.4	0.3	6.9	2.2	1.8	7.7	30.6	57.8	1.3	36.3	37.4	8.9	22.3	3.9	9.2	0.0	7.7	59.0	1.0	1.8	2.2	10.8	0.0	4.1	0.5	1.9	11.0	13.5	0.0	4.9	21.3	1.7	11.2	1.2	10.7	1.7	0.0	14.7	11.4	0.0	0.2	0.4	6.3	0.0	0.5	2.3	10.8	0.9	0.1	0.9	9.3	0.5	4.6	2.7	0.4	8.2	9.6	6.0	33.0	3.6	0.3	0.1	0.0	15.5	0.0	13.3	0.0	0.1	0.0	0.8	0.1	2.4	1.2	0.8	0.2	0.2	0.4	0.8	0.8	0.9	0.3	0.1	4.3	0.7	0.3	1.3	1.4	0.9	1.3	1.5	1.1	1.0	1.2	1.8	0.9
KHDC1	"bA257K9.4, C6orf147, C6orf148, Em:AC019205.8, MGC10818, NDG1"	ENSG00000135314	"KH domain containing 1"	Q4VXA5	6	73241314-73310365	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA029032			Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA029032: AB_10602914"	"unprognostic (3.46e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.73e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.54e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.83e-4)"	"unprognostic (8.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.17e-3)"	2.9	2.9	10.3	2.0	12.9	0.9	2.2	8.8	14.6	4.7	1.3	2.6	1.2	0.6	3.9	3.3	2.7	6.2	2.6	3.4	8.5	8.4	1.3	0.4	1.8	3.1	8.6	5.7	7.4	4.4	5.0	9.6	1.5	4.7	4.4	1.4	2.9	1.3	3.6	2.7	1.0	1.1	2.4	6.2	0.9	2.9	8.2	4.1	5.4	5.9	1.7	3.4	2.2	2.1	2.7	2.6	3.8	0.2	2.5	5.2	2.0	2.8	4.2	0.8	2.2	4.0	4.5	2.0	5.6	5.4	8.7	12.8	4.0	2.2	6.1	2.2	2.4	2.8	5.8	1.1	6.6	5.8	4.2	4.1	3.4	0.0	5.1	1.9	0.1	5.8	2.4	8.6	2.4	1.9	3.0	7.3	3.4	6.8	0.4	1.8	3.8	8.3	0.9	0.0	4.9	1.3	0.1	10.3	2.1	3.2	0.1	0.2	0.1	6.1	0.1	1.8	4.0	1.1	5.9	12.5	7.5	4.4	0.1	1.7	0.6	3.8	0.2	0.0	4.4	0.0	2.6	2.7	2.8	4.9	0.7	1.9	2.2	3.4	0.0	2.5	0.0	2.6	5.2	2.0	10.3	12.9	8.8	12.4	8.5	8.4	8.6	5.7	4.7	4.1
KIAA0825	"C5orf36, DKFZp686F0372, MGC34713"	ENSG00000185261	KIAA0825	Q8IV33	5	94152966-94618597	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 22.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 13.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"neutrophil: 13.4"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 13.4"									"HPA038030, HPA038031"	Uncertain									"HPA038030: AB_10672735, HPA038031: "	"unprognostic (1.26e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.93e-4)"	"unprognostic (2.72e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.63e-3)"	"unprognostic (4.44e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.02e-5)"	"unprognostic (3.00e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.09e-2)"	2.7	3.5	5.1	1.9	10.4	2.9	3.6	14.1	10.7	4.5	2.1	1.2	4.1	1.4	4.4	5.4	3.4	8.0	3.8	2.7	4.9	4.8	5.4	2.9	3.1	2.1	2.6	4.2	5.2	2.8	5.5	22.4	2.8	5.3	3.4	2.4	4.9	2.2	3.0	1.9	1.9	2.3	3.0	2.6	4.0	1.9	8.5	1.9	4.1	5.9	1.3	1.6	3.7	2.6	0.7	0.6	13.4	0.6	0.6	0.7	0.2	0.7	0.3	1.0	2.5	3.3	4.3	0.3	2.3	2.1	1.5	2.2	0.0	1.7	0.4	2.5	0.9	1.2	0.4	1.6	2.1	0.0	0.5	0.4	13.6	0.3	2.3	0.4	0.2	2.3	1.7	2.0	0.5	1.6	0.3	0.1	2.9	1.5	1.1	1.1	1.3	0.3	1.2	0.2	0.1	3.1	0.7	1.5	1.9	2.4	0.2	0.4	1.2	1.7	1.5	1.3	0.3	1.9	0.9	0.6	0.5	0.0	3.0	0.8	1.2	0.0	0.6	0.0	0.4	0.3	0.2	0.7	0.4	0.7	0.5	0.5	0.2	0.4	13.4	0.6	0.4	0.6	0.2	0.2	5.1	10.4	14.1	10.7	4.9	4.8	2.6	4.2	5.3	1.9
KIAA0895		ENSG00000164542	KIAA0895	Q8NCT3	7	36324221-36390125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021036, HPA061066"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"				Nucleoplasm	"Plasma membrane, Cell Junctions, Cytosol"	"HPA021036: , HPA061066: "	"unprognostic (4.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.79e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.49e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.24e-2)"	1.5	9.9	8.1	1.3	11.0	2.8	5.2	28.9	13.5	3.7	3.0	5.8	6.0	3.0	4.6	9.1	3.6	8.6	4.6	2.6	6.2	8.1	13.1	10.4	4.2	0.7	4.2	8.2	12.7	12.4	18.6	14.7	2.0	8.0	4.6	2.1	6.6	4.1	4.7	2.1	7.8	1.7	4.4	4.7	1.2	14.3	27.1	4.9	2.1	5.5	1.5	0.9	2.3	2.7	0.6	0.5	1.3	0.1	0.5	1.5	0.4	7.2	4.4	9.1	8.9	0.2	0.2	2.0	1.9	2.2	4.3	5.3	1.9	3.7	0.0	2.0	0.4	4.2	11.8	3.8	3.8	0.6	7.5	0.1	6.9	1.7	1.6	1.1	0.2	1.0	7.0	3.9	4.9	0.1	2.9	0.1	0.4	2.3	3.6	2.5	0.4	1.0	1.4	0.3	0.0	9.9	0.8	27.9	9.7	3.6	8.5	2.5	8.5	1.2	0.0	0.6	2.2	1.3	2.8	4.1	9.2	0.0	1.7	0.3	2.1	0.8	0.1	0.3	0.1	0.1	1.3	0.3	0.9	0.2	0.1	0.6	1.4	0.6	1.3	0.5	0.1	0.5	1.5	0.4	8.1	11.0	28.9	13.5	6.2	8.1	4.2	8.2	8.0	4.9
KIAA0895L	LOC653319	ENSG00000196123	"KIAA0895 like"	Q68EN5	16	67175602-67184040	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.3;plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065996	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA065996: "	"unprognostic (8.71e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.90e-1)"	"prognostic favourable (3.16e-4)"	"unprognostic (3.74e-2)"	"unprognostic (2.67e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.00e-3)"	9.5	20.7	18.1	8.1	19.8	5.2	5.9	46.3	25.0	8.8	6.8	11.5	11.5	10.7	15.4	13.4	6.6	15.0	10.0	7.7	15.1	10.6	9.8	4.6	8.7	3.6	13.0	27.7	21.8	7.6	18.0	24.1	9.5	18.5	10.5	8.8	13.2	8.4	10.3	5.9	9.8	9.5	11.7	16.2	11.0	13.7	13.5	12.4	4.4	13.2	4.3	3.2	7.2	6.8	0.0	2.8	0.0	0.8	0.2	1.1	0.3	2.3	4.0	14.6	9.1	2.7	6.4	9.7	6.3	1.6	2.8	2.6	4.0	2.4	4.4	4.2	2.4	9.1	4.1	3.5	1.7	4.2	5.7	6.4	10.4	3.7	2.1	2.7	13.2	3.6	1.5	3.5	1.3	4.6	6.5	4.3	3.5	3.7	6.6	4.9	3.3	6.6	18.4	7.1	8.2	4.8	5.6	17.3	14.6	7.1	3.6	1.8	8.0	4.7	5.3	9.9	7.0	4.6	2.6	5.6	4.6	4.5	12.5	4.2	5.1	0.0	0.8	0.0	0.2	0.7	0.0	0.0	0.9	1.1	2.3	0.0	0.1	0.2	0.0	0.2	0.4	2.8	0.0	0.3	18.1	19.8	46.3	24.1	15.1	10.6	13.0	27.7	18.5	12.4
KIAA1024		ENSG00000169330	KIAA1024	Q9UPX6	15	79432516-79472290	"Predicted membrane proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 16.8;brain: 10.8"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 14.1"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"cerebellum: 10.8;pons and medulla: 8.5"	"Group enriched"	"Detected in some"	12	"eosinophil: 2.5;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	12	"granulocytes: 2.5;monocytes: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011545	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA011545: AB_1852361"	"unprognostic (5.45e-5)"	"unprognostic (3.26e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.82e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.45e-2)"	"unprognostic (6.66e-13)"	"unprognostic (7.08e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.19e-1)"	0.1	16.8	0.8	0.2	0.6	0.7	0.5	10.8	2.0	0.6	0.2	0.4	0.1	0.0	0.4	0.5	0.5	0.1	0.6	0.1	0.5	1.4	0.2	0.1	0.1	0.6	1.2	1.5	0.2	3.5	0.0	0.7	0.5	8.5	1.2	0.3	0.7	4.2	0.2	0.6	0.2	0.2	0.2	1.7	0.3	0.2	1.1	1.0	0.1	0.2	0.1	0.4	0.2	0.1	0.1	0.1	2.5	1.9	0.0	0.1	0.0	0.4	0.3	0.6	0.8	1.8	1.6	0.7	0.8	1.5	0.7	0.8	0.0	0.4	1.1	0.2	1.3	0.3	1.5	0.1	0.5	1.3	1.7	3.0	0.7	0.0	1.0	4.0	1.5	0.7	0.3	1.2	0.2	0.8	0.2	0.0	0.2	0.0	0.6	1.4	0.7	0.7	0.6	0.1	0.6	0.2	0.0	3.0	1.6	0.3	2.6	1.5	0.3	2.0	0.5	14.1	0.5	0.0	2.9	1.8	2.1	0.5	1.4	2.2	1.7	0.0	0.0	2.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.8	0.6	10.8	2.0	0.5	1.4	1.2	1.5	8.5	1.0
KIAA1210		ENSG00000250423	KIAA1210	Q9ULL0	X	119078635-119150579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 24.6;seminal vesicle: 12.3;testis: 19.8"	"Group enriched"	"Detected in some"	9	"Daudi: 2.1;MCF7: 4.1;SK-BR-3: 2.2;U-2 OS: 2.5"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.3"					"Group enriched"	"Detected in some"	5	"basophil: 2.0;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.0"									"HPA000551, HPA048322"	Enhanced									"HPA000551: AB_1079165, HPA048322: "	"unprognostic (2.48e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.26e-4)"	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.7	24.6	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.1	0.0		2.7	0.0		0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8			0.0		0.0	0.1	0.0	0.2	0.2	2.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	2.2	0.2	0.1	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	1.2	0.3	0.1	0.2	0.0	0.0										
KIAA1257		ENSG00000114656	KIAA1257	Q9ULG3	3	128909866-129002690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.3;testis: 38.5"	"Cell line enhanced"	"Detected in many"		"AF22: 8.3;BEWO: 12.9;HL-60: 14.0;THP-1: 8.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	14	"neutrophil: 23.3"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 23.3"									"HPA042811, HPA048445"	Uncertain									"HPA042811: , HPA048445: "	"unprognostic (4.17e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.41e-3)"	"unprognostic (2.45e-1)"	"unprognostic (6.74e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.48e-3)"	"unprognostic (7.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.50e-2)"	0.6	0.5	1.7	0.9	7.7	1.9	0.8	0.8	3.2	0.5	0.5	2.4	0.2	0.8	0.5	1.7	1.0	4.1	1.6	0.5	2.5	1.6	0.6	0.4	1.8	0.9	0.6	1.7	1.3	0.6	1.1	3.6	3.7	2.1	0.9	0.7	0.1	0.7	0.7	0.4	5.3	0.6	0.3	0.5	1.0	0.9	38.5	0.9	0.8	0.7	0.0	0.1	0.7	0.5	0.3	0.2	23.3	0.4	0.1	0.4	0.1	1.1	1.8	8.3	1.7	0.0	0.1	12.9	0.1	0.2	0.0	0.0	2.3	1.2	2.1	0.4	0.0	1.3	2.8	0.1	0.0	0.8	1.5	4.2	1.1	1.0	0.1	14.0	0.8	0.0	1.4	0.0	0.0	0.0	1.0	2.3	0.0	1.6	1.8	3.0	1.7	1.8	1.2	0.8	1.3	0.0	1.9	1.6	0.7	0.5	0.4	0.7	2.3	8.7	0.3	0.8	1.4	0.7	0.6	2.8	2.6	3.6	0.7	5.3	0.8	0.4	0.4	1.7	0.3	0.1	0.2	0.3	0.2	0.2	0.1	0.3	0.3	0.4	23.3	0.1	0.2	0.2	0.1	0.1	1.7	7.7	0.8	3.2	2.5	1.6	0.6	1.7	2.1	0.9
KIAA1324	"EIG121, maba1"	ENSG00000116299	KIAA1324	Q6UXG2	1	109113679-109206781	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 79.8;salivary gland: 169.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 14.1;SCLC-21H: 9.1;SK-BR-3: 11.0;T-47d: 37.8;U-87 MG: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 33.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 33.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA029869, HPA070749"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA029869: AB_10794320, HPA070749: AB_2686304"	"unprognostic (2.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.99e-2)"	"prognostic favourable (2.14e-7)"	"unprognostic (4.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-3)"	"prognostic favourable (5.69e-5)"	"unprognostic (2.79e-2)"	"prognostic favourable (2.16e-4)"	"unprognostic (3.50e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.22e-16)"	"unprognostic (2.46e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.02e-2)"	0.7	0.9	3.7	3.6	7.9	0.0	16.4	0.7	5.6	23.9	11.8	0.4	0.0	14.6	5.5	5.7	1.3	7.8	19.1	0.6	3.3	2.3	0.6	0.6	2.2	0.7	1.0	2.7	1.2	79.8	6.1	46.6	0.0	1.1	15.8	10.0	0.0	169.4	0.0	0.6	2.5	16.5	0.2	0.9	0.9	27.3	9.4	1.1	0.0	3.9	5.2	11.5	0.9	0.6	0.2	0.0	33.8	0.0	0.2	4.6	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.0	0.0	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	14.1	0.1	0.1	0.2	0.0	0.0	0.1	0.5	0.2	0.0	9.1	0.2	0.0	11.0	0.0	37.8	0.0	0.2	0.0	1.4	0.0	0.1	0.8	2.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	3.9	0.2	3.9	1.7	0.0	0.0	1.8	0.7	33.8	0.2	0.0	0.0	4.6	1.0	3.7	7.9	0.7	5.6	3.3	2.3	1.0	2.7	1.1	1.1
KIAA1549L	"C11orf41, C11orf69, G2, MGC34830"	ENSG00000110427	"KIAA1549 like"	Q6ZVL6	11	33376466-33674102	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"brain: 30.4;parathyroid gland: 64.4"	"Cell line enhanced"	"Detected in many"		"TIME: 22.7;U-138 MG: 30.0;WM-115: 20.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010132, HPA051594"			Approved	Nucleoplasm,Vesicles			27000	Nucleoplasm	Vesicles	"HPA010132: AB_1078313, HPA051594: "	"unprognostic (3.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.34e-5)"	"unprognostic (2.63e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.89e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.59e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.08e-3)"	"unprognostic (8.46e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.09e-1)"	0.8	0.9	8.2	0.7	20.5	0.6	1.2	6.2	30.4	0.7	0.7	1.7	0.0	0.6	0.7	0.6	0.9	0.6	0.8	0.6	5.3	2.4	0.9	0.6	0.6	0.7	1.6	17.1	0.7	0.8	64.4	1.0	1.4	2.3	0.7	0.7	0.0	0.7	0.6	0.6	1.9	0.6	0.7	1.1	0.6	0.7	1.3	1.6	0.0	0.6	0.0	1.1	0.9	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	3.3	0.1	0.5	3.7	0.0	13.1	7.7	2.1	1.2	0.0	0.3	10.1	0.1	11.6	0.7	0.4	3.8	3.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	3.2	5.7	9.3	0.0	9.6	8.2	0.0	0.1	0.0	0.7	4.8	0.0	0.8	0.0	0.0	5.0	1.1	1.2	0.1	0.0	3.1	0.0	0.0	22.7	30.0	6.3	0.7	10.5	0.0	0.0	0.0	7.9	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.2	20.5	6.2	30.4	5.3	2.4	1.6	17.1	2.3	1.6
KIAA1614		ENSG00000135835	KIAA1614	Q5VZ46	1	180913154-180951614	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 58.8;retina: 23.8"	"Cell line enhanced"	"Detected in many"		"RH-30: 12.0;SH-SY5Y: 30.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	5	"cerebellum: 58.8"	"Cell type enhanced"	"Detected in some"		"basophil: 4.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.4"					"Low region specificity"	"Detected in all"			"HPA028227, HPA061684"	Approved		Approved	"Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"		"HPA028227: AB_10601765, HPA061684: "	"unprognostic (3.23e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.55e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.61e-5)"	"unprognostic (8.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.35e-2)"	4.6	1.5	2.4	1.4	2.6	0.1	2.2	58.8	11.3	4.5	4.6	1.8	0.8	3.0	5.2	1.6	4.6	3.5	3.1	7.5	2.7	1.4	3.0	0.4	3.2	1.1	1.5	3.8	6.3	2.1	0.0	1.3	3.6	3.3	3.5	0.5	23.8	4.6	2.8	2.1	3.0	2.5	4.1	1.4	2.6	2.2	1.2	2.5	0.4	7.6	0.9	0.4	4.3	5.1	0.5	0.5	4.4	0.5	0.5	0.6	0.3	1.1	0.5	0.9	2.0	3.0	7.3	3.2	2.2	2.6	1.1	0.6	1.0	1.1	0.5	2.1	2.7	2.1	0.2	0.0	0.3	0.6	0.9	1.6	0.4	1.4	4.1	1.0	1.1	3.5	0.1	0.1	0.0	1.5	1.3	0.7	0.9	0.9	1.3	0.4	2.2	0.3	0.7	12.0	1.6	1.7	1.0	8.3	30.4	0.6	0.8	4.8	0.8	1.4	3.4	2.3	1.7	2.7	0.8	1.5	2.0	1.0	0.3	0.8	1.5	4.4	0.5	1.2	0.3	0.3	0.4	0.5	0.3	0.3	0.5	0.4	0.6	0.4	0.7	0.5	0.1	0.5	0.2	0.3	2.4	2.6	58.8	11.3	2.7	1.4	1.5	3.8	3.3	2.5
KIAA1755	RP5-1054A22.3	ENSG00000149633	KIAA1755	Q5JYT7	20	38210488-38260772	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.2"	"Cell line enhanced"	"Detected in some"		"AF22: 39.9;ASC diff: 6.1;ASC TERT1: 9.2;WM-115: 10.1"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051064	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"				Nucleoli	"Golgi apparatus, Vesicles"	"HPA051064: "	"unprognostic (3.98e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-8)"	"unprognostic (1.41e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.53e-3)"	6.1	2.5	13.6	5.8	27.3	0.7	3.8	4.8	22.1	13.2	8.1	47.2	3.1	2.7	15.5	7.2	5.6	10.0	16.9	11.5	13.9	8.4	4.6	1.7	2.7	4.9	22.7	13.7	14.7	1.5	0.3	3.1	0.4	24.5	7.3	4.7	8.8	6.1	8.2	1.3	1.6	4.5	15.8	20.4	2.8	4.1	2.9	29.2	0.0	2.6	1.6	4.9	6.8	5.4	0.3	0.5	0.9	0.4	0.4	0.7	0.0	1.5	0.1	39.9	0.0	6.1	9.2	0.0	3.9	2.2	0.0	0.0	0.2	1.1	0.0	0.2	1.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.3	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.6	0.2	0.7	0.0	0.0	0.0	0.1	0.0	10.1	0.9	0.4	0.1	0.7	0.2	0.5	0.1	0.5	0.6	0.1	0.3	0.4	0.4	0.7	0.4	0.1	0.5	0.0	0.0	13.6	27.3	4.8	15.7	13.9	8.4	22.7	13.7	24.5	29.2
KIAA1841		ENSG00000162929	KIAA1841	Q6NSI8	2	61065871-61138034	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051240	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA051240: "	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.71e-8)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-3)"	"unprognostic (7.53e-2)"	"unprognostic (6.09e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.85e-6)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.25e-1)"	5.1	3.6	9.8	3.9	8.9	2.3	4.3	13.3	12.4	10.0	7.1	7.0	1.0	5.5	4.4	6.8	3.8	7.5	3.6	5.2	9.6	11.6	2.6	2.3	8.0	3.2	8.8	12.1	2.4	3.6	3.9	8.2	3.5	20.6	9.6	8.3	3.6	3.6	3.1	3.7	8.5	5.9	5.4	10.1	3.3	5.6	7.5	6.2	3.3	4.0	2.7	3.5	4.3	3.7	1.5	1.2	4.8	2.5	1.4	3.7	0.6	4.6	9.0	11.8	5.1	6.8	7.6	3.7	8.9	2.2	4.6	4.3	2.7	3.0	1.9	2.3	6.8	5.8	7.4	3.0	6.4	8.0	1.8	1.7	6.2	7.5	3.6	2.1	1.7	3.6	4.8	8.3	2.9	6.3	1.7	1.5	12.7	0.4	1.8	1.4	3.7	1.8	6.0	9.7	0.4	5.8	9.5	7.0	4.3	10.7	2.4	3.2	1.8	2.5	8.4	7.5	2.8	6.0	6.0	0.8	2.4	2.8	5.4	1.5	5.1	0.8	1.4	4.8	1.3	1.5	1.2	1.5	1.2	0.6	1.2	0.6	0.2	1.0	3.0	1.4	2.5	0.8	3.7	0.6	9.8	8.9	13.3	12.4	9.6	11.6	8.8	12.1	20.6	6.2
KIAA2012		ENSG00000182329	KIAA2012	Q0VF49	2	202073289-202205203	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.0;fallopian tube: 19.2"	"Cell line enhanced"	"Detected in some"		"AF22: 1.6;BJ hTERT+: 1.2;CAPAN-2: 1.8;SCLC-21H: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077834	Enhanced									"HPA077834: "	"unprognostic (1.91e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.23e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.31e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.94e-5)"	"unprognostic (1.60e-1)"	"unprognostic (9.44e-2)"	"unprognostic (3.37e-1)"	"unprognostic (9.95e-3)"	0.3	0.5	6.2	0.4	10.0	0.3	0.4	0.6	8.4	1.2	0.4	5.1	0.0	0.5	0.5	2.5	0.4	19.2	0.4	0.4	6.7	3.5	0.4	2.5	2.0	0.4	0.2	4.4	3.8	0.4	0.3	2.8	0.4	6.5	0.4	0.5	0.0	0.4	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.4	2.6	1.0	0.0	0.4	0.0	0.3	0.4	0.1	0.6	0.5	0.9	0.6	0.5	0.8	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.7	1.2	0.1	0.0	0.4	1.8	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.1	0.9	0.3	0.6	0.2	0.2	0.5	0.5	0.2	0.6	0.8	0.4	0.3	0.5	0.5	0.5	0.0	0.0	6.2	10.0	0.6	8.4	6.7	3.5	0.2	4.4	6.5	1.0
KIAA2026	FLJ20375	ENSG00000183354	KIAA2026	Q5HYC2	9	5881596-6007901	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 21.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002109	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol				"Vesicles, Cytosol"	Nucleoplasm	"HPA002109: AB_1078071"	"unprognostic (7.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.41e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.52e-1)"	"prognostic favourable (8.34e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.00e-2)"	7.0	6.3	10.3	13.7	11.1	6.6	6.7	21.4	12.4	10.2	7.5	8.6	5.7	5.5	9.7	7.0	7.2	6.7	7.4	6.2	11.7	9.0	7.5	5.4	6.4	7.0	16.7	7.1	13.0	6.0	13.9	14.5	8.1	9.9	8.0	5.9	5.9	12.8	15.6	15.3	9.4	6.7	7.7	11.2	9.1	7.8	13.3	12.9	11.0	10.3	3.7	7.5	8.0	17.8	7.0	4.1	9.4	5.9	7.0	7.5	1.2	5.8	2.9	5.9	3.8	4.5	7.2	2.9	4.0	5.6	3.6	3.4	1.8	3.2	7.3	1.5	4.8	3.0	3.4	3.0	5.5	16.8	2.8	21.9	6.4	2.9	3.5	7.7	10.1	4.4	4.1	3.1	5.3	5.6	2.3	13.1	4.6	1.6	4.1	13.3	3.4	2.5	4.6	3.8	3.7	3.9	3.8	8.1	4.8	3.7	3.3	3.0	3.3	9.9	6.7	6.9	4.2	3.5	4.3	10.2	8.0	7.3	3.5	3.6	2.0	5.2	3.4	9.4	6.4	2.6	7.3	7.0	6.2	5.7	1.3	6.1	6.8	7.5	8.8	7.0	5.9	4.1	3.6	1.2	10.3	11.1	21.4	12.4	11.7	9.0	16.7	7.1	9.9	12.9
KIF17	"KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3"	ENSG00000117245	"Kinesin family member 17"	Q9P2E2	1	20664014-20718017	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.2;testis: 19.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.7;hTERT-HME1: 8.2;U-2 OS: 4.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 2.4;basal ganglia: 5.2;cerebral cortex: 3.6;hippocampal formation: 1.8;hypothalamus: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA032085	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA032085: AB_10669917"	"unprognostic (4.15e-3)"	"unprognostic (8.60e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.34e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-2)"	0.1	0.4	2.4	0.2	5.2	0.1	0.1	0.0	3.9	0.4	0.2	0.4	0.0	0.3	0.4	0.8	0.1	3.1	0.2	0.2	1.8	3.5	0.2	0.1	0.4	0.1	0.4	0.7	0.6	0.1	0.2	1.5	0.7	0.5	0.4	0.1	0.0	0.1	0.8	0.1	0.1	0.2	0.9	0.3	0.1	0.1	19.4	0.0	0.0	0.9	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.5	0.9	0.0	0.0	0.1	0.2	2.7	3.7	1.5	0.9	0.4	1.0	0.0	1.2	1.9	0.0	1.3	0.9	1.1	0.0	0.3	0.0	0.0	0.4	1.6	0.0	0.0	0.3	0.8	1.0	8.2	0.0	0.6	0.0	1.8	0.1	0.0	0.0	2.5	1.7	0.0	0.1	0.0	0.6	0.0	0.6	1.5	0.4	0.0	0.3	0.0	0.0	0.0	0.6	4.9	0.5	0.3	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	5.2	0.0	3.6	1.8	3.5	0.4	0.7	0.5	0.0
KIF19	"FLJ37300, KIF19A"	ENSG00000196169	"Kinesin family member 19"	Q2TAC6	17	74326210-74355820	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.9;fallopian tube: 25.2"	"Cell line enriched"	"Detected in single"	11	"SCLC-21H: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 5.5"	"Lineage enriched"	"Detected in single"	55	"T-cells: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043638, HPA073303"	Enhanced		Approved	"Plasma membrane,Actin filaments,Centrosome"				"Plasma membrane"	"Actin filaments, Centrosome"	"HPA043638: AB_10962579, HPA073303: "	"unprognostic (1.59e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.59e-9)"	"unprognostic (5.16e-5)"	"unprognostic (2.72e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.53e-1)"	1.6	0.9	9.3	1.6	29.5	1.1	1.1	25.8	14.1	2.1	3.1	17.4	0.0	6.6	1.1	1.1	1.1	25.2	1.6	1.1	11.9	6.6	0.9	1.6	3.1	1.0	25.0	4.2	1.1	3.0	0.9	0.3	0.8	6.5	0.9	2.1	0.8	2.5	1.3	1.0	0.8	5.2	1.6	6.2	11.6	2.2	1.2	29.9	0.0	2.3	0.0	1.0	1.3	1.3	0.0	0.0	0.0	0.0	0.0	5.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	9.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.6	0.0	0.9	1.6	0.0	0.0	0.7	2.4	0.0	0.0	0.0	0.0	0.0	0.7	9.3	29.5	25.8	14.1	11.9	6.6	25.0	4.2	6.5	29.9
KIF25	KNSL3	ENSG00000125337	"Kinesin family member 25"	Q9UIL4	6	167996241-168045089	"Predicted intracellular proteins"		"Motor protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 6.2;brain: 9.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.1;HDLM-2: 5.1;HMC-1: 2.7;SiHa: 2.2;U-266/84: 3.1;U-937: 3.0;WM-115: 2.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in many"			HPA046153	Uncertain									"HPA046153: AB_10960550"	"unprognostic (1.11e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.08e-5)"	"unprognostic (1.55e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.77e-3)"	6.2	0.0	2.0	0.2	3.1	0.1	1.3	9.9	2.7	0.2	0.3			0.2	0.1	0.9	0.0	0.6	1.5	1.9	2.7	2.3	0.0	0.3	0.3	0.9	3.5		2.0	0.0	0.0	0.0	1.9		0.8	1.1		1.0	0.1	3.1	2.0	0.2	0.2	3.1	0.8	0.3	1.6			0.0		0.3	1.6	0.0	0.7	0.3	1.7	0.3	0.1	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.5	0.0	0.0	0.0	2.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	1.7	5.1	0.8	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.0	0.0	0.2	0.5	0.1	0.5	1.5	0.1	0.0	0.8	0.2	0.5	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.1	3.1	0.1	0.1	3.0	2.2	1.7	0.3	0.9	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.7	0.2	0.2	1.4	0.1	0.2	0.3	0.1	0.1										
KIF26B	FLJ10157	ENSG00000162849	"Kinesin family member 26B"	Q2KJY2	1	245154985-245709431	"Predicted intracellular proteins"		"Developmental protein, Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HSkMC: 10.4;REH: 18.5;SH-SY5Y: 10.1;U-937: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	58	"plasmacytoid DC: 6.3"	"Lineage enriched"	"Detected in single"	58	"dendritic cells: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027709, HPA028478, HPA028561, HPA028562"	Enhanced		Approved	"Plasma membrane,Microtubules"				"Plasma membrane, Microtubules"		"HPA027709: AB_10600215, HPA028478: AB_10601231, HPA028561: AB_10601960, HPA028562: AB_10602417"	"unprognostic (3.66e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (4.50e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.63e-2)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (8.30e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.17e-4)"	"unprognostic (7.22e-3)"	0.7	3.9	7.1	3.0	6.3	0.7	2.1	10.2	9.7	5.2	1.7	8.7	6.0	1.2	3.7	2.9	1.3	2.1	4.2	1.3	5.6	7.2	3.2	1.1	2.7	1.7	7.8	4.6	1.2	1.8	1.4	1.4	7.6	9.6	3.7	0.8	1.1	1.2	7.7	0.9	2.7	1.1	2.3	4.9	1.1	2.9	2.9	3.7	1.3	3.4	1.2	1.4	4.0	0.8	0.0	6.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	2.5	0.5	0.8	1.9	2.0	1.5	0.1	0.1	3.1	0.0	0.0	3.4	0.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.3	0.3	10.4	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	18.5	0.1	0.0	1.8	0.0	2.6	10.1	0.0	0.0	0.0	0.0	1.0	0.3	1.9	0.1	0.0	0.8	0.0	0.0	0.0	0.3	9.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	0.0	0.0	7.1	6.3	10.2	9.7	5.6	7.2	7.8	4.6	9.6	3.7
KIF4B		ENSG00000226650	"Kinesin family member 4B"	Q2VIQ3	5	155013755-155018132	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 9.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA034745, HPA034746, HPA061583"	Uncertain		Uncertain	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: "	"unprognostic (9.87e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.71e-1)"		"unprognostic (4.76e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.37e-2)"		"unprognostic (6.48e-9)"	"unprognostic (7.24e-2)"	"unprognostic (5.10e-2)"		"unprognostic (1.71e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.4	0.1	0.0	0.1	0.6	0.0	0.1	0.2	0.0	0.9	0.0	0.5	0.0	0.5	0.1	0.0	0.1	0.7	0.0	0.4	1.0	0.4	0.0	0.4	0.7	0.0	0.3	0.2	0.0	1.1	0.2	2.4	0.4	0.0	0.8	0.5	0.5	0.5	0.7	1.1	1.0	0.0	0.7	0.5	0.5	1.3	0.2	0.3	0.5	0.5	0.2	0.7	1.2	0.7	1.2	0.4	0.6	0.5	0.4	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0										
KIFC2		ENSG00000167702	"Kinesin family member C2"	Q96AC6	8	144466043-144474202	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 36.2;skin 1: 48.2"	"Cell line enhanced"	"Detected in many"		"T-47d: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029264	Approved		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA029264: AB_10609999"	"unprognostic (2.03e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.87e-3)"	"unprognostic (4.12e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.71e-2)"	4.2	5.1	18.7	4.2	28.4	4.5	3.4	36.2	35.0	3.1	6.3	2.3	6.6	8.8	2.7	5.2	7.0	2.9	4.4	2.2	13.5	7.2	4.7	2.8	3.8	4.8	4.4	16.8	2.1	7.9	9.8	7.9	2.5	8.3	7.2	4.8	2.2	7.5	6.5	2.3	48.2	7.9	2.1	2.6	8.1	8.7	5.2	6.6	1.6	4.1	1.3	3.5	5.0	4.9	0.8	0.1	0.1	0.1	0.0	0.8	0.1	7.9	6.8	3.3	7.2	4.8	2.9	7.8	4.8	3.4	2.6	2.6	2.7	9.9	8.3	2.7	2.7	16.3	3.3	4.3	1.1	8.4	2.9	5.0	16.7	3.5	6.2	1.3	14.8	3.7	15.5	2.6	3.4	1.7	5.4	8.7	1.9	13.6	6.0	4.2	0.5	10.1	15.1	0.2	4.9	10.8	12.5	10.4	9.5	3.4	10.6	3.8	27.9	2.7	4.6	5.1	15.4	5.4	4.8	4.3	2.0	2.3	9.9	7.0	2.8	0.0	0.1	0.0	0.5	0.0	0.8	0.0	0.3	0.6	0.1	0.8	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.1	18.7	28.4	36.2	35.0	13.5	7.2	4.4	16.8	8.3	6.6
KLF7	UKLF	ENSG00000118263	"Kruppel like factor 7"	O75840	2	207074137-207167267	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 24.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030490	Approved		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA030490: AB_10601922"	"unprognostic (5.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.85e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.47e-1)"	"prognostic favourable (4.26e-4)"	"unprognostic (3.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.47e-2)"	22.2	10.1	10.3	15.1	12.0	40.7	17.3	30.2	12.0	12.2	12.1	14.6	9.3	5.7	19.7	13.4	11.6	10.2	13.8	12.1	10.3	8.0	9.9	8.4	17.1	15.7	12.9	9.1	17.1	6.1	3.0	6.4	7.0	17.4	10.2	6.7	7.0	8.9	9.3	6.2	7.9	11.9	24.2	25.7	11.3	10.7	7.9	14.7	14.4	10.8	8.5	8.3	18.4	18.2	4.5	3.0	24.0	11.7	12.9	9.0	3.5	4.4	3.2	8.7	0.6	3.0	7.9	1.8	5.2	4.2	8.2	3.6	0.0	3.7	0.0	3.4	10.7	11.2	7.3	24.2	4.4	3.1	0.4	0.1	8.8	1.8	5.3	2.3	3.6	10.5	8.2	5.7	18.9	9.5	0.0	4.3	6.3	0.1	2.8	0.8	5.1	1.6	1.2	2.3	3.2	1.9	3.5	13.4	16.4	4.5	6.4	4.2	1.0	3.6	18.8	16.4	7.9	6.9	6.2	3.3	2.2	0.0	14.4	2.0	3.2	11.5	5.4	6.8	0.9	6.8	0.4	3.0	5.1	1.0	3.0	4.5	9.0	6.1	24.0	12.9	11.7	1.4	4.1	3.5	10.3	12.0	30.2	12.0	10.3	8.0	12.9	9.1	17.4	14.7
KLHDC1	MST025	ENSG00000197776	"Kelch domain containing 1"	Q8N7A1	14	49693105-49753152	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 8.8;ASC TERT1: 8.4;HSkMC: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020461	Approved		Supported	Cytosol				Cytosol		"HPA020461: AB_1852556"	"unprognostic (2.97e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.49e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.53e-1)"	"prognostic favourable (1.94e-4)"	"unprognostic (3.42e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.24e-1)"	8.6	9.7	8.5	8.0	14.5	3.3	11.0	13.4	15.2	10.9	8.7	15.4	8.6	4.5	13.3	13.3	5.3	8.9	7.2	9.9	9.2	10.0	7.2	5.9	6.6	7.5	12.0	12.2	18.2	6.7	11.0	13.2	6.0	10.7	10.2	5.6	12.4	7.1	14.2	14.1	11.3	6.5	11.0	12.9	7.9	6.5	11.7	11.7	2.9	12.5	4.4	6.0	7.1	8.5	3.0	3.7	2.5	2.2	1.6	4.8	1.7	1.0	0.5	0.9	0.7	8.8	8.4	0.0	2.3	3.1	0.7	0.6	0.0	2.8	0.5	0.5	0.9	0.7	0.3	0.0	0.7	2.3	0.8	0.4	0.2	0.0	4.6	0.2	1.0	7.0	0.4	0.3	0.3	1.8	0.4	0.0	3.4	0.3	0.6	1.1	0.0	0.4	0.6	0.7	0.0	1.7	0.2	0.3	2.3	0.4	0.0	0.9	1.0	1.8	2.6	1.9	2.2	0.7	0.2	0.8	0.1	0.6	1.9	0.3	1.1	1.4	1.0	2.5	2.1	2.2	4.2	3.0	2.8	2.4	1.1	2.1	4.8	4.0	0.1	1.6	1.1	3.7	0.9	1.7	8.5	14.5	13.4	15.2	9.2	10.0	12.0	12.2	10.7	11.7
KLHDC3	"dJ20C7.3, hPeas, PEAS"	ENSG00000124702	"Kelch domain containing 3"	Q9BQ90	6	43014103-43021298	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 122.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030131, HPA030132, HPA030133, HPA030134"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA030131: AB_10599712, HPA030132: AB_10600880, HPA030133: AB_10611532, HPA030134: AB_10601350"	"unprognostic (3.85e-2)"	"prognostic favourable (9.15e-4)"	"unprognostic (5.31e-2)"	"prognostic unfavourable (4.52e-4)"	"unprognostic (9.97e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.58e-3)"	"prognostic favourable (9.08e-4)"	"unprognostic (6.34e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.52e-1)"	16.1	19.0	37.2	11.6	41.6	14.7	17.6	38.0	68.2	15.2	16.7	14.6	15.4	14.4	12.8	21.2	16.1	19.9	13.6	34.0	34.2	25.7	14.8	20.2	14.4	14.4	26.7	41.6	20.3	15.2	15.6	17.6	20.9	29.6	16.3	15.0	13.5	21.3	18.5	122.7	15.1	14.7	15.9	14.6	14.1	15.4	47.0	15.3	17.4	19.3	17.6	15.6	13.7	11.2	19.5	39.4	41.6	36.3	21.6	31.5	29.8	27.6	8.5	28.5	47.6	19.6	14.9	20.4	12.5	16.2	24.6	26.9	24.6	14.5	27.5	14.4	18.3	14.7	30.3	16.1	16.9	14.6	41.3	34.2	24.6	25.5	19.3	20.0	24.4	23.9	16.3	18.9	11.1	23.7	41.4	19.6	9.2	34.3	32.8	34.6	37.1	9.2	32.0	20.9	32.9	15.1	16.1	52.9	41.3	13.3	15.3	21.3	26.5	58.2	14.0	11.2	20.9	12.3	12.4	21.5	26.9	39.9	4.9	28.8	9.4	14.9	36.3	41.6	28.5	33.8	24.0	19.2	23.8	25.8	39.4	19.5	31.5	24.5	17.7	21.6	25.8	21.8	25.1	29.8	37.2	41.6	38.0	68.2	34.2	25.7	26.7	41.6	29.6	15.3
KLHDC7B	MGC16635	ENSG00000130487	"Kelch domain containing 7B"	Q96G42	22	50548033-50551022	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 8.4;parathyroid gland: 12.5"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 46.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 42.3;urothelial cancer: 40.7"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA000518, HPA076540"	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA000518: AB_1079213, HPA076540: "	"prognostic favourable (1.30e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.96e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	0.4	0.4	0.3	3.9	1.2	1.2	0.7	0.3	1.5	1.3	0.3	0.3	0.3	0.3	0.3	0.3	0.7	0.2	0.3	0.3	0.3	0.1	8.4	1.1	1.1	4.0	0.3	0.3	0.8	0.3	12.5	2.2	0.3	0.9	0.7	0.0	0.8	3.0	0.3	0.3	0.3	2.0	0.3	0.3	5.4	0.5	0.3	0.3	6.5	2.9	0.3	1.7	3.0	0.3	3.8	2.0	2.4	4.0	1.4	5.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	46.4	0.0	0.5	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	2.4	2.2	0.2	4.5	4.0	3.3	3.8	4.7	5.7	2.0	3.1	5.2	4.3	0.4	1.4	2.8	0.7	4.1	2.5	0.3	1.2	0.3	1.5	0.3	0.1	0.3	0.3	0.9	0.3
KLHDC8B	MGC35097	ENSG00000185909	"Kelch domain containing 8B"	Q8IXV7	3	49171611-49176486	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 19.4"	"Group enriched"	"Detected in many"	9	"granulocytes: 19.4;monocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008463, HPA014467"	Approved		Enhanced	Cytosol				Cytosol		"HPA008463: AB_1852563, HPA014467: AB_1852565"	"unprognostic (1.66e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.31e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.66e-1)"	"unprognostic (5.03e-3)"	"unprognostic (1.71e-3)"	"prognostic favourable (1.47e-4)"	"unprognostic (6.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-3)"	"unprognostic (4.78e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-2)"	15.0	44.0	5.6	4.7	5.8	3.2	12.6	4.5	8.8	12.8	19.3	6.2	10.5	4.6	15.9	12.2	22.6	11.6	13.6	30.5	3.7	8.5	5.6	8.8	6.6	6.3	4.9	5.4	29.6	6.2	5.2	4.2	7.9	5.2	15.2	2.5	21.8	8.4	9.5	15.8	9.8	5.4	18.0	2.4	6.7	6.7	10.0	3.0	2.0	17.1	10.7	6.6	20.0	8.8	0.1	0.6	19.4	5.7	0.0	1.4	1.6	1.5	3.4	14.2	7.2	8.7	5.2	4.4	5.2	3.0	5.2	4.2	2.2	4.6	0.0	2.9	8.6	0.0	3.5	3.1	1.3	2.8	0.9	9.1	9.2	5.7	16.6	0.0	5.4	8.6	15.2	6.7	0.5	13.3	14.1	0.1	3.9	0.4	0.9	10.1	4.6	8.1	1.4	1.3	0.4	3.9	0.8	0.6	16.0	4.2	0.1	10.4	4.3	4.4	5.7	4.0	11.2	7.1	1.6	1.3	0.4	0.1	2.9	0.0	1.9	0.0	3.8	19.4	0.8	5.7	0.3	0.0	0.4	0.6	0.3	0.1	1.4	0.8	6.7	0.0	5.0	0.6	0.1	1.6	5.6	5.8	4.5	8.8	3.7	8.5	4.9	5.4	5.2	3.0
KLHL1	"FLJ30047, KIAA1490, MRP2"	ENSG00000150361	"Kelch like family member 1"	Q9NR64	13	69700594-70108493	"Predicted intracellular proteins"		Actin-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"brain: 17.6"	"Cell line enriched"	"Detected in single"	14	"HeLa: 7.2"	"Cancer enriched"	"Detected in single"	7	"breast cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021196	Uncertain									"HPA021196: AB_1852567"					"unprognostic (5.81e-2)"					"unprognostic (7.40e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.41e-1)"						0.3	1.4	2.0	0.5	5.0	0.3	0.3	3.5	6.9	0.3	0.5	0.0	0.0	0.4	0.3	0.3	0.4	0.3	0.3	0.3	1.8	7.6	0.8	0.3	0.3	0.3	17.6	2.3	0.3	0.7	0.5	1.9	0.3	16.2	2.1	0.4	1.0	0.3	0.4	0.3	0.3	0.6	0.4	5.3	0.3	0.7	1.5	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	5.0	3.5	4.2	1.8	7.6	17.6	2.3	16.2	0.0
KLHL17		ENSG00000187961	"Kelch like family member 17"	Q6TDP4	1	960587-965715	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031251	Approved		Uncertain	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA031251: AB_10601539"	"unprognostic (1.28e-1)"	"prognostic unfavourable (4.22e-4)"	"unprognostic (1.18e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-2)"	"prognostic unfavourable (1.89e-6)"	"unprognostic (3.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavourable (2.70e-6)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.73e-2)"	4.7	7.0	9.9	8.7	8.9	8.2	8.8	14.0	10.0	6.2	5.1	4.9	4.1	8.4	6.5	4.8	9.9	4.6	5.8	4.2	8.4	4.2	7.2	6.1	5.6	8.1	6.7	3.4	1.5	9.5	5.4	12.4	5.7	6.3	6.8	2.3	6.0	11.6	5.6	5.2	19.1	6.1	6.6	4.2	9.8	7.7	9.8	8.2	5.6	5.4	4.0	7.6	6.5	6.7	0.4	1.0	0.0	1.2	0.0	1.7	0.4	4.5	5.1	6.4	15.3	2.2	2.4	7.0	9.0	2.4	5.1	4.9	6.7	6.9	1.6	6.3	3.9	9.8	5.9	3.7	0.8	9.2	14.3	3.0	18.6	9.4	1.5	3.4	9.4	2.0	1.8	4.9	1.4	3.1	9.8	3.0	2.2	5.3	5.5	11.9	7.0	7.6	9.0	2.6	3.2	2.7	1.8	15.6	14.7	2.6	8.1	8.2	4.4	6.0	5.3	9.7	13.0	8.4	7.4	5.9	2.1	3.9	5.6	7.7	4.4	0.0	1.2	0.0	1.7	0.1	0.4	0.4	0.3	0.4	0.0	0.4	0.7	0.4	0.0	0.0	0.6	1.0	0.0	0.4	9.9	8.9	14.0	10.0	8.4	4.2	6.7	3.4	6.3	8.2
KLHL28	"BTBD5, FLJ20081"	ENSG00000179454	"Kelch like family member 28"	Q9NXS3	14	44924319-45042322	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000988			Approved	Cytosol				Cytosol		"HPA000988: AB_1845480"	"unprognostic (8.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.84e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.36e-3)"	"unprognostic (4.92e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.68e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.53e-2)"	10.9	9.0	8.8	11.6	12.7	39.2	10.4	22.9	15.5	12.1	9.9	11.1	10.5	9.1	12.6	9.4	12.8	11.2	9.9	8.9	10.3	10.4	8.6	11.2	10.1	13.5	11.2	9.4	14.4	10.6	9.8	18.1	9.9	16.7	10.2	10.8	12.2	12.6	9.0	13.8	11.5	11.0	10.5	12.8	11.5	8.8	14.2	10.9	27.9	13.6	8.6	12.7	11.3	10.8	10.2	6.0	17.7	7.0	13.0	23.1	4.5	4.5	6.9	9.2	6.0	8.4	7.6	7.0	6.1	6.8	9.1	7.7	3.0	7.2	6.8	6.7	10.6	8.0	8.2	6.5	10.0	12.6	4.4	5.9	7.1	3.5	7.6	9.4	12.9	5.8	9.1	5.8	9.3	7.2	5.2	17.0	5.2	6.6	7.4	4.8	5.7	6.7	6.5	10.3	3.7	5.2	8.3	10.6	6.5	7.9	5.3	8.4	10.0	4.0	9.1	8.1	9.5	5.7	3.4	10.1	11.0	9.4	2.8	4.2	4.9	17.7	5.0	11.9	12.4	6.9	23.1	10.2	12.4	13.0	4.4	9.6	14.9	12.6	11.6	13.0	7.0	6.0	9.3	4.5	8.8	12.7	22.9	15.5	10.3	10.4	11.2	9.4	16.7	10.9
KLHL29	"KBTBD9, KIAA1921"	ENSG00000119771	"Kelch like family member 29"	Q96CT2	2	23385217-23708611	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 15.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049057, HPA057379"	Approved		Approved	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA049057: , HPA057379: "	"unprognostic (8.08e-3)"	"unprognostic (2.91e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.18e-1)"	"prognostic favourable (2.19e-4)"	"unprognostic (2.53e-1)"	"prognostic unfavourable (6.29e-4)"	"unprognostic (1.12e-2)"	"unprognostic (9.06e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.25e-4)"	9.5	20.8	8.9	6.4	14.5	0.8	7.4	9.0	11.7	6.7	9.4	2.6	5.2	2.6	10.9	3.5	5.4	4.8	10.7	3.3	6.7	7.5	4.7	5.4	6.2	5.7	3.6	9.0	4.0	4.7	5.8	17.7	7.6	6.3	10.8	3.4	11.7	4.2	11.7	12.0	6.9	4.2	7.2	2.7	10.6	5.5	2.5	3.7	0.5	1.9	1.8	4.0	7.5	6.4	0.1	0.4	0.0	0.0	0.9	0.7	0.0	1.0	0.9	6.1	3.1	5.8	3.9	10.5	6.2	4.8	2.5	1.8	0.0	0.3	4.0	2.1	2.4	0.2	1.4	5.3	1.7	0.0	6.4	0.0	5.2	0.0	2.0	0.0	8.0	2.8	7.2	3.3	9.5	4.3	0.0	0.0	1.4	0.5	1.3	0.0	3.0	1.8	0.3	15.6	0.0	4.7	1.8	9.2	1.9	0.8	0.7	3.5	0.0	0.0	4.2	2.5	11.9	5.4	2.1	0.1	0.0	0.0	9.7	0.4	8.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.7	0.7	0.0	0.9	0.0	0.4	0.0	0.0	8.9	14.5	9.0	11.7	6.7	7.5	3.6	9.0	6.3	3.7
KLHL30	FLJ43374	ENSG00000168427	"Kelch like family member 30"	Q0D2K2	2	238138722-238152947	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"skeletal muscle: 62.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.0;CAPAN-2: 3.1;EFO-21: 3.0;RH-30: 8.6;THP-1: 4.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	35	"olfactory region: 11.6"	"Low region specificity"	"Detected in all"			HPA062095			Approved	"Centriolar satellite"				"Centriolar satellite"		"HPA062095: "	"unprognostic (3.42e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.07e-4)"	"unprognostic (6.02e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.17e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.06e-1)"	4.4	0.1	0.1	0.3	0.1	0.1	2.4	0.1	0.1	1.2	0.5	0.1	0.1	0.2	1.2	2.3	1.3	0.4	0.4	6.1	0.1	0.1	0.3	0.1	0.3	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.7	0.3	1.4	0.1	0.8	1.7	0.6	62.8	0.2	0.3	1.5	0.1	0.1	0.3	0.4	0.0	0.0	0.9	8.7	0.2	1.6	1.4	0.7	1.4	1.1	2.5	0.5	0.3	0.3	0.1	0.1	0.0	0.1	0.0	0.0	6.0	0.0	0.1	0.1	0.0	0.2	3.1	0.0	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.6	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.2	2.1	0.2	0.0	2.6	8.6	1.4	0.6	0.0	0.1	0.2	0.1	0.8	0.2	0.0	4.2	0.0	0.1	0.5	0.2	0.0	0.3	0.3	0.1	0.2	0.5	0.1	0.5	2.5	0.3	0.2	0.5	0.2	0.7	0.1	0.1	1.4	0.6	0.2	0.3	1.1	0.5	0.3	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0
KLHL32	"BKLHD5, KIAA1900"	ENSG00000186231	"Kelch like family member 32"	Q96NJ5	6	96924620-97140754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"brain: 47.1;fallopian tube: 12.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.0;HDLM-2: 8.1;RPMI-8226: 3.7;SCLC-21H: 3.5;U-266/70: 4.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 2.2;T-cells: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039150	Enhanced									"HPA039150: "	"unprognostic (1.75e-1)"	"unprognostic (7.99e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.22e-2)"	"unprognostic (5.00e-1)"	"unprognostic (3.12e-3)"	"unprognostic (5.88e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.51e-5)"	"unprognostic (5.82e-2)"	"unprognostic (6.04e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.48e-2)"	"unprognostic (4.49e-4)"	1.0	2.6	14.2	1.5	47.1	1.1	1.5	8.8	36.9	1.5	2.0	19.4	0.0	2.3	1.3	1.8	1.0	12.8	1.5	2.1	16.2	11.1	4.3	2.0	2.2	1.6	31.0	14.7	2.7	3.2	2.6	3.0	1.0	22.0	1.2	2.5	0.1	1.8	1.3	2.9	1.1	2.9	1.2	30.6	1.4	1.7	3.7	32.2	0.0	2.3	0.0	1.6	1.1	0.5	2.2	0.1	0.1	0.0	0.7	5.5	1.5	0.0	0.0	0.7	0.0	0.5	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.5	6.0	0.2	0.0	0.2	0.6	0.2	0.0	8.1	1.3	0.4	0.1	0.2	0.2	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.9	3.0	0.0	0.0	1.5	0.4	0.4	0.3	0.2	0.0	3.7	0.0	0.0	3.5	1.2	0.0	0.0	0.8	0.2	0.2	0.4	0.0	0.1	0.0	0.0	4.3	0.7	2.4	0.2	0.3	0.4	0.0	0.0	0.0	0.9	0.0	2.1	2.2	3.6	1.3	0.1	1.5	4.2	5.5	0.1	0.7	0.0	0.0	2.5	1.5	14.2	47.1	8.8	36.9	16.2	11.1	31.0	14.7	22.0	32.2
KLHL34	"FLJ34960, RP11-450P7.3"	ENSG00000185915	"Kelch like family member 34"	Q8N239	X	21654690-21658330	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 31.1"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.1;PC-3: 1.1;SCLC-21H: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA060287	Uncertain									"HPA060287: "	"unprognostic (2.00e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.74e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.29e-1)"	0.3	0.1	0.7	0.1	0.9	0.0	0.0	1.7	0.8	0.0	0.3	0.1	0.0	1.1	0.0	0.0	0.3	0.0	0.0	1.8	0.5	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	3.1	0.6	0.0	31.1	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	2.8	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.5	0.0	0.5	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.1	0.0	1.1	1.1	0.1	0.8	0.2	0.0	0.2	1.0	0.5	0.0	0.1	0.0	0.1	0.1	0.8	0.2	0.1	0.1	0.5	0.1	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.3	3.0	0.9	0.0	0.0	0.0	0.0	0.6	0.5	0.7	0.9	1.7	0.8	0.5	0.3	0.2	0.0	0.2	0.0
KLHL5		ENSG00000109790	"Kelch like family member 5"	Q96PQ7	4	39045039-39126857	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 75.8;HHSteC: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013958	Approved									"HPA013958: AB_1852590"	"unprognostic (6.02e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.92e-1)"	"unprognostic (7.54e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.24e-3)"	24.6	15.0	31.9	21.2	27.6	5.1	33.1	10.4	20.9	11.9	29.5	20.7	15.6	8.1	12.7	9.2	21.3	6.7	15.1	10.1	31.5	25.2	16.4	35.2	14.0	19.6	33.4	11.9	12.5	7.3	7.3	6.4	33.1	18.1	24.4	10.9	6.5	8.1	44.5	6.1	4.6	9.8	32.3	34.2	14.3	10.9	6.9	20.7	6.9	14.0	4.6	23.9	25.7	14.3	7.4	4.1	5.6	5.2	1.8	2.6	1.3	12.8	18.2	9.7	7.1	5.5	14.3	14.1	10.3	75.8	8.7	8.5	14.9	9.4	19.8	12.6	10.5	0.7	11.9	26.2	11.2	2.0	2.3	8.4	17.2	10.6	47.9	2.4	2.8	18.1	14.7	13.2	33.1	17.3	6.3	4.0	20.5	5.4	2.5	4.4	3.0	17.8	4.7	12.7	0.5	7.5	5.3	0.6	7.1	5.8	1.9	5.0	4.5	5.2	21.9	23.3	16.0	6.0	12.3	4.6	4.1	18.3	18.9	6.5	5.4	5.6	3.9	0.8	1.4	5.2	2.1	7.4	2.6	1.5	4.1	5.9	2.1	1.0	4.3	1.8	2.3	1.5	0.5	1.3	31.9	27.6	10.4	15.8	31.5	25.2	33.4	11.9	18.1	20.7
KLK13	KLK-L4	ENSG00000167759	"Kallikrein related peptidase 13"	Q9UKR3	19	51056206-51065114	"Cancer-related genes, Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"esophagus: 100.5"	"Cell line enriched"	"Detected in some"	11	"HaCaT: 20.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 42.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA062136	Enhanced				"Secreted in other tissues"					"HPA062136: "	"unprognostic (1.99e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"		"unprognostic (3.43e-1)"		"unprognostic (2.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.30e-2)"	"unprognostic (7.07e-6)"	"unprognostic (7.33e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.06e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.2	15.7	0.4	0.2	0.1	0.2	0.3	0.1	100.5	0.2	0.9	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.4	1.7	0.0	0.5	0.1	0.2	0.1	0.0	0.3	12.4	0.1	1.2	2.1	0.4	0.1	0.1	0.1	0.2	6.1	0.1	0.1	0.1	17.9	12.8	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	20.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
KLK9	KLK-L3	ENSG00000213022	"Kallikrein related peptidase 9"	Q9UKQ9	19	51003111-51009634	"Cancer-related genes, Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"tongue: 37.6"	"Group enriched"	"Detected in some"	27	"HaCaT: 1.2;HBEC3-KT: 4.1"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB025049	Enhanced				"Secreted to digestive system"					"CAB025049: "						"unprognostic (3.22e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	37.6	3.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLRC3	NKG2-E	ENSG00000205810	"Killer cell lectin like receptor C3"	Q07444	12	10412312-10420595	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 28.5;brain: 9.7;lymphoid tissue: 6.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.5;HEL: 2.2;HeLa: 11.8;HSkMC: 2.2;U-698: 3.2"	"Cancer enriched"	"Detected in single"	9	"glioma: 0.6"					"Cell type enriched"	"Detected in some"	5	"NK-cell: 28.5"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 28.5"									"HPA039910, HPA062570"	Approved		Uncertain	Vesicles				Vesicles		"HPA039910: , HPA062570: "	"unprognostic (8.92e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.32e-1)"	"unprognostic (5.07e-3)"		"unprognostic (2.48e-1)"	"unprognostic (3.22e-1)"		"unprognostic (9.12e-2)"		"unprognostic (3.52e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.15e-1)"		0.1	0.0	4.6	0.2	2.4	2.5	0.0	0.2	9.7	0.0	0.6			1.2	0.7	0.0	0.1	0.3	0.9	0.0	3.7	2.9	0.0	0.6	0.8	2.7	3.0		0.0	0.0	0.0	0.0	0.0		0.0	0.5		0.0	0.0	0.0	0.0	1.9	0.0	2.1	6.9	0.7	0.1			0.1		1.0	0.1	0.0	0.0	0.0	0.3	0.0	28.5	5.6	1.5	0.0	0.0	0.2	0.7	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	2.2	11.8	0.1	0.0	0.3	0.0	2.2	0.0	0.0	0.2	0.0	0.4	0.2	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.2	0.9	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	4.4	0.3	28.5	0.0	0.0	0.0	1.5										
KNCN	"FLJ32011, KINO, L5"	ENSG00000162456	Kinocilin	A6PVL3	1	46545644-46551527	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 3.9;pituitary gland: 1.0;testis: 2.5"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA046357	Uncertain									"HPA046357: AB_10961149"				"unprognostic (6.99e-3)"	"unprognostic (2.28e-2)"					"unprognostic (2.80e-2)"								0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	2.1	0.3	0.0			0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.0	1.6		0.0	0.0	0.0	1.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KNDC1	"bB439H18.3, C10orf23, FLJ25027, KIAA1768, RASGEF2, v-KIND, Very-KIND"	ENSG00000171798	"Kinase non-catalytic C-lobe domain containing 1"	Q76NI1	10	133160447-133226412	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.2;EFO-21: 3.0;MCF7: 2.7;NTERA-2: 3.7;RPMI-8226: 5.2;U-2 OS: 2.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"intermediate monocyte: 1.4;non-classical monocyte: 3.1"	"Lineage enriched"	"Detected in single"	10	"monocytes: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039624	Uncertain				"Intracellular and membrane"					"HPA039624: AB_10671045"	"unprognostic (2.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (1.59e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.80e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.41e-2)"	1.1	11.4	14.7	1.2	13.2	1.0	1.2	23.9	26.2	2.1	1.1	5.4	0.0	1.1	3.9	2.7	1.0	14.6	1.5	1.2	11.3	12.1	1.5	5.5	4.2	1.1	8.3	13.2	10.9	2.1	1.0	13.2	1.9	8.5	2.0	1.1	0.7	2.5	3.2	1.2	1.2	1.2	1.9	3.2	1.7	1.4	2.8	3.5	0.0	2.4	0.0	1.1	1.1	0.3	0.3	0.0	0.0	3.1	0.0	0.0	0.1	0.6	0.9	0.5	4.2	0.0	0.1	0.0	0.6	0.3	0.0	0.0	1.5	0.6	0.0	3.0	0.3	0.6	0.1	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	3.7	0.0	0.0	0.1	5.2	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	14.7	13.2	23.9	25.2	11.3	12.1	8.3	13.2	8.5	3.5
KRBOX1		ENSG00000240747	"KRAB box domain containing 1"	C9JBD0	3	42809483-42942792	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	8	"placenta: 78.4;testis: 68.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.7;CAPAN-2: 23.0;EFO-21: 11.3;hTEC/SVTERT24-B: 16.2;hTERT-HME1: 10.9;U-2197: 32.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 9.0"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 9.0"									HPA046901			Approved	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA046901: "	"unprognostic (2.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-3)"	"unprognostic (7.63e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.95e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	1.1	1.8	1.6	0.3	2.1	0.3	1.4	2.1	2.3	1.9	1.6	1.8	1.2	0.8	2.6	5.4	2.1	1.9	1.2	2.3	1.4	1.2	1.4	0.3	0.7	0.7	1.4	1.2	3.2	2.3	0.3	1.9	78.4	1.6	1.6	1.0	2.3	2.1	2.7	0.5	2.5	1.0	2.3	1.8	0.7	1.1	68.5	0.6	0.2	2.5	1.1	0.8	1.2	1.1	0.8	1.7	1.2	1.2	9.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.1	10.7	0.0	0.0	0.0	23.0	0.0	11.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	4.6	0.0	16.2	10.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	8.3	0.0	32.0	0.0	3.4	1.1	0.0	1.8	0.0	0.6	0.0	0.6	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.3	0.9	0.0	9.0	1.2	1.7	0.5	0.2	1.6	2.1	2.1	2.3	1.4	1.2	1.4	1.2	1.6	0.6
KRBOX4	"FLJ20344, ZNF673"	ENSG00000147121	"KRAB box domain containing 4"	Q5JUW0	X	46446857-46497422	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA065295			Approved	Nucleoplasm				Nucleoplasm		"HPA065295: "	"unprognostic (4.12e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (2.87e-6)"	"prognostic favourable (4.67e-5)"	"unprognostic (1.73e-2)"	"unprognostic (2.61e-3)"	"unprognostic (3.27e-2)"	"unprognostic (4.75e-3)"	"prognostic unfavourable (1.98e-7)"	"unprognostic (7.94e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-1)"	"prognostic favourable (2.17e-4)"	17.8	11.3	16.9	10.5	22.3	6.8	17.0	24.9	21.0	14.4	14.2	19.9	11.7	7.9	25.6	27.9	8.5	16.0	14.1	10.6	13.6	16.6	12.0	16.4	13.5	15.5	16.1	16.8	22.4	14.0	17.3	24.5	20.3	22.2	16.8	11.1	13.2	9.8	14.6	8.7	13.4	10.5	18.1	17.2	19.7	10.3	6.4	19.0	12.6	17.0	9.3	14.5	14.3	12.9	17.4	12.5	13.7	8.8	13.8	17.8	8.2	15.7	9.0	14.5	11.0	14.3	15.0	8.8	15.4	14.1	14.3	13.2	7.9	14.5	9.0	10.2	13.2	11.3	17.9	8.6	16.9	8.8	7.6	7.4	18.7	7.6	15.4	10.9	12.2	16.8	9.5	19.6	16.3	13.3	7.9	9.9	12.8	9.1	11.2	5.5	13.0	16.5	8.0	13.4	11.1	9.2	6.6	5.3	10.2	13.2	6.5	14.8	10.7	11.0	12.0	16.1	16.0	20.8	12.5	10.9	12.3	12.9	13.8	0.5	14.4	12.2	6.7	13.7	12.7	8.2	13.3	13.2	13.7	12.2	6.6	17.4	17.8	12.7	5.1	13.8	8.8	12.5	11.6	8.2	16.9	22.3	24.9	21.0	13.6	16.6	16.1	16.8	22.2	19.0
KRCC1	FLJ22333	ENSG00000172086	"Lysine rich coiled-coil 1"	Q9NPI7	2	88027205-88055729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045618, HPA052666"	Approved		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA045618: AB_10960406, HPA052666: "	"unprognostic (7.37e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-3)"	22.5	15.0	23.1	30.6	27.3	5.7	25.9	23.5	20.4	23.3	29.9	15.8	19.9	20.7	17.8	29.1	26.4	18.4	16.5	21.4	27.0	15.7	21.5	28.1	23.4	22.3	30.3	15.2	20.3	19.4	24.8	23.8	17.3	23.8	24.0	29.7	12.1	20.8	37.9	23.0	16.7	28.9	24.7	28.2	22.0	17.5	10.0	29.9	20.2	26.9	14.5	20.5	22.1	20.2	18.3	12.7	37.2	11.6	14.8	16.5	8.0	11.5	7.1	11.2	8.1	27.0	32.0	8.3	18.3	20.4	9.8	9.6	0.6	15.5	16.4	6.6	11.5	6.0	2.5	3.8	11.1	17.1	3.5	3.1	1.8	1.1	19.7	4.7	2.2	16.0	19.1	6.5	14.0	11.0	4.4	8.2	21.1	9.8	5.4	6.6	8.5	4.7	11.1	2.0	1.7	14.7	6.3	8.7	8.8	6.9	9.7	21.3	6.8	19.5	15.3	11.6	0.8	19.0	5.7	18.6	12.9	13.1	12.5	12.7	27.3	24.7	11.0	37.2	10.1	11.6	11.7	18.3	12.4	12.3	12.7	16.9	14.2	11.2	17.9	14.8	10.0	11.2	16.5	8.0	23.1	27.3	23.5	20.4	27.0	15.7	30.3	15.2	23.8	29.9
KREMEN2	"KRM2, MGC10791"	ENSG00000131650	"Kringle containing transmembrane protein 2"	Q8NCW0	16	2963944-2968383	"Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.1;skin 1: 12.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 19.9;MCF7: 10.0;RPMI-8226: 18.7;T-47d: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"memory B-cell: 3.2;naive B-cell: 3.0;non-classical monocyte: 1.4"	"Group enriched"	"Detected in many"	6	"B-cells: 3.2;monocytes: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA003223	Uncertain		Approved	Nucleoli	"Intracellular and membrane"			Nucleoli		"HPA003223: AB_1079217"	"unprognostic (8.36e-2)"	"unprognostic (4.65e-1)"	"unprognostic (6.24e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.02e-3)"	"prognostic unfavourable (8.98e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.57e-2)"	"unprognostic (7.79e-12)"	"unprognostic (6.69e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.58e-3)"	0.2	0.1	1.6	2.0	0.7	1.7	0.2	0.2	3.0	1.8	0.4	0.2	4.5	0.3	0.3	0.8	3.8	0.6	0.3	0.2	1.9	0.3	0.2	0.2	0.2	0.8	0.7	0.2	0.2	0.4	0.0	0.2	0.2	0.3	1.6	0.0	1.9	1.6	0.2	0.6	12.5	0.6	0.2	1.7	0.9	0.5	2.1	0.2	13.1	0.2	1.8	6.8	0.2	0.6	3.2	0.3	0.0	1.4	0.0	0.0	0.0	1.2	0.8	0.3	7.1	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.9	1.1	5.2	1.4	0.0	5.9	0.9	0.5	0.0	0.8	0.8	0.3	1.7	1.7	0.0	0.4	19.9	0.2	0.0	0.0	0.1	0.0	2.1	2.1	0.0	10.0	1.2	2.3	2.0	1.5	3.1	8.2	18.7	0.0	0.2	2.1	1.2	1.4	3.2	3.2	10.1	1.9	0.1	0.6	8.7	0.7	0.4	3.7	0.8	3.1	0.3	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.6	0.7	0.2	2.3	1.9	0.3	0.7	0.2	0.3	0.2
KRT222	"KA21, KRT222P, MGC45562"	ENSG00000213424	"Keratin 222"	Q8N1A0	17	40654665-40665181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.7"	"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 15.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA054586, HPA068724, HPA069774"	Enhanced		Approved	"Vesicles,Lipid droplets"				"Vesicles, Lipid droplets"		"HPA054586: AB_2682532, HPA068724: , HPA069774: "	"unprognostic (2.72e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.12e-2)"	"unprognostic (5.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.41e-2)"	3.8	5.0	9.6	0.7	18.3	0.6	1.3	15.6	21.7	2.3	1.8	0.2	0.9	1.2	1.9	11.8	1.2	1.2	8.3	1.0	10.0	10.0	1.3	9.4	1.4	1.1	8.6	13.4	0.9	1.7	1.6	5.2	0.6	14.3	3.2	2.3	0.8	0.7	4.6	0.6	0.8	2.3	3.1	3.3	3.4	1.0	1.4	3.3	0.0	1.2	0.3	1.1	2.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.5	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	18.3	15.6	21.7	10.0	10.0	8.6	13.4	14.3	3.3
KRT33A	"Ha-3I, Krt1-3, KRTHA3A"	ENSG00000006059	"Keratin 33A"	O76009	17	41346092-41350812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 30.4"	"Cell line enriched"	"Detected in some"	5	"RT4: 5.4"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA055194	Supported						160000000			"HPA055194: "	"unprognostic (1.93e-1)"	"unprognostic (1.30e-2)"				"unprognostic (4.58e-2)"		"unprognostic (4.34e-1)"									"unprognostic (2.16e-1)"	0.5	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	5.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	30.4	0.1	0.1	0.1	0.1	0.0	3.3	0.1	2.8	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRT84	"Hb-4, KRTHB4"	ENSG00000161849	"Keratin 84"	Q9NSB2	12	52377812-52385652	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"tongue: 86.0"	"Cell line enhanced"	"Detected in some"		"A-431: 1.2;HaCaT: 1.6;U-251 MG: 1.0"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"gdT-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039714	Supported						79000000			"HPA039714: "		"unprognostic (1.08e-1)"				"unprognostic (1.65e-2)"		"unprognostic (1.65e-1)"	"unprognostic (3.47e-1)"					"unprognostic (1.59e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.4	0.0	86.0	3.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
KRTAP2-1	KAP2.1A	ENSG00000212725	"Keratin associated protein 2-1"	Q9BYU5	17	41046541-41047316	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	62	"skin 1: 34.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.1;SCLC-21H: 2.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059203	Supported									"HPA059203: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.5		0.0	0.0		0.0	0.0	0.0	34.7	0.0	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP2-2	KAP2.2	ENSG00000214518	"Keratin associated protein 2-2"	Q9BYT5	17	41054498-41055230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	305	"skin 1: 30.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059203	Supported									"HPA059203: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	30.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP24-1	KAP24.1	ENSG00000188694	"Keratin associated protein 24-1"	Q3LI83	21	30281309-30282958	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"skin 1: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA017604	Enhanced									"HPA017604: "																		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP27-1		ENSG00000206107	"Keratin associated protein 27-1"	Q3LI81	21	30337013-30337694	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021522, HPA048826"	Approved									"HPA021522: AB_1852643, HPA048826: AB_2680534"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTCAP3	KCP3	ENSG00000157992	"Keratinocyte associated protein 3"	Q53RY4	2	27442366-27446481	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.8"	"Cell line enhanced"	"Detected in some"		"A-431: 27.9;CAPAN-2: 32.0;HaCaT: 10.2;SCLC-21H: 15.0;SK-BR-3: 9.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"MAIT T-cell: 6.9;memory B-cell: 5.4;memory CD4 T-cell: 6.2;memory CD8 T-cell: 3.2;naive B-cell: 4.6;naive CD4 T-cell: 7.0;naive CD8 T-cell: 3.3;T-reg: 4.8"	"Group enriched"	"Detected in many"	19	"B-cells: 5.4;T-cells: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047136, HPA060203"	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA047136: AB_2679949, HPA060203: "	"prognostic favourable (2.67e-5)"	"unprognostic (5.93e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.44e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.21e-2)"	"unprognostic (9.42e-3)"	0.9	1.0	0.5	10.0	0.8	0.5	6.3	1.3	1.7	4.6	24.4	0.7	13.3	16.2	1.5	3.2	8.5	9.8	16.5	1.7	0.7	0.3	4.8	6.5	11.8	1.9	0.7	1.4	2.7	28.8	3.3	6.9	1.5	1.5	9.7	6.2	1.9	17.4	22.6	1.0	4.9	34.8	0.9	0.9	1.0	16.7	1.8	0.8	2.3	12.3	6.9	5.4	7.6	4.5	5.4	0.0	0.1	0.0	0.3	7.0	1.8	27.9	0.2	0.7	0.5	0.0	0.0	5.8	0.0	0.0	0.0	0.1	9.0	32.0	0.2	0.2	0.0	10.2	0.2	7.2	0.0	0.2	0.2	0.0	0.2	0.6	0.0	0.0	0.3	0.0	0.6	0.0	0.2	0.0	0.3	0.1	0.0	7.5	0.3	1.9	6.0	0.1	0.1	0.2	0.7	0.0	0.0	15.0	0.5	0.4	9.3	0.6	0.2	0.2	0.0	0.3	0.7	0.2	0.2	1.6	1.0	0.1	0.5	0.2	0.1	0.0	0.0	0.1	0.6	0.0	6.9	5.4	6.2	3.2	0.0	4.6	7.0	3.3	0.0	0.3	0.0	0.0	4.8	1.8	0.5	0.8	1.3	1.7	0.7	0.3	0.7	1.4	1.5	0.8
LAMB4		ENSG00000091128	"Laminin subunit beta 4"	A4D0S4	7	108023548-108130356	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"esophagus: 13.8;placenta: 26.2;skin 1: 31.1;tongue: 21.6"	"Group enriched"	"Detected in some"	5	"BEWO: 6.0;HMC-1: 3.5"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA020242, HPA024247"	Approved				"Secreted to extracellular matrix"					"HPA020242: , HPA024247: "	"unprognostic (7.41e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.79e-2)"	"unprognostic (6.29e-4)"	"unprognostic (8.90e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.23e-4)"	"unprognostic (4.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.2	13.8	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	31.1	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	21.6	2.0	0.1	0.1	0.6	0.5	1.6	0.3	1.0	0.4	0.2	0.0	0.9	0.2	0.1	0.6	0.5	6.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.8	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.4	0.1	0.0	3.5	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.3	0.4	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	1.6	0.3	0.1	0.4	0.1	0.2	0.2	0.2	0.2	0.1	0.6	0.3	0.2	1.6	1.0	0.2	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LANCL3	FLJ42925	ENSG00000147036	"LanC like 3"	Q6ZV70	X	37571569-37684463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 7.1;lung: 6.8"	"Cell line enhanced"	"Detected in some"		"HEL: 16.8;HMC-1: 5.5;K-562: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 7.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005470, HPA076575"	Approved		Approved	Mitochondria				Mitochondria		"HPA005470: AB_2134886, HPA076575: "	"unprognostic (6.76e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.90e-5)"	"unprognostic (4.01e-3)"	"unprognostic (7.93e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.08e-2)"	1.2	0.8	0.7	0.3	2.3	0.9	0.4	2.5	2.4	1.2	3.8	0.7	0.2	0.6	0.5	0.3	4.6	0.2	0.9	0.7	1.1	2.8	0.4	0.2	6.8	0.4	1.3	1.3	1.3	0.2	0.1	1.7	0.2	2.2	0.6	2.8	2.5	1.1	0.9	1.0	2.6	1.1	1.9	1.8	0.2	2.2	1.8	0.9	0.2	1.2	1.7	1.2	1.8	2.9	0.3	0.2	7.1	0.2	1.1	1.8	0.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	1.1	2.4	0.3	0.0	0.0	0.3	16.8	1.7	0.0	0.0	0.0	5.5	0.0	0.4	0.0	0.1	0.3	3.8	0.0	1.2	0.0	0.2	0.3	0.4	1.7	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.2	0.0	0.0	1.5	0.7	0.0	0.0	2.8	0.0	0.4	7.1	0.2	0.9	1.0	0.2	0.8	0.2	0.4	1.8	0.1	0.3	0.1	1.0	1.1	1.1	0.2	0.2	0.6	0.7	0.7	2.3	2.5	2.4	1.1	2.8	1.3	1.3	2.2	0.9
LAYN	"FLJ30977, FLJ31092"	ENSG00000204381	Layilin	Q6UX15	11	111540280-111561745	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 39.4;BJ hTERT+: 43.0;BJ hTERT+ SV40 Large T+ RasG12V: 27.4;fHDF/TERT166: 25.5;HSkMC: 25.3;U-138 MG: 29.6;U-2 OS: 21.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"myeloid DC: 10.3;T-reg: 11.8"	"Group enriched"	"Detected in many"	111	"dendritic cells: 10.3;T-cells: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040087	Approved		Approved	Cytosol				Cytosol		"HPA040087: AB_10793927"	"unprognostic (2.27e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.75e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.35e-2)"	7.7	2.3	9.3	5.9	12.8	1.3	8.0	1.7	12.5	11.3	21.2	28.9	3.0	4.0	15.1	10.5	5.3	12.8	17.0	5.6	12.6	7.5	4.1	1.4	9.6	12.4	20.6	5.9	39.5	2.3	1.6	5.4	13.1	12.3	13.2	3.8	10.9	4.4	17.9	4.8	2.1	8.2	21.7	10.1	7.5	12.1	4.6	13.1	4.6	26.9	4.8	5.0	11.3	10.1	0.0	10.3	0.0	0.0	0.0	11.8	0.4	0.1	1.0	0.2	0.0	7.0	13.6	1.9	39.4	43.0	20.0	27.4	0.0	0.0	0.0	0.3	25.5	0.8	2.5	0.2	20.7	0.0	0.1	0.2	0.0	0.0	12.0	0.0	0.0	25.3	0.0	8.2	0.0	0.2	0.0	0.0	8.1	0.0	0.0	0.0	1.2	0.0	0.0	3.0	0.0	0.1	0.0	1.3	4.8	0.1	0.0	0.1	0.0	0.1	0.1	29.6	21.8	0.2	19.2	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	10.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	11.8	0.4	9.3	12.8	1.7	12.5	12.6	7.5	20.6	5.9	12.3	13.1
LBX1	"HPX6, LBX1H"	ENSG00000138136	"Ladybird homeobox 1"	P52954	10	101226195-101229794	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	76	"brain: 11.8;skeletal muscle: 25.0"	"Group enriched"	"Detected in some"	5	"HEK 293: 4.9;RH-30: 6.2;SCLC-21H: 13.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	7	"cerebellum: 11.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"cerebellum: 1.8;pons and medulla: 3.2"	"Group enriched"	"Detected in some"	20	"cerebellum: 2.9;pons and medulla: 2.8"	"HPA002016, HPA002086"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA002016: , HPA002086: AB_1079242"		"unprognostic (4.13e-1)"			"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"		"unprognostic (2.29e-1)"	"unprognostic (7.28e-3)"	"unprognostic (3.31e-1)"				"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"			0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	25.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.0	13.3	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.8	0.8	0.0	0.0	0.0	0.0	1.7	0.0
LCN9		ENSG00000148386	"Lipocalin 9"	Q8WX39	9	135663322-135666422	"Predicted secreted proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"ductus deferens: 17.2;epididymis: 5.0;seminal vesicle: 7.7"	"Cell line enriched"	"Detected in some"	15	"BEWO: 19.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA060941	Enhanced				"Secreted in male reproductive system"					"HPA060941: "					"unprognostic (7.64e-4)"													0.3	0.0	0.5	0.0	0.5	0.0	0.0	0.2	2.1	0.2	0.0	0.1	17.2	0.0	0.0	5.0	0.0	0.5	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	7.7	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	0.4	0.5	0.3	0.9	0.0	0.1	0.0
LDLRAD2		ENSG00000187942	"Low density lipoprotein receptor class A domain containing 2"	Q5SZI1	1	21812265-21825221	"Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;NTERA-2: 2.5;REH: 3.4;THP-1: 2.8;TIME: 6.1"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in some"		"basophil: 1.9;plasmacytoid DC: 2.5"	"Low lineage specificity"	"Detected in many"											HPA030478	Approved				"Secreted - unknown location"					"HPA030478: AB_10601541"	"unprognostic (4.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.35e-2)"	"unprognostic (4.85e-2)"	"unprognostic (7.52e-2)"	"unprognostic (3.80e-2)"	"unprognostic (5.34e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.39e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	5.4	1.9	0.2	2.2	0.2	2.7	2.2	0.0	0.1	1.7	3.2			4.7	3.1	0.0	1.3	2.2	1.6	3.6	0.5	1.1	1.5	0.1	1.0	1.8	0.0		0.5	1.1	0.0	0.9	0.2		3.1	0.3		5.7	0.1	2.7	1.3	1.7	0.2	0.0	2.3	3.2	0.8			1.6		0.9	2.2	1.8	0.6	2.5	1.9	0.0	0.7	0.0	0.0	0.5	0.7	0.4	0.6	0.2	0.0	1.2	0.9	0.0	0.0	0.0	0.4	1.5	0.0	2.4	0.2	0.8	0.1	0.0	0.0	0.0	0.1	0.4	1.2	0.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	1.4	2.5	0.4	3.4	0.5	0.0	0.0	0.3	0.0	0.3	0.5	0.1	0.1	0.2	2.8	6.1	0.6	0.6	0.8	0.0	0.0	0.1	0.4	0.1	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	2.5	0.0	0.0										
LDLRAD3	LRAD3	ENSG00000179241	"Low density lipoprotein receptor class A domain containing 3"	Q86YD5	11	35943981-36232136	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 32.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 28.1;RH-30: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.1;non-classical monocyte: 7.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038251	Approved		Approved	"Cell Junctions"				"Cell Junctions"		"HPA038251: AB_10675790"	"unprognostic (1.59e-3)"	"prognostic unfavourable (2.24e-4)"	"unprognostic (3.25e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavourable (9.34e-6)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.68e-2)"	"unprognostic (6.93e-2)"	"prognostic unfavourable (5.05e-8)"	"unprognostic (3.32e-2)"	"unprognostic (9.21e-3)"	"unprognostic (9.33e-2)"	"prognostic unfavourable (2.14e-5)"	12.0	5.0	9.5	6.0	13.7	2.0	23.4	32.5	17.9	9.3	2.8	20.7	1.7	2.9	8.2	4.7	8.8	5.0	6.5	3.6	10.8	7.2	3.0	2.6	3.3	4.4	18.0	4.0	15.0	5.1	1.5	9.2	3.4	18.1	14.8	3.2	5.3	23.9	6.0	5.5	17.0	3.3	7.2	24.4	2.9	3.4	4.8	13.5	0.1	3.0	2.6	4.8	5.3	6.5	0.0	4.1	1.9	7.7	0.0	0.0	2.0	4.8	4.6	14.2	8.6	11.3	12.5	10.8	2.8	2.5	6.3	5.6	3.4	3.0	0.0	2.1	3.0	2.4	4.3	6.2	8.8	0.4	9.2	15.5	3.0	1.0	15.0	3.3	1.9	14.9	28.1	2.8	24.9	10.5	4.0	0.5	11.6	2.7	0.0	0.7	5.8	8.0	0.0	26.5	1.5	1.1	0.7	4.8	11.0	4.8	5.3	15.6	7.3	4.5	10.6	7.6	6.8	0.6	9.2	0.3	0.0	0.0	3.8	4.1	13.5	1.9	6.1	0.6	0.0	6.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.0	7.7	0.3	0.0	2.0	9.5	13.7	32.5	9.1	10.8	7.2	18.0	4.0	18.1	13.5
LEFTY1	"LEFTB, LEFTYB"	ENSG00000243709	"Left-right determination factor 1"	O75610	1	225886282-225911382	"Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 12.1;epididymis: 19.0;intestine: 26.6;pancreas: 46.5"	"Cell line enriched"	"Detected in some"	6	"NTERA-2: 33.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.8"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	35	"basophil: 12.1"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 12.1"									"HPA047883, HPA056210"	Approved				"Secreted in other tissues"					"HPA047883: , HPA056210: "	"unprognostic (2.81e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.76e-2)"	"unprognostic (6.13e-2)"	"prognostic unfavourable (2.48e-6)"	"unprognostic (2.78e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.61e-2)"	0.2	0.0	0.6	4.5	1.1	0.0	0.2	1.2	0.9	0.6	26.6	0.2	1.5	0.0	0.7	19.0	0.4	0.1	0.2	0.2	0.6	0.7	3.6	0.2	0.3	0.2	0.2	0.2	2.0	46.5	0.0	0.3	0.3	0.2	0.6	15.1	0.3	0.5	1.6	0.2	0.0	0.8	0.4	0.2	0.2	0.4	2.1	0.2	0.3	0.2	0.2	0.2	0.9	0.2	0.0	0.0	12.1	0.0	0.3	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	3.5	0.3	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	1.7	0.6	1.1	1.2	0.9	0.6	0.7	0.2	0.2	0.2	0.2
LEKR1	FLJ16641	ENSG00000197980	"Leucine, glutamate and lysine rich 1"	Q6ZMV7	3	156825481-157046129	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 29.8"	"Cell line enhanced"	"Detected in many"		"A-431: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA044039, HPA047774"	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA044039: AB_10794288, HPA047774: "	"unprognostic (5.42e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.66e-3)"	"unprognostic (3.50e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.80e-2)"	1.4	1.7	1.4	2.5	4.6	0.6	2.7	1.4	2.2	1.5	1.0	1.6	3.5	1.7	1.3	8.2	0.9	6.3	1.7	1.4	1.5	2.0	2.8	1.3	3.0	1.6	1.1	1.4	2.9	2.7	4.8	4.5	0.5	2.2	1.7	1.1	2.5	1.6	4.9	0.7	0.9	1.6	0.8	1.9	1.8	1.5	29.8	0.7	4.4	4.0	0.7	1.4	1.2	1.8	3.2	1.9	2.5	0.3	2.5	2.0	0.4	6.5	2.7	0.1	1.6	1.1	0.6	0.4	0.4	1.0	1.4	1.1	0.3	3.8	0.1	1.9	1.1	2.5	0.0	0.5	2.6	1.2	0.6	2.5	0.4	0.0	0.0	2.1	0.5	3.1	1.6	0.5	1.9	0.6	1.5	1.6	2.4	2.4	0.0	1.9	2.1	1.5	0.0	1.7	1.5	2.1	0.6	4.1	1.7	2.1	1.5	0.1	4.5	3.6	0.0	0.4	0.7	0.5	1.0	6.1	1.0	0.0	1.2	1.5	2.3	2.5	0.3	0.3	0.7	0.1	1.4	3.1	1.6	0.6	1.2	3.2	1.8	0.9	0.3	2.5	0.2	1.9	2.0	0.4	1.4	4.6	1.4	2.2	1.5	2.0	1.1	1.4	2.2	0.7
LEMD1	"CT50, LEMP-1"	ENSG00000186007	"LEM domain containing 1"	Q68G75	1	205381378-205457091	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 13.1;testis: 34.8"	"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 29.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.6"	"Group enriched"	"Detected in some"	13	"cerebellum: 2.6;pons and medulla: 5.3"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045425			Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA045425: AB_10960538"	"unprognostic (1.78e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.20e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.48e-1)"		"unprognostic (2.72e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (1.26e-4)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (3.31e-1)"	"unprognostic (5.66e-6)"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-2)"	0.2	0.2	0.2	0.0	0.3	0.0	0.3	2.6	0.2	0.4	1.4	0.0	3.8	0.6	1.0	13.1	1.0	1.5	0.7	0.2	0.2	0.3	0.9	0.2	0.4	0.0	0.3	0.0	0.6	0.6	0.0	0.6	4.7	5.3	0.3	0.0	0.3	3.2	0.4	0.2	0.3	1.4	0.1	0.2	0.2	0.3	34.8	0.0	0.0	4.8	2.2	2.6	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.7	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	29.2	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.2	0.3	2.6	0.2	0.2	0.3	0.3	0.0	5.3	0.0
LETM2	"FLJ25409, SLC55A2"	ENSG00000165046	"Leucine zipper and EF-hand containing transmembrane protein 2"	Q2VYF4	8	38386207-38409527	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.8;testis: 28.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 16.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 16.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 16.8"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 50.6"	HPA025032	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA025032: AB_1852808"	"unprognostic (3.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.27e-4)"	"unprognostic (3.20e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.25e-2)"	2.3	1.3	3.3	1.7	7.9	6.8	1.5	9.9	6.6	2.6	1.3	2.9	0.5	1.5	2.1	2.1	2.1	2.1	2.0	1.4	4.3	4.1	3.5	1.4	3.2	1.7	3.1	4.2	2.6	1.4	3.6	5.5	6.7	3.3	1.9	1.5	3.0	1.4	1.4	0.8	1.8	1.1	1.2	3.2	2.3	4.1	28.6	1.6	3.8	1.6	1.0	2.2	3.1	1.7	1.4	1.3	16.8	3.8	1.2	4.0	1.2	13.6	2.5	1.9	1.7	1.5	4.2	1.4	4.6	5.5	6.6	4.0	1.0	5.4	1.7	10.8	1.0	1.5	3.8	16.5	6.9	0.8	1.5	2.0	1.9	2.4	1.8	0.3	1.9	1.2	4.6	7.0	15.0	6.9	1.7	2.7	5.8	2.8	4.9	1.2	0.4	11.6	1.7	3.1	1.0	10.8	0.6	1.6	1.5	1.5	0.3	0.5	1.6	0.8	11.8	2.0	14.6	3.7	1.1	1.7	1.0	1.3	3.2	2.1	1.5	0.9	3.4	0.5	0.9	1.3	1.5	1.4	0.8	1.3	1.3	1.4	1.6	1.5	16.8	1.2	3.8	0.6	4.0	1.2	3.3	7.9	9.9	6.6	4.3	4.1	3.1	4.2	3.3	1.6
LEUTX		ENSG00000213921	"Leucine twenty homeobox"	A8MZ59	19	39776595-39786167	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"CACO-2: 1.0;HDLM-2: 2.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041498	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA041498: AB_10796346"															"unprognostic (6.60e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.3		0.0	0.6		0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LEXM	"C1orf177, FLJ40201, LEM"	ENSG00000162398	"Lymphocyte expansion molecule"	Q3ZCV2	1	54806063-54842252	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 7.0;esophagus: 14.2;testis: 5.2"	"Cell line enhanced"	"Detected in some"		"A-431: 1.1;CAPAN-2: 2.5;HaCaT: 1.6;Karpas-707: 1.8;U-266/84: 2.0;U-87 MG: 1.2"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in many"		"gdT-cell: 7.0"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035889, HPA035890"	Uncertain									"HPA035889: AB_2674844, HPA035890: AB_10669535"	"unprognostic (1.61e-1)"	"unprognostic (2.18e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.69e-2)"		"unprognostic (1.50e-2)"	"unprognostic (8.32e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.81e-1)"	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.5	0.5			2.3	0.0	0.0	14.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.5		0.6	0.0	0.0	1.3	1.7	0.0	0.0	0.0	0.2	5.2			0.0		0.6	0.0	3.8	0.0	0.2	1.6	0.0	3.0	7.0	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.5	0.1	0.2	0.0	1.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.2	0.8	0.2	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.7	0.0	1.0	2.0	0.0	1.2	0.3	0.1	0.0	0.0	1.6	7.0	0.0	0.4	0.0	1.5	3.4	0.0	0.0	0.3	4.6	0.0	3.0	0.0	0.2	0.3	1.4										
LGI2	"FLJ10675, KIAA1916"	ENSG00000153012	"Leucine rich repeat LGI family member 2"	Q8N0V4	4	24998847-25030879	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"parathyroid gland: 113.9"	"Cell line enhanced"	"Detected in some"		"AF22: 22.2;HAP1: 4.0;RPMI-8226: 10.2;SCLC-21H: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	10	"monocytes: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017140	Approved		Approved	Centrosome	"Secreted to blood"			Centrosome		"HPA017140: AB_1852833"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.20e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.38e-5)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.03e-3)"	2.5	1.6	2.8	6.7	3.3	0.8	2.3	7.9	7.8	3.7	4.0	0.0	1.0	1.1	8.9	4.9	4.1	11.4	4.2	3.7	2.4	3.9	3.0	0.9	1.4	2.0	7.2	0.4	9.1	2.6	113.9	0.5	2.6	18.7	1.0	1.6	6.0	0.9	1.4	0.9	0.9	2.6	7.1	2.9	1.2	2.4	2.0	0.9	0.6	1.8	0.6	4.6	1.8	1.1	0.0	0.1	0.0	1.3	0.0	0.0	0.2	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.6	0.0	0.0	4.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.6	0.7	0.0	0.9	10.2	0.4	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.6	0.0	0.6	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	3.3	7.9	7.8	2.4	3.9	7.2	0.4	18.7	0.9
LGI3		ENSG00000168481	"Leucine rich repeat LGI family member 3"	Q8N145	8	22146825-22157084	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 52.2;lung: 17.7;skin 1: 16.3;thyroid gland: 14.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.2;SCLC-21H: 4.5;SK-MEL-30: 4.5;U-2 OS: 2.5;WM-115: 2.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 14.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024826			Approved	Cytosol	"Secreted in brain"			Cytosol		"HPA024826: AB_10601131"	"unprognostic (4.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.59e-5)"	"unprognostic (1.36e-2)"	"unprognostic (9.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	1.2	4.8	13.1	1.1	26.4	1.1	1.2	7.7	52.2	2.6	1.2	35.5	0.0	1.4	1.5	1.3	6.1	2.0	1.1	1.5	20.7	15.7	1.1	1.0	17.7	1.0	24.2	10.4	1.1	1.5	0.9	0.7	1.0	24.9	2.3	1.1	4.6	1.2	4.2	1.0	16.3	1.4	1.7	29.8	1.1	1.3	1.4	14.8	0.0	14.9	0.0	1.3	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.2	0.0	1.0	0.8	0.3	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	4.5	0.6	0.0	0.0	4.5	0.5	0.0	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.0	1.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	26.4	7.7	32.1	20.7	15.7	24.2	10.4	24.9	14.8
LHFPL1		ENSG00000182508	"LHFPL tetraspan subfamily member 1"	Q86WI0	X	112630648-112680054	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 13.7;pituitary gland: 15.9;salivary gland: 8.2"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 1.4;NTERA-2: 2.5;REH: 1.5;SK-MEL-30: 7.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in many"	5	"olfactory region: 6.1"	HPA003029	Uncertain									"HPA003029: AB_1079248"	"unprognostic (2.23e-2)"	"unprognostic (2.78e-3)"		"unprognostic (2.49e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.41e-3)"	"unprognostic (5.19e-5)"	"unprognostic (1.33e-1)"	"unprognostic (7.63e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.92e-1)"	0.2	0.6	3.1	0.4	13.7	0.1	2.0	0.1	3.8	1.5	0.3	0.6	0.9	0.3	0.6	0.9	0.5	1.3	0.2	2.2	2.8	2.5	0.6	0.2	0.2	0.4	4.5	1.5	1.1	0.1	0.3	15.9	0.5	3.8	1.2	0.4	0.0	8.2	3.3	0.5	0.3	0.5	0.3	0.5	0.4	0.2	0.4	1.6	0.3	6.1	0.1	0.5	0.5	0.2	0.7	0.0	0.0	0.0	0.8	2.6	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	2.5	0.0	1.5	0.3	0.9	0.1	0.4	0.2	0.2	0.0	0.0	7.0	0.0	0.0	0.0	0.2	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.2	0.7	1.0	2.6	0.0	0.6	0.2	0.8	0.0	0.8	0.0	0.0	0.1	0.4	3.1	13.7	0.1	2.7	2.8	2.5	4.5	1.5	3.8	1.6
LHFPL2	KIAA0206	ENSG00000145685	"LHFPL tetraspan subfamily member 2"	Q6ZUX7	5	78485215-78770021	"Predicted membrane proteins"	Fertilization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.0;plasmacytoid DC: 7.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.9;granulocytes: 8.0;monocytes: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042402	Uncertain		Approved	"Vesicles,Actin filaments"			110000	"Actin filaments"	Vesicles	"HPA042402: AB_10794276"	"unprognostic (2.19e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.45e-2)"	"prognostic unfavourable (2.73e-4)"	"unprognostic (3.44e-3)"	"unprognostic (2.32e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (3.45e-7)"	"unprognostic (3.40e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.85e-2)"	17.1	18.2	10.3	16.1	11.7	11.5	34.7	3.5	9.1	15.8	15.4	12.0	14.1	17.6	14.6	15.0	7.6	10.7	17.6	14.1	11.7	7.6	3.8	4.7	17.2	10.3	15.2	7.2	18.7	18.0	9.2	7.3	11.3	12.9	13.3	13.5	18.2	21.4	20.5	4.6	6.7	27.1	16.6	18.0	4.7	10.8	10.9	13.1	5.7	10.3	4.9	10.4	15.4	18.2	0.9	7.9	8.0	4.7	0.0	0.1	1.5	3.5	13.1	4.0	5.2	24.3	7.0	12.3	4.0	10.4	7.1	12.4	4.6	10.5	8.8	1.8	7.9	6.1	3.8	4.3	11.7	0.1	3.4	8.8	2.7	7.8	18.0	0.0	0.0	7.9	17.6	21.6	33.7	16.6	0.0	6.6	16.0	1.8	0.0	0.5	4.4	3.8	1.7	5.6	2.4	2.6	15.6	0.7	5.4	6.6	2.4	22.5	1.4	1.1	10.9	8.2	4.5	22.6	12.0	0.2	0.0	12.7	21.9	0.0	14.7	8.0	4.7	4.8	0.0	1.8	0.1	0.9	0.0	0.0	1.1	0.9	0.0	0.0	1.0	0.0	0.6	7.9	0.1	1.5	10.3	11.7	3.5	9.1	11.7	7.6	15.2	7.2	12.9	13.1
LHFPL3	LHFPL4	ENSG00000187416	"LHFPL tetraspan subfamily member 3"	Q86UP9	7	104328656-104907232	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"brain: 36.5"	"Cell line enhanced"	"Detected in some"		"K-562: 2.2;SCLC-21H: 4.0;SH-SY5Y: 5.3;SK-BR-3: 4.5;SK-MEL-30: 2.3"	"Cancer enriched"	"Detected in some"	12	"glioma: 27.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069691			Approved	Vesicles				Vesicles		"HPA069691: "		"unprognostic (1.20e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.59e-3)"	"unprognostic (5.03e-2)"			"unprognostic (2.27e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.96e-2)"	"unprognostic (5.81e-2)"	"unprognostic (5.99e-3)"	"unprognostic (8.50e-3)"	"unprognostic (3.07e-1)"		"unprognostic (1.33e-1)"	0.5	0.6	6.4	0.6	7.7	0.5	0.5	2.3	36.5	4.3	0.8	6.1	0.0	2.0	0.7	0.5	0.5	0.9	0.5	0.5	4.9	5.6	1.4	0.5	2.2	0.5	4.8	4.2	0.7	1.5	0.5	0.1	0.5	5.6	0.7	0.6	3.8	0.5	0.5	0.5	0.7	1.4	0.5	6.0	0.9	0.8	0.7	6.7	0.0	0.5	0.0	0.6	0.5	0.2	0.5	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	4.0	5.3	0.0	4.5	2.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	7.7	2.3	7.1	4.9	5.6	4.8	4.2	5.6	6.7
LHFPL4		ENSG00000156959	"LHFPL tetraspan subfamily member 4"	Q7Z7J7	3	9498361-9553802	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 29.1;pituitary gland: 9.0"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 4.6;SCLC-21H: 10.7;SH-SY5Y: 13.4;U-266/84: 11.2;WM-115: 4.1"	"Group enriched"	"Detected in some"	13	"glioma: 6.8;pancreatic cancer: 1.3;testis cancer: 5.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041421	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA041421: AB_10796673"	"unprognostic (6.81e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.03e-3)"	"unprognostic (8.21e-2)"	0.9	4.9	8.0	1.0	11.4	0.9	0.9	16.0	29.1	0.9	1.4	1.5	0.0	1.2	0.9	0.8	0.9	0.9	0.9	0.8	8.4	8.5	0.9	0.8	1.0	0.8	4.2	8.6	0.8	1.8	1.2	9.0	0.8	9.2	0.9	1.4	1.7	0.9	0.9	0.8	0.9	1.3	0.9	4.2	0.8	1.3	1.6	1.8	0.0	0.9	0.0	0.8	0.8	0.1	0.0	1.2	0.6	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	10.7	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.0	0.0	11.2	0.0	0.5	0.0	4.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	1.2	0.0	0.0	8.0	11.4	16.0	15.6	8.4	8.5	4.2	8.6	9.2	1.8
LHFPL6	"LHFP, MGC22429"	ENSG00000183722	"LHFPL tetraspan subfamily member 6"	Q9Y693	13	39342892-39603528	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 65.0;HSkMC: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 9.4;plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058975	Approved		Approved	Nucleoli				Nucleoli		"HPA058975: "	"unprognostic (6.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (1.20e-7)"	"unprognostic (4.41e-3)"	"unprognostic (5.25e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavourable (2.30e-4)"	57.2	26.8	12.5	14.8	17.7	0.9	45.7	40.8	19.0	20.3	16.4	12.3	8.5	5.3	28.6	23.7	17.9	27.0	34.9	49.4	12.7	12.9	12.8	6.9	27.0	27.4	19.3	12.6	25.7	8.3	7.1	14.3	62.0	16.8	21.4	8.4	19.8	11.4	18.8	13.6	13.1	9.6	33.1	18.5	18.5	10.2	16.2	11.9	1.3	22.7	22.1	8.3	20.1	25.8	0.2	9.4	0.1	0.6	0.0	0.0	0.4	2.7	0.9	29.5	1.2	65.0	29.5	12.9	15.0	21.7	7.7	5.8	0.1	2.8	4.2	0.3	20.9	4.2	3.7	8.8	6.4	4.0	4.3	11.3	0.9	0.0	6.8	0.2	0.3	47.5	1.1	6.9	11.5	7.1	0.0	0.0	14.7	2.3	0.0	3.4	2.2	3.9	1.8	12.8	0.0	5.1	3.6	0.1	0.9	1.3	1.8	4.0	1.6	0.0	13.2	19.6	2.9	6.0	8.1	0.2	0.0	11.8	8.1	0.0	14.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.4	0.2	0.0	0.0	0.1	0.0	0.1	3.2	0.0	0.4	12.5	17.7	40.8	19.0	12.7	12.9	19.3	12.6	16.8	11.9
LIMS3		ENSG00000256977	"LIM zinc finger domain containing 3"	P0CW19	2	109898428-109924868	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 11.9;endometrium 1: 9.7"	"Cell line enhanced"	"Detected in many"		"HEL: 9.6;HMC-1: 29.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"eosinophil: 11.9"	"Low lineage specificity"	"Detected in many"											HPA058455	Uncertain		Approved	"Focal adhesion sites,Cytosol"				Cytosol	"Focal adhesion sites"	"HPA058455: "										"unprognostic (2.23e-2)"								1.2	2.8	0.5	2.2	0.5	0.0	1.0	0.8	0.5	1.0	0.7	0.3	4.2	0.2	9.7	2.8	1.2	7.1	0.9	2.6	0.5	0.5	2.6	0.6	0.8	2.8	0.6	0.3	2.2	0.7	0.3	2.4	5.6	0.3	1.0	0.8	0.6	2.2	0.6	3.0	0.8	0.5	1.2	0.6	0.6	0.7	3.7	0.3	0.3	1.0	0.3	0.3	2.6	0.7	0.7	2.5	11.9	5.5	1.1	6.2	8.0	0.0	0.1	1.2	1.5	0.5	0.4	0.0	1.5	0.0	0.2	0.6	1.5	0.0	0.0	4.6	0.3	0.8	0.0	1.8	1.3	2.3	0.0	9.6	0.4	0.9	1.4	1.7	29.2	2.1	1.1	1.1	1.3	2.4	2.0	1.6	3.2	0.1	0.0	0.2	1.5	0.5	1.7	3.1	1.0	0.8	1.5	0.4	3.5	3.9	0.0	0.7	0.0	0.5	7.1	6.3	5.8	3.2	0.3	0.0	0.0	1.8	0.8	0.0	1.9	4.7	3.3	11.9	0.9	5.5	1.5	0.7	5.0	1.7	2.5	0.2	0.9	0.3	0.7	1.1	5.2	0.2	6.2	8.0	0.5	0.5	0.8	0.5	0.5	0.5	0.6	0.3	0.3	0.3
LINGO2	"LERN3, LRRN6C"	ENSG00000174482	"Leucine rich repeat and Ig domain containing 2"	Q7L985	9	27948078-28670286	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 10.5;smooth muscle: 11.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2;hTERT-HME1: 2.3;SH-SY5Y: 13.4;U-87 MG: 2.3;WM-115: 5.9"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	8	"NK-cell: 3.4"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA016633, CAB025361"	Approved									"CAB025361: , HPA016633: AB_1853362"	"unprognostic (1.27e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.98e-4)"	"unprognostic (9.86e-4)"	"unprognostic (7.55e-3)"		"unprognostic (2.67e-6)"	"unprognostic (1.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.74e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.95e-4)"	0.0	0.3	1.8	0.0	1.7	0.0	0.0	1.0	3.4	0.3	0.0			0.0	10.5	1.0	0.0	0.4	1.0	0.0	1.4	4.1	0.6	0.0	0.0	0.0	0.6		0.0	0.0	2.7	0.6	1.8		0.6	0.0		0.0	1.9	0.0	0.0	0.0	11.4	0.3	0.0	0.4	1.8			3.7		0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.4	0.4	1.7	0.0	0.5	0.3	3.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	1.1	0.3	2.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	13.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.3	0.0	5.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	1.7										
LINGO4	LRRN6D	ENSG00000213171	"Leucine rich repeat and Ig domain containing 4"	Q6UY18	1	151800264-151806154	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 5.4;skeletal muscle: 17.7"	"Group enriched"	"Detected in some"	4	"HDLM-2: 4.0;Karpas-707: 1.1;SH-SY5Y: 1.7"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA060781	Uncertain									"HPA060781: "	"unprognostic (2.71e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.49e-5)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.94e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.94e-4)"	"unprognostic (3.84e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (5.60e-2)"	0.0	2.5	0.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0			0.0	0.0	0.9	0.0	0.8	0.0	0.3	0.0	0.1	0.3	0.7	0.1	0.1	0.0		0.0	0.3	0.4	1.2	0.0		0.8	0.0		0.4	0.1	17.7	0.3	0.0	0.0	0.3	0.0	0.3	0.4			0.4		0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.7	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LIPJ	"bA425M17.2, LIPL1"	ENSG00000204022	"Lipase family member J"	Q5W064	10	88586753-88606976	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"testis: 11.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.6;NB-4: 1.0;SK-MEL-30: 2.3;U-2197: 1.0"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"eosinophil: 1.0"	"Low lineage specificity"	"Detected in single"											HPA048594	Uncertain									"HPA048594: "	"unprognostic (4.79e-3)"	"unprognostic (6.77e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.90e-3)"	"unprognostic (7.50e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.21e-4)"	"unprognostic (9.87e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.88e-1)"	0.2	0.0	0.3	0.0	0.3	0.0	0.2	1.0	0.3	0.1	0.0			0.4	0.2	1.6	0.0	1.1	0.1	0.1	0.4	0.5	0.2	0.7	0.0	0.3	0.0		0.1	0.6	0.0	0.1	0.0		0.3	0.2		0.6	0.0	0.4	0.1	0.1	0.3	0.1	0.1	0.3	11.5			0.9		0.4	0.5	0.1	0.7	0.0	1.0	0.1	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.3	0.0	0.8	0.0	0.1	0.7	1.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0										
LIX1	"C5orf11, Lft"	ENSG00000145721	"Limb and CNS expressed 1"	Q8N485	5	97091867-97142872	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 35.9"	"Cell line enriched"	"Detected in some"	12	"RPTEC TERT1: 26.8"	"Cancer enhanced"	"Detected in many"		"glioma: 13.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"naive B-cell: 5.9"	"Lineage enriched"	"Detected in single"	9	"B-cells: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058426	Uncertain		Approved	"Vesicles,Cytokinetic bridge,Cytosol"				Cytosol	"Vesicles, Cytokinetic bridge"	"HPA058426: "	"unprognostic (3.18e-1)"	"unprognostic (4.53e-2)"	"unprognostic (9.46e-2)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (8.96e-2)"	"unprognostic (6.60e-2)"		"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.61e-2)"	1.0	1.2	14.9	1.3	16.9	1.4	1.1	6.1	35.9	1.0	1.3	19.2	1.0	1.2	1.2	1.2	1.0	1.2	1.1	1.1	24.6	10.7	4.9	1.0	1.1	1.6	11.7	13.2	1.0	1.0	1.0	1.2	1.4	12.4	3.0	1.4	3.3	1.1	8.3	1.1	1.1	1.2	1.2	10.1	1.2	1.2	1.1	13.0	0.0	6.5	0.0	1.0	1.0	0.2	5.9	0.1	0.6	0.1	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.2	1.2	0.1	0.0	0.0	5.9	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	14.9	16.9	6.1	11.9	24.6	10.7	11.7	13.2	12.4	13.0
LIX1L	MGC46719	ENSG00000271601	"Limb and CNS expressed 1 like"	Q8IVB5	1	145933423-145958001	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063598			Approved	Cytosol				Cytosol		"HPA063598: "	"unprognostic (5.21e-2)"	"unprognostic (4.09e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.85e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (9.81e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.51e-2)"	"prognostic unfavourable (3.19e-5)"	"unprognostic (2.10e-3)"	"unprognostic (4.95e-1)"	"unprognostic (1.25e-2)"	"prognostic unfavourable (5.27e-4)"	13.8	8.9	4.6	6.5	4.4	2.1	6.0	4.1	5.9	14.4	8.0	7.1	3.2	2.7	15.9	7.6	5.8	6.3	10.6	10.0	4.3		4.2	5.4	6.4	9.2	5.7	4.0	19.6	1.7	4.4	9.4	7.5	4.0	11.6	4.2	11.4	3.3	10.7	10.5	2.4	4.0	12.7	4.2	9.4	2.6	7.4	5.8	11.1	4.6	4.5	9.5	11.8	8.4	4.3	4.2	5.1	4.4	4.8	11.1	3.1	3.2	4.6	14.1	15.6	29.6	25.2	0.2	7.2	13.3	11.3	8.3	0.3	3.0	8.6	8.0	14.6	0.1	6.5	6.1	10.8	7.9	2.1	4.8	5.1	4.5	9.7	11.3	11.4	15.3	2.8	9.3	13.5	21.9	7.0	13.9	17.9	0.1	14.8	9.5	4.1	6.0	10.1	7.1	14.1	11.7	0.0	5.1	14.5	14.9	0.0	10.8	0.5	8.9	16.9	19.4	5.3	12.6	12.2	11.2	7.9	8.8	13.6	9.4	9.3	4.8	2.9	4.6	8.0	2.7	9.7	4.0	9.2	8.0	2.7	4.3	8.6	11.1	5.1	4.8	4.4	4.2	6.7	3.1										
LKAAEAR1	C20orf201	ENSG00000171695	"LKAAEAR motif containing 1"	Q8TD35	20	64083380-64084359	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 12.5;testis: 18.0"	"Group enriched"	"Detected in some"	4	"REH: 9.0;SCLC-21H: 9.4"	"Low cancer specificity"	"Detected in some"							"Group enriched"	"Detected in some"	9	"intermediate monocyte: 7.9;non-classical monocyte: 12.5"	"Lineage enriched"	"Detected in many"	11	"monocytes: 12.5"					"Low region specificity"	"Detected in many"			HPA056463			Approved	Nucleoplasm				Nucleoplasm		"HPA056463: "	"unprognostic (5.47e-3)"	"unprognostic (1.18e-1)"		"unprognostic (1.20e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.78e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.16e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.30e-2)"	0.5	0.0	3.4	0.3	2.9	0.6	0.1	1.5	2.9	0.0	0.2			0.6	0.1	0.0	0.0	1.8	0.0	0.0	1.7	3.1	0.1	0.0	0.3	0.2	1.2		0.0	0.7	0.7	0.1	0.0		0.2	0.0		0.3	0.0	0.2	0.3	0.0	0.0	0.3	0.5	0.3	18.0			0.1		0.0	0.0	0.0	0.1	1.0	0.8	12.5	0.0	0.8	0.8	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.7	0.7	0.3	1.5	9.0	0.0	0.2	0.0	0.0	9.4	2.2	0.0	0.1	0.1	0.2	0.5	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.8	0.1	7.9	0.6	0.1	0.7	0.2	1.0	0.0	0.8	0.2	0.0	0.0	12.5	0.2	0.0	0.8										
LMLN	"Gp63, LMNL1, Msp"	ENSG00000185621	"Leishmanolysin like peptidase"	Q96KR4	3	197960200-198043720	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016481, HPA028844"	Uncertain		Supported	"Focal adhesion sites,Cytosol"				Cytosol	"Focal adhesion sites"	"HPA016481: AB_1852955, HPA028844: AB_10602347"	"unprognostic (2.54e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.63e-2)"	"prognostic favourable (6.77e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.78e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.63e-1)"	3.9	4.9	5.2	2.5	11.0	2.3	4.5	6.1	9.1	6.2	3.5	5.8	14.3	2.2	4.8	20.3	3.5	9.3	5.1	5.9	5.7	7.4	6.6	3.7	8.1	3.5	5.6	8.9	6.5	6.1	8.8	15.0	3.9	11.6	4.6	4.1	5.4	4.2	11.7	3.7	6.5	2.3	4.0	5.5	3.0	3.9	27.0	4.4	1.2	7.6	3.0	2.6	3.5	3.7	1.9	1.9	0.8	2.4	1.8	2.4	1.2	6.5	2.5	3.0	3.5	5.9	8.3	2.5	3.4	3.1	6.2	5.1	2.4	2.4	2.1	16.0	2.4	2.5	2.8	2.7	9.0	0.3	2.0	1.2	2.1	1.8	3.7	3.7	1.8	3.9	6.1	7.7	5.0	2.7	6.3	4.0	5.9	4.9	2.2	3.2	3.3	6.0	2.5	0.7	2.2	6.4	1.7	4.8	1.4	4.8	4.3	3.4	11.1	2.8	5.7	7.6	1.1	9.2	5.7	7.1	13.8	0.6	10.9	6.4	6.9	0.2	0.6	0.5	1.2	2.4	1.7	1.9	0.8	1.6	1.9	1.1	2.2	2.4	0.8	1.8	0.9	0.5	0.0	1.2	5.2	11.0	6.1	9.1	5.7	7.4	5.6	8.9	11.6	4.4
LMNTD1	"FLJ36004, IFLTD1, Pas1c1"	ENSG00000152936	"Lamin tail domain containing 1"	Q8N9Z9	12	25409307-25648579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;fallopian tube: 19.0;pituitary gland: 21.3;testis: 15.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.4;RT4: 6.6;SH-SY5Y: 6.7;U-2197: 23.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038640			Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA038640: "				"unprognostic (8.92e-3)"	"unprognostic (3.21e-1)"			"unprognostic (2.41e-1)"		"unprognostic (1.19e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.68e-1)"		"unprognostic (6.18e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.89e-2)"	0.4	0.3	4.3	0.7	6.7	0.4	1.1	3.3	1.6	1.4	3.9	7.1	0.0	1.5	0.8	6.0	0.3	19.0	0.9	0.5	8.5	2.8	0.8	0.2	4.1	0.4	1.1	3.0	4.0	0.7	0.1	21.3	0.3	13.4	0.4	3.8	1.3	0.2	0.3	0.2	0.6	0.6	1.2	4.1	0.6	0.6	15.0	6.5	0.0	1.1	0.0	0.2	0.4	0.3	2.6	2.2	2.7	0.9	0.7	1.6	0.6	0.3	0.3	0.1	0.2	0.2	1.5	2.3	3.1	5.4	1.2	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.2	0.1	0.3	0.9	0.1	0.9	0.8	1.9	0.3	0.1	0.1	0.5	0.2	1.6	0.4	0.1	1.9	0.3	0.0	0.4	0.0	0.3	1.6	0.5	0.4	0.2	0.2	0.2	6.6	0.1	6.7	0.2	0.4	3.8	0.3	1.5	0.3	0.2	0.9	23.5	0.2	0.8	1.3	1.6	0.3	1.5	2.5	1.9	0.9	0.6	1.4	0.3	0.5	2.1	1.0	1.3	0.4	2.6	1.4	1.6	2.7	0.7	0.4	2.2	0.5	0.6	4.3	6.7	3.3	1.6	8.5	2.8	1.1	3.0	13.4	6.5
LMO7DN	C13orf45	ENSG00000178734	"LMO7 downstream neighbor"	F2Z398	13	75871038-75883811	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"gallbladder: 3.4"	"Cell line enhanced"	"Detected in some"		"BJ: 1.4;fHDF/TERT166: 2.4;LHCN-M2: 5.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"											HPA052013	Uncertain									"HPA052013: "	"unprognostic (2.85e-2)"	"unprognostic (2.83e-2)"			"unprognostic (2.37e-2)"	"unprognostic (1.51e-2)"		"unprognostic (3.08e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.04e-1)"		"unprognostic (2.43e-3)"	"unprognostic (1.91e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.72e-3)"	"unprognostic (6.19e-2)"	0.6	0.1	0.1	0.0	0.8	0.2	1.8	0.0	0.8	0.0	0.1			1.2	0.3	0.6	2.7	0.8	3.4	0.2	0.3	0.5	0.3	0.0	1.6	0.4	0.3		0.6	0.0	0.1	3.0	0.2		0.1	0.1		0.7	0.0	0.4	0.3	1.3	0.6	0.3	0.0	0.6	1.4			0.7		0.0	0.4	0.4	0.2	0.1	0.0	0.0	1.0	0.3	0.1	0.3	0.3	0.3	0.4	0.6	0.5	0.3	1.4	0.3	0.0	0.6	1.2	0.2	0.1	0.0	2.4	0.7	0.0	0.0	0.1	0.1	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	1.4	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.0	1.0	0.0	0.1	0.0	0.1										
LNP1	NP3	ENSG00000206535	"Leukemia NUP98 fusion partner 1"	A1A4G5	3	100401193-100456319	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 31.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 9.4;cerebral cortex: 11.0;hippocampal formation: 10.1;olfactory region: 9.4"	HPA047926			Approved	"Nuclear speckles,Vesicles,Cytosol"				Vesicles	"Nuclear speckles, Cytosol"	"HPA047926: "	"unprognostic (1.78e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.40e-3)"	"unprognostic (6.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.08e-2)"	3.1	2.8	6.5	1.7	11.4	0.6	2.7	7.9	9.7	3.4	2.3	1.5	3.4	1.2	4.6	8.4	1.9	4.0	2.7	9.5	5.3	7.2	4.8	7.4	3.8	1.4	5.7	5.6	6.3	4.5	3.0	17.0	3.7	7.4	2.8	2.2	9.0	2.4	3.3	4.3	1.0	1.5	4.5	4.2	1.8	1.9	31.9	3.5	1.6	5.3	0.8	1.7	3.1	1.8	0.9	0.2	0.0	0.4	0.2	2.7	0.8	2.8	1.6	8.3	1.2	5.4	2.3	0.7	2.2	5.5	1.8	2.2	0.6	0.7	2.5	1.0	1.6	1.8	2.2	1.9	2.2	2.6	2.3	6.1	0.8	2.8	1.6	3.5	0.7	2.5	0.7	1.0	4.7	0.4	2.3	9.5	1.6	2.1	4.9	3.5	5.7	12.5	3.8	4.6	5.0	1.7	0.3	8.6	4.3	1.6	2.4	3.4	0.6	0.4	0.6	0.9	8.9	0.8	2.0	11.2	11.9	7.3	2.5	3.0	1.5	0.0	0.4	0.0	1.1	0.2	2.5	0.9	1.1	0.6	0.2	0.9	1.0	1.1	0.0	0.2	0.0	0.0	2.7	0.8	6.5	11.4	7.9	9.7	5.3	7.2	5.7	5.6	7.4	3.5
LONRF2	"FLJ45273, RNF192"	ENSG00000170500	"LON peptidase N-terminal domain and ring finger 2"	Q1L5Z9	2	100273291-100322733	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.9;epididymis: 32.6"	"Cell line enhanced"	"Detected in some"		"A549: 6.5;HAP1: 6.4;HEK 293: 6.9;HMC-1: 5.7;PC-3: 5.9;SCLC-21H: 14.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 15.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057366	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA057366: "	"unprognostic (9.81e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.20e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.72e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.86e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.32e-1)"	"prognostic favourable (6.42e-5)"	"unprognostic (1.14e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.66e-3)"	"unprognostic (6.34e-2)"	1.6	23.0	8.4	0.6	32.9	0.2	2.2	21.1	15.4	5.1	1.7	1.3	2.3	0.5	19.0	32.6	2.0	17.8	1.7	4.3	5.6	9.9	1.3	0.7	1.5	0.5	3.9	7.0	10.5	4.4	9.6	7.8	0.6	6.4	3.2	0.7	1.6	1.5	3.2	4.6	0.4	0.5	19.8	4.5	0.5	1.5	1.8	4.3	0.4	3.5	0.8	0.4	1.4	1.3	0.7	0.5	1.7	0.4	0.7	0.5	0.1	0.0	6.5	2.0	2.4	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	1.2	0.0	1.1	0.0	0.0	6.4	0.0	0.0	0.5	6.9	0.0	0.4	0.0	0.2	0.1	5.7	0.0	0.0	0.3	0.0	0.0	3.7	0.1	0.0	4.2	0.0	0.3	0.4	5.9	0.0	0.0	0.0	1.6	0.2	14.1	3.8	0.0	0.0	1.0	3.5	0.1	0.1	0.1	0.8	0.0	0.4	0.0	0.0	0.0	2.8	0.0	0.3	1.1	0.4	0.4	0.3	0.3	0.3	0.4	0.3	0.3	0.2	0.7	0.4	0.5	1.7	0.7	0.3	0.5	0.2	0.1	8.4	32.9	21.1	9.7	5.6	9.9	3.9	7.0	6.4	4.3
LPAR5	"GPR92, GPR93, KPG_010, LPA5"	ENSG00000184574	"Lysophosphatidic acid receptor 5"	Q9H1C0	12	6618835-6636447	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 28.4;brain: 20.3;esophagus: 21.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.5;HEL: 13.7;HMC-1: 19.9;K-562: 10.2;U-698: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 28.4;T-cells: 23.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA013170	Approved									"HPA013170: AB_1849314"	"unprognostic (1.94e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.27e-2)"	"unprognostic (7.99e-3)"	"unprognostic (5.43e-1)"	"prognostic favourable (6.56e-5)"	"unprognostic (7.43e-2)"	2.1	3.2	11.2	5.6	12.4	1.1	1.6	1.3	8.9	5.8	10.2	20.3	0.5	11.2	0.7	3.2	21.1	2.0	1.9	3.6	10.9	4.0	1.3	1.5	2.1	9.2	9.3	4.0	0.9	0.8	0.9	1.4	7.2	9.2	1.7	9.7	1.7	6.3	1.6	0.3	6.8	9.3	1.3	11.7	10.6	8.3	1.7	13.6	2.2	2.0	1.1	13.5	3.4	9.0	28.4	5.5	2.5	1.8	1.3	23.9	6.5	4.0	0.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	7.5	3.2	1.0	0.0	5.2	0.0	2.2	0.0	0.0	0.0	13.7	0.4	0.3	0.0	0.0	19.9	0.0	2.5	0.1	1.1	0.0	10.2	0.0	0.0	0.3	0.4	4.3	0.0	0.7	3.5	0.0	0.0	0.0	2.4	0.1	0.1	2.0	0.0	0.0	0.0	1.6	0.1	0.0	3.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	2.5	0.1	0.0	23.9	1.0	18.0	28.4	4.0	14.1	5.5	27.8	4.0	8.9	0.2	1.3	1.8	0.3	5.4	6.5	11.2	12.4	1.3	8.9	10.9	4.0	9.3	4.0	9.2	13.6
LRCH2	KIAA1495	ENSG00000130224	"Leucine rich repeats and calponin homology domain containing 2"	Q5VUJ6	X	115110616-115234072	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 17.8;U-266/70: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003233	Approved		Approved	"Nucleoli,Plasma membrane"				Nucleoli	"Plasma membrane"	"HPA003233: AB_2265929"	"unprognostic (9.74e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.22e-5)"	"unprognostic (2.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.09e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.16e-2)"	5.1	8.7	11.6	3.4	10.2	0.7	3.3	11.2	10.6	11.2	11.6	5.5	4.0	1.6	9.9	4.5	3.6	4.6	5.3	4.7	7.9	8.9	2.6	1.0	5.7	1.8	5.7	4.6	13.8	1.6	1.3	20.9	13.7	7.6	16.4	4.2	2.5	1.3	14.5	1.2	1.1	3.2	13.7	6.4	3.7	3.6	4.3	7.9	0.0	4.8	0.4	1.1	11.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	3.9	5.5	4.6	0.0	3.5	7.6	3.4	7.9	0.0	0.0	0.1	0.0	4.6	0.3	17.8	0.0	5.2	0.0	4.8	0.0	0.0	0.0	4.4	0.0	0.1	2.7	0.0	1.4	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.2	0.0	3.8	0.0	4.3	0.5	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	4.9	11.8	2.0	0.0	1.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	10.2	11.2	8.4	7.9	8.9	5.7	4.6	7.6	7.9
LRFN3	"FIGLER1, MGC2656, SALM4"	ENSG00000126243	"Leucine rich repeat and fibronectin type III domain containing 3"	Q9BTN0	19	35935358-35945767	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in single"	5	"T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048923	Approved									"HPA048923: "	"unprognostic (1.88e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.37e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.74e-1)"	"prognostic favourable (8.46e-7)"	"unprognostic (6.84e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.03e-1)"	7.2	4.8	6.5	3.6	10.6	0.2	3.8	13.8	17.1	5.9	4.6	3.2	2.9	7.5	7.4	2.6	4.3	5.1	5.4	3.8	6.3	5.1	4.5	6.9	8.9	2.1	3.8	9.4	9.3	7.1	8.1	9.3	3.2	5.0	5.7	3.2	4.4	7.7	7.6	6.5	5.3	7.2	5.8	2.2	5.0	6.3	7.7	2.9	3.2	3.9	2.2	2.1	4.9	5.0	0.5	0.1	0.0	0.0	0.0	2.9	0.5	10.1	11.6	5.3	8.2	11.1	5.9	2.5	4.3	5.5	4.1	4.2	2.0	4.8	5.8	9.0	5.1	3.8	2.3	4.8	2.4	11.6	4.5	0.6	2.5	2.2	4.3	0.3	9.0	6.5	6.6	2.5	2.6	5.0	1.7	8.6	3.8	7.4	4.6	0.2	4.1	5.1	6.1	3.1	0.2	3.0	3.8	6.8	9.1	5.9	4.5	3.5	3.6	2.8	6.3	9.6	8.6	8.7	6.6	3.4	3.4	0.2	8.6	3.1	6.6	0.0	0.0	0.0	2.7	0.0	2.9	0.3	2.2	2.6	0.0	0.5	1.4	0.5	0.0	0.0	0.0	0.1	1.1	0.5	6.5	10.6	13.8	17.1	6.3	5.1	3.8	9.4	5.0	2.9
LRGUK	"CFAP246, FLJ32786"	ENSG00000155530	"Leucine rich repeats and guanylate kinase domain containing"	Q96M69	7	134127299-134264591	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.5;pituitary gland: 11.5;testis: 22.4"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 5.0;SH-SY5Y: 4.8;SK-MEL-30: 5.0"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029505, HPA029506"	Uncertain									"HPA029505: AB_10599606, HPA029506: AB_10601752"	"unprognostic (4.08e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.94e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.64e-2)"	"unprognostic (7.85e-4)"	"unprognostic (6.92e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.28e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.22e-3)"	"unprognostic (3.83e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.10e-2)"	0.7	0.6	2.3	0.6	6.4	1.3	1.2	0.5	1.4	1.2	0.5	4.1	0.3	0.5	1.5	4.0	0.4	9.1	0.7	0.4	2.4	1.2	1.2	0.9	3.4	0.4	0.3	0.6	2.4	1.9	0.4	11.5	0.4	12.5	1.6	0.7	2.2	1.3	0.5	0.2	1.2	0.5	0.5	1.6	1.3	0.6	22.4	0.9	0.0	2.2	0.0	0.6	0.5	0.4	0.5	0.3	0.0	0.4	0.0	0.0	0.0	0.3	0.4	0.7	1.1	0.1	0.3	0.3	0.0	0.1	0.5	0.4	0.0	0.9	0.2	0.3	0.1	0.3	0.4	0.1	0.8	0.5	0.5	0.1	0.3	0.2	0.1	0.2	0.5	0.3	0.7	0.9	0.0	0.2	0.2	0.8	0.8	0.2	0.3	0.6	5.0	1.2	0.7	0.1	0.0	0.8	0.4	1.6	4.8	1.5	0.0	5.0	0.2	1.1	0.0	0.3	0.5	0.3	0.6	1.1	1.7	1.5	1.3	0.2	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	6.4	0.5	1.4	2.4	1.2	0.3	0.6	12.5	0.9
LRIG2	KIAA0806	ENSG00000198799	"Leucine rich repeats and immunoglobulin like domains 2"	O94898	1	113073209-113132260	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015538	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"			510000	"Golgi apparatus"	Nucleoplasm	"HPA015538: AB_2250170"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.08e-2)"	"prognostic unfavourable (9.37e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (3.27e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	8.3	7.7	10.1	11.4	10.6	4.7	10.7	15.6	10.0	11.6	9.2	16.1	6.0	10.8	15.1	14.9	7.8	9.2	8.2	7.3	9.3	9.1	9.2	6.3	8.0	9.7	13.0	6.7	15.0	8.5	13.4	11.6	10.1	9.2	9.3	8.6	14.6	9.0	11.2	13.1	16.6	9.5	8.9	11.6	10.1	8.1	9.4	13.4	10.4	12.6	5.0	10.7	8.6	10.7	4.4	2.6	4.9	2.5	4.8	3.9	1.7	4.4	2.4	6.7	5.1	6.5	6.7	3.9	2.8	4.2	3.4	5.8	3.5	2.8	4.5	5.0	3.6	5.0	4.6	3.0	5.8	3.1	2.7	4.8	4.6	1.7	6.6	5.7	2.3	6.5	5.5	5.4	7.1	4.4	5.7	4.3	4.2	3.2	5.8	6.1	6.3	4.0	5.3	8.4	2.2	3.3	3.0	4.8	3.9	5.0	3.3	6.4	2.5	6.5	6.6	6.4	3.5	8.7	4.5	4.8	2.2	4.6	6.8	3.6	5.9	4.9	2.5	1.5	3.1	2.0	3.5	3.1	3.4	3.2	1.9	4.4	3.9	3.6	1.7	4.8	2.1	2.6	2.6	1.7	10.1	10.6	15.6	10.0	9.3	9.1	13.0	6.7	9.2	13.4
LRIG3	"FLJ90440, KIAA3016"	ENSG00000139263	"Leucine rich repeats and immunoglobulin like domains 3"	Q6UXM1	12	58872149-58920522	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010773	Approved		Approved	Cytosol				Cytosol		"HPA010773: AB_1853275"	"unprognostic (1.79e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.46e-2)"	15.8	1.7	3.6	11.8	4.1	0.0	16.4	1.0	3.7	18.7	14.8	7.8	12.1	8.4	14.2	13.8	17.1	9.9	17.8	4.7	4.6	1.8	6.5	6.1	9.6	5.0	3.6	2.6	14.7	15.3	4.8	10.3	6.8	5.8	15.5	16.0	13.5	24.9	11.6	5.0	25.9	10.0	21.6	3.0	7.2	13.5	6.4	6.6	5.4	37.6	15.0	12.8	15.7	20.7	0.0	0.0	0.0	0.0	0.0	0.4	0.1	2.0	1.9	7.3	0.5	13.4	15.6	1.7	4.9	14.1	4.7	5.0	5.7	2.6	1.9	9.9	5.4	9.4	2.7	12.4	3.4	14.4	9.5	0.5	3.3	2.8	2.6	0.7	0.2	15.5	27.0	5.0	10.8	12.9	0.1	2.4	3.1	0.9	2.3	0.0	7.8	2.9	0.0	6.2	4.7	3.6	10.4	7.4	0.0	4.3	2.7	4.4	5.0	0.1	5.5	6.5	4.4	3.8	6.3	1.0	0.0	0.0	1.3	0.0	3.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	4.1	1.0	3.7	4.6	1.8	3.6	2.6	5.8	6.6
LRIT2	"AC022389.4, LRRC22"	ENSG00000204033	"Leucine rich repeat, Ig-like and transmembrane domains 2"	A6NDA9	10	84220495-84225589	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"retina: 25.4;skin 1: 8.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"basal ganglia: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037788	Enhanced									"HPA037788: AB_10672393"			"unprognostic (3.12e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.99e-1)"	"unprognostic (9.44e-2)"				"unprognostic (2.36e-1)"			"unprognostic (1.76e-2)"		"unprognostic (2.41e-1)"			0.1	0.2	0.2	0.1	3.4	0.0	0.1	0.1	2.2	0.1	1.6	0.1	0.1	0.0	0.1	0.1	0.4	0.0	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	25.4	0.1	0.1	0.1	8.5	0.7	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.4	0.1	0.5	0.3	0.3	0.3	0.1	0.1	0.1
LRP11	"bA350J20.3, MANSC3"	ENSG00000120256	"LDL receptor related protein 11"	Q86VZ4	6	149818798-149864026	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064002			Approved	Mitochondria			640000	Mitochondria		"HPA064002: "	"prognostic unfavourable (2.31e-8)"	"unprognostic (3.85e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.25e-3)"	"prognostic unfavourable (2.01e-5)"	"unprognostic (5.05e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.23e-2)"	12.0	16.5	17.8	4.4	26.9	1.6	11.2	17.9	25.6	14.0	11.5	15.1	9.4	10.5	10.6	14.8	20.2	20.2	10.5	8.0	19.7	19.3	18.2	9.0	12.1	2.2	15.0	16.9	15.3	17.2	46.2	15.2	14.7	20.6	23.3	11.4	10.8	14.2	12.3	8.1	20.2	8.7	10.9	13.3	3.6	14.4	7.2	15.6	0.8	20.8	13.8	6.4	17.3	14.2	3.5	1.0	0.0	1.7	0.0	0.7	0.1	9.7	8.5	6.5	5.7	14.5	26.5	1.3	10.2	19.8	7.1	8.6	2.5	20.3	0.1	13.9	15.9	25.9	7.3	18.5	5.1	15.6	7.3	4.6	31.3	11.2	8.9	4.7	0.1	16.5	36.0	9.1	18.1	10.9	9.4	4.3	8.4	16.7	0.1	0.1	3.9	8.5	5.0	9.7	2.3	12.8	19.9	8.6	5.7	32.1	17.9	6.0	14.7	9.7	8.5	8.9	2.1	18.6	7.7	0.0	3.1	2.3	16.1	4.7	5.1	0.0	0.1	0.0	0.2	0.4	0.0	3.5	0.7	0.6	1.0	0.6	0.2	0.3	0.0	0.0	1.7	0.0	0.0	0.1	17.8	26.9	17.9	25.6	19.7	19.3	15.0	16.9	20.6	15.6
LRP3	"hLRp105, LRP-3"	ENSG00000130881	"LDL receptor related protein 3"	O75074	19	33177603-33208867	"Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 50.0"	"Cell line enhanced"	"Detected in many"		"THP-1: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.8;non-classical monocyte: 2.6"	"Lineage enriched"	"Detected in single"	4	"monocytes: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041658			Approved	"Lipid droplets"				"Lipid droplets"		"HPA041658: "	"unprognostic (3.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.67e-2)"	"prognostic favourable (6.12e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.71e-3)"	"unprognostic (4.36e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.32e-1)"	23.5	16.6	28.3	5.1	33.1	15.3	15.6	14.2	41.2	12.1	7.8	6.6	4.4	7.1	11.2	8.8	7.4	12.4	8.2	10.9	27.6	13.0	4.2	15.5	5.3	3.2	15.4	19.4	50.0	16.8	9.8	10.3	3.8	11.0	15.5	3.4	10.0	14.4	12.7	21.9	5.0	6.6	10.6	6.3	4.8	7.0	5.6	7.7	0.0	9.5	4.7	3.1	9.0	9.1	0.0	0.0	0.6	2.8	0.5	0.1	0.7	0.0	20.4	5.6	20.2	14.1	5.4	4.2	5.2	5.1	4.8	1.8	5.8	0.2	0.0	13.7	6.4	0.0	5.4	0.5	0.4	0.0	11.0	0.0	4.6	20.4	5.4	7.3	0.7	8.0	4.8	1.3	0.7	3.9	0.0	0.0	6.1	18.8	0.0	8.2	11.5	1.0	0.0	2.6	0.0	0.0	8.1	12.4	18.7	8.4	0.0	1.5	8.6	25.8	0.0	10.0	9.0	14.9	2.9	0.0	0.0	0.1	0.0	12.3	2.9	0.0	2.8	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	2.6	0.0	0.0	0.7	28.3	33.1	14.2	41.2	27.6	13.0	15.4	19.4	11.0	7.7
LRP5L	DKFZp434O0213	ENSG00000100068	"LDL receptor related protein 5 like"	A4QPB2	22	25351418-25405377	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 6.3;NK-cell: 10.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 6.3;NK-cells: 10.7"									HPA028717	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA028717: AB_10601767"	"unprognostic (5.90e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.98e-3)"	"unprognostic (5.11e-1)"	"unprognostic (9.64e-2)"	"unprognostic (9.78e-2)"	"unprognostic (4.38e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.44e-1)"	"prognostic favourable (6.93e-6)"	6.0	4.7	4.8	8.0	3.8	17.6	18.5	1.5	6.2	10.0	7.0	4.1	11.4	4.1	8.2	8.1	3.9	6.3	8.0	5.3	3.9	2.0	9.1	17.4	5.9	8.5	8.1	1.7	7.7	8.0	6.3	3.8	2.1	4.1	8.9	4.7	6.5	11.0	12.2	2.7	6.1	5.7	7.7	3.4	8.4	4.8	5.0	3.6	3.7	15.5	4.3	6.7	6.3	7.5	1.1	0.2	6.3	0.5	10.7	1.0	0.3	2.0	3.0	1.2	6.1	2.3	1.0	2.2	1.7	2.8	2.3	2.6	2.9	1.0	0.8	2.4	1.9	4.0	2.2	3.1	1.5	2.9	6.9	3.9	5.1	7.2	2.7	7.6	8.1	4.1	3.0	2.7	11.4	1.0	2.5	2.5	1.6	6.8	1.4	7.1	2.7	4.4	6.8	2.7	3.0	2.8	4.7	4.0	4.6	1.3	2.2	2.1	2.6	2.8	1.8	2.6	11.6	1.8	2.9	6.3	1.2	1.7	1.6	4.6	1.4	6.3	0.5	2.1	1.0	0.4	0.9	0.2	0.3	0.3	0.1	1.1	0.1	0.3	0.2	10.7	0.2	0.2	0.0	0.3	4.8	3.8	1.5	6.2	3.9	2.0	8.1	1.7	4.1	3.6
LRRC15	LIB	ENSG00000172061	"Leucine rich repeat containing 15"	Q8TF66	3	194355247-194369743	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 48.1"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 47.8;U-138 MG: 9.3;U-87 MG: 25.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 25.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035503	Uncertain		Approved	"Vesicles,Plasma membrane"			1800000	Vesicles	"Plasma membrane"	"HPA035503: AB_10961253"	"unprognostic (3.20e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-8)"	"unprognostic (5.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.62e-3)"	"unprognostic (7.54e-3)"	3.3	0.5	0.5	3.1	0.6	0.0	5.3	0.5	0.5	4.6	2.1	0.2	0.0	0.4	3.5	0.3	1.0	1.3	2.0	1.8	0.5	0.5	0.5	0.5	2.5	0.8	0.5	0.0	3.1	0.8	0.0	0.5	48.1	0.3	0.6	4.2	0.7	1.6	0.0	1.0	9.1	0.8	0.7	0.5	1.3	1.9	0.9	0.0	1.1	1.8	7.7	7.7	2.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.0	0.1	0.0	0.0	0.4	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.3	1.5	1.2	0.0	0.0	0.0	0.0	25.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.5	0.5	0.5	0.5	0.5	0.0	0.3	0.0
LRRC17	"H_RG318M05.3, P37NB"	ENSG00000128606	"Leucine rich repeat containing 17"	Q8N6Y2	7	102912991-102944949	"Predicted secreted proteins"	Osteogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 39.0"	"Cell line enriched"	"Detected in some"	5	"LHCN-M2: 168.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	17	"eosinophil: 12.0"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 12.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073458			Approved	"Vesicles,Cytokinetic bridge"	"Secreted in other tissues"			Vesicles	"Cytokinetic bridge"	"HPA073458: "	"unprognostic (1.77e-1)"	"unprognostic (7.73e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.76e-4)"	"unprognostic (6.09e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavourable (4.12e-6)"	"unprognostic (8.57e-3)"	"unprognostic (4.48e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavourable (6.30e-4)"	5.1	1.3	1.1	0.5	1.2	0.0	6.2	1.4	2.0	15.0	1.4	1.5	5.6	0.5	8.3	17.1	5.2	8.9	13.5	6.4	1.2	1.3	1.5	1.4	1.6	1.6	1.1	2.1	39.0	2.6	1.2	1.7	1.8	2.5	7.8	1.4	2.7	2.8	2.5	5.3	2.0	2.6	5.1	1.2	1.2	3.5	5.1	0.2	2.2	2.6	6.7	1.3	6.7	4.2	0.1	0.1	12.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.8	4.2	0.0	0.2	2.4	0.0	0.4	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	3.9	0.1	2.9	0.0	19.1	0.0	0.0	168.8	0.0	0.0	0.0	0.4	0.0	0.0	33.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.2	2.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	1.2	1.4	2.0	1.2	1.3	1.1	2.1	2.5	0.2
LRRC18	"MGC34773, UNQ933, UNQ9338, VKGE9338"	ENSG00000165383	"Leucine rich repeat containing 18"	Q8N456	10	48909483-48914232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 9.1;testis: 15.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.4;HDLM-2: 1.5;HL-60: 2.2;NB-4: 3.8"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"					"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.4;naive B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039256	Enhanced									"HPA039256: AB_10671873"	"unprognostic (1.31e-2)"		"unprognostic (3.66e-2)"	"unprognostic (9.83e-4)"	"unprognostic (3.10e-1)"	"unprognostic (4.82e-2)"		"unprognostic (1.98e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.16e-2)"		"unprognostic (8.57e-3)"	"unprognostic (4.08e-1)"		"unprognostic (1.13e-1)"	0.0	0.0	0.3	0.2	0.7	0.2	0.2	0.0	0.0	0.6	0.2			0.1	0.0	0.0	0.2	9.1	0.1	0.2	0.8	0.9	0.0	0.0	3.1	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.6	0.6		0.0	0.0	0.0	0.8	0.3	0.0	0.1	0.0	0.0	15.5			0.0		0.0	0.3	0.0	1.4	0.5	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.5	0.1	1.4	0.0	0.2	0.2	0.1	0.0	0.0	1.5	0.0	0.4	0.2	0.0	0.0	2.2	0.6	0.5	0.5	0.0	0.2	0.8	0.3	0.0	0.0	0.0	0.1	3.8	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.2	0.1	0.4	0.0	0.3	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.2	1.2	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0										
LRRC2		ENSG00000163827	"Leucine rich repeat containing 2"	Q9BYS8	3	46515423-46580099	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 53.9;skeletal muscle: 70.3;tongue: 20.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.6;HEL: 6.1;LHCN-M2: 6.1;TIME: 4.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 5.6"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064844			Approved	Nucleoplasm				Nucleoplasm		"HPA064844: "	"unprognostic (1.32e-4)"	"unprognostic (3.44e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.24e-1)"	1.8	0.5	1.9	0.4	1.4	0.4	1.0	1.4	3.0	2.6	1.1	0.2	0.0	0.4	3.9	1.4	1.1	1.1	1.4	53.9	1.3	0.4	2.2	2.5	0.6	0.3	0.5	2.3	2.8	0.7	0.1	2.2	0.5	1.0	1.2	0.8	0.4	1.4	0.2	70.3	1.2	0.6	2.3	0.4	1.3	1.0	0.4	0.0	1.4	10.1	20.0	1.2	1.7	1.8	1.2	0.8	2.6	0.7	1.1	2.5	0.3	0.2	0.0	0.2	0.3	1.0	2.2	0.1	0.8	1.5	0.5	0.8	0.0	0.2	0.3	0.2	10.6	0.2	3.7	0.0	1.4	0.5	0.1	6.1	0.4	0.2	0.2	0.2	0.1	0.2	0.1	4.3	0.0	0.2	0.1	0.4	6.1	0.1	0.8	0.1	1.5	0.2	0.1	0.1	0.3	0.1	0.3	0.5	1.2	0.8	0.2	1.6	0.2	0.8	4.9	0.3	0.6	2.5	1.6	0.4	0.3	2.9	0.2	0.1	1.4	2.2	0.7	0.6	0.6	0.4	0.4	0.7	1.6	0.3	0.2	1.2	0.8	0.6	2.6	1.1	0.5	0.8	2.5	0.3	1.9	1.4	1.4	3.0	1.3	0.4	0.5	2.3	1.0	0.0
LRRC23	"B7, LRPB7"	ENSG00000010626	"Leucine rich repeat containing 23"	Q53EV4	12	6873569-6914243	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"fallopian tube: 94.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037766, HPA057533"	Enhanced		Supported	Nucleoli				Nucleoli		"HPA037766: AB_10672609, HPA057533: "	"prognostic favourable (6.02e-4)"	"unprognostic (7.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.25e-2)"	3.6	4.2	11.4	2.4	12.8	3.4	4.8	10.5	10.9	5.8	3.1	10.8	6.9	2.2	6.0	13.1	2.9	94.2	4.2	4.7	12.2	12.9	6.9	3.7	9.4	2.9	7.3	9.6	5.9	2.5	9.3	9.0	3.4	9.9	4.8	3.3	9.4	4.0	5.0	5.5	3.5	2.1	4.8	7.0	3.5	4.5	21.1	8.4	2.2	7.1	2.4	3.7	3.1	3.1	7.8	5.9	9.0	4.4	5.3	4.7	2.2	5.5	10.8	1.8	4.0	8.2	6.2	6.4	2.2	7.7	3.8	7.1	2.2	11.4	4.9	2.5	5.9	1.4	3.3	4.7	8.0	3.8	1.6	3.5	4.2	4.4	6.6	1.9	3.3	4.3	8.8	7.1	6.5	5.0	2.0	2.8	4.3	6.2	4.2	1.3	1.2	3.2	4.0	9.0	5.6	7.6	1.6	3.0	7.0	3.6	4.8	6.8	2.4	4.4	2.2	3.7	9.9	4.2	2.5	2.6	1.8	4.0	9.1	2.5	5.3	1.3	4.4	9.0	3.7	4.2	4.7	7.8	3.6	3.1	4.0	4.8	4.1	4.0	0.7	5.3	3.8	5.9	0.2	2.2	11.4	12.8	10.5	10.9	12.2	12.9	7.3	9.6	9.9	8.4
LRRC24	LRRC14OS	ENSG00000254402	"Leucine rich repeat containing 24"	Q50LG9	8	144522377-144527032	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.9"	"Cell line enhanced"	"Detected in some"		"MCF7: 4.1;SCLC-21H: 4.4;SH-SY5Y: 12.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028171, HPA052250"	Enhanced		Approved	Vesicles				Vesicles		"HPA028171: , HPA052250: "					"unprognostic (1.75e-1)"					"unprognostic (5.76e-2)"		"unprognostic (2.33e-3)"		"unprognostic (3.63e-2)"				2.5	4.0	5.1	1.4	9.3	1.7	1.5	12.3	16.9	2.3	2.1	1.6	0.6	2.0	2.5	1.7	1.7	2.8	1.3	1.5	4.5	7.9	2.2	1.6	2.0	1.4	4.5	8.4	4.5	3.2	9.3	8.4	1.5	5.9	11.4	1.1	10.3	2.8	3.2	2.3	1.7	2.0	1.6	2.1	2.2	1.9	1.5	1.3	0.6	1.6	1.0	1.1	1.4	1.6	0.0	0.5	0.0	0.1	0.1	0.5	0.0	0.3	0.8	0.6	1.5	0.8	0.5	1.8	0.5	0.6	0.6	0.6	0.2	1.6	0.8	3.4	0.2	0.1	0.0	0.0	0.1	1.2	2.2	0.5	1.0	0.3	0.6	0.0	1.0	0.7	0.4	0.5	0.1	0.3	0.9	0.1	0.1	4.1	1.2	1.6	0.1	0.8	1.8	0.1	0.6	0.1	0.5	4.4	12.2	0.4	0.1	0.4	3.7	1.3	0.0	0.1	1.2	0.4	0.2	1.0	0.1	0.1	0.6	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	9.3	12.3	16.9	4.5	7.9	4.5	8.4	5.9	1.3
LRRC27	KIAA1674	ENSG00000148814	"Leucine rich repeat containing 27"	Q9C0I9	10	132332154-132379918	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in all"	5	"testis: 52.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037595, HPA067395"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA037595: , HPA067395: "	"unprognostic (1.97e-1)"	"unprognostic (5.76e-4)"	"unprognostic (1.48e-3)"	"unprognostic (1.94e-3)"	"unprognostic (6.76e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.27e-4)"	2.1	2.8	8.1	1.5	8.4	1.0	4.1	2.2	8.9	3.6	2.1	6.1	7.5	2.0	3.8	5.6	1.6	10.5	3.5	2.2	6.6	5.4	4.4	2.4	3.1	1.9	4.3	7.3	5.4	3.1	7.5	5.8	2.1	6.5	4.1	2.1	4.8	3.1	4.0	1.2	2.1	2.6	3.4	3.5	3.3	3.0	52.9	4.5	0.7	5.1	1.0	1.2	2.5	1.8	4.7	7.8	4.4	6.8	3.1	2.8	2.7	2.7	5.0	11.2	15.7	9.8	10.1	1.1	2.7	8.8	4.5	4.1	0.8	5.7	1.5	1.6	6.3	1.9	2.5	1.3	2.9	3.2	2.2	0.3	3.5	2.6	7.0	1.2	1.8	4.4	8.7	4.6	6.1	3.2	0.9	1.1	3.5	4.6	2.3	3.4	3.1	1.7	2.1	1.8	0.8	8.1	0.7	2.0	5.7	1.3	0.9	3.5	2.5	2.8	4.2	1.8	2.3	4.1	1.6	0.8	0.3	0.8	8.3	2.3	1.1	4.4	6.8	1.1	1.7	5.7	1.3	3.4	1.1	1.0	7.3	4.7	2.8	1.6	0.5	3.1	3.6	7.8	0.7	2.7	8.1	8.4	2.2	8.9	6.6	5.4	4.3	7.3	6.5	4.5
LRRC28	"FLJ34269, FLJ45242, MGC24976"	ENSG00000168904	"Leucine rich repeat containing 28"	Q86X40	15	99251362-99390729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039378, HPA040784, HPA066130"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Mitochondria"				Nucleoplasm	"Golgi apparatus, Mitochondria"	"HPA039378: AB_2676476, HPA040784: AB_2677135, HPA066130: "	"unprognostic (4.84e-2)"	"prognostic favourable (1.41e-4)"	"unprognostic (2.82e-3)"	"unprognostic (9.86e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-1)"	"prognostic favourable (9.97e-5)"	"unprognostic (2.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.41e-1)"	9.1	9.5	7.5	5.3	12.7	7.4	7.3	12.7	15.4	7.7	10.4	8.1	6.1	15.8	6.9	7.6	9.9	5.0	8.8	10.8	7.5	6.5	17.7	42.3	6.2	6.3	6.9	8.4	5.8	18.1	9.1	10.8	5.9	9.8	6.3	9.5	9.3	8.6	6.9	18.0	12.1	18.2	7.8	6.7	6.3	9.1	24.1	5.2	17.7	7.4	8.2	8.6	7.9	7.3	4.8	6.0	21.8	6.9	3.4	7.0	4.2	3.1	7.5	7.5	9.7	10.8	15.3	3.2	3.3	9.2	5.7	6.7	5.8	6.7	6.3	6.1	7.8	6.9	5.4	10.5	8.3	3.9	8.0	4.2	3.5	5.9	9.6	4.1	6.9	9.0	14.5	5.3	10.7	17.8	3.7	6.3	11.7	6.0	11.3	7.0	3.1	2.7	6.9	6.4	5.7	12.0	9.9	3.4	4.4	7.8	4.2	12.1	6.6	7.8	6.4	5.6	3.9	4.2	6.4	12.9	17.7	3.9	7.1	4.1	10.4	15.6	6.9	21.8	5.5	5.5	4.3	4.8	5.2	5.7	6.0	4.1	4.8	4.1	3.6	3.4	5.3	5.0	7.0	4.2	7.5	12.7	12.7	15.4	7.5	6.5	6.9	8.4	9.8	5.2
LRRC34	MGC27085	ENSG00000171757	"Leucine rich repeat containing 34"	Q8IZ02	3	169793428-169812986	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 13.7;testis: 23.8"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.5;HEL: 9.4;HL-60: 9.9;NTERA-2: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.2;myeloid DC: 1.4;naive B-cell: 1.5;plasmacytoid DC: 4.6"	"Group enriched"	"Detected in many"	7	"B-cells: 2.2;dendritic cells: 4.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA035747	Approved		Approved	"Cell Junctions,Microtubules"				"Cell Junctions, Microtubules"		"HPA035747: AB_10670120"	"unprognostic (1.04e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.74e-3)"	"unprognostic (5.46e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.79e-1)"	2.8	1.1	4.8	1.2	9.6	2.7	2.3	1.1	4.0	2.3	0.9	4.2	1.4	1.0	1.9	3.9	1.0	13.7	1.1	2.0	4.1	3.8	2.1	0.9	3.4	1.9	3.5	5.6	2.2	0.5	1.0	7.9	0.9	11.8	2.0	0.7	2.6	1.3	2.4	0.9	1.0	1.1	2.0	3.6	1.8	1.1	23.8	4.8	1.7	2.7	0.5	1.2	1.0	0.9	2.2	4.6	0.1	0.3	0.0	0.5	0.4	2.7	0.4	0.8	0.0	1.1	4.1	0.0	1.2	2.4	2.8	2.7	0.1	0.0	1.6	0.0	0.7	0.0	2.5	0.0	1.0	0.4	7.5	9.4	0.1	0.0	0.7	9.9	2.5	1.4	0.5	1.1	0.0	1.8	0.2	0.0	1.1	0.0	0.9	2.0	10.0	3.1	4.9	0.0	0.5	2.3	0.2	4.9	3.8	0.8	0.1	0.0	0.0	4.8	0.4	0.6	0.0	0.3	0.0	0.0	0.0	2.3	4.5	0.1	2.7	0.0	0.2	0.0	0.0	0.3	0.2	2.2	0.0	0.0	1.4	1.5	0.0	0.0	0.1	0.0	0.0	4.6	0.5	0.4	4.8	9.6	1.1	4.0	4.1	3.8	3.5	5.6	11.8	4.8
LRRC36	FLJ11004	ENSG00000159708	"Leucine rich repeat containing 36"	Q1X8D7	16	67326798-67385203	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 11.7;placenta: 9.3;testis: 31.9"	"Cell line enhanced"	"Detected in some"		"HBF TERT88: 1.6;hTEC/SVTERT24-B: 5.0;TIME: 3.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	10	"plasmacytoid DC: 11.7"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 11.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA058479	Enhanced									"HPA058479: "	"unprognostic (4.59e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.26e-5)"	"unprognostic (5.27e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.32e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.88e-2)"	0.2	0.1	0.3	0.0	1.5	0.0	0.2	0.5	0.4	0.3	0.1	0.0	0.0	0.0	0.4	2.3	0.1	2.6	0.3	0.1	1.2	0.4	0.3	0.1	4.3	0.2	0.2	0.0	0.3	2.0	0.0	1.2	9.3	2.5	0.1	0.4	0.5	0.2	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.4	31.9	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.0	11.7	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.6	0.4	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.3	1.5	0.5	0.4	1.2	0.4	0.2	0.0	2.5	0.2
LRRC37A	KIAA0563	ENSG00000176681	"Leucine rich repeat containing 37A"	A6NMS7	17	46292733-46337794	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 9.4;testis: 15.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 7.8"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042121, HPA043056, HPA045090, HPA049080"	Supported		Approved	Vesicles				Vesicles		"HPA042121: , HPA043056: , HPA045090: , HPA049080: "	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.75e-2)"	"unprognostic (6.02e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.20e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.37e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.30e-2)"	0.9	0.4	1.4	2.0	1.8	1.4	1.7	2.6	1.7	0.7	0.9			0.5	1.1	0.4	1.1	1.0	0.5	1.1	1.5	1.2	0.9	0.6	0.9	1.5	0.6		1.2	0.9	0.5	2.1	0.7		1.3	1.0		1.0	0.9	9.4	1.8	1.3	0.6	0.8	1.2	0.8	15.2			1.2		0.9	1.1	1.1	1.4	1.7	2.1	1.4	2.1	1.5	0.2	0.2	0.2	1.5	0.2	0.3	0.0	0.5	0.1	0.4	0.1	0.2	3.5	0.3	7.8	0.3	0.2	0.3	0.0	0.0	0.0	0.5	1.2	0.4	3.9	2.7	0.6	0.0	0.2	0.0	1.0	0.0	0.0	0.5	0.2	0.5	0.9	0.0	0.3	0.7	1.2	0.0	2.7	2.8	1.8	0.0	1.8	0.4	1.0	0.2	0.6	0.1	0.5	3.6	1.2	1.4	2.3	0.4	0.2	3.5	2.5	0.5	1.2	2.4	2.2	2.1	1.1	1.0	1.0	1.0	0.9	0.8	0.8	1.5	1.1	1.4	1.3	1.1	1.9	2.1	1.4	1.7	1.0	0.2										
LRRC37A2	FLJ45049	ENSG00000238083	"Leucine rich repeat containing 37 member A2"	A6NM11	17	46511511-46555650	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 13.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.0;THP-1: 4.2"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	7	"eosinophil: 2.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.9"									"HPA042121, HPA043056, HPA045090, HPA049080"	Supported		Approved	Vesicles				Vesicles		"HPA042121: , HPA043056: , HPA045090: , HPA049080: "	"unprognostic (1.59e-2)"	"unprognostic (3.75e-2)"	"unprognostic (8.96e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.97e-3)"	"unprognostic (4.61e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-3)"	"unprognostic (8.00e-2)"	"unprognostic (3.02e-7)"	"unprognostic (8.40e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.77e-2)"	0.5	0.0	0.3	0.4	0.7	0.9	0.8	0.9	0.4	0.1	0.4			0.0	0.2	0.1	0.5	0.3	0.0	0.1	0.4	0.4	0.5	0.4	0.7	0.5	0.1		0.3	0.1	0.1	1.2	0.1		0.4	0.9		0.4	0.7	0.6	0.9	0.4	0.5	0.2	0.0	0.5	13.5			0.4		0.5	0.6	0.3	0.2	0.3	2.9	0.1	0.1	0.4	0.0	0.4	0.6	0.3	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.8	0.0	4.0	0.1	0.3	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.9	0.5	0.7	0.0	0.0	0.0	0.8	0.0	0.3	1.9	0.0	0.8	2.0	0.0	0.3	0.1	0.2	0.1	1.8	0.8	0.4	0.0	1.4	0.2	0.4	0.3	0.0	0.3	1.4	4.2	0.8	2.5	1.9	0.0	0.8	1.3	1.0	0.5	0.2	0.9	1.5	0.0	0.0	2.9	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.0										
LRRC37A3	"FLJ34306, KIAA0563"	ENSG00000176809	"Leucine rich repeat containing 37 member A3"	O60309	17	64854312-64919480	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042121, HPA043056, HPA045090"	Supported		Approved	Vesicles				Vesicles		"HPA042121: , HPA043056: , HPA045090: "	"unprognostic (2.28e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.31e-6)"	"unprognostic (1.83e-1)"	"prognostic unfavourable (3.25e-6)"	"unprognostic (2.26e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.43e-3)"	4.4	6.6	14.8	5.5	14.0	6.2	8.8	27.9	16.0	4.3	3.6	7.4	5.4	3.2	6.9	16.0	3.9	7.8	6.8	3.8	15.1	15.0	15.7	3.4	4.8	4.3	12.8	7.2	8.4	5.2	5.7	18.8	4.6	12.1	6.7	4.0	8.3	4.3	6.2	6.4	7.1	4.0	4.2	6.6	4.6	4.2	25.8	12.6	7.3	14.3	0.3	3.1	4.6	10.0	2.3	2.3	5.3	1.0	3.1	1.2	0.3	2.4	4.9	4.7	10.6	5.3	3.3	3.4	3.5	2.8	2.5	2.7	2.1	3.7	2.5	1.6	1.8	2.1	1.3	1.0	1.1	3.2	4.8	7.6	2.9	1.5	2.1	2.9	2.0	2.2	1.8	1.7	0.8	1.7	1.5	1.4	1.8	6.6	1.4	4.9	3.7	1.4	1.6	2.5	1.1	5.4	2.3	3.1	11.9	1.3	6.0	1.4	2.6	5.2	5.7	4.3	1.3	1.7	1.8	2.1	1.9	1.9	3.0	12.1	7.3	5.3	0.4	0.7	0.7	0.7	0.8	0.6	1.0	0.4	0.6	2.3	1.2	1.1	2.0	3.1	1.0	2.3	0.9	0.3	14.8	14.0	27.9	16.0	15.1	15.0	12.8	7.2	12.1	12.6
LRRC37B		ENSG00000185158	"Leucine rich repeat containing 37B"	Q96QE4	17	32007872-32053504	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 2.8;NK-cells: 6.4;T-cells: 4.9"									HPA015135	Approved		Approved	Cytosol				Cytosol		"HPA015135: AB_1853309"	"unprognostic (5.46e-3)"	"unprognostic (2.56e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.60e-2)"	"unprognostic (9.65e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.72e-4)"	"unprognostic (6.99e-2)"	"unprognostic (5.72e-3)"	"unprognostic (6.94e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.36e-3)"	4.7	5.0	13.7	4.8	15.0	28.5	6.4	35.5	14.4	5.9	5.2	7.2	5.0	4.5	8.3	6.5	4.6	8.2	4.8	2.7	10.7	8.5	3.7	3.0	6.7	5.5	8.6	10.2	12.1	4.3	7.4	13.8	4.6	8.9	5.3	6.4	6.1	6.5	4.2	3.5	11.7	6.3	7.2	8.5	7.6	6.6	24.5	10.3	8.3	4.4	1.8	5.8	5.3	10.2	0.8	1.1	2.8	0.5	6.4	4.9	0.5	2.0	3.9	12.4	7.0	3.1	3.9	3.8	1.8	7.0	5.4	7.0	5.4	2.0	5.6	4.0	4.2	2.8	7.3	1.5	4.3	1.6	6.2	2.6	5.7	2.0	4.6	9.9	4.7	4.1	4.6	5.0	12.6	4.6	6.0	5.4	2.0	1.9	17.3	15.4	3.7	2.6	12.3	2.9	4.5	3.1	5.2	2.3	3.9	4.7	3.1	6.4	8.1	16.1	3.8	3.8	2.6	8.5	4.6	5.4	7.6	5.5	2.7	10.1	2.7	0.0	0.4	2.8	1.1	0.5	2.1	0.2	2.2	3.0	0.8	0.8	3.0	0.8	1.1	6.4	0.2	1.1	4.9	0.5	13.7	15.0	35.5	14.4	10.7	8.5	8.6	10.2	8.9	10.3
LRRC3C		ENSG00000204913	"Leucine rich repeat containing 3C"	A6NJW4	17	39941474-39944747	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"parathyroid gland: 1.9;testis: 3.0"	"Group enriched"	"Detected in some"	6	"HDLM-2: 2.1;Karpas-707: 3.8;U-266/70: 2.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071271	Uncertain									"HPA071271: "	"unprognostic (1.59e-1)"			"unprognostic (6.57e-2)"	"unprognostic (6.17e-2)"		"unprognostic (2.81e-1)"	"unprognostic (3.16e-4)"		"unprognostic (9.20e-2)"		"unprognostic (4.27e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.90e-2)"		0.2	0.0	0.3	0.3	0.2	0.1	0.2	0.0	0.2	0.6	0.1			0.0	0.4	0.3	0.0	0.8	0.0	0.6	0.2	0.0	0.2	0.5	0.2	0.0	0.1		0.3	0.1	1.9	0.0	0.0		0.4	0.0		0.3	0.2	0.1	0.4	0.1	0.1	0.2	0.0	0.2	3.0			0.7		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.5	0.0	0.0	0.4	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LRRC43	MGC35140	ENSG00000158113	"Leucine rich repeat containing 43"	Q8N309	12	122167738-122203471	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.6"	"Cell line enhanced"	"Detected in some"		"HHSteC: 2.8;HSkMC: 3.2;HUVEC TERT2: 6.4;SCLC-21H: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA039425			Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus"	Vesicles	"HPA039425: "	"unprognostic (6.42e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.56e-2)"	"unprognostic (6.03e-5)"	"unprognostic (1.19e-1)"	"unprognostic (4.52e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.21e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.49e-1)"	0.9	0.9	3.0	0.3	5.0	0.8	0.7	1.2	4.6	1.5	0.7	4.1	1.3	1.0	1.4	6.6	0.4	26.6	1.6	1.5	4.5	3.0	3.1	0.5	2.5	0.4	3.1	1.5	3.3	1.2	3.5	3.4	0.5	6.4	1.3	0.5	2.9	1.8	2.2	0.4	0.8	0.5	0.6	1.0	0.8	0.7	10.8	1.8	0.0	2.5	0.0	0.4	0.7	0.3	0.0	0.9	0.0	0.6	2.9	1.9	0.8	0.0	0.0	0.3	0.0	0.3	0.7	0.4	0.0	1.8	0.5	0.5	0.6	0.1	0.0	1.3	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	2.8	0.1	0.6	3.2	0.0	1.0	0.0	6.4	0.0	0.0	1.2	0.0	0.0	1.3	0.0	0.3	0.1	0.0	0.1	0.0	0.3	5.2	1.1	0.0	0.2	0.3	0.8	1.6	0.5	0.0	0.0	0.3	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.8	0.0	0.0	1.9	0.0	2.9	0.6	0.9	0.0	0.8	3.0	5.0	1.2	4.6	4.5	3.0	3.1	1.5	6.4	1.8
LRRC46	MGC16309	ENSG00000141294	"Leucine rich repeat containing 46"	Q96FV0	17	47831627-47837713	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"fallopian tube: 51.2;testis: 94.4"	"Cell line enhanced"	"Detected in many"		"T-47d: 7.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.4"	"Region enriched"	"Detected in many"	4	"pons and medulla: 14.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021882, HPA074893"	Enhanced		Approved	Cytosol				Cytosol		"HPA021882: AB_1853320, HPA074893: "	"unprognostic (1.06e-1)"	"unprognostic (6.01e-2)"	"unprognostic (9.24e-2)"	"prognostic favourable (2.11e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.81e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.98e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.14e-1)"	0.3	0.4	1.8	0.3	3.3	0.6	0.5	0.4	0.5	2.3	0.3	5.2	1.6	0.4	1.5	13.8	0.4	51.2	0.5	0.5	2.0	2.4	0.7	0.4	11.8	0.5	0.3	0.1	8.8	0.5	0.3	4.2	0.4	14.0	0.5	0.3	1.8	0.4	1.3	0.3	0.3	0.3	0.3	0.6	0.5	0.3	94.4	1.1	1.2	1.4	0.0	0.4	0.3	0.1	0.6	2.5	4.4	1.6	2.4	1.0	0.5	1.4	6.3	0.8	3.2	0.5	1.4	1.8	0.2	1.7	1.7	3.3	3.0	1.4	0.6	4.0	0.8	1.4	0.8	1.1	2.6	2.8	2.7	1.2	1.7	1.0	0.3	0.1	1.5	0.0	1.0	3.5	1.3	0.3	1.2	0.8	2.2	2.3	2.1	0.3	0.2	1.3	2.0	0.2	1.3	2.7	1.1	2.6	1.9	0.7	0.0	0.9	7.5	0.2	0.5	3.4	1.3	0.6	0.4	1.4	1.2	1.3	2.3	0.5	0.3	4.4	1.3	2.0	0.2	1.6	0.0	0.6	0.1	1.0	2.5	0.4	0.7	0.0	1.6	2.4	1.5	1.3	0.2	0.5	1.8	3.3	0.4	0.5	2.0	2.4	0.3	0.1	14.0	1.1
LRRC49	FLJ20156	ENSG00000137821	"Leucine rich repeat containing 49"	Q8IUZ0	15	70853239-71053657	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 50.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 23.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015596	Uncertain									"HPA015596: "	"unprognostic (9.74e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.10e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.66e-4)"	"unprognostic (3.02e-1)"	"unprognostic (5.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.09e-2)"	2.1	5.0	9.1	2.0	17.8	1.1	3.6	27.4	17.9	6.0	3.1	5.6	2.9	1.8	9.2	28.8	2.7	10.7	4.7	50.3	10.3	11.1	4.8	1.3	3.7	1.4	11.6	10.8	12.8	2.3	14.3	27.3	2.1	23.0	6.5	2.9	6.1	2.1	6.1	1.6	2.3	2.1	6.7	5.9	1.6	2.8	13.2	7.2	0.1	5.3	1.1	1.5	5.7	3.5	1.0	0.6	0.6	2.4	0.9	1.7	0.6	1.9	3.7	7.5	11.7	2.8	4.6	0.0	2.6	6.1	2.2	4.4	1.0	1.6	0.0	2.8	2.5	3.0	9.0	4.6	2.3	0.0	3.4	0.6	3.1	0.1	23.2	0.0	0.9	2.7	1.1	7.2	12.5	5.5	0.1	0.0	3.1	0.7	0.0	0.6	4.2	2.1	0.0	4.8	0.0	5.3	3.2	13.4	12.9	4.2	1.3	3.2	3.4	1.0	3.7	2.2	8.1	5.2	5.4	1.3	3.7	0.0	5.8	0.1	2.3	0.6	0.2	0.1	1.5	2.4	1.7	1.0	1.1	0.1	0.6	0.4	0.1	0.7	0.4	0.9	0.8	0.2	0.0	0.6	9.1	17.8	27.4	17.9	10.3	11.1	11.6	10.8	23.0	7.2
LRRC4B	"DKFZp761A179, HSM, LRIG4"	ENSG00000131409	"Leucine rich repeat containing 4B"	Q9NT99	19	50516892-50568045	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 21.7;SH-SY5Y: 18.9;U-2 OS: 17.8;WM-115: 6.7"	"Group enriched"	"Detected in many"	9	"glioma: 36.5;testis cancer: 9.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058986	Uncertain						2300000			"HPA058986: "	"unprognostic (1.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.56e-1)"	"unprognostic (5.39e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.28e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.11e-3)"	"unprognostic (3.41e-1)"	"unprognostic (3.15e-5)"	"unprognostic (4.29e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.64e-1)"	"unprognostic (2.17e-1)"	3.0	8.8	28.7	2.3	24.6	1.2	1.3	21.7	52.9	13.4	2.3	4.0	0.0	2.3	9.4	1.4	3.3	3.6	2.8	2.5	23.4	22.9	1.7	1.7	3.6	2.7	17.8	20.6	2.8	1.7	1.3	8.8	6.9	12.8	2.2	1.4	2.2	2.3	2.8	1.7	1.7	3.2	3.1	15.0	1.9	2.4	2.3	8.5	0.0	1.8	0.0	1.9	3.2	3.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	3.5	0.3	0.0	0.6	0.1	0.0	5.6	0.0	5.9	0.0	0.1	0.0	0.0	0.0	18.9	0.0	0.0	3.7	0.0	0.1	0.0	0.0	17.8	0.0	0.0	0.4	0.0	0.0	0.1	0.2	6.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	28.7	24.6	21.7	31.9	23.4	22.9	17.8	20.6	12.8	8.5
LRRC56	"DKFZp761L1518, FLJ00101"	ENSG00000161328	"Leucine rich repeat containing 56"	Q8IYG6	11	537527-554916	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 15.5;testis: 20.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.1;Daudi: 2.9;Karpas-707: 5.8;SK-BR-3: 3.7;T-47d: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038728	Uncertain									"HPA038728: AB_10671864"	"unprognostic (2.77e-2)"	"unprognostic (9.54e-3)"	"unprognostic (1.28e-2)"	"prognostic favourable (7.39e-4)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.29e-2)"	"prognostic favourable (6.19e-4)"	"unprognostic (2.65e-3)"	"unprognostic (1.86e-1)"	"prognostic favourable (6.32e-4)"	"unprognostic (1.17e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.52e-3)"	0.6	0.7	2.4	2.9	9.6	1.1	0.6	3.2	1.7	1.6	1.7	1.2	8.1	0.9	1.2	9.1	2.1	4.6	5.0	0.5	2.1	1.6	1.7	0.8	7.8	3.0	0.5	1.3	3.4	4.5	0.4	15.5	0.6	2.8	1.9	0.8	1.7	2.2	2.0	1.1	4.8	2.8	0.5	0.4	1.0	3.6	20.8	0.7	0.3	1.8	0.1	5.3	1.0	0.8	0.5	0.1	0.2	0.3	0.3	1.2	0.7	0.0	0.0	0.1	4.1	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.5	0.0	2.9	0.0	0.0	0.9	0.1	0.4	0.0	0.0	0.0	0.0	1.5	0.1	1.7	1.0	2.6	0.9	1.8	0.0	0.3	0.0	0.0	5.8	0.0	0.0	0.2	1.5	0.0	1.6	0.0	0.0	1.1	0.5	0.0	0.8	0.5	0.0	3.7	0.0	4.5	0.1	0.1	0.7	0.1	0.2	0.2	0.8	0.2	0.1	0.0	0.0	1.0	0.2	0.2	0.0	0.2	0.3	0.1	0.5	0.1	0.6	0.1	0.1	0.1	0.6	0.0	0.3	0.1	0.0	1.2	0.7	2.4	9.6	3.2	1.7	2.1	1.6	0.5	1.3	2.8	0.7
LRRC61	"FLJ31392, HSPC295, MGC3036"	ENSG00000127399	"Leucine rich repeat containing 61"	Q9BV99	7	150322639-150338150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 41.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 30.8;Hep G2: 20.5;NTERA-2: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019355	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA019355: AB_1853339"	"unprognostic (4.05e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.61e-3)"	"unprognostic (5.91e-3)"	"prognostic unfavourable (1.11e-5)"	"unprognostic (1.46e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-2)"	"prognostic favourable (2.85e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.69e-3)"	2.8	14.7	6.7	9.0	9.3	2.3	4.1	7.5	7.3	6.7	6.0	3.5	4.5	5.8	7.0	4.0	6.4	20.8	8.0	3.3	5.4	13.1	10.8	18.3	4.8	9.1	5.0	3.4	18.5	12.7	12.2	10.9	7.3	5.1	6.4	2.9	10.6	6.2	6.7	3.0	5.4	7.9	3.8	3.0	10.1	6.6	6.6	3.9	41.0	16.4	3.0	11.8	4.2	9.0	9.5	15.1	11.6	2.4	6.5	10.5	4.2	7.8	0.2	0.2	0.0	0.0	0.0	3.6	0.0	0.0	1.0	3.1	14.7	7.7	2.4	3.3	0.1	7.0	0.0	0.0	0.5	30.8	10.1	2.8	9.4	20.5	5.7	0.0	1.5	0.6	3.1	0.0	0.0	0.0	9.7	4.5	0.0	14.1	14.2	1.2	27.1	0.0	0.0	0.0	6.4	2.2	5.1	14.0	13.6	13.1	2.8	5.4	2.2	1.7	0.0	0.0	0.0	0.0	0.0	5.1	1.6	0.0	0.0	0.0	0.0	2.3	2.4	6.7	9.5	1.0	7.6	8.0	6.8	7.3	2.6	9.5	6.7	7.7	11.6	6.5	1.0	15.1	10.5	4.2	6.7	9.3	7.5	7.3	5.4	13.1	5.0	3.4	5.1	3.9
LRRC66		ENSG00000188993	"Leucine rich repeat containing 66"	Q68CR7	4	51993702-52017620	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 50.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.5;CAPAN-2: 5.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA014549, HPA027839"	Uncertain									"HPA014549: AB_1853062, HPA027839: AB_10602705"	"unprognostic (1.10e-1)"	"unprognostic (4.87e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.57e-2)"	"unprognostic (4.83e-3)"	"unprognostic (2.93e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.06e-1)"	0.5	0.1	0.8	2.6	1.0	0.0	0.5	1.4	0.9	0.5	11.3	0.5	0.5	19.6	0.5	0.5	0.5	0.5	1.6	0.6	0.8	0.8	0.9	0.5	0.5	0.5	0.8	0.5	0.5	0.5	0.5	3.1	0.5	0.5	0.5	5.2	0.5	0.5	0.5	6.7	0.0	50.2	0.5	0.6	0.5	4.6	0.7	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.2	0.4	0.7	1.9	4.5	0.2	0.7	1.1	0.4	0.8	0.2	5.7	0.0	0.1	1.1	0.0	0.3	0.3	0.3	1.8	0.7	0.0	0.2	0.0	0.2	0.1	0.1	1.7	1.0	0.9	0.3	0.4	0.0	0.0	2.2	0.0	0.2	0.1	0.0	1.0	0.0	0.0	0.2	0.2	0.0	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.4	1.2	0.1	0.7	0.5	0.7	0.0	0.1	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	1.4	0.9	0.8	0.8	0.8	0.5	0.5	0.5
LRRC69		ENSG00000214954	"Leucine rich repeat containing 69"	Q6ZNQ3	8	91101832-91219236	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 6.6"	"Cell line enhanced"	"Detected in some"		"HEK 293: 6.8;U-266/70: 17.5;U-266/84: 9.7"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046337	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA046337: "	"unprognostic (1.63e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.69e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-6)"	"unprognostic (6.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.68e-5)"	0.8	0.9	0.2	1.5	0.2	0.0	1.0	0.0	0.1	0.7	0.5			0.1	0.5	1.9	0.7	0.4	0.5	1.1	0.1	0.1	0.9	0.7	0.7	1.9	0.3		0.4	0.7	0.3	0.6	0.5		1.0	1.5		1.1	0.3	0.6	3.5	0.6	1.4	0.3	1.2	0.6	6.6			1.3		1.1	1.0	0.8	1.9	2.0	1.5	1.1	0.4	2.3	0.1	0.6	0.7	0.2	0.5	0.7	1.5	1.2	0.4	0.1	0.3	0.3	1.1	0.9	1.0	0.5	0.2	0.6	0.7	1.2	0.3	0.3	6.8	1.4	1.7	0.5	0.2	0.5	1.1	0.4	1.1	0.4	0.8	0.1	1.1	0.6	0.4	0.2	0.3	0.5	0.7	0.4	0.8	0.0	0.7	0.2	0.7	0.0	0.2	0.0	0.4	1.0	1.6	1.2	0.2	0.3	0.7	0.2	0.9	17.5	9.7	4.0	0.1	2.2	0.9	1.3	0.6	1.5	1.5	1.1	1.5	1.2	1.6	0.6	0.1	1.9	2.3	1.2	0.1	0.4	0.6	2.0	2.1	0.1										
LRRC70	"LOC100130733, SLRN"	ENSG00000186105	"Leucine rich repeat containing 70"	Q7Z2Q7	5	62578735-62581448	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"HUVEC TERT2: 17.9;TIME: 9.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.0"	"Group enriched"	"Detected in many"	20	"granulocytes: 1.5;NK-cells: 3.0;T-cells: 1.3"					"Low region specificity"	"Detected in all"			HPA013409	Uncertain									"HPA013409: AB_10601911"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.17e-4)"	"unprognostic (3.03e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.40e-4)"	"unprognostic (5.67e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	18.4	1.6	1.3	3.2	2.1	5.9	18.0	0.9	2.2	9.5	4.2	0.0	3.4	1.5	5.3	2.4	5.4	4.2	6.7	4.6	2.0	1.6	10.0	5.9	3.9	5.9	1.7	0.2	5.7	2.2	2.6	4.8	9.6	2.7	6.8	2.7	2.8	2.4	1.1	2.8	4.9	3.5	6.5	3.4	25.2	2.3	4.9	1.8	3.5	10.4	4.1	1.5	6.1	17.6	0.0	0.0	1.5	0.0	3.0	1.3	0.2	0.2	0.0	0.2	0.1	0.5	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	17.9	0.2	0.7	0.0	0.1	0.5	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.1	0.0	9.7	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	1.3	0.2	1.5	3.0	0.0	0.0	0.0	0.2	1.3	2.1	0.9	2.2	2.0	1.6	1.7	0.2	2.7	1.8
LRRC72		ENSG00000205858	"Leucine rich repeat containing 72"	A6NJI9	7	16526880-16581568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 15.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA020554	Uncertain									"HPA020554: AB_1859508"															"unprognostic (1.58e-2)"			0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0
LRRC73	"C6orf154, dJ337H4.2"	ENSG00000204052	"Leucine rich repeat containing 73"	Q5JTD7	6	43506969-43510686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.5;testis: 31.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.2;MCF7: 6.2;T-47d: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046698	Enhanced		Approved	Cytosol				Cytosol		"HPA046698: AB_10959526"	"unprognostic (3.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.52e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.89e-2)"	1.2	6.1	10.4	0.9	19.4	0.8	1.1	2.3	23.5	1.4	1.3	2.3	0.9	2.1	1.4	1.5	1.0	11.3	1.8	1.8	8.9	5.2	3.0	1.2	1.6	0.9	3.1	12.1	2.0	2.8	7.5	4.1	1.2	6.2	1.9	1.1	0.6	1.4	2.1	1.0	1.1	1.2	1.5	1.1	1.2	1.8	31.6	1.8	0.0	1.6	0.0	0.9	1.4	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.9	6.2	1.0	3.2	0.2	0.2	1.8	0.5	0.3	0.0	0.3	0.2	0.1	1.1	2.4	0.7	0.7	0.0	0.1	1.0	0.0	0.4	0.2	1.0	0.0	0.1	0.5	1.2	2.0	0.3	0.2	0.4	0.6	1.1	6.2	0.0	0.1	0.1	0.8	0.0	0.0	0.1	1.6	0.0	2.3	2.7	0.6	0.4	0.2	6.3	0.0	0.3	0.5	0.6	2.3	0.2	0.6	0.4	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	19.4	2.3	23.5	8.9	5.2	3.1	12.1	6.2	1.8
LRRC74A	"C14orf166B, LRRC74"	ENSG00000100565	"Leucine rich repeat containing 74A"	Q0VAA2	14	76826372-76870302	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 19.8"	"Group enriched"	"Detected in some"	8	"NTERA-2: 1.0;RH-30: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035094	Uncertain									"HPA035094: AB_10600793"	"unprognostic (7.71e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.77e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.29e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.30e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.11e-2)"	"unprognostic (5.21e-4)"	"unprognostic (1.72e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.09e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LRRC74B		ENSG00000187905	"Leucine rich repeat containing 74B"	Q6ZQY2	22	21045960-21064168	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 17.1;epididymis: 5.6;fallopian tube: 11.4"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 1.6;U-87 MG: 3.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"pons and medulla: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049947	Uncertain									"HPA049947: "	"unprognostic (3.43e-2)"	"unprognostic (1.76e-1)"		"unprognostic (3.28e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.44e-3)"		"unprognostic (2.23e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.57e-9)"	"unprognostic (4.20e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.92e-2)"	0.2	0.2	2.1	0.2	2.3	0.2	0.2	0.4	1.6	1.5	0.2	3.7	0.0	0.4	0.3	5.6	0.2	11.4	0.2	0.2	1.5	1.2	0.2	0.2	1.9	0.2	0.1	0.7	1.9	0.2	0.2	0.9	0.2	17.1	0.2	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.5	0.2	0.2	3.6	0.3	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.3	0.4	1.6	1.5	1.2	0.1	0.7	17.1	0.3
LRRC75A	"C17orf76, FAM211A, FLJ35696"	ENSG00000181350	"Leucine rich repeat containing 75A"	Q8NAA5	17	16441577-16492153	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 42.3"	"Cell line enhanced"	"Detected in some"		"HEL: 11.8;HUVEC TERT2: 3.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028528, HPA065840"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA028528: AB_10600755, HPA065840: "	"unprognostic (1.09e-1)"	"unprognostic (5.60e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.85e-5)"	"unprognostic (3.93e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (7.74e-2)"	"unprognostic (2.84e-1)"	"prognostic favourable (7.46e-5)"	"unprognostic (8.36e-2)"	"unprognostic (4.28e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.06e-1)"	1.0	8.9	5.2	2.8	3.7	1.7	0.6	0.7	6.3	2.2	26.3	1.5	1.4	15.0	1.9	0.5	0.4	0.9	0.5	0.4	4.1	2.4	0.8	0.2	1.6	1.9	1.6	3.2	1.8	1.6	3.7	4.1	1.5	2.1	1.1	10.4	1.9	0.3	1.7	0.4	0.4	42.3	3.0	0.8	6.4	1.3	8.5	0.4	0.5	1.2	0.0	1.9	1.3	0.7	0.8	0.0	0.3	0.6	0.3	0.6	0.2	1.1	1.0	1.2	0.8	0.3	0.5	0.1	0.3	0.8	2.7	2.2	1.1	0.3	0.0	0.8	0.1	0.4	0.3	0.2	0.1	0.4	0.9	11.8	0.6	0.0	0.4	0.2	0.9	0.0	0.0	0.6	0.0	3.8	0.5	0.2	0.0	1.9	1.9	0.8	0.2	0.1	0.6	0.7	0.1	0.5	0.2	2.3	0.6	0.0	0.2	2.8	0.2	0.1	0.0	0.3	1.4	0.9	1.5	1.5	0.3	0.2	0.1	0.7	1.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.6	0.3	0.3	0.6	0.0	0.0	0.2	5.2	3.7	0.7	6.3	4.1	2.4	1.6	3.2	2.1	0.4
LRRC75B	"C22orf36, FAM211B, MGC131773"	ENSG00000178026	"Leucine rich repeat containing 75B"	Q2VPJ9	22	24585620-24593208	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 8.3;MCF7: 7.4;SH-SY5Y: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 2.7;NK-cell: 2.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.7;NK-cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002540	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA002540: AB_1079263"	"unprognostic (1.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.40e-2)"	"unprognostic (9.69e-2)"	4.2	1.9	7.5	1.4	6.0	3.0	2.6	3.8	6.6	3.5	3.8	2.6	11.5	1.4	2.4	5.8	3.4	3.3	9.8	4.3	5.5	9.1	6.0	3.4	1.7	1.7	7.8	4.0	7.3	7.2	1.4	1.5	2.3	4.1	6.9	2.0	4.9	7.5	15.0	10.7	4.3	8.2	6.7	7.0	2.7	2.6	8.3	0.5	0.0	8.6	3.0	2.1	5.5	2.7	0.0	0.3	2.7	0.4	2.0	0.2	0.0	0.1	4.2	0.0	2.3	0.6	1.7	0.4	0.6	0.7	1.5	1.6	3.0	0.0	0.0	1.0	1.2	4.7	0.4	2.3	0.0	1.3	2.8	0.3	0.6	8.3	4.2	0.0	0.0	0.0	1.7	1.5	0.2	1.1	0.4	0.0	0.1	7.4	0.0	1.5	2.1	1.7	0.0	0.2	0.0	1.9	0.4	2.2	6.6	2.2	0.7	0.6	0.0	0.7	2.3	2.5	1.6	0.9	0.8	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.3	2.7	0.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	7.5	6.0	3.8	5.6	5.5	9.1	7.8	4.0	4.1	0.5
LRRC9	FLJ46156	ENSG00000131951	"Leucine rich repeat containing 9"	Q6ZRR7	14	59919713-60063559	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 16.4;pituitary gland: 13.9;testis: 14.3"	"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CACO-2: 2.0;NTERA-2: 4.2;SCLC-21H: 1.9;SH-SY5Y: 1.3;U-2 OS: 1.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 7.3;pons and medulla: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040965, HPA041381"	Uncertain									"HPA040965: , HPA041381: "	"unprognostic (1.01e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.62e-3)"	"unprognostic (8.54e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.29e-2)"	0.6	0.4	0.6	0.1	7.3	0.2	0.1	0.2	1.1	0.3	0.1	3.2	0.0	0.1	0.2	1.4	0.1	3.4	0.1	0.1	1.4	1.2	0.2	0.2	0.1	0.1	0.5	1.3	1.0	0.2	4.8	13.9	0.1	16.4	1.3	0.1	0.0	0.1	0.2	0.1	0.1	0.7	0.1	0.9	0.1	0.2	14.3	2.2	0.0	0.1	0.0	0.1	0.2	0.1	0.6	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	7.3	0.2	1.1	1.4	1.2	0.5	1.3	16.4	2.2
LRRIQ1	"FLJ12303, KIAA1801"	ENSG00000133640	"Leucine rich repeats and IQ motif containing 1"	Q96JM4	12	85036314-85263224	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.5;pituitary gland: 24.9;testis: 20.1"	"Cell line enhanced"	"Detected in many"		"AF22: 3.8;RPTEC TERT1: 6.5;SH-SY5Y: 4.3;U-138 MG: 3.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 21.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046162	Uncertain									"HPA046162: AB_10963055"	"unprognostic (3.55e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.69e-2)"		"unprognostic (4.81e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.35e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.64e-1)"	0.4	1.2	2.4	0.5	8.2	0.3	1.5	0.4	3.1	2.0	0.5	2.2	2.0	0.2	1.9	8.2	0.3	13.4	0.9	0.5	4.7	3.7	5.3	0.3	4.6	0.3	1.0	3.4	4.7	0.7	3.1	24.9	0.3	21.5	1.8	0.3	1.0	0.6	1.0	0.2	0.3	0.3	1.0	1.0	0.4	0.6	20.1	3.4	0.0	2.8	0.2	0.3	0.3	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.8	0.0	1.0	2.0	0.4	0.6	0.6	1.7	0.4	0.0	0.1	0.0	0.2	0.4	0.1	1.4	1.7	0.4	0.0	2.5	0.6	0.2	0.0	0.0	0.0	0.0	1.0	2.7	1.3	1.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.0	2.4	0.0	0.6	0.0	6.5	0.0	2.4	4.3	0.2	0.2	0.2	1.9	0.0	0.0	3.6	1.0	1.4	0.2	0.0	1.1	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	8.2	0.4	3.1	4.7	3.7	1.0	3.4	21.5	3.4
LRRN2	"FIGLER7, GAC1, LRANK1, LRRN5"	ENSG00000170382	"Leucine rich repeat neuronal 2"	O75325	1	204617170-204685733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.3"	"Cell line enhanced"	"Detected in some"		"HEL: 7.1;NTERA-2: 14.2;RPMI-8226: 22.1;T-47d: 7.9"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.1;endometrial cancer: 10.6;glioma: 16.8;ovarian cancer: 18.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029124	Uncertain		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA029124: AB_10601545"	"unprognostic (2.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (2.59e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.59e-3)"	4.9	6.6	11.8	3.7	16.5	2.4	3.3	9.7	20.3	1.9	7.9	5.3	1.0	1.9	3.9	0.8	2.4	10.2	6.1	6.0	11.7	12.8	7.3	0.7	2.5	2.9	6.3	13.8	3.3	1.4	19.1	9.7	1.3	8.1	1.6	7.5	12.2	2.8	3.7	2.2	0.7	3.3	9.9	3.1	6.3	1.4	3.8	6.1	3.2	2.8	0.0	1.3	2.1	1.5	0.4	0.1	1.7	0.3	0.7	0.8	0.2	0.0	3.3	2.7	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.1	7.1	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	1.1	0.0	14.2	0.1	0.2	0.0	22.1	0.0	0.1	1.9	0.3	4.3	0.1	0.0	7.9	0.0	0.0	0.0	3.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.2	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.4	0.1	0.2	0.7	0.7	0.0	0.1	0.8	0.2	11.8	16.5	9.7	15.7	11.7	12.8	6.3	13.8	8.1	6.1
LRRN3	"FIGLER5, FLJ11129, NLRR3"	ENSG00000173114	"Leucine rich repeat neuronal 3"	Q9H3W5	7	111091006-111125454	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 26.5;brain: 23.8"	"Cell line enhanced"	"Detected in some"		"AF22: 14.6;BJ: 8.2;BJ hTERT+: 18.0;SH-SY5Y: 26.2;T-47d: 14.3"	"Group enriched"	"Detected in many"	7	"glioma: 17.5;thyroid cancer: 4.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 20.3;naive CD8 T-cell: 18.4"	"Lineage enriched"	"Detected in single"	98	"T-cells: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043820, HPA046792"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA043820: , HPA046792: "	"unprognostic (4.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.23e-2)"	7.8	26.5	12.7	1.6	21.2	1.1	2.1	20.0	23.8	3.6	1.4	1.9	0.8	1.0	1.0	3.1	1.9	1.3	1.6	9.0	10.4	10.7	0.9	2.7	8.7	3.6	7.7	13.0	7.9	1.5	0.7	4.9	6.7	9.0	4.7	1.6	0.8	1.9	6.4	4.0	0.8	2.1	1.0	2.9	2.0	0.9	16.4	6.3	8.8	22.3	0.0	4.4	1.6	1.3	0.2	0.0	0.1	0.0	0.0	20.3	4.0	0.0	0.0	14.6	1.7	6.8	2.9	0.0	8.2	18.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.1	7.1	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	26.2	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.6	1.2	0.0	0.0	20.3	18.4	0.1	0.0	0.0	0.0	0.2	4.0	12.7	21.2	20.0	23.8	10.4	10.7	7.7	13.0	9.0	6.3
LRRN4CL		ENSG00000177363	"LRRN4 C-terminal like"	Q8ND94	11	62686402-62689899	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.6;ASC TERT1: 18.7;HHSteC: 14.6;HSkMC: 7.9;LHCN-M2: 9.5"	"Cancer enriched"	"Detected in many"	5	"melanoma: 26.5"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA050317	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA050317: AB_2681084"	"unprognostic (1.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.84e-1)"	"unprognostic (9.95e-3)"	"unprognostic (2.61e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-7)"	"unprognostic (2.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.86e-2)"	15.7	4.8	0.2	5.0	0.6	0.6	11.6	0.6	0.9	27.2	12.1	0.1	3.5	2.1	27.0	14.0	19.1	11.4	6.7	9.3	0.3	0.2	0.8	0.2	3.1	1.8	0.3	0.6	24.9	2.1	0.4	1.2	4.4	2.2	10.8	2.5	17.8	3.2	6.7	17.0	6.8	4.3	15.1	1.9	0.3	5.7	8.5	0.0	0.0	3.5	10.4	2.4	18.2	11.2	0.9	0.6	3.3	0.8	0.8	0.6	0.1	0.0	0.0	0.2	0.2	5.6	18.7	0.2	2.0	2.9	0.2	1.0	0.2	0.1	0.1	0.2	3.2	0.3	0.1	0.0	0.3	0.1	0.2	0.3	0.1	0.1	14.6	0.2	0.1	7.9	0.1	0.4	0.0	0.0	0.2	0.1	9.5	0.0	0.2	0.4	0.4	0.1	0.1	1.3	0.3	0.0	0.1	0.6	0.2	0.2	0.2	0.6	0.1	0.2	0.2	1.7	0.1	2.0	0.1	0.2	0.1	0.2	1.1	0.2	0.0	0.9	0.8	0.3	0.4	0.3	0.3	0.4	0.4	0.3	0.1	0.9	0.5	0.6	3.3	0.8	0.4	0.6	0.2	0.1	0.2	0.6	0.6	0.9	0.3	0.2	0.3	0.6	2.2	0.0
LRRTM1	FLJ32082	ENSG00000162951	"Leucine rich repeat transmembrane neuronal 1"	Q86UE6	2	80288351-80304749	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 17.8;salivary gland: 19.8"	"Cell line enhanced"	"Detected in some"		"AF22: 2.1;CAPAN-2: 3.2;NTERA-2: 2.1;SH-SY5Y: 4.6;U-266/70: 1.6"	"Group enriched"	"Detected in many"	11	"endometrial cancer: 8.8;ovarian cancer: 16.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062660	Approved									"HPA062660: "		"unprognostic (2.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.63e-2)"		"unprognostic (6.67e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.03e-3)"	"unprognostic (7.10e-4)"		"unprognostic (3.16e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.96e-4)"		0.7	2.2	8.1	1.0	17.8	0.5	0.6	0.5	17.6	1.5	2.2	2.7	0.1	1.7	1.7	1.2	1.1	2.8	0.9	1.3	10.7	6.3	0.9	0.7	0.7	0.5	2.5	7.8	0.9	0.5	0.5	1.3	0.5	1.8	0.9	1.1	1.7	19.8	2.8	0.5	0.7	1.9	1.1	2.1	0.5	0.9	0.7	2.4	0.0	2.9	0.0	0.6	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	17.8	0.5	17.6	10.7	6.3	2.5	7.8	1.8	2.4
LRRTM3		ENSG00000198739	"Leucine rich repeat transmembrane neuronal 3"	Q86VH5	10	66926006-67099830	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 7.3;brain: 29.1;ovary: 8.0;pituitary gland: 26.6"	"Cell line enhanced"	"Detected in some"		"AF22: 3.7;Daudi: 2.2;HAP1: 10.6;NTERA-2: 2.3;RPMI-8226: 1.8"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA070444, HPA078598"			Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA070444: , HPA078598: "					"unprognostic (1.21e-2)"					"unprognostic (4.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.02e-2)"		"unprognostic (1.15e-4)"	"unprognostic (8.11e-2)"		"unprognostic (4.77e-1)"	0.9	7.3	12.9	1.0	18.7	0.9	0.9	19.7	29.1	1.7	0.9	3.2	0.0	1.0	1.2	0.9	1.4	0.9	0.9	0.9	7.0	6.5	1.0	0.9	1.4	0.9	3.7	16.0	8.0	3.7	0.9	26.6	0.9	4.5	1.2	0.9	0.0	1.0	1.2	1.0	0.9	1.1	1.0	2.8	0.9	0.9	1.9	5.9	0.0	0.9	0.0	0.9	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.3	0.4	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	18.7	19.7	21.3	7.0	6.5	3.7	16.0	4.5	5.9
LRTM2		ENSG00000166159	"Leucine rich repeats and transmembrane domains 2"	Q8N967	12	1820267-1836752	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"brain: 18.7"	"Group enriched"	"Detected in some"	8	"HEL: 9.0;SCLC-21H: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055094, HPA062745"	Uncertain		Approved	Cytosol				Cytosol		"HPA055094: , HPA062745: "	"unprognostic (1.84e-3)"			"unprognostic (4.83e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"		"unprognostic (5.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.24e-1)"		"unprognostic (6.20e-4)"	"unprognostic (2.21e-1)"	"unprognostic (8.02e-2)"		0.7	0.7	5.1	0.7	12.3	0.7	0.7	0.8	18.7	0.7	0.7	1.7	0.0	0.7	0.7	0.7	0.7	0.7	0.7	0.7	3.3	5.0	0.7	0.7	0.7	0.7	1.7	10.5	0.7	0.7	0.7	0.1	0.7	4.7	0.7	0.7	0.1	0.7	0.8	0.7	0.7	0.7	0.7	1.7	0.7	0.8	0.9	4.3	0.0	0.7	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	12.3	0.8	18.7	3.3	5.0	1.7	10.5	4.7	4.3
LTB4R2	"BLT2, BLTR2, JULF2, NOP9"	ENSG00000213906	"Leukotriene B4 receptor 2"	Q9NPC1	14	24305734-24312053	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 38.9;lymphoid tissue: 26.8;skin 1: 21.4;tongue: 43.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 15.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB022689, HPA029680, HPA072921"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"CAB022689: , HPA029680: AB_10603013, HPA072921: "	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.05e-11)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.19e-1)"	1.5	1.2	0.4	1.8	0.5	4.8	1.1	0.4	0.6	7.9	0.4	0.6	0.8	2.4	1.0	4.7	38.9	0.8	0.7	0.4	0.5	0.1	6.1	0.5	1.1	1.8	0.4	0.7	0.7	0.5	0.3	0.7	0.8	0.5	1.8	0.3	0.5	4.7	1.1	0.9	21.4	1.8	0.4	0.4	3.5	1.0	1.4	0.4	3.1	0.9	43.6	26.8	0.6	9.0	0.3	2.2	1.4	2.0	0.9	2.7	1.1	2.4	4.3	1.8	1.8	0.4	0.6	7.6	0.9	0.4	1.3	0.9	3.4	1.5	3.2	1.6	0.6	15.7	1.3	2.7	0.9	3.9	4.8	2.2	3.5	1.6	0.5	3.6	4.1	0.5	3.6	1.9	2.3	0.6	2.7	3.5	0.6	4.8	1.9	3.8	1.0	5.4	7.8	1.7	1.8	0.4	3.1	3.4	1.6	1.6	2.0	1.3	3.7	2.7	1.6	2.6	3.2	4.0	1.3	7.9	2.2	5.2	0.5	6.0	2.0	0.0	2.0	1.4	2.7	1.6	1.6	0.1	2.2	2.0	2.2	0.3	1.7	0.9	1.3	0.9	0.8	0.6	0.4	1.1	0.4	0.5	0.4	0.6	0.5	0.1	0.4	0.7	0.5	0.4
LUZP2		ENSG00000187398	"Leucine zipper protein 2"	Q86TE4	11	24496970-25082631	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 11.1;brain: 32.7"	"Group enriched"	"Detected in some"	4	"HaCaT: 14.3;HAP1: 7.1"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;prostate cancer: 4.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							"HPA039007, HPA046161"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted in brain"			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039007: , HPA046161: "	"unprognostic (4.49e-2)"	"unprognostic (2.74e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.22e-3)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.67e-4)"	"unprognostic (2.40e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.09e-2)"	"unprognostic (5.18e-3)"	"unprognostic (9.41e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.64e-2)"	1.2	11.1	14.5	0.9	10.8	0.9	1.6	2.6	32.7	0.9	2.1	5.9	0.0	0.9	1.0	0.8	0.9	0.8	1.0	1.0	10.3	13.8	1.0	2.3	1.1	0.8	13.7	5.6	0.8	0.8	0.7	1.9	0.8	26.7	4.5	1.7	0.0	1.0	0.9	0.8	0.9	1.1	1.2	30.0	0.9	0.9	1.6	14.5	0.0	0.8	0.9	0.8	1.6	0.3	0.5	0.4	1.9	0.3	0.3	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	14.3	7.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.2	0.2	0.0	1.5	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.5	0.3	0.4	0.2	0.1	0.2	0.2	0.1	0.3	0.1	0.5	0.3	0.2	1.9	0.3	0.2	0.4	0.1	0.0	14.5	10.8	2.6	9.3	10.3	13.8	13.7	5.6	26.7	14.5
LUZP6	"MPD6, MTPNUT"	ENSG00000267697	"Leucine zipper protein 6"	Q538Z0	7	135927274-135927450	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MOLT-4: 9.8;SK-MEL-30: 19.3"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"naive CD4 T-cell: 2.4;naive CD8 T-cell: 2.7;plasmacytoid DC: 2.9;T-reg: 4.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;T-cells: 4.4"									HPA077907			Approved	"Lipid droplets"				"Lipid droplets"		"HPA077907: "																		1.2	1.2	2.3	1.2	3.5	1.2	1.2	1.2	1.8	3.6	1.2			1.2	1.2	1.2	4.9	2.9	1.2	1.2	2.1	0.8	1.2	1.3	1.2	1.2	1.9		1.2	1.2	1.2	2.0	1.2		1.2	1.2		1.2	1.2	7.2	1.2	1.2	1.2	0.5	3.4	1.2	1.2			1.2		1.2	1.2	1.2	0.5	2.9	0.1	0.0	0.6	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	2.4	2.7	0.0	0.6	0.0	2.9	4.4	0.0										
LYPD2	"LYPDC2, RGTR430, UNQ430"	ENSG00000197353	"LY6/PLAUR domain containing 2"	Q6UXB3	8	142750150-142752534	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"blood: 76.5;esophagus: 77.5;lymphoid tissue: 69.2;tongue: 37.9"	"Group enriched"	"Detected in some"	18	"EFO-21: 14.8;HaCaT: 4.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	13	"non-classical monocyte: 76.5"	"Lineage enriched"	"Detected in many"	20	"monocytes: 76.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA028599	Uncertain				"Intracellular and membrane"					"HPA028599: AB_10603777"		"prognostic favourable (2.00e-4)"		"unprognostic (3.10e-2)"		"prognostic favourable (2.63e-4)"	"unprognostic (3.85e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.11e-3)"		"unprognostic (1.53e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.04e-1)"	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	6.7	0.0	0.0	0.1	0.0	0.3	0.0	77.5	0.2	0.1	1.2	0.0	0.0	0.0	3.6	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.4	7.7	0.0	0.5	6.5	0.0	0.0	0.0	0.1	11.6	0.0	0.0	5.7	0.0	37.9	69.2	0.0	10.1	0.2	3.7	0.0	76.5	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	14.8	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	76.5	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
LYPD6B	"CT116, LYPD7"	ENSG00000150556	"LY6/PLAUR domain containing 6B"	Q8NI32	2	149038107-149215262	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 38.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 25.4;LHCN-M2: 40.8;NB-4: 13.3;RT4: 21.5;SK-BR-3: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 14.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049239	Uncertain				"Intracellular and membrane"					"HPA049239: "	"unprognostic (2.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.59e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.32e-3)"	0.2	0.2	1.4	0.1	1.5	0.0	8.9	0.7	2.4	1.4	2.3	0.6	21.8	1.1	1.1	0.5	2.1	12.2	27.3	0.1	5.0	2.4	4.0	0.4	2.7	2.4	0.7	0.6	1.7	13.2	9.8	0.6	0.6	0.9	5.0	1.5	2.5	11.9	26.6	0.1	38.9	2.9	1.8	0.6	1.3	20.3	16.9	0.7	0.2	0.2	0.6	2.3	9.1	3.7	2.8	0.0	14.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.6	0.0	0.0	0.0	3.1	0.6	2.6	1.0	0.3	0.0	0.0	0.0	25.4	5.5	0.6	0.6	8.4	0.0	2.9	0.0	0.8	0.0	0.0	0.0	0.0	0.2	8.7	0.0	0.0	0.0	0.0	0.0	40.8	9.2	0.0	13.3	0.8	0.1	0.0	0.1	1.6	1.3	21.5	1.5	0.0	0.1	12.9	0.0	1.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	14.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	1.5	0.7	2.4	5.0	2.4	0.7	0.6	0.9	0.7
LYRM1	A211C6.1	ENSG00000102897	"LYR motif containing 1"	O43325	16	20899868-20925006	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 101.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059840			Supported	Nucleoplasm,Midbody				Nucleoplasm	Midbody	"HPA059840: "	"unprognostic (4.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-2)"	"prognostic favourable (7.48e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-1)"	"prognostic unfavourable (4.80e-4)"	"unprognostic (1.57e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"prognostic favourable (9.50e-4)"	25.4	18.9	19.1	15.0	17.4	12.8	25.5	12.6	17.8	17.5	16.6	9.6	14.0	9.5	17.1	21.1	16.2	24.9	17.0	34.2	15.4	18.2	30.6	101.6	11.2	19.2	18.8	13.8	25.3	26.1	20.5	13.9	9.0	24.9	21.1	14.0	13.1	14.1	19.1	28.7	10.6	12.6	27.6	17.9	11.5	15.7	22.9	9.0	16.2	19.4	14.9	12.9	25.3	19.7	12.7	7.2	47.4	10.2	8.4	14.2	10.1	11.8	12.8	11.9	9.4	32.3	25.7	3.9	9.9	16.6	5.7	8.7	14.3	14.9	8.4	38.7	11.9	8.4	5.2	10.4	9.4	15.6	8.1	3.8	3.5	36.9	24.0	12.4	7.5	18.6	9.2	16.0	46.0	23.6	8.4	14.8	24.7	15.8	12.3	8.4	12.4	6.7	16.9	6.6	10.0	20.6	7.0	11.6	11.2	6.1	10.3	16.5	10.6	7.3	6.2	8.2	6.0	12.9	6.8	14.7	20.5	13.1	21.5	13.4	7.1	47.4	7.2	23.3	8.6	9.1	11.8	12.7	13.2	10.6	5.9	11.2	10.7	10.8	26.8	8.4	10.2	7.2	14.2	10.1	19.1	17.4	12.6	17.8	15.4	18.2	18.8	13.8	24.9	9.0
LYSMD4	FLJ33008	ENSG00000183060	"LysM domain containing 4"	Q5XG99	15	99715697-99733561	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029152, HPA059824"	Approved		Approved	"Actin filaments,Cytosol"				"Actin filaments"	Cytosol	"HPA029152: AB_10602033, HPA059824: "	"unprognostic (2.43e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.53e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.35e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.30e-1)"	8.8	4.7	5.8	11.6	8.7	4.7	11.1	8.6	14.1	9.5	6.4	7.8	3.6	8.1	9.3	11.4	11.4	5.5	8.3	9.2	7.1	5.6	4.7	6.6	7.0	3.9	4.7	5.7	7.8	6.5	14.9	5.4	5.0	6.7	6.3	5.9	8.3	15.9	7.7	12.3	25.2	6.5	6.9	7.9	4.5	5.6	6.8	6.3	5.4	4.1	11.1	6.3	4.6	8.4	3.1	4.8	8.0	4.0	1.0	6.2	3.4	3.8	3.7	7.6	4.4	8.5	7.7	4.5	4.5	3.1	3.9	5.7	9.2	3.5	4.3	2.7	4.1	11.5	5.9	7.2	4.5	0.9	10.6	2.8	7.5	6.3	4.9	2.0	5.4	4.4	10.7	3.5	4.2	5.2	6.8	5.5	2.5	4.6	5.3	5.6	5.0	4.2	3.7	5.4	2.1	6.9	10.2	4.4	3.9	8.2	2.5	4.3	1.7	3.9	6.6	3.2	8.7	4.3	1.8	7.4	9.8	3.5	4.1	5.0	3.4	0.0	2.0	8.0	3.8	3.3	2.9	1.8	5.2	4.5	1.1	3.1	6.2	2.8	0.7	1.0	4.0	4.8	5.0	3.4	5.8	8.7	8.6	14.1	7.1	5.6	4.7	5.7	6.7	6.3
LYZL4	"LYC4, MGC26768"	ENSG00000157093	"Lysozyme like 4"	Q96KX0	3	42397078-42410600	"Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"testis: 29.0"	"Cell line enhanced"	"Detected in some"		"HEL: 1.0;SK-BR-3: 1.2;WM-115: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA038806	Approved				"Secreted in male reproductive system"					"HPA038806: AB_10674841"					"unprognostic (4.03e-1)"							"unprognostic (5.68e-1)"		"unprognostic (1.06e-1)"				0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
LZTS3	"KIAA0552, ProSAPiP1"	ENSG00000088899	"Leucine zipper tumor suppressor family member 3"	O60299	20	3162617-3173592	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.9;salivary gland: 36.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031008, HPA031009"	Approved		Approved	Vesicles				Vesicles		"HPA031008: AB_10601610, HPA031009: AB_10670162"	"unprognostic (4.09e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-2)"	"prognostic unfavourable (7.26e-4)"	"unprognostic (1.15e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.14e-1)"	"prognostic favourable (7.98e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.57e-2)"	"unprognostic (9.69e-3)"	"prognostic favourable (5.92e-8)"	"unprognostic (4.63e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.38e-1)"	2.4	5.3	17.6	1.4	31.1	1.7	3.5	51.9	45.7	11.5	2.4	4.2	2.1	8.6	4.6	3.7	1.7	6.4	6.8	5.4	16.4	10.7	11.9	2.7	5.6	1.2	7.1	17.4	9.0	17.0	11.8	4.1	2.2	10.5	5.0	2.2	7.4	36.2	7.9	5.1	1.4	6.5	2.7	4.5	1.7	7.7	1.9	6.0	0.0	7.1	0.4	1.0	2.6	1.5	0.2	0.8	0.0	0.0	0.0	0.9	0.0	2.7	2.6	3.7	4.1	5.2	1.5	2.6	2.8	6.0	4.7	7.0	15.0	7.9	4.7	1.5	5.4	1.3	2.0	2.9	3.6	0.1	2.7	0.2	0.5	12.3	11.8	0.2	1.3	1.9	6.5	6.6	2.5	0.7	2.7	1.5	2.3	1.2	0.3	0.6	8.4	2.6	1.2	1.2	5.0	5.9	1.0	14.8	4.5	2.3	3.2	2.2	7.6	0.1	4.2	5.1	9.6	2.0	0.8	3.0	0.4	1.4	2.5	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.8	0.5	0.0	17.6	31.1	51.9	45.7	16.4	10.7	7.1	17.4	10.5	6.0
MAGEA10	"CT1.10, MAGE10, MGC10599"	ENSG00000124260	"MAGE family member A10"	P43363	X	152133310-152138578	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 48.7"	"Group enriched"	"Detected in some"	7	"PC-3: 9.3;SH-SY5Y: 5.9;U-266/84: 6.3;WM-115: 14.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA003333, HPA070780"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA003333: AB_10962837, HPA070780: "		"unprognostic (1.92e-1)"				"unprognostic (1.06e-1)"		"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.91e-2)"				"unprognostic (5.97e-3)"	"unprognostic (1.11e-1)"		"unprognostic (1.25e-1)"	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	48.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.9	0.8	2.6	0.8	1.2	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.1	0.0	9.3	0.0	0.1	0.0	0.0	0.0	0.2	5.9	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.2	0.0	0.0	1.2	6.3	0.0	0.5	0.0	14.9	2.6	0.8	0.7	0.4	0.7	0.4	0.7	0.5	0.4	0.3	0.9	0.6	0.7	2.6	1.2	0.5	0.8	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0
MAGEB3	CT3.5	ENSG00000198798	"MAGE family member B3"	O15480	X	30230436-30237492	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"epididymis: 20.5;testis: 7.8"	"Cell line enriched"	"Detected in single"	13	"U-266/70: 6.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA072203	Approved									"HPA072203: "															"unprognostic (3.34e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8			0.0		0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	6.9	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0										
MAGEB5	"CT3.3, MAGE-B5"	ENSG00000188408	"MAGE family member B5"	Q9BZ81	X	26216169-26218270	"Cancer-related genes, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	10	"testis: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052627	Uncertain									"HPA052627: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MAGEE2	HCA3	ENSG00000186675	"MAGE family member E2"	Q8TD90	X	75782988-75785236	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 8.8"	"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.1"	"Cancer enriched"	"Detected in single"	9	"glioma: 1.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030625	Uncertain									"HPA030625: AB_10601863"	"unprognostic (5.92e-2)"				"unprognostic (9.33e-2)"			"unprognostic (2.24e-2)"		"unprognostic (6.92e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.01e-3)"	"unprognostic (5.79e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.43e-2)"		0.5	3.6	2.6	0.5	6.4	0.3	0.7	8.1	8.8	0.9	1.0	0.3	0.0	0.8	1.2	1.2	0.8	0.6	1.0	0.8	2.5	6.7	1.0	0.4	0.9	0.3	2.0	3.8	1.6	0.3	0.3	1.9	0.3	4.1	1.1	1.4	0.4	0.8	1.1	0.3	0.9	1.1	1.3	2.0	0.4	0.4	0.5	0.9	0.0	0.5	0.0	0.4	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	6.4	8.1	7.2	2.5	6.7	2.0	3.8	4.1	0.9
MAMDC2	MGC21981	ENSG00000165072	"MAM domain containing 2"	Q7Z304	9	70043581-70226970	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 22.6;HHSteC: 23.6;LHCN-M2: 29.4;TIME: 28.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 2.6"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 2.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021814, HPA022249"	Uncertain		Approved	"Nuclear speckles,Plasma membrane"	"Secreted in other tissues"			"Nuclear speckles, Plasma membrane"		"HPA021814: AB_1853508, HPA022249: AB_2139157"	"unprognostic (1.88e-1)"	"unprognostic (3.16e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.67e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (7.78e-4)"	"unprognostic (2.79e-3)"	9.0	4.3	0.6	11.1	0.5	0.0	14.7	0.6	0.8	32.3	27.7	0.3	9.1	4.3	40.7	33.7	31.6	28.7	44.9	13.5	0.6	0.6	2.0	1.0	42.4	2.3	0.7	0.8	35.5	2.4	1.0	0.8	2.6	1.3	13.9	6.6	16.1	5.4	10.8	15.5	5.0	14.2	46.3	2.6	12.0	10.7	20.0	0.0	0.3	6.8	24.6	6.1	36.4	27.5	0.0	0.3	0.0	0.0	2.6	0.6	0.0	0.1	0.0	0.2	0.0	22.6	7.7	0.7	4.4	1.9	1.0	1.8	0.0	0.5	0.0	0.3	0.8	3.6	0.0	0.3	0.9	0.0	0.0	0.0	7.3	0.0	23.6	0.0	0.0	1.4	0.2	0.6	0.4	1.9	0.0	0.2	29.4	0.0	0.0	0.0	3.1	0.0	0.0	3.5	2.7	9.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.8	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.6	0.5	0.6	0.8	0.6	0.6	0.7	0.8	1.3	0.0
MAMDC4	"AEGP, DKFZp434M1411"	ENSG00000177943	"MAM domain containing 4"	Q6UXC1	9	136850943-136860799	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.9;liver: 48.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 18.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	10	"cerebellum: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB026377, HPA059977"			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB026377: , HPA059977: "	"unprognostic (2.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (4.09e-3)"	"unprognostic (6.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.37e-2)"	"prognostic favourable (1.88e-6)"	"unprognostic (8.22e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.22e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	2.0	1.6	1.2	1.9	1.5	1.4	1.2	14.9	1.2	1.2	2.3	1.2	1.2	5.0	1.2	1.2	1.2	1.7	1.2	1.6	1.2	0.4	2.6	48.9	1.2	2.5	1.2	1.2	1.2	3.4	0.5	7.2	1.2	1.2	3.2	0.9	1.2	3.5	1.4	1.7	1.5	6.1	1.2	1.2	5.1	2.3	6.5	1.2	1.2	5.1	1.2	1.2	1.2	1.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	1.5	2.5	1.4	2.8	0.6	0.1	18.5	2.7	0.3	0.3	0.6	2.0	1.6	1.3	0.6	0.7	2.2	0.3	1.3	0.0	2.0	0.9	0.8	5.2	2.2	1.2	0.1	4.8	0.8	1.7	1.4	0.6	0.6	2.6	1.2	0.2	4.1	0.9	3.6	1.4	0.7	1.6	0.4	2.4	0.9	1.3	1.6	2.0	0.5	1.2	1.1	4.3	0.8	0.8	7.5	4.7	1.5	0.4	3.1	1.6	0.4	1.7	1.9	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.5	14.9	1.2	1.2	0.4	1.2	1.2	1.2	1.2
MAMSTR	"FLJ36070, MASTR"	ENSG00000176909	"MEF2 activating motif and SAP domain containing transcriptional regulator"	Q6ZN01	19	48712742-48719721	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 53.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 7.5;RH-30: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049765			Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA049765: "	"unprognostic (6.00e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.50e-3)"	"unprognostic (4.34e-4)"	"unprognostic (2.11e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.39e-2)"	2.4	14.7	1.8	1.0	1.9	0.5	0.9	8.0	4.3	7.9	1.0	2.2	1.1	0.7	13.5	3.5	2.7	4.8	1.0	2.7	1.6	1.0	0.7	0.4	0.9	0.7	1.0	4.3	9.5	1.0	2.7	2.7	1.4	0.7	4.7	0.8	3.3	1.5	1.7	53.9	1.7	0.9	3.6	0.8	2.9	0.7	7.7	1.1	0.0	0.9	9.2	1.1	1.4	2.4	4.1	2.9	1.1	0.9	0.7	4.0	0.6	0.6	1.4	1.5	3.8	2.9	5.1	1.5	5.0	4.0	2.5	3.9	1.4	0.9	0.7	0.3	4.7	1.1	0.2	0.9	1.0	0.5	1.7	0.3	0.5	7.5	1.5	0.1	1.0	3.1	1.0	3.5	0.5	0.9	0.3	0.9	1.6	0.6	1.2	0.6	0.1	1.1	1.4	17.9	0.4	0.3	0.3	1.6	3.0	0.8	0.3	0.3	0.5	0.0	0.3	5.1	0.9	4.1	0.7	1.1	0.7	0.5	1.9	0.6	0.9	0.0	0.5	1.1	3.9	0.9	2.5	3.1	4.0	3.8	1.0	4.1	4.0	3.5	0.4	0.7	0.9	2.9	1.7	0.6	1.8	1.9	8.0	4.3	1.6	1.0	1.0	4.3	0.7	1.1
MAN2A2	"HsT19662, MANA2X"	ENSG00000196547	"Mannosidase alpha class 2A member 2"	P49641	15	90902218-90922584	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.4;neutrophil: 10.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077930			Approved	"Cytoplasmic bodies"			30000000	"Cytoplasmic bodies"		"HPA077930: "	"unprognostic (5.17e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavourable (8.95e-4)"	"unprognostic (7.55e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.33e-2)"	17.8	12.1	15.9	11.5	24.3	58.1	17.3	33.7	31.2	7.2	9.9	52.4	6.3	12.0	8.9	9.8	7.6	8.0	9.4	22.7	17.8	14.0	8.1	16.7	13.3	12.4	31.6	19.7	9.7	24.0	13.0	15.2	12.4	31.0	9.2	9.0	17.2	20.6	12.6	41.8	14.8	13.0	7.6	33.1	19.1	12.4	12.7	28.3	3.8	13.8	2.7	9.1	7.5	10.7	1.5	2.1	10.0	3.2	0.1	1.4	1.5	5.7	5.9	4.2	10.0	12.7	3.4	8.2	4.2	3.9	4.4	3.4	4.8	4.3	0.8	10.4	4.9	6.5	4.4	2.4	2.7	14.2	10.4	39.2	9.0	3.2	4.2	5.7	21.3	2.5	4.6	5.3	4.3	5.7	14.7	5.1	2.0	7.8	3.7	11.3	1.4	1.8	5.1	4.0	6.0	5.5	13.8	10.2	5.9	5.8	10.9	8.2	5.1	18.7	4.9	3.6	3.9	4.4	5.5	8.0	24.4	2.1	4.2	8.3	6.1	8.4	1.6	0.6	1.4	1.1	0.9	1.0	0.6	0.8	0.3	1.5	0.4	0.4	10.0	0.1	3.2	2.1	1.3	1.5	15.9	24.3	33.7	31.2	17.8	14.0	31.6	19.7	31.0	28.3
MANBA		ENSG00000109323	"Mannosidase beta"	O00462	4	102630770-102760994	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053478	Approved		Supported	Vesicles	"Intracellular and membrane"		12000000	Vesicles		"HPA053478: "	"unprognostic (2.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (7.56e-5)"	"unprognostic (4.11e-2)"	"prognostic unfavourable (3.74e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.13e-1)"	12.7	23.5	8.5	12.2	11.9	8.6	17.1	13.4	8.4	12.1	9.9	12.9	11.7	8.1	11.6	13.6	9.3	11.0	15.5	12.1	8.7	8.6	11.8	10.3	17.7	20.2	15.1	6.2	16.7	18.1	25.1	18.4	25.0	10.8	12.0	10.8	12.4	27.4	11.4	5.4	7.8	14.0	14.2	15.3	21.3	14.4	4.6	13.5	9.4	19.2	3.6	12.8	17.9	12.6	3.9	9.5	25.2	11.6	3.6	3.1	3.9	7.3	4.1	2.0	1.9	39.0	18.1	5.1	5.1	10.1	2.2	4.4	5.3	8.5	7.9	6.9	7.1	3.5	5.2	11.3	1.8	5.5	2.1	4.5	4.6	8.1	11.9	8.3	20.5	15.4	19.3	9.5	7.9	4.1	7.5	8.2	8.0	3.3	2.0	8.0	2.8	3.4	4.1	4.7	2.2	6.4	8.7	1.3	1.0	6.1	10.5	7.9	15.0	5.7	3.1	6.1	3.0	13.6	2.7	4.3	9.0	0.8	11.0	3.7	4.4	6.2	11.5	25.2	1.8	10.6	1.4	3.8	3.1	2.0	9.5	3.9	3.0	2.0	10.1	3.6	11.6	2.3	1.6	3.9	8.5	11.9	13.4	8.4	8.7	8.6	15.1	6.2	10.8	13.5
MANEAL	FLJ31434	ENSG00000185090	"Mannosidase endo-alpha like"	Q5VSG8	1	37793802-37801137	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.6"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063423			Approved	"Golgi apparatus"	"Intracellular and membrane"		24000	"Golgi apparatus"		"HPA063423: "	"unprognostic (8.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.92e-2)"	"prognostic favourable (5.28e-4)"	"prognostic unfavourable (3.32e-4)"	"unprognostic (3.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.29e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.26e-1)"	1.6	9.5	12.3	2.6	15.2	0.4	6.4	11.2	21.7	4.1	7.6	6.6	2.4	4.5	2.6	8.8	4.8	3.8	2.4	1.5	12.0	20.3	3.8	11.4	3.9	1.5	10.4	9.6	1.8	12.8	6.2	16.2	1.3	15.4	5.6	8.2	4.1	4.4	3.8	4.6	5.2	4.4	3.1	6.2	1.9	6.3	3.5	3.8	0.8	7.3	1.8	2.4	2.7	2.1	0.6	0.3	0.1	0.4	0.0	3.6	0.6	8.0	10.3	1.8	19.9	2.6	0.9	18.0	1.5	9.0	7.8	3.3	17.0	19.1	13.4	6.7	1.0	1.8	3.8	2.0	2.8	15.8	8.1	9.9	9.3	13.6	0.2	14.1	8.2	0.3	10.7	0.4	0.3	0.2	5.7	10.7	1.2	15.8	3.9	0.0	6.3	10.9	6.1	13.7	15.6	4.5	21.4	49.4	14.9	21.6	0.7	8.0	9.5	1.5	1.2	11.0	6.7	10.6	13.8	15.4	14.6	4.4	1.8	4.6	8.1	0.0	0.0	0.0	1.5	0.1	3.6	0.6	0.7	0.8	0.0	0.6	0.0	1.2	0.1	0.0	0.4	0.3	0.6	0.6	12.3	15.2	11.2	21.7	12.0	20.3	10.4	9.6	15.4	3.8
MANSC1	"FLJ10298, LOH12CR3"	ENSG00000111261	"MANSC domain containing 1"	Q9H8J5	12	12326056-12350541	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 29.9;RPTEC TERT1: 15.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	24	"neutrophil: 37.5"	"Lineage enriched"	"Detected in many"	36	"granulocytes: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007955, HPA007956"	Approved		Approved	"Golgi apparatus,Vesicles"			28000000	"Golgi apparatus, Vesicles"		"HPA007955: AB_1079306, HPA007956: AB_1079305"	"unprognostic (5.41e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.46e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.03e-1)"	"prognostic favourable (3.30e-5)"	"unprognostic (1.15e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.03e-2)"	13.1	8.8	9.7	5.1	13.7	4.2	14.7	10.1	18.4	13.5	17.8	7.5	12.9	13.4	15.1	14.1	27.3	11.2	19.3	7.9	9.2	7.6	9.5	7.6	8.4	6.6	6.9	9.0	11.3	26.4	18.5	19.5	11.0	9.0	15.0	18.5	12.8	42.6	15.2	3.6	13.3	13.3	14.4	5.8	8.4	21.3	9.1	6.2	0.0	9.5	16.7	18.2	12.6	12.9	0.2	0.2	37.5	0.5	0.2	1.0	0.1	0.2	3.3	1.0	0.0	3.4	3.3	3.6	2.3	2.7	1.2	1.5	2.7	10.7	0.0	2.5	2.2	0.4	4.2	1.9	0.9	0.0	3.8	4.7	4.1	2.2	0.6	0.7	1.4	2.1	3.1	0.7	0.5	29.9	3.0	0.0	0.4	6.2	0.0	0.3	3.7	1.8	0.1	0.0	0.1	15.5	10.9	1.4	5.9	1.2	10.0	3.4	9.0	3.0	11.7	1.7	1.4	0.4	3.1	0.2	0.1	1.6	1.2	0.0	1.2	1.5	0.5	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.2	1.0	0.1	37.5	0.2	0.1	0.0	0.0	0.1	9.7	13.7	10.1	18.4	9.2	7.6	6.9	9.0	9.0	6.2
MAP1LC3B2	ATG8G	ENSG00000258102	"Microtubule associated protein 1 light chain 3 beta 2"	A6NCE7	12	116548105-116576448	"Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"blood: 33.1"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 11.1"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042824, HPA052474, HPA052484, HPA053767"	Uncertain		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA042824: , HPA052474: , HPA052484: , HPA053767: "	"unprognostic (1.50e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.43e-3)"	"unprognostic (3.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-3)"	"unprognostic (6.66e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.42e-1)"	0.4	3.5	0.4	0.4	0.4	2.0	0.4	0.4	1.8	0.4	0.7	0.4	0.4	2.2	1.0	0.4	0.5	0.0	0.4	0.4	0.4		0.5	0.4	0.4	0.4	0.4	0.4	0.4	0.9	0.0	0.4	0.4	2.6	0.4	0.2	0.4	0.8	0.4	3.9	1.1	0.8	0.6	0.4	0.4	0.5	0.4	0.4	0.4	0.4	0.4	0.5	0.7	0.4	7.0	8.0	33.1	10.1	7.2	11.4	8.5	2.6	0.0	0.7	2.9	0.4	1.4	1.6	3.0	0.6	0.2	0.4	3.7	2.6	0.1	3.7	0.7	1.6	1.1	0.8	1.2	0.7	0.0	0.0	0.6	3.1	2.3	1.9	1.8	0.4	1.0	2.3	1.9	0.5	1.6	4.7	0.7	0.9	1.4	2.9	1.6	0.7	2.0	0.4	0.6	0.4	1.4	0.9	4.3	1.2	1.1	11.1	1.5	0.2	0.9	4.0	1.1	3.5	2.6	3.8	2.9	4.6	4.7	1.2	2.4	22.7	9.3	25.1	6.6	8.9	6.2	7.0	7.4	6.3	7.7	6.1	5.1	5.6	33.1	7.2	10.1	8.0	11.4	8.5										
MAP3K19	"FLJ23074, RCK, YSK4"	ENSG00000176601	"Mitogen-activated protein kinase kinase kinase 19"	Q56UN5	2	134964491-135047468	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 18.3;fallopian tube: 23.9"	"Group enriched"	"Detected in some"	5	"RPMI-8226: 4.0;U-266/70: 2.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.8"	"Region enhanced"	"Detected in many"		"pons and medulla: 18.3"	"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 20.2"	HPA011388			Uncertain	Cytosol				Cytosol		"HPA011388: AB_1848822"	"unprognostic (7.12e-3)"	"unprognostic (6.55e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.63e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.04e-6)"	"unprognostic (1.50e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.83e-4)"	0.1	0.2	1.7	0.2	6.2	0.1	0.1	0.0	0.5	1.1	0.2	7.3	0.0	0.2	1.0	6.7	0.2	23.9	0.1	0.1	2.9	3.8	0.2	0.2	5.6	0.2	0.5	1.5	7.3	0.1	0.1	1.0	0.1	18.3	0.3	0.2	0.0	0.2	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.2	7.6	3.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.0	4.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.7	6.2	0.0	0.5	2.9	3.8	0.5	1.5	18.3	3.1
MARCH4	"KIAA1399, MARCH-IV, RNF174"	ENSG00000144583	"Membrane associated ring-CH-type finger 4"	Q9P2E8	2	216257865-216372027	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 16.6;pituitary gland: 13.1"	"Cell line enhanced"	"Detected in many"		"BJ: 33.3;fHDF/TERT166: 21.2;TIME: 15.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014348	Approved									"HPA014348: AB_1853578"	"unprognostic (4.84e-2)"	"unprognostic (1.02e-4)"	"unprognostic (1.63e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.49e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.81e-5)"	"unprognostic (4.82e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.09e-3)"	0.7	2.9	7.0	0.7	11.9	0.7	0.6	1.0	16.6	0.6	1.1	0.3	0.0	1.5	0.7	0.7	0.6	2.5	0.6	0.6	5.8	5.6	0.6	0.6	0.8	0.6	2.0	4.8	0.6	1.5	0.6	13.1	3.1	3.4	0.7	1.2	0.1	0.6	0.6	0.6	0.7	1.4	0.6	1.6	0.6	5.1	0.7	1.1	0.0	0.6	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	5.5	1.2	0.0	0.0	0.1	0.8	0.0	33.3	11.4	7.2	2.5	0.0	0.5	0.0	5.2	21.2	0.0	0.0	13.1	7.1	0.0	0.0	2.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	6.5	9.9	9.3	0.0	0.0	11.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.9	0.0	0.0	0.0	0.0	0.0	15.6	11.2	11.6	0.0	8.9	0.0	0.0	0.0	2.5	0.0	7.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.0	11.9	1.0	16.6	5.8	5.6	2.0	4.8	3.4	1.1
MARVELD3	MRVLDC3	ENSG00000140832	"MARVEL domain containing 3"	Q96A59	16	71626161-71642114	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.9;pancreas: 34.5"	"Cell line enhanced"	"Detected in some"		"A-431: 11.5;BEWO: 17.3;CACO-2: 12.8;CAPAN-2: 12.4;HaCaT: 11.7;MCF7: 21.8;RT4: 10.2;SK-BR-3: 10.3;T-47d: 14.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043514, HPA045471"			Approved	"Vesicles,Intermediate filaments"				Vesicles	"Intermediate filaments"	"HPA043514: AB_10959475, HPA045471: "	"unprognostic (1.18e-1)"	"unprognostic (3.92e-1)"	"unprognostic (9.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.16e-2)"	"prognostic favourable (6.80e-10)"	"unprognostic (2.63e-3)"	"unprognostic (4.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.43e-1)"	0.4	0.3	0.4	12.5	0.3	0.0	5.0	0.7	1.2	2.0	35.7	0.3	5.2	17.3	1.3	8.6	4.1	2.1	15.4	0.5	0.5	0.4	14.2	4.3	3.3	0.5	0.3	0.1	1.0	34.5	5.4	1.2	5.3	2.4	6.5	10.5	2.4	10.4	4.3	0.3	3.0	52.9	0.7	0.4	0.4	2.1	1.2	0.1	1.3	8.3	2.3	4.6	3.0	3.4	1.5	1.4	4.1	0.8	1.5	0.8	0.2	11.5	0.4	0.2	0.5	0.0	0.1	17.3	0.0	0.0	0.0	0.0	12.8	12.4	0.1	1.3	0.0	11.7	1.0	5.6	0.0	0.0	6.7	0.0	0.1	3.3	0.0	0.1	0.1	0.5	7.0	0.0	0.1	0.0	0.2	0.1	0.0	21.8	0.1	0.2	1.9	0.1	0.0	0.0	4.6	0.2	10.2	2.1	0.1	0.2	10.3	0.0	14.6	0.2	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	4.1	0.8	0.8	0.7	0.5	0.4	0.8	0.8	0.6	0.3	1.5	0.7	0.7	4.0	1.5	0.5	1.4	0.7	0.2	0.4	0.3	0.7	0.5	0.5	0.4	0.3	0.1	2.4	0.1
MAS1L	"dJ994E9.2, MAS-L, MRG"	ENSG00000204687	"MAS1 proto-oncogene like, G protein-coupled receptor"	P35410	6	29486697-29487956	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 7.5;epididymis: 4.0"	"Cell line enriched"	"Detected in single"	39	"HEL: 3.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA017983	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA017983: AB_1849332"	"unprognostic (3.66e-2)"										"unprognostic (2.51e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.65e-1)"				2.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	7.5	1.3			0.4	1.2	4.0	2.1	0.2	1.2	0.4	0.0	0.0	0.1	0.1	0.3	0.1	0.0		0.0	0.1	0.0	0.0	0.0		0.8	1.1		1.5	0.3	0.2	1.7	1.5	1.1	0.0	0.0	0.5	0.3			0.0		0.5	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MBD3L2		ENSG00000230522	"Methyl-CpG binding domain protein 3 like 2"	Q8NHZ7	19	7049321-7051735	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"testis: 1.8"	"Cell line enriched"	"Detected in single"	29	"U-2 OS: 2.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051259	Uncertain									"HPA051259: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.6		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MBOAT2	"FLJ14415, FLJ90298, OACT2"	ENSG00000143797	"Membrane bound O-acyltransferase domain containing 2"	Q6ZWT7	2	8852690-9003813	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 34.7"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 25.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 6.3;eosinophil: 2.8;neutrophil: 6.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014836	Uncertain		Approved	Vesicles				Vesicles		"HPA014836: AB_1854745"	"unprognostic (2.49e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (2.13e-9)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.97e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.66e-2)"	"prognostic unfavourable (5.32e-4)"	2.3	2.9	12.8	2.9	18.0	24.2	10.1	10.1	20.2	6.0	8.2	16.6	1.2	3.1	5.3	3.5	14.2	3.7	4.3	5.1	14.7	12.4	8.0	1.3	10.9	2.9	23.3	10.3	6.8	2.1	34.7	5.5	3.8	16.2	16.1	9.3	6.4	5.6	4.1	1.2	12.3	4.3	4.6	18.5	2.5	6.9	2.7	17.8	1.9	5.3	16.1	10.3	4.4	7.5	0.0	0.8	6.7	0.7	0.0	0.2	0.3	8.3	2.5	7.8	3.3	3.5	7.9	4.6	4.0	1.4	5.2	3.5	0.7	13.3	2.4	4.8	9.5	6.4	6.9	8.1	7.9	7.4	11.9	10.0	3.7	0.0	4.4	0.0	3.2	5.7	4.8	5.0	3.4	2.7	8.5	1.9	4.5	2.1	2.9	0.2	3.1	9.9	4.4	12.3	0.1	7.7	1.2	4.7	14.3	4.2	25.1	3.9	4.7	2.8	1.5	9.2	4.9	7.1	11.4	0.7	0.2	2.6	14.5	1.4	3.1	6.3	0.7	2.8	0.0	0.2	0.0	0.0	0.2	0.1	0.8	0.0	0.2	0.1	6.7	0.0	0.2	0.1	0.0	0.3	12.8	18.0	10.1	15.8	14.7	12.4	23.3	10.3	16.2	17.8
MCF2L2	"ARHGEF22, KIAA0861"	ENSG00000053524	"MCF.2 cell line derived transforming sequence-like 2"	Q86YR7	3	183178043-183428778	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.4;brain: 23.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 9.2;Karpas-707: 8.1;REH: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"T-reg: 4.6"	"Lineage enriched"	"Detected in single"	8	"T-cells: 4.6"					"Low region specificity"	"Detected in all"			"HPA038946, HPA038947"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038946: AB_10670914, HPA038947: AB_10672655"	"unprognostic (2.17e-2)"	"unprognostic (4.42e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.80e-4)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.09e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.78e-1)"	0.9	16.4	12.8	1.4	14.9	1.1	1.1	11.3	23.7	1.3	1.4	3.6	0.0	0.9	1.3	1.3	1.3	1.0	1.5	1.1	12.2	7.6	1.4	0.8	1.2	1.7	5.6	13.0	1.2	1.2	10.5	8.9	0.8	7.3	2.1	1.4	7.5	0.8	1.6	1.4	1.0	1.2	1.4	4.5	5.3	1.2	5.5	4.3	0.0	0.9	0.0	2.1	1.6	0.4	0.1	0.0	0.6	0.0	0.1	4.6	0.2	0.1	0.6	0.2	1.7	0.1	0.2	0.4	0.0	0.1	0.3	0.0	1.2	0.2	1.5	0.2	0.1	0.0	0.3	0.2	0.1	9.2	1.4	3.9	0.3	0.0	0.3	1.2	0.8	0.3	0.0	0.0	0.6	0.7	1.2	8.1	0.4	1.2	1.2	0.8	1.3	1.6	5.3	0.0	1.5	0.4	0.1	2.5	0.9	1.0	0.0	2.0	0.5	0.8	0.6	0.0	0.9	0.1	0.1	3.2	3.4	1.7	0.8	1.4	0.1	0.1	0.0	0.1	0.4	0.0	1.0	0.0	1.0	0.6	0.0	0.1	0.0	0.9	0.6	0.1	0.0	0.0	4.6	0.2	12.8	14.9	11.3	23.7	12.2	7.6	5.6	13.0	7.3	4.3
MCTP1	FLJ22344	ENSG00000175471	"Multiple C2 and transmembrane domain containing 1"	Q6DN14	5	94703741-95284575	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 49.2;brain: 42.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 20.7;Karpas-707: 28.3;RPMI-8226: 28.0;RPTEC TERT1: 21.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	41	"basophil: 11.5;classical monocyte: 12.9;eosinophil: 5.8;intermediate monocyte: 19.2;myeloid DC: 10.1;neutrophil: 18.7;non-classical monocyte: 17.6;plasmacytoid DC: 5.3"	"Group enriched"	"Detected in many"	52	"dendritic cells: 10.1;granulocytes: 18.7;monocytes: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019018			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA019018: AB_1853665"	"unprognostic (1.20e-2)"	"unprognostic (6.70e-4)"	"unprognostic (1.77e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.99e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.91e-6)"	"unprognostic (5.38e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.43e-2)"	49.2	2.7	6.5	11.4	42.4	36.9	18.3	18.3	16.5	6.9	7.2	0.3	4.4	5.0	11.1	9.2	6.5	4.1	16.7	4.6	8.5	7.4	3.0	3.8	11.3	5.5	4.1	3.8	3.3	3.4	3.1	5.2	7.1	3.9	5.9	7.3	1.0	4.3	2.7	5.1	4.5	4.8	10.9	5.7	8.2	5.3	4.0	8.1	5.5	5.0	21.2	4.3	17.3	12.6	0.3	10.1	18.7	19.2	0.2	0.2	3.3	0.1	2.0	1.3	0.0	19.9	8.0	0.0	0.1	9.8	0.9	3.2	0.0	5.2	7.2	7.7	0.0	0.0	0.1	0.1	1.1	0.0	1.4	4.3	4.8	0.0	2.6	8.9	5.8	2.9	0.0	3.6	13.1	20.7	0.1	28.3	7.4	0.2	0.5	6.8	1.6	8.2	0.3	0.0	28.0	21.3	11.3	4.0	0.2	0.6	0.0	14.6	0.0	8.4	0.1	3.6	5.6	0.1	1.6	2.0	0.0	0.0	16.9	14.9	3.5	11.5	12.9	5.8	0.0	19.2	0.0	0.3	0.0	0.1	10.1	0.1	0.2	0.0	18.7	0.2	17.6	5.3	0.0	3.3	6.5	42.4	18.3	12.2	8.5	7.4	4.1	3.8	3.9	8.1
MDH1B	"FLJ25341, RP11-95H11"	ENSG00000138400	"Malate dehydrogenase 1B"	Q5I0G3	2	206737763-206765547	"Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.7;testis: 27.6"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 7.1;SCLC-21H: 6.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073761	Approved									"HPA073761: "	"unprognostic (1.03e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.09e-2)"	"unprognostic (7.84e-3)"	"unprognostic (3.01e-1)"	0.9	2.3	3.1	0.7	9.0	0.6	1.9	1.5	5.7	2.0	1.1	5.0	3.6	0.5	2.5	6.6	1.1	26.7	1.5	1.9	3.4	4.2	4.2	0.6	3.6	0.8	2.4	3.5	4.5	1.1	6.3	15.1	0.5	9.5	1.3	1.1	2.8	1.7	2.2	0.9	1.0	0.6	1.5	1.6	0.6	1.1	27.6	1.8	0.1	5.2	0.0	0.7	0.9	0.5	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.7	2.3	1.7	4.9	0.3	2.3	0.7	0.0	0.8	1.0	0.7	0.2	1.6	1.0	1.1	0.2	1.1	0.1	1.4	1.0	0.1	0.1	0.5	0.4	1.5	1.1	0.8	2.5	1.4	0.4	0.1	0.3	1.4	0.1	1.4	0.7	2.9	1.5	0.6	3.1	2.8	3.1	1.8	0.1	7.1	0.3	6.7	1.4	2.1	1.1	0.6	2.1	0.0	0.1	1.2	1.2	0.3	0.6	0.7	2.9	0.4	2.6	0.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	3.1	9.0	1.5	5.7	3.4	4.2	2.4	3.5	9.5	1.8
ME3		ENSG00000151376	"Malic enzyme 3"	Q16798	11	86441108-86672636	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 26.9;HUVEC TERT2: 17.9;TIME: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 5.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038473	Approved									"HPA038473: AB_10672747"	"unprognostic (1.83e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.96e-2)"	"prognostic favourable (3.86e-4)"	17.2	15.9	16.0	6.3	27.7	5.8	13.1	15.7	26.1	19.3	14.3	4.8	7.3	7.8	15.8	7.6	5.0	9.0	12.9	21.9	12.2	13.1	12.6	3.9	8.1	4.3	12.5	18.1	22.1	16.7	28.5	15.4	5.4	20.2	13.0	15.0	11.5	13.6	10.3	21.2	3.0	7.1	15.6	5.5	7.3	20.8	8.8	8.4	2.8	8.2	6.3	2.9	10.3	10.2	0.0	5.0	0.0	0.9	2.2	3.1	1.0	0.0	9.0	2.5	0.0	4.1	8.5	0.0	3.1	4.7	6.4	8.1	6.8	26.9	0.0	2.7	2.8	0.1	0.0	0.0	2.9	4.7	0.0	4.6	7.4	0.0	6.1	0.5	0.0	5.9	1.4	5.1	0.0	17.9	0.1	0.0	4.2	0.9	1.2	0.0	0.6	3.7	3.9	0.0	0.3	5.7	10.5	3.1	0.0	1.9	0.0	0.0	0.4	0.7	19.8	0.8	0.6	13.3	0.4	0.0	1.6	0.0	0.7	8.3	0.8	0.0	0.9	0.0	1.9	0.1	0.0	0.0	1.9	3.1	5.0	0.0	2.3	2.7	0.0	2.2	0.3	0.6	0.0	1.0	16.0	27.7	15.7	26.1	12.2	13.1	12.5	18.1	20.2	8.4
MEGF9	EGFL5	ENSG00000106780	"Multiple EGF like domains 9"	Q9H1U4	9	120600813-120714470	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 19.1;monocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014319, HPA050238"	Approved		Approved	Nucleoplasm,Cytosol			32000000	Nucleoplasm	Cytosol	"HPA014319: AB_1848035, HPA050238: "	"unprognostic (1.18e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.97e-2)"	"prognostic favourable (5.48e-11)"	"unprognostic (1.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.41e-1)"	15.0	9.6	22.4	9.9	21.7	15.4	12.8	27.9	26.2	11.7	6.7	29.3	2.1	6.4	6.1	5.5	12.8	12.8	7.9	6.1	24.6	16.4	12.5	33.8	17.9	7.0	28.6	16.0	9.3	5.4	15.6	6.8	4.8	22.6	8.4	5.8	21.4	7.8	6.6	6.0	19.0	6.5	8.1	21.1	12.9	7.2	3.1	25.8	3.2	25.5	4.6	5.6	11.3	9.6	0.3	2.2	19.1	5.7	0.3	0.6	1.3	2.8	11.3	9.9	3.0	13.8	8.5	3.2	2.9	2.5	0.8	1.1	0.6	1.7	10.6	4.5	2.8	12.4	14.2	5.1	2.1	8.6	4.1	1.4	21.1	4.6	5.9	4.2	9.1	4.0	15.5	4.9	3.9	6.9	3.3	5.1	8.2	8.2	8.3	1.5	0.4	3.0	6.4	11.0	4.5	20.3	9.3	9.8	8.3	3.5	2.8	8.3	8.6	4.3	8.1	3.0	1.7	10.9	4.4	9.3	10.9	3.5	4.2	5.0	16.9	0.4	5.7	3.6	0.6	1.9	0.2	0.3	0.6	0.5	2.2	0.3	0.5	0.4	19.1	0.3	3.0	0.2	0.5	1.3	22.4	21.7	27.9	21.5	24.6	16.4	28.6	16.0	22.6	25.8
MEI1	"MGC40042, SPATA38"	ENSG00000167077	"Meiotic double-stranded break formation protein 1"	Q5TIA1	22	41699499-41799456	"Predicted intracellular proteins, Predicted secreted proteins"	Meiosis		"Disease mutation"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 26.8;lymphoid tissue: 20.3;testis: 34.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 7.8;HMC-1: 6.3;Karpas-707: 20.9;U-266/70: 22.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 5.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	17	"amygdala: 1.6;basal ganglia: 1.7;cerebral cortex: 2.6;hippocampal formation: 1.7;olfactory region: 1.9"	"Low region specificity"	"Detected in many"			HPA049240	Approved				"Secreted in male reproductive system"					"HPA049240: "	"unprognostic (1.95e-3)"	"prognostic favourable (1.59e-6)"	"unprognostic (6.13e-3)"	"unprognostic (1.86e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.96e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.45e-10)"	"unprognostic (2.82e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.39e-2)"	2.1	0.9	1.4	7.7	1.4	12.4	3.1	1.7	3.3	1.6	6.3	0.5	0.9	2.6	0.8	3.6	1.6	1.2	1.9	1.5	1.2	1.8	2.2	1.3	3.5	20.3	1.1	0.4	0.9	1.0	0.0	1.0	1.6	1.6	1.2	3.3	3.3	6.0	1.0	0.7	1.1	6.5	0.6	1.1	15.5	4.5	34.7	0.3	3.8	1.9	1.8	17.1	4.0	1.3	11.0	3.2	7.3	3.7	7.8	26.8	8.8	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	1.6	0.0	0.2	0.4	0.1	0.3	0.4	0.1	0.1	0.0	0.0	0.0	4.9	0.0	1.3	7.8	0.9	1.3	0.9	6.3	0.1	0.1	0.0	0.0	0.3	0.2	20.9	0.0	0.0	0.0	4.6	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.7	0.4	0.0	0.0	0.0	22.2	3.5	0.9	0.3	2.0	0.1	6.2	3.7	7.3	15.8	2.7	15.2	11.0	15.8	13.3	3.2	7.3	11.7	12.8	0.7	7.8	1.1	1.2	26.8	8.8	1.4	1.4	1.7	3.3	1.2	1.8	1.1	0.4	1.6	0.3
MEIOC	"C17orf104, FLJ35848"	ENSG00000180336	"Meiosis specific with coiled-coil domain"	A2RUB1	17	44656404-44690308	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	24	"testis: 59.6"	"Cell line enhanced"	"Detected in some"		"HAP1: 13.4;HMC-1: 20.6;NTERA-2: 7.1;SiHa: 7.5;THP-1: 10.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA027266	Enhanced		Uncertain	"Cell Junctions"				"Cell Junctions"		"HPA027266: AB_1848900"	"unprognostic (5.82e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.63e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.83e-4)"	"unprognostic (1.85e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.91e-3)"	"unprognostic (8.89e-3)"	0.2	0.2	0.4	0.2	0.8	0.6	0.2	2.5	0.9	0.2	0.2	0.2	0.2	0.1	0.2	0.3	0.2	0.0	0.2	0.3	0.7	0.6	1.4	0.3	0.2	0.3	0.4	0.2	0.2	0.2	0.0	0.4	0.2	0.3	0.2	0.0	0.2	0.2	0.2	1.5	0.7	0.2	0.2	0.3	0.2	0.1	59.6	0.2	0.2	0.3	0.2	0.3	0.2	0.2	1.8	1.9	2.2	0.8	0.8	1.0	0.1	0.2	6.2	0.9	1.0	0.2	0.0	0.5	0.8	0.0	0.5	1.7	0.4	0.2	0.7	1.5	0.3	0.2	13.4	0.0	0.2	0.6	5.4	0.5	0.8	0.3	0.0	0.5	20.6	0.0	0.0	0.8	0.0	0.0	0.4	0.6	0.1	1.2	0.4	1.2	7.1	0.6	0.3	0.7	0.4	0.0	0.2	1.5	2.0	7.5	0.2	0.1	0.9	10.2	0.2	0.4	0.2	1.5	0.7	0.5	0.8	0.3	0.5	0.7	1.2	1.9	0.8	0.7	0.9	0.5	0.5	0.9	0.8	0.5	0.2	1.8	1.0	0.9	2.2	0.8	0.6	1.9	0.5	0.1	0.4	0.8	2.5	0.9	0.7	0.6	0.4	0.2	0.3	0.2
MEIS3	"DKFZp547H236, MRG2"	ENSG00000105419	"Meis homeobox 3"	Q99687	19	47403124-47419523	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 35.3;endometrium 1: 28.8"	"Cell line enhanced"	"Detected in many"		"AF22: 27.9;HMC-1: 24.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046699	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA046699: AB_2616456"	"unprognostic (3.27e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.49e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.12e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.76e-2)"	"prognostic unfavourable (1.78e-6)"	"unprognostic (9.29e-3)"	"unprognostic (9.21e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.80e-3)"	5.6	3.9	35.3	4.7	10.6	0.0	5.0	11.0	25.3	8.4	4.7	2.4	3.8	3.5	28.8	2.2	6.0	14.2	6.0	3.7	23.2	11.6	1.5	1.1	3.1	1.2	2.6	14.6	7.4	1.7	1.1	4.9	7.4	3.8	7.0	2.1	4.1	3.6	6.4	1.4	1.6	3.8	22.5	1.7	2.4	2.6	3.3	2.0	0.5	3.4	1.6	1.4	6.1	4.7	0.0	0.2	0.5	0.7	0.0	0.1	0.4	0.3	11.9	27.9	0.1	15.2	13.1	0.4	12.4	19.1	9.7	17.2	1.0	1.9	0.0	1.4	20.4	1.4	2.9	3.4	3.3	18.6	4.2	0.0	4.3	0.1	9.8	0.2	24.2	9.6	0.7	3.8	2.0	0.0	0.2	2.8	1.1	11.3	0.0	0.1	8.1	0.7	0.0	2.0	0.3	0.6	0.8	1.1	22.6	10.7	0.9	5.1	0.6	3.5	0.0	7.5	18.9	5.4	1.6	0.0	0.0	0.0	20.9	1.1	14.9	0.1	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.1	0.4	35.3	10.6	11.0	25.3	23.2	11.6	2.6	14.6	3.8	2.0
MESP1	"bHLHc5, MGC10676"	ENSG00000166823	"Mesoderm posterior bHLH transcription factor 1"	Q9BRJ9	15	89748661-89751310	"Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 14.1;prostate: 10.9"	"Cell line enhanced"	"Detected in some"		"A-431: 5.6;HDLM-2: 4.9;HEK 293: 4.9;PC-3: 9.3;SCLC-21H: 4.3"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 6.3;prostate cancer: 26.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069981			Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA069981: "	"unprognostic (4.17e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.83e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.03e-2)"	14.1	1.6	6.8	1.4	4.3	1.1	3.8	7.3	8.8	2.5	1.9	1.1	0.1	1.3	1.0	1.0	0.9	1.0	2.9	3.9	4.9	5.0	1.3	1.2	1.1	1.1	3.3	4.3	1.0	1.2	1.1	1.1	0.8	2.4	10.9	1.0	1.3	3.0	1.2	7.0	0.9	1.1	0.9	1.4	0.9	1.0	1.4	1.9	0.0	1.0	2.2	0.9	0.9	0.4	0.0	0.1	0.0	0.1	0.0	0.8	0.1	5.6	2.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.3	0.0	2.2	0.0	0.0	0.4	0.0	0.0	4.9	4.9	0.2	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.8	1.4	0.0	9.3	0.2	0.0	1.3	0.1	0.0	4.3	0.1	1.1	1.8	1.1	0.1	0.7	0.0	0.0	0.3	3.4	1.1	2.2	0.7	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.1	6.8	4.3	7.3	8.8	4.9	5.0	3.3	4.3	2.4	1.9
MEST	PEG1	ENSG00000106484	"Mesoderm specific transcript"	Q5EB52	7	130486171-130506465	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 63.8;placenta: 193.5"	"Cell line enriched"	"Detected in many"	6	"AN3-CA: 513.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 18.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005623			Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"			"Golgi apparatus, Cytosol"		"HPA005623: AB_1079364"	"unprognostic (6.14e-2)"	"unprognostic (5.06e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.64e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.36e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.81e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavourable (6.20e-5)"	"unprognostic (7.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.67e-2)"	44.9	26.0	7.8	4.7	12.9	3.4	63.8	2.6	22.7	2.4	7.5	3.4	1.1	7.9	7.3	4.6	2.6	5.2	6.6	3.7	7.9	8.0	6.7	13.7	18.8	4.1	3.3	9.0	7.8	13.0	2.5	15.4	193.5	15.5	4.1	6.1	8.4	7.0	2.5	2.2	2.1	7.2	5.3	3.2	22.4	3.0	10.1	3.3	2.0	4.3	2.5	1.9	4.5	3.7	3.1	6.7	8.6	2.0	2.7	18.8	5.3	3.1	1.7	8.3	513.1	0.1	0.0	0.0	3.5	1.6	3.6	1.7	9.8	4.8	1.5	1.1	0.1	0.4	0.1	0.0	1.4	0.0	0.0	2.7	2.6	1.6	14.1	0.1	0.0	0.2	0.1	2.7	0.0	1.3	3.0	0.0	6.9	4.4	0.3	3.4	5.2	0.8	0.0	92.3	1.0	3.9	2.9	29.2	0.0	3.0	10.0	0.0	0.3	2.3	1.3	1.2	0.0	11.5	0.2	0.1	0.3	0.0	4.4	0.0	0.4	8.6	1.9	6.2	0.7	2.0	1.7	3.1	2.0	1.4	6.7	2.8	7.6	18.8	1.1	2.7	1.2	0.3	0.1	5.3	7.8	12.9	2.6	22.7	7.9	8.0	3.3	9.0	15.5	3.3
METRN	"C16orf23, MGC2601"	ENSG00000103260	"Meteorin, glial cell differentiation regulator"	Q9UJH8	16	715115-719655	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 58.9"	"Cell line enhanced"	"Detected in many"		"MCF7: 52.2;PC-3: 40.4"	"Cancer enhanced"	"Detected in all"		"glioma: 69.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 549.1"	"Low region specificity"	"Detected in many"			HPA051164	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted in brain"			"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA051164: "	"unprognostic (1.60e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (5.03e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.17e-2)"	7.7	14.9	44.7	5.1	58.9	2.6	4.6	14.2	45.4	4.1	7.0	24.1	19.8	5.6	5.3	7.8	3.1	27.4	6.4	12.4	39.6	31.6	10.5	8.5	6.0	4.2	45.7	15.1	2.7	43.1	5.2	15.1	5.3	15.3	7.4	2.5	9.2	27.3	16.8	21.5	3.9	5.9	4.4	39.5	5.4	8.3	4.6	19.0	2.5	6.6	3.4	3.0	3.9	5.0	3.2	0.9	0.8	1.0	1.7	2.9	0.5	2.6	22.1	4.3	22.0	7.7	4.3	7.0	5.2	2.6	2.1	1.3	3.2	6.5	0.4	12.3	3.7	9.7	0.6	5.1	0.3	1.4	9.7	0.8	4.0	16.6	4.7	1.8	2.8	10.4	5.6	0.6	1.3	0.7	1.5	0.5	1.5	52.2	0.7	6.4	1.6	40.4	7.1	5.0	7.1	5.4	0.7	6.9	8.7	2.1	5.8	26.8	8.7	3.7	2.4	6.0	11.4	6.9	4.5	3.3	0.9	0.4	9.4	1.4	14.1	0.0	0.3	0.8	2.9	1.0	1.7	3.2	1.5	2.7	0.2	0.5	0.9	1.9	0.0	1.7	1.0	0.9	2.8	0.5	44.7	58.9	14.2	27.4	39.6	31.6	45.7	15.1	15.3	19.0
METRNL		ENSG00000176845	"Meteorin like, glial cell differentiation regulator"	Q641Q3	17	83079691-83095119	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 39.8;U-2197: 53.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023792	Uncertain				"Secreted to blood"	444843				"HPA023792: AB_2144182"	"unprognostic (7.99e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.41e-3)"	"unprognostic (7.35e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.50e-3)"	"unprognostic (4.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.61e-2)"	21.8	4.0	3.7	13.3	4.0	16.9	19.9	3.4	4.8	20.4	18.8	4.2	8.8	25.9	7.5	12.7	37.0	8.5	13.3	29.4	3.7	2.9	15.6	4.4	19.4	9.7	3.1	2.8	11.4	17.7	16.0	8.2	27.9	8.0	10.1	4.6	15.6	15.3	8.5	10.3	52.3	21.8	13.3	4.1	13.9	13.5	8.8	3.3	2.5	25.3	23.3	18.0	20.5	26.3	1.2	4.8	10.8	7.8	3.2	2.1	1.4	3.8	0.1	1.9	2.3	2.1	7.8	8.8	4.1	1.8	3.0	3.3	0.4	2.8	0.2	1.6	3.1	9.5	0.6	0.2	1.9	2.7	1.4	8.5	10.6	1.0	5.1	2.6	16.3	3.7	0.8	11.9	0.8	1.5	5.3	0.0	2.5	6.0	0.2	7.9	0.3	5.2	2.6	3.7	1.2	0.4	1.5	0.1	1.2	5.7	10.1	4.4	8.9	2.8	3.5	39.8	4.5	53.5	1.2	0.0	0.0	0.1	9.3	1.1	2.4	6.5	3.6	10.8	2.1	6.2	0.1	1.2	0.4	1.4	4.8	0.2	0.0	0.6	6.1	3.2	7.8	1.8	1.8	1.4	3.7	4.0	3.4	4.8	3.7	2.9	3.1	2.8	8.0	3.3
METTL24	"C6orf186, dJ71D21.2"	ENSG00000053328	"Methyltransferase like 24"	Q5JXM2	6	110245928-110358272	"Predicted secreted proteins"		"Methyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 2.8;fHDF/TERT166: 2.7;HHSteC: 3.2;SCLC-21H: 4.8;SH-SY5Y: 2.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.3"	"Lineage enriched"	"Detected in single"	34	"T-cells: 7.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037441, HPA037442"	Uncertain				"Secreted - unknown location"					"HPA037441: AB_10670933, HPA037442: AB_10696931"	"unprognostic (6.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.31e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.54e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.78e-3)"	2.1	1.9	2.4	3.7	2.8	0.0	1.8	2.8	2.1	11.9	10.8	2.9	4.8	1.5	16.2	5.0	5.6	7.0	9.6	3.2	2.1	1.9	5.2	1.1	2.4	0.6	2.1	2.7	9.2	2.3	5.8	4.6	0.3	2.2	8.6	5.0	10.2	1.1	8.6	0.4	1.1	4.0	16.1	2.8	0.6	6.0	2.8	1.5	0.6	2.1	3.0	1.5	13.3	5.1	0.0	0.1	0.0	0.0	0.2	7.3	0.1	0.0	0.0	2.8	0.1	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.8	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	7.3	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	2.4	2.8	2.8	2.1	2.1	1.9	2.1	2.7	2.2	1.5
METTL25	"C12orf26, FLJ22789"	ENSG00000127720	"Methyltransferase like 25"	Q8N6Q8	12	82358497-82479236	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039534, HPA041207"	Uncertain		Uncertain	"Plasma membrane,Mitochondria,Cytosol"				"Plasma membrane, Mitochondria, Cytosol"		"HPA039534: AB_10794749, HPA041207: AB_10794406"	"unprognostic (1.60e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.20e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.00e-3)"	"unprognostic (2.15e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.44e-2)"	8.3	9.2	8.7	8.5	8.1	5.0	11.1	23.6	8.3	8.2	7.7	8.1	9.0	7.5	8.2	9.1	10.0	8.0	5.8	8.7	9.1	3.1	8.8	6.3	6.5	8.1	7.6	5.7	10.8	6.5	7.8	25.9	6.8	7.6	8.0	9.2	5.8	10.5	6.0	10.7	9.7	8.2	7.5	5.8	8.6	6.7	11.0	13.0	9.9	10.2	8.7	7.4	8.8	8.5	7.9	13.2	14.4	7.6	9.8	7.6	3.8	1.4	3.3	4.5	0.9	5.1	6.0	4.5	7.0	4.0	3.7	2.7	4.3	3.8	8.5	1.5	5.1	1.5	8.8	1.1	2.4	8.1	7.5	4.1	1.8	4.0	3.1	7.1	4.9	4.4	4.1	1.2	0.0	7.6	3.0	3.8	3.7	4.9	3.0	6.3	6.8	1.0	1.7	2.7	4.4	11.4	5.1	3.3	2.6	2.5	4.2	4.4	3.7	6.8	2.8	1.7	1.6	2.8	3.9	4.9	2.9	3.2	2.8	4.4	3.9	14.4	7.6	4.4	4.9	6.4	7.3	6.4	5.3	4.0	6.0	7.9	7.6	5.4	13.6	9.8	5.7	13.2	4.5	3.8	8.7	8.1	23.6	8.3	9.1	3.1	7.6	5.7	7.6	13.0
METTL4	"FLJ23017, HsT661"	ENSG00000101574	"Methyltransferase like 4"	Q8N3J2	18	2537525-2571509	"Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA040061, HPA046734"	Approved		Approved	Mitochondria				Mitochondria		"HPA040061: AB_10697713, HPA046734: "	"unprognostic (1.85e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.12e-5)"	"unprognostic (1.74e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.72e-2)"	"unprognostic (3.26e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-3)"	13.2	8.9	10.1	13.5	15.7	6.1	15.8	18.4	15.6	13.5	10.6	8.6	15.7	9.7	14.0	12.3	11.9	11.1	10.9	9.9	10.1	11.8	10.5	9.2	11.2	19.9	15.9	8.5	13.9	8.6	16.3	23.6	10.4	14.2	12.9	12.7	10.1	17.7	15.6	6.4	11.0	14.6	12.6	17.3	19.9	10.0	12.4	15.8	15.3	16.2	7.2	19.5	13.8	16.8	7.5	3.5	14.4	2.5	5.6	9.4	4.8	7.6	3.3	10.6	6.3	4.8	7.4	12.2	12.1	11.0	12.6	12.5	6.7	5.8	16.2	7.6	5.6	6.8	17.0	6.4	16.3	11.6	5.8	6.2	6.7	5.7	7.4	14.3	8.2	4.8	14.5	12.9	8.3	13.0	8.6	20.3	10.8	3.8	10.7	4.7	6.1	5.5	7.3	8.4	11.1	7.4	4.8	19.0	8.7	9.6	6.6	12.6	7.5	9.9	8.4	14.5	18.2	14.0	17.2	10.1	25.9	9.4	9.7	10.1	16.7	14.4	2.5	6.5	6.6	2.3	8.0	6.8	7.6	8.6	1.9	7.5	9.4	8.6	10.1	5.6	2.0	3.5	8.4	4.8	10.1	15.7	18.4	15.6	10.1	11.8	15.9	8.5	14.2	15.8
METTL6	MGC24132	ENSG00000206562	"Methyltransferase like 6"	Q8TCB7	3	15381275-15440566	"Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035166	Uncertain		Approved	Vesicles				Vesicles		"HPA035166: AB_10602709"	"unprognostic (2.73e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (2.66e-6)"	"unprognostic (3.98e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.46e-1)"	8.6	9.6	19.4	8.6	19.3	5.0	11.7	18.4	18.9	11.7	7.1	16.8	6.2	7.1	10.7	10.6	10.0	11.5	7.7	9.3	13.1	14.3	8.4	7.9	7.8	10.3	13.3	9.6	14.8	10.7	12.5	17.9	11.0	13.7	10.6	8.7	12.0	7.5	11.3	7.8	8.8	6.4	12.4	14.2	8.7	7.8	20.2	11.3	11.8	11.8	3.8	12.0	9.0	8.3	14.1	16.5	15.7	14.0	14.2	14.5	9.4	7.9	13.1	14.3	12.4	12.9	15.1	38.4	14.5	15.9	19.4	19.5	8.3	10.7	13.5	9.5	14.2	6.7	14.9	12.6	19.9	9.4	16.6	13.1	12.9	11.8	25.9	12.4	11.3	13.2	16.3	22.9	10.5	16.6	13.5	13.7	18.9	17.8	13.0	9.7	15.9	16.7	10.0	18.5	13.2	11.1	11.4	6.3	11.5	12.4	12.3	11.8	17.8	10.8	10.7	14.0	8.9	13.6	13.1	14.7	24.8	16.4	14.6	12.1	13.0	9.0	11.1	15.7	13.8	14.0	13.4	10.6	13.1	13.5	12.3	14.1	13.4	14.5	6.7	14.2	13.0	16.5	11.9	9.4	19.4	19.3	18.4	18.9	13.1	14.3	13.3	9.6	13.7	11.3
METTL8	"FLJ13984, TIP"	ENSG00000123600	"Methyltransferase like 8"	Q9H825	2	171317405-171434802	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035421	Uncertain		Approved	Cytosol				Cytosol		"HPA035421: AB_10670116"	"unprognostic (3.13e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.92e-2)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (1.76e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.43e-4)"	"unprognostic (2.94e-3)"	"unprognostic (7.29e-2)"	"unprognostic (6.52e-3)"	"unprognostic (4.83e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (6.75e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.59e-3)"	10.8	8.0	7.4	8.4	9.6	6.8	8.8	6.2	8.5	9.4	12.6	10.4	9.2	4.6	8.4	6.3	21.0	5.9	7.2	6.7	8.7	6.4	8.6	8.6	5.5	6.0	13.2	4.5	6.4	8.1	6.1	5.0	7.8	10.9	10.9	14.1	5.2	6.2	11.6	6.9	15.1	8.2	20.5	12.5	7.8	6.3	11.2	10.1	4.0	4.7	13.5	8.9	13.7	10.3	6.6	10.1	1.2	4.4	7.0	7.5	3.6	8.3	6.4	3.1	9.5	10.3	12.3	17.1	10.4	8.0	9.9	12.3	13.9	11.7	17.4	8.3	4.9	8.5	11.1	16.9	12.4	9.1	5.8	9.6	5.6	19.6	8.3	14.6	7.5	12.1	18.8	15.6	24.5	19.4	17.7	4.0	13.4	9.2	10.3	3.6	13.0	5.7	5.5	12.1	18.8	7.3	8.2	11.4	4.5	11.0	8.4	7.6	6.0	5.5	9.5	8.6	6.8	6.1	5.7	2.1	9.3	10.5	6.9	10.4	8.9	0.8	3.0	0.9	5.4	4.4	7.5	4.3	6.3	5.0	4.0	6.6	2.9	3.3	1.2	7.0	2.1	10.1	6.3	3.6	7.4	9.6	6.2	8.5	8.7	6.4	13.2	4.5	10.9	10.1
METTL9	DREV1	ENSG00000197006	"Methyltransferase like 9"	Q9H1A3	16	21597218-21657473	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA053588, HPA056347"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"			"Nucleoplasm, Cell Junctions"	Cytosol	"HPA053588: , HPA056347: "	"unprognostic (1.55e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.43e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavourable (8.71e-4)"	"unprognostic (3.44e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.57e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.65e-1)"	24.0	45.5	29.6	18.8	34.9	50.0	45.1	12.2	31.9	34.2	19.1	18.7	15.5	14.9	23.4	35.6	30.2	23.8	19.4	32.0	22.2	20.0	61.0	8.7	24.0	38.8	26.8	8.4	22.8	28.8	37.2	25.0	25.4	17.7	23.8	20.3	32.5	22.1	19.3	30.6	21.5	20.6	21.1	25.0	29.6	18.8	10.8	18.1	39.8	37.8	20.0	25.9	24.9	24.6	4.9	14.1	30.5	24.5	5.6	7.3	7.6	13.4	10.3	26.0	22.5	26.9	48.8	9.3	21.6	31.0	17.1	20.7	7.4	24.6	23.7	18.5	37.8	8.4	17.2	19.3	23.4	18.0	14.1	10.2	10.4	27.5	19.3	8.0	21.3	28.7	20.6	17.6	23.1	32.6	15.1	19.5	33.8	14.9	20.8	13.4	23.3	10.7	30.4	20.3	21.5	28.2	13.2	15.1	27.3	18.3	12.7	46.0	12.9	4.2	18.4	28.5	12.4	17.3	13.3	16.6	26.6	19.0	27.9	19.9	20.0	30.5	24.5	10.7	4.0	4.5	4.8	4.6	6.8	7.3	14.1	4.9	7.3	5.4	12.5	5.6	3.9	4.4	5.4	7.6	29.6	34.9	12.2	31.9	22.2	20.0	26.8	8.4	17.7	18.1
MFAP2	"MAGP, MAGP-1"	ENSG00000117122	"Microfibril associated protein 2"	P55001	1	16974502-16980835	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 51.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 48.1;ASC TERT1: 49.6;HUVEC TERT2: 50.7;SH-SY5Y: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"gdT-cell: 2.1"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA007354	Enhanced				"Secreted to extracellular matrix"					"HPA007354: AB_1079365"	"unprognostic (5.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.72e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.45e-3)"	"unprognostic (9.12e-2)"	"prognostic unfavourable (2.52e-8)"	"unprognostic (2.18e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-3)"	13.1	1.6	0.2	6.0	0.4	0.0	20.8	0.4	0.8	24.8	5.0	0.5	6.7	1.6	28.7	14.0	5.7	6.6	29.7	29.6	0.6	0.3	3.4	0.8	12.5	1.2	0.3	1.0	23.6	33.9	0.0	4.7	51.7	1.8	16.9	1.7	15.4	6.9	5.0	4.6	10.9	4.3	18.3	2.9	1.3	3.5	10.4	0.3	0.7	3.8	7.4	3.3	10.3	13.2	0.3	0.0	0.0	0.1	0.0	2.1	0.2	0.0	0.0	18.7	0.0	48.1	49.6	1.2	4.7	19.7	7.4	14.5	4.3	0.2	0.0	16.4	16.5	0.0	1.3	1.5	3.0	0.0	14.6	0.0	6.9	0.4	4.5	0.0	0.0	20.3	3.7	20.9	8.3	50.7	0.0	3.1	3.6	2.2	0.0	0.0	21.9	0.1	0.2	0.0	0.6	0.2	0.0	1.0	42.6	1.6	7.1	1.8	2.4	2.5	14.1	13.0	27.1	10.4	0.5	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.4	0.8	0.6	0.3	0.3	1.0	1.8	0.3
MFAP3		ENSG00000037749	"Microfibril associated protein 3"	P55082	5	154038906-154220478	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015883, HPA049198"	Approved		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"			"Golgi apparatus"	Nucleoplasm	"HPA015883: AB_1853840, HPA049198: "	"unprognostic (6.02e-2)"	"prognostic unfavourable (4.28e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.16e-3)"	"unprognostic (9.35e-3)"	21.3	7.6	5.8	8.0	12.2	7.9	11.3	12.6	11.4	11.1	8.3	6.3	7.8	7.2	14.1	7.3	11.6	7.5	8.9	9.2	7.2	6.8	9.5	9.4	10.9	6.8	6.4	7.1	9.4	6.3	27.2	9.6	15.0	8.8	7.8	8.4	9.5	8.8	6.4	13.2	6.4	9.5	11.7	8.9	7.9	7.4	8.3	7.0	9.1	11.3	6.3	9.2	12.2	10.1	3.0	10.6	14.6	10.3	7.7	9.6	5.4	9.5	12.5	21.3	22.3	19.2	18.0	20.9	17.4	18.6	18.1	23.5	18.8	21.8	13.8	20.1	16.3	21.6	20.0	21.7	29.0	6.2	13.1	9.0	19.2	6.8	18.3	16.1	10.6	19.4	21.5	21.7	18.5	25.3	10.3	15.0	15.7	6.3	8.9	3.7	11.0	7.4	8.6	25.2	12.6	11.7	13.6	22.0	24.5	19.0	21.5	17.1	22.6	8.0	23.0	23.6	16.5	13.0	17.6	15.0	19.3	13.0	12.0	11.2	18.5	8.1	10.3	14.6	6.5	9.8	9.6	3.0	5.6	4.9	10.6	3.0	7.4	5.4	8.4	7.7	7.0	3.8	4.9	5.4	5.8	12.2	12.6	11.4	7.2	6.8	6.4	7.1	8.8	7.0
MFSD1	"FLJ14153, UG0581B09"	ENSG00000118855	"Major facilitator superfamily domain containing 1"	Q9H3U5	3	158732198-158829719	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 45.3;granulocytes: 42.6;monocytes: 49.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057924, HPA065858"	Approved		Approved	Nucleoplasm,Nucleoli			14000	Nucleoplasm	Nucleoli	"HPA057924: , HPA065858: "	"unprognostic (9.94e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.92e-1)"	"prognostic favourable (5.60e-5)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.57e-1)"	26.2	29.5	11.4	22.0	11.8	17.2	24.2	9.1	14.0	18.7	15.7	13.4	18.9	13.2	18.3	20.6	37.0	18.4	17.5	17.7	10.8	10.3	20.7	24.8	24.9	39.8	15.7	11.7	15.3	16.8	16.5	16.8	18.3	13.6	14.7	11.5	14.5	34.5	17.9	9.2	18.6	16.8	15.0	14.5	29.1	19.9	15.0	14.3	11.3	18.7	16.3	16.7	23.8	24.1	10.5	45.3	42.6	49.6	5.4	7.3	35.3	14.7	6.3	1.6	4.9	8.6	8.1	10.2	23.1	10.4	8.2	8.1	2.6	14.6	4.1	17.0	14.8	7.7	4.0	5.1	7.7	16.4	10.7	11.1	4.8	1.1	9.3	40.9	27.8	12.1	6.7	7.4	2.0	6.4	8.6	8.5	14.6	3.4	2.5	12.0	1.6	16.2	5.5	2.4	36.3	3.0	3.9	4.8	7.2	17.1	13.2	4.1	10.4	16.0	21.1	11.8	4.5	17.4	11.3	27.1	19.0	2.3	14.8	29.6	8.2	14.0	49.6	42.6	7.3	38.5	6.6	10.5	5.8	6.5	45.3	8.5	6.4	7.0	17.6	5.4	31.6	14.7	6.8	35.3	11.4	11.8	9.1	14.0	10.8	10.3	15.7	11.7	13.6	14.3
MFSD11	"FLJ20226, FLJ22196"	ENSG00000092931	"Major facilitator superfamily domain containing 11"	O43934	17	76735865-76781449	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022001	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA022001: AB_2297599"	"unprognostic (2.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.43e-2)"	"prognostic unfavourable (7.69e-4)"	"unprognostic (4.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.78e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.18e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavourable (7.90e-4)"	17.2	20.7	13.9	14.3	21.3	15.6	18.7	20.4	25.0	18.0	20.9	19.6	16.9	17.4	18.8	18.8	24.1	13.4	14.3	23.5	13.3	14.8	13.3	19.2	17.4	22.0	20.1	16.1	14.4	17.4	24.6	27.9	27.4	18.1	14.8	22.8	32.8	21.3	17.3	26.8	20.8	17.7	16.8	17.9	19.0	21.7	28.6	19.7	15.6	18.0	16.8	18.6	16.8	21.6	8.0	14.9	16.7	16.1	6.3	18.3	8.2	13.5	7.7	9.1	8.7	19.6	11.9	10.7	12.1	11.2	11.7	10.4	15.6	24.9	11.1	10.3	12.3	13.4	6.4	6.3	12.2	5.1	12.9	11.1	14.7	10.7	9.4	5.9	11.0	14.2	10.3	15.0	6.8	22.2	13.2	16.5	14.8	10.4	13.3	9.7	3.8	4.5	10.5	11.9	22.9	9.0	10.1	8.9	15.0	11.5	16.5	10.3	28.9	9.1	15.6	21.4	10.5	13.4	10.1	18.4	7.3	16.7	16.5	5.2	14.1	11.2	14.1	11.3	15.2	16.1	6.4	7.5	13.6	15.3	14.9	8.0	8.5	10.6	16.7	6.3	12.5	10.7	18.3	8.2	13.9	21.3	20.4	25.0	13.3	14.8	20.1	16.1	18.1	19.7
MFSD13A	"bA18I14.8, C10orf77, FLJ22529, TMEM180"	ENSG00000138111	"Major facilitator superfamily domain containing 13A"	Q14CX5	10	102461395-102477045	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018031	Uncertain		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA018031: AB_2204891"	"unprognostic (2.24e-2)"	"prognostic favourable (8.29e-4)"	"unprognostic (7.73e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.16e-3)"	"unprognostic (4.70e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavourable (8.51e-4)"	"unprognostic (1.66e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.02e-2)"	3.8	3.3	8.8	5.9	15.7	9.0	2.6	18.0	18.7	2.4	7.0	8.5	0.4	10.2	4.3	1.8	3.0	2.4	4.7	5.2	9.0	6.5	3.3	5.7	14.1	5.6	7.9	8.7	2.3	5.1	2.8	4.4	7.2	8.2	3.1	6.4	3.9	3.0	2.3	3.9	17.4	7.5	4.9	5.2	6.9	7.1	5.8	8.6	2.3	5.7	1.8	6.7	3.1	2.5	5.0	7.5	5.5	7.2	2.2	5.8	3.4	9.3	4.3	3.3	7.9	0.3	0.3	5.1	1.9	4.9	3.7	8.7	8.5	12.9	8.4	9.8	0.7	11.7	6.1	5.0	1.4	10.5	5.5	10.3	6.1	4.4	8.5	5.2	10.1	4.3	2.1	2.1	3.8	4.3	2.3	4.6	0.3	1.9	8.7	3.4	5.6	4.2	10.6	0.5	1.4	1.7	2.5	8.2	7.8	1.8	1.0	4.2	4.8	3.5	1.3	1.7	2.1	2.1	2.6	1.6	4.1	10.9	9.6	8.6	2.4	0.7	7.2	5.5	5.2	5.3	5.2	5.0	5.0	4.1	7.5	2.8	5.2	5.8	4.4	2.2	3.0	0.8	1.4	3.4	8.8	15.7	18.0	18.7	9.0	6.5	7.9	8.7	8.2	8.6
MFSD14B	"FLJ14753, HIATL1"	ENSG00000148110	"Major facilitator superfamily domain containing 14B"	Q5SR56	9	94374551-94461042	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 86.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017978			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA017978: AB_2116836"	"unprognostic (3.03e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.96e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.13e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.12e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.01e-2)"	15.1	18.9	13.3	14.3	14.7	9.0	20.2	11.6	12.8	14.9	14.2	19.7	15.5	9.9	18.6	16.1	28.1	14.4	12.5	13.4	13.3	12.4	14.7	9.0	25.7	21.5	14.6	7.8	15.9	21.5	86.0	9.2	24.2	28.3	14.5	15.4	21.6	15.9	14.2	7.3	21.8	16.0	12.8	19.1	19.3	13.0	9.2	13.2	24.0	16.7	14.2	23.9	14.1	18.8	4.6	7.8	10.4	11.4	3.6	7.1	3.6	25.9	16.8	13.1	10.3	28.9	20.7	20.9	25.3	22.0	22.6	22.2	8.4	31.2	31.3	15.1	21.8	57.6	15.6	16.2	22.0	22.3	8.4	10.8	16.1	12.6	20.5	33.9	20.0	19.0	24.4	23.9	18.4	19.3	20.3	18.7	30.0	19.7	24.8	19.5	19.2	13.5	12.5	30.2	10.1	24.0	20.1	12.6	16.7	21.6	25.5	26.8	11.6	20.1	20.6	23.7	16.7	36.3	23.4	20.7	25.6	8.6	21.1	16.6	21.1	0.6	7.9	5.9	5.6	11.4	5.1	4.6	5.1	5.6	7.8	2.9	5.1	7.1	10.4	3.6	7.7	7.7	5.1	3.6	13.3	14.7	11.6	12.8	13.3	12.4	14.6	7.8	28.3	13.2
MFSD3		ENSG00000167700	"Major facilitator superfamily domain containing 3"	Q96ES6	8	144509074-144511213	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056013	Uncertain		Approved	Vesicles				Vesicles		"HPA056013: "	"unprognostic (7.92e-2)"	"prognostic unfavourable (5.08e-4)"	"unprognostic (2.00e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.49e-2)"	"unprognostic (5.29e-2)"	"prognostic favourable (5.44e-7)"	"unprognostic (4.08e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.81e-2)"	7.7	12.3	12.5	7.4	12.5	3.0	7.2	12.0	17.3	5.6	12.7	5.6	19.6	19.8	4.3	12.5	8.0	6.3	10.3	10.2	8.8	9.2	17.7	21.2	8.0	6.4	10.0	15.3	3.5	19.2	14.3	9.7	4.8	10.4	10.5	5.5	5.0	24.0	9.4	23.5	11.3	13.1	3.0	4.6	6.4	12.7	4.1	9.1	4.2	12.8	8.7	5.5	5.8	4.9	4.7	17.2	3.4	6.6	3.2	4.0	3.2	7.7	10.7	2.7	2.3	3.0	2.3	8.9	2.5	2.6	1.4	2.1	3.5	5.5	11.3	8.8	2.3	7.6	1.2	5.9	0.2	5.3	21.9	3.6	9.6	8.8	5.7	1.7	5.0	3.3	11.2	0.9	3.9	3.6	6.7	3.1	3.4	25.8	4.2	9.0	7.2	18.4	4.8	1.4	19.8	6.6	4.6	19.8	9.9	6.4	15.8	5.3	16.5	2.5	3.9	1.9	5.1	2.1	3.4	3.0	1.2	3.8	4.1	5.5	3.2	1.6	6.6	3.4	3.7	5.6	3.5	4.7	3.6	3.8	9.9	2.4	3.5	3.5	0.4	3.2	3.1	17.2	4.0	3.2	12.5	12.5	12.0	17.3	8.8	9.2	10.0	15.3	10.4	9.1
MFSD4B	"KIAA1919, MGC33953"	ENSG00000173214	"Major facilitator superfamily domain containing 4B"	Q5TF39	6	111259348-111271167	"Predicted membrane proteins"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA031784	Approved									"HPA031784: AB_10603775"	"unprognostic (2.98e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.07e-2)"	"unprognostic (7.50e-5)"	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.41e-1)"	"unprognostic (6.04e-3)"	"unprognostic (9.27e-2)"	"unprognostic (3.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.98e-4)"	4.7	5.8	5.3	7.2	8.7	4.6	6.4	5.5	6.6	6.4	8.3	4.1	7.8	9.1	6.8	10.1	5.4	5.9	3.9	5.5	3.4	3.5	13.3	8.4	5.4	5.0	3.2	2.6	5.7	6.2	6.0	12.3	26.1	3.3	5.2	5.3	6.9	7.8	8.0	6.1	8.3	14.6	4.0	3.6	5.9	5.3	9.1	3.0	8.1	6.5	2.7	7.6	5.0	5.3	6.0	4.0	3.6	3.3	2.4	3.7	1.8	1.4	2.5	2.9	6.8	2.3	1.4	5.2	2.0	2.3	2.6	3.5	5.4	2.9	3.8	3.0	1.7	3.8	5.0	1.9	3.6	2.9	2.2	5.3	4.3	4.4	3.2	4.9	8.5	1.2	3.9	3.2	2.1	2.1	5.9	4.8	2.9	2.4	3.4	3.1	2.0	1.0	3.7	2.1	1.7	4.5	3.2	2.5	2.4	2.2	2.5	1.3	2.0	4.3	3.0	3.3	2.1	15.4	3.1	3.4	2.6	3.8	4.0	3.0	3.3	3.0	3.3	3.6	3.7	3.1	3.6	6.0	2.1	2.9	2.5	3.9	3.1	3.5	3.5	2.4	2.3	4.0	1.5	1.8	5.3	8.7	5.5	6.6	3.4	3.5	3.2	2.6	3.3	3.0
MFSD6L	FLJ35773	ENSG00000185156	"Major facilitator superfamily domain containing 6 like"	Q8IWD5	17	8797162-8799349	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 8.5;testis: 20.1"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 13.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023164	Uncertain									"HPA023164: AB_2142777"	"prognostic favourable (1.84e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.07e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.25e-1)"	0.5	0.0	0.5	3.2	0.5	0.0	0.5	0.5	0.5	1.4	2.1	0.5	0.5	1.8	0.5	0.9	0.5	1.6	0.5	0.5	0.5	0.0	1.1	0.5	2.2	0.5	0.5	0.5	0.5	8.5	4.8	4.3	0.5	0.5	0.5	2.6	0.5	5.5	1.8	0.5	0.2	1.0	0.5	0.5	0.5	3.4	20.1	0.5	0.5	3.1	0.5	0.5	0.7	0.5	0.0	0.3	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.5	0.5	0.0	0.5	0.5	0.5	0.5
MFSD9	MGC11332	ENSG00000135953	"Major facilitator superfamily domain containing 9"	Q8NBP5	2	102715840-102736888	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055293, HPA061859"	Approved		Approved	Nucleoli				Nucleoli		"HPA055293: , HPA061859: "	"unprognostic (1.27e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-2)"	"prognostic unfavourable (8.38e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.28e-2)"	4.3	4.1	3.0	3.5	3.1	6.2	6.2	12.9	5.2	4.6	8.4	2.4	11.0	11.6	2.8	3.8	7.2	2.7	4.1	3.8	2.3	2.8	7.2	16.2	3.0	4.5	2.3	1.5	3.3	16.8	6.3	10.7	3.4	4.8	3.4	7.9	5.1	9.0	6.8	2.2	4.4	16.0	4.0	2.7	4.8	6.7	2.7	1.7	10.0	5.0	3.9	6.3	5.5	3.5	3.0	4.4	6.4	3.2	4.1	4.3	3.0	3.9	3.2	3.5	6.3	4.1	1.8	8.7	2.6	2.4	3.8	3.9	9.9	6.0	3.2	4.2	1.8	6.2	4.9	2.6	2.7	12.9	5.0	5.7	3.6	13.0	3.6	4.5	7.7	2.1	6.4	2.6	1.3	2.5	3.5	2.0	1.8	3.8	4.3	6.9	3.4	3.7	3.5	5.5	3.3	6.7	13.4	6.8	5.0	2.5	7.8	7.7	3.3	6.5	1.9	3.0	5.6	4.2	3.4	4.7	3.7	2.4	2.8	9.6	3.6	3.7	1.2	6.4	4.3	3.2	3.3	3.0	3.4	3.1	2.6	2.7	3.7	3.8	5.0	4.1	1.9	4.4	2.2	3.0	3.0	3.1	12.9	5.2	2.3	2.8	2.3	1.5	4.8	1.7
MGAM2		ENSG00000257743	"Maltase-glucoamylase 2 (putative)"	Q2M2H8	7	142111749-142222324	"Enzymes, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 61.2;pancreas: 15.6;salivary gland: 35.4"	"Cell line enriched"	"Detected in single"	7	"RH-30: 5.0"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"					"Low region specificity"	"Detected in all"			HPA055697	Enhanced		Approved	Vesicles,Cytosol				Vesicles	Cytosol	"HPA055697: "	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-4)"	"unprognostic (7.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.33e-2)"	0.2	0.1	0.1	2.5	0.1	0.2	1.3	0.1	0.1	0.1	28.8	0.0	0.0	15.0	0.1	0.4	0.1	0.3	7.0	0.1	0.1	0.1	0.1	0.2	0.4	0.0	0.4	0.0	0.1	15.6	0.0	0.1	0.0	0.1	0.1	1.4	0.7	35.4	0.0	0.1	0.2	61.2	0.0	0.5	1.5	0.7	1.0	0.0	0.0	0.1	1.7	0.8	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.0
MGAT3	GNT-III	ENSG00000128268	"Mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase"	Q09327	22	39457344-39492194	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.0;intestine: 27.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 28.7;HMC-1: 24.8;U-266/70: 32.2;U-266/84: 13.0;U-698: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.5;eosinophil: 3.3;memory B-cell: 1.7;naive B-cell: 1.2"	"Group enriched"	"Detected in many"	9	"B-cells: 1.7;granulocytes: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017598	Approved				"Intracellular and membrane"		78000			"HPA017598: AB_1853853"	"unprognostic (1.41e-3)"	"unprognostic (5.98e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.71e-3)"	"unprognostic (8.92e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.35e-3)"	"unprognostic (6.77e-2)"	"unprognostic (8.12e-3)"	"unprognostic (8.74e-2)"	"prognostic unfavourable (5.04e-8)"	"unprognostic (6.73e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.89e-2)"	"unprognostic (4.92e-2)"	5.3	1.2	17.1	3.9	18.7	9.2	3.6	29.0	24.6	7.1	11.9	8.9	0.0	21.1	3.4	1.2	1.4	4.0	7.9	3.0	18.1	14.9	3.3	0.4	14.9	7.2	13.1	13.4	1.0	3.1	0.9	1.4	10.5	10.7	1.0	4.9	1.7	2.1	1.4	1.6	2.5	27.1	3.2	10.4	3.3	7.8	4.9	9.0	0.2	1.1	0.0	8.9	3.0	2.7	1.7	0.1	3.5	0.2	0.0	0.2	0.1	0.1	0.1	4.7	0.4	0.0	0.0	28.7	0.2	0.3	0.2	0.0	6.3	1.6	9.9	3.5	0.0	0.5	2.4	0.0	0.0	0.0	0.2	8.0	0.0	0.0	0.1	0.0	24.8	0.0	0.0	0.0	0.0	0.0	6.5	1.2	0.0	0.1	0.2	0.6	1.4	0.0	0.5	0.0	1.6	0.2	0.2	2.6	1.9	0.0	0.0	0.0	0.3	0.4	0.0	0.0	3.7	0.0	0.0	32.2	13.0	13.9	0.0	0.0	0.7	3.5	0.1	3.3	0.1	0.2	0.1	1.7	0.0	0.0	0.1	1.2	0.2	0.2	0.4	0.0	0.0	0.0	0.1	0.1	17.1	18.7	29.0	24.6	18.1	14.9	13.1	13.4	10.7	9.0
MGAT4C	HGNT-IV-H	ENSG00000182050	"MGAT4 family member C"	Q9UBM8	12	85955666-86838904	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 12.8;epididymis: 10.9;pituitary gland: 25.9;testis: 7.8;thyroid gland: 18.0"	"Group enriched"	"Detected in some"	13	"NTERA-2: 10.9;SCLC-21H: 4.8"	"Cancer enriched"	"Detected in single"	19	"thyroid cancer: 2.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA016418	Approved									"HPA016418: AB_1853854"	"unprognostic (5.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.64e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.32e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.85e-10)"	"unprognostic (3.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.74e-3)"	1.0	3.0	5.5	1.0	12.3	1.1	0.9	4.9	12.8	1.3	1.2	2.5	0.4	0.9	1.0	10.9	1.1	1.1	1.2	3.6	9.4	3.9	1.0	0.9	1.0	0.9	3.0	9.3	0.9	0.9	0.9	25.9	0.8	10.6	1.1	1.2	0.0	0.9	2.4	0.8	1.0	1.0	1.0	4.3	0.9	1.0	7.8	5.1	0.0	18.0	0.0	0.8	0.9	0.6	0.5	0.3	0.8	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.0	10.9	0.1	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.1	0.8	0.2	0.1	0.3	0.2	0.0	5.5	12.3	4.9	12.8	9.4	3.9	3.0	9.3	10.6	5.1
MGAT4D	GnT1IP	ENSG00000205301	"MGAT4 family member D"	A6NG13	4	140442262-140498377	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	56	"testis: 33.8"	"Cell line enriched"	"Detected in single"	9	"HEL: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036523	Enhanced									"HPA036523: AB_10670110"										"unprognostic (2.70e-1)"		"unprognostic (3.16e-2)"						0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
MGAT5	GNT-V	ENSG00000152127	"Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase"	Q09328	2	134119983-134454621	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010919	Approved						96000			"HPA010919: AB_10601864"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.76e-1)"	"unprognostic (4.45e-3)"	"unprognostic (3.41e-3)"	"unprognostic (5.68e-2)"	"unprognostic (8.63e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.91e-1)"	8.4	9.8	13.0	21.7	15.7	12.0	8.0	21.3	17.6	9.0	13.2	17.2	4.6	14.2	8.5	6.3	8.2	17.5	15.1	33.9	13.9	17.5	14.3	4.9	9.3	20.1	23.6	11.6	11.3	11.1	18.8	7.9	22.0	28.0	7.9	13.8	8.3	11.9	9.1	3.2	6.6	19.2	10.1	28.7	23.1	15.0	6.6	13.2	16.5	10.3	5.1	28.9	11.0	9.2	7.5	1.8	2.3	0.8	2.4	3.1	1.1	10.0	4.0	10.3	7.3	9.2	17.6	7.2	13.4	20.5	5.4	4.6	1.6	5.0	16.1	10.3	10.6	3.5	8.0	6.3	10.4	15.7	4.7	9.0	5.2	21.0	6.0	8.7	32.2	4.8	6.6	11.4	7.1	40.4	4.6	11.0	9.8	6.4	4.7	4.1	4.7	10.0	5.8	12.1	10.1	4.2	12.3	17.0	21.0	4.3	3.7	25.6	2.9	6.1	18.2	17.2	9.1	12.4	7.0	3.1	1.4	6.1	14.4	12.6	27.2	1.2	0.7	1.8	1.6	0.7	2.7	5.6	3.1	2.1	0.6	7.5	1.3	1.6	2.3	2.4	0.8	1.8	1.9	1.1	13.0	15.7	21.3	17.2	13.9	17.5	23.6	11.6	28.0	13.2
MICU3	"DKFZp313A0139, EFHA2"	ENSG00000155970	"Mitochondrial calcium uptake family member 3"	Q86XE3	8	17027238-17122644	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 11.9;HBF TERT88: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024048, HPA024771, HPA024779"	Uncertain									"HPA024048: AB_1848021, HPA024771: AB_1848022, HPA024779: AB_1848023"	"unprognostic (2.99e-2)"	"unprognostic (7.73e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.25e-2)"	"unprognostic (9.01e-5)"	"unprognostic (9.82e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.45e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.65e-2)"	9.1	11.7	13.7	3.3	18.7	1.4	7.0	34.1	32.3	8.6	4.1	7.7	1.9	2.0	10.4	7.0	5.1	5.4	6.0	6.6	15.4	12.0	7.3	14.8	5.5	4.1	10.5	15.1	12.9	4.6	13.9	13.3	22.1	19.8	9.5	3.5	5.8	5.2	7.5	5.4	2.4	2.7	9.1	10.2	6.9	3.5	7.9	6.3	1.8	7.9	1.3	3.2	6.1	7.5	1.4	0.0	0.1	0.0	0.8	0.9	0.0	0.0	1.1	5.6	2.1	4.3	6.5	1.4	8.3	11.9	6.4	5.2	0.0	0.2	0.1	1.7	4.3	0.0	2.5	1.7	12.1	0.0	1.5	0.0	0.0	2.0	7.5	0.0	0.3	4.9	0.0	5.4	5.5	2.4	0.3	1.6	6.0	0.0	0.7	1.0	4.0	1.4	0.0	2.6	0.0	4.4	0.0	9.2	4.4	0.0	0.0	3.3	0.0	0.0	3.1	2.8	1.1	0.4	1.5	1.6	1.2	2.8	5.2	0.0	1.7	0.0	0.0	0.1	0.1	0.0	0.8	0.2	0.4	0.0	0.0	1.4	0.9	0.7	0.0	0.8	0.0	0.0	0.0	0.0	13.7	18.7	34.1	24.3	15.4	12.0	10.5	15.1	19.8	6.3
MISP3		ENSG00000141854	"MISP family member 3"	Q96FF7	19	14072536-14075062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 11.4;RPMI-8226: 12.9;U-266/70: 7.9;U-266/84: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.7;gdT-cell: 1.8;neutrophil: 4.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 4.8;T-cells: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042225	Uncertain									"HPA042225: AB_10795396"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.76e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.46e-1)"	"prognostic favourable (9.52e-4)"	"prognostic favourable (3.11e-5)"	"unprognostic (2.97e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.78e-2)"	3.0	2.8	14.7	2.0	11.6	2.6	2.7	16.0	16.0	2.8	11.9	6.8	8.7	16.0	1.9	3.0	2.8	7.8	5.2	6.0	14.3	13.2	12.9	3.6	4.2	1.2	11.8	9.8	1.1	16.2	5.5	2.4	8.6	7.8	4.8	6.5	2.1	17.0	8.6	3.7	6.7	15.4	1.6	10.8	2.0	13.5	1.6	7.2	0.0	3.6	1.4	2.9	2.0	2.2	0.0	0.4	4.8	0.5	0.0	1.8	4.2	3.6	1.9	0.7	1.4	1.3	0.9	0.3	0.2	0.3	0.1	0.3	0.1	0.7	0.2	2.5	0.2	1.3	1.7	0.0	0.2	4.4	3.2	0.6	0.9	1.7	0.2	0.3	0.8	0.3	0.1	0.2	0.2	0.4	0.5	11.4	0.0	6.2	0.6	1.5	0.0	1.6	1.0	0.3	12.9	2.3	0.1	3.4	0.9	0.0	1.2	1.3	2.1	0.1	0.3	0.0	1.0	1.2	0.0	7.9	8.8	0.9	1.8	2.8	0.3	0.0	0.5	1.7	1.8	0.2	0.2	0.0	0.5	0.6	0.3	0.0	0.0	0.3	4.8	0.0	0.2	0.4	0.3	4.2	14.7	11.6	16.0	16.0	14.3	13.2	11.8	9.8	7.8	7.2
MKX	"C10orf48, IRXL1, MGC39616"	ENSG00000150051	"Mohawk homeobox"	Q8IYA7	10	27672875-27746060	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 21.3;prostate: 24.3"	"Cell line enhanced"	"Detected in some"		"BJ: 18.8;BJ hTERT+: 10.8;BJ hTERT+ SV40 Large T+: 12.4;BJ hTERT+ SV40 Large T+ RasG12V: 8.5;fHDF/TERT166: 53.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"myeloid DC: 1.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006927	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"HPA006927: AB_1853981"	"unprognostic (2.04e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.38e-3)"	3.7	3.2	1.6	1.4	2.1	0.3	3.0	2.6	5.9	4.9	4.3	1.4	0.9	0.5	1.8	3.4	1.8	7.1	2.7	0.8	1.4	2.5	0.6	1.9	1.2	0.5	2.7	1.4	21.3	1.0	0.3	13.9	0.3	6.7	24.3	1.5	2.9	0.9	7.7	0.5	1.0	0.7	10.6	2.7	0.8	3.4	1.3	0.1	0.0	4.5	0.5	0.3	8.7	1.6	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.8	10.8	12.4	8.5	0.0	0.0	0.0	0.0	53.9	0.0	0.1	0.0	3.3	0.0	1.2	0.0	3.4	0.0	0.5	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.2	1.6	0.0	0.2	0.0	0.0	0.0	0.2	0.0	7.8	0.0	0.0	1.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.1	2.6	5.9	1.4	2.5	2.7	1.4	6.7	0.1
MMD	"MMA, PAQR11"	ENSG00000108960	"Monocyte to macrophage differentiation associated"	Q15546	17	55392613-55421992	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 61.1;brain: 40.5;breast: 46.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 32.1;HSkMC: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026978			Approved	Vesicles				Vesicles		"HPA026978: "	"unprognostic (1.33e-1)"	"unprognostic (2.92e-2)"	"prognostic favourable (3.52e-5)"	"prognostic unfavourable (3.88e-4)"	"unprognostic (2.48e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavourable (6.39e-5)"	"unprognostic (8.07e-3)"	"unprognostic (6.67e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.06e-3)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (3.71e-3)"	"unprognostic (7.93e-2)"	"prognostic unfavourable (8.62e-4)"	"unprognostic (1.12e-2)"	61.1	6.6	33.4	7.1	40.5	5.3	46.0	2.0	23.7	2.6	5.6	4.1	1.7	5.0	3.2	4.9	3.6	1.8	4.7	5.0	26.9	7.5	3.2	6.0	4.7	9.0	11.2	5.1	1.5	1.6	0.9	2.1	13.4	4.6	3.2	6.5	3.2	2.2	4.1	2.5	2.5	4.7	5.4	6.5	8.7	2.4	7.8	5.0	1.4	3.3	1.2	5.6	5.7	4.1	4.1	3.6	9.6	1.6	2.2	4.2	15.9	5.0	12.9	19.1	3.7	32.1	25.4	9.4	3.1	1.4	2.0	2.9	2.0	15.0	7.2	9.3	1.1	0.3	5.2	4.0	4.2	9.5	1.9	2.7	0.7	23.4	8.6	2.5	0.7	58.1	1.3	2.9	3.2	2.5	0.9	5.8	4.2	0.7	7.1	1.9	5.2	3.3	2.9	12.4	2.7	5.5	1.4	1.7	18.2	1.1	2.0	2.9	4.3	4.6	2.3	5.3	6.4	4.2	3.5	2.6	1.2	10.2	7.6	2.1	4.2	9.6	1.3	1.5	1.4	1.6	4.2	3.6	1.6	2.9	3.6	4.1	2.7	2.9	3.8	2.2	1.5	1.1	1.7	15.9	33.4	40.5	2.0	16.9	26.9	7.5	11.2	5.1	4.6	5.0
MMEL1	"MMEL2, NEPII, NL1, NL2, SEP"	ENSG00000142606	"Membrane metalloendopeptidase like 1"	Q495T6	1	2590639-2632990	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 30.2"	"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 17.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 8.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007876, HPA008205, CAB020786"	Uncertain				"Intracellular and membrane"					"CAB020786: , HPA007876: AB_1854012, HPA008205: AB_1854011"	"unprognostic (5.80e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.54e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.18e-3)"	"unprognostic (7.01e-4)"	1.5	0.5	0.8	1.8	8.5	0.6	1.8	0.4	0.6	4.3	4.2	0.4	1.9	3.2	0.8	10.3	3.0	3.0	9.6	1.3	1.0	2.6	1.4	0.4	1.4	1.4	1.7	0.4	1.1	7.3	0.3	0.4	0.7	0.5	4.2	1.4	0.4	2.0	2.0	0.4	0.3	2.6	0.9	0.7	1.4	7.9	30.2	0.9	0.8	1.1	0.8	0.8	3.7	1.6	0.6	1.1	6.6	5.1	2.3	6.1	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	2.9	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.5	0.0	17.4	0.0	1.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	1.5	6.6	0.5	3.9	0.3	0.6	1.7	0.7	1.1	0.0	4.5	2.2	1.0	2.3	5.1	0.2	6.1	2.2	0.8	8.5	0.4	0.6	1.0	2.6	1.7	0.4	0.5	0.9
MMP24	MT5-MMP	ENSG00000125966	"Matrix metallopeptidase 24"	Q9Y5R2	20	35226654-35277000	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 38.5"	"Cell line enhanced"	"Detected in some"		"A549: 19.6;CACO-2: 29.9;EFO-21: 8.8;RPTEC TERT1: 13.5;U-2 OS: 10.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 38.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 91.3"	"HPA049280, HPA078816"	Approved		Approved	"Nucleoli,Plasma membrane"	"Secreted to extracellular matrix"			"Nucleoli, Plasma membrane"		"HPA049280: , HPA078816: "	"unprognostic (1.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.51e-4)"	"unprognostic (2.47e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.12e-2)"	"prognostic favourable (8.17e-11)"	"unprognostic (3.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.90e-4)"	1.6	1.3	4.0	0.4	7.8	0.6	0.4	38.5	8.9	0.7	0.3	1.3	0.2	2.8	1.6	0.9	0.2	2.8	0.6	1.0	2.7	3.2	8.6	0.9	6.1	0.3	1.8	1.5	0.9	8.0	0.0	3.8	0.6	1.7	2.2	0.1	0.5	0.4	6.0	0.2	1.5	1.7	2.5	0.9	0.6	0.7	0.4	1.4	0.2	0.8	0.2	0.2	0.5	0.2	0.8	0.4	2.2	0.8	0.6	1.2	0.3	0.3	19.6	0.0	0.1	0.1	0.0	0.6	1.1	1.2	2.1	1.1	29.9	5.3	0.0	8.8	1.3	0.3	4.6	0.0	0.9	0.1	0.2	1.0	0.5	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.2	0.1	0.1	7.5	1.3	0.0	0.1	0.0	13.5	0.1	7.8	5.4	1.4	0.5	0.2	0.3	0.1	0.3	4.2	10.1	1.0	0.4	0.1	0.1	0.0	0.9	0.1	0.6	1.0	0.6	0.1	1.0	0.7	1.2	0.6	0.7	0.8	0.4	0.8	0.6	0.6	2.2	0.6	0.8	0.2	0.0	0.3	4.0	7.8	38.5	5.3	2.7	3.2	1.8	1.5	1.7	1.4
MMP28	"EPILYSIN, MM28, MMP-25, MMP-28"	ENSG00000271447	"Matrix metallopeptidase 28"	Q9H239	17	35756249-35795707	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"HaCaT: 28.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.2;naive CD8 T-cell: 5.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057288, HPA057890"			Approved	"Nucleoplasm,Focal adhesion sites"	"Secreted to extracellular matrix"			Nucleoplasm	"Focal adhesion sites"	"HPA057288: , HPA057890: "	"unprognostic (7.99e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (6.28e-6)"	"unprognostic (9.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.27e-3)"	8.0	1.6	1.8	2.7	3.7	0.5	4.3	0.0	5.1	1.7	7.3	1.6	1.4	3.0	3.2	4.8	4.3	1.5	12.3	0.5	2.8		0.8	0.2	10.3	0.4	0.0	2.9	0.1	1.3	0.5	0.0	0.7	1.3	2.9	4.1	2.7	0.1	2.1	0.6	4.5	9.3	4.3	0.2	0.6	7.2	13.4	0.2	0.0	4.2	4.4	2.5	5.5	2.2	1.1	1.5	0.1	0.2	1.3	7.2	0.9	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.7	0.0	28.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.5	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.6	0.0	0.0	0.0	1.6	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	2.0	1.1	0.4	1.7	0.1	0.9	7.2	5.9	0.1	1.3	0.2	1.5	0.0	0.9										
MOGAT1	"DGAT2L, DGAT2L1, MGAT1"	ENSG00000124003	"Monoacylglycerol O-acyltransferase 1"	Q96PD6	2	222671786-222709930	"Enzymes, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"gallbladder: 40.9"	"Cell line enhanced"	"Detected in single"		"Hep G2: 1.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 3.4"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA049944	Uncertain									"HPA049944: "	"unprognostic (6.32e-2)"		"unprognostic (2.38e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.41e-1)"		"unprognostic (4.28e-3)"	"unprognostic (4.39e-2)"	"unprognostic (4.32e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.59e-2)"	"unprognostic (3.07e-3)"	"unprognostic (4.99e-2)"	"unprognostic (3.89e-1)"	"unprognostic (9.03e-3)"		2.3	0.1	0.6	0.1	0.5	0.1	1.3	0.2	0.9	0.3	0.6	0.5	0.2	0.0	1.0	1.1	0.5	0.1	40.9	0.8	0.5	0.2	5.7	7.6	1.1	0.3	0.2	0.9	0.1	1.5	2.3	0.4	0.0	0.9	0.2	0.1	0.0	1.4	2.6	0.5	1.6	0.2	0.1	0.3	0.1	1.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	3.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	1.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.6	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.5	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.6	0.5	0.2	0.9	0.5	0.2	0.2	0.9	0.9	0.0
MOK	"RAGE, RAGE1, STK30"	ENSG00000080823	"MOK protein kinase"	Q9UQ07	14	102224500-102305200	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"testis: 45.0"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 28.0;hTEC/SVTERT24-B: 71.2;NB-4: 88.6;U-138 MG: 37.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 10.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027292			Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA027292: AB_10600989"	"unprognostic (8.16e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.68e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.49e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.48e-1)"	5.9	6.8	12.9	2.7	17.3	3.7	7.8	9.7	15.9	7.6	3.6	8.7	6.2	4.7	7.6	10.2	3.9	26.4	6.4	8.3	13.5	10.2	7.7	3.6	6.1	2.5	6.0	13.7	12.4	8.6	9.4	22.1	3.6	16.6	5.1	3.0	15.2	6.1	5.4	1.9	8.6	4.1	5.9	6.2	3.8	11.7	45.0	6.2	0.4	11.7	2.3	2.2	6.2	3.9	0.7	3.9	0.9	1.1	10.6	2.4	1.3	3.3	3.0	0.4	1.7	0.7	2.5	0.7	6.8	2.0	9.9	11.9	0.2	8.3	2.5	0.5	1.3	0.7	0.6	3.5	28.0	2.8	2.5	0.6	0.3	2.2	3.0	0.2	3.3	2.1	0.9	71.2	6.6	0.3	0.6	0.1	6.4	2.2	0.2	88.6	0.1	7.2	0.4	0.1	0.0	4.0	0.1	1.1	0.7	1.2	0.4	19.2	2.0	0.2	0.2	37.6	1.9	1.4	2.1	0.2	0.4	0.2	7.5	0.2	17.0	0.0	1.1	0.0	0.7	0.7	1.2	0.0	0.5	1.9	3.9	0.7	1.1	2.4	0.9	10.6	0.1	0.0	0.0	1.3	12.9	17.3	9.7	15.9	13.5	10.2	6.0	13.7	16.6	6.2
MORC1	"CT33, MORC, ZCW6"	ENSG00000114487	"MORC family CW-type zinc finger 1"	Q86VD1	3	108958239-109118142	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 21.0"	"Group enriched"	"Detected in some"	10	"Karpas-707: 4.2;RPMI-8226: 12.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.0"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036413	Enhanced									"HPA036413: AB_10669989"					"unprognostic (1.66e-1)"				"unprognostic (4.30e-2)"	"unprognostic (2.17e-2)"		"unprognostic (2.63e-1)"	"unprognostic (7.45e-6)"	"unprognostic (4.80e-2)"	"unprognostic (2.49e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0
MORN1	FLJ13941	ENSG00000116151	"MORN repeat containing 1"	Q5T089	1	2321253-2391707	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA005858, HPA070703"	Uncertain		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA005858: AB_1848709, HPA070703: "	"unprognostic (1.39e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.21e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (8.88e-3)"	"unprognostic (2.53e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	4.2	4.0	6.9	5.6	15.1	2.5	4.9	25.8	6.6	7.3	4.4	6.1	14.4	4.5	9.3	13.9	3.7	23.5	7.4	3.0	5.5	5.7	7.8	4.1	5.8	3.5	3.9	8.0	15.2	8.6	4.9	11.6	2.5	11.7	6.7	3.1	8.8	9.1	11.7	4.7	6.4	4.3	6.0	4.9	4.6	5.4	17.3	4.8	5.8	15.0	3.3	3.8	3.5	4.6	2.1	3.7	4.2	4.3	0.8	2.6	1.0	6.3	7.6	5.3	4.8	1.8	0.9	5.5	1.9	1.3	3.1	2.7	3.6	7.1	1.7	4.1	1.2	7.8	1.1	3.1	3.1	3.8	8.2	1.7	14.0	4.1	1.6	2.1	0.9	1.1	0.7	3.0	2.6	2.2	2.6	2.0	1.1	8.7	2.1	0.7	3.1	6.7	2.2	4.8	2.7	2.5	2.8	8.7	4.3	5.0	9.3	4.0	4.9	0.6	0.7	3.6	5.2	2.5	2.3	4.7	1.7	1.1	7.2	1.2	2.4	0.0	0.8	0.2	1.4	0.3	0.8	1.0	1.5	1.1	1.0	2.1	2.6	1.2	4.2	0.8	4.3	3.7	0.1	1.0	6.9	15.1	25.8	6.6	5.5	5.7	3.9	8.0	11.7	4.8
MOSPD1	dJ473B4	ENSG00000101928	"Motile sperm domain containing 1"	Q9UJG1	X	134887626-134915267	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031158	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA031158: AB_10603874"	"unprognostic (2.23e-3)"	"unprognostic (3.37e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.36e-1)"	"unprognostic (6.78e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.45e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.15e-1)"	11.0	19.7	6.2	6.5	8.0	12.3	7.9	7.8	10.4	11.1	6.9	8.8	5.5	5.4	19.3	12.5	20.5	25.1	6.6	17.4	7.3	6.2	11.8	10.3	8.0	5.5	9.9	7.4	12.9	8.9	10.3	8.1	23.2	21.2	8.1	7.0	10.3	14.6	7.6	17.6	14.5	6.9	10.7	9.0	8.3	7.5	16.4	7.5	10.2	9.1	13.5	10.1	9.5	12.0	6.2	8.3	12.3	6.8	6.0	14.3	5.1	7.9	6.3	5.3	3.6	8.4	4.9	11.6	13.4	24.4	12.9	12.6	15.3	3.2	2.7	18.7	8.5	2.9	8.2	6.9	17.1	8.9	4.8	2.2	16.6	6.2	35.8	6.3	3.9	8.9	8.5	14.5	6.3	9.4	2.8	10.9	15.6	11.1	4.4	2.8	5.4	14.3	3.3	9.4	5.0	5.5	22.8	3.1	3.9	6.8	6.8	23.1	2.7	3.9	4.7	6.4	3.9	23.7	11.9	8.5	11.4	4.3	8.7	10.8	8.3	6.0	6.8	12.3	7.6	5.0	10.0	6.2	9.0	8.3	7.5	5.1	10.2	9.8	4.0	6.0	5.5	8.3	14.3	5.1	6.2	8.0	7.8	10.4	7.3	6.2	9.9	7.4	21.2	7.5
MOSPD3	"CDS3, NET30"	ENSG00000106330	"Motile sperm domain containing 3"	O75425	7	100612102-100615384	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041137, HPA048240"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA041137: AB_10803996, HPA048240: "	"unprognostic (1.24e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.20e-2)"	13.8	22.3	13.0	7.7	12.8	17.4	9.8	9.0	16.9	14.7	9.1	14.5	13.9	9.9	12.0	12.9	22.5	12.0	14.9	10.2	11.2	10.8	19.3	29.8	11.1	18.5	10.6	11.6	13.1	17.1	6.7	9.8	7.8	12.0	12.9	4.8	14.9	19.1	11.3	11.3	24.4	10.6	10.3	9.5	11.8	14.7	37.0	9.9	16.6	12.2	13.6	16.8	12.4	13.4	11.6	17.9	22.2	16.7	20.9	29.7	8.0	5.9	8.1	6.5	11.2	3.4	2.5	4.6	4.5	5.4	4.7	4.8	7.4	8.0	3.7	10.0	4.1	4.6	3.8	6.5	0.8	9.7	5.0	3.8	6.0	11.1	4.4	2.9	14.9	7.2	5.6	4.0	2.4	8.0	9.0	7.7	4.8	17.6	8.3	22.6	5.9	12.2	7.7	6.7	8.9	7.4	8.9	3.6	21.3	8.5	13.1	4.5	8.0	8.8	9.1	9.2	14.4	18.9	4.3	6.0	5.7	2.5	9.1	33.1	11.2	18.5	16.7	22.2	18.8	12.4	22.2	11.6	21.8	21.8	17.9	11.3	13.0	13.5	12.3	20.9	8.5	12.0	29.7	8.0	13.0	12.8	9.0	16.9	11.2	10.8	10.6	11.6	12.0	9.9
MOV10L1	"CHAMP, DJ402G11.8, DKFZp434B0717"	ENSG00000073146	"Mov10 RISC complex RNA helicase like 1"	Q9BXT6	22	50089879-50161690	"Enzymes, Predicted intracellular proteins"		"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 27.7"	"Cell line enhanced"	"Detected in some"		"HHSteC: 3.2;HUVEC TERT2: 15.7;TIME: 7.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA019034	Approved									"HPA019034: AB_1854070"	"unprognostic (1.39e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.88e-2)"	"unprognostic (7.91e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.43e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.02e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-1)"	0.4	0.1	0.7	0.2	1.5	0.3	0.2	1.3	1.3	0.9	0.8	0.6	0.2	0.1	3.0	2.0	0.4	1.0	1.2	0.3	0.9	0.6	0.3	1.0	0.3	0.2	0.5	1.5	1.8	0.2	0.1	0.4	0.6	2.1	1.0	0.2	0.6	0.2	0.2	0.2	0.3	0.4	1.9	0.7	0.2	0.1	27.7	0.2	0.2	0.5	0.2	0.3	0.4	2.0	0.0	0.0	0.0	0.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.5	1.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	3.2	0.0	1.5	0.2	0.0	0.0	0.0	15.7	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	7.2	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	1.5	1.3	1.3	0.9	0.6	0.5	1.5	2.1	0.2
MPEG1	MPG1	ENSG00000197629	"Macrophage expressed 1"	Q2M385	11	59208510-59212951	"Predicted membrane proteins, Transporters"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 47.3;lymphoid tissue: 108.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.8;HMC-1: 1.3;THP-1: 3.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 47.3;intermediate monocyte: 38.9;myeloid DC: 26.6;non-classical monocyte: 41.6;plasmacytoid DC: 38.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 38.3;monocytes: 47.3"									HPA046801	Approved									"HPA046801: "	"unprognostic (1.24e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.86e-2)"	17.6	6.4	2.2	27.7	2.1	3.6	5.9	1.3	1.8	3.3	9.5	4.9	0.9	9.0	3.2	13.2	3.7	4.9	8.2	7.7	2.2	2.3	7.0	17.3	13.1	51.3	2.6	1.0	4.2	2.7	0.8	2.3	13.4	2.5	5.6	10.0	8.9	7.5	2.4	2.9	2.6	20.6	6.0	3.9	108.6	4.0	3.2	1.7	18.5	3.7	5.5	23.0	11.0	2.7	2.9	38.3	7.0	47.3	0.2	0.1	29.1	0.0	0.0	0.2	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.5	0.5	0.0	0.5	0.4	0.7	0.0	0.5	0.3	0.5	0.2	0.0	0.0	0.0	3.7	0.4	0.0	0.2	0.4	0.0	0.9	0.1	0.5	0.0	0.2	0.1	0.0	47.3	1.4	0.1	38.9	0.1	2.4	0.0	0.0	26.6	2.9	0.0	0.0	7.0	0.2	41.6	38.3	0.1	29.1	2.2	2.1	1.3	1.8	2.2	2.3	2.6	1.0	2.5	1.7
MRGPRD	mrgD	ENSG00000172938	"MAS related GPR family member D"	Q8TDS7	11	68980021-68980986	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 2.5"	"Cell line enhanced"	"Detected in single"		"U-2197: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA031346	Uncertain									"HPA031346: AB_10602710"										"unprognostic (1.92e-1)"		"unprognostic (7.14e-2)"		"unprognostic (1.72e-1)"				0.4	0.4	0.0	0.3	0.0	0.5	0.1	2.0	0.0	0.9	2.5			0.0	1.8	0.0	0.9	0.9	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0		0.1	0.0	0.0	0.0	0.0		0.3	0.1		0.0	2.2	0.0	0.1	0.8	1.1	0.0	0.0	0.5	0.3			0.0		0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MRGPRE	"GPR167, mrgE"	ENSG00000184350	"MAS related GPR family member E"	Q86SM8	11	3227698-3232386	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 34.9"	"Group enriched"	"Detected in some"	6	"NB-4: 2.6;RPMI-8226: 4.9;SCLC-21H: 8.0"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.9"	"Region enriched"	"Detected in many"	14	"pons and medulla: 34.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA046556	Uncertain									"HPA046556: AB_10961404"	"unprognostic (1.18e-1)"			"unprognostic (7.52e-4)"	"unprognostic (1.04e-1)"			"unprognostic (9.09e-2)"		"unprognostic (6.65e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.22e-2)"		"unprognostic (1.19e-1)"		0.1	0.8	0.1	0.1	0.3	2.1	0.8	1.5	2.0	3.5	0.8	0.0	0.0	0.0	2.0	0.7	0.6	1.7	0.5	1.1	0.6	2.3	0.1	0.0	0.3	0.0	2.5	0.0	0.1	0.3	0.0	0.5	1.8	34.9	1.1	0.0	3.9	1.6	1.3	0.1	0.3	0.3	0.5	1.5	1.9	0.1	0.2	0.1	0.0	0.9	0.2	0.0	0.6	1.6	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	4.9	0.0	0.0	8.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.1	0.3	1.5	2.0	0.6	2.3	2.5	0.0	34.9	0.1
MRGPRF	"GPR140, GPR168, MGC21621, mrgF"	ENSG00000172935	"MAS related GPR family member F"	Q96AM1	11	69004395-69013409	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 26.2;ASC TERT1: 11.7;BJ: 14.7;BJ hTERT+: 37.3;BJ hTERT+ SV40 Large T+: 14.0;U-2197: 17.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"cerebellum: 16.6"	"Low region specificity"	"Detected in all"			HPA028811	Approved		Supported	"Nuclear membrane,Plasma membrane"				"Nuclear membrane, Plasma membrane"		"HPA028811: AB_10603875"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.55e-7)"	"unprognostic (2.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.62e-3)"	10.8	1.7	0.8	7.6	1.2	0.0	26.6	7.8	1.5	61.9	39.5	1.2	13.9	4.8	49.2	22.3	28.2	28.0	30.6	6.2	0.7	0.4	4.2	2.1	4.8	5.6	1.1	1.3	25.6	0.9	0.4	1.1	5.9	1.8	29.6	4.8	5.8	2.9	25.5	3.1	4.0	10.1	41.1	1.0	8.2	14.2	13.1	0.6	0.1	3.8	6.4	2.7	42.2	19.6	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.2	11.7	0.5	14.7	37.3	14.0	9.3	0.0	0.6	0.0	0.3	11.3	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.0	0.0	3.3	0.0	0.0	8.6	0.0	8.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	17.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	7.8	1.5	0.7	0.4	1.1	1.3	1.8	0.6
MRGPRG	"GPR169, mrgG"	ENSG00000182170	"MAS related GPR family member G"	Q86SM5	11	3217944-3218813	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	8	"testis: 4.4"	"Group enriched"	"Detected in some"	4	"NB-4: 1.1;REH: 2.5;SCLC-21H: 3.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA058909	Uncertain									"HPA058909: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.3	0.1		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MRO	"B29, C18orf3, FLJ30140"	ENSG00000134042	Maestro	Q9BYG7	18	50795120-50825402	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 17.5;kidney: 24.3;testis: 30.9"	"Group enriched"	"Detected in some"	4	"ASC diff: 4.5;ASC TERT1: 13.7"	"Cancer enriched"	"Detected in some"	7	"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022011	Approved									"HPA022011: AB_2670880"	"unprognostic (9.21e-5)"	"unprognostic (5.22e-2)"	"unprognostic (7.87e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.71e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.99e-3)"	"unprognostic (6.06e-4)"	2.7	3.2	12.2	0.9	13.9	0.6	1.0	4.5	17.5	0.7	0.7	13.9	1.0	8.3	0.5	4.1	0.9	0.7	1.7	4.4	15.4	5.9	24.3	7.7	0.7	0.7	9.1	10.3	3.8	2.2	3.8	1.3	1.2	11.1	0.7	0.6	1.6	0.7	2.7	2.4	0.5	5.3	0.7	10.7	2.5	1.8	30.9	12.4	0.0	6.6	0.0	0.5	0.8	0.6	0.8	0.9	2.1	1.2	0.5	0.4	0.0	0.0	0.0	0.1	0.3	4.5	13.7	1.1	0.0	0.0	0.0	0.0	0.2	0.2	0.4	2.1	0.1	0.0	0.3	0.0	0.0	0.4	0.6	0.1	0.4	0.2	0.4	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.2	1.0	0.5	0.2	0.3	0.9	0.3	0.4	0.3	0.3	0.1	0.8	0.4	0.4	2.1	0.5	1.2	0.9	0.2	0.0	12.2	13.9	4.5	11.2	15.4	5.9	9.1	10.3	11.1	12.4
MROH1	"HEATR7A, KIAA1833"	ENSG00000179832	"Maestro heat like repeat family member 1"	Q8NDA8	8	144148016-144261940	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024287, HPA044465"	Approved	Supported	Approved	Nucleoplasm				Nucleoplasm		"HPA024287: , HPA044465: AB_10960985"	"unprognostic (1.25e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.38e-1)"	"prognostic favourable (6.74e-4)"	"unprognostic (2.97e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.92e-1)"	"prognostic favourable (3.65e-6)"	"unprognostic (1.61e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.48e-2)"	5.7	7.5	11.9	7.6	10.0	19.7	6.1	17.8	16.0	6.0	8.5	4.5	13.0	16.7	5.4	7.3	9.2	6.8	7.0	5.4	7.0	6.0	8.3	5.8	9.4	8.1	5.2	11.7	5.1	17.3	5.4	11.1	8.3	10.3	9.0	4.5	6.9	14.3	9.8	5.2	13.4	14.3	6.5	3.9	11.5	14.0	7.5	5.0	5.2	33.3	3.9	7.5	8.5	6.6	1.9	5.5	4.4	9.5	1.1	5.6	2.8	9.7	4.0	0.5	3.9	1.9	2.0	17.7	4.3	3.0	2.4	3.3	6.8	17.6	5.2	6.3	2.4	9.4	0.6	6.6	1.1	2.9	5.6	6.2	11.7	6.1	4.8	2.7	6.6	3.8	6.9	3.8	5.6	3.4	2.5	2.3	2.7	20.8	4.7	5.8	1.5	19.1	6.2	1.3	5.3	3.5	19.3	4.5	3.9	10.8	10.4	3.2	7.7	3.8	8.5	4.9	9.3	9.9	3.5	4.1	2.0	5.5	9.7	8.4	2.9	4.4	7.4	1.9	2.4	9.5	1.9	1.1	2.1	2.5	5.5	1.9	2.0	1.4	1.5	1.1	7.9	1.7	5.6	2.8	11.9	10.0	17.8	16.0	7.0	6.0	5.2	11.7	10.3	5.0
MROH2B	"DKFZp781F0822, FLJ40243, HEATR7B2"	ENSG00000171495	"Maestro heat like repeat family member 2B"	Q7Z745	5	40998017-41071342	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	107	"testis: 46.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"liver cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059457	Enhanced									"HPA059457: "							"unprognostic (1.81e-1)"	"unprognostic (3.54e-2)"		"unprognostic (1.08e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.91e-5)"	"unprognostic (2.51e-3)"	"unprognostic (2.53e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MROH7	"C1orf175, FLJ46354, HEATR8"	ENSG00000184313	"Maestro heat like repeat family member 7"	Q68CQ1	1	54641754-54710266	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"testis: 54.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.6;SH-SY5Y: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	29	"eosinophil: 2.9"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 2.9"									HPA071840	Enhanced									"HPA071840: "	"unprognostic (1.52e-3)"	"unprognostic (1.51e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.88e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.93e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.38e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.15e-2)"	0.3	0.0	0.5	0.3	0.4	0.5	0.3	0.3	0.4	0.3	1.0	0.3	0.8	0.1	0.3	0.9	0.5	0.4	0.3	0.7	0.3	0.4	0.7	0.3	0.3	0.3	0.3	0.3	1.3	0.3	0.7	1.8	0.3	0.3	0.8	0.3	0.3	1.4	0.6	0.6	0.9	0.4	0.3	0.3	0.3	0.5	54.2	0.3	0.3	2.3	0.3	0.3	0.8	0.3	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.3	0.4	0.3	0.4	0.3	0.3	0.3	0.3
MROH8	"C20orf131, C20orf132, dJ621N11.3, dJ621N11.4"	ENSG00000101353	"Maestro heat like repeat family member 8"	Q9H579	20	37101226-37179588	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"							HPA060298	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA060298: "	"unprognostic (1.16e-2)"	"unprognostic (6.65e-3)"	"unprognostic (5.88e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.17e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.50e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-3)"	"unprognostic (9.70e-3)"	"unprognostic (5.00e-9)"	"unprognostic (1.39e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.62e-1)"	3.6	3.1	4.0	1.8	5.9	2.7	2.9	6.6	7.7	3.4	3.4	4.6	2.4	2.1	4.3	9.5	2.0	4.0	2.2	4.9	3.6	5.0	3.6	4.0	1.7	5.5	3.8	5.0	3.7	4.5	4.8	7.3	1.9	4.1	3.4	2.1	6.2	4.7	5.9	12.0	3.4	1.9	4.1	3.4	2.6	2.5	33.7	2.7	3.1	4.8	2.4	3.7	2.8	2.0	2.6	7.2	8.0	2.2	1.0	2.0	1.1	1.3	3.6	8.8	2.2	3.5	3.5	1.4	1.3	4.9	3.0	3.8	2.3	1.7	7.6	0.4	1.3	2.2	2.3	1.0	2.4	1.3	0.2	2.3	1.9	1.9	3.1	2.4	3.8	2.1	2.2	1.1	0.1	2.4	3.2	1.6	1.9	0.7	6.8	6.9	1.0	2.2	5.9	1.9	1.5	1.7	1.4	3.1	4.2	2.3	0.9	1.5	2.2	2.7	2.8	9.4	1.4	0.5	0.6	2.9	2.2	4.7	3.2	1.6	3.1	1.9	2.1	0.7	1.8	2.2	2.0	2.6	1.2	2.0	1.0	2.5	0.6	1.4	8.0	1.0	1.0	7.2	0.7	1.1	4.0	5.9	6.6	7.7	3.6	5.0	3.8	5.0	4.1	2.7
MS4A10	"CD20L7, MS4A9"	ENSG00000172689	"Membrane spanning 4-domains A10"	Q96PG2	11	60785348-60801305	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	33	"intestine: 115.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;NB-4: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA014778	Uncertain									"HPA014778: "					"unprognostic (7.67e-3)"						"unprognostic (1.28e-1)"	"unprognostic (8.73e-3)"		"unprognostic (1.27e-1)"	"unprognostic (5.21e-2)"			0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	28.3	0.0	0.0	33.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	115.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	3.5	0.5	0.9	0.5	0.1	0.3	0.9	0.4	0.2	0.2	0.0	2.3	0.2	0.1	0.1	0.0	0.8	0.2	0.4	0.3	0.1	0.7	0.2	0.3	0.2	0.0	0.3	2.1	0.7	0.3	0.1	0.5	1.8	0.0	0.0	0.5	0.3	0.0	0.5	1.4	0.7	0.3	0.5	2.4	0.0	0.3	0.2	0.0	1.7	0.1	0.4	1.0	0.9	0.4	0.6	0.0	0.4	0.2	1.4	0.7	0.2	1.4	0.3	0.2	0.2	0.4	0.4	0.7	0.2	3.5	0.4	0.7	0.5	0.3	0.4	0.5	0.3	0.3	0.2	0.8	0.5	0.5	1.4	0.9	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MS4A13		ENSG00000204979	"Membrane spanning 4-domains A13"	Q5J8X5	11	60515413-60542721	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	85	"testis: 8.4"	"Group enriched"	"Detected in some"	5	"U-2 OS: 2.0;U-266/70: 6.2;U-266/84: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045017, HPA063626"	Uncertain									"HPA045017: AB_10962976, HPA063626: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.7	0.0	6.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MS4A14	"DKFZp434H092, FLJ32856, MS4A16, NYD-SP21"	ENSG00000166928	"Membrane spanning 4-domains A14"	Q96JA4	11	60378530-60417756	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 79.3;testis: 53.6"	"Cell line enriched"	"Detected in single"	24	"THP-1: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 6.8;non-classical monocyte: 9.2"	"Lineage enriched"	"Detected in many"	5	"monocytes: 9.2"									HPA058973			Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA058973: "	"unprognostic (1.78e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.50e-6)"	"unprognostic (3.73e-2)"	"unprognostic (7.16e-3)"	"unprognostic (8.40e-2)"	"unprognostic (7.11e-2)"	14.5	4.4	2.0	4.6	2.3	1.5	5.4	0.8	1.5	2.4	3.9	1.9	1.1	1.5	1.9	6.4	1.8	1.3	2.3	6.4	2.5	2.3	3.5	13.3	18.0	11.3	2.4	0.1	1.3	1.5	1.2	3.2	6.0	2.4	3.0	2.2	4.5	2.1	1.6	1.3	1.3	4.0	2.4	5.5	79.3	1.5	53.6	1.5	3.7	1.7	0.7	3.0	2.4	1.7	0.5	1.8	0.1	9.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	4.3	0.0	0.0	6.8	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.1	0.0	9.2	0.0	0.0	0.9	2.0	2.3	0.8	1.5	2.5	2.3	2.4	0.1	2.4	1.5
MS4A15		ENSG00000166961	"Membrane spanning 4-domains A15"	Q8N5U1	11	60756953-60776732	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"blood: 9.9;lung: 32.4"	"Group enriched"	"Detected in some"	4	"HEL: 9.0;Karpas-707: 3.7;MOLT-4: 4.0;U-266/70: 13.2;U-266/84: 5.6"	"Cancer enhanced"	"Detected in many"		"lung cancer: 6.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 9.9"	"Lineage enriched"	"Detected in single"	15	"T-cells: 9.9"	"Region enriched"	"Detected in single"	28	"olfactory region: 205.0"	"Region enriched"	"Detected in single"	29	"olfactory region: 39.1"	HPA054563			Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA054563: "	"unprognostic (1.85e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.59e-2)"	"unprognostic (5.89e-4)"	"unprognostic (4.49e-1)"	"unprognostic (1.09e-3)"		"unprognostic (3.92e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.04e-9)"	"unprognostic (7.02e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-1)"	0.3	0.2	0.3	0.3	0.3	0.0	1.3	0.3	0.3	0.3	0.3	0.3	0.3	0.6	1.8	0.3	0.4	1.0	0.3	0.3	0.3	0.2	0.3	0.3	32.4	0.3	0.3	0.3	2.4	0.3	0.0	0.3	1.1	0.3	0.3	0.5	0.3	0.3	1.9	0.3	0.2	1.4	1.7	0.3	0.3	0.2	0.6	0.3	0.3	0.3	0.3	1.0	0.7	0.3	0.2	0.0	0.0	0.0	0.6	9.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.2	0.1	9.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	1.6	3.7	0.0	0.0	4.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	13.2	5.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	2.9	0.5	0.0	0.0	1.8	0.7	0.0	0.6	0.0	0.0	9.9	0.7	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	0.3
MS4A18		ENSG00000214782	"Membrane spanning 4-domains A18"	Q3C1V0	11	60729304-60744212	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 7.8;intestine: 21.9;testis: 4.3"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 2.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045121	Approved									"HPA045121: AB_10969456"	"unprognostic (1.02e-1)"											"unprognostic (8.87e-2)"		"unprognostic (2.51e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0			21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0		0.0	0.0	0.0	0.1	0.0		0.1	0.0		0.0	0.0	0.0	0.2	3.1	0.0	0.0	0.0	0.0	4.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MS4A2	"APY, FCER1B, IGER, MS4A1"	ENSG00000149534	"Membrane spanning 4-domains A2"	Q01362	11	60088261-60098466	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 72.0"	"Cell line enhanced"	"Detected in some"		"HEL: 6.9;NB-4: 2.6;THP-1: 4.1;U-937: 1.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	720	"basophil: 72.0"	"Lineage enriched"	"Detected in single"	720	"granulocytes: 72.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059967	Enhanced									"HPA059967: "	"unprognostic (7.28e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.50e-4)"	"unprognostic (4.97e-2)"	"unprognostic (4.47e-1)"	"unprognostic (2.40e-6)"	"unprognostic (1.88e-2)"	"unprognostic (6.21e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.63e-3)"	"unprognostic (6.49e-3)"	"unprognostic (9.95e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.74e-1)"	4.9	0.5	0.4	5.1	0.4	0.2	2.1	0.4	0.4	11.9	4.6	0.1	4.5	4.7	14.3	11.2	5.9	1.1	14.6	2.1	0.4	0.4	1.5	0.9	12.9	0.5	0.4	0.1	1.1	1.2	0.2	0.6	0.6	0.1	17.5	5.6	4.5	3.2	5.4	1.5	4.3	7.4	15.9	0.4	0.6	4.5	2.7	0.2	1.2	0.6	6.7	3.4	5.1	4.1	0.0	0.0	72.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.2	0.0	0.3	0.0	0.0	0.1	0.3	0.2	0.4	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.0	6.9	0.4	0.2	0.3	0.8	0.4	0.1	0.1	0.0	0.1	0.1	0.9	0.3	0.0	0.1	0.0	2.6	0.1	0.1	0.1	0.0	0.2	0.0	1.0	0.2	0.1	0.1	0.2	0.0	0.3	4.1	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.2	1.8	0.2	72.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.1	0.1	0.2
MS4A4E		ENSG00000214787	"Membrane spanning 4-domains A4E"	Q96PG1	11	60201253-60243088	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 17.1"	"Cell line enhanced"	"Detected in some"		"K-562: 5.1;NB-4: 1.7;THP-1: 7.3"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in some"	7	"basophil: 17.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 17.1"									HPA040075	Uncertain									"HPA040075: AB_10793915"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.05e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.16e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.97e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.05e-2)"	4.7	2.2	0.2	1.2	0.2	7.1	3.4	0.1	0.2	0.5	1.6			1.0	0.8	1.1	1.2	0.9	2.9	1.2	0.3	0.3	1.0	0.8	1.9	1.6	0.2		0.8	0.8	0.8	0.7	1.0		0.9	1.2		1.9	0.1	0.6	1.0	2.8	3.3	0.5	3.1	1.6	0.5			0.7		0.4	2.1	0.9	0.0	2.4	17.1	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	17.1	0.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	1.3	1.0	0.0	0.2										
MS4A5	CD20L2	ENSG00000166930	"Membrane spanning 4-domains A5"	Q9H3V2	11	60429589-60455214	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	54	"testis: 46.6"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 2.1;U-2 OS: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043732	Uncertain									"HPA043732: AB_10959759"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MS4A6A	"CD20L3, MS4A6"	ENSG00000110077	"Membrane spanning 4-domains A6A"	Q9H2W1	11	60172014-60184666	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 112.4;lymphoid tissue: 89.5"	"Cell line enriched"	"Detected in some"	9	"THP-1: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 32.4;classical monocyte: 112.4;intermediate monocyte: 35.6;myeloid DC: 65.3;plasmacytoid DC: 46.3"	"Group enriched"	"Detected in many"	96	"dendritic cells: 65.3;granulocytes: 32.4;monocytes: 112.4"									HPA011391	Approved									"HPA011391: AB_10603876"	"unprognostic (1.17e-1)"	"prognostic favourable (6.33e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.75e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.97e-2)"	29.3	17.8	12.3	18.3	26.7	9.1	18.1	2.8	14.6	10.2	14.9	4.7	4.0	9.0	7.0	28.3	8.7	11.3	21.0	23.1	10.7	6.9	18.0	35.6	23.0	89.5	22.2	2.4	7.7	6.0	2.4	8.8	21.5	20.5	9.6	19.0	10.2	11.8	6.3	6.0	5.1	20.4	17.2	32.0	78.1	8.5	8.3	19.4	8.5	7.0	6.7	15.4	21.5	6.3	0.7	65.3	32.4	112.4	0.2	0.3	61.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	2.8	3.7	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	31.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	32.4	112.4	0.7	0.1	35.6	0.3	0.7	0.2	0.1	65.3	0.1	0.1	0.1	7.4	0.2	2.3	46.3	0.1	61.3	12.3	26.7	2.8	14.6	10.7	6.9	22.2	2.4	20.5	19.4
MS4A7	"CD20L4, CFFM4, MS4A8"	ENSG00000166927	"Membrane spanning 4-domains A7"	Q9GZW8	11	60378482-60395951	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in all"	4	"blood: 132.8;lymphoid tissue: 126.7"	"Cell line enriched"	"Detected in some"	24	"THP-1: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 71.2;non-classical monocyte: 132.8"	"Lineage enriched"	"Detected in many"	11	"monocytes: 132.8"					"Low region specificity"	"Detected in all"			"HPA017418, CAB026387"	Approved									"CAB026387: , HPA017418: AB_1854137"	"unprognostic (1.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (3.24e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.85e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	24.2	11.9	4.4	15.1	4.9	2.0	9.7	1.3	3.5	5.9	7.4	4.2	2.9	5.2	4.2	11.0	4.0	4.8	15.2	11.3	5.1	3.9	6.8	22.3	29.7	19.1	4.6	1.3	3.2	3.4	2.3	6.2	13.3	5.0	5.9	7.5	8.4	5.3	3.4	2.2	2.3	8.1	4.8	9.9	126.7	4.3	6.0	3.5	7.0	3.3	2.3	5.6	9.7	3.9	2.0	11.9	0.9	132.8	0.1	0.1	10.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.3	0.2	0.0	49.9	0.0	0.0	0.0	0.1	0.1	0.1	0.1	1.2	0.0	1.6	0.0	0.5	18.8	0.2	0.1	71.2	0.1	2.0	0.0	0.0	11.9	1.8	0.0	0.0	0.9	0.1	132.8	0.3	0.0	10.9	4.4	4.9	1.3	3.5	5.1	3.9	4.6	1.3	5.0	3.5
MS4A8	"CD20L5, MS4A4, MS4A8B"	ENSG00000166959	"Membrane spanning 4-domains A8"	Q9BY19	11	60699574-60715811	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"fallopian tube: 36.8;intestine: 123.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;CAPAN-2: 1.7;HDLM-2: 1.6;NB-4: 2.5;RPMI-8226: 4.4;SCLC-21H: 3.2;SH-SY5Y: 1.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 14.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA007318, HPA007319"	Enhanced									"HPA007318: AB_1854139, HPA007319: AB_1854138"	"unprognostic (7.28e-3)"	"unprognostic (2.11e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.52e-2)"			"unprognostic (9.41e-2)"	"unprognostic (4.89e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.40e-9)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-2)"		"unprognostic (1.59e-3)"	0.1	0.2	1.4	2.0	0.2	0.0	0.1	0.2	0.6	7.1	43.9	0.4	0.6	46.6	2.5	5.9	0.3	36.8	8.9	0.3	0.6	0.3	0.2	0.1	8.6	0.1	0.1	0.5	4.2	1.2	0.0	4.7	0.1	1.0	2.3	4.0	0.2	0.4	10.9	0.8	0.1	123.9	0.1	0.1	0.1	12.7	0.7	0.1	0.2	0.1	0.1	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	4.4	0.0	0.0	3.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.2	0.6	0.6	0.3	0.1	0.5	1.0	0.1
MTHFD2L	MGC72244	ENSG00000163738	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like"	Q9H903	4	74114174-74303099	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035434	Uncertain									"HPA035434: AB_10601038"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.42e-4)"	"unprognostic (3.45e-3)"	"unprognostic (4.23e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.81e-3)"	5.4	11.7	10.2	6.0	8.8	5.2	10.3	6.9	8.5	4.5	5.6	5.9	8.2	5.3	5.6	10.9	6.3	5.0	5.6	17.7	9.3	10.7	6.9	16.2	7.0	5.8	10.5	4.1	5.8	13.6	6.1	7.4	5.8	6.6	5.3	4.0	4.8	4.9	6.2	9.3	4.2	5.6	4.9	11.0	5.1	4.1	2.9	7.3	14.8	10.5	5.0	3.8	3.8	8.4	3.9	3.9	1.4	6.5	2.5	2.7	2.5	2.6	2.7	3.9	3.5	1.4	2.1	0.9	3.2	2.5	2.2	2.4	2.0	2.5	2.9	4.4	1.4	1.6	3.1	2.1	3.2	2.9	1.9	3.5	1.8	2.5	2.4	5.4	0.7	1.5	5.0	3.2	7.8	4.6	6.0	3.5	2.6	2.5	10.0	7.7	1.1	3.0	10.2	2.6	4.7	13.9	1.3	3.6	7.9	1.8	2.7	3.3	1.5	3.8	4.6	2.5	3.8	4.7	5.3	3.6	4.6	8.3	15.3	1.3	3.7	0.4	2.1	0.9	0.7	2.0	0.7	3.9	0.6	0.9	3.3	1.5	2.1	2.2	1.4	2.5	6.5	3.9	2.7	2.5	10.2	8.8	6.9	7.3	9.3	10.7	10.5	4.1	6.6	7.3
MTMR11	CRA	ENSG00000014914	"Myotubularin related protein 11"	A4FU01	1	149928651-149936869	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 49.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 11.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"classical monocyte: 1.9;intermediate monocyte: 3.2;myeloid DC: 4.2;non-classical monocyte: 3.0"	"Group enriched"	"Detected in many"	37	"dendritic cells: 4.2;monocytes: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030351	Approved		Approved	Centrosome				Centrosome		"HPA030351: AB_10602185"	"unprognostic (1.14e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-2)"	"unprognostic (5.81e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.12e-2)"	3.2	12.0	4.9	15.0	8.4	0.0	5.4	1.5	3.9	9.5	36.8	2.7	5.8	15.9	10.0	6.2	4.4	7.2	17.0	3.1	2.6	2.8	9.7	1.8	3.4	1.5	2.0	2.8	14.5	2.2	5.8	6.3	9.6	5.2	5.5	20.8	4.5	2.1	6.5	1.1	7.4	49.9	11.4	5.0	1.8	4.0	4.9	2.5	0.0	1.6	4.0	1.5	5.8	6.8	0.0	4.2	0.0	3.2	0.0	0.0	0.5	2.6	6.4	2.8	2.3	8.4	9.5	5.2	2.7	9.2	3.6	4.5	0.1	11.6	0.0	6.3	9.4	3.7	0.3	4.6	2.0	0.2	0.0	0.0	1.9	0.8	2.1	0.0	0.0	5.8	1.5	3.6	6.0	4.3	0.1	0.1	7.0	8.6	0.0	0.1	0.6	2.3	0.0	1.0	0.1	5.4	0.8	0.1	0.2	1.6	2.5	0.9	2.8	0.0	2.9	3.9	4.9	3.3	2.1	0.3	1.1	0.0	3.7	0.0	0.3	0.0	1.9	0.0	0.0	3.2	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.5	4.9	8.4	1.5	3.9	2.6	2.8	2.0	2.8	5.2	2.5
MUC15		ENSG00000169550	"Mucin 15, cell surface associated"	Q8N387	11	26559033-26572233	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 265.1;placenta: 56.8;thyroid gland: 77.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;K-562: 9.8;SK-BR-3: 16.7;U-266/70: 6.6;U-266/84: 17.6"	"Cancer enriched"	"Detected in many"	11	"thyroid cancer: 56.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebellum: 1.3;thalamus: 1.5"	"Low region specificity"	"Detected in all"			"HPA026110, HPA073304"	Enhanced				"Intracellular and membrane"					"HPA026110: AB_1854200, HPA073304: "	"unprognostic (1.49e-1)"	"unprognostic (2.08e-3)"		"unprognostic (7.71e-5)"		"unprognostic (5.09e-3)"	"unprognostic (2.77e-2)"	"unprognostic (3.04e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.54e-3)"	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	3.9	0.0	0.0	9.3	0.0	0.1	265.1	11.0	1.0	0.1	0.1	0.0	0.0	5.2	0.1	4.8	0.1	0.0	0.0	0.1	1.8	0.0	2.1	56.8	0.0	0.8	0.0	0.0	14.4	1.0	0.0	12.0	0.0	0.0	0.0	0.0	0.2	4.1	0.0	1.1	77.8	8.1	1.7	3.0	6.5	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	9.8	0.1	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.6	0.0	16.7	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	6.6	17.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MUM1L1	FLJ33516	ENSG00000157502	"MUM1 like 1"	Q5H9M0	X	106168305-106208956	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 79.4;thyroid gland: 26.9"	"Cell line enhanced"	"Detected in some"		"AF22: 5.1;HHSteC: 2.8;HSkMC: 5.2;LHCN-M2: 9.4;NTERA-2: 3.6;T-47d: 3.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000168, HPA020464"	Enhanced									"HPA000168: AB_1079431, HPA020464: AB_1854209"	"unprognostic (2.79e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.83e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.12e-6)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"		"unprognostic (3.86e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.11e-5)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (2.53e-2)"	1.5	1.8	5.2	0.2	1.3	0.2	0.6	0.1	8.8	7.3	0.2	0.0	2.0	0.2	7.3	4.2	0.3	6.7	0.7	1.9	2.9	2.3	1.0	0.8	0.4	0.2	0.5	4.9	79.4	11.4	0.2	12.8	4.8	4.8	2.3	0.2	0.0	0.2	1.7	4.1	0.2	0.2	1.5	0.3	0.2	0.6	17.0	0.8	0.0	26.9	1.5	0.2	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.1	0.0	0.0	2.8	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.1	3.6	0.0	0.0	1.5	0.0	0.0	0.7	0.0	0.0	0.0	1.2	0.0	3.2	0.0	0.0	0.4	2.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	1.3	0.1	8.8	2.9	2.3	0.5	4.9	4.8	0.8
MYADML2	LOC255275	ENSG00000185105	"Myeloid associated differentiation marker like 2"	A6NDP7	17	81939645-81947233	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	20	"skeletal muscle: 44.5"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 8.2"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA041856, HPA048476"	Uncertain									"HPA041856: , HPA048476: "	"unprognostic (1.83e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.90e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.62e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.16e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.91e-1)"		"unprognostic (8.68e-2)"	0.0	0.0	0.7	0.0	2.0	0.0	0.0	0.4	2.2	0.0	0.0			0.2	0.0	0.0	0.5	0.0	0.0	1.5	0.6	1.5	0.0	0.0	0.0	0.0	1.1		0.0	0.1	0.0	0.0	0.0		0.3	0.0		0.3	0.0	44.5	0.0	0.2	0.0	0.1	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.3	1.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.0	0.1	0.6	0.5	0.0	0.4	0.1	0.0	0.2	8.2	0.6	0.2	0.2	0.6	0.2	0.0	0.0	0.3	0.7	0.2	0.0	1.5	1.1	0.3	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MYEOV	OCIM	ENSG00000172927	"Myeloma overexpressed"	Q96EZ4	11	69294138-69367726	"Predicted membrane proteins"			Proto-oncogene	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 29.4;breast: 16.9;esophagus: 17.3"	"Cell line enhanced"	"Detected in some"		"A-431: 57.8;A549: 27.8;CAPAN-2: 8.5;U-2 OS: 12.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"											HPA012949	Uncertain		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA012949: AB_1854241"	"unprognostic (1.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.36e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.28e-3)"	"unprognostic (7.58e-3)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (3.49e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (1.54e-7)"	"unprognostic (2.83e-1)"	"prognostic unfavourable (1.48e-5)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.69e-2)"	29.4	0.2	0.0	2.4	0.0	0.2	16.9	0.1	0.0	2.6	1.1	0.0	0.4	0.4	0.5	8.1	17.3	0.0	1.3	0.1	0.0	0.2	0.2	8.6	0.1	0.2	0.0	0.1	0.1	2.1	0.0	0.1	0.0	0.0	0.1	0.6	0.9	2.0	0.0	0.6	4.9	0.8	0.1	0.0	0.3	10.7	0.4	0.0	0.1	0.1	5.3	13.6	0.2	4.7	0.5	0.0	0.0	0.1	1.0	0.3	2.1	57.8	27.8	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	8.5	0.2	2.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.7	0.8	0.0	0.0	1.2	0.0	0.0	0.0	2.2	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	1.0	0.1	0.8	0.0	12.8	0.0	0.6	0.1	0.6	0.1	0.0	0.2	1.1	0.0	0.1	0.0	0.2	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0
MYF5	bHLHc2	ENSG00000111049	"Myogenic factor 5"	P13349	12	80716912-80719673	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"skeletal muscle: 23.1;tongue: 13.0"	"Cell line enriched"	"Detected in some"	22	"LHCN-M2: 102.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA041691			Supported	Nucleoplasm				Nucleoplasm		"HPA041691: AB_10796780"						"unprognostic (2.65e-2)"												0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	13.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.4	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYH4	"MYH2B, MyHC-2B, MyHC-IIb"	ENSG00000264424	"Myosin heavy chain 4"	Q9Y623	17	10443290-10469559	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	29	"skeletal muscle: 15.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.5;U-2 OS: 1.4"	"Cancer enriched"	"Detected in single"	115	"liver cancer: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"amygdala: 0.9"	HPA001349	Supported						34000000			"HPA001349: AB_1079437"	"unprognostic (3.27e-2)"		"unprognostic (2.94e-2)"			"unprognostic (4.94e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.72e-1)"			"unprognostic (1.37e-1)"		"unprognostic (3.32e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.52e-4)"		"unprognostic (9.97e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MYL1		ENSG00000168530	"Myosin light chain 1"	P05976	2	210290150-210315190	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"skeletal muscle: 743.1;tongue: 350.7"	"Cell line enriched"	"Detected in some"	5	"HSkMC: 33.8"	"Group enriched"	"Detected in some"	18	"head and neck cancer: 36.0;prostate cancer: 12.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA046859, HPA063034, HPA073827"	Enhanced				"Intracellular and membrane"		20000000			"HPA046859: , HPA063034: , HPA073827: "						"prognostic unfavourable (6.59e-4)"									"unprognostic (1.88e-1)"			12.9	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	16.1	9.9	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	6.1	0.0	0.0	13.4	0.0	743.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	2.4	350.7	9.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.0	0.0	7.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MYL10	"MGC3479, MYLC2PL, PLRLC"	ENSG00000106436	"Myosin light chain 10"	Q9BUA6	7	101613325-101629296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 4.5;skeletal muscle: 9.1"	"Group enriched"	"Detected in some"	7	"PC-3: 12.2;RH-30: 7.0"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019763	Uncertain		Uncertain	Microtubules				Microtubules		"HPA019763: AB_1854243"		"unprognostic (2.32e-2)"		"unprognostic (3.09e-1)"					"unprognostic (1.11e-1)"		"unprognostic (1.74e-2)"	"unprognostic (2.78e-3)"		"unprognostic (5.04e-3)"	"unprognostic (8.93e-2)"		"unprognostic (1.10e-2)"	0.2	0.1	0.2	0.2	0.2	1.5	0.2	0.2	0.3	1.9	0.2	0.2	0.2	0.1	0.9	0.4	0.2	0.4	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	2.7	2.0	0.2	2.9	0.9	0.2	0.3	0.2	9.1	1.1	0.2	0.2	0.2	0.2	0.1	0.9	0.2	0.2	0.2	2.9	0.6	1.0	0.2	1.4	1.0	4.5	0.9	1.4	1.3	0.2	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.8	0.0	0.3	0.1	0.5	0.1	0.2	0.0	0.2	0.2	0.1	0.2	0.1	0.0	0.1	0.2	0.2	0.8	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.5	0.0	0.2	0.3	12.2	0.0	7.0	0.0	0.1	0.5	0.2	0.0	0.1	0.1	1.2	0.2	0.1	0.2	0.6	1.3	0.0	0.2	0.4	0.2	1.2	0.1	0.3	0.0	4.5	0.9	0.8	0.4	0.5	0.4	0.9	0.6	0.8	0.3	1.4	0.9	0.7	3.4	1.4	0.5	1.0	1.3	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
MYL5		ENSG00000215375	"Myosin light chain 5"	Q02045	4	673580-682033	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 61.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA037381, HPA039262"	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA037381: AB_10672484, HPA039262: "	"unprognostic (6.30e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-2)"	9.9	11.4	14.5	10.1	12.7	8.5	12.6	13.4	14.6	6.1	10.9	14.7	14.6	18.0	7.1	19.5	10.6	7.1	8.0	4.9	13.9	11.4	9.7	11.3	7.8	19.5	10.8	10.0	7.5	15.4	13.2	7.7	5.3	10.5	9.8	11.8	10.0	61.5	10.7	18.6	16.2	15.4	10.1	9.3	8.8	7.3	15.5	3.9	7.5	7.5	24.2	9.9	6.5	6.9	11.0	12.6	8.2	9.5	15.4	6.5	4.5	2.2	3.6	13.3	7.0	33.2	22.9	6.4	5.3	7.2	5.5	5.0	4.4	9.3	2.5	2.6	8.7	3.2	2.1	3.7	1.6	4.7	2.6	3.8	5.0	4.1	11.6	5.8	3.5	17.2	3.5	4.3	4.6	3.3	3.9	3.5	6.7	4.1	3.1	4.0	2.8	5.5	2.8	2.8	1.5	9.0	10.4	6.1	3.4	1.8	4.5	3.6	7.3	5.3	5.4	4.7	0.9	4.0	3.1	13.3	2.6	1.5	5.2	5.2	2.4	8.2	7.4	1.1	3.1	4.7	3.9	7.9	5.1	1.8	6.6	11.0	6.5	6.3	5.0	15.4	9.5	12.6	2.3	4.5	14.5	12.7	13.4	14.6	13.9	11.4	10.8	10.0	10.5	3.9
MYLPF	"HUMMLC2B, MRLC2, MYL11"	ENSG00000180209	"Myosin light chain, phosphorylatable, fast skeletal muscle"	Q96A32	16	30370934-30377991	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	27	"skeletal muscle: 689.9;tongue: 215.7"	"Group enriched"	"Detected in some"	18	"BEWO: 25.5;HSkMC: 57.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 15.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	71	"plasmacytoid DC: 16.5"	"Lineage enriched"	"Detected in single"	71	"dendritic cells: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039262, HPA055059"	Enhanced						28000			"HPA039262: , HPA055059: "	"unprognostic (8.81e-3)"	"unprognostic (7.55e-3)"	"unprognostic (1.05e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.37e-3)"	"unprognostic (8.26e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.14e-4)"	"unprognostic (1.84e-1)"	"unprognostic (3.88e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.44e-2)"	16.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	2.1	5.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	10.4	0.0	689.9	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	215.7	5.8	0.0	0.0	0.1	16.5	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	57.3	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	16.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MYO1A	"DFNA48, MYHL"	ENSG00000166866	"Myosin IA"	Q9UBC5	12	57028517-57051198	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"intestine: 148.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;CACO-2: 11.9;Hep G2: 7.9;NB-4: 2.3"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 17.8;pancreatic cancer: 4.8;stomach cancer: 9.8"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.3"	"Group enriched"	"Detected in some"	5	"classical monocyte: 1.2;intermediate monocyte: 1.1;myeloid DC: 2.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;monocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053490	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA053490: "	"unprognostic (2.77e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.04e-2)"	"unprognostic (4.26e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.01e-1)"	"unprognostic (5.81e-2)"	"unprognostic (8.72e-2)"	0.1	0.1	0.1	5.2	0.2	0.0	0.1	0.1	0.2	0.1	57.2	0.3	0.1	70.0	0.1	0.1	0.1	0.1	5.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.2	1.3	0.1	14.1	0.1	0.2	0.1	0.1	0.1	148.0	0.4	4.7	0.1	3.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	2.9	0.0	1.2	0.0	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	11.9	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	7.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	2.3	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.8	0.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	1.1	0.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.5	0.1	1.3	0.1
MYO3B		ENSG00000071909	"Myosin IIIB"	Q8WXR4	2	170178145-170655171	"Enzymes, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 20.0;parathyroid gland: 12.6;retina: 21.6"	"Group enriched"	"Detected in some"	10	"HDLM-2: 11.0;HEL: 10.1;RT4: 11.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.4;naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.4"	"Region enriched"	"Detected in single"	5	"basal ganglia: 4.7"	"Not detected"	"Not detected"			HPA045483	Approved									"HPA045483: "	"unprognostic (1.65e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.61e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.12e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.25e-5)"	"unprognostic (2.34e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.07e-1)"	0.2	0.2	0.3	0.0	0.3	0.0	0.2	0.2	0.3	0.6	0.2	0.0	4.6	0.0	0.3	20.0	0.3	0.5	0.0	0.3	0.3	0.5	8.5	0.2	0.3	0.5	0.3	0.3	0.4	2.2	12.6	1.0	0.0	0.3	0.3	0.0	21.6	1.4	1.1	0.2	0.5	0.2	0.5	0.2	0.3	0.2	4.2	0.0	0.0	2.2	0.0	0.8	4.4	0.3	0.1	0.3	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.2	0.3	0.3	0.5	0.3	0.3	0.3	0.0
MYRFL	"bcm1377, C12orf15, C12orf28, FLJ25056"	ENSG00000166268	"Myelin regulatory factor-like"	Q96LU7	12	69825304-69959097	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	15	"intestine: 56.1"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 6.8;SK-BR-3: 3.4;T-47d: 15.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"cerebellum: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049340	Approved		Approved	Nucleoli	"Intracellular and membrane"			Nucleoli		"HPA049340: AB_2680719"	"unprognostic (2.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.08e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.96e-2)"	0.3	0.3	0.5	0.0	0.6	0.0	0.5	3.6	0.6	0.1	20.7	0.0	0.4	21.4	0.1	0.9	0.1	0.1	0.7	0.2	0.4	0.2	2.0	0.3	0.2	0.2	0.5	0.2	0.0	0.8	0.0	1.0	0.3	0.7	0.6	0.1	0.3	1.3	0.4	0.0	1.6	56.1	0.1	1.0	0.1	0.1	2.4	0.5	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	6.8	0.0	0.1	0.0	1.1	1.0	0.0	0.3	0.1	0.0	3.4	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.4	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	3.6	0.6	0.4	0.2	0.5	0.2	0.7	0.5
MYT1L	"KIAA1106, NZF1, ZC2H2C2, ZC2HC4B"	ENSG00000186487	"Myelin transcription factor 1 like"	Q9UL68	2	1789113-2331348	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Autism spectrum disorder, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 50.2"	"Group enriched"	"Detected in some"	9	"SCLC-21H: 11.0;SH-SY5Y: 8.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3;naive CD8 T-cell: 1.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 2.3;T-cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060245			Approved	Vesicles				Vesicles		"HPA060245: "	"unprognostic (9.90e-3)"	"unprognostic (3.74e-1)"		"unprognostic (1.30e-1)"	"unprognostic (9.61e-3)"	"unprognostic (7.17e-2)"		"unprognostic (3.73e-2)"		"unprognostic (2.44e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-2)"	1.2	3.4	11.0	1.4	20.0	1.1	1.1	19.5	50.2	1.1	1.2	0.5	0.0	1.1	1.2	1.1	1.3	1.1	1.1	1.1	15.6	10.3	1.1	1.1	1.1	1.2	5.1	14.5	1.1	1.5	1.0	10.7	1.1	6.8	1.3	1.3	0.4	1.1	1.1	1.1	1.1	1.2	1.1	1.5	1.0	1.1	4.6	2.0	0.0	1.1	0.0	1.1	1.1	0.0	0.0	0.2	2.3	0.0	0.0	1.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.6	0.1	0.0	0.0	11.0	8.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.2	0.0	0.6	11.0	20.0	19.5	26.7	15.6	10.3	5.1	14.5	6.8	2.0
N4BP2L1	CG018	ENSG00000139597	"NEDD4 binding protein 2 like 1"	Q5TBK1	13	32400723-32428311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 13.0;NB-4: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038971	Approved		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038971: AB_10673408"	"unprognostic (2.66e-3)"	"unprognostic (2.38e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.32e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.40e-2)"	"prognostic favourable (3.11e-4)"	"unprognostic (6.91e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.57e-3)"	12.1	9.4	19.6	10.5	22.2	29.5	22.1	24.5	21.8	12.3	11.0	9.4	4.2	11.6	14.6	12.8	8.3	14.0	9.6	6.3	15.0	16.6	7.4	57.8	17.3	17.6	12.1	18.8	30.1	11.0	7.3	21.2	10.0	11.0	11.3	11.3	7.3	7.6	9.5	11.0	17.5	13.4	11.3	10.6	19.2	7.2	3.6	15.5	14.2	10.4	5.1	12.9	13.5	16.5	15.9	28.0	24.2	25.5	15.2	13.5	17.4	0.5	0.1	0.7	0.2	2.9	2.3	0.2	0.3	1.2	0.7	1.1	2.1	2.9	5.6	0.8	0.6	0.0	2.1	0.2	0.9	8.4	1.3	13.0	0.6	6.2	4.5	4.8	0.8	1.6	0.5	0.5	0.6	0.4	0.0	10.4	0.5	0.4	9.9	32.8	1.0	0.3	9.5	0.3	4.7	2.8	1.0	1.9	2.4	2.1	0.0	0.9	0.3	9.3	0.2	0.2	0.1	0.1	0.1	5.9	3.5	0.3	0.3	1.8	0.4	24.2	25.5	6.6	9.8	23.1	8.5	14.0	9.5	11.9	21.9	15.9	13.1	11.3	6.2	15.2	15.8	28.0	13.5	17.4	19.6	22.2	24.5	21.8	15.0	16.6	12.1	18.8	11.0	15.5
NANOGNB		ENSG00000205857	"NANOG neighbor homeobox"	Q7Z5D8	12	7765216-7774121	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.0;testis: 2.0"	"Cell line enhanced"	"Detected in some"		"A549: 2.0;HL-60: 1.7;HSkMC: 1.6;U-2197: 2.9"	"Cancer enriched"	"Detected in single"	18	"testis cancer: 1.2"					"Group enriched"	"Detected in some"	4	"basophil: 1.8;neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.0"									HPA060371	Uncertain									"HPA060371: "															"unprognostic (2.76e-1)"			0.1	0.3	0.1	0.7	0.1	1.4	0.1	0.1	0.1	0.9	0.1			0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1		0.1	1.2	0.6	0.1	0.0		0.1	0.0		0.1	0.3	0.9	0.5	0.1	0.0	0.1	0.2	0.1	2.0			0.1		0.0	0.1	0.1	0.4	0.2	2.0	0.4	0.3	0.4	0.1	0.1	2.0	0.2	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.5	0.4	1.0	0.0	0.0	1.7	0.0	1.6	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.9	0.2	0.0	0.1	0.4	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.9	0.4	1.3	2.9	0.2	0.9	0.5	0.1	0.8	0.2	0.0	1.8	0.3	0.3	0.4	0.4	0.4	0.2	0.3	0.3	0.0	0.4	0.4	0.3	2.0	0.3	0.3	0.2	0.1	0.1										
NAP1L3	"MB20, MGC26312, NPL3"	ENSG00000186310	"Nucleosome assembly protein 1 like 3"	Q99457	X	93670930-93673568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.2"	"Cell line enhanced"	"Detected in some"		"AF22: 10.2;HAP1: 9.9;NTERA-2: 18.1;RH-30: 8.0;U-2 OS: 8.3;U-2197: 12.1"	"Cancer enhanced"	"Detected in many"		"glioma: 12.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 6.9"	"Group enriched"	"Detected in many"	24	"NK-cells: 4.5;T-cells: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026075			Approved	Vesicles				Vesicles		"HPA026075: AB_1854301"	"unprognostic (7.18e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.26e-2)"	"unprognostic (4.83e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.23e-4)"	2.3	10.4	24.4	2.4	25.7	1.2	2.4	44.9	60.2	16.0	2.4	5.3	0.0	1.6	9.5	4.7	1.5	8.1	4.4	8.4	22.0	42.3	2.9	1.4	1.8	2.1	18.5	31.0	13.1	1.5	1.1	7.9	1.6	20.9	3.9	2.3	2.4	1.6	4.6	0.8	1.7	2.0	6.5	13.1	3.6	1.4	11.9	7.0	0.0	4.6	0.0	1.5	3.3	1.2	0.0	0.0	0.2	0.0	4.5	6.9	1.6	0.0	0.1	10.2	7.4	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	5.6	0.0	9.9	0.0	0.0	0.0	0.2	4.7	0.0	0.1	0.5	0.0	0.3	4.7	0.0	0.5	4.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	18.1	4.2	0.0	8.0	0.0	0.3	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.5	0.0	5.7	8.3	12.1	0.5	7.7	3.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	3.0	0.0	1.1	0.0	4.3	1.6	0.0	0.0	6.9	4.8	0.2	4.5	0.0	0.0	1.3	1.6	24.4	25.7	44.9	60.2	22.0	42.3	18.5	31.0	20.9	7.0
NAT16	"C7orf52, FLJ39237"	ENSG00000167011	"N-acetyltransferase 16 (putative)"	Q8N8M0	7	101170493-101180276	"Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.1;pancreas: 6.0;pituitary gland: 5.8;thyroid gland: 4.6"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 4.5;SH-SY5Y: 6.8;SK-MEL-30: 5.0;U-2 OS: 5.9;U-87 MG: 3.4"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.1"	"Group enriched"	"Detected in many"	4	"amygdala: 3.1;basal ganglia: 9.1;cerebral cortex: 2.9;hypothalamus: 4.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA021918	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA021918: AB_1848922"	"unprognostic (4.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.69e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.35e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.53e-5)"	"unprognostic (7.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.02e-5)"	"unprognostic (1.59e-1)"	0.2	0.4	3.1	0.2	9.1	0.7	0.1	0.4	8.2	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.1	0.2	0.1	0.1	0.9	4.8	0.1	0.5	0.1	0.2	0.7	0.6	0.1	6.0	0.2	5.8	0.1	0.8	0.2	0.3	0.5	0.3	0.1	0.3	0.4	0.2	0.2	0.4	0.3	1.2	0.4	1.2	0.0	4.6	0.0	0.0	0.1	0.0	1.2	0.7	2.2	0.6	1.3	0.8	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.1	0.0	0.0	1.3	0.5	0.5	0.1	0.1	0.8	0.6	0.2	0.1	4.5	0.0	0.4	0.1	6.8	0.0	0.3	5.0	0.3	0.0	0.0	0.4	5.9	0.5	0.1	0.1	0.0	0.1	3.4	0.0	1.6	0.4	0.6	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.2	1.2	0.8	0.4	2.2	1.3	0.3	0.7	0.3	0.0	3.1	9.1	0.4	2.9	0.9	4.8	0.7	0.6	0.8	1.2
NAT6	FUS2	ENSG00000243477	"N-acetyltransferase 6"	Q93015	3	50296402-50299421	"Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 59.3"	"Cell line enhanced"	"Detected in all"		"HMC-1: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"eosinophil: 29.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039576	Approved									"HPA039576: AB_10794750"	"prognostic favourable (3.62e-4)"	"unprognostic (1.02e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.78e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.38e-2)"	"prognostic favourable (1.71e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.16e-2)"	"unprognostic (2.55e-1)"	7.9	6.9	9.3	7.7	17.5	30.6	8.6	15.4	24.8	9.6	7.0	8.8	12.9	6.8	10.7	11.1	9.7	10.6	11.6	10.9	11.5	9.9	8.9	8.8	9.8	10.1	8.8	12.1	13.4	8.8	14.5	8.8	6.3	22.3	10.6	8.7	8.5	13.2	12.6	12.0	15.5	7.9	7.6	8.9	9.9	10.0	59.3	6.7	7.2	8.8	11.1	10.4	8.0	9.3	6.1	2.8	29.0	2.3	5.3	6.1	2.8	4.0	3.1	4.7	4.9	5.7	6.7	3.1	3.8	7.7	6.1	5.2	2.6	7.7	12.4	2.8	6.6	5.1	2.9	12.5	2.5	7.8	4.9	24.7	17.7	6.2	5.1	4.1	31.8	8.0	8.8	10.2	7.1	7.3	2.2	11.8	5.4	4.2	4.8	18.9	2.6	10.4	3.2	1.6	14.8	10.3	2.0	3.3	4.7	4.3	9.1	1.8	3.9	12.1	5.9	4.9	4.9	5.9	3.6	8.0	4.2	3.0	8.4	7.8	4.5	6.7	1.6	29.0	4.2	2.3	6.1	6.1	5.7	5.0	2.8	4.3	4.6	3.7	0.5	5.3	1.4	1.4	5.1	2.8	9.3	17.5	15.4	24.8	11.5	9.9	8.8	12.1	22.3	6.7
NBEAL1	"ALS2CR16, ALS2CR17, MGC164581"	ENSG00000144426	"Neurobeachin like 1"	Q6ZS30	2	203014879-203226378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							"HPA049189, HPA049447"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA049189: , HPA049447: "	"unprognostic (3.66e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.52e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.77e-3)"	"unprognostic (2.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.98e-3)"	"unprognostic (7.59e-2)"	11.2	7.8	5.2	7.3	7.9	2.7	13.4	7.5	6.0	9.2	14.5	6.5	8.4	9.9	19.1	7.0	8.7	7.9	8.9	8.2	4.8	2.9	14.4	12.3	14.7	3.3	5.1	2.7	8.8	8.5	9.2	13.6	10.2	7.0	6.7	14.4	9.7	8.1	10.6	6.9	6.6	11.7	11.9	7.3	5.0	14.7	9.9	6.2	2.8	10.1	6.4	5.3	9.8	9.5	0.9	0.7	0.9	0.6	0.6	3.0	0.2	4.9	4.6	1.9	1.7	12.0	9.4	2.7	4.7	3.5	2.5	3.9	5.2	2.6	1.1	3.9	7.9	4.0	3.8	5.5	5.9	2.2	1.6	1.9	6.9	2.9	2.9	1.7	2.3	3.6	3.7	4.2	5.2	4.0	3.3	1.7	5.7	3.4	0.7	0.9	0.9	4.3	0.8	3.2	1.1	7.1	9.2	1.2	0.9	4.1	3.0	3.1	3.5	1.7	6.7	6.7	5.7	3.2	2.1	2.9	2.2	1.5	4.0	0.8	2.3	0.0	0.5	0.9	0.8	0.4	1.0	0.4	0.9	0.5	0.4	0.9	0.7	0.5	0.3	0.6	0.6	0.7	3.0	0.2	5.2	7.9	7.5	6.0	4.8	2.9	5.1	2.7	7.0	6.2
NBPF11	NBPF24	ENSG00000263956	"NBPF member 11"	Q86T75	1	148102046-148152322	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA038748: , HPA038752: , HPA042595: , HPA043105: , HPA044023: , HPA046971: , HPA058050: "	"unprognostic (2.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (6.87e-4)"	"unprognostic (8.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.78e-2)"	"unprognostic (6.67e-6)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.68e-1)"	"prognostic favourable (3.20e-5)"	1.5	2.1	3.4	2.1	3.9	3.0	3.8	5.7	5.3	4.6	1.5	3.1	9.6	1.4	5.7	9.6	1.2	3.0	1.5	0.7	3.0		1.4	3.7	3.3	3.0	6.0	1.1	5.3	3.2	5.4	1.6	3.3	4.4	2.9	2.4	3.4	3.2	5.6	0.6	5.7	2.0	3.0	5.7	3.1	2.1	1.5	3.1	1.5	3.0	0.0	3.5	1.3	0.0	5.2	3.9	6.1	3.5	1.0	4.1	1.0	5.6	4.5	8.9	8.6	6.2	5.2	6.0	5.1	4.7	4.3	4.6	3.5	5.7	9.4	4.0	6.0	7.3	5.6	1.9	5.3	5.1	6.1	4.1	14.0	3.7	4.4	5.9	15.2	4.5	5.2	5.5	10.4	3.1	6.7	0.6	4.3	11.0	6.7	10.7	7.8	5.8	9.1	5.2	3.6	4.2	10.9	3.6	9.4	8.0	5.5	7.6	8.0	10.1	7.7	5.7	4.7	8.8	6.4	5.6	4.6	6.5	5.4	3.8	3.2	6.1	1.9	5.7	4.1	1.3	2.9	3.3	3.4	2.4	1.9	5.2	3.8	2.9	0.3	1.0	3.5	3.9	1.3	1.0										
NBPF15	"MGC8902, NBPF16"	ENSG00000266338	"NBPF member 15"	Q8N660	1	144421386-144461674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 3.1;NK-cells: 2.7;T-cells: 5.5"									"HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: "	"unprognostic (1.38e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.84e-3)"	"unprognostic (3.50e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavourable (4.11e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.26e-2)"	2.2	1.1	1.3	2.7	3.3	0.0	4.9	6.1	3.6	3.2	1.1	1.8	2.9	0.4	4.0	7.7	1.7	2.4	1.9	0.5	7.1		1.5	4.9	2.8	5.0	1.4	1.5	3.4	1.7	3.6	3.2	2.7	4.2	2.8	2.1	3.0	5.2	3.1	0.7	2.2	0.7	3.8	6.3	3.6	0.9	0.9	4.8	1.0	3.0	1.9	3.7	1.4	0.5	3.1	0.2	0.6	0.4	2.7	5.5	1.8	7.4	4.8	8.9	16.6	10.5	16.6	10.9	13.5	13.2	8.3	8.5	4.2	8.1	3.7	3.7	9.8	5.8	9.7	4.3	13.2	12.4	5.2	0.3	11.0	5.2	8.0	0.3	3.7	13.5	7.6	9.8	20.6	11.5	1.6	11.4	19.9	15.9	0.2	3.3	3.6	11.0	3.3	5.2	5.9	9.1	6.8	0.8	20.0	5.7	8.8	9.3	8.8	3.3	12.3	13.4	8.8	11.8	12.5	10.1	10.9	6.4	0.2	0.4	6.2	0.2	0.3	0.1	1.3	0.0	1.9	3.1	3.5	2.4	0.2	1.8	4.2	1.6	0.6	2.7	0.4	0.2	5.5	1.8										
NBPF3	AE2	ENSG00000142794	"NBPF member 3"	Q9H094	1	21440128-21485005	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"testis: 29.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 15.1;HHSteC: 14.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA042595, HPA043692, HPA044023, HPA046971, HPA058050"	Supported		Approved	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA042595: , HPA043692: , HPA044023: , HPA046971: , HPA058050: "	"unprognostic (5.49e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.31e-5)"	"unprognostic (8.35e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.66e-2)"	3.2	5.1	4.5	2.6	4.6	2.3	6.5	12.7	5.3	4.1	3.5	3.7	4.2	1.5	3.7	4.6	3.7	3.6	2.9	2.8	4.7	3.5	4.0	4.6	3.0	3.0	5.0	3.8	4.7	4.3	2.6	9.4	11.7	4.5	4.5	3.6	3.3	4.9	4.0	2.2	6.2	4.0	5.3	4.6	3.2	4.7	29.5	4.9	2.4	4.8	1.3	4.5	5.1	5.6	1.1	0.3	2.3	0.7	1.1	5.3	1.6	1.7	2.4	0.2	5.6	3.7	1.3	4.7	3.2	15.1	4.4	3.7	3.3	5.7	2.8	1.3	8.3	0.2	2.6	3.8	0.5	1.5	2.9	1.9	0.1	1.2	14.6	1.1	1.9	1.0	1.1	4.0	0.7	0.4	0.8	1.0	1.0	6.3	0.0	2.8	0.8	3.5	0.0	0.0	2.6	0.7	2.4	3.9	4.0	4.9	1.3	3.9	1.8	2.4	3.6	1.8	2.2	5.5	1.3	0.0	1.6	4.5	0.4	2.4	2.5	0.0	0.5	2.3	3.8	0.7	5.3	1.1	1.6	3.0	0.3	0.5	2.8	3.5	0.2	1.1	0.0	0.0	1.5	1.6	4.5	4.6	12.7	5.3	4.7	3.5	5.0	3.8	4.5	4.9
NBPF4	FLJ32833	ENSG00000196427	"NBPF member 4"	Q96M43	1	108223341-108244081	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 3.1;testis: 8.8"	"Group enriched"	"Detected in some"	4	"BEWO: 8.0;K-562: 11.5;Karpas-707: 3.4;MCF7: 13.6;THP-1: 4.1"	"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA045044: , HPA046411: , HPA047447: , HPA058050: "	"unprognostic (6.33e-2)"		"unprognostic (2.08e-1)"						"unprognostic (2.18e-2)"					"unprognostic (8.29e-2)"	"unprognostic (2.90e-1)"		"unprognostic (8.73e-2)"	0.0	0.0	0.0	0.0	1.0	0.0	1.3	0.0	0.0	0.0	0.6			0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.5	1.4		0.0	0.8		0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	8.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	3.4	0.0	13.6	0.0	0.0	0.6	0.0	0.0	2.0	0.6	0.0	0.0	0.3	0.0	0.0	0.2	1.6	0.2	4.1	0.0	0.0	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NBPF6		ENSG00000186086	"NBPF member 6"	Q5VWK0	1	108450282-108471002	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 1.9;testis: 7.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.7;K-562: 13.6;SK-BR-3: 3.3;SK-MEL-30: 2.4"	"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA045044: , HPA046411: , HPA047447: , HPA058050: "	"unprognostic (4.36e-2)"		"unprognostic (5.87e-2)"						"unprognostic (4.62e-2)"					"unprognostic (2.39e-1)"	"unprognostic (2.61e-1)"		"unprognostic (8.02e-2)"	0.0	0.0	0.0	0.0	1.7	0.0	1.1	0.0	0.1	0.0	0.1			0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.6	1.4		0.0	0.9		0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.1			0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	1.5	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	3.3	2.4	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NDN	"HsT16328, PWCR"	ENSG00000182636	"Necdin, MAGE family member"	Q99608	15	23685400-23687330	"Plasma proteins, Predicted membrane proteins"	"Growth regulation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 20.7;ASC diff: 20.4;HSkMC: 27.5;NTERA-2: 16.5;U-2 OS: 30.8;U-266/70: 19.5;U-266/84: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.5;plasmacytoid DC: 4.3"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074457			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA074457: "	"unprognostic (3.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.04e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavourable (4.52e-4)"	"unprognostic (1.89e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.81e-2)"	29.9	35.5	19.2	7.7	39.1	1.3	25.0	2.6	28.2	32.7	12.9	12.9	8.1	8.0	29.9	17.7	12.3	21.4	19.1	20.3	18.1	40.3	6.9	3.0	10.3	8.9	14.8	17.6	50.7	7.1	2.1	23.2	22.4	19.0	18.8	8.1	16.5	9.2	29.3	9.2	4.7	8.4	23.5	11.8	11.8	8.6	16.4	7.3	7.1	8.4	8.7	4.9	13.1	17.3	0.0	4.3	0.0	0.8	0.4	0.0	0.0	0.0	0.0	20.7	0.0	20.4	7.8	0.0	13.1	0.0	0.3	3.6	0.0	0.0	0.0	0.0	3.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	12.0	27.5	0.0	3.8	0.0	0.0	0.4	0.0	6.7	0.0	9.8	0.0	16.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.1	0.0	3.5	0.0	0.0	1.0	30.8	0.0	0.0	19.5	18.1	0.0	2.1	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.6	4.3	0.0	0.0	19.2	39.1	2.6	28.2	18.1	40.3	14.8	17.6	19.0	7.3
NDST3	HSST3	ENSG00000164100	"N-deacetylase and N-sulfotransferase 3"	O95803	4	118033618-118258648	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 22.2;lymphoid tissue: 6.8;pituitary gland: 7.6"	"Cell line enriched"	"Detected in single"	19	"MOLT-4: 18.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 17.0;cerebellum: 22.2;cerebral cortex: 5.7"	"Cell type enhanced"	"Detected in some"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056189	Uncertain									"HPA056189: "	"unprognostic (1.95e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.34e-3)"	"unprognostic (2.55e-7)"	"unprognostic (4.05e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.39e-3)"	"unprognostic (6.83e-2)"	"unprognostic (8.85e-2)"	0.3	2.0	3.2	0.3	17.0	0.6	0.3	22.2	6.9	2.1	0.4	0.0	0.0	0.3	0.4	0.2	0.3	1.3	0.4	0.3	2.3	2.0	0.9	4.6	0.4	0.6	0.9	1.7	0.6	0.2	0.2	7.6	0.4	1.7	0.5	0.4	1.3	0.2	1.2	0.3	0.4	0.4	0.4	0.6	6.8	1.0	0.5	2.4	6.8	0.6	0.0	0.4	0.3	0.3	0.3	0.4	1.3	0.2	0.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.9	1.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	1.3	0.4	0.1	0.4	0.0	0.0	3.2	17.0	22.2	5.7	2.3	2.0	0.9	1.7	1.7	2.4
NDST4		ENSG00000138653	"N-deacetylase and N-sulfotransferase 4"	Q9H3R1	4	114827763-115113876	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 34.6"	"Cell line enriched"	"Detected in some"	4	"RH-30: 17.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	17	"pons and medulla: 34.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA011129	Uncertain									"HPA011129: AB_1079460"	"unprognostic (5.58e-2)"				"unprognostic (5.90e-2)"					"unprognostic (4.82e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.94e-1)"		"unprognostic (6.55e-2)"	0.1	0.0	1.3	0.0	1.7	0.0	0.1	0.2	3.4	1.4	0.3	0.3	0.3	0.1	1.5	0.0	0.1	0.1	0.3	0.1	0.7	1.9	0.1	0.0	0.1	0.0	1.3	1.4	5.7	0.1	0.0	0.6	0.0	34.6	1.5	0.1	0.0	0.5	0.6	0.1	0.2	0.1	1.6	1.0	2.5	1.1	0.7	0.0	0.0	0.1	0.1	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.7	0.2	1.7	0.7	1.9	1.3	1.4	34.6	0.0
NEK10	FLJ32685	ENSG00000163491	"NIMA related kinase 10"	Q6ZWH5	3	27110085-27369460	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 31.4"	"Cell line enhanced"	"Detected in many"		"BJ: 7.6;LHCN-M2: 10.5;U-2 OS: 8.9"	"Cancer enriched"	"Detected in single"	5	"breast cancer: 1.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038941	Uncertain		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA038941: AB_10673600"	"prognostic favourable (4.20e-4)"	"unprognostic (2.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.14e-1)"	0.4	0.5	4.5	0.5	14.6	0.4	14.2	0.6	6.8	1.6	2.0	1.1	2.0	2.5	0.9	8.3	2.0	10.5	2.1	3.1	8.4	3.8	1.4	2.5	4.5	0.6	0.8	6.7	2.7	0.8	0.5	9.0	0.3	3.4	1.9	0.7	1.3	0.5	1.4	10.5	0.4	1.0	1.2	0.8	0.6	1.1	31.4	1.3	0.3	0.8	0.3	0.7	1.4	0.4	0.4	0.2	1.9	0.1	0.1	0.6	0.1	1.0	2.0	1.0	1.2	0.9	2.0	0.4	7.6	1.2	2.1	1.9	0.0	0.5	0.7	1.9	3.2	0.1	0.5	0.5	2.3	1.4	0.8	0.2	4.1	3.7	0.2	0.4	1.0	2.4	0.5	3.2	0.1	1.4	0.1	0.7	10.5	0.1	0.8	0.5	0.7	0.3	1.0	0.4	0.3	4.0	0.6	0.2	0.2	1.2	0.4	0.6	6.1	0.4	0.9	5.6	8.9	0.3	0.7	0.3	0.2	0.5	4.8	0.8	2.1	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.5	0.4	0.0	0.4	0.1	0.5	1.9	0.1	0.0	0.2	0.0	0.1	4.5	14.6	0.6	6.8	8.4	3.8	0.8	6.7	3.4	1.3
NEK5		ENSG00000197168	"NIMA related kinase 5"	Q6P3R8	13	52033611-52129078	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 11.8;fallopian tube: 12.7;testis: 15.7"	"Cell line enhanced"	"Detected in some"		"T-47d: 4.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035565, HPA041399"	Enhanced									"HPA035565: AB_10672095, HPA041399: "	"unprognostic (4.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.80e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.57e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-3)"	"unprognostic (9.44e-3)"	0.6	0.3	3.2	1.4	3.2	0.7	0.9	0.4	2.6	0.9	0.4	5.4	0.3	0.5	2.5	3.0	0.4	12.7	0.5	1.3	3.2	1.6	0.9	0.3	4.9	0.5	0.7	1.3	2.8	0.5	0.9	5.3	0.8	11.8	1.5	0.4	0.3	0.5	0.3	0.6	0.5	0.4	0.5	0.9	0.4	0.3	15.7	2.1	0.0	0.7	0.0	0.3	0.4	0.4	0.9	1.1	2.5	0.5	0.6	0.4	0.0	0.5	0.6	0.4	2.2	0.3	1.4	2.8	0.0	0.0	0.0	0.3	0.2	1.4	0.7	0.2	0.0	0.5	0.3	0.5	0.1	0.2	0.4	0.8	0.8	0.5	0.4	1.4	1.7	0.4	1.1	0.2	0.8	0.3	1.5	1.0	0.0	1.7	0.7	1.1	0.6	0.8	0.3	0.2	0.0	2.4	0.6	0.8	1.1	0.5	0.0	1.2	4.2	1.7	0.6	0.2	0.3	0.2	0.3	0.4	0.2	0.4	0.1	0.3	0.4	2.5	0.5	0.1	0.3	0.3	0.4	0.5	0.2	0.2	0.1	0.9	0.3	0.3	0.9	0.6	0.1	1.1	0.2	0.0	3.2	3.2	0.4	2.6	3.2	1.6	0.7	1.3	11.8	2.1
NEMP2	TMEM194B	ENSG00000189362	"Nuclear envelope integral membrane protein 2"	A6NFY4	2	190504342-190534722	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 27.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							HPA057719			Approved	Nucleoplasm				Nucleoplasm		"HPA057719: "	"unprognostic (3.51e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.65e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (6.42e-4)"	"unprognostic (5.82e-2)"	"unprognostic (7.76e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.32e-1)"	7.8	4.9	2.9	14.5	2.9	4.5	4.3	7.5	3.6	6.0	3.6	4.3	2.2	2.5	8.5	6.8	4.4	3.3	3.0	4.3	3.5	2.9	5.7	5.7	9.3	11.3	3.8	3.2	5.6	3.2	2.6	4.0	3.7	3.4	3.9	2.6	6.6	9.3	4.8	1.7	5.1	4.5	3.4	3.4	12.3	5.1	8.1	2.4	27.3	5.4	3.5	15.8	4.4	4.3	3.6	3.4	0.2	0.8	2.4	5.6	2.2	5.1	2.8	1.9	2.4	1.1	3.0	5.1	3.7	3.2	3.7	4.7	4.2	7.2	7.5	2.4	1.9	9.2	3.0	8.0	7.5	5.6	2.6	5.4	2.8	2.8	2.8	5.8	1.9	3.0	3.4	17.1	4.5	1.7	4.7	8.9	7.2	2.4	6.4	2.8	2.0	3.1	2.7	4.2	3.5	3.4	3.9	3.5	2.9	5.9	0.6	5.6	1.5	6.3	3.0	8.4	6.5	1.6	4.1	4.9	5.3	4.0	6.5	6.1	6.0	0.1	0.8	0.1	3.0	0.7	3.9	2.7	3.3	2.7	0.9	3.6	5.4	4.6	0.2	2.4	0.6	3.4	5.6	2.2	2.9	2.9	7.5	3.6	3.5	2.9	3.8	3.2	3.4	2.4
NETO1	"BCTL1, BTCL1"	ENSG00000166342	"Neuropilin and tolloid like 1"	Q8TDF5	18	72742314-72868146	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 47.9"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 14.8;REH: 14.5;RPMI-8226: 23.2;RT4: 15.4;SCLC-21H: 20.5;U-2 OS: 7.5"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	27	"memory B-cell: 1.6;naive B-cell: 3.7"	"Lineage enriched"	"Detected in single"	38	"B-cells: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA064630			Approved	"Golgi apparatus"	"Intracellular and membrane"			"Golgi apparatus"		"HPA064630: "	"unprognostic (4.02e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.35e-5)"	"unprognostic (4.05e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.13e-3)"	2.0	0.8	9.1	1.3	18.3	1.0	1.7	0.4	47.9	0.9	0.9	0.7	0.0	0.8	0.9	0.9	1.0	0.8	0.9	1.4	15.9	3.9	1.0	0.8	0.9	3.8	3.0	15.1	0.8	0.8	1.0	0.3	0.8	5.0	0.9	1.1	3.9	1.1	0.8	0.8	1.2	0.8	0.8	1.1	4.0	0.9	2.0	2.8	0.8	2.3	0.0	2.7	1.2	0.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.8	0.0	6.7	0.0	14.5	0.0	23.2	3.6	15.4	20.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	18.3	0.4	22.8	15.9	3.9	3.0	15.1	5.0	2.8
NEURL1	"h-neu, neu-1, NEURL, RNF67"	ENSG00000107954	"Neuralized E3 ubiquitin protein ligase 1"	O76050	10	103493979-103592552	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Translation regulation, Ubl conjugation pathway"	Transferase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 37.1;skeletal muscle: 83.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 12.9;HeLa: 7.6;HMC-1: 6.5;SCLC-21H: 16.2;SiHa: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"intermediate monocyte: 16.0;non-classical monocyte: 37.1"	"Lineage enriched"	"Detected in many"	17	"monocytes: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044204	Enhanced									"HPA044204: AB_10959383"	"unprognostic (1.21e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.58e-4)"	"unprognostic (1.31e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.91e-4)"	"unprognostic (3.23e-1)"	1.1	3.9	18.5	3.0	17.5	2.0	1.0	28.2	27.2	6.1	8.6	0.6	1.2	7.7	13.2	11.0	3.6	2.1	2.0	1.1	12.0	7.6	1.3	1.1	1.3	1.3	4.5	18.9	2.1	12.8	2.9	6.5	13.3	6.1	2.8	7.3	7.8	1.5	1.7	83.5	1.9	11.7	11.7	1.2	2.0	4.4	7.5	2.1	0.0	1.2	8.5	1.1	9.2	1.7	0.4	2.1	1.0	37.1	0.2	0.4	1.2	0.8	0.2	1.3	0.0	0.4	0.1	12.9	0.5	0.8	0.2	0.1	0.3	0.3	0.4	0.7	0.1	0.7	0.4	0.2	0.1	0.3	0.7	0.2	7.6	0.6	0.0	0.3	6.5	0.2	0.5	0.1	0.6	0.0	2.1	0.4	0.2	1.1	1.3	0.8	0.0	3.9	0.2	0.6	1.4	0.0	0.5	16.2	5.5	8.1	0.0	0.4	0.7	1.5	0.0	0.1	0.9	0.2	0.2	0.9	0.2	0.3	0.5	0.0	0.3	0.2	1.0	0.2	0.3	16.0	0.4	0.4	0.4	0.4	2.1	0.3	0.4	0.3	1.0	0.2	37.1	1.7	0.1	1.2	18.5	17.5	28.2	27.2	12.0	7.6	4.5	18.9	6.1	2.1
NEURL2	"C20orf163, dJ337O18.6, FLJ30259, Ozz, Ozz-E3"	ENSG00000124257	"Neuralized E3 ubiquitin protein ligase 2"	Q9BR09	20	45888625-45891287	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043402, HPA059842"	Approved		Approved	Vesicles				Vesicles		"HPA043402: , HPA059842: "	"unprognostic (6.26e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.73e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.58e-1)"	7.9	6.3	2.8	3.0	2.6	1.3	4.8	5.5	3.3	4.6	7.6	2.9	4.5	5.2	5.7	6.0	3.3	5.2	9.0	7.6	1.9	1.6	8.8	12.3	2.4	1.5	1.5	2.3	8.7	2.8	6.2	4.2	3.7	2.7	5.7	2.7	5.9	4.0	3.7	21.6	4.3	10.3	10.2	2.3	4.5	3.3	3.2	1.1	1.1	4.0	21.5	2.1	6.6	2.8	5.4	0.8	3.6	1.3	2.3	3.8	0.9	0.9	0.9	2.4	1.8	4.0	1.6	2.3	1.4	2.1	1.7	0.8	9.8	6.4	1.4	2.1	1.1	3.3	2.0	0.2	1.1	0.8	1.8	0.8	7.1	9.8	5.5	0.7	1.7	3.8	1.4	1.7	0.7	1.6	0.6	2.5	0.9	3.9	1.1	0.7	1.6	3.6	1.9	1.7	0.6	1.0	0.8	5.6	4.6	2.0	5.1	6.1	4.1	2.0	2.5	2.0	1.5	1.3	1.3	8.1	1.4	0.2	2.1	1.0	1.6	0.0	1.3	3.6	0.9	0.7	0.5	5.4	1.8	1.6	0.4	2.6	3.8	3.5	0.7	2.3	0.4	0.8	1.0	0.9	2.8	2.6	5.5	3.0	1.9	1.6	1.5	2.3	2.7	1.1
NEUROD6	"Atoh2, bHLHa2, Math-2, Nex1, NEX1M"	ENSG00000164600	"Neuronal differentiation 6"	Q96NK8	7	31337461-31340894	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"brain: 30.6"	"Cell line enriched"	"Detected in single"	116	"SCLC-21H: 11.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 8.3;basal ganglia: 10.7;cerebral cortex: 25.5;hippocampal formation: 30.6;olfactory region: 17.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"cerebral cortex: 99.2;hippocampal formation: 246.6"	"Group enriched"	"Detected in some"	10	"cerebral cortex: 26.0;hippocampal formation: 108.7"	HPA074530	Enhanced									"HPA074530: "					"unprognostic (3.68e-2)"													0.5	0.5	8.3	0.5	10.7	0.5	0.5	3.9	25.5	0.5	0.5	0.7	0.0	0.5	0.5	0.5	0.5	0.5	0.5	0.5	30.6	0.5	0.5	0.5	0.5	0.5	1.3	17.4	0.5	0.5	0.5	0.1	0.5	0.4	0.5	0.5	0.0	0.5	0.5	0.5	0.5	0.5	0.5	0.4	0.5	0.5	0.5	0.0	0.0	0.5	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	10.7	3.9	25.5	30.6	0.5	1.3	17.4	0.4	0.0
NEUROG2	"Atoh4, bHLHa8, Math4A, ngn-2, NGN2"	ENSG00000178403	"Neurogenin 2"	Q9H2A3	4	112513516-112516172	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 4.1;testis: 5.1"	"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 67.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in single"	18	"hippocampal formation: 17.3"	CAB012342	Uncertain									"CAB012342: "	"unprognostic (1.09e-1)"	"unprognostic (2.52e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.75e-2)"		"unprognostic (1.04e-1)"	"unprognostic (1.13e-3)"						"unprognostic (1.02e-1)"	"unprognostic (3.30e-1)"		0.4	0.1	3.0	0.0	3.6	0.1	1.2	4.1	1.6	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	3.9	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.2	0.1	0.2	0.1	0.6	0.0	0.1	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	67.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.6	4.1	0.8	3.9	0.1	0.0	0.0	0.9	0.0
NHLRC3		ENSG00000188811	"NHL repeat containing 3"	Q5JS37	13	39038306-39050109	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013738	Uncertain				"Secreted - unknown location"		240000			"HPA013738: AB_1854455"	"unprognostic (7.92e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.90e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.81e-2)"	21.3	14.5	12.3	18.8	14.7	7.3	17.6	13.8	19.1	13.9	14.2	18.2	16.4	12.7	17.8	37.1	9.8	13.8	18.0	13.0	12.4	12.2	20.1	28.2	17.6	17.7	15.5	15.9	21.9	17.2	7.8	16.5	24.4	15.2	13.0	19.0	18.4	15.7	22.9	10.8	13.5	14.8	13.6	17.3	20.1	18.3	14.0	13.1	13.0	21.2	8.9	13.1	14.6	12.6	5.7	7.9	2.0	9.2	5.6	7.3	4.6	3.4	2.2	9.4	4.4	10.9	11.3	14.3	5.3	6.5	5.7	7.5	6.6	15.2	9.2	10.1	3.4	7.1	3.7	3.0	4.9	13.2	4.1	7.5	4.4	7.3	7.0	7.3	10.9	9.1	4.0	3.8	3.8	3.5	2.6	11.4	5.1	2.5	5.7	11.6	2.5	2.1	6.1	24.9	5.1	8.6	6.8	2.1	3.9	3.3	4.7	11.9	6.1	11.7	4.1	7.7	3.8	10.1	5.5	9.2	7.8	3.7	10.3	7.9	5.5	2.0	9.0	1.0	6.6	9.2	7.3	5.7	4.8	5.3	7.9	4.6	4.9	7.0	0.8	5.6	8.2	7.3	5.4	4.6	12.3	14.7	13.8	19.1	12.4	12.2	15.5	15.9	15.2	13.1
NICN1	MGC12936	ENSG00000145029	"Nicolin 1"	Q9BSH3	3	49422946-49429326	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA058014			Supported	Nucleoplasm				Nucleoplasm		"HPA058014: "	"unprognostic (4.10e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.88e-2)"	"prognostic favourable (1.11e-4)"	"unprognostic (2.46e-1)"	"prognostic favourable (8.81e-7)"	"unprognostic (3.11e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.96e-2)"	9.6	12.1	19.3	5.7	23.4	3.6	10.5	21.5	27.9	9.2	9.7	8.4	12.8	7.8	12.0	12.8	5.3	10.7	8.7	16.9	12.7	10.9	16.8	10.9	10.4	8.5	9.6	21.6	13.7	12.6	10.1	10.2	6.1	12.5	10.9	5.8	10.3	13.0	10.2	14.4	8.6	8.3	9.7	8.1	9.7	10.0	13.5	10.6	7.0	13.7	7.0	8.8	9.5	8.9	9.2	8.1	8.1	8.5	6.7	10.9	7.3	2.8	9.6	10.0	7.0	4.2	5.1	3.7	3.4	3.3	3.3	4.0	2.1	9.0	9.3	3.7	7.6	2.6	5.8	4.5	3.2	16.7	3.7	8.9	10.0	10.8	7.8	3.9	6.1	10.4	5.5	7.3	2.4	4.5	5.6	0.2	3.7	2.9	6.5	6.4	3.9	3.0	4.8	3.1	11.8	6.0	1.6	2.3	4.0	2.6	2.8	7.0	5.0	2.6	12.0	2.3	2.7	2.3	1.8	10.4	4.2	3.2	8.1	9.8	4.4	8.1	7.3	6.9	8.0	5.4	5.3	9.2	5.0	9.4	5.9	5.6	6.2	7.6	2.1	6.7	8.5	8.1	10.9	7.3	19.3	23.4	21.5	26.2	12.7	10.9	9.6	21.6	12.5	10.6
NIPA2	SLC57A2	ENSG00000140157	"Non imprinted in Prader-Willi/Angelman syndrome 2"	Q8N8Q9	15	22838641-22868384	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067160, HPA071342"	Approved		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA067160: , HPA071342: "	"unprognostic (2.88e-3)"	"unprognostic (1.82e-1)"	"unprognostic (9.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.49e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.75e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.93e-2)"	19.3	26.9	18.6	26.1	22.2	22.1	19.9	17.7	28.2	16.8	30.0	16.6	23.9	28.4	21.7	18.3	26.5	16.1	21.3	17.4	16.7	21.3	26.3	27.8	22.5	35.0	17.9	13.8	19.0	30.8	21.1	24.7	31.3	18.5	20.6	30.1	20.0	26.9	14.0	18.8	16.4	37.1	18.2	13.5	43.9	21.4	19.5	13.1	27.9	21.1	19.2	31.5	22.2	17.2	38.1	40.3	27.2	26.5	22.1	24.6	21.5	29.8	30.5	15.6	18.4	15.0	17.1	17.7	33.5	29.7	23.1	27.0	22.5	19.0	29.5	21.4	19.3	24.0	28.7	16.9	23.5	31.3	18.6	26.4	20.4	18.2	22.4	37.4	25.1	16.8	19.1	19.0	19.8	26.9	39.5	35.4	29.5	11.8	11.9	17.5	18.3	28.2	25.9	26.6	22.4	22.1	36.7	21.0	22.2	25.6	25.4	28.2	23.1	35.2	27.9	30.5	19.9	22.1	67.9	28.1	40.7	31.9	23.3	37.9	26.2	27.2	21.4	18.0	21.4	26.5	24.4	38.1	19.3	23.5	26.2	32.7	18.4	18.7	15.8	22.1	24.9	40.3	24.6	21.5	18.6	22.2	17.7	28.2	16.7	21.3	17.9	13.8	18.5	13.1
NIPAL1	"DKFZp686A06115, NPAL1"	ENSG00000163293	"NIPA like domain containing 1"	Q6NVV3	4	47914142-48040173	"Predicted membrane proteins"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 30.8"	"Cell line enhanced"	"Detected in many"		"A-431: 10.9;CAPAN-2: 9.8;HaCaT: 12.9;HBEC3-KT: 9.3;RT4: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA036765	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA036765: AB_10672366"	"unprognostic (3.03e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.57e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.03e-7)"	"unprognostic (2.55e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-1)"	0.5	0.4	0.4	5.4	1.4	0.0	2.2	0.8	0.7	3.6	9.1	0.1	0.0	3.3	0.4	6.3	18.5	1.1	1.8	0.6	0.7	0.7	4.6	10.7	0.5	0.0	0.4	0.2	0.8	6.6	2.9	5.5	30.8	0.7	3.0	8.9	1.2	5.3	0.6	0.7	17.1	12.6	1.0	0.6	0.4	4.3	0.8	0.3	0.2	2.0	9.8	11.2	4.2	5.3	1.0	1.4	1.4	0.8	0.6	0.9	0.0	10.9	0.2	0.0	0.0	0.0	0.0	1.8	2.1	2.0	1.5	2.8	6.5	9.8	0.0	1.5	0.0	12.9	1.9	9.3	4.1	0.1	2.4	0.0	0.1	0.4	0.0	0.1	0.1	0.1	3.5	0.1	2.3	0.5	0.1	0.0	2.2	4.1	0.1	0.1	1.6	2.9	0.0	0.0	0.0	5.5	14.9	1.0	0.3	1.0	3.6	1.6	2.3	0.0	4.1	0.1	3.9	0.0	0.2	0.1	0.1	0.0	0.2	0.0	4.1	0.9	0.8	0.5	0.8	0.4	0.6	0.4	0.5	0.3	0.1	1.0	0.7	0.9	1.4	0.6	0.5	1.4	0.3	0.0	0.4	1.4	0.8	0.7	0.7	0.7	0.4	0.2	0.7	0.3
NIPAL2	"FLJ13955, NPAL2"	ENSG00000104361	"NIPA like domain containing 2"	Q9H841	8	98189833-98294393	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071759	Uncertain									"HPA071759: "	"unprognostic (5.14e-3)"	"unprognostic (6.43e-2)"	"unprognostic (8.01e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.72e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.67e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.76e-2)"	9.1	10.1	6.0	7.7	8.5	3.6	11.5	8.0	18.3	13.6	11.3	2.0	13.8	5.8	10.8	27.8	22.2	8.6	11.5	6.5	6.5	5.9	4.6	4.9	7.9	8.0	3.2	8.8	22.2	18.3	8.4	28.9	5.4	6.9	15.5	15.9	9.1	15.4	14.0	3.4	33.8	7.9	5.2	3.1	5.9	12.5	4.9	1.8	2.3	5.8	9.4	13.5	11.0	15.6	4.2	6.7	4.9	3.6	2.7	3.6	2.8	4.1	1.6	0.5	0.0	25.4	15.5	0.1	7.4	9.5	1.4	1.9	0.0	12.2	7.7	8.6	10.4	4.9	0.4	4.4	1.1	0.6	1.5	2.8	1.2	0.5	3.2	3.0	3.0	15.9	11.8	1.4	4.2	1.7	0.0	15.8	5.5	5.7	0.1	1.6	1.0	0.6	0.0	0.1	0.9	5.0	9.4	0.8	1.6	5.4	4.7	1.8	5.0	5.5	5.0	1.0	0.1	3.8	0.0	0.2	0.0	0.0	1.9	9.6	5.1	0.2	3.6	4.9	1.3	3.4	0.1	3.4	1.2	1.3	6.7	4.2	0.1	1.0	0.7	2.7	2.6	2.8	3.6	2.8	6.0	8.5	8.0	18.3	6.5	5.9	3.2	8.8	6.9	1.8
NIPSNAP3B	FLJ11275	ENSG00000165028	"Nipsnap homolog 3B"	Q9BS92	9	104764157-104777457	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 28.6;skeletal muscle: 34.6"	"Cell line enhanced"	"Detected in some"		"REH: 7.5;THP-1: 5.2;U-266/70: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.5"	"Group enriched"	"Detected in many"	5	"B-cells: 3.5;dendritic cells: 1.7;granulocytes: 6.5"					"Low region specificity"	"Detected in all"			HPA042491	Uncertain									"HPA042491: "	"unprognostic (1.72e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.25e-5)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.81e-2)"	14.4	8.4	6.1	2.1	11.3	1.2	10.1	3.7	7.8	4.0	1.7	1.5	4.2	1.5	5.0	4.5	3.1	3.5	3.0	28.6	4.4	6.8	2.3	1.3	2.1	2.2	4.4	7.7	5.4	4.7	2.5	8.0	5.1	5.0	5.1	1.7	3.8	2.2	5.9	34.6	1.7	1.9	3.2	3.4	2.5	1.9	2.0	2.8	0.4	3.1	14.1	2.8	2.2	2.5	3.5	1.7	6.5	0.5	0.8	0.6	0.5	0.0	0.3	0.5	0.2	1.9	1.7	1.3	0.4	0.9	1.3	0.6	0.3	0.8	0.8	0.3	0.8	0.0	0.5	0.5	0.5	0.0	0.6	3.4	1.9	0.2	1.6	0.6	0.8	1.4	0.7	0.5	0.1	0.5	3.1	0.2	0.2	0.4	1.5	3.1	0.7	0.5	7.5	0.0	0.2	0.5	0.4	1.2	3.9	4.6	0.0	0.4	3.6	5.2	0.3	0.6	1.6	0.7	0.1	5.7	2.2	0.1	0.0	0.2	0.1	6.5	0.1	2.4	0.2	0.1	0.0	3.5	0.4	0.0	1.7	2.0	0.6	0.3	0.0	0.8	0.5	1.2	0.0	0.5	6.1	11.3	3.7	7.8	4.4	6.8	4.4	7.7	5.0	2.8
NKAIN1	"FAM77C, FLJ12650"	ENSG00000084628	"Sodium/potassium transporting ATPase interacting 1"	Q4KMZ8	1	31179745-31239554	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 15.5;brain: 23.2;skeletal muscle: 26.2"	"Cell line enhanced"	"Detected in some"		"AF22: 10.2;AN3-CA: 16.8;NTERA-2: 43.3;SCLC-21H: 12.9;SH-SY5Y: 20.6"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.2;glioma: 4.6;prostate cancer: 10.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006873	Uncertain									"HPA006873: AB_1848410"	"unprognostic (1.58e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.11e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.30e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.31e-9)"	"unprognostic (1.00e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.62e-4)"	"unprognostic (5.50e-2)"	0.7	15.5	4.2	0.8	13.3	0.5	1.2	23.2	11.8	0.6	0.7	10.7	0.0	0.7	1.5	5.8	1.4	0.8	0.6	0.6	6.3	4.3	0.6	0.5	0.5	0.5	4.7	7.2	0.6	0.7	0.7	0.3	0.9	18.2	2.2	0.7	0.0	0.7	1.1	26.2	1.9	0.7	0.8	3.3	0.5	0.6	0.9	9.0	0.0	0.5	0.1	0.5	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.2	16.8	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.1	0.0	2.3	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	43.3	0.4	0.0	0.1	0.0	0.0	1.5	12.9	20.6	0.4	0.1	1.1	4.5	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	13.3	23.2	9.5	6.3	4.3	4.7	7.2	18.2	9.0
NKAIN2	"FAM77B, TCBA1"	ENSG00000188580	"Sodium/potassium transporting ATPase interacting 2"	Q5VXU1	6	123804141-124825657	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 43.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;Daudi: 3.8;HEK 293: 6.4;HEL: 8.0;Karpas-707: 13.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	44	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045860			Approved	Cytosol				Cytosol		"HPA045860: AB_10983192"	"unprognostic (3.09e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.67e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.63e-1)"	2.2	1.6	12.9	1.1	12.1	1.9	1.3	17.3	43.2	1.4	1.7	24.9	0.0	1.1	1.2	1.6	1.4	1.4	1.3	2.6	17.5	8.8	1.3	1.2	1.3	1.3	18.1	10.9	1.2	1.0	1.0	1.1	1.2	18.0	1.4	1.3	0.5	1.1	1.3	4.8	1.1	1.5	1.5	42.9	1.1	1.0	1.6	16.1	0.0	1.2	0.5	1.3	1.5	0.2	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	6.4	8.0	0.0	0.0	0.5	0.0	0.0	1.6	0.2	0.0	0.5	0.0	0.0	13.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	12.1	17.3	15.3	17.5	8.8	18.1	10.9	18.0	16.1
NKAIN3	"FAM77D, FLJ39630"	ENSG00000185942	"Sodium/potassium transporting ATPase interacting 3"	Q8N8D7	8	62248591-62999652	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 15.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.4;HeLa: 1.9;PC-3: 2.5;REH: 2.5;RT4: 1.6;SCLC-21H: 4.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018833	Enhanced									"HPA018833: "	"unprognostic (1.28e-1)"		"unprognostic (2.92e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.83e-1)"			"unprognostic (3.56e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.81e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.26e-1)"		"unprognostic (3.22e-2)"	"unprognostic (3.15e-2)"		"unprognostic (1.58e-1)"	0.8	3.4	13.7	1.2	15.5	0.8	1.0	0.6	9.7	1.3	1.4	6.9	0.0	0.7	1.7	0.7	0.8	1.1	0.8	1.1	15.1	1.6	0.8	0.9	0.7	0.8	2.3	7.5	0.9	0.7	0.7	0.8	1.0	7.3	1.0	0.8	0.3	5.9	1.4	2.2	0.7	2.3	0.7	7.3	0.9	0.9	1.9	7.1	0.0	0.8	0.0	0.7	2.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	2.5	0.0	0.0	0.0	1.6	4.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	15.5	0.6	9.7	15.1	1.6	2.3	7.5	7.3	7.1
NKAIN4	"bA261N11.2, C20orf58, FAM77A"	ENSG00000101198	"Sodium/potassium transporting ATPase interacting 4"	Q8IVV8	20	63240784-63272694	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"brain: 51.7"	"Cell line enhanced"	"Detected in some"		"AF22: 4.9;BEWO: 16.6;MOLT-4: 26.9;REH: 4.8;SK-MEL-30: 6.0"	"Cancer enriched"	"Detected in many"	6	"glioma: 45.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"amygdala: 3.2;cerebral cortex: 3.9;hippocampal formation: 2.5"	HPA029876	Approved									"HPA029876: AB_10602038"	"unprognostic (1.26e-1)"	"unprognostic (4.27e-1)"	"unprognostic (6.07e-5)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (6.65e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.44e-4)"	"unprognostic (5.66e-2)"	"unprognostic (6.74e-2)"	"unprognostic (4.01e-1)"	1.1	1.9	21.7	1.2	23.0	1.0	1.0	5.7	51.7	1.3	1.1	9.9	0.0	1.2	1.4	1.3	0.9	1.3	1.0	0.9	15.5	15.5	10.9	0.9	0.9	0.9	18.5	11.8	0.9	1.0	0.9	0.4	3.9	6.2	1.0	1.0	1.0	0.9	1.1	0.9	1.4	1.1	1.0	9.1	1.0	1.1	2.7	7.1	0.0	1.2	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.9	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.7	0.5	0.0	2.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	26.9	0.0	3.3	0.0	4.8	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.1	6.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	23.0	5.7	13.2	15.5	15.5	18.5	11.8	6.2	7.1
NKPD1	FLJ33600	ENSG00000179846	"NTPase KAP family P-loop domain containing 1"	Q17RQ9	19	45149750-45158737	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 17.5"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.0;SiHa: 3.5;U-266/70: 7.2"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043339	Uncertain									"HPA043339: AB_10962493"	"unprognostic (3.98e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.30e-4)"	"unprognostic (2.23e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.35e-2)"	"unprognostic (7.73e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.77e-5)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.13e-1)"	0.0	0.1	0.0	0.0	0.1	0.2	0.8	0.5	0.2	0.9	0.0			0.0	0.0	0.3	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.3	0.0		0.5	0.0		0.6	0.8	0.1	17.5	0.0	0.0	0.0	0.0	0.0	0.6			0.1		0.0	0.0	2.4	0.2	0.2	0.5	0.1	0.2	1.8	0.0	0.2	0.2	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.4	0.3	0.7	0.0	0.3	0.0	0.0	0.0	0.5	0.6	1.4	0.1	0.1	0.1	0.0	0.0	0.2	4.0	0.0	0.1	0.1	0.4	0.6	0.0	1.1	0.7	0.5	0.3	0.4	0.1	0.0	0.3	0.0	0.1	0.6	0.3	3.5	1.7	0.1	1.3	0.3	0.0	0.0	0.0	0.0	0.0	7.2	1.6	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.6	0.0	0.2	1.8	0.1	0.4	0.2	0.0	0.2	0.0	0.0										
NKX1-1	"HSPX153, SAX2"	ENSG00000235608	"NK1 homeobox 1"	Q15270	4	1402932-1406331	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	19	"pituitary gland: 1.0;testis: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"pons and medulla: 0.2"	HPA029367	Uncertain									"HPA029367: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NKX1-2	"bB238F13.2, C10orf121"	ENSG00000229544	"NK1 homeobox 2"	Q9UD57	10	124445239-124450184	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.7;intestine: 2.9;skin 1: 2.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.9;HEK 293: 2.7;hTCEpi: 6.7;NTERA-2: 13.3;SCLC-21H: 5.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA029367	Uncertain									"HPA029367: "	"unprognostic (2.43e-1)"	"unprognostic (7.85e-3)"		"unprognostic (6.81e-5)"	"unprognostic (1.55e-2)"	"unprognostic (3.61e-2)"		"unprognostic (5.40e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.20e-1)"		"unprognostic (3.73e-2)"		"unprognostic (2.69e-1)"	"unprognostic (1.71e-1)"		"unprognostic (8.68e-2)"	0.0	0.0	0.7	0.0	2.0	0.0	0.9	0.2	2.9	0.4	0.0	1.1	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.6	0.3	0.0	0.2	0.4	0.0	0.7	3.7	0.3	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	1.2	0.0	0.0	2.2	2.9	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	1.2	1.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	6.9	0.6	0.9	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.0	0.2	2.9	0.6	0.3	0.7	3.7	2.2	0.0
NKX2-2	"NKX2.2, NKX2B"	ENSG00000125820	"NK2 homeobox 2"	O95096	20	21511010-21514026	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 30.6;pancreas: 12.1"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.4;T-47d: 5.2;U-138 MG: 18.5;U-2 OS: 3.8;WM-115: 7.4"	"Group enriched"	"Detected in many"	5	"glioma: 9.5;pancreatic cancer: 7.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003468	Approved									"HPA003468: AB_1079490"	"unprognostic (5.13e-3)"		"unprognostic (5.54e-2)"		"unprognostic (3.10e-1)"	"unprognostic (2.29e-1)"			"unprognostic (1.75e-2)"		"unprognostic (2.93e-3)"	"unprognostic (1.10e-1)"		"unprognostic (3.24e-2)"	"unprognostic (3.29e-1)"			0.6	0.6	6.5	0.7	8.1	0.7	0.6	3.4	15.5	0.6	1.4	19.1	0.0	6.2	0.6	0.6	0.6	0.6	0.6	0.6	7.8	6.9	0.6	0.6	0.6	0.7	14.2	6.4	0.6	12.1	1.0	4.6	0.6	10.9	0.7	1.4	0.0	0.6	0.6	0.6	0.8	2.5	0.6	30.6	0.6	7.0	0.6	9.4	0.0	0.6	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.3	0.0	18.5	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	8.1	3.4	7.6	7.8	6.9	14.2	6.4	10.9	9.4
NKX2-3	"CSX3, NKX2.3, NKX2C, NKX4-3"	ENSG00000119919	"NK2 homeobox 3"	Q8TAU0	10	99532933-99536524	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 12.5;intestine: 21.6;lymphoid tissue: 36.8"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.1;NB-4: 4.7;REH: 6.0;THP-1: 1.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 0.3"	HPA047561	Uncertain		Uncertain	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA047561: "		"unprognostic (5.70e-2)"	"unprognostic (2.95e-1)"			"unprognostic (2.70e-4)"	"unprognostic (6.34e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	0.8	0.0	0.1	17.2	0.1	0.0	0.1	0.1	0.1	0.3	21.6	0.1	0.1	10.4	0.2	0.1	0.5	0.0	12.5	0.1	0.1	0.0	0.1	0.2	0.1	1.1	0.1	0.1	0.1	6.4	0.0	0.1	0.1	0.1	0.1	4.6	0.1	9.0	0.5	0.1	0.0	19.1	3.1	0.1	36.8	1.8	0.1	0.1	0.2	1.0	0.7	3.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	6.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.5	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NKX2-8	"Nkx2-9, NKX2.8, NKX2H"	ENSG00000136327	"NK2 homeobox 8"	O15522	14	36580579-36582607	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.6;lung: 7.7;testis: 22.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.9;HaCaT: 9.7;HEK 293: 2.3;PC-3: 5.7;SiHa: 2.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.3"	"Low region specificity"	"Detected in some"			HPA062879	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA062879: "	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.37e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.45e-4)"		"unprognostic (2.36e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.11e-1)"		"unprognostic (8.39e-3)"	"unprognostic (4.60e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	0.3	0.3	0.2	0.4	0.7	0.3	0.3	0.0	1.2	0.3	0.3	2.0	0.0	0.3	0.3	0.3	5.3	0.3	0.3	0.3	0.3	2.0	0.3	0.3	7.7	0.3	2.0	0.0	0.3	0.3	1.5	2.1	0.3	5.7	0.4	0.3	0.0	2.0	0.3	0.3	1.1	0.3	0.3	9.6	0.3	0.3	22.9	0.5	0.0	4.2	1.6	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	9.7	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.5	1.4	0.0	2.3	0.4	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	1.2	0.3	2.0	2.0	0.0	5.7	0.5
NKX3-2	"BAPX1, NKX3.2, NKX3B"	ENSG00000109705	"NK3 homeobox 2"	P78367	4	13540830-13545050	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 18.3;lymphoid tissue: 6.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.5;NB-4: 12.4;NTERA-2: 7.1;THP-1: 7.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027564	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA027564: AB_10601973"	"unprognostic (3.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.42e-3)"	"unprognostic (5.97e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.24e-5)"	"unprognostic (3.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.93e-8)"	"unprognostic (5.81e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-1)"	1.7	0.0	0.1	6.5	0.1	0.0	0.1	0.1	0.1	1.1	18.3	0.1	0.1	1.6	0.9	0.1	2.3	0.2	0.4	1.8	0.1	0.0	0.4	0.1	0.1	2.0	0.1	0.1	2.9	0.2	0.0	0.9	0.1	0.1	0.6	2.4	0.1	1.5	0.6	0.1	0.1	2.0	3.2	0.1	5.3	2.8	0.9	0.1	0.1	0.3	0.9	0.1	0.8	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	1.9	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.8	0.8	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	2.5	0.6	1.6	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.3	12.4	7.1	0.5	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	1.0	7.4	0.0	0.5	2.9	0.1	0.5	2.2	0.0	0.0	0.4	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NLGN4Y	KIAA0951	ENSG00000165246	"Neuroligin 4, Y-linked"	Q8NFZ3	Y	14522573-14845650	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 23.8;seminal vesicle: 15.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 19.6;fHDF/TERT166: 15.0;HDLM-2: 17.5;hTCEpi: 13.1;U-138 MG: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.0;memory CD4 T-cell: 1.7"	"Group enriched"	"Detected in many"	12	"B-cells: 3.0;T-cells: 1.7"									HPA001651	Approved				"Intracellular and membrane"					"HPA001651: AB_1079470"			"unprognostic (2.31e-1)"		"unprognostic (9.19e-2)"	"unprognostic (2.84e-5)"	"unprognostic (7.85e-2)"	"unprognostic (6.46e-2)"	"unprognostic (8.80e-3)"		"unprognostic (7.71e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.89e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.88e-1)"		"unprognostic (5.65e-2)"	1.4	1.9	4.7	1.4	18.7	0.4	1.3	11.2	23.8	0.4	2.5	11.2	2.4	1.2	0.4	4.0	4.3	0.4	4.8	0.8	4.9	5.7	2.0	4.4	1.3	2.7	3.7	0.0	0.5	3.3	0.4	2.9	0.9	12.6	12.6	3.1	7.2	2.2	15.3	0.6	1.3	2.0	3.7	3.5	1.1	1.5	1.3	0.0	2.5	2.6	4.0	2.5	6.0	0.0	3.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.3	19.6	1.2	1.6	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	3.1	17.5	0.0	0.0	0.0	2.9	2.1	0.0	0.0	6.8	13.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	1.2	0.0	4.0	0.0	0.0	1.3	0.0	4.7	7.5	2.6	0.0	0.0	0.0	0.0	0.0	0.4	5.6	14.4	0.0	0.0	3.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.0	1.7	0.8	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.6	0.0	4.7	18.7	11.2	23.8	4.9	5.7	3.7	0.0	12.6	0.0
NLRP11	"CLR19.6, NALP11, NOD17, PAN10, PYPAF6"	ENSG00000179873	"NLR family pyrin domain containing 11"	P59045	19	55785397-55836800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 4.0;liver: 3.3;lymphoid tissue: 4.5;testis: 3.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 38.2;RPMI-8226: 21.5;U-266/70: 38.0;U-266/84: 16.4;U-698: 27.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.4"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			"HPA046402, HPA078027"	Uncertain		Supported	Cytosol				Cytosol		"HPA046402: AB_10962951, HPA078027: "	"unprognostic (2.36e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.36e-3)"	"unprognostic (3.31e-2)"	"unprognostic (7.88e-2)"	"unprognostic (9.95e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.61e-2)"	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	4.0	0.1	0.3	0.2	0.1	0.1	0.0	0.7	3.3	0.1	0.6	0.1	0.1	0.9	0.4	0.0	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	1.2	0.1	0.1	0.3	0.5	3.6	0.1	0.1	0.1	0.1	4.5	0.1	0.1	1.4	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	38.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.7	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.6	0.0	0.0	38.0	16.4	27.6	0.6	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NLRP13	"CLR19.7, NALP13, NOD14, PAN13"	ENSG00000173572	"NLR family pyrin domain containing 13"	Q86W25	19	55891699-55932336	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"breast: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA060459	Uncertain									"HPA060459: "												"unprognostic (2.16e-1)"			"unprognostic (4.66e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.6	0.0	0.0	0.0	0.0		0.6	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0										
NLRP5	"CLR19.8, MATER, NALP5, PAN11, PYPAF8"	ENSG00000171487	"NLR family pyrin domain containing 5"	P59047	19	55999726-56061813	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"parathyroid gland: 19.3"	"Group enriched"	"Detected in some"	14	"Karpas-707: 3.0;U-2 OS: 8.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA056271	Uncertain				"Intracellular and membrane"					"HPA056271: "	"unprognostic (9.67e-2)"			"unprognostic (2.22e-2)"								"unprognostic (5.03e-1)"		"unprognostic (7.78e-2)"	"unprognostic (1.72e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		3.1	0.0	19.3	0.6	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NLRP8	"CLR19.2, NALP8, NOD16, PAN4"	ENSG00000179709	"NLR family pyrin domain containing 8"	Q86W28	19	55947832-55988629	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.7;breast: 1.9;heart muscle: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"basophil: 1.7"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			HPA056989	Uncertain									"HPA056989: "	"unprognostic (2.43e-2)"											"unprognostic (3.35e-1)"		"unprognostic (3.13e-1)"	"unprognostic (6.96e-2)"			0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.1	0.0			0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.0		0.9	0.0		0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.1	0.0	0.7	0.3	1.7	0.2	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.2	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.7	0.5	0.0	0.7	0.7	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.3	1.7	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.0	0.7	0.3	0.3	0.8	0.4	0.1	0.3	0.1	0.0										
NME8	"CILD6, NM23-H8, SPTRX2, TXNDC3"	ENSG00000086288	"NME/NM23 family member 8"	Q8N427	7	37848597-37900401	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 7.9;bone marrow: 13.4;testis: 11.3"	"Cell line enhanced"	"Detected in some"		"HEL: 1.6;HMC-1: 2.5;NB-4: 3.7;NTERA-2: 3.4;THP-1: 3.2;U-937: 9.8"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016416, HPA019259"	Enhanced									"CAB016416: , HPA019259: AB_1858475"	"unprognostic (7.44e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.20e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.13e-8)"	"unprognostic (5.90e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-1)"	0.1	0.0	0.1	0.5	0.1	13.4	0.0	0.0	0.0	0.1	0.1			0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.2	0.2	0.1	0.1	0.5	0.4	0.4		0.0	0.0	0.0	0.0	0.1		0.1	0.0		0.0	0.0	0.0	0.3	0.1	0.0	0.8	1.9	0.1	11.3			0.0		0.2	0.0	0.0	0.0	7.9	3.8	1.9	0.2	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	9.8	0.0	0.0	1.9	1.5	0.7	0.4	0.0	0.0	0.1	1.3	1.5	0.0	0.0	0.7	3.8	0.2	0.0	7.9	0.0	0.8										
NME9	"NM23-H9, TXL-2, TXNDC6"	ENSG00000181322	"NME/NM23 family member 9"	Q86XW9	3	138261437-138329886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 30.4"	"Cell line enhanced"	"Detected in many"		"HMC-1: 5.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.2"	"Lineage enriched"	"Detected in single"	4	"T-cells: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040000, HPA043881"	Enhanced									"HPA040000: AB_2676793, HPA043881: AB_2678712"	"unprognostic (2.71e-5)"	"unprognostic (1.68e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.17e-3)"	1.0	1.7	5.3	1.3	11.3	4.4	1.0	6.2	8.3	1.5	0.8	4.1	3.5	1.1	1.6	3.6	0.8	30.4	1.3	0.9	5.6	8.2	1.7	0.8	4.0	1.1	3.6	3.1	2.5	3.3	1.8	7.5	1.1	10.3	1.7	0.8	0.9	3.4	1.9	4.3	1.8	1.1	1.0	3.6	1.2	1.5	6.0	3.9	0.9	2.3	0.0	1.0	0.8	0.5	0.6	0.6	0.3	0.9	0.3	4.2	0.5	1.1	1.7	1.1	0.5	0.0	0.0	1.7	0.7	0.0	0.2	0.1	0.9	2.0	2.5	1.2	0.0	1.3	0.2	0.0	0.0	0.5	1.8	2.1	1.6	0.6	0.0	2.7	5.0	0.9	0.0	0.1	0.0	0.1	0.6	1.4	0.2	0.4	0.6	2.5	0.7	1.3	1.0	0.0	0.7	1.7	2.6	3.7	1.0	1.7	0.6	0.4	0.9	0.1	3.1	0.5	0.8	0.8	0.6	0.9	1.3	1.1	1.0	1.1	0.5	0.1	0.9	0.0	0.5	0.0	4.2	0.2	1.7	0.4	0.3	0.6	2.8	1.2	0.3	0.3	0.2	0.6	0.7	0.5	5.3	11.3	6.2	8.3	5.6	8.2	3.6	3.1	10.3	3.9
NMUR1	"FM-3, GPC-R, GPR66, NMU1R"	ENSG00000171596	"Neuromedin U receptor 1"	Q9HB89	2	231523160-231530495	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"gdT-cell: 15.2;MAIT T-cell: 3.9;memory CD8 T-cell: 7.3;naive CD8 T-cell: 4.6;NK-cell: 8.1"	"Group enriched"	"Detected in many"	18	"NK-cells: 8.1;T-cells: 15.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA027895	Uncertain									"HPA027895: AB_10602713"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.74e-3)"	"unprognostic (9.44e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.08e-4)"	"unprognostic (3.76e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.61e-1)"	"unprognostic (5.25e-2)"	13.6	2.2	0.6	1.2	0.9	3.5	3.2	2.1	0.8	2.5	3.5	0.4	4.4	4.4	1.8	3.8	3.3	3.0	4.6	12.6	0.3	0.3	2.1	2.0	6.4	0.5	0.3	0.1	2.8	7.7	0.2	0.6	4.8	0.6	4.0	1.2	8.4	4.6	3.6	0.3	0.8	7.3	8.4	0.6	7.3	1.7	3.0	0.7	0.2	1.8	0.6	0.8	4.4	1.4	0.0	0.3	0.6	0.1	8.1	15.2	3.6	0.3	1.1	1.4	1.5	0.1	0.4	1.2	0.5	0.0	0.0	0.1	0.4	0.5	0.8	0.4	0.4	0.7	2.5	0.5	0.1	0.5	0.9	0.8	1.1	0.4	0.1	0.8	1.3	0.7	0.3	0.4	0.0	0.6	2.4	1.4	0.1	0.7	0.6	1.1	0.7	0.3	0.4	0.7	0.6	0.1	0.9	0.6	0.7	1.0	0.6	0.3	1.3	1.6	1.6	1.7	1.2	0.8	0.4	2.0	0.1	0.6	0.5	0.8	0.5	0.4	0.1	0.0	15.2	0.0	3.9	0.0	1.2	7.3	0.0	0.0	0.1	4.6	0.6	8.1	0.1	0.3	0.5	3.6	0.6	0.9	2.1	0.8	0.3	0.3	0.3	0.1	0.6	0.7
NOCT	"Ccr4c, CCR4L, CCRN4L, NOC"	ENSG00000151014	Nocturnin	Q9UK39	4	139015789-139045939	"Enzymes, Predicted intracellular proteins"	"Biological rhythms"	"Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012287, HPA053714"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA012287: , HPA053714: "	"unprognostic (2.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.24e-1)"	"prognostic unfavourable (5.28e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-4)"	"prognostic unfavourable (6.23e-4)"	17.5	3.9	3.3	4.9	8.0	38.7	7.4	3.2	7.3	2.7	3.1	2.7	0.0	2.2	2.8	1.5	4.0	2.5	7.9	5.4	4.9	3.7	6.9	25.8	5.1	3.1	3.0	3.1	1.7	4.4	4.0	4.7	9.3	3.7	2.0	2.8	1.8	10.8	1.4	12.0	3.9	10.5	4.5	2.3	3.2	3.0	4.9	2.6	3.7	2.9	11.8	3.9	3.7	4.6	1.9	1.5	6.3	3.1	1.4	2.4	0.2	4.8	5.6	2.2	4.2	5.0	2.1	13.7	7.2	5.2	10.3	7.4	7.5	2.0	16.0	5.8	5.3	3.5	11.5	6.3	9.7	7.2	4.7	7.4	3.4	6.5	4.6	10.8	4.4	2.4	3.1	11.4	7.8	4.5	13.3	5.3	4.5	5.5	7.4	5.7	7.1	6.0	6.1	6.5	5.6	6.9	3.1	8.3	5.5	4.5	5.2	4.1	3.8	8.4	6.7	5.5	7.2	5.2	8.6	4.3	4.0	10.1	5.1	21.5	7.0	1.5	1.4	0.8	2.4	1.5	1.4	1.1	1.1	1.3	0.6	1.9	0.8	1.6	6.3	1.4	3.1	1.5	0.7	0.2	3.3	8.0	3.2	7.3	4.9	3.7	3.0	3.1	3.7	2.6
NOTO		ENSG00000214513	"Notochord homeobox"	A8MTQ0	2	73202258-73212513	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 5.7"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA034660	Uncertain									"HPA034660: AB_10601974"						"unprognostic (6.09e-2)"		"unprognostic (9.77e-2)"		"unprognostic (4.84e-2)"				"unprognostic (1.09e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-2)"		0.2	0.8	0.3	0.6	0.4	2.3	0.3	1.4	0.2	0.1	0.5	0.1	0.1	0.8	0.1	0.6	0.1	0.1	0.4	0.2	0.2	0.6	0.1	0.2	0.3	0.5	0.3	0.1	0.2	0.1	0.0	0.4	0.1	2.4	1.3	0.3	0.6	0.2	0.1	0.5	2.2	2.7	0.1	0.5	0.5	0.5	5.7	0.1	0.7	0.1	0.1	0.1	0.4	0.1	0.8	0.8	2.6	0.8	1.4	1.0	0.3	0.2	0.2	0.4	0.5	0.2	0.3	0.7	0.3	0.0	0.1	0.2	1.1	0.8	0.3	0.2	0.3	1.1	0.1	0.3	0.5	0.8	0.4	0.5	1.8	0.7	0.0	0.6	1.3	0.2	0.4	0.1	0.0	0.0	0.1	1.0	0.0	0.6	0.1	0.4	0.7	0.5	0.7	0.2	0.3	0.1	0.8	0.9	0.5	1.1	0.8	0.0	0.7	0.6	1.3	0.8	0.4	0.2	0.6	0.7	0.2	0.8	0.3	1.0	0.1	1.9	0.8	0.3	0.6	0.3	0.9	0.6	0.8	0.5	0.3	0.8	0.8	1.0	2.6	1.4	0.5	0.8	0.5	0.3	0.3	0.4	1.4	0.2	0.2	0.6	0.3	0.1	2.4	0.1
NOXRED1	"C14orf148, FLJ32809"	ENSG00000165555	"NADP dependent oxidoreductase domain containing 1"	Q6NXP6	14	77394021-77423517	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 13.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.9"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA055658	Approved									"HPA055658: "	"unprognostic (1.92e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.49e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.07e-3)"	0.4	0.8	0.5	0.4	0.9	0.1	0.7	0.4	0.4	0.4	0.7	0.4	0.4	0.7	0.6	0.8	0.4	1.2	0.9	0.4	0.5	0.7	0.6	0.5	0.4	0.8	0.4	0.4	0.4	0.7	0.8	1.4	0.4	0.4	0.4	0.6	0.4	0.4	0.5	0.4	1.8	0.4	0.6	0.4	0.6	0.2	13.9	0.4	0.4	1.5	0.4	0.4	0.4	0.4	0.2	0.0	2.9	0.0	0.0	0.8	0.0	1.2	2.6	1.0	1.4	0.5	2.5	1.8	1.2	1.8	1.3	0.8	1.4	1.2	2.5	0.6	2.1	0.7	0.5	0.5	1.5	1.2	0.9	1.4	0.1	2.4	0.9	0.5	2.3	1.4	3.4	1.1	1.8	0.7	0.6	1.8	0.6	2.7	0.6	0.8	0.0	2.2	0.7	0.6	0.1	1.2	0.6	2.5	1.8	1.6	0.6	0.4	2.4	1.5	3.1	0.9	0.8	1.6	0.4	2.5	2.3	1.4	1.3	0.3	1.0	0.0	0.0	2.9	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.3	0.0	0.0	0.0	0.8	0.0	0.5	0.9	0.4	0.4	0.5	0.7	0.4	0.4	0.4	0.4
NPAS1	"bHLHe11, MOP5, PASD5"	ENSG00000130751	"Neuronal PAS domain protein 1"	Q99742	19	47019820-47045775	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 14.2;skin 1: 10.5;stomach 1: 8.0"	"Cell line enhanced"	"Detected in many"		"BJ: 8.7;Daudi: 8.9;HEK 293: 9.8;HMC-1: 8.1;NB-4: 15.6;U-266/84: 9.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.2"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA043364, HPA072259"		Approved	Approved	Nucleoplasm				Nucleoplasm		"HPA043364: , HPA072259: "	"unprognostic (2.34e-3)"	"unprognostic (6.25e-2)"	"unprognostic (7.32e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.14e-8)"	"unprognostic (8.82e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.20e-2)"	0.6	0.6	9.5	1.3	4.1	0.9	1.3	0.4	14.2	0.4	0.9	0.4	0.0	0.5	0.6	0.4	0.8	1.2	0.5	0.9	9.0	5.2	1.2	0.8	0.9	1.7	3.0	4.1	0.4	1.5	0.7	1.1	0.8	5.1	0.6	0.5	3.4	0.7	0.5	0.5	10.5	0.4	0.7	0.8	3.9	8.0	0.8	0.2	0.0	0.6	0.0	1.3	0.5	0.4	2.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	2.1	0.2	0.4	0.2	0.1	0.0	8.7	0.2	0.1	0.4	0.6	0.5	8.9	2.0	7.0	0.2	1.8	0.2	0.1	0.6	9.8	0.7	0.8	2.1	0.0	4.7	8.1	0.8	0.3	0.0	0.1	0.2	3.0	0.7	1.1	0.7	0.3	15.6	2.1	1.5	0.8	0.3	0.7	0.5	0.5	0.7	0.6	0.7	0.3	2.0	1.9	1.5	0.1	0.1	0.9	0.1	0.2	4.9	9.5	1.9	1.1	0.9	6.4	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	9.5	4.1	0.4	14.2	9.0	5.2	3.0	4.1	5.1	0.2
NPAS3	"bHLHe12, MOP6, PASD6"	ENSG00000151322	"Neuronal PAS domain protein 3"	Q8IXF0	14	32934933-33804176	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.8"	"Group enriched"	"Detected in some"	11	"AF22: 8.8;U-266/70: 21.8;U-266/84: 6.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 6.4;glioma: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002892, HPA075337"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA002892: AB_1079403, HPA075337: "	"unprognostic (6.02e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.12e-3)"	"unprognostic (5.29e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.65e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.69e-3)"	"unprognostic (3.27e-1)"	1.8	2.4	17.4	1.4	14.4	1.0	2.7	8.5	29.8	14.0	1.8	15.8	0.7	1.5	9.1	2.6	1.6	8.5	2.2	1.6	18.7	10.3	2.4	1.3	1.3	1.3	11.7	13.0	6.4	2.2	2.5	1.6	2.0	16.2	2.5	1.7	0.8	2.7	3.6	2.0	1.4	1.6	2.2	13.8	3.1	2.8	3.5	16.3	0.0	4.4	0.0	1.5	1.1	1.4	0.0	0.6	0.1	0.2	0.0	0.2	0.0	0.0	0.0	8.8	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	21.8	6.2	0.0	0.3	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.6	0.0	0.0	17.4	14.4	8.5	15.3	18.7	10.3	11.7	13.0	16.2	16.3
NPFFR1	"GPR147, NPFF1R1, OT7T022"	ENSG00000148734	"Neuropeptide FF receptor 1"	Q9GZQ6	10	70247329-70283676	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	6	"brain: 34.9"	"Cell line enhanced"	"Detected in some"		"U-2 OS: 4.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"	"Group enriched"	"Detected in all"	5	"basal ganglia: 10.2;cerebellum: 34.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basal ganglia: 16.1;hypothalamus: 7.3"	"Low region specificity"	"Detected in many"			HPA037521	Uncertain									"HPA037521: "	"unprognostic (1.73e-3)"	"unprognostic (7.29e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.51e-1)"	"unprognostic (9.62e-2)"	"unprognostic (6.78e-2)"	"unprognostic (5.84e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	0.6	0.5	1.9	1.8	10.2	1.3	0.9	34.9	2.6	0.9	0.6	2.6	0.0	0.8	1.0	1.2	0.4	1.6	0.6	0.4	2.7	4.1	0.5	0.5	1.3	2.5	2.2	4.1	0.8	0.3	0.9	0.4	0.4	4.7	0.6	0.8	5.4	0.4	1.1	1.0	1.0	0.8	0.4	4.0	1.0	1.4	4.7	2.0	0.0	0.6	0.0	1.4	0.6	0.7	1.0	1.2	2.4	2.2	1.3	0.6	2.6	1.1	0.7	0.9	0.7	0.8	1.2	0.7	0.3	0.4	0.3	0.3	1.3	2.3	0.8	0.7	1.0	1.0	2.2	1.2	0.7	0.7	0.8	1.0	1.0	1.0	0.8	0.8	1.3	0.7	1.0	0.5	0.8	0.9	0.9	0.9	0.5	0.9	0.7	0.9	0.7	0.3	0.9	0.8	0.5	0.8	0.8	0.8	0.8	0.8	1.1	0.4	0.5	0.6	1.0	0.9	4.7	0.8	1.0	0.7	0.8	0.5	0.6	0.9	0.7	2.4	2.2	0.4	0.5	0.7	0.5	0.5	0.5	0.4	1.2	1.0	0.6	0.6	1.9	1.3	0.4	0.9	0.4	2.6	1.9	10.2	34.9	2.6	2.7	4.1	2.2	4.1	4.7	2.0
NPIPA1	"morpheus, NPIP"	ENSG00000183426	"Nuclear pore complex interacting protein family member A1"	Q9UND3	16	14922802-14952060	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 33.1"	"Cell line enhanced"	"Detected in many"		"HHSteC: 33.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	16	"B-cells: 2.3;granulocytes: 1.7;T-cells: 1.3"									HPA053611	Supported		Approved	Nucleoplasm				Nucleoplasm		"HPA053611: "	"unprognostic (2.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.82e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.74e-7)"	"unprognostic (2.28e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-5)"	5.1	6.0	5.9	3.8	4.9	4.2	4.8	33.1	8.3	5.0	5.8			1.8	15.6	0.0	3.0	16.3	2.7	4.6	7.0	6.2	6.6	3.0	4.3	5.4	3.7		25.2	4.7	1.1	13.6	3.0		7.8	3.3		2.5	11.7	7.9	16.3	3.0	12.4	3.8	5.0	3.2	6.5			6.1		4.1	5.0	4.0	2.3	0.0	1.7	0.1	0.1	1.3	0.7	0.1	5.2	24.1	9.3	0.0	0.4	4.2	9.2	6.4	8.5	7.6	3.6	5.7	1.5	13.2	12.7	4.2	11.1	1.2	8.7	4.7	4.2	0.0	8.1	19.2	33.5	11.5	2.7	18.6	18.2	7.0	12.8	4.1	1.2	6.4	9.6	11.1	0.0	6.1	0.2	0.2	4.5	0.1	2.1	13.6	11.1	1.0	9.2	4.9	0.6	10.4	1.9	10.1	0.8	11.3	0.5	0.2	2.9	3.8	2.7	3.0	0.4	0.7	5.7	1.7	0.0	0.0	0.8	0.0	1.3	2.3	0.3	1.2	0.0	1.3	0.6	0.4	0.0	0.1	0.1	0.0	0.7	0.7										
NPIPA5		ENSG00000183793	"Nuclear pore complex interacting protein family member A5"	E9PKD4	16	15363624-15381047	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 25.3"	"Cell line enhanced"	"Detected in many"		"THP-1: 15.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA053611	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA053611: "	"unprognostic (1.20e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.19e-4)"	"unprognostic (5.85e-2)"	"unprognostic (5.92e-2)"	"unprognostic (7.85e-2)"	"unprognostic (6.58e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.57e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.85e-1)"	"unprognostic (9.18e-2)"	"unprognostic (4.02e-2)"	2.0	2.7	4.9	0.8	4.0	3.2	3.3	25.3	6.6	3.2	4.5			2.4	8.0	8.4	4.0	5.8	4.8	4.2	5.5	5.7	1.9	2.5	4.5	2.4	3.6		5.5	4.0	7.6	8.9	1.0		3.3	2.4		1.6	2.5	4.6	13.9	2.1	2.6	2.5	2.7	2.3	8.8			2.9		1.0	2.8	2.5	0.8	0.3	0.1	0.1	1.1	0.7	0.1	0.9	1.4	4.9	0.7	9.2	9.7	0.7	1.9	4.6	6.4	6.5	2.0	0.8	2.0	0.5	4.9	2.0	1.7	4.9	3.3	3.9	1.9	2.6	5.8	9.7	1.3	0.6	3.6	1.9	8.4	2.5	3.4	3.3	2.7	1.5	6.1	1.0	2.0	3.2	6.8	0.9	0.7	0.7	0.6	5.4	1.9	0.0	0.7	5.4	2.4	6.0	2.4	15.5	7.7	0.0	2.5	7.5	0.4	4.3	6.0	7.2	0.9	3.7	1.3	0.1	0.1	0.0	0.1	0.0	0.7	0.8	0.4	0.2	0.3	0.4	0.2	0.1	0.0	1.1	0.1	0.1	0.1	0.1										
NPIPB3	"KIAA0220, NPIPL3"	ENSG00000169246	"Nuclear pore complex interacting protein family member B3"	Q92617	16	21402237-21448567	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 53.2"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA053611	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA053611: "	"unprognostic (2.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.66e-5)"	"unprognostic (1.50e-7)"	"unprognostic (1.30e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.94e-2)"	"unprognostic (9.00e-4)"	7.3	5.0	8.2	8.6	9.8	32.4	8.8	15.5	8.8	6.4	7.6			6.9	5.2	12.4	6.2	6.4	6.8	5.5	9.6	7.2	8.2	9.6	7.9	18.1	6.7		6.7	5.9	4.0	9.5	5.0		9.8	8.2		11.7	5.6	19.7	36.9	9.6	6.1	7.6	14.6	7.1	7.3			9.7		7.9	5.2	6.6	5.3	9.0	6.5	3.6	3.4	5.7	0.4	13.5	12.3	8.4	14.7	11.4	6.5	25.1	9.4	3.3	5.0	5.6	19.0	16.7	19.7	9.4	12.8	15.5	5.5	13.9	4.6	11.0	7.8	8.6	17.0	53.2	10.2	15.7	16.7	3.5	6.0	12.0	15.4	6.6	15.7	26.2	6.8	24.3	16.6	38.6	15.5	14.4	26.5	8.8	11.6	10.0	7.9	10.7	8.2	5.4	12.9	9.8	12.7	7.6	10.8	23.8	13.1	2.2	13.6	13.9	9.7	17.8	9.4	13.9	12.5	6.5	3.6	2.6	5.7	2.7	2.3	4.4	3.0	2.9	2.2	5.3	3.9	2.6	3.9	3.4	2.0	9.0	2.0	0.4										
NPIPB5		ENSG00000243716	"Nuclear pore complex interacting protein family member B5"	A8MRT5	16	22479121-22536521	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA053611	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA053611: "	"unprognostic (7.52e-4)"	"unprognostic (2.08e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.43e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.64e-3)"	"unprognostic (2.40e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.90e-10)"	"unprognostic (1.10e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.76e-5)"	10.8	7.0	13.4	34.7	12.0	30.6	10.4	18.3	13.4	9.6	10.8	9.6	12.5	7.7	8.6	33.3	7.2	8.4	6.6	8.4	24.1	6.1	8.7	6.1	13.6	19.3	17.5	16.7	9.9	10.1	6.4	8.7	7.2	13.7	10.5	12.1	14.6	12.2	22.9	17.8	54.2	17.1	6.8	9.7	16.3	8.9	10.6	11.8	7.0	14.4	6.8	14.2	8.0	10.0	11.7	7.0	8.3	3.5	4.4	5.9	1.3	10.8	9.5	6.0	7.7	10.4	9.7	14.4	6.7	2.3	4.2	5.3	13.4	18.3	15.0	12.4	8.8	9.7	14.1	9.5	7.5	18.5	5.1	5.8	25.0	25.8	10.0	31.3	9.7	11.8	7.3	10.2	18.8	7.4	15.9	24.3	5.1	18.5	13.8	42.0	16.9	4.1	15.2	4.4	17.9	7.6	6.3	6.7	5.7	8.2	11.6	5.6	6.8	10.8	25.0	13.4	6.1	11.1	11.2	13.5	6.3	19.5	5.6	22.8	6.0	6.7	3.5	2.7	5.5	1.7	2.3	8.6	5.2	3.7	2.0	11.7	5.9	4.9	8.3	4.4	3.2	7.0	2.4	1.3	13.4	12.0	18.3	13.4	24.1	6.1	17.5	16.7	13.7	11.8
NPNT	"EGFL6L, POEM"	ENSG00000168743	Nephronectin	Q6UXI9	4	105894775-106004027	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 125.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.9;HeLa: 16.8;Hep G2: 13.5;MCF7: 12.0;RPTEC TERT1: 19.6;T-47d: 26.3"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 104.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003711, HPA050203"	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to extracellular matrix"			"Nucleoplasm, Cell Junctions, Cytosol"		"HPA003711: AB_1854591, HPA050203: "	"unprognostic (1.24e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.85e-3)"	"unprognostic (4.78e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"prognostic favourable (8.28e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-2)"	5.4	1.6	3.4	2.4	4.4	0.0	8.3	0.7	2.5	13.3	11.0	1.9	4.2	16.4	8.7	11.4	5.7	5.9	19.0	2.5	2.5	2.7	22.7	1.3	34.9	0.9	7.5	2.4	4.1	11.6	0.0	14.6	3.0	2.2	26.3	7.6	16.9	2.8	5.7	2.6	2.1	37.7	4.0	0.9	4.4	4.0	3.0	2.8	3.4	125.3	3.7	2.3	3.7	6.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	14.9	0.1	0.0	0.0	0.0	7.4	9.7	0.1	0.4	0.1	0.9	3.7	0.0	0.0	0.0	3.8	0.3	16.8	13.5	0.0	0.0	0.1	1.6	1.3	0.0	0.0	0.0	0.0	0.2	0.0	12.0	0.2	0.7	0.1	6.0	0.0	0.0	0.1	19.6	0.8	0.8	0.3	0.9	7.2	0.0	26.3	0.6	0.0	0.3	0.2	0.2	0.5	0.1	0.5	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.4	0.7	2.5	2.5	2.7	7.5	2.4	2.2	2.8
NPTX1		ENSG00000171246	"Neuronal pentraxin 1"	Q15818	17	80467148-80477843	"Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 68.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 12.1;HeLa: 9.5;SiHa: 15.4;U-138 MG: 33.0;WM-115: 45.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 74.8;cerebellum: 228.3;cerebral cortex: 119.6;hippocampal formation: 173.6"	HPA077062	Enhanced				"Secreted in brain"		1000000			"HPA077062: "	"unprognostic (2.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.05e-6)"	"unprognostic (1.41e-4)"	"unprognostic (1.35e-1)"	"unprognostic (8.86e-6)"	"unprognostic (2.71e-3)"	1.0	3.4	28.8	1.4	14.7	0.8	1.1	68.9	62.5	0.8	9.1	0.2	0.0	1.3	1.3	2.5	1.4	1.4	1.7	0.7	15.5	3.0	0.8	0.7	1.0	1.4	1.0	18.2	0.7	0.7	0.7	0.8	1.6	4.6	1.3	2.5	0.6	0.7	2.9	1.0	3.2	1.5	1.4	1.9	2.3	1.5	1.3	0.0	0.9	0.7	0.0	0.7	0.9	0.2	0.0	0.0	0.0	0.0	1.5	0.3	0.1	0.0	0.7	0.2	0.0	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	12.1	0.0	0.0	0.0	7.5	0.0	9.5	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.5	0.0	0.0	3.1	0.0	0.0	8.2	0.0	15.4	0.0	0.0	0.0	0.2	0.1	33.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	45.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	28.8	14.7	68.9	29.9	15.5	3.0	1.0	18.2	4.6	0.0
NPY4R	"PP1, PPYR1, Y4"	ENSG00000204174	"Neuropeptide Y receptor Y4"	P50391	10	46461099-46465881	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 9.4;skin 1: 4.3"	"Cell line enriched"	"Detected in some"	5	"A549: 24.9"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.8"	"Group enriched"	"Detected in some"	5	"cerebellum: 1.6;cerebral cortex: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA027863	Approved									"HPA027863: AB_10602819"		"unprognostic (2.26e-6)"	"unprognostic (2.94e-1)"			"unprognostic (8.17e-2)"		"unprognostic (1.20e-1)"		"unprognostic (1.30e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.64e-3)"	"unprognostic (6.58e-2)"			"unprognostic (9.79e-2)"	0.2	0.0	0.2	0.7	0.2	0.0	0.2	1.6	1.2	0.3	7.4	0.2	0.2	2.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.9	9.4	0.2	0.2	0.2	0.2	4.3	2.6	1.4	0.2	0.2	2.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	24.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.7	0.0	5.1	0.0	0.4	0.1	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.6	1.2	0.2	0.2	0.2	0.2	0.2	0.2
NRARP	MGC61598	ENSG00000198435	"NOTCH regulated ankyrin repeat protein"	Q7Z6K4	9	137300482-137302251	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 41.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 23.3;HEK 293: 11.7;NTERA-2: 17.1;T-47d: 11.9;TIME: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA025729	Approved		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA025729: AB_1854633"	"unprognostic (9.92e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (6.73e-6)"	"unprognostic (2.85e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.28e-3)"	7.9	1.6	6.5	8.4	7.8	1.7	13.8	3.9	11.7	5.6	41.7	6.1	1.1	17.1	5.2	1.9	17.4	3.2	26.0	7.1	5.0	6.5	3.2	2.9	7.0	1.8	6.0	3.0	5.6	14.2	3.1	7.1	8.9	7.4	11.8	22.8	5.6	1.9	2.8	4.4	19.7	15.7	4.5	3.2	7.7	8.7	6.0	3.4	2.3	4.2	14.0	14.4	7.6	10.2	0.2	0.0	0.0	0.3	0.4	0.0	0.0	2.5	0.5	3.5	4.2	0.0	0.0	1.6	0.1	0.1	0.0	0.0	2.7	1.4	0.0	6.4	0.0	23.3	6.4	0.2	0.1	0.2	11.7	0.7	1.0	2.6	0.4	0.9	2.3	0.0	1.1	0.0	0.2	5.3	6.9	0.1	0.0	7.7	0.1	2.7	17.1	3.5	4.6	0.7	8.4	0.6	0.2	2.4	4.4	0.7	1.2	0.0	11.9	1.9	17.0	0.0	0.0	0.1	0.9	0.1	0.1	1.4	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	6.5	7.8	3.9	6.8	5.0	6.5	6.0	3.0	7.4	3.4
NRN1L	"MRCC2446, UNQ2446"	ENSG00000188038	"Neuritin 1 like"	Q496H8	16	67884805-67888855	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 20.9"	"Cell line enriched"	"Detected in some"	5	"BEWO: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041761	Uncertain				"Secreted - unknown location"					"HPA041761: AB_10961155"										"unprognostic (2.79e-2)"				"unprognostic (3.32e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.99e-2)"	"unprognostic (4.85e-1)"	1.9	2.1	3.4	1.9	11.6	7.2	1.8	8.5	5.1	2.0	1.7	6.3	0.4	3.1	2.2	0.9	1.5	2.5	1.7	4.8	5.9	5.3	1.6	1.8	4.4	4.4	5.7	3.1	4.9	2.6	3.6	6.5	1.6	6.4	2.6	1.4	20.9	4.4	2.0	4.5	6.8	2.6	1.6	3.5	4.3	2.2	2.6	6.1	0.4	2.4	1.5	1.5	3.9	1.9	1.6	0.5	2.1	1.9	0.8	3.8	0.9	0.1	0.4	0.6	0.7	0.3	0.8	26.7	0.4	0.0	0.3	0.2	0.0	0.4	0.3	0.5	0.1	0.3	0.0	0.2	0.2	0.3	0.6	0.2	1.1	1.5	0.6	0.1	1.1	0.5	0.9	0.0	0.0	0.0	0.7	0.6	0.2	1.3	0.5	3.3	5.0	0.3	1.3	0.0	0.5	0.2	0.3	0.8	0.3	0.4	0.4	0.4	0.9	1.1	0.5	0.3	0.2	0.0	0.0	0.2	0.3	0.7	0.1	0.3	0.1	0.0	1.9	0.0	3.8	1.1	2.0	1.6	2.3	1.2	0.5	1.3	2.0	1.1	2.1	0.8	1.3	0.4	1.3	0.9	3.4	11.6	8.5	5.1	5.9	5.3	5.7	3.1	6.4	6.1
NRSN2	"C20orf98, dJ1103G7.6"	ENSG00000125841	"Neurensin 2"	Q9GZP1	20	346782-359660	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015967	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				Vesicles	"Nucleoplasm, Cytosol"	"HPA015967: AB_1854647"	"unprognostic (5.67e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.92e-2)"	"prognostic favourable (1.61e-4)"	"unprognostic (6.96e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.85e-3)"	"unprognostic (1.73e-3)"	8.4	18.6	34.3	6.0	39.3	0.9	7.2	22.7	70.9	12.8	6.6	11.0	4.9	3.5	12.5	16.0	6.1	13.4	9.3	13.5	31.1	24.9	10.1	1.8	8.7	4.1	17.1	28.5	18.3	10.5	26.5	16.3	10.1	27.8	12.2	6.1	12.8	13.3	16.5	1.4	5.0	3.8	16.3	8.7	5.7	5.3	12.8	6.8	1.3	14.9	2.5	4.2	9.4	4.8	9.4	4.8	1.5	1.1	3.4	3.9	1.5	18.7	22.9	13.8	13.0	18.3	20.5	5.4	12.5	24.2	22.7	22.9	12.6	0.4	0.0	4.4	23.1	8.3	11.1	1.9	14.5	0.1	11.2	6.8	10.9	23.8	18.5	0.2	1.1	23.2	1.5	16.2	2.7	15.6	13.4	12.2	19.9	3.3	0.3	5.8	10.6	11.8	10.7	7.7	0.9	22.7	0.1	28.2	20.3	14.9	4.4	21.4	18.3	7.0	10.4	24.4	12.9	0.9	15.2	2.2	0.4	5.1	3.2	0.2	12.8	0.0	1.1	1.5	3.8	0.3	1.1	7.2	1.1	3.9	2.1	9.4	1.6	2.7	0.0	3.4	0.4	4.8	0.9	1.5	34.3	39.3	22.7	70.9	31.1	24.9	17.1	28.5	27.8	6.8
NRXN1	"Hs.22998, KIAA0578"	ENSG00000179915	"Neurexin 1"	"P58400, Q9ULB1"	2	49918505-51225575	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Angiogenesis, Cell adhesion"		"Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 81.9"	"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 28.3"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 4.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071400			Supported	"Plasma membrane"	"Intracellular and membrane"		620000	"Plasma membrane"		"HPA071400: "	"unprognostic (7.01e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.74e-4)"	"unprognostic (2.46e-1)"	"unprognostic (8.95e-2)"		"unprognostic (2.02e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-2)"	"unprognostic (6.37e-4)"	"unprognostic (2.85e-2)"	"unprognostic (6.68e-7)"	"unprognostic (3.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.99e-3)"	2.1	3.2	22.4	2.1	20.3	1.4	1.7	56.5	81.9	2.8	5.1	3.0	0.5	2.1	2.1	3.7	3.0	1.4	2.2	3.8	16.9	13.8	1.5	1.6	1.5	1.4	8.3	25.9	2.1	2.3	1.3	4.8	1.1	12.6	2.5	3.8	2.0	3.5	9.3	1.3	2.0	3.1	2.1	6.5	1.3	2.3	6.5	4.7	0.0	1.4	0.0	1.4	2.0	1.6	0.0	0.0	4.4	0.1	0.3	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.2	0.0	0.0	28.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	2.4	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.3	0.0	0.0	0.0	0.0	22.4	20.3	56.5	33.2	16.9	13.8	8.3	25.9	12.6	4.7
NSG2	"CALY3, HMP19, Nsg2"	ENSG00000170091	"Neuronal vesicle trafficking associated 2"	Q9Y328	5	174045604-174243501	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 120.8"	"Group enriched"	"Detected in some"	58	"SCLC-21H: 21.3;SH-SY5Y: 34.3"	"Cancer enriched"	"Detected in some"	8	"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046531, HPA056191"	Enhanced		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"HPA046531: , HPA056191: "	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.36e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.20e-2)"	"unprognostic (9.31e-4)"	"unprognostic (1.55e-1)"	1.7	23.1	31.6	3.0	92.4	1.4	1.4	19.7	120.8	1.4	3.6	5.0	0.0	2.8	1.4	1.7	1.5	1.4	1.6	1.6	27.3	40.2	1.6	1.4	1.6	1.4	20.2	27.6	1.4	2.0	1.4	0.9	1.4	22.5	1.4	4.1	0.8	1.4	1.5	1.4	1.4	3.8	2.5	4.6	1.4	3.3	5.0	11.7	0.0	1.8	0.0	1.4	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	92.4	19.7	49.8	27.3	40.2	20.2	27.6	22.5	11.7
NSUN7	FLJ14001	ENSG00000179299	"NOP2/Sun RNA methyltransferase family member 7"	Q8NE18	4	40749897-40809985	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 39.5"	"Cell line enhanced"	"Detected in some"		"A-431: 3.9;CAPAN-2: 8.6;Karpas-707: 6.3;MCF7: 4.1;RPTEC TERT1: 4.2;T-47d: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA020653	Uncertain		Supported	Vesicles				Vesicles		"HPA020653: AB_1848710"	"unprognostic (2.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.01e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.42e-2)"	"prognostic favourable (2.76e-8)"	"unprognostic (3.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-2)"	0.7	1.2	0.9	2.8	2.0	0.7	5.1	0.2	1.0	3.2	7.0	2.4	7.3	2.3	5.9	9.7	4.5	9.1	5.4	5.5	1.0	1.9	6.6	0.7	8.1	4.2	1.0	0.5	4.6	14.1	7.7	7.5	2.8	2.6	5.7	3.2	4.3	15.2	10.3	0.1	1.9	6.7	2.6	1.8	3.6	3.8	39.5	0.2	2.4	11.9	1.5	5.3	3.7	1.5	1.1	0.0	6.1	0.1	0.0	0.0	0.0	3.9	0.4	1.9	0.0	0.0	0.0	2.9	0.0	0.3	0.2	0.2	1.5	8.6	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	4.1	0.1	0.0	2.3	0.5	0.1	0.1	0.0	4.2	1.1	1.0	2.3	0.6	2.7	0.0	6.3	0.0	0.2	0.0	3.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.9	2.0	0.2	1.0	1.0	1.9	1.0	0.5	2.6	0.2
NT5C1B	"AIRP, CN-IB"	ENSG00000185013	"5'-nucleotidase, cytosolic IB"	Q96P26	2	18562872-18589572	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 52.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA056683	Uncertain									"HPA056683: "	"unprognostic (4.18e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.84e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.77e-1)"	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.3	0.7	0.0	0.4	0.3	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.5	52.6	0.1	0.1	0.5	0.1	0.1	0.5	0.1	1.2	3.7	0.0	0.1	0.7	2.6	0.4	3.2	0.7	0.3	0.0	0.0	0.0	0.5	2.5	0.0	0.0	0.0	0.0	3.5	1.6	0.5	0.0	1.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.9	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	1.1	0.2	0.0	2.9	0.1	0.2	0.7	1.7	0.3	0.7	0.8	0.1	3.0	2.5	1.2	2.6	0.4	1.5	0.8	0.7	1.7	1.5	1.0	2.9	0.5	1.0	0.7	2.0	2.5	0.0	1.2	0.0	0.1	0.0	1.3	0.0	2.3	0.1	1.3	1.3	0.3	1.2	2.6	2.2	0.0	0.7	0.1	3.7	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NT5DC4		ENSG00000144130	"5'-nucleotidase domain containing 4"	Q86YG4	2	112721486-112742879	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 3.0;testis: 6.0"	"Cell line enriched"	"Detected in some"	7	"K-562: 18.2"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"					"Cell type enhanced"	"Detected in single"		"eosinophil: 3.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.0"					"Low region specificity"	"Detected in all"			HPA046856	Uncertain									"HPA046856: "	"unprognostic (2.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.20e-4)"	"unprognostic (2.26e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.38e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.60e-4)"	"unprognostic (9.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-4)"	0.1	0.0	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0		0.0	0.0	0.0	0.0	0.1		0.0	0.0		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0	6.0			0.0		1.0	0.0	0.0	0.0	0.0	3.0	0.4	0.0	0.0	0.1	1.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.2	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.5	0.2	0.7	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	18.2	1.5	0.0	0.0	0.2	2.5	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.4	0.1	0.1	0.0	0.2	0.6	0.0	0.2	0.1	0.1	0.0	0.2	3.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1										
NUDT13	DKFZp586P2219	ENSG00000166321	"Nudix hydrolase 13"	Q86X67	10	73110375-73131828	"Predicted intracellular proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040636	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA040636: AB_10960360"	"unprognostic (3.75e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.40e-2)"	"unprognostic (5.07e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.96e-2)"	4.3	7.4	3.7	9.9	8.9	5.0	6.3	3.5	5.1	3.4	8.1	7.2	9.5	7.0	6.5	13.8	3.8	4.5	7.0	7.0	5.9	3.0	7.1	12.8	5.1	5.3	7.3	4.5	4.4	7.8	7.4	4.1	3.6	5.8	5.2	4.7	3.7	5.0	8.8	8.6	7.2	5.8	5.2	11.8	5.8	6.0	5.6	7.2	2.4	4.6	2.8	4.8	6.8	3.7	6.2	1.9	2.5	3.4	4.9	3.7	1.1	5.0	3.6	5.9	7.4	3.7	3.2	1.3	4.5	4.0	2.3	2.6	9.5	10.6	2.5	2.2	2.7	5.9	0.6	4.2	2.4	1.9	10.3	6.9	5.9	5.2	0.3	3.8	2.8	2.3	4.6	3.0	1.7	1.8	5.8	3.9	2.3	2.3	2.2	5.4	2.2	11.6	5.0	1.0	0.2	3.3	2.3	2.6	3.8	2.4	6.1	2.0	3.4	2.5	3.4	2.1	8.1	0.8	1.7	2.9	3.3	3.3	5.7	7.0	1.9	0.1	2.6	2.5	1.8	2.5	2.1	3.0	1.5	1.6	1.9	6.2	2.3	2.4	1.0	4.9	3.4	0.6	3.7	1.1	3.7	8.9	3.5	5.1	5.9	3.0	7.3	4.5	5.8	7.2
NUP210L		ENSG00000143552	"Nucleoporin 210 like"	Q5VU65	1	153992685-154155116	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 42.7"	"Cell line enriched"	"Detected in single"	43	"MCF7: 18.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA047195, HPA064245, HPA066707"	Enhanced		Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA047195: , HPA064245: , HPA066707: "	"unprognostic (2.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.45e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.51e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.35e-10)"	"unprognostic (4.20e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.09e-2)"	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.9	0.1	0.1	1.5	0.0	0.0	1.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.0	0.4	0.4	0.6	0.1	0.0	0.8	0.9	0.4	0.1	0.1	0.1	3.4	0.2	0.1	0.1	42.7	0.0	0.3	0.3	0.0	0.1	1.2	0.1	0.6	0.6	1.8	0.2	0.9	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.1	0.2	0.6	0.4	0.5	0.0	0.5	0.8	0.3	1.8	0.9	0.0	0.6	0.7	0.0	0.1	0.3	0.1	0.9	0.1	0.2	0.1	0.0	0.6	0.0
NUTM2A	FAM22A	ENSG00000184923	"NUT family member 2A"	Q8IVF1	10	87225448-87236908	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 14.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"eosinophil: 1.3"	"Low lineage specificity"	"Detected in single"											HPA064635			Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA064635: "	"unprognostic (1.75e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.29e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.75e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.65e-1)"	3.5	1.8	2.8	0.4	2.5	1.7	1.1	1.5	2.9	1.1	1.8			1.3	1.7	2.1	0.9	1.9	0.8	3.0	3.4	2.2	1.5	1.3	1.6	0.9	2.9		3.0	2.4	2.9	2.0	1.3		2.5	1.0		5.9	0.8	2.3	4.4	2.0	0.7	3.6	1.7	1.8	2.4			2.6		0.2	1.4	1.2	0.4	0.0	1.3	0.2	0.0	0.2	0.2	1.4	0.2	0.7	0.0	1.8	0.9	0.9	0.6	1.8	0.8	0.5	0.2	0.7	1.4	0.1	0.0	1.4	0.0	0.9	0.1	0.3	1.5	1.7	0.4	0.2	0.7	0.6	14.2	0.5	4.1	0.9	1.1	0.0	1.8	0.4	0.2	0.7	1.1	2.4	3.2	0.5	1.7	0.2	0.0	0.5	0.1	1.8	2.7	0.7	0.6	0.6	0.3	0.9	1.4	0.0	0.2	0.8	0.1	0.0	0.1	0.7	0.8	1.4	0.0	0.0	0.2	1.3	0.1	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.2										
NUTM2F	"DKFZp434I1117, FAM22F"	ENSG00000130950	"NUT family member 2F"	A1L443	9	94318196-94328644	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	9	"testis: 5.5"	"Cell line enriched"	"Detected in single"	9	"NTERA-2: 5.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA064635			Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA064635: "	"unprognostic (1.40e-1)"	"unprognostic (4.93e-3)"	"unprognostic (4.16e-2)"			"unprognostic (1.47e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.03e-1)"		"unprognostic (2.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.72e-3)"	"unprognostic (8.48e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.14e-1)"		"unprognostic (1.83e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.1		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	5.5			0.0		0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1										
NWD2	KIAA1239	ENSG00000174145	"NACHT and WD repeat domain containing 2"	Q9ULI1	4	37244220-37449465	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.8;breast: 20.0"	"Cell line enhanced"	"Detected in single"		"AF22: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046911	Uncertain									"HPA046911: "	"unprognostic (1.14e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.53e-1)"		"unprognostic (5.47e-2)"	"unprognostic (9.42e-2)"	"unprognostic (2.55e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.86e-2)"	"unprognostic (7.65e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.26e-2)"	4.9	0.3	2.1	0.3	2.9	0.2	20.0	1.0	11.8	0.3	1.6	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.3	0.2	2.3	3.2	0.2	0.5	0.2	0.3	0.7	2.0	0.2	0.7	0.3	0.3	0.3	2.0	0.2	0.8	0.0	0.4	0.2	0.2	0.7	0.4	0.4	0.3	0.2	0.3	0.6	0.0	0.4	2.7	0.0	0.3	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.9	1.0	8.9	2.3	3.2	0.7	2.0	2.0	0.0
NXF5		ENSG00000126952	"Nuclear RNA export factor 5"	Q9H1B4	X	101832112-101857577	"Disease related genes, Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"epididymis: 1.5"	"Cell line enhanced"	"Detected in single"		"PC-3: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA002079	Uncertain									"HPA002079: AB_1079515"	"unprognostic (1.23e-1)"				"unprognostic (2.85e-1)"		"unprognostic (2.73e-1)"				"unprognostic (1.44e-3)"	"unprognostic (9.58e-2)"	"unprognostic (5.65e-2)"		"unprognostic (2.24e-1)"	"unprognostic (2.91e-2)"		0.7	0.2	0.3	0.0	0.4	0.7	0.2	0.8	0.7	0.0	0.0			0.0	0.0	1.5	0.1	0.3	0.4	0.1	0.6	0.5	0.8	0.5	0.2	0.4	0.7		0.2	0.1	0.0	0.1	0.0		0.2	0.0		0.0	0.4	0.6	0.0	0.1	0.2	0.9	0.8	0.0	0.1			0.3		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NXNL2	"C9orf121, RdCVF2"	ENSG00000130045	"Nucleoredoxin like 2"	Q5VZ03	9	88535101-88584274	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ovary: 11.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 15.0"	"Group enriched"	"Detected in some"	7	"breast cancer: 1.7;endometrial cancer: 4.0;ovarian cancer: 7.2;renal cancer: 2.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045526	Uncertain		Approved	Cytosol				Cytosol		"HPA045526: AB_10961044"	"prognostic favourable (6.53e-4)"	"unprognostic (9.70e-2)"	"unprognostic (4.78e-3)"	"prognostic favourable (3.83e-8)"	"unprognostic (2.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.62e-3)"	"unprognostic (5.58e-2)"	"prognostic favourable (9.60e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-2)"	7.2	0.4	1.6	1.0	1.6	4.4	3.2	0.6	1.1	6.7	0.5	2.0	0.4	0.6	6.2	9.7	0.8	6.6	0.7	0.5	1.8	2.9	4.4	5.1	0.4	0.4	1.3	1.0	11.7	0.5	0.0	0.7	3.9	1.2	0.8	0.0	2.0	1.4	3.7	1.0	1.3	0.5	0.4	1.8	0.8	0.5	2.2	0.4	0.4	1.2	0.4	0.4	1.2	1.5	1.2	1.1	4.8	1.0	1.7	2.4	0.7	1.9	4.1	1.7	1.5	0.1	1.1	1.2	3.8	1.0	0.5	0.7	0.8	1.3	1.0	1.6	0.4	2.0	0.6	0.2	1.3	0.6	1.2	1.9	4.0	1.3	0.8	1.1	1.4	0.8	0.3	0.4	0.4	0.0	1.3	4.1	1.0	0.9	1.1	1.8	2.1	0.9	0.8	0.8	1.4	15.0	1.4	1.1	0.7	2.3	1.2	0.7	1.7	1.0	1.4	1.4	2.8	2.1	0.8	1.4	1.2	1.1	1.2	1.6	1.0	4.8	1.0	2.3	2.1	0.5	2.1	0.8	1.2	2.4	0.3	1.2	2.1	2.4	2.8	1.7	0.5	1.1	2.0	0.7	1.6	1.6	0.6	1.1	1.8	2.9	1.3	1.0	1.2	0.4
NXPE1	"FAM55A, MGC34290"	ENSG00000095110	"Neurexophilin and PC-esterase domain family member 1"	Q8N323	11	114521645-114559895	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"intestine: 44.0;lymphoid tissue: 20.4"	"Cell line enhanced"	"Detected in single"		"U-138 MG: 1.0"	"Cancer enriched"	"Detected in single"	23	"colorectal cancer: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049133	Enhanced				"Intracellular and membrane"					"HPA049133: AB_2680647"	"unprognostic (2.81e-1)"		"unprognostic (2.19e-3)"		"unprognostic (3.40e-3)"			"unprognostic (4.10e-1)"		"unprognostic (1.05e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.76e-1)"				0.1	0.0	0.1	20.4	0.1	0.0	0.1	0.1	0.1	0.1	44.0	0.1	0.1	0.4	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	36.9	0.1	0.3	0.1	0.1	0.0	4.4	1.0	0.1	0.1	0.0	2.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
NXPE3	"FAM55C, MGC15606"	ENSG00000144815	"Neurexophilin and PC-esterase domain family member 3"	Q969Y0	3	101779202-101827392	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 37.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036259	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"		7600	Vesicles	Nucleoplasm	"HPA036259: AB_10671838"	"unprognostic (3.30e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.42e-5)"	"unprognostic (4.98e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.43e-1)"	"prognostic unfavourable (7.76e-6)"	"unprognostic (2.89e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.75e-3)"	6.1	4.7	7.2	7.6	16.6	7.8	5.3	6.1	16.2	6.3	5.2	29.5	6.0	2.4	7.9	2.6	4.5	8.2	4.8	12.6	9.8	5.9	3.0	2.5	6.9	10.7	24.0	8.6	5.5	2.6	15.8	6.9	4.7	22.0	6.2	3.4	3.4	4.2	7.5	44.6	2.5	4.9	7.6	9.4	8.7	4.6	5.1	17.2	6.6	5.3	4.1	9.8	7.3	5.0	8.9	11.6	15.9	13.6	6.7	19.5	11.1	7.7	11.8	10.2	3.7	11.0	11.6	2.2	8.6	10.9	10.3	15.1	2.7	0.8	11.4	25.5	9.7	1.7	11.3	9.2	12.9	14.1	3.6	8.7	7.5	7.3	14.6	7.4	8.2	6.6	1.6	8.6	3.1	11.1	1.8	37.3	17.1	4.0	9.8	1.8	5.8	7.3	4.5	12.4	4.8	7.6	1.9	8.1	9.6	3.7	0.9	6.4	1.7	10.6	9.6	11.5	13.7	1.3	8.9	17.7	17.6	13.4	9.8	32.8	2.2	6.3	13.6	15.9	12.7	10.4	8.8	8.9	14.2	13.2	11.6	5.8	19.5	15.5	6.9	6.7	9.9	7.4	16.3	11.1	7.2	16.6	6.1	16.2	9.8	5.9	24.0	8.6	22.0	17.2
NXPE4	"C11orf33, FAM55D, FLJ20127"	ENSG00000137634	"Neurexophilin and PC-esterase domain family member 4"	Q6UWF7	11	114570591-114595762	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"intestine: 44.3;lymphoid tissue: 21.7;salivary gland: 71.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	15	"colorectal cancer: 13.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042801	Approved				"Secreted to digestive system"					"HPA042801: AB_10793986"	"unprognostic (1.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.27e-1)"		"unprognostic (3.51e-3)"		"unprognostic (1.06e-1)"		"unprognostic (1.32e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.47e-3)"	"unprognostic (4.36e-2)"		"unprognostic (2.05e-1)"		0.2	0.2	0.2	21.7	0.2	0.0	0.2	0.2	0.2	0.2	41.5	0.1	0.1	0.0	0.2	2.4	0.3	0.3	0.1	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.1	0.2	0.2	0.0	0.2	0.1	0.1	2.1	44.3	0.1	71.7	0.1	0.2	0.2	0.5	1.9	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.3	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1
NXPH2	NPH2	ENSG00000144227	"Neurexophilin 2"	O95156	2	138670772-138780348	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	15	"brain: 23.0;kidney: 8.0;ovary: 19.3"	"Cell line enhanced"	"Detected in some"		"AF22: 6.2;SCLC-21H: 2.4;SiHa: 6.0;U-2 OS: 9.9;U-251 MG: 3.2"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	4	"pons and medulla: 23.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034759	Approved				"Secreted in brain"					"HPA034759: AB_10669732"	"unprognostic (5.83e-2)"				"unprognostic (8.83e-2)"			"unprognostic (1.41e-1)"		"unprognostic (2.72e-1)"	"unprognostic (1.80e-1)"							0.4	0.5	3.1	0.6	3.7	0.2	0.4	0.8	6.0	0.6	0.3	0.0	0.0	0.2	1.1	0.5	0.2	0.6	0.2	0.2	1.9	1.5	8.0	0.3	0.3	0.2	2.4	2.0	19.3	0.2	0.4	0.4	0.4	23.0	0.3	0.3	0.5	0.2	1.1	0.2	0.2	0.4	0.3	0.7	0.2	0.2	0.4	0.8	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	2.4	1.6	6.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.7	0.8	5.6	1.9	1.5	2.4	2.0	23.0	0.8
NYAP1	"C7orf51, FLJ37538, KIAA1486L"	ENSG00000166924	"Neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1"	Q6ZVC0	7	100483927-100494799	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.8"	"Cell line enhanced"	"Detected in some"		"AF22: 4.4;HUVEC TERT2: 5.6;SH-SY5Y: 13.6"	"Cancer enhanced"	"Detected in some"		"glioma: 4.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022251	Uncertain		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA022251: AB_1848915"	"unprognostic (6.59e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.51e-4)"	"unprognostic (2.89e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.06e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.65e-2)"	3.1	6.3	11.8	1.6	15.2	1.3	1.4	15.4	32.8	1.8	1.6	3.8	0.0	1.6	2.8	1.3	1.5	1.9	1.6	1.2	13.2	12.8	1.9	1.1	1.3	1.4	7.4	13.4	5.7	2.1	1.1	10.2	1.7	11.4	2.9	1.4	1.0	2.3	3.2	1.2	1.9	1.8	2.1	3.9	1.6	2.3	9.0	4.4	0.0	1.2	0.0	1.2	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.4	2.0	2.9	1.9	0.4	0.1	1.4	0.2	0.6	0.6	0.3	0.0	1.5	0.4	0.2	0.9	0.2	0.1	1.9	0.3	0.2	0.4	0.2	2.1	0.0	1.2	1.9	0.0	0.6	0.7	5.6	0.7	0.1	0.1	0.5	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.1	0.0	1.3	13.6	0.5	0.3	1.3	0.2	0.0	2.0	0.0	2.8	0.8	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	15.2	15.4	20.6	13.2	12.8	7.4	13.4	11.4	4.4
NYNRIN	"CGIN1, FLJ11811, KIAA1305"	ENSG00000205978	"NYN domain and retroviral integrase containing"	Q9P2P1	14	24398786-24419288	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 45.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 9.0;HEL: 9.0;HUVEC TERT2: 22.3;RT4: 18.4;TIME: 10.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 26.6"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018945	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA018945: AB_1859538"	"unprognostic (9.41e-3)"	"unprognostic (3.96e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.49e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.43e-1)"	8.1	2.8	2.1	4.3	2.2	0.2	6.8	26.6	2.6	16.7	7.6	2.5	29.6	2.9	14.6	45.9	11.6	13.4	14.5	5.1	2.2	4.2	6.1	3.6	7.5	2.0	1.8	1.8	28.0	2.9	4.5	4.9	10.5	2.4	9.8	4.1	9.1	5.5	20.2	2.5	9.1	4.5	8.0	1.5	5.2	4.5	7.3	1.4	3.5	7.5	8.5	6.5	8.6	10.2	0.0	1.7	0.0	0.1	0.5	0.1	0.0	0.1	0.0	2.9	0.0	4.1	8.5	0.2	1.3	1.4	0.9	1.0	2.0	9.0	0.2	0.4	5.3	0.0	4.7	0.1	1.0	0.0	0.5	9.0	1.2	0.2	3.0	0.0	0.0	8.6	0.3	0.6	0.0	22.3	1.4	0.0	0.1	0.4	0.0	0.4	1.7	0.0	1.1	0.0	0.0	0.0	18.4	0.4	6.4	0.0	0.8	0.1	1.6	1.3	10.8	0.1	5.4	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.0	0.0	2.1	2.2	26.6	2.6	2.2	4.2	1.8	1.8	2.4	1.4
OAF	MGC52117	ENSG00000184232	"Out at first homolog"	Q86UD1	11	120210767-120230332	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 34.3;Hep G2: 53.7;NB-4: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 6.2;intermediate monocyte: 2.9;myeloid DC: 4.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 4.6;monocytes: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047412	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"		65000000	Nucleoplasm		"HPA047412: AB_10960631"	"unprognostic (1.59e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.69e-2)"	"prognostic unfavourable (5.71e-5)"	"unprognostic (2.11e-1)"	"unprognostic (3.98e-3)"	"unprognostic (5.09e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-1)"	16.2	22.5	8.6	6.9	15.4	3.5	24.9	1.2	10.3	18.7	16.8	4.0	8.0	19.4	14.3	17.2	10.7	13.4	20.6	13.7	8.7	1.4	21.5	93.4	5.6	8.1	5.4	6.4	26.2	43.7	2.4	7.4	4.6	3.2	10.3	13.5	18.2	26.5	5.8	3.7	3.0	22.1	11.7	3.3	15.3	9.9	5.5	5.5	1.2	6.8	8.6	3.6	11.2	10.9	0.1	4.6	0.3	6.2	0.0	0.4	1.3	6.9	2.1	8.2	4.1	12.9	14.5	0.4	13.5	14.0	5.5	8.0	2.1	10.8	0.0	34.3	9.1	7.3	2.3	3.4	2.1	5.0	5.6	5.7	1.3	53.7	11.5	12.6	2.3	18.0	2.1	5.2	14.6	15.7	3.7	6.5	1.3	2.5	0.0	36.0	3.3	11.0	3.2	0.2	6.7	8.2	3.8	0.4	2.9	3.9	4.4	11.2	1.4	20.9	9.5	11.8	4.4	12.0	1.3	0.2	0.1	0.1	9.1	21.0	4.0	0.0	6.2	0.0	0.2	2.9	0.1	0.1	0.0	0.0	4.6	0.0	0.1	0.4	0.3	0.0	0.6	0.9	0.3	1.3	8.6	15.4	1.2	10.3	8.7	1.4	5.4	6.4	3.2	5.5
OCEL1	FLJ22709	ENSG00000099330	"Occludin/ELL domain containing 1"	Q9H607	19	17226204-17229219	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042070, HPA043223"	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA042070: , HPA043223: "	"unprognostic (6.34e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.00e-3)"	"unprognostic (6.40e-2)"	"unprognostic (2.06e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.73e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.18e-3)"	12.1	14.3	9.2	7.3	7.4	5.9	10.6	7.3	16.5	9.6	18.6	6.2	14.0	20.4	9.7	21.3	8.8	14.7	11.0	9.1	8.3	8.2	23.3	48.1	11.1	7.6	9.9	9.5	12.3	15.9	12.3	6.5	13.0	7.8	13.4	13.7	9.9	11.5	21.7	8.6	5.6	32.2	8.2	8.1	11.8	15.1	4.9	8.1	9.4	20.5	6.8	10.0	9.7	13.6	12.2	18.2	17.2	23.7	11.2	14.4	9.5	5.8	4.4	2.5	2.0	23.6	9.7	6.1	3.5	9.4	2.8	4.8	3.1	6.6	4.9	13.7	5.1	2.7	3.0	3.7	2.6	4.2	3.6	4.7	4.7	15.1	8.0	1.0	7.3	8.0	3.8	3.6	5.3	3.9	3.8	4.7	5.1	4.6	2.4	2.7	3.7	7.7	2.2	2.0	11.9	11.9	7.6	0.8	3.8	2.2	7.1	6.1	10.9	4.2	2.5	1.7	2.0	3.7	1.8	13.4	10.0	3.7	6.0	4.3	1.1	17.2	23.7	11.2	8.1	15.7	7.9	12.0	12.2	9.2	18.2	12.2	14.0	8.7	7.5	11.2	12.4	8.0	14.4	9.5	9.2	7.4	7.3	16.5	8.3	8.2	9.9	9.5	7.8	8.1
OCSTAMP	"C20orf123, dJ257E24.3"	ENSG00000149635	"Osteoclast stimulatory transmembrane protein"	Q9BR26	20	46540946-46550574	"Predicted membrane proteins, Transporters"	Differentiation			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 6.9;blood: 2.6"	"Cell line enhanced"	"Detected in some"		"AF22: 2.6;HMC-1: 5.1;Karpas-707: 2.9;NB-4: 5.5;RPMI-8226: 2.4;U-266/70: 1.8;U-266/84: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	26	"plasmacytoid DC: 2.6"	"Lineage enriched"	"Detected in single"	26	"dendritic cells: 2.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA031116	Uncertain									"HPA031116: AB_10600758"	"unprognostic (2.77e-1)"		"unprognostic (3.04e-1)"		"unprognostic (8.80e-2)"	"unprognostic (5.02e-2)"		"unprognostic (2.42e-1)"	"unprognostic (2.71e-1)"					"unprognostic (2.65e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.08e-1)"		6.9	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.6	0.0	0.0	0.1	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.1	0.2	0.6	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	5.5	0.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.4	0.0	0.1	0.3	0.2	0.5	0.0	0.0	0.0
ODF2L	KIAA1229	ENSG00000122417	"Outer dense fiber of sperm tails 2 like"	Q9ULJ1	1	86346824-86396342	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028020, HPA028095, HPA028333"	Uncertain									"HPA028020: AB_10601670, HPA028095: AB_10611385, HPA028333: AB_10601007"	"unprognostic (4.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.80e-3)"	"unprognostic (5.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.08e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.27e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavourable (4.69e-7)"	"unprognostic (2.40e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.04e-3)"	16.1	15.7	14.9	13.8	16.7	15.4	22.3	16.6	23.0	18.1	14.4	10.6	14.8	8.6	19.1	26.0	13.8	22.6	16.2	10.2	12.2	15.6	14.1	6.6	19.2	15.4	9.6	16.9	16.7	9.5	6.3	37.8	10.5	15.9	15.7	15.9	13.5	14.4	13.6	4.1	12.4	17.4	10.3	15.3	29.0	7.2	10.9	12.6	36.5	18.5	9.5	13.4	12.3	13.9	11.0	6.1	6.3	2.0	6.7	27.2	2.5	14.1	3.8	9.7	7.5	10.6	18.3	10.2	13.9	8.5	13.9	16.0	3.0	8.0	0.3	13.2	7.3	7.4	4.0	8.1	11.8	6.6	6.3	3.5	11.7	0.3	8.1	6.1	4.6	8.6	10.0	20.7	5.7	22.1	4.7	3.4	8.0	2.0	7.3	6.6	11.9	7.1	9.9	7.3	1.5	14.4	19.3	9.7	7.0	12.5	12.9	25.6	4.2	6.0	20.2	11.6	10.7	15.8	14.0	1.0	0.5	5.8	2.7	3.1	13.0	2.2	1.2	6.3	13.8	1.6	27.2	10.2	16.1	10.9	1.1	11.0	10.4	9.9	3.2	6.7	2.0	6.1	14.9	2.5	14.9	16.7	16.6	23.0	12.2	15.6	9.6	16.9	15.9	12.6
ODF3	"CT135, hSHIPPO, SHIPPO1"	ENSG00000177947	"Outer dense fiber of sperm tails 3"	Q96PU9	11	196738-200261	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"testis: 12.5"	"Cell line enhanced"	"Detected in single"		"U-266/70: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038919, HPA039241"	Enhanced									"HPA038919: AB_2676270, HPA039241: AB_10673417"					"unprognostic (4.17e-1)"					"unprognostic (2.41e-1)"				"unprognostic (1.24e-2)"	"unprognostic (1.99e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5			0.0		0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	1.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.6										
ODF3B		ENSG00000177989	"Outer dense fiber of sperm tails 3B"	A8MYP8	22	50529710-50532580	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 22.8;U-266/70: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 31.6;intermediate monocyte: 24.3;myeloid DC: 18.2;neutrophil: 19.2;non-classical monocyte: 16.4"	"Group enriched"	"Detected in many"	15	"dendritic cells: 18.2;granulocytes: 19.2;monocytes: 31.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA062837	Enhanced									"HPA062837: "	"unprognostic (4.30e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.98e-2)"	"prognostic favourable (2.84e-4)"	"unprognostic (2.60e-2)"	"prognostic favourable (4.89e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (2.65e-5)"	"unprognostic (2.72e-1)"	"unprognostic (1.51e-2)"	"unprognostic (6.10e-2)"	"unprognostic (3.61e-2)"	16.1	2.6	3.4	18.8	5.7	8.8	10.7	5.9	2.5	7.5	6.3	7.4	5.4	5.2	5.0	31.1	11.7	49.0	9.3	5.8	4.7	5.0	9.6	20.1	33.2	15.4	1.4	1.2	12.4	8.8	1.7	3.9	6.5	12.3	10.4	1.4	6.2	34.3	8.7	5.4	5.6	9.3	3.5	6.2	16.3	9.1	7.4	2.3	4.0	12.4	13.7	13.0	6.3	4.9	1.4	18.2	19.2	31.6	0.0	0.8	8.0	1.5	0.9	0.1	0.4	0.0	2.1	0.9	0.0	0.3	0.1	1.0	1.7	7.4	0.5	1.9	0.0	4.4	0.0	0.0	0.0	0.8	0.5	0.3	1.1	1.3	5.7	0.0	3.6	1.2	0.9	0.0	0.0	0.1	0.4	22.8	0.0	0.0	0.0	0.8	0.1	1.0	0.8	0.1	3.8	0.0	0.0	0.1	6.5	0.7	0.9	0.1	0.7	1.1	0.5	0.2	0.6	0.4	0.1	32.3	2.9	0.5	0.7	0.1	0.6	2.3	31.6	3.4	0.2	24.3	0.3	1.4	0.6	0.4	18.2	0.8	0.3	0.2	19.2	0.0	16.4	1.7	0.8	8.0	3.4	5.7	5.9	2.5	4.7	5.0	1.4	1.2	12.3	2.3
OGFOD2	"FLJ13491, FLJ37501"	ENSG00000111325	"2-oxoglutarate and iron dependent oxygenase domain containing 2"	Q6N063	12	122974580-122980043	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039448, HPA040306"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA039448: AB_10795035, HPA040306: AB_10794026"	"unprognostic (2.14e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.13e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	6.2	15.0	8.9	11.7	11.7	10.0	7.5	13.4	10.6	7.5	13.4	11.6	14.1	18.5	9.6	14.9	11.2	12.8	13.1	8.5	8.0	8.8	12.9	18.9	8.0	13.4	14.5	9.3	11.6	24.3	10.9	13.5	10.6	13.4	11.4	7.8	9.7	20.1	14.6	13.2	15.9	17.9	8.7	8.0	14.4	11.5	25.1	13.8	10.9	13.3	10.8	12.0	7.4	8.0	16.4	13.4	18.0	16.6	8.8	15.6	9.3	7.2	11.7	4.9	8.0	3.4	3.7	13.2	4.4	4.6	6.2	5.6	11.0	6.5	8.1	9.2	3.8	10.5	3.5	6.0	2.3	5.6	7.7	12.9	10.0	11.3	7.4	12.8	10.1	5.4	9.1	5.7	5.1	6.5	14.9	6.0	3.1	13.9	10.7	24.1	3.0	15.1	12.0	4.7	14.3	4.7	6.5	6.3	5.8	6.0	8.7	8.3	21.9	11.0	4.1	8.5	8.7	10.0	4.5	15.2	9.1	7.7	11.7	6.7	8.2	12.5	12.2	18.0	10.1	13.1	8.7	16.4	8.2	9.8	13.4	11.4	9.3	8.5	10.0	8.8	16.6	8.0	15.6	9.3	8.9	11.7	13.4	10.6	8.0	8.8	14.5	9.3	13.4	13.8
OGFRL1	dJ331H24.1	ENSG00000119900	"Opioid growth factor receptor like 1"	Q5TC84	6	71288803-71308950	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 12.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027122			Approved	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA027122: AB_2156775"	"unprognostic (8.44e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.24e-3)"	"prognostic unfavourable (3.62e-4)"	"unprognostic (9.62e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.58e-3)"	16.9	8.7	20.2	11.3	26.8	16.9	36.0	22.3	33.3	6.7	7.2	29.1	2.8	2.9	8.3	10.7	24.5	5.2	8.3	5.8	30.2	17.6	5.7	4.8	8.5	9.6	27.7	18.3	5.4	6.0	5.8	10.0	9.9	37.8	6.7	4.3	3.3	31.8	10.3	4.1	14.6	5.7	24.1	52.2	11.7	5.4	2.4	29.1	3.2	4.8	4.3	17.8	5.4	9.4	0.7	2.4	12.8	3.0	0.5	0.5	0.6	3.8	1.1	4.0	0.0	11.0	10.1	1.5	17.1	10.6	6.9	7.0	1.4	0.7	23.3	23.5	7.3	1.9	3.1	11.7	24.6	4.9	2.5	5.1	4.1	0.6	9.0	2.4	1.8	10.2	10.2	5.1	16.1	5.5	0.3	1.8	23.7	3.2	0.0	3.8	1.6	0.9	1.6	12.4	5.3	16.0	0.3	13.9	6.3	5.0	3.1	1.1	5.4	18.9	8.4	17.0	8.6	1.8	5.6	2.5	0.1	3.0	5.7	16.2	2.9	3.1	3.0	0.1	0.5	2.0	0.5	0.4	0.4	0.5	2.4	0.7	0.1	0.3	12.8	0.5	1.4	0.9	0.2	0.6	20.2	26.8	22.3	27.4	30.2	17.6	27.7	18.3	37.8	29.1
OLFML2A	FLJ00237	ENSG00000185585	"Olfactomedin like 2A"	Q68BL7	9	124777158-124814885	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 57.9;HeLa: 14.6;WM-115: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021180, HPA022254"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"			"Nucleoplasm, Cytosol"		"HPA021180: AB_1854790, HPA022254: AB_1854791"	"unprognostic (1.12e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (3.73e-5)"	"unprognostic (5.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.05e-2)"	17.3	2.1	1.0	7.4	1.7	0.1	10.9	1.9	3.4	34.2	18.9	3.1	6.3	2.3	29.2	8.3	11.8	4.2	7.6	12.5	1.2	1.0	3.0	0.6	10.3	1.5	2.1	1.5	13.2	3.4	3.6	2.1	5.0	4.0	16.1	4.6	18.9	4.7	9.5	9.8	11.6	5.0	33.7	1.6	23.8	4.0	3.1	0.6	3.7	20.0	11.9	5.0	22.0	10.4	1.4	0.7	2.6	0.9	0.6	0.6	0.4	0.3	5.2	0.4	0.1	6.0	57.9	0.0	0.8	2.8	1.2	1.2	0.0	0.7	0.0	1.5	0.0	9.7	0.1	0.3	1.4	0.0	0.0	0.0	14.6	0.0	0.3	0.0	0.0	4.1	0.9	3.6	0.4	0.0	0.0	0.0	0.6	0.1	0.0	0.1	1.3	0.5	0.0	3.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	1.4	1.3	0.1	0.0	1.8	1.9	2.0	0.2	0.7	0.0	0.0	5.5	0.3	22.6	1.9	0.9	0.4	0.4	0.3	0.3	0.5	0.3	0.3	0.7	1.4	0.4	0.6	2.6	0.6	0.3	0.6	0.3	0.4	1.0	1.7	1.9	3.4	1.2	1.0	2.1	1.5	4.0	0.6
OLFML2B	DKFZP586L151	ENSG00000162745	"Olfactomedin like 2B"	Q68BL8	1	161983192-162023854	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 15.7;HSkMC: 44.4;RH-30: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 8.8;non-classical monocyte: 6.5"	"Lineage enriched"	"Detected in single"	10	"monocytes: 8.8"	"Region enriched"	"Detected in many"	6	"hippocampal formation: 45.1"	"Low region specificity"	"Detected in many"			"HPA054136, HPA062739"	Approved		Approved	Cytosol	"Secreted - unknown location"			Cytosol		"HPA054136: , HPA062739: "	"unprognostic (2.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavourable (4.67e-4)"	"unprognostic (5.97e-3)"	"unprognostic (7.32e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"prognostic unfavourable (1.01e-12)"	"unprognostic (1.64e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.97e-2)"	19.6	6.6	1.7	12.8	3.0	0.3	12.3	0.6	4.1	13.0	14.5	2.9	6.5	1.5	14.2	21.8	3.2	9.8	33.7	25.4	2.9	1.6	3.9	1.2	12.8	24.1	2.9	1.2	7.0	2.3	3.2	2.6	27.6	2.2	6.6	2.2	14.5	9.0	6.1	6.1	8.9	5.0	15.1	3.6	22.4	3.4	12.5	2.1	1.9	18.3	13.7	8.5	12.4	7.3	0.0	0.8	0.3	8.8	0.0	0.1	0.2	0.0	0.1	2.5	0.8	8.2	15.7	0.0	0.8	4.0	1.6	4.5	0.0	0.0	0.0	0.1	9.5	0.0	0.2	0.0	0.9	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.3	44.4	0.0	2.0	0.0	0.2	0.0	0.4	7.3	0.0	0.0	0.0	0.8	0.3	0.0	33.8	3.2	0.6	0.0	0.3	0.1	3.4	0.0	0.2	0.0	0.0	0.0	1.0	0.2	1.5	1.3	0.0	0.0	0.0	9.7	1.0	0.5	0.0	0.6	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.3	0.0	6.5	0.0	0.0	0.2	1.7	3.0	0.6	4.1	2.9	1.6	2.9	1.2	2.2	2.1
OLFML3	"HNOEL-iso, OLF44"	ENSG00000116774	"Olfactomedin like 3"	Q9NRN5	1	113979391-114035572	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 83.1;ASC TERT1: 45.4;BJ hTERT+: 51.8;HSkMC: 83.1;LHCN-M2: 82.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"myeloid DC: 5.4"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 5.4"	"Low region specificity"	"Detected in many"							HPA027991			Supported	Vesicles	"Secreted to extracellular matrix"		1500000	Vesicles		"HPA027991: "	"unprognostic (1.04e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (3.45e-5)"	"unprognostic (6.80e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.41e-3)"	25.8	11.8	3.9	9.7	6.6	0.0	25.6	1.4	7.9	75.3	22.7	16.2	17.9	3.9	57.7	41.8	13.8	33.9	31.5	20.3	3.0	2.3	9.7	9.4	18.4	5.7	7.1	4.0	52.6	11.7	1.0	6.6	29.1	8.9	33.1	9.6	41.4	6.1	21.9	5.8	13.5	10.8	29.4	5.1	2.5	19.1	13.3	4.6	0.6	7.8	15.0	7.0	28.0	37.6	0.0	5.4	0.0	0.4	0.0	0.0	0.2	0.0	2.6	1.3	0.0	83.1	45.4	0.0	10.6	51.8	3.7	12.1	3.4	0.0	0.0	0.5	30.4	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	2.5	21.6	0.0	0.0	83.1	0.0	5.2	0.0	0.2	0.0	0.0	82.9	0.0	0.0	0.0	6.3	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.4	30.7	0.1	0.2	2.1	4.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	12.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	3.9	6.6	1.4	7.9	3.0	2.3	7.1	4.0	8.9	4.6
OLIG2	"BHLHB1, bHLHe19, OLIGO2, PRKCBP2, RACK17"	ENSG00000205927	"Oligodendrocyte transcription factor 2"	Q13516	21	33025845-33029196	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 66.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 29.3;NB-4: 21.2;THP-1: 18.4;WM-115: 6.0"	"Cancer enriched"	"Detected in some"	52	"glioma: 46.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"eosinophil: 15.4"	"Lineage enriched"	"Detected in single"	154	"granulocytes: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003254, CAB019381"	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"CAB019381: , HPA003254: AB_1854795"		"unprognostic (5.14e-1)"	"unprognostic (4.56e-1)"		"unprognostic (1.44e-2)"	"unprognostic (8.27e-2)"		"unprognostic (3.24e-2)"	"unprognostic (4.34e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.41e-2)"		"unprognostic (1.39e-1)"	"unprognostic (5.78e-5)"	"unprognostic (2.76e-1)"			1.3	1.3	24.1	1.4	19.1	1.4	1.3	4.2	66.2	1.3	1.3	41.4	0.0	1.7	1.3	1.3	1.3	1.3	1.3	1.3	23.6	15.6	1.3	1.3	1.3	1.3	20.9	15.5	1.3	1.3	1.3	0.0	1.3	17.1	1.3	1.3	0.0	1.3	1.3	1.3	1.3	1.5	1.3	16.8	1.3	1.4	1.3	16.6	0.0	1.3	0.0	1.3	1.4	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.6	4.2	0.0	0.0	0.0	0.8	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	21.2	1.9	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	6.0	1.8	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	19.1	4.2	27.6	23.6	15.6	20.9	15.5	17.1	16.6
ONECUT1	"HNF-6, HNF6, HNF6A"	ENSG00000169856	"One cut homeobox 1"	Q9UBC0	15	52756989-52791078	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"gallbladder: 40.1;liver: 59.9;pancreas: 46.3"	"Cell line enhanced"	"Detected in some"		"AF22: 3.3;Hep G2: 4.0;MCF7: 5.1;RT4: 4.0;WM-115: 3.7"	"Group enriched"	"Detected in some"	7	"liver cancer: 2.9;pancreatic cancer: 0.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.1"	"Low region specificity"	"Detected in all"			HPA003457	Enhanced									"HPA003457: AB_1079525"		"unprognostic (5.12e-2)"		"unprognostic (2.45e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.82e-2)"	"unprognostic (9.19e-2)"	"unprognostic (7.05e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.03e-1)"		"unprognostic (1.70e-7)"	"unprognostic (9.76e-3)"	"unprognostic (2.11e-1)"		"unprognostic (1.17e-1)"	0.1	0.1	0.5	0.0	0.1	1.2	0.1	0.9	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	40.1	0.1	0.2	0.2	0.1	59.9	0.1	0.0	0.1	0.0	0.1	46.3	0.0	0.1	0.0	1.4	0.1	0.0	3.5	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.1	0.1	2.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.3	1.2	3.3	1.4	0.0	0.0	1.5	0.0	0.0	0.0	0.1	1.4	0.2	2.1	0.1	0.0	0.2	0.2	0.0	0.0	0.3	0.2	0.2	1.4	4.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	5.1	0.0	0.0	2.5	0.3	0.9	0.2	0.0	0.0	4.0	1.7	0.0	0.5	0.1	0.4	1.0	0.2	0.0	2.1	2.7	0.0	0.4	0.3	0.1	0.3	0.4	0.4	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.9	0.3	0.2	0.2	0.1	0.0	1.4	0.0
ONECUT2	OC-2	ENSG00000119547	"One cut homeobox 2"	O95948	18	57435685-57491297	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.6;gallbladder: 60.7;intestine: 18.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 18.2;HeLa: 11.6;RT4: 6.2;SCLC-21H: 9.5"	"Group enriched"	"Detected in many"	7	"liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 18.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"basal ganglia: 10.6;cerebellum: 9.9;cerebral cortex: 6.6;hippocampal formation: 4.3;hypothalamus: 4.3"	HPA057058	Enhanced		Supported	"Nucleoplasm,Actin filaments"				Nucleoplasm	"Actin filaments"	"HPA057058: "	"unprognostic (3.02e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.06e-3)"	"unprognostic (3.79e-5)"	"unprognostic (1.13e-2)"	"unprognostic (4.48e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.56e-3)"	"unprognostic (8.66e-3)"	"unprognostic (1.16e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.21e-1)"	0.3	0.4	0.3	0.3	18.6	0.2	0.3	3.0	3.7	0.2	16.5	0.0	0.0	15.0	0.3	0.3	0.3	0.2	60.7	0.2	0.5	0.9	0.3	12.8	0.3	0.3	0.5	0.9	0.3	4.3	3.2	5.1	0.2	1.1	0.3	0.3	0.7	0.3	0.3	0.3	0.3	18.0	0.3	0.3	0.3	0.5	0.6	6.6	0.0	0.3	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.1	2.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	3.2	0.0	0.1	18.2	2.9	0.7	11.6	2.7	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	3.5	0.6	0.0	0.4	1.7	0.0	0.1	0.7	0.0	1.1	0.0	1.6	6.2	9.5	1.6	0.1	0.0	0.2	0.4	0.6	0.0	1.0	1.2	0.2	0.2	0.3	2.7	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.6	3.0	3.7	0.5	0.9	0.5	0.9	1.1	6.6
OOSP2	"FLJ36198, PLAC1L, TMEM122"	ENSG00000149507	"Oocyte secreted protein 2"	Q86WS3	11	60040275-60048044	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 48.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	32	"basophil: 3.2"	"Lineage enriched"	"Detected in single"	32	"granulocytes: 3.2"					"Not detected"	"Not detected"			HPA050914	Enhanced				"Secreted in male reproductive system"					"HPA050914: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPALIN	"HTMP10, TMEM10, TMP10"	ENSG00000197430	"Oligodendrocytic myelin paranodal and inner loop protein"	Q96PE5	10	96343216-96359365	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	43	"brain: 69.7"	"Group enriched"	"Detected in some"	11	"MOLT-4: 2.2;REH: 4.5"	"Cancer enriched"	"Detected in single"	36	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014372	Supported									"HPA014372: AB_2158172"					"unprognostic (1.18e-1)"													1.5	1.5	35.0	1.5	42.1	1.6	1.5	2.8	69.7	1.5	1.5	52.5	0.0	1.5	1.5	1.5	1.5	1.5	1.5	1.5	40.1	15.1	1.5	1.5	1.5	1.5	19.9	17.8	1.5	1.5	1.5	0.0	1.5	13.8	1.5	1.5	0.0	1.5	1.5	1.5	1.5	1.5	1.5	17.8	1.5	1.5	1.5	29.5	0.0	1.5	0.0	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.0	42.1	2.8	33.4	40.1	15.1	19.9	17.8	13.8	29.5
OR10AD1	OR10AD1P	ENSG00000172640	"Olfactory receptor family 10 subfamily AD member 1"	Q8NGE0	12	48202083-48203387	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.2;K-562: 1.1;U-937: 4.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Low lineage specificity"	"Detected in single"											HPA049913	Uncertain									"HPA049913: "	"unprognostic (2.90e-1)"	"unprognostic (2.79e-1)"			"unprognostic (2.67e-2)"			"unprognostic (1.70e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.74e-1)"		0.0	2.5	0.2	1.7	0.5	0.2	0.0	1.9	0.6	0.3	0.6			1.0	0.6	0.0	0.6	0.6	0.1	0.2	0.1	0.3	0.4	0.0	0.3	1.6	0.0		1.4	0.3	0.0	2.9	0.4		0.7	0.0		0.7	0.0	0.3	0.9	0.7	0.0	0.0	0.9	0.6	2.5			1.5		0.0	0.6	0.3	0.0	0.0	0.0	0.4	0.2	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.6	0.3	0.2	1.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.3	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.4	0.0	0.0	0.9	0.9	0.1	0.0	4.1	0.1	0.0	0.4	0.0	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.8	0.7	0.0	0.2	0.0	0.0	0.3	0.0										
OR10C1	"hs6M1-17, OR10C1P, OR10C2"	ENSG00000206474	"Olfactory receptor family 10 subfamily C member 1 (gene/pseudogene)"	Q96KK4	6	29439306-29440977	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049336	Uncertain									"HPA049336: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR10K1		ENSG00000173285	"Olfactory receptor family 10 subfamily K member 1"	Q8NGX5	1	158461574-158470857	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.4;esophagus: 2.9"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA059125	Uncertain									"HPA059125: "																		0.2	0.4	0.2	0.8	0.3	2.0	0.2	0.2	0.4	0.7	0.3			0.2	0.3	0.8	2.9	0.2	0.2	0.3	0.2	0.2	0.3	0.3	0.2	0.3	0.2		0.3	0.3	0.1	0.3	0.0		0.2	0.0		0.2	0.0	1.6	0.4	0.3	0.0	0.3	0.5	0.3	0.9			0.2		1.0	0.8	0.3	1.4	0.5	2.4	0.6	0.9	1.2	0.1	1.2	1.0	1.1	1.0	0.7	0.6	1.3	0.7	0.5	0.1	0.4	0.6	0.9	1.2	1.8	0.3	1.0	0.4	0.4	1.5	1.7	0.4	1.3	1.1	0.8	0.3	0.9	1.6	0.1	0.1	0.9	0.4	0.1	1.0	3.8	0.1	0.4	1.3	1.6	2.2	0.2	1.0	0.5	0.8	0.0	0.9	0.8	1.2	0.8	0.4	2.0	0.9	1.1	0.4	1.2	2.2	2.1	0.9	2.1	1.7	1.0	0.7	1.0	1.9	1.6	0.6	0.2	1.2	0.5	1.2	0.7	0.9	1.0	0.3	1.4	0.9	1.0	2.4	0.9	0.4	0.5	0.8	0.1										
OR10S1		ENSG00000196248	"Olfactory receptor family 10 subfamily S member 1"	Q8NGN2	11	123976661-123977781	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"thyroid gland: 1.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.3;hTCEpi: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA019038	Uncertain									"HPA019038: AB_1854785"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.9	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			1.4		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR11H12		ENSG00000257115	"Olfactory receptor family 11 subfamily H member 12"	B2RN74	14	18601045-18602129	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"AN3-CA: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047370	Uncertain									"HPA047370: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0			0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.3	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR11H4		ENSG00000176198	"Olfactory receptor family 11 subfamily H member 4"	Q8NGC9	14	20239286-20244349	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"skin 1: 1.2"	"Cell line enhanced"	"Detected in some"		"RT4: 1.0;U-266/70: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA052790	Uncertain									"HPA052790: "																		0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.9	0.3	0.1	0.0			0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.2	0.0		0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.6			0.3		0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR13A1		ENSG00000256574	"Olfactory receptor family 13 subfamily A member 1"	Q8NGR1	10	45302298-45315608	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.3;urinary bladder: 4.2"	"Group enriched"	"Detected in some"	34	"Daudi: 13.2;U-698: 12.2"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.8"					"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"							HPA057237	Uncertain									"HPA057237: "	"unprognostic (7.88e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.33e-5)"	"unprognostic (6.43e-3)"	"unprognostic (6.04e-2)"		"unprognostic (8.65e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-15)"	"unprognostic (6.54e-2)"	"unprognostic (2.87e-1)"	"unprognostic (8.55e-2)"	"unprognostic (4.09e-3)"	0.0	0.0	0.1	0.4	0.2	0.5	0.1	1.9	0.1	0.0	0.2			0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.4	2.2	0.2		0.1	0.2	0.0	0.0	0.0		0.9	0.3		0.5	0.0	0.3	0.0	1.6	0.0	0.4	2.3	0.2	0.3			0.0		2.0	4.2	0.3	2.0	0.0	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.0	0.2	0.0	0.0	0.1	0.3	0.9	0.0	0.0	0.9	0.0	0.0	0.0										
OR13C3		ENSG00000204246	"Olfactory receptor family 13 subfamily C member 3"	Q8NGS6	9	104535749-104536856	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	9	"testis: 2.1"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA053978	Uncertain									"HPA053978: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR13D1		ENSG00000179055	"Olfactory receptor family 13 subfamily D member 1"	Q8NGV5	9	104694379-104695485	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	6	"testis: 2.3"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA055921	Uncertain									"HPA055921: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0			0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0		0.1	0.0	0.0	0.2	0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	2.3			0.0		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0										
OR1L3	OR9-D	ENSG00000171481	"Olfactory receptor family 1 subfamily L member 3"	Q8NH93	9	122675036-122676153	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"epididymis: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058878	Uncertain									"HPA058878: "																		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.0			0.0	0.1	1.3	0.7	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.1		0.0	0.0		0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.8			0.0		0.0	0.5	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR1Q1	"HSTPCR106, OR1Q2, OR1Q3, OR9-A, OST226, OST226OR9-A, TPCR106"	ENSG00000165202	"Olfactory receptor family 1 subfamily Q member 1"	Q15612	9	122614738-122615682	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"epididymis: 4.4;urinary bladder: 1.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.2;CAPAN-2: 1.4;fHDF/TERT166: 2.3;HSkMC: 1.4;Karpas-707: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA044828	Uncertain									"HPA044828: AB_10960565"										"unprognostic (5.41e-2)"				"unprognostic (2.00e-1)"			"unprognostic (1.98e-1)"	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.1	0.2			0.0	0.7	4.4	0.2	0.5	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.4	0.2		0.2	0.2		0.3	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.4	0.3			0.0		0.1	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	1.2	0.2	1.0	3.2	0.0	0.0	0.0	1.4	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR2A25	"OR2A25P, OR2A27"	ENSG00000221933	"Olfactory receptor family 2 subfamily A member 25"	A4D2G3	7	144069811-144075870	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.4"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;THP-1: 1.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA058272	Uncertain									"HPA058272: "																		0.1	0.7	0.0	1.1	0.0	0.5	0.3	0.0	0.1	0.3	0.1			0.5	0.3	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.0		0.5	0.4	0.0	0.2	0.1		0.2	0.3		0.3	0.0	0.2	1.0	0.3	0.0	0.0	0.2	0.1	0.4			1.0		0.1	0.1	0.2	1.4	0.8	3.4	0.5	0.7	0.5	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.3	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.2	0.3	0.4	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.2	1.5	0.0	0.0	0.3	0.4	0.1	0.4	0.0	0.0	0.2	0.2	0.2	3.4	0.5	0.2	0.3	0.3	0.3	0.6	0.5	0.4	0.2	1.4	0.4	0.5	1.8	0.7	0.2	0.8	0.4	0.5										
OR2A4	OR2A10	ENSG00000180658	"Olfactory receptor family 2 subfamily A member 4"	O95047	6	131699644-131701401	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"blood: 10.6"	"Cell line enhanced"	"Detected in some"		"HEL: 1.2;HMC-1: 1.1;MCF7: 1.7"	"Cancer enriched"	"Detected in single"	17	"renal cancer: 0.8"					"Group enriched"	"Detected in some"	48	"basophil: 10.6;NK-cell: 3.8"	"Group enriched"	"Detected in many"	48	"granulocytes: 10.6;NK-cells: 3.8"									HPA058272	Uncertain									"HPA058272: "													"unprognostic (1.22e-5)"	"unprognostic (3.60e-2)"				0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.2			1.4	2.1	0.0	0.0	0.4	0.4	0.8	0.0	0.0	0.6	0.4	0.0	0.0	0.0		0.4	0.0	0.0	0.0	0.1		1.0	0.0		1.0	0.3	0.5	0.0	0.6	0.0	0.0	0.0	0.4	1.1			0.0		0.0	0.9	0.2	0.0	0.0	10.6	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.5	0.5	0.0	0.6	0.1	0.5	0.0	0.0	0.0	0.9	0.0	0.3	1.2	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.9	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0										
OR2A7	HSDJ0798C17	ENSG00000243896	"Olfactory receptor family 2 subfamily A member 7"	Q96R45	7	144257663-144264792	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 10.0;hTCEpi: 5.1;RT4: 4.0;SK-BR-3: 4.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"basophil: 7.8"	"Low lineage specificity"	"Detected in many"											HPA058272	Uncertain									"HPA058272: "	"unprognostic (6.48e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.05e-1)"	"unprognostic (4.13e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.33e-1)"	"unprognostic (9.08e-2)"	"unprognostic (3.58e-3)"	"unprognostic (5.52e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.22e-1)"	0.9	0.1	0.0	0.2	0.0	1.4	3.9	0.0	0.0	2.7	3.4			6.5	0.7	2.2	3.9	2.3	1.6	0.7	0.0	0.0	3.3	2.1	2.1	0.4	0.0		2.6	4.8	2.3	1.3	0.7		3.7	3.4		4.0	0.6	0.0	7.9	4.5	0.3	0.0	0.8	3.8	0.2			8.1		0.4	2.5	2.8	2.0	0.0	7.8	0.0	1.5	1.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.4	2.7	0.0	0.0	0.0	1.8	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	5.1	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.6	4.0	0.0	0.0	2.5	4.4	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	7.8	0.0	0.0	0.7	0.0	0.2	0.5	1.0	0.5	0.0	2.0	0.6	0.5	0.0	1.5	0.0	0.0	0.6	0.0										
OR2AE1	OR2AE2	ENSG00000244623	"Olfactory receptor family 2 subfamily AE member 1"	Q8NHA4	7	99875987-99877057	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Cell line enhanced"	"Detected in some"		"HBF TERT88: 1.0;hTEC/SVTERT24-B: 1.2;U-2197: 2.2;U-266/70: 1.0;U-266/84: 1.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.5"									HPA042957	Uncertain									"HPA042957: AB_10794539"	"unprognostic (6.75e-2)"				"unprognostic (6.22e-2)"				"unprognostic (5.21e-2)"				"unprognostic (1.58e-1)"	"unprognostic (3.16e-2)"				0.4	0.4	0.0	0.0	0.2	0.1	1.2	0.3	0.2	0.4	0.1			1.1	0.7	1.4	0.3	0.4	0.0	0.3	0.0	0.1	0.3	0.1	0.4	0.6	0.0		0.2	0.3	1.2	0.8	0.2		0.5	0.5		1.3	0.2	1.2	0.8	0.2	0.4	0.1	0.3	0.1	0.1			0.3		0.4	0.3	0.1	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.6	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.1	1.0	1.1	0.1	0.2	0.5	0.5	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR2AK2	OR2AK1P	ENSG00000187080	"Olfactory receptor family 2 subfamily AK member 2"	Q8NG84	1	247965233-247966386	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"bone marrow: 2.5;testis: 1.3"	"Cell line enhanced"	"Detected in single"		"PC-3: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052544	Uncertain									"HPA052544: "																		0.0	0.2	0.0	0.0	0.3	2.5	0.0	0.1	0.2	0.4	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.3			0.2		0.0	0.2	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3										
OR2B11		ENSG00000177535	"Olfactory receptor family 2 subfamily B member 11"	Q5JQS5	1	247449118-247458105	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.1"	"Cell line enriched"	"Detected in single"	5	"THP-1: 5.0"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047459	Uncertain									"HPA047459: AB_10963692"					"unprognostic (1.83e-1)"													1.5	0.1	0.1	1.2	0.1	3.1	0.1	0.0	0.2	0.3	0.1			0.0	0.0	0.1	0.1	0.7	1.0	0.2	0.1	0.1	0.0	0.1	0.4	0.3	0.1		0.1	1.1	0.0	0.0	0.1		0.0	0.0		0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.7	0.1	0.2			0.3		0.0	0.3	0.0	0.0	0.0	0.5	1.5	0.0	0.3	0.0	0.1	0.2	0.6	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.3	0.1	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	5.0	0.6	0.1	0.4	0.1	0.1	0.1	0.1	0.4	0.9	0.6	0.1	0.5	0.8	0.0	0.3	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0										
OR2C3	"OR2C4, OR2C5P, OST742"	ENSG00000196242	"Olfactory receptor family 2 subfamily C member 3"	Q8N628	1	247524677-247536440	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 4.2;testis: 4.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	12	"basophil: 4.2;plasmacytoid DC: 1.3"	"Group enriched"	"Detected in many"	18	"dendritic cells: 1.3;granulocytes: 4.2"									HPA058578			Approved	"Plasma membrane"				"Plasma membrane"		"HPA058578: "									"unprognostic (1.96e-1)"			"unprognostic (7.29e-2)"		"unprognostic (3.45e-2)"	"unprognostic (1.03e-1)"			0.2	0.4	0.1	0.0	0.1	0.1	0.2	0.4	0.1	0.9	0.1			0.0	0.2	0.9	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1		0.3	0.2	1.3	0.1	0.4		0.7	0.0		0.1	0.0	0.5	0.1	0.1	0.4	0.1	0.1	0.1	4.6			0.1		0.0	0.2	0.1	0.0	1.3	4.2	0.0	0.1	0.1	0.0	0.5	0.3	0.6	0.2	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.3	1.8	0.6	0.2	0.0	0.3	0.0	0.1	0.0	0.7	0.5	0.1	0.2	0.1	0.1	0.2	0.5	0.5	0.0	0.1	0.0	0.1	1.2	0.7	0.1	0.0	0.4	0.2	0.2	0.3	0.0	0.3	0.0	0.0	0.4	0.8	0.3	0.0	0.3	0.5	0.6	0.3	0.7	0.4	1.2	0.1	0.1	0.0	0.2	0.3	0.5	0.1	0.5	4.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.1	0.0										
OR2D3		ENSG00000178358	"Olfactory receptor family 2 subfamily D member 3"	Q8NGH3	11	6920974-6922043	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"K-562: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"							HPA052551	Uncertain									"HPA052551: "														"unprognostic (4.52e-1)"				0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8			0.4		0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0										
OR2K2	"HSHTPCRH06, HTPCRH06, OR2AR1P"	ENSG00000171133	"Olfactory receptor family 2 subfamily K member 2"	Q8NGT1	9	111327483-111330183	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 3.2;skeletal muscle: 1.6;testis: 1.7"	"Cell line enhanced"	"Detected in some"		"HSkMC: 1.7;Karpas-707: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA024261	Uncertain									"HPA024261: AB_1854786"					"unprognostic (1.03e-1)"													0.0	0.2	0.3	0.0	0.4	0.4	0.4	0.0	0.4	0.0	0.0			0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.9	0.8	0.0	0.0	0.0	0.1	1.8		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.2	1.6	0.7	0.0	0.2	3.2	0.0	0.0	1.7			0.0		0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.5	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.3	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR2M4	"HSHTPCRX18, HTPCRX18, OST710, TPCR100"	ENSG00000171180	"Olfactory receptor family 2 subfamily M member 4"	Q96R27	1	248231417-248244679	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 2.6"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA051308	Uncertain									"HPA051308: "																		0.4	0.1	0.5	0.0	0.6	2.6	0.5	0.4	1.3	0.3	0.2			0.2	0.3	1.1	0.1	0.5	0.5	0.1	0.7	1.3	0.1	1.5	0.1	0.2	1.1		0.8	1.4	0.6	0.3	0.0		0.2	0.0		0.7	0.0	0.1	1.0	0.2	0.0	1.0	0.2	0.2	0.4			0.4		0.0	0.2	0.2	1.0	0.6	2.1	0.6	1.3	0.7	0.3	0.7	0.2	0.5	0.7	1.2	2.3	0.4	0.4	0.2	0.1	0.0	0.8	0.4	0.7	0.3	0.3	0.4	0.5	0.7	0.1	0.1	0.3	1.0	1.6	0.7	0.1	1.1	0.7	1.6	0.1	0.3	0.2	0.8	0.9	1.8	0.2	0.9	0.3	0.9	0.8	0.8	1.9	0.4	0.8	0.2	1.3	1.3	1.0	0.4	0.5	0.7	0.6	0.1	1.7	0.8	0.8	0.9	0.3	1.3	0.7	0.3	0.6	1.0	1.0	1.9	0.6	0.4	0.6	0.5	0.4	0.5	0.5	0.4	0.1	1.0	0.5	0.7	2.1	1.3	0.6	0.6	0.4	0.3										
OR2T10		ENSG00000184022	"Olfactory receptor family 2 subfamily T member 10"	Q8NGZ9	1	248590487-248597700	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"kidney: 11.2"	"Group enriched"	"Detected in some"	7	"BJ hTERT+: 3.0;Karpas-707: 2.3"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.7"					"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	15	"B-cells: 1.4"									HPA052019	Uncertain									"HPA052019: "													"unprognostic (8.58e-2)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0		0.0	0.3	0.0	0.0	0.0		0.4	0.0		0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1			0.0		0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR2W3	"OR2W3P, OR2W8P, OST718"	ENSG00000238243	"Olfactory receptor family 2 subfamily W member 3"	Q7Z3T1	1	247895587-247896531	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"bone marrow: 13.8;thyroid gland: 8.2"	"Cell line enhanced"	"Detected in some"		"HEL: 12.8;PC-3: 12.9;U-2 OS: 8.4;U-937: 6.0;WM-115: 9.2"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"					"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in many"											HPA045594	Uncertain									"HPA045594: AB_10960280"	"unprognostic (9.44e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.57e-5)"	"unprognostic (1.98e-1)"	"unprognostic (5.11e-2)"		"unprognostic (2.79e-6)"	"unprognostic (2.71e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.71e-3)"	"unprognostic (9.05e-3)"	"unprognostic (9.34e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.48e-1)"	0.2	0.7	0.6	0.3	1.6	13.8	0.2	0.0	2.2	0.4	0.7			0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.4	1.7	0.0	0.1	0.5	0.0	1.1		0.0	0.2	0.0	0.3	1.6		0.5	0.6		0.0	0.0	0.0	0.3	0.2	0.4	0.4	0.8	0.1	1.1			8.2		0.0	0.3	0.2	0.6	1.4	1.0	0.6	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	3.8	0.0	0.0	0.0	0.3	12.8	0.0	0.0	0.0	1.6	0.4	0.4	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.1	0.5	12.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	8.4	0.0	0.0	1.4	0.0	0.0	0.0	6.0	9.2	0.0	0.2	1.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.6	0.2	0.0	0.8	0.0	0.5	0.0	0.0	1.5										
OR2Z1	OR2Z2	ENSG00000181733	"Olfactory receptor family 2 subfamily Z member 1"	Q8NG97	19	8721634-8732160	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA048760	Uncertain									"HPA048760: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.4		0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0										
OR4C3		ENSG00000176547	"Olfactory receptor family 4 subfamily C member 3"	Q8NH37	11	48324920-48328471	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"epididymis: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA049116	Uncertain									"HPA049116: "																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0			0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR4D5		ENSG00000171014	"Olfactory receptor family 4 subfamily D member 5"	Q8NGN0	11	123939543-123940637	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"pancreas: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045005	Uncertain									"HPA045005: AB_10959302"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	2.1	0.0	0.0	0.0		0.0	0.6		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3			0.2		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR4F16		ENSG00000284662	"Olfactory receptor family 4 subfamily F member 16"	Q6IEY1	1	685679-686673	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"testis: 1.4"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047705	Uncertain									"HPA047705: "																		0.0	0.0		0.0		0.0	0.2		0.0	0.1	0.0			0.3	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.2	0.0	0.0			0.0	0.0	0.1		0.0		0.0	0.2		0.2	0.0	0.0	0.2	0.0	0.0		0.0	0.0	1.4			0.0		0.0	0.0		0.3	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.4	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.3	0.0	0.3	0.0	0.0	0.3	0.7	0.2	0.2	0.4	0.0	0.5	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.1	0.2	0.4	0.0	0.0	0.0	0.0										
OR4F29		ENSG00000284733	"Olfactory receptor family 4 subfamily F member 29"	Q6IEY1	1	450703-451697	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"testis: 1.4"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047705	Uncertain									"HPA047705: "																		0.0	0.0		0.0		0.0	0.2		0.0	0.1	0.0			0.3	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.2	0.0	0.0			0.0	0.0	0.1		0.0		0.0	0.2		0.2	0.0	0.0	0.2	0.0	0.0		0.0	0.0	1.4			0.0		0.0	0.0		0.3	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.4	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.3	0.0	0.3	0.0	0.0	0.3	0.7	0.2	0.2	0.4	0.0	0.5	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.1	0.2	0.4	0.0	0.0	0.0	0.0										
OR4F3		ENSG00000230178	"Olfactory receptor family 4 subfamily F member 3"	Q6IEY1	5	181367268-181368262	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"testis: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047705	Uncertain									"HPA047705: "																		0.0	0.1	0.1	0.0	0.4	0.0	0.4	0.2	0.2	0.3	0.1			0.4	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.1		0.2	0.2	0.2	0.4	0.1		0.1	0.4		0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.6			0.1		0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.4	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.3	0.0	0.3	0.0	0.0	0.3	0.7	0.2	0.2	0.4	0.0	0.5	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.1	0.2	0.4	0.0	0.0	0.0	0.0										
OR4K1		ENSG00000155249	"Olfactory receptor family 4 subfamily K member 1"	Q8NGD4	14	19930917-19936757	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	7	"testis: 2.2"	"Cell line enriched"	"Detected in single"	5	"HEL: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA028877	Uncertain									"HPA028877: AB_10600923"																		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2			0.0		0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0										
OR4K15	OR4K15Q	ENSG00000169488	"Olfactory receptor family 4 subfamily K member 15"	Q8NH41	14	19975444-19976659	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA055732	Uncertain									"HPA055732: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.1	0.0	0.2	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0										
OR4M1		ENSG00000176299	"Olfactory receptor family 4 subfamily M member 1"	Q8NGD0	14	19773504-19783696	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	32	"testis: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058889	Uncertain									"HPA058889: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR4M2		ENSG00000274102	"Olfactory receptor family 4 subfamily M member 2"	Q8NGB6	15	22070241-22083221	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"testis: 1.1"	"Cell line enriched"	"Detected in single"	10	"U-2 OS: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058889	Uncertain									"HPA058889: "																		0.0	0.0		0.0		0.2	0.1		0.9	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	1.1			0.0		0.0	0.0		0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0										
OR4N4		ENSG00000183706	"Olfactory receptor family 4 subfamily N member 4"	Q8N0Y3	15	22094522-22095472	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	22	"testis: 13.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.7;THP-1: 2.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057442	Uncertain		Uncertain	Centrosome				Centrosome		"HPA057442: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR51A7		ENSG00000176895	"Olfactory receptor family 51 subfamily A member 7"	Q8NH64	11	4903783-4909462	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	5	"testis: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA061356	Uncertain									"HPA061356: "												"unprognostic (4.57e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR51B5		ENSG00000167355	"Olfactory receptor family 51 subfamily B member 5"	Q9H339	11	5303444-5505652	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.0;epididymis: 1.7"	"Group enriched"	"Detected in some"	6	"K-562: 9.1;U-2197: 2.7"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.1"					"Cell type enriched"	"Detected in single"	4	"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.0"					"Region enhanced"	"Detected in single"		"olfactory region: 0.3"	HPA063124	Uncertain									"HPA063124: "	"unprognostic (9.22e-3)"				"unprognostic (1.80e-1)"		"unprognostic (2.01e-1)"	"unprognostic (3.76e-2)"		"unprognostic (4.75e-1)"		"unprognostic (1.36e-1)"	"unprognostic (7.37e-5)"	"unprognostic (2.94e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.71e-2)"	0.0	0.0		0.0		0.0	0.2		0.0	0.0	0.0			0.0	0.5	1.7	0.0	0.3	0.0	0.1			0.5	0.3	0.0	0.0			0.6	0.0	0.0		0.4		0.1	0.0		0.2	0.0	0.0	0.3	0.0	0.0		0.0	0.0	0.7			0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.9	2.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR51D1	OR51D1Q	ENSG00000197428	"Olfactory receptor family 51 subfamily D member 1"	Q8NGF3	11	4637477-4643060	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.3"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA061240	Uncertain									"HPA061240: "												"unprognostic (1.90e-1)"						1.1	0.1	0.0	0.2	0.0	0.8	0.0	0.0	0.5	0.0	0.1			0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0		0.4	0.1	0.4	0.0	0.0		0.7	0.1		0.4	0.0	0.1	0.4	0.1	0.0	0.0	0.3	0.1	0.3			0.0		0.0	0.5	0.0	1.0	0.6	1.3	0.7	0.1	0.6	0.0	0.3	0.3	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.9	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.2	1.1	0.2	0.0	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.3	0.1	0.3	0.0	0.1	1.3	0.7	0.4	0.6	0.3	0.5	0.4	0.5	0.3	0.1	1.0	0.5	0.6	1.3	0.1	0.4	0.6	0.2	0.0										
OR51E1	"GPR136, GPR164, OR51E1P, OR52A3P"	ENSG00000180785	"Olfactory receptor family 51 subfamily E member 1"	Q8TCB6	11	4643420-4655488	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"placenta: 10.0;prostate: 12.1"	"Cell line enriched"	"Detected in single"	114	"SCLC-21H: 14.1"	"Cancer enriched"	"Detected in many"	21	"prostate cancer: 34.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"CAB019995, HPA051439"	Approved									"CAB019995: AB_10283600, HPA051439: "	"unprognostic (6.67e-3)"	"unprognostic (2.34e-3)"	"unprognostic (9.71e-2)"	"unprognostic (4.87e-5)"	"unprognostic (3.55e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.94e-3)"	"unprognostic (7.36e-2)"	"unprognostic (6.15e-2)"	"prognostic unfavourable (1.23e-6)"	"unprognostic (2.72e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.86e-1)"	7.6	0.0	0.6	1.9	0.8	0.0	5.1	0.1	0.6	0.9	2.6	0.1	0.1	0.4	2.5	0.3	0.8	0.8	0.7	4.8	0.1	0.2	1.6	0.1	0.1	1.9	0.6	0.1	1.0	0.1	0.2	1.0	10.0	0.6	12.1	1.1	0.8	4.4	0.8	2.4	0.3	2.1	1.3	1.8	0.1	0.9	0.3	0.1	0.1	0.9	0.9	0.4	1.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.1	0.6	0.1	0.2	0.6	0.1	0.6	0.1
OR51Q1		ENSG00000167360	"Olfactory receptor family 51 subfamily Q member 1 (gene/pseudogene)"	Q8NH59	11	5422111-5423206	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.0;epididymis: 2.0"	"Cell line enriched"	"Detected in single"	30	"RT4: 7.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Region enriched"	"Detected in single"	11	"olfactory region: 4.5"	HPA044998	Uncertain									"HPA044998: AB_10794780"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.2	0.0			0.0	0.0	2.0	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR52D1		ENSG00000181609	"Olfactory receptor family 52 subfamily D member 1"	Q9H346	11	5488685-5489749	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	19	"testis: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA046965	Uncertain									"HPA046965: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR52I2		ENSG00000226288	"Olfactory receptor family 52 subfamily I member 2"	Q8NH67	11	4581743-4593340	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"epididymis: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049343	Uncertain									"HPA049343: "																		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0			0.0	0.1	2.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0		0.1	0.0	0.0	0.0	0.0		0.1	0.0		0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR56B1	OR56B1P	ENSG00000181023	"Olfactory receptor family 56 subfamily B member 1"	Q8NGI3	11	5736448-5738522	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA045043	Uncertain									"HPA045043: AB_10794296"																		0.2	0.0	0.0	1.2	0.0	0.3	0.3	0.0	0.2	0.9	0.1			0.0	0.3	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.2	0.0	0.5	1.3	0.0		0.8	0.0	0.7	0.1	0.0		0.3	0.1		0.2	0.5	0.0	0.0	0.7	0.0	0.0	1.4	0.0	0.2			0.1		0.9	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR5A2		ENSG00000172324	"Olfactory receptor family 5 subfamily A member 2"	Q8NGI9	11	59416969-59426412	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 4.8"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA047135, HPA049575"	Uncertain									"HPA047135: , HPA049575: "																		0.4	0.4	0.4	0.5	0.4	2.1	0.4	0.4	0.9	0.9	0.4			0.6	0.9	1.1	0.4	1.0	0.2	0.4	0.4	0.4	0.5	0.6	0.4	0.8	0.4		0.4	0.4	0.0	0.4	0.0		0.4	0.2		0.6	0.1	0.8	1.5	1.0	0.0	0.5	1.2	0.4	1.2			0.6		0.1	0.4	0.4	1.2	0.7	2.7	1.3	1.0	1.1	0.2	0.7	0.9	1.6	1.3	0.5	0.6	1.0	0.6	0.4	0.5	0.8	0.8	0.9	1.4	0.4	0.3	1.2	1.6	0.2	0.8	4.8	0.7	1.2	2.0	1.2	0.1	0.6	2.5	0.4	0.5	0.3	0.4	0.3	1.1	2.7	0.2	0.9	0.8	1.3	1.9	0.3	1.8	1.1	0.8	0.6	1.1	1.2	0.5	0.9	0.4	1.7	0.7	0.8	1.1	0.6	1.3	1.7	0.4	2.4	1.6	1.0	0.8	2.2	0.6	1.5	0.7	1.0	1.1	0.8	0.9	0.8	1.0	0.9	0.4	1.2	1.1	0.8	2.7	1.0	1.3	0.7	0.7	0.2										
OR5F1	OR11-10	ENSG00000149133	"Olfactory receptor family 5 subfamily F member 1"	O95221	11	55993681-55994625	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059360	Uncertain									"HPA059360: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR5L1	OST262	ENSG00000279395	"Olfactory receptor family 5 subfamily L member 1 (gene/pseudogene)"	Q8NGL2	11	55811367-55812476	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047524	Uncertain									"HPA047524: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.4			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR5L2	"HSHTPCRX16, HTPCRX16"	ENSG00000205030	"Olfactory receptor family 5 subfamily L member 2"	Q8NGL0	11	55827219-55828154	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047524	Uncertain									"HPA047524: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR5P3	JCG1	ENSG00000182334	"Olfactory receptor family 5 subfamily P member 3"	Q8WZ94	11	7824818-7830840	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 1.7;skin 1: 2.1;urinary bladder: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060787	Uncertain									"HPA060787: "																	"unprognostic (1.54e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.5			0.0		0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR5T1	OR5T1P	ENSG00000181698	"Olfactory receptor family 5 subfamily T member 1"	Q8NG75	11	56274154-56276819	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA050952	Uncertain									"HPA050952: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR5V1	hs6M1-21	ENSG00000243729	"Olfactory receptor family 5 subfamily V member 1"	Q9UGF6	6	29353749-29431967	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	6	"testis: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046707	Uncertain									"HPA046707: "																		0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR6B1	OR7-3	ENSG00000221813	"Olfactory receptor family 6 subfamily B member 1"	O95007	7	144000320-144008793	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"pancreas: 3.2;testis: 2.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.5;RPMI-8226: 2.0;U-266/84: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"olfactory region: 0.1"	HPA053164	Uncertain									"HPA053164: "																		0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0			0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1		0.1	3.2	0.1	0.0	0.1		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.3			0.1		0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.5	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.5	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.5	0.1	0.5	0.1	0.0	0.1	0.3	0.0										
OR6B2	OR6B2P	ENSG00000182083	"Olfactory receptor family 6 subfamily B member 2"	Q6IFH4	2	240028965-240030456	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	6	"testis: 2.9"	"Cell line enhanced"	"Detected in single"		"MCF7: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047529	Uncertain									"HPA047529: "																		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.1	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	2.9			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR6M1		ENSG00000196099	"Olfactory receptor family 6 subfamily M member 1"	Q8NGM8	11	123805335-123806387	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"pancreas: 3.1;testis: 1.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.0;SCLC-21H: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA048674	Uncertain									"HPA048674: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	3.1	0.0	0.0	0.1		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.2	0.0	0.1	0.0	0.0										
OR6T1		ENSG00000181499	"Olfactory receptor family 6 subfamily T member 1"	Q8NGN1	11	123942785-123943873	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	16	"pancreas: 4.5;testis: 1.7"	"Cell line enriched"	"Detected in single"	4	"hTCEpi: 2.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA060893	Uncertain									"HPA060893: "	"unprognostic (9.30e-4)"																	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	4.5	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR7A5	HTPCR2	ENSG00000188269	"Olfactory receptor family 7 subfamily A member 5"	Q15622	19	14824251-14835285	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 16.4;pituitary gland: 33.6"	"Low cell line specificity"	"Detected in some"			"Cancer enriched"	"Detected in single"	8	"melanoma: 2.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA053823	Uncertain									"HPA053823: "	"unprognostic (3.26e-4)"	"unprognostic (1.44e-1)"		"unprognostic (7.46e-2)"	"unprognostic (6.19e-3)"	"unprognostic (4.89e-2)"		"unprognostic (1.49e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.01e-7)"	"unprognostic (6.45e-2)"	"unprognostic (9.64e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.47e-3)"	0.3	0.7	1.7	0.4	7.3	1.0	2.0	0.4	3.8	0.7	0.5	4.7	3.2	0.5	0.4	10.1	0.5	0.5	0.5	0.3	4.4	2.1	0.6	0.8	0.6	0.5	16.4	1.3	0.4	0.8	6.9	33.6	0.4	10.9	1.5	0.6	7.0	0.9	2.6	0.5	2.2	0.7	0.3	6.1	0.5	6.4	5.0	16.4	0.0	0.5	0.0	0.3	0.4	0.9	1.0	0.7	1.3	0.3	0.4	0.5	0.0	0.5	0.6	0.4	0.6	0.1	0.1	0.7	0.2	0.2	0.0	0.1	0.5	0.7	0.6	0.3	0.0	0.5	0.2	0.1	0.0	0.3	0.3	0.5	1.7	0.6	0.1	1.1	0.3	1.8	0.7	0.4	0.2	0.2	0.4	1.0	0.0	0.6	0.3	0.5	1.1	0.2	0.6	0.1	0.6	0.0	1.5	0.4	0.4	0.6	0.2	1.8	0.1	0.1	0.7	0.4	0.5	0.5	0.3	1.0	0.3	0.5	0.4	0.6	0.7	1.1	0.3	0.3	0.5	0.2	0.3	0.4	0.3	0.2	0.1	1.0	0.4	0.5	1.3	0.4	0.2	0.7	0.1	0.0	1.7	7.3	0.4	3.8	4.4	2.1	16.4	1.3	10.9	16.4
OR7C1	"OR19-5, OR7C4"	ENSG00000127530	"Olfactory receptor family 7 subfamily C member 1"	O76099	19	14789260-14835376	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 16.6;pituitary gland: 34.0"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	9	"melanoma: 1.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.8;monocytes: 1.5"									HPA047127	Uncertain									"HPA047127: "	"unprognostic (7.68e-4)"	"unprognostic (1.31e-1)"			"unprognostic (2.13e-1)"	"unprognostic (1.71e-1)"		"unprognostic (1.90e-1)"	"unprognostic (1.39e-1)"			"unprognostic (4.30e-2)"	"unprognostic (6.11e-4)"		"unprognostic (1.90e-1)"	"unprognostic (6.80e-2)"	"unprognostic (6.91e-2)"	0.5	3.3	1.4	0.7	7.4	1.9	1.5	0.5	3.9	0.7	0.5	4.7	3.2	0.7	0.5	5.9	0.5	0.5	0.6	0.5	3.2	0.9	0.6	0.6	0.5	0.8	16.6	1.4	0.5	0.5	7.3	34.0	0.5	11.0	3.0	0.4	7.1	1.1	2.9	3.6	3.1	0.7	0.3	3.8	0.7	0.6	6.3	16.6	0.0	1.0	0.0	0.4	0.5	1.0	0.7	0.5	4.8	1.5	0.5	0.4	0.2	0.8	1.1	0.8	2.2	0.7	0.5	1.1	0.5	0.3	0.6	0.8	1.1	1.8	1.3	1.5	0.6	1.0	0.3	0.5	0.8	0.7	0.6	1.0	2.1	0.6	0.5	0.9	1.4	0.8	0.3	0.4	0.4	0.3	0.7	3.0	0.3	0.5	0.6	1.4	1.1	1.0	0.8	0.4	0.6	0.7	1.3	1.6	1.0	0.6	0.7	1.0	0.6	1.5	0.9	1.0	2.2	1.1	0.7	1.3	0.7	1.0	0.9	0.8	0.7	2.9	0.9	1.7	0.3	0.8	0.3	0.4	0.3	0.2	0.4	0.7	0.3	0.4	4.8	0.5	1.5	0.5	0.2	0.2	1.4	7.4	0.5	3.9	3.2	0.9	16.6	1.4	11.0	16.6
OR8D1	"OR8D3, OST004"	ENSG00000196341	"Olfactory receptor family 8 subfamily D member 1"	Q8WZ84	11	124302831-124315099	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.2;testis: 3.6"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 1.3;K-562: 1.7;PC-3: 1.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"eosinophil: 1.2"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			HPA059510	Uncertain									"HPA059510: "																		0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.3			0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0		0.1	0.0	0.0	0.0	0.0		0.1	0.1		0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	3.6			0.0		0.0	0.1	0.0	0.1	0.2	1.2	0.0	0.0	0.4	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.4	0.3	0.0	0.0	0.1	0.2	0.1	0.0	1.3	0.0	1.7	0.7	0.0	0.9	0.1	0.0	0.2	1.4	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.6	0.8	0.1	0.6	0.2	0.0	0.0	0.0	1.2	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.0										
OR8K1		ENSG00000150261	"Olfactory receptor family 8 subfamily K member 1"	Q8NGG5	11	56345945-56347031	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055233	Uncertain									"HPA055233: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR9K2		ENSG00000170605	"Olfactory receptor family 9 subfamily K member 2"	Q8NGE7	12	55126406-55132750	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA015808	Uncertain									"HPA015808: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.1	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OSGEPL1	"OSGEPL, Qri7"	ENSG00000128694	"O-sialoglycoprotein endopeptidase like 1"	Q9H4B0	2	189746660-189763227	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030693	Uncertain		Supported	Mitochondria				Mitochondria		"HPA030693: AB_10601978"	"unprognostic (1.10e-1)"	"unprognostic (8.72e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.38e-2)"	"prognostic unfavourable (3.71e-4)"	"unprognostic (4.18e-3)"	"unprognostic (1.06e-3)"	"prognostic favourable (3.19e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.51e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.55e-3)"	6.6	17.0	8.6	6.5	12.1	2.6	11.1	12.9	10.9	7.3	5.6	14.8	2.9	5.0	11.8	9.1	7.0	8.1	4.8	13.0	8.4	7.3	13.0	11.6	5.8	11.2	18.9	9.3	13.8	6.1	7.5	9.8	6.1	11.6	6.9	6.1	9.0	9.7	6.1	16.6	9.2	6.5	8.1	13.4	9.6	5.8	9.4	15.4	10.6	8.2	7.3	9.2	8.0	5.8	9.3	6.0	2.1	2.6	6.6	11.5	3.0	5.7	3.2	14.1	10.8	11.2	6.2	8.4	8.9	6.3	12.7	13.7	3.7	6.0	3.8	10.0	3.7	8.4	12.5	10.6	14.5	9.8	9.6	12.4	7.8	4.8	5.9	7.0	6.5	6.8	9.0	9.6	4.7	9.4	4.5	6.1	8.3	3.2	5.5	8.0	6.8	14.6	6.0	11.3	6.5	8.2	3.2	8.6	9.5	6.0	10.9	19.4	8.5	7.7	3.9	8.3	7.3	12.1	5.5	6.2	5.2	6.2	11.0	9.0	9.0	0.2	2.6	2.1	7.3	2.4	10.5	7.4	7.7	8.4	3.5	9.3	11.5	10.2	0.4	6.6	2.1	6.0	5.9	3.0	8.6	12.1	12.9	10.9	8.4	7.3	18.9	9.3	11.6	15.4
OSGIN2	"C8orf1, hT41"	ENSG00000164823	"Oxidative stress induced growth inhibitor family member 2"	Q9Y236	8	89901859-89927888	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 56.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028515, HPA050595"	Approved		Approved	Nucleoli				Nucleoli		"HPA028515: AB_10602014, HPA050595: "	"unprognostic (3.29e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.42e-3)"	"unprognostic (3.26e-2)"	"prognostic unfavourable (3.91e-6)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.22e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.25e-2)"	15.2	7.5	12.5	7.8	13.9	40.4	16.8	9.6	17.5	7.6	13.3	26.4	6.0	6.8	26.1	6.1	11.7	8.1	14.2	11.2	14.2	13.4	14.7	16.2	15.7	9.1	13.7	13.0	15.9	7.8	53.5	25.2	6.5	18.2	9.1	8.6	8.3	8.6	7.3	13.2	7.6	8.7	17.1	25.3	9.0	7.5	20.5	14.7	7.1	12.9	8.0	8.9	11.1	8.5	3.0	1.5	17.0	1.4	2.0	2.5	1.3	11.9	11.7	3.0	6.0	6.6	4.8	3.9	8.6	16.5	7.9	7.7	5.5	11.5	8.2	17.6	4.4	4.4	5.6	6.8	12.4	11.8	4.5	12.5	4.6	3.0	11.2	6.3	7.8	5.6	8.9	9.2	7.6	9.7	7.2	14.7	5.6	9.3	10.8	4.2	1.5	6.3	4.8	4.4	7.0	12.0	9.3	2.8	6.9	6.4	56.3	10.4	11.5	9.4	6.5	8.7	8.0	7.1	7.9	13.6	11.6	9.0	14.4	7.7	6.1	17.0	1.4	5.8	1.7	0.9	2.4	3.0	2.5	1.5	1.5	1.8	2.1	2.3	10.3	2.0	1.1	1.1	2.5	1.3	12.5	13.9	9.6	17.5	14.2	13.4	13.7	13.0	18.2	14.7
OSR1	ODD	ENSG00000143867	"Odd-skipped related transciption factor 1"	Q8TAX0	2	19351485-19358653	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 68.3;urinary bladder: 62.1"	"Cell line enriched"	"Detected in some"	11	"U-2197: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015525	Uncertain									"HPA015525: AB_1854822"	"unprognostic (1.71e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.85e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.47e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.87e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.62e-1)"	16.9	1.3	0.2	5.0	0.5	0.1	40.0	0.7	1.0	12.6	11.7	0.3	2.0	1.3	9.2	5.6	18.5	4.0	5.7	21.3	0.6	0.2	0.9	0.3	7.9	2.6	0.2	0.8	5.2	2.6	0.2	1.2	3.7	1.5	45.5	1.9	1.6	28.4	3.6	5.9	5.1	5.2	68.3	0.5	0.1	5.1	5.7	0.0	0.1	6.0	7.2	5.0	62.1	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	2.1	1.5	4.4	0.0	2.7	1.2	2.6	1.3	0.0	0.0	0.0	0.0	3.8	0.0	1.3	0.6	0.6	0.0	0.1	0.0	0.0	1.5	1.9	0.0	0.0	2.1	0.0	2.4	3.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	47.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.7	1.0	0.6	0.2	0.2	0.8	1.5	0.0
OTOGL	"C12orf64, FLJ90579"	ENSG00000165899	"Otogelin like"	Q3ZCN5	12	80099537-80380879	"Disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 9.8;kidney: 13.3;pituitary gland: 21.0"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 3.8;U-2 OS: 2.5;U-87 MG: 7.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in many"	4	"amygdala: 3.5;basal ganglia: 4.3;cerebral cortex: 5.8;olfactory region: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"basal ganglia: 5.2"	"HPA040364, HPA053392"	Uncertain		Approved	Cytosol	"Intracellular and membrane"			Cytosol		"HPA040364: AB_10795365, HPA053392: "	"unprognostic (2.43e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.95e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.04e-2)"	0.4	0.2	3.5	0.2	4.3	0.1	0.4	0.2	5.8	0.4	2.7	0.0	0.0	0.2	0.5	3.1	0.5	0.5	0.4	9.8	1.0	0.4	13.3	0.1	0.3	0.5	0.5	3.6	0.2	0.7	0.2	21.0	1.4	0.3	0.5	0.3	1.4	0.3	0.5	1.0	0.3	0.6	0.6	0.3	0.4	0.4	0.8	0.0	0.0	0.2	0.0	0.3	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.5	0.0	1.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.5	3.8	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.5	2.5	0.0	0.2	0.9	0.0	0.1	7.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.3	0.2	5.8	1.0	0.4	0.5	3.6	0.3	0.0
OTOP1		ENSG00000163982	"Otopetrin 1"	Q7RTM1	4	4188803-4226889	"Predicted membrane proteins, Transporters"	"Biomineralization, Hydrogen ion transport, Ion transport, Transport"	"Ion channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 1.1;skin 1: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA035599	Uncertain									"HPA035599: AB_10600924"										"unprognostic (1.83e-1)"					"unprognostic (1.09e-1)"			0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.0			0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.1	0.8			0.0		0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OTOP2		ENSG00000183034	"Otopetrin 2"	Q7RTS6	17	74924275-74933912	"Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 20.4;testis: 5.1"	"Cell line enriched"	"Detected in single"	47	"HDLM-2: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.4"	"Region enriched"	"Detected in single"	13	"olfactory region: 15.6"	"Low region specificity"	"Detected in all"			"HPA024524, HPA053090"	Uncertain									"HPA024524: , HPA053090: "		"unprognostic (1.62e-2)"	"unprognostic (1.45e-1)"			"unprognostic (7.25e-2)"		"unprognostic (3.21e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.30e-1)"			"unprognostic (2.85e-2)"	"unprognostic (3.81e-1)"	"unprognostic (9.04e-2)"		"unprognostic (2.04e-2)"	0.1	0.0	0.1	2.9	0.1	0.0	0.1	0.1	0.1	0.1	20.4	0.1	0.1	0.2	0.5	0.1	1.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	10.9	0.1	0.1	0.1	0.1	0.2	11.3	0.2	0.1	0.1	0.0	5.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.4	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
OVGP1	"CHIT5, MUC9"	ENSG00000085465	"Oviductal glycoprotein 1"	Q12889	1	111414314-111427777	"Plasma proteins, Predicted intracellular proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"fallopian tube: 240.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.8;SK-BR-3: 8.0"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 58.7;ovarian cancer: 27.9"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"cerebellum: 6.6"	"Low region specificity"	"Detected in many"			HPA062205	Enhanced				"Intracellular and membrane"					"HPA062205: "	"unprognostic (1.52e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.35e-2)"	"prognostic favourable (1.36e-4)"	"unprognostic (8.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.34e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.86e-3)"	"prognostic favourable (3.93e-5)"	0.4	0.1	0.4	0.4	0.9	0.2	0.4	1.9	1.0	0.7	0.4	0.4	0.4	0.2	9.7	7.1	0.4	240.9	0.4	0.4	0.5	0.5	0.5	1.0	0.4	0.4	0.4	0.4	32.5	0.4	1.5	0.4	0.4	0.4	0.7	0.3	0.4	0.4	0.4	0.4	1.1	0.6	0.4	0.4	0.5	0.2	1.3	0.4	0.6	0.4	0.4	0.4	0.5	0.4	0.8	0.9	0.0	0.5	0.0	1.6	0.2	0.7	0.6	1.5	0.8	3.0	3.4	2.7	0.4	2.2	0.5	1.2	0.9	0.0	1.3	2.9	0.9	0.8	0.4	0.5	0.9	3.2	7.8	0.4	1.0	3.7	1.1	1.3	3.6	3.1	4.8	0.1	1.7	0.6	0.5	2.4	0.2	0.8	1.0	1.9	0.4	2.8	1.0	0.3	1.1	2.3	5.8	1.0	0.9	0.3	8.0	1.1	0.6	1.3	1.3	0.3	0.4	4.0	1.1	3.0	0.8	0.7	0.3	2.5	0.3	0.0	0.5	0.0	0.7	0.0	0.0	0.3	0.5	0.0	0.9	0.8	1.6	1.2	0.0	0.0	0.5	0.0	0.1	0.2	0.4	0.9	1.9	1.0	0.5	0.5	0.4	0.4	0.4	0.4
OVOL1	HOVO1	ENSG00000172818	"Ovo like transcriptional repressor 1"	O14753	11	65787022-65797219	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.6;tongue: 37.4"	"Cell line enhanced"	"Detected in some"		"A-431: 9.9;BEWO: 28.5;CACO-2: 7.2;HaCaT: 16.8;RT4: 16.6;SK-BR-3: 13.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"memory CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA003984	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA003984: AB_1854854"	"unprognostic (4.26e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (1.87e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.91e-1)"	"prognostic favourable (1.00e-13)"	"unprognostic (4.26e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.04e-3)"	0.2	0.1	0.2	3.3	0.3	0.0	2.2	0.4	0.2	7.2	11.5	0.0	3.0	9.6	0.4	0.7	42.6	0.3	4.2	0.1	0.2	0.2	4.7	0.2	1.7	0.0	0.2	0.0	0.1	5.6	5.0	0.2	14.4	0.0	2.3	5.1	1.1	13.9	6.1	0.5	24.1	14.2	0.8	0.2	0.2	0.8	17.3	0.0	0.6	1.8	37.4	25.3	8.3	9.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	9.9	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	7.2	2.7	0.0	0.1	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	16.6	0.1	0.0	0.0	13.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0
OXCT2	"FKSG25, FLJ00030, SCOT-T"	ENSG00000198754	"3-oxoacid CoA-transferase 2"	Q9BYC2	1	39769523-39771348	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 31.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 9.8;THP-1: 10.5;U-266/70: 8.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	9	"memory B-cell: 3.3;naive B-cell: 1.9;NK-cell: 1.4"	"Group enriched"	"Detected in many"	9	"B-cells: 3.3;NK-cells: 1.4"									HPA075423	Enhanced									"HPA075423: "	"unprognostic (2.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.16e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.74e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.39e-5)"	"unprognostic (3.24e-1)"	"unprognostic (4.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.85e-1)"	0.0	0.6	0.2	0.2	0.2	0.1	0.0	0.8	0.5	0.3	0.3			0.4	0.5	0.7	0.4	0.2	0.5	3.9	0.4	0.1	0.0	0.1	0.0	0.3	0.3		1.5	0.4	0.2	0.3	0.0		0.8	0.2		0.0	1.2	0.0	1.4	0.5	0.4	0.4	0.3	0.2	31.8			1.6		0.0	0.1	0.0	3.3	0.0	0.0	0.2	1.4	0.0	0.1	0.5	0.3	0.0	1.2	0.4	1.4	0.0	1.4	0.0	1.4	0.7	4.9	0.6	0.0	1.0	2.0	0.5	1.5	0.1	0.7	0.0	3.2	0.9	3.2	0.2	2.4	0.0	0.5	0.7	0.4	0.2	0.1	1.0	0.3	9.8	0.2	1.4	0.0	1.5	0.1	1.3	1.3	1.5	1.5	0.3	1.0	1.6	0.8	4.3	0.3	1.4	0.5	10.5	1.1	0.0	0.3	4.7	0.0	8.1	4.3	0.6	0.1	0.6	2.3	0.0	0.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1										
OXGR1	"aKGR, GPR80, GPR99, P2RY15, P2Y15"	ENSG00000165621	"Oxoglutarate receptor 1"	Q96P68	13	96985719-96994730	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 7.0"	"Cell line enhanced"	"Detected in some"		"RT4: 7.6;SK-BR-3: 3.5;T-47d: 1.7;U-2 OS: 4.0"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	5	"myeloid DC: 2.9;plasmacytoid DC: 5.2"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 5.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA067673			Supported	"Plasma membrane"				"Plasma membrane"		"HPA067673: "	"unprognostic (1.83e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.97e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.52e-1)"		"unprognostic (8.38e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.68e-2)"	2.1	0.0	0.7	1.7	0.2	0.0	6.7	0.0	2.0	1.6	3.0			0.1	0.6	4.0	3.2	2.5	0.0	0.0	0.8	0.8	7.0	0.0	0.5	0.0	0.7		0.0	0.6	0.0	0.3	1.2		0.5	2.4		4.9	0.3	0.1	4.3	0.5	0.5	1.6	0.3	0.1	0.0			0.8		0.9	1.8	0.9	0.0	5.2	0.1	0.5	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.6	0.0	0.2	0.0	3.5	0.0	1.7	0.0	0.0	0.0	4.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.1	0.0	0.1	0.8	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.1	0.0	0.0	5.2	0.0	0.1										
OXLD1	"C17orf90, MGC104712"	ENSG00000204237	"Oxidoreductase like domain containing 1"	Q5BKU9	17	81665036-81666635	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA056878, HPA057019"	Uncertain		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA056878: , HPA057019: "	"unprognostic (1.08e-1)"	"prognostic favourable (2.91e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.30e-2)"	13.7	12.2	11.0	10.1	11.5	16.0	8.4	6.0	15.1	6.4	12.4	7.0	16.0	14.0	6.5	11.8	10.3	8.7	9.2	11.4	10.2	8.5	9.2	11.9	7.7	9.9	9.6	6.5	4.2	19.6	2.7	4.6	8.2	8.0	8.2	1.9	9.4	27.7	10.8	17.3	12.9	10.3	4.7	7.1	15.1	11.2	18.5	7.1	11.6	10.2	7.2	11.4	7.8	5.6	22.8	23.7	13.3	18.5	25.1	27.9	18.7	7.9	29.3	0.3	6.9	1.8	0.5	5.1	3.2	0.1	0.1	1.1	7.8	7.8	2.4	6.5	0.0	7.0	0.0	4.5	0.0	4.0	14.5	2.2	13.5	19.0	12.5	1.5	6.0	3.1	3.9	1.7	1.8	2.9	3.7	4.1	0.6	19.3	5.8	6.1	3.9	12.7	4.8	0.2	10.3	1.5	4.4	1.5	6.5	1.6	10.5	14.6	15.8	9.0	2.1	6.0	4.2	6.5	4.5	10.5	3.7	3.2	8.2	6.1	6.1	12.9	18.5	13.3	19.1	15.1	20.0	19.7	25.9	22.2	17.2	22.8	27.9	21.5	13.1	25.1	15.6	23.7	21.8	18.7	11.0	11.5	6.0	15.1	10.2	8.5	9.6	6.5	8.0	7.1
P2RX5	"LRH-1, P2X5"	ENSG00000083454	"Purinergic receptor P2X 5"	Q93086	17	3672199-3696404	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 30.4;intestine: 12.0;lymphoid tissue: 39.1;skeletal muscle: 11.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 24.0;Karpas-707: 15.5;RPMI-8226: 27.0;U-698: 22.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	18	"memory B-cell: 28.1;naive B-cell: 30.4"	"Lineage enriched"	"Detected in many"	19	"B-cells: 30.4"									"HPA021948, HPA067827"	Supported		Supported	Cytosol				Cytosol		"HPA021948: AB_1854878, HPA067827: "	"unprognostic (1.08e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.99e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.63e-2)"	0.6	0.3	2.2	32.0	4.9	4.8	0.5	4.1	5.1	0.3	1.4	0.0	0.4	0.9	0.2	0.2	2.4	0.2	0.8	4.9	1.8	3.0	0.8	0.4	1.0	39.1	1.5	2.1	0.2	0.8	0.1	1.2	0.2	1.7	0.5	1.2	0.0	5.4	0.1	11.4	0.2	12.0	0.4	0.6	29.6	1.8	0.6	0.2	9.3	0.5	1.9	27.6	2.2	0.3	30.4	0.1	0.7	0.0	0.0	1.6	1.6	3.8	3.2	0.0	0.0	0.1	0.6	0.0	4.0	1.8	0.4	1.3	2.4	4.7	24.0	2.4	1.9	2.0	8.6	0.0	0.8	0.4	1.5	1.2	8.5	2.9	0.6	1.6	2.1	1.0	0.9	0.1	5.6	0.0	0.2	15.5	8.7	0.0	10.8	3.6	2.4	9.7	0.4	0.0	27.0	0.1	2.9	2.0	0.0	3.3	1.1	1.8	1.0	1.5	0.0	0.0	2.2	0.1	0.7	5.5	11.7	22.3	0.0	2.3	0.2	0.0	0.0	0.7	1.1	0.0	1.6	28.1	1.0	0.8	0.1	30.4	0.1	0.1	0.0	0.0	0.0	0.0	0.5	1.6	2.2	4.9	4.1	5.1	1.8	3.0	1.5	2.1	1.7	0.2
P2RY10	P2Y10	ENSG00000078589	"P2Y receptor family member 10"	O00398	X	78945332-78961954	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 51.6;lymphoid tissue: 47.0"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 52.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 51.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036757, HPA065766"	Enhanced									"HPA036757: AB_10696786, HPA065766: "	"unprognostic (3.02e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.50e-6)"	"unprognostic (6.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-4)"	"unprognostic (3.33e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-2)"	"prognostic unfavourable (3.63e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.99e-2)"	1.9	0.5	0.4	19.1	0.5	5.7	1.0	0.4	0.4	1.4	3.8	0.0	0.1	1.7	1.0	0.5	2.6	0.8	2.2	0.8	0.5	0.5	1.4	1.0	6.2	47.0	0.5	0.0	1.1	0.5	0.0	0.6	0.1	0.1	0.9	2.5	0.8	3.9	0.3	0.5	0.8	11.0	0.4	0.7	31.2	2.3	0.5	0.0	23.3	1.5	1.8	30.0	9.9	1.3	19.3	0.9	51.6	2.3	4.0	9.7	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.6	0.0	0.1	0.0	51.6	0.0	36.8	3.2	0.2	2.9	17.8	7.3	6.4	0.9	19.3	6.8	5.0	6.8	4.0	2.3	0.7	9.7	3.2	0.4	0.5	0.4	0.4	0.5	0.5	0.5	0.0	0.1	0.0
P2RY11	P2Y11	ENSG00000244165	"Purinergic receptor P2Y11"	Q96G91	19	10111538-10115372	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 20.1;NB-4: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 6.8;MAIT T-cell: 16.4;memory CD8 T-cell: 6.9;naive CD8 T-cell: 5.4;NK-cell: 10.7"	"Group enriched"	"Detected in all"	6	"NK-cells: 10.7;T-cells: 16.4"									HPA014232	Approved									"HPA014232: AB_1854883"	"unprognostic (1.13e-1)"	"unprognostic (3.12e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.22e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.76e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.58e-1)"	"prognostic favourable (1.77e-4)"	9.0	3.6	4.8	21.7	6.7	8.5	4.9	5.5	6.5	3.1	9.4	6.0	3.4	7.8	3.2	3.2	4.4	5.3	3.5	3.8	5.1	4.6	2.9	4.9	13.6	11.1	3.2	2.3	4.3	6.3	1.5	4.2	3.4	4.0	5.0	1.8	5.0	7.6	2.5	6.6	9.0	9.2	2.8	4.9	13.4	5.1	4.9	2.5	7.5	5.2	2.6	22.8	2.9	3.1	1.5	1.2	2.1	2.1	10.7	16.4	4.3	3.6	3.4	1.2	3.9	1.6	1.3	6.6	1.5	0.6	0.7	1.2	4.0	1.8	6.3	2.2	0.3	5.2	1.0	3.0	0.1	3.1	20.1	5.6	5.0	2.4	2.2	2.9	9.5	2.2	2.4	1.1	1.7	0.4	2.7	8.3	0.7	5.2	4.4	21.0	7.5	4.2	6.7	2.3	3.6	1.2	4.6	4.7	7.7	0.9	2.6	8.2	2.1	8.3	1.3	4.3	2.0	7.6	2.8	17.0	12.2	2.3	3.0	12.5	3.8	2.1	1.9	0.3	6.8	2.1	16.4	1.5	1.5	6.9	1.2	1.0	1.2	5.4	0.4	10.7	1.4	0.7	1.8	4.3	4.8	6.7	5.5	5.2	5.1	4.6	3.2	2.3	4.0	2.5
P2RY13	"FKSG77, GPR86, GPR94, P2Y13"	ENSG00000181631	"Purinergic receptor P2Y13"	Q9BPV8	3	151326312-151329548	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 88.4;lymphoid tissue: 44.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.1;U-937: 1.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 88.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 88.4;monocytes: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049047	Enhanced									"HPA049047: "	"unprognostic (1.09e-3)"	"unprognostic (7.51e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.95e-2)"	"unprognostic (8.66e-3)"	"unprognostic (7.66e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.05e-1)"	"unprognostic (4.46e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.78e-1)"	4.0	2.6	5.1	13.4	6.1	15.1	2.7	1.7	8.2	1.7	2.8	13.8	0.1	3.0	1.5	2.2	2.1	2.1	2.5	1.7	4.9	4.7	1.8	5.1	5.0	35.1	7.1	3.4	1.3	2.1	1.0	1.7	3.2	8.1	2.1	4.2	2.0	1.9	2.1	1.3	1.6	7.4	3.5	8.2	44.1	1.8	1.2	5.1	2.0	1.5	1.1	5.5	3.8	1.5	0.2	10.1	88.4	26.1	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.1	0.2	0.2	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.2	0.8	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	1.1	0.1	0.1	23.6	20.3	0.0	23.5	0.0	0.2	0.0	0.0	10.1	0.0	0.0	0.0	88.4	0.0	26.1	0.1	0.0	10.2	5.1	6.1	1.7	8.2	4.9	4.7	7.1	3.4	8.1	5.1
P2RY14	"GPR105, KIAA0001"	ENSG00000174944	"Purinergic receptor P2Y14"	Q15391	3	151212117-151278467	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 54.9"	"Cell line enriched"	"Detected in single"	73	"HMC-1: 39.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"eosinophil: 54.9;plasmacytoid DC: 24.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 24.4;granulocytes: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022646	Uncertain									"CAB022646: "	"unprognostic (9.78e-2)"	"unprognostic (7.47e-4)"	"unprognostic (3.89e-2)"	"unprognostic (4.52e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.57e-5)"	"unprognostic (2.68e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (1.72e-5)"	"unprognostic (3.79e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.58e-2)"	14.3	0.9	3.9	9.0	6.9	0.5	6.1	1.9	3.8	5.2	17.6	1.3	1.3	5.7	7.2	9.4	17.6	1.2	4.4	4.4	4.3	3.0	2.1	0.7	8.5	7.1	5.0	2.8	1.8	0.9	2.2	4.7	25.9	3.7	10.4	8.3	11.2	2.1	1.1	4.2	2.8	16.3	15.8	2.3	4.4	17.2	2.1	4.2	4.7	3.6	8.9	5.3	21.4	1.7	4.9	24.4	54.9	0.1	2.8	5.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.1	54.9	0.2	0.0	5.0	0.8	0.1	0.5	3.3	4.9	0.0	0.0	2.2	2.8	0.0	24.4	0.2	0.5	3.9	6.9	1.9	3.8	4.3	3.0	5.0	2.8	3.7	4.2
P2RY2	P2U	ENSG00000175591	"Purinergic receptor P2Y2"	P41231	11	73218298-73236352	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.1;skeletal muscle: 29.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 16.1;HL-60: 15.2;MCF7: 12.1;NB-4: 12.4;PC-3: 12.6;SK-BR-3: 14.0;THP-1: 35.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 28.1"	"Group enriched"	"Detected in many"	12	"granulocytes: 28.1;monocytes: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB022642	Uncertain		Uncertain	Cytosol				Cytosol		"CAB022642: "	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (6.50e-4)"	"unprognostic (2.04e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavourable (2.19e-5)"	"unprognostic (9.69e-2)"	"unprognostic (4.92e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.57e-3)"	0.4	2.3	0.9	1.4	1.2	10.8	1.3	0.3	1.1	5.5	3.1	1.1	0.3	2.2	1.3	2.3	20.0	1.2	2.8	11.7	0.6	0.3	0.9	2.6	2.9	1.5	1.2	0.6	1.7	1.7	6.1	1.1	10.3	1.0	1.7	2.4	3.3	4.0	1.6	29.5	3.4	10.8	0.4	0.4	6.6	0.6	0.7	0.6	0.6	20.2	20.6	12.8	2.1	10.9	0.0	1.6	28.1	10.4	0.0	0.0	1.2	3.5	3.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	8.2	2.8	0.0	5.5	0.2	16.1	0.4	7.5	0.0	0.0	0.3	1.2	0.2	1.5	0.0	15.2	0.0	0.0	3.5	1.2	0.2	0.7	0.6	0.0	0.0	12.1	0.0	12.4	0.2	12.6	0.0	0.0	0.5	1.2	8.6	0.0	0.0	0.2	14.0	0.0	6.5	35.6	5.2	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	2.7	0.0	0.2	3.4	28.1	0.0	10.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	1.2	0.9	1.2	0.3	1.1	0.6	0.3	1.2	0.6	1.0	0.6
PABPC1L	"C20orf119, dJ1069P2.3, ePAB, PABPC1L1"	ENSG00000101104	"Poly(A) binding protein cytoplasmic 1 like"	Q4VXU2	20	44910062-44959035	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.9"	"Group enriched"	"Detected in many"	5	"B-cells: 3.3;granulocytes: 3.9;T-cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA066650			Approved	"Nuclear bodies,Cytosol"				Cytosol	"Nuclear bodies"	"HPA066650: "	"unprognostic (4.98e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (3.80e-4)"	"unprognostic (1.73e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.77e-3)"	"unprognostic (4.92e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.28e-3)"	"unprognostic (7.96e-2)"	"prognostic unfavourable (4.00e-15)"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.63e-2)"	"prognostic favourable (8.84e-4)"	4.7	8.1	9.8	29.3	20.4	14.0	16.0	3.4	6.0	8.4	5.7	6.2	20.4	6.9	8.3	26.1	7.6	9.1	13.0	3.7	8.6	4.2	21.7	29.2	14.6	16.3	5.6	9.3	16.9	29.3	7.7	23.7	5.1	7.1	15.2	6.4	7.6	10.2	14.7	0.9	10.3	10.0	6.2	10.9	12.5	10.0	9.2	6.5	20.3	28.1	6.3	12.9	9.0	12.1	3.3	0.4	3.9	0.5	0.3	1.9	0.1	6.5	8.5	11.4	16.6	4.4	9.3	26.3	14.4	2.9	5.6	7.5	23.3	12.0	8.5	24.3	5.7	15.2	5.1	13.2	4.6	5.1	10.4	6.8	23.4	21.5	9.9	5.8	2.8	9.7	23.4	11.9	21.1	1.3	7.6	12.4	6.7	18.6	7.3	14.0	4.5	15.0	9.4	2.5	4.5	7.9	8.1	7.1	7.1	5.7	18.0	19.5	35.1	4.7	4.6	25.0	16.8	10.9	6.9	16.3	16.2	4.3	8.1	2.4	8.2	0.1	0.5	0.1	0.9	0.1	1.9	1.4	0.2	0.7	0.2	3.3	0.3	0.5	3.9	0.3	0.2	0.4	0.5	0.1	9.8	20.4	3.4	6.0	8.6	4.2	5.6	9.3	7.1	6.5
PABPC1L2A	RBM32A	ENSG00000186288	"Poly(A) binding protein cytoplasmic 1 like 2A"	Q5JQF8	X	73077276-73079512	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.6;prostate: 5.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 8.9;NTERA-2: 3.3;SK-MEL-30: 1.8"	"Cancer enriched"	"Detected in single"	15	"prostate cancer: 1.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041573	Approved									"HPA041573: "					"unprognostic (4.30e-2)"							"unprognostic (2.19e-1)"			"unprognostic (3.22e-1)"			0.1	3.5	3.3	0.2	5.0	0.0	0.1	7.1	9.6	0.1	0.2			0.4	0.1	1.4	0.0	0.2	0.2	0.0	3.5	9.2	0.2	0.1	0.1	0.0	2.9		0.4	0.1	0.0	1.2	0.0		5.2	0.1		0.8	0.6	0.1	0.1	0.2	0.0	2.4	0.7	0.1	3.2			0.3		0.1	0.2	0.0	0.2	0.1	0.7	0.2	0.8	0.1	0.3	0.0	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.1	0.1	0.9	0.1	0.0	0.0	0.0	0.0	8.9	0.4	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.4	0.1	1.8	0.0	0.0	0.1	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.7	0.3	0.1	0.5	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.8	0.2	0.1	0.0	0.3										
PABPC1L2B	RBM32B	ENSG00000184388	"Poly(A) binding protein cytoplasmic 1 like 2B"	Q5JQF8	X	73003517-73005713	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 12.2;prostate: 6.6"	"Group enriched"	"Detected in some"	30	"HAP1: 2.7;NTERA-2: 5.6;U-2 OS: 1.8"	"Cancer enriched"	"Detected in single"	23	"prostate cancer: 2.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041573	Approved									"HPA041573: "					"unprognostic (1.73e-1)"							"unprognostic (2.26e-1)"			"unprognostic (3.31e-1)"			0.1	1.6	3.3	0.1	4.9	0.1	0.1	6.4	12.2	0.1	0.1			0.4	0.1	0.5	0.1	0.1	0.1	0.1	3.5	10.2	0.1	0.1	0.1	0.1	3.3		0.1	0.1	0.1	1.0	0.1		6.6	0.1		0.8	0.5	0.1	0.1	0.1	0.1	2.1	0.2	0.1	1.5			0.1		0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PABPC5	PABP5	ENSG00000174740	"Poly(A) binding protein cytoplasmic 5"	Q96DU9	X	91434595-91438584	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 20.9"	"Cell line enhanced"	"Detected in some"		"AF22: 9.7;HSkMC: 4.0;LHCN-M2: 2.6;RH-30: 11.6;U-2 OS: 2.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000164, HPA000165"	Approved									"HPA000164: AB_1079551, HPA000165: AB_1079552"	"unprognostic (1.05e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.55e-2)"	"unprognostic (8.07e-2)"	4.3	14.1	5.3	1.9	4.3	0.4	7.3	2.2	6.2	8.1	4.0	5.7	1.3	1.2	10.3	5.2	2.8	3.9	2.9	3.6	3.7	3.7	2.0	1.0	2.4	1.8	5.1	2.4	20.9	1.3	1.5	11.7	1.8	4.9	5.5	1.9	3.8	1.9	4.3	1.3	1.3	1.9	5.8	5.2	3.4	2.3	3.3	4.9	0.0	4.5	2.1	1.4	4.9	6.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	4.0	0.0	1.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.2	0.1	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.3	2.2	5.9	3.7	3.7	5.1	2.4	4.9	4.9
PABPN1L	ePABP2	ENSG00000205022	"Poly(A) binding protein nuclear 1 like, cytoplasmic"	A6NDY0	16	88863333-88866660	"Predicted intracellular proteins"		RNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 3.6;bone marrow: 3.0;brain: 5.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 4.9;NB-4: 3.4;SCLC-21H: 9.3;T-47d: 2.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebellum: 3.6"	HPA043415	Uncertain									"HPA043415: AB_10981610"	"unprognostic (2.19e-1)"							"unprognostic (1.50e-2)"			"unprognostic (1.40e-3)"	"unprognostic (8.96e-3)"		"unprognostic (1.57e-1)"	"unprognostic (3.19e-1)"			0.5	3.6	0.0	0.2	1.1	3.0	0.1	5.3	0.5	0.0	0.1			0.1	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.1	0.0	0.3	0.2	1.1	0.0		0.1	1.8	0.0	0.3	0.0		0.8	0.0		0.3	0.0	0.6	0.0	0.4	0.0	0.0	1.1	0.0	0.5			0.0		0.3	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	4.9	0.6	3.4	0.0	0.0	0.2	0.4	0.3	0.0	0.0	9.3	0.2	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0										
PANX2	"hPANX2, PX2"	ENSG00000073150	"Pannexin 2"	Q96RD6	22	50170731-50180294	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 8.9;HDLM-2: 13.7;Hep G2: 16.0;MCF7: 8.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.2"	"Group enriched"	"Detected in many"	36	"dendritic cells: 1.8;granulocytes: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004624, HPA039117"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA004624: , HPA039117: AB_10805354"	"unprognostic (1.00e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-9)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.08e-1)"	1.6	2.6	10.3	2.6	9.2	5.3	1.4	22.4	31.4	1.8	1.1	1.2	10.5	1.1	2.4	2.7	3.8	4.9	2.3	1.1	14.2	8.8	3.4	7.8	2.4	1.2	15.9	7.9	3.5	3.0	1.0	4.1	1.6	23.9	3.8	1.0	1.5	5.5	6.2	1.5	2.6	1.2	1.2	4.5	2.7	1.4	2.6	2.4	0.0	3.8	0.2	1.5	1.8	0.9	0.0	1.8	5.2	0.0	0.0	0.0	0.0	0.8	1.8	0.3	1.9	0.0	0.2	4.2	2.2	2.2	0.5	0.3	0.4	6.7	0.0	8.9	0.2	0.4	1.1	0.8	0.1	13.7	1.2	0.3	2.8	16.0	0.7	0.1	1.0	0.1	0.9	0.6	0.0	0.5	1.1	0.0	0.2	8.8	0.0	0.8	3.3	3.6	0.8	0.0	3.3	0.0	1.3	8.4	0.8	1.4	0.1	5.1	0.5	0.6	3.8	0.4	3.6	5.8	4.1	1.5	0.1	0.5	0.2	0.0	6.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	1.8	0.0	0.0	10.3	9.2	22.4	31.4	14.2	8.8	15.9	7.9	23.9	2.4
PAPLN	MGC50452	ENSG00000100767	"Papilin, proteoglycan like sulfated glycoprotein"	O95428	14	73237497-73274640	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 12.9;HSkMC: 24.3;hTCEpi: 9.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"neutrophil: 4.4;plasmacytoid DC: 8.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 8.8;granulocytes: 4.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA048682, HPA053453"	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"		46000000	Nucleoplasm		"HPA048682: , HPA053453: "	"unprognostic (1.97e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.56e-3)"	"unprognostic (7.42e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.46e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.69e-2)"	"unprognostic (5.58e-2)"	9.3	6.1	13.6	11.8	14.8	2.9	11.0	4.1	11.1	10.8	7.0	6.0	3.8	4.1	14.2	19.5	4.6	12.1	8.0	4.8	15.7	3.0	24.9	1.9	7.8	23.3	4.1	9.7	10.9	2.7	1.0	11.1	5.2	5.7	8.1	6.2	14.9	4.7	10.2	1.8	16.2	10.3	8.6	6.0	17.6	7.4	6.5	8.9	5.1	15.3	2.2	16.5	6.8	5.6	1.1	8.8	4.4	0.8	0.5	0.5	0.2	2.0	1.9	0.8	0.3	1.5	1.8	4.6	0.4	0.0	0.1	0.1	2.5	0.6	0.4	2.1	0.0	3.3	2.0	1.5	0.2	2.3	3.1	0.9	3.2	0.3	12.9	0.3	1.7	24.3	9.0	0.4	1.3	0.4	0.6	0.3	0.0	1.0	0.2	2.2	0.5	0.6	0.3	0.3	2.1	1.8	0.4	0.2	0.4	4.8	5.4	0.9	0.1	3.6	0.4	0.6	1.8	0.2	0.2	1.0	0.1	0.2	1.1	1.0	0.5	1.1	0.8	0.6	0.4	0.5	0.2	0.7	0.3	0.5	0.2	1.1	0.5	0.5	4.4	0.5	0.4	8.8	0.5	0.2	13.6	14.8	4.1	11.1	15.7	3.0	4.1	9.7	5.7	8.9
PAQR4	FLJ30002	ENSG00000162073	"Progestin and adipoQ receptor family member 4"	Q8N4S7	16	2969245-2973489	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.4;parathyroid gland: 32.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"non-classical monocyte: 6.7"	"Lineage enriched"	"Detected in single"	8	"monocytes: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068394			Approved	Vesicles				Vesicles		"HPA068394: "	"unprognostic (1.93e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.30e-3)"	"unprognostic (8.39e-2)"	"unprognostic (3.00e-2)"	"prognostic unfavourable (6.86e-4)"	"unprognostic (2.62e-2)"	"unprognostic (7.59e-2)"	"unprognostic (9.65e-3)"	"unprognostic (5.21e-2)"	"unprognostic (8.59e-2)"	"prognostic unfavourable (3.01e-6)"	"prognostic favourable (1.70e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.79e-2)"	"unprognostic (6.06e-3)"	3.1	3.2	14.1	5.2	19.2	10.3	2.3	8.0	26.3	2.4	4.8	49.6	1.3	4.9	1.8	1.0	4.2	3.0	5.5	4.2	24.1	11.7	1.7	1.6	3.9	6.3	30.6	11.1	0.4	6.6	32.8	0.9	2.2	19.1	9.6	4.5	16.8	17.0	1.3	12.3	12.3	4.9	2.8	54.4	3.2	7.4	1.6	20.3	3.6	1.5	3.5	7.8	2.1	1.7	0.5	0.9	0.1	6.7	0.0	0.4	0.5	12.7	10.9	12.3	17.8	2.0	3.7	4.1	4.8	5.9	9.0	8.6	6.5	13.7	12.8	6.6	5.6	18.0	12.8	7.6	3.7	13.5	5.6	3.9	21.3	8.9	0.2	8.3	14.2	0.9	4.0	4.9	1.2	5.9	7.6	34.7	7.7	25.6	11.9	8.9	10.4	7.5	23.9	16.2	41.2	6.1	4.4	28.4	13.2	18.0	17.5	13.1	18.7	12.9	3.6	15.8	9.7	7.3	6.8	15.2	10.5	17.0	7.0	11.3	17.3	0.0	1.0	0.1	0.4	0.5	0.0	0.5	0.2	0.1	0.9	0.1	0.0	0.3	0.1	0.0	6.7	0.5	0.1	0.5	14.1	19.2	8.0	21.2	24.1	11.7	30.6	11.1	19.1	20.3
PAQR7	"MPRA, mSR"	ENSG00000182749	"Progestin and adipoQ receptor family member 7"	Q86WK9	1	25861210-25871253	"Predicted membrane proteins"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 29.7;HaCaT: 24.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046936	Approved		Approved	Cytosol				Cytosol		"HPA046936: "	"unprognostic (1.12e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.03e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.41e-1)"	"prognostic unfavourable (1.14e-4)"	"unprognostic (1.47e-1)"	"unprognostic (4.59e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"prognostic favourable (1.05e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.54e-2)"	1.2	9.5	1.8	0.7	2.3	1.0	1.4	1.8	1.8	2.8	1.6			6.7	4.1	10.2	6.1	6.8	2.1	0.6	1.7	2.6	11.9	1.9	1.6	0.6	2.0		13.2	1.8	3.9	2.1	6.9		2.4	0.4		1.5	8.9	0.2	10.7	5.7	2.9	1.4	3.5	2.3	16.2			1.4		1.0	6.3	4.6	3.2	5.5	10.8	11.7	2.4	1.4	0.8	11.5	2.3	2.3	7.6	2.8	6.1	8.2	7.6	6.8	7.6	6.9	3.8	29.7	0.1	5.4	7.5	24.4	1.2	12.8	4.6	4.5	1.3	9.8	3.2	4.6	4.8	0.1	1.2	6.1	17.2	5.4	4.1	2.9	1.0	0.8	5.6	2.7	0.0	0.7	3.6	3.9	0.8	0.2	1.4	15.5	8.9	1.2	4.6	12.4	16.2	5.6	4.6	1.7	3.1	1.2	3.9	4.1	2.0	0.1	0.1	0.5	5.8	0.3	2.6	3.1	5.7	10.8	1.1	10.2	1.1	3.2	0.6	0.8	5.5	1.2	1.0	1.4	2.6	2.4	11.7	0.6	0.2	0.8										
PAQR8	"C6orf33, LMPB1, MPRB"	ENSG00000170915	"Progestin and adipoQ receptor family member 8"	Q8TEZ7	6	52361421-52407777	"Predicted membrane proteins"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064625			Supported	"Golgi apparatus,Plasma membrane"				"Plasma membrane"	"Golgi apparatus"	"HPA064625: "	"prognostic favourable (4.61e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.77e-3)"	"unprognostic (8.23e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.66e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.14e-2)"	"prognostic favourable (6.40e-4)"	2.4	3.5	25.6	6.6	32.4	1.3	2.2	14.9	31.0	4.2	28.9	35.5	14.2	14.5	4.4	6.7	13.7	5.4	4.9	2.9	27.3	17.5	5.3	1.5	5.8	7.2	48.5	15.8	19.5	2.5	3.7	1.8	5.5	28.2	3.8	28.1	1.9	1.9	28.5	1.1	2.7	25.1	5.2	69.2	4.8	24.1	3.1	36.5	3.1	2.6	0.4	6.0	7.3	3.3	1.0	6.0	2.0	2.6	7.0	16.3	3.2	0.6	0.6	7.0	3.0	4.3	7.0	4.8	2.1	7.9	1.3	2.9	2.6	2.4	0.7	0.8	1.4	0.3	0.9	3.4	2.1	9.4	1.2	4.2	0.6	26.5	1.2	1.1	0.6	1.9	0.4	0.9	5.0	7.5	0.9	4.2	5.4	0.9	2.7	3.8	3.6	0.3	7.3	1.1	1.7	8.2	2.0	2.7	5.7	0.5	0.2	8.0	0.2	9.4	3.1	2.7	1.1	0.8	1.2	1.2	1.6	1.0	2.5	10.9	14.0	2.0	2.6	1.3	2.5	0.5	3.8	0.9	7.6	5.2	6.0	1.0	16.3	7.6	0.5	7.0	0.5	3.0	4.7	3.2	25.6	32.4	14.9	22.8	27.3	17.5	48.5	15.8	28.2	36.5
PARP6	pART17	ENSG00000137817	"Poly(ADP-ribose) polymerase family member 6"	Q2NL67	15	72241181-72272999	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026991	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA026991: AB_1854989"	"unprognostic (3.88e-2)"	"prognostic favourable (3.17e-5)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (3.36e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.92e-2)"	"prognostic unfavourable (8.02e-8)"	"unprognostic (6.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.42e-2)"	13.7	16.6	28.0	12.8	32.4	25.1	26.5	46.6	41.2	15.5	16.2	16.9	18.2	14.1	23.3	23.8	14.0	17.0	20.2	18.4	26.1	22.4	14.3	9.0	15.7	16.8	19.9	21.8	26.3	20.9	20.6	30.8	17.0	19.4	19.3	14.3	14.5	21.3	18.8	23.9	20.3	14.4	19.6	14.2	18.2	18.2	25.1	15.8	9.6	21.7	12.5	15.8	16.3	15.8	4.1	4.0	12.1	5.3	4.3	4.3	2.9	7.2	13.1	13.8	17.9	14.8	12.4	11.2	6.2	9.4	10.3	15.2	8.6	13.2	10.0	3.9	9.4	9.5	15.2	8.4	5.9	11.8	13.7	14.5	22.9	0.1	12.4	7.4	13.9	15.9	20.8	9.6	26.6	6.9	7.3	11.5	8.3	13.2	6.3	13.1	6.4	0.0	11.8	9.8	7.8	9.6	14.4	39.0	20.7	10.4	8.5	17.0	10.8	8.6	6.5	13.0	11.9	16.9	9.4	13.0	11.9	10.8	9.4	14.6	9.0	1.7	5.3	12.1	3.8	4.4	2.7	3.3	2.7	4.0	4.0	4.1	4.3	3.2	5.7	4.3	4.9	3.1	4.2	2.9	28.0	32.4	46.6	41.2	26.1	22.4	19.9	21.8	19.4	15.8
PARP8	"FLJ21308, pART16"	ENSG00000151883	"Poly(ADP-ribose) polymerase family member 8"	Q8N3A8	5	50665899-50846522	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"THP-1: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049183	Approved		Approved	"Nucleoplasm,Midbody ring,Cytosol"				Nucleoplasm	"Midbody ring, Cytosol"	"HPA049183: "	"unprognostic (1.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.33e-2)"	"unprognostic (8.86e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.23e-2)"	"prognostic favourable (1.12e-4)"	6.2	7.8	8.8	17.1	9.5	33.5	5.3	2.4	18.7	5.6	5.5	3.3	0.6	6.8	5.2	5.4	5.2	7.4	12.3	3.6	12.8	8.0	5.8	4.2	10.9	18.2	4.9	11.0	5.9	7.1	9.8	14.4	5.6	5.4	6.1	4.3	4.1	7.6	4.2	1.7	4.2	14.2	5.4	7.0	20.1	10.2	6.4	2.8	9.9	21.9	1.1	12.3	8.8	7.0	7.1	3.9	13.1	5.9	15.5	32.0	9.5	11.7	0.0	5.4	8.6	1.5	2.7	8.6	1.9	7.0	1.9	5.6	0.3	15.4	6.9	8.2	0.2	5.8	0.9	5.9	4.5	9.7	7.5	5.1	4.7	0.5	2.9	11.9	0.1	3.3	4.9	3.8	2.7	0.1	0.7	4.2	2.6	3.8	14.3	15.1	5.8	2.9	7.2	11.5	8.0	3.5	5.8	6.0	9.3	6.3	10.3	1.6	0.4	42.2	0.0	0.4	7.3	0.5	5.7	3.1	0.1	13.5	6.5	3.4	8.0	10.3	5.9	13.1	20.6	1.6	32.0	6.0	16.1	23.0	3.9	7.1	10.0	16.7	12.3	15.5	1.1	1.8	9.5	9.5	8.8	9.5	2.4	18.7	12.8	8.0	4.9	11.0	5.4	2.8
PATE4	"FLJ41047, PATE-B"	ENSG00000237353	"Prostate and testis expressed 4"	P0C8F1	11	125833316-125840069	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"ductus deferens: 194.5;seminal vesicle: 232.9"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA045632	Approved				"Secreted in male reproductive system"					"HPA045632: AB_10960489"	"unprognostic (4.90e-1)"									"unprognostic (2.93e-2)"		"unprognostic (1.03e-1)"		"unprognostic (1.91e-1)"				0.1	0.1	0.2	0.0	0.2	0.1	0.1	0.4	0.2	0.2	0.1	0.0	194.5	0.0	0.1	7.3	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.0	8.4	0.0	0.0	0.1	232.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.1	0.0	0.0	2.1	0.2	1.6	1.5	1.2	0.6	0.6	0.9	0.1	0.5	0.5	0.8	1.4	0.4	0.5	0.4	0.3	0.2	0.0	0.3	0.6	0.9	1.6	0.5	0.0	0.9	0.1	0.1	0.4	0.3	0.3	0.6	1.5	0.8	0.1	0.5	3.1	0.7	0.3	0.2	0.6	0.1	0.9	2.6	0.2	0.7	0.2	0.9	1.6	0.8	0.6	0.6	0.6	0.5	1.8	0.4	0.3	0.5	0.1	0.3	0.9	0.1	1.7	1.3	1.5	2.5	0.8	1.4	0.7	0.8	1.1	0.2	1.3	0.6	0.6	0.3	0.9	0.5	0.6	1.4	0.7	0.4	0.3	1.6	0.9	0.8	1.2	0.6	0.4	1.5	0.2	0.1	0.2	0.2	0.4	0.2	0.1	0.2	0.1	0.0	0.0	0.0
PBOV1	"UC28, UROC28"	ENSG00000254440	"Prostate and breast cancer overexpressed 1"	Q9GZY1	6	138215986-138218491	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.5;bone marrow: 1.9;brain: 1.9"	"Cell line enhanced"	"Detected in single"		"MCF7: 1.0"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 2.5"	"Low lineage specificity"	"Detected in many"											HPA063021	Uncertain									"HPA063021: "	"unprognostic (3.32e-3)"							"unprognostic (8.23e-2)"		"unprognostic (9.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.77e-2)"		"unprognostic (2.51e-1)"			"unprognostic (1.35e-4)"	0.0	0.0	0.2	0.0	0.3	1.9	0.2	1.9	0.2	0.0	0.0			0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.3	0.2	1.1	0.1	0.1	0.0	0.1		0.0	0.8	0.7	0.3	0.0		0.5	0.0		0.5	0.0	0.2	0.5	0.2	0.1	0.2	0.2	0.3	0.2			0.2		0.0	0.0	0.0	0.8	0.4	2.5	0.4	1.1	0.4	0.1	0.0	0.5	0.1	0.8	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.8	0.3	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.2	1.0	0.4	0.8	0.4	0.0	0.3	0.1	0.3	0.0	0.4	0.3	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.9	0.1	0.0	0.4	0.1	0.0	2.5	0.4	0.3	0.2	0.2	0.1	0.4	0.2	0.3	0.1	0.8	0.4	0.4	2.0	1.1	0.2	0.4	0.1	0.1										
PCBP3	"FLJ44028, PCBP3-OT1, PCBP3OT"	ENSG00000183570	"Poly(rC) binding protein 3"	P57721	21	45643694-45942454	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 14.5;HDLM-2: 26.6;HSkMC: 20.4;SH-SY5Y: 23.1;U-87 MG: 12.3;U-937: 14.8"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"cerebellum: 47.4;pons and medulla: 23.0"	"Cell type enhanced"	"Detected in many"		"eosinophil: 5.9"	"Group enriched"	"Detected in many"	6	"B-cells: 2.9;granulocytes: 5.9;T-cells: 1.6"	"Region enriched"	"Detected in all"	5	"olfactory region: 280.8"	"Region enhanced"	"Detected in all"		"olfactory region: 184.8"	HPA030247	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria				"Nucleoplasm, Mitochondria"	Vesicles	"HPA030247: AB_10601244"	"unprognostic (3.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.01e-4)"	"unprognostic (9.89e-4)"	"unprognostic (2.74e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.96e-6)"	"unprognostic (8.67e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.97e-2)"	6.5	11.7	6.0	11.2	6.7	12.3	6.3	47.4	12.6	3.8	7.9	7.0	2.2	3.1	9.3	12.4	1.4	3.2	4.4	2.7	6.5	7.3	2.2	1.1	1.8	5.0	6.9	3.7	3.4	3.5	0.6	14.8	2.3	23.0	1.5	3.0	20.2	1.7	1.9	1.1	1.6	4.8	12.3	7.3	11.6	3.4	20.5	6.1	22.6	0.8	0.0	4.6	2.3	1.8	2.9	0.0	5.9	0.4	0.6	1.6	0.5	0.0	0.0	0.2	0.0	6.7	14.5	0.0	0.8	0.2	1.5	0.6	0.0	0.0	0.0	0.3	3.9	0.0	0.8	0.0	0.2	26.6	0.0	0.0	0.0	0.0	6.9	0.0	0.0	20.4	0.1	0.2	0.4	0.0	0.0	0.1	0.9	0.3	7.6	1.5	0.4	1.3	0.0	0.0	1.1	0.0	0.0	2.5	23.1	0.5	0.0	0.0	0.0	4.1	0.0	0.0	0.0	6.0	0.0	0.3	1.4	0.0	12.3	14.8	0.5	4.4	0.4	5.9	1.6	0.3	0.3	2.9	0.9	0.0	0.0	1.9	1.5	0.2	1.4	0.6	0.2	0.0	0.8	0.5	6.0	6.7	47.4	6.0	6.5	7.3	6.9	3.7	23.0	6.1
PCBP4	"LIP4, MCG10"	ENSG00000090097	"Poly(rC) binding protein 4"	P57723	3	51957454-51974016	"Predicted intracellular proteins"		"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 97.5"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 48.5;SK-MEL-30: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	20	"B-cells: 4.6;granulocytes: 4.6;T-cells: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057754			Supported	Cytosol				Cytosol		"HPA057754: "	"unprognostic (7.17e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.94e-2)"	"unprognostic (4.97e-3)"	"unprognostic (4.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.72e-2)"	19.5	16.6	27.2	9.6	21.9	3.0	10.6	86.0	56.3	12.7	16.7	36.2	16.0	15.1	15.4	12.1	14.5	10.4	18.3	36.5	29.2	29.9	21.2	38.9	13.9	17.0	28.9	13.0	16.3	22.0	22.9	15.8	7.8	16.4	20.1	8.6	47.3	20.3	19.6	97.5	13.6	29.0	14.4	44.4	10.9	13.3	10.6	19.7	11.9	17.3	11.0	15.7	13.3	9.6	4.6	0.3	4.6	0.0	0.1	10.2	2.4	10.0	3.4	13.8	20.1	6.3	11.3	2.3	23.1	11.3	13.9	9.0	12.8	3.6	0.3	3.4	18.3	2.4	12.9	8.1	6.5	15.9	2.0	1.2	11.6	13.2	10.2	1.3	9.8	15.3	15.1	8.9	3.9	6.9	0.6	4.5	22.3	4.7	0.5	1.5	6.7	9.3	7.0	6.7	1.8	4.9	7.2	27.3	48.5	6.3	3.4	41.0	6.4	4.9	13.8	15.0	28.3	4.7	12.3	3.0	1.9	2.0	17.3	2.8	21.7	4.6	0.0	3.1	10.2	0.0	7.1	4.6	9.6	9.8	0.3	2.3	4.6	3.5	0.0	0.1	0.0	0.1	10.0	2.4	27.2	21.9	86.0	24.2	29.2	29.9	28.9	13.0	16.4	19.7
PCDH10	"KIAA1400, OL-PCDH"	ENSG00000138650	"Protocadherin 10"	Q9P2E7	4	133149315-133208606	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.0;placenta: 31.1;seminal vesicle: 23.6"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 15.8;MOLT-4: 13.2;TIME: 31.4;U-138 MG: 8.5;U-251 MG: 7.2"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011220, HPA073462"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA011220: AB_1855041, HPA073462: "	"unprognostic (7.20e-2)"	"unprognostic (8.74e-3)"	"unprognostic (4.30e-2)"	"unprognostic (8.12e-5)"	"unprognostic (8.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.27e-3)"	"unprognostic (4.51e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.68e-4)"	"unprognostic (8.88e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.16e-4)"	1.9	7.6	17.9	1.5	35.5	1.2	1.3	1.7	48.0	3.3	1.5	23.2	4.5	1.3	3.1	1.9	1.6	2.6	1.9	1.8	17.5	12.6	3.7	1.3	2.0	1.2	13.2	16.3	4.1	1.4	1.2	1.7	31.1	13.6	14.7	1.5	1.3	1.8	23.6	1.2	1.3	1.7	2.0	6.8	1.2	1.3	2.9	19.2	0.9	1.5	0.0	1.2	3.6	3.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	5.1	0.0	0.1	0.0	0.0	4.9	2.7	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.2	0.0	2.4	0.0	13.2	0.0	0.0	0.1	0.3	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	31.4	8.5	0.0	0.0	7.2	0.0	0.0	0.0	0.5	0.0	4.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.9	35.5	1.7	27.7	17.5	12.6	13.2	16.3	13.6	19.2
PCDH11X	"PCDH-X, PCDH11, PCDHX, PPP1R119"	ENSG00000102290	"Protocadherin 11 X-linked"	Q9BZA7	X	91779261-92623230	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 7.0;ovary: 12.6;parathyroid gland: 5.2"	"Group enriched"	"Detected in some"	5	"AF22: 4.2;AN3-CA: 6.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA077495	Approved									"HPA077495: "	"unprognostic (4.22e-3)"	"unprognostic (1.16e-1)"		"unprognostic (1.39e-4)"	"unprognostic (1.18e-1)"			"unprognostic (8.20e-3)"		"unprognostic (6.32e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.19e-2)"		"unprognostic (4.58e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.86e-1)"	0.0	0.3	2.6	0.1	7.0	0.0	0.2	0.0	4.8	1.7	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	4.2	0.0	0.0	0.0	0.2	1.3		12.6	0.0	5.2	0.3	1.2		0.0	0.0		0.0	0.4	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0			0.1		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PCDH17	"PCDH68, PCH68"	ENSG00000118946	"Protocadherin 17"	O14917	13	57631810-57729311	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.2;lymphoid tissue: 32.7"	"Cell line enhanced"	"Detected in some"		"AF22: 15.8;HEK 293: 9.9;U-87 MG: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026817	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"			31000	Cytosol	"Vesicles, Plasma membrane"	"HPA026817: AB_1855044"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.26e-4)"	"unprognostic (3.56e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.82e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.31e-5)"	"unprognostic (1.07e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.40e-2)"	2.0	2.4	8.0	2.1	11.2	0.3	0.9	4.6	18.2	2.9	1.2	6.2	0.3	1.1	2.6	1.3	1.7	2.5	3.6	2.3	6.5	12.1	1.6	1.4	13.5	0.9	7.4	4.8	0.8	6.2	2.0	1.0	4.7	4.4	1.2	1.2	1.1	1.0	1.1	1.8	0.6	0.7	2.6	4.4	32.7	1.8	8.9	7.7	0.0	3.4	0.4	0.8	3.4	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	2.7	0.0	0.0	1.8	0.0	0.0	0.0	9.9	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.4	0.0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.4	0.0	1.0	0.0	0.0	0.0	6.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	11.2	4.6	7.8	6.5	12.1	7.4	4.8	4.4	7.7
PCDH18	"KIAA1562, PCDH68L"	ENSG00000189184	"Protocadherin 18"	Q9HCL0	4	137518918-137532494	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 35.0;ASC diff: 42.3;ASC TERT1: 47.1;BJ hTERT+: 20.7;fHDF/TERT166: 33.4;HHSteC: 31.2;HSkMC: 47.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 1.3;memory CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017976	Approved		Approved	"Golgi apparatus,Cytosol"			1200000	Cytosol	"Golgi apparatus"	"HPA017976: AB_1855045"	"unprognostic (2.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.20e-2)"	"unprognostic (8.76e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavourable (3.21e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (4.71e-4)"	28.4	3.5	4.2	7.2	4.0	0.0	16.2	2.0	2.7	30.4	13.3	2.1	9.8	6.0	34.0	8.7	11.2	8.6	14.9	8.9	2.7	3.6	5.4	3.0	5.9	2.6	5.2	1.4	14.9	2.4	1.8	3.5	29.0	5.4	23.3	9.5	21.8	6.3	9.5	10.3	5.1	9.0	25.4	5.4	4.0	5.5	9.7	4.0	1.0	8.2	7.7	1.9	17.5	16.3	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	35.0	0.0	42.3	47.1	0.0	6.3	20.7	1.2	1.8	0.0	0.0	0.0	0.0	33.4	0.0	8.1	0.1	0.6	0.0	0.2	0.0	0.0	0.0	31.2	0.0	0.0	47.9	0.0	2.2	0.9	0.2	0.0	0.1	0.6	0.0	0.9	0.0	0.0	0.6	2.6	1.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	16.4	1.0	3.3	0.1	0.0	0.0	0.0	0.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.2	4.0	2.0	2.7	2.7	3.6	5.2	1.4	5.4	4.0
PCDH20	"FLJ22218, PCDH13"	ENSG00000280165	"Protocadherin 20"	Q8N6Y1	13	61409685-61415522	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;smooth muscle: 12.7"	"Cell line enriched"	"Detected in some"	14	"RPTEC TERT1: 33.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062669			Approved	"Vesicles,Cytokinetic bridge"				Vesicles	"Cytokinetic bridge"	"HPA062669: "	"unprognostic (2.40e-1)"		"unprognostic (1.80e-1)"		"unprognostic (2.45e-1)"		"unprognostic (7.83e-2)"	"unprognostic (6.79e-4)"			"unprognostic (2.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.34e-4)"	"unprognostic (6.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.12e-1)"		0.3	1.6	6.7	0.4	5.8	0.0	1.3	0.0	13.1	3.5	4.5	0.0	0.2	1.2	4.3	4.3	1.8	0.2	0.9	4.8	13.4		1.2	1.8	4.7	0.0	8.8	3.8	0.3	0.1	0.0	0.7	1.3	6.9	1.5	2.5	0.0	0.7	1.5	0.1	0.5	1.4	12.7	8.4	1.6	1.5	0.4	6.3	0.0	0.3	0.0	0.1	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	33.8	0.0	0.5	1.2	0.0	2.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PCDH8	"ARCADLIN, PAPC"	ENSG00000136099	"Protocadherin 8"	O95206	13	52842889-52848641	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 20.6"	"Cell line enriched"	"Detected in some"	4	"AF22: 22.5"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010509	Uncertain		Uncertain	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA010509: AB_10601384"	"unprognostic (3.50e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.11e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.97e-2)"		"unprognostic (7.01e-2)"		"unprognostic (1.13e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.59e-1)"		"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.32e-1)"		0.8	0.9	11.5	1.1	18.6	0.8	0.8	0.4	20.6	0.9	1.0	1.1	0.0	0.9	1.0	0.8	0.8	0.8	0.8	0.8	18.2	4.8	0.8	0.8	0.9	0.8	3.6	8.4	0.8	0.8	0.8	1.4	0.8	0.8	1.7	0.9	0.8	0.8	0.8	1.4	0.8	1.1	0.9	0.9	0.8	1.2	2.3	2.5	0.0	1.4	0.0	0.8	0.9	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	1.6	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	18.6	0.4	20.6	18.2	4.8	3.6	8.4	0.8	2.5
PCDHA1		ENSG00000204970	"Protocadherin alpha 1"	Q9Y5I3	5	140786136-141012347	"Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 7.1;testis: 3.1"	"Cell line enriched"	"Detected in some"	7	"T-47d: 14.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035969	Enhanced		Approved	"Plasma membrane"	"Secreted - unknown location"			"Plasma membrane"		"HPA035969: AB_10673492"	"unprognostic (2.76e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.09e-4)"	"unprognostic (7.38e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.01e-5)"	"unprognostic (2.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.29e-1)"	0.2	1.5	4.6	0.2	4.4	0.1	0.2	3.3	7.1	0.2	0.3			0.7	0.5	0.1	0.2	0.2	0.4	0.1	5.0	3.7	0.6	0.1	0.2	0.3	3.4		0.2	0.2	1.0	1.4	0.1		0.2	0.2		0.1	0.1	0.1	0.1	0.6	0.2	3.4	0.2	0.3	3.1			0.2		0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.4	1.0	0.0	0.2	1.8	14.1	0.5	0.0	1.5	1.0	0.7	0.1	0.0	0.1	0.0	0.4	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PCDHA11	"CNR7, CNRN7, CNRS7, CRNR7, PCDH-ALPHA11"	ENSG00000249158	"Protocadherin alpha 11"	Q9Y5I1	5	140868183-141012344	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.3;parathyroid gland: 4.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 16.5;EFO-21: 8.6;MCF7: 4.4;T-47d: 5.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077160			Approved	"Vesicles,Cell Junctions,Cytoplasmic bodies"				"Vesicles, Cell Junctions"	"Cytoplasmic bodies"	"HPA077160: "	"unprognostic (1.54e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.98e-3)"		"unprognostic (1.36e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.40e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.13e-4)"	"unprognostic (9.91e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.26e-2)"	0.1	0.6	1.0	0.1	1.6	0.0	0.2	7.0	9.3	1.3	0.0			0.0	0.6	0.1	0.0	0.2	1.0	0.0	0.8	1.0	1.2	0.0	0.8	0.0	0.3		0.0	3.3	4.7	1.6	0.0		0.1	0.0		1.3	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	1.6			1.5		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	3.9	16.5	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	8.6	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.0	0.1	0.0	4.4	0.0	0.0	3.6	3.1	0.0	0.0	0.0	0.4	1.9	0.8	2.2	0.0	1.8	0.4	5.8	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PCDHA12	PCDH-ALPHA12	ENSG00000251664	"Protocadherin alpha 12"	Q9UN75	5	140875302-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.6"	"Cell line enhanced"	"Detected in some"		"A549: 10.0;AN3-CA: 4.0;hTCEpi: 6.2;PC-3: 7.6;RT4: 7.5;SH-SY5Y: 4.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 14.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA035812	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA035812: "	"unprognostic (3.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.74e-2)"			"unprognostic (2.24e-2)"		"unprognostic (2.08e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.18e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.97e-2)"	1.0	1.7	0.9	0.3	1.2	0.0	0.9	14.6	3.7	3.5	0.4	1.1	0.0	0.1	1.0	0.5	0.2	1.9	4.3	0.3	1.0	0.7	3.8	1.7	5.7	0.2	0.5	0.8	0.3	2.4	0.9	4.6	0.0	2.3	0.4	0.1	1.5	5.7	0.3	0.1	0.2	0.2	0.6	0.8	0.2	0.3	2.1	0.2	0.0	3.4	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	2.4	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	6.2	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.4	7.6	0.0	0.0	0.0	0.3	7.5	0.3	4.3	0.0	0.9	0.1	1.6	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.2	14.6	3.7	1.0	0.7	0.5	0.8	2.3	0.2
PCDHA5	"CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5"	ENSG00000204965	"Protocadherin alpha 5"	Q9Y5H7	5	140821604-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"brain: 13.6"	"Cell line enhanced"	"Detected in some"		"A549: 2.6;EFO-21: 7.3;T-47d: 7.5;WM-115: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							HPA044557	Approved		Approved	"Nuclear speckles,Plasma membrane,Mitochondria"				"Plasma membrane"	"Nuclear speckles, Mitochondria"	"HPA044557: AB_10970597"	"unprognostic (4.95e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.81e-4)"	"unprognostic (5.10e-2)"	"unprognostic (6.25e-3)"	"unprognostic (6.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.10e-4)"	"unprognostic (9.30e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.17e-5)"	"unprognostic (2.11e-1)"	0.9	1.2	3.4	0.5	3.6	0.6	0.6	13.6	10.2	0.6	0.6	0.4	0.0	0.5	1.2	0.5	0.4	0.5	1.1	0.3	1.6	2.0	1.1	0.4	0.7	0.4	1.3	5.1	0.6	1.2	0.4	2.5	0.4	2.3	0.6	0.5	0.0	0.4	0.4	0.4	0.5	0.5	0.7	1.1	0.4	0.7	0.9	0.1	0.0	0.5	0.0	0.3	0.5	0.2	0.6	0.6	1.6	0.5	0.3	0.3	0.2	0.0	2.6	0.9	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.0	7.5	0.1	0.1	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.5	0.5	0.5	0.3	0.3	0.2	0.4	0.3	0.2	0.1	0.6	0.3	0.3	1.6	0.3	0.4	0.6	0.2	0.2	3.4	3.6	13.6	7.2	1.6	2.0	1.3	5.1	2.3	0.1
PCDHA6	"CNR2, CNRS2, CRNR2, PCDH-ALPHA6"	ENSG00000081842	"Protocadherin alpha 6"	Q9UN73	5	140827958-141012344	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.7;pituitary gland: 11.2"	"Cell line enhanced"	"Detected in some"		"AF22: 2.9;EFO-21: 12.4;U-2 OS: 5.2;WM-115: 7.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA059326, HPA078110"	Enhanced		Approved	Vesicles	"Intracellular and membrane"			Vesicles		"HPA059326: , HPA078110: "	"unprognostic (1.15e-1)"	"unprognostic (7.00e-2)"	"unprognostic (5.07e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.18e-4)"	"unprognostic (4.23e-3)"	"unprognostic (8.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.56e-1)"	"unprognostic (5.66e-3)"	"unprognostic (3.55e-2)"	1.1	1.8	2.9	0.8	7.1	0.4	1.6	10.2	10.7	1.9	0.7	2.3	0.0	1.2	2.9	2.3	0.4	1.6	1.6	0.5	3.8	3.8	2.3	0.4	1.1	0.7	4.6	4.1	2.1	3.7	4.7	11.2	0.4	3.6	1.3	0.7	1.6	0.7	0.5	0.4	0.6	1.3	1.4	3.4	0.8	0.7	1.4	3.2	0.0	0.9	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	2.1	1.3	0.6	0.0	1.9	0.0	5.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	7.1	10.2	9.6	3.8	3.8	4.6	4.1	3.6	3.2
PCDHA8		ENSG00000204962	"Protocadherin alpha 8"	Q9Y5H6	5	140841187-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 6.2"	"Group enriched"	"Detected in some"	6	"AN3-CA: 17.8;SCLC-21H: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044585	Uncertain									"HPA044585: AB_10793953"	"unprognostic (1.11e-2)"			"unprognostic (1.15e-2)"	"unprognostic (1.35e-1)"			"unprognostic (1.95e-1)"	"unprognostic (4.20e-2)"	"unprognostic (9.67e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.87e-4)"	"unprognostic (5.62e-3)"	"unprognostic (2.22e-2)"	"unprognostic (5.48e-1)"	"unprognostic (1.20e-2)"		0.2	1.6	1.0	0.2	2.3	0.2	0.2	6.2	4.7	0.4	0.4	1.4	0.0	0.3	0.8	0.2	0.3	0.3	0.4	0.2	1.2	1.2	0.5	0.3	0.4	0.3	1.0	3.6	0.7	0.9	0.2	1.8	0.3	2.8	0.3	0.5	0.7	0.5	0.2	0.2	0.2	0.4	0.7	1.1	0.2	0.2	1.7	1.3	0.0	0.3	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	17.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	5.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.3	6.2	4.7	1.2	1.2	1.0	3.6	2.8	1.3
PCDHAC1		ENSG00000248383	"Protocadherin alpha subfamily C, 1"	Q9H158	5	140926369-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"parathyroid gland: 33.3"	"Cell line enhanced"	"Detected in some"		"A549: 8.5;EFO-21: 3.6;hTCEpi: 11.0;PC-3: 6.2;SCLC-21H: 4.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA052775			Approved	Nucleoplasm,Nucleoli,Vesicles				"Nucleoplasm, Nucleoli"	Vesicles	"HPA052775: "	"unprognostic (2.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.63e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.04e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.29e-2)"	0.3	0.4	0.9	0.3	1.0	0.0	0.0	2.0	2.8	0.4	0.0			0.0	0.2	0.1	0.0	0.0	0.9	0.0	1.0	1.6	0.2	0.1	0.8	1.0	1.1		0.0	1.5	33.3	1.9	0.0		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.8			0.8		0.4	0.0	0.0	0.2	0.1	0.5	0.2	0.2	0.1	0.0	0.0	8.5	1.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.6	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	11.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.2	0.0	0.0	0.0	0.5	0.4	4.9	2.3	0.0	0.6	0.0	0.5	0.0	0.0	0.6	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.5	0.2	0.2	0.1	0.0	0.0										
PCDHAC2	PCDH-ALPHA-C2	ENSG00000243232	"Protocadherin alpha subfamily C, 2"	Q9Y5I4	5	140966235-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 14.1;parathyroid gland: 52.5"	"Cell line enriched"	"Detected in some"	4	"AN3-CA: 36.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA076190			Approved	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA076190: "	"unprognostic (1.47e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.31e-4)"	"unprognostic (3.89e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.46e-4)"	"unprognostic (9.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-3)"	1.1	1.7	5.7	1.0	9.2	0.5	0.7	13.6	14.1	1.5	0.9	2.3	0.0	0.7	1.2	0.6	0.6	0.8	3.2	1.2	4.5	5.2	0.9	1.3	2.5	2.2	2.9	6.4	0.7	0.9	52.5	3.1	2.2	3.8	0.9	0.9	2.7	1.1	0.7	0.6	0.6	0.7	1.4	2.0	2.1	1.0	2.4	1.7	0.0	1.6	0.0	1.1	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.7	36.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.7	3.9	0.0	0.0	0.1	0.0	8.2	0.0	0.5	0.0	0.0	0.1	5.3	0.0	1.5	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.4	1.3	0.0	0.0	0.0	1.3	0.0	1.6	6.4	0.0	0.0	0.0	1.4	0.2	0.0	0.7	0.7	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	9.2	13.6	14.1	4.5	5.2	2.9	6.4	3.8	1.7
PCDHB1	PCDH-BETA1	ENSG00000171815	"Protocadherin beta 1"	Q9Y5F3	5	141051135-141059344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skeletal muscle: 4.9"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053921	Uncertain									"HPA053921: "	"unprognostic (5.54e-2)"	"unprognostic (1.60e-2)"		"unprognostic (9.01e-4)"	"unprognostic (8.65e-2)"			"unprognostic (8.00e-2)"		"unprognostic (7.82e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.17e-5)"	"unprognostic (3.38e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-4)"	0.1	0.3	0.3	0.1	0.5	1.0	0.1	0.1	0.2	0.5	0.5			0.4	0.1	0.6	0.1	1.8	0.0	0.1	0.4	0.4	0.7	0.1	0.2	0.4	0.2		0.1	1.1	0.7	1.9	0.0		0.1	0.0		0.5	0.0	4.9	0.8	0.5	0.0	0.3	0.3	0.8	1.8			0.3		0.0	0.1	0.1	1.3	0.7	2.5	0.6	1.0	0.6	0.2	0.8	0.4	0.7	1.1	0.2	0.2	1.1	1.1	0.2	0.1	0.1	1.6	1.4	1.1	1.6	0.3	1.5	0.0	0.1	0.2	0.9	1.2	1.1	1.9	0.7	0.1	1.4	1.2	0.2	0.3	0.2	0.2	0.2	0.8	2.6	0.2	1.4	0.7	0.9	1.2	0.4	1.2	1.0	0.8	0.1	1.0	2.2	0.7	0.1	1.8	1.3	0.6	0.5	1.2	1.0	0.7	0.8	0.6	1.5	0.6	1.0	1.1	1.0	1.2	2.3	0.6	0.7	0.5	0.4	0.5	0.7	0.5	0.4	0.2	1.3	0.6	0.5	2.5	1.0	0.4	0.7	0.3	0.2										
PCDHB11	"ME2, PCDH-BETA11"	ENSG00000197479	"Protocadherin beta 11"	Q9Y5F2	5	141199582-141203779	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.0;EFO-21: 11.6;U-2 OS: 4.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA045042	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA045042: "	"unprognostic (1.32e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.96e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.47e-3)"	13.6	2.4	2.8	2.0	4.1	1.1	3.4	8.8	5.0	8.6	3.1	1.4	0.0	1.4	4.9	3.4	4.1	3.1	3.1	3.0	1.4	1.8	5.0	1.3	2.9	1.0	1.5	3.7	11.0	12.0	15.8	3.6	2.2	3.0	4.5	1.7	6.8	3.3	3.6	2.0	2.9	1.8	5.1	1.6	2.2	2.9	2.6	1.3	0.0	2.8	2.3	1.1	5.5	4.2	1.2	1.0	2.8	0.9	1.4	0.8	0.1	0.0	0.2	2.5	8.0	0.1	0.3	1.7	0.2	0.8	0.0	0.0	0.0	0.2	0.0	11.6	0.7	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.2	0.2	0.3	0.0	0.0	0.1	0.1	2.0	0.4	0.2	0.0	0.2	0.3	0.4	0.0	3.1	0.0	0.1	0.3	3.3	0.5	1.8	0.2	1.0	1.9	0.0	0.4	0.1	4.2	3.3	0.1	0.1	0.1	0.1	2.1	0.2	2.0	2.2	0.9	0.8	0.8	0.5	0.5	0.6	0.6	0.5	0.3	1.2	0.5	0.7	2.8	1.4	0.4	1.0	0.4	0.1	2.8	4.1	8.8	5.0	1.4	1.8	1.5	3.7	3.0	1.3
PCDHB12	PCDH-BETA12	ENSG00000120328	"Protocadherin beta 12"	Q9Y5F1	5	141208697-141212571	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.7;ASC diff: 4.6;EFO-21: 5.3;RH-30: 5.7;U-2 OS: 4.4;U-2197: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045042	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA045042: "	"unprognostic (1.43e-2)"	"unprognostic (3.22e-3)"	"unprognostic (4.18e-3)"	"unprognostic (8.43e-2)"	"unprognostic (3.95e-3)"	"unprognostic (7.87e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.63e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.86e-2)"	"unprognostic (2.94e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.22e-3)"	"unprognostic (4.97e-3)"	"unprognostic (3.83e-2)"	"unprognostic (6.41e-3)"	4.2	2.5	4.4	1.9	5.0	0.4	3.4	9.1	7.5	5.8	3.3	2.5	1.5	1.3	8.0	3.5	1.8	4.9	3.9	3.9	3.1	2.2	2.6	1.5	3.6	0.9	3.0	6.4	8.3	4.0	3.6	13.9	2.0	3.7	4.5	1.8	3.2	1.9	3.9	1.8	1.6	1.7	6.8	3.9	2.6	2.1	3.1	2.7	0.0	1.9	1.2	0.9	3.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.7	4.6	2.7	0.7	0.1	3.3	0.3	0.4	0.0	0.0	0.0	5.3	0.5	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	1.2	0.0	0.0	0.4	0.0	1.2	1.2	0.3	0.0	0.0	0.1	1.0	0.8	5.7	0.0	0.0	0.0	2.8	1.6	0.0	0.0	1.0	3.7	0.8	0.3	0.7	4.4	4.3	0.1	0.0	0.0	0.0	2.8	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	5.0	9.1	7.5	3.1	2.2	3.0	6.4	3.7	2.7
PCDHB15	PCDH-BETA15	ENSG00000113248	"Protocadherin beta 15"	Q9Y5E8	5	141245349-141249365	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 9.2;LHCN-M2: 7.6;WM-115: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"memory CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"									"HPA007172, CAB026471, HPA074676"	Uncertain		Approved	Mitochondria				Mitochondria		"CAB026471: , HPA007172: AB_1079576, HPA074676: "	"unprognostic (1.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.37e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.06e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.58e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.00e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-1)"	8.6	3.6	7.9	5.5	8.4	0.6	4.0	15.1	17.1	8.5	5.3	8.0	0.3	1.5	12.9	6.0	3.5	7.2	4.7	8.6	5.9	4.1	3.8	2.6	5.4	2.0	4.9	6.0	13.6	5.7	2.7	5.7	3.6	8.9	6.4	2.6	3.7	3.1	5.1	2.9	2.6	2.7	9.1	9.4	5.6	4.8	9.1	7.6	0.0	4.5	4.4	1.6	5.6	5.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.1	9.2	1.1	2.5	2.6	0.1	0.7	1.8	0.1	0.5	0.0	0.5	0.0	1.8	1.4	0.2	0.2	0.0	0.3	0.0	0.0	0.0	1.0	0.3	0.3	0.0	0.0	1.1	2.1	0.1	0.3	0.4	0.1	1.7	7.6	0.0	0.0	0.2	2.2	0.1	0.3	0.6	0.0	0.6	0.0	0.5	1.3	0.3	0.5	2.4	0.4	0.0	0.0	0.7	1.0	2.9	0.1	0.1	1.2	0.0	1.2	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	8.4	15.1	7.3	5.9	4.1	4.9	6.0	8.9	7.6
PCDHB3	PCDH-BETA3	ENSG00000113205	"Protocadherin beta 3"	Q9Y5E6	5	141100473-141103827	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 12.1;HAP1: 3.7;SH-SY5Y: 16.2;U-138 MG: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA050296	Uncertain		Supported	Vesicles				Vesicles		"HPA050296: "	"unprognostic (2.72e-2)"	"unprognostic (7.47e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-4)"	"unprognostic (9.34e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.52e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.18e-4)"	5.7	4.6	3.1	2.6	9.3	0.4	5.9	3.8	6.2	4.8	2.5	2.2	1.3	1.4	8.0	3.0	1.3	3.1	3.1	3.6	3.8	3.0	4.9	0.8	3.3	1.0	3.0	3.8	5.6	3.9	4.4	17.3	1.8	4.0	5.4	2.1	3.4	2.4	2.4	1.9	2.0	2.1	3.8	3.0	1.5	1.8	11.6	2.0	0.0	2.1	2.3	0.7	2.4	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.3	2.1	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.2	0.0	3.7	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.4	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.6	16.2	0.0	0.2	0.0	2.0	0.1	0.0	5.7	0.8	0.6	0.3	0.3	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	9.3	3.8	6.2	3.8	3.0	3.0	3.8	4.0	2.0
PCDHB4	PCDH-BETA4	ENSG00000081818	"Protocadherin beta 4"	Q9Y5E5	5	141121799-141125623	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 12.7;SH-SY5Y: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	17	"T-reg: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.6"									HPA014466	Approved		Uncertain	"Plasma membrane,Intermediate filaments,Cytosol"				"Plasma membrane, Cytosol"	"Intermediate filaments"	"HPA014466: AB_1855058"	"unprognostic (2.60e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.60e-3)"	"unprognostic (4.03e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.32e-4)"	"unprognostic (5.18e-3)"	7.1	5.3	13.0	2.0	12.0	0.6	5.9	11.3	11.4	8.0	3.4	12.9	0.1	1.9	12.3	9.1	4.0	5.8	5.7	4.3	10.9	6.3	4.1	1.3	5.1	1.4	13.1	11.3	9.9	18.2	7.3	5.1	0.9	11.0	6.1	2.7	3.7	5.0	5.1	3.8	3.1	2.6	7.9	21.1	2.0	2.6	1.6	12.3	0.0	2.8	1.5	1.1	5.6	5.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	2.1	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	12.7	8.5	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.2	0.3	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	13.0	12.0	11.3	11.4	10.9	6.3	13.1	11.3	11.0	12.3
PCDHB5	"DKFZp586B0217, PCDH-BETA5"	ENSG00000113209	"Protocadherin beta 5"	Q9Y5E4	5	141135218-141138625	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 12.2;NTERA-2: 11.6;RH-30: 9.2;SCLC-21H: 10.8;T-47d: 11.4;U-138 MG: 21.5;U-2 OS: 9.6;WM-115: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA013191	Approved									"HPA013191: AB_1855059"	"unprognostic (2.21e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.65e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.55e-3)"	3.8	4.6	8.1	1.6	10.7	0.7	3.6	7.7	11.0	9.0	2.9	7.9	3.6	1.2	10.4	9.2	2.5	7.5	4.9	4.9	7.9	4.1	6.6	2.3	4.0	1.1	3.6	7.1	14.9	11.2	6.3	7.6	1.6	6.4	7.6	1.4	6.9	5.6	5.9	3.0	1.9	1.5	5.7	5.2	2.2	2.4	6.1	5.9	0.0	6.6	0.7	1.0	4.4	3.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.6	12.2	0.2	0.9	0.5	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	6.3	0.0	0.0	6.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.6	0.5	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	9.2	0.0	0.0	0.0	10.8	0.3	0.0	0.1	3.7	11.4	2.7	0.0	21.5	9.6	3.5	0.0	0.0	0.0	0.0	1.1	0.0	9.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.1	10.7	7.7	10.5	7.9	4.1	3.6	7.1	6.4	5.9
PCDHB6	PCDH-BETA6	ENSG00000113211	"Protocadherin beta 6"	Q9Y5E3	5	141150022-141153287	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 13.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 16.5;SH-SY5Y: 7.0;T-47d: 5.3;U-2197: 7.5;WM-115: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029566	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA029566: AB_10601385"	"unprognostic (3.25e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.05e-2)"	"unprognostic (7.65e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.73e-3)"	"unprognostic (9.64e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.28e-2)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (5.52e-4)"	"unprognostic (8.60e-4)"	"unprognostic (2.31e-2)"	"unprognostic (7.08e-3)"	"unprognostic (6.52e-2)"	2.5	2.4	3.9	1.0	5.1	0.4	2.5	4.2	8.4	2.3	1.5	2.6	0.0	0.6	4.5	3.7	0.7	2.1	1.4	1.6	3.5	1.9	1.6	1.4	1.7	0.7	2.6	3.6	3.7	1.5	13.4	6.4	1.5	2.9	1.5	0.9	0.7	2.5	1.5	1.4	2.4	1.0	3.0	3.3	1.5	0.9	5.4	3.1	0.0	1.1	1.0	0.7	1.8	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	16.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	7.0	0.0	0.1	3.5	5.3	2.1	0.0	0.6	1.3	7.5	0.0	0.0	0.0	0.0	3.8	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	5.1	4.2	8.4	3.5	1.9	2.6	3.6	2.9	3.1
PCDHB7	PCDH-BETA7	ENSG00000113212	"Protocadherin beta 7"	Q9Y5E2	5	141172619-141176383	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.3;EFO-21: 6.4;U-138 MG: 4.3;U-2197: 12.8;U-87 MG: 4.4;WM-115: 4.3"	"Cancer enhanced"	"Detected in many"		"glioma: 5.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA059271	Approved									"HPA059271: "	"unprognostic (2.13e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.69e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.78e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.78e-4)"	5.8	2.5	4.0	2.7	3.4	0.4	4.3	3.7	4.9	8.1	3.1	8.9	0.0	1.5	11.6	5.0	1.4	5.0	4.6	3.6	4.0	1.8	3.0	1.4	4.9	1.9	3.0	2.7	7.5	1.5	1.6	8.1	1.1	4.5	4.8	1.7	7.0	1.5	3.4	1.4	1.6	2.3	9.0	3.9	3.6	1.8	3.6	5.1	0.0	3.3	0.9	1.0	6.2	5.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.6	5.3	2.6	0.0	0.3	0.7	0.1	0.1	0.0	0.1	0.0	6.4	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	1.9	1.3	0.4	0.0	1.0	2.8	0.0	0.9	4.3	0.8	12.8	0.1	0.0	0.0	0.0	4.4	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.4	3.7	4.9	4.0	1.8	3.0	2.7	4.5	5.1
PCDHB8	"PCDH-BETA8, PCDH3I"	ENSG00000120322	"Protocadherin beta 8"	Q9UN66	5	141177790-141180529	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 13.8;T-47d: 20.4;U-138 MG: 8.1;U-2197: 22.4"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057773	Uncertain									"HPA057773: "	"unprognostic (1.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.56e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.72e-3)"	"unprognostic (5.82e-4)"	"unprognostic (3.54e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.09e-2)"	"unprognostic (3.12e-2)"	"unprognostic (6.30e-4)"	2.3	1.2	0.9	0.3	1.3	0.0	1.5	0.8	2.7	1.3	0.8			0.0	3.7	1.8	0.9	1.1	1.7	1.5	1.1	0.6	1.3	0.1	1.8	0.0	0.8		2.9	1.5	1.2	2.2	0.4		0.9	0.3		0.6	0.8	0.1	0.9	0.2	1.9	1.4	0.3	0.3	2.5			0.5		0.0	0.5	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.5	1.6	0.1	0.1	5.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	1.1	4.0	0.1	0.0	0.0	0.0	0.3	0.0	5.4	0.0	0.0	0.0	4.0	1.0	0.0	0.0	0.7	20.4	0.0	0.5	8.1	4.1	22.4	0.0	0.0	0.0	0.0	2.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PCDHB9	"PCDH-BETA9, PCDH3H"	ENSG00000177839	"Protocadherin beta 9"	Q9Y5E1	5	141187127-141191541	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 10.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 10.5;ASC TERT1: 9.8;SH-SY5Y: 14.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA013445	Uncertain									"HPA013445: AB_1855054"	"unprognostic (1.85e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.86e-4)"	"unprognostic (1.71e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.01e-2)"	1.9	1.9	5.3	0.3	4.1	0.3	1.6	1.8	10.9	3.6	1.0	3.2	0.0	0.2	2.8	4.7	0.9	2.3	1.6	2.0	5.9		0.9	0.2	1.4	0.2	1.2	3.1	4.7	1.7	2.1	6.6	1.1	4.1	1.1	0.6	1.2	1.4	0.8	0.7	0.9	1.0	2.6	4.6	0.6	0.5	1.2	2.5	0.0	0.8	0.3	0.2	0.7	1.0	0.5	0.2	1.9	0.2	0.9	1.3	0.0	0.0	0.0	0.9	6.0	10.5	9.8	0.2	0.1	3.5	0.4	0.5	0.0	1.0	0.4	4.0	0.1	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.9	0.0	0.0	0.0	0.0	2.6	2.9	0.9	0.5	0.7	0.3	0.4	2.7	5.5	0.0	0.5	0.1	2.1	14.5	0.6	0.1	1.0	2.8	0.2	0.9	5.9	0.5	4.9	1.2	0.1	0.0	0.0	3.2	0.2	2.2	1.1	0.2	0.5	0.2	0.1	0.1	0.2	0.4	1.3	0.0	0.5	0.3	0.3	1.9	0.9	0.1	0.2	0.2	0.0										
PCDHGA1	PCDH-GAMMA-A1	ENSG00000204956	"Protocadherin gamma subfamily A, 1"	Q9Y5H4	5	141330571-141512981	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.7"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 6.9;T-47d: 11.3;WM-115: 5.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA008755, HPA010580, HPA036547"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA036547: AB_10669798"	"unprognostic (9.50e-4)"	"unprognostic (2.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.45e-3)"	1.4	1.3	2.7	0.9	11.7	1.0	1.1	6.8	7.9	1.4	1.2	2.7	0.5	1.0	2.8	3.9	1.3	1.1	0.8	3.9	3.5	2.8	1.2	0.5	1.2	1.0	2.5	2.5	2.9	2.5	2.8	6.1	2.3	5.4	1.5	0.9	2.4	1.1	1.0	1.7	1.5	0.6	1.8	2.4	1.1	0.8	2.7	1.1	0.0	1.3	0.6	0.7	1.2	0.9	1.2	0.9	2.7	0.5	0.8	1.0	0.2	0.1	0.4	0.5	1.9	1.2	2.0	0.3	1.7	1.1	0.5	1.0	0.4	0.2	0.5	2.8	1.0	0.2	0.2	0.3	1.1	0.3	0.3	0.2	0.4	0.3	0.3	0.1	0.2	1.7	0.5	0.0	0.7	0.1	0.2	0.8	6.9	0.1	0.2	0.8	0.3	0.3	3.0	2.6	0.3	0.3	0.3	1.7	2.1	0.2	0.9	1.7	11.3	0.4	0.8	3.2	0.7	1.6	0.4	0.3	1.0	0.2	3.8	0.2	5.1	2.7	0.5	0.5	0.7	0.4	0.4	0.7	0.7	0.5	0.2	1.2	1.0	0.8	1.1	0.8	0.5	0.9	0.6	0.2	2.7	11.7	6.8	6.1	3.5	2.8	2.5	2.5	5.4	1.1
PCDHGA10	PCDH-GAMMA-A10	ENSG00000253846	"Protocadherin gamma subfamily A, 10"	Q9Y5H3	5	141412987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 33.7"	"Cell line enhanced"	"Detected in many"		"AF22: 12.0;HSkMC: 13.5;T-47d: 16.0;U-2197: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077276"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA077276: "	"unprognostic (2.92e-1)"	"unprognostic (2.17e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.64e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.83e-3)"	5.2	4.2	7.9	1.6	11.4	1.2	2.7	2.4	33.7	3.6	2.9	9.8	1.2	2.4	3.0	2.4	4.3	3.6	3.7	2.3	9.1	4.4	2.0	6.5	3.5	1.7	5.1	7.2	3.6	1.9	1.4	2.4	7.4	5.3	3.6	2.6	4.9	4.1	4.6	2.0	4.7	2.9	3.1	6.7	2.5	4.7	2.0	6.5	0.0	4.9	1.5	3.3	2.5	3.5	0.9	1.1	1.5	0.7	0.8	1.0	0.2	0.0	0.0	12.0	6.1	5.3	2.3	5.7	2.0	0.1	2.9	4.7	0.2	0.7	0.6	7.9	2.9	0.3	2.8	1.9	2.3	0.7	0.0	0.0	0.3	0.0	2.1	1.2	0.2	13.5	0.3	2.0	0.8	1.1	0.0	0.1	7.3	0.0	0.1	0.3	1.1	0.1	0.1	1.0	0.0	2.0	0.0	1.6	0.6	0.3	0.0	0.3	16.0	1.5	2.6	5.5	0.3	9.4	0.1	0.2	0.9	0.1	2.8	0.0	0.3	1.5	0.3	0.3	1.0	0.4	1.0	0.6	0.4	0.6	0.1	0.9	0.4	0.9	0.9	0.8	0.7	1.1	0.3	0.2	7.9	11.4	2.4	8.5	9.1	4.4	5.1	7.2	5.3	6.5
PCDHGA11	PCDH-GAMMA-A11	ENSG00000253873	"Protocadherin gamma subfamily A, 11"	Q9Y5H2	5	141421047-141512979	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.9;ASC TERT1: 16.1;HSkMC: 11.5;REH: 9.6;SK-MEL-30: 12.4;WM-115: 25.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.13e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.89e-1)"	3.4	2.5	7.4	2.8	9.4	0.5	2.1	4.1	8.5	2.4	2.5	8.5	0.0	1.2	2.6	1.7	3.1	2.1	2.1	3.4	11.6	1.9	1.9	1.2	2.3	1.8	4.5	5.2	3.8	2.3	1.3	1.9	8.3	5.0	2.5	1.5	3.3	2.8	3.4	2.8	6.6	1.2	3.3	4.9	1.6	1.8	2.2	7.1	0.1	3.4	0.6	1.7	1.7	2.2	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.4	14.9	16.1	0.5	3.2	6.2	2.5	4.0	0.0	0.1	0.3	5.4	3.2	2.1	0.1	0.3	4.0	0.1	1.4	0.0	0.0	0.0	2.5	0.2	0.0	11.5	0.1	4.4	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	9.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.4	0.3	1.8	4.5	0.5	0.1	0.4	0.0	0.0	0.2	0.0	0.1	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	7.4	9.4	4.1	8.5	11.6	1.9	4.5	5.2	5.0	7.1
PCDHGA12	"CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12"	ENSG00000253159	"Protocadherin gamma subfamily A, 12"	O60330	5	141430589-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.9"	"Cell line enhanced"	"Detected in some"		"BJ: 7.6;BJ hTERT+: 12.6;fHDF/TERT166: 18.7;HHSteC: 6.1;HSkMC: 14.0;TIME: 6.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Low lineage specificity"	"Detected in many"											"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.17e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.65e-4)"	"unprognostic (2.98e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.28e-4)"	"unprognostic (8.30e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.85e-3)"	5.1	12.7	14.8	2.8	18.9	0.7	2.4	4.7	13.8	4.9	1.8	8.6	0.6	1.4	5.4	2.3	3.5	2.7	11.3	6.5	15.7	5.6	3.1	2.8	6.5	1.6	4.7	7.3	6.2	3.6	2.0	2.7	6.5	8.4	3.5	1.7	3.4	1.7	4.9	1.9	5.1	1.5	5.3	8.4	3.7	2.2	1.6	12.4	0.4	3.0	0.6	1.7	4.5	3.6	3.7	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.6	1.2	0.1	7.6	12.6	0.0	0.0	0.0	0.0	0.4	0.0	18.7	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.0	14.0	0.0	3.7	0.0	4.4	0.0	0.0	2.6	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	6.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	14.8	18.9	4.7	10.4	15.7	5.6	4.7	7.3	8.4	12.4
PCDHGA2	PCDH-GAMMA-A2	ENSG00000081853	"Protocadherin gamma subfamily A, 2"	Q9Y5H1	5	141338760-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.9;BJ: 5.4;fHDF/TERT166: 6.4;HSkMC: 5.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA038625"	Approved		Approved	"Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA038625: "	"unprognostic (2.43e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.23e-4)"	5.1	4.3	6.7	2.1	8.0	0.6	4.2	5.2	12.6	6.6	2.6	4.6	1.0	0.9	6.5	5.7	2.4	5.5	5.5	11.1	6.5	4.6	3.3	2.4	4.6	1.1	6.0	2.3	15.3	8.4	9.2	10.6	2.2	7.8	5.3	1.4	13.8	3.3	5.8	2.6	2.9	1.4	5.2	5.6	1.9	2.1	10.4	3.5	0.0	4.3	1.2	1.1	3.2	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.3	3.9	9.9	0.1	5.4	2.1	0.5	0.9	0.1	0.1	0.1	0.7	6.4	0.2	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	5.1	0.2	0.1	0.3	2.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	1.4	0.3	0.2	0.8	0.0	0.3	0.7	0.0	3.6	0.1	0.7	0.0	3.3	0.9	0.5	0.3	0.1	0.0	0.4	0.0	2.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	8.0	5.2	7.2	6.5	4.6	6.0	2.3	7.8	3.5
PCDHGA3	PCDH-GAMMA-A3	ENSG00000254245	"Protocadherin gamma subfamily A, 3"	Q9Y5H0	5	141343829-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"AF22: 11.0;BJ: 3.6;EFO-21: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (6.47e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.12e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.52e-4)"	4.0	4.5	11.7	1.4	10.5	0.7	2.5	6.9	13.7	4.7	1.3	7.9	0.0	0.7	4.5	3.5	1.5	2.9	3.5	12.2	8.5	5.8	2.5	2.5	2.6	1.0	6.6	7.7	8.6	3.6	1.8	6.3	5.7	8.7	3.0	1.3	4.6	2.9	3.2	1.5	1.9	1.1	3.6	6.0	1.5	1.2	5.2	3.8	0.0	3.3	1.3	1.0	1.7	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.1	0.2	1.5	0.0	3.6	0.3	0.0	0.1	0.0	0.0	0.1	8.9	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.4	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	10.5	6.9	13.7	8.5	5.8	6.6	7.7	8.7	3.8
PCDHGA4	PCDH-GAMMA-A4	ENSG00000262576	"Protocadherin gamma subfamily A, 4"	Q9Y5G9	5	141355025-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.2;BJ: 5.6;HSkMC: 5.9;HUVEC TERT2: 5.6;U-87 MG: 8.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 1.9"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.27e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.00e-2)"	"unprognostic (6.54e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.31e-4)"	5.4	4.7	6.5	1.8	8.3	0.5	3.0	8.5	11.2	4.8	2.0	10.4	1.5	1.2	5.0	3.0	1.9	3.4	3.1	4.8	6.3	5.9	2.0	2.7	3.6	0.9	5.6	8.1	5.8	6.7	8.5	3.4	2.8	6.1	4.1	1.4	3.5	4.3	4.2	1.5	1.8	1.2	5.0	5.9	1.3	1.4	2.7	4.0	0.0	2.6	2.7	0.9	2.3	2.5	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	1.0	0.6	4.5	10.2	0.0	5.6	4.5	0.3	1.1	0.0	0.1	0.9	1.9	4.7	0.1	0.1	0.2	0.6	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.4	5.9	0.2	0.1	0.0	5.6	0.2	0.3	2.4	0.8	0.3	0.2	0.2	0.2	0.3	1.6	0.1	0.3	0.0	0.8	1.7	0.2	0.3	1.1	2.1	0.0	3.6	2.4	0.7	3.1	0.4	0.2	0.3	0.2	8.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	8.3	8.5	9.3	6.3	5.9	5.6	8.1	6.1	4.0
PCDHGA5	"CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5"	ENSG00000253485	"Protocadherin gamma subfamily A, 5"	Q9Y5G8	5	141364232-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 19.1"	"Group enriched"	"Detected in some"	7	"ASC diff: 18.4;ASC TERT1: 7.3"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.61e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.83e-1)"	"unprognostic (6.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.38e-4)"	4.0	2.7	6.1	1.8	9.1	0.9	3.9	19.1	9.6	9.0	2.7	7.7	4.1	1.0	7.6	3.2	3.3	4.7	4.5	4.9	6.9	4.0	1.5	1.2	3.3	1.3	3.2	3.8	6.6	1.7	3.3	3.7	2.7	4.6	5.6	1.6	4.1	2.5	4.0	1.5	3.0	1.5	4.3	6.3	1.4	1.7	1.7	3.7	0.0	1.8	0.9	1.0	2.5	4.2	0.9	0.8	1.6	0.6	1.9	0.7	0.2	0.0	0.4	0.3	0.1	18.4	7.3	0.0	0.8	0.1	0.1	0.3	0.0	0.0	0.8	0.3	0.3	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.1	1.8	0.2	0.0	0.0	0.6	0.1	0.6	0.7	0.3	0.5	0.7	0.1	0.3	0.9	0.6	0.1	0.0	0.0	0.2	0.3	0.1	0.3	0.3	1.6	0.0	1.0	0.6	0.2	1.0	0.7	0.1	1.0	0.1	0.3	0.2	0.7	1.5	0.6	0.6	0.7	0.3	0.3	0.6	0.6	0.4	0.1	0.9	0.7	0.7	1.6	1.9	0.2	0.8	0.4	0.2	6.1	9.1	19.1	9.6	6.9	4.0	3.2	3.8	4.6	3.7
PCDHGA6	PCDH-GAMMA-A6	ENSG00000253731	"Protocadherin gamma subfamily A, 6"	Q9Y5G7	5	141373914-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.6"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 11.0;T-47d: 6.4;WM-115: 13.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (4.49e-2)"	"unprognostic (8.91e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.86e-3)"	"unprognostic (2.02e-2)"	"unprognostic (5.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.19e-3)"	4.1	3.8	6.1	2.3	8.4	0.8	2.9	19.6	10.8	7.9	3.4	8.3	2.9	1.0	6.9	4.7	2.6	4.3	3.6	3.7	5.0	4.3	2.8	1.7	3.3	1.4	2.9	4.7	9.7	2.5	2.5	4.5	6.9	3.3	4.0	1.6	5.8	4.1	5.3	2.1	4.7	1.5	6.1	2.8	2.8	1.7	2.2	2.9	0.2	3.8	1.2	1.5	4.6	3.6	1.3	0.7	2.8	0.6	0.5	0.8	0.2	0.1	0.3	3.1	0.5	1.5	5.3	0.1	2.3	0.8	1.2	1.2	0.0	0.2	2.1	3.0	3.6	0.5	0.1	0.5	0.8	0.0	0.3	0.0	0.3	0.3	0.8	0.1	0.1	5.7	0.4	0.3	0.1	1.8	0.3	1.3	0.4	0.5	0.7	1.8	0.3	0.1	1.5	0.4	0.0	0.4	0.1	11.0	0.9	0.1	0.3	0.7	6.4	0.1	5.4	0.9	0.4	0.8	0.8	0.4	1.8	0.4	0.9	0.7	13.7	1.8	0.6	0.3	0.8	0.3	0.3	0.8	0.6	0.2	0.1	1.3	0.3	0.5	2.8	0.5	0.3	0.7	0.5	0.2	6.1	8.4	19.6	10.8	5.0	4.3	2.9	4.7	3.3	2.9
PCDHGA7	PCDH-GAMMA-A7	ENSG00000253537	"Protocadherin gamma subfamily A, 7"	Q9Y5G6	5	141382739-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.9;BJ hTERT+: 17.3;SH-SY5Y: 15.5;T-47d: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.00e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.42e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.21e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.42e-3)"	1.7	2.0	3.1	1.3	9.0	0.6	2.1	5.3	14.9	3.5	3.0	7.1	2.1	1.0	4.2	4.1	2.2	3.3	1.9	3.0	5.1	3.3	3.2	1.9	2.2	1.0	5.1	6.6	4.7	2.5	4.6	3.4	4.8	5.4	3.7	1.5	5.8	2.6	3.3	1.6	3.8	1.2	3.0	6.3	1.3	1.4	2.1	5.1	0.0	6.6	1.5	1.0	2.4	2.5	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	1.9	0.0	5.8	9.9	0.0	2.6	17.3	3.5	5.2	0.0	0.0	0.4	4.3	0.5	0.1	0.0	0.1	2.9	0.0	0.3	0.0	0.4	0.1	1.0	0.0	0.0	4.3	0.1	0.0	0.6	1.4	0.0	0.1	0.0	0.1	0.5	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	15.5	0.0	0.1	0.1	6.8	0.0	5.2	0.1	0.1	2.5	0.0	0.1	1.5	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	9.0	5.3	7.7	5.1	3.3	5.1	6.6	5.4	5.1
PCDHGA8	"KIAA0327, PCDH-GAMMA-A8"	ENSG00000253767	"Protocadherin gamma subfamily A, 8"	Q9Y5G5	5	141390157-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 7.1"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 2.9;neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.28e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.10e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.59e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.99e-3)"	0.6	0.7	0.8	0.7	0.6	2.5	0.7	2.3	2.2	1.2	1.2	1.0	7.1	0.4	2.3	1.5	2.1	0.7	0.9	2.0	1.4	0.5	0.5	0.9	1.1	0.7	0.5	0.4	2.6	0.6	0.2	1.9	1.4	3.5	0.9	0.8	0.4	0.8	0.5	2.2	2.5	1.1	0.7	1.6	0.7	0.7	1.0	1.3	1.1	2.4	0.4	0.6	0.6	1.2	0.7	0.4	2.9	0.4	0.5	0.3	0.1	0.3	0.2	1.1	0.6	1.1	2.6	0.6	2.4	1.6	1.7	0.7	0.2	0.4	1.1	1.0	1.8	0.4	0.0	0.0	1.3	0.3	0.2	0.3	0.5	0.3	0.1	0.4	0.8	1.4	0.1	0.5	0.1	0.4	0.2	0.9	0.2	0.2	0.5	0.7	2.7	0.1	1.0	0.2	0.1	0.1	0.3	0.7	0.7	0.3	0.9	0.4	1.2	1.7	2.5	2.6	0.9	0.6	0.2	0.3	0.3	0.4	1.3	0.4	1.3	2.9	0.4	0.5	0.3	0.2	0.2	0.4	0.3	0.2	0.1	0.7	0.2	0.3	2.8	0.5	0.3	0.4	0.2	0.1	0.8	0.6	2.3	2.2	1.4	0.5	0.5	0.4	3.5	1.3
PCDHGA9	PCDH-GAMMA-A9	ENSG00000261934	"Protocadherin gamma subfamily A, 9"	Q9Y5G4	5	141402932-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.9;HSkMC: 6.6;TIME: 7.2;U-87 MG: 8.3"	"Cancer enhanced"	"Detected in some"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.98e-2)"	"unprognostic (7.47e-3)"	"unprognostic (9.86e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-2)"	5.6	5.4	12.0	2.6	12.6	0.9	3.7	11.5	17.3	6.9	2.7	11.2	0.1	2.1	7.6	3.9	4.8	6.3	6.5	3.2	10.3	8.5	3.0	2.8	5.0	2.1	9.6	7.1	9.1	3.0	3.8	3.0	3.6	10.9	5.2	2.7	7.7	3.8	7.3	1.9	5.5	2.0	5.9	13.0	3.6	2.9	2.0	5.9	0.0	4.6	1.4	2.5	4.8	3.7	0.5	0.3	1.0	0.5	0.2	1.0	0.0	0.0	0.3	1.0	2.5	0.2	0.5	0.4	1.2	0.0	1.0	1.1	0.4	0.6	2.0	5.9	3.1	0.1	0.2	0.3	1.1	0.1	0.5	0.0	0.2	0.0	1.8	0.1	0.4	6.6	0.3	0.6	0.5	1.6	0.1	0.3	0.5	0.6	0.3	0.7	0.3	0.1	0.3	0.7	0.0	0.3	0.3	0.7	1.8	0.6	0.1	0.8	1.5	0.7	7.2	0.5	0.5	0.1	3.9	0.3	0.1	0.1	8.3	0.2	1.4	1.0	0.5	0.3	1.0	0.3	0.6	0.3	0.4	0.2	0.1	0.5	0.4	0.7	1.0	0.2	0.2	0.3	0.1	0.0	12.0	12.6	11.5	16.2	10.3	8.5	9.6	7.1	10.9	5.9
PCDHGB1	PCDH-GAMMA-B1	ENSG00000254221	"Protocadherin gamma subfamily B, 1"	Q9Y5G3	5	141350102-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 32.2;pituitary gland: 13.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.9;ASC TERT1: 7.7;T-47d: 9.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA076182"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody"				"Vesicles, Plasma membrane"	"Nucleoplasm, Focal adhesion sites, Midbody"	"HPA008755: AB_1079577, HPA010580: , HPA076182: "	"unprognostic (1.53e-2)"	"unprognostic (1.94e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.37e-1)"	"unprognostic (9.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.78e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.63e-3)"	2.3	2.7	8.2	1.4	7.5	1.0	2.1	4.3	32.2	2.5	1.4	9.4	0.1	1.2	3.7	2.0	1.7	1.9	2.1	2.2	7.6	5.7	2.1	1.3	2.4	1.2	5.5	5.0	4.1	2.8	1.4	13.7	1.6	7.0	2.5	1.4	2.6	1.7	3.1	1.1	1.4	1.3	3.0	6.9	1.4	1.2	1.5	5.6	0.0	2.5	0.0	1.2	1.4	1.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	2.1	1.8	0.0	14.9	7.7	0.1	1.4	3.6	0.5	0.8	0.2	0.5	0.5	4.7	0.5	0.6	0.4	0.2	0.5	0.0	0.9	0.0	0.2	1.3	0.2	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.2	0.2	3.3	1.9	0.4	0.3	0.2	0.0	0.0	2.8	0.1	0.0	0.0	1.1	0.8	0.0	0.9	0.1	9.6	0.0	1.1	0.2	1.6	1.2	0.0	0.0	2.6	0.3	2.9	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	7.5	4.3	9.6	7.6	5.7	5.5	5.0	7.0	5.6
PCDHGB2	PCDH-GAMMA-B2	ENSG00000253910	"Protocadherin gamma subfamily B, 2"	Q9Y5G2	5	141360042-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.4;ASC TERT1: 10.5;LHCN-M2: 8.5;REH: 7.8"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077526"	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane, Cytosol"	Nucleoplasm	"HPA008755: AB_1079577, HPA010580: , HPA077526: "	"unprognostic (7.14e-3)"	"unprognostic (8.79e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (8.67e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.59e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.36e-4)"	4.9	3.6	11.3	2.2	9.7	0.9	3.7	8.7	12.2	7.2	2.4	11.6	0.3	1.2	9.2	3.2	3.2	5.6	6.2	4.6	9.3	7.0	2.7	2.7	5.4	1.4	7.0	8.6	9.0	2.6	7.5	3.0	3.9	7.3	4.4	2.8	3.1	2.4	4.4	1.9	2.9	2.1	5.0	7.0	2.2	2.0	1.8	7.8	0.1	2.6	1.3	1.4	2.8	3.3	0.9	0.9	0.5	0.0	0.0	0.7	0.0	0.1	0.3	2.1	0.2	14.4	10.5	0.1	2.2	3.0	0.6	3.4	0.0	0.3	3.8	1.0	1.7	0.5	0.5	0.3	1.0	0.0	0.2	0.0	0.3	0.4	0.6	0.2	0.2	2.7	0.5	0.2	0.1	1.7	0.2	1.2	8.5	0.4	2.9	0.6	0.1	0.9	7.8	2.7	0.2	0.2	0.3	1.6	1.7	0.2	0.4	0.4	3.1	0.2	6.0	3.0	0.7	4.6	3.9	0.2	2.2	0.7	3.3	1.0	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.4	0.0	0.0	0.4	0.0	0.6	0.5	0.0	0.0	0.9	0.0	0.0	11.3	9.7	8.7	10.6	9.3	7.0	7.0	8.6	7.3	7.8
PCDHGB4	"CDH20, FIB2, PCDH-GAMMA-B4"	ENSG00000253953	"Protocadherin gamma subfamily B, 4"	Q9UN71	5	141387698-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 28.5;TIME: 14.3"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	7	"NK-cell: 1.6"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.33e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.27e-2)"	2.4	2.2	2.4	0.7	4.2	0.0	1.2	1.8	2.1	2.6	1.4			0.2	3.2	3.5	1.1	2.1	0.8	2.8	2.3	4.1	2.9	3.3	2.1	0.0	1.8		5.1	1.9	3.0	2.5	6.2		2.6	0.7		3.0	3.1	1.2	3.4	0.3	1.9	2.0	0.6	0.4	0.9			3.6		0.2	1.6	2.0	0.0	0.2	0.0	0.0	1.6	0.2	0.2	0.0	0.7	7.0	0.0	4.6	5.9	0.8	6.8	28.5	2.8	1.9	0.0	0.0	0.2	5.5	0.2	2.0	0.0	0.0	3.2	0.0	0.0	0.0	0.1	1.6	1.8	0.0	0.0	5.7	0.0	2.7	0.0	4.3	0.2	0.0	0.0	0.0	0.6	0.1	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	3.6	2.6	14.3	3.8	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2										
PCDHGB5	PCDH-GAMMA-B5	ENSG00000276547	"Protocadherin gamma subfamily B, 5"	Q9Y5G0	5	141397987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 11.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 32.2;ASC TERT1: 24.3;BJ hTERT+ SV40 Large T+: 13.9;BJ hTERT+ SV40 Large T+ RasG12V: 15.6"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (2.71e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.69e-4)"	"unprognostic (9.63e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.25e-4)"	2.1	1.9	0.8	0.3	3.2	0.0	3.6	2.0	4.3	1.4	0.4	2.5	1.9	0.0	2.1	2.5	1.1	2.1	0.8	1.9	0.0		1.6	3.1	6.8	2.6	0.9	1.5	4.9	2.8	11.2	2.1	9.5	1.5	2.2	0.2	3.7	3.2	3.2	1.4	2.6	0.0	1.9	3.0	0.5	0.7	1.0	2.2	0.8	3.5	0.0	0.7	1.9	1.4	0.5	0.2	0.0	0.3	0.0	1.9	0.1	0.0	1.1	0.1	0.0	32.2	24.3	0.6	8.5	0.0	13.9	15.6	1.3	4.6	4.8	11.1	9.4	6.4	0.0	3.5	7.8	0.0	1.4	0.0	0.0	0.0	3.3	0.0	3.1	8.5	0.7	0.8	4.5	4.2	0.1	0.0	0.4	3.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.8	2.5	0.0	0.0	0.0	0.0	0.0	9.0	0.0	4.3	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.3	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.1										
PCDHGB6	PCDH-GAMMA-B6	ENSG00000253305	"Protocadherin gamma subfamily B, 6"	Q9Y5F9	5	141408021-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 26.6"	"Cell line enhanced"	"Detected in some"		"AF22: 18.2;EFO-21: 6.2;HSkMC: 4.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.71e-4)"	6.7	7.2	8.8	2.6	9.9	1.6	4.4	6.1	26.6	5.8	4.1	10.1	0.3	1.8	7.2	5.7	3.0	5.1	4.4	4.6	8.9	5.7	3.2	9.4	4.4	2.2	6.9	4.4	13.3	5.2	16.1	4.7	6.8	5.9	4.0	2.3	9.0	5.3	5.9	5.7	4.7	2.2	4.8	4.1	4.0	2.5	2.1	6.7	0.3	6.1	1.9	2.1	4.2	5.1	0.8	0.5	3.2	0.4	0.5	0.9	0.2	0.0	0.1	18.2	0.1	0.6	0.7	0.9	1.6	0.0	0.4	1.0	0.2	0.2	1.5	6.2	1.0	0.3	0.0	0.3	1.2	0.0	0.3	0.0	0.2	0.1	1.5	0.1	0.1	4.2	2.0	0.9	0.1	0.6	0.1	0.3	0.1	0.3	0.1	1.2	0.8	0.0	0.2	0.1	0.1	2.9	0.2	0.2	0.3	0.0	0.1	0.1	1.4	0.4	2.9	0.1	0.3	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.8	1.1	0.4	0.2	0.9	0.3	0.2	0.6	0.4	0.2	0.1	0.8	0.4	0.3	3.2	0.5	0.3	0.5	0.2	0.2	8.8	9.9	6.1	7.9	8.9	5.7	6.9	4.4	5.9	6.7
PCDHGB7	"ME6, PCDH-GAMMA-B7"	ENSG00000254122	"Protocadherin gamma subfamily B, 7"	Q9Y5F8	5	141417645-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"AN3-CA: 42.5;HSkMC: 13.5"	"Cancer enhanced"	"Detected in many"		"glioma: 7.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (1.22e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.68e-2)"	10.1	9.8	12.6	3.8	13.5	0.8	8.0	19.1	12.9	10.2	7.0	16.1	1.2	2.3	11.6	5.0	6.8	7.8	9.2	8.5	14.5	7.9	5.4	3.5	11.6	2.6	10.4	7.3	17.3	5.5	9.5	5.3	11.0	9.4	8.3	3.8	15.5	7.1	12.0	5.6	6.8	3.2	10.5	20.1	5.3	4.5	4.2	14.3	0.6	8.4	3.0	2.3	4.6	6.9	0.2	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	42.5	1.0	0.2	0.4	2.8	0.3	1.0	2.1	0.0	2.6	0.3	2.3	5.6	0.7	0.1	0.5	1.0	0.0	0.3	0.0	0.0	0.0	3.2	0.2	0.0	13.5	0.3	0.8	0.4	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	4.7	0.9	0.0	0.1	0.0	4.6	6.3	0.1	0.0	0.0	0.4	0.4	5.5	5.1	0.1	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	12.6	13.5	19.1	12.9	14.5	7.9	10.4	7.3	9.4	14.3
PCDHGC4	PCDH-GAMMA-C4	ENSG00000242419	"Protocadherin gamma subfamily C, 4"	Q9Y5F7	5	141484997-141512979	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 23.6"	"Cell line enhanced"	"Detected in some"		"REH: 9.7;SCLC-21H: 8.2;SH-SY5Y: 15.9"	"Cancer enriched"	"Detected in single"	10	"glioma: 4.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (6.05e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.20e-4)"	"unprognostic (8.78e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.75e-2)"	0.7	2.9	5.7	0.7	9.5	0.5	0.8	23.6	21.9	1.0	1.1	2.3	0.0	0.6	0.9	1.2	0.8	1.0	1.0	1.3	4.1	10.1	0.6	0.6	1.0	0.9	3.3	4.5	0.8	1.2	0.8	1.3	0.8	8.6	0.8	0.8	1.9	1.0	0.7	1.2	1.5	0.7	0.9	2.3	0.8	0.7	1.5	0.8	0.0	0.7	0.0	1.0	0.6	0.2	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.2	0.2	0.8	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.3	0.9	0.9	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.0	1.5	0.0	9.7	0.6	0.0	0.0	0.1	8.2	15.9	0.1	0.0	0.2	0.1	0.3	0.1	0.9	0.1	0.2	0.7	0.2	0.0	0.2	0.6	0.1	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	9.5	23.6	15.6	4.1	10.1	3.3	4.5	8.6	0.8
PCDHGC5	PCDH-GAMMA-C5	ENSG00000240764	"Protocadherin gamma subfamily C, 5"	Q9Y5F6	5	141489121-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 43.7"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 16.3;U-251 MG: 7.0;U-87 MG: 10.0"	"Group enriched"	"Detected in some"	13	"glioma: 3.1;head and neck cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4"					"HPA008755, HPA010580, HPA076140"	Supported		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA076140: "	"unprognostic (2.86e-3)"	"unprognostic (7.63e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.52e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-9)"	"unprognostic (6.87e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.77e-3)"	1.0	1.1	7.4	1.1	34.5	0.9	1.1	3.0	43.7	1.1	1.0	2.8	0.0	0.9	1.4	1.3	1.0	1.2	1.2	2.8	11.8	2.8	0.9	0.9	1.1	0.9	2.2	10.0	1.1	1.0	1.0	1.1	1.0	2.3	1.3	1.0	0.0	0.9	1.6	1.6	1.5	0.9	2.0	0.8	1.0	1.0	1.3	1.1	0.0	1.0	0.0	1.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	1.7	0.2	0.8	0.6	0.5	0.6	0.0	0.0	0.5	1.6	2.4	0.1	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.9	0.8	0.3	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.2	0.1	16.3	0.2	0.2	7.0	0.0	0.0	0.0	10.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	34.5	3.0	39.2	11.8	2.8	2.2	10.0	2.3	1.1
PCMTD2	"C20orf36, FLJ10883"	ENSG00000203880	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2"	Q9NV79	20	64255695-64287821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057849	Approved		Approved	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA057849: "	"unprognostic (2.41e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.59e-1)"	"prognostic favourable (2.13e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.40e-2)"	"prognostic favourable (3.82e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.05e-3)"	18.5	22.6	24.2	28.9	24.9	9.7	32.4	49.7	27.3	20.1	14.9	21.1	19.2	14.9	26.0	33.5	15.2	17.2	21.2	26.2	19.8	20.2	22.9	20.2	20.0	25.6	18.5	22.8	38.9	18.1	20.4	21.8	26.3	18.0	19.9	13.6	57.8	20.5	16.9	25.7	42.1	15.7	17.3	19.6	22.1	13.7	17.0	18.2	31.2	19.5	10.5	18.5	17.7	18.1	9.5	7.5	8.3	6.6	14.1	18.1	7.9	10.9	4.0	16.0	12.4	15.4	19.2	15.3	6.8	7.5	9.9	6.1	9.5	17.7	16.5	12.1	8.1	13.6	8.7	11.0	13.4	3.5	11.9	7.9	18.0	15.8	13.0	8.2	12.2	27.1	15.3	5.2	9.1	14.4	14.6	14.9	8.1	7.1	18.8	27.2	11.7	17.0	15.8	6.3	19.6	15.1	12.7	25.4	30.0	13.0	15.0	17.6	16.0	16.5	10.4	14.9	5.3	9.5	5.4	18.1	14.6	15.9	9.9	8.7	8.7	7.6	6.6	7.6	8.4	4.5	10.0	8.9	12.5	9.5	7.5	9.5	17.7	12.7	8.3	14.1	4.1	4.7	18.1	7.9	24.2	24.9	49.7	27.3	19.8	20.2	18.5	22.8	18.0	18.2
PCNX2	"FLJ11383, KIAA0435, PCNXL2"	ENSG00000135749	"Pecanex homolog 2"	A6NKB5	1	232983435-233295713	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 29.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013815, HPA014427"	Uncertain		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA013815: AB_2236561, HPA014427: AB_1855081"	"unprognostic (3.15e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (2.27e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.29e-1)"	4.7	4.7	11.4	7.5	16.8	4.2	7.7	29.6	23.1	4.9	3.9	6.3	4.2	3.4	6.6	14.0	5.2	9.0	8.1	2.3	11.9	8.2	5.4	1.2	4.7	9.4	8.0	13.1	11.4	5.2	8.6	18.6	2.4	14.3	6.2	4.8	6.0	6.0	8.1	5.6	6.3	5.6	5.2	5.8	5.3	5.8	5.5	5.5	4.0	7.9	3.4	8.8	6.0	5.7	1.5	1.8	0.9	0.9	0.8	3.1	1.1	3.8	9.2	5.1	0.1	8.3	9.0	1.5	2.3	6.7	2.4	4.2	3.0	4.6	8.0	5.4	6.2	6.3	2.2	6.6	5.7	6.7	6.8	0.1	4.7	0.0	3.7	2.6	1.6	6.9	5.8	4.7	18.9	4.5	0.0	4.3	2.3	2.3	7.3	0.2	16.3	5.6	0.1	1.3	1.1	4.3	5.9	8.7	7.2	3.4	1.4	1.4	3.4	0.7	1.7	6.7	4.3	7.6	7.5	5.2	5.3	0.1	6.1	2.9	7.7	0.9	0.9	0.4	3.1	0.5	2.4	1.5	2.5	2.9	1.8	1.3	1.1	2.1	0.7	0.8	0.7	0.6	2.7	1.1	11.4	16.8	29.6	23.1	11.9	8.2	8.0	13.1	14.3	5.5
PDE1A		ENSG00000115252	"Phosphodiesterase 1A"	P54750	2	182140036-182523192	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 66.0;kidney: 37.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 22.3;HHSteC: 13.2;HSkMC: 28.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"amygdala: 118.0;basal ganglia: 76.2;cerebral cortex: 161.5;hippocampal formation: 155.8;hypothalamus: 47.8"	"Low region specificity"	"Detected in many"			HPA022151	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA022151: AB_1855118"	"unprognostic (3.63e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.55e-3)"	"unprognostic (2.50e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.40e-3)"	7.6	3.9	13.8	3.6	11.5	0.5	4.1	66.0	25.3	11.5	8.8	6.2	1.7	2.6	7.3	6.7	4.7	7.4	18.2	11.8	12.6	4.1	37.1	3.2	3.1	1.8	7.1	15.7	9.2	2.0	1.3	2.3	1.3	6.9	3.8	5.6	3.0	1.8	4.8	2.4	2.1	4.6	11.8	10.1	2.6	4.6	24.6	9.0	0.0	35.1	2.6	1.1	8.3	9.0	0.0	1.4	0.8	0.2	0.0	0.0	0.0	0.0	0.1	2.2	0.0	22.3	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	3.1	0.0	13.2	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	4.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	3.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	13.8	11.5	66.0	25.3	12.6	4.1	7.1	15.7	6.9	9.0
PDP2	"KIAA1348, PPM2B, PPM2C2"	ENSG00000172840	"Pyruvate dehyrogenase phosphatase catalytic subunit 2"	Q9P2J9	16	66878589-66895754	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019950, HPA062059"	Approved		Supported	Mitochondria				Mitochondria		"HPA019950: AB_1855156, HPA062059: "	"unprognostic (8.42e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.90e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.39e-1)"	"prognostic favourable (9.75e-7)"	"unprognostic (1.89e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.15e-2)"	10.7	7.2	7.4	3.7	10.5	3.2	8.7	11.5	16.5	4.9	7.5	10.1	5.7	10.4	7.9	7.2	8.9	7.2	6.0	4.8	7.4	7.1	18.1	16.5	8.6	5.0	9.0	9.4	14.9	13.8	12.0	7.0	7.7	16.0	7.8	8.4	8.5	7.1	6.9	6.3	4.7	6.2	4.6	6.3	4.0	6.7	8.6	8.9	4.6	18.0	4.0	5.9	6.3	5.5	3.3	1.3	1.8	0.4	6.1	6.3	2.0	7.2	8.8	5.5	10.7	14.7	7.6	6.9	3.7	14.7	8.8	13.2	17.9	5.1	10.0	5.4	5.3	9.1	15.8	8.5	8.5	2.3	8.0	5.0	4.4	11.6	8.0	6.4	8.9	5.7	6.4	12.4	12.9	3.7	9.6	7.2	7.8	4.7	12.5	4.6	6.4	11.2	12.3	7.6	15.8	4.6	7.7	11.0	6.2	12.1	5.0	4.5	6.6	3.1	3.5	5.4	7.3	3.2	5.5	12.8	11.8	10.0	7.4	5.1	5.3	1.3	0.4	1.8	6.3	0.3	5.2	1.8	3.1	5.1	1.3	3.3	4.5	5.0	1.3	6.1	0.2	0.8	0.9	2.0	7.4	10.5	11.5	16.5	7.4	7.1	9.0	9.4	16.0	8.9
PDZRN4	"DKFZp434B0417, FLJ33777, IMAGE5767589, LNX4"	ENSG00000165966	"PDZ domain containing ring finger 4"	Q6ZMN7	12	41188448-41574590	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 18.3;seminal vesicle: 20.8"	"Cell line enriched"	"Detected in some"	9	"U-266/70: 8.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA042101	Enhanced									"HPA042101: "	"unprognostic (6.74e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.19e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.80e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.41e-3)"	1.6	1.3	2.4	5.0	1.8	0.1	2.6	2.7	3.7	3.1	13.9	1.0	13.8	1.3	1.1	18.3	4.1	3.4	3.0	0.5	2.1	2.1	0.8	0.9	0.5	0.1	1.8	2.4	3.3	0.8	0.3	0.7	4.5	2.5	8.3	4.0	4.8	0.6	20.8	0.6	0.8	4.2	17.2	5.0	0.4	5.9	4.1	2.0	0.0	0.5	0.5	0.5	7.3	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.8	2.7	3.3	2.1	2.1	1.8	2.4	2.5	2.0
PEAK3	"C19orf35, FLJ45778"	ENSG00000188305	"PEAK family member 3"	Q6ZS72	19	2274622-2282176	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.5;lymphoid tissue: 19.1"	"Cell line enriched"	"Detected in some"	10	"HMC-1: 16.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 24.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 24.5"					"Group enriched"	"Detected in some"	5	"basal ganglia: 6.4;cerebellum: 6.0"	HPA057806	Uncertain									"HPA057806: "	"unprognostic (9.42e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.27e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.40e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.90e-1)"	1.9	1.3	1.4	4.7	3.3	8.2	0.9	0.8	2.0	1.3	1.7	2.1	0.1	1.1	0.7	1.0	0.8	1.6	0.9	2.1	2.0	0.9	3.8	2.0	4.4	14.3	3.3	0.9	1.0	0.8	0.6	1.2	0.8	2.3	1.0	1.1	0.7	0.8	0.6	1.5	1.0	2.5	0.9	4.0	19.1	1.1	0.6	1.7	0.6	0.8	0.0	2.7	0.9	1.9	0.2	1.1	24.5	3.4	2.8	1.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.1	0.2	0.5	0.1	16.5	0.1	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	5.3	2.7	6.6	1.0	3.4	0.1	0.1	0.1	0.1	1.1	0.2	0.0	0.2	24.5	2.8	1.1	0.1	0.0	0.5	1.4	3.3	0.8	2.0	2.0	0.9	3.3	0.9	2.3	1.7
PERM1	"C1orf170, MGC13275, Perm1, RP11-54O7.8"	ENSG00000187642	"PPARGC1 and ESRR induced regulator, muscle 1"	Q5SV97	1	975204-982093	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"heart muscle: 23.8;skeletal muscle: 68.1;tongue: 24.7"	"Cell line enhanced"	"Detected in some"		"A-431: 2.4;HaCaT: 4.4;MCF7: 3.0;SK-BR-3: 4.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA031711, HPA031712"	Enhanced									"HPA031711: AB_10669636, HPA031712: "	"unprognostic (3.67e-2)"	"unprognostic (5.72e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.58e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.96e-2)"	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.0	1.1	0.0	0.0	23.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.9	0.0	68.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	24.7	0.9	0.1	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.4	0.1	0.0	0.2	0.0	0.0	0.3	1.6	0.0	0.0	0.0	1.4	1.5	0.0	0.5	0.0	4.4	0.0	0.0	0.0	1.4	0.5	0.0	1.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	3.0	0.0	0.0	0.0	1.1	0.0	0.0	1.7	0.0	0.9	0.0	0.1	1.3	4.6	1.0	0.4	0.0	0.9	0.7	0.9	0.0	0.7	0.5	0.0	0.0	1.8	0.4	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PERP	"dJ496H19.1, KCP1, KRTCAP1, PIGPC1, THW"	ENSG00000112378	"PERP, TP53 apoptosis effector"	Q96FX8	6	138088505-138107511	"Predicted membrane proteins"	"Apoptosis, Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 250.2;skin 1: 157.9;tongue: 230.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 37.2;hTCEpi: 139.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 21.3"	"Group enriched"	"Detected in many"	9	"granulocytes: 21.3;T-cells: 5.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA022269	Enhanced									"HPA022269: AB_1855219"	"prognostic unfavourable (5.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-3)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (4.02e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.51e-2)"	4.2	1.6	1.0	2.7	1.2	0.0	25.5	1.3	0.9	51.9	12.5	0.5	7.1	6.3	6.4	11.7	250.2	7.7	15.6	14.7	1.2	1.5	4.4	28.0	8.4	1.7	1.3	0.3	3.3	11.5	5.0	3.3	31.5	1.6	17.5	5.0	2.4	46.6	7.9	1.4	157.9	23.4	7.1	1.3	0.6	8.4	1.9	0.6	6.7	8.7	230.6	113.6	14.0	57.8	1.4	0.0	21.3	0.0	0.0	5.6	0.8	10.0	11.3	0.0	1.1	7.9	8.4	23.6	16.4	18.5	2.3	1.7	9.2	20.8	0.0	5.9	4.1	37.2	2.0	29.6	0.5	15.8	9.2	0.0	11.3	8.7	5.7	0.0	0.0	6.3	139.5	0.2	15.2	9.2	0.1	4.4	0.2	6.9	0.0	0.5	4.8	6.0	0.0	3.7	0.0	15.8	11.7	3.9	0.0	17.3	9.3	7.9	5.2	2.0	11.0	4.1	1.6	4.4	0.0	1.3	1.7	0.0	3.3	0.0	8.7	21.3	0.0	0.0	3.0	0.0	5.2	1.4	3.8	2.6	0.0	0.4	0.4	1.7	0.2	0.0	0.0	0.0	5.6	0.8	1.0	1.2	1.3	0.9	1.2	1.5	1.3	0.3	1.6	0.6
PFKFB4		ENSG00000114268	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4"	Q16877	3	48517684-48562015	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.0"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 37.1;WM-115: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.5;eosinophil: 11.4;intermediate monocyte: 7.3;neutrophil: 21.6;non-classical monocyte: 12.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 21.6;monocytes: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047719, HPA066058"	Uncertain		Approved	Nucleoli				Nucleoli		"HPA047719: , HPA066058: "	"unprognostic (7.60e-2)"	"prognostic unfavourable (3.04e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.90e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-6)"	"unprognostic (1.65e-1)"	"unprognostic (3.75e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavourable (3.91e-8)"	"unprognostic (2.04e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.35e-2)"	2.0	2.2	4.0	3.9	4.9	12.7	2.1	6.3	6.3	2.6	17.1	8.6	3.0	17.8	2.1	18.5	6.4	1.5	1.8	1.4	4.2	5.2	3.6	1.7	3.8	6.3	7.4	2.7	3.5	18.9	4.1	5.1	9.5	6.9	3.3	3.5	3.3	2.5	2.0	4.8	3.3	24.0	2.5	5.3	10.0	1.2	26.0	5.2	0.4	1.6	3.6	2.6	4.9	4.2	0.2	2.7	21.6	12.2	0.2	0.5	2.1	5.1	1.6	3.7	3.4	1.2	1.8	7.2	2.6	4.4	5.3	12.8	2.6	1.8	2.2	2.5	2.0	1.5	1.5	4.4	4.7	1.5	1.2	5.2	3.3	2.8	1.0	0.9	2.3	1.9	6.8	8.5	0.8	1.3	1.7	1.9	4.2	1.1	0.3	7.2	2.3	3.4	0.4	1.8	2.4	2.0	4.8	1.0	2.3	2.8	1.2	10.1	2.8	2.2	0.4	5.4	2.2	0.7	15.6	8.9	1.9	1.3	37.1	1.9	32.3	0.0	6.5	11.4	0.2	7.3	0.1	0.2	0.3	0.0	2.7	0.1	0.5	0.1	21.6	0.2	12.2	0.3	0.0	2.1	4.0	4.9	6.3	6.3	4.2	5.2	7.4	2.7	6.9	5.2
PGBD2		ENSG00000185220	"PiggyBac transposable element derived 2"	Q6P3X8	1	248906196-248919946	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA029888, HPA029889, HPA029890"	Uncertain		Supported	Vesicles				Vesicles		"HPA029888: AB_10600088, HPA029889: AB_10611386, HPA029890: AB_10602002"	"unprognostic (1.06e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.40e-1)"	"prognostic favourable (6.08e-4)"	"unprognostic (1.94e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavourable (7.86e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.25e-1)"	"prognostic favourable (2.05e-4)"	5.8	7.0	5.0	11.1	6.8	5.7	9.5	10.5	7.7	7.6	7.7	11.9	10.2	8.9	8.6	8.2	11.1	6.8	8.6	4.5	5.1	4.6	7.2	11.8	5.7	10.4	7.4	5.4	10.2	14.7	8.3	5.6	12.7	7.8	9.9	9.9	6.0	10.0	12.8	2.9	12.3	11.9	8.4	5.6	17.3	7.9	13.9	8.6	5.5	12.5	3.9	12.2	7.5	18.2	12.7	8.0	13.9	9.1	7.8	10.9	5.7	4.6	6.3	10.0	5.8	8.8	5.8	12.1	4.5	3.9	7.7	7.4	4.7	6.3	12.1	5.7	4.3	7.5	5.9	5.6	9.0	7.1	2.8	11.6	9.8	7.0	5.1	5.9	11.4	5.2	5.9	9.2	5.2	4.4	18.4	10.6	5.6	8.3	3.3	7.0	9.2	7.4	14.3	3.1	3.9	4.6	6.0	3.7	6.5	6.4	9.3	7.2	4.1	11.7	5.4	5.3	5.2	4.6	4.9	10.1	10.1	5.5	5.6	13.3	4.8	13.9	8.8	13.2	9.8	6.2	9.4	12.7	8.6	9.1	8.0	12.6	8.7	10.9	6.5	7.8	9.1	3.8	5.8	5.7	5.0	6.8	10.5	7.7	5.1	4.6	7.4	5.4	7.8	8.6
PGBD4	"FLJ32638, FLJ37497"	ENSG00000182405	"PiggyBac transposable element derived 4"	Q96DM1	15	34102073-34108684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 18.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA040896, HPA059823"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA040896: AB_10805831, HPA059823: "	"unprognostic (9.54e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-2)"	"unprognostic (7.43e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-2)"	"unprognostic (6.47e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.32e-3)"	"unprognostic (9.70e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.73e-2)"	2.5	3.6	3.9	4.1	8.5	6.7	3.4	5.3	11.1	2.6	2.8	4.8	4.7	3.2	2.6	3.9	3.8	4.6	2.4	4.0	5.4	3.6	3.4	5.3	2.4	5.2	6.0	6.1	3.0	4.6	4.9	6.7	2.5	12.7	3.0	3.4	3.2	3.3	2.6	18.6	4.4	5.1	2.2	4.0	6.0	4.5	7.9	5.8	4.5	3.3	2.0	4.2	3.2	2.7	2.8	1.7	6.4	1.4	1.6	2.6	0.6	2.0	3.6	2.5	4.1	7.4	4.9	1.6	3.1	3.0	2.0	2.5	2.5	2.7	4.2	2.6	2.4	5.6	1.5	3.6	2.5	4.3	3.8	6.7	6.9	1.8	3.1	2.3	6.1	3.8	4.1	2.6	4.7	2.2	4.6	5.0	4.1	1.4	3.8	5.5	1.0	2.7	5.6	3.5	2.1	2.6	4.3	3.7	3.4	1.6	3.6	1.1	3.5	3.6	2.6	6.1	3.5	3.2	2.1	5.9	3.8	2.3	5.4	5.3	3.6	6.4	1.4	1.5	1.3	1.2	1.1	1.5	1.7	1.3	0.8	2.8	2.6	2.4	3.2	1.6	0.9	1.7	1.3	0.6	3.9	8.5	5.3	11.1	5.4	3.6	6.0	6.1	12.7	5.8
PGPEP1L		ENSG00000183571	"Pyroglutamyl-peptidase I-like"	A6NFU8	15	98968230-99007795	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 34.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.9;U-2 OS: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"basophil: 2.0;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.0"					"Not detected"	"Not detected"			HPA041781	Uncertain									"HPA041781: AB_10795642"	"unprognostic (2.48e-1)"	"unprognostic (2.82e-2)"		"unprognostic (8.26e-2)"	"unprognostic (2.43e-3)"	"unprognostic (7.18e-2)"		"unprognostic (3.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.65e-1)"	0.7	0.1	0.5	0.2	1.4	0.1	0.6	0.2	0.5	0.4	0.4	0.4	0.0	0.2	0.2	0.4	0.8	0.2	0.5	3.6	0.6	0.4	0.4	0.0	0.2	0.3	0.4	0.2	0.2	0.5	0.0	0.1	0.3	0.4	0.6	0.0	1.6	0.9	0.5	34.7	0.1	0.2	0.3	0.3	0.1	0.2	5.0	0.2	0.1	0.1	8.6	0.5	0.2	0.3	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.1	0.7	0.0	0.2	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	1.9	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.9	1.4	0.1	0.0	0.2	0.4	1.3	0.4	0.4	0.1	1.2	0.0	0.9	0.3	0.4	0.5	1.4	0.2	0.8	0.0	0.7	0.0	4.4	0.2	0.1	0.8	0.2	0.7	0.0	0.5	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.2	0.5	0.6	0.4	0.4	0.2	0.4	0.2
PGS1	DKFZP762M186	ENSG00000087157	"Phosphatidylglycerophosphate synthase 1"	Q32NB8	17	78378640-78425114	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022526	Approved		Approved	"Vesicles,Cell Junctions,Intermediate filaments"				"Vesicles, Cell Junctions, Intermediate filaments"		"HPA022526: AB_1855271"	"unprognostic (1.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.71e-2)"	"prognostic unfavourable (1.37e-4)"	"unprognostic (5.76e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.46e-3)"	"prognostic favourable (7.33e-5)"	"prognostic unfavourable (9.94e-4)"	"prognostic unfavourable (1.16e-5)"	"unprognostic (9.94e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.72e-2)"	16.4	11.6	14.5	20.8	20.3	41.4	28.2	17.6	17.4	14.4	13.1	18.4	13.2	13.7	17.3	13.2	14.5	16.9	17.2	14.0	15.7	16.1	14.3	8.0	25.5	19.1	21.6	17.0	18.3	14.0	16.0	13.3	24.0	15.3	13.9	10.2	12.9	13.1	16.8	13.8	11.9	15.1	13.4	18.0	22.6	12.6	13.9	18.8	17.7	18.6	7.8	14.3	16.9	32.3	8.0	14.0	26.0	12.6	6.7	11.3	8.4	13.1	11.6	11.3	8.5	10.0	16.0	13.4	12.4	11.9	13.3	14.7	10.8	10.4	13.6	7.5	7.0	10.2	13.4	8.4	10.5	20.4	15.2	14.9	13.8	10.8	9.8	11.2	12.1	16.3	11.1	9.6	8.7	25.4	17.3	9.5	9.0	7.2	25.3	10.1	11.8	11.2	13.3	20.3	11.6	13.0	12.1	15.0	22.8	10.6	11.7	11.3	12.3	13.6	15.9	17.3	12.0	9.2	10.4	10.5	6.2	10.3	13.1	12.6	12.8	1.5	12.6	13.2	8.4	10.4	9.8	7.8	8.8	8.8	14.0	8.0	11.3	8.1	26.0	6.7	4.6	6.6	10.4	8.4	14.5	20.3	17.6	17.4	15.7	16.1	21.6	17.0	15.3	18.8
PHKG1	PHKG	ENSG00000164776	"Phosphorylase kinase catalytic subunit gamma 1"	Q16816	7	56080283-56092996	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 105.6;tongue: 32.9"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in many"	18	"glioma: 23.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012057	Enhanced									"HPA012057: AB_1855305"	"unprognostic (2.00e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.09e-3)"	"unprognostic (5.87e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.14e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.97e-9)"	"unprognostic (6.61e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.85e-2)"	2.0	1.5	4.9	0.8	6.1	1.1	1.5	6.0	5.8	0.7	2.6	6.5	0.0	1.0	0.9	1.5	3.2	0.9	1.1	11.8	4.1	2.9	0.6	0.7	0.9	0.8	3.5	3.9	1.0	0.8	1.2	0.6	0.6	6.8	1.4	0.8	0.0	1.6	0.8	105.6	1.6	0.9	1.1	3.6	0.8	0.8	0.7	4.8	0.0	0.6	32.9	1.2	1.8	0.3	1.3	0.6	3.3	0.7	0.3	1.9	0.2	2.9	2.1	0.5	1.7	3.1	5.3	1.4	0.3	0.6	1.0	0.8	0.7	1.3	0.8	0.5	1.0	1.5	1.2	0.2	0.8	0.8	2.1	0.8	2.9	0.7	0.8	1.5	3.2	3.3	2.2	1.6	0.7	0.3	2.2	3.9	0.1	1.3	2.2	5.5	1.0	1.3	1.2	0.3	1.0	0.6	1.9	1.5	1.6	0.3	2.1	0.1	1.1	1.9	0.8	0.5	1.7	4.4	1.1	1.8	0.7	2.2	1.2	1.4	1.0	0.4	0.5	0.0	0.8	0.2	1.9	0.3	1.2	0.3	0.2	1.3	0.6	0.6	3.3	0.3	0.7	0.6	0.5	0.2	4.9	6.1	6.0	5.8	4.1	2.9	3.5	3.9	6.8	4.8
PHLDB3	FLJ40193	ENSG00000176531	"Pleckstrin homology like domain family B member 3"	Q6NSJ2	19	43474954-43504935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043425	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"				"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA043425: AB_10797142"	"unprognostic (2.50e-2)"	"unprognostic (4.22e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.60e-2)"	"prognostic favourable (6.36e-6)"	"unprognostic (4.62e-2)"	"prognostic unfavourable (4.11e-5)"	"prognostic unfavourable (5.77e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.37e-1)"	2.7	8.5	6.6	11.7	5.9	3.6	6.0	2.1	5.2	8.7	4.8	1.8	7.1	5.8	8.8	6.5	28.4	7.3	15.9	4.5	5.2	2.9	4.8	9.6	4.0	7.8	3.5	5.8	9.5	7.7	6.8	7.9	6.4	3.2	11.7	2.2	6.7	11.1	7.6	9.0	28.7	9.4	7.5	3.0	6.4	5.4	18.7	3.0	12.2	5.7	15.2	23.2	9.3	14.8	4.4	8.1	0.9	3.3	2.6	5.5	2.3	5.3	5.6	2.4	5.9	2.1	4.4	15.3	3.8	3.4	3.9	2.7	5.7	5.6	3.2	12.2	2.3	6.2	1.7	6.7	0.7	7.5	5.3	3.5	5.4	6.8	5.3	1.3	6.8	3.7	8.6	4.1	2.5	3.4	6.2	4.9	1.9	8.4	5.4	0.3	1.4	4.6	6.4	3.1	2.1	1.8	18.1	0.1	5.1	4.9	10.7	4.6	7.6	4.5	4.3	2.5	6.7	3.0	3.6	12.6	13.7	3.5	2.3	2.6	4.1	0.3	3.3	0.5	4.0	2.3	2.9	3.7	3.7	3.0	6.9	4.4	5.5	4.8	0.9	2.6	0.2	8.1	3.6	2.3	6.6	5.9	2.1	5.2	5.2	2.9	3.5	5.8	3.2	3.0
PHTF1	PHTF	ENSG00000116793	"Putative homeodomain transcription factor 1"	Q9UMS5	1	113696831-113759489	"Plasma proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059486			Approved	"Nucleoli,Nuclear bodies"				"Nuclear bodies"	Nucleoli	"HPA059486: "	"unprognostic (1.52e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.70e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (1.21e-6)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.25e-1)"	6.5	10.4	11.5	7.9	8.6	19.5	11.8	31.6	15.1	7.1	5.4	4.0	7.6	4.5	6.6	9.6	3.4	13.1	8.8	8.2	10.1	12.4	8.9	10.1	10.8	11.9	8.2	12.9	4.0	8.2	15.3	20.9	8.5	10.4	5.8	6.5	8.2	5.2	6.9	5.5	2.4	4.9	8.4	6.4	10.5	8.0	33.8	6.6	3.4	6.1	2.4	7.7	8.1	6.3	3.0	4.5	6.0	2.6	4.3	5.7	1.7	12.7	6.7	19.1	10.1	9.5	8.6	5.0	11.8	15.7	10.6	17.4	7.3	10.4	3.7	16.8	8.1	7.1	7.2	4.7	12.2	15.2	7.2	8.9	14.1	8.4	7.9	10.9	12.6	7.2	1.3	14.1	3.1	19.5	5.3	17.0	12.8	19.0	0.1	11.0	15.1	10.9	11.5	28.7	7.3	17.0	5.6	13.4	12.4	13.2	6.5	7.0	2.6	8.8	20.5	8.3	11.5	15.3	11.4	23.8	24.2	6.9	20.5	9.5	22.6	3.0	2.6	4.9	3.0	1.3	2.3	3.0	3.7	3.7	4.5	1.6	0.1	2.6	6.0	4.3	1.7	3.0	5.7	1.7	11.5	8.6	31.6	15.1	10.1	12.4	8.2	12.9	10.4	6.6
PHTF2	DKFZp434D166	ENSG00000006576	"Putative homeodomain transcription factor 2"	Q8N3S3	7	77798792-77957503	"Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"non-classical monocyte: 18.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012312	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA012312: "	"unprognostic (1.96e-1)"	"unprognostic (2.60e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.36e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (3.09e-7)"	"unprognostic (8.28e-3)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (2.78e-4)"	"unprognostic (5.53e-2)"	7.5	4.5	5.6	15.1	8.6	7.7	5.9	8.7	10.3	7.0	5.9	8.9	5.3	3.2	7.3	4.6	6.4	5.7	7.8	9.1	7.0	5.2	5.4	4.7	6.8	13.7	7.0	6.3	7.4	4.7	27.7	8.2	11.4	9.3	5.9	5.1	4.7	5.7	6.9	67.0	5.5	7.8	8.5	8.2	12.1	4.7	9.1	5.8	9.2	5.7	18.2	15.5	7.9	6.3	6.7	2.1	9.2	18.2	3.8	6.2	2.0	15.0	6.9	9.5	19.3	8.3	9.2	7.9	26.7	24.5	16.0	18.2	11.8	12.3	13.6	2.2	20.6	12.5	13.5	6.9	22.8	9.1	10.8	5.5	7.6	3.4	9.0	7.3	15.3	5.4	6.6	9.3	14.1	5.7	9.0	24.1	17.0	9.5	6.0	4.8	8.6	8.2	6.0	19.3	11.0	4.4	20.4	9.2	12.8	14.9	17.0	9.7	18.0	5.7	5.6	27.6	14.9	15.4	15.6	11.4	13.3	16.9	8.7	11.8	23.7	9.2	2.1	3.4	1.5	9.2	3.0	6.7	4.7	1.4	2.1	4.2	1.4	1.5	1.2	3.8	18.2	1.0	6.2	2.0	5.6	8.6	8.7	10.3	7.0	5.2	7.0	6.3	9.3	5.8
PIANP	"C12orf53, DKFZp547D2210, PANP"	ENSG00000139200	"PILR alpha associated neural protein"	Q8IYJ0	12	6693792-6700800	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 55.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.0;HAP1: 8.0;NTERA-2: 16.9;SH-SY5Y: 15.9;U-2 OS: 8.9"	"Cancer enhanced"	"Detected in many"		"glioma: 14.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.4"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010631	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA010631: AB_10603680"	"unprognostic (1.82e-1)"	"unprognostic (9.21e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.41e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.30e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.34e-2)"	1.5	8.3	28.0	2.2	55.7	1.2	1.5	27.4	52.8	7.2	2.7	2.6	0.5	1.9	11.6	4.1	1.8	2.2	3.3	1.5	19.5	26.2	1.5	1.1	1.5	2.4	11.0	20.9	1.8	1.7	1.2	4.0	1.5	9.0	3.4	2.0	1.7	2.2	8.7	1.3	1.7	2.2	8.1	4.6	1.6	2.1	4.4	8.3	0.0	1.4	0.0	1.7	1.8	2.5	0.3	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.4	6.0	1.2	0.2	0.3	0.2	1.6	8.0	4.2	3.8	0.1	0.2	0.1	0.0	2.8	0.2	8.0	0.2	2.0	0.2	1.0	0.3	0.2	0.0	0.2	0.3	0.3	1.0	0.0	1.7	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	16.9	0.0	1.1	0.0	0.1	0.1	0.1	2.2	15.9	0.0	0.1	0.0	0.0	0.0	0.0	4.3	8.9	4.5	1.1	0.2	0.0	0.3	5.9	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.4	0.0	0.7	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	28.0	55.7	27.4	27.8	19.5	26.2	11.0	20.9	9.0	8.3
PIGC		ENSG00000135845	"Phosphatidylinositol glycan anchor biosynthesis class C"	Q92535	1	172370189-172444086	"Enzymes, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036663	Uncertain									"HPA036663: AB_10669912"	"unprognostic (3.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.72e-3)"	"prognostic unfavourable (4.49e-4)"	"unprognostic (7.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (1.43e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.90e-1)"	13.8	13.1	10.0	9.0	11.2	14.4	13.9	11.3	12.3	14.4	12.3	9.0	20.9	9.3	14.5	26.1	11.6	15.1	12.1	14.1	8.4	10.2	11.5	12.5	9.0	13.1	12.0	6.6	14.9	16.4	9.2	11.6	14.4	9.6	17.1	12.3	13.2	12.7	15.7	14.8	21.3	15.8	13.5	9.9	12.4	10.5	13.5	9.8	14.2	15.8	10.8	12.3	11.0	10.8	18.9	12.5	27.4	14.5	25.1	33.8	19.2	19.1	16.6	22.6	15.3	17.1	15.6	16.8	12.5	14.1	21.7	19.0	14.8	28.2	10.3	18.5	14.9	20.8	14.6	18.2	17.5	22.8	17.0	12.6	15.8	18.5	19.0	25.8	16.6	23.3	21.9	15.5	17.1	13.7	19.1	19.8	17.4	9.8	19.6	23.2	23.2	23.2	16.2	18.3	18.4	33.3	14.2	11.8	22.5	18.1	21.5	28.2	19.0	18.5	12.5	13.9	23.3	16.9	13.3	13.3	18.8	16.2	9.9	17.0	26.2	27.4	14.5	27.3	19.4	13.5	16.4	18.9	22.7	20.4	12.5	16.7	33.8	24.2	9.5	25.1	14.1	12.4	19.8	19.2	10.0	11.2	11.3	12.3	8.4	10.2	12.0	6.6	9.6	9.8
PIGX	FLJ20522	ENSG00000163964	"Phosphatidylinositol glycan anchor biosynthesis class X"	Q8TBF5	3	196639775-196736007	"Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 15.5;eosinophil: 34.5;neutrophil: 8.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029409	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA029409: AB_10610280"	"unprognostic (8.83e-2)"	"prognostic favourable (2.12e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.25e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavourable (7.45e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.01e-1)"	19.1	13.7	25.1	12.7	25.5	9.3	19.2	16.9	25.8	13.1	15.5	13.1	7.8	12.3	15.2	18.5	16.6	12.6	12.7	13.9	23.2	25.4	18.1	12.5	15.6	27.0	24.8	13.4	10.9	16.0	28.1	18.2	17.7	14.5	18.6	17.1	16.3	12.9	18.5	18.6	12.3	11.8	17.1	21.7	18.4	10.6	9.0	14.2	24.6	15.5	10.6	14.7	13.6	10.7	1.7	3.2	34.5	4.4	3.6	2.1	1.5	21.9	10.0	13.1	9.2	13.9	10.6	7.5	9.9	12.0	12.2	12.7	9.7	14.3	10.8	33.3	9.9	12.1	11.2	9.4	15.1	9.8	10.4	8.9	6.9	6.5	12.9	10.0	16.7	7.9	14.8	9.8	9.3	6.6	6.1	21.7	11.1	19.9	25.8	13.0	5.9	11.3	14.0	15.5	15.6	12.6	7.4	12.7	14.1	16.7	11.5	13.6	39.8	9.4	3.4	11.7	5.1	12.8	15.2	27.4	31.5	20.4	10.6	12.3	12.0	15.5	3.0	34.5	1.5	4.4	1.3	1.7	1.4	2.1	3.2	1.7	1.6	1.4	8.6	3.6	4.4	1.4	1.7	1.5	25.1	25.5	16.9	25.8	23.2	25.4	24.8	13.4	14.5	14.2
PIGZ	"FLJ12768, MGC52163, SMP3"	ENSG00000119227	"Phosphatidylinositol glycan anchor biosynthesis class Z"	Q86VD9	3	196946343-196969060	"Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 26.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.3"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.6;granulocytes: 1.4;monocytes: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA058599, HPA059920"	Approved		Uncertain	Vesicles				Vesicles		"HPA058599: , HPA059920: "	"unprognostic (1.46e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.25e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (5.60e-5)"	"unprognostic (1.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.38e-5)"	"unprognostic (5.02e-3)"	6.6	3.1	5.7	5.3	8.6	1.9	3.4	18.5	16.3	3.3	26.5	3.2	2.0	2.9	2.3	1.7	3.2	2.8	4.5	6.4	5.3	7.5	1.6	1.6	3.1	2.0	4.4	6.4	0.8	5.9	2.7	2.9	2.1	10.8	4.6	24.5	4.3	4.7	4.6	10.0	4.5	7.4	5.3	2.8	1.8	3.1	1.4	3.0	3.2	1.7	2.8	2.1	9.9	2.9	0.1	1.6	1.4	3.3	0.0	0.2	0.3	2.0	1.4	0.8	3.3	9.1	4.4	0.8	3.0	8.5	2.3	1.9	1.9	1.7	0.3	6.0	6.7	3.4	0.2	0.4	0.6	0.6	0.4	0.9	0.7	7.3	4.3	0.0	3.4	4.4	6.5	0.3	1.1	2.8	0.2	2.6	2.2	3.6	0.3	1.7	0.1	1.1	0.5	0.1	0.6	3.5	3.8	1.3	1.5	4.2	0.3	1.6	8.4	2.9	6.9	1.9	0.5	5.5	1.0	1.2	0.2	0.1	0.4	1.2	0.7	0.0	1.1	0.8	0.2	3.3	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.1	1.4	0.0	1.4	0.3	0.0	0.3	5.7	8.6	18.5	16.3	5.3	7.5	4.4	6.4	10.8	3.0
PINLYP		ENSG00000234465	"Phospholipase A2 inhibitor and LY6/PLAUR domain containing"	A6NC86	19	43576800-43583964	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 33.9;HMC-1: 22.6;REH: 13.8;THP-1: 17.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 17.4"	"Low lineage specificity"	"Detected in many"											HPA061218	Uncertain		Approved	Vesicles	"Secreted to blood"			Vesicles		"HPA061218: "	"unprognostic (6.72e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.60e-2)"	3.6	2.0	5.6	1.8	6.5	1.2	4.0	3.7	2.5	7.4	3.9			0.6	6.8	7.1	5.0	13.1	6.6	4.2	4.4	4.6	7.9	0.3	2.9	2.9	4.2		13.1	0.6	0.0	5.6	1.6		4.5	2.0		2.3	8.1	0.0	2.0	1.7	8.3	2.9	3.0	2.1	1.8			4.0		3.3	2.7	4.4	3.2	17.4	6.6	1.2	0.9	3.3	1.5	0.3	0.1	0.9	0.0	1.7	2.2	0.1	0.4	0.6	0.8	2.2	0.0	0.0	0.0	0.1	8.9	2.0	0.0	0.0	0.8	0.0	0.1	33.9	0.3	0.0	5.1	0.0	22.6	5.0	0.3	5.1	0.0	1.4	0.4	0.4	0.3	0.2	4.0	0.5	0.9	0.3	13.8	0.1	0.0	0.4	0.2	0.2	0.0	0.0	0.1	0.0	0.0	17.1	0.6	2.2	0.4	0.0	1.5	0.0	0.0	2.0	7.8	0.0	0.1	6.6	1.2	0.5	2.6	0.8	3.2	1.4	0.8	2.1	1.8	3.2	0.2	3.3	0.0	0.9	0.2	17.4	1.6	1.5										
PIP5KL1	"bA203J24.5, MGC46424"	ENSG00000167103	"Phosphatidylinositol-4-phosphate 5-kinase like 1"	Q5T9C9	9	127920879-127930797	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Karpas-707: 28.9;RPMI-8226: 18.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"intermediate monocyte: 1.2;MAIT T-cell: 1.0;memory B-cell: 1.0;myeloid DC: 1.0;naive B-cell: 2.4;plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA056240	Uncertain		Supported	Cytosol				Cytosol		"HPA056240: "	"unprognostic (2.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.23e-3)"	"unprognostic (8.51e-5)"	"unprognostic (1.44e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.29e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.57e-3)"	"unprognostic (9.95e-8)"	"unprognostic (1.87e-1)"	"unprognostic (7.21e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.59e-1)"	0.6	0.7	3.1	0.6	1.0	1.4	2.5	2.4	5.3	2.1	0.6	1.9	0.6	0.5	1.3	0.6	3.7	1.8	1.2	0.6	2.1	2.9	1.3	0.6	2.9	0.6	1.4	2.6	0.7	1.3	6.5	4.8	1.6	8.3	3.3	0.2	1.0	8.7	4.1	0.6	4.7	0.6	1.0	1.5	0.6	2.4	2.5	1.2	0.6	2.9	0.6	0.6	1.2	4.0	2.4	1.3	0.0	1.2	0.0	1.0	0.3	0.0	0.4	0.4	0.5	0.5	1.3	2.7	0.6	0.5	0.1	0.1	0.2	3.5	0.3	1.1	2.3	1.1	0.0	2.6	0.1	0.3	1.7	0.0	0.8	0.0	0.8	0.0	0.1	1.4	1.7	0.3	0.0	0.0	0.0	28.9	0.0	2.4	0.0	1.0	0.2	0.4	0.2	0.0	18.9	0.0	0.0	0.9	1.7	0.1	0.7	0.0	1.0	1.3	0.3	0.3	1.0	0.6	0.1	2.6	1.7	0.6	5.2	0.4	0.3	0.0	0.0	0.0	0.0	1.2	1.0	1.0	0.1	0.0	1.0	2.4	0.2	0.1	0.0	0.0	0.1	1.3	0.0	0.3	3.1	1.0	2.4	5.3	2.1	2.9	1.4	2.6	8.3	1.2
PIRT		ENSG00000233670	"Phosphoinositide interacting regulator of transient receptor potential channels"	P0C851	17	10822475-10838445	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 7.3;brain: 24.8;intestine: 7.5"	"Cell line enhanced"	"Detected in single"		"HMC-1: 1.4"	"Cancer enriched"	"Detected in single"	40	"glioma: 5.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA042337	Uncertain		Uncertain	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA042337: AB_10794795"	"unprognostic (2.95e-1)"		"unprognostic (2.19e-2)"	"unprognostic (7.57e-2)"	"unprognostic (6.58e-3)"						"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"		"unprognostic (2.85e-3)"				0.4	7.3	9.9	3.2	14.0	0.3	0.3	5.6	5.2	0.4	6.3	10.8	0.0	2.9	0.4	0.4	0.8	0.9	0.7	0.3	13.1	11.6	0.3	0.3	0.4	0.3	12.5	2.3	0.4	0.3	0.3	0.1	0.3	24.8	0.4	7.5	0.0	0.4	0.4	0.4	0.4	5.2	2.5	19.9	0.3	4.9	0.5	12.8	0.0	0.3	0.0	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	14.0	5.6	5.2	13.1	11.6	12.5	2.3	24.8	12.8
PISD	"dJ858B16.2, PSDC"	ENSG00000241878	"Phosphatidylserine decarboxylase"	Q9UG56	22	31618491-31662432	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA031090, HPA031091"	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA031090: AB_10600114, HPA031091: AB_10600893"	"unprognostic (7.96e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.44e-3)"	"unprognostic (8.13e-3)"	"unprognostic (6.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.92e-2)"	"prognostic favourable (5.27e-5)"	38.3	12.3	9.5	15.1	10.9	20.9	18.5	34.5	12.3	5.9	7.3	6.2	7.4	11.4	9.6	14.4	7.0	10.0	9.5	6.9	6.4	6.9	11.9	8.4	12.9	14.6	8.3	10.1	7.5	10.9	6.0	11.7	38.1	8.6	8.2	3.3	7.7	7.9	7.9	6.4	10.2	8.0	6.2	5.8	16.5	9.7	17.8	7.7	4.2	10.6	5.3	9.8	6.2	7.0	6.9	11.0	28.6	12.9	5.7	6.8	7.9	10.4	9.6	2.9	2.9	8.9	3.4	6.7	8.5	6.8	6.0	6.5	13.9	3.3	6.3	9.1	4.3	11.8	3.9	7.6	1.0	6.9	8.4	6.6	5.9	11.4	18.5	13.7	17.3	6.4	4.3	10.7	4.6	5.3	19.0	3.7	3.4	39.0	5.9	5.9	2.8	4.0	8.4	3.2	6.3	3.8	9.2	7.2	4.2	4.9	16.0	5.5	13.2	7.5	10.3	7.6	9.0	4.8	7.9	4.5	6.2	7.8	7.2	9.2	6.0	9.9	12.9	9.3	6.8	9.5	6.5	6.9	4.9	5.7	11.0	6.3	6.7	5.5	28.6	5.7	5.0	5.4	4.7	7.9	9.5	10.9	34.5	12.3	6.4	6.9	8.3	10.1	8.6	7.7
PIWIL3	HIWI3	ENSG00000184571	"Piwi like RNA-mediated gene silencing 3"	Q7Z3Z3	22	24719034-24774720	"Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"testis: 4.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HeLa: 1.5;RPMI-8226: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA061955	Uncertain									"HPA061955: "					"unprognostic (9.05e-2)"				"unprognostic (2.20e-1)"				"unprognostic (3.12e-4)"	"unprognostic (2.73e-1)"	"unprognostic (7.33e-2)"		"unprognostic (1.72e-1)"	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.4	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	4.7			0.0		0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	1.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0										
PIWIL4	"FLJ36156, HIWI2, Miwi2"	ENSG00000134627	"Piwi like RNA-mediated gene silencing 4"	Q7Z3Z4	11	94543840-94621421	"Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.8;testis: 30.9"	"Cell line enriched"	"Detected in some"	5	"NB-4: 43.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036587, HPA036588, HPA057508"	Enhanced		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA036587: , HPA036588: AB_10673502, HPA057508: AB_2683452"	"unprognostic (1.43e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.22e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.96e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.80e-2)"	1.9	0.6	1.9	1.9	3.1	17.8	2.7	4.1	1.7	2.2	3.8	1.7	1.7	4.5	2.5	1.7	1.7	2.0	3.6	1.7	1.9	1.7	1.7	1.7	1.7	2.5	1.7	1.7	2.2	8.2	0.2	1.7	2.3	1.7	1.7	5.0	1.7	7.6	2.0	1.7	0.8	4.3	1.7	2.5	2.3	3.6	30.9	1.7	1.7	1.7	1.7	1.8	1.7	1.7	0.0	0.8	0.5	2.4	0.3	1.3	1.0	0.1	0.0	0.2	0.0	3.2	2.2	0.2	0.2	0.1	0.1	0.4	0.3	0.3	0.0	0.2	1.3	0.0	0.4	0.0	0.1	1.2	0.1	0.1	0.3	0.0	1.3	3.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.2	0.1	43.9	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.1	0.1	0.1	0.4	0.2	0.0	9.6	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	2.4	0.5	1.0	1.0	0.0	0.0	0.1	0.6	0.8	0.0	1.3	0.4	0.0	0.3	1.0	0.0	0.4	1.0	1.9	3.1	4.1	1.7	1.9	1.7	1.7	1.7	1.7	1.7
PKD2L2	TRPP5	ENSG00000078795	"Polycystin 2 like 2, transient receptor potential cation channel"	Q9NZM6	5	137887968-137942747	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 7.5;testis: 29.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 5.8;U-266/70: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA041903, HPA043634"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA041903: , HPA043634: "	"unprognostic (7.53e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.40e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-1)"	0.5	1.5	2.0	0.6	2.5	2.2	1.2	1.7	1.9	0.5	0.3	0.7	0.7	0.3	0.5	1.0	0.5	0.4	0.6	1.7	1.0	0.8	0.4	0.3	0.4	1.3	1.2	1.3	0.6	1.1	0.0	1.5	0.2	1.8	0.5	0.1	0.2	0.7	0.0	3.3	0.8	0.3	0.0	0.7	1.0	0.6	29.3	0.4	0.0	1.0	0.0	0.2	0.4	0.6	3.9	3.5	7.5	1.7	1.9	1.9	0.8	1.6	1.2	0.2	0.1	0.4	0.5	1.7	0.6	0.0	0.0	0.0	0.1	3.2	2.3	3.4	0.0	0.7	0.1	0.0	0.1	1.5	1.0	1.3	4.2	0.1	0.0	0.4	1.8	0.1	0.2	0.0	0.0	0.6	1.5	5.8	0.8	0.5	1.1	2.3	0.6	1.0	0.0	0.1	0.0	0.0	2.3	0.8	0.9	1.4	0.2	0.9	0.4	0.5	0.5	1.0	1.8	0.6	1.0	4.6	3.3	0.4	2.2	0.7	1.7	7.1	1.7	3.0	1.8	1.2	1.0	2.5	1.6	1.4	0.9	3.9	1.9	1.7	7.5	1.9	1.0	3.5	1.1	0.8	2.0	2.5	1.7	1.9	1.0	0.8	1.2	1.3	1.8	0.4
PKDCC	"SgK493, Vlk"	ENSG00000162878	"Protein kinase domain containing, cytoplasmic"	Q504Y2	2	42048020-42058528	"Enzymes, Predicted secreted proteins"	"Differentiation, Osteogenesis, Protein transport, Transport"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 30.5;ASC diff: 24.2;CACO-2: 36.1;HHSteC: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026427, HPA026442, HPA026526"	Approved				"Secreted to blood"		10000			"HPA026427: AB_10600773, HPA026442: AB_10601237, HPA026526: AB_10602416"	"unprognostic (6.77e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.73e-3)"	"unprognostic (2.58e-3)"	21.4	5.7	1.9	8.4	1.8	0.8	18.9	0.3	4.7	20.8	13.7	1.7	6.3	9.3	17.6	16.0	9.2	10.0	29.6	17.0	2.3	0.7	4.7	3.5	8.0	3.7	3.7	0.3	43.6	3.3	0.9	3.2	3.2	2.6	13.0	5.2	17.0	38.6	5.6	40.2	1.7	7.7	26.2	2.3	4.6	4.8	14.1	2.3	4.2	3.1	13.1	2.1	22.8	23.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.9	5.4	30.5	24.2	0.3	1.9	0.1	0.0	0.4	0.6	36.1	0.0	0.0	0.1	0.6	0.0	0.5	0.0	0.0	2.9	1.2	0.0	1.3	9.5	20.8	0.0	0.4	2.1	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.1	0.0	0.1	8.9	0.6	0.0	10.5	0.0	0.0	0.0	1.1	1.9	0.5	0.0	0.0	0.0	0.2	0.0	0.2	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.8	0.3	4.7	2.3	0.7	3.7	0.3	2.6	2.3
PKDREJ		ENSG00000130943	"Polycystin family receptor for egg jelly"	Q9NTG1	22	46255663-46263355	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"testis: 13.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA034587	Enhanced									"HPA034587: AB_10670570"	"unprognostic (9.48e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.11e-2)"	"unprognostic (5.06e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.41e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.37e-1)"	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.2	0.2	0.5	0.3	0.2	0.3	0.3	0.4	2.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.4	0.0	0.3	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0.3	1.5	0.5	0.2	0.2	0.2	0.2	13.8	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.8	0.1	0.5	1.6	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.2	0.1	0.8	0.1	0.0	0.2	0.0	0.0	0.0	2.1	0.9	0.2	0.0	0.4	0.1	0.4	0.8	0.1	0.0	0.0	0.0	0.0	1.5	0.4	0.0	1.2	0.4	0.6	0.3	0.0	0.3	1.4	0.0	0.0	0.3	0.9	1.8	0.6	0.3	1.0	0.0	0.4	0.2	0.2	1.9	0.1	0.3	0.8	0.1	0.1	0.1	1.8	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.7	0.2
PKHD1L1		ENSG00000205038	"PKHD1 like 1"	Q86WI1	8	109362477-109530330	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"thyroid gland: 91.7"	"Cell line enhanced"	"Detected in some"		"HHSteC: 4.1;HUVEC TERT2: 2.3;TIME: 4.6;U-266/70: 4.3"	"Group enriched"	"Detected in some"	18	"endometrial cancer: 5.2;ovarian cancer: 1.9;thyroid cancer: 3.8"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Group enriched"	"Detected in some"	9	"memory B-cell: 1.8;naive B-cell: 1.5"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA044458	Uncertain						5100000			"HPA044458: "	"unprognostic (9.07e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.37e-2)"	"prognostic favourable (7.61e-4)"	"unprognostic (5.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.76e-6)"	"unprognostic (4.56e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.73e-2)"	12.4	1.5	0.1	4.2	0.1	0.4	2.6	0.0	0.2	13.8	5.7	0.1	2.1	1.1	3.5	8.9	2.5	11.5	3.5	5.2	0.1	0.1	0.8	0.8	16.9	22.5	0.4	0.0	3.5	0.7	0.2	0.4	0.2	1.1	1.4	1.6	4.2	1.7	1.5	2.0	0.9	2.0	3.2	0.2	0.3	0.8	1.6	0.0	0.0	91.7	2.9	1.1	2.1	3.2	1.8	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	4.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	1.1	0.0
PKIG		ENSG00000168734	"CAMP-dependent protein kinase inhibitor gamma"	Q9Y2B9	20	44531785-44624247	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 102.0;HSkMC: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"memory B-cell: 58.2;naive B-cell: 62.1"	"Lineage enriched"	"Detected in many"	10	"B-cells: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042703, HPA063690"	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA042703: AB_10797018, HPA063690: "	"unprognostic (3.15e-2)"	"unprognostic (5.65e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.38e-1)"	"prognostic favourable (4.90e-5)"	"unprognostic (6.26e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.96e-2)"	21.1	25.1	39.2	22.7	31.9	7.5	18.4	12.9	37.7	28.0	44.0	13.5	15.4	12.5	31.8	19.3	31.7	31.4	29.3	107.1	23.0	17.2	22.9	14.4	39.0	17.9	16.7	25.9	17.2	13.3	13.8	19.5	32.6	14.3	30.2	13.3	26.2	18.8	32.5	25.6	8.0	17.9	52.8	11.9	13.2	24.1	41.5	11.4	3.2	25.8	18.6	18.2	42.2	20.3	62.1	6.2	0.4	0.3	0.7	1.6	3.1	5.1	5.3	8.7	5.6	13.1	26.8	1.2	12.5	102.0	14.2	10.7	12.2	2.4	20.1	10.3	10.9	2.0	1.7	2.7	4.6	10.1	3.2	3.1	0.8	8.6	12.2	0.4	0.2	41.4	5.5	6.9	1.5	31.6	2.4	0.5	1.3	6.6	3.1	5.1	4.6	7.7	0.5	0.2	0.4	7.8	1.0	3.5	11.5	3.2	1.5	8.4	4.0	2.5	20.4	19.5	8.7	8.6	6.0	2.7	7.5	14.1	9.7	0.3	8.3	0.4	0.3	0.1	0.2	0.2	0.2	58.2	0.3	0.3	1.5	62.1	1.0	1.6	0.4	0.7	0.2	6.2	0.1	3.1	39.2	31.9	12.9	37.7	23.0	17.2	16.7	25.9	14.3	11.4
PKNOX2		ENSG00000165495	"PBX/knotted 1 homeobox 2"	Q96KN3	11	125164687-125433389	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 26.7;AN3-CA: 6.6;hTEC/SVTERT24-B: 5.3;LHCN-M2: 7.8;SK-MEL-30: 5.3;WM-115: 14.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028867, CAB034342, HPA055368, HPA066962"	Supported		Enhanced	"Nucleoplasm,Cytokinetic bridge"				Nucleoplasm	"Cytokinetic bridge"	"CAB034342: AB_2164138, HPA028867: , HPA055368: , HPA066962: "	"unprognostic (2.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.10e-6)"	"unprognostic (1.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.48e-3)"	5.8	4.1	10.0	3.3	12.4	0.7	1.7	16.3	25.7	5.1	2.8	3.6	0.2	2.0	5.6	4.7	2.7	9.8	3.4	7.9	7.3	6.9	2.9	1.1	9.6	2.4	5.2	12.3	23.6	6.3	0.9	7.3	12.8	6.9	10.2	2.8	24.3	2.5	8.7	19.5	4.0	2.4	4.6	4.6	3.4	2.5	7.2	3.1	0.0	18.3	8.4	2.2	3.3	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	26.7	6.6	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	1.3	0.0	5.3	0.0	0.0	0.0	0.0	7.8	0.2	0.0	0.0	2.6	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	12.4	16.3	25.7	7.3	6.9	5.2	12.3	6.9	3.1
PLA1A	ps-PLA1	ENSG00000144837	"Phospholipase A1 member A"	Q53H76	3	119597842-119629811	"Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 47.8;epididymis: 63.1;seminal vesicle: 123.8"	"Cell line enriched"	"Detected in some"	18	"SK-MEL-30: 23.4"	"Group enriched"	"Detected in many"	5	"liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"T-reg: 1.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059740			Approved	"Nucleoplasm,Nuclear speckles,Cytoplasmic bodies"	"Secreted in other tissues"			"Nuclear speckles, Cytoplasmic bodies"	Nucleoplasm	"HPA059740: "	"unprognostic (1.35e-1)"	"prognostic favourable (2.81e-7)"	"unprognostic (2.24e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.67e-1)"	2.5	0.4	3.8	1.5	4.7	0.2	1.8	1.4	2.5	2.5	1.3	1.7	47.8	0.6	3.2	63.1	0.8	2.7	1.3	5.0	3.6	4.3	9.3	17.2	13.7	6.1	6.0	1.0	0.5	1.8	11.4	1.0	4.4	7.0	6.0	1.2	10.7	1.5	123.8	10.3	0.3	1.9	4.2	7.4	0.5	2.2	2.0	2.5	0.4	5.0	0.4	3.7	2.1	1.3	0.0	0.0	0.0	0.4	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.7	0.2	0.5	0.1	0.0	0.2	0.0	0.0	23.4	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	0.0	3.8	4.7	1.4	2.5	3.6	4.3	6.0	1.0	7.0	2.5
PLA2G4E	FLJ45651	ENSG00000188089	"Phospholipase A2 group IVE"	Q3MJ16	15	41981582-42051190	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 19.9"	"Group enriched"	"Detected in some"	7	"CACO-2: 3.4;HaCaT: 2.1"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 11.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041105	Enhanced									"HPA041105: "	"unprognostic (2.98e-1)"	"unprognostic (5.52e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.99e-2)"		"unprognostic (5.12e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.83e-7)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0			0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.6	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0			0.0		2.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PLA2G4F	PLA2G4F/Z	ENSG00000168907	"Phospholipase A2 group IVF"	Q68DD2	15	42139034-42156636	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 30.4;skin 1: 48.1"	"Cell line enriched"	"Detected in some"	4	"RT4: 13.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042713, HPA056752"	Enhanced		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA042713: AB_10793982, HPA056752: "	"unprognostic (1.99e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (2.00e-4)"		"unprognostic (1.06e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.63e-1)"	0.1	0.1	0.0	2.5	0.3	0.3	1.8	0.0	0.1	4.5	11.0	0.0	4.7	4.2	0.4	9.7	10.4	0.2	3.1	1.0	0.0	0.0	10.8	0.2	30.4	0.1	0.0	0.0	0.1	0.1	0.7	4.1	0.3	0.0	3.3	2.5	0.0	5.3	2.8	8.6	48.1	12.3	1.1	0.1	0.2	1.6	0.1	0.0	6.2	1.6	14.9	3.4	2.2	6.3	0.6	0.3	0.2	0.1	0.0	0.3	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.7	0.5	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.2	0.2	0.0	3.2	0.0	0.0	0.0	0.1	0.1	0.0	1.2	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	13.2	0.7	0.1	0.0	1.4	0.0	1.4	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLAC1	"CT92, OOSP2L"	ENSG00000170965	"Placenta specific 1"	Q9HBJ0	X	134565838-134764322	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"placenta: 90.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 18.3;hTCEpi: 14.4;hTERT-HME1: 5.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA063425	Enhanced				"Secreted in female reproductive system"					"HPA063425: "	"unprognostic (2.93e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.89e-4)"	"unprognostic (1.35e-7)"	"unprognostic (3.83e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.33e-16)"	"unprognostic (7.64e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.1	90.4	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.5	0.0	0.0	0.1	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.8	0.0	1.1	0.0	0.2	1.0	0.3	0.3	0.9	0.0	0.2	0.1	1.7	0.3	0.4	18.3	0.0	0.1	0.2	2.2	0.0	0.0	0.8	14.4	0.1	5.8	2.1	0.1	1.6	0.1	0.9	0.0	0.2	0.0	2.4	0.0	0.3	3.2	0.0	0.0	2.8	0.0	0.0	3.4	0.6	0.1	0.0	0.0	0.4	0.7	0.2	0.0	0.4	0.0	0.3	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLAC8	"C15, onzin"	ENSG00000145287	"Placenta specific 8"	Q9NZF1	4	83090048-83137075	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 181.6;intestine: 66.5;lymphoid tissue: 74.8"	"Cell line enhanced"	"Detected in many"		"A-431: 31.5;CAPAN-2: 91.0;HL-60: 56.4;NB-4: 27.7;RPMI-8226: 40.7;THP-1: 32.8;U-937: 26.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 181.6"	"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040465, HPA077912"	Enhanced		Approved	Cytosol				Cytosol		"HPA040465: AB_10794875, HPA077912: "	"unprognostic (6.82e-5)"	"prognostic favourable (3.03e-4)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-7)"	"unprognostic (3.89e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	2.3	1.3	1.7	47.9	5.9	62.0	1.6	0.7	4.1	6.1	44.1	0.6	0.2	14.6	1.0	0.9	34.5	3.1	7.5	2.4	1.4	1.9	1.6	12.4	23.4	51.6	2.5	0.2	1.9	1.2	0.0	1.3	32.3	3.0	2.0	31.4	1.3	9.7	1.0	0.8	0.7	66.5	3.1	5.2	74.8	21.8	0.7	2.7	18.2	1.5	1.4	53.1	3.4	2.5	41.5	181.6	7.0	47.8	77.6	32.9	36.0	31.5	0.2	0.1	0.2	0.0	0.0	5.2	0.8	0.2	2.0	2.4	0.6	91.0	5.3	0.2	9.2	3.3	0.5	0.2	7.5	0.0	0.1	0.1	6.3	2.6	0.3	56.4	0.3	0.1	0.6	0.3	0.4	0.1	0.0	0.4	5.2	0.1	10.7	27.7	0.1	0.1	1.4	1.9	40.7	0.1	0.9	4.6	0.0	0.2	5.2	0.1	0.3	32.8	0.2	0.2	5.9	0.1	0.1	0.3	0.0	14.1	0.4	26.0	0.0	2.7	11.0	7.0	32.9	47.8	24.9	41.5	15.7	18.7	10.0	38.4	19.4	22.0	2.4	77.6	25.8	181.6	1.0	36.0	1.7	5.9	0.7	4.1	1.4	1.9	2.5	0.2	3.0	2.7
PLAC8L1		ENSG00000173261	"PLAC8 like 1"	A1L4L8	5	146084386-146104369	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"testis: 20.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074266			Approved	Nucleoplasm				Nucleoplasm		"HPA074266: "	"unprognostic (6.38e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.62e-2)"	"unprognostic (7.48e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.45e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-6)"	"unprognostic (9.72e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.18e-2)"	0.4	0.1	0.9	0.4	1.0	0.1	1.0	1.6	0.8	0.4	0.4	0.4	0.4	0.0	0.5	0.5	0.4	0.6	0.4	0.4	1.0	1.0	0.4	0.5	0.4	0.4	1.1	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.4	0.9	3.1	0.6	0.5	1.9	0.4	0.1	20.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.2	1.3	0.0	0.0	0.0	0.5	0.0	0.9	2.7	2.6	9.6	0.7	1.1	0.6	1.0	0.4	4.2	2.7	0.4	1.2	1.5	2.1	1.1	0.7	3.9	0.0	3.4	3.2	5.5	2.2	0.9	1.0	0.5	0.9	1.8	0.0	6.2	3.1	2.5	1.4	0.2	2.0	1.1	0.0	0.9	2.9	0.4	3.8	0.9	0.4	0.0	0.3	0.0	2.3	1.2	1.1	0.4	2.3	0.2	0.8	1.1	0.0	3.6	1.1	1.9	1.2	3.1	1.2	0.7	1.6	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.9	1.0	1.6	0.8	1.0	1.0	1.1	0.4	0.4	0.4
PLCD4		ENSG00000115556	"Phospholipase C delta 4"	Q9BRC7	2	218607765-218637184	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"retina: 23.0;skeletal muscle: 62.5;smooth muscle: 33.1"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009914, HPA038139, HPA038140"	Enhanced		Approved	"Nuclear membrane,Plasma membrane,Cytosol"				Cytosol	"Nuclear membrane, Plasma membrane"	"CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.65e-5)"	"unprognostic (7.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.87e-3)"	"unprognostic (7.54e-5)"	"unprognostic (3.28e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.32e-2)"	"unprognostic (8.46e-3)"	"unprognostic (3.09e-1)"	1.1	2.5	1.5	1.0	1.6	0.5	1.0	0.9	2.4	0.6	6.4	0.3	3.8	0.9	0.8	1.1	3.7	0.6	0.9	0.9	1.0	1.5	3.9	0.5	0.7	0.7	1.6	1.0	0.7	0.4	1.4	4.7	0.6	2.6	6.4	1.5	23.0	1.4	0.6	62.5	0.8	1.4	33.1	1.1	0.5	3.5	3.9	0.5	0.0	1.4	6.8	0.5	9.6	5.3	0.9	1.2	0.3	0.4	0.9	0.9	1.0	0.6	1.5	2.1	0.4	0.2	1.4	1.2	1.2	2.6	0.4	1.4	2.4	0.3	1.4	1.8	0.4	1.0	0.0	1.5	0.3	0.5	1.8	1.2	3.5	1.9	0.2	1.2	0.6	3.0	0.1	1.9	0.5	2.7	1.0	1.1	2.2	1.8	0.4	1.2	0.7	3.4	0.9	0.8	0.5	4.3	3.0	2.3	21.1	1.0	0.8	0.3	2.5	0.5	6.0	1.5	1.2	0.7	0.7	0.5	0.8	0.9	4.6	0.3	1.6	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.3	0.9	0.3	0.9	0.7	0.8	0.3	0.9	0.0	1.2	0.7	1.0	1.5	1.6	0.9	2.4	1.0	1.5	1.6	1.0	2.6	0.5
PLCH2	"KIAA0450, PLC-eta2, PLCeta2, PLCL4, RP3-395M20.1"	ENSG00000149527	"Phospholipase C eta 2"	O75038	1	2425980-2505530	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0;retina: 28.6;skin 1: 36.6"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 49.5;hTCEpi: 23.3;hTERT-HME1: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"NK-cells: 2.9;T-cells: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA072705	Enhanced									"HPA072705: "	"unprognostic (2.06e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.95e-2)"	"unprognostic (6.61e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.64e-2)"	"unprognostic (5.80e-2)"	0.5	1.2	6.4	2.9	9.1	1.4	3.1	32.0	25.1	3.2	0.9	1.6	0.5	1.6	0.3	1.7	9.7	2.5	2.4	0.3	20.2	2.7	0.8	0.8	1.2	4.0	2.6	8.4	0.2	1.7	0.1	3.0	0.4	2.6	6.7	0.7	28.6	8.6	4.9	0.2	36.6	2.0	0.2	6.4	4.0	1.7	0.8	2.0	0.2	1.2	0.2	4.9	8.3	6.4	0.3	0.1	0.0	0.0	2.9	2.4	0.9	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	6.9	0.0	49.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	13.9	0.0	0.0	1.2	0.1	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	2.7	5.6	1.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.9	0.3	1.5	1.4	0.0	0.3	1.1	0.7	0.0	2.9	0.0	0.1	2.1	0.9	6.4	9.1	32.0	25.1	20.2	2.7	2.6	8.4	2.6	2.0
PLCXD1	FLJ11323	ENSG00000182378	"Phosphatidylinositol specific phospholipase C X domain containing 1"	Q9NUJ7	X	276322-303356	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.3"	"Cell line enhanced"	"Detected in many"		"HEL: 53.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 42.3;cerebellum: 24.6;cerebral cortex: 19.1;pons and medulla: 29.2"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA007721	Approved		Approved	Cytosol				Cytosol		"HPA007721: AB_1079630"	"unprognostic (2.73e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (3.80e-2)"	"prognostic favourable (2.50e-4)"	"unprognostic (1.47e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.80e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.11e-3)"	"prognostic unfavourable (7.82e-14)"	"unprognostic (6.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.78e-1)"	7.4	1.5	6.5	5.3	42.3	18.8	8.7	24.6	19.1	8.9	3.7	2.1	2.1	5.3	9.1	2.1	11.4	3.5	5.3	2.8	7.1	4.2	3.1	5.4	3.5	10.0	4.8	3.6	19.3	4.3	2.3	5.5	12.5	29.2	3.5	3.5	2.1	7.0	2.4	4.5	11.6	5.9	2.1	22.2	10.5	17.3	3.6	6.7	2.1	5.1	2.1	5.4	4.7	7.9	5.8	2.9	6.3	11.9	1.8	4.1	2.7	8.7	33.4	8.1	12.1	1.7	1.3	6.4	7.9	0.9	4.2	4.1	13.5	9.5	11.2	5.5	3.4	2.7	2.0	5.2	2.2	6.7	14.9	53.0	10.8	18.0	5.2	5.4	20.9	6.9	0.7	15.6	1.6	3.2	13.8	6.1	3.0	2.7	16.3	8.0	17.2	6.5	9.3	4.4	16.4	1.3	4.1	8.7	4.6	8.0	4.8	7.3	9.1	7.5	2.3	5.6	9.0	6.1	8.6	2.1	5.5	26.0	3.7	14.4	6.0	4.3	3.8	6.3	2.8	8.1	3.9	2.3	2.2	3.4	2.9	5.8	2.8	2.7	4.9	1.8	11.9	2.7	4.1	2.7	6.5	42.3	24.6	19.1	7.1	4.2	4.8	3.6	29.2	6.7
PLCXD2	FLJ31579	ENSG00000240891	"Phosphatidylinositol specific phospholipase C X domain containing 2"	Q0VAA5	3	111674676-111846447	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"placenta: 16.0"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 9.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.2;NK-cells: 2.1;T-cells: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055947	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA055947: "	"unprognostic (2.68e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.04e-1)"	"prognostic favourable (1.23e-7)"	"unprognostic (7.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"prognostic favourable (2.99e-4)"	1.5	1.0	1.9	3.4	5.8	9.6	1.2	5.8	10.9	1.6	2.8	0.4	0.0	6.1	1.0	0.6	1.8	1.2	1.9	1.5	3.6	2.5	2.5	4.1	2.0	5.9	2.9	6.8	1.1	2.3	0.4	4.1	16.0	10.3	1.5	3.6	4.1	2.0	0.7	1.2	1.5	5.9	0.9	2.9	3.5	2.1	4.2	1.1	3.1	3.2	0.5	4.8	1.9	1.6	0.9	7.2	0.6	0.0	2.1	3.6	0.6	3.0	2.7	2.6	1.2	0.1	0.1	0.8	5.2	2.5	4.9	4.3	1.9	1.5	2.1	2.7	0.2	7.3	1.1	5.0	9.6	0.6	1.3	0.5	4.9	1.7	0.4	0.7	2.6	0.0	1.0	1.6	2.9	2.7	0.1	5.3	0.5	0.3	1.5	0.5	0.9	6.7	1.4	3.7	2.0	2.3	3.1	0.6	4.6	1.1	0.7	1.0	0.4	0.2	2.6	1.1	6.6	0.5	1.0	6.3	0.9	0.4	0.5	0.4	0.3	0.6	0.0	0.0	3.6	0.0	3.5	0.5	1.9	3.5	0.3	0.9	0.9	2.0	0.2	2.1	0.0	7.2	1.7	0.6	1.9	5.8	5.8	10.9	3.6	2.5	2.9	6.8	10.3	1.1
PLCXD3		ENSG00000182836	"Phosphatidylinositol specific phospholipase C X domain containing 3"	Q63HM9	5	41306954-41510628	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.4;heart muscle: 36.6;ovary: 27.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.2;PC-3: 5.5;SH-SY5Y: 25.7;TIME: 13.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in all"		"cerebellum: 33.4"	"Cell type enhanced"	"Detected in single"		"basophil: 2.3"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046849	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA046849: "	"unprognostic (1.71e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.12e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.15e-3)"	"unprognostic (5.91e-5)"	"unprognostic (5.11e-2)"	"unprognostic (6.75e-2)"	7.0	15.3	6.9	1.2	4.5	0.8	4.5	33.4	6.5	4.5	1.4	2.0	1.4	1.3	1.6	1.7	1.4	2.5	3.4	36.6	4.8	8.1	7.3	2.2	2.0	7.9	4.2	4.2	27.6	4.8	1.3	13.7	0.8	9.0	1.9	1.5	0.5	1.2	2.0	0.9	0.9	1.7	2.1	5.8	0.9	5.9	1.1	2.1	0.0	1.4	0.0	1.0	1.4	6.1	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	1.3	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.3	25.7	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	6.9	4.5	33.4	5.5	4.8	8.1	4.2	4.2	9.0	2.1
PLD4	C14orf175	ENSG00000166428	"Phospholipase D family member 4"	Q96BZ4	14	104924816-104937790	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"blood: 229.9"	"Group enriched"	"Detected in some"	5	"HMC-1: 34.0;RPMI-8226: 24.4;THP-1: 61.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 229.9"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 229.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA051512	Uncertain						2000000			"HPA051512: "	"unprognostic (4.50e-3)"	"unprognostic (1.78e-4)"	"unprognostic (7.12e-2)"	"unprognostic (5.30e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.19e-3)"	"unprognostic (3.45e-3)"	"unprognostic (3.89e-1)"	"unprognostic (6.90e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.41e-1)"	0.7	1.6	8.9	6.7	8.8	15.0	1.9	5.7	10.0	1.5	1.3	23.1	0.1	5.6	1.5	0.5	1.1	2.8	3.5	0.8	8.7	8.4	1.2	0.9	2.6	14.4	14.5	3.4	0.9	1.6	1.0	2.8	1.2	9.0	2.1	0.8	1.5	4.6	2.3	0.5	0.9	5.5	0.9	19.0	11.6	3.5	0.8	9.2	2.7	1.0	0.0	11.2	3.9	0.9	14.7	229.9	43.4	17.7	1.7	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	34.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.0	8.6	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	2.8	43.4	0.0	11.9	0.1	14.7	0.0	0.0	35.1	12.3	0.1	0.0	0.6	1.7	17.7	229.9	0.0	4.4	8.9	8.8	5.7	9.6	8.7	8.4	14.5	3.4	9.0	9.2
PLD5	FLJ40773	ENSG00000180287	"Phospholipase D family member 5"	Q8N7P1	1	242082986-242524696	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 54.8;retina: 37.7"	"Cell line enhanced"	"Detected in some"		"A549: 3.9;AF22: 13.7;HDLM-2: 6.8;SH-SY5Y: 3.8;U-2 OS: 4.7"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Region enriched"	"Detected in all"	4	"cerebellum: 54.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028389, HPA050367"			Approved	Vesicles,Mitochondria,Cytosol				Mitochondria	"Vesicles, Cytosol"	"HPA028389: AB_10602145, HPA050367: "	"unprognostic (5.20e-2)"	"unprognostic (1.05e-1)"		"unprognostic (9.14e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.16e-5)"	"unprognostic (2.79e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.44e-3)"	"unprognostic (2.18e-1)"	1.1	5.4	5.0	0.4	3.7	0.4	1.6	54.8	7.6	2.2	0.8	7.7	0.0	0.4	3.5	0.9	1.6	1.8	0.8	0.8	4.4	4.6	1.5	0.5	0.8	3.3	5.4	2.5	6.6	3.1	1.4	7.2	1.5	12.7	2.7	0.6	37.7	2.2	9.3	0.8	0.6	0.5	2.9	6.0	2.2	0.8	4.2	6.2	0.0	1.0	0.0	1.5	0.4	1.0	0.4	0.2	1.0	0.2	0.3	0.4	0.0	0.0	3.9	13.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	6.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.5	2.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.2	0.3	0.3	0.2	0.3	0.2	0.3	0.3	0.1	0.4	0.3	0.4	1.0	0.3	0.2	0.2	0.2	0.0	5.0	3.7	54.8	5.5	4.4	4.6	5.4	2.5	12.7	6.2
PLEKHD1	UPF0639	ENSG00000175985	"Pleckstrin homology and coiled-coil domain containing D1"	A6NEE1	14	69484692-69531551	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 7.4;brain: 16.0"	"Cell line enhanced"	"Detected in some"		"SK-BR-3: 6.2;T-47d: 5.9;U-266/70: 2.8"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	7	"cerebellum: 16.0"	"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 7.4"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 7.4"	"Region enhanced"	"Detected in many"		"cerebellum: 33.7"	"Low region specificity"	"Detected in all"			HPA051875	Uncertain									"HPA051875: "	"unprognostic (8.73e-2)"	"unprognostic (4.64e-3)"	"unprognostic (3.73e-2)"	"unprognostic (4.03e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.64e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.56e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.49e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.42e-2)"	0.3	0.3	0.4	0.1	1.5	1.1	1.4	16.0	2.2	0.5	0.2	0.5	2.5	0.3	0.2	4.2	0.2	0.2	0.2	0.3	0.6	0.5	1.8	0.1	0.4	2.0	0.8	0.1	0.2	0.5	4.5	0.6	0.1	1.4	0.2	0.0	4.1	3.9	4.0	0.2	2.0	0.2	0.1	0.6	0.4	0.3	1.8	0.4	0.8	4.0	0.1	0.5	0.2	0.2	0.2	7.4	0.6	0.1	0.1	0.1	0.0	0.3	0.3	0.5	0.9	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.7	0.5	0.5	0.1	0.5	0.8	0.1	0.1	0.5	0.4	0.1	0.4	0.1	0.1	0.5	0.7	0.1	0.3	0.0	0.1	0.0	0.2	1.2	0.1	0.9	0.4	0.4	0.7	0.1	0.3	0.1	0.2	0.5	0.5	0.8	1.9	0.2	6.2	0.1	5.9	0.2	0.2	0.3	0.8	0.4	0.3	2.8	0.6	0.3	0.2	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.6	0.1	0.1	7.4	0.1	0.0	0.4	1.5	16.0	2.2	0.6	0.5	0.8	0.1	1.4	0.4
PLEKHG7	FLJ46688	ENSG00000187510	"Pleckstrin homology and RhoGEF domain containing G7"	Q6ZR37	12	92721462-92772455	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 5.6;fallopian tube: 7.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.8;HBF TERT88: 1.3;RPMI-8226: 5.0;RT4: 1.1;SK-BR-3: 4.1"	"Low cancer specificity"	"Detected in single"							"Group enriched"	"Detected in some"	31	"memory B-cell: 4.5;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	45	"B-cells: 4.5"									HPA060632	Uncertain									"HPA060632: "	"unprognostic (4.47e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.80e-2)"	"unprognostic (9.91e-5)"	"unprognostic (1.38e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.75e-1)"		"unprognostic (3.27e-5)"	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	3.3	0.6			0.1	0.4	5.6	0.1	7.9	0.3	0.0	0.0	0.0	0.7	0.5	2.2	2.0	0.0		0.0	1.4	0.0	0.0	0.0		0.8	0.4		0.1	0.6	0.0	0.0	2.6	0.0	0.0	1.6	2.7	0.1			0.0		2.9	2.9	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.2	1.8	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	5.0	0.1	1.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PLEKHH1	KIAA1200	ENSG00000054690	"Pleckstrin homology, MyTH4 and FERM domain containing H1"	Q9ULM0	14	67533301-67589612	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 61.0;thyroid gland: 30.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.9;BEWO: 9.6;RT4: 9.7;SK-MEL-30: 12.0;T-47d: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047707, HPA051964"	Uncertain		Approved	Centrosome				Centrosome		"HPA047707: , HPA051964: "	"unprognostic (2.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (3.94e-2)"	"prognostic favourable (8.03e-5)"	"unprognostic (4.74e-1)"	"unprognostic (9.15e-3)"	"unprognostic (8.43e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.85e-1)"	"prognostic favourable (4.03e-7)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (2.26e-4)"	1.3	4.5	9.7	1.6	33.7	0.5	2.9	8.6	26.8	3.5	6.8	61.0	2.5	11.6	1.9	8.9	1.6	3.8	2.5	1.1	16.2	8.7	2.7	0.8	1.2	0.6	35.8	16.6	0.6	7.7	10.3	3.3	2.0	26.9	10.7	7.0	5.1	20.3	2.9	1.1	4.1	9.0	1.3	38.1	1.3	6.6	2.3	34.4	0.0	30.2	0.0	0.7	2.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	1.2	2.0	9.9	0.2	0.0	9.6	0.0	0.0	0.1	0.1	3.1	1.5	0.0	1.6	0.0	2.2	3.5	0.8	0.1	0.3	3.4	0.0	1.6	1.9	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	3.7	0.0	0.0	7.1	0.0	0.2	3.0	0.6	0.1	0.3	1.4	1.1	9.7	2.7	2.5	0.8	1.8	12.0	9.5	2.0	0.0	0.8	3.6	0.9	0.6	0.0	0.0	0.0	0.5	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	33.7	8.6	18.1	16.2	8.7	35.8	16.6	26.9	34.4
PLEKHM3	"DAPR, PLEKHM1L"	ENSG00000178385	"Pleckstrin homology domain containing M3"	Q6ZWE6	2	207821288-208025560	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035046	Uncertain		Approved	Vesicles,Cytosol				Cytosol	Vesicles	"HPA035046: AB_10603128"	"unprognostic (3.62e-1)"	"unprognostic (1.58e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.18e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.06e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.86e-4)"	"unprognostic (2.42e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.33e-2)"	6.5	10.9	10.0	4.1	11.2	11.1	5.1	11.8	16.8	5.6	5.0	10.6	2.1	3.3	6.2	3.4	4.2	4.5	4.5	6.6	7.3	7.8	5.1	6.8	6.2	4.3	6.2	11.4	9.1	4.8	17.3	7.2	4.6	13.1	6.4	4.9	6.5	5.4	4.8	5.1	5.2	3.9	5.9	8.6	4.9	4.6	5.3	7.5	4.1	10.6	2.3	4.5	4.8	5.4	2.3	1.9	6.7	2.1	2.0	2.7	0.6	1.5	1.3	3.4	1.9	5.6	5.7	5.1	3.1	3.3	2.5	2.3	1.7	1.3	1.3	3.1	3.5	1.6	3.4	4.4	3.3	2.4	5.3	2.6	4.2	2.7	3.4	2.8	1.5	4.8	5.5	2.8	3.3	2.6	1.6	3.6	3.1	0.8	3.4	1.9	3.3	1.6	2.7	2.9	2.7	1.3	1.7	7.2	3.8	2.8	0.3	3.0	0.9	2.3	3.7	3.9	2.4	2.4	2.0	4.0	4.7	1.3	4.5	1.7	2.9	3.0	2.1	0.9	2.5	0.8	1.0	2.3	2.3	2.2	1.9	1.7	2.7	2.3	6.7	2.0	1.7	1.9	1.3	0.6	10.0	11.2	11.8	16.8	7.3	7.8	6.2	11.4	13.1	7.5
PLET1	C11orf34	ENSG00000188771	"Placenta expressed transcript 1"	Q6UQ28	11	112248479-112260860	"Predicted membrane proteins"	Differentiation			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skin 1: 2.8"	"Cell line enhanced"	"Detected in single"		"AN3-CA: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA040237	Uncertain									"HPA040237: AB_10793960"								"unprognostic (8.70e-2)"		"unprognostic (1.75e-1)"			"unprognostic (8.51e-3)"	"unprognostic (5.19e-2)"				0.2	0.7	0.0	0.2	0.0	1.1	0.2	0.3	0.1	0.5	0.2			0.0	0.2	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.4	0.1	0.2	0.0		0.3	0.5	0.0	1.2	0.1		0.1	0.0		0.2	0.0	0.5	2.8	0.3	0.0	0.0	0.1	0.1	0.3			0.2		0.0	0.1	0.1	0.7	0.0	0.5	0.1	0.0	0.7	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.4	0.0	0.6	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.4	0.0	0.2	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.0	0.5	0.0	0.2	0.3	0.0	0.1	0.0	0.7	0.0	0.7	0.0	0.1	0.0	0.0	0.7	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0										
PLPP7	"C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3"	ENSG00000160539	"Phospholipid phosphatase 7 (inactive)"	Q8NBV4	9	131289459-131359022	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 29.0;skeletal muscle: 107.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 10.7;ASC diff: 11.3;ASC TERT1: 8.7;SCLC-21H: 11.1;SH-SY5Y: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070252	Uncertain		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA070252: "	"unprognostic (2.19e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.78e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.72e-3)"	3.6	3.7	3.3	1.7	4.6	1.2	2.8	7.7	8.2	2.3	3.2	4.6	0.0	1.5	2.5	3.1	2.5	2.0	2.3	29.0	3.6	3.9	1.9	1.1	1.5	1.3	3.7	4.2	3.9	1.8	1.1	1.7	1.4	3.7	2.6	1.3	2.0	1.6	2.6	107.3	1.3	1.6	2.9	3.2	1.7	1.4	2.2	3.2	0.0	1.2	22.6	1.2	2.1	1.6	1.3	4.6	0.0	5.2	2.3	0.5	1.9	0.0	0.0	2.2	10.7	11.3	8.7	2.2	1.6	1.1	0.3	0.0	0.0	0.0	0.0	0.3	4.3	0.0	0.2	0.0	0.1	0.0	1.9	0.0	0.1	3.4	2.8	0.0	0.0	2.9	0.0	3.1	0.0	0.0	0.2	0.0	5.1	0.1	0.0	0.1	2.5	0.0	0.0	0.0	0.0	2.4	0.0	11.1	8.5	0.0	0.1	0.0	0.3	2.7	0.1	0.1	0.8	0.5	0.0	0.0	0.4	0.0	1.8	0.0	1.7	0.0	5.2	0.0	0.0	3.3	0.0	1.0	0.0	0.0	4.6	1.3	0.4	0.5	0.0	2.3	2.8	2.0	0.0	1.9	3.3	4.6	7.7	8.2	3.6	3.9	3.7	4.2	3.7	3.2
PLPPR1	"FLJ20300, LPPR1, MGC26189, PRG-3"	ENSG00000148123	"Phospholipid phosphatase related 1"	Q8TBJ4	9	101028709-101325135	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 38.5;kidney: 24.4"	"Group enriched"	"Detected in some"	4	"Hep G2: 5.6;SCLC-21H: 10.3"	"Group enriched"	"Detected in some"	5	"glioma: 11.1;liver cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014760, HPA014968, HPA014979"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA014760: , HPA014968: AB_1855702, HPA014979: "	"unprognostic (1.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.41e-1)"	"prognostic favourable (1.37e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.86e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-6)"	"unprognostic (3.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.83e-2)"	0.8	0.9	12.6	0.7	38.5	0.7	1.4	1.7	24.4	1.0	0.9	7.6	0.0	0.8	0.8	5.2	0.8	1.0	0.9	0.8	12.7	7.0	24.4	5.0	2.8	0.7	7.5	5.5	0.7	1.1	0.7	0.1	0.8	5.3	1.0	1.0	0.1	1.1	0.8	0.8	0.8	0.8	0.8	10.2	0.7	0.9	1.5	9.3	0.0	0.7	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.9	10.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	38.5	1.7	6.4	12.7	7.0	7.5	5.5	5.3	9.3
PLPPR2	"LPPR2, PRG-4"	ENSG00000105520	"Phospholipid phosphatase related 2"	Q96GM1	19	11355386-11365698	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 32.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 32.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048973	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA048973: "	"unprognostic (1.29e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (6.45e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.72e-1)"	"prognostic favourable (6.82e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (7.46e-11)"	"unprognostic (1.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.17e-1)"	12.0	17.1	32.5	10.5	39.9	14.1	6.6	17.7	51.2	14.0	11.1	10.8	5.1	6.0	12.7	8.4	8.4	9.7	13.7	10.4	37.0	22.3	5.5	18.0	10.0	5.4	11.8	17.9	15.2	12.4	11.7	22.7	11.5	12.3	18.5	5.1	11.8	13.1	15.1	23.1	16.2	5.7	16.8	10.5	10.6	9.3	7.6	9.4	0.5	7.7	4.4	3.3	9.8	8.1	0.0	2.9	32.3	7.2	0.0	0.3	2.3	8.7	5.4	3.0	12.5	12.7	12.2	0.8	15.6	14.6	9.7	9.9	1.0	1.6	1.7	9.3	19.9	1.6	1.7	4.7	5.2	4.6	3.2	0.5	3.8	1.0	6.6	0.5	17.8	10.9	8.5	8.3	1.6	6.5	8.4	14.0	8.1	12.9	0.2	2.4	3.3	30.4	0.2	0.4	4.8	4.5	4.1	3.2	10.8	6.5	5.6	3.3	8.1	11.2	7.5	22.0	4.7	37.1	8.2	8.7	5.3	0.6	21.3	8.0	8.6	0.8	7.2	3.7	0.3	6.7	0.0	0.0	0.1	0.0	2.9	0.0	0.1	0.0	32.3	0.0	4.4	0.1	0.3	2.3	32.5	39.9	17.7	51.2	37.0	22.3	11.8	17.9	12.3	9.4
PLPPR3	"FLJ11535, LPPR3, PRG-2, PRG2"	ENSG00000129951	"Phospholipid phosphatase related 3"	Q6T4P5	19	812488-821977	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6"	"Group enriched"	"Detected in some"	6	"NB-4: 23.5;THP-1: 49.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"eosinophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052293, HPA057034"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA052293: , HPA057034: "	"unprognostic (7.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.32e-1)"	"unprognostic (4.51e-4)"	"unprognostic (8.06e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-12)"	"unprognostic (1.21e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.91e-1)"	0.7	0.7	20.5	1.2	30.0	18.2	2.1	0.1	21.3	0.9	0.7	0.7	0.0	0.7	1.3	0.7	0.7	12.6	1.1	0.7	14.4	13.1	0.7	0.7	2.6	0.9	3.9	14.9	1.0	0.7	0.7	0.1	0.8	4.7	0.9	0.7	0.1	0.7	0.8	0.9	0.8	1.0	0.7	1.1	0.9	0.9	3.0	3.1	0.0	0.7	0.0	0.7	0.8	0.0	0.1	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.6	4.8	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.4	0.0	0.1	0.9	0.0	0.0	0.0	2.0	0.0	0.6	0.0	0.2	1.6	0.1	0.6	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.4	0.0	23.5	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	6.2	0.1	0.0	0.0	2.1	49.8	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	3.8	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	30.0	0.1	21.3	14.4	13.1	3.9	14.9	4.7	3.1
PLPPR5	"LPPR5, PAP2, PAP2D, PRG5"	ENSG00000117598	"Phospholipid phosphatase related 5"	Q32ZL2	1	98890245-99005032	"Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 18.6;testis: 5.5"	"Group enriched"	"Detected in some"	7	"PC-3: 12.0;SH-SY5Y: 21.5"	"Group enriched"	"Detected in some"	13	"glioma: 2.7;renal cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018072, HPA059085"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA018072: AB_1854958, HPA059085: "	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.07e-1)"		"prognostic unfavourable (6.22e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.28e-1)"		"unprognostic (2.33e-1)"	0.5	1.8	7.8	0.7	8.7	0.5	0.5	0.8	18.6	1.4	0.6	2.1	0.0	0.7	0.7	0.5	0.6	0.5	0.6	0.5	8.0	6.6	0.7	0.5	0.7	0.5	2.5	4.5	0.6	1.6	0.5	0.3	0.5	3.6	0.6	0.8	1.8	0.5	1.0	0.9	0.6	0.7	0.6	1.0	0.5	0.7	5.5	1.8	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	12.0	0.0	0.0	0.0	0.5	0.1	0.4	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.8	8.7	0.8	11.6	8.0	6.6	2.5	4.5	3.6	1.8
PLSCR5		ENSG00000231213	"Phospholipid scramblase family member 5"	A0PG75	3	146576555-146606216	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.8;intestine: 1.8;parathyroid gland: 5.6"	"Cell line enhanced"	"Detected in single"		"HSkMC: 1.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA047249	Uncertain									"HPA047249: "																		0.1	0.0	0.5	0.1	1.8	0.0	0.1	0.1	0.3	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.2	0.1	0.4	0.1	0.1	0.1	5.6	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	1.8	0.1	0.1	0.1	0.0	0.6	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.1	0.3	0.1	0.5	0.4	0.1	0.1	0.1
PLVAP	"FELS, gp68, PV-1, PV1"	ENSG00000130300	"Plasmalemma vesicle associated protein"	Q9BX97	19	17351448-17377350	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 128.3"	"Cell line enriched"	"Detected in some"	28	"EFO-21: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 22.1"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 22.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA002279	Supported		Approved	"Plasma membrane,Centrosome,Cytosol"			53000	Cytosol	"Plasma membrane, Centrosome"	"HPA002279: AB_1079636"	"unprognostic (3.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.17e-2)"	128.3	9.8	0.8	16.4	0.9	0.0	56.3	0.4	1.5	28.7	29.8	3.2	12.8	20.2	32.0	19.8	27.4	16.6	43.1	18.9	1.1	0.4	33.7	4.6	13.1	34.6	0.9	0.5	14.3	22.9	13.8	16.1	12.6	2.7	26.1	5.2	26.3	16.0	10.4	20.7	11.5	23.7	13.5	1.2	77.8	22.1	9.5	0.7	3.8	88.3	13.9	15.2	30.1	87.7	0.0	22.1	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	109.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	22.1	0.0	0.3	0.8	0.9	0.4	1.5	1.1	0.4	0.9	0.5	2.7	0.7
PMFBP1		ENSG00000118557	"Polyamine modulated factor 1 binding protein 1"	Q8TBY8	16	72112157-72176878	"Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 13.6;testis: 30.8"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 20.6;SH-SY5Y: 10.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA056716, HPA075825"	Approved		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA056716: , HPA075825: "	"unprognostic (1.46e-1)"	"unprognostic (3.62e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.06e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.68e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.67e-2)"	1.1	0.9	1.1	1.1	1.1	3.9	1.1	2.1	1.1	1.1	2.1	1.1	1.1	2.6	1.1	13.6	1.6	0.9	1.1	1.1	1.1	0.7	1.3	1.6	1.1	1.5	1.1	1.1	1.5	4.2	2.9	1.5	1.1	1.1	2.1	3.3	1.1	1.1	1.1	1.1	4.1	2.9	1.1	1.1	2.9	1.1	30.8	1.1	1.1	1.1	1.1	1.1	1.1	1.1	0.5	1.9	0.9	2.0	0.0	0.3	0.2	0.2	0.4	2.7	2.5	0.0	0.6	1.8	0.5	0.2	0.5	2.0	1.0	2.6	1.8	0.4	0.1	1.7	1.0	0.1	1.3	0.2	4.1	1.8	2.9	2.9	0.0	4.0	3.1	0.0	0.8	0.1	2.1	0.7	0.3	1.5	0.1	2.3	1.0	5.9	0.8	1.1	2.7	0.2	1.4	0.3	0.7	20.6	10.3	0.0	0.0	0.2	0.5	2.5	1.7	1.3	2.1	0.6	1.3	3.8	1.4	1.1	0.6	2.6	0.7	0.0	1.6	0.9	0.1	0.5	0.0	0.0	0.1	0.2	1.6	0.5	0.1	0.1	0.2	0.0	2.0	1.9	0.3	0.2	1.1	1.1	2.1	1.1	1.1	0.7	1.1	1.1	1.1	1.1
PNCK	"CaMK1b, MGC45419"	ENSG00000130822	"Pregnancy up-regulated nonubiquitous CaM kinase"	Q6P2M8	X	153669730-153689010	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.4;seminal vesicle: 38.5"	"Cell line enriched"	"Detected in some"	8	"AN3-CA: 26.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007458	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA007458: AB_1079644"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.95e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (1.04e-6)"	"unprognostic (2.86e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.26e-3)"	1.6	1.8	21.4	2.2	35.4	0.6	0.9	3.7	24.9	0.9	21.9	0.9	6.9	3.8	4.2	3.1	14.5	2.9	2.9	3.8	19.5	17.0	1.0	0.5	0.7	0.6	6.1	15.5	0.7	0.5	1.4	0.3	2.4	3.8	12.6	4.2	0.4	0.7	38.5	2.2	1.4	5.2	15.3	2.6	0.7	5.5	4.7	1.7	0.0	0.5	0.0	0.7	10.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	26.5	0.0	0.0	2.8	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.4	0.0	0.0	0.0	3.2	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.1	0.0	0.1	2.1	0.2	0.3	0.0	0.2	1.1	0.0	0.2	0.2	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	35.4	3.7	23.2	19.5	17.0	6.1	15.5	3.8	1.7
PNLIPRP3		ENSG00000203837	"Pancreatic lipase related protein 3"	Q17RR3	10	116427867-116477957	"Enzymes, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 8.5;breast: 15.9;esophagus: 12.0;skin 1: 15.5"	"Cell line enriched"	"Detected in some"	18	"hTCEpi: 84.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA046202, HPA052009"	Uncertain				"Secreted - unknown location"					"HPA046202: AB_10959739, HPA052009: "					"unprognostic (2.62e-4)"	"unprognostic (1.60e-1)"			"unprognostic (6.97e-2)"									8.5	0.1	0.0	0.0	0.2	0.0	15.9	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.0	0.4	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	15.5	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.0	8.1	1.9	0.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
PNMA3	"MA3, MA5, MGC132756, MGC132758"	ENSG00000183837	"PNMA family member 3"	Q9UL41	X	153056409-153060467	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 17.4;epididymis: 35.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.8;NTERA-2: 8.0;SCLC-21H: 2.6;SH-SY5Y: 2.0;THP-1: 2.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA047920	Approved									"HPA047920: "	"unprognostic (1.66e-2)"	"unprognostic (8.97e-3)"	"unprognostic (8.70e-2)"	"prognostic unfavourable (4.14e-5)"	"unprognostic (9.43e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.77e-4)"	"unprognostic (2.84e-2)"	"unprognostic (6.20e-2)"	"unprognostic (7.62e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.92e-3)"	"unprognostic (2.93e-3)"	"unprognostic (7.25e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.07e-2)"	0.4	1.4	4.8	0.8	6.8	0.4	0.3	3.0	17.4	0.5	0.3	0.2	0.0	0.4	0.5	35.5	0.3	1.2	0.4	1.4	4.9		1.0	0.3	0.3	1.4	0.0	13.7	0.6	0.5	0.4	0.7	0.3	11.2	0.5	0.3	0.7	0.4	0.6	0.3	0.6	0.5	0.3	1.3	0.8	0.3	5.9	0.0	0.0	0.9	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	8.0	0.0	0.1	0.0	0.3	0.0	0.0	2.6	2.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0										
PNMA8B	"KIAA1183, PNMAL2"	ENSG00000204851	"PNMA family member 8B"	Q9ULN7	19	46486906-46496498	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 10.3;brain: 22.5"	"Cell line enhanced"	"Detected in some"		"AF22: 3.7;AN3-CA: 4.7;fHDF/TERT166: 1.6;NTERA-2: 1.9;SH-SY5Y: 3.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.8"	"Low region specificity"	"Detected in all"							HPA054810	Enhanced									"HPA054810: "	"unprognostic (1.31e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.15e-1)"	"unprognostic (4.19e-3)"	"unprognostic (4.26e-4)"	"unprognostic (7.30e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.32e-2)"	2.3	10.3	9.1	0.3	6.7	0.0	0.5	2.5	22.5	0.8	0.3			0.3	0.6	0.5	0.4	0.7	0.9	1.2	9.0	15.6	0.4	0.2	0.6	0.3	6.4		3.9	0.8	0.1	1.8	0.3		1.0	0.1		1.4	1.0	0.4	1.6	0.5	0.5	2.8	1.6	0.4	0.6			0.2		0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.3	1.8	0.3	0.0	0.0	3.7	4.7	1.1	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.4	3.9	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.4	0.2	0.0	0.0	1.8	0.4	0.0	0.3	0.0	0.0	0.1	0.3										
PNPLA4	"DXS1283E, GS2, iPLA2eta"	ENSG00000006757	"Patatin like phospholipase domain containing 4"	P41247	X	7898247-7927739	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA003656	Approved				"Intracellular and membrane"					"HPA003656: AB_1079033"	"unprognostic (2.97e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.17e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavourable (5.29e-4)"	"prognostic unfavourable (5.37e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.27e-1)"	"prognostic favourable (2.23e-12)"	"unprognostic (5.23e-2)"	"unprognostic (6.71e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.12e-1)"	11.3	18.1	12.6	6.0	18.8	4.7	13.9	5.0	11.5	8.9	8.9	8.5	13.3	11.2	9.2	11.4	13.2	15.0	6.2	24.0	10.9	11.9	26.5	39.8	5.8	6.3	12.0	8.7	14.0	21.0	13.3	17.0	4.7	12.2	8.0	7.5	13.1	18.9	10.7	40.9	10.8	10.5	7.4	11.2	5.4	11.5	7.8	10.6	7.2	23.6	21.1	8.9	6.6	9.5	13.2	18.3	7.6	10.4	9.0	10.3	8.4	18.6	7.6	1.2	19.3	0.4	0.2	5.2	5.8	0.6	10.1	6.2	7.7	6.9	5.9	0.0	1.9	11.0	0.0	19.5	17.3	0.2	13.7	4.2	14.8	16.1	12.8	7.3	6.2	13.2	20.0	5.1	12.1	7.0	16.4	0.2	0.1	4.9	0.1	7.2	20.4	16.3	0.1	0.1	6.5	13.3	8.5	11.1	5.6	17.6	7.3	9.9	11.3	5.5	4.0	0.1	5.1	15.5	0.1	8.9	0.1	11.1	0.1	0.1	1.6	5.2	9.8	7.6	5.4	10.4	6.2	12.3	7.8	5.9	18.3	13.2	10.3	9.8	0.7	9.0	9.7	13.5	4.8	8.4	12.6	18.8	5.0	11.5	10.9	11.9	12.0	8.7	12.2	10.6
PNPLA5	"dJ388M5.4, GS2L"	ENSG00000100341	"Patatin like phospholipase domain containing 5"	Q7Z6Z6	22	43879678-43892013	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 5.6;epididymis: 6.2;skin 1: 4.6"	"Group enriched"	"Detected in some"	5	"NTERA-2: 3.9;RPMI-8226: 7.1;SCLC-21H: 2.4"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.9"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA050409, HPA054211"	Uncertain									"HPA050409: , HPA054211: "				"unprognostic (6.69e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.27e-2)"		"unprognostic (3.33e-3)"				"unprognostic (1.05e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.31e-2)"		0.0	0.1	0.5	0.2	5.6	1.0	0.9	0.1	2.4	0.1	0.0			0.1	0.3	6.2	0.0	0.6	0.5	0.0	0.8	0.9	0.0	1.7	0.1	0.1	0.4		0.0	0.0	0.0	1.3	0.1		0.2	0.0		0.1	0.1	0.0	4.6	0.0	0.1	0.1	0.2	0.1	0.4			0.5		0.0	0.0	0.0	0.7	1.0	2.2	0.5	0.2	0.7	0.0	0.2	0.0	0.1	0.3	0.1	0.4	0.2	0.1	0.3	0.1	0.8	0.3	0.4	0.1	0.4	0.2	0.4	0.2	0.5	0.1	0.7	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.2	0.3	0.4	0.3	0.1	0.3	3.9	0.1	0.2	0.2	7.1	0.1	0.0	2.4	0.2	0.5	0.1	0.0	0.3	0.1	0.2	0.6	0.2	0.3	0.1	0.3	0.1	0.2	0.4	0.2	0.1	2.2	0.5	0.1	0.7	0.3	0.5	0.4	0.6	0.6	0.1	0.7	0.4	0.6	1.6	0.2	0.5	1.0	0.6	0.0										
PODNL1	"FLJ23447, SLRR5B"	ENSG00000132000	"Podocan like 1"	Q6PEZ8	19	13931187-13953392	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 24.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 10.2;HHSteC: 7.9;HSkMC: 18.8;SiHa: 15.0;U-2 OS: 11.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042807	Approved				"Secreted - unknown location"					"HPA042807: AB_10795514"	"unprognostic (1.24e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (5.61e-8)"	"unprognostic (1.78e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.94e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavourable (4.49e-4)"	2.4	1.6	2.2	3.5	4.1	2.2	4.5	7.9	3.2	6.7	2.3	3.0	2.2	1.9	1.7	2.5	8.7	1.7	5.9	4.4	2.0	7.5	1.4	1.0	3.8	1.3	4.2	2.3	3.1	2.5	0.7	4.7	24.5	5.0	6.1	1.5	11.1	4.2	4.1	3.7	12.7	2.7	2.6	3.8	1.3	3.0	7.6	2.1	0.8	2.4	14.9	3.9	4.8	9.9	0.9	3.4	1.3	1.7	1.0	0.8	0.6	0.5	0.6	0.6	0.3	1.0	2.4	0.2	6.4	3.9	1.2	2.6	0.5	0.7	0.3	0.5	10.2	2.4	0.2	0.2	0.7	2.3	1.0	1.2	0.4	0.1	7.9	0.3	0.8	18.8	1.1	1.7	0.2	0.0	0.6	0.4	2.6	4.1	0.3	0.4	0.2	0.6	0.2	0.2	0.0	0.5	0.1	1.2	0.7	15.0	0.2	0.5	0.1	0.8	1.1	3.2	11.0	0.9	0.4	0.5	0.1	0.1	1.2	1.4	0.3	0.7	1.7	0.7	0.8	1.4	0.3	0.9	0.6	0.3	3.4	0.5	0.4	0.3	1.3	1.0	0.2	0.5	0.2	0.6	2.2	4.1	7.9	3.2	2.0	7.5	4.2	2.3	5.0	2.1
POM121L12	DKFZp564N2472	ENSG00000221900	"POM121 transmembrane nucleoporin like 12"	Q8N7R1	7	53035642-53036924	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	175	"testis: 36.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA027836	Enhanced									"HPA027836: AB_10669592"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POMZP3	"POM-ZP3, POM121"	ENSG00000146707	"POM121 and ZP3 fusion"	Q6PJE2	7	76609986-76627261	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA049817	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA049817: "	"unprognostic (2.23e-1)"	"prognostic favourable (4.34e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (3.78e-4)"	"unprognostic (4.31e-1)"	"unprognostic (7.49e-2)"	"prognostic favourable (9.31e-4)"	"unprognostic (4.94e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.99e-2)"	4.0	3.0	4.7	3.4	5.6	6.6	4.5	6.0	5.3	4.7	4.6			2.4	5.8	5.2	3.8	2.8	2.1	3.8	4.7	3.5	4.4	2.2	3.6	3.1	3.5		5.8	4.7	2.0	3.1	1.7		4.5	3.7		4.3	5.1	14.2	5.3	3.0	7.0	4.0	2.5	3.9	9.5			3.9		3.6	4.0	3.9	4.2	3.5	5.7	3.3	3.0	4.8	1.1	1.9	8.1	13.1	16.8	8.6	3.4	2.0	2.9	4.5	2.1	2.7	4.7	3.7	1.2	0.8	2.6	1.2	3.0	1.3	2.0	5.0	4.7	5.4	4.4	2.8	2.0	2.4	3.6	2.9	5.4	7.2	2.5	1.3	2.9	9.4	9.3	2.5	4.3	10.0	5.8	4.1	1.8	9.5	2.0	1.6	3.0	6.8	12.4	2.5	11.9	4.3	4.5	3.2	5.0	6.7	0.9	16.5	6.8	2.4	2.1	8.8	1.3	9.8	9.2	1.4	3.3	5.7	2.4	1.5	3.5	2.5	3.9	4.0	3.3	4.2	4.8	2.7	3.8	3.0	1.6	3.5	3.4	1.1										
POPDC2	POP2	ENSG00000121577	"Popeye domain containing 2"	Q9HBU9	3	119636457-119665324	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 90.5"	"Cell line enriched"	"Detected in single"	27	"SH-SY5Y: 25.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA024255	Enhanced									"HPA024255: AB_1855545"	"unprognostic (1.13e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.91e-3)"	"unprognostic (9.48e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-2)"	1.3	0.3	0.2	1.0	0.2	0.0	0.6	0.3	0.2	1.8	16.0	0.2	7.6	0.6	2.0	1.3	3.3	1.8	6.1	90.5	0.2	0.0	0.5	0.3	0.3	1.4	0.2	0.3	0.8	0.7	0.1	0.2	0.3	0.3	5.0	1.5	0.3	0.6	13.4	12.1	0.4	2.2	12.6	0.2	0.5	2.4	0.5	0.2	0.3	0.5	3.8	0.8	10.2	1.1	0.9	0.7	2.1	3.0	0.3	2.2	0.4	0.0	0.1	0.4	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.2	25.5	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.7	0.0	0.1	0.1	0.2	0.5	2.1	0.1	1.3	0.9	0.1	1.1	0.3	1.1	1.0	0.1	0.9	2.2	0.7	0.1	0.3	3.0	0.7	1.6	0.4	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.3	0.3	0.2
POPDC3	"bA355M14.1, MGC22671, POP3"	ENSG00000132429	"Popeye domain containing 3"	Q9HBV1	6	105158280-105179995	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"heart muscle: 23.9;skeletal muscle: 68.9"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 13.2;RH-30: 14.7;SH-SY5Y: 12.2;U-87 MG: 13.3;WM-115: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA012514			Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA012514: "	"unprognostic (2.17e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (2.24e-3)"	"prognostic unfavourable (5.79e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.83e-9)"	"unprognostic (6.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.33e-2)"	0.9	0.8	2.2	1.4	4.5	0.6	2.5	0.4	6.8	0.8	1.4	2.1	0.8	0.7	1.3	2.2	2.1	0.7	1.1	23.9	3.7	2.3	0.6	0.6	0.7	0.7	6.1	3.5	0.7	0.6	0.6	3.2	1.2	4.0	1.2	0.6	1.9	1.0	0.8	68.9	0.6	0.6	0.6	3.6	0.6	1.6	3.6	4.0	0.0	0.8	8.8	0.6	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.6	0.4	0.1	2.7	6.9	0.6	2.7	2.8	4.7	5.8	0.0	1.5	0.1	1.1	5.4	0.0	1.3	1.2	3.9	0.0	2.9	0.0	1.0	0.0	0.1	0.0	0.0	2.7	0.2	7.6	1.0	0.3	2.8	8.1	13.2	0.0	0.0	1.0	3.0	4.6	0.4	14.7	0.0	0.0	0.0	6.7	12.2	0.0	0.0	9.5	0.0	5.2	6.0	2.9	0.0	1.9	9.9	0.0	0.0	0.0	13.3	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	4.5	0.4	6.8	3.7	2.3	6.1	3.5	4.0	4.0
POTEE	"A26C1, A26C1A, CT104.2, POTE-2, POTE2, POTE2gamma"	ENSG00000188219	"POTE ankyrin domain family member E"	Q6S8J3	2	131218067-131265278	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 2.4;prostate: 2.0;testis: 4.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.7;BEWO: 3.5;K-562: 3.6;U-2 OS: 6.8;U-266/84: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA041264, HPA041271, HPA043260"	Uncertain									"HPA041264: , HPA041271: , HPA043260: "	"unprognostic (3.13e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.59e-3)"		"unprognostic (3.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.61e-3)"	"unprognostic (5.77e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.90e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.6		2.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.9			0.0		0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	2.4	0.1	0.0	0.2	2.7	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.1	0.7	2.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4										
POU2F3	"Epoc-1, OCT11, PLA-1, Skn-1a"	ENSG00000137709	"POU class 2 homeobox 3"	Q9UKI9	11	120236640-120319944	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.1;SK-BR-3: 5.2;T-47d: 9.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019652, HPA073468"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol"				Nucleoplasm	"Nucleoli, Nuclear bodies, Plasma membrane, Cytosol"	"HPA019652: AB_1855585, HPA073468: "	"unprognostic (1.75e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (8.56e-3)"	"unprognostic (9.34e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.70e-1)"	"prognostic favourable (8.14e-4)"	"unprognostic (1.45e-1)"	0.2	0.2	0.1	0.2	0.1	0.0	1.6	0.1	0.1	1.2	0.9	0.0	36.5	0.7	0.4	1.2	2.5	0.3	0.4	0.2	0.1	0.1	0.3	0.2	1.6	0.4	0.1	0.0	0.2	0.3	6.4	1.3	4.4	0.1	1.1	0.1	0.0	1.1	13.2	0.1	38.2	1.0	0.2	0.1	0.2	0.4	0.6	0.0	0.4	4.5	4.8	2.2	0.7	2.6	1.0	0.7	2.1	0.5	0.9	0.6	0.2	2.4	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.6	0.0	0.0	0.1	7.1	0.3	2.6	0.0	1.3	0.0	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.7	0.4	0.0	0.0	1.3	0.0	0.1	0.1	0.2	0.3	0.6	0.0	0.0	0.1	0.0	1.8	0.4	0.1	0.1	5.2	0.0	9.4	0.4	0.8	0.0	0.2	0.3	0.1	0.1	0.0	0.0	1.1	0.1	0.1	1.4	0.4	0.5	0.5	0.3	0.5	0.5	0.6	0.4	0.1	1.0	0.6	0.6	2.1	0.9	0.5	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
POU3F1	"OCT6, OTF6, SCIP"	ENSG00000185668	"POU class 3 homeobox 1"	Q03052	1	38044611-38046794	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 10.5;skin 1: 31.0"	"Cell line enhanced"	"Detected in some"		"AF22: 10.8;HDLM-2: 18.8;NTERA-2: 5.2;SCLC-21H: 3.7;SK-MEL-30: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 7.0;cerebral cortex: 3.5;hippocampal formation: 9.7"	"HPA055980, HPA073824"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA055980: , HPA073824: "	"unprognostic (9.99e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.61e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.67e-3)"	0.8	2.1	4.0	0.9	10.5	0.7	0.8	1.2	6.8	0.6	0.7	1.1	0.0	0.6	0.7	0.8	3.4	0.7	0.7	0.7	7.7	0.9	0.7	0.6	0.6	1.7	3.9	2.9	0.7	0.8	0.6	0.0	0.6	1.4	3.6	0.6	1.6	0.6	0.7	1.3	31.0	0.7	2.5	0.6	0.7	0.7	1.5	2.6	0.0	0.7	1.3	1.7	1.5	0.4	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	10.8	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	18.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.1	0.0	0.0	0.1	0.0	0.7	3.7	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.0	10.5	1.2	6.8	7.7	0.9	3.9	2.9	1.4	2.6
POU3F3	"BRN1, OTF8"	ENSG00000198914	"POU class 3 homeobox 3"	P20264	2	104855511-104858574	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"brain: 18.9;epididymis: 27.2;kidney: 23.7;seminal vesicle: 12.1"	"Group enriched"	"Detected in some"	6	"AF22: 27.0;AN3-CA: 25.8;HEK 293: 10.0;RPTEC TERT1: 30.6;SH-SY5Y: 8.5"	"Group enriched"	"Detected in some"	6	"glioma: 21.5;renal cancer: 24.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052792, HPA056039, HPA067151"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA052792: , HPA056039: , HPA067151: AB_2685790"	"unprognostic (3.05e-2)"		"unprognostic (1.07e-1)"	"prognostic unfavourable (4.26e-5)"	"unprognostic (9.66e-2)"	"unprognostic (1.97e-1)"			"unprognostic (4.69e-1)"	"unprognostic (1.16e-1)"			"unprognostic (7.28e-2)"	"unprognostic (1.15e-3)"	"unprognostic (7.15e-2)"			0.2	0.2	9.0	0.1	8.6	0.0	0.1	4.3	18.9	0.0	0.3			0.0	0.0	27.2	0.0	0.0	0.0	0.0	9.9	6.0	23.7	0.0	0.0	0.1	8.9		0.1	0.0	0.0	0.0	0.0		0.0	0.1		0.0	12.1	0.0	0.5	0.0	0.0	10.0	0.0	0.1	0.1			0.0		0.1	0.0	0.0	0.4	0.4	0.9	0.2	0.3	0.2	0.0	0.0	0.0	27.0	25.8	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	3.2	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	2.8	0.6	0.0	30.6	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.0	0.4	0.0	0.0										
POU4F1	"BRN3A, RDC-1"	ENSG00000152192	"POU class 4 homeobox 1"	Q01851	13	78598362-78603560	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 25.3"	"Cell line enhanced"	"Detected in some"		"HEK 293: 10.9;HEL: 11.5;REH: 8.1;RH-30: 13.9;SCLC-21H: 13.3;U-266/70: 12.5"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	23	"pons and medulla: 25.3"	"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.1"	"Group enriched"	"Detected in some"	14	"midbrain: 3.0;pons and medulla: 2.2;thalamus: 2.4"	"Group enriched"	"Detected in some"	25	"midbrain: 3.1;pons and medulla: 7.4;thalamus: 2.5"	HPA068024	Enhanced	Approved								"HPA068024: "	"unprognostic (6.70e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-3)"		"unprognostic (1.32e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.98e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.53e-1)"		"unprognostic (4.75e-3)"	0.1	0.0	1.1	2.3	1.0	1.2	1.0	0.2	0.4	0.1	0.1	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.2	1.0	1.0	0.0	0.5	0.1	2.3	0.7	0.0	0.0	0.1	0.1	0.0	0.9	25.3	0.0	0.3	6.3	0.2	0.0	1.8	0.4	0.3	0.0	2.5	0.3	0.3	4.4	0.4	2.7	0.0	0.2	3.5	0.3	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	10.9	11.5	0.0	1.4	0.0	5.7	3.4	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.5	0.0	0.8	1.0	0.0	0.0	8.1	13.9	0.0	0.0	0.0	13.3	0.1	0.0	0.0	0.5	0.0	1.1	0.1	0.0	0.0	0.2	0.0	12.5	3.7	0.0	0.0	6.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.1	1.0	0.2	0.4	1.0	1.0	0.7	0.0	25.3	0.4
POU5F2	"FLJ25680, SPRM-1"	ENSG00000248483	"POU domain class 5, transcription factor 2"	Q8N7G0	5	93733220-93741637	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 26.8"	"Cell line enriched"	"Detected in some"	7	"U-2 OS: 8.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA077615	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA077615: "	"unprognostic (1.07e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.03e-1)"	"unprognostic (9.17e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.87e-3)"	"unprognostic (4.58e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.84e-1)"	"unprognostic (6.16e-9)"	"unprognostic (1.87e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-3)"	0.2	0.2	0.2	0.2	0.2	1.2	0.8	0.2	0.9	0.2	0.2	0.2	0.2	0.6	0.2	0.6	0.2	0.1	0.4	0.2	0.2	0.2	0.2	0.2	0.4	0.4	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.1	0.2	0.2	0.2	0.2	1.4	0.6	0.2	0.2	0.3	0.5	26.8	0.2	0.2	0.5	0.2	0.2	0.2	0.2	2.0	0.5	2.7	0.6	1.1	1.3	0.3	0.4	0.6	1.1	0.5	0.2	0.4	0.5	0.2	0.0	0.3	0.1	0.3	0.4	0.9	0.4	0.2	0.6	0.8	0.3	0.5	0.5	0.7	0.8	0.7	0.6	0.2	0.8	0.8	0.5	0.7	0.5	0.4	0.1	0.6	1.1	0.3	0.4	0.7	1.0	0.7	0.2	0.5	1.1	0.9	0.2	0.3	1.0	0.9	0.6	0.7	0.2	0.5	0.7	0.6	0.5	8.3	0.7	0.7	0.8	0.5	0.8	0.4	0.9	0.4	1.4	0.6	0.3	1.0	0.4	1.0	0.8	0.7	0.6	0.1	2.0	0.7	1.1	2.7	1.1	0.4	0.5	1.3	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
PP2D1	"C3orf48, FLJ25449"	ENSG00000183977	"Protein phosphatase 2C like domain containing 1"	A8MPX8	3	19979961-20012330	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	9	"testis: 28.8"	"Cell line enhanced"	"Detected in some"		"U-266/84: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036870, HPA066083"	Enhanced		Uncertain	"Nucleoplasm,Intermediate filaments"				Nucleoplasm	"Intermediate filaments"	"HPA036870: AB_10671246, HPA066083: "	"unprognostic (1.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.76e-1)"	"unprognostic (6.27e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.35e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.50e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.04e-1)"	0.2	0.1	0.1	0.2	0.1	3.0	0.1	0.7	0.4	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.3	0.3	0.2	0.1	0.1	0.3	0.2	28.8	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.7	0.5	1.2	0.6	0.0	0.9	0.0	0.3	0.5	0.7	0.9	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.5	0.8	1.5	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.6	0.6	0.9	0.2	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.2	1.0	0.8	1.0	0.3	0.8	0.9	1.6	0.0	0.3	0.4	1.9	0.1	2.2	1.3	0.7	0.8	0.2	0.0	0.3	0.3	0.5	0.6	4.0	1.6	1.8	0.8	0.3	0.0	0.5	0.9	0.8	0.6	0.3	0.2	0.5	0.4	0.1	0.7	0.9	0.8	1.2	0.0	0.4	0.5	0.0	0.0	0.1	0.1	0.7	0.3	0.1	0.1	0.1	0.1	0.1	0.1
PPAN	"BXDC3, SSF, SSF1, SSF2"	ENSG00000130810	"Peter pan homolog (Drosophila)"	Q9NQ55	19	10106289-10111634	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043265	Approved									"HPA043265: AB_10793943"	"unprognostic (1.91e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.23e-2)"	"unprognostic (9.47e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.80e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.01e-3)"	"unprognostic (8.75e-3)"	"unprognostic (7.52e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.92e-3)"	18.9	17.5	15.9	26.0	23.2	19.2	17.8	21.5	21.7	14.9	15.1	15.3	8.8	20.8	18.7	14.4	24.6	17.3	13.1	14.9	15.0	12.2	13.0	22.3	13.5	29.3	15.0	15.7	22.1	25.3	16.9	13.2	14.0	14.8	17.8	11.3	13.5	19.5	15.1	27.4	27.2	17.2	15.5	10.8	24.7	16.4	19.7	19.6	23.3	14.8	17.5	25.3	15.0	17.5	13.8	6.0	4.2	6.4	5.6	12.0	2.8	13.6	11.5	4.4	9.7	3.1	3.3	9.9	7.7	3.5	9.5	7.4	15.2	5.2	15.9	14.0	4.6	11.7	11.8	13.0	4.2	8.7	31.8	29.2	12.7	15.1	7.9	17.9	17.3	5.1	10.2	10.3	13.2	4.7	20.9	14.5	4.9	20.2	21.6	67.5	21.0	32.1	15.9	5.7	21.7	5.3	11.8	9.4	11.5	6.7	11.7	10.4	6.4	9.5	5.8	12.7	7.0	14.0	19.2	32.0	15.1	16.6	8.7	15.6	11.1	1.6	6.4	3.1	7.0	4.7	9.2	13.8	8.9	11.6	6.0	13.2	12.0	6.3	4.2	5.6	3.3	4.5	8.0	2.8	15.9	23.2	21.5	21.7	15.0	12.2	15.0	15.7	14.8	19.6
PPFIA4		ENSG00000143847	"PTPRF interacting protein alpha 4"	O75335	1	203026498-203078740	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 72.6;heart muscle: 26.2;skeletal muscle: 20.4"	"Cell line enhanced"	"Detected in many"		"A-431: 7.7;LHCN-M2: 6.5;RH-30: 13.7;U-266/70: 8.6;U-87 MG: 12.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"cerebellum: 72.6;cerebral cortex: 21.1"	"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053419, HPA054132"	Enhanced									"HPA053419: , HPA054132: "	"unprognostic (2.83e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.38e-5)"	"unprognostic (3.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.49e-8)"	"unprognostic (4.65e-1)"	"unprognostic (6.01e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavourable (1.73e-8)"	"unprognostic (6.82e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.28e-2)"	0.6	1.3	9.2	1.0	10.9	1.6	0.9	72.6	21.1	1.8	1.0	1.4	0.0	1.1	1.7	3.5	1.3	1.2	2.6	26.2	6.6	5.0	1.9	0.6	1.2	0.8	3.0	10.8	0.9	0.6	1.3	0.7	3.9	11.4	1.5	0.8	0.6	1.4	1.3	20.4	2.9	1.3	2.0	2.0	2.2	0.8	3.3	2.3	0.0	0.9	0.4	0.8	0.9	0.9	0.0	1.4	1.3	0.9	0.0	0.6	0.0	7.7	0.0	0.1	1.9	0.0	0.3	0.4	0.4	0.9	0.7	3.3	0.4	0.3	0.4	1.6	1.7	0.9	0.6	1.5	1.5	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.0	2.5	0.1	0.4	0.0	0.0	0.1	0.3	6.5	1.1	0.5	1.0	0.9	0.3	1.3	13.7	2.2	0.0	0.0	2.6	3.3	0.8	0.2	1.1	0.2	0.6	0.0	4.9	3.0	0.1	0.0	8.6	0.2	0.1	12.6	0.7	0.5	0.0	0.9	1.3	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.6	0.0	9.2	10.9	72.6	21.1	6.6	5.0	3.0	10.8	11.4	2.3
PPIAL4A	"COAS2, PPIAL4, PPIAL4B"	ENSG00000263353	"Peptidylprolyl isomerase A like 4A"	Q9Y536	1	120889746-120890405	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 3.5;intestine: 1.6"	"Cell line enhanced"	"Detected in many"		"NB-4: 4.5;SK-BR-3: 4.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA058345	Uncertain									"HPA058345: "	"unprognostic (3.49e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-1)"	0.3	0.8		1.0		1.4	0.2		1.2	0.0	0.0			1.6	0.0	0.0	0.0	0.0	0.0	0.1			0.2	1.2	0.0	0.5			0.1	0.0	0.0		0.4		0.0	0.0		0.0	0.0	0.0	0.2	1.0	0.0		0.4	0.4	0.0			0.0		0.0	0.0		3.0	3.2	0.6	1.6	2.2	2.4	3.5	0.9	0.0	0.1	1.4	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	1.0	0.7	0.2	0.0	1.7	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.8	0.0	0.0	0.3	0.2	3.7	0.3	0.6	1.7	4.5	2.4	0.0	0.8	1.5	1.9	0.0	0.0	1.0	0.3	0.3	4.6	0.4	3.0	2.5	0.7	3.0	1.2	2.9	1.6	1.3	0.9	2.4	2.6	1.5	3.1	0.2	1.6	0.6	1.4	1.2	1.4	3.0	2.3	2.4	3.1	2.2	1.5	2.4	0.0	2.2	1.2	3.2	2.4	3.5										
PPIAL4C		ENSG00000263464	"Peptidylprolyl isomerase A like 4C"	A0A0B4J2A2	1	149583865-149584464	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 10.9;intestine: 5.5"	"Cell line enhanced"	"Detected in many"		"NB-4: 14.2;THP-1: 16.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA058345	Uncertain									"HPA058345: "	"unprognostic (3.16e-1)"	"unprognostic (2.83e-2)"			"unprognostic (1.50e-2)"	"unprognostic (7.93e-2)"		"unprognostic (5.98e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"				"unprognostic (6.61e-2)"			"unprognostic (2.25e-1)"	0.0	3.3		2.7		0.1	0.0		1.5	0.0	0.8			5.5	0.8	0.0	0.0	0.0	0.0	0.0			1.0	0.0	1.0	2.9			0.2	0.0	0.9		0.7		0.3	0.0		0.0	0.0	0.2	0.5	2.9	0.0		1.4	0.9	0.0			0.0		0.3	0.0		9.1	9.7	1.9	6.0	4.6	7.8	10.9	3.5	0.3	0.4	3.1	0.1	0.3	2.0	0.5	0.4	1.0	0.7	0.0	4.8	1.2	2.1	0.0	3.9	0.0	0.2	0.6	3.5	0.0	0.5	0.0	0.0	0.1	2.0	1.9	0.1	0.5	0.6	0.3	0.0	0.9	5.3	0.7	0.4	5.2	14.2	6.1	0.1	5.2	0.0	8.9	0.2	0.0	3.9	5.4	1.1	11.1	6.0	5.2	16.6	1.2	3.5	5.5	3.3	8.0	4.2	5.5	9.0	3.8	4.6	7.7	0.9	4.3	1.9	5.4	6.0	6.0	9.1	6.1	5.7	9.4	7.2	5.0	5.9	0.0	4.6	5.3	9.7	7.8	10.9										
PPIL6	"bA425D10.6, dJ919F19.1, MGC41939, RSPH12"	ENSG00000185250	"Peptidylprolyl isomerase like 6"	Q8IXY8	6	109390215-109441171	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 36.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.6;ASC diff: 10.6;ASC TERT1: 13.2;hTCEpi: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036717, HPA058165"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA036717: AB_10671969, HPA058165: "	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.32e-1)"	1.5	1.4	5.5	1.1	8.6	0.7	3.6	5.0	4.8	4.6	1.7	7.2	7.4	1.9	3.8	12.7	2.0	36.5	1.7	2.6	6.0	5.4	4.9	1.2	8.9	1.1	3.4	3.2	6.3	4.3	6.6	7.6	1.6	18.3	1.8	1.6	2.6	2.8	5.0	3.9	1.7	1.1	5.4	3.2	1.3	2.3	20.4	5.3	0.0	17.2	1.4	1.1	2.9	2.0	5.1	1.7	2.0	1.3	1.7	1.3	1.1	1.8	1.1	1.2	6.6	10.6	13.2	1.2	0.0	2.4	0.6	0.2	0.1	1.8	0.0	0.5	0.6	1.2	1.0	0.0	0.4	0.5	0.9	0.5	0.1	0.0	5.3	0.6	0.3	2.7	6.3	0.2	4.0	0.8	0.9	0.4	0.4	0.6	0.1	0.6	0.2	1.3	0.8	0.0	0.6	5.1	0.1	1.5	2.5	0.2	0.3	4.4	0.5	1.0	0.4	0.1	0.2	1.1	0.2	0.3	0.1	0.1	2.2	0.1	0.4	2.0	1.2	1.2	0.9	1.3	0.9	5.1	1.2	1.1	1.7	3.2	1.1	1.0	1.6	1.7	1.1	1.7	1.3	1.1	5.5	8.6	5.0	4.8	6.0	5.4	3.4	3.2	18.3	5.3
PPM1M	"FLJ32332, PP2Ceta"	ENSG00000164088	"Protein phosphatase, Mg2+/Mn2+ dependent 1M"	Q96MI6	3	52245793-52250597	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 23.0;U-266/70: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA036905, HPA062291"	Uncertain		Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA036905: AB_10602818, HPA062291: "	"unprognostic (4.26e-3)"	"prognostic favourable (7.73e-4)"	"unprognostic (2.55e-2)"	"unprognostic (4.85e-3)"	"unprognostic (5.64e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"prognostic favourable (6.69e-4)"	"unprognostic (4.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (1.61e-5)"	"unprognostic (1.49e-1)"	"unprognostic (4.14e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.37e-2)"	14.3	7.2	13.9	22.7	14.8	16.5	26.3	3.6	9.2	16.9	12.5	4.6	7.8	4.4	13.6	12.0	10.8	11.7	19.4	14.5	8.7	8.5	8.7	4.9	30.1	38.0	5.4	12.3	14.9	5.9	6.9	7.5	8.6	4.9	15.1	6.7	11.0	10.8	12.4	3.1	7.5	8.8	18.1	6.8	22.5	8.3	6.2	5.9	20.5	11.3	9.9	20.5	11.3	13.5	5.0	9.6	19.6	18.6	7.4	15.0	10.1	0.4	2.5	1.6	3.7	22.9	23.0	2.5	5.8	12.6	8.3	6.4	1.5	2.0	4.2	1.7	15.2	0.7	5.2	1.1	3.4	5.1	1.2	9.6	6.7	1.5	16.8	1.4	9.2	18.9	2.5	9.2	5.8	10.6	1.6	7.0	9.6	1.0	6.3	0.4	2.0	7.1	1.4	0.7	9.3	3.6	1.1	1.1	4.6	4.2	1.1	5.2	3.6	3.7	7.4	3.1	5.3	1.8	0.7	26.3	4.9	4.5	6.3	2.5	3.8	1.2	15.7	8.5	15.0	12.4	11.7	5.0	11.8	13.8	9.6	3.8	11.1	13.8	19.6	7.4	18.6	5.8	13.2	10.1	13.9	14.8	3.6	9.2	8.7	8.5	5.4	12.3	4.9	5.9
PPM1N	FLJ40125	ENSG00000213889	"Protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)"	Q8N819	19	45488777-45502510	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 43.7;skeletal muscle: 81.9"	"Cell line enhanced"	"Detected in many"		"RT4: 21.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"non-classical monocyte: 43.7"	"Lineage enriched"	"Detected in all"	10	"monocytes: 43.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043577			Supported	Vesicles				Vesicles		"HPA043577: "	"unprognostic (2.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.53e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.11e-16)"	"unprognostic (3.42e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.86e-3)"	1.7	0.9	5.4	1.2	4.5	1.3	1.9	0.7	4.1	1.3	1.7	0.1	0.7	0.6	1.5	1.0	2.2	0.8	1.0	0.9	3.3	2.3	1.2	1.5	1.5	1.6	2.6	2.2	0.8	0.5	1.3	1.4	2.4	2.7	2.3	1.0	10.6	1.5	1.4	81.9	2.4	1.4	2.6	3.4	15.7	1.7	2.9	3.5	2.5	0.9	0.0	2.4	4.0	1.9	1.9	4.3	2.3	43.7	1.1	2.9	1.9	1.9	5.1	0.9	3.9	4.5	6.1	11.2	1.4	2.3	0.4	1.7	1.3	12.0	8.1	2.4	1.3	5.7	2.3	1.7	0.7	7.9	3.3	6.4	2.0	1.5	1.1	0.5	13.7	2.5	2.6	2.3	1.3	0.7	7.3	7.3	0.8	1.4	2.2	3.5	3.1	1.1	1.4	1.1	2.3	2.5	21.8	4.4	5.2	0.7	8.4	6.3	2.8	1.9	1.1	6.4	3.9	3.1	1.0	1.2	3.2	1.6	4.7	1.7	5.5	1.7	1.6	1.0	2.2	7.2	2.0	1.9	1.4	2.2	4.3	1.3	1.6	2.9	2.3	1.1	43.7	0.8	1.5	1.9	5.4	4.5	0.7	4.1	3.3	2.3	2.6	2.2	2.7	3.5
PPP1R42	"dtr, LRRC67, TLLR"	ENSG00000178125	"Protein phosphatase 1 regulatory subunit 42"	Q7Z4L9	8	66964099-67056604	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 11.2;fallopian tube: 10.2;testis: 20.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 1.2;RPTEC TERT1: 1.7;SCLC-21H: 1.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA024313, HPA027983, HPA028628"	Uncertain									"HPA024313: AB_1853053, HPA027983: AB_10599300, HPA028628: AB_2250064"	"unprognostic (8.03e-3)"	"unprognostic (5.45e-2)"		"unprognostic (4.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.92e-1)"		"unprognostic (5.42e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.61e-3)"	"unprognostic (6.86e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.33e-1)"	0.3	0.5	2.3	0.3	5.7	0.3	0.3	0.3	2.3	0.9	0.3	3.5	0.0	0.3	0.6	8.0	0.3	10.2	0.4	0.4	3.1	1.4	1.1	0.3	4.1	0.3	0.6	0.8	2.6	0.5	1.0	6.7	0.3	11.2	0.3	0.3	0.8	0.3	1.5	0.3	0.3	0.3	0.4	2.0	0.3	0.3	20.2	1.8	0.0	1.3	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	5.7	0.3	2.3	3.1	1.4	0.6	0.8	11.2	1.8
PPP5D1		ENSG00000230510	"PPP5 tetratricopeptide repeat domain containing 1"	E7EU14	19	46480796-46601200	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.2"	"Low lineage specificity"	"Detected in all"											HPA073186	Uncertain		Uncertain	Cytosol				Cytosol		"HPA073186: "	"unprognostic (2.84e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.00e-4)"	"unprognostic (3.90e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-1)"	1.9	4.5	8.9	0.9	6.8	1.5	2.2	3.6	7.5	3.5	1.5	5.8	6.6	0.9	3.9	7.4	1.1	6.8	2.6	2.8	6.5	8.7	1.6	1.2	2.2	1.4	6.9	5.9	5.8	2.3	2.8	6.9	2.3	4.1	4.4	0.9	3.7	7.2	4.3	2.4	2.2	0.9	1.9	5.4	1.9	1.8	5.3	4.7	1.0	5.8	0.6	1.4	1.9	2.4	2.0	2.2	6.2	1.4	2.6	1.8	0.5	1.7	1.0	1.3	1.0	0.9	3.0	0.3	1.0	0.9	2.6	0.6	0.1	1.2	1.8	1.7	3.4	1.0	2.3	0.4	1.4	2.0	5.8	3.0	1.5	1.7	1.4	1.0	2.3	2.3	3.6	0.4	1.2	0.8	1.2	1.4	2.3	6.7	1.0	3.0	0.7	1.4	3.2	0.5	0.5	1.3	1.0	4.3	1.6	1.0	0.6	0.7	0.8	1.6	1.9	0.2	0.6	0.4	0.8	0.9	0.8	1.5	0.9	3.0	0.7	6.2	1.4	0.7	0.9	1.0	0.5	1.7	0.4	0.7	2.2	2.0	0.8	1.8	2.0	2.6	0.4	0.9	0.4	0.5	8.9	6.8	3.6	7.5	6.5	8.7	6.9	5.9	4.1	4.7
PPTC7	TA-PP2C	ENSG00000196850	"PTC7 protein phosphatase homolog"	Q8NI37	12	110533245-110583320	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 53.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039335, HPA040614"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039335: AB_10805474, HPA040614: AB_10795526"	"unprognostic (2.44e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (1.43e-5)"	"prognostic unfavourable (6.76e-4)"	"unprognostic (1.09e-1)"	"prognostic favourable (4.48e-5)"	"unprognostic (5.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.83e-1)"	10.4	15.3	6.5	10.3	9.6	26.2	10.3	8.3	12.9	9.7	11.8	5.7	4.9	7.5	9.3	4.6	12.6	7.8	8.8	35.3	9.0	9.0	12.6	11.9	13.1	10.9	10.4	6.8	8.9	7.5	13.0	12.7	6.9	15.3	7.7	9.8	8.0	12.9	8.2	53.8	13.4	11.7	13.1	7.4	9.4	8.4	8.2	6.5	16.1	8.0	15.5	13.1	12.4	12.4	2.1	1.4	6.1	1.7	1.7	2.4	0.6	12.0	6.9	5.9	6.2	14.8	13.1	8.5	5.6	7.4	6.1	6.2	7.8	4.8	21.2	5.8	5.4	11.8	11.9	12.9	12.4	15.4	9.8	18.8	7.4	8.4	14.1	20.7	15.5	11.2	21.3	8.6	25.5	11.6	13.9	6.1	9.9	3.1	18.3	17.8	8.4	12.9	15.3	8.0	12.9	25.4	13.6	9.6	7.5	10.5	14.6	12.3	6.9	11.1	13.2	5.6	6.0	17.1	9.3	17.6	19.4	23.7	9.5	11.5	11.0	0.1	1.7	1.3	2.3	1.5	2.4	1.3	1.9	1.8	1.3	2.1	2.2	1.9	6.1	1.7	1.1	1.4	1.3	0.6	6.5	9.6	8.3	12.9	9.0	9.0	10.4	6.8	15.3	6.5
PQLC2L	C3orf55	ENSG00000174899	"PQ loop repeat containing 2 like"	A1A4F0	3	157543246-157677749	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 29.8;breast: 36.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 33.6;ASC TERT1: 18.6;EFO-21: 12.7;HSkMC: 12.1;LHCN-M2: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA054395	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA054395: "	"unprognostic (1.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.83e-5)"	"unprognostic (2.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.34e-2)"	"unprognostic (4.59e-3)"	"unprognostic (7.47e-7)"	"unprognostic (1.17e-3)"	"unprognostic (2.75e-1)"	"unprognostic (4.81e-2)"	"unprognostic (7.56e-3)"	29.8	1.6	0.2	1.8	1.3	0.1	36.0	0.0	0.8	5.3	4.1	0.0	0.0	0.1	1.3	2.0	3.1	1.8	4.3	5.6	0.3	1.2	4.5	0.1	8.4	1.6	0.5	0.1	0.4	1.4	0.1	5.9	2.6	1.3	3.9	1.4	4.6	4.5	1.0	4.8	2.2	1.6	3.4	0.3	0.1	3.8	2.7	0.0	0.0	11.8	3.0	0.5	4.2	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.7	0.0	0.0	33.6	18.6	0.0	1.7	3.5	0.7	1.0	0.0	2.4	0.0	12.7	5.3	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	12.1	0.6	5.2	0.3	5.3	0.3	0.0	16.9	0.1	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.1	2.1	0.0	0.1	0.1	1.1	0.0	4.8	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	1.3	0.0	0.8	0.3	1.2	0.5	0.1	1.3	0.0
PQLC3	"C2orf22, MGC33602"	ENSG00000162976	"PQ loop repeat containing 3"	Q8N755	2	11155198-11178874	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061607			Approved	Cytosol				Cytosol		"HPA061607: "	"unprognostic (3.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.11e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.93e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.00e-2)"	26.9	21.3	5.1	16.5	6.2	4.2	16.7	2.4	6.2	22.2	14.4	11.3	8.6	5.6	19.7	27.0	18.1	15.4	19.5	14.9	5.4	5.1	20.6	9.8	21.0	26.9	7.9	5.8	20.7	33.3	5.3	5.4	15.5	7.8	18.5	10.5	15.5	14.1	11.2	14.0	9.8	16.5	19.8	13.1	26.3	12.7	12.0	5.7	12.0	17.6	13.0	15.0	15.7	14.7	11.4	36.9	37.0	46.9	14.4	18.4	33.0	3.1	10.7	1.9	6.0	30.3	20.7	7.2	6.5	8.6	3.1	3.6	1.9	12.3	1.1	4.9	12.7	4.1	3.0	3.4	3.1	19.6	1.6	2.9	1.3	1.3	12.1	1.4	9.2	15.0	11.4	1.9	4.4	6.9	2.8	6.9	8.3	14.1	2.2	2.9	4.3	3.8	2.7	3.3	3.3	11.4	5.3	0.7	3.4	5.5	17.3	12.2	15.4	5.4	9.7	4.5	1.9	4.7	1.8	11.8	8.6	0.5	11.7	7.0	8.6	15.1	37.3	37.0	18.4	45.7	16.1	11.4	18.2	18.0	36.9	7.7	10.1	13.9	2.3	14.4	46.9	7.1	18.2	33.0	5.1	6.2	2.4	6.2	5.4	5.1	7.9	5.8	7.8	5.7
PRAC1	"C17orf92, PRAC"	ENSG00000159182	"PRAC1 small nuclear protein"	Q96KF2	17	48721719-48722522	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"intestine: 62.1;prostate: 40.3"	"Cell line enriched"	"Detected in some"	33	"PC-3: 90.3"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 291.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in single"											HPA047871	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA047871: "			"unprognostic (7.59e-2)"									"unprognostic (2.43e-2)"			"unprognostic (2.04e-1)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.6	2.0	30.8	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	40.3	62.1	0.1	0.1	0.1	0.1	0.0	0.1	1.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	9.9	5.1	0.8	0.0	2.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	90.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.5	0.0	0.2	0.5	0.0	0.4	0.0	0.8	0.1	0.1	2.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1
PRAMEF7		ENSG00000204510	"PRAME family member 7"	Q5VXH5	1	12916610-12920482	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049887, HPA051704"	Uncertain									"HPA049887: , HPA051704: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRAMEF8		ENSG00000182330	"PRAME family member 8"	Q5VWM4	1	13281035-13285174	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049887, HPA051704"	Uncertain									"HPA049887: , HPA051704: "															"unprognostic (1.86e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRDM13		ENSG00000112238	"PR/SET domain 13"	Q9H4Q3	6	99606730-99615578	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"blood: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070592	Uncertain									"HPA070592: "		"unprognostic (4.09e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.30e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.55e-1)"		"unprognostic (3.16e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.93e-1)"				"unprognostic (1.86e-2)"	"unprognostic (7.54e-2)"		"unprognostic (1.29e-1)"	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRELID2	"FLJ38376, MGC21644"	ENSG00000186314	"PRELI domain containing 2"	Q8N945	5	145471799-145835369	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 31.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 15.8;myeloid DC: 5.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 5.2;granulocytes: 15.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042486	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA042486: AB_10797498"	"unprognostic (9.45e-3)"	"unprognostic (1.95e-1)"	"unprognostic (7.58e-3)"	"unprognostic (2.71e-5)"	"unprognostic (1.96e-3)"	"unprognostic (6.53e-4)"	"unprognostic (6.62e-5)"	"unprognostic (2.27e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (3.78e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavourable (9.65e-6)"	"unprognostic (2.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.83e-4)"	"unprognostic (6.42e-3)"	6.6	2.4	1.6	5.3	2.0	3.9	4.4	0.7	2.9	4.9	16.4	2.3	2.8	10.6	5.2	2.9	2.4	3.0	14.5	6.4	1.4	1.4	2.6	2.7	2.4	2.7	2.3	1.1	5.2	15.9	1.3	2.8	0.9	2.0	4.2	16.2	9.2	4.3	2.7	1.3	3.0	31.2	6.2	2.5	2.1	7.8	2.5	1.5	0.8	4.1	2.4	1.9	4.3	11.6	1.8	5.2	15.8	1.9	1.8	2.0	0.9	11.2	3.7	3.5	5.6	0.8	2.0	0.0	3.7	6.5	7.0	9.9	12.0	18.5	0.0	6.4	4.4	3.4	2.7	8.4	10.4	3.2	4.4	12.9	4.1	6.2	2.1	1.7	13.8	1.1	3.6	8.0	7.1	7.9	7.0	5.2	3.4	1.9	0.0	1.9	1.8	2.5	0.1	0.0	1.8	3.3	1.7	1.5	3.1	4.7	0.6	7.4	5.6	2.5	7.2	6.1	3.3	10.7	8.4	0.2	0.0	0.0	11.0	0.0	2.4	15.8	1.3	0.4	0.8	1.9	0.4	1.7	1.6	1.2	5.2	1.8	0.2	1.2	0.5	1.8	1.3	0.6	2.0	0.9	1.6	2.0	0.7	2.9	1.4	1.4	2.3	1.1	2.0	1.5
PRELID3B	"C20orf45, dJ543J19.5, SLMO2"	ENSG00000101166	"PRELI domain containing 3B"	Q9Y3B1	20	59033145-59042909	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 91.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047721	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA047721: "	"unprognostic (1.62e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavourable (5.04e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavourable (6.96e-5)"	"unprognostic (5.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.20e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.61e-2)"	"unprognostic (8.96e-2)"	18.6	17.0	14.1	17.0	13.9	13.7	20.4	10.3	14.1	10.0	45.2	8.7	11.2	41.3	9.6	9.6	26.7	8.8	10.3	13.3	12.9	13.4	20.5	30.1	13.5	19.1	15.4	10.0	11.1	24.2	12.7	34.3	28.8	12.3	10.5	30.0	6.1	15.3	12.6	17.2	14.0	91.2	11.6	16.7	19.9	19.3	11.5	12.1	21.4	18.9	25.5	21.2	13.9	14.4	25.8	17.5	26.6	21.0	27.1	27.6	20.2	25.9	12.9	12.6	16.4	9.3	13.3	17.7	19.3	17.2	36.3	19.4	35.8	22.0	41.4	34.1	14.8	28.5	25.4	30.6	38.1	24.5	15.9	28.7	21.8	7.6	19.8	37.4	26.7	11.7	40.6	20.8	48.4	11.7	11.2	18.2	15.4	33.4	42.2	16.7	6.2	35.7	22.0	28.5	23.4	18.0	22.3	22.7	21.7	30.9	52.6	44.4	26.5	29.2	13.8	13.1	12.7	24.0	10.1	12.3	17.5	33.5	14.3	18.4	14.7	26.6	13.6	13.5	21.4	17.9	25.9	25.8	26.1	24.0	17.5	18.6	23.6	24.8	11.7	27.1	21.0	14.7	27.6	20.2	14.1	13.9	10.3	14.1	12.9	13.4	15.4	10.0	12.3	12.1
PREX2	"DEP.2, DEPDC2, FLJ12987, P-REX2, PPP1R129"	ENSG00000046889	"Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2"	Q70Z35	8	67952118-68237030	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 12.7;HUVEC TERT2: 17.3;NTERA-2: 11.0;RH-30: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015234, HPA075956"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA015234: AB_1847604, HPA075956: "	"unprognostic (2.25e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.19e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.53e-2)"	"unprognostic (8.77e-2)"	"prognostic unfavourable (1.61e-7)"	"unprognostic (8.30e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (6.64e-2)"	18.8	3.0	14.1	3.3	17.9	1.0	8.5	11.4	16.4	10.8	4.4	13.1	3.0	4.3	6.2	4.5	4.4	12.4	7.6	7.6	15.5	8.1	4.1	3.2	9.1	2.4	12.4	10.0	5.2	3.1	3.7	4.4	17.5	17.2	6.3	4.4	2.6	3.0	5.7	4.9	4.4	4.0	6.1	12.7	3.5	4.1	2.7	16.2	0.0	12.1	3.9	2.9	5.9	15.8	1.1	0.3	0.8	0.1	0.2	0.4	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	3.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	2.6	0.0	11.0	0.0	0.0	5.0	0.0	0.6	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.1	0.1	0.4	0.1	0.2	0.5	0.2	0.2	0.0	1.1	0.2	0.3	0.5	0.2	0.1	0.3	0.0	0.0	14.1	17.9	11.4	13.6	15.5	8.1	12.4	10.0	17.2	16.2
PRICKLE4	"C6orf49, DKFZp761H221, OEBT"	ENSG00000278224	"Prickle planar cell polarity protein 4"	Q2TBC4	6	41780762-41787372	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 7.0;HeLa: 7.8"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"									"HPA031240, HPA055593"	Approved		Approved	"Mitotic spindle,Centriolar satellite"				"Centriolar satellite"	"Mitotic spindle"	"HPA031240: AB_10600929, HPA055593: "	"unprognostic (1.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.47e-4)"	"unprognostic (4.25e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.56e-5)"	"unprognostic (3.64e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.17e-3)"	4.5	2.2	0.5	3.9	1.2	0.0	8.9	0.0	2.1	6.8	3.0	0.4	5.4	1.8	10.8	4.7	4.1	4.8	5.5	2.1	0.9		2.1	1.6	12.2	0.6	0.6	0.2	2.6	1.0	3.7	1.6	2.5	1.9	5.6	2.6	2.0	2.3	8.4	2.7	1.9	0.4	4.4	0.5	8.8	5.0	1.3	0.2	0.0	5.8	4.4	4.2	3.6	13.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.6	1.4	4.3	2.3	0.4	3.0	7.0	0.3	0.4	0.1	0.2	1.8	1.5	0.8	2.8	1.9	3.8	0.0	0.2	0.0	0.6	0.6	0.3	7.8	1.7	0.0	0.0	0.1	2.7	0.4	0.1	0.0	0.1	2.4	0.9	0.9	1.2	0.2	1.2	0.5	0.5	2.4	1.2	0.1	2.7	4.2	0.5	0.9	0.0	5.0	0.4	1.2	1.2	3.2	1.6	1.7	0.8	0.0	0.5	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0										
PRLH	PRH	ENSG00000071677	"Prolactin releasing hormone"	P81277	2	237566574-237567175	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 8.1;heart muscle: 4.5"	"Cell line enhanced"	"Detected in some"		"A549: 5.9;MCF7: 4.3;RPMI-8226: 3.6;SK-BR-3: 1.8;T-47d: 2.0;U-87 MG: 2.4"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	58	"hypothalamus: 13.4;pons and medulla: 22.5"	"Region enriched"	"Detected in single"	13	"pons and medulla: 5.1"	HPA014976	Approved				"Secreted - unknown location"					"HPA014976: "	"unprognostic (8.28e-4)"			"unprognostic (3.22e-2)"						"unprognostic (5.42e-2)"								0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	1.8	0.0	4.5	0.0	0.6	0.0	0.0	0.5	0.0	0.0		0.0	0.0	0.0	0.5	0.0		0.1	0.0		1.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.3	1.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.8	0.3	2.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PROB1	C5orf65	ENSG00000228672	"Proline rich basic protein 1"	E7EW31	5	139390592-139395713	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 37.7"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 47.0"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.1;T-reg: 1.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060103	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA060103: "	"unprognostic (4.14e-2)"	"prognostic favourable (9.26e-4)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"unprognostic (3.21e-2)"	"unprognostic (4.84e-4)"	"unprognostic (7.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.89e-2)"	"unprognostic (8.24e-2)"	0.6	1.6	0.7	0.3	0.8	0.0	0.3	0.0	0.3	0.3	0.3			0.6	0.5	0.1	0.3	0.7	0.1	6.6	0.7	0.6	0.7	0.0	0.0	0.4	0.5		0.0	0.0	1.8	0.8	0.2		1.3	0.0		0.7	0.6	37.7	0.0	0.8	0.1	0.2	0.3	0.6	0.0			0.1		0.1	0.3	0.1	0.5	1.1	0.0	0.1	0.0	1.1	0.0	0.6	0.4	0.1	0.1	0.0	0.2	0.2	0.5	0.1	0.5	0.5	1.9	1.2	2.9	0.5	1.5	0.3	0.2	0.0	0.1	47.0	0.6	0.7	1.1	0.2	1.3	0.0	1.6	0.4	0.4	1.1	0.3	0.0	0.2	3.0	1.6	0.5	2.4	1.2	0.6	1.2	7.5	0.2	5.6	0.1	0.0	0.6	0.3	2.8	2.9	0.1	1.1	1.6	0.2	0.0	0.1	0.1	0.2	0.4	0.8	4.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.1	1.1	1.1	0.0										
PROCA1	MGC39650	ENSG00000167525	"Protein interacting with cyclin A1"	Q8NCQ7	17	28703197-28711854	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 58.8"	"Cell line enhanced"	"Detected in many"		"NB-4: 12.1;REH: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA023648	Approved									"HPA023648: AB_1855726"	"unprognostic (5.78e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.07e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.26e-3)"	"unprognostic (6.90e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.01e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.00e-2)"	1.2	1.1	1.7	1.8	2.6	1.6	1.1	7.8	2.8	2.1	2.0	2.6	2.9	1.8	1.8	1.2	0.9	2.2	1.0	1.0	1.9	2.0	1.8	0.5	1.3	2.6	1.7	2.3	3.1	0.7	0.9	1.2	0.9	3.5	1.2	1.0	4.0	0.8	1.4	2.2	1.3	2.1	1.2	2.4	3.5	1.1	58.8	1.6	1.0	0.7	0.0	1.5	0.9	1.6	3.1	5.0	6.2	3.0	1.1	2.2	1.1	1.1	1.4	4.5	8.5	3.3	2.4	3.1	1.4	0.6	1.1	0.9	1.3	4.2	0.2	0.8	0.8	3.6	3.5	0.2	0.6	2.1	1.9	3.3	3.3	0.9	0.5	6.3	0.3	1.6	0.4	1.8	0.7	0.8	4.1	2.7	0.9	0.9	4.0	12.1	7.0	0.9	12.4	4.6	0.1	1.3	1.0	2.1	1.9	1.4	0.6	0.5	6.9	5.3	0.5	0.8	1.4	0.9	0.9	1.5	1.9	1.9	1.3	6.9	1.0	6.2	2.2	6.2	1.1	3.0	0.4	3.1	2.2	0.7	1.4	1.1	1.0	1.8	1.3	1.1	2.5	5.0	1.2	1.1	1.7	2.6	7.8	2.8	1.9	2.0	1.7	2.3	3.5	1.6
PROSER3	"C19orf55, FLJ30657"	ENSG00000167595	"Proline and serine rich 3"	Q2NL68	19	35758143-35771028	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.4"	"Low lineage specificity"	"Detected in many"											HPA058492	Approved		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA058492: "	"unprognostic (1.35e-2)"	"unprognostic (1.29e-2)"	"unprognostic (6.74e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.25e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.52e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavourable (3.74e-7)"	"unprognostic (8.60e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.87e-2)"	"unprognostic (9.54e-2)"	4.6	5.2	4.4	7.5	6.8	8.5	5.6	3.9	8.6	6.7	6.0	6.3	7.3	3.5	8.9	7.0	5.6	8.5	6.4	4.9	4.4	3.6	5.0	3.6	6.3	5.4	4.2	4.3	10.3	9.4	7.5	12.8	5.4	5.0	6.2	3.6	8.8	5.8	7.2	3.7	10.5	5.7	9.6	3.5	5.2	7.2	26.2	5.1	13.9	8.7	3.3	6.5	8.3	6.6	3.6	1.7	12.4	2.1	0.9	2.3	0.2	7.7	22.4	8.0	7.8	3.3	3.5	2.5	5.7	6.6	6.3	6.8	6.7	5.4	4.3	6.3	5.4	4.6	3.4	10.1	4.3	10.4	5.8	6.1	9.4	2.8	2.8	5.0	13.5	4.1	5.8	8.9	7.9	2.7	5.3	8.1	5.5	3.8	8.7	2.0	2.1	3.3	6.5	1.9	3.2	4.1	8.2	7.9	7.1	6.3	4.7	0.9	7.4	4.2	6.8	6.6	7.1	6.9	5.9	10.2	6.8	3.5	7.1	3.2	4.9	5.8	2.1	4.6	1.4	1.2	2.3	2.5	2.0	1.3	0.5	3.6	1.8	0.7	12.4	0.9	1.2	1.7	1.7	0.2	4.4	6.8	3.9	8.6	4.4	3.6	4.2	4.3	5.0	5.1
PROX2	FLJ36749	ENSG00000119608	"Prospero homeobox 2"	Q3B8N5	14	74852871-74871940	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skin 1: 5.8"	"Cell line enhanced"	"Detected in some"		"AF22: 5.1;CACO-2: 3.8;U-698: 3.6"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 4.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045057	Uncertain									"HPA045057: AB_10960259"	"unprognostic (4.38e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.95e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.98e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.73e-4)"	0.6	0.3	0.4	1.6	1.6	4.1	0.6	1.8	1.2	1.9	0.5			0.6	0.9	2.1	0.6	1.2	0.3	0.4	0.5	0.9	0.5	0.2	0.8	2.4	0.8		2.9	0.6	0.8	1.4	0.6		1.3	1.0		0.9	1.1	0.5	5.8	1.0	0.2	1.0	2.0	0.4	0.7			1.7		1.5	0.6	1.2	0.8	1.0	4.2	0.7	3.5	0.7	0.3	0.2	0.5	5.1	1.9	1.5	0.6	1.5	0.4	0.0	0.0	0.3	3.8	0.5	0.3	0.4	0.0	1.1	0.4	0.0	0.0	0.0	0.2	1.8	1.7	1.0	0.5	0.1	2.4	0.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	2.2	0.2	0.8	0.3	0.5	1.2	0.9	0.1	0.0	1.0	1.4	0.6	0.2	0.4	0.0	0.5	1.7	0.3	1.3	0.5	0.4	0.3	0.8	0.4	3.6	0.1	1.6	0.0	0.2	0.7	3.0	0.5	0.6	0.7	0.8	0.2	0.4	0.4	0.5	0.4	0.6	4.2	3.5	0.5	1.0	0.0	0.3										
PRR15		ENSG00000176532	"Proline rich 15"	Q8IV56	7	29563811-29567295	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 66.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 13.2;CAPAN-2: 17.2;HaCaT: 19.9;RT4: 15.2;SK-BR-3: 33.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040996, HPA048121"	Enhanced		Uncertain	"Vesicles,Cell Junctions"				Vesicles	"Cell Junctions"	"HPA040996: , HPA048121: "	"unprognostic (5.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.97e-2)"	"prognostic favourable (6.37e-4)"	"unprognostic (7.49e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavourable (7.23e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.25e-1)"	"prognostic favourable (1.83e-6)"	"unprognostic (1.30e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.58e-2)"	3.8	0.5	0.7	14.4	0.4	0.0	3.1	0.4	0.8	22.8	58.9	0.8	2.6	24.8	6.8	13.3	0.7	2.9	12.1	1.0	0.6	0.5	12.7	0.5	3.7	0.6	0.4	0.4	4.0	2.0	0.0	2.7	19.0	0.5	2.7	18.5	0.3	4.6	0.9	0.5	0.3	66.1	1.1	1.1	0.4	16.6	1.4	0.4	0.3	1.0	1.0	1.9	7.0	1.9	1.6	0.0	0.0	0.5	0.0	0.0	0.6	7.2	10.3	0.0	0.0	4.0	5.0	13.2	0.3	0.5	0.2	0.1	9.0	17.2	0.0	1.9	2.4	19.9	2.2	0.0	0.0	0.0	1.4	0.5	1.9	9.8	1.3	0.0	0.0	0.0	3.3	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.2	1.4	1.6	8.2	0.0	0.0	9.1	11.9	15.2	0.2	0.1	1.0	33.5	0.0	2.4	0.0	8.8	0.2	0.0	0.0	0.4	0.8	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	0.4	0.8	0.6	0.5	0.4	0.4	0.5	0.4
PRR18	MGC35308	ENSG00000176381	"Proline rich 18"	Q8N4B5	6	166305300-166308448	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 35.7"	"Group enriched"	"Detected in some"	7	"SCLC-21H: 9.1;SH-SY5Y: 5.3"	"Cancer enhanced"	"Detected in some"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077250	Enhanced									"HPA077250: "	"unprognostic (2.91e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.65e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.79e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.35e-3)"	"unprognostic (9.49e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.07e-1)"	1.3	0.9	12.4	0.9	17.3	0.9	0.9	1.7	34.8	1.1	0.9	35.7	0.0	1.4	0.9	0.9	0.9	4.4	0.9	0.9	18.6	9.0	1.0	6.4	1.1	0.9	23.1	7.0	1.0	1.1	3.3	0.4	0.9	11.0	1.3	0.9	0.0	1.0	1.1	0.9	0.9	1.0	0.9	21.7	0.9	1.2	0.9	18.9	0.0	1.1	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	9.1	5.3	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	17.3	1.7	14.9	18.6	9.0	23.1	7.0	11.0	18.9
PRR20A	"FLJ40296, PRR20"	ENSG00000204919	"Proline rich 20A"	P86496	13	57140918-57143939	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	15	"testis: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059485	Uncertain									"HPA059485: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRR22	MGC24975	ENSG00000212123	"Proline rich 22"	Q8IZ63	19	5782960-5784765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"testis: 82.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA044157	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA044157: AB_10960694"	"unprognostic (8.09e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.19e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.42e-3)"	"unprognostic (9.37e-3)"	"unprognostic (4.18e-2)"	"unprognostic (9.93e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.07e-1)"	"unprognostic (2.79e-3)"	1.1	1.0	1.1	1.7	1.5	2.0	1.1	1.1	1.7	1.1	1.3	1.2	1.1	3.1	1.1	1.1	1.6	2.5	1.1	1.1	1.1	0.7	2.4	4.4	1.1	1.5	1.1	1.1	1.1	2.7	1.0	1.2	1.1	1.1	2.7	0.3	1.1	3.2	1.1	1.1	5.4	3.3	1.1	1.1	2.7	2.4	82.5	1.1	1.1	2.3	1.1	1.1	1.1	1.1	0.2	0.0	0.0	0.2	0.0	0.9	0.1	1.8	3.1	1.3	6.6	0.0	0.2	6.5	1.3	0.5	1.0	1.6	3.1	1.8	2.9	3.7	0.2	2.3	1.0	1.3	0.2	4.5	10.2	1.3	1.3	1.1	0.5	3.1	15.9	0.8	1.1	1.4	0.4	0.2	7.1	0.0	0.8	6.8	3.5	3.8	8.1	3.2	3.4	1.2	4.5	0.2	2.1	1.7	3.2	0.3	2.4	3.6	2.7	2.5	1.0	2.4	6.7	8.6	1.6	9.3	7.2	5.5	0.2	6.2	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.9	0.4	0.0	0.0	0.2	0.0	0.0	0.1	1.1	1.5	1.1	1.1	1.1	0.7	1.1	1.1	1.1	1.1
PRR23B	FLJ46116	ENSG00000184814	"Proline rich 23B"	Q6ZRT6	3	139019031-139020926	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	36	"testis: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047473	Uncertain									"HPA047473: "															"unprognostic (7.57e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRR23C	FLJ46210	ENSG00000233701	"Proline rich 23C"	Q6ZRP0	3	139042102-139044892	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"blood: 3.4;testis: 4.3"	"Cell line enhanced"	"Detected in single"		"HeLa: 1.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"											HPA047473	Uncertain									"HPA047473: "															"unprognostic (1.00e-1)"			0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.1	4.3			0.0		0.0	0.0	0.0	1.0	0.4	3.4	0.4	0.8	0.4	0.2	0.1	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.8	1.2	0.0	0.3	0.6	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.2	0.3	0.3	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.1	3.4	0.4	0.6	0.2	0.2	0.2	0.3	0.3	0.1	0.0	1.0	0.3	0.4	2.2	0.8	0.1	0.4	0.3	0.2										
PRR26	"C10orf108, FLJ38681"	ENSG00000180525	"Proline rich 26"	Q8N8Z3	10	649948-669581	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"CACO-2: 4.0;CAPAN-2: 3.3;EFO-21: 3.7;Hep G2: 2.5;RPTEC TERT1: 6.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"pons and medulla: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA066037	Uncertain									"HPA066037: "	"unprognostic (2.29e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.92e-2)"	"unprognostic (8.67e-3)"	"unprognostic (1.69e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-3)"	18.5	0.2	0.5	3.5	0.6	0.2	3.2	0.6	0.3	3.4	18.8	0.0	1.9	8.4	5.1	1.3	7.1	1.8	18.0	10.2	0.6	0.4	9.6	13.6	0.7	0.9	0.5	0.0	2.6	17.9	0.0	2.9	0.2	2.9	5.3	7.2	2.5	0.3	3.1	2.5	0.5	15.9	8.2	0.5	1.8	6.8	1.5	0.0	0.0	0.5	0.3	0.0	4.9	3.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.0	3.3	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.3	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.3	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.6	0.3	0.6	0.4	0.5	0.0	2.9	0.0
PRR27	C4orf40	ENSG00000187533	"Proline rich 27"	Q6MZM9	4	70133616-70176799	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	268	"salivary gland: 669.3"	"Cell line enhanced"	"Detected in single"		"HeLa: 1.2"	"Cancer enriched"	"Detected in single"	10	"breast cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.4"									"HPA036150, HPA036151"	Enhanced				"Secreted to digestive system"					"HPA036150: AB_10673001, HPA036151: AB_2674971"														"unprognostic (9.52e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	669.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.5	0.2	2.4	0.3	0.5	0.2	0.0	0.3	0.2	0.1	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.0	0.3	0.0	0.0	0.0	0.7	0.2	0.2	1.2	0.1	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.0	0.2	0.5	0.0	0.7	0.1	0.4	0.5	0.1	0.2	0.1	0.5	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.4	0.0	0.3	0.2	0.2	0.2	0.2	0.4	0.1	0.3	0.1	0.0	0.4	1.5	0.3	0.2	0.2	0.2	0.0	0.3	0.1	0.2	0.0	0.5	0.2	0.2	2.4	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR29	"C17orf72, DKFZp761M2312, FLJ11724"	ENSG00000224383	"Proline rich 29"	P0C7W0	17	63998351-64004304	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 17.9;fallopian tube: 48.7;testis: 23.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.7;REH: 6.8;RPMI-8226: 2.8;TIME: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA051264			Uncertain	Nucleoli				Nucleoli		"HPA051264: "	"unprognostic (2.05e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.22e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.30e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.98e-3)"	0.9	0.5	3.3	0.8	7.6	0.6	0.9	0.1	2.1	4.0	0.5	8.3	0.4	0.6	1.0	17.9	0.6	48.7	1.0	0.7	5.6	5.5	0.6	0.6	7.3	0.7	1.6	0.8	8.1	0.5	0.9	5.8	0.7	15.2	0.6	0.4	0.2	0.9	0.9	0.6	0.5	0.5	0.6	1.1	2.5	0.5	23.5	1.0	0.0	2.5	0.0	0.7	1.0	0.0	1.0	0.7	3.1	1.8	1.0	3.0	1.6	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.2	0.0	0.0	0.4	0.0	6.7	0.0	0.7	0.0	0.0	0.1	0.4	0.2	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	1.0	0.0	0.0	0.0	2.3	0.0	0.2	0.2	6.8	0.1	2.8	0.5	0.0	0.4	2.0	0.0	0.3	0.4	1.0	0.0	5.5	0.2	2.3	0.7	0.2	0.7	0.1	0.5	0.9	0.3	0.0	3.1	0.9	0.0	2.0	1.8	0.4	0.7	1.7	1.0	0.7	1.0	3.0	1.7	0.8	1.0	1.7	0.1	1.1	1.6	3.3	7.6	0.1	2.1	5.6	5.5	1.6	0.8	15.2	1.0
PRRG3	TMG3	ENSG00000130032	"Proline rich and Gla domain 3"	Q9BZD7	X	151695124-151705924	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 12.4;epididymis: 10.3"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.7;HMC-1: 2.2;NTERA-2: 4.1;U-2197: 2.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA060566	Uncertain									"HPA060566: "	"unprognostic (1.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.42e-4)"	"unprognostic (7.24e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.84e-2)"	3.1	0.2	5.6	1.2	12.4	0.4	2.0	1.0	10.2	9.2	1.1	1.0	0.1	0.3	3.0	10.3	4.0	1.0	3.3	1.6	5.3	11.6	0.4	0.1	2.0	0.2	3.2	5.3	3.9	0.1	0.4	1.3	1.3	5.3	1.1	1.0	1.4	1.3	0.4	3.3	2.5	0.5	2.4	1.2	2.6	0.6	0.6	0.7	0.1	0.7	0.6	0.4	1.4	2.4	1.2	1.4	3.8	1.8	2.4	1.4	1.0	0.2	0.2	0.3	0.3	0.2	0.0	0.3	0.2	0.0	0.0	0.0	1.2	0.4	0.3	0.2	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.1	2.7	0.4	0.2	0.3	2.2	0.3	0.0	0.1	0.2	0.0	0.1	0.5	0.2	0.3	0.1	0.5	4.1	0.1	0.2	0.0	0.1	0.1	0.5	1.0	0.4	0.0	0.3	0.1	0.2	0.2	0.1	0.5	0.5	2.3	0.1	0.1	1.4	0.1	0.3	0.2	0.1	3.8	1.3	1.3	1.2	1.2	1.4	1.1	0.9	0.9	1.0	1.2	1.3	1.1	3.1	2.4	1.8	1.4	1.1	1.0	5.6	12.4	1.0	10.2	5.3	11.6	3.2	5.3	5.3	0.7
PRRT4		ENSG00000224940	"Proline rich transmembrane protein 4"	C9JH25	7	128350325-128361685	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"bone marrow: 49.0"	"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 70.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA046373, HPA052681"	Uncertain		Approved	"Nucleoplasm,Peroxisomes,Plasma membrane"	"Intracellular and membrane"			Nucleoplasm	"Peroxisomes, Plasma membrane"	"HPA046373: , HPA052681: "	"unprognostic (1.72e-1)"	"unprognostic (4.55e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.20e-4)"	"unprognostic (2.60e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.73e-4)"	"unprognostic (5.28e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.27e-2)"	12.1	1.9	2.0	5.9	11.3	49.0	6.8	6.5	3.1	1.6	2.7	0.6	0.0	0.6	0.7	0.5	1.9	1.0	1.1	2.4	1.7	6.2	0.5	0.7	0.8	0.6	1.6	2.4	1.0	0.6	0.8	0.0	0.6	2.9	0.8	0.7	3.4	1.9	1.3	4.2	1.5	0.8	1.0	2.8	1.3	1.6	0.7	1.5	0.7	0.7	1.7	1.0	2.0	3.2	0.0	0.4	0.4	0.4	0.0	1.5	0.4	0.0	0.0	0.1	0.1	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	13.8	0.3	0.0	3.8	0.2	0.3	0.0	0.0	0.1	70.3	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.2	0.5	0.0	0.0	1.5	0.7	0.4	0.0	0.0	0.4	0.0	0.4	2.0	11.3	6.5	3.1	1.7	6.2	1.6	2.4	2.9	1.5
PRRX2	"PMX2, PRX2"	ENSG00000167157	"Paired related homeobox 2"	Q99811	9	129665641-129722674	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 7.9;BJ: 16.7;BJ hTERT+: 12.0;fHDF/TERT166: 24.0;U-2197: 20.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA006607, HPA026808"	Approved		Approved	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA006607: , HPA026808: AB_10603228"	"unprognostic (4.02e-2)"	"unprognostic (5.17e-2)"	"unprognostic (7.65e-3)"	"unprognostic (4.47e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.03e-2)"	"unprognostic (8.58e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.94e-10)"	"unprognostic (6.66e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.47e-3)"	8.4	2.1	0.4	2.5	0.4	0.2	7.3	0.2	0.6	15.6	2.4	0.5	3.5	0.7	4.6	5.4	5.3	2.1	2.3	8.6	0.4	0.2	0.6	0.4	2.8	1.8	0.3	0.1	3.2	2.2	0.3	2.8	2.6	1.7	15.1	0.7	12.8	4.6	5.2	6.6	15.8	1.1	10.2	1.2	0.4	1.6	6.7	0.0	0.6	7.9	9.3	6.5	10.8	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	2.0	7.9	0.0	16.7	12.0	2.1	2.4	0.0	0.0	0.0	6.1	24.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	2.6	3.7	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.8	0.0	0.0	1.6	0.3	0.0	0.0	5.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.6	0.4	0.2	0.3	0.1	1.7	0.0
PRSS12	"BSSP-3, MRT1"	ENSG00000164099	"Serine protease 12"	P56730	4	118280038-118353003	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.5;testis: 31.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 20.4;SH-SY5Y: 64.8;THP-1: 29.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 11.6;basal ganglia: 8.7;cerebral cortex: 26.5;hippocampal formation: 15.3;olfactory region: 11.0"	"Low region specificity"	"Detected in all"			HPA035054	Uncertain		Approved	"Nucleoplasm,Actin filaments"	"Secreted - unknown location"			"Actin filaments"	Nucleoplasm	"HPA035054: AB_10603990"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.41e-2)"	"prognostic favourable (2.66e-4)"	"prognostic favourable (1.03e-4)"	"unprognostic (4.21e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.83e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.09e-1)"	0.9	0.5	2.1	4.1	1.4	0.0	1.9	0.5	2.8	16.5	6.0	2.0	1.3	2.2	3.0	2.7	3.6	9.8	27.5	0.3	2.2	0.9	1.1	0.8	8.0	0.0	0.7	2.4	1.9	9.8	0.0	0.9	20.4	4.1	2.0	5.8	20.0	3.1	3.2	0.3	5.9	8.6	1.0	0.5	0.3	8.1	31.3	0.2	0.3	0.6	7.7	7.7	3.1	16.2	0.3	0.4	0.0	0.1	0.0	0.7	0.0	1.4	0.0	0.5	0.0	0.0	4.1	0.0	13.5	12.2	2.9	4.8	0.0	5.5	0.0	0.0	20.4	0.2	9.1	2.7	3.8	0.0	2.1	0.0	1.1	0.0	0.4	0.0	0.0	1.2	5.2	1.0	3.0	0.0	0.0	0.0	2.3	0.0	0.1	2.7	0.6	0.8	0.0	11.5	0.0	0.0	2.0	1.5	64.8	0.0	0.0	0.8	0.0	29.0	0.0	5.8	0.8	3.6	2.6	0.3	0.0	0.0	0.3	0.9	3.3	0.0	0.1	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.4	0.3	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	2.1	1.4	0.5	2.8	2.2	0.9	0.7	2.4	4.1	0.2
PRSS35	"C6orf158, dJ223E3.1, MGC46520"	ENSG00000146250	"Serine protease 35"	Q8N3Z0	6	83512538-83525704	"Enzymes, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.1;ovary: 16.3"	"Group enriched"	"Detected in some"	4	"CACO-2: 42.1;RPTEC TERT1: 12.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 4.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	9	"MAIT T-cell: 17.1"	"Lineage enriched"	"Detected in single"	172	"T-cells: 17.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 4.2;cerebellum: 7.0;cerebral cortex: 7.5;hippocampal formation: 6.8;olfactory region: 5.7"	"HPA038787, HPA038788"	Uncertain				"Secreted in female reproductive system"					"HPA038787: AB_10675951, HPA038788: AB_2676208"	"unprognostic (6.17e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.70e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.33e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.88e-6)"	"unprognostic (7.15e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-4)"	2.0	3.8	7.7	1.3	11.3	0.0	0.6	0.2	9.3	4.8	0.4	2.5	0.3	0.5	2.2	2.1	0.6	2.2	6.2	5.6	4.8	1.1	4.9	0.7	2.0	3.0	1.1	5.4	16.3	0.6	0.9	1.5	5.2	2.7	2.7	0.6	11.1	0.4	0.7	0.4	0.5	0.4	2.2	1.4	1.1	0.6	4.6	1.3	0.0	0.7	0.4	0.2	2.0	0.9	0.0	0.0	0.0	0.0	0.0	17.1	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.1	5.1	0.5	1.0	42.1	0.0	0.0	0.0	0.2	0.0	6.3	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	4.1	0.0	0.0	0.0	12.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	17.1	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.7	11.3	0.2	7.1	4.8	1.1	1.1	5.4	2.7	1.3
PRSS38	MPN2	ENSG00000185888	"Serine protease 38"	A1L453	1	227815693-227846470	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"blood: 2.2;testis: 8.4"	"Cell line enriched"	"Detected in single"	20	"U-266/84: 5.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	18	"gdT-cell: 1.4;NK-cell: 2.2"	"Group enriched"	"Detected in many"	18	"NK-cells: 2.2;T-cells: 1.4"	"Not detected"	"Not detected"							"HPA028003, HPA055809"	Enhanced				"Secreted in male reproductive system"					"HPA028003: AB_1853572, HPA055809: AB_2682931"										"unprognostic (9.54e-3)"					"unprognostic (3.61e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0										
PRSS45	TESSP5	ENSG00000188086	"Serine protease 45"	Q7RTY3	3	46742092-46744755	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 7.6;skeletal muscle: 6.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.2;HBF TERT88: 1.0;HHSteC: 2.6"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	19	"naive B-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"B-cells: 1.9"									HPA060284	Uncertain									"HPA060284: "	"unprognostic (4.55e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-4)"	"unprognostic (2.33e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.97e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.5	0.2			0.1	0.2	7.6	0.1	0.8	0.0	0.2	0.0	0.0	0.9	0.7	0.2	0.1	0.0		0.3	1.3	2.0	0.5	0.1		0.5	0.0		0.5	0.3	6.7	0.3	0.0	0.0	0.0	0.0	0.2	1.6			3.2		0.0	0.4	0.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRSS48	ESSPL	ENSG00000189099	"Serine protease 48"	Q7RTY5	4	151277171-151291453	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 1.0;skin 1: 1.9;testis: 4.1"	"Cell line enhanced"	"Detected in some"		"HHSteC: 1.4;LHCN-M2: 1.3;PC-3: 1.5;RT4: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053801	Uncertain				"Secreted in male reproductive system"					"HPA053801: "			"unprognostic (9.68e-2)"		"unprognostic (1.35e-2)"			"unprognostic (2.15e-1)"		"unprognostic (2.18e-2)"				"unprognostic (3.76e-2)"	"unprognostic (4.10e-2)"			0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.1			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.2		0.0	0.0	0.0	0.0	0.1		0.0	0.0		0.0	0.3	0.0	1.9	0.0	0.0	0.5	0.0	0.0	4.1			0.0		0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0										
PRSS53	POL3S	ENSG00000151006	"Serine protease 53"	Q2L4Q9	16	31083425-31089628	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"liver: 10.9"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 9.8"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034955, HPA034956"	Uncertain				"Secreted - unknown location"					"HPA034955: , HPA034956: AB_10696365"	"unprognostic (3.13e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.63e-4)"	"unprognostic (2.53e-12)"	"unprognostic (1.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	0.3	0.0	0.0	0.5	0.3	0.0	0.1	2.9	0.4	0.2	0.3			1.4	1.0	0.0	0.1	0.3	0.6	0.2	0.1	0.3	0.6	10.9	0.5	0.9	0.1		0.3	2.2	0.0	0.8	0.2		1.2	0.0		0.0	0.8	0.0	3.9	0.5	0.4	0.2	1.0	1.3	0.0			0.3		0.0	0.5	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.8	0.3	0.0	0.3	0.0	0.0	0.0	1.0	0.5	1.1	1.0	0.0	0.2	0.0	0.3	0.7	0.0	1.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.5	0.0	0.0	0.0	0.1	0.3	0.1	1.3	0.3	1.6	0.8	1.9	1.6	0.0	0.0	0.0	0.0	9.8	0.8	0.9	0.0	1.0	0.7	0.1	0.7	1.0	0.7	2.5	0.2	1.4	0.1	0.3	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8										
PRSS54	"CT67, FLJ25339, KLKBL4"	ENSG00000103023	"Serine protease 54"	Q6PEW0	16	58279997-58295047	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	95	"testis: 35.1"	"Cell line enhanced"	"Detected in single"		"BEWO: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA041549	Enhanced				"Secreted in male reproductive system"					"HPA041549: AB_10795640"	"unprognostic (1.13e-1)"			"unprognostic (3.24e-2)"	"unprognostic (3.09e-2)"				"unprognostic (3.08e-1)"	"unprognostic (4.88e-2)"			"unprognostic (1.23e-1)"					0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PRTG	"FLJ25756, IGDCC5"	ENSG00000166450	Protogenin	Q2VWP7	15	55611546-55743090	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 16.5;thyroid gland: 23.9"	"Cell line enriched"	"Detected in many"	6	"AF22: 57.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"non-classical monocyte: 1.7"	"Lineage enriched"	"Detected in single"	18	"monocytes: 1.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA032138			Approved	"Vesicles,Plasma membrane,Cytosol"				Cytosol	"Vesicles, Plasma membrane"	"HPA032138: AB_10669675"	"unprognostic (2.80e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.32e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.42e-6)"	"unprognostic (8.81e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.70e-1)"	1.3	2.2	1.5	1.1	1.8	0.6	2.4	1.2	2.2	4.7	1.4	3.6	1.1	0.7	11.0	4.6	0.7	2.4	1.0	1.3	1.6	1.6	2.6	0.6	5.0	0.6	3.0	2.0	4.5	0.6	6.4	2.7	6.5	4.3	1.4	0.9	16.5	0.9	1.4	3.9	0.6	0.9	2.9	3.5	0.5	1.5	6.5	2.3	0.0	23.9	0.8	0.9	1.2	1.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.5	1.2	57.4	1.2	0.0	0.0	5.8	0.4	1.7	1.4	2.1	9.6	0.3	0.0	2.4	0.0	0.0	0.2	0.1	2.0	0.0	3.0	0.4	0.4	3.6	0.4	0.4	0.0	0.2	0.0	0.6	1.0	1.0	1.0	0.0	0.8	0.8	0.0	0.0	2.3	1.4	0.0	9.1	0.0	1.1	0.1	0.7	3.3	0.5	0.7	3.1	0.2	0.1	0.1	0.8	0.6	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.5	1.8	1.2	2.2	1.6	1.6	3.0	2.0	4.3	2.3
PSAPL1		ENSG00000178597	"Prosaposin like 1 (gene/pseudogene)"	Q6NUJ1	4	7430294-7434973	"Predicted secreted proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"skin 1: 42.2;stomach 1: 23.9;testis: 19.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.0;HaCaT: 3.8;hTCEpi: 4.8;RPMI-8226: 20.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038013, HPA038482"	Approved		Enhanced	Cytosol	"Secreted - unknown location"			Cytosol		"HPA038013: AB_10673652, HPA038482: "		"unprognostic (2.64e-2)"				"unprognostic (2.40e-1)"		"unprognostic (9.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.52e-1)"		"unprognostic (2.08e-2)"	"unprognostic (2.75e-1)"		"unprognostic (2.63e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	3.2	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	1.4	0.6	0.0	1.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	42.2	0.1	0.1	0.1	0.1	23.9	19.9	0.1	2.5	0.1	0.1	2.1	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PSG11	"MGC22484, PSG13, PSG14"	ENSG00000243130	"Pregnancy specific beta-1-glycoprotein 11"	Q9UQ72	19	43007656-43026512	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	220	"placenta: 151.1"	"Cell line enriched"	"Detected in single"	25	"U-2197: 19.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA042240, HPA046327"	Enhanced				"Secreted in female reproductive system"					"HPA042240: AB_10797384, HPA046327: "					"unprognostic (2.58e-1)"													0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	151.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0
PSG3		ENSG00000221826	"Pregnancy specific beta-1-glycoprotein 3"	Q16557	19	42721638-42740569	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	146	"placenta: 495.8"	"Cell line enriched"	"Detected in single"	6	"U-2197: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046327	Supported				"Secreted in female reproductive system"					"HPA046327: "																		0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	495.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.7	0.5	0.2	0.0	0.0	0.0	0.5	0.7	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSG4		ENSG00000243137	"Pregnancy specific beta-1-glycoprotein 4"	Q00888	19	43192702-43207299	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 348.5"	"Group enriched"	"Detected in some"	6	"fHDF/TERT166: 105.1;U-2197: 28.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046327	Supported				"Secreted in female reproductive system"					"HPA046327: "	"unprognostic (4.29e-2)"	"unprognostic (5.18e-2)"		"unprognostic (9.49e-2)"		"unprognostic (2.52e-2)"		"unprognostic (3.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.75e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.03e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.57e-1)"	0.6	0.4	0.2	0.5	0.2	0.0	1.4	0.2	0.2	0.2	8.2	0.2	0.2	0.0	0.2	0.2	1.2	0.0	0.2	0.2	0.2	0.0	2.0	0.2	0.2	0.2	0.2	0.2	0.2	2.0	49.1	0.6	348.5	0.2	0.6	5.8	0.2	4.4	0.2	0.2	6.3	0.2	0.2	0.2	0.2	1.1	0.2	0.2	0.2	0.2	0.3	0.3	0.2	1.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.3	105.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	10.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.8	0.4	1.0	28.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
PSG6		ENSG00000170848	"Pregnancy specific beta-1-glycoprotein 6"	Q00889	19	42902079-42919563	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	124	"placenta: 330.8"	"Cell line enriched"	"Detected in some"	17	"U-2197: 56.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	27	"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	27	"granulocytes: 2.6"									HPA046327	Supported				"Secreted in female reproductive system"					"HPA046327: "						"unprognostic (4.23e-1)"												0.1	0.1	0.2	0.0	0.1	0.8	0.1	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	330.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.2	0.4	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0
PSG8		ENSG00000124467	"Pregnancy specific beta-1-glycoprotein 8"	Q9UQ74	19	42752686-42855691	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	88	"placenta: 142.2"	"Cell line enhanced"	"Detected in some"		"A-431: 1.8;CAPAN-2: 1.1;HBF TERT88: 1.3;U-2197: 2.6"	"Cancer enriched"	"Detected in single"	17	"thyroid cancer: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046327	Supported				"Secreted in female reproductive system"					"HPA046327: "																"unprognostic (1.85e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.2	142.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.4	0.0	0.0	1.1	0.0	0.1	0.2	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSG9	"PSG11, PSGII"	ENSG00000183668	"Pregnancy specific beta-1-glycoprotein 9"	Q00887	19	43211791-43269530	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	205	"placenta: 299.0"	"Cell line enhanced"	"Detected in some"		"BJ: 6.1;BJ hTERT+ SV40 Large T+: 5.4;HBF TERT88: 11.2;T-47d: 5.1;U-2197: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.4"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.4"									HPA046327	Supported				"Secreted in female reproductive system"					"HPA046327: "	"unprognostic (9.32e-2)"	"unprognostic (3.28e-1)"				"unprognostic (2.15e-1)"												0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.6	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.2	299.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.4	0.2	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	6.1	3.4	5.4	2.8	0.1	0.1	0.0	0.2	1.7	0.3	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.7	5.1	0.0	0.3	0.2	2.6	11.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.0	0.0	0.0
PSKH2		ENSG00000147613	"Protein serine kinase H2"	Q96QS6	8	86048373-86088621	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"kidney: 1.9;placenta: 1.2;testis: 2.0"	"Cell line enriched"	"Detected in single"	18	"HEL: 13.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015095, HPA056839"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA015095: AB_1855815, HPA056839: "															"unprognostic (1.77e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PSMB11	beta5t	ENSG00000222028	"Proteasome subunit beta 11"	A5LHX3	14	23042167-23044276	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 32.7"	"Cell line enriched"	"Detected in single"	4	"PC-3: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"naive CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.1"	"Region enriched"	"Detected in single"	7	"olfactory region: 2.3"	"Not detected"	"Not detected"			"HPA028967, HPA056970"	Enhanced									"HPA028967: AB_2732444, HPA056970: AB_2683293"				"unprognostic (7.96e-2)"	"unprognostic (2.77e-1)"													0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.4	0.0	32.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0
PSORS1C1	"C6orf16, SEEK1"	ENSG00000204540	"Psoriasis susceptibility 1 candidate 1"	Q9UIG5	6	31114750-31140092	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	7	"testis: 52.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.1;hTCEpi: 5.5;U-2 OS: 1.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045049			Uncertain	Nucleoplasm				Nucleoplasm		"HPA045049: "	"unprognostic (1.15e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.48e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.56e-2)"	"unprognostic (5.72e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.30e-1)"	0.9	0.7	1.1	0.7	2.8	0.7	0.8	0.5	1.5	3.4	6.9	2.2	2.6	0.7	7.7	6.4	2.1	1.1	7.5	0.7	0.7	0.6	1.0	0.7	3.7	0.7	4.4	0.0	1.9	1.5	0.7	0.4	1.7	3.0	1.7	1.1	0.2	0.9	1.8	0.7	2.0	6.0	6.5	3.4	0.7	1.1	52.2	0.9	0.0	1.8	1.1	0.7	3.6	3.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	5.5	0.6	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.4	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.8	0.5	1.5	0.7	0.6	4.4	0.0	3.0	0.9
PSPN	PSP	ENSG00000125650	Persephin	O60542	19	6375148-6379058	"Predicted secreted proteins"		"Growth factor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025366	Uncertain				"Secreted in other tissues"					"CAB025366: "	"unprognostic (3.21e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.54e-6)"	"unprognostic (5.39e-3)"	"unprognostic (1.01e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.60e-1)"	1.0	1.7	2.5	1.1	2.7	1.6	1.1	6.4	3.4	1.8	1.4			1.1	1.6	3.5	1.3	2.5	1.3	1.1	2.3	2.1	2.5	2.2	1.1	1.2	1.5		2.8	1.6	2.7	2.4	1.1		1.8	1.5		1.8	1.6	1.3	1.7	1.8	1.4	0.8	1.9	1.5	1.5			2.5		1.5	1.1	1.0	2.6	2.8	4.6	2.6	1.8	3.0	1.6	1.6	3.8	2.2	5.5	5.1	3.4	1.2	1.9	1.9	2.2	2.3	3.8	1.4	2.0	3.1	2.4	2.4	3.7	1.4	2.4	3.0	3.0	2.0	2.3	2.9	3.7	1.6	2.9	4.0	4.3	1.7	2.8	1.4	2.4	2.6	2.4	2.9	3.7	3.3	2.2	4.3	3.2	2.7	1.3	3.6	2.2	3.0	4.7	3.2	3.0	2.5	3.4	1.9	1.8	2.7	2.6	4.7	1.2	4.4	7.0	1.1	5.0	3.3	2.6	4.6	2.1	1.8	2.1	1.6	3.0	2.0	1.5	2.6	1.2	2.6	2.3	2.3	3.6	1.8	2.6	2.8	1.7	1.6										
PTCHD1	FLJ30296	ENSG00000165186	"Patched domain containing 1"	Q96NR3	X	23334016-23404372	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Autism, Autism spectrum disorder"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 27.8"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.3;RT4: 3.1;WM-115: 10.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	4	"cerebellum: 27.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046110	Uncertain									"HPA046110: "	"unprognostic (1.50e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.50e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.68e-4)"	"unprognostic (5.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	1.6	2.3	6.6	0.9	5.5	0.7	6.0	27.8	8.9	6.2	8.4	1.0	3.5	1.4	5.1	2.1	4.5	0.9	0.8	0.8	5.3	2.7	0.8	0.6	1.2	0.6	3.1	5.8	0.8	0.8	0.5	1.7	0.5	6.5	4.4	2.9	0.0	1.8	11.7	1.1	0.8	1.8	10.2	2.6	1.4	3.4	1.1	3.8	0.0	1.0	0.0	0.6	5.4	2.9	0.7	0.4	1.2	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.3	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	1.2	0.4	0.0	1.4	0.0	0.0	3.1	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	10.4	1.2	0.3	0.4	0.3	0.2	0.2	0.3	0.3	0.2	0.1	0.7	0.3	0.3	1.0	0.3	0.2	0.4	0.1	0.0	6.6	5.5	27.8	6.5	5.3	2.7	3.1	5.8	6.5	3.8
PTCHD4	"C6orf138, dJ402H5.2, FLJ41841, PTCH53"	ENSG00000244694	"Patched domain containing 4"	Q6ZW05	6	47878028-48068689	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3"	"Cell line enhanced"	"Detected in some"		"AF22: 10.8;BEWO: 14.4;Hep G2: 24.0;LHCN-M2: 11.4;TIME: 12.1;WM-115: 10.5"	"Group enriched"	"Detected in some"	6	"melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041276	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041276: AB_10796570"	"unprognostic (1.35e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic favourable (1.49e-6)"	"unprognostic (5.03e-4)"	"unprognostic (9.84e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.56e-3)"	2.1	0.7	4.6	0.1	7.4	0.2	1.3	2.7	11.3	3.8	1.2	0.3	0.0	0.6	1.7	3.7	1.9	3.2	1.4	1.4	2.2	1.3	2.2	2.1	3.1	0.2	1.4	5.5	1.1	1.1	0.4	3.9	1.9	1.8	2.3	1.2	1.6	2.1	6.4	0.6	0.3	0.4	1.9	1.3	0.2	0.5	0.9	0.8	0.0	3.6	0.0	0.3	2.8	1.3	0.4	0.4	0.8	0.2	0.1	0.2	0.0	0.0	0.0	10.8	0.0	1.8	5.3	14.4	1.6	3.4	0.1	0.4	0.0	0.7	0.0	0.0	0.9	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.3	24.0	0.5	0.0	0.0	7.9	7.7	0.0	0.1	1.6	0.0	0.0	11.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	2.5	0.6	0.0	0.0	0.0	0.0	0.0	12.1	2.6	1.7	0.0	0.2	0.0	0.0	0.0	3.6	0.0	10.5	0.8	0.1	0.5	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.4	0.2	0.2	0.8	0.1	0.2	0.4	0.0	0.0	4.6	7.4	2.7	11.3	2.2	1.3	1.4	5.5	1.8	0.8
PTGDR	"DP, DP1, PTGDR1"	ENSG00000168229	"Prostaglandin D2 receptor"	Q13258	14	52267713-52276724	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.1"	"Group enriched"	"Detected in some"	4	"ASC diff: 1.4;HSkMC: 1.5;REH: 2.4;U-138 MG: 1.8"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"pons and medulla: 13.9"	"Group enriched"	"Detected in many"	5	"gdT-cell: 25.4;MAIT T-cell: 12.7;memory CD8 T-cell: 15.2;naive CD8 T-cell: 8.9;NK-cell: 30.1"	"Group enriched"	"Detected in many"	30	"NK-cells: 30.1;T-cells: 25.4"	"Low region specificity"	"Detected in many"							HPA049668	Enhanced									"HPA049668: "	"unprognostic (9.32e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.11e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.38e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.60e-8)"	"unprognostic (1.14e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.89e-2)"	3.9	0.9	0.7	9.6	2.5	1.8	9.3	1.4	1.4	5.5	10.0	0.7	0.9	1.1	4.1	2.2	2.1	2.5	4.9	2.3	0.8	0.8	1.5	1.8	3.4	8.9	1.0	3.5	2.3	0.8	0.8	4.5	0.4	13.9	2.1	12.8	11.2	2.6	3.5	0.9	1.3	2.4	2.0	3.6	10.9	2.0	0.9	0.8	1.8	2.5	0.1	3.1	3.3	3.2	0.0	0.0	0.9	0.1	30.1	25.4	4.1	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	25.4	0.0	12.7	0.0	3.5	15.2	0.0	0.0	0.6	8.9	0.9	30.1	0.1	0.0	0.0	4.1	0.7	2.5	1.4	1.4	0.8	0.8	1.0	3.5	13.9	0.8
PTTG2		ENSG00000250254	"Pituitary tumor-transforming 2"	Q9NZH5	4	37960435-37961125	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.5;MOLT-4: 3.0;U-698: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.4;T-reg: 1.0"	"Low lineage specificity"	"Detected in many"											"HPA008890, HPA045034"	Uncertain		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA008890: AB_1079717, HPA045034: "	"unprognostic (3.29e-1)"	"unprognostic (4.41e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.74e-1)"		"unprognostic (7.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.60e-5)"	1.0	0.4	0.9	5.2	1.2	5.0	0.5	2.2	2.4	1.1	3.9	0.2	0.0	0.0	1.6	2.2	3.3	1.8	1.5	2.5	1.0	0.4	0.7	0.5	0.9	1.0	0.7	0.4	1.2	1.0	1.4	0.4	1.8	0.3	0.8	0.7	0.0	0.2	1.4	1.9	0.6	3.1	2.0	0.9	2.3	1.0	5.3	0.0	15.8	1.3	7.5	7.3	1.8	0.7	0.4	0.0	1.4	0.4	0.0	1.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.5	0.0	0.0	0.7	0.5	0.9	0.0	0.4	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	2.1	0.0	0.9	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.0	1.4	0.0	0.0	0.0	1.0	0.1	0.9	1.2	2.2	2.4	1.0	0.4	0.7	0.4	0.3	0.0
PTX4	C16orf38	ENSG00000251692	"Pentraxin 4"	Q96A99	16	1485886-1488981	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.0;bone marrow: 4.0;testis: 3.9"	"Group enriched"	"Detected in some"	6	"HL-60: 19.0;NB-4: 14.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	21	"intermediate monocyte: 1.1;non-classical monocyte: 3.0"	"Lineage enriched"	"Detected in single"	31	"monocytes: 3.0"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	"Low region specificity"	"Detected in all"			HPA073694	Supported				"Secreted - unknown location"					"HPA073694: "	"unprognostic (1.04e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.84e-4)"	"unprognostic (3.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.52e-4)"	"unprognostic (2.23e-3)"	"unprognostic (4.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.03e-1)"	0.2	1.0	0.6	0.2	0.8	4.0	0.2	0.8	0.5	0.4	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.4	0.3	0.2	0.8	1.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.5	0.0	0.2	0.2	0.2	0.4	0.0	0.4	0.4	0.2	0.9	0.1	3.9	0.2	1.5	0.2	0.2	0.2	0.4	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	14.1	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.6	0.8	0.8	0.3	0.8	1.0	0.2	0.2	0.2	0.2
PURG	"PURG-A, PURG-B"	ENSG00000172733	"Purine rich element binding protein G"	Q9UJV8	8	30995802-31033715	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.7"	"Cell line enhanced"	"Detected in some"		"AF22: 8.8;HEK 293: 4.4;HUVEC TERT2: 4.3;NTERA-2: 6.9;SH-SY5Y: 8.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047746	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				"Nucleoplasm, Plasma membrane"	Nucleoli	"HPA047746: "	"unprognostic (3.37e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.79e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.30e-2)"	1.3	1.9	11.0	1.2	10.3	0.6	0.9	14.7	13.5	2.4	1.0	2.4	0.5	1.0	5.6	2.6	1.5	1.6	3.0	1.6	9.4	6.2	1.7	0.7	1.4	1.3	4.9	7.3	1.6	0.7	0.6	3.9	1.5	6.2	1.9	1.1	1.7	1.6	2.6	1.0	0.9	1.0	5.0	4.5	2.5	1.3	8.1	6.4	0.0	0.8	0.0	1.0	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.2	0.1	0.0	0.0	0.2	0.4	0.7	1.8	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	1.1	0.0	4.4	1.6	0.0	0.2	0.0	0.0	0.2	1.3	0.0	1.3	0.0	4.3	0.4	0.5	0.2	0.0	0.9	0.0	6.9	0.3	2.2	1.2	0.0	0.0	0.0	1.2	8.3	0.0	0.0	0.0	0.0	0.0	2.7	3.0	3.7	0.0	0.4	0.3	0.0	0.2	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	10.3	14.7	8.9	9.4	6.2	4.9	7.3	6.2	6.4
PWP2	"EHOC-17, PWP2H, UTP1"	ENSG00000241945	"PWP2, small subunit processome component"	Q15269	21	44107290-44131181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 30.5;Daudi: 26.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA024573	Uncertain		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (1.85e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.36e-4)"	"unprognostic (6.37e-5)"	"unprognostic (6.12e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.55e-1)"	6.1	6.1	11.3	7.7	14.6	3.6	6.3	9.7	12.8	4.0	9.0	9.6	2.4	4.4	7.8	9.2	8.2	5.9	4.8	4.6	6.8	4.8	6.9	8.7	5.0	7.9	15.4	5.7	5.0	12.8	1.4	4.0	7.6	8.9	8.1	1.8	4.9	8.2	5.2	8.0	14.7	5.6	2.2	6.4	8.8	10.6	5.3	17.2	3.6	4.8	8.6	16.8	5.0	5.7	6.8	2.6	2.9	4.3	3.4	6.9	5.0	1.1	0.4	0.3	1.2	3.5	3.6	9.2	11.8	6.2	15.7	10.6	30.5	0.5	26.4	0.4	0.0	1.3	0.5	8.9	9.1	6.4	19.0	3.1	5.5	7.0	2.3	2.3	0.9	0.2	0.0	10.9	0.0	0.5	10.1	10.6	5.2	0.3	0.1	0.7	0.3	1.1	1.5	0.1	13.6	0.0	0.4	9.2	1.6	0.6	1.0	7.4	0.0	1.0	6.0	6.4	1.1	14.2	1.4	14.3	17.0	1.2	0.4	2.8	9.1	0.2	2.2	2.9	6.0	3.1	6.6	6.8	4.9	6.9	1.6	4.1	4.9	6.1	1.2	3.4	4.3	2.6	3.5	5.0	11.3	14.6	9.7	12.8	6.8	4.8	15.4	5.7	8.9	17.2
PXDC1	C6orf145	ENSG00000168994	"PX domain containing 1"	Q5TGL8	6	3722614-3752026	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 79.6"	"Cell line enhanced"	"Detected in many"		"HHSteC: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"memory B-cell: 4.2"	"Lineage enriched"	"Detected in single"	4	"B-cells: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019246			Approved	"Plasma membrane"				"Plasma membrane"		"HPA019246: "	"unprognostic (1.55e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavourable (3.64e-4)"	"prognostic unfavourable (1.14e-4)"	"unprognostic (2.82e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.84e-1)"	26.3	5.5	5.9	5.9	6.5	0.4	30.6	3.2	6.6	11.1	10.3	6.4	5.3	10.7	10.1	14.4	13.9	8.3	18.5	10.8	6.5	4.4	13.4	79.6	14.2	5.8	7.5	3.1	6.2	10.0	3.4	4.3	32.9	6.2	9.1	3.1	7.5	12.3	8.1	11.9	11.7	16.9	20.6	7.0	6.1	8.9	3.9	6.9	1.0	16.8	11.5	5.8	14.9	21.0	4.2	0.3	0.5	0.0	0.0	0.9	0.3	11.5	4.9	8.1	5.4	25.6	19.3	26.0	21.0	16.2	18.0	13.9	8.1	2.3	0.0	13.7	34.4	8.7	1.6	5.8	8.6	11.7	1.6	0.0	3.5	7.2	42.8	0.0	0.0	17.5	19.0	11.1	24.0	19.6	0.0	1.5	14.0	0.7	0.0	0.1	0.3	5.9	0.6	4.3	0.4	6.8	9.7	0.9	0.4	14.0	14.4	28.3	1.1	0.7	20.5	15.3	6.5	5.9	14.3	0.0	0.0	0.0	3.4	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.3	4.2	0.1	0.0	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.3	5.9	6.5	3.2	6.6	6.5	4.4	7.5	3.1	6.2	6.9
QRFP	"26RFa, P518"	ENSG00000188710	"Pyroglutamylated RFamide peptide"	P83859	9	130892702-130896812	"Predicted secreted proteins"		Neuropeptide		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 7.4"	"Low cancer specificity"	"Detected in some"							"Group enriched"	"Detected in some"	10	"classical monocyte: 1.8;intermediate monocyte: 3.3;non-classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	15	"monocytes: 3.3"	"Region enriched"	"Detected in single"	18	"hypothalamus: 1.0"	"Low region specificity"	"Detected in all"			HPA043377	Uncertain				"Secreted in other tissues"					"HPA043377: AB_10959754"	"unprognostic (1.79e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-3)"	"unprognostic (4.14e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.04e-3)"	0.9	0.3	0.0	0.9	0.1	0.6	0.3	0.0	0.4	1.4	3.7			0.7	1.1	0.0	4.2	0.8	1.1	0.5	0.1	0.2	0.4	0.0	0.5	0.4	0.0		1.0	4.9	0.0	1.8	0.4		3.2	0.2		0.3	0.0	0.4	0.7	1.3	0.0	0.2	0.2	1.7	1.8			1.1		0.0	3.0	1.0	0.0	0.0	0.0	3.3	0.0	0.2	0.5	1.2	0.6	0.5	3.3	0.0	0.0	1.7	1.3	0.0	0.0	0.0	2.1	0.8	0.5	0.5	0.0	0.5	0.0	0.0	0.0	0.2	0.4	0.1	1.7	1.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	4.3	0.5	2.9	2.8	0.4	3.0	1.9	1.3	0.0	1.1	1.1	1.4	1.1	0.4	1.3	1.8	1.0	0.4	7.4	1.9	2.9	3.5	0.3	1.2	1.5	1.3	0.8	3.7	0.0	1.8	0.0	0.0	3.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.5										
QRFPR	GPR103	ENSG00000186867	"Pyroglutamylated RFamide peptide receptor"	Q96P65	4	121329312-121381059	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 6.9;heart muscle: 4.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 5.2;hTERT-HME1: 7.1;RPTEC TERT1: 4.5;SCLC-21H: 2.9;U-2 OS: 7.7;WM-115: 4.3"	"Cancer enriched"	"Detected in some"	6	"renal cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA014300, HPA050236"	Approved									"HPA014300: AB_1849251, HPA050236: "	"unprognostic (1.24e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.93e-2)"		"unprognostic (3.21e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.21e-4)"	"unprognostic (2.71e-1)"	"unprognostic (5.77e-3)"	"unprognostic (5.37e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.12e-1)"	"prognostic favourable (3.09e-4)"	"unprognostic (3.09e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-1)"		1.6	1.2	0.7	0.3	1.9	0.0	0.5	0.1	2.0	0.3	0.2	0.3	0.0	0.0	0.2	1.1	0.8	0.1	1.1	4.6	1.3	6.9	3.2	0.2	0.1	0.0	0.8	0.8	0.4	0.0	1.0	0.8	0.2	4.9	0.6	0.1	3.3	0.0	2.3	0.1	0.0	0.4	0.2	2.6	0.0	1.3	0.7	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.2	0.0	0.1	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	4.5	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.7	0.0	0.0	0.1	1.8	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.9	0.1	2.0	1.3	6.9	0.8	0.8	4.9	0.0
R3HDML	dJ881L22.3	ENSG00000101074	"R3H domain containing like"	Q9H3Y0	20	44336986-44351235	"Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 2.4;intestine: 5.9"	"Cell line enhanced"	"Detected in some"		"AF22: 1.9;CACO-2: 3.9;U-2 OS: 2.9"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA070264	Enhanced				"Secreted - unknown location"					"HPA070264: "	"unprognostic (1.89e-1)"		"unprognostic (2.23e-1)"				"unprognostic (9.86e-2)"	"unprognostic (9.12e-2)"	"unprognostic (6.06e-3)"		"unprognostic (2.64e-1)"			"unprognostic (6.32e-2)"	"unprognostic (4.95e-3)"			0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.0	1.5			5.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.4	0.5	0.2	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.8	1.4			0.1		0.0	0.0	0.0	0.3	0.5	0.9	0.0	0.2	0.2	0.0	0.0	0.3	1.9	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	3.9	0.9	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.5	0.2	1.3	0.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.4	0.2	0.0	0.4	0.2	0.0	0.0	0.4	2.9	0.0	0.3	0.1	0.2	0.2	0.0	0.0	0.6	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.2	0.2	0.0	0.5	0.0	0.0										
RAB19	RAB19B	ENSG00000146955	"RAB19, member RAS oncogene family"	A4D1S5	7	140404043-140426250	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 14.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.8;HDLM-2: 12.5;MCF7: 5.6;RPTEC TERT1: 4.1;RT4: 8.1;SK-BR-3: 6.3;T-47d: 7.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	4	"T-cells: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051077	Uncertain									"HPA051077: "	"unprognostic (3.40e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.53e-1)"	"prognostic favourable (2.36e-8)"	"unprognostic (1.73e-3)"	"unprognostic (6.42e-2)"	"unprognostic (3.44e-1)"	"unprognostic (6.09e-3)"	0.4	0.3	0.3	2.8	0.3	6.7	0.8	0.3	0.3	0.6	5.2	0.0	0.8	4.0	0.4	2.8	0.7	1.2	8.7	0.3	0.3	0.3	8.9	0.5	2.4	4.7	0.3	0.0	0.3	14.5	5.6	10.5	1.5	0.0	2.6	5.0	0.0	5.7	0.2	0.3	0.7	12.1	0.0	0.3	1.1	2.4	0.5	0.0	3.6	11.3	1.7	3.6	1.7	0.4	0.8	0.0	0.3	0.0	0.6	3.5	0.4	0.8	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.1	5.8	0.0	0.6	0.0	0.9	0.0	1.6	0.0	12.5	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	4.1	8.1	1.0	0.0	0.0	6.3	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.1	0.8	0.9	3.2	0.0	0.0	1.4	1.4	0.3	0.6	0.0	0.0	3.5	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0
RAB36		ENSG00000100228	"RAB36, member RAS oncogene family"	O95755	22	23145326-23164350	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 38.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 17.5;U-266/84: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 12.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059631			Approved	Vesicles	"Intracellular and membrane"			Vesicles		"HPA059631: "	"unprognostic (2.74e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.02e-3)"	"unprognostic (5.56e-3)"	"prognostic favourable (4.55e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.08e-1)"	2.4	5.9	7.6	2.0	11.9	1.3	3.5	2.7	14.1	6.5	2.8	6.8	9.3	1.4	5.4	12.7	3.0	38.2	6.6	1.9	7.7	8.4	8.2	0.8	6.1	1.7	4.5	9.3	8.1	4.3	1.9	16.6	7.0	5.8	5.1	1.8	4.8	4.6	11.2	1.2	1.9	1.5	4.9	2.6	1.9	2.7	12.8	3.1	0.0	20.7	1.2	1.9	3.6	2.1	1.0	0.3	12.7	0.6	1.7	0.7	0.3	5.5	6.5	5.0	7.6	1.2	2.5	2.0	3.1	6.4	7.0	2.6	0.4	0.0	0.0	3.5	4.1	7.0	0.2	3.7	2.3	0.0	3.0	0.0	0.2	0.6	3.0	0.0	0.9	3.1	1.4	6.5	1.3	1.0	0.3	5.7	0.3	4.4	0.0	0.1	0.6	1.7	0.0	0.0	17.5	9.0	1.0	12.4	5.4	0.2	2.7	1.6	0.0	0.6	0.5	0.9	2.1	2.4	4.5	12.4	17.2	0.0	6.4	0.0	4.1	0.3	0.6	0.0	0.7	0.3	0.4	1.0	0.1	0.2	0.3	0.3	0.5	0.4	12.7	1.7	0.3	0.0	0.1	0.3	7.6	11.9	2.7	14.1	7.7	8.4	4.5	9.3	5.8	3.1
RAB3C		ENSG00000152932	"RAB3C, member RAS oncogene family"	Q96E17	5	58582221-58859394	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 13.6;brain: 47.4;pituitary gland: 14.1"	"Cell line enhanced"	"Detected in some"		"AF22: 2.4;HEL: 3.4;SCLC-21H: 14.3;SH-SY5Y: 5.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							"HPA003160, HPA048156"	Enhanced		Approved	Cytosol				Cytosol		"HPA003160: AB_1079731, HPA048156: "	"unprognostic (1.30e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.94e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.73e-3)"	"unprognostic (3.40e-2)"	"unprognostic (6.90e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.52e-4)"	"unprognostic (1.51e-3)"	"unprognostic (3.70e-5)"	"unprognostic (4.70e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.61e-3)"	2.5	13.6	19.8	2.5	36.1	1.1	1.3	7.7	47.4	1.3	1.8	2.1	0.0	3.1	2.1	1.0	1.3	1.3	1.9	1.1	22.9	23.6	1.2	1.2	1.2	1.3	14.5	23.6	1.2	3.3	1.4	14.1	1.2	25.6	1.1	2.1	0.0	1.1	1.1	1.1	1.1	3.3	2.0	3.2	1.0	2.3	1.3	4.1	0.0	1.1	0.0	1.4	1.7	0.4	0.3	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.7	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	14.3	5.2	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	19.8	36.1	7.7	32.4	22.9	23.6	14.5	23.6	25.6	4.1
RAB40A	"Rar-2, RAR2A"	ENSG00000172476	"RAB40A, member RAS oncogene family"	Q8WXH6	X	103499130-103519489	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 34.0"	"Cell line enhanced"	"Detected in many"		"AF22: 6.4;NTERA-2: 7.1"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"basal ganglia: 4.2"	"Cell type enriched"	"Detected in single"	5	"memory B-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.2"									HPA076172			Uncertain	Vesicles				Vesicles		"HPA076172: "	"unprognostic (3.49e-1)"	"unprognostic (6.01e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.49e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.43e-1)"	"unprognostic (7.36e-4)"	"unprognostic (7.85e-3)"	"unprognostic (9.39e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.11e-3)"	2.0	1.4	0.6	0.6	4.2	0.0	0.8	0.6	1.1	2.8	0.8	0.6	11.9	0.5	5.5	34.0	10.6	2.6	2.9	0.6	0.6	0.9	1.3	0.6	2.0	1.7	0.6	0.6	5.4	0.6	0.6	2.4	0.8	0.8	5.5	0.4	0.6	0.6	6.2	0.6	0.7	0.9	1.3	0.6	0.8	0.5	7.8	0.6	0.6	0.6	0.6	0.6	1.5	2.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.4	1.7	6.4	0.2	1.4	1.9	3.1	1.9	0.4	0.3	0.5	1.3	0.9	1.6	2.4	0.3	0.1	0.4	0.1	0.3	0.0	3.7	0.5	2.9	0.3	0.6	0.1	0.2	1.5	0.3	0.6	0.4	0.3	2.3	1.0	0.6	0.4	0.4	0.2	7.1	1.0	0.0	0.5	0.1	0.1	0.6	2.7	3.3	0.6	0.1	1.3	0.0	0.2	3.2	2.6	1.5	4.0	1.8	1.1	0.7	1.2	2.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.6	4.2	0.6	0.6	0.6	0.9	0.6	0.6	0.8	0.6
RAB40B	"RAR, SEC4L"	ENSG00000141542	"RAB40B, member RAS oncogene family"	Q12829	17	82654973-82698728	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 43.4"	"Cell line enhanced"	"Detected in many"		"HEK 293: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 10.0"	"Low lineage specificity"	"Detected in all"											HPA076172			Approved	Vesicles				Vesicles		"HPA076172: "	"unprognostic (2.21e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.34e-2)"	"prognostic favourable (9.77e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.14e-2)"	"prognostic favourable (2.95e-6)"	"unprognostic (1.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.13e-2)"	"unprognostic (9.83e-3)"	6.3	7.5	29.7	2.1	43.4	1.0	6.5	9.3	34.2	6.2	12.5	38.3	1.5	7.3	6.5	15.0	5.0	5.8	5.3	13.4	25.8	13.7	15.9	6.4	5.3	2.1	21.3	17.0	8.6	5.0	5.3	5.9	3.3	19.8	8.7	7.9	2.2	8.0	5.9	29.6	8.5	5.3	4.4	28.7	4.0	16.7	3.0	23.2	0.0	4.3	3.9	2.5	4.6	3.4	3.5	10.0	2.1	4.5	2.8	2.6	1.0	4.9	8.1	2.5	7.4	6.3	7.9	3.7	5.5	1.5	3.5	1.1	2.7	1.3	0.6	11.0	5.5	9.0	4.7	4.4	3.1	0.4	23.3	1.9	8.4	7.4	3.1	0.6	2.2	6.7	7.2	2.0	1.5	3.2	5.7	0.7	4.7	6.6	1.9	4.3	0.5	10.7	4.6	6.4	4.2	12.2	9.2	13.7	8.6	3.9	3.5	7.4	7.6	4.0	6.5	9.8	3.0	10.2	4.4	3.9	3.1	7.0	2.3	1.3	1.7	2.1	0.7	0.1	1.6	1.9	2.2	3.5	2.0	2.6	1.2	1.3	2.5	1.3	0.3	2.8	4.5	10.0	2.6	1.0	29.7	43.4	9.3	26.8	25.8	13.7	21.3	17.0	19.8	23.2
RAB6D	"RAB6CL, WTH3DI"	ENSG00000233087	"RAB6D, member RAS oncogene family"		2	131361111-131364142	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	7	"parathyroid gland: 13.4"	"Group enriched"	"Detected in some"	4	"MOLT-4: 6.4;REH: 2.5;U-2 OS: 2.5"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.3"					"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA059131	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA059131: "	"unprognostic (4.19e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.08e-1)"	"unprognostic (4.79e-2)"		"unprognostic (4.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.12e-1)"	0.0	0.0		0.0		0.0	0.0		1.1	0.0	1.1			0.0	0.0	0.2	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	13.4		0.0		1.9	1.0		0.0	0.0	0.0	0.0	0.8	0.0		0.0	0.0	1.0			0.0		0.0	0.0		0.2	0.3	1.4	0.4	0.5	0.5	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	6.4	0.1	0.9	0.0	2.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	2.5	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.1	1.4	0.3	0.5	0.4	0.4	0.4	0.1	0.5	0.3	0.3	0.2	0.5	0.4	0.2	0.5	0.4	0.1	0.5	0.5										
RAD21L1	"dJ545L17.2, RAD21L"	ENSG00000244588	"RAD21 cohesin complex component like 1"	Q9H4I0	20	1226056-1296421	"Predicted intracellular proteins"	"Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 17.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.7;BJ hTERT+ SV40 Large T+: 2.5;TIME: 4.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 3.1;cerebral cortex: 1.2;olfactory region: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA053282	Approved									"HPA053282: "	"unprognostic (2.90e-1)"				"unprognostic (3.35e-1)"			"unprognostic (1.62e-4)"		"unprognostic (2.04e-1)"			"unprognostic (8.87e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.84e-1)"		0.0	0.0	0.3	0.0	3.1	0.0	0.0	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.1	0.0	0.7	0.0	0.0	17.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.6	4.7	2.5	0.9	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.1	1.2	0.8	0.2	0.1	0.1	0.0	0.7	0.0	0.7	0.1	0.0	0.6	0.0	0.7	0.8	0.0	1.4	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.9	0.1	0.1	0.7	0.0	0.0	0.1	0.0	0.0	4.7	0.8	0.1	1.1	0.0	0.8	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.3	3.1	0.1	1.2	0.3	0.1	0.1	1.0	0.2	0.2
RANBP17		ENSG00000204764	"RAN binding protein 17"	Q9H2T7	5	170861870-171300015	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029568, HPA029569"	Uncertain		Approved	"Nuclear membrane,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nuclear membrane, Cytosol"	"HPA029568: AB_10599825, HPA029569: AB_10601571"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.12e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.56e-3)"	1.6	4.9	1.3	1.8	2.1	0.8	1.8	10.4	3.6	1.8	2.0	2.9	1.1	1.5	5.3	2.8	1.0	2.2	2.7	1.5	1.4	2.2	2.4	1.8	4.1	2.4	1.5	1.7	1.8	7.2	3.6	9.4	5.0	5.3	2.4	2.3	5.4	5.1	2.7	1.0	1.1	2.6	2.4	3.1	1.0	2.5	16.3	0.4	0.1	4.7	0.1	1.4	1.5	1.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	1.1	5.4	4.5	1.5	0.5	3.4	3.9	1.8	2.8	1.7	2.3	0.0	0.1	3.3	3.8	0.0	0.0	1.7	5.7	0.0	4.3	1.1	2.1	0.0	1.5	0.0	0.0	4.4	0.3	0.3	0.0	2.6	0.4	0.0	1.6	2.7	0.0	0.0	0.4	0.5	0.0	3.5	0.0	0.9	1.4	0.3	2.0	0.0	5.4	2.8	0.9	1.5	3.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	2.1	10.4	3.6	1.4	2.2	1.5	1.7	5.3	0.4
RASA4	"CAPRI, GAPL, KIAA0538"	ENSG00000105808	"RAS p21 protein activator 4"	O43374	7	102573807-102616757	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 58.0"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 27.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA043010	Uncertain		Uncertain	Vesicles				Vesicles		"HPA043010: "	"unprognostic (6.44e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.62e-3)"	"unprognostic (4.19e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.18e-2)"	5.5	2.3	4.2	2.5	2.6	1.6	4.4	2.7	4.7	4.9	4.0			3.6	6.3	1.8	1.9	3.6	1.9	1.5	3.6	3.0	3.3	0.2	2.7	3.6	1.9		4.1	2.1	6.8	3.7	4.0		3.3	1.6		2.0	5.6	58.0	5.4	4.3	3.2	1.2	4.1	2.2	0.6			2.2		2.4	3.9	4.7	3.6	11.3	2.2	9.4	1.5	3.7	3.1	0.7	1.2	9.1	1.8	1.6	4.7	0.3	9.3	4.7	3.1	3.3	3.7	2.7	7.1	6.9	14.1	9.1	0.4	0.1	2.3	1.3	2.4	2.0	3.6	0.9	1.8	1.3	2.7	4.3	1.1	0.8	0.4	1.6	3.1	10.5	0.7	3.6	7.1	4.9	0.7	4.7	9.7	2.0	10.2	0.3	3.4	8.9	18.6	1.7	2.1	1.2	1.8	3.6	2.3	27.3	13.3	3.1	2.3	16.6	10.2	6.1	3.4	3.0	3.3	0.4	8.4	0.3	1.9	9.4	3.7	2.8	3.2	2.2	11.3	3.6	3.4	2.4	2.2	1.5	1.2	9.8	3.5	3.1										
RASGEF1A	"CG4853, FLJ37817"	ENSG00000198915	"RasGEF domain family member 1A"	Q8N9B8	10	43194535-43266919	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.6;brain: 18.3"	"Cell line enhanced"	"Detected in some"		"K-562: 13.0;SCLC-21H: 12.6;SK-BR-3: 11.4;T-47d: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035593	Enhanced		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA035593: AB_10602083"	"prognostic favourable (1.86e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (4.28e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.73e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.52e-1)"	"prognostic unfavourable (4.11e-7)"	"unprognostic (2.88e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.83e-2)"	1.1	2.3	13.1	1.6	16.2	16.6	4.4	11.0	18.3	2.1	0.9	4.0	0.0	1.2	1.6	0.7	1.5	3.4	3.0	1.5	12.3	10.6	1.4	0.4	1.8	6.0	7.2	8.7	1.8	4.8	10.7	3.3	1.1	7.2	1.7	0.7	2.3	4.6	2.6	1.1	0.9	0.8	1.7	3.5	3.5	1.0	3.1	4.1	0.0	1.2	0.2	4.6	2.2	1.9	2.1	5.8	10.4	0.6	7.1	3.6	1.1	7.4	6.4	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0	0.0	0.2	4.1	6.5	7.0	0.6	0.1	1.0	6.1	0.0	0.0	5.0	0.0	0.1	0.3	3.1	0.0	2.4	1.6	7.0	0.6	0.0	0.0	13.0	0.0	0.0	1.5	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.5	3.5	12.6	0.0	0.0	11.4	0.1	12.5	0.1	0.0	0.0	2.9	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	6.6	3.6	0.6	1.3	0.2	0.9	2.6	3.3	2.1	0.3	1.8	10.4	7.1	0.4	5.8	0.0	1.1	13.1	16.2	11.0	17.8	12.3	10.6	7.2	8.7	7.2	4.1
RASGEF1C	FLJ35841	ENSG00000146090	"RasGEF domain family member 1C"	Q8N431	5	180100791-180209153	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 27.4;testis: 7.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;HEK 293: 2.7;MCF7: 3.8;SCLC-21H: 12.4;U-2 OS: 3.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.4"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028242	Uncertain		Approved	Mitochondria				Mitochondria		"HPA028242: AB_10602294"	"unprognostic (2.21e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.75e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.65e-4)"	"unprognostic (5.89e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.77e-2)"	1.1	1.1	7.0	1.1	5.4	0.6	1.4	27.4	22.0	1.4	2.3	9.2	0.0	0.8	0.6	0.8	1.2	1.7	1.2	1.5	4.5	2.8	0.6	0.6	0.6	0.6	5.1	4.9	0.8	0.9	0.8	0.2	0.8	7.7	0.8	1.1	0.4	3.0	2.7	0.7	1.1	1.4	1.0	8.3	0.7	0.8	7.1	4.7	0.0	2.1	0.0	0.6	0.8	0.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	3.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	3.8	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	7.0	5.4	27.4	11.1	4.5	2.8	5.1	4.9	7.7	4.7
RASL10B	"RRP17, VTS58635"	ENSG00000270885	"RAS like family 10 member B"	Q96S79	17	35731649-35743521	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 24.6;skeletal muscle: 26.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 14.0;HHSteC: 16.0;HSkMC: 11.6;NTERA-2: 23.9;REH: 11.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 14.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046842, HPA057092"	Enhanced		Approved	Vesicles				Vesicles		"HPA046842: , HPA057092: "	"unprognostic (5.78e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.36e-2)"	"prognostic unfavourable (6.38e-6)"	"unprognostic (8.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.71e-6)"	"unprognostic (2.41e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.60e-3)"	12.8	0.9	6.3	0.3	9.1	0.2	2.8	0.3	12.3	1.8	0.3	1.0	24.6	0.8	1.3	0.8	0.3	3.9	0.8	10.9	4.7		1.0	1.1	0.4	0.2	0.0	2.8	2.5	4.7	2.5	1.1	2.8	6.3	0.9	0.2	1.1	12.6	15.2	26.7	0.3	0.9	0.9	0.6	0.2	0.3	1.6	2.5	0.0	0.9	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	3.6	0.0	0.6	0.4	1.0	0.6	0.4	2.5	2.1	4.5	0.0	0.0	0.4	0.1	0.0	14.0	0.0	0.8	0.0	4.6	0.0	2.3	5.2	16.0	0.0	0.0	11.6	0.9	0.8	0.0	0.0	3.0	0.0	0.2	0.2	6.3	0.0	23.9	0.0	11.6	6.4	10.4	0.0	0.0	10.7	10.4	0.7	0.2	0.9	1.3	0.7	0.0	1.2	8.6	0.0	0.3	0.0	0.0	2.8	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RASL11A		ENSG00000122035	"RAS like family 11 member A"	Q6T310	13	27270327-27273690	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"ASC diff: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 4.5"	"Group enriched"	"Detected in many"	5	"B-cells: 4.5;granulocytes: 3.3;monocytes: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004859, HPA053296"	Supported		Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA004859: AB_2667270, HPA053296: "	"unprognostic (1.59e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.65e-2)"	"prognostic favourable (5.43e-4)"	"unprognostic (3.85e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (3.52e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.34e-1)"	18.9	5.0	2.3	8.1	9.8	3.3	36.4	5.9	5.8	11.6	15.7	7.3	4.3	13.1	14.1	10.4	9.7	14.1	6.5	9.4	4.7	2.1	17.1	30.0	11.6	26.7	3.3	1.2	13.7	3.2	1.4	7.2	5.2	3.6	15.9	20.7	8.1	6.6	10.4	4.9	6.1	24.4	28.5	3.3	17.7	8.9	8.7	5.3	0.9	7.6	3.9	16.4	16.8	27.5	4.5	0.6	3.3	2.9	0.4	0.7	0.2	0.3	1.2	0.3	0.6	42.2	4.3	0.2	1.8	1.8	0.1	0.1	7.6	0.8	0.4	0.6	1.4	0.2	2.2	0.8	0.1	1.7	8.7	1.7	0.2	0.5	6.8	0.5	0.6	4.7	0.7	0.1	0.1	0.6	0.2	0.0	0.0	0.8	0.0	2.3	1.2	9.8	0.5	0.0	0.2	1.5	5.7	0.8	0.2	0.6	3.2	0.1	0.2	0.7	0.3	0.1	0.4	2.9	0.3	0.1	0.0	0.0	0.3	1.8	0.1	1.2	2.0	0.8	0.0	0.4	0.0	0.1	0.0	0.1	0.6	4.5	0.2	0.7	3.3	0.4	2.9	0.1	0.0	0.2	2.3	9.8	5.9	5.8	4.7	2.1	3.3	1.2	3.6	5.3
RASL11B		ENSG00000128045	"RAS like family 11 member B"	Q9BPW5	4	52862290-52866835	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ovary: 38.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.7;CACO-2: 7.6;NTERA-2: 10.4;RPTEC TERT1: 6.5;SH-SY5Y: 26.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057803	Uncertain		Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA057803: "	"unprognostic (1.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.32e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.66e-2)"	"unprognostic (7.45e-3)"	"unprognostic (4.95e-2)"	"unprognostic (9.71e-2)"	"unprognostic (8.72e-2)"	"unprognostic (7.20e-4)"	"unprognostic (7.17e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.00e-6)"	"unprognostic (1.10e-1)"	1.1	1.6	9.2	0.6	3.8	0.2	0.7	9.8	11.5	2.2	0.4	0.1	12.5	0.1	5.3	2.7	0.3	2.9	2.4	12.4	2.7	1.9	8.5	0.5	0.7	0.7	0.7	5.5	38.0	0.8	19.9	0.4	8.8	0.4	2.2	0.3	1.3	0.8	20.2	0.3	2.0	0.5	1.9	0.5	15.2	2.5	3.9	0.0	0.0	0.6	0.0	1.0	1.2	2.8	0.2	0.9	0.0	0.1	2.2	1.3	0.2	0.2	0.0	3.8	0.0	3.5	1.6	9.7	0.1	0.0	0.2	0.0	7.6	0.0	0.0	0.3	0.0	0.0	0.5	2.2	0.0	0.0	0.9	0.3	0.0	0.0	0.7	0.0	0.3	1.6	4.0	0.0	0.1	0.0	0.4	0.0	0.0	0.8	0.7	0.0	10.4	0.1	0.0	4.5	0.0	6.5	1.0	2.2	26.4	0.1	1.7	0.8	0.9	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.9	0.0	2.2	0.0	0.9	0.0	0.2	9.2	3.8	9.8	11.5	2.7	1.9	0.7	5.5	0.4	0.0
RASSF10		ENSG00000189431	"Ras association domain family member 10"	A6NK89	11	13009577-13012106	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 9.3"	"Group enriched"	"Detected in some"	5	"A549: 9.3;CAPAN-2: 8.3;HaCaT: 12.8;HMC-1: 6.4;RPTEC TERT1: 13.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA040406			Approved	Vesicles,Cytosol				Vesicles	Cytosol	"HPA040406: "	"unprognostic (6.71e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.41e-3)"	"unprognostic (6.25e-3)"	"prognostic favourable (2.76e-4)"		"unprognostic (3.43e-3)"	"unprognostic (8.04e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"prognostic favourable (4.12e-5)"	"unprognostic (4.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.65e-2)"	0.2	0.0	0.4	0.2	1.0	0.0	3.9	0.0	1.7	1.1	1.4	1.0	0.0	1.8	0.0	1.3	9.3	5.2	2.5	0.2	1.0		4.7	0.0	1.8	0.0	0.0	0.6	1.2	0.0	3.8	0.1	0.0	0.6	1.6	0.5	0.4	8.0	0.1	0.8	4.1	0.6	0.0	0.1	0.0	5.6	2.4	1.0	1.1	0.1	8.1	7.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	9.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.3	0.0	0.6	0.0	12.8	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.3	0.0	0.0	13.0	1.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RASSF9	"P-CIP1, PAMCI"	ENSG00000198774	"Ras association domain family member 9"	O75901	12	85800697-85836570	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 3.7;HeLa: 6.8;hTCEpi: 3.6;HUVEC TERT2: 4.3;RPTEC TERT1: 6.6;U-138 MG: 4.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 19.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039428, HPA039678"	Approved									"HPA039428: AB_10795251, HPA039678: AB_10796332"	"unprognostic (1.75e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.00e-3)"	"unprognostic (2.88e-3)"	"unprognostic (7.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.90e-5)"	7.9	5.1	1.7	4.1	4.6	0.1	9.1	0.5	0.6	14.4	3.2	4.7	3.1	3.1	15.8	6.3	10.6	11.6	4.4	7.4	3.0	2.8	7.1	3.9	17.1	7.6	4.4	1.4	7.6	4.1	1.2	2.6	0.7	19.1	6.6	2.1	2.5	4.2	6.1	5.0	7.1	3.0	5.5	4.6	10.4	2.6	3.1	2.8	2.6	14.8	8.1	4.6	6.8	12.1	0.7	0.4	1.1	0.5	0.6	0.3	0.0	0.1	2.2	0.0	0.0	0.2	1.6	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.0	0.2	2.8	0.3	0.0	3.7	0.0	0.0	0.6	0.0	6.8	0.0	0.3	0.0	0.0	2.7	3.6	1.2	0.2	4.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.3	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	4.9	1.7	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.5	0.0	0.2	0.1	0.3	0.3	0.3	0.3	0.1	0.7	0.3	0.3	1.1	0.6	0.1	0.4	0.3	0.0	1.7	4.6	0.5	0.6	3.0	2.8	4.4	1.4	19.1	2.8
RBFOX3	"FOX-3, HRNBP3, NeuN"	ENSG00000167281	"RNA binding fox-1 homolog 3"	A6NFN3	17	79089345-79516148	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.4;seminal vesicle: 21.5"	"Group enriched"	"Detected in some"	6	"A549: 12.9;NTERA-2: 11.7;SCLC-21H: 18.7;U-2 OS: 8.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.1"	"Region enhanced"	"Detected in all"		"cerebellum: 60.4"	"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030790, CAB078782"	Enhanced	Supported	Supported	Nucleoplasm				Nucleoplasm		"CAB078782: , HPA030790: AB_10602305"	"unprognostic (2.84e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.22e-15)"	"unprognostic (8.92e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.88e-1)"	0.5	1.0	10.2	0.6	23.5	0.6	0.2	60.4	33.2	0.5	15.2	0.3	0.2	1.5	9.3	3.0	8.3	1.0	0.3	0.3	8.6	3.3	0.4	0.2	0.3	0.4	1.8	3.5	0.3	0.5	0.2	0.9	0.3	5.5	13.2	2.2	0.2	0.2	21.5	0.3	0.3	1.3	8.1	2.3	0.4	0.5	7.2	5.6	0.2	0.3	0.2	0.2	15.2	1.0	0.7	0.2	0.0	0.7	0.0	1.4	0.2	0.0	12.9	0.2	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	11.7	0.2	0.2	0.5	0.0	0.0	0.0	18.7	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.8	0.5	0.0	0.7	0.0	0.3	0.4	0.3	0.0	0.0	0.7	0.0	1.4	0.3	0.0	0.7	0.1	0.4	0.2	0.7	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.2	10.2	23.5	60.4	19.5	8.6	3.3	1.8	3.5	5.5	5.6
RBM18	MGC2734	ENSG00000119446	"RNA binding motif protein 18"	Q96H35	9	122237624-122264839	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057281, HPA077955"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Midbody,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Midbody, Cytosol"	"HPA057281: , HPA077955: "	"unprognostic (1.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.39e-3)"	"unprognostic (7.27e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"prognostic favourable (8.00e-7)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	12.8	14.8	16.5	9.1	16.5	15.1	24.6	18.1	20.3	14.4	13.4	10.5	13.7	10.4	13.6	16.2	11.8	11.6	11.7	27.2	16.7	18.6	17.3	12.2	10.7	10.9	17.8	13.2	15.1	13.7	16.0	18.2	16.2	16.3	17.2	12.6	8.2	12.6	13.9	29.4	10.1	10.8	13.2	16.0	12.4	12.3	7.6	15.0	11.9	15.3	13.5	11.1	13.0	14.4	8.7	9.5	16.0	13.0	7.7	10.0	8.2	5.8	6.1	8.4	9.3	12.5	15.4	7.4	13.3	11.0	9.2	8.5	7.0	5.8	10.2	5.8	8.6	13.8	13.1	13.9	11.6	10.5	6.0	7.6	10.2	5.9	14.0	15.2	10.6	13.1	15.8	9.6	19.7	13.1	10.4	8.1	13.7	6.4	7.9	9.4	6.5	10.2	7.0	17.5	13.9	12.8	6.6	17.7	9.3	10.0	14.2	15.1	8.2	8.6	7.2	8.6	4.9	13.7	13.0	11.8	21.7	8.6	14.2	9.4	10.3	6.8	9.2	16.0	10.0	10.5	9.6	8.7	8.9	9.7	9.5	6.0	9.3	9.7	9.7	7.7	13.0	6.9	9.1	8.2	16.5	16.5	18.1	20.3	16.7	18.6	17.8	13.2	16.3	15.0
RBM44	FLJ40411	ENSG00000177483	"RNA binding motif protein 44"	Q6ZP01	2	237798389-237842808	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 40.1"	"Cell line enhanced"	"Detected in some"		"NB-4: 3.5;RPTEC TERT1: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	33	"basophil: 3.3"	"Lineage enriched"	"Detected in single"	33	"granulocytes: 3.3"	"Not detected"	"Not detected"							HPA003298	Enhanced									"HPA003298: AB_2284846"	"unprognostic (1.29e-1)"	"unprognostic (2.66e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.47e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (8.12e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.57e-2)"	"unprognostic (5.01e-5)"	"unprognostic (1.90e-1)"	"unprognostic (4.27e-2)"	"unprognostic (6.85e-3)"	"unprognostic (7.89e-3)"	0.5	0.0	0.1	0.1	0.1	0.8	0.4	0.1	0.3	0.4	0.2	0.1	0.1	0.0	0.3	0.1	0.2	0.2	0.2	0.2	0.1	0.0	0.3	0.1	0.5	0.8	0.3	0.1	0.2	0.4	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.6	0.1	0.2	0.2	0.2	0.3	0.1	0.4	0.2	40.1	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	0.4	0.9	0.3	1.0	0.7	0.5	0.7	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.3	1.3	0.4	0.2	0.9	0.7	0.1	1.5	1.3	0.8	0.6	1.4	1.3	0.1	1.0	0.2	1.2	0.4	0.1	1.2	0.0	0.2	0.9	3.5	0.7	1.1	0.3	0.2	0.9	3.5	1.1	0.6	0.9	0.0	0.4	0.3	0.5	2.1	0.0	0.0	0.3	0.0	0.8	0.7	0.2	0.2	0.7	1.5	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.1	0.3	0.1
RBM48	"C7orf64, DKFZp564O0523, HSPC304"	ENSG00000127993	"RNA binding motif protein 48"	Q5RL73	7	92528773-92538005	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021777, HPA025306"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA021777: AB_1845763, HPA025306: AB_1845764"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavourable (3.17e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.43e-2)"	"unprognostic (8.04e-2)"	11.1	13.0	23.9	10.8	36.0	24.6	14.1	28.3	34.2	11.7	9.0	18.4	7.1	10.3	12.0	12.4	9.9	10.9	8.9	12.1	22.8	15.2	12.4	10.5	9.9	17.1	42.4	15.1	17.0	10.6	11.1	18.3	10.6	20.7	11.5	11.0	9.0	13.0	8.9	16.5	10.8	10.7	9.7	28.0	14.5	9.8	12.5	36.9	13.6	14.5	6.6	13.9	10.2	10.1	20.1	10.6	37.5	12.1	18.1	25.8	14.0	7.4	5.5	9.5	14.9	11.8	12.2	7.5	9.0	9.3	11.9	11.3	6.4	10.3	10.6	16.2	7.6	7.7	9.8	7.2	13.3	12.0	12.0	8.4	12.0	7.3	10.0	14.7	10.0	9.4	14.2	11.7	12.5	11.9	16.6	18.9	11.0	8.8	18.9	15.0	8.5	9.2	8.8	8.4	14.4	9.5	7.2	11.4	15.9	8.9	17.3	12.5	5.4	14.5	6.1	16.9	9.2	13.3	12.8	11.3	14.9	18.2	7.9	12.9	15.4	37.5	10.1	21.0	18.5	12.1	20.2	20.1	20.3	18.9	9.7	18.5	25.8	22.1	13.4	18.1	9.9	10.6	18.3	14.0	23.9	36.0	28.3	34.2	22.8	15.2	42.4	15.1	20.7	36.9
RBMXL3	"CXorf55, FLJ40249"	ENSG00000175718	"RNA binding motif protein, X-linked like 3"	Q8N7X1	X	115189427-115192868	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	68	"testis: 6.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	25	"testis cancer: 1.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051842	Supported									"HPA051842: "															"unprognostic (1.05e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RBMY1B		ENSG00000242875	"RNA binding motif protein, Y-linked, family 1, member B"	A6NDE4	Y	21511338-21549094	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	47	"testis: 6.5"	"Cell line enriched"	"Detected in single"	5	"HEL: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001534, HPA053147"	Supported									"HPA001534: AB_2178972, HPA053147: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RBMY1D		ENSG00000244395	"RNA binding motif protein, Y-linked, family 1, member D"	P0C7P1	Y	21880076-21894526	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	15	"testis: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001534, HPA053147"	Supported									"HPA001534: AB_2178972, HPA053147: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RBMY1E		ENSG00000242389	"RNA binding motif protein, Y-linked, family 1, member E"	A6NEQ0	Y	21903618-21918067	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	71	"testis: 7.1"	"Cell line enriched"	"Detected in single"	10	"U-266/84: 6.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001534, HPA053147"	Supported									"HPA001534: AB_2178972, HPA053147: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RBPJL	"RBP-L, RBPSUHL, SUH, SUHL"	ENSG00000124232	"Recombination signal binding protein for immunoglobulin kappa J region like"	Q9UBG7	20	45306851-45317824	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	279	"pancreas: 188.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.1;NB-4: 4.7;SK-MEL-30: 1.2;U-937: 2.6"	"Group enriched"	"Detected in some"	22	"liver cancer: 1.2;ovarian cancer: 1.2;pancreatic cancer: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"thalamus: 0.5"	CAB006846	Enhanced									"CAB006846: "	"unprognostic (1.19e-1)"	"unprognostic (2.28e-2)"		"unprognostic (1.34e-2)"	"unprognostic (6.09e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.92e-3)"	"unprognostic (2.48e-7)"	"unprognostic (5.08e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (3.49e-5)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	188.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.2	0.0	0.8	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.1	0.0	2.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RCAN2	"DSCR1L1, ZAKI-4"	ENSG00000172348	"Regulator of calcineurin 2"	Q14206	6	46220736-46491972	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 98.8"	"Group enriched"	"Detected in some"	6	"fHDF/TERT166: 24.7;HDLM-2: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"gdT-cell: 3.9;memory CD4 T-cell: 2.6;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	43	"T-cells: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053880	Uncertain		Approved	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA053880: "	"unprognostic (2.82e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.55e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.33e-1)"	"prognostic favourable (2.48e-4)"	"unprognostic (1.37e-1)"	"prognostic favourable (1.12e-6)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	13.7	7.2	13.2	4.3	33.4	0.8	5.9	19.5	51.8	10.9	10.6	13.4	2.3	5.5	7.3	27.6	13.9	7.8	18.0	98.8	14.7	24.2	17.5	4.0	8.3	2.6	38.3	27.1	13.5	6.2	47.7	6.7	1.1	60.3	13.8	12.2	27.9	5.5	14.9	29.3	5.9	7.7	14.2	17.0	4.1	14.0	3.5	11.0	0.0	10.8	14.4	4.1	15.9	8.8	0.0	0.0	0.1	0.1	0.0	4.8	0.8	0.0	0.0	0.6	0.0	0.3	0.1	0.0	0.4	5.9	0.4	0.0	0.0	0.0	0.0	0.3	24.7	0.0	0.0	0.0	0.1	49.7	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	1.1	0.1	0.1	5.5	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	2.6	4.8	0.0	0.0	0.0	3.7	0.1	0.0	0.1	0.0	0.0	0.8	13.2	33.4	19.5	51.8	14.7	24.2	38.3	27.1	60.3	11.0
RERGL	FLJ22655	ENSG00000111404	"RERG like"	Q9H628	12	18080869-18320107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	708	"REH: 70.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA041740	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA041740: AB_10795694"	"unprognostic (3.53e-2)"	"unprognostic (7.03e-4)"	"unprognostic (6.29e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.14e-2)"		"unprognostic (5.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.66e-2)"	22.4	4.0	5.4	3.2	8.3	0.0	13.0	1.8	8.9	33.4	10.3	4.3	3.5	2.1	16.5	29.2	8.7	19.6	17.3	4.7	7.5	6.1	12.8	0.9	3.1	0.9	9.4	6.0	11.3	1.0	0.8	0.7	0.3	9.0	12.6	12.3	1.6	2.1	14.1	7.7	5.6	6.3	11.8	6.2	1.1	3.9	11.7	4.2	0.4	7.0	8.0	1.1	8.5	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	8.3	1.8	8.9	7.5	6.1	9.4	6.0	9.0	4.2
RETNLB	"FIZZ2, HXCP2, RELMb"	ENSG00000163515	"Resistin like beta"	Q9BQ08	3	108743424-108757384	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"intestine: 71.9"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.6"	"Cancer enriched"	"Detected in some"	10	"colorectal cancer: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA049152	Approved				"Secreted to blood"	123000				"HPA049152: "			"prognostic favourable (6.86e-5)"			"unprognostic (1.19e-3)"		"unprognostic (3.37e-2)"		"unprognostic (4.69e-2)"				"unprognostic (2.67e-2)"	"unprognostic (5.78e-2)"		"unprognostic (4.26e-1)"	0.1	0.0	0.1	7.0	0.1	0.0	0.1	0.1	0.1	0.1	20.6	0.1	0.1	4.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	71.9	0.1	0.1	0.1	0.1	0.0	24.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
REXO5	NEF-sp	ENSG00000005189	"RNA exonuclease 5"	Q96IC2	16	20806429-20849668	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"blood: 33.9;testis: 119.4"	"Cell line enhanced"	"Detected in many"		"K-562: 24.1;U-266/70: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	15	"basophil: 33.9"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 33.9"					"Low region specificity"	"Detected in all"			"HPA040755, HPA040868"	Enhanced		Approved	"Nuclear membrane,Nucleoli,Endoplasmic reticulum"				"Nuclear membrane"	"Nucleoli, Endoplasmic reticulum"	"HPA040755: AB_10965790, HPA040868: AB_10963549"	"unprognostic (2.39e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.42e-4)"	"unprognostic (1.01e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.93e-2)"	0.8	0.7	0.7	1.4	1.9	2.6	1.0	1.0	1.0	0.4	0.6	0.6	0.2	0.7	0.9	0.8	0.6	1.1	0.7	1.1	0.6	0.5	0.5	0.5	0.6	0.7	0.4	1.2	0.8	0.6	3.3	0.4	0.4	0.6	1.4	0.8	0.7	0.8	0.7	0.4	0.6	0.6	0.7	0.3	0.3	1.6	119.4	0.4	4.1	0.3	0.5	0.9	0.8	0.6	0.0	0.3	33.9	0.2	0.8	0.7	0.1	6.3	3.5	5.7	2.5	2.3	4.8	1.9	4.2	4.7	4.7	5.3	2.6	5.5	3.9	6.8	3.6	3.2	4.3	1.9	5.0	4.0	3.1	6.4	5.4	3.6	0.5	9.5	9.4	2.2	0.8	5.5	7.2	1.6	24.1	17.3	11.5	8.2	1.5	7.2	3.1	3.7	7.7	10.6	6.9	1.4	2.1	5.1	5.7	4.0	5.4	1.3	9.2	8.1	0.8	3.5	3.1	4.6	5.1	24.9	16.8	1.5	7.3	12.3	3.3	33.9	0.2	2.2	0.1	0.0	0.2	0.0	0.2	0.2	0.3	0.0	0.0	0.1	0.1	0.8	0.1	0.1	0.7	0.1	0.7	1.9	1.0	1.0	0.6	0.5	0.4	1.2	0.6	0.4
RFNG		ENSG00000169733	"RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q9Y644	17	82047902-82051831	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 34.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011564, HPA031673"	Uncertain		Supported	Nucleoplasm			450000	Nucleoplasm		"HPA011564: AB_1079803, HPA031673: "	"unprognostic (4.17e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"prognostic favourable (4.81e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.14e-2)"	19.5	13.0	13.8	9.3	13.3	11.7	43.8	14.3	13.8	11.4	11.8	9.0	22.7	14.9	13.5	20.9	13.4	16.3	17.0	12.2	11.6	8.7	12.5	34.5	16.7	10.1	11.2	8.0	19.7	26.6	4.1	10.7	8.2	9.9	11.8	4.8	10.6	27.3	20.4	32.6	13.3	12.7	12.9	8.5	8.9	13.2	12.8	10.6	5.7	12.6	10.5	7.6	12.4	12.8	3.4	3.4	4.3	5.0	0.4	6.3	1.5	9.3	9.3	2.7	9.4	7.0	6.2	12.1	8.7	5.1	4.2	3.3	5.7	6.7	2.2	6.3	13.8	5.2	1.9	7.5	0.8	2.8	9.8	3.2	2.2	23.1	34.7	1.2	6.9	11.2	5.1	7.2	12.3	7.8	4.0	8.2	3.3	11.5	6.9	3.3	2.7	9.8	4.8	3.3	4.9	4.7	5.7	4.8	12.2	3.3	5.7	25.7	15.7	6.7	2.9	6.6	9.0	6.3	4.7	11.0	2.1	2.3	8.3	2.0	5.7	2.3	5.0	4.3	4.1	1.4	1.5	2.5	2.8	4.3	3.4	3.4	2.8	1.9	2.0	0.4	1.5	2.7	6.3	1.5	13.8	13.3	14.3	13.8	11.6	8.7	11.2	8.0	9.9	10.6
RFPL1	RNF78	ENSG00000128250	"Ret finger protein like 1"	O75677	22	29438583-29442455	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 20.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.9;HMC-1: 4.2;Karpas-707: 4.5;SH-SY5Y: 5.7;SiHa: 2.7;THP-1: 5.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA048320, HPA072380"			Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles"	"Plasma membrane"	"HPA048320: , HPA072380: "		"unprognostic (4.54e-1)"				"unprognostic (6.63e-8)"						"unprognostic (3.14e-3)"			"unprognostic (1.89e-1)"			0.0	3.3	0.2	0.1	0.7	0.0	0.0	0.4	20.4	0.2	0.0			0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0	1.9	0.0	0.1	0.4		2.8	0.0	0.0	0.6	0.0		3.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	4.5			0.0		0.0	0.0	0.4	1.6	0.9	0.0	1.8	0.0	1.2	0.5	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.9	0.7	0.0	1.0	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.3	4.5	0.0	0.2	0.1	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	5.7	2.7	0.0	0.0	0.0	5.2	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.2	1.2	0.8	0.0	0.6	1.0	0.9	1.6	0.1	1.1	0.0	0.0	1.8	0.0	1.2	0.5										
RFPL2	RNF79	ENSG00000128253	"Ret finger protein like 2"	O75678	22	32190435-32203477	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"brain: 7.9;prostate: 10.8"	"Cell line enhanced"	"Detected in some"		"A549: 2.4;REH: 1.0;SCLC-21H: 1.8;SK-MEL-30: 1.2"	"Cancer enriched"	"Detected in single"	15	"prostate cancer: 5.6"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"HPA046608, HPA048320, HPA072380"	Approved		Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles"	"Plasma membrane"	"HPA046608: , HPA048320: , HPA072380: "	"unprognostic (3.81e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.29e-2)"	"unprognostic (9.66e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.22e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.64e-3)"	"prognostic favourable (4.16e-4)"	"unprognostic (2.04e-4)"	"unprognostic (6.02e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.62e-7)"	"unprognostic (3.50e-2)"	0.1	0.3	2.3	0.2	3.9	1.1	0.1	2.7	7.9	0.1	0.1			0.2	0.1	0.1	0.3	0.1	0.1	0.1	3.1	5.6	0.2	0.5	0.1	0.4	1.9		0.1	0.1	0.1	0.0	0.1		10.8	0.1		0.1	0.1	0.1	0.4	0.2	0.1	0.4	0.2	0.2	0.2			0.2		0.1	0.1	0.0	0.0	0.5	0.0	0.8	0.0	1.2	0.2	0.0	2.4	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.3	0.0	0.0	1.0	0.1	0.0	0.0	0.2	1.8	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.1	0.8	0.0	1.2	1.2	0.5	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.2										
RFPL4AL1	RNF210B	ENSG00000229292	"Ret finger protein like 4A like 1"	F8VTS6	19	55769141-55773179	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"blood: 5.4;epididymis: 1.7;liver: 3.0;lymphoid tissue: 2.3;testis: 1.5"	"Cell line enriched"	"Detected in some"	24	"U-2 OS: 24.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"classical monocyte: 5.4;myeloid DC: 2.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.5;monocytes: 5.4"									HPA046368	Uncertain		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA046368: "															"unprognostic (8.87e-2)"			0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1			0.0	0.0	1.7	0.0	0.1	0.3	0.0	0.0	0.0	0.3	3.0	0.0	0.4	0.0		0.6	0.7	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.3	0.0	0.1	2.3	0.2	1.5			0.3		0.0	0.3	0.0	0.0	2.5	0.4	5.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	2.2										
RFPL4B	RNF211	ENSG00000251258	"Ret finger protein like 4B"	Q6ZWI9	6	112347330-112351296	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"testis: 8.0"	"Cell line enhanced"	"Detected in some"		"K-562: 3.1;RPTEC TERT1: 4.0;U-266/70: 1.7;U-266/84: 12.4"	"Group enriched"	"Detected in some"	7	"liver cancer: 0.6;testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA059324, HPA066464"	Uncertain									"HPA059324: , HPA066464: "	"unprognostic (4.26e-1)"				"unprognostic (1.45e-1)"						"unprognostic (6.66e-2)"	"unprognostic (3.78e-1)"	"unprognostic (2.80e-3)"		"unprognostic (3.73e-2)"			0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.7	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0
RFX8	FLJ42986	ENSG00000196460	"RFX family member 8, lacking RFX DNA binding domain"	Q6ZV50	2	101397361-101474703	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 10.0;breast: 7.5;lymphoid tissue: 7.8"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.9;hTEC/SVTERT24-B: 15.4;LHCN-M2: 7.3;U-87 MG: 10.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	12	"basophil: 2.0"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 2.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059745			Approved	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA059745: "	"unprognostic (1.02e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.56e-3)"	"unprognostic (8.14e-2)"	"unprognostic (3.63e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.73e-5)"	"unprognostic (4.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-2)"	2.1	0.6	0.4	0.8	0.7	10.0	7.5	0.2	2.3	0.9	0.5	0.8	1.3	0.4	0.7	1.7	0.7	0.2	1.0	0.8	0.4	0.9	0.6	0.7	0.7	0.9	0.7	1.6	0.7	0.6	1.0	2.2	0.9	1.6	0.5	0.1	0.8	0.9	0.1	0.5	1.4	0.3	0.8	0.8	0.4	0.4	2.6	0.0	7.8	1.5	0.0	0.3	0.6	2.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	2.0	1.4	1.3	1.4	0.0	3.1	0.0	0.0	1.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	2.0	0.0	15.4	0.1	0.0	0.0	0.0	7.3	0.0	0.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	3.8	0.2	0.0	0.0	1.9	2.8	0.0	0.0	0.0	10.1	4.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.2	2.3	0.4	0.9	0.7	1.6	1.6	0.0
RGL4	Rgr	ENSG00000159496	"Ral guanine nucleotide dissociation stimulator like 4"	Q8IZJ4	22	23688136-23699176	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 81.3;bone marrow: 55.8"	"Group enriched"	"Detected in many"	5	"MOLT-4: 14.8;U-937: 34.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"neutrophil: 81.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 81.3"									HPA035979	Uncertain		Approved	Centrosome	"Intracellular and membrane"			Centrosome		"HPA035979: AB_10673227"	"unprognostic (1.48e-4)"	"unprognostic (2.75e-4)"	"unprognostic (4.44e-2)"	"unprognostic (1.11e-4)"	"unprognostic (3.10e-1)"	"unprognostic (2.93e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.11e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-3)"	1.6	1.0	0.5	9.8	0.6	55.8	0.6	1.0	0.8	0.4	1.0	0.2	0.0	1.3	1.0	1.0	1.1	1.2	1.8	10.8	0.5	0.5	0.8	1.5	6.7	19.9	0.6	0.0	1.4	1.0	0.0	0.7	0.8	0.5	0.5	0.2	0.4	2.2	0.0	0.8	1.9	4.1	0.0	0.6	21.6	0.9	18.4	0.3	11.1	1.0	0.3	8.9	1.1	3.6	0.9	0.8	81.3	12.0	4.8	17.8	5.8	0.9	0.3	3.4	1.5	0.0	0.0	1.4	1.0	0.0	0.0	0.0	0.7	0.6	1.1	0.2	0.0	1.6	0.0	0.0	0.0	1.1	2.1	0.5	1.2	0.2	0.0	1.9	2.3	0.0	0.0	0.0	0.0	0.0	1.2	1.8	0.0	0.5	14.8	2.1	0.2	0.4	5.3	1.2	0.8	0.0	1.0	1.0	1.6	1.0	2.2	0.3	0.7	1.1	1.4	1.9	1.2	1.3	0.6	3.1	0.5	0.7	1.1	34.8	0.9	11.8	0.4	58.6	9.5	2.9	9.8	0.9	12.4	10.9	0.8	0.7	17.8	15.9	81.3	4.8	12.0	0.1	17.0	5.8	0.5	0.6	1.0	0.5	0.5	0.5	0.6	0.0	0.5	0.3
RGPD1	RGP1	ENSG00000187627	"RANBP2-like and GRIP domain containing 1"	P0DJD0	2	86907953-87013976	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 10.4;placenta: 8.0;testis: 17.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.0;MOLT-4: 13.5;NTERA-2: 4.1;RPMI-8226: 3.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA049497, HPA051675, HPA067564"	Uncertain		Approved	"Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"		"HPA049497: , HPA051675: , HPA067564: "	"unprognostic (8.24e-2)"	"unprognostic (6.05e-2)"		"unprognostic (6.41e-2)"	"unprognostic (1.39e-2)"	"unprognostic (9.06e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.80e-1)"		"unprognostic (2.42e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.88e-5)"	"unprognostic (2.23e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.99e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	10.4	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	3.0	0.0	0.1	0.2		0.2	1.7	1.1	4.8	8.0		0.0	0.0		0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.3	0.3	17.7			0.2		0.5	0.0	0.1	1.3	0.0	0.1	0.0	1.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	13.5	0.2	4.1	0.0	0.1	0.1	3.0	0.0	0.0	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	1.1	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	1.3	0.5	0.7	0.0	0.2	0.1	0.8	0.0	1.1	0.0	0.0	0.1	0.1										
RGPD2	"RANBP2L2, RGP2"	ENSG00000185304	"RANBP2-like and GRIP domain containing 2"	P0DJD1	2	87755955-87825952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 11.3;testis: 12.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.9;K-562: 4.1;MOLT-4: 13.6;NTERA-2: 5.9;SiHa: 4.8;THP-1: 5.5"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in some"	4	"T-reg: 11.3"	"Lineage enriched"	"Detected in single"	12	"T-cells: 11.3"									"HPA049497, HPA051675, HPA067564"	Uncertain		Approved	"Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"		"HPA049497: , HPA051675: , HPA067564: "	"unprognostic (4.49e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.05e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.83e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.59e-1)"	0.7	2.1	0.1	0.6	0.2	7.1	0.8	1.3	0.3	4.6	0.8			1.2	1.1	0.0	0.3	2.4	0.0	0.5	0.0	0.2	0.4	0.8	1.2	1.3	0.1		1.7	6.3	0.1	2.7	7.5		0.6	0.1		0.8	0.1	0.6	0.6	1.8	0.0	0.1	0.9	1.7	12.3			0.9		1.6	0.3	0.9	0.9	0.0	0.5	0.1	0.0	11.3	0.4	0.0	0.0	0.7	0.0	0.0	0.0	11.9	0.5	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	0.1	0.1	2.8	0.3	0.0	0.0	4.1	0.3	0.0	0.5	13.6	0.0	5.9	0.0	0.3	0.0	0.3	0.0	0.0	0.0	3.0	4.8	0.1	0.0	0.0	5.5	0.2	0.9	0.1	0.0	0.0	2.7	0.3	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.2	0.0	0.4	0.9	2.7	0.5	0.0	0.9	1.4	0.2	0.4	0.0	0.0	0.0	11.3	0.4										
RGPD4	"DKFZp686P0288, RGP4"	ENSG00000196862	"RANBP2-like and GRIP domain containing 4"	Q7Z3J3	2	107826937-107890841	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"testis: 8.6"	"Cell line enriched"	"Detected in single"	12	"U-266/70: 4.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.5"									"HPA049497, HPA051675, HPA067564"	Uncertain		Uncertain	"Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"		"HPA049497: , HPA051675: , HPA067564: "	"unprognostic (4.96e-2)"	"unprognostic (3.04e-1)"			"unprognostic (4.38e-1)"	"unprognostic (1.31e-1)"		"unprognostic (2.46e-1)"		"unprognostic (1.29e-1)"	"unprognostic (3.05e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.47e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.69e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6			0.0		0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.3	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.4	0.2	0.1	0.1	0.2	0.0	1.5	0.1										
RGS13		ENSG00000127074	"Regulator of G protein signaling 13"	O14921	1	192636138-192660306	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.9"	"Cell line enriched"	"Detected in some"	17	"Daudi: 33.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	35	"basophil: 9.2"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 9.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA044952	Uncertain									"HPA044952: AB_10964914"	"unprognostic (1.99e-2)"	"unprognostic (6.08e-3)"	"unprognostic (3.25e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.37e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.96e-1)"	2.2	0.1	0.1	46.9	0.6	0.2	1.3	0.1	0.1	2.4	4.2	0.0	1.1	2.2	1.5	1.3	1.3	0.4	3.5	0.4	0.1	0.4	0.5	0.2	3.6	31.7	0.2	0.0	0.2	0.7	0.0	0.8	0.0	0.1	3.9	1.0	0.5	1.4	1.6	0.3	1.9	11.9	2.9	0.2	1.2	1.9	0.7	0.0	0.6	0.6	1.7	22.9	1.4	1.8	0.2	0.1	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.4	0.2	0.0	0.1	0.0
RGS21		ENSG00000253148	"Regulator of G protein signaling 21"	Q2M5E4	1	192316992-192367285	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA052843	Uncertain									"HPA052843: "																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RGS7BP	R7BP	ENSG00000186479	"Regulator of G protein signaling 7 binding protein"	Q6MZT1	5	64506257-64612312	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.1"	"Cell line enriched"	"Detected in some"	6	"HUVEC TERT2: 15.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039600	Approved		Uncertain	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039600: "	"unprognostic (2.93e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.35e-2)"	"unprognostic (4.77e-2)"	"unprognostic (7.57e-2)"	"unprognostic (8.59e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.81e-3)"	"unprognostic (1.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.65e-3)"	"unprognostic (3.39e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.46e-2)"	"unprognostic (8.50e-3)"	2.8	4.7	10.2	1.1	22.6	0.4	1.1	10.4	31.1	6.0	1.3	1.5	0.5	1.6	3.7	5.7	2.7	10.9	2.7	3.7	10.8	4.3	3.3	1.7	2.2	0.8	4.0	16.0	3.8	0.8	0.7	1.7	0.4	8.2	7.8	1.4	1.8	2.7	10.9	0.7	1.0	1.7	2.3	1.9	1.3	1.5	1.5	6.7	0.0	1.0	0.0	0.6	2.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	22.6	10.4	25.1	10.8	4.3	4.0	16.0	8.2	6.7
RGS9BP	"FLJ45744, PERRS, R9AP, RGS9"	ENSG00000186326	"Regulator of G protein signaling 9 binding protein"	Q6ZS82	19	32675407-32678300	"Disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 38.3;skeletal muscle: 15.8"	"Cell line enhanced"	"Detected in some"		"HEL: 10.4;HMC-1: 2.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"pons and medulla: 6.8"	"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.4;memory CD8 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049791	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"		"HPA049791: "	"unprognostic (2.82e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.20e-7)"	"unprognostic (1.49e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.71e-2)"	"unprognostic (6.74e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.34e-2)"	0.4	0.5	0.8	0.3	1.1	0.3	0.4	0.2	0.7	0.3	0.4	1.4	0.2	0.4	0.3	0.6	1.1	0.4	0.3	6.7	1.0	0.8	0.9	0.3	0.9	0.3	1.1	0.3	0.3	0.4	0.4	0.6	0.4	6.8	1.3	0.3	38.3	0.5	0.6	15.8	0.6	0.3	7.4	1.3	0.4	0.4	0.9	0.9	0.1	0.4	4.3	0.3	2.3	1.0	0.0	0.3	0.0	0.9	0.5	1.5	0.0	0.2	0.2	0.0	0.9	0.5	0.2	0.5	0.0	0.5	0.3	0.2	0.2	0.3	0.4	0.5	0.1	0.0	1.8	0.1	0.1	0.5	0.2	10.4	0.3	0.0	0.2	0.3	2.8	0.0	0.5	0.0	0.4	0.0	0.9	1.5	0.2	0.4	0.0	1.7	0.0	2.0	0.1	0.4	0.2	0.0	0.1	0.3	0.1	0.0	1.1	0.1	1.0	0.5	0.0	0.5	0.7	0.2	0.3	0.6	0.7	0.1	0.3	0.6	0.8	0.0	0.3	0.0	1.4	0.9	0.0	0.0	0.2	1.5	0.3	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.0	0.0	0.8	1.1	0.2	0.7	1.0	0.8	1.1	0.3	6.8	0.9
RHBDD2	"NPD007, RHBDL7"	ENSG00000005486	"Rhomboid domain containing 2"	Q6NTF9	7	75842602-75888926	"Enzymes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045074, HPA051960"	Uncertain		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"HPA045074: AB_10965705, HPA051960: AB_2681673"	"unprognostic (2.75e-1)"	"unprognostic (3.89e-2)"	"prognostic unfavourable (3.31e-5)"	"unprognostic (9.79e-2)"	"prognostic unfavourable (1.81e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.87e-2)"	"prognostic favourable (8.68e-6)"	"unprognostic (3.73e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.03e-1)"	12.3	50.9	44.3	9.2	64.6	12.1	12.1	14.4	68.3	17.9	11.9	18.5	43.8	18.2	8.5	31.8	14.2	22.6	12.5	14.1	48.5	69.1	18.5	21.7	22.1	8.9	33.6	29.9	12.3	23.6	81.3	56.5	10.6	37.1	15.8	9.1	23.0	22.8	57.3	6.0	14.4	12.5	7.0	16.2	9.5	15.3	15.5	10.7	9.5	34.3	4.2	7.6	10.0	9.6	11.1	13.5	76.4	14.0	13.2	27.4	12.2	7.4	24.6	11.1	22.4	6.5	4.2	4.6	4.5	17.8	10.3	8.7	13.3	20.6	2.8	4.0	8.5	12.2	7.3	5.3	3.2	8.5	14.4	2.5	15.5	12.7	17.9	4.2	23.2	9.2	13.1	11.6	5.2	6.6	5.7	18.3	8.7	49.6	8.0	23.7	10.8	14.1	5.9	7.7	21.4	16.9	13.4	14.7	29.3	16.8	35.7	17.1	23.3	8.0	6.2	16.2	13.5	10.6	9.3	15.2	5.3	4.4	16.1	6.7	19.7	76.4	14.0	17.6	18.9	13.9	16.6	11.1	21.3	16.7	13.5	10.8	18.0	15.3	24.0	13.2	7.9	11.1	27.4	12.2	44.3	64.6	14.4	68.3	48.5	69.1	33.6	29.9	37.1	10.7
RHBDD3	"C22orf3, PTAG"	ENSG00000100263	"Rhomboid domain containing 3"	Q9Y3P4	22	29259852-29268209	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043979	Approved		Approved	Microtubules				Microtubules		"HPA043979: AB_10960539"	"unprognostic (9.38e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.22e-1)"	"prognostic favourable (2.67e-6)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (2.24e-4)"	"unprognostic (2.11e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.42e-3)"	9.6	16.2	9.0	6.8	10.0	7.9	4.9	13.0	10.1	6.7	7.9	8.1	15.8	14.0	8.8	12.7	6.2	9.0	8.2	7.3	8.9	10.3	7.7	16.4	5.6	8.6	9.2	6.7	6.2	15.4	5.5	11.7	10.9	8.9	11.5	2.7	11.4	10.9	14.2	12.1	7.6	9.7	5.3	8.7	8.2	8.4	17.6	6.9	7.1	8.9	3.5	4.5	5.3	4.1	2.4	13.2	2.2	5.7	3.8	4.7	3.1	3.1	5.2	3.1	8.8	1.0	1.7	17.2	2.0	2.8	2.6	3.2	4.7	7.2	9.0	8.9	2.0	9.9	1.8	1.6	0.3	11.4	14.3	3.2	4.2	6.0	11.2	7.2	8.3	4.8	4.5	1.1	3.1	3.5	3.8	5.9	1.8	6.4	4.6	11.0	14.1	6.2	8.2	5.6	10.1	1.1	3.2	6.7	3.5	7.1	7.5	8.1	5.0	6.1	4.8	7.0	3.0	2.9	3.0	14.6	4.4	10.3	2.9	3.1	5.7	0.0	5.7	2.2	3.2	4.7	3.8	2.4	3.1	4.7	5.6	1.3	2.4	3.3	1.8	3.8	4.5	13.2	4.6	3.1	9.0	10.0	13.0	10.1	8.9	10.3	9.2	6.7	8.9	6.9
RHBDL1	"RHBDL, RRP"	ENSG00000103269	"Rhomboid like 1"	O75783	16	675666-678268	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.3"	"Cell line enhanced"	"Detected in many"		"HeLa: 9.1;MCF7: 9.6;U-266/70: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 3.4"	"Group enriched"	"Detected in many"	20	"B-cells: 2.2;NK-cells: 1.3;T-cells: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030359, HPA030360, HPA046593"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA030359: , HPA030360: , HPA046593: "	"prognostic favourable (8.12e-4)"	"unprognostic (1.70e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.78e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.97e-2)"	"unprognostic (5.63e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.49e-2)"	1.7	6.3	10.0	1.1	8.3	2.3	0.7	21.3	14.5	1.3	2.2	1.3	2.2	5.8	1.3	1.7	1.1	1.0	1.2	2.4	8.4	9.9	3.9	1.2	0.8	1.1	5.5	7.2	0.9	6.2	2.2	4.4	1.1	4.6	1.5	1.1	1.5	6.1	2.6	0.8	3.1	5.9	0.7	2.2	0.6	4.5	2.2	1.9	0.7	0.6	0.6	0.5	0.8	0.5	2.2	0.1	0.0	0.0	1.3	3.4	0.7	1.7	2.3	1.3	2.0	1.0	2.6	6.7	0.8	1.2	0.4	0.1	4.7	1.3	0.7	1.6	0.5	1.2	0.1	0.4	0.0	1.7	8.5	1.0	9.1	1.9	0.9	1.7	1.3	1.8	3.2	0.3	0.0	0.1	1.3	1.3	0.1	9.6	0.4	4.6	1.2	0.7	8.1	1.2	1.7	0.1	1.6	1.6	2.2	1.0	0.5	2.2	3.5	4.8	0.5	2.8	2.6	0.9	0.6	11.7	1.6	2.3	1.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.4	0.3	0.0	0.5	0.5	0.2	0.0	1.3	0.0	0.1	1.2	0.7	10.0	8.3	21.3	14.5	8.4	9.9	5.5	7.2	4.6	1.9
RHBDL3	"RHBDL4, VRHO"	ENSG00000141314	"Rhomboid like 3"	P58872	17	32266176-32324661	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7"	"Cell line enhanced"	"Detected in some"		"A549: 5.9;AF22: 5.9;AN3-CA: 4.7;HDLM-2: 8.1;NTERA-2: 8.8;U-2 OS: 6.2"	"Cancer enhanced"	"Detected in some"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA059607	Uncertain									"HPA059607: "	"unprognostic (7.70e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.87e-2)"	1.0	8.2	6.8	1.2	7.4	0.7	1.1	11.3	23.7	1.4	1.2	2.9	3.3	0.9	2.0	1.9	1.3	4.4	0.9	9.7	10.1	6.6	0.8	0.6	0.7	0.7	9.1	4.6	3.4	1.1	0.6	1.9	1.0	6.7	2.1	1.4	3.9	1.0	5.6	0.6	0.9	0.9	1.8	3.6	0.6	0.9	2.5	4.0	0.0	0.6	0.0	0.8	1.9	1.1	0.8	0.0	0.0	0.0	0.0	0.3	0.3	0.0	5.9	5.9	4.7	0.9	0.0	0.1	0.3	0.6	1.9	2.0	0.1	0.0	0.0	0.4	0.7	0.1	1.6	0.0	0.5	8.1	2.3	1.0	4.0	0.3	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.5	0.1	0.2	0.0	8.8	0.0	1.0	0.0	0.0	0.0	3.2	0.1	1.6	0.8	0.1	0.1	0.4	0.1	0.0	0.0	6.2	0.3	3.0	0.0	0.0	0.0	0.3	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	6.8	7.4	11.3	15.6	10.1	6.6	9.1	4.6	6.7	4.0
RHOBTB1	KIAA0740	ENSG00000072422	"Rho related BTB domain containing 1"	O94844	10	60869438-61001440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 50.9;skeletal muscle: 63.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.6;NK-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040205, HPA040226"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040205: , HPA040226: AB_10795377"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.57e-2)"	7.6	9.8	2.7	2.0	5.8	0.5	4.5	0.8	5.0	8.8	4.7	7.2	16.5	3.4	10.2	4.9	1.9	6.8	6.3	6.6	3.7	2.5	20.5	3.4	5.4	1.4	6.7	2.3	6.9	6.0	7.4	2.2	50.9	4.6	4.9	2.6	13.3	1.4	20.3	63.5	1.9	3.5	7.7	3.8	7.4	11.7	8.5	5.7	0.6	2.3	5.2	0.9	5.0	5.2	0.5	1.6	0.7	0.6	1.3	0.0	1.3	0.1	6.1	9.3	0.0	4.4	3.9	0.0	2.7	2.5	2.2	3.4	0.3	0.1	0.0	11.5	14.3	0.1	2.7	0.8	2.7	0.0	2.5	0.5	4.5	33.9	4.9	0.6	0.2	5.7	1.5	1.4	1.4	10.7	5.0	0.0	9.9	0.2	2.5	0.0	4.0	4.0	2.2	13.1	3.2	7.4	0.3	2.6	10.0	3.2	3.6	3.5	0.7	1.2	9.5	4.4	11.5	0.1	2.9	0.0	0.0	0.0	2.1	2.0	2.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.7	1.3	0.6	0.0	0.0	1.3	2.7	5.8	0.8	5.0	3.7	2.5	6.7	2.3	4.6	5.7
RIMKLA	"FAM80A, MGC47816, NAAGS-II, RP11-157D18.1"	ENSG00000177181	"Ribosomal modification protein rimK like family member A"	Q8IXN7	1	42380795-42422578	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.8;Karpas-707: 9.0;SCLC-21H: 11.8;U-266/70: 8.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027826	Uncertain		Uncertain	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA027826: AB_10603992"	"unprognostic (4.04e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.68e-3)"	"unprognostic (9.84e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.63e-3)"	"prognostic favourable (1.43e-4)"	"unprognostic (8.89e-2)"	"unprognostic (3.76e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.99e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.44e-1)"	0.9	1.2	6.2	1.5	10.4	0.8	1.3	7.8	18.4	1.0	7.9	1.7	0.0	1.4	1.0	0.8	1.0	0.9	1.8	8.5	7.5	5.9	2.5	0.7	5.4	0.8	7.9	8.5	0.7	2.5	6.6	2.0	1.3	20.1	2.2	9.0	3.3	1.1	1.2	1.4	1.1	1.3	2.4	3.6	1.1	2.1	2.3	1.2	0.0	2.2	0.0	0.8	1.1	0.4	0.3	1.6	1.3	0.2	0.4	2.0	0.1	0.0	0.8	0.1	7.8	0.1	0.0	1.4	0.0	0.0	0.2	0.5	0.4	0.2	0.0	1.6	0.0	0.0	4.6	0.0	0.4	4.1	3.0	0.3	0.1	1.3	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.3	2.1	0.0	3.9	5.5	0.0	0.3	0.4	0.6	2.0	11.8	5.0	0.4	0.3	0.1	0.4	2.0	0.0	0.0	0.4	0.0	0.7	8.2	4.6	5.4	0.1	0.0	0.0	1.1	0.2	1.3	0.2	0.2	2.0	0.2	0.1	1.0	0.0	0.3	0.1	0.2	1.0	0.4	0.1	1.6	0.1	0.1	6.2	10.4	7.8	18.4	7.5	5.9	7.9	8.5	20.1	1.2
RIMKLB	"FAM80B, KIAA1238, NAAGS, NAAGS-I"	ENSG00000166532	"Ribosomal modification protein rimK like family member B"	Q9ULI2	12	8681600-8783095	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 53.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059552			Approved	"Nucleoplasm,Centriolar satellite"				"Nucleoplasm, Centriolar satellite"		"HPA059552: "	"unprognostic (5.29e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.89e-5)"	"unprognostic (2.40e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.52e-2)"	"unprognostic (8.67e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.99e-1)"	22.5	10.7	15.9	10.7	19.2	15.8	20.1	23.3	21.2	18.1	17.6	16.4	11.2	5.1	35.9	18.2	10.4	25.4	12.5	10.7	17.6	12.8	9.2	3.2	13.9	7.6	10.2	19.0	22.7	7.3	36.2	10.1	21.2	19.9	11.7	6.5	18.0	9.0	13.5	9.5	8.8	8.7	25.5	14.0	11.5	7.7	27.8	12.1	13.6	15.6	4.8	6.4	11.8	18.4	4.0	1.3	5.3	2.9	2.8	3.9	2.5	1.2	7.2	16.6	17.7	2.3	2.0	23.8	6.9	3.4	5.9	4.0	0.6	7.6	10.5	6.6	4.5	2.7	8.4	9.3	6.5	0.1	5.1	4.8	20.3	0.0	2.6	1.4	4.9	4.4	4.2	5.5	9.7	7.6	6.6	0.0	3.6	4.3	9.6	0.6	19.6	0.4	15.1	22.7	0.0	9.0	3.7	0.5	10.9	7.6	9.9	6.8	2.1	4.8	14.3	6.2	20.7	3.2	2.2	0.1	0.0	53.0	5.4	0.9	4.3	5.3	2.9	1.2	2.4	1.1	3.0	2.2	2.4	3.5	1.2	4.0	3.9	1.5	0.7	2.8	1.4	1.3	0.1	2.5	15.9	19.2	23.3	19.5	17.6	12.8	10.2	19.0	19.9	12.1
RINL	FLJ45909	ENSG00000187994	"Ras and Rab interactor like"	Q6ZS11	19	38867834-38878279	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 17.0;Karpas-707: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042083, HPA042103"	Uncertain		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA042083: AB_10793977, HPA042103: AB_10797380"	"unprognostic (1.30e-1)"	"prognostic favourable (6.49e-5)"	"unprognostic (7.38e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.05e-2)"	"prognostic favourable (1.64e-4)"	"unprognostic (2.61e-2)"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.40e-3)"	5.5	3.7	6.3	10.2	10.3	5.4	10.4	6.5	5.8	2.6	3.9	4.2	6.2	3.4	1.8	2.4	5.3	4.6	6.1	3.9	5.1	6.4	5.0	6.0	7.0	20.4	5.5	3.8	1.7	17.4	4.9	5.7	3.3	5.5	2.6	3.5	5.9	7.9	4.5	3.0	3.2	6.3	2.6	4.5	13.0	6.1	1.4	3.5	7.6	6.4	3.1	15.7	4.3	2.9	16.6	12.3	3.1	2.1	4.1	8.7	2.9	0.0	1.3	0.4	0.2	0.6	0.3	2.6	0.3	0.2	0.3	0.4	2.3	6.9	7.7	3.6	0.4	0.2	1.3	2.9	0.4	1.7	0.8	9.6	2.0	4.9	1.6	5.4	17.0	1.6	0.5	0.9	0.6	3.4	1.9	20.0	0.0	1.2	1.7	3.8	0.6	0.3	1.1	0.1	5.8	1.9	0.2	2.6	1.1	3.1	5.1	2.7	0.6	6.6	2.2	0.1	1.5	0.4	0.0	8.6	7.1	6.1	0.6	3.0	0.4	3.1	0.9	1.5	8.7	2.1	5.5	12.4	5.8	6.3	1.6	16.6	4.6	5.4	2.8	4.1	2.0	12.3	6.1	2.9	6.3	10.3	6.5	5.8	5.1	6.4	5.5	3.8	5.5	3.5
RNASE10	"RAH1, RNASE9"	ENSG00000182545	"Ribonuclease A family member 10 (inactive)"	Q5GAN6	14	20505537-20511169	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Fertilization"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 8.8;U-2 OS: 14.5"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 2.0;testis cancer: 1.8"					"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA052593	Uncertain				"Secreted in male reproductive system"					"HPA052593: "	"unprognostic (2.48e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.91e-3)"	"unprognostic (5.03e-3)"	"unprognostic (5.58e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.88e-4)"	"unprognostic (1.58e-1)"	"unprognostic (3.62e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.58e-1)"	3.1	3.2	0.9	2.3	1.1	1.4	1.2	1.4	2.0	1.5	1.0			2.5	3.5	1.6	2.0	3.0	0.7	0.9	1.0	1.0	1.5	2.4	2.5	0.9	1.1		2.6	1.1	0.5	1.7	1.1		1.8	0.2		1.4	0.9	3.0	4.2	2.7	0.5	1.3	1.9	1.7	3.4			1.6		0.2	1.8	1.7	0.9	1.3	3.5	1.3	0.6	0.5	0.1	5.4	2.6	1.1	2.5	0.3	0.6	3.5	0.3	0.5	0.1	0.4	1.7	1.5	0.8	1.8	0.7	2.9	0.0	0.3	0.2	2.2	0.9	0.1	1.8	0.9	0.7	0.3	2.7	0.9	1.9	0.2	3.0	1.3	1.2	3.2	0.0	1.4	0.9	1.5	0.8	0.4	4.2	0.4	3.2	0.9	2.3	1.5	1.9	8.8	2.3	1.0	2.1	0.8	0.6	1.0	14.5	1.2	1.0	3.1	1.4	0.4	1.1	0.8	1.2	3.5	0.5	0.0	0.5	0.4	0.4	0.9	0.4	0.2	0.1	0.8	0.2	0.5	2.1	0.6	1.3	1.3	0.1	0.1										
RNASE11	"C14orf6, RAJ1"	ENSG00000173464	"Ribonuclease A family member 11 (inactive)"	Q8TAA1	14	20583559-20609884	"Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	18	"epididymis: 106.3;testis: 33.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;NB-4: 2.7;RPMI-8226: 1.4;SH-SY5Y: 1.3;U-937: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA003724	Uncertain				"Secreted in male reproductive system"					"HPA003724: AB_1079817"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	106.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNASE12	RAI1	ENSG00000258436	"Ribonuclease A family member 12 (inactive)"	Q5GAN4	14	20590193-20590823	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	43	"epididymis: 143.2"	"Group enriched"	"Detected in some"	5	"NB-4: 3.6;SH-SY5Y: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044175, HPA059465"	Enhanced				"Secreted in male reproductive system"					"HPA044175: AB_10960390, HPA059465: AB_2732638"																		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0			0.0	0.0	143.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.6	0.0		0.3	0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RNASEK	MGC71993	ENSG00000219200	"Ribonuclease K"	Q6P5S7	17	7012417-7014532	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA044708	Uncertain									"HPA044708: AB_10962051"	"unprognostic (7.59e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.63e-2)"	"unprognostic (5.92e-2)"	"unprognostic (9.73e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.50e-3)"	"prognostic favourable (1.92e-4)"	"unprognostic (2.93e-3)"	"unprognostic (1.72e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-3)"	61.6	116.2	79.8	55.0	81.4	86.1	114.0	49.9	121.1	56.4	50.2	41.5	64.3	54.0	50.7	51.3	60.4	67.0	65.9	90.9	79.4	95.6	92.6	85.2	111.9	141.9	76.7	69.2	57.2	72.7	61.5	98.7	56.3	76.3	53.3	41.6	51.0	69.4	64.6	74.0	60.1	50.2	50.5	82.8	80.7	51.0	61.3	34.7	62.8	64.6	56.6	55.5	63.2	47.0	52.7	92.8	191.8	97.9	34.9	39.2	73.7	32.7	55.1	24.9	42.4	65.0	59.1	22.2	34.1	61.3	45.2	51.3	23.1	31.2	23.6	34.6	66.3	49.4	30.5	41.9	24.4	47.3	80.3	23.2	44.9	37.5	74.7	14.5	115.9	73.5	51.0	53.1	30.4	53.5	20.2	50.7	53.9	31.0	19.9	48.5	17.1	48.2	23.6	14.3	26.9	58.3	29.5	12.8	45.8	28.9	20.8	60.3	26.9	26.5	48.5	47.8	20.7	58.9	42.7	41.4	40.4	10.0	74.3	33.9	38.7	67.6	97.9	114.1	35.0	86.6	34.7	52.7	39.2	35.4	73.9	49.1	31.9	30.5	191.8	34.9	81.4	92.8	38.4	73.7	79.8	81.4	49.9	121.1	79.4	95.6	76.7	69.2	76.3	34.7
RNF122	FLJ12526	ENSG00000133874	"Ring finger protein 122"	Q9H9V4	8	33547755-33567125	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"ovary: 66.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 38.8;Karpas-707: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003888	Uncertain									"HPA003888: AB_1079822"	"unprognostic (2.36e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.09e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.78e-3)"	"unprognostic (1.71e-2)"	"unprognostic (5.46e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.95e-2)"	"prognostic favourable (5.37e-4)"	"prognostic unfavourable (4.50e-7)"	"unprognostic (4.45e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (1.88e-4)"	"unprognostic (7.15e-2)"	23.6	14.6	2.3	15.9	5.9	6.5	13.4	16.7	4.4	8.3	8.2	3.2	3.1	2.5	8.8	10.3	9.3	20.0	13.3	28.5	6.7	2.1	4.4	7.1	25.0	10.1	4.3	0.7	66.3	5.6	3.4	3.2	2.8	12.3	12.8	5.1	5.5	5.1	5.8	31.9	6.4	8.3	14.4	14.4	13.3	7.9	9.6	2.5	8.1	4.3	17.3	11.4	20.6	11.8	5.0	14.2	7.4	9.9	1.8	1.6	0.3	0.3	2.0	10.4	4.3	0.9	0.3	1.4	0.6	0.9	1.3	2.1	0.3	0.4	4.8	3.2	1.6	0.3	2.2	0.9	0.7	0.3	38.8	1.0	0.5	2.7	0.6	0.3	7.9	1.0	0.8	0.7	0.5	4.1	0.9	25.1	1.0	0.9	4.2	3.2	5.7	1.1	4.6	2.0	3.7	1.5	0.6	2.0	11.7	0.7	0.2	1.5	0.4	1.3	2.4	1.8	1.6	3.2	0.7	10.1	5.7	8.8	1.1	1.3	0.2	4.6	0.9	7.4	1.5	4.5	1.3	2.9	0.9	1.1	0.8	5.0	1.5	1.6	6.7	1.8	9.9	14.2	0.6	0.3	2.3	5.9	16.7	4.4	6.7	2.1	4.3	0.7	12.3	2.5
RNF145	FLJ31951	ENSG00000145860	"Ring finger protein 145"	Q96MT1	5	159157409-159210053	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036562	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA036562: AB_10696657"	"unprognostic (1.57e-1)"	"unprognostic (9.02e-3)"	"unprognostic (4.11e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavourable (1.64e-6)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	13.3	20.1	23.9	15.6	23.0	7.1	24.1	30.2	27.3	11.3	11.7	5.7	5.3	4.7	12.6	13.6	26.7	11.4	20.8	16.8	22.0	8.4	8.2	6.1	30.7	36.3	17.5	9.7	14.1	6.0	26.9	29.0	21.9	18.5	11.8	12.6	10.2	17.8	14.8	5.5	14.9	11.0	13.8	12.4	12.7	11.2	7.9	18.0	12.4	14.3	8.0	19.6	19.3	15.7	8.9	2.7	14.4	2.6	2.1	6.2	1.3	20.1	20.0	30.7	36.8	32.5	14.5	6.0	16.2	28.3	15.0	24.4	6.9	16.8	6.9	29.1	14.2	26.5	24.2	21.3	26.5	28.5	8.6	14.6	22.7	5.7	13.9	9.6	14.0	8.9	38.5	13.9	20.5	14.7	14.5	26.8	14.0	0.5	10.9	3.0	13.2	10.2	14.6	13.4	13.8	20.0	7.0	11.2	20.7	16.3	17.5	26.6	12.3	8.8	15.6	16.8	15.5	13.4	28.6	5.9	8.3	6.5	19.6	12.0	36.0	2.8	2.6	14.4	3.2	2.5	3.7	8.9	4.7	3.8	1.9	4.4	6.2	4.3	9.7	2.1	2.2	2.7	5.7	1.3	23.9	23.0	30.2	27.3	22.0	8.4	17.5	9.7	18.5	18.0
RNF149	FLJ90504	ENSG00000163162	"Ring finger protein 149"	Q8NC42	2	101271219-101308701	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 123.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 123.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 123.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011424	Approved		Approved	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA011424: AB_1079825"	"unprognostic (2.56e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.17e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.69e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (2.04e-8)"	"unprognostic (1.39e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.70e-1)"	"prognostic favourable (2.91e-4)"	20.3	13.4	7.9	29.0	10.9	32.9	13.5	7.9	10.8	12.5	16.6	10.8	11.4	12.3	11.3	12.8	28.9	14.3	14.5	12.1	9.5	9.4	15.1	19.6	24.5	47.4	13.7	6.2	14.3	21.1	14.3	10.6	19.4	11.2	11.1	12.0	12.8	15.8	8.1	8.8	20.2	16.8	9.6	13.9	65.0	13.8	15.2	9.7	17.0	12.7	13.1	24.4	14.9	17.2	2.1	9.3	123.7	21.3	2.3	9.0	9.9	9.6	5.7	4.3	5.5	16.3	16.4	25.5	12.0	15.8	16.2	18.3	14.4	25.6	2.8	14.5	11.8	19.7	6.1	12.2	15.1	8.4	8.4	6.0	5.1	24.3	21.8	6.4	9.7	15.0	20.1	19.2	12.7	29.5	5.2	9.0	16.2	8.2	8.6	6.5	3.0	10.4	5.6	7.2	11.1	19.1	23.7	5.7	4.2	7.2	17.9	17.3	4.8	8.7	19.5	8.2	4.7	12.2	2.6	18.3	10.7	0.1	2.6	9.0	6.0	5.8	13.0	14.8	8.2	20.4	7.4	2.1	7.3	8.1	4.8	1.5	5.1	5.3	123.7	2.3	21.3	9.3	9.0	9.9	7.9	10.9	7.9	10.8	9.5	9.4	13.7	6.2	11.2	9.7
RNF150	KIAA1214	ENSG00000170153	"Ring finger protein 150"	Q9ULK6	4	140859807-141212877	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.5;fHDF/TERT166: 17.3;SH-SY5Y: 25.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037987	Uncertain				"Intracellular and membrane"					"HPA037987: AB_10669512"	"prognostic favourable (1.41e-4)"	"unprognostic (1.95e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.38e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.32e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.88e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.41e-2)"	12.3	14.4	9.2	4.1	26.2	0.9	7.6	13.2	9.6	12.2	18.9	2.5	5.1	1.5	14.1	13.0	8.3	14.5	4.4	18.6	8.0	5.1	10.3	1.5	2.0	3.6	3.2	6.7	12.8	2.8	0.9	18.1	2.6	4.7	10.2	4.8	17.2	30.3	13.6	18.9	1.6	5.0	19.2	4.4	7.7	6.3	2.3	3.8	0.6	7.3	5.9	3.7	12.4	5.8	0.1	0.9	0.4	1.1	0.1	0.1	0.1	0.2	0.3	3.1	2.9	13.5	1.0	0.1	5.4	2.2	1.7	0.8	0.0	0.1	0.0	0.7	17.3	0.0	6.9	0.1	1.0	0.0	3.3	0.0	7.8	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.1	3.5	0.1	1.8	1.3	2.1	8.1	0.1	1.9	0.0	1.5	25.2	0.4	0.2	1.2	0.1	0.0	0.0	8.9	3.7	5.7	2.5	0.2	0.0	0.0	0.1	0.0	6.6	0.4	1.1	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.9	0.1	0.1	0.1	0.4	0.1	0.2	0.1	0.0	0.1	9.2	26.2	13.2	9.6	8.0	5.1	3.2	6.7	4.7	3.8
RNF166	"MGC14381, MGC2647"	ENSG00000158717	"Ring finger protein 166"	Q96A37	16	88696495-88706421	"Predicted intracellular proteins"	"Autophagy, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.9"	"Cell line enhanced"	"Detected in all"		"NB-4: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042970			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA042970: AB_10796682"	"unprognostic (3.01e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.96e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.38e-2)"	"prognostic favourable (1.04e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (9.45e-6)"	"unprognostic (1.54e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-2)"	9.2	8.1	9.2	22.8	8.9	63.9	10.5	13.7	15.3	6.7	7.2	11.2	3.7	12.0	8.1	8.3	6.4	9.1	12.3	10.0	8.6	7.3	9.6	9.7	20.8	30.5	8.9	6.5	9.7	11.4	5.3	8.5	7.5	8.4	8.9	4.9	11.0	12.1	6.0	14.8	8.2	16.0	8.3	11.1	47.2	10.9	9.2	9.1	21.6	8.8	7.8	23.8	9.7	6.7	2.0	11.8	28.7	12.5	5.5	17.1	9.7	4.1	6.7	5.2	8.2	2.5	2.2	9.9	4.2	2.7	5.0	2.3	4.5	2.7	5.0	5.5	2.4	4.6	3.0	2.8	2.0	2.6	9.0	6.8	4.9	7.6	6.8	6.7	8.7	2.6	2.7	4.0	3.2	5.2	11.3	3.7	2.0	8.2	15.6	43.8	8.5	9.0	14.7	3.3	13.0	2.2	1.9	4.8	5.4	9.6	2.0	5.2	5.7	22.9	7.2	3.8	5.6	5.6	5.1	8.4	4.9	12.2	3.3	25.5	5.2	3.0	12.5	28.7	17.1	9.1	14.8	2.0	10.4	14.8	11.8	1.9	8.7	12.5	20.4	5.5	10.5	7.3	10.5	9.7	9.2	8.9	13.7	15.3	8.6	7.3	8.9	6.5	8.4	9.1
RNF180		ENSG00000164197	"Ring finger protein 180"	Q86T96	5	64165844-64372869	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 54.0"	"Cell line enriched"	"Detected in some"	7	"RPMI-8226: 24.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006897	Approved		Approved	Cytosol				Cytosol		"HPA006897: AB_1856348"	"unprognostic (7.46e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.19e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (3.68e-2)"	"prognostic favourable (6.81e-5)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.81e-3)"	8.1	8.1	9.9	3.1	12.8	1.6	6.3	6.0	13.0	10.1	7.1	5.5	20.1	3.4	12.7	11.8	6.9	8.1	7.3	10.4	7.4	10.6	12.4	7.2	6.1	3.4	9.4	9.3	12.0	6.6	54.0	16.1	2.0	10.7	11.5	3.0	11.3	7.3	16.4	4.4	6.6	3.2	15.0	11.0	5.1	5.0	8.1	7.1	0.0	20.6	2.5	2.4	10.9	7.9	2.4	1.0	4.2	1.8	2.0	4.2	0.3	0.0	0.1	1.3	0.0	0.0	0.0	0.3	1.1	0.5	1.1	0.6	0.0	0.1	0.0	0.1	0.8	0.2	0.0	0.5	0.2	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.2	0.1	2.6	0.0	0.1	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.5	1.3	0.1	3.3	24.9	1.8	0.3	0.3	0.1	0.0	0.3	0.0	1.3	0.1	0.1	0.0	3.2	0.1	2.8	0.0	0.0	0.0	0.5	0.0	3.5	3.0	1.8	4.2	1.9	0.6	2.5	1.4	3.0	3.2	0.6	2.4	4.2	3.9	2.6	2.0	0.8	1.0	1.8	0.3	9.9	12.8	6.0	11.7	7.4	10.6	9.4	9.3	10.7	7.1
RNF186	FLJ20225	ENSG00000178828	"Ring finger protein 186"	Q9NXI6	1	19814029-19815278	"Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"epididymis: 25.8;intestine: 59.0;kidney: 44.0;pancreas: 30.5"	"Cell line enriched"	"Detected in some"	5	"RPMI-8226: 6.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 18.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034547, HPA035558"	Enhanced									"HPA034547: AB_10670975, HPA035558: "	"unprognostic (1.66e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.93e-3)"			"unprognostic (1.77e-3)"	"unprognostic (3.23e-1)"			"unprognostic (3.05e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.40e-1)"		"unprognostic (8.60e-3)"	0.2	0.1	0.1	7.8	0.1	0.0	0.8	0.1	0.1	0.2	38.2	0.0	0.5	47.1	0.2	25.8	0.2	0.2	0.1	0.1	0.1	0.1	44.0	0.7	0.1	0.0	0.1	0.0	0.3	30.5	0.0	0.2	0.0	0.0	0.6	5.4	0.0	0.2	0.0	0.1	0.2	59.0	0.0	0.1	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	6.1	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
RNF212	"FLJ38841, LOC285498"	ENSG00000178222	"Ring finger protein 212"	Q495C1	4	1056250-1113562	"Predicted intracellular proteins"	"Meiosis, Ubl conjugation pathway"	Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 18.1"	"Group enriched"	"Detected in some"	4	"A-431: 8.6;HeLa: 26.3;SiHa: 15.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA057527	Uncertain									"HPA057527: "	"unprognostic (2.75e-2)"	"prognostic favourable (1.39e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.05e-1)"	2.9	1.9	3.1	1.7	8.4	4.5	3.9	11.4	4.7	4.6	2.4	4.3	2.0	1.2	2.7	4.3	2.4	4.0	2.1	1.3	2.4	1.6	4.7	0.6	2.9	2.7	3.4	1.1	8.8	13.0	0.8	18.1	1.0	5.3	3.3	1.8	3.6	4.2	1.4	1.9	4.4	1.8	2.2	4.1	1.9	2.6	12.1	2.1	0.5	8.2	1.0	1.9	1.4	3.0	2.1	1.2	0.1	0.7	0.4	3.8	0.9	8.6	0.5	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.0	3.8	0.1	0.0	2.2	0.0	2.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	2.9	0.0	15.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	2.2	0.7	1.8	0.6	3.8	1.0	1.2	2.1	3.8	1.2	0.0	0.4	0.0	0.4	1.1	0.9	3.1	8.4	11.4	4.7	2.4	1.6	3.4	1.1	5.3	2.1
RNF212B	C14orf164	ENSG00000215277	"Ring finger protein 212B"	A8MTL3	14	23185316-23273477	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"kidney: 24.3;testis: 7.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;CAPAN-2: 2.5;Daudi: 3.7;Karpas-707: 2.6;U-266/70: 3.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 9.3"	HPA053574	Uncertain									"HPA053574: "	"unprognostic (2.88e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.79e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.96e-3)"	"unprognostic (4.45e-1)"	"unprognostic (7.33e-5)"	"unprognostic (9.60e-2)"	"unprognostic (3.40e-1)"	"unprognostic (7.56e-2)"	"unprognostic (5.39e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.3	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	7.5			0.4		0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	1.2	0.0	0.0	0.6	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	2.5	3.7	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	2.6	0.0	0.7	0.2	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.2	0.0	0.0	3.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.5	0.0	0.3	0.0	0.0	0.0	0.0	1.2										
RNF217	"C6orf172, dJ84N20.1, IBRDC1, MGC26996"	ENSG00000146373	"Ring finger protein 217"	Q8TC41	6	124962545-125092633	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 63.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.9;myeloid DC: 1.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029598	Uncertain									"HPA029598: AB_10602297"	"unprognostic (2.96e-2)"	"unprognostic (2.34e-3)"	"unprognostic (8.07e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.22e-3)"	"unprognostic (4.94e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (4.60e-5)"	"unprognostic (8.29e-4)"	"unprognostic (2.16e-1)"	"unprognostic (7.52e-2)"	"prognostic unfavourable (1.92e-4)"	9.6	3.5	3.3	4.2	4.7	10.5	14.6	3.8	3.5	8.0	7.7	5.7	6.4	2.3	5.9	5.6	6.2	7.5	12.1	6.5	3.8	1.7	2.5	6.3	7.3	3.7	4.3	2.9	11.5	3.8	63.3	4.0	12.0	3.4	6.4	2.3	6.0	6.0	6.9	10.1	10.9	3.1	13.0	2.3	2.6	4.5	7.4	5.7	0.1	7.4	3.6	1.6	8.7	13.6	0.0	1.2	0.6	1.9	0.3	0.2	0.3	4.1	4.2	1.5	0.5	5.4	2.1	8.5	5.7	7.7	3.9	5.1	0.0	3.9	0.0	7.9	5.4	6.0	0.9	5.1	5.5	0.0	4.8	2.3	6.3	1.3	5.2	0.0	0.2	5.9	4.7	2.9	8.6	4.4	11.6	0.0	6.8	0.0	0.0	0.0	1.3	1.1	0.1	5.9	0.0	4.0	1.9	0.7	0.0	2.5	0.6	2.1	4.1	0.6	6.9	3.2	10.3	0.0	12.1	0.0	0.0	0.0	2.4	0.0	3.8	0.6	1.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	0.3	0.0	0.0	0.3	3.3	4.7	3.8	3.5	3.8	1.7	4.3	2.9	3.4	5.7
RNF44	KIAA1100	ENSG00000146083	"Ring finger protein 44"	Q7L0R7	5	176526697-176538025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038981	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA038981: AB_10674846"	"unprognostic (1.85e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (2.57e-7)"	"unprognostic (1.50e-1)"	"unprognostic (2.56e-2)"	"prognostic unfavourable (8.45e-4)"	"unprognostic (1.61e-1)"	"unprognostic (4.54e-2)"	"unprognostic (5.36e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.15e-2)"	10.8	12.7	16.5	27.1	17.7	38.5	12.4	27.1	21.6	10.3	14.8	14.3	7.3	20.5	12.6	10.0	17.0	12.1	12.4	10.0	15.7	10.9	15.2	9.3	14.1	34.9	14.6	13.7	17.8	16.0	10.3	11.0	20.6	13.4	12.8	13.5	11.1	15.9	10.8	10.2	20.5	22.2	8.6	14.5	38.1	16.4	14.5	16.1	43.3	17.3	7.5	24.1	14.1	13.3	4.1	1.9	9.4	3.1	3.3	5.5	2.6	3.6	8.4	13.5	12.6	2.7	2.2	36.3	2.1	1.9	1.4	1.8	12.8	8.2	7.0	13.3	1.2	10.0	6.0	12.9	1.6	27.2	10.6	7.5	7.2	11.7	3.4	8.7	10.4	4.3	10.4	1.6	4.9	4.0	8.3	10.6	1.9	12.7	20.1	19.5	17.9	10.4	8.3	3.6	10.1	4.9	8.6	16.6	20.3	3.2	8.9	12.3	9.8	17.5	6.4	3.6	5.5	2.9	4.0	13.5	10.1	9.6	1.8	17.9	4.7	0.0	2.7	4.7	5.5	3.1	4.1	3.5	4.2	4.6	1.8	4.1	4.2	5.0	9.4	3.3	2.5	1.9	5.0	2.6	16.5	17.7	27.1	21.6	15.7	10.9	14.6	13.7	13.4	16.1
RNFT2	"FLJ14627, TMEM118"	ENSG00000135119	"Ring finger protein, transmembrane 2"	Q96EX2	12	116738178-116853631	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064161	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA064161: "	"unprognostic (1.56e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.98e-1)"	"unprognostic (3.10e-2)"	"unprognostic (8.14e-5)"	"unprognostic (8.62e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.75e-1)"	"unprognostic (7.61e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.36e-3)"	"unprognostic (4.01e-4)"	1.7	3.2	8.8	2.6	15.1	3.5	1.4	13.6	21.0	1.5	1.6	6.6	0.0	2.0	1.5	4.3	1.5	1.5	1.6	1.4	9.9	12.1	2.0	1.0	1.5	4.1	9.7	9.8	1.7	1.4	2.6	7.5	2.9	19.0	1.2	1.7	3.6	2.6	1.2	2.1	2.7	1.8	1.4	6.2	2.9	1.9	7.0	3.4	2.5	2.1	0.0	4.4	1.2	0.4	4.3	2.2	4.0	1.1	2.8	3.1	0.9	1.5	9.0	4.7	15.3	0.2	0.0	7.9	0.6	0.7	1.9	1.7	3.6	1.7	7.9	2.2	0.1	1.9	10.0	0.7	1.8	7.5	5.0	1.5	7.3	4.8	2.0	0.6	4.6	0.2	0.2	3.1	1.0	0.3	6.0	2.9	0.2	7.6	7.7	1.9	4.7	1.8	5.0	2.7	4.1	3.7	1.8	7.3	6.6	2.2	1.2	2.2	7.2	1.7	0.5	1.3	5.2	3.1	3.1	3.6	12.0	8.3	5.7	0.8	1.0	4.0	1.1	1.3	2.0	0.7	0.6	4.3	1.8	1.4	0.6	3.3	2.9	3.1	3.4	2.8	0.8	2.2	1.1	0.9	8.8	15.1	13.6	20.9	9.9	12.1	9.7	9.8	19.0	3.4
RPEL1		ENSG00000235376	"Ribulose-5-phosphate-3-epimerase like 1"	Q2QD12	10	103245887-103248016	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.4;brain: 1.2;pituitary gland: 1.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;NB-4: 1.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: , HPA036499: AB_10670109"	"unprognostic (7.52e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.83e-1)"		"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.91e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.72e-2)"	"unprognostic (5.06e-2)"	0.0	0.1	0.1	1.0	0.3	0.1	0.1	1.2	0.2	0.0	0.0			0.3	0.4	0.4	0.1	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.0	0.4	0.1		0.0	0.8	0.0	1.2	0.2		0.1	0.0		0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.1	0.0	0.2			0.1		0.1	0.0	0.0	0.4	1.0	0.3	0.7	1.4	0.6	0.2	0.5	0.5	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.4	0.7	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.3	1.1	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	1.0	0.7	0.0	0.0	0.1	0.3	0.5	0.2	0.3	0.1	0.3	0.4	0.2	0.1	0.4	0.0	0.1	0.9	0.1	0.2	0.3	0.1	0.3	0.7	0.4	0.1	0.3	0.7	0.2	0.5	0.7	0.5	0.4	0.4	0.3	1.0	0.4	0.5	0.6	0.0	1.4	0.4	0.3	0.4	0.2										
RPL3L		ENSG00000140986	"Ribosomal protein L3 like"	Q92901	16	1943974-1957606	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 49.0;skeletal muscle: 148.3;tongue: 36.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 7.6;Karpas-707: 5.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049136	Enhanced		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA049136: "	"unprognostic (2.53e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.27e-4)"	"unprognostic (6.38e-4)"	"unprognostic (4.36e-2)"	"unprognostic (3.48e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.32e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.60e-2)"	1.1	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.5	1.4	0.0	0.1	49.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	2.8	0.0	148.3	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.4	36.7	2.1	0.0	0.0	1.8	1.7	4.9	1.5	0.9	1.4	0.5	2.1	2.4	0.5	2.3	0.1	0.1	1.4	0.9	0.0	0.1	0.0	7.6	4.1	1.3	1.4	0.0	2.1	0.2	0.2	0.0	1.0	1.2	0.8	1.7	2.6	0.0	0.5	0.9	0.2	0.3	0.2	0.2	0.0	0.8	5.6	0.1	1.2	1.6	1.9	1.3	4.9	0.7	0.7	1.7	0.3	0.8	3.3	1.0	1.0	2.7	1.2	1.4	1.1	1.1	1.1	2.8	1.6	0.8	2.5	1.1	1.1	1.6	0.6	0.4	1.6	1.5	1.3	1.4	1.1	0.9	1.4	1.1	1.2	0.5	1.8	1.2	1.4	4.9	0.9	1.0	1.7	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RPRML	MGC43894	ENSG00000179673	"Reprimo like"	Q8N4K4	17	46978156-46979248	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"brain: 27.0"	"Cell line enhanced"	"Detected in some"		"AF22: 2.6;Daudi: 15.8;HEK 293: 4.9;NTERA-2: 2.5;SCLC-21H: 2.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"naive B-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.3"	"Group enriched"	"Detected in many"	13	"amygdala: 44.0;basal ganglia: 29.6;cerebral cortex: 41.6;hippocampal formation: 38.9;olfactory region: 24.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 311.4"	HPA062668	Uncertain									"HPA062668: "			"unprognostic (7.79e-4)"		"unprognostic (1.66e-2)"		"unprognostic (8.35e-2)"	"unprognostic (2.42e-2)"		"unprognostic (2.31e-1)"	"unprognostic (8.93e-4)"	"unprognostic (2.78e-2)"		"unprognostic (1.00e-1)"	"unprognostic (1.65e-1)"			0.8	0.6	6.6	0.6	27.0	0.6	0.8	3.6	16.5	0.6	0.8	0.0	0.0	0.8	0.6	2.5	0.6	0.7	0.6	0.6	4.9	1.3	0.7	0.6	0.6	0.6	0.8	10.1	0.6	0.6	0.6	0.1	0.6	0.0	0.8	0.6	0.4	0.7	0.6	3.9	1.0	0.8	0.6	0.0	0.7	1.3	0.7	2.7	0.0	0.6	0.0	0.6	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	2.5	0.6	0.9	0.3	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	27.0	3.6	11.6	4.9	1.3	0.8	10.1	0.0	2.7
RPS4Y2	RPS4Y2P	ENSG00000280969	"Ribosomal protein S4, Y-linked 2"	Q8TD47	Y	20756164-20781032	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 10.7;prostate: 6.8;salivary gland: 3.8;testis: 3.3"	"Cell line enriched"	"Detected in single"	7	"U-266/84: 6.3"	"Cancer enriched"	"Detected in single"	9	"prostate cancer: 1.8"					"Cell type enriched"	"Detected in some"	5	"neutrophil: 10.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.7"									HPA000857	Uncertain									"HPA000857: AB_1079849"					"unprognostic (1.50e-2)"							"unprognostic (3.63e-1)"		"unprognostic (6.39e-6)"	"unprognostic (5.92e-2)"			0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.2	0.0	10.7	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	2.2	0.1	0.0	10.7	0.0	0.0	0.0	0.0	0.0										
RPS6KL1	MGC11287	ENSG00000198208	"Ribosomal protein S6 kinase like 1"	Q9Y6S9	14	74903954-74923396	"Enzymes, Predicted intracellular proteins"		"Kinase, Ribonucleoprotein, Ribosomal protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 12.8;SCLC-21H: 24.5;SK-BR-3: 14.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.0;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.0;plasmacytoid DC: 5.4"	"Group enriched"	"Detected in many"	26	"B-cells: 2.0;dendritic cells: 5.4;T-cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027451, HPA027794"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA027451: AB_10599304, HPA027794: AB_10602098"	"unprognostic (2.71e-2)"	"unprognostic (9.33e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.49e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.03e-2)"	"unprognostic (7.52e-2)"	4.2	7.5	14.7	2.3	13.6	4.2	5.7	18.2	29.1	2.1	4.8	9.0	2.2	3.8	5.1	8.8	5.3	2.5	3.7	10.2	14.3	13.7	2.3	2.1	2.5	2.5	11.1	15.3	1.5	6.7	4.0	10.6	1.4	8.4	2.8	5.6	5.9	3.2	5.4	12.7	1.2	2.8	6.9	8.8	1.7	2.0	11.4	6.8	0.0	3.8	1.2	2.5	1.9	0.8	2.0	5.4	0.1	0.0	0.0	2.0	0.1	2.3	0.3	0.9	3.7	0.1	0.0	4.4	0.4	0.2	1.8	0.5	5.5	1.6	0.0	3.4	0.7	0.3	1.8	0.3	2.3	0.0	0.8	1.9	0.7	4.1	4.6	2.2	12.8	0.3	3.2	2.0	0.0	5.8	2.6	0.7	0.1	7.5	0.0	0.7	0.8	3.6	1.8	0.0	7.1	1.8	0.0	24.5	3.0	0.2	14.1	2.3	1.3	1.5	3.9	0.1	0.2	3.0	0.0	9.9	5.2	5.2	1.3	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.2	2.0	0.4	0.1	0.0	0.4	1.9	2.0	0.1	0.0	0.0	5.4	0.0	0.1	14.7	13.6	18.2	18.2	14.3	13.7	11.1	15.3	8.4	6.8
RRNAD1	"C1orf66, CGI-41, METTL25B"	ENSG00000143303	"Ribosomal RNA adenine dimethylase domain containing 1"	Q96FB5	1	156728442-156736960	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047426	Approved		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA047426: "	"unprognostic (2.12e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (5.60e-5)"	"unprognostic (2.00e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.03e-3)"	14.1	19.4	12.4	22.6	19.0	8.7	19.1	15.3	18.8	17.6	25.7	20.8	31.2	22.5	20.3	22.9	18.4	24.4	20.2	12.5	13.3	10.9	15.9	25.8	14.5	14.4	19.9	14.5	24.5	29.2	24.3	18.8	20.5	16.1	21.8	14.8	20.2	22.5	24.5	21.9	23.9	26.6	12.9	14.7	18.5	19.3	25.9	17.7	11.9	30.3	13.5	15.9	21.7	27.9	4.9	5.9	7.0	4.0	6.5	8.6	2.9	5.9	11.8	8.7	8.5	23.6	10.8	13.3	4.5	13.8	7.8	5.9	6.3	27.5	10.2	13.5	7.1	25.5	12.2	10.6	3.1	20.1	10.2	6.1	11.1	4.7	14.8	9.0	16.8	16.7	20.3	7.7	14.8	6.5	14.6	22.9	4.1	14.4	4.6	10.7	10.1	3.6	7.6	5.8	23.5	9.2	6.4	11.4	16.4	8.0	16.4	9.7	21.7	19.5	6.2	4.8	6.0	7.5	6.0	26.8	26.2	12.5	5.4	10.2	5.8	6.7	3.3	4.7	6.8	2.5	6.9	3.4	6.6	4.8	5.9	4.9	5.3	6.0	7.0	6.5	4.0	2.2	8.6	2.9	12.4	19.0	15.3	18.8	13.3	10.9	19.9	14.5	16.1	17.7
RSAD1	FLJ11164	ENSG00000136444	"Radical S-adenosyl methionine domain containing 1"	Q9HA92	17	50478800-50485975	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA022436, HPA022967"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA022436: AB_2180789, HPA022967: AB_1856484"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.93e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.13e-2)"	"prognostic favourable (5.04e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.22e-2)"	13.5	22.2	16.1	16.8	23.9	8.9	14.1	32.2	20.3	16.8	13.1	12.7	13.5	13.9	13.8	15.1	8.8	12.9	13.6	25.7	13.7	11.6	18.5	28.2	14.0	16.6	19.0	13.7	20.9	46.0	20.3	12.9	10.1	16.3	12.8	14.9	12.6	21.4	14.0	37.0	13.5	12.0	13.7	23.6	16.7	16.0	8.8	19.1	11.6	15.8	20.9	14.0	11.7	12.4	7.4	5.8	3.8	4.6	6.7	10.9	5.1	6.2	21.4	10.3	16.9	17.6	14.5	3.7	11.0	10.8	14.2	12.1	21.1	8.0	17.1	24.5	7.7	6.0	11.6	15.4	12.3	18.8	21.1	22.9	9.6	20.5	12.3	13.8	16.1	10.5	17.0	9.4	18.3	13.8	17.6	16.3	11.9	14.7	23.0	10.1	4.1	23.1	9.5	11.8	15.3	17.2	9.6	5.6	19.3	2.8	13.3	14.2	19.9	14.1	9.7	14.9	15.9	11.3	12.9	25.4	17.8	6.6	11.1	19.8	10.3	1.1	4.1	3.8	9.5	4.6	9.9	5.1	8.2	9.4	5.1	7.4	10.9	10.5	0.0	6.7	4.3	5.8	6.2	5.1	16.1	23.9	32.2	20.3	13.7	11.6	19.0	13.7	16.3	19.1
RSPH10B		ENSG00000155026	"Radial spoke head 10 homolog B"	P0C881	7	5925550-5970683	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"fallopian tube: 9.6;testis: 20.8"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.4"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.4"									HPA049182	Supported									"HPA049182: "	"unprognostic (4.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.06e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.31e-3)"	0.0	0.1	1.1	0.0	1.3	0.0	0.0	0.2	0.2	0.8	0.0			0.0	0.3	0.2	0.0	9.6	0.0	0.0	1.5	1.6	0.0	0.2	1.4	0.0	0.1		0.0	0.0	2.2	0.8	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	20.8			0.1		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.7	0.1	0.2	1.0	0.0	0.4	0.2	0.0	0.0	0.2	0.1	0.1	0.4	0.2	0.4	0.3	0.2	0.0	0.1	0.5	1.1	0.3	0.2	1.8	0.6	0.0	0.5	0.4	2.9	0.1	0.5	0.1	1.0	0.7	1.0	0.2	0.5	0.4	1.6	0.7	0.4	0.4	0.1	0.0	0.0	0.0	0.5	0.1	0.7	0.1	0.0	1.2	0.0	0.0	1.3	0.0	0.0	0.9	1.3	0.1	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RSPH10B2		ENSG00000169402	"Radial spoke head 10 homolog B2"	B2RC85	7	6754109-6799365	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"fallopian tube: 10.7;testis: 19.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;SH-SY5Y: 1.4;U-266/84: 3.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049182	Supported									"HPA049182: "	"unprognostic (7.74e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.28e-2)"	"unprognostic (5.35e-3)"	"unprognostic (3.41e-1)"	"unprognostic (3.05e-3)"		"unprognostic (2.58e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.69e-5)"	"unprognostic (1.66e-1)"	"unprognostic (4.38e-2)"	"unprognostic (8.27e-3)"	"unprognostic (7.02e-2)"	0.0	0.0	0.4	0.0	0.9	0.2	0.0	0.1	0.0	0.3	0.0			0.0	0.1	0.3	0.0	10.7	0.0	0.0	0.9	1.0	0.0	0.0	1.3	0.0	0.0		0.0	0.0	2.4	0.5	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	19.3			0.0		0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.1	0.4	0.8	0.0	0.1	2.0	0.1	0.0	0.2	0.0	0.1	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.7	0.1	1.0	0.1	0.0	0.2	0.0	0.8	0.0	0.3	0.2	0.4	0.0	0.4	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.4	0.2	0.0	0.3	3.3	0.0	0.4	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RSPH6A	"RSHL1, RSP4, RSP6, RSPH4B"	ENSG00000104941	"Radial spoke head 6 homolog A"	Q9H0K4	19	45795710-45815319	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 48.1"	"Cell line enriched"	"Detected in single"	11	"RPMI-8226: 7.8"	"Cancer enriched"	"Detected in single"	5	"thyroid cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA045382	Enhanced									"HPA045382: AB_10959735"	"unprognostic (1.99e-1)"	"unprognostic (3.23e-1)"		"unprognostic (6.55e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.72e-3)"		"unprognostic (4.16e-4)"	"unprognostic (2.33e-1)"	"unprognostic (5.89e-2)"		"unprognostic (1.72e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.99e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	7.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RTKN2	"bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1"	ENSG00000182010	"Rhotekin 2"	Q8IZC4	10	62183035-62268707	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lung: 67.6"	"Cell line enhanced"	"Detected in many"		"A-431: 24.9;HaCaT: 20.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in some"	7	"T-reg: 15.4"	"Lineage enriched"	"Detected in single"	47	"T-cells: 15.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037946, HPA038446"	Enhanced		Approved	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA037946: AB_10795398, HPA038446: AB_10796218"	"unprognostic (2.33e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-3)"	"unprognostic (6.66e-5)"	"unprognostic (7.81e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.48e-4)"	"unprognostic (3.70e-11)"	"unprognostic (3.95e-2)"	"unprognostic (9.34e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.55e-1)"	0.3	0.1	0.7	1.8	0.8	0.5	0.7	0.1	1.6	1.5	1.1	0.0	0.1	0.7	0.6	0.1	7.1	0.2	0.4	0.2	0.5	0.2	0.5	0.2	67.6	2.3	0.2	0.5	0.3	0.2	0.2	0.8	0.7	0.1	0.7	1.2	0.1	1.6	0.1	0.1	0.7	1.1	0.3	0.2	0.8	0.7	5.3	0.1	6.9	0.8	1.3	4.1	0.7	3.0	0.3	0.2	0.3	0.1	0.2	15.4	0.2	24.9	1.4	13.4	6.2	0.0	0.1	3.3	3.6	4.2	4.1	6.5	10.4	5.0	0.0	1.6	1.4	20.0	7.5	0.6	4.3	3.5	5.1	4.1	3.0	4.3	0.0	5.5	3.2	0.2	0.3	5.1	0.5	0.6	0.2	0.2	5.5	3.1	10.8	7.2	5.6	5.1	9.3	14.3	0.0	2.6	10.9	7.3	8.4	2.4	8.4	3.4	7.6	3.1	0.0	1.9	12.2	0.1	9.1	0.1	0.0	9.5	2.4	0.0	2.9	0.1	0.1	0.1	1.3	0.0	0.1	0.1	2.1	0.4	0.0	0.3	0.8	0.3	0.3	0.2	0.1	0.2	15.4	0.2	0.7	0.8	0.1	1.6	0.5	0.2	0.2	0.5	0.1	0.1
RTL3	"FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5"	ENSG00000179300	"Retrotransposon Gag like 3"	Q8N8U3	X	78656069-78659328	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 2.5;intestine: 2.6;smooth muscle: 2.7;stomach 1: 3.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 2.4;BJ hTERT+ SV40 Large T+ RasG12V: 2.6;fHDF/TERT166: 4.0;HBF TERT88: 5.4;hTEC/SVTERT24-B: 3.9;RH-30: 4.7;U-251 MG: 3.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA051991, HPA053174, HPA075136"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"				Nucleoplasm	"Golgi apparatus, Plasma membrane"	"HPA051991: , HPA053174: , HPA075136: "	"unprognostic (3.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"			"unprognostic (6.74e-2)"		"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.00e-6)"	"unprognostic (1.53e-2)"	"unprognostic (3.64e-1)"		"unprognostic (2.49e-1)"	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	2.6			0.2	2.5	0.2	0.5	0.4	0.5	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0		0.2	0.2	0.0	0.0	0.0		0.2	0.5		0.7	0.0	0.1	0.3	1.1	2.7	0.0	0.0	3.2	0.0			0.1		0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.9	2.4	2.6	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.0	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	1.4	0.2	3.4	0.2	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RTL4	"FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16"	ENSG00000187823	"Retrotransposon Gag like 4"	Q6ZR62	X	112454500-112457112	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"kidney: 3.5;liver: 4.7"	"Cell line enhanced"	"Detected in single"		"NTERA-2: 2.0"	"Group enriched"	"Detected in some"	8	"testis cancer: 1.4;thyroid cancer: 3.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003272	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003272: AB_2257414"							"unprognostic (9.86e-2)"						"unprognostic (2.04e-4)"		"unprognostic (6.35e-2)"	"unprognostic (5.33e-3)"		0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	3.5	4.7	0.0	0.0	0.7		0.0	0.4	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2			0.3		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RTL5	"KIAA2001, Mar5, Mart5, RGAG4, SIRH8"	ENSG00000242732	"Retrotransposon Gag like 5"	Q5HYW3	X	72127110-72131901	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 5.5;AN3-CA: 6.1;SCLC-21H: 7.5;SH-SY5Y: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003652	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA003652: AB_1079805"	"unprognostic (7.97e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.29e-3)"	"unprognostic (2.98e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.20e-1)"	"prognostic favourable (7.30e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.82e-1)"	"prognostic favourable (3.41e-4)"	"unprognostic (4.23e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.19e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-2)"	5.4	7.2	7.0	2.7	12.5	1.9	7.7	22.7	14.2	4.9	4.5	3.5	6.2	2.8	9.6	10.1	2.6	4.9	6.0	4.0	10.3	8.9	4.4	4.2	5.5	2.4	5.2	11.2	10.5	1.1	7.4	16.3	5.2	6.3	5.7	3.0	3.0	3.7	6.9	2.3	2.1	3.2	6.7	9.5	2.7	5.4	12.4	4.8	0.0	11.7	0.8	2.0	5.5	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	5.5	6.1	1.4	1.7	0.3	2.0	0.7	0.3	0.8	0.3	0.0	0.0	0.9	0.4	0.0	1.1	0.1	1.1	0.0	0.8	0.2	0.1	0.0	0.1	0.0	0.7	3.3	0.1	0.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.6	2.7	0.0	0.0	0.0	0.0	0.1	0.0	7.5	10.4	0.4	0.0	0.0	0.2	0.0	0.6	0.7	0.7	1.4	0.0	0.1	0.0	0.0	1.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.0	12.5	22.7	14.2	10.3	8.9	5.2	11.2	6.3	4.8
RTL6	"dJ1033E15.2, DKFZp761O17121, LDOC1L, Mar6, Mart6, SIRH3"	ENSG00000188636	"Retrotransposon Gag like 6"	Q6ICC9	22	44492572-44498298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005697	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA005697: AB_1079244"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.71e-3)"	"unprognostic (1.57e-1)"	"unprognostic (9.64e-3)"	"unprognostic (5.40e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-1)"	11.6	14.1	19.3	7.7	17.4	3.2	10.2	16.2	30.0	13.6	12.2	14.7	15.2	9.7	17.8	14.2	9.4	19.1	12.4	16.7	17.1	16.1	10.9	4.9	10.4	6.3	16.9	11.4	22.6	12.1	18.9	9.9	5.9	11.9	11.5	10.4	9.2	7.7	16.3	15.5	3.7	9.2	19.0	16.5	7.9	10.7	12.6	9.5	14.4	11.6	7.2	5.3	11.8	10.2	0.2	1.1	0.1	1.4	0.9	4.5	2.1	6.9	9.7	12.6	16.7	9.9	8.1	3.3	9.2	11.0	13.0	10.3	3.2	4.1	0.0	5.8	17.2	6.1	8.5	9.1	8.1	3.3	16.5	0.0	18.7	0.0	12.2	0.9	4.6	8.7	8.9	11.9	9.2	11.6	3.9	0.0	8.8	12.3	22.1	2.0	7.7	10.4	6.1	6.7	0.0	11.2	8.1	13.6	15.9	15.1	7.3	9.3	7.3	9.8	11.9	10.2	13.9	13.5	7.4	4.4	1.7	0.0	15.2	2.3	15.2	0.0	1.4	0.1	4.3	0.6	4.5	0.0	2.5	3.6	1.1	0.2	1.0	2.5	0.0	0.9	0.8	0.1	0.4	2.1	19.3	17.4	16.2	27.8	17.1	16.1	16.9	11.4	11.9	9.5
RUNDC3B	"RPIB9, RPIP9"	ENSG00000105784	"RUN domain containing 3B"	Q96NL0	7	87627548-87832296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 13.2;brain: 16.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.9;SCLC-21H: 6.5;SH-SY5Y: 3.0;U-266/70: 3.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1;memory CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056968, HPA057155"	Uncertain									"HPA056968: , HPA057155: "	"unprognostic (2.49e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.42e-5)"	"unprognostic (4.44e-1)"	"prognostic favourable (2.62e-6)"	"unprognostic (1.97e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.55e-2)"	1.1	13.2	3.6	0.8	9.4	0.1	1.4	16.4	7.9	2.7	3.7	1.0	1.0	4.7	3.4	1.2	1.0	2.0	1.7	1.4	2.8	5.1	3.3	9.7	0.8	0.4	2.8	4.8	2.3	0.5	0.5	2.0	0.2	7.9	1.1	2.7	0.7	0.9	0.8	1.1	0.9	5.2	3.8	2.2	0.4	0.6	3.1	1.0	0.0	0.6	0.1	0.5	1.6	1.1	0.1	0.0	0.4	0.0	0.0	2.1	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	2.9	0.4	0.2	0.3	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	2.4	0.1	1.5	1.0	0.1	1.2	0.4	0.0	0.7	0.0	0.4	1.2	1.2	0.0	0.0	1.3	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.0	0.2	6.5	3.0	0.0	0.2	0.1	0.1	0.0	0.4	2.5	0.0	0.1	0.0	3.9	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.4	2.1	0.0	0.8	0.1	0.0	1.7	0.0	0.1	0.3	1.2	0.3	0.0	0.0	0.0	0.0	0.1	3.6	9.4	16.4	6.5	2.8	5.1	2.8	4.8	7.9	1.0
S1PR5	"Edg-8, EDG8"	ENSG00000180739	"Sphingosine-1-phosphate receptor 5"	Q9H228	19	10512742-10517931	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 62.0;brain: 37.8;skin 1: 25.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 21.5;HBEC3-KT: 8.3;RT4: 14.0;T-47d: 8.9;U-2 OS: 8.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 11.7;head and neck cancer: 8.0;lung cancer: 3.7;urothelial cancer: 6.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 62.0;MAIT T-cell: 38.0;memory CD8 T-cell: 29.2;naive CD8 T-cell: 23.2"	"Lineage enriched"	"Detected in many"	8	"T-cells: 62.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029683	Enhanced									"HPA029683: AB_10603237"	"unprognostic (9.07e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.55e-4)"	"unprognostic (4.21e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (6.71e-7)"	"unprognostic (2.46e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.52e-1)"	1.4	1.0	10.0	1.6	17.4	21.0	1.1	1.9	15.1	2.7	1.0	37.8	0.0	0.9	1.1	6.9	6.5	1.0	1.0	0.9	15.7	8.0	1.1	2.7	3.0	1.7	28.8	9.3	0.7	0.8	0.6	0.2	2.8	13.9	2.0	0.8	0.7	1.3	1.4	1.4	25.4	1.0	0.9	26.2	11.6	0.9	0.9	21.0	0.0	0.8	0.2	3.3	3.1	5.0	0.1	0.1	0.8	0.1	8.1	62.0	10.2	1.4	2.2	0.4	0.0	0.0	0.1	0.1	0.5	0.3	0.6	0.4	0.2	0.1	0.0	5.9	0.2	21.5	1.4	8.3	1.6	0.0	1.4	0.2	1.7	0.0	0.0	0.0	0.1	0.0	3.9	2.3	0.4	0.0	0.1	0.0	0.0	2.7	0.8	0.0	3.4	0.4	0.0	1.6	0.0	0.0	14.0	0.0	0.0	3.5	0.0	0.4	8.9	2.5	0.0	1.1	8.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.2	62.0	0.0	38.0	0.1	7.8	29.2	0.1	0.1	2.4	23.2	0.8	8.1	0.1	0.1	0.1	10.2	10.0	17.4	1.9	15.1	15.7	8.0	28.8	9.3	13.9	21.0
SAMD10	C20orf136	ENSG00000130590	"Sterile alpha motif domain containing 10"	Q9BYL1	20	63974113-63980008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.9;T-cells: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040973	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA040973: AB_10794258"	"unprognostic (5.89e-3)"	"unprognostic (1.16e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.84e-3)"	"prognostic unfavourable (4.60e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.97e-3)"	"unprognostic (4.20e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.94e-3)"	2.4	2.8	6.4	6.1	14.5	3.4	5.4	25.7	10.4	2.3	4.4	1.6	9.2	7.3	1.4	3.0	10.3	4.7	8.8	3.2	5.5	5.0	6.5	4.4	3.6	10.1	3.5	3.5	0.5	5.6	5.3	3.3	3.3	3.2	4.8	3.7	2.7	9.7	6.5	1.7	9.3	6.8	1.5	1.9	5.7	10.2	3.2	2.4	5.7	3.1	2.7	12.3	5.4	4.2	2.9	1.0	0.6	0.4	1.0	6.2	1.6	5.9	0.0	2.0	0.2	0.5	0.6	0.1	1.9	1.5	3.9	1.8	5.7	11.4	0.4	4.0	0.9	8.0	1.9	2.4	2.0	11.9	4.0	1.9	5.9	8.5	0.8	9.8	16.0	0.5	4.3	2.1	0.3	1.8	4.7	4.9	0.7	4.5	4.4	9.2	3.2	9.1	6.3	0.1	10.4	6.4	10.3	2.2	4.6	1.3	11.1	2.4	7.5	4.9	1.7	1.2	2.8	0.0	0.3	1.0	0.7	3.3	3.8	8.0	1.1	0.0	0.2	0.6	4.9	0.2	2.7	2.9	3.3	2.9	0.6	1.3	5.6	6.2	0.0	1.0	0.4	1.0	2.5	1.6	6.4	14.5	25.7	10.4	5.5	5.0	3.5	3.5	3.2	2.4
SAMD12	FLJ39458	ENSG00000177570	"Sterile alpha motif domain containing 12"	Q8N8I0	8	118189459-118621995	"Predicted intracellular proteins"			Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 23.2;U-266/70: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 6.8;dendritic cells: 4.3;T-cells: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024634	Uncertain		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA024634: AB_1856549"	"unprognostic (6.96e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (1.11e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.94e-3)"	"unprognostic (2.01e-1)"	"prognostic favourable (1.52e-6)"	"unprognostic (3.31e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.35e-3)"	2.1	3.0	14.1	3.1	16.2	1.1	5.0	13.8	20.2	4.6	6.9	7.7	8.9	7.1	2.7	8.0	9.7	8.8	6.7	10.8	10.8	7.0	8.3	4.0	6.2	2.3	9.6	13.7	2.1	4.7	12.7	20.8	0.9	13.7	6.3	8.1	2.6	5.7	12.8	2.0	2.3	4.8	1.9	10.9	4.2	9.5	3.2	8.6	0.7	15.8	2.5	4.5	10.8	3.0	6.8	4.3	0.2	0.0	1.1	3.7	0.9	7.4	0.3	0.6	0.0	0.0	0.0	2.0	3.5	5.4	6.2	3.2	1.6	7.0	10.3	0.7	4.3	1.8	2.4	4.0	9.0	0.2	0.8	0.1	4.6	0.0	0.0	0.0	0.3	0.2	1.3	4.5	0.7	0.2	0.0	6.1	3.1	1.8	2.2	0.0	1.0	1.1	0.0	0.0	7.2	2.8	11.2	3.2	0.0	2.2	23.2	0.3	1.7	0.0	0.0	0.1	3.0	1.3	0.8	11.9	9.7	0.8	1.4	0.0	1.2	0.1	0.0	0.0	0.6	0.0	3.7	6.8	2.6	1.7	0.3	2.9	3.7	1.8	0.2	1.1	0.0	4.3	2.4	0.9	14.1	16.2	13.8	20.2	10.8	7.0	9.6	13.7	13.7	8.6
SAMD13		ENSG00000203943	"Sterile alpha motif domain containing 13"	Q5VXD3	1	84298366-84389957	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"basophil: 11.2"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 11.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA058929	Enhanced		Approved	Mitochondria				Mitochondria		"HPA058929: "	"unprognostic (3.78e-2)"	"unprognostic (4.93e-2)"	"unprognostic (8.51e-3)"	"unprognostic (7.55e-2)"	"prognostic favourable (1.14e-8)"	"unprognostic (1.78e-1)"	"unprognostic (1.65e-6)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.80e-3)"	"unprognostic (9.42e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.98e-7)"	"unprognostic (3.99e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.56e-3)"	1.2	5.2	4.9	1.0	12.9	2.1	2.0	9.1	5.8	1.5	16.6	7.4	0.6	2.6	1.8	4.5	1.1	3.7	1.4	1.7	4.8	2.3	1.7	0.4	0.7	0.8	7.9	6.5	0.5	2.3	1.0	2.3	0.5	4.5	3.4	19.4	0.4	13.6	1.9	7.6	1.2	3.0	2.1	5.1	1.5	5.6	12.4	8.5	3.5	8.6	2.0	0.4	2.7	0.7	0.6	1.4	11.2	0.8	0.7	0.5	0.3	0.7	2.6	1.2	4.1	4.3	4.3	2.7	0.3	0.3	0.3	0.3	0.2	4.1	4.3	7.6	0.2	0.8	0.4	1.4	0.6	2.3	2.1	1.5	1.8	0.4	1.1	4.9	0.1	1.5	2.0	0.1	1.2	10.2	0.6	1.2	1.2	1.2	6.3	0.6	4.1	2.6	0.7	3.1	1.6	8.0	2.7	1.7	6.3	0.1	0.2	9.3	1.2	4.6	1.6	1.4	0.4	0.4	1.1	3.3	0.6	7.3	0.5	4.4	1.3	11.2	0.4	0.0	0.1	0.8	0.3	0.2	0.1	0.1	0.9	0.6	0.5	0.5	0.2	0.7	0.3	1.4	0.0	0.3	4.9	12.9	9.1	5.8	4.8	2.3	7.9	6.5	4.5	8.5
SAMD14	FLJ36890	ENSG00000167100	"Sterile alpha motif domain containing 14"	Q8IZD0	17	50110040-50129882	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 45.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.6;HEL: 6.7;HMC-1: 22.7;SH-SY5Y: 10.7"	"Cancer enhanced"	"Detected in some"		"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051916	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA051916: "	"unprognostic (2.33e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.48e-4)"	2.8	3.8	18.3	3.9	19.5	2.0	1.0	45.8	18.5	2.4	2.2	3.1	1.1	2.0	3.2	4.3	1.6	1.3	2.2	1.5	15.4	10.3	2.9	1.7	5.4	2.2	7.9	16.1	1.7	1.5	2.9	2.1	3.9	10.9	3.9	1.8	4.3	1.3	4.0	6.1	1.6	2.6	2.8	6.8	3.0	3.2	4.6	6.9	0.0	1.3	0.0	3.2	2.2	0.9	0.0	0.0	2.3	0.0	0.3	0.0	0.4	0.0	0.1	3.9	0.0	1.0	0.2	0.0	2.5	0.9	0.0	0.0	0.5	0.0	0.1	3.6	1.0	0.1	0.2	0.0	0.1	10.6	0.1	6.7	0.2	0.0	0.6	0.0	22.7	0.3	0.0	0.0	0.0	0.6	0.2	0.3	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.1	0.0	0.0	3.6	10.7	0.0	0.0	0.0	0.2	0.1	0.1	0.4	1.4	0.2	0.0	0.2	0.0	0.0	1.9	0.0	0.8	2.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	18.3	19.5	45.8	18.5	15.4	10.3	7.9	16.1	10.9	6.9
SAMD15	"C14orf174, FAM15A, FLJ35963"	ENSG00000100583	"Sterile alpha motif domain containing 15"	Q9P1V8	14	77376689-77391497	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 29.1;testis: 22.1"	"Cell line enhanced"	"Detected in many"		"MCF7: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in many"			"HPA030673, HPA030677"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"				"Nucleoplasm, Nuclear membrane, Nucleoli"		"HPA030673: AB_10600655, HPA030677: AB_10599938"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.70e-3)"	"unprognostic (5.20e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.83e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.87e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.76e-2)"	0.8	1.3	5.3	0.5	6.7	0.9	1.5	0.8	3.3	1.2	0.7	2.2	3.1	0.6	1.5	7.5	0.7	6.2	1.5	0.6	3.7	2.9	6.0	0.6	1.8	1.9	1.4	3.1	3.2	2.7	5.2	29.1	0.5	7.9	1.3	0.5	4.4	0.8	1.1	0.5	0.8	0.6	0.6	1.5	0.7	0.7	22.1	2.3	0.1	6.9	0.0	1.8	1.9	0.7	0.6	0.2	2.3	0.5	0.6	0.4	0.1	3.5	4.8	1.9	4.0	0.5	2.1	1.8	1.4	1.3	3.9	3.5	3.5	3.2	3.9	1.6	1.4	3.4	1.4	2.0	5.4	0.3	0.7	0.6	1.4	0.9	0.2	0.7	4.2	1.9	1.3	3.3	0.4	2.6	0.4	1.2	1.6	10.6	0.9	0.4	0.8	1.5	1.7	1.8	0.2	6.8	1.9	4.2	2.6	5.0	0.8	0.7	6.3	1.2	1.0	3.7	2.2	3.8	1.9	0.6	3.2	2.6	4.6	0.2	1.8	0.7	0.5	1.2	0.2	0.1	0.1	0.2	0.2	0.1	0.2	0.6	0.3	0.4	2.3	0.6	0.5	0.1	0.4	0.1	5.3	6.7	0.8	3.3	3.7	2.9	1.4	3.1	7.9	2.3
SAPCD1	"C6orf26, NG23"	ENSG00000228727	"Suppressor APC domain containing 1"	Q5SSQ6	6	31762799-31764851	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"retina: 8.8;skin 1: 14.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 7.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA071699			Approved	"Vesicles,Cell Junctions"				Vesicles	"Cell Junctions"	"HPA071699: "	"unprognostic (9.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.28e-1)"	"unprognostic (9.34e-2)"	"unprognostic (8.02e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.15e-10)"	"unprognostic (2.65e-2)"	"unprognostic (4.45e-1)"	"unprognostic (3.57e-1)"	"unprognostic (7.98e-5)"	0.8	0.3	0.7	1.6	1.0	4.8	1.8	0.7	1.3	2.0	1.0	1.3	0.7	0.2	1.2	0.8	0.7	1.8	2.5	0.7	0.7	0.8	3.2	0.9	1.4	2.5	1.9	0.7	1.6	0.7	0.2	2.9	3.3	3.9	2.6	1.1	8.8	0.7	1.6	0.7	14.7	1.5	0.7	3.1	2.1	0.8	1.2	0.7	0.7	0.7	0.7	0.7	0.8	0.7	0.0	0.5	0.2	0.1	0.0	0.7	0.0	0.5	0.0	0.0	0.5	0.4	0.8	0.8	0.5	0.2	0.2	0.0	2.9	1.0	0.8	0.1	0.2	1.7	0.0	0.8	0.1	0.0	3.2	3.9	7.7	1.1	0.2	0.4	0.1	0.2	0.0	1.2	1.4	0.5	0.5	1.2	0.0	3.9	2.9	2.4	0.0	0.9	0.4	0.9	0.0	0.6	0.7	1.2	0.6	0.3	0.7	0.5	0.3	0.0	0.3	0.1	3.1	0.0	0.3	2.2	2.1	2.0	0.2	2.8	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.7	1.0	0.7	1.3	0.7	0.8	1.9	0.7	3.9	0.7
SATL1		ENSG00000184788	"Spermidine/spermine N1-acetyl transferase like 1"	Q86VE3	X	85092287-85243961	"Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 2.7;brain: 5.4;pituitary gland: 7.2;testis: 4.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;HAP1: 3.4;HEL: 1.1;RH-30: 1.5;SH-SY5Y: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060369	Uncertain									"HPA060369: "					"unprognostic (1.77e-1)"	"unprognostic (2.06e-1)"				"unprognostic (4.69e-3)"			"unprognostic (7.88e-2)"					0.3	2.7	2.9	0.4	2.6	0.4	0.4	5.4	4.6	0.4	0.4	0.2	0.0	0.3	0.4	0.3	0.3	0.4	0.3	0.5	2.2	2.0	1.1	0.4	0.3	0.3	1.1	2.7	0.4	0.3	0.3	7.2	0.4	2.2	0.5	0.4	0.0	0.4	0.3	0.7	0.6	0.3	0.3	1.4	0.4	0.3	4.8	0.4	0.0	0.4	0.2	0.3	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	3.4	0.0	0.0	0.0	0.6	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.0	1.5	0.0	0.0	0.1	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.6	5.4	4.6	2.2	2.0	1.1	2.7	2.2	0.4
SAXO2	"DKFZp666G057, FAM154B"	ENSG00000188659	"Stabilizer of axonemal microtubules 2"	Q658L1	15	82262810-82284930	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 46.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 12.0;K-562: 11.0;SCLC-21H: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 6.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040487, HPA040833"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA040487: AB_10796457, HPA040833: AB_10796561"	"unprognostic (3.03e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.13e-1)"	"unprognostic (4.69e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.87e-2)"	0.9	1.3	4.1	1.3	5.4	0.7	2.8	4.4	5.3	2.7	1.2	3.5	5.0	0.9	2.1	14.8	0.7	46.8	1.9	1.4	5.5	2.8	2.3	1.1	9.1	1.1	3.1	2.8	9.2	2.6	4.7	11.5	0.7	5.6	2.4	1.8	1.6	2.3	3.0	1.2	1.9	1.6	0.9	2.3	1.3	2.3	18.0	3.7	1.0	3.1	0.1	1.6	1.0	1.2	6.7	1.3	5.3	0.2	3.2	2.7	0.5	1.6	2.1	1.3	4.8	1.1	2.2	0.6	0.5	0.4	0.9	1.8	0.2	2.6	1.6	1.2	0.0	12.0	2.1	1.8	2.1	1.1	7.8	0.5	3.7	0.0	0.1	0.4	0.5	1.5	2.6	1.7	1.4	1.9	11.0	0.9	1.2	1.1	0.6	0.0	3.2	0.9	1.5	0.6	1.0	0.9	1.1	9.2	1.4	1.3	0.0	1.7	4.6	0.4	0.2	2.3	1.4	4.9	0.9	2.5	2.7	1.0	2.2	0.6	1.5	0.0	0.1	5.3	1.1	0.0	1.4	2.5	0.4	2.7	0.1	6.7	1.8	0.8	0.1	3.2	0.2	1.3	0.1	0.5	4.1	5.4	4.4	5.3	5.5	2.8	3.1	2.8	5.6	3.7
SAYSD1	"C6orf64, FLJ11101"	ENSG00000112167	"SAYSVFN motif domain containing 1"	Q9NPB0	6	39104064-39115189	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 52.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007959		Approved	Supported	Vesicles				Vesicles		"HPA007959: AB_1078359"	"unprognostic (2.65e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.90e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.08e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.00e-3)"	8.2	7.2	7.2	5.7	8.7	5.9	11.2	7.1	9.0	7.9	7.3	8.1	6.9	8.8	7.9	10.5	6.5	8.1	9.3	6.7	7.3	6.9	8.1	8.3	6.3	8.2	9.3	6.5	8.4	9.5	4.9	6.1	6.1	7.0	8.5	7.2	6.4	11.1	8.0	5.6	6.6	8.6	6.3	7.0	6.8	6.9	52.7	7.3	18.2	8.4	5.1	9.0	6.2	7.7	14.8	9.3	19.4	12.2	11.7	19.1	9.5	11.4	7.4	6.7	7.9	11.1	14.7	6.9	5.3	5.8	6.4	6.8	10.6	8.2	10.4	7.7	6.9	7.9	5.8	5.0	6.8	6.5	10.5	6.8	4.5	9.2	9.0	7.7	10.3	10.1	12.4	2.5	6.4	5.9	11.5	6.4	7.2	15.7	12.2	12.8	5.8	3.8	1.7	8.2	4.1	13.4	8.1	18.9	7.6	9.2	8.0	8.1	13.1	10.2	7.6	8.5	6.2	2.6	6.8	0.1	3.2	12.8	4.9	11.2	6.2	7.6	9.0	19.4	12.2	12.2	14.2	13.1	13.3	11.0	9.3	14.8	19.1	15.8	4.3	11.7	11.9	7.4	17.3	9.5	7.2	8.7	7.1	9.0	7.3	6.9	9.3	6.5	7.0	7.3
SBNO2	"FLJ00173, KIAA0963, Sno, Stno"	ENSG00000064932	"Strawberry notch homolog 2"	Q9Y2G9	19	1107636-1174283	"Predicted intracellular proteins"	"Differentiation, Osteogenesis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 20.3;HDLM-2: 31.1;U-266/70: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 6.3"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041867	Approved									"HPA041867: "	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.68e-2)"	"unprognostic (8.48e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.58e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavourable (7.98e-8)"	"unprognostic (1.34e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.88e-1)"	36.6	13.8	6.5	25.3	11.1	29.8	15.4	4.0	10.3	12.6	14.6	7.3	11.5	7.9	11.6	10.2	19.9	12.6	13.7	10.5	6.7	2.9	16.4	16.3	24.6	22.6	12.9	1.6	15.7	12.1	3.3	17.6	13.6	9.8	16.7	3.8	9.6	17.3	18.4	19.7	16.7	14.2	9.3	12.1	26.0	30.8	9.1	9.2	14.5	13.3	12.4	23.8	13.5	24.7	0.3	0.3	6.3	0.8	0.2	0.5	0.3	20.3	2.6	0.4	0.2	0.0	1.4	7.6	6.1	0.6	1.4	0.8	0.1	3.4	4.3	8.8	1.1	6.7	0.0	0.9	0.5	31.1	4.6	4.5	7.5	0.0	1.2	2.6	13.6	3.4	0.9	2.1	0.8	1.3	7.0	6.1	0.5	2.6	2.9	3.3	6.0	8.9	6.2	3.5	4.6	1.9	0.9	5.1	7.7	3.6	7.0	7.0	2.4	2.0	6.9	3.7	3.0	11.5	10.0	23.9	11.3	3.4	7.7	2.3	4.2	0.1	0.8	0.3	0.5	0.5	0.1	0.3	0.3	0.5	0.3	0.3	0.3	0.3	6.3	0.2	0.3	0.2	0.1	0.3	6.5	11.1	4.0	10.3	6.7	2.9	12.9	1.6	9.8	9.2
SCGB1D2	"LIPB, LPHB"	ENSG00000124935	"Secretoglobin family 1D member 2"	O95969	11	62242210-62244808	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 101.5;cervix, uterine: 315.2"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 14.4"	"Group enriched"	"Detected in many"	6	"breast cancer: 625.1;endometrial cancer: 226.0"	"Region enriched"	"Detected in some"	6	"pons and medulla: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA035318	Approved				"Secreted in other tissues"					"HPA035318: AB_10610421"	"unprognostic (8.76e-2)"	"unprognostic (2.14e-1)"		"prognostic favourable (3.46e-6)"	"unprognostic (2.39e-2)"				"unprognostic (5.89e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.43e-2)"	"prognostic favourable (8.03e-6)"		"unprognostic (1.55e-1)"	"unprognostic (1.15e-2)"		1.8	0.4	0.8	0.2	0.6	0.0	101.5	0.9	0.5	315.2	0.2	0.9	6.2	0.0	18.4	43.8	0.8	8.5	0.4	1.0	1.2	0.4	1.1	0.2	0.2	0.2	1.0	0.5	1.1	2.9	0.0	1.0	0.6	7.3	1.1	0.0	1.2	9.5	0.5	2.4	59.6	0.2	0.2	0.4	0.2	0.0	1.6	0.5	0.2	0.3	2.1	1.2	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	14.4	0.2	0.0	2.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.9	0.5	1.2	0.4	1.0	0.5	7.3	0.5
SCGN	"CALBL, DJ501N12.8, SECRET, SEGN"	ENSG00000079689	"Secretagogin, EF-hand calcium binding protein"	O76038	6	25652201-25701783	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.3;pancreas: 39.7;pituitary gland: 47.9"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 23.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 38.2"	"Group enriched"	"Detected in many"	11	"cerebellum: 22.3;hippocampal formation: 6.2;hypothalamus: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	16	"olfactory region: 100.5"	"Region enriched"	"Detected in some"	9	"olfactory region: 282.4"	"CAB004005, HPA006641, CAB044060, CAB062563, CAB068232"	Enhanced	Supported	Supported	Cytosol	"Intracellular and membrane"			Cytosol		"CAB004005: , CAB044060: , CAB062563: , CAB068232: , HPA006641: AB_1079874"	"unprognostic (8.15e-2)"		"unprognostic (4.31e-3)"		"unprognostic (1.46e-1)"		"unprognostic (1.25e-2)"	"unprognostic (4.70e-1)"			"unprognostic (1.78e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-1)"		1.5	2.1	0.7	6.0	0.8	0.1	2.0	22.3	1.5	0.4	10.5	0.5	0.9	7.2	0.1	0.3	0.3	0.0	0.5	5.0	6.2	22.0	3.8	2.5	0.4	0.1	0.5	1.2	0.2	39.7	0.0	47.9	1.8	1.4	1.1	11.7	1.8	3.7	3.0	0.1	0.3	8.0	0.7	1.0	0.1	12.5	0.6	0.1	0.5	1.1	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	23.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	22.3	1.5	6.2	22.0	0.5	1.2	1.4	0.1
SCRT2	ZNF898B	ENSG00000215397	"Scratch family transcriptional repressor 2"	Q9NQ03	20	661596-676179	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 17.9;retina: 6.1"	"Group enriched"	"Detected in some"	5	"Karpas-707: 3.9;NTERA-2: 3.6;RPMI-8226: 7.9;SCLC-21H: 3.8;SH-SY5Y: 4.2"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.0"	"Group enriched"	"Detected in many"	4	"cerebellum: 8.8;cerebral cortex: 17.9"	"Cell type enriched"	"Detected in single"	25	"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA067697			Approved	Nucleoplasm				Nucleoplasm		"HPA067697: "					"unprognostic (9.71e-2)"					"unprognostic (2.03e-1)"	"unprognostic (6.97e-2)"			"unprognostic (9.70e-2)"	"unprognostic (1.70e-1)"			0.3	0.3	0.7	0.3	0.7	0.3	0.3	8.8	17.9	0.3	0.3	0.6	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.7	0.6	0.3	0.3	0.3	0.3	1.9	0.0	0.3	1.3	0.3	0.0	0.4	3.2	0.3	0.3	6.1	0.3	0.3	0.3	0.3	0.3	0.3	1.1	0.6	0.3	0.7	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	7.9	0.0	0.0	3.8	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.7	0.7	8.8	17.9	0.7	0.6	1.9	0.0	3.2	0.0
SCTR		ENSG00000080293	"Secretin receptor"	P47872	2	119439843-119525301	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"intestine: 13.5;pancreas: 35.3"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 8.0"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 15.3"					"Cell type enhanced"	"Detected in some"		"basophil: 3.8"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	12	"midbrain: 1.2;pons and medulla: 1.3;thalamus: 1.5"	HPA007269	Uncertain									"HPA007269: AB_1856640"	"unprognostic (1.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.99e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.68e-2)"	"unprognostic (9.08e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.38e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.38e-2)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			13.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.2	4.1	0.0	0.0		0.0	35.3	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.9	0.2			0.2		0.0	0.0	0.0	0.5	0.1	3.8	0.3	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.8	0.0	0.5	0.1	0.0	0.0	0.0	0.6	0.0	0.0	8.0	0.7	0.5	0.1	0.0	0.8	0.0	0.1	0.0	1.4	0.3	0.5	0.0	0.3	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.3	0.6	0.0	0.9	0.3	0.1	0.0	0.0	0.1	3.8	0.3	0.9	0.3	0.2	0.4	0.3	0.3	0.0	0.0	0.5	0.3	0.2	1.2	0.3	0.3	0.1	0.4	0.0										
SDK1	FLJ31425	ENSG00000146555	"Sidekick cell adhesion molecule 1"	Q7Z5N4	7	3301448-4269000	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 8.0;BEWO: 9.9;RPTEC TERT1: 8.3;RT4: 10.3;SH-SY5Y: 7.3;U-2 OS: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	28	"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA011392	Approved		Approved	Cytosol			2700000	Cytosol		"HPA011392: AB_1856648"	"unprognostic (2.39e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-1)"	"prognostic favourable (4.08e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.37e-1)"	5.8	1.1	2.2	6.1	1.7	1.4	5.8	0.9	3.1	16.6	6.2	1.4	6.8	1.8	6.1	10.9	2.9	4.5	4.8	1.9	3.4	2.2	3.9	0.7	7.0	8.7	1.6	1.4	4.3	22.4	1.5	6.3	2.9	2.1	6.9	2.4	5.6	2.6	9.4	1.8	2.9	4.2	16.5	1.9	16.3	3.6	7.7	1.9	1.8	1.5	3.6	3.4	9.5	13.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.0	1.7	8.0	0.0	0.0	0.0	9.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	2.3	0.0	0.1	0.8	0.0	0.2	0.0	4.6	0.0	0.3	0.2	4.0	0.0	0.0	1.6	0.0	0.3	0.5	0.6	0.0	0.0	3.9	2.0	0.0	0.0	2.7	0.0	5.6	5.6	0.0	8.3	10.3	5.0	7.3	0.0	0.0	0.0	0.0	2.5	0.2	0.0	12.4	0.0	3.4	0.0	0.0	0.0	0.0	1.6	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	2.2	1.7	0.9	3.1	3.4	2.2	1.6	1.4	2.1	1.9
SDR16C5	"EPHD-2, RDH-E2, RDHE2"	ENSG00000170786	"Short chain dehydrogenase/reductase family 16C member 5"	Q8N3Y7	8	56300010-56320776	"Enzymes, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 27.5;lung: 34.0;skin 1: 35.9;tongue: 25.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 19.9;HaCaT: 9.9;hTCEpi: 16.4;T-47d: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	36	"memory B-cell: 9.1;naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	56	"B-cells: 9.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025224	Enhanced									"HPA025224: AB_1856163"	"unprognostic (1.66e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.18e-4)"	"unprognostic (8.83e-3)"	"prognostic favourable (7.88e-4)"		"unprognostic (1.66e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.48e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	0.3	0.2	2.0	2.0	1.9	0.0	7.4	0.9	6.2	8.1	5.9	0.2	0.0	1.7	0.2	0.0	27.5	0.2	1.5	0.2	0.6	1.2	0.2	0.2	34.0	0.3	1.4	2.9	0.2	0.3	0.0	0.5	0.0	10.6	0.3	3.0	0.2	9.2	0.0	0.3	35.9	16.9	0.2	0.4	0.2	12.9	0.5	0.2	0.0	0.2	25.8	21.1	1.0	11.5	9.1	0.0	0.0	0.0	0.0	0.1	0.1	3.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.0	9.9	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.4	0.0	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	7.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	1.9	0.9	6.2	0.6	1.2	1.4	2.9	10.6	0.2
SDR42E1	HSPC105	ENSG00000184860	"Short chain dehydrogenase/reductase family 42E, member 1"	Q8WUS8	16	81988855-82011488	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 7.3;hTCEpi: 10.6;MCF7: 7.0;RT4: 17.1;SCLC-21H: 7.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 4.0;NK-cells: 3.6;T-cells: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014388	Uncertain									"HPA014388: AB_1851226"	"unprognostic (2.09e-1)"	"unprognostic (4.90e-1)"	"unprognostic (9.52e-3)"	"unprognostic (3.81e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.93e-4)"	"unprognostic (4.90e-7)"	"unprognostic (2.18e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.21e-2)"	"unprognostic (8.27e-2)"	1.3	0.3	0.2	6.5	0.5	0.3	5.8	0.2	0.2	3.5	12.2	0.0	4.1	7.9	4.6	3.9	11.5	2.1	2.6	2.2	0.2	0.4	7.4	8.3	4.1	3.6	0.2	0.1	0.6	14.3	3.8	14.9	0.3	0.2	3.1	2.2	1.4	18.8	3.4	0.7	16.7	21.3	1.5	0.3	3.8	3.6	7.3	0.1	8.2	6.1	7.3	13.7	4.3	4.7	4.0	0.4	0.8	0.0	3.6	4.6	2.0	2.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	4.4	0.0	1.5	0.0	7.3	0.0	5.7	0.0	0.0	0.5	0.0	1.5	0.0	0.1	0.0	0.0	0.2	10.6	1.4	5.4	0.0	1.2	0.0	0.7	7.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	2.3	17.1	7.4	0.0	0.2	3.5	0.0	0.0	0.0	0.2	0.0	3.9	0.0	0.0	3.7	4.9	0.4	0.0	0.0	0.0	0.1	0.0	0.8	1.8	0.0	2.4	4.0	1.5	2.5	0.3	2.1	4.6	3.6	0.1	3.6	0.0	0.4	3.0	2.0	0.2	0.5	0.2	0.2	0.2	0.4	0.2	0.1	0.2	0.1
SEL1L2	"C20orf50, DKFZp434C1826"	ENSG00000101251	"SEL1L2 ERAD E3 ligase adaptor subunit"	Q5TEA6	20	13849247-13996443	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA059121	Approved									"HPA059121: "	"unprognostic (6.70e-2)"	"unprognostic (1.64e-2)"		"unprognostic (2.72e-3)"	"unprognostic (2.19e-1)"				"unprognostic (8.51e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.12e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SEM1	"C7orf76, DSS1, ECD, FLJ42280, SHFD1, Shfdg1, SHFM1, SHSF1"	ENSG00000127922	"SEM1, 26S proteasome complex subunit"	"P60896, Q6ZVN7"	7	96481626-96709891	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA020429, HPA072648"	Uncertain		Approved	Cytosol				Cytosol		"HPA020429: AB_1859527, HPA072648: "	"unprognostic (5.41e-3)"	"unprognostic (6.25e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-1)"	"prognostic favourable (2.52e-4)"	"unprognostic (4.55e-1)"	"unprognostic (6.92e-2)"	"prognostic unfavourable (7.19e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.64e-1)"	"prognostic favourable (8.00e-5)"	44.1	58.5	33.3	38.6	48.7	23.1	29.0	25.0	36.3	29.6	48.4	16.8	44.0	41.5	33.5	44.1	45.4	24.0	29.5	69.9	34.8	27.9	34.7	91.6	24.3	28.2	31.7	31.8	45.7	43.6	14.8	51.2	63.5	32.2	32.2	27.8	22.0	43.4	34.5	109.5	34.2	39.0	42.1	43.8	25.0	40.0	52.5	28.8	28.8	28.7	61.8	28.0	31.5	34.0	50.6	94.9	36.7	65.7	42.0	79.0	48.9	62.6	37.0	51.6	53.6	22.1	19.3	27.8	51.2	25.2	21.6	27.1	33.5	52.2	41.4	127.4	24.9	32.5	43.2	34.6	30.7	48.1	32.6	49.6	54.5	52.0	20.2	73.3	37.1	24.5	27.1	32.3	33.1	28.8	64.2	51.1	21.9	79.4	82.7	103.9	69.8	33.9	32.2	66.5	48.9	30.6	62.4	42.5	53.8	95.7	80.4	52.2	22.9	55.9	59.2	42.7	74.3	78.8	63.9	32.2	86.3	119.6	46.6	64.8	58.7	36.7	61.3	15.8	45.5	65.7	43.2	50.6	59.3	53.1	86.3	45.3	46.9	47.2	4.1	42.0	55.4	94.9	79.0	48.9	33.3	48.7	25.0	36.3	34.8	27.9	31.7	31.8	32.2	28.8
SEMA3B	"LUCA-1, SemA, sema5, SEMAA, semaV"	ENSG00000012171	"Semaphorin 3B"	Q13214	3	50267558-50277546	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 147.6"	"Cell line enhanced"	"Detected in many"		"HeLa: 22.5;Hep G2: 34.0;SK-BR-3: 17.7;WM-115: 55.3"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	7	"eosinophil: 3.3"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030651	Approved				"Secreted in other tissues"		29000			"HPA030651: AB_10602224"	"prognostic favourable (1.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.27e-1)"	"unprognostic (7.99e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.89e-1)"	"unprognostic (8.87e-3)"	"unprognostic (1.69e-2)"	3.3	18.8	2.5	2.0	7.4	0.0	1.0	0.3	9.2	9.2	6.0	18.6	2.3	13.3	4.4	3.5	2.5	3.4	5.6	3.4	3.6		7.7	0.0	8.1	0.0	12.9	4.9	2.6	5.6	3.5	0.0	147.6	8.2	2.8	2.8	8.5	1.2	6.8	1.5	0.5	19.7	3.9	5.9	0.3	11.9	0.5	9.5	0.0	1.6	0.6	0.0	1.9	0.6	0.0	0.4	3.3	0.0	0.0	0.0	0.0	3.9	2.6	0.2	2.5	0.2	0.3	0.6	5.2	7.1	1.5	2.5	1.9	9.9	0.0	4.8	5.0	0.6	0.1	8.3	0.6	0.0	0.2	0.0	22.5	34.0	5.6	0.0	0.2	1.7	0.1	1.7	1.3	0.0	0.0	0.6	0.2	7.0	0.0	0.2	0.3	1.4	0.1	0.4	0.1	2.4	0.4	0.3	1.2	1.3	17.7	2.6	1.2	0.0	0.1	0.4	5.2	1.4	1.6	1.4	0.0	0.0	2.6	0.0	55.3	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0										
SEMA3C	"SEMAE, SemE"	ENSG00000075223	"Semaphorin 3C"	Q99985	7	80742538-80922359	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 46.6;T-47d: 52.8;U-2197: 68.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"basophil: 25.8"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042418			Approved	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted in other tissues"			"Golgi apparatus, Cytosol"	"Plasma membrane"	"HPA042418: AB_10797389"	"unprognostic (1.93e-2)"	"unprognostic (2.54e-3)"	"unprognostic (4.94e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.74e-2)"	"prognostic unfavourable (5.72e-5)"	"unprognostic (9.28e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.01e-2)"	"prognostic unfavourable (4.08e-5)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-2)"	27.1	4.1	3.7	11.9	5.6	0.2	25.1	1.2	6.8	37.0	31.7	7.6	21.6	4.3	26.9	25.1	20.0	7.1	16.4	12.4	5.2	6.1	5.8	1.1	12.3	0.3	13.1	3.0	23.5	1.5	0.0	4.1	5.9	25.5	29.6	14.1	27.4	13.6	19.7	7.3	9.7	10.6	48.8	8.5	8.9	13.3	11.6	6.0	0.2	2.5	15.2	1.5	35.5	14.5	0.0	2.0	25.8	3.2	0.0	0.0	0.8	1.2	15.0	31.3	0.1	7.0	17.1	0.0	10.2	11.8	5.2	6.6	2.4	28.4	0.0	0.4	3.4	6.1	0.1	9.2	8.5	0.0	3.1	1.9	13.5	0.1	8.5	0.1	0.0	7.4	6.1	12.7	12.6	0.1	0.1	0.0	8.7	21.8	0.0	0.0	0.2	2.4	0.0	15.1	0.2	27.1	46.6	0.1	16.1	28.6	7.4	1.7	52.8	0.0	24.5	28.4	13.0	68.4	17.9	0.2	0.0	0.0	10.7	0.0	28.1	25.8	3.2	0.5	0.0	1.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.5	0.0	1.0	1.8	0.0	0.8	3.7	5.6	1.2	6.8	5.2	6.1	13.1	3.0	25.5	6.0
SEMA3D	"coll-2, Sema-Z2"	ENSG00000153993	"Semaphorin 3D"	O95025	7	84995553-85186855	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.8;thyroid gland: 33.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 16.8;HaCaT: 17.1;TIME: 26.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"amygdala: 17.1"	"Cell type enriched"	"Detected in single"	5	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037522	Uncertain		Approved	"Golgi apparatus,Plasma membrane"	"Secreted in other tissues"		77000	"Golgi apparatus"	"Plasma membrane"	"HPA037522: AB_10672494"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.58e-3)"	"unprognostic (4.02e-3)"	"unprognostic (9.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-3)"	"unprognostic (5.25e-3)"	4.1	2.2	17.1	1.9	2.3	0.1	4.3	0.8	2.8	4.6	2.9	1.8	2.5	1.4	1.9	7.4	1.3	3.9	1.4	2.0	3.6	2.7	3.0	1.0	3.6	6.1	2.4	3.1	4.1	0.8	0.4	1.5	0.6	5.4	6.2	2.6	2.6	5.6	2.9	0.7	2.1	2.7	3.2	4.8	33.8	2.4	4.3	2.5	0.0	33.0	0.6	1.1	4.7	3.9	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.3	4.5	4.9	5.4	2.6	0.0	0.0	0.0	1.4	16.8	17.1	1.9	0.0	3.6	0.0	3.5	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	4.4	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	4.5	1.2	5.4	3.9	1.7	0.0	0.1	0.6	0.0	0.0	0.2	0.2	0.0	26.2	0.0	1.7	0.2	0.0	3.3	1.9	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	17.1	2.3	0.8	2.2	3.6	2.7	2.4	3.1	5.4	2.5
SEMA3F	"Sema4, SEMAK"	ENSG00000001617	"Semaphorin 3F"	Q13275	3	50155045-50189075	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 23.9;HUVEC TERT2: 41.7;RT4: 24.2;SK-BR-3: 38.8;TIME: 74.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035008	Approved				"Secreted to blood"	1700000	4000000			"HPA035008: AB_10604091"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.71e-1)"	"prognostic unfavourable (5.15e-4)"	"unprognostic (1.71e-1)"	"unprognostic (9.05e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.88e-3)"	"unprognostic (6.87e-3)"	17.4	3.7	2.8	5.0	3.6	1.5	26.5	3.5	5.0	12.2	7.5	2.5	45.3	8.1	9.2	10.5	42.6	9.7	8.2	12.3	3.1	3.1	15.1	4.9	20.4	5.8	2.9	0.5	5.5	4.2	2.9	5.7	28.9	6.4	14.8	4.1	19.3	12.5	22.1	7.9	44.4	9.3	5.7	2.6	57.6	10.2	3.1	3.6	2.7	13.8	19.5	21.5	14.7	22.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.0	0.7	0.1	3.2	0.0	0.3	0.6	1.7	5.4	1.4	2.3	1.1	1.3	0.1	17.5	0.2	10.3	1.5	22.4	0.5	0.0	0.4	0.1	23.9	3.9	1.2	0.3	0.7	1.4	12.5	3.4	10.3	41.7	0.6	0.0	0.2	2.6	0.3	1.6	1.9	2.1	2.5	0.0	0.1	1.6	24.2	0.2	0.5	2.8	38.8	0.0	15.2	1.5	74.8	0.9	7.4	6.6	1.2	0.0	0.0	0.1	0.0	0.9	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.6	3.5	5.0	3.1	3.1	2.9	0.5	6.4	3.6
SEMA3G	"FLJ00014, sem2"	ENSG00000010319	"Semaphorin 3G"	Q9NS98	3	52433053-52445085	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 46.2;breast: 89.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.4;Hep G2: 6.2;HUVEC TERT2: 6.6;THP-1: 5.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"T-reg: 4.5"	"Lineage enriched"	"Detected in single"	18	"T-cells: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001761	Uncertain				"Secreted to blood"		4400000			"HPA001761: AB_1079902"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.79e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.14e-2)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.14e-1)"	"prognostic favourable (8.86e-5)"	"unprognostic (5.63e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.14e-1)"	46.2	1.6	3.1	2.4	5.0	0.2	89.1	11.5	5.3	3.5	5.4	2.8	1.5	2.1	3.3	3.0	3.5	3.2	4.5	8.0	3.8	3.3	8.8	0.7	30.4	1.2	5.5	2.5	2.0	2.2	1.1	1.1	19.3	3.1	2.9	2.8	6.8	13.6	2.1	8.0	5.2	6.7	3.2	3.6	7.2	2.7	2.0	1.1	0.4	3.5	4.7	1.4	3.7	5.3	0.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.1	0.2	23.4	0.2	2.6	0.0	0.0	0.0	0.0	0.7	0.4	3.0	1.3	0.0	0.0	0.1	0.0	0.0	0.2	1.2	3.4	0.2	6.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	6.6	0.0	0.3	0.0	0.2	0.2	4.0	1.2	0.1	0.0	0.0	3.7	0.0	0.2	0.6	0.6	0.0	0.3	0.4	2.0	5.8	2.5	0.0	2.5	0.0	0.0	0.4	1.7	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.1	5.0	11.5	5.3	3.8	3.3	5.5	2.5	3.1	1.1
SEMA4F	"SEMAM, SEMAW"	ENSG00000135622	"Ssemaphorin 4F"	O95754	2	74654228-74683853	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064095, HPA065969"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"				Nucleoplasm	"Plasma membrane, Centrosome"	"HPA064095: , HPA065969: "	"unprognostic (9.69e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.58e-2)"	"prognostic unfavourable (5.94e-5)"	"prognostic unfavourable (6.96e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.95e-2)"	"unprognostic (9.01e-3)"	"unprognostic (6.53e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (9.74e-6)"	"unprognostic (2.60e-2)"	"unprognostic (8.08e-2)"	"prognostic favourable (6.94e-4)"	"unprognostic (4.69e-2)"	8.1	5.1	15.5	3.5	15.5	1.3	5.7	12.9	21.3	5.2	3.8	3.3	2.3	1.9	6.6	6.7	2.7	5.6	3.5	4.9	17.2	12.2	4.8	2.1	8.1	5.1	5.3	16.5	9.1	4.6	13.7	10.2	3.5	7.8	5.2	4.2	3.6	5.0	5.7	3.0	4.9	3.0	7.0	5.7	4.7	4.3	7.2	3.8	2.9	4.7	1.3	4.9	3.5	4.7	2.8	0.2	1.4	0.4	2.5	5.6	2.1	7.1	4.9	5.3	7.5	8.7	4.8	3.3	5.0	10.4	9.1	8.4	2.0	4.1	2.4	5.4	7.9	2.1	7.7	8.5	10.1	6.3	6.6	4.2	2.0	4.0	3.1	0.9	6.7	4.4	7.4	6.1	3.2	3.9	0.3	0.1	5.3	2.1	3.8	0.7	2.9	4.7	0.0	6.9	0.0	7.1	3.4	3.3	8.0	7.2	3.0	9.0	3.5	0.5	4.2	15.5	7.5	3.7	9.1	5.8	5.8	0.3	18.9	0.3	8.3	0.5	0.2	1.4	5.6	0.1	3.2	2.8	3.0	4.9	0.2	2.1	3.3	3.9	0.8	2.5	0.4	0.1	2.2	2.1	15.5	15.5	12.9	21.3	17.2	12.2	5.3	16.5	7.8	3.8
SEMA5B	"FLJ10372, KIAA1445, SEMAG, SemG"	ENSG00000082684	"Semaphorin 5B"	Q9P283	3	122909193-123028605	"Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.6;heart muscle: 11.7"	"Cell line enhanced"	"Detected in some"		"AF22: 41.4;NTERA-2: 8.0;SH-SY5Y: 11.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 18.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066548	Enhanced		Supported	Cytosol				Cytosol		"HPA066548: "	"unprognostic (7.34e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.92e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.66e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (1.31e-3)"	"unprognostic (5.96e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.12e-1)"	1.5	1.2	12.0	0.7	12.3	0.3	1.1	0.8	13.6	2.1	1.5	4.3	0.4	1.9	2.8	5.5	1.5	3.0	4.7	11.7	13.0	3.3	6.1	1.4	2.2	1.1	2.5	3.3	1.3	3.1	1.1	2.5	5.0	2.0	1.8	1.8	6.0	0.9	3.1	1.6	1.2	1.3	3.8	1.7	0.5	0.7	1.1	5.7	0.1	2.2	2.5	1.3	3.3	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	41.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	11.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.0	12.3	0.8	13.2	13.0	3.3	2.5	3.3	2.0	5.7
SEMA6C	KIAA1869	ENSG00000143434	"Semaphorin 6C"	Q9H3T2	1	151131685-151146664	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 124.1;tongue: 43.4"	"Cell line enhanced"	"Detected in many"		"AF22: 11.7;HUVEC TERT2: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076150, HPA077625"			Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"		290000	"Nucleoplasm, Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"HPA076150: , HPA077625: "	"unprognostic (6.97e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.56e-3)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.25e-2)"	"prognostic favourable (3.06e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"	3.2	1.9	2.3	1.5	3.0	1.3	3.4	16.8	5.8	4.2	2.6	1.5	0.8	6.7	4.1	3.5	3.2	2.9	3.9	12.7	2.3	3.5	3.0	3.3	1.9	3.4	1.7	3.3	4.8	1.7	1.7	4.3	1.6	2.7	2.8	1.6	3.4	3.1	1.9	124.1	3.4	5.2	3.6	1.1	1.3	1.6	15.0	0.6	0.5	1.3	43.4	2.9	2.2	3.6	0.9	0.6	0.7	0.0	0.1	1.4	0.2	0.7	0.8	11.7	4.5	4.9	1.6	1.0	0.8	0.4	0.8	1.1	0.2	0.5	0.5	3.4	2.7	1.1	1.1	0.4	0.7	1.0	3.4	6.1	0.5	0.9	0.6	0.1	2.3	2.8	1.4	1.0	0.5	20.4	0.5	0.6	1.9	0.4	1.0	0.8	5.2	1.3	7.2	2.6	0.2	0.4	0.3	5.9	7.7	1.1	0.5	0.9	1.3	1.0	9.5	2.0	2.8	2.9	0.4	4.9	0.9	5.0	0.5	0.2	0.7	0.0	0.0	0.7	0.1	0.0	1.4	0.0	0.2	0.0	0.0	0.9	0.5	0.0	0.5	0.1	0.0	0.6	0.3	0.2	2.3	3.0	16.8	5.8	2.3	3.5	1.7	3.3	2.7	0.6
SERF1A	"4F5, FAM2A, H4F5, SERF1, SMAM1"	ENSG00000172058	"Small EDRK-rich factor 1A"	O75920	5	70900665-70918530	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA075271			Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA075271: "	"unprognostic (1.14e-1)"	"unprognostic (3.00e-2)"	"unprognostic (9.58e-2)"		"unprognostic (3.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.81e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.53e-2)"	1.3	1.2	6.4	1.8	5.0	3.0	1.5	5.3	7.2	1.2	1.8			0.2	3.1	7.8	1.8	1.1	3.7	1.6	5.4	5.2	4.1	0.4	1.9	3.3	4.9		2.6	2.6	3.2	2.5	0.8		2.4	3.5		2.1	1.2	1.9	2.8	1.4	3.1	3.5	2.4	2.0	2.8			4.4		0.6	5.8	1.6	7.3	2.6	2.8	1.2	2.1	6.3	0.9	3.6	0.3	3.2	4.5	3.0	4.3	6.3	1.0	0.8	0.9	1.4	1.2	1.5	3.2	6.3	2.6	1.0	1.7	1.1	2.4	1.5	3.2	3.6	2.0	1.7	1.5	0.7	1.3	2.0	1.4	0.7	1.0	2.6	0.5	2.0	2.4	1.7	9.5	11.3	2.3	1.0	0.5	4.5	5.0	3.2	3.0	9.7	2.9	10.0	0.5	9.9	6.3	1.3	8.6	3.8	1.2	2.9	1.4	0.8	1.0	3.2	1.9	0.5	8.7	1.0	0.3	2.8	4.2	1.2	5.1	4.9	4.0	6.3	0.5	7.3	4.7	3.9	2.8	2.1	0.8	2.6	3.0	0.9										
SERF1B	"FAM2B, H4F5C"	ENSG00000205572	"Small EDRK-rich factor 1B"	O75920	5	70025247-70043113	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 23.8;SiHa: 38.9;SK-MEL-30: 25.9;WM-115: 20.6"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA075271			Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA075271: "	"unprognostic (1.00e-1)"	"unprognostic (2.52e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.98e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.74e-2)"	"unprognostic (3.52e-1)"	3.7	2.4	7.6	1.6	8.3	2.6	2.6	5.7	10.4	2.9	3.4			0.9	3.2	22.7	5.0	1.6	4.7	3.1	6.6	6.7	8.4	1.6	3.5	3.2	7.5		2.5	3.9	11.6	4.0	2.0		4.7	3.9		7.8	5.1	4.1	2.7	2.6	10.3	5.5	3.9	5.7	20.5			4.9		1.4	7.9	3.0	7.0	6.4	10.9	4.5	5.7	8.7	1.8	11.5	0.2	1.7	2.2	8.5	6.4	8.4	3.4	6.1	2.1	1.8	0.3	1.1	1.1	23.8	5.2	3.3	0.9	0.7	3.6	2.9	0.3	6.4	0.4	0.6	0.5	0.7	1.1	0.4	12.7	0.7	0.1	0.6	0.4	1.6	0.2	0.1	10.9	6.6	1.7	0.2	1.2	6.6	4.8	1.3	0.5	8.5	6.3	38.9	1.8	25.9	17.2	3.1	18.4	10.0	0.7	0.4	0.6	0.7	1.1	9.0	0.6	0.0	20.6	0.3	0.9	10.9	6.4	3.0	6.9	6.0	8.2	5.8	3.5	7.0	8.7	5.8	2.5	5.7	4.5	6.4	5.8	1.8										
SERINC2	"FKSG84, PRO0899, TDE2, TDE2L"	ENSG00000168528	"Serine incorporator 2"	Q96SA4	1	31409565-31434680	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 113.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 46.5;HaCaT: 53.0;HBEC3-KT: 83.7;hTCEpi: 47.6;RT4: 57.3;SK-BR-3: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 12.0"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 12.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA005974	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA005974: AB_10603239"	"unprognostic (1.41e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.78e-3)"	"prognostic favourable (1.69e-7)"	"unprognostic (6.78e-2)"	"unprognostic (5.31e-2)"	"prognostic unfavourable (2.11e-4)"	"prognostic unfavourable (5.70e-4)"	"unprognostic (3.12e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.63e-3)"	"unprognostic (2.67e-2)"	2.0	6.6	0.6	13.5	1.2	1.1	12.1	0.8	0.8	17.3	32.9	0.8	52.1	27.4	3.7	26.5	32.5	4.3	34.4	2.0	1.0	0.6	57.5	113.9	10.3	7.1	1.8	0.5	1.7	12.9	5.7	5.1	33.9	1.4	17.0	12.8	5.0	58.6	74.4	20.2	14.2	73.0	6.7	1.2	1.7	20.7	3.5	0.8	5.7	13.1	12.7	19.1	31.1	19.9	0.2	12.0	2.3	2.7	0.0	0.0	0.5	12.8	3.0	2.7	8.7	5.9	8.0	7.4	24.7	18.4	1.6	2.0	4.6	46.5	8.5	32.6	23.2	53.0	0.3	83.7	0.3	0.8	2.0	0.0	2.7	2.4	6.6	0.0	9.9	7.3	47.6	10.2	22.5	1.0	0.3	0.0	2.7	2.1	0.3	0.3	2.8	6.5	0.0	5.3	2.8	8.8	57.3	1.1	6.6	6.3	47.9	1.0	28.0	1.4	6.1	0.4	2.0	0.2	0.5	0.4	0.3	0.4	0.2	0.2	2.0	0.0	2.7	2.3	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	12.0	0.0	0.5	0.6	1.2	0.8	0.8	1.0	0.6	1.8	0.5	1.4	0.8
SERINC3	"AIGP1, DIFF33, SBBI99, TDE, TDE1, TMS-1"	ENSG00000132824	"Serine incorporator 3"	Q13530	20	44496221-44522109	"Predicted membrane proteins, Transporters"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048116	Uncertain									"HPA048116: "	"unprognostic (3.16e-2)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.85e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.64e-2)"	42.5	47.1	35.5	22.8	63.0	21.0	38.9	28.9	80.6	39.0	27.4	52.8	14.8	22.9	31.8	25.4	32.8	28.3	34.2	34.9	40.8	35.2	25.0	45.1	33.0	20.6	40.5	33.9	35.4	24.7	55.9	33.6	55.8	60.9	29.6	31.8	29.4	30.2	33.4	45.3	35.9	25.6	35.2	42.6	26.3	26.2	51.2	33.3	29.2	40.6	20.5	23.8	32.8	28.8	19.6	31.4	58.9	34.5	34.4	34.4	38.7	14.4	15.4	7.4	9.4	65.2	46.9	11.5	29.6	51.5	23.9	22.0	34.7	35.8	10.5	40.5	35.2	26.0	8.8	30.4	25.5	12.2	9.9	12.3	16.0	17.6	35.3	15.1	26.9	33.2	44.5	23.6	35.4	23.2	13.6	31.3	25.0	18.1	15.4	12.0	4.3	23.4	7.8	11.1	16.0	19.1	16.6	9.3	7.1	28.4	27.8	18.8	19.8	17.0	29.7	57.0	9.4	25.1	20.5	18.5	20.4	8.1	42.5	10.7	17.8	57.9	30.2	37.9	33.8	31.5	34.4	19.3	29.5	32.8	31.4	19.6	30.6	30.4	58.9	34.4	34.5	28.9	33.1	38.7	35.5	63.0	28.9	80.6	40.8	35.2	40.5	33.9	60.9	33.3
SERINC5	"C5orf12, TPO1"	ENSG00000164300	"Serine incorporator 5"	Q86VE9	5	80111651-80256079	"Predicted membrane proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 26.6;RT4: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037898, HPA037899"	Supported		Supported	"Vesicles,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Vesicles, Centrosome"	"HPA037898: AB_10673649, HPA037899: "	"unprognostic (2.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.68e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.17e-2)"	6.9	21.1	9.0	7.8	11.2	3.0	6.7	5.3	15.6	10.2	16.3	28.8	11.2	5.1	6.9	12.9	9.7	9.6	8.4	4.1	9.5	7.3	5.3	26.3	8.0	9.3	13.4	7.0	9.8	7.8	4.2	5.3	24.7	12.1	20.3	17.5	3.6	9.8	8.4	3.1	10.9	9.5	4.4	9.7	8.3	9.7	18.9	15.0	7.8	5.2	6.7	12.3	9.3	7.7	0.8	4.0	6.2	6.9	0.4	17.5	4.7	5.1	9.2	3.1	2.0	4.3	4.6	9.3	4.2	2.8	1.8	1.9	18.5	26.6	0.8	4.3	5.4	14.9	4.2	11.1	2.7	0.7	2.2	0.6	1.1	9.9	1.6	0.6	1.9	5.2	6.2	4.8	12.6	3.4	1.6	4.4	4.9	8.8	10.3	2.5	4.3	3.2	12.3	2.7	1.4	5.5	25.4	0.2	3.0	3.7	8.7	16.3	3.8	3.2	3.7	5.4	1.5	5.4	5.2	5.7	1.6	13.3	10.2	1.8	22.0	6.2	6.9	4.4	1.6	3.4	1.2	0.5	13.9	4.2	4.0	0.8	17.5	10.5	3.6	0.4	1.0	0.9	4.5	4.7	9.0	11.2	5.3	10.9	9.5	7.3	13.4	7.0	12.1	15.0
SERPINE3		ENSG00000253309	"Serpin family E member 3"	A8MV23	13	51335773-51364735	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"retina: 49.3"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.7;TIME: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA051904, HPA055804"	Uncertain				"Secreted in other tissues"					"HPA051904: , HPA055804: "	"unprognostic (1.60e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.66e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.67e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.94e-6)"	"unprognostic (1.29e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.31e-2)"	2.6	0.9	0.6	1.2	0.8	0.2	0.6	1.9	1.7	0.6	0.8	0.6	0.6	0.8	1.1	2.0	1.1	0.9	1.4	1.9	0.7	0.5	0.8	1.2	0.6	1.4	0.6	0.6	1.0	5.7	0.1	0.6	0.6	1.2	0.6	0.1	49.3	0.9	0.6	0.6	4.0	3.2	0.6	1.1	0.8	0.8	1.0	0.6	0.6	1.1	0.6	0.6	0.9	0.9	1.6	0.0	0.1	0.9	0.0	0.8	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.2	0.8	0.3	0.0	0.7	0.0	0.0	0.0	0.9	0.1	0.9	2.7	0.2	0.0	1.9	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.3	0.8	2.3	0.0	0.3	0.0	0.0	1.3	1.1	0.3	2.1	0.1	0.2	1.0	2.1	2.9	0.7	1.9	0.2	1.3	0.4	0.7	0.2	1.5	0.2	1.4	0.0	0.2	0.0	0.3	0.9	0.0	0.0	0.8	0.1	0.0	1.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.9	0.6	0.7	0.5	0.6	0.6	1.2	0.6
SERTAD4	DJ667H12.2	ENSG00000082497	"SERTA domain containing 4"	Q9NUC0	1	210232799-210246631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 36.3"	"Cell line enhanced"	"Detected in many"		"A-431: 7.3;BEWO: 7.6;SCLC-21H: 7.6;SK-BR-3: 8.7;T-47d: 10.7;U-2 OS: 9.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027344, HPA028514"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA027344: AB_10601770, HPA028514: AB_10611391"	"unprognostic (1.75e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.74e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.69e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.85e-2)"	"unprognostic (6.55e-2)"	"unprognostic (4.24e-1)"	1.5	1.0	2.3	0.7	7.7	0.1	12.3	2.6	4.3	6.2	6.2	1.5	4.6	1.1	6.2	3.2	15.7	3.2	2.9	4.2	1.8	2.1	2.5	0.2	3.4	0.4	2.8	0.4	2.5	0.2	1.5	1.4	11.7	3.0	3.6	3.3	1.0	36.3	11.1	0.5	5.3	1.1	6.0	2.7	0.3	2.3	0.7	2.1	1.9	3.2	14.6	7.7	1.7	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.2	1.6	0.0	0.8	0.8	7.6	1.8	1.8	1.4	2.5	0.3	0.9	0.0	0.2	0.4	3.6	0.3	0.6	0.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.2	0.3	0.0	0.0	0.3	1.7	0.0	0.0	5.3	0.3	0.0	2.5	0.0	1.2	1.3	7.6	6.6	1.2	8.7	0.1	10.7	0.0	2.3	2.1	9.1	0.1	5.5	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	7.7	2.6	4.3	1.8	2.1	2.8	0.4	3.0	2.1
SETD4	"C21orf18, C21orf27"	ENSG00000185917	"SET domain containing 4"	Q9NVD3	21	36034541-36079389	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024073, HPA035405"	Approved		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA024073: AB_1856755, HPA035405: "	"unprognostic (4.23e-1)"	"unprognostic (5.67e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.05e-3)"	"unprognostic (7.86e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.17e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.60e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.99e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.28e-2)"	10.9	12.1	14.4	10.6	19.4	10.2	12.4	19.8	20.8	11.5	12.9	22.0	13.8	15.1	14.7	15.8	14.1	14.9	10.6	13.4	13.6	13.6	12.6	9.1	11.2	10.6	21.0	14.0	13.8	10.5	18.0	17.2	11.9	18.9	13.2	13.0	14.2	12.7	11.3	11.6	18.0	18.0	15.1	14.5	11.1	13.1	28.9	21.7	10.9	13.5	8.6	16.3	12.3	13.4	17.1	17.4	11.9	14.2	10.9	13.4	8.4	9.3	6.6	10.0	12.8	5.0	6.1	16.3	12.5	11.0	12.8	8.7	13.9	8.6	5.1	8.8	5.7	7.0	7.5	7.4	11.2	9.0	9.1	13.7	10.5	8.7	12.1	12.9	7.9	6.3	12.6	8.7	11.2	9.6	17.8	9.4	7.9	9.8	8.6	18.7	21.0	8.5	12.9	7.4	12.4	14.0	6.7	8.3	13.3	12.6	13.7	12.6	12.0	10.9	8.0	11.2	4.2	7.0	11.3	15.0	21.7	7.9	11.8	17.9	9.6	6.7	14.2	11.9	9.8	11.0	10.8	17.1	12.1	10.3	16.2	13.9	8.9	10.3	10.7	10.9	10.5	17.4	13.4	8.4	14.4	19.4	19.8	20.8	13.6	13.6	21.0	14.0	18.9	21.7
SETD9	"C5orf35, MGC33648"	ENSG00000155542	"SET domain containing 9"	Q8NE22	5	56909260-56925532	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 23.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049936			Approved	Nucleoplasm				Nucleoplasm		"HPA049936: "	"unprognostic (1.13e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.37e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.06e-1)"	7.2	2.6	2.3	1.2	4.4	2.4	11.1	1.4	5.2	2.6	4.4	4.7	4.6	4.4	2.7	2.5	2.4	1.9	2.1	7.0	2.1	2.4	5.4	8.8	2.4	5.3	5.3	3.8	2.6	7.3	2.4	2.0	2.6	3.7	4.3	3.3	2.8	5.3	1.2	4.1	1.9	5.2	4.4	3.6	1.8	2.7	23.8	3.2	1.1	4.4	3.4	2.0	2.9	8.1	1.1	2.0	4.3	3.0	1.6	2.9	0.8	4.8	1.8	3.0	3.8	4.6	2.5	5.2	1.4	2.2	2.4	6.1	4.5	5.6	4.5	7.0	2.1	4.5	3.2	1.8	6.2	3.1	6.7	1.2	1.5	3.7	1.8	1.4	4.2	1.2	2.5	2.2	3.2	3.9	3.7	3.2	5.5	7.1	0.7	3.4	4.6	7.2	4.6	1.9	5.9	2.6	1.7	3.4	5.4	1.2	3.5	5.9	5.5	3.4	4.2	1.6	7.3	4.5	3.0	3.3	9.5	7.4	2.1	1.3	0.7	1.4	2.3	4.3	1.4	2.0	1.3	0.5	1.6	0.4	2.0	1.1	0.5	0.6	2.7	1.6	3.0	0.8	2.9	0.8	2.3	4.4	1.4	5.2	2.1	2.4	5.3	3.8	3.7	3.2
SGCZ	ZSG1	ENSG00000185053	"Sarcoglycan zeta"	Q96LD1	8	14089864-15238339	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 21.2;ovary: 11.3;pituitary gland: 7.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.2;REH: 2.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"amygdala: 5.6;basal ganglia: 9.5;cerebellum: 21.2;cerebral cortex: 6.8;pons and medulla: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA017585	Uncertain									"HPA017585: AB_1856799"					"unprognostic (3.83e-1)"						"unprognostic (1.41e-1)"			"unprognostic (5.87e-4)"	"unprognostic (1.21e-1)"			1.1	0.4	5.6	0.5	9.5	0.6	2.6	21.2	6.8	0.8	0.7	0.0	0.0	0.7	0.9	1.4	0.4	0.5	0.7	0.5	1.4	2.2	1.0	0.7	0.4	0.4	1.3	2.3	11.3	0.7	0.4	7.3	0.5	5.3	0.8	0.5	0.1	0.4	0.6	0.4	0.9	0.5	0.9	3.2	0.5	0.7	1.4	1.1	0.0	0.4	0.0	0.5	1.5	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.6	9.5	21.2	6.8	1.4	2.2	1.3	2.3	5.3	1.1
SH2D4B		ENSG00000178217	"SH2 domain containing 4B"	Q5SQS7	10	80537902-80646560	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.8;bone marrow: 2.5;epididymis: 2.4"	"Cell line enriched"	"Detected in single"	87	"REH: 24.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA040022	Uncertain									"HPA040022: AB_10805601"	"unprognostic (1.19e-2)"	"unprognostic (4.51e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.65e-6)"	"unprognostic (9.37e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.81e-1)"	0.6	0.0	0.2	0.2	0.3	2.5	0.3	0.1	0.3	0.1	0.1	0.1	0.1	0.3	0.2	2.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.2	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.0	1.3	0.1	0.1	0.5	0.1	0.2	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1
SH2D6	FLJ35993	ENSG00000152292	"SH2 domain containing 6"	Q7Z4S9	2	85418721-85437029	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 4.2;pancreas: 1.7;testis: 6.4;thyroid gland: 2.4"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 6.5;RH-30: 2.4;SCLC-21H: 1.5"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA053873	Uncertain									"HPA053873: AB_2682286"	"unprognostic (4.70e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.67e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.06e-7)"	"unprognostic (2.54e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.65e-3)"	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.3	0.4	0.0	1.9			4.2	0.0	0.2	0.0	0.0	0.2	0.0	0.4	0.2	0.3	0.2	0.0	0.0	0.6		0.0	1.7	0.0	0.1	0.0		0.0	0.4		0.0	0.0	0.0	0.0	2.8	0.0	0.4	0.0	0.8	6.4			2.4		0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.6	0.3	0.0	0.1	0.6	0.1	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.3	0.0	0.0	0.2	0.1	0.2	0.4	0.0	0.0	0.2	6.5	0.0	0.0	0.0	0.1	0.4	0.1	2.4	0.0	0.7	0.0	1.5	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	1.2	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.3	0.1	0.0	0.5	0.6	0.0	0.0	0.3	0.0										
SH3BGR	21-GARP	ENSG00000185437	"SH3 domain binding glutamate rich protein"	P55822	21	39445855-39515506	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 219.7"	"Cell line enhanced"	"Detected in many"		"U-266/70: 15.3;U-87 MG: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.5"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"cerebellum: 34.0;midbrain: 14.7;olfactory region: 12.3;pons and medulla: 29.7"	"Low region specificity"	"Detected in all"			"CAB003685, HPA030690"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB003685: AB_425682, HPA030690: "	"unprognostic (3.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.68e-3)"	"unprognostic (6.05e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.89e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.97e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.75e-1)"	"unprognostic (5.98e-3)"	"unprognostic (7.16e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.06e-2)"	2.4	5.2	7.2	1.2	7.3	0.9	2.9	1.1	4.3	2.9	6.1	3.0	2.0	1.9	2.1	6.6	5.3	2.1	5.0	30.0	6.6	5.4	3.2	2.8	1.5	0.9	7.5	5.0	1.8	2.8	2.1	4.5	1.1	6.1	5.8	2.0	1.2	3.2	5.2	219.7	0.9	1.4	12.4	7.9	1.2	2.9	3.7	5.9	0.1	3.9	41.5	2.2	7.3	8.6	2.7	11.5	2.6	1.7	2.8	4.0	1.2	1.0	1.3	1.7	2.5	3.7	4.3	0.5	1.9	0.9	0.9	0.7	0.7	2.2	3.3	5.1	5.0	0.1	0.9	1.5	1.4	2.0	3.4	3.3	0.6	1.3	7.6	1.2	0.7	3.5	6.2	3.2	6.3	1.0	2.5	4.3	3.5	4.1	2.2	1.9	1.7	2.9	3.5	6.4	2.1	4.6	0.8	4.8	2.0	2.9	2.4	3.1	9.0	0.6	0.8	2.5	0.3	1.5	3.7	15.3	3.2	3.3	47.5	2.9	3.3	2.3	0.7	0.0	1.2	1.7	3.1	2.7	1.1	1.8	1.9	1.4	4.0	3.0	2.6	2.8	1.7	11.5	0.7	1.2	7.2	7.3	1.1	4.3	6.6	5.4	7.5	5.0	6.1	5.9
SH3D21	"C1orf113, FLJ22938"	ENSG00000214193	"SH3 domain containing 21"	A4FU49	1	36306387-36324886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 26.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 16.1;SK-BR-3: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0;NK-cell: 2.7"	"Low lineage specificity"	"Detected in many"											"HPA042212, HPA042456, HPA066168"	Approved		Supported	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA042212: AB_10961180, HPA042456: AB_10959746, HPA066168: "	"prognostic favourable (2.60e-4)"	"unprognostic (8.35e-3)"	"unprognostic (3.86e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.32e-3)"	"unprognostic (2.04e-4)"	"unprognostic (7.47e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.38e-3)"	"prognostic unfavourable (1.76e-6)"	"unprognostic (8.88e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.59e-2)"	1.6	1.1	11.6	3.4	9.5	1.9	10.1	12.2	11.3	4.4	5.3	1.1	1.4	16.6	2.8	2.7	7.1	1.9	3.0	2.2	5.2	2.2	8.6	1.4	4.5	2.8	1.9	7.0	4.0	1.0	1.3	2.2	19.4	7.4	7.0	6.0	12.4	12.7	2.6	1.0	16.2	24.3	2.0	2.4	1.6	2.3	6.6	1.9	0.0	26.2	4.1	4.5	3.7	6.7	0.1	0.3	2.0	0.5	2.7	0.6	0.0	9.9	0.3	1.9	2.2	0.6	1.2	10.8	4.8	1.0	3.6	1.6	5.6	4.0	1.8	5.3	2.0	16.1	1.7	3.6	3.0	0.5	0.7	1.6	3.4	4.4	1.6	0.9	2.4	0.6	3.0	2.4	1.8	1.3	0.2	3.1	1.7	5.9	1.6	0.9	1.2	1.9	2.4	0.1	1.2	4.1	1.2	4.0	2.0	1.1	12.1	3.8	0.4	0.4	2.8	1.5	0.8	4.8	0.5	3.5	1.1	2.1	4.1	0.9	0.3	0.0	0.5	0.0	0.4	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.0	2.0	2.7	0.0	0.0	0.0	0.0	11.6	9.5	12.2	11.3	5.2	2.2	1.9	7.0	7.4	1.9
SHISA4	"C1orf40, hShisa4, TMEM58"	ENSG00000198892	"Shisa family member 4"	Q96DD7	1	201888680-201892306	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 175.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 18.3;intermediate monocyte: 6.4;neutrophil: 8.2;non-classical monocyte: 7.8"	"Group enriched"	"Detected in many"	9	"granulocytes: 18.3;monocytes: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061273, HPA067885"	Uncertain									"HPA061273: , HPA067885: "	"unprognostic (1.13e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.48e-3)"	"unprognostic (2.12e-3)"	"unprognostic (6.59e-2)"	"unprognostic (8.29e-3)"	"unprognostic (7.06e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-1)"	5.2	15.8	22.2	3.8	18.8	2.5	3.3	9.6	34.8	4.7	3.3	29.1	2.1	2.7	4.4	4.5	4.0	3.9	4.7	14.7	17.5	14.6	4.1	3.8	4.0	2.7	19.2	14.8	6.8	4.1	4.1	3.8	3.8	21.3	6.2	2.9	7.2	12.1	5.1	175.2	4.2	3.2	4.7	14.0	3.4	3.2	4.2	8.2	0.0	6.3	18.8	2.7	3.9	2.6	0.0	0.7	18.3	7.8	0.0	1.5	0.5	1.2	9.4	1.1	6.7	10.2	6.1	1.0	8.2	13.4	3.4	4.8	1.6	2.5	0.0	11.2	10.1	2.4	0.1	1.3	2.2	1.0	0.6	0.1	2.8	1.1	7.2	0.0	6.0	6.2	3.0	4.4	2.2	6.2	0.1	0.3	6.0	1.1	0.0	0.0	0.7	11.4	0.1	0.0	1.8	3.3	3.6	0.4	6.1	2.9	1.3	8.3	3.8	0.8	6.2	4.8	4.8	2.7	4.2	1.6	1.3	0.0	7.9	0.0	8.4	0.0	1.4	18.3	1.5	6.4	0.6	0.0	0.3	0.3	0.7	0.0	0.0	0.3	8.2	0.0	7.8	0.0	0.0	0.5	22.2	18.8	9.6	34.8	17.5	14.6	19.2	14.8	21.3	8.2
SHISA6	FLJ45455	ENSG00000188803	"Shisa family member 6"	Q6ZSJ9	17	11241263-11564063	"Predicted membrane proteins, Transporters"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.6;cervix, uterine: 22.4"	"Cell line enriched"	"Detected in some"	7	"NTERA-2: 7.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA023440	Uncertain									"HPA023440: AB_1848945"	"unprognostic (1.70e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"prognostic unfavourable (8.41e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.47e-2)"	2.2	0.7	5.8	0.6	5.5	0.2	1.2	9.8	7.5	22.4	0.9	2.5	1.9	0.4	4.2	2.4	0.9	1.7	0.5	1.1	12.1	9.9	2.5	0.2	1.5	0.2	11.8	2.9	0.6	1.4	6.0	0.0	0.3	13.6	5.9	0.8	0.8	0.2	10.1	1.0	0.5	0.4	1.2	9.6	0.2	6.0	2.9	2.1	0.0	0.7	0.0	0.2	0.6	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.5	9.8	4.9	12.1	9.9	11.8	2.9	13.6	2.1
SHISA7		ENSG00000187902	"Shisa family member 7"	A6NL88	19	55428740-55442863	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 24.9"	"Group enriched"	"Detected in some"	5	"HEL: 6.5;HMC-1: 6.9;THP-1: 3.5"	"Cancer enriched"	"Detected in single"	9	"glioma: 2.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058935	Uncertain		Approved	Cytosol				Cytosol		"HPA058935: "	"unprognostic (3.98e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"		"unprognostic (3.08e-1)"	"unprognostic (4.40e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.87e-7)"	"unprognostic (7.53e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.29e-4)"	"unprognostic (4.04e-1)"	0.7	1.7	11.3	0.7	16.7	2.6	0.7	4.0	24.9	0.7	0.8	7.2	0.0	0.7	0.7	0.7	0.7	0.7	0.7	0.7	11.2	8.2	0.7	0.7	0.7	0.7	8.3	3.1	0.7	0.8	0.7	2.4	0.7	5.5	0.7	0.8	0.0	0.7	0.7	0.7	0.8	0.8	0.7	4.0	0.7	0.8	2.2	14.6	0.0	0.7	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	6.5	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	1.2	0.6	0.0	1.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	16.7	4.0	10.9	11.2	8.2	8.3	3.1	5.5	14.6
SHISAL1	KIAA1644	ENSG00000138944	"Shisa like 1"	Q3SXP7	22	44243667-44312851	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 22.5;endometrium 1: 34.2;smooth muscle: 31.9"	"Cell line enhanced"	"Detected in some"		"SiHa: 16.7;U-2197: 37.9;U-87 MG: 22.0;WM-115: 12.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051178	Uncertain		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA051178: "	"unprognostic (4.07e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.10e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.51e-7)"	"unprognostic (1.48e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.99e-4)"	"unprognostic (1.10e-4)"	0.7	1.3	13.8	1.3	3.6	0.0	0.5	1.6	13.0	22.5	7.7	0.5	6.9	1.4	34.2	4.5	1.5	1.9	2.3	0.5	5.4	9.1	0.5	0.5	0.6	0.5	3.6	0.5	1.7	0.6	0.1	0.8	5.7	0.5	5.8	1.5	0.5	0.5	8.9	0.5	0.4	0.8	31.9	0.5	0.5	0.5	1.5	0.5	0.5	0.5	0.5	0.5	11.9	3.3	0.0	0.1	0.7	0.0	0.2	0.1	0.0	0.0	0.1	1.6	0.5	0.0	0.0	0.0	0.4	1.1	1.1	0.6	0.0	0.0	0.0	0.0	1.0	0.0	2.3	0.1	0.1	0.0	1.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	6.1	0.0	16.7	0.0	0.1	0.0	0.1	0.0	6.2	0.9	37.9	0.2	0.0	0.0	0.0	22.0	0.0	12.7	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.0	0.0	13.8	3.6	1.6	11.8	5.4	9.1	3.6	0.5	0.5	0.5
SHISAL2A	"FAM159A, MGC52498"	ENSG00000182183	"Shisa like 2A"	Q6UWV7	1	52633344-52669683	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 10.8;lymphoid tissue: 25.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.3;Karpas-707: 12.7;NB-4: 3.6;RPMI-8226: 16.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"hypothalamus: 8.8"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 10.8;NK-cells: 5.7;T-cells: 7.9"	"Region enhanced"	"Detected in single"		"hypothalamus: 4.7"	"Low region specificity"	"Detected in many"			HPA030744	Uncertain									"HPA030744: AB_10963060"	"unprognostic (7.94e-6)"	"unprognostic (8.50e-3)"	"unprognostic (8.29e-3)"	"unprognostic (2.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.67e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.31e-3)"	"unprognostic (7.27e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.64e-2)"	0.6	0.4	1.0	25.4	1.4	3.5	0.5	1.3	2.0	1.3	1.2	1.2	0.0	1.0	1.1	1.9	1.0	0.9	1.3	0.3	0.9	8.8	0.8	0.4	1.2	20.4	2.8	0.2	0.2	0.7	0.0	3.2	0.5	1.2	0.7	0.9	0.6	3.7	1.0	0.7	0.2	5.7	0.6	2.1	12.1	1.2	1.2	0.7	3.5	1.3	0.3	24.0	3.2	0.4	10.8	0.1	1.9	0.0	5.7	7.9	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	5.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	3.6	2.1	0.0	0.0	0.0	16.7	0.1	0.0	0.5	0.0	1.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	7.9	0.0	4.5	10.7	7.2	6.4	0.1	10.8	5.0	3.1	0.0	5.7	0.0	0.1	2.2	1.8	1.0	1.4	1.3	2.0	0.9	8.8	2.8	0.2	1.2	0.7
SIAH3	FLJ39203	ENSG00000215475	"Siah E3 ubiquitin protein ligase family member 3"	Q8IW03	13	45777243-45851736	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 10.2;fallopian tube: 11.8"	"Cell line enriched"	"Detected in single"	8	"EFO-21: 4.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060576	Uncertain									"HPA060576: "	"unprognostic (1.07e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.00e-2)"		"unprognostic (1.05e-1)"		"unprognostic (7.53e-2)"	"unprognostic (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-3)"	"unprognostic (3.24e-3)"	"unprognostic (9.03e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.18e-1)"	0.6	1.3	5.1	0.9	8.3	0.9	0.6	5.6	10.2	4.1	0.6	0.0	0.1	0.8	1.7	2.0	0.6	11.8	0.7	0.6	4.0	2.8	1.7	0.6	0.8	0.8	3.4	6.6	0.7	0.6	0.5	0.4	0.5	8.9	0.6	0.7	2.8	1.7	3.6	0.6	0.8	0.8	0.8	1.3	0.8	0.7	0.8	0.7	0.4	0.6	0.0	0.9	0.7	0.4	0.1	0.1	0.5	0.1	0.2	1.5	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	4.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	1.5	0.7	0.5	0.2	0.0	0.1	0.0	0.0	5.1	8.3	5.6	10.2	4.0	2.8	3.4	6.6	8.9	0.7
SIDT1	"FLJ20174, SID-1"	ENSG00000072858	"SID1 transmembrane family member 1"	Q9NXL6	3	113532296-113629578	"Predicted membrane proteins, Transporters"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.6"	"Cell line enhanced"	"Detected in some"		"MCF7: 11.9;PC-3: 16.8;REH: 4.8;RT4: 11.7;T-47d: 11.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035862	Approved									"HPA035862: AB_10671110"	"unprognostic (4.23e-1)"	"prognostic favourable (3.78e-4)"	"unprognostic (3.43e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.64e-4)"	"unprognostic (2.93e-4)"	"unprognostic (1.50e-1)"	"unprognostic (4.02e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.32e-2)"	"prognostic favourable (4.09e-5)"	1.8	4.1	7.5	13.6	5.9	4.1	7.8	17.3	11.7	4.7	8.4	5.5	3.7	2.8	1.2	0.7	2.7	2.8	5.1	1.1	7.9	9.2	1.6	1.1	2.7	17.6	4.7	8.5	0.9	1.7	1.5	12.8	1.6	4.7	7.2	14.0	0.4	13.2	9.7	0.8	1.3	8.4	1.3	4.5	11.6	4.9	1.8	1.2	13.2	1.3	0.7	13.3	6.8	1.9	4.9	21.6	0.2	0.4	5.9	4.9	2.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.1	0.0	1.1	0.0	0.4	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	11.9	3.2	0.1	0.0	16.8	4.8	0.0	0.4	0.0	11.7	0.1	0.1	0.0	3.4	0.1	11.1	0.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	4.9	0.1	4.9	4.9	3.2	3.9	0.9	4.3	4.2	3.5	0.1	5.9	0.0	21.6	2.5	2.1	7.5	5.9	17.3	11.7	7.9	9.2	4.7	8.5	4.7	1.2
SIM1	bHLHe14	ENSG00000112246	"Single-minded family bHLH transcription factor 1"	P81133	6	100385015-100464929	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 13.2;kidney: 21.6;seminal vesicle: 17.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 7.8;BJ: 12.5;BJ hTERT+: 18.3;RPTEC TERT1: 14.4"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.8"	"Region enriched"	"Detected in single"	21	"hypothalamus: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"hypothalamus: 6.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 2.6;hypothalamus: 5.2"	HPA024385			Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA024385: AB_1856879"	"unprognostic (1.04e-1)"			"unprognostic (4.34e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.76e-2)"		"prognostic favourable (5.32e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.19e-1)"			5.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	13.2	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	2.2	21.6	0.5	0.0	0.0	0.1	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	17.5	4.7	0.8	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.2	7.8	0.0	12.5	18.3	5.6	5.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	4.8	5.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0
SIRPB2	"dJ776F14.2, PTPN1L, PTPNS1L3"	ENSG00000196209	"Signal regulatory protein beta 2"	Q5JXA9	20	1470741-1491587	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.5;lymphoid tissue: 21.2"	"Cell line enhanced"	"Detected in some"		"A-431: 5.2;HBEC3-KT: 4.5;HMC-1: 9.1;hTCEpi: 9.8;HUVEC TERT2: 4.8;THP-1: 8.6;TIME: 4.3;U-937: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"classical monocyte: 19.8;eosinophil: 12.3;intermediate monocyte: 12.8;myeloid DC: 8.8;neutrophil: 29.5;non-classical monocyte: 9.7"	"Group enriched"	"Detected in many"	194	"dendritic cells: 8.8;granulocytes: 29.5;monocytes: 19.8"					"Low region specificity"	"Detected in all"			"HPA011548, HPA048032"	Uncertain		Approved	"Nuclear bodies"			100000	"Nuclear bodies"		"HPA011548: , HPA048032: "	"unprognostic (3.22e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.50e-5)"	"unprognostic (3.59e-3)"	"unprognostic (9.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.06e-1)"	8.1	4.2	5.8	15.8	11.0	8.1	5.2	0.8	6.5	2.8	2.4	3.3	0.0	1.3	1.9	4.5	2.6	3.1	5.2	2.7	5.9	3.1	2.6	2.5	9.5	17.3	9.2	1.7	1.4	1.6	0.7	1.4	10.0	7.9	1.8	2.5	2.4	2.8	1.0	1.2	1.5	3.3	5.5	13.1	21.2	2.0	1.8	9.1	1.0	1.7	0.3	4.3	6.4	3.9	0.0	8.8	29.5	19.8	0.0	0.0	6.4	5.2	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.3	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	9.1	0.0	9.8	0.0	0.2	4.8	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.1	8.6	4.3	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	9.2	0.1	1.2	19.8	12.3	0.0	12.8	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	29.5	0.0	9.7	0.3	0.0	6.4	5.8	11.0	0.8	6.5	5.9	3.1	9.2	1.7	7.9	9.1
SIRPD	"dJ576H24.4, PTPNS1L2"	ENSG00000125900	"Signal regulatory protein delta"	Q9H106	20	1534251-1558843	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"blood: 19.9;testis: 64.2"	"Cell line enhanced"	"Detected in some"		"HL-60: 2.6;HMC-1: 3.4;NB-4: 4.5;THP-1: 9.7;U-937: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.9"	"Group enriched"	"Detected in many"	4	"granulocytes: 19.9;monocytes: 12.5"									HPA042663	Enhanced				"Secreted in male reproductive system"					"HPA042663: "	"unprognostic (4.91e-2)"	"unprognostic (1.51e-2)"			"unprognostic (3.01e-2)"	"unprognostic (4.47e-1)"		"unprognostic (2.49e-1)"		"unprognostic (1.02e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.66e-8)"	"unprognostic (2.14e-1)"	"unprognostic (3.32e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.44e-2)"	0.1	0.1	0.1	1.9	0.1	1.7	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.1	1.3	0.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.9	0.0	64.2	0.1	0.1	0.1	0.1	0.2	0.3	0.1	0.0	4.0	19.9	12.5	0.0	0.1	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	12.5	11.2	0.0	7.3	0.1	0.0	0.0	0.1	4.0	0.0	0.0	0.0	19.9	0.0	3.1	2.3	0.1	3.6	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1
SLAMF9	"CD2F-10, CD84-H1, SF2001"	ENSG00000162723	"SLAM family member 9"	Q96A28	1	159951492-159954254	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"adipose tissue: 20.3;blood: 5.5"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 6.5;HEL: 8.9;PC-3: 3.6;SK-MEL-30: 3.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"myeloid DC: 5.5"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 5.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035153	Uncertain									"HPA035153: AB_10670586"	"unprognostic (1.05e-1)"	"unprognostic (1.54e-5)"	"unprognostic (6.12e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.54e-4)"	"unprognostic (5.27e-4)"	"unprognostic (5.47e-2)"	"unprognostic (6.17e-5)"	"unprognostic (8.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	20.3	0.0	0.1	2.3	0.1	1.1	0.9	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.7	1.0	0.1	0.4	0.1	0.0	0.1	2.6	1.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.2	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.2	0.7	0.2	2.9	0.1	0.5	0.1	0.7	0.5	2.9	0.5	0.1	5.5	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	6.5	0.0	0.0	0.0	8.9	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.1	3.9	0.7	1.5	0.0	1.3	1.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	5.5	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SLC10A3	"DXS253E, P3"	ENSG00000126903	"Solute carrier family 10 member 3"	P09131	X	154487306-154490690	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	9	"basophil: 51.2"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 51.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021656	Approved		Approved	"Intermediate filaments"				"Intermediate filaments"		"HPA021656: AB_1856955"	"unprognostic (1.60e-1)"	"prognostic favourable (4.53e-4)"	"prognostic unfavourable (4.15e-5)"	"unprognostic (8.00e-3)"	"prognostic unfavourable (9.97e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.28e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (7.22e-4)"	"unprognostic (3.42e-1)"	"unprognostic (2.52e-3)"	"unprognostic (6.23e-2)"	"unprognostic (2.99e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.99e-2)"	14.5	14.6	3.6	11.6	5.1	22.5	13.4	5.0	8.1	21.5	15.3	8.1	16.3	10.6	25.0	36.1	22.8	15.4	21.1	19.5	6.0	4.6	17.7	6.7	16.3	14.0	5.8	6.2	32.3	25.7	6.1	12.7	40.1	7.6	23.7	6.4	12.4	11.7	13.3	13.7	26.2	13.6	20.1	5.3	13.1	12.6	11.6	4.7	12.6	15.7	23.3	18.6	23.3	18.3	1.6	2.7	51.2	1.7	2.2	3.8	1.8	24.6	10.6	2.8	14.5	10.0	10.9	18.8	18.4	11.2	12.4	12.6	9.4	12.0	18.8	35.0	17.6	21.3	9.3	9.4	3.3	12.2	4.4	5.8	14.0	7.4	18.4	6.9	9.5	13.6	10.7	11.6	6.3	8.5	6.5	18.5	8.1	32.8	3.7	6.2	2.2	20.5	6.1	7.6	14.2	9.4	9.2	2.6	4.7	11.6	21.0	4.8	6.8	5.5	11.1	14.9	9.3	34.4	23.2	13.2	12.7	19.4	15.8	14.5	7.6	51.2	1.3	5.6	3.8	1.7	2.9	1.6	2.6	2.8	1.1	1.6	1.9	1.8	1.7	2.2	1.5	2.7	1.8	1.8	3.6	5.1	5.0	8.1	6.0	4.6	5.8	6.2	7.6	4.7
SLC10A5		ENSG00000253598	"Solute carrier family 10 member 5"	Q5PT55	8	81693607-81696174	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 5.1;liver: 10.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025966	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA025966: AB_1856959"	"unprognostic (6.42e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.13e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.71e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.82e-7)"	0.0	0.3	0.9	0.1	2.3	0.0	0.2	5.1	1.8	0.3	2.5			2.9	0.3	0.9	0.2	0.3	1.4	0.1	0.9	2.1	1.8	10.3	0.3	0.0	0.8		0.4	1.0	0.3	1.9	0.0		0.5	3.5		0.3	0.2	0.1	0.4	3.5	0.2	0.3	0.3	3.4	0.0			0.8		0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.9	0.4	1.0	1.1	0.9	1.7	0.9	1.1	0.5	0.4	0.7	0.4	0.6	1.1	1.6	0.3	1.1	1.3	0.9	1.6	0.8	2.9	2.2	3.0	1.7	0.5	0.1	0.3	0.4	2.6	0.8	2.0	0.5	1.9	1.4	1.6	0.8	0.6	1.4	0.5	0.6	0.4	0.4	0.7	1.4	3.7	2.6	1.1	0.8	0.8	0.4	1.9	0.7	1.1	1.3	1.8	1.7	1.7	1.8	2.6	0.2	1.3	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.5	0.0	0.0										
SLC11A1	"LSH, NRAMP, NRAMP1"	ENSG00000018280	"Solute carrier family 11 member 1"	P49279	2	218382029-218396894	"Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 37.6;lymphoid tissue: 23.8"	"Cell line enhanced"	"Detected in some"		"HEL: 3.7;HMC-1: 3.6;NB-4: 3.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 7.9;intermediate monocyte: 5.8;myeloid DC: 2.4;neutrophil: 6.0;non-classical monocyte: 7.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.4;granulocytes: 6.0;monocytes: 7.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"cerebellum: 0.8"	HPA029590	Uncertain									"HPA029590: AB_10794613"	"unprognostic (2.64e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (2.58e-8)"	"unprognostic (9.55e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.08e-2)"	13.5	4.7	4.3	14.9	13.3	11.6	2.6	0.6	9.3	1.7	1.8	4.6	0.0	1.3	1.3	2.1	1.4	4.1	3.0	6.5	15.0	2.6	2.1	3.2	37.6	19.9	17.1	0.7	2.4	3.3	1.2	1.9	6.2	11.3	1.7	1.0	1.7	2.0	1.2	2.0	1.0	1.2	4.6	18.1	23.8	1.7	2.4	10.3	0.0	1.8	0.2	1.0	7.1	1.3	0.4	2.4	6.0	7.9	0.2	0.4	2.6	0.3	0.7	0.0	0.4	0.1	0.1	0.9	0.0	0.0	0.1	0.2	0.9	2.1	0.2	0.2	0.0	0.8	0.0	0.0	0.0	0.7	0.1	3.7	0.6	0.7	0.1	0.0	3.6	0.3	0.1	0.0	0.2	0.0	1.0	0.7	0.1	1.3	0.2	3.1	0.0	0.2	0.2	0.6	0.4	0.1	0.3	0.8	0.2	0.5	0.4	0.4	0.3	1.0	0.2	0.7	0.4	0.2	0.0	0.3	0.3	0.6	0.2	0.4	0.4	0.3	7.9	0.6	0.4	5.8	0.3	0.1	0.2	0.2	2.4	0.4	0.4	0.3	6.0	0.2	7.0	0.2	0.2	2.6	4.3	13.3	0.6	9.3	15.0	2.6	17.1	0.7	11.3	10.3
SLC12A8	CCC9	ENSG00000221955	"Solute carrier family 12 member 8"	A0AV02	3	125082636-125212864	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;thyroid gland: 20.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.9;HHSteC: 18.4;U-2197: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031123	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA031123: AB_2301872"	"unprognostic (4.74e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.35e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-2)"	"prognostic unfavourable (5.56e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.78e-2)"	1.1	1.1	11.1	0.7	19.4	0.0	2.0	0.8	7.0	1.2	3.0	1.7	0.4	4.9	0.4	2.9	3.5	1.7	8.1	0.5	3.8	1.2	2.1	5.7	1.9	0.4	1.0	3.6	0.5	9.0	8.2	1.9	2.2	8.6	2.5	4.1	6.2	10.0	0.4	1.8	1.0	3.4	0.4	1.3	0.4	3.8	4.6	2.0	0.4	20.5	0.4	0.7	1.9	1.7	0.2	0.2	1.8	0.5	0.0	0.2	0.0	8.3	0.0	1.4	0.0	1.8	2.5	4.1	0.4	1.0	0.5	0.9	10.9	4.0	0.0	1.0	3.7	5.1	0.0	0.0	0.2	0.0	0.0	0.0	3.7	0.0	18.4	0.0	0.6	4.7	5.0	1.4	0.6	0.0	0.0	0.3	0.7	2.2	0.0	0.0	5.7	0.4	0.0	0.1	0.0	4.2	0.6	2.4	0.0	4.9	5.1	0.1	9.2	0.2	0.1	0.1	0.7	35.7	0.0	0.1	1.0	2.8	1.7	0.0	0.7	1.8	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	19.4	0.8	7.0	3.8	1.2	1.0	3.6	8.6	2.0
SLC13A2	NaDC-1	ENSG00000007216	"Solute carrier family 13 member 2"	Q13183	17	28473293-28497781	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 181.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.0;RPMI-8226: 2.3;SH-SY5Y: 1.2;SK-BR-3: 1.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 1.8"	HPA014963	Enhanced									"HPA014963: AB_1857096"	"unprognostic (8.47e-2)"	"unprognostic (7.63e-3)"	"unprognostic (4.36e-3)"	"unprognostic (2.06e-1)"		"unprognostic (2.36e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.28e-4)"		"unprognostic (1.50e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.00e-2)"	"prognostic favourable (9.00e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.64e-1)"		"unprognostic (1.50e-2)"	0.1	0.1	0.1	0.0	0.1	0.0	1.4	0.1	0.1	0.1	142.8	0.0	10.7	34.6	0.1	0.5	0.1	0.1	3.4	0.1	0.1	0.1	12.5	0.3	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	1.8	0.0	14.9	17.1	0.1	2.1	181.4	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.7	0.1	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SLC15A1	"HPECT1, HPEPT1, PEPT1"	ENSG00000088386	"Solute carrier family 15 member 1"	P46059	13	98683801-98752654	"Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"intestine: 134.9"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 29.5;SK-BR-3: 29.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002827	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA002827: AB_1856974"	"unprognostic (8.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.88e-4)"	"unprognostic (2.11e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.87e-2)"	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	1.1	51.7	0.2	0.3	42.7	1.9	2.2	0.9	0.1	16.6	0.1	0.1	0.1	6.3	8.2	0.2	0.1	0.1	0.1	0.2	7.1	4.3	0.3	1.0	0.3	0.9	0.5	0.2	0.3	0.3	0.1	9.9	134.9	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.7	0.4	0.5	1.9	1.1	1.1	2.3	0.7	1.2	0.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.8	29.5	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.6	1.7	0.6	0.1	0.3	0.0	29.4	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.7	0.7	0.9	0.3	0.8	0.8	0.7	0.7	0.2	1.1	0.9	0.8	2.2	1.2	0.4	1.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1
SLC16A14	"FLJ30794, MCT14"	ENSG00000163053	"Solute carrier family 16 member 14"	Q7RTX9	2	230034974-230068999	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 16.4;Karpas-707: 11.3;REH: 14.1;RPMI-8226: 12.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"eosinophil: 12.0"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 12.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040518	Uncertain		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA040518: AB_10794877"	"unprognostic (2.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.20e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.51e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.10e-1)"	5.4	5.2	7.0	2.2	11.1	6.6	4.0	14.4	16.2	6.5	4.6	3.2	1.1	1.3	4.9	3.2	5.3	4.1	3.6	3.0	6.9	8.2	1.7	2.5	2.5	1.6	6.2	8.2	10.2	1.1	12.4	1.9	1.6	6.7	5.9	5.0	12.0	20.5	4.7	1.3	13.4	1.6	4.9	4.4	10.1	1.8	2.0	1.3	1.1	2.0	3.4	3.3	3.8	4.8	0.4	0.5	12.0	0.0	0.1	0.4	0.1	2.1	1.2	1.0	0.0	0.0	0.2	0.0	0.2	0.0	0.5	0.3	0.0	0.4	0.0	0.2	0.0	0.4	3.6	1.1	0.1	0.0	6.2	0.1	2.4	0.0	0.2	16.4	0.0	0.4	2.9	0.0	0.0	0.1	0.0	11.3	0.2	0.0	1.6	2.1	0.8	2.0	14.1	0.0	12.7	4.3	1.9	4.7	1.5	3.4	0.0	0.1	5.6	1.4	0.0	0.0	0.9	2.3	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.0	0.4	0.0	0.3	0.4	0.2	0.0	0.5	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	7.0	11.1	14.4	16.2	6.9	8.2	6.2	8.2	6.7	1.3
SLC16A4	"MCT4, MCT5"	ENSG00000168679	"Solute carrier family 16 member 4"	O15374	1	110362848-110391082	"Predicted membrane proteins"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.4;placenta: 76.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 12.6;BJ hTERT+: 12.7;CAPAN-2: 18.8;HHSteC: 12.6;SK-MEL-30: 19.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 35.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.0"	"Group enriched"	"Detected in many"	4	"B-cells: 5.0;granulocytes: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046986, HPA060163"	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"				"Microtubules, Cytosol"	"Cytokinetic bridge"	"HPA046986: , HPA060163: "	"unprognostic (2.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.50e-1)"	"prognostic favourable (1.69e-4)"	"unprognostic (3.68e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.46e-2)"	3.8	2.4	1.9	2.1	2.8	0.6	3.4	2.3	1.7	2.7	4.5	2.9	2.7	4.7	2.3	11.9	4.3	2.4	9.6	4.0	2.6	2.1	61.4	7.9	6.1	1.4	2.7	1.4	21.3	0.8	0.5	3.5	76.5	6.9	3.7	0.9	17.3	1.9	3.2	1.1	0.8	14.0	1.8	3.6	2.0	2.5	4.0	1.8	0.0	8.0	1.3	1.3	3.1	3.0	5.0	0.1	1.3	0.6	0.0	0.7	0.3	0.2	6.0	1.3	1.9	4.3	8.5	12.6	3.3	12.7	1.1	3.2	1.8	18.8	0.3	3.5	10.3	0.3	0.1	1.2	1.2	0.3	1.5	0.3	1.3	1.9	12.6	0.4	0.3	6.3	0.2	1.9	0.1	2.6	0.3	0.6	2.1	0.6	0.2	0.3	0.4	0.2	0.1	0.9	0.1	2.2	0.3	0.7	0.4	0.3	6.1	19.3	0.3	0.0	0.3	0.7	0.5	0.2	0.9	0.3	0.1	0.9	0.6	0.3	3.5	0.0	0.6	0.3	0.5	0.2	0.2	5.0	0.6	0.1	0.1	1.0	0.6	0.7	1.3	0.0	0.2	0.0	0.2	0.3	1.9	2.8	2.3	1.7	2.6	2.1	2.7	1.4	6.9	1.8
SLC16A8	"MCT3, REMP"	ENSG00000100156	"Solute carrier family 16 member 8"	O95907	22	38078134-38084093	"Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 70.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.9;SiHa: 6.4;T-47d: 7.7;U-266/70: 11.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075017	Enhanced		Approved	"Intermediate filaments,Focal adhesion sites"				"Focal adhesion sites"	"Intermediate filaments"	"HPA075017: "	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.99e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-5)"	1.6	2.6	1.9	0.8	5.1	1.2	0.8	0.8	3.3	0.8	0.8	0.8	0.8	0.5	1.3	0.8	1.1	1.2	2.7	2.9	2.7	2.9	0.8	0.8	0.8	0.9	2.8	0.8	0.8	2.1	0.0	2.6	0.8	1.3	4.0	0.0	70.9	10.0	0.8	1.9	4.2	0.8	0.8	3.7	1.8	2.3	2.0	0.8	0.8	0.9	0.8	0.8	1.6	0.8	0.0	0.0	0.0	0.0	0.5	0.6	0.0	1.3	0.7	1.1	0.2	0.0	0.0	5.9	0.5	0.0	0.0	0.0	1.2	3.5	0.4	1.7	0.0	0.8	0.0	0.0	0.0	0.0	1.8	0.3	1.0	0.1	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	3.9	0.0	0.0	1.4	0.1	2.0	0.0	0.0	0.0	4.4	1.9	0.3	6.4	0.3	0.9	7.7	0.2	0.0	0.0	3.5	0.3	0.0	11.3	1.6	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	5.1	0.8	1.2	2.7	2.9	2.8	0.8	1.3	0.8
SLC17A2	NPT3	ENSG00000112337	"Solute carrier family 17 member 2"	O00624	6	25912754-25930726	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	333	"liver: 80.2"	"Cell line enriched"	"Detected in single"	20	"Hep G2: 8.9"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038270	Uncertain									"HPA038270: AB_10672511"							"prognostic favourable (8.54e-4)"						"unprognostic (1.90e-2)"		"unprognostic (4.14e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC17A4	KIAA2138	ENSG00000146039	"Solute carrier family 17 member 4"	Q9Y2C5	6	25754699-25781191	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"gallbladder: 14.9;intestine: 24.6;liver: 27.2;pancreas: 14.2"	"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 5.7"	"Group enriched"	"Detected in some"	6	"liver cancer: 11.0;renal cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"							HPA055564	Approved									"HPA055564: "			"unprognostic (6.52e-2)"				"unprognostic (5.64e-3)"			"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"			0.2	0.0	0.2	1.8	0.2	0.0	0.2	0.2	0.2	0.2	12.8	0.2	0.2	14.8	0.2	0.4	0.2	0.1	14.9	0.2	0.2	0.1	2.2	27.2	0.2	0.2	0.2	0.2	0.2	14.2	0.0	0.2	0.2	0.2	0.2	14.2	0.2	0.2	0.2	0.2	0.0	24.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	1.3	0.1	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.0	0.3	0.0	0.4	0.0	0.1	0.7	5.7	0.0	0.2	0.3	0.1	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.3	0.0	0.2	0.1	0.1	0.2	0.0	0.3	0.0	0.1	1.3	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
SLC17A6	"DNPI, VGLUT2"	ENSG00000091664	"Solute carrier family 17 member 6"	Q9P2U8	11	22338097-22379503	"Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 75.2"	"Cell line enriched"	"Detected in single"	222	"SCLC-21H: 26.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"hypothalamus: 20.2;pons and medulla: 75.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 54.1;hypothalamus: 163.2;midbrain: 206.4;pons and medulla: 90.5;thalamus: 180.7"	"Low region specificity"	"Detected in many"			"CAB037130, HPA039226, CAB078204"	Supported	Supported								"CAB037130: AB_477611, CAB078204: , HPA039226: "					"unprognostic (1.39e-1)"						"unprognostic (1.93e-1)"							0.5	0.5	7.6	0.5	1.1	0.5	0.5	0.2	13.8	0.5	0.5	1.3	0.0	0.5	0.5	0.5	0.5	0.5	0.5	0.5	1.1	20.2	0.5	0.5	0.5	0.5	7.1	2.1	0.5	1.5	0.5	5.3	0.5	75.2	0.5	0.5	1.4	0.5	0.5	0.5	0.5	0.5	0.5	5.9	0.5	0.5	0.5	0.0	0.0	0.5	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	1.1	0.2	8.4	1.1	20.2	7.1	2.1	75.2	0.0
SLC17A7	"BNPI, VGLUT1"	ENSG00000104888	"Solute carrier family 17 member 7"	Q9P2U7	19	49429401-49442360	"Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"brain: 150.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 20.7;K-562: 6.5;REH: 3.8;SCLC-21H: 4.8"	"Cancer enriched"	"Detected in some"	6	"glioma: 7.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 281.0;cerebellum: 378.0;cerebral cortex: 391.3;hippocampal formation: 626.6"	"CAB037183, HPA050458, HPA063679"	Enhanced	Supported								"CAB037183: AB_261840, HPA050458: , HPA063679: "	"unprognostic (1.79e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (8.32e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.26e-12)"	"unprognostic (8.36e-4)"	"unprognostic (4.27e-1)"	"unprognostic (1.35e-2)"	"unprognostic (6.17e-3)"	2.1	1.2	58.3	1.0	27.6	1.0	1.7	52.7	150.0	1.3	1.3	1.5	0.0	1.1	1.2	1.2	1.4	1.3	1.3	1.4	74.3	1.7	1.1	1.0	1.1	1.3	6.0	36.4	1.0	1.0	1.0	0.1	1.0	20.0	1.0	1.2	9.1	1.1	1.1	1.4	1.6	1.3	1.2	0.9	1.0	1.1	1.5	0.0	0.0	1.2	0.0	1.2	1.2	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.4	1.6	0.3	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.3	0.5	0.1	1.8	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.1	0.3	0.0	0.0	6.5	0.9	0.0	0.2	0.0	0.1	0.0	0.3	3.8	0.1	0.1	0.0	0.0	4.8	0.4	0.0	0.1	0.1	0.1	0.1	0.1	0.3	2.3	0.8	0.0	0.4	0.3	0.3	0.6	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.3	27.6	52.7	76.0	74.3	1.7	6.0	36.4	20.0	0.0
SLC1A6	EAAT4	ENSG00000105143	"Solute carrier family 1 member 6"	P48664	19	14950034-15022990	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 52.1;testis: 23.3"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.4;NTERA-2: 5.3;U-698: 24.1"	"Cancer enriched"	"Detected in some"	7	"urothelial cancer: 5.2"	"Region enriched"	"Detected in many"	5	"cerebellum: 52.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 152.9"	"Low region specificity"	"Detected in all"			"HPA041505, HPA044066"	Enhanced		Supported	"Plasma membrane,Intermediate filaments"				"Plasma membrane"	"Intermediate filaments"	"HPA041505: , HPA044066: "	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"		"unprognostic (4.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.94e-3)"	"unprognostic (8.90e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavourable (6.88e-6)"	0.4	0.5	3.2	0.5	9.6	1.2	0.8	52.1	12.8	0.4	0.5	0.6	0.0	0.6	0.8	4.2	0.4	0.5	0.5	0.4	4.8	4.0	0.4	0.5	0.5	0.5	1.6	3.4	0.6	0.9	0.6	0.0	4.3	3.0	0.9	0.6	0.1	0.7	0.9	0.5	9.2	0.5	0.5	1.4	0.7	0.5	23.3	0.9	0.0	0.6	0.0	0.6	0.4	0.0	2.0	0.7	2.2	0.7	0.5	0.6	0.1	0.1	0.0	0.3	0.3	0.2	0.2	0.8	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	1.2	6.4	0.1	0.1	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.6	0.1	0.5	0.0	0.3	5.3	0.1	0.1	0.0	0.1	0.0	0.2	0.4	0.2	0.2	2.5	0.0	0.3	0.1	0.0	0.3	1.0	0.2	0.1	0.4	0.1	24.1	0.1	0.3	0.1	1.6	0.7	0.5	0.6	0.4	0.4	1.0	0.5	0.3	0.3	2.0	0.6	0.6	2.2	0.5	0.4	0.7	0.3	0.1	3.2	9.6	52.1	6.5	4.8	4.0	1.6	3.4	3.0	0.9
SLC1A7	EAAT5	ENSG00000162383	"Solute carrier family 1 member 7"	O00341	1	53087179-53142632	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	7	"retina: 70.1"	"Cell line enriched"	"Detected in some"	9	"HHSteC: 23.8"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"gdT-cell: 5.7;memory CD8 T-cell: 2.2;naive CD8 T-cell: 2.6"	"Lineage enriched"	"Detected in single"	58	"T-cells: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049124	Enhanced									"HPA049124: "	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.48e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.26e-3)"	"unprognostic (4.35e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.58e-3)"	"unprognostic (5.43e-2)"	"unprognostic (8.12e-2)"	"unprognostic (4.70e-3)"	2.0	0.2	1.1	0.6	0.6	0.0	1.2	0.6	0.7	0.9	1.0	0.7	0.6	4.1	1.3	1.2	2.1	2.2	9.6	2.9	1.7	1.1	0.7	2.8	0.9	0.6	1.2	0.6	3.8	0.6	0.0	0.6	0.6	1.1	0.9	0.0	70.1	0.6	0.6	2.1	1.2	5.3	0.6	1.3	0.6	1.1	0.9	0.6	0.6	0.6	0.6	0.6	2.5	0.9	0.0	0.0	0.0	0.0	0.0	5.7	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.2	2.6	0.0	0.0	0.0	0.0	0.1	0.8	1.1	0.6	0.6	0.7	1.7	1.1	1.2	0.6	1.1	0.6
SLC22A13	"OAT10, OCTL1, OCTL3, ORCTL3"	ENSG00000172940	"Solute carrier family 22 member 13"	Q9Y226	3	38265812-38278315	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 16.4"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.2;hTERT-HME1: 1.5"	"Cancer enriched"	"Detected in single"	7	"renal cancer: 0.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"T-reg: 2.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.3"					"Low region specificity"	"Detected in all"			"HPA035603, HPA035962"	Enhanced									"HPA035603: AB_10672869, HPA035962: "	"unprognostic (2.73e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.68e-2)"	"unprognostic (7.13e-3)"	"unprognostic (3.50e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.65e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.74e-1)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	16.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.1	0.3	0.0	2.3	0.0	0.2	0.5	0.1	0.6	0.4	0.5	0.1	0.3	0.0	0.2	0.3	0.0	0.5	0.9	0.2	0.1	0.8	0.4	0.7	0.1	0.4	0.1	0.0	2.2	0.0	0.1	0.0	0.8	0.0	0.5	0.1	1.5	0.0	0.0	0.1	1.1	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.0	1.2	0.1	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.3	0.7	1.2	0.3	0.3	0.4	0.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.4	0.1	0.3	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A15	FLIPT1	ENSG00000163393	"Solute carrier family 22 member 15"	Q8IZD6	1	115976498-116070054	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.6;brain: 27.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 20.6;hTERT-HME1: 27.4;NB-4: 14.9;THP-1: 16.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.9"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.9;monocytes: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019785	Approved									"HPA019785: AB_1857011"	"unprognostic (3.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.01e-3)"	"unprognostic (5.62e-2)"	"unprognostic (5.22e-2)"	"unprognostic (5.85e-5)"	"unprognostic (8.91e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (7.29e-3)"	"unprognostic (8.78e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.97e-4)"	"unprognostic (1.30e-1)"	2.9	4.5	7.0	3.2	14.1	34.6	2.3	8.6	11.1	2.6	2.1	27.8	0.7	1.7	1.9	2.2	5.5	2.4	2.9	6.1	9.9	8.0	4.9	1.3	6.3	1.7	20.0	8.1	2.0	4.2	7.5	4.5	2.9	15.1	2.8	2.7	2.5	4.6	2.7	0.8	11.8	1.7	1.7	14.1	3.5	4.8	1.8	17.6	0.0	4.0	0.8	1.9	2.5	4.6	0.5	0.3	3.9	2.9	0.2	0.0	0.3	1.6	0.1	1.2	0.0	2.1	2.6	0.8	2.6	3.9	1.6	2.9	0.0	0.3	1.8	2.9	1.3	2.5	2.0	5.4	1.6	0.0	1.3	1.7	1.8	0.2	7.2	2.7	2.4	2.6	20.6	0.0	27.4	0.0	0.1	0.0	2.6	1.4	0.0	14.9	1.7	1.3	0.0	0.0	0.0	2.2	0.9	1.2	1.1	4.5	0.9	7.6	0.2	16.2	0.0	2.9	1.6	0.5	0.6	2.7	2.5	0.2	3.0	4.4	4.5	1.0	2.5	0.9	0.0	0.7	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	3.9	0.2	2.9	0.0	0.0	0.3	7.0	14.1	8.6	11.1	9.9	8.0	20.0	8.1	15.1	17.6
SLC22A17	"BOCT, BOIT, NGALR"	ENSG00000092096	"Solute carrier family 22 member 17"	Q8WUG5	14	23346306-23352912	"Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 112.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.4;ASC diff: 17.0;SH-SY5Y: 23.7"	"Cancer enhanced"	"Detected in all"		"glioma: 51.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 1.1;naive CD4 T-cell: 3.6;naive CD8 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	26	"T-cells: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002728	Uncertain									"HPA002728: AB_1079998"	"unprognostic (9.34e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.22e-1)"	"prognostic favourable (1.73e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.87e-2)"	6.0	24.2	32.9	4.0	63.4	1.6	7.0	40.7	112.4	12.1	5.6	27.4	2.4	4.5	8.0	10.1	4.7	10.2	7.6	9.1	35.6	69.4	8.6	2.0	5.0	3.8	28.5	27.3	11.0	14.5	13.3	39.4	5.3	33.1	21.9	3.5	13.2	20.5	24.4	2.1	6.6	6.6	7.7	21.8	3.6	6.1	6.6	22.1	0.0	10.8	0.1	2.6	4.2	4.8	0.1	0.0	0.0	0.0	0.0	3.6	0.2	0.0	1.2	12.8	20.4	17.0	8.9	1.9	4.4	8.8	1.7	1.3	0.1	1.2	0.0	1.7	8.2	0.2	0.6	0.5	0.1	0.0	0.7	2.8	0.0	0.1	9.1	0.0	2.8	11.6	0.8	2.0	0.0	0.5	0.0	0.1	2.6	1.8	0.1	0.1	6.9	0.0	0.0	0.5	0.1	0.0	1.2	12.1	23.7	3.6	0.0	0.0	2.3	0.4	0.0	1.9	5.5	10.2	0.0	0.0	2.0	0.0	1.2	0.0	7.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.1	3.6	1.8	0.0	0.0	0.0	0.0	0.0	0.2	32.9	63.4	40.7	64.3	35.6	69.4	28.5	27.3	33.1	22.1
SLC22A18AS	"BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS"	ENSG00000254827	"Solute carrier family 22 member 18 antisense"	Q8N1D0	11	2887780-2903740	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 20.1;kidney: 13.4;liver: 13.6"	"Cell line enhanced"	"Detected in some"		"A549: 7.0;CAPAN-2: 6.9;MCF7: 13.0;SK-MEL-30: 24.1;WM-115: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 9.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 4.9;granulocytes: 5.2;monocytes: 9.1"									HPA068288	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA068288: "	"unprognostic (1.43e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.36e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.16e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	1.4	0.3	0.2	6.0	0.7	0.0	0.6	0.2	2.2	0.5	13.7	0.6	0.2	12.8	0.8	1.2	1.1	0.4	4.9	0.3	0.2	0.3	13.4	13.6	0.6	0.2	1.3	1.5	0.4	0.2	0.0	0.3	2.0	1.6	0.7	9.8	0.2	4.2	0.2	0.4	1.0	20.1	0.6	1.6	0.8	1.4	0.6	0.4	0.2	0.3	1.6	0.3	0.5	0.9	0.0	4.9	5.2	9.1	0.5	0.6	2.7	0.8	7.0	0.1	0.3	0.0	0.0	0.6	0.4	0.3	0.0	0.2	1.6	6.9	0.0	0.6	0.0	0.4	0.0	0.2	0.0	0.3	0.1	0.0	0.6	4.0	0.5	0.0	0.1	0.1	0.2	0.0	0.4	0.2	0.0	0.6	0.0	13.0	0.0	0.3	0.1	0.3	0.2	0.0	0.6	0.6	0.0	0.1	0.2	0.3	0.3	24.1	0.0	0.6	1.4	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.2	1.9	10.8	5.2	9.1	1.6	0.3	5.1	0.1	0.0	0.1	0.3	4.9	0.0	0.0	0.1	2.2	0.5	3.5	0.0	0.6	2.7	0.2	0.7	0.2	2.2	0.2	0.3	1.3	1.5	1.6	0.4
SLC22A24	"MGC34821, NET46"	ENSG00000197658	"Solute carrier family 22 member 24"	Q8N4F4	11	63079940-63144221	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"kidney: 10.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	11	"renal cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045015	Uncertain									"HPA045015: "							"unprognostic (5.72e-3)"						"unprognostic (1.80e-7)"					0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	2.1	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SLC22A25	"HIMTP, MGC120420, UST6"	ENSG00000196600	"Solute carrier family 22 member 25"	Q6T423	11	63163776-63229652	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	165	"liver: 16.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	66	"liver cancer: 3.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA039390	Uncertain									"HPA039390: AB_10671996"	"unprognostic (3.19e-2)"				"unprognostic (2.38e-1)"	"unprognostic (4.51e-1)"	"prognostic favourable (7.04e-4)"							"unprognostic (1.01e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SLC23A3	"FLJ31168, SVCT3, Yspl1"	ENSG00000213901	"Solute carrier family 23 member 3"	Q6PIS1	2	219161465-219170095	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"intestine: 36.5;kidney: 32.4"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 8.9;U-266/70: 6.5"	"Cancer enriched"	"Detected in some"	9	"renal cancer: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.3"	"Low region specificity"	"Detected in single"			HPA019059			Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA019059: AB_1857017"	"unprognostic (2.49e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.05e-4)"	"unprognostic (6.97e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.12e-4)"	"unprognostic (9.42e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.52e-5)"	0.4	0.0	0.3	2.3	0.3	0.0	0.5	0.3	0.5	0.8	14.9	0.3	0.3	5.3	1.1	0.3	0.9	0.5	0.3	0.3	0.3	0.0	32.4	3.1	0.7	0.3	0.3	0.3	1.0	0.4	0.5	0.3	0.5	0.3	1.4	0.8	0.3	0.4	0.3	0.3	1.1	36.5	0.3	0.3	0.4	0.5	0.3	0.3	0.3	1.3	0.3	0.4	0.6	1.3	0.8	0.0	0.0	0.8	0.0	0.5	0.0	0.9	0.4	0.2	1.1	3.9	2.2	0.8	2.2	0.6	0.4	1.3	2.3	1.6	0.5	0.8	1.5	3.2	0.7	0.3	0.6	1.8	1.8	2.0	1.9	0.1	0.7	0.2	0.9	0.7	8.9	0.9	2.9	1.2	0.3	0.9	0.6	0.3	0.1	1.0	0.0	0.2	0.5	0.5	0.8	3.1	3.7	0.5	1.0	0.2	0.0	2.3	0.9	1.1	2.6	2.1	1.4	2.2	0.7	6.5	0.3	2.9	0.6	0.7	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.8	0.0	0.2	0.0	0.3	0.3	0.3	0.5	0.3	0.0	0.3	0.3	0.3	0.3
SLC24A3		ENSG00000185052	"Solute carrier family 24 member 3"	Q9HC58	20	19212646-19722937	"Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 40.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	53	"basophil: 7.1;eosinophil: 3.3"	"Lineage enriched"	"Detected in single"	72	"granulocytes: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043400, HPA045497"	Uncertain		Uncertain	"Golgi apparatus"				"Golgi apparatus"		"HPA043400: , HPA045497: "	"unprognostic (8.74e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (6.08e-4)"	"unprognostic (7.36e-3)"	7.0	2.5	10.9	4.6	11.0	1.0	3.6	7.4	9.2	17.6	8.9	5.5	7.0	2.9	26.3	19.0	15.3	17.2	14.5	1.7	27.1	12.0	1.2	0.6	6.2	1.5	4.5	3.4	14.8	1.2	7.9	1.6	3.0	5.3	8.5	4.1	5.5	6.1	13.8	26.4	5.2	4.4	21.7	2.9	1.7	2.7	1.7	3.1	0.9	2.5	11.0	4.9	8.1	20.7	0.0	0.0	7.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.4	6.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	9.0	0.0	0.0	0.4	0.0	40.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	4.6	0.0	8.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.1	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.9	11.0	7.4	6.5	27.1	12.0	4.5	3.4	5.3	3.1
SLC25A14	"BMCP1, UCP5"	ENSG00000102078	"Solute carrier family 25 member 14"	O95258	X	130339888-130373361	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060316			Approved	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA060316: "	"unprognostic (1.65e-2)"	"prognostic favourable (1.72e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.36e-3)"	"unprognostic (8.92e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.95e-3)"	"prognostic favourable (1.78e-4)"	"unprognostic (2.18e-2)"	"prognostic unfavourable (5.52e-6)"	"unprognostic (6.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.92e-2)"	"prognostic favourable (1.39e-5)"	3.1	9.3	9.2	3.4	18.3	3.7	5.5	13.6	20.6	4.8	3.8	6.1	4.2	2.2	6.7	11.0	4.3	9.7	4.6	7.7	8.7	15.8	5.2	4.1	4.6	4.1	7.3	11.4	6.8	4.5	5.6	15.0	3.6	11.2	5.1	4.1	5.7	5.1	6.7	3.4	4.7	3.6	7.7	5.3	3.5	4.8	10.2	4.2	4.2	5.7	4.6	5.3	3.1	3.8	7.5	9.3	8.7	7.2	8.1	9.5	4.9	6.8	9.0	6.5	4.7	4.4	4.1	3.5	5.2	6.9	10.0	10.1	3.6	4.1	4.7	18.0	6.9	3.9	9.3	3.8	10.0	5.9	11.8	1.5	8.3	8.4	6.1	5.9	2.8	3.8	4.7	12.7	3.8	5.5	4.1	6.6	15.9	10.5	6.1	8.2	5.4	14.8	5.2	8.4	9.3	5.8	3.0	8.1	7.2	5.5	5.5	8.7	3.5	3.3	3.7	5.4	3.5	12.3	10.4	6.2	15.9	4.1	9.8	7.2	4.8	5.8	7.2	5.2	6.4	5.8	7.8	7.5	5.4	6.1	7.5	4.6	4.2	7.0	8.7	8.1	5.2	9.3	9.5	4.9	9.2	18.3	13.6	15.6	8.7	15.8	7.3	11.4	11.2	4.2
SLC25A27	"FLJ33552, UCP4"	ENSG00000153291	"Solute carrier family 25 member 27"	O95847	6	46652915-46678193	"Plasma proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 25.8;hTCEpi: 14.6;U-698: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069732			Supported	Mitochondria				Mitochondria		"HPA069732: "	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"prognostic favourable (6.16e-4)"	"unprognostic (3.82e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.47e-3)"	13.3	15.0	18.5	6.6	28.8	1.5	18.7	63.8	30.2	11.8	13.2	20.2	11.3	5.0	28.4	50.9	7.6	13.9	14.2	11.9	17.6	10.5	12.6	12.2	10.1	4.2	24.7	28.9	39.4	9.7	25.8	37.8	2.6	19.6	31.0	11.5	23.6	14.3	17.9	11.2	28.1	6.8	17.0	18.0	6.3	9.1	12.6	26.9	0.4	21.7	7.7	3.8	11.4	17.6	0.0	0.4	0.3	0.0	0.0	0.3	0.0	2.0	1.3	2.3	7.8	8.9	6.2	0.1	1.1	3.6	1.1	0.2	0.0	2.8	0.8	5.4	1.9	4.0	1.1	3.4	0.7	0.0	11.6	0.0	25.8	2.8	4.7	0.1	0.3	9.6	14.6	0.0	9.2	0.2	0.1	0.0	0.9	0.8	0.0	0.1	1.2	3.0	0.0	3.0	0.1	5.9	7.3	7.1	0.7	5.4	0.3	2.9	5.8	0.0	0.8	4.9	3.3	0.5	0.9	3.1	0.0	15.9	0.7	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	18.5	28.8	63.8	30.2	17.6	10.5	24.7	28.9	19.6	26.9
SLC25A31	"ANT4, DKFZP434N1235"	ENSG00000151475	"Solute carrier family 25 member 31"	Q9H0C2	4	127730378-127774299	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	687	"testis: 68.6"	"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA015064, HPA016841, HPA046835, HPA071684"	Uncertain		Enhanced	Mitochondria				Mitochondria		"HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: , HPA071684: "					"unprognostic (8.15e-2)"									"unprognostic (1.62e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.32e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC25A34	DKFZp781A10161	ENSG00000162461	"Solute carrier family 25 member 34"	Q6PIV7	1	15736405-15741396	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 38.8;skeletal muscle: 22.2"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 7.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 10.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069806			Approved	Mitochondria				Mitochondria		"HPA069806: "	"unprognostic (2.06e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-4)"	"unprognostic (5.74e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.40e-4)"	2.5	2.4	1.2	0.9	1.9	2.8	0.7	10.4	1.8	1.1	25.9	0.8	0.5	13.5	1.7	1.4	1.6	1.3	3.6	13.3	1.5	1.2	7.3	3.9	1.1	1.1	0.7	1.8	2.4	18.6	0.6	2.1	1.2	1.5	1.1	1.9	3.7	11.1	0.8	22.2	0.8	38.8	1.0	1.1	1.9	1.4	2.3	1.2	0.5	1.9	11.0	1.9	0.7	1.1	0.7	0.5	2.0	0.5	2.2	4.1	1.1	0.7	0.5	3.5	1.6	1.7	0.7	1.5	0.5	0.3	0.9	0.7	1.5	1.9	0.9	0.8	0.7	0.7	0.6	0.6	0.8	1.2	0.7	1.5	1.2	0.5	0.6	0.4	2.2	0.8	2.7	1.1	0.5	0.4	0.6	3.3	0.6	1.8	3.7	2.0	2.9	1.0	2.0	3.1	1.0	0.3	0.1	0.7	2.8	0.8	1.0	7.5	1.9	2.5	1.8	1.7	2.2	2.3	0.6	3.9	3.6	0.7	0.6	2.2	1.4	1.2	0.5	0.4	1.4	0.2	3.1	0.5	3.0	2.0	0.2	0.7	4.1	2.3	2.0	2.2	0.2	0.5	1.3	1.1	1.2	1.9	10.4	1.8	1.5	1.2	0.7	1.8	1.5	1.2
SLC25A35	FLJ40217	ENSG00000125434	"Solute carrier family 25 member 35"	Q3KQZ1	17	8287763-8295343	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 44.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA051720	Uncertain		Approved	Vesicles,Mitochondria				"Vesicles, Mitochondria"		"HPA051720: "	"unprognostic (4.73e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.21e-2)"	"prognostic favourable (3.37e-7)"	"unprognostic (1.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.18e-1)"	"prognostic favourable (1.14e-6)"	"unprognostic (5.31e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"prognostic favourable (1.91e-5)"	6.8	8.2	4.0	10.2	8.3	7.4	8.1	2.6	6.0	13.0	7.2	11.1	18.2	8.3	14.1	11.6	5.3	8.6	7.5	4.4	8.2	3.7	14.4	4.4	7.2	8.2	8.9	5.2	3.4	9.6	6.6	12.9	44.4	9.2	8.2	7.9	11.3	6.2	24.9	3.4	4.2	7.2	6.0	9.7	9.4	9.8	20.2	7.2	9.0	9.1	4.1	7.1	7.2	4.6	3.8	7.2	9.0	11.1	3.2	5.6	2.9	4.4	12.3	2.1	9.2	7.1	2.8	5.1	2.9	2.6	3.2	3.6	1.4	11.5	5.1	3.0	3.4	10.0	2.6	3.5	1.7	2.7	3.2	4.3	9.1	1.7	2.6	0.5	11.7	5.8	2.0	6.1	1.1	5.1	1.2	1.8	2.6	2.4	4.6	2.4	0.7	4.1	5.0	1.5	2.2	2.5	11.4	1.1	2.7	8.5	5.1	3.6	11.4	3.3	6.6	2.2	1.7	5.2	2.5	3.9	2.3	1.7	5.6	7.6	5.6	4.5	7.3	9.0	5.5	11.1	4.3	2.6	4.8	5.6	7.2	3.8	1.7	3.5	1.4	3.2	7.8	3.6	4.9	2.9	4.0	8.3	2.6	6.0	8.2	3.7	8.9	5.2	9.2	7.2
SLC25A37	"HT015, MFRN, MFRN1, MSCP"	ENSG00000147454	"Solute carrier family 25 member 37"	Q9NYZ2	8	23528805-23575463	"Predicted intracellular proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.8"	"Cell line enriched"	"Detected in all"	4	"HEL: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 28.9"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 28.9"	"Low region specificity"	"Detected in all"							HPA045680	Uncertain		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA045680: AB_10963693"	"unprognostic (6.15e-3)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (4.37e-6)"	"unprognostic (8.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	8.2	18.3	5.8	13.7	8.3	88.8	13.1	4.2	8.2	13.4	16.4	6.5	11.7	39.7	10.3	6.8	8.2	9.5	8.5	16.8	6.2	5.2	9.4	11.8	25.7	18.5	12.2	5.1	17.2	14.8	15.6	8.8	23.9	10.3	17.1	5.8	7.9	21.1	17.4	13.8	7.6	17.6	7.9	10.2	28.7	8.0	15.0	8.6	1.9	9.0	5.9	5.7	13.9	33.0	1.2	1.4	28.9	1.6	0.7	1.2	0.8	3.9	4.3	4.6	4.2	6.1	7.5	6.9	3.1	4.1	2.3	2.6	4.3	8.5	6.4	3.8	2.6	5.1	4.2	8.5	3.2	1.0	2.2	49.4	7.2	1.5	5.1	2.7	1.9	6.4	8.3	5.0	5.0	3.6	10.8	3.2	3.6	1.7	3.3	11.7	2.4	3.4	3.5	2.3	2.5	7.1	2.2	1.4	2.0	4.3	6.6	3.1	1.8	4.3	5.7	11.2	1.7	6.6	6.0	2.6	1.0	4.0	10.6	6.8	7.0	0.6	1.6	1.4	0.6	0.6	0.6	1.2	0.4	0.3	1.4	0.8	1.2	0.7	28.9	0.7	0.8	0.4	0.7	0.8	5.8	8.3	4.2	8.2	6.2	5.2	12.2	5.1	10.3	8.6
SLC25A39	"CGI-69, FLJ22407"	ENSG00000013306	"Solute carrier family 25 member 39"	Q9BZJ4	17	44319625-44324870	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Heme biosynthesis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026785	Approved									"HPA026785: AB_10601715"	"unprognostic (8.10e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.35e-3)"	"prognostic unfavourable (5.90e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (3.58e-5)"	"unprognostic (1.67e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.21e-2)"	14.6	36.5	17.8	19.0	19.4	101.0	21.9	15.4	18.1	18.8	29.8	17.4	22.9	30.2	16.0	20.5	43.2	19.1	24.5	19.3	16.4	18.5	58.8	69.8	25.0	29.8	18.6	15.6	25.1	63.3	27.2	24.6	33.5	17.1	23.4	19.9	20.6	39.9	26.5	13.7	25.6	28.7	13.5	17.6	28.8	23.8	39.7	16.2	18.0	46.4	36.4	29.3	16.8	18.6	34.0	35.2	11.2	27.4	43.9	30.2	31.0	43.5	27.7	8.7	36.3	16.9	13.1	30.3	14.5	13.2	19.0	14.7	27.3	21.2	23.5	25.7	20.5	22.5	27.0	44.1	6.7	27.4	43.3	12.3	25.1	49.7	18.5	21.3	27.0	19.9	39.3	17.7	22.8	19.3	36.1	37.6	16.0	82.4	26.8	20.8	17.0	76.9	32.4	24.0	67.2	32.6	23.3	58.9	22.0	16.8	26.9	29.4	51.7	18.3	13.8	24.9	34.9	42.4	28.3	23.6	28.3	21.5	22.4	16.7	15.0	11.2	19.5	9.4	26.6	27.3	30.2	34.0	28.9	28.6	30.5	25.3	29.9	27.4	2.9	43.9	27.4	35.2	26.6	31.0	17.8	19.4	15.4	18.1	16.4	18.5	18.6	15.6	17.1	16.2
SLC25A41	"APC4, FLJ40442, MGC34725"	ENSG00000181240	"Solute carrier family 25 member 41"	Q8N5S1	19	6426037-6433779	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 8.1;testis: 26.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.3;HMC-1: 6.9;U-937: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"							HPA043591	Uncertain									"HPA043591: AB_10964585"	"unprognostic (1.87e-3)"	"unprognostic (2.52e-3)"	"unprognostic (6.81e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.29e-4)"	"unprognostic (4.43e-3)"	"unprognostic (2.81e-2)"	"unprognostic (9.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	0.3	0.2	2.4	0.3	6.3	0.0	0.5	8.1	3.2	0.3	0.5	0.3	0.3	0.4	0.3	0.8	1.7	0.4	0.3	1.6	2.6	1.3	0.3	0.3	0.3	0.3	0.6	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.5	0.9	1.3	1.2	0.3	0.5	0.6	0.3	0.0	26.5	0.3	0.3	0.4	0.3	0.3	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.1	0.4	0.0	0.0	0.7	0.0	0.0	0.4	0.2	0.0	0.0	0.3	0.4	0.0	2.3	1.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	6.9	0.7	1.7	0.0	0.0	0.0	2.1	0.0	0.0	0.8	0.0	1.7	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.4	1.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	4.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	6.3	8.1	2.7	2.6	1.3	0.6	0.3	0.3	0.3
SLC25A43		ENSG00000077713	"Solute carrier family 25 member 43"	Q8WUT9	X	119399060-119454478	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035188	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA035188: AB_10602400"	"unprognostic (6.05e-3)"	"unprognostic (1.48e-1)"	"unprognostic (9.92e-2)"	"prognostic unfavourable (3.76e-5)"	"unprognostic (4.99e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (5.06e-8)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.92e-2)"	12.7	3.0	4.4	11.1	3.7	1.3	11.8	5.9	3.8	8.9	12.3	4.3	5.6	12.8	8.0	7.3	23.5	5.8	6.3	6.0	5.1	3.4	11.4	11.3	10.4	9.5	3.8	2.7	7.8	15.6	4.0	3.0	7.3	5.8	8.5	14.2	7.4	12.8	4.4	6.3	14.0	13.3	7.7	8.2	9.0	7.9	4.3	4.3	1.9	5.7	9.6	16.2	8.9	12.9	4.3	6.3	0.2	10.7	6.6	3.2	1.4	13.6	10.1	0.7	4.0	14.0	21.1	5.4	7.4	9.6	6.1	5.9	5.2	6.9	1.5	4.6	21.0	10.1	7.9	7.1	5.4	11.7	2.4	4.9	3.3	7.0	8.6	4.6	5.2	8.7	12.6	10.1	8.5	7.5	0.9	7.3	7.0	24.3	0.0	6.4	4.6	15.8	1.2	0.0	2.0	10.1	4.7	0.6	0.0	10.1	21.5	11.9	3.8	4.6	10.4	10.0	2.9	10.8	11.5	0.1	5.7	3.3	9.9	7.6	8.7	0.0	3.4	0.2	1.0	5.1	1.8	4.3	2.0	3.2	6.3	3.6	1.1	1.9	0.0	6.6	10.7	1.6	1.6	1.4	4.4	3.7	5.9	3.8	5.1	3.4	3.8	2.7	5.8	4.3
SLC25A44	"FLJ90431, KIAA0446"	ENSG00000160785	"Solute carrier family 25 member 44"	Q96H78	1	156193932-156212796	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065411			Approved	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA065411: "	"unprognostic (1.58e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.72e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-1)"	"prognostic favourable (2.49e-4)"	"unprognostic (3.37e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.37e-1)"	14.3	9.0	15.9	9.3	23.1	10.2	8.9	18.6	31.9	9.1	10.4	19.7	6.6	16.8	8.1	11.1	9.0	7.8	10.7	10.6	16.1	16.7	25.9	31.2	10.6	8.7	14.4	18.1	7.1	8.3	17.7	10.9	7.8	22.5	8.7	11.1	9.3	7.0	9.5	12.8	9.1	13.9	10.8	13.5	13.3	8.4	8.9	12.1	10.6	9.7	6.0	11.2	9.7	7.9	3.7	6.3	33.8	9.1	4.2	4.9	5.6	10.2	17.5	8.6	11.3	18.8	10.1	6.8	11.0	16.2	20.0	16.4	17.1	9.3	8.1	9.7	16.4	15.3	31.4	12.9	17.8	9.3	10.5	7.4	11.2	10.3	14.4	9.6	13.7	14.3	11.4	20.2	12.3	16.2	7.7	13.5	13.7	18.4	10.0	6.8	20.3	18.2	6.4	8.7	13.9	26.2	12.2	13.4	18.2	12.8	23.4	14.6	17.6	15.8	13.1	11.6	9.8	13.0	13.1	13.8	10.5	12.3	12.8	10.1	11.4	6.5	8.4	8.7	4.7	9.1	4.9	3.7	3.8	4.4	6.3	2.4	3.1	3.7	33.8	4.2	7.1	2.8	3.3	5.6	15.9	23.1	18.6	31.9	16.1	16.7	14.4	18.1	22.5	12.1
SLC25A45		ENSG00000162241	"Solute carrier family 25 member 45"	Q8N413	11	65375192-65383701	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 60.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.7;Karpas-707: 18.6;RPMI-8226: 13.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA050821	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA050821: "	"unprognostic (3.73e-2)"	"unprognostic (2.19e-3)"	"unprognostic (8.44e-4)"	"unprognostic (6.17e-3)"	"unprognostic (2.57e-2)"	"unprognostic (2.84e-7)"	"unprognostic (7.57e-3)"	"unprognostic (4.59e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.06e-2)"	"prognostic favourable (2.83e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.43e-1)"	2.2	1.8	2.1	4.0	2.3	3.1	3.2	1.0	2.6	1.7	4.5	4.0	4.7	4.1	1.0	5.4	1.5	1.3	1.3	2.8	2.5	1.1	3.9	7.7	5.3	9.4	1.8	2.3	1.3	60.5	4.2	4.7	1.2	2.3	2.5	1.2	3.5	5.0	1.3	4.1	2.0	11.0	1.5	2.3	9.6	1.9	2.4	2.0	5.8	9.0	2.8	8.2	1.9	1.7	10.8	19.2	6.0	10.1	13.5	11.4	2.5	0.3	4.6	0.2	6.8	1.3	0.6	3.4	0.8	2.1	0.4	0.4	1.0	2.2	4.1	3.9	1.9	0.5	0.5	0.3	0.0	13.7	1.0	4.4	2.5	0.3	0.8	1.4	4.7	1.6	0.1	0.5	0.4	0.7	0.6	18.6	0.7	1.5	3.2	0.1	0.3	2.1	6.0	0.9	13.4	0.7	0.0	2.3	3.0	1.4	3.6	0.7	1.8	0.7	1.3	0.5	1.7	4.4	0.3	7.7	4.8	1.1	1.4	1.0	2.6	6.0	5.5	3.9	7.9	9.0	8.4	8.9	7.0	7.5	5.7	10.8	11.4	8.5	3.3	13.5	10.1	19.2	6.3	2.5	2.1	2.3	1.0	2.6	2.5	1.1	1.8	2.3	2.3	2.0
SLC25A51	"CG7943, MCART1, MGC14836"	ENSG00000122696	"Solute carrier family 25 member 51"	Q9H1U9	9	37879400-37904353	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 13.4"	"Low lineage specificity"	"Detected in all"											"HPA046388, HPA058261"	Uncertain		Approved	Mitochondria				Mitochondria		"HPA046388: , HPA058261: "	"unprognostic (5.46e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavourable (5.67e-5)"	"unprognostic (6.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-3)"	"unprognostic (5.37e-2)"	"prognostic favourable (1.52e-4)"	"unprognostic (8.27e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (2.08e-2)"	17.6	9.1	11.7	9.9	12.9	21.2	27.6	11.3	14.2	12.0	10.7	12.0	10.8	15.3	10.3	10.2	12.6	8.1	10.7	11.5	12.9	9.3	13.3	9.7	14.6	10.8	11.9	14.9	11.0	16.7	20.6	12.8	9.7	11.9	10.5	9.0	8.2	13.3	8.4	15.9	11.7	13.4	12.2	11.4	12.6	9.7	18.8	12.4	14.4	9.8	7.6	12.9	9.1	10.2	3.1	1.4	13.4	3.9	2.1	3.6	1.1	8.1	6.5	5.1	7.9	24.3	10.6	5.1	7.0	7.2	6.1	8.9	8.5	3.5	17.2	4.1	16.4	4.0	13.5	9.8	11.6	11.8	4.1	5.2	18.0	11.8	13.7	8.2	7.7	10.6	11.4	9.0	11.6	10.8	11.5	13.7	12.9	4.7	9.9	1.9	6.2	4.7	7.0	6.7	10.6	6.0	6.0	10.6	6.8	5.6	6.7	4.0	3.6	9.0	11.8	10.2	12.0	4.8	8.6	5.3	11.1	12.0	13.4	6.0	8.4	13.4	1.9	3.2	2.1	3.9	3.6	3.1	2.3	3.0	1.4	2.2	2.2	2.5	1.5	2.1	1.6	0.6	3.4	1.1	11.7	12.9	11.3	14.2	12.9	9.3	11.9	14.9	11.9	12.4
SLC25A53	MCART6	ENSG00000269743	"Solute carrier family 25 member 53"	Q5H9E4	X	104099214-104157027	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Daudi: 7.0;Karpas-707: 16.7"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034959	Uncertain									"HPA034959: AB_10602025"	"unprognostic (4.70e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.16e-3)"	"unprognostic (5.94e-2)"	"unprognostic (2.68e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.49e-3)"	"unprognostic (4.45e-3)"	"unprognostic (7.94e-2)"	"unprognostic (9.76e-5)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.76e-2)"	2.8	2.4	3.2	5.6	4.6	2.8	2.1	6.3	8.6	3.9	2.5	2.8	5.7	3.1	5.1	3.4	2.2	1.9	2.9	2.8	3.6		1.8	1.6	2.0	8.8	3.1	2.7	3.2	4.4	1.2	5.8	1.4	3.6	4.6	2.9	3.1	3.0	5.0	1.5	2.1	3.8	4.8	4.2	6.6	3.1	3.9	4.5	1.4	2.7	0.8	8.4	4.7	9.0	1.7	0.5	3.0	0.5	1.0	2.9	0.7	0.0	0.1	2.0	1.3	0.1	0.0	0.1	0.2	0.1	0.3	0.2	0.1	0.0	7.0	0.2	0.1	0.1	2.4	0.0	0.2	0.6	1.0	0.8	0.2	0.2	0.1	1.3	0.8	0.4	0.1	0.3	0.0	0.5	0.2	16.7	0.1	0.1	0.3	0.1	2.7	0.5	2.8	1.1	0.3	0.3	0.2	1.8	2.6	0.1	0.0	0.0	0.1	0.1	0.4	0.1	1.0	0.1	0.4	0.2	0.0	2.6	0.1	1.9	0.5	0.9	0.4	0.8	1.3	0.5	2.9	1.7	1.2	2.4	0.5	1.4	0.4	1.6	3.0	1.0	0.3	0.3	1.8	0.7										
SLC26A10		ENSG00000135502	"Solute carrier family 26 member 10"	Q8NG04	12	57619527-57626151	"Predicted membrane proteins, Transporters"	"Antiport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 8.5"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.4;NTERA-2: 5.5;RH-30: 4.3;SH-SY5Y: 7.8;U-266/70: 5.3"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Region enhanced"	"Detected in single"		"cerebellum: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA044719	Uncertain									"HPA044719: AB_10962362"	"unprognostic (1.16e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.12e-5)"	"unprognostic (3.22e-3)"	"unprognostic (2.65e-12)"	"unprognostic (1.28e-2)"	"unprognostic (3.80e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.40e-1)"	2.0	0.7	0.4	0.5	0.9	0.0	0.4	3.8	0.9	0.4	0.8	0.4	0.4	0.0	2.9	1.2	0.4	1.9	1.8	8.5	0.4	0.2	0.4	0.4	0.4	0.5	0.4	0.4	0.9	0.4	0.0	0.4	0.4	0.4	2.1	0.5	0.4	0.8	1.6	2.6	0.1	1.1	1.9	0.4	0.7	0.6	0.4	0.4	0.4	0.4	0.4	0.4	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.0	0.0	0.0	0.5	1.1	0.2	0.7	0.3	0.1	0.0	0.3	0.2	0.0	0.0	0.7	0.0	0.2	0.0	3.4	0.4	0.2	0.7	0.7	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.9	1.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	4.3	0.0	0.0	0.0	2.2	7.8	0.0	0.0	0.5	0.1	0.6	0.0	0.6	1.3	0.6	0.0	5.3	0.5	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	3.8	0.9	0.4	0.2	0.4	0.4	0.4	0.4
SLC26A11		ENSG00000181045	"Solute carrier family 26 member 11"	Q86WA9	17	80219699-80253500	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.3;monocytes: 2.3;T-cells: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029893	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA029893: AB_10600809"	"unprognostic (5.86e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavourable (1.55e-5)"	"unprognostic (3.80e-2)"	"unprognostic (2.63e-3)"	"prognostic unfavourable (1.82e-6)"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.03e-1)"	"prognostic favourable (1.43e-5)"	"unprognostic (2.86e-1)"	"unprognostic (3.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (8.40e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.32e-2)"	9.9	30.9	10.2	10.2	19.3	16.3	8.4	9.1	18.0	11.6	8.2	12.6	14.1	8.7	11.6	14.6	6.9	9.2	10.0	5.1	9.4	30.5	12.4	6.9	12.8	14.3	10.5	17.4	18.3	7.9	14.9	25.6	21.1	17.2	11.8	5.1	15.6	12.2	14.8	6.5	13.1	11.9	11.6	9.3	17.3	7.3	4.8	7.3	1.8	18.1	4.9	6.7	9.8	14.1	0.4	1.3	0.1	2.3	0.1	4.9	1.9	0.5	8.3	9.8	7.6	4.9	3.7	11.4	4.7	5.9	10.7	6.7	9.5	1.7	0.1	9.7	4.9	3.2	5.4	3.5	4.2	11.3	9.8	0.0	10.5	8.8	13.1	0.0	1.5	6.7	5.8	5.1	2.4	9.0	4.1	12.1	6.3	7.8	0.4	0.2	4.4	8.1	0.4	1.1	4.4	9.7	9.1	3.9	12.0	4.8	11.9	12.3	14.3	0.2	6.7	8.6	5.1	7.3	0.5	13.6	5.1	1.3	4.5	0.0	6.9	0.0	2.3	0.0	1.8	0.9	2.6	0.4	3.2	2.6	1.3	0.2	4.9	2.0	0.1	0.1	0.3	0.0	4.0	1.9	10.2	19.3	9.1	18.0	9.4	30.5	10.5	17.4	17.2	7.3
SLC27A3	"ACSVL3, FATP3, MGC4365"	ENSG00000143554	"Solute carrier family 27 member 3"	Q5K4L6	1	153774354-153780157	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.0;MCF7: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.9;granulocytes: 13.7;monocytes: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA006935, HPA067508"	Enhanced		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA006935: AB_1080003, HPA067508: "	"unprognostic (1.88e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.39e-2)"	"prognostic favourable (5.23e-4)"	"unprognostic (4.67e-2)"	"prognostic unfavourable (6.33e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.08e-1)"	20.7	3.7	4.9	6.4	4.3	3.7	15.0	7.5	6.6	11.1	11.6	3.6	7.9	3.5	10.1	39.1	9.4	9.5	9.2	7.0	3.5	2.4	12.2	19.5	21.1	7.0	3.5	4.7	13.6	5.7	4.5	6.7	9.7	3.3	11.6	6.1	4.6	7.7	9.7	3.6	11.0	6.8	10.5	1.8	6.9	14.4	15.4	3.4	3.5	8.6	10.3	5.5	9.7	9.4	0.6	5.9	13.7	8.7	2.2	2.2	2.5	3.9	0.2	1.7	0.8	35.0	6.8	3.0	1.5	3.0	0.6	0.8	2.3	1.8	0.5	4.1	1.6	12.2	1.6	1.4	0.4	0.3	2.3	0.8	2.1	0.9	4.2	1.4	2.8	4.5	4.6	0.2	0.8	4.7	0.3	0.7	0.2	18.5	0.1	4.0	4.0	1.9	7.0	0.3	0.4	0.9	0.4	3.4	3.8	0.8	8.1	1.5	2.1	4.0	1.1	0.8	1.7	4.3	0.0	1.3	1.1	0.1	2.0	4.7	0.6	7.2	8.7	13.7	2.1	7.3	1.5	0.5	1.0	2.2	5.9	0.6	0.5	1.1	1.7	2.2	7.2	1.0	0.3	2.5	4.9	4.3	7.5	6.6	3.5	2.4	3.5	4.7	3.3	3.4
SLC27A6	"ACSVL2, FACVL2, FATP6, VLCS-H1"	ENSG00000113396	"Solute carrier family 27 member 6"	Q9Y2P4	5	128538013-129033642	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.2"	"Cell line enriched"	"Detected in some"	9	"BEWO: 31.2"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 19.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA008987	Approved		Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA008987: AB_1857065"	"unprognostic (5.39e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.34e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.53e-1)"		"unprognostic (2.64e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.66e-4)"	0.5	23.2	6.3	0.5	6.8	0.3	2.9	0.6	2.8	4.1	0.9	8.2	0.0	0.6	4.2	0.5	7.2	19.5	2.7	20.6	3.2	3.3	0.2	0.3	0.9	0.4	10.4	0.0	9.7	0.3	0.2	7.7	19.6	13.3	3.7	1.8	1.7	3.9	0.4	0.5	2.2	1.1	1.0	12.7	0.3	0.6	11.3	15.1	5.4	3.9	8.7	5.5	1.5	3.2	0.2	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	31.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	0.6	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.1	2.3	0.0	2.1	1.4	0.0	1.5	0.0	0.0	0.0	0.2	0.2	3.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.3	6.8	0.6	2.8	3.2	3.3	10.4	0.0	13.3	15.1
SLC28A2	"CNT2, HCNT2, HsT17153, SPNT1"	ENSG00000137860	"Solute carrier family 28 member 2"	O43868	15	45252230-45277845	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"gallbladder: 28.7;intestine: 49.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;NB-4: 2.2"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 3.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA046068, HPA055623"	Enhanced									"HPA046068: AB_2679523, HPA055623: AB_2682866"	"unprognostic (2.75e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.40e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.44e-2)"	"unprognostic (8.95e-2)"	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.2	0.2	0.8	18.5	0.2	0.1	25.7	0.4	0.1	0.3	0.2	28.7	0.1	0.2	0.2	1.0	0.3	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.2	1.6	0.1	0.2	13.8	0.1	0.1	0.1	0.1	0.2	49.3	0.1	0.2	0.1	8.5	0.4	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.6	0.2	1.3	0.5	0.6	0.7	0.0	0.1	0.3	0.1	0.1	0.0	0.1	4.2	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.6	0.2	0.0	0.0	0.7	0.0	0.1	0.2	0.6	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.1	0.3	2.2	0.2	0.3	0.2	0.4	1.3	0.0	0.2	1.1	1.6	0.0	0.1	0.3	0.2	0.6	0.3	0.4	0.5	1.2	0.2	0.7	0.2	0.3	0.4	0.6	0.2	1.3	0.2	0.1	0.4	0.1	0.2	0.5	0.3	0.1	0.2	0.6	0.4	0.7	0.2	0.6	0.5	0.1	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1
SLC2A11	"GLUT10, GLUT11"	ENSG00000133460	"Solute carrier family 2 member 11"	Q9BYW1	22	23856703-23886309	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042960, HPA071184"	Uncertain		Uncertain	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	Nucleoplasm	"HPA042960: , HPA071184: "	"unprognostic (1.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (4.89e-2)"	"prognostic favourable (3.83e-4)"	"unprognostic (2.32e-1)"	"prognostic favourable (5.77e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.29e-2)"	4.3	7.8	8.5	6.1	15.3	3.5	6.2	22.9	17.0	4.1	4.9	6.4	17.2	3.9	7.7	9.0	2.8	5.0	5.2	8.5	11.0	13.4	19.5	4.9	4.5	7.1	9.5	10.9	6.6	28.8	18.6	14.0	21.0	9.7	7.6	6.0	10.4	6.1	11.4	13.6	4.2	4.8	10.4	9.6	5.3	6.1	4.5	6.2	1.6	9.2	2.4	6.4	4.5	5.3	2.2	4.6	1.5	1.1	1.2	1.6	0.3	2.6	1.3	1.7	7.6	1.7	3.5	0.8	1.6	2.0	1.8	1.3	1.8	1.8	3.4	0.9	2.2	2.2	3.2	0.9	1.0	2.4	2.9	1.7	2.8	2.6	2.5	1.6	1.8	1.3	3.2	2.7	2.3	0.7	0.7	7.6	1.0	2.8	0.3	0.7	2.5	2.1	4.6	0.2	3.8	5.6	0.7	4.1	2.4	0.8	12.1	2.7	6.3	0.8	0.5	0.7	1.2	0.7	0.8	7.2	2.0	3.4	1.5	1.2	1.8	1.5	0.4	0.9	0.9	1.1	0.7	2.1	0.8	0.8	0.2	2.2	1.6	1.1	1.2	1.2	0.7	4.6	0.2	0.3	8.5	15.3	22.9	17.0	11.0	13.4	9.5	10.9	9.7	6.2
SLC2A12	"GLUT12, GLUT8"	ENSG00000146411	"Solute carrier family 2 member 12"	Q8TD20	6	133988697-134052636	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 46.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 7.6;CAPAN-2: 10.4;HaCaT: 7.9;HEK 293: 6.5;U-2 OS: 11.3"	"Cancer enriched"	"Detected in many"	6	"prostate cancer: 18.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.3;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.0;monocytes: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA031593, HPA031594"	Approved		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Cell Junctions"	"HPA031593: AB_10600810, HPA031594: "	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-3)"	0.9	1.2	5.2	0.4	6.7	0.1	1.5	14.6	5.5	4.8	3.0	7.1	4.9	8.1	9.7	2.6	7.0	3.4	3.0	11.4	6.5	2.8	6.7	7.9	3.4	0.2	3.4	5.2	1.5	1.3	1.2	2.5	1.9	19.7	27.0	1.4	46.6	5.2	11.2	4.2	3.9	11.9	14.8	1.6	0.3	14.4	0.5	3.3	0.6	0.6	1.9	2.7	6.7	2.0	0.0	1.0	0.0	1.3	0.0	0.1	0.1	3.0	1.0	2.6	0.0	2.0	1.1	0.2	1.8	7.6	1.0	4.2	0.0	10.4	0.4	1.6	0.1	7.9	0.0	0.8	1.5	0.0	6.5	0.0	0.9	0.1	0.3	0.0	0.0	1.5	0.7	0.8	0.2	0.6	0.6	0.9	0.2	0.9	0.1	0.1	2.3	0.7	0.0	1.3	2.8	2.3	1.0	0.3	0.8	0.1	2.4	0.0	0.1	0.0	0.1	0.2	11.3	0.2	1.0	3.9	3.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.1	5.2	6.7	14.6	5.5	6.5	2.8	3.4	5.2	19.7	3.3
SLC2A14	"GLUT14, SLC2A3P3"	ENSG00000173262	"Solute carrier family 2 member 14"	Q8TDB8	12	7812512-7891148	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis, Sugar transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 52.4"	"Group enriched"	"Detected in some"	4	"BEWO: 14.6;CACO-2: 23.7;Hep G2: 6.1"	"Cancer enriched"	"Detected in single"	35	"testis cancer: 7.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.9"									HPA006539	Supported		Approved	"Plasma membrane"				"Plasma membrane"		"HPA006539: AB_1078984"	"unprognostic (2.52e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.82e-3)"	"unprognostic (8.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.46e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-2)"	0.4	3.1	0.1	0.1	0.6	3.0	0.4	0.1	0.2	0.4	0.4	0.3	0.1	0.0	0.3	0.8	0.8	0.1	0.3	0.1	0.2	0.3	0.1	2.0	0.2	0.2	0.1	0.1	2.7	7.4	0.0	0.6	0.5	0.3	0.6	0.2	0.1	0.1	0.1	0.1	0.1	0.7	0.2	0.1	0.1	0.0	52.4	0.2	0.1	0.1	0.1	0.1	0.6	0.1	0.6	0.4	6.9	0.7	1.3	1.7	0.2	0.0	0.4	0.3	0.3	0.2	0.8	14.6	0.0	0.0	0.0	0.2	23.7	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	2.4	0.6	6.1	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.1	0.1	2.7	0.0	0.2	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.0	1.5	0.3	0.1	0.6	0.4	0.1	0.1	0.1	0.3	0.3	0.0	0.3	5.5	0.7	1.8	1.0	0.2	1.2	0.5	1.0	0.8	0.4	0.6	0.7	0.9	6.9	1.3	0.2	0.3	1.7	0.2	0.1	0.6	0.1	0.2	0.2	0.3	0.1	0.1	0.3	0.2
SLC2A7	GLUT7	ENSG00000197241	"Solute carrier family 2 member 7"	Q6PXP3	1	9003300-9026345	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"intestine: 19.3"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039931	Uncertain									"HPA039931: AB_10671046"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-1)"				"unprognostic (1.96e-2)"		"unprognostic (2.20e-1)"		"unprognostic (1.05e-2)"	"unprognostic (3.43e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.69e-4)"	"unprognostic (5.09e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.35e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.6	0.0	0.0	7.2	0.0	0.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	19.3	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC30A7	"ZNT7, ZnTL2"	ENSG00000162695	"Solute carrier family 30 member 7"	Q8NEW0	1	100896076-100981753	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018034	Uncertain		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA018034: AB_1857089"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.05e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.37e-1)"	15.6	14.2	5.0	13.1	6.4	10.3	12.7	7.4	7.6	13.3	10.8	6.2	17.2	10.8	13.3	13.7	10.8	9.4	13.2	9.3	5.9	5.6	13.0	43.1	18.1	25.6	7.7	4.6	10.5	19.1	17.1	17.7	25.2	9.2	11.9	14.7	10.8	17.5	18.1	5.7	12.6	15.8	9.0	8.1	16.2	13.3	7.5	6.4	24.7	13.2	10.9	17.4	10.5	11.1	5.5	8.2	13.9	14.9	8.4	10.7	5.9	10.7	5.7	6.1	13.5	13.1	13.4	15.5	7.1	19.0	8.7	11.4	5.8	7.8	4.3	15.5	14.5	10.7	7.1	10.6	13.3	6.8	4.4	8.5	9.6	10.3	14.7	11.2	9.1	15.2	6.8	14.6	17.9	14.0	5.1	19.0	11.8	4.9	8.2	5.6	6.6	7.0	4.1	11.0	5.6	7.7	12.7	3.4	6.6	12.8	14.3	9.2	7.1	6.2	15.1	20.6	7.9	19.0	11.4	13.0	6.8	4.8	21.0	9.2	5.4	13.9	10.7	7.4	10.7	10.4	9.2	5.3	9.9	8.4	8.2	5.5	8.9	9.6	5.3	8.4	14.9	7.7	7.2	5.9	5.0	6.4	7.4	7.6	5.9	5.6	7.7	4.6	9.2	6.4
SLC32A1	"bA122O1.1, VGAT, VIAAT"	ENSG00000101438	"Solute carrier family 32 member 1"	Q9H598	20	38724462-38729372	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 38.3"	"Group enriched"	"Detected in some"	14	"MOLT-4: 5.4;SH-SY5Y: 1.6"	"Cancer enhanced"	"Detected in single"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037156, HPA058859, HPA059985"	Enhanced	Supported								"CAB037156: AB_532294, HPA058859: AB_2683836, HPA059985: AB_2684187"					"unprognostic (1.13e-2)"					"unprognostic (2.09e-1)"				"unprognostic (1.17e-1)"	"unprognostic (6.57e-2)"			1.0	1.1	4.6	1.0	38.3	1.5	1.0	4.9	25.8	1.0	1.0	0.8	0.0	1.0	1.0	1.0	1.0	1.1	1.0	1.0	3.9	9.7	1.0	1.0	1.0	1.0	4.4	6.8	1.0	1.1	1.0	4.1	1.0	10.4	1.0	1.0	0.7	1.0	1.0	1.0	1.0	1.1	1.0	4.4	1.0	1.0	1.6	7.9	0.0	1.0	0.0	1.0	1.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	4.6	38.3	4.9	11.9	3.9	9.7	4.4	6.8	10.4	7.9
SLC35A4		ENSG00000176087	"Solute carrier family 35 member A4"	"Q96G79, L0R6Q1"	5	140564456-140569103	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062210			Approved	Nucleoplasm				Nucleoplasm		"HPA062210: "	"unprognostic (3.01e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.91e-3)"	"unprognostic (9.63e-2)"	"unprognostic (3.61e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.87e-1)"	"prognostic favourable (4.56e-5)"	"unprognostic (2.96e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.55e-1)"	22.0	30.4	12.3	18.6	17.1	8.4	19.6	14.0	21.8	18.2	25.5	24.9	22.6	19.2	18.2	19.8	30.3	20.6	26.0	25.7	13.1	10.3	35.1	39.2	23.1	22.5	16.0	11.1	19.0	28.3	28.2	14.9	24.6	19.4	20.4	26.5	20.5	32.6	15.9	54.3	28.3	30.6	19.8	13.0	28.5	21.7	30.5	15.3	26.0	29.2	28.0	27.5	18.3	18.0	15.4	32.8	15.8	36.9	26.9	27.6	32.4	15.3	46.1	18.4	34.7	25.3	15.9	27.5	22.3	15.1	27.3	28.8	55.7	17.7	45.4	27.7	21.0	17.0	0.0	32.7	23.5	55.2	25.2	33.9	45.0	0.2	18.0	33.2	25.6	21.0	25.6	27.2	24.3	23.3	26.2	45.8	27.0	28.4	34.5	14.4	12.5	23.5	25.7	37.3	39.3	20.4	30.4	20.6	27.5	28.3	47.1	22.0	39.1	14.2	27.3	24.6	17.1	24.4	25.0	19.1	44.7	19.1	18.1	37.5	28.5	7.5	26.9	15.8	27.6	36.9	26.3	14.3	22.1	24.7	32.8	15.4	25.9	23.0	9.9	26.9	33.3	12.0	14.7	32.4	12.3	17.1	14.0	21.8	13.1	10.3	16.0	11.1	19.4	15.3
SLC35D3	FRCL1	ENSG00000182747	"Solute carrier family 35 member D3"	Q5M8T2	6	136922264-136925639	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.9;retina: 16.4"	"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 18.3"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.3"	"Group enriched"	"Detected in some"	4	"basal ganglia: 9.9;hypothalamus: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 26.6;olfactory region: 10.4"	"Region enriched"	"Detected in some"	6	"basal ganglia: 24.4"	"HPA030431, HPA067497"	Uncertain		Approved	"Centriolar satellite"				"Centriolar satellite"		"HPA030431: AB_10601716, HPA067497: "	"unprognostic (6.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-2)"		"unprognostic (2.48e-1)"		"unprognostic (9.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.03e-1)"	0.1	4.9	0.0	0.4	9.9	1.2	0.1	0.0	0.4	2.0	0.4	0.4	0.0	0.7	0.1	0.0	0.6	0.1	0.1	0.4	0.0	4.8	4.0	0.0	2.1	0.0	1.7	0.0	0.8	1.2	0.0	0.0	0.1	0.5	4.3	0.6	16.4	0.2	0.1	0.0	0.2	1.3	0.3	0.0	0.2	3.2	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	4.2	18.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	9.9	0.0	0.4	0.0	4.8	1.7	0.0	0.5	0.2
SLC35E2	KIAA0447	ENSG00000215790	"Solute carrier family 35 member E2"	P0CK97	1	1724838-1745999	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA062711	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm		"HPA062711: "	"unprognostic (3.03e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-4)"	"unprognostic (9.52e-4)"	"unprognostic (6.57e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.15e-3)"	"unprognostic (4.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.87e-4)"	3.0	4.1	8.0	5.2	5.1	0.6	3.0	9.8	6.2	4.0	3.0	2.9	1.6	4.9	6.0	10.5	4.5	5.8	7.6	3.0	5.0	3.5	2.5	2.4	4.8	11.6	4.4	4.7	5.5	3.5	6.9	5.9	3.5	4.0	3.6	5.4	3.6	9.1	1.6	4.7	6.4	4.8	3.7	3.7	6.8	6.2	6.2	5.5	5.5	3.5	3.8	4.3	4.3	7.7	5.0	5.2	6.4	3.4	3.1	6.5	3.2	1.6	1.6	5.3	11.4	11.1	10.8	3.5	7.4	15.1	7.0	8.9	4.6	15.0	4.8	1.3	1.7	7.4	1.4	2.8	7.5	6.8	1.7	6.4	7.4	1.2	2.3	1.3	7.1	8.7	3.7	1.2	6.2	2.1	2.1	2.2	1.3	1.2	1.9	3.1	1.0	1.9	3.6	4.9	1.0	7.3	5.3	15.0	3.1	2.1	9.1	8.7	17.7	3.6	9.5	7.2	1.5	2.2	0.4	3.0	0.4	1.6	5.2	3.9	1.1	6.4	3.4	2.1	5.5	2.6	6.5	4.5	4.8	5.3	1.5	5.0	5.5	4.8	4.0	3.1	1.6	5.2	4.5	3.2	8.0	5.1	9.8	6.2	5.0	3.5	4.4	4.7	4.0	5.5
SLC35E2B		ENSG00000189339	"Solute carrier family 35 member E2B"	P0CK96	1	1659529-1692728	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045641, HPA062711"	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm		"HPA045641: , HPA062711: "	"unprognostic (9.00e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-1)"	"prognostic favourable (7.64e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.09e-2)"	"unprognostic (5.70e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.54e-2)"	"prognostic favourable (5.15e-4)"	7.4	9.7	11.3	5.8	9.3	6.4	14.2	15.5	14.5	8.1	15.4	9.7	15.4	12.5	10.2	10.5	6.8	9.0	9.8	5.0	11.7	7.5	7.7	14.2	8.6	18.8	10.0	8.5	15.0	16.6	6.5	14.4	11.0	9.2	9.7	7.3	8.7	12.1	10.2	10.4	10.5	12.1	13.6	7.1	12.8	8.2	3.9	12.6	8.5	9.8	7.2	10.2	7.3	13.0	4.8	8.7	6.8	3.9	4.5	9.5	5.0	6.1	7.7	27.5	19.3	15.4	14.7	6.9	3.4	8.0	4.0	4.1	3.5	8.4	8.3	12.4	16.3	4.5	10.8	5.9	3.5	11.6	10.3	12.3	13.7	9.9	15.3	11.5	10.0	13.7	13.7	10.6	11.9	16.8	14.6	14.9	9.3	3.8	15.2	13.2	9.5	9.1	12.7	5.8	14.4	9.9	3.4	18.5	23.8	12.7	11.1	20.1	8.9	15.8	12.4	11.5	6.0	4.9	4.1	12.5	9.6	17.5	9.1	21.1	8.0	1.7	3.9	3.3	8.3	3.5	8.9	4.3	6.8	9.5	2.8	4.8	8.1	6.7	6.8	4.5	2.5	8.7	6.4	5.0	11.3	9.3	15.5	14.5	11.7	7.5	10.0	8.5	9.2	12.6
SLC35E3	BLOV1	ENSG00000175782	"Solute carrier family 35 member E3"	Q7Z769	12	68746106-68793964	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 18.9;U-698: 19.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049403	Uncertain									"HPA049403: "	"unprognostic (1.49e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.19e-1)"	"prognostic favourable (1.78e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.26e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.98e-2)"	"unprognostic (6.85e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.80e-1)"	8.1	12.3	7.9	7.2	11.9	12.0	12.4	14.1	13.7	8.2	6.2	18.9	3.5	5.7	7.4	9.6	8.7	5.5	5.8	6.2	8.9	7.4	8.0	12.7	7.6	9.2	13.9	10.6	8.7	9.8	7.7	6.7	5.8	14.4	10.2	5.9	9.7	11.8	5.8	7.3	14.5	5.5	7.4	15.7	8.2	9.2	5.7	11.0	18.8	6.9	5.3	9.0	8.0	6.6	4.4	3.7	9.5	3.8	3.6	4.6	1.5	2.2	2.4	3.7	2.3	4.7	2.2	3.3	1.9	4.0	4.5	2.0	4.8	2.8	10.3	1.3	4.0	3.1	2.1	4.2	2.7	2.3	3.6	4.4	3.0	8.0	3.5	2.2	2.3	4.7	3.2	5.6	2.9	3.6	2.3	3.8	4.5	3.3	2.8	7.2	3.7	3.5	18.9	5.8	2.6	3.3	5.4	2.8	4.9	3.9	3.1	2.5	5.6	1.1	2.6	5.5	2.3	3.1	2.0	8.4	4.1	19.1	6.5	2.0	2.9	4.7	3.3	4.2	4.0	3.1	4.6	3.1	3.2	3.2	2.4	4.4	3.6	2.9	9.5	3.6	3.8	3.7	2.7	1.5	7.9	11.9	14.1	13.7	8.9	7.4	13.9	10.6	14.4	11.0
SLC35E4		ENSG00000100036	"Solute carrier family 35 member E4"	Q6ICL7	22	30635652-30669016	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 20.2;testis: 22.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 14.7;U-2197: 14.2;U-87 MG: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049558	Approved		Approved	Cytosol				Cytosol		"HPA049558: "	"unprognostic (2.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.03e-4)"	"unprognostic (5.71e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.45e-7)"	"unprognostic (2.77e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.05e-3)"	4.0	2.5	5.6	3.3	11.8	3.4	2.6	4.0	11.4	2.7	5.9	8.1	2.1	2.7	4.2	3.5	4.5	3.1	2.9	5.6	5.2	4.7	2.0	1.1	2.4	2.1	13.0	6.3	2.8	4.1	3.1	2.8	1.6	6.6	2.9	4.2	2.4	2.6	3.5	20.2	7.3	2.5	3.5	2.6	2.4	3.8	22.5	10.1	0.0	2.0	6.6	2.1	3.6	7.6	0.7	3.6	1.6	2.8	2.1	3.2	0.9	6.4	2.8	1.1	2.1	2.9	7.5	0.6	4.2	3.7	2.9	2.7	0.2	1.8	0.4	2.3	4.3	4.1	1.9	2.4	1.5	14.7	2.1	0.1	2.1	0.2	4.2	0.3	1.8	2.4	1.1	11.7	3.7	9.9	0.6	1.9	4.5	1.8	0.2	1.3	1.3	10.7	1.1	2.2	0.2	1.3	0.5	5.8	2.3	4.4	1.9	2.0	1.3	0.5	13.1	12.5	3.9	14.2	4.0	0.6	0.5	0.2	15.2	0.2	3.2	1.6	2.1	0.3	0.9	2.8	1.4	0.3	2.1	3.2	3.6	0.7	2.1	1.7	0.8	2.1	2.2	1.0	2.3	0.9	5.6	11.8	4.0	11.4	5.2	4.7	13.0	6.3	6.6	10.1
SLC35F1	"C6orf169, dJ230I3.1"	ENSG00000196376	"Solute carrier family 35 member F1"	Q5T1Q4	6	117907526-118317676	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 41.9"	"Group enriched"	"Detected in some"	9	"AF22: 23.3;WM-115: 39.2"	"Group enriched"	"Detected in some"	16	"glioma: 15.1;melanoma: 3.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019576	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"				Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA019576: AB_2190216"	"unprognostic (1.46e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.31e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.44e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.83e-4)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.02e-1)"	2.8	2.7	13.8	2.1	14.5	0.9	1.2	3.6	41.9	1.7	3.5	4.3	0.0	1.6	2.7	5.5	1.8	1.5	1.8	5.3	10.4	10.2	1.7	1.0	1.1	1.0	9.3	15.3	1.4	1.4	1.0	0.6	1.0	5.6	2.3	2.3	2.6	1.7	2.9	1.2	1.6	1.8	2.6	4.1	1.6	1.4	1.8	5.6	0.0	1.8	0.0	1.0	1.4	2.6	0.2	0.6	1.0	0.1	0.3	0.9	0.1	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	2.9	3.3	0.0	0.0	0.1	0.0	39.2	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	1.0	0.3	0.0	0.6	0.0	0.1	13.8	14.5	3.6	17.4	10.4	10.2	9.3	15.3	5.6	5.6
SLC35F3	FLJ37712	ENSG00000183780	"Solute carrier family 35 member F3"	Q8IY50	1	233904933-234324516	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 48.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	49	"plasmacytoid DC: 7.1"	"Lineage enriched"	"Detected in single"	69	"dendritic cells: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051327, HPA061582"	Uncertain		Approved	"Nucleoli,Golgi apparatus"				"Golgi apparatus"	Nucleoli	"HPA051327: , HPA061582: "	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.69e-5)"	"unprognostic (3.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.58e-1)"	0.8	3.5	4.6	1.3	26.0	0.7	6.8	25.1	16.7	1.4	0.8	0.5	0.0	0.8	1.0	2.5	1.6	1.7	0.8	0.6	5.4	4.6	1.6	0.6	1.2	2.4	4.8	6.6	0.6	3.6	4.6	2.8	0.7	4.1	2.0	0.8	0.0	6.6	1.1	1.1	0.8	0.9	1.1	4.8	1.0	2.5	1.1	4.3	0.5	1.9	0.3	1.9	0.8	0.6	0.0	7.1	0.0	0.1	0.0	0.0	0.0	1.4	3.8	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.2	0.0	3.5	0.0	48.3	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.3	0.0	0.0	0.0	3.6	0.0	2.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	7.1	0.0	0.0	4.6	26.0	25.1	11.6	5.4	4.6	4.8	6.6	4.1	4.3
SLC35F4	"C14orf36, FLJ37712"	ENSG00000151812	"Solute carrier family 35 member F4"	A4IF30	14	57563922-57982194	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 29.5;seminal vesicle: 10.5"	"Group enriched"	"Detected in some"	4	"RPMI-8226: 4.4;U-87 MG: 6.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"cerebellum: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043853	Uncertain		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA043853: AB_10963083"	"unprognostic (2.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-4)"	"unprognostic (4.88e-2)"	"unprognostic (8.64e-2)"		"unprognostic (1.38e-1)"		"unprognostic (1.76e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.03e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.68e-3)"	"unprognostic (9.23e-2)"	0.1	0.1	1.2	0.1	4.9	0.1	0.1	29.5	1.1	1.0	0.2	0.1	0.5	0.2	1.5	0.2	0.1	0.2	0.5	0.1	0.9	2.2	0.4	0.1	0.1	0.1	0.8	1.2	0.3	0.1	0.1	0.2	0.1	2.9	3.5	0.1	2.4	0.1	10.5	0.1	0.1	0.4	1.1	1.3	0.1	0.1	2.7	0.7	0.0	2.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	4.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.9	29.5	1.1	0.9	2.2	0.8	1.2	2.9	0.7
SLC37A1		ENSG00000160190	"Solute carrier family 37 member 1"	P57057	21	42496008-42581440	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 45.9"	"Cell line enhanced"	"Detected in many"		"HEL: 48.6;MCF7: 19.3;SK-BR-3: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030418, CAB034154"	Approved									"CAB034154: AB_2190373, HPA030418: AB_10601602"	"unprognostic (1.44e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.12e-1)"	"prognostic favourable (9.22e-5)"	"unprognostic (1.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.99e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.08e-2)"	"unprognostic (7.94e-2)"	"prognostic favourable (3.43e-5)"	"unprognostic (1.61e-2)"	4.7	6.6	7.2	15.8	5.3	7.5	7.3	8.0	6.1	6.3	28.6	2.7	5.1	31.0	2.4	10.6	9.8	6.9	18.4	2.3	3.4	4.9	4.7	4.0	8.0	6.1	3.5	4.6	3.9	4.8	2.2	14.0	9.7	3.9	10.8	13.7	5.5	14.5	9.0	6.4	4.6	45.9	3.0	7.1	7.0	16.7	16.8	3.3	9.3	9.3	4.4	16.2	7.1	5.9	7.8	13.1	23.0	10.5	4.1	6.7	4.0	5.2	2.1	0.5	1.0	0.0	0.1	4.6	0.2	0.0	0.2	0.1	1.2	10.7	3.7	5.5	0.0	2.1	1.0	2.7	0.0	1.7	2.6	48.6	1.8	0.1	1.3	1.0	4.8	0.3	1.6	0.0	0.1	1.6	0.9	5.2	0.0	19.3	3.6	2.7	3.7	1.2	3.8	0.0	0.1	4.5	10.0	5.7	0.7	3.1	16.9	1.2	6.3	5.4	2.8	0.0	1.0	0.0	0.0	10.0	6.2	3.6	0.0	8.0	0.5	2.1	3.2	23.0	5.2	8.6	6.7	7.8	3.6	4.6	4.6	5.4	3.1	4.3	3.8	4.1	10.5	13.1	1.8	4.0	7.2	5.3	8.0	6.1	3.4	4.9	3.5	4.6	3.9	3.3
SLC37A2	FLJ00171	ENSG00000134955	"Solute carrier family 37 member 2"	Q8TED4	11	125063067-125090312	"Predicted membrane proteins, Transporters"	"Antiport, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.2;salivary gland: 85.6"	"Cell line enhanced"	"Detected in some"		"A-431: 12.5;CAPAN-2: 26.6;hTCEpi: 12.0;hTERT-HME1: 28.6;U-138 MG: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"classical monocyte: 8.0;intermediate monocyte: 9.9;myeloid DC: 3.7;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	12	"dendritic cells: 3.7;monocytes: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014948	Uncertain									"HPA014948: AB_2190374"	"unprognostic (8.47e-2)"	"unprognostic (4.85e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.66e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.24e-2)"	7.1	26.4	1.0	47.2	1.4	0.0	3.4	0.4	1.0	2.5	3.6	3.5	0.5	3.7	0.7	2.0	7.2	1.0	2.4	2.3	1.3	0.7	1.0	2.7	7.2	6.4	1.5	0.3	1.8	0.7	0.0	0.6	3.2	1.5	2.0	4.6	2.4	85.6	0.6	0.4	16.3	4.6	1.3	1.7	10.2	0.8	0.7	1.2	1.4	0.6	3.3	3.1	6.6	6.5	0.1	3.7	0.6	11.9	0.0	0.0	3.1	12.5	0.0	0.2	0.0	0.2	0.4	0.0	0.4	1.2	0.3	1.2	0.1	26.6	0.0	3.8	0.1	6.6	0.2	7.1	1.8	0.3	0.2	2.8	0.2	0.6	0.0	0.0	0.1	0.3	12.0	1.2	28.6	0.7	0.1	0.1	1.2	0.0	0.0	0.6	0.3	0.2	0.0	0.9	0.2	0.3	6.4	0.0	0.1	2.3	0.0	0.8	0.0	0.5	1.4	20.4	0.0	0.2	0.5	0.3	0.4	0.0	0.7	0.7	1.6	0.0	8.0	0.0	0.0	9.9	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.6	0.0	11.9	0.0	0.0	3.1	1.0	1.4	0.4	1.0	1.3	0.7	1.5	0.3	1.5	1.2
SLC38A11	"AVT2, FLJ39822"	ENSG00000169507	"Solute carrier family 38 member 11"	Q08AI6	2	164896186-164955525	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 35.6"	"Cell line enriched"	"Detected in some"	9	"BJ hTERT+: 73.8"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 7.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	54	"memory B-cell: 2.7;naive B-cell: 7.9"	"Lineage enriched"	"Detected in single"	79	"B-cells: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043432	Uncertain									"HPA043432: AB_10793948"	"unprognostic (1.52e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.28e-3)"	"unprognostic (3.53e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.99e-1)"	"prognostic favourable (2.00e-8)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.36e-2)"	1.8	3.9	5.1	1.4	8.0	0.4	1.1	1.4	9.7	2.7	1.5	2.7	6.5	5.4	2.1	35.6	1.3	1.2	19.1	1.1	5.6	4.0	7.2	2.5	0.6	2.8	5.8	2.6	0.6	2.7	2.1	11.7	0.5	22.1	9.9	2.7	15.6	1.0	15.9	1.8	0.8	2.6	2.1	2.4	11.2	10.2	1.1	3.2	0.0	2.1	2.9	1.4	2.1	1.5	7.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.5	73.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	8.0	1.4	9.7	5.6	4.0	5.8	2.6	22.1	3.2
SLC39A11	C17orf26	ENSG00000133195	"Solute carrier family 39 member 11"	Q8N1S5	17	72645949-73092712	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021455			Approved	Nucleoplasm				Nucleoplasm		"HPA021455: "	"unprognostic (2.29e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.45e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.96e-3)"	"unprognostic (3.85e-2)"	10.4	7.4	12.4	7.8	17.9	10.7	10.8	5.3	14.4	9.3	13.3	19.8	6.6	11.5	4.8	9.6	13.0	5.6	8.6	4.2	13.3	6.3	7.9	21.9	8.2	4.8	27.8	6.6	2.8	23.8	3.1	3.8	7.0	15.3	5.3	13.8	6.7	16.6	5.2	3.7	11.2	12.7	5.7	15.7	6.5	27.6	4.1	22.5	6.0	20.6	3.6	8.6	8.3	7.6	6.0	14.9	9.8	16.2	8.7	6.9	6.3	4.2	7.8	0.9	3.8	6.8	5.5	5.3	4.6	4.1	2.1	2.8	2.9	19.4	5.3	4.7	4.6	3.7	1.3	2.3	3.2	5.7	2.7	4.9	2.0	3.3	4.1	5.2	47.6	4.7	4.4	4.3	2.5	2.1	2.5	6.7	2.6	6.0	3.3	11.4	0.7	3.3	2.2	3.5	4.4	3.5	4.4	2.2	3.0	2.4	18.4	2.7	12.6	7.3	1.8	4.2	3.9	3.5	2.8	5.4	2.4	3.7	6.8	10.7	2.4	5.5	16.2	9.8	6.9	15.4	4.6	6.0	5.3	5.2	14.9	3.9	3.8	5.2	2.5	8.7	11.9	10.5	6.5	6.3	12.4	17.9	5.3	14.4	13.3	6.3	27.8	6.6	15.3	22.5
SLC39A8	BIGM103	ENSG00000138821	"Solute carrier family 39 member 8"	Q9C0K1	4	102251041-102431258	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 67.3;salivary gland: 54.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 44.6;HL-60: 32.5;Karpas-707: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038832, HPA038833"	Approved									"HPA038832: , HPA038833: AB_10670910"	"prognostic favourable (6.69e-4)"	"unprognostic (1.29e-2)"	"prognostic favourable (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.59e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.78e-2)"	"prognostic favourable (6.34e-6)"	"unprognostic (3.25e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.13e-3)"	22.0	2.0	3.7	11.4	5.5	10.3	6.1	2.8	4.3	31.4	18.1	2.2	1.1	2.1	3.9	7.3	1.7	7.2	2.6	17.8	4.3	3.5	6.2	18.4	67.3	8.6	5.1	1.6	5.4	42.1	25.7	6.7	44.8	5.9	5.7	14.9	4.3	54.6	2.3	1.8	5.1	3.4	3.0	8.8	6.5	2.5	2.3	3.2	7.5	4.9	2.3	5.6	5.8	6.0	3.1	2.7	1.0	1.5	11.5	10.5	3.4	5.4	5.4	1.2	0.0	4.5	10.4	2.8	0.6	44.6	1.6	2.7	0.2	20.2	5.3	5.9	0.1	0.3	3.8	1.2	0.9	9.1	11.0	13.8	11.4	0.1	1.8	32.5	4.7	5.5	1.4	0.8	2.6	0.6	13.8	48.4	8.6	3.6	11.7	15.2	3.6	5.3	3.0	0.0	17.3	9.4	2.0	1.6	4.0	15.2	0.2	1.4	3.7	12.1	3.1	5.4	2.0	11.0	8.6	21.7	9.0	25.1	8.9	21.2	4.9	0.0	1.5	1.0	5.6	1.0	9.8	1.3	10.5	9.0	2.7	3.1	7.9	5.4	0.1	11.5	0.3	1.0	3.9	3.4	3.7	5.5	2.8	4.3	4.3	3.5	5.1	1.6	5.9	3.2
SLC41A1	MgtE	ENSG00000133065	"Solute carrier family 41 member 1"	Q8IVJ1	1	205789093-205813748	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 78.1;pancreas: 36.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014721, HPA015138"	Uncertain		Approved	Mitochondria				Mitochondria		"HPA014721: , HPA015138: AB_1857160"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.48e-4)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.23e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.65e-1)"	6.0	7.2	6.2	4.0	7.3	3.3	3.4	9.0	8.3	3.6	3.9	10.8	4.0	1.6	5.0	5.9	3.8	7.3	4.7	78.1	7.2	3.8	6.1	1.2	5.3	4.5	7.8	4.9	7.5	36.8	5.8	3.6	2.6	6.9	5.1	1.5	5.8	2.8	4.8	26.5	2.6	2.7	4.0	8.5	3.3	6.6	11.6	7.3	2.1	11.2	11.9	4.5	5.2	5.0	1.8	0.0	0.1	0.3	1.0	4.6	2.0	10.7	9.5	6.0	9.6	7.5	7.4	8.1	11.0	10.9	11.3	9.9	4.7	6.1	15.5	7.0	10.1	11.2	5.9	8.1	3.9	28.4	8.8	3.8	9.4	0.7	7.2	0.0	10.9	9.4	6.8	12.8	9.2	6.9	6.9	6.5	9.0	6.6	6.9	1.1	7.2	4.3	8.2	18.1	3.7	2.6	13.4	5.0	6.4	8.5	7.6	6.9	5.4	4.0	8.6	13.4	8.7	12.2	11.4	21.7	14.4	5.1	10.4	4.9	8.3	0.0	0.1	0.1	3.6	0.3	4.6	1.5	3.4	3.4	0.0	1.8	3.2	3.3	0.0	1.0	0.0	0.0	3.3	2.0	6.2	7.3	9.0	8.3	7.2	3.8	7.8	4.9	6.9	7.3
SLC44A5	"CTL5, MGC34032"	ENSG00000137968	"Solute carrier family 44 member 5"	Q8NCS7	1	75202131-75611116	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 32.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 7.4;RPTEC TERT1: 7.3;SH-SY5Y: 11.4;TIME: 14.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047455, HPA051011"	Uncertain		Approved	Cytosol				Cytosol		"HPA047455: , HPA051011: AB_2681309"	"unprognostic (9.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.19e-2)"	"prognostic unfavourable (6.52e-4)"	"unprognostic (1.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.30e-1)"	1.0	0.4	2.4	1.0	1.5	0.0	6.3	1.0	3.6	1.0	1.8	1.0	1.0	0.9	1.0	1.0	7.7	3.7	1.0	2.2	2.8	2.8	2.0	1.0	1.0	1.0	2.3	1.0	1.0	1.8	5.6	3.7	3.8	1.0	1.0	2.9	1.0	1.6	1.0	1.5	11.3	1.0	1.0	1.0	1.0	1.3	32.6	1.0	1.0	1.0	1.0	1.8	2.2	1.9	3.2	0.3	0.6	0.3	0.5	1.1	0.3	0.2	0.2	4.6	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.4	0.0	0.0	2.7	0.0	0.0	0.9	0.0	0.0	0.0	4.6	0.6	1.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.5	2.6	0.0	0.0	1.8	0.0	4.6	0.6	0.0	0.0	2.2	7.3	5.0	1.1	11.4	0.0	4.7	0.0	0.2	0.0	14.1	0.4	1.3	0.0	1.4	2.1	1.9	3.1	0.2	0.0	0.7	0.4	0.3	0.2	0.4	0.1	0.9	3.2	0.8	1.1	0.1	2.4	0.6	0.4	0.6	0.5	0.2	0.3	0.6	0.3	2.4	1.5	1.0	3.4	2.8	2.8	2.3	1.0	1.0	1.0
SLC45A3	"IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein"	ENSG00000158715	"Solute carrier family 45 member 3"	Q96JT2	1	205657851-205680459	"Cancer-related genes, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"prostate: 115.0"	"Cell line enriched"	"Detected in some"	30	"HMC-1: 138.2"	"Cancer enriched"	"Detected in all"	49	"prostate cancer: 539.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	226	"basophil: 22.6"	"Lineage enriched"	"Detected in single"	226	"granulocytes: 22.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA019073, HPA019075"	Enhanced		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA019073: AB_1857177, HPA019075: AB_1857179"	"unprognostic (1.80e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavourable (4.04e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.96e-1)"	"prognostic favourable (7.33e-5)"	0.8	1.5	2.5	1.5	6.2	0.7	0.8	0.4	5.8	1.9	2.1	19.0	0.0	2.1	0.9	0.6	0.9	1.1	1.8	0.7	4.2	2.0	1.1	4.0	1.7	1.6	13.2	1.6	1.0	0.7	0.5	1.9	0.6	7.2	115.0	1.6	0.2	0.9	0.7	2.2	0.9	2.1	0.8	12.4	5.0	6.4	1.4	11.1	0.0	0.5	0.7	0.7	1.5	0.4	0.0	0.0	22.6	0.0	0.0	0.0	0.2	1.5	0.4	0.4	0.4	0.0	0.0	0.3	0.2	0.0	0.5	0.4	1.1	2.9	0.4	0.7	0.0	0.5	0.2	0.5	0.0	0.6	0.4	4.6	0.1	0.3	0.3	0.7	138.2	0.0	0.1	0.3	0.0	1.5	0.7	0.2	0.2	0.3	0.1	1.3	2.0	1.7	0.1	0.6	0.2	0.6	2.1	0.2	0.4	0.2	3.4	0.6	0.7	0.2	1.5	0.2	1.5	0.5	1.1	0.0	0.1	0.0	0.3	0.2	1.1	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	6.2	0.4	5.8	4.2	2.0	13.2	1.6	7.2	11.1
SLC46A2	"Ly110, TSCOT"	ENSG00000119457	"Solute carrier family 46 member 2"	Q9BY10	9	112878920-112890913	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 21.1;lymphoid tissue: 31.8;skin 1: 22.3"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 1.1;U-2197: 1.0"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 17.0;intermediate monocyte: 8.7"	"Lineage enriched"	"Detected in many"	4	"monocytes: 17.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA020098	Approved									"HPA020098: "	"unprognostic (1.26e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.53e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.10e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.82e-2)"	0.2	0.1	0.1	0.5	0.1	0.0	1.0	1.1	0.5	17.7	0.1	0.0	21.1	0.0	3.6	10.4	1.4	0.1	0.3	0.1	0.1	0.3	0.2	0.2	17.1	1.9	0.1	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.8	0.0	0.1	0.4	9.9	0.1	22.3	0.2	0.6	0.2	1.0	0.1	1.5	0.0	31.8	0.1	0.0	0.3	5.4	0.7	0.0	3.8	0.2	17.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.1	0.2	0.0	0.0	1.1	0.0	1.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.2	0.0	6.5	0.1	0.0	4.1	0.1	0.1	1.1	0.5	0.1	0.3	0.1	0.2	0.0	0.0
SLC46A3	"DKFZp686A1775, FLJ42613"	ENSG00000139508	"Solute carrier family 46 member 3"	Q7Z3Q1	13	28700064-28718970	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 62.9;liver: 50.0"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 20.4;T-47d: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039930	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039930: AB_10673263"	"unprognostic (5.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"prognostic favourable (7.09e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.69e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.60e-2)"	"unprognostic (9.14e-3)"	"unprognostic (6.47e-3)"	6.9	14.2	3.8	5.9	5.7	1.4	6.4	7.6	6.5	8.3	19.6	6.9	2.8	24.0	5.2	7.4	3.1	4.1	12.7	8.1	4.2	4.2	10.4	50.0	6.0	11.4	4.7	3.9	5.0	5.5	4.2	18.2	5.0	6.6	5.3	10.1	17.4	10.3	5.6	8.2	4.0	62.9	4.5	5.1	11.6	4.8	9.3	3.7	11.8	6.8	3.0	6.9	6.1	4.7	9.1	10.4	22.6	15.9	5.6	11.2	7.4	0.0	2.0	0.0	5.5	4.5	1.8	0.1	2.0	11.1	2.2	3.2	0.1	4.7	3.8	3.7	2.8	0.4	2.5	1.0	3.3	2.8	4.9	2.5	0.0	0.0	8.4	0.0	3.3	7.2	2.1	3.3	5.4	4.0	2.7	0.0	10.5	2.0	6.2	0.4	0.2	1.7	2.6	9.9	0.1	20.4	0.6	0.9	0.3	0.0	10.1	4.0	15.0	3.3	1.5	1.1	2.1	0.3	11.7	3.1	1.5	0.5	0.6	0.0	2.0	22.6	8.0	3.0	9.8	11.5	8.4	6.6	7.9	9.6	10.4	9.1	11.2	10.6	8.2	5.6	15.9	9.7	9.2	7.4	3.8	5.7	7.6	6.5	4.2	4.2	4.7	3.9	6.6	3.7
SLC49A3	"FLJ22269, LP2561, MFSD7"	ENSG00000169026	"Solute carrier family 49 member 3"	Q6UXD7	4	681829-689441	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.3;SK-BR-3: 7.2;T-47d: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043593	Uncertain									"HPA043593: AB_10959611"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.08e-1)"	"prognostic favourable (2.66e-5)"	"unprognostic (8.35e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.11e-1)"	13.8	3.3	4.8	5.4	3.1	3.8	13.9	4.6	4.5	4.7	6.5	1.7	4.1	7.4	4.2	10.0	7.5	3.5	5.0	8.9	1.8	1.5	7.7	8.8	17.6	9.2	2.4	2.4	2.8	8.7	11.1	2.4	4.1	3.6	5.3	2.8	7.4	10.6	2.8	2.9	9.6	7.2	4.2	3.0	9.7	9.8	23.6	2.2	2.2	9.2	4.6	2.8	4.9	5.2	0.0	0.6	4.2	1.8	1.2	0.3	0.9	0.1	0.1	2.4	1.7	1.6	3.8	7.3	0.8	0.0	0.8	0.5	0.4	4.9	0.1	0.1	3.8	0.2	0.0	0.0	0.2	0.5	0.4	1.4	0.6	0.2	0.6	0.0	1.0	2.3	0.0	3.1	0.0	1.1	0.3	0.5	0.0	0.1	0.1	0.5	0.2	0.3	0.0	0.3	0.5	0.0	0.3	0.8	0.6	0.0	7.2	0.4	22.6	1.4	0.3	0.7	0.2	0.3	0.2	2.5	1.3	0.1	0.2	0.6	0.0	0.0	1.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.2	1.2	0.7	0.0	0.3	0.9	4.8	3.1	4.6	4.5	1.8	1.5	2.4	2.4	3.6	2.2
SLC4A10	"NBCn2, NCBE"	ENSG00000144290	"Solute carrier family 4 member 10"	Q6U841	2	161424332-161985282	"Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"blood: 31.2;brain: 48.1"	"Cell line enriched"	"Detected in some"	11	"Karpas-707: 13.7"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"MAIT T-cell: 31.2"	"Lineage enriched"	"Detected in single"	78	"T-cells: 31.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034755	Supported									"HPA034755: AB_10670296"	"unprognostic (4.64e-4)"	"unprognostic (3.88e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.89e-3)"	"unprognostic (5.99e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.26e-1)"	1.0	3.7	21.6	1.9	24.1	1.2	1.3	14.9	48.1	1.1	3.3	2.1	0.0	1.4	1.0	2.8	1.0	1.8	1.5	1.0	20.4	10.8	1.0	1.3	1.1	1.1	4.3	29.6	1.0	2.9	1.0	4.4	1.0	17.7	1.3	2.7	1.7	1.0	1.1	1.0	1.0	1.5	1.1	1.9	3.0	1.3	1.4	3.5	0.0	1.0	0.0	1.5	1.3	0.3	0.0	0.0	0.0	0.0	0.4	31.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	1.2	0.0	31.2	0.0	0.6	3.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	21.6	24.1	14.9	37.9	20.4	10.8	4.3	29.6	17.7	3.5
SLC4A3	"AE3, SLC2C"	ENSG00000114923	"Solute carrier family 4 member 3"	P48751	2	219627327-219641980	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 103.6;ovary: 30.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	36	"myeloid DC: 2.3;plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in single"	58	"dendritic cells: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063498			Approved	Nucleoplasm				Nucleoplasm		"HPA063498: "	"unprognostic (9.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (8.92e-4)"	"unprognostic (1.77e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.15e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (4.12e-4)"	1.8	5.4	11.8	1.6	22.5	1.2	2.0	8.8	22.0	2.8	1.3	3.0	0.4	1.4	3.4	2.6	2.9	2.7	2.3	103.6	10.4	8.2	1.6	1.0	1.3	1.4	6.5	9.0	30.2	2.7	4.5	9.9	2.5	24.1	4.2	1.1	4.9	3.1	4.3	1.2	1.6	1.3	3.1	1.6	2.6	1.4	4.2	3.5	0.0	1.5	0.0	1.3	1.6	0.9	0.0	8.9	0.0	0.1	0.0	0.0	0.0	6.8	0.3	2.5	7.1	0.4	0.5	4.9	4.3	4.5	5.8	4.1	5.0	4.0	0.0	1.7	1.6	4.0	1.2	7.7	1.7	0.0	1.1	0.0	0.0	0.1	1.2	0.1	0.4	3.4	7.4	0.0	2.3	0.0	0.2	0.0	1.7	2.3	0.0	0.0	4.0	5.8	0.0	0.0	0.0	4.0	1.6	1.5	7.0	2.7	7.5	3.7	0.7	1.8	0.0	3.6	6.3	0.0	3.4	0.0	0.0	0.0	3.0	0.0	9.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	11.8	22.5	8.8	22.0	10.4	8.2	6.5	9.0	24.1	3.5
SLC4A5	NBC4	ENSG00000188687	"Solute carrier family 4 member 5"	Q9BY07	2	74216242-74343414	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Anion exchange, Ion transport, Sodium transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 109.1"	"Cell line enhanced"	"Detected in many"		"U-266/70: 14.2"	"Cancer enriched"	"Detected in single"	11	"thyroid cancer: 3.3"	"Group enriched"	"Detected in many"	5	"cerebellum: 3.4;pons and medulla: 9.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA036621	Uncertain									"HPA036621: AB_10696779"	"unprognostic (1.30e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.83e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.56e-3)"	"unprognostic (5.37e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.72e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.27e-4)"	1.2	0.4	1.0	0.8	0.8	1.6	1.1	3.4	1.2	0.7	0.8	2.5	0.6	0.3	0.9	1.7	0.6	1.4	0.8	0.7	1.2	1.0	0.7	3.2	1.7	1.0	1.0	0.6	1.3	0.9	1.5	2.3	0.6	9.0	0.9	0.3	109.1	1.3	0.8	1.1	3.7	0.7	0.9	1.6	0.7	0.5	16.1	0.7	1.0	21.4	0.6	0.7	0.9	0.9	2.5	5.8	6.1	0.9	1.7	2.5	0.6	0.4	0.8	1.4	1.4	1.5	2.5	1.8	0.4	1.3	0.8	1.2	0.4	1.0	2.1	0.4	0.0	0.1	1.5	0.2	0.3	1.8	0.9	3.2	1.4	0.8	0.2	1.1	2.3	0.7	1.9	0.1	0.3	0.5	0.7	2.3	0.3	5.1	0.5	2.2	1.1	0.3	1.1	1.3	0.0	0.3	1.0	1.0	2.0	0.5	1.7	2.3	1.6	2.2	0.0	1.5	2.4	1.5	0.5	14.2	2.0	1.6	0.9	1.2	0.3	6.1	0.9	0.9	1.5	0.8	1.0	1.8	2.3	2.0	0.6	2.5	2.1	2.5	4.2	1.7	0.3	5.8	2.4	0.6	1.0	0.8	3.4	1.2	1.2	1.0	1.0	0.6	9.0	0.7
SLC4A9	AE4	ENSG00000113073	"Solute carrier family 4 member 9"	Q96Q91	5	140360202-140375143	"Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"kidney: 26.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;Karpas-707: 1.0;U-266/70: 1.2;U-698: 2.6"	"Cancer enriched"	"Detected in single"	8	"renal cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.0"	"Low region specificity"	"Detected in all"			HPA051307	Uncertain									"HPA051307: "	"unprognostic (1.68e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.82e-2)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	26.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.1	0.0	0.5	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.7	0.2	0.3	0.0	0.8	0.1	0.3	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	1.0	0.0	0.5	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.1	0.3	0.1	0.0	1.2	0.6	2.6	0.0	0.1	0.3	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.1	0.2	0.1	0.4	0.0	0.0	0.0
SLC50A1	"HsSWEET1, RAG1AP1, RP11-540D14.5, RZPDo834D038D, SCP, slv, SWEET1"	ENSG00000169241	"Solute carrier family 50 member 1"	Q9BRV3	1	155135344-155138857	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018095	Approved									"HPA018095: AB_1856048"	"unprognostic (4.75e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (3.88e-7)"	"unprognostic (4.36e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.50e-3)"	"unprognostic (4.39e-2)"	11.6	23.4	4.9	16.3	5.7	7.2	13.6	4.2	6.7	13.6	19.8	5.6	28.7	17.2	11.5	49.0	20.3	10.0	21.3	7.5	5.1	7.0	23.8	34.5	22.8	24.3	5.3	4.3	13.6	55.3	12.7	10.3	19.5	6.2	14.4	25.0	11.3	37.5	17.2	4.5	15.9	28.6	9.8	6.1	27.0	19.9	9.3	6.7	12.8	23.4	15.9	25.0	12.4	10.2	32.2	15.3	12.0	18.2	24.0	14.7	15.3	15.6	4.8	5.1	9.3	13.6	13.0	10.6	6.1	16.0	10.4	14.0	8.5	54.2	11.1	16.9	9.0	22.4	7.1	18.6	8.1	19.4	2.4	9.1	4.6	5.4	21.0	6.0	12.4	14.2	42.3	12.3	30.5	9.3	10.0	17.1	10.0	15.4	4.4	8.7	6.9	16.1	8.5	3.0	33.3	21.1	4.5	9.1	6.8	10.3	21.1	16.7	43.9	8.7	5.3	6.9	6.1	9.0	3.1	19.4	11.5	9.7	11.2	13.8	6.8	11.3	12.9	12.0	10.4	18.2	12.6	27.1	13.6	12.2	15.3	32.2	14.7	12.9	5.8	24.0	16.8	14.9	13.7	15.3	4.9	5.7	4.2	6.7	5.1	7.0	5.3	4.3	6.2	6.7
SLC51A	OSTalpha	ENSG00000163959	"Solute carrier family 51 alpha subunit"	Q86UW1	3	196211487-196243178	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"intestine: 53.9;liver: 59.5"	"Cell line enhanced"	"Detected in many"		"REH: 7.9"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 15.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.7;neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039123	Enhanced									"HPA039123: AB_10672770"	"unprognostic (1.63e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.40e-2)"	"prognostic favourable (7.54e-4)"	"unprognostic (5.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.98e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-5)"	0.5	2.3	0.3	3.8	0.3	2.4	0.4	0.3	0.4	0.5	12.3	0.4	0.7	13.6	0.4	2.8	0.5	0.5	0.5	0.5	0.3	0.1	2.2	59.5	0.8	0.3	0.3	0.3	0.6	0.3	1.4	0.5	0.3	0.3	0.5	0.1	0.3	0.6	0.3	0.5	1.0	53.9	0.3	0.3	0.8	0.2	1.8	0.3	0.6	0.8	0.3	0.5	0.3	0.7	0.2	0.0	1.7	0.6	0.4	0.6	0.1	1.0	1.6	1.4	1.7	0.0	1.0	0.1	0.8	0.0	0.1	0.0	0.7	0.4	0.1	1.9	1.1	0.9	0.2	0.0	0.0	0.7	2.8	1.0	0.8	1.7	0.2	1.4	1.4	0.3	0.0	0.2	1.3	0.2	0.2	3.3	0.0	0.6	0.1	1.2	0.1	2.0	7.9	0.1	0.5	0.0	0.9	0.3	0.5	0.5	3.2	0.3	2.3	0.5	0.5	1.6	0.7	1.3	0.9	3.3	4.0	0.6	1.1	0.6	0.6	0.0	0.2	1.7	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.6	1.6	0.4	0.5	0.0	0.1	0.1	0.3	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.3	0.3
SLC51B	OSTbeta	ENSG00000186198	"Solute carrier family 51 beta subunit"	Q86UW2	15	65045370-65053396	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 85.0"	"Group enriched"	"Detected in some"	10	"CACO-2: 16.5;EFO-21: 11.1;Hep G2: 13.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008398, HPA008533"	Enhanced		Approved	Vesicles,Mitochondria				Mitochondria	Vesicles	"HPA008398: , HPA008533: AB_1854824"	"unprognostic (6.18e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.49e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.34e-2)"	"prognostic favourable (8.46e-5)"	"unprognostic (5.87e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-2)"	0.4	0.5	0.4	3.8	0.6	0.0	0.4	0.4	0.8	14.0	34.9	0.4	0.4	28.1	0.9	3.3	0.4	1.0	0.5	0.4	0.5	0.6	7.5	2.4	1.6	0.4	0.6	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.8	9.5	0.4	0.4	0.8	0.4	0.1	85.0	0.4	0.4	0.4	0.2	4.1	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.0	0.0	0.7	0.1	0.0	0.5	0.3	0.0	1.4	0.2	0.7	0.0	0.1	0.4	0.0	0.0	0.2	0.0	16.5	0.0	0.1	11.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	13.8	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.3	0.4	0.4	0.0	0.0	0.8	0.4	0.0	0.6	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.5	0.0	0.3	0.2	0.0	0.0	0.1	0.3	0.7	0.0	0.1	0.0	0.0	0.3	0.4	0.6	0.4	0.4	0.5	0.6	0.6	0.4	0.4	0.4
SLC5A12	"MGC52019, SMCT2"	ENSG00000148942	"Solute carrier family 5 member 12"	Q1EHB4	11	26667019-26723427	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 60.8;kidney: 90.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.1;NTERA-2: 4.4;T-47d: 3.3;U-266/70: 2.7"	"Cancer enriched"	"Detected in single"	26	"renal cancer: 9.0"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA060904	Enhanced									"HPA060904: "	"unprognostic (3.69e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.21e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.1	0.0	11.3	0.0	0.2	1.7	0.0	18.5	0.0	0.0	0.0	3.4	0.1	0.1	90.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.8	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.8	1.0	0.7	0.9	0.7	0.1	0.5	0.1	0.3	0.7	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.7	0.3	0.7	1.0	0.3	0.3	0.2	0.1	0.1	0.0	0.0	0.1	0.9	0.2	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.5	6.1	0.1	0.3	0.2	0.6	4.4	0.1	0.1	0.0	0.7	0.1	1.3	2.3	0.4	2.0	0.3	0.0	3.3	0.6	0.7	0.5	0.2	0.5	0.3	2.7	0.8	0.3	0.3	0.1	0.0	1.0	0.5	0.1	0.6	0.7	0.4	1.1	0.4	0.4	0.5	1.5	0.7	0.6	0.4	0.9	0.6	0.8	0.1	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SLC5A6	SMVT	ENSG00000138074	"Solute carrier family 5 member 6"	Q9Y289	2	27199587-27212958	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.0;placenta: 51.7"	"Cell line enhanced"	"Detected in all"		"BEWO: 68.0;SK-BR-3: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036958	Approved		Approved	"Cell Junctions"				"Cell Junctions"		"HPA036958: AB_10672343"	"unprognostic (5.85e-2)"	"unprognostic (8.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.61e-3)"	"unprognostic (9.38e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (7.92e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.46e-2)"	"prognostic unfavourable (3.60e-7)"	"unprognostic (2.40e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.56e-3)"	"unprognostic (4.18e-2)"	20.9	4.6	5.0	7.6	8.5	8.5	15.9	7.9	8.1	4.0	6.4	5.6	6.4	10.9	7.4	36.7	5.5	5.9	6.3	3.5	5.3	5.7	5.9	64.0	6.0	6.4	7.0	8.1	5.6	6.0	4.5	4.2	51.7	7.1	4.8	6.6	5.6	6.7	10.6	7.9	4.6	7.6	4.9	4.4	4.8	4.8	17.5	6.1	5.8	5.1	4.3	13.0	4.6	10.1	6.8	10.0	2.0	9.0	6.3	10.4	5.8	16.4	17.0	10.9	14.3	10.1	3.7	68.0	6.0	4.1	9.1	6.3	25.1	5.9	11.4	9.1	3.2	9.2	23.3	6.9	6.4	8.8	13.7	20.2	7.3	38.4	12.0	25.9	10.6	12.7	5.9	11.2	8.7	8.2	29.5	4.7	5.8	33.8	8.8	12.6	31.4	6.2	14.8	12.8	16.5	5.2	15.8	9.2	13.6	6.5	73.1	8.6	16.2	5.6	3.7	10.1	13.8	6.1	16.0	7.9	18.0	18.1	5.5	18.2	14.1	0.1	6.5	2.0	8.5	7.3	10.4	6.8	8.3	8.2	9.7	6.7	8.5	10.1	0.3	6.3	9.0	10.0	8.2	5.8	5.0	8.5	7.9	8.1	5.3	5.7	7.0	8.1	7.1	6.1
SLC6A11	GAT3	ENSG00000132164	"Solute carrier family 6 member 11"	P48066	3	10816200-10940733	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 37.0;esophagus: 10.5;skin 1: 11.5"	"Cell line enhanced"	"Detected in some"		"A-431: 4.6;HaCaT: 12.4;Hep G2: 14.3;hTCEpi: 11.2;NTERA-2: 6.3;T-47d: 4.7"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037981	Supported	Supported	Uncertain	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA037981: AB_10671383"	"unprognostic (6.04e-2)"	"unprognostic (8.01e-2)"		"unprognostic (1.21e-7)"	"unprognostic (8.60e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.39e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.51e-3)"	"unprognostic (6.06e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.31e-2)"	0.8	0.8	11.5	0.7	14.1	0.8	2.9	3.1	23.0	0.9	0.8	5.0	0.0	0.7	1.7	1.1	10.5	1.8	0.7	0.8	8.4	24.5	0.7	0.9	0.8	0.7	37.0	5.9	0.8	1.0	0.7	0.2	1.6	35.4	2.3	0.8	0.4	1.1	0.7	1.0	11.5	0.8	1.0	10.4	1.5	0.7	3.4	9.2	0.0	0.8	0.2	1.1	1.3	0.7	0.5	0.3	1.2	0.4	0.2	0.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	2.0	0.0	0.0	0.2	0.2	0.0	14.3	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	2.8	1.8	4.3	3.6	0.1	0.0	4.7	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.3	0.2	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.5	0.2	0.2	1.2	0.2	0.4	0.3	0.3	0.0	11.5	14.1	3.1	14.7	8.4	24.5	37.0	5.9	35.4	9.2
SLC6A14		ENSG00000268104	"Solute carrier family 6 member 14"	Q9UN76	X	116436622-116461458	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		Obesity	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 17.8;pituitary gland: 14.4;salivary gland: 26.3;tongue: 23.5"	"Group enriched"	"Detected in some"	4	"HeLa: 3.8;Hep G2: 8.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003193	Uncertain		Approved	Vesicles				Vesicles		"HPA003193: AB_2190122"	"unprognostic (3.06e-2)"	"unprognostic (3.55e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.83e-2)"	"prognostic unfavourable (9.74e-4)"	"unprognostic (1.34e-2)"		"unprognostic (3.89e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	5.9	0.0	0.0	6.3	0.8	0.0	11.8	0.4	0.1	0.0	1.8	0.0	1.0	0.0	0.0		0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.2	0.5	0.3	0.0	26.3	5.8	0.0	1.1	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	23.5	1.2	1.0	1.0	0.4	0.2	1.1	0.4	0.3	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	3.8	8.2	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.2	0.0	1.4	0.5	0.0	0.0	0.1	0.0	1.1	0.4	0.5	0.4	0.1	0.3	0.4	0.2	0.2	0.1	0.4	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.0										
SLC6A16	NTT5	ENSG00000063127	"Solute carrier family 6 member 16"	Q9GZN6	19	49289638-49325225	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"testis: 102.2"	"Cell line enhanced"	"Detected in many"		"AF22: 17.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA076812			Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA076812: "	"unprognostic (1.98e-1)"	"unprognostic (7.15e-3)"	"unprognostic (6.39e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.83e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.93e-2)"	"unprognostic (4.18e-2)"	1.5	0.4	0.8	1.1	0.9	1.9	1.0	0.8	0.8	1.3	1.1	0.8	0.8	0.3	1.5	1.0	0.8	2.0	1.0	0.8	0.8	0.3	2.0	3.6	1.6	3.1	0.8	0.8	2.9	2.6	0.7	0.8	1.3	0.8	1.8	0.3	0.9	0.8	1.2	0.8	0.7	1.2	0.8	0.8	1.7	1.0	102.2	0.8	0.8	1.1	0.8	2.4	0.8	1.2	7.8	2.1	4.8	3.7	3.8	3.1	2.2	0.0	6.9	17.5	6.3	0.3	2.8	3.2	0.9	1.4	0.6	1.9	0.4	0.6	8.1	1.1	0.7	0.3	1.9	0.3	2.1	1.3	2.0	0.7	0.7	1.5	1.3	0.5	2.9	2.8	1.1	1.3	1.0	1.5	1.5	1.1	2.2	1.5	0.4	0.5	6.2	0.9	0.3	4.2	1.5	0.9	0.0	0.2	0.4	2.7	0.1	0.6	2.8	0.2	8.7	1.4	6.6	4.1	0.0	3.9	4.1	7.3	0.1	1.9	0.4	0.4	0.8	4.8	3.1	2.2	3.0	7.8	1.1	3.1	0.8	4.5	2.7	1.8	4.0	3.8	3.7	2.1	1.7	2.2	0.8	0.9	0.8	0.8	0.8	0.3	0.8	0.8	0.8	0.8
SLC6A18	"FLJ31236, Xtrp2"	ENSG00000164363	"Solute carrier family 6 member 18"	Q96N87	5	1225355-1246189	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	32	"kidney: 14.1"	"Cell line enhanced"	"Detected in single"		"MCF7: 1.2"	"Cancer enriched"	"Detected in single"	44	"renal cancer: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011885	Enhanced									"HPA011885: AB_1857198"			"unprognostic (2.02e-1)"										"unprognostic (5.69e-3)"	"unprognostic (2.90e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.4	0.6	0.0	0.0	0.6	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC6A7	PROT	ENSG00000011083	"Solute carrier family 6 member 7"	Q99884	5	150189957-150222788	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 40.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.9;SK-BR-3: 1.5;U-87 MG: 1.1"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028907	Uncertain									"HPA028907: AB_10602404"	"unprognostic (3.01e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.82e-4)"	"unprognostic (6.42e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.50e-1)"	"unprognostic (3.73e-4)"	"unprognostic (8.11e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.70e-3)"	0.5	0.4	3.9	1.0	9.7	0.4	0.5	40.2	22.4	0.6	5.7	0.3	0.0	2.6	0.5	0.6	0.4	0.4	0.5	0.5	6.5	4.5	0.4	0.4	0.5	0.7	1.3	14.5	0.4	0.5	0.4	0.2	0.4	1.6	0.4	7.7	0.0	0.8	0.4	0.5	0.5	4.9	0.7	1.4	0.4	0.4	0.5	0.0	0.0	0.4	0.0	0.7	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	9.7	40.2	22.4	6.5	4.5	1.3	14.5	1.6	0.0
SLC7A10	asc-1	ENSG00000130876	"Solute carrier family 7 member 10"	Q9NS82	19	33208664-33225850	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.9;brain: 13.6;breast: 15.6"	"Group enriched"	"Detected in some"	5	"BEWO: 4.2;HHSteC: 2.5;HSkMC: 3.6;THP-1: 8.2;U-2 OS: 2.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041884, HPA057036"	Uncertain		Uncertain	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA041884: AB_10794494, HPA057036: "	"unprognostic (1.85e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-3)"	"unprognostic (8.91e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.18e-2)"	40.9	1.0	9.8	1.9	13.6	1.0	15.6	2.4	12.1	1.0	2.2	0.8	0.0	1.0	1.0	1.0	1.0	1.0	1.0	1.1	4.7	6.2	1.3	1.0	1.0	1.2	7.6	5.0	1.0	1.2	1.0	0.0	1.2	9.0	1.0	1.0	8.4	2.3	1.0	1.0	1.1	1.0	1.1	0.8	1.0	1.0	1.4	1.8	0.0	1.4	0.0	1.4	1.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.2	8.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	9.8	13.6	2.4	12.1	4.7	6.2	7.6	5.0	9.0	1.8
SLC7A14	"KIAA1613, PPP1R142"	ENSG00000013293	"Solute carrier family 7 member 14"	Q8TBB6	3	170459584-170586074	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.4;pituitary gland: 14.5"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 7.0;SCLC-21H: 7.0"	"Group enriched"	"Detected in some"	11	"glioma: 0.8;pancreatic cancer: 0.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045929	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA045929: "	"unprognostic (1.00e-1)"		"unprognostic (9.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.68e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.03e-6)"	"unprognostic (1.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.24e-3)"	1.1	5.8	12.1	1.9	17.7	1.4	1.1	14.9	33.4	1.0	1.8	8.0	0.0	1.6	1.1	1.2	1.1	1.1	1.3	1.1	11.5	12.1	1.3	1.2	1.1	1.1	6.7	12.8	1.3	2.4	1.1	14.5	1.1	11.8	1.2	1.9	0.1	1.1	1.1	1.2	1.3	1.7	1.3	9.0	1.1	1.5	1.3	6.3	0.0	1.1	0.0	1.1	1.1	0.3	1.0	0.6	2.1	0.5	0.7	0.6	0.1	0.0	0.0	0.4	0.1	1.2	2.0	0.1	0.6	0.2	0.8	0.8	0.1	0.1	0.1	0.0	0.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	1.8	0.0	0.1	1.2	0.2	0.0	0.2	7.0	0.0	0.0	0.2	0.9	0.1	0.1	0.0	0.1	0.0	0.1	7.0	2.0	0.0	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	2.1	0.5	0.5	0.4	0.3	0.3	0.8	0.3	0.3	0.1	1.0	0.6	0.5	1.2	0.7	0.3	0.6	0.3	0.1	12.1	17.7	14.9	16.9	11.5	12.1	6.7	12.8	11.8	6.3
SLC7A4	"CAT-4, HCAT3, VH"	ENSG00000099960	"Solute carrier family 7 member 4"	O43246	22	21028718-21032840	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 19.6;testis: 29.1"	"Cell line enriched"	"Detected in some"	21	"BEWO: 55.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.4;naive CD8 T-cell: 2.4"	"Group enriched"	"Detected in many"	18	"NK-cells: 1.0;T-cells: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA031023	Enhanced									"HPA031023: AB_10669669"	"unprognostic (1.02e-3)"	"unprognostic (4.34e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.69e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.00e-3)"	2.7	3.5	2.2	0.4	3.8	0.1	2.6	6.0	5.9	2.8	1.8	0.4	1.4	1.7	1.5	0.7	8.5	1.6	4.1	1.2	2.7	7.1	0.2	0.3	1.4	1.2	2.4	4.3	0.3	0.4	0.1	5.1	19.6	2.4	4.1	1.4	3.3	4.3	5.3	0.6	1.9	2.0	0.6	0.6	0.9	2.4	29.1	0.4	0.2	0.1	1.3	2.1	2.4	0.7	0.0	0.0	0.0	0.0	1.0	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	55.9	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.4	0.0	0.2	1.2	0.0	0.0	0.1	2.4	0.0	1.0	0.0	0.0	0.0	0.8	2.2	3.8	6.0	5.9	2.7	7.1	2.4	4.3	2.4	0.4
SLC8A2	"KIAA1087, NCX2"	ENSG00000118160	"Solute carrier family 8 member A2"	Q9UPR5	19	47428017-47472168	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 50.9"	"Group enriched"	"Detected in some"	6	"NTERA-2: 4.3;SCLC-21H: 12.2;SH-SY5Y: 6.6;SiHa: 5.1;U-2 OS: 7.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"amygdala: 80.3;basal ganglia: 95.4;cerebral cortex: 125.2;hippocampal formation: 110.1"	"Low region specificity"	"Detected in all"			"HPA050818, HPA054671"	Enhanced									"HPA050818: AB_2681248, HPA054671: AB_2682568"	"unprognostic (3.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.95e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.63e-2)"	1.2	4.0	16.6	1.0	18.1	0.9	0.9	50.9	50.7	1.0	2.4	1.8	1.0	1.3	5.4	1.0	2.3	2.2	1.1	0.9	21.4	6.8	1.0	0.9	0.9	0.9	2.1	21.1	0.9	10.3	0.9	3.2	1.0	2.0	1.4	1.4	0.0	1.2	4.4	0.9	1.0	1.2	5.5	2.0	1.0	1.3	1.9	1.2	0.0	1.0	0.0	0.9	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.4	0.1	12.2	6.6	5.1	0.6	0.4	0.1	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	18.1	50.9	34.6	21.4	6.8	2.1	21.1	2.0	1.2
SLC9A2	NHE2	ENSG00000115616	"Solute carrier family 9 member A2"	Q9UBY0	2	102619707-102711318	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 16.8;intestine: 16.1;stomach 1: 19.8"	"Cell line enhanced"	"Detected in some"		"A-431: 8.1;CACO-2: 5.6;MCF7: 6.3;RT4: 14.2;SK-BR-3: 12.6;T-47d: 15.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035121, HPA035122"	Approved		Supported	"Cell Junctions"				"Cell Junctions"		"HPA035121: AB_10602894, HPA035122: "	"unprognostic (1.53e-2)"	"unprognostic (8.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-1)"	0.2	0.4	0.9	10.8	1.4	0.0	1.0	0.5	1.9	1.0	15.0	0.6	8.4	4.6	0.2	5.8	0.5	0.2	16.8	0.2	1.5	1.0	4.6	0.2	0.2	0.0	0.9	0.7	0.2	0.2	0.1	1.7	0.0	1.8	4.5	16.1	0.9	3.7	11.7	4.4	1.3	9.5	0.4	1.3	0.2	19.8	5.3	0.6	1.0	0.6	1.8	3.1	2.8	0.2	0.0	0.0	0.3	0.0	0.3	0.1	0.0	8.1	5.1	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.2	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.8	2.5	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	6.3	0.0	0.1	0.2	4.3	0.0	0.0	0.0	1.0	14.2	0.0	0.0	0.0	12.6	0.0	15.8	0.0	0.0	0.0	0.6	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.9	1.4	0.5	1.9	1.5	1.0	0.9	0.7	1.8	0.6
SLC9A4	NHE4	ENSG00000180251	"Solute carrier family 9 member A4"	Q6AI14	2	102473303-102533972	"Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"gallbladder: 23.2;kidney: 12.3;stomach 1: 33.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.0;HDLM-2: 5.0;RT4: 8.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	18	"hippocampal formation: 11.6;olfactory region: 8.3"	"Region enriched"	"Detected in single"	5	"olfactory region: 1.7"	HPA036096	Supported		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA036096: "	"unprognostic (1.41e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.09e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.46e-1)"		"unprognostic (7.17e-2)"	"unprognostic (5.35e-1)"	"unprognostic (9.44e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.12e-1)"	"unprognostic (5.04e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-2)"	0.0	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.3	0.0	1.1	0.1	0.0	1.3	0.1	23.2	0.2	0.1	0.1	12.3	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.0	3.7	2.4	0.7	0.2	0.2	0.0	0.1	0.1	33.9	0.3	0.0	0.2	0.1	0.5	0.4	0.6	0.2	1.5	0.9	1.8	0.8	1.2	1.2	0.1	0.2	0.3	0.3	0.8	0.0	0.1	0.1	0.3	0.0	0.0	0.0	1.4	0.5	0.2	3.0	0.0	0.4	0.0	0.0	0.0	5.0	0.2	0.3	0.5	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.3	1.1	0.0	0.5	0.1	0.2	1.4	0.6	0.2	0.6	0.4	0.0	8.9	0.2	0.3	0.2	0.5	0.1	0.2	0.2	0.6	0.6	1.4	0.9	0.3	0.3	0.2	0.1	0.7	0.2	0.1	1.6	0.7	1.1	1.2	0.6	0.8	0.8	0.9	0.9	0.5	1.5	1.0	1.2	1.8	1.2	0.8	0.9	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
SLC9B1	"NHA1, NHEDC1"	ENSG00000164037	"Solute carrier family 9 member B1"	Q4ZJI4	4	102885048-103019739	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Fertilization, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 43.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.0;dendritic cells: 1.9;T-cells: 4.9"	"Not detected"	"Not detected"							"HPA058971, HPA065520"			Supported	"Centriolar satellite,Mitochondria"				Mitochondria	"Centriolar satellite"	"HPA058971: , HPA065520: "	"unprognostic (4.87e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.26e-4)"	"unprognostic (2.53e-1)"	"unprognostic (3.39e-1)"	"unprognostic (5.06e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.07e-3)"	"unprognostic (7.68e-2)"	"unprognostic (3.03e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.66e-5)"	"unprognostic (5.78e-2)"	1.1	1.1	1.1	1.1	3.1	0.9	0.9	1.4	2.0	0.9	0.8	3.7	0.0	0.8	2.6	2.3	0.7	0.9	1.6	0.9	1.6	1.0	0.8	0.7	1.1	2.4	2.4	1.1	1.5	1.3	1.2	2.4	0.9	3.1	1.1	0.8	2.8	0.7	0.9	0.7	1.9	0.8	0.7	4.4	1.0	0.8	43.1	2.3	4.2	1.1	0.0	1.7	1.2	0.9	2.0	1.9	0.6	0.6	0.4	4.9	0.6	0.4	0.0	2.2	3.3	4.5	3.3	0.7	0.8	1.1	0.0	0.2	0.0	0.2	1.7	0.6	1.7	0.0	1.7	0.9	1.5	3.2	2.3	2.5	2.0	0.0	0.0	0.7	0.5	0.5	1.0	0.0	1.8	1.3	1.2	1.7	1.7	1.3	1.0	2.2	0.8	0.0	2.7	1.8	0.5	0.9	0.5	2.1	5.0	0.6	0.8	2.5	0.4	1.7	0.7	0.9	0.3	1.0	1.1	5.5	4.0	1.4	1.2	1.0	2.4	0.6	0.6	0.1	1.5	0.4	1.7	1.8	1.2	1.8	0.7	2.0	4.9	2.8	0.3	0.4	0.3	1.9	1.7	0.6	1.1	3.1	1.4	2.0	1.6	1.0	2.4	1.1	3.1	2.3
SLCO1A2	"OATP, OATP-A, OATP1A2, SLC21A3"	ENSG00000084453	"Solute carrier organic anion transporter family member 1A2"	P46721	12	21264600-21419594	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 13.7;RPMI-8226: 9.5;U-266/70: 20.5;U-266/84: 8.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA071152			Supported	"Plasma membrane"				"Plasma membrane"		"HPA071152: "	"unprognostic (5.43e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.52e-2)"	"unprognostic (3.20e-1)"		"unprognostic (1.24e-1)"	0.2	0.1	3.3	0.0	3.4	0.0	3.6	3.4	17.9	0.1	0.1	1.9	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.9	4.1	2.5	1.1	11.2	2.7	0.6	3.0	4.0	0.2	2.3	0.5	0.5	1.2	9.7	0.7	0.0	14.2	14.5	0.0	0.4	0.4	0.2	0.0	2.9	0.4	0.4	1.6	1.4	0.0	0.3	0.0	0.3	0.4	0.1	1.3	0.7	4.3	0.4	1.1	2.3	0.2	2.1	0.5	0.8	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	3.0	1.7	0.1	2.1	0.1	0.2	0.2	0.1	0.4	0.5	0.7	0.0	0.5	1.1	0.0	0.3	0.2	0.0	1.4	0.1	0.1	0.1	3.5	1.4	0.0	2.1	0.3	0.1	13.7	0.1	0.1	0.2	9.5	0.0	2.1	1.9	2.3	0.0	0.2	0.2	2.7	0.7	0.0	0.0	1.4	0.7	0.3	20.5	8.2	0.1	0.2	0.2	0.1	0.6	0.4	0.3	1.4	0.3	2.3	1.3	2.2	1.5	0.1	1.0	2.1	1.6	4.3	1.1	0.1	0.7	1.8	0.2	3.3	3.4	3.4	5.0	4.1	2.5	3.0	4.0	9.7	1.4
SLCO5A1	"OATP-J, OATP5A1, OATPRP4, SLC21A15"	ENSG00000137571	"Solute carrier organic anion transporter family member 5A1"	Q9H2Y9	8	69667047-69835064	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 21.4;lymphoid tissue: 9.5;skeletal muscle: 13.9;tongue: 16.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.8;NTERA-2: 5.9;RPMI-8226: 5.5;SCLC-21H: 6.4;U-266/70: 3.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"basal ganglia: 2.3;olfactory region: 8.2"					HPA025062	Uncertain		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"HPA025062: AB_1857220"	"unprognostic (1.30e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.37e-4)"	"unprognostic (1.75e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-6)"	"unprognostic (2.20e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.50e-2)"	0.7	0.2	0.5	1.5	0.7	1.5	0.2	0.1	0.8	0.3	0.4	0.1	0.0	0.4	0.5	1.5	1.0	0.5	0.4	21.4	0.7	0.7	0.2	0.4	0.3	4.1	0.3	0.3	0.2	0.7	0.0	4.7	0.0	0.5	4.2	0.7	0.6	0.9	0.0	13.9	0.3	0.7	0.2	0.2	0.8	0.3	0.4	0.0	9.5	0.5	16.2	1.7	0.9	0.2	1.7	0.1	0.7	0.0	0.2	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	2.3	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.1	5.9	0.9	1.0	0.9	5.5	0.1	0.0	6.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.5	0.1	1.2	3.4	0.5	0.0	0.3	0.0	1.7	0.7	0.0	0.1	0.3	0.0	0.0	0.5	0.1	0.2	0.0	1.7	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.0	0.5	0.7	0.1	0.7	0.7	0.7	0.3	0.3	0.5	0.0
SLCO6A1	"CT48, MGC26949, OATP6A1, OATPY"	ENSG00000205359	"Solute carrier organic anion transporter family member 6A1"	Q86UG4	5	102371782-102499016	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	93	"testis: 39.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;SCLC-21H: 2.4;U-266/84: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Group enriched"	"Detected in many"	9	"amygdala: 0.9;basal ganglia: 1.1;cerebral cortex: 0.8;hippocampal formation: 2.1"	HPA054126	Enhanced									"HPA054126: "		"unprognostic (1.17e-1)"			"unprognostic (2.59e-1)"	"unprognostic (4.37e-2)"		"unprognostic (4.65e-1)"		"unprognostic (1.84e-1)"					"unprognostic (2.60e-2)"		"unprognostic (6.70e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.8	2.4	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLFN12	FLJ10260	ENSG00000172123	"Schlafen family member 12"	Q8IYM2	17	35411060-35433283	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 23.0"	"Low lineage specificity"	"Detected in all"											HPA022523	Uncertain									"HPA022523: "	"unprognostic (7.08e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.72e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.00e-1)"	"prognostic unfavourable (4.14e-5)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.05e-1)"	12.4	10.2	2.6	8.5	4.9	2.0	10.5	2.0	2.4	10.1	6.0	2.4	7.9	3.4	10.8	9.0	5.1	7.1	7.4	5.4	5.5	2.0	6.3	2.9	9.9	9.7	9.3	1.9	7.2	3.4	4.7	3.7	6.3	5.1	9.0	3.8	6.9	6.9	5.0	2.1	2.9	5.3	6.2	4.3	16.4	4.6	4.8	4.8	5.8	13.3	3.2	5.0	9.7	9.2	1.5	6.8	23.0	10.5	6.0	2.3	2.0	0.1	0.1	9.8	0.0	2.7	4.5	0.0	8.0	4.9	19.4	19.7	0.0	0.0	0.0	17.1	7.3	5.4	0.2	5.4	18.9	0.4	1.5	3.0	8.2	0.0	3.4	3.9	2.1	7.0	1.9	8.5	1.8	14.4	0.0	1.0	15.3	0.0	0.0	4.9	0.2	0.0	0.4	13.6	0.0	7.5	9.6	0.0	0.0	0.0	2.2	6.6	4.5	3.6	15.9	9.3	13.2	3.1	10.6	3.1	0.7	0.1	3.5	4.0	11.3	23.0	10.5	7.5	2.2	6.0	2.0	1.5	1.1	1.9	6.8	1.4	0.6	1.7	4.9	6.0	3.0	1.1	2.3	2.0	2.6	4.9	2.0	2.4	5.5	2.0	9.3	1.9	5.1	4.8
SLFN12L		ENSG00000205045	"Schlafen family member 12 like"	Q6IEE8	17	35464249-35537861	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 19.4;Karpas-707: 13.7;U-266/70: 4.9;U-266/84: 4.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdT-cell: 9.5;MAIT T-cell: 8.8;memory CD4 T-cell: 6.3;memory CD8 T-cell: 8.0;naive CD4 T-cell: 4.8;naive CD8 T-cell: 5.2;NK-cell: 6.8;T-reg: 4.7"	"Group enriched"	"Detected in many"	7	"NK-cells: 6.8;T-cells: 9.5"									HPA024447	Uncertain									"HPA024447: AB_1856614"	"unprognostic (1.93e-3)"	"unprognostic (2.10e-4)"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.18e-3)"	"unprognostic (2.98e-5)"	"unprognostic (4.59e-3)"	"unprognostic (2.75e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.67e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.25e-6)"	"unprognostic (2.30e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.02e-2)"	"unprognostic (8.88e-3)"	7.2	0.9	1.0	11.2	1.2	6.6	2.7	0.8	1.4	1.6	3.0	0.9	1.2	3.9	3.6	3.0	2.3	2.0	3.8	1.4	1.1	1.1	1.8	1.8	9.1	10.6	1.7	0.5	1.3	1.2	0.5	1.0	0.6	2.9	1.8	2.0	2.1	6.2	1.3	0.9	1.2	7.0	1.1	1.9	18.4	3.0	0.8	1.1	5.8	2.8	2.1	16.3	2.3	2.0	0.4	0.3	1.1	0.4	6.8	9.5	1.9	0.5	0.2	0.2	0.2	0.1	0.0	0.2	0.2	0.0	0.6	1.4	0.1	0.4	0.5	0.1	0.0	0.3	0.0	0.0	0.7	19.4	0.1	1.2	0.7	0.1	0.0	0.4	0.2	0.3	0.1	0.2	0.0	0.1	0.3	13.7	0.1	0.0	0.4	0.3	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.3	0.1	0.4	0.1	0.1	0.1	1.9	0.5	0.3	1.2	0.5	0.2	4.9	4.3	0.1	0.2	0.3	0.5	0.8	0.4	0.9	9.5	0.1	8.8	0.3	6.3	8.0	0.3	0.4	4.8	5.2	1.1	6.8	0.1	0.3	4.7	1.9	1.0	1.2	0.8	1.4	1.1	1.1	1.7	0.5	2.9	1.1
SLFN13	FLJ31952	ENSG00000154760	"Schlafen family member 13"	Q68D06	17	35435096-35448837	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 50.6"	"Cell line enhanced"	"Detected in many"		"HL-60: 46.0;REH: 26.4;U-266/70: 23.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.1"	"Low lineage specificity"	"Detected in many"											"HPA022532, HPA023064"	Uncertain		Approved	"Cytokinetic bridge"				"Cytokinetic bridge"		"HPA022532: AB_1856615, HPA023064: AB_1856616"	"unprognostic (1.11e-1)"	"prognostic favourable (3.82e-4)"	"unprognostic (4.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.06e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	3.0	1.0	1.1	6.4	1.7	11.8	4.8	0.5	1.0	5.2	6.5	2.6	4.8	4.0	5.6	6.0	6.5	12.4	6.1	1.8	1.3	0.7	5.1	1.7	5.2	4.8	0.9	0.5	2.7	2.0	14.3	3.2	1.2	2.0	2.4	3.1	0.9	50.6	2.0	1.4	1.5	5.7	1.8	1.5	11.3	5.7	1.5	1.1	24.8	12.7	5.4	12.9	2.0	2.0	1.4	0.4	6.5	0.5	8.1	1.9	0.5	0.0	2.5	5.0	0.0	0.1	0.5	0.0	0.6	0.1	2.4	3.9	0.0	0.0	0.0	14.4	0.4	4.2	0.5	1.7	2.8	1.3	0.8	13.1	2.2	0.0	0.2	46.0	0.3	0.1	0.2	1.3	0.0	0.8	0.0	13.4	0.0	0.0	0.3	9.9	2.5	0.0	26.4	0.1	1.3	4.2	12.1	0.0	0.0	0.0	2.3	0.1	3.5	7.4	0.1	0.0	0.7	3.7	0.2	23.3	3.2	0.0	0.0	7.4	0.3	5.0	0.4	6.5	1.9	0.5	1.5	1.4	0.9	1.0	0.4	1.3	0.8	0.6	1.4	8.1	0.2	0.1	0.7	0.5	1.1	1.7	0.5	1.0	1.3	0.7	0.9	0.5	2.0	1.1
SLFNL1	FLJ23878	ENSG00000171790	"Schlafen like 1"	Q499Z3	1	41015597-41023237	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 49.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054956			Approved	Cytosol				Cytosol		"HPA054956: "	"unprognostic (7.01e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.11e-4)"	"unprognostic (8.98e-3)"	"unprognostic (1.02e-3)"	"unprognostic (8.40e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.71e-4)"	"unprognostic (2.70e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.43e-1)"	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.4	0.3	0.2	0.4	0.2	0.2	0.2	0.5	2.6	0.2	0.5	0.2	0.2	0.2	0.0	0.2	0.8	1.9	0.2	0.2	0.2	0.6	0.3	0.1	0.3	0.2	0.2	0.6	0.0	0.2	3.4	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.1	49.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.4	1.3	0.0	0.0	0.7	0.0	1.0	1.6	0.7	1.1	0.0	0.3	4.9	2.1	0.1	0.0	0.1	10.0	1.0	1.8	1.8	0.1	1.7	0.1	0.0	0.0	1.3	3.0	1.3	2.4	1.3	0.7	1.9	1.2	0.2	0.2	0.1	0.0	0.2	1.1	2.2	0.1	0.8	1.1	2.0	1.8	2.6	2.5	1.3	1.0	0.0	2.7	1.3	0.5	0.4	0.9	0.8	0.6	1.1	0.8	2.0	2.4	1.0	1.4	1.1	0.6	2.2	0.3	2.1	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.2	0.4	0.3	0.2	0.0	0.2	0.2	0.2	0.2
SLIT1	"MEGF4, SLIL1, Slit-1, slit1, SLIT3"	ENSG00000187122	"Slit guidance ligand 1"	O75093	10	96998038-97185920	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 44.3"	"Cell line enriched"	"Detected in some"	15	"MOLT-4: 41.2"	"Group enriched"	"Detected in many"	10	"glioma: 9.2;prostate cancer: 2.2;thyroid cancer: 10.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.6;plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006879			Approved	"Plasma membrane"	"Secreted in brain"			"Plasma membrane"		"HPA006879: AB_1078197"	"unprognostic (2.72e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.43e-5)"	"unprognostic (8.40e-2)"	"unprognostic (2.60e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.66e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.39e-3)"	1.2	0.8	13.4	0.9	16.1	0.9	0.8	0.4	44.3	0.8	0.9	0.5	0.0	0.9	0.8	0.7	0.8	1.0	0.8	0.8	13.9	10.5	0.8	0.7	1.0	0.9	4.6	13.2	0.8	1.4	0.8	8.0	0.8	2.2	1.1	0.8	0.3	0.8	0.7	0.9	0.8	0.9	0.8	1.4	0.9	1.1	2.0	0.3	3.3	3.6	0.0	0.9	0.8	0.0	0.0	1.6	0.4	0.7	0.0	0.0	0.2	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	41.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.6	1.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.4	1.6	0.0	0.2	13.4	16.1	0.4	24.8	13.9	10.5	4.6	13.2	2.2	0.3
SLIT3	"MEGF5, SLIL2, Slit-3, SLIT1, slit2"	ENSG00000184347	"Slit guidance ligand 3"	O75094	5	168661733-169301129	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 79.7;fHDF/TERT166: 28.3;RT4: 24.7;SH-SY5Y: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"NK-cell: 4.1"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 4.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051630	Approved		Supported	"Cell Junctions"	"Secreted in other tissues"			"Cell Junctions"		"HPA051630: "	"unprognostic (2.86e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (2.45e-5)"	"unprognostic (5.90e-3)"	"unprognostic (8.56e-2)"	"unprognostic (4.27e-1)"	"unprognostic (3.53e-1)"	38.5	12.5	6.7	6.3	7.9	0.2	31.8	20.3	10.8	28.0	13.2	1.8	13.0	3.2	21.6	22.4	18.2	14.8	32.5	28.3	6.2	4.6	12.0	1.5	24.9	6.7	2.2	7.1	29.4	4.6	37.6	3.8	12.4	10.7	28.5	5.9	7.7	10.7	9.8	4.9	17.5	7.1	44.4	2.0	7.7	8.2	6.3	0.3	11.8	16.6	10.8	6.2	36.8	32.1	0.1	0.0	0.5	0.1	4.1	0.0	0.0	0.0	2.6	0.0	0.0	79.7	1.4	0.0	4.4	0.7	1.0	2.1	0.0	0.0	0.0	1.0	28.3	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	1.0	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.7	0.2	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	6.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	4.1	0.0	0.0	0.0	0.0	6.7	7.9	20.3	10.8	6.2	4.6	2.2	7.1	10.7	0.3
SLITRK3	KIAA0848	ENSG00000121871	"SLIT and NTRK like family member 3"	O94933	3	165186720-165197109	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.4;liver: 12.8"	"Cell line enhanced"	"Detected in some"		"AF22: 6.5;HAP1: 5.4;Karpas-707: 1.5;SCLC-21H: 3.5"	"Cancer enriched"	"Detected in single"	22	"glioma: 7.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017636, HPA048042"	Enhanced		Approved	Mitochondria			1400000	Mitochondria		"HPA017636: AB_1857232, HPA048042: "	"unprognostic (8.91e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.08e-2)"		"unprognostic (1.96e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.59e-2)"		"unprognostic (2.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.22e-1)"		"unprognostic (6.74e-3)"	"unprognostic (5.03e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.03e-4)"	0.6	0.6	7.4	2.0	12.0	0.4	0.5	10.6	17.4	9.9	3.0	1.5	0.3	1.1	12.1	2.0	7.6	12.6	0.8	1.0	13.2	5.5	0.6	12.8	0.9	0.5	3.7	6.5	2.5	0.4	0.4	0.3	0.4	4.2	3.3	3.1	0.3	0.8	9.6	0.9	0.5	1.5	6.2	2.3	0.4	0.8	1.0	2.4	0.0	0.6	0.0	0.5	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	1.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	12.0	10.6	15.7	13.2	5.5	3.7	6.5	4.2	2.4
SLITRK5	"bA364G4.2, KIAA0918, LRRC11"	ENSG00000165300	"SLIT and NTRK like family member 5"	O94991	13	87672615-87696272	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.2;fallopian tube: 6.7;salivary gland: 7.4"	"Cell line enhanced"	"Detected in some"		"AF22: 11.2;HeLa: 5.5;U-138 MG: 3.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013843	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA013843: AB_1857233"	"unprognostic (1.92e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.11e-4)"	"unprognostic (6.94e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	0.1	0.3	3.3	0.1	6.8	0.1	0.2	3.1	9.2	0.4	0.2			0.0	0.1	1.0	0.2	6.7	0.1	0.1	4.8	4.2	0.0	0.0	0.2	0.1	2.6		0.6	0.8	0.0	0.0	0.0		1.8	0.3		7.4	3.1	0.2	0.2	0.0	0.0	1.0	0.1	0.5	0.2			2.0		0.3	0.0	0.4	0.7	1.4	1.6	0.3	1.4	0.4	0.1	0.0	1.2	11.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	2.0	1.3	5.5	0.0	0.8	0.0	0.0	2.5	0.2	0.0	1.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	2.8	1.4	1.0	0.3	0.2	0.4	0.0	1.7	0.3	0.0	0.3	0.0	0.8	2.6	0.0	3.9	0.0	0.0	0.6	1.7	0.0	0.0	3.5	0.1	1.1	1.1	0.3	0.4	0.4	0.2	0.4	0.4	0.4	0.3	0.1	0.7	0.4	0.3	1.6	1.4	0.3	1.4	0.2	0.1										
SLITRK6	FLJ22774	ENSG00000184564	"SLIT and NTRK like family member 6"	Q9H5Y7	13	85792787-85806683	"Disease related genes, Predicted membrane proteins"	"Hearing, Sensory transduction, Vision"		Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 24.2;salivary gland: 22.8;smooth muscle: 22.4;urinary bladder: 27.8"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 13.3;RT4: 45.6;WM-115: 10.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 21.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 11.1;cerebellum: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"thalamus: 24.7"	"Low region specificity"	"Detected in many"			"HPA014491, HPA014513"	Uncertain		Supported	"Plasma membrane"			9500	"Plasma membrane"		"HPA014491: AB_10601603, HPA014513: "	"unprognostic (6.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.46e-2)"	"prognostic unfavourable (8.52e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.82e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.31e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.51e-2)"	0.4	0.3	0.3	2.7	11.1	0.0	2.9	4.9	0.3	1.0	4.5	0.0	0.2	2.8	0.7	3.4	3.6	0.3	1.1	1.9	0.3	1.3	0.3	1.1	3.1	0.0	0.6	0.0	0.3	0.4	0.0	0.4	4.1	0.8	24.2	5.8	1.7	22.8	1.8	0.3	4.5	7.2	22.4	0.4	0.2	1.2	0.5	1.8	0.0	0.6	3.4	0.7	27.8	5.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.2	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	13.3	0.0	1.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	45.6	0.4	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	10.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.1	4.9	0.3	0.3	1.3	0.6	0.0	0.8	1.8
SMC1B	"bK268H5, SMC1L2"	ENSG00000077935	"Structural maintenance of chromosomes 1B"	Q8NDV3	22	45344063-45413619	"Predicted intracellular proteins"	"Cell cycle, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	46	"testis: 35.4"	"Cell line enhanced"	"Detected in some"		"A-431: 9.0;EFO-21: 4.3;SiHa: 18.7;U-266/70: 4.2"	"Cancer enriched"	"Detected in many"	6	"cervical cancer: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001500	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA001500: AB_1080030"	"unprognostic (1.18e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.21e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.83e-9)"	"unprognostic (2.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.98e-3)"	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	35.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.7	0.2	0.0	0.5	0.0	9.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.8	0.1	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.4	0.2	0.1	0.0	18.7	0.1	0.0	0.1	1.6	0.1	0.0	0.0	0.5	0.0	4.2	0.0	0.0	0.0	0.3	1.9	0.0	0.2	0.7	0.4	0.0	0.4	0.0	0.2	0.5	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	0.1	0.3	0.6	0.0	0.0	0.0	0.2	0.0
SMCO2	"C12orf70, LOC341346"	ENSG00000165935	"Single-pass membrane protein with coiled-coil domains 2"	A6NFE2	12	27466810-27502185	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 2.3;testis: 3.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.8;HDLM-2: 5.4"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA014366	Uncertain									"HPA014366: AB_1845544"	"unprognostic (2.64e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.86e-3)"	"unprognostic (5.44e-3)"	"unprognostic (2.81e-1)"	"unprognostic (8.86e-2)"	"unprognostic (9.21e-5)"	"unprognostic (2.59e-1)"	"unprognostic (7.02e-3)"	"unprognostic (5.48e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.69e-1)"	0.2	0.3	0.2	1.7	0.1	0.1	0.4	0.3	0.5	0.1	0.4			0.0	0.1	0.0	2.3	0.0	0.8	0.0	0.3	0.4	0.0	0.7	0.4	0.5	0.2		0.0	0.0	0.0	0.0	0.3		0.1	0.0		0.5	0.0	0.1	2.1	0.0	0.4	0.0	0.0	1.5	3.1			0.0		1.9	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.2	0.1	0.0	0.2	2.5	0.2	0.1	0.1	1.8	0.0	3.8	0.0	0.9	0.0	0.6	0.2	0.6	1.1	5.4	0.0	0.2	0.9	0.0	0.0	2.0	0.4	1.1	0.6	0.7	3.1	1.9	0.0	1.6	0.0	0.3	0.9	2.2	1.0	1.9	0.9	0.0	0.0	0.6	0.8	0.6	0.0	0.0	0.0	0.4	0.0	0.1	0.7	1.6	0.7	1.8	3.0	0.1	0.3	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SMIM11A	"C21orf51, FAM165B, SMIM11"	ENSG00000205670	"Small integral membrane protein 11A"	P58511	21	34375480-34407866	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA051321	Uncertain		Approved	"Focal adhesion sites"				"Focal adhesion sites"		"HPA051321: "	"unprognostic (2.62e-2)"	"unprognostic (4.28e-2)"			"unprognostic (1.27e-1)"		"unprognostic (5.86e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.04e-1)"		"unprognostic (4.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.74e-1)"		"unprognostic (8.84e-2)"	"unprognostic (4.83e-3)"	2.1	6.7	7.8	1.4	7.4	1.0	5.0	4.4	9.5	2.9	4.1			2.2	4.3	6.0	1.4	6.3	4.8	8.8	6.9	6.1	5.1	4.5	5.0	3.3	6.7		5.0	3.8	5.2	4.1	2.4		3.7	6.2		4.8	2.9	16.4	2.6	4.6	3.7	6.5	3.7	17.0	1.7			12.1		5.0	4.3	2.2	4.6	6.5	6.3	4.8	3.4	11.8	3.6	7.5	8.8	0.0	5.9	6.2	5.2	0.0	0.0	4.6	5.7	6.0	6.1	7.5	14.5	4.2	0.3	5.6	0.0	0.1	8.4	26.9	16.9	3.1	0.0	3.6	4.7	3.9	7.2	0.1	8.9	0.0	4.8	10.2	13.5	12.3	3.7	5.6	2.2	3.8	12.4	17.4	4.8	7.1	20.5	2.6	2.4	5.3	10.4	0.1	8.5	12.2	15.5	5.0	0.0	14.1	1.7	4.0	10.1	10.5	12.8	5.1	4.3	6.8	6.9	0.3	3.0	6.3	1.8	4.8	2.7	4.6	3.4	5.0	6.5	2.5	4.6	2.5	0.7	3.4	1.2	1.2	11.8	3.6										
SMIM22		ENSG00000267795	"Small integral membrane protein 22"	K7EJ46	16	4788397-4796491	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.3"	"Group enriched"	"Detected in some"	7	"CAPAN-2: 72.8;RT4: 26.8;SCLC-21H: 19.0;SK-BR-3: 54.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA077331			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA077331: "	"unprognostic (6.55e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.69e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.84e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.73e-3)"	0.8	0.0	0.8	14.4	0.8	0.2	10.9	0.8	0.8	10.8	47.0	0.9	37.8	27.5	2.5	12.1	2.6	18.0	28.1	0.8	0.8	0.0	6.2	0.9	6.8	0.8	0.8	0.8	2.8	36.2	0.0	12.1	4.1	0.8	10.2	28.1	0.8	42.2	35.3	0.8	2.2	54.3	1.7	0.8	0.8	41.7	27.2	0.8	1.0	0.9	2.8	4.5	18.5	3.6	1.9	1.5	3.9	1.3	0.9	1.6	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	72.8	0.0	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.2	0.0	0.2	0.1	6.2	0.3	26.8	19.0	0.3	0.1	54.7	0.0	4.3	0.0	0.0	0.2	0.2	0.3	0.0	0.1	0.1	0.1	0.0	0.2	0.1	3.9	1.3	1.6	1.3	0.5	0.6	0.7	1.3	0.6	0.3	1.9	1.6	0.7	3.3	0.9	0.6	1.5	0.9	0.3	0.8	0.8	0.8	0.8	0.8	0.0	0.8	0.8	0.8	0.8
SMIM24	"C19orf77, HSPC323"	ENSG00000095932	"Small integral membrane protein 24"	O75264	19	3473986-3480542	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 160.8;intestine: 204.2;kidney: 76.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 45.8;HEL: 21.6;Hep G2: 34.2;MOLT-4: 32.6;REH: 17.9;U-937: 25.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 78.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA045046, HPA056027"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA045046: AB_10964444, HPA056027: AB_2683012"	"unprognostic (2.18e-4)"	"unprognostic (4.63e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (4.13e-10)"	"unprognostic (1.68e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.11e-2)"	0.2	0.1	0.7	0.6	0.9	7.0	0.3	0.2	2.2	0.2	137.0	0.4	2.4	71.4	0.2	160.8	0.3	0.3	46.7	0.3	0.4	0.5	76.9	7.2	0.3	0.3	0.4	0.6	0.3	1.6	0.0	0.9	0.2	0.3	0.3	2.0	0.2	0.3	0.4	0.2	0.3	204.2	0.2	0.6	0.4	24.8	1.2	0.3	8.8	0.2	0.2	0.2	0.2	0.2	3.2	2.4	3.0	0.0	8.6	2.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	45.8	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.2	34.2	0.0	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	32.6	4.6	0.0	0.0	17.9	0.0	1.2	0.4	0.0	0.4	0.7	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.8	0.0	25.7	0.0	3.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.1	0.6	0.7	1.7	0.0	8.6	0.0	2.4	2.1	1.1	0.7	0.9	0.2	2.2	0.4	0.5	0.4	0.6	0.3	0.3
SMIM29	"C6orf1, LBH, MGC57858"	ENSG00000186577	"Small integral membrane protein 29"	Q86T20	6	34246380-34249470	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 67.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA037659, HPA037660"	Uncertain									"HPA037659: , HPA037660: AB_10671881"	"unprognostic (2.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.12e-2)"	"prognostic favourable (7.98e-4)"	"unprognostic (9.32e-2)"	"prognostic unfavourable (4.38e-4)"	"unprognostic (3.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.66e-1)"	9.6	18.5	42.0	10.4	21.8	9.9	12.4	14.8	36.8	10.5	7.6	15.2	4.6	7.1	9.1	24.4	13.3	11.5	12.3	19.0	34.6	34.4	7.9	6.0	13.3	13.5	35.7	16.5	8.8	10.7	7.0	12.2	10.0	25.7	9.7	4.8	12.5	7.5	13.6	7.8	29.2	6.7	8.3	23.9	15.2	9.4	5.2	14.0	5.8	15.2	8.3	11.0	16.0	9.3	22.4	10.4	67.8	15.0	9.8	15.8	11.0	8.7	9.8	1.9	11.6	24.4	20.4	2.0	9.1	19.3	8.4	10.3	2.4	3.4	4.9	7.3	8.1	5.4	3.7	8.7	2.5	12.7	6.3	3.6	2.4	6.7	13.5	4.3	23.0	11.0	8.3	11.9	12.6	13.4	4.7	24.7	19.1	5.6	4.6	7.9	0.7	7.2	1.6	1.3	7.6	10.0	11.4	9.4	4.5	0.9	6.5	23.7	4.8	5.1	9.8	19.2	5.3	22.1	7.6	15.7	22.1	1.6	11.2	8.6	27.9	15.3	15.0	67.8	15.8	10.7	10.3	22.4	12.6	13.5	10.4	21.8	8.7	12.5	38.7	9.8	7.6	8.8	15.3	11.0	42.0	21.8	14.8	36.8	34.6	34.4	35.7	16.5	25.7	14.0
SMIM34A		ENSG00000243627	"Small integral membrane protein 34A"	A8MWV9	21	34418715-34423966	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"kidney: 9.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.4;SK-MEL-30: 1.2;U-87 MG: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA029085	Uncertain									"HPA029085: AB_10669867"																		0.3	0.1	0.3	0.3	0.5	0.2	2.9	1.6	0.3	0.4	0.3	0.3	0.3	0.0	0.3	0.3	0.3	2.1	0.3	0.6	0.3	0.2	9.6	0.5	0.9	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.7	0.3	0.3	0.3	0.7	1.0	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.7	0.0	0.6	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.5	1.6	0.3	0.3	0.2	0.3	0.3	0.3	0.3
SMIM34B		ENSG00000278961	"Small integral membrane protein 34B"	A8MWV9	21	7784482-7793954	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 4.5;kidney: 16.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.4;SK-MEL-30: 2.6;U-87 MG: 2.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"eosinophil: 3.1;myeloid DC: 1.7"	"Low lineage specificity"	"Detected in many"											HPA029085	Uncertain									"HPA029085: AB_10669867"																		0.0	0.0		0.0		0.0	4.5		0.0	0.0	0.0			0.0	0.0	0.1	0.0	3.7	0.0	0.4			16.1	0.1	0.4	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.1	0.5	0.7	0.0	0.0		0.0	0.0	0.2			0.0		0.0	0.0		0.0	1.7	3.1	0.6	0.0	0.0	0.4	1.1	0.2	0.2	0.0	0.0	0.0	0.3	0.2	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.5	0.6	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	2.6	1.2	0.3	0.0	0.0	0.5	0.4	0.0	1.1	0.1	0.0	2.5	0.3	0.1	0.0	0.5	3.1	0.0	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.4										
SMPX	"DFN6, DFNX4"	ENSG00000091482	"Small muscle protein, X-linked"	Q9UHP9	X	21705972-21758163	"Disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"heart muscle: 108.8;skeletal muscle: 155.8;tongue: 74.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;Hep G2: 6.7;HSkMC: 7.3;Karpas-707: 5.0;U-266/70: 7.4;U-266/84: 2.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA077360			Approved	"Plasma membrane"			45000	"Plasma membrane"		"HPA077360: "	"unprognostic (7.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (3.04e-5)"	"unprognostic (1.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.27e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-2)"		"unprognostic (2.67e-2)"	"unprognostic (2.82e-1)"		"unprognostic (8.38e-2)"	1.4	0.0	0.1	0.6	0.1	0.0	0.2	0.6	0.9	0.1	4.0	0.0	0.0	0.1	0.1	4.7	4.0	0.1	0.1	108.8	0.1	0.2	0.0	0.2	0.0	0.1	0.7	0.3	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.5	0.0	3.6	0.1	155.8	0.0	0.9	1.8	0.1	0.0	1.5	0.1	0.0	0.0	1.0	74.5	4.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	5.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.9	0.1	0.2	0.7	0.3	0.0	0.0
SMYD4	"KIAA1936, ZMYND21"	ENSG00000186532	"SET and MYND domain containing 4"	Q8IYR2	17	1779485-1830634	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030059	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"				"Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA030059: AB_2191728"	"unprognostic (1.45e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.26e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	10.6	10.0	8.6	13.8	9.6	4.8	11.0	16.3	11.8	9.9	10.8	9.6	9.6	11.5	15.3	8.7	6.3	10.1	7.1	11.0	6.3	6.1	6.1	7.4	8.5	10.4	7.4	6.7	15.5	21.7	5.4	11.3	7.7	9.2	10.1	8.3	10.7	14.1	15.5	19.3	10.6	12.9	10.0	9.2	10.0	7.6	9.2	8.2	12.8	9.1	5.6	12.2	10.8	12.8	6.1	6.3	11.5	4.3	4.1	7.9	3.0	6.0	11.3	11.4	8.1	7.8	5.4	13.3	9.8	5.7	10.5	10.8	18.0	5.2	16.1	6.7	4.0	11.7	10.8	6.4	13.1	4.6	10.9	5.9	12.0	4.8	3.9	5.9	5.8	3.8	5.8	10.7	9.5	5.1	6.1	6.3	8.1	3.7	10.9	4.2	5.2	5.6	13.5	5.8	4.1	4.2	7.3	4.7	6.5	9.1	3.8	9.4	5.5	3.7	5.0	10.3	5.3	8.6	8.5	4.4	5.9	5.8	5.8	5.3	10.0	11.5	3.6	3.2	7.9	4.3	6.5	6.1	4.6	5.0	2.1	3.8	5.3	7.6	2.1	4.1	3.3	6.3	4.8	3.0	8.6	9.6	16.3	11.8	6.3	6.1	7.4	6.7	9.2	8.2
SNAI3	"SMUC, Zfp293, ZNF293"	ENSG00000185669	"Snail family transcriptional repressor 3"	Q3KNW1	16	88677682-88686493	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 25.5;skeletal muscle: 33.9"	"Group enriched"	"Detected in some"	5	"NB-4: 14.4;RPMI-8226: 22.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.3"	"Low region specificity"	"Detected in many"			HPA071127			Approved	Nucleoplasm				Nucleoplasm		"HPA071127: "	"unprognostic (1.03e-2)"	"prognostic favourable (1.39e-4)"	"unprognostic (2.20e-2)"	"unprognostic (6.19e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.98e-3)"	"unprognostic (3.24e-2)"	"unprognostic (7.79e-2)"	"prognostic favourable (3.58e-4)"	"unprognostic (9.09e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.46e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.47e-2)"	0.9	0.8	2.4	6.3	2.3	2.3	0.8	1.9	2.9	1.3	3.4	2.1	0.2	2.2	0.8	1.3	1.3	1.4	2.6	2.4	2.5	1.7	1.3	1.0	5.3	4.5	3.1	0.8	1.5	6.1	2.1	1.0	0.9	2.2	1.6	0.8	1.4	3.6	0.7	33.9	1.1	4.6	1.1	2.4	9.2	3.5	2.1	2.2	2.1	3.0	9.5	13.0	2.7	2.4	4.6	9.2	25.5	7.7	0.5	11.6	5.4	0.2	0.7	0.2	1.1	0.0	0.0	0.5	0.2	0.0	0.0	0.1	2.8	0.2	1.9	0.4	0.0	0.6	0.2	0.2	0.0	0.3	1.1	0.8	0.1	0.9	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.6	3.5	0.0	2.6	0.1	14.4	0.3	0.3	3.1	0.2	22.7	0.0	0.3	1.4	0.1	0.6	0.0	0.2	1.0	1.7	0.3	0.1	0.9	0.2	0.0	0.6	3.2	3.2	0.2	3.9	0.4	2.8	7.7	25.5	6.1	2.9	10.9	4.6	9.9	5.7	9.2	3.8	6.1	3.8	17.1	0.5	0.7	6.5	11.6	5.4	2.4	2.3	1.9	2.4	2.5	1.7	3.1	0.8	2.2	2.2
SNED1	"FLJ00133, Snep, SST3"	ENSG00000162804	"Sushi, nidogen and EGF like domains 1"	Q8TER0	2	240998838-241095568	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"ASC TERT1: 92.3;HSkMC: 46.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 5.3"	"Group enriched"	"Detected in many"	28	"B-cells: 5.3;monocytes: 1.7;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036414, HPA036415"	Uncertain				"Secreted - unknown location"		15000000			"HPA036414: AB_10960852, HPA036415: AB_10964128"	"unprognostic (1.41e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.57e-3)"	"unprognostic (4.62e-2)"	"unprognostic (7.77e-4)"	"unprognostic (3.49e-2)"	"unprognostic (4.96e-1)"	"unprognostic (7.85e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.72e-1)"	"unprognostic (5.51e-3)"	"unprognostic (4.95e-3)"	18.8	8.3	4.6	10.3	3.7	1.3	23.7	21.9	7.4	21.7	7.0	7.6	19.1	4.9	19.1	23.9	6.8	17.4	19.2	8.4	5.6	2.5	6.0	5.4	9.5	6.3	5.8	3.9	23.2	7.8	2.4	5.5	2.2	11.8	12.9	3.9	15.6	11.0	11.1	14.3	9.0	6.8	8.2	7.7	11.0	4.2	11.9	7.3	2.7	29.1	8.4	5.7	9.0	17.1	5.3	0.0	0.0	1.7	0.0	1.3	0.2	0.0	0.1	0.0	1.0	13.6	92.3	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.8	0.0	0.5	0.0	0.1	46.7	0.0	0.1	0.0	2.0	0.0	0.5	2.4	0.4	0.3	0.0	0.1	0.0	0.0	1.7	0.0	1.2	0.1	0.1	0.0	0.4	1.7	0.9	0.3	0.1	4.9	1.9	0.1	10.9	0.3	0.1	0.0	0.3	2.5	0.0	0.5	0.0	0.1	0.0	0.0	0.9	1.0	5.3	1.3	0.7	0.0	2.0	0.7	0.7	0.0	0.0	1.7	0.0	1.3	0.2	4.6	3.7	21.9	7.4	5.6	2.5	5.8	3.9	11.8	7.3
SNORC	"ASCL830, C2orf82, UNQ830"	ENSG00000182600	"Secondary ossification center associated regulator of chondrocyte maturation"	Q6UX34	2	232857270-232878708	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 27.9;breast: 19.6"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 35.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"basophil: 6.3"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 6.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA052824	Uncertain		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"			"Nucleoplasm, Nucleoli"		"HPA052824: "	"unprognostic (4.58e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.30e-7)"	"unprognostic (1.83e-3)"	"unprognostic (8.15e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-2)"	1.4	1.5	4.8	0.8	6.4	1.5	19.6	2.8	9.0	0.3	2.4	9.3	0.0	2.7	0.7	2.0	0.3	0.4	0.3	0.4	8.8	7.8	1.2	2.1	1.3	1.7	11.9	7.0	0.5	4.2	0.7	0.3	0.9	9.1	3.0	1.1	0.0	3.2	0.6	2.8	10.8	2.0	0.6	27.9	1.4	1.3	6.2	7.4	0.0	0.9	0.0	0.5	0.5	0.0	0.0	0.0	6.3	0.0	0.0	0.3	0.0	0.5	0.0	0.2	0.8	0.6	1.0	1.5	0.1	0.0	0.2	0.4	0.0	0.1	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.4	1.3	0.3	0.2	35.5	0.5	0.0	1.0	0.0	0.8	0.2	0.5	0.9	0.1	0.1	0.1	0.1	0.1	0.3	0.0	1.4	0.2	0.3	0.2	0.0	0.5	0.1	0.5	0.2	0.0	1.3	0.0	1.6	0.5	0.1	0.5	0.5	0.4	2.3	2.5	0.1	0.0	0.8	0.2	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	6.4	2.8	9.0	8.8	7.8	11.9	7.0	9.1	7.4
SNTN	"FLJ44379, S100AL"	ENSG00000188817	"Sentan, cilia apical structure protein"	A6NMZ2	3	63652668-63679020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 26.6;fallopian tube: 73.9;lung: 29.5;ovary: 18.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.5;RH-30: 2.6;SH-SY5Y: 3.6"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.9;lung cancer: 0.8;ovarian cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 1.2"	"HPA043322, HPA058399"	Enhanced									"HPA043322: AB_10793945, HPA058399: AB_2683705"	"unprognostic (9.70e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.20e-3)"				"unprognostic (4.34e-3)"		"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.73e-1)"		"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"		"unprognostic (8.43e-3)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.0	0.5	0.0	0.0	1.1	26.6	0.0	73.9	0.0	0.0	0.6	0.3	0.0	0.0	29.5	0.0	0.0	0.0	18.5	0.1	0.0	1.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.1	5.8	0.0	0.1	0.0	0.0	0.9	0.4	1.6	0.2	0.4	0.5	0.1	0.3	0.2	0.6	0.8	0.1	1.5	0.5	0.0	0.0	0.0	0.3	0.2	0.9	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.3	0.1	0.5	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.3	0.4	0.2	0.0	0.4	2.6	0.2	0.2	0.4	0.3	3.6	0.1	0.4	0.0	0.1	0.3	0.0	0.7	0.6	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.6	1.6	0.2	0.2	0.3	0.2	0.3	0.1	0.2	0.3	0.0	0.9	0.5	0.4	1.1	0.4	0.2	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.6	0.3	0.0	0.0	0.6	0.0
SNX21	"C20orf161, dJ337O18.4, SNX-L"	ENSG00000124104	"Sorting nexin family member 21"	Q969T3	20	45833810-45843275	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 16.1;PC-3: 19.6;U-87 MG: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 3.9;classical monocyte: 2.9;eosinophil: 7.3;intermediate monocyte: 5.0;non-classical monocyte: 3.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 7.3;monocytes: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046359	Approved		Approved	"Vesicles,Centriolar satellite"				"Vesicles, Centriolar satellite"		"HPA046359: AB_10963216"	"unprognostic (1.97e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.18e-1)"	25.4	21.0	10.0	4.4	9.8	1.9	14.1	10.3	18.3	18.8	8.4	8.6	10.3	10.0	17.6	13.8	11.3	14.3	15.3	9.1	7.5	6.4	8.9	5.2	9.5	2.7	7.9	7.5	19.1	4.2	5.5	6.9	6.9	8.8	14.1	2.9	13.6	10.2	11.2	43.4	35.2	6.1	19.8	7.6	6.6	9.3	7.2	6.4	0.0	6.0	14.9	3.7	15.4	12.0	0.2	0.3	7.3	5.0	0.0	1.0	0.7	3.6	4.6	0.8	6.6	3.8	3.4	3.2	4.7	4.2	5.1	3.9	3.4	2.8	0.0	16.1	4.7	4.7	0.1	3.7	0.5	0.4	0.6	0.1	2.3	3.2	2.9	0.0	1.1	2.5	2.1	4.5	0.2	3.1	0.0	0.0	1.7	9.0	0.0	0.3	1.2	19.6	0.0	0.6	0.0	1.6	0.6	0.8	7.3	10.6	10.0	5.6	6.5	0.9	3.4	7.5	5.8	14.0	4.2	0.0	0.5	0.2	17.8	0.0	4.0	3.9	2.9	7.3	0.0	5.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.0	3.3	0.1	1.0	0.7	10.0	9.8	10.3	18.3	7.5	6.4	7.9	7.5	8.8	6.4
SOHLH2	"bHLHe81, FLJ20449, SPATA28, TEB1"	ENSG00000120669	"Spermatogenesis and oogenesis specific basic helix-loop-helix 2"	Q9NX45	13	36168208-36214615	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 23.6"	"Cell line enhanced"	"Detected in some"		"A-431: 7.1;HL-60: 9.3;Karpas-707: 10.6;NB-4: 13.6;U-266/84: 13.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"											HPA029182			Uncertain	Vesicles				Vesicles		"HPA029182: AB_10602409"	"unprognostic (1.00e-1)"	"unprognostic (1.65e-1)"		"unprognostic (1.99e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.54e-2)"		"unprognostic (3.01e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.10e-1)"	"unprognostic (8.56e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.93e-2)"	0.3	0.3	0.9	0.3	2.1	0.5	0.4	0.3	3.5	0.3	1.8	0.3	0.3	0.2	0.3	2.0	0.3	0.2	0.3	0.9	1.2	1.2	0.6	0.3	0.3	0.3	1.2	0.3	0.3	0.3	0.2	0.3	3.5	0.3	1.8	0.0	0.3	0.3	1.2	0.4	0.2	0.3	0.4	0.6	0.3	0.1	23.6	0.3	0.3	0.4	0.3	0.3	1.3	0.3	1.0	0.3	0.5	0.3	0.0	0.5	0.0	7.1	0.2	0.7	0.0	0.6	1.1	4.3	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.1	9.3	0.0	2.0	0.6	0.0	0.0	0.9	0.3	10.6	2.1	0.1	0.0	13.6	0.2	0.0	0.2	0.2	0.8	1.0	0.7	0.1	1.3	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.8	0.5	0.5	1.4	13.6	0.2	0.8	5.0	0.5	0.0	0.3	0.5	0.2	0.0	0.1	0.1	0.1	0.1	0.0	1.0	0.2	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.9	2.1	0.3	3.5	1.2	1.2	1.2	0.3	0.3	0.3
SOWAHD	ANKRD58	ENSG00000187808	"Sosondowah ankyrin repeat domain family member D"	A6NJG2	X	119758613-119760164	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 11.1;lymphoid tissue: 12.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.0;NB-4: 3.8;SK-BR-3: 4.5;THP-1: 11.2;U-937: 10.0"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 8.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 11.1"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in some"			HPA065955	Uncertain									"HPA065955: "	"unprognostic (1.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.04e-5)"	"unprognostic (5.82e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.74e-3)"	0.7	0.9	1.0	3.9	2.5	4.2	0.5	0.7	2.1	0.6	1.8	4.0	2.0	4.6	0.4	0.0	0.6	0.8	1.5	1.1	0.9	0.9	1.3	0.8	3.5	6.7	2.5	1.1	0.8	2.2	0.3	0.5	9.6	1.5	0.9	1.1	0.9	5.0	1.0	0.4	0.6	6.7	0.2	3.0	12.6	1.8	8.0	2.0	0.7	0.4	1.1	3.2	0.8	0.5	11.1	2.3	3.7	3.6	0.3	1.9	0.7	0.6	0.0	0.2	0.1	0.0	0.0	6.0	0.1	0.0	0.6	0.9	1.2	0.2	0.3	0.8	0.0	0.1	0.0	0.0	0.1	1.0	0.7	0.1	0.1	1.6	0.3	1.1	0.1	0.3	0.1	0.1	0.0	0.0	0.1	1.1	0.1	0.6	0.0	3.8	1.3	0.4	3.3	0.1	0.2	0.1	0.2	0.4	0.2	1.3	4.5	0.2	0.7	11.2	0.1	0.1	0.1	0.2	0.1	0.6	0.1	0.1	0.0	10.0	0.1	0.0	3.4	1.9	0.1	3.6	0.0	9.0	0.5	0.4	2.3	11.1	1.9	1.0	3.7	0.3	3.0	1.1	0.0	0.7	1.0	2.5	0.7	2.1	0.9	0.9	2.5	1.1	1.5	2.0
SOX12	SOX22	ENSG00000177732	"SRY-box 12"	O15370	20	325595-330224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"B-cells: 1.8;dendritic cells: 1.5;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055052, HPA061627"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA055052: , HPA061627: "	"unprognostic (1.02e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.81e-3)"	"unprognostic (8.80e-2)"	"prognostic unfavourable (6.64e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.66e-1)"	"unprognostic (3.12e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.20e-2)"	5.2	7.4	11.0	4.9	10.2	5.4	10.3	27.5	14.1	8.2	7.8	10.1	11.0	4.1	10.9	11.3	5.8	10.2	5.2	6.8	10.9	8.8	8.3	4.7	5.3	5.1	11.3	5.7	14.6	12.6	7.7	7.0	5.0	8.4	8.7	3.0	7.8	8.8	13.8	2.3	9.0	4.8	8.5	6.9	7.6	5.0	8.2	10.9	12.1	8.2	2.0	3.8	7.8	9.0	1.8	1.5	0.3	0.2	0.2	1.3	0.2	3.6	12.9	12.7	8.6	6.1	4.5	3.8	5.1	4.5	4.7	4.6	2.6	3.8	8.3	3.9	5.8	4.4	9.2	1.6	2.6	4.1	6.4	5.3	5.0	25.8	7.9	7.3	1.4	6.2	5.3	3.9	1.6	6.1	12.4	4.3	3.0	9.0	2.5	18.0	20.7	17.1	13.0	3.2	6.6	6.6	0.4	15.6	18.2	3.4	15.1	18.8	14.3	10.2	6.8	18.1	18.0	0.4	4.5	12.5	13.2	8.5	3.3	7.2	3.5	0.3	0.2	0.3	0.5	0.1	0.2	1.7	0.6	0.8	0.2	1.8	1.3	1.1	0.1	0.2	0.0	1.5	0.8	0.2	11.0	10.2	27.5	10.7	10.9	8.8	11.3	5.7	8.4	10.9
SOX21	SOX25	ENSG00000125285	"SRY-box 21"	Q9Y651	13	94709622-94712399	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.2;skin 1: 18.3;stomach 1: 38.7"	"Group enriched"	"Detected in some"	4	"AF22: 41.6;NTERA-2: 11.2"	"Cancer enhanced"	"Detected in many"		"glioma: 12.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048337, HPA064084"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA048337: , HPA064084: "	"unprognostic (3.33e-1)"	"prognostic favourable (7.60e-4)"		"unprognostic (7.96e-2)"	"prognostic favourable (8.79e-5)"	"unprognostic (1.54e-2)"	"unprognostic (3.87e-1)"	"unprognostic (9.02e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-1)"	0.6	0.6	11.0	0.7	10.1	0.6	1.5	2.5	13.2	0.7	0.6	7.5	0.0	0.6	0.7	0.6	8.3	0.7	0.7	0.6	10.9	5.5	0.6	0.6	0.8	0.6	6.0	8.2	0.6	0.6	0.6	0.1	0.6	5.8	1.2	0.6	0.0	1.7	0.6	0.7	18.3	0.6	0.7	6.1	0.6	38.7	0.8	9.8	0.0	0.7	1.0	4.3	1.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	41.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	6.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	10.1	2.5	12.3	10.9	5.5	6.0	8.2	5.8	9.8
SOX8		ENSG00000005513	"SRY-box 8"	P57073	16	981808-986979	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 64.9"	"Cell line enriched"	"Detected in some"	5	"RH-30: 50.5"	"Cancer enriched"	"Detected in many"	6	"glioma: 46.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.2;naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041640, HPA058665"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA041640: AB_10964357, HPA058665: "	"unprognostic (1.40e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.58e-2)"	"unprognostic (7.16e-3)"	"unprognostic (6.05e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.53e-3)"	"unprognostic (4.46e-2)"	"unprognostic (1.20e-3)"	"unprognostic (8.50e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.47e-1)"	"unprognostic (9.09e-2)"	1.6	1.5	18.4	1.8	25.1	1.0	2.5	3.2	64.9	1.2	1.4	20.9	0.0	1.1	1.1	1.1	1.2	1.1	1.5	1.8	22.6	14.5	1.0	1.0	1.0	2.7	26.5	5.4	1.0	1.5	1.0	0.1	1.4	12.0	1.3	1.5	0.9	8.6	1.4	1.3	1.3	1.2	1.2	27.1	1.8	1.7	1.9	30.4	0.0	1.1	0.0	3.1	1.1	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.2	1.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.1	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	50.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.2	18.4	25.1	3.2	11.8	22.6	14.5	26.5	5.4	12.0	30.4
SP5		ENSG00000204335	"Sp5 transcription factor"	Q6BEB4	2	170715351-170718078	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 50.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Low region specificity"	"Detected in many"			HPA074123			Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA074123: "	"unprognostic (1.16e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.77e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-8)"	"unprognostic (8.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.17e-1)"	8.7	1.8	0.5	2.5	0.6	0.1	7.4	1.6	1.0	11.4	3.9	1.4	3.2	3.1	7.2	3.0	1.9	3.0	5.1	0.8	0.6	1.4	0.8	5.9	4.6	3.1	0.2	0.8	1.5	0.5	0.1	0.1	2.1	0.4	7.2	1.0	3.8	2.1	0.9	0.7	6.6	3.1	3.1	0.1	0.2	7.3	2.4	0.0	0.2	0.1	0.8	6.5	3.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.6	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	1.4	0.1	0.1	0.0	50.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	1.6	1.0	0.6	1.4	0.2	0.8	0.4	0.0
SP6	"Epfn, KLF14"	ENSG00000189120	"Sp6 transcription factor"	Q3SY56	17	47844908-47855874	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 33.7;placenta: 24.7;seminal vesicle: 26.2"	"Cell line enriched"	"Detected in some"	5	"BEWO: 44.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 1.3;pons and medulla: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024516, HPA044469"			Supported	"Nucleoplasm,Mitotic spindle,Centrosome"				Nucleoplasm	"Mitotic spindle, Centrosome"	"HPA024516: AB_10960551, HPA044469: AB_10966430"	"unprognostic (3.06e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (2.11e-6)"	"unprognostic (1.22e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.59e-3)"	"prognostic favourable (6.39e-4)"	"unprognostic (3.33e-1)"	"unprognostic (9.93e-2)"	"prognostic favourable (5.72e-4)"	0.9	1.0	0.1	0.5	0.0	0.0	3.8	1.3	0.2	1.7	1.8	0.1	33.7	1.5	0.4	4.1	5.8	1.1	0.4	0.4	0.1	0.1	0.9	0.1	3.6	0.5	0.1	0.0	3.6	0.4	2.0	0.2	24.7	1.1	6.9	0.7	0.2	1.0	26.2	0.1	14.9	5.3	0.3	0.3	0.9	0.3	0.4	0.0	0.8	1.3	5.6	3.6	5.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.1	0.4	0.0	0.0	0.0	0.0	44.6	0.2	0.2	0.9	0.2	9.4	0.9	0.0	0.3	0.0	1.3	0.0	1.6	0.2	0.1	0.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.9	0.1	2.1	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	5.6	1.4	0.0	0.0	5.7	0.0	2.3	0.0	3.0	0.2	1.3	0.0	0.2	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.3	0.2	0.1	0.1	0.1	0.0	1.1	0.0
SPACA5	"dJ54B20.3, LYC5, LYZL5, PNPK6288, SLLP2, UNQ6288"	ENSG00000171489	"Sperm acrosome associated 5"	Q96QH8	X	48004336-48009729	"Enzymes, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 15.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.3;NB-4: 3.9;RPMI-8226: 1.1;T-47d: 1.1;U-266/70: 1.2;U-266/84: 2.0"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"T-reg: 1.9"	"Low lineage specificity"	"Detected in single"											"HPA044747, HPA047149"	Supported				"Secreted in male reproductive system"					"HPA044747: , HPA047149: "																		0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.2	0.4	0.0	0.0			0.0	0.2	0.8	0.0	0.3	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.5	0.4		0.3	1.4	0.0	0.0	0.0		0.2	0.0		0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.0	0.0	15.1			1.3		0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.9	0.9	0.0	0.4	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.4	0.0	0.7	0.0	1.2	2.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.8	1.9	0.3										
SPACA5B	LYZL5B	ENSG00000171478	"Sperm acrosome associated 5B"	Q96QH8	X	48130657-48132613	"Enzymes, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 18.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	19	"T-reg: 1.9"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"									"HPA044747, HPA047149"	Supported				"Secreted in male reproductive system"					"HPA044747: , HPA047149: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0										
SPAG11A	"EDDM2A, HE2"	ENSG00000178287	"Sperm associated antigen 11A"	Q6PDA7	8	7847876-7868867	"Predicted intracellular proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	225	"epididymis: 332.8"	"Cell line enriched"	"Detected in some"	4	"NB-4: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA023842, HPA057479"	Supported		Approved	"Golgi apparatus"	"Secreted in male reproductive system"			"Golgi apparatus"		"HPA023842: , HPA057479: "																		0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	332.8	1.4	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0
SPAG11B	"EDDM2B, EP2, EP2C, EP2D, HE2"	ENSG00000164871	"Sperm associated antigen 11B"	Q08648	8	7442684-7463674	"Predicted intracellular proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	232	"epididymis: 362.2"	"Group enriched"	"Detected in some"	11	"BEWO: 5.5;NB-4: 12.3;RPMI-8226: 5.7;SH-SY5Y: 5.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA023842, HPA057479"	Supported		Approved	"Golgi apparatus"	"Secreted in male reproductive system"			"Golgi apparatus"		"HPA023842: , HPA057479: "																		0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0			0.0	0.4	362.2	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.1	0.0		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.6	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0										
SPAG16	"DKFZp666P1710, FLJ22724, PF20, WDR29"	ENSG00000144451	"Sperm associated antigen 16"	Q8N0X2	2	213284379-214410501	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA037542	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA037542: AB_10672353"	"unprognostic (4.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (4.90e-4)"	"prognostic favourable (3.82e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.17e-1)"	11.1	13.0	28.2	5.4	29.8	1.7	15.8	12.0	22.0	16.7	11.5	21.9	23.1	13.7	14.0	24.8	16.0	34.8	17.0	15.7	27.7	24.6	22.6	13.8	8.1	7.7	31.5	22.0	20.2	11.2	24.0	32.8	7.3	25.7	17.1	13.1	11.1	11.8	19.8	6.1	18.2	7.9	14.3	36.9	5.7	19.2	34.3	18.1	10.5	19.9	11.4	9.8	14.8	11.9	7.5	4.1	1.1	1.1	12.1	10.6	3.0	12.3	4.9	14.2	0.0	9.7	17.5	0.1	6.8	8.2	8.8	9.4	9.8	13.7	5.2	8.1	7.5	8.8	6.4	8.2	18.9	0.0	5.1	2.7	12.6	12.6	10.9	2.9	0.0	14.9	11.4	7.9	4.6	3.6	8.6	5.9	8.8	0.0	9.7	0.0	7.8	4.1	10.4	14.9	0.2	14.2	12.1	10.4	12.3	7.8	7.2	9.6	33.7	1.2	3.7	8.6	5.1	4.5	7.0	9.7	4.4	0.2	14.0	0.0	3.8	1.1	0.2	0.7	7.1	1.1	10.1	7.5	8.0	8.9	2.5	7.3	10.6	9.2	0.4	12.1	0.8	4.1	7.4	3.0	28.2	29.8	12.0	22.0	27.7	24.6	31.5	22.0	25.7	18.1
SPAG17	"CT143, FLJ34497, PF6, RP4-776P7.2"	ENSG00000155761	"Sperm associated antigen 17"	Q6Q759	1	117953861-118185223	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.1;epididymis: 16.3;testis: 24.7"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.8;HMC-1: 1.6;RT4: 2.8;SCLC-21H: 3.3;U-2 OS: 1.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 24.1"	"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"midbrain: 12.2"	"HPA028597, HPA028666"	Enhanced									"HPA028597: AB_10600221, HPA028666: AB_10602281"	"unprognostic (3.67e-2)"	"unprognostic (4.86e-3)"	"unprognostic (3.42e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.35e-3)"	"unprognostic (2.36e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.76e-5)"	"unprognostic (4.81e-1)"	"unprognostic (9.90e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.67e-2)"	0.8	0.1	1.4	0.2	5.6	0.2	1.3	0.0	0.2	2.0	0.2	7.4	2.2	0.2	0.9	16.3	8.6	11.8	0.7	0.2	2.6	3.0	3.0	0.1	6.1	0.1	0.1	0.3	7.8	0.7	0.3	9.2	0.3	24.1	0.2	0.2	0.6	0.3	0.4	0.5	0.3	0.2	0.2	0.4	0.2	0.9	24.7	1.5	0.0	1.4	0.1	0.8	2.1	2.7	0.0	1.4	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.6	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	1.8	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.8	3.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.2	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	5.6	0.0	0.2	2.6	3.0	0.1	0.3	24.1	1.5
SPAG6	"CT141, pf16, Repro-SA-1"	ENSG00000077327	"Sperm associated antigen 6"	O75602	10	22345445-22454224	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.1;fallopian tube: 29.5;testis: 70.6"	"Cell line enriched"	"Detected in some"	28	"U-937: 47.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 31.1"	"Cell type enhanced"	"Detected in some"		"eosinophil: 2.9"	"Low lineage specificity"	"Detected in many"							"Region enhanced"	"Detected in many"		"midbrain: 17.9"	HPA038440	Enhanced									"HPA038440: AB_10671742"	"unprognostic (5.02e-2)"	"unprognostic (9.52e-2)"		"unprognostic (8.94e-6)"	"unprognostic (2.21e-1)"	"unprognostic (2.51e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.78e-4)"	0.3	0.3	2.8	0.3	5.2	0.5	1.4	0.0	2.0	1.1	0.3	8.6	0.0	0.3	0.4	8.7	0.3	29.5	0.3	0.3	5.0	5.1	0.5	0.4	5.3	0.3	0.7	0.6	3.1	0.5	0.3	12.4	0.3	31.1	0.8	0.3	0.5	0.3	0.3	0.3	0.3	0.3	0.3	1.1	0.3	0.3	70.6	1.6	0.0	0.3	0.0	0.3	0.3	0.1	0.0	1.2	2.9	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.1	0.0	47.7	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.5	0.0	2.8	5.2	0.0	2.0	5.0	5.1	0.7	0.6	31.1	1.6
SPANXB1	"CT11.2, SPANXB2, SPANXF1, SPANXF2"	ENSG00000227234	"SPANX family member B1"	Q9NS25	X	141002591-141003706	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	40	"testis: 38.5"	"Group enriched"	"Detected in some"	26	"A-431: 40.4;U-2 OS: 14.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046423, HPA073647"	Supported		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA046423: , HPA073647: "															"unprognostic (8.55e-2)"			0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	40.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.1	1.0	0.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPANXN3	"CT11.8, SPANX-N3"	ENSG00000189252	"SPANX family member N3"	Q5MJ09	X	143508735-143517475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	31	"testis: 28.4"	"Cell line enriched"	"Detected in some"	5	"U-2 OS: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045652			Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"HPA045652: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPATA19	"CT132, FLJ25851, SPAS1, spergen1"	ENSG00000166118	"Spermatogenesis associated 19"	Q7Z5L4	11	133840631-133845538	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	128	"testis: 46.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;HBEC3-KT: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA040082	Enhanced									"HPA040082: "					"unprognostic (9.90e-3)"	"unprognostic (3.34e-2)"										"unprognostic (2.66e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	46.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0
SPATA20	"FLJ21347, SSP411, Tisp78"	ENSG00000006282	"Spermatogenesis associated 20"	Q8TB22	17	50543058-50555852	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 26.7;MCF7: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022023, HPA027144, HPA031442"	Enhanced		Approved	Nucleoplasm	"Secreted in male reproductive system"			Nucleoplasm		"HPA022023: AB_1857417, HPA027144: AB_1857418, HPA031442: AB_10610557"	"unprognostic (9.27e-3)"	"unprognostic (1.90e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.74e-3)"	"unprognostic (2.63e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-1)"	"unprognostic (7.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.12e-3)"	"unprognostic (4.93e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.66e-1)"	"prognostic favourable (9.69e-5)"	9.7	29.0	14.9	15.2	13.1	4.6	8.2	17.7	22.8	11.7	13.4	11.4	16.8	9.8	16.0	21.1	10.7	13.5	25.4	36.3	9.8	14.3	15.7	13.1	11.2	8.7	15.0	18.3	20.4	22.4	11.9	10.4	6.9	13.3	15.4	5.8	29.0	18.9	15.0	17.9	8.7	9.9	12.7	13.0	14.1	22.8	62.7	6.8	2.5	22.3	8.5	9.9	13.1	7.9	3.2	8.9	1.1	4.7	9.3	2.6	2.9	3.4	15.7	0.9	10.3	2.4	7.4	2.9	5.8	6.7	2.7	2.2	11.7	5.0	3.7	14.1	4.1	2.6	0.5	2.8	1.4	4.9	2.2	2.5	3.4	26.7	10.9	0.9	7.3	11.7	3.8	1.5	4.3	3.6	0.3	6.8	2.5	26.3	0.0	0.9	1.1	6.9	1.5	2.5	1.0	13.5	16.7	1.8	4.2	5.1	3.9	6.2	7.4	0.4	7.9	2.7	8.8	1.6	1.1	13.0	3.9	0.0	5.8	0.5	2.8	0.0	4.5	1.1	2.0	4.7	2.6	3.2	1.5	1.5	8.9	2.2	2.0	2.2	0.3	9.3	4.0	2.0	0.8	2.9	14.9	13.1	17.7	22.8	9.8	14.3	15.0	18.3	13.3	6.8
SPATA21	"spergen-2, spergen2"	ENSG00000187144	"Spermatogenesis associated 21"	Q7Z572	1	16387117-16437424	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"blood: 4.6;testis: 11.3"	"Cell line enriched"	"Detected in some"	7	"Hep G2: 10.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 4.6"	"Low lineage specificity"	"Detected in many"											HPA032080			Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA032080: "	"unprognostic (3.09e-1)"	"unprognostic (8.26e-2)"	"unprognostic (5.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.74e-10)"	"unprognostic (1.25e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.71e-2)"	0.0	0.2	0.0	0.0	0.1	1.3	0.0	1.1	0.0	0.1	0.0			0.6	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.3	0.1		0.1	0.7	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.9	0.1	0.0	0.1	0.2	0.3	11.3			0.0		0.0	0.3	0.0	1.3	0.6	4.6	0.8	0.9	0.8	0.4	0.2	0.7	0.3	0.7	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	1.5	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.0	1.5	10.7	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.2	0.7	0.2	0.1	0.5	0.2	0.3	0.4	0.3	0.1	0.2	0.0	0.3	0.2	0.0	0.0	1.1	0.6	0.5	0.2	0.3	0.2	0.1	0.4	0.0	0.4	0.4	0.2	0.3	0.3	0.0	4.6	0.5	0.9	0.7	0.8	0.5	1.1	0.7	0.6	0.4	1.3	0.8	0.3	2.3	0.9	0.5	0.6	0.7	0.4										
SPATA2L	"C16orf76, MGC26885, tamo"	ENSG00000158792	"Spermatogenesis associated 2 like"	Q8IUW3	16	89696343-89701705	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041182, HPA042453"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria"	Cytosol	"HPA041182: AB_2677352, HPA042453: AB_2678005"	"unprognostic (1.22e-1)"	"unprognostic (9.04e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.13e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.86e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.32e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.86e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.55e-1)"	6.8	5.3	6.3	5.4	10.3	8.8	3.7	6.8	14.1	4.1	6.9	1.6	4.9	12.3	4.7	7.2	3.9	4.6	7.7	2.8	7.2	4.9	7.5	11.4	6.3	3.6	3.4	7.6	5.4	17.0	5.1	12.9	6.5	2.8	4.2	2.2	4.9	6.1	3.4	1.8	5.0	10.7	3.3	2.0	5.6	7.7	4.6	2.6	6.7	5.6	0.7	5.4	4.0	2.2	5.8	5.9	16.5	7.8	2.4	7.3	4.7	5.2	4.2	1.4	6.9	1.1	1.2	8.1	3.6	1.7	1.7	1.1	7.8	4.5	1.8	4.9	1.1	9.1	1.3	2.0	0.3	1.7	14.8	1.2	1.4	10.6	3.8	0.9	3.7	1.2	2.5	2.7	0.8	1.8	5.4	1.2	1.2	23.8	3.1	5.6	4.2	5.6	6.7	0.7	5.1	2.4	1.8	8.1	5.3	3.8	3.9	4.5	10.1	4.0	4.7	1.7	6.3	0.3	1.7	3.1	1.9	1.6	5.2	2.9	3.2	3.3	4.9	6.0	7.3	7.8	5.1	4.8	5.2	5.3	5.3	5.8	4.6	4.9	16.5	2.4	5.8	5.9	3.9	4.7	6.3	10.3	6.8	14.1	7.2	4.9	3.4	7.6	2.8	2.6
SPATA3	TSARG1	ENSG00000173699	"Spermatogenesis associated 3"	Q8NHX4	2	230990324-231025055	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	42	"testis: 82.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;U-698: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	13	"cerebellum: 11.0"	HPA018254	Enhanced									"HPA018254: AB_1857419"					"unprognostic (6.94e-3)"									"unprognostic (6.98e-2)"	"unprognostic (9.62e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	1.5	0.2	0.2	0.3	0.0	0.1	0.3	0.2	0.1	0.0	0.2	3.6	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.0	0.1	0.5	0.1	1.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.9	0.0	0.2	0.7	0.2	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.2	0.7	0.0	0.2	0.0	1.1	0.3	0.1	0.1	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.4	0.2	0.3	0.2	0.2	0.1	0.3	0.3	0.0	0.2	0.5	0.0	0.0	1.5	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPATA31D1	"FAM75D1, FLJ46321"	ENSG00000214929	"SPATA31 subfamily D member 1"	Q6ZQQ2	9	81988772-81995256	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	134	"testis: 13.3"	"Cell line enriched"	"Detected in single"	5	"HDLM-2: 3.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047897	Uncertain									"HPA047897: "															"unprognostic (1.25e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SPATA31E1	"C9orf79, FAM75E1, FLJ35866"	ENSG00000177992	"SPATA31 subfamily E member 1"	Q6ZUB1	9	87882826-87888899	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	139	"testis: 18.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.4;hTEC/SVTERT24-B: 1.2;Karpas-707: 1.1;SCLC-21H: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA024253	Enhanced									"HPA024253: AB_1845839"													"unprognostic (2.16e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.72e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPATA33	"C16orf55, FLJ31606"	ENSG00000167523	"Spermatogenesis associated 33"	Q96N06	16	89657802-89671272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 70.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045648, HPA073096"	Enhanced		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA045648: AB_2679405, HPA073096: "	"unprognostic (1.05e-2)"	"prognostic favourable (1.06e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.03e-3)"	"unprognostic (8.82e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.52e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.60e-1)"	2.0	2.7	6.9	2.8	7.3	3.3	3.2	7.8	7.7	2.9	2.9	4.3	1.8	4.8	3.2	9.2	2.7	14.8	3.7	2.1	6.0	5.7	5.3	2.9	4.3	2.3	4.7	6.5	2.1	3.0	4.0	7.3	1.9	5.3	3.2	3.4	2.5	2.4	2.8	1.5	4.1	5.7	2.6	3.6	3.0	3.8	70.4	4.3	2.4	5.1	2.2	3.1	2.1	2.5	5.7	5.5	5.8	3.3	7.3	6.3	3.6	10.1	9.7	12.1	4.3	3.2	2.8	4.2	6.9	2.8	10.0	4.3	9.1	8.5	1.0	3.7	4.6	13.7	5.3	3.7	7.6	2.0	7.5	1.7	11.8	13.4	1.4	2.1	4.1	2.9	4.4	6.9	3.0	2.2	10.8	1.4	6.5	11.9	6.4	5.5	6.6	7.4	13.0	6.7	3.4	5.9	3.5	11.3	6.2	15.3	2.8	3.7	12.5	2.9	2.1	7.7	9.7	6.4	5.5	3.5	5.2	4.1	7.5	12.2	2.7	5.8	3.3	5.4	5.2	3.2	6.3	5.7	4.7	6.2	2.6	3.2	5.2	4.1	4.1	7.3	2.9	5.5	3.5	3.6	6.9	7.3	7.8	7.7	6.0	5.7	4.7	6.5	5.3	4.3
SPATA6L	"C9orf68, FLJ10058"	ENSG00000106686	"Spermatogenesis associated 6 like"	Q8N4H0	9	4553386-4666674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 23.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.4;CAPAN-2: 5.7;HDLM-2: 3.2;RPTEC TERT1: 4.3;SCLC-21H: 3.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	18	"T-cells: 1.8"					"Low region specificity"	"Detected in all"			HPA039585	Enhanced									"HPA039585: AB_10674984"	"unprognostic (8.18e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.03e-3)"	"unprognostic (4.10e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.27e-3)"	1.7	1.1	4.9	0.6	7.3	0.2	3.0	15.3	5.3	1.5	1.6	1.7	4.1	2.6	1.7	5.4	2.3	9.4	4.0	1.4	3.2	1.7	2.5	7.6	4.0	1.7	1.2	2.5	1.7	5.3	3.9	23.0	1.3	3.8	1.9	1.2	0.0	1.3	1.6	0.9	1.6	3.6	0.5	1.3	1.0	3.4	13.2	1.5	0.0	2.9	0.8	0.9	1.6	3.1	0.0	0.0	0.0	0.0	0.0	1.8	0.4	1.1	0.4	0.6	0.0	0.0	0.1	3.4	0.1	0.3	0.0	0.1	0.1	5.7	0.0	0.2	0.2	0.3	0.5	0.0	0.0	3.2	0.1	0.9	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.4	4.3	0.0	3.7	2.0	0.0	1.4	0.0	0.6	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.4	0.0	1.0	0.9	0.0	0.0	1.7	1.8	0.0	0.0	0.0	0.0	0.9	0.4	4.9	7.3	15.3	5.3	3.2	1.7	1.2	2.5	3.8	1.5
SPATA9	"FLJ35906, NYD-SP16"	ENSG00000145757	"Spermatogenesis associated 9"	Q9BWV2	5	95652181-95698711	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 29.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.7;HaCaT: 2.8;NB-4: 2.3;THP-1: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	20	"eosinophil: 2.0"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA010848, HPA076967"	Approved		Approved	Mitochondria				Mitochondria		"HPA010848: AB_1857422, HPA076967: "	"unprognostic (4.46e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.60e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.49e-13)"	"unprognostic (3.39e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.87e-2)"	0.9	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	29.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.0	2.7	0.0	0.0	0.2	0.3	0.0	0.4	0.0	0.1	0.0	0.5	0.3	2.8	0.0	0.0	0.0	0.2	0.5	1.7	0.2	0.0	0.6	0.5	0.4	1.6	0.0	0.6	0.0	0.5	1.7	0.0	2.1	0.0	0.7	2.3	0.8	0.2	0.0	0.2	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.4	0.0	3.9	0.0	0.7	0.2	0.5	0.4	0.0	0.2	0.0	0.0	0.4	1.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SPATS1	"FLJ25442, SPATA8, SRSP1"	ENSG00000249481	"Spermatogenesis associated serine rich 1"	Q496A3	6	44342660-44377167	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"fallopian tube: 9.0;testis: 33.5"	"Cell line enriched"	"Detected in single"	67	"SK-MEL-30: 12.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"pons and medulla: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA030897, HPA049722"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA030897: , HPA049722: "				"unprognostic (2.30e-3)"														0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.4	0.3	0.0	1.5	0.0	0.0	0.1	4.8	0.1	9.0	0.0	0.0	0.7	0.7	0.0	0.0	1.5	0.0	0.4	0.0	1.6	0.0	0.2	0.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	33.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	1.0	0.0	0.4	0.7	0.7	0.4	0.0	3.5	0.1
SPDYE1	"Ringo1, SPDYE, WBSCR19"	ENSG00000136206	"Speedy/RINGO cell cycle regulator family member E1"	Q8NFV5	7	44000889-44010122	"Disease related genes, Predicted intracellular proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 10.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 4.9"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA051750	Supported									"HPA051750: "	"unprognostic (2.16e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.98e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.95e-6)"	"unprognostic (2.68e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.19e-2)"	0.1	0.2	0.1	1.1	0.2	1.7	0.2	0.5	0.5	0.3	0.2			0.8	0.3	0.0	0.4	0.1	0.1	0.2	0.1	0.1	0.2	0.3	0.3	1.0	0.1		0.5	0.5	0.0	0.3	0.2		0.4	0.0		0.6	0.0	1.5	2.2	0.9	0.0	0.1	0.8	0.5	10.2			0.5		0.0	0.3	0.3	2.9	2.3	3.0	1.6	1.0	1.5	0.6	1.6	1.0	1.4	2.4	0.0	0.0	1.6	1.9	0.0	0.0	0.0	0.7	1.7	1.7	0.9	0.0	2.4	0.0	0.0	0.0	1.4	1.3	0.8	3.0	0.7	0.0	1.5	2.0	0.0	0.0	0.0	0.0	0.0	1.9	4.9	0.0	1.3	1.2	1.6	2.0	0.6	2.5	0.7	1.7	0.0	2.2	1.5	1.0	1.6	1.0	0.1	1.5	0.7	1.5	2.3	2.0	1.0	2.3	2.6	1.8	1.7	0.7	2.0	3.0	3.0	1.6	1.9	1.5	1.6	1.5	1.5	1.3	0.4	0.6	2.9	1.0	1.5	2.8	1.0	1.0	2.3	0.3	0.6										
SPDYE3		ENSG00000214300	"Speedy/RINGO cell cycle regulator family member E3"	A6NKU9	7	100307702-100322196	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 1.3;testis: 5.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"											HPA051750	Supported									"HPA051750: "	"prognostic favourable (8.73e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (2.00e-6)"	"unprognostic (1.06e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.90e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.99e-2)"	"unprognostic (7.32e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.08e-2)"	"unprognostic (5.06e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.58e-1)"	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0		0.0	0.2	0.0	0.2	0.0		0.1	0.0		0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.1	5.2			0.1		0.0	0.0	0.0	1.3	0.7	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.2	1.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.4	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.0	1.1	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.4	2.4	0.0	0.1	0.2	0.8	0.4	0.1	0.3	0.3	0.1	0.0	0.4	0.0	0.4	0.4	0.1	0.0	0.4	0.0	0.0	0.5	0.5	0.5	0.3	0.6	0.5	1.1	0.1	0.6	0.3	0.0	0.1	0.0	0.2	0.1	0.2	1.3	0.2	0.1	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.7	0.0	0.0										
SPDYE4		ENSG00000183318	"Speedy/RINGO cell cycle regulator family member E4"	A6NLX3	17	8753106-8758559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	11	"testis: 17.4"	"Cell line enhanced"	"Detected in some"		"A549: 4.5;HeLa: 4.6;NB-4: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA025704, HPA051750"	Enhanced									"HPA025704: AB_1853093, HPA051750: "										"unprognostic (3.20e-1)"	"unprognostic (7.16e-4)"		"unprognostic (3.15e-3)"			"unprognostic (2.79e-1)"		0.1	0.0	0.1	0.2	0.2	1.3	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.3	0.1	0.1	0.1	0.2	17.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.6	0.7	1.2	0.9	0.0	1.1	0.4	0.9	4.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	4.6	0.0	0.0	1.2	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.5	0.0	2.8	0.0	0.0	0.7	0.0	0.0	0.0	2.1	0.7	0.2	0.7	1.0	0.0	0.9	0.0	0.0	0.4	0.2	1.4	1.0	0.7	0.1	0.8	0.0	0.2	0.5	0.7	0.9	1.2	1.0	0.4	0.5	0.5	0.6	0.6	0.0	1.6	0.8	1.1	0.4	0.0	0.9	0.7	0.1	0.4	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SPEF2	"CT122, FLJ23577, KPL2"	ENSG00000152582	"Sperm flagellar 2"	Q9C093	5	35617844-35814611	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 14.2;T-47d: 8.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 5.2;MAIT T-cell: 6.5;memory CD4 T-cell: 3.1;memory CD8 T-cell: 5.4;naive CD4 T-cell: 3.5;naive CD8 T-cell: 4.2;NK-cell: 4.1"	"Group enriched"	"Detected in many"	8	"NK-cells: 4.1;T-cells: 6.5"					"Low region specificity"	"Detected in many"			"HPA039606, HPA040343"	Enhanced									"HPA039606: AB_10671044, HPA040343: AB_2676930"	"unprognostic (3.81e-2)"	"unprognostic (3.17e-1)"	"unprognostic (6.23e-2)"	"unprognostic (8.71e-2)"	"unprognostic (4.55e-2)"	"unprognostic (8.23e-2)"	"unprognostic (8.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.01e-4)"	"unprognostic (4.50e-2)"	"unprognostic (6.34e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.12e-2)"	2.4	5.4	5.9	4.1	14.5	2.1	7.6	3.6	10.3	15.8	2.6	5.3	8.8	1.5	17.3	19.1	1.8	21.7	4.5	2.8	4.7	7.0	10.9	2.1	6.8	2.7	3.0	6.1	9.1	6.4	13.3	22.5	6.5	12.9	8.3	3.1	4.9	4.7	9.4	1.0	1.9	2.3	6.4	3.0	3.6	3.3	9.0	3.1	2.3	11.9	0.6	1.5	3.7	7.9	0.6	0.6	0.4	0.5	4.1	6.5	1.3	0.9	1.4	1.7	4.7	1.2	1.4	0.2	2.2	1.4	5.3	3.5	0.0	2.5	0.0	1.2	3.1	0.1	1.5	2.1	5.3	14.2	0.5	0.0	6.2	0.5	1.6	3.7	0.0	2.1	3.8	2.9	1.6	0.1	1.7	0.9	0.8	2.4	0.0	0.0	0.1	1.3	3.2	0.0	0.0	3.7	0.4	0.1	1.3	0.0	2.6	0.4	8.4	7.2	0.0	1.5	2.0	3.0	0.8	0.0	0.0	0.3	4.3	0.1	0.0	0.0	0.5	0.0	5.2	0.5	6.5	0.2	3.1	5.4	0.6	0.6	3.5	4.2	0.4	4.1	0.2	0.2	0.7	1.3	5.9	14.5	3.6	10.3	4.7	7.0	3.0	6.1	12.9	3.1
SPEM2	C17orf74	ENSG00000184560	"SPEM family member 2"	Q0P670	17	7425615-7427568	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 45.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.2;hTEC/SVTERT24-B: 1.0;U-2 OS: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023649	Uncertain									"HPA023649: AB_1845606"					"unprognostic (3.00e-1)"					"unprognostic (3.88e-1)"			"unprognostic (1.12e-4)"		"unprognostic (1.25e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPNS3	MGC29671	ENSG00000182557	"Sphingolipid transporter 3 (putative)"	Q6ZMD2	17	4433688-4488208	"Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 51.8;bone marrow: 23.1;lymphoid tissue: 15.1"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 4.7;NB-4: 16.0;THP-1: 17.3;U-698: 4.2;U-937: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 51.8;plasmacytoid DC: 25.1"	"Group enriched"	"Detected in many"	24	"dendritic cells: 25.1;granulocytes: 51.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023928	Uncertain									"HPA023928: AB_1844393"	"unprognostic (4.39e-2)"	"unprognostic (8.10e-5)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.94e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (8.09e-4)"	"unprognostic (6.18e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.69e-2)"	0.3	0.5	1.1	2.0	0.9	23.1	0.3	0.5	1.6	0.4	1.3	3.7	0.0	0.6	0.5	0.1	0.4	0.7	0.7	0.7	1.2	1.6	0.4	0.3	1.2	1.3	2.4	0.1	0.2	0.3	0.1	0.5	0.1	2.0	0.5	0.2	0.0	1.3	0.5	0.1	0.5	0.8	0.2	4.2	2.9	0.3	1.3	2.2	15.1	0.2	0.0	1.6	0.3	0.3	0.0	25.1	51.8	1.5	0.0	0.2	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	4.7	16.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	13.3	0.0	0.0	1.5	51.8	0.1	0.3	0.1	0.0	0.0	0.2	11.5	0.0	0.0	0.2	0.2	0.0	0.0	25.1	0.0	1.0	1.1	0.9	0.5	1.6	1.2	1.6	2.4	0.1	2.0	2.2
SPOCD1	"FLJ25348, PPP1R146"	ENSG00000134668	"SPOC domain containing 1"	Q6ZMY3	1	31790422-31816051	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.9;urinary bladder: 13.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.6;hTEC/SVTERT24-B: 19.3;RT4: 32.6;TIME: 16.9;U-87 MG: 32.1"	"Group enriched"	"Detected in many"	7	"glioma: 13.9;urothelial cancer: 5.6"	"Region enhanced"	"Detected in many"		"pons and medulla: 8.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.9"					"Low region specificity"	"Detected in some"			"HPA031713, HPA031714, HPA031715"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA031713: AB_10604099, HPA031714: , HPA031715: "	"unprognostic (7.78e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.60e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-2)"	"prognostic favourable (4.05e-5)"	28.9	0.5	1.8	5.1	1.6	0.3	1.6	0.4	3.9	2.0	0.7	1.5	0.1	1.6	2.4	2.8	0.3	2.1	1.6	0.4	1.2	1.6	0.5	0.2	12.9	0.9	2.6	0.3	1.8	0.1	0.1	1.6	3.5	8.2	1.8	0.9	1.8	0.1	0.3	0.4	0.1	0.9	2.4	3.1	1.9	1.1	11.9	0.6	0.1	0.4	0.8	0.2	13.7	2.1	0.0	0.0	1.9	0.1	0.0	0.0	7.3	10.6	0.3	0.0	0.0	0.2	1.5	0.5	13.9	18.6	13.5	9.0	0.2	0.6	0.1	1.9	15.6	1.4	0.0	0.2	4.3	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.2	6.8	0.2	19.3	0.6	9.1	0.2	0.2	7.9	0.0	0.1	0.0	0.2	0.3	0.0	1.4	0.0	0.0	32.6	0.0	0.0	0.3	0.0	0.9	8.0	0.0	16.9	14.2	1.4	9.2	5.2	0.0	0.1	0.0	32.1	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.3	1.8	1.6	0.4	0.6	1.2	1.6	2.6	0.3	8.2	0.6
SPRED3		ENSG00000188766	"Sprouty related EVH1 domain containing 3"	Q2MJR0	19	38388421-38399587	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 10.7"	"Cell line enhanced"	"Detected in many"		"TIME: 15.0;U-87 MG: 9.6"	"Cancer enhanced"	"Detected in many"		"glioma: 3.6"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071521			Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA071521: "	"unprognostic (1.09e-1)"	"unprognostic (1.88e-3)"	"unprognostic (8.71e-3)"	"unprognostic (3.35e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.09e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.40e-11)"	"unprognostic (6.21e-4)"	"unprognostic (3.67e-1)"	"unprognostic (1.04e-3)"	"unprognostic (8.45e-3)"	2.0	1.2	4.3	2.7	10.1	0.9	1.2	2.8	10.7	0.9	0.6	1.7	0.0	4.7	1.2	1.2	0.9	0.7	2.0	1.1	5.0	4.7	1.2	0.4	0.9	0.5	2.8	4.6	0.5	2.9	4.5	5.8	0.8	4.7	1.2	0.8	0.9	0.8	1.1	0.9	2.3	3.7	2.3	1.7	0.5	1.3	1.7	0.9	0.0	1.8	0.0	0.6	0.9	0.8	0.8	0.7	2.2	0.6	0.9	0.5	0.3	0.2	1.1	3.9	3.2	0.6	1.9	2.2	7.7	5.1	2.6	2.4	0.4	0.8	0.2	2.8	2.6	0.1	0.6	0.9	2.3	0.7	1.4	0.0	0.2	0.4	1.4	2.1	0.1	1.3	0.9	6.0	1.8	8.0	0.6	1.4	7.8	0.4	0.0	0.1	1.8	3.9	0.9	1.4	0.1	5.6	0.6	0.2	3.0	0.1	0.2	0.3	0.6	0.1	15.0	2.8	8.8	2.3	4.2	0.6	0.2	0.5	9.6	0.3	4.8	1.6	0.6	0.4	0.4	0.2	0.3	0.3	0.5	0.3	0.1	0.8	0.4	0.3	2.2	0.9	0.5	0.7	0.2	0.3	4.3	10.1	2.8	9.8	5.0	4.7	2.8	4.6	4.7	0.9
SPRR4		ENSG00000184148	"Small proline rich protein 4"	Q96PI1	1	152970666-152972574	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"skin 1: 51.9;tongue: 18.9"	"Group enriched"	"Detected in some"	4	"HaCaT: 3.5;hTCEpi: 2.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055963	Enhanced									"HPA055963: "		"unprognostic (4.40e-2)"				"unprognostic (7.38e-3)"			"unprognostic (1.45e-1)"								"unprognostic (6.75e-2)"	0.1	0.0	0.1	0.7	0.1	0.0	4.9	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.4	0.1	0.8	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	51.9	0.1	0.1	0.1	0.1	0.0	2.9	0.1	1.8	0.1	18.9	0.4	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SRL		ENSG00000185739	Sarcalumenin	Q86TD4	16	4189374-4242080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"heart muscle: 70.9;skeletal muscle: 104.1;tongue: 48.3"	"Cell line enriched"	"Detected in single"	13	"HSkMC: 9.6"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.5;thyroid cancer: 5.9"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in many"			"HPA041535, HPA045520"	Enhanced				"Intracellular and membrane"		26000			"HPA041535: AB_2677538, HPA045520: AB_2679358"	"unprognostic (1.24e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.04e-7)"	"unprognostic (1.41e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.40e-4)"	"unprognostic (4.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (7.78e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.68e-4)"	3.1	0.1	0.2	0.2	0.2	0.0	0.4	0.1	1.0	0.8	0.3	0.0	1.2	0.1	0.9	4.2	2.9	0.8	0.4	70.9	0.2	0.2	0.5	0.1	0.3	0.1	0.3	0.2	0.4	0.1	0.1	0.1	0.3	0.4	1.3	0.2	0.1	2.1	0.6	104.1	0.2	0.4	0.8	0.2	0.4	0.3	0.5	0.1	0.2	0.9	48.3	3.4	0.9	0.7	0.6	0.3	2.4	0.5	0.8	0.5	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.2	0.2	9.6	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.4	0.0	2.4	0.2	0.8	0.5	0.5	0.2	0.3	0.3	0.3	0.1	0.6	0.4	0.4	1.3	0.8	0.3	0.3	0.3	0.9	0.2	0.2	0.1	1.0	0.2	0.2	0.3	0.2	0.4	0.1
SRP19		ENSG00000153037	"Signal recognition particle 19"	"P09132, Q15695"	5	112861188-112898371	"Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029272	Approved									"HPA029272: AB_10600910"	"unprognostic (4.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (3.72e-10)"	"unprognostic (1.82e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.69e-3)"	20.3	24.6	21.2	21.3	24.2	52.3	23.0	20.2	27.4	16.9	17.9	18.4	20.1	18.7	20.1	30.7	23.1	17.5	18.3	20.2	20.0	25.2	27.1	53.2	18.8	27.2	19.3	21.6	16.6	36.2	18.2	45.2	24.5	24.9	26.3	21.7	12.7	34.5	19.9	25.6	18.3	20.4	23.5	19.3	23.4	19.4	14.7	19.8	23.5	31.2	20.1	29.3	18.5	16.9	27.3	43.0	26.2	19.3	23.8	35.0	17.5	22.4	15.2	19.3	31.0	18.2	21.2	47.2	32.0	19.8	27.3	33.0	26.0	17.9	23.6	22.1	20.3	15.1	20.8	32.6	33.0	25.2	33.8	21.1	28.9	30.5	28.7	16.7	23.3	24.6	32.1	25.9	38.1	25.2	15.5	28.6	23.2	26.5	26.9	29.9	20.1	24.1	17.4	17.2	35.4	26.7	28.7	22.1	19.5	25.6	16.8	14.8	25.3	24.3	20.2	23.0	19.4	22.7	37.4	33.8	40.8	41.1	22.3	28.6	23.6	26.2	17.7	20.9	26.5	18.0	32.4	27.3	29.8	27.9	19.8	23.2	25.6	28.3	24.2	23.8	19.3	43.0	35.0	17.5	21.2	24.2	20.2	27.4	20.0	25.2	19.3	21.6	24.9	19.8
SRRD	"HC/HCC, SRR1L"	ENSG00000100104	"SRR1 domain containing"	Q9UH36	22	26483877-26494658	"Predicted intracellular proteins"	"Biological rhythms, Heme biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA002945	Uncertain		Approved	Cytosol				Cytosol		"HPA002945: AB_1079265"	"unprognostic (3.25e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavourable (2.16e-6)"	"unprognostic (9.00e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.96e-1)"	8.7	7.2	12.5	7.1	14.3	9.6	11.3	20.0	17.2	10.6	10.9	10.4	10.5	6.6	12.7	11.5	9.9	10.3	6.9	16.2	10.5	10.1	11.5	15.7	9.5	11.4	10.5	11.8	13.3	14.9	11.8	10.6	9.4	9.4	12.7	9.6	9.6	13.1	13.7	30.0	10.8	7.8	12.5	9.6	9.7	9.0	13.8	7.5	10.4	18.8	11.4	12.4	10.0	9.1	3.2	1.6	1.4	1.4	2.6	3.8	1.0	7.2	4.4	7.6	7.7	7.8	4.7	4.3	5.2	7.3	10.5	9.7	4.3	3.2	16.2	3.7	6.7	6.7	11.6	10.8	10.3	8.3	11.6	7.2	3.7	6.9	5.5	15.7	5.6	4.5	9.5	7.4	11.8	9.0	11.6	10.3	6.8	6.3	7.0	4.9	4.6	5.6	15.9	9.4	11.7	6.9	5.3	8.0	5.5	6.0	5.4	13.3	6.5	6.2	6.9	8.2	27.1	4.6	9.0	6.8	5.5	13.6	5.6	6.5	10.6	0.6	1.4	0.8	2.3	1.4	3.4	3.2	2.8	3.3	1.6	2.4	3.8	3.8	1.4	2.6	1.2	1.2	0.7	1.0	12.5	14.3	20.0	17.2	10.5	10.1	10.5	11.8	9.4	7.5
SRSF12	"SFRS13B, SFRS19, SRrp35"	ENSG00000154548	"Serine and arginine rich splicing factor 12"	Q8WXF0	6	89095959-89118081	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 21.4"	"Cell line enhanced"	"Detected in some"		"AF22: 9.7;AN3-CA: 9.8;HAP1: 7.7;HEK 293: 7.8;REH: 7.6;SCLC-21H: 8.5;SH-SY5Y: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049782	Approved									"HPA049782: "	"unprognostic (6.18e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.58e-4)"	"unprognostic (4.19e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-3)"	"unprognostic (4.17e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.09e-4)"	"unprognostic (2.83e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.96e-3)"	1.5	1.5	6.2	1.7	8.8	1.2	1.5	5.5	9.0	2.0	0.9	1.0	1.1	0.7	2.2	1.8	1.0	1.7	2.3	0.9	7.5	6.3	1.5	0.8	0.8	1.0	3.1	4.5	3.2	1.8	3.2	4.5	1.1	5.7	2.6	0.8	1.6	1.0	2.0	0.7	1.2	0.7	2.3	2.2	0.8	1.4	21.4	2.5	0.0	3.0	0.0	0.9	1.2	0.8	1.4	0.8	1.6	0.6	2.9	1.1	0.2	0.0	0.9	9.7	9.8	0.0	0.0	0.1	0.1	0.1	0.5	1.0	0.3	0.1	0.0	0.9	0.0	0.0	7.7	0.2	1.0	0.1	7.8	0.0	0.1	0.6	1.1	0.0	0.0	0.1	0.4	0.2	0.5	0.0	0.1	0.2	0.2	0.1	0.0	0.3	2.2	0.2	7.6	0.5	0.1	4.8	0.0	8.5	8.3	0.2	0.1	1.4	0.1	2.3	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	1.1	0.6	0.4	1.1	0.4	0.8	0.6	0.8	0.6	0.2	1.4	1.1	0.7	1.6	2.9	0.3	0.8	0.5	0.2	6.2	8.8	5.5	8.9	7.5	6.3	3.1	4.5	5.7	2.5
SSC4D	"S4D-SRCRB, SRCRB-S4D, SRCRB4D"	ENSG00000146700	"Scavenger receptor cysteine rich family member with 4 domains"	Q8WTU2	7	76389334-76409695	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"salivary gland: 9.3;seminal vesicle: 9.5;thyroid gland: 8.6"	"Group enriched"	"Detected in some"	13	"EFO-21: 6.0;Hep G2: 8.1;U-2 OS: 23.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.6"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA062611	Uncertain				"Secreted - unknown location"					"HPA062611: "	"unprognostic (3.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavourable (2.83e-6)"	"prognostic unfavourable (7.08e-4)"	"unprognostic (3.52e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.18e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavourable (4.71e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.73e-2)"	1.1	0.5	0.1	0.1	0.1	0.0	0.4	0.0	0.2	1.0	0.2	0.3	3.0	0.2	0.3	0.8	0.0	0.4	0.1	0.0	0.2	0.2	7.7	0.7	0.2	0.1	0.2	0.8	2.3	4.4	7.8	7.2	0.7	0.4	0.1	0.0	0.8	9.3	9.5	0.4	0.0	0.0	0.2	0.7	0.3	0.1	0.3	0.0	0.0	8.6	0.0	0.2	0.0	0.0	0.3	0.1	0.0	1.6	0.0	0.2	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.8	0.2	0.0	0.7	0.1	0.0	0.0	0.1	0.9	0.4	0.0	0.0	0.1	0.0	0.0	0.0	23.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.6	0.1	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.2	0.2	0.8	0.4	0.0
SSPN	"KRAG, SPN1, SPN2"	ENSG00000123096	Sarcospan	Q14714	12	26121991-26299290	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 20.6;ASC TERT1: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"memory B-cell: 29.7"	"Lineage enriched"	"Detected in many"	21	"B-cells: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066432			Approved	"Nucleoplasm,Nuclear membrane"				"Nuclear membrane"	Nucleoplasm	"HPA066432: "	"unprognostic (4.82e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavourable (2.77e-5)"	"unprognostic (2.64e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.21e-1)"	12.5	6.8	13.9	6.6	12.6	0.1	11.5	16.5	11.4	24.9	12.7	11.1	4.1	2.7	14.6	10.3	11.4	15.0	14.3	26.2	21.0	6.1	3.8	1.4	5.4	4.5	17.2	8.7	21.5	4.7	2.9	4.8	2.5	20.9	14.5	7.3	7.8	6.8	21.1	38.7	3.6	6.3	20.1	20.4	4.9	6.7	5.8	19.0	3.2	10.0	15.4	6.5	18.2	10.8	29.7	0.0	1.4	0.0	0.0	0.2	0.3	0.6	1.1	3.1	0.0	20.6	11.9	0.2	6.1	8.5	0.8	2.4	0.0	7.5	0.0	1.3	8.3	2.4	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	7.4	0.7	2.7	0.6	0.3	0.0	0.1	6.4	1.4	0.4	1.8	6.9	2.0	0.2	8.5	2.3	1.9	6.3	0.3	6.0	2.3	0.4	5.9	0.6	0.3	2.2	2.9	1.5	2.9	1.5	0.2	0.8	0.1	4.5	0.0	7.4	0.0	0.0	1.2	0.0	0.0	0.2	29.7	0.0	0.0	0.0	6.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	13.9	12.6	16.5	11.4	21.0	6.1	17.2	8.7	20.9	19.0
SSTR4		ENSG00000132671	"Somatostatin receptor 4"	P31391	20	23035386-23036812	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	4	"brain: 3.8"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA064252	Uncertain									"HPA064252: "																		0.0	0.0	1.7	0.0	1.1	0.0	0.0	3.0	3.8	0.0	0.0			0.0	0.7	0.0	0.0	0.1	0.0	0.0	1.3	0.4	0.0	0.0	0.8	0.0	0.1		0.0	0.0	0.0	0.0	0.1		0.0	0.1		0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SSX4	CT5.4	ENSG00000268009	"SSX family member 4"	O60224	X	48383516-48393347	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	14	"testis: 6.8"	"Group enriched"	"Detected in some"	10	"BEWO: 3.5;Karpas-707: 8.6;U-266/70: 5.1;U-266/84: 9.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045683	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045683: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.3	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	8.6	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	5.1	9.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0										
SSX4B	OTTHUMT00000056510	ENSG00000269791	"SSX family member 4B"	O60224	X	48402078-48411910	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	14	"testis: 6.7"	"Group enriched"	"Detected in some"	10	"BEWO: 3.5;Karpas-707: 8.6;U-266/70: 5.1;U-266/84: 9.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045683	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045683: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.4	0.0	0.3			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	6.7			0.0		0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	8.6	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	5.1	9.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0										
SSX7		ENSG00000187754	"SSX family member 7"	Q7RTT5	X	52644090-52654900	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Cell line enhanced"	"Detected in some"		"HEL: 1.7;HMC-1: 7.9;RT4: 4.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"											HPA045683	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045683: "																"unprognostic (1.29e-1)"		0.1	0.2	0.2	0.4	0.1	0.7	0.1	0.1	1.0	0.1	0.2			0.6	0.2	0.0	1.5	0.3	0.5	0.1	0.1	0.2	0.1	0.1	0.5	0.3	0.1		0.8	0.1	0.0	0.1	0.0		0.1	0.0		1.8	0.0	0.1	1.5	0.1	0.0	0.1	0.6	0.4	1.0			0.4		0.0	0.2	0.1	0.0	0.2	1.0	0.7	0.3	0.4	0.0	0.4	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.9	0.0	0.1	0.1	0.5	0.3	1.7	0.7	0.3	0.0	0.0	7.9	0.0	0.2	0.2	0.0	0.1	0.2	1.4	0.1	1.0	0.7	0.2	0.0	0.0	0.4	0.5	0.0	0.0	4.2	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.3	0.4	0.6	0.1	0.0	0.1	0.1	0.1	0.5	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.0	0.3	0.7	0.1	0.0	0.0										
ST3GAL1	"SIAT4A, SIATFL, ST3GalA.1, ST3O"	ENSG00000008513	"ST3 beta-galactoside alpha-2,3-sialyltransferase 1"	Q11201	8	133454848-133571940	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 47.8;RT4: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040466	Approved				"Intracellular and membrane"		290000			"HPA040466: AB_10805712"	"unprognostic (1.36e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.83e-3)"	"unprognostic (5.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.83e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.95e-2)"	14.4	14.4	5.1	11.8	3.6	10.2	7.8	3.7	6.5	9.8	5.4	4.1	18.1	1.8	8.5	11.8	9.0	9.0	17.0	35.4	4.2	3.4	23.1	44.5	11.9	12.4	4.7	2.5	10.3	8.2	4.4	7.6	49.8	6.4	7.1	2.9	11.2	18.2	15.1	20.9	4.0	6.5	12.3	3.9	17.3	9.4	5.0	1.4	6.3	40.2	7.9	16.8	14.0	14.3	22.7	7.0	21.3	9.8	21.9	19.9	9.5	4.7	2.5	1.0	2.9	10.3	5.4	5.3	5.4	13.1	2.1	1.6	4.4	5.3	1.1	3.7	10.0	1.4	3.4	4.0	1.9	13.3	0.6	9.9	7.6	8.8	7.9	2.0	7.9	6.3	2.0	7.6	4.2	9.2	0.1	15.4	1.5	5.0	2.8	2.7	0.7	47.8	3.3	1.3	8.1	0.9	36.8	0.2	0.8	2.4	8.2	2.5	1.5	2.7	8.9	6.5	10.3	5.6	2.3	19.0	13.6	1.2	14.8	6.9	6.6	20.5	4.7	21.3	14.4	4.5	13.3	12.8	14.6	16.4	2.9	22.7	19.9	18.5	8.6	21.9	9.8	7.0	8.9	9.5	5.1	3.6	3.7	6.5	4.2	3.4	4.7	2.5	6.4	1.4
ST3GAL2	"SIAT4B, ST3GalA.2, ST3GALII"	ENSG00000157350	"ST3 beta-galactoside alpha-2,3-sialyltransferase 2"	Q16842	16	70375978-70439237	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017270	Approved		Approved	Vesicles	"Intracellular and membrane"			Vesicles		"HPA017270: AB_1857523"	"unprognostic (2.76e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (1.14e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-2)"	"prognostic favourable (2.33e-4)"	"unprognostic (9.54e-2)"	"prognostic unfavourable (3.34e-6)"	"unprognostic (7.42e-2)"	"unprognostic (8.83e-3)"	"unprognostic (4.64e-2)"	"unprognostic (5.20e-2)"	12.6	9.1	9.3	17.2	11.9	14.3	8.9	24.1	10.6	11.3	8.8	5.1	9.3	9.2	13.9	5.6	5.8	9.0	6.8	9.2	10.4	6.0	8.8	12.9	9.3	14.9	5.1	4.7	13.6	4.2	8.8	7.2	8.8	6.8	7.5	4.7	9.9	4.9	9.0	33.3	6.0	10.5	12.0	4.0	17.7	5.4	9.6	5.9	16.0	6.6	4.9	12.6	9.1	12.0	3.2	14.3	11.2	2.2	2.8	4.2	1.1	1.4	8.3	7.2	9.6	3.9	5.3	1.7	5.9	6.3	6.6	3.3	4.9	3.3	4.0	10.6	6.4	1.0	2.9	2.4	3.1	9.5	4.6	17.2	3.4	7.4	4.8	6.2	28.3	4.1	1.4	6.6	1.2	9.0	23.4	3.9	3.6	0.6	6.6	17.1	9.8	4.5	12.6	2.7	5.4	4.4	1.1	3.2	9.5	14.7	0.3	6.5	1.6	7.0	9.6	8.4	10.0	3.5	4.3	8.2	3.2	8.2	9.1	5.2	11.6	2.7	2.0	5.7	2.0	2.2	1.9	1.7	2.4	2.2	1.0	3.2	4.2	3.3	11.2	2.8	1.3	14.3	2.7	1.1	9.3	11.9	24.1	10.6	10.4	6.0	5.1	4.7	6.8	5.9
ST3GAL4	"CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ"	ENSG00000110080	"ST3 beta-galactoside alpha-2,3-sialyltransferase 4"	Q11206	11	126355640-126440344	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 74.2"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 44.7;WM-115: 101.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 57.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 31.3;neutrophil: 22.8;plasmacytoid DC: 29.6"	"Group enriched"	"Detected in many"	11	"dendritic cells: 29.6;granulocytes: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049827	Approved				"Intracellular and membrane"					"HPA049827: "	"unprognostic (8.89e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.93e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.90e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.16e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.36e-3)"	"unprognostic (8.78e-3)"	7.8	38.0	6.2	6.5	12.2	7.8	12.9	4.0	13.6	8.3	27.0	26.4	5.1	2.0	6.0	42.1	25.5	6.0	11.4	26.5	8.6	6.2	16.7	11.5	12.4	9.0	18.7	9.0	39.3	5.1	0.8	5.6	74.2	13.8	12.1	31.5	35.7	14.4	8.0	1.9	5.6	3.8	11.0	23.0	17.0	4.8	18.8	12.4	2.2	6.1	4.3	10.1	21.1	13.2	0.1	29.6	31.3	2.6	1.2	1.7	1.8	4.8	4.0	3.2	2.7	9.4	7.8	7.9	5.6	10.9	5.1	3.5	2.3	8.4	1.4	4.3	8.9	7.6	6.6	3.7	4.0	5.2	1.9	12.4	10.1	2.7	6.1	14.8	25.4	6.2	5.9	7.7	12.2	6.8	7.7	3.7	6.3	20.0	4.7	15.2	2.0	26.5	4.8	9.8	0.6	1.1	14.0	6.0	3.8	6.2	37.7	44.7	13.1	9.8	2.5	12.3	2.8	8.7	10.6	0.3	0.8	0.7	5.6	22.8	101.5	31.3	1.6	0.2	1.7	2.6	1.6	0.1	0.6	1.1	6.6	0.0	0.1	0.8	22.8	1.2	1.2	29.6	0.0	1.8	6.2	12.2	4.0	13.6	8.6	6.2	18.7	9.0	13.8	12.4
ST6GALNAC1	"SIAT7A, ST6GalNAcI"	ENSG00000070526	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1"	Q9NSC7	17	76624761-76643838	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 69.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.1;HaCaT: 6.8;HEL: 10.9;K-562: 32.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 11.2;naive CD4 T-cell: 4.2"	"Lineage enriched"	"Detected in single"	25	"T-cells: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA014767, HPA014975"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"			1200000	"Golgi apparatus"	Nucleoplasm	"HPA014767: , HPA014975: AB_1857529"	"unprognostic (4.59e-2)"	"unprognostic (8.60e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.31e-3)"	"prognostic favourable (2.54e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.87e-3)"	"unprognostic (5.58e-2)"	1.4	0.3	1.2	13.9	2.6	0.7	1.3	0.8	3.2	20.4	50.9	3.1	0.3	19.8	6.3	1.8	19.6	1.5	26.6	4.1	1.6	1.3	0.4	1.1	5.7	1.1	1.8	1.2	2.0	1.1	0.1	0.4	1.7	3.7	2.6	69.4	0.1	20.8	1.4	0.9	0.6	49.0	1.9	1.5	6.0	23.9	4.0	0.6	0.0	0.5	4.5	21.6	1.9	2.6	0.0	0.0	0.4	0.0	0.0	11.2	1.1	0.1	1.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	6.1	0.0	6.8	0.0	1.8	0.0	0.0	0.0	10.9	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	32.6	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.2	0.2	0.0	0.0	4.2	0.0	0.4	0.0	0.0	0.0	1.4	1.1	1.2	2.6	0.8	3.2	1.6	1.3	1.8	1.2	3.7	0.6
ST6GALNAC3	SIAT7C	ENSG00000184005	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3"	Q8NDV1	1	76074719-76634601	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 18.2;HUVEC TERT2: 23.1;SK-MEL-30: 31.5;TIME: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054566, HPA055399"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA054566: , HPA055399: "	"unprognostic (7.85e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.70e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.55e-3)"	"unprognostic (7.31e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.97e-4)"	"unprognostic (3.33e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.44e-4)"	20.7	2.9	7.0	3.6	13.0	5.3	13.9	3.8	9.7	4.3	4.0	13.4	2.0	1.8	10.7	2.1	3.8	4.2	4.7	7.8	8.8	6.0	14.9	3.9	7.5	5.1	16.3	3.6	4.7	2.2	12.6	4.3	5.7	12.9	2.5	4.7	2.8	2.3	3.5	3.3	1.9	2.7	8.3	19.0	3.0	3.0	1.2	12.5	0.0	23.2	1.5	1.7	5.5	5.2	5.9	3.0	5.2	8.3	0.4	1.9	2.6	0.1	0.0	18.2	0.0	0.3	0.0	0.0	0.0	2.1	0.3	0.2	5.8	0.0	0.3	1.2	0.1	0.0	0.0	0.2	0.1	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.8	0.8	0.0	0.0	0.0	1.4	4.5	0.0	0.0	31.5	0.0	0.1	10.2	0.1	1.4	0.0	1.6	0.0	0.0	0.0	0.0	4.1	2.7	0.0	8.3	3.7	0.0	2.9	0.0	3.3	0.5	0.8	3.0	5.9	1.9	1.9	5.2	0.4	5.3	0.0	0.0	2.6	7.0	13.0	3.8	9.7	8.8	6.0	16.3	3.6	12.9	12.5
ST6GALNAC4	"SIAT3C, SIAT7D, ST6GALNACIV"	ENSG00000136840	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4"	Q9H4F1	9	127907886-127917038	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.8;pancreas: 61.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.9;RPMI-8226: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"plasmacytoid DC: 58.8"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009042			Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA009042: AB_1079963"	"unprognostic (2.05e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (8.63e-7)"	"unprognostic (1.62e-2)"	"unprognostic (4.26e-1)"	"prognostic unfavourable (5.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavourable (8.39e-4)"	"unprognostic (1.30e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.03e-2)"	8.0	7.8	5.6	7.9	5.6	26.2	12.1	9.8	8.5	9.2	9.3	4.8	28.9	11.7	8.7	9.6	6.9	8.7	12.2	18.4	5.2	3.4	9.4	5.0	13.5	9.7	4.2	4.7	14.9	61.0	2.4	9.4	4.3	4.8	6.1	5.4	4.8	9.3	30.0	12.6	4.0	9.7	6.1	3.9	18.2	7.2	4.3	4.7	4.7	6.3	5.9	12.5	8.9	8.3	6.7	58.8	0.8	3.2	4.3	3.4	2.4	3.1	5.4	1.4	6.9	9.7	7.4	1.0	5.5	6.1	5.6	3.3	3.0	5.8	20.1	8.4	6.8	7.7	2.8	5.8	0.9	34.9	2.4	6.4	17.2	11.4	11.9	0.5	6.7	9.1	6.2	5.0	4.5	14.9	4.6	13.5	2.7	1.4	1.2	0.7	1.6	13.3	6.0	3.6	49.4	5.7	0.1	11.8	2.6	8.0	17.3	1.0	3.5	4.1	10.6	4.6	5.3	14.3	8.6	21.9	11.3	6.3	9.2	2.8	0.6	0.8	2.1	0.0	2.9	1.9	3.3	6.7	1.8	3.4	2.8	4.9	2.3	3.1	0.2	4.3	3.2	58.8	3.3	2.4	5.6	5.6	9.8	8.5	5.2	3.4	4.2	4.7	4.8	4.7
ST6GALNAC5	"MGC3184, SIAT7E, ST6GalNAcV"	ENSG00000117069	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5"	Q9BVH7	1	76867441-77065711	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.4"	"Cell line enhanced"	"Detected in some"		"AF22: 9.0;fHDF/TERT166: 10.6;HaCaT: 5.1;SH-SY5Y: 7.7;U-2 OS: 8.8;U-251 MG: 4.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.9"	"Group enriched"	"Detected in many"	4	"amygdala: 22.1;basal ganglia: 22.3;cerebral cortex: 12.7;hippocampal formation: 29.4;olfactory region: 14.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA065593, HPA070354"	Uncertain		Approved	Vesicles	"Intracellular and membrane"			Vesicles		"HPA065593: , HPA070354: "	"unprognostic (1.32e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.90e-3)"	"unprognostic (9.66e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.69e-2)"	0.7	10.1	22.1	5.2	22.3	0.4	4.2	0.6	12.7	2.9	3.4	0.3	0.0	1.4	0.9	0.7	3.7	6.9	12.6	1.4	29.4	2.7	0.7	0.6	12.1	1.6	3.0	14.2	6.5	0.8	0.4	8.5	0.9	4.7	4.2	2.7	5.8	1.5	1.6	0.6	1.0	2.1	10.2	0.8	1.0	3.7	1.2	0.2	0.0	0.6	0.0	1.4	4.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	2.3	0.0	9.0	0.0	0.0	0.0	0.0	0.8	3.1	2.6	0.8	0.0	0.2	0.0	0.0	10.6	5.1	0.0	0.0	2.8	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	3.6	0.0	0.0	0.7	0.6	0.0	0.1	2.5	7.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	8.8	0.0	4.9	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	22.1	22.3	0.6	12.7	29.4	2.7	3.0	14.2	4.7	0.2
ST7L	"FAM4B, FLJ20284, ST7R, STLR"	ENSG00000007341	"Suppression of tumorigenicity 7 like"	Q8TDW4	1	112523518-112620825	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042324, HPA075418"	Uncertain		Approved	Centrosome				Centrosome		"HPA042324: AB_10794273, HPA075418: "	"unprognostic (2.99e-2)"	"unprognostic (1.07e-2)"	"prognostic favourable (8.34e-5)"	"prognostic unfavourable (8.96e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.84e-6)"	"unprognostic (2.24e-3)"	"prognostic unfavourable (5.16e-4)"	"prognostic favourable (3.04e-5)"	"unprognostic (2.98e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.12e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.27e-2)"	7.7	9.3	5.7	5.5	9.0	8.6	8.2	12.1	7.9	8.1	6.9	10.0	7.2	5.5	10.0	7.8	6.1	7.9	6.0	8.6	5.6	5.9	6.3	7.6	5.7	5.3	6.1	5.1	9.4	11.6	5.2	12.8	6.4	6.3	7.3	8.0	9.4	7.0	9.0	10.2	8.9	6.2	7.9	6.4	5.2	5.8	49.0	7.0	4.6	11.8	4.6	5.6	6.8	7.7	4.2	3.5	0.3	2.1	6.9	5.2	1.9	4.8	1.5	8.6	6.1	11.8	11.7	2.1	6.2	4.7	2.6	3.9	2.7	4.8	2.1	2.5	2.5	3.4	10.1	8.0	4.1	3.1	6.0	5.9	7.5	1.8	6.8	4.9	6.3	2.1	2.0	3.1	6.4	8.6	3.4	6.8	10.9	1.9	2.6	1.9	3.9	5.3	4.2	4.5	0.7	5.4	5.9	6.3	3.9	3.3	4.7	4.4	3.5	3.0	8.3	6.1	6.0	7.9	6.0	1.8	1.3	2.1	5.5	8.0	13.4	0.1	1.8	0.2	2.4	2.1	3.9	4.2	3.6	1.8	1.7	1.8	5.2	2.8	0.3	6.9	1.6	3.5	2.4	1.9	5.7	9.0	12.1	7.9	5.6	5.9	6.1	5.1	6.3	7.0
ST8SIA2	"HsT19690, SIAT8B, ST8SIA-II, STX"	ENSG00000140557	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2"	Q92186	15	92393828-92468728	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 17.7;heart muscle: 10.0"	"Cell line enhanced"	"Detected in some"		"AF22: 21.8;LHCN-M2: 6.4;RH-30: 9.8;RPMI-8226: 7.1;WM-115: 6.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"pons and medulla: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054518	Approved		Approved	"Centriolar satellite"	"Intracellular and membrane"			"Centriolar satellite"		"HPA054518: "	"unprognostic (4.70e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.87e-2)"		"unprognostic (2.32e-1)"	"unprognostic (1.28e-5)"	"unprognostic (3.91e-2)"	"unprognostic (5.39e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.44e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.00e-1)"	0.3	1.1	1.3	0.2	2.2	0.1	1.2	1.5	3.7	2.6	0.3	0.0	0.0	0.1	1.3	2.5	0.4	0.1	0.7	10.0	3.0	3.6	0.3	0.1	0.1	0.2	2.2	1.4	0.1	0.1	0.1	0.9	0.1	17.7	0.3	0.2	1.0	0.8	0.5	2.1	0.1	0.4	0.2	0.2	0.1	0.2	0.8	0.1	2.5	0.2	1.5	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.2	0.0	3.5	0.0	0.0	9.8	7.1	0.0	0.0	0.5	4.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.2	1.5	2.6	3.0	3.6	2.2	1.4	17.7	0.1
ST8SIA6	SIAT8F	ENSG00000148488	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6"	P61647	10	17318383-17454330	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 17.5"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 105.7"	"Cancer enhanced"	"Detected in some"		"breast cancer: 5.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011635, HPA072708"	Uncertain		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"		"HPA011635: AB_2194921, HPA072708: "	"unprognostic (4.86e-3)"	"unprognostic (7.01e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.23e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.26e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.07e-3)"	1.8	0.9	3.1	1.0	5.0	4.0	14.4	2.5	3.4	1.1	1.7	3.3	0.4	1.0	1.6	10.4	2.4	1.3	1.9	9.1	3.7	4.4	2.5	2.4	17.5	0.8	8.8	1.7	1.1	0.5	0.3	1.3	3.5	5.5	4.3	1.8	13.7	1.9	0.6	2.0	2.8	1.3	1.3	4.3	1.5	1.0	1.2	2.5	0.0	1.8	0.5	2.0	1.1	3.9	0.9	0.7	3.8	1.4	2.1	5.6	0.9	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	13.0	0.0	0.1	0.0	0.0	105.7	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.9	1.2	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.4	1.3	2.5	0.4	0.5	0.3	1.2	1.4	0.7	0.9	1.0	1.7	2.9	2.1	0.7	0.6	5.6	0.9	3.1	5.0	2.5	3.4	3.7	4.4	8.8	1.7	5.5	2.5
STARD4		ENSG00000164211	"StAR related lipid transfer domain containing 4"	Q96DR4	5	111496033-111512590	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046177, HPA048081"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA046177: , HPA048081: "	"unprognostic (1.13e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (4.80e-5)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (5.89e-5)"	"unprognostic (2.00e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.01e-3)"	"prognostic unfavourable (2.84e-4)"	5.2	12.4	9.7	11.2	27.3	12.6	3.2	20.7	17.5	8.5	11.0	6.8	5.5	30.0	6.4	12.9	8.4	4.6	7.6	11.0	12.5	12.5	8.2	25.3	22.0	8.8	10.5	7.3	6.6	4.7	17.2	10.8	27.8	25.5	16.5	13.1	7.1	5.9	8.0	1.6	2.6	29.9	5.4	17.0	8.8	13.2	5.1	16.3	5.1	7.7	5.7	7.4	5.2	8.8	2.8	2.8	11.0	3.1	2.9	4.2	2.1	6.9	3.4	16.8	10.1	15.1	30.3	5.7	7.1	16.1	10.7	31.9	12.7	20.6	8.3	2.9	4.5	3.1	8.5	24.6	10.2	7.9	3.6	6.4	11.0	7.6	16.8	3.1	4.1	16.1	16.9	22.6	16.8	19.6	3.5	16.0	7.1	1.3	7.7	5.7	5.7	1.9	1.8	18.8	7.5	15.6	2.2	9.6	37.3	0.0	4.2	6.4	5.5	10.2	28.9	9.0	8.2	6.0	3.0	5.5	5.1	7.3	8.5	11.9	4.5	11.0	2.1	1.5	4.2	3.1	2.2	2.8	2.0	3.0	2.8	2.7	2.1	3.1	0.0	2.9	2.2	1.9	1.2	2.1	9.7	27.3	20.7	17.5	12.5	12.5	10.5	7.3	25.5	16.3
STEAP1	"PRSS24, STEAP"	ENSG00000164647	"STEAP family member 1"	Q9UHE8	7	90154375-90164829	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 44.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 29.1;CAPAN-2: 34.8;U-138 MG: 44.3"	"Cancer enriched"	"Detected in all"	6	"prostate cancer: 94.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.7"	"Low lineage specificity"	"Detected in single"											HPA030985	Uncertain									"HPA030985: "	"unprognostic (2.88e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.21e-3)"	"unprognostic (9.20e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.74e-3)"	"unprognostic (6.36e-2)"	"unprognostic (6.45e-3)"	"unprognostic (8.31e-3)"	"unprognostic (3.79e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.38e-1)"	19.8	1.5	2.9	16.5	1.4	0.0	26.0	0.9	6.3	5.5	10.0	0.1	0.7	2.7	3.0	4.4	10.0	7.3	8.4	7.1	1.4	0.5	5.3	21.2	9.3	2.9	0.5	2.7	12.4	6.5	0.2	5.8	0.5	1.4	44.7	7.3	1.2	9.8	5.3	3.9	3.3	7.4	13.7	1.4	2.8	7.4	2.1	0.7	0.0	4.6	6.5	3.7	12.5	16.1	0.8	1.7	0.0	0.0	0.0	0.0	0.2	6.7	13.6	0.8	2.5	29.1	24.2	0.2	4.6	5.7	0.6	0.8	10.2	34.8	0.0	0.2	7.5	1.4	5.9	6.4	1.2	0.0	2.2	0.0	0.1	3.4	1.1	0.0	0.0	17.0	0.9	19.2	10.2	25.0	0.3	19.4	7.9	0.1	0.0	0.1	4.1	6.5	0.0	0.0	0.0	5.5	1.4	0.0	0.3	1.7	0.0	3.1	7.7	0.1	12.8	44.3	2.2	22.2	5.6	3.6	0.1	0.0	21.7	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	1.4	0.9	6.3	1.4	0.5	0.5	2.7	1.4	0.7
STK31	"SgK396, TDRD8"	ENSG00000196335	"Serine/threonine kinase 31"	Q9BXU1	7	23710167-23832513	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"testis: 56.0"	"Cell line enriched"	"Detected in some"	8	"CACO-2: 19.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023194	Enhanced									"HPA023194: AB_1857590"	"unprognostic (4.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.29e-6)"	"unprognostic (7.83e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.65e-1)"	0.1	0.0	0.1	0.1	0.7	0.0	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	56.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	19.7	2.4	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.8	0.1	0.2	0.0	0.1	0.1	0.1	0.1
STK32B	"HSA250839, STK32, STKG6, YANK2"	ENSG00000152953	"Serine/threonine kinase 32B"	Q9NY57	4	5051442-5500998	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 23.6;lymphoid tissue: 33.6"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 11.5;REH: 10.1;U-2197: 18.5;WM-115: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"naive B-cell: 1.3;plasmacytoid DC: 3.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.3;dendritic cells: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA058536			Approved	Vesicles,Microtubules				Microtubules	Vesicles	"HPA058536: "	"unprognostic (4.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.64e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.82e-2)"	"prognostic favourable (1.63e-8)"	"unprognostic (8.10e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-3)"	5.2	0.8	6.0	2.1	4.8	2.3	7.3	1.0	5.8	6.0	2.1	5.2	1.6	1.2	5.7	1.6	2.3	2.5	4.7	0.9	4.5	7.6	23.6	0.5	1.3	2.8	5.3	2.2	1.2	4.9	0.8	0.8	5.1	4.2	2.3	2.2	3.0	2.9	1.9	2.1	3.6	1.6	7.0	3.9	0.6	9.5	7.1	2.9	33.6	2.8	2.1	1.9	4.2	6.1	1.3	3.5	0.0	0.5	0.0	0.0	0.0	0.0	5.7	0.3	0.0	0.2	0.4	0.0	4.0	0.5	2.7	0.1	0.0	0.0	0.0	0.8	8.1	0.0	0.6	0.0	1.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	11.5	0.0	0.0	1.4	0.0	0.0	0.8	1.7	0.0	10.1	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	2.9	0.0	1.1	18.5	0.0	0.4	0.0	0.0	0.0	0.0	47.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	6.0	4.8	1.0	5.8	4.5	7.6	5.3	2.2	4.2	2.9
STKLD1	"C9orf96, MGC43306, SGK071"	ENSG00000198870	"Serine/threonine kinase like domain containing 1"	Q8NE28	9	133376367-133406096	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 16.2"	"Low cell line specificity"	"Detected in some"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA029902	Uncertain									"HPA029902: AB_10603554"	"unprognostic (6.65e-2)"	"unprognostic (9.43e-3)"	"unprognostic (7.54e-4)"	"unprognostic (8.15e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.05e-2)"	"unprognostic (2.94e-4)"	"unprognostic (1.92e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.93e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.52e-2)"	0.4	0.4	0.4	0.2	1.4	0.5	0.4	0.7	2.2	0.4	0.3	2.2	1.3	0.5	0.9	2.1	0.3	0.6	0.5	0.3	0.8	0.3	0.3	0.4	0.3	0.8	0.5	1.3	0.8	0.4	0.1	0.3	0.5	1.5	0.5	0.1	0.8	0.6	0.4	0.6	0.8	0.5	0.3	0.5	0.4	0.4	16.2	0.7	0.0	0.3	0.0	0.3	0.3	0.3	0.6	0.4	0.0	0.2	0.2	0.6	0.0	0.0	0.6	0.4	0.6	0.5	0.5	1.1	0.2	0.0	0.1	0.2	0.9	0.3	0.3	0.2	0.0	0.6	0.1	0.0	0.0	0.4	0.8	0.7	0.9	0.5	0.3	0.5	0.4	0.4	0.1	0.0	0.1	0.0	0.8	1.0	0.0	0.2	0.6	0.8	0.3	1.0	0.3	0.3	0.8	0.1	0.1	1.0	1.0	0.3	0.9	2.1	1.3	0.2	0.6	1.0	0.6	0.9	0.1	2.2	2.1	0.6	0.4	0.4	0.3	0.0	0.2	0.0	0.3	0.0	0.2	0.2	0.4	0.2	0.1	0.6	0.6	0.2	0.0	0.2	0.1	0.4	0.0	0.0	0.4	1.4	0.7	2.2	0.8	0.3	0.5	1.3	1.5	0.7
STMN4	RB3	ENSG00000015592	"Stathmin 4"	Q9H169	8	27235323-27258420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"brain: 132.2"	"Cell line enriched"	"Detected in some"	26	"SCLC-21H: 44.0"	"Cancer enriched"	"Detected in some"	27	"glioma: 14.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027765			Uncertain	"Golgi apparatus,Vesicles"				"Golgi apparatus"	Vesicles	"HPA027765: AB_1857607"	"unprognostic (1.52e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.19e-6)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.31e-3)"	"unprognostic (9.84e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.37e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.63e-2)"	1.5	7.9	30.8	1.5	23.4	1.5	1.5	22.2	132.2	1.5	2.3	37.3	0.0	1.8	1.5	2.0	1.5	1.5	1.6	1.4	36.3	27.9	1.5	1.4	1.5	1.5	34.9	37.2	1.4	1.4	1.5	0.0	1.4	21.4	1.5	2.3	0.0	1.5	1.5	1.4	1.5	2.2	1.8	71.8	1.4	1.5	1.6	6.6	0.0	1.4	0.0	1.4	1.5	0.0	1.0	0.9	0.3	0.2	0.1	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.7	0.0	0.1	0.3	0.2	0.4	0.1	1.0	0.7	0.2	0.3	0.1	0.2	0.9	0.4	0.0	30.8	23.4	22.2	34.4	36.3	27.9	34.9	37.2	21.4	6.6
STMND1	FLJ23152	ENSG00000230873	"Stathmin domain containing 1"	H3BQB6	6	17102258-17131372	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.8;pancreas: 9.1"	"Group enriched"	"Detected in some"	5	"HEK 293: 4.0;SCLC-21H: 9.6;T-47d: 11.6"	"Group enriched"	"Detected in some"	6	"breast cancer: 4.1;endometrial cancer: 1.5"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA067970	Enhanced		Approved	"Actin filaments"				"Actin filaments"		"HPA067970: "	"unprognostic (7.70e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (6.88e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.22e-2)"		"unprognostic (3.13e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.72e-2)"	"unprognostic (5.29e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-2)"		0.1	0.0	0.4	0.1	0.8	0.0	3.7	0.6	0.6	1.6	1.0	2.8	1.4	0.1	0.6	4.7	0.1	21.8	6.0	0.1	0.7	0.9	0.1	0.1	7.7	0.1	0.1	0.1	3.5	9.1	0.0	0.7	0.1	2.5	0.1	1.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.2	0.1	0.0	7.4	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.9	1.6	2.8	1.1	0.8	0.8	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.3	0.6	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.2	0.8	0.0	4.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	9.6	0.0	0.0	0.1	0.0	11.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	1.1	0.7	0.3	0.8	0.6	0.4	0.7	0.3	0.2	0.9	0.8	0.7	2.8	0.8	0.8	1.6	0.2	0.4	0.4	0.8	0.6	0.6	0.7	0.9	0.1	0.1	2.5	0.1
STOX2	DKFZp762K222	ENSG00000173320	"Storkhead box 2"	Q9P2F5	4	183797692-184023526	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 11.4;HeLa: 9.7;NTERA-2: 14.4;SH-SY5Y: 13.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049776, HPA065002"	Uncertain		Uncertain	"Nucleoplasm,Actin filaments,Cytosol"				"Nucleoplasm, Cytosol"	"Actin filaments"	"HPA049776: , HPA065002: "	"unprognostic (9.79e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.33e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.57e-4)"	"unprognostic (8.97e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.49e-1)"	3.0	2.8	12.0	1.2	12.6	8.4	3.1	20.3	17.5	3.9	2.1	18.2	1.6	1.6	3.2	5.9	8.2	4.7	4.5	4.9	9.6	8.3	3.4	4.0	3.5	1.1	16.2	18.0	5.8	10.6	12.0	8.1	2.4	11.8	4.1	1.7	2.5	11.0	4.2	3.2	6.2	1.8	3.2	9.2	6.2	3.7	1.6	16.4	0.8	9.6	0.8	1.9	4.3	3.4	0.0	0.1	0.2	0.0	0.0	0.0	0.2	1.7	3.6	11.4	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.2	1.5	0.0	2.3	0.0	0.2	6.3	1.0	0.0	0.0	5.0	0.0	9.7	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.5	0.0	0.5	0.0	0.1	14.4	0.5	0.1	4.2	0.0	2.7	3.5	5.9	13.8	2.7	0.0	0.0	0.2	0.3	0.0	0.0	2.5	0.0	0.1	0.1	3.1	1.8	0.6	0.4	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	12.0	12.6	20.3	16.6	9.6	8.3	16.2	18.0	11.8	16.4
STPG3	"C9orf173, FLJ40246"	ENSG00000197768	"Sperm-tail PG-rich repeat containing 3"	Q8N7X2	9	137251261-137253483	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 55.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.1;RPMI-8226: 3.0;SK-BR-3: 2.9;T-47d: 4.5;U-266/70: 2.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044352			Uncertain	Vesicles				Vesicles		"HPA044352: AB_10965328"	"unprognostic (1.20e-1)"	"unprognostic (5.32e-2)"	"unprognostic (4.32e-3)"	"unprognostic (4.72e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.59e-4)"	"unprognostic (2.09e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.95e-2)"	0.8	0.4	0.2	0.2	0.2	0.1	0.4	0.2	0.2	0.3	0.2	0.2	0.2	4.4	0.2	1.2	0.2	0.3	0.2	0.2	0.2	0.0	1.1	1.7	0.2	0.2	0.2	0.2	0.2	1.4	0.0	1.1	0.2	0.2	0.2	0.0	0.2	1.5	0.2	0.2	0.5	3.2	0.2	0.2	0.2	0.5	55.3	0.2	0.2	1.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.9	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.6	2.0	1.2	0.3	0.0	1.0	0.0	0.0	0.0	7.1	0.0	0.1	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	1.3	1.1	0.0	1.7	0.0	0.2	0.0	0.4	0.0	0.0	3.0	0.0	0.0	0.9	0.6	0.4	2.9	0.0	4.5	0.0	0.0	0.8	1.4	0.2	0.0	2.8	1.5	1.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
STPG4	"C2orf61, FLJ40172"	ENSG00000239605	"Sperm-tail PG-rich repeat containing 4"	Q8N801	2	47045538-47155378	"Predicted intracellular proteins"		"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 29.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047366, HPA052691"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA047366: , HPA052691: "	"unprognostic (6.74e-3)"	"unprognostic (5.81e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.55e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.36e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.64e-6)"	"unprognostic (5.14e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.53e-1)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	29.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.5	2.0	0.6	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.6	0.1	0.0	0.2	0.4	0.0	0.2	0.7	0.5	0.4	0.4	0.4	0.0	0.2	0.0	0.6	0.5	0.5	0.6	0.0	0.1	0.0	0.0	0.6	0.0	1.1	0.9	0.1	0.3	0.1	6.5	0.8	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.4	1.7	0.4	0.0	0.0	0.3	0.1	0.0	0.2	0.6	0.3	0.9	0.1	0.2	0.8	0.2	0.0	0.0	0.6	0.2	0.0	0.1	0.9	0.0	0.6	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.0	2.0	0.0	0.1	1.5	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.6	0.0
STRC	DFNB16	ENSG00000242866	Stereocilin	Q7RTU9	15	43599563-43618800	"Disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"brain: 22.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.5;hTCEpi: 2.2;SCLC-21H: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA048083	Enhanced									"HPA048083: "	"unprognostic (8.60e-3)"	"unprognostic (5.77e-3)"	"unprognostic (6.14e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.99e-4)"	"unprognostic (1.58e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.59e-4)"	0.2	0.5	1.7	0.2	4.2	0.1	0.8	22.9	5.1	0.0	0.2			0.4	0.1	4.7	0.1	0.3	0.2	0.0	2.3	3.2	0.0	0.1	0.1	0.0	1.6		0.4	0.5	0.1	1.7	0.0		0.7	0.2		1.5	0.1	0.4	2.7	0.4	0.0	1.1	0.2	0.2	3.3			0.6		0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.2	0.0	0.8	0.0	0.0	0.1	1.0	1.5	0.0	0.7	0.0	0.0	0.5	0.6	0.5	2.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.2	0.0	0.3	0.5	0.0	0.0	0.1	0.1	1.9	0.1	0.0	0.4	0.9	0.4	0.1	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
STUM	"C1orf95, DKFZp761P211"	ENSG00000203685	"Stum, mechanosensory transduction mediator homolog"	Q69YW2	1	226548800-226609214	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.2"	"Cell line enriched"	"Detected in some"	6	"HEL: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 137.0;basal ganglia: 92.5;cerebral cortex: 117.9;hippocampal formation: 203.1;thalamus: 84.4"	"Group enriched"	"Detected in many"	4	"amygdala: 176.7;basal ganglia: 134.5;cerebral cortex: 191.4;hippocampal formation: 216.5"	HPA074381			Approved	Cytosol				Cytosol		"HPA074381: "	"unprognostic (3.23e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.07e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.62e-2)"	"unprognostic (3.28e-2)"	"prognostic favourable (6.40e-4)"	"unprognostic (1.14e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.79e-3)"	2.8	2.2	30.4	2.1	16.2	0.6	3.5	2.4	32.2	3.7	8.1	6.3	0.0	2.8	3.7	3.0	8.9	3.1	1.6	2.5	21.8	7.0	5.8	0.7	1.2	0.9	6.8	15.9	2.7	1.0	1.9	4.2	1.2	18.2	6.2	3.7	1.4	2.0	2.4	5.0	3.7	3.5	8.7	3.0	1.8	1.8	2.0	7.4	0.0	0.8	0.4	1.0	5.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.0	4.1	0.3	25.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.2	0.0	3.8	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.4	16.2	2.4	30.0	21.8	7.0	6.8	15.9	18.2	7.4
STYXL1	"DUSP24, MK-STYX"	ENSG00000127952	"Serine/threonine/tyrosine interacting like 1"	Q9Y6J8	7	75996338-76048004	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050261	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA050261: "	"unprognostic (6.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.88e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.50e-3)"	"unprognostic (4.77e-2)"	"unprognostic (8.01e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.28e-1)"	"prognostic favourable (8.22e-4)"	9.4	19.2	16.0	10.2	23.1	12.7	17.5	12.8	19.8	15.7	15.1	19.6	13.9	10.5	10.3	21.0	21.1	28.2	9.4	13.2	16.6	12.1	14.8	20.1	11.3	13.7	20.9	13.5	15.4	30.0	15.9	19.9	24.6	16.8	16.6	20.1	12.2	16.0	13.9	12.4	19.3	10.3	14.0	17.0	17.4	14.0	25.0	19.7	20.8	19.9	12.1	19.5	14.8	14.6	19.7	23.0	30.8	29.3	24.7	22.1	17.4	19.7	10.6	8.3	11.1	13.2	14.4	8.7	8.9	12.7	14.5	14.4	12.2	18.0	4.6	4.5	11.8	8.8	13.5	17.9	21.1	14.7	5.9	5.6	5.0	10.9	18.8	7.8	10.3	14.0	21.0	17.4	43.7	14.1	18.1	13.9	12.9	16.0	3.0	33.4	7.0	25.6	11.9	7.0	12.2	18.4	12.9	11.0	11.4	8.3	19.2	22.3	21.1	15.1	7.0	12.5	5.3	13.7	12.6	15.1	9.6	15.7	11.1	14.9	19.4	30.8	29.3	25.8	13.7	25.3	15.2	19.7	13.2	15.2	23.0	15.6	11.7	13.2	24.6	24.7	23.7	15.1	22.1	17.4	16.0	23.1	12.8	19.8	16.6	12.1	20.9	13.5	16.8	19.7
SUSD3	MGC26847	ENSG00000157303	"Sushi domain containing 3"	Q96L08	9	93058688-93085138	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 52.8;testis: 64.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 50.6;MCF7: 12.3;NB-4: 25.8;RPMI-8226: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042310	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA042310: AB_10796902"	"prognostic favourable (5.13e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.65e-1)"	"unprognostic (8.34e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.41e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.33e-2)"	3.2	1.0	3.3	16.9	3.2	18.7	8.0	1.2	3.2	8.3	3.3	8.5	0.6	2.2	11.6	12.8	1.9	18.2	1.9	1.0	2.4	2.7	18.5	13.9	3.8	25.8	4.0	2.3	20.9	0.8	0.2	3.2	1.4	3.7	1.8	0.9	3.0	7.5	1.5	0.4	1.6	9.7	3.0	5.4	20.2	1.9	64.8	3.1	13.9	2.5	0.8	19.9	3.0	3.7	20.4	9.2	16.7	3.9	2.2	52.8	17.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.1	1.1	0.4	50.6	0.2	0.2	0.1	0.8	0.0	0.0	4.4	0.0	6.9	0.0	0.7	3.4	0.0	1.6	3.5	0.2	0.0	0.0	0.0	2.0	11.2	0.0	12.3	0.0	25.8	0.6	1.5	2.1	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.7	11.6	0.1	0.0	0.0	0.0	0.0	2.3	1.2	3.1	0.0	0.0	0.1	0.1	3.9	16.7	5.7	3.4	6.4	20.4	30.1	10.5	9.2	14.4	52.8	21.3	1.3	2.2	0.6	0.8	39.8	17.0	3.3	3.2	1.2	3.2	2.4	2.7	4.0	2.3	3.7	3.1
SUSD4	FLJ10052	ENSG00000143502	"Sushi domain containing 4"	Q5VX71	1	223220819-223364202	"Predicted intracellular proteins, Predicted membrane proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 33.0;esophagus: 33.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 7.0;RPTEC TERT1: 8.3;SCLC-21H: 28.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 7.4;naive CD4 T-cell: 11.7"	"Lineage enriched"	"Detected in single"	66	"T-cells: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058296	Uncertain		Approved	Vesicles	"Intracellular and membrane"			Vesicles		"HPA058296: "	"unprognostic (2.90e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.27e-3)"	"prognostic unfavourable (4.28e-4)"	"unprognostic (2.12e-1)"	"unprognostic (7.01e-2)"	"unprognostic (7.53e-3)"	"unprognostic (1.82e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.51e-6)"	"unprognostic (3.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.11e-2)"	0.8	5.2	15.9	1.5	33.0	0.9	8.1	9.9	21.3	3.4	0.9	4.0	4.7	1.5	0.9	24.3	33.8	3.6	1.3	9.6	30.6	14.6	13.7	4.0	3.2	1.9	6.8	12.8	27.8	7.6	8.3	16.5	1.0	6.6	4.4	0.8	1.2	13.2	5.7	1.2	3.5	0.9	0.9	2.4	0.8	7.6	5.1	3.8	0.3	1.5	8.1	13.8	2.7	9.1	0.0	0.0	0.0	0.1	0.1	11.7	1.8	4.2	0.4	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.7	0.5	4.4	1.3	0.0	1.4	0.1	7.0	0.2	1.0	0.7	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.5	0.0	0.4	0.0	0.3	3.2	3.0	0.0	0.1	0.8	0.0	0.1	0.0	8.3	1.9	28.5	0.3	0.0	2.3	0.0	1.8	0.2	0.0	1.2	5.1	0.0	2.5	0.5	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.3	0.1	6.0	0.0	7.4	1.9	0.0	0.0	11.7	2.1	0.0	0.1	0.0	0.0	1.0	1.8	15.9	33.0	9.9	17.9	30.6	14.6	6.8	12.8	6.6	3.8
SVOP	DKFZp761H039	ENSG00000166111	"SV2 related protein"	Q8N4V2	12	108907741-109021240	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 30.3"	"Group enriched"	"Detected in some"	13	"Karpas-707: 6.1;RPMI-8226: 6.2;SCLC-21H: 3.4;SH-SY5Y: 3.0;U-266/84: 2.8"	"Group enriched"	"Detected in some"	9	"glioma: 0.6;pancreatic cancer: 1.1"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016573	Uncertain									"HPA016573: AB_2197027"	"unprognostic (6.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.51e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.25e-1)"		"unprognostic (3.38e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.28e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.26e-2)"		"unprognostic (6.17e-2)"	0.6	2.9	6.9	0.7	14.0	0.7	0.6	8.2	30.3	0.6	0.8	0.5	0.0	1.3	0.6	0.7	0.6	1.1	0.6	1.1	8.9	1.9	0.7	0.6	0.7	0.6	0.7	10.0	0.6	1.7	0.5	6.8	0.6	6.4	0.8	0.8	1.5	0.6	0.7	0.7	0.6	1.0	0.6	0.8	0.6	1.8	1.0	0.7	0.0	0.7	0.0	0.5	0.6	0.7	0.6	0.4	2.0	0.4	0.9	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	6.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.2	0.0	0.0	3.4	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	2.8	0.1	0.0	0.1	0.0	1.5	0.4	0.4	0.3	0.2	0.2	0.2	0.3	0.2	0.1	0.6	0.3	0.3	2.0	0.9	0.3	0.4	0.2	0.1	6.9	14.0	8.2	21.6	8.9	1.9	0.7	10.0	6.4	0.7
SVOPL	MGC46715	ENSG00000157703	"SVOP like"	Q8N434	7	138594285-138701352	"Predicted membrane proteins"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"parathyroid gland: 13.9;salivary gland: 6.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 8.1;NTERA-2: 2.3;RT4: 1.9;T-47d: 8.2"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	41	"eosinophil: 4.1"	"Lineage enriched"	"Detected in single"	41	"granulocytes: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018035	Uncertain									"HPA018035: AB_2197028"	"unprognostic (6.70e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.59e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.22e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.51e-2)"	0.0	2.1	0.5	0.0	1.1	0.0	1.2	0.0	0.1	0.3	0.9			0.0	0.0	0.7	0.0	2.3	0.0	0.0	1.0	0.8	2.7	0.0	0.2	0.0	0.2		0.7	0.3	13.9	1.8	0.5		0.1	0.1		6.5	0.7	0.0	0.4	0.0	0.0	0.8	0.0	0.0	1.5			1.0		0.0	0.4	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.3	0.0	0.9	0.0	0.3	0.0	1.9	0.1	0.9	0.0	0.7	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SWT1	"C1orf26, FLJ20121, HsSwt1"	ENSG00000116668	"SWT1, RNA endoribonuclease homolog"	Q5T5J6	1	185157080-185291765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.1"	"Cell line enhanced"	"Detected in many"		"U-266/70: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024214, HPA027334"	Enhanced		Approved	Cytosol				Cytosol		"HPA024214: AB_1845642, HPA027334: AB_1845643"	"unprognostic (2.67e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.17e-3)"	"unprognostic (8.41e-3)"	"unprognostic (5.71e-3)"	"unprognostic (9.26e-3)"	"unprognostic (7.37e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.28e-1)"	"prognostic favourable (5.63e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.35e-2)"	5.0	4.8	4.1	3.4	6.0	8.7	8.4	6.5	5.9	5.0	5.8	5.7	7.1	5.6	6.6	5.4	3.8	4.1	4.5	4.4	4.2	4.7	5.7	4.7	5.4	7.6	5.2	4.6	7.7	12.4	5.8	9.9	18.1	6.8	5.7	4.1	3.2	6.7	7.9	5.0	3.9	5.4	4.0	9.1	4.8	6.1	39.1	6.5	7.6	6.1	3.2	3.6	5.2	9.1	4.5	1.5	12.0	4.8	1.0	7.2	1.5	1.9	1.7	4.7	2.6	8.0	6.2	4.0	1.9	3.4	2.5	3.8	1.4	1.6	1.9	3.9	1.5	1.7	2.9	2.6	3.1	5.1	2.0	2.0	1.2	1.8	3.9	0.6	1.7	4.5	2.7	2.7	2.4	6.0	4.3	9.7	2.5	0.6	2.2	1.8	5.1	1.0	1.8	4.3	4.7	2.4	1.2	1.0	7.4	1.6	2.4	6.8	2.8	1.3	2.8	3.2	2.2	3.1	1.2	17.6	13.4	0.7	3.6	1.2	1.2	12.0	2.5	3.4	2.0	2.2	3.7	3.1	4.0	3.0	1.5	4.5	3.9	2.9	7.2	1.0	4.8	1.4	7.2	1.5	4.1	6.0	6.5	5.9	4.2	4.7	5.2	4.6	6.8	6.5
SYCE1L	MRP2	ENSG00000205078	"Synaptonemal complex central element protein 1 like"	A8MT33	16	77199397-77213215	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 22.4"	"Cell line enhanced"	"Detected in many"		"HEK 293: 12.7;U-698: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA062464, HPA066691"			Enhanced	"Intermediate filaments"				"Intermediate filaments"		"HPA062464: , HPA066691: "	"unprognostic (5.54e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.65e-1)"	"prognostic favourable (6.65e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-3)"	"unprognostic (6.28e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.48e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavourable (2.11e-5)"	"unprognostic (9.27e-2)"	"unprognostic (4.27e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.73e-2)"	3.5	3.4	2.8	4.1	2.7	2.9	3.7	5.2	2.4	8.7	5.0	0.4	11.5	2.1	7.8	7.6	4.4	2.8	1.8	7.0	2.8	3.0	4.3	1.4	1.9	4.5	2.1	1.4	8.5	2.7	2.3	2.3	1.6	1.5	6.6	1.6	5.4	11.1	8.7	1.7	4.3	4.6	2.0	2.5	4.2	2.3	22.4	0.4	6.4	8.0	2.0	2.4	2.3	4.4	3.5	12.2	12.0	2.2	2.7	10.5	3.4	2.8	1.1	2.7	1.3	0.3	0.0	0.5	0.8	0.3	0.5	0.9	0.6	5.6	1.8	3.7	0.6	4.0	0.2	0.0	0.3	1.7	12.7	0.4	1.0	0.0	1.8	0.9	1.2	0.1	0.4	0.1	0.3	1.9	0.7	0.2	0.3	4.1	0.7	1.2	1.8	4.4	6.5	0.7	0.6	2.5	0.7	2.8	3.4	0.4	0.3	0.0	0.1	1.1	6.3	0.4	6.4	0.9	0.2	5.4	2.0	9.9	2.8	0.7	0.1	4.0	1.3	12.0	6.1	2.2	7.3	3.5	7.9	8.4	1.6	2.6	8.7	8.0	1.3	2.7	1.6	12.2	10.5	3.4	2.8	2.7	5.2	2.2	2.8	3.0	2.1	1.4	1.5	0.4
SYCN	"FLJ27441, INSSA1, SYL"	ENSG00000179751	Syncollin	Q0VAF6	19	39202831-39204266	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	681	"pancreas: 1347.2"	"Cell line enhanced"	"Detected in some"		"U-2 OS: 1.3;U-266/84: 2.4"	"Cancer enriched"	"Detected in single"	842	"pancreatic cancer: 369.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA047654	Enhanced				"Intracellular and membrane"		1100000			"HPA047654: "											"unprognostic (8.02e-2)"							0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1347.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SYCP2	SCP2	ENSG00000196074	"Synaptonemal complex protein 2"	Q9BX26	20	59863563-59933655	"Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 11.1;testis: 41.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 10.2;MOLT-4: 21.1;SiHa: 37.2;T-47d: 33.6"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.7;cervical cancer: 11.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA062401, HPA065613"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA062401: , HPA065613: "	"unprognostic (8.10e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.74e-1)"	"unprognostic (7.02e-3)"	"unprognostic (4.84e-3)"	"unprognostic (8.48e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.21e-1)"	2.2	0.5	1.3	0.9	2.3	1.4	11.1	2.5	5.7	1.3	1.2	1.0	0.8	1.1	1.1	0.9	0.8	0.8	2.0	2.1	1.2	1.2	3.3	0.8	1.6	3.1	1.8	2.7	0.4	4.9	1.3	3.0	2.9	3.9	2.9	0.8	0.6	3.0	0.7	0.8	2.0	1.7	0.6	1.6	2.3	4.5	41.7	0.8	3.0	1.9	0.2	1.5	1.3	1.0	0.9	0.1	2.6	0.3	0.0	2.7	0.5	0.1	0.5	0.1	0.5	0.2	0.3	0.6	1.6	0.4	0.7	0.1	10.2	1.0	0.0	1.6	0.7	0.2	0.2	0.0	0.4	3.2	0.2	0.1	2.0	0.1	0.0	0.1	7.6	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	4.9	21.1	1.1	0.2	0.1	0.0	0.0	0.1	0.9	2.4	0.1	1.8	37.2	5.4	1.1	33.6	1.9	0.2	0.0	1.1	4.5	0.0	0.0	0.0	0.0	0.0	0.7	2.1	2.5	0.3	2.3	2.6	0.0	2.7	0.7	1.5	1.7	0.1	0.9	0.9	1.5	2.6	0.0	0.1	0.1	1.0	0.5	1.3	2.3	2.5	5.7	1.2	1.2	1.8	2.7	3.9	0.8
SYNGR4		ENSG00000105467	"Synaptogyrin 4"	O95473	19	48364395-48376376	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 41.5"	"Group enriched"	"Detected in some"	5	"A549: 8.9;SCLC-21H: 22.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"cerebellum: 4.1"	"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA030075, HPA059286"	Enhanced		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA030075: AB_10610559, HPA059286: AB_2683965"	"unprognostic (1.58e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.49e-4)"	"unprognostic (2.51e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.72e-3)"	"unprognostic (2.87e-2)"	"unprognostic (6.19e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.02e-7)"	"unprognostic (1.06e-2)"	"unprognostic (1.74e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	0.0	0.0	0.2	0.0	0.7	0.0	0.0	4.1	2.0	0.0	0.2	0.0	0.9	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.7	3.0	0.2	0.2	0.3	0.1	0.2	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.1	0.1	0.0	41.5	0.0	0.3	0.1	0.0	0.2	0.2	0.0	1.3	0.7	0.1	0.5	0.0	0.9	0.6	0.1	8.9	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.5	0.2	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.5	2.9	0.5	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	3.3	0.1	0.2	0.5	0.2	0.0	1.7	0.6	0.0	2.5	0.0	0.0	22.3	0.6	0.1	0.4	0.0	0.3	0.1	0.1	0.0	0.8	0.0	0.0	3.1	1.0	0.7	0.0	0.2	0.4	0.1	0.5	0.0	0.0	0.0	0.0	1.3	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.7	4.1	0.9	0.2	0.1	0.3	0.0	0.3	0.0
SYNPO2L	FLJ12921	ENSG00000166317	"Synaptopodin 2 like"	Q9H987	10	73644881-73663803	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.5;HSkMC: 6.0;RH-30: 5.8;SK-BR-3: 6.1"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA055192, HPA057142"	Enhanced		Supported	"Nuclear speckles,Cell Junctions,Cytosol"				"Nuclear speckles"	"Cell Junctions, Cytosol"	"HPA055192: , HPA057142: "	"unprognostic (2.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-1)"	3.8	0.1	0.0	0.0	0.1	0.1	1.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	3.2	3.3	0.0	0.0	69.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.8	0.0	0.0	1.6	0.0	72.8	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.3	29.3	3.4	0.0	0.3	0.7	1.0	3.0	0.7	0.7	0.7	0.1	0.5	0.1	0.8	0.2	0.1	0.0	1.1	0.9	1.2	0.2	0.0	7.5	0.7	0.3	0.5	0.9	0.1	0.1	0.0	0.4	0.1	0.2	0.3	0.6	0.4	0.6	0.2	0.2	6.0	0.1	1.2	0.1	0.0	0.3	0.3	0.3	0.3	0.2	1.8	0.2	0.7	0.2	5.8	0.2	0.0	0.6	0.3	0.4	0.1	6.1	0.1	0.4	0.7	0.0	0.6	1.0	0.2	0.3	1.0	0.3	0.3	0.2	0.6	0.0	2.9	0.7	0.7	0.7	0.4	0.3	0.5	0.3	0.3	0.2	0.7	0.4	0.4	3.0	0.7	0.4	1.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0
SYPL2	Mg29	ENSG00000143028	"Synaptophysin like 2"	Q5VXT5	1	109466628-109482137	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skeletal muscle: 102.5;tongue: 25.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 19.8;ASC TERT1: 8.3;BJ: 8.4;BJ hTERT+: 26.7;fHDF/TERT166: 13.8;HAP1: 7.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA076657			Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA076657: "	"unprognostic (1.82e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.90e-4)"	"unprognostic (6.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-1)"	"prognostic favourable (3.05e-4)"	"unprognostic (2.54e-3)"	"unprognostic (3.40e-1)"	"unprognostic (9.46e-3)"	"unprognostic (6.39e-4)"	0.9	3.9	0.8	0.3	0.7	0.1	1.4	0.5	1.2	1.6	1.9	0.3	0.8	0.3	2.5	4.3	1.6	0.4	1.1	7.4	0.8	0.2	6.0	4.7	0.6	0.3	0.3	0.0	1.1	3.2	3.7	0.4	1.2	0.8	1.2	0.5	1.7	1.6	2.2	102.5	0.2	0.6	3.5	0.1	0.4	1.1	6.0	0.2	0.0	5.1	25.6	1.2	2.5	2.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	19.8	8.3	0.0	8.4	26.7	2.6	1.0	0.0	0.0	0.0	0.0	13.8	0.0	7.1	0.0	0.5	0.0	3.1	0.0	0.2	0.1	0.4	0.0	0.6	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.9	2.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.5	1.2	0.8	0.2	0.3	0.0	0.8	0.2
SYT10		ENSG00000110975	"Synaptotagmin 10"	Q6XYQ8	12	33374238-33439819	"Predicted membrane proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.6;fallopian tube: 8.1"	"Cell line enhanced"	"Detected in some"		"AF22: 3.7;K-562: 2.2;MCF7: 7.5;NTERA-2: 1.9;RPTEC TERT1: 1.9;RT4: 3.0;SCLC-21H: 3.9"	"Cancer enriched"	"Detected in single"	5	"renal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA055426	Uncertain		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA055426: "	"unprognostic (3.60e-1)"	"unprognostic (4.93e-2)"		"unprognostic (9.34e-4)"				"unprognostic (5.53e-2)"		"unprognostic (3.67e-1)"	"unprognostic (4.74e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.97e-6)"	"unprognostic (4.00e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.91e-1)"	0.3	1.5	0.6	0.7	10.1	0.1	0.3	0.2	4.1	2.9	3.6	0.9	3.0	1.0	0.3	0.8	0.3	8.1	0.4	0.5	0.8	3.1	3.3	1.4	0.2	0.1	0.6	3.4	0.4	0.2	0.1	5.8	0.2	14.6	1.6	1.6	0.1	1.8	3.2	0.2	0.2	1.3	0.6	2.7	0.2	1.6	0.6	0.3	0.0	0.2	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	7.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.9	3.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.1	0.2	4.1	0.8	3.1	0.6	3.4	14.6	0.3
SYT15	CHR10SYT	ENSG00000204176	"Synaptotagmin 15"	Q9BQS2	10	46578217-46594173	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 26.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA036971, HPA036972, HPA064559"	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA036971: , HPA036972: , HPA064559: "	"unprognostic (1.64e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.54e-1)"	"unprognostic (6.91e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.19e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.15e-3)"	4.7	2.4	5.7	6.5	4.8	0.2	3.9	3.1	7.0	11.5	1.6	3.3	1.1	1.3	7.1	3.9	5.3	5.3	3.3	4.3	6.1	4.7	2.9	1.1	13.2	5.3	5.1	2.8	2.4	10.4	4.7	2.3	5.6	11.3	2.7	2.0	7.4	9.2	5.6	2.3	11.4	2.4	3.8	2.7	3.1	1.4	2.4	1.1	1.1	2.7	8.3	4.1	3.1	4.3	1.2	1.8	1.2	3.8	1.8	2.2	1.1	2.2	2.7	1.6	0.6	1.5	1.6	1.8	2.8	4.7	1.8	2.2	5.5	4.7	0.6	1.9	2.4	8.3	0.0	0.7	2.7	1.2	3.0	1.3	2.3	3.7	4.9	2.5	2.4	2.9	0.9	1.4	3.8	1.1	0.6	1.6	0.9	3.9	1.3	4.1	1.0	0.9	1.6	0.0	1.5	2.9	1.2	0.9	1.1	1.9	26.2	1.3	3.7	1.3	3.0	0.8	3.0	1.9	1.7	2.2	2.2	1.9	1.8	1.5	0.7	0.0	1.7	1.2	2.2	3.8	2.1	1.0	1.7	1.1	1.8	1.2	1.5	1.9	0.7	1.8	2.3	1.1	0.5	1.1	5.7	4.8	3.1	6.4	6.1	4.7	5.1	2.8	11.3	1.1
SYT8	DKFZp434K0322	ENSG00000149043	"Synaptotagmin 8"	Q8NBV8	11	1828307-1837521	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 61.8;skin 1: 41.6;urinary bladder: 31.4"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 27.1;hTCEpi: 43.2;T-47d: 11.6"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 33.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052700	Uncertain									"HPA052700: "	"unprognostic (1.66e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.25e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-6)"	"unprognostic (2.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.77e-2)"	0.1	0.1	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.7	0.9	0.0	6.8	0.7	0.1	7.3	19.9	0.6	61.8	0.1	0.1	0.0	0.5	0.3	2.3	0.0	0.0	0.0	0.1	7.8	0.0	0.1	5.7	0.0	5.6	0.1	0.3	11.8	4.2	0.1	41.6	3.6	6.3	0.1	0.1	3.1	0.1	0.0	0.0	0.1	19.4	13.3	31.4	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	27.1	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	43.2	0.0	5.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.8	0.0	0.2	0.0	2.3	0.0	11.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SYTL3	"exophilin-6, SLP3"	ENSG00000164674	"Synaptotagmin like 3"	Q4VX76	6	158650014-158764876	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 55.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.4;U-138 MG: 12.5;U-2 OS: 13.6;U-266/70: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"basophil: 55.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 55.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA030584, HPA030585, HPA030586"	Approved		Approved	"Nucleoli fibrillar center,Vesicles"				"Nucleoli fibrillar center, Vesicles"		"HPA030584: AB_10600196, HPA030585: AB_10601239, HPA030586: AB_10601226"	"unprognostic (3.56e-3)"	"prognostic favourable (8.84e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.33e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.83e-1)"	8.3	1.5	2.3	9.0	3.7	9.4	3.8	0.8	2.4	5.1	7.4	7.1	0.6	2.9	4.6	5.5	3.6	11.6	7.3	5.3	3.4	2.0	4.7	2.2	20.2	26.7	3.5	1.3	2.5	2.3	0.9	2.1	1.3	5.5	5.3	1.8	4.8	12.4	4.8	11.4	3.0	12.0	3.5	10.4	21.9	5.8	3.2	3.9	2.3	21.7	1.2	24.5	18.8	3.6	0.2	1.3	55.6	4.5	10.9	10.2	4.4	4.8	0.7	0.0	0.3	0.7	0.7	0.2	1.9	1.3	0.5	1.4	0.4	3.9	0.0	0.4	3.4	0.5	0.1	0.6	1.9	9.5	0.2	3.7	0.1	0.0	1.2	1.0	16.4	2.2	1.4	4.1	0.7	0.9	0.2	3.7	4.9	0.2	0.1	1.3	0.1	0.7	0.0	4.0	0.4	1.9	0.2	10.9	0.8	0.7	6.9	0.5	1.3	0.2	5.7	12.5	13.6	0.3	0.4	19.2	4.3	0.4	8.1	5.3	0.4	55.6	4.5	0.2	10.2	0.8	6.0	0.2	4.1	6.8	1.3	0.0	4.5	5.5	9.2	10.9	0.3	0.3	4.1	4.4	2.3	3.7	0.8	2.4	3.4	2.0	3.5	1.3	5.5	3.9
TAAR1	"TA1, TAR1, TRAR1"	ENSG00000146399	"Trace amine associated receptor 1"	Q96RJ0	6	132644984-132646003	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"stomach 1: 13.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.7;HBF TERT88: 1.1"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055614	Approved									"HPA055614: "											"unprognostic (2.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.3	0.1	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.4	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	13.6	0.0			0.0		0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TAAR5	PNR	ENSG00000135569	"Trace amine associated receptor 5"	O14804	6	132588673-132589686	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051703	Uncertain									"HPA051703: "																		0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.6	0.2	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TAF7L	"CT40, TAF2Q"	ENSG00000102387	"TATA-box binding protein associated factor 7 like"	Q5H9L4	X	101268253-101293057	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 36.1"	"Cell line enriched"	"Detected in some"	17	"SiHa: 35.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.4"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	10	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.6"					"Low region specificity"	"Detected in all"			HPA001879	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA001879: AB_1857751"	"unprognostic (1.70e-2)"	"prognostic favourable (8.71e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.97e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.12e-2)"	0.1	0.0	1.4	0.1	1.7	0.2	0.1	0.1	0.6	1.6	0.5	0.2	0.1	0.0	0.7	3.5	0.1	0.0	0.1	0.1	0.8	0.2	0.3	0.5	0.1	0.1	0.1	0.8	0.1	0.1	2.5	0.2	0.4	0.3	1.8	0.0	0.4	0.1	1.8	0.1	0.6	0.3	0.1	0.4	0.1	0.1	36.1	0.1	0.1	0.1	0.1	0.1	0.2	0.5	0.1	0.1	1.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.6	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.6	0.0	0.1	0.2	0.1	1.7	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	35.2	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.4	1.7	0.1	0.6	0.8	0.2	0.1	0.8	0.3	0.1
TAS1R1	"GPR70, T1R1, TR1"	ENSG00000173662	"Taste 1 receptor member 1"	Q7RTX1	1	6555181-6579757	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"salivary gland: 10.9;testis: 8.7"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.7;HDLM-2: 4.6;Hep G2: 4.5;LHCN-M2: 3.6;U-698: 2.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	15	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA034579, HPA034580"	Approved									"HPA034579: , HPA034580: AB_10671504"	"unprognostic (2.03e-2)"	"unprognostic (9.29e-3)"	"unprognostic (5.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.53e-4)"	"unprognostic (3.89e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.17e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.22e-2)"	0.4	0.8	0.7	0.1	0.8	1.5	0.4	0.6	1.2	0.7	0.9	0.1	0.1	0.4	0.1	0.1	0.4	0.4	1.0	0.1	1.2	0.2	0.1	0.1	0.6	0.2	0.2	0.1	0.9	0.1	0.0	0.5	0.3	0.5	0.1	0.0	0.7	10.9	2.1	0.6	1.4	0.5	0.1	0.1	1.3	0.5	8.7	0.1	0.1	0.1	2.2	0.5	0.4	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.5	0.1	0.3	0.1	2.7	0.0	0.3	0.0	0.0	4.6	0.0	0.0	0.1	4.5	0.1	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.7	0.8	0.6	1.2	1.2	0.2	0.2	0.1	0.5	0.1
TAS2R38	"PTC, T2R61"	ENSG00000257138	"Taste 2 receptor member 38"	P59533	7	141972631-141973773	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"intestine: 2.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.3;NB-4: 1.1;SK-BR-3: 1.1;U-266/70: 2.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA043862, HPA054366"	Uncertain									"HPA043862: , HPA054366: "			"unprognostic (5.18e-3)"			"unprognostic (6.87e-2)"		"unprognostic (1.22e-1)"		"unprognostic (3.58e-1)"	"unprognostic (1.25e-1)"			"unprognostic (8.36e-2)"	"unprognostic (5.86e-2)"		"unprognostic (8.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5			1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.5		0.1	1.9		0.1	0.0	0.0	0.0	2.2	0.2	0.0	0.2	0.2	0.4			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TAS2R39		ENSG00000236398	"Taste 2 receptor member 39"	P59534	7	143183419-143184435	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA053456, HPA060680"	Uncertain									"HPA053456: , HPA060680: "																		0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.1	0.6	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4		0.5	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TAS2R41	T2R59	ENSG00000221855	"Taste 2 receptor member 41"	P59536	7	143477873-143478796	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057063	Uncertain									"HPA057063: "																		0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.1			0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1			0.0		0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TAS2R42	"hT2R55, T2R24, T2R55, TAS2R55"	ENSG00000186136	"Taste 2 receptor member 42"	Q7RTR8	12	11185993-11186937	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"brain: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA036149	Uncertain		Approved	"Nucleoplasm,Actin filaments,Focal adhesion sites"				"Nucleoplasm, Actin filaments"	"Focal adhesion sites"	"HPA036149: AB_10672080"														"unprognostic (2.45e-2)"	"unprognostic (4.17e-2)"			0.0	0.7	0.2	0.2	0.4	0.0	0.0	1.0	0.2	0.0	0.1			0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.6	0.0		0.7	0.0	0.0	0.4	0.0		0.1	0.0		0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.4	0.2	0.4			0.1		0.0	0.0	0.0	0.7	0.4	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.5	0.0	0.0	0.1	0.0	0.5	0.0	0.4	0.7	0.1	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0										
TAS2R60	T2R60	ENSG00000185899	"Taste 2 receptor member 60"	P59551	7	143443453-143444409	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.3;liver: 1.4;pancreas: 1.3"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 2.3;U-937: 1.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030416	Uncertain									"HPA030416: AB_10603344"						"unprognostic (1.78e-2)"								"unprognostic (7.98e-2)"				0.1	0.0	0.0	0.4	0.0	0.9	0.0	0.1	0.0	0.2	0.3			0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.2	0.0		0.0	1.3	0.5	0.0	0.3		0.0	0.1		0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.5	0.1	0.0			0.0		0.2	0.1	0.2	0.0	0.0	1.0	0.9	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	1.3	0.5	1.0	0.0	0.9	0.0	0.0	0.3										
TBC1D16	"FLJ20748, MGC25062"	ENSG00000167291	"TBC1 domain family member 16"	Q8TBP0	17	79932343-80035848	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 51.3;SK-MEL-30: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"intermediate monocyte: 4.6;naive B-cell: 1.5;non-classical monocyte: 4.7"	"Group enriched"	"Detected in many"	6	"B-cells: 1.5;monocytes: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024482, HPA065839"	Approved		Approved	"Intermediate filaments"				"Intermediate filaments"		"HPA024482: AB_1857790, HPA065839: "	"unprognostic (4.53e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-3)"	"unprognostic (3.99e-3)"	32.2	8.1	10.1	7.8	18.2	1.0	32.6	25.5	11.2	10.7	8.6	6.0	28.4	7.5	11.9	20.9	9.8	12.8	9.3	10.0	8.1	7.8	18.1	13.2	8.5	13.7	8.7	5.6	11.8	18.7	9.3	6.6	7.1	8.2	17.3	5.8	15.4	25.5	24.2	4.5	15.8	7.9	10.8	8.1	8.7	7.6	5.2	9.5	2.7	9.7	7.0	3.9	9.2	14.6	1.5	0.3	0.1	4.7	0.1	0.5	0.3	8.0	7.7	12.0	14.1	51.3	27.1	2.3	4.7	4.7	3.0	3.4	14.5	2.8	0.0	3.3	7.9	2.5	12.7	4.4	2.3	0.4	5.9	0.0	3.5	6.7	8.7	0.1	1.1	30.4	7.9	6.5	4.7	12.7	1.9	5.4	5.5	4.9	2.1	0.7	14.4	4.2	6.8	7.6	4.6	3.5	9.9	12.3	16.0	4.2	11.8	54.4	7.7	3.6	8.5	10.5	7.5	8.2	4.1	16.8	2.9	0.8	4.5	3.0	13.2	0.0	0.3	0.0	0.1	4.6	0.5	0.0	0.1	0.2	0.3	1.5	0.2	0.3	0.1	0.1	4.7	0.0	0.0	0.3	10.1	18.2	25.5	11.2	8.1	7.8	8.7	5.6	8.2	9.5
TBC1D26	MGC51025	ENSG00000214946	"TBC1 domain family member 26"	Q86UD7	17	15732247-15749192	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"testis: 15.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.4;HMC-1: 1.9;U-698: 5.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA050460	Uncertain									"HPA050460: "	"unprognostic (3.65e-2)"	"unprognostic (2.31e-1)"		"unprognostic (7.90e-2)"	"unprognostic (3.22e-1)"			"unprognostic (1.16e-1)"		"unprognostic (3.20e-1)"			"unprognostic (5.15e-9)"	"unprognostic (9.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.24e-1)"	"unprognostic (6.16e-2)"	0.1	0.0	1.5	0.1	3.3	0.0	0.3	0.0	0.5	0.0	0.1			0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.0	0.1	0.0	0.0	0.3	0.1	0.1		0.2	0.1	0.2	0.0	0.1		0.1	0.0		0.1	0.1	0.0	0.3	0.0	0.2	0.1	0.1	0.0	15.3			0.0		0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	1.4	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.9	0.2	0.0	1.9	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.2	1.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	1.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TBC1D29	DKFZP434O047	ENSG00000266733	"TBC1 domain family member 29"	Q9UFV1	17	30557112-30563493	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"testis: 10.9"	"Cell line enhanced"	"Detected in some"		"U-937: 4.0"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"											HPA059178	Uncertain									"HPA059178: "	"unprognostic (5.64e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.58e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.96e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.49e-4)"	"unprognostic (7.32e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-4)"	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.5	0.1	0.0	0.0			0.1	0.0	1.5	0.0	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.1		0.0	0.1	0.0	0.4	0.0		0.2	0.1		0.2	0.1	0.3	0.8	0.1	0.0	0.1	0.2	0.2	10.9			0.3		0.3	0.2	0.0	0.9	0.3	1.1	0.2	0.0	0.4	0.0	1.5	1.4	1.0	0.5	0.5	0.5	2.0	0.6	0.2	0.3	0.7	0.8	1.3	0.5	0.5	0.1	2.5	0.3	0.3	0.4	0.5	1.2	0.7	2.8	0.1	0.0	1.0	1.5	1.0	0.8	1.1	0.3	0.2	0.1	1.5	0.2	0.6	0.2	1.2	0.4	0.7	0.7	0.7	0.9	0.3	2.2	0.4	0.7	0.1	0.2	0.2	1.6	0.2	0.6	0.6	1.3	0.8	0.3	1.5	1.2	0.1	0.4	4.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.9	0.0	0.4	1.1	0.0	0.0	0.2	0.0	0.0										
TBC1D32	"bA57L9.1, BROMI, C6orf170, C6orf171, dJ310J6.1, FLJ30899, FLJ34235"	ENSG00000146350	"TBC1 domain family member 32"	Q96NH3	6	121079494-121334745	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 25.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 21.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013413	Uncertain		Approved	Mitochondria				Mitochondria		"HPA013413: AB_10602702"	"unprognostic (3.31e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.12e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.60e-4)"	"unprognostic (7.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.57e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.06e-1)"	3.2	7.3	7.3	5.5	8.8	2.4	5.0	3.9	11.1	5.7	3.5	4.8	3.8	4.5	5.1	4.1	4.1	4.8	5.6	3.5	7.0	4.1	4.5	1.8	3.2	3.0	8.1	7.8	6.5	4.0	9.7	25.4	8.2	8.0	5.0	2.4	4.2	4.6	3.2	1.7	5.5	4.6	2.4	7.0	3.1	3.8	9.2	7.9	8.1	7.0	2.1	3.2	3.7	5.1	6.4	10.7	5.8	1.3	3.4	3.7	0.4	1.6	1.9	3.1	4.2	2.8	4.4	1.6	1.8	2.7	3.1	4.5	0.1	1.1	2.9	3.0	2.0	1.5	1.5	1.6	3.7	21.6	2.1	3.6	0.6	0.7	1.2	1.7	1.4	1.7	1.1	2.8	2.0	0.6	2.1	0.0	2.4	1.0	2.0	1.1	1.8	0.7	1.8	1.6	0.2	1.7	0.7	6.5	3.2	2.2	1.3	1.0	2.0	1.5	0.4	2.0	2.0	0.5	2.0	1.4	0.0	1.2	2.7	1.0	3.2	5.8	1.3	1.7	2.6	0.7	1.9	3.4	1.9	1.8	0.8	6.4	3.7	2.8	1.1	3.4	1.1	10.7	2.1	0.4	7.3	8.8	3.9	11.1	7.0	4.1	8.1	7.8	8.0	7.9
TBC1D3B	"PRC17, TBC1D3I"	ENSG00000274808	"TBC1 domain family member 3B"	A6NDS4	17	36165681-36176636	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skin 1: 6.6;testis: 3.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 11.3;HeLa: 9.7;T-47d: 7.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles		"HPA046969: , HPA047745: , HPA052553: "	"unprognostic (1.05e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.15e-2)"	"unprognostic (9.96e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.34e-1)"	0.0	0.1		1.0		0.4	0.4		0.1	0.0	0.1			1.2	0.0	0.0	1.0	0.4	0.2	0.0			0.0	0.0	0.2	0.6			0.1	1.3	0.0		0.0		0.2	0.0		0.8	0.8	1.2	6.6	0.5	0.0		2.0	1.9	3.5			0.0		0.1	0.4		0.0	0.0	0.7	0.0	1.0	0.4	0.1	1.4	2.4	1.4	1.8	1.5	1.8	4.8	1.2	0.7	1.3	2.1	0.5	11.3	0.2	0.9	0.7	4.9	0.7	1.1	0.5	2.0	3.8	0.8	9.7	0.7	0.9	0.3	1.4	1.5	2.2	1.5	0.2	0.9	0.7	1.1	0.4	0.1	1.0	4.3	0.5	0.5	1.5	0.4	0.1	1.5	1.4	0.9	1.3	1.1	0.7	0.9	7.9	1.0	2.7	0.5	0.4	3.9	0.5	1.6	1.2	0.5	1.4	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.1										
TBC1D3C	MGC44903	ENSG00000278299	"TBC1 domain family member 3C"	Q6IPX1	17	38057693-38068592	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.3;skin 1: 3.5;testis: 3.4"	"Cell line enriched"	"Detected in some"	5	"CAPAN-2: 26.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles		"HPA046969: , HPA047745: , HPA052553: "																		0.0	0.0		0.6		3.3	0.0		0.0	0.0	0.0			0.9	0.2	0.0	0.0	0.5	1.2	0.5			0.1	0.0	1.8	1.0			0.7	0.0	0.0		0.0		0.0	0.0		0.8	0.0	1.3	3.5	0.0	0.1		0.0	1.5	3.4			0.0		0.9	0.0		0.0	0.0	0.8	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.2	0.1	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.5	0.2	0.0	1.0	0.0	0.0	5.4	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0										
TBC1D3D		ENSG00000274419	"TBC1 domain family member 3D"	A0A087WVF3	17	38003976-38014902	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 7.9;skin 1: 4.2"	"Cell line enhanced"	"Detected in some"		"AF22: 3.8;CAPAN-2: 11.3;HaCaT: 8.2;HeLa: 9.2;RPMI-8226: 4.9;RT4: 5.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles		"HPA046969: , HPA047745: , HPA052553: "																		0.0	0.0		0.0		0.0	0.2		0.0	0.0	0.0			2.0	1.1	0.0	0.0	0.0	0.0	0.9			0.0	0.0	0.4	0.2			0.0	0.0	0.0		0.8		1.5	0.8		0.0	0.0	0.8	4.2	7.9	0.0		0.0	0.0	2.6			0.0		0.5	0.0		0.0	0.0	0.7	0.2	0.0	0.3	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	2.1	9.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	4.9	0.0	5.5	0.5	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	2.9	1.0	0.0	3.4	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0										
TBC1D3E		ENSG00000278599	"TBC1 domain family member 3E"	A0A087X179	17	38127951-38138862	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.9;gallbladder: 3.0;pancreas: 4.3;testis: 4.1"	"Cell line enriched"	"Detected in some"	4	"HHSteC: 9.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles		"HPA046969: , HPA047745: , HPA052553: "	"unprognostic (1.18e-1)"	"unprognostic (3.35e-1)"			"unprognostic (3.51e-1)"					"unprognostic (4.22e-2)"	"unprognostic (6.28e-2)"		"unprognostic (1.87e-2)"	"unprognostic (5.07e-3)"			"unprognostic (1.32e-3)"	0.0	0.0		0.0		3.9	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	3.0	0.0			0.0	0.0	0.0	1.7			0.0	4.3	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.1			0.0		0.0	0.0		0.0	0.5	0.9	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	9.5	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0										
TBC1D3G		ENSG00000260287	"TBC1 domain family member 3G"	Q6DHY5	17	36323884-36334759	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	10	"testis: 8.7"	"Group enriched"	"Detected in some"	35	"SiHa: 5.4;U-2197: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Supported		Approved	Vesicles				Vesicles		"HPA046969: , HPA047745: , HPA052553: "					"unprognostic (4.41e-1)"					"unprognostic (1.17e-2)"				"unprognostic (5.01e-2)"				0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	8.7			0.0		0.0	0.0		0.0	0.0	0.5	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1										
TBC1D3H		ENSG00000274226	"TBC1 domain family member 3H"	P0C7X1	17	36377531-36388423	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"cervix, uterine: 1.6;testis: 5.0;urinary bladder: 3.3"	"Cell line enriched"	"Detected in some"	10	"CAPAN-2: 11.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Approved	Vesicles				Vesicles		"HPA046969: , HPA047745: , HPA052553: "																		0.0	0.0		0.0		0.2	0.0		0.0	1.6	0.0			0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.5	0.0	0.0	0.0	0.0	0.0		0.0	0.0	5.0			0.0		0.0	3.3		0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1										
TBC1D3L		ENSG00000274512	"TBC1 domain family member 3L"	B9A6J9	17	37977972-37989048	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skin 1: 10.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.9;NB-4: 22.1"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in some"		"neutrophil: 3.8"	"Low lineage specificity"	"Detected in many"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles		"HPA046969: , HPA047745: , HPA052553: "	"unprognostic (5.14e-2)"	"unprognostic (8.71e-2)"	"unprognostic (8.44e-2)"		"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.63e-6)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-3)"	0.5	2.4		1.8		0.6	1.8		1.3	0.2	1.2			2.4	0.0	2.9	2.4	1.2	0.8	0.0			0.0	0.6	1.0	1.8			0.5	0.3	0.1		0.3		1.4	1.1		3.3	1.3	4.1	10.8	1.0	0.2		2.7	1.8	0.9			0.0		0.3	1.2		0.6	0.3	3.8	0.8	1.0	1.0	0.4	7.4	9.8	4.0	6.0	7.5	6.9	23.9	3.4	2.3	3.1	3.6	5.4	0.1	2.5	0.1	4.3	12.2	3.6	3.2	2.0	7.3	9.3	0.0	15.9	2.3	5.4	1.0	9.3	5.8	8.0	4.0	2.3	4.1	1.9	8.8	5.0	4.0	4.4	22.1	3.8	2.2	2.9	4.6	0.0	9.7	10.2	5.5	7.6	0.0	4.0	4.4	5.8	1.5	9.4	0.0	5.4	4.1	4.6	6.2	2.7	0.0	6.2	3.1	3.5	0.0	0.8	0.9	0.3	0.6	0.0	0.1	0.3	0.9	0.1	0.6	0.6	1.0	3.8	1.0	0.8	0.3	0.3	0.4										
TBC1D9	"GRAMD9, KIAA0882, MDR1"	ENSG00000109436	"TBC1 domain family member 9"	Q6ZT07	4	140620765-140756120	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	7	"breast cancer: 85.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 9.0"	"Group enriched"	"Detected in many"	38	"B-cells: 9.0;dendritic cells: 4.6;monocytes: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000262, HPA006503"	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA000262: , HPA006503: "	"unprognostic (1.41e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.77e-2)"	"prognostic favourable (1.61e-6)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.16e-2)"	15.9	6.2	8.1	9.2	10.0	1.0	33.6	37.6	13.7	9.2	6.7	3.8	32.1	5.2	5.5	6.4	5.9	6.7	9.4	5.7	7.5	13.9	10.7	8.0	10.4	9.6	9.6	8.2	10.9	6.0	9.9	5.7	13.1	11.0	9.8	4.3	10.6	7.3	27.4	1.7	2.8	9.9	5.0	5.3	20.4	10.0	2.9	3.8	1.6	4.3	3.0	12.2	11.1	8.9	9.0	4.6	0.1	2.4	0.1	0.0	0.9	0.4	6.3	5.9	5.1	14.5	13.7	12.1	8.1	8.8	5.9	7.6	1.3	5.6	0.0	5.2	10.6	1.2	7.4	5.8	5.6	0.0	4.1	3.6	4.6	5.4	5.3	0.4	0.5	11.3	9.7	5.1	20.6	16.3	0.0	0.0	5.5	6.3	0.8	0.0	0.9	5.6	3.9	9.7	9.3	6.7	11.7	8.7	6.2	8.4	14.9	5.5	3.5	0.2	25.3	15.7	4.7	10.1	6.9	0.0	0.0	0.0	9.5	0.7	8.5	0.0	2.4	0.0	0.0	1.9	0.0	9.0	0.0	0.0	4.0	4.0	0.0	0.0	0.1	0.1	0.7	4.6	0.0	0.9	8.1	10.0	37.6	13.7	7.5	13.9	9.6	8.2	11.0	3.8
TBL1Y	TBL1	ENSG00000092377	"Transducin beta like 1 Y-linked"	Q9BQ87	Y	6910686-7091683	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 15.1;thyroid gland: 10.8"	"Cell line enriched"	"Detected in some"	6	"U-698: 14.1"	"Cancer enriched"	"Detected in single"	6	"prostate cancer: 1.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"MAIT T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"									HPA060073	Uncertain									"HPA060073: "						"unprognostic (2.81e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.06e-1)"			"unprognostic (7.76e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.47e-1)"		"unprognostic (3.24e-2)"	1.0	0.0	0.1	0.2	0.5	0.1	1.0	0.1	0.4	0.0	0.4	0.5	0.0	0.2	0.1	1.5	1.3	0.1	3.8	0.1	0.1	0.2	1.4	3.3	3.0	0.8	0.1	0.0	0.1	15.1	0.0	0.1	0.3	0.7	7.2	0.4	1.6	5.8	0.7	1.3	0.6	0.3	0.1	0.0	0.1	0.7	3.5	0.0	0.1	10.8	2.9	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	2.2	0.0	2.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.4	0.1	0.2	0.1	0.0	0.7	0.0
TBPL2	"TBP2, TRF3"	ENSG00000182521	"TATA-box binding protein like 2"	Q6SJ96	14	55413541-55456726	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"skeletal muscle: 3.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.9;HMC-1: 5.2;U-937: 6.7"	"Cancer enriched"	"Detected in single"	40	"testis cancer: 2.0"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA056241	Uncertain									"HPA056241: "					"unprognostic (3.42e-1)"	"unprognostic (1.16e-1)"				"unprognostic (1.50e-1)"			"unprognostic (3.06e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"		0.4	0.9	0.2	1.7	0.6	0.7	0.4	0.4	0.4	0.8	0.5			2.0	1.3	0.0	0.2	0.2	0.0	0.3	0.3	0.4	0.6	0.3	0.5	0.4	0.5		1.1	0.2	0.2	0.3	0.0		0.3	0.0		1.0	0.0	3.9	3.1	1.2	0.0	0.3	0.8	0.9	1.9			0.5		0.0	0.2	0.3	1.5	1.1	1.5	1.1	1.6	0.9	0.5	3.2	1.0	0.0	1.0	0.0	1.1	2.2	0.0	0.0	0.0	0.4	0.4	0.5	0.6	2.7	0.0	0.8	0.2	0.0	0.0	8.9	0.0	0.6	0.8	0.0	0.0	0.0	5.2	0.0	1.7	0.0	0.4	0.0	0.5	3.2	0.0	2.3	0.5	1.7	0.7	0.9	0.8	0.0	0.6	0.0	1.3	1.8	0.9	0.0	0.2	0.3	1.2	1.1	0.0	0.3	4.2	0.4	0.7	3.1	1.4	0.4	0.5	6.7	0.2	1.5	0.5	0.5	0.9	1.1	0.6	1.0	0.5	0.4	0.6	1.5	0.5	0.2	1.0	1.6	0.3	1.1	0.1	0.5										
TBX10	"TBX13, TBX7"	ENSG00000167800	"T-box 10"	O75333	11	67631303-67639560	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	14	"intestine: 12.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.9;NTERA-2: 6.6;RPMI-8226: 4.3;SK-BR-3: 15.5;U-2 OS: 3.3"	"Group enriched"	"Detected in some"	5	"breast cancer: 0.8;colorectal cancer: 2.6;liver cancer: 0.5;prostate cancer: 1.9;stomach cancer: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"pons and medulla: 0.4"	"Low region specificity"	"Detected in many"			HPA047881	Uncertain				"Intracellular and membrane"					"HPA047881: "	"unprognostic (4.66e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.83e-4)"	"unprognostic (3.12e-1)"	"unprognostic (3.29e-2)"		"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.90e-1)"	"unprognostic (1.17e-10)"	"unprognostic (6.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.75e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	9.9	0.2	0.2	6.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.8	0.2	0.2	0.2	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	9.1	0.2	0.4	0.2	0.2	0.0	12.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.0	15.5	0.0	0.0	0.1	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
TCEAL2	"my048, MY0876G05, WEX1"	ENSG00000184905	"Transcription elongation factor A like 2"	Q9H3H9	X	102125688-102127711	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.0;ovary: 46.5"	"Group enriched"	"Detected in some"	4	"HAP1: 7.2;SCLC-21H: 7.9;U-2 OS: 14.2"	"Cancer enhanced"	"Detected in many"		"glioma: 22.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.8;naive CD8 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 2.1"									HPA076317			Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA076317: "	"unprognostic (2.34e-3)"	"unprognostic (1.35e-2)"	"unprognostic (7.59e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.80e-2)"	"unprognostic (3.47e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.11e-3)"	2.4	19.6	34.1	2.6	44.6	1.1	2.4	40.9	84.0	5.8	7.0	8.5	1.8	3.1	19.5	8.6	5.3	7.3	6.4	5.1	30.0	37.9	8.2	1.3	4.4	1.6	25.4	26.5	46.5	3.7	2.8	38.3	1.1	30.1	19.4	3.8	6.6	16.4	21.6	1.2	1.7	3.2	14.0	16.1	2.9	4.2	19.7	9.6	0.0	25.6	0.0	2.1	4.3	2.6	0.1	0.1	0.0	0.1	0.0	2.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.1	0.0	0.0	7.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.8	0.1	1.7	0.0	0.1	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.1	0.4	34.1	44.6	40.9	41.8	30.0	37.9	25.4	26.5	30.1	9.6
TCEAL6	WEX2	ENSG00000204071	"Transcription elongation factor A like 6"	Q6IPX3	X	102140476-102142970	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 14.3;brain: 48.4;pituitary gland: 20.7;testis: 21.9"	"Cell line enhanced"	"Detected in some"		"BJ: 1.1;SCLC-21H: 1.9"	"Cancer enriched"	"Detected in single"	9	"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											"HPA045564, HPA058982"	Supported									"HPA045564: , HPA058982: "	"unprognostic (5.43e-2)"			"unprognostic (6.54e-2)"	"unprognostic (1.87e-3)"			"unprognostic (6.69e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.18e-1)"		1.1	14.3	16.6	1.3	15.2	1.0	1.1	31.4	48.4	1.2	1.4	2.5	0.0	1.3	5.3	2.8	1.1	3.2	1.1	1.1	11.3	26.0	1.2	1.0	1.0	1.0	15.2	7.5	6.1	1.3	1.1	20.7	1.0	12.5	1.9	1.3	2.0	3.1	1.9	1.0	1.0	1.3	1.9	7.5	1.0	1.0	21.9	2.8	0.0	1.8	0.0	1.0	1.0	1.7	0.7	0.6	0.1	0.5	1.3	0.7	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.3	0.0	0.0	0.7	0.0	0.3	0.1	0.5	0.1	0.5	0.3	0.7	0.4	0.2	0.3	0.5	0.7	0.4	0.6	0.0	1.3	0.0	0.6	0.6	0.6	16.6	15.2	31.4	26.0	11.3	26.0	15.2	7.5	12.5	2.8
TCEAL7	"MGC23947, WEX5"	ENSG00000182916	"Transcription elongation factor A like 7"	Q9BRU2	X	103330196-103332326	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 70.4"	"Cell line enhanced"	"Detected in some"		"AF22: 23.2;BJ hTERT+ SV40 Large T+ RasG12V: 20.9;hTEC/SVTERT24-B: 23.2;LHCN-M2: 19.6;SCLC-21H: 58.6;U-87 MG: 21.8"	"Cancer enriched"	"Detected in many"	10	"glioma: 39.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA051507, HPA065080"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA051507: , HPA065080: "	"unprognostic (1.09e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (4.31e-4)"	"prognostic unfavourable (3.53e-4)"	"unprognostic (2.62e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.35e-3)"	4.9	22.1	31.7	3.8	33.4	1.0	7.8	33.0	70.4	16.8	6.4	20.1	1.8	3.9	36.4	14.7	5.1	5.4	9.7	9.5	31.1	44.2	4.6	2.6	3.8	2.5	34.4	27.4	23.2	1.3	1.3	14.0	2.5	51.8	10.3	6.9	2.0	2.9	11.3	2.9	1.5	4.9	23.3	45.1	5.0	2.6	3.2	19.4	0.0	3.0	2.2	1.9	7.5	5.7	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	23.2	0.0	10.2	15.8	4.1	3.3	17.0	7.3	20.9	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.4	12.6	0.0	0.2	0.1	0.0	0.0	5.1	0.0	0.0	13.2	0.0	23.2	0.0	7.5	0.1	0.0	19.6	0.0	0.0	0.0	0.1	0.0	0.0	14.7	0.0	0.0	0.0	58.6	15.7	0.0	0.1	0.0	0.0	0.0	0.0	10.8	0.4	0.1	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	31.7	33.4	33.0	46.7	31.1	44.2	34.4	27.4	51.8	19.4
TCF15	"bHLHa40, EC2, PARAXIS"	ENSG00000125878	"Transcription factor 15"	Q12870	20	603797-610398	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 11.4;heart muscle: 19.4;skeletal muscle: 18.0"	"Cell line enhanced"	"Detected in some"		"HEL: 10.7;HMC-1: 17.6;U-2 OS: 3.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050998, HPA060221"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA050998: , HPA060221: "	"unprognostic (2.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavourable (3.25e-4)"	"unprognostic (1.52e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.21e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.11e-1)"	"unprognostic (6.99e-2)"	8.4	0.3	0.9	0.4	1.0	0.2	11.4	0.1	1.1	0.6	1.3	0.1	0.0	0.4	0.8	0.3	1.7	0.4	0.7	19.4	1.2	0.7	0.5	0.3	0.9	0.3	1.0	0.0	0.2	0.1	0.4	0.3	8.2	0.7	1.0	0.3	0.3	0.8	0.3	18.0	0.2	0.4	1.3	1.1	0.2	0.4	1.6	0.6	0.2	1.3	6.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	1.5	0.0	0.0	0.0	3.0	10.7	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	1.6	0.0	1.4	0.0	0.0	1.4	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.1	1.1	1.2	0.7	1.0	0.0	0.7	0.6
TCF21	"bHLHa23, POD1"	ENSG00000118526	"Transcription factor 21"	O43680	6	133889138-133895553	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lung: 74.4;ovary: 61.6"	"Cell line enriched"	"Detected in some"	12	"HHSteC: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013189	Uncertain									"HPA013189: AB_10601215"	"unprognostic (2.43e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-1)"		"unprognostic (8.60e-2)"	"unprognostic (4.78e-5)"	"unprognostic (2.58e-2)"		"unprognostic (6.66e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.95e-1)"	4.7	2.2	0.2	11.6	0.5	0.0	0.4	0.2	0.2	12.7	16.8	0.4	9.6	5.2	12.9	9.6	19.1	2.2	14.6	13.2	0.2	0.2	17.0	4.1	74.4	1.0	0.2	0.0	61.6	1.9	0.0	2.4	48.4	1.2	57.8	5.3	0.0	0.2	16.0	0.8	0.3	13.9	21.1	0.2	52.2	5.7	5.9	0.0	0.0	0.5	0.0	0.0	19.6	24.6	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.0	1.2	0.0
TCF23	"bHLHa24, OUT"	ENSG00000163792	"Transcription factor 23"	Q7RTU1	2	27149004-27156974	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis"	"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 28.0;endometrium 1: 56.4;ovary: 49.9"	"Cell line enriched"	"Detected in single"	10	"THP-1: 8.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA044596			Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA044596: AB_10797258"	"unprognostic (1.04e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.41e-5)"	"unprognostic (7.58e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.58e-4)"	"unprognostic (2.64e-2)"	0.3	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.1	28.0	0.5	0.0	0.5	0.0	56.4	7.2	0.1	14.0	0.4	0.6	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	49.9	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	16.7	0.1	6.2	0.1	7.5	0.0	0.0	0.1	0.0	0.0	0.7	1.5	1.8	1.4	4.4	1.0	1.3	1.2	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.3	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.5	0.0	0.5	0.1	0.6	0.3	0.1	0.8	0.1	0.7	0.0	0.3	0.2	0.1	0.2	0.3	0.0	0.3	8.6	0.0	0.2	0.2	0.3	0.2	0.1	0.0	0.2	0.1	0.3	0.0	4.4	1.0	0.9	1.0	0.5	0.8	1.1	1.1	0.8	0.2	1.8	1.2	1.0	3.9	1.3	0.5	1.4	0.6	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
TCF7L1	TCF3	ENSG00000152284	"Transcription factor 7 like 1"	Q9HCS4	2	85133410-85310388	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 17.9;NTERA-2: 41.8;RH-30: 19.0;T-47d: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071298			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA071298: "	"unprognostic (1.59e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.64e-3)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (6.16e-5)"	"unprognostic (1.79e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (2.06e-4)"	"prognostic unfavourable (2.72e-4)"	"unprognostic (1.70e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (5.38e-4)"	21.0	3.9	3.3	6.5	6.4	4.2	28.7	5.1	5.3	28.2	14.7	7.5	14.5	4.1	21.2	11.8	13.8	10.4	9.1	11.6	6.0	3.0	9.3	7.6	11.1	5.5	4.5	3.8	20.3	3.2	11.6	5.7	4.8	6.3	14.0	4.3	16.8	8.8	19.6	13.4	8.3	6.9	17.8	5.9	7.9	6.8	7.3	5.5	2.2	18.6	8.7	6.1	18.0	20.4	3.7	2.0	8.4	1.2	1.8	2.2	0.4	0.9	0.7	14.2	10.8	5.4	1.1	8.7	1.0	3.5	2.4	2.3	2.1	0.9	0.4	1.7	2.3	2.2	10.8	17.9	1.7	0.8	1.7	0.3	0.8	0.9	0.5	0.8	2.1	0.9	3.3	0.2	0.6	4.7	0.3	0.8	2.8	0.6	0.0	0.8	41.8	0.3	0.3	19.0	0.2	1.1	1.6	0.4	4.4	1.6	7.2	0.5	18.6	0.3	5.1	2.8	4.1	0.2	1.3	0.5	0.2	0.3	0.1	0.5	2.2	8.4	1.2	2.2	1.2	1.0	1.5	2.1	1.4	1.6	0.4	3.7	1.7	2.2	3.4	1.8	1.0	2.0	1.1	0.4	3.3	6.4	5.1	4.0	6.0	3.0	4.5	3.8	6.3	5.5
TCFL5	"bHLHe82, CHA, E2BP-1, Figlb"	ENSG00000101190	"Transcription factor like 5"	Q9UL49	20	62841115-62861763	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 32.9;testis: 55.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055223	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA055223: AB_2682745"	"unprognostic (4.05e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (3.24e-4)"	"unprognostic (2.78e-1)"	"unprognostic (2.72e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.77e-2)"	"unprognostic (4.89e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.01e-2)"	5.4	3.9	18.6	4.0	18.9	3.7	6.4	4.6	14.8	6.5	4.1	22.5	6.1	3.2	5.7	6.6	6.0	5.9	5.0	5.5	20.0	15.5	5.0	4.6	3.6	4.7	25.4	10.7	8.3	4.8	7.5	3.0	4.8	17.0	4.9	3.8	6.3	4.9	6.3	4.5	10.9	3.5	5.5	32.9	4.1	3.7	55.7	12.0	8.3	14.9	2.1	5.0	4.6	3.2	1.4	1.9	2.9	1.6	1.2	3.2	0.7	12.7	3.8	8.5	9.7	18.2	18.5	7.5	8.2	11.4	16.1	9.0	9.4	7.8	6.4	9.5	7.2	14.0	8.4	9.3	14.1	4.5	7.0	5.3	11.0	13.7	7.2	7.7	6.4	6.8	13.9	4.5	9.5	7.3	5.9	2.4	7.4	15.4	34.0	9.8	5.5	12.1	18.8	14.8	9.0	4.3	3.7	12.2	6.6	14.6	5.9	22.2	10.1	14.5	7.7	12.9	8.4	11.1	9.6	6.3	4.2	5.4	7.7	9.7	7.0	0.5	1.6	2.9	3.2	1.5	1.9	1.3	2.3	2.1	1.2	1.4	2.5	1.7	2.8	1.2	1.5	1.9	2.3	0.7	18.6	18.9	4.6	14.8	20.0	15.5	25.4	10.7	17.0	12.0
TCHHL1	"S100A17, THHL1"	ENSG00000182898	"Trichohyalin like 1"	Q5QJ38	1	152084144-152089064	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 1.7;skin 1: 3.8;tongue: 7.0"	"Cell line enriched"	"Detected in single"	59	"SK-BR-3: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			"HPA042579, HPA063483"	Enhanced		Approved	"Nuclear membrane,Nucleoli"				"Nuclear membrane, Nucleoli"		"HPA042579: AB_10794283, HPA063483: AB_2685021"						"unprognostic (8.21e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TCP10		ENSG00000203690	"T-complex 10"	Q12799	6	167357031-167384510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	11	"testis: 16.8"	"Group enriched"	"Detected in some"	7	"NTERA-2: 2.4;SCLC-21H: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044709, HPA078219"	Enhanced									"HPA044709: AB_10961410, HPA078219: "			"unprognostic (8.33e-2)"				"unprognostic (1.52e-1)"			"unprognostic (2.27e-1)"				"unprognostic (7.79e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	16.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TCP11L2	MGC40368	ENSG00000166046	"T-complex 11 like 2"	Q8N4U5	12	106301929-106347015	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 32.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039483, HPA042188"	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA039483: AB_10795291, HPA042188: AB_10794415"	"unprognostic (1.41e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.97e-1)"	"prognostic favourable (9.52e-4)"	"unprognostic (3.87e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.05e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.67e-1)"	9.1	12.0	8.1	6.2	18.2	22.3	9.0	10.4	13.0	9.7	8.6	31.5	3.3	6.2	10.3	7.1	20.1	11.6	8.1	18.9	8.3	5.8	6.1	5.6	14.4	12.9	22.2	9.4	9.7	8.6	11.1	7.2	12.3	16.2	7.5	7.9	9.5	15.9	5.9	18.0	14.0	10.3	10.2	14.6	10.2	10.2	8.7	18.4	16.4	12.2	6.3	14.0	11.3	11.8	6.2	0.8	32.1	3.2	1.9	6.3	1.7	2.6	6.6	1.0	1.9	9.2	10.7	4.2	1.7	8.6	1.1	2.8	1.0	3.6	0.9	2.7	6.7	12.6	0.8	3.7	2.0	1.4	2.8	0.5	2.5	4.0	9.0	0.3	1.8	13.4	8.7	1.3	6.5	6.2	1.6	1.3	1.5	1.9	1.6	1.4	1.2	4.2	0.8	0.2	3.0	8.7	12.5	4.2	3.1	4.5	1.4	5.2	3.9	0.3	4.7	1.6	1.4	2.4	0.4	8.4	0.6	3.2	4.6	0.2	0.8	10.8	3.2	4.9	2.4	1.4	1.8	6.2	4.9	2.7	0.8	5.7	6.3	4.1	32.1	1.9	2.2	0.6	5.6	1.7	8.1	18.2	10.4	13.0	8.3	5.8	22.2	9.4	16.2	18.4
TCTE1	"D6S46, DRC5, FAP155, MGC33600"	ENSG00000146221	"T-complex-associated-testis-expressed 1"	Q5JU00	6	44278743-44297688	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"fallopian tube: 17.3;testis: 48.6"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 2.6;Karpas-707: 3.8;SCLC-21H: 3.1;U-266/70: 1.7;U-266/84: 3.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031739			Uncertain	Vesicles				Vesicles		"HPA031739: AB_10601269"	"unprognostic (3.27e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.57e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.23e-5)"	"unprognostic (7.68e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.68e-1)"	0.2	0.2	2.2	0.2	2.2	1.1	0.2	5.8	1.8	0.7	0.2	1.1	0.0	0.2	0.6	3.0	0.2	17.3	0.3	0.2	2.8	2.0	0.2	0.2	2.1	0.2	0.8	1.0	2.2	0.3	0.2	0.2	0.2	3.2	0.4	0.2	0.0	0.4	0.4	0.2	0.6	0.3	0.3	0.6	0.3	0.2	48.6	0.3	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.9	0.0	0.1	0.0	0.2	0.1	0.3	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.3	0.1	0.2	0.1	0.6	0.3	0.0	0.0	2.6	0.0	0.1	3.8	0.0	0.3	0.2	0.5	0.2	0.0	0.9	0.4	0.0	0.0	0.1	3.1	1.0	0.0	0.2	1.2	0.0	0.2	0.1	0.0	0.2	0.0	0.0	1.7	3.2	0.3	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.1	0.2	0.0	2.2	2.2	5.8	1.8	2.8	2.0	0.8	1.0	3.2	0.3
TCTN1	"FLJ21127, JBTS13, TECT1"	ENSG00000204852	"Tectonic family member 1"	Q2MV58	12	110614027-110649430	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039687, HPA040036"	Approved		Approved	"Nucleoplasm,Actin filaments"	"Intracellular and membrane"			"Nucleoplasm, Actin filaments"		"HPA039687: AB_10795293, HPA040036: AB_10794759"	"unprognostic (2.54e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.28e-1)"	"prognostic favourable (1.13e-5)"	"unprognostic (2.89e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.05e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.20e-3)"	"unprognostic (9.60e-2)"	"unprognostic (9.97e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.27e-2)"	8.0	12.4	11.2	5.1	13.8	3.0	8.9	5.6	10.1	17.7	5.4	12.3	20.6	4.1	10.3	28.7	5.4	35.4	12.3	14.4	11.0	13.0	16.1	7.2	11.6	5.5	11.0	5.3	15.5	9.1	24.1	32.9	8.4	22.1	14.5	4.0	16.3	10.2	20.6	8.0	5.3	4.1	10.3	8.9	6.0	7.2	24.7	8.0	4.4	25.5	3.9	5.2	8.8	12.2	13.7	5.0	8.4	3.5	1.1	2.9	1.9	7.4	9.5	6.7	18.4	19.2	16.8	3.4	5.4	11.0	5.0	4.3	2.1	2.3	1.5	4.7	13.2	5.3	3.9	4.1	3.6	3.2	6.2	0.4	3.9	4.6	9.1	0.8	0.8	10.5	6.2	6.5	8.0	3.6	5.2	3.2	6.1	10.9	0.6	2.6	3.3	12.8	1.9	3.5	10.7	15.2	1.8	5.7	7.6	9.3	2.2	4.5	15.5	8.6	4.0	8.6	2.2	3.0	4.6	3.1	1.5	2.0	8.5	0.8	6.8	0.3	2.4	0.4	1.3	3.5	2.9	6.3	1.9	2.7	3.7	13.7	2.9	2.4	8.4	1.1	2.0	5.0	0.6	1.9	11.2	13.8	5.6	10.1	11.0	13.0	11.0	5.3	22.1	8.0
TCTN2	"C12orf38, FLJ12975, JBTS24, MKS8, TECT2"	ENSG00000168778	"Tectonic family member 2"	Q96GX1	12	123671113-123708403	"Disease related genes, Predicted membrane proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA039900	Enhanced		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA039900: AB_10673366"	"unprognostic (3.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.09e-3)"	"unprognostic (3.14e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.68e-1)"	5.5	5.5	6.4	5.1	18.1	2.3	8.4	10.5	10.0	11.2	5.6	9.1	12.0	2.9	15.7	14.1	4.1	32.0	7.2	5.4	6.2	10.2	11.8	2.3	9.4	4.0	4.4	8.3	18.0	7.9	16.1	18.8	5.3	18.5	11.0	4.9	17.6	11.9	10.2	1.9	10.2	3.9	7.1	4.2	4.5	6.1	17.2	3.2	3.1	15.6	5.1	4.2	5.9	7.5	4.5	4.7	2.4	1.1	1.4	5.4	0.4	10.7	10.6	8.1	11.2	11.0	12.4	9.4	4.1	7.9	8.5	7.2	6.7	10.8	0.3	6.7	6.4	14.0	4.3	3.7	8.6	2.3	6.5	1.0	7.4	5.0	3.9	2.8	4.1	6.1	7.4	12.0	3.5	11.3	5.7	0.2	6.0	5.6	3.1	5.8	5.0	6.5	3.1	8.0	1.5	10.6	7.8	4.8	6.3	12.7	4.3	5.8	18.3	3.8	7.0	12.0	6.2	10.7	4.9	3.0	6.1	1.0	15.3	0.3	7.1	2.4	0.5	2.2	3.9	1.1	5.4	3.8	4.4	4.0	0.8	4.5	5.0	5.0	0.8	1.4	0.9	4.7	2.5	0.4	6.4	18.1	10.5	10.0	6.2	10.2	4.4	8.3	18.5	3.2
TDRD10	DKFZp434M202	ENSG00000163239	"Tudor domain containing 10"	Q5VZ19	1	154502219-154548147	"Cancer-related genes, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 48.4"	"Group enriched"	"Detected in some"	10	"EFO-21: 2.2;HUVEC TERT2: 7.5;RPMI-8226: 2.1;TIME: 4.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA054327			Approved	Vesicles				Vesicles		"HPA054327: "	"unprognostic (1.30e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.33e-3)"	"unprognostic (9.69e-3)"	"unprognostic (5.80e-3)"	"unprognostic (2.99e-1)"	"unprognostic (5.97e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.00e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (8.04e-5)"	"unprognostic (1.62e-1)"	4.1	1.4	0.7	1.1	0.9	0.0	2.6	0.7	1.4	1.3	0.8	0.9	1.4	0.5	2.1	2.0	1.0	2.1	1.2	2.3	0.7	0.0	1.0	1.5	3.3	1.6	0.9	1.2	4.6	0.7	0.8	0.8	1.4	1.2	1.1	1.1	0.7	0.7	1.0	1.1	0.7	1.0	1.4	1.2	3.5	0.5	48.4	0.8	0.7	4.9	1.5	1.0	1.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	4.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.9	0.7	1.4	0.7	0.0	0.9	1.2	1.2	0.8
TDRD15		ENSG00000218819	"Tudor domain containing 15"	B5MCY1	2	21123917-21143272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 11.3"	"Group enriched"	"Detected in some"	4	"U-266/70: 12.7;U-266/84: 4.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA051770, HPA054675"	Uncertain									"HPA051770: , HPA054675: "							"unprognostic (4.20e-3)"								"unprognostic (1.46e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3			0.0		0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.7	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TDRD6	"bA446F17.4, CT41.2, NY-CO-45, SPATA36"	ENSG00000180113	"Tudor domain containing 6"	O60522	6	46687875-46704319	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 37.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.6;HeLa: 3.9;hTCEpi: 2.2;PC-3: 3.3;SCLC-21H: 1.6"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.1"	"Region enriched"	"Detected in many"	6	"cerebellum: 8.2"	"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;intermediate monocyte: 1.4"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA075923	Enhanced									"HPA075923: "	"unprognostic (2.01e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.25e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.38e-3)"	0.7	1.4	0.7	2.6	1.3	0.0	0.7	8.2	1.3	0.7	0.7	0.7	0.7	0.3	0.7	2.9	0.7	0.3	1.7	0.7	1.0	0.8	0.7	1.3	0.7	3.0	1.1	0.7	0.7	0.7	0.4	1.8	1.1	0.7	1.6	0.0	0.9	0.9	0.7	1.5	2.9	0.7	0.7	0.9	1.9	0.3	37.9	0.7	0.7	5.2	0.7	0.7	1.6	0.7	0.0	0.7	0.1	2.4	0.0	0.0	0.4	0.0	0.0	0.2	1.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.4	0.0	0.0	0.0	1.6	0.0	3.9	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.3	0.0	0.0	0.0	0.9	0.6	1.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.1	0.0	1.1	0.0	0.4	0.0	0.0	0.7	0.0	2.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.7	1.3	8.2	0.9	1.0	0.8	1.1	0.7	0.7	0.7
TENM3	"KIAA1455, ODZ3, Ten-M3"	ENSG00000218336	"Teneurin transmembrane protein 3"	Q9P273	4	182143987-182803024	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"		Microphthalmia	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 24.0;BEWO: 23.0;HDLM-2: 31.2;T-47d: 30.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA047043	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA047043: "	"unprognostic (5.79e-2)"	"unprognostic (3.01e-2)"	"unprognostic (6.62e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.47e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.25e-4)"	9.5	10.8	11.3	3.7	12.5	1.0	9.3	8.5	17.8	3.9	8.5	1.5	5.7	2.4	6.4	2.6	2.4	2.9	5.3	3.5	11.8	9.4	2.7	1.4	2.4	2.3	3.5	15.4	8.4	3.2	17.0	15.0	24.5	5.4	8.3	2.5	6.4	2.0	8.0	4.3	1.4	2.5	5.2	6.1	4.8	2.2	4.7	2.3	0.8	12.3	1.8	3.0	3.7	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	24.0	0.1	4.9	8.8	23.0	2.8	0.9	2.5	2.2	11.9	6.2	0.0	0.3	18.5	1.2	5.7	1.2	2.5	31.2	9.5	0.0	0.0	0.0	0.4	0.0	0.0	11.6	0.4	7.8	5.5	3.4	0.0	0.1	3.8	0.8	0.0	0.0	7.7	1.0	0.0	6.2	0.0	0.0	0.0	9.9	9.2	1.4	0.1	0.0	30.9	1.2	7.5	19.7	14.2	0.0	13.9	0.0	0.0	0.0	10.3	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	12.5	8.5	17.8	11.8	9.4	3.5	15.4	5.4	2.3
TEPP		ENSG00000159648	"Testis, prostate and placenta expressed"	Q6URK8	16	57976435-57988116	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 46.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;HMC-1: 2.0;RPMI-8226: 2.4;TIME: 2.1"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 4.5"	"Lineage enriched"	"Detected in single"	6	"T-cells: 4.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA062092	Enhanced				"Secreted in male reproductive system"					"HPA062092: "	"unprognostic (4.86e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.79e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.59e-1)"	0.1	0.7	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.3	0.1	0.4	0.1	0.0	0.1	0.5	0.3	0.6	0.1	0.3	0.1	0.2	0.1	0.1	0.8	0.1	0.1	0.3	0.7	0.1	0.0	0.1	0.1	0.4	0.3	0.0	0.1	0.2	1.2	0.1	0.1	0.1	0.1	0.3	0.1	0.0	46.3	0.2	0.1	2.6	0.1	0.2	1.6	0.5	0.7	0.2	0.3	0.0	0.2	4.5	1.3	0.0	0.0	0.6	0.0	0.0	0.0	2.9	0.0	0.4	0.5	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	2.5	0.1	3.0	2.0	0.0	0.7	2.9	4.5	0.0	0.2	0.0	0.2	1.4	1.3	0.1	0.1	0.1	0.4	0.1	0.2	0.1	0.3	0.4	0.2
TERB2	"C15orf43, MGC33951"	ENSG00000167014	"Telomere repeat binding bouquet formation protein 2"	Q8NHR7	15	44956702-44979229	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"testis: 51.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041780			Uncertain	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA041780: AB_10796460"							"unprognostic (1.42e-3)"					"unprognostic (4.19e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.62e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX101	"CT131, MGC4766, SGRG, SPATA44"	ENSG00000131126	"Testis expressed 101"	Q9BY14	19	43401496-43418597	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"blood: 24.5;testis: 56.6"	"Cell line enhanced"	"Detected in many"		"THP-1: 4.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	246	"basophil: 24.5"	"Lineage enriched"	"Detected in single"	246	"granulocytes: 24.5"									"HPA041915, HPA042513"	Enhanced				"Secreted in male reproductive system"					"HPA041915: AB_10795268, HPA042513: AB_10795507"	"unprognostic (2.50e-2)"	"unprognostic (5.67e-4)"	"unprognostic (2.64e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.78e-4)"		"unprognostic (1.70e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.54e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.67e-7)"	"unprognostic (8.83e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.49e-2)"	"unprognostic (7.04e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.0	56.6	0.1	0.1	0.1	0.1	0.4	0.1	0.3	0.0	0.0	24.5	0.0	0.0	0.0	0.0	0.9	0.5	1.3	0.7	1.0	2.4	0.7	0.4	0.6	0.9	1.0	0.2	0.4	0.4	1.0	1.6	0.4	0.4	1.0	0.7	1.2	0.0	0.3	1.3	0.4	1.9	0.4	0.9	1.2	1.5	0.1	1.0	1.9	0.3	1.0	1.1	0.2	0.6	0.9	0.7	1.0	2.7	0.2	1.2	2.2	0.2	0.9	0.4	0.3	0.8	2.2	0.3	4.8	0.4	0.8	0.8	0.7	1.4	1.0	1.1	0.6	0.9	0.7	0.6	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TEX12		ENSG00000150783	"Testis expressed 12"	Q9BXU0	11	112167372-112172559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 29.9"	"Cell line enhanced"	"Detected in some"		"U-698: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038289, HPA038290"	Enhanced									"HPA038289: AB_10672742, HPA038290: AB_2675934"	"unprognostic (1.49e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.91e-1)"	"unprognostic (9.20e-4)"	"unprognostic (1.71e-2)"	"unprognostic (2.97e-1)"	"unprognostic (6.54e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.16e-3)"	0.3	0.0	0.1	0.6	0.2	0.3	0.4	0.1	0.4	0.2	0.2	0.3	0.1	0.6	0.2	0.5	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.9	0.7	0.4	0.2	0.1	0.2	0.2	29.9	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.5	0.5	1.5	0.5	0.0	0.9	0.3	0.1	0.0	0.6	0.3	1.1	0.7	0.2	0.3	0.4	0.4	1.1	0.4	1.4	2.5	0.6	0.7	0.0	0.5	0.4	0.7	1.5	0.0	1.1	0.0	0.0	1.5	1.4	0.8	0.9	0.6	1.0	0.4	0.1	0.3	1.2	0.0	0.0	1.1	2.4	0.1	0.9	0.8	0.3	2.1	1.1	0.1	0.3	0.4	0.0	1.4	0.0	0.1	2.5	0.0	0.4	1.5	0.8	0.5	0.2	0.2	4.8	0.6	1.3	0.0	0.0	0.1	1.5	0.1	0.5	0.0	0.5	0.5	0.9	0.0	0.0	0.0	0.3	0.8	0.0	0.4	0.5	0.0	0.3	0.1	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1
TEX15	CT42	ENSG00000133863	"Testis expressed 15, meiosis and synapsis associated"	Q9BXT5	8	30831544-30913003	"Predicted intracellular proteins"	"Differentiation, DNA damage, DNA repair, Meiosis, Spermatogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 5.4;endometrium 1: 10.0;pituitary gland: 6.9;smooth muscle: 8.5;testis: 21.3"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.7;HEL: 19.7;K-562: 5.5;NTERA-2: 3.7;SCLC-21H: 4.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA036800	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA036800: AB_10671714"	"unprognostic (3.10e-1)"	"unprognostic (2.56e-1)"		"unprognostic (3.30e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-5)"	"unprognostic (8.88e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.92e-1)"	0.1	0.1	0.7	0.2	5.4	0.1	0.1	0.1	1.1	1.2	0.1	0.0	0.0	0.1	10.0	0.6	0.2	0.1	0.8	0.1	1.7	0.5	0.1	0.1	0.1	0.1	0.3	0.3	0.4	0.1	0.1	6.9	0.1	0.9	0.1	0.1	0.3	0.1	0.5	0.1	0.1	0.2	8.5	0.4	0.4	0.9	21.3	1.4	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	8.7	1.1	0.0	1.1	3.1	19.7	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.1	0.1	0.1	3.7	0.3	0.0	0.0	0.0	0.0	0.0	4.3	1.4	0.0	0.0	3.7	0.2	1.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.4	0.1	1.1	1.7	0.5	0.3	0.3	0.9	1.4
TEX22		ENSG00000226174	"Testis expressed 22"	C9J3V5	14	105398579-105450106	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 25.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.3;U-266/70: 5.3;U-937: 3.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA065576	Enhanced									"HPA065576: "	"unprognostic (3.99e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.62e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.53e-5)"	"unprognostic (1.42e-4)"	"unprognostic (8.13e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.91e-3)"	1.2	0.7	3.2	2.4	3.1	2.3	4.2	4.6	4.2	1.5	0.8	1.5	1.4	1.3	1.3	3.8	0.8	2.9	1.3	0.9	4.3	1.5	1.5	0.7	3.0	2.9	3.0	3.0	2.3	4.6	2.0	1.0	1.0	3.0	2.0	0.8	0.9	1.9	2.5	1.2	1.7	1.5	0.6	2.7	2.5	1.6	25.4	2.9	4.0	1.4	0.5	1.7	1.0	1.7	0.5	1.1	0.0	1.4	0.0	0.6	0.1	0.3	0.7	0.7	3.1	1.0	0.1	0.7	0.3	0.1	0.0	0.4	0.4	0.4	1.9	0.2	0.2	0.3	0.5	0.1	0.1	6.3	0.3	0.3	0.8	0.0	0.4	0.5	2.0	0.7	0.4	0.1	0.1	0.1	0.1	2.0	0.1	1.8	0.2	0.4	0.2	0.1	1.8	0.1	0.1	0.4	0.5	0.6	0.7	0.0	0.1	0.3	0.5	0.7	0.0	0.3	0.1	0.7	0.1	5.3	0.7	0.7	0.1	3.9	2.7	0.0	1.4	0.0	0.0	0.3	0.5	0.2	0.0	0.6	0.1	0.5	0.3	0.0	0.0	0.0	0.4	1.1	0.5	0.1	3.2	3.1	4.6	4.2	4.3	1.5	3.0	3.0	3.0	2.9
TEX261	"MGC32043, TEG-261"	ENSG00000144043	"Testis expressed 261"	Q6UWH6	2	70985938-70994945	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA016631	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA016631: AB_2240434"	"unprognostic (3.22e-3)"	"unprognostic (2.06e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (6.17e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavourable (4.23e-4)"	"unprognostic (5.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.70e-3)"	"unprognostic (3.36e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.99e-1)"	22.9	27.1	14.5	11.1	15.4	9.3	22.2	13.4	21.4	19.9	15.9	21.6	20.9	13.8	17.3	27.2	17.3	20.9	21.2	21.6	14.4	12.0	25.1	36.9	19.8	16.1	17.0	10.9	23.7	50.8	36.1	20.1	19.3	15.0	18.9	18.9	28.7	22.3	21.0	33.5	12.9	23.6	19.6	17.4	16.0	18.4	23.8	15.3	15.5	31.7	14.3	16.3	14.9	13.9	3.8	4.4	12.0	5.3	3.4	6.7	2.8	19.9	18.9	13.3	16.8	40.6	20.7	15.0	23.1	22.1	27.0	17.1	22.2	16.6	16.3	8.8	40.6	15.1	25.2	27.6	39.3	12.3	21.0	19.5	9.8	23.4	23.9	22.7	16.4	18.6	18.5	25.9	17.7	27.4	24.2	10.9	31.5	15.7	19.5	12.6	8.8	22.4	13.9	41.1	14.0	19.6	17.5	21.8	11.5	24.0	24.0	15.1	15.6	13.5	21.9	33.2	28.8	17.7	30.7	8.5	7.5	19.4	29.0	30.0	27.8	12.0	5.3	10.0	5.1	5.3	4.3	2.6	5.4	6.7	4.0	3.8	6.2	4.9	4.0	3.4	5.2	4.4	4.3	2.8	14.5	15.4	13.4	21.4	14.4	12.0	17.0	10.9	15.0	15.3
TEX30	C13orf27	ENSG00000151287	"Testis expressed 30"	Q5JUR7	13	102765990-102773811	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 64.1;testis: 71.9"	"Cell line enhanced"	"Detected in many"		"NB-4: 73.5;THP-1: 47.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 64.1;eosinophil: 16.4"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 64.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053545	Enhanced									"HPA053545: "	"unprognostic (5.26e-2)"	"prognostic favourable (2.09e-5)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.49e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavourable (2.10e-6)"	"unprognostic (1.89e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-1)"	4.5	2.9	4.3	3.0	4.6	5.6	3.6	5.8	5.3	3.1	2.6	1.7	14.0	2.6	5.4	34.7	4.1	2.7	2.4	6.1	3.5	4.9	8.8	18.5	2.9	4.9	6.3	2.8	3.7	2.8	1.2	4.5	7.1	5.2	3.2	2.2	2.0	2.4	7.0	4.4	3.5	2.7	3.9	3.9	3.2	2.7	71.9	3.1	7.0	2.8	3.8	3.3	3.5	3.5	2.7	3.7	64.1	2.0	5.9	3.8	1.9	11.5	4.2	9.9	8.0	6.4	4.6	0.1	14.8	4.0	10.3	9.7	10.1	11.0	6.6	6.3	5.9	6.3	9.0	5.5	14.7	13.5	5.4	11.3	8.8	0.1	4.3	22.6	22.3	2.6	3.5	9.1	5.6	8.2	6.6	0.0	12.4	6.0	15.1	73.5	3.6	9.8	9.3	4.4	4.6	15.5	4.5	13.3	6.0	9.4	11.7	8.7	8.3	47.2	3.4	7.2	5.5	11.4	15.9	6.0	7.2	0.0	12.3	13.5	11.7	64.1	1.7	16.4	2.4	1.9	3.4	2.7	2.7	3.1	1.8	2.5	3.1	2.6	0.8	5.9	2.0	3.7	3.8	1.9	4.3	4.6	5.8	5.3	3.5	4.9	6.3	2.8	5.2	3.1
TEX35	"C1orf49, DKFZP564J047, TSC24"	ENSG00000240021	"Testis expressed 35"	Q5T0J7	1	178513077-178548602	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 66.9"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039190	Approved									"HPA039190: AB_10794425"	"unprognostic (2.20e-1)"	"unprognostic (1.77e-2)"				"unprognostic (1.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (8.92e-3)"	"unprognostic (1.08e-2)"	"unprognostic (7.04e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.51e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.23e-1)"	"unprognostic (5.41e-2)"	0.2	0.1	0.2	0.2	0.3	1.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.4	0.2	1.0	0.2	0.1	0.2	0.4	0.2	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	1.5	0.2	0.2	0.2	0.2	0.6	66.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.7	1.0	3.4	0.9	0.4	1.1	0.0	1.4	0.8	2.9	3.8	2.4	3.5	8.3	1.4	2.2	1.3	0.8	2.0	1.0	2.5	1.4	1.0	1.1	2.6	0.8	1.2	2.1	1.0	2.6	3.2	3.7	0.5	3.2	1.3	2.9	1.3	1.7	3.4	0.6	2.1	2.3	1.1	1.0	1.8	2.1	5.1	1.5	1.6	1.3	2.0	2.1	2.0	2.1	1.7	2.9	3.5	0.8	1.5	2.1	2.3	3.4	2.4	2.0	2.1	2.6	3.1	1.9	2.6	2.4	0.7	0.9	0.8	1.2	1.0	0.3	0.3	0.9	0.9	0.7	0.5	1.7	1.1	0.7	3.4	0.4	0.9	1.0	0.5	0.0	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
TEX47	"C7orf62, MGC26647"	ENSG00000164645	"Testis expressed 47"	Q8TBZ9	7	88794106-88795721	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	158	"testis: 26.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA023817, HPA024163"			Uncertain	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA023817: AB_1853868, HPA024163: AB_1853869"					"unprognostic (1.43e-1)"													0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
TGFBR3L		ENSG00000260001	"Transforming growth factor beta receptor 3 like"	H3BV60	19	7916145-7919097	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"pituitary gland: 56.6"	"Cell line enhanced"	"Detected in some"		"PC-3: 5.6;REH: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA074356	Enhanced		Approved	Vesicles				Vesicles		"HPA074356: "	"unprognostic (1.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.65e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.62e-3)"	0.3	2.0	1.6	0.2	2.8	0.6	0.3	1.9	6.4	5.0	0.6	0.0	0.3	6.0	2.8	0.5	0.3	0.7	0.2	2.1	0.7	0.8	3.7	4.0	0.3	0.1	0.5	1.7	0.3	0.3	0.9	56.6	0.4	1.9	2.5	0.1	0.6	0.8	0.7	0.3	0.5	5.7	2.0	0.6	0.3	0.4	0.5	0.0	0.0	0.3	0.0	0.1	1.1	0.8	0.1	0.3	0.0	0.1	0.0	2.9	0.1	0.1	0.2	0.1	0.5	0.1	0.0	3.3	2.6	0.0	0.2	0.0	0.5	0.0	0.1	3.0	0.1	1.9	0.0	0.0	0.0	3.4	1.1	0.5	0.2	0.6	0.2	1.7	0.3	0.2	0.1	0.0	0.0	0.0	0.7	0.5	0.0	1.5	1.2	0.2	0.6	5.6	13.6	0.0	3.0	0.2	0.0	1.0	2.5	0.3	0.0	0.6	0.9	0.5	0.2	1.8	2.9	2.0	0.9	0.8	0.9	0.8	0.4	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.6	0.1	0.9	1.9	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.3	0.0	0.1	1.6	2.8	1.9	6.4	0.7	0.8	0.5	1.7	1.9	0.0
THEGL		ENSG00000249693	"Theg spermatid protein like"	P0DJG4	4	56530609-56603507	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.9;vagina: 10.7"	"Cell line enhanced"	"Detected in some"		"HHSteC: 1.7;HSkMC: 3.6;hTEC/SVTERT24-B: 2.2;K-562: 2.9;SH-SY5Y: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA068093	Uncertain									"HPA068093: "	"unprognostic (4.33e-2)"	"unprognostic (2.88e-3)"		"unprognostic (7.97e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.69e-2)"		"unprognostic (3.26e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.37e-1)"		"unprognostic (4.70e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.41e-2)"	0.1	0.2	0.6	0.1	0.5	0.8	1.9	0.1	1.1	1.7	0.7	0.6	1.0	0.1	0.4	1.3	0.2	0.4	0.8	0.1	0.2	0.4	0.1	0.1	0.1	0.0	0.2	0.3	0.5	0.1	0.0	0.3	0.0	0.8	0.7	0.1	0.2	0.2	0.5	0.1	1.2	0.2	1.8	0.2	0.1	0.3	8.9	0.4	0.0	0.1	0.0	0.1	3.0	10.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.3	3.6	0.0	2.2	0.0	0.4	2.9	0.0	0.8	0.0	0.8	0.0	0.2	0.4	0.4	0.4	0.0	0.0	0.0	0.1	1.9	0.8	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.2	0.8	0.1	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.1	1.1	0.2	0.4	0.2	0.3	0.8	0.4
THNSL2	"FLJ10916, SOFAT, TSH2"	ENSG00000144115	"Threonine synthase like 2"	Q86YJ6	2	88170295-88186636	"Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 17.6;hTCEpi: 10.7;MCF7: 11.1;T-47d: 16.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA035395	Approved				"Secreted - unknown location"					"HPA035395: AB_10601600"	"unprognostic (1.51e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.53e-2)"	"unprognostic (8.73e-2)"	"unprognostic (6.64e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.01e-3)"	"unprognostic (6.98e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.24e-2)"	8.6	9.5	5.5	6.0	8.1	0.7	12.0	3.3	10.8	8.7	10.5	17.3	16.3	7.8	11.5	27.0	11.2	11.1	15.1	10.9	5.0	7.1	24.0	29.9	11.7	3.6	7.2	8.6	10.4	8.7	32.4	16.2	14.4	11.3	12.5	3.7	21.1	15.4	9.6	28.7	7.0	12.8	13.7	7.5	4.7	6.6	13.6	1.0	0.9	18.0	9.3	3.8	6.5	5.8	3.4	1.5	0.9	1.1	0.5	1.3	0.8	1.0	0.0	0.0	0.0	2.1	1.3	1.7	4.8	3.6	5.7	7.2	7.3	5.6	0.0	2.2	0.0	0.2	0.0	0.1	4.9	0.0	0.0	0.0	0.2	0.0	17.6	0.0	0.9	3.3	10.7	1.8	0.0	0.0	0.0	0.0	3.3	11.1	0.0	0.1	4.3	0.8	0.0	0.0	0.0	3.5	0.3	2.1	0.0	5.7	0.9	9.1	16.4	1.0	0.0	4.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.6	0.9	1.3	1.0	0.9	1.6	0.4	1.0	1.5	3.4	0.7	0.3	0.4	0.5	1.1	0.0	0.0	0.8	5.5	8.1	3.3	10.8	5.0	7.1	7.2	8.6	11.3	1.0
THSD1	TMTSP	ENSG00000136114	"Thrombospondin type 1 domain containing 1"	Q9NS62	13	52377167-52406494	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 12.0;HBEC3-KT: 12.1;hTCEpi: 12.0;hTERT-HME1: 12.3;HUVEC TERT2: 25.1;LHCN-M2: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012611, CAB020796"	Uncertain		Supported	Cytosol	"Intracellular and membrane"		810000	Cytosol		"CAB020796: , HPA012611: AB_1857990"	"unprognostic (1.21e-1)"	"unprognostic (7.54e-3)"	"unprognostic (3.49e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.90e-2)"	9.7	1.8	8.3	1.8	7.2	0.4	11.1	2.9	6.4	7.6	2.6	1.9	3.6	1.2	6.8	4.9	4.4	5.7	4.9	9.0	8.1	2.2	2.0	2.1	19.8	4.7	2.2	4.6	2.3	1.2	2.5	3.4	16.8	2.1	8.5	2.3	5.5	3.9	3.2	9.7	6.0	2.3	7.4	2.2	6.6	1.9	2.7	1.1	0.7	5.2	5.2	2.5	5.9	4.5	0.3	0.0	0.0	0.0	0.4	0.7	0.0	0.5	2.4	0.2	2.1	2.0	6.5	0.5	5.1	2.5	2.0	3.2	0.0	0.3	0.2	0.6	12.0	2.7	0.0	12.1	3.1	5.6	1.7	0.3	0.0	0.0	1.2	1.2	0.3	2.6	12.0	9.7	12.3	25.1	0.0	0.1	11.5	0.0	0.4	0.2	0.1	0.5	0.3	2.7	0.0	2.7	0.1	0.0	0.4	0.1	0.0	0.4	0.2	0.2	5.8	0.6	1.1	0.0	3.8	0.3	0.0	0.0	1.1	0.3	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.5	0.7	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	8.3	7.2	2.9	6.4	8.1	2.2	2.2	4.6	2.1	1.1
THSD7B	KIAA1679	ENSG00000144229	"Thrombospondin type 1 domain containing 7B"	Q9C0I4	2	136765545-137677717	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.2;epididymis: 11.6;retina: 14.9"	"Group enriched"	"Detected in some"	8	"Daudi: 10.1;SCLC-21H: 21.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	7	"pons and medulla: 24.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051416, HPA056745"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA051416: , HPA056745: "	"unprognostic (4.65e-3)"	"unprognostic (2.25e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.47e-6)"	"unprognostic (2.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.30e-2)"	4.7	0.3	1.7	0.3	1.6	0.1	2.6	0.7	3.2	0.9	0.5	1.1	0.8	0.3	0.9	11.6	1.6	2.8	0.8	1.4	1.8	3.3	2.7	0.6	0.5	0.2	1.8	1.5	0.4	0.3	1.3	3.0	0.7	24.2	2.1	0.3	14.9	1.2	0.7	0.3	0.2	1.5	2.2	3.2	0.2	0.3	1.1	0.3	0.1	2.1	0.0	0.3	0.8	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	10.1	0.0	0.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.4	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	0.7	3.2	1.8	3.3	1.8	1.5	24.2	0.3
THUMPD2	"C2orf8, MGC2454"	ENSG00000138050	"THUMP domain containing 2"	Q9BTF0	2	39736060-39779267	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043042, HPA058025"	Approved		Uncertain	Nucleoplasm				Nucleoplasm		"HPA043042: AB_10964424, HPA058025: "	"unprognostic (6.30e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.48e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (6.05e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (7.27e-5)"	"unprognostic (2.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-3)"	6.9	7.1	6.3	8.2	7.4	13.3	9.3	21.1	7.9	8.5	6.0	5.0	4.5	7.7	12.0	6.8	9.2	4.3	5.1	8.7	6.0	6.8	7.9	7.3	5.8	9.4	7.1	5.0	10.8	5.9	5.4	19.7	4.3	6.7	6.9	5.1	6.4	6.0	6.4	14.5	5.8	6.5	6.4	5.5	6.6	6.7	3.8	6.4	13.5	7.8	5.1	9.3	6.0	9.6	6.1	9.9	0.3	4.5	8.6	5.2	3.1	9.6	6.3	2.1	9.3	3.1	4.8	4.8	4.0	4.5	4.4	4.8	7.8	7.1	12.4	4.5	2.9	3.5	12.0	6.9	5.2	15.2	14.3	9.0	4.3	7.6	6.7	10.6	5.6	5.0	4.5	4.3	1.7	6.7	9.7	4.3	8.6	3.2	9.1	9.0	0.2	4.4	6.9	8.1	7.3	4.8	5.8	9.3	6.8	3.5	8.7	6.1	3.9	5.9	4.0	7.5	6.4	3.4	8.4	6.9	7.9	13.0	4.3	16.9	5.7	0.0	4.5	0.2	3.3	3.2	3.9	6.1	5.2	3.4	5.5	4.7	4.8	4.2	0.3	8.6	2.1	9.9	4.2	3.1	6.3	7.4	21.1	7.9	6.0	6.8	7.1	5.0	6.7	6.4
TIAM2	STEF	ENSG00000146426	"T cell lymphoma invasion and metastasis 2"	Q8IVF5	6	154832697-155257723	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 11.3;brain: 21.1;intestine: 27.4;testis: 15.6;thyroid gland: 7.8"	"Cell line enhanced"	"Detected in many"		"AF22: 34.4;HDLM-2: 14.7;RH-30: 22.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.3"	"Group enriched"	"Detected in many"	4	"B-cells: 3.3;granulocytes: 8.3;monocytes: 11.3"	"Group enriched"	"Detected in many"	5	"amygdala: 20.4;basal ganglia: 31.5;cerebral cortex: 23.6;hippocampal formation: 19.4;olfactory region: 70.6"	"Low region specificity"	"Detected in many"			"HPA011134, HPA013903"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA011134: AB_1858005, HPA013903: AB_1858004"	"unprognostic (9.14e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.05e-1)"	0.6	2.1	5.3	1.7	9.4	0.7	1.5	7.9	21.1	1.5	11.6	0.7	0.1	11.0	1.2	0.8	1.0	1.2	4.0	3.5	4.7	2.0	0.7	0.7	0.9	2.0	1.7	9.5	0.9	1.8	0.2	1.8	0.8	0.6	3.0	1.1	1.3	2.4	3.6	3.0	1.0	27.4	1.4	0.9	1.2	4.0	15.6	1.9	0.0	7.8	0.0	2.5	2.3	1.2	3.3	0.9	8.3	11.3	0.8	1.8	0.4	4.3	0.8	34.4	4.0	1.5	4.2	0.4	1.8	1.1	1.7	2.9	0.5	2.5	1.0	1.8	3.1	0.6	1.2	0.0	1.2	14.7	1.9	0.2	0.6	2.0	0.9	0.3	1.0	2.8	0.1	0.6	0.1	2.4	0.5	0.1	3.8	0.4	0.4	0.9	2.5	0.9	4.4	22.4	0.4	0.1	0.2	0.9	7.9	0.1	0.4	0.2	0.3	0.5	0.8	0.3	8.7	0.3	0.9	0.2	1.7	0.2	0.1	0.5	2.2	0.4	0.2	3.1	0.2	3.2	0.3	3.3	0.5	0.3	0.9	1.0	0.6	0.4	8.3	0.8	11.3	0.3	1.8	0.4	5.3	9.4	7.9	21.1	4.7	2.0	1.7	9.5	0.6	1.9
TIGD3		ENSG00000173825	"Tigger transposable element derived 3"	Q6B0B8	11	65354767-65357613	"Predicted intracellular proteins"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 14.9;brain: 8.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"basophil: 6.5;eosinophil: 8.4;neutrophil: 14.9"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040016			Approved	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA040016: AB_10805600"	"unprognostic (1.33e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.48e-4)"	"unprognostic (6.97e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.94e-3)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (7.55e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.75e-3)"	0.1	0.7	1.8	0.8	2.7	1.3	3.0	8.6	4.6	0.3	4.1	0.9	0.0	2.6	0.4	0.8	0.4	0.5	0.6	0.4	2.0	1.9	0.8	0.7	1.1	1.1	1.2	0.0	1.0	1.5	1.5	1.9	0.4	3.1	0.5	0.4	1.1	0.5	0.5	0.3	0.2	6.4	0.3	2.0	2.6	1.0	6.9	0.4	3.0	0.4	1.0	0.8	0.6	0.0	0.3	1.2	14.9	1.2	0.1	0.1	0.1	1.3	2.6	2.2	5.9	0.0	0.0	0.8	0.1	0.3	0.6	0.8	2.0	0.3	1.0	1.0	0.2	1.4	2.2	0.1	0.2	1.7	2.3	0.4	1.3	4.6	0.1	0.9	4.4	0.0	0.2	0.3	0.0	0.3	1.4	3.0	0.0	3.4	2.8	1.9	1.3	1.1	4.1	1.0	4.0	0.1	1.3	6.6	4.2	1.7	2.6	1.0	4.2	1.4	0.0	0.2	1.1	1.5	1.0	6.3	4.0	1.3	0.1	1.8	0.6	6.5	0.5	8.4	0.0	0.3	0.0	0.3	0.0	0.0	0.8	0.2	0.1	0.0	14.9	0.1	1.2	1.2	0.0	0.1	1.8	2.7	8.6	4.6	2.0	1.9	1.2	0.0	3.1	0.4
TIGD4		ENSG00000169989	"Tigger transposable element derived 4"	Q8IY51	4	152769354-152779764	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 14.1;testis: 11.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.5;U-266/70: 6.6;U-266/84: 12.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035649	Approved		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA035649: AB_10670956"	"unprognostic (1.71e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.23e-4)"	"unprognostic (6.19e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.90e-2)"	"unprognostic (4.47e-2)"	0.7	1.0	2.2	0.7	8.6	0.2	2.1	3.5	3.6	2.5	0.8	2.1	3.9	1.1	2.0	4.2	0.6	5.5	0.8	1.0	4.8	2.1	2.0	0.6	3.5	0.5	1.6	3.2	1.7	0.9	5.4	14.1	0.5	5.8	1.3	0.9	5.4	2.0	1.1	1.2	1.3	0.8	0.9	2.7	0.8	1.0	11.8	1.3	0.3	2.1	0.6	0.5	1.0	0.8	0.4	0.0	1.6	1.1	2.1	1.3	0.0	0.6	0.5	2.9	1.2	0.2	0.4	0.3	0.1	0.7	0.3	0.6	0.5	1.3	1.0	0.1	0.1	0.5	1.1	0.5	0.5	1.0	0.2	1.5	0.7	0.3	0.2	0.6	0.3	0.1	0.5	0.5	0.3	0.1	0.4	4.5	0.3	0.3	2.8	0.3	1.3	0.4	0.5	0.6	0.0	2.0	0.1	1.4	1.6	0.2	0.3	2.8	0.7	0.2	0.0	0.4	0.6	0.5	0.6	6.6	12.9	0.6	1.0	1.5	2.1	0.0	0.3	0.8	0.0	1.1	0.2	0.0	0.3	1.3	0.0	0.4	0.1	0.4	1.6	2.1	0.2	0.0	0.0	0.0	2.2	8.6	3.5	3.6	4.8	2.1	1.6	3.2	5.8	1.3
TIGD6	DKFZp761E2110	ENSG00000164296	"Tigger transposable element derived 6"	Q17RP2	5	149993118-150001167	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA044599	Uncertain		Approved	"Nucleoplasm,Vesicles,Actin filaments"				Nucleoplasm	"Vesicles, Actin filaments"	"HPA044599: AB_10961286"	"unprognostic (1.06e-1)"	"unprognostic (3.25e-1)"	"prognostic favourable (5.35e-4)"	"unprognostic (1.94e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.30e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.85e-2)"	"prognostic favourable (5.88e-4)"	"unprognostic (1.94e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.18e-1)"	6.9	10.5	5.9	3.9	10.7	2.8	9.9	9.3	9.4	5.8	6.1	10.0	8.9	4.7	6.5	11.1	5.0	6.9	5.1	4.5	6.4	4.7	7.7	7.0	5.3	3.9	7.3	7.1	8.6	6.8	28.0	10.5	5.5	7.1	8.8	5.7	6.4	8.1	12.6	3.8	7.2	5.2	5.9	7.6	5.8	6.1	9.8	8.0	6.1	6.5	3.6	4.3	6.2	6.1	3.5	3.3	2.1	4.0	6.3	8.0	2.6	2.3	6.2	4.2	9.1	12.1	10.0	6.6	6.6	7.0	5.2	5.2	4.0	4.1	1.1	5.9	7.7	4.1	3.7	4.8	6.1	4.9	3.1	1.9	3.2	2.1	10.8	2.7	5.0	10.3	9.2	6.7	8.8	4.0	2.6	5.3	6.3	5.4	3.6	1.2	1.7	5.3	4.1	4.8	2.9	4.9	3.3	3.3	4.2	4.6	7.5	9.3	8.3	4.8	5.3	4.2	3.3	4.6	4.8	3.9	1.5	3.0	6.7	3.0	6.5	0.2	4.0	2.1	2.8	3.9	2.5	2.7	3.8	2.8	3.3	3.5	8.0	5.1	0.0	6.3	2.2	2.2	3.7	2.6	5.9	10.7	9.3	9.4	6.4	4.7	7.3	7.1	7.1	8.0
TINAG		ENSG00000137251	"Tubulointerstitial nephritis antigen"	Q9UJW2	6	54307859-54390152	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"intestine: 27.2;kidney: 53.0"	"Cell line enriched"	"Detected in some"	34	"RPTEC TERT1: 45.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035427, HPA073753"	Approved				"Secreted to extracellular matrix"		26000			"HPA035427: AB_10601822, HPA073753: "			"unprognostic (7.62e-3)"			"unprognostic (1.12e-2)"	"prognostic unfavourable (2.05e-5)"	"unprognostic (7.27e-2)"			"unprognostic (5.99e-3)"		"prognostic favourable (8.75e-5)"	"unprognostic (7.10e-2)"				0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.2	0.0	9.5	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.1	53.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.0	0.2	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.4	0.0
TIPARP	"DDF1, DKFZP434J214, DKFZp686N0351, PARP-1, PARP-7, PARP7, pART14, RM1"	ENSG00000163659	"TCDD inducible poly(ADP-ribose) polymerase"	Q7Z3E1	3	156673235-156706770	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 50.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 24.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036796			Approved	Microtubules				Microtubules		"HPA036796: AB_10672268"	"prognostic favourable (2.00e-5)"	"unprognostic (3.50e-1)"	"unprognostic (7.62e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.56e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.16e-3)"	"unprognostic (4.90e-3)"	31.6	29.8	10.9	11.1	24.7	31.8	19.9	7.1	16.3	16.2	12.7	14.2	18.8	6.8	18.3	20.7	27.2	27.8	18.8	26.5	16.0	9.4	14.2	21.3	20.2	15.2	16.2	6.2	37.0	14.5	73.8	11.4	6.1	30.9	13.6	7.5	10.0	8.2	36.0	17.4	26.2	22.1	21.6	37.4	8.4	11.3	23.1	12.5	8.4	10.8	19.1	13.8	18.7	16.7	3.7	3.3	24.1	5.4	7.0	6.0	2.2	12.5	8.8	3.0	2.5	11.1	8.1	2.4	20.9	17.0	10.7	14.9	5.0	26.1	3.7	6.8	23.7	13.0	7.5	50.2	15.9	7.9	5.6	6.3	9.2	3.4	4.7	2.1	11.6	6.6	31.5	10.8	26.2	9.7	4.9	15.1	37.0	2.4	1.8	2.8	3.4	7.4	3.0	6.8	12.8	11.2	5.9	9.2	2.3	16.4	5.1	3.5	7.9	3.7	20.9	4.6	1.5	8.6	7.5	16.9	3.0	3.3	7.9	3.3	15.5	24.1	3.5	4.7	4.2	2.2	6.0	1.9	4.2	5.6	2.3	3.7	2.6	3.5	10.7	7.0	5.4	3.3	4.7	2.2	10.9	24.7	7.1	16.3	16.0	9.4	16.2	6.2	30.9	12.5
TLCD1		ENSG00000160606	"TLC domain containing 1"	Q96CP7	17	28724348-28727935	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 45.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	14	"plasmacytoid DC: 17.7"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042366	Enhanced									"HPA042366: AB_10794419"	"unprognostic (1.23e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.80e-2)"	"prognostic unfavourable (3.28e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.47e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (9.05e-5)"	"unprognostic (1.56e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.93e-2)"	2.7	3.7	10.0	4.5	12.6	1.0	5.3	6.3	9.5	4.5	7.7	3.0	9.0	7.8	1.7	14.4	8.7	14.7	3.2	1.4	8.6	5.7	12.9	12.0	6.0	4.6	7.0	7.7	2.1	12.4	5.0	2.8	9.0	4.8	5.7	8.3	1.6	9.8	9.6	1.8	13.0	5.5	0.9	3.0	2.5	8.6	7.8	1.7	5.3	4.4	9.6	9.3	4.2	3.4	1.2	17.7	1.1	0.8	0.3	0.5	0.4	4.7	21.7	5.9	5.0	4.1	7.6	13.9	3.9	7.0	1.8	2.7	12.1	8.5	1.5	6.2	4.7	7.6	6.5	12.3	2.8	1.2	6.3	2.4	14.1	14.5	4.4	5.2	0.4	5.1	10.1	6.8	12.1	1.6	9.2	0.2	3.2	16.3	0.5	2.1	6.8	4.0	1.8	2.5	9.0	15.2	8.5	11.4	2.2	8.2	45.6	4.2	22.7	1.9	1.6	2.0	6.6	3.5	6.3	1.6	1.7	3.3	3.7	3.1	6.4	1.1	0.8	0.1	0.2	0.8	0.5	1.2	0.5	0.3	0.8	0.6	0.2	0.3	0.5	0.3	0.6	17.7	0.3	0.4	10.0	12.6	6.3	9.5	8.6	5.7	7.0	7.7	4.8	1.7
TLDC2	"C20orf118, dJ132F21.2"	ENSG00000101342	"TBC/LysM-associated domain containing 2"	A0PJX2	20	36876121-36894235	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.9"	"Cell line enriched"	"Detected in some"	10	"HMC-1: 27.5"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 9.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"basophil: 7.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.1"	"Region enriched"	"Detected in many"	4	"cerebellum: 6.3"	"Region enriched"	"Detected in single"	12	"cerebellum: 15.5"	HPA047468	Enhanced									"HPA047468: "	"unprognostic (9.06e-3)"	"unprognostic (3.35e-4)"	"unprognostic (4.60e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (9.97e-5)"	"unprognostic (7.25e-2)"	"unprognostic (6.20e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.87e-2)"	5.5	1.2	0.9	11.3	0.9	1.4	3.4	0.9	0.9	2.1	21.1	0.9	1.6	18.4	2.5	1.8	1.8	2.7	16.0	3.5	0.9	0.2	3.2	0.9	6.0	2.5	0.9	0.9	2.8	2.1	0.0	1.1	0.9	0.9	2.8	12.8	1.6	2.1	0.9	0.9	2.3	54.9	1.8	0.9	4.5	1.5	1.9	0.9	1.1	2.0	1.7	1.3	2.3	2.6	0.8	1.4	7.1	1.0	1.4	1.2	0.7	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.4	0.2	0.1	0.5	0.3	0.0	0.0	0.0	0.1	0.2	1.0	0.1	2.8	0.0	0.3	27.5	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.1	0.1	7.1	1.0	0.1	0.3	0.9	0.6	0.3	0.5	0.2	1.4	0.8	1.2	0.3	0.0	1.4	0.9	0.4	0.7	0.7	0.9	0.9	0.9	0.9	0.9	0.2	0.9	0.9	0.9	0.9
TLR7		ENSG00000196664	"Toll like receptor 7"	Q9NYK1	X	12867083-12890380	"FDA approved drug targets, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.5"	"Group enriched"	"Detected in some"	5	"Daudi: 15.6;U-266/70: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059613	Supported									"HPA059613: "	"unprognostic (1.22e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.36e-3)"	"unprognostic (9.29e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.27e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.75e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.53e-3)"	"unprognostic (1.34e-1)"	2.9	3.1	7.6	7.2	11.3	1.0	7.6	1.7	7.9	2.5	3.3	10.6	0.0	3.2	1.8	2.9	1.8	1.7	5.3	4.1	8.4	5.1	2.2	1.5	7.7	6.9	17.4	2.6	1.6	1.9	1.5	2.2	11.0	12.9	2.2	4.0	1.5	2.7	2.0	1.4	1.4	4.9	3.5	26.5	6.7	3.0	1.5	17.2	7.7	1.7	0.5	9.4	5.2	1.6	6.9	15.7	3.2	8.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	16.1	0.0	3.0	0.0	0.3	0.0	0.2	7.2	3.2	0.0	8.9	0.0	6.9	0.0	0.0	3.7	5.8	0.0	0.0	0.4	0.0	6.8	15.7	0.0	2.2	7.6	11.3	1.7	7.9	8.4	5.1	17.4	2.6	12.9	17.2
TM2D2	BLP1	ENSG00000169490	"TM2 domain containing 2"	Q9BX73	8	38988808-38996824	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047152, HPA050547"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"				"Nucleoplasm, Vesicles, Plasma membrane"		"HPA047152: , HPA050547: AB_2681168"	"prognostic unfavourable (7.49e-4)"	"unprognostic (1.49e-1)"	"prognostic favourable (1.71e-4)"	"unprognostic (2.55e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-2)"	"unprognostic (8.61e-2)"	21.6	26.2	19.9	14.9	24.3	11.3	24.5	18.8	29.6	21.0	15.3	18.4	25.4	17.5	20.1	27.6	17.2	17.9	22.9	19.4	18.7	20.4	32.6	29.0	21.1	18.1	20.5	17.3	23.3	26.8	25.9	17.5	32.6	25.7	22.8	16.6	22.9	18.8	23.4	14.6	18.5	20.7	17.7	16.4	24.3	19.2	26.1	13.9	11.1	39.7	14.9	14.9	16.7	19.5	14.4	33.5	27.2	18.8	17.4	22.8	19.2	13.9	22.5	10.6	14.5	24.7	16.6	14.5	29.7	18.3	22.5	20.5	17.1	12.1	4.9	23.4	21.9	15.2	11.1	17.9	24.6	5.8	8.6	11.2	13.3	18.5	21.8	3.3	14.6	20.1	17.7	17.7	8.6	28.9	12.3	14.6	30.0	8.6	8.1	11.3	13.3	9.0	7.0	13.6	8.2	25.7	11.1	3.5	6.9	11.3	8.0	14.6	19.5	7.0	25.9	18.3	13.7	26.6	14.9	10.3	22.5	8.6	13.9	7.6	12.7	27.2	16.2	14.5	18.0	18.8	19.6	14.3	21.2	19.6	17.0	14.4	20.2	19.6	4.5	17.4	15.6	33.5	22.8	19.2	19.9	24.3	18.8	29.6	18.7	20.4	20.5	17.3	25.7	13.9
TM2D3	"BLP2, FLJ22604"	ENSG00000184277	"TM2 domain containing 3"	Q9BRN9	15	101621444-101652391	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054064	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA054064: "	"unprognostic (1.41e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.78e-2)"	17.8	25.1	32.8	14.1	33.1	15.4	26.0	30.7	46.7	24.9	16.9	21.3	15.3	15.2	26.3	29.1	15.3	22.5	18.7	28.3	35.3	49.8	20.6	32.8	17.5	23.0	28.2	35.8	37.6	28.2	23.5	25.7	19.6	26.8	21.5	15.6	19.1	20.9	24.0	22.6	16.8	15.0	20.7	22.7	17.0	15.8	20.6	19.1	16.0	29.1	14.2	19.2	19.2	16.1	21.4	14.3	38.4	20.2	24.1	24.1	18.0	8.7	21.8	11.7	21.1	33.6	25.1	14.3	11.6	19.2	13.8	15.5	11.7	25.0	14.3	16.1	15.7	20.6	18.2	15.0	11.0	13.6	40.0	21.4	18.9	19.8	22.2	16.6	25.6	20.7	30.4	8.3	17.3	19.0	17.5	21.7	21.7	17.7	12.1	17.6	18.0	7.3	14.8	14.8	22.2	27.9	23.2	15.8	14.4	16.0	17.0	23.1	16.1	22.0	15.1	14.6	15.0	9.7	12.7	20.6	30.4	15.5	12.4	20.9	12.0	14.8	20.2	38.4	21.7	19.9	24.1	15.5	17.9	16.5	14.3	21.4	23.9	22.1	34.4	24.1	15.0	12.1	18.0	18.0	32.8	33.1	30.7	46.7	35.3	49.8	28.2	35.8	26.8	19.1
TM4SF18	L6D	ENSG00000163762	"Transmembrane 4 L six family member 18"	Q96CE8	3	149318498-149334414	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 29.1;EFO-21: 61.5;HUVEC TERT2: 20.3;NTERA-2: 14.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 17.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.8"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA053639, HPA069378"	Approved		Approved	Vesicles,Cytosol				Vesicles	Cytosol	"HPA053639: , HPA069378: "	"unprognostic (2.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.05e-2)"	"prognostic favourable (8.63e-4)"	"unprognostic (2.84e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.97e-1)"	17.9	4.8	7.1	4.0	8.8	0.1	14.4	3.7	7.3	7.9	3.5	1.7	4.7	3.1	7.6	7.2	5.4	5.6	9.0	10.8	8.4	6.2	26.6	9.7	7.4	8.0	9.3	1.5	5.4	8.0	4.2	7.4	14.1	12.3	9.1	2.9	11.9	3.5	5.6	9.3	2.7	3.9	12.3	7.4	34.6	3.5	2.6	8.2	0.6	12.0	5.7	4.0	6.0	5.8	0.9	0.6	1.2	0.4	2.8	0.5	0.0	0.0	29.1	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	61.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	20.3	0.0	0.0	1.9	0.2	0.0	0.0	14.6	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	4.7	1.2	0.4	0.4	0.3	0.2	0.1	0.5	0.4	0.2	0.0	0.9	0.4	0.5	0.5	2.8	0.3	0.6	0.1	0.0	7.1	8.8	3.7	7.3	8.4	6.2	9.3	1.5	12.3	8.2
TM4SF5		ENSG00000142484	"Transmembrane 4 L six family member 5"	O14894	17	4771884-4783213	"Predicted membrane proteins"	"Cell cycle"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"intestine: 80.9;liver: 69.8"	"Group enriched"	"Detected in some"	14	"CACO-2: 24.3;Hep G2: 42.1"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 219.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA055674			Uncertain	"Nucleoplasm,Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA055674: "		"unprognostic (1.81e-1)"	"unprognostic (1.61e-1)"				"unprognostic (1.31e-1)"				"unprognostic (4.44e-2)"		"unprognostic (9.33e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.95e-1)"		"unprognostic (5.21e-3)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	45.1	0.1	0.1	50.5	0.1	0.2	0.1	0.1	7.0	0.1	0.1	0.1	3.1	69.8	0.1	0.1	0.1	0.1	0.1	0.9	4.1	0.1	0.6	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.1	80.9	0.1	0.1	0.1	8.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.1	0.0	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	24.3	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
TM7SF2	"ANG1, DHCR14A, NET47"	ENSG00000149809	"Transmembrane 7 superfamily member 2"	O76062	11	65111845-65116384	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 78.1"	"Cell line enhanced"	"Detected in many"		"MCF7: 21.6;RPTEC TERT1: 24.9;T-47d: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 22.6"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA030691, HPA072704"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"				"Endoplasmic reticulum"	Vesicles	"HPA030691: AB_10602480, HPA072704: "	"unprognostic (1.62e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.98e-2)"	"unprognostic (6.06e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.69e-1)"	"prognostic favourable (8.49e-8)"	"unprognostic (8.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.44e-2)"	27.7	78.1	6.9	2.2	12.5	2.0	10.0	5.6	21.7	4.7	3.1	22.4	5.1	4.8	1.5	11.0	11.5	6.4	8.5	28.2	7.4	6.6	8.3	38.6	5.1	1.7	10.3	9.6	13.5	22.6	11.8	6.2	2.2	13.2	19.8	2.3	5.4	28.5	3.3	3.3	17.9	2.8	1.3	7.3	1.9	8.8	5.3	8.8	1.9	7.4	13.6	10.4	2.6	6.1	7.4	22.6	1.8	1.0	7.3	7.6	3.0	2.6	3.5	8.3	12.0	3.3	0.2	5.3	0.6	1.3	1.0	1.1	8.6	12.2	5.3	9.4	0.4	4.3	3.7	5.8	0.7	5.0	1.8	3.3	1.0	17.3	6.8	1.3	3.6	1.5	1.8	4.8	0.6	0.9	1.9	4.1	0.3	21.6	2.2	5.7	4.5	4.0	7.1	0.4	12.4	24.9	3.8	9.5	10.6	0.4	9.1	2.1	48.4	3.5	0.6	0.1	1.2	1.2	0.8	9.4	5.9	3.0	0.8	2.0	0.3	0.5	1.0	1.8	5.5	0.8	4.3	7.1	3.5	4.5	0.9	7.4	7.6	5.5	0.7	7.3	0.5	22.6	3.1	3.0	6.9	12.5	5.6	21.7	7.4	6.6	10.3	9.6	13.2	8.8
TM7SF3		ENSG00000064115	"Transmembrane 7 superfamily member 3"	Q9NS93	12	26973195-27014434	"Predicted intracellular proteins, Predicted membrane proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057640			Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA057640: "	"unprognostic (4.24e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.04e-3)"	"unprognostic (8.80e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (1.32e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.58e-1)"	12.0	27.6	12.1	8.1	17.4	18.5	15.9	7.9	18.9	12.4	17.2	18.1	13.1	10.7	10.9	16.6	27.8	12.7	16.4	10.6	11.7	11.6	69.8	39.9	15.9	15.0	13.0	11.6	12.1	52.6	15.4	33.2	11.0	10.7	14.5	19.7	20.5	21.9	14.2	5.8	15.4	12.8	13.2	13.9	12.0	14.9	11.0	10.6	31.2	14.1	12.3	17.1	15.3	16.5	10.5	10.6	16.0	6.9	11.8	11.4	3.9	8.5	20.5	12.2	14.7	18.5	12.3	64.1	10.6	17.3	8.8	15.1	11.2	36.7	11.5	13.7	10.0	9.4	12.7	72.0	12.2	11.3	7.6	17.3	25.7	21.3	12.3	62.3	12.2	7.5	61.4	18.8	16.9	23.1	7.4	7.9	13.3	17.6	30.4	36.2	24.8	12.2	28.5	19.2	20.4	15.2	39.3	2.0	10.8	13.1	7.1	18.7	19.4	13.2	8.7	7.7	12.6	21.1	13.1	4.8	12.3	21.6	14.8	21.2	11.6	8.6	6.9	16.0	6.0	6.9	5.7	7.3	7.6	7.8	10.2	10.5	10.9	7.2	7.8	11.8	3.5	10.6	11.4	3.9	12.1	17.4	7.9	18.9	11.7	11.6	13.0	11.6	10.7	10.6
TM9SF1	"HMP70, MP70"	ENSG00000100926	"Transmembrane 9 superfamily member 1"	O15321	14	24189143-24195687	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA059249	Supported		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA059249: "	"unprognostic (3.27e-1)"	"prognostic unfavourable (8.94e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-3)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.18e-3)"	13.3	20.4	6.3	10.9	6.6	3.4	14.0	5.4	8.1	18.5	15.6	10.4	33.1	10.7	17.7	21.8	14.1	23.4	18.4	14.6	6.2	6.0	24.5	46.4	17.0	14.6	6.2	7.1	17.6	39.9	27.4	12.3	25.1	6.5	16.9	9.4	15.6	31.8	36.0	10.1	12.0	16.8	13.6	5.9	12.7	14.7	10.3	5.6	9.6	32.3	12.9	12.1	12.8	12.4	10.6	25.8	18.0	13.6	14.5	10.8	8.6	9.4	15.8	7.0	5.4	14.0	10.9	11.0	18.6	21.1	22.2	25.1	7.9	18.4	5.6	12.4	15.7	21.3	4.4	11.2	12.2	9.4	7.4	4.3	8.3	16.3	9.8	8.1	10.2	12.7	15.7	14.0	8.1	12.6	5.2	10.9	13.3	14.9	4.7	5.5	3.2	18.7	7.1	10.4	9.4	7.8	12.8	7.1	8.2	22.4	10.1	9.0	9.6	3.6	12.7	19.5	8.9	10.2	11.6	15.3	11.7	4.1	6.5	4.5	13.2	17.2	13.6	15.2	10.0	10.9	10.8	10.2	9.9	8.7	15.0	10.6	9.2	8.7	18.0	14.5	10.4	25.8	9.9	8.6	6.3	6.6	5.4	8.1	6.2	6.0	6.2	7.1	6.5	5.6
TMC3		ENSG00000188869	"Transmembrane channel like 3"	Q7Z5M5	15	81331217-81374213	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	15	"parathyroid gland: 66.9"	"Cell line enhanced"	"Detected in many"		"U-266/70: 4.6"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 1.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA040265, HPA040510"	Enhanced		Supported	Cytosol				Cytosol		"HPA040265: AB_10795379, HPA040510: AB_10796123"	"unprognostic (1.17e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.14e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.20e-5)"	"unprognostic (2.32e-1)"	"unprognostic (1.97e-7)"	"unprognostic (1.60e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.96e-2)"	0.0	0.1	0.0	1.7	0.0	0.3	0.2	0.4	1.4	1.5	1.5	0.0	0.0	0.2	0.8	4.6	0.7	0.8	0.2	0.2	0.0	0.1	0.1	1.3	0.0	0.1	0.0	0.0	0.2	0.2	66.9	1.5	0.7	1.6	1.0	0.1	0.4	0.2	2.9	0.0	0.2	0.5	1.7	1.9	0.1	0.8	3.0	0.0	0.0	1.5	0.0	0.0	1.3	3.6	1.6	0.7	0.2	0.2	0.2	1.8	0.7	0.9	1.0	0.5	2.7	0.4	0.2	1.9	0.8	0.3	0.2	0.3	0.7	1.9	2.3	0.1	0.0	0.7	0.3	0.2	0.1	1.7	1.4	1.9	1.1	0.9	0.3	1.5	1.1	0.5	0.1	0.4	0.3	0.0	0.6	2.8	0.2	0.8	1.0	1.4	1.5	0.9	0.7	1.0	4.3	0.2	0.6	1.1	2.0	0.9	1.0	2.0	2.3	1.1	0.4	1.5	1.8	1.3	0.5	4.6	1.8	1.4	1.1	2.5	0.9	0.1	0.0	0.2	0.7	0.1	0.6	1.2	0.8	0.4	0.1	1.6	1.8	1.3	0.2	0.2	0.2	0.7	0.9	0.7	0.0	0.0	0.4	1.4	0.0	0.1	0.0	0.0	1.6	0.0
TMC5	FLJ13593	ENSG00000103534	"Transmembrane channel like 5"	Q6UXY8	16	19410496-19499113	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"intestine: 108.7"	"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 38.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA040810, HPA042037"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA040810: AB_10795627, HPA042037: AB_10804126"	"unprognostic (2.47e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-2)"	"prognostic unfavourable (7.96e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.75e-1)"	0.7	0.3	0.3	4.8	0.3	0.1	5.6	0.3	0.7	3.8	66.1	0.6	0.6	19.1	2.1	16.9	1.4	1.9	15.9	0.4	0.4	0.3	0.3	1.8	17.6	0.2	0.3	0.4	1.8	5.4	4.5	1.0	3.7	1.0	8.4	9.8	1.7	18.9	0.2	0.3	0.8	108.7	0.3	0.2	0.3	19.5	2.6	0.2	0.2	0.8	1.7	4.1	1.5	1.1	0.5	0.7	2.2	0.6	0.9	0.8	0.3	3.6	6.0	0.0	0.1	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	38.9	0.0	0.2	0.0	2.4	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.1	1.4	1.7	0.0	0.0	1.4	0.1	0.1	0.4	0.1	0.0	1.2	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.6	0.2	0.3	0.3	0.2	0.4	0.8	0.3	0.2	0.5	0.2	0.3	2.2	0.9	0.4	0.7	0.1	0.3	0.3	0.3	0.3	0.7	0.4	0.3	0.3	0.4	1.0	0.2
TMCC3	KIAA1145	ENSG00000057704	"Transmembrane and coiled-coil domain family 3"	Q9ULS5	12	94567124-94650562	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 17.9;Karpas-707: 24.2;U-266/84: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 19.2;neutrophil: 30.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 30.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014272	Approved		Approved	"Endoplasmic reticulum,Vesicles"				"Endoplasmic reticulum"	Vesicles	"HPA014272: AB_1858059"	"unprognostic (1.03e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavourable (4.87e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.80e-3)"	"unprognostic (9.11e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.41e-2)"	"unprognostic (4.75e-2)"	10.6	4.0	10.2	7.7	20.9	8.1	9.9	2.7	9.9	11.0	19.7	32.6	6.8	13.1	6.9	3.0	6.1	5.5	4.7	4.4	14.7	10.8	7.4	3.5	5.9	3.9	25.8	7.4	5.2	2.8	5.0	4.7	15.7	17.8	7.7	15.0	7.3	5.8	5.1	20.2	7.0	23.0	7.2	25.5	11.6	6.4	2.2	20.4	0.1	12.0	3.3	5.3	7.2	5.9	2.5	1.1	30.0	3.0	1.3	1.5	1.1	4.3	0.2	1.1	0.0	0.4	1.6	7.9	0.0	0.0	0.2	1.1	0.0	0.9	0.1	0.0	0.0	10.8	6.1	7.3	1.5	1.9	1.5	2.8	0.4	0.0	0.3	0.0	5.9	1.0	1.0	4.1	5.9	17.9	0.1	24.2	0.6	0.2	0.0	0.2	0.5	3.7	0.0	0.3	2.8	1.2	9.2	0.1	0.5	0.1	4.6	0.2	0.0	0.2	10.7	0.0	0.1	0.0	1.9	11.2	16.1	0.1	2.2	0.9	1.0	6.5	1.8	19.2	1.5	2.6	0.1	2.5	0.6	0.8	1.0	1.4	0.0	1.0	30.0	1.3	3.0	1.1	0.0	1.1	10.2	20.9	2.7	9.9	14.7	10.8	25.8	7.4	17.8	20.4
TMCO4	DKFZp686C23231	ENSG00000162542	"Transmembrane and coiled-coil domains 4"	Q5TGY1	1	19682213-19799945	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA014601, HPA014620"	Uncertain		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA014601: AB_2204302, HPA014620: "	"unprognostic (3.31e-3)"	"unprognostic (8.94e-2)"	"unprognostic (9.71e-2)"	"prognostic favourable (3.71e-4)"	"unprognostic (6.99e-3)"	"unprognostic (5.46e-2)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (9.21e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-2)"	"prognostic favourable (4.12e-11)"	"unprognostic (1.67e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.81e-2)"	"prognostic favourable (3.64e-4)"	10.6	8.8	2.4	9.0	3.3	2.5	11.3	0.9	2.3	9.1	6.1	2.8	15.2	11.8	16.9	15.1	8.0	7.3	7.4	4.9	1.6	1.3	9.5	7.9	5.2	12.6	2.6	1.2	8.6	15.3	17.3	10.5	7.3	3.3	12.1	3.9	8.8	25.8	19.0	2.0	5.2	6.4	11.2	2.0	9.1	8.7	3.3	2.4	3.5	10.8	7.6	9.5	11.6	10.0	7.2	9.3	2.7	8.1	4.6	6.7	4.4	5.7	3.6	0.0	0.2	4.9	3.5	4.0	4.3	13.2	8.5	4.8	2.9	27.1	10.1	6.4	12.3	4.4	1.1	4.3	1.7	8.5	1.0	3.8	4.3	1.4	4.0	0.0	5.3	3.7	4.9	2.8	1.6	4.0	0.7	6.8	3.7	4.9	0.0	2.1	0.4	5.0	1.9	11.4	6.2	7.3	4.5	0.0	0.5	5.7	7.9	9.0	6.9	6.5	2.5	6.6	3.0	4.6	2.9	0.8	0.3	2.9	7.5	8.7	4.1	0.1	4.8	2.7	6.3	8.1	6.2	5.6	6.7	6.6	9.3	7.2	5.2	4.3	0.3	4.6	4.9	0.2	4.9	4.4	2.4	3.3	0.9	2.3	1.6	1.3	2.6	1.2	3.3	2.4
TMCO5A	"MGC35118, TMCO5"	ENSG00000166069	"Transmembrane and coiled-coil domains 5A"	Q8N6Q1	15	37921939-37967724	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	130	"testis: 43.9"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.2;hTERT-HME1: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"amygdala: 6.0;basal ganglia: 2.2;cerebral cortex: 5.7;hippocampal formation: 6.7"	"Low region specificity"	"Detected in many"			HPA056530	Enhanced									"HPA056530: "										"unprognostic (2.60e-1)"	"unprognostic (1.69e-4)"							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMED6	"MGC23911, p24g5, p24gamma5"	ENSG00000157315	"Transmembrane p24 trafficking protein 6"	Q8WW62	16	69343248-69351809	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"pancreas: 144.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 17.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA012532	Approved									"HPA012532: AB_1858065"	"unprognostic (6.85e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.31e-3)"	"prognostic favourable (7.74e-5)"	"unprognostic (9.84e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.94e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.58e-3)"	"unprognostic (9.71e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.52e-3)"	0.2	0.2	0.2	0.7	0.2	0.0	0.2	0.2	0.2	0.4	0.9	0.2	2.0	2.7	0.3	4.5	0.2	5.6	0.3	0.2	0.2	0.1	6.1	3.1	0.7	0.2	0.2	0.2	1.0	144.2	0.0	0.2	0.2	0.2	0.2	1.7	0.2	0.2	3.5	0.2	0.1	2.8	0.2	0.2	0.3	16.6	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.2	0.0	0.6	0.0	2.0	0.2	0.7	1.9	1.6	1.1	0.1	0.1	1.0	2.3	0.1	0.0	0.3	2.4	1.0	4.8	0.8	0.0	1.2	0.2	0.2	0.4	0.7	2.0	2.4	0.8	17.3	0.1	3.0	1.1	0.2	0.9	0.1	0.3	0.1	1.6	0.6	0.3	1.9	1.3	3.3	2.2	1.8	2.6	1.4	1.8	0.7	2.0	3.8	1.5	3.1	1.1	1.2	0.6	2.1	2.1	2.7	1.5	0.9	1.5	1.6	1.5	5.2	1.4	2.5	0.9	0.0	0.4	0.0	0.8	0.6	1.5	0.6	2.0	0.4	0.2	0.3	0.5	2.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
TMEM108	"CT124, MGC3040"	ENSG00000144868	"Transmembrane protein 108"	Q6UXF1	3	133038391-133397792	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 25.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 11.6;LHCN-M2: 6.5;SCLC-21H: 10.0;SH-SY5Y: 44.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063350	Enhanced		Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"	"Nucleoli, Vesicles"	"HPA063350: "	"unprognostic (4.75e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.06e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.27e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.36e-2)"	2.2	15.1	12.7	2.2	13.8	0.7	2.4	15.6	21.7	3.2	1.8	7.5	0.2	1.1	3.7	1.3	12.7	2.4	1.6	8.4	10.0	8.1	1.0	0.6	12.1	2.5	5.3	13.7	0.8	1.0	6.1	2.8	9.1	4.9	4.0	2.2	16.1	1.8	3.2	25.6	2.2	2.0	10.4	4.4	2.0	2.2	16.8	4.3	0.0	4.1	1.5	3.3	12.0	1.3	0.8	0.4	1.0	0.4	0.6	0.8	0.6	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.3	0.4	0.8	3.9	0.0	0.0	0.0	0.0	11.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	6.5	0.3	0.0	0.1	1.8	0.0	0.0	2.2	0.0	0.5	0.0	10.0	44.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.3	0.8	0.0	1.7	1.0	0.3	0.2	0.5	0.3	0.3	0.3	0.2	0.5	0.0	0.8	0.3	0.4	0.9	0.6	0.4	0.4	0.8	0.6	12.7	13.8	15.6	21.7	10.0	8.1	5.3	13.7	4.9	4.3
TMEM116	FLJ90167	ENSG00000198270	"Transmembrane protein 116"	Q8NCL8	12	111931282-112013185	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	4	"T-cells: 14.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040720	Approved		Approved	Nucleoplasm,Microtubules				Microtubules	Nucleoplasm	"HPA040720: AB_10795623"	"unprognostic (8.91e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.12e-2)"	"prognostic favourable (1.08e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.19e-3)"	3.7	10.7	4.4	3.0	8.4	1.0	10.2	6.7	6.6	5.3	4.1	11.2	9.1	9.5	3.9	6.4	4.9	4.2	5.8	20.2	5.3	3.7	26.8	10.0	7.2	3.7	8.7	5.5	4.7	4.1	31.2	9.6	2.7	14.0	4.5	3.4	5.9	12.5	7.0	5.0	11.8	9.0	5.1	8.2	3.9	8.7	20.8	7.3	6.0	6.6	3.6	5.6	8.6	4.5	2.5	3.0	3.0	3.3	1.5	14.9	3.4	4.1	4.4	6.2	6.9	6.2	4.9	4.2	3.4	5.5	4.5	4.9	3.3	3.5	4.8	2.2	2.5	4.3	3.4	3.6	3.9	11.6	2.8	3.1	4.2	4.1	9.9	1.2	0.5	6.0	6.3	5.7	10.0	1.5	5.9	3.9	4.5	6.2	1.8	9.8	7.7	2.9	4.9	2.5	8.3	14.0	23.6	5.9	3.9	3.7	3.2	5.7	11.8	16.3	1.1	4.2	1.3	3.8	1.5	4.7	8.1	4.6	5.9	3.8	5.9	0.8	1.8	3.0	6.5	3.3	5.2	2.1	14.9	12.1	2.1	2.5	7.9	8.6	0.3	1.5	2.4	3.0	13.5	3.4	4.4	8.4	6.7	6.6	5.3	3.7	8.7	5.5	14.0	7.3
TMEM121	"hole, MGC4659, TMEM121A"	ENSG00000184986	"Transmembrane protein 121"	Q9BTD3	14	105526603-105530202	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 12.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.4;MCF7: 8.7;PC-3: 11.4;REH: 7.3;SCLC-21H: 6.0;WM-115: 6.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 1.8;MAIT T-cell: 2.6;memory B-cell: 4.7;memory CD4 T-cell: 3.1;memory CD8 T-cell: 1.6;naive B-cell: 1.7;naive CD4 T-cell: 1.9;naive CD8 T-cell: 1.2;NK-cell: 1.8"	"Group enriched"	"Detected in many"	6	"B-cells: 4.7;NK-cells: 1.8;T-cells: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049857	Uncertain		Approved	Cytosol				Cytosol		"HPA049857: "	"unprognostic (4.25e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.88e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-3)"	"unprognostic (5.31e-2)"	"unprognostic (5.48e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavourable (5.87e-4)"	"unprognostic (5.90e-2)"	3.2	2.6	7.2	2.5	8.8	1.5	1.7	3.3	12.6	2.5	1.6	7.9	1.9	1.5	3.0	2.9	1.6	3.1	1.3	2.3	7.4	6.0	2.5	3.0	1.9	2.5	5.0	3.9	2.7	2.9	2.5	3.5	1.6	3.0	3.8	0.8	2.7	2.8	2.7	1.1	2.1	1.9	1.6	4.3	7.1	3.4	1.6	1.6	0.0	2.9	0.4	1.0	1.1	4.7	4.7	0.5	0.0	0.0	1.8	3.1	0.6	0.0	4.4	0.4	4.1	0.0	0.2	0.8	2.8	0.6	0.4	0.0	0.0	1.5	1.3	9.4	0.0	0.4	0.4	0.1	0.0	0.6	2.2	0.1	0.4	1.5	0.7	0.0	1.6	0.3	0.0	0.1	0.0	0.4	0.1	0.0	0.2	8.7	0.2	0.0	1.4	11.4	7.3	0.0	0.1	0.1	0.0	6.0	2.2	0.5	0.0	2.1	2.7	0.3	1.6	1.3	2.4	0.2	0.4	0.6	0.0	0.0	0.1	0.5	6.1	0.0	0.0	0.0	1.8	0.0	2.6	4.7	3.1	1.6	0.5	1.7	1.9	1.2	0.0	1.8	0.0	0.0	0.2	0.6	7.2	8.8	3.3	8.2	7.4	6.0	5.0	3.9	3.0	1.6
TMEM121B	CECR6	ENSG00000183307	"Transmembrane protein 121B"	Q9BXQ6	22	17116299-17121367	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.1;prostate: 14.1"	"Cell line enhanced"	"Detected in some"		"AF22: 6.2;SCLC-21H: 14.7;THP-1: 11.8;U-937: 9.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 6.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.2;intermediate monocyte: 1.4;neutrophil: 4.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.3;monocytes: 3.2"	"Group enriched"	"Detected in many"	8	"amygdala: 22.5;basal ganglia: 24.0;cerebral cortex: 29.3;hippocampal formation: 26.2;olfactory region: 20.0"	"Low region specificity"	"Detected in many"			HPA068790	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"				Vesicles	"Nucleoplasm, Plasma membrane"	"HPA068790: "	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.11e-3)"	"unprognostic (4.49e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.12e-3)"	"unprognostic (5.32e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.88e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.10e-4)"	"unprognostic (1.02e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.71e-1)"	1.3	1.8	7.4	2.2	12.0	2.2	2.0	8.1	19.1	1.0	0.8	2.4	0.0	1.1	1.1	2.3	0.8	1.2	1.0	2.3	7.1	4.0	0.8	0.8	0.9	0.8	2.9	6.9	0.9	2.7	0.8	2.0	1.9	2.3	14.1	1.0	0.2	1.2	1.0	2.8	1.5	0.9	1.3	2.5	1.1	1.0	2.4	4.2	0.0	0.6	0.0	0.8	1.0	0.3	0.0	0.5	4.3	3.2	0.0	0.0	0.6	0.0	0.0	6.2	0.8	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.2	0.1	1.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.8	3.1	2.2	0.1	0.2	3.0	0.0	0.3	0.1	14.7	2.2	0.0	0.0	0.3	0.0	11.8	0.6	0.7	0.3	0.2	0.0	0.2	0.3	0.9	0.0	9.8	0.3	0.0	3.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.6	7.4	12.0	8.1	18.0	7.1	4.0	2.9	6.9	2.3	4.2
TMEM125	MGC17299	ENSG00000179178	"Transmembrane protein 125"	Q96AQ2	1	43269994-43274002	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 73.6;salivary gland: 47.8"	"Cell line enhanced"	"Detected in some"		"A-431: 13.5;BEWO: 11.6;CACO-2: 10.6;CAPAN-2: 25.2;SK-BR-3: 21.7;T-47d: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015796			Approved	Midbody,Cytosol				"Midbody, Cytosol"		"HPA015796: AB_1858081"	"unprognostic (2.53e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (8.37e-3)"	"prognostic favourable (5.11e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-1)"	"prognostic favourable (2.91e-9)"	"unprognostic (1.86e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.16e-2)"	0.8	0.0	5.3	4.6	7.1	0.0	4.9	0.9	5.0	7.4	14.4	1.0	20.7	15.1	1.8	12.5	3.3	6.6	18.9	1.0	8.9	4.3	9.4	1.4	42.5	0.8	10.7	0.8	2.0	73.6	9.6	15.7	5.6	1.1	8.8	9.1	1.5	47.8	19.0	0.8	3.7	29.4	0.8	21.1	0.8	11.6	1.2	0.8	1.1	33.6	3.8	5.0	1.4	3.5	0.0	0.8	0.0	0.0	1.8	0.9	0.2	13.5	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	10.6	25.2	0.0	0.6	0.0	6.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.2	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.2	4.3	6.6	0.0	0.0	21.7	0.0	17.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.9	0.2	0.0	1.8	0.0	0.8	0.0	0.2	5.3	7.1	0.9	1.9	8.9	4.3	10.7	0.8	1.1	0.8
TMEM130	"DKFZp761L1417, FLJ42643"	ENSG00000166448	"Transmembrane protein 130"	Q8N3G9	7	98846488-98870771	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 28.2;brain: 82.2;pituitary gland: 24.0;testis: 26.4"	"Cell line enhanced"	"Detected in some"		"BJ: 3.9;BJ hTERT+: 8.8;EFO-21: 8.6;NTERA-2: 5.1;SH-SY5Y: 10.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012928	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA012928: AB_1858085"	"unprognostic (1.36e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.97e-1)"	"prognostic favourable (7.84e-4)"	"unprognostic (1.07e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.86e-3)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.73e-1)"	1.3	28.2	27.3	2.0	53.8	1.4	1.8	14.1	82.2	3.5	1.8	2.8	0.0	1.6	1.8	8.0	2.2	1.7	2.2	1.4	29.3	47.0	2.8	1.1	5.4	2.4	13.4	35.1	1.7	1.6	1.5	24.0	1.3	25.8	2.7	1.9	1.0	1.3	6.2	2.1	1.3	2.1	1.6	9.2	1.4	1.4	26.4	3.9	0.1	1.4	0.0	1.2	1.7	1.2	1.0	0.6	4.8	0.9	1.0	0.7	0.3	0.0	0.7	0.0	0.0	0.3	0.0	0.2	3.9	8.8	0.7	0.6	0.1	0.1	0.1	8.6	2.2	0.1	0.0	0.0	0.1	0.2	0.4	0.1	0.3	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.4	0.2	0.7	0.4	0.7	0.2	0.2	5.1	0.0	0.2	0.0	0.8	0.1	0.0	0.6	10.5	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.4	0.3	0.1	0.4	0.5	0.2	2.2	0.9	0.6	0.5	0.4	0.4	0.7	0.5	0.4	0.2	1.0	0.7	0.6	4.8	1.0	0.6	0.6	0.4	0.3	27.3	53.8	14.1	44.2	29.3	47.0	13.4	35.1	25.8	3.9
TMEM132B	"KIAA1786, KIAA1906"	ENSG00000139364	"Transmembrane protein 132B"	Q14DG7	12	125186836-125662377	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 19.3"	"Cell line enhanced"	"Detected in some"		"HSkMC: 7.8;NTERA-2: 8.9;RPMI-8226: 3.8;U-138 MG: 13.9;U-937: 3.9"	"Cancer enriched"	"Detected in single"	7	"glioma: 3.3"					"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.0"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035661, HPA035662"	Uncertain									"HPA035661: AB_10669774, HPA035662: "	"unprognostic (3.38e-3)"	"unprognostic (4.39e-2)"	"unprognostic (6.73e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.46e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.23e-3)"	"unprognostic (1.29e-2)"	"unprognostic (4.29e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.73e-3)"	0.2	0.2	6.1	0.1	7.5	0.0	0.1	0.2	19.3	0.6	0.3			0.2	0.8	1.0	0.5	0.2	0.3	0.7	5.1	2.6	0.1	0.0	0.0	0.1	2.6		0.1	0.2	0.0	1.1	0.2		0.4	0.4		2.8	0.6	0.5	2.4	0.2	0.2	0.5	0.0	0.3	0.8			2.7		0.3	0.1	0.0	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	3.6	0.0	2.6	2.8	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.1	0.0	0.0	2.9	0.3	0.0	0.0	0.0	8.9	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.9	0.0	0.1	0.0	0.0	0.2	0.0	2.2	3.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0										
TMEM132C	"DKFZp761O2018, PPP1R152"	ENSG00000181234	"Transmembrane protein 132C"	Q8N3T6	12	128267403-128707915	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 37.5"	"Group enriched"	"Detected in some"	6	"AF22: 5.9;ASC diff: 8.5;Daudi: 9.5"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.6;testis cancer: 4.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"gdT-cell: 5.4"	"Lineage enriched"	"Detected in single"	55	"T-cells: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015633, HPA015984"			Supported	Centrosome,Cytosol			110000000	"Centrosome, Cytosol"		"HPA015633: AB_1858089, HPA015984: AB_1858088"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (7.34e-2)"	"unprognostic (8.60e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.99e-3)"		"unprognostic (5.48e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.29e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.33e-3)"	37.5	4.2	9.6	1.1	7.0	0.8	23.3	5.0	6.6	22.0	2.5	4.2	8.9	1.2	5.9	5.7	4.7	13.4	5.1	3.5	5.0	3.8	1.3	0.8	1.6	2.0	4.9	3.1	7.9	4.1	0.9	0.6	5.1	4.6	3.7	1.3	5.3	2.9	9.1	1.9	2.2	1.4	2.1	3.9	1.1	1.5	2.1	5.4	0.0	1.1	0.9	1.3	3.8	10.5	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.0	5.9	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.6	7.0	5.0	6.6	5.0	3.8	4.9	3.1	4.6	5.4
TMEM135	FLJ22104	ENSG00000166575	"Transmembrane protein 135"	Q86UB9	11	87037844-87323758	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056685, HPA069473"	Uncertain		Supported	Vesicles				Vesicles		"HPA056685: , HPA069473: "	"unprognostic (1.55e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.65e-1)"	"prognostic favourable (9.02e-4)"	"unprognostic (3.48e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.80e-1)"	31.6	28.9	10.5	9.5	12.0	5.9	23.3	11.4	14.8	8.3	14.3	12.8	18.9	21.8	15.1	7.8	7.4	8.4	12.6	12.6	9.9	11.3	16.5	31.2	11.7	9.8	13.8	10.2	14.1	9.2	14.7	24.4	13.5	12.9	15.4	12.1	12.8	16.9	17.8	14.9	7.5	20.1	11.1	11.2	8.3	10.1	15.7	11.4	14.1	15.0	6.4	7.0	10.7	9.9	5.9	7.0	2.2	6.0	8.4	10.4	4.5	4.2	6.9	4.8	6.6	15.7	15.1	6.2	3.2	8.5	3.9	8.4	12.1	19.2	12.0	8.4	4.2	4.1	6.6	7.9	4.2	10.5	4.1	9.6	7.3	42.2	8.8	5.2	4.9	17.3	4.8	5.2	3.6	9.8	8.8	16.4	4.2	3.4	12.7	6.1	5.8	5.9	6.7	3.9	9.5	8.8	13.1	2.5	6.3	5.1	14.6	7.0	20.8	5.8	5.2	4.3	5.3	14.7	2.5	6.9	12.4	13.0	3.0	5.9	7.8	0.9	5.8	1.7	9.7	6.0	8.5	5.9	6.3	10.4	6.6	5.2	7.1	6.8	2.2	8.4	2.7	7.0	6.5	4.5	10.5	12.0	11.4	14.8	9.9	11.3	13.8	10.2	12.9	11.4
TMEM136	MGC17839	ENSG00000181264	"Transmembrane protein 136"	Q6ZRR5	11	120325129-120333682	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 5.7"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 5.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA074432			Approved	Vesicles,Cytosol				Vesicles	Cytosol	"HPA074432: "	"unprognostic (1.02e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (6.65e-4)"	"unprognostic (1.65e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.81e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.28e-2)"	4.4	18.9	9.1	2.7	13.8	1.0	5.7	5.8	15.1	4.6	2.9	13.8	3.2	2.1	7.6	14.0	2.6	7.4	5.6	19.1	8.2	5.7	4.8	1.9	4.9	4.0	13.0	7.7	9.0	9.7	9.4	7.9	10.4	12.0	8.4	2.3	9.0	2.4	5.9	1.8	2.0	3.1	6.9	13.7	4.2	2.8	5.4	8.8	0.0	7.8	0.7	2.9	3.2	4.1	0.0	5.7	0.0	0.0	0.0	0.9	0.0	1.7	4.5	8.4	8.0	8.4	13.2	2.1	3.7	9.2	6.0	9.7	2.2	7.5	0.0	11.6	2.3	1.2	7.4	2.8	6.7	0.0	4.6	5.5	4.0	3.9	9.4	0.0	0.0	11.4	2.1	8.4	13.1	6.9	1.5	11.1	8.0	2.1	0.0	0.0	3.6	2.8	4.2	3.4	0.6	7.9	1.6	5.4	5.3	5.2	0.6	1.0	6.9	0.2	4.9	6.6	6.7	1.4	2.2	0.1	0.0	0.0	1.9	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.9	0.0	9.1	13.8	5.8	11.5	8.2	5.7	13.0	7.7	12.0	8.8
TMEM143	FLJ10922	ENSG00000161558	"Transmembrane protein 143"	Q96AN5	19	48332356-48364237	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 70.1"	"Cell line enhanced"	"Detected in all"		"U-266/70: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014476, HPA058645"	Approved		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA014476: AB_1858092, HPA058645: "	"unprognostic (1.23e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.50e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.11e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.08e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.82e-2)"	"prognostic favourable (1.53e-7)"	"unprognostic (5.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.04e-1)"	6.2	5.6	3.3	3.5	5.7	2.7	3.2	5.1	6.6	2.6	4.4	4.4	4.1	4.3	4.1	3.8	4.0	3.0	3.2	27.0	3.4	2.7	6.1	9.7	2.9	3.5	4.7	4.5	3.2	4.2	3.1	3.2	3.0	3.9	3.4	3.1	4.7	4.5	4.1	70.1	4.8	4.8	5.3	3.2	4.6	3.7	2.5	4.3	5.4	3.9	16.5	5.1	3.7	2.5	5.0	3.4	3.6	2.3	7.6	5.7	2.7	3.5	5.7	1.9	3.5	3.9	6.3	3.8	3.4	2.0	2.4	3.1	5.0	4.7	6.6	6.5	2.3	4.1	1.9	2.5	1.4	9.0	4.3	4.0	4.6	8.3	3.3	3.2	3.9	5.4	3.1	1.2	3.3	1.9	2.9	9.9	3.0	2.1	4.4	12.3	2.4	2.1	7.1	1.4	11.0	3.2	2.7	7.1	7.0	1.9	2.5	1.5	3.5	2.8	2.3	2.8	3.2	2.0	1.7	20.9	6.2	5.4	2.3	4.2	2.4	3.6	2.3	2.7	4.7	1.5	5.7	5.0	3.7	4.0	3.4	3.4	5.5	3.3	1.7	7.6	2.3	1.3	2.3	2.7	3.3	5.7	5.1	6.6	3.4	2.7	4.7	4.5	3.9	4.3
TMEM144	FLJ11155	ENSG00000164124	"Transmembrane protein 144"	Q7Z5S9	4	158201604-158255411	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	6	"brain: 88.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.3;hTCEpi: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.3;intermediate monocyte: 1.4;myeloid DC: 3.7;plasmacytoid DC: 4.3"	"Group enriched"	"Detected in many"	10	"dendritic cells: 4.3;monocytes: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063554			Approved	Mitochondria				Mitochondria		"HPA063554: "	"unprognostic (1.26e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.06e-2)"	"prognostic favourable (2.89e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.27e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavourable (8.48e-4)"	"unprognostic (9.34e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.05e-2)"	4.7	6.7	20.7	2.0	60.9	1.5	9.2	4.7	37.7	4.7	7.4	88.7	0.2	14.3	3.7	8.3	3.1	3.9	6.8	8.2	31.5	18.3	1.9	1.7	3.5	0.9	80.4	26.6	8.6	3.8	3.0	1.4	3.5	48.9	5.4	8.6	0.0	3.1	7.2	1.4	1.9	9.6	4.2	79.2	2.2	5.4	15.8	67.4	0.0	9.2	0.0	0.8	5.1	1.9	0.0	4.3	0.1	3.3	0.4	0.1	0.7	2.5	7.0	0.1	1.4	5.1	7.7	23.3	1.1	1.9	1.0	1.6	8.8	9.6	0.0	1.4	0.3	1.2	3.2	10.8	1.4	0.0	3.2	4.3	2.1	7.8	1.8	5.4	1.3	5.5	13.4	4.6	1.6	5.8	2.8	0.1	8.0	3.0	0.0	0.0	1.8	1.7	0.0	0.0	0.3	2.0	7.4	1.1	0.0	0.2	9.5	2.6	6.7	1.5	1.1	2.2	1.7	0.4	1.3	0.0	0.6	0.6	3.0	0.8	1.5	0.0	3.3	0.0	0.0	1.4	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.4	0.7	4.3	0.0	0.7	20.7	60.9	4.7	35.1	31.5	18.3	80.4	26.6	48.9	67.4
TMEM145	FLJ90805	ENSG00000167619	"Transmembrane protein 145"	Q8NBT3	19	42313325-42325062	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"brain: 74.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 11.7;SCLC-21H: 22.2;SH-SY5Y: 10.6"	"Cancer enhanced"	"Detected in many"		"glioma: 8.8"	"Region enriched"	"Detected in all"	4	"cerebellum: 74.5"	"Group enriched"	"Detected in some"	8	"basophil: 4.5;neutrophil: 15.5"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060462	Enhanced	Approved	Approved	Vesicles				Vesicles		"HPA060462: "	"unprognostic (9.56e-3)"	"unprognostic (8.61e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.27e-3)"	"unprognostic (1.53e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.20e-4)"	"unprognostic (7.35e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.31e-2)"	1.6	6.2	8.0	1.2	7.7	2.5	1.3	74.5	30.5	0.6	1.2	3.8	0.0	1.7	1.1	1.6	1.0	1.1	1.4	1.3	5.8	8.5	0.9	1.4	0.8	1.5	5.1	7.6	1.2	3.7	3.0	6.4	0.6	9.3	1.2	1.2	2.8	1.1	0.9	2.3	3.3	1.1	1.2	3.9	1.5	2.0	3.3	3.2	0.0	1.3	0.0	1.1	1.0	0.3	1.3	0.8	15.5	0.9	0.6	0.9	0.8	0.5	2.7	2.1	6.4	0.2	0.2	0.8	0.2	0.1	1.0	2.6	0.5	0.7	1.5	0.3	0.6	0.2	1.5	0.4	1.2	6.7	1.6	2.8	2.5	2.4	0.2	1.6	11.7	0.5	0.5	0.4	0.6	1.1	1.5	5.5	0.1	0.6	0.4	1.9	1.3	8.6	0.2	0.6	5.2	0.1	1.0	22.2	10.6	0.9	0.7	1.3	1.9	1.8	0.3	1.8	1.9	1.3	0.7	1.2	3.0	1.4	0.7	1.1	5.1	4.5	0.9	0.9	0.6	0.8	0.3	1.0	0.6	0.4	0.2	1.3	0.6	0.9	15.5	0.6	0.7	0.8	0.4	0.8	8.0	7.7	74.5	18.1	5.8	8.5	5.1	7.6	9.3	3.2
TMEM150C	"FLJ12993, TTN3"	ENSG00000249242	"Transmembrane protein 150C"	B9EJG8	4	82483170-82562357	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"epididymis: 74.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.9;MCF7: 24.6;SCLC-21H: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052921	Enhanced									"HPA052921: "	"unprognostic (2.99e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.71e-3)"	"prognostic favourable (7.87e-4)"	"unprognostic (2.94e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.94e-2)"	"prognostic favourable (5.68e-4)"	"unprognostic (4.57e-2)"	"prognostic favourable (4.59e-6)"	"unprognostic (4.18e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	7.0	30.0	10.8	3.2	12.8	1.5	12.4	0.6	16.0	8.4	4.4	8.3	12.9	4.4	3.2	74.9	2.5	4.6	3.9	7.4	12.7	7.9	9.7	7.7	3.6	8.1	7.5	10.3	18.0	2.2	1.7	10.5	5.5	7.3	7.1	2.6	12.4	10.3	4.7	3.5	3.1	4.4	4.0	5.4	7.6	3.0	4.2	6.8	2.7	7.0	1.6	6.9	3.2	3.3	5.5	1.4	5.0	0.9	1.3	0.7	0.3	0.3	0.9	6.8	8.9	0.0	0.1	0.7	1.5	3.7	0.9	1.1	0.0	0.4	0.2	0.7	0.2	0.1	4.2	0.0	1.1	0.4	2.1	0.5	0.8	0.0	0.0	0.0	1.0	4.1	0.4	0.0	0.0	2.2	0.0	0.1	0.1	24.6	0.4	0.6	3.1	0.4	0.9	0.1	0.8	0.3	3.4	17.3	2.7	0.5	0.2	2.4	0.4	0.1	0.5	0.4	0.2	0.1	0.8	0.1	0.3	0.3	0.5	0.3	1.9	5.0	0.9	1.0	0.7	0.4	0.4	3.5	0.7	0.6	0.2	5.5	0.5	0.6	3.7	1.3	0.6	1.4	0.2	0.3	10.8	12.8	0.6	16.0	12.7	7.9	7.5	10.3	7.3	6.8
TMEM151A	"MGC33486, TMEM151"	ENSG00000179292	"Transmembrane protein 151A"	Q8N4L1	11	66291870-66296664	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 48.5"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 18.2"	"Cancer enhanced"	"Detected in some"		"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041035	Uncertain		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA041035: AB_10794404"	"unprognostic (1.20e-1)"	"unprognostic (8.24e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.48e-3)"	"unprognostic (8.57e-2)"	"unprognostic (8.73e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.02e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.69e-3)"	"unprognostic (2.80e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.67e-2)"	1.4	3.8	12.4	1.5	16.8	1.4	1.4	5.9	48.5	1.4	1.5	41.8	0.0	1.5	1.4	1.4	1.4	1.4	2.8	1.6	22.7	14.3	1.4	1.4	1.4	1.4	21.2	13.1	1.5	2.4	1.8	3.3	1.4	22.2	1.4	1.4	1.0	1.5	1.4	1.4	1.4	1.5	1.4	43.2	1.4	3.9	1.6	13.6	0.0	1.4	0.0	1.4	1.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.6	0.0	1.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	18.2	4.1	0.5	0.0	0.3	0.1	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.4	16.8	5.9	31.1	22.7	14.3	21.2	13.1	22.2	13.6
TMEM151B	"bA444E17.5, C6orf137, TMEM193"	ENSG00000178233	"Transmembrane protein 151B"	Q8IW70	6	44270466-44307506	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 52.2"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 24.7"	"Cancer enhanced"	"Detected in single"		"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.0"	"Low region specificity"	"Detected in all"							HPA055167	Uncertain									"HPA055167: "	"unprognostic (1.28e-3)"	"unprognostic (6.25e-2)"	"unprognostic (5.06e-2)"	"unprognostic (7.02e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.01e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.65e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.56e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.66e-1)"	1.0	5.7	16.9	1.6	8.4	1.2	1.0	52.2	39.5	0.9	1.7	1.2	0.0	1.7	1.3	1.0	1.2	1.0	1.0	1.1	21.6	8.9	1.0	0.9	1.0	1.2	7.9	18.1	1.0	1.1	0.9	1.4	1.0	10.0	1.1	1.5	0.0	1.2	0.9	1.2	1.2	2.0	1.1	2.3	1.0	1.4	1.6	3.7	0.0	0.9	0.0	1.0	0.9	0.1	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.1	5.4	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.5	4.2	0.2	0.4	0.0	0.1	0.0	0.1	24.7	5.1	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.0	0.1	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	16.9	8.4	52.2	28.1	21.6	8.9	7.9	18.1	10.0	3.7
TMEM155	FLJ30834	ENSG00000164112	"Transmembrane protein 155"	Q4W5P6	4	121758933-121765427	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 25.6"	"Group enriched"	"Detected in some"	5	"fHDF/TERT166: 7.2;HAP1: 3.3;LHCN-M2: 10.2;MOLT-4: 6.2"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"cerebral cortex: 25.6"	"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.3;T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.3"									HPA077585	Approved				"Secreted in brain"					"HPA077585: "	"unprognostic (9.67e-3)"	"unprognostic (3.25e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.82e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.04e-1)"	0.6	0.3	5.9	0.5	8.3	0.3	0.3	0.3	25.6	0.4	1.3	0.0	0.0	0.4	0.3	0.3	0.5	0.3	0.4	0.4	7.9	1.6	0.3	0.3	0.6	4.0	0.9	8.9	0.3	0.3	0.2	0.2	6.1	0.7	0.5	0.7	0.9	0.5	0.6	0.3	0.3	0.6	0.9	0.3	0.8	0.5	0.7	0.0	0.0	0.3	0.0	0.6	0.5	0.3	0.0	0.0	0.7	0.0	0.0	2.3	0.3	0.0	0.0	0.1	0.0	1.4	0.2	1.0	0.7	0.2	0.3	0.5	0.0	0.0	0.0	0.0	7.2	0.0	3.3	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.2	0.0	0.3	0.0	0.0	10.2	0.0	6.2	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.3	5.9	8.3	0.3	25.6	7.9	1.6	0.9	8.9	0.7	0.0
TMEM158	"p40BBp, RIS1"	ENSG00000249992	"Transmembrane protein 158 (gene/pseudogene)"	Q8WZ71	3	45224466-45226278	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.8;endometrium 1: 31.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 65.0;U-138 MG: 27.5;U-87 MG: 90.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 46.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 85.5"	"Low region specificity"	"Detected in all"			HPA074974	Approved									"HPA074974: "	"unprognostic (3.84e-1)"	"unprognostic (9.83e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.77e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.31e-2)"	"unprognostic (4.67e-3)"	"unprognostic (6.23e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.84e-3)"	"prognostic favourable (6.43e-5)"	"prognostic unfavourable (5.42e-9)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.49e-3)"	1.8	6.4	16.4	4.5	46.8	2.2	2.3	2.1	10.9	13.1	3.4	2.3	18.5	1.4	31.1	7.3	21.3	2.0	11.0	0.8	9.0	11.2	1.9	1.2	1.0	1.1	2.5	5.0	1.7	2.4	0.7	5.7	1.4	2.6	15.6	2.7	0.5	1.3	27.0	2.4	2.7	1.2	19.6	1.8	0.8	2.2	3.0	4.3	0.0	0.7	0.8	1.7	6.7	1.6	0.0	0.0	0.9	0.1	0.0	0.0	1.1	2.3	0.4	0.8	0.1	1.5	3.7	0.7	6.0	65.0	3.3	5.4	0.1	0.1	0.0	0.3	2.0	3.3	1.0	0.2	9.9	0.1	0.3	0.0	1.2	0.0	2.1	0.4	1.2	4.9	0.1	6.6	0.5	0.3	14.8	0.1	5.9	0.1	0.0	4.1	7.3	9.0	0.0	0.2	0.9	1.3	2.2	1.2	0.2	2.3	0.0	0.3	0.0	0.8	0.9	27.5	2.0	17.3	20.8	0.0	0.0	0.0	90.2	2.3	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.1	16.4	46.8	2.1	10.9	9.0	11.2	2.5	5.0	2.6	4.3
TMEM161B	MGC33214	ENSG00000164180	"Transmembrane protein 161B"	Q8NDZ6	5	88189633-88269476	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 35.4;HMC-1: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044562	Uncertain									"HPA044562: AB_10794291"	"unprognostic (2.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.62e-3)"	"unprognostic (9.35e-2)"	9.7	11.7	10.5	13.0	12.8	6.7	19.2	34.0	14.7	10.4	12.2	10.4	13.5	14.6	15.4	17.6	13.9	10.6	7.2	10.0	10.8	10.3	13.4	14.5	11.9	10.0	11.1	10.7	13.8	16.2	29.5	24.0	15.3	10.9	15.0	13.8	9.6	15.9	11.4	15.4	17.9	17.2	7.9	11.0	11.9	25.1	16.1	13.6	13.5	24.8	9.7	13.2	11.2	11.8	4.8	5.2	2.8	5.7	5.6	6.3	2.3	5.2	3.5	4.0	4.3	2.5	4.9	8.4	4.5	6.9	6.8	10.0	4.1	13.8	8.0	2.5	3.4	5.5	4.5	6.0	8.6	7.1	5.0	35.4	4.4	2.5	6.7	7.1	38.7	4.4	8.7	5.8	8.5	2.9	17.1	7.4	5.9	2.5	5.0	5.9	2.5	6.6	4.3	4.7	8.8	6.1	7.4	5.1	4.4	2.7	7.4	10.7	4.5	6.1	2.5	4.3	4.0	6.4	8.5	9.3	14.5	6.7	10.6	6.8	6.2	2.8	3.0	1.9	6.3	5.7	6.1	4.8	5.4	4.6	1.6	4.8	5.5	4.1	1.7	5.6	2.0	5.2	4.3	2.3	10.5	12.8	34.0	14.7	10.8	10.3	11.1	10.7	10.9	13.6
TMEM163	"DKFZP566N034, SV31"	ENSG00000152128	"Transmembrane protein 163"	Q8TC26	2	134455759-134719000	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.8;pancreas: 19.7"	"Cell line enhanced"	"Detected in some"		"HEL: 10.5;RPTEC TERT1: 36.1;SCLC-21H: 16.4;U-937: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 1.6;NK-cells: 2.0;T-cells: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007224	Uncertain									"HPA007224: "	"unprognostic (1.05e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.08e-3)"	"prognostic favourable (7.94e-4)"	"unprognostic (9.05e-2)"	"unprognostic (9.62e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.62e-1)"	"unprognostic (6.75e-3)"	"prognostic favourable (3.15e-4)"	3.8	6.4	8.1	5.4	5.7	0.5	1.5	31.8	13.4	0.5	0.8	5.8	0.0	0.9	0.8	0.7	0.4	3.4	10.4	7.2	9.1	13.7	1.8	1.7	16.4	10.9	6.9	3.8	1.2	19.7	0.4	11.2	4.2	14.8	0.5	0.9	2.6	3.5	0.5	0.6	0.4	0.8	0.7	13.9	1.9	8.3	6.9	5.0	0.0	1.3	0.0	17.4	9.9	0.3	1.6	0.3	0.1	0.0	2.0	2.5	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.5	0.0	0.1	0.0	0.3	0.0	0.0	2.8	1.2	0.0	0.0	0.0	36.1	5.3	16.4	0.5	0.0	0.0	0.8	0.0	0.0	3.7	0.0	0.2	0.0	0.8	0.8	0.0	0.0	0.0	6.5	0.7	0.0	0.0	0.0	1.3	0.0	1.7	1.6	0.5	2.4	0.3	0.6	0.1	0.5	0.1	2.0	0.0	0.0	2.5	0.8	8.1	5.7	31.8	9.7	9.1	13.7	6.9	3.8	14.8	5.0
TMEM164	"FLJ22679, RP13-360B22.2"	ENSG00000157600	"Transmembrane protein 164"	Q5U3C3	X	110002631-110182734	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 69.7"	"Cell line enhanced"	"Detected in all"		"HMC-1: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 25.9;eosinophil: 7.2;neutrophil: 8.8"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038784	Approved		Approved	"Vesicles,Cell Junctions"				Vesicles	"Cell Junctions"	"HPA038784: AB_10670790"	"unprognostic (2.14e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.65e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavourable (8.17e-6)"	"unprognostic (9.85e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.66e-2)"	"prognostic favourable (3.14e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.81e-2)"	"unprognostic (4.19e-3)"	15.0	8.6	9.2	6.1	10.9	11.1	9.2	2.6	6.8	3.9	17.0	6.0	36.3	14.5	4.5	4.1	10.5	5.5	8.8	14.7	6.6	5.9	8.4	1.7	35.8	7.6	4.6	3.5	11.9	17.2	11.1	8.7	6.6	7.0	6.2	14.8	18.7	7.6	69.7	32.0	15.2	33.1	4.6	2.9	6.9	9.9	2.2	5.1	4.5	11.4	6.0	5.8	5.0	5.1	0.4	1.4	25.9	1.7	1.1	0.9	0.8	4.7	10.9	9.0	5.8	11.1	8.2	5.5	2.4	5.6	5.1	3.3	8.5	7.5	3.8	16.3	3.7	7.0	7.7	12.6	5.0	10.5	5.3	25.9	5.9	3.5	6.6	11.4	37.1	11.3	22.3	9.1	12.7	9.9	8.0	4.6	9.0	9.5	11.9	14.5	8.0	7.9	5.5	6.9	3.2	8.1	5.0	8.4	9.4	15.3	15.1	7.0	4.4	11.4	22.0	4.3	3.2	5.0	3.4	2.7	3.4	3.1	11.3	14.3	11.5	25.9	1.7	7.2	0.3	1.5	0.9	0.1	0.4	0.3	1.4	0.4	0.2	0.3	8.8	1.1	0.9	0.2	0.5	0.8	9.2	10.9	2.6	6.8	6.6	5.9	4.6	3.5	7.0	5.1
TMEM168	"DKFZp564C012, FLJ13576"	ENSG00000146802	"Transmembrane protein 168"	Q9H0V1	7	112762382-112790592	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020389, HPA077143"	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA020389: AB_1858101, HPA077143: "	"unprognostic (1.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.92e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.30e-3)"	"prognostic favourable (4.07e-6)"	"unprognostic (1.60e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.89e-3)"	"unprognostic (3.30e-2)"	14.4	14.9	9.0	11.4	14.6	5.6	15.4	6.9	15.7	15.7	21.2	17.9	17.6	13.2	17.4	18.3	19.1	15.0	12.1	18.9	11.8	8.2	18.8	11.8	13.5	21.3	12.6	7.8	17.5	9.9	28.2	12.7	26.3	15.5	16.6	24.3	18.4	19.6	14.5	11.0	25.5	18.4	19.7	15.7	16.4	14.3	13.9	12.4	17.8	17.5	12.6	17.4	14.7	16.9	15.4	17.9	16.5	16.9	13.7	22.4	10.0	9.1	7.8	7.3	6.6	12.6	25.8	10.4	10.2	9.6	3.8	3.4	9.9	9.8	9.8	6.9	10.1	10.0	7.4	8.9	10.0	15.3	7.6	8.2	9.6	5.6	8.5	9.4	10.8	12.5	23.2	4.4	6.6	11.2	11.3	9.0	13.9	14.7	8.0	5.9	5.9	6.0	5.4	3.6	14.2	9.7	17.6	5.5	10.9	13.4	18.4	7.8	10.3	8.3	15.9	18.7	9.4	8.6	13.1	15.4	13.0	11.0	12.1	8.3	23.4	16.5	16.9	12.5	14.2	13.7	16.9	12.4	15.3	13.8	17.9	15.4	22.4	15.5	9.4	13.7	13.5	12.2	13.7	10.0	9.0	14.6	6.9	15.7	11.8	8.2	12.6	7.8	15.5	12.4
TMEM169	FLJ34263	ENSG00000163449	"Transmembrane protein 169"	Q96HH4	2	216081866-216102783	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.8"	"Cell line enhanced"	"Detected in some"		"AF22: 8.3;LHCN-M2: 6.7;RPTEC TERT1: 12.2;SCLC-21H: 10.5;SH-SY5Y: 15.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062462, HPA062797, HPA070657, HPA074877"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA062462: , HPA062797: , HPA070657: , HPA074877: "	"unprognostic (5.15e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.87e-3)"	"unprognostic (4.69e-7)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.43e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.51e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-1)"	1.7	2.9	5.9	2.5	6.2	1.3	0.9	9.7	16.8	2.1	1.3	3.9	1.6	1.9	1.1	1.9	0.9	2.9	2.5	1.1	5.5	6.3	4.9	4.2	2.1	2.4	5.5	4.8	1.1	1.0	0.8	2.4	0.7	9.1	1.4	1.2	4.9	0.9	1.1	1.5	1.6	1.7	1.2	6.6	2.6	1.0	1.3	2.5	0.7	6.7	0.0	2.0	1.1	0.7	3.0	0.2	4.3	5.7	0.7	6.3	1.3	0.1	0.4	8.3	0.2	0.9	0.1	0.0	0.3	0.2	0.2	0.8	0.4	2.4	0.1	6.1	0.3	0.2	1.1	0.0	0.2	1.2	0.4	2.7	0.1	1.5	1.8	0.2	0.6	0.6	0.6	0.6	0.8	0.0	0.0	0.4	6.7	0.7	0.2	0.3	4.3	0.1	1.5	2.4	0.2	12.2	0.0	10.5	15.1	0.2	0.2	6.0	0.4	1.1	0.1	0.2	0.4	0.2	0.4	1.9	2.0	0.4	1.9	0.2	1.5	1.3	1.8	0.3	2.3	1.5	1.7	2.4	4.0	2.7	0.0	3.0	4.2	1.9	4.3	0.7	5.7	0.2	6.3	1.3	5.9	6.2	9.7	11.5	5.5	6.3	5.5	4.8	9.1	2.5
TMEM176A	"HCA112, MS4B1"	ENSG00000002933	"Transmembrane protein 176A"	Q96HP8	7	150800403-150805120	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 76.8;liver: 234.5"	"Cell line enriched"	"Detected in some"	30	"HSkMC: 124.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 210.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 38.4;intermediate monocyte: 27.1"	"Lineage enriched"	"Detected in many"	4	"monocytes: 38.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA008770	Approved		Approved	Mitochondria				Mitochondria		"HPA008770: AB_2256120"	"unprognostic (4.70e-2)"	"unprognostic (7.71e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.09e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.91e-2)"	10.5	4.9	5.8	17.1	6.0	0.7	7.8	1.2	4.3	6.2	32.2	4.8	2.0	16.1	3.6	12.8	7.5	6.3	34.2	15.0	5.2	4.5	76.8	234.5	8.8	23.5	6.9	3.4	19.0	5.0	0.4	2.2	8.9	6.6	6.3	22.3	22.8	3.9	2.0	3.1	3.3	51.2	6.5	6.9	17.3	7.1	3.7	5.4	2.1	4.8	4.8	9.2	13.5	9.1	0.4	9.3	3.3	38.4	0.0	0.1	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	124.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.4	3.3	0.1	27.1	0.1	0.4	0.0	0.1	9.3	0.0	0.0	0.0	0.5	0.0	12.9	0.6	0.1	10.7	5.8	6.0	1.2	4.3	5.2	4.5	6.9	3.4	6.6	5.4
TMEM178A	"MGC33926, TMEM178"	ENSG00000152154	"Transmembrane protein 178A"	Q8NBL3	2	39664982-39717963	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 87.4"	"Cell line enriched"	"Detected in some"	5	"AF22: 55.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.0"	"Region enriched"	"Detected in all"	5	"cerebellum: 87.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052128	Uncertain		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA052128: "	"unprognostic (3.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.82e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.74e-2)"	"unprognostic (5.11e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.01e-3)"	2.9	4.2	13.3	0.9	10.6	0.6	6.8	87.4	35.6	1.6	1.9	6.4	0.0	2.3	3.8	2.0	1.8	3.3	3.1	3.6	16.4	7.4	18.9	2.7	5.8	0.8	10.7	10.9	1.8	2.2	1.3	2.5	3.6	17.0	12.2	2.2	3.7	3.8	2.1	2.3	3.5	2.4	2.9	22.6	1.6	3.5	1.2	5.3	0.0	5.7	0.8	2.2	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	0.1	1.7	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	7.0	0.0	0.6	0.0	0.0	0.4	0.1	10.2	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	10.6	87.4	18.8	16.4	7.4	10.7	10.9	17.0	5.3
TMEM178B	DKFZp547G036	ENSG00000261115	"Transmembrane protein 178B"	H3BS89	7	141074232-141480380	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;parathyroid gland: 20.6;pituitary gland: 18.5"	"Cell line enhanced"	"Detected in many"		"HAP1: 6.9;HDLM-2: 6.3;NTERA-2: 5.9;RPTEC TERT1: 9.6;SCLC-21H: 7.6;WM-115: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048771	Uncertain		Approved	Nucleoli,Vesicles				Vesicles	Nucleoli	"HPA048771: "	"unprognostic (7.33e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.79e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.05e-1)"	"prognostic favourable (4.10e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.35e-3)"	"unprognostic (8.98e-2)"	0.9	1.7	5.2	0.7	7.4	0.1	0.7	3.2	13.4	0.5	0.8	1.0	2.3	0.1	1.1	0.6	1.8	0.3	0.7	11.6	4.8	5.8	2.9	0.6	0.4	1.5	4.9	1.0	0.2	2.6	20.6	18.5	0.1	1.8	2.8	0.4	0.5	4.4	0.8	4.5	0.2	1.2	1.3	2.4	0.8	0.5	0.8	0.4	1.0	9.5	0.1	3.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.6	0.3	1.8	0.1	2.7	0.8	1.0	0.0	0.0	2.2	2.3	0.2	0.0	6.9	0.0	2.3	6.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	5.9	0.0	0.4	1.1	2.9	9.6	2.7	7.6	4.6	0.1	0.3	1.0	1.0	0.0	0.0	0.1	1.1	3.1	0.0	0.1	0.0	0.0	0.5	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	7.4	3.2	9.6	4.8	5.8	4.9	1.0	1.8	0.4
TMEM179	"C14orf90, FLJ42486, TMEM179A"	ENSG00000258986	"Transmembrane protein 179"	Q6ZVK1	14	104474678-104605647	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 20.2;brain: 30.4;pituitary gland: 23.0"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 6.4;SCLC-21H: 27.6;SH-SY5Y: 8.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002942			Uncertain	Mitochondria				Mitochondria		"HPA002942: AB_1078113"	"unprognostic (8.65e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-4)"	"unprognostic (8.68e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.71e-6)"	"unprognostic (1.70e-2)"	1.1	20.2	11.8	1.5	18.9	0.9	0.9	10.3	30.4	1.0	1.8	3.4	0.0	1.4	1.0	1.6	1.1	1.1	1.1	1.2	12.4	21.7	1.0	1.1	0.9	0.9	13.7	7.2	1.0	4.8	1.0	23.0	2.3	8.3	1.4	1.4	2.2	1.1	1.3	1.0	1.0	1.8	1.4	6.1	0.9	1.8	3.1	4.5	0.0	1.0	0.0	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.1	0.0	0.0	27.6	8.7	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	18.9	10.3	16.7	12.4	21.7	13.7	7.2	8.3	4.5
TMEM186	"C16orf51, DKFZP564K2062"	ENSG00000184857	"Transmembrane protein 186"	Q96B77	16	8780384-8797648	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018226, HPA063559"	Uncertain		Approved	"Cell Junctions"				"Cell Junctions"		"HPA018226: AB_1845579, HPA063559: "	"unprognostic (3.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.06e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.99e-2)"	"prognostic favourable (1.93e-8)"	"unprognostic (1.06e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.89e-2)"	6.6	12.0	8.2	6.2	10.4	1.9	11.0	5.4	13.2	7.4	10.6	8.2	9.4	10.1	11.0	14.2	9.6	10.4	9.7	11.5	7.4	7.6	9.6	15.9	6.2	8.2	9.1	12.6	9.7	11.8	16.3	11.8	8.4	7.8	8.4	12.5	10.4	14.0	8.4	16.9	8.8	9.2	15.1	10.3	10.1	9.1	11.7	6.2	7.0	11.9	7.7	11.0	10.4	6.2	14.3	10.4	11.8	13.8	9.5	17.2	8.4	6.7	10.6	7.9	10.0	13.6	7.2	7.5	7.8	8.0	10.3	8.5	10.2	11.3	20.6	6.7	5.7	13.0	14.0	11.0	11.8	11.9	13.5	8.6	13.7	21.8	15.3	9.6	7.0	8.7	18.8	11.3	16.6	9.3	14.7	11.3	5.9	18.2	7.3	9.4	10.0	9.3	15.6	10.4	22.5	10.9	5.8	12.2	11.6	10.6	15.1	9.1	18.1	7.8	5.9	7.3	10.3	18.0	6.4	10.4	11.0	10.0	11.4	17.6	5.8	11.8	10.0	7.5	9.4	9.6	12.5	14.3	10.0	10.6	10.4	12.7	17.2	13.2	4.8	9.5	13.8	8.1	13.0	8.4	8.2	10.4	5.4	13.2	7.4	7.6	9.1	12.6	7.8	6.2
TMEM196	MGC42090	ENSG00000173452	"Transmembrane protein 196"	Q5HYL7	7	19719310-19773598	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 15.0;pituitary gland: 12.6"	"Group enriched"	"Detected in some"	9	"ASC diff: 8.6;ASC TERT1: 8.5"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043163	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"			"Nucleoplasm, Golgi apparatus"		"HPA043163: AB_10794772"					"unprognostic (6.08e-3)"					"unprognostic (1.88e-2)"	"unprognostic (2.14e-2)"		"unprognostic (9.30e-2)"	"unprognostic (5.63e-2)"				0.7	3.7	8.0	0.6	8.6	0.4	0.4	0.3	15.0	1.2	0.6	0.3	0.0	0.4	3.8	1.5	0.5	1.2	0.4	0.4	3.6	10.1	0.6	0.4	0.4	0.4	2.9	7.4	0.4	3.0	0.7	12.6	0.4	5.0	0.5	0.5	0.5	0.4	0.4	0.4	0.4	0.4	1.0	1.4	0.4	2.6	0.5	2.8	0.0	0.4	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	8.6	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	8.6	0.3	7.3	3.6	10.1	2.9	7.4	5.0	2.8
TMEM200B	TTMB	ENSG00000253304	"Transmembrane protein 200B"	Q69YZ2	1	29119428-29123935	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 15.5;BJ hTERT+ SV40 Large T+: 14.4;BJ hTERT+ SV40 Large T+ RasG12V: 16.0;fHDF/TERT166: 15.1;HBF TERT88: 13.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 14.0;cerebellum: 23.9"					HPA055254	Uncertain									"HPA055254: "	"unprognostic (2.55e-1)"	"unprognostic (2.12e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-3)"	9.1	2.0	1.4	2.9	3.7	0.0	15.7	9.7	1.3	33.3	10.9	1.2	7.4	1.1	32.8	7.7	6.0	7.0	7.3	2.4	0.5	0.2	3.5	3.0	3.7	1.2	1.3	0.9	21.6	0.7	15.4	1.2	3.5	2.5	17.2	2.3	6.0	1.5	23.9	2.9	2.1	3.4	20.6	1.4	2.4	2.3	13.6	0.6	0.7	2.1	3.5	1.5	13.1	12.2	0.0	0.0	0.1	0.0	0.0	0.5	0.0	10.7	0.0	1.8	0.0	15.5	13.0	0.6	7.6	12.0	14.4	16.0	0.6	1.2	0.0	1.9	15.1	0.2	1.2	0.0	13.8	0.0	0.5	0.0	2.7	0.9	10.8	0.0	0.0	6.9	1.4	10.8	2.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	1.0	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.9	10.8	0.0	0.0	0.0	0.0	0.0	5.1	0.2	10.6	0.2	0.0	0.0	0.0	6.3	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.4	3.7	9.7	1.3	0.5	0.2	1.3	0.9	2.5	0.6
TMEM200C	TTMA	ENSG00000206432	"Transmembrane protein 200C"	A6NKL6	18	5882072-5895955	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 10.1"	"Cell line enhanced"	"Detected in some"		"AF22: 5.7;NTERA-2: 4.4;PC-3: 20.3;U-2 OS: 10.4;U-251 MG: 3.5"	"Cancer enhanced"	"Detected in single"		"glioma: 1.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA047253, HPA050490"	Uncertain		Approved	Microtubules				Microtubules		"HPA047253: , HPA050490: "	"unprognostic (6.57e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.82e-4)"	"unprognostic (2.48e-10)"	"unprognostic (2.94e-2)"	"unprognostic (6.38e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.38e-2)"	0.4	6.3	2.6	1.0	3.7	0.1	3.5	0.7	5.7	0.8	0.5	1.7	0.1	0.5	1.6	3.2	0.6	1.1	1.3	2.9	2.7	3.5	2.0	5.3	0.5	1.1	3.7	1.6	1.9	0.2	0.1	3.3	0.1	1.7	0.9	0.3	2.7	10.1	0.7	0.1	0.7	0.6	0.5	1.2	1.6	1.3	3.5	1.5	0.1	0.2	0.1	1.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	20.3	1.2	0.0	0.0	0.0	0.0	1.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.4	0.0	3.5	0.0	0.0	0.0	1.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.7	0.7	4.7	2.7	3.5	3.7	1.6	1.7	1.5
TMEM204	"C16orf30, CLP24, FLJ20898"	ENSG00000131634	"Transmembrane protein 204"	Q9BSN7	16	1528688-1555580	"Predicted membrane proteins"	"Stress response"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.5;BJ: 10.1;BJ hTERT+: 13.7;fHDF/TERT166: 9.1;HHSteC: 24.8;HSkMC: 9.9;TIME: 7.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 44.7"	"Lineage enriched"	"Detected in many"	5	"T-cells: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014028	Approved									"HPA014028: AB_2204906"	"unprognostic (1.51e-1)"	"unprognostic (6.35e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.81e-2)"	"prognostic favourable (4.76e-4)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (7.89e-4)"	"unprognostic (8.44e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.62e-3)"	"unprognostic (5.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.53e-2)"	36.4	12.9	3.7	9.6	6.2	0.6	33.4	2.9	6.6	20.2	11.5	3.4	9.0	5.9	17.1	11.4	11.5	10.5	13.9	19.8	4.2	3.3	24.3	12.6	29.6	22.9	5.3	6.2	11.5	9.2	3.4	6.4	11.6	5.5	14.6	2.9	18.4	7.7	13.9	13.9	7.6	11.8	10.5	3.4	12.3	9.3	7.8	4.7	4.2	21.0	12.2	9.8	12.1	14.2	0.4	0.5	0.8	0.2	8.2	44.7	12.1	0.0	0.1	0.6	0.1	5.0	8.5	0.1	10.1	13.7	1.7	1.7	0.4	0.0	0.1	0.1	9.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.1	24.8	0.0	0.0	9.9	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.4	0.0	0.1	0.0	0.1	0.3	0.2	0.3	0.0	1.1	0.0	0.0	7.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.1	0.0	6.8	0.2	12.6	0.1	22.3	15.3	0.5	0.4	44.7	22.9	0.8	8.2	0.2	0.1	9.4	12.1	3.7	6.2	2.9	6.6	4.2	3.3	5.3	6.2	5.5	4.7
TMEM211	bA9F11.1	ENSG00000206069	"Transmembrane protein 211"	Q6ICI0	22	24934954-24946695	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"cervix, uterine: 5.3;salivary gland: 6.6;stomach 1: 5.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.4;HEK 293: 1.4"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.8;endometrial cancer: 3.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA066784	Uncertain									"HPA066784: "	"unprognostic (7.89e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.09e-2)"		"unprognostic (5.97e-3)"		"unprognostic (5.88e-2)"		"unprognostic (1.31e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.43e-2)"	0.0	0.0	0.0	0.4	0.4	0.0	0.8	0.4	0.1	5.3	0.4			0.0	1.2	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.1	0.2	0.0	0.2	0.0		0.1	0.1		6.6	0.0	0.0	1.4	0.1	0.0	0.0	0.0	5.8	0.1			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TMEM212	FLJ23172	ENSG00000186329	"Transmembrane protein 212"	A6NML5	3	171843349-171938715	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.2;lung: 10.0;ovary: 12.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045736			Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"				"Nucleoli fibrillar center, Endoplasmic reticulum"		"HPA045736: "	"unprognostic (3.39e-2)"			"unprognostic (1.78e-2)"	"unprognostic (3.05e-1)"			"unprognostic (5.54e-2)"		"unprognostic (3.06e-1)"				"unprognostic (2.87e-1)"				0.4	0.4	0.5	0.6	0.8	2.2	0.4	0.4	0.5	1.6	0.8	0.9	0.4	0.2	1.3	2.5	0.8	19.2	0.4	0.4	0.6	0.7	0.4	3.3	10.0	0.6	0.4	0.4	12.8	0.4	0.0	0.4	0.4	0.7	0.4	0.8	0.4	0.4	2.1	1.1	1.5	0.5	0.4	0.4	0.4	0.4	1.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	4.1	3.2	6.3	2.1	3.8	2.7	0.5	4.0	2.5	2.8	3.0	0.8	0.4	5.4	2.9	0.9	1.1	1.2	2.0	3.2	5.3	3.6	1.4	2.8	1.7	1.3	2.5	7.0	2.7	6.3	6.4	2.6	0.5	3.6	5.3	1.1	1.5	1.4	1.1	1.3	4.4	8.5	0.9	2.6	3.2	4.0	4.8	2.6	2.7	4.4	4.4	1.1	3.1	3.3	3.2	4.0	3.0	2.2	3.6	3.3	6.5	4.5	4.9	7.1	3.1	5.0	4.0	3.5	2.3	3.3	2.3	6.3	2.1	1.8	2.7	1.8	2.1	1.9	2.0	1.8	1.1	4.1	2.3	2.5	5.0	3.8	2.0	3.2	1.3	0.5	0.5	0.8	0.4	0.4	0.6	0.7	0.4	0.4	0.7	0.4
TMEM215		ENSG00000188133	"Transmembrane protein 215"	Q68D42	9	32783499-32787399	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 8.0;retina: 6.5;testis: 17.9"	"Group enriched"	"Detected in some"	6	"NTERA-2: 6.4;SH-SY5Y: 1.9"	"Cancer enriched"	"Detected in single"	14	"thyroid cancer: 4.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052804, HPA063207"	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"				Nucleoplasm	"Endoplasmic reticulum, Vesicles"	"HPA052804: , HPA063207: "	"unprognostic (1.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.38e-3)"		"unprognostic (2.17e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.83e-2)"		"unprognostic (1.23e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-2)"		0.1	0.0	1.8	0.4	1.5	0.0	0.1	0.1	0.9	1.9	0.0	0.0	0.0	0.0	8.0	0.9	0.1	0.1	0.0	0.9	0.9	1.5	0.0	0.0	0.1	0.0	1.7	0.2	0.7	0.0	0.0	0.1	0.0	0.6	0.1	0.0	6.5	0.1	0.0	0.3	0.1	0.1	0.0	1.0	0.0	0.0	17.9	0.0	0.0	3.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.5	0.1	0.8	0.9	1.5	1.7	0.2	0.6	0.0
TMEM217	"C6orf128, dJ355M6.2"	ENSG00000172738	"Transmembrane protein 217"	Q8N7C4	6	37212180-37258155	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"testis: 20.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 3.6;HEL: 4.7;hTEC/SVTERT24-B: 3.3;HUVEC TERT2: 4.9;TIME: 12.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA045432, HPA071187"			Supported	Nucleoli				Nucleoli		"HPA045432: , HPA071187: "	"unprognostic (7.78e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.23e-4)"	"unprognostic (8.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.62e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.59e-1)"	0.3	2.7	0.4	0.4	1.4	1.3	0.3	0.4	1.1	0.3	0.3	1.6	0.0	0.4	0.2	1.1	1.4	0.4	0.7	0.4	0.3	0.4	0.9	0.5	0.5	0.1	0.9	1.0	1.1	3.1	0.6	2.3	0.2	1.0	0.4	0.3	1.1	1.5	0.1	1.0	0.5	0.4	0.5	1.6	0.2	0.2	20.1	0.9	0.0	0.5	0.0	0.3	0.4	0.3	0.1	0.4	0.2	0.0	0.0	0.6	0.1	0.1	0.0	0.3	0.0	0.2	1.2	0.0	0.3	2.7	1.0	3.6	0.7	0.5	0.1	0.2	0.0	0.5	0.3	0.3	1.0	0.1	0.2	4.7	0.0	0.1	0.3	0.0	2.7	0.5	0.7	3.3	0.2	4.9	1.3	0.0	0.5	0.0	0.1	0.4	0.2	0.0	0.2	0.0	0.0	1.2	0.2	0.0	0.0	0.5	0.0	0.2	0.0	0.1	12.8	0.2	0.1	0.0	0.2	0.1	0.2	0.5	0.0	0.9	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.4	0.0	0.1	0.4	1.4	0.4	1.1	0.3	0.4	0.9	1.0	1.0	0.9
TMEM220		ENSG00000187824	"Transmembrane protein 220"	Q6QAJ8	17	10699015-10730316	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"liver: 58.2"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 10.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047680			Uncertain	Nucleoplasm				Nucleoplasm		"HPA047680: "	"unprognostic (1.71e-2)"	"unprognostic (4.60e-2)"	"unprognostic (6.31e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.84e-4)"	"prognostic favourable (2.23e-5)"	"unprognostic (4.58e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.81e-1)"	"prognostic favourable (1.72e-4)"	"unprognostic (2.97e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.63e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.97e-2)"	6.5	7.4	4.5	2.4	4.6	3.3	7.8	1.3	2.8	4.7	6.1	3.8	14.3	8.1	4.9	11.1	3.3	3.9	10.1	6.3	3.8	2.4	6.4	58.2	4.6	3.1	2.9	1.2	4.8	6.0	2.4	2.4	1.7	4.9	12.0	2.8	6.6	3.5	18.5	4.1	3.7	15.4	5.4	2.5	4.7	7.1	17.2	3.5	0.6	9.4	2.6	2.4	4.1	3.4	11.6	2.9	2.3	2.5	4.5	9.0	1.9	0.5	3.5	1.3	8.1	5.1	5.1	1.0	6.8	7.2	4.7	6.7	0.0	0.3	1.2	0.5	4.2	0.4	3.3	0.6	3.4	0.4	1.5	0.5	0.2	2.8	7.4	0.9	0.8	3.4	0.4	1.5	0.3	2.1	0.4	0.3	2.9	0.4	1.1	1.4	4.9	0.0	4.7	0.2	0.6	10.9	0.2	0.5	5.8	0.3	0.1	0.7	0.4	1.8	4.7	0.4	1.3	2.6	0.4	0.8	0.3	0.3	4.9	1.4	0.6	1.4	2.5	2.3	0.9	1.8	1.1	4.2	2.2	1.3	2.9	11.6	9.0	6.1	2.1	4.5	0.8	2.3	0.4	1.9	4.5	4.6	1.3	2.8	3.8	2.4	2.9	1.2	4.9	3.5
TMEM229A		ENSG00000234224	"Transmembrane protein 229A"	B2RXF0	7	124030916-124033023	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;intestine: 16.4;testis: 10.6"	"Cell line enriched"	"Detected in some"	44	"SH-SY5Y: 54.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA056391	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA056391: "					"unprognostic (2.52e-2)"			"unprognostic (3.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.21e-2)"		"unprognostic (4.74e-2)"	"unprognostic (2.31e-1)"		"unprognostic (4.31e-3)"	0.4	1.5	6.9	0.5	7.6	0.4	0.4	1.3	9.0	0.8	0.5	7.6	0.0	16.4	0.7	1.2	0.4	1.7	0.6	0.9	8.0	4.6	0.5	0.4	0.5	0.4	10.6	4.9	1.0	0.4	2.5	1.0	0.6	5.6	0.8	0.6	0.6	0.7	0.5	0.4	0.4	7.7	0.7	7.3	0.6	3.7	10.6	8.7	0.0	0.5	0.0	0.4	1.1	0.1	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.1	0.0	6.9	7.6	1.3	6.1	8.0	4.6	10.6	4.9	5.6	8.7
TMEM229B	"C14orf83, FLJ33387"	ENSG00000198133	"Transmembrane protein 229B"	Q8NBD8	14	67447084-67533739	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 27.8;ductus deferens: 27.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 9.1;MCF7: 9.5;SK-MEL-30: 8.1;U-937: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046562	Approved									"HPA046562: AB_10960265"	"prognostic favourable (5.38e-4)"	"unprognostic (6.55e-2)"	"unprognostic (1.23e-1)"	"prognostic favourable (1.21e-5)"	"unprognostic (7.37e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.95e-2)"	"unprognostic (5.18e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.20e-2)"	"prognostic favourable (1.79e-5)"	1.6	14.5	9.4	5.2	7.1	1.6	3.8	27.8	11.5	11.8	5.9	2.7	27.5	15.9	1.5	11.9	1.3	2.2	4.2	1.7	10.6	7.9	2.2	1.5	3.5	8.3	9.0	5.7	1.2	5.7	5.8	8.1	7.7	13.3	2.9	3.4	5.1	4.1	11.8	0.6	1.4	14.1	3.3	6.5	9.4	4.2	5.6	2.0	8.9	9.7	0.0	6.1	5.9	1.7	1.2	2.8	8.7	6.9	5.5	11.0	5.0	2.2	0.3	0.0	0.6	0.2	0.0	0.9	0.4	0.5	0.6	2.4	0.0	7.2	9.1	0.0	0.2	0.0	0.2	0.5	0.1	2.9	0.7	5.5	0.0	0.0	0.8	5.9	1.1	0.1	0.3	0.1	0.0	0.0	0.1	0.3	0.0	9.5	3.5	2.2	0.1	0.4	3.3	0.1	1.3	0.1	4.8	1.4	0.3	0.0	3.5	8.1	7.5	5.7	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.4	24.3	5.1	6.0	5.1	8.7	11.0	6.7	10.6	1.2	6.5	8.7	2.8	1.1	5.7	7.1	0.1	5.5	6.9	1.6	2.6	5.0	9.4	7.1	27.8	11.5	10.6	7.9	9.0	5.7	13.3	2.0
TMEM232	FLJ43080	ENSG00000186952	"Transmembrane protein 232"	C9JQI7	5	110289233-110738956	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.8;pituitary gland: 19.8;testis: 23.7"	"Cell line enhanced"	"Detected in some"		"U-266/70: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049386	Uncertain									"HPA049386: "	"unprognostic (1.12e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-1)"	"unprognostic (8.49e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-4)"	"unprognostic (8.96e-2)"	1.2	2.3	4.6	0.7	5.9	0.5	2.0	3.0	6.8	2.1	1.0	3.7	4.9	1.2	1.7	4.8	1.2	21.8	2.8	1.4	4.7	4.5	6.1	1.4	2.9	0.9	2.9	4.8	3.4	1.3	3.6	19.8	1.1	9.2	1.6	0.9	3.1	1.3	1.6	0.7	1.0	0.9	1.0	3.1	0.8	1.7	23.7	4.4	0.5	6.1	0.0	0.8	1.3	0.9	1.1	0.0	0.8	0.1	0.3	0.6	0.1	0.9	0.4	2.7	0.9	2.4	4.0	0.5	0.0	0.0	0.5	0.5	0.4	0.4	1.2	0.8	0.1	0.9	0.5	2.0	0.6	2.5	0.4	0.4	0.0	0.0	2.0	0.7	0.5	1.1	0.3	0.6	1.0	0.4	0.7	0.8	1.6	0.3	1.4	0.8	0.3	0.0	0.5	0.3	0.5	2.8	0.0	2.6	2.7	0.3	0.0	2.3	1.0	0.3	0.0	2.6	0.3	0.2	0.1	6.6	2.2	1.0	2.1	0.7	0.4	0.0	0.1	0.8	0.0	0.0	0.5	1.1	0.0	0.1	0.0	0.0	0.4	0.6	0.0	0.3	0.0	0.0	0.0	0.1	4.6	5.9	3.0	6.8	4.7	4.5	2.9	4.8	9.2	4.4
TMEM235		ENSG00000204278	"Transmembrane protein 235"	A6NFC5	17	78231310-78240987	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	26	"brain: 33.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;HUVEC TERT2: 1.2"	"Cancer enriched"	"Detected in single"	15	"glioma: 0.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA053939	Uncertain									"HPA053939: "					"unprognostic (1.47e-1)"	"unprognostic (6.91e-3)"								"unprognostic (3.92e-2)"	"unprognostic (1.71e-1)"			1.0	1.0	12.2	1.0	17.4	1.0	1.0	2.0	25.6	1.0	1.0	33.0	0.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	20.9	9.7	1.0	1.0	1.0	1.1	18.3	8.6	1.1	1.0	1.0	0.0	1.2	10.3	1.0	1.0	0.0	1.0	1.0	1.0	1.0	1.0	1.0	20.7	1.0	1.0	1.2	18.0	0.0	1.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	17.4	2.0	10.2	20.9	9.7	18.3	8.6	10.3	18.0
TMEM236	"bA162I21.2, bA16O1.2, FAM23A, FAM23B"	ENSG00000148483	"Transmembrane protein 236"	Q5W0B7	10	17752252-17800868	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"intestine: 76.4"	"Cell line enriched"	"Detected in some"	10	"MOLT-4: 14.9"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045096	Enhanced									"HPA045096: "	"unprognostic (4.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.88e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.54e-2)"	0.5	0.3	0.3	4.9	0.3	0.0	0.3	0.3	0.3	0.4	32.0	0.1	0.1	13.7	0.5	0.1	0.4	0.2	0.1	0.3	0.3	0.3	0.5	0.4	0.6	0.1	0.3	0.1	0.3	0.7	0.0	0.3	0.6	0.1	0.3	9.1	0.1	0.3	0.1	0.5	0.3	76.4	0.3	0.3	0.3	0.3	0.5	0.1	0.1	0.3	0.1	0.1	0.3	0.3	1.3	0.9	2.6	0.6	1.0	0.6	0.1	0.3	0.2	0.4	0.5	0.1	0.1	0.5	0.3	0.0	0.1	0.3	0.5	0.5	0.2	0.2	0.2	0.3	0.2	0.2	0.8	0.2	0.5	0.6	0.5	0.5	0.1	0.5	1.5	0.2	0.4	0.1	0.2	0.4	0.2	0.4	0.2	0.3	14.9	0.3	0.3	0.1	0.6	0.4	0.3	0.1	0.3	0.3	0.2	0.2	0.1	0.5	0.2	0.0	0.7	0.5	0.6	0.2	0.2	0.3	0.2	0.3	0.2	0.2	0.2	2.6	0.6	0.9	0.6	0.4	0.4	0.7	0.5	0.4	0.4	1.3	0.5	0.6	2.2	1.0	0.4	0.9	0.4	0.1	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.1
TMEM241	"C18orf45, FLJ44259, MGC11386"	ENSG00000134490	"Transmembrane protein 241"	Q24JQ0	18	23197144-23437961	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029489, HPA059922"	Uncertain		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus"	Vesicles	"HPA029489: , HPA059922: "	"unprognostic (1.44e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.15e-4)"	"unprognostic (7.07e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-3)"	"unprognostic (9.53e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.93e-1)"	"prognostic unfavourable (5.80e-4)"	5.8	3.6	6.4	4.3	11.3	2.6	6.3	2.0	11.9	6.0	4.3	4.2	2.2	4.1	5.7	5.0	5.2	4.6	4.5	4.0	3.9	4.0	3.1	5.4	4.3	3.6	3.1	5.2	4.9	6.5	7.0	6.5	6.1	5.2	2.7	6.3	3.5	4.8	2.6	3.4	3.9	2.9	7.6	3.5	4.1	3.7	2.1	2.6	1.9	6.8	4.9	5.1	5.4	4.7	3.0	2.3	1.3	3.1	8.4	2.2	1.4	3.1	6.2	1.2	4.1	6.5	5.8	3.7	1.5	2.0	1.5	3.5	1.2	7.4	11.9	3.4	3.0	6.0	3.3	5.6	5.2	1.4	0.4	2.5	4.5	2.6	3.6	2.6	2.0	6.6	6.1	6.2	7.4	6.8	5.2	4.2	5.5	3.4	2.7	0.5	1.4	1.2	2.0	5.6	11.4	2.6	2.3	4.4	4.2	7.3	3.9	4.7	4.1	1.2	2.6	10.6	2.5	3.7	4.2	8.4	6.4	5.0	3.4	8.0	6.8	1.3	0.7	0.0	1.3	3.1	2.2	1.8	0.2	1.2	2.3	3.0	1.1	1.9	0.0	8.4	1.2	0.7	1.5	1.4	6.4	11.3	2.0	11.9	3.9	4.0	3.1	5.2	5.2	2.6
TMEM249	C8orfK29	ENSG00000261587	"Transmembrane protein 249"	Q2WGJ8	8	144352219-144354914	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	70	"testis: 35.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.5;PC-3: 2.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA078901	Approved									"HPA078901: "	"unprognostic (2.23e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.03e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.13e-7)"	"unprognostic (6.56e-3)"	"unprognostic (1.62e-2)"	"unprognostic (8.44e-3)"	"unprognostic (3.46e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.2	0.3	0.0	0.6	0.2	0.1	2.5	0.8	0.0	0.2	0.2	0.0	0.7	1.5	0.0	0.3	0.2	0.0	0.1	0.0	1.5	0.4	0.4	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.7	2.3	1.6	0.7	0.0	0.0	1.1	1.3	1.7	0.0	0.3	2.1	0.8	1.0	0.0	0.5	2.0	0.8	0.2	0.5	0.4	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TMEM251	"C14orf109, DKFZP564F1123"	ENSG00000153485	"Transmembrane protein 251"	Q8N6I4	14	93184951-93187089	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048559	Uncertain		Approved	"Golgi apparatus,Cell Junctions"				"Cell Junctions"	"Golgi apparatus"	"HPA048559: "	"unprognostic (1.21e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.61e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.03e-2)"	"prognostic unfavourable (6.14e-7)"	"unprognostic (1.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.99e-3)"	"unprognostic (5.80e-3)"	"unprognostic (1.58e-1)"	"prognostic favourable (1.10e-4)"	"unprognostic (5.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.17e-2)"	15.8	19.5	12.2	10.7	14.3	3.9	23.1	11.5	14.2	21.9	19.6	11.4	19.6	15.5	13.0	26.2	10.8	15.8	11.5	23.2	12.2	12.8	25.0	14.4	24.1	19.1	19.0	11.1	12.4	23.6	16.4	17.2	12.5	15.8	26.1	19.5	18.3	18.7	18.5	22.6	10.4	17.9	11.5	17.3	13.3	16.5	8.7	15.1	14.2	19.4	11.0	11.7	13.3	11.8	6.0	8.7	13.7	12.7	5.4	6.6	4.4	7.0	7.5	10.1	10.6	11.7	4.6	6.8	4.9	5.8	8.6	11.1	5.3	7.4	8.0	10.0	4.7	9.5	10.9	8.0	11.7	7.3	8.5	6.8	5.6	10.6	11.1	9.5	11.0	6.1	9.2	6.9	11.1	8.6	5.6	7.9	6.9	33.7	6.8	7.7	5.9	8.1	4.1	10.1	7.1	10.7	14.3	9.7	9.1	7.4	4.1	29.0	11.2	6.9	3.8	4.3	7.0	9.0	6.2	10.5	12.5	8.2	8.1	4.0	6.5	4.8	10.8	13.7	4.7	9.7	3.1	5.3	5.5	5.3	8.7	6.0	6.1	6.6	10.7	5.4	12.7	7.6	4.4	4.4	12.2	14.3	11.5	14.2	12.2	12.8	19.0	11.1	15.8	15.1
TMEM255A	"FAM70A, FLJ20716"	ENSG00000125355	"Transmembrane protein 255A"	Q5JRV8	X	120258650-120311556	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 30.4;ovary: 29.6"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 16.9;RPMI-8226: 10.8;SK-MEL-30: 17.7;U-2 OS: 7.6;U-87 MG: 19.3"	"Group enriched"	"Detected in many"	10	"glioma: 21.3;melanoma: 8.0;renal cancer: 7.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"gdT-cell: 5.9;MAIT T-cell: 3.3;memory CD8 T-cell: 2.2;naive CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	10	"T-cells: 5.9"	"Low region specificity"	"Detected in all"							HPA048470	Approved		Uncertain	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA048470: AB_2680406"	"unprognostic (3.41e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.55e-4)"	3.9	5.5	6.8	3.4	14.4	1.5	5.4	6.8	7.8	11.2	3.5	12.4	1.7	1.9	3.2	2.9	4.4	6.3	2.1	2.4	5.3	25.4	2.4	1.5	4.8	5.0	30.4	4.4	29.6	1.1	0.6	6.6	0.8	18.4	3.8	3.9	7.1	1.3	3.3	2.4	4.0	2.8	2.0	13.0	2.8	2.1	0.9	7.8	6.4	0.9	1.8	5.7	1.6	8.0	0.5	0.3	0.0	0.6	0.0	5.9	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.3	0.1	0.0	0.1	0.2	0.0	0.0	1.1	0.4	0.5	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	16.9	0.3	0.0	0.0	0.0	5.9	0.0	0.0	0.0	10.8	0.0	0.0	3.4	0.1	0.3	0.0	17.7	0.0	0.2	0.0	0.0	7.6	0.0	2.8	0.0	3.2	2.4	19.3	0.0	0.0	0.0	0.6	0.0	5.9	0.2	3.3	0.5	0.4	2.2	0.3	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.9	6.8	14.4	6.8	3.9	5.3	25.4	30.4	4.4	18.4	7.8
TMEM255B	"FAM70B, MGC20579"	ENSG00000184497	"Transmembrane protein 255B"	Q8WV15	13	113759240-113816995	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 15.5;HUVEC TERT2: 20.1;PC-3: 20.4;RPMI-8226: 13.0;TIME: 18.8;U-87 MG: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Group enriched"	"Detected in many"	7	"granulocytes: 17.0;monocytes: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA043334	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA043334: AB_10795982"	"unprognostic (2.20e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.00e-2)"	"unprognostic (9.39e-2)"	"prognostic unfavourable (4.12e-5)"	"unprognostic (4.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.83e-1)"	18.5	6.6	3.9	7.1	4.5	1.5	11.8	2.0	4.7	11.1	3.9	2.3	4.3	3.5	10.1	5.3	3.9	6.6	7.5	7.3	6.5	3.7	9.0	6.6	11.7	7.9	5.4	2.1	4.6	4.7	3.1	8.0	2.4	6.1	8.8	3.2	3.3	3.8	5.1	4.6	6.0	4.5	10.4	4.9	9.5	4.4	4.6	4.0	0.1	12.4	2.4	3.7	8.1	29.9	1.5	1.3	17.0	4.8	0.0	0.0	1.0	5.2	0.0	0.3	0.0	1.4	0.0	0.0	2.5	5.6	2.9	1.8	0.2	0.1	0.1	0.0	3.9	0.7	0.5	0.3	1.2	0.0	0.6	0.1	0.1	0.0	0.9	1.4	15.5	1.0	1.3	6.2	2.4	20.1	0.0	0.1	6.2	0.1	0.7	0.4	0.6	20.4	0.9	0.4	13.0	2.8	0.2	1.2	2.8	0.1	0.7	0.0	0.3	4.1	18.8	0.8	5.7	0.3	0.8	0.0	0.0	1.0	21.5	1.4	0.1	17.0	4.8	0.6	0.0	4.5	0.0	0.8	0.0	0.0	1.3	1.5	0.0	0.0	2.2	0.0	3.2	0.0	0.0	1.0	3.9	4.5	2.0	4.7	6.5	3.7	5.4	2.1	6.1	4.0
TMEM266	"C15orf27, FLJ38190"	ENSG00000169758	"Transmembrane protein 266"	Q2M3C6	15	76059837-76229121	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 50.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.9;HEK 293: 3.6;NTERA-2: 3.6;U-937: 3.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"	"Region enriched"	"Detected in many"	12	"cerebellum: 50.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	6	"cerebellum: 65.8"	"Region enriched"	"Detected in all"	6	"cerebellum: 66.4"	"HPA041921, HPA049425"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041921: AB_10796789, HPA049425: "	"unprognostic (8.63e-3)"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-3)"	"unprognostic (9.17e-5)"	"unprognostic (4.67e-1)"	"unprognostic (2.61e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.86e-2)"	0.1	1.9	1.1	0.2	1.9	0.2	0.4	50.7	4.2	0.2	0.2	0.6	0.0	0.3	0.2	0.1	0.3	0.3	0.1	0.1	0.9	1.3	0.9	0.1	1.1	0.3	0.7	0.3	0.1	2.4	0.2	5.1	2.4	1.9	0.4	0.2	1.1	0.2	0.1	10.6	1.5	0.1	0.1	0.4	0.6	0.3	1.4	0.0	0.0	0.2	0.7	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.8	0.8	0.0	1.9	3.6	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	50.7	4.2	0.9	1.3	0.7	0.3	1.9	0.0
TMEM267	"C5orf28, FLJ21657"	ENSG00000151881	"Transmembrane protein 267"	Q0VDI3	5	43444252-43483893	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059946			Approved	Nucleoplasm				Nucleoplasm		"HPA059946: "	"unprognostic (8.20e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.11e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (2.82e-2)"	"unprognostic (4.77e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.07e-2)"	"unprognostic (4.40e-3)"	9.9	8.1	9.0	7.8	9.4	3.9	14.2	13.8	12.5	11.7	7.7	5.7	6.8	7.1	11.1	11.7	9.4	8.9	7.5	8.3	6.3	8.5	12.1	7.1	8.1	9.0	9.9	11.2	10.9	17.3	9.9	23.0	6.3	11.6	9.6	9.7	8.9	12.3	9.9	7.1	9.8	8.6	9.2	9.4	9.5	9.1	7.9	7.9	6.1	36.8	7.6	8.8	10.4	9.0	11.6	9.7	9.0	11.6	13.7	18.0	11.0	9.9	9.2	4.9	11.0	9.4	18.8	5.7	14.3	8.9	7.8	5.7	4.0	21.5	11.1	19.8	14.6	8.4	4.7	6.5	11.3	13.3	7.7	6.4	19.8	4.4	17.1	13.1	9.4	15.4	18.6	11.6	16.6	8.7	8.4	20.7	17.0	8.6	7.2	7.7	2.2	9.1	4.9	12.3	13.5	9.7	10.2	6.9	4.9	28.7	16.4	14.0	23.9	9.5	11.2	12.7	10.3	7.8	7.1	8.9	12.7	10.9	9.5	19.0	11.1	9.0	8.6	3.1	12.3	10.0	18.0	11.6	16.4	13.0	9.7	9.6	16.9	14.0	1.6	13.7	11.6	7.5	13.0	11.0	9.0	9.4	13.8	12.5	6.3	8.5	9.9	11.2	11.6	7.9
TMEM268	"C9orf91, DKFZp547P234, FLJ38045"	ENSG00000157693	"Transmembrane protein 268"	Q5VZI3	9	114611206-114646422	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 30.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017199	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA017199: AB_1845845"	"unprognostic (8.57e-2)"	"unprognostic (3.37e-1)"	"unprognostic (8.33e-2)"	"prognostic favourable (3.61e-4)"	"unprognostic (2.09e-1)"	"unprognostic (7.16e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.47e-1)"	9.1	9.0	9.6	8.5	15.8	3.8	9.7	4.4	31.0	7.3	6.6	5.1	3.4	4.3	7.7	7.6	4.8	5.7	4.8	3.7	12.5	9.1	3.8	6.3	6.6	10.6	8.5	15.3	10.2	5.6	15.1	4.6	5.9	8.7	15.9	6.8	11.1	8.9	9.1	5.0	4.3	6.4	8.8	7.7	15.5	7.5	4.8	5.0	10.3	7.9	2.0	11.4	7.8	5.4	4.3	8.4	2.3	2.5	1.5	1.9	0.9	2.5	4.6	2.2	4.6	6.2	4.6	1.7	2.5	4.5	3.5	3.6	3.4	1.0	11.5	2.2	2.9	4.5	4.3	2.1	3.0	5.8	2.9	3.6	3.4	2.1	10.7	7.4	1.7	4.0	3.7	4.9	5.2	2.3	7.1	30.1	2.5	7.7	8.7	2.2	5.7	4.5	9.9	2.5	9.7	2.0	2.1	7.5	4.7	8.5	11.1	22.8	14.8	6.9	1.3	3.4	4.1	1.4	4.6	16.7	15.6	12.4	1.9	6.3	6.4	0.5	2.5	0.5	1.3	2.1	0.5	2.3	1.3	0.7	1.4	4.3	1.9	1.5	2.3	1.5	1.8	8.4	0.2	0.9	9.6	15.8	4.4	31.0	12.5	9.1	8.5	15.3	8.7	5.0
TMEM270	"MGC26719, WBSCR28"	ENSG00000175877	"Transmembrane protein 270"	Q6UE05	7	73861159-73865893	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"testis: 35.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.1;MCF7: 5.3;PC-3: 1.8;RPMI-8226: 1.4;U-2197: 1.4;U-87 MG: 1.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"T-reg: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA077196			Approved	Vesicles				Vesicles		"HPA077196: "	"unprognostic (3.84e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.87e-5)"	"unprognostic (1.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.31e-3)"		"unprognostic (2.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.23e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	2.1	0.2	0.0	0.3	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.4	0.0	1.8	0.0	0.0	1.4	0.3	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.1	1.4	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM35A	"FLJ14084, TMEM35"	ENSG00000126950	"Transmembrane protein 35A"	Q53FP2	X	101078720-101096364	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;seminal vesicle: 46.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.3;HUVEC TERT2: 31.7;SH-SY5Y: 8.1"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048583	Enhanced		Supported	"Vesicles,Focal adhesion sites,Cytosol"				Vesicles	"Focal adhesion sites, Cytosol"	"HPA048583: "	"unprognostic (7.98e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.34e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.49e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.37e-3)"	3.6	6.7	12.8	1.7	28.2	0.7	1.3	21.2	28.6	3.3	17.3	2.5	6.8	3.5	7.4	3.9	10.4	4.3	3.6	1.1	14.4	33.8	1.1	0.7	2.6	0.8	12.2	10.0	7.7	0.9	6.1	1.5	0.8	30.0	20.5	9.1	2.9	1.0	46.4	1.3	0.9	4.1	11.8	3.9	1.3	3.4	1.8	2.3	0.0	1.3	0.0	0.9	13.3	2.7	0.2	0.0	0.2	0.1	0.6	0.8	0.4	0.0	0.0	3.3	0.0	2.4	6.3	0.0	0.6	0.4	0.3	0.1	0.0	0.0	0.0	0.0	1.9	0.0	2.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	2.1	0.0	1.1	0.0	31.7	0.0	0.0	4.0	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	1.4	8.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.5	0.2	0.5	0.2	0.0	0.0	0.6	0.4	0.2	0.6	0.1	0.0	0.8	0.4	12.8	28.2	21.2	28.6	14.4	33.8	12.2	10.0	30.0	2.3
TMEM37	"PR, PR1"	ENSG00000171227	"Transmembrane protein 37"	Q8WXS4	2	119429901-119438520	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 110.5;kidney: 82.5"	"Group enriched"	"Detected in some"	5	"EFO-21: 13.1;Hep G2: 34.4;RPTEC TERT1: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 2.8;naive CD4 T-cell: 3.3"	"Group enriched"	"Detected in many"	31	"monocytes: 2.8;T-cells: 3.3"	"Low region specificity"	"Detected in many"							HPA053794	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA053794: "	"unprognostic (2.54e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.56e-1)"	"unprognostic (9.60e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.61e-2)"	18.5	5.2	0.6	5.9	1.0	0.0	10.0	0.5	1.2	6.7	60.3	1.8	3.8	16.2	3.1	3.8	2.8	1.4	18.5	5.7	1.0	0.4	82.5	40.8	9.5	8.7	0.9	0.7	5.9	5.8	20.1	0.7	13.4	1.3	4.5	5.6	6.3	2.8	6.5	1.6	4.4	110.5	1.9	1.4	11.5	6.6	6.4	0.7	1.2	21.0	1.6	2.2	3.4	2.4	0.0	0.0	0.0	2.8	0.0	3.3	0.6	0.0	3.4	0.3	0.1	2.1	0.2	0.5	0.1	0.0	0.0	0.0	5.3	3.0	0.0	13.1	1.6	0.8	1.4	0.0	0.0	0.0	1.3	0.4	2.0	34.4	2.9	0.0	0.0	4.8	0.0	0.0	0.0	2.8	0.1	5.2	0.0	0.3	0.0	0.3	2.5	0.1	0.0	0.0	4.5	28.8	2.3	0.4	0.2	0.1	1.4	0.0	0.6	0.8	1.8	0.0	5.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.6	1.0	0.5	1.2	1.0	0.4	0.9	0.7	1.3	0.7
TMEM39A	FLJ10902	ENSG00000176142	"Transmembrane protein 39A"	Q9NV64	3	119429500-119468830	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039140	Approved		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA039140: AB_10673303"	"unprognostic (2.16e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavourable (3.26e-4)"	"unprognostic (9.68e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavourable (1.00e-5)"	"unprognostic (4.07e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.41e-2)"	13.7	12.7	5.6	13.0	8.8	9.3	13.2	10.5	6.4	18.3	8.7	10.4	27.0	9.6	20.8	18.3	10.9	13.5	13.4	14.4	5.1	3.8	9.7	16.7	15.2	11.0	8.9	2.4	17.6	37.5	8.3	47.9	19.5	7.6	13.9	9.5	12.1	30.2	30.0	8.7	10.7	10.6	9.6	8.4	11.8	11.5	15.4	8.0	11.3	17.4	9.5	19.2	11.9	13.0	8.6	18.1	11.5	11.2	11.9	13.8	9.2	15.7	7.9	14.1	10.0	28.2	26.4	14.9	15.6	26.8	16.9	23.6	13.9	12.1	6.6	14.8	14.4	16.4	14.6	6.2	18.7	6.5	5.6	8.1	6.0	14.1	19.0	15.0	12.2	16.0	10.3	12.3	30.0	11.2	8.0	19.1	9.4	7.3	7.9	5.5	13.6	15.8	8.6	7.4	14.2	4.9	6.1	6.1	8.6	14.7	8.5	21.1	8.1	14.1	9.6	10.5	10.0	7.3	9.8	22.0	6.2	15.7	15.7	10.9	14.9	11.5	11.2	8.0	13.5	6.2	13.8	8.5	8.4	11.3	13.2	8.6	7.0	7.1	4.7	11.9	4.8	18.1	9.8	9.2	5.6	8.8	10.5	6.4	5.1	3.8	8.9	2.4	7.6	8.0
TMEM42	MGC29956	ENSG00000169964	"Transmembrane protein 42"	Q69YG0	3	44861869-44865670	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052569	Uncertain		Uncertain	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA052569: "	"prognostic favourable (5.23e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.93e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.64e-2)"	"unprognostic (9.16e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"prognostic favourable (1.10e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-1)"	11.1	14.6	18.6	5.7	26.1	4.6	13.4	7.8	17.3	12.7	8.5	17.7	8.5	6.1	10.4	25.9	7.2	16.8	8.9	10.2	18.4	19.7	12.9	19.1	9.7	9.3	19.1	14.1	17.1	17.5	12.7	16.5	8.9	16.4	12.7	8.5	8.5	10.9	12.7	16.6	8.6	6.2	9.2	19.8	8.7	9.9	20.0	15.5	11.6	17.1	6.5	9.1	7.5	8.7	13.9	11.8	4.2	10.2	9.1	15.9	9.2	4.0	4.1	1.2	2.3	15.9	12.5	0.1	3.4	4.8	4.1	4.1	0.8	8.0	2.8	6.6	6.5	2.7	0.3	5.2	4.2	4.3	0.0	1.7	5.3	4.3	16.9	2.0	0.1	13.0	13.2	4.3	9.5	7.0	0.1	5.7	6.2	3.2	1.7	3.4	2.2	1.9	1.4	0.6	0.6	9.0	1.6	1.3	1.7	4.1	1.4	1.6	3.0	3.5	4.6	3.6	0.4	5.3	3.7	2.0	1.5	0.8	7.3	2.4	1.6	3.7	8.6	4.2	7.8	7.7	8.2	13.9	11.6	7.2	10.6	11.9	15.9	12.6	1.6	9.1	10.2	11.8	9.2	9.2	18.6	26.1	7.8	17.3	18.4	19.7	19.1	14.1	16.4	15.5
TMEM52B	"C12orf59, FLJ31166"	ENSG00000165685	"Transmembrane protein 52B"	Q4KMG9	12	10170542-10191801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	23	"kidney: 85.1"	"Cell line enriched"	"Detected in some"	8	"CACO-2: 45.3"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 6.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA058096	Enhanced		Approved	"Focal adhesion sites"				"Focal adhesion sites"		"HPA058096: AB_2683603"	"unprognostic (1.10e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (8.65e-2)"	"unprognostic (7.14e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.80e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.18e-1)"	0.1	0.0	0.1	0.1	0.6	0.9	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	85.1	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.0	0.1	2.0	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.9	3.7	1.4	1.3	0.6	0.5	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	45.3	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.8	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	3.3	4.3	0.0	2.4	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	1.4	1.3	1.0	0.4	0.2	0.4	0.4	0.4	0.5	3.7	0.9	0.5	0.5	1.0	0.6	0.2	0.6	0.4	0.4	0.1	0.6	0.1	0.2	0.2	0.1	0.3	0.1	0.1	0.1
TMEM53	"FLJ22353, NET4"	ENSG00000126106	"Transmembrane protein 53"	Q6P2H8	1	44635238-44674555	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.7;liver: 44.7"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 38.7"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 38.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021134	Approved		Approved	"Golgi apparatus,Focal adhesion sites"				"Golgi apparatus"	"Focal adhesion sites"	"HPA021134: AB_2205162"	"unprognostic (5.28e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.19e-2)"	"prognostic favourable (6.96e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (1.02e-5)"	"unprognostic (1.15e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.29e-2)"	8.3	9.0	6.0	4.4	8.7	6.0	7.0	2.4	11.8	4.9	11.0	8.8	4.6	16.6	5.7	7.2	4.5	5.3	7.6	9.3	6.2	6.1	14.8	44.7	7.3	6.4	6.8	6.2	7.7	5.4	3.3	6.4	4.3	8.0	5.2	7.2	13.9	6.0	3.8	4.2	3.9	16.4	4.5	6.1	4.8	7.7	18.8	4.4	3.6	8.2	3.1	4.0	7.3	3.7	5.3	38.7	3.6	8.6	2.8	3.1	2.8	7.6	8.8	8.0	5.8	10.4	7.9	9.6	2.2	6.7	4.4	6.6	2.8	24.1	2.4	7.3	2.1	6.9	2.2	4.7	2.3	3.8	5.6	2.8	3.6	13.4	10.4	2.2	10.2	9.3	7.3	8.8	1.9	2.4	1.2	3.1	2.6	4.5	2.5	6.5	4.6	5.2	4.0	1.1	23.5	13.1	8.0	5.6	5.4	2.4	9.6	12.4	2.9	5.8	1.0	3.2	5.5	4.6	2.8	2.2	2.6	1.3	8.4	5.7	3.7	3.6	5.2	2.3	3.0	8.6	2.6	5.3	3.1	2.5	2.6	5.0	1.5	2.0	0.5	2.8	6.0	38.7	3.0	2.8	6.0	8.7	2.4	11.8	6.2	6.1	6.8	6.2	8.0	4.4
TMEM54	CAC-1	ENSG00000121900	"Transmembrane protein 54"	Q969K7	1	32894594-32901438	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA061992			Approved	Vesicles				Vesicles		"HPA061992: "	"unprognostic (2.67e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (6.82e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.40e-2)"	3.2	3.3	16.1	21.5	10.7	0.0	8.5	2.7	10.6	10.0	70.0	8.2	7.0	37.9	8.5	9.4	28.8	5.0	24.2	4.5	9.7	9.4	11.4	4.4	7.2	2.4	10.9	5.7	6.2	12.4	9.0	4.7	47.3	6.8	14.7	37.4	7.4	11.8	8.4	1.9	26.9	76.7	7.3	7.3	3.1	35.0	3.7	6.0	1.1	23.6	16.9	14.2	12.5	15.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	31.3	8.5	0.0	8.1	15.6	9.4	30.6	4.6	7.5	11.1	14.4	21.2	50.5	0.0	13.7	6.2	19.3	7.3	27.1	3.4	36.4	1.5	0.0	3.0	1.1	11.3	0.1	0.4	8.0	24.8	17.1	4.7	4.9	4.2	0.0	5.8	33.6	0.0	0.6	2.6	14.8	4.2	12.8	0.1	4.1	40.2	0.4	4.2	3.2	21.0	10.5	22.8	6.1	9.3	11.0	11.7	24.6	9.8	1.1	2.6	3.6	7.8	0.8	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	10.7	2.7	10.6	9.7	9.4	10.9	5.7	6.8	6.0
TMEM59L	"BSMAP, C19orf4"	ENSG00000105696	"Transmembrane protein 59 like"	Q9UK28	19	18607430-18621039	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 148.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 20.3;ASC diff: 24.7;EFO-21: 14.6;Hep G2: 14.8;HSkMC: 9.1;SH-SY5Y: 12.0"	"Cancer enriched"	"Detected in many"	8	"glioma: 44.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010661, HPA070701"	Approved		Approved	"Nucleoplasm,Actin filaments"				"Actin filaments"	Nucleoplasm	"HPA010661: AB_1078338, HPA070701: "	"unprognostic (3.24e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.24e-4)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.40e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-3)"	"prognostic favourable (8.80e-4)"	"unprognostic (4.65e-2)"	"unprognostic (9.17e-7)"	"unprognostic (1.47e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-5)"	2.6	12.8	36.9	2.5	39.4	1.7	1.9	41.9	148.3	2.2	2.9	7.5	0.0	2.0	2.5	2.0	2.5	2.1	2.9	3.5	39.9	49.6	1.9	1.8	1.9	1.8	17.7	32.8	1.8	2.8	4.9	13.2	2.3	24.1	2.2	2.2	1.9	2.3	2.6	2.5	1.8	3.0	3.1	7.3	1.7	2.0	2.4	5.2	0.0	1.8	0.0	1.7	2.0	0.1	0.5	0.7	0.0	0.0	0.0	0.5	0.4	0.0	0.6	0.2	20.3	24.7	1.2	0.0	2.1	0.4	0.8	0.4	0.0	1.0	0.1	14.6	1.3	0.3	6.0	0.0	0.7	0.1	0.9	0.0	0.3	14.8	3.8	0.0	0.3	9.1	0.0	0.2	0.7	0.0	0.0	0.1	0.5	0.8	0.1	0.0	1.8	0.6	0.1	0.0	0.2	0.0	0.0	0.3	12.0	1.4	0.0	0.0	0.2	0.0	0.2	0.4	4.9	0.1	1.3	3.0	1.1	0.1	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.4	36.9	39.4	41.9	70.3	39.9	49.6	17.7	32.8	24.1	5.2
TMEM60	"C7orf35, DC32"	ENSG00000135211	"Transmembrane protein 60"	Q9H2L4	7	77793728-77798580	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062625	Approved									"HPA062625: "	"prognostic favourable (3.09e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-3)"	"unprognostic (3.91e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.73e-3)"	"unprognostic (3.46e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.43e-3)"	16.4	19.7	14.6	16.2	14.8	6.9	22.8	8.6	21.3	17.4	18.0	10.0	17.1	13.3	16.4	23.1	15.0	14.5	13.6	15.1	14.6	17.8	25.5	25.8	19.3	18.8	15.7	12.2	18.6	24.1	33.9	30.6	20.1	19.7	17.9	18.4	16.0	27.5	21.3	19.2	15.1	19.6	14.7	15.3	22.7	14.2	20.3	9.8	18.8	30.9	17.2	20.5	14.0	14.1	25.9	15.6	48.3	17.2	8.8	23.1	12.2	17.6	11.8	18.8	21.8	25.1	22.3	8.5	16.7	31.4	17.6	28.2	10.9	22.6	13.7	4.1	15.3	18.6	17.4	9.6	19.9	10.5	16.5	7.3	11.1	15.1	17.8	10.3	13.9	16.3	13.9	13.1	16.0	12.5	17.2	27.5	27.5	18.7	7.8	26.5	13.1	15.5	9.5	14.8	19.5	20.8	13.1	9.4	15.2	12.4	17.6	24.8	21.2	19.1	8.3	22.8	16.0	19.8	12.2	11.3	17.2	19.6	17.3	21.6	20.1	48.3	16.0	28.6	9.4	17.2	10.1	25.9	16.5	11.6	11.9	20.9	14.0	11.8	15.6	8.8	15.7	15.6	23.1	12.2	14.6	14.8	8.6	21.3	14.6	17.8	15.7	12.2	19.7	9.8
TMEM61		ENSG00000143001	"Transmembrane protein 61"	Q8N0U2	1	54980792-54992293	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 22.1;pituitary gland: 29.1;salivary gland: 34.1"	"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 22.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 5.2;pons and medulla: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA030614	Uncertain									"HPA030614: AB_10603216"	"unprognostic (7.62e-2)"	"unprognostic (1.67e-3)"	"prognostic favourable (1.07e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.63e-4)"	"unprognostic (6.15e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.24e-2)"	"prognostic favourable (1.78e-7)"	"unprognostic (8.47e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.62e-3)"	0.2	3.9	0.4	0.7	1.0	0.0	2.7	5.2	0.5	0.9	3.7	0.2	4.9	2.4	0.2	3.8	2.9	2.0	1.7	0.0	0.5	0.6	22.1	0.0	2.4	0.0	1.1	0.7	1.1	4.2	7.8	29.1	0.5	5.2	2.4	2.3	0.5	34.1	6.7	0.4	1.8	3.5	5.3	0.8	0.4	2.2	0.2	0.1	0.1	0.6	0.8	1.8	4.7	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	22.1	2.3	0.0	1.1	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.0	5.2	0.5	0.5	0.6	1.1	0.7	5.2	0.1
TMEM63C	"C14orf171, CSC1, DKFZp434P0111, hsCSC1"	ENSG00000165548	"Transmembrane protein 63C"	Q9P1W3	14	77116568-77259495	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.8;pituitary gland: 21.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 11.6;Karpas-707: 15.6;RPMI-8226: 7.9;SCLC-21H: 21.2;SK-BR-3: 18.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 63.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030657	Uncertain		Approved	Centrosome				Centrosome		"HPA030657: AB_10601699"	"unprognostic (2.74e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-8)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.34e-7)"	"unprognostic (5.90e-3)"	0.4	14.1	3.4	1.0	8.4	1.1	5.2	63.8	16.3	1.5	5.8	1.9	0.0	1.8	0.3	6.8	4.8	0.6	0.5	0.3	3.2	9.7	0.7	0.4	0.9	0.6	4.6	6.0	0.4	6.7	1.2	21.1	1.1	6.6	0.4	4.3	0.9	1.3	0.2	0.8	4.4	2.2	1.1	1.8	3.2	3.1	9.9	1.2	0.0	3.2	0.6	0.6	0.3	2.9	0.1	0.7	2.0	1.7	1.7	1.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	11.6	2.2	0.0	1.6	2.4	0.9	0.0	0.7	0.9	0.2	1.1	0.0	0.0	2.0	0.1	0.0	4.9	0.0	0.1	0.0	0.0	15.6	0.0	5.8	1.6	0.1	0.5	0.0	0.0	0.8	7.9	0.2	0.0	21.2	3.2	0.2	18.8	0.0	1.8	1.0	0.0	0.0	4.0	0.0	0.0	1.2	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	0.0	0.5	1.0	0.7	0.1	0.5	0.4	2.0	1.7	1.7	0.0	0.0	0.4	3.4	8.4	63.8	13.0	3.2	9.7	4.6	6.0	6.6	1.2
TMEM64	DKFZp762C1112	ENSG00000180694	"Transmembrane protein 64"	Q6YI46	8	90621995-90791632	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"epididymis: 84.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB034221	Enhanced									"CAB034221: AB_1567653"	"unprognostic (3.61e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.55e-3)"	"unprognostic (4.84e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.97e-1)"	9.2	12.6	4.3	5.2	5.3	2.1	6.1	2.7	6.1	10.6	10.8	16.2	14.5	5.7	11.9	84.0	7.3	5.7	6.3	5.8	6.2	5.5	11.6	11.7	7.2	6.7	11.2	3.3	10.1	11.3	4.1	5.9	6.1	10.0	10.7	3.7	15.1	12.4	11.0	8.2	6.8	11.3	9.6	12.1	7.2	5.4	9.7	7.5	2.3	20.0	5.2	7.2	11.9	10.9	5.7	0.6	3.2	0.8	5.9	3.7	1.6	12.6	9.9	5.0	2.6	23.3	17.0	2.7	9.4	9.0	7.4	8.2	2.7	8.7	8.2	3.8	5.7	4.4	13.2	6.3	9.8	16.6	4.8	15.4	3.9	6.2	8.2	0.9	2.6	22.1	7.0	3.0	6.9	7.4	6.9	18.3	12.4	16.9	0.0	2.2	0.7	5.2	1.8	11.0	4.2	14.6	24.6	3.5	10.0	6.1	5.4	11.3	5.4	0.7	7.3	7.5	6.6	5.4	7.6	12.1	0.2	9.0	6.8	1.9	9.8	3.2	0.2	0.3	3.0	0.6	3.7	5.7	3.2	3.4	0.6	2.9	1.5	2.1	0.1	5.9	0.8	0.4	1.4	1.6	4.3	5.3	2.7	6.1	6.2	5.5	11.2	3.3	10.0	7.5
TMEM68	FLJ32370	ENSG00000167904	"Transmembrane protein 68"	Q96MH6	8	55696424-55773407	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018216, HPA019173"	Uncertain		Approved	Vesicles				Vesicles		"HPA018216: AB_2205185, HPA019173: AB_1858129"	"unprognostic (4.43e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.63e-1)"	10.4	18.3	14.0	8.4	18.0	10.6	14.6	18.9	20.5	13.0	15.1	16.3	16.0	14.6	15.4	17.9	16.1	25.4	12.5	7.4	13.8	13.2	20.6	14.6	11.3	10.5	12.7	10.2	15.7	13.5	15.9	18.5	15.6	13.2	15.8	16.6	13.1	14.0	12.2	7.8	17.6	18.3	14.4	13.3	12.9	12.0	9.8	11.7	22.7	18.8	13.4	12.3	17.1	13.0	9.2	7.2	21.7	7.7	8.2	10.5	3.9	12.6	7.6	13.0	7.9	11.0	12.7	22.8	11.3	8.7	10.9	10.6	10.8	24.0	13.9	13.4	7.5	16.1	10.1	15.1	12.2	19.1	11.4	16.9	6.9	11.3	12.2	7.1	9.4	8.6	23.2	11.0	26.1	9.9	16.1	14.1	15.9	6.6	17.8	9.8	14.1	4.0	13.1	5.4	8.9	18.1	9.9	10.9	9.6	7.6	12.3	22.2	18.2	9.3	7.7	8.3	10.5	14.3	9.2	12.2	15.2	17.6	11.4	11.9	12.9	21.7	7.1	5.0	7.2	4.4	10.5	9.2	8.6	7.6	7.2	9.2	7.2	10.1	7.9	8.2	7.7	6.4	6.3	3.9	14.0	18.0	18.9	20.5	13.8	13.2	12.7	10.2	13.2	11.7
TMEM69	"C1orf154, FLJ21029"	ENSG00000159596	"Transmembrane protein 69"	Q5SWH9	1	45687214-45694443	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026993	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA026993: AB_10601824"	"prognostic favourable (2.24e-4)"	"unprognostic (2.47e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (3.66e-8)"	"unprognostic (4.05e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.17e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.41e-3)"	"unprognostic (3.65e-2)"	6.0	9.0	7.0	5.8	11.0	2.6	12.2	6.8	13.8	5.3	7.5	7.3	2.9	8.3	5.6	9.9	12.1	6.0	5.6	11.6	6.3	6.2	8.4	7.6	8.3	8.8	6.9	5.0	8.9	7.8	10.7	5.5	6.8	10.8	7.0	8.4	4.7	7.9	5.7	8.2	7.7	8.2	6.2	9.1	7.8	5.7	12.1	9.4	10.1	7.5	8.8	9.3	8.4	11.1	8.7	10.9	5.4	15.6	4.6	8.2	6.1	12.9	3.2	9.0	7.3	6.9	8.9	22.1	8.5	10.0	14.3	14.0	8.9	6.8	15.7	5.9	8.1	17.6	7.2	19.3	14.8	10.9	8.4	32.1	7.9	9.6	12.3	15.3	15.8	10.3	20.1	13.2	8.4	11.8	19.2	10.9	9.0	4.7	8.4	11.0	21.3	8.7	13.3	8.2	15.9	15.2	13.7	10.4	9.4	8.9	24.2	14.5	12.6	15.7	8.8	6.6	11.4	14.5	10.2	8.7	10.8	12.1	9.2	11.6	9.7	5.0	12.2	5.0	5.1	12.7	6.4	8.7	7.2	5.7	10.9	8.3	8.2	6.3	5.4	4.6	15.6	6.8	6.8	6.1	7.0	11.0	6.8	13.8	6.3	6.2	6.9	5.0	10.8	9.4
TMEM71	FLJ33069	ENSG00000165071	"Transmembrane protein 71"	Q6P5X7	8	132685007-132760712	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 65.7;lymphoid tissue: 31.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.0;HDLM-2: 32.3;Karpas-707: 6.9;U-937: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 65.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 65.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA058401, HPA070655"	Uncertain		Enhanced	Mitochondria				Mitochondria		"HPA058401: , HPA070655: "	"unprognostic (1.39e-3)"	"unprognostic (7.27e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.10e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.29e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	4.2	1.1	1.4	8.2	1.5	20.8	5.4	0.7	1.2	2.5	9.9	0.8	0.4	1.2	1.0	2.0	4.8	1.9	4.1	25.5	1.8	1.2	1.9	2.3	8.3	20.9	2.2	0.8	1.9	2.9	0.0	1.4	1.0	1.7	2.2	2.2	5.8	5.8	1.3	1.3	1.3	7.2	2.2	4.2	18.2	2.9	0.9	1.4	31.3	2.2	2.5	10.6	7.0	2.8	1.4	8.2	65.7	13.5	2.9	14.8	8.4	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.7	8.0	0.3	0.5	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.2	0.9	32.3	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	1.2	0.6	0.0	6.9	1.4	0.0	1.6	1.2	0.7	0.2	0.1	1.1	0.4	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.3	0.5	0.7	3.3	0.0	1.6	0.0	5.7	19.1	2.4	12.5	13.5	23.9	8.0	3.9	14.8	1.4	5.9	5.6	8.2	1.3	9.0	6.5	65.7	2.9	3.2	0.2	0.7	8.4	1.4	1.5	0.7	1.2	1.8	1.2	2.2	0.8	1.7	1.4
TMEM72	"bA285G1.3, C10orf127, KSP37"	ENSG00000187783	"Transmembrane protein 72"	A0PK05	10	44911200-44937002	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 46.5;retina: 17.1"	"Group enriched"	"Detected in some"	118	"RPMI-8226: 25.5;U-937: 15.9"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 8.7"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 1.2;pons and medulla: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039894, HPA062907"	Enhanced									"HPA039894: AB_10795261, HPA062907: AB_2684900"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.08e-1)"		"unprognostic (4.57e-2)"	"unprognostic (3.24e-2)"		"unprognostic (8.58e-2)"	"unprognostic (5.45e-2)"		"prognostic favourable (1.01e-4)"	"unprognostic (4.99e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"		0.1	0.0	0.1	0.9	0.2	0.1	0.0	0.3	0.2	0.0	4.2	1.3	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.1	1.2	0.3	46.5	0.1	0.0	0.0	0.4	0.0	0.0	5.7	0.1	0.3	0.0	4.9	0.0	4.9	17.1	2.7	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	1.9	0.0	0.4	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.2	1.2	0.3	0.4	0.0	4.9	0.0
TMEM74B	"C20orf46, FLJ11190"	ENSG00000125895	"Transmembrane protein 74B"	Q9NUR3	20	1180561-1185415	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.9;intestine: 16.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.7;Hep G2: 9.7;K-562: 16.4;Karpas-707: 7.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045213	Approved		Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA045213: AB_10961999"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-4)"	"unprognostic (9.58e-2)"	"prognostic favourable (3.07e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.55e-7)"	"unprognostic (1.20e-1)"	"unprognostic (9.77e-2)"	"unprognostic (8.37e-2)"	"unprognostic (5.07e-3)"	2.3	0.3	4.3	0.3	13.9	0.0	1.1	2.3	7.3	0.1	0.7			12.5	0.6	0.3	0.7	3.9	2.5	3.9	2.3	6.9	0.6	1.0	9.4	0.9	2.3		0.0	0.6	0.2	3.5	12.2		0.5	0.9		3.3	11.3	2.9	4.6	16.0	1.1	1.1	0.6	2.7	0.9			1.6		0.4	0.7	0.0	1.6	0.1	0.0	0.1	0.0	0.5	0.3	0.0	4.8	2.7	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	7.7	0.7	0.1	0.9	0.0	0.3	3.6	0.5	0.1	0.0	4.6	1.1	0.0	9.7	0.0	0.0	1.3	0.0	1.0	0.0	0.2	0.1	16.4	7.4	0.0	0.1	0.1	0.1	3.3	0.4	0.0	0.2	0.0	0.8	0.7	0.7	2.1	0.1	0.0	0.1	0.0	0.1	2.0	0.0	3.2	0.1	0.1	3.2	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3										
TMEM78	FLJ40168	ENSG00000177800	"Transmembrane protein 78"	Q5T7P6	1	229249636-229251810	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 5.3;bone marrow: 2.5"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 5.3"	"Low lineage specificity"	"Detected in many"											HPA042351	Uncertain									"HPA042351: AB_10961259"	"unprognostic (2.45e-2)"		"unprognostic (3.07e-1)"		"unprognostic (1.23e-1)"			"unprognostic (1.51e-1)"		"unprognostic (3.33e-1)"		"unprognostic (9.45e-2)"		"unprognostic (5.59e-2)"	"unprognostic (1.29e-1)"			0.1	0.4	0.5	0.2	0.5	2.5	0.4	0.7	0.7	0.1	0.1			0.1	0.5	0.6	0.1	0.3	0.2	0.1	0.4	0.3	0.1	0.6	0.0	0.7	0.3		0.2	0.7	0.5	0.2	0.0		0.4	0.3		0.7	0.0	1.8	1.2	0.2	0.0	0.3	0.6	0.1	0.7			0.3		0.2	0.1	0.1	1.3	2.6	5.3	0.5	1.3	0.9	0.1	0.4	1.3	0.7	2.1	0.2	0.0	0.6	0.4	0.0	0.1	0.1	0.2	1.9	0.4	0.5	0.4	1.0	0.0	0.0	0.3	0.6	0.6	0.7	1.8	0.3	0.0	0.5	0.5	0.2	0.0	0.1	0.0	0.1	0.3	0.7	0.0	0.3	0.6	1.5	0.6	0.6	0.4	0.4	0.2	0.2	1.0	0.4	0.5	0.5	0.2	0.0	0.5	0.1	0.0	0.6	0.5	0.5	0.3	0.9	0.6	0.8	0.5	0.6	0.8	5.3	0.5	0.7	0.7	0.3	0.5	0.8	0.6	0.5	0.1	1.3	0.9	0.8	2.6	1.3	0.5	2.6	0.4	0.1										
TMEM80	FLJ38216	ENSG00000177042	"Transmembrane protein 80"	Q96HE8	11	695428-705028	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA059592, HPA067046"	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA059592: , HPA067046: "	"unprognostic (1.48e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.36e-2)"	"unprognostic (5.39e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.03e-1)"	"prognostic favourable (2.47e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.23e-3)"	12.9	12.7	10.5	17.7	18.9	4.4	20.0	15.9	20.5	14.8	14.1	18.3	12.8	19.1	17.9	21.8	22.9	17.0	10.9	7.7	15.3	9.4	16.5	10.2	12.2	15.5	12.6	15.2	18.2	16.1	16.8	19.7	7.6	13.5	17.9	15.0	18.1	25.2	19.1	12.6	20.4	16.5	15.4	9.4	20.0	19.3	13.8	14.3	33.8	27.2	7.4	18.3	16.3	15.8	21.5	16.1	24.6	21.5	13.9	17.7	14.0	19.5	9.9	6.3	8.2	14.1	6.7	10.0	4.8	2.7	5.1	5.7	11.1	23.9	8.8	4.2	7.5	15.1	9.3	5.5	3.7	6.1	23.6	5.3	9.8	7.9	8.3	6.9	9.7	15.4	11.4	2.3	3.6	6.1	6.5	10.2	6.6	6.4	9.1	4.8	5.9	4.6	6.3	4.3	17.2	7.4	3.1	17.4	5.7	7.1	13.7	6.7	10.0	6.6	8.6	8.7	4.2	1.9	3.5	4.9	1.5	7.9	9.2	8.9	3.7	6.1	19.8	24.6	16.3	18.8	14.2	19.8	12.3	12.2	15.7	21.5	17.7	15.5	9.4	13.9	21.5	16.1	14.8	14.0	10.5	18.9	15.9	20.5	15.3	9.4	12.6	15.2	13.5	14.3
TMEM81	"HC3107, KVLA2788, MGC75217, UNQ2788"	ENSG00000174529	"Transmembrane protein 81"	Q6P7N7	1	205083129-205084460	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA052515			Approved	"Intermediate filaments"				"Intermediate filaments"		"HPA052515: "	"unprognostic (9.19e-3)"	"unprognostic (3.53e-1)"	"unprognostic (1.91e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (3.25e-6)"	"unprognostic (3.66e-2)"	"unprognostic (2.68e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.48e-2)"	"prognostic unfavourable (6.65e-9)"	"unprognostic (8.91e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.42e-1)"	"prognostic favourable (2.67e-4)"	1.5	2.7	2.8	1.6	3.8	2.0	2.1	11.2	5.3	2.1	1.3			1.2	1.5	3.5	1.4	1.2	1.1	2.2	3.3	2.7	4.2	3.3	1.5	2.3	2.8		2.3	1.0	3.4	2.2	2.0		1.8	1.7		1.4	2.1	4.6	4.1	1.2	1.7	2.4	3.0	1.0	6.1			1.4		2.7	0.9	1.6	1.5	1.5	4.3	1.4	0.2	4.6	0.9	2.4	3.7	6.2	8.2	9.1	3.6	3.2	4.5	2.7	2.3	1.4	6.6	1.7	4.5	3.2	2.5	2.1	10.0	3.8	4.1	3.9	3.9	3.7	5.2	3.3	6.3	1.9	2.1	3.7	6.9	3.6	1.8	4.6	8.4	1.9	2.9	4.7	4.4	8.2	4.8	5.4	3.0	7.2	4.7	5.4	2.3	3.9	6.1	2.8	3.4	7.2	2.5	8.1	2.1	4.4	2.3	5.6	4.9	4.3	5.3	3.6	6.3	2.9	7.4	4.3	1.2	0.2	4.6	1.4	0.2	1.5	2.3	1.1	1.5	1.4	2.5	4.0	2.5	0.2	1.4	1.5	2.7	0.9										
TMEM82		ENSG00000162460	"Transmembrane protein 82"	A0PJX8	1	15742422-15747982	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 35.6;liver: 30.1"	"Cell line enriched"	"Detected in some"	4	"CACO-2: 8.2"	"Cancer enhanced"	"Detected in some"		"liver cancer: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060282	Uncertain		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA060282: "	"unprognostic (2.46e-2)"		"unprognostic (7.96e-2)"	"unprognostic (4.88e-2)"			"unprognostic (1.40e-2)"	"unprognostic (6.45e-2)"		"unprognostic (6.90e-2)"	"unprognostic (4.80e-2)"		"prognostic favourable (3.80e-7)"	"unprognostic (1.41e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.09e-1)"	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	18.9	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	7.5	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM86A	FLJ90119	ENSG00000151117	"Transmembrane protein 86A"	Q8N2M4	11	18693122-18704785	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 6.5"	"Group enriched"	"Detected in many"	12	"dendritic cells: 6.5;monocytes: 3.7;T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057119	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA057119: "	"unprognostic (1.25e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.24e-1)"	6.9	4.9	4.7	3.6	5.7	0.7	5.6	3.4	9.7	3.8	3.3	7.0	1.2	2.5	4.0	3.8	3.9	4.4	6.6	8.1	6.9	3.7	15.3	6.7	5.7	11.1	6.7	3.2	12.3	8.2	7.0	3.9	7.1	5.0	2.9	3.2	16.7	4.6	2.7	4.7	24.4	3.2	3.4	7.2	9.2	3.3	4.1	3.7	5.3	3.7	3.9	4.2	5.2	5.4	0.2	6.5	0.3	3.7	0.2	1.7	1.4	0.0	0.2	0.7	3.4	3.0	0.0	0.1	0.7	0.5	0.6	0.5	0.0	0.4	0.0	1.3	0.6	0.3	0.2	0.1	0.4	0.2	1.9	0.2	0.1	0.0	2.4	0.0	3.0	4.2	1.3	0.1	0.2	1.8	0.6	0.0	1.4	1.7	0.0	0.0	0.2	1.7	0.0	5.5	0.0	18.8	4.0	1.0	1.4	1.0	3.5	1.4	4.2	0.4	2.0	0.5	0.3	0.2	0.1	3.4	2.7	0.0	1.2	0.0	1.2	0.0	3.7	0.3	0.4	2.8	1.0	0.0	0.4	0.9	6.5	0.2	1.0	1.7	0.0	0.2	0.9	3.8	1.0	1.4	4.7	5.7	3.4	9.7	6.9	3.7	6.7	3.2	5.0	3.7
TMEM89		ENSG00000183396	"Transmembrane protein 89"	A2RUT3	3	48620759-48621855	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 28.3"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.8;U-2197: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053577	Uncertain									"HPA053577: "	"unprognostic (1.61e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.31e-3)"	"unprognostic (5.90e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.83e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.86e-2)"	0.1	0.0	0.1	0.1	0.1	2.8	0.1	0.1	0.5	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.5	0.1	0.2	0.1	0.1	0.5	0.5	0.1	0.1	0.1	0.7	28.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.7	0.4	1.1	0.3	1.1	0.7	0.0	0.2	0.0	1.1	0.2	0.4	0.0	0.0	0.3	0.0	0.5	0.8	0.6	0.5	0.0	1.5	0.0	1.4	1.9	0.6	0.0	0.0	0.0	0.0	0.8	0.0	2.8	0.6	0.0	0.7	0.5	0.0	0.7	1.2	0.1	0.9	0.0	0.7	0.4	0.8	0.0	0.0	1.4	1.5	3.1	1.5	0.5	0.8	0.5	1.8	0.7	2.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1
TMEM91	"FLJ27310, IFITMD6"	ENSG00000142046	"Transmembrane protein 91"	Q6ZNR0	19	41350911-41384083	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 15.1;HSkMC: 16.2;TIME: 15.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 51.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 51.9"	"Low region specificity"	"Detected in all"							HPA053240	Uncertain									"HPA053240: "	"unprognostic (3.02e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.69e-3)"	"prognostic favourable (3.54e-5)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (3.52e-7)"	"unprognostic (1.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.06e-2)"	10.5	6.2	12.1	9.2	42.0	35.5	22.0	5.2	13.0	12.1	9.8	9.5	12.9	4.3	17.3	12.8	11.2	15.8	9.7	7.2	11.3	22.9	8.3	4.2	13.9	6.8	9.3	13.7	9.7	12.9	4.3	19.2	10.8	11.6	12.3	5.1	12.3	8.6	13.5	4.0	29.7	5.4	10.9	8.1	15.7	6.0	15.2	14.7	6.0	10.7	3.8	8.6	14.4	12.1	0.4	3.4	51.9	12.5	0.3	2.0	11.0	2.2	5.5	4.1	1.9	5.1	11.0	3.7	1.7	2.5	0.9	1.7	0.4	2.0	1.1	1.6	2.2	0.7	1.1	1.9	2.3	1.6	2.5	15.1	3.6	8.1	9.3	2.5	4.1	16.2	9.6	3.1	7.0	6.9	2.8	4.5	1.6	5.0	1.4	4.5	1.7	3.3	3.0	1.1	1.0	2.6	1.3	1.2	2.3	3.9	0.8	2.5	0.7	7.0	15.2	2.6	2.3	2.3	2.1	3.0	0.4	0.9	5.0	3.1	0.9	7.1	12.5	0.9	1.5	2.6	1.8	0.1	0.8	0.7	2.1	0.4	2.0	0.9	51.9	0.3	1.8	3.4	1.0	11.0	12.1	42.0	5.2	13.0	11.3	22.9	9.3	13.7	11.6	14.7
TMEM92	FLJ33318	ENSG00000167105	"Transmembrane protein 92"	Q6UXU6	17	50271406-50281485	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 74.7"	"Group enriched"	"Detected in some"	4	"A549: 9.7;CACO-2: 16.5;CAPAN-2: 15.9;EFO-21: 33.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 5.5"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 5.5"					"Low region specificity"	"Detected in all"			"HPA063009, HPA069820"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA063009: , HPA069820: "	"unprognostic (3.54e-3)"	"unprognostic (2.39e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.63e-1)"	"prognostic unfavourable (8.35e-4)"	"unprognostic (4.37e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.39e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.97e-2)"	"prognostic unfavourable (1.14e-6)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.81e-2)"	0.2	0.1	0.3	1.9	0.3	0.4	0.3	0.3	0.3	3.3	27.9	0.3	0.1	23.3	1.2	0.3	1.0	0.7	11.7	0.1	0.8	0.3	0.4	10.2	6.1	0.1	0.3	0.2	2.4	1.2	0.0	0.1	0.3	0.9	1.2	1.8	1.1	4.3	1.2	0.1	0.2	74.7	0.4	0.4	0.3	17.9	0.5	0.3	0.1	0.1	0.4	1.6	2.2	3.7	0.1	0.2	5.5	0.1	0.0	0.0	0.0	1.0	9.7	0.2	0.0	0.0	0.4	2.1	0.2	0.3	0.0	0.0	16.5	15.9	0.0	33.0	0.7	0.1	0.2	1.8	0.1	2.6	0.1	0.0	1.0	1.6	0.1	0.1	0.1	0.1	1.9	0.1	0.5	0.0	1.5	0.0	0.0	0.0	0.0	0.2	3.6	4.3	0.2	0.0	4.1	3.6	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.5	0.0	0.1	2.3	0.0	0.0	0.0	0.2	0.1	0.2	1.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.3	0.3	0.8	0.3	0.3	0.2	0.9	0.3
TMOD4	Sk-Tmod	ENSG00000163157	"Tropomodulin 4"	Q9NZQ9	1	151169986-151176284	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 153.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 6.4;NB-4: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 1.5;memory B-cell: 1.7;memory CD4 T-cell: 1.5;naive B-cell: 1.0;naive CD4 T-cell: 1.6;naive CD8 T-cell: 3.5;plasmacytoid DC: 1.0"	"Group enriched"	"Detected in many"	5	"B-cells: 1.7;dendritic cells: 1.0;T-cells: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028203	Enhanced									"HPA028203: AB_10600830"																		2.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	4.0	1.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	1.6	0.1	153.5	0.2	0.1	0.7	0.1	0.1	0.1	0.1	0.0	0.0	0.3	35.0	1.6	0.4	0.1	1.7	1.0	0.4	0.3	0.0	3.5	0.6	0.5	0.4	0.9	0.1	0.7	0.2	1.6	0.1	0.6	0.4	0.1	0.0	0.6	1.4	0.7	1.6	0.5	1.4	0.3	0.5	2.7	6.4	2.6	2.2	0.0	1.0	1.4	3.2	0.0	0.4	1.2	3.0	0.8	1.6	2.3	0.2	2.3	0.7	8.0	1.4	2.6	2.5	0.3	0.1	0.5	1.5	1.8	1.1	0.7	0.0	0.1	0.8	4.9	1.0	0.2	1.1	2.3	0.7	2.9	5.5	1.2	0.8	4.4	0.6	0.0	0.3	0.4	1.5	0.0	0.4	1.7	1.5	0.2	0.1	1.0	1.6	3.5	0.2	0.0	0.3	1.0	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
TMPPE	FLJ45032	ENSG00000188167	"Transmembrane protein with metallophosphoesterase domain"	Q6ZT21	3	33090421-33096801	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"BEWO: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 5.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027019	Approved		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA027019: AB_1848942"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-7)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.33e-2)"	6.3	5.4	3.7	6.8	5.2	20.3	6.8	5.3	7.4	4.5	6.9	4.1	7.4	6.4	6.5	12.0	7.0	5.4	9.9	4.4	3.6	3.7	13.9	13.1	9.3	9.6	3.5	3.0	5.7	9.7	12.1	5.2	8.4	4.9	4.6	6.5	9.0	7.7	6.5	3.8	10.3	11.0	4.6	3.8	7.2	6.8	3.2	2.3	2.4	9.5	2.2	7.2	5.3	5.0	0.8	2.2	4.2	5.5	0.1	1.4	0.9	1.2	1.7	1.0	1.5	1.2	1.0	25.0	0.5	0.9	1.5	0.9	2.4	3.4	0.7	1.1	1.5	1.3	1.6	1.4	2.4	3.7	0.6	3.0	1.6	1.8	0.8	2.6	4.4	1.1	1.1	1.9	1.3	1.7	2.2	2.6	1.1	1.1	1.0	1.2	0.9	1.0	1.2	0.5	1.6	1.4	1.7	0.2	0.6	0.8	2.4	0.6	1.3	3.7	2.4	2.2	2.8	1.2	2.3	2.1	1.3	0.4	2.8	2.0	1.5	0.0	2.3	0.7	0.4	5.5	1.4	0.8	0.5	0.1	2.2	0.3	0.0	0.0	4.2	0.1	2.3	0.4	0.5	0.9	3.7	5.2	5.3	7.4	3.6	3.7	3.5	3.0	4.9	2.3
TMPRSS11F	FLJ16046	ENSG00000198092	"Transmembrane serine protease 11F"	Q6ZWK6	4	68053198-68129880	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 18.3;lymphoid tissue: 11.4;skin 1: 10.9;tongue: 13.1"	"Group enriched"	"Detected in some"	8	"HEL: 2.4;K-562: 5.4;Karpas-707: 1.6;U-266/70: 1.6"	"Group enriched"	"Detected in some"	7	"cervical cancer: 1.6;head and neck cancer: 2.1;lung cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026911	Uncertain									"HPA026911: AB_2205589"		"unprognostic (9.46e-2)"			"unprognostic (5.30e-1)"	"unprognostic (7.16e-2)"		"unprognostic (8.79e-3)"	"unprognostic (1.09e-1)"			"unprognostic (2.40e-1)"			"unprognostic (1.22e-1)"	"unprognostic (5.08e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.2	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.1	0.0	0.0	1.4	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	13.1	11.4	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMPRSS7		ENSG00000176040	"Transmembrane serine protease 7"	Q7RTY8	3	112034843-112081269	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.2;testis: 5.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.4;hTCEpi: 2.7;RT4: 1.3;U-266/70: 1.8"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA040630	Uncertain									"HPA040630: AB_10796124"	"unprognostic (4.02e-2)"	"unprognostic (9.87e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.64e-3)"		"unprognostic (6.63e-2)"		"unprognostic (2.16e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.23e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.06e-2)"	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.2	0.0	0.1			0.4	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0		0.0	0.7	0.0	0.8	0.0		0.0	0.2		0.1	0.1	0.0	0.5	0.8	0.0	0.0	0.0	1.0	5.2			0.3		0.0	0.2	0.0	0.8	0.5	2.2	0.3	0.5	0.7	0.1	0.3	0.0	0.7	0.2	0.4	0.1	0.9	0.6	0.7	0.2	0.5	0.6	0.2	0.0	0.0	0.0	1.4	0.0	0.9	0.6	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.8	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.1	0.4	0.0	0.8	0.0	0.5	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	2.2	0.3	0.7	0.2	0.2	0.1	0.6	0.3	0.2	0.0	0.8	0.7	0.2	1.7	0.5	0.2	0.5	0.2	0.1										
TMTC2	DKFZp762A217	ENSG00000179104	"Transmembrane and tetratricopeptide repeat containing 2"	Q8N394	12	82686880-83134870	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 16.2;WM-115: 39.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.1;myeloid DC: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026954, HPA026955"	Uncertain		Approved	"Plasma membrane,Actin filaments"				"Plasma membrane"	"Actin filaments"	"HPA026954: AB_2256025, HPA026955: AB_10602282"	"unprognostic (1.56e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.61e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.73e-3)"	"unprognostic (5.06e-2)"	"prognostic favourable (2.84e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.06e-2)"	"unprognostic (8.06e-2)"	4.7	1.7	9.1	8.9	19.7	2.9	5.9	8.1	15.7	8.1	12.5	27.3	15.2	4.6	8.5	7.4	11.4	15.4	11.9	3.1	13.4	8.7	10.6	1.7	9.6	2.8	17.6	15.3	3.1	6.6	6.5	4.7	5.1	14.3	9.9	9.1	2.5	8.3	30.3	2.0	7.4	6.2	10.4	22.5	2.2	13.1	4.6	18.0	0.4	7.9	1.1	4.3	10.5	11.5	0.8	2.6	0.0	3.1	0.0	0.3	0.9	0.8	3.2	16.2	0.1	2.1	2.1	1.4	1.0	0.3	0.8	0.1	0.2	1.7	0.0	0.2	5.8	1.4	4.6	2.4	0.2	3.6	2.7	0.0	2.4	0.1	0.2	1.0	0.5	0.5	2.1	0.1	0.8	1.3	0.0	2.2	0.2	1.6	0.8	4.2	0.6	2.7	0.0	0.6	0.3	1.5	7.1	4.3	7.8	1.5	2.3	10.5	2.4	0.2	0.8	2.8	0.9	3.6	1.3	4.0	2.8	0.6	0.6	1.8	39.5	0.0	3.1	0.0	0.1	1.0	0.3	0.8	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.9	9.1	19.7	8.1	11.6	13.4	8.7	17.6	15.3	14.3	18.0
TMTC4	"FLJ14624, FLJ22153"	ENSG00000125247	"Transmembrane and tetratricopeptide repeat containing 4"	Q5T4D3	13	100603927-100675093	"Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016489	Uncertain		Approved	Vesicles				Vesicles		"HPA016489: AB_1858157"	"unprognostic (1.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.04e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.65e-2)"	4.1	4.4	11.4	4.4	13.7	1.9	5.7	10.6	21.8	6.6	7.0	45.7	8.3	8.5	8.7	7.5	4.8	13.2	4.9	3.2	16.9	8.7	11.5	9.8	3.5	3.6	16.9	10.0	5.3	12.8	7.5	3.3	4.0	29.6	7.9	7.6	4.6	6.9	5.6	9.4	6.5	7.3	6.0	25.2	3.9	7.9	9.7	11.3	4.2	7.2	3.9	4.6	7.7	4.3	2.4	6.4	0.2	3.3	1.3	4.4	1.4	4.9	4.2	22.1	11.7	2.9	5.9	24.7	2.8	2.5	2.7	2.2	4.2	9.3	14.9	9.5	2.4	3.5	6.8	3.0	3.2	8.4	4.9	6.3	7.9	6.7	3.1	8.1	0.1	8.3	5.8	1.0	4.9	12.1	4.7	1.9	3.1	4.4	5.9	4.7	5.9	4.2	6.4	3.9	3.3	11.1	3.9	11.4	11.8	5.5	10.7	2.8	7.9	23.0	18.8	2.4	4.2	2.2	4.9	5.0	4.0	2.8	11.8	5.3	7.0	0.0	2.0	0.2	2.7	2.1	2.4	2.0	2.6	4.4	6.4	2.4	3.0	1.1	0.0	1.3	3.3	4.2	3.8	1.4	11.4	13.7	10.6	21.8	16.9	8.7	16.9	10.0	29.6	11.3
TNFAIP2	"B94, EXOC3L3"	ENSG00000185215	"TNF alpha induced protein 2"	Q03169	14	103123442-103137439	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"RT4: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 25.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004598, HPA030624"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	"Nucleoplasm, Nuclear membrane"	"CAB004598: AB_628370, HPA030624: "	"unprognostic (5.01e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (4.10e-4)"	"prognostic favourable (2.79e-5)"	"unprognostic (1.75e-2)"	"unprognostic (3.83e-2)"	"prognostic favourable (7.17e-5)"	27.3	17.0	3.8	58.2	5.7	20.1	19.3	2.5	3.6	23.5	12.9	2.8	4.7	8.1	16.7	18.7	35.5	14.3	30.9	12.7	2.9	3.6	18.8	13.6	32.0	17.9	4.6	3.0	9.7	9.0	17.4	3.5	33.0	6.1	21.7	6.1	16.3	25.1	7.1	12.5	13.2	11.3	28.0	3.8	35.9	8.3	13.0	2.9	11.0	8.5	31.4	48.6	39.8	16.3	0.1	5.0	25.9	9.8	0.1	0.1	1.9	5.4	26.9	0.1	0.1	1.7	7.7	9.0	1.6	6.9	4.3	1.5	0.2	24.4	0.0	20.1	7.8	17.4	1.9	0.0	2.1	0.9	0.1	2.4	18.8	0.1	3.3	1.2	3.4	2.9	0.2	1.4	0.0	2.2	2.4	5.9	0.6	0.5	0.0	1.9	1.6	2.2	1.0	3.1	3.9	13.8	126.5	0.2	0.3	24.7	8.6	0.3	13.9	8.0	4.6	0.9	2.3	5.0	5.0	5.3	0.3	0.1	6.5	5.5	2.6	2.5	8.8	4.6	0.0	9.8	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.1	25.9	0.1	6.9	0.2	0.0	1.9	3.8	5.7	2.5	3.6	2.9	3.6	4.6	3.0	6.1	2.9
TOGARAM2	"Crescerin-2, FAM179A, FLJ43249, LOC165186"	ENSG00000189350	"TOG array regulator of axonemal microtubules 2"	Q6ZUX3	2	28956611-29061373	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.3;epididymis: 14.4;fallopian tube: 15.7;lung: 14.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.8;NB-4: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA037561, HPA037562"	Uncertain									"HPA037561: AB_10670384, HPA037562: "	"unprognostic (8.35e-5)"	"unprognostic (2.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.53e-3)"	"unprognostic (3.93e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.92e-2)"	"unprognostic (3.94e-11)"	"unprognostic (3.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.81e-3)"	0.3	2.3	3.0	1.7	8.4	2.6	0.4	3.4	1.7	0.6	0.6	7.1	0.0	0.8	1.1	14.4	0.7	15.7	0.5	2.6	3.3	3.9	0.3	0.5	14.2	1.1	2.1	2.0	4.5	0.8	0.1	6.1	0.6	15.3	0.5	0.4	0.1	0.5	0.1	1.7	0.6	0.7	0.8	2.5	2.2	1.5	3.2	6.1	0.0	0.3	0.3	1.3	0.4	0.3	0.3	0.3	0.6	0.3	0.6	3.7	1.0	0.2	0.2	0.3	0.2	0.3	0.0	0.7	0.1	2.3	0.7	2.2	0.4	0.3	0.3	0.3	0.0	0.9	0.4	0.0	0.7	0.4	1.4	0.2	2.0	0.5	0.9	2.0	3.8	0.2	0.3	0.0	0.0	0.3	0.3	1.0	0.8	0.2	0.8	3.6	2.7	0.7	0.1	0.7	1.5	1.1	0.3	2.6	1.8	0.1	0.1	0.1	0.4	0.2	0.2	0.2	0.5	0.2	0.3	0.5	0.5	0.2	1.7	1.3	0.1	0.5	0.3	0.3	3.7	0.1	2.0	0.2	0.6	2.9	0.1	0.3	0.4	1.0	0.6	0.6	0.2	0.3	1.5	1.0	3.0	8.4	3.4	1.2	3.3	3.9	2.1	2.0	15.3	6.1
TOMM20L	UNQ9438	ENSG00000196860	"Translocase of outer mitochondrial membrane 20 like"	Q6UXN7	14	58395916-58408701	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 28.3"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 3.3"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.9"	"Group enriched"	"Detected in many"	10	"B-cells: 1.0;T-cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA076397	Enhanced									"HPA076397: "	"unprognostic (1.72e-1)"	"unprognostic (2.34e-4)"	"unprognostic (8.13e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.06e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.57e-6)"	"unprognostic (8.75e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.66e-3)"	0.5	0.4	0.2	0.2	0.6	0.1	0.5	0.6	0.8	0.5	0.5	0.8	0.0	0.0	0.9	1.8	0.2	0.4	0.5	0.3	0.2	0.2	0.7	0.3	0.4	2.2	0.3	0.0	0.7	1.2	1.1	0.5	0.3	0.6	0.8	0.5	1.7	0.5	0.5	0.2	0.3	0.4	1.4	0.3	0.3	0.6	28.3	0.0	0.0	0.9	0.0	0.6	0.3	0.2	1.0	0.1	0.0	0.1	0.0	1.9	0.4	1.8	0.0	0.5	1.9	0.0	0.0	2.0	0.3	0.0	0.3	0.0	0.0	0.5	1.6	0.2	1.0	0.3	0.0	0.0	0.0	2.8	0.6	0.5	0.0	0.5	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.9	1.2	0.5	0.8	2.0	2.1	0.7	0.3	0.3	0.5	3.3	2.3	0.5	0.4	0.5	1.4	2.8	0.0	0.2	0.4	0.0	0.5	0.0	0.3	0.2	1.5	1.4	0.5	0.0	0.0	0.0	0.4	0.1	0.0	1.0	0.1	0.5	0.0	0.2	0.1	1.9	0.0	0.0	0.1	0.1	0.0	0.4	0.2	0.6	0.6	0.8	0.2	0.2	0.3	0.0	0.6	0.0
TOPAZ1	"C3orf77, FLJ36157"	ENSG00000173769	"Testis and ovary specific PAZ domain containing 1"	Q8N9V7	3	44241886-44332098	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	49	"testis: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047431, HPA051034"	Uncertain									"HPA047431: , HPA051034: "														"unprognostic (1.68e-1)"	"unprognostic (8.88e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2			0.0		0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0										
TOR2A	"FLJ14771, TORP1"	ENSG00000160404	"Torsin family 2 member A"	"Q5JU69, Q8N2E6"	9	127731524-127735317	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071229	Approved				"Secreted to blood"					"HPA071229: "	"unprognostic (1.67e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.98e-2)"	"prognostic favourable (7.51e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.82e-2)"	7.3	10.1	6.2	11.8	6.2	33.3	10.9	11.3	9.1	7.2	13.5	6.1	8.2	16.4	6.3	10.1	9.9	7.9	11.8	5.8	5.8	5.6	10.2	16.2	12.8	22.8	4.9	7.3	7.9	18.3	3.2	8.3	15.0	5.1	7.1	8.4	6.1	9.7	10.2	2.8	8.3	20.9	4.5	4.0	18.9	12.6	16.9	5.6	18.6	8.0	6.8	10.9	7.2	6.3	6.2	26.3	34.5	28.8	10.0	13.1	13.4	4.0	6.1	5.3	6.6	2.6	2.6	7.1	3.1	3.4	4.4	3.5	4.2	6.8	7.4	4.2	2.3	12.7	1.6	3.4	1.2	11.8	6.1	2.8	5.4	5.0	4.3	5.8	15.2	4.1	6.5	4.1	2.2	6.2	8.5	20.3	2.5	22.6	7.4	18.3	4.8	5.7	12.8	2.5	16.0	4.5	3.7	11.5	4.7	2.6	9.0	2.6	20.1	11.3	3.8	2.8	3.4	5.0	3.2	13.1	11.3	3.0	3.5	9.5	2.7	8.8	25.3	34.5	13.1	28.8	10.2	4.8	7.6	12.6	26.3	6.2	5.8	10.2	17.1	10.0	26.6	6.1	11.6	13.4	6.2	6.2	11.3	9.1	5.8	5.6	4.9	7.3	5.1	5.6
TP53AIP1	p53AIP1	ENSG00000120471	"Tumor protein p53 regulated apoptosis inducing protein 1"	Q9HCN2	11	128934731-128943399	"Predicted intracellular proteins"	Apoptosis			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 19.6;lymphoid tissue: 15.2;skin 1: 22.5;tongue: 31.5"	"Cell line enhanced"	"Detected in some"		"RT4: 3.4;SK-BR-3: 2.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.9"									"HPA044300, HPA048797"	Uncertain									"HPA044300: , HPA048797: "	"unprognostic (4.12e-7)"	"unprognostic (3.00e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.57e-6)"	"unprognostic (1.10e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.78e-2)"	0.1	0.3	0.3	0.1	0.3	0.2	1.6	0.3	0.3	4.6	0.1	0.2	4.2	0.0	0.4	8.9	19.6	3.2	0.1	0.1	0.3	0.6	0.5	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.9	0.1	0.1	1.2	0.1	0.1	3.0	1.2	0.9	22.5	0.2	0.1	0.1	0.1	0.2	0.6	0.1	15.2	0.1	31.5	6.7	0.2	11.0	0.4	0.1	1.9	0.2	0.2	0.3	0.1	0.4	0.0	0.2	0.5	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.5	0.0	0.3	0.2	0.0	0.4	0.4	0.5	0.0	0.1	1.6	0.0	0.1	1.0	0.0	0.8	0.6	0.0	0.4	0.0	0.0	3.4	1.1	0.1	0.0	2.3	0.0	0.7	0.0	0.0	0.7	0.7	0.5	0.4	0.0	0.0	0.4	0.0	0.2	0.1	1.3	0.1	0.1	0.2	0.2	0.1	0.2	0.3	0.0	0.0	0.4	0.2	0.1	1.9	0.2	0.1	0.1	0.3	0.1	0.3	0.3	0.3	0.3	0.3	0.6	0.1	0.1	0.1	0.1
TPGS2	"C18orf10, DKFZP586M1523, HsT3006"	ENSG00000134779	"Tubulin polyglutamylase complex subunit 2"	Q68CL5	18	36777647-36829216	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040596, HPA040617"	Uncertain									"HPA040596: AB_10796458, HPA040617: AB_10794037"	"unprognostic (6.51e-3)"	"prognostic favourable (4.09e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavourable (1.24e-5)"	"unprognostic (3.78e-2)"	"unprognostic (2.36e-1)"	"prognostic favourable (1.93e-5)"	"unprognostic (2.50e-2)"	"unprognostic (1.33e-3)"	"unprognostic (7.19e-3)"	"unprognostic (2.51e-2)"	"prognostic favourable (7.74e-4)"	"unprognostic (4.03e-2)"	"unprognostic (5.28e-2)"	16.3	21.1	27.6	10.4	31.1	22.3	20.9	15.2	38.3	18.3	14.9	26.0	7.2	10.2	14.8	13.1	22.2	21.8	16.7	21.9	23.9	36.0	18.5	10.1	18.4	13.7	43.8	19.9	27.4	15.3	15.9	8.4	13.3	42.1	13.9	16.1	21.8	12.4	14.3	5.5	17.5	12.8	18.6	35.7	9.5	12.2	72.2	14.0	37.0	19.7	10.3	23.7	22.3	15.2	13.1	13.3	57.4	16.6	14.3	27.0	15.2	29.4	23.3	45.3	39.4	22.7	24.9	19.0	32.5	44.5	46.0	55.9	11.2	21.3	29.0	22.7	65.0	29.4	37.2	45.7	54.5	37.8	12.6	20.3	42.5	30.2	23.3	26.1	18.2	33.0	23.9	40.9	21.2	54.6	29.2	21.6	60.3	17.5	41.3	15.3	27.3	15.2	31.0	41.8	35.3	50.7	28.9	31.9	34.9	48.9	12.8	14.3	24.5	25.2	30.5	46.5	17.3	6.6	25.9	27.5	25.9	34.3	37.3	21.3	25.8	57.4	13.4	25.6	14.2	14.7	14.0	13.1	16.6	14.6	13.3	9.5	12.6	14.3	4.1	14.3	16.6	10.6	27.0	15.2	27.6	31.1	15.2	38.3	23.9	36.0	43.8	19.9	42.1	14.0
TPRG1	"FAM79B, FLJ41238, FLJ43694"	ENSG00000188001	"Tumor protein p63 regulated 1"	Q6ZUI0	3	188947214-189325304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.3;lymphoid tissue: 32.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.5;HDLM-2: 12.2;Karpas-707: 6.2;T-47d: 5.5;U-266/70: 5.9;U-266/84: 4.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 7.0"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044751, HPA060187"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA044751: , HPA060187: "	"prognostic favourable (5.43e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.10e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.52e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	16.1	1.0	0.3	0.9	0.8	0.0	14.4	1.7	0.8	19.7	1.2	0.1	1.0	0.0	5.0	1.6	43.3	5.2	1.6	2.4	0.2	0.2	0.6	5.1	2.7	0.3	0.3	0.5	1.9	0.3	0.0	0.8	1.0	0.5	2.5	0.0	0.8	3.7	0.7	5.0	14.5	0.5	1.9	0.3	0.7	0.4	2.6	0.3	7.9	0.8	25.5	32.9	2.3	17.8	0.2	0.7	1.3	2.3	0.0	6.3	1.3	1.2	0.2	0.5	0.1	2.8	2.3	0.0	0.0	0.0	0.1	0.1	1.4	2.9	1.8	4.5	0.2	0.3	0.0	0.1	0.0	12.2	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.7	0.6	0.0	0.0	0.0	0.0	6.2	0.2	0.5	0.0	0.0	0.9	0.4	0.0	0.0	2.2	0.1	2.4	0.0	0.0	0.3	0.7	0.0	5.5	0.8	0.1	0.2	0.4	0.0	0.4	5.9	4.6	0.5	0.1	0.1	0.1	0.0	2.3	0.0	6.0	1.8	0.9	0.2	4.9	6.3	0.7	0.0	1.0	2.5	1.3	0.0	1.6	0.1	5.4	1.3	0.3	0.8	1.7	0.8	0.2	0.2	0.3	0.5	0.5	0.3
TPSD1		ENSG00000095917	"Tryptase delta 1"	Q9BZJ3	16	1256059-1258998	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	48	"HEL: 18.3;HMC-1: 27.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	65	"basophil: 6.4"	"Lineage enriched"	"Detected in single"	65	"granulocytes: 6.4"									"CAB002215, CAB032871, HPA040182, HPA049554"	Supported		Uncertain	"Nuclear speckles"	"Intracellular and membrane"			"Nuclear speckles"		"CAB002215: AB_563870, CAB032871: AB_2206475, HPA040182: , HPA049554: "	"unprognostic (5.99e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.15e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.30e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.50e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.89e-1)"	"unprognostic (7.46e-3)"	6.6	0.1	0.6	3.8	0.6	0.8	3.7	0.6	0.8	3.2	5.6	0.6	0.6	2.7	7.5	3.3	7.6	2.3	13.0	2.0	0.6	0.0	1.3	2.3	17.0	13.7	0.6	0.6	0.6	0.9	0.1	0.6	0.9	0.6	4.3	0.4	3.1	3.6	0.7	1.6	7.8	9.3	4.7	0.6	0.6	15.7	3.5	0.6	1.6	1.1	2.8	2.6	8.9	6.6	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.1	27.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.8	0.6	0.0	0.6	0.6	0.6	0.6
TPSG1	"PRSS31, TMT"	ENSG00000116176	"Tryptase gamma 1"	Q9NRR2	16	1221651-1225257	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 16.0"	"Group enriched"	"Detected in some"	9	"HMC-1: 22.3;MCF7: 7.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA060458	Enhanced									"HPA060458: "	"unprognostic (1.86e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavourable (1.76e-8)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (8.65e-4)"	"unprognostic (5.70e-2)"	1.3	0.6	0.4	4.5	0.4	0.0	3.1	0.4	0.4	0.6	14.4	0.4	0.4	14.0	1.2	0.4	0.7	0.5	1.0	0.4	0.4	0.0	0.4	0.4	0.6	0.4	0.4	0.4	2.0	0.4	0.0	3.2	0.4	0.4	1.1	8.8	0.4	0.4	0.4	0.4	1.1	16.0	1.2	0.4	0.4	1.0	1.3	0.4	0.4	0.4	1.1	0.4	1.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
TPTE	"CT44, PTEN2"	ENSG00000274391	"Transmembrane phosphatase with tensin homology"	P56180	21	10521553-10606140	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	69	"testis: 78.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.5;K-562: 8.7;Karpas-707: 7.1;MCF7: 5.2;PC-3: 5.3;RPMI-8226: 9.6;U-2 OS: 4.7;U-266/70: 8.6"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049690, HPA068342"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"				Cytosol	"Endoplasmic reticulum"	"HPA049690: , HPA068342: "															"unprognostic (3.63e-2)"			0.1	0.0	0.0	0.7	0.2	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0		0.1	0.8	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.2	0.7	0.3	0.0	0.0	0.2	0.4	0.0	0.9	0.0	78.6	0.0	0.4	0.1	0.4	0.8	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	7.1	0.0	5.2	0.0	0.0	1.2	5.3	0.0	0.0	9.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	4.7	2.4	0.0	8.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0										
TRABD2A	"C2orf89, TIKI1"	ENSG00000186854	"TraB domain containing 2A"	Q86V40	2	84821650-84907008	"Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 29.3;intestine: 26.6;lymphoid tissue: 24.7;ovary: 23.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 24.3;HDLM-2: 18.3;HSkMC: 13.0;hTEC/SVTERT24-B: 10.7;SiHa: 10.4"	"Group enriched"	"Detected in many"	9	"colorectal cancer: 14.4;stomach cancer: 3.0"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 29.3"	"Lineage enriched"	"Detected in many"	17	"T-cells: 29.3"									HPA045817	Approved				"Intracellular and membrane"					"HPA045817: "	"unprognostic (7.49e-3)"	"unprognostic (3.35e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.82e-5)"	"unprognostic (2.46e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.47e-4)"	"unprognostic (4.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.37e-1)"	1.8	0.5	0.7	24.7	1.6	2.1	6.3	0.6	3.7	0.5	23.2	0.9	0.0	2.4	0.5	0.4	0.5	1.3	0.2	0.7	0.9	0.8	0.9	0.9	3.0	11.3	0.9	3.1	23.7	0.4	0.4	0.6	2.0	0.2	0.5	26.6	1.2	3.3	0.0	0.3	1.2	9.3	1.8	0.9	3.1	0.6	0.6	0.0	6.4	0.7	0.0	6.3	0.7	0.7	1.7	0.6	0.5	0.1	1.3	29.3	5.3	0.7	0.6	0.2	0.1	7.2	7.8	24.3	1.2	1.9	3.5	6.4	0.3	2.7	0.0	0.3	3.8	0.0	1.7	0.3	5.2	18.3	0.4	0.0	5.1	0.0	0.8	0.0	0.0	13.0	0.0	10.7	4.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.1	0.0	0.1	0.2	3.4	0.4	0.0	1.2	2.2	0.0	0.0	3.0	2.0	0.0	0.0	0.1	0.0	3.3	0.1	4.0	0.3	13.1	5.0	0.6	1.7	29.3	18.2	0.5	1.3	0.0	0.6	8.5	5.3	0.7	1.6	0.6	3.7	0.9	0.8	0.9	3.1	0.2	0.0
TRAM1L1	MGC26568	ENSG00000174599	"Translocation associated membrane protein 1 like 1"	Q8N609	4	117083554-117085576	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 9.5;U-138 MG: 11.6;U-266/70: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044560	Uncertain		Approved	Mitochondria				Mitochondria		"HPA044560: AB_10796097"	"unprognostic (9.06e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.17e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.23e-2)"	2.1	4.3	7.8	1.1	10.0	0.3	7.3	5.6	14.9	4.6	1.8	9.4	0.0	0.9	3.4	10.5	1.6	6.8	3.1	2.2	8.8	8.6	11.9	0.5	2.9	1.0	8.5	5.9	4.1	5.0	0.6	8.5	1.2	10.3	7.5	2.2	4.5	2.5	4.7	0.7	4.1	1.1	3.6	10.3	1.2	3.2	5.9	7.4	0.0	8.4	0.3	0.9	3.2	1.2	0.1	0.2	0.0	0.0	0.1	0.2	0.0	1.4	1.0	4.4	2.2	0.0	0.0	0.0	0.6	0.5	0.9	2.7	0.1	5.2	0.0	0.5	1.2	0.1	2.1	2.3	3.6	0.0	0.1	1.2	1.2	0.6	1.3	1.3	0.0	4.9	2.0	1.1	0.0	0.0	0.0	2.7	7.2	0.3	2.3	0.0	0.3	1.1	0.0	5.7	0.0	0.7	0.3	2.6	9.5	0.0	3.7	4.4	6.4	1.4	3.1	11.6	5.2	0.1	1.8	9.5	2.1	0.0	4.5	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	7.8	10.0	5.6	13.9	8.8	8.6	8.5	5.9	10.3	7.4
TRANK1	"KIAA0342, LBA1"	ENSG00000168016	"Tetratricopeptide repeat and ankyrin repeat containing 1"	O15050	3	36826820-36945098	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 42.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 38.1;HMC-1: 15.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 42.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 42.3"	"Low region specificity"	"Detected in all"							HPA035508	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA035508: AB_10671105"	"unprognostic (7.11e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.04e-3)"	"unprognostic (9.13e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.59e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (2.52e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.07e-3)"	4.1	3.6	4.5	10.4	11.2	6.9	4.7	21.5	12.0	8.5	14.2	1.7	3.1	8.6	12.3	4.5	3.1	19.3	7.3	4.1	3.3	3.9	3.2	7.9	6.2	13.9	2.9	6.6	9.0	2.8	5.0	3.8	3.7	6.0	7.9	10.9	4.4	4.9	5.0	2.6	2.9	23.1	10.5	3.2	9.9	6.0	2.9	1.7	15.1	5.8	1.1	16.2	9.8	6.0	5.2	0.5	42.3	1.3	2.8	5.7	0.9	0.7	0.9	0.2	0.0	2.4	9.5	0.0	0.7	5.0	2.3	4.4	0.0	3.9	38.1	1.5	2.8	0.2	0.1	0.5	0.4	1.9	0.0	6.2	2.5	0.0	3.1	1.7	15.3	3.1	1.9	1.7	0.1	2.8	4.9	5.5	1.6	0.0	4.8	0.7	0.2	1.0	1.3	0.1	0.7	0.7	1.7	0.3	0.0	3.8	1.0	0.3	0.6	2.1	1.9	1.8	0.7	0.1	0.6	5.4	1.1	8.4	0.3	1.3	0.2	2.5	0.6	3.9	5.6	0.9	4.2	4.0	4.8	5.7	0.5	5.2	4.4	4.2	42.3	2.8	1.3	0.0	4.0	0.9	4.5	11.2	21.5	12.0	3.3	3.9	2.9	6.6	6.0	1.7
TREML4	TLT4	ENSG00000188056	"Triggering receptor expressed on myeloid cells like 4"	Q6UXN2	6	41228324-41238882	"Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"blood: 10.3;bone marrow: 3.1;lung: 3.1;lymphoid tissue: 9.5"	"Cell line enriched"	"Detected in single"	7	"HEL: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"eosinophil: 5.4;neutrophil: 10.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 10.3"									HPA065044	Uncertain				"Secreted - unknown location"					"HPA065044: "	"unprognostic (1.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.58e-2)"		"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.03e-1)"		"unprognostic (5.50e-2)"	"unprognostic (9.50e-3)"		"unprognostic (1.18e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.21e-2)"	0.3	0.1	0.1	1.2	0.3	3.1	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.6	0.3	0.2	0.1	0.2	0.1	0.2	3.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.4	9.5	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	1.3	0.9	10.3	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	5.4	0.0	0.5	0.0	0.1	0.0	0.0	0.5	1.3	0.0	0.0	10.3	0.0	0.4	0.9	0.0	0.3	0.1	0.3	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0
TRIM16L	TRIM70	ENSG00000108448	"Tripartite motif containing 16 like"	Q309B1	17	18697998-18736118	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 22.5"	"Cell line enhanced"	"Detected in many"		"A549: 48.6;CAPAN-2: 20.9;HaCaT: 24.8;HeLa: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA066431	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA066431: "	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.89e-3)"	"unprognostic (5.66e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavourable (2.87e-4)"	"unprognostic (7.08e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (2.29e-5)"	"unprognostic (1.13e-2)"	2.8	4.4	2.0	1.0	3.1	0.5	7.1	1.0	3.0	2.2	3.6	1.3	1.0	2.0	1.4	3.2	10.5	3.3	8.1	16.8	2.0	2.5	3.5	2.8	2.4	1.0	4.7	1.0	1.3	1.3	0.1	1.0	1.8	3.1	3.6	1.0	2.1	2.6	3.7	22.5	0.8	1.1	6.5	4.7	1.0	3.0	2.9	1.4	1.0	4.5	12.7	3.4	6.7	11.8	1.5	0.8	0.4	1.4	2.7	2.1	1.8	5.2	48.6	0.3	2.0	5.9	2.4	3.8	0.4	4.0	1.8	3.7	0.8	20.9	0.5	3.8	13.9	24.8	0.5	1.1	0.9	0.2	0.7	0.3	38.8	0.5	14.6	0.0	0.5	2.5	1.4	2.7	1.0	0.5	0.0	0.0	4.7	5.1	0.1	0.5	0.5	1.0	0.5	2.5	0.0	3.5	3.0	0.1	1.1	5.5	1.1	2.9	2.5	0.4	10.9	1.2	6.3	1.9	7.0	0.6	0.6	0.0	4.1	0.4	9.2	0.1	0.7	0.4	0.7	1.4	1.0	1.5	1.0	0.6	0.8	1.1	1.6	1.5	0.3	2.7	0.5	0.2	2.1	1.8	2.0	3.1	1.0	1.9	2.0	2.5	4.7	1.0	3.1	1.4
TRIM46	"FLJ23229, TRIFIC"	ENSG00000163462	"Tripartite motif containing 46"	Q7Z4K8	1	155173787-155184971	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.4;epididymis: 11.0"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055583	Enhanced									"HPA055583: "	"unprognostic (1.06e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.86e-2)"	"prognostic unfavourable (2.61e-7)"	"unprognostic (1.75e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.65e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.29e-12)"	"unprognostic (8.58e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-2)"	1.3	1.7	6.0	2.4	12.6	1.7	1.7	21.4	15.5	1.7	1.2	6.5	0.0	1.6	3.4	11.0	1.1	2.9	2.0	1.0	7.8	7.4	1.1	0.9	1.7	2.3	5.1	7.3	1.0	2.1	0.8	4.5	1.1	7.4	1.7	1.4	0.5	0.9	3.6	1.0	1.2	1.8	3.9	5.8	1.8	1.6	2.5	3.5	6.7	0.9	0.0	1.7	1.3	0.8	0.4	0.5	1.5	0.4	0.8	3.0	0.6	2.0	2.8	2.1	0.2	0.4	1.8	0.1	2.1	2.2	2.5	3.1	0.0	1.2	0.9	1.5	2.5	2.4	0.0	1.0	0.7	5.0	0.9	1.7	3.0	0.1	1.1	0.5	6.2	1.9	0.5	2.6	0.9	3.8	0.0	4.4	1.3	1.4	3.3	0.3	7.6	3.1	5.1	0.2	1.0	0.6	0.0	5.7	13.1	0.9	0.7	1.5	4.1	4.1	4.5	4.9	1.9	0.3	1.0	4.1	1.6	0.8	5.2	0.8	1.4	1.5	0.1	0.1	1.2	0.4	1.1	0.3	2.1	2.0	0.2	0.4	0.8	1.0	0.8	0.8	0.3	0.5	3.0	0.6	6.0	12.6	21.4	14.2	7.8	7.4	5.1	7.3	7.4	3.5
TRIM51	"SPRYD5, TRIM51A"	ENSG00000124900	"Tripartite motif-containing 51"	Q9BSJ1	11	55883297-55891810	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"blood: 11.0"	"Group enriched"	"Detected in some"	124	"SK-MEL-30: 35.2;WM-115: 9.0"	"Cancer enriched"	"Detected in single"	50	"melanoma: 4.3"					"Cell type enriched"	"Detected in single"	111	"basophil: 11.0"	"Lineage enriched"	"Detected in single"	111	"granulocytes: 11.0"									"HPA044988, HPA077883"	Uncertain		Approved	Nucleoli,Vesicles				Vesicles	Nucleoli	"HPA044988: , HPA077883: "									"unprognostic (9.60e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.8	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3			0.0		0.0	0.1	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TRIM58	BIA2	ENSG00000162722	"Tripartite motif containing 58"	Q8NG06	1	247857199-247878205	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.8;placenta: 22.4;thyroid gland: 15.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 7.9;HEL: 21.0;K-562: 11.6;PC-3: 20.2;U-2 OS: 16.5;WM-115: 21.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023637	Uncertain						310000			"HPA023637: AB_1858309"	"unprognostic (3.85e-1)"	"unprognostic (5.24e-3)"	"unprognostic (7.00e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.14e-5)"	"unprognostic (3.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.57e-2)"	0.7	0.8	1.3	1.0	4.4	24.8	0.7	0.3	3.7	0.6	1.3	0.2	0.0	0.3	0.5	0.4	0.5	1.4	0.5	0.8	1.5	3.2	0.5	0.6	3.4	0.4	2.4	1.2	1.1	0.4	0.3	0.7	22.4	6.9	1.7	1.0	1.1	0.5	0.4	0.5	1.2	0.6	0.8	1.3	5.8	0.7	4.9	0.1	0.0	15.2	0.0	0.4	1.9	0.7	3.1	0.6	3.7	0.7	1.7	0.3	1.9	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.0	7.9	0.0	0.0	0.0	0.8	21.0	0.0	0.0	0.0	2.8	1.6	0.0	0.0	0.0	0.0	0.0	11.6	0.1	0.0	0.0	0.0	0.1	1.3	20.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.1	0.0	0.0	16.5	0.0	0.0	3.5	0.0	0.0	0.0	5.9	21.3	2.8	0.7	1.8	0.3	0.5	0.2	3.1	0.2	0.2	0.6	1.0	0.3	0.2	3.7	1.7	0.6	0.6	0.2	1.9	1.3	4.4	0.3	3.7	1.5	3.2	2.4	1.2	6.9	0.1
TRIM60	"FLJ35882, RNF129, RNF33"	ENSG00000176979	"Tripartite motif containing 60"	Q495X7	4	165031953-165041744	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"placenta: 5.0;testis: 6.6"	"Cell line enriched"	"Detected in some"	14	"BEWO: 17.6"	"Cancer enriched"	"Detected in single"	103	"testis cancer: 5.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA035809, HPA035810, HPA061496"	Uncertain									"HPA035809: , HPA035810: AB_10601827, HPA061496: "															"unprognostic (1.10e-1)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.7	1.1	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.4	0.1	0.2	1.1	0.2	0.3	0.0	0.5	0.3	0.2	1.1	0.1	0.1	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM61	RNF35	ENSG00000183439	"Tripartite motif containing 61"	Q5EBN2	4	164954446-164977668	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 16.1;thyroid gland: 15.5"	"Cell line enhanced"	"Detected in some"		"HHSteC: 9.9;HSkMC: 6.6;U-266/70: 13.1;U-266/84: 6.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA049109	Uncertain		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"				"Nucleoli fibrillar center, Endoplasmic reticulum"		"HPA049109: "	"unprognostic (2.05e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.92e-1)"	"unprognostic (9.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.32e-2)"	2.4	5.4	1.8	3.0	2.5	3.3	1.6	1.3	2.1	2.6	1.4	1.1	7.2	2.2	2.8	1.9	0.8	3.5	3.1	5.9	2.4	3.0	1.0	1.1	2.1	2.9	2.7	1.3	5.8	0.9	1.5	6.8	1.8	3.8	2.1	1.1	2.9	0.9	1.9	1.2	1.1	1.7	2.1	4.2	4.7	1.5	16.1	1.6	2.7	15.5	0.7	2.8	3.0	5.2	5.5	5.1	3.6	1.3	7.8	4.1	1.5	0.2	0.4	1.0	0.8	0.6	0.6	0.6	2.4	0.8	0.0	0.0	0.3	0.3	0.7	0.2	3.6	0.3	0.6	0.6	0.4	0.4	0.5	0.2	0.5	0.7	9.9	0.5	0.6	6.6	0.5	2.1	0.2	0.2	0.5	1.5	0.3	0.4	0.3	0.8	3.8	0.0	0.5	0.2	1.0	0.3	0.9	0.8	0.5	0.1	0.3	0.4	0.3	0.3	0.7	1.2	0.4	0.1	0.2	13.1	6.6	0.4	0.3	0.2	0.4	3.6	1.3	0.1	3.3	1.1	3.4	3.6	1.6	3.3	1.5	5.5	4.1	4.0	0.5	7.8	0.8	5.1	0.4	1.5	1.8	2.5	1.3	2.1	2.4	3.0	2.7	1.3	3.8	1.6
TRIM64	"C11orf28, TRIM64A"	ENSG00000204450	"Tripartite motif containing 64"	A6NGJ6	11	89968502-89975228	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	65	"blood: 8.6;placenta: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	86	"basophil: 8.6"	"Lineage enriched"	"Detected in single"	86	"granulocytes: 8.6"									HPA045370	Approved									"HPA045370: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		4.3		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TRIM66	"C11orf29, KIAA0298, TIF1D"	ENSG00000166436	"Tripartite motif containing 66"	O15016	11	8612037-8682694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027420	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA027420: AB_1858316"	"unprognostic (1.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.43e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.49e-2)"	"unprognostic (6.79e-2)"	"prognostic favourable (8.89e-4)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (3.96e-4)"	"unprognostic (1.67e-1)"	"unprognostic (4.26e-1)"	"unprognostic (4.67e-2)"	"unprognostic (4.31e-1)"	5.6	8.0	4.1	7.0	12.1	4.5	8.3	10.5	11.3	4.9	6.0	12.5	13.2	6.1	9.9	19.4	6.7	5.7	6.1	3.2	4.4	5.2	5.6	12.9	4.8	8.6	3.5	5.8	5.5	11.3	7.8	17.3	4.1	8.3	5.6	8.3	9.3	5.7	11.3	5.7	19.9	6.9	6.3	5.3	7.7	6.4	19.8	3.7	8.8	9.2	4.5	12.3	5.9	5.3	2.5	3.8	0.9	3.5	1.9	3.3	0.7	6.1	5.7	3.4	12.3	7.5	5.7	4.3	3.8	4.3	2.7	3.5	7.2	11.8	6.1	2.6	3.3	8.2	3.7	3.3	3.3	7.0	2.9	5.7	9.0	4.0	3.1	4.7	4.8	8.9	3.4	2.3	7.9	3.5	3.1	6.4	3.5	6.8	2.5	4.0	1.8	5.2	3.5	2.6	2.5	3.9	7.5	2.5	2.4	5.5	3.9	2.6	5.1	1.1	2.8	5.2	4.8	2.9	3.3	2.8	4.1	7.7	3.5	5.5	2.9	0.1	1.4	0.9	1.9	0.4	1.2	1.5	2.1	2.5	2.0	2.5	1.9	3.3	0.7	1.9	3.5	3.8	1.4	0.7	4.1	12.1	10.5	11.3	4.4	5.2	3.5	5.8	8.3	3.7
TRIM67	TNL	ENSG00000119283	"Tripartite motif containing 67"	Q6ZTA4	1	231162112-231221556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 14.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.3;HMC-1: 1.6;HSkMC: 1.3;SCLC-21H: 7.0;SH-SY5Y: 1.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"cerebellum: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034776	Uncertain									"HPA034776: AB_10603997"	"unprognostic (1.56e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.93e-10)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.10e-3)"	0.3	0.7	1.3	0.2	1.3	0.1	0.1	13.3	14.4	0.2	0.2	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.2	0.3	1.2	1.9	0.2	0.1	0.1	0.2	1.5	0.0	0.2	0.2	0.1	1.9	0.4	1.9	0.1	0.2	1.7	0.2	0.1	0.1	0.4	0.3	0.2	0.9	0.2	0.2	0.5	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	1.6	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.0	7.0	1.9	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.3	13.3	1.9	1.2	1.9	1.5	0.0	1.9	0.2
TRIM73	TRIM50B	ENSG00000178809	"Tripartite motif containing 73"	Q86UV7	7	75395063-75410996	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"stomach 1: 11.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.7;Hep G2: 13.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA047843, HPA051845"	Uncertain		Uncertain	Cytosol				Cytosol		"HPA047843: , HPA051845: "	"unprognostic (1.01e-2)"	"unprognostic (9.85e-5)"	"unprognostic (4.72e-3)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.17e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.46e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-3)"	1.9	1.6	0.3	1.2	0.9	2.4	1.6	4.0	0.6	2.4	0.6			4.2	1.7	0.3	0.3	3.8	1.0	0.9	0.4	0.5	1.7	2.3	1.1	2.3	0.2		2.3	7.2	1.3	1.7	0.1		2.1	0.0		1.9	1.9	2.6	2.4	2.2	0.0	0.5	1.8	11.5	5.4			2.4		0.2	0.7	1.3	1.3	1.4	2.0	0.8	1.7	2.2	1.3	1.3	4.0	1.7	2.4	0.0	0.8	0.6	0.5	0.1	0.1	1.0	0.0	1.9	2.3	0.3	0.2	1.3	0.3	0.0	0.2	5.0	7.7	1.4	3.0	13.1	0.9	0.8	5.5	2.2	0.0	0.3	0.4	0.1	0.7	6.4	0.0	0.9	2.0	2.6	0.2	1.3	3.5	0.2	1.2	0.4	0.0	2.0	1.6	2.5	0.9	2.1	0.6	2.4	1.6	1.1	1.9	1.7	1.1	3.0	1.7	2.4	1.7	3.2	1.5	1.1	0.8	0.7	2.2	0.6	1.2	1.1	1.3	0.4	0.4	1.3	2.1	1.6	2.0	1.7	0.2	1.4	2.0	1.3										
TRIM77	TRIM77P	ENSG00000214414	"Tripartite motif containing 77"	I1YAP6	11	89710299-89717872	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"testis: 1.0"	"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA039896	Uncertain									"HPA039896: "																		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TRMO	"C9orf156, HSPC219"	ENSG00000136932	"TRNA methyltransferase O"	Q9BU70	9	97904489-97922570	"Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021281, HPA052197"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA021281: , HPA052197: "	"unprognostic (2.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.99e-2)"	"prognostic favourable (4.81e-10)"	"unprognostic (1.97e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.39e-2)"	12.2	15.9	13.6	22.5	14.2	20.4	19.3	15.9	14.9	13.5	10.0	19.2	14.9	9.4	15.1	17.3	12.9	15.0	10.6	9.1	13.0	12.3	13.9	17.6	17.9	23.0	14.2	16.3	13.9	13.7	15.7	26.7	10.4	13.3	14.0	11.6	13.4	19.7	11.7	14.1	15.0	14.8	10.1	15.0	20.8	12.8	18.2	14.2	22.8	26.1	10.3	19.1	11.9	10.7	15.8	13.4	28.8	13.7	11.9	25.8	12.0	15.1	9.7	5.2	6.4	6.6	5.5	9.1	7.8	8.9	12.3	9.3	13.4	11.0	9.6	5.4	7.5	14.4	8.5	6.2	9.7	11.3	6.9	7.6	11.7	11.9	13.8	14.8	12.9	9.6	13.8	6.7	5.8	5.4	12.3	12.2	8.5	22.0	6.3	10.4	7.3	11.0	7.7	11.6	6.9	11.6	12.4	9.4	8.3	5.9	12.3	12.6	5.4	8.3	8.2	6.9	6.9	14.2	11.7	13.5	9.6	4.9	7.2	7.8	6.0	20.1	12.8	28.8	12.9	13.7	15.9	11.9	19.8	15.5	13.4	15.8	25.8	17.9	20.9	11.9	9.1	7.8	20.2	12.0	13.6	14.2	15.9	14.9	13.0	12.3	14.2	16.3	13.3	14.2
TRMT9B	"C8orf79, FLJ36980, hTRM9L, KIAA1456, TRM9L"	ENSG00000250305	"TRNA methyltransferase 9B (putative)"	Q9P272	8	12945642-13031503	"Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 64.7;thyroid gland: 26.5"	"Cell line enhanced"	"Detected in some"		"AF22: 7.0;BJ: 10.0;fHDF/TERT166: 13.4;RPTEC TERT1: 4.7;SCLC-21H: 5.1;U-266/84: 4.8"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.2"	"Group enriched"	"Detected in all"	7	"cerebellum: 64.7;pons and medulla: 31.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 77.4"	HPA024673	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA024673: AB_1845788"	"unprognostic (9.85e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-4)"	"unprognostic (1.06e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.88e-1)"	"prognostic favourable (2.77e-7)"	"unprognostic (2.22e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.27e-3)"	"unprognostic (3.34e-2)"	2.1	0.9	2.0	1.1	4.1	1.2	3.5	64.7	6.0	2.0	1.8	6.6	0.8	1.4	1.9	2.5	1.3	2.4	2.7	6.0	6.7	2.9	2.7	1.7	1.7	1.0	2.0	2.8	0.6	1.7	2.3	1.2	7.1	31.5	1.2	2.1	5.8	2.3	1.9	4.4	5.1	1.5	0.9	1.9	1.6	1.5	1.8	1.0	0.0	26.5	1.3	0.7	1.3	0.9	1.0	0.6	2.8	0.6	1.9	0.6	0.0	0.1	0.2	7.0	0.0	0.0	0.0	1.7	10.0	2.3	1.4	0.7	0.1	0.3	0.2	0.5	13.4	0.3	0.1	0.3	1.5	0.1	0.4	0.4	0.4	0.1	0.0	0.2	0.7	0.2	3.5	0.0	0.1	0.0	0.1	0.2	0.3	0.3	0.1	0.2	0.8	0.0	1.1	0.1	0.1	4.7	0.2	5.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.2	0.9	1.0	0.1	0.4	4.8	0.1	0.1	0.2	1.8	2.6	0.6	0.4	0.5	0.4	0.4	0.5	0.4	0.5	0.2	1.0	0.5	0.6	2.8	1.9	0.3	0.6	0.2	0.0	2.0	4.1	64.7	5.0	6.7	2.9	2.0	2.8	31.5	1.0
TRPM3	"GON-2, KIAA1616, LTRPC3"	ENSG00000083067	"Transient receptor potential cation channel subfamily M member 3"	Q9HCF6	9	70529063-71446904	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 36.6;kidney: 28.0;retina: 105.2"	"Cell line enriched"	"Detected in some"	4	"HAP1: 19.0"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	16	"NK-cell: 2.1"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 2.1"	"Low region specificity"	"Detected in all"							"HPA072650, HPA074393"	Enhanced		Approved	Vesicles				Vesicles		"HPA072650: , HPA074393: "	"unprognostic (3.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-7)"	"unprognostic (3.51e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.50e-2)"	0.9	1.7	6.0	0.7	4.5	1.1	0.8	36.6	5.1	0.8	0.7	9.6	2.1	1.8	2.4	3.0	0.7	1.3	1.3	1.4	9.4	6.0	28.0	0.9	0.8	0.7	8.3	3.5	5.3	1.5	0.7	6.8	0.8	34.8	1.4	0.7	105.2	0.8	5.0	1.1	0.8	0.7	1.0	8.1	1.1	1.6	5.3	5.9	0.0	2.1	0.0	0.6	0.8	0.5	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	1.0	0.1	1.2	2.9	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	19.0	0.0	0.1	0.0	0.1	0.1	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.1	4.4	0.0	0.0	0.0	1.3	0.1	0.0	0.2	0.0	0.9	0.0	1.3	0.0	0.2	0.0	0.3	0.0	0.0	3.5	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	6.0	4.5	36.6	3.8	9.4	6.0	8.3	3.5	34.8	5.9
TRPM5	"LTRPC5, MTR1"	ENSG00000070985	"Transient receptor potential cation channel subfamily M member 5"	Q9NZQ8	11	2404515-2423045	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 4.1;intestine: 6.3;pancreas: 4.5;seminal vesicle: 4.0"	"Cell line enhanced"	"Detected in some"		"MCF7: 3.2;RPMI-8226: 1.4"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043315	Uncertain									"HPA043315: "	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.47e-5)"	"unprognostic (6.81e-4)"	"unprognostic (7.90e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.91e-2)"	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7			6.1	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0		0.0	4.5	0.0	0.5	0.0		0.2	0.5		0.0	4.0	0.0	0.0	6.3	0.0	0.0	0.0	0.5	0.9			3.1		0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0										
TSGA13		ENSG00000213265	"Testis specific 13"	Q96PP4	7	130668648-130687432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 16.5"	"Cell line enhanced"	"Detected in single"		"THP-1: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA022968	Uncertain									"HPA022968: "					"unprognostic (1.49e-1)"					"unprognostic (1.13e-2)"		"unprognostic (1.86e-1)"		"unprognostic (1.34e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	1.2	0.6	0.8	0.5	0.3	0.1	0.4	0.0	0.0	0.8	0.7	0.2	0.4	0.0	0.2	0.9	0.0	0.6	0.2	0.1	0.0	0.1	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.4	0.9	0.1	0.3	0.4	0.1	0.2	1.1	0.6	0.2	0.5	0.2	0.3	0.2	0.2	0.1	0.2	0.6	0.5	0.4	1.2	0.8	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSKU	"E2IG4, LRRC54, TSK"	ENSG00000182704	"Tsukushi, small leucine rich proteoglycan"	Q8WUA8	11	76782251-76798154	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 86.8"	"Cell line enhanced"	"Detected in many"		"A549: 42.5;ASC diff: 72.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA008164	Approved		Approved	"Nucleoplasm,Nuclear bodies"	"Secreted - unknown location"		2100000	Nucleoplasm	"Nuclear bodies"	"HPA008164: AB_1853327"	"unprognostic (1.07e-2)"	"unprognostic (2.29e-3)"	"unprognostic (6.15e-2)"	"prognostic favourable (3.66e-4)"	"unprognostic (7.05e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.81e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavourable (2.87e-4)"	"prognostic favourable (1.66e-4)"	"prognostic unfavourable (2.80e-8)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.88e-2)"	33.1	2.8	1.0	3.6	1.4	0.6	26.9	1.5	2.0	38.8	16.1	1.8	6.4	11.5	13.2	25.5	17.8	15.3	8.6	9.3	1.2	0.3	31.8	86.8	5.1	3.7	1.7	1.3	27.8	12.2	2.6	4.3	43.0	3.4	15.7	4.5	48.5	9.3	10.8	7.0	15.0	21.4	13.0	0.8	3.0	8.7	9.0	0.8	1.5	12.2	16.0	12.4	18.2	27.9	1.8	0.7	2.1	0.4	0.7	1.3	0.2	0.8	42.5	4.7	4.6	72.7	9.3	8.7	1.4	8.0	3.1	3.0	5.5	11.7	0.1	8.3	5.3	17.0	2.7	10.4	1.0	8.7	1.4	2.0	11.0	15.2	13.7	0.7	3.2	9.5	11.5	5.6	4.6	3.9	4.6	0.3	2.9	19.6	0.1	1.5	6.2	1.8	1.4	4.5	6.7	7.4	7.4	4.3	7.1	8.1	6.4	3.8	8.5	0.6	1.2	8.9	7.1	21.7	3.4	0.3	0.1	0.3	4.2	2.2	1.6	1.8	0.4	0.5	0.9	0.2	0.4	1.8	0.8	0.7	0.4	1.8	0.9	1.3	2.1	0.7	0.4	0.7	0.8	0.2	1.0	1.4	1.5	2.0	1.2	0.3	1.7	1.3	3.4	0.8
TSPAN11		ENSG00000110900	"Tetraspanin 11"	A1L157	12	30926428-30996599	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 25.6"	"Group enriched"	"Detected in some"	6	"AF22: 18.5;HSkMC: 18.3;NTERA-2: 14.7;SCLC-21H: 7.1;SH-SY5Y: 14.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA066789			Approved	Vesicles				Vesicles		"HPA066789: "	"unprognostic (4.10e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.51e-1)"	"prognostic favourable (5.28e-4)"	"unprognostic (4.28e-2)"	"prognostic favourable (3.43e-4)"	"unprognostic (7.89e-3)"	"unprognostic (8.05e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.04e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.79e-1)"	3.1	2.5	6.4	16.0	3.8	0.0	2.5	15.2	12.7	9.0	25.6	9.0	3.0	4.4	6.4	7.8	8.8	2.4	12.2	8.8	5.0	4.7	1.6	1.0	8.5	2.6	4.1	3.8	1.9	1.4	0.3	1.5	0.8	3.8	5.4	11.0	12.2	3.8	6.8	0.8	6.5	10.9	8.3	2.6	2.6	4.5	1.6	3.7	0.0	4.0	12.3	8.9	6.6	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.5	0.0	0.0	0.2	0.1	0.2	0.5	0.0	0.0	0.0	0.5	0.0	1.1	1.6	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	18.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	14.7	0.1	0.0	0.0	0.3	0.0	0.0	7.1	14.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	3.8	15.2	4.3	5.0	4.7	4.1	3.8	3.8	3.7
TSPAN13	"NET-6, TM4SF13"	ENSG00000106537	"Tetraspanin 13"	O95857	7	16753535-16784536	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 36.2;SK-BR-3: 52.4;T-47d: 98.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 24.7;plasmacytoid DC: 51.3"	"Group enriched"	"Detected in many"	41	"B-cells: 24.7;dendritic cells: 51.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007426	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA007426: AB_10603137"	"unprognostic (3.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (3.56e-5)"	"unprognostic (2.63e-2)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (5.69e-2)"	"unprognostic (6.63e-2)"	"prognostic favourable (2.20e-4)"	"unprognostic (1.50e-1)"	"unprognostic (3.07e-1)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-1)"	20.8	24.2	17.7	7.6	24.9	6.2	25.6	10.7	33.0	18.6	23.6	3.0	21.0	25.2	5.9	12.3	8.8	5.7	16.0	6.8	14.5	21.7	3.3	22.2	53.4	14.8	12.0	15.9	2.1	55.2	4.6	48.0	19.0	14.0	15.1	29.1	8.5	49.1	19.2	4.1	4.7	27.8	5.9	3.6	12.9	31.3	3.1	3.4	3.6	13.0	7.1	18.5	12.1	10.6	24.7	51.3	0.9	0.0	0.8	0.0	1.2	7.5	6.2	8.0	8.4	1.0	0.0	2.2	16.3	2.6	0.4	0.8	22.0	11.7	0.2	4.1	5.8	11.8	9.2	13.6	3.6	0.2	9.9	3.2	2.6	2.3	2.2	0.3	0.6	0.9	5.9	0.8	1.0	4.9	10.5	0.0	0.4	21.6	0.4	0.4	5.6	7.7	8.7	0.0	7.8	25.4	14.4	36.2	5.4	2.9	52.4	0.7	98.0	0.8	0.4	0.2	2.9	0.2	5.3	4.8	0.1	0.1	7.5	0.1	11.4	0.1	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.2	24.7	0.0	0.0	0.9	0.8	0.0	51.3	0.0	1.2	17.7	24.9	10.7	33.0	14.5	21.7	12.0	15.9	14.0	3.4
TSPAN16	"TM-8, TM4-B, TM4SF16"	ENSG00000130167	"Tetraspanin 16"	Q9UKR8	19	11296139-11326996	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"blood: 21.8;testis: 46.1"	"Cell line enhanced"	"Detected in some"		"MCF7: 2.9;THP-1: 1.0;U-937: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"basophil: 6.9;eosinophil: 10.8;neutrophil: 21.8"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 21.8"					"Not detected"	"Not detected"			HPA076551	Approved									"HPA076551: "	"unprognostic (1.06e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.06e-3)"		"unprognostic (1.37e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.69e-4)"	"unprognostic (8.81e-8)"	"unprognostic (1.98e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.95e-3)"	"unprognostic (2.67e-1)"	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	46.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	21.8	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	2.9	0.0	0.9	0.3	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	1.0	0.0	0.2	0.0	0.2	0.1	0.0	0.2	0.0	0.0	2.9	0.0	6.9	1.3	10.8	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	21.8	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
TSPAN17	"FBX23, FBXO23, TM4SF17"	ENSG00000048140	"Tetraspanin 17"	Q96FV3	5	176647387-176659054	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030447			Approved	Nucleoplasm				Nucleoplasm		"HPA030447: "	"unprognostic (1.70e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.21e-3)"	"unprognostic (3.82e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.60e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.41e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.32e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.46e-1)"	11.1	29.3	18.7	12.8	12.6	39.1	14.7	18.3	20.9	8.7	14.7	7.1	12.4	13.1	9.0	10.5	16.6	11.2	16.8	16.5	13.3	10.4	16.4	15.0	13.5	19.8	9.2	9.2	8.6	30.5	12.3	19.5	10.3	10.4	12.4	11.8	9.1	11.7	15.8	30.2	11.2	14.6	11.7	6.6	15.7	15.3	18.4	11.2	3.4	11.9	13.7	15.8	14.5	9.4	2.6	3.1	0.8	4.9	3.7	9.3	3.4	16.2	16.5	11.1	20.1	15.4	13.3	17.3	12.2	18.0	18.1	18.1	5.0	18.8	7.3	22.4	21.1	12.4	5.5	28.5	11.1	53.7	11.5	2.8	7.2	5.9	14.0	5.9	10.2	15.7	16.1	14.4	8.8	24.8	13.7	7.9	18.3	26.8	1.2	2.6	8.9	18.2	6.2	9.4	4.0	17.0	12.0	16.8	11.9	13.3	15.5	16.5	12.7	7.5	19.2	19.8	20.6	14.8	15.3	4.5	5.8	3.1	21.5	12.6	11.5	0.0	3.1	0.8	5.4	3.1	4.3	1.6	4.1	8.8	3.1	2.6	2.9	3.9	0.5	3.7	4.9	0.8	9.3	3.4	18.7	12.6	18.3	20.9	13.3	10.4	9.2	9.2	10.4	11.2
TSPAN3	"TM4-A, TM4SF8, TSPAN-3"	ENSG00000140391	"Tetraspanin 3"	O60637	15	77041404-77083984	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 69.4;naive B-cell: 69.7;plasmacytoid DC: 46.7"	"Group enriched"	"Detected in all"	5	"B-cells: 69.7;dendritic cells: 46.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015996	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA015996: AB_1858406"	"unprognostic (5.94e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.41e-3)"	"unprognostic (3.51e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.35e-1)"	64.0	31.4	71.6	16.9	66.5	6.0	43.3	36.8	67.5	31.4	75.3	49.4	74.2	70.6	28.4	95.9	16.8	53.8	39.4	24.6	58.1	63.7	44.9	17.8	41.9	22.9	64.4	45.8	33.0	31.6	53.6	44.0	23.1	54.1	21.3	82.7	44.3	30.8	60.9	79.3	16.3	71.2	27.6	49.2	19.1	46.1	21.3	40.4	14.2	43.0	24.7	25.4	23.2	15.2	69.7	46.7	1.5	10.8	8.3	6.9	12.1	21.0	57.5	47.8	30.1	84.0	51.7	15.8	33.8	36.8	41.7	45.6	35.0	44.1	20.7	50.3	34.8	47.9	45.3	23.1	31.4	23.2	68.7	14.8	44.1	33.1	40.8	19.0	10.9	48.7	28.0	23.0	20.5	50.9	15.6	18.3	40.7	8.0	16.8	18.1	33.8	25.6	21.2	59.4	21.8	68.5	12.0	43.4	48.0	23.1	19.6	62.8	21.0	36.1	48.2	38.7	15.1	23.3	47.2	40.3	54.8	11.0	34.3	28.5	22.0	0.8	7.5	1.5	5.1	9.9	5.4	69.4	2.6	3.7	14.8	69.7	6.9	6.3	0.7	8.3	10.8	46.7	0.6	12.1	71.6	66.5	36.8	64.2	58.1	63.7	64.4	45.8	54.1	40.4
TSPAN31	SAS	ENSG00000135452	"Tetraspanin 31"	Q12999	12	57738013-57750211	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 59.0"	"Cancer enhanced"	"Detected in all"		"glioma: 54.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030758, HPA057489"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA030758: , HPA057489: "	"unprognostic (2.66e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (4.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.51e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.79e-1)"	"prognostic favourable (9.91e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.58e-1)"	27.0	26.4	19.4	18.2	22.5	5.4	21.8	14.3	20.5	21.9	20.1	30.5	23.0	16.3	23.1	37.6	21.3	27.7	23.3	23.3	19.1	17.8	32.1	29.2	20.7	14.5	20.3	16.0	32.0	32.1	31.4	22.7	31.5	19.4	23.3	19.0	32.1	24.6	22.0	19.8	15.2	24.0	17.5	24.3	23.1	18.2	11.4	17.1	14.6	42.4	16.5	20.7	20.2	16.8	17.6	35.4	18.6	24.8	23.7	22.0	18.8	3.5	8.7	8.9	2.2	20.7	13.6	5.8	5.6	7.5	3.0	3.0	6.0	19.2	3.2	12.6	13.0	7.4	2.3	12.0	4.3	8.5	6.3	4.4	7.2	2.5	20.4	4.3	7.6	12.0	14.2	5.9	12.5	8.0	3.1	9.4	9.8	7.2	3.3	2.5	1.9	2.8	4.2	59.0	8.4	12.5	7.3	3.1	7.6	6.1	8.9	4.4	16.8	6.8	10.9	4.9	4.1	2.6	3.0	11.7	2.6	1.5	13.3	2.9	7.4	18.6	15.7	11.1	22.0	15.7	21.3	17.6	17.8	18.9	15.6	16.8	17.8	16.7	5.3	23.7	24.8	35.4	12.1	18.8	19.4	22.5	14.3	18.5	19.1	17.8	20.3	16.0	19.4	17.1
TSPAN32	"PHEMX, TSSC6"	ENSG00000064201	"Tetraspanin 32"	Q96QS1	11	2301997-2318200	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.3;bone marrow: 17.5;heart muscle: 11.9;lymphoid tissue: 11.5"	"Group enriched"	"Detected in some"	8	"HEL: 15.4;HL-60: 6.7;NB-4: 5.6;THP-1: 5.9;U-937: 9.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA024135	Uncertain		Approved	Nucleoplasm			37000	Nucleoplasm		"HPA024135: AB_1858409"	"unprognostic (7.50e-3)"	"unprognostic (4.88e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.45e-3)"	"unprognostic (2.10e-4)"	"unprognostic (7.72e-3)"	"unprognostic (8.25e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-1)"	"unprognostic (4.35e-1)"	"unprognostic (8.13e-2)"	1.2	0.4	0.3	6.3	0.5	17.5	0.5	0.4	1.0	1.3	1.3	2.1	0.0	0.2	1.6	1.6	0.9	0.6	1.4	11.9	0.3	0.4	0.9	0.8	3.1	5.1	0.5	0.3	0.8	0.4	0.0	0.4	0.9	0.5	1.2	0.1	1.7	5.6	0.9	0.3	0.5	1.1	1.8	0.8	5.8	1.4	0.4	1.1	7.4	0.5	2.1	11.5	1.0	0.8	1.1	14.9	17.9	19.3	25.3	13.2	9.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	15.4	0.0	0.1	0.7	6.7	1.1	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	9.4	0.0	17.9	15.2	2.0	13.0	17.9	8.1	1.1	4.7	11.1	14.9	0.6	3.7	13.2	8.4	25.3	19.3	0.7	5.8	9.5	0.3	0.5	0.4	1.0	0.3	0.4	0.5	0.3	0.5	1.1
TSPEAR	"C21orf29, DFNB98, MGC11251, TSP-EAR"	ENSG00000175894	"Thrombospondin type laminin G domain and EAR repeats"	Q8WU66	21	44497892-44711580	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Hearing		"Deafness, Disease mutation, Ectodermal dysplasia, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 14.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;Hep G2: 2.6;HMC-1: 2.5;SH-SY5Y: 5.0;U-2 OS: 3.5"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.5"	"Cell type enriched"	"Detected in single"	10	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.5"	"Region enhanced"	"Detected in some"		"olfactory region: 2.0"	"CAB034203, CAB034204, HPA052995"	Uncertain				"Secreted in other tissues"					"CAB034203: AB_1567654, CAB034204: AB_1567655, HPA052995: "	"unprognostic (8.61e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.86e-4)"	"unprognostic (7.87e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.86e-4)"	"unprognostic (2.13e-2)"	"unprognostic (4.80e-7)"	"unprognostic (2.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.98e-2)"	0.3	0.1	0.2	0.3	2.5	0.0	0.5	0.2	0.9	0.2	0.2	0.2	0.2	0.7	0.2	0.4	0.2	1.1	0.2	2.7	0.2	0.1	0.5	1.4	1.4	0.8	0.2	0.2	0.2	0.2	2.6	14.9	0.2	1.0	0.2	0.0	0.2	0.2	0.2	0.2	3.9	0.5	0.2	0.2	0.6	0.3	4.6	0.2	0.5	2.8	0.2	0.4	0.2	0.2	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.2	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.0	0.0	0.0	1.1	5.0	0.0	0.1	0.0	0.1	0.2	1.4	0.0	3.5	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.2	0.9	0.2	0.1	0.2	0.2	1.0	0.2
TTC13	FLJ22584	ENSG00000143643	"Tetratricopeptide repeat domain 13"	Q8NBP0	1	230906243-230978875	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018022, HPA051558"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA018022: AB_2211524, HPA051558: "	"unprognostic (2.68e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.42e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.10e-2)"	"prognostic favourable (7.66e-4)"	"unprognostic (2.60e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.80e-2)"	"prognostic favourable (4.59e-5)"	"unprognostic (2.29e-1)"	"prognostic unfavourable (1.60e-11)"	"unprognostic (4.48e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.54e-3)"	10.5	7.1	8.9	16.6	26.7	13.1	9.6	11.2	12.4	7.3	13.6	12.5	8.6	10.5	9.3	9.2	8.5	9.2	8.9	7.0	9.9	7.9	6.9	9.0	12.2	23.4	13.3	9.3	8.2	13.7	13.5	15.5	9.9	12.6	8.1	21.6	7.9	9.6	9.5	15.6	12.8	15.6	8.4	14.7	21.3	15.6	3.9	13.7	18.4	9.8	6.2	18.9	8.0	9.1	4.2	10.8	7.6	7.7	11.9	10.0	5.1	7.9	8.2	8.0	15.7	7.5	4.9	16.6	11.7	9.3	6.6	7.5	11.9	8.8	14.8	10.8	7.0	12.9	5.3	4.3	4.4	16.5	16.2	4.4	8.7	8.1	8.0	9.0	4.1	4.3	7.7	6.2	5.8	11.6	4.7	8.6	6.0	4.1	4.8	8.6	9.1	10.2	7.7	11.6	20.5	6.9	5.5	11.1	9.6	8.9	9.3	15.6	9.8	11.8	5.9	7.8	1.1	10.5	20.7	10.7	17.5	4.5	7.7	5.7	12.7	7.6	7.6	6.8	10.0	5.8	6.8	4.2	7.0	8.2	10.8	3.9	5.7	6.8	2.9	11.9	7.7	7.4	5.4	5.1	8.9	26.7	11.2	12.4	9.9	7.9	13.3	9.3	12.6	13.7
TTC21A	"IFT139A, STI2"	ENSG00000168026	"Tetratricopeptide repeat domain 21A"	Q8NDW8	3	39107704-39138903	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 51.9"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.0;naive B-cell: 2.7"	"Group enriched"	"Detected in many"	6	"B-cells: 2.7;monocytes: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035510, HPA035511"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA035510: , HPA035511: AB_10671514"	"unprognostic (1.85e-3)"	"unprognostic (6.95e-3)"	"unprognostic (7.74e-3)"	"prognostic favourable (1.79e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.58e-5)"	"unprognostic (2.29e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (9.76e-2)"	"unprognostic (3.91e-4)"	0.9	0.8	2.5	2.2	4.1	0.7	0.8	1.0	2.9	0.9	0.9	2.2	1.9	0.9	1.8	3.0	0.9	2.0	0.7	0.9	2.4	0.8	0.9	0.9	1.0	1.0	0.9	3.6	1.0	2.1	0.9	7.0	0.7	2.9	0.9	0.7	1.4	1.0	0.8	1.0	0.9	0.8	0.6	0.9	0.8	0.9	51.9	1.9	0.0	0.9	0.0	1.6	0.8	0.9	2.7	0.3	0.3	1.7	0.0	0.0	0.1	0.6	1.1	0.3	0.7	0.0	0.7	0.9	1.2	0.9	0.8	0.5	0.0	0.6	2.5	0.0	0.4	0.5	0.4	1.6	0.2	1.1	0.5	0.1	1.1	0.0	1.3	1.0	0.7	0.9	0.9	0.0	1.3	0.0	0.0	3.8	0.0	1.2	0.1	0.4	0.1	0.0	0.2	0.2	0.4	0.0	1.1	1.3	0.5	1.2	3.0	1.3	2.8	0.1	0.6	0.3	0.5	2.4	0.5	2.6	0.3	0.2	1.0	0.0	0.6	0.0	0.5	0.0	0.0	1.7	0.0	2.0	0.0	0.0	0.3	2.7	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	2.5	4.1	1.0	2.9	2.4	0.8	0.9	3.6	2.9	1.9
TTC22	FLJ20619	ENSG00000006555	"Tetratricopeptide repeat domain 22"	Q5TAA0	1	54779712-54801267	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 46.8"	"Cell line enhanced"	"Detected in some"		"A-431: 8.9;CAPAN-2: 11.0;HaCaT: 12.6;hTCEpi: 7.2;RPMI-8226: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							HPA035072	Uncertain									"HPA035072: AB_10602252"	"prognostic favourable (2.06e-4)"	"unprognostic (8.52e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.10e-2)"	"prognostic unfavourable (7.73e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.51e-3)"	"unprognostic (5.08e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.21e-1)"	0.3	0.4	1.0	4.2	3.5	0.6	1.5	0.2	0.4	12.1	11.8	0.2	5.1	10.1	1.6	2.4	46.8	2.1	7.7	0.2	1.1	0.6	6.6	6.4	5.0	1.5	0.3	0.5	0.6	5.7	8.2	5.7	0.5	0.6	3.6	7.3	1.0	9.5	3.9	0.1	12.2	27.7	0.3	0.3	1.1	8.7	0.5	0.7	3.0	5.3	18.4	21.0	1.8	18.8	1.2	0.1	4.0	0.1	2.9	6.5	0.7	8.9	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.0	11.0	0.1	0.4	0.0	12.6	0.0	3.7	0.0	3.9	0.1	0.1	0.2	0.1	0.0	0.1	0.3	0.0	7.2	0.0	0.0	0.0	0.1	3.4	0.0	0.0	0.0	0.1	0.1	1.2	0.1	0.0	8.1	0.5	2.2	0.3	0.2	0.7	0.1	0.0	0.4	0.2	0.1	0.2	0.0	0.2	0.1	0.8	2.1	0.1	0.1	0.1	0.0	1.4	0.1	4.0	6.0	0.0	3.6	1.2	2.9	6.5	0.1	0.9	2.5	3.1	2.3	2.9	0.1	0.1	3.9	0.7	1.0	3.5	0.2	0.4	1.1	0.6	0.3	0.5	0.6	0.7
TTC26	"dyf-13, DYF13, FLJ12571, IFT56"	ENSG00000105948	"Tetratricopeptide repeat domain 26"	A0AVF1	7	139133744-139191986	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036338, HPA036339"	Enhanced		Approved	"Nuclear speckles,Intermediate filaments,Cytosol"				"Nuclear speckles, Intermediate filaments, Cytosol"		"HPA036338: AB_10673351, HPA036339: AB_10673386"	"unprognostic (3.40e-2)"	"unprognostic (8.88e-2)"	"unprognostic (5.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.46e-7)"	"unprognostic (1.72e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.56e-1)"	3.5	6.5	6.9	2.5	8.1	3.3	5.6	6.9	8.3	6.1	3.1	4.4	7.4	1.3	6.6	7.6	3.1	20.9	4.5	3.5	5.7	5.1	8.3	1.9	5.1	2.8	2.7	4.8	8.8	3.2	13.0	20.1	3.8	8.4	5.6	2.8	5.4	3.6	5.5	2.3	3.2	2.2	4.6	2.7	2.6	3.1	17.4	3.9	3.8	7.3	2.8	3.1	3.7	3.9	3.6	2.5	5.3	1.5	1.6	2.3	0.9	11.3	8.6	7.6	9.0	9.5	11.1	3.8	5.5	5.8	9.1	9.3	5.5	8.2	2.5	9.3	4.3	5.7	8.5	6.5	13.3	7.1	7.3	3.1	6.9	4.7	4.7	8.8	2.1	6.3	5.9	13.6	6.2	6.7	6.8	1.6	7.2	10.7	14.9	10.3	7.6	7.6	5.2	9.0	4.0	7.9	3.4	11.2	8.0	13.7	5.8	7.8	7.0	4.7	4.6	8.5	7.4	7.7	10.2	3.7	4.6	1.9	14.9	4.3	9.9	1.2	0.5	1.2	2.1	0.5	1.1	3.6	1.5	1.4	1.1	2.4	2.3	1.7	5.3	1.6	1.5	2.5	1.0	0.9	6.9	8.1	6.9	8.3	5.7	5.1	2.7	4.8	8.4	3.9
TTC29	NYD-SP14	ENSG00000137473	"Tetratricopeptide repeat domain 29"	Q8NA56	4	146706638-146945882	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 55.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.9;hTERT-HME1: 3.1;Karpas-707: 2.2;U-266/70: 4.1;U-87 MG: 2.1"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 4.3;pons and medulla: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA037006, HPA061473"	Uncertain									"HPA037006: AB_10670379, HPA061473: "	"unprognostic (1.28e-3)"			"unprognostic (1.52e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.70e-1)"		"unprognostic (6.70e-2)"		"unprognostic (1.35e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.67e-4)"	"unprognostic (9.81e-4)"	"unprognostic (7.30e-2)"	"unprognostic (6.88e-4)"		0.2	0.1	0.9	0.1	4.3	0.1	0.1	0.1	1.2	0.8	0.1	1.7	0.5	0.1	0.3	10.7	0.1	13.3	0.1	0.1	1.5	1.3	0.2	0.1	7.0	0.1	0.3	0.7	2.6	0.1	0.8	0.2	0.1	12.7	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.4	0.1	0.1	55.9	0.6	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	9.9	0.0	0.0	0.8	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.1	0.9	3.1	0.3	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	4.1	0.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.3	0.1	1.2	1.5	1.3	0.3	0.7	12.7	0.6
TTC30A	"FLJ13946, IFT70A"	ENSG00000197557	"Tetratricopeptide repeat domain 30A"	Q86WT1	2	177612992-177618966	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA051714, HPA052100, HPA052487"	Supported		Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA051714: , HPA052100: , HPA052487: "	"unprognostic (7.75e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.67e-3)"	"unprognostic (6.07e-2)"	2.7	4.1	3.8	1.5	7.1	0.4	5.6	2.2	7.1	4.2	3.4	5.9	7.8	2.2	5.0	10.9	2.4	8.4	4.8	4.4	3.7	4.2	6.9	4.6	3.7	1.4	3.6	6.6	5.5	4.4	11.6	8.1	1.9	4.8	3.9	3.3	5.0	8.1	4.0	3.5	1.9	2.5	3.6	3.0	1.7	3.6	24.5	2.1	2.6	9.6	4.6	1.7	3.1	1.7	0.5	1.6	1.9	1.6	0.2	2.7	1.0	5.7	3.3	3.3	0.0	6.8	5.6	2.4	2.8	8.1	5.0	5.3	1.0	4.2	1.3	5.5	4.9	4.8	2.2	6.2	5.5	0.4	1.8	1.1	1.6	1.4	2.7	1.4	1.3	3.4	4.1	2.8	1.1	2.3	0.8	0.5	3.5	2.9	4.4	2.6	1.8	1.2	2.9	8.8	0.6	6.3	1.5	10.9	7.2	2.5	5.0	3.0	2.8	1.4	2.1	3.1	1.9	3.4	2.3	2.3	2.1	0.4	7.8	0.1	3.0	0.0	1.3	1.9	0.4	1.6	0.1	0.4	0.1	0.4	1.6	0.5	2.7	1.2	0.7	0.2	1.3	0.6	1.0	1.0	3.8	7.1	2.2	7.1	3.7	4.2	3.6	6.6	4.8	2.1
TTC34		ENSG00000215912	"Tetratricopeptide repeat domain 34"	A8MYJ7	1	2635976-2801717	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 3.5;testis: 4.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.7;Karpas-707: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA066832	Uncertain									"HPA066832: "	"unprognostic (1.45e-4)"	"unprognostic (5.00e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.69e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.16e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.68e-4)"	0.1	0.2	0.6	0.3	1.2	0.0	0.4	0.2	0.3	0.4	0.0			0.0	0.5	0.6	0.0	3.5	0.0	0.0	0.9	0.7	0.0	0.0	0.4	0.1	0.1		0.6	0.0	0.2	0.3	0.0		0.3	0.0		0.2	0.3	0.0	0.0	0.3	0.0	0.1	0.5	0.3	4.6			1.5		0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.6	0.2	0.7	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.7	0.2	0.0	0.0	0.8	0.1	0.0	0.0	1.0	0.0	0.0	0.3	0.3	0.2	0.0	0.7	0.5	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.7	0.1	0.3	0.4	0.1	0.2	0.0	0.0	0.2	0.1	0.3	0.4	0.1	0.3	0.0	0.1	0.0	0.2	0.7	0.7	0.1	0.0	0.7	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0										
TTC39A	"C1orf34, DEME-6, KIAA0452"	ENSG00000085831	"Tetratricopeptide repeat domain 39A"	Q5SRH9	1	51287258-51345116	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.5;MCF7: 16.9;SK-BR-3: 52.6;T-47d: 38.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	46	"plasmacytoid DC: 23.4"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 23.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028098, HPA043440"	Uncertain		Approved	Centrosome				Centrosome		"HPA028098: AB_10601705, HPA043440: "	"unprognostic (5.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.86e-2)"	"prognostic unfavourable (5.05e-5)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.73e-3)"	"unprognostic (5.40e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.06e-1)"	1.2	4.9	3.2	6.0	5.5	0.6	23.4	0.7	4.3	8.5	18.0	0.2	8.1	3.3	1.4	10.4	10.4	4.5	17.9	8.3	3.3	7.4	40.4	3.1	12.4	0.5	4.2	2.4	0.9	22.3	6.1	12.1	0.9	10.1	12.3	20.2	3.1	10.1	10.7	2.2	5.6	4.5	0.8	4.9	0.3	18.7	28.2	2.0	0.2	5.5	8.5	6.2	5.0	5.0	0.1	23.4	0.5	0.0	0.0	0.0	0.2	2.2	1.2	0.2	0.1	0.1	0.2	9.3	0.1	0.0	0.0	0.0	5.7	0.9	0.0	4.1	0.1	0.0	1.2	0.0	0.0	21.5	4.3	0.1	0.5	1.1	0.4	0.0	0.2	0.0	0.5	0.0	0.0	0.5	0.1	0.0	0.0	16.9	0.2	0.0	1.6	0.2	0.0	0.0	1.4	9.2	2.9	7.8	0.7	0.1	52.6	0.5	38.1	0.2	0.2	0.1	1.0	0.1	0.1	2.2	2.8	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	23.4	0.0	0.2	3.2	5.5	0.7	4.3	3.3	7.4	4.2	2.4	10.1	2.0
TTC39C	"C18orf17, FLJ33761, HsT2697"	ENSG00000168234	"Tetratricopeptide repeat domain 39C"	Q8N584	18	23992773-24135610	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 92.2"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"liver cancer: 19.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065705, HPA065713"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA065705: , HPA065713: "	"prognostic favourable (1.48e-4)"	"unprognostic (6.37e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (2.60e-5)"	"unprognostic (2.32e-1)"	"unprognostic (3.51e-1)"	"unprognostic (8.94e-3)"	"unprognostic (4.48e-3)"	9.0	14.2	6.2	12.0	4.9	17.7	10.9	5.1	12.2	8.7	6.3	2.4	1.5	5.1	9.8	6.5	9.4	9.0	17.2	3.9	5.3	2.7	3.3	92.2	7.1	14.1	2.2	6.7	5.9	9.8	1.3	13.4	1.5	6.2	9.7	4.6	20.8	11.8	3.9	4.7	24.2	6.2	5.3	2.2	6.7	6.1	14.3	1.0	12.0	3.7	5.7	20.9	8.3	9.3	5.2	8.8	0.5	1.9	5.7	35.5	4.2	6.5	4.9	3.3	2.2	20.8	22.0	11.9	9.4	21.5	7.5	7.7	0.6	3.6	10.8	9.3	16.4	8.2	6.4	8.2	6.0	16.0	6.6	3.1	23.5	12.1	4.0	16.9	8.3	17.7	11.1	4.3	6.1	0.5	0.1	0.1	4.8	5.1	2.7	5.1	8.1	12.6	15.5	5.0	4.1	7.8	10.0	8.7	6.9	18.1	6.1	5.7	4.8	6.2	4.2	6.6	4.9	5.0	4.7	0.2	0.0	15.7	8.8	17.7	4.5	0.5	1.9	0.0	11.2	1.9	28.8	5.2	24.9	14.0	2.5	3.3	10.7	9.0	0.5	5.7	1.5	8.8	35.5	4.2	6.2	4.9	5.1	12.2	5.3	2.7	2.2	6.7	6.2	1.0
TTC6	"C14orf25, NCRNA00291"	ENSG00000139865	"Tetratricopeptide repeat domain 6"	Q86TZ1	14	37595847-38041442	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 9.7;prostate: 20.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 7.2;MCF7: 10.5;RT4: 7.3;T-47d: 20.2"	"Group enriched"	"Detected in some"	7	"breast cancer: 2.2;prostate cancer: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA069293			Approved	Centrosome				Centrosome		"HPA069293: "	"unprognostic (7.92e-2)"	"unprognostic (6.95e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.98e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.60e-4)"	"unprognostic (6.75e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-4)"	"unprognostic (5.60e-2)"	"unprognostic (8.91e-8)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.07e-3)"	0.0	0.0	0.3	1.3	0.6	0.0	9.7	0.3	0.6	0.2	2.2	0.2	0.0	0.6	0.0	1.3	0.6	0.4	1.0	0.0	0.8	0.9	0.0	7.9	5.6	0.0	0.7	0.4	0.4	0.0	0.0	1.1	0.3	0.1	20.5	0.5	0.0	3.0	1.1	0.0	0.8	1.2	2.5	0.6	0.0	3.8	6.0	0.0	0.0	0.0	0.6	2.3	2.2	4.6	0.6	0.2	0.4	0.0	0.0	0.1	0.0	0.6	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.4	0.0	2.1	1.2	0.2	0.0	0.0	3.0	0.0	0.9	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.5	0.0	0.0	0.0	4.0	0.0	0.0	0.0	1.0	7.3	2.2	0.0	0.0	4.0	0.0	20.2	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.3	0.6	0.8	0.9	0.7	0.4	0.1	0.0
TTC9B	FLJ30373	ENSG00000174521	"Tetratricopeptide repeat domain 9B"	Q8N6N2	19	40216058-40218399	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"brain: 47.9"	"Cell line enriched"	"Detected in some"	19	"SCLC-21H: 24.5"	"Cancer enriched"	"Detected in single"	15	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042496	Approved				"Secreted in brain"					"HPA042496: AB_10795506"	"unprognostic (2.31e-1)"	"unprognostic (1.39e-4)"	"unprognostic (5.09e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.39e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.24e-2)"	1.0	1.8	45.5	1.4	10.3	1.0	1.0	24.6	47.9	1.0	1.2	1.2	0.0	1.1	1.0	1.0	1.0	1.0	1.0	1.0	22.3	14.0	1.0	1.0	1.0	1.0	7.5	9.9	1.0	1.0	1.0	0.0	1.0	7.1	1.0	1.0	0.3	1.0	1.0	1.0	1.0	1.2	1.1	2.5	1.0	1.1	1.1	1.0	0.0	1.0	0.0	1.0	1.0	0.0	0.1	0.5	0.0	1.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	24.5	1.3	0.1	0.0	0.9	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.3	0.0	45.5	10.3	24.6	31.3	22.3	14.0	7.5	9.9	7.1	1.0
TTLL1	C22orf7	ENSG00000100271	"Tubulin tyrosine ligase like 1"	O95922	22	43039644-43089428	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048392	Approved		Approved	Nucleoli,Mitochondria				Nucleoli	Mitochondria	"HPA048392: "	"unprognostic (1.02e-1)"	"unprognostic (4.06e-3)"	"unprognostic (1.51e-1)"	"prognostic favourable (1.85e-4)"	"unprognostic (6.18e-3)"	"unprognostic (4.27e-3)"	"prognostic unfavourable (2.34e-5)"	"unprognostic (8.22e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.82e-1)"	"prognostic favourable (1.68e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.38e-2)"	4.0	7.3	16.5	3.6	12.0	2.9	6.8	12.8	16.6	7.6	4.6	8.8	0.9	2.5	7.1	12.5	5.7	14.6	5.7	12.5	13.9	12.6	6.1	2.1	5.3	4.9	9.2	14.1	8.3	4.2	8.5	9.8	3.9	13.2	7.7	4.6	6.8	4.7	6.0	4.4	5.8	2.9	5.9	10.0	4.5	5.4	14.0	8.4	4.7	10.3	1.8	4.8	5.4	4.6	4.7	10.4	7.0	6.5	9.9	14.1	6.2	0.8	1.5	12.8	9.7	14.5	12.9	0.6	4.3	4.8	2.5	4.2	0.1	1.9	0.9	3.1	7.9	0.6	1.1	1.1	2.5	1.1	2.1	1.3	0.7	1.2	10.4	3.2	1.7	10.6	16.6	1.6	4.1	8.1	0.3	8.3	9.2	4.2	3.0	5.2	1.7	0.9	7.4	7.2	0.7	4.6	1.1	3.2	6.1	3.4	1.7	11.8	5.1	5.4	7.8	2.7	1.8	6.2	0.6	2.9	0.8	0.3	6.8	5.9	4.8	5.2	5.9	7.0	13.0	6.5	12.2	3.1	11.4	14.1	10.4	4.7	9.7	12.2	1.7	9.9	4.9	6.7	6.9	6.2	16.5	12.0	12.8	16.6	13.9	12.6	9.2	14.1	13.2	8.4
TTLL2	"C6orf104, dJ366N23.3, NYD-TSPG"	ENSG00000120440	"Tubulin tyrosine ligase like 2"	Q9BWV7	6	167325086-167359503	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"testis: 54.1"	"Cell line enriched"	"Detected in some"	5	"CACO-2: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"							HPA027985			Approved	"Nuclear membrane,Nucleoli"				"Nuclear membrane, Nucleoli"		"HPA027985: AB_2211832"	"unprognostic (5.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.47e-4)"		"unprognostic (7.57e-2)"	"unprognostic (2.63e-4)"	"unprognostic (3.50e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.94e-1)"	"unprognostic (8.02e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	54.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.8	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0
TTLL8		ENSG00000138892	"Tubulin tyrosine ligase like 8"	A6PVC2	22	50015123-50056935	"Predicted intracellular proteins"		Ligase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	36	"testis: 8.4"	"Cell line enriched"	"Detected in single"	5	"U-266/70: 4.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA016882	Uncertain									"HPA016882: AB_10603223"								"unprognostic (1.81e-1)"		"unprognostic (1.08e-2)"				"unprognostic (8.18e-2)"	"unprognostic (1.21e-1)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4			0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TTLL9	"C20orf125, dJ310O13.1"	ENSG00000131044	"Tubulin tyrosine ligase like 9"	Q3SXZ7	20	31870702-31944963	"Cancer-related genes, Predicted intracellular proteins"		Ligase	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 16.0;epididymis: 8.9;fallopian tube: 9.2;testis: 11.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.0;REH: 2.0"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041772, HPA055676"	Uncertain		Uncertain	Nucleoplasm,Microtubules				"Nucleoplasm, Microtubules"		"HPA041772: AB_10959904, HPA055676: "	"unprognostic (8.77e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.59e-1)"	"unprognostic (9.05e-3)"	"unprognostic (6.17e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.23e-2)"	0.4	0.6	3.4	0.5	8.9	0.4	1.3	1.0	2.8	0.6	0.5	10.9	1.8	0.6	1.1	8.9	0.6	9.2	0.8	0.5	4.8	3.7	0.8	0.5	1.7	0.7	5.2	0.6	1.8	0.4	2.8	2.8	0.7	16.0	0.6	0.5	0.0	0.5	1.8	0.4	0.6	0.4	0.6	4.5	0.5	0.6	11.0	4.0	0.0	2.1	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.3	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.9	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.4	0.8	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.6	0.3	0.0	0.1	0.5	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	8.9	1.0	2.7	4.8	3.7	5.2	0.6	16.0	4.0
TTYH1		ENSG00000167614	"Tweety family member 1"	Q9H313	19	54415219-54436900	"Predicted membrane proteins, Transporters"	"Cell adhesion, Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 66.9"	"Group enriched"	"Detected in some"	4	"AF22: 6.2;AN3-CA: 19.2;U-2 OS: 7.1"	"Cancer enriched"	"Detected in many"	15	"glioma: 63.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023617, HPA050655"	Approved									"HPA023617: AB_10600836, HPA050655: "	"prognostic favourable (3.64e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.50e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.60e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.09e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.69e-1)"	2.2	2.7	49.5	2.1	55.4	2.1	2.3	17.9	66.9	2.4	2.3	33.9	0.0	2.4	2.6	2.1	2.2	4.4	2.3	2.3	31.0	23.4	2.1	2.1	2.1	2.1	39.3	24.4	2.2	10.4	2.1	1.9	2.1	19.7	2.5	2.1	1.9	2.8	2.4	3.0	2.2	2.1	2.2	29.7	2.4	2.2	7.4	18.0	0.0	2.1	0.0	2.1	2.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.2	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	49.5	55.4	17.9	42.9	31.0	23.4	39.3	24.4	19.7	18.0
TUBD1	"FLJ12709, TUBD"	ENSG00000108423	"Tubulin delta 1"	Q9UJT1	17	59859482-59892945	"FDA approved drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004609, HPA023980, HPA027090"	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB004609: AB_628416, HPA023980: AB_1858456, HPA027090: AB_1858457"	"unprognostic (1.92e-1)"	"unprognostic (5.95e-2)"	"prognostic favourable (2.04e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavourable (1.00e-5)"	"unprognostic (2.86e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (6.06e-4)"	"unprognostic (4.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.83e-2)"	8.7	8.0	9.3	8.1	13.8	6.8	12.4	19.9	12.2	12.3	11.2	13.5	16.6	6.7	13.6	16.4	18.2	10.0	8.3	8.4	8.9	7.2	8.5	9.3	8.8	10.2	16.1	8.5	16.3	13.2	10.4	18.7	7.2	12.3	12.3	8.2	11.7	11.4	12.2	9.9	11.6	7.5	9.3	13.4	9.3	9.6	9.2	16.4	16.2	15.5	10.3	13.8	14.1	13.0	10.1	8.8	14.1	7.6	8.1	17.6	6.9	5.9	8.1	6.4	6.7	3.6	2.6	5.4	4.6	2.7	6.1	5.1	8.8	3.9	5.4	7.9	1.0	5.0	8.9	2.8	5.9	3.1	10.9	6.3	6.9	10.4	1.9	3.7	3.4	1.4	4.4	5.3	2.0	4.8	13.5	3.8	2.1	41.9	7.6	4.3	5.6	3.6	8.2	9.4	8.4	2.4	2.7	6.0	3.6	3.3	2.6	3.2	6.3	3.6	1.5	4.4	9.8	3.1	5.0	4.4	6.6	8.2	2.1	4.3	3.9	5.6	7.6	14.1	10.9	5.0	12.4	10.1	13.5	11.5	5.2	8.6	17.6	14.2	8.2	8.1	5.3	8.8	14.1	6.9	9.3	13.8	19.9	12.2	8.9	7.2	16.1	8.5	12.3	16.4
TUBE1	"dJ142L7.2, FLJ22589, TUBE"	ENSG00000074935	"Tubulin epsilon 1"	Q9UJT0	6	112070777-112087529	"FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA032073, HPA032074"	Approved									"HPA032073: AB_10601773, HPA032074: AB_10601216"	"unprognostic (4.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.99e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.59e-3)"	10.3	10.7	12.4	7.0	18.5	5.1	11.9	32.4	18.9	15.5	10.3	12.2	11.4	6.7	21.4	11.5	6.6	12.7	11.6	17.4	10.5	12.2	11.4	47.4	8.4	8.8	15.4	14.5	14.9	12.5	11.8	20.4	11.7	14.0	12.1	8.5	9.3	9.9	12.6	7.1	13.8	7.0	14.4	18.2	8.0	10.5	32.7	15.5	5.3	10.6	4.3	7.3	11.5	12.6	3.2	1.7	2.2	1.4	3.6	7.5	2.8	1.2	1.8	4.6	13.9	10.5	5.8	4.0	5.6	8.3	4.2	7.2	2.9	2.5	4.5	3.5	2.2	3.9	5.2	2.6	7.1	2.7	4.8	2.1	1.0	3.5	17.3	9.7	6.3	6.2	15.4	5.4	13.4	5.1	9.2	6.4	3.2	1.1	5.4	11.4	4.3	3.7	5.9	2.8	3.0	5.3	1.3	6.9	6.3	4.3	3.6	14.5	2.7	19.8	2.7	3.2	3.1	29.0	5.4	2.1	0.7	5.3	5.0	10.8	8.1	0.1	0.9	2.2	2.7	1.2	7.5	3.2	5.3	3.5	1.7	2.5	7.4	5.8	0.6	3.6	1.4	1.5	5.1	2.8	12.4	18.5	32.4	18.9	10.5	12.2	15.4	14.5	14.0	15.5
TUBG2		ENSG00000037042	"Tubulin gamma 2"	Q9NRH3	17	42659305-42667006	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 55.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011495	Approved		Supported	"Centriolar satellite"				"Centriolar satellite"		"CAB011495: AB_443396"	"unprognostic (2.60e-1)"	"unprognostic (5.85e-3)"	"unprognostic (6.21e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.33e-3)"	"unprognostic (5.11e-2)"	"prognostic unfavourable (4.68e-5)"	"unprognostic (3.53e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (3.49e-4)"	"unprognostic (2.31e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.73e-1)"	"unprognostic (7.61e-3)"	15.4	17.7	32.9	5.8	34.5	2.8	10.3	21.7	55.7	13.3	9.6	24.2	5.5	5.8	13.9	14.2	9.9	14.4	10.2	17.2	34.5	24.3	12.6	5.2	10.9	6.6	25.7	29.2	20.7	29.9	17.6	14.2	8.7	30.4	13.5	5.4	11.7	15.7	22.5	6.6	11.2	5.3	13.5	19.4	9.1	9.5	8.3	20.8	1.0	13.0	3.1	5.2	12.2	9.7	2.1	7.1	0.5	1.4	1.4	5.9	2.7	5.0	10.5	5.1	7.7	20.2	11.2	3.3	9.0	10.1	7.3	7.2	5.8	3.7	2.5	5.4	12.9	18.9	0.1	8.2	5.9	4.9	6.0	1.8	13.3	11.5	8.8	0.2	6.8	12.3	8.7	8.4	9.0	5.2	0.5	5.6	13.8	10.5	4.8	4.3	1.8	2.7	3.7	3.2	5.6	7.6	5.2	5.9	4.1	5.7	9.2	5.9	17.6	2.4	5.8	23.2	1.6	5.8	5.1	29.4	5.2	0.8	8.1	0.2	13.5	0.0	1.4	0.3	5.0	0.9	2.3	2.1	5.4	1.9	1.5	0.9	5.9	3.9	0.5	1.4	0.3	7.1	2.4	2.7	32.9	34.5	21.7	55.7	34.5	24.3	25.7	29.2	30.4	20.8
TUSC5	"BEC-1, IFITMD3, LOST1"	ENSG00000184811	"Tumor suppressor candidate 5"	Q8IXB3	17	1279663-1300987	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"adipose tissue: 79.1;breast: 63.0"	"Cell line enriched"	"Detected in single"	262	"ASC diff: 26.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA050825	Approved									"HPA050825: "	"unprognostic (5.84e-2)"	"unprognostic (7.21e-2)"		"unprognostic (1.15e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.90e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (5.10e-1)"	79.1	0.9	0.0	2.1	0.0	0.1	63.0	0.0	0.1	0.2	4.1	0.0	0.0	0.1	0.1	0.9	0.2	0.2	3.4	5.2	0.0	0.0	0.4	0.1	0.1	2.2	0.0	0.0	0.2	0.5	0.1	0.0	0.1	0.0	0.1	0.2	0.0	2.5	1.4	4.4	0.8	1.1	0.2	0.0	0.1	0.2	0.2	0.0	0.0	0.6	2.7	0.1	0.8	2.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
TVP23A	"FAM18A, YDR084C"	ENSG00000166676	"Trans-golgi network vesicle protein 23 homolog A"	A6NH52	16	10760919-10818794	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 13.3"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.5;SH-SY5Y: 6.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060582	Uncertain		Approved	Vesicles				Vesicles		"HPA060582: "	"unprognostic (6.70e-4)"	"unprognostic (1.64e-3)"	"unprognostic (2.38e-2)"	"unprognostic (8.24e-3)"	"unprognostic (2.72e-2)"	"unprognostic (4.39e-5)"	"unprognostic (4.96e-2)"	"unprognostic (4.68e-2)"	"unprognostic (4.42e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.78e-7)"	"unprognostic (1.20e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.87e-4)"	1.9	4.3	10.1	3.3	11.0	5.5	1.1	5.6	13.3	1.7	1.4	2.3	1.6	2.4	2.4	2.3	1.2	2.3	3.2	2.5	9.4	8.0	1.3	1.5	2.3	6.1	6.6	11.8	8.7	2.0	0.5	3.6	0.8	5.7	4.6	1.4	3.1	2.1	3.7	1.9	2.5	2.6	2.8	2.9	3.2	2.1	2.8	3.1	1.3	1.5	0.0	2.6	2.4	1.4	1.6	3.8	0.8	0.8	0.5	0.8	0.4	0.3	0.8	0.9	1.0	0.0	0.3	0.7	0.2	0.0	0.0	0.1	0.2	0.7	1.3	0.4	0.2	1.1	0.0	0.0	0.0	2.7	0.6	0.4	1.7	1.2	0.0	0.3	1.5	0.4	0.0	0.4	0.0	0.0	0.4	1.2	0.0	0.8	0.8	1.1	3.5	0.1	1.9	0.3	0.3	0.1	1.3	0.5	6.0	0.2	0.6	0.1	0.6	0.5	0.9	1.0	0.8	1.1	0.5	3.2	0.5	0.8	0.9	1.1	0.5	0.6	0.8	0.2	0.6	0.6	0.4	0.9	0.8	0.2	3.8	1.6	0.4	0.4	0.8	0.5	0.6	0.8	0.2	0.4	10.1	11.0	5.6	13.3	9.4	8.0	6.6	11.8	5.7	3.1
TXNRD3NB	"TR2IT1, TXNRD3IT1, TXNRD3NT1"	ENSG00000206483	"Thioredoxin reductase 3 neighbor"	Q6F5E7	3	126571789-126572636	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"ovary: 1.4;testis: 2.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.2;HL-60: 2.1;NTERA-2: 1.5;PC-3: 1.0;U-937: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058257	Uncertain									"HPA058257: "																		0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.6	0.1	0.4	0.0			0.0	0.3	0.7	0.8	0.8	0.1	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0		1.4	0.0	0.0	0.1	0.0		0.1	0.0		0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2			0.3		0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.8	2.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.2	0.0	0.8	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TXNRD3NB	"TR2IT1, TXNRD3IT1, TXNRD3NT1"	ENSG00000283374	"Thioredoxin reductase 3 neighbor"	Q6F5E7	3	126571779-126608555	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"parathyroid gland: 1.1"	"Cell line enhanced"	"Detected in some"		"A549: 1.8;PC-3: 1.3"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058257	Uncertain									"HPA058257: "																		0.1	0.0		0.1		0.0	0.0		0.0	0.0	0.0			0.0	0.2	0.0	0.0	0.5	0.0	0.0			0.2	0.0	0.2	0.0			0.7	0.0	1.1		0.0		0.0	0.0		0.0	0.0	0.7	0.0	0.1	0.0		0.0	0.0	0.7			0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.6	0.0	0.7	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TYW1	"FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W"	ENSG00000198874	"TRNA-yW synthesizing protein 1 homolog"	Q9NV66	7	66995173-67239519	"Enzymes, Predicted membrane proteins"	"tRNA processing"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097"	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA013568: , HPA014118: , HPA015535: AB_1856487, HPA043136: , HPA047029: , HPA047052: , HPA052097: "	"unprognostic (1.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.79e-2)"	15.4	19.1	10.2	12.3	15.4	11.9	15.1	14.9	15.3	18.8	12.9	21.2	18.2	14.1	22.7	15.3	12.0	15.5	10.8	12.9	10.8	9.8	15.2	17.7	11.1	15.5	14.1	10.8	19.4	23.9	22.9	28.0	13.2	14.5	14.9	16.5	17.8	15.3	14.7	26.2	14.4	12.8	14.0	13.9	15.1	12.6	13.7	13.4	19.7	19.0	13.6	23.3	15.3	15.2	9.6	8.3	3.6	9.1	11.2	11.8	5.3	10.5	13.5	8.3	17.1	12.4	8.6	9.6	11.3	8.6	9.0	8.4	15.4	13.8	18.4	17.4	10.4	12.5	17.1	13.9	13.0	14.4	13.1	7.9	11.2	10.4	12.3	18.3	10.6	8.8	14.1	12.1	18.7	8.1	20.9	11.1	10.2	10.4	11.5	15.3	14.5	12.1	13.1	11.6	23.1	12.2	10.7	12.7	12.6	13.6	26.4	11.3	18.0	13.0	9.5	10.3	7.4	8.2	15.4	11.2	15.8	22.2	8.4	17.2	14.2	2.0	7.0	3.6	8.6	7.8	11.7	8.5	9.4	9.8	8.3	9.6	11.5	11.8	2.0	11.2	9.1	6.6	6.8	5.3	10.2	15.4	14.9	15.3	10.8	9.8	14.1	10.8	14.5	13.4
TYW3	"C1orf171, FLJ40918"	ENSG00000162623	"TRNA-yW synthesizing protein 3 homolog"	Q6IPR3	1	74733152-74766678	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029641	Approved		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA029641: AB_2272535"	"unprognostic (6.89e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavourable (1.49e-7)"	"unprognostic (3.79e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.98e-3)"	16.5	19.7	13.7	13.5	17.7	11.9	18.3	15.0	19.9	20.4	17.7	7.5	13.7	9.5	21.0	15.2	20.6	16.4	10.0	21.1	11.1	12.9	20.4	17.0	11.3	14.3	16.2	17.2	30.0	14.4	22.2	34.3	13.5	17.0	20.7	12.3	8.6	13.8	15.7	12.3	10.5	10.9	24.7	15.6	16.0	14.8	12.3	18.1	12.3	23.5	14.3	16.9	23.5	33.3	9.7	9.0	6.0	8.0	13.6	13.9	5.2	8.4	7.1	12.4	8.8	14.1	15.4	18.8	14.6	13.4	14.0	12.3	15.1	7.2	22.3	13.4	12.6	6.9	14.1	16.9	17.6	13.8	12.2	17.5	21.8	29.2	9.2	34.9	11.3	11.7	17.1	17.8	17.3	12.4	30.3	17.1	17.9	7.2	17.0	11.7	32.8	16.7	16.1	25.8	10.0	12.0	11.1	9.6	8.2	6.9	19.1	22.4	10.4	12.8	8.0	6.2	17.0	16.8	17.5	9.9	17.9	15.6	13.9	12.7	17.8	6.0	6.0	1.6	10.3	8.0	9.9	9.7	9.1	9.3	9.0	8.8	13.2	13.9	0.5	13.6	5.9	8.7	8.4	5.2	13.7	17.7	15.0	19.9	11.1	12.9	16.2	17.2	17.0	18.1
UBALD1	FAM100A	ENSG00000153443	"UBA like domain containing 1"	Q8TB05	16	4608883-4615027	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066771	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytosol"				"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA066771: "	"unprognostic (7.09e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.67e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.63e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.35e-2)"	23.0	16.7	20.5	17.9	25.0	37.5	11.9	32.4	39.2	12.1	19.3	15.1	11.7	23.7	20.4	11.0	15.0	13.9	12.4	14.8	20.9	14.2	19.6	32.9	15.7	13.8	12.0	22.2	14.8	27.2	9.0	12.1	27.9	16.9	18.9	5.3	13.6	19.4	18.1	38.3	16.7	19.5	14.2	11.5	23.9	25.9	13.2	13.0	9.9	17.3	11.3	11.6	17.8	12.8	1.9	2.8	11.3	4.5	1.5	2.6	1.5	5.4	15.7	3.7	5.9	2.5	3.3	16.8	8.2	3.4	3.2	4.6	7.7	6.4	8.1	9.2	2.5	15.0	2.4	8.4	0.9	17.0	23.9	7.6	16.4	11.9	5.2	4.7	13.0	4.6	6.3	4.9	2.4	3.4	11.4	8.5	1.2	26.8	7.8	25.7	14.0	13.9	11.3	4.6	26.2	2.8	7.9	10.9	10.0	9.7	15.0	12.9	9.6	7.7	10.0	6.5	7.3	25.8	5.3	16.6	13.3	9.1	2.6	6.4	3.3	1.3	2.3	11.3	2.5	3.5	1.6	1.9	2.0	2.6	2.8	1.8	2.1	2.2	3.9	1.5	4.5	1.8	2.4	1.5	20.5	25.0	32.4	39.2	20.9	14.2	12.0	22.2	16.9	13.0
UBAP1L		ENSG00000246922	"Ubiquitin associated protein 1 like"	F5GYI3	15	65092770-65115197	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	8	"retina: 91.1"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 6.8;U-266/70: 3.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	10	"cerebellum: 49.0;pons and medulla: 8.6"	HPA065334			Uncertain	"Nuclear bodies"				"Nuclear bodies"		"HPA065334: "	"unprognostic (6.89e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.59e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.62e-5)"	"unprognostic (6.40e-3)"	"unprognostic (3.11e-6)"	"unprognostic (5.03e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.70e-1)"	"unprognostic (6.11e-3)"	1.4	1.5	2.4	0.9	2.4	1.1	1.3	11.5	3.6	1.5	0.9	0.9	0.9	0.4	2.7	1.1	1.2	1.5	0.9	0.9	2.8	3.2	0.9	1.1	1.0	1.1	2.6	0.9	3.2	1.0	0.5	0.9	0.9	3.6	1.1	0.2	91.1	2.0	1.8	6.2	1.5	1.1	1.2	3.1	2.0	0.9	1.5	0.9	0.9	1.2	0.9	2.2	0.9	0.9	0.1	1.3	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.8	2.0	0.6	0.2	1.8	1.3	0.1	0.6	0.6	1.1	0.3	0.9	1.6	0.2	1.4	1.1	0.1	0.0	1.7	1.1	0.1	1.1	0.2	0.8	1.0	0.9	0.6	0.9	0.3	0.4	0.2	0.5	0.7	0.2	0.2	0.3	1.2	0.7	0.7	1.5	0.5	1.1	0.0	0.3	1.0	0.6	0.6	0.2	6.8	0.4	1.0	0.0	0.6	0.3	0.6	0.6	3.6	0.6	0.4	0.4	0.7	0.5	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.4	0.0	1.3	0.0	0.0	2.4	2.4	11.5	3.1	2.8	3.2	2.6	0.9	3.6	0.9
UBE2L5	UBE2L5P	ENSG00000236444	"Ubiquitin conjugating enzyme E2 L5"		13	30422488-30428616	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	9	"testis: 31.5"	"Low cell line specificity"	"Detected in some"			"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in single"			"HPA045609, HPA062415"	Approved		Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA045609: AB_10961322, HPA062415: "	"unprognostic (2.09e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.01e-3)"	"unprognostic (6.41e-4)"	"unprognostic (1.78e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (3.50e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.44e-2)"	"unprognostic (8.75e-2)"	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.3	0.3	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.7		0.3	0.2	0.2	0.1	0.2	0.5	0.3	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	31.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.2	1.9	2.7	3.6	1.9	2.0	2.8	0.6	0.3	1.2	1.6	0.6	0.6	0.6	1.1	0.6	0.4	0.2	0.0	3.0	1.4	0.5	1.3	0.6	0.8	0.4	1.1	2.4	0.6	0.4	0.8	0.2	0.2	0.7	1.5	0.2	0.3	0.6	0.2	0.9	0.7	1.3	0.3	0.0	1.6	2.5	1.3	0.2	0.4	0.6	0.4	0.9	1.5	1.2	0.3	0.4	0.1	1.8	0.6	2.4	0.0	0.7	0.5	0.7	1.1	1.5	0.3	1.6	1.0	0.9	0.4	1.8	1.1	1.9	1.4	3.6	1.2	3.2	1.5	1.6	1.5	1.7	1.4	2.0	2.7	1.9	1.6	1.9	2.0	2.8										
UBR3	"DKFZp434P117, FLJ37422, KIAA2024, ZNF650"	ENSG00000144357	"Ubiquitin protein ligase E3 component n-recognin 3 (putative)"	Q6ZT12	2	169827458-170084131	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035390	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA035390: AB_10670699"	"unprognostic (1.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.18e-1)"	11.9	15.5	10.9	6.1	18.3	5.4	9.6	15.5	18.9	9.9	10.0	9.8	9.1	6.7	11.5	7.1	10.7	8.1	7.8	23.1	10.3	7.2	12.9	16.9	9.2	5.6	11.9	14.0	8.9	9.8	20.9	14.9	7.2	14.7	11.2	7.3	8.0	11.1	9.2	76.3	11.5	8.4	9.6	10.2	6.9	9.2	7.9	11.4	6.3	14.9	10.9	6.0	12.8	8.7	2.0	2.8	1.9	2.1	2.4	4.3	1.2	8.8	7.5	8.0	10.6	16.0	12.7	6.8	16.0	9.3	9.3	7.5	11.5	5.6	10.0	13.9	12.4	11.7	9.5	8.1	11.6	10.4	8.2	36.6	8.0	12.2	8.0	12.1	11.9	7.6	7.6	12.1	8.1	9.1	19.0	10.9	15.7	8.3	7.8	5.9	6.3	6.3	7.5	13.2	10.6	6.7	12.5	15.8	8.6	11.2	10.4	6.5	6.8	6.8	11.5	14.0	5.7	10.9	10.0	8.9	6.9	9.2	11.5	7.1	7.7	0.0	2.1	1.7	3.2	1.8	4.2	2.0	1.9	2.7	2.8	1.2	3.3	4.3	1.9	2.4	1.6	2.4	3.1	1.2	10.9	18.3	15.5	18.6	10.3	7.2	11.9	14.0	14.7	11.4
UCMA	C10orf49	ENSG00000165623	"Upper zone of growth plate and cartilage matrix associated"	Q8WVF2	10	13221767-13234334	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 6.2;heart muscle: 3.2;ovary: 5.4;pituitary gland: 2.4"	"Cell line enhanced"	"Detected in single"		"THP-1: 3.5"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Group enriched"	"Detected in some"	6	"amygdala: 6.2;basal ganglia: 3.7;cerebral cortex: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046718	Uncertain				"Secreted to extracellular matrix"					"HPA046718: "															"unprognostic (4.25e-1)"			0.0	0.0	6.2	0.2	3.7	0.0	0.0	0.2	6.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	3.2	0.7	0.2	0.0	0.1	0.5	0.0	0.1	0.9	5.4	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	3.7	0.2	6.1	0.7	0.2	0.1	0.9	0.0	0.0
UFSP1	UFSP	ENSG00000176125	"UFM1 specific peptidase 1 (inactive)"	Q6NVU6	7	100888723-100889718	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA027099	Uncertain									"HPA027099: AB_2214069"	"unprognostic (8.56e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.71e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.09e-2)"	7.4	6.3	2.8	3.9	5.4	2.6	4.0	3.1	4.1	3.1	4.5	6.1	2.8	4.3	5.6	6.1	4.1	4.6	2.5	3.6	4.8	4.6	5.3	6.5	2.8	5.9	8.9	4.1	5.8	8.6	3.4	6.8	5.7	3.9	4.8	2.8	3.0	6.4	5.0	10.6	3.4	5.8	4.0	3.5	4.3	5.1	2.0	7.8	6.5	4.2	2.8	5.0	4.8	4.7	5.9	7.2	2.4	3.9	4.4	6.4	3.1	3.6	4.7	1.1	4.8	4.8	2.8	3.0	2.8	0.9	1.2	0.8	1.9	2.6	0.8	2.2	2.2	7.0	1.4	1.7	0.7	3.2	10.5	3.0	3.8	2.2	4.7	1.3	1.5	3.2	2.1	1.5	6.0	0.3	4.5	2.3	1.8	9.0	3.0	7.4	3.6	6.5	1.5	1.4	6.9	2.1	1.5	3.4	5.5	5.5	7.2	3.0	1.7	1.1	1.2	3.2	3.2	3.4	2.2	2.3	2.7	0.2	1.1	2.3	3.6	0.0	3.9	2.4	5.4	3.4	6.1	1.8	4.7	2.9	4.8	5.9	5.3	6.4	0.8	4.4	3.3	7.2	2.0	3.1	2.8	5.4	3.1	4.1	4.8	4.6	8.9	4.1	3.9	7.8
UGT2A3	FLJ21934	ENSG00000135220	"UDP glucuronosyltransferase family 2 member A3"	Q6UWM9	4	68928463-68951791	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 150.5;kidney: 43.2"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 20.5"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 46.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"eosinophil: 5.3"	"Lineage enriched"	"Detected in single"	53	"granulocytes: 5.3"									HPA045108	Supported									"HPA045108: "			"prognostic favourable (3.31e-4)"				"unprognostic (3.97e-3)"				"unprognostic (8.87e-3)"		"prognostic favourable (6.07e-7)"	"unprognostic (2.10e-2)"				0.1	0.1	0.1	4.3	0.1	0.0	0.7	0.1	0.1	0.1	63.8	0.1	0.1	31.9	0.1	1.7	0.1	0.1	14.6	0.3	0.1	0.1	43.2	9.6	0.1	0.1	0.1	0.1	0.1	12.0	0.0	0.1	0.1	0.1	0.1	8.6	0.1	0.1	0.1	0.1	0.1	150.5	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
UGT2B11		ENSG00000213759	"UDP glucuronosyltransferase family 2 member B11"	O75310	4	69199951-69214731	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"breast: 77.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;HL-60: 3.0;NB-4: 2.4;RPTEC TERT1: 3.6;U-2197: 1.4"	"Group enriched"	"Detected in some"	17	"breast cancer: 17.4;liver cancer: 13.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	62	"basophil: 6.8;eosinophil: 5.6"	"Lineage enriched"	"Detected in single"	68	"granulocytes: 6.8"									HPA045108	Uncertain									"HPA045108: "	"unprognostic (1.12e-1)"						"unprognostic (1.18e-3)"			"unprognostic (1.49e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	77.4	0.1	0.1	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.0	3.3	0.1	0.1	0.0	1.2	7.3	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	7.0	0.1	0.1	1.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	3.6	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	6.8	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
UGT3A1	FLJ34658	ENSG00000145626	"UDP glycosyltransferase family 3 member A1"	Q6NUS8	5	35951010-36001028	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 44.0;liver: 47.7"	"Cell line enriched"	"Detected in single"	42	"RH-30: 24.7"	"Group enriched"	"Detected in some"	15	"liver cancer: 6.7;renal cancer: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA047697, HPA056290"	Uncertain		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA047697: , HPA056290: "				"unprognostic (2.41e-3)"			"unprognostic (4.47e-1)"			"unprognostic (4.04e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.05e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.76e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	5.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	44.0	47.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	3.2	0.1	6.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.4	0.2	0.2	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
UGT3A2		ENSG00000168671	"UDP glycosyltransferase family 3 member A2"	Q3SY77	5	36035017-36071358	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;T-47d: 5.7;THP-1: 12.9"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 4.4"	"Region enhanced"	"Detected in single"		"pons and medulla: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059475	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059475: "	"unprognostic (1.83e-4)"	"unprognostic (9.94e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.82e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.52e-3)"	0.1	1.1	0.1	0.0	0.2	6.4	1.6	0.1	0.6	0.1	0.1	0.5	0.4	0.0	0.1	0.8	0.1	0.1	0.2	0.2	0.1	0.6	5.6	0.8	0.1	0.0	0.5	0.0	0.2	0.0	0.0	1.7	0.2	2.0	0.6	0.0	2.9	0.1	0.0	0.1	14.4	0.1	0.0	0.3	1.4	0.1	13.2	0.0	37.0	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.4	5.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	4.0	0.0	21.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.6	0.1	0.6	0.5	0.0	2.0	0.0
UGT8	CGT	ENSG00000174607	"UDP glycosyltransferase 8"	Q16880	4	114598455-114678224	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 96.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 25.3;RH-30: 12.1;RPTEC TERT1: 25.0;SCLC-21H: 14.2;U-87 MG: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 7.3;naive B-cell: 10.6"	"Lineage enriched"	"Detected in single"	12	"B-cells: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014405, HPA065785"	Enhanced		Approved	Mitochondria				Mitochondria		"HPA014405: AB_1858606, HPA065785: "	"unprognostic (7.38e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-1)"	"prognostic favourable (8.55e-5)"	"unprognostic (2.80e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.49e-1)"	0.9	0.8	13.2	2.8	30.0	1.0	3.1	2.7	44.8	4.9	15.5	66.6	0.0	18.4	2.7	0.6	1.2	3.0	7.1	0.9	24.2	12.4	20.1	0.8	1.0	3.2	53.9	15.9	0.8	4.8	0.3	0.9	0.5	38.3	0.9	17.3	0.0	4.5	0.8	0.8	1.8	16.1	1.5	96.6	1.3	10.0	3.3	42.6	0.0	8.5	0.0	3.4	0.8	1.0	10.6	0.0	0.9	0.0	0.0	0.6	0.3	0.3	0.1	2.0	0.3	0.1	0.0	0.3	0.1	0.0	0.0	1.5	6.8	25.3	7.6	0.6	0.1	10.7	0.0	0.0	0.0	0.1	5.3	0.1	11.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	6.4	1.5	0.0	0.1	0.1	0.8	3.0	3.8	0.7	12.1	0.2	25.0	0.3	14.2	2.1	0.1	2.2	0.3	0.4	2.4	0.5	0.5	8.6	0.3	7.9	2.5	0.4	0.2	12.5	0.4	7.8	0.2	0.0	0.9	0.0	0.0	0.6	7.3	0.1	0.0	0.0	10.6	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.3	13.2	30.0	2.7	24.4	24.2	12.4	53.9	15.9	38.3	42.6
UMODL1		ENSG00000177398	"Uromodulin like 1"	Q5DID0	21	42062959-42143453	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 22.7"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 3.6;U-266/70: 8.9"	"Group enriched"	"Detected in some"	7	"lung cancer: 0.6;testis cancer: 2.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA067245	Uncertain									"HPA067245: "	"unprognostic (4.70e-3)"	"unprognostic (3.75e-5)"	"unprognostic (2.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.72e-7)"	"unprognostic (2.38e-1)"	"unprognostic (9.47e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.82e-1)"	"unprognostic (9.24e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-4)"	"unprognostic (2.68e-1)"	0.6	0.1	0.4	3.6	0.1	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	4.9	0.0	0.2	0.2	0.3	0.4	0.4	0.6	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.1	0.8	0.2	3.8	0.0	22.7	0.1	0.0	2.0	0.1	0.0	0.5	0.1	0.3	0.5	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.5	0.5	0.0	0.1	0.3	0.7	0.6	0.0	0.0	0.5	0.0	1.0	0.2	0.4	0.1	0.1	0.3	0.2	0.3	0.0	0.0	0.0	0.0
UNC79	KIAA1409	ENSG00000133958	"Unc-79 homolog, NALCN channel complex subunit"	Q9P2D8	14	93333219-93707876	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.6;pituitary gland: 18.9"	"Group enriched"	"Detected in some"	5	"REH: 8.3;SCLC-21H: 6.1;SH-SY5Y: 3.9;U-937: 3.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA071881			Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA071881: "	"unprognostic (8.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.70e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.73e-3)"	"unprognostic (8.03e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.03e-2)"	"unprognostic (7.47e-2)"	1.1	3.9	7.1	1.0	12.1	0.9	1.0	17.6	14.6	1.0	1.1	4.5	0.0	1.1	1.1	1.1	1.2	2.0	1.1	1.2	6.7	5.8	1.4	1.1	1.0	1.0	3.2	9.1	1.1	5.0	1.4	18.9	1.0	6.8	1.0	1.1	1.3	1.0	1.0	1.6	1.0	1.1	1.2	3.0	0.9	1.9	7.0	3.5	0.0	1.3	0.0	1.0	1.0	0.3	0.1	0.2	0.6	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	0.0	8.3	0.0	0.0	0.2	0.2	6.1	3.9	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	7.1	12.1	17.6	14.6	6.7	5.8	3.2	9.1	6.8	3.5
UNC93A	"dJ366N23.1, dJ366N23.2"	ENSG00000112494	"Unc-93 homolog A"	Q86WB7	6	167271169-167316019	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 9.8;liver: 17.4;skin 1: 18.8"	"Group enriched"	"Detected in some"	9	"CACO-2: 11.7;Hep G2: 4.8;SCLC-21H: 5.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			HPA035729	Uncertain									"HPA035729: AB_10696508"		"unprognostic (2.49e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.32e-1)"		"unprognostic (1.28e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.99e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.92e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.5	1.4	0.1	0.1	9.2	0.1	0.5	5.9	1.0	1.6	0.1	0.1	0.0	2.5	17.4	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.5	0.1	0.1	18.8	9.8	0.1	0.1	0.1	0.1	0.1	0.1	1.6	0.1	3.9	2.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
UPK3BL1	"UPK3BL, UPLP"	ENSG00000267368	"Uroplakin 3B like 1"	"B0FP48, E5RIL1"	7	102637025-102642791	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 45.1;lymphoid tissue: 34.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 47.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA011403	Supported									"HPA011403: "	"unprognostic (4.63e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.39e-3)"	"unprognostic (4.00e-1)"	"unprognostic (8.11e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.15e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.93e-2)"	3.0	2.2	2.1	3.3	2.7	7.9	3.0	4.5	2.1	6.5	2.9			3.6	3.4	1.7	45.1	3.7	1.0	2.2	3.0	1.9	4.6	4.0	3.4	7.1	2.1		3.7	3.8	3.4	4.3	1.7		5.9	1.5		7.7	23.7	6.5	5.1	4.6	0.9	2.0	8.8	3.0	1.3			13.1		34.6	11.8	15.1	5.3	6.8	13.6	5.9	7.1	9.6	4.7	7.2	5.7	3.7	1.6	1.5	0.2	5.1	0.0	0.8	0.8	2.1	0.9	4.0	1.1	1.4	0.9	47.8	1.1	5.3	0.6	6.5	8.4	1.1	2.4	1.7	0.5	1.9	1.9	3.2	6.9	0.0	1.3	6.7	2.8	4.0	2.4	16.6	2.9	15.9	1.7	1.7	2.9	2.0	6.0	6.8	5.8	2.5	5.8	9.9	2.6	2.4	0.8	2.9	2.3	14.2	6.1	5.0	2.8	4.2	1.9	0.6	3.0	4.4	2.3	13.6	5.9	8.5	9.6	5.2	4.4	5.3	5.0	4.7	6.8	4.9	6.3	4.8	7.1	7.1	1.7	6.8	7.9	4.7										
URB2	"KIAA0133, NET10, NPA2"	ENSG00000135763	"URB2 ribosome biogenesis 2 homolog (S. cerevisiae)"	Q14146	1	229626234-229660199	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008902, HPA046788"	Uncertain		Enhanced	Nucleoli				Nucleoli		"HPA008902: AB_2213805, HPA046788: "	"unprognostic (1.26e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.16e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.45e-1)"	9.8	6.2	7.0	7.2	7.8	7.6	6.5	5.8	11.0	4.7	5.0	9.5	2.9	4.3	7.4	3.8	8.0	6.9	5.2	4.9	5.3	3.7	4.3	10.4	4.9	12.0	8.2	7.7	7.2	13.7	6.5	9.9	6.5	8.0	5.0	4.9	6.4	5.8	3.8	14.0	5.8	5.3	6.6	5.8	8.4	5.8	15.6	7.2	10.3	4.6	6.2	9.0	5.5	4.8	2.7	2.7	0.5	3.9	1.9	5.6	2.9	7.3	11.0	7.2	9.6	4.5	3.8	22.0	5.8	3.6	9.1	6.9	10.9	5.8	15.2	6.8	4.1	10.1	17.8	7.1	8.3	7.4	16.9	9.4	9.3	6.4	4.3	13.8	8.2	3.7	5.2	9.0	7.0	4.3	20.0	7.1	5.6	5.8	15.3	6.8	24.1	7.3	17.2	10.2	15.2	4.0	9.3	10.8	13.2	6.9	7.2	5.8	8.1	7.9	4.7	7.5	9.4	9.4	16.6	7.9	7.6	22.8	4.0	10.4	13.5	0.2	1.9	0.5	3.0	3.9	5.6	2.0	2.8	3.6	2.7	2.7	4.3	3.3	0.2	1.9	1.3	1.6	3.1	2.9	7.0	7.8	5.8	11.0	5.3	3.7	8.2	7.7	8.0	7.2
USP29		ENSG00000131864	"Ubiquitin specific peptidase 29"	Q9HBJ7	19	57119138-57131926	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 4.1;bone marrow: 2.7;pancreas: 2.1;skin 1: 2.3;testis: 8.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.3;HEK 293: 3.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA076515	Enhanced									"HPA076515: "															"unprognostic (1.32e-1)"			0.1	0.1	0.2	0.0	0.2	2.7	0.1	0.1	0.4	0.1	0.1			0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.3	0.2	0.1	0.1	0.1	0.3	0.1		0.2	2.1	0.0	0.1	0.0		0.1	0.0		0.7	0.0	0.2	2.3	0.1	0.0	0.1	0.1	0.4	8.4			0.4		0.0	0.7	0.1	1.1	1.9	4.1	1.1	1.2	0.8	0.6	0.1	0.7	0.8	0.3	0.0	0.0	3.3	0.0	0.0	0.1	0.1	1.7	0.0	0.9	0.0	0.0	2.0	0.0	0.0	0.0	1.0	3.2	0.8	0.0	0.0	1.1	0.0	1.9	0.9	1.0	1.4	0.0	0.0	0.3	0.9	0.0	0.7	0.0	1.2	0.0	1.0	0.9	0.0	1.0	0.0	2.1	2.0	0.7	0.6	0.4	0.2	0.8	1.3	1.5	1.2	0.5	0.0	0.0	1.6	0.5	1.5	0.5	0.8	0.0	3.1	1.1	1.1	0.8	0.7	0.6	0.5	0.7	0.3	0.3	1.1	0.7	0.7	4.1	1.2	0.4	1.9	0.5	0.6										
USP31	KIAA1203	ENSG00000103404	"Ubiquitin specific peptidase 31"	Q70CQ4	16	23061406-23149270	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006937	Uncertain		Approved	Cytosol				Cytosol		"HPA006937: AB_1080523"	"unprognostic (6.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (4.41e-5)"	"unprognostic (5.59e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.98e-3)"	6.3	5.3	11.2	4.0	16.6	7.1	8.7	12.7	16.5	10.9	4.9	19.7	2.6	3.7	15.3	7.7	9.3	6.5	4.1	11.0	9.0	6.3	6.2	7.7	7.3	3.6	24.6	8.1	3.7	6.3	20.6	10.4	7.4	17.4	9.6	4.9	2.8	6.0	8.5	10.9	15.9	3.4	14.2	14.8	2.8	3.5	20.7	19.3	1.7	4.2	2.4	4.9	13.4	9.5	0.5	0.8	0.6	1.3	0.1	2.1	0.2	9.4	10.0	2.9	4.0	5.3	4.1	2.7	3.3	3.0	4.3	5.1	6.3	5.8	3.2	3.5	4.1	12.5	7.1	12.9	7.1	2.3	2.9	1.3	5.8	13.2	6.6	3.3	3.6	3.5	11.2	7.9	18.3	7.6	3.8	9.9	5.8	6.5	1.6	2.7	5.7	3.1	7.9	8.1	6.3	6.4	14.2	7.7	5.0	5.1	10.2	2.9	4.1	7.3	4.4	8.7	6.4	4.4	8.9	3.3	5.4	3.4	6.2	4.4	3.4	0.1	0.7	0.6	0.8	0.3	2.1	0.1	0.7	1.5	0.8	0.5	0.8	0.8	0.1	0.1	1.3	0.2	1.3	0.2	11.2	16.6	12.7	16.5	9.0	6.3	24.6	8.1	17.4	19.3
USP50		ENSG00000170236	"Ubiquitin specific peptidase 50"	Q70EL3	15	50500562-50546708	"Enzymes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	15	"testis: 20.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.2;HEL: 1.1;RH-30: 1.0;SK-BR-3: 1.7;SK-MEL-30: 2.9;U-698: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	9	"hippocampal formation: 0.4"	"Low region specificity"	"Detected in single"			HPA039470	Uncertain									"HPA039470: AB_10672964"	"unprognostic (7.05e-3)"	"unprognostic (2.38e-1)"		"unprognostic (2.01e-2)"	"unprognostic (4.04e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.49e-4)"	"unprognostic (3.03e-1)"	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.2	1.7	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.6	1.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP9Y	DFFRY	ENSG00000114374	"Ubiquitin specific peptidase 9, Y-linked"	O00507	Y	12701231-12860839	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 16.0;RT4: 8.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.7"					"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 2.4;dendritic cells: 2.0;T-cells: 2.7"	"Not detected"	"Not detected"							HPA057687			Uncertain	Vesicles				Vesicles		"HPA057687: "			"unprognostic (2.63e-1)"		"unprognostic (8.97e-2)"	"unprognostic (1.10e-5)"	"unprognostic (8.46e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.42e-1)"	1.2	2.2	1.4	0.9	3.1	1.7	1.1	9.6	4.0	0.0	1.6			1.4	0.0	8.6	4.4	0.0	3.8	2.4	1.8	3.4	2.9	2.2	2.2	1.4	2.1		0.0	2.7	0.0	4.8	1.7		9.3	4.8		2.3	7.6	2.8	2.0	1.8	0.0	1.5	2.2	1.5	2.9			2.8		4.5	3.2	0.0	2.4	2.0	0.1	0.2	0.5	2.7	0.2	0.0	2.2	0.0	0.0	0.0	0.0	2.4	7.1	7.1	3.6	3.9	0.0	0.0	4.0	0.0	5.9	0.0	0.0	0.0	3.2	2.2	0.0	2.5	0.0	7.0	4.0	0.0	0.0	5.9	5.2	0.0	0.0	0.0	0.0	0.0	6.4	0.0	4.0	0.0	1.5	0.0	0.0	2.0	0.8	16.0	8.6	2.8	0.0	0.0	0.0	2.1	0.0	0.0	5.5	4.4	0.0	0.0	3.2	0.0	3.7	7.0	0.1	0.0	0.0	0.0	0.1	0.0	1.9	0.2	2.7	1.2	2.2	1.5	0.3	2.4	2.2	1.3	0.1	0.5	0.0	2.0	1.6	0.2										
UST	2OST	ENSG00000111962	"Uronyl 2-sulfotransferase"	Q9Y2C2	6	148747328-149076990	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 6.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032022	Approved									"HPA032022: AB_10603326"	"unprognostic (3.43e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.22e-5)"	"unprognostic (1.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.25e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.02e-2)"	8.6	16.0	4.8	7.1	9.3	0.8	8.5	20.9	10.8	12.8	8.6	6.0	6.6	2.6	10.8	8.1	8.2	10.4	12.2	4.5	6.3	12.6	5.2	2.2	8.6	4.9	14.1	4.5	15.6	19.0	0.7	2.3	6.1	13.0	9.8	4.0	10.7	4.3	6.9	3.7	8.6	5.6	11.5	9.1	8.0	5.7	12.1	6.5	3.1	37.5	5.7	4.9	10.6	21.0	1.5	1.3	0.1	0.9	6.2	1.7	0.4	0.0	2.1	12.5	9.5	15.1	12.6	0.1	5.2	13.9	2.6	6.8	0.0	0.8	4.4	1.1	8.2	3.8	8.8	4.4	5.2	5.8	6.6	0.1	7.0	0.1	5.6	0.2	1.9	6.5	10.0	6.7	12.6	0.1	0.0	0.0	2.0	5.4	0.0	0.0	7.2	2.8	2.0	1.7	5.0	0.1	9.9	6.4	0.0	17.6	4.3	3.3	3.2	0.2	0.2	7.5	0.9	1.7	4.7	0.0	0.0	0.0	8.4	3.5	4.2	0.0	0.2	0.0	1.7	0.7	1.4	0.8	1.3	1.5	1.1	1.5	0.1	0.7	0.1	6.2	0.9	1.3	0.4	0.4	4.8	9.3	20.9	7.4	6.3	12.6	14.1	4.5	13.0	6.5
UTP6	"C17orf40, HCA66"	ENSG00000108651	"UTP6, small subunit processome component"	Q9NYH9	17	31860899-31901765	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025936, HPA055806"	Supported		Enhanced	Nucleoli				Nucleoli		"HPA025936: AB_1845588, HPA055806: "	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavourable (1.86e-5)"	"unprognostic (5.68e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (1.16e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-2)"	"unprognostic (4.76e-2)"	19.3	17.9	18.7	16.9	19.3	19.0	26.4	28.7	19.3	17.7	19.5	18.0	12.5	10.8	23.4	30.4	15.7	13.3	10.7	13.0	19.5	17.0	16.7	20.7	15.4	23.3	16.2	16.1	19.5	17.0	14.1	26.0	21.4	16.2	19.9	15.9	15.0	15.9	15.0	17.0	25.3	15.2	17.0	18.8	23.1	16.4	18.5	19.1	23.2	17.1	18.5	28.1	16.0	15.5	15.4	19.7	13.1	10.9	5.7	8.0	7.0	8.3	5.5	7.7	4.4	8.0	5.3	9.4	7.2	4.1	11.0	8.5	19.6	4.4	12.6	9.1	6.6	11.0	10.9	9.0	10.2	3.2	16.4	7.8	12.3	17.8	8.8	12.0	8.1	8.1	9.0	10.8	7.9	7.0	13.8	7.2	8.7	6.8	11.2	32.0	10.2	8.6	11.7	11.0	12.3	11.3	7.7	5.1	7.7	7.6	5.4	12.1	13.3	22.5	7.3	16.6	12.5	8.7	14.5	8.1	14.5	18.3	11.4	8.4	8.9	10.6	10.8	6.7	7.6	10.9	7.3	12.7	8.0	8.0	13.6	15.4	7.1	8.0	13.1	5.7	9.7	19.7	7.7	7.0	18.7	19.3	28.7	19.3	19.5	17.0	16.2	16.1	16.2	19.1
VCX	"VCX-10r, VCX-B1, VCX1, VCX10R"	ENSG00000182583	"Variable charge, X-linked"	Q9H320	X	7842262-7844143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	51	"testis: 22.7"	"Cell line enhanced"	"Detected in some"		"NB-4: 3.7;RPMI-8226: 3.0;THP-1: 3.4;U-138 MG: 3.3;U-266/70: 6.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044996, HPA049357"	Supported									"HPA044996: , HPA049357: "					"unprognostic (1.65e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.73e-1)"			"unprognostic (7.89e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.20e-1)"		"unprognostic (7.18e-3)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.4	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.7	2.2	0.0	0.8	0.0	3.7	1.8	0.4	0.5	0.0	3.0	0.0	1.5	0.1	0.2	0.0	0.0	0.0	1.5	3.4	0.0	3.3	0.8	2.2	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0
VCX2	VCX-2r	ENSG00000177504	"Variable charge, X-linked 2"	Q9H322	X	8169944-8171267	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	106	"testis: 21.5"	"Group enriched"	"Detected in some"	5	"T-47d: 1.8;U-266/70: 2.4"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 0.8;testis cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044642, HPA044996, HPA049357"	Enhanced									"HPA044642: , HPA044996: , HPA049357: "															"unprognostic (1.34e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	21.5			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
VCX3A	"VCX-8r, VCX-A, VCX3"	ENSG00000169059	"Variable charge, X-linked 3A"	Q9NNX9	X	6533618-6535118	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	195	"testis: 28.8"	"Cell line enhanced"	"Detected in some"		"HMC-1: 7.3;PC-3: 3.7;U-138 MG: 11.0;U-2197: 2.7;U-266/70: 6.9"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044996, HPA049357"	Supported									"HPA044996: , HPA049357: "					"unprognostic (1.11e-1)"			"unprognostic (1.39e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.43e-1)"					"unprognostic (3.29e-2)"		"unprognostic (1.64e-2)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.1		0.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	28.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	3.7	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.0	11.0	0.0	2.7	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
VCX3B	VCX-C	ENSG00000205642	"Variable charge, X-linked 3B"	Q9H321	X	8464830-8466510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	61	"testis: 21.7"	"Cell line enriched"	"Detected in some"	19	"U-138 MG: 20.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044996, HPA049357"	Supported									"HPA044996: , HPA049357: "		"unprognostic (1.60e-1)"		"unprognostic (1.25e-1)"	"unprognostic (1.67e-1)"			"unprognostic (7.51e-2)"		"unprognostic (2.07e-1)"		"unprognostic (4.19e-3)"	"unprognostic (4.41e-2)"		"unprognostic (3.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.58e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1		0.0	0.1	0.0	0.0	0.0		0.1	0.0		0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.7			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	20.4	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
VCY	"BPY1, VCY1, VCY1A"	ENSG00000129864	"Variable charge, Y-linked"	O14598	Y	13985772-13986513	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	122	"testis: 31.5"	"Cell line enriched"	"Detected in single"	6	"U-266/70: 5.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044996, HPA049357"	Supported									"HPA044996: , HPA049357: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.5	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
VCY1B	BPY1B	ENSG00000129862	"Variable charge, Y-linked 1B"	O14598	Y	14056217-14056958	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	113	"testis: 30.4"	"Cell line enriched"	"Detected in single"	6	"U-266/70: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044996, HPA049357"	Supported									"HPA044996: , HPA049357: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.5	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VILL		ENSG00000136059	"Villin like"	O15195	3	37988059-38007188	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.3;stomach 1: 52.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 20.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 22.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035675	Enhanced									"HPA035675: AB_10671223"	"unprognostic (7.86e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavourable (1.35e-4)"	"prognostic favourable (1.75e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.66e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.43e-3)"	2.7	2.1	7.1	12.3	7.2	6.3	3.4	4.7	5.3	5.3	28.0	1.7	3.9	33.2	6.2	3.2	3.8	4.1	21.8	3.3	5.3	4.1	2.8	0.6	7.0	7.3	2.9	4.6	3.9	2.2	0.6	3.4	3.6	2.9	8.5	14.8	4.5	3.8	4.8	1.0	5.1	46.3	3.8	3.4	6.3	52.5	3.5	3.5	12.1	4.5	3.1	9.6	15.0	3.8	5.4	4.6	0.1	3.9	4.0	9.2	4.8	6.4	0.0	0.2	0.3	2.3	1.9	0.7	1.8	1.5	1.9	1.8	4.8	20.1	3.1	2.9	1.2	1.5	1.4	0.2	0.4	0.6	0.0	5.7	0.0	0.4	2.9	5.9	7.8	2.8	1.9	1.8	0.0	3.7	5.6	1.8	2.1	0.0	9.5	6.8	0.1	0.0	3.7	0.0	1.5	0.6	7.8	0.1	0.2	0.0	0.4	1.3	0.5	9.8	2.2	0.8	0.3	2.5	0.0	1.2	2.3	0.9	0.5	8.6	4.0	0.0	3.9	0.0	8.7	2.4	9.2	4.4	5.8	4.9	2.6	5.4	7.4	5.4	0.1	4.0	1.6	4.6	6.8	4.8	7.1	7.2	4.7	5.3	5.3	4.1	2.9	4.6	2.9	3.5
VN1R1	"V1RL1, VNR19I1, ZVNH1, ZVNR1"	ENSG00000178201	"Vomeronasal 1 receptor 1"	Q9GZP7	19	57454790-57457142	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Pheromone response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 9.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 6.1;U-266/70: 5.5;U-266/84: 6.5"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"											HPA062209			Uncertain	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA062209: "	"unprognostic (7.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.59e-5)"	0.1	1.4	2.0	0.3	2.9	0.3	1.5	9.2	3.5	0.2	0.7			0.0	0.5	5.3	0.9	0.8	0.6	1.9	1.9	2.0	0.8	0.9	0.9	0.7	1.5		1.6	0.4	3.6	3.5	1.1		2.0	0.4		0.8	1.3	3.6	4.0	0.5	0.5	1.5	1.1	0.9	1.4			2.7		0.4	0.5	0.3	2.3	0.3	0.5	0.3	0.6	0.4	0.1	0.5	0.1	1.8	1.9	0.1	0.5	0.9	0.4	0.7	0.4	1.8	0.0	0.2	0.2	0.9	0.2	0.0	0.4	0.2	0.7	0.0	6.1	0.9	0.0	0.6	0.3	0.4	1.2	0.7	0.6	0.1	0.4	0.2	0.3	0.9	0.9	0.3	0.4	2.0	0.5	0.6	0.4	1.2	0.9	0.6	1.0	3.3	1.4	0.0	0.5	0.1	0.9	0.6	0.1	1.5	0.2	0.4	0.6	5.5	6.5	0.5	0.5	0.1	1.1	0.5	0.3	0.3	0.4	0.0	0.2	1.3	0.3	0.3	0.2	2.3	0.4	0.3	0.5	0.6	0.2	0.3	0.0	0.1										
VN1R2	V1RL2	ENSG00000196131	"Vomeronasal 1 receptor 2"	Q8NFZ6	19	53258292-53261837	"G-protein coupled receptors, Predicted membrane proteins"	"Pheromone response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 5.0;testis: 3.2"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA044551	Uncertain									"HPA044551: "					"unprognostic (9.54e-2)"							"unprognostic (3.17e-1)"			"unprognostic (1.06e-1)"			0.2	0.2	0.4	0.8	0.4	0.5	0.3	0.6	0.8	0.2	0.3			0.2	0.5	1.6	0.3	0.2	0.0	5.0	0.4	0.4	0.3	0.3	0.2	1.7	0.3		0.6	0.2	0.3	0.2	0.0		0.3	0.0		0.4	0.0	0.4	0.9	0.6	0.0	0.3	0.3	0.2	3.2			0.5		0.0	0.3	0.3	0.8	0.5	1.3	0.5	0.6	1.1	0.2	0.8	0.8	0.8	1.3	0.0	0.0	0.3	1.0	0.0	0.0	0.3	0.0	2.2	1.9	0.5	0.5	0.6	0.0	0.0	0.0	0.8	0.7	1.2	2.6	1.5	0.0	0.2	1.7	0.6	0.4	0.1	0.0	0.0	0.8	0.6	0.4	0.9	0.4	1.1	0.5	0.7	1.1	2.1	0.0	0.5	2.2	1.3	1.2	0.2	0.8	0.3	1.3	0.1	1.6	1.0	0.8	1.3	0.4	1.7	0.6	0.8	1.2	0.5	0.8	0.4	0.5	0.5	1.1	0.3	0.4	0.2	0.4	0.2	0.2	0.8	0.3	1.0	1.3	0.6	0.4	0.5	0.1	0.2										
VN1R4	V1RL4	ENSG00000228567	"Vomeronasal 1 receptor 4"	Q7Z5H5	19	53266676-53267723	"G-protein coupled receptors, Predicted membrane proteins"	"Pheromone response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"testis: 2.5"	"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA027018	Uncertain									"HPA027018: AB_10603142"																		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
VPREB3	8HS20	ENSG00000128218	"V-set pre-B cell surrogate light chain 3"	Q9UKI3	22	23752743-23754468	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 90.4;epididymis: 27.9;intestine: 32.7;lymphoid tissue: 77.9"	"Group enriched"	"Detected in some"	45	"Daudi: 56.9;REH: 67.3;U-698: 17.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	730	"memory B-cell: 79.9;naive B-cell: 90.4"	"Lineage enriched"	"Detected in single"	775	"B-cells: 90.4"	"Not detected"	"Not detected"							HPA003041	Supported				"Intracellular and membrane"					"HPA003041: AB_1080577"	"unprognostic (2.06e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.79e-2)"	"unprognostic (6.63e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.84e-2)"	"unprognostic (8.44e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.12e-1)"	0.5	9.2	0.7	62.6	0.9	7.5	0.3	0.7	0.8	0.3	1.3	0.3	0.2	0.2	0.3	27.9	2.3	0.1	0.7	0.4	0.6	0.7	1.1	0.9	1.2	77.9	0.8	0.2	0.3	0.3	0.1	1.4	0.3	0.2	0.6	0.9	0.4	4.8	0.2	0.8	0.4	32.7	0.2	0.5	31.6	1.4	1.4	0.2	1.6	0.8	1.0	36.0	3.1	0.2	90.4	0.0	0.1	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	56.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.1	0.2	0.0	0.2	67.3	0.1	1.0	0.0	0.0	0.1	0.2	0.0	0.1	0.8	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.3	0.0	17.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.9	0.0	0.0	0.0	90.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.7	0.9	0.7	0.8	0.6	0.7	0.8	0.2	0.2	0.2
VPS26C	"DCRA, DSCR3"	ENSG00000157538	"VPS26 endosomal protein sorting factor C"	O14972	21	37223420-37267919	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023288	Uncertain		Approved	Mitochondria				Mitochondria		"HPA023288: AB_1847872"	"unprognostic (1.01e-3)"	"unprognostic (6.42e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.15e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.97e-1)"	"prognostic favourable (8.54e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.16e-1)"	23.5	29.1	14.2	15.9	17.4	16.5	17.0	17.1	19.4	16.2	23.4	20.8	12.1	25.5	17.8	13.8	20.6	15.4	17.6	21.3	17.1	11.9	29.2	28.6	19.9	18.1	18.3	16.9	16.8	23.9	14.5	14.7	20.9	15.6	15.9	23.7	22.1	17.3	15.3	30.8	16.8	31.2	19.7	17.4	24.6	21.5	7.4	17.8	21.3	16.7	13.3	20.6	23.0	16.1	19.6	24.2	40.3	30.2	24.9	26.9	24.5	12.2	5.8	12.8	10.8	23.6	21.2	14.2	12.3	27.3	11.3	16.6	8.0	13.4	8.8	4.6	28.2	6.1	13.6	13.2	10.9	21.0	9.8	14.9	5.9	7.7	20.6	11.0	10.1	18.4	13.0	13.0	21.1	21.0	9.3	19.6	21.5	5.8	18.8	9.4	14.2	5.6	17.5	6.1	12.8	13.8	9.5	10.3	13.9	8.4	16.5	26.0	15.7	8.9	16.6	12.9	4.5	13.6	7.1	30.2	30.4	12.2	20.3	18.8	14.1	23.5	24.5	40.3	26.9	30.2	25.0	19.6	23.2	24.4	24.2	14.7	21.5	22.6	25.4	24.9	26.3	9.6	26.7	24.5	14.2	17.4	17.1	19.4	17.1	11.9	18.3	16.9	15.6	17.8
VSIG10		ENSG00000176834	"V-set and immunoglobulin domain containing 10"	Q8N0Z9	12	118063593-118136026	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 60.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA062022	Enhanced		Approved	"Centriolar satellite,Cytosol"				Cytosol	"Centriolar satellite"	"HPA062022: "	"unprognostic (1.32e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.42e-2)"	"prognostic unfavourable (1.76e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (7.53e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-2)"	8.1	10.2	2.6	9.8	3.1	0.4	18.0	2.9	2.6	8.2	31.6	2.7	5.2	11.7	4.5	4.5	8.9	4.0	7.6	3.6	2.4	2.2	6.2	11.9	11.6	3.8	3.2	1.4	5.9	10.9	8.9	4.0	12.2	3.4	8.4	13.9	4.0	6.3	6.4	12.9	4.6	60.9	3.8	2.5	3.3	5.5	3.9	2.5	1.7	26.3	6.1	4.9	6.1	8.6	0.7	2.4	3.5	2.0	0.4	0.6	0.4	4.9	7.3	3.2	10.6	13.2	6.0	8.0	8.6	5.6	4.3	3.5	2.1	11.9	0.7	3.4	6.3	12.2	22.1	2.2	5.1	2.4	3.3	1.1	6.9	3.2	2.6	0.7	1.8	2.7	6.5	3.3	2.1	9.3	1.4	0.1	4.0	5.3	0.0	0.7	9.8	4.7	1.8	8.7	0.0	6.2	16.2	2.7	3.4	8.4	3.5	2.2	7.8	3.4	10.8	4.9	3.1	6.1	4.3	0.1	0.1	0.0	7.1	3.5	9.8	0.6	2.0	2.3	0.4	0.6	0.6	0.0	0.4	0.2	2.4	0.7	0.4	0.6	3.5	0.4	0.2	0.7	0.6	0.4	2.6	3.1	2.9	2.2	2.4	2.2	3.2	1.4	3.4	2.5
VSIG10L		ENSG00000186806	"V-set and immunoglobulin domain containing 10 like"	Q86VR7	19	51331536-51342124	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 70.9;lymphoid tissue: 52.2;salivary gland: 72.9;tongue: 37.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 7.0;T-47d: 12.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA060453, HPA066745"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA060453: , HPA066745: "	"unprognostic (1.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (8.75e-4)"	"unprognostic (2.40e-3)"	"unprognostic (2.78e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.90e-4)"	"unprognostic (1.42e-2)"	"unprognostic (8.51e-2)"	"unprognostic (7.74e-2)"	"unprognostic (5.19e-3)"	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.3	0.1	9.8	0.1	0.0	2.0	0.1	0.6	0.0	70.9	0.0	0.9	0.1	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	1.2	0.1	0.0	72.9	2.6	0.2	4.9	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	37.6	52.2	0.1	10.8	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.1	1.4	0.1	0.6	0.6	0.1	0.3	0.1	0.1	0.0	0.2	0.4	1.1	0.9	0.1	0.1	0.1	0.0	0.0	0.1	0.8	0.8	0.2	0.2	7.0	0.0	0.0	1.2	0.0	0.8	0.2	0.0	0.0	0.6	2.0	0.0	0.6	0.0	0.1	0.9	0.7	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.9	0.0	12.8	0.0	0.1	0.0	0.2	1.1	0.0	1.7	1.1	0.1	0.8	0.2	0.4	0.0	0.6	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0
VSIG8		ENSG00000243284	"V-set and immunoglobulin domain containing 8"	P0DPA2	1	159854316-159862657	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"tongue: 83.5"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.5;Karpas-707: 1.7;U-2 OS: 1.1;U-266/70: 1.3;U-87 MG: 2.1"	"Group enriched"	"Detected in some"	6	"cervical cancer: 3.0;endometrial cancer: 3.0;head and neck cancer: 4.6;urothelial cancer: 1.0"	"Region enriched"	"Detected in single"	13	"cerebellum: 4.2"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA023219	Uncertain									"HPA023219: AB_1845635"	"unprognostic (8.66e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.50e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.26e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.93e-3)"	"unprognostic (9.32e-2)"	"unprognostic (7.94e-7)"	"unprognostic (1.72e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.99e-1)"	0.4	0.1	0.2	0.2	0.3	0.0	0.2	4.2	0.2	2.2	0.2	0.2	0.2	0.2	0.2	0.2	2.5	1.0	0.2	0.2	0.2	0.2	2.7	0.2	0.2	0.2	0.2	0.2	1.2	0.2	0.0	0.2	0.3	0.2	0.2	0.0	0.2	4.3	0.2	0.2	18.9	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.8	0.4	83.5	9.2	0.2	2.0	0.6	0.0	0.1	0.0	0.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.5	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.1	0.0	0.2	0.2	0.4	1.0	1.1	0.2	0.0	1.3	0.0	0.0	2.1	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.5	0.6	0.3	0.5	0.0	0.0	0.7	0.5	0.1	0.7	0.0	0.0	0.3	0.0	0.2	0.3	4.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
VWA3A	"FLJ40941, FLJ46765"	ENSG00000175267	"Von Willebrand factor A domain containing 3A"	A6NCI4	16	22092538-22156966	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 26.8;fallopian tube: 27.0"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 1.5;U-266/70: 1.2;U-266/84: 2.4;WM-115: 1.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041696, HPA042044"	Uncertain				"Secreted - unknown location"					"HPA041696: AB_10964202, HPA042044: AB_10968997"	"unprognostic (2.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.75e-4)"	"prognostic favourable (8.15e-4)"	"unprognostic (2.70e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.79e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.16e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.06e-4)"	1.0	1.1	3.6	0.7	8.3	1.1	0.9	0.3	12.2	8.1	0.8	13.2	0.0	0.8	2.3	9.6	0.8	27.0	0.7	0.9	4.8	5.8	0.9	0.7	5.5	0.8	0.7	6.7	3.0	1.0	0.9	10.0	0.8	26.8	0.9	0.8	0.0	0.8	0.8	0.8	2.3	1.1	0.7	3.8	1.0	0.9	5.0	3.6	0.0	0.9	0.0	0.9	0.9	0.1	0.2	0.1	0.0	0.5	0.0	0.4	0.0	0.1	1.0	0.6	0.7	0.2	0.1	0.0	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.1	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	1.2	2.4	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	3.6	8.3	0.3	12.2	4.8	5.8	0.7	6.7	26.8	3.6
VWA5A	"BCSC-1, LOH11CR2A"	ENSG00000110002	"Von Willebrand factor A domain containing 5A"	O00534	11	124115362-124147721	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.7;HEL: 20.0;HHSteC: 15.5;HUVEC TERT2: 18.4;RPTEC TERT1: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 25.6"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA037813, HPA037814, HPA061500"	Uncertain		Enhanced	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: "	"unprognostic (2.69e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.48e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.38e-2)"	"prognostic favourable (1.55e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.65e-1)"	14.8	20.2	13.8	7.5	13.4	1.6	16.0	2.3	9.3	15.5	23.9	7.5	10.0	16.7	16.6	17.0	12.6	9.9	19.9	6.5	14.1	24.6	16.0	4.3	19.4	6.8	12.5	6.6	9.6	15.3	5.5	34.2	25.9	15.2	22.5	28.4	10.3	31.2	13.2	3.0	17.9	24.0	13.6	15.0	6.0	17.8	6.3	7.6	3.9	13.7	7.1	9.8	14.9	11.8	4.5	4.8	25.6	5.3	4.3	7.5	3.6	0.0	0.2	3.6	0.2	3.8	3.5	1.3	0.5	0.2	0.3	0.1	0.2	27.7	0.0	3.4	0.5	0.1	0.7	6.3	0.0	9.4	0.0	20.0	5.0	0.6	15.5	0.2	9.4	10.5	0.7	0.6	2.1	18.4	1.0	3.4	1.1	0.0	0.4	0.3	5.6	0.7	0.0	12.3	0.1	20.2	0.2	3.1	0.3	0.5	0.2	1.0	2.5	0.9	0.4	0.1	2.6	0.1	0.0	1.2	1.1	0.0	11.5	0.4	0.2	25.6	4.8	0.5	2.9	3.3	0.7	4.5	3.2	1.7	4.8	2.3	4.1	2.6	0.3	4.3	5.3	2.6	7.5	3.6	13.8	13.4	2.3	9.3	14.1	24.6	12.5	6.6	15.2	7.6
VWA5B2	"DKFZp761K032, LOC90113"	ENSG00000145198	"Von Willebrand factor A domain containing 5B2"	Q8N398	3	184230429-184242329	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 35.9;brain: 10.1;pancreas: 11.0"	"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 26.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036823, HPA036824, HPA061412"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA036823: AB_10672269, HPA036824: , HPA061412: "	"unprognostic (3.92e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.32e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.12e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.83e-1)"	0.4	35.9	9.2	0.4	4.8	0.2	0.4	9.8	10.1	0.5	2.5	0.4	0.4	1.7	0.4	0.4	0.4	1.2	0.4	0.4	9.5	3.3	0.4	0.4	2.4	0.4	1.9	0.4	3.7	11.0	1.6	3.4	0.4	0.4	0.9	0.4	0.4	0.5	2.4	0.4	0.1	2.4	0.4	0.4	0.4	2.8	1.1	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	1.5	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.0	0.0	26.5	1.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.7	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	4.8	9.8	10.1	9.5	3.3	1.9	0.4	0.4	0.4
VWA7	"C6orf27, G7c, NG37"	ENSG00000204396	"Von Willebrand factor A domain containing 7"	Q9Y334	6	31765590-31777294	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.6;pituitary gland: 20.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.1;HeLa: 3.3;Karpas-707: 3.0;RPTEC TERT1: 2.2;U-266/70: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebellum: 7.8;pons and medulla: 4.1"	"Low region specificity"	"Detected in many"			"HPA046954, HPA054262"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"			"Plasma membrane, Cytosol"		"HPA046954: , HPA054262: "	"unprognostic (9.13e-2)"	"unprognostic (8.60e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.38e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.25e-2)"	"prognostic favourable (4.35e-8)"	"unprognostic (3.75e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.48e-2)"	"unprognostic (7.66e-2)"	1.1	1.6	3.1	1.4	9.5	1.1	1.2	5.6	10.5	1.1	1.9	0.0	3.9	2.6	4.6	3.0	1.1	19.6	2.0	3.9	1.6	5.5	5.6	1.5	2.5	1.2	1.7	5.4	1.4	2.5	5.1	20.5	1.0	9.7	1.3	1.7	0.8	1.7	2.0	5.3	1.7	3.3	2.3	2.3	1.3	5.8	1.3	2.3	0.0	1.8	0.6	1.3	1.3	0.8	0.2	0.0	1.2	0.0	0.0	0.4	0.0	0.4	1.1	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.1	2.1	0.5	0.7	0.3	0.9	0.7	0.2	0.0	0.0	0.0	0.1	3.3	0.5	0.1	0.0	0.9	0.1	0.9	0.1	0.0	0.0	0.2	3.0	0.0	0.2	0.0	0.5	0.0	0.1	0.3	0.0	2.0	2.2	0.0	0.3	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.3	0.8	0.0	0.1	4.4	1.2	0.1	0.0	0.6	0.1	1.2	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.0	3.1	9.5	5.6	10.5	1.6	5.5	1.7	5.4	9.7	2.3
VWCE	"FLJ32009, URG11, VWC1"	ENSG00000167992	"Von Willebrand factor C and EGF domains"	Q96DN2	11	61258286-61295424	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 19.8;ovary: 10.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.6;Hep G2: 18.9;HSkMC: 11.1;REH: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA040401, HPA043921"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"		1300000	Nucleoplasm	"Vesicles, Cytosol"	"HPA040401: , HPA043921: "	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.96e-3)"	"unprognostic (9.27e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.01e-4)"	"unprognostic (3.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.58e-4)"	"unprognostic (7.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-1)"	2.9	1.1	0.9	0.6	1.3	2.3	3.1	0.7	1.3	2.8	1.0	1.4	3.4	0.5	1.4	2.9	1.5	5.7	1.4	1.0	1.3	1.2	0.6	19.8	0.8	0.3	0.4	1.1	10.7	0.1	0.5	0.5	9.1	0.3	1.8	0.6	1.3	1.7	1.0	1.9	0.9	1.1	1.2	0.2	0.9	0.3	1.8	0.5	6.5	0.8	1.0	1.0	1.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.2	1.1	0.4	0.2	1.7	0.0	0.2	5.6	0.0	0.3	0.0	0.4	0.0	2.0	0.0	0.1	0.4	0.0	0.5	0.0	18.9	1.0	0.0	0.1	11.1	0.5	0.5	0.0	1.7	0.2	0.3	0.3	0.0	4.1	0.0	1.6	0.0	10.6	0.1	0.0	0.1	0.1	0.4	0.8	0.0	0.1	0.5	0.7	0.0	0.4	0.2	0.3	0.5	0.1	0.2	0.4	0.9	0.8	0.2	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.7	1.3	1.3	1.2	0.4	1.1	0.3	0.5
VWDE	FLJ14712	ENSG00000146530	"Von Willebrand factor D and EGF domains"	Q8N2E2	7	12330885-12403941	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pituitary gland: 29.5"	"Cell line enhanced"	"Detected in many"		"K-562: 10.6;NTERA-2: 5.3;SCLC-21H: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA026619, HPA036044"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"			Cytosol	Nucleoplasm	"HPA026619: , HPA036044: "	"unprognostic (6.39e-2)"	"unprognostic (1.65e-3)"	"unprognostic (5.36e-3)"	"unprognostic (1.78e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.73e-1)"	0.4	0.5	1.6	0.3	2.7	2.3	2.3	0.4	2.3	0.8	0.9	0.0	0.9	0.2	0.7	4.9	0.8	1.5	0.7	4.1	0.8	0.5	0.7	0.5	0.7	0.2	0.4	0.5	0.5	0.9	0.0	29.5	0.3	0.5	1.5	0.3	0.1	5.7	5.5	0.4	0.6	0.6	0.2	0.4	0.5	2.0	0.6	0.0	0.1	6.2	0.0	1.3	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.6	0.0	0.5	0.0	0.3	1.7	0.0	2.0	0.7	0.8	0.4	3.0	0.2	0.0	0.0	0.4	2.1	1.9	0.6	3.9	2.2	3.5	4.7	0.0	0.0	1.0	2.3	0.1	0.3	0.0	1.2	0.8	10.6	0.0	0.0	1.2	0.0	0.0	5.3	0.6	0.0	0.0	1.6	0.0	1.3	8.5	1.3	0.0	1.7	0.0	0.0	1.1	0.1	0.0	1.0	0.0	0.8	3.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.9	0.1	1.6	2.7	0.4	2.3	0.8	0.5	0.4	0.5	0.5	0.0
WBP2NL	"FLJ26145, GRAMD7, MGC26816, PAWP"	ENSG00000183066	"WBP2 N-terminal like"	Q6ICG8	22	41998725-42058456	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 24.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.2;HDLM-2: 1.0;HHSteC: 1.1;HSkMC: 1.0;THP-1: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA048557	Enhanced									"HPA048557: "	"unprognostic (1.90e-2)"	"unprognostic (2.25e-4)"	"unprognostic (2.77e-3)"	"unprognostic (6.12e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (9.84e-4)"	"unprognostic (3.31e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.36e-5)"	1.1	0.9	3.0	1.2	2.9	0.6	2.4	3.6	4.6	0.9	0.9	3.2	1.8	0.8	1.4	4.1	0.8	2.0	1.1	0.8	2.3	1.2	1.2	0.9	1.3	1.1	2.0	2.4	2.4	2.8	2.6	2.4	0.8	2.8	1.3	1.0	2.0	1.9	1.5	0.8	1.6	1.0	0.9	3.7	1.0	1.1	24.8	3.3	0.0	2.3	0.0	1.1	0.9	1.7	1.1	1.5	0.0	0.6	0.4	1.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	4.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.1	1.6	0.0	0.0	0.2	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.1	0.0	0.0	0.9	0.4	0.0	1.5	1.1	0.3	0.3	0.0	0.4	0.2	0.6	1.4	0.2	3.0	2.9	3.6	4.6	2.3	1.2	2.0	2.4	2.8	3.3
WDR17		ENSG00000150627	"WD repeat domain 17"	Q8IZU2	4	176065834-176182818	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.9;parathyroid gland: 19.0;pituitary gland: 22.5"	"Cell line enhanced"	"Detected in many"		"AF22: 8.9;SCLC-21H: 10.3;SH-SY5Y: 7.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042766, HPA054501"	Approved		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA042766: AB_10806372, HPA054501: "	"unprognostic (3.41e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.43e-7)"	"unprognostic (3.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.39e-3)"	"unprognostic (6.04e-4)"	"unprognostic (3.66e-4)"	"unprognostic (9.25e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.32e-3)"	"unprognostic (8.24e-3)"	2.1	5.8	12.4	2.2	22.1	1.5	3.3	12.2	23.9	2.0	2.9	3.4	0.0	1.6	4.5	6.2	1.9	3.5	3.0	1.3	9.7	7.1	6.2	1.0	3.6	1.8	4.4	16.3	4.0	3.0	19.0	22.5	0.7	7.9	2.3	3.1	6.0	1.7	2.2	0.7	1.2	1.8	2.8	4.0	2.9	3.1	4.1	6.9	0.1	10.2	0.0	1.6	1.9	1.5	1.1	0.7	2.6	1.6	1.3	0.8	0.2	0.0	3.7	8.9	0.1	0.2	0.6	0.3	0.2	0.0	0.8	3.1	0.2	0.1	6.1	0.0	0.1	0.1	3.9	2.0	0.8	0.0	3.2	0.0	0.7	0.0	0.3	3.3	4.8	1.4	1.2	0.1	0.5	0.0	0.0	0.3	0.6	1.6	3.4	0.1	2.0	1.9	0.0	3.8	0.0	0.5	0.0	10.3	7.4	0.0	2.4	6.2	0.4	0.0	0.0	1.2	1.7	0.1	5.8	4.4	2.9	3.5	7.0	0.0	2.4	2.6	0.6	0.3	0.6	1.6	0.3	1.1	0.6	0.4	0.2	0.8	0.7	0.8	1.7	1.3	0.3	0.7	0.3	0.2	12.4	22.1	12.2	21.8	9.7	7.1	4.4	16.3	7.9	6.9
WDR31	FLJ35921	ENSG00000148225	"WD repeat domain 31"	Q8NA23	9	113313222-113340298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019340, HPA019347"	Approved		Approved	"Nuclear bodies,Cytosol"				Cytosol	"Nuclear bodies"	"HPA019340: AB_1858800, HPA019347: AB_2215267"	"unprognostic (2.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.78e-3)"	"prognostic favourable (1.85e-4)"	"unprognostic (4.54e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.64e-1)"	"prognostic favourable (1.90e-9)"	"unprognostic (9.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-3)"	"unprognostic (8.50e-2)"	2.2	6.8	4.1	1.0	8.2	1.5	4.7	1.7	5.5	3.2	2.4	4.0	8.8	1.5	4.5	3.3	2.4	6.3	2.3	8.9	3.3	4.1	5.6	3.1	2.3	0.9	3.5	2.7	3.7	3.0	16.6	11.2	1.0	4.0	3.4	2.2	5.8	10.2	7.5	1.3	2.5	1.1	2.2	3.6	0.8	2.1	7.3	1.7	3.8	7.1	1.4	0.8	3.0	2.0	1.6	0.9	4.4	1.0	2.3	1.4	0.8	5.5	4.2	1.5	3.0	5.0	5.9	1.4	1.4	2.7	1.4	1.7	0.7	3.6	2.1	1.0	2.0	3.6	1.2	2.7	2.7	3.3	0.3	1.7	2.2	0.7	5.7	0.9	0.3	3.1	3.6	5.8	5.1	1.1	4.5	1.9	1.5	3.8	2.4	1.4	0.9	5.2	2.1	1.2	2.5	3.7	1.2	3.6	2.7	6.7	1.2	3.2	8.7	0.9	0.6	2.0	2.2	5.0	1.5	4.0	3.8	0.5	3.0	1.4	1.9	4.4	1.0	1.0	0.9	0.6	0.8	0.9	1.0	0.8	0.8	1.6	1.4	1.3	3.4	2.3	0.7	0.9	0.7	0.8	4.1	8.2	1.7	5.5	3.3	4.1	3.5	2.7	4.0	1.7
WDR38		ENSG00000136918	"WD repeat domain 38"	Q5JTN6	9	124853417-124857890	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"fallopian tube: 51.4"	"Cell line enhanced"	"Detected in some"		"A549: 1.3;CAPAN-2: 2.5;HDLM-2: 2.9;HeLa: 1.9"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 12.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA056607	Uncertain									"HPA056607: "	"unprognostic (5.66e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.51e-2)"	"prognostic favourable (3.97e-4)"	"unprognostic (1.14e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.29e-3)"	"unprognostic (7.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.75e-5)"	"unprognostic (1.01e-1)"	"unprognostic (3.25e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.42e-2)"	0.2	0.2	2.0	0.2	3.1	0.2	0.2	0.2	0.5	2.9	0.2	10.6	0.0	0.2	0.7	11.9	0.2	51.4	0.2	0.3	2.8	3.3	0.2	0.2	10.8	0.2	0.3	0.4	6.0	0.2	0.2	1.0	0.2	8.8	0.2	0.2	0.0	0.2	0.3	0.3	0.3	0.2	0.3	0.7	0.2	0.2	7.0	1.3	0.0	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.3	0.5	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.1	0.4	2.5	0.1	0.1	0.2	0.1	0.2	0.0	0.0	2.9	0.3	0.0	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.7	0.1	0.6	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.0	0.4	0.5	0.2	0.4	0.5	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.1	0.2	0.5	2.8	3.3	0.3	0.4	8.8	1.3
WDR45B	"WDR45L, WIPI3"	ENSG00000141580	"WD repeat domain 45B"	Q5MNZ6	17	82614562-82648553	"Predicted intracellular proteins"	Autophagy		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017886			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA017886: AB_1858810"	"unprognostic (1.91e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.88e-2)"	"prognostic unfavourable (2.98e-5)"	"unprognostic (1.23e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.22e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.93e-3)"	"unprognostic (8.89e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.02e-1)"	25.4	31.0	37.1	17.2	39.0	38.7	38.9	30.3	38.1	27.4	23.5	35.3	19.9	21.8	25.6	24.9	39.9	32.7	29.5	29.4	36.6	29.2	26.6	22.9	23.5	26.6	38.2	28.5	32.8	35.6	29.9	24.2	19.6	39.2	26.6	21.2	18.8	32.6	23.8	20.9	28.4	25.0	29.3	53.3	19.3	29.5	47.7	39.1	6.8	26.5	23.3	23.5	23.3	24.8	10.0	15.6	22.1	19.3	8.9	12.6	11.9	28.7	19.8	16.7	15.2	15.5	14.4	19.9	21.5	24.3	35.3	30.3	23.6	15.4	8.3	13.5	19.2	16.0	16.0	18.3	32.5	5.2	31.9	16.8	11.3	18.3	20.4	13.2	12.9	15.5	19.3	18.8	17.7	28.4	12.5	7.8	19.6	18.5	9.4	9.1	21.3	26.4	10.3	30.1	8.5	19.1	28.9	21.8	32.1	21.3	21.8	25.1	25.9	10.1	19.3	36.7	28.8	25.8	38.4	20.1	8.6	12.2	23.8	13.4	26.8	16.5	19.3	22.1	12.3	19.2	12.6	10.0	9.7	10.4	15.6	9.9	8.7	7.9	16.2	8.9	14.8	8.0	7.6	11.9	37.1	39.0	30.3	38.1	36.6	29.2	38.2	28.5	39.2	39.1
WDR49	FLJ33620	ENSG00000174776	"WD repeat domain 49"	Q8IV35	3	167478684-167653983	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 21.6;fallopian tube: 20.7"	"Cell line enhanced"	"Detected in some"		"AF22: 3.3;NTERA-2: 3.7;THP-1: 16.7;U-937: 8.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 5.6;myeloid DC: 4.1;plasmacytoid DC: 5.2"	"Group enriched"	"Detected in many"	24	"dendritic cells: 5.2;monocytes: 5.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA036225, HPA036226"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA036225: AB_10696652, HPA036226: "	"unprognostic (1.68e-3)"	"unprognostic (1.24e-3)"		"unprognostic (2.48e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.67e-2)"		"unprognostic (5.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.02e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.60e-9)"	"unprognostic (1.79e-4)"	"unprognostic (3.50e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.07e-1)"	0.5	0.7	6.5	1.1	6.8	3.6	0.6	12.6	5.0	1.2	0.9	8.5	0.0	3.9	1.2	4.4	2.1	20.7	0.7	4.7	12.3	5.4	1.0	0.4	4.0	0.9	7.6	2.8	3.2	0.9	0.4	1.7	0.4	21.6	0.7	0.6	0.0	0.7	0.4	0.4	0.5	8.0	0.7	17.6	1.1	0.8	1.5	14.2	0.0	0.5	0.0	1.0	0.8	0.6	0.2	5.2	0.0	5.6	0.0	0.0	0.7	0.1	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.8	0.0	0.0	5.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.0	0.0	0.1	5.2	0.0	0.7	6.5	6.8	12.6	3.7	12.3	5.4	7.6	2.8	21.6	14.2
WDR53	"MGC12928, MGC64882"	ENSG00000185798	"WD repeat domain 53"	Q7Z5U6	3	196554177-196568674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016420	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA016420: AB_1858812"	"unprognostic (3.29e-2)"	"unprognostic (4.24e-3)"	"unprognostic (9.89e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.71e-2)"	"prognostic unfavourable (1.57e-6)"	"unprognostic (4.49e-2)"	"prognostic unfavourable (3.09e-4)"	"unprognostic (2.57e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.48e-3)"	"unprognostic (8.01e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-1)"	4.3	4.3	5.9	6.8	6.9	7.2	5.2	6.4	5.9	4.0	4.2	4.5	7.1	2.1	4.9	6.6	5.1	3.9	3.5	4.0	4.8	3.8	4.0	5.4	3.8	5.5	5.9	4.3	4.3	3.3	7.5	11.9	4.4	6.1	4.1	4.1	4.8	4.0	4.5	6.8	6.7	4.5	4.1	5.0	6.2	4.0	48.0	4.6	7.4	4.2	3.2	6.5	3.9	4.2	7.5	5.9	13.9	6.7	6.5	14.9	4.9	18.7	4.0	7.3	6.5	7.4	6.5	11.6	9.9	7.7	11.3	10.7	11.0	10.0	8.9	33.4	6.0	11.0	9.1	8.5	14.2	14.0	7.9	9.0	9.9	7.2	9.3	12.6	7.4	5.3	12.6	10.0	11.0	8.8	8.8	17.3	8.6	17.5	10.7	13.0	9.9	11.8	12.9	12.5	19.0	6.2	6.6	7.2	7.8	6.9	10.3	14.5	26.4	11.8	8.1	9.6	9.1	10.7	19.3	14.7	29.4	26.7	6.3	16.3	9.6	9.6	5.1	13.9	8.6	4.4	14.0	7.5	12.3	8.7	4.1	7.1	10.3	6.2	4.4	6.5	6.7	5.9	14.9	4.9	5.9	6.9	6.4	5.9	4.8	3.8	5.9	4.3	6.1	4.6
WDR5B	FLJ11287	ENSG00000196981	"WD repeat domain 5B"	Q86VZ2	3	122412332-122416051	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042994	Approved									"HPA042994: AB_10960397"	"unprognostic (5.61e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.54e-2)"	"unprognostic (7.45e-3)"	10.8	8.4	6.2	5.8	9.0	2.8	11.0	7.1	6.3	7.6	4.2	7.6	13.7	5.8	6.2	17.5	5.4	12.5	3.8	4.9	6.9	4.6	7.4	10.4	5.6	8.7	11.3	5.0	8.6	12.5	7.9	19.5	7.4	10.7	8.2	4.8	5.7	7.8	15.5	3.9	5.8	7.5	4.4	9.2	10.9	7.7	7.3	11.1	12.3	14.7	3.4	8.9	5.7	4.7	4.6	2.3	5.1	8.1	2.4	6.7	2.6	6.6	4.1	6.2	7.2	11.8	9.8	3.9	5.0	7.7	7.1	6.2	3.7	6.0	4.0	7.1	4.8	9.4	5.0	3.8	9.3	2.5	4.1	5.9	4.7	3.6	7.6	3.2	6.5	6.4	10.6	5.3	12.3	5.5	2.6	3.5	5.8	7.9	5.0	5.9	3.1	7.0	5.0	6.2	3.5	6.7	2.8	7.1	7.6	5.1	3.4	9.8	9.8	7.0	4.2	5.5	6.9	2.6	3.3	3.0	1.3	8.0	7.2	3.2	6.8	5.1	4.3	2.8	2.9	4.7	3.6	2.7	4.3	2.5	2.3	4.6	6.7	4.8	1.6	2.4	8.1	1.4	4.8	2.6	6.2	9.0	7.1	6.3	6.9	4.6	11.3	5.0	10.7	11.1
WDR63	"DIC3, FLJ30067, NYD-SP29"	ENSG00000162643	"WD repeat domain 63"	Q8IWG1	1	84999147-85133138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 21.3;brain: 39.7;testis: 31.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.7;HBEC3-KT: 5.2;HSkMC: 7.1;hTCEpi: 8.5;LHCN-M2: 7.6"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.9"	"Region enriched"	"Detected in many"	9	"pons and medulla: 39.7"	"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038526	Enhanced									"HPA038526: AB_2676063"	"unprognostic (3.12e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-4)"	"unprognostic (1.10e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.14e-5)"	"unprognostic (8.57e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.82e-1)"	0.3	21.3	2.0	0.4	4.6	0.1	0.9	0.1	0.9	1.3	0.6	4.2	1.0	0.3	0.7	11.7	0.6	14.0	0.4	0.9	3.0	2.9	2.5	0.1	3.7	0.3	0.4	0.9	4.9	0.5	3.9	14.6	0.5	39.7	0.3	0.6	0.3	1.8	0.3	0.3	1.9	0.2	0.4	0.9	0.2	0.2	31.0	1.9	0.0	1.1	1.0	0.2	0.7	0.3	0.0	0.5	0.0	0.0	0.0	2.2	0.4	0.2	0.5	0.1	0.4	3.8	10.7	2.0	2.0	4.2	0.7	1.1	0.0	0.6	0.5	0.0	0.4	0.0	0.4	5.2	0.9	0.1	0.4	0.3	0.0	0.0	0.6	0.0	0.0	7.1	8.5	3.5	0.2	0.1	0.0	0.0	7.6	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.2	0.2	0.0	0.0	0.2	1.2	0.0	3.4	0.0	0.6	0.3	0.0	0.5	0.0	0.0	0.4	4.1	0.2	1.4	0.0	0.0	0.0	2.2	0.0	1.3	0.0	1.2	0.9	0.1	0.0	0.8	1.9	0.0	0.0	0.0	0.5	0.0	0.4	2.0	4.6	0.1	0.9	3.0	2.9	0.4	0.9	39.7	1.9
WDR64	FLJ32978	ENSG00000162843	"WD repeat domain 64"	B1ANS9	1	241652278-241802133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 17.8"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 3.1;U-266/84: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"							HPA046186	Uncertain									"HPA046186: AB_10960064"	"unprognostic (6.44e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.52e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.49e-2)"	"unprognostic (4.56e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.28e-3)"	"unprognostic (2.21e-1)"	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.5	0.2	0.5	0.1	0.1	0.2	0.1	1.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.5	0.1	0.0	0.1	0.9	0.1	0.1	0.0	0.1	0.5	0.3	0.1	0.0	0.3	0.1	0.1	0.2	0.2	17.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.1	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.0	1.7	0.3	0.0	0.1	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1
WDR66	"CaM-IP4, MGC33630"	ENSG00000158023	"WD repeat domain 66"	Q8TBY9	12	121917862-122003927	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.6;pituitary gland: 28.4;testis: 35.0"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 21.4;hTCEpi: 20.2;hTERT-HME1: 13.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 4.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039902, HPA040005"	Supported		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039902: AB_10795236, HPA040005: AB_10795160"	"unprognostic (4.92e-3)"	"unprognostic (9.05e-2)"	"unprognostic (7.99e-3)"	"prognostic favourable (3.11e-4)"	"unprognostic (5.58e-3)"	"unprognostic (6.89e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.35e-1)"	1.3	1.2	6.3	1.0	13.2	0.4	1.7	0.4	4.0	4.4	0.5	4.5	1.5	0.4	2.5	11.3	0.5	24.6	2.0	1.5	6.4	3.7	3.2	1.8	6.4	0.9	0.7	3.2	3.9	2.1	4.7	28.4	1.3	18.0	0.8	0.4	1.3	1.3	2.2	0.5	1.8	0.5	1.0	0.9	2.0	0.8	35.0	2.4	0.0	6.7	0.0	1.2	0.8	1.7	0.2	4.9	0.4	0.0	0.1	0.3	0.0	1.8	0.2	0.3	0.1	0.3	0.3	0.3	0.2	1.7	0.8	2.0	0.2	0.9	0.1	2.4	0.1	0.6	0.2	21.4	3.0	0.1	0.3	0.1	0.4	0.2	2.6	0.0	5.9	1.2	20.2	1.6	13.7	0.9	4.8	0.0	1.2	0.6	0.2	0.3	0.3	0.1	0.3	0.5	0.0	3.7	0.3	1.7	0.1	0.2	0.0	0.1	0.5	0.1	0.7	1.7	2.6	0.3	0.3	0.3	0.1	2.5	2.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.4	0.1	0.0	4.9	0.3	0.0	6.3	13.2	0.4	4.0	6.4	3.7	0.7	3.2	18.0	2.4
WDR72	FLJ38736	ENSG00000166415	"WD repeat domain 72"	Q3MJ13	15	53513741-53762878	"Disease related genes, Predicted intracellular proteins"	Biomineralization		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 64.1;thyroid gland: 36.3"	"Cell line enhanced"	"Detected in some"		"A549: 9.3;EFO-21: 6.1;NTERA-2: 5.6;RPMI-8226: 15.8;RPTEC TERT1: 10.3;U-266/70: 7.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048212, HPA057410, HPA059819"	Uncertain		Approved	Vesicles				Vesicles		"HPA048212: , HPA057410: , HPA059819: "	"unprognostic (6.39e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.09e-2)"	"prognostic favourable (3.33e-16)"	"unprognostic (2.83e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.80e-4)"	"unprognostic (7.67e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.7	0.2	0.1	3.0	0.8	0.6	4.9	0.3	0.8	4.6	0.2	0.1	0.1	64.1	13.1	0.8	0.1	0.1	0.1	0.5	1.3	1.5	0.9	0.8	0.1	0.2	0.1	0.3	11.2	0.4	0.1	1.1	0.6	0.1	0.1	0.1	0.2	1.1	0.1	0.1	36.3	0.4	0.5	0.6	0.1	0.2	0.0	0.1	0.0	0.2	0.8	0.1	0.0	9.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	3.0	0.1	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.1	15.8	10.3	3.3	1.8	0.0	0.0	0.1	0.0	2.3	0.0	0.1	0.3	0.5	0.0	0.1	7.3	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.2	0.3	0.5	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
WDR88	PQWD	ENSG00000166359	"WD repeat domain 88"	Q6ZMY6	19	33132090-33175795	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 25.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			"HPA041916, HPA050336"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA041916: AB_10804121, HPA050336: "	"unprognostic (1.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.33e-4)"	"unprognostic (5.14e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-2)"	"unprognostic (6.67e-2)"	0.3	0.5	0.4	1.1	0.6	1.0	0.3	0.7	1.4	0.3	0.3	0.3	0.3	0.7	0.3	0.3	0.7	0.2	0.6	1.2	0.4	0.4	0.3	0.3	0.3	1.6	0.3	0.3	1.0	1.0	0.0	0.5	0.3	0.3	0.3	0.0	0.3	1.1	0.3	0.3	0.9	0.9	0.3	0.3	0.6	0.3	25.2	0.3	0.3	1.4	0.3	0.3	0.3	0.3	1.2	0.6	0.6	1.3	2.9	1.4	0.3	1.1	2.3	1.5	2.8	0.8	0.0	2.1	0.9	0.0	0.2	0.0	1.1	2.2	2.8	1.4	0.0	0.8	0.0	0.3	0.0	5.7	0.8	2.6	1.8	0.5	0.0	2.0	2.3	0.0	0.0	0.0	0.0	0.0	1.8	2.9	0.0	3.3	1.1	1.2	1.1	0.9	2.1	0.8	0.5	0.0	1.3	4.1	4.1	2.8	1.3	0.6	3.5	2.1	1.5	0.7	2.2	1.2	0.4	2.7	1.8	1.6	0.5	4.4	1.2	0.0	0.4	0.4	1.4	1.3	1.3	0.0	1.2	1.0	0.3	1.2	0.8	0.7	0.6	2.9	0.6	0.6	0.2	0.3	0.4	0.6	0.7	0.8	0.4	0.4	0.3	0.3	0.3	0.3
WDR89	"C14orf150, MGC9907"	ENSG00000140006	"WD repeat domain 89"	Q96FK6	14	63597039-63641861	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000813	Uncertain		Approved	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"		"HPA000813: AB_1078324"	"prognostic favourable (3.37e-4)"	"unprognostic (6.46e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavourable (3.26e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.08e-2)"	"unprognostic (8.66e-3)"	"unprognostic (3.63e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.29e-1)"	13.2	12.6	11.5	11.6	13.4	4.6	13.7	19.3	18.8	12.5	10.3	9.5	7.4	8.0	14.6	11.5	10.5	11.9	8.6	8.1	11.0	10.7	14.8	16.1	9.1	17.8	15.7	11.6	15.0	14.0	16.2	16.3	12.9	12.3	12.0	12.1	8.3	8.7	8.4	13.2	10.8	8.9	10.5	11.8	13.8	8.5	8.6	14.4	21.0	16.9	7.6	17.0	11.6	10.2	7.0	4.3	0.6	3.6	8.4	14.0	4.9	25.2	11.0	13.8	7.3	8.3	9.1	19.6	10.2	5.6	10.3	11.5	7.8	11.9	24.5	8.4	3.0	11.7	16.8	9.9	18.3	15.8	9.6	16.7	6.9	9.7	10.5	21.1	11.5	8.2	12.9	11.8	17.7	10.0	13.5	13.6	7.7	12.6	17.6	12.0	12.3	21.9	13.1	13.9	13.7	11.4	9.8	11.7	9.6	10.9	11.7	7.7	13.5	11.5	6.9	12.5	11.9	8.1	12.1	7.9	5.9	15.0	5.6	15.6	8.8	0.0	2.5	0.3	8.2	2.5	10.5	7.0	8.7	7.5	4.3	6.9	14.0	12.1	0.6	8.4	3.6	2.8	8.7	4.9	11.5	13.4	19.3	18.8	11.0	10.7	15.7	11.6	12.3	14.4
WDR93		ENSG00000140527	"WD repeat domain 93"	Q6P2C0	15	89690797-89743638	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 12.0;testis: 28.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA046196, HPA048112"	Uncertain		Uncertain	"Actin filaments"				"Actin filaments"		"HPA046196: , HPA048112: "	"unprognostic (2.56e-3)"	"unprognostic (3.21e-3)"	"unprognostic (7.31e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.40e-2)"	"unprognostic (4.73e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.44e-2)"	0.5	0.3	1.2	0.7	2.3	0.8	1.1	1.1	1.4	1.2	0.2	3.7	0.0	0.0	0.6	8.0	0.1	12.0	0.3	1.6	1.6	1.6	2.5	0.2	1.3	0.3	0.3	0.4	1.7	0.8	0.4	3.0	0.2	6.2	0.9	0.2	2.5	1.1	1.9	0.3	0.4	0.2	0.0	0.5	0.3	0.2	28.6	1.2	0.1	3.3	0.0	0.2	0.2	0.1	0.5	1.1	2.2	0.3	1.3	0.6	0.2	1.1	1.0	0.1	0.5	1.3	1.0	1.5	1.0	0.5	1.2	0.7	0.4	2.7	0.6	1.0	0.7	0.7	0.0	0.8	1.9	1.2	0.8	0.8	1.3	0.6	1.7	1.1	0.2	1.6	1.9	0.4	0.1	0.3	0.1	0.9	0.9	1.0	1.0	0.5	1.4	0.5	0.4	0.4	0.4	2.6	0.6	3.3	0.8	2.7	0.8	3.6	0.5	1.8	0.0	1.0	0.8	1.6	0.6	0.5	0.9	0.8	1.2	0.4	0.6	1.2	0.3	0.4	0.5	0.3	0.2	0.2	0.3	0.2	0.3	0.5	0.3	0.6	2.2	1.3	0.2	1.1	0.2	0.2	1.2	2.3	1.1	1.4	1.6	1.6	0.3	0.4	6.2	1.2
WDR97	KIAA1875	ENSG00000179698	"WD repeat domain 97"	A6NE52	8	144107726-144118315	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 4.1;testis: 7.8"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.2;PC-3: 2.7;U-2 OS: 1.2"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in single"	7	"pons and medulla: 4.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA059409	Uncertain									"HPA059409: "	"unprognostic (3.95e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.58e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.01e-4)"	"unprognostic (3.10e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.97e-3)"	"unprognostic (6.92e-2)"	"unprognostic (6.11e-6)"	"unprognostic (2.79e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.73e-4)"	0.1	0.5	0.2	0.2	0.1	0.6	0.0	0.2	0.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.2	0.5	0.0	0.2	0.0	0.1	0.6	0.0	0.1	0.0	4.1	0.1	0.2	0.0	0.0	0.0	0.5	0.4	0.1	0.0	0.1	0.1	0.2	7.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.6	0.9	0.3	1.3	0.8	0.1	0.2	1.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.5	0.4	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.3	0.3	1.2	0.1	0.2	0.1	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.2	2.7	0.2	0.4	0.2	0.0	0.5	0.4	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.6	0.3	0.2	0.4	0.1	0.7	0.3	0.4	0.2	0.0	0.7	0.8	0.4	0.9	1.3	0.2	0.6	0.1	0.1	0.2	0.1	0.2	0.6	0.2	0.1	0.2	0.0	4.1	0.0
WFDC1	PS20	ENSG00000103175	"WAP four-disulfide core domain 1"	Q9HC57	16	84294646-84329851	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 64.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 18.7;BJ: 12.8;HEL: 10.7;HeLa: 17.1;THP-1: 6.2;U-937: 6.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031411	Uncertain				"Secreted to extracellular matrix"					"HPA031411: AB_10600921"	"unprognostic (6.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.61e-2)"	"unprognostic (8.66e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.78e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.04e-1)"	3.9	12.0	6.3	4.2	5.5	0.9	1.9	7.0	5.9	15.8	28.8	2.2	12.0	3.9	11.4	8.3	10.6	3.4	64.5	2.8	5.5	5.0	8.7	1.9	16.0	2.5	3.7	4.3	3.3	0.6	0.3	2.2	40.7	1.9	29.9	7.5	43.8	4.2	50.6	1.2	1.1	6.6	47.5	1.7	1.9	8.9	9.4	0.7	0.0	2.0	4.6	2.2	30.3	5.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	18.7	0.0	0.1	0.1	12.8	1.5	0.0	0.0	0.0	0.0	0.0	3.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	10.7	17.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.2	0.0	0.0	1.4	0.0	0.0	3.5	0.1	0.0	0.3	2.0	0.1	6.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.3	5.5	7.0	5.9	5.5	5.0	3.7	4.3	1.9	0.7
WFDC8	"C20orf170, dJ461P17.1, WAP8"	ENSG00000158901	"WAP four-disulfide core domain 8"	Q8IUA0	20	45551153-45579326	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"epididymis: 103.1"	"Cell line enriched"	"Detected in some"	6	"U-87 MG: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			"HPA042710, HPA071119"	Enhanced				"Secreted in male reproductive system"					"HPA042710: AB_2732501, HPA071119: AB_2732172"				"unprognostic (5.63e-3)"						"unprognostic (1.09e-2)"				"unprognostic (2.34e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.07e-2)"		0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.0	5.6	0.0	1.0	103.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.7	0.0	0.0	0.1	0.1	1.0	0.6	1.0	0.9	0.7	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.1	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	7.7	0.0	0.1	0.6	0.9	0.2	0.3	0.3	0.2	0.2	0.2	0.1	0.1	1.0	0.4	0.4	1.0	0.7	0.4	0.6	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
WNT2	"INT1L1, IRP"	ENSG00000105989	"Wnt family member 2"	P09544	7	117276631-117323289	"Cancer-related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 10.4;lung: 10.9;placenta: 40.9"	"Cell line enriched"	"Detected in some"	5	"U-2197: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 12.6"	"Low region specificity"	"Detected in all"			HPA020920			Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA020920: AB_1858850"	"unprognostic (1.90e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.43e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-1)"	1.8	0.0	0.2	0.1	1.1	0.0	1.4	0.3	2.3	3.0	0.2	0.4	0.4	0.0	10.4	2.7	0.4	1.0	0.2	0.7	0.9	0.9	0.3	0.8	10.9	0.0	0.1	0.5	0.8	0.1	0.0	0.2	40.9	0.5	7.6	0.0	0.9	0.1	0.5	0.0	1.1	0.2	1.2	0.2	1.5	0.1	0.7	0.0	0.0	0.2	0.0	0.1	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.4	2.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.3	2.3	0.9	0.9	0.1	0.5	0.5	0.0
WNT5B		ENSG00000111186	"Wnt family member 5B"	Q9H1J7	12	1529891-1647243	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 51.3;BJ hTERT+: 32.2;BJ hTERT+ SV40 Large T+: 37.6;BJ hTERT+ SV40 Large T+ RasG12V: 31.3;fHDF/TERT166: 35.8;HBF TERT88: 33.1;hTEC/SVTERT24-B: 32.8;U-138 MG: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"classical monocyte: 4.6;eosinophil: 3.5;intermediate monocyte: 2.1;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.1;granulocytes: 3.5;monocytes: 4.6"	"Low region specificity"	"Detected in many"							HPA061991			Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA061991: "	"unprognostic (7.44e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.71e-2)"	4.1	1.7	1.6	6.5	3.4	0.1	4.1	1.0	1.7	8.0	14.1	1.3	19.4	3.0	6.3	6.2	11.9	4.8	3.6	2.9	1.4	3.0	2.7	3.3	2.7	4.0	1.8	0.5	5.3	0.7	13.6	7.1	2.7	2.3	23.4	4.4	5.8	14.2	16.5	0.7	3.4	5.2	17.8	1.4	4.3	4.0	1.7	1.0	2.9	1.2	5.1	5.0	23.3	14.3	0.0	2.1	3.5	4.6	0.0	0.2	1.3	0.0	0.0	0.3	0.0	8.0	14.3	0.0	51.3	32.2	37.6	31.3	1.9	0.2	0.6	0.0	35.8	0.7	0.7	0.0	33.1	11.9	1.7	2.7	0.0	0.0	1.9	0.0	0.0	11.9	0.7	32.8	9.4	0.0	2.0	11.7	8.8	0.0	0.0	0.0	1.3	0.1	0.0	0.5	0.8	0.4	0.0	0.2	0.7	1.0	0.1	0.0	0.0	0.2	0.0	32.6	1.3	12.8	26.1	3.1	0.4	0.1	3.1	0.0	0.3	0.0	4.6	3.5	0.0	2.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	1.3	1.6	3.4	1.0	1.7	1.4	3.0	1.8	0.5	2.3	1.0
WNT8B		ENSG00000075290	"Wnt family member 8B"	Q93098	10	100463041-100483744	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 3.3;parathyroid gland: 3.8"	"Cell line enhanced"	"Detected in some"		"AF22: 6.5;MOLT-4: 2.2;RPMI-8226: 2.6;SCLC-21H: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA036570	Uncertain				"Secreted to extracellular matrix"					"HPA036570: AB_10670113"	"unprognostic (6.92e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.13e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.16e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.24e-2)"	0.2	3.3	0.2	0.2	0.5	0.0	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.4	2.3	0.2	0.2	0.2	0.2	0.2	0.3	1.6	3.8	0.5	0.2	0.2	0.7	0.0	0.2	2.1	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.1	2.6	0.2	2.2	0.2	0.2	0.2	1.6	0.2	0.0	0.3	0.7	0.0	0.0	1.3	0.3	0.0	0.0	6.5	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.1	0.0	1.0	0.2	0.0	0.0	0.6	1.3	0.0	0.0	0.2	0.0	1.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	1.8	2.2	0.0	0.0	0.4	0.7	0.0	2.6	0.0	1.9	3.0	0.8	0.0	0.0	0.1	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.7	0.0	0.0	0.3	0.0	0.3	0.2	0.5	0.3	0.2	0.2	0.4	0.2	0.2	0.2	0.2
WSB2	"MGC10210, SBA2"	ENSG00000176871	"WD repeat and SOCS box containing 2"	Q9NYS7	12	118032694-118062430	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052606	Uncertain									"HPA052606: "	"unprognostic (5.02e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.91e-2)"	"prognostic unfavourable (2.42e-5)"	"unprognostic (2.42e-3)"	"unprognostic (4.66e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.42e-2)"	15.6	21.2	50.8	13.3	39.3	7.8	19.2	20.2	61.7	10.0	20.8	16.7	7.1	16.5	9.0	12.1	25.0	8.6	12.1	25.5	44.3	29.3	17.3	19.8	14.5	10.3	39.7	26.5	6.8	17.9	14.8	14.0	9.0	21.7	13.2	22.1	9.4	8.2	13.4	41.9	9.9	17.9	16.6	37.4	8.6	14.9	8.6	12.7	5.6	22.4	17.9	12.7	18.4	7.6	2.3	4.9	13.5	8.8	3.8	6.0	2.1	11.1	18.1	13.0	22.3	19.5	11.4	9.3	30.0	22.5	32.7	19.9	9.4	15.8	1.6	10.0	39.2	6.0	10.8	18.2	23.9	20.3	7.0	6.2	9.0	9.1	20.6	3.6	16.9	15.3	18.6	17.4	12.3	17.2	18.3	3.1	34.2	16.8	2.3	2.4	7.7	11.2	6.5	13.7	0.5	20.2	48.9	14.0	20.9	23.1	5.2	16.5	17.8	8.8	26.3	39.7	16.6	12.6	35.9	5.0	3.3	3.1	35.6	4.8	62.8	9.3	6.4	13.5	5.9	8.8	5.2	0.9	5.8	6.0	4.2	2.3	2.8	4.7	6.6	3.8	5.9	4.9	5.9	2.1	50.8	39.3	20.2	61.7	44.3	29.3	39.7	26.5	21.7	12.7
WSCD1	KIAA0523	ENSG00000179314	"WSC domain containing 1"	Q658N2	17	6057807-6124427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.7;lymphoid tissue: 16.7"	"Cell line enhanced"	"Detected in some"		"AF22: 21.9;HUVEC TERT2: 13.3;PC-3: 13.5;RH-30: 27.7;SCLC-21H: 8.5"	"Group enriched"	"Detected in many"	7	"glioma: 18.8;renal cancer: 4.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015919	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"			Nucleoplasm	"Golgi apparatus"	"HPA015919: AB_2216211"	"unprognostic (1.50e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.46e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.62e-2)"	3.9	2.6	11.2	1.6	7.3	0.4	1.3	17.1	24.7	1.5	8.7	11.2	0.0	4.7	1.5	1.4	1.2	1.7	1.6	3.8	10.5	9.7	6.2	1.1	1.8	1.9	11.9	5.3	0.8	2.4	2.3	2.7	6.5	8.5	1.2	5.4	1.1	1.8	1.3	13.3	2.0	5.7	2.1	12.2	16.7	1.4	12.9	10.5	0.6	1.3	0.0	1.6	1.0	2.3	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	3.1	21.9	1.7	0.1	0.0	1.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	5.4	0.1	0.0	0.0	7.3	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.3	13.3	0.0	0.5	0.6	0.4	0.0	0.0	7.3	13.5	0.0	27.7	0.8	4.6	1.1	8.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	11.2	7.3	17.1	7.3	10.5	9.7	11.9	5.3	8.5	10.5
WSCD2	KIAA0789	ENSG00000075035	"WSC domain containing 2"	Q2TBF2	12	108129471-108250537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.0;seminal vesicle: 18.2;thyroid gland: 21.8"	"Cell line enriched"	"Detected in some"	21	"RT4: 26.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.6"	"Region enhanced"	"Detected in all"		"cerebellum: 44.0"	"Cell type enhanced"	"Detected in single"		"T-reg: 2.5"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013346, HPA048133"	Approved		Uncertain	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA013346: AB_1858865, HPA048133: "	"unprognostic (1.50e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.43e-3)"	"unprognostic (3.03e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.43e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.62e-3)"	1.4	1.2	6.5	0.5	12.5	0.4	1.0	44.0	15.2	5.4	1.7	1.6	0.0	0.7	6.9	3.0	3.8	2.0	0.5	0.5	10.0	3.0	1.3	0.4	0.8	0.5	1.3	6.0	0.6	2.1	0.4	0.9	0.6	1.9	6.0	0.7	9.9	0.5	18.2	0.5	0.6	0.9	9.2	1.5	0.5	2.0	0.6	2.0	0.0	21.8	0.2	0.5	3.0	0.9	0.8	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	26.9	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	6.5	12.5	44.0	15.2	10.0	3.0	1.3	6.0	1.9	2.0
XKR3	"MGC57211, XTES"	ENSG00000172967	"XK related 3"	Q5GH77	22	16783412-16821699	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	44	"blood: 4.7;testis: 13.5"	"Cell line enriched"	"Detected in some"	16	"Karpas-707: 71.4"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	8	"basophil: 1.5;neutrophil: 4.7"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 4.7"									"HPA003379, HPA035081"	Uncertain									"HPA003379: AB_10602682, HPA035081: "	"unprognostic (4.57e-1)"				"unprognostic (3.37e-1)"								"unprognostic (3.11e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.77e-2)"			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	13.5			0.0		0.0	0.0	0.0	0.0	0.2	4.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.4	71.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	0.0	1.5	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.1										
XKR4	KIAA1889	ENSG00000206579	"XK related 4"	Q5GH76	8	55102389-55542054	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.7"	"Group enriched"	"Detected in some"	11	"REH: 3.6;RPTEC TERT1: 14.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							"HPA025072, HPA028083"	Uncertain		Approved	Vesicles				Vesicles		"HPA025072: AB_1858886, HPA028083: AB_10601025"	"unprognostic (7.15e-4)"	"unprognostic (1.28e-3)"	"unprognostic (6.98e-2)"	"unprognostic (5.63e-3)"	"unprognostic (7.39e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.33e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.38e-3)"	"unprognostic (6.63e-2)"	"unprognostic (3.46e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.96e-2)"	1.2	1.4	18.7	4.3	5.6	0.8	0.7	4.4	12.1	2.1	5.1	0.6	0.3	1.5	1.0	1.4	2.5	1.1	1.4	2.6	8.6	4.5	0.9	0.7	0.7	2.0	2.0	8.8	0.9	1.1	0.5	5.3	0.6	2.0	1.2	2.2	2.5	2.0	2.9	0.8	1.4	2.0	3.5	1.2	0.9	1.5	0.9	3.4	0.6	0.7	0.6	2.3	1.0	1.6	0.8	0.3	2.2	0.2	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.6	0.0	0.0	14.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.3	0.2	0.1	0.1	0.6	0.2	0.1	0.0	0.8	0.2	0.3	1.2	0.7	0.1	0.3	0.1	0.1	18.7	5.6	4.4	11.5	8.6	4.5	2.0	8.8	2.0	3.4
XKR6	"C8orf21, C8orf5, C8orf7"	ENSG00000171044	"XK related 6"	Q5GH73	8	10896045-11201366	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 21.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 6.2;U-266/84: 10.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA024828, HPA064769"	Uncertain		Approved	"Actin filaments"				"Actin filaments"		"HPA024828: AB_2215165, HPA064769: "	"unprognostic (8.63e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.92e-6)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.75e-3)"	"unprognostic (8.65e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.29e-3)"	2.0	2.9	3.0	4.8	13.1	4.1	2.5	21.4	6.3	1.9	2.7	1.4	1.9	1.7	2.4	1.3	3.8	2.2	2.0	1.5	3.4	1.6	2.3	1.0	2.7	3.9	1.3	4.4	0.9	5.1	3.3	8.8	1.2	5.3	3.2	2.1	1.1	5.2	5.0	0.8	3.9	3.3	1.6	1.4	3.8	3.3	7.5	2.4	0.1	3.0	0.2	3.6	3.0	2.3	1.3	0.6	0.0	0.0	1.2	0.3	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.0	2.0	0.6	0.6	1.7	0.0	0.5	4.9	0.0	1.0	0.2	2.2	2.7	0.9	0.1	0.6	1.6	0.2	0.0	0.9	0.0	4.2	0.5	1.8	0.0	2.1	1.1	0.1	6.2	0.8	0.5	0.0	0.0	3.2	1.2	0.0	0.0	1.2	2.3	1.8	3.2	1.8	1.0	0.1	0.0	0.0	0.8	0.0	2.6	1.2	0.0	0.9	1.7	10.0	4.6	1.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	0.2	1.0	0.0	0.1	0.0	1.3	0.2	0.0	0.0	1.2	0.0	0.6	0.2	0.1	3.0	13.1	21.4	6.3	3.4	1.6	1.3	4.4	5.3	2.4
XKR7	"C20orf159, dJ310O13.4"	ENSG00000260903	"XK related 7"	Q5GH72	20	31968002-32003387	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 28.0;pituitary gland: 12.3"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 21.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 25.6"	HPA040854	Uncertain									"HPA040854: AB_10795481"	"unprognostic (2.74e-2)"	"unprognostic (5.60e-3)"	"unprognostic (8.03e-2)"	"unprognostic (3.74e-7)"	"unprognostic (4.29e-2)"	"unprognostic (9.34e-2)"		"unprognostic (1.45e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.68e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-5)"	"unprognostic (1.99e-1)"	0.5	1.5	2.9	0.6	4.4	0.5	0.4	28.0	10.0	0.4	0.5	0.0	0.0	0.6	0.4	0.5	0.4	0.5	0.5	0.4	1.2	1.5	0.5	0.4	0.5	0.4	0.8	4.6	0.4	1.8	0.4	12.3	0.4	3.5	0.4	0.6	2.0	0.4	0.5	0.4	0.5	0.5	0.4	0.6	0.5	1.7	1.2	0.0	0.0	0.4	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	21.2	4.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.9	4.4	28.0	8.7	1.2	1.5	0.8	4.6	3.5	0.0
XKR9		ENSG00000221947	"XK related 9"	Q5GH70	8	70669365-70790371	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 17.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.3;hTCEpi: 10.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA044430	Enhanced		Approved	Mitochondria				Mitochondria		"HPA044430: AB_10961283"	"unprognostic (1.79e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-2)"	"prognostic unfavourable (7.20e-4)"	"unprognostic (2.29e-1)"	"unprognostic (6.96e-6)"	"unprognostic (3.65e-1)"	"unprognostic (3.26e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.71e-2)"	0.9	3.4	1.9	0.8	4.3	0.9	1.1	0.6	6.4	0.9	1.7	1.9	0.0	4.9	0.7	2.5	1.1	0.7	4.1	1.0	2.3	1.5	1.0	7.5	2.1	1.0	1.3	7.3	1.0	1.3	0.3	2.1	0.8	7.4	1.4	1.0	2.6	2.0	0.2	0.9	1.7	9.6	3.5	1.7	1.0	3.6	17.1	0.7	0.0	1.0	0.0	1.0	2.5	1.2	1.2	0.3	0.9	0.2	0.6	3.1	0.2	3.8	0.3	0.8	0.4	0.0	1.0	0.6	1.6	0.8	0.5	1.6	5.3	0.4	0.5	2.7	0.1	0.1	0.1	0.9	2.0	0.7	0.5	0.4	0.3	0.6	0.1	1.2	2.2	1.1	10.9	0.3	0.0	0.0	0.2	3.9	0.3	0.5	0.7	0.6	2.1	0.5	0.5	1.1	0.2	0.3	2.9	2.3	0.4	0.9	1.6	0.5	0.5	0.1	0.4	0.5	1.1	0.8	0.6	3.4	0.9	2.5	0.2	0.4	0.3	0.9	0.1	0.3	0.9	0.1	1.7	0.9	1.7	0.8	0.1	1.2	2.6	1.7	0.6	0.6	0.2	0.3	3.1	0.2	1.9	4.3	0.6	6.4	2.3	1.5	1.3	7.3	7.4	0.7
XRRA1	FLJ00225	ENSG00000166435	"X-ray radiation resistance associated 1"	Q6P2D8	11	74807739-74949200	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039263			Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA039263: "	"unprognostic (3.58e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.94e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.27e-1)"	7.1	7.9	6.2	19.5	8.6	3.7	10.7	5.7	7.5	8.6	7.3	7.6	22.9	5.8	9.0	13.5	6.6	9.6	8.7	9.5	7.9	5.9	6.9	8.1	9.5	4.1	5.7	7.0	9.3	22.7	11.9	8.1	5.3	10.8	10.5	5.6	7.4	13.1	16.8	15.7	5.8	5.9	10.1	13.7	7.2	6.4	35.0	6.1	5.6	14.3	4.1	5.8	6.3	7.4	3.5	3.4	6.2	5.2	2.0	8.5	3.0	3.9	2.2	0.5	3.7	5.8	3.8	1.6	1.7	1.8	1.0	1.0	1.1	2.1	1.6	6.3	1.9	3.2	4.5	2.2	2.1	6.3	0.4	1.4	1.3	2.2	1.7	0.8	0.7	3.6	2.6	4.2	27.7	2.0	3.6	3.8	4.8	1.4	1.4	2.0	1.2	2.0	0.7	3.0	1.2	0.8	3.0	3.6	3.0	7.9	3.4	10.6	2.1	4.1	1.3	6.0	3.9	4.3	1.6	5.3	4.7	4.4	1.4	0.8	2.0	2.9	4.3	3.8	6.3	5.2	6.6	3.5	4.6	4.7	3.4	3.5	4.6	4.5	6.2	2.0	3.2	2.5	8.5	3.0	6.2	8.6	5.7	7.5	7.9	5.9	5.7	7.0	10.8	6.1
YPEL3	MGC10500	ENSG00000090238	"Yippee like 3"	P61236	16	30092314-30096915	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 29.1;RPMI-8226: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 8.7;eosinophil: 15.6;neutrophil: 24.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030501, HPA045621"	Uncertain									"HPA030501: AB_10602683, HPA045621: "	"unprognostic (1.11e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.58e-2)"	"prognostic favourable (1.09e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.64e-1)"	"unprognostic (5.42e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.40e-3)"	32.6	24.5	49.7	26.6	34.7	36.7	27.6	68.4	77.5	17.5	20.5	27.5	15.1	26.1	23.2	14.5	21.6	20.7	19.6	26.0	43.7	32.1	20.1	13.4	28.9	30.1	31.6	37.7	30.5	43.8	25.4	19.1	31.0	38.8	21.4	10.6	19.4	44.8	24.8	77.4	41.0	31.8	13.6	22.5	46.4	27.5	9.1	30.2	20.1	27.9	16.0	25.7	22.3	31.3	2.3	1.0	24.8	1.7	2.7	2.4	0.7	5.0	1.2	3.4	1.1	13.1	13.2	14.3	8.2	5.2	1.9	4.9	0.6	17.2	1.6	29.1	6.1	2.9	1.9	4.3	0.8	9.9	6.6	1.9	3.5	6.7	9.8	0.0	15.9	21.8	6.0	2.9	0.8	6.8	1.6	12.9	2.7	9.6	0.3	1.5	3.1	1.1	9.1	0.0	36.9	3.9	4.3	7.1	18.7	3.3	4.2	6.6	5.9	6.1	7.1	0.5	3.6	1.6	0.0	21.8	7.0	2.6	5.8	2.9	1.6	8.7	1.7	15.6	1.3	0.8	1.5	1.8	2.4	1.8	1.0	2.3	2.3	1.3	24.8	2.7	0.7	1.0	2.1	0.7	49.7	34.7	68.4	77.5	43.7	32.1	31.6	37.7	38.8	30.2
YPEL4	FLJ30213	ENSG00000166793	"Yippee like 4"	Q96NS1	11	57645087-57649944	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 27.4"	"Cell line enhanced"	"Detected in some"		"AF22: 6.1;ASC diff: 3.8;ASC TERT1: 3.5;SK-MEL-30: 7.2;U-87 MG: 3.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045621	Uncertain									"HPA045621: "	"unprognostic (6.91e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.62e-3)"	"unprognostic (2.40e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.34e-6)"	"unprognostic (1.50e-4)"	"unprognostic (9.56e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.92e-1)"	2.1	7.5	17.8	1.5	13.5	12.3	2.4	27.4	26.3	5.0	1.7	6.0	0.0	1.9	5.1	1.3	1.9	1.8	3.1	1.9	9.8	10.6	1.1	1.1	1.9	1.3	8.0	17.7	8.7	1.6	1.0	3.5	2.2	8.5	1.3	1.4	0.2	1.4	2.0	1.0	1.6	1.9	3.5	5.3	1.8	1.3	2.5	8.9	0.0	1.1	0.0	1.2	1.6	1.9	0.0	0.0	0.0	0.3	0.0	1.6	0.1	0.7	0.1	6.1	0.3	3.8	3.5	0.7	0.2	2.8	0.0	0.0	0.4	0.1	0.1	0.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.0	3.2	1.5	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.4	2.5	0.0	2.4	0.7	0.4	0.1	0.0	0.0	1.6	0.3	0.6	7.2	0.5	0.0	0.0	0.4	1.6	0.0	0.0	2.7	0.0	0.0	3.6	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.4	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.1	17.8	13.5	27.4	23.1	9.8	10.6	8.0	17.7	8.5	8.9
YY2	ZNF631	ENSG00000230797	"YY2 transcription factor"	O15391	X	21855987-21858727	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 9.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA001119, HPA030335"	Enhanced		Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA001119: AB_1858930, HPA030335: "	"unprognostic (1.90e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.75e-2)"	"unprognostic (8.39e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.78e-4)"	"unprognostic (4.04e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-1)"	1.6	1.8	0.7	1.4	0.9	0.3	1.4	1.8	0.8	1.6	1.2			0.3	2.8	1.9	1.3	1.6	1.2	1.2	0.5	0.6	1.0	2.5	1.4	0.7	0.8		3.3	1.4	1.5	2.5	2.2		1.8	0.9		1.3	1.6	1.2	1.8	0.8	2.0	1.1	0.9	0.9	9.5			1.6		0.6	1.1	1.5	1.5	1.2	0.0	0.6	1.4	2.7	0.5	3.6	3.3	2.3	7.3	2.8	1.2	0.3	4.0	2.3	4.6	5.3	2.6	6.0	4.1	2.3	5.2	2.0	4.9	5.4	8.1	2.9	4.7	1.1	8.8	2.1	5.0	4.4	2.2	2.4	4.1	3.5	5.7	2.9	4.2	4.9	8.1	2.5	2.4	4.6	4.3	4.3	2.3	3.8	6.3	2.5	1.6	1.3	3.2	2.3	2.0	6.5	3.5	1.4	3.1	8.5	1.7	14.7	4.7	3.3	3.9	2.6	5.6	2.2	6.7	0.0	0.6	0.0	0.8	0.1	0.6	1.5	1.3	0.8	0.6	1.1	2.7	0.6	0.0	1.4	0.4	1.2	1.2	0.5										
ZAR1L	Z3CXXC7	ENSG00000189167	"Zygote arrest 1 like"	A6NP61	13	32303700-32315344	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.2;gallbladder: 2.7;testis: 3.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.0;MCF7: 2.1;U-698: 2.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"cerebral cortex: 2.2;thalamus: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 1.0;basal ganglia: 1.8;cerebral cortex: 2.8;hippocampal formation: 2.2"	"Low region specificity"	"Detected in many"			HPA041319	Uncertain									"HPA041319: AB_10794407"	"unprognostic (4.03e-1)"	"unprognostic (1.79e-1)"		"unprognostic (4.38e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.33e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.66e-1)"				"unprognostic (8.34e-2)"	"unprognostic (3.73e-1)"		"unprognostic (7.51e-2)"	0.2	0.1	0.1	0.1	0.1	0.8	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	2.7	0.0	0.1	0.2	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.1	0.2	0.0	3.5	1.3	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.8	0.5	0.3	0.2	0.0	0.1	0.0	0.1	0.4	0.3	0.0	0.2	0.2	0.0	0.6	0.5	3.0	0.3	1.2	0.4	0.0	0.3	1.2	0.2	0.4	0.6	0.0	0.3	0.4	0.3	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.2	0.4	0.4	0.2	2.1	0.3	0.6	1.1	0.7	1.2	1.0	0.3	0.0	0.3	0.1	0.2	0.0	0.4	0.2	0.1	1.0	0.0	0.4	0.0	0.9	0.0	0.8	0.5	2.3	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.2	0.1	0.2	0.0	0.0	0.0	1.3
ZBBX	FLJ23049	ENSG00000169064	"Zinc finger B-box domain containing"	A8MT70	3	167240287-167381346	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.0;epididymis: 14.2;fallopian tube: 23.4;testis: 33.3"	"Cell line enhanced"	"Detected in some"		"AF22: 2.9;CAPAN-2: 2.2;NTERA-2: 1.5;PC-3: 1.2;SCLC-21H: 1.9;U-138 MG: 1.4;U-87 MG: 2.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA036327, HPA036328"	Enhanced									"HPA036327: AB_10672240, HPA036328: AB_2675063"	"unprognostic (2.68e-3)"	"unprognostic (4.49e-2)"		"unprognostic (6.94e-2)"	"unprognostic (3.99e-1)"			"unprognostic (4.08e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-1)"		0.3	0.6	2.5	0.3	12.9	0.3	0.3	0.0	3.3	1.3	0.4	4.5	0.0	0.3	1.1	14.2	0.3	23.4	0.3	0.3	4.7	3.9	0.5	0.3	7.2	0.4	0.4	2.6	6.9	0.3	0.8	5.3	0.4	22.0	0.4	0.3	0.0	0.3	0.4	0.4	0.3	0.3	0.4	0.5	0.3	0.4	33.3	3.4	0.0	0.4	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.5	1.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.5	0.0	0.0	1.4	0.7	0.0	0.1	0.8	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	12.9	0.0	3.3	4.7	3.9	0.4	2.6	22.0	3.4
ZBED5	Buster1	ENSG00000236287	"Zinc finger BED-type containing 5"	Q49AG3	11	10812074-10858796	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA048472, HPA050994"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"				"Golgi apparatus"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA048472: , HPA050994: "	"unprognostic (7.74e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.72e-2)"	"unprognostic (3.40e-1)"	"unprognostic (9.05e-2)"	"prognostic unfavourable (2.19e-5)"	"unprognostic (5.69e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"prognostic favourable (3.87e-4)"	21.6	18.5	20.4	32.6	21.6	21.5	27.5	43.2	30.2	35.6	24.7	22.0	17.2	18.4	34.7	27.6	22.5	30.8	19.8	32.7	21.3	13.1	24.0	13.0	24.5	38.1	24.0	23.4	40.2	24.4	42.0	44.6	20.9	27.1	30.1	22.7	16.3	24.9	19.1	32.6	36.8	29.4	22.4	30.5	35.6	22.2	17.2	25.3	45.0	34.9	17.7	32.3	30.0	26.4	18.4	12.4	5.8	8.4	13.4	14.5	6.2	19.7	16.0	27.9	18.2	15.2	24.0	14.4	16.2	16.9	11.1	11.0	11.4	43.2	22.0	12.3	12.0	24.6	17.4	16.8	15.1	21.1	15.7	5.6	33.6	7.0	12.5	18.0	7.6	16.1	24.8	8.3	18.5	13.7	14.7	24.9	15.9	10.0	17.5	19.5	15.1	21.3	26.6	15.5	11.6	13.1	27.9	13.8	24.6	16.8	21.7	12.9	20.5	10.2	13.5	24.0	17.3	15.9	11.3	12.2	15.1	17.3	20.7	12.7	18.1	0.7	6.7	5.8	9.3	7.3	12.0	16.7	11.1	11.7	9.6	18.4	14.5	14.0	5.6	13.4	8.4	12.4	9.4	6.2	20.4	21.6	43.2	30.2	21.3	13.1	24.0	23.4	27.1	25.3
ZBED6CL	C7orf29	ENSG00000188707	"ZBED6 C-terminal like"	Q96FA7	7	150329789-150332721	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"adrenal gland: 37.4;parathyroid gland: 11.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 40.1;K-562: 17.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA019724, HPA055805"	Approved		Approved	"Nuclear membrane,Vesicles"				"Nuclear membrane"	Vesicles	"HPA019724: AB_1845756, HPA055805: "	"prognostic favourable (9.48e-5)"	"unprognostic (6.77e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.41e-2)"	"prognostic unfavourable (3.12e-5)"	"unprognostic (3.35e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.78e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.44e-1)"	"prognostic favourable (2.44e-5)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (1.38e-5)"	"unprognostic (1.86e-2)"	"unprognostic (7.82e-2)"	"unprognostic (8.52e-3)"	"unprognostic (1.50e-3)"	0.4	37.4	0.4	2.6	0.4	1.7	0.8	0.3	0.2	1.1	1.4			1.6	2.0	0.2	1.2	1.9	0.4	0.4	0.3	0.6	1.8	5.6	1.5	3.9	0.3		3.1	3.2	11.3	2.5	0.0		1.5	1.5		1.1	0.9	0.1	2.2	2.1	0.6	0.1	2.3	1.7	0.3			1.8		3.7	1.3	0.8	3.6	1.0	2.8	1.0	2.8	3.5	2.4	4.4	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.4	6.2	4.7	2.5	2.2	0.0	1.8	0.0	0.0	0.3	40.1	3.2	3.1	6.6	10.5	1.3	0.0	4.7	0.8	2.4	0.0	0.0	0.2	17.2	6.7	0.0	2.0	7.6	1.8	3.0	0.0	0.0	0.3	5.6	2.1	8.9	8.5	4.9	6.8	1.9	0.3	0.5	2.1	0.1	0.0	0.0	0.0	0.0	5.4	1.5	0.0	0.0	0.0	0.0	0.0	1.0	1.0	2.7	0.7	3.2	2.2	2.4	3.4	0.7	3.6	3.5	2.9	2.8	2.8	0.2	1.0	2.2	2.4										
ZBED9	"Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452"	ENSG00000232040	"Zinc finger BED-type containing 9"	Q6R2W3	6	28570535-28616212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 13.2;testis: 17.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 7.7;hTCEpi: 7.0;K-562: 12.3;U-266/84: 5.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA007246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				Nucleoli	"Nucleoplasm, Golgi apparatus"	"HPA007246: AB_1080727"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-5)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (3.96e-2)"	"unprognostic (9.46e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.73e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.34e-3)"	"unprognostic (8.21e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.66e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-1)"	0.8	1.8	2.6	0.4	7.2	0.4	2.3	9.5	4.7	2.3	1.1	0.3	9.3	0.7	1.6	7.5	1.0	3.1	0.7	1.2	2.4	2.3	2.3	3.2	1.9	0.5	1.3	2.9	4.1	3.4	3.2	6.9	3.0	3.5	3.4	1.5	0.8	2.4	13.2	0.5	0.7	0.8	1.1	0.8	0.6	1.0	17.6	0.7	0.0	4.1	0.0	0.6	1.4	1.2	0.5	0.7	1.1	0.7	0.4	1.4	0.2	1.8	1.8	1.8	0.0	0.0	0.0	2.2	0.4	0.0	0.4	1.1	0.0	1.2	0.0	7.7	0.1	1.0	0.0	2.1	0.4	0.0	5.1	0.4	1.2	1.8	1.2	0.0	0.0	1.1	7.0	0.1	3.5	0.0	12.3	0.0	0.1	1.3	0.0	0.1	1.8	0.9	0.6	0.8	0.1	2.0	2.1	2.0	4.8	0.0	1.9	0.0	0.0	0.6	0.0	0.0	2.2	0.0	1.2	0.0	5.9	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.3	0.4	0.1	0.2	0.4	0.4	0.2	0.5	1.4	1.0	1.1	0.4	0.7	0.7	0.1	0.2	2.6	7.2	9.5	4.7	2.4	2.3	1.3	2.9	3.5	0.7
ZBTB37	"MGC2629, ZNF908"	ENSG00000185278	"Zinc finger and BTB domain containing 37"	Q5TC79	1	173868082-173903549	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023438	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA023438: AB_1858954"	"unprognostic (1.18e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.66e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.96e-2)"	6.4	4.0	6.9	6.5	9.8	11.1	5.8	6.4	7.9	5.3	4.0	11.2	3.7	4.0	9.1	5.5	3.4	4.6	4.7	5.6	7.2	3.7	5.3	4.8	6.0	7.7	9.9	5.2	7.6	4.5	6.8	9.2	4.7	7.8	5.3	3.9	10.6	4.6	4.9	4.0	7.0	5.2	6.8	9.5	7.9	5.1	18.4	8.8	7.7	6.1	2.8	6.3	4.8	5.5	1.8	2.4	6.0	1.0	2.3	2.8	0.8	2.4	3.7	5.6	2.4	3.4	2.8	6.2	2.2	1.6	4.0	2.9	4.6	3.1	6.6	4.6	3.4	3.1	4.7	2.4	3.3	3.6	3.0	9.0	3.9	2.2	2.0	5.3	5.7	2.5	1.7	6.0	4.0	2.0	8.0	4.4	4.2	1.8	3.6	1.4	5.3	0.8	2.4	4.9	2.2	2.2	6.0	4.2	5.2	3.1	4.3	4.3	6.2	5.5	3.6	5.2	5.6	2.6	3.5	8.0	5.9	10.5	3.5	3.0	3.1	0.4	1.0	3.4	2.8	1.0	1.2	0.7	1.3	2.0	0.6	1.8	0.7	1.8	6.0	2.3	1.0	2.4	1.0	0.8	6.9	9.8	6.4	7.9	7.2	3.7	9.9	5.2	7.8	8.8
ZBTB45	"FLJ14486, ZNF499"	ENSG00000119574	"Zinc finger and BTB domain containing 45"	Q96K62	19	58513530-58538911	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035754	Uncertain		Approved	Cytosol				Cytosol		"HPA035754: AB_10603461"	"unprognostic (1.38e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.34e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.22e-1)"	"prognostic favourable (5.38e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.40e-1)"	15.3	11.1	11.8	12.0	13.4	11.1	10.2	15.1	24.9	15.2	10.9	13.5	11.4	14.6	14.9	8.7	11.6	12.5	10.3	10.0	12.6	10.0	9.8	7.7	11.0	10.1	10.3	8.5	16.6	13.9	9.1	8.8	10.9	11.2	14.5	4.7	13.2	21.5	11.0	21.0	17.2	14.7	11.8	7.3	13.3	14.6	7.5	9.2	15.8	15.9	9.1	14.4	13.5	10.5	7.9	8.7	13.2	11.3	7.0	9.8	5.5	10.4	15.1	3.9	6.2	4.0	3.3	4.7	5.5	2.3	1.4	1.4	2.9	7.0	16.6	8.4	3.2	6.5	2.0	4.9	0.6	10.8	27.0	8.8	7.6	3.6	2.4	5.3	5.7	3.1	3.6	2.3	2.0	2.9	7.8	0.8	2.3	7.6	8.7	5.7	5.7	13.1	6.8	2.4	10.1	3.1	10.1	12.7	8.8	4.2	11.8	3.0	18.4	3.8	5.4	6.7	2.9	2.2	5.5	19.4	13.6	8.6	7.8	2.2	4.2	9.2	6.7	13.2	8.1	10.2	9.8	6.1	5.8	7.7	7.2	7.9	7.1	5.0	5.9	7.0	11.3	8.7	5.1	5.5	11.8	13.4	15.1	24.9	12.6	10.0	10.3	8.5	11.2	9.2
ZBTB8B	"DKFZp547H154, RP1-27O5.1, ZNF916B"	ENSG00000273274	"Zinc finger and BTB domain containing 8B"	Q8NAP8	1	32465069-32496686	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 10.8"	"Cell line enhanced"	"Detected in some"		"RT4: 3.7;SCLC-21H: 3.6"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA055553	Enhanced									"HPA055553: "	"unprognostic (8.32e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.83e-5)"	"unprognostic (1.86e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.67e-4)"	"unprognostic (1.57e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.44e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.88e-3)"	0.4	1.3	5.1	0.6	2.8	2.5	0.6	2.2	5.0	0.4	0.3	1.3	0.7	0.5	1.2	1.3	0.7	0.7	0.6	0.4	3.3	4.7	0.6	0.6	0.5	0.9	2.6	2.7	1.0	0.8	1.0	10.8	0.7	4.1	0.8	0.4	0.2	1.7	0.5	3.4	1.7	0.5	0.5	1.6	0.8	0.5	3.1	1.6	0.0	0.8	0.0	0.6	1.0	0.4	1.4	1.2	3.2	0.8	1.3	0.7	0.2	0.2	0.1	2.0	1.5	0.2	0.5	0.6	0.2	0.1	0.7	0.6	0.2	0.5	0.4	0.7	0.1	0.7	2.3	0.2	0.5	0.7	2.5	0.3	0.7	0.4	0.0	0.3	0.4	0.2	0.2	0.5	0.0	0.2	0.2	0.9	0.1	0.3	0.3	0.6	2.1	0.9	0.3	0.2	0.3	0.4	3.7	3.6	2.2	1.3	0.5	0.2	0.4	0.3	0.9	0.5	0.4	0.6	0.3	0.7	0.7	0.4	0.5	0.4	0.4	3.2	0.8	1.0	0.6	0.5	0.6	0.8	0.6	0.5	0.3	1.4	0.7	0.7	2.9	1.3	0.7	1.2	0.5	0.2	5.1	2.8	2.2	5.0	3.3	4.7	2.6	2.7	4.1	1.6
ZC3H12B	"CXorf32, MCPIP2"	ENSG00000102053	"Zinc finger CCCH-type containing 12B"	Q5HYM0	X	65366638-65507887	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 6.1"	"Cell line enhanced"	"Detected in many"		"AF22: 5.2;Karpas-707: 4.2"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA000836	Uncertain		Approved	"Endoplasmic reticulum,Golgi apparatus,Vesicles"				"Endoplasmic reticulum"	"Golgi apparatus, Vesicles"	"HPA000836: AB_2217374"	"unprognostic (1.91e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.44e-3)"	"unprognostic (7.86e-3)"	"unprognostic (5.46e-2)"	"unprognostic (3.32e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.71e-2)"	0.3	0.9	2.6	0.5	3.9	0.1	0.5	2.8	6.1	1.9	1.1			0.9	2.6	0.8	0.4	2.0	1.1	0.5	2.8	2.5	1.2	0.5	0.6	0.7	1.7		3.3	0.1	2.7	2.7	0.0		1.8	1.1		0.3	2.4	0.0	0.3	0.9	1.8	1.5	0.4	1.3	0.0			1.5		0.2	1.0	0.7	1.3	0.8	0.7	0.4	0.8	1.8	0.2	0.3	0.4	5.2	0.8	0.0	0.0	0.7	1.3	2.8	0.0	0.8	0.7	0.5	0.8	0.3	1.4	0.8	1.3	0.0	0.1	0.8	3.8	1.7	2.4	0.7	0.1	1.6	0.4	0.2	0.0	0.1	0.0	0.0	0.9	4.2	0.1	0.0	2.2	0.6	2.1	1.1	2.5	0.2	1.0	0.1	0.2	0.2	2.5	0.0	0.2	0.2	0.1	1.3	0.0	0.1	1.0	1.7	0.5	0.9	1.0	1.7	3.3	2.2	0.0	0.6	0.4	0.1	0.6	0.2	0.5	0.9	0.8	0.8	0.2	1.3	1.8	0.8	0.7	0.8	0.2	0.8	0.4	0.2										
ZDHHC1	"C16orf1, HSU90653, ZNF377"	ENSG00000159714	"Zinc finger DHHC-type containing 1"	Q8WTX9	16	67394419-67416833	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.4;ASC TERT1: 14.9;U-138 MG: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 2.6;intermediate monocyte: 3.6;myeloid DC: 2.4;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.4;monocytes: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042531, HPA048659"	Uncertain		Approved	Cytosol				Cytosol		"HPA042531: , HPA048659: "	"unprognostic (8.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.05e-3)"	"prognostic favourable (1.25e-6)"	"unprognostic (1.68e-2)"	"unprognostic (9.33e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.67e-1)"	"prognostic favourable (5.99e-4)"	"unprognostic (2.17e-1)"	"prognostic favourable (1.55e-6)"	"unprognostic (2.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.63e-3)"	9.6	6.3	4.3	3.9	6.6	0.5	10.2	5.3	10.5	16.9	7.4	5.5	7.9	3.8	13.5	16.4	6.3	22.6	14.0	6.2	4.5	3.7	11.2	3.8	7.8	4.9	5.3	3.5	17.1	16.2	11.5	14.0	15.1	6.5	11.6	3.2	11.2	14.7	12.1	8.0	10.8	3.9	9.3	3.3	10.1	6.2	25.7	2.6	0.6	31.3	9.3	4.9	6.9	9.7	0.0	2.4	0.3	3.6	0.0	0.0	0.8	5.0	6.1	1.5	8.1	13.4	14.9	0.0	2.8	11.0	2.9	3.4	0.0	3.2	0.0	1.3	5.1	3.3	0.5	0.5	0.6	1.5	4.6	0.4	0.1	0.4	6.8	0.3	4.3	7.1	6.3	3.1	0.8	3.7	0.0	0.0	2.0	0.5	0.0	0.0	3.0	0.1	0.0	0.1	0.0	4.1	3.1	2.1	7.4	0.5	0.2	6.6	2.1	1.2	4.9	12.9	2.1	6.2	3.4	1.5	0.3	0.0	7.9	0.1	5.3	0.0	2.6	0.0	0.0	3.6	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.8	4.3	6.6	5.3	10.5	4.5	3.7	5.3	3.5	6.5	2.6
ZDHHC11	"FLJ13153, ZNF399"	ENSG00000188818	"Zinc finger DHHC-type containing 11"	Q9H8X9	5	795606-850986	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.2"	"Cell line enhanced"	"Detected in many"		"T-47d: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA057886, HPA069008"	Uncertain		Approved	"Lipid droplets"				"Lipid droplets"		"HPA057886: , HPA069008: "	"unprognostic (2.67e-1)"	"unprognostic (9.76e-3)"	"unprognostic (4.47e-5)"	"unprognostic (5.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.68e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.65e-1)"	"unprognostic (5.23e-5)"	"unprognostic (4.80e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-2)"	1.8	1.4	3.4	1.0	4.2	0.7	2.7	11.0	3.8	1.6	1.5	6.3	1.0	9.5	1.7	2.9	3.2	10.3	1.2	6.4	4.2	3.8	2.0	2.6	7.5	1.0	15.2	1.9	1.5	1.9	1.8	7.8	1.2	10.9	2.7	1.2	1.0	1.4	3.4	2.1	2.7	1.7	1.0	5.0	2.4	5.9	6.3	6.1	1.0	1.1	2.3	1.8	1.0	1.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.3	7.4	4.1	0.8	1.3	0.3	5.5	0.3	0.1	0.2	0.1	1.0	0.3	3.0	0.8	0.1	6.9	2.2	0.0	0.1	9.0	4.8	0.3	2.6	3.7	0.3	4.3	0.3	0.4	0.3	0.9	1.0	0.0	0.7	1.7	0.2	3.3	0.4	2.6	7.3	2.9	4.5	2.8	4.1	0.2	1.5	4.1	0.7	0.2	0.1	3.1	11.5	0.7	0.4	0.2	6.9	3.9	0.1	5.5	7.7	0.9	0.3	8.9	0.2	0.0	0.0	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.2	11.0	3.8	4.2	3.8	15.2	1.9	10.9	6.1
ZDHHC12	"FLJ14524, ZNF400"	ENSG00000160446	"Zinc finger DHHC-type containing 12"	Q96GR4	9	128720869-128724127	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 77.4"	"Cell line enhanced"	"Detected in many"		"MCF7: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA059339	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"				Nucleoplasm	"Intermediate filaments"	"HPA059339: "	"unprognostic (2.05e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.34e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.50e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.42e-2)"	"unprognostic (9.97e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.82e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.23e-1)"	7.3	10.9	3.9	15.3	4.5	21.8	11.2	2.5	6.5	7.5	21.2	6.8	19.3	16.2	5.9	8.3	27.2	6.9	21.5	9.2	3.5	3.1	20.6	23.6	14.2	28.0	3.8	3.8	5.0	40.5	4.3	5.0	24.7	4.8	11.1	8.4	7.7	26.3	13.3	7.5	16.8	33.0	5.4	5.8	14.9	18.7	9.2	2.7	23.6	10.3	16.4	24.4	10.1	11.7	22.2	50.6	77.4	28.7	17.4	26.1	18.8	14.1	38.8	1.6	8.4	5.1	3.5	16.4	9.2	8.2	10.0	6.7	31.8	16.4	9.9	8.6	6.8	37.5	3.5	18.1	1.0	18.2	9.3	5.2	29.5	13.9	10.3	8.7	24.1	5.6	12.6	8.2	3.1	7.4	5.2	25.2	1.9	54.5	11.9	17.4	7.2	32.1	5.4	5.8	28.4	7.6	13.3	11.6	8.4	12.4	17.2	4.8	26.5	9.3	7.4	0.0	10.5	7.1	12.2	16.3	28.8	4.4	16.8	10.0	11.0	39.2	26.5	77.4	23.5	24.7	20.3	20.3	21.8	22.5	21.0	22.2	22.7	20.6	56.8	17.4	28.7	50.6	26.1	18.8	3.9	4.5	2.5	6.5	3.5	3.1	3.8	3.8	4.8	2.7
ZDHHC15	"DHHC15, FLJ31812, MRX91"	ENSG00000102383	"Zinc finger DHHC-type containing 15"	Q96MV8	X	75368427-75523502	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 5.6;K-562: 3.5;LHCN-M2: 3.9;MOLT-4: 4.1;NTERA-2: 3.7;RH-30: 5.7;RPTEC TERT1: 3.1;SH-SY5Y: 4.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003618	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA003618: AB_2217686"	"unprognostic (8.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.62e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.00e-4)"	"unprognostic (1.96e-2)"	"unprognostic (3.19e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.78e-13)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.67e-4)"	3.0	5.4	4.9	1.5	6.8	1.1	5.3	6.2	9.9	5.8	3.4	3.9	2.4	1.3	6.5	3.7	3.2	4.5	3.3	5.4	5.9	8.7	5.3	1.2	4.1	1.6	4.8	5.3	8.5	4.7	5.0	8.7	0.7	7.0	4.0	2.3	5.4	12.7	6.9	1.6	2.8	1.8	5.2	6.4	2.9	2.1	2.6	3.1	2.0	6.6	2.1	1.5	2.6	3.1	0.3	0.4	0.7	0.2	0.5	1.6	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	3.9	0.0	4.1	0.1	3.7	0.0	0.0	5.7	0.0	3.1	0.0	1.6	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.0	0.0	0.7	2.8	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.0	0.1	0.3	0.6	0.0	0.0	0.2	1.6	1.1	0.7	0.5	0.1	0.4	0.0	0.3	4.9	6.8	6.2	9.6	5.9	8.7	4.8	5.3	7.0	3.1
ZDHHC21	"DHHC21, DNZ1, HSPC097"	ENSG00000175893	"Zinc finger DHHC-type containing 21"	Q8IVQ6	9	14611071-14693471	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 22.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065254	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA065254: "	"unprognostic (2.95e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.37e-2)"	"unprognostic (9.79e-3)"	"unprognostic (3.97e-2)"	"prognostic favourable (1.29e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.87e-2)"	"prognostic favourable (9.28e-6)"	6.5	10.8	15.9	7.9	16.8	4.2	11.6	29.0	22.6	7.8	8.5	9.3	3.8	12.2	9.8	11.7	14.4	7.5	6.7	9.0	13.8	10.4	9.4	4.8	9.2	11.1	9.4	16.5	10.0	8.4	11.5	22.2	7.8	14.8	10.0	9.9	6.6	8.3	7.4	7.7	15.7	12.6	7.7	9.9	9.5	7.9	7.3	9.7	4.7	11.3	9.9	10.7	7.7	11.3	5.2	1.4	0.5	0.8	2.8	1.7	0.6	5.3	2.7	5.4	3.5	0.9	1.0	4.2	6.8	2.1	2.4	2.8	1.3	2.5	5.3	1.7	4.8	3.5	3.7	2.2	3.5	10.6	2.9	22.5	6.0	2.6	2.9	3.9	7.5	1.8	5.2	2.8	1.8	14.2	1.8	0.6	4.3	2.9	0.9	3.8	3.8	5.2	0.0	2.6	2.6	7.6	5.9	3.3	8.9	3.1	3.9	2.1	4.9	6.5	10.1	1.8	2.7	1.7	6.2	2.2	4.1	0.0	3.7	0.2	1.8	0.5	0.4	0.1	1.2	0.8	1.3	5.2	1.2	1.1	0.2	3.5	0.8	1.2	0.0	2.8	0.6	1.4	1.7	0.6	15.9	16.8	29.0	22.6	13.8	10.4	9.4	16.5	14.8	9.7
ZFAND4	"ANUBL1, FLJ40185"	ENSG00000172671	"Zinc finger AN1-type containing 4"	Q86XD8	10	45615501-45672780	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"testis: 49.1"	"Cell line enriched"	"Detected in many"	5	"Daudi: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA057543, HPA074103"	Enhanced		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA057543: , HPA074103: "	"unprognostic (1.57e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.55e-1)"	"unprognostic (3.16e-1)"	"unprognostic (8.85e-5)"	"unprognostic (3.23e-1)"	"unprognostic (9.15e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.07e-3)"	2.7	4.1	3.0	7.3	5.2	2.6	4.5	14.7	3.6	3.5	2.9	6.8	4.2	2.9	5.0	2.5	2.5	4.1	2.9	3.3	3.2	4.4	3.2	4.4	3.3	6.1	5.0	1.7	3.3	3.7	3.1	9.7	2.0	5.5	3.9	3.5	4.8	2.9	3.9	2.7	4.0	2.6	3.0	5.1	3.6	2.4	49.1	5.8	9.7	4.8	2.1	6.2	2.9	2.8	1.9	0.8	2.0	1.6	3.2	2.4	0.4	0.9	0.8	1.4	1.8	3.1	2.5	0.0	1.2	2.3	1.2	1.4	0.0	0.9	30.6	1.4	0.8	0.2	1.1	0.7	1.6	4.5	1.2	0.8	1.1	0.8	2.2	0.0	6.3	2.3	1.5	0.4	1.3	1.4	0.7	5.4	1.3	0.1	2.9	0.6	1.2	0.7	0.4	1.0	0.0	1.2	0.8	2.6	1.7	0.9	1.2	1.0	2.6	1.6	0.9	0.5	2.2	2.0	1.5	3.7	6.5	0.0	1.0	3.0	0.5	2.0	0.8	0.0	1.9	0.6	2.4	1.9	1.9	1.6	0.7	1.4	1.5	2.2	0.1	3.2	1.6	0.8	1.2	0.4	3.0	5.2	14.7	3.6	3.2	4.4	5.0	1.7	5.5	5.8
ZFHX2	"KIAA1056, KIAA1762, ZFH-5, ZNF409"	ENSG00000136367	"Zinc finger homeobox 2"	Q9C0A1	14	23520855-23556192	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.5;testis: 17.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000720, HPA005146"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"HPA000720: AB_10603462, HPA005146: AB_1859250"	"unprognostic (7.54e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.71e-2)"	"unprognostic (5.08e-4)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-3)"	"unprognostic (3.75e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.90e-2)"	1.7	2.6	5.1	1.9	5.8	0.9	1.7	15.5	12.4	1.7	1.6	3.9	1.2	1.1	1.9	2.0	1.2	6.6	1.9	1.2	6.8	4.9	3.0	1.1	2.1	1.5	4.5	6.3	2.0	1.9	7.4	8.1	1.2	5.4	2.0	1.2	1.6	1.8	4.0	2.3	2.1	1.2	2.4	3.2	1.1	1.8	17.9	6.1	0.0	2.1	0.0	1.4	1.8	0.7	0.3	0.5	2.3	0.4	0.0	0.9	0.0	0.2	5.3	4.2	8.4	2.9	0.4	0.3	1.2	0.4	0.6	2.1	0.5	0.4	0.4	0.5	0.1	0.1	2.2	0.3	0.9	3.7	1.3	4.3	0.0	1.0	0.5	0.7	3.0	0.6	0.2	0.9	0.3	0.6	0.6	0.7	0.1	1.4	0.5	0.5	5.1	1.2	2.3	0.1	0.0	2.3	2.0	4.6	3.0	0.7	1.1	0.3	1.7	1.1	0.1	0.0	2.1	1.3	0.5	0.5	1.7	0.2	0.1	0.3	0.2	0.0	0.4	0.0	0.1	0.3	0.9	0.0	0.0	0.2	0.5	0.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	5.1	5.8	15.5	12.4	6.8	4.9	4.5	6.3	5.4	6.1
ZFP14	"KIAA1559, ZNF531"	ENSG00000142065	"ZFP14 zinc finger protein"	Q9HCL3	19	36334453-36379199	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030637	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA030637: AB_10602353"	"unprognostic (1.89e-1)"	"unprognostic (3.80e-2)"	"unprognostic (9.61e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.04e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.20e-1)"	"prognostic favourable (2.75e-5)"	4.8	6.7	9.1	6.0	11.7	2.7	10.0	13.8	11.5	7.5	5.1	10.3	5.6	6.7	11.4	13.1	5.6	8.0	4.8	4.6	9.6	7.8	8.2	5.0	5.0	8.3	14.6	9.8	10.7	5.1	12.9	14.9	5.1	10.6	7.8	5.2	6.5	6.0	8.0	3.5	7.9	6.5	7.6	11.6	8.3	6.1	2.8	12.8	9.2	10.9	3.1	8.3	6.2	7.0	10.4	5.7	5.7	4.4	5.8	9.5	1.7	2.1	3.8	7.7	7.1	6.7	3.4	1.8	1.0	3.3	2.1	3.3	2.5	1.7	6.1	2.8	1.5	0.8	3.2	0.5	2.3	2.3	2.4	5.4	3.8	2.1	2.2	4.4	5.8	1.5	1.4	0.9	0.2	2.9	1.6	0.1	3.3	1.5	6.8	1.8	5.8	1.7	5.7	4.4	1.8	2.2	4.2	4.3	6.5	3.8	1.2	2.2	2.4	3.5	2.0	2.2	4.9	2.3	1.1	1.7	2.7	3.2	0.4	0.6	3.8	5.7	4.0	5.3	6.2	4.4	6.3	10.4	6.8	7.8	3.8	9.4	9.5	9.5	2.5	5.8	3.9	5.7	6.3	1.7	9.1	11.7	13.8	11.5	9.6	7.8	14.6	9.8	10.6	12.8
ZFP37	ZNF906	ENSG00000136866	"ZFP37 zinc finger protein"	Q9Y6Q3	9	113038380-113056759	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049112	Uncertain		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA049112: "	"unprognostic (3.18e-1)"	"unprognostic (9.57e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.54e-3)"	"prognostic favourable (1.96e-4)"	"unprognostic (7.84e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.07e-1)"	3.8	4.4	4.9	3.1	19.2	0.9	6.7	10.9	9.9	6.5	3.6	5.3	4.0	2.1	10.5	5.8	3.2	6.3	3.5	3.7	10.5	5.6	5.8	1.7	3.2	2.8	6.7	10.6	17.0	3.2	4.3	8.5	3.2	10.7	6.3	2.9	2.8	3.2	4.8	3.2	3.2	2.5	6.2	9.1	4.7	3.0	5.1	5.9	0.4	6.9	2.4	3.2	4.3	5.6	2.3	0.9	0.2	0.4	1.3	5.6	0.7	0.6	1.8	7.6	6.4	4.3	8.2	3.9	2.4	3.5	2.7	2.2	0.0	1.8	4.3	1.9	2.5	1.6	0.0	0.9	4.2	5.3	0.9	0.2	3.8	1.9	2.3	0.0	0.9	2.3	0.8	3.1	6.2	1.5	0.4	3.8	5.5	0.0	0.0	0.0	7.8	0.0	0.0	10.6	0.6	2.0	0.0	6.5	6.1	7.4	1.6	1.4	6.3	0.0	0.6	6.2	2.7	7.3	3.6	1.5	2.8	0.0	4.8	0.1	3.8	0.2	0.1	0.1	2.5	0.4	1.9	2.3	2.2	2.2	0.9	1.1	1.8	2.5	0.2	1.3	0.0	0.1	5.6	0.7	4.9	19.2	10.9	9.9	10.5	5.6	6.7	10.6	10.7	5.9
ZFP69	"FLJ16030, ZFP69A, ZKSCAN23A, ZNF642, ZSCAN54A"	ENSG00000187815	"ZFP69 zinc finger protein"	Q49AA0	1	40477215-40496343	"Predicted intracellular proteins, Transcription factors"	"Lipid metabolism, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"THP-1: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA027808, HPA054942"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA027808: AB_10601031, HPA054942: "	"unprognostic (1.07e-2)"	"unprognostic (6.00e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.52e-1)"	"prognostic favourable (9.31e-4)"	"unprognostic (7.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.40e-3)"	"unprognostic (6.34e-3)"	"unprognostic (2.31e-1)"	"unprognostic (4.46e-2)"	"prognostic unfavourable (5.00e-6)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.81e-1)"	5.1	3.4	8.3	5.8	8.5	4.1	5.1	6.8	5.8	4.7	5.3	7.5	5.1	4.4	5.6	5.6	4.4	5.2	8.9	7.3	6.7	5.6	3.7	4.7	5.6	6.3	9.0	2.4	6.8	6.7	8.1	3.1	5.3	8.6	5.6	4.9	3.9	4.9	6.0	1.2	6.7	4.9	9.7	8.7	6.9	4.8	8.4	8.4	9.4	5.2	2.9	6.8	6.1	14.3	1.1	0.6	0.1	0.5	4.8	2.0	0.6	3.2	0.0	2.0	2.6	2.5	2.5	3.3	1.8	2.1	2.8	3.2	1.7	2.6	5.8	2.3	2.8	2.6	3.7	1.5	3.2	5.3	2.5	4.4	3.0	2.9	1.9	0.1	4.7	2.6	3.9	1.8	2.8	1.6	2.5	0.0	1.6	1.7	4.4	5.5	3.7	0.0	2.4	7.0	2.7	1.5	2.5	2.5	4.1	3.0	2.8	5.0	0.0	35.6	0.7	1.3	2.6	3.6	0.2	0.1	4.5	3.7	2.3	0.9	3.4	0.0	0.5	0.1	1.6	0.2	2.0	1.1	1.2	1.9	0.6	0.6	0.6	2.0	0.1	4.8	0.4	0.0	0.6	0.6	8.3	8.5	6.8	5.8	6.7	5.6	9.0	2.4	8.6	8.4
ZFP92	ZNF897	ENSG00000189420	"ZFP92 zinc finger protein"	A6NM28	X	153418322-153426481	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 6.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.0;HMC-1: 5.8;U-937: 9.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.2"					"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.8"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"hypothalamus: 10.3"	"Low region specificity"	"Detected in all"			HPA003030	Uncertain									"HPA003030: "	"unprognostic (6.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.57e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.51e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.49e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.66e-3)"	2.0	2.8	1.1	0.4	1.5	4.0	0.8	3.6	2.5	1.1	0.5			0.1	1.8	4.3	0.0	5.4	0.4	0.7	0.9	1.9	0.8	0.2	2.3	0.3	0.9		6.7	0.8	1.3	1.8	0.8		0.5	0.0		0.0	2.5	0.0	0.0	0.6	1.5	0.2	0.6	0.4	0.7			0.4		0.4	0.0	0.0	0.4	0.0	0.1	1.8	0.0	0.9	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.8	1.4	1.3	1.3	0.7	0.1	0.0	0.8	0.9	0.7	0.6	0.7	1.1	6.0	0.0	2.2	0.0	0.0	2.5	0.7	5.8	0.4	0.9	0.0	0.0	2.3	1.8	0.0	0.0	0.0	1.4	0.5	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.5	1.5	0.0	0.0	1.5	0.1	3.8	0.0	0.0	2.9	0.0	0.0	1.4	0.0	1.5	0.0	9.9	0.6	0.0	0.7	0.0	0.9	1.8	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.3										
ZFR2	KIAA1086	ENSG00000105278	"Zinc finger RNA binding protein 2"	Q9UPR6	19	3804024-3869032	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.0;pituitary gland: 19.8;testis: 20.3"	"Group enriched"	"Detected in some"	12	"HMC-1: 17.4;NTERA-2: 29.9;SiHa: 8.8"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043275, HPA055678"	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm		"HPA043275: , HPA055678: "	"unprognostic (1.74e-3)"	"unprognostic (2.32e-3)"	"unprognostic (4.05e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.60e-3)"	"unprognostic (5.47e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (3.58e-1)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.18e-2)"	1.0	6.8	13.0	1.2	17.0	1.3	1.3	2.2	16.9	1.5	0.9	1.9	0.0	0.9	0.9	0.8	0.8	2.4	1.2	1.1	7.6	12.2	0.9	0.9	1.4	1.1	4.9	10.9	1.0	1.7	0.8	19.8	0.8	7.4	1.3	1.0	5.7	1.2	1.1	0.9	1.2	1.4	0.8	3.9	1.3	1.3	20.3	2.3	0.0	1.2	0.0	1.4	0.8	0.2	0.9	0.2	1.5	0.2	1.7	4.5	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	29.9	0.0	0.0	0.0	0.0	1.4	0.0	1.0	0.6	8.8	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.5	0.2	0.2	3.4	0.0	4.5	0.2	2.6	1.9	0.0	0.9	3.9	3.4	0.5	1.7	0.0	0.2	0.8	1.4	13.0	17.0	2.2	15.0	7.6	12.2	4.9	10.9	7.4	2.3
ZFX	ZNF926	ENSG00000005889	"Zinc finger protein, X-linked"	P17010	X	24149173-24216255	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA001748, HPA003877, HPA071863"	Supported		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA001748: AB_1080650, HPA003877: AB_1080648, HPA071863: "	"unprognostic (2.60e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.99e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.22e-3)"	"unprognostic (2.39e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.95e-2)"	20.3	8.8	10.8	8.2	11.7	25.9	23.5	22.1	12.6	18.5	12.2	7.2	8.4	6.6	18.5	11.0	10.6	15.8	7.2	17.8	10.1	6.6	16.6	11.3	9.7	12.7	13.1	9.6	20.2	11.8	20.2	17.9	23.2	10.4	16.4	6.5	7.0	9.4	13.1	24.1	8.9	11.8	15.7	11.3	12.4	10.1	5.4	14.7	16.4	13.9	8.9	10.6	12.5	25.3	11.9	9.6	16.6	10.3	9.9	10.7	7.0	8.0	10.9	11.3	13.1	15.3	10.7	5.9	7.6	7.2	8.8	9.2	6.7	6.0	9.3	10.3	11.7	10.3	12.9	14.1	11.8	9.0	16.0	8.2	33.8	3.9	6.4	10.8	14.5	9.3	4.5	17.1	22.3	11.0	9.7	10.1	6.3	4.4	7.7	8.0	6.5	8.4	10.6	9.0	8.0	5.2	13.0	6.0	9.0	23.0	9.2	7.4	5.8	5.7	10.8	7.8	4.6	10.8	5.3	5.7	7.5	9.3	6.1	4.6	9.0	11.2	8.7	13.5	10.6	10.3	10.7	8.4	9.9	10.6	9.6	11.9	9.9	9.4	16.6	9.9	9.4	6.9	5.7	7.0	10.8	11.7	22.1	12.6	10.1	6.6	13.1	9.6	10.4	14.7
ZGLP1	"GATAD3, GLP-1, GLP1"	ENSG00000220201	"Zinc finger, GATA-like protein 1"	P0C6A0	19	10304803-10309880	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 26.0"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA049855	Uncertain		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA049855: "	"unprognostic (1.73e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.10e-4)"	"unprognostic (2.82e-2)"	"unprognostic (6.57e-7)"	"unprognostic (6.86e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.57e-4)"	0.5	0.9	2.5	2.0	6.5	0.9	1.0	8.0	5.4	1.4	0.9			2.2	2.1	0.7	0.6	2.6	1.8	0.6	2.9	3.4	2.4	3.0	1.0	3.6	1.0		3.9	3.1	1.9	4.8	2.0		3.4	0.3		5.1	2.5	1.4	4.8	1.6	0.2	0.9	2.6	1.4	3.7			5.3		1.4	1.2	0.9	0.3	0.3	0.1	0.3	0.0	1.0	0.1	0.4	1.0	1.4	0.5	0.9	0.4	3.5	0.8	0.2	0.7	1.5	1.0	0.3	1.5	0.7	0.2	1.4	1.0	0.3	0.2	1.3	4.5	1.4	1.3	0.5	0.6	0.0	0.4	0.8	2.1	0.7	0.4	0.2	1.4	1.0	0.9	1.5	0.1	26.0	2.2	1.6	1.4	0.6	0.6	0.6	0.6	1.2	1.4	0.3	0.3	1.2	2.0	0.4	0.5	2.0	2.4	2.0	0.2	5.1	6.0	0.6	0.4	6.6	0.9	0.0	0.3	0.0	1.0	0.1	0.6	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.1										
ZHX1-C8orf76		ENSG00000259305	"ZHX1-C8orf76 readthrough"	Q96EF9	8	123226189-123274284	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 23.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA023708	Uncertain		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA023708: AB_1845785"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.49e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.91e-2)"	"unprognostic (9.34e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.64e-11)"	"unprognostic (1.79e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-2)"	8.6	7.4	11.4	5.0	11.0	25.9	8.7	10.3	10.7	8.5	6.2	5.9	8.9	8.1	7.3	8.1	10.4	5.9	5.4	8.7	11.2	5.0	7.1	9.7	9.7	8.7	9.6	7.4	8.7	6.8	7.1	12.7	7.1	8.8	8.7	9.9	4.5	9.0	8.7	11.9	9.9	9.3	7.7	11.4	10.5	6.6	5.1	11.7	5.8	10.5	4.6	10.2	7.5	11.6	5.5	4.6	8.0	8.3	4.8	8.5	3.3	3.0	3.9	2.9	2.0	1.8	2.0	2.1	1.3	1.4	3.3	2.6	3.1	2.4	1.8	1.2	2.2	2.1	3.2	1.7	5.0	2.9	6.6	5.3	2.7	3.7	1.8	1.1	2.9	2.7	2.7	2.7	1.7	3.9	4.3	2.5	2.9	9.4	4.4	3.4	0.7	4.4	3.5	1.9	2.4	2.3	3.1	4.4	3.2	2.8	23.9	1.4	3.5	1.0	0.3	1.4	2.7	2.3	3.1	3.6	4.4	3.8	2.0	2.9	1.0	3.1	5.7	8.0	4.1	8.3	3.7	5.5	5.3	3.5	4.6	4.6	4.4	3.6	1.8	4.8	5.9	4.0	8.5	3.3	11.4	11.0	10.3	10.7	11.2	5.0	9.6	7.4	8.8	11.7
ZIC4		ENSG00000174963	"Zic family member 4"	Q8N9L1	3	147386046-147406860	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 52.2"	"Cell line enhanced"	"Detected in some"		"AF22: 18.2;ASC diff: 5.2;MCF7: 5.2;SH-SY5Y: 5.5;U-2197: 4.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	18	"cerebellum: 52.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 118.4"	HPA030194	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA030194: "	"unprognostic (1.12e-1)"			"unprognostic (9.95e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.13e-2)"			"unprognostic (1.10e-10)"	"unprognostic (3.50e-2)"	"unprognostic (8.69e-2)"			0.2	0.0	0.2	0.0	0.4	0.0	0.0	52.2	7.9	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.8	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	1.0	0.0	0.0	3.7	3.5	0.5	0.0	1.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.2	0.0	5.2	2.1	3.9	1.9	0.4	0.2	0.5	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.2	0.0	0.4	5.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.5	0.0	0.0	2.5	0.0	0.0	0.0	1.3	0.0	4.3	1.9	0.0	0.0	0.0	1.7	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	52.2	0.4	0.3	0.8	0.3	0.4	2.9	0.3
ZIK1	ZNF762	ENSG00000171649	"Zinc finger protein interacting with K protein 1"	Q3SY52	19	57578456-57593777	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 16.5;NTERA-2: 19.7;REH: 14.2;U-266/84: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA059975	Uncertain		Approved	"Intermediate filaments"				"Intermediate filaments"		"HPA059975: "	"unprognostic (2.14e-2)"	"unprognostic (9.03e-3)"	"unprognostic (9.42e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.34e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.18e-6)"	"unprognostic (6.21e-2)"	"unprognostic (5.15e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.50e-1)"	4.0	4.9	5.6	4.1	6.7	6.2	5.2	14.4	8.2	5.2	4.5	4.8	4.7	1.2	5.0	7.5	2.3	8.3	4.0	5.4	4.3	5.0	3.8	1.3	4.1	10.8	3.7	5.3	10.4	2.7	12.9	6.2	5.4	5.5	6.2	2.4	7.5	5.7	7.2	5.0	3.8	5.0	4.5	3.7	8.4	2.8	8.2	3.0	12.7	9.3	1.9	10.1	6.5	2.8	10.8	3.3	8.8	2.2	4.3	8.4	3.0	0.0	0.0	13.0	0.0	0.5	0.5	0.0	4.5	4.2	6.5	5.9	0.0	0.1	0.0	3.2	2.2	0.3	0.0	7.2	9.3	0.0	16.5	2.6	0.0	1.3	1.5	0.0	4.9	2.7	0.0	5.0	0.0	0.5	0.1	0.0	2.1	0.0	9.7	1.3	19.7	1.6	14.2	0.0	3.1	1.9	0.0	9.5	9.6	0.1	0.0	0.4	0.0	0.2	0.0	6.0	3.1	0.0	5.2	0.1	18.5	4.8	0.0	0.0	5.8	2.1	1.8	8.8	2.2	2.2	4.4	8.0	4.3	2.8	2.9	10.8	8.4	3.9	0.5	4.3	1.8	3.3	4.9	3.0	5.6	6.7	14.4	8.2	4.3	5.0	3.7	5.3	5.5	3.0
ZIM3	ZNF657	ENSG00000141946	"Zinc finger imprinted 3"	Q96PE6	19	57134096-57145202	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 3.5;testis: 2.8"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA034575	Uncertain									"HPA034575: AB_10603463"														"unprognostic (9.06e-2)"	"unprognostic (1.46e-1)"			0.1	0.1	0.1	0.3	0.1	0.7	0.1	0.1	0.1	0.1	0.1			0.2	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1		0.1	0.1	0.0	0.1	0.0		0.1	0.0		0.1	0.0	1.4	1.6	0.1	0.0	0.1	0.5	0.1	2.8			0.2		0.1	0.1	0.1	1.4	0.7	3.5	0.5	0.7	1.0	0.3	0.6	0.9	0.1	1.1	0.2	0.0	0.2	0.5	0.0	0.0	0.1	0.0	0.7	0.6	0.2	0.0	0.4	0.1	0.0	0.0	0.2	0.2	0.6	0.9	0.9	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.2	1.1	0.0	0.3	0.7	0.5	0.3	0.0	0.4	0.1	0.2	0.0	0.8	0.5	0.3	0.0	0.8	0.0	0.8	0.1	0.0	0.4	0.6	0.3	0.2	1.2	0.4	0.2	0.6	0.8	0.1	3.5	0.4	0.5	0.5	0.3	0.5	0.7	0.7	0.5	0.1	1.4	0.6	1.0	2.1	0.7	0.5	0.7	0.3	0.3										
ZMAT1	KIAA1789	ENSG00000166432	"Zinc finger matrin-type 1"	Q5H9K5	X	101882288-101932031	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"epididymis: 38.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 12.4;U-266/70: 6.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA012827	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA012827: AB_1859070"	"unprognostic (9.30e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.20e-3)"	"unprognostic (2.22e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.09e-2)"	"prognostic favourable (1.72e-5)"	"unprognostic (6.33e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.38e-2)"	6.1	13.0	11.4	9.9	12.4	10.0	9.9	7.1	12.8	5.0	4.9	16.5	7.0	4.0	7.4	38.7	3.0	7.3	7.2	7.6	11.1	9.6	9.6	6.5	10.8	10.9	10.2	11.4	11.9	7.3	14.5	31.4	2.3	9.2	9.3	3.4	13.6	7.9	14.2	5.1	4.3	5.4	8.3	12.0	10.7	4.1	5.9	11.3	7.0	18.8	3.2	7.5	3.3	3.7	3.7	3.2	2.6	1.1	0.6	1.6	0.6	0.4	0.0	1.4	1.5	0.0	0.0	0.2	0.6	0.1	0.0	0.7	0.0	1.8	2.7	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.4	0.7	0.0	0.0	0.0	0.3	1.1	0.0	12.4	0.9	0.0	0.1	0.2	1.9	0.2	2.1	0.0	0.1	3.3	0.0	0.6	1.7	1.0	0.0	0.1	2.1	3.0	3.0	0.9	0.0	0.0	0.1	6.2	0.4	0.0	0.6	2.9	0.9	2.6	1.1	1.7	0.9	0.4	1.6	2.0	1.3	1.4	0.2	3.7	1.6	1.4	0.8	0.6	0.7	3.2	0.6	0.6	11.4	12.4	7.1	12.8	11.1	9.6	10.2	11.4	9.2	11.3
ZMYND15	DKFZp434N127	ENSG00000141497	"Zinc finger MYND-type containing 15"	Q9H091	17	4740015-4746119	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 25.6"	"Cell line enhanced"	"Detected in some"		"A-431: 5.0;CAPAN-2: 4.7;HaCaT: 3.9;T-47d: 3.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.1;non-classical monocyte: 1.5"	"Group enriched"	"Detected in many"	11	"granulocytes: 1.1;monocytes: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023286			Uncertain	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA023286: AB_1859076"	"unprognostic (2.30e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.62e-2)"	"unprognostic (7.86e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.49e-1)"	"unprognostic (6.72e-3)"	"unprognostic (4.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.07e-1)"	3.6	1.6	2.3	2.9	2.0	0.9	2.0	0.7	2.7	1.3	1.0	5.1	1.4	5.2	1.8	4.5	1.2	1.5	3.8	3.8	3.6	1.8	2.4	3.5	6.1	4.9	3.7	1.7	0.9	4.7	12.5	1.8	1.5	3.4	1.9	1.0	4.2	3.8	2.7	0.4	1.8	3.9	1.2	4.8	6.2	2.4	25.6	2.9	0.7	1.4	0.7	0.8	1.6	0.9	0.0	0.1	1.1	1.5	0.0	0.0	0.2	5.0	0.8	0.0	2.4	0.0	0.2	0.4	0.1	1.4	1.3	3.0	2.3	4.7	0.0	0.1	0.0	3.9	0.9	0.4	0.1	0.5	1.7	0.0	0.5	1.2	0.8	0.0	1.4	0.2	0.6	0.2	0.2	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.6	0.0	0.1	1.4	1.6	2.3	3.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	1.5	0.0	0.0	0.2	2.3	2.0	0.7	2.7	3.6	1.8	3.7	1.7	3.4	2.9
ZNF100		ENSG00000197020	"Zinc finger protein 100"	Q8IYN0	19	21722766-21767628	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA059135	Uncertain									"HPA059135: "	"unprognostic (2.20e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.02e-4)"	"unprognostic (1.94e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.22e-2)"	"prognostic favourable (5.47e-4)"	17.6	7.7	5.0	9.2	7.3	9.9	7.5	20.5	7.9	10.9	8.3	8.1	2.1	2.3	8.3	6.5	5.1	6.9	4.1	5.1	4.7	4.7	7.4	3.7	6.4	10.0	9.1	8.7	13.9	7.3	3.7	7.0	10.0	11.1	6.8	7.6	5.4	6.7	11.3	7.2	6.6	6.6	7.1	10.1	12.4	5.8	18.8	6.9	22.6	11.4	1.8	10.1	7.5	6.3	8.8	6.3	7.5	6.0	4.8	6.3	2.3	0.3	0.1	8.3	2.9	1.4	1.8	8.1	3.1	2.4	5.6	8.3	2.7	2.1	4.9	5.7	1.7	2.3	8.4	2.4	10.5	0.0	6.1	5.7	2.6	1.4	1.0	0.1	3.6	2.2	0.3	4.1	0.2	2.1	10.1	0.3	4.1	3.2	22.0	3.5	7.1	3.9	9.5	9.9	3.3	2.8	8.5	5.3	3.9	5.1	0.2	2.3	2.9	4.1	3.1	2.4	1.9	4.0	4.3	0.3	3.2	9.8	0.0	5.3	2.8	6.8	6.0	6.0	2.6	5.6	2.5	5.7	4.0	3.2	6.3	8.8	6.3	5.0	7.5	4.8	3.8	3.9	3.7	2.3	5.0	7.3	20.5	7.8	4.7	4.7	9.1	8.7	11.1	6.9
ZNF117	"H-plk, HPF9"	ENSG00000152926	"Zinc finger protein 117"	Q03924	7	64971776-65006684	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 14.9;AN3-CA: 15.6;THP-1: 15.8"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"neutrophil: 6.2"	"Low lineage specificity"	"Detected in many"											HPA031148			Approved	"Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center, Cytosol"		"HPA031148: "	"unprognostic (1.04e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.35e-1)"	"unprognostic (7.10e-2)"	"prognostic unfavourable (2.17e-11)"	"unprognostic (1.08e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.21e-1)"	11.1	13.2	1.3	3.4	1.5	2.1	7.1	2.1	3.7	3.1	2.1			0.5	4.2	6.5	5.2	2.8	5.6	2.7	1.1	1.3	2.3	0.9	3.9	2.6	1.0		5.0	2.1	2.4	4.0	5.3		2.8	2.2		3.6	2.4	0.6	4.2	1.6	2.8	1.3	3.4	1.8	5.3			3.4		2.6	2.5	4.5	1.0	0.7	6.2	1.9	0.9	0.6	0.2	1.2	0.1	14.9	15.6	5.7	2.6	8.4	3.2	0.8	0.8	1.6	0.6	6.4	5.5	2.7	1.6	1.0	1.7	0.4	1.8	1.6	1.5	2.5	0.4	3.0	0.5	0.0	1.5	3.3	0.6	0.6	0.6	2.5	10.1	3.7	3.7	2.7	5.6	5.7	6.3	0.2	7.4	1.0	1.1	2.0	2.4	2.3	12.7	1.6	0.7	0.7	2.8	15.8	7.4	4.5	0.5	2.7	2.0	2.5	4.7	2.9	1.6	7.1	2.7	0.4	0.6	1.0	0.6	1.9	0.6	1.0	0.4	0.4	0.7	1.0	0.4	0.4	6.2	0.9	0.5	0.7	0.5	0.2										
ZNF132	pHZ-12	ENSG00000131849	"Zinc finger protein 132"	P52740	19	58432814-58440222	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA008726	Uncertain		Approved	"Vesicles,Intermediate filaments"				Vesicles	"Intermediate filaments"	"HPA008726: AB_1080664"	"unprognostic (4.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.06e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.29e-1)"	"prognostic favourable (1.92e-4)"	"unprognostic (4.51e-1)"	"prognostic favourable (7.26e-13)"	"unprognostic (2.70e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.09e-2)"	"unprognostic (3.72e-1)"	2.9	4.7	4.0	2.5	5.9	0.8	5.1	11.8	8.5	5.9	4.1	6.6	4.5	2.5	4.2	7.2	3.5	7.9	4.7	5.9	6.0	4.5	6.2	2.1	3.6	3.3	4.4	5.5	7.6	4.3	15.3	12.1	3.7	5.9	6.1	2.4	5.4	5.8	6.7	3.7	4.7	2.6	5.9	4.2	4.5	3.6	7.2	6.0	3.1	10.8	2.8	4.3	5.7	6.3	3.9	2.9	2.0	2.6	2.6	5.7	2.1	1.7	2.1	4.8	1.7	5.6	4.6	0.2	3.6	4.5	3.0	2.7	0.1	1.4	4.5	0.3	4.4	1.8	0.0	5.4	2.1	0.7	8.2	0.8	1.4	1.0	5.0	1.7	3.0	5.1	1.9	5.1	3.2	2.6	0.7	0.5	5.6	0.6	1.0	0.1	4.9	1.7	0.6	1.1	1.3	1.8	2.0	4.3	4.4	1.4	1.3	1.5	0.3	4.4	3.3	3.1	0.4	0.8	0.7	5.9	1.1	0.0	1.5	0.1	1.9	0.0	1.9	2.0	2.2	2.2	5.7	2.9	2.9	1.2	2.9	3.9	4.6	3.7	0.2	2.6	2.6	2.4	2.5	2.1	4.0	5.9	11.8	8.5	6.0	4.5	4.4	5.5	5.9	6.0
ZNF135	"pHZ-17, ZNF61, ZNF78L1"	ENSG00000176293	"Zinc finger protein 135"	P52742	19	58059239-58086310	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HMC-1: 6.2;HSkMC: 6.7;MOLT-4: 6.9;NTERA-2: 6.2;T-47d: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA006961	Approved		Approved	Cytosol				Cytosol		"HPA006961: AB_1080670"	"unprognostic (4.87e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.85e-2)"	"unprognostic (9.18e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.34e-1)"	"prognostic favourable (3.93e-5)"	"unprognostic (2.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.25e-1)"	4.6	3.5	8.4	3.1	13.7	1.7	8.6	7.3	10.6	7.9	5.4	12.0	4.5	1.9	11.8	11.2	3.9	8.6	5.7	4.5	6.4	5.2	5.9	1.1	3.8	2.9	6.4	9.1	15.9	3.3	21.4	11.0	5.3	8.1	8.6	3.0	9.5	3.0	7.6	2.6	6.2	2.7	9.6	5.3	4.9	3.4	8.9	10.4	7.3	10.6	1.2	3.2	6.4	5.1	3.9	3.9	3.4	0.2	4.5	3.7	0.8	0.0	0.0	1.5	0.0	0.1	0.0	0.0	3.6	0.0	5.1	0.3	0.0	0.2	0.0	3.9	5.4	0.2	0.0	0.0	5.6	0.0	5.9	0.0	0.0	0.0	2.3	0.0	6.2	6.7	0.0	2.8	0.0	0.0	0.0	0.0	3.9	0.0	6.9	0.0	6.2	0.0	0.0	0.0	0.0	2.7	4.3	5.8	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	3.4	0.0	0.0	0.3	2.4	0.0	0.0	0.0	2.9	0.0	0.1	3.4	0.0	0.2	0.2	0.9	0.3	0.3	1.7	3.9	3.7	2.1	0.1	4.5	0.0	3.9	0.2	0.8	8.4	13.7	7.3	10.6	6.4	5.2	6.4	9.1	8.1	10.4
ZNF14	"GIOT-4, KOX6"	ENSG00000105708	"Zinc finger protein 14"	P17017	19	19710471-19733097	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA049863	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA049863: "	"unprognostic (1.04e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (7.96e-4)"	"unprognostic (1.84e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.55e-2)"	"prognostic favourable (8.09e-6)"	"unprognostic (1.83e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.17e-2)"	"unprognostic (9.05e-3)"	7.4	5.3	7.9	8.7	10.5	11.9	12.8	23.3	10.3	11.3	7.0	8.1	6.6	3.9	9.4	9.6	5.7	9.3	6.0	6.6	8.1	7.6	8.4	1.7	4.9	10.5	12.2	6.0	15.7	7.5	12.7	10.7	8.8	9.4	12.3	5.1	6.5	7.1	9.9	3.4	7.2	7.2	8.9	9.0	9.4	7.0	6.2	10.7	7.1	13.8	3.1	10.9	9.8	7.7	10.3	3.0	11.4	3.6	6.5	18.4	6.3	3.5	3.5	6.0	7.8	4.0	4.4	7.2	3.7	5.0	5.4	5.9	3.3	2.7	9.4	6.1	3.8	3.5	6.2	3.6	6.8	2.3	7.2	4.4	2.7	4.5	4.9	0.1	6.8	4.4	3.9	3.8	3.3	3.4	5.1	4.5	5.3	5.8	7.9	5.1	7.8	10.3	4.2	9.8	4.5	3.9	7.1	6.0	4.3	0.1	4.2	5.7	5.9	9.1	2.1	4.8	1.3	5.5	4.7	3.5	4.2	8.3	0.3	4.9	2.8	11.4	1.8	6.1	9.6	3.1	15.1	10.3	13.1	12.0	2.6	8.2	18.4	14.5	4.1	6.5	3.6	3.0	8.4	6.3	7.9	10.5	23.3	10.3	8.1	7.6	12.2	6.0	9.4	10.7
ZNF140	pHZ-39	ENSG00000196387	"Zinc finger protein 140"	P52738	12	133079838-133107544	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA048332	Uncertain									"HPA048332: "	"unprognostic (1.88e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.76e-3)"	"unprognostic (7.67e-2)"	"unprognostic (8.23e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.13e-3)"	13.0	12.5	8.8	8.3	11.8	5.4	14.7	15.5	12.7	14.4	9.4	11.1	12.7	11.5	16.6	13.9	10.7	13.8	10.6	10.4	11.0	8.2	11.4	10.9	9.0	14.0	12.2	10.0	18.1	14.4	9.6	23.5	9.9	9.2	14.4	7.4	9.4	12.9	12.5	9.6	13.5	9.6	15.5	8.8	10.0	10.3	10.2	10.2	15.0	17.6	9.3	13.4	10.8	11.6	13.7	9.4	14.9	8.7	14.2	18.8	8.0	4.3	3.6	7.7	0.1	4.7	8.1	8.2	4.2	2.3	2.9	3.0	2.5	2.1	1.8	7.1	4.7	4.0	4.1	3.0	3.6	0.2	5.1	5.1	4.6	4.0	8.6	4.5	9.3	9.0	7.6	5.1	13.3	5.7	2.5	2.2	7.1	6.1	9.4	9.9	7.8	2.6	7.3	1.0	4.7	5.4	7.9	7.0	10.0	8.1	4.9	4.9	7.7	8.1	8.2	0.7	5.2	4.0	2.5	2.3	0.0	4.0	0.8	4.8	4.4	10.2	5.5	14.9	10.8	8.7	14.8	13.7	12.5	12.5	9.4	10.8	18.8	14.0	9.8	14.2	5.3	4.9	13.8	8.0	8.8	11.8	15.5	12.7	11.0	8.2	12.2	10.0	9.2	10.2
ZNF154	pHZ-92	ENSG00000179909	"Zinc finger protein 154"	Q13106	19	57697367-57709194	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 9.0;HSkMC: 5.1;MOLT-4: 7.2;NTERA-2: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA076284	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA076284: "	"unprognostic (3.32e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.20e-3)"	"unprognostic (9.39e-2)"	"unprognostic (3.35e-1)"	"unprognostic (8.38e-3)"	"unprognostic (1.11e-1)"	2.8	5.9	7.9	5.7	10.2	2.5	4.3	17.9	9.3	3.1	5.7	2.6	9.9	2.2	2.8	3.6	4.4	3.1	4.1	5.6	7.8	3.1	3.8	1.8	3.6	8.8	2.2	6.4	3.4	3.4	11.9	11.5	6.0	5.1	4.5	2.8	7.3	5.0	12.6	3.1	2.0	5.4	5.6	3.6	8.4	3.2	2.3	3.9	11.4	10.5	0.6	8.3	6.6	2.1	3.1	1.5	5.1	0.3	2.7	3.2	0.8	0.2	0.4	9.0	0.3	0.0	0.0	0.6	1.3	0.0	0.0	0.1	0.2	0.4	0.5	0.2	2.2	0.3	0.0	0.0	0.3	0.3	0.7	0.3	1.3	0.2	3.2	0.5	0.9	5.1	0.0	0.6	0.0	0.1	0.4	0.7	2.0	0.2	7.2	0.4	5.0	0.2	0.3	0.9	0.2	0.1	1.2	0.5	0.3	0.4	0.3	0.1	0.4	0.6	0.2	0.2	0.5	0.2	0.4	0.9	0.3	0.5	0.1	0.3	0.2	1.8	0.3	5.1	1.1	0.1	3.2	1.3	0.6	1.5	0.3	3.1	1.0	1.4	1.9	2.7	0.2	1.5	0.1	0.8	7.9	10.2	17.9	9.3	7.8	3.1	2.2	6.4	5.1	3.9
ZNF157	HZF22	ENSG00000147117	"Zinc finger protein 157"	P51786	X	47370583-47414305	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;epididymis: 4.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.5;SH-SY5Y: 2.9;U-266/84: 6.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA003319	Uncertain									"HPA003319: AB_1080677"	"unprognostic (1.85e-1)"	"unprognostic (3.99e-1)"		"unprognostic (7.24e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-2)"		"unprognostic (7.38e-4)"	"unprognostic (2.99e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.59e-4)"	"unprognostic (5.36e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.51e-2)"	"unprognostic (7.15e-2)"	"unprognostic (4.92e-2)"	0.1	0.3	0.8	0.2	1.0	0.4	0.3	4.4	1.6	0.6	0.1			0.2	0.7	4.4	0.2	3.8	0.1	0.1	0.8	1.0	0.6	0.0	0.1	1.4	0.8		1.0	0.1	2.3	3.0	0.0		0.5	0.1		0.2	0.7	0.1	0.3	0.2	0.5	0.9	0.4	0.1	0.8			1.4		0.8	0.3	0.3	1.4	0.7	1.3	0.3	0.7	2.8	0.9	0.0	0.3	1.0	0.1	0.3	0.3	0.2	0.0	0.0	0.2	0.5	0.1	0.3	1.4	0.7	0.3	0.0	2.5	1.3	0.2	0.1	1.1	0.5	0.4	0.0	0.0	0.0	0.5	0.3	0.0	1.4	0.1	0.0	0.1	3.5	0.4	0.0	1.0	0.3	2.1	0.1	0.3	0.0	0.0	0.5	0.2	2.6	2.9	0.0	0.3	0.2	1.6	0.3	0.0	1.1	1.1	0.1	0.1	1.9	6.0	1.7	0.3	0.1	0.0	0.7	0.3	0.4	0.4	0.3	0.2	1.4	0.5	2.2	0.1	1.2	2.8	1.8	1.3	0.7	0.3	0.7	0.8	0.9										
ZNF160	"F11, FLJ00032, HKr18, HZF5, KIAA1611, KR18"	ENSG00000170949	"Zinc finger protein 160"	Q9HCG1	19	53066606-53103436	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA023599	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA023599: AB_2218442"	"unprognostic (1.18e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.90e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.65e-5)"	"unprognostic (5.20e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.87e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.71e-1)"	"prognostic favourable (2.67e-5)"	17.7	28.0	15.7	18.5	19.9	8.1	17.2	26.4	20.0	16.3	15.5	21.6	14.1	9.6	22.7	17.2	11.0	15.5	16.8	13.8	14.5	8.9	19.7	13.2	17.3	12.8	22.5	15.2	25.9	12.7	20.9	18.2	16.1	18.8	15.1	13.3	9.9	14.3	19.3	10.2	13.1	12.1	17.4	19.6	31.5	13.2	15.2	22.4	19.0	29.5	7.5	12.5	18.0	15.0	9.1	4.3	10.7	5.9	17.5	11.2	5.4	5.9	5.3	7.4	11.3	12.5	8.8	12.6	6.5	8.7	5.3	8.5	4.6	3.8	6.8	5.6	6.0	4.4	6.9	6.7	10.6	5.0	8.4	10.5	4.0	2.5	6.8	0.0	7.2	10.9	6.9	5.7	8.0	5.6	5.3	0.0	9.9	4.1	8.6	6.4	6.9	8.6	5.5	7.8	5.2	8.3	30.2	6.3	8.1	0.0	5.2	1.0	5.5	6.1	10.7	14.8	5.3	4.3	4.7	3.9	16.1	9.7	2.6	2.6	7.0	9.0	3.1	10.7	7.1	4.2	10.3	8.4	7.3	9.5	4.3	9.1	11.2	8.7	6.5	17.5	5.9	4.1	7.3	5.4	15.7	19.9	26.4	20.0	14.5	8.9	22.5	15.2	18.8	22.4
ZNF182	"HHZ150, KOX14, Zfp182, ZNF21"	ENSG00000147118	"Zinc finger protein 182"	P17025	X	47974851-48003978	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059574	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA059574: "	"unprognostic (1.86e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.51e-3)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (1.88e-3)"	"unprognostic (6.88e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.42e-2)"	"prognostic unfavourable (2.42e-5)"	"unprognostic (1.01e-1)"	"unprognostic (9.49e-2)"	"unprognostic (8.59e-2)"	"prognostic favourable (1.55e-7)"	6.8	6.9	10.2	7.3	15.2	8.7	8.8	22.1	12.9	8.3	6.5	7.1	5.4	5.7	8.1	9.7	4.7	7.6	6.5	5.0	9.1	6.4	7.7	7.3	7.0	11.9	10.2	7.1	9.9	9.4	11.0	16.9	6.7	9.9	8.4	7.1	4.7	6.1	7.7	4.2	7.3	7.9	6.1	7.7	12.6	7.3	5.8	12.9	16.1	13.2	3.5	12.1	7.0	8.7	7.9	4.3	7.4	8.5	4.9	9.0	4.4	3.7	5.0	6.4	6.1	3.7	4.1	2.5	4.8	5.7	7.1	8.5	3.9	5.1	9.7	3.6	3.1	4.7	10.4	2.8	8.6	6.8	6.1	4.9	6.4	4.9	4.6	8.9	7.9	3.5	6.0	5.9	7.2	4.2	4.1	7.3	6.5	2.8	6.9	16.0	10.0	5.9	5.9	12.0	10.6	6.2	2.6	5.9	8.1	7.9	2.6	4.5	6.4	7.8	4.2	5.7	6.2	8.0	4.0	9.6	7.8	7.6	3.9	7.7	3.7	3.1	3.4	7.0	6.2	3.4	7.0	7.9	5.6	5.7	4.3	5.6	9.0	7.5	7.4	4.9	8.5	3.2	5.2	4.4	10.2	15.2	22.1	12.9	9.1	6.4	10.2	7.1	9.9	12.9
ZNF19	"KOX12, MGC51021"	ENSG00000157429	"Zinc finger protein 19"	P17023	16	71464555-71565089	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 32.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA063685	Approved		Approved	Mitochondria				Mitochondria		"HPA063685: "	"unprognostic (5.59e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-4)"	"unprognostic (6.02e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.84e-2)"	"unprognostic (8.90e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.04e-6)"	"unprognostic (3.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.87e-2)"	4.7	3.3	4.8	4.1	6.8	2.5	6.3	4.3	5.2	3.8	2.6	7.1	2.9	3.3	5.6	14.4	4.6	9.1	6.9	4.7	4.9	4.1	5.6	3.4	4.5	3.4	3.0	4.4	4.8	6.4	3.9	32.0	1.7	6.8	3.6	2.2	5.2	4.9	3.2	9.0	6.9	3.4	2.6	4.5	3.1	3.0	18.7	5.5	3.0	8.9	2.0	2.6	2.8	1.9	6.1	3.5	4.4	2.5	2.5	4.3	1.7	2.5	1.7	5.7	6.2	2.8	3.8	3.7	3.0	1.4	2.4	3.0	3.8	6.3	4.5	4.1	1.6	2.4	3.0	2.9	1.1	2.7	3.3	4.6	4.1	4.9	0.9	4.9	4.1	5.0	3.8	2.8	5.3	2.3	2.9	4.2	1.8	3.5	3.3	3.6	2.9	4.5	2.1	4.7	1.8	2.9	5.5	9.1	5.8	6.1	1.8	5.0	4.5	3.7	2.7	6.2	3.1	4.3	3.5	4.0	3.3	1.7	5.6	3.0	3.4	4.4	2.4	2.1	3.1	2.2	1.3	5.4	3.4	3.0	1.9	6.1	4.3	3.9	4.3	2.5	2.5	3.5	1.4	1.7	4.8	6.8	4.3	4.8	4.9	4.1	3.0	4.4	6.8	5.5
ZNF197	"D3S1363E, P18, ZKSCAN9, ZNF166, ZSCAN41"	ENSG00000186448	"Zinc finger protein 197"	O14709	3	44584888-44648471	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 8.4"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA054567	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA054567: "	"unprognostic (1.06e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (6.78e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.14e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.85e-2)"	9.9	9.9	14.0	12.4	16.1	4.2	12.7	23.7	15.4	13.5	10.9	8.6	18.3	8.9	13.6	13.4	8.3	11.0	9.2	9.8	13.2	12.4	10.2	12.8	9.4	9.7	15.0	14.0	18.4	10.2	17.8	23.5	11.1	16.0	13.7	11.1	9.2	9.0	19.8	18.2	10.8	8.8	17.6	18.3	10.1	9.2	10.1	16.2	11.8	15.9	8.9	9.6	12.0	15.7	2.7	3.2	0.9	8.4	2.5	1.7	0.7	3.0	1.4	13.8	4.5	7.8	8.5	0.4	6.1	7.8	5.3	5.8	2.9	2.6	3.0	3.7	5.1	2.1	7.0	5.3	6.0	0.7	1.7	12.5	5.2	2.1	7.5	10.1	3.2	8.9	8.0	5.7	9.7	3.8	7.8	5.0	8.6	0.7	5.7	6.6	9.1	4.4	1.9	10.0	3.6	5.6	3.7	5.9	10.0	5.7	2.7	8.3	7.7	8.6	4.3	5.9	4.3	8.3	5.1	6.4	7.4	1.9	4.6	3.1	5.8	0.6	1.4	0.9	1.5	0.6	1.5	1.1	1.4	1.4	1.9	2.7	1.7	1.0	0.9	2.5	8.4	3.2	1.5	0.7	14.0	16.1	23.7	14.7	13.2	12.4	15.0	14.0	16.0	16.2
ZNF200		ENSG00000010539	"Zinc finger protein 200"	P98182	16	3222325-3236221	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 27.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018981, HPA059310"	Uncertain		Approved	Mitochondria				Mitochondria		"HPA018981: AB_1859021, HPA059310: "	"unprognostic (1.74e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.21e-2)"	"unprognostic (8.78e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.23e-3)"	5.4	5.5	4.4	7.5	5.4	3.0	5.7	8.6	7.0	5.1	4.9	6.0	4.7	5.5	6.0	6.8	5.1	5.9	4.7	5.2	4.0	4.3	4.8	6.4	5.2	9.5	4.6	3.3	6.2	3.9	7.3	7.1	8.2	5.6	5.3	5.0	4.2	5.1	4.7	4.0	4.1	5.4	5.3	3.8	10.4	4.7	27.3	5.0	9.6	6.8	2.9	8.3	5.8	4.9	5.8	5.0	19.3	5.1	8.7	10.1	5.4	4.8	5.1	11.5	8.2	4.2	4.5	13.9	6.3	7.9	8.8	8.1	7.6	4.1	9.5	4.9	5.1	3.7	9.0	6.8	10.4	8.8	8.2	7.9	6.8	6.3	5.7	13.4	18.7	4.5	5.7	6.4	5.8	7.4	8.7	7.2	7.6	4.5	9.5	6.9	18.1	4.9	11.6	15.8	11.0	5.4	2.8	6.6	9.7	6.0	4.7	5.2	6.6	15.0	5.2	8.9	8.3	3.1	5.5	18.7	18.2	8.1	2.1	8.3	6.8	19.3	3.9	13.6	8.5	5.1	8.2	5.8	7.8	10.1	5.0	5.6	8.0	8.9	16.9	8.7	4.7	3.1	9.0	5.4	4.4	5.4	8.6	7.0	4.0	4.3	4.6	3.3	5.6	5.0
ZNF211	"CH2H2-25, ZNF-25"	ENSG00000121417	"Zinc finger protein 211"	Q13398	19	57630395-57642779	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA011340, HPA049967"	Approved		Approved	"Mitochondria,Rods & Rings"				Mitochondria	"Rods & Rings"	"HPA011340: , HPA049967: "	"unprognostic (6.47e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.81e-2)"	"unprognostic (3.72e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.72e-3)"	8.8	11.3	11.1	10.1	13.5	24.2	11.7	18.3	14.2	10.1	10.0	17.5	14.8	5.2	12.3	13.2	7.2	10.9	9.3	11.5	11.0	10.4	11.3	6.5	11.1	13.3	12.0	12.4	13.4	7.3	25.7	16.7	13.9	12.2	12.6	10.2	15.4	8.7	14.9	6.8	12.0	12.5	10.3	10.7	17.7	17.6	6.1	9.1	17.7	16.5	5.4	15.1	12.9	10.3	10.5	7.6	12.7	6.2	7.0	13.7	6.5	3.9	2.6	11.7	10.5	6.8	6.9	6.8	5.6	6.9	8.0	5.3	2.0	2.4	3.8	2.5	5.8	0.9	5.5	8.4	16.9	4.7	13.7	7.3	5.7	4.9	5.9	5.1	7.7	6.3	10.2	6.0	5.6	6.1	1.6	4.8	9.8	1.8	10.3	3.5	4.8	6.2	6.4	8.8	3.3	6.9	15.3	5.4	7.5	6.7	3.4	2.5	3.6	7.2	3.8	8.1	4.0	3.4	4.6	6.8	8.6	7.9	2.2	4.2	4.8	7.9	6.2	12.7	8.4	5.9	13.7	8.8	11.1	12.1	7.6	10.5	13.2	9.3	8.3	7.0	3.9	1.6	11.8	6.5	11.1	13.5	18.3	14.2	11.0	10.4	12.0	12.4	12.2	9.1
ZNF213	"CR53, ZKSCAN21, ZSCAN53"	ENSG00000085644	"Zinc finger protein 213"	O14771	16	3129777-3142805	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035000, HPA056750"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"				"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA035000: AB_10669997, HPA056750: "	"unprognostic (1.94e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavourable (6.74e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.57e-1)"	5.7	8.2	9.0	6.0	10.3	6.0	5.7	10.8	16.7	5.0	6.2	14.6	4.7	9.3	7.5	5.1	8.4	6.8	6.0	9.1	9.5	7.7	4.4	2.4	6.3	8.8	7.1	9.3	10.3	12.1	8.7	7.3	4.1	9.1	6.5	2.5	6.8	17.4	5.9	11.1	16.9	11.2	6.8	7.6	7.5	6.9	20.1	8.0	7.5	9.2	4.7	5.4	7.1	5.8	4.8	3.2	3.5	2.5	4.0	4.7	1.8	3.3	10.6	4.7	11.2	4.6	3.8	5.9	6.2	2.5	3.3	3.8	3.4	7.0	4.1	6.1	4.0	8.2	2.2	6.8	1.3	8.5	8.2	2.9	11.7	6.6	8.8	7.0	7.6	3.7	8.5	4.6	1.7	2.4	7.4	9.2	2.1	14.5	6.5	8.6	8.1	8.1	8.8	5.5	7.5	2.6	2.3	9.8	8.5	9.3	5.6	4.4	7.3	12.1	6.0	6.7	6.1	7.5	4.3	5.2	4.8	6.3	2.7	9.3	5.1	0.0	1.6	3.4	3.7	2.5	3.2	2.7	3.6	2.4	1.6	4.8	4.7	3.4	3.5	4.0	1.9	3.2	2.0	1.8	9.0	10.3	10.8	16.7	9.5	7.7	7.1	9.3	9.1	8.0
ZNF214		ENSG00000149050	"Zinc finger protein 214"	Q9UL59	11	6999318-7020368	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA055391	Uncertain									"HPA055391: "	"unprognostic (3.01e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.77e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.28e-3)"	"unprognostic (7.53e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.22e-2)"	1.8	2.9	4.6	1.2	5.7	0.4	5.5	4.7	6.0	7.4	3.3	2.3	8.1	1.9	6.0	7.7	1.8	10.0	2.5	2.4	4.2	3.7	7.0	3.4	3.3	0.9	2.9	4.8	11.1	3.1	8.4	7.8	0.8	4.6	7.9	3.0	4.8	3.1	9.2	1.2	1.3	2.0	4.8	2.7	0.9	2.2	8.0	3.1	0.0	9.2	1.0	0.9	4.1	3.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.9	1.6	5.9	0.0	1.1	4.0	1.5	2.3	6.0	3.0	3.5	0.0	4.4	0.0	0.8	1.5	0.8	0.6	1.7	3.3	0.0	1.6	0.0	0.8	0.4	2.3	0.0	0.2	1.4	3.7	0.1	3.5	2.7	0.3	0.0	1.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	3.8	1.0	0.0	4.6	2.5	0.3	0.2	1.0	0.0	0.3	1.9	2.6	5.4	0.0	0.0	0.0	0.0	3.4	0.0	2.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	5.7	4.7	6.0	4.2	3.7	2.9	4.8	4.6	3.1
ZNF215	"ZKSCAN11, ZSCAN43"	ENSG00000149054	"Zinc finger protein 215"	Q9UL58	11	6926404-7001004	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.6"	"Cell line enhanced"	"Detected in many"		"U-698: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA047243, HPA051010"	Enhanced		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA047243: , HPA051010: "	"unprognostic (2.18e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.01e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.29e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.90e-1)"	1.2	1.4	1.5	9.0	1.8	1.4	2.7	0.7	4.0	1.9	4.2	0.3	0.9	4.6	2.3	5.2	2.8	1.4	1.1	1.4	1.2	2.2	2.9	1.6	1.5	6.7	0.7	1.4	1.9	10.4	0.0	0.8	0.7	1.9	2.7	5.5	1.2	4.2	2.0	0.9	1.6	5.5	0.9	1.1	4.8	1.6	6.1	0.0	6.5	2.7	2.1	11.6	3.3	2.2	2.5	2.9	4.0	1.8	1.5	1.4	0.8	2.6	1.2	1.7	0.6	1.3	1.6	5.7	6.1	5.2	3.2	6.3	0.2	0.1	8.5	2.0	3.2	3.0	5.0	6.0	6.0	0.0	6.9	0.1	0.8	0.1	1.2	5.3	0.4	2.8	2.9	0.1	6.5	5.0	10.0	3.0	1.3	0.1	0.2	0.2	8.4	1.7	0.2	0.1	1.0	0.2	4.7	0.1	0.2	0.0	2.1	0.2	0.2	2.1	2.4	2.0	5.7	2.3	0.1	0.4	0.1	17.8	4.5	0.3	1.7	4.0	1.8	0.6	0.8	1.0	0.3	2.5	0.6	1.4	1.7	2.5	1.4	0.8	2.7	1.5	0.5	2.9	0.7	0.8	1.5	1.8	0.7	4.0	1.2	2.2	0.7	1.4	1.9	0.0
ZNF222		ENSG00000159885	"Zinc finger protein 222"	Q9UK12	19	44025342-44033112	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA004086	Approved		Approved	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA004086: AB_2273259"	"unprognostic (1.91e-3)"	"unprognostic (3.41e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.75e-3)"	"unprognostic (6.75e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.58e-2)"	"prognostic favourable (5.56e-7)"	"unprognostic (2.19e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.42e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-3)"	4.8	7.7	8.1	5.1	9.1	8.0	8.3	18.3	12.6	6.2	4.4	7.5	5.3	2.9	5.1	7.3	3.5	5.5	6.4	7.5	11.5	8.2	5.9	5.1	5.7	7.2	8.8	7.8	8.9	5.4	6.6	12.7	5.4	10.7	6.6	5.0	5.7	6.9	6.4	3.7	4.5	5.0	6.0	9.3	8.8	5.5	15.4	11.1	10.3	7.6	5.0	7.3	8.5	6.6	7.6	4.0	8.9	3.6	6.1	9.7	4.0	3.9	4.6	7.8	7.1	6.0	6.1	0.4	4.2	7.5	4.9	7.7	2.4	2.5	1.3	6.5	4.6	1.3	5.4	4.0	6.3	5.7	5.9	6.4	5.8	3.7	7.6	0.2	5.9	4.6	5.4	4.1	7.0	4.6	1.2	2.7	6.1	0.5	4.4	2.6	4.7	2.2	0.1	8.3	2.1	4.1	12.3	4.2	9.6	6.8	1.3	5.7	1.7	6.3	3.4	5.5	5.3	3.2	5.2	11.2	9.1	0.1	2.9	0.1	6.0	8.9	3.6	7.0	9.2	2.3	7.7	7.4	8.7	8.9	3.6	7.6	9.7	7.3	7.5	6.1	2.8	4.0	6.0	4.0	8.1	9.1	18.3	12.6	11.5	8.2	8.8	7.8	10.7	11.1
ZNF226		ENSG00000167380	"Zinc finger protein 226"	Q9NYT6	19	44165073-44178381	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA006145, CAB034353"	Uncertain		Approved	"Nuclear bodies"				"Nuclear bodies"		"CAB034353: AB_2219110, HPA006145: AB_10696203"	"unprognostic (1.30e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.79e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.05e-2)"	"prognostic favourable (8.34e-4)"	"unprognostic (4.09e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.46e-1)"	"prognostic favourable (2.37e-5)"	10.5	26.2	23.2	10.2	24.9	8.9	18.6	37.6	20.8	9.6	12.0	18.0	14.9	12.0	12.4	23.9	9.4	14.7	15.0	13.9	19.9	19.1	13.8	15.6	11.1	16.0	26.8	22.3	18.7	7.8	12.2	38.7	11.5	21.3	19.6	13.1	12.2	9.7	14.8	7.6	10.9	12.0	11.0	21.5	15.5	14.0	14.5	28.6	15.9	21.5	5.5	13.5	14.4	11.3	19.4	13.3	24.6	10.6	16.9	19.7	9.4	9.2	10.3	11.6	8.5	11.1	17.8	5.2	9.7	21.8	10.9	20.1	7.2	11.5	3.3	12.3	12.4	5.2	5.1	9.6	13.2	5.3	12.2	13.1	12.7	5.3	9.7	8.5	8.9	20.0	12.7	13.2	26.8	14.2	2.7	3.2	20.8	3.0	9.2	3.6	5.6	7.7	5.6	9.3	6.5	10.7	25.8	8.4	13.4	19.5	7.2	4.4	11.7	12.4	11.0	10.1	12.4	5.5	11.5	16.2	14.8	9.6	9.2	5.9	10.7	24.6	10.5	6.6	16.2	10.6	18.2	13.8	16.4	15.9	12.4	19.4	19.7	17.2	7.9	16.9	9.0	13.3	17.7	9.4	23.2	24.9	37.6	20.8	19.9	19.1	26.8	22.3	21.3	28.6
ZNF233	FLJ38032	ENSG00000159915	"Zinc finger protein 233"	A6NK53	19	44259880-44275317	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 25.2"	"Cell line enhanced"	"Detected in many"		"U-266/70: 10.6;U-266/84: 9.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA020975	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA020975: AB_1859145"	"unprognostic (2.26e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.72e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.77e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.65e-1)"	"unprognostic (6.28e-3)"	"unprognostic (6.88e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.71e-4)"	"unprognostic (1.55e-1)"	0.6	2.3	4.4	2.1	6.3	3.9	2.5	10.9	8.5	1.3	4.3	0.8	0.2	1.9	0.9	2.8	1.4	2.2	1.8	4.8	4.1	5.0	2.1	0.8	1.2	2.3	3.3	6.1	1.2	1.6	3.1	11.2	2.2	6.2	4.8	2.2	2.1	1.6	2.3	2.5	3.8	1.8	1.6	3.4	2.2	2.1	25.2	2.4	3.3	3.5	2.7	1.0	1.6	0.8	4.7	3.9	3.3	1.2	3.4	2.2	0.5	0.7	2.7	3.0	3.0	3.1	0.6	1.3	1.2	0.8	1.0	1.8	2.8	3.3	1.2	2.9	0.8	1.3	0.1	0.7	1.1	0.6	3.8	1.9	3.5	2.8	2.2	1.2	1.3	0.7	0.5	0.7	1.9	1.3	1.3	5.8	0.2	1.6	0.9	1.0	3.2	0.8	2.0	0.4	2.4	0.7	2.4	4.2	6.4	1.2	0.8	2.0	5.0	1.5	0.8	1.3	0.8	0.8	0.8	10.6	9.9	2.2	4.4	1.2	1.4	3.3	1.0	0.9	1.6	1.1	1.5	2.7	1.4	1.1	0.5	4.7	2.0	2.2	2.4	3.4	1.2	3.9	2.1	0.5	4.4	6.3	10.9	8.5	4.1	5.0	3.3	6.1	6.2	2.4
ZNF234	"HZF4, ZNF269"	ENSG00000263002	"Zinc finger protein 234"	Q14588	19	44141557-44160309	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA001664	Approved		Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA001664: AB_1080694"	"unprognostic (9.03e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.31e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.96e-1)"	"unprognostic (7.77e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.07e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.57e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.31e-2)"	"prognostic favourable (4.34e-5)"	8.0	11.7	8.2	8.1	12.7	1.4	10.1	18.3	10.5	8.3	7.6	12.0	9.5	7.6	8.5	6.4	7.5	7.0	7.0	9.4	8.8	5.1	8.1	7.2	7.5	9.0	14.7	8.2	11.7	7.3	12.4	14.3	9.6	10.6	8.9	7.8	7.4	8.7	7.8	7.7	9.2	9.0	9.0	11.1	12.2	8.0	6.4	14.2	11.6	10.1	3.4	10.4	8.5	7.7	6.2	4.2	5.4	4.4	7.2	7.7	3.1	4.8	3.4	8.3	7.9	9.9	10.2	3.7	6.3	4.5	4.9	8.3	4.1	3.0	0.1	4.3	5.7	3.7	6.2	4.0	6.0	0.0	7.5	9.5	7.0	5.5	4.7	0.0	6.7	5.7	9.1	5.4	6.2	5.5	0.6	0.1	7.4	1.5	6.4	2.3	5.5	3.2	0.0	9.4	1.5	3.1	9.4	4.6	7.7	4.5	3.8	3.3	4.2	3.9	5.6	9.3	7.6	1.7	5.7	5.1	4.3	0.1	1.0	0.0	7.4	2.4	3.6	5.4	6.8	4.4	5.7	4.1	4.0	4.7	4.2	6.2	7.7	7.3	1.4	7.2	3.1	2.9	2.1	3.1	8.2	12.7	18.3	10.5	8.8	5.1	14.7	8.2	10.6	14.2
ZNF235	"ANF270, HZF6, ZFP93, ZNF270"	ENSG00000159917	"Zinc finger protein 235"	Q14590	19	44228729-44305046	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045582	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA045582: AB_10963792"	"unprognostic (2.11e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.91e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.23e-4)"	"unprognostic (4.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.46e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.65e-3)"	"unprognostic (3.38e-2)"	5.6	4.8	8.1	6.6	10.4	1.8	8.1	13.9	10.3	6.1	7.7	10.7	10.1	5.0	13.2	6.5	5.2	7.1	4.9	6.9	7.8	7.5	6.7	5.5	6.6	7.4	8.5	4.1	8.1	6.2	10.1	9.0	7.3	9.4	7.7	6.0	6.9	5.8	8.2	6.5	4.4	6.4	6.9	7.1	8.2	5.3	6.8	8.5	10.7	9.1	2.9	9.3	6.2	5.9	10.9	8.3	14.5	3.7	5.6	7.5	2.4	1.9	3.2	6.3	6.3	4.7	2.8	2.4	1.2	3.7	2.3	2.7	2.0	3.5	3.3	3.2	2.4	1.7	5.5	2.6	2.8	0.0	6.8	7.2	4.8	2.9	3.9	4.0	4.3	2.8	3.5	2.6	3.1	3.7	1.6	0.0	2.5	1.6	6.6	0.8	7.5	2.0	3.2	6.0	2.9	4.5	5.0	4.6	12.8	3.4	4.1	3.0	3.1	4.9	4.4	2.1	2.9	0.6	1.4	7.7	7.7	2.4	1.8	1.1	3.4	14.5	3.7	3.6	6.8	3.0	4.7	6.9	5.1	5.8	2.7	10.9	7.5	6.5	2.0	5.6	2.9	8.3	3.7	2.4	8.1	10.4	13.9	10.3	7.8	7.5	8.5	4.1	9.4	8.5
ZNF236		ENSG00000130856	"Zinc finger protein 236"	Q9UL36	18	76822607-76970727	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008600	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"				"Cell Junctions"	"Nucleoplasm, Cytosol"	"HPA008600: AB_1080696"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.88e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.95e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	5.7	5.2	7.0	9.1	11.2	10.8	10.0	15.3	11.0	7.2	5.8	7.3	6.7	5.0	7.6	7.1	5.6	7.6	6.3	5.1	8.3	5.7	4.7	4.3	6.4	6.2	8.3	3.5	11.3	7.1	12.2	8.9	5.6	7.3	6.2	4.1	5.4	6.6	12.6	5.7	9.9	5.5	5.8	6.5	5.5	5.8	16.6	10.6	10.4	6.5	1.9	10.0	6.2	12.7	9.0	4.6	5.9	3.4	3.0	5.4	1.2	4.3	5.8	8.2	6.0	6.3	6.1	3.7	3.4	4.7	5.4	4.3	4.1	4.1	6.2	1.7	4.4	8.0	5.7	4.8	4.6	6.5	5.7	5.9	6.7	4.8	3.9	9.4	6.8	6.0	5.2	5.1	7.9	5.4	5.6	5.2	5.4	4.1	11.4	5.2	4.5	4.6	7.3	8.5	4.1	4.0	6.8	4.7	4.9	6.1	3.7	4.2	4.4	6.6	5.6	9.3	3.7	2.5	5.0	3.5	4.9	8.0	6.2	5.2	6.9	1.1	3.4	5.9	5.4	2.9	5.2	9.0	4.0	3.7	2.2	8.1	4.6	4.8	3.7	3.0	2.7	4.6	3.9	1.2	7.0	11.2	15.3	11.0	8.3	5.7	8.3	3.5	7.3	10.6
ZNF25	"FLJ31890, KOX19, Zfp9"	ENSG00000175395	"Zinc finger protein 25"	P17030	10	37949572-37976633	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030190	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA030190: AB_10602687"	"unprognostic (9.42e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.61e-1)"	9.7	12.1	17.0	4.0	21.7	2.7	8.7	23.2	27.6	10.9	8.1	7.3	3.4	2.7	11.3	7.5	6.5	7.3	7.1	11.1	13.3	16.7	6.8	3.5	6.9	4.9	12.7	23.7	13.1	4.0	7.1	10.7	5.4	16.0	8.9	5.4	5.1	4.5	11.0	22.9	5.1	3.7	11.6	9.5	7.1	4.4	5.2	11.6	1.2	6.3	5.7	4.9	8.4	5.4	2.3	3.4	6.0	8.5	1.8	3.7	2.2	1.6	3.0	3.3	6.8	12.7	9.7	0.6	3.6	5.0	2.9	4.4	0.5	2.3	3.0	1.1	6.4	0.4	0.9	1.5	4.7	7.1	1.6	4.9	0.0	1.0	8.1	3.2	3.2	6.9	6.8	3.2	3.7	4.9	0.4	2.3	6.9	0.9	1.1	2.5	0.6	2.2	1.2	3.8	0.6	3.4	0.6	1.2	7.8	1.2	0.2	4.6	3.0	5.2	7.0	4.5	0.8	7.3	2.2	2.9	1.4	1.3	8.5	6.3	2.9	2.3	2.8	6.0	3.1	4.7	3.4	2.0	2.7	2.6	3.4	2.3	3.7	3.0	0.5	1.8	8.5	0.5	2.2	2.2	17.0	21.7	23.2	27.6	13.3	16.7	12.7	23.7	16.0	11.6
ZNF280A	"3'OY11.1, SUHW1, ZNF280, ZNF636"	ENSG00000169548	"Zinc finger protein 280A"	P59817	22	22513736-22520270	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.6;epididymis: 5.6;retina: 2.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;K-562: 12.7;SK-MEL-30: 3.4"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA044475			Approved	Nucleoplasm				Nucleoplasm		"HPA044475: AB_10960420"			"unprognostic (7.53e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-2)"		"unprognostic (3.14e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.65e-3)"			"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"			0.0	5.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.1	5.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.5	0.0	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	1.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	12.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.5	0.3	0.5	0.2	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0
ZNF285	ZNF285A	ENSG00000267508	"Zinc finger protein 285"	Q96NJ3	19	44382298-44401608	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 6.8"	"Low lineage specificity"	"Detected in many"											"HPA046100, HPA049212"	Uncertain									"HPA046100: , HPA049212: "	"unprognostic (3.23e-2)"	"unprognostic (1.90e-3)"	"unprognostic (6.42e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.91e-3)"	"unprognostic (3.60e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.42e-6)"	"unprognostic (1.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.55e-3)"	2.2	4.9	7.5	2.0	9.7	0.7	5.8	11.9	6.8	3.0	3.4	5.7	2.1	2.1	5.2	3.9	2.6	6.7	2.7	4.9	6.9	7.5	3.9	1.6	1.8	2.8	7.2	8.9	14.9	2.4	5.6	7.7	2.6	6.7	4.9	2.7	2.5	2.1	4.8	4.0	2.0	1.9	5.2	6.4	3.6	3.3	6.4	8.9	2.0	6.6	1.0	3.3	3.8	2.8	6.8	1.0	3.2	0.7	2.1	4.3	1.0	0.3	4.5	4.4	0.0	3.6	3.7	0.2	1.6	1.6	2.2	3.0	0.8	2.7	0.0	2.4	1.0	1.5	0.0	3.0	3.8	0.0	3.0	6.2	1.6	1.2	5.0	0.8	0.1	2.9	0.0	0.9	9.0	4.0	0.1	0.2	2.9	0.1	0.0	0.1	1.2	2.3	0.0	0.0	2.7	2.5	3.7	1.9	3.3	0.2	0.8	0.0	5.5	2.1	3.7	2.5	2.0	1.2	0.1	2.8	5.8	0.0	2.3	0.0	2.8	3.2	0.2	0.0	0.2	0.4	0.1	3.0	0.6	0.4	1.0	6.8	4.3	4.3	0.1	2.1	0.7	0.8	0.8	1.0	7.5	9.7	11.9	6.8	6.9	7.5	7.2	8.9	6.7	8.9
ZNF287	"ZKSCAN13, ZSCAN45"	ENSG00000141040	"Zinc finger protein 287"	Q9HBT7	17	16551387-16569206	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029290	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA029290: AB_10603465"	"unprognostic (4.74e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.19e-1)"	"prognostic favourable (5.28e-5)"	"unprognostic (5.69e-3)"	"unprognostic (5.74e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.87e-1)"	5.9	8.8	7.3	3.6	10.2	1.4	7.1	13.7	12.6	7.2	4.8	11.5	3.0	1.9	6.7	9.1	4.5	6.5	4.5	9.8	7.7	6.0	6.5	0.8	4.9	5.2	9.5	7.3	9.8	4.7	16.3	13.6	3.3	10.8	7.1	4.3	8.1	4.5	8.3	6.2	7.5	4.0	6.8	6.4	5.1	5.1	5.5	9.9	8.2	8.4	4.5	6.0	7.7	4.3	9.6	2.7	0.4	2.5	6.0	9.5	4.1	3.9	7.1	6.7	7.0	4.6	8.8	1.6	3.5	6.2	6.8	8.4	1.4	3.0	1.8	3.8	5.7	6.3	4.0	6.0	8.2	2.8	3.3	0.0	0.4	0.0	5.8	0.0	6.0	6.6	4.3	2.8	4.2	4.1	0.4	0.0	9.4	3.7	5.7	0.3	1.6	3.4	0.0	7.6	0.1	4.1	2.1	3.8	6.2	10.6	1.4	4.2	5.2	0.6	3.1	4.1	2.2	5.2	4.5	3.3	2.4	0.0	6.1	0.0	5.2	0.0	0.6	0.4	7.9	0.8	6.7	9.6	8.5	7.9	2.7	7.0	9.5	9.4	0.0	6.0	2.5	1.7	6.3	4.1	7.3	10.2	13.7	12.6	7.7	6.0	9.5	7.3	10.8	9.9
ZNF30	"DKFZp686N19164, FLJ20562, KOX28"	ENSG00000168661	"Zinc finger protein 30"	P17039	19	34926903-34945170	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA030400	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA030400: AB_10603245"	"unprognostic (3.04e-1)"	"unprognostic (9.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.38e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.10e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.42e-1)"	"prognostic favourable (1.16e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.86e-2)"	3.4	5.2	11.1	2.6	10.9	0.7	5.9	21.4	11.6	5.3	3.9	5.0	2.9	4.2	4.5	3.4	3.4	7.0	2.6	5.0	7.0	5.4	4.6	6.5	6.0	5.1	10.0	6.5	5.6	6.9	6.4	7.7	3.3	6.6	5.8	4.5	5.8	4.6	5.2	5.3	5.6	3.9	5.1	7.2	5.4	4.8	3.9	8.3	2.4	4.4	2.0	5.1	3.8	4.0	3.4	1.3	2.8	0.4	6.9	7.2	1.8	3.7	8.2	3.5	8.8	6.4	4.1	0.1	3.6	2.6	3.4	3.7	5.8	1.2	0.0	4.8	2.3	2.3	10.1	5.2	4.2	0.0	4.8	2.7	4.5	4.4	3.2	3.6	2.5	3.5	4.6	3.4	4.5	5.2	8.8	0.0	5.3	2.8	2.6	1.6	4.9	4.3	3.4	2.7	0.9	2.5	3.2	4.6	6.7	0.0	0.1	3.4	3.3	1.0	3.8	7.1	3.7	2.6	4.9	2.4	11.6	1.0	1.4	0.0	4.1	2.8	0.1	0.1	4.8	0.4	4.7	3.4	3.8	2.2	1.3	2.1	7.2	7.2	0.0	6.9	0.0	1.2	3.4	1.8	11.1	10.9	21.4	11.6	7.0	5.4	10.0	6.5	6.6	8.3
ZNF311		ENSG00000197935	"Zinc finger protein 311"	Q5JNZ3	6	28994785-29005316	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;K-562: 1.2;MCF7: 1.5;RT4: 2.0;SK-MEL-30: 1.2;THP-1: 1.6;U-2 OS: 2.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA050541	Approved									"HPA050541: "	"unprognostic (1.62e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.03e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.41e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.05e-4)"	"unprognostic (9.70e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.14e-1)"	1.2	1.9	2.0	3.3	2.2	0.8	2.6	1.5	2.7	2.5	2.5	1.8	6.4	1.5	1.8	4.6	1.6	4.2	1.7	1.1	1.5	0.9	1.3	1.5	1.6	1.0	4.7	1.2	3.5	1.4	0.8	0.8	0.8	2.6	2.7	1.4	1.6	1.6	3.2	0.8	2.1	1.6	1.7	5.6	1.5	1.5	6.6	1.9	0.0	4.2	0.0	1.2	1.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	1.2	0.0	1.6	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.2	1.5	2.7	1.5	0.9	4.7	1.2	2.6	1.9
ZNF324	"ZF5128, ZNF324A"	ENSG00000083812	"Zinc finger protein 324"	O75467	19	58467045-58475436	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA039774	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA039774: AB_10673149"	"unprognostic (8.60e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.36e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (4.74e-5)"	"unprognostic (6.39e-2)"	"prognostic favourable (1.34e-7)"	"unprognostic (1.19e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavourable (6.99e-4)"	"unprognostic (3.56e-1)"	7.7	8.0	8.9	11.5	10.8	12.6	7.4	15.8	14.0	9.8	8.8	11.9	10.2	8.5	12.0	9.1	12.7	10.5	9.2	7.6	9.9	9.3	6.5	10.5	7.7	10.5	10.4	11.5	14.6	15.0	10.2	12.7	7.1	7.1	10.6	6.0	7.2	11.2	13.3	5.8	11.9	7.3	8.2	9.3	8.3	8.6	8.0	9.7	16.8	11.9	8.1	10.7	9.3	7.2	6.4	6.4	13.1	5.0	6.0	11.8	3.4	4.0	5.1	3.5	5.3	4.0	3.5	3.8	3.3	4.1	3.3	3.0	4.5	2.0	6.3	3.1	2.7	5.1	4.5	4.5	1.6	5.5	34.8	4.4	3.9	2.1	3.2	7.3	5.2	2.6	5.6	4.7	2.2	2.3	6.2	4.1	3.6	3.3	6.5	4.0	2.8	7.8	7.0	4.4	4.0	2.4	8.2	7.1	5.6	3.6	5.8	2.5	2.9	5.3	4.1	10.0	2.2	3.5	5.6	6.0	6.0	3.2	5.0	3.6	3.1	2.3	4.7	7.2	9.5	5.0	10.7	5.3	7.6	10.5	3.2	6.4	11.8	8.9	13.1	6.0	3.9	6.4	7.2	3.4	8.9	10.8	15.8	14.0	9.9	9.3	10.4	11.5	7.1	9.7
ZNF333	KIAA1806	ENSG00000160961	"Zinc finger protein 333"	Q96JL9	19	14689801-14733746	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043973, HPA054680"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA043973: AB_10961277, HPA054680: "	"unprognostic (8.16e-2)"	"unprognostic (2.80e-4)"	"unprognostic (5.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.32e-5)"	"unprognostic (4.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.06e-3)"	10.7	8.1	8.8	7.8	11.3	12.2	9.4	16.2	12.1	11.4	9.9	14.3	7.0	4.5	16.5	11.0	5.3	10.8	6.6	6.3	8.6	6.9	5.8	4.9	8.7	7.3	16.8	9.8	15.3	9.1	8.2	7.5	7.4	10.3	8.8	5.9	10.3	5.7	8.5	14.5	7.7	6.5	11.6	9.6	13.0	6.7	8.8	12.8	6.7	6.9	4.3	6.6	9.5	8.8	2.7	4.9	7.9	5.0	13.5	5.4	2.4	1.5	0.9	5.7	7.7	8.3	7.8	2.2	3.5	4.8	3.0	4.4	0.4	1.4	2.4	3.9	4.5	1.4	2.0	1.4	4.6	5.5	1.5	9.8	2.1	2.4	6.8	3.9	5.6	7.1	3.8	2.8	8.0	4.4	2.0	4.7	3.8	0.8	2.5	9.4	2.3	1.7	3.6	3.2	2.3	3.0	2.0	3.1	6.1	3.1	0.4	5.6	1.5	6.6	7.1	5.2	2.4	8.3	3.6	2.2	1.0	2.4	5.4	6.8	6.1	7.9	4.0	6.0	4.0	5.0	5.4	2.6	3.6	3.0	4.9	2.7	4.1	3.6	7.0	13.5	4.3	2.4	3.0	2.4	8.8	11.3	16.2	12.1	8.6	6.9	16.8	9.8	10.3	12.8
ZNF345	HZF10	ENSG00000251247	"Zinc finger protein 345"	Q14585	19	36850361-36913029	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA025816	Uncertain									"HPA025816: AB_10602354"	"unprognostic (1.55e-3)"	"unprognostic (9.11e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.17e-4)"	"unprognostic (6.14e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.54e-2)"	"unprognostic (5.78e-5)"	"unprognostic (1.70e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.27e-3)"	"unprognostic (3.33e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.32e-2)"	"unprognostic (3.87e-5)"	7.4	6.8	10.6	7.0	13.6	6.0	10.1	27.9	16.3	7.7	7.4	7.4	8.9	7.4	9.4	11.2	6.5	7.2	6.4	6.6	9.7	4.7	6.2	5.6	6.9	9.4	14.6	5.1	11.5	5.8	12.4	11.9	6.9	11.6	8.6	7.1	7.6	8.8	6.7	3.7	11.7	8.4	7.0	8.6	8.9	6.8	21.3	12.3	10.1	9.6	4.2	8.0	8.7	8.7	4.1	2.1	12.0	1.9	3.5	7.7	3.2	0.3	1.0	10.8	6.4	3.0	3.4	3.5	2.3	2.4	2.3	4.6	0.7	3.0	2.3	5.1	1.5	2.6	3.0	2.3	3.0	8.1	6.3	4.8	2.3	2.5	2.4	3.8	4.7	6.8	3.2	3.0	0.0	3.2	1.0	1.2	3.5	1.8	7.7	5.3	4.0	2.2	5.6	7.8	3.9	1.5	7.6	7.3	7.2	5.5	0.6	1.7	3.4	3.7	2.9	4.7	5.8	3.1	1.8	7.5	4.4	4.8	0.2	0.2	5.7	12.0	1.9	6.0	4.6	1.7	4.7	2.7	5.4	4.2	1.6	4.1	7.7	6.1	2.5	3.5	1.7	2.1	5.3	3.2	10.6	13.6	27.9	16.3	9.7	4.7	14.6	5.1	11.6	12.3
ZNF365	"KIAA0844, UAN"	ENSG00000138311	"Zinc finger protein 365"	"Q70YC4, Q70YC5"	10	62374192-62672011	"Disease related genes, Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.3"	"Cell line enhanced"	"Detected in many"		"HaCaT: 17.2;PC-3: 11.1;U-251 MG: 14.3;U-87 MG: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 3.4;memory CD4 T-cell: 3.1;memory CD8 T-cell: 3.5;naive CD8 T-cell: 3.7;NK-cell: 7.4;T-reg: 7.5"	"Group enriched"	"Detected in many"	51	"NK-cells: 7.4;T-cells: 7.5"	"Group enriched"	"Detected in all"	4	"amygdala: 328.0;basal ganglia: 309.9;cerebral cortex: 424.1;hippocampal formation: 348.1;thalamus: 127.9"	"Low region specificity"	"Detected in all"			HPA052446	Enhanced		Supported	"Vesicles,Centriolar satellite"				"Vesicles, Centriolar satellite"		"HPA052446: "	"unprognostic (7.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.05e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.12e-6)"	"unprognostic (2.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.89e-2)"	0.9	2.5	11.8	1.0	19.4	1.0	1.3	8.4	41.3	2.0	0.9	13.1	0.0	1.1	1.2	1.5	11.7	1.0	4.0	2.0	9.6	7.4	1.1	1.2	3.1	1.1	7.5	16.0	1.0	1.3	9.0	1.8	1.2	6.9	3.0	1.1	1.0	1.2	3.3	1.0	2.6	0.9	0.9	10.5	1.3	1.0	1.6	9.1	0.0	1.6	0.0	2.2	1.9	1.2	0.1	0.0	0.1	0.1	7.4	7.5	1.0	5.7	0.8	0.5	0.7	0.6	0.3	0.3	4.3	4.5	2.2	1.9	0.6	1.4	0.4	0.7	2.6	17.2	0.5	0.3	2.9	0.2	0.4	0.3	1.5	0.4	0.2	0.3	1.4	0.3	0.3	5.8	0.8	0.7	0.4	0.6	4.2	2.1	0.7	0.5	0.8	11.1	0.4	0.5	0.4	0.5	2.6	0.2	0.9	1.1	0.9	0.4	0.1	0.3	3.1	1.2	5.6	0.6	14.3	0.2	0.5	0.3	10.2	0.6	1.9	0.0	0.0	0.0	3.4	0.1	0.0	0.0	3.1	3.5	0.0	0.1	0.6	3.7	0.1	7.4	0.1	0.0	7.5	1.0	11.8	19.4	8.4	32.3	9.6	7.4	7.5	16.0	6.9	9.1
ZNF37A	"KOX21, ZNF37"	ENSG00000075407	"Zinc finger protein 37A"	P17032	10	38094334-38150293	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003172	Approved		Approved	Vesicles				Vesicles		"HPA003172: AB_1080709"	"unprognostic (8.64e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.22e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavourable (2.83e-4)"	"unprognostic (7.65e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (2.31e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.09e-2)"	8.2	10.1	11.9	9.9	15.3	4.9	9.9	23.2	13.9	11.8	9.9	11.0	6.6	8.0	12.5	10.5	6.9	10.1	8.7	7.8	11.5	9.9	10.4	9.1	10.2	9.2	16.3	10.7	13.5	16.7	20.0	25.0	8.2	12.8	10.3	8.5	9.0	12.7	15.4	6.7	10.7	9.0	16.3	12.0	9.7	10.1	4.1	16.2	8.2	14.0	3.9	9.8	8.5	8.4	5.6	2.9	2.5	4.7	6.4	5.4	1.7	11.5	6.0	5.3	10.0	8.2	8.0	5.8	8.9	3.4	4.1	5.6	4.7	3.4	17.0	2.7	4.9	4.7	9.9	7.5	6.5	10.9	9.4	17.1	6.8	6.7	7.1	17.9	11.1	6.1	12.6	7.1	6.0	5.4	11.1	12.1	8.8	2.7	10.1	2.8	4.7	9.8	7.3	14.6	3.4	4.4	4.5	4.3	7.4	6.1	5.0	5.0	9.1	5.6	9.2	7.8	8.4	7.5	8.6	13.6	14.7	6.7	5.2	12.9	4.9	2.5	2.4	2.2	3.9	1.9	5.1	3.5	4.5	3.9	2.3	5.6	5.4	4.5	2.0	6.4	4.7	2.9	2.4	1.7	11.9	15.3	23.2	13.9	11.5	9.9	16.3	10.7	12.8	16.2
ZNF382	"FLJ14686, KS1"	ENSG00000161298	"Zinc finger protein 382"	Q96SR6	19	36604817-36634113	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 27.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 10.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049259	Approved		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA049259: "	"unprognostic (5.43e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.68e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.85e-3)"	"unprognostic (5.63e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.76e-5)"	"unprognostic (8.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.22e-2)"	3.3	5.9	6.7	3.5	10.5	1.9	3.3	27.6	13.8	4.2	3.9	4.9	2.3	1.3	4.8	4.2	3.1	5.8	3.0	7.5	6.2	6.2	3.8	1.5	2.7	5.1	5.6	11.2	4.7	2.6	4.8	11.0	4.6	9.4	3.6	1.9	4.4	3.3	3.1	1.7	1.4	2.8	4.3	5.5	5.5	2.2	6.7	5.3	3.6	5.7	2.0	6.3	4.0	2.0	9.0	2.4	3.5	0.7	4.5	9.0	2.7	0.2	0.1	4.6	6.4	1.9	2.6	1.5	2.0	0.6	5.9	6.1	0.2	0.4	3.9	4.3	2.4	0.1	5.8	0.1	3.8	10.9	2.7	6.4	0.3	1.6	5.2	0.9	7.7	3.6	0.2	3.3	0.2	0.7	0.1	0.2	3.9	0.6	8.8	2.1	3.0	2.2	0.4	1.9	1.7	1.6	0.2	0.6	8.7	0.3	0.3	3.6	2.7	0.7	0.2	1.4	0.3	0.3	5.8	10.1	0.7	0.4	0.1	0.1	3.5	2.1	0.6	3.5	5.6	0.7	9.0	9.0	8.8	6.2	2.3	6.6	7.6	8.4	1.2	4.5	0.7	2.4	5.0	2.7	6.7	10.5	27.6	13.8	6.2	6.2	5.6	11.2	9.4	5.3
ZNF383	FLJ35863	ENSG00000188283	"Zinc finger protein 383"	Q8NA42	19	37217926-37248738	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063945	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA063945: "	"unprognostic (1.92e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.27e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (9.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.01e-3)"	"prognostic favourable (3.71e-4)"	9.1	7.5	9.3	10.4	12.1	6.9	10.7	20.4	10.8	9.1	8.2	12.6	10.4	7.5	11.6	7.8	8.9	8.2	6.1	9.6	8.7	6.9	9.3	7.4	7.2	11.3	14.2	6.5	12.9	9.2	9.4	11.0	6.5	11.8	9.6	7.4	8.7	8.5	8.7	14.0	11.8	9.5	10.8	13.7	10.8	8.4	10.5	12.1	13.2	11.4	5.7	11.9	10.2	9.4	11.4	4.0	6.3	5.4	5.7	11.6	4.8	3.7	8.5	6.0	9.1	7.4	7.7	3.9	5.1	7.1	5.2	7.9	3.9	4.5	5.1	7.9	4.9	3.8	4.9	6.8	7.7	7.1	5.3	7.7	6.4	3.1	8.4	8.8	8.4	9.8	5.9	5.0	9.8	4.7	4.0	2.7	6.7	1.6	7.6	4.0	5.3	3.0	5.6	10.7	4.6	4.6	10.7	7.2	5.3	8.2	4.9	7.2	5.8	5.2	2.9	6.8	4.6	4.8	4.9	8.3	7.9	9.8	1.0	4.2	6.2	3.6	4.1	6.3	7.6	4.7	10.7	9.8	7.2	9.2	4.0	11.4	11.6	9.1	5.0	5.7	5.4	3.8	7.0	4.8	9.3	12.1	20.4	10.8	8.7	6.9	14.2	6.5	11.8	12.1
ZNF385D	"FLJ22419, ZNF659"	ENSG00000151789	"Zinc finger protein 385D"	Q9H6B1	3	21412222-22373321	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 17.7;brain: 59.5;testis: 18.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.8;fHDF/TERT166: 2.4;RPTEC TERT1: 6.6;U-87 MG: 12.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	7	"cerebellum: 59.5"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA036190	Uncertain									"HPA036190: AB_10602355"	"unprognostic (4.07e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-7)"	"unprognostic (8.70e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.76e-3)"	"unprognostic (2.15e-5)"	17.7	1.1	4.0	2.2	5.9	1.1	5.3	59.5	9.1	4.3	2.2	0.1	1.2	1.2	2.3	3.9	4.0	2.3	4.7	3.9	3.9	3.6	3.2	0.9	1.9	2.0	7.4	4.0	1.7	2.5	1.3	0.5	0.7	4.1	3.0	1.8	4.1	1.9	3.2	2.8	2.4	1.3	3.5	1.9	1.3	1.3	18.5	1.7	0.1	1.5	5.2	2.0	4.0	5.7	0.7	0.3	2.0	0.2	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.5	4.8	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.3	1.4	0.0	0.0	0.0	6.6	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.4	0.2	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.0	0.7	0.0	0.1	2.0	0.1	0.0	0.3	0.0	0.2	4.0	5.9	59.5	9.1	3.9	3.6	7.4	4.0	4.1	1.7
ZNF391	dJ153G14.3	ENSG00000124613	"Zinc finger protein 391"	Q9UJN7	6	27374615-27403904	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA050886	Uncertain									"HPA050886: "	"unprognostic (1.59e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.68e-3)"	"unprognostic (6.27e-5)"	"unprognostic (2.18e-2)"	"unprognostic (2.50e-1)"	"prognostic favourable (1.89e-4)"	"unprognostic (5.62e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.82e-2)"	4.1	4.3	9.9	1.7	11.8	0.5	6.4	7.0	15.1	7.5	3.3	3.3	3.3	1.6	6.4	6.3	3.6	7.9	2.5	2.4	8.1	4.9	5.6	0.7	3.6	3.4	3.5	9.9	10.1	4.7	6.8	4.6	2.7	6.5	5.5	3.3	3.4	3.9	7.2	1.0	3.4	2.4	5.7	4.3	4.2	3.0	8.8	4.6	2.0	7.9	0.4	3.1	4.4	3.5	3.7	1.2	0.3	0.1	0.8	3.1	0.7	5.0	0.8	3.1	10.7	1.3	1.8	6.3	1.3	1.0	1.8	4.2	2.8	1.1	0.0	4.6	1.2	1.7	6.1	4.7	2.9	0.0	3.7	1.9	0.2	1.0	2.1	5.4	2.7	5.4	6.1	0.3	4.8	0.2	8.2	0.0	0.3	1.0	6.4	7.8	3.8	3.4	0.0	0.0	1.4	1.2	2.0	1.2	5.0	0.0	7.1	0.6	1.2	4.7	0.6	5.9	1.9	0.3	3.8	3.4	8.0	0.0	0.3	0.5	6.3	0.3	0.1	0.0	0.9	0.1	2.0	3.7	1.5	0.8	0.0	3.6	3.1	1.9	0.2	0.8	0.0	1.2	0.2	0.7	9.9	11.8	7.0	15.1	8.1	4.9	3.5	9.9	6.5	4.6
ZNF416	FLJ20557	ENSG00000083817	"Zinc finger protein 416"	Q9BWM5	19	57571566-57578927	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA063318			Approved	"Nuclear bodies,Cytosol"				Cytosol	"Nuclear bodies"	"HPA063318: "	"unprognostic (1.40e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.57e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.54e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.37e-2)"	"prognostic favourable (1.20e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.70e-1)"	6.1	6.8	7.0	5.1	10.7	5.0	8.7	13.0	10.7	6.8	6.1	7.0	5.9	3.2	6.9	9.5	8.9	8.2	4.4	6.1	6.5	5.3	6.1	4.6	6.7	7.1	5.3	8.6	10.9	3.9	8.7	7.0	6.6	5.8	6.7	4.9	7.0	6.3	7.6	6.6	13.5	4.8	8.2	3.8	6.3	4.9	9.3	8.1	12.8	8.8	4.8	9.1	7.7	6.9	9.7	4.4	1.9	2.8	9.5	9.4	4.3	3.2	3.2	6.9	5.4	4.2	6.0	4.6	3.3	6.0	6.5	4.2	2.3	1.7	2.2	2.5	4.2	1.2	4.0	5.6	8.1	3.5	16.1	5.3	3.6	1.8	7.5	4.7	3.5	6.0	5.9	4.1	8.7	4.5	0.7	1.8	8.7	1.3	9.8	2.2	8.0	6.0	4.9	10.2	4.8	4.5	7.0	4.9	5.6	5.9	3.1	3.0	2.8	5.7	3.3	7.1	3.4	2.3	4.9	5.7	9.3	6.1	1.6	3.1	4.3	1.1	2.8	1.9	4.8	2.1	8.9	7.4	6.8	7.2	4.4	9.7	9.4	6.8	0.9	9.5	1.8	3.9	3.1	4.3	7.0	10.7	13.0	10.7	6.5	5.3	5.3	8.6	5.8	8.1
ZNF429		ENSG00000197013	"Zinc finger protein 429"	Q86V71	19	21496682-21556270	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA004139			Approved	Nucleoplasm				Nucleoplasm		"HPA004139: "	"unprognostic (1.06e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.19e-1)"	"prognostic favourable (1.96e-8)"	"prognostic favourable (7.30e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.48e-1)"	6.3	14.3	12.0	4.8	13.1	4.3	11.2	15.3	14.2	10.2	6.7	12.3	10.3	5.4	7.5	12.4	6.2	10.8	5.6	4.9	9.6	7.6	11.3	11.1	6.4	9.0	12.6	8.6	14.3	14.3	17.7	24.1	7.4	12.3	8.7	8.9	8.4	9.3	8.2	5.2	11.0	6.2	5.7	9.1	10.6	8.4	11.3	12.9	7.5	16.6	5.1	7.5	7.8	7.5	7.2	2.7	10.4	2.4	9.2	9.5	2.8	0.3	0.9	5.4	6.3	3.7	3.8	4.8	2.7	2.1	3.9	6.0	0.6	3.4	4.6	7.8	1.8	1.5	3.1	1.2	7.7	1.3	3.7	0.9	0.7	1.7	2.0	4.8	1.9	3.4	1.9	2.3	0.8	0.2	7.4	1.0	6.1	3.3	11.3	3.0	5.4	1.7	5.1	3.0	1.9	4.3	5.3	8.8	3.6	0.2	0.2	1.9	6.3	3.0	0.7	0.5	1.2	4.4	2.1	0.7	3.7	6.1	0.3	0.4	1.7	10.0	1.8	8.4	4.9	2.2	5.3	7.2	6.8	6.5	1.6	6.4	9.5	8.6	10.4	9.2	2.4	2.7	4.1	2.8	12.0	13.1	15.3	14.2	9.6	7.6	12.6	8.6	12.3	12.9
ZNF43	"HTF6, KOX27, ZNF39L1"	ENSG00000198521	"Zinc finger protein 43"	P17038	19	21804949-21852125	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 16.5;MOLT-4: 22.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA050271	Uncertain									"HPA050271: "	"unprognostic (9.25e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.16e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.47e-3)"	"unprognostic (4.45e-3)"	"prognostic favourable (3.16e-5)"	"unprognostic (2.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.43e-3)"	12.2	11.1	8.7	10.0	11.8	14.8	12.9	15.7	10.8	13.8	7.3	6.6	9.1	5.4	10.6	14.1	7.2	11.3	6.2	7.3	9.0	8.8	11.5	2.4	8.1	12.2	13.2	9.4	18.5	8.0	12.3	15.8	7.9	14.6	11.7	8.9	6.4	8.8	8.8	6.6	10.6	8.3	7.4	16.7	15.7	7.6	15.9	12.5	26.0	13.1	6.2	11.0	10.7	8.5	14.4	5.9	17.2	3.3	5.8	13.9	2.4	0.2	2.1	16.5	12.2	1.6	4.0	6.5	4.0	1.9	5.5	7.6	0.2	2.2	3.6	4.4	2.4	0.3	0.2	0.4	9.2	0.4	3.9	0.1	0.7	1.7	0.9	0.1	4.5	3.3	0.6	5.5	0.2	1.1	0.2	0.7	4.0	2.4	22.9	5.3	10.9	3.3	13.4	6.6	3.8	3.5	11.0	10.1	7.9	0.1	0.0	1.3	6.1	3.3	0.2	0.4	0.5	3.5	4.1	0.9	6.2	6.4	0.2	0.5	0.5	17.2	3.3	4.1	6.6	3.3	6.3	12.3	8.7	7.1	3.0	14.4	13.9	9.4	3.4	5.8	2.7	5.9	5.4	2.4	8.7	11.8	15.7	10.8	9.0	8.8	13.2	9.4	14.6	12.5
ZNF431	KIAA1969	ENSG00000196705	"Zinc finger protein 431"	Q8TF32	19	21142024-21196053	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA059135	Uncertain									"HPA059135: "	"unprognostic (1.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.93e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.37e-3)"	"unprognostic (4.68e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.01e-3)"	9.2	16.2	8.0	11.8	13.0	16.7	9.7	21.9	12.3	10.0	6.1	8.0	8.8	4.7	9.1	10.1	27.8	6.9	4.5	9.5	8.3	4.1	5.8	2.7	10.1	11.5	11.3	5.0	29.5	9.6	7.1	12.5	7.4	8.8	8.2	6.9	6.2	10.7	7.7	8.4	15.0	7.5	9.3	14.0	9.4	8.3	13.1	14.0	18.0	16.7	7.6	12.5	7.7	16.5	10.4	7.7	8.7	5.3	11.6	8.5	2.3	8.8	2.7	8.1	9.5	2.3	4.6	12.3	4.6	4.0	8.8	8.9	4.8	6.4	11.2	8.2	3.1	5.9	7.0	5.0	10.8	4.0	9.0	8.5	6.2	2.9	2.3	4.2	9.0	3.4	9.2	5.5	5.3	6.7	15.4	6.7	5.1	3.8	13.3	4.8	9.5	7.5	7.3	10.5	3.2	3.4	10.3	7.8	6.5	11.9	0.1	4.2	5.0	7.6	4.0	5.5	0.4	7.6	6.7	5.3	10.1	15.1	1.3	7.4	3.7	4.3	4.7	8.7	4.1	4.1	5.7	9.9	6.9	5.2	3.1	10.4	8.5	6.6	6.8	11.6	5.3	7.7	5.1	2.3	8.0	13.0	21.9	12.3	8.3	4.1	11.3	5.0	8.8	14.0
ZNF44	"KOX7, ZNF504, ZNF55, ZNF58"	ENSG00000197857	"Zinc finger protein 44"	P15621	19	12224686-12294887	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003146	Supported		Approved	Nucleoplasm,Microtubules,Cytosol				Nucleoplasm	"Microtubules, Cytosol"	"HPA003146: AB_1080723"	"unprognostic (1.51e-1)"	"unprognostic (2.47e-3)"	"unprognostic (7.07e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.63e-2)"	"prognostic favourable (8.74e-4)"	"unprognostic (8.39e-2)"	"prognostic favourable (7.54e-4)"	"unprognostic (5.65e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.75e-3)"	"unprognostic (3.56e-3)"	"unprognostic (7.30e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.69e-2)"	"prognostic favourable (9.21e-6)"	10.5	8.4	9.6	7.3	13.1	20.2	13.6	19.3	9.8	9.8	11.6	7.9	20.8	8.2	9.6	13.2	10.3	9.5	8.1	7.0	8.5	4.6	11.7	15.2	9.6	9.6	12.2	6.9	15.9	11.1	8.7	12.1	7.0	9.4	11.1	13.0	9.1	9.2	18.1	17.3	15.4	11.1	14.1	11.6	13.9	9.6	13.8	12.8	6.5	11.3	6.5	10.5	10.7	10.8	4.7	3.1	15.1	3.0	11.5	9.5	3.5	3.5	1.0	2.7	4.8	2.7	2.7	11.8	5.2	2.3	8.2	7.3	4.8	2.0	3.6	6.4	4.9	3.8	3.5	3.6	7.1	0.0	3.2	3.4	4.7	12.7	3.8	0.0	9.2	2.9	5.6	5.0	6.5	3.2	2.2	0.7	5.2	3.7	5.2	5.9	2.7	6.1	3.5	6.1	4.4	4.9	8.5	3.1	3.7	6.5	2.5	1.6	5.4	5.7	3.7	9.9	2.6	9.6	4.4	7.6	9.5	3.4	0.2	3.1	2.9	9.8	1.6	15.1	8.0	3.0	9.4	4.7	8.6	8.6	1.4	3.2	9.5	9.2	5.3	11.5	3.0	3.1	5.7	3.5	9.6	13.1	19.3	9.8	8.5	4.6	12.2	6.9	9.4	12.8
ZNF441	FLJ38637	ENSG00000197044	"Zinc finger protein 441"	Q8N8Z8	19	11767000-11784078	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA063338			Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA063338: "	"unprognostic (1.97e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.42e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.70e-3)"	7.6	5.7	7.5	10.6	15.5	1.6	11.3	18.4	11.1	9.6	6.0	4.4	9.4	4.4	8.9	12.1	5.4	7.7	6.9	7.0	7.0	6.7	12.4	8.1	6.6	9.5	5.4	7.1	16.4	6.6	12.1	13.3	8.1	11.6	11.1	6.3	6.6	6.7	9.9	13.9	6.1	7.9	10.8	4.9	8.2	5.9	5.0	5.5	7.2	13.5	3.8	8.1	11.1	7.0	4.5	1.5	2.1	3.6	2.1	4.2	1.7	2.6	0.0	3.3	2.8	4.0	4.3	3.4	6.4	3.6	4.7	4.6	2.9	0.9	5.4	3.4	4.2	2.0	2.1	3.9	5.6	0.0	2.3	2.6	2.1	4.7	3.6	0.1	4.6	5.2	4.4	3.4	2.7	2.7	4.0	0.1	7.4	0.0	5.7	1.6	0.6	4.5	2.2	6.5	1.7	3.9	4.4	2.4	3.9	4.2	1.5	2.3	4.2	5.7	1.3	10.4	2.4	9.1	4.2	5.7	8.2	2.4	0.6	0.1	4.1	0.0	1.0	2.1	2.9	0.9	2.2	3.6	2.9	3.9	1.5	4.5	3.8	4.2	1.3	2.1	3.6	1.0	2.1	1.7	7.5	15.5	18.4	11.1	7.0	6.7	5.4	7.1	11.6	5.5
ZNF442	FLJ14356	ENSG00000198342	"Zinc finger protein 442"	Q9H7R0	19	12345949-12365905	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 8.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA045738, HPA053407"	Uncertain		Approved	"Nuclear membrane,Vesicles"				"Nuclear membrane"	Vesicles	"HPA045738: AB_10968057, HPA053407: "	"unprognostic (2.61e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.52e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.99e-2)"	4.7	3.1	2.8	5.5	6.0	1.5	5.1	8.3	3.8	6.6	3.4	1.0	2.9	1.9	5.5	5.5	3.8	5.5	2.0	3.9	2.6	2.5	8.1	5.2	3.4	3.6	2.7	2.4	17.1	4.8	4.3	5.2	3.1	7.1	6.2	3.9	4.3	3.0	6.8	8.0	3.6	2.6	8.7	5.0	4.7	2.7	3.5	3.4	3.9	5.8	2.5	3.1	8.5	4.6	5.7	1.3	5.0	1.0	1.0	3.4	0.9	0.3	0.1	2.8	3.6	1.8	1.0	0.4	3.8	1.1	3.4	2.7	2.7	0.9	3.2	1.2	2.0	0.8	2.3	1.9	3.3	0.1	0.5	0.2	4.1	2.4	1.4	0.1	3.2	1.5	2.0	1.4	0.5	0.4	4.6	0.4	3.1	2.5	3.8	0.6	2.3	1.6	0.2	4.2	0.1	1.4	2.1	0.2	0.7	0.0	0.2	0.0	3.7	2.5	0.1	4.5	2.2	5.6	2.3	3.4	8.5	0.1	0.2	0.1	1.7	1.0	0.7	5.0	2.0	1.0	1.3	5.7	1.3	1.2	1.3	1.3	3.4	2.1	1.7	1.0	0.9	1.2	0.1	0.9	2.8	6.0	8.3	3.8	2.6	2.5	2.7	2.4	7.1	3.4
ZNF443	ZK1	ENSG00000180855	"Zinc finger protein 443"	Q9Y2A4	19	12429707-12441112	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA003150, HPA018683"	Approved		Approved	"Nucleoplasm,Centriolar satellite"				Nucleoplasm	"Centriolar satellite"	"HPA003150: AB_1080725, HPA018683: "	"unprognostic (5.64e-3)"	"unprognostic (1.51e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.38e-3)"	"unprognostic (3.42e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.05e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.92e-2)"	"prognostic favourable (2.74e-7)"	"unprognostic (3.85e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.19e-2)"	"prognostic favourable (3.91e-4)"	5.5	3.4	5.5	9.5	6.9	1.0	8.5	13.6	5.9	7.6	7.2	2.0	21.4	4.0	6.6	6.3	4.9	5.2	4.2	3.3	4.3	4.5	10.6	5.8	4.7	3.2	4.2	3.0	4.9	5.9	9.3	4.1	6.3	5.0	7.0	6.7	1.9	5.7	12.9	1.9	7.3	8.9	3.6	5.9	3.6	4.7	3.4	4.1	16.9	4.8	3.7	4.3	7.9	9.6	4.0	2.2	4.8	1.2	3.1	7.1	2.0	3.3	1.4	5.9	5.2	1.7	1.5	8.1	2.4	1.8	3.2	3.1	3.2	0.9	3.8	4.3	1.9	2.0	3.8	2.4	2.8	0.0	2.1	1.6	1.8	7.3	0.4	3.6	4.5	1.4	1.5	1.6	0.7	1.9	2.7	0.0	3.5	3.9	13.6	5.0	5.0	5.1	1.5	6.1	4.6	3.9	12.1	2.8	4.6	4.0	2.2	0.5	0.1	4.6	1.2	6.5	2.7	3.6	2.3	2.4	3.6	2.5	0.9	3.8	1.4	4.8	1.2	1.6	2.1	0.6	7.1	4.0	4.5	4.3	2.2	3.2	4.0	2.7	0.7	3.1	0.3	1.1	3.3	2.0	5.5	6.9	13.6	5.9	4.3	4.5	4.2	3.0	5.0	4.1
ZNF454	FLJ37444	ENSG00000178187	"Zinc finger protein 454"	Q8N9F8	5	178941191-178966433	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.6"	"Cell line enhanced"	"Detected in some"		"AF22: 2.6;EFO-21: 5.0;HHSteC: 3.8;HSkMC: 4.5;NTERA-2: 3.7;RPTEC TERT1: 2.3;SH-SY5Y: 2.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024556	Uncertain									"HPA024556: AB_1859283"	"unprognostic (1.27e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.35e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.34e-2)"	"unprognostic (9.52e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.68e-2)"	"unprognostic (8.43e-3)"	"unprognostic (2.78e-1)"	3.4	2.6	7.5	1.5	7.5	0.6	4.6	20.6	8.7	5.9	3.3	3.6	1.7	1.6	6.2	3.1	2.2	7.1	4.7	3.6	6.5	4.6	3.4	1.2	3.1	1.0	5.7	5.2	8.3	3.5	1.0	18.1	3.5	6.7	6.3	2.8	3.9	3.5	5.7	1.0	2.3	2.1	6.1	2.5	2.2	3.1	7.7	7.2	0.0	5.4	0.0	1.5	3.8	3.3	0.2	0.0	0.7	0.0	0.3	0.3	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	0.6	0.0	1.7	0.4	0.0	0.0	0.0	5.0	1.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.1	4.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.0	2.3	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.3	0.6	0.3	0.0	0.0	0.1	0.0	7.5	7.5	20.6	8.7	6.5	4.6	5.7	5.2	6.7	7.2
ZNF461	"GIOT-1, MGC33911"	ENSG00000197808	"Zinc finger protein 461"	Q8TAF7	19	36637192-36666853	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA021139	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA021139: AB_10961418"	"unprognostic (8.37e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (3.64e-4)"	"unprognostic (2.08e-2)"	"unprognostic (6.32e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.11e-1)"	"unprognostic (7.01e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.86e-2)"	"unprognostic (5.11e-3)"	6.0	8.7	8.1	5.6	12.3	6.3	7.2	13.5	12.0	7.1	5.9	8.5	4.7	1.5	10.2	7.1	5.2	7.6	5.8	5.0	6.9	7.5	6.8	5.1	5.4	6.9	7.0	8.6	10.8	4.0	7.9	12.1	8.7	8.7	6.7	4.7	5.7	4.8	6.3	4.1	5.9	5.4	8.5	7.4	7.9	5.4	8.1	9.2	5.9	10.6	3.1	7.6	6.2	7.3	3.3	2.3	1.0	2.3	2.2	6.2	1.6	2.8	5.3	4.0	5.1	2.8	6.2	2.4	3.1	3.5	4.8	6.8	0.9	1.3	0.4	6.6	4.3	0.5	2.8	3.4	5.2	5.4	3.9	4.6	0.7	1.9	4.5	3.9	5.5	3.9	6.2	1.5	4.3	3.0	0.2	0.4	4.8	3.1	6.0	1.0	2.2	2.0	0.4	3.8	0.9	1.5	6.6	4.6	6.6	0.2	2.3	4.1	2.4	1.5	3.0	2.9	3.8	1.9	3.7	8.7	12.8	1.6	0.0	0.7	3.8	0.0	0.8	1.0	2.5	2.3	3.1	2.8	4.1	6.2	2.3	3.3	3.1	2.2	0.1	2.2	0.4	0.7	3.5	1.6	8.1	12.3	13.5	12.0	6.9	7.5	7.0	8.6	8.7	9.2
ZNF468		ENSG00000204604	"Zinc finger protein 468"	"A2RRD8, Q5VIY5"	19	52838008-52890375	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 65.5"	"Cell line enhanced"	"Detected in many"		"RT4: 46.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA043696, HPA062474"	Uncertain		Uncertain	"Nucleoplasm,Cytoplasmic bodies"				Nucleoplasm	"Cytoplasmic bodies"	"HPA043696: AB_10793951, HPA062474: "	"prognostic unfavourable (6.87e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.25e-2)"	"prognostic favourable (3.94e-7)"	"unprognostic (1.04e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.59e-2)"	6.6	7.6	6.6	3.5	5.1	5.2	6.9	8.4	5.1	6.2	6.2	4.3	11.0	3.2	4.7	6.4	6.3	6.3	8.0	4.6	4.2	2.9	8.2	3.4	4.9	9.8	4.2	2.8	4.8	10.0	8.8	5.5	65.5	5.2	7.9	7.2	3.1	7.0	5.8	3.7	4.6	10.8	6.2	3.9	5.1	7.1	3.4	3.3	12.0	10.4	1.9	5.5	8.0	5.4	8.8	7.0	11.5	10.3	19.1	12.5	8.6	6.1	0.8	5.6	9.8	6.0	4.5	16.4	4.9	6.2	6.4	9.5	6.0	3.8	9.4	5.0	5.2	3.2	3.9	5.0	8.4	0.0	5.7	7.2	6.2	2.6	12.1	0.4	9.2	7.0	6.0	7.9	6.5	5.3	7.1	0.4	5.6	1.4	9.0	5.8	6.9	6.0	5.4	8.1	6.3	8.6	46.1	5.8	8.5	6.2	5.6	1.5	7.4	5.6	4.3	2.1	5.6	2.9	7.2	3.8	13.6	8.4	0.5	0.8	7.9	8.3	6.1	11.5	12.3	10.3	12.5	8.1	8.0	9.8	7.0	8.8	10.0	9.2	6.3	19.1	8.0	5.3	9.3	8.6	6.6	5.1	8.4	5.1	4.2	2.9	4.2	2.8	5.2	3.3
ZNF469	KIAA1858	ENSG00000225614	"Zinc finger protein 469"	Q96JG9	16	88427471-88440757	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 5.6;BJ hTERT+: 6.1;HeLa: 5.5;SiHa: 6.6;THP-1: 8.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.5"					"Low region specificity"	"Detected in many"			HPA069784			Approved	Vesicles				Vesicles		"HPA069784: "	"unprognostic (1.80e-1)"	"unprognostic (7.79e-3)"	"unprognostic (7.71e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.17e-3)"	"unprognostic (7.08e-3)"	"unprognostic (5.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.71e-7)"	"unprognostic (2.24e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.34e-2)"	1.8	0.8	2.5	2.3	2.2	0.1	0.7	0.0	2.2	4.3	0.2			0.4	2.9	0.0	0.2	1.3	2.6	0.4	2.5	1.6	0.0	0.1	0.5	1.3	1.6		4.3	0.8	0.0	0.0	0.5		1.3	0.0		0.6	0.8	1.5	0.2	0.8	2.1	1.6	1.9	0.9	0.3			0.0		0.5	1.7	0.4	0.1	1.5	0.0	0.3	0.0	0.2	0.0	0.0	5.6	0.2	0.0	0.9	1.3	0.0	3.5	6.1	0.8	0.1	0.0	0.2	0.0	0.1	4.7	0.1	0.0	0.0	0.1	0.0	0.0	0.2	5.5	0.0	4.1	0.2	0.1	1.3	0.0	1.4	0.0	3.7	0.0	0.0	1.0	0.5	0.0	0.9	0.7	4.6	0.4	0.0	0.0	0.0	0.0	0.0	2.9	6.6	0.0	0.0	1.2	8.4	4.4	5.0	1.3	2.7	0.9	0.0	0.0	0.0	0.0	1.2	0.5	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0										
ZNF470	"CZF-1, FLJ26175"	ENSG00000197016	"Zinc finger protein 470"	Q6ECI4	19	56567511-56588911	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA029000	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA029000: AB_10603843"	"unprognostic (1.40e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.91e-2)"	"unprognostic (9.21e-4)"	"unprognostic (3.46e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.45e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.76e-3)"	"unprognostic (2.88e-3)"	4.6	6.5	11.7	2.9	10.6	1.4	5.3	12.7	12.1	6.3	4.8	5.5	1.3	2.8	5.7	8.8	4.3	5.8	5.1	5.4	12.4	11.7	6.7	8.6	5.1	3.6	11.8	9.4	7.2	4.5	9.3	7.2	4.6	9.8	7.0	3.4	5.8	3.8	6.9	3.0	5.1	3.1	5.4	11.6	4.4	3.6	8.3	9.9	3.6	6.8	1.2	4.6	4.6	5.2	3.2	2.0	2.9	1.0	2.3	4.4	0.9	0.0	1.7	6.4	2.7	3.5	3.2	5.4	3.1	1.1	2.3	4.5	0.4	1.5	0.0	2.0	3.3	0.1	2.7	1.3	2.6	0.0	13.2	5.6	0.1	0.4	3.1	1.2	6.6	3.8	2.0	2.6	0.8	1.5	0.1	0.1	3.5	0.1	1.2	2.0	5.4	0.7	0.2	4.7	0.9	2.7	4.0	2.4	6.3	0.1	0.5	0.9	2.0	3.4	1.1	0.2	2.7	2.2	4.1	2.0	2.8	0.2	0.0	3.5	1.0	1.3	0.8	2.9	2.2	0.6	4.4	2.5	1.9	1.3	1.4	3.2	3.0	3.0	2.2	2.3	1.0	2.0	1.5	0.9	11.7	10.6	12.7	12.1	12.4	11.7	11.8	9.4	9.8	9.9
ZNF471	"KIAA1396, Z1971"	ENSG00000196263	"Zinc finger protein 471"	Q9BX82	19	56507843-56530221	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 10.9;U-138 MG: 9.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066695	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA066695: "	"unprognostic (2.89e-2)"	"unprognostic (2.79e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.47e-4)"	"unprognostic (9.36e-2)"	"prognostic favourable (2.37e-4)"	"unprognostic (3.84e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.89e-2)"	"unprognostic (3.44e-3)"	5.8	7.2	18.5	4.1	18.5	3.0	7.8	23.1	19.3	7.8	8.2	11.2	5.9	2.1	14.2	17.8	5.4	9.8	7.4	5.8	17.4	7.5	5.5	2.6	6.2	3.2	12.2	13.3	24.7	3.9	16.3	10.9	6.6	15.1	9.3	5.1	4.6	6.5	8.5	4.9	10.1	3.2	10.4	11.5	4.6	4.5	8.7	21.3	1.6	10.6	3.1	2.2	6.7	9.9	3.1	1.6	5.4	1.3	3.0	2.1	0.3	0.6	0.6	6.2	0.9	5.2	5.8	0.7	5.6	2.0	2.6	2.3	0.9	0.9	0.9	3.8	6.0	0.5	0.8	0.5	2.6	1.3	2.3	4.4	1.5	0.7	5.1	1.3	4.0	10.9	2.0	3.3	0.3	0.2	1.4	2.0	2.9	0.7	0.5	0.8	1.6	2.4	0.7	4.0	0.6	4.5	4.7	1.0	3.7	0.6	0.3	0.3	0.8	0.9	0.9	9.7	4.2	1.0	4.2	1.5	1.3	0.6	0.8	0.7	0.7	3.9	1.3	0.9	1.9	1.0	1.5	1.2	1.7	1.2	0.7	3.1	1.7	2.1	5.4	3.0	1.0	1.6	1.0	0.3	18.5	18.5	23.1	19.3	17.4	7.5	12.2	13.3	15.1	21.3
ZNF485		ENSG00000198298	"Zinc finger protein 485"	Q8NCK3	10	43606407-43617903	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA059356	Uncertain									"HPA059356: "	"prognostic unfavourable (5.24e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.40e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-3)"	"unprognostic (4.12e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.46e-6)"	"unprognostic (8.45e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.41e-2)"	4.6	4.7	5.6	4.9	7.6	1.8	8.8	5.3	7.7	4.4	4.8	6.5	3.4	4.0	6.1	4.5	5.8	6.6	3.8	3.6	6.1	4.2	3.6	5.1	3.1	7.1	8.9	6.7	9.6	12.9	4.6	3.6	2.5	8.0	6.5	5.1	3.6	6.1	4.7	8.5	9.1	4.6	7.7	6.8	6.2	5.6	17.4	5.8	2.9	4.6	3.6	7.8	4.8	4.7	5.4	2.3	0.8	3.3	12.9	9.3	3.1	3.2	2.5	2.1	7.6	4.0	4.8	0.2	3.9	1.1	3.9	6.1	6.6	5.1	11.3	3.8	1.5	3.5	4.4	3.7	7.1	4.5	3.5	0.1	3.1	3.2	3.1	1.9	5.6	3.4	5.9	2.7	5.1	1.7	10.4	0.2	8.5	5.4	5.6	5.5	10.4	3.1	3.1	1.4	2.7	3.9	3.3	7.6	5.8	1.8	6.3	2.3	9.9	3.9	2.3	3.0	4.7	4.8	6.1	8.0	8.2	2.4	0.7	2.9	3.0	0.1	1.8	0.8	4.3	3.3	6.6	5.4	5.4	4.6	2.3	5.0	9.3	5.7	0.3	12.9	1.1	1.5	4.3	3.1	5.6	7.6	5.3	7.7	6.1	4.2	8.9	6.7	8.0	5.8
ZNF500	"KIAA0557, ZKSCAN18, ZSCAN50"	ENSG00000103199	"Zinc finger protein 500"	O60304	16	4748239-4767624	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA035498, HPA057963"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA035498: AB_10602356, HPA057963: "	"unprognostic (3.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.61e-3)"	"unprognostic (8.72e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.10e-2)"	"prognostic favourable (3.41e-4)"	"unprognostic (8.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.19e-2)"	8.1	6.4	10.2	9.4	7.5	5.9	8.1	13.8	11.4	10.3	8.0	11.7	11.5	8.4	12.2	10.9	6.2	8.9	10.4	6.0	6.2	5.1	6.0	5.2	7.2	12.5	6.6	9.4	13.9	8.5	9.1	8.0	6.7	6.6	9.3	5.3	10.6	11.3	14.9	7.5	8.5	7.5	7.5	5.4	11.4	7.7	7.2	8.4	9.9	9.2	7.1	8.3	9.2	8.4	5.3	6.5	3.4	2.5	3.0	4.9	2.1	2.0	8.4	2.8	7.3	3.3	3.0	12.8	6.1	6.7	7.6	5.2	3.7	4.0	4.4	5.3	3.3	4.7	5.8	3.2	5.6	3.2	8.8	3.6	10.6	4.9	4.7	2.5	4.0	3.5	7.8	3.4	6.5	4.3	5.3	7.0	3.0	4.6	5.2	4.4	3.6	3.0	9.3	6.7	8.7	2.5	2.4	10.4	6.8	5.2	7.9	2.3	5.1	4.1	4.8	7.2	5.5	8.0	2.9	6.7	4.5	3.9	2.2	2.1	4.5	2.3	2.5	3.4	3.9	2.4	3.3	4.9	2.5	3.0	1.4	5.3	4.2	4.9	2.9	3.0	1.7	6.5	3.9	2.1	10.2	7.5	13.8	11.4	6.2	5.1	6.6	9.4	6.6	8.4
ZNF501	"MGC21738, ZNF52"	ENSG00000186446	"Zinc finger protein 501"	Q96CX3	3	44729596-44737083	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 6.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA044161	Uncertain		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA044161: "	"unprognostic (8.89e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.25e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.81e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.48e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.02e-2)"	5.6	2.8	6.8	3.6	8.3	1.3	8.5	11.7	8.0	7.0	6.2	7.5	4.7	2.6	7.5	4.0	4.7	7.3	4.5	5.6	7.3	4.8	5.0	2.3	4.7	6.8	5.9	6.7	10.0	5.3	2.7	5.7	5.9	4.9	8.1	4.1	3.6	4.9	7.3	5.3	4.4	3.6	8.0	6.3	4.9	4.4	6.7	9.8	4.2	6.6	3.4	4.3	7.2	7.2	3.4	1.1	2.9	1.1	2.7	3.5	1.2	0.0	0.0	2.1	0.0	3.9	6.7	0.8	2.4	2.2	2.6	2.9	0.9	0.9	1.8	0.0	1.1	0.7	0.0	0.9	2.4	0.0	1.2	0.0	0.2	1.7	5.3	0.0	0.0	3.9	2.5	2.9	0.2	1.6	0.0	0.0	0.7	0.0	0.8	0.1	4.9	0.0	1.3	0.0	1.0	2.2	1.4	2.6	1.7	1.4	1.5	1.0	0.1	0.1	0.9	0.1	2.3	2.4	1.9	4.2	2.6	0.0	0.1	0.0	3.0	2.0	0.7	2.9	2.4	0.9	3.3	2.9	2.3	2.6	1.1	3.4	3.5	2.4	1.1	2.7	1.1	1.0	2.3	1.2	6.8	8.3	11.7	8.0	7.3	4.8	5.9	6.7	4.9	9.8
ZNF510	KIAA0972	ENSG00000081386	"Zinc finger protein 510"	Q9Y2H8	9	96755865-96778129	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049139	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA049139: "	"unprognostic (2.70e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.50e-3)"	"unprognostic (3.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.34e-2)"	"prognostic favourable (5.94e-4)"	"unprognostic (1.02e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.18e-2)"	9.1	9.2	10.9	6.5	15.7	5.7	12.7	23.0	13.9	14.4	8.8	6.3	11.6	4.6	11.5	8.1	7.9	10.7	6.5	7.4	11.5	10.3	8.9	8.5	8.4	11.4	8.6	12.3	14.9	10.7	13.5	19.8	6.9	10.1	12.6	9.3	5.2	7.5	11.2	9.2	6.2	6.8	11.3	9.2	10.1	6.8	8.2	9.1	14.9	11.2	4.3	13.3	13.9	10.7	5.9	1.3	3.8	2.9	6.4	7.7	2.1	5.0	5.2	11.4	8.5	9.7	9.1	5.9	5.7	11.4	9.6	8.5	4.8	3.8	6.6	3.0	6.0	11.1	3.3	5.3	8.6	10.7	5.4	9.4	9.6	2.4	5.8	3.6	6.2	7.9	7.2	8.2	10.3	9.2	9.5	6.5	9.4	4.6	10.4	4.7	8.1	5.2	6.8	18.6	3.2	5.0	4.9	11.8	9.5	11.1	5.2	5.6	3.8	6.8	8.1	6.2	5.9	6.9	6.6	11.3	11.9	4.9	3.5	2.5	6.2	2.3	1.2	3.8	3.8	1.9	7.7	3.6	5.0	3.0	1.0	5.9	5.7	5.2	0.4	6.4	2.9	1.3	7.1	2.1	10.9	15.7	23.0	13.9	11.5	10.3	8.6	12.3	10.1	9.1
ZNF514	FLJ14457	ENSG00000144026	"Zinc finger protein 514"	Q96K75	2	95147330-95165413	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028974	Approved		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA028974: AB_10603845"	"unprognostic (8.79e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.79e-2)"	7.1	7.6	7.8	5.1	16.4	1.7	12.7	14.9	12.9	10.4	10.5	15.7	12.0	9.4	15.0	27.1	8.1	11.5	6.7	8.4	14.2	8.4	9.8	5.0	8.4	7.0	17.0	9.9	20.6	9.6	12.5	23.5	7.9	11.5	12.1	9.6	10.1	11.5	11.6	12.0	11.6	9.4	10.6	12.5	8.9	10.0	19.8	18.0	14.0	15.2	10.3	7.8	8.9	10.9	7.7	5.2	10.4	5.3	6.4	11.3	5.5	14.6	5.2	13.7	9.1	10.3	13.7	10.5	5.8	6.2	9.3	10.0	7.6	5.5	2.3	2.9	6.2	8.9	7.2	5.4	10.7	4.8	9.6	2.7	6.9	6.2	4.3	1.5	7.4	8.3	16.4	5.9	4.2	4.6	7.5	2.7	7.3	7.0	3.9	7.4	4.6	5.1	7.1	4.8	5.2	6.3	6.2	12.8	9.3	6.1	3.0	6.2	5.6	5.4	4.8	6.7	9.2	2.2	4.7	7.8	5.7	3.8	7.4	3.1	4.4	10.4	5.3	9.9	5.1	2.6	6.1	7.3	6.8	4.8	5.2	7.7	11.3	9.2	1.5	6.4	3.0	4.1	7.1	5.5	7.8	16.4	14.9	12.9	14.2	8.4	17.0	9.9	11.5	18.0
ZNF517		ENSG00000197363	"Zinc finger protein 517"	Q6ZMY9	8	144798876-144811169	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA055337			Approved	Nucleoplasm				Nucleoplasm		"HPA055337: "	"unprognostic (9.54e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.83e-2)"	"unprognostic (9.64e-2)"	"prognostic favourable (1.66e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.57e-2)"	2.9	6.5	5.3	3.1	4.5	1.5	8.5	7.3	8.6	3.3	3.0	2.7	5.3	3.6	5.6	3.1	3.2	4.1	3.2	5.8	6.8	3.2	3.9	3.2	4.6	6.5	5.6	6.1	7.5	3.8	4.5	3.9	4.4	4.2	3.7	0.5	5.4	6.9	1.9	9.6	10.5	4.5	1.4	4.1	4.3	3.6	3.6	4.4	3.0	4.1	1.4	1.4	4.1	2.8	4.1	1.1	0.5	2.4	1.4	2.2	1.2	2.0	3.8	6.4	6.2	1.0	1.9	3.4	1.8	0.5	0.4	0.3	1.3	2.3	1.1	4.5	0.6	2.1	0.2	0.7	0.9	4.5	1.7	2.6	2.0	13.7	2.4	0.6	2.7	1.4	1.6	0.3	1.3	1.4	3.0	1.8	1.1	3.3	2.6	1.6	4.5	4.3	3.8	1.9	0.9	0.6	2.5	2.8	8.2	5.2	2.1	1.9	5.3	2.4	1.8	4.4	6.7	2.2	1.8	2.9	0.5	0.8	4.7	1.1	3.5	0.4	1.2	0.0	1.8	2.4	1.5	4.1	1.7	1.2	1.1	0.7	1.4	1.2	0.5	1.4	1.4	0.5	2.2	1.2	5.3	4.5	7.3	8.6	6.8	3.2	5.6	6.1	4.2	4.4
ZNF519	"FLJ36809, HsT2362"	ENSG00000175322	"Zinc finger protein 519"	Q8TB69	18	14057457-14132490	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA028982	Uncertain		Approved	Nucleoli				Nucleoli		"HPA028982: AB_10610705"	"unprognostic (1.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-5)"	"unprognostic (1.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.65e-4)"	1.8	1.4	2.8	1.9	7.6	1.4	2.8	13.7	14.4	5.7	4.6	0.7	0.8	1.2	7.0	2.6	3.4	4.5	1.8	1.9	3.4	1.6	0.8	1.0	2.7	6.6	1.7	4.0	8.7	1.2	1.1	1.5	1.2	3.0	2.6	2.6	2.0	1.6	2.7	1.0	2.0	2.1	6.0	2.1	2.2	1.4	3.0	2.5	1.1	2.0	0.9	1.9	4.3	3.8	1.7	0.1	0.0	0.6	0.5	3.5	0.7	1.3	0.3	5.9	6.2	0.8	1.2	1.6	1.6	0.9	3.5	3.1	2.6	1.2	3.1	1.6	1.2	0.9	4.8	1.2	4.0	1.8	3.3	5.4	1.7	1.1	0.2	11.1	2.4	0.6	1.5	2.8	1.2	0.6	2.7	4.6	2.0	1.8	6.7	4.4	2.6	1.4	7.2	5.7	3.8	0.9	1.8	9.1	2.4	2.3	0.7	1.8	0.7	3.0	0.4	5.6	7.5	2.5	1.8	1.8	1.2	4.5	1.8	4.3	4.7	0.0	0.3	0.0	1.1	0.6	1.8	1.7	1.4	1.5	0.1	0.8	3.5	2.2	0.0	0.5	0.5	0.1	2.0	0.7	2.8	7.6	13.7	14.4	3.4	1.6	1.7	4.0	3.0	2.5
ZNF527	KIAA1829	ENSG00000189164	"Zinc finger protein 527"	Q8NB42	19	37371061-37393066	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA037740, HPA037741"	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"				"Nuclear speckles"	"Golgi apparatus"	"HPA037740: AB_10672284, HPA037741: "	"unprognostic (4.36e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.26e-2)"	"unprognostic (8.70e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.05e-4)"	"unprognostic (8.34e-3)"	"unprognostic (8.92e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.17e-4)"	6.0	6.3	6.7	4.7	10.2	6.6	8.5	10.2	13.0	7.8	6.8	9.3	2.7	3.4	9.6	6.0	5.5	6.1	4.3	7.1	8.0	5.7	7.3	5.9	5.2	7.2	6.8	9.1	10.8	6.4	10.2	13.5	5.4	9.8	6.9	7.4	8.2	5.8	7.6	10.1	5.0	5.0	9.5	5.8	6.7	5.1	7.2	7.5	6.7	7.6	4.8	7.3	6.9	7.2	6.3	2.6	6.8	2.5	4.7	6.8	3.9	3.9	4.3	3.9	4.7	4.0	6.8	2.3	4.0	3.5	4.0	5.1	3.5	0.9	3.5	4.9	3.8	1.1	6.7	3.6	4.9	6.7	2.7	4.3	4.6	0.9	4.7	7.1	4.7	4.8	3.9	4.6	8.0	3.5	1.8	2.5	4.3	1.4	5.5	1.6	2.2	1.5	4.5	6.0	4.8	2.6	3.8	5.0	2.7	6.2	2.0	2.0	4.6	4.8	5.0	5.0	4.4	3.7	4.5	7.1	9.1	10.2	0.0	4.9	3.2	2.7	1.6	6.8	6.5	2.5	5.5	6.3	4.0	5.9	2.6	5.4	6.4	6.8	0.8	4.7	1.4	2.4	4.2	3.9	6.7	10.2	10.2	13.0	8.0	5.7	6.8	9.1	9.8	7.5
ZNF528	KIAA1827	ENSG00000167555	"Zinc finger protein 528"	Q3MIS6	19	52397849-52418412	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 24.3;U-266/84: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA065435			Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA065435: "	"unprognostic (1.90e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.26e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.60e-3)"	9.8	11.7	16.6	8.9	20.2	5.8	12.2	21.1	21.4	12.4	9.1	15.7	7.9	5.5	15.3	21.7	10.0	15.6	11.4	11.4	15.3	11.2	11.1	5.2	9.3	9.3	17.5	11.4	21.3	6.4	12.7	21.0	10.9	15.3	13.4	10.0	13.3	12.8	12.1	7.6	12.6	7.5	9.8	15.6	11.8	10.0	13.8	22.0	8.2	19.9	5.1	11.5	12.6	10.8	10.5	8.4	10.6	5.0	16.5	12.7	3.4	0.1	0.0	2.9	17.5	6.8	8.4	7.4	6.5	10.8	4.0	9.0	0.2	3.2	0.1	1.6	8.0	2.0	0.0	4.3	5.1	0.0	4.8	2.7	1.0	1.6	10.0	0.1	7.4	8.5	7.5	4.4	0.0	9.5	1.7	0.3	5.8	0.1	9.8	1.4	7.6	4.6	0.1	11.8	3.1	4.9	24.3	12.2	10.1	0.0	0.5	4.1	11.7	1.5	10.9	7.0	8.1	2.7	8.8	0.3	30.6	5.9	3.5	0.1	10.8	7.1	5.0	10.6	6.7	4.7	12.7	7.3	8.1	10.0	5.0	10.5	8.0	7.1	1.4	16.5	5.0	8.4	8.9	3.4	16.6	20.2	21.1	21.4	15.3	11.2	17.5	11.4	15.3	22.0
ZNF530	KIAA1508	ENSG00000183647	"Zinc finger protein 530"	Q6P9A1	19	57599885-57612722	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"HEK 293: 37.0;U-266/84: 26.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA045868	Uncertain		Approved	Vesicles				Vesicles		"HPA045868: "	"unprognostic (1.57e-1)"	"unprognostic (3.02e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.80e-2)"	"unprognostic (9.69e-3)"	"unprognostic (4.98e-3)"	"unprognostic (3.19e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.06e-1)"	3.2	3.5	6.3	4.7	6.9	7.0	4.4	12.4	7.1	2.5	2.6	2.6	1.4	2.7	2.9	5.3	2.3	2.0	3.1	11.0	5.1	4.4	3.2	2.3	4.6	7.6	5.8	4.0	2.4	4.1	3.2	2.0	3.4	3.3	4.0	2.3	4.5	3.7	3.9	14.6	4.7	2.6	2.1	4.1	5.4	4.6	3.6	3.5	7.2	2.5	2.7	5.6	3.6	2.5	6.5	3.6	3.5	3.1	5.6	6.5	3.4	3.2	2.9	2.1	1.8	0.1	1.0	3.4	2.0	0.8	3.4	1.9	2.0	0.5	0.4	1.6	0.7	1.0	1.7	1.4	3.7	0.1	37.0	6.4	5.4	1.2	0.2	2.3	3.1	0.7	0.8	3.2	0.9	0.7	0.8	1.6	1.1	1.2	3.3	1.8	3.2	7.0	0.4	6.8	3.1	0.6	5.5	2.5	2.3	2.3	0.6	0.6	1.5	3.6	1.0	4.3	2.7	0.9	4.0	7.4	26.9	4.4	2.6	2.5	2.9	1.9	3.1	1.8	6.3	1.9	5.0	6.5	4.3	6.5	3.6	5.8	5.9	4.8	3.5	5.6	2.1	3.5	5.6	3.4	6.3	6.9	12.4	7.1	5.1	4.4	5.8	4.0	3.3	3.5
ZNF547	FLJ31100	ENSG00000152433	"Zinc finger protein 547"	Q8IVP9	19	57363477-57379565	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA056001	Uncertain									"HPA056001: "	"unprognostic (9.21e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.23e-3)"	"unprognostic (4.39e-5)"	"unprognostic (7.16e-4)"	"unprognostic (4.45e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.62e-4)"	6.6	9.0	7.6	5.5	10.3	3.1	8.9	21.3	9.0	4.6	5.1	3.1	6.2	3.4	4.2	11.7	5.7	5.8	7.1	14.6	9.7	8.9	6.3	4.7	6.3	7.9	6.8	7.6	7.6	7.1	9.9	11.9	9.0	9.7	8.3	5.8	4.4	6.4	9.1	11.9	13.3	5.1	5.7	7.9	10.8	5.3	17.3	4.8	6.5	10.5	8.9	11.4	8.1	4.7	9.4	4.8	5.1	4.8	4.8	5.2	2.6	1.3	1.5	4.5	5.8	5.4	2.4	2.1	3.3	4.2	3.1	7.9	1.5	0.8	3.6	2.1	1.7	0.9	2.7	1.4	4.8	0.9	12.4	2.5	5.5	3.1	1.5	2.2	5.5	2.5	5.8	1.8	3.9	1.7	0.5	0.1	5.3	0.1	3.8	1.5	2.0	3.6	1.7	5.1	0.9	2.4	5.9	4.2	3.1	2.2	0.6	1.7	2.4	3.5	5.2	5.7	1.8	2.1	3.0	2.5	1.3	2.2	2.5	1.4	2.9	5.1	3.3	2.5	2.4	4.8	5.2	9.4	3.7	3.5	3.7	5.9	4.8	3.7	2.2	4.8	2.7	4.8	1.9	2.6	7.6	10.3	21.3	9.0	9.7	8.9	6.8	7.6	9.7	4.8
ZNF556	FLJ11637	ENSG00000172000	"Zinc finger protein 556"	Q9HAH1	19	2867335-2883445	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.6;brain: 22.3;ovary: 11.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.1;HBEC3-KT: 7.6;Hep G2: 11.8;RH-30: 17.6;THP-1: 6.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	16	"cerebellum: 22.3"	"Cell type enriched"	"Detected in some"	11	"plasmacytoid DC: 14.6"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 14.6"									HPA060593			Approved	Nucleoplasm				Nucleoplasm		"HPA060593: "	"unprognostic (1.36e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.23e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.14e-4)"	"unprognostic (2.85e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.26e-3)"	"unprognostic (5.54e-3)"	0.3	0.2	0.5	0.3	0.5	1.0	0.5	22.3	0.5	0.7	0.3	0.0	1.7	0.1	1.6	0.7	3.1	4.2	0.8	0.2	0.4	0.3	2.6	0.1	0.4	0.3	0.4	0.1	11.3	2.6	0.4	1.6	0.8	1.3	0.4	0.1	0.1	1.0	0.1	4.5	0.7	0.2	0.3	0.5	0.3	0.3	3.5	0.0	0.6	0.2	8.7	0.9	0.2	0.2	0.4	14.6	1.2	0.2	0.6	0.2	0.1	1.8	0.3	0.0	3.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	7.1	0.1	2.3	1.2	0.1	0.1	0.0	7.6	0.0	0.1	0.0	0.1	3.1	11.8	0.1	0.2	3.7	0.6	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.2	0.0	0.1	0.0	17.6	1.5	0.0	0.3	0.1	2.9	0.0	0.3	0.0	3.6	6.4	0.0	0.1	0.1	4.6	0.1	2.1	3.8	0.1	0.2	0.1	0.1	1.2	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.4	0.2	0.2	1.2	0.6	0.1	14.6	0.1	0.1	0.5	0.5	22.3	0.5	0.4	0.3	0.4	0.1	1.3	0.0
ZNF557	MGC4054	ENSG00000130544	"Zinc finger protein 557"	Q8N988	19	7069444-7087968	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA003151, HPA029291"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"				"Nucleoplasm, Intermediate filaments"	Cytosol	"HPA003151: AB_1859344, HPA029291: AB_10602357"	"unprognostic (1.05e-1)"	"unprognostic (2.96e-3)"	"unprognostic (5.29e-2)"	"prognostic favourable (5.70e-4)"	"unprognostic (2.56e-2)"	"prognostic favourable (3.67e-6)"	"unprognostic (1.32e-1)"	"prognostic favourable (2.62e-4)"	"unprognostic (2.51e-2)"	"unprognostic (2.51e-2)"	"prognostic favourable (1.51e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.52e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.81e-3)"	6.8	9.2	7.2	8.1	9.4	13.1	8.5	12.4	9.9	7.0	6.5	11.1	7.2	5.1	9.5	7.7	8.7	8.5	6.0	5.5	5.9	5.6	6.9	10.3	6.8	9.7	7.6	8.1	9.8	9.0	7.0	12.9	6.7	9.2	7.5	6.4	7.2	9.2	10.5	5.3	7.2	7.6	7.6	6.7	11.7	8.0	8.4	9.8	21.7	9.0	4.0	11.3	7.0	7.1	10.7	11.1	9.3	6.7	13.7	11.5	4.0	3.6	4.4	4.0	8.2	6.3	4.6	3.3	3.8	4.9	5.1	6.8	5.0	2.5	7.0	6.8	4.7	4.9	7.9	5.1	4.8	9.0	4.8	10.1	7.8	2.6	4.4	10.1	10.8	6.1	5.9	5.5	7.5	4.7	4.1	12.6	7.4	5.3	7.8	3.1	3.9	6.2	5.5	6.0	4.2	3.2	9.4	4.7	5.8	5.7	4.2	4.4	3.5	6.2	6.9	4.4	3.2	8.5	4.1	12.0	9.2	6.7	4.8	5.4	3.4	9.3	6.7	8.6	9.5	5.5	10.6	7.6	10.3	8.6	7.2	10.7	11.5	9.6	7.4	13.7	5.2	11.1	9.3	4.0	7.2	9.4	12.4	9.9	5.9	5.6	7.6	8.1	9.2	9.8
ZNF560	FLJ31986	ENSG00000198028	"Zinc finger protein 560"	Q96MR9	19	9466507-9498607	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"testis: 21.1"	"Group enriched"	"Detected in some"	5	"HEL: 17.9;HMC-1: 4.4;NTERA-2: 17.9"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045439, HPA074438"			Enhanced	"Nucleoplasm,Nuclear speckles"				Nucleoplasm	"Nuclear speckles"	"HPA045439: , HPA074438: "	"unprognostic (4.43e-3)"			"unprognostic (8.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.43e-2)"		"unprognostic (1.17e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.57e-3)"	"unprognostic (6.33e-5)"	"unprognostic (5.60e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.15e-3)"	"unprognostic (1.65e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.4	2.6	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	21.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.8	2.4	0.0	1.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	1.0	17.9	0.0	0.0	1.3	0.0	4.4	2.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0
ZNF562	FLJ20079	ENSG00000171466	"Zinc finger protein 562"	Q6V9R5	19	9641808-9675086	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA055332, HPA062397"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA055332: , HPA062397: "	"unprognostic (2.14e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.02e-2)"	"prognostic favourable (4.17e-4)"	"unprognostic (4.44e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.62e-3)"	"unprognostic (9.44e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.13e-3)"	12.3	11.2	13.9	11.3	15.8	11.6	21.4	20.5	15.2	11.8	15.0	13.5	20.9	9.8	14.6	10.9	26.1	12.0	12.1	11.4	13.4	10.9	11.1	12.2	12.9	10.2	14.9	11.9	13.7	15.5	13.8	22.6	11.1	14.3	13.1	15.0	9.0	15.7	23.4	7.0	12.9	10.6	15.1	16.1	14.0	11.5	6.3	16.8	10.9	11.8	9.4	13.3	16.6	14.5	6.4	8.5	5.5	9.6	6.5	7.9	2.6	8.2	6.5	9.5	17.5	5.7	4.6	0.5	7.8	6.0	8.6	8.9	4.8	4.5	7.4	8.0	6.2	6.3	11.5	9.6	11.3	8.6	9.0	27.1	6.6	5.0	5.7	9.9	20.2	8.1	7.0	10.9	18.2	9.1	13.1	13.2	8.1	4.1	9.8	2.9	12.1	4.6	3.9	10.4	3.8	4.0	21.7	10.4	6.7	12.5	5.1	6.2	7.3	8.4	8.5	16.2	5.5	7.4	10.4	11.6	25.4	12.4	2.2	0.6	7.9	4.1	6.2	5.5	7.0	9.6	7.9	6.3	5.6	4.3	8.5	6.4	5.8	7.1	2.4	6.5	9.2	5.1	4.0	2.6	13.9	15.8	20.5	15.2	13.4	10.9	14.9	11.9	14.3	16.8
ZNF563	FLJ34797	ENSG00000188868	"Zinc finger protein 563"	Q8TA94	19	12317477-12333720	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 5.5;T-cells: 11.6"									HPA042136	Uncertain									"HPA042136: AB_10795395"	"unprognostic (1.40e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.81e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.16e-4)"	"unprognostic (1.02e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-3)"	"unprognostic (9.90e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.18e-2)"	4.6	5.4	5.6	7.7	7.9	2.1	6.9	7.5	6.0	5.5	3.7	3.6	6.2	2.5	4.5	6.2	4.7	5.7	4.1	7.3	6.4	2.2	8.7	17.2	3.6	4.6	4.8	4.8	6.4	4.0	4.9	9.3	2.2	5.4	8.5	4.0	3.8	4.9	7.1	3.5	6.8	4.0	4.3	4.6	4.4	3.2	22.6	7.2	6.1	9.1	2.0	5.1	5.8	6.4	5.5	1.7	1.1	1.4	1.6	11.6	2.6	2.4	0.3	0.9	3.4	3.4	2.3	0.3	2.9	5.4	3.4	5.4	3.0	0.9	5.5	3.0	3.5	1.9	2.8	6.7	3.2	0.1	0.5	0.7	0.5	11.8	3.0	0.5	3.6	3.9	4.9	3.6	2.3	0.1	1.1	1.3	3.1	1.6	3.1	1.1	1.4	2.3	0.2	2.6	0.2	3.9	3.4	0.9	1.6	0.3	0.7	0.4	2.3	0.3	0.4	5.4	1.0	6.4	1.7	5.6	4.3	0.4	1.0	0.5	2.0	0.7	1.3	0.8	3.4	1.3	2.0	3.8	5.8	3.1	1.6	5.5	11.6	6.5	1.1	1.6	1.4	1.7	4.5	2.6	5.6	7.9	7.5	6.0	6.4	2.2	4.8	4.8	5.4	7.2
ZNF565	FLJ36991	ENSG00000196357	"Zinc finger protein 565"	Q8N9K5	19	36182060-36246257	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA044123	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA044123: AB_10794395"	"unprognostic (1.51e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.46e-3)"	"unprognostic (6.08e-3)"	"unprognostic (7.97e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.49e-3)"	"unprognostic (3.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.93e-4)"	5.9	5.7	12.1	4.2	11.6	7.1	7.1	10.4	12.8	5.7	5.2	16.8	4.8	4.4	7.1	6.5	5.2	6.7	4.8	5.3	8.0	7.7	5.5	6.2	4.6	4.4	17.3	10.1	11.1	5.7	4.9	7.5	4.6	12.1	7.0	5.8	4.1	8.0	5.6	7.8	6.6	4.1	6.2	17.3	4.5	6.1	13.5	14.9	2.3	6.8	3.5	5.7	6.6	8.4	2.1	3.6	13.8	3.7	3.1	4.5	2.3	3.8	5.5	6.6	4.6	10.4	6.9	1.8	3.8	6.3	4.6	7.9	3.2	3.4	2.9	5.0	4.9	2.3	3.3	2.8	7.3	5.0	1.5	5.3	4.7	4.2	4.4	3.5	3.7	8.1	8.0	3.0	8.0	5.5	3.5	3.6	5.6	4.9	4.2	0.9	2.6	2.6	3.6	3.9	2.9	4.6	5.2	5.3	5.5	3.1	3.6	3.5	2.5	3.8	4.5	6.6	3.8	4.8	5.5	1.1	1.8	1.9	6.3	2.9	3.2	13.8	3.1	4.8	3.5	3.2	3.8	2.1	4.0	3.4	3.6	2.1	4.5	3.5	1.5	3.1	3.7	1.9	2.0	2.3	12.1	11.6	10.4	12.8	8.0	7.7	17.3	10.1	12.1	14.9
ZNF568	DKFZp686B0797	ENSG00000198453	"Zinc finger protein 568"	Q3ZCX4	19	36916329-36998700	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA024541, HPA052061"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA024541: , HPA052061: "	"unprognostic (3.62e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.83e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.05e-5)"	"unprognostic (2.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.06e-3)"	"unprognostic (9.98e-3)"	6.9	11.3	11.8	5.6	14.7	5.9	9.2	30.4	13.4	11.3	7.3	10.5	6.3	4.5	12.3	8.1	5.9	10.3	5.6	8.9	11.5	13.0	7.8	5.5	6.9	6.5	15.0	9.8	16.3	6.8	14.4	24.6	8.4	13.7	8.5	5.0	8.1	8.6	9.0	8.5	6.8	5.2	10.6	13.0	9.3	7.0	9.5	16.3	6.4	13.2	7.6	7.0	7.6	7.3	8.7	3.0	12.8	2.3	7.1	10.1	3.1	0.2	4.4	7.3	2.4	6.8	7.6	2.3	6.1	6.1	5.2	7.0	0.2	2.6	0.3	7.3	7.6	1.2	0.1	3.5	5.3	1.0	5.3	2.3	0.6	0.8	8.7	0.2	5.9	9.9	4.2	5.1	0.1	2.6	0.4	0.9	7.5	0.3	1.6	1.2	5.9	0.3	0.6	5.3	2.3	4.9	9.7	7.2	9.2	0.3	0.2	5.4	5.9	1.0	5.1	3.6	10.1	5.7	4.1	8.6	10.5	5.3	0.2	0.2	11.2	12.8	1.9	6.5	8.4	1.5	7.6	8.7	7.9	7.0	3.0	7.6	10.1	8.0	1.6	7.1	2.3	2.9	6.7	3.1	11.8	14.7	30.4	13.4	11.5	13.0	15.0	9.8	13.7	16.3
ZNF57	ZNF424	ENSG00000171970	"Zinc finger protein 57"	Q68EA5	19	2900898-2918476	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA061915			Approved	Nucleoli				Nucleoli		"HPA061915: "	"unprognostic (3.59e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.91e-2)"	"unprognostic (8.86e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.07e-2)"	"unprognostic (7.66e-2)"	"prognostic favourable (6.26e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.04e-2)"	"prognostic favourable (7.72e-4)"	"unprognostic (2.34e-3)"	"prognostic favourable (4.11e-9)"	"unprognostic (6.26e-3)"	"unprognostic (2.82e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.49e-3)"	3.6	2.9	3.6	3.2	4.7	4.0	7.3	17.2	5.7	6.2	15.7	2.3	5.1	7.8	5.6	4.2	11.0	4.7	4.0	4.2	3.3	2.7	9.2	3.9	4.9	2.9	2.6	3.2	5.4	7.4	3.9	4.1	5.8	4.2	6.1	10.1	3.6	5.5	8.7	7.4	18.6	18.5	2.1	2.4	3.6	11.7	26.4	3.9	2.9	5.4	7.0	6.6	5.0	7.9	4.9	3.6	1.4	5.8	6.3	8.4	4.1	6.8	3.2	4.5	6.6	4.3	3.8	7.6	2.9	2.3	4.7	4.9	6.7	2.7	5.8	3.8	2.4	8.1	7.1	10.1	5.9	0.0	3.7	3.4	3.8	8.8	3.3	0.0	6.4	3.0	11.3	4.1	9.0	3.5	6.0	0.1	3.7	6.9	8.8	3.8	2.9	5.7	8.2	13.8	1.3	6.4	11.3	2.3	3.4	4.3	8.1	2.8	5.0	5.6	2.8	3.3	3.2	7.4	4.1	1.2	6.6	2.9	2.7	0.9	2.5	0.0	3.3	1.4	6.5	5.8	5.4	4.9	7.1	6.7	3.6	4.9	8.4	7.4	1.2	6.3	3.1	3.4	7.1	4.1	3.6	4.7	17.2	5.7	3.3	2.7	2.6	3.2	4.2	3.9
ZNF570	FLJ30791	ENSG00000171827	"Zinc finger protein 570"	Q96NI8	19	37467585-37488652	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028881	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA028881: AB_10603938"	"unprognostic (2.93e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.54e-2)"	"unprognostic (4.59e-2)"	"prognostic favourable (4.06e-5)"	"unprognostic (5.30e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.20e-3)"	7.4	5.8	7.6	3.7	8.8	4.3	6.7	8.2	9.8	6.1	4.7	6.7	3.0	4.4	7.1	4.9	5.2	4.9	5.0	5.4	6.6	5.7	6.7	4.0	4.6	5.6	9.3	6.2	8.3	4.5	13.6	8.0	4.8	8.3	6.8	2.9	4.5	5.0	5.3	4.9	4.1	4.0	5.4	9.0	6.9	4.7	14.7	10.0	7.2	7.5	4.9	5.4	5.7	7.8	3.7	2.0	3.9	3.3	4.7	5.6	2.3	1.9	2.7	3.6	10.7	4.9	6.2	1.8	3.8	2.0	3.6	4.9	0.0	0.8	0.5	5.2	2.8	0.4	3.1	2.3	4.4	2.1	2.2	2.5	0.3	1.2	3.4	0.2	5.5	5.3	2.2	2.4	0.1	3.6	0.4	0.2	3.8	0.8	6.0	1.9	2.4	1.1	1.1	3.8	2.0	3.0	3.0	3.3	6.9	0.0	0.1	1.2	2.2	2.8	1.8	1.4	2.8	2.4	2.7	6.1	5.2	2.8	0.0	0.3	2.9	1.4	1.9	2.3	3.6	3.3	2.9	3.6	5.6	2.4	1.9	3.7	5.0	5.0	3.9	4.7	1.4	2.0	3.4	2.3	7.6	8.8	8.2	9.8	6.6	5.7	9.3	6.2	8.3	10.0
ZNF571	HSPC059	ENSG00000180479	"Zinc finger protein 571"	Q7Z3V5	19	37554782-37594790	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 61.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA054762			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA054762: "	"unprognostic (1.16e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.03e-4)"	"unprognostic (5.77e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-4)"	6.5	6.7	8.6	3.2	12.9	6.1	12.5	12.5	12.8	5.9	4.2	9.8	4.4	2.3	6.7	8.7	3.9	6.0	4.5	4.2	10.4	7.2	6.4	4.2	4.1	4.4	15.3	9.4	8.5	3.8	11.5	12.2	4.8	13.4	7.1	3.4	5.1	3.6	4.5	3.5	7.1	3.7	7.7	14.3	4.8	3.5	8.5	15.8	3.7	61.8	3.3	5.0	6.6	5.3	9.4	4.1	4.9	1.3	3.7	8.4	3.2	1.8	1.0	6.3	9.1	4.7	4.7	2.0	2.7	4.4	6.6	8.2	1.9	1.7	9.6	8.6	2.8	2.4	2.0	2.9	11.0	2.1	7.9	5.1	2.7	1.1	5.4	1.9	5.8	2.6	5.2	6.3	5.7	1.3	2.4	0.8	5.3	1.7	9.5	2.1	15.8	3.5	4.8	3.0	5.0	9.0	11.6	13.6	9.5	6.4	2.1	3.2	9.7	1.3	0.8	3.0	3.9	3.2	6.9	7.7	15.8	13.2	0.5	0.8	6.5	1.8	0.8	4.9	6.7	1.3	6.1	8.7	6.3	6.5	2.7	9.4	7.8	8.4	1.5	3.7	1.2	4.1	4.2	3.2	8.6	12.9	12.5	12.8	10.4	7.2	15.3	9.4	13.4	15.8
ZNF573	FLJ30921	ENSG00000189144	"Zinc finger protein 573"	Q86YE8	19	37735833-37817300	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA042776	Uncertain		Approved	"Intermediate filaments,Cytosol"				"Intermediate filaments"	Cytosol	"HPA042776: AB_10961399"	"unprognostic (3.79e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.60e-2)"	6.2	6.4	7.3	4.2	8.6	7.2	7.6	14.1	9.5	6.3	4.6	8.6	5.2	4.3	7.5	10.8	4.8	5.0	6.8	5.3	5.8	4.1	5.3	4.2	6.0	4.1	10.0	5.7	8.4	6.8	6.7	11.7	5.7	6.2	5.5	4.9	5.9	6.4	5.6	5.3	7.8	5.3	6.9	6.8	5.3	7.5	10.0	9.5	4.5	9.8	4.0	6.2	7.4	6.2	6.3	3.3	3.3	2.6	3.6	5.7	1.0	1.0	3.6	2.8	2.4	1.4	3.4	1.2	2.3	2.7	0.9	2.2	3.5	2.8	3.5	2.3	2.1	2.2	2.8	3.8	3.4	1.8	1.9	4.0	5.4	1.8	1.4	3.3	2.6	3.0	1.4	4.8	2.1	2.8	1.8	1.6	0.7	1.4	2.7	2.0	4.5	0.4	2.8	5.7	1.1	0.2	1.6	3.7	3.7	4.6	1.5	0.4	3.5	3.1	1.0	3.2	3.3	2.8	3.8	4.2	5.3	5.7	0.8	0.4	2.6	3.2	1.0	3.3	4.2	1.2	3.4	3.4	3.5	4.5	1.9	6.3	5.7	4.4	0.4	3.6	2.6	3.3	2.0	1.0	7.3	8.6	14.1	9.5	5.8	4.1	10.0	5.7	6.2	9.5
ZNF577	MGC4400	ENSG00000161551	"Zinc finger protein 577"	Q9BSK1	19	51804816-51890950	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041499, HPA046761"	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA041499: , HPA046761: "	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.17e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.51e-3)"	"unprognostic (2.81e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.02e-2)"	"prognostic favourable (2.03e-4)"	7.9	6.8	13.4	5.8	15.5	4.2	13.9	14.6	12.1	10.2	10.9	9.9	15.5	5.1	12.3	11.1	6.3	10.0	8.9	8.0	14.8	5.6	11.0	5.5	6.8	5.6	7.6	8.7	27.2	7.1	17.4	7.5	10.1	9.9	17.4	7.6	17.2	12.9	16.1	9.4	22.3	8.1	14.4	11.0	10.1	7.1	22.5	14.9	3.8	16.3	5.2	6.3	8.8	10.2	9.4	3.2	7.1	4.0	4.6	4.6	1.8	1.2	0.1	6.6	8.1	11.4	12.4	0.0	7.7	2.9	3.0	6.1	0.8	1.0	1.3	0.8	3.5	2.1	2.6	1.6	1.6	0.0	7.6	12.7	0.1	1.1	8.9	2.8	4.3	9.7	5.0	4.4	1.3	1.5	2.8	0.0	3.8	0.0	7.8	3.6	7.6	0.2	3.4	3.3	2.3	4.9	2.9	2.7	1.4	1.9	0.9	6.5	1.3	3.1	1.0	5.6	7.7	1.6	2.8	5.4	0.0	1.7	1.5	0.5	8.9	7.1	2.6	5.7	1.7	4.0	4.6	9.4	3.0	3.6	2.8	5.1	3.8	2.4	1.2	4.6	3.0	3.2	1.4	1.8	13.4	15.5	14.6	12.1	14.8	5.6	7.6	8.7	9.9	14.9
ZNF582	FLJ30927	ENSG00000018869	"Zinc finger protein 582"	Q96NG8	19	56375846-56393545	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 23.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028858	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA028858: AB_10603247"	"unprognostic (1.19e-3)"	"unprognostic (9.86e-4)"	"unprognostic (3.88e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.02e-7)"	"unprognostic (3.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.54e-2)"	"unprognostic (5.00e-3)"	4.8	8.7	7.7	4.7	8.9	2.7	6.3	9.4	9.0	4.7	4.9	7.8	3.6	2.3	7.9	13.5	4.8	6.1	6.4	8.0	8.2	7.1	5.9	4.8	5.2	8.0	9.6	3.9	10.2	4.0	7.5	11.4	5.4	8.9	8.4	2.7	4.4	4.1	5.5	3.5	5.6	3.3	5.5	7.7	7.2	3.4	8.9	13.1	7.8	13.8	2.2	3.7	5.4	5.9	5.9	3.4	5.9	3.3	11.0	6.5	2.8	0.0	1.0	5.9	1.2	1.5	1.5	0.0	2.4	2.5	1.6	1.2	0.0	0.3	0.0	1.6	1.3	0.0	0.7	0.3	1.2	0.0	23.8	5.7	0.0	0.4	2.5	1.5	4.6	5.3	1.3	1.0	0.0	0.9	1.3	0.0	0.9	0.0	3.3	3.6	3.3	0.0	1.5	2.0	2.1	1.3	3.3	0.0	3.9	0.0	0.8	0.0	2.7	3.1	1.0	3.1	6.3	0.8	3.2	5.1	5.5	3.6	0.2	0.3	1.7	4.3	2.2	5.9	4.4	3.3	6.5	5.9	5.2	4.4	3.3	4.3	3.8	4.8	0.5	11.0	2.4	3.4	1.6	2.8	7.7	8.9	9.4	9.0	8.2	7.1	9.6	3.9	8.9	13.1
ZNF583	FLJ31030	ENSG00000198440	"Zinc finger protein 583"	Q96ND8	19	56397966-56436035	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023805, HPA023957"	Uncertain		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA023805: , HPA023957: "	"unprognostic (9.89e-3)"	"unprognostic (5.52e-3)"	"unprognostic (8.14e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.79e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.54e-2)"	7.2	5.9	7.9	3.9	9.3	2.3	4.7	11.6	12.4	5.6	4.6	5.6	3.7	3.2	6.1	5.5	3.6	5.8	5.4	5.0	7.7	7.3	6.6	5.9	6.6	4.5	7.5	6.3	11.2	5.9	7.3	8.4	4.7	8.3	6.0	3.5	3.3	2.6	4.7	4.8	2.1	3.1	6.2	7.6	5.4	3.9	15.8	7.6	5.0	7.9	2.1	4.1	4.4	5.7	6.3	3.5	9.4	4.7	9.2	7.4	2.8	0.0	1.9	4.6	0.0	3.3	2.6	0.0	5.7	5.8	2.6	2.2	0.2	0.6	4.3	2.8	5.2	0.2	1.8	1.8	2.9	2.0	10.0	5.6	0.0	1.0	3.7	4.6	5.1	3.7	2.8	3.8	1.9	2.6	2.1	1.6	8.6	0.0	5.7	1.6	1.1	1.9	2.9	8.8	3.2	2.1	4.2	2.6	4.0	0.0	0.5	1.5	2.9	6.0	1.7	13.8	3.7	2.6	11.2	5.9	10.8	6.7	0.3	1.2	4.9	9.4	2.2	4.7	4.9	3.2	7.2	6.3	4.0	4.5	2.5	5.5	7.4	4.4	1.0	9.2	4.7	3.5	4.9	2.8	7.9	9.3	11.6	12.4	7.7	7.3	7.5	6.3	8.3	7.6
ZNF584	FLJ39899	ENSG00000171574	"Zinc finger protein 584"	Q8IVC4	19	58401504-58418327	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043408, HPA048075"	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA043408: , HPA048075: "	"unprognostic (6.06e-2)"	"unprognostic (3.27e-3)"	"unprognostic (3.76e-3)"	"unprognostic (8.15e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.04e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.90e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.36e-2)"	10.4	9.3	7.3	7.4	11.7	3.3	11.7	16.6	12.1	10.6	8.6	9.5	6.4	7.4	10.5	8.2	9.2	13.8	10.5	13.3	7.6	9.6	10.4	13.4	7.9	6.7	7.2	5.0	11.9	13.1	13.6	11.6	5.8	7.9	8.6	5.5	10.8	7.6	13.0	13.3	11.7	4.6	10.9	6.2	6.4	8.1	6.3	7.8	6.6	11.5	10.3	6.7	8.7	16.6	4.4	5.0	1.2	4.5	4.1	8.4	3.9	6.9	10.2	7.0	9.1	6.8	6.9	2.8	5.5	9.7	3.4	4.1	1.6	2.0	3.4	4.4	8.8	3.9	7.5	8.9	3.9	4.5	30.8	9.3	5.8	1.9	11.7	10.2	2.6	7.0	6.4	10.3	14.4	6.7	9.3	3.1	5.5	4.9	8.5	3.1	1.7	14.3	6.2	5.2	5.3	4.8	8.2	5.6	5.9	11.9	3.3	4.6	2.1	5.1	4.1	13.4	4.1	5.5	8.6	3.1	5.5	0.7	9.6	3.5	4.3	0.0	3.2	1.2	5.0	3.1	8.4	3.3	6.8	7.2	5.0	4.4	3.8	5.7	1.0	4.1	4.5	4.4	7.2	3.9	7.3	11.7	16.6	12.1	7.6	9.6	7.2	5.0	7.9	7.8
ZNF585B	"FLJ14928, SZFP41"	ENSG00000245680	"Zinc finger protein 585B"	Q52M93	19	37181579-37218153	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA075556			Approved	"Nucleoplasm,Cytoplasmic bodies"				"Nucleoplasm, Cytoplasmic bodies"		"HPA075556: "	"unprognostic (9.53e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.30e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.11e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.18e-3)"	6.6	8.3	11.2	5.8	13.4	2.6	9.3	17.9	12.9	10.0	8.1	8.7	11.4	5.6	11.6	15.2	5.8	8.8	7.5	7.2	9.8	10.0	8.7	5.2	6.2	7.3	14.1	9.8	15.0	6.2	23.4	22.6	8.0	10.1	8.9	7.2	8.3	6.3	11.6	5.0	6.3	7.2	10.1	12.3	9.7	7.6	9.2	12.4	9.5	13.1	5.6	9.1	9.3	7.2	6.5	1.9	3.7	4.2	2.9	7.1	2.9	2.4	4.1	3.7	7.4	6.2	9.8	2.0	3.2	5.1	5.8	8.8	2.2	3.0	0.1	6.8	4.1	0.7	0.1	4.9	7.3	4.8	1.9	3.2	5.4	1.2	6.0	0.3	6.7	7.6	3.0	6.6	3.5	2.4	0.0	0.2	3.4	1.5	5.5	2.1	4.2	1.1	0.2	2.1	0.1	3.1	9.9	6.6	4.3	0.0	0.3	1.4	2.8	3.4	2.0	0.6	1.4	4.9	3.8	5.7	7.4	6.8	0.3	0.1	6.4	3.3	1.6	3.7	5.0	3.1	6.3	6.5	3.6	4.4	1.9	4.9	5.2	7.1	2.5	2.9	4.2	1.7	3.5	2.9	11.2	13.4	17.9	12.9	9.8	10.0	14.1	9.8	10.1	12.4
ZNF586	FLJ20070	ENSG00000083828	"Zinc finger protein 586"	Q9NXT0	19	57769655-57819939	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 24.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA030306, HPA060782"	Approved		Approved	"Nucleoli fibrillar center,Vesicles"				"Nucleoli fibrillar center"	Vesicles	"HPA030306: , HPA060782: "	"prognostic favourable (9.83e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.72e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.72e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"prognostic favourable (5.36e-4)"	7.6	6.9	11.7	12.3	11.7	27.3	10.6	22.4	13.8	8.5	7.7	6.6	14.7	7.9	9.1	10.0	10.8	8.9	9.2	10.0	11.8	4.4	8.5	7.8	16.5	16.2	9.3	8.7	13.9	8.4	6.6	13.4	9.0	8.4	13.5	8.1	9.8	14.3	18.4	33.3	12.4	10.2	7.7	8.7	16.2	9.8	7.0	13.0	11.6	10.7	8.8	12.2	12.0	11.5	7.2	6.1	20.8	6.6	6.3	10.0	5.2	5.0	4.4	6.0	7.1	3.0	2.7	10.0	3.6	3.5	5.0	2.6	2.0	5.1	10.6	0.4	3.2	3.7	1.1	4.8	9.0	1.6	24.2	8.3	10.0	1.3	5.2	7.9	7.6	4.5	5.6	3.5	5.5	5.8	5.3	0.6	5.8	1.7	8.0	5.6	8.9	11.6	8.1	2.3	13.4	5.7	13.0	8.7	4.0	1.7	5.1	3.8	5.4	6.2	3.2	6.7	3.7	0.3	5.9	11.9	14.7	11.2	3.6	0.9	4.8	4.4	6.6	20.5	6.1	5.5	5.9	5.2	7.9	6.5	6.1	7.2	10.0	9.0	20.8	6.3	3.6	4.7	9.9	5.2	11.7	11.7	22.4	13.8	11.8	4.4	9.3	8.7	8.4	13.0
ZNF594	KIAA1871	ENSG00000180626	"Zinc finger protein 594"	Q96JF6	17	5179536-5191883	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA060283, HPA067178, HPA069360, HPA074493, HPA077596"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA060283: , HPA067178: , HPA069360: , HPA074493: , HPA077596: "	"unprognostic (6.67e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.93e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.24e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.33e-5)"	"unprognostic (4.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.99e-1)"	"unprognostic (5.21e-2)"	"unprognostic (6.59e-2)"	4.0	6.2	11.8	8.4	11.2	1.3	8.8	13.8	13.4	7.5	6.3	8.0	5.3	3.1	9.3	8.4	4.2	8.3	4.2	4.9	8.9	5.9	6.7	3.8	4.1	10.1	13.6	6.6	19.8	6.0	15.3	15.9	5.8	9.2	9.6	5.1	6.0	6.5	10.2	6.7	3.8	6.8	6.0	8.3	8.4	5.2	7.8	11.1	11.9	10.2	2.1	10.2	6.6	5.6	5.9	4.5	1.1	1.0	2.4	5.2	1.0	5.5	2.5	10.6	8.2	1.7	1.9	8.8	3.7	1.9	6.7	6.4	7.0	2.0	12.4	5.9	2.9	6.1	6.7	0.2	8.6	6.6	6.8	4.0	8.7	3.5	2.4	0.0	4.1	1.4	1.1	4.0	0.0	0.7	1.6	3.2	2.3	5.2	3.4	1.7	4.7	3.4	7.3	8.9	1.6	1.9	1.4	6.2	8.3	2.8	1.5	5.7	3.4	3.0	0.1	0.1	3.8	3.3	2.6	2.0	4.1	2.9	0.6	0.0	4.0	0.4	0.8	1.1	3.2	1.0	2.3	3.5	3.3	2.9	1.0	5.9	5.2	3.4	0.4	2.4	0.9	4.5	4.4	1.0	11.8	11.2	13.8	13.4	8.9	5.9	13.6	6.6	9.2	11.1
ZNF596		ENSG00000172748	"Zinc finger protein 596"	Q8TC21	8	232137-264703	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 13.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA055463	Uncertain		Approved	Nucleoli,Mitochondria				"Nucleoli, Mitochondria"		"HPA055463: AB_2682821"	"unprognostic (3.30e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.07e-3)"	"unprognostic (9.68e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.84e-1)"	"unprognostic (1.70e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.53e-1)"	4.9	6.2	6.3	9.9	7.4	2.6	8.5	18.2	10.1	6.7	4.4	8.3	8.3	4.3	10.4	11.9	4.7	6.7	6.3	5.1	7.5	7.0	6.1	5.3	4.8	5.3	6.8	7.3	7.8	7.1	13.5	10.9	5.5	6.2	6.1	5.3	6.6	4.2	9.4	10.2	6.7	4.1	7.7	7.8	6.8	5.4	22.4	7.8	7.4	9.2	4.2	4.4	4.5	4.8	6.8	4.4	6.4	5.0	2.9	7.3	2.6	1.8	1.1	5.4	13.8	2.8	2.6	4.6	4.1	1.9	1.6	2.9	1.3	2.2	1.7	1.3	3.4	3.6	1.5	3.2	2.1	1.4	2.1	3.9	3.3	1.3	3.1	1.7	1.8	6.1	0.5	1.9	2.9	1.3	2.3	5.9	9.6	5.8	4.2	1.6	2.8	1.3	1.9	1.2	3.2	5.4	3.2	3.1	8.1	2.8	1.4	2.0	4.1	5.0	3.2	4.0	1.1	0.3	1.8	2.1	5.2	2.2	4.8	1.4	2.5	6.4	2.8	4.5	4.8	2.3	6.7	6.4	5.2	4.2	3.6	6.8	6.2	7.3	3.1	2.9	5.0	4.4	5.6	2.6	6.3	7.4	18.2	10.1	7.5	7.0	6.8	7.3	6.2	7.8
ZNF605		ENSG00000196458	"Zinc finger protein 605"	Q86T29	12	132918308-132956306	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA061970, HPA062655"	Uncertain		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA061970: , HPA062655: "	"unprognostic (2.38e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.16e-6)"	"unprognostic (3.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.53e-2)"	"unprognostic (9.06e-3)"	5.5	8.2	10.9	7.6	9.9	3.2	12.2	19.0	12.8	10.1	8.3	8.4	9.5	6.7	10.2	13.1	7.3	9.3	6.6	9.9	10.8	7.9	9.9	8.1	7.6	8.0	7.8	8.2	13.3	8.2	16.9	12.9	10.2	8.1	10.7	6.9	9.9	8.8	9.6	14.6	11.5	8.3	8.2	7.4	7.4	8.7	4.8	9.1	8.5	15.5	6.1	7.5	8.5	9.9	2.6	1.4	1.9	1.2	1.7	3.0	0.8	4.5	3.7	9.5	9.0	5.2	10.9	7.1	6.2	3.6	2.9	2.0	0.6	0.6	1.9	3.4	5.3	2.5	4.1	1.5	3.6	1.5	7.1	8.7	2.9	2.9	4.0	3.6	9.6	6.9	6.9	2.0	4.4	2.2	1.3	0.1	7.2	1.3	4.7	5.1	7.3	5.1	4.4	6.2	1.3	4.9	7.8	6.1	7.0	2.8	1.7	4.3	10.3	10.5	4.3	3.6	5.8	5.3	2.5	0.0	0.0	1.5	0.1	3.0	2.1	1.6	1.2	1.3	1.6	0.8	0.9	2.6	1.4	1.7	0.9	2.2	3.0	1.9	1.9	1.7	0.9	1.4	0.4	0.8	10.9	9.9	19.0	12.8	10.8	7.9	7.8	8.2	8.1	9.1
ZNF606	"FLJ14260, KIAA1852, ZNF328"	ENSG00000166704	"Zinc finger protein 606"	Q8WXB4	19	57977053-58003349	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041712, HPA043584"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA041712: AB_10960410, HPA043584: "	"unprognostic (1.05e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.48e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.29e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.01e-2)"	"prognostic favourable (4.75e-6)"	6.9	7.1	13.0	7.1	12.8	5.5	12.8	18.2	11.6	9.6	7.8	12.8	11.3	8.6	11.1	14.6	6.6	14.0	9.8	6.7	15.0	6.9	9.0	6.9	7.7	11.2	16.9	8.2	14.6	8.3	18.9	18.1	6.7	12.3	12.4	7.2	10.2	11.1	10.0	9.9	11.0	10.3	9.2	10.8	12.9	10.0	8.9	11.7	20.1	17.8	6.3	9.8	9.2	7.7	9.8	7.9	9.1	3.0	6.3	8.5	2.4	1.3	2.5	11.1	9.3	3.4	4.7	8.1	3.3	1.1	3.3	2.1	3.2	3.9	2.2	2.7	2.2	3.4	1.4	3.3	4.5	0.0	19.8	5.4	0.8	3.1	2.6	0.0	4.4	5.6	1.7	2.8	1.7	2.4	2.7	0.1	4.2	1.3	7.2	1.3	6.7	4.8	8.1	4.1	3.2	3.6	6.8	10.4	7.0	6.0	0.2	2.4	5.4	5.1	2.7	2.6	3.9	1.1	1.1	6.6	7.1	1.6	0.2	0.6	3.5	9.1	3.0	7.4	3.0	2.4	4.1	8.3	4.8	3.4	2.6	9.8	8.5	4.7	7.8	6.3	2.6	7.9	3.2	2.4	13.0	12.8	18.2	11.6	15.0	6.9	16.9	8.2	12.3	11.7
ZNF610	FLJ36040	ENSG00000167554	"Zinc finger protein 610"	Q8N9Z0	19	52336245-52367778	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA055771, HPA078134"	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA055771: , HPA078134: "	"unprognostic (1.13e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.52e-1)"	"unprognostic (8.75e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.83e-1)"	"prognostic favourable (3.38e-4)"	"unprognostic (5.54e-2)"	"unprognostic (1.14e-2)"	"prognostic favourable (1.05e-7)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.88e-2)"	"unprognostic (5.73e-3)"	2.3	4.8	7.9	2.1	11.9	0.8	5.5	11.0	9.7	5.5	3.0	6.9	3.3	1.5	5.1	11.7	2.1	7.4	4.3	4.2	7.6	7.7	5.9	1.0	3.3	2.6	7.5	7.2	14.3	2.9	7.5	6.8	4.5	10.0	7.6	2.9	5.7	2.2	4.1	1.9	1.6	1.8	4.4	8.5	4.1	2.7	18.1	7.3	3.6	7.7	0.2	2.1	3.6	2.4	3.6	1.5	4.0	0.5	2.5	4.8	1.6	0.2	0.0	6.2	5.1	4.1	3.5	4.7	1.9	3.4	1.1	3.4	0.0	0.4	0.5	3.8	0.8	0.2	0.0	0.0	2.8	0.1	3.0	0.1	0.3	0.2	4.9	0.0	1.5	4.7	0.1	1.2	0.2	3.5	0.3	0.2	5.6	1.3	3.2	0.9	5.8	0.4	2.3	4.7	0.6	2.2	4.4	7.7	4.4	0.1	0.5	1.9	3.7	2.7	2.8	0.3	2.0	0.1	2.3	0.2	12.1	0.0	0.0	0.1	2.4	4.0	0.5	1.1	2.9	0.1	4.4	2.5	2.4	2.3	1.4	3.6	4.8	2.0	1.4	2.5	0.1	1.5	3.2	1.6	7.9	11.9	11.0	9.7	7.6	7.7	7.5	7.2	10.0	7.3
ZNF613	FLJ13590	ENSG00000176024	"Zinc finger protein 613"	Q6PF04	19	51927147-51948759	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 25.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA026833	Uncertain		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA026833: AB_1859377"	"unprognostic (1.10e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.84e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.78e-3)"	"prognostic favourable (1.92e-6)"	4.7	5.3	7.1	3.9	7.4	1.6	9.5	14.2	7.4	5.3	6.5	5.2	1.9	2.8	5.5	5.3	4.7	4.3	3.7	4.3	9.7	4.7	8.7	4.0	4.9	6.3	7.2	4.9	6.5	3.4	7.4	7.0	8.2	8.8	25.4	6.7	5.4	4.5	5.6	3.9	4.5	4.9	5.8	7.5	6.7	4.2	3.5	7.0	9.0	7.3	2.6	5.2	5.8	4.1	10.1	9.6	14.1	11.3	9.5	14.3	7.0	3.1	4.2	6.9	6.9	6.0	6.9	1.7	5.3	8.5	7.1	9.2	1.4	3.7	2.6	2.8	6.6	3.6	6.7	6.6	7.7	0.1	8.6	5.5	3.0	3.9	6.1	0.3	7.9	5.1	7.6	6.7	5.5	7.6	2.5	0.0	7.1	0.6	9.2	4.1	4.9	5.9	5.0	7.3	2.8	6.9	10.8	4.6	4.5	8.5	6.3	5.0	6.6	6.8	4.8	3.1	5.9	2.4	5.6	6.0	0.0	5.1	0.2	0.0	9.3	7.7	7.4	14.1	10.4	7.5	9.3	7.6	11.1	12.1	9.6	10.1	11.2	14.3	7.6	9.5	11.3	4.8	10.0	7.0	7.1	7.4	14.2	7.4	9.7	4.7	7.2	4.9	8.8	7.0
ZNF615	FLJ33710	ENSG00000197619	"Zinc finger protein 615"	Q8N8J6	19	51991332-52008230	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA052422	Uncertain		Approved	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA052422: "	"unprognostic (2.20e-1)"	"unprognostic (4.66e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.08e-3)"	"unprognostic (7.28e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.68e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.16e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.82e-1)"	"prognostic favourable (2.98e-4)"	10.2	7.4	11.9	6.0	16.4	7.5	10.1	20.7	12.2	8.2	8.8	7.3	6.9	5.2	12.0	7.8	6.5	9.8	7.6	8.5	8.5	7.1	9.5	6.1	7.6	6.2	11.7	9.8	15.7	7.5	16.6	17.8	8.3	9.9	26.9	5.8	8.0	7.7	11.0	7.2	7.2	6.0	9.6	12.8	7.9	6.7	5.5	13.6	7.3	11.7	3.8	6.1	11.1	8.8	4.7	4.8	6.9	4.4	12.0	7.8	3.8	1.3	5.2	5.8	11.8	10.6	7.7	4.4	3.9	6.6	5.4	5.6	1.1	1.4	2.1	2.2	4.7	1.4	4.0	2.6	5.0	0.3	8.9	6.7	5.2	4.0	8.3	0.0	4.0	6.6	2.8	8.6	9.1	2.9	0.0	0.0	4.1	0.4	0.0	3.5	6.0	8.8	4.2	9.1	3.7	3.7	9.1	5.2	4.5	4.8	4.5	3.2	6.5	3.3	5.2	5.1	5.9	3.3	2.8	4.0	10.5	2.6	3.0	0.0	8.2	6.9	3.0	5.8	3.7	4.4	7.8	3.9	6.6	5.3	4.8	4.7	6.6	4.3	4.1	12.0	2.7	2.9	5.7	3.8	11.9	16.4	20.7	12.2	8.5	7.1	11.7	9.8	9.9	13.6
ZNF616	MGC45556	ENSG00000204611	"Zinc finger protein 616"	Q08AN1	19	52113091-52139922	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA062639, HPA071539"	Approved		Approved	Centrosome				Centrosome		"HPA062639: , HPA071539: "	"unprognostic (5.98e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.32e-3)"	10.5	18.1	9.2	4.9	10.6	2.7	8.6	18.7	10.2	9.1	6.6	6.2	5.6	4.9	9.4	8.6	7.2	9.8	6.0	6.3	8.7	4.8	8.4	8.5	7.6	6.3	12.6	8.1	16.1	10.4	12.7	17.7	9.0	9.1	9.9	8.2	6.1	8.0	11.5	5.4	8.0	6.4	8.0	13.7	7.6	6.7	5.3	10.3	11.9	11.6	4.4	7.2	9.3	12.5	4.7	4.5	4.7	10.9	15.7	6.3	2.5	4.1	3.7	12.5	8.5	15.0	12.3	0.1	5.6	6.6	5.4	8.6	4.2	3.4	5.8	3.9	5.3	2.8	12.9	6.3	8.3	3.9	17.1	10.2	9.6	9.0	8.8	9.8	6.4	8.9	8.9	4.8	17.8	7.3	11.3	2.8	7.8	2.8	9.4	5.1	12.8	11.1	8.3	17.0	8.3	3.9	10.6	12.6	7.0	9.3	4.5	2.9	5.6	3.3	5.9	4.2	5.0	4.7	5.7	5.7	8.4	8.2	3.6	5.8	8.1	3.2	3.5	4.0	6.3	2.3	5.8	3.8	5.8	5.1	3.9	4.7	5.3	4.9	4.7	15.7	10.9	4.5	3.7	2.5	9.2	10.6	18.7	10.2	8.7	4.8	12.6	8.1	9.1	10.3
ZNF619	FLJ90764	ENSG00000177873	"Zinc finger protein 619"	Q8N2I2	3	40477113-40490236	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA045094	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"				Nucleoplasm	"Intermediate filaments"	"HPA045094: AB_10959900"	"unprognostic (7.16e-2)"	"unprognostic (5.94e-1)"	"unprognostic (8.38e-3)"	"unprognostic (5.42e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.99e-2)"	"unprognostic (6.15e-3)"	"unprognostic (8.28e-6)"	"unprognostic (1.94e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.38e-2)"	8.8	7.6	6.3	9.2	9.5	9.0	9.2	7.9	8.7	7.0	6.7	13.3	8.4	7.3	9.3	6.6	6.4	8.4	8.9	6.9	7.8	5.8	7.1	8.1	9.6	18.0	12.7	9.2	9.4	12.3	14.0	6.6	6.3	7.3	7.0	8.2	9.7	8.6	10.4	8.5	7.3	7.5	7.6	9.6	9.0	7.3	3.8	9.3	6.0	10.2	5.0	9.4	8.0	6.8	4.1	4.5	5.1	4.5	5.2	5.1	2.7	2.7	4.0	4.7	4.1	6.8	7.2	1.7	3.6	4.4	7.0	6.9	1.2	3.9	0.3	2.2	3.4	3.0	4.3	7.4	7.6	4.7	1.6	8.2	3.2	1.9	7.2	5.8	7.4	5.8	5.6	7.1	10.5	6.4	5.4	3.9	4.3	3.4	0.1	2.6	2.5	3.6	1.6	4.8	4.5	2.9	6.3	3.0	3.1	4.0	5.9	3.2	4.8	3.8	4.9	5.1	3.9	2.8	4.1	2.2	2.8	0.3	3.1	3.6	5.3	2.8	3.2	5.1	3.0	4.5	3.3	3.3	3.0	3.8	4.5	4.1	3.1	3.9	3.8	5.2	4.3	2.8	5.1	2.7	6.3	9.5	7.9	8.7	7.8	5.8	12.7	9.2	7.3	9.3
ZNF620	MGC50836	ENSG00000177842	"Zinc finger protein 620"	Q6ZNG0	3	40505992-40518736	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 14.2"	"Low lineage specificity"	"Detected in all"											"HPA031452, HPA059383"	Uncertain		Approved	Centrosome				Centrosome		"HPA031452: AB_10603939, HPA059383: "	"unprognostic (1.42e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.15e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.21e-5)"	"unprognostic (1.28e-1)"	"unprognostic (4.78e-1)"	"unprognostic (2.61e-2)"	"unprognostic (9.19e-4)"	5.8	5.7	5.2	3.0	8.2	8.0	6.1	15.6	8.5	3.7	5.0	8.9	4.8	4.4	4.0	6.3	3.1	5.3	3.2	4.4	5.6	5.7	6.2	4.5	6.2	3.4	10.3	5.8	4.5	8.1	8.7	15.2	6.3	6.4	5.2	5.9	6.1	3.5	5.7	6.3	2.4	4.7	4.3	5.3	5.2	7.3	3.0	7.4	3.7	9.5	3.7	3.1	4.8	4.5	2.0	1.3	14.2	1.0	3.1	3.9	1.2	2.3	3.5	8.4	3.1	0.9	0.9	4.4	0.6	0.9	4.0	5.8	8.2	5.2	0.0	2.6	0.4	0.6	12.4	1.1	2.9	7.1	9.7	6.0	8.7	4.5	1.5	2.1	1.2	0.5	0.8	2.5	1.1	2.7	3.1	1.0	0.5	4.0	0.4	1.8	9.7	1.9	3.2	3.5	1.1	3.7	8.4	9.9	7.5	0.6	5.8	3.8	7.6	2.3	1.8	0.4	5.7	0.8	2.6	1.3	2.1	0.1	1.3	1.2	1.5	14.2	0.6	1.2	2.6	1.0	3.2	0.8	1.0	2.7	0.6	2.0	2.1	2.7	0.9	3.1	0.3	1.3	3.9	1.2	5.2	8.2	15.6	8.5	5.6	5.7	10.3	5.8	6.4	7.4
ZNF621	FLJ45246	ENSG00000172888	"Zinc finger protein 621"	Q6ZSS3	3	40524878-40574685	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA065518, HPA071440"			Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA065518: , HPA071440: "	"unprognostic (1.09e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.52e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.04e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.33e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.01e-3)"	12.3	11.3	14.6	10.6	27.1	11.6	16.6	20.4	17.3	14.2	11.1	26.2	15.5	9.6	16.4	18.3	9.1	10.9	11.3	9.3	17.3	14.1	11.8	10.0	12.5	11.1	26.7	12.1	14.1	15.0	18.4	15.6	10.6	17.6	13.3	11.4	12.1	12.6	14.8	10.5	16.2	10.4	15.9	22.7	11.6	11.2	8.6	24.7	4.8	13.9	8.1	11.5	10.4	10.6	7.4	4.3	5.5	3.4	4.9	4.8	1.8	9.2	4.9	13.0	12.8	9.5	14.1	7.0	9.7	11.8	12.7	12.3	10.4	5.0	3.7	7.2	12.9	3.1	12.5	7.1	14.9	13.0	13.8	12.4	18.5	9.6	15.1	11.8	12.2	11.3	16.3	12.9	20.8	9.9	12.7	10.9	10.6	5.0	2.9	13.7	7.6	10.1	1.3	8.4	3.9	6.7	11.3	4.3	11.4	9.0	7.2	11.4	10.9	9.7	12.2	21.4	10.6	10.1	13.9	16.5	15.4	7.9	10.2	8.7	13.2	5.5	3.0	2.5	3.9	3.4	2.7	6.1	3.8	4.8	2.4	7.4	4.4	3.9	4.4	4.9	1.9	4.3	3.1	1.8	14.6	27.1	20.4	17.3	17.3	14.1	26.7	12.1	17.6	24.7
ZNF626		ENSG00000188171	"Zinc finger protein 626"	Q68DY1	19	20620061-20661596	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 13.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA045631	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"	Nucleoplasm	"HPA045631: "	"unprognostic (1.75e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.51e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.31e-1)"	8.1	13.9	10.2	6.0	15.6	4.1	18.5	15.2	14.8	11.2	8.3	12.0	21.6	2.4	13.0	9.5	8.0	14.0	10.7	10.8	10.1	10.1	12.7	6.5	7.2	12.4	10.9	11.1	29.2	9.6	36.3	14.8	8.3	11.0	12.8	4.4	13.6	8.9	23.9	7.3	10.8	6.0	11.9	12.1	7.8	9.1	5.8	11.9	13.6	26.9	4.9	10.7	21.3	9.7	11.4	4.2	11.6	4.3	9.1	8.6	4.2	0.1	0.0	4.3	0.7	5.3	6.9	0.5	4.9	0.5	7.0	6.2	0.2	0.2	0.7	2.5	6.0	0.8	0.0	0.2	8.9	0.0	0.2	0.0	0.1	1.7	9.4	0.1	0.1	12.8	2.2	4.1	2.2	3.3	3.0	0.5	7.3	0.1	0.8	1.1	9.3	2.2	4.3	3.2	1.6	7.0	5.3	1.5	8.3	0.2	0.5	4.4	10.3	0.4	0.0	3.2	0.2	12.7	0.5	6.9	13.8	6.2	0.1	0.1	0.5	0.8	1.1	6.0	7.6	1.0	7.3	7.9	8.0	8.6	3.2	11.4	7.7	6.6	11.6	9.1	4.3	4.2	3.7	4.2	10.2	15.6	15.2	14.8	10.1	10.1	10.9	11.1	11.0	11.9
ZNF630	"BC037316, dJ54B20.2, FLJ20573, MGC138344"	ENSG00000221994	"Zinc finger protein 630"	Q2M218	X	47983356-48071658	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 7.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA001053, HPA068130"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA001053: , HPA068130: "	"unprognostic (1.03e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.86e-3)"	"unprognostic (5.83e-2)"	"unprognostic (9.06e-3)"	"unprognostic (8.68e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (7.51e-5)"	4.0	5.2	5.3	6.4	9.0	2.1	6.7	8.8	8.5	7.0	5.4	5.9	11.3	3.5	6.3	7.5	5.0	4.8	5.8	5.9	6.0	4.6	5.2	3.0	5.0	5.4	12.3	5.8	11.2	8.3	11.9	10.1	4.9	8.8	8.4	6.2	6.4	6.1	6.9	2.3	4.0	4.2	7.5	7.3	4.8	6.8	1.8	10.1	1.0	9.3	1.5	3.6	8.4	13.7	2.6	3.8	5.8	1.9	1.5	2.8	2.0	1.4	1.1	0.3	0.0	0.1	0.1	0.0	1.9	0.6	1.0	0.9	3.3	5.4	0.1	1.0	2.0	2.3	0.0	1.0	1.3	0.0	0.0	0.0	1.4	0.0	1.4	0.0	0.0	1.3	5.7	3.2	0.0	1.0	0.0	5.4	3.6	5.7	0.0	0.0	2.1	1.6	0.7	1.3	0.0	2.5	3.0	3.2	2.6	7.1	4.8	2.1	5.7	1.4	1.2	0.0	2.6	2.5	0.0	0.0	4.7	0.0	0.0	0.1	4.5	5.8	1.9	4.8	2.2	1.0	2.4	2.6	2.0	2.0	3.8	1.8	2.5	2.8	2.1	1.5	0.6	0.9	1.1	2.0	5.3	9.0	8.8	8.5	6.0	4.6	12.3	5.8	8.8	10.1
ZNF654	"FLJ10997, FLJ21142"	ENSG00000175105	"Zinc finger protein 654"	Q8IZM8	3	88059274-88144665	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036172, HPA036173, HPA049262, HPA077939"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle"				Microtubules	"Nucleoplasm, Cytokinetic bridge, Mitotic spindle"	"HPA036172: AB_10672081, HPA036173: , HPA049262: , HPA077939: "	"unprognostic (2.54e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.89e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.72e-3)"	"prognostic unfavourable (9.97e-6)"	"unprognostic (1.29e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.50e-2)"	18.2	8.9	10.9	13.2	11.6	15.1	12.6	18.6	13.3	13.5	11.8	9.8	13.5	9.7	14.0	12.1	14.4	9.5	10.8	10.4	11.3	8.5	11.0	15.4	11.8	12.3	13.9	10.3	14.7	9.5	12.8	21.8	11.9	11.1	12.8	9.8	10.7	12.5	10.2	13.9	14.9	13.4	13.1	15.8	10.1	10.0	12.3	14.8	22.2	13.4	9.4	12.0	16.6	14.6	2.6	2.3	10.0	2.0	6.5	4.0	1.7	4.6	1.9	3.4	4.7	7.5	6.2	3.0	6.1	5.6	4.1	5.9	2.9	2.8	7.4	4.3	5.3	3.1	3.6	5.7	8.3	4.5	2.0	4.6	2.6	2.1	5.6	5.2	5.2	6.1	5.7	4.6	5.5	5.6	3.1	6.0	9.3	3.6	5.2	4.8	1.8	3.2	3.6	2.3	3.5	4.0	6.1	2.5	2.2	4.5	3.6	11.7	4.9	4.1	6.3	9.2	6.1	34.5	4.4	6.9	4.7	5.2	7.5	5.0	5.9	10.0	1.9	2.7	2.9	2.0	3.3	1.8	3.2	4.0	2.3	2.6	3.9	2.6	2.7	6.5	1.4	1.1	2.2	1.7	10.9	11.6	18.6	13.3	11.3	8.5	13.9	10.3	11.1	14.8
ZNF665	FLJ14345	ENSG00000197497	"Zinc finger protein 665"	Q9H7R5	19	53159213-53193386	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA023437	Uncertain		Approved	"Nuclear membrane"				"Nuclear membrane"		"HPA023437: "	"unprognostic (8.01e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.63e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.81e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.45e-1)"	"unprognostic (9.27e-2)"	4.3	3.8	4.2	4.3	6.7	2.3	5.1	10.7	6.2	5.3	4.0	5.7	2.6	1.6	6.4	5.2	3.2	6.7	2.9	2.6	5.2	2.6	2.6	1.1	3.6	4.2	5.5	3.2	11.5	2.7	7.7	4.8	2.9	4.8	6.0	2.6	6.0	2.9	4.0	1.4	3.3	2.6	5.5	6.5	3.9	2.9	3.4	7.0	7.2	5.8	1.5	3.2	5.4	4.1	5.4	1.6	1.5	1.1	4.9	2.2	0.5	1.1	0.2	1.2	3.8	1.2	2.2	2.7	2.7	1.7	2.7	3.8	0.4	1.0	2.0	2.0	2.0	0.4	0.7	0.2	4.4	0.0	0.1	0.1	0.7	0.1	2.7	0.5	1.0	2.5	0.0	2.4	0.0	0.2	0.4	0.6	0.1	0.4	5.3	1.6	2.2	0.6	0.1	0.1	0.8	0.5	5.2	0.5	2.4	0.2	0.4	0.1	1.5	1.1	0.7	1.8	2.2	1.7	1.0	0.3	4.5	4.8	0.1	1.4	2.6	1.5	0.5	1.1	0.8	0.3	1.0	2.7	1.0	2.2	0.9	5.4	1.8	1.9	1.4	4.9	1.1	1.6	0.7	0.5	4.2	6.7	10.7	6.2	5.2	2.6	5.5	3.2	4.8	7.0
ZNF667	FLJ14011	ENSG00000198046	"Zinc finger protein 667"	Q5HYK9	19	56439325-56478065	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 9.3;HEL: 10.8;U-138 MG: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 6.2"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA030731, HPA046673"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA030731: , HPA046673: "	"unprognostic (6.10e-2)"	"unprognostic (7.87e-3)"	"unprognostic (2.91e-2)"	"unprognostic (4.81e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.26e-3)"	"unprognostic (8.55e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.77e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.09e-2)"	"unprognostic (8.34e-3)"	"unprognostic (3.54e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.55e-2)"	2.4	7.7	8.0	1.7	18.2	6.2	6.8	12.1	16.1	4.7	2.6	5.3	1.8	1.6	6.4	11.6	2.4	6.3	4.3	4.0	10.2	9.9	4.1	1.3	2.1	2.4	6.5	8.3	11.1	3.5	6.1	18.9	3.0	9.7	5.6	0.9	3.2	4.5	4.5	2.0	2.9	1.1	5.6	6.6	2.4	1.8	5.9	5.3	2.9	12.6	0.6	1.8	3.7	4.2	6.2	2.2	0.4	0.0	4.5	3.7	0.6	0.1	0.2	9.3	0.1	0.0	0.0	0.2	3.9	3.0	3.6	2.9	0.2	0.1	0.5	5.5	1.4	0.1	0.0	0.1	5.5	0.0	2.1	10.8	0.1	0.2	2.8	6.3	4.9	6.0	0.1	0.7	0.0	0.0	0.0	0.3	2.8	0.2	0.1	0.2	6.8	1.8	0.0	3.5	7.4	3.6	0.6	0.3	5.4	0.2	0.1	0.0	2.5	0.0	0.0	13.6	3.7	0.2	6.9	0.2	5.8	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	1.2	0.4	0.3	0.3	6.2	1.5	3.7	0.4	4.5	0.0	2.2	0.0	0.6	8.0	18.2	12.1	14.4	10.2	9.9	6.5	8.3	9.7	5.3
ZNF669	FLJ12606	ENSG00000188295	"Zinc finger protein 669"	Q96BR6	1	247099962-247104372	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA044043	Uncertain									"HPA044043: AB_10964039"	"unprognostic (1.88e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.09e-1)"	"prognostic favourable (4.59e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.81e-2)"	10.6	5.3	4.7	7.1	6.5	17.4	9.6	11.0	9.2	8.8	6.2	8.2	3.0	4.9	9.7	5.8	5.5	7.3	5.2	4.5	5.2	5.5	7.7	4.8	6.2	11.1	4.9	3.9	8.6	8.3	5.8	9.1	5.0	8.2	6.5	6.4	5.2	7.0	6.0	5.0	6.2	7.0	6.6	5.2	10.5	6.6	9.6	4.4	24.1	8.8	4.3	9.4	6.9	5.2	8.2	5.5	11.1	3.3	5.6	8.5	3.4	3.2	2.3	7.6	8.8	4.5	4.0	7.8	4.7	5.0	6.9	6.8	5.5	3.4	4.7	7.3	3.3	4.2	7.4	5.8	7.4	2.4	1.8	0.3	5.3	4.0	3.6	4.1	5.6	3.7	6.1	5.4	3.9	3.9	8.1	3.2	6.9	2.9	11.1	4.4	17.8	4.8	8.9	7.4	3.3	4.9	9.5	8.2	14.6	6.3	3.3	2.4	6.5	15.9	4.2	4.7	5.3	4.3	8.9	8.3	15.0	9.5	1.2	2.2	4.6	11.1	3.3	9.9	6.1	2.1	8.0	8.2	7.4	5.8	4.1	7.2	8.5	8.0	8.1	5.6	3.0	5.5	7.6	3.4	4.7	6.5	11.0	9.2	5.2	5.5	4.9	3.9	8.2	4.4
ZNF671	FLJ23506	ENSG00000083814	"Zinc finger protein 671"	Q8TAW3	19	57719751-57727624	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA046099, HPA056043"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA046099: AB_10962484, HPA056043: "	"prognostic favourable (2.20e-4)"	"unprognostic (4.16e-3)"	"unprognostic (6.02e-2)"	"unprognostic (5.91e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.97e-3)"	"unprognostic (6.12e-2)"	"unprognostic (5.56e-3)"	"unprognostic (8.26e-3)"	"unprognostic (2.04e-1)"	"prognostic favourable (3.57e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.22e-1)"	3.3	7.9	9.1	6.3	10.1	5.6	6.6	28.5	10.4	5.4	6.7	4.5	4.5	2.7	3.3	8.4	3.2	6.9	4.2	8.1	9.0	6.7	6.2	3.3	5.6	13.2	8.0	7.5	5.4	4.1	16.1	11.3	5.9	7.9	6.6	3.7	7.8	4.5	9.4	10.3	3.2	7.1	6.6	9.0	15.1	3.8	7.1	8.9	15.6	10.4	1.1	12.1	6.2	2.5	22.2	11.0	13.7	10.0	13.9	19.4	10.9	0.1	0.2	2.5	0.0	0.4	0.1	0.0	2.7	1.6	5.4	1.9	0.3	0.4	5.5	0.9	3.9	0.1	2.1	2.2	6.3	6.0	4.0	0.1	0.9	0.0	4.7	0.0	8.1	7.0	1.6	3.4	1.9	0.8	0.8	2.8	4.8	0.1	10.5	0.1	3.5	5.6	4.1	7.5	3.3	2.0	0.2	0.2	0.0	0.0	0.1	3.6	1.6	7.7	0.0	0.6	2.9	0.0	2.1	5.0	0.1	3.0	0.6	1.3	1.8	12.1	7.6	13.7	6.4	7.0	16.7	17.2	13.3	11.0	11.0	22.2	19.4	15.5	5.6	13.9	10.0	10.0	13.1	10.9	9.1	10.1	28.5	10.4	9.0	6.7	8.0	7.5	7.9	8.9
ZNF672	FLJ22301	ENSG00000171161	"Zinc finger protein 672"	Q499Z4	1	248838210-248849517	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055779, HPA062506"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA055779: , HPA062506: "	"unprognostic (1.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (7.42e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.40e-2)"	"prognostic favourable (7.51e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.35e-3)"	"prognostic favourable (1.79e-5)"	11.3	12.5	11.1	16.4	13.6	15.1	12.1	18.6	15.3	10.2	13.0	17.3	15.0	13.8	12.1	10.7	15.9	11.3	13.3	20.1	11.4	10.2	14.8	27.5	13.6	16.7	14.1	7.5	12.0	14.1	20.4	14.1	16.1	12.4	18.7	11.1	15.1	24.1	14.8	46.6	13.3	16.8	11.3	11.2	16.0	12.7	12.4	14.5	28.1	21.7	21.0	17.3	14.5	10.4	14.5	20.8	9.6	13.4	10.5	8.0	10.3	10.0	11.5	9.5	10.5	5.4	3.7	17.8	9.6	5.2	6.8	7.5	6.3	10.6	11.4	9.9	6.3	10.0	5.2	7.1	4.5	16.6	2.9	17.4	10.7	8.4	6.9	7.6	13.5	4.2	5.9	9.1	6.5	6.4	21.2	9.6	4.8	7.3	13.4	7.6	10.8	19.6	25.3	8.9	8.9	7.1	8.4	13.9	12.2	8.6	13.1	8.5	7.6	15.5	5.4	9.7	5.8	6.4	19.5	28.7	10.7	6.7	8.9	13.4	7.9	7.6	13.3	9.6	8.0	13.4	6.7	10.8	5.7	7.9	20.8	14.5	6.3	5.6	8.1	10.5	12.4	11.7	6.5	10.3	11.1	13.6	18.6	15.3	11.4	10.2	14.1	7.5	12.4	14.5
ZNF674	"MRX92, ZNF673B"	ENSG00000251192	"Zinc finger protein 674"	Q2M3X9	X	46497727-46545457	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA031026, HPA065295"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA031026: AB_10602690, HPA065295: "	"unprognostic (6.11e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.41e-5)"	"unprognostic (2.74e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.25e-4)"	"unprognostic (8.45e-4)"	6.7	5.1	5.7	4.0	10.1	3.8	5.5	12.6	9.8	4.7	4.5	6.8	1.9	4.2	6.3	6.5	4.1	3.7	4.9	4.9	5.7	6.3	5.6	8.1	4.3	5.1	6.4	5.8	7.2	7.4	4.8	11.2	4.5	9.6	8.2	5.1	6.8	4.5	5.7	5.0	5.4	4.6	6.9	6.8	5.8	3.9	3.7	7.0	6.0	6.9	1.8	4.6	4.5	5.1	2.3	2.5	5.8	3.5	1.9	2.7	2.1	2.7	3.6	3.6	4.5	3.3	3.2	3.5	3.0	4.1	3.9	4.2	2.4	2.3	3.0	1.9	5.0	2.7	4.8	3.6	4.3	2.6	3.0	1.4	3.9	2.0	4.4	3.3	5.6	3.1	5.8	2.9	9.5	3.1	1.6	4.7	3.5	1.8	3.3	1.5	5.8	3.4	1.6	6.0	3.5	2.6	1.1	1.4	3.0	4.6	1.5	9.4	3.8	2.4	2.7	5.0	5.7	3.0	2.8	5.5	4.8	1.3	2.1	1.7	5.0	2.5	2.2	2.9	1.9	3.5	2.0	2.3	2.7	1.5	2.1	1.4	2.2	2.3	5.8	1.9	0.8	2.5	2.2	2.1	5.7	10.1	12.6	9.8	5.7	6.3	6.4	5.8	9.6	7.0
ZNF677	MGC48625	ENSG00000197928	"Zinc finger protein 677"	Q86XU0	19	53235381-53254898	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.5"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA023106	Approved		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA023106: AB_1859409"	"unprognostic (2.06e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.73e-2)"	"unprognostic (4.07e-3)"	"unprognostic (7.87e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.70e-8)"	"unprognostic (6.57e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.17e-2)"	9.1	7.3	5.9	4.3	8.3	4.2	9.3	13.0	7.3	7.4	7.0	13.9	1.3	2.9	12.3	5.7	4.6	9.7	6.2	9.4	5.3	4.3	6.3	2.3	6.8	7.3	9.9	4.8	14.3	4.4	9.1	9.9	7.5	6.6	8.9	3.4	7.6	7.4	6.2	3.9	7.5	3.9	8.1	10.5	7.0	5.7	40.5	8.7	6.7	10.1	5.2	5.0	8.2	6.6	17.4	14.5	10.1	2.8	10.3	15.4	4.1	0.2	0.2	11.8	0.4	4.0	6.2	2.1	7.7	5.9	8.0	7.2	0.0	0.5	0.1	5.8	6.7	0.7	0.0	6.0	2.3	0.2	4.2	0.3	0.5	0.2	10.0	0.1	7.9	10.7	0.0	7.6	0.1	3.5	0.1	0.5	5.3	0.2	6.4	0.2	20.3	2.7	0.1	0.0	0.2	2.3	3.1	0.2	11.2	0.2	2.9	0.2	0.4	0.3	2.2	12.6	0.3	0.2	5.0	0.3	0.1	0.2	0.2	0.3	0.1	10.1	2.2	6.4	5.1	2.8	7.3	9.6	7.2	5.6	6.1	17.4	15.4	10.0	2.6	10.3	1.8	14.5	4.5	4.1	5.9	8.3	13.0	7.0	5.3	4.3	9.9	4.8	6.6	8.7
ZNF678	MGC42493	ENSG00000181450	"Zinc finger protein 678"	Q5SXM1	1	227563543-227677443	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA028507	Uncertain		Approved	Nucleoli,Mitochondria,Cytosol				"Mitochondria, Cytosol"	Nucleoli	"HPA028507: AB_10603567"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.54e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-4)"	9.0	7.6	8.2	6.6	16.2	7.1	8.8	19.4	10.8	9.3	7.2	6.7	7.1	5.4	9.2	6.2	6.1	7.7	7.4	7.4	8.9	6.3	6.4	5.3	7.8	9.8	12.7	8.2	9.9	12.6	7.2	19.4	9.7	8.9	10.6	10.8	4.6	7.6	6.3	6.2	5.2	6.6	7.5	14.2	9.5	7.6	8.7	15.5	12.0	12.7	5.1	9.1	8.2	9.4	6.6	3.2	7.1	1.1	2.2	3.2	1.5	2.0	3.2	11.8	13.4	1.4	3.4	7.1	2.7	2.7	4.0	4.3	2.5	2.5	8.2	7.1	1.2	3.9	6.9	1.8	6.7	3.4	13.2	3.9	2.5	1.6	2.6	6.5	10.5	2.9	3.3	2.4	5.3	3.8	9.7	13.0	4.4	1.7	9.0	2.3	10.3	5.4	7.0	7.6	3.2	3.0	6.4	5.0	9.8	4.1	4.8	2.0	6.7	8.3	2.5	5.1	4.8	4.5	5.5	4.2	9.5	9.0	2.1	1.2	5.2	7.1	1.1	1.3	2.5	0.3	3.0	6.6	2.5	1.4	2.1	4.5	2.2	3.2	0.2	2.2	0.7	3.2	2.7	1.5	8.2	16.2	19.4	10.8	8.9	6.3	12.7	8.2	8.9	15.5
ZNF682	BC39498_3	ENSG00000197124	"Zinc finger protein 682"	O95780	19	19997058-20039506	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 11.8;AN3-CA: 17.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA055998	Uncertain		Uncertain	"Golgi apparatus"				"Golgi apparatus"		"HPA055998: "	"unprognostic (8.96e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.70e-4)"	"unprognostic (1.77e-3)"	"unprognostic (4.06e-7)"	"unprognostic (2.07e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.19e-1)"	"prognostic favourable (3.51e-4)"	4.1	4.9	11.0	5.2	14.1	4.1	7.6	13.6	12.9	5.9	5.3	10.3	8.5	3.5	5.2	8.1	5.3	6.9	5.3	7.1	10.5	7.6	6.3	6.9	8.1	7.9	12.5	6.5	4.6	4.9	4.6	12.0	6.7	9.4	11.0	5.8	4.3	3.3	16.2	6.7	13.9	4.6	5.6	9.7	6.7	5.4	5.6	12.4	6.5	17.4	4.6	9.6	6.2	4.8	5.7	2.2	7.6	1.0	2.2	6.4	2.1	0.0	0.0	11.8	17.8	0.9	1.2	0.5	2.5	1.2	4.2	6.8	2.0	2.5	0.1	4.3	3.5	2.2	4.8	0.4	4.7	0.0	5.0	0.0	0.1	1.3	1.7	0.0	4.2	1.8	1.4	2.3	0.0	0.0	0.0	0.1	3.1	3.6	6.7	1.0	6.5	1.5	4.2	6.1	0.1	2.2	7.7	6.5	7.1	0.0	2.2	0.0	4.4	2.3	0.0	6.2	1.0	10.5	4.3	0.0	6.9	1.1	0.0	0.0	2.0	7.6	0.7	1.4	4.0	0.8	3.0	5.7	5.8	3.1	2.2	4.3	6.3	6.4	2.4	2.2	1.0	1.9	6.2	2.1	11.0	14.1	13.6	12.3	10.5	7.6	12.5	6.5	9.4	12.4
ZNF684	MGC27466	ENSG00000117010	"Zinc finger protein 684"	Q5T5D7	1	40531561-40548169	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 27.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059153	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA059153: "	"unprognostic (4.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.67e-4)"	"unprognostic (8.49e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.10e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.96e-2)"	"prognostic favourable (4.89e-10)"	"unprognostic (4.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.52e-2)"	3.6	6.4	4.1	2.9	8.9	8.2	4.2	5.8	7.4	3.6	3.8	2.3	5.4	3.2	3.6	4.3	3.2	3.1	3.4	10.6	4.4	3.3	18.3	20.8	3.4	4.4	9.8	3.6	3.8	5.4	2.5	4.6	2.1	5.4	5.1	4.8	1.6	3.5	4.1	4.4	4.1	3.4	3.2	5.9	5.1	4.2	4.3	7.8	6.4	5.6	4.1	3.5	3.1	2.7	6.0	3.9	7.0	7.7	3.5	5.9	2.4	2.1	0.7	2.7	3.7	2.5	3.7	1.6	2.0	1.9	2.3	4.0	1.3	2.8	3.7	1.6	1.2	2.7	2.7	1.9	3.8	3.2	4.6	4.0	2.5	3.5	1.3	4.3	4.4	2.5	0.8	2.9	1.1	3.6	2.1	5.5	3.4	0.6	6.3	5.0	6.7	2.3	2.9	8.2	2.6	3.6	1.9	2.0	3.5	3.6	3.6	4.0	1.5	27.5	2.1	2.4	5.1	2.3	3.9	4.7	3.3	4.3	2.1	4.6	3.7	7.0	4.0	1.9	5.9	7.7	3.2	6.0	4.2	3.6	2.4	3.5	2.8	5.5	2.3	3.5	4.1	3.9	4.7	2.4	4.1	8.9	5.8	7.4	4.4	3.3	9.8	3.6	5.4	7.8
ZNF688		ENSG00000229809	"Zinc finger protein 688"	P0C7X2	16	30569346-30572734	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048922	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"				Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA048922: AB_2680557"	"prognostic favourable (5.90e-4)"	"prognostic favourable (7.74e-4)"	"unprognostic (1.68e-1)"	"prognostic favourable (4.58e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.01e-1)"	"prognostic favourable (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.26e-2)"	"prognostic favourable (6.61e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.14e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.03e-2)"	10.7	11.9	14.2	11.8	11.8	13.7	8.0	13.8	16.7	8.8	15.3	15.5	12.1	20.5	11.5	9.6	12.0	13.5	14.5	17.2	13.1	10.6	11.2	12.4	10.3	19.9	12.1	11.5	12.9	14.7	8.4	14.0	7.8	11.2	11.8	9.0	11.0	13.8	10.1	32.5	9.5	14.4	14.2	11.0	13.9	13.0	24.6	8.3	21.6	13.7	8.3	10.0	10.4	13.3	6.1	5.4	12.6	5.4	15.1	6.8	2.8	7.6	5.8	5.9	6.2	11.3	2.9	2.5	4.4	6.1	3.7	2.9	1.8	11.7	4.1	8.9	5.5	5.7	1.6	2.8	4.1	12.0	3.6	2.8	2.3	1.4	3.0	3.8	12.5	5.8	6.2	4.0	4.8	3.7	2.9	9.5	4.2	4.6	10.9	4.3	2.1	1.9	9.3	2.4	6.0	6.5	2.5	8.5	9.4	1.5	11.6	9.8	12.7	6.4	2.9	3.2	3.5	3.8	3.4	13.5	9.4	4.3	9.9	3.3	5.5	12.6	3.9	8.3	4.8	3.9	5.8	5.5	5.6	5.4	3.9	6.1	4.8	4.4	6.0	15.1	5.4	5.4	6.8	2.8	14.2	11.8	13.8	16.7	13.1	10.6	12.1	11.5	11.2	8.3
ZNF70	"Cos17, MGC48959"	ENSG00000187792	"Zinc finger protein 70"	Q9UC06	22	23738678-23751092	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA018821	Uncertain		Supported	Cytosol				Cytosol		"HPA018821: AB_1859423"	"unprognostic (3.17e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.18e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.69e-2)"	5.5	5.0	8.4	7.6	8.5	5.5	5.5	14.3	10.3	7.5	5.5	8.2	10.7	3.4	7.8	8.7	3.6	7.4	5.9	6.3	8.6	3.8	4.1	3.0	4.7	4.9	7.1	5.7	15.3	6.5	10.1	6.2	4.5	7.1	5.9	4.8	9.0	7.2	8.4	9.1	4.3	5.1	7.0	4.9	5.2	5.1	4.7	10.9	3.9	6.7	1.1	5.6	5.8	5.4	1.5	1.6	4.2	1.0	2.0	1.2	0.4	1.9	2.5	4.7	4.9	7.1	3.4	1.6	1.8	3.6	4.0	5.8	2.4	1.3	2.7	1.2	3.8	2.1	3.3	2.3	5.2	1.8	3.0	5.2	4.4	2.1	4.3	4.6	4.5	3.3	1.6	5.5	4.6	3.2	1.8	3.9	3.0	2.7	2.7	2.3	1.2	1.1	11.2	4.5	0.6	1.4	2.6	2.7	3.3	2.6	3.4	2.0	1.7	2.2	4.2	4.6	5.7	3.0	2.0	4.1	0.7	2.6	4.0	2.2	3.8	4.2	1.0	0.9	1.0	0.8	0.6	0.8	1.0	0.6	0.5	1.5	1.1	1.2	3.2	2.0	0.8	1.6	0.4	0.4	8.4	8.5	14.3	10.3	8.6	3.8	7.1	5.7	7.1	10.9
ZNF700	DKFZp434I1610	ENSG00000196757	"Zinc finger protein 700"	Q9H0M5	19	11925068-11950773	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA047845	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm		"HPA047845: "	"unprognostic (1.92e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.51e-1)"	"prognostic favourable (1.27e-4)"	"unprognostic (8.63e-2)"	"unprognostic (8.68e-2)"	"prognostic unfavourable (2.58e-4)"	"unprognostic (9.02e-2)"	"unprognostic (7.44e-2)"	"prognostic unfavourable (1.75e-4)"	"prognostic unfavourable (2.01e-5)"	"unprognostic (8.38e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.30e-1)"	"prognostic favourable (2.53e-5)"	10.2	10.3	7.7	22.2	9.6	19.7	21.6	10.2	8.9	8.3	11.3	5.7	13.6	8.4	9.5	12.7	11.8	8.6	13.9	6.8	7.2	3.8	13.6	16.7	13.5	14.6	8.6	5.4	13.1	23.7	13.4	12.4	6.9	7.4	12.0	15.2	7.2	15.8	11.5	5.1	21.8	15.3	14.4	7.1	20.7	11.3	17.3	8.5	10.3	11.2	6.7	14.7	10.8	13.4	6.9	6.4	9.5	8.1	7.2	8.3	3.8	6.4	0.3	7.0	7.2	4.5	4.9	7.1	6.9	6.0	6.2	8.2	5.4	3.3	8.5	6.1	4.5	5.1	5.7	5.0	8.6	4.8	3.0	8.8	6.4	4.8	3.8	12.4	13.1	4.0	6.0	5.3	6.0	3.9	9.9	19.3	9.0	5.3	6.8	11.5	7.1	6.4	5.8	9.3	6.6	8.8	7.5	4.2	5.0	6.3	4.2	8.1	7.2	14.3	5.5	16.1	4.2	11.0	7.9	13.4	7.1	9.1	4.2	10.3	5.2	9.5	4.6	9.0	6.9	5.2	7.8	6.9	5.7	8.3	6.4	4.4	5.5	6.9	7.3	7.2	8.1	4.1	6.4	3.8	7.7	9.6	10.2	8.9	7.2	3.8	8.6	5.4	7.4	8.5
ZNF709	FLJ38281	ENSG00000242852	"Zinc finger protein 709"	Q8N972	19	12461184-12513854	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 26.6"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA045573, HPA053153"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA045573: , HPA053153: "	"unprognostic (2.27e-1)"	"unprognostic (7.40e-4)"	"unprognostic (3.53e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.58e-4)"	"unprognostic (6.76e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.53e-5)"	3.4	3.0	7.8	4.8	8.4	2.0	5.1	12.7	7.3	5.0	2.7	3.2	5.6	0.7	5.5	5.3	2.4	6.6	2.4	3.6	6.2	5.4	5.4	2.0	3.0	2.7	3.8	4.6	8.4	4.1	6.2	8.0	3.5	4.9	5.7	2.1	3.3	3.4	4.5	2.5	2.8	2.7	5.1	5.5	4.0	2.6	26.6	5.0	7.2	8.5	0.0	4.0	4.1	4.5	2.0	1.3	3.5	1.1	5.5	4.4	1.0	1.8	0.0	6.2	7.6	1.2	1.8	1.0	1.8	2.1	2.1	2.2	1.7	0.2	1.8	1.2	2.0	1.3	3.4	1.3	2.3	0.3	0.9	1.6	1.1	1.2	2.5	0.4	2.7	1.0	0.6	1.2	0.0	1.4	1.0	0.2	2.6	3.5	3.9	2.2	2.1	2.0	2.1	6.0	5.6	2.1	3.0	2.8	3.9	0.0	0.3	0.8	1.5	1.0	0.0	3.3	0.6	1.4	1.3	3.3	4.8	2.6	0.0	0.0	1.5	3.5	0.4	0.1	2.0	0.1	3.1	1.7	3.3	2.1	0.9	2.0	4.4	3.1	0.1	5.5	1.1	1.3	1.8	1.0	7.8	8.4	12.7	7.3	6.2	5.4	3.8	4.6	4.9	5.0
ZNF713	FLJ39963	ENSG00000178665	"Zinc finger protein 713"	Q8N859	7	55887475-55942225	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.9"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA059425, HPA062887"	Uncertain		Approved	Nucleoli				Nucleoli		"HPA059425: , HPA062887: "	"unprognostic (5.27e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.07e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.77e-3)"	"unprognostic (7.78e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.63e-3)"	2.0	2.7	7.0	2.6	9.7	4.1	4.0	5.6	9.3	3.8	2.2	10.6	2.7	2.7	5.5	3.5	1.7	7.1	2.9	2.4	7.8	6.1	3.9	1.7	2.6	1.7	13.4	4.8	5.6	3.2	4.2	8.1	2.2	7.3	4.1	1.9	2.6	2.4	2.9	4.7	3.1	1.9	3.7	9.8	2.5	4.0	9.4	10.6	6.9	4.9	0.4	1.8	2.1	2.0	2.2	1.7	6.9	1.3	1.4	1.0	0.4	1.7	1.2	7.3	6.6	0.9	1.0	2.6	0.8	0.5	1.0	1.4	0.6	2.3	3.0	2.6	0.6	0.7	1.8	0.6	1.4	1.7	2.9	0.7	2.5	1.9	1.2	3.7	2.0	1.7	1.5	0.5	1.3	1.7	1.9	1.4	1.2	1.6	3.6	2.2	4.9	1.4	3.1	1.8	0.4	3.5	3.2	8.4	10.0	4.2	1.1	1.2	2.7	3.2	1.9	0.9	3.5	0.7	1.2	1.6	2.2	1.3	0.6	2.0	6.2	3.7	1.3	3.3	0.9	1.0	0.6	1.3	0.7	0.6	0.4	2.2	0.9	1.0	6.9	1.4	1.0	1.7	0.4	0.4	7.0	9.7	5.6	9.3	7.8	6.1	13.4	4.8	7.3	10.6
ZNF720		ENSG00000197302	"Zinc finger protein 720"	Q7Z2F6	16	31713229-31794869	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA041570	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA041570: AB_10795126"	"unprognostic (5.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-3)"	"unprognostic (8.72e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.47e-3)"	"unprognostic (3.70e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.91e-2)"	15.1	15.8	11.1	13.7	11.8	9.9	12.7	16.8	17.6	14.3	12.4	11.3	17.7	7.2	11.7	17.4	16.4	12.8	10.3	10.1	11.1	15.1	14.2	11.6	10.7	17.5	15.5	11.0	9.6	12.9	13.4	24.5	19.4	15.5	14.5	14.0	11.4	13.9	17.7	10.3	17.3	10.1	13.2	14.3	18.4	14.1	13.7	15.9	16.6	19.2	11.0	18.1	14.6	11.6	14.4	8.9	23.0	5.5	12.8	14.2	5.0	10.2	7.2	9.0	7.9	7.9	12.0	8.7	11.0	7.2	5.4	7.2	5.2	11.0	5.0	19.4	3.7	7.2	8.8	4.2	8.0	22.2	4.6	2.7	3.9	14.8	11.8	5.9	15.3	8.1	11.8	3.7	5.4	10.1	9.2	6.6	5.8	16.6	6.0	7.8	8.8	5.7	11.4	4.0	7.8	6.1	6.5	4.1	6.1	11.1	5.0	9.8	9.6	11.7	6.5	3.9	3.1	7.8	3.3	11.0	12.0	14.3	3.5	9.1	6.1	13.9	4.8	23.0	14.2	5.4	10.6	13.7	10.0	12.7	5.2	14.4	9.3	11.7	6.3	12.8	5.5	8.9	12.2	5.0	11.1	11.8	16.8	17.6	11.1	15.1	15.5	11.0	15.5	15.9
ZNF736		ENSG00000234444	"Zinc finger protein 736"	B4DX44	7	64307459-64354860	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA051027, HPA061215"	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm		"HPA051027: , HPA061215: "	"unprognostic (2.41e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.17e-3)"	"prognostic unfavourable (3.03e-4)"	"unprognostic (4.14e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.20e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.01e-2)"	"prognostic unfavourable (5.01e-4)"	"unprognostic (2.26e-1)"	"unprognostic (9.63e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.22e-3)"	"prognostic favourable (8.65e-4)"	7.1	5.4	8.5	8.2	17.4	17.0	12.9	8.3	19.8	7.7	5.5	7.8	4.7	3.9	8.4	9.8	5.4	7.7	6.3	5.3	7.5	6.0	8.2	3.7	7.4	14.0	5.5	8.2	13.1	7.5	6.2	7.6	5.4	13.8	8.6	6.1	11.5	7.7	5.7	4.2	13.1	8.5	6.3	5.8	10.1	6.2	16.8	7.0	17.1	10.6	2.0	11.4	6.1	7.4	4.7	3.5	2.8	2.1	0.3	2.4	1.0	0.5	0.2	4.6	15.8	1.7	3.1	4.7	2.5	0.1	3.3	5.4	1.2	2.5	11.8	3.8	2.1	2.0	3.4	1.0	5.3	0.2	3.2	4.8	1.3	0.1	1.7	2.1	6.8	2.5	1.0	3.7	0.1	0.4	5.6	2.5	4.6	3.0	7.1	11.2	8.8	0.9	6.2	7.1	5.7	4.1	7.0	5.0	7.2	5.7	4.0	1.5	11.3	8.7	0.3	5.1	3.7	1.3	3.0	3.0	4.3	14.4	0.1	2.6	0.1	0.0	1.9	2.8	1.5	1.8	1.1	4.7	2.3	1.3	2.1	4.5	2.4	1.9	0.4	0.3	2.1	3.5	1.0	1.0	8.5	17.4	8.3	19.8	7.5	6.0	5.5	8.2	13.8	7.0
ZNF738		ENSG00000172687	"Zinc finger protein 738"	Q8NE65	19	21358930-21379302	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 24.0;NTERA-2: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA059135	Uncertain									"HPA059135: "	"unprognostic (1.00e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.48e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.27e-3)"	"prognostic favourable (2.27e-4)"	"unprognostic (2.10e-1)"	"unprognostic (3.51e-2)"	"unprognostic (7.39e-5)"	"unprognostic (2.34e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.20e-2)"	5.1	4.6	8.1	7.8	21.5	17.5	5.8	25.1	12.5	6.3	4.7	13.6	3.4	4.8	9.4	6.7	5.9	6.3	4.8	4.3	9.3	10.1	4.4	1.4	5.3	9.8	18.6	9.9	14.8	4.7	3.9	4.5	10.6	14.7	6.3	6.4	7.3	6.0	5.2	3.0	6.7	5.5	6.5	13.2	6.9	5.2	7.5	16.0	14.8	6.3	3.0	9.5	5.8	6.2	8.8	5.4	10.0	7.9	7.6	7.2	3.2	1.5	0.9	24.0	9.0	2.9	2.3	17.0	5.9	2.3	11.1	11.5	2.0	7.5	5.1	6.1	2.1	4.2	8.4	2.7	15.2	6.5	6.5	4.1	1.7	1.6	1.6	1.5	1.4	2.0	1.6	6.3	3.5	4.8	0.2	0.2	6.7	1.7	19.0	7.8	25.4	4.3	19.9	9.7	3.2	2.8	3.6	11.3	5.5	2.2	0.2	3.2	2.8	14.3	3.2	1.4	1.6	7.4	5.2	0.5	7.9	13.5	0.3	0.5	2.8	7.2	6.2	7.8	3.9	6.4	3.5	7.2	4.8	4.6	5.3	8.8	4.8	4.7	10.0	7.6	7.9	5.4	7.2	3.2	8.1	21.5	25.1	12.5	9.3	10.1	18.6	9.9	14.7	16.0
ZNF75A	FLJ31529	ENSG00000162086	"Zinc finger protein 75a"	Q96N20	16	3305406-3318852	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA001665	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA001665: AB_1080751"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.79e-3)"	"unprognostic (6.32e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.75e-3)"	"unprognostic (6.79e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.47e-2)"	"unprognostic (8.97e-3)"	10.0	11.4	13.6	14.8	15.7	9.0	15.0	19.6	15.4	10.6	10.1	17.2	14.4	8.0	12.4	26.1	9.5	14.1	9.0	9.0	13.2	12.2	12.7	16.2	10.4	18.1	12.8	14.4	19.3	13.6	32.1	23.5	12.7	17.7	16.2	15.1	10.1	10.6	15.4	10.4	13.8	12.8	10.8	10.3	15.6	10.1	13.5	15.9	15.8	17.9	7.7	18.0	10.2	8.6	25.2	13.8	15.2	9.1	17.8	23.0	3.3	4.5	6.7	12.6	6.4	6.0	5.5	10.7	7.3	3.0	6.9	8.2	0.1	5.9	7.3	5.0	5.3	3.4	7.5	4.4	10.4	3.0	10.1	15.5	7.8	0.6	4.3	9.9	15.7	7.4	4.6	7.2	5.4	6.2	8.7	12.0	9.6	6.2	15.0	6.8	19.5	4.7	31.3	6.2	8.7	7.4	7.4	11.4	8.1	11.4	4.6	4.5	14.8	12.6	7.2	5.1	12.9	4.9	5.8	8.3	7.3	20.9	1.7	11.2	7.8	13.3	6.7	15.2	13.0	6.2	16.0	16.8	14.8	13.3	5.2	25.2	23.0	17.2	4.8	17.8	9.1	13.8	11.9	3.3	13.6	15.7	19.6	15.4	13.2	12.2	12.8	14.4	17.7	15.9
ZNF75D	"D8C6, ZKSCAN24, ZNF75, ZNF82, ZSCAN28"	ENSG00000186376	"Zinc finger protein 75D"	P51815	X	135248920-135344087	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA004705	Supported		Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA004705: AB_1080749"	"unprognostic (1.56e-3)"	"unprognostic (7.96e-3)"	"unprognostic (3.07e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.00e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"prognostic favourable (1.31e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"prognostic favourable (7.42e-5)"	8.4	18.8	8.2	14.6	9.7	9.2	9.9	11.4	10.5	11.8	10.6	9.2	10.4	6.9	10.7	12.8	7.6	9.8	7.9	7.6	5.6	7.7	10.6	13.4	9.7	11.2	6.2	7.7	10.1	12.9	12.6	14.7	8.0	9.2	15.0	8.4	7.5	10.0	11.8	6.6	9.9	10.6	7.5	5.9	18.6	9.7	3.4	6.7	16.6	13.2	9.3	13.3	8.0	8.6	3.7	1.8	4.1	2.1	5.2	6.5	2.9	3.4	4.6	5.0	8.0	8.5	10.4	7.6	5.9	8.0	4.8	10.3	2.8	4.4	3.6	8.7	5.0	4.8	16.3	2.6	4.6	3.5	4.3	2.5	8.3	3.6	3.7	4.2	7.2	5.1	6.4	3.0	3.7	4.9	2.1	5.8	4.2	8.3	5.1	7.7	2.4	6.2	4.9	5.0	3.2	5.4	4.8	1.7	5.7	3.3	5.7	0.9	2.0	6.1	5.1	4.6	1.1	7.7	5.5	2.9	4.1	2.7	2.9	4.7	2.9	4.1	2.1	3.7	4.9	1.5	4.5	2.9	5.2	5.6	1.8	3.7	6.5	5.9	2.6	5.2	1.5	1.6	6.3	2.9	8.2	9.7	11.4	10.5	5.6	7.7	6.2	7.7	9.2	6.7
ZNF763	ZNF440L	ENSG00000197054	"Zinc finger protein 763"	Q0D2J5	19	11965037-11980381	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA047845	Approved		Uncertain	Nucleoplasm				Nucleoplasm		"HPA047845: "	"unprognostic (4.09e-3)"	"unprognostic (6.15e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.43e-1)"	"unprognostic (8.26e-3)"	"unprognostic (9.36e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.07e-6)"	"unprognostic (1.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.89e-3)"	7.0	5.2	3.6	4.1	6.6	3.0	9.1	5.5	5.4	7.3	9.0	5.6	6.8	4.8	8.3	5.4	5.1	6.0	4.5	9.7	4.0	3.3	11.1	3.6	7.1	6.3	5.5	3.5	12.6	7.6	12.4	7.5	8.6	5.6	9.5	5.7	9.2	6.5	10.3	4.9	4.7	7.1	6.2	4.6	9.4	5.5	7.1	7.1	8.0	14.3	3.9	6.5	7.3	7.6	8.0	3.2	11.1	4.8	4.9	4.2	2.1	0.4	0.0	2.9	3.1	1.9	0.8	9.8	2.7	2.4	2.2	2.2	1.0	0.7	3.1	2.5	2.0	0.8	0.0	1.5	1.0	0.4	0.1	1.2	0.1	0.1	0.4	1.7	3.4	4.2	2.0	0.5	0.4	0.4	0.4	1.3	2.2	0.3	3.4	0.8	1.3	0.4	0.2	0.1	1.0	4.4	2.8	0.5	1.2	0.2	0.1	0.7	5.6	1.8	0.4	3.0	0.1	2.5	0.7	4.6	5.8	0.9	0.7	0.6	0.4	11.1	1.9	5.7	3.1	2.5	2.3	3.4	2.8	4.2	3.2	8.0	3.5	3.8	10.5	4.9	4.8	2.5	1.5	2.1	3.6	6.6	5.5	5.4	4.0	3.3	5.5	3.5	5.6	7.1
ZNF77	pT1	ENSG00000175691	"Zinc finger protein 77"	Q15935	19	2933218-2944971	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA023397	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA023397: AB_1859447"	"unprognostic (1.17e-2)"	"prognostic favourable (8.49e-4)"	"unprognostic (2.18e-1)"	"prognostic favourable (6.65e-5)"	"unprognostic (2.01e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"prognostic favourable (6.79e-6)"	"unprognostic (2.06e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.93e-3)"	"unprognostic (2.65e-3)"	"unprognostic (3.20e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.79e-3)"	6.3	6.6	6.6	5.4	8.9	5.6	13.2	18.2	9.8	8.4	6.1	8.4	9.9	4.1	8.5	8.5	7.5	7.3	4.2	7.4	5.9	5.8	6.4	6.3	12.7	6.6	7.0	7.8	9.7	8.2	8.2	8.2	8.2	6.5	6.9	6.4	8.9	11.4	6.7	6.1	8.3	6.1	8.7	5.5	6.8	8.1	8.3	4.3	9.6	8.8	4.0	9.3	6.4	6.7	5.5	3.7	1.3	3.1	3.9	6.2	3.3	4.7	2.2	10.8	6.3	2.3	3.0	4.9	2.9	4.3	5.8	6.9	7.3	1.9	5.3	2.4	3.2	3.8	7.0	4.7	9.8	0.4	5.2	6.4	3.4	8.1	5.7	0.2	5.3	4.6	6.5	4.5	6.7	8.0	8.4	0.0	3.9	5.2	7.8	4.6	2.4	3.1	8.9	8.3	3.7	4.6	7.4	4.4	8.3	4.4	4.2	5.0	4.0	11.1	3.8	2.4	3.1	6.8	5.2	5.5	5.3	2.5	6.2	0.1	4.4	0.0	2.7	1.3	5.5	2.6	6.2	5.5	5.8	5.9	3.7	5.3	4.5	6.2	0.2	3.9	3.1	3.0	2.8	3.3	6.6	8.9	18.2	9.8	5.9	5.8	7.0	7.8	6.5	4.3
ZNF773	"MGC4728, ZNF419B"	ENSG00000152439	"Zinc finger protein 773"	Q6PK81	19	57499915-57518404	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003152	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA003152: AB_1080716"	"unprognostic (6.53e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.50e-4)"	"unprognostic (2.97e-2)"	"unprognostic (3.56e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.71e-3)"	9.0	10.3	7.3	7.0	10.8	10.7	12.5	15.4	11.3	6.0	7.7	6.0	11.2	8.2	8.4	11.4	6.8	8.7	8.4	7.3	7.2	6.9	8.2	4.9	8.1	16.1	8.6	7.8	12.1	5.6	16.0	14.6	8.7	8.2	9.7	7.1	9.6	9.0	8.1	17.8	10.7	7.9	8.8	9.7	11.3	6.9	8.8	4.7	12.7	12.3	6.2	10.4	9.2	9.6	14.8	6.9	16.2	4.8	8.9	17.2	5.8	1.8	3.2	5.5	7.2	4.0	4.9	0.3	5.3	8.0	4.7	19.6	3.3	2.6	3.4	2.9	3.5	1.4	2.7	5.6	7.0	0.1	17.1	5.8	0.4	1.9	7.6	4.4	4.7	11.2	8.0	3.4	13.6	3.3	0.2	0.6	6.0	0.4	8.2	3.1	5.7	9.5	4.5	8.8	5.3	3.3	6.4	5.9	7.2	0.9	2.5	6.1	4.1	8.1	2.8	7.5	3.4	1.9	5.6	8.7	8.9	5.6	2.8	4.3	6.7	16.2	4.8	7.6	8.4	3.6	13.6	11.8	10.4	9.0	6.4	14.8	17.2	13.8	2.2	8.9	3.1	6.9	7.2	5.8	7.3	10.8	15.4	11.3	7.2	6.9	8.6	7.8	8.2	4.7
ZNF780A	ZNF780	ENSG00000197782	"Zinc finger protein 780A"	O75290	19	40069152-40090938	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003311	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA003311: AB_1080757"	"unprognostic (1.92e-1)"	"unprognostic (9.25e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-2)"	"prognostic favourable (9.30e-4)"	6.9	9.2	11.1	8.6	8.5	4.1	7.7	12.8	10.8	8.7	6.6	5.8	13.9	5.7	8.2	10.8	10.4	7.8	7.8	6.7	7.1	6.1	7.9	11.8	7.0	11.3	10.5	8.9	8.6	11.0	15.8	14.1	7.0	6.8	7.9	6.0	6.8	10.0	11.4	4.5	8.0	9.1	6.0	10.4	12.0	8.2	7.9	9.7	7.8	11.2	5.3	11.3	8.8	7.9	3.9	4.6	8.4	7.7	3.3	5.9	2.5	4.8	9.2	6.0	5.6	5.5	5.0	4.3	5.6	4.5	4.6	7.1	6.0	3.3	4.3	3.7	2.7	4.1	3.8	3.2	5.1	7.4	5.2	6.8	7.6	5.7	4.9	7.0	5.6	5.2	3.6	4.7	3.9	4.7	7.6	7.3	3.9	2.8	2.8	2.4	4.8	2.9	2.3	10.6	2.5	3.8	10.0	3.7	7.1	8.4	3.2	3.7	4.0	8.5	3.5	5.7	7.6	5.1	4.5	7.2	6.3	4.3	3.6	4.9	3.8	2.7	5.4	8.4	3.9	4.9	5.1	3.7	4.2	3.5	4.6	3.9	5.9	5.1	4.7	3.3	7.7	3.6	4.5	2.5	11.1	8.5	12.8	10.8	7.1	6.1	10.5	8.9	6.8	9.7
ZNF780B	ZNF779	ENSG00000128000	"Zinc finger protein 780B"	Q9Y6R6	19	40028260-40056209	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA003311	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA003311: AB_1080757"	"unprognostic (3.28e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.56e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.89e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-3)"	6.3	8.2	12.4	9.8	18.8	3.3	10.3	22.2	14.0	8.2	8.5	8.2	11.6	5.7	10.8	12.3	5.5	10.0	6.6	12.5	9.4	7.2	9.4	6.7	5.9	9.7	8.1	10.8	16.6	8.1	10.5	24.7	7.1	11.6	9.7	7.6	9.3	7.9	10.5	6.9	7.1	7.6	9.7	7.8	9.2	7.2	5.0	11.4	8.7	14.0	6.4	9.8	9.1	8.2	4.2	5.9	1.5	3.2	2.3	5.1	1.3	2.6	3.4	5.8	4.0	3.5	2.3	0.0	3.0	2.2	3.3	4.4	6.2	2.4	6.4	2.8	3.1	1.5	4.8	1.9	4.0	5.4	2.4	5.0	6.1	3.9	2.4	7.4	4.2	3.4	1.2	4.6	2.9	3.1	5.2	8.7	3.4	1.2	2.4	1.2	5.7	3.6	3.5	10.2	2.2	1.9	14.2	6.4	6.8	5.3	2.3	1.9	2.7	3.2	5.6	3.3	8.1	5.7	4.6	6.6	8.5	5.0	3.0	3.9	2.7	0.1	3.2	1.5	2.8	2.8	2.9	2.5	3.4	3.3	2.4	4.2	5.1	4.2	0.6	2.3	1.8	5.9	1.9	1.3	12.4	18.8	22.2	14.0	9.4	7.2	8.1	10.8	11.6	11.4
ZNF781	FLJ37549	ENSG00000196381	"Zinc finger protein 781"	Q8N8C0	19	37667751-37692322	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 4.7;ASC diff: 4.7;HSkMC: 4.6;SH-SY5Y: 4.6;U-266/84: 5.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"B-cells: 1.0;T-cells: 3.2"									HPA062512	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA062512: "	"unprognostic (3.01e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.11e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-1)"	4.9	5.3	5.7	4.6	12.9	0.5	2.9	15.8	13.6	4.3	4.5	3.8	1.9	1.6	7.3	4.8	2.2	4.8	3.1	6.5	5.8	5.8	2.6	1.3	3.7	3.5	6.1	6.8	9.8	1.3	4.8	7.4	5.0	7.6	4.5	3.1	3.8	1.5	5.2	1.5	2.0	2.4	8.5	9.6	5.0	2.2	4.8	5.5	0.6	5.3	1.3	2.5	4.7	5.4	1.0	0.1	0.1	0.2	0.0	3.2	0.7	0.0	0.0	1.9	4.7	4.7	1.0	1.0	1.7	0.0	1.7	1.2	0.2	0.0	0.2	0.0	1.1	0.0	0.1	0.0	1.9	0.0	0.1	0.1	0.0	2.0	2.3	0.0	0.1	4.6	0.0	1.3	0.1	0.4	0.9	0.0	0.0	0.0	1.1	1.0	0.5	0.0	0.0	3.3	0.0	0.7	1.2	0.0	4.6	0.0	0.0	0.0	2.1	0.1	0.0	0.2	0.0	0.0	1.0	1.5	5.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	1.1	0.4	1.8	2.5	0.1	1.0	2.6	3.2	0.1	0.0	0.0	0.1	0.8	0.7	5.7	12.9	15.8	13.6	5.8	5.8	6.1	6.8	7.6	5.5
ZNF782	FLJ16636	ENSG00000196597	"Zinc finger protein 782"	Q6ZMW2	9	96816472-96875623	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA011013	Approved		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA011013: AB_1080758"	"unprognostic (5.51e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.68e-3)"	"unprognostic (3.63e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.95e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.39e-2)"	5.3	4.2	7.4	7.4	8.4	2.5	7.6	19.8	8.0	7.5	5.3	6.9	5.9	6.1	7.9	8.5	5.2	5.5	5.8	4.0	6.8	4.5	7.1	5.5	4.4	5.9	5.9	4.8	9.3	12.7	11.8	15.1	4.9	7.7	7.5	6.9	5.4	8.0	7.3	9.2	8.6	7.1	5.3	6.5	6.4	6.6	13.9	8.3	6.0	8.8	2.5	7.4	5.6	10.8	2.3	0.2	0.7	0.5	1.0	2.2	0.4	2.9	2.3	5.8	8.9	1.6	2.2	4.0	2.8	2.8	4.5	3.4	2.7	3.0	5.7	3.7	2.0	4.1	5.1	1.8	4.5	5.7	2.2	5.2	4.7	2.7	1.7	7.2	3.7	1.3	3.8	3.7	1.9	1.5	7.0	5.8	2.7	4.9	7.6	3.5	4.3	5.1	6.8	7.1	1.9	3.1	1.9	5.9	4.5	3.8	2.3	3.0	4.3	4.2	3.3	6.0	3.5	6.0	3.1	5.5	3.9	2.7	2.4	1.8	4.3	0.0	0.5	0.2	1.1	0.5	2.2	2.0	1.0	0.0	0.2	2.3	0.9	0.7	0.7	1.0	0.2	0.2	0.6	0.4	7.4	8.4	19.8	8.0	6.8	4.5	5.9	4.8	7.7	8.3
ZNF786	DKFZp762I137	ENSG00000197362	"Zinc finger protein 786"	Q8N393	7	149069643-149090782	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021518, HPA053459"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"				"Nuclear speckles"	Nucleoplasm	"HPA021518: , HPA053459: "	"unprognostic (3.13e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.84e-2)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (5.62e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.85e-2)"	"prognostic favourable (2.01e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.39e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.47e-2)"	3.9	4.3	8.7	6.1	9.6	3.3	5.1	10.4	15.2	6.0	5.1	4.2	6.4	4.6	6.9	6.1	6.8	6.7	4.8	3.2	6.4	6.1	4.5	5.4	7.3	8.2	4.8	5.8	8.3	6.0	7.6	8.5	3.8	4.0	6.8	3.4	5.4	5.3	5.8	4.1	13.0	5.1	6.6	3.4	7.7	5.1	2.9	4.2	8.4	6.1	5.8	6.5	6.2	6.1	7.2	4.5	2.9	5.0	8.4	12.1	5.3	4.4	8.0	6.4	10.8	3.9	1.6	9.2	2.7	2.9	3.1	2.4	4.2	4.2	6.3	6.6	1.9	5.1	3.9	3.7	2.0	6.8	6.0	3.1	4.7	5.3	3.3	6.1	4.2	2.3	4.2	3.8	2.7	2.8	5.5	3.6	2.8	13.8	10.3	10.4	11.8	6.1	7.7	3.2	4.1	2.5	6.2	7.7	12.1	6.7	6.4	5.0	4.1	2.9	3.6	3.6	2.1	6.2	3.9	13.2	9.7	3.5	6.0	3.9	4.0	1.7	3.7	2.9	12.1	5.0	9.8	7.2	8.5	10.7	4.5	7.1	11.3	9.5	1.1	8.4	3.9	3.9	5.1	5.3	8.7	9.6	10.4	15.2	6.4	6.1	4.8	5.8	4.0	4.2
ZNF789		ENSG00000198556	"Zinc finger protein 789"	Q5FWF6	7	99472841-99503650	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029500, HPA050793"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA029500: AB_10603009, HPA050793: "	"unprognostic (6.84e-3)"	"unprognostic (5.75e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.25e-3)"	"unprognostic (4.38e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (7.14e-4)"	"unprognostic (1.58e-2)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (6.63e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	"prognostic favourable (5.31e-6)"	6.1	5.5	11.0	15.9	10.0	11.6	9.2	31.9	14.4	6.1	9.2	9.2	11.0	15.1	10.9	12.8	5.0	7.8	6.6	4.0	10.0	8.5	9.0	8.1	6.5	10.5	6.8	9.8	8.9	7.8	6.3	13.3	4.6	7.6	16.4	12.5	14.8	10.3	13.8	8.9	13.3	12.6	8.5	8.6	11.2	8.4	17.6	8.1	8.4	9.3	4.8	10.1	4.1	5.6	3.9	14.2	2.0	1.6	4.1	7.0	2.1	11.2	3.8	6.2	11.2	1.8	2.1	8.6	5.8	2.2	3.5	7.7	6.4	7.7	8.6	4.8	2.6	5.7	3.5	3.3	4.9	3.9	6.0	6.5	10.6	10.8	3.1	4.4	14.9	2.3	3.0	7.5	3.3	3.7	9.6	8.4	3.1	10.7	5.3	11.8	6.3	6.0	6.9	5.9	9.0	4.6	3.5	6.2	6.8	4.1	11.2	6.5	3.0	7.0	6.9	6.7	8.2	10.0	5.6	5.1	7.0	10.8	10.6	8.0	7.2	2.0	1.6	1.5	2.7	1.1	2.9	2.7	3.4	2.9	5.6	3.9	7.0	4.2	0.4	4.1	1.4	14.2	5.3	2.1	11.0	10.0	31.9	14.4	10.0	8.5	6.8	9.8	7.6	8.1
ZNF790	"FLJ20350, MGC62100"	ENSG00000197863	"Zinc finger protein 790"	Q6PG37	19	36817428-36850787	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA056134, HPA060288"	Uncertain		Approved	Nucleoli				Nucleoli		"HPA056134: , HPA060288: "	"unprognostic (1.14e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavourable (7.66e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-2)"	6.6	8.9	9.3	9.9	15.9	3.2	7.2	21.5	14.8	7.6	6.4	12.5	7.1	6.4	7.7	7.7	7.5	6.1	8.1	8.8	10.8	7.9	10.3	13.8	6.1	7.9	14.2	7.2	7.8	7.3	11.6	14.5	6.0	13.1	6.8	4.5	7.4	5.7	7.3	7.3	15.6	6.1	6.1	11.4	7.4	7.9	20.4	15.9	8.5	13.2	4.9	6.8	7.7	7.9	9.7	6.8	6.8	6.2	6.7	9.0	3.0	0.0	0.7	6.3	11.5	4.4	4.7	4.1	4.5	6.1	3.6	6.5	0.0	1.4	1.4	9.0	3.2	1.7	5.0	4.0	3.2	10.3	4.5	7.4	0.7	1.7	3.8	3.2	5.5	6.0	3.4	3.1	0.0	6.1	0.2	0.1	7.9	3.5	8.3	2.6	4.3	0.8	1.5	5.3	5.6	3.8	8.3	7.9	7.2	4.2	0.1	2.5	5.2	6.2	6.6	4.9	3.8	4.5	5.8	9.0	12.6	5.2	0.0	0.2	3.9	6.0	3.7	6.8	5.9	6.2	6.1	9.0	8.4	8.3	6.8	9.7	9.0	7.4	1.3	6.7	2.2	5.6	6.8	3.0	9.3	15.9	21.5	14.8	10.8	7.9	14.2	7.2	13.1	15.9
ZNF791	FLJ90396	ENSG00000173875	"Zinc finger protein 791"	Q3KP31	19	12610918-12633840	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021537	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA021537: "	"unprognostic (1.95e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.73e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.86e-2)"	"prognostic favourable (9.07e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-2)"	"prognostic favourable (1.39e-5)"	16.7	12.0	11.9	18.0	15.4	22.5	18.6	30.3	17.1	20.0	15.0	12.7	14.1	10.9	16.6	16.3	14.0	15.4	10.1	13.0	11.5	10.9	13.4	11.9	17.0	15.8	14.7	12.5	21.5	15.3	20.2	32.1	13.4	15.5	16.6	13.4	11.8	15.5	18.2	15.9	17.1	15.3	17.9	16.0	16.6	13.8	7.0	13.8	14.4	25.4	8.9	19.6	23.7	18.1	11.6	10.5	9.7	3.8	10.9	8.3	2.6	6.9	3.8	7.5	7.4	9.3	12.0	6.5	9.0	9.9	6.7	8.2	4.8	4.2	1.6	8.7	9.3	6.6	7.3	8.5	11.2	4.7	7.6	6.9	9.5	6.7	7.6	8.9	7.7	10.3	9.7	8.0	13.0	7.0	7.9	11.2	8.3	11.1	5.5	3.4	8.5	11.7	4.0	12.3	5.7	6.7	13.4	8.3	10.0	8.0	6.5	8.5	6.5	7.7	8.7	13.5	5.7	11.7	7.2	16.8	20.0	4.9	9.2	7.0	7.9	9.7	3.3	5.2	7.0	2.1	7.2	7.4	6.3	8.0	3.0	11.6	7.4	8.3	5.6	10.9	3.8	10.5	5.4	2.6	11.9	15.4	30.3	17.1	11.5	10.9	14.7	12.5	15.5	13.8
ZNF793		ENSG00000188227	"Zinc finger protein 793"	Q6ZN11	19	37506939-37548762	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.4;RT4: 9.7;U-266/70: 16.9;U-266/84: 11.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA034781	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA034781: AB_10602784"	"unprognostic (4.80e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.26e-1)"	"unprognostic (7.13e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.69e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.03e-4)"	"unprognostic (4.94e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.24e-2)"	"unprognostic (8.12e-3)"	3.1	7.7	12.5	4.9	11.9	2.1	6.4	22.1	14.0	6.4	4.2	12.8	4.6	3.0	9.3	6.9	5.2	6.7	4.6	6.8	10.3	8.0	6.2	1.1	3.3	5.6	8.3	10.0	14.1	4.0	15.7	18.4	4.5	11.2	7.5	6.0	8.1	3.6	5.8	3.7	10.7	3.6	6.1	10.1	5.6	5.3	12.3	9.6	2.1	11.0	3.2	4.9	4.9	5.7	4.0	2.1	7.2	1.6	4.0	2.8	1.4	0.1	0.2	4.2	11.4	0.9	0.9	0.2	3.3	0.2	0.7	0.3	0.2	1.3	2.9	5.5	1.7	0.4	0.3	2.8	0.3	0.8	4.2	0.3	0.4	0.3	2.1	0.2	2.6	3.4	2.5	0.6	0.1	0.1	0.1	0.5	0.5	3.2	0.3	0.4	6.9	0.3	0.1	0.1	0.6	2.8	9.7	3.1	6.7	0.2	0.2	0.0	6.4	0.3	0.4	0.1	1.8	0.2	3.2	16.9	11.3	0.2	0.0	0.2	0.5	7.2	1.6	1.2	1.5	0.6	2.3	2.0	2.8	2.5	1.2	4.0	1.9	2.4	4.2	4.0	0.6	2.1	2.2	1.4	12.5	11.9	22.1	14.0	10.3	8.0	8.3	10.0	11.2	9.6
ZNF799	"HIT-40, MGC71805, ZNF842"	ENSG00000196466	"Zinc finger protein 799"	Q96GE5	19	12390016-12401271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA003150, HPA018683"	Approved		Approved	"Nucleoplasm,Centriolar satellite"				Nucleoplasm	"Centriolar satellite"	"HPA003150: AB_1080725, HPA018683: "	"unprognostic (2.96e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.84e-2)"	"prognostic favourable (2.39e-4)"	"unprognostic (3.63e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.02e-1)"	"unprognostic (8.83e-3)"	"unprognostic (4.47e-5)"	"unprognostic (1.45e-1)"	"unprognostic (5.56e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-3)"	7.9	7.2	6.1	11.9	5.5	3.2	10.1	7.7	8.0	12.6	8.2	4.6	12.9	4.7	6.9	5.8	7.6	9.3	4.9	4.1	6.6	4.3	7.8	8.3	6.6	5.3	6.3	1.8	10.8	10.7	7.6	2.8	10.5	6.3	8.4	6.2	3.3	6.2	6.8	5.5	5.6	6.1	5.6	5.0	7.4	4.5	5.8	6.7	9.1	7.5	6.4	5.2	7.1	6.5	7.5	4.6	4.6	4.3	4.5	10.3	3.9	3.7	2.9	4.1	9.2	2.1	2.0	8.0	2.1	2.8	5.1	4.9	5.9	1.5	4.9	3.7	2.4	3.1	3.1	3.6	4.9	0.1	3.1	3.7	2.4	9.6	0.7	2.9	7.0	2.5	2.2	3.6	2.9	2.4	3.9	0.0	3.3	5.2	6.1	4.1	2.0	8.1	0.7	5.9	4.9	5.1	9.3	2.9	3.0	4.2	0.9	1.1	4.1	5.3	2.3	5.4	3.0	6.2	2.3	3.4	5.4	3.8	0.8	3.0	2.2	4.4	4.1	4.6	6.9	4.3	8.3	7.5	6.5	10.3	3.4	6.7	6.5	5.0	4.3	4.5	2.6	4.6	6.9	3.9	6.1	5.5	7.7	8.0	6.6	4.3	6.3	1.8	6.3	6.7
ZNF804A	C2orf10	ENSG00000170396	"Zinc finger protein 804A"	Q7Z570	2	184598366-184939492	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 31.6;lymphoid tissue: 9.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 20.4;RH-30: 14.0;THP-1: 10.3;U-698: 15.2"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Region enriched"	"Detected in many"	4	"cerebellum: 31.6"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029195	Uncertain		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA029195: AB_10603011"	"unprognostic (1.10e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.98e-4)"	"unprognostic (6.21e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.45e-2)"	"unprognostic (4.93e-2)"	0.4	1.0	4.3	9.6	7.2	1.8	0.4	31.6	10.7	0.6	0.8	0.1	0.8	1.5	0.4	0.3	0.6	0.4	4.8	0.3	5.2	7.3	1.8	0.6	1.2	2.7	2.2	3.0	0.8	0.3	0.2	0.4	0.5	5.4	4.1	1.1	2.4	1.1	4.4	0.3	0.3	3.3	0.5	1.5	1.8	1.2	0.9	0.4	0.0	4.4	0.0	2.9	1.8	2.1	2.0	1.2	1.0	1.7	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.1	4.8	1.6	1.5	0.0	0.0	20.4	0.0	0.0	0.0	0.3	0.0	3.6	0.1	0.0	5.4	0.8	0.1	8.0	5.1	0.0	2.5	0.0	0.0	1.3	3.8	0.0	0.9	0.0	0.0	0.0	4.8	0.0	3.3	0.0	14.0	0.8	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	10.3	0.0	5.1	0.1	0.2	2.0	2.2	0.0	15.2	5.9	1.5	1.7	0.0	1.1	0.0	0.0	1.7	0.0	2.0	0.0	0.0	1.2	0.3	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.3	4.3	7.2	31.6	7.5	5.2	7.3	2.2	3.0	5.4	0.4
ZNF804B	FLJ32110	ENSG00000182348	"Zinc finger protein 804B"	A4D1E1	7	88759368-89337057	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	9	"thyroid gland: 31.4"	"Cell line enriched"	"Detected in single"	5	"AF22: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA026702	Uncertain									"HPA026702: AB_1859459"					"unprognostic (1.10e-1)"							"unprognostic (5.00e-2)"			"unprognostic (1.29e-1)"	"unprognostic (1.99e-1)"		0.2	0.2	0.6	0.7	1.3	0.1	0.4	0.2	2.0	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.6	0.2	0.4	2.5	0.2	0.2	3.3	0.2	0.5	0.5	1.3	0.1	0.4	0.6	1.6	0.6	0.1	1.3	1.2	0.1	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.0	0.0	31.4	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.3	0.2	2.0	0.2	0.4	0.2	0.5	1.6	0.0
ZNF805		ENSG00000204524	"Zinc finger protein 805"	Q5CZA5	19	57240685-57255135	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA046330, HPA058895"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA046330: , HPA058895: "	"unprognostic (2.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.68e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.64e-1)"	8.4	8.8	3.6	5.5	7.2	18.5	9.6	4.8	9.4	6.6	6.1	8.3	5.8	3.9	9.1	6.4	6.6	6.0	5.9	6.3	3.4	3.5	5.4	6.2	6.8	5.1	6.4	5.2	10.2	7.2	9.8	9.0	7.5	5.8	6.2	5.7	6.8	7.9	5.8	9.0	7.7	6.3	7.2	5.2	7.2	6.1	8.6	5.9	9.2	6.7	2.4	7.4	7.1	11.6	3.9	2.1	5.3	1.8	5.6	4.9	2.4	2.3	3.6	3.6	4.7	6.5	4.8	4.5	2.3	5.3	3.9	7.7	3.1	2.1	4.5	1.8	5.5	1.4	3.9	3.8	7.0	2.4	9.8	4.6	3.0	3.0	5.8	4.2	4.6	6.0	4.8	5.1	8.9	3.6	1.7	6.1	2.7	1.6	5.0	1.4	3.0	4.1	2.5	7.6	3.9	2.5	7.7	3.8	3.8	6.1	3.5	3.6	2.4	4.1	4.0	5.7	3.9	2.6	2.6	6.1	4.2	4.4	3.6	2.3	3.1	0.0	1.8	5.3	3.8	0.5	4.9	3.9	3.3	4.8	2.1	1.7	3.3	3.1	2.0	5.6	0.9	1.5	3.6	2.4	3.6	7.2	4.8	9.4	3.4	3.5	6.4	5.2	5.8	5.9
ZNF813	FLJ16542	ENSG00000198346	"Zinc finger protein 813"	Q6ZN06	19	53467735-53496255	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA056406	Uncertain		Approved	Vesicles				Vesicles		"HPA056406: "	"unprognostic (1.20e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.56e-2)"	5.9	3.7	4.0	5.0	4.3	2.5	4.8	3.2	3.6	5.8	4.3	2.5	1.7	3.8	4.1	8.7	4.0	4.1	3.0	2.4	2.5	2.3	5.0	2.5	4.7	4.1	4.6	1.6	4.8	4.1	5.2	3.5	12.7	4.7	10.7	3.7	2.0	4.8	3.3	1.6	4.0	6.3	4.5	6.3	6.5	4.0	4.2	5.2	10.2	5.8	2.8	4.3	6.4	9.5	4.8	2.5	2.4	5.5	6.8	6.8	2.6	0.8	0.8	2.5	4.3	2.2	2.7	6.0	2.3	2.4	1.6	2.3	4.4	2.6	6.6	2.3	2.2	1.4	6.1	2.6	3.1	0.0	9.6	6.6	1.7	5.0	1.2	0.0	7.1	2.3	2.2	1.8	1.3	1.4	3.5	0.1	2.5	1.2	8.5	3.6	3.2	2.3	5.3	5.6	3.2	1.6	17.4	1.1	2.5	0.0	4.4	1.5	1.7	3.2	2.3	0.9	3.2	0.1	2.2	3.6	5.2	7.4	0.0	0.0	4.5	2.4	2.2	1.7	3.7	3.2	3.7	3.4	3.5	4.1	2.5	4.8	6.8	5.2	1.1	6.8	5.5	2.4	2.6	2.6	4.0	4.3	3.2	3.6	2.5	2.3	4.6	1.6	4.7	5.2
ZNF816	ZNF816A	ENSG00000180257	"Zinc finger protein 816"	Q0VGE8	19	52949379-52962911	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA042466	Uncertain		Approved	Nucleoli				Nucleoli		"HPA042466: AB_10797497"	"unprognostic (1.83e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.36e-3)"	"unprognostic (6.21e-2)"	"unprognostic (5.45e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.39e-2)"	6.2	6.4	4.9	8.0	8.3	2.8	8.0	14.7	6.6	10.2	8.9	4.5	12.5	4.7	6.7	10.1	8.4	12.1	9.8	5.8	5.0	3.3	9.6	3.2	7.0	7.1	10.4	3.4	9.5	8.7	6.7	11.8	9.2	6.1	15.5	10.4	4.5	8.6	9.8	2.4	5.3	7.3	8.0	9.1	11.0	9.4	5.4	8.9	18.9	10.2	5.8	8.5	14.3	9.4	11.6	8.4	14.4	7.7	17.6	17.5	7.4	4.0	0.1	3.7	9.5	6.9	7.6	10.9	3.4	3.5	4.4	6.5	3.2	2.7	10.9	7.2	3.0	2.4	5.3	3.9	4.3	5.4	11.2	5.1	4.2	4.9	2.3	0.0	7.9	3.6	5.0	2.6	5.1	3.7	8.0	0.4	5.5	3.2	8.7	5.8	4.4	5.0	4.9	8.0	5.4	6.9	32.9	2.8	5.2	0.4	5.7	2.2	3.8	5.9	3.5	3.2	3.2	2.1	3.8	3.8	10.9	10.2	0.4	5.4	3.8	10.0	7.3	14.4	13.6	6.2	17.5	9.9	12.7	13.1	8.4	11.6	17.2	13.8	4.1	17.6	7.7	8.3	11.5	7.4	4.9	8.3	14.7	6.6	5.0	3.3	10.4	3.4	6.1	8.9
ZNF829	DKFZp779O175	ENSG00000185869	"Zinc finger protein 829"	Q3KNS6	19	36888124-36916291	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 20.1"	"Cell line enhanced"	"Detected in many"		"U-266/84: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA073073			Approved	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA073073: "	"unprognostic (4.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.44e-4)"	"unprognostic (1.32e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.35e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-4)"	"unprognostic (5.47e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.92e-4)"	2.6	2.8	4.9	2.4	5.9	1.9	4.3	8.0	4.8	2.9	2.6	2.3	5.0	1.7	3.6	2.0	2.2	3.1	1.8	2.4	3.3	2.5	2.6	1.8	2.2	2.8	6.4	2.9	5.3	2.1	3.8	3.4	3.6	3.3	3.6	1.6	1.6	2.6	3.0	1.9	3.5	2.1	4.8	4.4	2.8	2.3	20.1	5.1	3.4	5.2	1.0	2.9	3.1	4.7	3.3	1.4	4.2	0.8	2.1	4.9	1.0	0.0	1.2	3.3	0.1	1.8	2.8	1.4	3.7	2.1	4.6	7.0	0.1	0.6	0.1	4.3	2.3	0.7	0.0	2.6	5.4	0.0	5.2	1.8	0.1	0.1	1.8	0.0	5.2	2.8	2.6	5.0	0.0	0.5	0.0	0.1	4.9	0.8	0.7	0.8	5.5	0.0	0.0	4.4	1.6	1.2	5.4	3.7	5.5	0.1	0.0	3.1	3.4	0.3	1.4	2.9	3.9	3.7	3.9	9.6	14.7	6.2	0.0	0.0	6.8	4.2	0.6	2.9	3.2	0.7	4.2	2.2	3.2	4.9	1.0	3.3	4.1	4.2	1.3	2.1	0.8	1.4	3.2	1.0	4.9	5.9	8.0	4.8	3.3	2.5	6.4	2.9	3.3	5.1
ZNF83	"FLJ11015, HPF1, ZNF816B"	ENSG00000167766	"Zinc finger protein 83"	P51522	19	52594060-52690496	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA025970	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA025970: AB_1859463"	"unprognostic (6.38e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.18e-1)"	"prognostic favourable (3.83e-4)"	"unprognostic (3.38e-3)"	"unprognostic (3.67e-1)"	"prognostic unfavourable (9.20e-4)"	"prognostic favourable (9.06e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.85e-3)"	"prognostic unfavourable (3.13e-5)"	"unprognostic (2.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.33e-1)"	"prognostic favourable (6.92e-6)"	13.1	19.0	14.5	16.2	66.8	14.6	22.3	42.6	20.2	21.6	16.4	11.7	41.4	8.4	23.3	54.0	11.4	27.2	16.0	11.1	17.2	11.5	26.0	4.0	12.9	18.5	25.7	12.5	34.5	11.8	22.3	29.4	44.2	21.9	25.5	14.0	11.0	11.8	32.6	5.8	16.2	12.3	21.0	20.4	19.0	14.7	9.8	24.4	16.9	24.3	8.1	15.9	15.9	34.3	9.9	4.3	8.5	4.9	12.8	9.3	3.7	9.2	0.5	13.2	9.5	11.8	24.0	7.4	14.2	9.9	8.6	11.7	3.6	8.0	9.6	7.5	9.6	4.1	7.9	9.4	12.1	1.3	9.1	8.1	8.2	4.5	9.7	5.6	11.3	19.3	12.0	7.2	36.1	9.7	8.9	7.9	14.2	6.2	8.0	9.8	3.7	9.0	8.0	11.3	6.4	22.1	18.5	7.6	6.2	9.1	9.0	3.5	9.6	6.0	13.2	8.7	5.4	4.4	14.6	0.9	8.4	13.2	0.5	6.1	6.9	4.4	3.6	8.5	7.6	3.9	7.8	6.9	8.9	9.3	4.3	9.9	7.6	8.7	3.3	12.8	4.9	2.9	4.3	3.7	14.5	66.8	42.6	20.2	17.2	11.5	25.7	12.5	21.9	24.4
ZNF831	"C20orf174, dJ492J12.1"	ENSG00000124203	"Zinc finger protein 831"	Q5JPB2	20	59123381-59259113	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.8;pituitary gland: 6.6"	"Group enriched"	"Detected in some"	13	"Daudi: 9.1;HMC-1: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdT-cell: 4.1;MAIT T-cell: 3.3;memory CD4 T-cell: 2.3;memory CD8 T-cell: 3.3;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.4;NK-cell: 2.3;T-reg: 4.2"	"Group enriched"	"Detected in many"	6	"NK-cells: 2.3;T-cells: 4.2"	"Group enriched"	"Detected in many"	4	"amygdala: 5.3;basal ganglia: 4.3;cerebral cortex: 5.1;hippocampal formation: 6.0;olfactory region: 4.7"	"Group enriched"	"Detected in many"	26	"amygdala: 6.5;basal ganglia: 5.1;cerebral cortex: 4.5;hippocampal formation: 7.1;olfactory region: 11.1"	HPA016839	Uncertain									"HPA016839: AB_1859466"	"unprognostic (2.90e-3)"	"unprognostic (7.70e-6)"	"unprognostic (9.71e-4)"	"unprognostic (1.31e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.00e-5)"	"unprognostic (3.08e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.31e-1)"	"unprognostic (3.40e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.93e-2)"	0.6	0.1	1.7	9.1	3.6	1.3	0.4	0.2	1.2	0.2	0.4	0.2	0.2	0.3	0.2	0.4	0.8	0.4	0.8	0.2	1.5	0.6	0.3	0.3	1.3	10.0	0.2	0.2	0.2	0.3	0.0	6.6	0.2	0.2	0.2	0.5	0.2	0.5	0.2	0.2	0.1	4.2	0.2	0.2	9.3	0.9	0.4	0.2	0.4	0.7	0.9	13.8	3.1	0.2	0.4	0.0	0.5	0.0	2.3	4.2	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.5	4.1	0.0	3.3	0.4	2.3	3.3	0.0	0.4	1.9	2.4	0.2	2.3	0.0	0.0	4.2	0.8	1.7	3.6	0.2	1.2	1.5	0.6	0.2	0.2	0.2	0.2
ZNF835	BC37295_3	ENSG00000127903	"Zinc finger protein 835"	Q9Y2P0	19	56661981-56671783	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.3;EFO-21: 3.6;HEL: 2.9;NTERA-2: 8.3;SH-SY5Y: 4.4;U-266/84: 6.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA051136	Uncertain		Approved	Microtubules				Microtubules		"HPA051136: "	"unprognostic (3.15e-1)"	"unprognostic (4.80e-2)"	"unprognostic (4.89e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.58e-5)"	"unprognostic (6.65e-2)"	"unprognostic (5.35e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.72e-4)"	"unprognostic (5.31e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.29e-2)"	"unprognostic (6.21e-2)"	4.8	5.0	6.8	3.8	7.1	2.2	3.0	12.2	10.5	4.7	5.4	7.8	5.0	1.6	6.4	3.2	3.5	6.6	2.4	6.8	6.6	5.4	3.6	1.3	3.1	3.8	5.7	7.2	14.0	3.4	7.9	4.7	2.6	4.8	4.8	1.2	3.6	6.1	5.3	6.3	1.7	2.2	5.1	5.4	5.5	2.4	1.8	7.8	1.1	5.5	1.6	3.5	4.6	3.5	5.2	3.3	4.7	1.0	3.8	5.1	1.4	0.1	0.1	1.0	0.1	0.0	0.0	4.3	0.3	0.0	0.3	0.0	0.1	0.3	0.1	3.6	0.0	0.2	0.0	0.0	0.0	0.1	0.3	2.9	0.3	0.3	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.4	8.3	0.0	0.2	0.1	0.2	0.0	0.2	0.1	4.4	0.1	0.2	0.0	0.3	0.1	0.0	0.2	1.2	0.3	0.1	0.3	6.7	0.5	0.1	0.1	0.1	4.7	1.0	0.9	0.8	0.7	1.8	3.8	3.0	2.0	1.2	5.2	5.1	3.4	2.3	3.8	0.7	3.3	1.6	1.4	6.8	7.1	12.2	10.5	6.6	5.4	5.7	7.2	4.8	7.8
ZNF839	C14orf131	ENSG00000022976	"Zinc finger protein 839"	A8K0R7	14	102317377-102342702	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA020434	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA020434: AB_10669862"	"unprognostic (7.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.73e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.10e-3)"	"prognostic favourable (4.57e-4)"	"unprognostic (2.40e-2)"	"prognostic favourable (5.00e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	8.9	9.9	10.9	10.6	14.1	11.3	15.7	11.6	16.9	11.1	10.2	14.4	9.0	8.1	15.3	11.2	8.4	19.7	7.8	8.4	11.1	10.1	9.7	13.0	6.8	11.0	8.8	13.4	12.9	15.6	14.3	13.2	9.0	8.9	10.1	9.5	13.0	11.9	13.4	18.6	21.6	10.3	10.6	8.3	15.2	8.7	39.7	7.8	11.3	12.9	8.8	11.8	7.8	9.5	1.9	2.1	3.5	1.9	0.3	2.6	0.4	8.6	7.9	10.3	18.6	4.8	8.2	17.7	6.8	5.6	8.5	7.0	3.0	7.4	9.0	5.6	4.6	8.5	6.7	17.1	6.6	12.0	12.7	6.2	7.2	5.0	4.3	5.8	5.5	6.5	12.9	16.5	15.4	11.3	13.2	11.8	11.9	16.1	8.8	9.4	13.8	8.0	19.2	6.3	5.6	7.6	7.1	5.6	17.5	5.6	7.2	6.0	16.2	9.6	4.4	5.5	5.0	7.6	6.0	11.7	8.4	10.3	4.3	7.0	9.0	0.0	0.7	2.3	2.4	1.9	2.6	1.9	1.6	1.5	1.3	1.4	2.6	2.2	3.5	0.3	0.4	2.1	2.1	0.4	10.9	14.1	11.6	16.9	11.1	10.1	8.8	13.4	8.9	7.8
ZNF853	DKFZp434J1015	ENSG00000236609	"Zinc finger protein 853"	P0CG23	7	6615617-6624290	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 28.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.5;SH-SY5Y: 21.6;U-2 OS: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 3.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.1;NK-cells: 1.1;T-cells: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067690	Approved		Approved	Nucleoli				Nucleoli		"HPA067690: "	"unprognostic (1.35e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.17e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.87e-3)"	"unprognostic (9.28e-2)"	"prognostic favourable (2.30e-6)"	"unprognostic (4.41e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.30e-3)"	"unprognostic (4.01e-2)"	3.7	3.9	16.6	2.9	14.4	1.0	4.6	4.5	13.5	7.8	7.7	10.4	2.8	1.8	9.4	5.9	5.6	11.8	5.8	12.3	16.1	15.5	3.3	0.9	4.5	4.3	14.8	9.1	15.6	10.6	7.3	4.5	3.7	11.9	7.6	2.5	6.0	6.7	11.5	28.9	2.4	2.7	8.5	10.1	4.3	3.6	3.0	9.9	2.6	9.9	2.7	2.7	6.5	11.7	0.3	0.4	3.1	0.0	1.1	1.5	0.3	0.0	1.1	3.4	14.5	0.1	0.0	0.1	0.3	0.0	1.5	0.3	2.5	0.5	0.0	5.7	0.0	0.0	5.2	0.1	1.5	0.0	1.9	0.4	0.0	2.6	2.1	0.0	0.1	0.5	0.5	0.2	0.0	0.0	2.2	0.0	0.9	0.1	0.3	1.8	5.4	0.0	1.6	5.7	0.1	1.1	5.4	4.6	21.6	0.0	0.2	0.9	0.8	3.0	0.0	1.1	14.5	0.0	1.3	0.3	0.1	0.0	0.0	0.0	5.6	0.0	0.0	3.1	1.2	0.0	1.5	0.3	0.8	1.4	0.0	0.3	0.2	1.4	0.0	1.1	0.0	0.4	0.0	0.3	16.6	14.4	4.5	12.4	16.1	15.5	14.8	9.1	11.9	9.9
ZNF862		ENSG00000106479	"Zinc finger protein 862"	O60290	7	149838367-149867479	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA024154	Uncertain		Approved	Mitochondria				Mitochondria		"HPA024154: AB_1859469"	"unprognostic (1.82e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.72e-3)"	"unprognostic (2.74e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.73e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.29e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.30e-2)"	"prognostic favourable (8.66e-4)"	7.1	9.7	12.7	11.2	15.5	7.5	11.8	22.6	13.6	11.1	10.0	16.7	18.8	6.6	12.1	18.1	9.0	13.7	12.2	8.0	13.1	8.7	11.3	9.4	9.6	12.8	17.1	12.1	15.1	14.7	22.6	17.7	5.8	12.2	11.5	10.7	12.3	16.9	14.5	8.6	24.1	10.8	10.0	12.6	13.2	9.4	7.4	19.8	18.7	18.2	6.7	13.2	9.9	9.1	3.1	3.0	1.6	4.3	1.6	6.9	2.0	2.9	3.2	7.1	11.2	8.3	9.0	0.2	6.0	5.9	2.0	3.3	0.3	7.7	1.4	7.9	6.8	2.0	2.0	2.9	1.5	4.3	3.1	1.3	2.2	0.0	7.3	2.1	1.3	10.0	10.7	2.0	3.2	4.8	1.5	5.6	3.4	7.5	2.5	5.4	2.3	3.2	4.5	0.9	7.9	5.7	1.8	2.8	9.5	5.2	3.9	5.3	2.9	2.6	8.6	5.1	0.2	11.6	2.2	8.6	4.6	1.3	8.8	5.6	5.8	0.0	2.4	1.6	6.9	4.3	1.9	3.1	2.6	3.6	3.0	1.3	3.1	2.7	0.2	1.6	1.3	3.0	1.8	2.0	12.7	15.5	22.6	13.6	13.1	8.7	17.1	12.1	12.2	19.8
ZNF879	DKFZp686E2433	ENSG00000234284	"Zinc finger protein 879"	B4DU55	5	179023752-179035064	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.3;BEWO: 12.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA068608	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA068608: "	"unprognostic (3.20e-2)"	"unprognostic (5.24e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.83e-2)"	"unprognostic (8.80e-3)"	"unprognostic (3.19e-3)"	"unprognostic (6.04e-2)"	"unprognostic (5.69e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.17e-3)"	5.9	4.0	5.5	5.3	7.2	1.9	6.6	13.5	8.0	6.1	5.8	6.3	4.9	2.9	7.3	5.5	5.0	6.2	4.0	6.3	7.4	4.7	5.9	3.6	4.7	7.2	7.0	5.7	10.2	4.9	8.4	7.6	6.7	6.1	7.7	3.0	4.4	5.2	8.1	7.9	8.2	5.2	5.6	6.9	7.1	4.6	14.5	10.7	12.1	9.1	2.5	7.9	6.2	5.0	5.4	4.4	13.1	4.9	6.0	9.1	3.7	0.0	4.1	3.7	11.3	3.5	2.7	12.3	2.0	2.9	4.9	6.1	3.8	2.0	3.0	2.9	1.9	1.7	0.0	2.3	3.9	0.0	0.3	0.0	2.5	0.7	5.8	0.0	5.7	2.7	2.2	2.7	1.4	1.7	0.6	0.0	4.0	2.0	3.4	1.2	4.1	1.0	3.1	1.3	0.4	3.6	3.3	1.6	3.7	3.9	0.6	5.3	5.5	3.4	1.5	2.3	4.2	2.6	0.5	0.0	0.0	4.6	0.0	0.0	3.0	13.1	4.9	4.7	6.3	4.1	6.5	5.2	5.8	5.3	4.4	5.4	9.1	7.1	0.1	6.0	3.9	2.8	6.7	3.7	5.5	7.2	13.5	8.0	7.4	4.7	7.0	5.7	6.1	10.7
ZNF891		ENSG00000214029	"Zinc finger protein 891"	A8MT65	12	133106817-133130473	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA040301	Uncertain		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA040301: AB_10795380"	"unprognostic (3.05e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.72e-1)"	"unprognostic (7.51e-3)"	"unprognostic (5.98e-3)"	"unprognostic (1.94e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (2.07e-3)"	"unprognostic (6.68e-2)"	3.6	5.3	7.0	4.0	9.3	4.2	5.4	13.2	7.2	4.6	4.4	3.6	2.6	3.4	5.5	4.6	2.9	4.0	2.9	3.5	7.9	3.3	3.4	2.9	2.9	4.3	7.8	2.7	6.4	3.8	4.9	8.8	3.0	6.6	3.8	3.5	2.3	4.5	4.0	4.3	6.9	3.3	4.5	7.0	4.5	4.0	14.0	8.9	4.2	5.6	2.9	3.8	4.3	4.5	2.9	1.6	2.3	1.2	2.4	2.7	0.7	1.5	1.7	4.6	0.3	1.9	2.2	3.0	0.8	0.9	1.2	1.0	1.3	0.7	0.3	1.3	1.0	2.1	2.4	1.2	1.3	0.1	2.3	3.8	5.0	1.7	0.9	3.4	2.7	1.6	1.2	1.8	1.6	1.0	2.3	0.8	1.5	1.0	3.8	4.1	2.9	1.9	3.5	2.6	1.5	0.9	2.7	4.6	2.9	3.0	1.1	1.0	3.1	1.4	1.8	2.4	2.4	2.0	1.3	0.5	0.2	3.1	0.6	1.3	1.8	2.0	1.2	1.4	1.8	0.7	1.6	1.9	1.7	1.7	0.6	2.9	2.7	2.3	2.3	2.4	0.8	1.6	1.1	0.7	7.0	9.3	13.2	7.2	7.9	3.3	7.8	2.7	6.6	8.9
ZNF90	HTF9	ENSG00000213988	"Zinc finger protein 90"	Q03938	19	20077994-20127076	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 20.3;seminal vesicle: 36.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.7;HBF TERT88: 6.5;NTERA-2: 16.5;U-2197: 6.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"											HPA003227	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA003227: AB_1859471"	"unprognostic (4.52e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.93e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-2)"	"unprognostic (7.34e-3)"	"unprognostic (4.95e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.60e-2)"	1.5	1.0	1.1	3.6	2.5	1.6	1.8	6.9	1.1	3.0	1.7	1.2	20.3	0.5	3.3	2.7	2.1	2.8	1.0	1.4	0.8	0.6	1.7	0.7	2.4	3.0	2.1	0.3	4.7	3.4	12.7	1.4	3.8	1.7	4.1	2.1	3.2	1.2	36.4	1.2	2.8	2.3	3.3	1.6	2.3	2.7	1.6	2.2	4.1	10.3	0.7	2.9	4.9	2.9	0.5	0.4	1.8	0.2	0.3	0.9	0.2	0.0	0.0	3.9	9.7	0.0	0.0	0.0	1.0	0.4	3.8	4.5	3.3	2.3	1.4	1.8	0.7	1.0	0.0	0.6	6.5	0.0	0.9	0.0	0.0	0.6	0.3	0.0	0.0	0.3	0.0	3.6	0.0	0.0	0.3	0.0	0.0	0.1	2.0	5.5	16.5	0.0	0.0	3.5	0.2	2.0	3.4	0.0	3.5	0.0	1.2	0.2	1.9	0.0	0.0	1.0	0.0	6.9	3.8	0.0	1.5	0.0	0.0	0.0	1.5	0.8	0.2	0.3	0.1	0.0	0.9	0.2	0.2	0.4	0.4	0.5	0.3	0.1	1.8	0.3	0.0	0.2	0.7	0.2	1.1	2.5	6.9	1.1	0.8	0.6	2.1	0.3	1.7	2.2
ZNF92	"HPF12, TF12"	ENSG00000146757	"Zinc finger protein 92"	Q03936	7	65373799-65401135	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003173			Approved	Nucleoplasm				Nucleoplasm		"HPA003173: AB_1080744"	"unprognostic (1.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (6.56e-4)"	"unprognostic (5.48e-3)"	"unprognostic (1.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.50e-3)"	6.7	9.3	9.6	13.7	13.0	20.8	16.3	24.4	11.9	8.3	6.2	5.0	6.1	6.1	5.7	7.2	11.2	5.4	6.3	4.6	9.6	8.9	7.9	5.6	5.7	14.8	12.1	8.6	8.8	6.9	7.7	13.4	5.7	12.6	6.6	7.0	2.5	6.9	6.6	4.7	4.9	10.1	3.9	18.5	14.8	7.6	7.6	15.7	26.0	9.4	5.1	14.0	8.3	5.7	10.7	2.3	5.6	2.7	9.4	6.0	2.2	4.4	3.0	13.5	13.4	3.5	4.2	6.4	3.7	2.8	4.1	6.0	5.6	6.7	17.5	7.3	2.1	4.5	10.5	2.5	6.8	6.5	7.0	7.8	1.6	5.5	1.2	9.4	7.5	3.5	2.2	3.8	2.9	5.1	10.1	7.2	5.9	1.3	13.8	10.7	18.2	4.2	12.6	7.9	5.9	4.5	9.1	11.5	8.8	5.7	9.0	4.2	6.4	12.9	3.7	4.8	4.4	2.9	5.3	4.6	4.0	25.4	3.2	7.6	4.3	5.6	1.6	4.0	2.7	2.1	5.7	10.7	4.2	4.1	2.3	9.2	5.1	5.2	1.3	9.4	2.7	2.2	6.0	2.2	9.6	13.0	24.4	11.9	9.6	8.9	12.1	8.6	12.6	15.7
ZNFX1	"FLJ11277, KIAA1404"	ENSG00000124201	"Zinc finger NFX1-type containing 1"	Q9P2E3	20	49237946-49278426	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046629	Approved		Approved	Mitochondria				Mitochondria		"HPA046629: AB_2616451"	"unprognostic (1.03e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.71e-3)"	"unprognostic (7.40e-2)"	"unprognostic (7.86e-2)"	27.2	14.9	13.2	21.5	15.1	32.8	19.3	14.4	19.7	16.6	16.0	20.1	12.1	14.5	21.3	17.4	13.1	17.2	19.2	16.5	12.3	12.0	16.5	13.4	28.2	20.5	13.4	13.8	18.3	12.2	23.8	14.6	17.4	17.1	15.5	14.4	21.1	14.4	13.7	23.0	17.6	20.6	18.3	14.4	25.9	16.2	23.9	14.6	18.6	21.4	14.4	22.7	16.8	15.0	5.7	5.1	30.0	14.0	5.6	8.3	5.4	5.7	9.0	2.1	3.0	11.9	9.4	3.7	7.9	18.6	49.5	20.7	10.2	4.8	4.8	10.2	15.6	11.2	4.0	10.7	17.2	4.5	1.3	5.7	6.5	4.5	10.3	4.6	7.0	9.9	10.0	11.0	8.2	7.4	4.3	6.0	12.3	2.4	4.9	3.1	2.0	7.5	3.1	7.3	1.3	8.1	8.0	2.2	1.6	11.6	22.7	8.1	5.8	3.9	18.5	24.3	6.9	8.8	7.6	4.0	1.4	2.6	9.8	3.1	5.3	8.8	6.7	10.8	8.3	8.8	7.3	5.7	8.3	7.8	5.1	4.6	8.0	6.1	30.0	5.6	14.0	3.0	6.0	5.4	13.2	15.1	14.4	19.7	12.3	12.0	13.4	13.8	17.1	14.6
ZNRD1	"HTEX-6, hZR14, RPA12, tctex-6"	ENSG00000066379	"Zinc ribbon domain containing 1"	Q9P1U0	6	30058899-30064909	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA055074, HPA077979"	Supported		Supported	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA055074: , HPA077979: "	"unprognostic (4.94e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.88e-2)"	"unprognostic (8.55e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.96e-1)"	"unprognostic (9.52e-3)"	"unprognostic (5.18e-1)"	"unprognostic (3.28e-1)"	"prognostic unfavourable (2.17e-7)"	"unprognostic (2.57e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.97e-2)"	"prognostic favourable (2.75e-5)"	11.7	13.5	6.7	14.1	7.2	8.7	17.1	7.4	8.9	12.3	15.3	6.8	9.1	13.2	12.5	10.2	15.4	13.0	10.4	11.0	6.4	6.3	13.4	12.2	14.8	18.8	8.3	6.1	13.6	22.0	10.2	9.4	11.4	6.2	12.5	14.5	9.7	14.7	10.2	13.5	11.2	14.2	9.1	6.3	17.5	12.7	22.9	6.8	37.0	15.0	15.3	18.9	12.2	15.0	8.2	8.4	6.4	5.9	8.1	13.0	7.9	4.2	0.9	4.7	6.7	2.3	2.8	1.8	1.6	2.5	3.0	2.7	4.7	3.0	3.4	1.4	2.7	3.6	7.8	6.4	3.2	2.4	7.9	8.0	2.1	7.0	9.5	8.4	3.7	5.5	3.7	4.7	16.1	8.1	13.4	2.1	2.0	5.7	7.2	18.3	0.0	5.6	8.9	4.4	6.6	2.6	7.0	1.7	3.2	2.9	4.5	2.7	3.4	7.0	1.7	3.5	3.0	0.0	5.2	5.3	10.0	10.9	1.3	13.7	4.6	6.2	5.9	5.7	12.5	5.6	13.0	7.3	10.8	11.5	5.6	8.2	9.8	10.2	6.4	8.1	5.2	8.4	10.9	7.9	6.7	7.2	7.4	8.9	6.4	6.3	8.3	6.1	6.2	6.8
ZPBP	"SP38, ZPBP1"	ENSG00000042813	"Zona pellucida binding protein"	Q9BS86	7	49850421-50121329	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	95	"testis: 90.4"	"Cell line enhanced"	"Detected in some"		"K-562: 1.4;NTERA-2: 1.2;SCLC-21H: 1.6;U-698: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058673	Enhanced				"Secreted in male reproductive system"					"HPA058673: "	"unprognostic (1.16e-1)"							"unprognostic (6.46e-2)"		"unprognostic (7.80e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.15e-7)"		"unprognostic (9.49e-2)"	"unprognostic (2.34e-4)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.4	0.1	0.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0
ZPBP2	"MGC41930, ZPBPL"	ENSG00000186075	"Zona pellucida binding protein 2"	Q6X784	17	39868164-39877896	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"testis: 85.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.8;U-698: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.6"	"Group enriched"	"Detected in many"	8	"B-cells: 2.6;T-cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA027997, HPA053070"	Enhanced				"Secreted in male reproductive system"					"HPA027997: AB_1859488, HPA053070: AB_2682033"		"unprognostic (2.14e-2)"						"unprognostic (3.38e-1)"				"unprognostic (1.62e-1)"		"unprognostic (2.87e-1)"	"unprognostic (5.39e-1)"		"unprognostic (2.54e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	85.7	0.0	0.0	0.1	0.0	0.3	0.0	0.0	2.6	0.1	0.1	0.2	0.0	1.0	0.2	0.1	0.1	1.0	0.4	0.3	0.5	0.1	0.3	0.2	0.2	0.5	0.4	0.1	2.8	0.2	0.4	0.1	0.5	0.2	0.5	0.6	1.3	0.4	0.4	0.0	0.3	0.4	0.2	0.2	0.7	0.1	0.2	0.3	0.3	0.8	0.0	0.1	0.1	0.6	0.9	0.7	0.4	0.9	2.1	0.3	0.3	1.0	0.3	0.1	0.6	0.3	0.2	0.0	0.4	0.3	0.3	0.6	0.1	1.0	0.2	10.2	0.3	0.4	0.5	0.0	0.0	0.1	0.4	0.0	0.1	0.8	0.4	1.0	0.0	2.6	1.0	0.5	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
ZPLD1		ENSG00000170044	"Zona pellucida like domain containing 1"	Q8TCW7	3	102099244-102479841	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.0;gallbladder: 6.7;kidney: 2.6"	"Cell line enriched"	"Detected in some"	8	"RPTEC TERT1: 12.2"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	8	"non-classical monocyte: 3.0"	"Lineage enriched"	"Detected in single"	11	"monocytes: 3.0"	"Region enriched"	"Detected in single"	7	"olfactory region: 3.4"	"Low region specificity"	"Detected in all"			HPA077519			Approved	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA077519: "	"unprognostic (2.49e-1)"	"unprognostic (2.83e-3)"		"unprognostic (6.38e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.63e-1)"	"unprognostic (2.89e-4)"	"unprognostic (4.59e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5			2.5	1.0	0.0	0.0	0.2	6.7	0.3	0.0	0.6	2.6	0.3	0.0	0.0	0.3		0.7	0.2	0.0	0.0	0.0		0.0	0.0		0.3	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.1	1.9			0.0		0.0	0.0	0.0	0.2	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	12.2	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0										
ZSCAN18	"FLJ12895, ZNF447"	ENSG00000121413	"Zinc finger and SCAN domain containing 18"	Q8TBC5	19	58083838-58118427	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 48.6;SCLC-21H: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA024318	Supported		Approved	Nucleoplasm				Nucleoplasm		"HPA024318: AB_1859494"	"unprognostic (1.85e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.07e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.59e-1)"	"prognostic favourable (3.95e-7)"	"unprognostic (3.68e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.70e-1)"	"unprognostic (9.04e-2)"	18.1	18.1	26.7	10.4	34.3	5.3	11.8	27.9	47.7	20.5	17.1	20.8	16.0	8.7	26.2	20.3	13.4	33.9	18.6	28.9	27.0	33.7	19.3	7.3	15.0	12.2	23.7	31.1	31.8	16.8	23.7	28.0	15.1	21.1	21.1	6.0	17.7	18.2	27.5	15.9	9.9	10.0	29.0	20.7	17.0	12.9	20.0	18.3	7.4	28.9	8.7	6.1	15.9	14.6	4.6	2.3	3.9	0.8	2.2	2.4	0.7	0.0	0.4	5.1	13.1	0.6	0.8	12.6	3.3	0.1	4.2	0.7	0.0	3.1	1.2	7.5	4.5	0.0	0.4	2.5	4.5	0.0	48.6	0.0	0.0	0.0	9.0	0.0	9.8	7.8	0.1	3.2	0.0	0.2	0.0	0.6	6.4	0.0	6.7	2.5	8.3	0.0	8.0	0.0	0.6	4.1	10.0	23.3	5.6	0.0	0.2	0.0	15.2	0.0	0.0	0.2	6.0	5.7	0.0	5.8	16.7	0.0	0.0	0.0	3.9	2.0	0.5	3.5	0.4	0.3	2.1	1.7	1.7	1.8	0.9	4.6	2.4	2.2	3.9	2.2	0.8	2.3	0.1	0.7	26.7	34.3	27.9	31.4	27.0	33.7	23.7	31.1	21.1	18.3
ZSCAN2	"FLJ20595, ZFP29, ZNF854"	ENSG00000176371	"Zinc finger and SCAN domain containing 2"	Q7Z7L9	15	84600986-84627796	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 36.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007296, HPA024331"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA007296: , HPA024331: AB_1859497"	"unprognostic (4.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.49e-2)"	"unprognostic (6.76e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.95e-1)"	"prognostic favourable (3.52e-4)"	"unprognostic (4.24e-1)"	"prognostic favourable (7.46e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.98e-1)"	"prognostic favourable (4.16e-5)"	9.8	7.6	5.2	7.2	7.4	9.7	15.0	5.9	6.3	7.3	6.2	5.8	9.0	4.1	9.5	8.4	3.4	5.3	8.2	8.2	4.8	4.7	9.1	10.1	4.5	8.0	6.2	5.0	10.2	36.9	6.9	6.3	2.8	5.1	7.1	4.3	6.7	12.4	5.1	9.5	3.4	5.5	9.0	5.1	8.1	8.5	12.0	6.0	24.4	6.3	3.9	6.9	6.5	9.7	7.1	10.5	10.0	12.2	9.0	12.1	6.4	1.7	9.8	7.7	12.7	4.5	3.0	6.7	1.9	5.3	4.1	5.5	7.5	4.0	3.6	5.4	3.0	4.3	6.5	3.7	3.6	7.4	10.0	4.6	5.7	15.8	3.9	2.9	3.7	4.5	4.5	5.2	5.0	12.1	6.1	2.9	4.9	4.8	13.4	6.8	14.1	5.8	14.0	4.4	6.8	4.3	12.5	10.8	19.1	5.9	3.3	9.1	6.8	8.2	7.9	5.0	9.6	2.4	2.4	5.0	6.6	12.1	3.3	6.8	3.1	10.0	9.6	8.3	10.9	10.5	5.4	7.1	9.2	8.2	10.5	7.1	7.6	8.2	5.4	9.0	12.2	10.2	12.1	6.4	5.2	7.4	5.9	6.3	4.8	4.7	6.2	5.0	5.1	6.0
ZSWIM1	"C20orf162, dJ337O18.5"	ENSG00000168612	"Zinc finger SWIM-type containing 1"	Q9BR11	20	45881227-45885266	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041147, HPA046751"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041147: , HPA046751: "	"unprognostic (6.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (5.47e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.02e-1)"	"prognostic favourable (1.77e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.64e-1)"	"unprognostic (4.29e-2)"	11.3	13.8	7.3	7.6	11.4	10.2	7.8	17.2	15.7	7.3	8.5	10.4	5.6	8.8	10.1	7.8	9.3	9.3	10.1	9.8	7.5	7.7	12.8	11.3	6.9	9.5	6.9	8.5	12.6	14.1	10.0	11.4	12.2	6.3	10.3	7.7	14.1	10.4	8.1	27.3	12.3	10.6	9.1	8.1	12.2	8.7	9.0	9.5	16.1	11.5	9.8	13.3	9.6	7.0	5.4	4.4	6.9	3.7	1.2	5.3	1.4	6.3	8.0	6.0	7.2	10.9	6.4	6.1	4.3	5.7	10.0	9.2	18.2	7.5	7.6	13.2	6.3	15.3	9.7	12.3	7.5	2.9	5.7	9.9	10.0	12.4	6.7	8.0	10.2	9.1	10.4	8.3	8.0	7.7	8.7	6.1	5.7	19.2	9.0	6.6	3.3	9.0	6.9	8.7	5.3	6.4	9.4	8.0	5.1	15.1	22.3	5.1	13.2	6.0	6.3	10.9	6.8	5.8	6.3	6.1	4.3	7.7	8.6	6.3	5.5	3.8	2.9	6.9	1.0	3.7	0.7	5.4	3.7	1.6	1.6	5.1	5.3	4.7	3.1	1.2	3.5	4.4	3.0	1.4	7.3	11.4	17.2	15.7	7.5	7.7	6.9	8.5	6.3	9.5
ZSWIM3	"C20orf164, dJ337O18.7, PPP1R174"	ENSG00000132801	"Zinc finger SWIM-type containing 3"	Q96MP5	20	45857617-45879122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055692, HPA060508"	Uncertain		Approved	"Nucleoli fibrillar center,Vesicles,Cytosol"				Vesicles	"Nucleoli fibrillar center, Cytosol"	"HPA055692: , HPA060508: "	"prognostic unfavourable (9.32e-5)"	"unprognostic (8.53e-2)"	"unprognostic (3.55e-1)"	"prognostic unfavourable (4.21e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.77e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.72e-3)"	"unprognostic (9.28e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.13e-2)"	5.1	9.6	8.3	5.6	8.2	2.2	5.7	15.2	9.6	6.1	6.7	6.3	5.2	7.4	6.7	8.9	5.9	6.8	5.4	6.0	7.3	7.2	5.6	7.0	5.9	9.3	6.2	7.4	9.0	5.0	6.9	9.5	5.3	6.7	6.1	7.3	9.4	5.4	5.4	3.9	6.7	7.4	5.5	6.0	10.5	5.8	9.5	6.3	13.7	5.9	2.9	11.2	6.1	4.7	4.3	3.8	3.2	8.5	3.3	6.3	2.1	2.1	1.7	5.3	3.0	6.5	4.6	3.1	3.3	4.0	6.1	6.1	7.3	3.3	6.6	11.5	2.8	3.5	7.6	3.5	4.6	4.0	3.2	6.4	3.3	4.7	7.9	3.6	8.7	4.2	4.0	4.6	2.9	5.2	5.8	3.2	4.6	10.5	4.9	7.1	2.0	7.2	4.9	4.9	4.8	1.7	1.3	7.0	3.5	5.3	6.2	4.2	3.0	9.4	5.1	6.2	2.0	2.3	2.0	6.9	3.6	4.2	5.2	4.3	2.0	2.1	2.3	3.2	3.0	3.2	6.3	4.3	3.3	4.2	3.8	3.6	3.2	4.3	1.7	3.3	8.5	2.3	4.9	2.1	8.3	8.2	15.2	9.6	7.3	7.2	6.2	7.4	6.7	6.3
ZSWIM4	FLJ12221	ENSG00000132003	"Zinc finger SWIM-type containing 4"	Q9H7M6	19	13795460-13832230	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042084	Uncertain									"HPA042084: AB_10795392"	"unprognostic (3.29e-2)"	"unprognostic (4.07e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.25e-3)"	"unprognostic (6.14e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.15e-2)"	"prognostic unfavourable (7.85e-5)"	"unprognostic (3.47e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.63e-2)"	6.2	7.5	4.7	9.4	5.0	4.6	6.3	4.1	8.9	6.2	3.5	4.8	6.7	5.2	7.6	3.5	19.7	4.0	7.1	5.3	5.2	4.0	6.7	3.1	8.2	5.4	6.1	2.5	5.0	9.3	4.1	8.6	9.3	6.5	6.5	1.9	9.2	18.5	7.7	3.8	9.9	3.8	4.5	5.7	6.2	7.3	2.3	4.9	11.3	7.6	4.9	14.2	5.7	8.8	1.2	0.5	2.8	0.4	0.8	1.5	0.2	7.2	4.2	8.4	4.2	1.1	0.9	8.0	3.1	6.8	2.8	3.0	1.5	4.0	2.6	5.0	2.7	3.1	1.4	2.8	2.0	9.2	2.6	0.4	4.7	0.9	6.9	0.7	2.1	4.5	0.8	3.2	1.2	6.8	2.3	5.7	0.8	4.0	4.1	5.7	9.7	4.3	9.0	7.9	4.2	3.9	3.4	2.4	16.1	5.4	13.4	5.6	2.0	4.9	7.8	8.5	3.1	2.4	10.7	7.0	4.2	1.7	5.4	3.0	5.9	0.0	0.3	0.3	0.4	0.4	1.5	0.3	0.4	0.4	0.4	1.2	0.5	0.2	2.8	0.8	0.1	0.5	0.0	0.2	4.7	5.0	4.1	8.9	5.2	4.0	6.1	2.5	6.5	4.9
ZSWIM5	KIAA1511	ENSG00000162415	"Zinc finger SWIM-type containing 5"	Q9P217	1	45016399-45306209	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 7.0;Hep G2: 7.8;SCLC-21H: 9.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 2.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018211	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA018211: AB_1859502"	"unprognostic (1.86e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.12e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.16e-1)"	1.8	18.5	5.9	4.4	6.5	0.7	3.2	17.3	6.6	3.8	7.2	6.6	3.8	7.5	5.2	4.5	2.2	4.5	5.4	2.5	6.4	4.6	5.2	1.3	3.8	2.0	4.9	4.0	14.0	5.4	16.9	16.0	1.8	6.1	5.6	8.5	6.2	6.3	4.4	2.0	2.7	11.7	5.4	3.2	2.9	3.2	6.6	7.1	0.0	7.1	1.3	1.9	4.4	3.7	0.1	0.5	0.0	0.0	0.7	2.4	0.3	0.5	1.8	4.1	7.0	0.6	0.2	1.0	0.2	5.6	1.0	0.9	0.5	0.7	0.4	0.1	0.1	0.2	2.9	0.1	1.3	2.9	5.2	0.3	5.7	7.8	0.0	0.8	0.9	0.1	0.2	0.3	0.0	1.2	0.3	0.3	0.1	2.3	0.5	0.3	3.8	2.0	1.8	0.1	0.2	0.1	1.3	9.7	5.0	2.7	1.0	0.5	2.0	0.2	0.3	1.0	0.5	0.3	1.1	1.9	0.3	0.1	3.9	0.2	0.8	0.0	0.0	0.0	0.9	0.0	0.5	0.1	0.5	0.8	0.0	0.0	2.4	0.3	0.0	0.7	0.0	0.5	0.9	0.3	5.9	6.5	17.3	6.6	6.4	4.6	4.9	4.0	6.1	7.1
ZXDB	ZNF905	ENSG00000198455	"Zinc finger, X-linked, duplicated B"	P98169	X	57591652-57597545	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 24.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA043789	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA043789: "	"unprognostic (1.87e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.61e-3)"	"unprognostic (4.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.36e-1)"	"unprognostic (9.04e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.87e-3)"	2.6	2.1	2.4	1.9	3.0	5.1	3.4	6.3	3.4	3.5	2.5			1.6	4.0	2.0	2.1	4.1	2.8	2.3	2.4	3.2	2.4	11.2	2.3	2.9	2.3		4.5	4.3	5.3	1.9	1.4		3.6	2.5		2.8	3.1	3.6	3.9	2.9	4.2	2.4	2.9	3.2	0.5			3.8		2.9	4.1	2.3	1.3	1.3	0.0	0.6	0.5	2.4	0.3	3.6	4.4	2.8	3.8	4.9	4.8	3.9	2.6	3.3	2.1	2.3	1.8	2.7	3.2	3.9	4.7	4.2	8.1	13.9	4.2	7.8	4.4	1.7	5.7	4.9	6.3	2.9	2.0	4.2	24.2	5.5	15.0	6.5	1.9	3.4	5.8	2.6	2.6	2.4	11.4	5.5	3.3	10.4	1.8	2.9	5.8	2.4	4.5	5.3	3.9	4.0	4.0	3.3	5.6	4.7	9.3	4.0	2.6	0.0	1.4	4.4	3.3	2.6	2.1	0.0	0.3	0.0	1.5	0.5	1.3	1.3	1.1	2.4	0.4	1.2	2.1	1.1	0.0	0.5	0.6	1.3	0.9	0.3										
ZYG11A	ZYG11	ENSG00000203995	"Zyg-11 family member A, cell cycle regulator"	Q6WRX3	1	52842511-52894998	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 21.2;thyroid gland: 8.1"	"Cell line enhanced"	"Detected in many"		"HeLa: 10.5;hTEC/SVTERT24-B: 10.1;K-562: 9.7;SiHa: 10.2"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 11.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 2.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA030378, HPA030379"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA030378: AB_10604159, HPA030379: "	"unprognostic (7.94e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.06e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.00e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	0.3	0.1	0.2	3.0	0.2	0.4	1.4	0.7	0.1	0.6	0.2	0.1	0.8	0.4	0.1	3.0	1.7	0.1	0.4	0.9	0.1	0.3	6.4	3.1	0.1	1.0	0.1	0.0	0.6	0.3	0.6	0.5	1.0	2.2	1.7	0.2	1.0	0.5	0.0	0.3	0.6	0.3	0.5	1.3	0.3	0.1	21.2	0.0	0.9	8.1	1.3	5.6	0.5	1.1	1.0	0.8	3.1	0.6	0.9	0.7	0.2	0.0	1.9	0.3	0.0	0.0	0.0	4.4	1.2	1.3	5.6	4.6	0.1	0.1	0.0	2.9	1.7	0.1	3.8	0.1	6.7	0.3	7.2	0.0	10.5	0.0	2.7	0.0	0.8	0.0	0.3	10.1	0.1	1.3	9.7	5.4	0.2	5.2	0.0	5.2	1.4	0.9	0.0	1.2	4.6	3.5	0.2	1.4	2.2	10.2	0.5	0.0	5.7	2.9	0.1	0.0	0.1	0.0	0.0	2.7	4.5	0.1	0.0	0.1	0.8	1.8	0.6	0.8	0.5	0.3	0.3	0.7	0.5	0.5	0.1	1.0	0.6	0.7	3.1	0.9	0.3	0.8	0.4	0.2	0.2	0.2	0.7	0.1	0.1	0.3	0.1	0.0	2.2	0.0